query accession pident length evalue bitscore title id Reviewed protein_name organism go_ids go_bp go_cc go_mf g3452.t1 Q9Y6A2 36.842 380 6.41e-73 238.0 sp|Q9Y6A2|CP46A_HUMAN Cholesterol 24-hydroxylase OS=Homo sapiens OX=9606 GN=CYP46A1 PE=1 SV=1 g3453.t1 Q9Y6A2 39.574 470 2.83e-111 342.0 sp|Q9Y6A2|CP46A_HUMAN Cholesterol 24-hydroxylase OS=Homo sapiens OX=9606 GN=CYP46A1 PE=1 SV=1 g3454.t1 Q9H4F8 41.026 156 3.35e-31 129.0 sp|Q9H4F8|SMOC1_HUMAN SPARC-related modular calcium-binding protein 1 OS=Homo sapiens OX=9606 GN=SMOC1 PE=1 SV=1 SMOC1_HUMAN reviewed SPARC-related modular calcium-binding protein 1 (Secreted modular calcium-binding protein 1) (SMOC-1) Homo sapiens (Human) GO:0001654; GO:0005509; GO:0005604; GO:0005615; GO:0008201; GO:0030154; GO:0030198; GO:0045667; GO:0050840; GO:0060173 cell differentiation [GO:0030154]; extracellular matrix organization [GO:0030198]; eye development [GO:0001654]; limb development [GO:0060173]; regulation of osteoblast differentiation [GO:0045667] basement membrane [GO:0005604]; extracellular space [GO:0005615] calcium ion binding [GO:0005509]; extracellular matrix binding [GO:0050840]; heparin binding [GO:0008201] g3454.t1 Q9H4F8 36.715 207 8.16e-28 119.0 sp|Q9H4F8|SMOC1_HUMAN SPARC-related modular calcium-binding protein 1 OS=Homo sapiens OX=9606 GN=SMOC1 PE=1 SV=1 SMOC1_HUMAN reviewed SPARC-related modular calcium-binding protein 1 (Secreted modular calcium-binding protein 1) (SMOC-1) Homo sapiens (Human) GO:0001654; GO:0005509; GO:0005604; GO:0005615; GO:0008201; GO:0030154; GO:0030198; GO:0045667; GO:0050840; GO:0060173 cell differentiation [GO:0030154]; extracellular matrix organization [GO:0030198]; eye development [GO:0001654]; limb development [GO:0060173]; regulation of osteoblast differentiation [GO:0045667] basement membrane [GO:0005604]; extracellular space [GO:0005615] calcium ion binding [GO:0005509]; extracellular matrix binding [GO:0050840]; heparin binding [GO:0008201] g3454.t1 Q9H4F8 33.019 212 7e-24 107.0 sp|Q9H4F8|SMOC1_HUMAN SPARC-related modular calcium-binding protein 1 OS=Homo sapiens OX=9606 GN=SMOC1 PE=1 SV=1 SMOC1_HUMAN reviewed SPARC-related modular calcium-binding protein 1 (Secreted modular calcium-binding protein 1) (SMOC-1) Homo sapiens (Human) GO:0001654; GO:0005509; GO:0005604; GO:0005615; GO:0008201; GO:0030154; GO:0030198; GO:0045667; GO:0050840; GO:0060173 cell differentiation [GO:0030154]; extracellular matrix organization [GO:0030198]; eye development [GO:0001654]; limb development [GO:0060173]; regulation of osteoblast differentiation [GO:0045667] basement membrane [GO:0005604]; extracellular space [GO:0005615] calcium ion binding [GO:0005509]; extracellular matrix binding [GO:0050840]; heparin binding [GO:0008201] g3455.t1 Q9D844 35.028 177 1.3800000000000001e-22 95.9 sp|Q9D844|DNJC4_MOUSE DnaJ homolog subfamily C member 4 OS=Mus musculus OX=10090 GN=Dnajc4 PE=2 SV=2 g3457.t1 Q9NRC6 31.11 1649 0.0 758.0 sp|Q9NRC6|SPTN5_HUMAN Spectrin beta chain, non-erythrocytic 5 OS=Homo sapiens OX=9606 GN=SPTBN5 PE=1 SV=2 g3457.t1 Q9NRC6 23.574 1701 2.33e-99 363.0 sp|Q9NRC6|SPTN5_HUMAN Spectrin beta chain, non-erythrocytic 5 OS=Homo sapiens OX=9606 GN=SPTBN5 PE=1 SV=2 g3457.t1 Q9NRC6 20.766 1618 2.66e-36 156.0 sp|Q9NRC6|SPTN5_HUMAN Spectrin beta chain, non-erythrocytic 5 OS=Homo sapiens OX=9606 GN=SPTBN5 PE=1 SV=2 g3457.t1 Q9NRC6 19.298 1311 2.5199999999999997e-30 136.0 sp|Q9NRC6|SPTN5_HUMAN Spectrin beta chain, non-erythrocytic 5 OS=Homo sapiens OX=9606 GN=SPTBN5 PE=1 SV=2 g3457.t1 Q9NRC6 20.599 835 1.3300000000000001e-27 127.0 sp|Q9NRC6|SPTN5_HUMAN Spectrin beta chain, non-erythrocytic 5 OS=Homo sapiens OX=9606 GN=SPTBN5 PE=1 SV=2 g3458.t1 P16546 36.947 655 1.11e-123 414.0 sp|P16546|SPTN1_MOUSE Spectrin alpha chain, non-erythrocytic 1 OS=Mus musculus OX=10090 GN=Sptan1 PE=1 SV=4 g3458.t1 P16546 32.938 759 6.15e-120 404.0 sp|P16546|SPTN1_MOUSE Spectrin alpha chain, non-erythrocytic 1 OS=Mus musculus OX=10090 GN=Sptan1 PE=1 SV=4 g3458.t1 P16546 27.138 538 4.0100000000000002e-56 214.0 sp|P16546|SPTN1_MOUSE Spectrin alpha chain, non-erythrocytic 1 OS=Mus musculus OX=10090 GN=Sptan1 PE=1 SV=4 g3458.t1 P16546 24.342 760 1.16e-49 194.0 sp|P16546|SPTN1_MOUSE Spectrin alpha chain, non-erythrocytic 1 OS=Mus musculus OX=10090 GN=Sptan1 PE=1 SV=4 g3458.t1 P16546 23.219 758 1.3e-44 178.0 sp|P16546|SPTN1_MOUSE Spectrin alpha chain, non-erythrocytic 1 OS=Mus musculus OX=10090 GN=Sptan1 PE=1 SV=4 g3458.t1 P16546 21.169 770 7.44e-41 167.0 sp|P16546|SPTN1_MOUSE Spectrin alpha chain, non-erythrocytic 1 OS=Mus musculus OX=10090 GN=Sptan1 PE=1 SV=4 g3458.t1 P16546 23.758 745 6.22e-38 157.0 sp|P16546|SPTN1_MOUSE Spectrin alpha chain, non-erythrocytic 1 OS=Mus musculus OX=10090 GN=Sptan1 PE=1 SV=4 g3458.t1 P16546 25.116 860 9.09e-37 154.0 sp|P16546|SPTN1_MOUSE Spectrin alpha chain, non-erythrocytic 1 OS=Mus musculus OX=10090 GN=Sptan1 PE=1 SV=4 g3458.t1 P16546 21.594 778 2.9e-36 152.0 sp|P16546|SPTN1_MOUSE Spectrin alpha chain, non-erythrocytic 1 OS=Mus musculus OX=10090 GN=Sptan1 PE=1 SV=4 g3458.t1 P16546 20.464 733 3.26e-35 149.0 sp|P16546|SPTN1_MOUSE Spectrin alpha chain, non-erythrocytic 1 OS=Mus musculus OX=10090 GN=Sptan1 PE=1 SV=4 g3458.t1 P16546 21.689 687 8.589999999999999e-30 131.0 sp|P16546|SPTN1_MOUSE Spectrin alpha chain, non-erythrocytic 1 OS=Mus musculus OX=10090 GN=Sptan1 PE=1 SV=4 g3458.t1 P16546 23.117 385 3.8100000000000004e-21 103.0 sp|P16546|SPTN1_MOUSE Spectrin alpha chain, non-erythrocytic 1 OS=Mus musculus OX=10090 GN=Sptan1 PE=1 SV=4 g3459.t1 Q00963 45.908 782 0.0 691.0 sp|Q00963|SPTCB_DROME Spectrin beta chain OS=Drosophila melanogaster OX=7227 GN=beta-Spec PE=1 SV=2 SPTCB_DROME reviewed Spectrin beta chain Drosophila melanogaster (Fruit fly) GO:0005200; GO:0005516; GO:0005546; GO:0005886; GO:0007026; GO:0007274; GO:0007399; GO:0007409; GO:0007411; GO:0008017; GO:0008091; GO:0016199; GO:0016328; GO:0030036; GO:0030054; GO:0030424; GO:0030506; GO:0030864; GO:0031594; GO:0042062; GO:0042995; GO:0045169; GO:0045170; GO:0048666; GO:0048790; GO:0050807; GO:0051015; GO:0051693; GO:0072499; GO:1903729 actin cytoskeleton organization [GO:0030036]; actin filament capping [GO:0051693]; axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; axonogenesis [GO:0007409]; long-term strengthening of neuromuscular junction [GO:0042062]; maintenance of presynaptic active zone structure [GO:0048790]; negative regulation of microtubule depolymerization [GO:0007026]; nervous system development [GO:0007399]; neuromuscular synaptic transmission [GO:0007274]; neuron development [GO:0048666]; photoreceptor cell axon guidance [GO:0072499]; regulation of plasma membrane organization [GO:1903729]; regulation of synapse organization [GO:0050807] axon [GO:0030424]; cell junction [GO:0030054]; cell projection [GO:0042995]; cortical actin cytoskeleton [GO:0030864]; fusome [GO:0045169]; lateral plasma membrane [GO:0016328]; neuromuscular junction [GO:0031594]; plasma membrane [GO:0005886]; spectrin [GO:0008091]; spectrosome [GO:0045170] actin filament binding [GO:0051015]; ankyrin binding [GO:0030506]; calmodulin binding [GO:0005516]; microtubule binding [GO:0008017]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; structural constituent of cytoskeleton [GO:0005200] g3459.t1 Q00963 22.11 493 9.8e-28 125.0 sp|Q00963|SPTCB_DROME Spectrin beta chain OS=Drosophila melanogaster OX=7227 GN=beta-Spec PE=1 SV=2 SPTCB_DROME reviewed Spectrin beta chain Drosophila melanogaster (Fruit fly) GO:0005200; GO:0005516; GO:0005546; GO:0005886; GO:0007026; GO:0007274; GO:0007399; GO:0007409; GO:0007411; GO:0008017; GO:0008091; GO:0016199; GO:0016328; GO:0030036; GO:0030054; GO:0030424; GO:0030506; GO:0030864; GO:0031594; GO:0042062; GO:0042995; GO:0045169; GO:0045170; GO:0048666; GO:0048790; GO:0050807; GO:0051015; GO:0051693; GO:0072499; GO:1903729 actin cytoskeleton organization [GO:0030036]; actin filament capping [GO:0051693]; axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; axonogenesis [GO:0007409]; long-term strengthening of neuromuscular junction [GO:0042062]; maintenance of presynaptic active zone structure [GO:0048790]; negative regulation of microtubule depolymerization [GO:0007026]; nervous system development [GO:0007399]; neuromuscular synaptic transmission [GO:0007274]; neuron development [GO:0048666]; photoreceptor cell axon guidance [GO:0072499]; regulation of plasma membrane organization [GO:1903729]; regulation of synapse organization [GO:0050807] axon [GO:0030424]; cell junction [GO:0030054]; cell projection [GO:0042995]; cortical actin cytoskeleton [GO:0030864]; fusome [GO:0045169]; lateral plasma membrane [GO:0016328]; neuromuscular junction [GO:0031594]; plasma membrane [GO:0005886]; spectrin [GO:0008091]; spectrosome [GO:0045170] actin filament binding [GO:0051015]; ankyrin binding [GO:0030506]; calmodulin binding [GO:0005516]; microtubule binding [GO:0008017]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; structural constituent of cytoskeleton [GO:0005200] g3459.t1 Q00963 26.225 347 1.54e-25 119.0 sp|Q00963|SPTCB_DROME Spectrin beta chain OS=Drosophila melanogaster OX=7227 GN=beta-Spec PE=1 SV=2 SPTCB_DROME reviewed Spectrin beta chain Drosophila melanogaster (Fruit fly) GO:0005200; GO:0005516; GO:0005546; GO:0005886; GO:0007026; GO:0007274; GO:0007399; GO:0007409; GO:0007411; GO:0008017; GO:0008091; GO:0016199; GO:0016328; GO:0030036; GO:0030054; GO:0030424; GO:0030506; GO:0030864; GO:0031594; GO:0042062; GO:0042995; GO:0045169; GO:0045170; GO:0048666; GO:0048790; GO:0050807; GO:0051015; GO:0051693; GO:0072499; GO:1903729 actin cytoskeleton organization [GO:0030036]; actin filament capping [GO:0051693]; axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; axonogenesis [GO:0007409]; long-term strengthening of neuromuscular junction [GO:0042062]; maintenance of presynaptic active zone structure [GO:0048790]; negative regulation of microtubule depolymerization [GO:0007026]; nervous system development [GO:0007399]; neuromuscular synaptic transmission [GO:0007274]; neuron development [GO:0048666]; photoreceptor cell axon guidance [GO:0072499]; regulation of plasma membrane organization [GO:1903729]; regulation of synapse organization [GO:0050807] axon [GO:0030424]; cell junction [GO:0030054]; cell projection [GO:0042995]; cortical actin cytoskeleton [GO:0030864]; fusome [GO:0045169]; lateral plasma membrane [GO:0016328]; neuromuscular junction [GO:0031594]; plasma membrane [GO:0005886]; spectrin [GO:0008091]; spectrosome [GO:0045170] actin filament binding [GO:0051015]; ankyrin binding [GO:0030506]; calmodulin binding [GO:0005516]; microtubule binding [GO:0008017]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; structural constituent of cytoskeleton [GO:0005200] g3460.t1 Q9WVK8 38.248 468 2.1699999999999998e-106 329.0 sp|Q9WVK8|CP46A_MOUSE Cholesterol 24-hydroxylase OS=Mus musculus OX=10090 GN=Cyp46a1 PE=1 SV=1 CP46A_MOUSE reviewed Cholesterol 24-hydroxylase (CH24H) (EC 1.14.14.25) (Cholesterol 24-monooxygenase) (Cholesterol 24S-hydroxylase) (Cytochrome P450 46A1) Mus musculus (Mouse) GO:0005506; GO:0005789; GO:0006707; GO:0006805; GO:0008395; GO:0020037; GO:0030425; GO:0033781; GO:0042448; GO:0050649; GO:0062184; GO:0098793; GO:0098794; GO:1900271; GO:1903044 cholesterol catabolic process [GO:0006707]; progesterone metabolic process [GO:0042448]; protein localization to membrane raft [GO:1903044]; regulation of long-term synaptic potentiation [GO:1900271]; xenobiotic metabolic process [GO:0006805] dendrite [GO:0030425]; endoplasmic reticulum membrane [GO:0005789]; postsynapse [GO:0098794]; presynapse [GO:0098793] cholesterol 24-hydroxylase activity [GO:0033781]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; steroid hydroxylase activity [GO:0008395]; testosterone 16-beta-hydroxylase activity [GO:0062184]; testosterone 6-beta-hydroxylase activity [GO:0050649] g3461.t1 Q9Y6A2 37.681 414 2.4500000000000002e-86 275.0 sp|Q9Y6A2|CP46A_HUMAN Cholesterol 24-hydroxylase OS=Homo sapiens OX=9606 GN=CYP46A1 PE=1 SV=1 g3462.t1 Q8NFJ9 52.075 530 0.0 548.0 sp|Q8NFJ9|BBS1_HUMAN BBSome complex member BBS1 OS=Homo sapiens OX=9606 GN=BBS1 PE=1 SV=1 g3465.t1 Q9TXQ1 32.081 692 2.12e-63 245.0 sp|Q9TXQ1|TNKS1_CAEEL Poly [ADP-ribose] polymerase tankyrase OS=Caenorhabditis elegans OX=6239 GN=tank-1 PE=2 SV=1 g3465.t1 Q9TXQ1 33.705 448 2.33e-57 225.0 sp|Q9TXQ1|TNKS1_CAEEL Poly [ADP-ribose] polymerase tankyrase OS=Caenorhabditis elegans OX=6239 GN=tank-1 PE=2 SV=1 g3465.t2 Q9TXQ1 32.081 692 2.15e-63 245.0 sp|Q9TXQ1|TNKS1_CAEEL Poly [ADP-ribose] polymerase tankyrase OS=Caenorhabditis elegans OX=6239 GN=tank-1 PE=2 SV=1 g3465.t2 Q9TXQ1 33.259 448 2.08e-57 225.0 sp|Q9TXQ1|TNKS1_CAEEL Poly [ADP-ribose] polymerase tankyrase OS=Caenorhabditis elegans OX=6239 GN=tank-1 PE=2 SV=1 g3465.t3 Q9TXQ1 32.081 692 2.11e-63 245.0 sp|Q9TXQ1|TNKS1_CAEEL Poly [ADP-ribose] polymerase tankyrase OS=Caenorhabditis elegans OX=6239 GN=tank-1 PE=2 SV=1 g3465.t3 Q9TXQ1 33.857 446 1.45e-57 226.0 sp|Q9TXQ1|TNKS1_CAEEL Poly [ADP-ribose] polymerase tankyrase OS=Caenorhabditis elegans OX=6239 GN=tank-1 PE=2 SV=1 g3465.t4 Q9TXQ1 31.161 706 9.77e-63 243.0 sp|Q9TXQ1|TNKS1_CAEEL Poly [ADP-ribose] polymerase tankyrase OS=Caenorhabditis elegans OX=6239 GN=tank-1 PE=2 SV=1 g3465.t4 Q9TXQ1 33.705 448 2.3500000000000002e-57 225.0 sp|Q9TXQ1|TNKS1_CAEEL Poly [ADP-ribose] polymerase tankyrase OS=Caenorhabditis elegans OX=6239 GN=tank-1 PE=2 SV=1 g3465.t5 Q9TXQ1 31.161 706 9.77e-63 243.0 sp|Q9TXQ1|TNKS1_CAEEL Poly [ADP-ribose] polymerase tankyrase OS=Caenorhabditis elegans OX=6239 GN=tank-1 PE=2 SV=1 g3465.t5 Q9TXQ1 33.705 448 2.3500000000000002e-57 225.0 sp|Q9TXQ1|TNKS1_CAEEL Poly [ADP-ribose] polymerase tankyrase OS=Caenorhabditis elegans OX=6239 GN=tank-1 PE=2 SV=1 g3466.t1 A0NLY7 32.093 215 1.2400000000000001e-26 107.0 sp|A0NLY7|ISAHY_ROSAI Isatin hydrolase OS=Roseibium aggregatum (strain ATCC 25650 / DSM 13394 / JCM 20685 / NBRC 16684 / NCIMB 2208 / IAM 12614 / B1) OX=384765 GN=SIAM614_09648 PE=1 SV=1 ISAHY_ROSAI reviewed Isatin hydrolase (EC 3.5.2.20) (Isatin amidohydrolase) (Isatin hydrolase isoform b) (IH-b) Roseibium aggregatum (strain ATCC 25650 / DSM 13394 / JCM 20685 / NBRC 16684 / NCIMB 2208 / IAM 12614 / B1) (Stappia aggregata) GO:0004061; GO:0016812; GO:0019441; GO:0030145 L-tryptophan catabolic process to kynurenine [GO:0019441] arylformamidase activity [GO:0004061]; hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides [GO:0016812]; manganese ion binding [GO:0030145] g3468.t1 Q9VBW3 50.534 281 1.32e-98 309.0 sp|Q9VBW3|CAD96_DROME Tyrosine kinase receptor Cad96Ca OS=Drosophila melanogaster OX=7227 GN=Cad96Ca PE=2 SV=2 CAD96_DROME reviewed Tyrosine kinase receptor Cad96Ca (EC 2.7.10.1) (Cadherin-96Ca) (Tyrosine kinase receptor HD-14) Drosophila melanogaster (Fruit fly) GO:0004713; GO:0004714; GO:0005509; GO:0005524; GO:0005886; GO:0006468; GO:0007030; GO:0007156; GO:0007169; GO:0016339; GO:0042060; GO:0043235; GO:0045177; GO:0045792; GO:0051897; GO:0090303 calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; Golgi organization [GO:0007030]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell size [GO:0045792]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of wound healing [GO:0090303]; protein phosphorylation [GO:0006468]; wound healing [GO:0042060] apical part of cell [GO:0045177]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; protein tyrosine kinase activity [GO:0004713]; transmembrane receptor protein tyrosine kinase activity [GO:0004714] g3469.t1 Q5VT25 56.511 814 0.0 903.0 sp|Q5VT25|MRCKA_HUMAN Serine/threonine-protein kinase MRCK alpha OS=Homo sapiens OX=9606 GN=CDC42BPA PE=1 SV=1 MRCKA_HUMAN reviewed Serine/threonine-protein kinase MRCK alpha (EC 2.7.11.1) (CDC42-binding protein kinase alpha) (DMPK-like alpha) (Myotonic dystrophy kinase-related CDC42-binding kinase alpha) (MRCK alpha) (Myotonic dystrophy protein kinase-like alpha) Homo sapiens (Human) GO:0000287; GO:0004674; GO:0005524; GO:0005737; GO:0005829; GO:0005856; GO:0005911; GO:0006468; GO:0008270; GO:0016477; GO:0030027; GO:0030036; GO:0031032; GO:0031252; GO:0042641; GO:0042802; GO:0070062; GO:0106310 actin cytoskeleton organization [GO:0030036]; actomyosin structure organization [GO:0031032]; cell migration [GO:0016477]; protein phosphorylation [GO:0006468] actomyosin [GO:0042641]; cell leading edge [GO:0031252]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; lamellipodium [GO:0030027] ATP binding [GO:0005524]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; zinc ion binding [GO:0008270] g3470.t1 Q3UU96 44.686 828 0.0 666.0 sp|Q3UU96|MRCKA_MOUSE Serine/threonine-protein kinase MRCK alpha OS=Mus musculus OX=10090 GN=Cdc42bpa PE=1 SV=2 g3471.t1 Q9NZM5 32.867 429 9.22e-41 154.0 sp|Q9NZM5|NOP53_HUMAN Ribosome biogenesis protein NOP53 OS=Homo sapiens OX=9606 GN=NOP53 PE=1 SV=2 NOP53_HUMAN reviewed Ribosome biogenesis protein NOP53 (Glioma tumor suppressor candidate region gene 2 protein) (Protein interacting with carboxyl terminus 1) (PICT-1) (p60) Homo sapiens (Human) GO:0000027; GO:0000122; GO:0001650; GO:0001932; GO:0002039; GO:0003723; GO:0005654; GO:0005730; GO:0005829; GO:0006281; GO:0006364; GO:0006974; GO:0007095; GO:0008097; GO:0031333; GO:0032435; GO:0032436; GO:0039535; GO:0042802; GO:0042981; GO:0050821; GO:0051726; GO:0051898; GO:0071456; GO:1901796; GO:1901797; GO:1901837; GO:1902570; GO:1903006; GO:1903715; GO:1990173 cellular response to hypoxia [GO:0071456]; DNA damage response [GO:0006974]; DNA repair [GO:0006281]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051898]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of protein-containing complex assembly [GO:0031333]; negative regulation of signal transduction by p53 class mediator [GO:1901797]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription of nucleolar large rRNA by RNA polymerase I [GO:1901837]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein K63-linked deubiquitination [GO:1903006]; protein localization to nucleolus [GO:1902570]; protein localization to nucleoplasm [GO:1990173]; protein stabilization [GO:0050821]; regulation of aerobic respiration [GO:1903715]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of protein phosphorylation [GO:0001932]; regulation of RIG-I signaling pathway [GO:0039535]; regulation of signal transduction by p53 class mediator [GO:1901796]; ribosomal large subunit assembly [GO:0000027]; rRNA processing [GO:0006364] cytosol [GO:0005829]; fibrillar center [GO:0001650]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654] 5S rRNA binding [GO:0008097]; identical protein binding [GO:0042802]; p53 binding [GO:0002039]; RNA binding [GO:0003723] g3472.t1 Q6P5P3 32.701 211 7.56e-26 102.0 sp|Q6P5P3|TTC9C_RAT Tetratricopeptide repeat protein 9C OS=Rattus norvegicus OX=10116 GN=Ttc9c PE=2 SV=1 g3473.t1 Q924S7 35.129 427 1.62e-65 218.0 sp|Q924S7|SPRE2_MOUSE Sprouty-related, EVH1 domain-containing protein 2 OS=Mus musculus OX=10090 GN=Spred2 PE=1 SV=1 g3475.t1 P29374 43.596 406 3.7e-70 263.0 sp|P29374|ARI4A_HUMAN AT-rich interactive domain-containing protein 4A OS=Homo sapiens OX=9606 GN=ARID4A PE=1 SV=3 ARI4A_HUMAN reviewed AT-rich interactive domain-containing protein 4A (ARID domain-containing protein 4A) (Retinoblastoma-binding protein 1) (RBBP-1) Homo sapiens (Human) GO:0000122; GO:0000976; GO:0003677; GO:0005634; GO:0005654; GO:0005886; GO:0006357; GO:0006366; GO:0007283; GO:0017053; GO:0030336; GO:0030512; GO:0045892; GO:0045944; GO:0048821; GO:0070822; GO:0071514; GO:0097368; GO:1902455; GO:1902459 erythrocyte development [GO:0048821]; establishment of Sertoli cell barrier [GO:0097368]; genomic imprinting [GO:0071514]; negative regulation of cell migration [GO:0030336]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of stem cell population maintenance [GO:1902455]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]; transcription by RNA polymerase II [GO:0006366] nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; Sin3-type complex [GO:0070822]; transcription repressor complex [GO:0017053] DNA binding [GO:0003677]; transcription cis-regulatory region binding [GO:0000976] g3477.t1 Q8C5L7 47.849 186 1.07e-58 200.0 sp|Q8C5L7|RBM34_MOUSE RNA-binding protein 34 OS=Mus musculus OX=10090 GN=Rbm34 PE=1 SV=2 g3479.t1 Q9HDC9 36.134 357 4.58e-76 246.0 sp|Q9HDC9|APMAP_HUMAN Adipocyte plasma membrane-associated protein OS=Homo sapiens OX=9606 GN=APMAP PE=1 SV=2 g3480.t1 Q920M9 87.843 255 5.48e-172 479.0 sp|Q920M9|SIAH1_RAT E3 ubiquitin-protein ligase SIAH1 OS=Rattus norvegicus OX=10116 GN=Siah1 PE=1 SV=2 SIAH1_RAT reviewed E3 ubiquitin-protein ligase SIAH1 (EC 2.3.2.27) (RING-type E3 ubiquitin transferase SIAH1) (Seven in absentia homolog 1) (Siah-1) (Siah-1a) Rattus norvegicus (Rat) GO:0004842; GO:0005634; GO:0005737; GO:0005769; GO:0005829; GO:0006511; GO:0007141; GO:0007283; GO:0008270; GO:0009791; GO:0016567; GO:0019005; GO:0030154; GO:0030163; GO:0030877; GO:0031624; GO:0031648; GO:0040014; GO:0042802; GO:0042803; GO:0043065; GO:0043161; GO:0051402; GO:0060070; GO:0061630; GO:0097718; GO:2001244 canonical Wnt signaling pathway [GO:0060070]; cell differentiation [GO:0030154]; male meiosis I [GO:0007141]; neuron apoptotic process [GO:0051402]; positive regulation of apoptotic process [GO:0043065]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; post-embryonic development [GO:0009791]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein catabolic process [GO:0030163]; protein destabilization [GO:0031648]; protein ubiquitination [GO:0016567]; regulation of multicellular organism growth [GO:0040014]; spermatogenesis [GO:0007283]; ubiquitin-dependent protein catabolic process [GO:0006511] beta-catenin destruction complex [GO:0030877]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005] disordered domain specific binding [GO:0097718]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] g3481.t1 O97529 30.844 308 6.3399999999999995e-34 135.0 sp|O97529|ANXA8_RABIT Annexin A8 OS=Oryctolagus cuniculus OX=9986 GN=ANXA8 PE=2 SV=1 g3481.t2 O97529 30.844 308 6.24e-34 135.0 sp|O97529|ANXA8_RABIT Annexin A8 OS=Oryctolagus cuniculus OX=9986 GN=ANXA8 PE=2 SV=1 g3489.t1 Q9TXQ1 30.973 678 4.23e-57 224.0 sp|Q9TXQ1|TNKS1_CAEEL Poly [ADP-ribose] polymerase tankyrase OS=Caenorhabditis elegans OX=6239 GN=tank-1 PE=2 SV=1 g3489.t1 Q9TXQ1 25.578 649 9.63e-39 164.0 sp|Q9TXQ1|TNKS1_CAEEL Poly [ADP-ribose] polymerase tankyrase OS=Caenorhabditis elegans OX=6239 GN=tank-1 PE=2 SV=1 g3489.t2 Q9TXQ1 28.631 482 4.66e-33 141.0 sp|Q9TXQ1|TNKS1_CAEEL Poly [ADP-ribose] polymerase tankyrase OS=Caenorhabditis elegans OX=6239 GN=tank-1 PE=2 SV=1 g3492.t1 P11498 68.646 1145 0.0 1575.0 sp|P11498|PYC_HUMAN Pyruvate carboxylase, mitochondrial OS=Homo sapiens OX=9606 GN=PC PE=1 SV=2 PYC_HUMAN reviewed Pyruvate carboxylase, mitochondrial (EC 6.4.1.1) (Pyruvic carboxylase) (PCB) Homo sapiens (Human) GO:0004736; GO:0005524; GO:0005737; GO:0005739; GO:0005759; GO:0005829; GO:0006094; GO:0006629; GO:0006739; GO:0009374; GO:0010629; GO:0019074; GO:0019076; GO:0019674; GO:0042802; GO:0044794; GO:0046872 gluconeogenesis [GO:0006094]; host-mediated activation of viral process [GO:0044794]; lipid metabolic process [GO:0006629]; NAD+ metabolic process [GO:0019674]; NADP+ metabolic process [GO:0006739]; negative regulation of gene expression [GO:0010629]; viral release from host cell [GO:0019076]; viral RNA genome packaging [GO:0019074] cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] ATP binding [GO:0005524]; biotin binding [GO:0009374]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; pyruvate carboxylase activity [GO:0004736] g3493.t1 Q9XY07 67.473 372 0.0 537.0 sp|Q9XY07|KARG_STIJA Arginine kinase OS=Stichopus japonicus OX=307972 GN=AK PE=1 SV=1 g3494.t1 Q9H1D9 62.658 316 2.61e-151 430.0 sp|Q9H1D9|RPC6_HUMAN DNA-directed RNA polymerase III subunit RPC6 OS=Homo sapiens OX=9606 GN=POLR3F PE=1 SV=1 g3495.t1 Q5RBG4 55.847 496 5.6799999999999995e-174 500.0 sp|Q5RBG4|KAT5_PONAB Histone acetyltransferase KAT5 OS=Pongo abelii OX=9601 GN=KAT5 PE=2 SV=1 KAT5_PONAB reviewed Histone acetyltransferase KAT5 (EC 2.3.1.48) (60 kDa Tat-interactive protein) (Tip60) (Histone acetyltransferase HTATIP) (Lysine acetyltransferase 5) (Protein 2-hydroxyisobutyryltransferase KAT5) (EC 2.3.1.-) (Protein acetyltransferase KAT5) (EC 2.3.1.-) (Protein crotonyltransferase KAT5) (EC 2.3.1.-) (Protein lactyltransferase KAT5) (EC 2.3.1.-) Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0000132; GO:0000724; GO:0000776; GO:0000812; GO:0000922; GO:0003682; GO:0003713; GO:0004402; GO:0005634; GO:0005730; GO:0005737; GO:0006289; GO:0006302; GO:0006974; GO:0007286; GO:0008270; GO:0010508; GO:0010867; GO:0018394; GO:0030330; GO:0032777; GO:0035267; GO:0042149; GO:0042753; GO:0043998; GO:0045087; GO:0045591; GO:0045663; GO:0045893; GO:0045944; GO:0046972; GO:0048471; GO:0061733; GO:0062033; GO:0106226; GO:0120300; GO:0140064; GO:0140065; GO:0140297; GO:1901701; GO:1902036; GO:1902425; GO:1905168; GO:1905691 cellular response to glucose starvation [GO:0042149]; cellular response to oxygen-containing compound [GO:1901701]; DNA damage response [GO:0006974]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; double-strand break repair [GO:0006302]; double-strand break repair via homologous recombination [GO:0000724]; establishment of mitotic spindle orientation [GO:0000132]; innate immune response [GO:0045087]; lipid droplet disassembly [GO:1905691]; nucleotide-excision repair [GO:0006289]; peptidyl-lysine acetylation [GO:0018394]; positive regulation of attachment of mitotic spindle microtubules to kinetochore [GO:1902425]; positive regulation of autophagy [GO:0010508]; positive regulation of circadian rhythm [GO:0042753]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of mitotic sister chromatid segregation [GO:0062033]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of regulatory T cell differentiation [GO:0045591]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of triglyceride biosynthetic process [GO:0010867]; regulation of hematopoietic stem cell differentiation [GO:1902036]; spermatid development [GO:0007286] cytoplasm [GO:0005737]; kinetochore [GO:0000776]; NuA4 histone acetyltransferase complex [GO:0035267]; nucleolus [GO:0005730]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; piccolo histone acetyltransferase complex [GO:0032777]; spindle pole [GO:0000922]; Swr1 complex [GO:0000812] chromatin binding [GO:0003682]; DNA-binding transcription factor binding [GO:0140297]; histone acetyltransferase activity [GO:0004402]; histone H2A acetyltransferase activity [GO:0043998]; histone H4K16 acetyltransferase activity [GO:0046972]; peptide 2-hydroxyisobutyryltransferase activity [GO:0106226]; peptide butyryltransferase activity [GO:0140065]; peptide crotonyltransferase activity [GO:0140064]; peptide lactyltransferase (CoA-dependent) activity [GO:0120300]; protein-lysine-acetyltransferase activity [GO:0061733]; transcription coactivator activity [GO:0003713]; zinc ion binding [GO:0008270] g3503.t1 F1RAX8 49.105 391 8.75e-123 369.0 sp|F1RAX8|COQ6_DANRE Ubiquinone biosynthesis monooxygenase COQ6, mitochondrial OS=Danio rerio OX=7955 GN=coq6 PE=2 SV=1 COQ6_DANRE reviewed Ubiquinone biosynthesis monooxygenase COQ6, mitochondrial (EC 1.14.15.45) (2-methoxy-6-polyprenolphenol 4-hydroxylase) (EC 1.14.15.46) (Coenzyme Q10 monooxygenase 6) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005739; GO:0005794; GO:0006744; GO:0016491; GO:0016712; GO:0031314; GO:0042995; GO:0071949; GO:0106364; GO:0120538 ubiquinone biosynthetic process [GO:0006744] cell projection [GO:0042995]; extrinsic component of mitochondrial inner membrane [GO:0031314]; Golgi apparatus [GO:0005794]; mitochondrion [GO:0005739] 2-methoxy-6-polyprenolphenol 4-hydroxylase activity [GO:0120538]; 4-hydroxy-3-all-trans-polyprenylbenzoate oxygenase activity [GO:0106364]; FAD binding [GO:0071949]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712] g3504.t1 Q8WMD0 46.795 156 7.2e-49 159.0 sp|Q8WMD0|COMD1_CANLF COMM domain-containing protein 1 OS=Canis lupus familiaris OX=9615 GN=COMMD1 PE=2 SV=1 g3505.t1 Q02280 61.224 735 0.0 867.0 sp|Q02280|KCNAE_DROME Potassium voltage-gated channel protein eag OS=Drosophila melanogaster OX=7227 GN=eag PE=1 SV=2 KCNAE_DROME reviewed Potassium voltage-gated channel protein eag (Ether-a-go-go protein) Drosophila melanogaster (Fruit fly) GO:0005249; GO:0005886; GO:0006813; GO:0007608; GO:0007611; GO:0007612; GO:0007619; GO:0008016; GO:0008076; GO:0022843; GO:0042066; GO:0042391; GO:0044325; GO:0048150; GO:0071805 behavioral response to ether [GO:0048150]; courtship behavior [GO:0007619]; learning [GO:0007612]; learning or memory [GO:0007611]; perineurial glial growth [GO:0042066]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; regulation of heart contraction [GO:0008016]; regulation of membrane potential [GO:0042391]; sensory perception of smell [GO:0007608] plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076] transmembrane transporter binding [GO:0044325]; voltage-gated monoatomic cation channel activity [GO:0022843]; voltage-gated potassium channel activity [GO:0005249] g3505.t2 Q02280 61.265 759 0.0 901.0 sp|Q02280|KCNAE_DROME Potassium voltage-gated channel protein eag OS=Drosophila melanogaster OX=7227 GN=eag PE=1 SV=2 KCNAE_DROME reviewed Potassium voltage-gated channel protein eag (Ether-a-go-go protein) Drosophila melanogaster (Fruit fly) GO:0005249; GO:0005886; GO:0006813; GO:0007608; GO:0007611; GO:0007612; GO:0007619; GO:0008016; GO:0008076; GO:0022843; GO:0042066; GO:0042391; GO:0044325; GO:0048150; GO:0071805 behavioral response to ether [GO:0048150]; courtship behavior [GO:0007619]; learning [GO:0007612]; learning or memory [GO:0007611]; perineurial glial growth [GO:0042066]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; regulation of heart contraction [GO:0008016]; regulation of membrane potential [GO:0042391]; sensory perception of smell [GO:0007608] plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076] transmembrane transporter binding [GO:0044325]; voltage-gated monoatomic cation channel activity [GO:0022843]; voltage-gated potassium channel activity [GO:0005249] g3506.t1 Q8BMT9 32.372 312 1.47e-44 166.0 sp|Q8BMT9|HHAT_MOUSE Protein-cysteine N-palmitoyltransferase HHAT OS=Mus musculus OX=10090 GN=Hhat PE=1 SV=1 HHAT_MOUSE reviewed Protein-cysteine N-palmitoyltransferase HHAT (EC 2.3.1.-) (Hedgehog acyltransferase) (Skinny hedgehog protein) Mus musculus (Mouse) GO:0000139; GO:0005525; GO:0005783; GO:0005789; GO:0005794; GO:0007224; GO:0016409; GO:0018009 N-terminal peptidyl-L-cysteine N-palmitoylation [GO:0018009]; smoothened signaling pathway [GO:0007224] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139] GTP binding [GO:0005525]; palmitoyltransferase activity [GO:0016409] g3511.t1 Q8CCP0 66.981 106 8.620000000000001e-35 131.0 sp|Q8CCP0|NEMF_MOUSE Ribosome quality control complex subunit NEMF OS=Mus musculus OX=10090 GN=Nemf PE=1 SV=2 NEMF_MOUSE reviewed Ribosome quality control complex subunit NEMF (Nuclear export mediator factor) Mus musculus (Mouse) GO:0000049; GO:0001680; GO:0005634; GO:0005829; GO:0022626; GO:0042780; GO:0043023; GO:0051168; GO:0065003; GO:0072344; GO:0140627; GO:0140708; GO:1904678; GO:1990112; GO:1990116 CAT tailing [GO:0140708]; nuclear export [GO:0051168]; protein-containing complex assembly [GO:0065003]; rescue of stalled ribosome [GO:0072344]; ribosome-associated ubiquitin-dependent protein catabolic process [GO:1990116]; tRNA 3'-end processing [GO:0042780]; tRNA 3'-terminal CCA addition [GO:0001680]; ubiquitin-dependent protein catabolic process via the C-end degron rule pathway [GO:0140627] cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; nucleus [GO:0005634]; RQC complex [GO:1990112] alpha-aminoacyl-tRNA binding [GO:1904678]; ribosomal large subunit binding [GO:0043023]; tRNA binding [GO:0000049] g3512.t1 Q8CCP0 50.862 232 8.3e-67 234.0 sp|Q8CCP0|NEMF_MOUSE Ribosome quality control complex subunit NEMF OS=Mus musculus OX=10090 GN=Nemf PE=1 SV=2 NEMF_MOUSE reviewed Ribosome quality control complex subunit NEMF (Nuclear export mediator factor) Mus musculus (Mouse) GO:0000049; GO:0001680; GO:0005634; GO:0005829; GO:0022626; GO:0042780; GO:0043023; GO:0051168; GO:0065003; GO:0072344; GO:0140627; GO:0140708; GO:1904678; GO:1990112; GO:1990116 CAT tailing [GO:0140708]; nuclear export [GO:0051168]; protein-containing complex assembly [GO:0065003]; rescue of stalled ribosome [GO:0072344]; ribosome-associated ubiquitin-dependent protein catabolic process [GO:1990116]; tRNA 3'-end processing [GO:0042780]; tRNA 3'-terminal CCA addition [GO:0001680]; ubiquitin-dependent protein catabolic process via the C-end degron rule pathway [GO:0140627] cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; nucleus [GO:0005634]; RQC complex [GO:1990112] alpha-aminoacyl-tRNA binding [GO:1904678]; ribosomal large subunit binding [GO:0043023]; tRNA binding [GO:0000049] g3513.t1 O60524 54.198 524 2.79e-175 525.0 sp|O60524|NEMF_HUMAN Ribosome quality control complex subunit NEMF OS=Homo sapiens OX=9606 GN=NEMF PE=1 SV=4 g3514.t1 Q9EQT3 70.857 175 1.3799999999999999e-89 270.0 sp|Q9EQT3|RHOU_MOUSE Rho-related GTP-binding protein RhoU OS=Mus musculus OX=10090 GN=Rhou PE=2 SV=1 RHOU_MOUSE reviewed Rho-related GTP-binding protein RhoU (Rho GTPase-like protein ARHU) (Wnt-1 responsive Cdc42 homolog 1) (WRCH-1) Mus musculus (Mouse) GO:0000082; GO:0000139; GO:0002102; GO:0003924; GO:0005525; GO:0005886; GO:0005925; GO:0006897; GO:0007010; GO:0007015; GO:0007165; GO:0008360; GO:0016601; GO:0019901; GO:0030010; GO:0030036; GO:0030674; GO:0046872; GO:0120183 actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; cytoskeleton organization [GO:0007010]; endocytosis [GO:0006897]; establishment of cell polarity [GO:0030010]; G1/S transition of mitotic cell cycle [GO:0000082]; positive regulation of focal adhesion disassembly [GO:0120183]; Rac protein signal transduction [GO:0016601]; regulation of cell shape [GO:0008360]; signal transduction [GO:0007165] focal adhesion [GO:0005925]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886]; podosome [GO:0002102] GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; protein kinase binding [GO:0019901]; protein-macromolecule adaptor activity [GO:0030674] g3517.t1 Q3T1I9 34.202 883 3.67e-133 435.0 sp|Q3T1I9|RPAP1_RAT RNA polymerase II-associated protein 1 OS=Rattus norvegicus OX=10116 GN=Rpap1 PE=1 SV=1 g3519.t1 Q9BWH6 35.055 542 3.1e-59 216.0 sp|Q9BWH6|RPAP1_HUMAN RNA polymerase II-associated protein 1 OS=Homo sapiens OX=9606 GN=RPAP1 PE=1 SV=3 g3522.t1 Q6IQE9 55.274 237 1.09e-82 249.0 sp|Q6IQE9|ALKB6_DANRE Probable RNA/DNA demethylase ALKBH6 OS=Danio rerio OX=7955 GN=alkbh6 PE=2 SV=1 g3523.t1 O62830 62.468 389 6.58e-176 501.0 sp|O62830|PPM1B_BOVIN Protein phosphatase 1B OS=Bos taurus OX=9913 GN=PPM1B PE=2 SV=2 g3526.t1 C3XRY1 51.852 243 6.38e-76 250.0 sp|C3XRY1|NO66_BRAFL Bifunctional lysine-specific demethylase and histidyl-hydroxylase NO66 OS=Branchiostoma floridae OX=7739 GN=BRAFLDRAFT_123918 PE=3 SV=1 NO66_BRAFL reviewed Bifunctional lysine-specific demethylase and histidyl-hydroxylase NO66 (EC 1.14.11.-) (EC 1.14.11.27) (Histone lysine demethylase NO66) Branchiostoma floridae (Florida lancelet) (Amphioxus) GO:0005506; GO:0005634; GO:0005730; GO:0016706; GO:0032453; GO:0034647; GO:0036139; GO:0045892; GO:0051864; GO:0140680 negative regulation of DNA-templated transcription [GO:0045892] nucleolus [GO:0005730]; nucleus [GO:0005634] 2-oxoglutarate-dependent dioxygenase activity [GO:0016706]; histone H3K36 demethylase activity [GO:0051864]; histone H3K36me/H3K36me2 demethylase activity [GO:0140680]; histone H3K4 demethylase activity [GO:0032453]; histone H3K4me/H3K4me2/H3K4me3 demethylase activity [GO:0034647]; iron ion binding [GO:0005506]; peptidyl-histidine dioxygenase activity [GO:0036139] g3531.t1 A3QJU3 63.205 443 0.0 584.0 sp|A3QJU3|COQ8B_DANRE Atypical kinase COQ8B, mitochondrial OS=Danio rerio OX=7955 GN=coq8b PE=3 SV=2 COQ8B_DANRE reviewed Atypical kinase COQ8B, mitochondrial (EC 2.7.-.-) (AarF domain-containing protein kinase 4) (Coenzyme Q protein 8B) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0004672; GO:0005524; GO:0005829; GO:0005886; GO:0006744; GO:0021692; GO:0031966; GO:0032836; GO:0072015 cerebellar Purkinje cell layer morphogenesis [GO:0021692]; glomerular basement membrane development [GO:0032836]; podocyte development [GO:0072015]; ubiquinone biosynthetic process [GO:0006744] cytosol [GO:0005829]; mitochondrial membrane [GO:0031966]; plasma membrane [GO:0005886] ATP binding [GO:0005524]; protein kinase activity [GO:0004672] g3532.t1 O75817 61.165 103 3.11e-29 108.0 sp|O75817|POP7_HUMAN Ribonuclease P protein subunit p20 OS=Homo sapiens OX=9606 GN=POP7 PE=1 SV=2 POP7_HUMAN reviewed Ribonuclease P protein subunit p20 (RNaseP protein p20) (Ribonucleases P/MRP protein subunit POP7 homolog) (hPOP7) Homo sapiens (Human) GO:0000172; GO:0001682; GO:0003723; GO:0005634; GO:0005654; GO:0005655; GO:0005730; GO:0005737; GO:0006364; GO:0008033; GO:0030681; GO:0033204 rRNA processing [GO:0006364]; tRNA 5'-leader removal [GO:0001682]; tRNA processing [GO:0008033] cytoplasm [GO:0005737]; multimeric ribonuclease P complex [GO:0030681]; nucleolar ribonuclease P complex [GO:0005655]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonuclease MRP complex [GO:0000172] ribonuclease P RNA binding [GO:0033204]; RNA binding [GO:0003723] g3533.t1 Q9QZ05 38.687 1706 0.0 1068.0 sp|Q9QZ05|E2AK4_MOUSE eIF-2-alpha kinase GCN2 OS=Mus musculus OX=10090 GN=Eif2ak4 PE=1 SV=2 g3534.t1 O60232 64.646 99 6.53e-42 144.0 sp|O60232|ZNRD2_HUMAN Protein ZNRD2 OS=Homo sapiens OX=9606 GN=ZNRD2 PE=1 SV=1 ZNRD2_HUMAN reviewed Protein ZNRD2 (Autoantigen p27) (Protein zinc ribbon domain type 2) (Sjoegren syndrome/scleroderma autoantigen 1) (Zinc ribbon domain-containing protein 2) Homo sapiens (Human) GO:0000278; GO:0005737; GO:0042802; GO:0046872; GO:0051301 cell division [GO:0051301]; mitotic cell cycle [GO:0000278] cytoplasm [GO:0005737] identical protein binding [GO:0042802]; metal ion binding [GO:0046872] g3537.t1 O95069 37.379 206 2.8099999999999998e-30 122.0 sp|O95069|KCNK2_HUMAN Potassium channel subfamily K member 2 OS=Homo sapiens OX=9606 GN=KCNK2 PE=1 SV=2 KCNK2_HUMAN reviewed Potassium channel subfamily K member 2 (Outward rectifying potassium channel protein TREK-1) (TREK-1 K(+) channel subunit) (Two pore domain potassium channel TREK1) (Two pore potassium channel TPKC1) (K2P2.1) Homo sapiens (Human) GO:0003231; GO:0005783; GO:0005789; GO:0005886; GO:0007186; GO:0007613; GO:0008076; GO:0009986; GO:0014047; GO:0015271; GO:0016324; GO:0019228; GO:0019870; GO:0022834; GO:0022841; GO:0030425; GO:0032228; GO:0033268; GO:0042383; GO:0042802; GO:0043025; GO:0044305; GO:0046872; GO:0046982; GO:0048678; GO:0050976; GO:0060044; GO:0071456; GO:0071805; GO:0090102; GO:0097449; GO:0098685; GO:0098782; GO:0098839; GO:0099565; GO:1900039; GO:1902476; GO:1904551; GO:2000279 cardiac ventricle development [GO:0003231]; cellular response to arachidonate [GO:1904551]; cellular response to hypoxia [GO:0071456]; chemical synaptic transmission, postsynaptic [GO:0099565]; chloride transmembrane transport [GO:1902476]; cochlea development [GO:0090102]; detection of mechanical stimulus involved in sensory perception of touch [GO:0050976]; G protein-coupled receptor signaling pathway [GO:0007186]; glutamate secretion [GO:0014047]; memory [GO:0007613]; negative regulation of cardiac muscle cell proliferation [GO:0060044]; negative regulation of DNA biosynthetic process [GO:2000279]; neuronal action potential [GO:0019228]; positive regulation of cellular response to hypoxia [GO:1900039]; potassium ion transmembrane transport [GO:0071805]; regulation of synaptic transmission, GABAergic [GO:0032228]; response to axon injury [GO:0048678] apical plasma membrane [GO:0016324]; astrocyte projection [GO:0097449]; calyx of Held [GO:0044305]; cell surface [GO:0009986]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; neuronal cell body [GO:0043025]; node of Ranvier [GO:0033268]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; sarcolemma [GO:0042383]; Schaffer collateral - CA1 synapse [GO:0098685]; voltage-gated potassium channel complex [GO:0008076] identical protein binding [GO:0042802]; ligand-gated channel activity [GO:0022834]; mechanosensitive potassium channel activity [GO:0098782]; metal ion binding [GO:0046872]; outward rectifier potassium channel activity [GO:0015271]; potassium channel inhibitor activity [GO:0019870]; potassium ion leak channel activity [GO:0022841]; protein heterodimerization activity [GO:0046982] g3538.t1 Q8IW70 50.98 357 7.9e-113 353.0 sp|Q8IW70|T151B_HUMAN Transmembrane protein 151B OS=Homo sapiens OX=9606 GN=TMEM151B PE=1 SV=2 g3540.t1 Q5JU00 51.62 463 2.4099999999999998e-170 492.0 sp|Q5JU00|DRC5_HUMAN Dynein regulatory complex subunit 5 OS=Homo sapiens OX=9606 GN=TCTE1 PE=1 SV=1 g3543.t1 Q13395 22.308 520 8.96e-34 144.0 sp|Q13395|TARB1_HUMAN tRNA (guanosine(18)-2'-O)-methyltransferase TARBP1 OS=Homo sapiens OX=9606 GN=TARBP1 PE=1 SV=1 TARB1_HUMAN reviewed tRNA (guanosine(18)-2'-O)-methyltransferase TARBP1 (EC 2.1.1.34) (TAR RNA-binding protein 1) (TAR RNA-binding protein of 185 kDa) (TRP-185) Homo sapiens (Human) GO:0000049; GO:0003723; GO:0005634; GO:0006357; GO:0016423; GO:0030488; GO:0141100 regulation of transcription by RNA polymerase II [GO:0006357]; tRNA methylation [GO:0030488] nucleus [GO:0005634] RNA binding [GO:0003723]; tRNA (guanine(18)-2'-O)-methyltransferase activity [GO:0141100]; tRNA (guanine) methyltransferase activity [GO:0016423]; tRNA binding [GO:0000049] g3544.t1 E9Q368 56.633 196 2.11e-62 213.0 sp|E9Q368|TARB1_MOUSE tRNA (guanosine(18)-2'-O)-methyltransferase TARBP1 OS=Mus musculus OX=10090 GN=Tarbp1 PE=1 SV=1 g3546.t1 Q6UXS0 40.559 143 5.709999999999999e-23 93.2 sp|Q6UXS0|CL19A_HUMAN C-type lectin domain family 19 member A OS=Homo sapiens OX=9606 GN=CLEC19A PE=1 SV=2 g3548.t1 Q2TGI8 31.718 227 5.88e-37 134.0 sp|Q2TGI8|ZDH22_RAT Palmitoyltransferase ZDHHC22 OS=Rattus norvegicus OX=10116 GN=Zdhhc22 PE=2 SV=1 g3550.t1 Q5ZJQ8 36.096 374 4.42e-52 179.0 sp|Q5ZJQ8|UBAC2_CHICK Ubiquitin-associated domain-containing protein 2 OS=Gallus gallus OX=9031 GN=UBAC2 PE=2 SV=1 UBAC2_CHICK reviewed Ubiquitin-associated domain-containing protein 2 (UBA domain-containing protein 2) (Phosphoglycerate dehydrogenase-like protein 1) Gallus gallus (Chicken) GO:0004252; GO:0005789; GO:0016055; GO:0090090 negative regulation of canonical Wnt signaling pathway [GO:0090090]; Wnt signaling pathway [GO:0016055] endoplasmic reticulum membrane [GO:0005789] serine-type endopeptidase activity [GO:0004252] g3555.t1 Q803I8 77.91 335 0.0 561.0 sp|Q803I8|SYVN1_DANRE E3 ubiquitin-protein ligase synoviolin OS=Danio rerio OX=7955 GN=syvn1 PE=2 SV=2 SYVN1_DANRE reviewed E3 ubiquitin-protein ligase synoviolin (EC 2.3.2.27) (RING-type E3 ubiquitin transferase synoviolin) (Synovial apoptosis inhibitor 1) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005789; GO:0006511; GO:0008270; GO:0012505; GO:0016567; GO:0036503; GO:0043161; GO:0044322; GO:0050821; GO:0061630; GO:1902236 ERAD pathway [GO:0036503]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein stabilization [GO:0050821]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511] endomembrane system [GO:0012505]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum quality control compartment [GO:0044322] ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] g3556.t1 Q8R496 59.686 191 3.44e-75 234.0 sp|Q8R496|SPDYA_RAT Speedy protein A OS=Rattus norvegicus OX=10116 GN=Spdya PE=2 SV=1 g3557.t1 P80404 53.465 101 1.17e-33 127.0 sp|P80404|GABT_HUMAN 4-aminobutyrate aminotransferase, mitochondrial OS=Homo sapiens OX=9606 GN=ABAT PE=1 SV=3 GABT_HUMAN reviewed 4-aminobutyrate aminotransferase, mitochondrial (EC 2.6.1.19) ((S)-3-amino-2-methylpropionate transaminase) (EC 2.6.1.22) (GABA aminotransferase) (GABA-AT) (Gamma-amino-N-butyrate transaminase) (GABA transaminase) (GABA-T) (L-AIBAT) Homo sapiens (Human) GO:0001666; GO:0005739; GO:0005759; GO:0007620; GO:0007626; GO:0009410; GO:0009448; GO:0009449; GO:0009450; GO:0010039; GO:0014053; GO:0021549; GO:0030170; GO:0031652; GO:0032024; GO:0032144; GO:0032145; GO:0033602; GO:0034386; GO:0035094; GO:0035640; GO:0042220; GO:0042802; GO:0045471; GO:0045776; GO:0045964; GO:0046872; GO:0047298; GO:0050877; GO:0051536; GO:0070474; GO:0097151; GO:1902722; GO:1904450 cerebellum development [GO:0021549]; copulation [GO:0007620]; exploration behavior [GO:0035640]; gamma-aminobutyric acid biosynthetic process [GO:0009449]; gamma-aminobutyric acid catabolic process [GO:0009450]; gamma-aminobutyric acid metabolic process [GO:0009448]; locomotory behavior [GO:0007626]; negative regulation of blood pressure [GO:0045776]; negative regulation of dopamine secretion [GO:0033602]; negative regulation of gamma-aminobutyric acid secretion [GO:0014053]; nervous system process [GO:0050877]; positive regulation of aspartate secretion [GO:1904450]; positive regulation of dopamine metabolic process [GO:0045964]; positive regulation of heat generation [GO:0031652]; positive regulation of inhibitory postsynaptic potential [GO:0097151]; positive regulation of insulin secretion [GO:0032024]; positive regulation of prolactin secretion [GO:1902722]; positive regulation of uterine smooth muscle contraction [GO:0070474]; response to cocaine [GO:0042220]; response to ethanol [GO:0045471]; response to hypoxia [GO:0001666]; response to iron ion [GO:0010039]; response to nicotine [GO:0035094]; response to xenobiotic stimulus [GO:0009410] 4-aminobutyrate transaminase complex [GO:0032144]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] (S)-3-amino-2-methylpropionate transaminase activity [GO:0047298]; 4-aminobutyrate:2-oxoglutarate transaminase activity [GO:0034386]; identical protein binding [GO:0042802]; iron-sulfur cluster binding [GO:0051536]; metal ion binding [GO:0046872]; pyridoxal phosphate binding [GO:0030170]; succinate-semialdehyde dehydrogenase binding [GO:0032145] g3558.t1 P80404 52.012 323 3.66e-125 370.0 sp|P80404|GABT_HUMAN 4-aminobutyrate aminotransferase, mitochondrial OS=Homo sapiens OX=9606 GN=ABAT PE=1 SV=3 GABT_HUMAN reviewed 4-aminobutyrate aminotransferase, mitochondrial (EC 2.6.1.19) ((S)-3-amino-2-methylpropionate transaminase) (EC 2.6.1.22) (GABA aminotransferase) (GABA-AT) (Gamma-amino-N-butyrate transaminase) (GABA transaminase) (GABA-T) (L-AIBAT) Homo sapiens (Human) GO:0001666; GO:0005739; GO:0005759; GO:0007620; GO:0007626; GO:0009410; GO:0009448; GO:0009449; GO:0009450; GO:0010039; GO:0014053; GO:0021549; GO:0030170; GO:0031652; GO:0032024; GO:0032144; GO:0032145; GO:0033602; GO:0034386; GO:0035094; GO:0035640; GO:0042220; GO:0042802; GO:0045471; GO:0045776; GO:0045964; GO:0046872; GO:0047298; GO:0050877; GO:0051536; GO:0070474; GO:0097151; GO:1902722; GO:1904450 cerebellum development [GO:0021549]; copulation [GO:0007620]; exploration behavior [GO:0035640]; gamma-aminobutyric acid biosynthetic process [GO:0009449]; gamma-aminobutyric acid catabolic process [GO:0009450]; gamma-aminobutyric acid metabolic process [GO:0009448]; locomotory behavior [GO:0007626]; negative regulation of blood pressure [GO:0045776]; negative regulation of dopamine secretion [GO:0033602]; negative regulation of gamma-aminobutyric acid secretion [GO:0014053]; nervous system process [GO:0050877]; positive regulation of aspartate secretion [GO:1904450]; positive regulation of dopamine metabolic process [GO:0045964]; positive regulation of heat generation [GO:0031652]; positive regulation of inhibitory postsynaptic potential [GO:0097151]; positive regulation of insulin secretion [GO:0032024]; positive regulation of prolactin secretion [GO:1902722]; positive regulation of uterine smooth muscle contraction [GO:0070474]; response to cocaine [GO:0042220]; response to ethanol [GO:0045471]; response to hypoxia [GO:0001666]; response to iron ion [GO:0010039]; response to nicotine [GO:0035094]; response to xenobiotic stimulus [GO:0009410] 4-aminobutyrate transaminase complex [GO:0032144]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] (S)-3-amino-2-methylpropionate transaminase activity [GO:0047298]; 4-aminobutyrate:2-oxoglutarate transaminase activity [GO:0034386]; identical protein binding [GO:0042802]; iron-sulfur cluster binding [GO:0051536]; metal ion binding [GO:0046872]; pyridoxal phosphate binding [GO:0030170]; succinate-semialdehyde dehydrogenase binding [GO:0032145] g3559.t1 Q9BVS5 36.97 330 4.39e-59 207.0 sp|Q9BVS5|TR61B_HUMAN tRNA (adenine(58)-N(1))-methyltransferase, mitochondrial OS=Homo sapiens OX=9606 GN=TRMT61B PE=1 SV=2 TR61B_HUMAN reviewed tRNA (adenine(58)-N(1))-methyltransferase, mitochondrial (EC 2.1.1.220) (mRNA methyladenosine-N(1)-methyltransferase) (EC 2.1.1.-) Homo sapiens (Human) GO:0005739; GO:0005759; GO:0006397; GO:0016433; GO:0030488; GO:0031515; GO:0061953; GO:0090646; GO:0160107 mitochondrial tRNA processing [GO:0090646]; mRNA processing [GO:0006397]; tRNA methylation [GO:0030488] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; tRNA (m1A) methyltransferase complex [GO:0031515] mRNA (adenine-N1-)-methyltransferase activity [GO:0061953]; rRNA (adenine) methyltransferase activity [GO:0016433]; tRNA (adenine(58)-N1)-methyltransferase activity [GO:0160107] g3560.t1 Q8WPD0 36.879 141 9.529999999999999e-23 92.0 sp|Q8WPD0|LECG_PATPE Alpha-N-acetylgalactosamine-specific lectin OS=Patiria pectinifera OX=7594 PE=1 SV=1 g3565.t1 Q3V6T2 40.941 1551 0.0 891.0 sp|Q3V6T2|GRDN_HUMAN Girdin OS=Homo sapiens OX=9606 GN=CCDC88A PE=1 SV=2 GRDN_HUMAN reviewed Girdin (Akt phosphorylation enhancer) (APE) (Coiled-coil domain-containing protein 88A) (G alpha-interacting vesicle-associated protein) (GIV) (Girders of actin filament) (Hook-related protein 1) (HkRP1) Homo sapiens (Human) GO:0001965; GO:0003779; GO:0005080; GO:0005085; GO:0005092; GO:0005154; GO:0005158; GO:0005654; GO:0005737; GO:0005783; GO:0005794; GO:0005813; GO:0005814; GO:0005829; GO:0005886; GO:0007264; GO:0007399; GO:0008017; GO:0010975; GO:0016020; GO:0016477; GO:0030027; GO:0030032; GO:0030705; GO:0031122; GO:0031410; GO:0031929; GO:0032147; GO:0032956; GO:0035091; GO:0036064; GO:0042127; GO:0042169; GO:0042803; GO:0043184; GO:0043422; GO:0043539; GO:0045724; GO:0045742; GO:0051496; GO:0051897; GO:0051959; GO:0061024; GO:0072660; GO:1903566 activation of protein kinase activity [GO:0032147]; cell migration [GO:0016477]; cytoplasmic microtubule organization [GO:0031122]; cytoskeleton-dependent intracellular transport [GO:0030705]; lamellipodium assembly [GO:0030032]; maintenance of protein location in plasma membrane [GO:0072660]; membrane organization [GO:0061024]; nervous system development [GO:0007399]; positive regulation of cilium assembly [GO:0045724]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of protein localization to cilium [GO:1903566]; positive regulation of stress fiber assembly [GO:0051496]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell population proliferation [GO:0042127]; regulation of neuron projection development [GO:0010975]; small GTPase-mediated signal transduction [GO:0007264]; TOR signaling [GO:0031929] centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; lamellipodium [GO:0030027]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] actin binding [GO:0003779]; dynein light intermediate chain binding [GO:0051959]; epidermal growth factor receptor binding [GO:0005154]; G-protein alpha-subunit binding [GO:0001965]; GDP-dissociation inhibitor activity [GO:0005092]; guanyl-nucleotide exchange factor activity [GO:0005085]; insulin receptor binding [GO:0005158]; microtubule binding [GO:0008017]; phosphatidylinositol binding [GO:0035091]; protein homodimerization activity [GO:0042803]; protein kinase B binding [GO:0043422]; protein kinase C binding [GO:0005080]; protein serine/threonine kinase activator activity [GO:0043539]; SH2 domain binding [GO:0042169]; vascular endothelial growth factor receptor 2 binding [GO:0043184] g3565.t2 Q3V6T2 40.627 1563 0.0 882.0 sp|Q3V6T2|GRDN_HUMAN Girdin OS=Homo sapiens OX=9606 GN=CCDC88A PE=1 SV=2 GRDN_HUMAN reviewed Girdin (Akt phosphorylation enhancer) (APE) (Coiled-coil domain-containing protein 88A) (G alpha-interacting vesicle-associated protein) (GIV) (Girders of actin filament) (Hook-related protein 1) (HkRP1) Homo sapiens (Human) GO:0001965; GO:0003779; GO:0005080; GO:0005085; GO:0005092; GO:0005154; GO:0005158; GO:0005654; GO:0005737; GO:0005783; GO:0005794; GO:0005813; GO:0005814; GO:0005829; GO:0005886; GO:0007264; GO:0007399; GO:0008017; GO:0010975; GO:0016020; GO:0016477; GO:0030027; GO:0030032; GO:0030705; GO:0031122; GO:0031410; GO:0031929; GO:0032147; GO:0032956; GO:0035091; GO:0036064; GO:0042127; GO:0042169; GO:0042803; GO:0043184; GO:0043422; GO:0043539; GO:0045724; GO:0045742; GO:0051496; GO:0051897; GO:0051959; GO:0061024; GO:0072660; GO:1903566 activation of protein kinase activity [GO:0032147]; cell migration [GO:0016477]; cytoplasmic microtubule organization [GO:0031122]; cytoskeleton-dependent intracellular transport [GO:0030705]; lamellipodium assembly [GO:0030032]; maintenance of protein location in plasma membrane [GO:0072660]; membrane organization [GO:0061024]; nervous system development [GO:0007399]; positive regulation of cilium assembly [GO:0045724]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of protein localization to cilium [GO:1903566]; positive regulation of stress fiber assembly [GO:0051496]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell population proliferation [GO:0042127]; regulation of neuron projection development [GO:0010975]; small GTPase-mediated signal transduction [GO:0007264]; TOR signaling [GO:0031929] centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; lamellipodium [GO:0030027]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] actin binding [GO:0003779]; dynein light intermediate chain binding [GO:0051959]; epidermal growth factor receptor binding [GO:0005154]; G-protein alpha-subunit binding [GO:0001965]; GDP-dissociation inhibitor activity [GO:0005092]; guanyl-nucleotide exchange factor activity [GO:0005085]; insulin receptor binding [GO:0005158]; microtubule binding [GO:0008017]; phosphatidylinositol binding [GO:0035091]; protein homodimerization activity [GO:0042803]; protein kinase B binding [GO:0043422]; protein kinase C binding [GO:0005080]; protein serine/threonine kinase activator activity [GO:0043539]; SH2 domain binding [GO:0042169]; vascular endothelial growth factor receptor 2 binding [GO:0043184] g3569.t1 Q8BH86 46.667 315 1.31e-91 288.0 sp|Q8BH86|GLUCM_MOUSE D-glutamate cyclase, mitochondrial OS=Mus musculus OX=10090 GN=Dglucy PE=1 SV=1 g3570.t1 A6LX31 40.856 257 1.81e-66 211.0 sp|A6LX31|Y2760_CLOB8 Putative hydro-lyase Cbei_2760 OS=Clostridium beijerinckii (strain ATCC 51743 / NCIMB 8052) OX=290402 GN=Cbei_2760 PE=3 SV=1 g3577.t1 Q6BEA0 31.509 749 4.3500000000000003e-103 362.0 sp|Q6BEA0|PLXA4_DANRE Plexin-A4 OS=Danio rerio OX=7955 GN=plxna4 PE=2 SV=1 PLXA4_DANRE reviewed Plexin-A4 Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001763; GO:0002116; GO:0005886; GO:0007411; GO:0007414; GO:0007416; GO:0016020; GO:0017154; GO:0030334; GO:0071526 axon guidance [GO:0007411]; axonal defasciculation [GO:0007414]; morphogenesis of a branching structure [GO:0001763]; regulation of cell migration [GO:0030334]; semaphorin-plexin signaling pathway [GO:0071526]; synapse assembly [GO:0007416] membrane [GO:0016020]; plasma membrane [GO:0005886]; semaphorin receptor complex [GO:0002116] semaphorin receptor activity [GO:0017154] g3578.t1 Q6BEA0 29.67 364 2.7e-30 125.0 sp|Q6BEA0|PLXA4_DANRE Plexin-A4 OS=Danio rerio OX=7955 GN=plxna4 PE=2 SV=1 PLXA4_DANRE reviewed Plexin-A4 Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001763; GO:0002116; GO:0005886; GO:0007411; GO:0007414; GO:0007416; GO:0016020; GO:0017154; GO:0030334; GO:0071526 axon guidance [GO:0007411]; axonal defasciculation [GO:0007414]; morphogenesis of a branching structure [GO:0001763]; regulation of cell migration [GO:0030334]; semaphorin-plexin signaling pathway [GO:0071526]; synapse assembly [GO:0007416] membrane [GO:0016020]; plasma membrane [GO:0005886]; semaphorin receptor complex [GO:0002116] semaphorin receptor activity [GO:0017154] g3579.t1 Q80T85 59.277 415 6.46e-164 504.0 sp|Q80T85|DCAF5_MOUSE DDB1- and CUL4-associated factor 5 OS=Mus musculus OX=10090 GN=Dcaf5 PE=1 SV=2 g3580.t1 Q9CWG8 54.061 394 2.41e-140 412.0 sp|Q9CWG8|NDUF7_MOUSE Protein arginine methyltransferase NDUFAF7, mitochondrial OS=Mus musculus OX=10090 GN=Ndufaf7 PE=1 SV=4 NDUF7_MOUSE reviewed Protein arginine methyltransferase NDUFAF7, mitochondrial (EC 2.1.1.320) (NADH dehydrogenase [ubiquinone] complex I, assembly factor 7) (Protein midA homolog) Mus musculus (Mouse) GO:0005739; GO:0019899; GO:0019918; GO:0032981; GO:0035243 mitochondrial respiratory chain complex I assembly [GO:0032981]; peptidyl-arginine methylation, to symmetrical-dimethyl arginine [GO:0019918] mitochondrion [GO:0005739] enzyme binding [GO:0019899]; protein-arginine omega-N symmetric methyltransferase activity [GO:0035243] g3581.t1 Q96Q07 64.089 582 0.0 786.0 sp|Q96Q07|BTBD9_HUMAN BTB/POZ domain-containing protein 9 OS=Homo sapiens OX=9606 GN=BTBD9 PE=1 SV=2 BTBD9_HUMAN reviewed BTB/POZ domain-containing protein 9 Homo sapiens (Human) GO:0005737; GO:0007616; GO:0008344; GO:0042428; GO:0042748; GO:0048512; GO:0050804; GO:0050951; GO:0060586; GO:0098978; GO:1900242 adult locomotory behavior [GO:0008344]; circadian behavior [GO:0048512]; circadian sleep/wake cycle, non-REM sleep [GO:0042748]; long-term memory [GO:0007616]; modulation of chemical synaptic transmission [GO:0050804]; multicellular organismal-level iron ion homeostasis [GO:0060586]; regulation of synaptic vesicle endocytosis [GO:1900242]; sensory perception of temperature stimulus [GO:0050951]; serotonin metabolic process [GO:0042428] cytoplasm [GO:0005737]; glutamatergic synapse [GO:0098978] g3583.t1 Q7L266 51.325 302 3.04e-83 257.0 sp|Q7L266|ASGL1_HUMAN Isoaspartyl peptidase/L-asparaginase OS=Homo sapiens OX=9606 GN=ASRGL1 PE=1 SV=2 ASGL1_HUMAN reviewed Isoaspartyl peptidase/L-asparaginase (EC 3.4.19.5) (EC 3.5.1.1) (Asparaginase-like protein 1) (Beta-aspartyl-peptidase) (Isoaspartyl dipeptidase) (L-asparagine amidohydrolase) [Cleaved into: Isoaspartyl peptidase/L-asparaginase alpha chain; Isoaspartyl peptidase/L-asparaginase beta chain] Homo sapiens (Human) GO:0001917; GO:0004067; GO:0005634; GO:0005737; GO:0005829; GO:0006508; GO:0008798; GO:0033345 L-asparagine catabolic process via L-aspartate [GO:0033345]; proteolysis [GO:0006508] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; photoreceptor inner segment [GO:0001917] asparaginase activity [GO:0004067]; beta-aspartyl-peptidase activity [GO:0008798] g3584.t1 Q05090 80.208 672 0.0 958.0 sp|Q05090|KLC_STRPU Kinesin light chain OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g3584.t2 Q05090 79.464 672 0.0 941.0 sp|Q05090|KLC_STRPU Kinesin light chain OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g3584.t3 Q05090 80.208 672 0.0 958.0 sp|Q05090|KLC_STRPU Kinesin light chain OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g3591.t1 Q69ZR2 69.334 1337 0.0 1777.0 sp|Q69ZR2|HECD1_MOUSE E3 ubiquitin-protein ligase HECTD1 OS=Mus musculus OX=10090 GN=Hectd1 PE=1 SV=2 HECD1_MOUSE reviewed E3 ubiquitin-protein ligase HECTD1 (EC 2.3.2.26) (HECT domain-containing protein 1) (HECT-type E3 ubiquitin transferase HECTD1) (Protein open mind) Mus musculus (Mouse) GO:0000209; GO:0001779; GO:0001843; GO:0001892; GO:0003170; GO:0003281; GO:0016607; GO:0035904; GO:0043161; GO:0046872; GO:0051865; GO:0060707; GO:0060708; GO:0061630; GO:0070534; GO:1903077 aorta development [GO:0035904]; embryonic placenta development [GO:0001892]; heart valve development [GO:0003170]; natural killer cell differentiation [GO:0001779]; negative regulation of protein localization to plasma membrane [GO:1903077]; neural tube closure [GO:0001843]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein K63-linked ubiquitination [GO:0070534]; protein polyubiquitination [GO:0000209]; spongiotrophoblast differentiation [GO:0060708]; trophoblast giant cell differentiation [GO:0060707]; ventricular septum development [GO:0003281] nuclear speck [GO:0016607] metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630] g3591.t1 Q69ZR2 55.556 171 1.5500000000000001e-47 192.0 sp|Q69ZR2|HECD1_MOUSE E3 ubiquitin-protein ligase HECTD1 OS=Mus musculus OX=10090 GN=Hectd1 PE=1 SV=2 HECD1_MOUSE reviewed E3 ubiquitin-protein ligase HECTD1 (EC 2.3.2.26) (HECT domain-containing protein 1) (HECT-type E3 ubiquitin transferase HECTD1) (Protein open mind) Mus musculus (Mouse) GO:0000209; GO:0001779; GO:0001843; GO:0001892; GO:0003170; GO:0003281; GO:0016607; GO:0035904; GO:0043161; GO:0046872; GO:0051865; GO:0060707; GO:0060708; GO:0061630; GO:0070534; GO:1903077 aorta development [GO:0035904]; embryonic placenta development [GO:0001892]; heart valve development [GO:0003170]; natural killer cell differentiation [GO:0001779]; negative regulation of protein localization to plasma membrane [GO:1903077]; neural tube closure [GO:0001843]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein K63-linked ubiquitination [GO:0070534]; protein polyubiquitination [GO:0000209]; spongiotrophoblast differentiation [GO:0060708]; trophoblast giant cell differentiation [GO:0060707]; ventricular septum development [GO:0003281] nuclear speck [GO:0016607] metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630] g3592.t1 Q9ULT8 59.223 618 0.0 717.0 sp|Q9ULT8|HECD1_HUMAN E3 ubiquitin-protein ligase HECTD1 OS=Homo sapiens OX=9606 GN=HECTD1 PE=1 SV=4 HECD1_HUMAN reviewed E3 ubiquitin-protein ligase HECTD1 (EC 2.3.2.26) (E3 ligase for inhibin receptor) (EULIR) (HECT domain-containing protein 1) Homo sapiens (Human) GO:0003170; GO:0003281; GO:0006511; GO:0016567; GO:0032436; GO:0035904; GO:0046872; GO:0061630 aorta development [GO:0035904]; heart valve development [GO:0003170]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]; ventricular septum development [GO:0003281] metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630] g3593.t1 C3XR70 56.25 256 6.39e-98 293.0 sp|C3XR70|ENOPH_BRAFL Enolase-phosphatase E1 OS=Branchiostoma floridae OX=7739 GN=BRAFLDRAFT_73099 PE=3 SV=1 g3597.t1 Q86UP2 36.0 300 2.61e-33 144.0 sp|Q86UP2|KTN1_HUMAN Kinectin OS=Homo sapiens OX=9606 GN=KTN1 PE=1 SV=1 KTN1_HUMAN reviewed Kinectin (CG-1 antigen) (Kinesin receptor) Homo sapiens (Human) GO:0003723; GO:0005783; GO:0005788; GO:0005789; GO:0005886; GO:0007018; GO:0015031; GO:0016020; GO:0019894; GO:0045296 microtubule-based movement [GO:0007018]; protein transport [GO:0015031] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; plasma membrane [GO:0005886] cadherin binding [GO:0045296]; kinesin binding [GO:0019894]; RNA binding [GO:0003723] g3597.t2 Q86UP2 36.0 300 3.2500000000000004e-33 143.0 sp|Q86UP2|KTN1_HUMAN Kinectin OS=Homo sapiens OX=9606 GN=KTN1 PE=1 SV=1 KTN1_HUMAN reviewed Kinectin (CG-1 antigen) (Kinesin receptor) Homo sapiens (Human) GO:0003723; GO:0005783; GO:0005788; GO:0005789; GO:0005886; GO:0007018; GO:0015031; GO:0016020; GO:0019894; GO:0045296 microtubule-based movement [GO:0007018]; protein transport [GO:0015031] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; plasma membrane [GO:0005886] cadherin binding [GO:0045296]; kinesin binding [GO:0019894]; RNA binding [GO:0003723] g3598.t1 O75689 34.444 360 4.15e-60 213.0 sp|O75689|ADAP1_HUMAN Arf-GAP with dual PH domain-containing protein 1 OS=Homo sapiens OX=9606 GN=ADAP1 PE=1 SV=2 ADAP1_HUMAN reviewed Arf-GAP with dual PH domain-containing protein 1 (Centaurin-alpha-1) (Cnt-a1) (Putative MAPK-activating protein PM25) Homo sapiens (Human) GO:0005096; GO:0005547; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0007166; GO:0008270; GO:0043087; GO:0043533; GO:1902936 cell surface receptor signaling pathway [GO:0007166]; regulation of GTPase activity [GO:0043087] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886] GTPase activator activity [GO:0005096]; inositol 1,3,4,5 tetrakisphosphate binding [GO:0043533]; phosphatidylinositol bisphosphate binding [GO:1902936]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; zinc ion binding [GO:0008270] g3598.t2 O75689 34.444 360 1.19e-60 213.0 sp|O75689|ADAP1_HUMAN Arf-GAP with dual PH domain-containing protein 1 OS=Homo sapiens OX=9606 GN=ADAP1 PE=1 SV=2 ADAP1_HUMAN reviewed Arf-GAP with dual PH domain-containing protein 1 (Centaurin-alpha-1) (Cnt-a1) (Putative MAPK-activating protein PM25) Homo sapiens (Human) GO:0005096; GO:0005547; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0007166; GO:0008270; GO:0043087; GO:0043533; GO:1902936 cell surface receptor signaling pathway [GO:0007166]; regulation of GTPase activity [GO:0043087] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886] GTPase activator activity [GO:0005096]; inositol 1,3,4,5 tetrakisphosphate binding [GO:0043533]; phosphatidylinositol bisphosphate binding [GO:1902936]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; zinc ion binding [GO:0008270] g3600.t1 Q8IMC6 66.488 373 1.41e-157 513.0 sp|Q8IMC6|ASATR_DROME Tau-tubulin kinase homolog Asator OS=Drosophila melanogaster OX=7227 GN=Asator PE=1 SV=2 ASATR_DROME reviewed Tau-tubulin kinase homolog Asator (EC 2.7.11.1) Drosophila melanogaster (Fruit fly) GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005819; GO:0007165; GO:0106310 signal transduction [GO:0007165] cytoplasm [GO:0005737]; nucleus [GO:0005634]; spindle [GO:0005819] ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g3601.t1 Q2KIA2 54.839 124 1.56e-46 149.0 sp|Q2KIA2|TR112_BOVIN Multifunctional methyltransferase subunit TRM112-like protein OS=Bos taurus OX=9913 GN=TRMT112 PE=2 SV=1 TR112_BOVIN reviewed Multifunctional methyltransferase subunit TRM112-like protein (tRNA methyltransferase 112 homolog) Bos taurus (Bovine) GO:0000470; GO:0005634; GO:0005654; GO:0005737; GO:0018364; GO:0030490; GO:0031167; GO:0043528; GO:0045815; GO:0046982; GO:0048471; GO:0070476; GO:0141106; GO:2000234 maturation of LSU-rRNA [GO:0000470]; maturation of SSU-rRNA [GO:0030490]; peptidyl-glutamine methylation [GO:0018364]; positive regulation of rRNA processing [GO:2000234]; rRNA (guanine-N7)-methylation [GO:0070476]; rRNA methylation [GO:0031167]; transcription initiation-coupled chromatin remodeling [GO:0045815] cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; tRNA (m2G10) methyltransferase complex [GO:0043528] protein heterodimerization activity [GO:0046982]; tRNA methyltransferase activator activity [GO:0141106] g3607.t1 Q3UN02 40.909 308 4.44e-75 238.0 sp|Q3UN02|LCLT1_MOUSE Lysocardiolipin acyltransferase 1 OS=Mus musculus OX=10090 GN=Lclat1 PE=1 SV=2 LCLT1_MOUSE reviewed Lysocardiolipin acyltransferase 1 (EC 2.3.1.-) (1-acylglycerol-3-phosphate O-acyltransferase 8) (1-AGP acyltransferase 8) (1-AGPAT 8) (EC 2.3.1.51) (Acyl-CoA:lysocardiolipin acyltransferase 1) Mus musculus (Mouse) GO:0003841; GO:0005783; GO:0005789; GO:0005829; GO:0012505; GO:0016024; GO:0016746; GO:0035965; GO:0036149 cardiolipin acyl-chain remodeling [GO:0035965]; CDP-diacylglycerol biosynthetic process [GO:0016024]; phosphatidylinositol acyl-chain remodeling [GO:0036149] cytosol [GO:0005829]; endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789] 1-acylglycerol-3-phosphate O-acyltransferase activity [GO:0003841]; acyltransferase activity [GO:0016746] g3609.t1 Q3SZW1 46.909 275 2.98e-78 246.0 sp|Q3SZW1|TSSK1_BOVIN Testis-specific serine/threonine-protein kinase 1 OS=Bos taurus OX=9913 GN=TSSK1B PE=2 SV=1 TSSK1_BOVIN reviewed Testis-specific serine/threonine-protein kinase 1 (TSK-1) (TSK1) (TSSK-1) (Testis-specific kinase 1) (EC 2.7.11.1) Bos taurus (Bovine) GO:0000226; GO:0000287; GO:0001669; GO:0004674; GO:0005524; GO:0005737; GO:0007286; GO:0031514; GO:0035556; GO:0050321; GO:0106310 intracellular signal transduction [GO:0035556]; microtubule cytoskeleton organization [GO:0000226]; spermatid development [GO:0007286] acrosomal vesicle [GO:0001669]; cytoplasm [GO:0005737]; motile cilium [GO:0031514] ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; tau-protein kinase activity [GO:0050321] g3611.t1 B1ANS9 35.257 1109 0.0 672.0 sp|B1ANS9|WDR64_HUMAN WD repeat-containing protein 64 OS=Homo sapiens OX=9606 GN=WDR64 PE=1 SV=1 g3613.t1 Q4JIM4 56.091 394 1.39e-112 342.0 sp|Q4JIM4|PSN1_CHICK Presenilin-1 OS=Gallus gallus OX=9031 GN=PSEN1 PE=1 SV=1 PSN1_CHICK reviewed Presenilin-1 (PS-1) (EC 3.4.23.-) [Cleaved into: Presenilin-1 NTF subunit; Presenilin-1 CTF subunit] Gallus gallus (Chicken) GO:0000139; GO:0005739; GO:0005783; GO:0005789; GO:0005794; GO:0005886; GO:0006509; GO:0006915; GO:0007155; GO:0007219; GO:0016020; GO:0016485; GO:0030424; GO:0034205; GO:0035556; GO:0042500; GO:0042982; GO:0045202; GO:0055074; GO:0060090; GO:0060828; GO:0070765 amyloid precursor protein metabolic process [GO:0042982]; amyloid-beta formation [GO:0034205]; apoptotic process [GO:0006915]; calcium ion homeostasis [GO:0055074]; cell adhesion [GO:0007155]; intracellular signal transduction [GO:0035556]; membrane protein ectodomain proteolysis [GO:0006509]; Notch signaling pathway [GO:0007219]; protein processing [GO:0016485]; regulation of canonical Wnt signaling pathway [GO:0060828] axon [GO:0030424]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; gamma-secretase complex [GO:0070765]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; synapse [GO:0045202] aspartic endopeptidase activity, intramembrane cleaving [GO:0042500]; molecular adaptor activity [GO:0060090] g3616.t1 Q9JLB4 23.612 1063 2.4199999999999997e-52 206.0 sp|Q9JLB4|CUBN_MOUSE Cubilin OS=Mus musculus OX=10090 GN=Cubn PE=1 SV=3 CUBN_MOUSE reviewed Cubilin (Intrinsic factor-cobalamin receptor) Mus musculus (Mouse) GO:0001701; GO:0005509; GO:0005737; GO:0005765; GO:0005768; GO:0005783; GO:0005794; GO:0005798; GO:0005903; GO:0005905; GO:0006898; GO:0007584; GO:0008203; GO:0009617; GO:0015889; GO:0016020; GO:0016324; GO:0020028; GO:0030135; GO:0030139; GO:0030492; GO:0030666; GO:0031419; GO:0031526; GO:0031528; GO:0032991; GO:0038023; GO:0038024; GO:0042366; GO:0042802; GO:0042803; GO:0042953; GO:0043202; GO:0043235; GO:0045177; GO:0070062 cholesterol metabolic process [GO:0008203]; cobalamin catabolic process [GO:0042366]; cobalamin transport [GO:0015889]; endocytic hemoglobin import into cell [GO:0020028]; in utero embryonic development [GO:0001701]; lipoprotein transport [GO:0042953]; receptor-mediated endocytosis [GO:0006898]; response to bacterium [GO:0009617]; response to nutrient [GO:0007584] apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; brush border [GO:0005903]; brush border membrane [GO:0031526]; clathrin-coated pit [GO:0005905]; coated vesicle [GO:0030135]; cytoplasm [GO:0005737]; endocytic vesicle [GO:0030139]; endocytic vesicle membrane [GO:0030666]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi-associated vesicle [GO:0005798]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; microvillus membrane [GO:0031528]; protein-containing complex [GO:0032991]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; cargo receptor activity [GO:0038024]; cobalamin binding [GO:0031419]; hemoglobin binding [GO:0030492]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023] g3616.t1 Q9JLB4 23.778 1207 7.13e-50 199.0 sp|Q9JLB4|CUBN_MOUSE Cubilin OS=Mus musculus OX=10090 GN=Cubn PE=1 SV=3 CUBN_MOUSE reviewed Cubilin (Intrinsic factor-cobalamin receptor) Mus musculus (Mouse) GO:0001701; GO:0005509; GO:0005737; GO:0005765; GO:0005768; GO:0005783; GO:0005794; GO:0005798; GO:0005903; GO:0005905; GO:0006898; GO:0007584; GO:0008203; GO:0009617; GO:0015889; GO:0016020; GO:0016324; GO:0020028; GO:0030135; GO:0030139; GO:0030492; GO:0030666; GO:0031419; GO:0031526; GO:0031528; GO:0032991; GO:0038023; GO:0038024; GO:0042366; GO:0042802; GO:0042803; GO:0042953; GO:0043202; GO:0043235; GO:0045177; GO:0070062 cholesterol metabolic process [GO:0008203]; cobalamin catabolic process [GO:0042366]; cobalamin transport [GO:0015889]; endocytic hemoglobin import into cell [GO:0020028]; in utero embryonic development [GO:0001701]; lipoprotein transport [GO:0042953]; receptor-mediated endocytosis [GO:0006898]; response to bacterium [GO:0009617]; response to nutrient [GO:0007584] apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; brush border [GO:0005903]; brush border membrane [GO:0031526]; clathrin-coated pit [GO:0005905]; coated vesicle [GO:0030135]; cytoplasm [GO:0005737]; endocytic vesicle [GO:0030139]; endocytic vesicle membrane [GO:0030666]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi-associated vesicle [GO:0005798]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; microvillus membrane [GO:0031528]; protein-containing complex [GO:0032991]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; cargo receptor activity [GO:0038024]; cobalamin binding [GO:0031419]; hemoglobin binding [GO:0030492]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023] g3616.t1 Q9JLB4 23.145 1024 1.46e-33 145.0 sp|Q9JLB4|CUBN_MOUSE Cubilin OS=Mus musculus OX=10090 GN=Cubn PE=1 SV=3 CUBN_MOUSE reviewed Cubilin (Intrinsic factor-cobalamin receptor) Mus musculus (Mouse) GO:0001701; GO:0005509; GO:0005737; GO:0005765; GO:0005768; GO:0005783; GO:0005794; GO:0005798; GO:0005903; GO:0005905; GO:0006898; GO:0007584; GO:0008203; GO:0009617; GO:0015889; GO:0016020; GO:0016324; GO:0020028; GO:0030135; GO:0030139; GO:0030492; GO:0030666; GO:0031419; GO:0031526; GO:0031528; GO:0032991; GO:0038023; GO:0038024; GO:0042366; GO:0042802; GO:0042803; GO:0042953; GO:0043202; GO:0043235; GO:0045177; GO:0070062 cholesterol metabolic process [GO:0008203]; cobalamin catabolic process [GO:0042366]; cobalamin transport [GO:0015889]; endocytic hemoglobin import into cell [GO:0020028]; in utero embryonic development [GO:0001701]; lipoprotein transport [GO:0042953]; receptor-mediated endocytosis [GO:0006898]; response to bacterium [GO:0009617]; response to nutrient [GO:0007584] apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; brush border [GO:0005903]; brush border membrane [GO:0031526]; clathrin-coated pit [GO:0005905]; coated vesicle [GO:0030135]; cytoplasm [GO:0005737]; endocytic vesicle [GO:0030139]; endocytic vesicle membrane [GO:0030666]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi-associated vesicle [GO:0005798]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; microvillus membrane [GO:0031528]; protein-containing complex [GO:0032991]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; cargo receptor activity [GO:0038024]; cobalamin binding [GO:0031419]; hemoglobin binding [GO:0030492]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023] g3616.t1 Q9JLB4 23.922 1183 1.62e-32 142.0 sp|Q9JLB4|CUBN_MOUSE Cubilin OS=Mus musculus OX=10090 GN=Cubn PE=1 SV=3 CUBN_MOUSE reviewed Cubilin (Intrinsic factor-cobalamin receptor) Mus musculus (Mouse) GO:0001701; GO:0005509; GO:0005737; GO:0005765; GO:0005768; GO:0005783; GO:0005794; GO:0005798; GO:0005903; GO:0005905; GO:0006898; GO:0007584; GO:0008203; GO:0009617; GO:0015889; GO:0016020; GO:0016324; GO:0020028; GO:0030135; GO:0030139; GO:0030492; GO:0030666; GO:0031419; GO:0031526; GO:0031528; GO:0032991; GO:0038023; GO:0038024; GO:0042366; GO:0042802; GO:0042803; GO:0042953; GO:0043202; GO:0043235; GO:0045177; GO:0070062 cholesterol metabolic process [GO:0008203]; cobalamin catabolic process [GO:0042366]; cobalamin transport [GO:0015889]; endocytic hemoglobin import into cell [GO:0020028]; in utero embryonic development [GO:0001701]; lipoprotein transport [GO:0042953]; receptor-mediated endocytosis [GO:0006898]; response to bacterium [GO:0009617]; response to nutrient [GO:0007584] apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; brush border [GO:0005903]; brush border membrane [GO:0031526]; clathrin-coated pit [GO:0005905]; coated vesicle [GO:0030135]; cytoplasm [GO:0005737]; endocytic vesicle [GO:0030139]; endocytic vesicle membrane [GO:0030666]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi-associated vesicle [GO:0005798]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; microvillus membrane [GO:0031528]; protein-containing complex [GO:0032991]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; cargo receptor activity [GO:0038024]; cobalamin binding [GO:0031419]; hemoglobin binding [GO:0030492]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023] g3616.t1 Q9JLB4 24.493 690 8.010000000000001e-31 136.0 sp|Q9JLB4|CUBN_MOUSE Cubilin OS=Mus musculus OX=10090 GN=Cubn PE=1 SV=3 CUBN_MOUSE reviewed Cubilin (Intrinsic factor-cobalamin receptor) Mus musculus (Mouse) GO:0001701; GO:0005509; GO:0005737; GO:0005765; GO:0005768; GO:0005783; GO:0005794; GO:0005798; GO:0005903; GO:0005905; GO:0006898; GO:0007584; GO:0008203; GO:0009617; GO:0015889; GO:0016020; GO:0016324; GO:0020028; GO:0030135; GO:0030139; GO:0030492; GO:0030666; GO:0031419; GO:0031526; GO:0031528; GO:0032991; GO:0038023; GO:0038024; GO:0042366; GO:0042802; GO:0042803; GO:0042953; GO:0043202; GO:0043235; GO:0045177; GO:0070062 cholesterol metabolic process [GO:0008203]; cobalamin catabolic process [GO:0042366]; cobalamin transport [GO:0015889]; endocytic hemoglobin import into cell [GO:0020028]; in utero embryonic development [GO:0001701]; lipoprotein transport [GO:0042953]; receptor-mediated endocytosis [GO:0006898]; response to bacterium [GO:0009617]; response to nutrient [GO:0007584] apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; brush border [GO:0005903]; brush border membrane [GO:0031526]; clathrin-coated pit [GO:0005905]; coated vesicle [GO:0030135]; cytoplasm [GO:0005737]; endocytic vesicle [GO:0030139]; endocytic vesicle membrane [GO:0030666]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi-associated vesicle [GO:0005798]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; microvillus membrane [GO:0031528]; protein-containing complex [GO:0032991]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; cargo receptor activity [GO:0038024]; cobalamin binding [GO:0031419]; hemoglobin binding [GO:0030492]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023] g3616.t1 Q9JLB4 22.379 849 1.6600000000000001e-21 106.0 sp|Q9JLB4|CUBN_MOUSE Cubilin OS=Mus musculus OX=10090 GN=Cubn PE=1 SV=3 CUBN_MOUSE reviewed Cubilin (Intrinsic factor-cobalamin receptor) Mus musculus (Mouse) GO:0001701; GO:0005509; GO:0005737; GO:0005765; GO:0005768; GO:0005783; GO:0005794; GO:0005798; GO:0005903; GO:0005905; GO:0006898; GO:0007584; GO:0008203; GO:0009617; GO:0015889; GO:0016020; GO:0016324; GO:0020028; GO:0030135; GO:0030139; GO:0030492; GO:0030666; GO:0031419; GO:0031526; GO:0031528; GO:0032991; GO:0038023; GO:0038024; GO:0042366; GO:0042802; GO:0042803; GO:0042953; GO:0043202; GO:0043235; GO:0045177; GO:0070062 cholesterol metabolic process [GO:0008203]; cobalamin catabolic process [GO:0042366]; cobalamin transport [GO:0015889]; endocytic hemoglobin import into cell [GO:0020028]; in utero embryonic development [GO:0001701]; lipoprotein transport [GO:0042953]; receptor-mediated endocytosis [GO:0006898]; response to bacterium [GO:0009617]; response to nutrient [GO:0007584] apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; brush border [GO:0005903]; brush border membrane [GO:0031526]; clathrin-coated pit [GO:0005905]; coated vesicle [GO:0030135]; cytoplasm [GO:0005737]; endocytic vesicle [GO:0030139]; endocytic vesicle membrane [GO:0030666]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi-associated vesicle [GO:0005798]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; microvillus membrane [GO:0031528]; protein-containing complex [GO:0032991]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; cargo receptor activity [GO:0038024]; cobalamin binding [GO:0031419]; hemoglobin binding [GO:0030492]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023] g3617.t1 F1RWC3 30.793 328 1.38e-28 124.0 sp|F1RWC3|CUBN_PIG Cubilin OS=Sus scrofa OX=9823 GN=CUBN PE=1 SV=3 CUBN_PIG reviewed Cubilin (Intrinsic factor-cobalamin receptor) Sus scrofa (Pig) GO:0004252; GO:0005509; GO:0005615; GO:0005765; GO:0005768; GO:0005905; GO:0008203; GO:0015031; GO:0016324; GO:0031419 cholesterol metabolic process [GO:0008203]; protein transport [GO:0015031] apical plasma membrane [GO:0016324]; clathrin-coated pit [GO:0005905]; endosome [GO:0005768]; extracellular space [GO:0005615]; lysosomal membrane [GO:0005765] calcium ion binding [GO:0005509]; cobalamin binding [GO:0031419]; serine-type endopeptidase activity [GO:0004252] g3622.t1 G3V8R8 36.552 290 2.5599999999999997e-48 167.0 sp|G3V8R8|KCNK6_RAT Potassium channel subfamily K member 6 OS=Rattus norvegicus OX=10116 GN=Kcnk6 PE=1 SV=1 KCNK6_RAT reviewed Potassium channel subfamily K member 6 Rattus norvegicus (Rat) GO:0003073; GO:0003085; GO:0005267; GO:0005765; GO:0005886; GO:0015271; GO:0022841; GO:0031902; GO:0046872; GO:0060075; GO:0062196; GO:0071805; GO:1900227 negative regulation of systemic arterial blood pressure [GO:0003085]; positive regulation of NLRP3 inflammasome complex assembly [GO:1900227]; potassium ion transmembrane transport [GO:0071805]; regulation of lysosome size [GO:0062196]; regulation of resting membrane potential [GO:0060075]; regulation of systemic arterial blood pressure [GO:0003073] late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886] metal ion binding [GO:0046872]; outward rectifier potassium channel activity [GO:0015271]; potassium channel activity [GO:0005267]; potassium ion leak channel activity [GO:0022841] g3624.t1 Q9WTN5 27.042 551 6.43e-29 123.0 sp|Q9WTN5|TPC1_RAT Two pore calcium channel protein 1 OS=Rattus norvegicus OX=10116 GN=Tpcn1 PE=1 SV=2 TPC1_RAT reviewed Two pore calcium channel protein 1 (Voltage-dependent calcium channel protein TPC1) Rattus norvegicus (Rat) GO:0005248; GO:0005765; GO:0010008; GO:0010508; GO:0015280; GO:0016020; GO:0019905; GO:0022832; GO:0031901; GO:0034702; GO:0035725; GO:0036019; GO:0042802; GO:0042803; GO:0055038; GO:0072345; GO:0075509; GO:0080025; GO:0097682 endocytosis involved in viral entry into host cell [GO:0075509]; positive regulation of autophagy [GO:0010508]; sodium ion transmembrane transport [GO:0035725] early endosome membrane [GO:0031901]; endolysosome [GO:0036019]; endosome membrane [GO:0010008]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; monoatomic ion channel complex [GO:0034702]; recycling endosome membrane [GO:0055038] identical protein binding [GO:0042802]; intracellularly phosphatidylinositol-3,5-bisphosphate-gated monatomic cation channel activity [GO:0097682]; ligand-gated sodium channel activity [GO:0015280]; NAADP-sensitive calcium-release channel activity [GO:0072345]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; protein homodimerization activity [GO:0042803]; syntaxin binding [GO:0019905]; voltage-gated channel activity [GO:0022832]; voltage-gated sodium channel activity [GO:0005248] g3624.t1 Q9WTN5 55.0 20 6.43e-29 27.3 sp|Q9WTN5|TPC1_RAT Two pore calcium channel protein 1 OS=Rattus norvegicus OX=10116 GN=Tpcn1 PE=1 SV=2 TPC1_RAT reviewed Two pore calcium channel protein 1 (Voltage-dependent calcium channel protein TPC1) Rattus norvegicus (Rat) GO:0005248; GO:0005765; GO:0010008; GO:0010508; GO:0015280; GO:0016020; GO:0019905; GO:0022832; GO:0031901; GO:0034702; GO:0035725; GO:0036019; GO:0042802; GO:0042803; GO:0055038; GO:0072345; GO:0075509; GO:0080025; GO:0097682 endocytosis involved in viral entry into host cell [GO:0075509]; positive regulation of autophagy [GO:0010508]; sodium ion transmembrane transport [GO:0035725] early endosome membrane [GO:0031901]; endolysosome [GO:0036019]; endosome membrane [GO:0010008]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; monoatomic ion channel complex [GO:0034702]; recycling endosome membrane [GO:0055038] identical protein binding [GO:0042802]; intracellularly phosphatidylinositol-3,5-bisphosphate-gated monatomic cation channel activity [GO:0097682]; ligand-gated sodium channel activity [GO:0015280]; NAADP-sensitive calcium-release channel activity [GO:0072345]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; protein homodimerization activity [GO:0042803]; syntaxin binding [GO:0019905]; voltage-gated channel activity [GO:0022832]; voltage-gated sodium channel activity [GO:0005248] g3625.t1 Q9Y575 33.147 537 3.33e-74 247.0 sp|Q9Y575|ASB3_HUMAN Ankyrin repeat and SOCS box protein 3 OS=Homo sapiens OX=9606 GN=ASB3 PE=1 SV=1 g3626.t1 Q86V25 58.661 254 5.34e-114 338.0 sp|Q86V25|VASH2_HUMAN Tubulinyl-Tyr carboxypeptidase 2 OS=Homo sapiens OX=9606 GN=VASH2 PE=1 SV=2 g3627.t1 Q96GC5 45.283 106 9.049999999999999e-23 94.0 sp|Q96GC5|RM48_HUMAN Large ribosomal subunit protein mL48 OS=Homo sapiens OX=9606 GN=MRPL48 PE=1 SV=2 g3631.t1 Q8AWD2 49.451 182 5.0799999999999996e-48 165.0 sp|Q8AWD2|MOCS3_DANRE Adenylyltransferase and sulfurtransferase MOCS3 OS=Danio rerio OX=7955 GN=mocs3 PE=2 SV=1 MOCS3_DANRE reviewed Adenylyltransferase and sulfurtransferase MOCS3 (Molybdenum cofactor synthesis protein 3) [Includes: Molybdopterin-synthase adenylyltransferase (EC 2.7.7.80) (Adenylyltransferase MOCS3) (Sulfur carrier protein MOCS2A adenylyltransferase); Molybdopterin-synthase sulfurtransferase (EC 2.8.1.11) (Sulfur carrier protein MOCS2A sulfurtransferase) (Sulfurtransferase MOCS3)] Danio rerio (Zebrafish) (Brachydanio rerio) GO:0002098; GO:0002143; GO:0004792; GO:0005524; GO:0005737; GO:0005829; GO:0006777; GO:0016779; GO:0016783; GO:0032447; GO:0034227; GO:0042292; GO:0046872; GO:0061604; GO:0061605 Mo-molybdopterin cofactor biosynthetic process [GO:0006777]; protein urmylation [GO:0032447]; tRNA thio-modification [GO:0034227]; tRNA wobble position uridine thiolation [GO:0002143]; tRNA wobble uridine modification [GO:0002098] cytoplasm [GO:0005737]; cytosol [GO:0005829] ATP binding [GO:0005524]; metal ion binding [GO:0046872]; molybdopterin-synthase adenylyltransferase activity [GO:0061605]; molybdopterin-synthase sulfurtransferase activity [GO:0061604]; nucleotidyltransferase activity [GO:0016779]; sulfurtransferase activity [GO:0016783]; thiosulfate-cyanide sulfurtransferase activity [GO:0004792]; URM1 activating enzyme activity [GO:0042292] g3632.t1 Q8AWD2 60.135 148 1.81e-40 145.0 sp|Q8AWD2|MOCS3_DANRE Adenylyltransferase and sulfurtransferase MOCS3 OS=Danio rerio OX=7955 GN=mocs3 PE=2 SV=1 MOCS3_DANRE reviewed Adenylyltransferase and sulfurtransferase MOCS3 (Molybdenum cofactor synthesis protein 3) [Includes: Molybdopterin-synthase adenylyltransferase (EC 2.7.7.80) (Adenylyltransferase MOCS3) (Sulfur carrier protein MOCS2A adenylyltransferase); Molybdopterin-synthase sulfurtransferase (EC 2.8.1.11) (Sulfur carrier protein MOCS2A sulfurtransferase) (Sulfurtransferase MOCS3)] Danio rerio (Zebrafish) (Brachydanio rerio) GO:0002098; GO:0002143; GO:0004792; GO:0005524; GO:0005737; GO:0005829; GO:0006777; GO:0016779; GO:0016783; GO:0032447; GO:0034227; GO:0042292; GO:0046872; GO:0061604; GO:0061605 Mo-molybdopterin cofactor biosynthetic process [GO:0006777]; protein urmylation [GO:0032447]; tRNA thio-modification [GO:0034227]; tRNA wobble position uridine thiolation [GO:0002143]; tRNA wobble uridine modification [GO:0002098] cytoplasm [GO:0005737]; cytosol [GO:0005829] ATP binding [GO:0005524]; metal ion binding [GO:0046872]; molybdopterin-synthase adenylyltransferase activity [GO:0061605]; molybdopterin-synthase sulfurtransferase activity [GO:0061604]; nucleotidyltransferase activity [GO:0016779]; sulfurtransferase activity [GO:0016783]; thiosulfate-cyanide sulfurtransferase activity [GO:0004792]; URM1 activating enzyme activity [GO:0042292] g3637.t1 P14866 49.474 95 4.7500000000000003e-26 103.0 sp|P14866|HNRPL_HUMAN Heterogeneous nuclear ribonucleoprotein L OS=Homo sapiens OX=9606 GN=HNRNPL PE=1 SV=2 HNRPL_HUMAN reviewed Heterogeneous nuclear ribonucleoprotein L (hnRNP L) Homo sapiens (Human) GO:0000381; GO:0000785; GO:0000976; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0005737; GO:0006396; GO:0006397; GO:0016020; GO:0035770; GO:0043484; GO:0045120; GO:0045202; GO:0045892; GO:0070062; GO:0097157; GO:1990904 mRNA processing [GO:0006397]; negative regulation of DNA-templated transcription [GO:0045892]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of RNA splicing [GO:0043484]; RNA processing [GO:0006396] chromatin [GO:0000785]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pronucleus [GO:0045120]; ribonucleoprotein complex [GO:1990904]; ribonucleoprotein granule [GO:0035770]; synapse [GO:0045202] mRNA binding [GO:0003729]; pre-mRNA intronic binding [GO:0097157]; RNA binding [GO:0003723]; transcription cis-regulatory region binding [GO:0000976] g3638.t1 Q8R081 51.055 237 2.64e-69 233.0 sp|Q8R081|HNRPL_MOUSE Heterogeneous nuclear ribonucleoprotein L OS=Mus musculus OX=10090 GN=Hnrnpl PE=1 SV=2 HNRPL_MOUSE reviewed Heterogeneous nuclear ribonucleoprotein L (hnRNP L) Mus musculus (Mouse) GO:0000381; GO:0000785; GO:0000976; GO:0003723; GO:0003729; GO:0003730; GO:0005634; GO:0005654; GO:0005737; GO:0006397; GO:0034198; GO:0035770; GO:0043484; GO:0045120; GO:0045202; GO:0045727; GO:0045892; GO:0048025; GO:0048471; GO:0097157; GO:1990715; GO:1990904 cellular response to amino acid starvation [GO:0034198]; mRNA processing [GO:0006397]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; positive regulation of translation [GO:0045727]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of RNA splicing [GO:0043484] chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; pronucleus [GO:0045120]; ribonucleoprotein complex [GO:1990904]; ribonucleoprotein granule [GO:0035770]; synapse [GO:0045202] mRNA 3'-UTR binding [GO:0003730]; mRNA binding [GO:0003729]; mRNA CDS binding [GO:1990715]; pre-mRNA intronic binding [GO:0097157]; RNA binding [GO:0003723]; transcription cis-regulatory region binding [GO:0000976] g3639.t1 Q15643 31.278 227 4.8e-22 108.0 sp|Q15643|TRIPB_HUMAN Thyroid receptor-interacting protein 11 OS=Homo sapiens OX=9606 GN=TRIP11 PE=1 SV=3 TRIPB_HUMAN reviewed Thyroid receptor-interacting protein 11 (TR-interacting protein 11) (TRIP-11) (Clonal evolution-related gene on chromosome 14 protein) (Golgi-associated microtubule-binding protein 210) (GMAP-210) (Trip230) Homo sapiens (Human) GO:0000139; GO:0002080; GO:0003281; GO:0003413; GO:0003713; GO:0005793; GO:0005794; GO:0005801; GO:0005856; GO:0005929; GO:0006366; GO:0006888; GO:0007030; GO:0030133; GO:0031267; GO:0033116; GO:0051216; GO:0060122; GO:0071806; GO:0090161; GO:0099041 cartilage development [GO:0051216]; chondrocyte differentiation involved in endochondral bone morphogenesis [GO:0003413]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; Golgi ribbon formation [GO:0090161]; inner ear receptor cell stereocilium organization [GO:0060122]; protein transmembrane transport [GO:0071806]; transcription by RNA polymerase II [GO:0006366]; ventricular septum development [GO:0003281]; vesicle tethering to Golgi [GO:0099041] acrosomal membrane [GO:0002080]; cilium [GO:0005929]; cis-Golgi network [GO:0005801]; cytoskeleton [GO:0005856]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; transport vesicle [GO:0030133] small GTPase binding [GO:0031267]; transcription coactivator activity [GO:0003713] g3640.t1 Q15643 37.027 370 1.69e-37 156.0 sp|Q15643|TRIPB_HUMAN Thyroid receptor-interacting protein 11 OS=Homo sapiens OX=9606 GN=TRIP11 PE=1 SV=3 TRIPB_HUMAN reviewed Thyroid receptor-interacting protein 11 (TR-interacting protein 11) (TRIP-11) (Clonal evolution-related gene on chromosome 14 protein) (Golgi-associated microtubule-binding protein 210) (GMAP-210) (Trip230) Homo sapiens (Human) GO:0000139; GO:0002080; GO:0003281; GO:0003413; GO:0003713; GO:0005793; GO:0005794; GO:0005801; GO:0005856; GO:0005929; GO:0006366; GO:0006888; GO:0007030; GO:0030133; GO:0031267; GO:0033116; GO:0051216; GO:0060122; GO:0071806; GO:0090161; GO:0099041 cartilage development [GO:0051216]; chondrocyte differentiation involved in endochondral bone morphogenesis [GO:0003413]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; Golgi ribbon formation [GO:0090161]; inner ear receptor cell stereocilium organization [GO:0060122]; protein transmembrane transport [GO:0071806]; transcription by RNA polymerase II [GO:0006366]; ventricular septum development [GO:0003281]; vesicle tethering to Golgi [GO:0099041] acrosomal membrane [GO:0002080]; cilium [GO:0005929]; cis-Golgi network [GO:0005801]; cytoskeleton [GO:0005856]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; transport vesicle [GO:0030133] small GTPase binding [GO:0031267]; transcription coactivator activity [GO:0003713] g3641.t1 Q9NS73 39.103 312 4.2099999999999995e-52 177.0 sp|Q9NS73|MBIP1_HUMAN MAP3K12-binding inhibitory protein 1 OS=Homo sapiens OX=9606 GN=MBIP PE=1 SV=2 MBIP1_HUMAN reviewed MAP3K12-binding inhibitory protein 1 (MAPK upstream kinase-binding inhibitory protein) (MUK-binding inhibitory protein) Homo sapiens (Human) GO:0000122; GO:0004860; GO:0005654; GO:0005730; GO:0005829; GO:0006355; GO:0006357; GO:0010628; GO:0042802; GO:0045995; GO:0046330; GO:0051302; GO:0051726; GO:0072686; GO:0140672 negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of gene expression [GO:0010628]; positive regulation of JNK cascade [GO:0046330]; regulation of cell cycle [GO:0051726]; regulation of cell division [GO:0051302]; regulation of DNA-templated transcription [GO:0006355]; regulation of embryonic development [GO:0045995]; regulation of transcription by RNA polymerase II [GO:0006357] ATAC complex [GO:0140672]; cytosol [GO:0005829]; mitotic spindle [GO:0072686]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654] identical protein binding [GO:0042802]; protein kinase inhibitor activity [GO:0004860] g3645.t1 Q4R834 53.102 403 5.699999999999999e-134 392.0 sp|Q4R834|SIR2_MACFA NAD-dependent protein deacetylase sirtuin-2 OS=Macaca fascicularis OX=9541 GN=SIRT2 PE=2 SV=1 SIR2_MACFA reviewed NAD-dependent protein deacetylase sirtuin-2 (EC 2.3.1.286) (NAD-dependent protein deacylase sirtuin-2) (EC 2.3.1.-) (NAD-dependent protein defatty-acylase sirtuin-2) (EC 2.3.1.-) (Regulatory protein SIR2 homolog 2) (SIR2-like protein 2) Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey) GO:0000122; GO:0000792; GO:0003682; GO:0004407; GO:0005634; GO:0005694; GO:0005737; GO:0005813; GO:0005814; GO:0005819; GO:0005829; GO:0005874; GO:0006476; GO:0010507; GO:0010801; GO:0016042; GO:0022011; GO:0030426; GO:0030496; GO:0031641; GO:0032436; GO:0033010; GO:0033270; GO:0033558; GO:0034599; GO:0034979; GO:0034983; GO:0040029; GO:0042177; GO:0042903; GO:0043161; GO:0043204; GO:0043209; GO:0043219; GO:0043220; GO:0043388; GO:0044224; GO:0045599; GO:0045836; GO:0045944; GO:0046872; GO:0046890; GO:0046970; GO:0048471; GO:0051301; GO:0051726; GO:0051781; GO:0051987; GO:0061433; GO:0062013; GO:0070403; GO:0070446; GO:0071456; GO:0071872; GO:0072686; GO:0072687; GO:0090042; GO:0097386; GO:0140219; GO:0140228; GO:0140773; GO:0140774; GO:1900119; GO:1900195; GO:2000378 cell division [GO:0051301]; cellular response to caloric restriction [GO:0061433]; cellular response to epinephrine stimulus [GO:0071872]; cellular response to hypoxia [GO:0071456]; cellular response to oxidative stress [GO:0034599]; epigenetic regulation of gene expression [GO:0040029]; lipid catabolic process [GO:0016042]; myelination in peripheral nervous system [GO:0022011]; negative regulation of autophagy [GO:0010507]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of oligodendrocyte progenitor proliferation [GO:0070446]; negative regulation of peptidyl-threonine phosphorylation [GO:0010801]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; negative regulation of transcription by RNA polymerase II [GO:0000122]; peptidyl-lysine deacetylation [GO:0034983]; positive regulation of attachment of spindle microtubules to kinetochore [GO:0051987]; positive regulation of cell division [GO:0051781]; positive regulation of DNA binding [GO:0043388]; positive regulation of execution phase of apoptosis [GO:1900119]; positive regulation of meiotic nuclear division [GO:0045836]; positive regulation of oocyte maturation [GO:1900195]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of small molecule metabolic process [GO:0062013]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deacetylation [GO:0006476]; regulation of cell cycle [GO:0051726]; regulation of lipid biosynthetic process [GO:0046890]; regulation of myelination [GO:0031641]; tubulin deacetylation [GO:0090042] centriole [GO:0005814]; centrosome [GO:0005813]; chromosome [GO:0005694]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; glial cell projection [GO:0097386]; growth cone [GO:0030426]; heterochromatin [GO:0000792]; juxtaparanode region of axon [GO:0044224]; lateral loop [GO:0043219]; meiotic spindle [GO:0072687]; microtubule [GO:0005874]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; myelin sheath [GO:0043209]; nucleus [GO:0005634]; paranodal junction [GO:0033010]; paranode region of axon [GO:0033270]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; Schmidt-Lanterman incisure [GO:0043220]; spindle [GO:0005819] chromatin binding [GO:0003682]; histone benzoyllysine debenzoylase activity [GO:0140228]; histone deacetylase activity [GO:0004407]; histone H4K16 deacetylase activity, NAD-dependent [GO:0046970]; histone methacryllysine demethacrylase activity [GO:0140219]; metal ion binding [GO:0046872]; NAD+ binding [GO:0070403]; NAD-dependent protein demyristoylase activity [GO:0140773]; NAD-dependent protein depalmitoylase activity [GO:0140774]; NAD-dependent protein lysine deacetylase activity [GO:0034979]; protein lysine deacetylase activity [GO:0033558]; tubulin deacetylase activity [GO:0042903] g3646.t1 Q9QYF1 53.974 302 2.67e-99 298.0 sp|Q9QYF1|RDH11_MOUSE Retinol dehydrogenase 11 OS=Mus musculus OX=10090 GN=Rdh11 PE=1 SV=2 RDH11_MOUSE reviewed Retinol dehydrogenase 11 (EC 1.1.1.300) (Androgen-regulated short-chain dehydrogenase/reductase 1) (Cell line MC/9.IL4-derived protein 1) (M42C60) (Prostate short-chain dehydrogenase/reductase 1) (Retinal reductase 1) (RalR1) (Short-chain aldehyde dehydrogenase) (SCALD) Mus musculus (Mouse) GO:0001523; GO:0001917; GO:0004745; GO:0005789; GO:0007601; GO:0033721; GO:0042572; GO:0042574; GO:0052650; GO:0102354; GO:0110095 cellular detoxification of aldehyde [GO:0110095]; retinal metabolic process [GO:0042574]; retinoid metabolic process [GO:0001523]; retinol metabolic process [GO:0042572]; visual perception [GO:0007601] endoplasmic reticulum membrane [GO:0005789]; photoreceptor inner segment [GO:0001917] 11-cis-retinol dehydrogenase (NADP+) activity [GO:0102354]; aldehyde dehydrogenase (NADP+) activity [GO:0033721]; all-trans-retinol dehydrogenase (NAD+) activity [GO:0004745]; all-trans-retinol dehydrogenase (NADP+) activity [GO:0052650] g3648.t1 Q8NBN7 54.333 300 7.9699999999999995e-84 258.0 sp|Q8NBN7|RDH13_HUMAN Retinol dehydrogenase 13 OS=Homo sapiens OX=9606 GN=RDH13 PE=1 SV=2 g3650.t1 C9JTQ0 44.966 149 1.11e-33 134.0 sp|C9JTQ0|ANR63_HUMAN Ankyrin repeat domain-containing protein 63 OS=Homo sapiens OX=9606 GN=ANKRD63 PE=1 SV=1 g3658.t1 Q5DU37 37.455 825 7.5099999999999994e-149 511.0 sp|Q5DU37|ZFY26_MOUSE Zinc finger FYVE domain-containing protein 26 OS=Mus musculus OX=10090 GN=Zfyve26 PE=1 SV=2 ZFY26_MOUSE reviewed Zinc finger FYVE domain-containing protein 26 Mus musculus (Mouse) GO:0000281; GO:0000724; GO:0005764; GO:0005769; GO:0005770; GO:0005813; GO:0007040; GO:0008270; GO:0019901; GO:0030496; GO:0032266; GO:0032465; GO:1905037 autophagosome organization [GO:1905037]; double-strand break repair via homologous recombination [GO:0000724]; lysosome organization [GO:0007040]; mitotic cytokinesis [GO:0000281]; regulation of cytokinesis [GO:0032465] centrosome [GO:0005813]; early endosome [GO:0005769]; late endosome [GO:0005770]; lysosome [GO:0005764]; midbody [GO:0030496] phosphatidylinositol-3-phosphate binding [GO:0032266]; protein kinase binding [GO:0019901]; zinc ion binding [GO:0008270] g3658.t1 Q5DU37 30.303 396 5.14e-34 147.0 sp|Q5DU37|ZFY26_MOUSE Zinc finger FYVE domain-containing protein 26 OS=Mus musculus OX=10090 GN=Zfyve26 PE=1 SV=2 ZFY26_MOUSE reviewed Zinc finger FYVE domain-containing protein 26 Mus musculus (Mouse) GO:0000281; GO:0000724; GO:0005764; GO:0005769; GO:0005770; GO:0005813; GO:0007040; GO:0008270; GO:0019901; GO:0030496; GO:0032266; GO:0032465; GO:1905037 autophagosome organization [GO:1905037]; double-strand break repair via homologous recombination [GO:0000724]; lysosome organization [GO:0007040]; mitotic cytokinesis [GO:0000281]; regulation of cytokinesis [GO:0032465] centrosome [GO:0005813]; early endosome [GO:0005769]; late endosome [GO:0005770]; lysosome [GO:0005764]; midbody [GO:0030496] phosphatidylinositol-3-phosphate binding [GO:0032266]; protein kinase binding [GO:0019901]; zinc ion binding [GO:0008270] g3660.t1 D2H5P6 23.601 822 4.2100000000000006e-27 123.0 sp|D2H5P6|ZFY26_AILME Zinc finger FYVE domain-containing protein 26 OS=Ailuropoda melanoleuca OX=9646 GN=ZFYVE26 PE=3 SV=1 ZFY26_AILME reviewed Zinc finger FYVE domain-containing protein 26 Ailuropoda melanoleuca (Giant panda) GO:0000281; GO:0000724; GO:0005765; GO:0005769; GO:0005770; GO:0005813; GO:0007040; GO:0008270; GO:0019901; GO:0030496; GO:0032266; GO:0032465; GO:1905037 autophagosome organization [GO:1905037]; double-strand break repair via homologous recombination [GO:0000724]; lysosome organization [GO:0007040]; mitotic cytokinesis [GO:0000281]; regulation of cytokinesis [GO:0032465] centrosome [GO:0005813]; early endosome [GO:0005769]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; midbody [GO:0030496] phosphatidylinositol-3-phosphate binding [GO:0032266]; protein kinase binding [GO:0019901]; zinc ion binding [GO:0008270] g3660.t2 D2H5P6 23.601 822 3.9600000000000006e-27 123.0 sp|D2H5P6|ZFY26_AILME Zinc finger FYVE domain-containing protein 26 OS=Ailuropoda melanoleuca OX=9646 GN=ZFYVE26 PE=3 SV=1 ZFY26_AILME reviewed Zinc finger FYVE domain-containing protein 26 Ailuropoda melanoleuca (Giant panda) GO:0000281; GO:0000724; GO:0005765; GO:0005769; GO:0005770; GO:0005813; GO:0007040; GO:0008270; GO:0019901; GO:0030496; GO:0032266; GO:0032465; GO:1905037 autophagosome organization [GO:1905037]; double-strand break repair via homologous recombination [GO:0000724]; lysosome organization [GO:0007040]; mitotic cytokinesis [GO:0000281]; regulation of cytokinesis [GO:0032465] centrosome [GO:0005813]; early endosome [GO:0005769]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; midbody [GO:0030496] phosphatidylinositol-3-phosphate binding [GO:0032266]; protein kinase binding [GO:0019901]; zinc ion binding [GO:0008270] g3661.t1 Q8UVR5 37.324 142 4.79e-24 106.0 sp|Q8UVR5|BAZ1A_XENLA Bromodomain adjacent to zinc finger domain protein 1A (Fragment) OS=Xenopus laevis OX=8355 GN=baz1a PE=1 SV=1 g3663.t1 Q9NRL2 35.385 520 3.7e-65 248.0 sp|Q9NRL2|BAZ1A_HUMAN Bromodomain adjacent to zinc finger domain protein 1A OS=Homo sapiens OX=9606 GN=BAZ1A PE=1 SV=2 g3663.t1 Q9NRL2 43.571 280 1.11e-60 233.0 sp|Q9NRL2|BAZ1A_HUMAN Bromodomain adjacent to zinc finger domain protein 1A OS=Homo sapiens OX=9606 GN=BAZ1A PE=1 SV=2 g3663.t1 Q9NRL2 44.961 258 2.34e-59 229.0 sp|Q9NRL2|BAZ1A_HUMAN Bromodomain adjacent to zinc finger domain protein 1A OS=Homo sapiens OX=9606 GN=BAZ1A PE=1 SV=2 g3665.t1 Q2TBI8 44.654 159 6.779999999999999e-42 144.0 sp|Q2TBI8|NUD22_BOVIN Uridine diphosphate glucose pyrophosphatase NUDT22 OS=Bos taurus OX=9913 GN=NUDT22 PE=2 SV=1 g3666.t1 Q5TYW6 49.458 277 1.86e-96 286.0 sp|Q5TYW6|RSPH9_DANRE Radial spoke head protein 9 homolog OS=Danio rerio OX=7955 GN=rsph9 PE=1 SV=1 RSPH9_DANRE reviewed Radial spoke head protein 9 homolog Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001535; GO:0003341; GO:0005929; GO:0005930; GO:0031514; GO:0035082; GO:0036126; GO:0044458; GO:0060091; GO:0060271; GO:0060294; GO:0062177; GO:0097729; GO:1904158 axonemal central apparatus assembly [GO:1904158]; axoneme assembly [GO:0035082]; cilium assembly [GO:0060271]; cilium movement [GO:0003341]; cilium movement involved in cell motility [GO:0060294]; motile cilium assembly [GO:0044458]; radial spoke assembly [GO:0062177] 9+2 motile cilium [GO:0097729]; axoneme [GO:0005930]; cilium [GO:0005929]; kinocilium [GO:0060091]; motile cilium [GO:0031514]; radial spoke head [GO:0001535]; sperm flagellum [GO:0036126] g3667.t1 Q9NVS2 42.466 146 3.1400000000000002e-31 114.0 sp|Q9NVS2|RT18A_HUMAN Large ribosomal subunit protein mL66 OS=Homo sapiens OX=9606 GN=MRPS18A PE=1 SV=1 g3668.t1 Q75WS4 62.984 516 0.0 678.0 sp|Q75WS4|CRYD_XENLA Cryptochrome DASH OS=Xenopus laevis OX=8355 GN=cry-dash PE=2 SV=1 g3671.t1 P05094 65.103 874 0.0 1163.0 sp|P05094|ACTN1_CHICK Alpha-actinin-1 OS=Gallus gallus OX=9031 GN=ACTN1 PE=1 SV=3 g3671.t2 P05094 65.446 874 0.0 1166.0 sp|P05094|ACTN1_CHICK Alpha-actinin-1 OS=Gallus gallus OX=9031 GN=ACTN1 PE=1 SV=3 g3671.t3 P05094 65.332 874 0.0 1162.0 sp|P05094|ACTN1_CHICK Alpha-actinin-1 OS=Gallus gallus OX=9031 GN=ACTN1 PE=1 SV=3 g3671.t4 A5D7D1 63.878 753 0.0 970.0 sp|A5D7D1|ACTN4_BOVIN Alpha-actinin-4 OS=Bos taurus OX=9913 GN=ACTN4 PE=2 SV=1 ACTN4_BOVIN reviewed Alpha-actinin-4 (Non-muscle alpha-actinin 4) Bos taurus (Bovine) GO:0001725; GO:0003713; GO:0005509; GO:0005634; GO:0005737; GO:0005886; GO:0015031; GO:0030018; GO:0030036; GO:0030054; GO:0030864; GO:0035357; GO:0042995; GO:0048384; GO:0048471; GO:0051015; GO:0055001; GO:0070161; GO:1990904 actin cytoskeleton organization [GO:0030036]; muscle cell development [GO:0055001]; peroxisome proliferator activated receptor signaling pathway [GO:0035357]; protein transport [GO:0015031]; retinoic acid receptor signaling pathway [GO:0048384] anchoring junction [GO:0070161]; cell junction [GO:0030054]; cell projection [GO:0042995]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; ribonucleoprotein complex [GO:1990904]; stress fiber [GO:0001725]; Z disc [GO:0030018] actin filament binding [GO:0051015]; calcium ion binding [GO:0005509]; transcription coactivator activity [GO:0003713] g3672.t1 Q8R086 51.19 168 9.74e-57 179.0 sp|Q8R086|SUOX_MOUSE Sulfite oxidase, mitochondrial OS=Mus musculus OX=10090 GN=Suox PE=1 SV=2 g3672.t1 Q8R086 63.636 44 9.74e-57 63.5 sp|Q8R086|SUOX_MOUSE Sulfite oxidase, mitochondrial OS=Mus musculus OX=10090 GN=Suox PE=1 SV=2 g3673.t1 P07850 55.251 219 1.37e-74 236.0 sp|P07850|SUOX_CHICK Sulfite oxidase OS=Gallus gallus OX=9031 GN=SUOX PE=1 SV=3 g3680.t1 Q5SVZ6 26.596 470 2.01e-36 151.0 sp|Q5SVZ6|ZMYM1_HUMAN Zinc finger MYM-type protein 1 OS=Homo sapiens OX=9606 GN=ZMYM1 PE=1 SV=1 g3685.t1 A6QLH6 60.846 544 0.0 704.0 sp|A6QLH6|SCYL1_BOVIN N-terminal kinase-like protein OS=Bos taurus OX=9913 GN=SCYL1 PE=2 SV=1 SCYL1_BOVIN reviewed N-terminal kinase-like protein (SCY1-like protein 1) Bos taurus (Bovine) GO:0004672; GO:0005524; GO:0005793; GO:0005794; GO:0005801; GO:0005813; GO:0006890; GO:0030126 retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890] centrosome [GO:0005813]; cis-Golgi network [GO:0005801]; COPI vesicle coat [GO:0030126]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi apparatus [GO:0005794] ATP binding [GO:0005524]; protein kinase activity [GO:0004672] g3686.t1 Q92541 48.998 549 1.1900000000000001e-124 389.0 sp|Q92541|RTF1_HUMAN RNA polymerase-associated protein RTF1 homolog OS=Homo sapiens OX=9606 GN=RTF1 PE=1 SV=4 RTF1_HUMAN reviewed RNA polymerase-associated protein RTF1 homolog Homo sapiens (Human) GO:0000122; GO:0001711; GO:0001832; GO:0003697; GO:0003723; GO:0005654; GO:0005730; GO:0006325; GO:0006368; GO:0016055; GO:0016593; GO:0019827 blastocyst growth [GO:0001832]; chromatin organization [GO:0006325]; endodermal cell fate commitment [GO:0001711]; negative regulation of transcription by RNA polymerase II [GO:0000122]; stem cell population maintenance [GO:0019827]; transcription elongation by RNA polymerase II [GO:0006368]; Wnt signaling pathway [GO:0016055] Cdc73/Paf1 complex [GO:0016593]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654] RNA binding [GO:0003723]; single-stranded DNA binding [GO:0003697] g3686.t2 Q92541 51.882 372 2.1500000000000002e-105 339.0 sp|Q92541|RTF1_HUMAN RNA polymerase-associated protein RTF1 homolog OS=Homo sapiens OX=9606 GN=RTF1 PE=1 SV=4 RTF1_HUMAN reviewed RNA polymerase-associated protein RTF1 homolog Homo sapiens (Human) GO:0000122; GO:0001711; GO:0001832; GO:0003697; GO:0003723; GO:0005654; GO:0005730; GO:0006325; GO:0006368; GO:0016055; GO:0016593; GO:0019827 blastocyst growth [GO:0001832]; chromatin organization [GO:0006325]; endodermal cell fate commitment [GO:0001711]; negative regulation of transcription by RNA polymerase II [GO:0000122]; stem cell population maintenance [GO:0019827]; transcription elongation by RNA polymerase II [GO:0006368]; Wnt signaling pathway [GO:0016055] Cdc73/Paf1 complex [GO:0016593]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654] RNA binding [GO:0003723]; single-stranded DNA binding [GO:0003697] g3687.t1 Q96L50 41.346 416 9.55e-100 306.0 sp|Q96L50|LLR1_HUMAN Leucine-rich repeat protein 1 OS=Homo sapiens OX=9606 GN=LRR1 PE=1 SV=2 g3688.t1 Q9NR09 46.802 1970 0.0 1368.0 sp|Q9NR09|BIRC6_HUMAN Dual E2 ubiquitin-conjugating enzyme/E3 ubiquitin-protein ligase BIRC6 OS=Homo sapiens OX=9606 GN=BIRC6 PE=1 SV=3 BIRC6_HUMAN reviewed Dual E2 ubiquitin-conjugating enzyme/E3 ubiquitin-protein ligase BIRC6 (EC 2.3.2.24) (BIR repeat-containing ubiquitin-conjugating enzyme) (BRUCE) (Baculoviral IAP repeat-containing protein 6) (Ubiquitin-conjugating BIR domain enzyme apollon) (APOLLON) Homo sapiens (Human) GO:0000922; GO:0004842; GO:0004869; GO:0005634; GO:0005768; GO:0005802; GO:0005813; GO:0005815; GO:0005829; GO:0006468; GO:0006915; GO:0008283; GO:0008284; GO:0016020; GO:0016567; GO:0030496; GO:0032465; GO:0042127; GO:0043066; GO:0046872; GO:0051301; GO:0060711; GO:0061631; GO:0090543; GO:2001237 apoptotic process [GO:0006915]; cell division [GO:0051301]; cell population proliferation [GO:0008283]; labyrinthine layer development [GO:0060711]; negative regulation of apoptotic process [GO:0043066]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; positive regulation of cell population proliferation [GO:0008284]; protein phosphorylation [GO:0006468]; protein ubiquitination [GO:0016567]; regulation of cell population proliferation [GO:0042127]; regulation of cytokinesis [GO:0032465] centrosome [GO:0005813]; cytosol [GO:0005829]; endosome [GO:0005768]; Flemming body [GO:0090543]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]; nucleus [GO:0005634]; spindle pole [GO:0000922]; trans-Golgi network [GO:0005802] cysteine-type endopeptidase inhibitor activity [GO:0004869]; metal ion binding [GO:0046872]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842] g3688.t1 Q9NR09 36.384 1344 0.0 655.0 sp|Q9NR09|BIRC6_HUMAN Dual E2 ubiquitin-conjugating enzyme/E3 ubiquitin-protein ligase BIRC6 OS=Homo sapiens OX=9606 GN=BIRC6 PE=1 SV=3 BIRC6_HUMAN reviewed Dual E2 ubiquitin-conjugating enzyme/E3 ubiquitin-protein ligase BIRC6 (EC 2.3.2.24) (BIR repeat-containing ubiquitin-conjugating enzyme) (BRUCE) (Baculoviral IAP repeat-containing protein 6) (Ubiquitin-conjugating BIR domain enzyme apollon) (APOLLON) Homo sapiens (Human) GO:0000922; GO:0004842; GO:0004869; GO:0005634; GO:0005768; GO:0005802; GO:0005813; GO:0005815; GO:0005829; GO:0006468; GO:0006915; GO:0008283; GO:0008284; GO:0016020; GO:0016567; GO:0030496; GO:0032465; GO:0042127; GO:0043066; GO:0046872; GO:0051301; GO:0060711; GO:0061631; GO:0090543; GO:2001237 apoptotic process [GO:0006915]; cell division [GO:0051301]; cell population proliferation [GO:0008283]; labyrinthine layer development [GO:0060711]; negative regulation of apoptotic process [GO:0043066]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; positive regulation of cell population proliferation [GO:0008284]; protein phosphorylation [GO:0006468]; protein ubiquitination [GO:0016567]; regulation of cell population proliferation [GO:0042127]; regulation of cytokinesis [GO:0032465] centrosome [GO:0005813]; cytosol [GO:0005829]; endosome [GO:0005768]; Flemming body [GO:0090543]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]; nucleus [GO:0005634]; spindle pole [GO:0000922]; trans-Golgi network [GO:0005802] cysteine-type endopeptidase inhibitor activity [GO:0004869]; metal ion binding [GO:0046872]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842] g3688.t1 Q9NR09 34.526 950 6.8e-116 421.0 sp|Q9NR09|BIRC6_HUMAN Dual E2 ubiquitin-conjugating enzyme/E3 ubiquitin-protein ligase BIRC6 OS=Homo sapiens OX=9606 GN=BIRC6 PE=1 SV=3 BIRC6_HUMAN reviewed Dual E2 ubiquitin-conjugating enzyme/E3 ubiquitin-protein ligase BIRC6 (EC 2.3.2.24) (BIR repeat-containing ubiquitin-conjugating enzyme) (BRUCE) (Baculoviral IAP repeat-containing protein 6) (Ubiquitin-conjugating BIR domain enzyme apollon) (APOLLON) Homo sapiens (Human) GO:0000922; GO:0004842; GO:0004869; GO:0005634; GO:0005768; GO:0005802; GO:0005813; GO:0005815; GO:0005829; GO:0006468; GO:0006915; GO:0008283; GO:0008284; GO:0016020; GO:0016567; GO:0030496; GO:0032465; GO:0042127; GO:0043066; GO:0046872; GO:0051301; GO:0060711; GO:0061631; GO:0090543; GO:2001237 apoptotic process [GO:0006915]; cell division [GO:0051301]; cell population proliferation [GO:0008283]; labyrinthine layer development [GO:0060711]; negative regulation of apoptotic process [GO:0043066]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; positive regulation of cell population proliferation [GO:0008284]; protein phosphorylation [GO:0006468]; protein ubiquitination [GO:0016567]; regulation of cell population proliferation [GO:0042127]; regulation of cytokinesis [GO:0032465] centrosome [GO:0005813]; cytosol [GO:0005829]; endosome [GO:0005768]; Flemming body [GO:0090543]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]; nucleus [GO:0005634]; spindle pole [GO:0000922]; trans-Golgi network [GO:0005802] cysteine-type endopeptidase inhibitor activity [GO:0004869]; metal ion binding [GO:0046872]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842] g3688.t1 Q9NR09 47.847 418 2.48e-114 416.0 sp|Q9NR09|BIRC6_HUMAN Dual E2 ubiquitin-conjugating enzyme/E3 ubiquitin-protein ligase BIRC6 OS=Homo sapiens OX=9606 GN=BIRC6 PE=1 SV=3 BIRC6_HUMAN reviewed Dual E2 ubiquitin-conjugating enzyme/E3 ubiquitin-protein ligase BIRC6 (EC 2.3.2.24) (BIR repeat-containing ubiquitin-conjugating enzyme) (BRUCE) (Baculoviral IAP repeat-containing protein 6) (Ubiquitin-conjugating BIR domain enzyme apollon) (APOLLON) Homo sapiens (Human) GO:0000922; GO:0004842; GO:0004869; GO:0005634; GO:0005768; GO:0005802; GO:0005813; GO:0005815; GO:0005829; GO:0006468; GO:0006915; GO:0008283; GO:0008284; GO:0016020; GO:0016567; GO:0030496; GO:0032465; GO:0042127; GO:0043066; GO:0046872; GO:0051301; GO:0060711; GO:0061631; GO:0090543; GO:2001237 apoptotic process [GO:0006915]; cell division [GO:0051301]; cell population proliferation [GO:0008283]; labyrinthine layer development [GO:0060711]; negative regulation of apoptotic process [GO:0043066]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; positive regulation of cell population proliferation [GO:0008284]; protein phosphorylation [GO:0006468]; protein ubiquitination [GO:0016567]; regulation of cell population proliferation [GO:0042127]; regulation of cytokinesis [GO:0032465] centrosome [GO:0005813]; cytosol [GO:0005829]; endosome [GO:0005768]; Flemming body [GO:0090543]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]; nucleus [GO:0005634]; spindle pole [GO:0000922]; trans-Golgi network [GO:0005802] cysteine-type endopeptidase inhibitor activity [GO:0004869]; metal ion binding [GO:0046872]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842] g3688.t2 Q9NR09 46.802 1970 0.0 1368.0 sp|Q9NR09|BIRC6_HUMAN Dual E2 ubiquitin-conjugating enzyme/E3 ubiquitin-protein ligase BIRC6 OS=Homo sapiens OX=9606 GN=BIRC6 PE=1 SV=3 BIRC6_HUMAN reviewed Dual E2 ubiquitin-conjugating enzyme/E3 ubiquitin-protein ligase BIRC6 (EC 2.3.2.24) (BIR repeat-containing ubiquitin-conjugating enzyme) (BRUCE) (Baculoviral IAP repeat-containing protein 6) (Ubiquitin-conjugating BIR domain enzyme apollon) (APOLLON) Homo sapiens (Human) GO:0000922; GO:0004842; GO:0004869; GO:0005634; GO:0005768; GO:0005802; GO:0005813; GO:0005815; GO:0005829; GO:0006468; GO:0006915; GO:0008283; GO:0008284; GO:0016020; GO:0016567; GO:0030496; GO:0032465; GO:0042127; GO:0043066; GO:0046872; GO:0051301; GO:0060711; GO:0061631; GO:0090543; GO:2001237 apoptotic process [GO:0006915]; cell division [GO:0051301]; cell population proliferation [GO:0008283]; labyrinthine layer development [GO:0060711]; negative regulation of apoptotic process [GO:0043066]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; positive regulation of cell population proliferation [GO:0008284]; protein phosphorylation [GO:0006468]; protein ubiquitination [GO:0016567]; regulation of cell population proliferation [GO:0042127]; regulation of cytokinesis [GO:0032465] centrosome [GO:0005813]; cytosol [GO:0005829]; endosome [GO:0005768]; Flemming body [GO:0090543]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]; nucleus [GO:0005634]; spindle pole [GO:0000922]; trans-Golgi network [GO:0005802] cysteine-type endopeptidase inhibitor activity [GO:0004869]; metal ion binding [GO:0046872]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842] g3688.t2 Q9NR09 36.384 1344 0.0 655.0 sp|Q9NR09|BIRC6_HUMAN Dual E2 ubiquitin-conjugating enzyme/E3 ubiquitin-protein ligase BIRC6 OS=Homo sapiens OX=9606 GN=BIRC6 PE=1 SV=3 BIRC6_HUMAN reviewed Dual E2 ubiquitin-conjugating enzyme/E3 ubiquitin-protein ligase BIRC6 (EC 2.3.2.24) (BIR repeat-containing ubiquitin-conjugating enzyme) (BRUCE) (Baculoviral IAP repeat-containing protein 6) (Ubiquitin-conjugating BIR domain enzyme apollon) (APOLLON) Homo sapiens (Human) GO:0000922; GO:0004842; GO:0004869; GO:0005634; GO:0005768; GO:0005802; GO:0005813; GO:0005815; GO:0005829; GO:0006468; GO:0006915; GO:0008283; GO:0008284; GO:0016020; GO:0016567; GO:0030496; GO:0032465; GO:0042127; GO:0043066; GO:0046872; GO:0051301; GO:0060711; GO:0061631; GO:0090543; GO:2001237 apoptotic process [GO:0006915]; cell division [GO:0051301]; cell population proliferation [GO:0008283]; labyrinthine layer development [GO:0060711]; negative regulation of apoptotic process [GO:0043066]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; positive regulation of cell population proliferation [GO:0008284]; protein phosphorylation [GO:0006468]; protein ubiquitination [GO:0016567]; regulation of cell population proliferation [GO:0042127]; regulation of cytokinesis [GO:0032465] centrosome [GO:0005813]; cytosol [GO:0005829]; endosome [GO:0005768]; Flemming body [GO:0090543]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]; nucleus [GO:0005634]; spindle pole [GO:0000922]; trans-Golgi network [GO:0005802] cysteine-type endopeptidase inhibitor activity [GO:0004869]; metal ion binding [GO:0046872]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842] g3688.t2 Q9NR09 34.526 950 6.51e-116 421.0 sp|Q9NR09|BIRC6_HUMAN Dual E2 ubiquitin-conjugating enzyme/E3 ubiquitin-protein ligase BIRC6 OS=Homo sapiens OX=9606 GN=BIRC6 PE=1 SV=3 BIRC6_HUMAN reviewed Dual E2 ubiquitin-conjugating enzyme/E3 ubiquitin-protein ligase BIRC6 (EC 2.3.2.24) (BIR repeat-containing ubiquitin-conjugating enzyme) (BRUCE) (Baculoviral IAP repeat-containing protein 6) (Ubiquitin-conjugating BIR domain enzyme apollon) (APOLLON) Homo sapiens (Human) GO:0000922; GO:0004842; GO:0004869; GO:0005634; GO:0005768; GO:0005802; GO:0005813; GO:0005815; GO:0005829; GO:0006468; GO:0006915; GO:0008283; GO:0008284; GO:0016020; GO:0016567; GO:0030496; GO:0032465; GO:0042127; GO:0043066; GO:0046872; GO:0051301; GO:0060711; GO:0061631; GO:0090543; GO:2001237 apoptotic process [GO:0006915]; cell division [GO:0051301]; cell population proliferation [GO:0008283]; labyrinthine layer development [GO:0060711]; negative regulation of apoptotic process [GO:0043066]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; positive regulation of cell population proliferation [GO:0008284]; protein phosphorylation [GO:0006468]; protein ubiquitination [GO:0016567]; regulation of cell population proliferation [GO:0042127]; regulation of cytokinesis [GO:0032465] centrosome [GO:0005813]; cytosol [GO:0005829]; endosome [GO:0005768]; Flemming body [GO:0090543]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]; nucleus [GO:0005634]; spindle pole [GO:0000922]; trans-Golgi network [GO:0005802] cysteine-type endopeptidase inhibitor activity [GO:0004869]; metal ion binding [GO:0046872]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842] g3688.t2 Q9NR09 47.847 418 2.4e-114 416.0 sp|Q9NR09|BIRC6_HUMAN Dual E2 ubiquitin-conjugating enzyme/E3 ubiquitin-protein ligase BIRC6 OS=Homo sapiens OX=9606 GN=BIRC6 PE=1 SV=3 BIRC6_HUMAN reviewed Dual E2 ubiquitin-conjugating enzyme/E3 ubiquitin-protein ligase BIRC6 (EC 2.3.2.24) (BIR repeat-containing ubiquitin-conjugating enzyme) (BRUCE) (Baculoviral IAP repeat-containing protein 6) (Ubiquitin-conjugating BIR domain enzyme apollon) (APOLLON) Homo sapiens (Human) GO:0000922; GO:0004842; GO:0004869; GO:0005634; GO:0005768; GO:0005802; GO:0005813; GO:0005815; GO:0005829; GO:0006468; GO:0006915; GO:0008283; GO:0008284; GO:0016020; GO:0016567; GO:0030496; GO:0032465; GO:0042127; GO:0043066; GO:0046872; GO:0051301; GO:0060711; GO:0061631; GO:0090543; GO:2001237 apoptotic process [GO:0006915]; cell division [GO:0051301]; cell population proliferation [GO:0008283]; labyrinthine layer development [GO:0060711]; negative regulation of apoptotic process [GO:0043066]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; positive regulation of cell population proliferation [GO:0008284]; protein phosphorylation [GO:0006468]; protein ubiquitination [GO:0016567]; regulation of cell population proliferation [GO:0042127]; regulation of cytokinesis [GO:0032465] centrosome [GO:0005813]; cytosol [GO:0005829]; endosome [GO:0005768]; Flemming body [GO:0090543]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]; nucleus [GO:0005634]; spindle pole [GO:0000922]; trans-Golgi network [GO:0005802] cysteine-type endopeptidase inhibitor activity [GO:0004869]; metal ion binding [GO:0046872]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842] g3688.t3 Q9NR09 46.65 1970 0.0 1368.0 sp|Q9NR09|BIRC6_HUMAN Dual E2 ubiquitin-conjugating enzyme/E3 ubiquitin-protein ligase BIRC6 OS=Homo sapiens OX=9606 GN=BIRC6 PE=1 SV=3 BIRC6_HUMAN reviewed Dual E2 ubiquitin-conjugating enzyme/E3 ubiquitin-protein ligase BIRC6 (EC 2.3.2.24) (BIR repeat-containing ubiquitin-conjugating enzyme) (BRUCE) (Baculoviral IAP repeat-containing protein 6) (Ubiquitin-conjugating BIR domain enzyme apollon) (APOLLON) Homo sapiens (Human) GO:0000922; GO:0004842; GO:0004869; GO:0005634; GO:0005768; GO:0005802; GO:0005813; GO:0005815; GO:0005829; GO:0006468; GO:0006915; GO:0008283; GO:0008284; GO:0016020; GO:0016567; GO:0030496; GO:0032465; GO:0042127; GO:0043066; GO:0046872; GO:0051301; GO:0060711; GO:0061631; GO:0090543; GO:2001237 apoptotic process [GO:0006915]; cell division [GO:0051301]; cell population proliferation [GO:0008283]; labyrinthine layer development [GO:0060711]; negative regulation of apoptotic process [GO:0043066]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; positive regulation of cell population proliferation [GO:0008284]; protein phosphorylation [GO:0006468]; protein ubiquitination [GO:0016567]; regulation of cell population proliferation [GO:0042127]; regulation of cytokinesis [GO:0032465] centrosome [GO:0005813]; cytosol [GO:0005829]; endosome [GO:0005768]; Flemming body [GO:0090543]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]; nucleus [GO:0005634]; spindle pole [GO:0000922]; trans-Golgi network [GO:0005802] cysteine-type endopeptidase inhibitor activity [GO:0004869]; metal ion binding [GO:0046872]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842] g3688.t3 Q9NR09 36.384 1344 0.0 655.0 sp|Q9NR09|BIRC6_HUMAN Dual E2 ubiquitin-conjugating enzyme/E3 ubiquitin-protein ligase BIRC6 OS=Homo sapiens OX=9606 GN=BIRC6 PE=1 SV=3 BIRC6_HUMAN reviewed Dual E2 ubiquitin-conjugating enzyme/E3 ubiquitin-protein ligase BIRC6 (EC 2.3.2.24) (BIR repeat-containing ubiquitin-conjugating enzyme) (BRUCE) (Baculoviral IAP repeat-containing protein 6) (Ubiquitin-conjugating BIR domain enzyme apollon) (APOLLON) Homo sapiens (Human) GO:0000922; GO:0004842; GO:0004869; GO:0005634; GO:0005768; GO:0005802; GO:0005813; GO:0005815; GO:0005829; GO:0006468; GO:0006915; GO:0008283; GO:0008284; GO:0016020; GO:0016567; GO:0030496; GO:0032465; GO:0042127; GO:0043066; GO:0046872; GO:0051301; GO:0060711; GO:0061631; GO:0090543; GO:2001237 apoptotic process [GO:0006915]; cell division [GO:0051301]; cell population proliferation [GO:0008283]; labyrinthine layer development [GO:0060711]; negative regulation of apoptotic process [GO:0043066]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; positive regulation of cell population proliferation [GO:0008284]; protein phosphorylation [GO:0006468]; protein ubiquitination [GO:0016567]; regulation of cell population proliferation [GO:0042127]; regulation of cytokinesis [GO:0032465] centrosome [GO:0005813]; cytosol [GO:0005829]; endosome [GO:0005768]; Flemming body [GO:0090543]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]; nucleus [GO:0005634]; spindle pole [GO:0000922]; trans-Golgi network [GO:0005802] cysteine-type endopeptidase inhibitor activity [GO:0004869]; metal ion binding [GO:0046872]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842] g3688.t3 Q9NR09 34.319 947 4.7e-116 421.0 sp|Q9NR09|BIRC6_HUMAN Dual E2 ubiquitin-conjugating enzyme/E3 ubiquitin-protein ligase BIRC6 OS=Homo sapiens OX=9606 GN=BIRC6 PE=1 SV=3 BIRC6_HUMAN reviewed Dual E2 ubiquitin-conjugating enzyme/E3 ubiquitin-protein ligase BIRC6 (EC 2.3.2.24) (BIR repeat-containing ubiquitin-conjugating enzyme) (BRUCE) (Baculoviral IAP repeat-containing protein 6) (Ubiquitin-conjugating BIR domain enzyme apollon) (APOLLON) Homo sapiens (Human) GO:0000922; GO:0004842; GO:0004869; GO:0005634; GO:0005768; GO:0005802; GO:0005813; GO:0005815; GO:0005829; GO:0006468; GO:0006915; GO:0008283; GO:0008284; GO:0016020; GO:0016567; GO:0030496; GO:0032465; GO:0042127; GO:0043066; GO:0046872; GO:0051301; GO:0060711; GO:0061631; GO:0090543; GO:2001237 apoptotic process [GO:0006915]; cell division [GO:0051301]; cell population proliferation [GO:0008283]; labyrinthine layer development [GO:0060711]; negative regulation of apoptotic process [GO:0043066]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; positive regulation of cell population proliferation [GO:0008284]; protein phosphorylation [GO:0006468]; protein ubiquitination [GO:0016567]; regulation of cell population proliferation [GO:0042127]; regulation of cytokinesis [GO:0032465] centrosome [GO:0005813]; cytosol [GO:0005829]; endosome [GO:0005768]; Flemming body [GO:0090543]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]; nucleus [GO:0005634]; spindle pole [GO:0000922]; trans-Golgi network [GO:0005802] cysteine-type endopeptidase inhibitor activity [GO:0004869]; metal ion binding [GO:0046872]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842] g3688.t3 Q9NR09 47.847 418 2.38e-114 416.0 sp|Q9NR09|BIRC6_HUMAN Dual E2 ubiquitin-conjugating enzyme/E3 ubiquitin-protein ligase BIRC6 OS=Homo sapiens OX=9606 GN=BIRC6 PE=1 SV=3 BIRC6_HUMAN reviewed Dual E2 ubiquitin-conjugating enzyme/E3 ubiquitin-protein ligase BIRC6 (EC 2.3.2.24) (BIR repeat-containing ubiquitin-conjugating enzyme) (BRUCE) (Baculoviral IAP repeat-containing protein 6) (Ubiquitin-conjugating BIR domain enzyme apollon) (APOLLON) Homo sapiens (Human) GO:0000922; GO:0004842; GO:0004869; GO:0005634; GO:0005768; GO:0005802; GO:0005813; GO:0005815; GO:0005829; GO:0006468; GO:0006915; GO:0008283; GO:0008284; GO:0016020; GO:0016567; GO:0030496; GO:0032465; GO:0042127; GO:0043066; GO:0046872; GO:0051301; GO:0060711; GO:0061631; GO:0090543; GO:2001237 apoptotic process [GO:0006915]; cell division [GO:0051301]; cell population proliferation [GO:0008283]; labyrinthine layer development [GO:0060711]; negative regulation of apoptotic process [GO:0043066]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; positive regulation of cell population proliferation [GO:0008284]; protein phosphorylation [GO:0006468]; protein ubiquitination [GO:0016567]; regulation of cell population proliferation [GO:0042127]; regulation of cytokinesis [GO:0032465] centrosome [GO:0005813]; cytosol [GO:0005829]; endosome [GO:0005768]; Flemming body [GO:0090543]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]; nucleus [GO:0005634]; spindle pole [GO:0000922]; trans-Golgi network [GO:0005802] cysteine-type endopeptidase inhibitor activity [GO:0004869]; metal ion binding [GO:0046872]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842] g3689.t1 Q9BLC5 83.937 442 0.0 740.0 sp|Q9BLC5|HSP83_BOMMO Heat shock protein 83 OS=Bombyx mori OX=7091 GN=Hsp83 PE=1 SV=1 g3689.t1 Q9BLC5 76.852 216 1.95e-105 340.0 sp|Q9BLC5|HSP83_BOMMO Heat shock protein 83 OS=Bombyx mori OX=7091 GN=Hsp83 PE=1 SV=1 g3690.t1 Q05481 31.781 966 3.66e-145 476.0 sp|Q05481|ZNF91_HUMAN Zinc finger protein 91 OS=Homo sapiens OX=9606 GN=ZNF91 PE=1 SV=2 ZNF91_HUMAN reviewed Zinc finger protein 91 (Zinc finger protein HPF7) (Zinc finger protein HTF10) Homo sapiens (Human) GO:0001227; GO:0003677; GO:0003700; GO:0005634; GO:0006357; GO:0008270; GO:0010526 regulation of transcription by RNA polymerase II [GO:0006357]; transposable element silencing [GO:0010526] nucleus [GO:0005634] DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; zinc ion binding [GO:0008270] g3690.t1 Q05481 32.046 958 6.08e-139 459.0 sp|Q05481|ZNF91_HUMAN Zinc finger protein 91 OS=Homo sapiens OX=9606 GN=ZNF91 PE=1 SV=2 ZNF91_HUMAN reviewed Zinc finger protein 91 (Zinc finger protein HPF7) (Zinc finger protein HTF10) Homo sapiens (Human) GO:0001227; GO:0003677; GO:0003700; GO:0005634; GO:0006357; GO:0008270; GO:0010526 regulation of transcription by RNA polymerase II [GO:0006357]; transposable element silencing [GO:0010526] nucleus [GO:0005634] DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; zinc ion binding [GO:0008270] g3690.t1 Q05481 30.478 899 8.71e-118 400.0 sp|Q05481|ZNF91_HUMAN Zinc finger protein 91 OS=Homo sapiens OX=9606 GN=ZNF91 PE=1 SV=2 ZNF91_HUMAN reviewed Zinc finger protein 91 (Zinc finger protein HPF7) (Zinc finger protein HTF10) Homo sapiens (Human) GO:0001227; GO:0003677; GO:0003700; GO:0005634; GO:0006357; GO:0008270; GO:0010526 regulation of transcription by RNA polymerase II [GO:0006357]; transposable element silencing [GO:0010526] nucleus [GO:0005634] DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; zinc ion binding [GO:0008270] g3690.t1 Q05481 28.843 631 5.67e-76 279.0 sp|Q05481|ZNF91_HUMAN Zinc finger protein 91 OS=Homo sapiens OX=9606 GN=ZNF91 PE=1 SV=2 ZNF91_HUMAN reviewed Zinc finger protein 91 (Zinc finger protein HPF7) (Zinc finger protein HTF10) Homo sapiens (Human) GO:0001227; GO:0003677; GO:0003700; GO:0005634; GO:0006357; GO:0008270; GO:0010526 regulation of transcription by RNA polymerase II [GO:0006357]; transposable element silencing [GO:0010526] nucleus [GO:0005634] DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; zinc ion binding [GO:0008270] g3690.t1 Q05481 32.587 402 1.1399999999999998e-42 174.0 sp|Q05481|ZNF91_HUMAN Zinc finger protein 91 OS=Homo sapiens OX=9606 GN=ZNF91 PE=1 SV=2 ZNF91_HUMAN reviewed Zinc finger protein 91 (Zinc finger protein HPF7) (Zinc finger protein HTF10) Homo sapiens (Human) GO:0001227; GO:0003677; GO:0003700; GO:0005634; GO:0006357; GO:0008270; GO:0010526 regulation of transcription by RNA polymerase II [GO:0006357]; transposable element silencing [GO:0010526] nucleus [GO:0005634] DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; zinc ion binding [GO:0008270] g3691.t1 Q3SZW1 52.333 300 3.59e-106 319.0 sp|Q3SZW1|TSSK1_BOVIN Testis-specific serine/threonine-protein kinase 1 OS=Bos taurus OX=9913 GN=TSSK1B PE=2 SV=1 TSSK1_BOVIN reviewed Testis-specific serine/threonine-protein kinase 1 (TSK-1) (TSK1) (TSSK-1) (Testis-specific kinase 1) (EC 2.7.11.1) Bos taurus (Bovine) GO:0000226; GO:0000287; GO:0001669; GO:0004674; GO:0005524; GO:0005737; GO:0007286; GO:0031514; GO:0035556; GO:0050321; GO:0106310 intracellular signal transduction [GO:0035556]; microtubule cytoskeleton organization [GO:0000226]; spermatid development [GO:0007286] acrosomal vesicle [GO:0001669]; cytoplasm [GO:0005737]; motile cilium [GO:0031514] ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; tau-protein kinase activity [GO:0050321] g3692.t1 B2RY56 47.222 216 2.98e-44 176.0 sp|B2RY56|RBM25_MOUSE RNA-binding protein 25 OS=Mus musculus OX=10090 GN=Rbm25 PE=1 SV=2 g3692.t1 B2RY56 48.792 207 2.53e-43 172.0 sp|B2RY56|RBM25_MOUSE RNA-binding protein 25 OS=Mus musculus OX=10090 GN=Rbm25 PE=1 SV=2 g3692.t2 P49756 47.222 216 3.39e-44 175.0 sp|P49756|RBM25_HUMAN RNA-binding protein 25 OS=Homo sapiens OX=9606 GN=RBM25 PE=1 SV=3 RBM25_HUMAN reviewed RNA-binding protein 25 (Arg/Glu/Asp-rich protein of 120 kDa) (RED120) (Protein S164) (RNA-binding motif protein 25) (RNA-binding region-containing protein 7) Homo sapiens (Human) GO:0000381; GO:0003723; GO:0003729; GO:0005654; GO:0005737; GO:0006397; GO:0008380; GO:0016607; GO:0042981 mRNA processing [GO:0006397]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of apoptotic process [GO:0042981]; RNA splicing [GO:0008380] cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654] mRNA binding [GO:0003729]; RNA binding [GO:0003723] g3692.t2 P49756 49.038 208 9.96e-44 174.0 sp|P49756|RBM25_HUMAN RNA-binding protein 25 OS=Homo sapiens OX=9606 GN=RBM25 PE=1 SV=3 RBM25_HUMAN reviewed RNA-binding protein 25 (Arg/Glu/Asp-rich protein of 120 kDa) (RED120) (Protein S164) (RNA-binding motif protein 25) (RNA-binding region-containing protein 7) Homo sapiens (Human) GO:0000381; GO:0003723; GO:0003729; GO:0005654; GO:0005737; GO:0006397; GO:0008380; GO:0016607; GO:0042981 mRNA processing [GO:0006397]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of apoptotic process [GO:0042981]; RNA splicing [GO:0008380] cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654] mRNA binding [GO:0003729]; RNA binding [GO:0003723] g3692.t3 B2RY56 47.222 216 1.17e-44 176.0 sp|B2RY56|RBM25_MOUSE RNA-binding protein 25 OS=Mus musculus OX=10090 GN=Rbm25 PE=1 SV=2 g3692.t3 B2RY56 48.792 207 1.07e-43 173.0 sp|B2RY56|RBM25_MOUSE RNA-binding protein 25 OS=Mus musculus OX=10090 GN=Rbm25 PE=1 SV=2 g3693.t1 P06027 38.028 142 3.850000000000001e-21 87.4 sp|P06027|LECE_HELCR Echinoidin OS=Heliocidaris crassispina OX=1043166 PE=1 SV=1 g3696.t1 O75899 40.712 393 8.47e-72 257.0 sp|O75899|GABR2_HUMAN Gamma-aminobutyric acid type B receptor subunit 2 OS=Homo sapiens OX=9606 GN=GABBR2 PE=1 SV=1 GABR2_HUMAN reviewed Gamma-aminobutyric acid type B receptor subunit 2 (GABA-B receptor 2) (GABA-B-R2) (GABA-BR2) (GABABR2) (Gb2) (G-protein coupled receptor 51) (HG20) Homo sapiens (Human) GO:0004888; GO:0004965; GO:0005737; GO:0005886; GO:0007186; GO:0007193; GO:0007194; GO:0007214; GO:0007268; GO:0038039; GO:0043005; GO:0045211; GO:0046982; GO:0051932; GO:0150099; GO:1902710; GO:1902712 adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; chemical synaptic transmission [GO:0007268]; G protein-coupled receptor signaling pathway [GO:0007186]; gamma-aminobutyric acid signaling pathway [GO:0007214]; negative regulation of adenylate cyclase activity [GO:0007194]; neuron-glial cell signaling [GO:0150099]; synaptic transmission, GABAergic [GO:0051932] cytoplasm [GO:0005737]; G protein-coupled GABA receptor complex [GO:1902712]; G protein-coupled receptor heterodimeric complex [GO:0038039]; GABA receptor complex [GO:1902710]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211] G protein-coupled GABA receptor activity [GO:0004965]; protein heterodimerization activity [GO:0046982]; transmembrane signaling receptor activity [GO:0004888] g3696.t1 O75899 30.952 294 1.0499999999999999e-38 159.0 sp|O75899|GABR2_HUMAN Gamma-aminobutyric acid type B receptor subunit 2 OS=Homo sapiens OX=9606 GN=GABBR2 PE=1 SV=1 GABR2_HUMAN reviewed Gamma-aminobutyric acid type B receptor subunit 2 (GABA-B receptor 2) (GABA-B-R2) (GABA-BR2) (GABABR2) (Gb2) (G-protein coupled receptor 51) (HG20) Homo sapiens (Human) GO:0004888; GO:0004965; GO:0005737; GO:0005886; GO:0007186; GO:0007193; GO:0007194; GO:0007214; GO:0007268; GO:0038039; GO:0043005; GO:0045211; GO:0046982; GO:0051932; GO:0150099; GO:1902710; GO:1902712 adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; chemical synaptic transmission [GO:0007268]; G protein-coupled receptor signaling pathway [GO:0007186]; gamma-aminobutyric acid signaling pathway [GO:0007214]; negative regulation of adenylate cyclase activity [GO:0007194]; neuron-glial cell signaling [GO:0150099]; synaptic transmission, GABAergic [GO:0051932] cytoplasm [GO:0005737]; G protein-coupled GABA receptor complex [GO:1902712]; G protein-coupled receptor heterodimeric complex [GO:0038039]; GABA receptor complex [GO:1902710]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211] G protein-coupled GABA receptor activity [GO:0004965]; protein heterodimerization activity [GO:0046982]; transmembrane signaling receptor activity [GO:0004888] g3697.t1 Q9Z0U4 36.776 397 1.51e-73 266.0 sp|Q9Z0U4|GABR1_RAT Gamma-aminobutyric acid type B receptor subunit 1 OS=Rattus norvegicus OX=10116 GN=Gabbr1 PE=1 SV=2 GABR1_RAT reviewed Gamma-aminobutyric acid type B receptor subunit 1 (GABA-B receptor 1) (GABA-B-R1) (GABA-BR1) (GABABR1) (Gb1) Rattus norvegicus (Rat) GO:0001649; GO:0004965; GO:0005615; GO:0005737; GO:0005789; GO:0005886; GO:0007193; GO:0007214; GO:0008021; GO:0008285; GO:0014048; GO:0014049; GO:0014053; GO:0016020; GO:0030673; GO:0031966; GO:0032811; GO:0033602; GO:0035094; GO:0038037; GO:0038039; GO:0042734; GO:0043025; GO:0043197; GO:0043198; GO:0043204; GO:0045211; GO:0045471; GO:0046982; GO:0050805; GO:0051932; GO:0060124; GO:0097060; GO:0098685; GO:0098793; GO:0098978; GO:0098982; GO:0099579; GO:0150047; GO:0150099; GO:1902710; GO:1902712; GO:1990430 adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; gamma-aminobutyric acid signaling pathway [GO:0007214]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of dopamine secretion [GO:0033602]; negative regulation of epinephrine secretion [GO:0032811]; negative regulation of gamma-aminobutyric acid secretion [GO:0014053]; negative regulation of synaptic transmission [GO:0050805]; neuron-glial cell signaling [GO:0150099]; osteoblast differentiation [GO:0001649]; positive regulation of glutamate secretion [GO:0014049]; positive regulation of growth hormone secretion [GO:0060124]; regulation of glutamate secretion [GO:0014048]; response to ethanol [GO:0045471]; response to nicotine [GO:0035094]; synaptic transmission, GABAergic [GO:0051932] axolemma [GO:0030673]; cytoplasm [GO:0005737]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; endoplasmic reticulum membrane [GO:0005789]; extracellular space [GO:0005615]; G protein-coupled GABA receptor complex [GO:1902712]; G protein-coupled receptor dimeric complex [GO:0038037]; G protein-coupled receptor heterodimeric complex [GO:0038039]; GABA receptor complex [GO:1902710]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; mitochondrial membrane [GO:0031966]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynapse [GO:0098793]; presynaptic membrane [GO:0042734]; Schaffer collateral - CA1 synapse [GO:0098685]; synaptic membrane [GO:0097060]; synaptic vesicle [GO:0008021] extracellular matrix protein binding [GO:1990430]; G protein-coupled GABA receptor activity [GO:0004965]; G protein-coupled neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential [GO:0099579]; G protein-coupled neurotransmitter receptor activity involved in regulation of presynaptic membrane potential [GO:0150047]; protein heterodimerization activity [GO:0046982] g3697.t1 Q9Z0U4 29.551 379 9.169999999999999e-41 166.0 sp|Q9Z0U4|GABR1_RAT Gamma-aminobutyric acid type B receptor subunit 1 OS=Rattus norvegicus OX=10116 GN=Gabbr1 PE=1 SV=2 GABR1_RAT reviewed Gamma-aminobutyric acid type B receptor subunit 1 (GABA-B receptor 1) (GABA-B-R1) (GABA-BR1) (GABABR1) (Gb1) Rattus norvegicus (Rat) GO:0001649; GO:0004965; GO:0005615; GO:0005737; GO:0005789; GO:0005886; GO:0007193; GO:0007214; GO:0008021; GO:0008285; GO:0014048; GO:0014049; GO:0014053; GO:0016020; GO:0030673; GO:0031966; GO:0032811; GO:0033602; GO:0035094; GO:0038037; GO:0038039; GO:0042734; GO:0043025; GO:0043197; GO:0043198; GO:0043204; GO:0045211; GO:0045471; GO:0046982; GO:0050805; GO:0051932; GO:0060124; GO:0097060; GO:0098685; GO:0098793; GO:0098978; GO:0098982; GO:0099579; GO:0150047; GO:0150099; GO:1902710; GO:1902712; GO:1990430 adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; gamma-aminobutyric acid signaling pathway [GO:0007214]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of dopamine secretion [GO:0033602]; negative regulation of epinephrine secretion [GO:0032811]; negative regulation of gamma-aminobutyric acid secretion [GO:0014053]; negative regulation of synaptic transmission [GO:0050805]; neuron-glial cell signaling [GO:0150099]; osteoblast differentiation [GO:0001649]; positive regulation of glutamate secretion [GO:0014049]; positive regulation of growth hormone secretion [GO:0060124]; regulation of glutamate secretion [GO:0014048]; response to ethanol [GO:0045471]; response to nicotine [GO:0035094]; synaptic transmission, GABAergic [GO:0051932] axolemma [GO:0030673]; cytoplasm [GO:0005737]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; endoplasmic reticulum membrane [GO:0005789]; extracellular space [GO:0005615]; G protein-coupled GABA receptor complex [GO:1902712]; G protein-coupled receptor dimeric complex [GO:0038037]; G protein-coupled receptor heterodimeric complex [GO:0038039]; GABA receptor complex [GO:1902710]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; mitochondrial membrane [GO:0031966]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynapse [GO:0098793]; presynaptic membrane [GO:0042734]; Schaffer collateral - CA1 synapse [GO:0098685]; synaptic membrane [GO:0097060]; synaptic vesicle [GO:0008021] extracellular matrix protein binding [GO:1990430]; G protein-coupled GABA receptor activity [GO:0004965]; G protein-coupled neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential [GO:0099579]; G protein-coupled neurotransmitter receptor activity involved in regulation of presynaptic membrane potential [GO:0150047]; protein heterodimerization activity [GO:0046982] g3697.t2 Q9Z0U4 36.776 397 1.11e-73 266.0 sp|Q9Z0U4|GABR1_RAT Gamma-aminobutyric acid type B receptor subunit 1 OS=Rattus norvegicus OX=10116 GN=Gabbr1 PE=1 SV=2 GABR1_RAT reviewed Gamma-aminobutyric acid type B receptor subunit 1 (GABA-B receptor 1) (GABA-B-R1) (GABA-BR1) (GABABR1) (Gb1) Rattus norvegicus (Rat) GO:0001649; GO:0004965; GO:0005615; GO:0005737; GO:0005789; GO:0005886; GO:0007193; GO:0007214; GO:0008021; GO:0008285; GO:0014048; GO:0014049; GO:0014053; GO:0016020; GO:0030673; GO:0031966; GO:0032811; GO:0033602; GO:0035094; GO:0038037; GO:0038039; GO:0042734; GO:0043025; GO:0043197; GO:0043198; GO:0043204; GO:0045211; GO:0045471; GO:0046982; GO:0050805; GO:0051932; GO:0060124; GO:0097060; GO:0098685; GO:0098793; GO:0098978; GO:0098982; GO:0099579; GO:0150047; GO:0150099; GO:1902710; GO:1902712; GO:1990430 adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; gamma-aminobutyric acid signaling pathway [GO:0007214]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of dopamine secretion [GO:0033602]; negative regulation of epinephrine secretion [GO:0032811]; negative regulation of gamma-aminobutyric acid secretion [GO:0014053]; negative regulation of synaptic transmission [GO:0050805]; neuron-glial cell signaling [GO:0150099]; osteoblast differentiation [GO:0001649]; positive regulation of glutamate secretion [GO:0014049]; positive regulation of growth hormone secretion [GO:0060124]; regulation of glutamate secretion [GO:0014048]; response to ethanol [GO:0045471]; response to nicotine [GO:0035094]; synaptic transmission, GABAergic [GO:0051932] axolemma [GO:0030673]; cytoplasm [GO:0005737]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; endoplasmic reticulum membrane [GO:0005789]; extracellular space [GO:0005615]; G protein-coupled GABA receptor complex [GO:1902712]; G protein-coupled receptor dimeric complex [GO:0038037]; G protein-coupled receptor heterodimeric complex [GO:0038039]; GABA receptor complex [GO:1902710]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; mitochondrial membrane [GO:0031966]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynapse [GO:0098793]; presynaptic membrane [GO:0042734]; Schaffer collateral - CA1 synapse [GO:0098685]; synaptic membrane [GO:0097060]; synaptic vesicle [GO:0008021] extracellular matrix protein binding [GO:1990430]; G protein-coupled GABA receptor activity [GO:0004965]; G protein-coupled neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential [GO:0099579]; G protein-coupled neurotransmitter receptor activity involved in regulation of presynaptic membrane potential [GO:0150047]; protein heterodimerization activity [GO:0046982] g3697.t2 Q9Z0U4 30.245 367 7.04e-43 173.0 sp|Q9Z0U4|GABR1_RAT Gamma-aminobutyric acid type B receptor subunit 1 OS=Rattus norvegicus OX=10116 GN=Gabbr1 PE=1 SV=2 GABR1_RAT reviewed Gamma-aminobutyric acid type B receptor subunit 1 (GABA-B receptor 1) (GABA-B-R1) (GABA-BR1) (GABABR1) (Gb1) Rattus norvegicus (Rat) GO:0001649; GO:0004965; GO:0005615; GO:0005737; GO:0005789; GO:0005886; GO:0007193; GO:0007214; GO:0008021; GO:0008285; GO:0014048; GO:0014049; GO:0014053; GO:0016020; GO:0030673; GO:0031966; GO:0032811; GO:0033602; GO:0035094; GO:0038037; GO:0038039; GO:0042734; GO:0043025; GO:0043197; GO:0043198; GO:0043204; GO:0045211; GO:0045471; GO:0046982; GO:0050805; GO:0051932; GO:0060124; GO:0097060; GO:0098685; GO:0098793; GO:0098978; GO:0098982; GO:0099579; GO:0150047; GO:0150099; GO:1902710; GO:1902712; GO:1990430 adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; gamma-aminobutyric acid signaling pathway [GO:0007214]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of dopamine secretion [GO:0033602]; negative regulation of epinephrine secretion [GO:0032811]; negative regulation of gamma-aminobutyric acid secretion [GO:0014053]; negative regulation of synaptic transmission [GO:0050805]; neuron-glial cell signaling [GO:0150099]; osteoblast differentiation [GO:0001649]; positive regulation of glutamate secretion [GO:0014049]; positive regulation of growth hormone secretion [GO:0060124]; regulation of glutamate secretion [GO:0014048]; response to ethanol [GO:0045471]; response to nicotine [GO:0035094]; synaptic transmission, GABAergic [GO:0051932] axolemma [GO:0030673]; cytoplasm [GO:0005737]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; endoplasmic reticulum membrane [GO:0005789]; extracellular space [GO:0005615]; G protein-coupled GABA receptor complex [GO:1902712]; G protein-coupled receptor dimeric complex [GO:0038037]; G protein-coupled receptor heterodimeric complex [GO:0038039]; GABA receptor complex [GO:1902710]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; mitochondrial membrane [GO:0031966]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynapse [GO:0098793]; presynaptic membrane [GO:0042734]; Schaffer collateral - CA1 synapse [GO:0098685]; synaptic membrane [GO:0097060]; synaptic vesicle [GO:0008021] extracellular matrix protein binding [GO:1990430]; G protein-coupled GABA receptor activity [GO:0004965]; G protein-coupled neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential [GO:0099579]; G protein-coupled neurotransmitter receptor activity involved in regulation of presynaptic membrane potential [GO:0150047]; protein heterodimerization activity [GO:0046982] g3698.t1 P21328 25.088 853 1.64e-36 153.0 sp|P21328|RTJK_DROME RNA-directed DNA polymerase from mobile element jockey OS=Drosophila melanogaster OX=7227 GN=pol PE=1 SV=1 g3699.t1 Q9UBS5 38.402 388 1.2e-75 271.0 sp|Q9UBS5|GABR1_HUMAN Gamma-aminobutyric acid type B receptor subunit 1 OS=Homo sapiens OX=9606 GN=GABBR1 PE=1 SV=1 GABR1_HUMAN reviewed Gamma-aminobutyric acid type B receptor subunit 1 (GABA-B receptor 1) (GABA-B-R1) (GABA-BR1) (GABABR1) (Gb1) Homo sapiens (Human) GO:0001649; GO:0004965; GO:0005615; GO:0005789; GO:0005886; GO:0007193; GO:0007214; GO:0008021; GO:0008285; GO:0014049; GO:0014053; GO:0030673; GO:0031966; GO:0032811; GO:0033602; GO:0035094; GO:0038039; GO:0042734; GO:0043025; GO:0043197; GO:0043198; GO:0045211; GO:0045471; GO:0046982; GO:0050805; GO:0051932; GO:0060124; GO:0098685; GO:0098978; GO:0098982; GO:0099579; GO:0150047; GO:0150099; GO:1902712; GO:1990430 adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; gamma-aminobutyric acid signaling pathway [GO:0007214]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of dopamine secretion [GO:0033602]; negative regulation of epinephrine secretion [GO:0032811]; negative regulation of gamma-aminobutyric acid secretion [GO:0014053]; negative regulation of synaptic transmission [GO:0050805]; neuron-glial cell signaling [GO:0150099]; osteoblast differentiation [GO:0001649]; positive regulation of glutamate secretion [GO:0014049]; positive regulation of growth hormone secretion [GO:0060124]; response to ethanol [GO:0045471]; response to nicotine [GO:0035094]; synaptic transmission, GABAergic [GO:0051932] axolemma [GO:0030673]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; endoplasmic reticulum membrane [GO:0005789]; extracellular space [GO:0005615]; G protein-coupled GABA receptor complex [GO:1902712]; G protein-coupled receptor heterodimeric complex [GO:0038039]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; mitochondrial membrane [GO:0031966]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; Schaffer collateral - CA1 synapse [GO:0098685]; synaptic vesicle [GO:0008021] extracellular matrix protein binding [GO:1990430]; G protein-coupled GABA receptor activity [GO:0004965]; G protein-coupled neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential [GO:0099579]; G protein-coupled neurotransmitter receptor activity involved in regulation of presynaptic membrane potential [GO:0150047]; protein heterodimerization activity [GO:0046982] g3699.t1 Q9UBS5 29.003 331 2.4500000000000002e-32 139.0 sp|Q9UBS5|GABR1_HUMAN Gamma-aminobutyric acid type B receptor subunit 1 OS=Homo sapiens OX=9606 GN=GABBR1 PE=1 SV=1 GABR1_HUMAN reviewed Gamma-aminobutyric acid type B receptor subunit 1 (GABA-B receptor 1) (GABA-B-R1) (GABA-BR1) (GABABR1) (Gb1) Homo sapiens (Human) GO:0001649; GO:0004965; GO:0005615; GO:0005789; GO:0005886; GO:0007193; GO:0007214; GO:0008021; GO:0008285; GO:0014049; GO:0014053; GO:0030673; GO:0031966; GO:0032811; GO:0033602; GO:0035094; GO:0038039; GO:0042734; GO:0043025; GO:0043197; GO:0043198; GO:0045211; GO:0045471; GO:0046982; GO:0050805; GO:0051932; GO:0060124; GO:0098685; GO:0098978; GO:0098982; GO:0099579; GO:0150047; GO:0150099; GO:1902712; GO:1990430 adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; gamma-aminobutyric acid signaling pathway [GO:0007214]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of dopamine secretion [GO:0033602]; negative regulation of epinephrine secretion [GO:0032811]; negative regulation of gamma-aminobutyric acid secretion [GO:0014053]; negative regulation of synaptic transmission [GO:0050805]; neuron-glial cell signaling [GO:0150099]; osteoblast differentiation [GO:0001649]; positive regulation of glutamate secretion [GO:0014049]; positive regulation of growth hormone secretion [GO:0060124]; response to ethanol [GO:0045471]; response to nicotine [GO:0035094]; synaptic transmission, GABAergic [GO:0051932] axolemma [GO:0030673]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; endoplasmic reticulum membrane [GO:0005789]; extracellular space [GO:0005615]; G protein-coupled GABA receptor complex [GO:1902712]; G protein-coupled receptor heterodimeric complex [GO:0038039]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; mitochondrial membrane [GO:0031966]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; Schaffer collateral - CA1 synapse [GO:0098685]; synaptic vesicle [GO:0008021] extracellular matrix protein binding [GO:1990430]; G protein-coupled GABA receptor activity [GO:0004965]; G protein-coupled neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential [GO:0099579]; G protein-coupled neurotransmitter receptor activity involved in regulation of presynaptic membrane potential [GO:0150047]; protein heterodimerization activity [GO:0046982] g3704.t1 O75096 36.861 274 8.75e-40 158.0 sp|O75096|LRP4_HUMAN Low-density lipoprotein receptor-related protein 4 OS=Homo sapiens OX=9606 GN=LRP4 PE=1 SV=4 LRP4_HUMAN reviewed Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7) Homo sapiens (Human) GO:0001822; GO:0001942; GO:0005509; GO:0005886; GO:0006897; GO:0007167; GO:0009953; GO:0009954; GO:0009986; GO:0014069; GO:0015026; GO:0016055; GO:0016601; GO:0030279; GO:0030425; GO:0030971; GO:0031594; GO:0034185; GO:0035022; GO:0042475; GO:0042733; GO:0042803; GO:0043025; GO:0044853; GO:0048699; GO:0048813; GO:0050771; GO:0050808; GO:0051124; GO:0060173; GO:0071340; GO:0090090; GO:0097060; GO:0097104; GO:0097105; GO:0097110; GO:0150052; GO:0150094; GO:1901631; GO:1904395 amyloid-beta clearance by cellular catabolic process [GO:0150094]; dendrite morphogenesis [GO:0048813]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; endocytosis [GO:0006897]; enzyme-linked receptor protein signaling pathway [GO:0007167]; generation of neurons [GO:0048699]; hair follicle development [GO:0001942]; kidney development [GO:0001822]; limb development [GO:0060173]; negative regulation of axonogenesis [GO:0050771]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of ossification [GO:0030279]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of presynaptic membrane organization [GO:1901631]; positive regulation of Rac protein signal transduction [GO:0035022]; positive regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904395]; postsynaptic membrane assembly [GO:0097104]; presynaptic membrane assembly [GO:0097105]; proximal/distal pattern formation [GO:0009954]; Rac protein signal transduction [GO:0016601]; regulation of postsynapse assembly [GO:0150052]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; synapse organization [GO:0050808]; synaptic assembly at neuromuscular junction [GO:0051124]; Wnt signaling pathway [GO:0016055] cell surface [GO:0009986]; dendrite [GO:0030425]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic density [GO:0014069]; synaptic membrane [GO:0097060] apolipoprotein binding [GO:0034185]; calcium ion binding [GO:0005509]; coreceptor activity [GO:0015026]; protein homodimerization activity [GO:0042803]; receptor tyrosine kinase binding [GO:0030971]; scaffold protein binding [GO:0097110] g3704.t1 O75096 33.091 275 8.42e-37 149.0 sp|O75096|LRP4_HUMAN Low-density lipoprotein receptor-related protein 4 OS=Homo sapiens OX=9606 GN=LRP4 PE=1 SV=4 LRP4_HUMAN reviewed Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7) Homo sapiens (Human) GO:0001822; GO:0001942; GO:0005509; GO:0005886; GO:0006897; GO:0007167; GO:0009953; GO:0009954; GO:0009986; GO:0014069; GO:0015026; GO:0016055; GO:0016601; GO:0030279; GO:0030425; GO:0030971; GO:0031594; GO:0034185; GO:0035022; GO:0042475; GO:0042733; GO:0042803; GO:0043025; GO:0044853; GO:0048699; GO:0048813; GO:0050771; GO:0050808; GO:0051124; GO:0060173; GO:0071340; GO:0090090; GO:0097060; GO:0097104; GO:0097105; GO:0097110; GO:0150052; GO:0150094; GO:1901631; GO:1904395 amyloid-beta clearance by cellular catabolic process [GO:0150094]; dendrite morphogenesis [GO:0048813]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; endocytosis [GO:0006897]; enzyme-linked receptor protein signaling pathway [GO:0007167]; generation of neurons [GO:0048699]; hair follicle development [GO:0001942]; kidney development [GO:0001822]; limb development [GO:0060173]; negative regulation of axonogenesis [GO:0050771]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of ossification [GO:0030279]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of presynaptic membrane organization [GO:1901631]; positive regulation of Rac protein signal transduction [GO:0035022]; positive regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904395]; postsynaptic membrane assembly [GO:0097104]; presynaptic membrane assembly [GO:0097105]; proximal/distal pattern formation [GO:0009954]; Rac protein signal transduction [GO:0016601]; regulation of postsynapse assembly [GO:0150052]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; synapse organization [GO:0050808]; synaptic assembly at neuromuscular junction [GO:0051124]; Wnt signaling pathway [GO:0016055] cell surface [GO:0009986]; dendrite [GO:0030425]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic density [GO:0014069]; synaptic membrane [GO:0097060] apolipoprotein binding [GO:0034185]; calcium ion binding [GO:0005509]; coreceptor activity [GO:0015026]; protein homodimerization activity [GO:0042803]; receptor tyrosine kinase binding [GO:0030971]; scaffold protein binding [GO:0097110] g3704.t1 O75096 32.5 280 2.1900000000000001e-32 136.0 sp|O75096|LRP4_HUMAN Low-density lipoprotein receptor-related protein 4 OS=Homo sapiens OX=9606 GN=LRP4 PE=1 SV=4 LRP4_HUMAN reviewed Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7) Homo sapiens (Human) GO:0001822; GO:0001942; GO:0005509; GO:0005886; GO:0006897; GO:0007167; GO:0009953; GO:0009954; GO:0009986; GO:0014069; GO:0015026; GO:0016055; GO:0016601; GO:0030279; GO:0030425; GO:0030971; GO:0031594; GO:0034185; GO:0035022; GO:0042475; GO:0042733; GO:0042803; GO:0043025; GO:0044853; GO:0048699; GO:0048813; GO:0050771; GO:0050808; GO:0051124; GO:0060173; GO:0071340; GO:0090090; GO:0097060; GO:0097104; GO:0097105; GO:0097110; GO:0150052; GO:0150094; GO:1901631; GO:1904395 amyloid-beta clearance by cellular catabolic process [GO:0150094]; dendrite morphogenesis [GO:0048813]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; endocytosis [GO:0006897]; enzyme-linked receptor protein signaling pathway [GO:0007167]; generation of neurons [GO:0048699]; hair follicle development [GO:0001942]; kidney development [GO:0001822]; limb development [GO:0060173]; negative regulation of axonogenesis [GO:0050771]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of ossification [GO:0030279]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of presynaptic membrane organization [GO:1901631]; positive regulation of Rac protein signal transduction [GO:0035022]; positive regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904395]; postsynaptic membrane assembly [GO:0097104]; presynaptic membrane assembly [GO:0097105]; proximal/distal pattern formation [GO:0009954]; Rac protein signal transduction [GO:0016601]; regulation of postsynapse assembly [GO:0150052]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; synapse organization [GO:0050808]; synaptic assembly at neuromuscular junction [GO:0051124]; Wnt signaling pathway [GO:0016055] cell surface [GO:0009986]; dendrite [GO:0030425]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic density [GO:0014069]; synaptic membrane [GO:0097060] apolipoprotein binding [GO:0034185]; calcium ion binding [GO:0005509]; coreceptor activity [GO:0015026]; protein homodimerization activity [GO:0042803]; receptor tyrosine kinase binding [GO:0030971]; scaffold protein binding [GO:0097110] g3704.t1 O75096 31.788 302 3.2200000000000004e-32 135.0 sp|O75096|LRP4_HUMAN Low-density lipoprotein receptor-related protein 4 OS=Homo sapiens OX=9606 GN=LRP4 PE=1 SV=4 LRP4_HUMAN reviewed Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7) Homo sapiens (Human) GO:0001822; GO:0001942; GO:0005509; GO:0005886; GO:0006897; GO:0007167; GO:0009953; GO:0009954; GO:0009986; GO:0014069; GO:0015026; GO:0016055; GO:0016601; GO:0030279; GO:0030425; GO:0030971; GO:0031594; GO:0034185; GO:0035022; GO:0042475; GO:0042733; GO:0042803; GO:0043025; GO:0044853; GO:0048699; GO:0048813; GO:0050771; GO:0050808; GO:0051124; GO:0060173; GO:0071340; GO:0090090; GO:0097060; GO:0097104; GO:0097105; GO:0097110; GO:0150052; GO:0150094; GO:1901631; GO:1904395 amyloid-beta clearance by cellular catabolic process [GO:0150094]; dendrite morphogenesis [GO:0048813]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; endocytosis [GO:0006897]; enzyme-linked receptor protein signaling pathway [GO:0007167]; generation of neurons [GO:0048699]; hair follicle development [GO:0001942]; kidney development [GO:0001822]; limb development [GO:0060173]; negative regulation of axonogenesis [GO:0050771]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of ossification [GO:0030279]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of presynaptic membrane organization [GO:1901631]; positive regulation of Rac protein signal transduction [GO:0035022]; positive regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904395]; postsynaptic membrane assembly [GO:0097104]; presynaptic membrane assembly [GO:0097105]; proximal/distal pattern formation [GO:0009954]; Rac protein signal transduction [GO:0016601]; regulation of postsynapse assembly [GO:0150052]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; synapse organization [GO:0050808]; synaptic assembly at neuromuscular junction [GO:0051124]; Wnt signaling pathway [GO:0016055] cell surface [GO:0009986]; dendrite [GO:0030425]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic density [GO:0014069]; synaptic membrane [GO:0097060] apolipoprotein binding [GO:0034185]; calcium ion binding [GO:0005509]; coreceptor activity [GO:0015026]; protein homodimerization activity [GO:0042803]; receptor tyrosine kinase binding [GO:0030971]; scaffold protein binding [GO:0097110] g3704.t2 O75096 36.861 274 3.65e-39 157.0 sp|O75096|LRP4_HUMAN Low-density lipoprotein receptor-related protein 4 OS=Homo sapiens OX=9606 GN=LRP4 PE=1 SV=4 LRP4_HUMAN reviewed Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7) Homo sapiens (Human) GO:0001822; GO:0001942; GO:0005509; GO:0005886; GO:0006897; GO:0007167; GO:0009953; GO:0009954; GO:0009986; GO:0014069; GO:0015026; GO:0016055; GO:0016601; GO:0030279; GO:0030425; GO:0030971; GO:0031594; GO:0034185; GO:0035022; GO:0042475; GO:0042733; GO:0042803; GO:0043025; GO:0044853; GO:0048699; GO:0048813; GO:0050771; GO:0050808; GO:0051124; GO:0060173; GO:0071340; GO:0090090; GO:0097060; GO:0097104; GO:0097105; GO:0097110; GO:0150052; GO:0150094; GO:1901631; GO:1904395 amyloid-beta clearance by cellular catabolic process [GO:0150094]; dendrite morphogenesis [GO:0048813]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; endocytosis [GO:0006897]; enzyme-linked receptor protein signaling pathway [GO:0007167]; generation of neurons [GO:0048699]; hair follicle development [GO:0001942]; kidney development [GO:0001822]; limb development [GO:0060173]; negative regulation of axonogenesis [GO:0050771]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of ossification [GO:0030279]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of presynaptic membrane organization [GO:1901631]; positive regulation of Rac protein signal transduction [GO:0035022]; positive regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904395]; postsynaptic membrane assembly [GO:0097104]; presynaptic membrane assembly [GO:0097105]; proximal/distal pattern formation [GO:0009954]; Rac protein signal transduction [GO:0016601]; regulation of postsynapse assembly [GO:0150052]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; synapse organization [GO:0050808]; synaptic assembly at neuromuscular junction [GO:0051124]; Wnt signaling pathway [GO:0016055] cell surface [GO:0009986]; dendrite [GO:0030425]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic density [GO:0014069]; synaptic membrane [GO:0097060] apolipoprotein binding [GO:0034185]; calcium ion binding [GO:0005509]; coreceptor activity [GO:0015026]; protein homodimerization activity [GO:0042803]; receptor tyrosine kinase binding [GO:0030971]; scaffold protein binding [GO:0097110] g3704.t2 O75096 33.091 275 1.98e-36 149.0 sp|O75096|LRP4_HUMAN Low-density lipoprotein receptor-related protein 4 OS=Homo sapiens OX=9606 GN=LRP4 PE=1 SV=4 LRP4_HUMAN reviewed Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7) Homo sapiens (Human) GO:0001822; GO:0001942; GO:0005509; GO:0005886; GO:0006897; GO:0007167; GO:0009953; GO:0009954; GO:0009986; GO:0014069; GO:0015026; GO:0016055; GO:0016601; GO:0030279; GO:0030425; GO:0030971; GO:0031594; GO:0034185; GO:0035022; GO:0042475; GO:0042733; GO:0042803; GO:0043025; GO:0044853; GO:0048699; GO:0048813; GO:0050771; GO:0050808; GO:0051124; GO:0060173; GO:0071340; GO:0090090; GO:0097060; GO:0097104; GO:0097105; GO:0097110; GO:0150052; GO:0150094; GO:1901631; GO:1904395 amyloid-beta clearance by cellular catabolic process [GO:0150094]; dendrite morphogenesis [GO:0048813]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; endocytosis [GO:0006897]; enzyme-linked receptor protein signaling pathway [GO:0007167]; generation of neurons [GO:0048699]; hair follicle development [GO:0001942]; kidney development [GO:0001822]; limb development [GO:0060173]; negative regulation of axonogenesis [GO:0050771]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of ossification [GO:0030279]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of presynaptic membrane organization [GO:1901631]; positive regulation of Rac protein signal transduction [GO:0035022]; positive regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904395]; postsynaptic membrane assembly [GO:0097104]; presynaptic membrane assembly [GO:0097105]; proximal/distal pattern formation [GO:0009954]; Rac protein signal transduction [GO:0016601]; regulation of postsynapse assembly [GO:0150052]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; synapse organization [GO:0050808]; synaptic assembly at neuromuscular junction [GO:0051124]; Wnt signaling pathway [GO:0016055] cell surface [GO:0009986]; dendrite [GO:0030425]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic density [GO:0014069]; synaptic membrane [GO:0097060] apolipoprotein binding [GO:0034185]; calcium ion binding [GO:0005509]; coreceptor activity [GO:0015026]; protein homodimerization activity [GO:0042803]; receptor tyrosine kinase binding [GO:0030971]; scaffold protein binding [GO:0097110] g3704.t2 O75096 32.5 280 5.38e-32 135.0 sp|O75096|LRP4_HUMAN Low-density lipoprotein receptor-related protein 4 OS=Homo sapiens OX=9606 GN=LRP4 PE=1 SV=4 LRP4_HUMAN reviewed Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7) Homo sapiens (Human) GO:0001822; GO:0001942; GO:0005509; GO:0005886; GO:0006897; GO:0007167; GO:0009953; GO:0009954; GO:0009986; GO:0014069; GO:0015026; GO:0016055; GO:0016601; GO:0030279; GO:0030425; GO:0030971; GO:0031594; GO:0034185; GO:0035022; GO:0042475; GO:0042733; GO:0042803; GO:0043025; GO:0044853; GO:0048699; GO:0048813; GO:0050771; GO:0050808; GO:0051124; GO:0060173; GO:0071340; GO:0090090; GO:0097060; GO:0097104; GO:0097105; GO:0097110; GO:0150052; GO:0150094; GO:1901631; GO:1904395 amyloid-beta clearance by cellular catabolic process [GO:0150094]; dendrite morphogenesis [GO:0048813]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; endocytosis [GO:0006897]; enzyme-linked receptor protein signaling pathway [GO:0007167]; generation of neurons [GO:0048699]; hair follicle development [GO:0001942]; kidney development [GO:0001822]; limb development [GO:0060173]; negative regulation of axonogenesis [GO:0050771]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of ossification [GO:0030279]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of presynaptic membrane organization [GO:1901631]; positive regulation of Rac protein signal transduction [GO:0035022]; positive regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904395]; postsynaptic membrane assembly [GO:0097104]; presynaptic membrane assembly [GO:0097105]; proximal/distal pattern formation [GO:0009954]; Rac protein signal transduction [GO:0016601]; regulation of postsynapse assembly [GO:0150052]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; synapse organization [GO:0050808]; synaptic assembly at neuromuscular junction [GO:0051124]; Wnt signaling pathway [GO:0016055] cell surface [GO:0009986]; dendrite [GO:0030425]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic density [GO:0014069]; synaptic membrane [GO:0097060] apolipoprotein binding [GO:0034185]; calcium ion binding [GO:0005509]; coreceptor activity [GO:0015026]; protein homodimerization activity [GO:0042803]; receptor tyrosine kinase binding [GO:0030971]; scaffold protein binding [GO:0097110] g3704.t2 O75096 31.788 302 9.180000000000001e-32 135.0 sp|O75096|LRP4_HUMAN Low-density lipoprotein receptor-related protein 4 OS=Homo sapiens OX=9606 GN=LRP4 PE=1 SV=4 LRP4_HUMAN reviewed Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7) Homo sapiens (Human) GO:0001822; GO:0001942; GO:0005509; GO:0005886; GO:0006897; GO:0007167; GO:0009953; GO:0009954; GO:0009986; GO:0014069; GO:0015026; GO:0016055; GO:0016601; GO:0030279; GO:0030425; GO:0030971; GO:0031594; GO:0034185; GO:0035022; GO:0042475; GO:0042733; GO:0042803; GO:0043025; GO:0044853; GO:0048699; GO:0048813; GO:0050771; GO:0050808; GO:0051124; GO:0060173; GO:0071340; GO:0090090; GO:0097060; GO:0097104; GO:0097105; GO:0097110; GO:0150052; GO:0150094; GO:1901631; GO:1904395 amyloid-beta clearance by cellular catabolic process [GO:0150094]; dendrite morphogenesis [GO:0048813]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; endocytosis [GO:0006897]; enzyme-linked receptor protein signaling pathway [GO:0007167]; generation of neurons [GO:0048699]; hair follicle development [GO:0001942]; kidney development [GO:0001822]; limb development [GO:0060173]; negative regulation of axonogenesis [GO:0050771]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of ossification [GO:0030279]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of presynaptic membrane organization [GO:1901631]; positive regulation of Rac protein signal transduction [GO:0035022]; positive regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904395]; postsynaptic membrane assembly [GO:0097104]; presynaptic membrane assembly [GO:0097105]; proximal/distal pattern formation [GO:0009954]; Rac protein signal transduction [GO:0016601]; regulation of postsynapse assembly [GO:0150052]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; synapse organization [GO:0050808]; synaptic assembly at neuromuscular junction [GO:0051124]; Wnt signaling pathway [GO:0016055] cell surface [GO:0009986]; dendrite [GO:0030425]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic density [GO:0014069]; synaptic membrane [GO:0097060] apolipoprotein binding [GO:0034185]; calcium ion binding [GO:0005509]; coreceptor activity [GO:0015026]; protein homodimerization activity [GO:0042803]; receptor tyrosine kinase binding [GO:0030971]; scaffold protein binding [GO:0097110] g3705.t1 Q9QYP1 35.115 262 1.15e-38 154.0 sp|Q9QYP1|LRP4_RAT Low-density lipoprotein receptor-related protein 4 OS=Rattus norvegicus OX=10116 GN=Lrp4 PE=1 SV=2 LRP4_RAT reviewed Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7) Rattus norvegicus (Rat) GO:0001822; GO:0001942; GO:0005509; GO:0005886; GO:0006897; GO:0007167; GO:0008104; GO:0009953; GO:0009954; GO:0009986; GO:0014069; GO:0015026; GO:0016055; GO:0016601; GO:0030279; GO:0030326; GO:0030425; GO:0030971; GO:0031594; GO:0034185; GO:0035022; GO:0042475; GO:0042733; GO:0042803; GO:0043025; GO:0043113; GO:0044853; GO:0045202; GO:0048699; GO:0048813; GO:0050771; GO:0050808; GO:0051124; GO:0060173; GO:0071340; GO:0090090; GO:0097060; GO:0097104; GO:0097105; GO:0097110; GO:0150052; GO:0150094; GO:1901631; GO:1904395 amyloid-beta clearance by cellular catabolic process [GO:0150094]; dendrite morphogenesis [GO:0048813]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; embryonic limb morphogenesis [GO:0030326]; endocytosis [GO:0006897]; enzyme-linked receptor protein signaling pathway [GO:0007167]; generation of neurons [GO:0048699]; hair follicle development [GO:0001942]; intracellular protein localization [GO:0008104]; kidney development [GO:0001822]; limb development [GO:0060173]; negative regulation of axonogenesis [GO:0050771]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of ossification [GO:0030279]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of presynaptic membrane organization [GO:1901631]; positive regulation of Rac protein signal transduction [GO:0035022]; positive regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904395]; postsynaptic membrane assembly [GO:0097104]; presynaptic membrane assembly [GO:0097105]; proximal/distal pattern formation [GO:0009954]; Rac protein signal transduction [GO:0016601]; receptor clustering [GO:0043113]; regulation of postsynapse assembly [GO:0150052]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; synapse organization [GO:0050808]; synaptic assembly at neuromuscular junction [GO:0051124]; Wnt signaling pathway [GO:0016055] cell surface [GO:0009986]; dendrite [GO:0030425]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic density [GO:0014069]; synapse [GO:0045202]; synaptic membrane [GO:0097060] apolipoprotein binding [GO:0034185]; calcium ion binding [GO:0005509]; coreceptor activity [GO:0015026]; protein homodimerization activity [GO:0042803]; receptor tyrosine kinase binding [GO:0030971]; scaffold protein binding [GO:0097110] g3705.t1 Q9QYP1 35.338 266 2.35e-38 154.0 sp|Q9QYP1|LRP4_RAT Low-density lipoprotein receptor-related protein 4 OS=Rattus norvegicus OX=10116 GN=Lrp4 PE=1 SV=2 LRP4_RAT reviewed Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7) Rattus norvegicus (Rat) GO:0001822; GO:0001942; GO:0005509; GO:0005886; GO:0006897; GO:0007167; GO:0008104; GO:0009953; GO:0009954; GO:0009986; GO:0014069; GO:0015026; GO:0016055; GO:0016601; GO:0030279; GO:0030326; GO:0030425; GO:0030971; GO:0031594; GO:0034185; GO:0035022; GO:0042475; GO:0042733; GO:0042803; GO:0043025; GO:0043113; GO:0044853; GO:0045202; GO:0048699; GO:0048813; GO:0050771; GO:0050808; GO:0051124; GO:0060173; GO:0071340; GO:0090090; GO:0097060; GO:0097104; GO:0097105; GO:0097110; GO:0150052; GO:0150094; GO:1901631; GO:1904395 amyloid-beta clearance by cellular catabolic process [GO:0150094]; dendrite morphogenesis [GO:0048813]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; embryonic limb morphogenesis [GO:0030326]; endocytosis [GO:0006897]; enzyme-linked receptor protein signaling pathway [GO:0007167]; generation of neurons [GO:0048699]; hair follicle development [GO:0001942]; intracellular protein localization [GO:0008104]; kidney development [GO:0001822]; limb development [GO:0060173]; negative regulation of axonogenesis [GO:0050771]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of ossification [GO:0030279]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of presynaptic membrane organization [GO:1901631]; positive regulation of Rac protein signal transduction [GO:0035022]; positive regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904395]; postsynaptic membrane assembly [GO:0097104]; presynaptic membrane assembly [GO:0097105]; proximal/distal pattern formation [GO:0009954]; Rac protein signal transduction [GO:0016601]; receptor clustering [GO:0043113]; regulation of postsynapse assembly [GO:0150052]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; synapse organization [GO:0050808]; synaptic assembly at neuromuscular junction [GO:0051124]; Wnt signaling pathway [GO:0016055] cell surface [GO:0009986]; dendrite [GO:0030425]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic density [GO:0014069]; synapse [GO:0045202]; synaptic membrane [GO:0097060] apolipoprotein binding [GO:0034185]; calcium ion binding [GO:0005509]; coreceptor activity [GO:0015026]; protein homodimerization activity [GO:0042803]; receptor tyrosine kinase binding [GO:0030971]; scaffold protein binding [GO:0097110] g3705.t1 Q9QYP1 37.931 203 1.41e-31 133.0 sp|Q9QYP1|LRP4_RAT Low-density lipoprotein receptor-related protein 4 OS=Rattus norvegicus OX=10116 GN=Lrp4 PE=1 SV=2 LRP4_RAT reviewed Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7) Rattus norvegicus (Rat) GO:0001822; GO:0001942; GO:0005509; GO:0005886; GO:0006897; GO:0007167; GO:0008104; GO:0009953; GO:0009954; GO:0009986; GO:0014069; GO:0015026; GO:0016055; GO:0016601; GO:0030279; GO:0030326; GO:0030425; GO:0030971; GO:0031594; GO:0034185; GO:0035022; GO:0042475; GO:0042733; GO:0042803; GO:0043025; GO:0043113; GO:0044853; GO:0045202; GO:0048699; GO:0048813; GO:0050771; GO:0050808; GO:0051124; GO:0060173; GO:0071340; GO:0090090; GO:0097060; GO:0097104; GO:0097105; GO:0097110; GO:0150052; GO:0150094; GO:1901631; GO:1904395 amyloid-beta clearance by cellular catabolic process [GO:0150094]; dendrite morphogenesis [GO:0048813]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; embryonic limb morphogenesis [GO:0030326]; endocytosis [GO:0006897]; enzyme-linked receptor protein signaling pathway [GO:0007167]; generation of neurons [GO:0048699]; hair follicle development [GO:0001942]; intracellular protein localization [GO:0008104]; kidney development [GO:0001822]; limb development [GO:0060173]; negative regulation of axonogenesis [GO:0050771]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of ossification [GO:0030279]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of presynaptic membrane organization [GO:1901631]; positive regulation of Rac protein signal transduction [GO:0035022]; positive regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904395]; postsynaptic membrane assembly [GO:0097104]; presynaptic membrane assembly [GO:0097105]; proximal/distal pattern formation [GO:0009954]; Rac protein signal transduction [GO:0016601]; receptor clustering [GO:0043113]; regulation of postsynapse assembly [GO:0150052]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; synapse organization [GO:0050808]; synaptic assembly at neuromuscular junction [GO:0051124]; Wnt signaling pathway [GO:0016055] cell surface [GO:0009986]; dendrite [GO:0030425]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic density [GO:0014069]; synapse [GO:0045202]; synaptic membrane [GO:0097060] apolipoprotein binding [GO:0034185]; calcium ion binding [GO:0005509]; coreceptor activity [GO:0015026]; protein homodimerization activity [GO:0042803]; receptor tyrosine kinase binding [GO:0030971]; scaffold protein binding [GO:0097110] g3705.t1 Q9QYP1 36.0 200 7.999999999999999e-30 128.0 sp|Q9QYP1|LRP4_RAT Low-density lipoprotein receptor-related protein 4 OS=Rattus norvegicus OX=10116 GN=Lrp4 PE=1 SV=2 LRP4_RAT reviewed Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7) Rattus norvegicus (Rat) GO:0001822; GO:0001942; GO:0005509; GO:0005886; GO:0006897; GO:0007167; GO:0008104; GO:0009953; GO:0009954; GO:0009986; GO:0014069; GO:0015026; GO:0016055; GO:0016601; GO:0030279; GO:0030326; GO:0030425; GO:0030971; GO:0031594; GO:0034185; GO:0035022; GO:0042475; GO:0042733; GO:0042803; GO:0043025; GO:0043113; GO:0044853; GO:0045202; GO:0048699; GO:0048813; GO:0050771; GO:0050808; GO:0051124; GO:0060173; GO:0071340; GO:0090090; GO:0097060; GO:0097104; GO:0097105; GO:0097110; GO:0150052; GO:0150094; GO:1901631; GO:1904395 amyloid-beta clearance by cellular catabolic process [GO:0150094]; dendrite morphogenesis [GO:0048813]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; embryonic limb morphogenesis [GO:0030326]; endocytosis [GO:0006897]; enzyme-linked receptor protein signaling pathway [GO:0007167]; generation of neurons [GO:0048699]; hair follicle development [GO:0001942]; intracellular protein localization [GO:0008104]; kidney development [GO:0001822]; limb development [GO:0060173]; negative regulation of axonogenesis [GO:0050771]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of ossification [GO:0030279]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of presynaptic membrane organization [GO:1901631]; positive regulation of Rac protein signal transduction [GO:0035022]; positive regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904395]; postsynaptic membrane assembly [GO:0097104]; presynaptic membrane assembly [GO:0097105]; proximal/distal pattern formation [GO:0009954]; Rac protein signal transduction [GO:0016601]; receptor clustering [GO:0043113]; regulation of postsynapse assembly [GO:0150052]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; synapse organization [GO:0050808]; synaptic assembly at neuromuscular junction [GO:0051124]; Wnt signaling pathway [GO:0016055] cell surface [GO:0009986]; dendrite [GO:0030425]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic density [GO:0014069]; synapse [GO:0045202]; synaptic membrane [GO:0097060] apolipoprotein binding [GO:0034185]; calcium ion binding [GO:0005509]; coreceptor activity [GO:0015026]; protein homodimerization activity [GO:0042803]; receptor tyrosine kinase binding [GO:0030971]; scaffold protein binding [GO:0097110] g3706.t1 Q9QYP1 39.713 209 1.51e-36 147.0 sp|Q9QYP1|LRP4_RAT Low-density lipoprotein receptor-related protein 4 OS=Rattus norvegicus OX=10116 GN=Lrp4 PE=1 SV=2 LRP4_RAT reviewed Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7) Rattus norvegicus (Rat) GO:0001822; GO:0001942; GO:0005509; GO:0005886; GO:0006897; GO:0007167; GO:0008104; GO:0009953; GO:0009954; GO:0009986; GO:0014069; GO:0015026; GO:0016055; GO:0016601; GO:0030279; GO:0030326; GO:0030425; GO:0030971; GO:0031594; GO:0034185; GO:0035022; GO:0042475; GO:0042733; GO:0042803; GO:0043025; GO:0043113; GO:0044853; GO:0045202; GO:0048699; GO:0048813; GO:0050771; GO:0050808; GO:0051124; GO:0060173; GO:0071340; GO:0090090; GO:0097060; GO:0097104; GO:0097105; GO:0097110; GO:0150052; GO:0150094; GO:1901631; GO:1904395 amyloid-beta clearance by cellular catabolic process [GO:0150094]; dendrite morphogenesis [GO:0048813]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; embryonic limb morphogenesis [GO:0030326]; endocytosis [GO:0006897]; enzyme-linked receptor protein signaling pathway [GO:0007167]; generation of neurons [GO:0048699]; hair follicle development [GO:0001942]; intracellular protein localization [GO:0008104]; kidney development [GO:0001822]; limb development [GO:0060173]; negative regulation of axonogenesis [GO:0050771]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of ossification [GO:0030279]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of presynaptic membrane organization [GO:1901631]; positive regulation of Rac protein signal transduction [GO:0035022]; positive regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904395]; postsynaptic membrane assembly [GO:0097104]; presynaptic membrane assembly [GO:0097105]; proximal/distal pattern formation [GO:0009954]; Rac protein signal transduction [GO:0016601]; receptor clustering [GO:0043113]; regulation of postsynapse assembly [GO:0150052]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; synapse organization [GO:0050808]; synaptic assembly at neuromuscular junction [GO:0051124]; Wnt signaling pathway [GO:0016055] cell surface [GO:0009986]; dendrite [GO:0030425]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic density [GO:0014069]; synapse [GO:0045202]; synaptic membrane [GO:0097060] apolipoprotein binding [GO:0034185]; calcium ion binding [GO:0005509]; coreceptor activity [GO:0015026]; protein homodimerization activity [GO:0042803]; receptor tyrosine kinase binding [GO:0030971]; scaffold protein binding [GO:0097110] g3706.t1 Q9QYP1 38.389 211 2.06e-35 144.0 sp|Q9QYP1|LRP4_RAT Low-density lipoprotein receptor-related protein 4 OS=Rattus norvegicus OX=10116 GN=Lrp4 PE=1 SV=2 LRP4_RAT reviewed Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7) Rattus norvegicus (Rat) GO:0001822; GO:0001942; GO:0005509; GO:0005886; GO:0006897; GO:0007167; GO:0008104; GO:0009953; GO:0009954; GO:0009986; GO:0014069; GO:0015026; GO:0016055; GO:0016601; GO:0030279; GO:0030326; GO:0030425; GO:0030971; GO:0031594; GO:0034185; GO:0035022; GO:0042475; GO:0042733; GO:0042803; GO:0043025; GO:0043113; GO:0044853; GO:0045202; GO:0048699; GO:0048813; GO:0050771; GO:0050808; GO:0051124; GO:0060173; GO:0071340; GO:0090090; GO:0097060; GO:0097104; GO:0097105; GO:0097110; GO:0150052; GO:0150094; GO:1901631; GO:1904395 amyloid-beta clearance by cellular catabolic process [GO:0150094]; dendrite morphogenesis [GO:0048813]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; embryonic limb morphogenesis [GO:0030326]; endocytosis [GO:0006897]; enzyme-linked receptor protein signaling pathway [GO:0007167]; generation of neurons [GO:0048699]; hair follicle development [GO:0001942]; intracellular protein localization [GO:0008104]; kidney development [GO:0001822]; limb development [GO:0060173]; negative regulation of axonogenesis [GO:0050771]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of ossification [GO:0030279]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of presynaptic membrane organization [GO:1901631]; positive regulation of Rac protein signal transduction [GO:0035022]; positive regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904395]; postsynaptic membrane assembly [GO:0097104]; presynaptic membrane assembly [GO:0097105]; proximal/distal pattern formation [GO:0009954]; Rac protein signal transduction [GO:0016601]; receptor clustering [GO:0043113]; regulation of postsynapse assembly [GO:0150052]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; synapse organization [GO:0050808]; synaptic assembly at neuromuscular junction [GO:0051124]; Wnt signaling pathway [GO:0016055] cell surface [GO:0009986]; dendrite [GO:0030425]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic density [GO:0014069]; synapse [GO:0045202]; synaptic membrane [GO:0097060] apolipoprotein binding [GO:0034185]; calcium ion binding [GO:0005509]; coreceptor activity [GO:0015026]; protein homodimerization activity [GO:0042803]; receptor tyrosine kinase binding [GO:0030971]; scaffold protein binding [GO:0097110] g3706.t1 Q9QYP1 36.792 212 2.2e-30 129.0 sp|Q9QYP1|LRP4_RAT Low-density lipoprotein receptor-related protein 4 OS=Rattus norvegicus OX=10116 GN=Lrp4 PE=1 SV=2 LRP4_RAT reviewed Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7) Rattus norvegicus (Rat) GO:0001822; GO:0001942; GO:0005509; GO:0005886; GO:0006897; GO:0007167; GO:0008104; GO:0009953; GO:0009954; GO:0009986; GO:0014069; GO:0015026; GO:0016055; GO:0016601; GO:0030279; GO:0030326; GO:0030425; GO:0030971; GO:0031594; GO:0034185; GO:0035022; GO:0042475; GO:0042733; GO:0042803; GO:0043025; GO:0043113; GO:0044853; GO:0045202; GO:0048699; GO:0048813; GO:0050771; GO:0050808; GO:0051124; GO:0060173; GO:0071340; GO:0090090; GO:0097060; GO:0097104; GO:0097105; GO:0097110; GO:0150052; GO:0150094; GO:1901631; GO:1904395 amyloid-beta clearance by cellular catabolic process [GO:0150094]; dendrite morphogenesis [GO:0048813]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; embryonic limb morphogenesis [GO:0030326]; endocytosis [GO:0006897]; enzyme-linked receptor protein signaling pathway [GO:0007167]; generation of neurons [GO:0048699]; hair follicle development [GO:0001942]; intracellular protein localization [GO:0008104]; kidney development [GO:0001822]; limb development [GO:0060173]; negative regulation of axonogenesis [GO:0050771]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of ossification [GO:0030279]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of presynaptic membrane organization [GO:1901631]; positive regulation of Rac protein signal transduction [GO:0035022]; positive regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904395]; postsynaptic membrane assembly [GO:0097104]; presynaptic membrane assembly [GO:0097105]; proximal/distal pattern formation [GO:0009954]; Rac protein signal transduction [GO:0016601]; receptor clustering [GO:0043113]; regulation of postsynapse assembly [GO:0150052]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; synapse organization [GO:0050808]; synaptic assembly at neuromuscular junction [GO:0051124]; Wnt signaling pathway [GO:0016055] cell surface [GO:0009986]; dendrite [GO:0030425]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic density [GO:0014069]; synapse [GO:0045202]; synaptic membrane [GO:0097060] apolipoprotein binding [GO:0034185]; calcium ion binding [GO:0005509]; coreceptor activity [GO:0015026]; protein homodimerization activity [GO:0042803]; receptor tyrosine kinase binding [GO:0030971]; scaffold protein binding [GO:0097110] g3706.t1 Q9QYP1 34.928 209 1.13e-28 124.0 sp|Q9QYP1|LRP4_RAT Low-density lipoprotein receptor-related protein 4 OS=Rattus norvegicus OX=10116 GN=Lrp4 PE=1 SV=2 LRP4_RAT reviewed Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7) Rattus norvegicus (Rat) GO:0001822; GO:0001942; GO:0005509; GO:0005886; GO:0006897; GO:0007167; GO:0008104; GO:0009953; GO:0009954; GO:0009986; GO:0014069; GO:0015026; GO:0016055; GO:0016601; GO:0030279; GO:0030326; GO:0030425; GO:0030971; GO:0031594; GO:0034185; GO:0035022; GO:0042475; GO:0042733; GO:0042803; GO:0043025; GO:0043113; GO:0044853; GO:0045202; GO:0048699; GO:0048813; GO:0050771; GO:0050808; GO:0051124; GO:0060173; GO:0071340; GO:0090090; GO:0097060; GO:0097104; GO:0097105; GO:0097110; GO:0150052; GO:0150094; GO:1901631; GO:1904395 amyloid-beta clearance by cellular catabolic process [GO:0150094]; dendrite morphogenesis [GO:0048813]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; embryonic limb morphogenesis [GO:0030326]; endocytosis [GO:0006897]; enzyme-linked receptor protein signaling pathway [GO:0007167]; generation of neurons [GO:0048699]; hair follicle development [GO:0001942]; intracellular protein localization [GO:0008104]; kidney development [GO:0001822]; limb development [GO:0060173]; negative regulation of axonogenesis [GO:0050771]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of ossification [GO:0030279]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of presynaptic membrane organization [GO:1901631]; positive regulation of Rac protein signal transduction [GO:0035022]; positive regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904395]; postsynaptic membrane assembly [GO:0097104]; presynaptic membrane assembly [GO:0097105]; proximal/distal pattern formation [GO:0009954]; Rac protein signal transduction [GO:0016601]; receptor clustering [GO:0043113]; regulation of postsynapse assembly [GO:0150052]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; synapse organization [GO:0050808]; synaptic assembly at neuromuscular junction [GO:0051124]; Wnt signaling pathway [GO:0016055] cell surface [GO:0009986]; dendrite [GO:0030425]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic density [GO:0014069]; synapse [GO:0045202]; synaptic membrane [GO:0097060] apolipoprotein binding [GO:0034185]; calcium ion binding [GO:0005509]; coreceptor activity [GO:0015026]; protein homodimerization activity [GO:0042803]; receptor tyrosine kinase binding [GO:0030971]; scaffold protein binding [GO:0097110] g3707.t1 A2RRH5 33.446 888 7.089999999999999e-159 489.0 sp|A2RRH5|WDR27_HUMAN WD repeat-containing protein 27 OS=Homo sapiens OX=9606 GN=WDR27 PE=1 SV=3 g3710.t1 Q0P6D6 39.015 264 9.31e-30 121.0 sp|Q0P6D6|CCD15_HUMAN Coiled-coil domain-containing protein 15 OS=Homo sapiens OX=9606 GN=CCDC15 PE=1 SV=2 CCD15_HUMAN reviewed Coiled-coil domain-containing protein 15 Homo sapiens (Human) GO:0005813; GO:0005814; GO:0034451; GO:0060271; GO:1903724 cilium assembly [GO:0060271]; positive regulation of centriole elongation [GO:1903724] centriolar satellite [GO:0034451]; centriole [GO:0005814]; centrosome [GO:0005813] g3711.t1 P07996 54.317 915 0.0 834.0 sp|P07996|TSP1_HUMAN Thrombospondin-1 OS=Homo sapiens OX=9606 GN=THBS1 PE=1 SV=2 TSP1_HUMAN reviewed Thrombospondin-1 (Glycoprotein G) Homo sapiens (Human) GO:0001666; GO:0001786; GO:0001937; GO:0001953; GO:0001968; GO:0002020; GO:0002040; GO:0002544; GO:0002581; GO:0002605; GO:0004866; GO:0005178; GO:0005201; GO:0005509; GO:0005576; GO:0005577; GO:0005615; GO:0005783; GO:0005788; GO:0006915; GO:0006954; GO:0006955; GO:0006986; GO:0007155; GO:0008201; GO:0008284; GO:0008285; GO:0009410; GO:0009612; GO:0009749; GO:0009897; GO:0009986; GO:0010595; GO:0010596; GO:0010748; GO:0010751; GO:0010754; GO:0010757; GO:0010759; GO:0010763; GO:0016477; GO:0016525; GO:0016529; GO:0017134; GO:0030141; GO:0030169; GO:0030335; GO:0030511; GO:0031012; GO:0031091; GO:0031093; GO:0032026; GO:0032570; GO:0032693; GO:0032695; GO:0032720; GO:0032760; GO:0032914; GO:0033574; GO:0034605; GO:0034976; GO:0038060; GO:0040037; GO:0042327; GO:0042803; GO:0043032; GO:0043066; GO:0043236; GO:0043394; GO:0043410; GO:0043536; GO:0043537; GO:0043652; GO:0045727; GO:0045766; GO:0048266; GO:0048661; GO:0050431; GO:0050921; GO:0051592; GO:0051895; GO:0051897; GO:0051918; GO:0070051; GO:0070052; GO:0070062; GO:0071356; GO:0071363; GO:0072378; GO:0090051; GO:0141151; GO:1902043; GO:1903588; GO:1903671; GO:2000353; GO:2000379; GO:2001027; GO:2001237 apoptotic process [GO:0006915]; behavioral response to pain [GO:0048266]; blood coagulation, fibrin clot formation [GO:0072378]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; cellular response to growth factor stimulus [GO:0071363]; cellular response to heat [GO:0034605]; cellular response to tumor necrosis factor [GO:0071356]; chronic inflammatory response [GO:0002544]; engulfment of apoptotic cell [GO:0043652]; immune response [GO:0006955]; inflammatory response [GO:0006954]; negative regulation of angiogenesis [GO:0016525]; negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II [GO:0002581]; negative regulation of apoptotic process [GO:0043066]; negative regulation of blood vessel endothelial cell migration [GO:0043537]; negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis [GO:1903588]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of cGMP-mediated signaling [GO:0010754]; negative regulation of dendritic cell antigen processing and presentation [GO:0002605]; negative regulation of endothelial cell chemotaxis [GO:2001027]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of fibrinolysis [GO:0051918]; negative regulation of fibroblast growth factor receptor signaling pathway [GO:0040037]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of interleukin-10 production [GO:0032693]; negative regulation of interleukin-12 production [GO:0032695]; negative regulation of long-chain fatty acid import across plasma membrane [GO:0010748]; negative regulation of nitric oxide mediated signal transduction [GO:0010751]; negative regulation of nitric oxide-cGMP mediated signal transduction [GO:0141151]; negative regulation of plasminogen activation [GO:0010757]; negative regulation of sprouting angiogenesis [GO:1903671]; negative regulation of tumor necrosis factor production [GO:0032720]; nitric oxide-cGMP-mediated signaling [GO:0038060]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of chemotaxis [GO:0050921]; positive regulation of endothelial cell apoptotic process [GO:2000353]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902043]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of macrophage activation [GO:0043032]; positive regulation of macrophage chemotaxis [GO:0010759]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of phosphorylation [GO:0042327]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; positive regulation of transforming growth factor beta1 production [GO:0032914]; positive regulation of translation [GO:0045727]; positive regulation of tumor necrosis factor production [GO:0032760]; response to calcium ion [GO:0051592]; response to endoplasmic reticulum stress [GO:0034976]; response to glucose [GO:0009749]; response to hypoxia [GO:0001666]; response to magnesium ion [GO:0032026]; response to mechanical stimulus [GO:0009612]; response to progesterone [GO:0032570]; response to testosterone [GO:0033574]; response to unfolded protein [GO:0006986]; response to xenobiotic stimulus [GO:0009410]; sprouting angiogenesis [GO:0002040] cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; fibrinogen complex [GO:0005577]; platelet alpha granule [GO:0031091]; platelet alpha granule lumen [GO:0031093]; sarcoplasmic reticulum [GO:0016529]; secretory granule [GO:0030141] calcium ion binding [GO:0005509]; collagen V binding [GO:0070052]; endopeptidase inhibitor activity [GO:0004866]; extracellular matrix structural constituent [GO:0005201]; fibrinogen binding [GO:0070051]; fibroblast growth factor binding [GO:0017134]; fibronectin binding [GO:0001968]; heparin binding [GO:0008201]; integrin binding [GO:0005178]; laminin binding [GO:0043236]; low-density lipoprotein particle binding [GO:0030169]; phosphatidylserine binding [GO:0001786]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; proteoglycan binding [GO:0043394]; transforming growth factor beta binding [GO:0050431] g3713.t1 Q5RFE6 46.901 484 3.71e-150 440.0 sp|Q5RFE6|THNS2_PONAB Threonine synthase-like 2 OS=Pongo abelii OX=9601 GN=THNSL2 PE=2 SV=1 g3724.t1 Q7L622 32.057 209 5.45e-27 111.0 sp|Q7L622|G2E3_HUMAN G2/M phase-specific E3 ubiquitin-protein ligase OS=Homo sapiens OX=9606 GN=G2E3 PE=1 SV=1 G2E3_HUMAN reviewed G2/M phase-specific E3 ubiquitin-protein ligase (EC 2.3.2.26) (G2/M phase-specific HECT-type E3 ubiquitin transferase) Homo sapiens (Human) GO:0005634; GO:0005730; GO:0005794; GO:0005829; GO:0006915; GO:0008270; GO:0016567; GO:0061630 apoptotic process [GO:0006915]; protein ubiquitination [GO:0016567] cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleolus [GO:0005730]; nucleus [GO:0005634] ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] g3728.t1 Q6GQ29 58.862 457 0.0 567.0 sp|Q6GQ29|CBPQ_XENLA Carboxypeptidase Q OS=Xenopus laevis OX=8355 GN=cpq PE=2 SV=1 CBPQ_XENLA reviewed Carboxypeptidase Q (EC 3.4.17.-) (Plasma glutamate carboxypeptidase) Xenopus laevis (African clawed frog) GO:0004180; GO:0005615; GO:0005737; GO:0005764; GO:0005783; GO:0005794; GO:0006508; GO:0042803; GO:0043171; GO:0046872; GO:0070573 peptide catabolic process [GO:0043171]; proteolysis [GO:0006508] cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; lysosome [GO:0005764] carboxypeptidase activity [GO:0004180]; metal ion binding [GO:0046872]; metallodipeptidase activity [GO:0070573]; protein homodimerization activity [GO:0042803] g3729.t1 P0CB42 46.503 286 4.9399999999999996e-82 265.0 sp|P0CB42|ALKB1_MOUSE Nucleic acid dioxygenase ALKBH1 OS=Mus musculus OX=10090 GN=Alkbh1 PE=1 SV=1 ALKB1_MOUSE reviewed Nucleic acid dioxygenase ALKBH1 (EC 1.14.11.-) (Alkylated DNA repair protein alkB homolog 1) (Alpha-ketoglutarate-dependent dioxygenase ABH1) (DNA 6mA demethylase) (DNA N6-methyl adenine demethylase ALKBH1) (EC 1.14.11.51) (DNA lyase ABH1) (EC 4.2.99.18) (DNA oxidative demethylase ALKBH1) (EC 1.14.11.33) (mRNA N(3)-methylcytidine demethylase) (EC 1.14.11.-) (tRNA N1-methyl adenine demethylase) (EC 1.14.11.-) Mus musculus (Mouse) GO:0000049; GO:0000791; GO:0001701; GO:0001764; GO:0001890; GO:0002101; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005783; GO:0006281; GO:0006446; GO:0006448; GO:0008198; GO:0010468; GO:0016706; GO:0030154; GO:0031175; GO:0035513; GO:0035515; GO:0035516; GO:0042056; GO:0042245; GO:0043524; GO:0048589; GO:0070129; GO:0140078; GO:0141131; GO:0141137; GO:0160290; GO:1990983; GO:1990984 cell differentiation [GO:0030154]; developmental growth [GO:0048589]; DNA repair [GO:0006281]; in utero embryonic development [GO:0001701]; negative regulation of neuron apoptotic process [GO:0043524]; neuron migration [GO:0001764]; neuron projection development [GO:0031175]; oxidative RNA demethylation [GO:0035513]; placenta development [GO:0001890]; positive regulation of gene expression, epigenetic [GO:0141137]; regulation of gene expression [GO:0010468]; regulation of mitochondrial translation [GO:0070129]; regulation of translational elongation [GO:0006448]; regulation of translational initiation [GO:0006446]; regulation of translational initiation by tRNA modification [GO:1990983]; RNA repair [GO:0042245]; tRNA wobble cytosine modification [GO:0002101] cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; euchromatin [GO:0000791]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] 2-oxoglutarate-dependent dioxygenase activity [GO:0016706]; 2-oxoglutarate-dependent tRNA 5-methylcytidine formyltransferase activity [GO:0160290]; broad specificity oxidative DNA demethylase activity [GO:0035516]; chemoattractant activity [GO:0042056]; class I DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0140078]; DNA N6-methyladenine demethylase activity [GO:0141131]; ferrous iron binding [GO:0008198]; oxidative RNA demethylase activity [GO:0035515]; tRNA binding [GO:0000049]; tRNA demethylase activity [GO:1990984] g3730.t1 Q9D8T7 48.81 84 5.0099999999999994e-24 91.7 sp|Q9D8T7|SLIRP_MOUSE SRA stem-loop-interacting RNA-binding protein, mitochondrial OS=Mus musculus OX=10090 GN=Slirp PE=1 SV=2 SLIRP_MOUSE reviewed SRA stem-loop-interacting RNA-binding protein, mitochondrial Mus musculus (Mouse) GO:0000961; GO:0001669; GO:0003729; GO:0003730; GO:0005634; GO:0005737; GO:0005739; GO:0005759; GO:0007005; GO:0007283; GO:0007286; GO:0007338; GO:0030317; GO:0034046; GO:0036126; GO:0048026; GO:0048471; GO:0097222; GO:1905638; GO:1990904 flagellated sperm motility [GO:0030317]; mitochondrial mRNA polyadenylation [GO:0097222]; mitochondrion organization [GO:0007005]; negative regulation of mitochondrial mRNA catabolic process [GO:1905638]; negative regulation of mitochondrial RNA catabolic process [GO:0000961]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; single fertilization [GO:0007338]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283] acrosomal vesicle [GO:0001669]; cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; ribonucleoprotein complex [GO:1990904]; sperm flagellum [GO:0036126] mRNA 3'-UTR binding [GO:0003730]; mRNA binding [GO:0003729]; poly(G) binding [GO:0034046] g3731.t1 Q5R7R9 67.343 542 0.0 608.0 sp|Q5R7R9|SNW1_PONAB SNW domain-containing protein 1 OS=Pongo abelii OX=9601 GN=SNW1 PE=2 SV=1 SNW1_PONAB reviewed SNW domain-containing protein 1 (Nuclear protein SkiP) (Ski-interacting protein) Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0000122; GO:0000398; GO:0003713; GO:0003714; GO:0005634; GO:0016363; GO:0016922; GO:0030511; GO:0042771; GO:0042809; GO:0042974; GO:0045944; GO:0046332; GO:0048026; GO:0048384; GO:0048385; GO:0050769; GO:0070562; GO:0071007 intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; positive regulation of neurogenesis [GO:0050769]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; regulation of retinoic acid receptor signaling pathway [GO:0048385]; regulation of vitamin D receptor signaling pathway [GO:0070562]; retinoic acid receptor signaling pathway [GO:0048384] nuclear matrix [GO:0016363]; nucleus [GO:0005634]; U2-type catalytic step 2 spliceosome [GO:0071007] nuclear receptor binding [GO:0016922]; nuclear retinoic acid receptor binding [GO:0042974]; nuclear vitamin D receptor binding [GO:0042809]; SMAD binding [GO:0046332]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714] g3732.t1 Q95218 45.116 215 1.5799999999999997e-42 163.0 sp|Q95218|DMBT1_RABIT Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Oryctolagus cuniculus OX=9986 GN=Dmbt1 PE=1 SV=2 g3732.t1 Q95218 38.372 258 2.1300000000000003e-37 147.0 sp|Q95218|DMBT1_RABIT Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Oryctolagus cuniculus OX=9986 GN=Dmbt1 PE=1 SV=2 g3732.t1 Q95218 38.077 260 3.35e-37 147.0 sp|Q95218|DMBT1_RABIT Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Oryctolagus cuniculus OX=9986 GN=Dmbt1 PE=1 SV=2 g3732.t1 Q95218 37.603 242 1.34e-33 136.0 sp|Q95218|DMBT1_RABIT Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Oryctolagus cuniculus OX=9986 GN=Dmbt1 PE=1 SV=2 g3734.t1 Q95218 45.283 212 3.52e-48 172.0 sp|Q95218|DMBT1_RABIT Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Oryctolagus cuniculus OX=9986 GN=Dmbt1 PE=1 SV=2 g3734.t1 Q95218 36.929 241 6.49e-40 149.0 sp|Q95218|DMBT1_RABIT Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Oryctolagus cuniculus OX=9986 GN=Dmbt1 PE=1 SV=2 g3734.t1 Q95218 37.657 239 2.36e-39 147.0 sp|Q95218|DMBT1_RABIT Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Oryctolagus cuniculus OX=9986 GN=Dmbt1 PE=1 SV=2 g3734.t1 Q95218 37.662 231 3.29e-36 138.0 sp|Q95218|DMBT1_RABIT Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Oryctolagus cuniculus OX=9986 GN=Dmbt1 PE=1 SV=2 g3735.t1 Q08380 49.138 116 4.87e-31 120.0 sp|Q08380|LG3BP_HUMAN Galectin-3-binding protein OS=Homo sapiens OX=9606 GN=LGALS3BP PE=1 SV=1 LG3BP_HUMAN reviewed Galectin-3-binding protein (Basement membrane autoantigen p105) (Lectin galactoside-binding soluble 3-binding protein) (Mac-2-binding protein) (MAC2BP) (Mac-2 BP) (Tumor-associated antigen 90K) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0006968; GO:0007155; GO:0007165; GO:0016020; GO:0031012; GO:0031089; GO:0070062; GO:0072562 cell adhesion [GO:0007155]; cellular defense response [GO:0006968]; signal transduction [GO:0007165] blood microparticle [GO:0072562]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; platelet dense granule lumen [GO:0031089] scavenger receptor activity [GO:0005044] g3736.t1 Q95218 46.226 212 3.12e-47 177.0 sp|Q95218|DMBT1_RABIT Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Oryctolagus cuniculus OX=9986 GN=Dmbt1 PE=1 SV=2 g3736.t1 Q95218 39.676 247 6.68e-42 161.0 sp|Q95218|DMBT1_RABIT Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Oryctolagus cuniculus OX=9986 GN=Dmbt1 PE=1 SV=2 g3736.t1 Q95218 38.153 249 1.4799999999999999e-40 157.0 sp|Q95218|DMBT1_RABIT Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Oryctolagus cuniculus OX=9986 GN=Dmbt1 PE=1 SV=2 g3736.t1 Q95218 38.095 231 2.99e-35 142.0 sp|Q95218|DMBT1_RABIT Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Oryctolagus cuniculus OX=9986 GN=Dmbt1 PE=1 SV=2 g3737.t1 Q95218 46.698 212 4.32e-48 179.0 sp|Q95218|DMBT1_RABIT Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Oryctolagus cuniculus OX=9986 GN=Dmbt1 PE=1 SV=2 g3737.t1 Q95218 38.961 231 1.12e-39 155.0 sp|Q95218|DMBT1_RABIT Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Oryctolagus cuniculus OX=9986 GN=Dmbt1 PE=1 SV=2 g3737.t1 Q95218 38.528 231 4.6300000000000004e-36 144.0 sp|Q95218|DMBT1_RABIT Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Oryctolagus cuniculus OX=9986 GN=Dmbt1 PE=1 SV=2 g3738.t1 Q95218 46.226 212 2.1500000000000001e-47 177.0 sp|Q95218|DMBT1_RABIT Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Oryctolagus cuniculus OX=9986 GN=Dmbt1 PE=1 SV=2 g3738.t1 Q95218 38.528 231 8.33e-39 152.0 sp|Q95218|DMBT1_RABIT Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Oryctolagus cuniculus OX=9986 GN=Dmbt1 PE=1 SV=2 g3738.t1 Q95218 38.095 231 1.67e-35 142.0 sp|Q95218|DMBT1_RABIT Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Oryctolagus cuniculus OX=9986 GN=Dmbt1 PE=1 SV=2 g3739.t1 Q95218 45.755 212 1.24e-47 178.0 sp|Q95218|DMBT1_RABIT Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Oryctolagus cuniculus OX=9986 GN=Dmbt1 PE=1 SV=2 g3739.t1 Q95218 38.057 247 1.69e-40 157.0 sp|Q95218|DMBT1_RABIT Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Oryctolagus cuniculus OX=9986 GN=Dmbt1 PE=1 SV=2 g3739.t1 Q95218 38.095 231 3.0600000000000004e-36 145.0 sp|Q95218|DMBT1_RABIT Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Oryctolagus cuniculus OX=9986 GN=Dmbt1 PE=1 SV=2 g3740.t1 Q9D0L4 45.738 481 5.11e-148 437.0 sp|Q9D0L4|ADCK1_MOUSE AarF domain-containing protein kinase 1 OS=Mus musculus OX=10090 GN=Adck1 PE=1 SV=1 g3741.t1 P36404 84.239 184 1.95e-113 323.0 sp|P36404|ARL2_HUMAN ADP-ribosylation factor-like protein 2 OS=Homo sapiens OX=9606 GN=ARL2 PE=1 SV=4 ARL2_HUMAN reviewed ADP-ribosylation factor-like protein 2 Homo sapiens (Human) GO:0003924; GO:0005525; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005739; GO:0005758; GO:0005759; GO:0005813; GO:0005814; GO:0005829; GO:0006110; GO:0006457; GO:0007098; GO:0010811; GO:0015630; GO:0016328; GO:0019003; GO:0031113; GO:0031116; GO:0034260; GO:0036064; GO:0051457; GO:0070830; GO:0097225; GO:1903715 bicellular tight junction assembly [GO:0070830]; centrosome cycle [GO:0007098]; maintenance of protein location in nucleus [GO:0051457]; negative regulation of GTPase activity [GO:0034260]; positive regulation of cell-substrate adhesion [GO:0010811]; positive regulation of microtubule polymerization [GO:0031116]; protein folding [GO:0006457]; regulation of aerobic respiration [GO:1903715]; regulation of glycolytic process [GO:0006110]; regulation of microtubule polymerization [GO:0031113] centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; lateral plasma membrane [GO:0016328]; microtubule cytoskeleton [GO:0015630]; mitochondrial intermembrane space [GO:0005758]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; sperm midpiece [GO:0097225] GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924] g3742.t1 Q8K4B0 57.787 732 0.0 780.0 sp|Q8K4B0|MTA1_MOUSE Metastasis-associated protein MTA1 OS=Mus musculus OX=10090 GN=Mta1 PE=1 SV=1 MTA1_MOUSE reviewed Metastasis-associated protein MTA1 Mus musculus (Mouse) GO:0000122; GO:0000978; GO:0003682; GO:0003713; GO:0003714; GO:0005634; GO:0005635; GO:0005654; GO:0005737; GO:0005783; GO:0005794; GO:0005829; GO:0005874; GO:0006302; GO:0006338; GO:0008270; GO:0010212; GO:0016581; GO:0019899; GO:0032922; GO:0033363; GO:0042659; GO:0042826; GO:0043153; GO:0043161; GO:0045475; GO:0045814; GO:0045892; GO:0045893; GO:0061629; GO:1902499; GO:2000736 chromatin remodeling [GO:0006338]; circadian regulation of gene expression [GO:0032922]; double-strand break repair [GO:0006302]; entrainment of circadian clock by photoperiod [GO:0043153]; locomotor rhythm [GO:0045475]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of protein autoubiquitination [GO:1902499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of cell fate specification [GO:0042659]; regulation of stem cell differentiation [GO:2000736]; response to ionizing radiation [GO:0010212]; secretory granule organization [GO:0033363] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; microtubule [GO:0005874]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; NuRD complex [GO:0016581] chromatin binding [GO:0003682]; enzyme binding [GO:0019899]; histone deacetylase binding [GO:0042826]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; zinc ion binding [GO:0008270] g3743.t1 Q5E9G1 82.892 415 0.0 707.0 sp|Q5E9G1|P2R3C_BOVIN Serine/threonine-protein phosphatase 2A regulatory subunit B'' subunit gamma OS=Bos taurus OX=9913 GN=PPP2R3C PE=2 SV=1 P2R3C_BOVIN reviewed Serine/threonine-protein phosphatase 2A regulatory subunit B'' subunit gamma Bos taurus (Bovine) GO:0000226; GO:0001782; GO:0005634; GO:0005737; GO:0005813; GO:0030865; GO:0035303; GO:0043029; GO:0045579; GO:0046872 B cell homeostasis [GO:0001782]; cortical cytoskeleton organization [GO:0030865]; microtubule cytoskeleton organization [GO:0000226]; positive regulation of B cell differentiation [GO:0045579]; regulation of dephosphorylation [GO:0035303]; T cell homeostasis [GO:0043029] centrosome [GO:0005813]; cytoplasm [GO:0005737]; nucleus [GO:0005634] metal ion binding [GO:0046872] g3744.t1 Q4R366 35.608 469 1.47e-77 259.0 sp|Q4R366|MRPP3_MACFA Mitochondrial ribonuclease P catalytic subunit OS=Macaca fascicularis OX=9541 GN=PRORP PE=2 SV=2 MRPP3_MACFA reviewed Mitochondrial ribonuclease P catalytic subunit (EC 3.1.26.5) (Mitochondrial ribonuclease P protein 3) (Mitochondrial RNase P protein 3) Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey) GO:0001682; GO:0004526; GO:0005759; GO:0030678; GO:0046872; GO:0097745 mitochondrial tRNA 5'-end processing [GO:0097745]; tRNA 5'-leader removal [GO:0001682] mitochondrial matrix [GO:0005759]; mitochondrial ribonuclease P complex [GO:0030678] metal ion binding [GO:0046872]; ribonuclease P activity [GO:0004526] g3745.t1 Q91ZN5 56.986 365 1.5100000000000002e-129 385.0 sp|Q91ZN5|S35B2_MOUSE Adenosine 3'-phospho 5'-phosphosulfate transporter 1 OS=Mus musculus OX=10090 GN=Slc35b2 PE=1 SV=1 g3745.t2 Q91ZN5 57.459 362 7.47e-130 385.0 sp|Q91ZN5|S35B2_MOUSE Adenosine 3'-phospho 5'-phosphosulfate transporter 1 OS=Mus musculus OX=10090 GN=Slc35b2 PE=1 SV=1 g3747.t1 Q5UR46 38.095 189 9.56e-24 105.0 sp|Q5UR46|YR571_MIMIV Uncharacterized protein R571 OS=Acanthamoeba polyphaga mimivirus OX=212035 GN=MIMI_R571 PE=3 SV=1 g3748.t1 A7YWS7 59.004 522 0.0 682.0 sp|A7YWS7|DPOE2_BOVIN DNA polymerase epsilon subunit 2 OS=Bos taurus OX=9913 GN=POLE2 PE=2 SV=1 g3749.t1 Q9BXJ7 26.287 369 4.010000000000001e-31 129.0 sp|Q9BXJ7|AMNLS_HUMAN Protein amnionless OS=Homo sapiens OX=9606 GN=AMN PE=1 SV=2 g3750.t1 Q5RBX7 59.615 104 5.3700000000000004e-36 122.0 sp|Q5RBX7|SRP14_PONAB Signal recognition particle 14 kDa protein OS=Pongo abelii OX=9601 GN=SRP14 PE=2 SV=1 g3751.t1 Q8JGT5 52.199 341 3.0300000000000004e-110 328.0 sp|Q8JGT5|SAE1_XENLA SUMO-activating enzyme subunit 1 OS=Xenopus laevis OX=8355 GN=sae1 PE=2 SV=1 g3752.t1 P79403 53.219 932 0.0 1033.0 sp|P79403|GANAB_PIG Neutral alpha-glucosidase AB OS=Sus scrofa OX=9823 GN=GANAB PE=1 SV=1 g3755.t1 Q8IVE3 52.305 564 3.97e-180 552.0 sp|Q8IVE3|PKHH2_HUMAN Pleckstrin homology domain-containing family H member 2 OS=Homo sapiens OX=9606 GN=PLEKHH2 PE=1 SV=2 PKHH2_HUMAN reviewed Pleckstrin homology domain-containing family H member 2 Homo sapiens (Human) GO:0003779; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0016604; GO:0030027; GO:0030835; GO:0030864 negative regulation of actin filament depolymerization [GO:0030835] cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; lamellipodium [GO:0030027]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] actin binding [GO:0003779] g3756.t1 Q9ULM0 46.816 267 1.45e-62 225.0 sp|Q9ULM0|PKHH1_HUMAN Pleckstrin homology domain-containing family H member 1 OS=Homo sapiens OX=9606 GN=PLEKHH1 PE=1 SV=2 g3758.t1 Q7Z449 37.037 486 8.81e-114 350.0 sp|Q7Z449|CP2U1_HUMAN Cytochrome P450 2U1 OS=Homo sapiens OX=9606 GN=CYP2U1 PE=1 SV=1 CP2U1_HUMAN reviewed Cytochrome P450 2U1 (Long-chain fatty acid omega-monooxygenase) (EC 1.14.14.80) Homo sapiens (Human) GO:0004497; GO:0005506; GO:0005737; GO:0005743; GO:0005789; GO:0006082; GO:0006805; GO:0008202; GO:0008395; GO:0016712; GO:0020037; GO:0052869; GO:0097267; GO:0102033; GO:1903604 cytochrome metabolic process [GO:1903604]; omega-hydroxylase P450 pathway [GO:0097267]; organic acid metabolic process [GO:0006082]; steroid metabolic process [GO:0008202]; xenobiotic metabolic process [GO:0006805] cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; mitochondrial inner membrane [GO:0005743] arachidonate omega-hydroxylase activity [GO:0052869]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; long-chain fatty acid omega-hydroxylase activity [GO:0102033]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; steroid hydroxylase activity [GO:0008395] g3759.t1 Q8TAM2 67.412 537 0.0 772.0 sp|Q8TAM2|TTC8_HUMAN Tetratricopeptide repeat protein 8 OS=Homo sapiens OX=9606 GN=TTC8 PE=1 SV=2 TTC8_HUMAN reviewed Tetratricopeptide repeat protein 8 (TPR repeat protein 8) (Bardet-Biedl syndrome 8 protein) Homo sapiens (Human) GO:0001650; GO:0001736; GO:0005739; GO:0005813; GO:0005814; GO:0005829; GO:0005929; GO:0007411; GO:0007608; GO:0015031; GO:0021772; GO:0032391; GO:0032880; GO:0033011; GO:0034451; GO:0034464; GO:0035264; GO:0036064; GO:0045198; GO:0045444; GO:0048560; GO:0050893; GO:0051492; GO:0060122; GO:0060170; GO:0060219; GO:0060271; GO:0061326; GO:0061629; GO:0072659; GO:0097730; GO:1903251; GO:1905515 axon guidance [GO:0007411]; camera-type eye photoreceptor cell differentiation [GO:0060219]; cilium assembly [GO:0060271]; establishment of anatomical structure orientation [GO:0048560]; establishment of epithelial cell apical/basal polarity [GO:0045198]; establishment of planar polarity [GO:0001736]; fat cell differentiation [GO:0045444]; inner ear receptor cell stereocilium organization [GO:0060122]; multi-ciliated epithelial cell differentiation [GO:1903251]; multicellular organism growth [GO:0035264]; non-motile cilium assembly [GO:1905515]; olfactory bulb development [GO:0021772]; protein localization to plasma membrane [GO:0072659]; protein transport [GO:0015031]; regulation of protein localization [GO:0032880]; regulation of stress fiber assembly [GO:0051492]; renal tubule development [GO:0061326]; sensory perception of smell [GO:0007608]; sensory processing [GO:0050893] BBSome [GO:0034464]; centriolar satellite [GO:0034451]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary membrane [GO:0060170]; cilium [GO:0005929]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; mitochondrion [GO:0005739]; non-motile cilium [GO:0097730]; perinuclear theca [GO:0033011]; photoreceptor connecting cilium [GO:0032391] RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629] g3760.t1 P54318 42.733 344 4.46e-84 264.0 sp|P54318|LIPR2_RAT Pancreatic lipase-related protein 2 OS=Rattus norvegicus OX=10116 GN=Pnliprp2 PE=1 SV=1 g3761.t1 Q64425 43.478 345 4.77e-76 254.0 sp|Q64425|LIPP_MYOCO Pancreatic triacylglycerol lipase (Fragment) OS=Myocastor coypus OX=10157 GN=PNLIP PE=2 SV=1 g3761.t1 Q64425 41.499 347 5.599999999999999e-68 232.0 sp|Q64425|LIPP_MYOCO Pancreatic triacylglycerol lipase (Fragment) OS=Myocastor coypus OX=10157 GN=PNLIP PE=2 SV=1 g3762.t1 Q78P75 86.364 88 1.26e-53 164.0 sp|Q78P75|DYL2_RAT Dynein light chain 2, cytoplasmic OS=Rattus norvegicus OX=10116 GN=Dynll2 PE=1 SV=1 DYL2_RAT reviewed Dynein light chain 2, cytoplasmic (Dynein light chain LC8-type 2) Rattus norvegicus (Rat) GO:0005813; GO:0005856; GO:0005868; GO:0005874; GO:0007017; GO:0014069; GO:0031475; GO:0042802; GO:0044877; GO:0045505; GO:0097110; GO:0097731; GO:0098794; GO:0098978 microtubule-based process [GO:0007017] 9+0 non-motile cilium [GO:0097731]; centrosome [GO:0005813]; cytoplasmic dynein complex [GO:0005868]; cytoskeleton [GO:0005856]; glutamatergic synapse [GO:0098978]; microtubule [GO:0005874]; myosin V complex [GO:0031475]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069] dynein intermediate chain binding [GO:0045505]; identical protein binding [GO:0042802]; protein-containing complex binding [GO:0044877]; scaffold protein binding [GO:0097110] g3764.t1 Q78P75 85.227 88 7.09e-53 162.0 sp|Q78P75|DYL2_RAT Dynein light chain 2, cytoplasmic OS=Rattus norvegicus OX=10116 GN=Dynll2 PE=1 SV=1 DYL2_RAT reviewed Dynein light chain 2, cytoplasmic (Dynein light chain LC8-type 2) Rattus norvegicus (Rat) GO:0005813; GO:0005856; GO:0005868; GO:0005874; GO:0007017; GO:0014069; GO:0031475; GO:0042802; GO:0044877; GO:0045505; GO:0097110; GO:0097731; GO:0098794; GO:0098978 microtubule-based process [GO:0007017] 9+0 non-motile cilium [GO:0097731]; centrosome [GO:0005813]; cytoplasmic dynein complex [GO:0005868]; cytoskeleton [GO:0005856]; glutamatergic synapse [GO:0098978]; microtubule [GO:0005874]; myosin V complex [GO:0031475]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069] dynein intermediate chain binding [GO:0045505]; identical protein binding [GO:0042802]; protein-containing complex binding [GO:0044877]; scaffold protein binding [GO:0097110] g3765.t1 Q78P75 81.111 90 1.13e-49 154.0 sp|Q78P75|DYL2_RAT Dynein light chain 2, cytoplasmic OS=Rattus norvegicus OX=10116 GN=Dynll2 PE=1 SV=1 DYL2_RAT reviewed Dynein light chain 2, cytoplasmic (Dynein light chain LC8-type 2) Rattus norvegicus (Rat) GO:0005813; GO:0005856; GO:0005868; GO:0005874; GO:0007017; GO:0014069; GO:0031475; GO:0042802; GO:0044877; GO:0045505; GO:0097110; GO:0097731; GO:0098794; GO:0098978 microtubule-based process [GO:0007017] 9+0 non-motile cilium [GO:0097731]; centrosome [GO:0005813]; cytoplasmic dynein complex [GO:0005868]; cytoskeleton [GO:0005856]; glutamatergic synapse [GO:0098978]; microtubule [GO:0005874]; myosin V complex [GO:0031475]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069] dynein intermediate chain binding [GO:0045505]; identical protein binding [GO:0042802]; protein-containing complex binding [GO:0044877]; scaffold protein binding [GO:0097110] g3766.t1 Q78P75 88.372 86 2.6799999999999996e-54 166.0 sp|Q78P75|DYL2_RAT Dynein light chain 2, cytoplasmic OS=Rattus norvegicus OX=10116 GN=Dynll2 PE=1 SV=1 DYL2_RAT reviewed Dynein light chain 2, cytoplasmic (Dynein light chain LC8-type 2) Rattus norvegicus (Rat) GO:0005813; GO:0005856; GO:0005868; GO:0005874; GO:0007017; GO:0014069; GO:0031475; GO:0042802; GO:0044877; GO:0045505; GO:0097110; GO:0097731; GO:0098794; GO:0098978 microtubule-based process [GO:0007017] 9+0 non-motile cilium [GO:0097731]; centrosome [GO:0005813]; cytoplasmic dynein complex [GO:0005868]; cytoskeleton [GO:0005856]; glutamatergic synapse [GO:0098978]; microtubule [GO:0005874]; myosin V complex [GO:0031475]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069] dynein intermediate chain binding [GO:0045505]; identical protein binding [GO:0042802]; protein-containing complex binding [GO:0044877]; scaffold protein binding [GO:0097110] g3767.t1 Q568K5 58.564 181 1.64e-75 233.0 sp|Q568K5|NAA40_DANRE N-alpha-acetyltransferase 40 OS=Danio rerio OX=7955 GN=naa40 PE=2 SV=1 g3768.t1 Q561L1 66.204 432 0.0 607.0 sp|Q561L1|PUA1A_XENLA Adenylosuccinate synthetase isozyme 1 A OS=Xenopus laevis OX=8355 GN=adss1-a PE=2 SV=1 g3770.t1 Q9D0E5 48.366 153 4.36e-47 154.0 sp|Q9D0E5|EFC11_MOUSE EF-hand calcium-binding domain-containing protein 11 OS=Mus musculus OX=10090 GN=Efcab11 PE=2 SV=1 g3771.t1 Q7TPD1 71.357 803 0.0 1198.0 sp|Q7TPD1|FBX11_MOUSE F-box only protein 11 OS=Mus musculus OX=10090 GN=Fbxo11 PE=1 SV=3 FBX11_MOUSE reviewed F-box only protein 11 Mus musculus (Mouse) GO:0001837; GO:0004842; GO:0005634; GO:0005654; GO:0005694; GO:0005730; GO:0005737; GO:0006511; GO:0007605; GO:0008270; GO:0010719; GO:0016274; GO:0016567; GO:0042981; GO:0043161; GO:0045732; GO:1904878; GO:1990756 epithelial to mesenchymal transition [GO:0001837]; negative regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904878]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; positive regulation of protein catabolic process [GO:0045732]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of apoptotic process [GO:0042981]; sensory perception of sound [GO:0007605]; ubiquitin-dependent protein catabolic process [GO:0006511] chromosome [GO:0005694]; cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] protein-arginine N-methyltransferase activity [GO:0016274]; ubiquitin-like ligase-substrate adaptor activity [GO:1990756]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] g3771.t2 Q7TPD1 71.715 799 0.0 1204.0 sp|Q7TPD1|FBX11_MOUSE F-box only protein 11 OS=Mus musculus OX=10090 GN=Fbxo11 PE=1 SV=3 FBX11_MOUSE reviewed F-box only protein 11 Mus musculus (Mouse) GO:0001837; GO:0004842; GO:0005634; GO:0005654; GO:0005694; GO:0005730; GO:0005737; GO:0006511; GO:0007605; GO:0008270; GO:0010719; GO:0016274; GO:0016567; GO:0042981; GO:0043161; GO:0045732; GO:1904878; GO:1990756 epithelial to mesenchymal transition [GO:0001837]; negative regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904878]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; positive regulation of protein catabolic process [GO:0045732]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of apoptotic process [GO:0042981]; sensory perception of sound [GO:0007605]; ubiquitin-dependent protein catabolic process [GO:0006511] chromosome [GO:0005694]; cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] protein-arginine N-methyltransferase activity [GO:0016274]; ubiquitin-like ligase-substrate adaptor activity [GO:1990756]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] g3771.t3 Q7TPD1 71.715 799 0.0 1202.0 sp|Q7TPD1|FBX11_MOUSE F-box only protein 11 OS=Mus musculus OX=10090 GN=Fbxo11 PE=1 SV=3 FBX11_MOUSE reviewed F-box only protein 11 Mus musculus (Mouse) GO:0001837; GO:0004842; GO:0005634; GO:0005654; GO:0005694; GO:0005730; GO:0005737; GO:0006511; GO:0007605; GO:0008270; GO:0010719; GO:0016274; GO:0016567; GO:0042981; GO:0043161; GO:0045732; GO:1904878; GO:1990756 epithelial to mesenchymal transition [GO:0001837]; negative regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904878]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; positive regulation of protein catabolic process [GO:0045732]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of apoptotic process [GO:0042981]; sensory perception of sound [GO:0007605]; ubiquitin-dependent protein catabolic process [GO:0006511] chromosome [GO:0005694]; cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] protein-arginine N-methyltransferase activity [GO:0016274]; ubiquitin-like ligase-substrate adaptor activity [GO:1990756]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] g3774.t1 B5X7E4 73.81 84 9.550000000000001e-37 127.0 sp|B5X7E4|IF43B_SALSA Intraflagellar transport protein 43 homolog B OS=Salmo salar OX=8030 GN=ift43b PE=2 SV=1 g3775.t1 Q02290 36.623 385 6.77e-45 172.0 sp|Q02290|XYNB_NEOPA Endo-1,4-beta-xylanase B OS=Neocallimastix patriciarum OX=4758 GN=xynB PE=2 SV=1 g3775.t1 Q02290 36.788 386 7.669999999999999e-45 172.0 sp|Q02290|XYNB_NEOPA Endo-1,4-beta-xylanase B OS=Neocallimastix patriciarum OX=4758 GN=xynB PE=2 SV=1 g3775.t1 Q02290 36.528 386 2.77e-44 171.0 sp|Q02290|XYNB_NEOPA Endo-1,4-beta-xylanase B OS=Neocallimastix patriciarum OX=4758 GN=xynB PE=2 SV=1 g3775.t1 Q02290 36.269 386 1.61e-43 168.0 sp|Q02290|XYNB_NEOPA Endo-1,4-beta-xylanase B OS=Neocallimastix patriciarum OX=4758 GN=xynB PE=2 SV=1 g3775.t1 Q02290 35.751 386 4.75e-42 164.0 sp|Q02290|XYNB_NEOPA Endo-1,4-beta-xylanase B OS=Neocallimastix patriciarum OX=4758 GN=xynB PE=2 SV=1 g3775.t1 Q02290 35.602 382 3.25e-41 161.0 sp|Q02290|XYNB_NEOPA Endo-1,4-beta-xylanase B OS=Neocallimastix patriciarum OX=4758 GN=xynB PE=2 SV=1 g3775.t1 Q02290 35.878 393 2.03e-40 159.0 sp|Q02290|XYNB_NEOPA Endo-1,4-beta-xylanase B OS=Neocallimastix patriciarum OX=4758 GN=xynB PE=2 SV=1 g3775.t1 Q02290 35.979 378 2.21e-40 159.0 sp|Q02290|XYNB_NEOPA Endo-1,4-beta-xylanase B OS=Neocallimastix patriciarum OX=4758 GN=xynB PE=2 SV=1 g3775.t1 Q02290 37.152 323 9.620000000000001e-36 145.0 sp|Q02290|XYNB_NEOPA Endo-1,4-beta-xylanase B OS=Neocallimastix patriciarum OX=4758 GN=xynB PE=2 SV=1 g3776.t1 P50428 48.655 446 8.43e-132 392.0 sp|P50428|ARSA_MOUSE Arylsulfatase A OS=Mus musculus OX=10090 GN=Arsa PE=1 SV=2 ARSA_MOUSE reviewed Arylsulfatase A (ASA) (EC 3.1.6.8) (Cerebroside-sulfatase) Mus musculus (Mouse) GO:0001669; GO:0004065; GO:0004098; GO:0005509; GO:0005615; GO:0005764; GO:0005768; GO:0005783; GO:0005886; GO:0006629; GO:0006914; GO:0007339; GO:0007584; GO:0008484; GO:0009268; GO:0016020; GO:0031232; GO:0043627; GO:0045471; GO:0051597 autophagy [GO:0006914]; binding of sperm to zona pellucida [GO:0007339]; lipid metabolic process [GO:0006629]; response to estrogen [GO:0043627]; response to ethanol [GO:0045471]; response to methylmercury [GO:0051597]; response to nutrient [GO:0007584]; response to pH [GO:0009268] acrosomal vesicle [GO:0001669]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; extracellular space [GO:0005615]; extrinsic component of external side of plasma membrane [GO:0031232]; lysosome [GO:0005764]; membrane [GO:0016020]; plasma membrane [GO:0005886] arylsulfatase activity [GO:0004065]; calcium ion binding [GO:0005509]; cerebroside-sulfatase activity [GO:0004098]; sulfuric ester hydrolase activity [GO:0008484] g3777.t1 Q9D552 39.118 363 7.22e-72 231.0 sp|Q9D552|SPT17_MOUSE Spermatogenesis-associated protein 17 OS=Mus musculus OX=10090 GN=Spata17 PE=2 SV=1 g3780.t1 Q80XK6 37.82 2229 0.0 1256.0 sp|Q80XK6|ATG2B_MOUSE Autophagy-related protein 2 homolog B OS=Mus musculus OX=10090 GN=Atg2b PE=1 SV=3 ATG2B_MOUSE reviewed Autophagy-related protein 2 homolog B Mus musculus (Mouse) GO:0000045; GO:0000407; GO:0000422; GO:0000425; GO:0005783; GO:0005789; GO:0005811; GO:0032266; GO:0034045; GO:0034727; GO:0043495; GO:0061709; GO:0061723; GO:0061908; GO:0120013 autophagosome assembly [GO:0000045]; autophagy of mitochondrion [GO:0000422]; glycophagy [GO:0061723]; pexophagy [GO:0000425]; piecemeal microautophagy of the nucleus [GO:0034727]; reticulophagy [GO:0061709] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; lipid droplet [GO:0005811]; phagophore [GO:0061908]; phagophore assembly site [GO:0000407]; phagophore assembly site membrane [GO:0034045] lipid transfer activity [GO:0120013]; phosphatidylinositol-3-phosphate binding [GO:0032266]; protein-membrane adaptor activity [GO:0043495] g3783.t1 Q3ZBD2 54.251 247 3.92e-89 273.0 sp|Q3ZBD2|ARP10_BOVIN Actin-related protein 10 OS=Bos taurus OX=9913 GN=ACTR10 PE=2 SV=1 g3784.t1 Q9QZB7 62.914 151 1.36e-63 203.0 sp|Q9QZB7|ARP10_MOUSE Actin-related protein 10 OS=Mus musculus OX=10090 GN=Actr10 PE=1 SV=2 g3785.t1 A0A1L8HYT7 35.743 498 1.42e-80 275.0 sp|A0A1L8HYT7|CIROP_XENLA Ciliated left-right organizer metallopeptidase OS=Xenopus laevis OX=8355 GN=cirop PE=2 SV=1 CIROP_XENLA reviewed Ciliated left-right organizer metallopeptidase (EC 3.4.24.-) (Leishmanolysin-like peptidase 2) Xenopus laevis (African clawed frog) GO:0004222; GO:0005737; GO:0006508; GO:0007155; GO:0008233; GO:0016020; GO:0046872; GO:0061371; GO:0061966 cell adhesion [GO:0007155]; determination of heart left/right asymmetry [GO:0061371]; establishment of left/right asymmetry [GO:0061966]; proteolysis [GO:0006508] cytoplasm [GO:0005737]; membrane [GO:0016020] metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; peptidase activity [GO:0008233] g3787.t1 Q9H477 57.475 301 1.19e-107 319.0 sp|Q9H477|RBSK_HUMAN Ribokinase OS=Homo sapiens OX=9606 GN=RBKS PE=1 SV=1 RBSK_HUMAN reviewed Ribokinase (RK) (EC 2.7.1.15) Homo sapiens (Human) GO:0004747; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006098; GO:0019303; GO:0042802; GO:0046872 D-ribose catabolic process [GO:0019303]; pentose-phosphate shunt [GO:0006098] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634] ATP binding [GO:0005524]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; ribokinase activity [GO:0004747] g3788.t2 Q7LHG5 38.8 250 1.59e-53 190.0 sp|Q7LHG5|YI31B_YEAST Transposon Ty3-I Gag-Pol polyprotein OS=Saccharomyces cerevisiae (strain ATCC 204508 / S288c) OX=559292 GN=TY3B-I PE=1 SV=2 YI31B_YEAST reviewed Transposon Ty3-I Gag-Pol polyprotein (Gag3-Pol3) (Transposon Ty3-2 TYA-TYB polyprotein) [Cleaved into: Capsid protein (CA) (p24); Spacer peptide p3; Nucleocapsid protein p11 (NC); Ty3 protease (PR) (EC 3.4.23.-) (p16); Spacer peptide J; Reverse transcriptase/ribonuclease H (RT) (RT-RH) (EC 2.7.7.49) (EC 2.7.7.7) (EC 3.1.26.4) (p55); Integrase p52 (IN); Integrase p49 (IN)] Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast) GO:0003677; GO:0003723; GO:0003887; GO:0003964; GO:0004190; GO:0004523; GO:0005524; GO:0005634; GO:0005737; GO:0006310; GO:0006508; GO:0008270; GO:0015074; GO:0075523 DNA integration [GO:0015074]; DNA recombination [GO:0006310]; proteolysis [GO:0006508]; viral translational frameshifting [GO:0075523] cytoplasm [GO:0005737]; nucleus [GO:0005634] aspartic-type endopeptidase activity [GO:0004190]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; RNA binding [GO:0003723]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; zinc ion binding [GO:0008270] g3793.t1 Q6PCL9 64.962 528 0.0 723.0 sp|Q6PCL9|PAPOG_MOUSE Poly(A) polymerase gamma OS=Mus musculus OX=10090 GN=Papolg PE=1 SV=1 PAPOG_MOUSE reviewed Poly(A) polymerase gamma (PAP-gamma) (EC 2.7.7.19) (Polynucleotide adenylyltransferase gamma) (SRP RNA 3'-adenylating enzyme) (Signal recognition particle RNA-adenylating enzyme) (SRP RNA-adenylating enzyme) Mus musculus (Mouse) GO:0003723; GO:0005524; GO:0005634; GO:0005654; GO:0005829; GO:0006397; GO:0016604; GO:0031123; GO:0046872; GO:1990817 mRNA processing [GO:0006397]; RNA 3'-end processing [GO:0031123] cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] ATP binding [GO:0005524]; metal ion binding [GO:0046872]; poly(A) RNA polymerase activity [GO:1990817]; RNA binding [GO:0003723] g3794.t1 Q9HAV4 43.255 897 0.0 677.0 sp|Q9HAV4|XPO5_HUMAN Exportin-5 OS=Homo sapiens OX=9606 GN=XPO5 PE=1 SV=1 XPO5_HUMAN reviewed Exportin-5 (Exp5) (Ran-binding protein 21) Homo sapiens (Human) GO:0000049; GO:0003723; GO:0003729; GO:0005049; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006405; GO:0006611; GO:0010586; GO:0016442; GO:0031267; GO:0035281; GO:0042565; GO:0070883; GO:1905172 miRNA metabolic process [GO:0010586]; pre-miRNA export from nucleus [GO:0035281]; protein export from nucleus [GO:0006611]; RNA export from nucleus [GO:0006405] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RISC complex [GO:0016442]; RNA nuclear export complex [GO:0042565] mRNA binding [GO:0003729]; nuclear export signal receptor activity [GO:0005049]; pre-miRNA binding [GO:0070883]; RISC complex binding [GO:1905172]; RNA binding [GO:0003723]; small GTPase binding [GO:0031267]; tRNA binding [GO:0000049] g3798.t1 Q924C1 38.426 216 6.44e-44 162.0 sp|Q924C1|XPO5_MOUSE Exportin-5 OS=Mus musculus OX=10090 GN=Xpo5 PE=1 SV=1 g3801.t1 Q17QR8 34.182 275 5.1800000000000006e-43 155.0 sp|Q17QR8|HARB1_BOVIN Putative nuclease HARBI1 OS=Bos taurus OX=9913 GN=HARBI1 PE=2 SV=1 g3802.t1 Q32KV4 51.026 341 3.9100000000000004e-123 362.0 sp|Q32KV4|DC2L1_BOVIN Cytoplasmic dynein 2 light intermediate chain 1 OS=Bos taurus OX=9913 GN=DYNC2LI1 PE=2 SV=1 g3804.t1 Q4R6I5 30.479 584 3.33e-83 276.0 sp|Q4R6I5|CLHC1_MACFA Clathrin heavy chain linker domain-containing protein 1 OS=Macaca fascicularis OX=9541 GN=CLHC1 PE=2 SV=1 g3806.t1 A0JM56 44.875 1444 0.0 1178.0 sp|A0JM56|LRRC9_XENTR Leucine-rich repeat-containing protein 9 OS=Xenopus tropicalis OX=8364 GN=lrrc9 PE=2 SV=2 g3810.t1 Q6NVP8 52.727 550 0.0 585.0 sp|Q6NVP8|FUT8_XENTR Alpha-(1,6)-fucosyltransferase OS=Xenopus tropicalis OX=8364 GN=fut8 PE=2 SV=1 FUT8_XENTR reviewed Alpha-(1,6)-fucosyltransferase (Alpha1-6FucT) (EC 2.4.1.68) (GDP-L-Fuc:N-acetyl-beta-D-glucosaminide alpha1,6-fucosyltransferase) (GDP-fucose--glycoprotein fucosyltransferase) (Glycoprotein 6-alpha-L-fucosyltransferase) Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0006487; GO:0008424; GO:0017124; GO:0018279; GO:0032580; GO:0046368; GO:0046921 GDP-L-fucose metabolic process [GO:0046368]; protein N-linked glycosylation [GO:0006487]; protein N-linked glycosylation via asparagine [GO:0018279] Golgi cisterna membrane [GO:0032580] alpha-(1->6)-fucosyltransferase activity [GO:0046921]; glycoprotein 6-alpha-L-fucosyltransferase activity [GO:0008424]; SH3 domain binding [GO:0017124] g3811.t1 Q7ZVN5 82.688 491 0.0 852.0 sp|Q7ZVN5|SRP54_DANRE Signal recognition particle subunit SRP54 OS=Danio rerio OX=7955 GN=srp54 PE=2 SV=1 SRP54_DANRE reviewed Signal recognition particle subunit SRP54 (EC 3.6.5.4) (Signal recognition particle 54 kDa protein) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0003924; GO:0005525; GO:0005783; GO:0005786; GO:0005829; GO:0006616; GO:0008312; GO:0016607; GO:0030593; GO:0030851; GO:0030942; GO:0031017 exocrine pancreas development [GO:0031017]; granulocyte differentiation [GO:0030851]; neutrophil chemotaxis [GO:0030593]; SRP-dependent cotranslational protein targeting to membrane, translocation [GO:0006616] cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nuclear speck [GO:0016607]; signal recognition particle, endoplasmic reticulum targeting [GO:0005786] 7S RNA binding [GO:0008312]; endoplasmic reticulum signal peptide binding [GO:0030942]; GTP binding [GO:0005525]; GTPase activity [GO:0003924] g3812.t1 Q6P6S9 43.577 397 1.21e-99 309.0 sp|Q6P6S9|ENTP5_RAT Ectonucleoside triphosphate diphosphohydrolase 5 OS=Rattus norvegicus OX=10116 GN=Entpd5 PE=2 SV=1 ENTP5_RAT reviewed Ectonucleoside triphosphate diphosphohydrolase 5 (NTPDase 5) (EC 3.6.1.6) (Guanosine-diphosphatase ENTPD5) (GDPase ENTPD5) (Uridine-diphosphatase ENTPD5) (UDPase ENTPD5) Rattus norvegicus (Rat) GO:0004382; GO:0005576; GO:0005615; GO:0005783; GO:0005788; GO:0006011; GO:0006256; GO:0006487; GO:0036384; GO:0043262; GO:0045134; GO:0051084; GO:1990003 'de novo' post-translational protein folding [GO:0051084]; protein N-linked glycosylation [GO:0006487]; UDP catabolic process [GO:0006256]; UDP-alpha-D-glucose metabolic process [GO:0006011] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; extracellular space [GO:0005615] ADP phosphatase activity [GO:0043262]; CDP phosphatase activity [GO:0036384]; GDP phosphatase activity [GO:0004382]; IDP phosphatase activity [GO:1990003]; UDP phosphatase activity [GO:0045134] g3814.t1 Q5R613 67.99 403 0.0 567.0 sp|Q5R613|SNX6_PONAB Sorting nexin-6 OS=Pongo abelii OX=9601 GN=SNX6 PE=2 SV=1 SNX6_PONAB reviewed Sorting nexin-6 [Cleaved into: Sorting nexin-6, N-terminally processed] Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0005634; GO:0005829; GO:0006886; GO:0030904; GO:0031901; GO:0034452; GO:0035091; GO:0042147; GO:0097422 intracellular protein transport [GO:0006886]; retrograde transport, endosome to Golgi [GO:0042147] cytosol [GO:0005829]; early endosome membrane [GO:0031901]; nucleus [GO:0005634]; retromer complex [GO:0030904]; tubular endosome [GO:0097422] dynactin binding [GO:0034452]; phosphatidylinositol binding [GO:0035091] g3818.t1 P31643 49.216 638 1.0500000000000001e-166 493.0 sp|P31643|SC6A6_RAT Sodium- and chloride-dependent taurine transporter OS=Rattus norvegicus OX=10116 GN=Slc6a6 PE=1 SV=1 g3823.t1 Q9Y256 46.809 235 7.78e-56 186.0 sp|Q9Y256|FACE2_HUMAN CAAX prenyl protease 2 OS=Homo sapiens OX=9606 GN=RCE1 PE=1 SV=1 FACE2_HUMAN reviewed CAAX prenyl protease 2 (EC 3.4.26.1) (Farnesylated proteins-converting enzyme 2) (FACE-2) (Prenyl protein-specific endoprotease 2) (RCE1 homolog) (hRCE1) Homo sapiens (Human) GO:0000165; GO:0004175; GO:0004197; GO:0004222; GO:0005789; GO:0005829; GO:0005886; GO:0008238; GO:0016020; GO:0018342; GO:0071586 CAAX-box protein processing [GO:0071586]; MAPK cascade [GO:0000165]; protein prenylation [GO:0018342] cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; plasma membrane [GO:0005886] cysteine-type endopeptidase activity [GO:0004197]; endopeptidase activity [GO:0004175]; exopeptidase activity [GO:0008238]; metalloendopeptidase activity [GO:0004222] g3824.t1 Q9P2K2 26.503 732 3.55e-69 247.0 sp|Q9P2K2|TXD16_HUMAN Thioredoxin domain-containing protein 16 OS=Homo sapiens OX=9606 GN=TXNDC16 PE=1 SV=4 TXD16_HUMAN reviewed Thioredoxin domain-containing protein 16 Homo sapiens (Human) GO:0005788; GO:0070062 endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062] g3825.t1 Q9JJL8 44.519 447 3.17e-129 388.0 sp|Q9JJL8|SYSM_MOUSE Serine--tRNA ligase, mitochondrial OS=Mus musculus OX=10090 GN=Sars2 PE=1 SV=2 g3826.t1 Q95NI4 80.272 147 1.76e-80 238.0 sp|Q95NI4|CALM_HALOK Calmodulin OS=Halichondria okadai OX=163232 PE=2 SV=3 g3828.t1 Q6NWH0 42.667 150 7.27e-27 106.0 sp|Q6NWH0|CK068_DANRE UPF0696 protein C11orf68 homolog OS=Danio rerio OX=7955 GN=P5436 PE=2 SV=1 g3829.t1 Q6NWH0 39.024 164 6.11e-23 97.1 sp|Q6NWH0|CK068_DANRE UPF0696 protein C11orf68 homolog OS=Danio rerio OX=7955 GN=P5436 PE=2 SV=1 g3830.t1 Q6NWH0 38.922 167 9.54e-23 101.0 sp|Q6NWH0|CK068_DANRE UPF0696 protein C11orf68 homolog OS=Danio rerio OX=7955 GN=P5436 PE=2 SV=1 g3831.t1 Q5R5C9 50.356 421 9.79e-153 442.0 sp|Q5R5C9|SCPDL_PONAB Saccharopine dehydrogenase-like oxidoreductase OS=Pongo abelii OX=9601 GN=SCCPDH PE=2 SV=1 g3833.t1 Q2PFW9 54.341 311 4.83e-92 293.0 sp|Q2PFW9|NOVA1_MACFA RNA-binding protein Nova-1 OS=Macaca fascicularis OX=9541 GN=NOVA1 PE=2 SV=1 g3833.t1 Q2PFW9 61.798 89 3.4e-25 112.0 sp|Q2PFW9|NOVA1_MACFA RNA-binding protein Nova-1 OS=Macaca fascicularis OX=9541 GN=NOVA1 PE=2 SV=1 g3834.t1 Q62261 58.913 2042 0.0 2301.0 sp|Q62261|SPTB2_MOUSE Spectrin beta chain, non-erythrocytic 1 OS=Mus musculus OX=10090 GN=Sptbn1 PE=1 SV=2 SPTB2_MOUSE reviewed Spectrin beta chain, non-erythrocytic 1 (Beta-II spectrin) (Embryonic liver fodrin) (Fodrin beta chain) Mus musculus (Mouse) GO:0000281; GO:0005200; GO:0005516; GO:0005543; GO:0005634; GO:0005730; GO:0005737; GO:0005829; GO:0005886; GO:0007009; GO:0007417; GO:0008091; GO:0012505; GO:0014069; GO:0016020; GO:0021556; GO:0030036; GO:0030054; GO:0030506; GO:0030673; GO:0030863; GO:0030864; GO:0031430; GO:0032437; GO:0032743; GO:0032991; GO:0042995; GO:0043001; GO:0044877; GO:0051015; GO:0051020; GO:0051693; GO:0060390; GO:0071709; GO:0072659; GO:0098794; GO:0098978; GO:1903076; GO:1903078 actin cytoskeleton organization [GO:0030036]; actin filament capping [GO:0051693]; central nervous system development [GO:0007417]; central nervous system formation [GO:0021556]; Golgi to plasma membrane protein transport [GO:0043001]; membrane assembly [GO:0071709]; mitotic cytokinesis [GO:0000281]; plasma membrane organization [GO:0007009]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of protein localization to plasma membrane [GO:1903078]; protein localization to plasma membrane [GO:0072659]; regulation of protein localization to plasma membrane [GO:1903076]; regulation of SMAD protein signal transduction [GO:0060390] axolemma [GO:0030673]; cell junction [GO:0030054]; cell projection [GO:0042995]; cortical actin cytoskeleton [GO:0030864]; cortical cytoskeleton [GO:0030863]; cuticular plate [GO:0032437]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; glutamatergic synapse [GO:0098978]; M band [GO:0031430]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; protein-containing complex [GO:0032991]; spectrin [GO:0008091] actin filament binding [GO:0051015]; ankyrin binding [GO:0030506]; calmodulin binding [GO:0005516]; GTPase binding [GO:0051020]; phospholipid binding [GO:0005543]; protein-containing complex binding [GO:0044877]; structural constituent of cytoskeleton [GO:0005200] g3834.t1 Q62261 49.231 130 3.5100000000000004e-26 122.0 sp|Q62261|SPTB2_MOUSE Spectrin beta chain, non-erythrocytic 1 OS=Mus musculus OX=10090 GN=Sptbn1 PE=1 SV=2 SPTB2_MOUSE reviewed Spectrin beta chain, non-erythrocytic 1 (Beta-II spectrin) (Embryonic liver fodrin) (Fodrin beta chain) Mus musculus (Mouse) GO:0000281; GO:0005200; GO:0005516; GO:0005543; GO:0005634; GO:0005730; GO:0005737; GO:0005829; GO:0005886; GO:0007009; GO:0007417; GO:0008091; GO:0012505; GO:0014069; GO:0016020; GO:0021556; GO:0030036; GO:0030054; GO:0030506; GO:0030673; GO:0030863; GO:0030864; GO:0031430; GO:0032437; GO:0032743; GO:0032991; GO:0042995; GO:0043001; GO:0044877; GO:0051015; GO:0051020; GO:0051693; GO:0060390; GO:0071709; GO:0072659; GO:0098794; GO:0098978; GO:1903076; GO:1903078 actin cytoskeleton organization [GO:0030036]; actin filament capping [GO:0051693]; central nervous system development [GO:0007417]; central nervous system formation [GO:0021556]; Golgi to plasma membrane protein transport [GO:0043001]; membrane assembly [GO:0071709]; mitotic cytokinesis [GO:0000281]; plasma membrane organization [GO:0007009]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of protein localization to plasma membrane [GO:1903078]; protein localization to plasma membrane [GO:0072659]; regulation of protein localization to plasma membrane [GO:1903076]; regulation of SMAD protein signal transduction [GO:0060390] axolemma [GO:0030673]; cell junction [GO:0030054]; cell projection [GO:0042995]; cortical actin cytoskeleton [GO:0030864]; cortical cytoskeleton [GO:0030863]; cuticular plate [GO:0032437]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; glutamatergic synapse [GO:0098978]; M band [GO:0031430]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; protein-containing complex [GO:0032991]; spectrin [GO:0008091] actin filament binding [GO:0051015]; ankyrin binding [GO:0030506]; calmodulin binding [GO:0005516]; GTPase binding [GO:0051020]; phospholipid binding [GO:0005543]; protein-containing complex binding [GO:0044877]; structural constituent of cytoskeleton [GO:0005200] g3835.t1 Q96JC1 59.534 472 1.1499999999999999e-176 521.0 sp|Q96JC1|VPS39_HUMAN Vam6/Vps39-like protein OS=Homo sapiens OX=9606 GN=VPS39 PE=1 SV=2 g3836.t1 Q96JC1 51.031 388 2.53e-124 381.0 sp|Q96JC1|VPS39_HUMAN Vam6/Vps39-like protein OS=Homo sapiens OX=9606 GN=VPS39 PE=1 SV=2 g3837.t1 Q9CXR1 44.262 305 3.12e-68 220.0 sp|Q9CXR1|DHRS7_MOUSE Dehydrogenase/reductase SDR family member 7 OS=Mus musculus OX=10090 GN=Dhrs7 PE=1 SV=2 g3838.t1 Q5HZQ9 39.286 1260 0.0 763.0 sp|Q5HZQ9|PCX4_XENLA Pecanex-like protein 4 OS=Xenopus laevis OX=8355 GN=pcnx4 PE=2 SV=1 g3839.t1 Q9CR63 47.115 104 3.0899999999999998e-28 102.0 sp|Q9CR63|COX16_MOUSE Cytochrome c oxidase assembly protein COX16 homolog, mitochondrial OS=Mus musculus OX=10090 GN=Cox16 PE=3 SV=1 g3841.t1 P59325 53.901 423 6.23e-139 407.0 sp|P59325|IF5_MOUSE Eukaryotic translation initiation factor 5 OS=Mus musculus OX=10090 GN=Eif5 PE=1 SV=1 g3842.t1 Q92797 53.517 1123 0.0 1114.0 sp|Q92797|SYMPK_HUMAN Symplekin OS=Homo sapiens OX=9606 GN=SYMPK PE=1 SV=2 SYMPK_HUMAN reviewed Symplekin Homo sapiens (Human) GO:0005654; GO:0005737; GO:0005829; GO:0005847; GO:0005856; GO:0005886; GO:0005923; GO:0006397; GO:0007155; GO:0032091; GO:0097165 cell adhesion [GO:0007155]; mRNA processing [GO:0006397]; negative regulation of protein binding [GO:0032091] bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; nuclear stress granule [GO:0097165]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] g3843.t1 O88994 38.697 261 2.74e-50 172.0 sp|O88994|MARC2_RAT Mitochondrial amidoxime reducing component 2 OS=Rattus norvegicus OX=10116 GN=Mtarc2 PE=2 SV=1 g3844.t1 Q5VT66 39.527 296 8e-60 198.0 sp|Q5VT66|MARC1_HUMAN Mitochondrial amidoxime-reducing component 1 OS=Homo sapiens OX=9606 GN=MTARC1 PE=1 SV=1 MARC1_HUMAN reviewed Mitochondrial amidoxime-reducing component 1 (mARC1) (EC 1.7.-.-) (Molybdenum cofactor sulfurase C-terminal domain-containing protein 1) (MOSC domain-containing protein 1) (Moco sulfurase C-terminal domain-containing protein 1) Homo sapiens (Human) GO:0005739; GO:0005741; GO:0006809; GO:0008940; GO:0016661; GO:0030151; GO:0030170; GO:0042126; GO:0043546; GO:0051410; GO:0070458; GO:0098809; GO:1903958 cellular detoxification of nitrogen compound [GO:0070458]; detoxification of nitrogen compound [GO:0051410]; nitrate metabolic process [GO:0042126]; nitric oxide biosynthetic process [GO:0006809] mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nitric-oxide synthase complex [GO:1903958] molybdenum ion binding [GO:0030151]; molybdopterin cofactor binding [GO:0043546]; nitrate reductase activity [GO:0008940]; nitrite reductase activity [GO:0098809]; oxidoreductase activity, acting on other nitrogenous compounds as donors [GO:0016661]; pyridoxal phosphate binding [GO:0030170] g3845.t1 Q8L0X4 47.11 346 1.7199999999999998e-114 343.0 sp|Q8L0X4|MEGL_FUSNP L-methionine gamma-lyase OS=Fusobacterium nucleatum subsp. polymorphum OX=76857 GN=mgl PE=1 SV=1 g3847.t1 Q96DM1 26.619 278 4.08e-22 102.0 sp|Q96DM1|PGBD4_HUMAN PiggyBac transposable element-derived protein 4 OS=Homo sapiens OX=9606 GN=PGBD4 PE=1 SV=3 g3849.t1 Q0V9V2 58.434 166 8.650000000000001e-66 201.0 sp|Q0V9V2|T229B_XENTR Transmembrane protein 229b OS=Xenopus tropicalis OX=8364 GN=tmem229b PE=2 SV=1 g3855.t1 Q96L93 44.864 847 0.0 667.0 sp|Q96L93|KI16B_HUMAN Kinesin-like protein KIF16B OS=Homo sapiens OX=9606 GN=KIF16B PE=1 SV=2 KI16B_HUMAN reviewed Kinesin-like protein KIF16B (Sorting nexin-23) Homo sapiens (Human) GO:0001704; GO:0001919; GO:0005524; GO:0005547; GO:0005737; GO:0005768; GO:0005769; GO:0005819; GO:0005829; GO:0005871; GO:0005874; GO:0006895; GO:0007173; GO:0007492; GO:0008017; GO:0008543; GO:0008574; GO:0016887; GO:0031901; GO:0032266; GO:0032801; GO:0043325; GO:0045022; GO:0047496; GO:0080025 early endosome to late endosome transport [GO:0045022]; endoderm development [GO:0007492]; epidermal growth factor receptor signaling pathway [GO:0007173]; fibroblast growth factor receptor signaling pathway [GO:0008543]; formation of primary germ layer [GO:0001704]; Golgi to endosome transport [GO:0006895]; receptor catabolic process [GO:0032801]; regulation of receptor recycling [GO:0001919]; vesicle transport along microtubule [GO:0047496] cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; spindle [GO:0005819] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule binding [GO:0008017]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-3-phosphate binding [GO:0032266]; plus-end-directed microtubule motor activity [GO:0008574] g3856.t1 Q5U3G6 53.191 282 1.37e-98 295.0 sp|Q5U3G6|YIF1B_DANRE Protein YIF1B OS=Danio rerio OX=7955 GN=yif1b PE=2 SV=2 g3857.t1 A4IF87 37.964 619 5.32e-147 446.0 sp|A4IF87|GNPAT_BOVIN Dihydroxyacetone phosphate acyltransferase OS=Bos taurus OX=9913 GN=GNPAT PE=2 SV=1 g3858.t1 Q33BP8 37.5 528 8.1e-74 245.0 sp|Q33BP8|FOXN3_PIG Forkhead box protein N3 OS=Sus scrofa OX=9823 GN=FOXN3 PE=2 SV=1 g3859.t1 Q6DC58 35.071 211 5.69e-37 134.0 sp|Q6DC58|TM223_DANRE Transmembrane protein 223 OS=Danio rerio OX=7955 GN=tmem223 PE=2 SV=1 g3860.t1 Q5ZL12 46.801 797 0.0 588.0 sp|Q5ZL12|PPR21_CHICK Protein phosphatase 1 regulatory subunit 21 OS=Gallus gallus OX=9031 GN=PPP1R21 PE=2 SV=1 PPR21_CHICK reviewed Protein phosphatase 1 regulatory subunit 21 (Coiled-coil domain-containing protein 128) (Ferry endosomal RAB5 effector complex subunit 2) (Fy-2) (KLRAQ motif-containing protein 1) Gallus gallus (Chicken) GO:0003723; GO:0005769 early endosome [GO:0005769] RNA binding [GO:0003723] g3861.t1 P00767 37.109 256 1.07e-43 150.0 sp|P00767|CTRB_BOVIN Chymotrypsinogen B OS=Bos taurus OX=9913 PE=1 SV=1 g3862.t1 P00767 41.154 260 1.7599999999999998e-52 174.0 sp|P00767|CTRB_BOVIN Chymotrypsinogen B OS=Bos taurus OX=9913 PE=1 SV=1 g3864.t1 Q5VV42 66.229 533 0.0 711.0 sp|Q5VV42|CDKAL_HUMAN Threonylcarbamoyladenosine tRNA methylthiotransferase OS=Homo sapiens OX=9606 GN=CDKAL1 PE=1 SV=1 CDKAL_HUMAN reviewed Threonylcarbamoyladenosine tRNA methylthiotransferase (EC 2.8.4.5) (CDK5 regulatory subunit-associated protein 1-like 1) (tRNA-t(6)A37 methylthiotransferase) Homo sapiens (Human) GO:0005783; GO:0005789; GO:0005791; GO:0016020; GO:0035598; GO:0035600; GO:0046872; GO:0051539; GO:1990145 maintenance of translational fidelity [GO:1990145]; tRNA methylthiolation [GO:0035600] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; rough endoplasmic reticulum [GO:0005791] 4 iron, 4 sulfur cluster binding [GO:0051539]; metal ion binding [GO:0046872]; tRNA (N(6)-L-threonylcarbamoyladenosine(37)-C(2))-methylthiotransferase activity [GO:0035598] g3866.t1 Q80X66 69.896 289 1.29e-138 407.0 sp|Q80X66|BTBDA_MOUSE BTB/POZ domain-containing protein 10 OS=Mus musculus OX=10090 GN=Btbd10 PE=1 SV=1 g3867.t1 P04642 60.18 334 1.64e-145 417.0 sp|P04642|LDHA_RAT L-lactate dehydrogenase A chain OS=Rattus norvegicus OX=10116 GN=Ldha PE=1 SV=1 LDHA_RAT reviewed L-lactate dehydrogenase A chain (LDH-A) (EC 1.1.1.27) (LDH muscle subunit) (LDH-M) Rattus norvegicus (Rat) GO:0001666; GO:0001889; GO:0004457; GO:0004459; GO:0005739; GO:0005829; GO:0006089; GO:0007519; GO:0007584; GO:0009410; GO:0009749; GO:0019661; GO:0019674; GO:0019900; GO:0035686; GO:0042542; GO:0042802; GO:0042867; GO:0043065; GO:0043627; GO:0051287; GO:0051591; GO:1904628; GO:1990204 cellular response to phorbol 13-acetate 12-myristate [GO:1904628]; glucose catabolic process to lactate via pyruvate [GO:0019661]; lactate metabolic process [GO:0006089]; liver development [GO:0001889]; NAD+ metabolic process [GO:0019674]; positive regulation of apoptotic process [GO:0043065]; pyruvate catabolic process [GO:0042867]; response to cAMP [GO:0051591]; response to estrogen [GO:0043627]; response to glucose [GO:0009749]; response to hydrogen peroxide [GO:0042542]; response to hypoxia [GO:0001666]; response to nutrient [GO:0007584]; response to xenobiotic stimulus [GO:0009410]; skeletal muscle tissue development [GO:0007519] cytosol [GO:0005829]; mitochondrion [GO:0005739]; oxidoreductase complex [GO:1990204]; sperm fibrous sheath [GO:0035686] identical protein binding [GO:0042802]; kinase binding [GO:0019900]; L-lactate dehydrogenase (NAD+) activity [GO:0004459]; lactate dehydrogenase activity [GO:0004457]; NAD binding [GO:0051287] g3867.t2 Q9PVK4 64.407 236 2.17e-107 316.0 sp|Q9PVK4|LDHBA_DANRE L-lactate dehydrogenase B-A chain OS=Danio rerio OX=7955 GN=ldhba PE=2 SV=4 g3867.t3 P06151 54.783 115 5.39e-34 123.0 sp|P06151|LDHA_MOUSE L-lactate dehydrogenase A chain OS=Mus musculus OX=10090 GN=Ldha PE=1 SV=3 LDHA_MOUSE reviewed L-lactate dehydrogenase A chain (LDH-A) (EC 1.1.1.27) (LDH muscle subunit) (LDH-M) Mus musculus (Mouse) GO:0004457; GO:0004459; GO:0005739; GO:0005829; GO:0006089; GO:0019244; GO:0019661; GO:0019900; GO:0035686; GO:0042802; GO:0042867; GO:0051287; GO:1990204 glucose catabolic process to lactate via pyruvate [GO:0019661]; lactate biosynthetic process from pyruvate [GO:0019244]; lactate metabolic process [GO:0006089]; pyruvate catabolic process [GO:0042867] cytosol [GO:0005829]; mitochondrion [GO:0005739]; oxidoreductase complex [GO:1990204]; sperm fibrous sheath [GO:0035686] identical protein binding [GO:0042802]; kinase binding [GO:0019900]; L-lactate dehydrogenase (NAD+) activity [GO:0004459]; lactate dehydrogenase activity [GO:0004457]; NAD binding [GO:0051287] g3871.t1 P21129 33.333 255 7.07e-33 135.0 sp|P21129|P3_MOUSE P3 protein OS=Mus musculus OX=10090 GN=Slc10a3 PE=2 SV=2 g3873.t1 Q5RD64 35.632 174 1.48e-25 108.0 sp|Q5RD64|CNTP2_PONAB Contactin-associated protein-like 2 OS=Pongo abelii OX=9601 GN=CNTNAP2 PE=2 SV=1 CNTP2_PONAB reviewed Contactin-associated protein-like 2 Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0007155; GO:0007417; GO:0016020; GO:0033010; GO:0044224; GO:0048812; GO:0071205 cell adhesion [GO:0007155]; central nervous system development [GO:0007417]; neuron projection morphogenesis [GO:0048812]; protein localization to juxtaparanode region of axon [GO:0071205] juxtaparanode region of axon [GO:0044224]; membrane [GO:0016020]; paranodal junction [GO:0033010] g3877.t1 F1QMV3 70.701 157 1e-81 241.0 sp|F1QMV3|TPC6B_DANRE Trafficking protein particle complex subunit 6b OS=Danio rerio OX=7955 GN=trappc6b PE=2 SV=1 g3878.t1 Q5R5X0 43.158 285 1.5399999999999999e-34 140.0 sp|Q5R5X0|PININ_PONAB Pinin OS=Pongo abelii OX=9601 GN=PNN PE=2 SV=1 g3879.t1 B0BM95 35.498 231 6.38e-36 134.0 sp|B0BM95|ACTMP_XENTR Actin maturation protease OS=Xenopus tropicalis OX=8364 GN=actmap PE=2 SV=2 g3881.t1 P32031 80.769 130 1.74e-66 221.0 sp|P32031|SLP2_DROME Fork head domain transcription factor slp2 OS=Drosophila melanogaster OX=7227 GN=slp2 PE=2 SV=3 g3882.t1 P12259 33.577 274 3.1299999999999997e-30 124.0 sp|P12259|FA5_HUMAN Coagulation factor V OS=Homo sapiens OX=9606 GN=F5 PE=1 SV=4 FA5_HUMAN reviewed Coagulation factor V (Activated protein C cofactor) (Proaccelerin, labile factor) [Cleaved into: Coagulation factor V heavy chain; Coagulation factor V light chain] Homo sapiens (Human) GO:0005507; GO:0005576; GO:0005615; GO:0005788; GO:0005886; GO:0007596; GO:0008015; GO:0016020; GO:0030134; GO:0031091; GO:0031093; GO:0032571; GO:0033116; GO:1903561 blood circulation [GO:0008015]; blood coagulation [GO:0007596]; response to vitamin K [GO:0032571] COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular vesicle [GO:1903561]; membrane [GO:0016020]; plasma membrane [GO:0005886]; platelet alpha granule [GO:0031091]; platelet alpha granule lumen [GO:0031093] copper ion binding [GO:0005507] g3882.t1 P12259 35.417 240 6.300000000000001e-27 114.0 sp|P12259|FA5_HUMAN Coagulation factor V OS=Homo sapiens OX=9606 GN=F5 PE=1 SV=4 FA5_HUMAN reviewed Coagulation factor V (Activated protein C cofactor) (Proaccelerin, labile factor) [Cleaved into: Coagulation factor V heavy chain; Coagulation factor V light chain] Homo sapiens (Human) GO:0005507; GO:0005576; GO:0005615; GO:0005788; GO:0005886; GO:0007596; GO:0008015; GO:0016020; GO:0030134; GO:0031091; GO:0031093; GO:0032571; GO:0033116; GO:1903561 blood circulation [GO:0008015]; blood coagulation [GO:0007596]; response to vitamin K [GO:0032571] COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular vesicle [GO:1903561]; membrane [GO:0016020]; plasma membrane [GO:0005886]; platelet alpha granule [GO:0031091]; platelet alpha granule lumen [GO:0031093] copper ion binding [GO:0005507] g3882.t1 P12259 32.443 262 1.14e-22 102.0 sp|P12259|FA5_HUMAN Coagulation factor V OS=Homo sapiens OX=9606 GN=F5 PE=1 SV=4 FA5_HUMAN reviewed Coagulation factor V (Activated protein C cofactor) (Proaccelerin, labile factor) [Cleaved into: Coagulation factor V heavy chain; Coagulation factor V light chain] Homo sapiens (Human) GO:0005507; GO:0005576; GO:0005615; GO:0005788; GO:0005886; GO:0007596; GO:0008015; GO:0016020; GO:0030134; GO:0031091; GO:0031093; GO:0032571; GO:0033116; GO:1903561 blood circulation [GO:0008015]; blood coagulation [GO:0007596]; response to vitamin K [GO:0032571] COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular vesicle [GO:1903561]; membrane [GO:0016020]; plasma membrane [GO:0005886]; platelet alpha granule [GO:0031091]; platelet alpha granule lumen [GO:0031093] copper ion binding [GO:0005507] g3883.t1 Q5M8Z0 50.27 370 6.17e-123 364.0 sp|Q5M8Z0|BHMT1_XENTR Betaine--homocysteine S-methyltransferase 1 OS=Xenopus tropicalis OX=8364 GN=bhmt PE=2 SV=1 g3884.t1 Q5RF32 52.514 358 4.98e-127 372.0 sp|Q5RF32|BHMT2_PONAB S-methylmethionine--homocysteine S-methyltransferase BHMT2 OS=Pongo abelii OX=9601 GN=BHMT2 PE=2 SV=1 g3890.t1 P57093 58.651 341 2.05e-146 419.0 sp|P57093|PAHX_RAT Phytanoyl-CoA dioxygenase, peroxisomal OS=Rattus norvegicus OX=10116 GN=Phyh PE=1 SV=2 PAHX_RAT reviewed Phytanoyl-CoA dioxygenase, peroxisomal (EC 1.14.11.18) (Phytanic acid oxidase) (Phytanoyl-CoA alpha-hydroxylase) (PhyH) Rattus norvegicus (Rat) GO:0001561; GO:0003824; GO:0005777; GO:0006103; GO:0006720; GO:0008198; GO:0019606; GO:0031406; GO:0031418; GO:0048244; GO:0097089; GO:0097731 2-oxobutyrate catabolic process [GO:0019606]; 2-oxoglutarate metabolic process [GO:0006103]; fatty acid alpha-oxidation [GO:0001561]; isoprenoid metabolic process [GO:0006720]; methyl-branched fatty acid metabolic process [GO:0097089] 9+0 non-motile cilium [GO:0097731]; peroxisome [GO:0005777] carboxylic acid binding [GO:0031406]; catalytic activity [GO:0003824]; ferrous iron binding [GO:0008198]; L-ascorbic acid binding [GO:0031418]; phytanoyl-CoA dioxygenase activity [GO:0048244] g3891.t1 Q9VMU8 35.959 292 5.2e-52 177.0 sp|Q9VMU8|SENJU_DROME UDP-galactose transporter senju OS=Drosophila melanogaster OX=7227 GN=senju PE=1 SV=2 SENJU_DROME reviewed UDP-galactose transporter senju Drosophila melanogaster (Fruit fly) GO:0000139; GO:0002225; GO:0005459; GO:0005794; GO:0005797; GO:0010560; GO:0045751; GO:0045824; GO:0055085; GO:0072334 negative regulation of innate immune response [GO:0045824]; negative regulation of Toll signaling pathway [GO:0045751]; positive regulation of antimicrobial peptide production [GO:0002225]; positive regulation of glycoprotein biosynthetic process [GO:0010560]; transmembrane transport [GO:0055085]; UDP-galactose transmembrane transport [GO:0072334] Golgi apparatus [GO:0005794]; Golgi medial cisterna [GO:0005797]; Golgi membrane [GO:0000139] UDP-galactose transmembrane transporter activity [GO:0005459] g3893.t1 Q80YR7 30.298 571 3.5499999999999996e-30 131.0 sp|Q80YR7|CLSPN_MOUSE Claspin OS=Mus musculus OX=10090 GN=Clspn PE=1 SV=2 CLSPN_MOUSE reviewed Claspin Mus musculus (Mouse) GO:0000076; GO:0000077; GO:0000217; GO:0005634; GO:0005654; GO:0005794; GO:0006281; GO:0007095; GO:0010997; GO:0033314 DNA damage checkpoint signaling [GO:0000077]; DNA repair [GO:0006281]; DNA replication checkpoint signaling [GO:0000076]; mitotic DNA replication checkpoint signaling [GO:0033314]; mitotic G2 DNA damage checkpoint signaling [GO:0007095] Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] anaphase-promoting complex binding [GO:0010997]; DNA secondary structure binding [GO:0000217] g3894.t1 G3UVW3 49.02 153 4.18e-43 152.0 sp|G3UVW3|S38A6_MOUSE Solute carrier family 38 member 6 OS=Mus musculus OX=10090 GN=Slc38a6 PE=1 SV=1 S38A6_MOUSE reviewed Solute carrier family 38 member 6 (Amino acid transporter SLC38A6) Mus musculus (Mouse) GO:0003333; GO:0005313; GO:0005886; GO:0006868; GO:0015186; GO:0045202 amino acid transmembrane transport [GO:0003333]; glutamine transport [GO:0006868] plasma membrane [GO:0005886]; synapse [GO:0045202] L-glutamate transmembrane transporter activity [GO:0005313]; L-glutamine transmembrane transporter activity [GO:0015186] g3895.t1 Q28HE5 53.546 282 5.6300000000000005e-80 253.0 sp|Q28HE5|S38A6_XENTR Probable sodium-coupled neutral amino acid transporter 6 OS=Xenopus tropicalis OX=8364 GN=slc38a6 PE=2 SV=1 g3896.t1 F6VSS6 49.153 413 6.99e-141 416.0 sp|F6VSS6|TRM5_XENTR tRNA (guanine(37)-N(1))-methyltransferase OS=Xenopus tropicalis OX=8364 GN=trmt5 PE=3 SV=1 g3897.t1 P51950 93.808 323 0.0 588.0 sp|P51950|MAT1_MARGL CDK-activating kinase assembly factor MAT1 OS=Marthasterias glacialis OX=7609 PE=1 SV=1 g3899.t1 Q9JJ61 56.371 518 0.0 597.0 sp|Q9JJ61|GLT16_MOUSE Polypeptide N-acetylgalactosaminyltransferase 16 OS=Mus musculus OX=10090 GN=Galnt16 PE=2 SV=2 GLT16_MOUSE reviewed Polypeptide N-acetylgalactosaminyltransferase 16 (EC 2.4.1.41) (Polypeptide GalNAc transferase 16) (GalNAc-T16) (Polypeptide GalNAc transferase-like protein 1) (GalNAc-T-like protein 1) (pp-GaNTase-like protein 1) (Polypeptide N-acetylgalactosaminyltransferase-like protein 1) (Protein-UDP acetylgalactosaminyltransferase-like protein 1) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase-like protein 1) Mus musculus (Mouse) GO:0000139; GO:0004653; GO:0005794; GO:0006493; GO:0030246; GO:0046872 protein O-linked glycosylation [GO:0006493] Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139] carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653] g3899.t2 Q9JJ61 55.405 518 0.0 587.0 sp|Q9JJ61|GLT16_MOUSE Polypeptide N-acetylgalactosaminyltransferase 16 OS=Mus musculus OX=10090 GN=Galnt16 PE=2 SV=2 GLT16_MOUSE reviewed Polypeptide N-acetylgalactosaminyltransferase 16 (EC 2.4.1.41) (Polypeptide GalNAc transferase 16) (GalNAc-T16) (Polypeptide GalNAc transferase-like protein 1) (GalNAc-T-like protein 1) (pp-GaNTase-like protein 1) (Polypeptide N-acetylgalactosaminyltransferase-like protein 1) (Protein-UDP acetylgalactosaminyltransferase-like protein 1) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase-like protein 1) Mus musculus (Mouse) GO:0000139; GO:0004653; GO:0005794; GO:0006493; GO:0030246; GO:0046872 protein O-linked glycosylation [GO:0006493] Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139] carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653] g3899.t3 Q9JJ61 55.832 523 0.0 592.0 sp|Q9JJ61|GLT16_MOUSE Polypeptide N-acetylgalactosaminyltransferase 16 OS=Mus musculus OX=10090 GN=Galnt16 PE=2 SV=2 GLT16_MOUSE reviewed Polypeptide N-acetylgalactosaminyltransferase 16 (EC 2.4.1.41) (Polypeptide GalNAc transferase 16) (GalNAc-T16) (Polypeptide GalNAc transferase-like protein 1) (GalNAc-T-like protein 1) (pp-GaNTase-like protein 1) (Polypeptide N-acetylgalactosaminyltransferase-like protein 1) (Protein-UDP acetylgalactosaminyltransferase-like protein 1) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase-like protein 1) Mus musculus (Mouse) GO:0000139; GO:0004653; GO:0005794; GO:0006493; GO:0030246; GO:0046872 protein O-linked glycosylation [GO:0006493] Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139] carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653] g3901.t1 Q8TBZ3 59.296 398 5.76e-156 459.0 sp|Q8TBZ3|WDR20_HUMAN WD repeat-containing protein 20 OS=Homo sapiens OX=9606 GN=WDR20 PE=1 SV=2 WDR20_HUMAN reviewed WD repeat-containing protein 20 (Protein DMR) Homo sapiens (Human) GO:0005634; GO:0005654; GO:0005737; GO:0035800 cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] deubiquitinase activator activity [GO:0035800] g3902.t1 B4F7E7 50.259 579 4.4e-179 541.0 sp|B4F7E7|PALS1_RAT Protein PALS1 OS=Rattus norvegicus OX=10116 GN=Pals1 PE=1 SV=1 PALS1_RAT reviewed Protein PALS1 (MAGUK p55 subfamily member 5) (Protein associated with Lin-7 1) Rattus norvegicus (Rat) GO:0002011; GO:0005524; GO:0005737; GO:0005794; GO:0005886; GO:0005912; GO:0005923; GO:0007009; GO:0008104; GO:0010467; GO:0016301; GO:0016324; GO:0016332; GO:0017015; GO:0019904; GO:0021954; GO:0021987; GO:0030424; GO:0032287; GO:0032288; GO:0032991; GO:0035749; GO:0035750; GO:0042802; GO:0043204; GO:0043219; GO:0043220; GO:0045177; GO:0045197; GO:0048699; GO:0072659 central nervous system neuron development [GO:0021954]; cerebral cortex development [GO:0021987]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; establishment or maintenance of polarity of embryonic epithelium [GO:0016332]; gene expression [GO:0010467]; generation of neurons [GO:0048699]; intracellular protein localization [GO:0008104]; morphogenesis of an epithelial sheet [GO:0002011]; myelin assembly [GO:0032288]; peripheral nervous system myelin maintenance [GO:0032287]; plasma membrane organization [GO:0007009]; protein localization to myelin sheath abaxonal region [GO:0035750]; protein localization to plasma membrane [GO:0072659]; regulation of transforming growth factor beta receptor signaling pathway [GO:0017015] adherens junction [GO:0005912]; apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; axon [GO:0030424]; bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; lateral loop [GO:0043219]; myelin sheath adaxonal region [GO:0035749]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; Schmidt-Lanterman incisure [GO:0043220] ATP binding [GO:0005524]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; protein domain specific binding [GO:0019904] g3902.t2 B4F7E7 51.687 563 0.0 551.0 sp|B4F7E7|PALS1_RAT Protein PALS1 OS=Rattus norvegicus OX=10116 GN=Pals1 PE=1 SV=1 PALS1_RAT reviewed Protein PALS1 (MAGUK p55 subfamily member 5) (Protein associated with Lin-7 1) Rattus norvegicus (Rat) GO:0002011; GO:0005524; GO:0005737; GO:0005794; GO:0005886; GO:0005912; GO:0005923; GO:0007009; GO:0008104; GO:0010467; GO:0016301; GO:0016324; GO:0016332; GO:0017015; GO:0019904; GO:0021954; GO:0021987; GO:0030424; GO:0032287; GO:0032288; GO:0032991; GO:0035749; GO:0035750; GO:0042802; GO:0043204; GO:0043219; GO:0043220; GO:0045177; GO:0045197; GO:0048699; GO:0072659 central nervous system neuron development [GO:0021954]; cerebral cortex development [GO:0021987]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; establishment or maintenance of polarity of embryonic epithelium [GO:0016332]; gene expression [GO:0010467]; generation of neurons [GO:0048699]; intracellular protein localization [GO:0008104]; morphogenesis of an epithelial sheet [GO:0002011]; myelin assembly [GO:0032288]; peripheral nervous system myelin maintenance [GO:0032287]; plasma membrane organization [GO:0007009]; protein localization to myelin sheath abaxonal region [GO:0035750]; protein localization to plasma membrane [GO:0072659]; regulation of transforming growth factor beta receptor signaling pathway [GO:0017015] adherens junction [GO:0005912]; apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; axon [GO:0030424]; bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; lateral loop [GO:0043219]; myelin sheath adaxonal region [GO:0035749]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; Schmidt-Lanterman incisure [GO:0043220] ATP binding [GO:0005524]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; protein domain specific binding [GO:0019904] g3904.t1 Q9D1E6 50.228 219 2.68e-68 213.0 sp|Q9D1E6|TBCB_MOUSE Tubulin-folding cofactor B OS=Mus musculus OX=10090 GN=Tbcb PE=1 SV=2 TBCB_MOUSE reviewed Tubulin-folding cofactor B (Cytoskeleton-associated protein 1) (Cytoskeleton-associated protein CKAPI) (Tubulin-specific chaperone B) Mus musculus (Mouse) GO:0005634; GO:0005737; GO:0005829; GO:0005938; GO:0007021; GO:0007023; GO:0007399; GO:0030154; GO:0031122; GO:0035371; GO:0043014; GO:0051010 cell differentiation [GO:0030154]; cytoplasmic microtubule organization [GO:0031122]; nervous system development [GO:0007399]; post-chaperonin tubulin folding pathway [GO:0007023]; tubulin complex assembly [GO:0007021] cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule plus-end [GO:0035371]; nucleus [GO:0005634] alpha-tubulin binding [GO:0043014]; microtubule plus-end binding [GO:0051010] g3905.t1 A5D7H2 60.574 766 0.0 832.0 sp|A5D7H2|STRN3_BOVIN Striatin-3 OS=Bos taurus OX=9913 GN=STRN3 PE=2 SV=1 STRN3_BOVIN reviewed Striatin-3 Bos taurus (Bovine) GO:0000122; GO:0005516; GO:0005654; GO:0005737; GO:0005794; GO:0005886; GO:0030425; GO:0030674; GO:0031267; GO:0033147; GO:0035331; GO:0043025; GO:0044877; GO:0045892; GO:0045944; GO:0051721; GO:0070016; GO:0090443; GO:0098794 negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of hippo signaling [GO:0035331]; negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944] cytoplasm [GO:0005737]; dendrite [GO:0030425]; FAR/SIN/STRIPAK complex [GO:0090443]; Golgi apparatus [GO:0005794]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; postsynapse [GO:0098794] armadillo repeat domain binding [GO:0070016]; calmodulin binding [GO:0005516]; protein phosphatase 2A binding [GO:0051721]; protein-containing complex binding [GO:0044877]; protein-macromolecule adaptor activity [GO:0030674]; small GTPase binding [GO:0031267] g3906.t1 O82201 61.151 139 1.86e-60 186.0 sp|O82201|AP4S_ARATH AP-4 complex subunit sigma OS=Arabidopsis thaliana OX=3702 GN=At2g19790 PE=1 SV=1 g3907.t1 Q5U378 43.561 528 7.02e-127 384.0 sp|Q5U378|TBCE_DANRE Tubulin-specific chaperone E OS=Danio rerio OX=7955 GN=tbce PE=2 SV=2 g3907.t2 Q5U378 43.561 528 7.02e-127 384.0 sp|Q5U378|TBCE_DANRE Tubulin-specific chaperone E OS=Danio rerio OX=7955 GN=tbce PE=2 SV=2 g3907.t3 Q5U378 42.991 535 6.910000000000001e-124 376.0 sp|Q5U378|TBCE_DANRE Tubulin-specific chaperone E OS=Danio rerio OX=7955 GN=tbce PE=2 SV=2 g3908.t1 Q5FWT1 46.386 332 1.9e-77 254.0 sp|Q5FWT1|FA98A_RAT Protein FAM98A OS=Rattus norvegicus OX=10116 GN=Fam98a PE=2 SV=1 g3909.t1 Q5M8Z0 56.391 133 5.39e-43 149.0 sp|Q5M8Z0|BHMT1_XENTR Betaine--homocysteine S-methyltransferase 1 OS=Xenopus tropicalis OX=8364 GN=bhmt PE=2 SV=1 g3910.t1 Q95332 48.677 189 5.869999999999999e-55 180.0 sp|Q95332|BHMT1_PIG Betaine--homocysteine S-methyltransferase 1 (Fragment) OS=Sus scrofa OX=9823 GN=BHMT PE=1 SV=3 BHMT1_PIG reviewed Betaine--homocysteine S-methyltransferase 1 (EC 2.1.1.5) Sus scrofa (Pig) GO:0005634; GO:0005829; GO:0006579; GO:0008270; GO:0032259; GO:0047150; GO:0071267 amino-acid betaine catabolic process [GO:0006579]; L-methionine salvage [GO:0071267]; methylation [GO:0032259] cytosol [GO:0005829]; nucleus [GO:0005634] betaine-homocysteine S-methyltransferase activity [GO:0047150]; zinc ion binding [GO:0008270] g3911.t1 Q7SZE5 76.25 80 3.7400000000000003e-57 140.0 sp|Q7SZE5|SC23A_DANRE Protein transport protein Sec23A OS=Danio rerio OX=7955 GN=sec23a PE=2 SV=1 g3911.t1 Q7SZE5 84.314 51 3.7400000000000003e-57 101.0 sp|Q7SZE5|SC23A_DANRE Protein transport protein Sec23A OS=Danio rerio OX=7955 GN=sec23a PE=2 SV=1 g3912.t1 Q01405 77.229 628 0.0 1031.0 sp|Q01405|SC23A_MOUSE Protein transport protein Sec23A OS=Mus musculus OX=10090 GN=Sec23a PE=1 SV=2 g3918.t1 Q8JFW4 40.991 222 3.81e-44 161.0 sp|Q8JFW4|ADAT3_DANRE Probable inactive tRNA-specific adenosine deaminase-like protein 3 OS=Danio rerio OX=7955 GN=adat3 PE=2 SV=2 g3918.t1 Q8JFW4 68.0 75 1.3600000000000002e-27 116.0 sp|Q8JFW4|ADAT3_DANRE Probable inactive tRNA-specific adenosine deaminase-like protein 3 OS=Danio rerio OX=7955 GN=adat3 PE=2 SV=2 g3919.t1 Q9TTK4 45.545 1201 0.0 1026.0 sp|Q9TTK4|LYST_BOVIN Lysosomal-trafficking regulator OS=Bos taurus OX=9913 GN=LYST PE=1 SV=1 g3919.t1 Q9TTK4 29.274 854 2.09e-85 319.0 sp|Q9TTK4|LYST_BOVIN Lysosomal-trafficking regulator OS=Bos taurus OX=9913 GN=LYST PE=1 SV=1 g3919.t1 Q9TTK4 25.217 460 3.81e-26 123.0 sp|Q9TTK4|LYST_BOVIN Lysosomal-trafficking regulator OS=Bos taurus OX=9913 GN=LYST PE=1 SV=1 g3919.t1 Q9TTK4 35.196 179 6.14e-26 122.0 sp|Q9TTK4|LYST_BOVIN Lysosomal-trafficking regulator OS=Bos taurus OX=9913 GN=LYST PE=1 SV=1 g3920.t1 Q4R8N7 53.047 558 0.0 563.0 sp|Q4R8N7|STIP1_MACFA Stress-induced-phosphoprotein 1 OS=Macaca fascicularis OX=9541 GN=STIP1 PE=2 SV=1 STIP1_MACFA reviewed Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey) GO:0005634; GO:0051879; GO:0120293 dynein axonemal particle [GO:0120293]; nucleus [GO:0005634] Hsp90 protein binding [GO:0051879] g3921.t1 Q5XEP2 50.926 108 4.03e-30 116.0 sp|Q5XEP2|HSOP2_ARATH Hsp70-Hsp90 organizing protein 2 OS=Arabidopsis thaliana OX=3702 GN=HOP2 PE=1 SV=1 g3921.t2 Q5XEP2 50.926 108 4.4199999999999995e-30 116.0 sp|Q5XEP2|HSOP2_ARATH Hsp70-Hsp90 organizing protein 2 OS=Arabidopsis thaliana OX=3702 GN=HOP2 PE=1 SV=1 g3922.t1 A5A6H9 64.508 417 0.0 554.0 sp|A5A6H9|ODBA_PANTR 2-oxoisovalerate dehydrogenase subunit alpha, mitochondrial OS=Pan troglodytes OX=9598 GN=BCKDHA PE=2 SV=1 ODBA_PANTR reviewed 2-oxoisovalerate dehydrogenase subunit alpha, mitochondrial (EC 1.2.4.4) (Branched-chain alpha-keto acid dehydrogenase E1 component alpha chain) (BCKDE1A) (BCKDH E1-alpha) Pan troglodytes (Chimpanzee) GO:0003863; GO:0005759; GO:0009083; GO:0046872; GO:0120552; GO:0160157 branched-chain alpha-keto acid decarboxylation to branched-chain acyl-CoA [GO:0120552]; branched-chain amino acid catabolic process [GO:0009083] branched-chain alpha-ketoacid dehydrogenase complex [GO:0160157]; mitochondrial matrix [GO:0005759] branched-chain 2-oxo acid dehydrogenase activity [GO:0003863]; metal ion binding [GO:0046872] g3925.t1 O00214 33.229 319 1.84e-49 170.0 sp|O00214|LEG8_HUMAN Galectin-8 OS=Homo sapiens OX=9606 GN=LGALS8 PE=1 SV=4 LEG8_HUMAN reviewed Galectin-8 (Gal-8) (Po66 carbohydrate-binding protein) (Po66-CBP) (Prostate carcinoma tumor antigen 1) (PCTA-1) Homo sapiens (Human) GO:0002317; GO:0005178; GO:0005615; GO:0005737; GO:0005829; GO:0016020; GO:0030246; GO:0031295; GO:0031410; GO:0098586; GO:0098792; GO:1904977 cellular response to virus [GO:0098586]; lymphatic endothelial cell migration [GO:1904977]; plasma cell differentiation [GO:0002317]; T cell costimulation [GO:0031295]; xenophagy [GO:0098792] cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; extracellular space [GO:0005615]; membrane [GO:0016020] carbohydrate binding [GO:0030246]; integrin binding [GO:0005178] g3925.t1 O00214 37.5 136 1.3099999999999999e-23 101.0 sp|O00214|LEG8_HUMAN Galectin-8 OS=Homo sapiens OX=9606 GN=LGALS8 PE=1 SV=4 LEG8_HUMAN reviewed Galectin-8 (Gal-8) (Po66 carbohydrate-binding protein) (Po66-CBP) (Prostate carcinoma tumor antigen 1) (PCTA-1) Homo sapiens (Human) GO:0002317; GO:0005178; GO:0005615; GO:0005737; GO:0005829; GO:0016020; GO:0030246; GO:0031295; GO:0031410; GO:0098586; GO:0098792; GO:1904977 cellular response to virus [GO:0098586]; lymphatic endothelial cell migration [GO:1904977]; plasma cell differentiation [GO:0002317]; T cell costimulation [GO:0031295]; xenophagy [GO:0098792] cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; extracellular space [GO:0005615]; membrane [GO:0016020] carbohydrate binding [GO:0030246]; integrin binding [GO:0005178] g3926.t1 Q5RHR0 48.015 1033 0.0 910.0 sp|Q5RHR0|PARP1_DANRE Poly [ADP-ribose] polymerase 1 OS=Danio rerio OX=7955 GN=parp1 PE=2 SV=1 PARP1_DANRE reviewed Poly [ADP-ribose] polymerase 1 (PARP-1) (EC 2.4.2.30) (ADP-ribosyltransferase diphtheria toxin-like 1) (ARTD1) (DNA ADP-ribosyltransferase PARP1) (EC 2.4.2.-) (NAD(+) ADP-ribosyltransferase 1) (ADPRT 1) (Poly[ADP-ribose] synthase 1) (Protein poly-ADP-ribosyltransferase PARP1) (EC 2.4.2.-) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000122; GO:0000785; GO:0003677; GO:0003684; GO:0003950; GO:0005634; GO:0005730; GO:0005829; GO:0006281; GO:0006302; GO:0006915; GO:0008270; GO:0016779; GO:0031491; GO:0042803; GO:0043596; GO:0045087; GO:0045187; GO:0045824; GO:0051287; GO:0070213; GO:0071932; GO:0090734; GO:0140805; GO:0140806; GO:0140807; GO:0140808; GO:0140815; GO:1990404 apoptotic process [GO:0006915]; DNA repair [GO:0006281]; double-strand break repair [GO:0006302]; innate immune response [GO:0045087]; negative regulation of innate immune response [GO:0045824]; negative regulation of transcription by RNA polymerase II [GO:0000122]; protein auto-ADP-ribosylation [GO:0070213]; regulation of circadian sleep/wake cycle, sleep [GO:0045187]; replication fork reversal [GO:0071932] chromatin [GO:0000785]; cytosol [GO:0005829]; nuclear replication fork [GO:0043596]; nucleolus [GO:0005730]; nucleus [GO:0005634]; site of DNA damage [GO:0090734] damaged DNA binding [GO:0003684]; DNA binding [GO:0003677]; NAD binding [GO:0051287]; NAD+ poly-ADP-ribosyltransferase activity [GO:0003950]; NAD+-protein mono-ADP-ribosyltransferase activity [GO:1990404]; NAD+-protein-aspartate ADP-ribosyltransferase activity [GO:0140806]; NAD+-protein-glutamate ADP-ribosyltransferase activity [GO:0140807]; NAD+-protein-histidine ADP-ribosyltransferase activity [GO:0140815]; NAD+-protein-serine ADP-ribosyltransferase activity [GO:0140805]; NAD+-protein-tyrosine ADP-ribosyltransferase activity [GO:0140808]; nucleosome binding [GO:0031491]; nucleotidyltransferase activity [GO:0016779]; protein homodimerization activity [GO:0042803]; zinc ion binding [GO:0008270] g3927.t1 F6XZJ7 52.336 107 2.42e-32 123.0 sp|F6XZJ7|SAM15_MOUSE Sterile alpha motif domain-containing protein 15 OS=Mus musculus OX=10090 GN=Samd15 PE=4 SV=2 g3928.t1 Q9H3P7 60.87 161 1.51e-49 179.0 sp|Q9H3P7|GCP60_HUMAN Golgi resident protein GCP60 OS=Homo sapiens OX=9606 GN=ACBD3 PE=1 SV=4 GCP60_HUMAN reviewed Golgi resident protein GCP60 (Acyl-CoA-binding domain-containing protein 3) (Golgi complex-associated protein 1) (GOCAP1) (Golgi phosphoprotein 1) (GOLPH1) (PBR- and PKA-associated protein 7) (Peripheral benzodiazepine receptor-associated protein PAP7) [Cleaved into: Golgi resident protein GCP60, N-terminally processed] Homo sapiens (Human) GO:0000062; GO:0000139; GO:0005739; GO:0005794; GO:0006694; GO:0016020; GO:0034237 steroid biosynthetic process [GO:0006694] Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; mitochondrion [GO:0005739] fatty-acyl-CoA binding [GO:0000062]; protein kinase A regulatory subunit binding [GO:0034237] g3928.t1 Q9H3P7 47.17 106 2.9299999999999997e-28 120.0 sp|Q9H3P7|GCP60_HUMAN Golgi resident protein GCP60 OS=Homo sapiens OX=9606 GN=ACBD3 PE=1 SV=4 GCP60_HUMAN reviewed Golgi resident protein GCP60 (Acyl-CoA-binding domain-containing protein 3) (Golgi complex-associated protein 1) (GOCAP1) (Golgi phosphoprotein 1) (GOLPH1) (PBR- and PKA-associated protein 7) (Peripheral benzodiazepine receptor-associated protein PAP7) [Cleaved into: Golgi resident protein GCP60, N-terminally processed] Homo sapiens (Human) GO:0000062; GO:0000139; GO:0005739; GO:0005794; GO:0006694; GO:0016020; GO:0034237 steroid biosynthetic process [GO:0006694] Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; mitochondrion [GO:0005739] fatty-acyl-CoA binding [GO:0000062]; protein kinase A regulatory subunit binding [GO:0034237] g3934.t1 P50748 31.152 1589 0.0 711.0 sp|P50748|KNTC1_HUMAN Kinetochore-associated protein 1 OS=Homo sapiens OX=9606 GN=KNTC1 PE=1 SV=1 KNTC1_HUMAN reviewed Kinetochore-associated protein 1 (Rough deal homolog) (HsROD) (Rod) (hRod) Homo sapiens (Human) GO:0000070; GO:0000922; GO:0005634; GO:0005737; GO:0005828; GO:0005829; GO:0005886; GO:0007094; GO:0007096; GO:0015629; GO:0031267; GO:0051301; GO:0051988; GO:0065003; GO:1903394; GO:1990423 cell division [GO:0051301]; mitotic sister chromatid segregation [GO:0000070]; mitotic spindle assembly checkpoint signaling [GO:0007094]; protein localization to kinetochore involved in kinetochore assembly [GO:1903394]; protein-containing complex assembly [GO:0065003]; regulation of attachment of spindle microtubules to kinetochore [GO:0051988]; regulation of exit from mitosis [GO:0007096] actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; kinetochore microtubule [GO:0005828]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; RZZ complex [GO:1990423]; spindle pole [GO:0000922] small GTPase binding [GO:0031267] g3935.t1 P50748 33.724 682 1.9700000000000002e-100 342.0 sp|P50748|KNTC1_HUMAN Kinetochore-associated protein 1 OS=Homo sapiens OX=9606 GN=KNTC1 PE=1 SV=1 KNTC1_HUMAN reviewed Kinetochore-associated protein 1 (Rough deal homolog) (HsROD) (Rod) (hRod) Homo sapiens (Human) GO:0000070; GO:0000922; GO:0005634; GO:0005737; GO:0005828; GO:0005829; GO:0005886; GO:0007094; GO:0007096; GO:0015629; GO:0031267; GO:0051301; GO:0051988; GO:0065003; GO:1903394; GO:1990423 cell division [GO:0051301]; mitotic sister chromatid segregation [GO:0000070]; mitotic spindle assembly checkpoint signaling [GO:0007094]; protein localization to kinetochore involved in kinetochore assembly [GO:1903394]; protein-containing complex assembly [GO:0065003]; regulation of attachment of spindle microtubules to kinetochore [GO:0051988]; regulation of exit from mitosis [GO:0007096] actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; kinetochore microtubule [GO:0005828]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; RZZ complex [GO:1990423]; spindle pole [GO:0000922] small GTPase binding [GO:0031267] g3936.t1 Q91YE3 40.374 374 5.4399999999999996e-83 264.0 sp|Q91YE3|EGLN1_MOUSE Egl nine homolog 1 OS=Mus musculus OX=10090 GN=Egln1 PE=1 SV=2 EGLN1_MOUSE reviewed Egl nine homolog 1 (EC 1.14.11.29) (Hypoxia-inducible factor prolyl hydroxylase 2) (HIF-PH2) (HIF-prolyl hydroxylase 2) (HPH-2) (Prolyl hydroxylase domain-containing protein 2) (PHD2) (SM-20) Mus musculus (Mouse) GO:0001666; GO:0004857; GO:0005634; GO:0005737; GO:0005829; GO:0006879; GO:0008198; GO:0008270; GO:0014069; GO:0016706; GO:0019899; GO:0031418; GO:0031543; GO:0031545; GO:0032364; GO:0043065; GO:0043523; GO:0043525; GO:0045765; GO:0045944; GO:0055008; GO:0060347; GO:0060412; GO:0060711; GO:0071456; GO:0071731; GO:0098978; GO:0099159; GO:0140252; GO:0160082; GO:1902072; GO:1905290 cardiac muscle tissue morphogenesis [GO:0055008]; cellular response to hypoxia [GO:0071456]; heart trabecula formation [GO:0060347]; intracellular iron ion homeostasis [GO:0006879]; intracellular oxygen homeostasis [GO:0032364]; labyrinthine layer development [GO:0060711]; negative regulation of CAMKK-AMPK signaling cascade [GO:1905290]; negative regulation of hypoxia-inducible factor-1alpha signaling pathway [GO:1902072]; positive regulation of apoptotic process [GO:0043065]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of angiogenesis [GO:0045765]; regulation of modification of postsynaptic structure [GO:0099159]; regulation of neuron apoptotic process [GO:0043523]; regulation protein catabolic process at postsynapse [GO:0140252]; response to hypoxia [GO:0001666]; response to nitric oxide [GO:0071731]; ventricular septum morphogenesis [GO:0060412] cytoplasm [GO:0005737]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; nucleus [GO:0005634]; postsynaptic density [GO:0014069] 2-oxoglutarate-dependent dioxygenase activity [GO:0016706]; enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; ferrous iron binding [GO:0008198]; hypoxia-inducible factor-proline dioxygenase activity [GO:0160082]; L-ascorbic acid binding [GO:0031418]; peptidyl-proline 4-dioxygenase activity [GO:0031545]; peptidyl-proline dioxygenase activity [GO:0031543]; zinc ion binding [GO:0008270] g3940.t1 Q7T1R4 85.484 124 2.61e-76 248.0 sp|Q7T1R4|FOXA2_XENTR Forkhead box protein A2 OS=Xenopus tropicalis OX=8364 GN=foxa2 PE=2 SV=1 g3942.t1 Q8TD10 42.183 339 3.4999999999999995e-55 197.0 sp|Q8TD10|MIPO1_HUMAN Mirror-image polydactyly gene 1 protein OS=Homo sapiens OX=9606 GN=MIPOL1 PE=1 SV=1 MIPO1_HUMAN reviewed Mirror-image polydactyly gene 1 protein Homo sapiens (Human) GO:0005634; GO:0042802 nucleus [GO:0005634] identical protein binding [GO:0042802] g3943.t1 Q5RFB7 65.108 278 6.609999999999999e-126 364.0 sp|Q5RFB7|ODC_PONAB Mitochondrial 2-oxodicarboxylate carrier OS=Pongo abelii OX=9601 GN=SLC25A21 PE=2 SV=1 g3945.t1 P47236 69.756 205 2.4300000000000003e-86 258.0 sp|P47236|PAX1_CHICK Paired box protein Pax-1 (Fragment) OS=Gallus gallus OX=9031 GN=PAX1 PE=3 SV=1 g3947.t1 Q28718 43.654 520 2.51e-120 375.0 sp|Q28718|CNGA2_RABIT Cyclic nucleotide-gated channel alpha-2 OS=Oryctolagus cuniculus OX=9986 GN=CNGA2 PE=2 SV=1 CNGA2_RABIT reviewed Cyclic nucleotide-gated channel alpha-2 (CNG channel alpha-2) (CNG-2) (CNG2) (Aorta CNG channel) (RACNG) (Olfactory cyclic nucleotide-gated channel subunit 1) (OCNC1) Oryctolagus cuniculus (Rabbit) GO:0005222; GO:0005223; GO:0005262; GO:0005516; GO:0006813; GO:0006814; GO:0006816; GO:0007608; GO:0017071; GO:0030552; GO:0030553; GO:0044877; GO:0098804 calcium ion transport [GO:0006816]; potassium ion transport [GO:0006813]; sensory perception of smell [GO:0007608]; sodium ion transport [GO:0006814] intracellular cyclic nucleotide activated cation channel complex [GO:0017071]; non-motile cilium membrane [GO:0098804] calcium channel activity [GO:0005262]; calmodulin binding [GO:0005516]; cAMP binding [GO:0030552]; cGMP binding [GO:0030553]; intracellularly cAMP-activated cation channel activity [GO:0005222]; intracellularly cGMP-activated cation channel activity [GO:0005223]; protein-containing complex binding [GO:0044877] g3947.t2 Q28718 40.966 559 2.4599999999999998e-114 360.0 sp|Q28718|CNGA2_RABIT Cyclic nucleotide-gated channel alpha-2 OS=Oryctolagus cuniculus OX=9986 GN=CNGA2 PE=2 SV=1 CNGA2_RABIT reviewed Cyclic nucleotide-gated channel alpha-2 (CNG channel alpha-2) (CNG-2) (CNG2) (Aorta CNG channel) (RACNG) (Olfactory cyclic nucleotide-gated channel subunit 1) (OCNC1) Oryctolagus cuniculus (Rabbit) GO:0005222; GO:0005223; GO:0005262; GO:0005516; GO:0006813; GO:0006814; GO:0006816; GO:0007608; GO:0017071; GO:0030552; GO:0030553; GO:0044877; GO:0098804 calcium ion transport [GO:0006816]; potassium ion transport [GO:0006813]; sensory perception of smell [GO:0007608]; sodium ion transport [GO:0006814] intracellular cyclic nucleotide activated cation channel complex [GO:0017071]; non-motile cilium membrane [GO:0098804] calcium channel activity [GO:0005262]; calmodulin binding [GO:0005516]; cAMP binding [GO:0030552]; cGMP binding [GO:0030553]; intracellularly cAMP-activated cation channel activity [GO:0005222]; intracellularly cGMP-activated cation channel activity [GO:0005223]; protein-containing complex binding [GO:0044877] g3950.t1 P42586 90.11 91 6.47e-54 178.0 sp|P42586|NKX22_MOUSE Homeobox protein Nkx-2.2 OS=Mus musculus OX=10090 GN=Nkx2-2 PE=1 SV=2 NKX22_MOUSE reviewed Homeobox protein Nkx-2.2 (Homeobox protein NK-2 homolog B) Mus musculus (Mouse) GO:0000978; GO:0000981; GO:0000987; GO:0001228; GO:0003323; GO:0003326; GO:0003327; GO:0003329; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0007224; GO:0007399; GO:0009749; GO:0010628; GO:0014003; GO:0021522; GO:0021529; GO:0021530; GO:0021554; GO:0030154; GO:0031018; GO:0032570; GO:0043565; GO:0045597; GO:0045665; GO:0045666; GO:0045944; GO:0048468; GO:0048565; GO:0048665; GO:0048708; GO:0048714; GO:0060580 astrocyte differentiation [GO:0048708]; cell development [GO:0048468]; cell differentiation [GO:0030154]; digestive tract development [GO:0048565]; endocrine pancreas development [GO:0031018]; negative regulation of neuron differentiation [GO:0045665]; nervous system development [GO:0007399]; neuron fate specification [GO:0048665]; oligodendrocyte development [GO:0014003]; optic nerve development [GO:0021554]; pancreatic A cell fate commitment [GO:0003326]; pancreatic PP cell fate commitment [GO:0003329]; positive regulation of cell differentiation [GO:0045597]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of oligodendrocyte differentiation [GO:0048714]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA-templated transcription [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; response to glucose [GO:0009749]; response to progesterone [GO:0032570]; smoothened signaling pathway [GO:0007224]; spinal cord motor neuron differentiation [GO:0021522]; spinal cord oligodendrocyte cell differentiation [GO:0021529]; spinal cord oligodendrocyte cell fate specification [GO:0021530]; type B pancreatic cell development [GO:0003323]; type B pancreatic cell fate commitment [GO:0003327]; ventral spinal cord interneuron fate determination [GO:0060580] nucleus [GO:0005634] cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565] g3953.t1 Q9H0D6 60.371 863 0.0 999.0 sp|Q9H0D6|XRN2_HUMAN 5'-3' exoribonuclease 2 OS=Homo sapiens OX=9606 GN=XRN2 PE=1 SV=1 g3954.t1 P43699 53.497 286 2.0599999999999998e-69 225.0 sp|P43699|NKX21_HUMAN Homeobox protein Nkx-2.1 OS=Homo sapiens OX=9606 GN=NKX2-1 PE=1 SV=1 NKX21_HUMAN reviewed Homeobox protein Nkx-2.1 (Homeobox protein NK-2 homolog A) (Thyroid nuclear factor 1) (Thyroid transcription factor 1) (TTF-1) (Thyroid-specific enhancer-binding protein) (T/EBP) Homo sapiens (Human) GO:0000122; GO:0000785; GO:0000976; GO:0000977; GO:0000978; GO:0000981; GO:0001161; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0005667; GO:0006355; GO:0006357; GO:0006644; GO:0007411; GO:0007420; GO:0007492; GO:0007626; GO:0009725; GO:0010467; GO:0010628; GO:0010719; GO:0019899; GO:0021759; GO:0021766; GO:0021795; GO:0021798; GO:0021854; GO:0021877; GO:0021892; GO:0021983; GO:0030154; GO:0030324; GO:0030336; GO:0030512; GO:0030878; GO:0030900; GO:0031128; GO:0033327; GO:0042753; GO:0045892; GO:0045893; GO:0045944; GO:0048511; GO:0048646; GO:0048709; GO:0060430; GO:0060441; GO:0060486; GO:0060510; GO:0061629; GO:1904936 anatomical structure formation involved in morphogenesis [GO:0048646]; axon guidance [GO:0007411]; brain development [GO:0007420]; cell differentiation [GO:0030154]; cerebral cortex cell migration [GO:0021795]; cerebral cortex GABAergic interneuron differentiation [GO:0021892]; club cell differentiation [GO:0060486]; developmental induction [GO:0031128]; endoderm development [GO:0007492]; epithelial tube branching involved in lung morphogenesis [GO:0060441]; forebrain development [GO:0030900]; forebrain dorsal/ventral pattern formation [GO:0021798]; forebrain neuron fate commitment [GO:0021877]; gene expression [GO:0010467]; globus pallidus development [GO:0021759]; hippocampus development [GO:0021766]; hypothalamus development [GO:0021854]; interneuron migration [GO:1904936]; Leydig cell differentiation [GO:0033327]; locomotory behavior [GO:0007626]; lung development [GO:0030324]; lung saccule development [GO:0060430]; negative regulation of cell migration [GO:0030336]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; oligodendrocyte differentiation [GO:0048709]; phospholipid metabolic process [GO:0006644]; pituitary gland development [GO:0021983]; positive regulation of circadian rhythm [GO:0042753]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA-templated transcription [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; response to hormone [GO:0009725]; rhythmic process [GO:0048511]; thyroid gland development [GO:0030878]; type II pneumocyte differentiation [GO:0060510] chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667] DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; enzyme binding [GO:0019899]; intronic transcription regulatory region sequence-specific DNA binding [GO:0001161]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription cis-regulatory region binding [GO:0000976] g3961.t1 Q8R0G9 39.153 1134 0.0 648.0 sp|Q8R0G9|NU133_MOUSE Nuclear pore complex protein Nup133 OS=Mus musculus OX=10090 GN=Nup133 PE=1 SV=2 NU133_MOUSE reviewed Nuclear pore complex protein Nup133 (133 kDa nucleoporin) (Nucleoporin Nup133) Mus musculus (Mouse) GO:0000776; GO:0000972; GO:0005635; GO:0005643; GO:0006406; GO:0006606; GO:0006913; GO:0006999; GO:0016973; GO:0017056; GO:0021915; GO:0022008; GO:0031080; GO:0031965; GO:0048339; GO:0061053; GO:0072006 mRNA export from nucleus [GO:0006406]; nephron development [GO:0072006]; neural tube development [GO:0021915]; neurogenesis [GO:0022008]; nuclear pore organization [GO:0006999]; nucleocytoplasmic transport [GO:0006913]; paraxial mesoderm development [GO:0048339]; poly(A)+ mRNA export from nucleus [GO:0016973]; protein import into nucleus [GO:0006606]; somite development [GO:0061053]; transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery [GO:0000972] kinetochore [GO:0000776]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nuclear pore outer ring [GO:0031080] structural constituent of nuclear pore [GO:0017056] g3963.t1 P55006 40.702 285 4.04e-62 202.0 sp|P55006|RDH7_RAT Retinol dehydrogenase 7 OS=Rattus norvegicus OX=10116 GN=Rdh7 PE=1 SV=1 g3966.t1 Q93015 46.099 141 1.2e-41 147.0 sp|Q93015|NAA80_HUMAN N-alpha-acetyltransferase 80 OS=Homo sapiens OX=9606 GN=NAA80 PE=1 SV=2 NAA80_HUMAN reviewed N-alpha-acetyltransferase 80 (HsNAAA80) (EC 2.3.1.-) (N-acetyltransferase 6) (Protein fusion-2) (Protein fus-2) Homo sapiens (Human) GO:0004596; GO:0005737; GO:0005829; GO:0006473; GO:0008064; GO:0008080; GO:0017190; GO:0018002; GO:0030047; GO:1905502 actin modification [GO:0030047]; N-terminal peptidyl-aspartic acid acetylation [GO:0017190]; N-terminal peptidyl-glutamic acid acetylation [GO:0018002]; protein acetylation [GO:0006473]; regulation of actin polymerization or depolymerization [GO:0008064] cytoplasm [GO:0005737]; cytosol [GO:0005829] acetyl-CoA binding [GO:1905502]; N-acetyltransferase activity [GO:0008080]; protein-N-terminal amino-acid acetyltransferase activity [GO:0004596] g3967.t1 Q58EM4 47.717 438 5.9099999999999995e-137 403.0 sp|Q58EM4|ARMT1_DANRE Damage-control phosphatase ARMT1 OS=Danio rerio OX=7955 GN=armt1 PE=2 SV=1 ARMT1_DANRE reviewed Damage-control phosphatase 1 (EC 3.1.3.-) (Acidic residue methyltransferase 1) (Protein-glutamate O-methyltransferase) (EC 2.1.1.-) (Sugar phosphate phosphatase ARMT1) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0006974; GO:0008757; GO:0016791; GO:0032259; GO:0046872; GO:0051998; GO:0097023; GO:0103026 DNA damage response [GO:0006974]; methylation [GO:0032259] fructose 6-phosphate aldolase activity [GO:0097023]; fructose-1-phosphatase activity [GO:0103026]; metal ion binding [GO:0046872]; phosphatase activity [GO:0016791]; protein carboxyl O-methyltransferase activity [GO:0051998]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757] g3968.t1 Q4KMJ1 55.556 180 4.6e-74 224.0 sp|Q4KMJ1|CHAC2_DANRE Putative glutathione-specific gamma-glutamylcyclotransferase 2 OS=Danio rerio OX=7955 GN=chac2 PE=2 SV=1 g3970.t1 Q9NWQ9 44.118 102 6.04e-24 92.8 sp|Q9NWQ9|CN119_HUMAN Uncharacterized protein C14orf119 OS=Homo sapiens OX=9606 GN=C14orf119 PE=1 SV=1 CN119_HUMAN reviewed Uncharacterized protein C14orf119 Homo sapiens (Human) GO:0005739; GO:0005829 cytosol [GO:0005829]; mitochondrion [GO:0005739] g3974.t1 Q80VA0 45.756 542 2.42e-155 465.0 sp|Q80VA0|GALT7_MOUSE N-acetylgalactosaminyltransferase 7 OS=Mus musculus OX=10090 GN=Galnt7 PE=1 SV=2 GALT7_MOUSE reviewed N-acetylgalactosaminyltransferase 7 (EC 2.4.1.41) (Polypeptide GalNAc transferase 7) (GalNAc-T7) (pp-GaNTase 7) (Protein-UDP acetylgalactosaminyltransferase 7) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 7) Mus musculus (Mouse) GO:0000139; GO:0004653; GO:0005794; GO:0006493; GO:0030246; GO:0046872 protein O-linked glycosylation [GO:0006493] Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139] carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653] g3975.t1 O61397 45.322 481 1.98e-136 412.0 sp|O61397|GALT7_CAEEL Probable N-acetylgalactosaminyltransferase 7 OS=Caenorhabditis elegans OX=6239 GN=gly-7 PE=2 SV=1 g3976.t1 Q29473 35.211 497 4.28e-85 273.0 sp|Q29473|CP2DF_CANLF Cytochrome P450 2D15 OS=Canis lupus familiaris OX=9615 GN=CYP2D15 PE=1 SV=3 g3976.t2 P12938 34.93 501 1.1600000000000001e-88 283.0 sp|P12938|CP2D3_RAT Cytochrome P450 2D3 OS=Rattus norvegicus OX=10116 GN=Cyp2d3 PE=2 SV=2 g3978.t1 P42674 44.286 420 4.69e-108 334.0 sp|P42674|BP10_PARLI Blastula protease 10 OS=Paracentrotus lividus OX=7656 GN=BP10 PE=2 SV=1 g3980.t1 Q2LC84 57.003 307 8.81e-111 349.0 sp|Q2LC84|NUMB_RAT Protein numb homolog OS=Rattus norvegicus OX=10116 GN=Numb PE=1 SV=2 NUMB_RAT reviewed Protein numb homolog Rattus norvegicus (Rat) GO:0005543; GO:0005634; GO:0005737; GO:0005769; GO:0005886; GO:0005905; GO:0007399; GO:0007405; GO:0007409; GO:0008013; GO:0010008; GO:0014069; GO:0016323; GO:0021670; GO:0021849; GO:0030136; GO:0030154; GO:0030335; GO:0030900; GO:0031410; GO:0034332; GO:0043197; GO:0045177; GO:0045294; GO:0045296; GO:0045664; GO:0050769; GO:0050775; GO:0098978; GO:0099149; GO:0150052; GO:1903077 adherens junction organization [GO:0034332]; axonogenesis [GO:0007409]; cell differentiation [GO:0030154]; forebrain development [GO:0030900]; lateral ventricle development [GO:0021670]; negative regulation of protein localization to plasma membrane [GO:1903077]; nervous system development [GO:0007399]; neuroblast division in subventricular zone [GO:0021849]; neuroblast proliferation [GO:0007405]; positive regulation of cell migration [GO:0030335]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of neurogenesis [GO:0050769]; regulation of neuron differentiation [GO:0045664]; regulation of postsynapse assembly [GO:0150052]; regulation of postsynaptic neurotransmitter receptor internalization [GO:0099149] apical part of cell [GO:0045177]; basolateral plasma membrane [GO:0016323]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; dendritic spine [GO:0043197]; early endosome [GO:0005769]; endosome membrane [GO:0010008]; glutamatergic synapse [GO:0098978]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069] alpha-catenin binding [GO:0045294]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; phospholipid binding [GO:0005543] g3981.t1 Q58CV6 46.114 386 2.2e-109 327.0 sp|Q58CV6|KLDC3_BOVIN Kelch domain-containing protein 3 OS=Bos taurus OX=9913 GN=KLHDC3 PE=2 SV=2 g3982.t1 G9G127 31.735 876 1.23e-81 297.0 sp|G9G127|NINL_DANRE Ninein-like protein OS=Danio rerio OX=7955 GN=Ninl PE=1 SV=1 g3982.t2 G9G127 31.735 876 2.17e-81 296.0 sp|G9G127|NINL_DANRE Ninein-like protein OS=Danio rerio OX=7955 GN=Ninl PE=1 SV=1 g3985.t1 Q86X10 44.843 1338 0.0 1033.0 sp|Q86X10|RLGPB_HUMAN Ral GTPase-activating protein subunit beta OS=Homo sapiens OX=9606 GN=RALGAPB PE=1 SV=1 g3985.t2 Q86X10 45.697 1313 0.0 1036.0 sp|Q86X10|RLGPB_HUMAN Ral GTPase-activating protein subunit beta OS=Homo sapiens OX=9606 GN=RALGAPB PE=1 SV=1 g3985.t3 Q86X10 45.461 1322 0.0 1033.0 sp|Q86X10|RLGPB_HUMAN Ral GTPase-activating protein subunit beta OS=Homo sapiens OX=9606 GN=RALGAPB PE=1 SV=1 g3986.t1 Q8BQZ4 58.407 113 2.35e-36 134.0 sp|Q8BQZ4|RLGPB_MOUSE Ral GTPase-activating protein subunit beta OS=Mus musculus OX=10090 GN=Ralgapb PE=1 SV=2 g3987.t1 Q9P0Z9 40.576 382 1.72e-83 263.0 sp|Q9P0Z9|SOX_HUMAN Peroxisomal sarcosine oxidase OS=Homo sapiens OX=9606 GN=PIPOX PE=1 SV=2 SOX_HUMAN reviewed Peroxisomal sarcosine oxidase (PSO) (EC 1.5.3.1) (EC 1.5.3.7) (L-pipecolate oxidase) (L-pipecolic acid oxidase) Homo sapiens (Human) GO:0005777; GO:0005782; GO:0005829; GO:0006554; GO:0008115; GO:0033514; GO:0050031; GO:0050660 L-lysine catabolic process to acetyl-CoA via L-pipecolate [GO:0033514]; lysine catabolic process [GO:0006554] cytosol [GO:0005829]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777] flavin adenine dinucleotide binding [GO:0050660]; L-pipecolate oxidase activity [GO:0050031]; sarcosine oxidase activity [GO:0008115] g3988.t1 O60706 44.361 399 4.04e-97 320.0 sp|O60706|ABCC9_HUMAN ATP-binding cassette sub-family C member 9 OS=Homo sapiens OX=9606 GN=ABCC9 PE=1 SV=2 ABCC9_HUMAN reviewed ATP-binding cassette sub-family C member 9 (Sulfonylurea receptor 2) Homo sapiens (Human) GO:0000165; GO:0001508; GO:0001666; GO:0003007; GO:0005267; GO:0005524; GO:0005739; GO:0005886; GO:0006357; GO:0007005; GO:0007519; GO:0008281; GO:0008282; GO:0010467; GO:0014823; GO:0015459; GO:0016887; GO:0019395; GO:0019829; GO:0030017; GO:0031004; GO:0033198; GO:0035865; GO:0042311; GO:0042383; GO:0042542; GO:0042626; GO:0043066; GO:0043225; GO:0043627; GO:0044325; GO:0044877; GO:0045333; GO:0045776; GO:0046034; GO:0048144; GO:0051607; GO:0055085; GO:0060976; GO:0061337; GO:0062197; GO:0071277; GO:0071318; GO:0071466; GO:0071805; GO:0072592; GO:0086003; GO:0098655; GO:0098662; GO:0099104; GO:0140359; GO:0150104; GO:1901379; GO:1901652; GO:1903409; GO:1904880; GO:1990573 action potential [GO:0001508]; ATP metabolic process [GO:0046034]; cardiac conduction [GO:0061337]; cardiac muscle cell contraction [GO:0086003]; cellular respiration [GO:0045333]; cellular response to ATP [GO:0071318]; cellular response to calcium ion [GO:0071277]; cellular response to chemical stress [GO:0062197]; cellular response to potassium ion [GO:0035865]; cellular response to xenobiotic stimulus [GO:0071466]; coronary vasculature development [GO:0060976]; defense response to virus [GO:0051607]; fatty acid oxidation [GO:0019395]; fibroblast proliferation [GO:0048144]; gene expression [GO:0010467]; heart morphogenesis [GO:0003007]; inorganic cation transmembrane transport [GO:0098662]; MAPK cascade [GO:0000165]; mitochondrion organization [GO:0007005]; monoatomic cation transmembrane transport [GO:0098655]; negative regulation of apoptotic process [GO:0043066]; negative regulation of blood pressure [GO:0045776]; oxygen metabolic process [GO:0072592]; potassium ion import across plasma membrane [GO:1990573]; potassium ion transmembrane transport [GO:0071805]; reactive oxygen species biosynthetic process [GO:1903409]; regulation of potassium ion transmembrane transport [GO:1901379]; regulation of transcription by RNA polymerase II [GO:0006357]; response to activity [GO:0014823]; response to ATP [GO:0033198]; response to estrogen [GO:0043627]; response to hydrogen peroxide [GO:0042542]; response to hydrogen sulfide [GO:1904880]; response to hypoxia [GO:0001666]; response to peptide [GO:1901652]; skeletal muscle tissue development [GO:0007519]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104]; vasodilation [GO:0042311] inward rectifying potassium channel [GO:0008282]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; potassium ion-transporting ATPase complex [GO:0031004]; sarcolemma [GO:0042383]; sarcomere [GO:0030017] ABC-type transporter activity [GO:0140359]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled inorganic anion transmembrane transporter activity [GO:0043225]; ATPase-coupled monoatomic cation transmembrane transporter activity [GO:0019829]; ATPase-coupled transmembrane transporter activity [GO:0042626]; potassium channel activator activity [GO:0099104]; potassium channel activity [GO:0005267]; potassium channel regulator activity [GO:0015459]; protein-containing complex binding [GO:0044877]; sulfonylurea receptor activity [GO:0008281]; transmembrane transporter binding [GO:0044325] g3990.t1 Q09429 35.304 575 1.0100000000000001e-72 258.0 sp|Q09429|ABCC8_RAT ATP-binding cassette sub-family C member 8 OS=Rattus norvegicus OX=10116 GN=Abcc8 PE=1 SV=4 ABCC8_RAT reviewed ATP-binding cassette sub-family C member 8 (Sulfonylurea receptor 1) Rattus norvegicus (Rat) GO:0001508; GO:0001678; GO:0005267; GO:0005524; GO:0005886; GO:0007565; GO:0007613; GO:0008281; GO:0008282; GO:0008542; GO:0009268; GO:0009410; GO:0010043; GO:0010989; GO:0016525; GO:0016887; GO:0019829; GO:0030672; GO:0031669; GO:0032496; GO:0032760; GO:0032868; GO:0032991; GO:0035774; GO:0042383; GO:0042734; GO:0043268; GO:0043531; GO:0044325; GO:0046676; GO:0046872; GO:0050768; GO:0050905; GO:0055085; GO:0060253; GO:0061535; GO:0061855; GO:0140359; GO:1900721; GO:1905075; GO:1905604; GO:1990573 action potential [GO:0001508]; cellular response to nutrient levels [GO:0031669]; female pregnancy [GO:0007565]; glutamate secretion, neurotransmission [GO:0061535]; intracellular glucose homeostasis [GO:0001678]; memory [GO:0007613]; negative regulation of angiogenesis [GO:0016525]; negative regulation of blood-brain barrier permeability [GO:1905604]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of insulin secretion [GO:0046676]; negative regulation of low-density lipoprotein particle clearance [GO:0010989]; negative regulation of neuroblast migration [GO:0061855]; negative regulation of neurogenesis [GO:0050768]; neuromuscular process [GO:0050905]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of potassium ion transport [GO:0043268]; positive regulation of tight junction disassembly [GO:1905075]; positive regulation of tumor necrosis factor production [GO:0032760]; positive regulation of uterine smooth muscle relaxation [GO:1900721]; potassium ion import across plasma membrane [GO:1990573]; response to insulin [GO:0032868]; response to lipopolysaccharide [GO:0032496]; response to pH [GO:0009268]; response to xenobiotic stimulus [GO:0009410]; response to zinc ion [GO:0010043]; transmembrane transport [GO:0055085]; visual learning [GO:0008542] inward rectifying potassium channel [GO:0008282]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; protein-containing complex [GO:0032991]; sarcolemma [GO:0042383]; synaptic vesicle membrane [GO:0030672] ABC-type transporter activity [GO:0140359]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled monoatomic cation transmembrane transporter activity [GO:0019829]; metal ion binding [GO:0046872]; potassium channel activity [GO:0005267]; sulfonylurea receptor activity [GO:0008281]; transmembrane transporter binding [GO:0044325] g3993.t1 A1A5F2 57.039 2067 0.0 1961.0 sp|A1A5F2|HTR5B_XENTR HEAT repeat-containing protein 5B OS=Xenopus tropicalis OX=8364 GN=heatr5b PE=2 SV=1 g3994.t1 Q0VFM0 48.287 321 2.65e-102 306.0 sp|Q0VFM0|ZFPL1_XENTR Zinc finger protein-like 1 OS=Xenopus tropicalis OX=8364 GN=zfpl1 PE=2 SV=1 g4000.t1 Q3MIT2 43.478 529 1.3e-135 407.0 sp|Q3MIT2|PUS10_HUMAN tRNA pseudouridine synthase Pus10 OS=Homo sapiens OX=9606 GN=PUS10 PE=1 SV=1 PUS10_HUMAN reviewed tRNA pseudouridine synthase Pus10 (Hup10) (EC 5.4.99.25) (Coiled-coil domain-containing protein 139) (tRNA pseudouridine 55 synthase) (Psi55 synthase) (tRNA pseudouridylate synthase) (tRNA-uridine isomerase) Homo sapiens (Human) GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0009982; GO:0031053; GO:0031119; GO:0046872; GO:0070878; GO:0106029; GO:0160148 primary miRNA processing [GO:0031053]; tRNA pseudouridine synthesis [GO:0031119] cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634] metal ion binding [GO:0046872]; primary miRNA binding [GO:0070878]; pseudouridine synthase activity [GO:0009982]; tRNA pseudouridine synthase activity [GO:0106029]; tRNA pseudouridine(55) synthase activity [GO:0160148] g4001.t1 Q5I4F8 30.502 259 5.85e-29 113.0 sp|Q5I4F8|AQP8_NOTAL Aquaporin-8 OS=Notomys alexis OX=184396 GN=AQP8 PE=2 SV=1 AQP8_NOTAL reviewed Aquaporin-8 (AQP-8) Notomys alexis (Spinifex hopping mouse) GO:0005739; GO:0005743; GO:0005790; GO:0005886; GO:0006833; GO:0008519; GO:0015250; GO:0015264; GO:0015265; GO:0015840; GO:0015843; GO:0016323; GO:0016324; GO:0030183; GO:0030868; GO:0031526; GO:0031966; GO:0035377; GO:0045540; GO:0046691; GO:0072488; GO:0072489; GO:0080170; GO:0097708; GO:0140157; GO:1990748 ammonium import across plasma membrane [GO:0140157]; ammonium transmembrane transport [GO:0072488]; B cell differentiation [GO:0030183]; cellular detoxification [GO:1990748]; hydrogen peroxide transmembrane transport [GO:0080170]; methylammonium transmembrane transport [GO:0072489]; methylammonium transport [GO:0015843]; regulation of cholesterol biosynthetic process [GO:0045540]; transepithelial water transport [GO:0035377]; urea transport [GO:0015840]; water transport [GO:0006833] apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; brush border membrane [GO:0031526]; intracellular canaliculus [GO:0046691]; intracellular vesicle [GO:0097708]; mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; smooth endoplasmic reticulum [GO:0005790]; smooth endoplasmic reticulum membrane [GO:0030868] ammonium channel activity [GO:0008519]; methylammonium channel activity [GO:0015264]; urea channel activity [GO:0015265]; water channel activity [GO:0015250] g4005.t1 Q5BKG8 34.139 331 5.15e-25 112.0 sp|Q5BKG8|NUSAP_XENTR Nucleolar and spindle-associated protein 1 OS=Xenopus tropicalis OX=8364 GN=nusap1 PE=2 SV=2 g4010.t1 Q01H84 48.505 301 1.23e-109 280.0 sp|Q01H84|SELN_XENTR Selenoprotein N OS=Xenopus tropicalis OX=8364 GN=selenon PE=2 SV=2 g4010.t1 Q01H84 68.254 63 1.23e-109 92.4 sp|Q01H84|SELN_XENTR Selenoprotein N OS=Xenopus tropicalis OX=8364 GN=selenon PE=2 SV=2 g4010.t1 Q01H84 47.436 78 1.23e-109 68.9 sp|Q01H84|SELN_XENTR Selenoprotein N OS=Xenopus tropicalis OX=8364 GN=selenon PE=2 SV=2 g4012.t1 O00189 36.522 460 2.5e-91 286.0 sp|O00189|AP4M1_HUMAN AP-4 complex subunit mu-1 OS=Homo sapiens OX=9606 GN=AP4M1 PE=1 SV=2 AP4M1_HUMAN reviewed AP-4 complex subunit mu-1 (AP-4 adaptor complex mu subunit) (Adaptor-related protein complex 4 subunit mu-1) (Mu subunit of AP-4) (Mu-adaptin-related protein 2) (mu-ARP2) (Mu4-adaptin) (mu4) Homo sapiens (Human) GO:0000045; GO:0005769; GO:0005802; GO:0005829; GO:0006605; GO:0006622; GO:0006886; GO:0006892; GO:0006895; GO:0008104; GO:0008320; GO:0016192; GO:0019904; GO:0030124; GO:0030131; GO:0031410; GO:0031904; GO:0032588; GO:0070062; GO:0090160; GO:1903361 autophagosome assembly [GO:0000045]; Golgi to endosome transport [GO:0006895]; Golgi to lysosome transport [GO:0090160]; intracellular protein localization [GO:0008104]; intracellular protein transport [GO:0006886]; post-Golgi vesicle-mediated transport [GO:0006892]; protein localization to basolateral plasma membrane [GO:1903361]; protein targeting [GO:0006605]; protein targeting to lysosome [GO:0006622]; vesicle-mediated transport [GO:0016192] AP-4 adaptor complex [GO:0030124]; clathrin adaptor complex [GO:0030131]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; early endosome [GO:0005769]; endosome lumen [GO:0031904]; extracellular exosome [GO:0070062]; trans-Golgi network [GO:0005802]; trans-Golgi network membrane [GO:0032588] protein domain specific binding [GO:0019904]; protein transmembrane transporter activity [GO:0008320] g4014.t1 P11708 60.245 327 6.48e-127 368.0 sp|P11708|MDHC_PIG Malate dehydrogenase, cytoplasmic OS=Sus scrofa OX=9823 GN=MDH1 PE=1 SV=4 g4015.t1 Q07130 68.182 484 0.0 686.0 sp|Q07130|UGPA_BOVIN UTP--glucose-1-phosphate uridylyltransferase OS=Bos taurus OX=9913 GN=UGP2 PE=1 SV=2 g4017.t1 Q4R4Q6 80.992 121 1.12e-70 210.0 sp|Q4R4Q6|YPEL5_MACFA Protein yippee-like 5 OS=Macaca fascicularis OX=9541 GN=YPEL5 PE=2 SV=1 g4019.t1 Q8BW86 26.667 435 2.2799999999999997e-23 110.0 sp|Q8BW86|ARG33_MOUSE Rho guanine nucleotide exchange factor 33 OS=Mus musculus OX=10090 GN=Arhgef33 PE=1 SV=3 g4020.t1 Q80UF4 33.333 606 4.69e-91 304.0 sp|Q80UF4|SDCG8_MOUSE Serologically defined colon cancer antigen 8 homolog OS=Mus musculus OX=10090 GN=Sdccag8 PE=1 SV=1 SDCG8_MOUSE reviewed Serologically defined colon cancer antigen 8 homolog (Centrosomal colon cancer autoantigen protein) (mCCCAP) Mus musculus (Mouse) GO:0001764; GO:0005654; GO:0005737; GO:0005813; GO:0005814; GO:0005829; GO:0005911; GO:0005929; GO:0007098; GO:0030010; GO:0030030; GO:0031023; GO:0034451; GO:0035148; GO:0036064; GO:0097733; GO:1902017 cell projection organization [GO:0030030]; centrosome cycle [GO:0007098]; establishment of cell polarity [GO:0030010]; microtubule organizing center organization [GO:0031023]; neuron migration [GO:0001764]; regulation of cilium assembly [GO:1902017]; tube formation [GO:0035148] cell-cell junction [GO:0005911]; centriolar satellite [GO:0034451]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; photoreceptor cell cilium [GO:0097733] g4021.t1 Q04865 47.284 313 7.949999999999999e-89 290.0 sp|Q04865|TF65_XENLA Putative transcription factor p65 homolog OS=Xenopus laevis OX=8355 GN=rela PE=2 SV=1 g4022.t1 Q9VZI3 47.486 716 0.0 621.0 sp|Q9VZI3|UN112_DROME Unc-112-related protein OS=Drosophila melanogaster OX=7227 GN=Fit1 PE=1 SV=1 g4023.t2 Q9NBX4 33.557 149 8.29e-22 83.6 sp|Q9NBX4|RTXE_DROME Probable RNA-directed DNA polymerase from transposon X-element OS=Drosophila melanogaster OX=7227 GN=X-element\ORF2 PE=3 SV=1 g4023.t2 Q9NBX4 39.13 46 8.29e-22 42.0 sp|Q9NBX4|RTXE_DROME Probable RNA-directed DNA polymerase from transposon X-element OS=Drosophila melanogaster OX=7227 GN=X-element\ORF2 PE=3 SV=1 g4025.t1 Q6PBN2 50.0 306 1.93e-93 282.0 sp|Q6PBN2|AIDA_DANRE Axin interactor, dorsalization-associated protein OS=Danio rerio OX=7955 GN=aida PE=1 SV=1 AIDA_DANRE reviewed Axin interactor, dorsalization-associated protein (Axin interaction partner and dorsalization antagonist) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0009953; GO:0016020; GO:0031333; GO:0035091; GO:0043508; GO:0046329; GO:0048264; GO:2000016 determination of ventral identity [GO:0048264]; dorsal/ventral pattern formation [GO:0009953]; negative regulation of determination of dorsal identity [GO:2000016]; negative regulation of JNK cascade [GO:0046329]; negative regulation of JUN kinase activity [GO:0043508]; negative regulation of protein-containing complex assembly [GO:0031333] membrane [GO:0016020] phosphatidylinositol binding [GO:0035091] g4026.t1 Q9VT65 46.132 698 0.0 604.0 sp|Q9VT65|CANB_DROME Calpain-B OS=Drosophila melanogaster OX=7227 GN=CalpB PE=1 SV=2 CANB_DROME reviewed Calpain-B (EC 3.4.22.-) (Calcium-activated neutral proteinase B) (CANP B) [Cleaved into: Calpain-B catalytic subunit 1; Calpain-B catalytic subunit 2] Drosophila melanogaster (Fruit fly) GO:0004198; GO:0005509; GO:0005737; GO:0006508; GO:0007298; GO:0016020; GO:0016322; GO:0016540 border follicle cell migration [GO:0007298]; neuron remodeling [GO:0016322]; protein autoprocessing [GO:0016540]; proteolysis [GO:0006508] cytoplasm [GO:0005737]; membrane [GO:0016020] calcium ion binding [GO:0005509]; calcium-dependent cysteine-type endopeptidase activity [GO:0004198] g4027.t1 Q8SQC1 35.763 439 5.2e-93 295.0 sp|Q8SQC1|SCRB1_PIG Scavenger receptor class B member 1 OS=Sus scrofa OX=9823 GN=SCARB1 PE=2 SV=1 g4028.t1 Q8SQC1 33.563 435 2.02e-80 263.0 sp|Q8SQC1|SCRB1_PIG Scavenger receptor class B member 1 OS=Sus scrofa OX=9823 GN=SCARB1 PE=2 SV=1 g4030.t1 Q8N9M1 39.13 207 1.2e-34 132.0 sp|Q8N9M1|CS047_HUMAN Uncharacterized protein C19orf47 OS=Homo sapiens OX=9606 GN=C19orf47 PE=1 SV=1 g4031.t1 Q6DHJ3 52.616 344 7.39e-127 374.0 sp|Q6DHJ3|NVD_DANRE Cholesterol 7-desaturase nvd OS=Danio rerio OX=7955 GN=nvd PE=1 SV=1 NVD_DANRE reviewed Cholesterol 7-desaturase nvd (EC 1.14.19.21) (Protein neverland) (Nvd protein) (nvd-Dr) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005737; GO:0008203; GO:0016020; GO:0016491; GO:0046872; GO:0051537; GO:0170056 cholesterol metabolic process [GO:0008203] cytoplasm [GO:0005737]; membrane [GO:0016020] 2 iron, 2 sulfur cluster binding [GO:0051537]; cholesterol 7-desaturase [NAD(P)H] activity [GO:0170056]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491] g4034.t1 Q9NRK6 55.537 614 0.0 609.0 sp|Q9NRK6|ABCBA_HUMAN ATP-binding cassette sub-family B member 10, mitochondrial OS=Homo sapiens OX=9606 GN=ABCB10 PE=1 SV=2 ABCBA_HUMAN reviewed ATP-binding cassette sub-family B member 10, mitochondrial (ABC-mitochondrial erythroid protein) (ABC-me protein) (ATP-binding cassette transporter 10) (ABC transporter 10 protein) (EC 7.6.2.-) (Mitochondrial ATP-binding cassette 2) (M-ABC2) Homo sapiens (Human) GO:0005524; GO:0005739; GO:0005743; GO:0006783; GO:0006839; GO:0016887; GO:0031966; GO:0034514; GO:0042803; GO:0045648; GO:0046872; GO:0046985; GO:0048821; GO:0070455; GO:0140359; GO:0170037 erythrocyte development [GO:0048821]; export from the mitochondrion [GO:0170037]; heme biosynthetic process [GO:0006783]; mitochondrial transport [GO:0006839]; mitochondrial unfolded protein response [GO:0034514]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of heme biosynthetic process [GO:0070455]; positive regulation of hemoglobin biosynthetic process [GO:0046985] mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739] ABC-type transporter activity [GO:0140359]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803] g4036.t1 Q5TYV4 35.499 431 2.36e-78 257.0 sp|Q5TYV4|SPE39_DANRE Spermatogenesis-defective protein 39 homolog OS=Danio rerio OX=7955 GN=vipas39 PE=2 SV=1 g4040.t1 Q58D06 52.116 378 4.92e-140 406.0 sp|Q58D06|WDR74_BOVIN WD repeat-containing protein 74 OS=Bos taurus OX=9913 GN=WDR74 PE=2 SV=1 WDR74_BOVIN reviewed WD repeat-containing protein 74 Bos taurus (Bovine) GO:0001825; GO:0005634; GO:0005730; GO:0006364; GO:0016070; GO:0030687; GO:0042273 blastocyst formation [GO:0001825]; ribosomal large subunit biogenesis [GO:0042273]; RNA metabolic process [GO:0016070]; rRNA processing [GO:0006364] nucleolus [GO:0005730]; nucleus [GO:0005634]; preribosome, large subunit precursor [GO:0030687] g4042.t1 Q6NXA9 40.606 330 3.66e-68 218.0 sp|Q6NXA9|UBXN1_DANRE UBX domain-containing protein 1 OS=Danio rerio OX=7955 GN=ubxn1 PE=2 SV=1 g4043.t1 Q9JI19 53.631 358 4.7999999999999995e-139 402.0 sp|Q9JI19|FIBP_MOUSE Acidic fibroblast growth factor intracellular-binding protein OS=Mus musculus OX=10090 GN=Fibp PE=1 SV=1 g4044.t1 Q86UA1 43.534 549 2.6e-149 459.0 sp|Q86UA1|PRP39_HUMAN Pre-mRNA-processing factor 39 OS=Homo sapiens OX=9606 GN=PRPF39 PE=1 SV=3 g4045.t1 A1A4N1 31.011 445 1.01e-52 189.0 sp|A1A4N1|S29A3_BOVIN Equilibrative nucleoside transporter 3 OS=Bos taurus OX=9913 GN=SLC29A3 PE=2 SV=1 S29A3_BOVIN reviewed Equilibrative nucleoside transporter 3 (Solute carrier family 29 member 3) Bos taurus (Bovine) GO:0005326; GO:0005337; GO:0005765; GO:0005794; GO:0005886; GO:0006837; GO:0008504; GO:0015101; GO:0015205; GO:0015208; GO:0015210; GO:0015212; GO:0015213; GO:0015851; GO:0015858; GO:0015861; GO:0015862; GO:0015872; GO:0015874; GO:0031902; GO:0031966; GO:0032238; GO:0035340; GO:1901642; GO:1903716; GO:1903791; GO:1904082; GO:1904823 adenosine transport [GO:0032238]; cytidine transport [GO:0015861]; dopamine transport [GO:0015872]; guanine transmembrane transport [GO:1903716]; inosine transport [GO:0035340]; norepinephrine transport [GO:0015874]; nucleobase transport [GO:0015851]; nucleoside transmembrane transport [GO:1901642]; nucleoside transport [GO:0015858]; purine nucleobase transmembrane transport [GO:1904823]; pyrimidine nucleobase transmembrane transport [GO:1904082]; serotonin transport [GO:0006837]; uracil transmembrane transport [GO:1903791]; uridine transmembrane transport [GO:0015862] Golgi apparatus [GO:0005794]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; mitochondrial membrane [GO:0031966]; plasma membrane [GO:0005886] cytidine transmembrane transporter activity [GO:0015212]; guanine transmembrane transporter activity [GO:0015208]; monoamine transmembrane transporter activity [GO:0008504]; neurotransmitter transmembrane transporter activity [GO:0005326]; nucleobase transmembrane transporter activity [GO:0015205]; nucleoside transmembrane transporter activity [GO:0005337]; organic cation transmembrane transporter activity [GO:0015101]; uracil transmembrane transporter activity [GO:0015210]; uridine transmembrane transporter activity [GO:0015213] g4049.t1 Q09815 33.247 388 1.98e-47 184.0 sp|Q09815|PPK5_SCHPO Serine/threonine-protein kinase ppk5 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) OX=284812 GN=ppk5 PE=1 SV=1 PPK5_SCHPO reviewed Serine/threonine-protein kinase ppk5 (EC 2.7.11.1) (Meiotically up-regulated gene 189 protein) Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast) GO:0004672; GO:0004674; GO:0005524; GO:0005737; GO:0005739; GO:0005856; GO:0010821; GO:0023052; GO:0032153; GO:0051321; GO:0051445; GO:0106310; GO:0110085; GO:1902412 meiotic cell cycle [GO:0051321]; regulation of meiotic cell cycle [GO:0051445]; regulation of mitochondrion organization [GO:0010821]; regulation of mitotic cytokinesis [GO:1902412]; signaling [GO:0023052] cell division site [GO:0032153]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; mitochondrion [GO:0005739]; mitotic actomyosin contractile ring [GO:0110085] ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g4057.t1 Q95M12 48.478 427 6.56e-142 415.0 sp|Q95M12|LGMN_BOVIN Legumain OS=Bos taurus OX=9913 GN=LGMN PE=1 SV=1 LGMN_BOVIN reviewed Legumain (EC 3.4.22.34) (Asparaginyl endopeptidase) (Protease, cysteine 1) Bos taurus (Bovine) GO:0003014; GO:0004197; GO:0005764; GO:0006508; GO:0006624; GO:0019886; GO:0032801; GO:0043202; GO:0051603; GO:1901185 antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; negative regulation of ERBB signaling pathway [GO:1901185]; proteolysis [GO:0006508]; proteolysis involved in protein catabolic process [GO:0051603]; receptor catabolic process [GO:0032801]; renal system process [GO:0003014]; vacuolar protein processing [GO:0006624] lysosomal lumen [GO:0043202]; lysosome [GO:0005764] cysteine-type endopeptidase activity [GO:0004197] g4058.t1 B0DOB5 57.73 511 0.0 591.0 sp|B0DOB5|DAA1A_XENLA Disheveled-associated activator of morphogenesis 1-A OS=Xenopus laevis OX=8355 GN=daam1-a PE=2 SV=1 g4058.t1 B0DOB5 56.024 498 3.03e-161 509.0 sp|B0DOB5|DAA1A_XENLA Disheveled-associated activator of morphogenesis 1-A OS=Xenopus laevis OX=8355 GN=daam1-a PE=2 SV=1 g4058.t2 B0DOB5 59.476 496 0.0 601.0 sp|B0DOB5|DAA1A_XENLA Disheveled-associated activator of morphogenesis 1-A OS=Xenopus laevis OX=8355 GN=daam1-a PE=2 SV=1 g4058.t2 B0DOB5 56.024 498 3.76e-161 508.0 sp|B0DOB5|DAA1A_XENLA Disheveled-associated activator of morphogenesis 1-A OS=Xenopus laevis OX=8355 GN=daam1-a PE=2 SV=1 g4060.t1 Q68EK7 86.449 214 9.51e-137 384.0 sp|Q68EK7|RAB4B_DANRE Ras-related protein Rab-4B OS=Danio rerio OX=7955 GN=rab4b PE=2 SV=1 RAB4B_DANRE reviewed Ras-related protein Rab-4B (EC 3.6.5.2) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0003924; GO:0003925; GO:0005525; GO:0005886; GO:0015031; GO:0016192; GO:0030100; GO:0031901; GO:0032482; GO:0032593; GO:0046872; GO:0055037 protein transport [GO:0015031]; Rab protein signal transduction [GO:0032482]; regulation of endocytosis [GO:0030100]; vesicle-mediated transport [GO:0016192] early endosome membrane [GO:0031901]; insulin-responsive compartment [GO:0032593]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037] G protein activity [GO:0003925]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872] g4061.t1 P51821 57.558 172 6.380000000000001e-66 203.0 sp|P51821|ARF1_CHLRE ADP-ribosylation factor 1 OS=Chlamydomonas reinhardtii OX=3055 GN=ARF1 PE=2 SV=2 g4062.t1 P91924 58.382 173 1.7e-66 204.0 sp|P91924|ARF_DUGJA ADP-ribosylation factor OS=Dugesia japonica OX=6161 PE=2 SV=3 g4064.t1 P22274 54.706 170 4.72e-53 171.0 sp|P22274|ARF_CANAL ADP-ribosylation factor OS=Candida albicans (strain SC5314 / ATCC MYA-2876) OX=237561 GN=ARF1 PE=1 SV=5 g4065.t1 P52162 72.566 113 6.46e-53 169.0 sp|P52162|MAX_CHICK Protein max OS=Gallus gallus OX=9031 GN=MAX PE=3 SV=1 g4066.t1 P49355 58.629 394 9.35e-155 447.0 sp|P49355|FNTB_BOVIN Protein farnesyltransferase subunit beta OS=Bos taurus OX=9913 GN=FNTB PE=2 SV=1 g4069.t1 Q6P632 75.843 178 5.02e-102 293.0 sp|Q6P632|NAA20_XENTR N-alpha-acetyltransferase 20 OS=Xenopus tropicalis OX=8364 GN=naa20 PE=2 SV=1 NAA20_XENTR reviewed N-alpha-acetyltransferase 20 (EC 2.3.1.254) (Methionine N-acetyltransferase) (N-acetyltransferase 5) (N-terminal acetyltransferase B complex catalytic subunit NAA20) (N-terminal acetyltransferase B complex catalytic subunit NAT5) (NatB complex subunit NAT5) (NatB catalytic subunit) Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0004596; GO:0005634; GO:0005737; GO:0006474; GO:0017190; GO:0017192; GO:0018002; GO:0031416; GO:0032956; GO:0120518 N-terminal peptidyl-aspartic acid acetylation [GO:0017190]; N-terminal peptidyl-glutamic acid acetylation [GO:0018002]; N-terminal peptidyl-glutamine acetylation [GO:0017192]; N-terminal protein amino acid acetylation [GO:0006474]; regulation of actin cytoskeleton organization [GO:0032956] cytoplasm [GO:0005737]; NatB complex [GO:0031416]; nucleus [GO:0005634] protein N-terminal-methionine acetyltransferase activity [GO:0120518]; protein-N-terminal amino-acid acetyltransferase activity [GO:0004596] g4070.t1 Q497V6 47.668 193 3.3399999999999997e-45 178.0 sp|Q497V6|BAHD1_MOUSE Bromo adjacent homology domain-containing 1 protein OS=Mus musculus OX=10090 GN=Bahd1 PE=1 SV=1 BAHD1_MOUSE reviewed Bromo adjacent homology domain-containing 1 protein (BAH domain-containing protein 1) Mus musculus (Mouse) GO:0000976; GO:0003682; GO:0005654; GO:0005677; GO:0005694; GO:0031507; GO:0045892 heterochromatin formation [GO:0031507]; negative regulation of DNA-templated transcription [GO:0045892] chromatin silencing complex [GO:0005677]; chromosome [GO:0005694]; nucleoplasm [GO:0005654] chromatin binding [GO:0003682]; transcription cis-regulatory region binding [GO:0000976] g4071.t1 Q5ZJQ3 69.369 111 7.9e-47 149.0 sp|Q5ZJQ3|LIN52_CHICK Protein lin-52 homolog OS=Gallus gallus OX=9031 GN=LIN52 PE=1 SV=1 g4072.t1 A1A4N1 34.856 416 9.16e-71 237.0 sp|A1A4N1|S29A3_BOVIN Equilibrative nucleoside transporter 3 OS=Bos taurus OX=9913 GN=SLC29A3 PE=2 SV=1 S29A3_BOVIN reviewed Equilibrative nucleoside transporter 3 (Solute carrier family 29 member 3) Bos taurus (Bovine) GO:0005326; GO:0005337; GO:0005765; GO:0005794; GO:0005886; GO:0006837; GO:0008504; GO:0015101; GO:0015205; GO:0015208; GO:0015210; GO:0015212; GO:0015213; GO:0015851; GO:0015858; GO:0015861; GO:0015862; GO:0015872; GO:0015874; GO:0031902; GO:0031966; GO:0032238; GO:0035340; GO:1901642; GO:1903716; GO:1903791; GO:1904082; GO:1904823 adenosine transport [GO:0032238]; cytidine transport [GO:0015861]; dopamine transport [GO:0015872]; guanine transmembrane transport [GO:1903716]; inosine transport [GO:0035340]; norepinephrine transport [GO:0015874]; nucleobase transport [GO:0015851]; nucleoside transmembrane transport [GO:1901642]; nucleoside transport [GO:0015858]; purine nucleobase transmembrane transport [GO:1904823]; pyrimidine nucleobase transmembrane transport [GO:1904082]; serotonin transport [GO:0006837]; uracil transmembrane transport [GO:1903791]; uridine transmembrane transport [GO:0015862] Golgi apparatus [GO:0005794]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; mitochondrial membrane [GO:0031966]; plasma membrane [GO:0005886] cytidine transmembrane transporter activity [GO:0015212]; guanine transmembrane transporter activity [GO:0015208]; monoamine transmembrane transporter activity [GO:0008504]; neurotransmitter transmembrane transporter activity [GO:0005326]; nucleobase transmembrane transporter activity [GO:0015205]; nucleoside transmembrane transporter activity [GO:0005337]; organic cation transmembrane transporter activity [GO:0015101]; uracil transmembrane transporter activity [GO:0015210]; uridine transmembrane transporter activity [GO:0015213] g4072.t2 A1A4N1 33.839 461 7.14e-76 248.0 sp|A1A4N1|S29A3_BOVIN Equilibrative nucleoside transporter 3 OS=Bos taurus OX=9913 GN=SLC29A3 PE=2 SV=1 S29A3_BOVIN reviewed Equilibrative nucleoside transporter 3 (Solute carrier family 29 member 3) Bos taurus (Bovine) GO:0005326; GO:0005337; GO:0005765; GO:0005794; GO:0005886; GO:0006837; GO:0008504; GO:0015101; GO:0015205; GO:0015208; GO:0015210; GO:0015212; GO:0015213; GO:0015851; GO:0015858; GO:0015861; GO:0015862; GO:0015872; GO:0015874; GO:0031902; GO:0031966; GO:0032238; GO:0035340; GO:1901642; GO:1903716; GO:1903791; GO:1904082; GO:1904823 adenosine transport [GO:0032238]; cytidine transport [GO:0015861]; dopamine transport [GO:0015872]; guanine transmembrane transport [GO:1903716]; inosine transport [GO:0035340]; norepinephrine transport [GO:0015874]; nucleobase transport [GO:0015851]; nucleoside transmembrane transport [GO:1901642]; nucleoside transport [GO:0015858]; purine nucleobase transmembrane transport [GO:1904823]; pyrimidine nucleobase transmembrane transport [GO:1904082]; serotonin transport [GO:0006837]; uracil transmembrane transport [GO:1903791]; uridine transmembrane transport [GO:0015862] Golgi apparatus [GO:0005794]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; mitochondrial membrane [GO:0031966]; plasma membrane [GO:0005886] cytidine transmembrane transporter activity [GO:0015212]; guanine transmembrane transporter activity [GO:0015208]; monoamine transmembrane transporter activity [GO:0008504]; neurotransmitter transmembrane transporter activity [GO:0005326]; nucleobase transmembrane transporter activity [GO:0015205]; nucleoside transmembrane transporter activity [GO:0005337]; organic cation transmembrane transporter activity [GO:0015101]; uracil transmembrane transporter activity [GO:0015210]; uridine transmembrane transporter activity [GO:0015213] g4074.t1 Q8IV35 31.86 543 4.91e-72 261.0 sp|Q8IV35|CF337_HUMAN Cilia- and flagella-associated protein 337 OS=Homo sapiens OX=9606 GN=CFAP337 PE=1 SV=2 g4077.t1 Q9UKY4 48.857 350 5.46e-101 318.0 sp|Q9UKY4|POMT2_HUMAN Protein O-mannosyl-transferase 2 OS=Homo sapiens OX=9606 GN=POMT2 PE=1 SV=2 g4078.t1 F1Q8R9 56.557 244 3.8200000000000003e-85 271.0 sp|F1Q8R9|POMT2_DANRE Protein O-mannosyl-transferase 2 OS=Danio rerio OX=7955 GN=pomt2 PE=1 SV=1 POMT2_DANRE reviewed Protein O-mannosyl-transferase 2 (EC 2.4.1.109) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0004169; GO:0005783; GO:0005789; GO:0035269; GO:0045494 photoreceptor cell maintenance [GO:0045494]; protein O-linked glycosylation via mannose [GO:0035269] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789] dolichyl-phosphate-mannose-protein mannosyltransferase activity [GO:0004169] g4080.t1 Q96DM1 23.78 492 1.3e-30 130.0 sp|Q96DM1|PGBD4_HUMAN PiggyBac transposable element-derived protein 4 OS=Homo sapiens OX=9606 GN=PGBD4 PE=1 SV=3 g4088.t1 A2VE39 54.8 750 0.0 825.0 sp|A2VE39|CMTR1_BOVIN Cap-specific mRNA (nucleoside-2'-O-)-methyltransferase 1 OS=Bos taurus OX=9913 GN=CMTR1 PE=2 SV=1 CMTR1_BOVIN reviewed Cap-specific mRNA (nucleoside-2'-O-)-methyltransferase 1 (EC 2.1.1.57) (Cap methyltransferase 1) (Cap1 2'O-ribose methyltransferase 1) (MTr1) (FtsJ methyltransferase domain-containing protein 2) Bos taurus (Bovine) GO:0003676; GO:0004483; GO:0005634; GO:0005737; GO:0006370; GO:0006397; GO:0032259 7-methylguanosine mRNA capping [GO:0006370]; methylation [GO:0032259]; mRNA processing [GO:0006397] cytoplasm [GO:0005737]; nucleus [GO:0005634] methyltransferase cap1 activity [GO:0004483]; nucleic acid binding [GO:0003676] g4090.t1 Q8CFK2 44.589 231 3.58e-23 105.0 sp|Q8CFK2|TF3B_MOUSE Transcription factor IIIB 90 kDa subunit OS=Mus musculus OX=10090 GN=Brf1 PE=1 SV=1 g4091.t1 M3XQV7 71.529 425 0.0 638.0 sp|M3XQV7|BTBD3_MUSPF BTB/POZ domain-containing protein 3 OS=Mustela putorius furo OX=9669 GN=BTBD3 PE=2 SV=2 g4092.t1 Q8CFK2 72.316 177 2.1399999999999998e-84 266.0 sp|Q8CFK2|TF3B_MOUSE Transcription factor IIIB 90 kDa subunit OS=Mus musculus OX=10090 GN=Brf1 PE=1 SV=1 g4103.t1 Q64319 31.692 650 6.579999999999999e-104 334.0 sp|Q64319|SLC31_RAT Amino acid transporter heavy chain SLC3A1 OS=Rattus norvegicus OX=10116 GN=Slc3a1 PE=1 SV=1 SLC31_RAT reviewed Amino acid transporter heavy chain SLC3A1 (D2) (Neutral and basic amino acid transport protein) (NBAT) (Solute carrier family 3 member 1) (b(0,+)-type amino acid transporter-related heavy chain) (NAA-TR) (rBAT) Rattus norvegicus (Rat) GO:0005774; GO:0005975; GO:0006865; GO:0010467; GO:0015810; GO:0015811; GO:0015813; GO:0016324; GO:0031526; GO:0044877; GO:0046872; GO:0046982 amino acid transport [GO:0006865]; aspartate transmembrane transport [GO:0015810]; carbohydrate metabolic process [GO:0005975]; gene expression [GO:0010467]; L-cystine transport [GO:0015811]; L-glutamate transmembrane transport [GO:0015813] apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; vacuolar membrane [GO:0005774] metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]; protein-containing complex binding [GO:0044877] g4103.t2 Q64319 31.49 651 1.83e-102 330.0 sp|Q64319|SLC31_RAT Amino acid transporter heavy chain SLC3A1 OS=Rattus norvegicus OX=10116 GN=Slc3a1 PE=1 SV=1 SLC31_RAT reviewed Amino acid transporter heavy chain SLC3A1 (D2) (Neutral and basic amino acid transport protein) (NBAT) (Solute carrier family 3 member 1) (b(0,+)-type amino acid transporter-related heavy chain) (NAA-TR) (rBAT) Rattus norvegicus (Rat) GO:0005774; GO:0005975; GO:0006865; GO:0010467; GO:0015810; GO:0015811; GO:0015813; GO:0016324; GO:0031526; GO:0044877; GO:0046872; GO:0046982 amino acid transport [GO:0006865]; aspartate transmembrane transport [GO:0015810]; carbohydrate metabolic process [GO:0005975]; gene expression [GO:0010467]; L-cystine transport [GO:0015811]; L-glutamate transmembrane transport [GO:0015813] apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; vacuolar membrane [GO:0005774] metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]; protein-containing complex binding [GO:0044877] g4104.t1 Q64319 31.073 634 1.93e-90 298.0 sp|Q64319|SLC31_RAT Amino acid transporter heavy chain SLC3A1 OS=Rattus norvegicus OX=10116 GN=Slc3a1 PE=1 SV=1 SLC31_RAT reviewed Amino acid transporter heavy chain SLC3A1 (D2) (Neutral and basic amino acid transport protein) (NBAT) (Solute carrier family 3 member 1) (b(0,+)-type amino acid transporter-related heavy chain) (NAA-TR) (rBAT) Rattus norvegicus (Rat) GO:0005774; GO:0005975; GO:0006865; GO:0010467; GO:0015810; GO:0015811; GO:0015813; GO:0016324; GO:0031526; GO:0044877; GO:0046872; GO:0046982 amino acid transport [GO:0006865]; aspartate transmembrane transport [GO:0015810]; carbohydrate metabolic process [GO:0005975]; gene expression [GO:0010467]; L-cystine transport [GO:0015811]; L-glutamate transmembrane transport [GO:0015813] apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; vacuolar membrane [GO:0005774] metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]; protein-containing complex binding [GO:0044877] g4105.t1 Q5VWZ2 53.879 232 2.09e-86 259.0 sp|Q5VWZ2|LYPL1_HUMAN Lysophospholipase-like protein 1 OS=Homo sapiens OX=9606 GN=LYPLAL1 PE=1 SV=3 LYPL1_HUMAN reviewed Lysophospholipase-like protein 1 (EC 3.1.2.22) Homo sapiens (Human) GO:0004622; GO:0005737; GO:0005739; GO:0005829; GO:0008474; GO:0016788; GO:0042997; GO:0160049 negative regulation of cGAS/STING signaling pathway [GO:0160049]; negative regulation of Golgi to plasma membrane protein transport [GO:0042997] cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739] hydrolase activity, acting on ester bonds [GO:0016788]; palmitoyl-(protein) hydrolase activity [GO:0008474]; phosphatidylcholine lysophospholipase activity [GO:0004622] g4106.t1 P15203 35.577 416 6.8699999999999995e-74 239.0 sp|P15203|TGFB3_PIG Transforming growth factor beta-3 proprotein OS=Sus scrofa OX=9823 GN=TGFB3 PE=2 SV=1 g4107.t1 Q6EMB2 44.792 192 1.07e-26 120.0 sp|Q6EMB2|TTLL5_HUMAN Tubulin polyglutamylase TTLL5 OS=Homo sapiens OX=9606 GN=TTLL5 PE=1 SV=3 TTLL5_HUMAN reviewed Tubulin polyglutamylase TTLL5 (EC 6.3.2.-) (SRC1 and TIF2-associated modulatory protein) (STAMP protein) (Tubulin--tyrosine ligase-like protein 5) Homo sapiens (Human) GO:0005524; GO:0005634; GO:0005813; GO:0005829; GO:0005874; GO:0005886; GO:0007288; GO:0015631; GO:0036064; GO:0046872; GO:0060041; GO:0070740; GO:0106437; GO:0106438 retina development in camera-type eye [GO:0060041]; sperm axoneme assembly [GO:0007288] centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytosol [GO:0005829]; microtubule [GO:0005874]; nucleus [GO:0005634]; plasma membrane [GO:0005886] ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein-glutamic acid ligase activity, elongating [GO:0106438]; protein-glutamic acid ligase activity, initiating [GO:0106437]; tubulin binding [GO:0015631]; tubulin-glutamic acid ligase activity [GO:0070740] g4108.t1 Q8CHB8 52.988 502 0.0 577.0 sp|Q8CHB8|TTLL5_MOUSE Tubulin polyglutamylase TTLL5 OS=Mus musculus OX=10090 GN=Ttll5 PE=1 SV=3 TTLL5_MOUSE reviewed Tubulin polyglutamylase TTLL5 (EC 6.3.2.-) (Tubulin--tyrosine ligase-like protein 5) Mus musculus (Mouse) GO:0005524; GO:0005634; GO:0005813; GO:0005829; GO:0005874; GO:0005886; GO:0005929; GO:0007283; GO:0007288; GO:0009566; GO:0015631; GO:0030317; GO:0036064; GO:0046872; GO:0060041; GO:0070740; GO:0097731; GO:0106437; GO:0106438 fertilization [GO:0009566]; flagellated sperm motility [GO:0030317]; retina development in camera-type eye [GO:0060041]; sperm axoneme assembly [GO:0007288]; spermatogenesis [GO:0007283] 9+0 non-motile cilium [GO:0097731]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytosol [GO:0005829]; microtubule [GO:0005874]; nucleus [GO:0005634]; plasma membrane [GO:0005886] ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein-glutamic acid ligase activity, elongating [GO:0106438]; protein-glutamic acid ligase activity, initiating [GO:0106437]; tubulin binding [GO:0015631]; tubulin-glutamic acid ligase activity [GO:0070740] g4109.t1 Q9VXE5 76.351 296 6.190000000000001e-156 463.0 sp|Q9VXE5|PAKM_DROME Serine/threonine-protein kinase PAK mbt OS=Drosophila melanogaster OX=7227 GN=mbt PE=1 SV=2 PAKM_DROME reviewed Serine/threonine-protein kinase PAK mbt (EC 2.7.11.1) (Protein mushroom bodies tiny) (p21-activated kinase-related protein) Drosophila melanogaster (Fruit fly) GO:0001751; GO:0004672; GO:0004674; GO:0005524; GO:0005737; GO:0005886; GO:0005912; GO:0006468; GO:0007010; GO:0007030; GO:0009267; GO:0016319; GO:0031267; GO:0035556; GO:0043408; GO:0045315; GO:0045792; GO:0048639; GO:0048749; GO:0106310; GO:2000047 cellular response to starvation [GO:0009267]; compound eye development [GO:0048749]; compound eye photoreceptor cell differentiation [GO:0001751]; cytoskeleton organization [GO:0007010]; Golgi organization [GO:0007030]; intracellular signal transduction [GO:0035556]; mushroom body development [GO:0016319]; negative regulation of cell size [GO:0045792]; positive regulation of compound eye photoreceptor development [GO:0045315]; positive regulation of developmental growth [GO:0048639]; protein phosphorylation [GO:0006468]; regulation of cell-cell adhesion mediated by cadherin [GO:2000047]; regulation of MAPK cascade [GO:0043408] adherens junction [GO:0005912]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886] ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; small GTPase binding [GO:0031267] g4111.t1 A8PU71 52.5 80 1.1100000000000001e-21 84.7 sp|A8PU71|SDHF1_BOVIN Succinate dehydrogenase assembly factor 1, mitochondrial OS=Bos taurus OX=9913 GN=SDHAF1 PE=3 SV=1 g4112.t1 Q5F4A1 43.871 310 2.41e-77 276.0 sp|Q5F4A1|G2E3_CHICK G2/M phase-specific E3 ubiquitin-protein ligase OS=Gallus gallus OX=9031 GN=G2E3 PE=2 SV=1 g4113.t1 Q08DB5 65.862 290 3.12e-127 372.0 sp|Q08DB5|STX5_BOVIN Syntaxin-5 OS=Bos taurus OX=9913 GN=STX5 PE=2 SV=1 STX5_BOVIN reviewed Syntaxin-5 Bos taurus (Bovine) GO:0000139; GO:0000149; GO:0005484; GO:0005829; GO:0006886; GO:0006888; GO:0006906; GO:0012505; GO:0031201; GO:0031982; GO:0033116; GO:0034498; GO:0045732; GO:0048278; GO:0090166; GO:1903358 early endosome to Golgi transport [GO:0034498]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi disassembly [GO:0090166]; intracellular protein transport [GO:0006886]; positive regulation of protein catabolic process [GO:0045732]; regulation of Golgi organization [GO:1903358]; vesicle docking [GO:0048278]; vesicle fusion [GO:0006906] cytosol [GO:0005829]; endomembrane system [GO:0012505]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi membrane [GO:0000139]; SNARE complex [GO:0031201]; vesicle [GO:0031982] SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149] g4116.t1 O73755 44.755 143 4.0500000000000004e-37 130.0 sp|O73755|GREM1_CHICK Gremlin-1 OS=Gallus gallus OX=9031 GN=GREM1 PE=2 SV=1 g4119.t1 Q9JL04 51.574 413 6.63e-121 422.0 sp|Q9JL04|FMN2_MOUSE Formin-2 OS=Mus musculus OX=10090 GN=Fmn2 PE=1 SV=2 FMN2_MOUSE reviewed Formin-2 Mus musculus (Mouse) GO:0003779; GO:0005634; GO:0005730; GO:0005783; GO:0005789; GO:0005819; GO:0005829; GO:0005884; GO:0005886; GO:0005902; GO:0005938; GO:0006974; GO:0008017; GO:0015031; GO:0015629; GO:0016192; GO:0016344; GO:0016477; GO:0030036; GO:0030659; GO:0040038; GO:0042177; GO:0043066; GO:0045010; GO:0046907; GO:0048471; GO:0048477; GO:0051017; GO:0051295; GO:0051758; GO:0070649; GO:0071456; GO:2000781 actin cytoskeleton organization [GO:0030036]; actin filament bundle assembly [GO:0051017]; actin nucleation [GO:0045010]; cell migration [GO:0016477]; cellular response to hypoxia [GO:0071456]; DNA damage response [GO:0006974]; establishment of meiotic spindle localization [GO:0051295]; formin-nucleated actin cable assembly [GO:0070649]; homologous chromosome movement towards spindle pole in meiosis I anaphase [GO:0051758]; intracellular transport [GO:0046907]; meiotic chromosome movement towards spindle pole [GO:0016344]; negative regulation of apoptotic process [GO:0043066]; negative regulation of protein catabolic process [GO:0042177]; oogenesis [GO:0048477]; polar body extrusion after meiotic divisions [GO:0040038]; positive regulation of double-strand break repair [GO:2000781]; protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192] actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; cell cortex [GO:0005938]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; microvillus [GO:0005902]; nucleolus [GO:0005730]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; spindle [GO:0005819] actin binding [GO:0003779]; microtubule binding [GO:0008017] g4120.t1 Q75WF2 55.152 330 2.97e-127 372.0 sp|Q75WF2|DNA2_ACAPL Plancitoxin-1 OS=Acanthaster planci OX=133434 PE=1 SV=1 g4121.t1 Q91YJ5 60.766 209 2.81e-74 246.0 sp|Q91YJ5|IF2M_MOUSE Translation initiation factor IF-2, mitochondrial OS=Mus musculus OX=10090 GN=Mtif2 PE=1 SV=2 g4122.t1 Q91YJ5 40.122 329 4.78e-79 257.0 sp|Q91YJ5|IF2M_MOUSE Translation initiation factor IF-2, mitochondrial OS=Mus musculus OX=10090 GN=Mtif2 PE=1 SV=2 g4123.t1 P79781 96.032 126 5.75e-58 179.0 sp|P79781|RS27A_CHICK Ubiquitin-ribosomal protein eS31 fusion protein OS=Gallus gallus OX=9031 GN=RPS27A PE=1 SV=3 RS27A_CHICK reviewed Ubiquitin-ribosomal protein eS31 fusion protein (Ubiquitin carboxyl extension protein 80) [Cleaved into: Ubiquitin; Small ribosomal subunit protein eS31 (40S ribosomal protein S27a)] Gallus gallus (Chicken) GO:0003735; GO:0005634; GO:0005654; GO:0005737; GO:0005840; GO:0006412; GO:0008270; GO:0016567; GO:0019941; GO:0031386; GO:0031625; GO:0032040; GO:0042274 modification-dependent protein catabolic process [GO:0019941]; protein ubiquitination [GO:0016567]; ribosomal small subunit biogenesis [GO:0042274]; translation [GO:0006412] cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribosome [GO:0005840]; small-subunit processome [GO:0032040] protein tag activity [GO:0031386]; structural constituent of ribosome [GO:0003735]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270] g4124.t1 Q86TV6 43.311 882 0.0 598.0 sp|Q86TV6|TTC7B_HUMAN Tetratricopeptide repeat protein 7B OS=Homo sapiens OX=9606 GN=TTC7B PE=1 SV=3 TTC7B_HUMAN reviewed Tetratricopeptide repeat protein 7B (TPR repeat protein 7B) (Tetratricopeptide repeat protein 7-like-1) (TPR repeat protein 7-like-1) Homo sapiens (Human) GO:0005829; GO:0005886; GO:0046854; GO:0072659 phosphatidylinositol phosphate biosynthetic process [GO:0046854]; protein localization to plasma membrane [GO:0072659] cytosol [GO:0005829]; plasma membrane [GO:0005886] g4124.t2 Q86TV6 44.264 863 0.0 611.0 sp|Q86TV6|TTC7B_HUMAN Tetratricopeptide repeat protein 7B OS=Homo sapiens OX=9606 GN=TTC7B PE=1 SV=3 TTC7B_HUMAN reviewed Tetratricopeptide repeat protein 7B (TPR repeat protein 7B) (Tetratricopeptide repeat protein 7-like-1) (TPR repeat protein 7-like-1) Homo sapiens (Human) GO:0005829; GO:0005886; GO:0046854; GO:0072659 phosphatidylinositol phosphate biosynthetic process [GO:0046854]; protein localization to plasma membrane [GO:0072659] cytosol [GO:0005829]; plasma membrane [GO:0005886] g4124.t3 Q86TV6 44.496 854 0.0 619.0 sp|Q86TV6|TTC7B_HUMAN Tetratricopeptide repeat protein 7B OS=Homo sapiens OX=9606 GN=TTC7B PE=1 SV=3 TTC7B_HUMAN reviewed Tetratricopeptide repeat protein 7B (TPR repeat protein 7B) (Tetratricopeptide repeat protein 7-like-1) (TPR repeat protein 7-like-1) Homo sapiens (Human) GO:0005829; GO:0005886; GO:0046854; GO:0072659 phosphatidylinositol phosphate biosynthetic process [GO:0046854]; protein localization to plasma membrane [GO:0072659] cytosol [GO:0005829]; plasma membrane [GO:0005886] g4129.t1 Q9VFJ2 51.773 141 9.66e-46 152.0 sp|Q9VFJ2|RM11_DROME Large ribosomal subunit protein uL11m OS=Drosophila melanogaster OX=7227 GN=mRpL11 PE=2 SV=1 g4131.t1 Q13435 71.281 484 0.0 624.0 sp|Q13435|SF3B2_HUMAN Splicing factor 3B subunit 2 OS=Homo sapiens OX=9606 GN=SF3B2 PE=1 SV=2 SF3B2_HUMAN reviewed Splicing factor 3B subunit 2 (Pre-mRNA-splicing factor SF3b 145 kDa subunit) (SF3b145) (Spliceosome-associated protein 145) (SAP 145) Homo sapiens (Human) GO:0000398; GO:0003723; GO:0005634; GO:0005654; GO:0005681; GO:0005684; GO:0005686; GO:0005689; GO:0006397; GO:0008380; GO:0016607; GO:0071005; GO:0071011; GO:0071013; GO:1903241 mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; RNA splicing [GO:0008380]; U2-type prespliceosome assembly [GO:1903241] catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; spliceosomal complex [GO:0005681]; U12-type spliceosomal complex [GO:0005689]; U2 snRNP [GO:0005686]; U2-type precatalytic spliceosome [GO:0071005]; U2-type spliceosomal complex [GO:0005684] RNA binding [GO:0003723] g4134.t1 Q3V1V3 44.333 600 3.9500000000000003e-103 340.0 sp|Q3V1V3|ESF1_MOUSE ESF1 homolog OS=Mus musculus OX=10090 GN=Esf1 PE=1 SV=1 g4134.t2 Q3V1V3 43.167 600 1.42e-102 338.0 sp|Q3V1V3|ESF1_MOUSE ESF1 homolog OS=Mus musculus OX=10090 GN=Esf1 PE=1 SV=1 g4135.t1 Q61079 35.279 394 7.320000000000001e-58 216.0 sp|Q61079|SIM2_MOUSE Single-minded homolog 2 OS=Mus musculus OX=10090 GN=Sim2 PE=1 SV=1 g4139.t1 Q5R7H0 52.386 901 0.0 1006.0 sp|Q5R7H0|DHTK1_PONAB 2-oxoadipate dehydrogenase complex component E1 OS=Pongo abelii OX=9601 GN=DHTKD1 PE=2 SV=1 g4143.t1 A8C754 30.435 253 2.8e-30 125.0 sp|A8C754|THADA_CHICK tRNA (32-2'-O)-methyltransferase regulator THADA OS=Gallus gallus OX=9031 GN=THADA PE=2 SV=1 g4145.t1 Q9XTL9 67.696 842 0.0 1157.0 sp|Q9XTL9|PYG_DROME Glycogen phosphorylase OS=Drosophila melanogaster OX=7227 GN=Glyp PE=2 SV=2 PYG_DROME reviewed Glycogen phosphorylase (EC 2.4.1.1) Drosophila melanogaster (Fruit fly) GO:0005737; GO:0005829; GO:0005980; GO:0008184; GO:0008286; GO:0008340; GO:0030170; GO:0042803; GO:0045824; GO:0050829 defense response to Gram-negative bacterium [GO:0050829]; determination of adult lifespan [GO:0008340]; glycogen catabolic process [GO:0005980]; insulin receptor signaling pathway [GO:0008286]; negative regulation of innate immune response [GO:0045824] cytoplasm [GO:0005737]; cytosol [GO:0005829] glycogen phosphorylase activity [GO:0008184]; protein homodimerization activity [GO:0042803]; pyridoxal phosphate binding [GO:0030170] g4146.t1 Q9P203 48.686 647 0.0 610.0 sp|Q9P203|BTBD7_HUMAN BTB/POZ domain-containing protein 7 OS=Homo sapiens OX=9606 GN=BTBD7 PE=1 SV=3 g4147.t1 Q99814 51.053 190 7.92e-54 188.0 sp|Q99814|EPAS1_HUMAN Endothelial PAS domain-containing protein 1 OS=Homo sapiens OX=9606 GN=EPAS1 PE=1 SV=3 EPAS1_HUMAN reviewed Endothelial PAS domain-containing protein 1 (EPAS-1) (Basic-helix-loop-helix-PAS protein MOP2) (Class E basic helix-loop-helix protein 73) (bHLHe73) (HIF-1-alpha-like factor) (HLF) (Hypoxia-inducible factor 2-alpha) (HIF-2-alpha) (HIF2-alpha) (Member of PAS protein 2) (PAS domain-containing protein 2) Homo sapiens (Human) GO:0000785; GO:0000977; GO:0000978; GO:0000981; GO:0001223; GO:0001228; GO:0001525; GO:0001666; GO:0001892; GO:0001974; GO:0002027; GO:0002070; GO:0005634; GO:0005654; GO:0005667; GO:0005829; GO:0006357; GO:0006979; GO:0007005; GO:0007165; GO:0007601; GO:0016607; GO:0030218; GO:0030324; GO:0032364; GO:0042415; GO:0042789; GO:0043129; GO:0045944; GO:0046982; GO:0048625; GO:0060586; GO:0061629; GO:0071456; GO:0120162; GO:2000434 angiogenesis [GO:0001525]; blood vessel remodeling [GO:0001974]; cellular response to hypoxia [GO:0071456]; embryonic placenta development [GO:0001892]; epithelial cell maturation [GO:0002070]; erythrocyte differentiation [GO:0030218]; intracellular oxygen homeostasis [GO:0032364]; lung development [GO:0030324]; mitochondrion organization [GO:0007005]; mRNA transcription by RNA polymerase II [GO:0042789]; multicellular organismal-level iron ion homeostasis [GO:0060586]; myoblast fate commitment [GO:0048625]; norepinephrine metabolic process [GO:0042415]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of heart rate [GO:0002027]; regulation of protein neddylation [GO:2000434]; regulation of transcription by RNA polymerase II [GO:0006357]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; signal transduction [GO:0007165]; surfactant homeostasis [GO:0043129]; visual perception [GO:0007601] chromatin [GO:0000785]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667] DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein heterodimerization activity [GO:0046982]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription coactivator binding [GO:0001223] g4148.t1 Q98SW2 45.54 213 7.71e-57 208.0 sp|Q98SW2|HIF1A_ONCMY Hypoxia-inducible factor 1-alpha OS=Oncorhynchus mykiss OX=8022 GN=hif1a PE=2 SV=1 g4149.t1 Q9UJA3 71.391 381 2.7799999999999997e-180 525.0 sp|Q9UJA3|MCM8_HUMAN DNA helicase MCM8 OS=Homo sapiens OX=9606 GN=MCM8 PE=1 SV=2 MCM8_HUMAN reviewed DNA helicase MCM8 (EC 5.6.2.4) (DNA 3'-5' helicase MCM8) (Minichromosome maintenance 8) Homo sapiens (Human) GO:0000724; GO:0003682; GO:0003697; GO:0005524; GO:0005634; GO:0005654; GO:0005694; GO:0006974; GO:0007292; GO:0016887; GO:0019899; GO:0032406; GO:0032407; GO:0032408; GO:0036298; GO:0042555; GO:0043138; GO:0048232; GO:0050821; GO:0070716; GO:0071168; GO:0097362 DNA damage response [GO:0006974]; double-strand break repair via homologous recombination [GO:0000724]; female gamete generation [GO:0007292]; male gamete generation [GO:0048232]; mismatch repair involved in maintenance of fidelity involved in DNA-dependent DNA replication [GO:0070716]; protein localization to chromatin [GO:0071168]; protein stabilization [GO:0050821]; recombinational interstrand cross-link repair [GO:0036298] chromosome [GO:0005694]; MCM complex [GO:0042555]; MCM8-MCM9 complex [GO:0097362]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] 3'-5' DNA helicase activity [GO:0043138]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; chromatin binding [GO:0003682]; enzyme binding [GO:0019899]; MutLbeta complex binding [GO:0032406]; MutSalpha complex binding [GO:0032407]; MutSbeta complex binding [GO:0032408]; single-stranded DNA binding [GO:0003697] g4150.t1 I0IUP3 52.551 392 1.5499999999999999e-131 405.0 sp|I0IUP3|MCM8_CHICK DNA helicase MCM8 OS=Gallus gallus OX=9031 GN=MCM8 PE=1 SV=1 g4151.t1 Q07889 54.46 1065 0.0 1119.0 sp|Q07889|SOS1_HUMAN Son of sevenless homolog 1 OS=Homo sapiens OX=9606 GN=SOS1 PE=1 SV=1 SOS1_HUMAN reviewed Son of sevenless homolog 1 (SOS-1) Homo sapiens (Human) GO:0001782; GO:0001942; GO:0002931; GO:0003209; GO:0003344; GO:0005085; GO:0005096; GO:0005154; GO:0005737; GO:0005829; GO:0005886; GO:0006357; GO:0007165; GO:0007173; GO:0007265; GO:0007296; GO:0007411; GO:0008286; GO:0008543; GO:0014044; GO:0014069; GO:0017124; GO:0019221; GO:0019901; GO:0033081; GO:0035022; GO:0035264; GO:0038095; GO:0042110; GO:0042127; GO:0042129; GO:0042552; GO:0043025; GO:0045742; GO:0046982; GO:0048009; GO:0048011; GO:0048514; GO:0050853; GO:0050900; GO:0060021; GO:0061029; GO:0061384; GO:0098978; GO:0140693; GO:1904693; GO:1905360; GO:2000973 axon guidance [GO:0007411]; B cell homeostasis [GO:0001782]; B cell receptor signaling pathway [GO:0050853]; blood vessel morphogenesis [GO:0048514]; cardiac atrium morphogenesis [GO:0003209]; cytokine-mediated signaling pathway [GO:0019221]; epidermal growth factor receptor signaling pathway [GO:0007173]; eyelid development in camera-type eye [GO:0061029]; Fc-epsilon receptor signaling pathway [GO:0038095]; fibroblast growth factor receptor signaling pathway [GO:0008543]; hair follicle development [GO:0001942]; heart trabecula morphogenesis [GO:0061384]; insulin receptor signaling pathway [GO:0008286]; insulin-like growth factor receptor signaling pathway [GO:0048009]; leukocyte migration [GO:0050900]; midbrain morphogenesis [GO:1904693]; multicellular organism growth [GO:0035264]; myelination [GO:0042552]; neurotrophin TRK receptor signaling pathway [GO:0048011]; pericardium morphogenesis [GO:0003344]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of Rac protein signal transduction [GO:0035022]; Ras protein signal transduction [GO:0007265]; regulation of cell population proliferation [GO:0042127]; regulation of pro-B cell differentiation [GO:2000973]; regulation of T cell differentiation in thymus [GO:0033081]; regulation of T cell proliferation [GO:0042129]; regulation of transcription by RNA polymerase II [GO:0006357]; response to ischemia [GO:0002931]; roof of mouth development [GO:0060021]; Schwann cell development [GO:0014044]; signal transduction [GO:0007165]; T cell activation [GO:0042110]; vitellogenesis [GO:0007296] cytoplasm [GO:0005737]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; GTPase complex [GO:1905360]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069] epidermal growth factor receptor binding [GO:0005154]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; molecular condensate scaffold activity [GO:0140693]; protein heterodimerization activity [GO:0046982]; protein kinase binding [GO:0019901]; SH3 domain binding [GO:0017124] g4152.t1 Q9UEU0 34.667 225 3.93e-22 93.2 sp|Q9UEU0|VTI1B_HUMAN Vesicle transport through interaction with t-SNAREs homolog 1B OS=Homo sapiens OX=9606 GN=VTI1B PE=1 SV=3 VTI1B_HUMAN reviewed Vesicle transport through interaction with t-SNAREs homolog 1B (Vesicle transport v-SNARE protein Vti1-like 1) (Vti1-rp1) Homo sapiens (Human) GO:0000149; GO:0005484; GO:0005576; GO:0005765; GO:0005789; GO:0005794; GO:0005829; GO:0006886; GO:0006891; GO:0006896; GO:0006904; GO:0008021; GO:0012507; GO:0016192; GO:0016236; GO:0019869; GO:0031093; GO:0031201; GO:0031901; GO:0031902; GO:0031982; GO:0042147; GO:0043025; GO:0048280; GO:0048471; GO:0055037; GO:0055038; GO:0061025; GO:0098954; GO:1903076 Golgi to vacuole transport [GO:0006896]; intra-Golgi vesicle-mediated transport [GO:0006891]; intracellular protein transport [GO:0006886]; macroautophagy [GO:0016236]; membrane fusion [GO:0061025]; regulation of protein localization to plasma membrane [GO:1903076]; retrograde transport, endosome to Golgi [GO:0042147]; vesicle docking involved in exocytosis [GO:0006904]; vesicle fusion with Golgi apparatus [GO:0048280]; vesicle-mediated transport [GO:0016192] cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endoplasmic reticulum membrane [GO:0005789]; ER to Golgi transport vesicle membrane [GO:0012507]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; platelet alpha granule lumen [GO:0031093]; presynaptic endosome membrane [GO:0098954]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; SNARE complex [GO:0031201]; synaptic vesicle [GO:0008021]; vesicle [GO:0031982] chloride channel inhibitor activity [GO:0019869]; SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149] g4153.t1 Q02253 69.355 496 0.0 709.0 sp|Q02253|MMSA_RAT Methylmalonate-semialdehyde/malonate-semialdehyde dehydrogenase [acylating], mitochondrial OS=Rattus norvegicus OX=10116 GN=Aldh6a1 PE=1 SV=1 g4154.t1 O54928 60.326 184 2.34e-70 239.0 sp|O54928|SOCS5_MOUSE Suppressor of cytokine signaling 5 OS=Mus musculus OX=10090 GN=Socs5 PE=1 SV=2 SOCS5_MOUSE reviewed Suppressor of cytokine signaling 5 (SOCS-5) (Cytokine-inducible SH2-containing protein 5) Mus musculus (Mouse) GO:0005154; GO:0005737; GO:0007173; GO:0007175; GO:0007259; GO:0009968; GO:0016567; GO:0019210; GO:0019221; GO:0030971; GO:0032436; GO:0032715; GO:0035556; GO:0045627; GO:0045629; GO:0050728; GO:0071404; GO:0071638; GO:0097699; GO:1904988 cell surface receptor signaling pathway via JAK-STAT [GO:0007259]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; cytokine-mediated signaling pathway [GO:0019221]; epidermal growth factor receptor signaling pathway [GO:0007173]; intracellular signal transduction [GO:0035556]; negative regulation of endothelial cell activation [GO:1904988]; negative regulation of epidermal growth factor-activated receptor activity [GO:0007175]; negative regulation of inflammatory response [GO:0050728]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of monocyte chemotactic protein-1 production [GO:0071638]; negative regulation of signal transduction [GO:0009968]; negative regulation of T-helper 2 cell differentiation [GO:0045629]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of T-helper 1 cell differentiation [GO:0045627]; protein ubiquitination [GO:0016567]; vascular endothelial cell response to fluid shear stress [GO:0097699] cytoplasm [GO:0005737] epidermal growth factor receptor binding [GO:0005154]; kinase inhibitor activity [GO:0019210]; receptor tyrosine kinase binding [GO:0030971] g4155.t1 O75717 50.155 646 0.0 656.0 sp|O75717|WDHD1_HUMAN WD repeat and HMG-box DNA-binding protein 1 OS=Homo sapiens OX=9606 GN=WDHD1 PE=1 SV=1 WDHD1_HUMAN reviewed WD repeat and HMG-box DNA-binding protein 1 (Acidic nucleoplasmic DNA-binding protein 1) (And-1) Homo sapiens (Human) GO:0000278; GO:0003677; GO:0003682; GO:0005654; GO:0005737; GO:0006261; GO:0006281; GO:0043596 DNA repair [GO:0006281]; DNA-templated DNA replication [GO:0006261]; mitotic cell cycle [GO:0000278] cytoplasm [GO:0005737]; nuclear replication fork [GO:0043596]; nucleoplasm [GO:0005654] chromatin binding [GO:0003682]; DNA binding [GO:0003677] g4156.t1 O13046 57.516 153 5.4700000000000005e-56 205.0 sp|O13046|WDHD1_XENLA WD repeat and HMG-box DNA-binding protein 1 OS=Xenopus laevis OX=8355 GN=wdhd1 PE=1 SV=1 g4158.t1 P59722 56.938 209 2.89e-80 254.0 sp|P59722|EGLN1_RAT Egl nine homolog 1 (Fragment) OS=Rattus norvegicus OX=10116 GN=Egln1 PE=2 SV=2 EGLN1_RAT reviewed Egl nine homolog 1 (EC 1.14.11.29) (Hypoxia-inducible factor prolyl hydroxylase 2) (HIF-PH2) (HIF-prolyl hydroxylase 2) (HPH-2) (Prolyl hydroxylase domain-containing protein 2) (PHD2) Rattus norvegicus (Rat) GO:0001666; GO:0004857; GO:0005634; GO:0005737; GO:0005829; GO:0006879; GO:0008198; GO:0014069; GO:0016706; GO:0019899; GO:0031418; GO:0031543; GO:0031545; GO:0032364; GO:0043065; GO:0043523; GO:0043525; GO:0045765; GO:0045944; GO:0055008; GO:0060347; GO:0060412; GO:0060711; GO:0071456; GO:0071731; GO:0098978; GO:0099159; GO:0140252; GO:0160082; GO:1902072; GO:1905290 cardiac muscle tissue morphogenesis [GO:0055008]; cellular response to hypoxia [GO:0071456]; heart trabecula formation [GO:0060347]; intracellular iron ion homeostasis [GO:0006879]; intracellular oxygen homeostasis [GO:0032364]; labyrinthine layer development [GO:0060711]; negative regulation of CAMKK-AMPK signaling cascade [GO:1905290]; negative regulation of hypoxia-inducible factor-1alpha signaling pathway [GO:1902072]; positive regulation of apoptotic process [GO:0043065]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of angiogenesis [GO:0045765]; regulation of modification of postsynaptic structure [GO:0099159]; regulation of neuron apoptotic process [GO:0043523]; regulation protein catabolic process at postsynapse [GO:0140252]; response to hypoxia [GO:0001666]; response to nitric oxide [GO:0071731]; ventricular septum morphogenesis [GO:0060412] cytoplasm [GO:0005737]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; nucleus [GO:0005634]; postsynaptic density [GO:0014069] 2-oxoglutarate-dependent dioxygenase activity [GO:0016706]; enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; ferrous iron binding [GO:0008198]; hypoxia-inducible factor-proline dioxygenase activity [GO:0160082]; L-ascorbic acid binding [GO:0031418]; peptidyl-proline 4-dioxygenase activity [GO:0031545]; peptidyl-proline dioxygenase activity [GO:0031543] g4161.t1 Q8BYN3 47.077 325 2.5799999999999998e-101 309.0 sp|Q8BYN3|ITPK1_MOUSE Inositol-tetrakisphosphate 1-kinase OS=Mus musculus OX=10090 GN=Itpk1 PE=2 SV=1 ITPK1_MOUSE reviewed Inositol-tetrakisphosphate 1-kinase (EC 2.7.1.134) (Inositol 1,3,4-trisphosphate 5/6-kinase) (Inositol-triphosphate 5/6-kinase) (Ins(1,3,4)P(3) 5/6-kinase) (EC 2.7.1.159) Mus musculus (Mouse) GO:0000287; GO:0000825; GO:0005524; GO:0016324; GO:0016787; GO:0016853; GO:0021915; GO:0032957; GO:0047325; GO:0052725; GO:0052726; GO:0052835; GO:0070266 inositol trisphosphate metabolic process [GO:0032957]; necroptotic process [GO:0070266]; neural tube development [GO:0021915] apical plasma membrane [GO:0016324] ATP binding [GO:0005524]; hydrolase activity [GO:0016787]; inositol-1,3,4,5-tetrakisphosphate 6-kinase activity [GO:0000825]; inositol-1,3,4-trisphosphate 5-kinase activity [GO:0052726]; inositol-1,3,4-trisphosphate 6-kinase activity [GO:0052725]; inositol-3,4,5,6-tetrakisphosphate 1-kinase activity [GO:0047325]; inositol-3,4,6-trisphosphate 1-kinase activity [GO:0052835]; isomerase activity [GO:0016853]; magnesium ion binding [GO:0000287] g4163.t1 A0A0F7Z3J2 40.385 104 7.04e-22 87.8 sp|A0A0F7Z3J2|CTHA2_CONVC Thyrostimulin alpha-2 subunit OS=Conus victoriae OX=319920 PE=1 SV=1 g4164.t1 Q86YW7 37.795 127 2.0499999999999999e-23 92.4 sp|Q86YW7|GPHB5_HUMAN Glycoprotein hormone beta-5 OS=Homo sapiens OX=9606 GN=GPHB5 PE=1 SV=1 GPHB5_HUMAN reviewed Glycoprotein hormone beta-5 (Thyrostimulin subunit beta) Homo sapiens (Human) GO:0002155; GO:0005179; GO:0005576; GO:0005615; GO:0005737; GO:0007186; GO:0007189; GO:0031531; GO:0046982 adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; G protein-coupled receptor signaling pathway [GO:0007186]; regulation of thyroid hormone receptor signaling pathway [GO:0002155] cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615] hormone activity [GO:0005179]; protein heterodimerization activity [GO:0046982]; thyrotropin-releasing hormone receptor binding [GO:0031531] g4167.t1 P54366 92.537 67 2.67e-36 136.0 sp|P54366|GSC_DROME Homeobox protein goosecoid OS=Drosophila melanogaster OX=7227 GN=Gsc PE=2 SV=2 g4168.t1 A1A4M4 63.603 272 3.32e-114 332.0 sp|A1A4M4|TATD3_BOVIN Putative deoxyribonuclease TATDN3 OS=Bos taurus OX=9913 GN=TATDN3 PE=2 SV=1 g4170.t1 P16537 61.538 117 1.87e-34 123.0 sp|P16537|SPC3_STRPU Protein SPEC3 OS=Strongylocentrotus purpuratus OX=7668 GN=SPEC3 PE=3 SV=1 g4172.t1 P98068 40.757 449 2.72e-102 320.0 sp|P98068|SPAN_STRPU Protein SpAN OS=Strongylocentrotus purpuratus OX=7668 GN=SPAN PE=2 SV=1 g4174.t1 Q8MV48 35.417 144 4.18e-24 100.0 sp|Q8MV48|GALT7_DROME N-acetylgalactosaminyltransferase 7 OS=Drosophila melanogaster OX=7227 GN=Pgant7 PE=1 SV=2 GALT7_DROME reviewed N-acetylgalactosaminyltransferase 7 (EC 2.4.1.41) (Protein-UDP acetylgalactosaminyltransferase 7) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 7) (pp-GaNTase 7) (dGalNAc-T2) Drosophila melanogaster (Fruit fly) GO:0000139; GO:0004653; GO:0005794; GO:0005795; GO:0006493; GO:0012505; GO:0016266; GO:0030246; GO:0046872 protein O-linked glycosylation [GO:0006493]; protein O-linked glycosylation via N-acetyl-galactosamine [GO:0016266] endomembrane system [GO:0012505]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795] carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653] g4175.t1 Q49A17 63.235 68 7.260000000000001e-27 103.0 sp|Q49A17|GLTL6_HUMAN Polypeptide N-acetylgalactosaminyltransferase-like 6 OS=Homo sapiens OX=9606 GN=GALNTL6 PE=2 SV=2 GLTL6_HUMAN reviewed Polypeptide N-acetylgalactosaminyltransferase-like 6 (EC 2.4.1.41) (Polypeptide GalNAc transferase 17) (GalNAc-T17) (pp-GaNTase 17) (Protein-UDP acetylgalactosaminyltransferase 17) (Putative polypeptide N-acetylgalactosaminyltransferase 17) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 17) Homo sapiens (Human) GO:0000139; GO:0004653; GO:0005794; GO:0006493; GO:0016266; GO:0030246; GO:0046872 protein O-linked glycosylation [GO:0006493]; protein O-linked glycosylation via N-acetyl-galactosamine [GO:0016266] Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139] carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653] g4175.t1 Q49A17 77.778 18 7.260000000000001e-27 36.6 sp|Q49A17|GLTL6_HUMAN Polypeptide N-acetylgalactosaminyltransferase-like 6 OS=Homo sapiens OX=9606 GN=GALNTL6 PE=2 SV=2 GLTL6_HUMAN reviewed Polypeptide N-acetylgalactosaminyltransferase-like 6 (EC 2.4.1.41) (Polypeptide GalNAc transferase 17) (GalNAc-T17) (pp-GaNTase 17) (Protein-UDP acetylgalactosaminyltransferase 17) (Putative polypeptide N-acetylgalactosaminyltransferase 17) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 17) Homo sapiens (Human) GO:0000139; GO:0004653; GO:0005794; GO:0006493; GO:0016266; GO:0030246; GO:0046872 protein O-linked glycosylation [GO:0006493]; protein O-linked glycosylation via N-acetyl-galactosamine [GO:0016266] Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139] carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653] g4176.t1 Q8MV48 56.0 200 8.49e-68 226.0 sp|Q8MV48|GALT7_DROME N-acetylgalactosaminyltransferase 7 OS=Drosophila melanogaster OX=7227 GN=Pgant7 PE=1 SV=2 GALT7_DROME reviewed N-acetylgalactosaminyltransferase 7 (EC 2.4.1.41) (Protein-UDP acetylgalactosaminyltransferase 7) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 7) (pp-GaNTase 7) (dGalNAc-T2) Drosophila melanogaster (Fruit fly) GO:0000139; GO:0004653; GO:0005794; GO:0005795; GO:0006493; GO:0012505; GO:0016266; GO:0030246; GO:0046872 protein O-linked glycosylation [GO:0006493]; protein O-linked glycosylation via N-acetyl-galactosamine [GO:0016266] endomembrane system [GO:0012505]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795] carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653] g4180.t1 A0A0G2L7I0 61.511 278 5e-111 347.0 sp|A0A0G2L7I0|SPRTN_DANRE DNA-dependent metalloprotease SPRTN OS=Danio rerio OX=7955 GN=sprtn PE=3 SV=1 SPRTN_DANRE reviewed DNA-dependent metalloprotease SPRTN (EC 3.4.24.-) (Protein with SprT-like domain at the N terminus) (Spartan) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000785; GO:0003690; GO:0003697; GO:0004222; GO:0005634; GO:0006508; GO:0006974; GO:0008270; GO:0016540; GO:0031593; GO:0106300 DNA damage response [GO:0006974]; protein autoprocessing [GO:0016540]; protein-DNA covalent cross-linking repair [GO:0106300]; proteolysis [GO:0006508] chromatin [GO:0000785]; nucleus [GO:0005634] double-stranded DNA binding [GO:0003690]; metalloendopeptidase activity [GO:0004222]; polyubiquitin modification-dependent protein binding [GO:0031593]; single-stranded DNA binding [GO:0003697]; zinc ion binding [GO:0008270] g4182.t1 Q8NBN7 61.95 318 1.7400000000000001e-121 357.0 sp|Q8NBN7|RDH13_HUMAN Retinol dehydrogenase 13 OS=Homo sapiens OX=9606 GN=RDH13 PE=1 SV=2 g4183.t1 A7SMW7 67.366 429 0.0 588.0 sp|A7SMW7|L2HDH_NEMVE L-2-hydroxyglutarate dehydrogenase, mitochondrial OS=Nematostella vectensis OX=45351 GN=v1g172254 PE=3 SV=1 g4184.t1 Q29RQ5 52.288 721 0.0 748.0 sp|Q29RQ5|TRIM9_BOVIN E3 ubiquitin-protein ligase TRIM9 OS=Bos taurus OX=9913 GN=TRIM9 PE=2 SV=1 TRIM9_BOVIN reviewed E3 ubiquitin-protein ligase TRIM9 (EC 2.3.2.27) (RING-type E3 ubiquitin transferase TRIM9) (Tripartite motif-containing protein 9) Bos taurus (Bovine) GO:0005737; GO:0005856; GO:0008021; GO:0008270; GO:0016567; GO:0030425; GO:0043161; GO:0061630 proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; dendrite [GO:0030425]; synaptic vesicle [GO:0008021] ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] g4185.t1 B5DG42 88.442 398 0.0 746.0 sp|B5DG42|IF4A3_SALSA Eukaryotic initiation factor 4A-III OS=Salmo salar OX=8030 GN=eif4a3 PE=2 SV=1 IF4A3_SALSA reviewed Eukaryotic initiation factor 4A-III (eIF-4A-III) (eIF4A-III) (EC 3.6.4.13) (ATP-dependent RNA helicase DDX48) (ATP-dependent RNA helicase eIF4A-3) (DEAD box protein 48) (Eukaryotic translation initiation factor 4A isoform 3) Salmo salar (Atlantic salmon) GO:0000184; GO:0000381; GO:0000398; GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005737; GO:0006417; GO:0016607; GO:0016887; GO:0051028; GO:0071006 mRNA splicing, via spliceosome [GO:0000398]; mRNA transport [GO:0051028]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of translation [GO:0006417] cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; U2-type catalytic step 1 spliceosome [GO:0071006] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724] g4186.t1 P18762 27.586 319 9.830000000000001e-26 109.0 sp|P18762|ADRB2_MOUSE Beta-2 adrenergic receptor OS=Mus musculus OX=10090 GN=Adrb2 PE=1 SV=2 ADRB2_MOUSE reviewed Beta-2 adrenergic receptor (Beta-2 adrenoreceptor) (Beta-2 adrenoceptor) Mus musculus (Mouse) GO:0001540; GO:0001965; GO:0001993; GO:0002024; GO:0002025; GO:0002028; GO:0002086; GO:0003059; GO:0004941; GO:0005634; GO:0005768; GO:0005769; GO:0005794; GO:0005886; GO:0005901; GO:0005929; GO:0006898; GO:0007186; GO:0007189; GO:0008179; GO:0008284; GO:0008306; GO:0009409; GO:0010666; GO:0010667; GO:0010765; GO:0015459; GO:0015630; GO:0016020; GO:0016324; GO:0016525; GO:0019899; GO:0030279; GO:0030424; GO:0030425; GO:0030501; GO:0031649; GO:0031713; GO:0032809; GO:0035249; GO:0035255; GO:0035811; GO:0036064; GO:0040015; GO:0042311; GO:0042383; GO:0042802; GO:0042803; GO:0043065; GO:0043197; GO:0043235; GO:0043268; GO:0043410; GO:0044877; GO:0045171; GO:0045211; GO:0045453; GO:0045744; GO:0045944; GO:0045986; GO:0048633; GO:0050873; GO:0051380; GO:0051721; GO:0051924; GO:0060079; GO:0061885; GO:0071456; GO:0071869; GO:0071875; GO:0071880; GO:0071881; GO:0072686; GO:0090722; GO:0098685; GO:0098793; GO:0098978; GO:0098990; GO:0098992; GO:0099171; GO:0106134; GO:0120162; GO:0141163; GO:1901098; GO:1904504; GO:1904646; GO:1905665 adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-inhibiting adrenergic receptor signaling pathway [GO:0071881]; adrenergic receptor signaling pathway [GO:0071875]; AMPA selective glutamate receptor signaling pathway [GO:0098990]; associative learning [GO:0008306]; bone resorption [GO:0045453]; brown fat cell differentiation [GO:0050873]; cellular response to amyloid-beta [GO:1904646]; cellular response to hypoxia [GO:0071456]; diaphragm contraction [GO:0002086]; diet induced thermogenesis [GO:0002024]; excitatory postsynaptic potential [GO:0060079]; G protein-coupled receptor signaling pathway [GO:0007186]; heat generation [GO:0031649]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of G protein-coupled receptor signaling pathway [GO:0045744]; negative regulation of multicellular organism growth [GO:0040015]; negative regulation of ossification [GO:0030279]; negative regulation of smooth muscle contraction [GO:0045986]; negative regulation of urine volume [GO:0035811]; norepinephrine-epinephrine-mediated vasodilation involved in regulation of systemic arterial blood pressure [GO:0002025]; positive regulation of apoptotic process [GO:0043065]; positive regulation of autophagosome maturation [GO:1901098]; positive regulation of bone mineralization [GO:0030501]; positive regulation of calcium ion import across plasma membrane [GO:1905665]; positive regulation of cAMP/PKA signal transduction [GO:0141163]; positive regulation of cardiac muscle cell apoptotic process [GO:0010666]; positive regulation of cardiac muscle cell contraction [GO:0106134]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of lipophagy [GO:1904504]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of mini excitatory postsynaptic potential [GO:0061885]; positive regulation of potassium ion transport [GO:0043268]; positive regulation of skeletal muscle tissue growth [GO:0048633]; positive regulation of sodium ion transport [GO:0010765]; positive regulation of the force of heart contraction by epinephrine [GO:0003059]; positive regulation of transcription by RNA polymerase II [GO:0045944]; presynaptic modulation of chemical synaptic transmission [GO:0099171]; receptor-mediated endocytosis [GO:0006898]; regulation of calcium ion transport [GO:0051924]; regulation of sodium ion transport [GO:0002028]; regulation of systemic arterial blood pressure by norepinephrine-epinephrine [GO:0001993]; response to catecholamine [GO:0071869]; response to cold [GO:0009409]; synaptic transmission, glutamatergic [GO:0035249]; vasodilation [GO:0042311] apical plasma membrane [GO:0016324]; axon [GO:0030424]; caveola [GO:0005901]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; early endosome [GO:0005769]; endosome [GO:0005768]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; intercellular bridge [GO:0045171]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; mitotic spindle [GO:0072686]; neuronal cell body membrane [GO:0032809]; neuronal dense core vesicle [GO:0098992]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynapse [GO:0098793]; receptor complex [GO:0043235]; sarcolemma [GO:0042383]; Schaffer collateral - CA1 synapse [GO:0098685] adenylate cyclase binding [GO:0008179]; amyloid-beta binding [GO:0001540]; B2 bradykinin receptor binding [GO:0031713]; beta2-adrenergic receptor activity [GO:0004941]; enzyme binding [GO:0019899]; G-protein alpha-subunit binding [GO:0001965]; identical protein binding [GO:0042802]; ionotropic glutamate receptor binding [GO:0035255]; norepinephrine binding [GO:0051380]; potassium channel regulator activity [GO:0015459]; protein homodimerization activity [GO:0042803]; protein phosphatase 2A binding [GO:0051721]; protein-containing complex binding [GO:0044877]; receptor-receptor interaction [GO:0090722] g4186.t2 Q9N2B2 27.473 273 5.4e-22 100.0 sp|Q9N2B2|HRH1_PANTR Histamine H1 receptor OS=Pan troglodytes OX=9598 GN=HRH1 PE=3 SV=1 g4188.t1 O43290 53.333 255 1.82e-65 238.0 sp|O43290|SNUT1_HUMAN U4/U6.U5 tri-snRNP-associated protein 1 OS=Homo sapiens OX=9606 GN=SART1 PE=1 SV=1 SNUT1_HUMAN reviewed U4/U6.U5 tri-snRNP-associated protein 1 (SNU66 homolog) (hSnu66) (Squamous cell carcinoma antigen recognized by T-cells 1) (SART-1) (hSART-1) (U4/U6.U5 tri-snRNP-associated 110 kDa protein) (allergen Hom s 1) Homo sapiens (Human) GO:0000387; GO:0000398; GO:0000481; GO:0003723; GO:0005634; GO:0005654; GO:0005681; GO:0005737; GO:0005794; GO:0005829; GO:0015030; GO:0016607; GO:0045292; GO:0045585; GO:0046540; GO:0071005; GO:0071013 maturation of 5S rRNA [GO:0000481]; mRNA cis splicing, via spliceosome [GO:0045292]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of cytotoxic T cell differentiation [GO:0045585]; spliceosomal snRNP assembly [GO:0000387] Cajal body [GO:0015030]; catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540] RNA binding [GO:0003723] g4188.t1 O43290 46.885 305 3.1199999999999998e-55 208.0 sp|O43290|SNUT1_HUMAN U4/U6.U5 tri-snRNP-associated protein 1 OS=Homo sapiens OX=9606 GN=SART1 PE=1 SV=1 SNUT1_HUMAN reviewed U4/U6.U5 tri-snRNP-associated protein 1 (SNU66 homolog) (hSnu66) (Squamous cell carcinoma antigen recognized by T-cells 1) (SART-1) (hSART-1) (U4/U6.U5 tri-snRNP-associated 110 kDa protein) (allergen Hom s 1) Homo sapiens (Human) GO:0000387; GO:0000398; GO:0000481; GO:0003723; GO:0005634; GO:0005654; GO:0005681; GO:0005737; GO:0005794; GO:0005829; GO:0015030; GO:0016607; GO:0045292; GO:0045585; GO:0046540; GO:0071005; GO:0071013 maturation of 5S rRNA [GO:0000481]; mRNA cis splicing, via spliceosome [GO:0045292]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of cytotoxic T cell differentiation [GO:0045585]; spliceosomal snRNP assembly [GO:0000387] Cajal body [GO:0015030]; catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540] RNA binding [GO:0003723] g4189.t1 Q5M7F6 70.621 354 0.0 516.0 sp|Q5M7F6|DAA10_XENLA Dynein axonemal assembly factor 10 OS=Xenopus laevis OX=8355 GN=dnaaf10 PE=2 SV=1 g4190.t1 P60901 79.268 246 3.26e-151 424.0 sp|P60901|PSA6_RAT Proteasome subunit alpha type-6 OS=Rattus norvegicus OX=10116 GN=Psma6 PE=1 SV=1 PSA6_RAT reviewed Proteasome subunit alpha type-6 (Macropain iota chain) (Multicatalytic endopeptidase complex iota chain) (Proteasome iota chain) (Proteasome subunit alpha-1) (alpha-1) Rattus norvegicus (Rat) GO:0000502; GO:0000932; GO:0003723; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0005839; GO:0005840; GO:0005929; GO:0016363; GO:0019773; GO:0030016; GO:0030017; GO:0043123; GO:0043161; GO:0050727; GO:0051059; GO:0051603 positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; proteolysis involved in protein catabolic process [GO:0051603]; regulation of inflammatory response [GO:0050727] cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; myofibril [GO:0030016]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; proteasome complex [GO:0000502]; proteasome core complex [GO:0005839]; proteasome core complex, alpha-subunit complex [GO:0019773]; ribosome [GO:0005840]; sarcomere [GO:0030017] NF-kappaB binding [GO:0051059]; RNA binding [GO:0003723] g4192.t1 Q28653 73.271 535 0.0 804.0 sp|Q28653|2A5D_RABIT Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit delta isoform OS=Oryctolagus cuniculus OX=9986 GN=PPP2R5D PE=2 SV=1 2A5D_RABIT reviewed Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit delta isoform (PP2A B subunit isoform B'-delta) (PP2A B subunit isoform B'-gamma) (PP2A B subunit isoform B56-delta) (PP2A B subunit isoform PR61-delta) (PP2A B subunit isoform R5-delta) Oryctolagus cuniculus (Rabbit) GO:0000159; GO:0005634; GO:0005829; GO:0007165; GO:0072542 signal transduction [GO:0007165] cytosol [GO:0005829]; nucleus [GO:0005634]; protein phosphatase type 2A complex [GO:0000159] protein phosphatase activator activity [GO:0072542] g4195.t1 Q8IXF0 53.493 458 2.32e-151 474.0 sp|Q8IXF0|NPAS3_HUMAN Neuronal PAS domain-containing protein 3 OS=Homo sapiens OX=9606 GN=NPAS3 PE=1 SV=1 g4195.t2 Q8IXF0 53.493 458 5.9e-152 475.0 sp|Q8IXF0|NPAS3_HUMAN Neuronal PAS domain-containing protein 3 OS=Homo sapiens OX=9606 GN=NPAS3 PE=1 SV=1 g4197.t1 Q9WVC7 25.721 451 5.2e-25 117.0 sp|Q9WVC7|AKAP6_RAT A-kinase anchor protein 6 OS=Rattus norvegicus OX=10116 GN=Akap6 PE=1 SV=1 AKAP6_RAT reviewed A-kinase anchor protein 6 (AKAP-6) (Protein kinase A-anchoring protein 6) (PRKA6) (mAKAP) Rattus norvegicus (Rat) GO:0001508; GO:0005634; GO:0005635; GO:0005737; GO:0005901; GO:0008179; GO:0010739; GO:0010880; GO:0014701; GO:0014704; GO:0016529; GO:0019899; GO:0030307; GO:0030315; GO:0031503; GO:0031965; GO:0032991; GO:0034237; GO:0034704; GO:0042383; GO:0043495; GO:0044325; GO:0045727; GO:0048471; GO:0051018; GO:0051281; GO:0051721; GO:0060090; GO:0060306; GO:0061051; GO:0070886; GO:0071320; GO:0071345; GO:0071872; GO:0086004; GO:0141161; GO:1901381; GO:1901897 action potential [GO:0001508]; cellular response to cAMP [GO:0071320]; cellular response to cytokine stimulus [GO:0071345]; cellular response to epinephrine stimulus [GO:0071872]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886]; positive regulation of cell growth [GO:0030307]; positive regulation of cell growth involved in cardiac muscle cell development [GO:0061051]; positive regulation of potassium ion transmembrane transport [GO:1901381]; positive regulation of protein kinase A signaling [GO:0010739]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; positive regulation of translation [GO:0045727]; protein-containing complex localization [GO:0031503]; regulation of cAMP/PKA signal transduction [GO:0141161]; regulation of cardiac muscle cell contraction [GO:0086004]; regulation of membrane repolarization [GO:0060306]; regulation of relaxation of cardiac muscle [GO:1901897]; regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0010880] calcium channel complex [GO:0034704]; caveola [GO:0005901]; cytoplasm [GO:0005737]; intercalated disc [GO:0014704]; junctional sarcoplasmic reticulum membrane [GO:0014701]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; sarcolemma [GO:0042383]; sarcoplasmic reticulum [GO:0016529]; T-tubule [GO:0030315] adenylate cyclase binding [GO:0008179]; enzyme binding [GO:0019899]; molecular adaptor activity [GO:0060090]; protein kinase A binding [GO:0051018]; protein kinase A regulatory subunit binding [GO:0034237]; protein phosphatase 2A binding [GO:0051721]; protein-membrane adaptor activity [GO:0043495]; transmembrane transporter binding [GO:0044325] g4199.t1 P25455 62.543 291 1.5400000000000002e-125 423.0 sp|P25455|PIP1_DROME 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase classes I and II OS=Drosophila melanogaster OX=7227 GN=Plc21C PE=2 SV=3 g4199.t1 P25455 70.37 135 1.21e-53 209.0 sp|P25455|PIP1_DROME 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase classes I and II OS=Drosophila melanogaster OX=7227 GN=Plc21C PE=2 SV=3 g4199.t2 P25455 62.543 291 1.41e-125 425.0 sp|P25455|PIP1_DROME 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase classes I and II OS=Drosophila melanogaster OX=7227 GN=Plc21C PE=2 SV=3 g4199.t2 P25455 70.37 135 6.51e-54 211.0 sp|P25455|PIP1_DROME 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase classes I and II OS=Drosophila melanogaster OX=7227 GN=Plc21C PE=2 SV=3 g4199.t3 P25455 62.543 291 1.34e-125 424.0 sp|P25455|PIP1_DROME 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase classes I and II OS=Drosophila melanogaster OX=7227 GN=Plc21C PE=2 SV=3 g4199.t3 P25455 70.37 135 7.749999999999999e-54 210.0 sp|P25455|PIP1_DROME 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase classes I and II OS=Drosophila melanogaster OX=7227 GN=Plc21C PE=2 SV=3 g4199.t4 P25455 62.543 291 1.41e-125 424.0 sp|P25455|PIP1_DROME 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase classes I and II OS=Drosophila melanogaster OX=7227 GN=Plc21C PE=2 SV=3 g4199.t4 P25455 70.37 135 7.53e-54 211.0 sp|P25455|PIP1_DROME 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase classes I and II OS=Drosophila melanogaster OX=7227 GN=Plc21C PE=2 SV=3 g4200.t1 P51432 45.238 294 1.43e-78 262.0 sp|P51432|PLCB3_MOUSE 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-3 OS=Mus musculus OX=10090 GN=Plcb3 PE=1 SV=2 PLCB3_MOUSE reviewed 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-3 (EC 3.1.4.11) (Phosphoinositide phospholipase C-beta-3) (Phospholipase C-beta-3) (PLC-beta-3) Mus musculus (Mouse) GO:0003073; GO:0004435; GO:0005509; GO:0005516; GO:0005634; GO:0005737; GO:0005829; GO:0006892; GO:0007186; GO:0007200; GO:0007208; GO:0031161; GO:0032957; GO:0032991; GO:0042383; GO:0046488; GO:0048015; GO:0051209; GO:0060090; GO:0099524; GO:0120548; GO:0140582; GO:0140677 adenylate cyclase-activating G protein-coupled cAMP receptor signaling pathway [GO:0140582]; G protein-coupled receptor signaling pathway [GO:0007186]; inositol trisphosphate metabolic process [GO:0032957]; phosphatidylinositol catabolic process [GO:0031161]; phosphatidylinositol metabolic process [GO:0046488]; phosphatidylinositol-mediated signaling [GO:0048015]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; phospholipase C-activating serotonin receptor signaling pathway [GO:0007208]; post-Golgi vesicle-mediated transport [GO:0006892]; regulation of systemic arterial blood pressure [GO:0003073]; release of sequestered calcium ion into cytosol [GO:0051209] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; postsynaptic cytosol [GO:0099524]; protein-containing complex [GO:0032991]; sarcolemma [GO:0042383] calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; molecular adaptor activity [GO:0060090]; molecular function activator activity [GO:0140677]; phosphatidylinositol phospholipase C activity [GO:0120548]; phosphatidylinositol-4,5-bisphosphate phospholipase C activity [GO:0004435] g4201.t1 Q15147 55.008 1198 0.0 1246.0 sp|Q15147|PLCB4_HUMAN 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-4 OS=Homo sapiens OX=9606 GN=PLCB4 PE=1 SV=3 g4201.t2 Q9QW07 61.981 626 0.0 791.0 sp|Q9QW07|PLCB4_RAT 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-4 OS=Rattus norvegicus OX=10116 GN=Plcb4 PE=1 SV=2 g4201.t2 Q9QW07 64.665 433 0.0 571.0 sp|Q9QW07|PLCB4_RAT 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-4 OS=Rattus norvegicus OX=10116 GN=Plcb4 PE=1 SV=2 g4202.t1 Q15147 55.814 86 1.22e-26 105.0 sp|Q15147|PLCB4_HUMAN 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-4 OS=Homo sapiens OX=9606 GN=PLCB4 PE=1 SV=3 g4204.t1 Q9Y3Q0 45.0 740 0.0 660.0 sp|Q9Y3Q0|NALD2_HUMAN N-acetylated-alpha-linked acidic dipeptidase 2 OS=Homo sapiens OX=9606 GN=NAALAD2 PE=1 SV=1 NALD2_HUMAN reviewed N-acetylated-alpha-linked acidic dipeptidase 2 (EC 3.4.17.21) (Glutamate carboxypeptidase III) (GCPIII) (N-acetylated-alpha-linked acidic dipeptidase II) (NAALADase II) Homo sapiens (Human) GO:0004180; GO:0004181; GO:0005886; GO:0006508; GO:0008236; GO:0008239; GO:0016020; GO:0016805; GO:0046395; GO:0046872; GO:0050129 carboxylic acid catabolic process [GO:0046395]; proteolysis [GO:0006508] membrane [GO:0016020]; plasma membrane [GO:0005886] carboxypeptidase activity [GO:0004180]; dipeptidase activity [GO:0016805]; dipeptidyl-peptidase activity [GO:0008239]; metal ion binding [GO:0046872]; metallocarboxypeptidase activity [GO:0004181]; N-formylglutamate deformylase activity [GO:0050129]; serine-type peptidase activity [GO:0008236] g4208.t1 O43166 49.179 913 0.0 840.0 sp|O43166|SI1L1_HUMAN Signal-induced proliferation-associated 1-like protein 1 OS=Homo sapiens OX=9606 GN=SIPA1L1 PE=1 SV=4 SI1L1_HUMAN reviewed Signal-induced proliferation-associated 1-like protein 1 (SIPA1-like protein 1) (High-risk human papilloma viruses E6 oncoproteins targeted protein 1) (E6-targeted protein 1) Homo sapiens (Human) GO:0005096; GO:0005737; GO:0005886; GO:0014069; GO:0015629; GO:0030036; GO:0043087; GO:0043197; GO:0046875; GO:0048013; GO:0048167; GO:0050770; GO:0051056; GO:0061001; GO:0090630 actin cytoskeleton organization [GO:0030036]; activation of GTPase activity [GO:0090630]; ephrin receptor signaling pathway [GO:0048013]; regulation of axonogenesis [GO:0050770]; regulation of dendritic spine morphogenesis [GO:0061001]; regulation of GTPase activity [GO:0043087]; regulation of small GTPase mediated signal transduction [GO:0051056]; regulation of synaptic plasticity [GO:0048167] actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; dendritic spine [GO:0043197]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069] ephrin receptor binding [GO:0046875]; GTPase activator activity [GO:0005096] g4208.t2 O43166 48.652 927 0.0 832.0 sp|O43166|SI1L1_HUMAN Signal-induced proliferation-associated 1-like protein 1 OS=Homo sapiens OX=9606 GN=SIPA1L1 PE=1 SV=4 SI1L1_HUMAN reviewed Signal-induced proliferation-associated 1-like protein 1 (SIPA1-like protein 1) (High-risk human papilloma viruses E6 oncoproteins targeted protein 1) (E6-targeted protein 1) Homo sapiens (Human) GO:0005096; GO:0005737; GO:0005886; GO:0014069; GO:0015629; GO:0030036; GO:0043087; GO:0043197; GO:0046875; GO:0048013; GO:0048167; GO:0050770; GO:0051056; GO:0061001; GO:0090630 actin cytoskeleton organization [GO:0030036]; activation of GTPase activity [GO:0090630]; ephrin receptor signaling pathway [GO:0048013]; regulation of axonogenesis [GO:0050770]; regulation of dendritic spine morphogenesis [GO:0061001]; regulation of GTPase activity [GO:0043087]; regulation of small GTPase mediated signal transduction [GO:0051056]; regulation of synaptic plasticity [GO:0048167] actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; dendritic spine [GO:0043197]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069] ephrin receptor binding [GO:0046875]; GTPase activator activity [GO:0005096] g4208.t3 O43166 48.652 927 0.0 832.0 sp|O43166|SI1L1_HUMAN Signal-induced proliferation-associated 1-like protein 1 OS=Homo sapiens OX=9606 GN=SIPA1L1 PE=1 SV=4 SI1L1_HUMAN reviewed Signal-induced proliferation-associated 1-like protein 1 (SIPA1-like protein 1) (High-risk human papilloma viruses E6 oncoproteins targeted protein 1) (E6-targeted protein 1) Homo sapiens (Human) GO:0005096; GO:0005737; GO:0005886; GO:0014069; GO:0015629; GO:0030036; GO:0043087; GO:0043197; GO:0046875; GO:0048013; GO:0048167; GO:0050770; GO:0051056; GO:0061001; GO:0090630 actin cytoskeleton organization [GO:0030036]; activation of GTPase activity [GO:0090630]; ephrin receptor signaling pathway [GO:0048013]; regulation of axonogenesis [GO:0050770]; regulation of dendritic spine morphogenesis [GO:0061001]; regulation of GTPase activity [GO:0043087]; regulation of small GTPase mediated signal transduction [GO:0051056]; regulation of synaptic plasticity [GO:0048167] actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; dendritic spine [GO:0043197]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069] ephrin receptor binding [GO:0046875]; GTPase activator activity [GO:0005096] g4209.t1 Q62728 53.846 338 2.9700000000000002e-123 392.0 sp|Q62728|PTN21_RAT Tyrosine-protein phosphatase non-receptor type 21 OS=Rattus norvegicus OX=10116 GN=Ptpn21 PE=1 SV=1 g4211.t1 Q62728 49.693 326 2.79e-93 307.0 sp|Q62728|PTN21_RAT Tyrosine-protein phosphatase non-receptor type 21 OS=Rattus norvegicus OX=10116 GN=Ptpn21 PE=1 SV=1 g4212.t1 P49454 42.953 149 2.0099999999999997e-23 112.0 sp|P49454|CENPF_HUMAN Centromere protein F OS=Homo sapiens OX=9606 GN=CENPF PE=1 SV=3 CENPF_HUMAN reviewed Centromere protein F (CENP-F) (AH antigen) (Kinetochore protein CENPF) (Mitosin) Homo sapiens (Human) GO:0000278; GO:0000775; GO:0000776; GO:0000785; GO:0000922; GO:0000940; GO:0001822; GO:0003682; GO:0005634; GO:0005635; GO:0005654; GO:0005737; GO:0005813; GO:0005819; GO:0005829; GO:0005930; GO:0007059; GO:0007094; GO:0007517; GO:0008017; GO:0009410; GO:0010389; GO:0015031; GO:0016202; GO:0016363; GO:0021591; GO:0030154; GO:0030496; GO:0036064; GO:0042803; GO:0045120; GO:0045892; GO:0048471; GO:0051301; GO:0051310; GO:0051382; GO:0070840; GO:0071897; GO:0097539; GO:0140297 cell differentiation [GO:0030154]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; DNA biosynthetic process [GO:0071897]; kidney development [GO:0001822]; kinetochore assembly [GO:0051382]; metaphase chromosome alignment [GO:0051310]; mitotic cell cycle [GO:0000278]; mitotic spindle assembly checkpoint signaling [GO:0007094]; muscle organ development [GO:0007517]; negative regulation of DNA-templated transcription [GO:0045892]; protein transport [GO:0015031]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; regulation of striated muscle tissue development [GO:0016202]; response to xenobiotic stimulus [GO:0009410]; ventricular system development [GO:0021591] axoneme [GO:0005930]; centrosome [GO:0005813]; chromatin [GO:0000785]; chromosome, centromeric region [GO:0000775]; ciliary basal body [GO:0036064]; ciliary transition fiber [GO:0097539]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; kinetochore [GO:0000776]; midbody [GO:0030496]; nuclear envelope [GO:0005635]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; outer kinetochore [GO:0000940]; perinuclear region of cytoplasm [GO:0048471]; pronucleus [GO:0045120]; spindle [GO:0005819]; spindle pole [GO:0000922] chromatin binding [GO:0003682]; DNA-binding transcription factor binding [GO:0140297]; dynein complex binding [GO:0070840]; microtubule binding [GO:0008017]; protein homodimerization activity [GO:0042803] g4218.t1 Q9BXW4 76.271 118 2.04e-62 190.0 sp|Q9BXW4|MLP3C_HUMAN Microtubule-associated protein 1 light chain 3 gamma OS=Homo sapiens OX=9606 GN=MAP1LC3C PE=1 SV=1 MLP3C_HUMAN reviewed Microtubule-associated protein 1 light chain 3 gamma (Autophagy-related protein LC3 C) (Autophagy-related ubiquitin-like modifier LC3 C) (MAP1 light chain 3-like protein 3) (Microtubule-associated proteins 1A/1B light chain 3C) (MAP1A/MAP1B LC3 C) (MAP1A/MAP1B light chain 3 C) Homo sapiens (Human) GO:0000045; GO:0000421; GO:0000423; GO:0005776; GO:0005829; GO:0005874; GO:0006995; GO:0008429; GO:0009267; GO:0012505; GO:0016236; GO:0031090; GO:0031410; GO:0031625; GO:0032527; GO:0035973; GO:0036464; GO:0097352 aggrephagy [GO:0035973]; autophagosome assembly [GO:0000045]; autophagosome maturation [GO:0097352]; cellular response to nitrogen starvation [GO:0006995]; cellular response to starvation [GO:0009267]; macroautophagy [GO:0016236]; mitophagy [GO:0000423]; protein exit from endoplasmic reticulum [GO:0032527] autophagosome [GO:0005776]; autophagosome membrane [GO:0000421]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; microtubule [GO:0005874]; organelle membrane [GO:0031090] phosphatidylethanolamine binding [GO:0008429]; ubiquitin protein ligase binding [GO:0031625] g4219.t1 Q1G7G9 29.642 587 3.34e-43 176.0 sp|Q1G7G9|TALD3_CHICK TALPID3 protein OS=Gallus gallus OX=9031 GN=TALPID3 PE=2 SV=2 TALD3_CHICK reviewed TALPID3 protein Gallus gallus (Chicken) GO:0005737; GO:0005813; GO:0005814; GO:0007224; GO:0036064; GO:0044458; GO:0051642; GO:0060271 centrosome localization [GO:0051642]; cilium assembly [GO:0060271]; motile cilium assembly [GO:0044458]; smoothened signaling pathway [GO:0007224] centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737] g4220.t1 Q6PCG7 44.803 712 3.1200000000000004e-160 480.0 sp|Q6PCG7|I2BLB_XENLA Interferon regulatory factor 2-binding protein-like B OS=Xenopus laevis OX=8355 GN=irf2bpl-b PE=2 SV=1 g4225.t2 Q99PP2 34.615 312 2.88e-45 184.0 sp|Q99PP2|ZN318_MOUSE Zinc finger protein 318 OS=Mus musculus OX=10090 GN=Znf318 PE=1 SV=3 ZN318_MOUSE reviewed Zinc finger protein 318 (Testicular zinc finger protein) Mus musculus (Mouse) GO:0003676; GO:0005634; GO:0005654; GO:0005829; GO:0008270; GO:0042803; GO:0045892; GO:0045893; GO:0046982; GO:0051321 meiotic cell cycle [GO:0051321]; negative regulation of DNA-templated transcription [GO:0045892]; positive regulation of DNA-templated transcription [GO:0045893] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] nucleic acid binding [GO:0003676]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; zinc ion binding [GO:0008270] g4227.t1 P83673 54.783 115 2.2099999999999997e-23 93.6 sp|P83673|LYS1_CRAVI Lysozyme 1 OS=Crassostrea virginica OX=6565 GN=lysoz1 PE=1 SV=3 LYS1_CRAVI reviewed Lysozyme 1 (EC 3.2.1.17) (1,4-beta-N-acetylmuramidase 1) (Invertebrate-type lysozyme 1) (cv-lysozyme 1) Crassostrea virginica (Eastern oyster) GO:0003796; GO:0005576; GO:0031640; GO:0050829; GO:0050830 defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; killing of cells of another organism [GO:0031640] extracellular region [GO:0005576] lysozyme activity [GO:0003796] g4227.t2 P83673 54.783 115 1.75e-23 94.0 sp|P83673|LYS1_CRAVI Lysozyme 1 OS=Crassostrea virginica OX=6565 GN=lysoz1 PE=1 SV=3 LYS1_CRAVI reviewed Lysozyme 1 (EC 3.2.1.17) (1,4-beta-N-acetylmuramidase 1) (Invertebrate-type lysozyme 1) (cv-lysozyme 1) Crassostrea virginica (Eastern oyster) GO:0003796; GO:0005576; GO:0031640; GO:0050829; GO:0050830 defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; killing of cells of another organism [GO:0031640] extracellular region [GO:0005576] lysozyme activity [GO:0003796] g4228.t1 P17200 33.407 455 5.84e-68 228.0 sp|P17200|ACM4_CHICK Muscarinic acetylcholine receptor M4 OS=Gallus gallus OX=9031 GN=CHRM4 PE=2 SV=1 g4231.t1 A3KP37 73.596 178 4.72e-92 275.0 sp|A3KP37|NDUF5_DANRE Arginine-hydroxylase NDUFAF5, mitochondrial OS=Danio rerio OX=7955 GN=ndufaf5 PE=2 SV=1 g4233.t1 P48601 89.342 441 0.0 771.0 sp|P48601|PRS4_DROME 26S proteasome regulatory subunit 4 OS=Drosophila melanogaster OX=7227 GN=Rpt2 PE=1 SV=2 g4235.t1 Q5RBP4 66.294 537 0.0 759.0 sp|Q5RBP4|EHD1_PONAB EH domain-containing protein 1 OS=Pongo abelii OX=9601 GN=EHD1 PE=2 SV=1 EHD1_PONAB reviewed EH domain-containing protein 1 Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0005509; GO:0005524; GO:0005525; GO:0005886; GO:0005929; GO:0006886; GO:0006897; GO:0010008; GO:0020018; GO:0031175; GO:0031901; GO:0032456; GO:0055038; GO:0060271; GO:0061512; GO:1901741; GO:1990090; GO:2001137 cellular response to nerve growth factor stimulus [GO:1990090]; cilium assembly [GO:0060271]; endocytic recycling [GO:0032456]; endocytosis [GO:0006897]; intracellular protein transport [GO:0006886]; neuron projection development [GO:0031175]; positive regulation of endocytic recycling [GO:2001137]; positive regulation of myoblast fusion [GO:1901741]; protein localization to cilium [GO:0061512] ciliary pocket membrane [GO:0020018]; cilium [GO:0005929]; early endosome membrane [GO:0031901]; endosome membrane [GO:0010008]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038] ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; GTP binding [GO:0005525] g4237.t1 Q9VBW3 42.466 292 1.1700000000000001e-75 262.0 sp|Q9VBW3|CAD96_DROME Tyrosine kinase receptor Cad96Ca OS=Drosophila melanogaster OX=7227 GN=Cad96Ca PE=2 SV=2 CAD96_DROME reviewed Tyrosine kinase receptor Cad96Ca (EC 2.7.10.1) (Cadherin-96Ca) (Tyrosine kinase receptor HD-14) Drosophila melanogaster (Fruit fly) GO:0004713; GO:0004714; GO:0005509; GO:0005524; GO:0005886; GO:0006468; GO:0007030; GO:0007156; GO:0007169; GO:0016339; GO:0042060; GO:0043235; GO:0045177; GO:0045792; GO:0051897; GO:0090303 calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; Golgi organization [GO:0007030]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell size [GO:0045792]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of wound healing [GO:0090303]; protein phosphorylation [GO:0006468]; wound healing [GO:0042060] apical part of cell [GO:0045177]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; protein tyrosine kinase activity [GO:0004713]; transmembrane receptor protein tyrosine kinase activity [GO:0004714] g4238.t1 Q9VBW3 42.395 309 2.11e-81 278.0 sp|Q9VBW3|CAD96_DROME Tyrosine kinase receptor Cad96Ca OS=Drosophila melanogaster OX=7227 GN=Cad96Ca PE=2 SV=2 CAD96_DROME reviewed Tyrosine kinase receptor Cad96Ca (EC 2.7.10.1) (Cadherin-96Ca) (Tyrosine kinase receptor HD-14) Drosophila melanogaster (Fruit fly) GO:0004713; GO:0004714; GO:0005509; GO:0005524; GO:0005886; GO:0006468; GO:0007030; GO:0007156; GO:0007169; GO:0016339; GO:0042060; GO:0043235; GO:0045177; GO:0045792; GO:0051897; GO:0090303 calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; Golgi organization [GO:0007030]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell size [GO:0045792]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of wound healing [GO:0090303]; protein phosphorylation [GO:0006468]; wound healing [GO:0042060] apical part of cell [GO:0045177]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; protein tyrosine kinase activity [GO:0004713]; transmembrane receptor protein tyrosine kinase activity [GO:0004714] g4239.t1 Q6ZMV9 68.72 422 0.0 618.0 sp|Q6ZMV9|KIF6_HUMAN Kinesin-like protein KIF6 OS=Homo sapiens OX=9606 GN=KIF6 PE=1 SV=3 g4240.t1 Q6ZMV9 40.625 256 5.3699999999999994e-42 161.0 sp|Q6ZMV9|KIF6_HUMAN Kinesin-like protein KIF6 OS=Homo sapiens OX=9606 GN=KIF6 PE=1 SV=3 g4242.t1 P60899 82.906 117 4.99e-74 219.0 sp|P60899|RPB9_PIG DNA-directed RNA polymerase II subunit RPB9 OS=Sus scrofa OX=9823 GN=POLR2I PE=1 SV=1 g4243.t1 D3ZVP7 42.979 235 6.1e-60 191.0 sp|D3ZVP7|ZFY21_RAT Zinc finger FYVE domain-containing protein 21 OS=Rattus norvegicus OX=10116 GN=Zfyve21 PE=3 SV=1 g4244.t1 Q5U2V5 56.216 185 2.3099999999999997e-67 214.0 sp|Q5U2V5|CRLS1_RAT Cardiolipin synthase (CMP-forming) OS=Rattus norvegicus OX=10116 GN=Crls1 PE=2 SV=1 g4245.t1 Q5RAL9 55.866 179 4.280000000000001e-59 186.0 sp|Q5RAL9|GNA1_PONAB Glucosamine 6-phosphate N-acetyltransferase OS=Pongo abelii OX=9601 GN=GNPNAT1 PE=2 SV=2 GNA1_PONAB reviewed Glucosamine 6-phosphate N-acetyltransferase (EC 2.3.1.4) (Phosphoglucosamine acetylase) (Phosphoglucosamine transacetylase) Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0000139; GO:0004343; GO:0005770; GO:0005793; GO:0006048; GO:0010008; GO:0042802; GO:1990830 cellular response to leukemia inhibitory factor [GO:1990830]; UDP-N-acetylglucosamine biosynthetic process [GO:0006048] endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endosome membrane [GO:0010008]; Golgi membrane [GO:0000139]; late endosome [GO:0005770] glucosamine 6-phosphate N-acetyltransferase activity [GO:0004343]; identical protein binding [GO:0042802] g4246.t1 Q0MQ83 49.01 202 5.58e-65 209.0 sp|Q0MQ83|CIA30_GORGO Complex I intermediate-associated protein 30, mitochondrial OS=Gorilla gorilla gorilla OX=9595 GN=NDUFAF1 PE=2 SV=1 g4247.t1 P61023 55.897 195 5.590000000000001e-56 177.0 sp|P61023|CHP1_RAT Calcineurin B homologous protein 1 OS=Rattus norvegicus OX=10116 GN=Chp1 PE=1 SV=2 CHP1_RAT reviewed Calcineurin B homologous protein 1 (Calcineurin B-like protein) (Calcium-binding protein CHP) (Calcium-binding protein p22) (EF-hand calcium-binding domain-containing protein p22) Rattus norvegicus (Rat) GO:0000139; GO:0001578; GO:0001933; GO:0004860; GO:0005509; GO:0005634; GO:0005737; GO:0005783; GO:0005793; GO:0005886; GO:0006469; GO:0006611; GO:0006903; GO:0006906; GO:0008017; GO:0010560; GO:0010923; GO:0015385; GO:0015630; GO:0019900; GO:0022406; GO:0030133; GO:0031122; GO:0031397; GO:0031953; GO:0032088; GO:0032417; GO:0042308; GO:0045121; GO:0048306; GO:0050821; GO:0051222; GO:0051259; GO:0051453; GO:0061024; GO:0061025; GO:0070885; GO:0071073; GO:0071468; GO:0090314; GO:1990351 cellular response to acidic pH [GO:0071468]; cytoplasmic microtubule organization [GO:0031122]; membrane docking [GO:0022406]; membrane fusion [GO:0061025]; membrane organization [GO:0061024]; microtubule bundle formation [GO:0001578]; negative regulation of calcineurin-NFAT signaling cascade [GO:0070885]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of phosphatase activity [GO:0010923]; negative regulation of protein autophosphorylation [GO:0031953]; negative regulation of protein import into nucleus [GO:0042308]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of protein ubiquitination [GO:0031397]; positive regulation of glycoprotein biosynthetic process [GO:0010560]; positive regulation of phospholipid biosynthetic process [GO:0071073]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of protein transport [GO:0051222]; positive regulation of sodium:proton antiporter activity [GO:0032417]; protein complex oligomerization [GO:0051259]; protein export from nucleus [GO:0006611]; protein stabilization [GO:0050821]; regulation of intracellular pH [GO:0051453]; vesicle fusion [GO:0006906]; vesicle targeting [GO:0006903] cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi membrane [GO:0000139]; membrane raft [GO:0045121]; microtubule cytoskeleton [GO:0015630]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; transport vesicle [GO:0030133]; transporter complex [GO:1990351] calcium ion binding [GO:0005509]; calcium-dependent protein binding [GO:0048306]; kinase binding [GO:0019900]; microtubule binding [GO:0008017]; protein kinase inhibitor activity [GO:0004860]; sodium:proton antiporter activity [GO:0015385] g4248.t1 Q9WVJ4 61.364 88 1.0800000000000001e-31 113.0 sp|Q9WVJ4|SYJ2B_RAT Synaptojanin-2-binding protein OS=Rattus norvegicus OX=10116 GN=Synj2bp PE=1 SV=2 g4250.t1 Q8NFU1 52.861 367 2.2400000000000002e-132 399.0 sp|Q8NFU1|BEST2_HUMAN Bestrophin-2a OS=Homo sapiens OX=9606 GN=BEST2 PE=1 SV=1 BEST2_HUMAN reviewed Bestrophin-2a (Vitelliform macular dystrophy 2-like protein 1) Homo sapiens (Human) GO:0005217; GO:0005254; GO:0005886; GO:0005929; GO:0007608; GO:0016323; GO:0034707; GO:0046872; GO:0051899; GO:0099094; GO:0099095; GO:0160133; GO:1902476 chloride transmembrane transport [GO:1902476]; membrane depolarization [GO:0051899]; sensory perception of smell [GO:0007608] basolateral plasma membrane [GO:0016323]; chloride channel complex [GO:0034707]; cilium [GO:0005929]; plasma membrane [GO:0005886] bicarbonate channel activity [GO:0160133]; chloride channel activity [GO:0005254]; intracellularly ligand-gated monoatomic ion channel activity [GO:0005217]; ligand-gated monoatomic anion channel activity [GO:0099095]; ligand-gated monoatomic cation channel activity [GO:0099094]; metal ion binding [GO:0046872] g4252.t1 Q28IT1 38.82 322 1.0699999999999999e-67 226.0 sp|Q28IT1|ERLEC_XENTR Endoplasmic reticulum lectin 1 OS=Xenopus tropicalis OX=8364 GN=erlec1 PE=2 SV=1 g4253.t1 Q8VEH8 61.111 72 1.5e-25 101.0 sp|Q8VEH8|ERLEC_MOUSE Endoplasmic reticulum lectin 1 OS=Mus musculus OX=10090 GN=Erlec1 PE=1 SV=1 g4263.t1 A8C750 36.212 1436 0.0 736.0 sp|A8C750|THADA_CANLF tRNA (32-2'-O)-methyltransferase regulator THADA OS=Canis lupus familiaris OX=9615 GN=THADA PE=2 SV=1 g4264.t1 P46952 42.606 284 5.08e-75 233.0 sp|P46952|3HAO_HUMAN 3-hydroxyanthranilate 3,4-dioxygenase OS=Homo sapiens OX=9606 GN=HAAO PE=1 SV=2 3HAO_HUMAN reviewed 3-hydroxyanthranilate 3,4-dioxygenase (EC 1.13.11.6) (3-hydroxyanthranilate oxygenase) (3-HAO) (h3HAO) (3-hydroxyanthranilic acid dioxygenase) (HAD) Homo sapiens (Human) GO:0000334; GO:0005737; GO:0005829; GO:0006569; GO:0008198; GO:0009055; GO:0009435; GO:0010043; GO:0019805; GO:0034354; GO:0043420; GO:0046686; GO:0046874; GO:0070050 'de novo' NAD+ biosynthetic process from L-tryptophan [GO:0034354]; anthranilate metabolic process [GO:0043420]; L-tryptophan catabolic process [GO:0006569]; NAD+ biosynthetic process [GO:0009435]; neuron cellular homeostasis [GO:0070050]; quinolinate biosynthetic process [GO:0019805]; quinolinate metabolic process [GO:0046874]; response to cadmium ion [GO:0046686]; response to zinc ion [GO:0010043] cytoplasm [GO:0005737]; cytosol [GO:0005829] 3-hydroxyanthranilate 3,4-dioxygenase activity [GO:0000334]; electron transfer activity [GO:0009055]; ferrous iron binding [GO:0008198] g4265.t1 Q9Z0U4 35.115 393 7.789999999999999e-74 265.0 sp|Q9Z0U4|GABR1_RAT Gamma-aminobutyric acid type B receptor subunit 1 OS=Rattus norvegicus OX=10116 GN=Gabbr1 PE=1 SV=2 GABR1_RAT reviewed Gamma-aminobutyric acid type B receptor subunit 1 (GABA-B receptor 1) (GABA-B-R1) (GABA-BR1) (GABABR1) (Gb1) Rattus norvegicus (Rat) GO:0001649; GO:0004965; GO:0005615; GO:0005737; GO:0005789; GO:0005886; GO:0007193; GO:0007214; GO:0008021; GO:0008285; GO:0014048; GO:0014049; GO:0014053; GO:0016020; GO:0030673; GO:0031966; GO:0032811; GO:0033602; GO:0035094; GO:0038037; GO:0038039; GO:0042734; GO:0043025; GO:0043197; GO:0043198; GO:0043204; GO:0045211; GO:0045471; GO:0046982; GO:0050805; GO:0051932; GO:0060124; GO:0097060; GO:0098685; GO:0098793; GO:0098978; GO:0098982; GO:0099579; GO:0150047; GO:0150099; GO:1902710; GO:1902712; GO:1990430 adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; gamma-aminobutyric acid signaling pathway [GO:0007214]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of dopamine secretion [GO:0033602]; negative regulation of epinephrine secretion [GO:0032811]; negative regulation of gamma-aminobutyric acid secretion [GO:0014053]; negative regulation of synaptic transmission [GO:0050805]; neuron-glial cell signaling [GO:0150099]; osteoblast differentiation [GO:0001649]; positive regulation of glutamate secretion [GO:0014049]; positive regulation of growth hormone secretion [GO:0060124]; regulation of glutamate secretion [GO:0014048]; response to ethanol [GO:0045471]; response to nicotine [GO:0035094]; synaptic transmission, GABAergic [GO:0051932] axolemma [GO:0030673]; cytoplasm [GO:0005737]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; endoplasmic reticulum membrane [GO:0005789]; extracellular space [GO:0005615]; G protein-coupled GABA receptor complex [GO:1902712]; G protein-coupled receptor dimeric complex [GO:0038037]; G protein-coupled receptor heterodimeric complex [GO:0038039]; GABA receptor complex [GO:1902710]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; mitochondrial membrane [GO:0031966]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynapse [GO:0098793]; presynaptic membrane [GO:0042734]; Schaffer collateral - CA1 synapse [GO:0098685]; synaptic membrane [GO:0097060]; synaptic vesicle [GO:0008021] extracellular matrix protein binding [GO:1990430]; G protein-coupled GABA receptor activity [GO:0004965]; G protein-coupled neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential [GO:0099579]; G protein-coupled neurotransmitter receptor activity involved in regulation of presynaptic membrane potential [GO:0150047]; protein heterodimerization activity [GO:0046982] g4265.t1 Q9Z0U4 30.96 323 4.08e-31 135.0 sp|Q9Z0U4|GABR1_RAT Gamma-aminobutyric acid type B receptor subunit 1 OS=Rattus norvegicus OX=10116 GN=Gabbr1 PE=1 SV=2 GABR1_RAT reviewed Gamma-aminobutyric acid type B receptor subunit 1 (GABA-B receptor 1) (GABA-B-R1) (GABA-BR1) (GABABR1) (Gb1) Rattus norvegicus (Rat) GO:0001649; GO:0004965; GO:0005615; GO:0005737; GO:0005789; GO:0005886; GO:0007193; GO:0007214; GO:0008021; GO:0008285; GO:0014048; GO:0014049; GO:0014053; GO:0016020; GO:0030673; GO:0031966; GO:0032811; GO:0033602; GO:0035094; GO:0038037; GO:0038039; GO:0042734; GO:0043025; GO:0043197; GO:0043198; GO:0043204; GO:0045211; GO:0045471; GO:0046982; GO:0050805; GO:0051932; GO:0060124; GO:0097060; GO:0098685; GO:0098793; GO:0098978; GO:0098982; GO:0099579; GO:0150047; GO:0150099; GO:1902710; GO:1902712; GO:1990430 adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; gamma-aminobutyric acid signaling pathway [GO:0007214]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of dopamine secretion [GO:0033602]; negative regulation of epinephrine secretion [GO:0032811]; negative regulation of gamma-aminobutyric acid secretion [GO:0014053]; negative regulation of synaptic transmission [GO:0050805]; neuron-glial cell signaling [GO:0150099]; osteoblast differentiation [GO:0001649]; positive regulation of glutamate secretion [GO:0014049]; positive regulation of growth hormone secretion [GO:0060124]; regulation of glutamate secretion [GO:0014048]; response to ethanol [GO:0045471]; response to nicotine [GO:0035094]; synaptic transmission, GABAergic [GO:0051932] axolemma [GO:0030673]; cytoplasm [GO:0005737]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; endoplasmic reticulum membrane [GO:0005789]; extracellular space [GO:0005615]; G protein-coupled GABA receptor complex [GO:1902712]; G protein-coupled receptor dimeric complex [GO:0038037]; G protein-coupled receptor heterodimeric complex [GO:0038039]; GABA receptor complex [GO:1902710]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; mitochondrial membrane [GO:0031966]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynapse [GO:0098793]; presynaptic membrane [GO:0042734]; Schaffer collateral - CA1 synapse [GO:0098685]; synaptic membrane [GO:0097060]; synaptic vesicle [GO:0008021] extracellular matrix protein binding [GO:1990430]; G protein-coupled GABA receptor activity [GO:0004965]; G protein-coupled neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential [GO:0099579]; G protein-coupled neurotransmitter receptor activity involved in regulation of presynaptic membrane potential [GO:0150047]; protein heterodimerization activity [GO:0046982] g4268.t1 Q8CEQ0 69.935 306 1.05e-144 417.0 sp|Q8CEQ0|CDKL1_MOUSE Cyclin-dependent kinase-like 1 OS=Mus musculus OX=10090 GN=Cdkl1 PE=2 SV=1 g4269.t1 Q61161 42.418 910 0.0 657.0 sp|Q61161|M4K2_MOUSE Mitogen-activated protein kinase kinase kinase kinase 2 OS=Mus musculus OX=10090 GN=Map4k2 PE=1 SV=1 g4269.t2 Q61161 41.981 929 0.0 659.0 sp|Q61161|M4K2_MOUSE Mitogen-activated protein kinase kinase kinase kinase 2 OS=Mus musculus OX=10090 GN=Map4k2 PE=1 SV=1 g4269.t3 Q61161 41.935 930 0.0 659.0 sp|Q61161|M4K2_MOUSE Mitogen-activated protein kinase kinase kinase kinase 2 OS=Mus musculus OX=10090 GN=Map4k2 PE=1 SV=1 g4269.t4 Q61161 41.693 933 0.0 651.0 sp|Q61161|M4K2_MOUSE Mitogen-activated protein kinase kinase kinase kinase 2 OS=Mus musculus OX=10090 GN=Map4k2 PE=1 SV=1 g4270.t1 Q792Q4 78.218 101 5.85e-53 164.0 sp|Q792Q4|CRIPT_RAT Cysteine-rich PDZ-binding protein OS=Rattus norvegicus OX=10116 GN=Cript PE=1 SV=1 g4272.t1 Q9HAR2 35.907 259 1.7e-33 144.0 sp|Q9HAR2|AGRL3_HUMAN Adhesion G protein-coupled receptor L3 OS=Homo sapiens OX=9606 GN=ADGRL3 PE=1 SV=2 g4272.t2 Q9HAR2 35.907 259 3.18e-33 143.0 sp|Q9HAR2|AGRL3_HUMAN Adhesion G protein-coupled receptor L3 OS=Homo sapiens OX=9606 GN=ADGRL3 PE=1 SV=2 g4273.t1 A6QLU6 32.22 419 2.02e-41 168.0 sp|A6QLU6|AGRD1_BOVIN Adhesion G-protein coupled receptor D1 OS=Bos taurus OX=9913 GN=ADGRD1 PE=2 SV=1 AGRD1_BOVIN reviewed Adhesion G-protein coupled receptor D1 (G-protein coupled receptor 133) [Cleaved into: Adhesion G-protein coupled receptor D1, N-terminal fragment (ADGRD1 N-terminal fragment); Adhesion G-protein coupled receptor D1, C-terminal fragment (ADGRD1 C-terminal fragment)] Bos taurus (Bovine) GO:0004930; GO:0005886; GO:0007166; GO:0007186; GO:0007189 adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186] plasma membrane [GO:0005886] G protein-coupled receptor activity [GO:0004930] g4275.t1 Q9JHB5 47.826 276 3.59e-78 242.0 sp|Q9JHB5|TSNAX_RAT Translin-associated protein X OS=Rattus norvegicus OX=10116 GN=Tsnax PE=1 SV=1 TSNAX_RAT reviewed Translin-associated protein X (Translin-associated factor X) Rattus norvegicus (Rat) GO:0003723; GO:0004521; GO:0005634; GO:0005654; GO:0005737; GO:0005794; GO:0007283; GO:0030154; GO:0030422; GO:0031687; GO:0043565; GO:0044877; GO:0046872; GO:0048471; GO:1902555 cell differentiation [GO:0030154]; siRNA processing [GO:0030422]; spermatogenesis [GO:0007283] cytoplasm [GO:0005737]; endoribonuclease complex [GO:1902555]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471] A2A adenosine receptor binding [GO:0031687]; metal ion binding [GO:0046872]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; RNA endonuclease activity [GO:0004521]; sequence-specific DNA binding [GO:0043565] g4279.t1 Q5RBN9 50.343 437 1.01e-127 395.0 sp|Q5RBN9|TAD2B_PONAB Transcriptional adapter 2-beta OS=Pongo abelii OX=9601 GN=TADA2B PE=2 SV=1 TAD2B_PONAB reviewed Transcriptional adapter 2-beta Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0003682; GO:0003713; GO:0005634; GO:0006338; GO:0006357; GO:0008270; GO:0070461 chromatin remodeling [GO:0006338]; regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634]; SAGA-type complex [GO:0070461] chromatin binding [GO:0003682]; transcription coactivator activity [GO:0003713]; zinc ion binding [GO:0008270] g4280.t1 Q8VCD5 45.566 654 4.3199999999999996e-176 518.0 sp|Q8VCD5|MED17_MOUSE Mediator of RNA polymerase II transcription subunit 17 OS=Mus musculus OX=10090 GN=Med17 PE=1 SV=1 g4280.t2 Q8VCD5 45.455 649 2.3999999999999997e-176 518.0 sp|Q8VCD5|MED17_MOUSE Mediator of RNA polymerase II transcription subunit 17 OS=Mus musculus OX=10090 GN=Med17 PE=1 SV=1 g4282.t1 Q5RCU0 77.941 68 2.56e-31 124.0 sp|Q5RCU0|TF2AA_PONAB Transcription initiation factor IIA subunit 1 OS=Pongo abelii OX=9601 GN=GTF2A1 PE=2 SV=1 g4283.t1 Q8IWX5 37.438 406 1.08e-78 251.0 sp|Q8IWX5|SGPP2_HUMAN Sphingosine-1-phosphate phosphatase 2 OS=Homo sapiens OX=9606 GN=SGPP2 PE=1 SV=1 g4284.t1 Q8IWX5 35.941 409 1.7999999999999997e-74 240.0 sp|Q8IWX5|SGPP2_HUMAN Sphingosine-1-phosphate phosphatase 2 OS=Homo sapiens OX=9606 GN=SGPP2 PE=1 SV=1 g4285.t1 Q8IWX5 35.128 390 1.74e-62 209.0 sp|Q8IWX5|SGPP2_HUMAN Sphingosine-1-phosphate phosphatase 2 OS=Homo sapiens OX=9606 GN=SGPP2 PE=1 SV=1 g4286.t1 P13255 57.475 301 6.25e-122 354.0 sp|P13255|GNMT_RAT Glycine N-methyltransferase OS=Rattus norvegicus OX=10116 GN=Gnmt PE=1 SV=2 GNMT_RAT reviewed Glycine N-methyltransferase (EC 2.1.1.20) (Folate-binding protein) Rattus norvegicus (Rat) GO:0005542; GO:0005829; GO:0005977; GO:0006111; GO:0006544; GO:0006555; GO:0006730; GO:0008757; GO:0016594; GO:0017174; GO:0032259; GO:0034708; GO:0042802; GO:0046498; GO:0046500; GO:0051289; GO:0098603; GO:1901052; GO:1904047 glycine metabolic process [GO:0006544]; glycogen metabolic process [GO:0005977]; methionine metabolic process [GO:0006555]; methylation [GO:0032259]; one-carbon metabolic process [GO:0006730]; protein homotetramerization [GO:0051289]; regulation of gluconeogenesis [GO:0006111]; S-adenosylhomocysteine metabolic process [GO:0046498]; S-adenosylmethionine metabolic process [GO:0046500]; sarcosine metabolic process [GO:1901052] cytosol [GO:0005829]; methyltransferase complex [GO:0034708] folic acid binding [GO:0005542]; glycine binding [GO:0016594]; glycine N-methyltransferase activity [GO:0017174]; identical protein binding [GO:0042802]; S-adenosyl-L-methionine binding [GO:1904047]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]; selenol Se-methyltransferase activity [GO:0098603] g4287.t1 Q9CQ40 45.27 148 1.27e-39 136.0 sp|Q9CQ40|RM49_MOUSE Large ribosomal subunit protein mL49 OS=Mus musculus OX=10090 GN=Mrpl49 PE=1 SV=1 g4288.t1 P62861 59.398 133 9.22e-47 150.0 sp|P62861|RS30_HUMAN Ubiquitin-like FUBI-ribosomal protein eS30 fusion protein OS=Homo sapiens OX=9606 GN=FAU PE=1 SV=2 RS30_HUMAN reviewed Ubiquitin-like FUBI-ribosomal protein eS30 fusion protein (FAU ubiquitin like and ribosomal protein S30 fusion) [Cleaved into: Ubiquitin-like protein FUBI; Small ribosomal subunit protein eS30 (40S ribosomal protein S30)] Homo sapiens (Human) GO:0002181; GO:0002227; GO:0003723; GO:0003735; GO:0005615; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006412; GO:0015935; GO:0016567; GO:0019731; GO:0019941; GO:0022626; GO:0022627; GO:0031386; GO:0031625; GO:0050830; GO:0061844 antibacterial humoral response [GO:0019731]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; cytoplasmic translation [GO:0002181]; defense response to Gram-positive bacterium [GO:0050830]; innate immune response in mucosa [GO:0002227]; modification-dependent protein catabolic process [GO:0019941]; protein ubiquitination [GO:0016567]; translation [GO:0006412] cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]; extracellular space [GO:0005615]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; small ribosomal subunit [GO:0015935] protein tag activity [GO:0031386]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; ubiquitin protein ligase binding [GO:0031625] g4290.t1 P59190 64.286 84 1.5200000000000002e-35 122.0 sp|P59190|RAB15_HUMAN Ras-related protein Rab-15 OS=Homo sapiens OX=9606 GN=RAB15 PE=1 SV=1 RAB15_HUMAN reviewed Ras-related protein Rab-15 (EC 3.6.5.2) Homo sapiens (Human) GO:0003925; GO:0005525; GO:0005737; GO:0005886; GO:0005929; GO:0006887; GO:0006898; GO:0010008; GO:0015031; GO:0032482; GO:0046872; GO:0048471; GO:0070062; GO:1903307 exocytosis [GO:0006887]; positive regulation of regulated secretory pathway [GO:1903307]; protein transport [GO:0015031]; Rab protein signal transduction [GO:0032482]; receptor-mediated endocytosis [GO:0006898] cilium [GO:0005929]; cytoplasm [GO:0005737]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886] G protein activity [GO:0003925]; GTP binding [GO:0005525]; metal ion binding [GO:0046872] g4291.t1 O00471 47.896 499 6.310000000000001e-163 480.0 sp|O00471|EXOC5_HUMAN Exocyst complex component 5 OS=Homo sapiens OX=9606 GN=EXOC5 PE=1 SV=1 EXOC5_HUMAN reviewed Exocyst complex component 5 (Exocyst complex component Sec10) (hSec10) Homo sapiens (Human) GO:0000145; GO:0000281; GO:0001736; GO:0005737; GO:0005829; GO:0006887; GO:0006892; GO:0006893; GO:0006904; GO:0015031; GO:0030496; GO:0031267; GO:0048873; GO:0072659; GO:0090148; GO:0090522; GO:1904019; GO:1905515 epithelial cell apoptotic process [GO:1904019]; establishment of planar polarity [GO:0001736]; exocytosis [GO:0006887]; Golgi to plasma membrane transport [GO:0006893]; homeostasis of number of cells within a tissue [GO:0048873]; membrane fission [GO:0090148]; mitotic cytokinesis [GO:0000281]; non-motile cilium assembly [GO:1905515]; post-Golgi vesicle-mediated transport [GO:0006892]; protein localization to plasma membrane [GO:0072659]; protein transport [GO:0015031]; vesicle docking involved in exocytosis [GO:0006904]; vesicle tethering involved in exocytosis [GO:0090522] cytoplasm [GO:0005737]; cytosol [GO:0005829]; exocyst [GO:0000145]; midbody [GO:0030496] small GTPase binding [GO:0031267] g4292.t1 P97878 53.714 175 5.87e-57 193.0 sp|P97878|EXOC5_RAT Exocyst complex component 5 OS=Rattus norvegicus OX=10116 GN=Exoc5 PE=1 SV=1 EXOC5_RAT reviewed Exocyst complex component 5 (71 kDa component of rsec6/8 secretory complex) (Exocyst complex component Sec10) (p71) Rattus norvegicus (Rat) GO:0000145; GO:0001736; GO:0001738; GO:0006887; GO:0006893; GO:0015031; GO:0030496; GO:0031267; GO:0043066; GO:0048873; GO:0072659; GO:1904019; GO:1905515 epithelial cell apoptotic process [GO:1904019]; establishment of planar polarity [GO:0001736]; exocytosis [GO:0006887]; Golgi to plasma membrane transport [GO:0006893]; homeostasis of number of cells within a tissue [GO:0048873]; morphogenesis of a polarized epithelium [GO:0001738]; negative regulation of apoptotic process [GO:0043066]; non-motile cilium assembly [GO:1905515]; protein localization to plasma membrane [GO:0072659]; protein transport [GO:0015031] exocyst [GO:0000145]; midbody [GO:0030496] small GTPase binding [GO:0031267] g4295.t1 P30937 27.273 330 4.86e-25 107.0 sp|P30937|SSR4_RAT Somatostatin receptor type 4 OS=Rattus norvegicus OX=10116 GN=Sstr4 PE=1 SV=1 SSR4_RAT reviewed Somatostatin receptor type 4 (SS-4-R) (SS4-R) (SS4R) Rattus norvegicus (Rat) GO:0004994; GO:0005886; GO:0007218; GO:0016477; GO:0030900; GO:0042923; GO:0043005; GO:0070374; GO:0071385; GO:0090238; GO:0106072 cell migration [GO:0016477]; cellular response to glucocorticoid stimulus [GO:0071385]; forebrain development [GO:0030900]; negative regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0106072]; neuropeptide signaling pathway [GO:0007218]; positive regulation of arachidonate secretion [GO:0090238]; positive regulation of ERK1 and ERK2 cascade [GO:0070374] neuron projection [GO:0043005]; plasma membrane [GO:0005886] neuropeptide binding [GO:0042923]; somatostatin receptor activity [GO:0004994] g4296.t1 P80146 39.474 380 5.0599999999999996e-55 189.0 sp|P80146|SEPR_THESR Extracellular serine proteinase OS=Thermus sp. (strain Rt41A) OX=32063 PE=1 SV=3 g4297.t1 P80146 40.938 320 4.1500000000000002e-50 176.0 sp|P80146|SEPR_THESR Extracellular serine proteinase OS=Thermus sp. (strain Rt41A) OX=32063 PE=1 SV=3 g4298.t1 P80146 41.47 381 4.48e-80 254.0 sp|P80146|SEPR_THESR Extracellular serine proteinase OS=Thermus sp. (strain Rt41A) OX=32063 PE=1 SV=3 g4299.t1 P80146 44.528 265 4.76e-60 199.0 sp|P80146|SEPR_THESR Extracellular serine proteinase OS=Thermus sp. (strain Rt41A) OX=32063 PE=1 SV=3 g4299.t2 P80146 39.521 334 1.15e-62 207.0 sp|P80146|SEPR_THESR Extracellular serine proteinase OS=Thermus sp. (strain Rt41A) OX=32063 PE=1 SV=3 g4300.t1 P80146 39.633 381 5.69e-75 241.0 sp|P80146|SEPR_THESR Extracellular serine proteinase OS=Thermus sp. (strain Rt41A) OX=32063 PE=1 SV=3 g4301.t1 Q2HZX7 40.244 410 2.5499999999999998e-95 295.0 sp|Q2HZX7|FUZZY_XENTR Protein fuzzy homolog OS=Xenopus tropicalis OX=8364 GN=fuz PE=1 SV=1 FUZZY_XENTR reviewed Protein fuzzy homolog (Xfy) Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0001736; GO:0001843; GO:0005737; GO:0005856; GO:0008589; GO:0010172; GO:0015031; GO:0016192; GO:0048704; GO:0060271; GO:1905515 cilium assembly [GO:0060271]; embryonic body morphogenesis [GO:0010172]; embryonic skeletal system morphogenesis [GO:0048704]; establishment of planar polarity [GO:0001736]; neural tube closure [GO:0001843]; non-motile cilium assembly [GO:1905515]; protein transport [GO:0015031]; regulation of smoothened signaling pathway [GO:0008589]; vesicle-mediated transport [GO:0016192] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856] g4301.t2 Q2HZX7 40.587 409 5.24e-94 292.0 sp|Q2HZX7|FUZZY_XENTR Protein fuzzy homolog OS=Xenopus tropicalis OX=8364 GN=fuz PE=1 SV=1 FUZZY_XENTR reviewed Protein fuzzy homolog (Xfy) Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0001736; GO:0001843; GO:0005737; GO:0005856; GO:0008589; GO:0010172; GO:0015031; GO:0016192; GO:0048704; GO:0060271; GO:1905515 cilium assembly [GO:0060271]; embryonic body morphogenesis [GO:0010172]; embryonic skeletal system morphogenesis [GO:0048704]; establishment of planar polarity [GO:0001736]; neural tube closure [GO:0001843]; non-motile cilium assembly [GO:1905515]; protein transport [GO:0015031]; regulation of smoothened signaling pathway [GO:0008589]; vesicle-mediated transport [GO:0016192] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856] g4302.t1 P10394 25.872 344 5.35e-36 145.0 sp|P10394|POL4_DROME Retrovirus-related Pol polyprotein from transposon 412 OS=Drosophila melanogaster OX=7227 GN=POL PE=4 SV=1 g4304.t1 Q9UBU9 38.78 508 6.6900000000000006e-105 334.0 sp|Q9UBU9|NXF1_HUMAN Nuclear RNA export factor 1 OS=Homo sapiens OX=9606 GN=NXF1 PE=1 SV=1 NXF1_HUMAN reviewed Nuclear RNA export factor 1 (Tip-associated protein) (Tip-associating protein) (mRNA export factor TAP) Homo sapiens (Human) GO:0003723; GO:0003729; GO:0005634; GO:0005643; GO:0005654; GO:0005737; GO:0005829; GO:0006406; GO:0010494; GO:0015031; GO:0016607; GO:0016973; GO:0042272; GO:0042405 mRNA export from nucleus [GO:0006406]; poly(A)+ mRNA export from nucleus [GO:0016973]; protein transport [GO:0015031] cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; nuclear inclusion body [GO:0042405]; nuclear pore [GO:0005643]; nuclear RNA export factor complex [GO:0042272]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] mRNA binding [GO:0003729]; RNA binding [GO:0003723] g4305.t1 Q6P823 99.265 136 1.43e-94 271.0 sp|Q6P823|H33_XENTR Histone H3.3 OS=Xenopus tropicalis OX=8364 GN=TGas113e22.1 PE=1 SV=3 H33_XENTR reviewed Histone H3.3 Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0000786; GO:0003677; GO:0005634; GO:0030527; GO:0046982 nucleosome [GO:0000786]; nucleus [GO:0005634] DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; structural constituent of chromatin [GO:0030527] g4306.t1 Q96K21 39.869 153 2.5599999999999998e-23 99.0 sp|Q96K21|ANCHR_HUMAN Abscission/NoCut checkpoint regulator OS=Homo sapiens OX=9606 GN=ZFYVE19 PE=1 SV=3 ANCHR_HUMAN reviewed Abscission/NoCut checkpoint regulator (ANCHR) (MLL partner containing FYVE domain) (Zinc finger FYVE domain-containing protein 19) Homo sapiens (Human) GO:0005813; GO:0008270; GO:0030496; GO:0032154; GO:0032266; GO:0032466; GO:0044878; GO:0061952; GO:0090543 midbody abscission [GO:0061952]; mitotic cytokinesis checkpoint signaling [GO:0044878]; negative regulation of cytokinesis [GO:0032466] centrosome [GO:0005813]; cleavage furrow [GO:0032154]; Flemming body [GO:0090543]; midbody [GO:0030496] phosphatidylinositol-3-phosphate binding [GO:0032266]; zinc ion binding [GO:0008270] g4307.t1 Q9DAZ9 51.02 98 1.25e-25 104.0 sp|Q9DAZ9|ANCHR_MOUSE Abscission/NoCut checkpoint regulator OS=Mus musculus OX=10090 GN=Zfyve19 PE=1 SV=2 ANCHR_MOUSE reviewed Abscission/NoCut checkpoint regulator (ANCHR) (Zinc finger FYVE domain-containing protein 19) Mus musculus (Mouse) GO:0005813; GO:0008270; GO:0030496; GO:0032154; GO:0032266; GO:0032466; GO:0044878; GO:0061952; GO:0090543 midbody abscission [GO:0061952]; mitotic cytokinesis checkpoint signaling [GO:0044878]; negative regulation of cytokinesis [GO:0032466] centrosome [GO:0005813]; cleavage furrow [GO:0032154]; Flemming body [GO:0090543]; midbody [GO:0030496] phosphatidylinositol-3-phosphate binding [GO:0032266]; zinc ion binding [GO:0008270] g4308.t1 Q06609 85.759 323 0.0 583.0 sp|Q06609|RAD51_HUMAN DNA repair protein RAD51 homolog 1 OS=Homo sapiens OX=9606 GN=RAD51 PE=1 SV=1 RAD51_HUMAN reviewed DNA repair protein RAD51 homolog 1 (HsRAD51) (hRAD51) (EC 3.6.4.-) (RAD51 homolog A) Homo sapiens (Human) GO:0000150; GO:0000152; GO:0000228; GO:0000722; GO:0000724; GO:0000730; GO:0000781; GO:0000785; GO:0000793; GO:0000794; GO:0000800; GO:0001673; GO:0003682; GO:0003690; GO:0003697; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005739; GO:0005759; GO:0005813; GO:0005829; GO:0006281; GO:0006310; GO:0006312; GO:0006974; GO:0007131; GO:0008094; GO:0009410; GO:0009636; GO:0010165; GO:0010569; GO:0010833; GO:0016605; GO:0017116; GO:0019899; GO:0031297; GO:0032991; GO:0032993; GO:0035861; GO:0036297; GO:0042148; GO:0042802; GO:0048471; GO:0051321; GO:0070182; GO:0070192; GO:0071479; GO:0071480; GO:0072711; GO:0072719; GO:0072757; GO:0099182; GO:0140664; GO:1904631; GO:1990414; GO:1990426; GO:1990918; GO:2000001 cellular response to camptothecin [GO:0072757]; cellular response to cisplatin [GO:0072719]; cellular response to gamma radiation [GO:0071480]; cellular response to hydroxyurea [GO:0072711]; cellular response to ionizing radiation [GO:0071479]; chromosome organization involved in meiotic cell cycle [GO:0070192]; DNA damage response [GO:0006974]; DNA recombinase assembly [GO:0000730]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA strand invasion [GO:0042148]; double-strand break repair involved in meiotic recombination [GO:1990918]; double-strand break repair via homologous recombination [GO:0000724]; interstrand cross-link repair [GO:0036297]; meiotic cell cycle [GO:0051321]; mitotic recombination [GO:0006312]; mitotic recombination-dependent replication fork processing [GO:1990426]; reciprocal meiotic recombination [GO:0007131]; regulation of DNA damage checkpoint [GO:2000001]; regulation of double-strand break repair via homologous recombination [GO:0010569]; replication fork processing [GO:0031297]; replication-born double-strand break repair via sister chromatid exchange [GO:1990414]; response to glucoside [GO:1904631]; response to toxic substance [GO:0009636]; response to X-ray [GO:0010165]; response to xenobiotic stimulus [GO:0009410]; telomere maintenance via recombination [GO:0000722]; telomere maintenance via telomere lengthening [GO:0010833] centrosome [GO:0005813]; chromatin [GO:0000785]; chromosome, telomeric region [GO:0000781]; condensed chromosome [GO:0000793]; condensed nuclear chromosome [GO:0000794]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; lateral element [GO:0000800]; male germ cell nucleus [GO:0001673]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nuclear chromosome [GO:0000228]; nuclear ubiquitin ligase complex [GO:0000152]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; PML body [GO:0016605]; presynaptic intermediate filament cytoskeleton [GO:0099182]; protein-containing complex [GO:0032991]; protein-DNA complex [GO:0032993]; site of double-strand break [GO:0035861] ATP binding [GO:0005524]; ATP-dependent activity, acting on DNA [GO:0008094]; ATP-dependent DNA damage sensor activity [GO:0140664]; chromatin binding [GO:0003682]; DNA polymerase binding [GO:0070182]; DNA strand exchange activity [GO:0000150]; double-stranded DNA binding [GO:0003690]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; single-stranded DNA binding [GO:0003697]; single-stranded DNA helicase activity [GO:0017116] g4309.t1 Q5M969 37.109 256 3.01e-46 157.0 sp|Q5M969|NANP_RAT N-acylneuraminate-9-phosphatase OS=Rattus norvegicus OX=10116 GN=Nanp PE=1 SV=1 NANP_RAT reviewed N-acylneuraminate-9-phosphatase (EC 3.1.3.29) (Haloacid dehalogenase-like hydrolase domain-containing protein 4) (N-acetylneuraminate-9-phosphate phosphatase) (Neu5Ac-9-Pase) Rattus norvegicus (Rat) GO:0005829; GO:0006045; GO:0006054; GO:0006055; GO:0046380; GO:0046872; GO:0050124 CMP-N-acetylneuraminate biosynthetic process [GO:0006055]; N-acetylglucosamine biosynthetic process [GO:0006045]; N-acetylneuraminate biosynthetic process [GO:0046380]; N-acetylneuraminate metabolic process [GO:0006054] cytosol [GO:0005829] metal ion binding [GO:0046872]; N-acylneuraminate-9-phosphatase activity [GO:0050124] g4310.t1 A7RZW4 61.878 724 0.0 914.0 sp|A7RZW4|DPP3_NEMVE Dipeptidyl peptidase 3 OS=Nematostella vectensis OX=45351 GN=dpp3 PE=3 SV=1 DPP3_NEMVE reviewed Dipeptidyl peptidase 3 (EC 3.4.14.4) (Dipeptidyl aminopeptidase III) (Dipeptidyl arylamidase III) (Dipeptidyl peptidase III) (DPP III) Nematostella vectensis (Starlet sea anemone) GO:0004177; GO:0005737; GO:0006508; GO:0008235; GO:0008239; GO:0046872 proteolysis [GO:0006508] cytoplasm [GO:0005737] aminopeptidase activity [GO:0004177]; dipeptidyl-peptidase activity [GO:0008239]; metal ion binding [GO:0046872]; metalloexopeptidase activity [GO:0008235] g4311.t1 P27987 62.013 308 1.22e-128 414.0 sp|P27987|IP3KB_HUMAN Inositol-trisphosphate 3-kinase B OS=Homo sapiens OX=9606 GN=ITPKB PE=1 SV=5 IP3KB_HUMAN reviewed Inositol-trisphosphate 3-kinase B (EC 2.7.1.127) (Inositol 1,4,5-trisphosphate 3-kinase B) (IP3 3-kinase B) (IP3K B) (InsP 3-kinase B) Homo sapiens (Human) GO:0000165; GO:0000828; GO:0002262; GO:0005516; GO:0005524; GO:0005634; GO:0005737; GO:0005783; GO:0005829; GO:0005856; GO:0007165; GO:0007166; GO:0008440; GO:0016020; GO:0032957; GO:0032958; GO:0033030; GO:0035726; GO:0045059; GO:0045638; GO:0046579; GO:0046638; GO:0046854; GO:0071277 cell surface receptor signaling pathway [GO:0007166]; cellular response to calcium ion [GO:0071277]; common myeloid progenitor cell proliferation [GO:0035726]; inositol phosphate biosynthetic process [GO:0032958]; inositol trisphosphate metabolic process [GO:0032957]; MAPK cascade [GO:0000165]; myeloid cell homeostasis [GO:0002262]; negative regulation of myeloid cell differentiation [GO:0045638]; negative regulation of neutrophil apoptotic process [GO:0033030]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; positive regulation of alpha-beta T cell differentiation [GO:0046638]; positive regulation of Ras protein signal transduction [GO:0046579]; positive thymic T cell selection [GO:0045059]; signal transduction [GO:0007165] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; membrane [GO:0016020]; nucleus [GO:0005634] ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; inositol hexakisphosphate kinase activity [GO:0000828]; inositol-1,4,5-trisphosphate 3-kinase activity [GO:0008440] g4312.t1 Q8BSL4 27.152 302 1.81e-26 111.0 sp|Q8BSL4|HS3S5_MOUSE Heparan sulfate glucosamine 3-O-sulfotransferase 5 OS=Mus musculus OX=10090 GN=Hs3st5 PE=2 SV=1 g4315.t1 Q21279 35.362 345 1.16e-66 219.0 sp|Q21279|TTL15_CAEEL Probable tubulin polyglutamylase ttll-15 OS=Caenorhabditis elegans OX=6239 GN=ttll-15 PE=2 SV=3 g4323.t1 P21251 100.0 149 6.33e-105 299.0 sp|P21251|CALM_STIJA Calmodulin OS=Stichopus japonicus OX=307972 PE=1 SV=2 g4324.t1 P62154 97.315 149 1.26e-101 290.0 sp|P62154|CALM_LOCMI Calmodulin OS=Locusta migratoria OX=7004 PE=1 SV=2 g4325.t1 P62154 98.658 149 1.6700000000000002e-103 295.0 sp|P62154|CALM_LOCMI Calmodulin OS=Locusta migratoria OX=7004 PE=1 SV=2 g4326.t1 P62154 99.329 149 1.12e-103 295.0 sp|P62154|CALM_LOCMI Calmodulin OS=Locusta migratoria OX=7004 PE=1 SV=2 g4327.t1 P29147 39.931 288 6.05e-78 246.0 sp|P29147|BDH_RAT D-beta-hydroxybutyrate dehydrogenase, mitochondrial OS=Rattus norvegicus OX=10116 GN=Bdh1 PE=1 SV=2 BDH_RAT reviewed D-beta-hydroxybutyrate dehydrogenase, mitochondrial (EC 1.1.1.30) (3-hydroxybutyrate dehydrogenase) (BDH) Rattus norvegicus (Rat) GO:0001889; GO:0003858; GO:0005543; GO:0005739; GO:0005743; GO:0005759; GO:0007584; GO:0008202; GO:0009410; GO:0009636; GO:0009725; GO:0032355; GO:0032868; GO:0042594; GO:0045471; GO:0046686; GO:0051412; GO:0060416; GO:0060612; GO:0099617 adipose tissue development [GO:0060612]; liver development [GO:0001889]; response to cadmium ion [GO:0046686]; response to corticosterone [GO:0051412]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to growth hormone [GO:0060416]; response to hormone [GO:0009725]; response to insulin [GO:0032868]; response to nutrient [GO:0007584]; response to starvation [GO:0042594]; response to toxic substance [GO:0009636]; response to xenobiotic stimulus [GO:0009410]; steroid metabolic process [GO:0008202] matrix side of mitochondrial inner membrane [GO:0099617]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] 3-hydroxybutyrate dehydrogenase activity [GO:0003858]; phospholipid binding [GO:0005543] g4328.t1 P29147 43.75 288 1.1e-81 255.0 sp|P29147|BDH_RAT D-beta-hydroxybutyrate dehydrogenase, mitochondrial OS=Rattus norvegicus OX=10116 GN=Bdh1 PE=1 SV=2 BDH_RAT reviewed D-beta-hydroxybutyrate dehydrogenase, mitochondrial (EC 1.1.1.30) (3-hydroxybutyrate dehydrogenase) (BDH) Rattus norvegicus (Rat) GO:0001889; GO:0003858; GO:0005543; GO:0005739; GO:0005743; GO:0005759; GO:0007584; GO:0008202; GO:0009410; GO:0009636; GO:0009725; GO:0032355; GO:0032868; GO:0042594; GO:0045471; GO:0046686; GO:0051412; GO:0060416; GO:0060612; GO:0099617 adipose tissue development [GO:0060612]; liver development [GO:0001889]; response to cadmium ion [GO:0046686]; response to corticosterone [GO:0051412]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to growth hormone [GO:0060416]; response to hormone [GO:0009725]; response to insulin [GO:0032868]; response to nutrient [GO:0007584]; response to starvation [GO:0042594]; response to toxic substance [GO:0009636]; response to xenobiotic stimulus [GO:0009410]; steroid metabolic process [GO:0008202] matrix side of mitochondrial inner membrane [GO:0099617]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] 3-hydroxybutyrate dehydrogenase activity [GO:0003858]; phospholipid binding [GO:0005543] g4329.t1 A2AKK5 36.111 432 3.76e-69 228.0 sp|A2AKK5|ACNT1_MOUSE Acyl-coenzyme A amino acid N-acyltransferase 1 OS=Mus musculus OX=10090 GN=Acnat1 PE=1 SV=1 ACNT1_MOUSE reviewed Acyl-coenzyme A amino acid N-acyltransferase 1 (EC 2.3.1.-) Mus musculus (Mouse) GO:0005777; GO:0006631; GO:0006637; GO:0016410; GO:0047617 acyl-CoA metabolic process [GO:0006637]; fatty acid metabolic process [GO:0006631] peroxisome [GO:0005777] fatty acyl-CoA hydrolase activity [GO:0047617]; N-acyltransferase activity [GO:0016410] g4330.t1 Q0KK59 47.468 790 0.0 640.0 sp|Q0KK59|UNC79_MOUSE Protein unc-79 homolog OS=Mus musculus OX=10090 GN=Unc79 PE=1 SV=1 UNC79_MOUSE reviewed Protein unc-79 homolog Mus musculus (Mouse) GO:0001967; GO:0005886; GO:0030534; GO:0035264; GO:0048149 adult behavior [GO:0030534]; behavioral response to ethanol [GO:0048149]; multicellular organism growth [GO:0035264]; suckling behavior [GO:0001967] plasma membrane [GO:0005886] g4330.t1 Q0KK59 41.429 210 1.25e-41 171.0 sp|Q0KK59|UNC79_MOUSE Protein unc-79 homolog OS=Mus musculus OX=10090 GN=Unc79 PE=1 SV=1 UNC79_MOUSE reviewed Protein unc-79 homolog Mus musculus (Mouse) GO:0001967; GO:0005886; GO:0030534; GO:0035264; GO:0048149 adult behavior [GO:0030534]; behavioral response to ethanol [GO:0048149]; multicellular organism growth [GO:0035264]; suckling behavior [GO:0001967] plasma membrane [GO:0005886] g4331.t1 Q0KK59 43.6 250 2.27e-65 232.0 sp|Q0KK59|UNC79_MOUSE Protein unc-79 homolog OS=Mus musculus OX=10090 GN=Unc79 PE=1 SV=1 UNC79_MOUSE reviewed Protein unc-79 homolog Mus musculus (Mouse) GO:0001967; GO:0005886; GO:0030534; GO:0035264; GO:0048149 adult behavior [GO:0030534]; behavioral response to ethanol [GO:0048149]; multicellular organism growth [GO:0035264]; suckling behavior [GO:0001967] plasma membrane [GO:0005886] g4333.t1 Q0KK59 37.908 612 2.62e-137 417.0 sp|Q0KK59|UNC79_MOUSE Protein unc-79 homolog OS=Mus musculus OX=10090 GN=Unc79 PE=1 SV=1 UNC79_MOUSE reviewed Protein unc-79 homolog Mus musculus (Mouse) GO:0001967; GO:0005886; GO:0030534; GO:0035264; GO:0048149 adult behavior [GO:0030534]; behavioral response to ethanol [GO:0048149]; multicellular organism growth [GO:0035264]; suckling behavior [GO:0001967] plasma membrane [GO:0005886] g4333.t1 Q0KK59 45.679 81 2.62e-137 95.5 sp|Q0KK59|UNC79_MOUSE Protein unc-79 homolog OS=Mus musculus OX=10090 GN=Unc79 PE=1 SV=1 UNC79_MOUSE reviewed Protein unc-79 homolog Mus musculus (Mouse) GO:0001967; GO:0005886; GO:0030534; GO:0035264; GO:0048149 adult behavior [GO:0030534]; behavioral response to ethanol [GO:0048149]; multicellular organism growth [GO:0035264]; suckling behavior [GO:0001967] plasma membrane [GO:0005886] g4336.t1 Q6TYB5 43.056 360 8.25e-62 205.0 sp|Q6TYB5|FEZ2_MOUSE Fasciculation and elongation protein zeta-2 OS=Mus musculus OX=10090 GN=Fez2 PE=2 SV=1 g4337.t1 P14000 47.49 478 8.34e-162 473.0 sp|P14000|ARS_HEMPU Arylsulfatase OS=Hemicentrotus pulcherrimus OX=7650 PE=1 SV=1 g4338.t1 Q80WT5 35.417 288 4.8300000000000003e-32 138.0 sp|Q80WT5|AFTIN_MOUSE Aftiphilin OS=Mus musculus OX=10090 GN=Aftph PE=1 SV=2 g4338.t2 Q80WT5 34.694 294 7.699999999999999e-30 131.0 sp|Q80WT5|AFTIN_MOUSE Aftiphilin OS=Mus musculus OX=10090 GN=Aftph PE=1 SV=2 g4342.t1 Q3B8R1 33.191 467 3.6099999999999996e-60 213.0 sp|Q3B8R1|EMARD_RAT Endoplasmic reticulum membrane-associated RNA degradation protein OS=Rattus norvegicus OX=10116 GN=Ermard PE=2 SV=2 g4342.t2 Q3B8R1 35.981 214 7.65e-28 114.0 sp|Q3B8R1|EMARD_RAT Endoplasmic reticulum membrane-associated RNA degradation protein OS=Rattus norvegicus OX=10116 GN=Ermard PE=2 SV=2 g4343.t1 Q6NWD4 55.805 267 8.7099999999999995e-106 320.0 sp|Q6NWD4|TIM50_DANRE Mitochondrial import inner membrane translocase subunit TIM50 OS=Danio rerio OX=7955 GN=timm50 PE=2 SV=2 TIM50_DANRE reviewed Mitochondrial import inner membrane translocase subunit TIM50 Danio rerio (Zebrafish) (Brachydanio rerio) GO:0004722; GO:0004725; GO:0005743; GO:0005744; GO:0006470; GO:0006915; GO:0007006; GO:0030150 apoptotic process [GO:0006915]; mitochondrial membrane organization [GO:0007006]; protein dephosphorylation [GO:0006470]; protein import into mitochondrial matrix [GO:0030150] mitochondrial inner membrane [GO:0005743]; TIM23 mitochondrial import inner membrane translocase complex [GO:0005744] protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine phosphatase activity [GO:0004725] g4344.t1 A6QNT4 33.735 249 2.39e-31 125.0 sp|A6QNT4|F120B_BOVIN Constitutive coactivator of peroxisome proliferator-activated receptor gamma OS=Bos taurus OX=9913 GN=FAM120B PE=2 SV=1 g4347.t1 Q8UWJ4 37.218 532 3.05e-97 320.0 sp|Q8UWJ4|DLLD_DANRE Delta-like protein D OS=Danio rerio OX=7955 GN=dld PE=1 SV=2 g4348.t1 B3STU3 50.0 158 2.99e-51 169.0 sp|B3STU3|CHAC1_RAT Glutathione-specific gamma-glutamylcyclotransferase 1 OS=Rattus norvegicus OX=10116 GN=Chac1 PE=2 SV=1 CHAC1_RAT reviewed Glutathione-specific gamma-glutamylcyclotransferase 1 (Gamma-GCG 1) (EC 4.3.2.7) (Blocks Notch protein) (Botch) (Cation transport regulator-like protein 1) (Neuroprotective protein 7) Rattus norvegicus (Rat) GO:0005112; GO:0005737; GO:0005802; GO:0005829; GO:0006751; GO:0006986; GO:0007219; GO:0010955; GO:0022008; GO:0045746; GO:0061771; GO:0061928; GO:0070059 glutathione catabolic process [GO:0006751]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of protein processing [GO:0010955]; neurogenesis [GO:0022008]; Notch signaling pathway [GO:0007219]; response to caloric restriction [GO:0061771]; response to unfolded protein [GO:0006986] cytoplasm [GO:0005737]; cytosol [GO:0005829]; trans-Golgi network [GO:0005802] glutathione specific gamma-glutamylcyclotransferase activity [GO:0061928]; Notch binding [GO:0005112] g4350.t1 Q6ZPV2 59.109 741 0.0 812.0 sp|Q6ZPV2|INO80_MOUSE Chromatin-remodeling ATPase INO80 OS=Mus musculus OX=10090 GN=Ino80 PE=1 SV=2 g4350.t1 Q6ZPV2 64.557 395 1.56e-127 436.0 sp|Q6ZPV2|INO80_MOUSE Chromatin-remodeling ATPase INO80 OS=Mus musculus OX=10090 GN=Ino80 PE=1 SV=2 g4355.t1 Q5SY80 25.821 670 1.0899999999999999e-54 206.0 sp|Q5SY80|CTSRE_HUMAN Cation channel sperm-associated auxiliary subunit epsilon OS=Homo sapiens OX=9606 GN=CATSPERE PE=1 SV=1 g4356.t1 Q91ZR5 40.893 291 8.65e-44 166.0 sp|Q91ZR5|CTSR1_MOUSE Cation channel sperm-associated protein 1 OS=Mus musculus OX=10090 GN=Catsper1 PE=1 SV=1 CTSR1_MOUSE reviewed Cation channel sperm-associated protein 1 (CatSper1) Mus musculus (Mouse) GO:0005227; GO:0005245; GO:0005886; GO:0006816; GO:0007283; GO:0007342; GO:0030154; GO:0030317; GO:0036126; GO:0036128; GO:0051924; GO:0060296; GO:0097228 calcium ion transport [GO:0006816]; cell differentiation [GO:0030154]; flagellated sperm motility [GO:0030317]; fusion of sperm to egg plasma membrane involved in single fertilization [GO:0007342]; regulation of calcium ion transport [GO:0051924]; regulation of cilium beat frequency involved in ciliary motility [GO:0060296]; spermatogenesis [GO:0007283] CatSper complex [GO:0036128]; plasma membrane [GO:0005886]; sperm flagellum [GO:0036126]; sperm principal piece [GO:0097228] calcium-activated cation channel activity [GO:0005227]; voltage-gated calcium channel activity [GO:0005245] g4357.t1 Q9DB05 69.675 277 7.42e-147 417.0 sp|Q9DB05|SNAA_MOUSE Alpha-soluble NSF attachment protein OS=Mus musculus OX=10090 GN=Napa PE=1 SV=1 SNAA_MOUSE reviewed Alpha-soluble NSF attachment protein (SNAP-alpha) (N-ethylmaleimide-sensitive factor attachment protein alpha) Mus musculus (Mouse) GO:0000149; GO:0005483; GO:0005739; GO:0005886; GO:0006886; GO:0007420; GO:0008021; GO:0010807; GO:0016082; GO:0019905; GO:0030182; GO:0030425; GO:0031410; GO:0031594; GO:0032984; GO:0035249; GO:0035494; GO:0042599; GO:0042734; GO:0043204; GO:0043209; GO:0044877; GO:0045176; GO:0045211; GO:0048787; GO:0070044; GO:0097060; GO:0098793; GO:0098794; GO:0098978 apical protein localization [GO:0045176]; brain development [GO:0007420]; intracellular protein transport [GO:0006886]; neuron differentiation [GO:0030182]; protein-containing complex disassembly [GO:0032984]; regulation of synaptic vesicle priming [GO:0010807]; SNARE complex disassembly [GO:0035494]; synaptic transmission, glutamatergic [GO:0035249]; synaptic vesicle priming [GO:0016082] cytoplasmic vesicle [GO:0031410]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; lamellar body [GO:0042599]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; neuromuscular junction [GO:0031594]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic membrane [GO:0045211]; presynapse [GO:0098793]; presynaptic active zone membrane [GO:0048787]; presynaptic membrane [GO:0042734]; synaptic membrane [GO:0097060]; synaptic vesicle [GO:0008021]; synaptobrevin 2-SNAP-25-syntaxin-1a complex [GO:0070044] protein-containing complex binding [GO:0044877]; SNARE binding [GO:0000149]; soluble NSF attachment protein activity [GO:0005483]; syntaxin binding [GO:0019905] g4357.t2 Q9DB05 69.675 277 7.42e-147 417.0 sp|Q9DB05|SNAA_MOUSE Alpha-soluble NSF attachment protein OS=Mus musculus OX=10090 GN=Napa PE=1 SV=1 SNAA_MOUSE reviewed Alpha-soluble NSF attachment protein (SNAP-alpha) (N-ethylmaleimide-sensitive factor attachment protein alpha) Mus musculus (Mouse) GO:0000149; GO:0005483; GO:0005739; GO:0005886; GO:0006886; GO:0007420; GO:0008021; GO:0010807; GO:0016082; GO:0019905; GO:0030182; GO:0030425; GO:0031410; GO:0031594; GO:0032984; GO:0035249; GO:0035494; GO:0042599; GO:0042734; GO:0043204; GO:0043209; GO:0044877; GO:0045176; GO:0045211; GO:0048787; GO:0070044; GO:0097060; GO:0098793; GO:0098794; GO:0098978 apical protein localization [GO:0045176]; brain development [GO:0007420]; intracellular protein transport [GO:0006886]; neuron differentiation [GO:0030182]; protein-containing complex disassembly [GO:0032984]; regulation of synaptic vesicle priming [GO:0010807]; SNARE complex disassembly [GO:0035494]; synaptic transmission, glutamatergic [GO:0035249]; synaptic vesicle priming [GO:0016082] cytoplasmic vesicle [GO:0031410]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; lamellar body [GO:0042599]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; neuromuscular junction [GO:0031594]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic membrane [GO:0045211]; presynapse [GO:0098793]; presynaptic active zone membrane [GO:0048787]; presynaptic membrane [GO:0042734]; synaptic membrane [GO:0097060]; synaptic vesicle [GO:0008021]; synaptobrevin 2-SNAP-25-syntaxin-1a complex [GO:0070044] protein-containing complex binding [GO:0044877]; SNARE binding [GO:0000149]; soluble NSF attachment protein activity [GO:0005483]; syntaxin binding [GO:0019905] g4358.t1 D3ZMM8 45.842 493 4.21e-142 421.0 sp|D3ZMM8|YLAT2_RAT Y+L amino acid transporter 2 OS=Rattus norvegicus OX=10116 GN=Slc7a6 PE=1 SV=1 YLAT2_RAT reviewed Y+L amino acid transporter 2 (Solute carrier family 7 member 6) (y(+)L-type amino acid transporter 2) (Y+LAT2) (y+LAT-2) Rattus norvegicus (Rat) GO:0003333; GO:0005886; GO:0006809; GO:0015174; GO:0015179; GO:0015804; GO:0015820; GO:0015822; GO:0031460; GO:0034618; GO:0061459; GO:0106439; GO:1903826 amino acid transmembrane transport [GO:0003333]; glycine betaine transport [GO:0031460]; L-arginine transmembrane transport [GO:1903826]; L-leucine transport [GO:0015820]; neutral amino acid transport [GO:0015804]; nitric oxide biosynthetic process [GO:0006809]; ornithine transport [GO:0015822] plasma membrane [GO:0005886] arginine binding [GO:0034618]; basic amino acid transmembrane transporter activity [GO:0015174]; L-amino acid transmembrane transporter activity [GO:0015179]; L-arginine transmembrane transporter activity [GO:0061459]; L-lysine:L-arginine antiporter activity [GO:0106439] g4358.t2 D3ZMM8 41.252 543 3.12e-130 393.0 sp|D3ZMM8|YLAT2_RAT Y+L amino acid transporter 2 OS=Rattus norvegicus OX=10116 GN=Slc7a6 PE=1 SV=1 YLAT2_RAT reviewed Y+L amino acid transporter 2 (Solute carrier family 7 member 6) (y(+)L-type amino acid transporter 2) (Y+LAT2) (y+LAT-2) Rattus norvegicus (Rat) GO:0003333; GO:0005886; GO:0006809; GO:0015174; GO:0015179; GO:0015804; GO:0015820; GO:0015822; GO:0031460; GO:0034618; GO:0061459; GO:0106439; GO:1903826 amino acid transmembrane transport [GO:0003333]; glycine betaine transport [GO:0031460]; L-arginine transmembrane transport [GO:1903826]; L-leucine transport [GO:0015820]; neutral amino acid transport [GO:0015804]; nitric oxide biosynthetic process [GO:0006809]; ornithine transport [GO:0015822] plasma membrane [GO:0005886] arginine binding [GO:0034618]; basic amino acid transmembrane transporter activity [GO:0015174]; L-amino acid transmembrane transporter activity [GO:0015179]; L-arginine transmembrane transporter activity [GO:0061459]; L-lysine:L-arginine antiporter activity [GO:0106439] g4358.t3 D3ZMM8 41.621 543 6.72e-132 397.0 sp|D3ZMM8|YLAT2_RAT Y+L amino acid transporter 2 OS=Rattus norvegicus OX=10116 GN=Slc7a6 PE=1 SV=1 YLAT2_RAT reviewed Y+L amino acid transporter 2 (Solute carrier family 7 member 6) (y(+)L-type amino acid transporter 2) (Y+LAT2) (y+LAT-2) Rattus norvegicus (Rat) GO:0003333; GO:0005886; GO:0006809; GO:0015174; GO:0015179; GO:0015804; GO:0015820; GO:0015822; GO:0031460; GO:0034618; GO:0061459; GO:0106439; GO:1903826 amino acid transmembrane transport [GO:0003333]; glycine betaine transport [GO:0031460]; L-arginine transmembrane transport [GO:1903826]; L-leucine transport [GO:0015820]; neutral amino acid transport [GO:0015804]; nitric oxide biosynthetic process [GO:0006809]; ornithine transport [GO:0015822] plasma membrane [GO:0005886] arginine binding [GO:0034618]; basic amino acid transmembrane transporter activity [GO:0015174]; L-amino acid transmembrane transporter activity [GO:0015179]; L-arginine transmembrane transporter activity [GO:0061459]; L-lysine:L-arginine antiporter activity [GO:0106439] g4359.t1 Q9MYY0 32.673 505 1.55e-78 259.0 sp|Q9MYY0|HPSE_BOVIN Heparanase OS=Bos taurus OX=9913 GN=HPSE PE=2 SV=2 g4360.t1 Q8BK64 47.536 345 6.2e-109 324.0 sp|Q8BK64|AHSA1_MOUSE Activator of 90 kDa heat shock protein ATPase homolog 1 OS=Mus musculus OX=10090 GN=Ahsa1 PE=1 SV=2 g4361.t1 Q5I0I4 32.749 171 3.1700000000000002e-27 109.0 sp|Q5I0I4|DMAC2_RAT Distal membrane-arm assembly complex protein 2 OS=Rattus norvegicus OX=10116 GN=Dmac2 PE=2 SV=1 g4362.t1 O14618 54.864 257 4.24e-97 289.0 sp|O14618|CCS_HUMAN Copper chaperone for superoxide dismutase OS=Homo sapiens OX=9606 GN=CCS PE=1 SV=1 CCS_HUMAN reviewed Copper chaperone for superoxide dismutase (Superoxide dismutase copper chaperone) Homo sapiens (Human) GO:0005507; GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0015035; GO:0016532; GO:0019430; GO:0034599; GO:0045296; GO:0051604 cellular response to oxidative stress [GO:0034599]; protein maturation [GO:0051604]; removal of superoxide radicals [GO:0019430] cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634] cadherin binding [GO:0045296]; copper ion binding [GO:0005507]; protein-disulfide reductase activity [GO:0015035]; superoxide dismutase copper chaperone activity [GO:0016532] g4363.t1 Q9Y2U9 42.857 357 1.99e-75 243.0 sp|Q9Y2U9|KLDC2_HUMAN Kelch domain-containing protein 2 OS=Homo sapiens OX=9606 GN=KLHDC2 PE=1 SV=1 g4366.t1 Q9BWU0 49.792 480 6.24e-133 418.0 sp|Q9BWU0|NADAP_HUMAN Kanadaptin OS=Homo sapiens OX=9606 GN=SLC4A1AP PE=1 SV=2 g4367.t1 Q16537 71.076 446 0.0 592.0 sp|Q16537|2A5E_HUMAN Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit epsilon isoform OS=Homo sapiens OX=9606 GN=PPP2R5E PE=1 SV=1 g4368.t1 Q62760 54.777 157 8.950000000000001e-43 142.0 sp|Q62760|TOM20_RAT Mitochondrial import receptor subunit TOM20 homolog OS=Rattus norvegicus OX=10116 GN=Tomm20 PE=1 SV=2 TOM20_RAT reviewed Mitochondrial import receptor subunit TOM20 homolog (Mitochondrial 20 kDa outer membrane protein) (Outer mitochondrial membrane receptor Tom20) Rattus norvegicus (Rat) GO:0005739; GO:0005740; GO:0005741; GO:0005742; GO:0006626; GO:0006886; GO:0014850; GO:0015450; GO:0016031; GO:0030150; GO:0030943; GO:0044233; GO:0051082; GO:0071944; GO:0097225; GO:0140494; GO:1905242 intracellular protein transport [GO:0006886]; protein import into mitochondrial matrix [GO:0030150]; protein targeting to mitochondrion [GO:0006626]; response to 3,3',5-triiodo-L-thyronine [GO:1905242]; response to muscle activity [GO:0014850]; tRNA import into mitochondrion [GO:0016031] cell periphery [GO:0071944]; migrasome [GO:0140494]; mitochondria-associated endoplasmic reticulum membrane contact site [GO:0044233]; mitochondrial envelope [GO:0005740]; mitochondrial outer membrane [GO:0005741]; mitochondrial outer membrane translocase complex [GO:0005742]; mitochondrion [GO:0005739]; sperm midpiece [GO:0097225] mitochondrion targeting sequence binding [GO:0030943]; protein-transporting ATPase activity [GO:0015450]; unfolded protein binding [GO:0051082] g4370.t1 Q9JK11 49.282 209 2.8899999999999997e-55 197.0 sp|Q9JK11|RTN4_RAT Reticulon-4 OS=Rattus norvegicus OX=10116 GN=Rtn4 PE=1 SV=1 g4370.t2 Q6IFY7 55.914 186 2.83e-55 182.0 sp|Q6IFY7|RTN1A_XENLA Reticulon-1-A OS=Xenopus laevis OX=8355 GN=rtn1-a PE=2 SV=1 g4371.t1 P97363 62.733 483 0.0 615.0 sp|P97363|SPTC2_MOUSE Serine palmitoyltransferase 2 OS=Mus musculus OX=10090 GN=Sptlc2 PE=1 SV=2 SPTC2_MOUSE reviewed Serine palmitoyltransferase 2 (EC 2.3.1.50) (Long chain base biosynthesis protein 2) (LCB 2) (Long chain base biosynthesis protein 2a) (LCB2a) (Serine-palmitoyl-CoA transferase 2) (SPT 2) Mus musculus (Mouse) GO:0004758; GO:0005739; GO:0005789; GO:0006686; GO:0017059; GO:0030148; GO:0030170; GO:0046511; GO:0046512; GO:0046513; GO:0060612; GO:1904504 adipose tissue development [GO:0060612]; ceramide biosynthetic process [GO:0046513]; positive regulation of lipophagy [GO:1904504]; sphinganine biosynthetic process [GO:0046511]; sphingolipid biosynthetic process [GO:0030148]; sphingomyelin biosynthetic process [GO:0006686]; sphingosine biosynthetic process [GO:0046512] endoplasmic reticulum membrane [GO:0005789]; mitochondrion [GO:0005739]; serine palmitoyltransferase complex [GO:0017059] pyridoxal phosphate binding [GO:0030170]; serine C-palmitoyltransferase activity [GO:0004758] g4372.t1 Q9D2G9 51.311 610 0.0 590.0 sp|Q9D2G9|HIPL2_MOUSE HHIP-like protein 2 OS=Mus musculus OX=10090 GN=Hhipl2 PE=2 SV=2 g4373.t1 Q8BW75 49.13 517 9.86e-175 505.0 sp|Q8BW75|AOFB_MOUSE Amine oxidase [flavin-containing] B OS=Mus musculus OX=10090 GN=Maob PE=1 SV=4 AOFB_MOUSE reviewed Amine oxidase [flavin-containing] B (EC 1.4.3.21) (EC 1.4.3.4) (Monoamine oxidase type B) (MAO-B) Mus musculus (Mouse) GO:0005739; GO:0005741; GO:0005743; GO:0008131; GO:0014063; GO:0019607; GO:0030425; GO:0042802; GO:0043025; GO:0045964; GO:0048545; GO:0050660; GO:0097621 negative regulation of serotonin secretion [GO:0014063]; phenylethylamine catabolic process [GO:0019607]; positive regulation of dopamine metabolic process [GO:0045964]; response to steroid hormone [GO:0048545] dendrite [GO:0030425]; mitochondrial inner membrane [GO:0005743]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025] flavin adenine dinucleotide binding [GO:0050660]; identical protein binding [GO:0042802]; monoamine oxidase activity [GO:0097621]; primary methylamine oxidase activity [GO:0008131] g4374.t1 D9IQ16 35.088 285 4.8e-32 131.0 sp|D9IQ16|GXN_ACRMI Galaxin OS=Acropora millepora OX=45264 PE=1 SV=1 g4374.t1 D9IQ16 31.579 285 2.83e-22 102.0 sp|D9IQ16|GXN_ACRMI Galaxin OS=Acropora millepora OX=45264 PE=1 SV=1 g4374.t1 D9IQ16 28.912 294 5.75e-22 101.0 sp|D9IQ16|GXN_ACRMI Galaxin OS=Acropora millepora OX=45264 PE=1 SV=1 g4374.t2 D9IQ16 35.088 285 3.6700000000000005e-32 131.0 sp|D9IQ16|GXN_ACRMI Galaxin OS=Acropora millepora OX=45264 PE=1 SV=1 g4374.t2 D9IQ16 30.072 276 2.61e-22 102.0 sp|D9IQ16|GXN_ACRMI Galaxin OS=Acropora millepora OX=45264 PE=1 SV=1 g4374.t2 D9IQ16 28.767 292 3.56e-21 99.4 sp|D9IQ16|GXN_ACRMI Galaxin OS=Acropora millepora OX=45264 PE=1 SV=1 g4375.t1 D9IQ16 28.994 338 4.850000000000001e-21 99.8 sp|D9IQ16|GXN_ACRMI Galaxin OS=Acropora millepora OX=45264 PE=1 SV=1 g4377.t1 Q32LD4 30.962 239 9.62e-29 115.0 sp|Q32LD4|TFB2M_BOVIN Dimethyladenosine transferase 2, mitochondrial OS=Bos taurus OX=9913 GN=TFB2M PE=2 SV=1 g4383.t1 O95279 33.81 210 4.13e-30 124.0 sp|O95279|KCNK5_HUMAN Potassium channel subfamily K member 5 OS=Homo sapiens OX=9606 GN=KCNK5 PE=1 SV=1 KCNK5_HUMAN reviewed Potassium channel subfamily K member 5 (Acid-sensitive potassium channel protein TASK-2) (TWIK-related acid-sensitive K(+) channel 2) Homo sapiens (Human) GO:0005267; GO:0005886; GO:0006813; GO:0015271; GO:0022841; GO:0034702; GO:0046872; GO:0046982; GO:0060075; GO:0071805; GO:0097623; GO:1990573 potassium ion export across plasma membrane [GO:0097623]; potassium ion import across plasma membrane [GO:1990573]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; regulation of resting membrane potential [GO:0060075] monoatomic ion channel complex [GO:0034702]; plasma membrane [GO:0005886] metal ion binding [GO:0046872]; outward rectifier potassium channel activity [GO:0015271]; potassium channel activity [GO:0005267]; potassium ion leak channel activity [GO:0022841]; protein heterodimerization activity [GO:0046982] g4384.t1 G3V8V5 34.211 228 4.82e-22 98.2 sp|G3V8V5|KCNK4_RAT Potassium channel subfamily K member 4 OS=Rattus norvegicus OX=10116 GN=Kcnk4 PE=2 SV=1 KCNK4_RAT reviewed Potassium channel subfamily K member 4 (TWIK-related arachidonic acid-stimulated potassium channel protein) (TRAAK) Rattus norvegicus (Rat) GO:0005267; GO:0005886; GO:0007613; GO:0015271; GO:0019228; GO:0019233; GO:0022841; GO:0033268; GO:0034705; GO:0042802; GO:0046872; GO:0050951; GO:0050976; GO:0071260; GO:0071398; GO:0071468; GO:0071469; GO:0071502; GO:0071805; GO:0097604; GO:0098782; GO:1904551; GO:1990478 cellular response to acidic pH [GO:0071468]; cellular response to alkaline pH [GO:0071469]; cellular response to arachidonate [GO:1904551]; cellular response to fatty acid [GO:0071398]; cellular response to mechanical stimulus [GO:0071260]; cellular response to temperature stimulus [GO:0071502]; detection of mechanical stimulus involved in sensory perception of touch [GO:0050976]; memory [GO:0007613]; neuronal action potential [GO:0019228]; potassium ion transmembrane transport [GO:0071805]; response to ultrasound [GO:1990478]; sensory perception of pain [GO:0019233]; sensory perception of temperature stimulus [GO:0050951] node of Ranvier [GO:0033268]; plasma membrane [GO:0005886]; potassium channel complex [GO:0034705] identical protein binding [GO:0042802]; mechanosensitive potassium channel activity [GO:0098782]; metal ion binding [GO:0046872]; outward rectifier potassium channel activity [GO:0015271]; potassium channel activity [GO:0005267]; potassium ion leak channel activity [GO:0022841]; temperature-gated cation channel activity [GO:0097604] g4389.t1 Q1JQ99 65.041 123 2.89e-50 160.0 sp|Q1JQ99|RM14_BOVIN Large ribosomal subunit protein uL14m OS=Bos taurus OX=9913 GN=MRPL14 PE=1 SV=1 RM14_BOVIN reviewed Large ribosomal subunit protein uL14m (39S ribosomal protein L14, mitochondrial) (L14mt) (MRP-L14) Bos taurus (Bovine) GO:0003735; GO:0005739; GO:0005743; GO:0005762; GO:0006412 translation [GO:0006412] mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739] structural constituent of ribosome [GO:0003735] g4390.t1 P57681 25.806 465 2.4800000000000002e-29 124.0 sp|P57681|PCYOX_ARATH Farnesylcysteine lyase OS=Arabidopsis thaliana OX=3702 GN=FCLY PE=1 SV=1 g4391.t1 Q5REC2 64.342 631 0.0 796.0 sp|Q5REC2|NEC2_PONAB Neuroendocrine convertase 2 OS=Pongo abelii OX=9601 GN=PCSK2 PE=2 SV=1 NEC2_PONAB reviewed Neuroendocrine convertase 2 (NEC 2) (EC 3.4.21.94) (Prohormone convertase 2) (Proprotein convertase 2) (PC2) Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0004252; GO:0005615; GO:0005654; GO:0007399; GO:0016020; GO:0016486; GO:0016540; GO:0030070; GO:0030133; GO:0030141; GO:0034230; GO:0043005 enkephalin processing [GO:0034230]; insulin processing [GO:0030070]; nervous system development [GO:0007399]; peptide hormone processing [GO:0016486]; protein autoprocessing [GO:0016540] extracellular space [GO:0005615]; membrane [GO:0016020]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; secretory granule [GO:0030141]; transport vesicle [GO:0030133] serine-type endopeptidase activity [GO:0004252] g4396.t1 Q8S7M7 37.5 192 7.9e-27 117.0 sp|Q8S7M7|PIRL5_ORYSJ Plant intracellular Ras-group-related LRR protein 5 OS=Oryza sativa subsp. japonica OX=39947 GN=IRL5 PE=2 SV=1 g4396.t1 Q8S7M7 38.017 242 8.83e-25 111.0 sp|Q8S7M7|PIRL5_ORYSJ Plant intracellular Ras-group-related LRR protein 5 OS=Oryza sativa subsp. japonica OX=39947 GN=IRL5 PE=2 SV=1 g4401.t1 Q9P055 52.893 242 9.64e-72 224.0 sp|Q9P055|JKAMP_HUMAN JNK1/MAPK8-associated membrane protein OS=Homo sapiens OX=9606 GN=JKAMP PE=1 SV=4 g4404.t1 Q8R418 48.611 648 4.3399999999999996e-172 556.0 sp|Q8R418|DICER_MOUSE Endoribonuclease Dicer OS=Mus musculus OX=10090 GN=Dicer1 PE=1 SV=3 DICER_MOUSE reviewed Endoribonuclease Dicer (EC 3.1.26.3) (Double-strand-specific ribonuclease mDCR-1) Mus musculus (Mouse) GO:0000122; GO:0000212; GO:0001525; GO:0001834; GO:0001942; GO:0003677; GO:0003723; GO:0003725; GO:0004386; GO:0004521; GO:0004525; GO:0004530; GO:0005524; GO:0005634; GO:0005737; GO:0005793; GO:0005829; GO:0006309; GO:0006364; GO:0006396; GO:0007284; GO:0008283; GO:0008593; GO:0009791; GO:0010070; GO:0010468; GO:0010595; GO:0010626; GO:0010628; GO:0010629; GO:0010660; GO:0010804; GO:0014040; GO:0014835; GO:0016442; GO:0019827; GO:0019904; GO:0021522; GO:0021675; GO:0021889; GO:0021987; GO:0030324; GO:0030326; GO:0030422; GO:0030424; GO:0030425; GO:0030426; GO:0031054; GO:0031069; GO:0031508; GO:0031641; GO:0031643; GO:0032290; GO:0032720; GO:0032967; GO:0035116; GO:0035194; GO:0035196; GO:0035197; GO:0035198; GO:0035264; GO:0042487; GO:0045069; GO:0045589; GO:0045595; GO:0045664; GO:0045944; GO:0046872; GO:0048255; GO:0048471; GO:0048536; GO:0048565; GO:0048608; GO:0048713; GO:0048730; GO:0048754; GO:0048812; GO:0050727; GO:0050767; GO:0051216; GO:0051225; GO:0051252; GO:0051607; GO:0051726; GO:0055013; GO:0060119; GO:0060253; GO:0060576; GO:0061309; GO:0061548; GO:0070062; GO:0070173; GO:0070578; GO:0070883; GO:0070922; GO:0071335; GO:0098795; GO:0098978; GO:0099092; GO:1903142; GO:1904899; GO:1904906; GO:1905564; GO:2000628; GO:2000630; GO:2000736 angiogenesis [GO:0001525]; apoptotic DNA fragmentation [GO:0006309]; branching morphogenesis of an epithelial tube [GO:0048754]; cardiac muscle cell development [GO:0055013]; cardiac neural crest cell development involved in outflow tract morphogenesis [GO:0061309]; cartilage development [GO:0051216]; cell population proliferation [GO:0008283]; cerebral cortex development [GO:0021987]; defense response to virus [GO:0051607]; digestive tract development [GO:0048565]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic limb morphogenesis [GO:0030326]; epidermis morphogenesis [GO:0048730]; ganglion development [GO:0061548]; global gene silencing by mRNA cleavage [GO:0098795]; hair follicle cell proliferation [GO:0071335]; hair follicle development [GO:0001942]; hair follicle morphogenesis [GO:0031069]; inner ear receptor cell development [GO:0060119]; intestinal epithelial cell development [GO:0060576]; lung development [GO:0030324]; meiotic spindle organization [GO:0000212]; miRNA processing [GO:0035196]; mRNA stabilization [GO:0048255]; multicellular organism growth [GO:0035264]; myoblast differentiation involved in skeletal muscle regeneration [GO:0014835]; negative regulation of gene expression [GO:0010629]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of Schwann cell proliferation [GO:0010626]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of tumor necrosis factor production [GO:0032720]; negative regulation of tumor necrosis factor-mediated signaling pathway [GO:0010804]; nerve development [GO:0021675]; neuron projection morphogenesis [GO:0048812]; olfactory bulb interneuron differentiation [GO:0021889]; pericentric heterochromatin formation [GO:0031508]; peripheral nervous system myelin formation [GO:0032290]; positive regulation of collagen biosynthetic process [GO:0032967]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell-matrix adhesion via fibronectin [GO:1904906]; positive regulation of establishment of endothelial barrier [GO:1903142]; positive regulation of gene expression [GO:0010628]; positive regulation of hepatic stellate cell proliferation [GO:1904899]; positive regulation of miRNA metabolic process [GO:2000630]; positive regulation of myelination [GO:0031643]; positive regulation of Schwann cell differentiation [GO:0014040]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of vascular endothelial cell proliferation [GO:1905564]; post-embryonic development [GO:0009791]; pre-miRNA processing [GO:0031054]; regulation of cell cycle [GO:0051726]; regulation of cell differentiation [GO:0045595]; regulation of enamel mineralization [GO:0070173]; regulation of gene expression [GO:0010468]; regulation of inflammatory response [GO:0050727]; regulation of miRNA metabolic process [GO:2000628]; regulation of muscle cell apoptotic process [GO:0010660]; regulation of myelination [GO:0031641]; regulation of neurogenesis [GO:0050767]; regulation of neuron differentiation [GO:0045664]; regulation of Notch signaling pathway [GO:0008593]; regulation of odontogenesis of dentin-containing tooth [GO:0042487]; regulation of oligodendrocyte differentiation [GO:0048713]; regulation of regulatory T cell differentiation [GO:0045589]; regulation of RNA metabolic process [GO:0051252]; regulation of stem cell differentiation [GO:2000736]; regulation of viral genome replication [GO:0045069]; regulatory ncRNA-mediated post-transcriptional gene silencing [GO:0035194]; reproductive structure development [GO:0048608]; RISC complex assembly [GO:0070922]; RNA processing [GO:0006396]; rRNA processing [GO:0006364]; siRNA processing [GO:0030422]; spermatogonial cell division [GO:0007284]; spinal cord motor neuron differentiation [GO:0021522]; spindle assembly [GO:0051225]; spleen development [GO:0048536]; stem cell population maintenance [GO:0019827]; trophectodermal cell proliferation [GO:0001834]; zygote asymmetric cell division [GO:0010070] axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic density, intracellular component [GO:0099092]; RISC complex [GO:0016442]; RISC-loading complex [GO:0070578] ATP binding [GO:0005524]; deoxyribonuclease I activity [GO:0004530]; DNA binding [GO:0003677]; double-stranded RNA binding [GO:0003725]; helicase activity [GO:0004386]; metal ion binding [GO:0046872]; miRNA binding [GO:0035198]; pre-miRNA binding [GO:0070883]; protein domain specific binding [GO:0019904]; ribonuclease III activity [GO:0004525]; RNA binding [GO:0003723]; RNA endonuclease activity [GO:0004521]; siRNA binding [GO:0035197] g4404.t1 Q8R418 44.022 368 1.39e-74 275.0 sp|Q8R418|DICER_MOUSE Endoribonuclease Dicer OS=Mus musculus OX=10090 GN=Dicer1 PE=1 SV=3 DICER_MOUSE reviewed Endoribonuclease Dicer (EC 3.1.26.3) (Double-strand-specific ribonuclease mDCR-1) Mus musculus (Mouse) GO:0000122; GO:0000212; GO:0001525; GO:0001834; GO:0001942; GO:0003677; GO:0003723; GO:0003725; GO:0004386; GO:0004521; GO:0004525; GO:0004530; GO:0005524; GO:0005634; GO:0005737; GO:0005793; GO:0005829; GO:0006309; GO:0006364; GO:0006396; GO:0007284; GO:0008283; GO:0008593; GO:0009791; GO:0010070; GO:0010468; GO:0010595; GO:0010626; GO:0010628; GO:0010629; GO:0010660; GO:0010804; GO:0014040; GO:0014835; GO:0016442; GO:0019827; GO:0019904; GO:0021522; GO:0021675; GO:0021889; GO:0021987; GO:0030324; GO:0030326; GO:0030422; GO:0030424; GO:0030425; GO:0030426; GO:0031054; GO:0031069; GO:0031508; GO:0031641; GO:0031643; GO:0032290; GO:0032720; GO:0032967; GO:0035116; GO:0035194; GO:0035196; GO:0035197; GO:0035198; GO:0035264; GO:0042487; GO:0045069; GO:0045589; GO:0045595; GO:0045664; GO:0045944; GO:0046872; GO:0048255; GO:0048471; GO:0048536; GO:0048565; GO:0048608; GO:0048713; GO:0048730; GO:0048754; GO:0048812; GO:0050727; GO:0050767; GO:0051216; GO:0051225; GO:0051252; GO:0051607; GO:0051726; GO:0055013; GO:0060119; GO:0060253; GO:0060576; GO:0061309; GO:0061548; GO:0070062; GO:0070173; GO:0070578; GO:0070883; GO:0070922; GO:0071335; GO:0098795; GO:0098978; GO:0099092; GO:1903142; GO:1904899; GO:1904906; GO:1905564; GO:2000628; GO:2000630; GO:2000736 angiogenesis [GO:0001525]; apoptotic DNA fragmentation [GO:0006309]; branching morphogenesis of an epithelial tube [GO:0048754]; cardiac muscle cell development [GO:0055013]; cardiac neural crest cell development involved in outflow tract morphogenesis [GO:0061309]; cartilage development [GO:0051216]; cell population proliferation [GO:0008283]; cerebral cortex development [GO:0021987]; defense response to virus [GO:0051607]; digestive tract development [GO:0048565]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic limb morphogenesis [GO:0030326]; epidermis morphogenesis [GO:0048730]; ganglion development [GO:0061548]; global gene silencing by mRNA cleavage [GO:0098795]; hair follicle cell proliferation [GO:0071335]; hair follicle development [GO:0001942]; hair follicle morphogenesis [GO:0031069]; inner ear receptor cell development [GO:0060119]; intestinal epithelial cell development [GO:0060576]; lung development [GO:0030324]; meiotic spindle organization [GO:0000212]; miRNA processing [GO:0035196]; mRNA stabilization [GO:0048255]; multicellular organism growth [GO:0035264]; myoblast differentiation involved in skeletal muscle regeneration [GO:0014835]; negative regulation of gene expression [GO:0010629]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of Schwann cell proliferation [GO:0010626]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of tumor necrosis factor production [GO:0032720]; negative regulation of tumor necrosis factor-mediated signaling pathway [GO:0010804]; nerve development [GO:0021675]; neuron projection morphogenesis [GO:0048812]; olfactory bulb interneuron differentiation [GO:0021889]; pericentric heterochromatin formation [GO:0031508]; peripheral nervous system myelin formation [GO:0032290]; positive regulation of collagen biosynthetic process [GO:0032967]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell-matrix adhesion via fibronectin [GO:1904906]; positive regulation of establishment of endothelial barrier [GO:1903142]; positive regulation of gene expression [GO:0010628]; positive regulation of hepatic stellate cell proliferation [GO:1904899]; positive regulation of miRNA metabolic process [GO:2000630]; positive regulation of myelination [GO:0031643]; positive regulation of Schwann cell differentiation [GO:0014040]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of vascular endothelial cell proliferation [GO:1905564]; post-embryonic development [GO:0009791]; pre-miRNA processing [GO:0031054]; regulation of cell cycle [GO:0051726]; regulation of cell differentiation [GO:0045595]; regulation of enamel mineralization [GO:0070173]; regulation of gene expression [GO:0010468]; regulation of inflammatory response [GO:0050727]; regulation of miRNA metabolic process [GO:2000628]; regulation of muscle cell apoptotic process [GO:0010660]; regulation of myelination [GO:0031641]; regulation of neurogenesis [GO:0050767]; regulation of neuron differentiation [GO:0045664]; regulation of Notch signaling pathway [GO:0008593]; regulation of odontogenesis of dentin-containing tooth [GO:0042487]; regulation of oligodendrocyte differentiation [GO:0048713]; regulation of regulatory T cell differentiation [GO:0045589]; regulation of RNA metabolic process [GO:0051252]; regulation of stem cell differentiation [GO:2000736]; regulation of viral genome replication [GO:0045069]; regulatory ncRNA-mediated post-transcriptional gene silencing [GO:0035194]; reproductive structure development [GO:0048608]; RISC complex assembly [GO:0070922]; RNA processing [GO:0006396]; rRNA processing [GO:0006364]; siRNA processing [GO:0030422]; spermatogonial cell division [GO:0007284]; spinal cord motor neuron differentiation [GO:0021522]; spindle assembly [GO:0051225]; spleen development [GO:0048536]; stem cell population maintenance [GO:0019827]; trophectodermal cell proliferation [GO:0001834]; zygote asymmetric cell division [GO:0010070] axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic density, intracellular component [GO:0099092]; RISC complex [GO:0016442]; RISC-loading complex [GO:0070578] ATP binding [GO:0005524]; deoxyribonuclease I activity [GO:0004530]; DNA binding [GO:0003677]; double-stranded RNA binding [GO:0003725]; helicase activity [GO:0004386]; metal ion binding [GO:0046872]; miRNA binding [GO:0035198]; pre-miRNA binding [GO:0070883]; protein domain specific binding [GO:0019904]; ribonuclease III activity [GO:0004525]; RNA binding [GO:0003723]; RNA endonuclease activity [GO:0004521]; siRNA binding [GO:0035197] g4405.t1 A0A974H8H3 41.765 759 7.36e-154 495.0 sp|A0A974H8H3|DICRL_XENLA Endoribonuclease Dicer-L OS=Xenopus laevis OX=8355 GN=dicer1.L PE=2 SV=1 DICRL_XENLA reviewed Endoribonuclease Dicer-L (EC 3.1.26.3) Xenopus laevis (African clawed frog) GO:0003723; GO:0004386; GO:0004525; GO:0004530; GO:0005524; GO:0005634; GO:0005737; GO:0006309; GO:0016441; GO:0030422; GO:0031054; GO:0046872; GO:0051239; GO:0070578 apoptotic DNA fragmentation [GO:0006309]; post-transcriptional gene silencing [GO:0016441]; pre-miRNA processing [GO:0031054]; regulation of multicellular organismal process [GO:0051239]; siRNA processing [GO:0030422] cytoplasm [GO:0005737]; nucleus [GO:0005634]; RISC-loading complex [GO:0070578] ATP binding [GO:0005524]; deoxyribonuclease I activity [GO:0004530]; helicase activity [GO:0004386]; metal ion binding [GO:0046872]; ribonuclease III activity [GO:0004525]; RNA binding [GO:0003723] g4406.t1 P38650 74.548 719 0.0 1083.0 sp|P38650|DYHC1_RAT Cytoplasmic dynein 1 heavy chain 1 OS=Rattus norvegicus OX=10116 GN=Dync1h1 PE=1 SV=1 DYHC1_RAT reviewed Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic) (MAP 1C) Rattus norvegicus (Rat) GO:0002177; GO:0005524; GO:0005635; GO:0005737; GO:0005813; GO:0005868; GO:0005874; GO:0005881; GO:0005938; GO:0007052; GO:0007097; GO:0007286; GO:0008090; GO:0008569; GO:0030175; GO:0030424; GO:0031122; GO:0032388; GO:0033962; GO:0034063; GO:0042802; GO:0043025; GO:0045505; GO:0051293; GO:0051301; GO:0051959; GO:0060236; GO:0090235; GO:0120162; GO:1904115; GO:1905243; GO:1905832; GO:1990090 cell division [GO:0051301]; cellular response to 3,3',5-triiodo-L-thyronine [GO:1905243]; cellular response to nerve growth factor stimulus [GO:1990090]; cytoplasmic microtubule organization [GO:0031122]; establishment of spindle localization [GO:0051293]; mitotic spindle organization [GO:0007052]; nuclear migration [GO:0007097]; P-body assembly [GO:0033962]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of intracellular transport [GO:0032388]; positive regulation of spindle assembly [GO:1905832]; regulation of metaphase plate congression [GO:0090235]; regulation of mitotic spindle organization [GO:0060236]; retrograde axonal transport [GO:0008090]; spermatid development [GO:0007286]; stress granule assembly [GO:0034063] axon [GO:0030424]; axon cytoplasm [GO:1904115]; cell cortex [GO:0005938]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; cytoplasmic microtubule [GO:0005881]; filopodium [GO:0030175]; manchette [GO:0002177]; microtubule [GO:0005874]; neuronal cell body [GO:0043025]; nuclear envelope [GO:0005635] ATP binding [GO:0005524]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; identical protein binding [GO:0042802]; minus-end-directed microtubule motor activity [GO:0008569] g4406.t2 Q9JHU4 69.754 1954 0.0 2741.0 sp|Q9JHU4|DYHC1_MOUSE Cytoplasmic dynein 1 heavy chain 1 OS=Mus musculus OX=10090 GN=Dync1h1 PE=1 SV=2 DYHC1_MOUSE reviewed Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic) Mus musculus (Mouse) GO:0002177; GO:0003341; GO:0005524; GO:0005635; GO:0005737; GO:0005813; GO:0005868; GO:0005874; GO:0005881; GO:0005938; GO:0007052; GO:0007097; GO:0008090; GO:0008569; GO:0030175; GO:0030286; GO:0030424; GO:0031122; GO:0032388; GO:0033962; GO:0034063; GO:0042802; GO:0043025; GO:0045505; GO:0051293; GO:0051301; GO:0051959; GO:0060236; GO:0090235; GO:0120162; GO:1904115; GO:1905832 cell division [GO:0051301]; cilium movement [GO:0003341]; cytoplasmic microtubule organization [GO:0031122]; establishment of spindle localization [GO:0051293]; mitotic spindle organization [GO:0007052]; nuclear migration [GO:0007097]; P-body assembly [GO:0033962]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of intracellular transport [GO:0032388]; positive regulation of spindle assembly [GO:1905832]; regulation of metaphase plate congression [GO:0090235]; regulation of mitotic spindle organization [GO:0060236]; retrograde axonal transport [GO:0008090]; stress granule assembly [GO:0034063] axon [GO:0030424]; axon cytoplasm [GO:1904115]; cell cortex [GO:0005938]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; cytoplasmic microtubule [GO:0005881]; dynein complex [GO:0030286]; filopodium [GO:0030175]; manchette [GO:0002177]; microtubule [GO:0005874]; neuronal cell body [GO:0043025]; nuclear envelope [GO:0005635] ATP binding [GO:0005524]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; identical protein binding [GO:0042802]; minus-end-directed microtubule motor activity [GO:0008569] g4406.t3 Q14204 68.384 1126 0.0 1563.0 sp|Q14204|DYHC1_HUMAN Cytoplasmic dynein 1 heavy chain 1 OS=Homo sapiens OX=9606 GN=DYNC1H1 PE=1 SV=5 DYHC1_HUMAN reviewed Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic) Homo sapiens (Human) GO:0003723; GO:0005524; GO:0005576; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0005881; GO:0005938; GO:0007052; GO:0007097; GO:0008090; GO:0008569; GO:0016020; GO:0030175; GO:0031122; GO:0032388; GO:0033962; GO:0034063; GO:0035578; GO:0042802; GO:0045505; GO:0051293; GO:0051301; GO:0051959; GO:0060236; GO:0070062; GO:0090235; GO:0120162; GO:1904115; GO:1905832 cell division [GO:0051301]; cytoplasmic microtubule organization [GO:0031122]; establishment of spindle localization [GO:0051293]; mitotic spindle organization [GO:0007052]; nuclear migration [GO:0007097]; P-body assembly [GO:0033962]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of intracellular transport [GO:0032388]; positive regulation of spindle assembly [GO:1905832]; regulation of metaphase plate congression [GO:0090235]; regulation of mitotic spindle organization [GO:0060236]; retrograde axonal transport [GO:0008090]; stress granule assembly [GO:0034063] axon cytoplasm [GO:1904115]; azurophil granule lumen [GO:0035578]; cell cortex [GO:0005938]; centrosome [GO:0005813]; cytoplasmic dynein complex [GO:0005868]; cytoplasmic microtubule [GO:0005881]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; filopodium [GO:0030175]; membrane [GO:0016020]; microtubule [GO:0005874] ATP binding [GO:0005524]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; identical protein binding [GO:0042802]; minus-end-directed microtubule motor activity [GO:0008569]; RNA binding [GO:0003723] g4407.t1 Q9JHU4 80.699 772 0.0 1338.0 sp|Q9JHU4|DYHC1_MOUSE Cytoplasmic dynein 1 heavy chain 1 OS=Mus musculus OX=10090 GN=Dync1h1 PE=1 SV=2 DYHC1_MOUSE reviewed Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic) Mus musculus (Mouse) GO:0002177; GO:0003341; GO:0005524; GO:0005635; GO:0005737; GO:0005813; GO:0005868; GO:0005874; GO:0005881; GO:0005938; GO:0007052; GO:0007097; GO:0008090; GO:0008569; GO:0030175; GO:0030286; GO:0030424; GO:0031122; GO:0032388; GO:0033962; GO:0034063; GO:0042802; GO:0043025; GO:0045505; GO:0051293; GO:0051301; GO:0051959; GO:0060236; GO:0090235; GO:0120162; GO:1904115; GO:1905832 cell division [GO:0051301]; cilium movement [GO:0003341]; cytoplasmic microtubule organization [GO:0031122]; establishment of spindle localization [GO:0051293]; mitotic spindle organization [GO:0007052]; nuclear migration [GO:0007097]; P-body assembly [GO:0033962]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of intracellular transport [GO:0032388]; positive regulation of spindle assembly [GO:1905832]; regulation of metaphase plate congression [GO:0090235]; regulation of mitotic spindle organization [GO:0060236]; retrograde axonal transport [GO:0008090]; stress granule assembly [GO:0034063] axon [GO:0030424]; axon cytoplasm [GO:1904115]; cell cortex [GO:0005938]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; cytoplasmic microtubule [GO:0005881]; dynein complex [GO:0030286]; filopodium [GO:0030175]; manchette [GO:0002177]; microtubule [GO:0005874]; neuronal cell body [GO:0043025]; nuclear envelope [GO:0005635] ATP binding [GO:0005524]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; identical protein binding [GO:0042802]; minus-end-directed microtubule motor activity [GO:0008569] g4408.t1 Q9JHU4 82.667 75 6.750000000000001e-43 134.0 sp|Q9JHU4|DYHC1_MOUSE Cytoplasmic dynein 1 heavy chain 1 OS=Mus musculus OX=10090 GN=Dync1h1 PE=1 SV=2 DYHC1_MOUSE reviewed Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic) Mus musculus (Mouse) GO:0002177; GO:0003341; GO:0005524; GO:0005635; GO:0005737; GO:0005813; GO:0005868; GO:0005874; GO:0005881; GO:0005938; GO:0007052; GO:0007097; GO:0008090; GO:0008569; GO:0030175; GO:0030286; GO:0030424; GO:0031122; GO:0032388; GO:0033962; GO:0034063; GO:0042802; GO:0043025; GO:0045505; GO:0051293; GO:0051301; GO:0051959; GO:0060236; GO:0090235; GO:0120162; GO:1904115; GO:1905832 cell division [GO:0051301]; cilium movement [GO:0003341]; cytoplasmic microtubule organization [GO:0031122]; establishment of spindle localization [GO:0051293]; mitotic spindle organization [GO:0007052]; nuclear migration [GO:0007097]; P-body assembly [GO:0033962]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of intracellular transport [GO:0032388]; positive regulation of spindle assembly [GO:1905832]; regulation of metaphase plate congression [GO:0090235]; regulation of mitotic spindle organization [GO:0060236]; retrograde axonal transport [GO:0008090]; stress granule assembly [GO:0034063] axon [GO:0030424]; axon cytoplasm [GO:1904115]; cell cortex [GO:0005938]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; cytoplasmic microtubule [GO:0005881]; dynein complex [GO:0030286]; filopodium [GO:0030175]; manchette [GO:0002177]; microtubule [GO:0005874]; neuronal cell body [GO:0043025]; nuclear envelope [GO:0005635] ATP binding [GO:0005524]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; identical protein binding [GO:0042802]; minus-end-directed microtubule motor activity [GO:0008569] g4408.t1 Q9JHU4 100.0 27 6.750000000000001e-43 59.3 sp|Q9JHU4|DYHC1_MOUSE Cytoplasmic dynein 1 heavy chain 1 OS=Mus musculus OX=10090 GN=Dync1h1 PE=1 SV=2 DYHC1_MOUSE reviewed Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic) Mus musculus (Mouse) GO:0002177; GO:0003341; GO:0005524; GO:0005635; GO:0005737; GO:0005813; GO:0005868; GO:0005874; GO:0005881; GO:0005938; GO:0007052; GO:0007097; GO:0008090; GO:0008569; GO:0030175; GO:0030286; GO:0030424; GO:0031122; GO:0032388; GO:0033962; GO:0034063; GO:0042802; GO:0043025; GO:0045505; GO:0051293; GO:0051301; GO:0051959; GO:0060236; GO:0090235; GO:0120162; GO:1904115; GO:1905832 cell division [GO:0051301]; cilium movement [GO:0003341]; cytoplasmic microtubule organization [GO:0031122]; establishment of spindle localization [GO:0051293]; mitotic spindle organization [GO:0007052]; nuclear migration [GO:0007097]; P-body assembly [GO:0033962]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of intracellular transport [GO:0032388]; positive regulation of spindle assembly [GO:1905832]; regulation of metaphase plate congression [GO:0090235]; regulation of mitotic spindle organization [GO:0060236]; retrograde axonal transport [GO:0008090]; stress granule assembly [GO:0034063] axon [GO:0030424]; axon cytoplasm [GO:1904115]; cell cortex [GO:0005938]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; cytoplasmic microtubule [GO:0005881]; dynein complex [GO:0030286]; filopodium [GO:0030175]; manchette [GO:0002177]; microtubule [GO:0005874]; neuronal cell body [GO:0043025]; nuclear envelope [GO:0005635] ATP binding [GO:0005524]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; identical protein binding [GO:0042802]; minus-end-directed microtubule motor activity [GO:0008569] g4409.t1 P45443 67.47 83 3.69e-29 111.0 sp|P45443|DYHC_NEUCR Dynein heavy chain, cytoplasmic OS=Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) OX=367110 GN=ro-1 PE=3 SV=1 g4410.t1 Q9JHU4 68.099 1583 0.0 2174.0 sp|Q9JHU4|DYHC1_MOUSE Cytoplasmic dynein 1 heavy chain 1 OS=Mus musculus OX=10090 GN=Dync1h1 PE=1 SV=2 DYHC1_MOUSE reviewed Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic) Mus musculus (Mouse) GO:0002177; GO:0003341; GO:0005524; GO:0005635; GO:0005737; GO:0005813; GO:0005868; GO:0005874; GO:0005881; GO:0005938; GO:0007052; GO:0007097; GO:0008090; GO:0008569; GO:0030175; GO:0030286; GO:0030424; GO:0031122; GO:0032388; GO:0033962; GO:0034063; GO:0042802; GO:0043025; GO:0045505; GO:0051293; GO:0051301; GO:0051959; GO:0060236; GO:0090235; GO:0120162; GO:1904115; GO:1905832 cell division [GO:0051301]; cilium movement [GO:0003341]; cytoplasmic microtubule organization [GO:0031122]; establishment of spindle localization [GO:0051293]; mitotic spindle organization [GO:0007052]; nuclear migration [GO:0007097]; P-body assembly [GO:0033962]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of intracellular transport [GO:0032388]; positive regulation of spindle assembly [GO:1905832]; regulation of metaphase plate congression [GO:0090235]; regulation of mitotic spindle organization [GO:0060236]; retrograde axonal transport [GO:0008090]; stress granule assembly [GO:0034063] axon [GO:0030424]; axon cytoplasm [GO:1904115]; cell cortex [GO:0005938]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; cytoplasmic microtubule [GO:0005881]; dynein complex [GO:0030286]; filopodium [GO:0030175]; manchette [GO:0002177]; microtubule [GO:0005874]; neuronal cell body [GO:0043025]; nuclear envelope [GO:0005635] ATP binding [GO:0005524]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; identical protein binding [GO:0042802]; minus-end-directed microtubule motor activity [GO:0008569] g4410.t2 Q9JHU4 67.754 1594 0.0 2165.0 sp|Q9JHU4|DYHC1_MOUSE Cytoplasmic dynein 1 heavy chain 1 OS=Mus musculus OX=10090 GN=Dync1h1 PE=1 SV=2 DYHC1_MOUSE reviewed Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic) Mus musculus (Mouse) GO:0002177; GO:0003341; GO:0005524; GO:0005635; GO:0005737; GO:0005813; GO:0005868; GO:0005874; GO:0005881; GO:0005938; GO:0007052; GO:0007097; GO:0008090; GO:0008569; GO:0030175; GO:0030286; GO:0030424; GO:0031122; GO:0032388; GO:0033962; GO:0034063; GO:0042802; GO:0043025; GO:0045505; GO:0051293; GO:0051301; GO:0051959; GO:0060236; GO:0090235; GO:0120162; GO:1904115; GO:1905832 cell division [GO:0051301]; cilium movement [GO:0003341]; cytoplasmic microtubule organization [GO:0031122]; establishment of spindle localization [GO:0051293]; mitotic spindle organization [GO:0007052]; nuclear migration [GO:0007097]; P-body assembly [GO:0033962]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of intracellular transport [GO:0032388]; positive regulation of spindle assembly [GO:1905832]; regulation of metaphase plate congression [GO:0090235]; regulation of mitotic spindle organization [GO:0060236]; retrograde axonal transport [GO:0008090]; stress granule assembly [GO:0034063] axon [GO:0030424]; axon cytoplasm [GO:1904115]; cell cortex [GO:0005938]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; cytoplasmic microtubule [GO:0005881]; dynein complex [GO:0030286]; filopodium [GO:0030175]; manchette [GO:0002177]; microtubule [GO:0005874]; neuronal cell body [GO:0043025]; nuclear envelope [GO:0005635] ATP binding [GO:0005524]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; identical protein binding [GO:0042802]; minus-end-directed microtubule motor activity [GO:0008569] g4414.t1 Q9H7Z3 35.363 509 3.72e-87 294.0 sp|Q9H7Z3|NRDE2_HUMAN Nuclear exosome regulator NRDE2 OS=Homo sapiens OX=9606 GN=NRDE2 PE=1 SV=3 g4415.t1 Q80XC6 33.051 472 2.14e-62 223.0 sp|Q80XC6|NRDE2_MOUSE Nuclear exosome regulator NRDE2 OS=Mus musculus OX=10090 GN=Nrde2 PE=1 SV=3 g4418.t1 Q9CYK2 42.088 297 1.01e-62 205.0 sp|Q9CYK2|QPCT_MOUSE Glutaminyl-peptide cyclotransferase OS=Mus musculus OX=10090 GN=Qpct PE=1 SV=2 QPCT_MOUSE reviewed Glutaminyl-peptide cyclotransferase (EC 2.3.2.5) (Glutaminyl cyclase) (QC) (Glutaminyl-tRNA cyclotransferase) Mus musculus (Mouse) GO:0005576; GO:0008270; GO:0016603; GO:0017186 peptidyl-pyroglutamic acid biosynthetic process, using glutaminyl-peptide cyclotransferase [GO:0017186] extracellular region [GO:0005576] glutaminyl-peptide cyclotransferase activity [GO:0016603]; zinc ion binding [GO:0008270] g4418.t2 Q9CYK2 42.088 297 9.67e-62 205.0 sp|Q9CYK2|QPCT_MOUSE Glutaminyl-peptide cyclotransferase OS=Mus musculus OX=10090 GN=Qpct PE=1 SV=2 QPCT_MOUSE reviewed Glutaminyl-peptide cyclotransferase (EC 2.3.2.5) (Glutaminyl cyclase) (QC) (Glutaminyl-tRNA cyclotransferase) Mus musculus (Mouse) GO:0005576; GO:0008270; GO:0016603; GO:0017186 peptidyl-pyroglutamic acid biosynthetic process, using glutaminyl-peptide cyclotransferase [GO:0017186] extracellular region [GO:0005576] glutaminyl-peptide cyclotransferase activity [GO:0016603]; zinc ion binding [GO:0008270] g4419.t1 Q5FWP2 37.716 753 1.11e-120 379.0 sp|Q5FWP2|SMAG1_XENLA Protein Smaug homolog 1 OS=Xenopus laevis OX=8355 GN=samd4a PE=2 SV=1 g4420.t1 Q8BMJ7 30.996 271 9.24e-34 130.0 sp|Q8BMJ7|CGRF1_MOUSE Cell growth regulator with RING finger domain protein 1 OS=Mus musculus OX=10090 GN=Cgrrf1 PE=2 SV=1 g4422.t1 P23790 68.927 177 3.26e-69 231.0 sp|P23790|SRF_XENLA Serum response factor OS=Xenopus laevis OX=8355 GN=srf PE=2 SV=1 g4424.t1 P50141 85.714 112 5.2999999999999995e-68 207.0 sp|P50141|GCH1_CHICK GTP cyclohydrolase 1 OS=Gallus gallus OX=9031 GN=GCH1 PE=2 SV=1 g4426.t1 Q9CR14 47.534 223 7.69e-68 216.0 sp|Q9CR14|FANCL_MOUSE E3 ubiquitin-protein ligase FANCL OS=Mus musculus OX=10090 GN=Fancl PE=1 SV=1 FANCL_MOUSE reviewed E3 ubiquitin-protein ligase FANCL (EC 2.3.2.27) (Fanconi anemia group L protein homolog) (Proliferation of germ cells protein) (RING-type E3 ubiquitin transferase FANCL) Mus musculus (Mouse) GO:0000785; GO:0004842; GO:0005634; GO:0005635; GO:0005737; GO:0006281; GO:0006513; GO:0006974; GO:0007276; GO:0008270; GO:0016604; GO:0031625; GO:0036297; GO:0042127; GO:0043240; GO:0061630 DNA damage response [GO:0006974]; DNA repair [GO:0006281]; gamete generation [GO:0007276]; interstrand cross-link repair [GO:0036297]; protein monoubiquitination [GO:0006513]; regulation of cell population proliferation [GO:0042127] chromatin [GO:0000785]; cytoplasm [GO:0005737]; Fanconi anaemia nuclear complex [GO:0043240]; nuclear body [GO:0016604]; nuclear envelope [GO:0005635]; nucleus [GO:0005634] ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] g4427.t1 Q80X41 48.87 354 2.3e-119 363.0 sp|Q80X41|VRK1_MOUSE Serine/threonine-protein kinase VRK1 OS=Mus musculus OX=10090 GN=Vrk1 PE=1 SV=2 VRK1_MOUSE reviewed Serine/threonine-protein kinase VRK1 (EC 2.7.11.1) (Serine/threonine-protein kinase 51PK) (Vaccinia-related kinase 1) Mus musculus (Mouse) GO:0000785; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005795; GO:0005829; GO:0006338; GO:0006974; GO:0007165; GO:0015030; GO:0016301; GO:0019901; GO:0030576; GO:0031175; GO:0031492; GO:0035175; GO:0042393; GO:0045944; GO:0051301; GO:0072354; GO:0090166; GO:0106310; GO:0120187; GO:0141003; GO:2001222 Cajal body organization [GO:0030576]; cell division [GO:0051301]; chromatin remodeling [GO:0006338]; DNA damage response [GO:0006974]; Golgi disassembly [GO:0090166]; neuron projection development [GO:0031175]; positive regulation of protein localization to chromatin [GO:0120187]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of neuron migration [GO:2001222]; signal transduction [GO:0007165] Cajal body [GO:0015030]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi stack [GO:0005795]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] ATP binding [GO:0005524]; histone binding [GO:0042393]; histone H2AX kinase activity [GO:0141003]; histone H3S10 kinase activity [GO:0035175]; histone H3T3 kinase activity [GO:0072354]; kinase activity [GO:0016301]; nucleosomal DNA binding [GO:0031492]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g4427.t2 Q80X41 48.87 354 1.8e-119 363.0 sp|Q80X41|VRK1_MOUSE Serine/threonine-protein kinase VRK1 OS=Mus musculus OX=10090 GN=Vrk1 PE=1 SV=2 VRK1_MOUSE reviewed Serine/threonine-protein kinase VRK1 (EC 2.7.11.1) (Serine/threonine-protein kinase 51PK) (Vaccinia-related kinase 1) Mus musculus (Mouse) GO:0000785; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005795; GO:0005829; GO:0006338; GO:0006974; GO:0007165; GO:0015030; GO:0016301; GO:0019901; GO:0030576; GO:0031175; GO:0031492; GO:0035175; GO:0042393; GO:0045944; GO:0051301; GO:0072354; GO:0090166; GO:0106310; GO:0120187; GO:0141003; GO:2001222 Cajal body organization [GO:0030576]; cell division [GO:0051301]; chromatin remodeling [GO:0006338]; DNA damage response [GO:0006974]; Golgi disassembly [GO:0090166]; neuron projection development [GO:0031175]; positive regulation of protein localization to chromatin [GO:0120187]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of neuron migration [GO:2001222]; signal transduction [GO:0007165] Cajal body [GO:0015030]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi stack [GO:0005795]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] ATP binding [GO:0005524]; histone binding [GO:0042393]; histone H2AX kinase activity [GO:0141003]; histone H3S10 kinase activity [GO:0035175]; histone H3T3 kinase activity [GO:0072354]; kinase activity [GO:0016301]; nucleosomal DNA binding [GO:0031492]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g4428.t1 Q1L994 52.381 420 1.99e-127 396.0 sp|Q1L994|PPR37_DANRE Protein phosphatase 1 regulatory subunit 37 OS=Danio rerio OX=7955 GN=ppp1r37 PE=2 SV=1 g4430.t1 Q8BRF7 62.519 643 0.0 816.0 sp|Q8BRF7|SCFD1_MOUSE Sec1 family domain-containing protein 1 OS=Mus musculus OX=10090 GN=Scfd1 PE=1 SV=1 g4432.t1 O09101 47.761 134 5.25e-26 104.0 sp|O09101|PIGF_MOUSE GPI ethanolamine phosphate transferase, stabilizing subunit OS=Mus musculus OX=10090 GN=Pigf PE=1 SV=1 g4433.t1 Q5E9P6 49.485 194 1.38e-59 203.0 sp|Q5E9P6|BSCL2_BOVIN Seipin OS=Bos taurus OX=9913 GN=BSCL2 PE=2 SV=1 g4434.t1 Q9CXS4 56.818 132 2.33e-51 167.0 sp|Q9CXS4|CENPV_MOUSE Centromere protein V OS=Mus musculus OX=10090 GN=Cenpv PE=1 SV=2 CENPV_MOUSE reviewed Centromere protein V (CENP-V) (Proline-rich protein 6) Mus musculus (Mouse) GO:0000776; GO:0001667; GO:0005634; GO:0005654; GO:0005829; GO:0015630; GO:0016846; GO:0030496; GO:0031508; GO:0031965; GO:0032467; GO:0033044; GO:0046872; GO:0051233; GO:0051301 ameboidal-type cell migration [GO:0001667]; cell division [GO:0051301]; pericentric heterochromatin formation [GO:0031508]; positive regulation of cytokinesis [GO:0032467]; regulation of chromosome organization [GO:0033044] cytosol [GO:0005829]; kinetochore [GO:0000776]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle midzone [GO:0051233] carbon-sulfur lyase activity [GO:0016846]; metal ion binding [GO:0046872] g4436.t1 Q8NF91 38.248 468 4.14e-89 309.0 sp|Q8NF91|SYNE1_HUMAN Nesprin-1 OS=Homo sapiens OX=9606 GN=SYNE1 PE=1 SV=4 g4436.t1 Q8NF91 57.237 152 1.24e-44 176.0 sp|Q8NF91|SYNE1_HUMAN Nesprin-1 OS=Homo sapiens OX=9606 GN=SYNE1 PE=1 SV=4 g4437.t1 M9MRD1 25.054 467 2.49e-36 148.0 sp|M9MRD1|MS300_DROME Muscle-specific protein 300 kDa OS=Drosophila melanogaster OX=7227 GN=Msp300 PE=1 SV=1 MS300_DROME reviewed Muscle-specific protein 300 kDa (Nesprin-like protein Msp300) Drosophila melanogaster (Fruit fly) GO:0003779; GO:0005635; GO:0005640; GO:0005737; GO:0005815; GO:0006997; GO:0007015; GO:0007097; GO:0007300; GO:0007498; GO:0007523; GO:0008335; GO:0016477; GO:0019901; GO:0030018; GO:0034453; GO:0034993; GO:0040011; GO:0048471; GO:0051015; GO:0051643; GO:0051646; GO:0051647; GO:0060361 actin filament organization [GO:0007015]; cell migration [GO:0016477]; endoplasmic reticulum localization [GO:0051643]; female germline ring canal stabilization [GO:0008335]; flight [GO:0060361]; larval visceral muscle development [GO:0007523]; locomotion [GO:0040011]; mesoderm development [GO:0007498]; microtubule anchoring [GO:0034453]; mitochondrion localization [GO:0051646]; nuclear migration [GO:0007097]; nucleus localization [GO:0051647]; nucleus organization [GO:0006997]; ovarian nurse cell to oocyte transport [GO:0007300] cytoplasm [GO:0005737]; meiotic nuclear membrane microtubule tethering complex [GO:0034993]; microtubule organizing center [GO:0005815]; nuclear envelope [GO:0005635]; nuclear outer membrane [GO:0005640]; perinuclear region of cytoplasm [GO:0048471]; Z disc [GO:0030018] actin binding [GO:0003779]; actin filament binding [GO:0051015]; protein kinase binding [GO:0019901] g4438.t1 M9MRD1 22.975 827 1.9600000000000002e-29 133.0 sp|M9MRD1|MS300_DROME Muscle-specific protein 300 kDa OS=Drosophila melanogaster OX=7227 GN=Msp300 PE=1 SV=1 MS300_DROME reviewed Muscle-specific protein 300 kDa (Nesprin-like protein Msp300) Drosophila melanogaster (Fruit fly) GO:0003779; GO:0005635; GO:0005640; GO:0005737; GO:0005815; GO:0006997; GO:0007015; GO:0007097; GO:0007300; GO:0007498; GO:0007523; GO:0008335; GO:0016477; GO:0019901; GO:0030018; GO:0034453; GO:0034993; GO:0040011; GO:0048471; GO:0051015; GO:0051643; GO:0051646; GO:0051647; GO:0060361 actin filament organization [GO:0007015]; cell migration [GO:0016477]; endoplasmic reticulum localization [GO:0051643]; female germline ring canal stabilization [GO:0008335]; flight [GO:0060361]; larval visceral muscle development [GO:0007523]; locomotion [GO:0040011]; mesoderm development [GO:0007498]; microtubule anchoring [GO:0034453]; mitochondrion localization [GO:0051646]; nuclear migration [GO:0007097]; nucleus localization [GO:0051647]; nucleus organization [GO:0006997]; ovarian nurse cell to oocyte transport [GO:0007300] cytoplasm [GO:0005737]; meiotic nuclear membrane microtubule tethering complex [GO:0034993]; microtubule organizing center [GO:0005815]; nuclear envelope [GO:0005635]; nuclear outer membrane [GO:0005640]; perinuclear region of cytoplasm [GO:0048471]; Z disc [GO:0030018] actin binding [GO:0003779]; actin filament binding [GO:0051015]; protein kinase binding [GO:0019901] g4438.t1 M9MRD1 22.207 752 3.07e-28 129.0 sp|M9MRD1|MS300_DROME Muscle-specific protein 300 kDa OS=Drosophila melanogaster OX=7227 GN=Msp300 PE=1 SV=1 MS300_DROME reviewed Muscle-specific protein 300 kDa (Nesprin-like protein Msp300) Drosophila melanogaster (Fruit fly) GO:0003779; GO:0005635; GO:0005640; GO:0005737; GO:0005815; GO:0006997; GO:0007015; GO:0007097; GO:0007300; GO:0007498; GO:0007523; GO:0008335; GO:0016477; GO:0019901; GO:0030018; GO:0034453; GO:0034993; GO:0040011; GO:0048471; GO:0051015; GO:0051643; GO:0051646; GO:0051647; GO:0060361 actin filament organization [GO:0007015]; cell migration [GO:0016477]; endoplasmic reticulum localization [GO:0051643]; female germline ring canal stabilization [GO:0008335]; flight [GO:0060361]; larval visceral muscle development [GO:0007523]; locomotion [GO:0040011]; mesoderm development [GO:0007498]; microtubule anchoring [GO:0034453]; mitochondrion localization [GO:0051646]; nuclear migration [GO:0007097]; nucleus localization [GO:0051647]; nucleus organization [GO:0006997]; ovarian nurse cell to oocyte transport [GO:0007300] cytoplasm [GO:0005737]; meiotic nuclear membrane microtubule tethering complex [GO:0034993]; microtubule organizing center [GO:0005815]; nuclear envelope [GO:0005635]; nuclear outer membrane [GO:0005640]; perinuclear region of cytoplasm [GO:0048471]; Z disc [GO:0030018] actin binding [GO:0003779]; actin filament binding [GO:0051015]; protein kinase binding [GO:0019901] g4438.t1 M9MRD1 20.353 850 3.6200000000000004e-21 105.0 sp|M9MRD1|MS300_DROME Muscle-specific protein 300 kDa OS=Drosophila melanogaster OX=7227 GN=Msp300 PE=1 SV=1 MS300_DROME reviewed Muscle-specific protein 300 kDa (Nesprin-like protein Msp300) Drosophila melanogaster (Fruit fly) GO:0003779; GO:0005635; GO:0005640; GO:0005737; GO:0005815; GO:0006997; GO:0007015; GO:0007097; GO:0007300; GO:0007498; GO:0007523; GO:0008335; GO:0016477; GO:0019901; GO:0030018; GO:0034453; GO:0034993; GO:0040011; GO:0048471; GO:0051015; GO:0051643; GO:0051646; GO:0051647; GO:0060361 actin filament organization [GO:0007015]; cell migration [GO:0016477]; endoplasmic reticulum localization [GO:0051643]; female germline ring canal stabilization [GO:0008335]; flight [GO:0060361]; larval visceral muscle development [GO:0007523]; locomotion [GO:0040011]; mesoderm development [GO:0007498]; microtubule anchoring [GO:0034453]; mitochondrion localization [GO:0051646]; nuclear migration [GO:0007097]; nucleus localization [GO:0051647]; nucleus organization [GO:0006997]; ovarian nurse cell to oocyte transport [GO:0007300] cytoplasm [GO:0005737]; meiotic nuclear membrane microtubule tethering complex [GO:0034993]; microtubule organizing center [GO:0005815]; nuclear envelope [GO:0005635]; nuclear outer membrane [GO:0005640]; perinuclear region of cytoplasm [GO:0048471]; Z disc [GO:0030018] actin binding [GO:0003779]; actin filament binding [GO:0051015]; protein kinase binding [GO:0019901] g4439.t1 Q6ZWR6 22.332 2539 1.37e-98 362.0 sp|Q6ZWR6|SYNE1_MOUSE Nesprin-1 OS=Mus musculus OX=10090 GN=Syne1 PE=1 SV=2 SYNE1_MOUSE reviewed Nesprin-1 (Enaptin) (KASH domain-containing protein 1) (KASH1) (Myocyte nuclear envelope protein 1) (Myne-1) (Nuclear envelope spectrin repeat protein 1) (Synaptic nuclear envelope protein 1) (Syne-1) Mus musculus (Mouse) GO:0000932; GO:0002053; GO:0003779; GO:0005102; GO:0005521; GO:0005635; GO:0005640; GO:0005654; GO:0005730; GO:0005737; GO:0005794; GO:0007030; GO:0007097; GO:0007283; GO:0016020; GO:0019899; GO:0030017; GO:0030496; GO:0031965; GO:0034993; GO:0042692; GO:0042802; GO:0042803; GO:0043197; GO:0044327; GO:0045211; GO:0048260; GO:0048471; GO:0048814; GO:0051015; GO:0051642; GO:0061886; GO:0090292; GO:0098843; GO:0098871; GO:0098978; GO:0099149; GO:1902017; GO:1903353; GO:2001054 centrosome localization [GO:0051642]; Golgi organization [GO:0007030]; muscle cell differentiation [GO:0042692]; negative regulation of mesenchymal cell apoptotic process [GO:2001054]; negative regulation of mini excitatory postsynaptic potential [GO:0061886]; nuclear matrix anchoring at nuclear membrane [GO:0090292]; nuclear migration [GO:0007097]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of receptor-mediated endocytosis [GO:0048260]; regulation of cilium assembly [GO:1902017]; regulation of dendrite morphogenesis [GO:0048814]; regulation of nucleus organization [GO:1903353]; regulation of postsynaptic neurotransmitter receptor internalization [GO:0099149]; spermatogenesis [GO:0007283] cytoplasm [GO:0005737]; dendritic spine [GO:0043197]; dendritic spine head [GO:0044327]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; meiotic nuclear membrane microtubule tethering complex [GO:0034993]; membrane [GO:0016020]; midbody [GO:0030496]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear outer membrane [GO:0005640]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; P-body [GO:0000932]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic actin cytoskeleton [GO:0098871]; postsynaptic endocytic zone [GO:0098843]; postsynaptic membrane [GO:0045211]; sarcomere [GO:0030017] actin binding [GO:0003779]; actin filament binding [GO:0051015]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; lamin binding [GO:0005521]; protein homodimerization activity [GO:0042803]; signaling receptor binding [GO:0005102] g4439.t1 Q6ZWR6 20.451 1330 1.37e-38 164.0 sp|Q6ZWR6|SYNE1_MOUSE Nesprin-1 OS=Mus musculus OX=10090 GN=Syne1 PE=1 SV=2 SYNE1_MOUSE reviewed Nesprin-1 (Enaptin) (KASH domain-containing protein 1) (KASH1) (Myocyte nuclear envelope protein 1) (Myne-1) (Nuclear envelope spectrin repeat protein 1) (Synaptic nuclear envelope protein 1) (Syne-1) Mus musculus (Mouse) GO:0000932; GO:0002053; GO:0003779; GO:0005102; GO:0005521; GO:0005635; GO:0005640; GO:0005654; GO:0005730; GO:0005737; GO:0005794; GO:0007030; GO:0007097; GO:0007283; GO:0016020; GO:0019899; GO:0030017; GO:0030496; GO:0031965; GO:0034993; GO:0042692; GO:0042802; GO:0042803; GO:0043197; GO:0044327; GO:0045211; GO:0048260; GO:0048471; GO:0048814; GO:0051015; GO:0051642; GO:0061886; GO:0090292; GO:0098843; GO:0098871; GO:0098978; GO:0099149; GO:1902017; GO:1903353; GO:2001054 centrosome localization [GO:0051642]; Golgi organization [GO:0007030]; muscle cell differentiation [GO:0042692]; negative regulation of mesenchymal cell apoptotic process [GO:2001054]; negative regulation of mini excitatory postsynaptic potential [GO:0061886]; nuclear matrix anchoring at nuclear membrane [GO:0090292]; nuclear migration [GO:0007097]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of receptor-mediated endocytosis [GO:0048260]; regulation of cilium assembly [GO:1902017]; regulation of dendrite morphogenesis [GO:0048814]; regulation of nucleus organization [GO:1903353]; regulation of postsynaptic neurotransmitter receptor internalization [GO:0099149]; spermatogenesis [GO:0007283] cytoplasm [GO:0005737]; dendritic spine [GO:0043197]; dendritic spine head [GO:0044327]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; meiotic nuclear membrane microtubule tethering complex [GO:0034993]; membrane [GO:0016020]; midbody [GO:0030496]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear outer membrane [GO:0005640]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; P-body [GO:0000932]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic actin cytoskeleton [GO:0098871]; postsynaptic endocytic zone [GO:0098843]; postsynaptic membrane [GO:0045211]; sarcomere [GO:0030017] actin binding [GO:0003779]; actin filament binding [GO:0051015]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; lamin binding [GO:0005521]; protein homodimerization activity [GO:0042803]; signaling receptor binding [GO:0005102] g4439.t1 Q6ZWR6 21.477 731 1.99e-28 130.0 sp|Q6ZWR6|SYNE1_MOUSE Nesprin-1 OS=Mus musculus OX=10090 GN=Syne1 PE=1 SV=2 SYNE1_MOUSE reviewed Nesprin-1 (Enaptin) (KASH domain-containing protein 1) (KASH1) (Myocyte nuclear envelope protein 1) (Myne-1) (Nuclear envelope spectrin repeat protein 1) (Synaptic nuclear envelope protein 1) (Syne-1) Mus musculus (Mouse) GO:0000932; GO:0002053; GO:0003779; GO:0005102; GO:0005521; GO:0005635; GO:0005640; GO:0005654; GO:0005730; GO:0005737; GO:0005794; GO:0007030; GO:0007097; GO:0007283; GO:0016020; GO:0019899; GO:0030017; GO:0030496; GO:0031965; GO:0034993; GO:0042692; GO:0042802; GO:0042803; GO:0043197; GO:0044327; GO:0045211; GO:0048260; GO:0048471; GO:0048814; GO:0051015; GO:0051642; GO:0061886; GO:0090292; GO:0098843; GO:0098871; GO:0098978; GO:0099149; GO:1902017; GO:1903353; GO:2001054 centrosome localization [GO:0051642]; Golgi organization [GO:0007030]; muscle cell differentiation [GO:0042692]; negative regulation of mesenchymal cell apoptotic process [GO:2001054]; negative regulation of mini excitatory postsynaptic potential [GO:0061886]; nuclear matrix anchoring at nuclear membrane [GO:0090292]; nuclear migration [GO:0007097]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of receptor-mediated endocytosis [GO:0048260]; regulation of cilium assembly [GO:1902017]; regulation of dendrite morphogenesis [GO:0048814]; regulation of nucleus organization [GO:1903353]; regulation of postsynaptic neurotransmitter receptor internalization [GO:0099149]; spermatogenesis [GO:0007283] cytoplasm [GO:0005737]; dendritic spine [GO:0043197]; dendritic spine head [GO:0044327]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; meiotic nuclear membrane microtubule tethering complex [GO:0034993]; membrane [GO:0016020]; midbody [GO:0030496]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear outer membrane [GO:0005640]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; P-body [GO:0000932]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic actin cytoskeleton [GO:0098871]; postsynaptic endocytic zone [GO:0098843]; postsynaptic membrane [GO:0045211]; sarcomere [GO:0030017] actin binding [GO:0003779]; actin filament binding [GO:0051015]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; lamin binding [GO:0005521]; protein homodimerization activity [GO:0042803]; signaling receptor binding [GO:0005102] g4445.t1 Q8NF91 30.143 1818 0.0 660.0 sp|Q8NF91|SYNE1_HUMAN Nesprin-1 OS=Homo sapiens OX=9606 GN=SYNE1 PE=1 SV=4 g4445.t2 Q8NF91 30.26 1811 0.0 671.0 sp|Q8NF91|SYNE1_HUMAN Nesprin-1 OS=Homo sapiens OX=9606 GN=SYNE1 PE=1 SV=4 g4446.t1 Q8NF91 58.849 469 0.0 593.0 sp|Q8NF91|SYNE1_HUMAN Nesprin-1 OS=Homo sapiens OX=9606 GN=SYNE1 PE=1 SV=4 g4446.t1 Q8NF91 33.333 546 2.12e-63 240.0 sp|Q8NF91|SYNE1_HUMAN Nesprin-1 OS=Homo sapiens OX=9606 GN=SYNE1 PE=1 SV=4 g4446.t2 Q8NF91 58.316 475 0.0 595.0 sp|Q8NF91|SYNE1_HUMAN Nesprin-1 OS=Homo sapiens OX=9606 GN=SYNE1 PE=1 SV=4 g4446.t2 Q8NF91 33.333 546 2.28e-63 240.0 sp|Q8NF91|SYNE1_HUMAN Nesprin-1 OS=Homo sapiens OX=9606 GN=SYNE1 PE=1 SV=4 g4447.t1 Q15573 29.859 355 2.94e-33 134.0 sp|Q15573|TAF1A_HUMAN TATA box-binding protein-associated factor RNA polymerase I subunit A OS=Homo sapiens OX=9606 GN=TAF1A PE=1 SV=1 TAF1A_HUMAN reviewed TATA box-binding protein-associated factor RNA polymerase I subunit A (RNA polymerase I-specific TBP-associated factor 48 kDa) (TAFI48) (TATA box-binding protein-associated factor 1A) (TBP-associated factor 1A) (Transcription factor SL1) (Transcription initiation factor SL1/TIF-IB subunit A) Homo sapiens (Human) GO:0003677; GO:0005654; GO:0005668; GO:0006360; GO:0006366; GO:0015630 transcription by RNA polymerase I [GO:0006360]; transcription by RNA polymerase II [GO:0006366] microtubule cytoskeleton [GO:0015630]; nucleoplasm [GO:0005654]; RNA polymerase transcription factor SL1 complex [GO:0005668] DNA binding [GO:0003677] g4448.t1 Q8R2K4 44.877 488 2.4799999999999998e-126 389.0 sp|Q8R2K4|TAF6L_MOUSE TAF6-like RNA polymerase II p300/CBP-associated factor-associated factor 65 kDa subunit 6L OS=Mus musculus OX=10090 GN=Taf6l PE=1 SV=1 TAF6L_MOUSE reviewed TAF6-like RNA polymerase II p300/CBP-associated factor-associated factor 65 kDa subunit 6L (TAF6L) (PCAF-associated factor 65-alpha) (PAF65-alpha) Mus musculus (Mouse) GO:0000124; GO:0003713; GO:0005634; GO:0005654; GO:0005669; GO:0006282; GO:0006355; GO:0016251; GO:0043484; GO:0045893; GO:0046695; GO:0046982; GO:0051123; GO:1904672 positive regulation of DNA-templated transcription [GO:0045893]; regulation of DNA repair [GO:0006282]; regulation of DNA-templated transcription [GO:0006355]; regulation of RNA splicing [GO:0043484]; regulation of somatic stem cell population maintenance [GO:1904672]; RNA polymerase II preinitiation complex assembly [GO:0051123] nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SAGA complex [GO:0000124]; SLIK (SAGA-like) complex [GO:0046695]; transcription factor TFIID complex [GO:0005669] protein heterodimerization activity [GO:0046982]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; transcription coactivator activity [GO:0003713] g4448.t2 Q8R2K4 44.581 489 4.2e-126 388.0 sp|Q8R2K4|TAF6L_MOUSE TAF6-like RNA polymerase II p300/CBP-associated factor-associated factor 65 kDa subunit 6L OS=Mus musculus OX=10090 GN=Taf6l PE=1 SV=1 TAF6L_MOUSE reviewed TAF6-like RNA polymerase II p300/CBP-associated factor-associated factor 65 kDa subunit 6L (TAF6L) (PCAF-associated factor 65-alpha) (PAF65-alpha) Mus musculus (Mouse) GO:0000124; GO:0003713; GO:0005634; GO:0005654; GO:0005669; GO:0006282; GO:0006355; GO:0016251; GO:0043484; GO:0045893; GO:0046695; GO:0046982; GO:0051123; GO:1904672 positive regulation of DNA-templated transcription [GO:0045893]; regulation of DNA repair [GO:0006282]; regulation of DNA-templated transcription [GO:0006355]; regulation of RNA splicing [GO:0043484]; regulation of somatic stem cell population maintenance [GO:1904672]; RNA polymerase II preinitiation complex assembly [GO:0051123] nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SAGA complex [GO:0000124]; SLIK (SAGA-like) complex [GO:0046695]; transcription factor TFIID complex [GO:0005669] protein heterodimerization activity [GO:0046982]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; transcription coactivator activity [GO:0003713] g4455.t1 Q17RD7 42.761 297 1.3200000000000001e-77 256.0 sp|Q17RD7|SYT16_HUMAN Synaptotagmin-16 OS=Homo sapiens OX=9606 GN=SYT16 PE=1 SV=2 SYT16_HUMAN reviewed Synaptotagmin-16 (Chr14Syt) (Synaptotagmin 14-like protein) (Synaptotagmin XIV-related protein) Homo sapiens (Human) GO:0005543; GO:0042802 identical protein binding [GO:0042802]; phospholipid binding [GO:0005543] g4456.t1 Q96NR8 53.153 111 2.93e-34 125.0 sp|Q96NR8|RDH12_HUMAN Retinol dehydrogenase 12 OS=Homo sapiens OX=9606 GN=RDH12 PE=1 SV=3 g4457.t1 Q17QW3 48.64 331 3.38e-85 263.0 sp|Q17QW3|RDH14_BOVIN Retinol dehydrogenase 14 OS=Bos taurus OX=9913 GN=RDH14 PE=2 SV=1 RDH14_BOVIN reviewed Retinol dehydrogenase 14 (EC 1.1.1.300) Bos taurus (Bovine) GO:0001750; GO:0005654; GO:0005783; GO:0005829; GO:0042572; GO:0052650; GO:0102354 retinol metabolic process [GO:0042572] cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nucleoplasm [GO:0005654]; photoreceptor outer segment [GO:0001750] 11-cis-retinol dehydrogenase (NADP+) activity [GO:0102354]; all-trans-retinol dehydrogenase (NADP+) activity [GO:0052650] g4458.t1 O35459 54.676 278 4.08e-109 323.0 sp|O35459|ECH1_MOUSE Delta(3,5)-Delta(2,4)-dienoyl-CoA isomerase, mitochondrial OS=Mus musculus OX=10090 GN=Ech1 PE=1 SV=1 g4459.t1 Q9CQ46 64.331 157 3.7099999999999995e-74 222.0 sp|Q9CQ46|DRC8_MOUSE Dynein regulatory complex protein 8 OS=Mus musculus OX=10090 GN=Efcab2 PE=1 SV=1 g4460.t1 Q8VDM6 54.822 394 3.9099999999999996e-146 460.0 sp|Q8VDM6|HNRL1_MOUSE Heterogeneous nuclear ribonucleoprotein U-like protein 1 OS=Mus musculus OX=10090 GN=Hnrnpul1 PE=1 SV=1 HNRL1_MOUSE reviewed Heterogeneous nuclear ribonucleoprotein U-like protein 1 Mus musculus (Mouse) GO:0000380; GO:0003723; GO:0005634; GO:0005654; GO:0019899; GO:0045202; GO:1990904 alternative mRNA splicing, via spliceosome [GO:0000380] nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; synapse [GO:0045202] enzyme binding [GO:0019899]; RNA binding [GO:0003723] g4463.t1 Q640B4 58.725 298 1.4699999999999998e-119 378.0 sp|Q640B4|MUS81_XENTR Structure-specific endonuclease subunit MUS81 OS=Xenopus tropicalis OX=8364 GN=mus81 PE=2 SV=1 g4463.t1 Q640B4 51.837 245 6.3e-61 221.0 sp|Q640B4|MUS81_XENTR Structure-specific endonuclease subunit MUS81 OS=Xenopus tropicalis OX=8364 GN=mus81 PE=2 SV=1 g4464.t1 P10079 43.644 763 0.0 620.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g4464.t1 P10079 39.535 817 2.47e-175 575.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g4464.t1 P10079 44.681 611 7.67e-158 524.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g4464.t1 P10079 43.322 584 3.0300000000000004e-144 484.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g4464.t1 P10079 44.262 305 4.09e-73 272.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g4464.t2 A0A1D5NSM8 30.16 1061 5.09e-113 409.0 sp|A0A1D5NSM8|SVEP1_DANRE Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 OS=Danio rerio OX=7955 GN=svep1 PE=1 SV=1 SVEP1_DANRE reviewed Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 (Polydom) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001945; GO:0005509; GO:0005576; GO:0005634; GO:0005737; GO:0008544; GO:0009913; GO:0016020; GO:0016477; GO:0036303; GO:0090136 cell migration [GO:0016477]; epidermal cell differentiation [GO:0009913]; epidermis development [GO:0008544]; epithelial cell-cell adhesion [GO:0090136]; lymph vessel development [GO:0001945]; lymph vessel morphogenesis [GO:0036303] cytoplasm [GO:0005737]; extracellular region [GO:0005576]; membrane [GO:0016020]; nucleus [GO:0005634] calcium ion binding [GO:0005509] g4464.t2 A0A1D5NSM8 31.341 619 8.77e-70 267.0 sp|A0A1D5NSM8|SVEP1_DANRE Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 OS=Danio rerio OX=7955 GN=svep1 PE=1 SV=1 SVEP1_DANRE reviewed Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 (Polydom) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001945; GO:0005509; GO:0005576; GO:0005634; GO:0005737; GO:0008544; GO:0009913; GO:0016020; GO:0016477; GO:0036303; GO:0090136 cell migration [GO:0016477]; epidermal cell differentiation [GO:0009913]; epidermis development [GO:0008544]; epithelial cell-cell adhesion [GO:0090136]; lymph vessel development [GO:0001945]; lymph vessel morphogenesis [GO:0036303] cytoplasm [GO:0005737]; extracellular region [GO:0005576]; membrane [GO:0016020]; nucleus [GO:0005634] calcium ion binding [GO:0005509] g4464.t2 A0A1D5NSM8 22.922 842 7.810000000000001e-27 125.0 sp|A0A1D5NSM8|SVEP1_DANRE Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 OS=Danio rerio OX=7955 GN=svep1 PE=1 SV=1 SVEP1_DANRE reviewed Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 (Polydom) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001945; GO:0005509; GO:0005576; GO:0005634; GO:0005737; GO:0008544; GO:0009913; GO:0016020; GO:0016477; GO:0036303; GO:0090136 cell migration [GO:0016477]; epidermal cell differentiation [GO:0009913]; epidermis development [GO:0008544]; epithelial cell-cell adhesion [GO:0090136]; lymph vessel development [GO:0001945]; lymph vessel morphogenesis [GO:0036303] cytoplasm [GO:0005737]; extracellular region [GO:0005576]; membrane [GO:0016020]; nucleus [GO:0005634] calcium ion binding [GO:0005509] g4464.t2 A0A1D5NSM8 23.817 1226 8.28e-27 125.0 sp|A0A1D5NSM8|SVEP1_DANRE Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 OS=Danio rerio OX=7955 GN=svep1 PE=1 SV=1 SVEP1_DANRE reviewed Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 (Polydom) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001945; GO:0005509; GO:0005576; GO:0005634; GO:0005737; GO:0008544; GO:0009913; GO:0016020; GO:0016477; GO:0036303; GO:0090136 cell migration [GO:0016477]; epidermal cell differentiation [GO:0009913]; epidermis development [GO:0008544]; epithelial cell-cell adhesion [GO:0090136]; lymph vessel development [GO:0001945]; lymph vessel morphogenesis [GO:0036303] cytoplasm [GO:0005737]; extracellular region [GO:0005576]; membrane [GO:0016020]; nucleus [GO:0005634] calcium ion binding [GO:0005509] g4465.t1 P78539 34.926 272 6.17e-33 132.0 sp|P78539|SRPX_HUMAN Sushi repeat-containing protein SRPX OS=Homo sapiens OX=9606 GN=SRPX PE=1 SV=1 SRPX_HUMAN reviewed Sushi repeat-containing protein SRPX Homo sapiens (Human) GO:0001845; GO:0005776; GO:0005783; GO:0006914; GO:0007155; GO:0009986; GO:0016020; GO:0031012; GO:0034976; GO:0060244; GO:2001241 autophagy [GO:0006914]; cell adhesion [GO:0007155]; negative regulation of cell proliferation involved in contact inhibition [GO:0060244]; phagolysosome assembly [GO:0001845]; positive regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001241]; response to endoplasmic reticulum stress [GO:0034976] autophagosome [GO:0005776]; cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; extracellular matrix [GO:0031012]; membrane [GO:0016020] g4466.t1 A7SL20 46.575 219 2.28e-39 140.0 sp|A7SL20|RRP36_NEMVE Ribosomal RNA processing protein 36 homolog OS=Nematostella vectensis OX=45351 GN=v1g245966 PE=3 SV=1 g4468.t1 Q6ZMW3 64.246 1969 0.0 2630.0 sp|Q6ZMW3|EMAL6_HUMAN Echinoderm microtubule-associated protein-like 6 OS=Homo sapiens OX=9606 GN=EML6 PE=1 SV=2 g4470.t1 P01125 30.496 282 1.5e-27 122.0 sp|P01125|REL_MELGA Proto-oncogene c-Rel (Fragment) OS=Meleagris gallopavo OX=9103 GN=REL PE=3 SV=3 g4471.t1 Q9QYY8 52.852 526 3.34e-160 496.0 sp|Q9QYY8|SPAST_MOUSE Spastin OS=Mus musculus OX=10090 GN=Spast PE=1 SV=3 g4471.t2 B2RYN7 59.02 449 1.97e-164 504.0 sp|B2RYN7|SPAST_RAT Spastin OS=Rattus norvegicus OX=10116 GN=Spast PE=1 SV=1 SPAST_RAT reviewed Spastin (EC 5.6.1.1) Rattus norvegicus (Rat) GO:0000281; GO:0000922; GO:0001578; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005783; GO:0005813; GO:0005819; GO:0005829; GO:0005874; GO:0006888; GO:0008017; GO:0008089; GO:0008568; GO:0010458; GO:0015630; GO:0016887; GO:0019896; GO:0021955; GO:0030424; GO:0030496; GO:0031117; GO:0031410; GO:0031468; GO:0031965; GO:0032467; GO:0032506; GO:0034214; GO:0043014; GO:0048471; GO:0048487; GO:0051013; GO:0051228; GO:0051260; GO:0071782; GO:0090148; GO:1904115 anterograde axonal transport [GO:0008089]; axonal transport of mitochondrion [GO:0019896]; central nervous system neuron axonogenesis [GO:0021955]; cytokinetic process [GO:0032506]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; exit from mitosis [GO:0010458]; membrane fission [GO:0090148]; microtubule bundle formation [GO:0001578]; microtubule severing [GO:0051013]; mitotic cytokinesis [GO:0000281]; mitotic spindle disassembly [GO:0051228]; nuclear membrane reassembly [GO:0031468]; positive regulation of cytokinesis [GO:0032467]; positive regulation of microtubule depolymerization [GO:0031117]; protein hexamerization [GO:0034214]; protein homooligomerization [GO:0051260] axon [GO:0030424]; axon cytoplasm [GO:1904115]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum tubular network [GO:0071782]; endosome [GO:0005768]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; spindle [GO:0005819]; spindle pole [GO:0000922] alpha-tubulin binding [GO:0043014]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; beta-tubulin binding [GO:0048487]; microtubule binding [GO:0008017]; microtubule severing ATPase activity [GO:0008568] g4472.t1 A7RP64 85.204 196 2.05e-109 318.0 sp|A7RP64|PNO1_NEMVE RNA-binding protein pno1 OS=Nematostella vectensis OX=45351 GN=pno1 PE=3 SV=1 g4473.t1 Q8VCX6 45.0 360 2.4e-85 273.0 sp|Q8VCX6|KPTN_MOUSE KICSTOR complex protein kaptin OS=Mus musculus OX=10090 GN=Kptn PE=2 SV=1 g4474.t1 Q1L673 30.732 205 1e-26 115.0 sp|Q1L673|VDRB_DANRE Vitamin D3 receptor B OS=Danio rerio OX=7955 GN=vdrb PE=2 SV=2 VDRB_DANRE reviewed Vitamin D3 receptor B (VDR-B) (1,25-dihydroxyvitamin D3 receptor B) (Nuclear receptor subfamily 1 group I member 1-B) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000122; GO:0000978; GO:0001947; GO:0003146; GO:0004879; GO:0005499; GO:0005634; GO:0005737; GO:0008270; GO:0030154; GO:0030522; GO:0045944; GO:0048701; GO:0060119; GO:0071599 cell differentiation [GO:0030154]; embryonic cranial skeleton morphogenesis [GO:0048701]; heart jogging [GO:0003146]; heart looping [GO:0001947]; inner ear receptor cell development [GO:0060119]; intracellular receptor signaling pathway [GO:0030522]; negative regulation of transcription by RNA polymerase II [GO:0000122]; otic vesicle development [GO:0071599]; positive regulation of transcription by RNA polymerase II [GO:0045944] cytoplasm [GO:0005737]; nucleus [GO:0005634] nuclear receptor activity [GO:0004879]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; vitamin D binding [GO:0005499]; zinc ion binding [GO:0008270] g4474.t1 Q1L673 39.568 139 1.8899999999999997e-23 106.0 sp|Q1L673|VDRB_DANRE Vitamin D3 receptor B OS=Danio rerio OX=7955 GN=vdrb PE=2 SV=2 VDRB_DANRE reviewed Vitamin D3 receptor B (VDR-B) (1,25-dihydroxyvitamin D3 receptor B) (Nuclear receptor subfamily 1 group I member 1-B) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000122; GO:0000978; GO:0001947; GO:0003146; GO:0004879; GO:0005499; GO:0005634; GO:0005737; GO:0008270; GO:0030154; GO:0030522; GO:0045944; GO:0048701; GO:0060119; GO:0071599 cell differentiation [GO:0030154]; embryonic cranial skeleton morphogenesis [GO:0048701]; heart jogging [GO:0003146]; heart looping [GO:0001947]; inner ear receptor cell development [GO:0060119]; intracellular receptor signaling pathway [GO:0030522]; negative regulation of transcription by RNA polymerase II [GO:0000122]; otic vesicle development [GO:0071599]; positive regulation of transcription by RNA polymerase II [GO:0045944] cytoplasm [GO:0005737]; nucleus [GO:0005634] nuclear receptor activity [GO:0004879]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; vitamin D binding [GO:0005499]; zinc ion binding [GO:0008270] g4476.t1 O93384 69.444 72 2.0800000000000004e-27 106.0 sp|O93384|RSAD2_ONCMY S-adenosylmethionine-dependent nucleotide dehydratase RSAD2 OS=Oncorhynchus mykiss OX=8022 GN=rsad2 PE=2 SV=1 g4477.t1 Q3SZW3 36.538 260 5.1199999999999994e-48 164.0 sp|Q3SZW3|ARV1_BOVIN Protein ARV1 OS=Bos taurus OX=9913 GN=ARV1 PE=2 SV=1 g4478.t1 A6NEE1 39.813 427 5.17e-83 271.0 sp|A6NEE1|PLHD1_HUMAN Pleckstrin homology domain-containing family D member 1 OS=Homo sapiens OX=9606 GN=PLEKHD1 PE=1 SV=3 g4478.t2 A6NEE1 39.813 427 5.3799999999999996e-83 270.0 sp|A6NEE1|PLHD1_HUMAN Pleckstrin homology domain-containing family D member 1 OS=Homo sapiens OX=9606 GN=PLEKHD1 PE=1 SV=3 g4480.t1 Q9QXF7 42.282 447 1.0100000000000001e-105 327.0 sp|Q9QXF7|CP2J4_RAT Cytochrome P450 2J4 OS=Rattus norvegicus OX=10116 GN=CYP2J4 PE=1 SV=1 g4481.t1 Q5RH95 71.383 311 2.9e-171 483.0 sp|Q5RH95|RSAD2_DANRE S-adenosylmethionine-dependent nucleotide dehydratase RSAD2 OS=Danio rerio OX=7955 GN=rsad2 PE=2 SV=1 RSAD2_DANRE reviewed S-adenosylmethionine-dependent nucleotide dehydratase RSAD2 (SAND) (Radical S-adenosyl methionine domain-containing protein 2) (Virus inhibitory protein, endoplasmic reticulum-associated, interferon-inducible) (Viperin) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0003824; GO:0005739; GO:0005783; GO:0005789; GO:0005811; GO:0009615; GO:0045087; GO:0046872; GO:0050778; GO:0051539; GO:0051607; GO:0090594 defense response to virus [GO:0051607]; inflammatory response to wounding [GO:0090594]; innate immune response [GO:0045087]; positive regulation of immune response [GO:0050778]; response to virus [GO:0009615] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; lipid droplet [GO:0005811]; mitochondrion [GO:0005739] 4 iron, 4 sulfur cluster binding [GO:0051539]; catalytic activity [GO:0003824]; metal ion binding [GO:0046872] g4482.t1 Q6NWH0 45.517 145 6.55e-33 123.0 sp|Q6NWH0|CK068_DANRE UPF0696 protein C11orf68 homolog OS=Danio rerio OX=7955 GN=P5436 PE=2 SV=1 g4483.t1 Q9Y243 64.73 482 0.0 601.0 sp|Q9Y243|AKT3_HUMAN RAC-gamma serine/threonine-protein kinase OS=Homo sapiens OX=9606 GN=AKT3 PE=1 SV=1 g4483.t2 Q9Y243 64.108 482 0.0 604.0 sp|Q9Y243|AKT3_HUMAN RAC-gamma serine/threonine-protein kinase OS=Homo sapiens OX=9606 GN=AKT3 PE=1 SV=1 g4487.t1 P24008 61.24 129 2.4e-56 179.0 sp|P24008|S5A1_RAT 3-oxo-5-alpha-steroid 4-dehydrogenase 1 OS=Rattus norvegicus OX=10116 GN=Srd5a1 PE=1 SV=2 S5A1_RAT reviewed 3-oxo-5-alpha-steroid 4-dehydrogenase 1 (EC 1.3.1.22) (SR type 1) (Steroid 5-alpha-reductase 1) (S5AR 1) Rattus norvegicus (Rat) GO:0001655; GO:0001889; GO:0003865; GO:0005789; GO:0006694; GO:0006702; GO:0006710; GO:0008209; GO:0008584; GO:0009267; GO:0009410; GO:0014850; GO:0016101; GO:0021510; GO:0021766; GO:0021794; GO:0021854; GO:0021983; GO:0021987; GO:0030154; GO:0030539; GO:0030540; GO:0032354; GO:0032355; GO:0032869; GO:0033218; GO:0033574; GO:0042448; GO:0043025; GO:0043627; GO:0046661; GO:0047751; GO:0048471; GO:0060348; GO:0060416; GO:0060992; GO:0070402; GO:0070852; GO:0071320; GO:0071363; GO:0071392; GO:0071394; GO:0071549; GO:0071872; GO:1904015; GO:1904638 androgen biosynthetic process [GO:0006702]; androgen catabolic process [GO:0006710]; androgen metabolic process [GO:0008209]; bone development [GO:0060348]; cell differentiation [GO:0030154]; cellular response to cAMP [GO:0071320]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to epinephrine stimulus [GO:0071872]; cellular response to estradiol stimulus [GO:0071392]; cellular response to growth factor stimulus [GO:0071363]; cellular response to insulin stimulus [GO:0032869]; cellular response to serotonin [GO:1904015]; cellular response to starvation [GO:0009267]; cellular response to testosterone stimulus [GO:0071394]; cerebral cortex development [GO:0021987]; diterpenoid metabolic process [GO:0016101]; female genitalia development [GO:0030540]; hippocampus development [GO:0021766]; hypothalamus development [GO:0021854]; liver development [GO:0001889]; male genitalia development [GO:0030539]; male gonad development [GO:0008584]; male sex differentiation [GO:0046661]; pituitary gland development [GO:0021983]; progesterone metabolic process [GO:0042448]; response to estradiol [GO:0032355]; response to estrogen [GO:0043627]; response to follicle-stimulating hormone [GO:0032354]; response to fungicide [GO:0060992]; response to growth hormone [GO:0060416]; response to muscle activity [GO:0014850]; response to resveratrol [GO:1904638]; response to testosterone [GO:0033574]; response to xenobiotic stimulus [GO:0009410]; spinal cord development [GO:0021510]; steroid biosynthetic process [GO:0006694]; thalamus development [GO:0021794]; urogenital system development [GO:0001655] cell body fiber [GO:0070852]; endoplasmic reticulum membrane [GO:0005789]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471] 3-oxo-5-alpha-steroid 4-dehydrogenase (NADP+) activity [GO:0047751]; 3-oxo-5-alpha-steroid 4-dehydrogenase activity [GO:0003865]; amide binding [GO:0033218]; NADPH binding [GO:0070402] g4488.t1 Q810J8 58.768 633 0.0 777.0 sp|Q810J8|ZFYV1_MOUSE Zinc finger FYVE domain-containing protein 1 OS=Mus musculus OX=10090 GN=Zfyve1 PE=1 SV=2 ZFYV1_MOUSE reviewed Zinc finger FYVE domain-containing protein 1 Mus musculus (Mouse) GO:0000407; GO:0005545; GO:0005547; GO:0005739; GO:0005776; GO:0005783; GO:0005789; GO:0005794; GO:0005795; GO:0005811; GO:0008270; GO:0009267; GO:0016236; GO:0032266; GO:0043325; GO:0044233; GO:0044829; GO:0048471; GO:0097629; GO:0140042; GO:1990462 cellular response to starvation [GO:0009267]; host-mediated activation of viral genome replication [GO:0044829]; lipid droplet formation [GO:0140042]; macroautophagy [GO:0016236] autophagosome [GO:0005776]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extrinsic component of omegasome membrane [GO:0097629]; Golgi apparatus [GO:0005794]; Golgi stack [GO:0005795]; lipid droplet [GO:0005811]; mitochondria-associated endoplasmic reticulum membrane contact site [GO:0044233]; mitochondrion [GO:0005739]; omegasome [GO:1990462]; perinuclear region of cytoplasm [GO:0048471]; phagophore assembly site [GO:0000407] 1-phosphatidylinositol binding [GO:0005545]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; phosphatidylinositol-3-phosphate binding [GO:0032266]; zinc ion binding [GO:0008270] g4489.t1 Q6A070 41.791 469 2.24e-96 345.0 sp|Q6A070|TGRM1_MOUSE TOG array regulator of axonemal microtubules protein 1 OS=Mus musculus OX=10090 GN=Togaram1 PE=1 SV=3 TGRM1_MOUSE reviewed TOG array regulator of axonemal microtubules protein 1 (Crescerin-1) (Protein FAM179B) Mus musculus (Mouse) GO:0000226; GO:0005881; GO:0005929; GO:0005930; GO:0008017; GO:0031116; GO:0035082; GO:0036064; GO:0060271; GO:1905515 axoneme assembly [GO:0035082]; cilium assembly [GO:0060271]; microtubule cytoskeleton organization [GO:0000226]; non-motile cilium assembly [GO:1905515]; positive regulation of microtubule polymerization [GO:0031116] axoneme [GO:0005930]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasmic microtubule [GO:0005881] microtubule binding [GO:0008017] g4489.t1 Q6A070 65.0 20 2.24e-96 32.3 sp|Q6A070|TGRM1_MOUSE TOG array regulator of axonemal microtubules protein 1 OS=Mus musculus OX=10090 GN=Togaram1 PE=1 SV=3 TGRM1_MOUSE reviewed TOG array regulator of axonemal microtubules protein 1 (Crescerin-1) (Protein FAM179B) Mus musculus (Mouse) GO:0000226; GO:0005881; GO:0005929; GO:0005930; GO:0008017; GO:0031116; GO:0035082; GO:0036064; GO:0060271; GO:1905515 axoneme assembly [GO:0035082]; cilium assembly [GO:0060271]; microtubule cytoskeleton organization [GO:0000226]; non-motile cilium assembly [GO:1905515]; positive regulation of microtubule polymerization [GO:0031116] axoneme [GO:0005930]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasmic microtubule [GO:0005881] microtubule binding [GO:0008017] g4489.t1 Q6A070 39.046 566 6.23e-88 323.0 sp|Q6A070|TGRM1_MOUSE TOG array regulator of axonemal microtubules protein 1 OS=Mus musculus OX=10090 GN=Togaram1 PE=1 SV=3 TGRM1_MOUSE reviewed TOG array regulator of axonemal microtubules protein 1 (Crescerin-1) (Protein FAM179B) Mus musculus (Mouse) GO:0000226; GO:0005881; GO:0005929; GO:0005930; GO:0008017; GO:0031116; GO:0035082; GO:0036064; GO:0060271; GO:1905515 axoneme assembly [GO:0035082]; cilium assembly [GO:0060271]; microtubule cytoskeleton organization [GO:0000226]; non-motile cilium assembly [GO:1905515]; positive regulation of microtubule polymerization [GO:0031116] axoneme [GO:0005930]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasmic microtubule [GO:0005881] microtubule binding [GO:0008017] g4494.t1 Q9CR40 53.943 558 0.0 637.0 sp|Q9CR40|KLH28_MOUSE Kelch-like protein 28 OS=Mus musculus OX=10090 GN=Klhl28 PE=2 SV=1 g4496.t1 A7UKY7 44.479 317 6.64e-62 210.0 sp|A7UKY7|INSM1_XENLA Insulinoma-associated protein 1 OS=Xenopus laevis OX=8355 GN=insm1 PE=2 SV=1 INSM1_XENLA reviewed Insulinoma-associated protein 1 (Zinc finger protein IA-1) Xenopus laevis (African clawed frog) GO:0000122; GO:0000978; GO:0001227; GO:0003309; GO:0003310; GO:0003700; GO:0005634; GO:0008270; GO:0010564; GO:0017053; GO:0030182; GO:0031018; GO:0031490; GO:0035987; GO:0048732; GO:0060290 endocrine pancreas development [GO:0031018]; endodermal cell differentiation [GO:0035987]; gland development [GO:0048732]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron differentiation [GO:0030182]; pancreatic A cell differentiation [GO:0003310]; regulation of cell cycle process [GO:0010564]; transdifferentiation [GO:0060290]; type B pancreatic cell differentiation [GO:0003309] nucleus [GO:0005634]; transcription repressor complex [GO:0017053] chromatin DNA binding [GO:0031490]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270] g4498.t1 O55007 48.433 1053 0.0 950.0 sp|O55007|RGPA1_RAT Ral GTPase-activating protein subunit alpha-1 OS=Rattus norvegicus OX=10116 GN=Ralgapa1 PE=1 SV=2 g4498.t1 O55007 39.974 773 8.69e-151 521.0 sp|O55007|RGPA1_RAT Ral GTPase-activating protein subunit alpha-1 OS=Rattus norvegicus OX=10116 GN=Ralgapa1 PE=1 SV=2 g4499.t1 Q8IYT3 41.108 343 1.0100000000000001e-79 261.0 sp|Q8IYT3|CC170_HUMAN Coiled-coil domain-containing protein 170 OS=Homo sapiens OX=9606 GN=CCDC170 PE=1 SV=3 CC170_HUMAN reviewed Coiled-coil domain-containing protein 170 Homo sapiens (Human) GO:0000226; GO:0005794; GO:0008017; GO:0030054; GO:0036064 microtubule cytoskeleton organization [GO:0000226] cell junction [GO:0030054]; ciliary basal body [GO:0036064]; Golgi apparatus [GO:0005794] microtubule binding [GO:0008017] g4500.t1 Q8IYT3 28.148 270 2.06e-25 112.0 sp|Q8IYT3|CC170_HUMAN Coiled-coil domain-containing protein 170 OS=Homo sapiens OX=9606 GN=CCDC170 PE=1 SV=3 CC170_HUMAN reviewed Coiled-coil domain-containing protein 170 Homo sapiens (Human) GO:0000226; GO:0005794; GO:0008017; GO:0030054; GO:0036064 microtubule cytoskeleton organization [GO:0000226] cell junction [GO:0030054]; ciliary basal body [GO:0036064]; Golgi apparatus [GO:0005794] microtubule binding [GO:0008017] g4503.t1 Q9NU02 45.07 781 0.0 664.0 sp|Q9NU02|ANKE1_HUMAN Ankyrin repeat and EF-hand domain-containing protein 1 OS=Homo sapiens OX=9606 GN=ANKEF1 PE=1 SV=2 g4504.t1 Q9WVR8 51.198 459 8.489999999999999e-150 451.0 sp|Q9WVR8|MEN1_RAT Menin OS=Rattus norvegicus OX=10116 GN=Men1 PE=1 SV=1 MEN1_RAT reviewed Menin Rattus norvegicus (Rat) GO:0000122; GO:0000165; GO:0000400; GO:0000403; GO:0000781; GO:0000785; GO:0000976; GO:0001216; GO:0001503; GO:0001776; GO:0002051; GO:0002076; GO:0003309; GO:0003677; GO:0003682; GO:0003690; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006338; GO:0006357; GO:0006974; GO:0008285; GO:0009411; GO:0010332; GO:0010468; GO:0010628; GO:0010812; GO:0016363; GO:0017053; GO:0030097; GO:0030511; GO:0030674; GO:0032154; GO:0032925; GO:0032991; GO:0035097; GO:0043565; GO:0044665; GO:0045064; GO:0045668; GO:0045669; GO:0045786; GO:0045815; GO:0045892; GO:0045893; GO:0045944; GO:0046329; GO:0046621; GO:0046697; GO:0048147; GO:0048704; GO:0050680; GO:0051219; GO:0051781; GO:0060021; GO:0060135; GO:0061469; GO:0070412; GO:0071333; GO:0071339; GO:0071375; GO:0071559; GO:1902807; GO:1904691; GO:2000045; GO:2000271; GO:2000647; GO:2000738 cellular response to glucose stimulus [GO:0071333]; cellular response to peptide hormone stimulus [GO:0071375]; chromatin remodeling [GO:0006338]; decidualization [GO:0046697]; DNA damage response [GO:0006974]; embryonic skeletal system morphogenesis [GO:0048704]; hemopoiesis [GO:0030097]; leukocyte homeostasis [GO:0001776]; MAPK cascade [GO:0000165]; maternal process involved in female pregnancy [GO:0060135]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell cycle G1/S phase transition [GO:1902807]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of JNK cascade [GO:0046329]; negative regulation of organ growth [GO:0046621]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of stem cell proliferation [GO:2000647]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of type B pancreatic cell proliferation [GO:1904691]; ossification [GO:0001503]; osteoblast development [GO:0002076]; osteoblast fate commitment [GO:0002051]; positive regulation of cell division [GO:0051781]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of fibroblast apoptotic process [GO:2000271]; positive regulation of gene expression [GO:0010628]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of stem cell differentiation [GO:2000738]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; regulation of activin receptor signaling pathway [GO:0032925]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of gene expression [GO:0010468]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of type B pancreatic cell proliferation [GO:0061469]; response to gamma radiation [GO:0010332]; response to transforming growth factor beta [GO:0071559]; response to UV [GO:0009411]; roof of mouth development [GO:0060021]; T-helper 2 cell differentiation [GO:0045064]; transcription initiation-coupled chromatin remodeling [GO:0045815]; type B pancreatic cell differentiation [GO:0003309] chromatin [GO:0000785]; chromosome, telomeric region [GO:0000781]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; histone methyltransferase complex [GO:0035097]; MLL1 complex [GO:0071339]; MLL1/2 complex [GO:0044665]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcription repressor complex [GO:0017053] chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity [GO:0001216]; double-stranded DNA binding [GO:0003690]; four-way junction DNA binding [GO:0000400]; phosphoprotein binding [GO:0051219]; protein-macromolecule adaptor activity [GO:0030674]; R-SMAD binding [GO:0070412]; sequence-specific DNA binding [GO:0043565]; transcription cis-regulatory region binding [GO:0000976]; Y-form DNA binding [GO:0000403] g4506.t1 Q9MA55 30.224 268 3.4000000000000004e-27 120.0 sp|Q9MA55|ACBP4_ARATH Acyl-CoA-binding domain-containing protein 4 OS=Arabidopsis thaliana OX=3702 GN=ACBP4 PE=1 SV=1 ACBP4_ARATH reviewed Acyl-CoA-binding domain-containing protein 4 (Acyl-CoA binding protein 4) Arabidopsis thaliana (Mouse-ear cress) GO:0000062; GO:0005737; GO:0005829; GO:0006869; GO:0009416; GO:0009723; GO:0009753 lipid transport [GO:0006869]; response to ethylene [GO:0009723]; response to jasmonic acid [GO:0009753]; response to light stimulus [GO:0009416] cytoplasm [GO:0005737]; cytosol [GO:0005829] fatty-acyl-CoA binding [GO:0000062] g4511.t1 D3YVL2 45.884 1142 0.0 934.0 sp|D3YVL2|CFA70_MOUSE Cilia- and flagella-associated protein 70 OS=Mus musculus OX=10090 GN=Cfap70 PE=1 SV=2 g4511.t2 D3YVL2 48.148 756 0.0 661.0 sp|D3YVL2|CFA70_MOUSE Cilia- and flagella-associated protein 70 OS=Mus musculus OX=10090 GN=Cfap70 PE=1 SV=2 g4511.t2 D3YVL2 58.547 234 2.05e-85 303.0 sp|D3YVL2|CFA70_MOUSE Cilia- and flagella-associated protein 70 OS=Mus musculus OX=10090 GN=Cfap70 PE=1 SV=2 g4512.t1 Q2T9V8 60.417 192 8.65e-72 224.0 sp|Q2T9V8|DTD1_BOVIN D-aminoacyl-tRNA deacylase 1 OS=Bos taurus OX=9913 GN=DTD1 PE=2 SV=1 DTD1_BOVIN reviewed D-aminoacyl-tRNA deacylase 1 (DTD) (EC 3.1.1.96) (DNA-unwinding element-binding protein B) (DUE-B) (Gly-tRNA(Ala) deacylase) Bos taurus (Bovine) GO:0000049; GO:0003677; GO:0005634; GO:0005737; GO:0006260; GO:0006399; GO:0046872; GO:0051500; GO:0106026 DNA replication [GO:0006260]; tRNA metabolic process [GO:0006399] cytoplasm [GO:0005737]; nucleus [GO:0005634] D-tyrosyl-tRNA(Tyr) deacylase activity [GO:0051500]; DNA binding [GO:0003677]; Gly-tRNA(Ala) deacylase activity [GO:0106026]; metal ion binding [GO:0046872]; tRNA binding [GO:0000049] g4513.t1 Q8NFF2 50.916 546 0.0 531.0 sp|Q8NFF2|NCKX4_HUMAN Sodium/potassium/calcium exchanger 4 OS=Homo sapiens OX=9606 GN=SLC24A4 PE=1 SV=2 NCKX4_HUMAN reviewed Sodium/potassium/calcium exchanger 4 (Na(+)/K(+)/Ca(2+)-exchange protein 4) (Solute carrier family 24 member 4) Homo sapiens (Human) GO:0005262; GO:0005516; GO:0005737; GO:0005886; GO:0006811; GO:0006874; GO:0007602; GO:0007608; GO:0008273; GO:0008277; GO:0009644; GO:0010628; GO:0015293; GO:0016020; GO:0016324; GO:0021630; GO:0031982; GO:0035725; GO:0036368; GO:0042756; GO:0048306; GO:0050849; GO:0050911; GO:0055074; GO:0070166; GO:0070588; GO:0071486; GO:0071805; GO:0086009; GO:0097186; GO:0098703; GO:0120199; GO:1903998; GO:1990034; GO:1990680; GO:1990834 amelogenesis [GO:0097186]; calcium ion export across plasma membrane [GO:1990034]; calcium ion homeostasis [GO:0055074]; calcium ion import across plasma membrane [GO:0098703]; calcium ion transmembrane transport [GO:0070588]; cellular response to high light intensity [GO:0071486]; cone photoresponse recovery [GO:0036368]; detection of chemical stimulus involved in sensory perception of smell [GO:0050911]; drinking behavior [GO:0042756]; enamel mineralization [GO:0070166]; intracellular calcium ion homeostasis [GO:0006874]; membrane repolarization [GO:0086009]; monoatomic ion transport [GO:0006811]; negative regulation of calcium-mediated signaling [GO:0050849]; olfactory nerve maturation [GO:0021630]; phototransduction [GO:0007602]; positive regulation of gene expression [GO:0010628]; potassium ion transmembrane transport [GO:0071805]; regulation of eating behavior [GO:1903998]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; response to high light intensity [GO:0009644]; response to melanocyte-stimulating hormone [GO:1990680]; response to odorant [GO:1990834]; sensory perception of smell [GO:0007608]; sodium ion transmembrane transport [GO:0035725] apical plasma membrane [GO:0016324]; cone photoreceptor outer segment [GO:0120199]; cytoplasm [GO:0005737]; membrane [GO:0016020]; plasma membrane [GO:0005886]; vesicle [GO:0031982] calcium channel activity [GO:0005262]; calcium, potassium:sodium antiporter activity [GO:0008273]; calcium-dependent protein binding [GO:0048306]; calmodulin binding [GO:0005516]; symporter activity [GO:0015293] g4514.t1 O88851 53.741 147 7.42e-57 179.0 sp|O88851|RBBP9_MOUSE Serine hydrolase RBBP9 OS=Mus musculus OX=10090 GN=Rbbp9 PE=1 SV=2 g4515.t1 O88350 58.621 174 1.21e-76 230.0 sp|O88350|RBBP9_RAT Serine hydrolase RBBP9 OS=Rattus norvegicus OX=10116 GN=Rbbp9 PE=1 SV=2 g4518.t1 Q8N806 45.575 452 7.27e-118 355.0 sp|Q8N806|UBR7_HUMAN Putative E3 ubiquitin-protein ligase UBR7 OS=Homo sapiens OX=9606 GN=UBR7 PE=1 SV=2 g4520.t1 Q5ZML9 48.6 500 2.44e-162 477.0 sp|Q5ZML9|SETD3_CHICK Actin-histidine N-methyltransferase OS=Gallus gallus OX=9031 GN=SETD3 PE=2 SV=1 g4521.t1 O88874 63.636 286 9.5e-124 381.0 sp|O88874|CCNK_MOUSE Cyclin-K OS=Mus musculus OX=10090 GN=Ccnk PE=1 SV=3 CCNK_MOUSE reviewed Cyclin-K Mus musculus (Mouse) GO:0001701; GO:0002944; GO:0002945; GO:0004693; GO:0005634; GO:0005654; GO:0006974; GO:0008024; GO:0008353; GO:0009966; GO:0019901; GO:0032786; GO:0032968; GO:0044828; GO:0045944; GO:0051301; GO:0061575; GO:2000737 cell division [GO:0051301]; DNA damage response [GO:0006974]; host-mediated suppression of viral genome replication [GO:0044828]; in utero embryonic development [GO:0001701]; negative regulation of stem cell differentiation [GO:2000737]; positive regulation of DNA-templated transcription, elongation [GO:0032786]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription elongation by RNA polymerase II [GO:0032968]; regulation of signal transduction [GO:0009966] cyclin K-CDK12 complex [GO:0002944]; cyclin K-CDK13 complex [GO:0002945]; cyclin/CDK positive transcription elongation factor complex [GO:0008024]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cyclin-dependent protein serine/threonine kinase activator activity [GO:0061575]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; protein kinase binding [GO:0019901]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353] g4522.t1 Q8NBP0 44.242 825 0.0 665.0 sp|Q8NBP0|TTC13_HUMAN Tetratricopeptide repeat protein 13 OS=Homo sapiens OX=9606 GN=TTC13 PE=1 SV=3 g4523.t1 Q92184 32.177 317 2.1e-44 161.0 sp|Q92184|SIA7B_CHICK Alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 2 OS=Gallus gallus OX=9031 GN=ST6GALNAC2 PE=1 SV=1 g4524.t1 Q5RKZ7 69.968 313 2.26e-160 467.0 sp|Q5RKZ7|MOCS1_MOUSE Molybdenum cofactor biosynthesis protein 1 OS=Mus musculus OX=10090 GN=Mocs1 PE=1 SV=2 MOCS1_MOUSE reviewed Molybdenum cofactor biosynthesis protein 1 [Includes: GTP 3',8-cyclase (EC 4.1.99.22) (MOCS1A) (Molybdenum cofactor biosynthesis protein A); Cyclic pyranopterin monophosphate synthase (EC 4.6.1.17) (MOCS1B) (Molybdenum cofactor biosynthesis protein C)] Mus musculus (Mouse) GO:0005525; GO:0005759; GO:0005829; GO:0006777; GO:0032324; GO:0046872; GO:0051539; GO:0061798; GO:0061799; GO:1904047 Mo-molybdopterin cofactor biosynthetic process [GO:0006777]; molybdopterin cofactor biosynthetic process [GO:0032324] cytosol [GO:0005829]; mitochondrial matrix [GO:0005759] 4 iron, 4 sulfur cluster binding [GO:0051539]; cyclic pyranopterin monophosphate synthase activity [GO:0061799]; GTP 3',8'-cyclase activity [GO:0061798]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]; S-adenosyl-L-methionine binding [GO:1904047] g4526.t1 Q1JQD7 61.111 144 3.7899999999999996e-46 161.0 sp|Q1JQD7|MOCS1_BOVIN Molybdenum cofactor biosynthesis protein 1 OS=Bos taurus OX=9913 GN=MOCS1 PE=2 SV=2 MOCS1_BOVIN reviewed Molybdenum cofactor biosynthesis protein 1 [Includes: GTP 3',8-cyclase (EC 4.1.99.22) (MOCS1A) (Molybdenum cofactor biosynthesis protein A); Cyclic pyranopterin monophosphate synthase (EC 4.6.1.17) (MOCS1B) (Molybdenum cofactor biosynthesis protein C)] Bos taurus (Bovine) GO:0005525; GO:0006777; GO:0046872; GO:0051539; GO:0061798; GO:0061799 Mo-molybdopterin cofactor biosynthetic process [GO:0006777] 4 iron, 4 sulfur cluster binding [GO:0051539]; cyclic pyranopterin monophosphate synthase activity [GO:0061799]; GTP 3',8'-cyclase activity [GO:0061798]; GTP binding [GO:0005525]; metal ion binding [GO:0046872] g4527.t1 A7MB54 67.368 95 2.99e-32 129.0 sp|A7MB54|HLX_BOVIN H2.0-like homeobox protein OS=Bos taurus OX=9913 GN=HLX PE=2 SV=1 HLX_BOVIN reviewed H2.0-like homeobox protein (Homeobox protein HLX1) Bos taurus (Bovine) GO:0000981; GO:0001889; GO:0005634; GO:0007519; GO:0035265; GO:0043565; GO:0045063; GO:0045064; GO:0045627; GO:0045629; GO:0046622; GO:0048484; GO:0048557; GO:0050673; GO:0050679 embryonic digestive tract morphogenesis [GO:0048557]; enteric nervous system development [GO:0048484]; epithelial cell proliferation [GO:0050673]; liver development [GO:0001889]; negative regulation of T-helper 2 cell differentiation [GO:0045629]; organ growth [GO:0035265]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of organ growth [GO:0046622]; positive regulation of T-helper 1 cell differentiation [GO:0045627]; skeletal muscle tissue development [GO:0007519]; T-helper 1 cell differentiation [GO:0045063]; T-helper 2 cell differentiation [GO:0045064] nucleus [GO:0005634] DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific DNA binding [GO:0043565] g4528.t1 Q9R0I7 63.889 72 2.0900000000000002e-22 92.4 sp|Q9R0I7|YLPM1_MOUSE YLP motif-containing protein 1 OS=Mus musculus OX=10090 GN=Ylpm1 PE=2 SV=2 g4529.t1 P0CB49 52.893 242 1.5499999999999998e-48 191.0 sp|P0CB49|YLPM1_RAT YLP motif-containing protein 1 OS=Rattus norvegicus OX=10116 GN=Ylpm1 PE=1 SV=1 g4534.t1 Q0V989 41.243 354 3.21e-53 183.0 sp|Q0V989|CC85C_XENTR Coiled-coil domain-containing protein 85C OS=Xenopus tropicalis OX=8364 GN=ccdc85c PE=2 SV=1 g4536.t1 Q8WUB8 65.041 123 1.0599999999999999e-54 185.0 sp|Q8WUB8|PHF10_HUMAN PHD finger protein 10 OS=Homo sapiens OX=9606 GN=PHF10 PE=1 SV=3 g4537.t1 Q63ZP1 49.259 270 1.07e-73 244.0 sp|Q63ZP1|PHF10_XENLA PHD finger protein 10 OS=Xenopus laevis OX=8355 GN=phf10 PE=2 SV=2 g4542.t1 Q6ZU80 30.39 1076 6.33e-101 346.0 sp|Q6ZU80|CE128_HUMAN Centrosomal protein of 128 kDa OS=Homo sapiens OX=9606 GN=CEP128 PE=1 SV=2 CE128_HUMAN reviewed Centrosomal protein 128 (Cep128) (Centrosomal protein of 128 kDa) Homo sapiens (Human) GO:0000922; GO:0005794; GO:0005813; GO:0005814; GO:0008104; GO:0010468; GO:0031965; GO:0036064; GO:0044458; GO:0120103; GO:0120212; GO:0120316 intracellular protein localization [GO:0008104]; motile cilium assembly [GO:0044458]; regulation of gene expression [GO:0010468]; sperm flagellum assembly [GO:0120316] centriolar subdistal appendage [GO:0120103]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; Golgi apparatus [GO:0005794]; nuclear membrane [GO:0031965]; sperm head-tail coupling apparatus [GO:0120212]; spindle pole [GO:0000922] g4543.t1 P08483 36.632 576 1.45e-112 351.0 sp|P08483|ACM3_RAT Muscarinic acetylcholine receptor M3 OS=Rattus norvegicus OX=10116 GN=Chrm3 PE=1 SV=1 ACM3_RAT reviewed Muscarinic acetylcholine receptor M3 Rattus norvegicus (Rat) GO:0003063; GO:0005789; GO:0005886; GO:0006939; GO:0006940; GO:0007187; GO:0007197; GO:0007207; GO:0007213; GO:0007268; GO:0007271; GO:0009925; GO:0016323; GO:0016907; GO:0019722; GO:0030425; GO:0031789; GO:0032024; GO:0032279; GO:0042166; GO:0042734; GO:0043679; GO:0045202; GO:0045907; GO:0045987; GO:0046541; GO:0050997; GO:0095500; GO:0098839; GO:0098978; GO:1904695; GO:1905144; GO:1990806 acetylcholine receptor signaling pathway [GO:0095500]; adenylate cyclase-inhibiting G protein-coupled acetylcholine receptor signaling pathway [GO:0007197]; calcium-mediated signaling [GO:0019722]; chemical synaptic transmission [GO:0007268]; G protein-coupled acetylcholine receptor signaling pathway [GO:0007213]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; ligand-gated ion channel signaling pathway [GO:1990806]; negative regulation of heart rate by acetylcholine [GO:0003063]; phospholipase C-activating G protein-coupled acetylcholine receptor signaling pathway [GO:0007207]; positive regulation of insulin secretion [GO:0032024]; positive regulation of smooth muscle contraction [GO:0045987]; positive regulation of vascular associated smooth muscle contraction [GO:1904695]; positive regulation of vasoconstriction [GO:0045907]; regulation of smooth muscle contraction [GO:0006940]; response to acetylcholine [GO:1905144]; saliva secretion [GO:0046541]; smooth muscle contraction [GO:0006939]; synaptic transmission, cholinergic [GO:0007271] asymmetric synapse [GO:0032279]; axon terminus [GO:0043679]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; dendrite [GO:0030425]; endoplasmic reticulum membrane [GO:0005789]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; presynaptic membrane [GO:0042734]; synapse [GO:0045202] acetylcholine binding [GO:0042166]; G protein-coupled acetylcholine receptor activity [GO:0016907]; G protein-coupled acetylcholine receptor binding [GO:0031789]; quaternary ammonium group binding [GO:0050997] g4544.t1 A4IIL4 44.444 441 5.44e-126 374.0 sp|A4IIL4|BROX_XENTR BRO1 domain-containing protein BROX OS=Xenopus tropicalis OX=8364 GN=brox PE=2 SV=1 g4545.t1 Q8BZ60 39.916 476 6.799999999999999e-104 354.0 sp|Q8BZ60|STON2_MOUSE Stonin-2 OS=Mus musculus OX=10090 GN=Ston2 PE=1 SV=1 STON2_MOUSE reviewed Stonin-2 (Stoned B) Mus musculus (Mouse) GO:0002244; GO:0005730; GO:0005829; GO:0007268; GO:0008021; GO:0030100; GO:0030122; GO:0030136; GO:0035615; GO:0043005; GO:0048488; GO:0072583; GO:0098793 chemical synaptic transmission [GO:0007268]; clathrin-dependent endocytosis [GO:0072583]; hematopoietic progenitor cell differentiation [GO:0002244]; regulation of endocytosis [GO:0030100]; synaptic vesicle endocytosis [GO:0048488] AP-2 adaptor complex [GO:0030122]; clathrin-coated vesicle [GO:0030136]; cytosol [GO:0005829]; neuron projection [GO:0043005]; nucleolus [GO:0005730]; presynapse [GO:0098793]; synaptic vesicle [GO:0008021] clathrin adaptor activity [GO:0035615] g4551.t1 Q8BGD7 41.176 289 2.9500000000000004e-56 214.0 sp|Q8BGD7|NPAS4_MOUSE Neuronal PAS domain-containing protein 4 OS=Mus musculus OX=10090 GN=Npas4 PE=1 SV=1 NPAS4_MOUSE reviewed Neuronal PAS domain-containing protein 4 (Neuronal PAS4) (HLH-PAS transcription factor NXF) (Limbic-enhanced PAS protein) (LE-PAS) Mus musculus (Mouse) GO:0000977; GO:0000978; GO:0000981; GO:0001228; GO:0005634; GO:0005654; GO:0005667; GO:0006357; GO:0007612; GO:0007614; GO:0007616; GO:0030154; GO:0032228; GO:0033554; GO:0035176; GO:0044877; GO:0045893; GO:0045944; GO:0046982; GO:0048167; GO:0060079; GO:0060080; GO:0071386; GO:0098794; GO:1904862 cell differentiation [GO:0030154]; cellular response to corticosterone stimulus [GO:0071386]; cellular response to stress [GO:0033554]; excitatory postsynaptic potential [GO:0060079]; inhibitory postsynaptic potential [GO:0060080]; inhibitory synapse assembly [GO:1904862]; learning [GO:0007612]; long-term memory [GO:0007616]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of synaptic plasticity [GO:0048167]; regulation of synaptic transmission, GABAergic [GO:0032228]; regulation of transcription by RNA polymerase II [GO:0006357]; short-term memory [GO:0007614]; social behavior [GO:0035176] nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynapse [GO:0098794]; transcription regulator complex [GO:0005667] DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein heterodimerization activity [GO:0046982]; protein-containing complex binding [GO:0044877]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977] g4552.t1 Q96FX7 59.091 264 4.17e-92 280.0 sp|Q96FX7|TRM61_HUMAN tRNA (adenine(58)-N(1))-methyltransferase catalytic subunit TRMT61A OS=Homo sapiens OX=9606 GN=TRMT61A PE=1 SV=1 g4553.t1 Q5TD94 70.412 267 2.4499999999999998e-104 332.0 sp|Q5TD94|RSH4A_HUMAN Radial spoke head protein 4 homolog A OS=Homo sapiens OX=9606 GN=RSPH4A PE=1 SV=1 RSH4A_HUMAN reviewed Radial spoke head protein 4 homolog A (Radial spoke head-like protein 3) Homo sapiens (Human) GO:0001534; GO:0001535; GO:0003341; GO:0003351; GO:0005576; GO:0005930; GO:0031514; GO:0035082; GO:0051649; GO:0060294; GO:0062177; GO:0097729; GO:0120221; GO:0120336; GO:0120337; GO:0120338 axoneme assembly [GO:0035082]; cilium movement [GO:0003341]; cilium movement involved in cell motility [GO:0060294]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; establishment of localization in cell [GO:0051649]; maintenance of ciliary planar beating movement pattern [GO:0120221]; radial spoke assembly [GO:0062177] 9+2 motile cilium [GO:0097729]; axoneme [GO:0005930]; extracellular region [GO:0005576]; motile cilium [GO:0031514]; radial spoke [GO:0001534]; radial spoke head [GO:0001535]; radial spoke head 1 [GO:0120336]; radial spoke head 2 [GO:0120337]; radial spoke head 3 [GO:0120338] g4553.t1 Q5TD94 47.436 156 5.94e-36 146.0 sp|Q5TD94|RSH4A_HUMAN Radial spoke head protein 4 homolog A OS=Homo sapiens OX=9606 GN=RSPH4A PE=1 SV=1 RSH4A_HUMAN reviewed Radial spoke head protein 4 homolog A (Radial spoke head-like protein 3) Homo sapiens (Human) GO:0001534; GO:0001535; GO:0003341; GO:0003351; GO:0005576; GO:0005930; GO:0031514; GO:0035082; GO:0051649; GO:0060294; GO:0062177; GO:0097729; GO:0120221; GO:0120336; GO:0120337; GO:0120338 axoneme assembly [GO:0035082]; cilium movement [GO:0003341]; cilium movement involved in cell motility [GO:0060294]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; establishment of localization in cell [GO:0051649]; maintenance of ciliary planar beating movement pattern [GO:0120221]; radial spoke assembly [GO:0062177] 9+2 motile cilium [GO:0097729]; axoneme [GO:0005930]; extracellular region [GO:0005576]; motile cilium [GO:0031514]; radial spoke [GO:0001534]; radial spoke head [GO:0001535]; radial spoke head 1 [GO:0120336]; radial spoke head 2 [GO:0120337]; radial spoke head 3 [GO:0120338] g4554.t1 Q8VEB2 48.069 233 6.71e-64 211.0 sp|Q8VEB2|SAV1_MOUSE Protein salvador homolog 1 OS=Mus musculus OX=10090 GN=Sav1 PE=1 SV=2 SAV1_MOUSE reviewed Protein salvador homolog 1 (45 kDa WW domain protein) (mWW45) Mus musculus (Mouse) GO:0001942; GO:0005634; GO:0005737; GO:0005829; GO:0006915; GO:0008285; GO:0030216; GO:0035329; GO:0035331; GO:0035332; GO:0042802; GO:0043065; GO:0043539; GO:0045600; GO:0046620; GO:0050680; GO:0050821; GO:0060044; GO:0060090; GO:0060412; GO:0060487; GO:0060575; GO:0140537; GO:2000036 apoptotic process [GO:0006915]; hair follicle development [GO:0001942]; hippo signaling [GO:0035329]; intestinal epithelial cell differentiation [GO:0060575]; keratinocyte differentiation [GO:0030216]; lung epithelial cell differentiation [GO:0060487]; negative regulation of cardiac muscle cell proliferation [GO:0060044]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of hippo signaling [GO:0035331]; positive regulation of apoptotic process [GO:0043065]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of hippo signaling [GO:0035332]; protein stabilization [GO:0050821]; regulation of organ growth [GO:0046620]; regulation of stem cell population maintenance [GO:2000036]; ventricular septum morphogenesis [GO:0060412] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634] identical protein binding [GO:0042802]; molecular adaptor activity [GO:0060090]; protein serine/threonine kinase activator activity [GO:0043539]; transcription regulator activator activity [GO:0140537] g4556.t1 O54728 44.068 354 3.62e-79 271.0 sp|O54728|PLB1_RAT Phospholipase B1, membrane-associated OS=Rattus norvegicus OX=10116 GN=Plb1 PE=1 SV=1 g4556.t1 O54728 40.176 341 8.62e-66 233.0 sp|O54728|PLB1_RAT Phospholipase B1, membrane-associated OS=Rattus norvegicus OX=10116 GN=Plb1 PE=1 SV=1 g4556.t1 O54728 36.812 345 1.13e-61 221.0 sp|O54728|PLB1_RAT Phospholipase B1, membrane-associated OS=Rattus norvegicus OX=10116 GN=Plb1 PE=1 SV=1 g4556.t1 O54728 27.566 341 6.51e-26 115.0 sp|O54728|PLB1_RAT Phospholipase B1, membrane-associated OS=Rattus norvegicus OX=10116 GN=Plb1 PE=1 SV=1 g4557.t1 Q06HQ7 47.024 336 4.88e-90 302.0 sp|Q06HQ7|PLB1_MONDO Phospholipase B1, membrane-associated OS=Monodelphis domestica OX=13616 GN=PLB1 PE=2 SV=1 g4557.t1 Q06HQ7 42.553 329 6e-77 265.0 sp|Q06HQ7|PLB1_MONDO Phospholipase B1, membrane-associated OS=Monodelphis domestica OX=13616 GN=PLB1 PE=2 SV=1 g4557.t1 Q06HQ7 38.623 334 5.790000000000001e-73 253.0 sp|Q06HQ7|PLB1_MONDO Phospholipase B1, membrane-associated OS=Monodelphis domestica OX=13616 GN=PLB1 PE=2 SV=1 g4558.t1 Q8WUJ0 57.416 209 1.25e-76 233.0 sp|Q8WUJ0|STYX_HUMAN Serine/threonine/tyrosine-interacting protein OS=Homo sapiens OX=9606 GN=STYX PE=1 SV=1 STYX_HUMAN reviewed Serine/threonine/tyrosine-interacting protein (Inactive tyrosine-protein phosphatase STYX) (Phosphoserine/threonine/tyrosine interaction protein) Homo sapiens (Human) GO:0001691; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0032091; GO:0062026; GO:0070372; GO:1990444 negative regulation of protein binding [GO:0032091]; negative regulation of SCF-dependent proteasomal ubiquitin-dependent catabolic process [GO:0062026]; regulation of ERK1 and ERK2 cascade [GO:0070372] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] F-box domain binding [GO:1990444]; pseudophosphatase activity [GO:0001691] g4559.t1 Q5TZ24 36.989 465 6.92e-112 349.0 sp|Q5TZ24|MOXD1_DANRE DBH-like monooxygenase protein 1 homolog OS=Danio rerio OX=7955 GN=moxd1 PE=2 SV=2 g4560.t1 L8E946 73.438 64 2.6499999999999996e-23 99.4 sp|L8E946|UNC42_CAEEL Homeobox protein unc-42 OS=Caenorhabditis elegans OX=6239 GN=unc-42 PE=1 SV=1 UNC42_CAEEL reviewed Homeobox protein unc-42 (Uncoordinated protein 42) Caenorhabditis elegans GO:0000977; GO:0000981; GO:0005634; GO:0006357; GO:0007411; GO:0008345; GO:0010468; GO:0030182; GO:0045944; GO:0048665; GO:0048666; GO:0050808; GO:0061564 axon development [GO:0061564]; axon guidance [GO:0007411]; larval locomotory behavior [GO:0008345]; neuron development [GO:0048666]; neuron differentiation [GO:0030182]; neuron fate specification [GO:0048665]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; regulation of transcription by RNA polymerase II [GO:0006357]; synapse organization [GO:0050808] nucleus [GO:0005634] DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977] g4562.t1 Q5R8Z6 56.25 80 1.92e-23 89.7 sp|Q5R8Z6|MCFD2_PONAB Multiple coagulation factor deficiency protein 2 homolog OS=Pongo abelii OX=9601 GN=MCFD2 PE=2 SV=1 MCFD2_PONAB reviewed Multiple coagulation factor deficiency protein 2 homolog Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0005509; GO:0005783; GO:0005793; GO:0005794; GO:0015031; GO:0016192 protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi apparatus [GO:0005794] calcium ion binding [GO:0005509] g4563.t1 A2AKK5 37.198 414 1.9400000000000002e-71 233.0 sp|A2AKK5|ACNT1_MOUSE Acyl-coenzyme A amino acid N-acyltransferase 1 OS=Mus musculus OX=10090 GN=Acnat1 PE=1 SV=1 ACNT1_MOUSE reviewed Acyl-coenzyme A amino acid N-acyltransferase 1 (EC 2.3.1.-) Mus musculus (Mouse) GO:0005777; GO:0006631; GO:0006637; GO:0016410; GO:0047617 acyl-CoA metabolic process [GO:0006637]; fatty acid metabolic process [GO:0006631] peroxisome [GO:0005777] fatty acyl-CoA hydrolase activity [GO:0047617]; N-acyltransferase activity [GO:0016410] g4563.t2 A2AKK5 34.368 451 9.01e-65 217.0 sp|A2AKK5|ACNT1_MOUSE Acyl-coenzyme A amino acid N-acyltransferase 1 OS=Mus musculus OX=10090 GN=Acnat1 PE=1 SV=1 ACNT1_MOUSE reviewed Acyl-coenzyme A amino acid N-acyltransferase 1 (EC 2.3.1.-) Mus musculus (Mouse) GO:0005777; GO:0006631; GO:0006637; GO:0016410; GO:0047617 acyl-CoA metabolic process [GO:0006637]; fatty acid metabolic process [GO:0006631] peroxisome [GO:0005777] fatty acyl-CoA hydrolase activity [GO:0047617]; N-acyltransferase activity [GO:0016410] g4564.t1 Q5FVR5 36.81 326 1.48e-51 179.0 sp|Q5FVR5|ACNT2_RAT Acyl-coenzyme A amino acid N-acyltransferase 2 OS=Rattus norvegicus OX=10116 GN=Acnat2 PE=2 SV=1 g4565.t1 Q96L93 46.914 162 6.66e-43 162.0 sp|Q96L93|KI16B_HUMAN Kinesin-like protein KIF16B OS=Homo sapiens OX=9606 GN=KIF16B PE=1 SV=2 KI16B_HUMAN reviewed Kinesin-like protein KIF16B (Sorting nexin-23) Homo sapiens (Human) GO:0001704; GO:0001919; GO:0005524; GO:0005547; GO:0005737; GO:0005768; GO:0005769; GO:0005819; GO:0005829; GO:0005871; GO:0005874; GO:0006895; GO:0007173; GO:0007492; GO:0008017; GO:0008543; GO:0008574; GO:0016887; GO:0031901; GO:0032266; GO:0032801; GO:0043325; GO:0045022; GO:0047496; GO:0080025 early endosome to late endosome transport [GO:0045022]; endoderm development [GO:0007492]; epidermal growth factor receptor signaling pathway [GO:0007173]; fibroblast growth factor receptor signaling pathway [GO:0008543]; formation of primary germ layer [GO:0001704]; Golgi to endosome transport [GO:0006895]; receptor catabolic process [GO:0032801]; regulation of receptor recycling [GO:0001919]; vesicle transport along microtubule [GO:0047496] cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; spindle [GO:0005819] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule binding [GO:0008017]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-3-phosphate binding [GO:0032266]; plus-end-directed microtubule motor activity [GO:0008574] g4565.t2 Q96L93 46.914 162 1.89e-43 162.0 sp|Q96L93|KI16B_HUMAN Kinesin-like protein KIF16B OS=Homo sapiens OX=9606 GN=KIF16B PE=1 SV=2 KI16B_HUMAN reviewed Kinesin-like protein KIF16B (Sorting nexin-23) Homo sapiens (Human) GO:0001704; GO:0001919; GO:0005524; GO:0005547; GO:0005737; GO:0005768; GO:0005769; GO:0005819; GO:0005829; GO:0005871; GO:0005874; GO:0006895; GO:0007173; GO:0007492; GO:0008017; GO:0008543; GO:0008574; GO:0016887; GO:0031901; GO:0032266; GO:0032801; GO:0043325; GO:0045022; GO:0047496; GO:0080025 early endosome to late endosome transport [GO:0045022]; endoderm development [GO:0007492]; epidermal growth factor receptor signaling pathway [GO:0007173]; fibroblast growth factor receptor signaling pathway [GO:0008543]; formation of primary germ layer [GO:0001704]; Golgi to endosome transport [GO:0006895]; receptor catabolic process [GO:0032801]; regulation of receptor recycling [GO:0001919]; vesicle transport along microtubule [GO:0047496] cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; spindle [GO:0005819] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule binding [GO:0008017]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-3-phosphate binding [GO:0032266]; plus-end-directed microtubule motor activity [GO:0008574] g4566.t1 B1AVY7 62.275 668 0.0 803.0 sp|B1AVY7|KI16B_MOUSE Kinesin-like protein KIF16B OS=Mus musculus OX=10090 GN=Kif16b PE=1 SV=1 KI16B_MOUSE reviewed Kinesin-like protein KIF16B Mus musculus (Mouse) GO:0001704; GO:0001919; GO:0005524; GO:0005547; GO:0005737; GO:0005768; GO:0005769; GO:0005819; GO:0005829; GO:0005871; GO:0005874; GO:0006895; GO:0007173; GO:0007492; GO:0008017; GO:0008543; GO:0008574; GO:0016887; GO:0031267; GO:0031901; GO:0032266; GO:0032801; GO:0043325; GO:0045022; GO:0045335; GO:0047496; GO:0071346; GO:0080025 cellular response to type II interferon [GO:0071346]; early endosome to late endosome transport [GO:0045022]; endoderm development [GO:0007492]; epidermal growth factor receptor signaling pathway [GO:0007173]; fibroblast growth factor receptor signaling pathway [GO:0008543]; formation of primary germ layer [GO:0001704]; Golgi to endosome transport [GO:0006895]; receptor catabolic process [GO:0032801]; regulation of receptor recycling [GO:0001919]; vesicle transport along microtubule [GO:0047496] cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; phagocytic vesicle [GO:0045335]; spindle [GO:0005819] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule binding [GO:0008017]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-3-phosphate binding [GO:0032266]; plus-end-directed microtubule motor activity [GO:0008574]; small GTPase binding [GO:0031267] g4567.t1 Q7RTX9 33.333 210 4.06e-26 115.0 sp|Q7RTX9|MOT14_HUMAN Monocarboxylate transporter 14 OS=Homo sapiens OX=9606 GN=SLC16A14 PE=1 SV=1 g4568.t1 Q8CE94 36.735 196 1.44e-28 121.0 sp|Q8CE94|MOT13_MOUSE Monocarboxylate transporter 13 OS=Mus musculus OX=10090 GN=Slc16a13 PE=2 SV=1 g4569.t1 Q24117 69.318 88 2.31e-42 137.0 sp|Q24117|DYL1_DROME Dynein light chain 1, cytoplasmic OS=Drosophila melanogaster OX=7227 GN=ctp PE=1 SV=1 DYL1_DROME reviewed Dynein light chain 1, cytoplasmic (8 kDa dynein light chain) (Cut up protein) Drosophila melanogaster (Fruit fly) GO:0000132; GO:0005198; GO:0005634; GO:0005737; GO:0005814; GO:0005829; GO:0005868; GO:0005874; GO:0007283; GO:0007290; GO:0007291; GO:0007476; GO:0008407; GO:0022416; GO:0030286; GO:0032991; GO:0034454; GO:0035220; GO:0042803; GO:0045505; GO:0048477; GO:0051017; GO:0051959; GO:0090571; GO:0097718; GO:0141006; GO:1904801 actin filament bundle assembly [GO:0051017]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; establishment of mitotic spindle orientation [GO:0000132]; imaginal disc-derived wing morphogenesis [GO:0007476]; microtubule anchoring at centrosome [GO:0034454]; oogenesis [GO:0048477]; positive regulation of neuron remodeling [GO:1904801]; sperm individualization [GO:0007291]; spermatid nucleus elongation [GO:0007290]; spermatogenesis [GO:0007283]; transposable element silencing by piRNA-mediated heterochromatin formation [GO:0141006]; wing disc development [GO:0035220] centriole [GO:0005814]; cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; cytosol [GO:0005829]; dynein complex [GO:0030286]; microtubule [GO:0005874]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; RNA polymerase II transcription repressor complex [GO:0090571] disordered domain specific binding [GO:0097718]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; protein homodimerization activity [GO:0042803]; structural molecule activity [GO:0005198] g4570.t1 Q24117 70.455 88 3.3199999999999997e-40 130.0 sp|Q24117|DYL1_DROME Dynein light chain 1, cytoplasmic OS=Drosophila melanogaster OX=7227 GN=ctp PE=1 SV=1 DYL1_DROME reviewed Dynein light chain 1, cytoplasmic (8 kDa dynein light chain) (Cut up protein) Drosophila melanogaster (Fruit fly) GO:0000132; GO:0005198; GO:0005634; GO:0005737; GO:0005814; GO:0005829; GO:0005868; GO:0005874; GO:0007283; GO:0007290; GO:0007291; GO:0007476; GO:0008407; GO:0022416; GO:0030286; GO:0032991; GO:0034454; GO:0035220; GO:0042803; GO:0045505; GO:0048477; GO:0051017; GO:0051959; GO:0090571; GO:0097718; GO:0141006; GO:1904801 actin filament bundle assembly [GO:0051017]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; establishment of mitotic spindle orientation [GO:0000132]; imaginal disc-derived wing morphogenesis [GO:0007476]; microtubule anchoring at centrosome [GO:0034454]; oogenesis [GO:0048477]; positive regulation of neuron remodeling [GO:1904801]; sperm individualization [GO:0007291]; spermatid nucleus elongation [GO:0007290]; spermatogenesis [GO:0007283]; transposable element silencing by piRNA-mediated heterochromatin formation [GO:0141006]; wing disc development [GO:0035220] centriole [GO:0005814]; cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; cytosol [GO:0005829]; dynein complex [GO:0030286]; microtubule [GO:0005874]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; RNA polymerase II transcription repressor complex [GO:0090571] disordered domain specific binding [GO:0097718]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; protein homodimerization activity [GO:0042803]; structural molecule activity [GO:0005198] g4571.t1 Q24117 73.81 84 5.8500000000000004e-43 138.0 sp|Q24117|DYL1_DROME Dynein light chain 1, cytoplasmic OS=Drosophila melanogaster OX=7227 GN=ctp PE=1 SV=1 DYL1_DROME reviewed Dynein light chain 1, cytoplasmic (8 kDa dynein light chain) (Cut up protein) Drosophila melanogaster (Fruit fly) GO:0000132; GO:0005198; GO:0005634; GO:0005737; GO:0005814; GO:0005829; GO:0005868; GO:0005874; GO:0007283; GO:0007290; GO:0007291; GO:0007476; GO:0008407; GO:0022416; GO:0030286; GO:0032991; GO:0034454; GO:0035220; GO:0042803; GO:0045505; GO:0048477; GO:0051017; GO:0051959; GO:0090571; GO:0097718; GO:0141006; GO:1904801 actin filament bundle assembly [GO:0051017]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; establishment of mitotic spindle orientation [GO:0000132]; imaginal disc-derived wing morphogenesis [GO:0007476]; microtubule anchoring at centrosome [GO:0034454]; oogenesis [GO:0048477]; positive regulation of neuron remodeling [GO:1904801]; sperm individualization [GO:0007291]; spermatid nucleus elongation [GO:0007290]; spermatogenesis [GO:0007283]; transposable element silencing by piRNA-mediated heterochromatin formation [GO:0141006]; wing disc development [GO:0035220] centriole [GO:0005814]; cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; cytosol [GO:0005829]; dynein complex [GO:0030286]; microtubule [GO:0005874]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; RNA polymerase II transcription repressor complex [GO:0090571] disordered domain specific binding [GO:0097718]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; protein homodimerization activity [GO:0042803]; structural molecule activity [GO:0005198] g4572.t1 P45878 64.748 139 3.7e-63 192.0 sp|P45878|FKBP2_MOUSE Peptidyl-prolyl cis-trans isomerase FKBP2 OS=Mus musculus OX=10090 GN=Fkbp2 PE=1 SV=1 g4573.t1 Q18786 81.356 118 2.2400000000000002e-58 179.0 sp|Q18786|SMD2_CAEEL Probable small nuclear ribonucleoprotein Sm D2 OS=Caenorhabditis elegans OX=6239 GN=snr-4 PE=1 SV=1 g4574.t1 Q8VE97 57.5 200 1.09e-70 230.0 sp|Q8VE97|SRSF4_MOUSE Serine/arginine-rich splicing factor 4 OS=Mus musculus OX=10090 GN=Srsf4 PE=2 SV=1 g4574.t2 Q8VE97 57.5 200 2.72e-71 229.0 sp|Q8VE97|SRSF4_MOUSE Serine/arginine-rich splicing factor 4 OS=Mus musculus OX=10090 GN=Srsf4 PE=2 SV=1 g4574.t3 Q8VE97 63.636 187 5.68e-76 241.0 sp|Q8VE97|SRSF4_MOUSE Serine/arginine-rich splicing factor 4 OS=Mus musculus OX=10090 GN=Srsf4 PE=2 SV=1 g4575.t1 Q9ERY9 39.695 131 3.81e-26 98.6 sp|Q9ERY9|ERG28_MOUSE Ergosterol biosynthetic protein 28 homolog OS=Mus musculus OX=10090 GN=Erg28 PE=2 SV=1 g4577.t1 Q96RV3 43.75 128 7.92e-30 117.0 sp|Q96RV3|PCX1_HUMAN Pecanex-like protein 1 OS=Homo sapiens OX=9606 GN=PCNX1 PE=1 SV=2 g4578.t1 Q96RV3 64.516 93 5.6900000000000005e-31 126.0 sp|Q96RV3|PCX1_HUMAN Pecanex-like protein 1 OS=Homo sapiens OX=9606 GN=PCNX1 PE=1 SV=2 g4579.t1 Q3U1V8 50.862 696 0.0 591.0 sp|Q3U1V8|M3K9_MOUSE Mitogen-activated protein kinase kinase kinase 9 OS=Mus musculus OX=10090 GN=Map3k9 PE=2 SV=2 g4580.t1 Q96M32 51.278 704 0.0 675.0 sp|Q96M32|KAD7_HUMAN Adenylate kinase 7 OS=Homo sapiens OX=9606 GN=AK7 PE=1 SV=3 KAD7_HUMAN reviewed Adenylate kinase 7 (AK 7) (EC 2.7.4.3) (EC 2.7.4.6) (ATP-AMP transphosphorylase 7) Homo sapiens (Human) GO:0004017; GO:0004550; GO:0005524; GO:0005737; GO:0005829; GO:0030030; GO:0036431; GO:0097228 cell projection organization [GO:0030030] cytoplasm [GO:0005737]; cytosol [GO:0005829]; sperm principal piece [GO:0097228] AMP kinase activity [GO:0004017]; ATP binding [GO:0005524]; dCMP kinase activity [GO:0036431]; nucleoside diphosphate kinase activity [GO:0004550] g4581.t1 Q6NYB7 89.268 205 5.69e-137 384.0 sp|Q6NYB7|RAB1A_RAT Ras-related protein Rab-1A OS=Rattus norvegicus OX=10116 GN=Rab1A PE=1 SV=3 RAB1A_RAT reviewed Ras-related protein Rab-1A (EC 3.6.5.2) Rattus norvegicus (Rat) GO:0000045; GO:0000139; GO:0003924; GO:0003925; GO:0005525; GO:0005769; GO:0005783; GO:0005789; GO:0005794; GO:0005829; GO:0006886; GO:0006888; GO:0006897; GO:0006914; GO:0007030; GO:0012505; GO:0016477; GO:0030252; GO:0032402; GO:0032482; GO:0032757; GO:0034446; GO:0042470; GO:0042742; GO:0043025; GO:0046872; GO:0047496; GO:0070382; GO:0090110; GO:0098793; GO:1903020 autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; cell migration [GO:0016477]; COPII-coated vesicle cargo loading [GO:0090110]; defense response to bacterium [GO:0042742]; endocytosis [GO:0006897]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; growth hormone secretion [GO:0030252]; intracellular protein transport [GO:0006886]; melanosome transport [GO:0032402]; positive regulation of glycoprotein metabolic process [GO:1903020]; positive regulation of interleukin-8 production [GO:0032757]; Rab protein signal transduction [GO:0032482]; substrate adhesion-dependent cell spreading [GO:0034446]; vesicle transport along microtubule [GO:0047496] cytosol [GO:0005829]; early endosome [GO:0005769]; endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; exocytic vesicle [GO:0070382]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; melanosome [GO:0042470]; neuronal cell body [GO:0043025]; presynapse [GO:0098793] G protein activity [GO:0003925]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872] g4582.t1 A5PJN2 36.813 182 1.23e-35 133.0 sp|A5PJN2|ERO1A_BOVIN ERO1-like protein alpha OS=Bos taurus OX=9913 GN=ERO1A PE=2 SV=1 ERO1A_BOVIN reviewed ERO1-like protein alpha (ERO1-L) (ERO1-L-alpha) (EC 1.8.3.2) (Endoplasmic reticulum oxidoreductase alpha) (Endoplasmic reticulum oxidoreductin-1-like protein) (Oxidoreductin-1-L-alpha) Bos taurus (Bovine) GO:0005615; GO:0005783; GO:0005789; GO:0005796; GO:0006457; GO:0015035; GO:0016972; GO:0030425; GO:0034975; GO:0034976; GO:0045454; GO:0051209; GO:0070059; GO:0071949 cell redox homeostasis [GO:0045454]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; protein folding [GO:0006457]; protein folding in endoplasmic reticulum [GO:0034975]; release of sequestered calcium ion into cytosol [GO:0051209]; response to endoplasmic reticulum stress [GO:0034976] dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796] FAD binding [GO:0071949]; protein-disulfide reductase activity [GO:0015035]; thiol oxidase activity [GO:0016972] g4583.t1 Q8R2E9 58.163 294 7.75e-109 326.0 sp|Q8R2E9|ERO1B_MOUSE ERO1-like protein beta OS=Mus musculus OX=10090 GN=Ero1b PE=1 SV=1 ERO1B_MOUSE reviewed ERO1-like protein beta (ERO1-L-beta) (EC 1.8.3.2) (Endoplasmic reticulum oxidoreductase beta) (Endoplasmic reticulum oxidoreductin-1-like protein B) (Oxidoreductin-1-L-beta) Mus musculus (Mouse) GO:0005788; GO:0005789; GO:0015035; GO:0015036; GO:0016020; GO:0016972; GO:0030070; GO:0030198; GO:0034975; GO:0042593; GO:0045454; GO:0051604; GO:0071949 cell redox homeostasis [GO:0045454]; extracellular matrix organization [GO:0030198]; glucose homeostasis [GO:0042593]; insulin processing [GO:0030070]; protein folding in endoplasmic reticulum [GO:0034975]; protein maturation [GO:0051604] endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020] disulfide oxidoreductase activity [GO:0015036]; FAD binding [GO:0071949]; protein-disulfide reductase activity [GO:0015035]; thiol oxidase activity [GO:0016972] g4583.t2 Q8R2E9 57.966 295 3.34e-109 327.0 sp|Q8R2E9|ERO1B_MOUSE ERO1-like protein beta OS=Mus musculus OX=10090 GN=Ero1b PE=1 SV=1 ERO1B_MOUSE reviewed ERO1-like protein beta (ERO1-L-beta) (EC 1.8.3.2) (Endoplasmic reticulum oxidoreductase beta) (Endoplasmic reticulum oxidoreductin-1-like protein B) (Oxidoreductin-1-L-beta) Mus musculus (Mouse) GO:0005788; GO:0005789; GO:0015035; GO:0015036; GO:0016020; GO:0016972; GO:0030070; GO:0030198; GO:0034975; GO:0042593; GO:0045454; GO:0051604; GO:0071949 cell redox homeostasis [GO:0045454]; extracellular matrix organization [GO:0030198]; glucose homeostasis [GO:0042593]; insulin processing [GO:0030070]; protein folding in endoplasmic reticulum [GO:0034975]; protein maturation [GO:0051604] endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020] disulfide oxidoreductase activity [GO:0015036]; FAD binding [GO:0071949]; protein-disulfide reductase activity [GO:0015035]; thiol oxidase activity [GO:0016972] g4585.t1 Q39580 75.824 91 3.58e-49 153.0 sp|Q39580|DYL1_CHLRE Dynein 8 kDa light chain, flagellar outer arm OS=Chlamydomonas reinhardtii OX=3055 PE=1 SV=1 g4586.t1 Q147X3 82.581 155 1.24e-86 272.0 sp|Q147X3|NAA30_HUMAN N-alpha-acetyltransferase 30 OS=Homo sapiens OX=9606 GN=NAA30 PE=1 SV=1 NAA30_HUMAN reviewed N-alpha-acetyltransferase 30 (EC 2.3.1.256) (N-acetyltransferase 12) (N-acetyltransferase MAK3 homolog) (NatC catalytic subunit) Homo sapiens (Human) GO:0004596; GO:0005634; GO:0005737; GO:0005829; GO:0031417; GO:0050821; GO:0120518 protein stabilization [GO:0050821] cytoplasm [GO:0005737]; cytosol [GO:0005829]; NatC complex [GO:0031417]; nucleus [GO:0005634] protein N-terminal-methionine acetyltransferase activity [GO:0120518]; protein-N-terminal amino-acid acetyltransferase activity [GO:0004596] g4588.t1 Q9I8C7 32.571 350 9.68e-66 219.0 sp|Q9I8C7|ACH10_CHICK Neuronal acetylcholine receptor subunit alpha-10 OS=Gallus gallus OX=9031 GN=CHRNA10 PE=3 SV=1 ACH10_CHICK reviewed Neuronal acetylcholine receptor subunit alpha-10 (Alpha 10 nAChR) (Nicotinic acetylcholine receptor subunit alpha-10) (NACHR alpha-10) Gallus gallus (Chicken) GO:0005231; GO:0005262; GO:0005886; GO:0005892; GO:0007268; GO:0022848; GO:0022850; GO:0034220; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0050910; GO:1902495; GO:1904315 chemical synaptic transmission [GO:0007268]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; monoatomic ion transmembrane transport [GO:0034220]; regulation of membrane potential [GO:0042391] acetylcholine-gated channel complex [GO:0005892]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; transmembrane transporter complex [GO:1902495] acetylcholine-gated monoatomic cation-selective channel activity [GO:0022848]; calcium channel activity [GO:0005262]; excitatory extracellular ligand-gated monoatomic ion channel activity [GO:0005231]; serotonin-gated monoatomic cation channel activity [GO:0022850]; transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315] g4590.t1 Q9MYM7 40.265 226 1.8999999999999998e-52 179.0 sp|Q9MYM7|B3GT1_PONPY Beta-1,3-galactosyltransferase 1 OS=Pongo pygmaeus OX=9600 GN=B3GALT1 PE=3 SV=1 g4591.t1 Q9MYM7 35.714 280 6.829999999999999e-52 178.0 sp|Q9MYM7|B3GT1_PONPY Beta-1,3-galactosyltransferase 1 OS=Pongo pygmaeus OX=9600 GN=B3GALT1 PE=3 SV=1 g4592.t1 Q9MYM7 39.738 229 2.48e-53 182.0 sp|Q9MYM7|B3GT1_PONPY Beta-1,3-galactosyltransferase 1 OS=Pongo pygmaeus OX=9600 GN=B3GALT1 PE=3 SV=1 g4599.t1 Q9WVL0 59.624 213 3.95e-94 276.0 sp|Q9WVL0|MAAI_MOUSE Maleylacetoacetate isomerase OS=Mus musculus OX=10090 GN=Gstz1 PE=1 SV=1 g4600.t1 Q64280 28.097 331 2.3600000000000003e-37 141.0 sp|Q64280|LFTY1_MOUSE Left-right determination factor 1 OS=Mus musculus OX=10090 GN=Lefty1 PE=2 SV=1 LFTY1_MOUSE reviewed Left-right determination factor 1 (Protein lefty-1) (Lefty protein) (Stimulated by retinoic acid gene 3 protein) (Transforming growth factor beta-4) (TGF-beta-4) Mus musculus (Mouse) GO:0000122; GO:0003007; GO:0005125; GO:0005160; GO:0005576; GO:0005615; GO:0007368; GO:0008083; GO:0008285; GO:0009948; GO:0030509; GO:0032526; GO:0038100; GO:0042074; GO:1900108; GO:1900124 anterior/posterior axis specification [GO:0009948]; BMP signaling pathway [GO:0030509]; cell migration involved in gastrulation [GO:0042074]; determination of left/right symmetry [GO:0007368]; heart morphogenesis [GO:0003007]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of nodal receptor complex assembly [GO:1900124]; negative regulation of nodal signaling pathway [GO:1900108]; negative regulation of transcription by RNA polymerase II [GO:0000122]; response to retinoic acid [GO:0032526] extracellular region [GO:0005576]; extracellular space [GO:0005615] cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; nodal binding [GO:0038100]; transforming growth factor beta receptor binding [GO:0005160] g4603.t1 Q5BJN8 33.019 212 1.02e-25 110.0 sp|Q5BJN8|SDE2_RAT UBL fusion protein SDE2 OS=Rattus norvegicus OX=10116 GN=Sde2 PE=1 SV=2 SDE2_RAT reviewed UBL fusion protein SDE2 (Replication stress response regulator SDE2) Rattus norvegicus (Rat) GO:0000479; GO:0003684; GO:0005634; GO:0005654; GO:0005737; GO:0005794; GO:0005829; GO:0005886; GO:0006260; GO:0016485; GO:0016567; GO:0016607; GO:0030515; GO:0031571; GO:0034644; GO:0045292; GO:0051301 cell division [GO:0051301]; cellular response to UV [GO:0034644]; DNA replication [GO:0006260]; endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000479]; mitotic G1 DNA damage checkpoint signaling [GO:0031571]; mRNA cis splicing, via spliceosome [GO:0045292]; protein processing [GO:0016485]; protein ubiquitination [GO:0016567] cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886] damaged DNA binding [GO:0003684]; snoRNA binding [GO:0030515] g4605.t1 Q14181 42.479 605 6.72e-150 447.0 sp|Q14181|DPOA2_HUMAN DNA polymerase alpha subunit B OS=Homo sapiens OX=9606 GN=POLA2 PE=1 SV=2 DPOA2_HUMAN reviewed DNA polymerase alpha subunit B (DNA polymerase alpha 70 kDa subunit) Homo sapiens (Human) GO:0003677; GO:0005654; GO:0005658; GO:0005829; GO:0006260; GO:0006269; GO:0006270; GO:0006606; GO:0036064 DNA replication [GO:0006260]; DNA replication initiation [GO:0006270]; DNA replication, synthesis of primer [GO:0006269]; protein import into nucleus [GO:0006606] alpha DNA polymerase:primase complex [GO:0005658]; ciliary basal body [GO:0036064]; cytosol [GO:0005829]; nucleoplasm [GO:0005654] DNA binding [GO:0003677] g4606.t1 O54910 33.607 366 5.5e-44 160.0 sp|O54910|IKBE_MOUSE NF-kappa-B inhibitor epsilon OS=Mus musculus OX=10090 GN=Nfkbie PE=1 SV=2 IKBE_MOUSE reviewed NF-kappa-B inhibitor epsilon (NF-kappa-BIE) (I-kappa-B-epsilon) (IkB-E) (IkB-epsilon) (IkappaBepsilon) Mus musculus (Mouse) GO:0001650; GO:0005654; GO:0005737; GO:0005829; GO:0042942; GO:0048471; GO:0140311 D-serine transmembrane transport [GO:0042942] cytoplasm [GO:0005737]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471] protein sequestering activity [GO:0140311] g4609.t1 Q1JQA5 63.366 101 1.15e-40 135.0 sp|Q1JQA5|NENF_BOVIN Neudesin OS=Bos taurus OX=9913 GN=NENF PE=2 SV=1 NENF_BOVIN reviewed Neudesin (Neuron-derived neurotrophic factor) (SCIRP10-related protein) (Spinal cord injury-related protein 10) Bos taurus (Bovine) GO:0000165; GO:0005615; GO:0005739; GO:0005783; GO:0008083; GO:0012505; GO:0016020; GO:0032099; GO:0043410; GO:0046872 MAPK cascade [GO:0000165]; negative regulation of appetite [GO:0032099]; positive regulation of MAPK cascade [GO:0043410] endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; membrane [GO:0016020]; mitochondrion [GO:0005739] growth factor activity [GO:0008083]; metal ion binding [GO:0046872] g4610.t1 Q96KQ4 48.438 320 1.9e-67 249.0 sp|Q96KQ4|ASPP1_HUMAN Apoptosis-stimulating of p53 protein 1 OS=Homo sapiens OX=9606 GN=PPP1R13B PE=1 SV=3 ASPP1_HUMAN reviewed Apoptosis-stimulating of p53 protein 1 (Protein phosphatase 1 regulatory subunit 13B) Homo sapiens (Human) GO:0002039; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0042981; GO:0045786; GO:0072332 intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; negative regulation of cell cycle [GO:0045786]; regulation of apoptotic process [GO:0042981] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886] p53 binding [GO:0002039] g4611.t1 Q62415 61.714 175 1.44e-65 220.0 sp|Q62415|ASPP1_MOUSE Apoptosis-stimulating of p53 protein 1 OS=Mus musculus OX=10090 GN=Ppp1r13b PE=1 SV=2 g4612.t1 Q6P4F7 35.583 326 4.4000000000000004e-35 149.0 sp|Q6P4F7|RHGBA_HUMAN Rho GTPase-activating protein 11A OS=Homo sapiens OX=9606 GN=ARHGAP11A PE=1 SV=2 RHGBA_HUMAN reviewed Rho GTPase-activating protein 11A (Rho-type GTPase-activating protein 11A) Homo sapiens (Human) GO:0005096; GO:0005634; GO:0005829; GO:0007165; GO:0043547; GO:0051056 positive regulation of GTPase activity [GO:0043547]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165] cytosol [GO:0005829]; nucleus [GO:0005634] GTPase activator activity [GO:0005096] g4613.t1 P62744 92.254 142 1.46e-94 272.0 sp|P62744|AP2S1_RAT AP-2 complex subunit sigma OS=Rattus norvegicus OX=10116 GN=Ap2s1 PE=1 SV=1 AP2S1_RAT reviewed AP-2 complex subunit sigma (Adaptor protein complex AP-2 subunit sigma) (Adaptor-related protein complex 2 subunit sigma) (Clathrin assembly protein 2 sigma small chain) (Clathrin coat assembly protein AP17) (Clathrin coat-associated protein AP17) (Plasma membrane adaptor AP-2 17 kDa protein) (Sigma-adaptin 3b) (Sigma2-adaptin) Rattus norvegicus (Rat) GO:0005886; GO:0006886; GO:0008021; GO:0016192; GO:0030122; GO:0035615; GO:0045202; GO:0048488; GO:0072583; GO:0098794; GO:0098884; GO:0098894; GO:0098978 clathrin-dependent endocytosis [GO:0072583]; intracellular protein transport [GO:0006886]; postsynaptic neurotransmitter receptor internalization [GO:0098884]; synaptic vesicle endocytosis [GO:0048488]; vesicle-mediated transport [GO:0016192] AP-2 adaptor complex [GO:0030122]; extrinsic component of presynaptic endocytic zone membrane [GO:0098894]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; synapse [GO:0045202]; synaptic vesicle [GO:0008021] clathrin adaptor activity [GO:0035615] g4614.t1 P52432 65.723 318 9.95e-154 437.0 sp|P52432|RPAC1_MOUSE DNA-directed RNA polymerases I and III subunit RPAC1 OS=Mus musculus OX=10090 GN=Polr1c PE=1 SV=3 g4616.t1 Q91048 47.619 126 5.9e-38 139.0 sp|Q91048|PTK7_CHICK Inactive tyrosine-protein kinase 7 OS=Gallus gallus OX=9031 GN=PTK7 PE=2 SV=1 PTK7_CHICK reviewed Inactive tyrosine-protein kinase 7 (Kinase-like protein) (Protein-tyrosine kinase 7) (Pseudo tyrosine kinase receptor 7) (Tyrosine-protein kinase-like 7) Gallus gallus (Chicken) GO:0004713; GO:0005524; GO:0005886; GO:0005911; GO:0007156; GO:0008046; GO:0016055; GO:0030424; GO:0043025; GO:0050808; GO:0060828 homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; regulation of canonical Wnt signaling pathway [GO:0060828]; synapse organization [GO:0050808]; Wnt signaling pathway [GO:0016055] axon [GO:0030424]; cell-cell junction [GO:0005911]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886] ATP binding [GO:0005524]; axon guidance receptor activity [GO:0008046]; protein tyrosine kinase activity [GO:0004713] g4617.t1 Q91048 33.048 702 7.3099999999999995e-112 369.0 sp|Q91048|PTK7_CHICK Inactive tyrosine-protein kinase 7 OS=Gallus gallus OX=9031 GN=PTK7 PE=2 SV=1 PTK7_CHICK reviewed Inactive tyrosine-protein kinase 7 (Kinase-like protein) (Protein-tyrosine kinase 7) (Pseudo tyrosine kinase receptor 7) (Tyrosine-protein kinase-like 7) Gallus gallus (Chicken) GO:0004713; GO:0005524; GO:0005886; GO:0005911; GO:0007156; GO:0008046; GO:0016055; GO:0030424; GO:0043025; GO:0050808; GO:0060828 homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; regulation of canonical Wnt signaling pathway [GO:0060828]; synapse organization [GO:0050808]; Wnt signaling pathway [GO:0016055] axon [GO:0030424]; cell-cell junction [GO:0005911]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886] ATP binding [GO:0005524]; axon guidance receptor activity [GO:0008046]; protein tyrosine kinase activity [GO:0004713] g4619.t1 Q7SXW3 30.403 273 2.28e-22 103.0 sp|Q7SXW3|LRC40_DANRE Leucine-rich repeat-containing protein 40 OS=Danio rerio OX=7955 GN=lrrc40 PE=2 SV=1 g4621.t1 Q6ZUK4 40.193 311 3.7e-48 168.0 sp|Q6ZUK4|TMM26_HUMAN Transmembrane protein 26 OS=Homo sapiens OX=9606 GN=TMEM26 PE=1 SV=1 g4622.t1 Q6ZUK4 37.92 327 6.53e-49 171.0 sp|Q6ZUK4|TMM26_HUMAN Transmembrane protein 26 OS=Homo sapiens OX=9606 GN=TMEM26 PE=1 SV=1 g4623.t1 Q6ZUK4 31.373 408 7.08e-39 147.0 sp|Q6ZUK4|TMM26_HUMAN Transmembrane protein 26 OS=Homo sapiens OX=9606 GN=TMEM26 PE=1 SV=1 g4624.t1 Q5VTE6 45.34 397 1.96e-94 303.0 sp|Q5VTE6|ANGE2_HUMAN Protein angel homolog 2 OS=Homo sapiens OX=9606 GN=ANGEL2 PE=1 SV=1 ANGE2_HUMAN reviewed RNA 2',3'-cyclic phosphatase ANGEL2 (EC 3.-.-.-) Homo sapiens (Human) GO:0000287; GO:0003730; GO:0005737; GO:0005739; GO:0005759; GO:0015030; GO:0033119; GO:0045930; GO:0070935; GO:0090616; GO:0160272; GO:0160273; GO:2000236 3'-UTR-mediated mRNA stabilization [GO:0070935]; mitochondrial mRNA 3'-end processing [GO:0090616]; negative regulation of mitotic cell cycle [GO:0045930]; negative regulation of RNA splicing [GO:0033119]; negative regulation of tRNA processing [GO:2000236] Cajal body [GO:0015030]; cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] magnesium ion binding [GO:0000287]; mRNA 3'-UTR binding [GO:0003730]; RNA 2',3'-cyclic phosphatase activity [GO:0160272]; RNA 2'-phosphatase activity [GO:0160273] g4628.t1 Q9Y6R7 24.724 453 7.07e-25 114.0 sp|Q9Y6R7|FCGBP_HUMAN IgGFc-binding protein OS=Homo sapiens OX=9606 GN=FCGBP PE=1 SV=3 FCGBP_HUMAN reviewed IgGFc-binding protein (Fcgamma-binding protein antigen) (FcgammaBP) Homo sapiens (Human) GO:0005201; GO:0005615; GO:0005796; GO:0031012; GO:0070062 extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796] extracellular matrix structural constituent [GO:0005201] g4632.t1 Q8BJ37 56.695 351 8.409999999999999e-138 407.0 sp|Q8BJ37|TYDP1_MOUSE Tyrosyl-DNA phosphodiesterase 1 OS=Mus musculus OX=10090 GN=Tdp1 PE=1 SV=2 TYDP1_MOUSE reviewed Tyrosyl-DNA phosphodiesterase 1 (Tyr-DNA phosphodiesterase 1) (EC 3.1.4.-) (Protein expressed in male leptotene and zygotene spermatocytes 501) (MLZ-501) Mus musculus (Mouse) GO:0000012; GO:0003690; GO:0003697; GO:0004527; GO:0005634; GO:0005654; GO:0005737; GO:0005886; GO:0006281; GO:0006302; GO:0017005 DNA repair [GO:0006281]; double-strand break repair [GO:0006302]; single strand break repair [GO:0000012] cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886] 3'-tyrosyl-DNA phosphodiesterase activity [GO:0017005]; double-stranded DNA binding [GO:0003690]; exonuclease activity [GO:0004527]; single-stranded DNA binding [GO:0003697] g4634.t1 Q9IAL1 66.286 175 5.54e-74 239.0 sp|Q9IAL1|VSX2_CHICK Visual system homeobox 2 OS=Gallus gallus OX=9031 GN=VSX2 PE=2 SV=1 g4636.t1 Q6PB03 47.191 445 1.54e-142 422.0 sp|Q6PB03|PLD3_XENLA 5'-3' exonuclease PLD3 OS=Xenopus laevis OX=8355 GN=pld3 PE=2 SV=1 PLD3_XENLA reviewed 5'-3' exonuclease PLD3 (EC 3.1.16.1) (Choline phosphatase 3) (Phosphatidylcholine-hydrolyzing phospholipase D3) (Phospholipase D3) (PLD 3) Xenopus laevis (African clawed frog) GO:0000139; GO:0002376; GO:0005789; GO:0006954; GO:0012505; GO:0014902; GO:0031901; GO:0031902; GO:0043202; GO:0045145; GO:1900015 immune system process [GO:0002376]; inflammatory response [GO:0006954]; myotube differentiation [GO:0014902]; regulation of cytokine production involved in inflammatory response [GO:1900015] early endosome membrane [GO:0031901]; endomembrane system [GO:0012505]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; late endosome membrane [GO:0031902]; lysosomal lumen [GO:0043202] single-stranded DNA 5'-3' DNA exonuclease activity [GO:0045145] g4637.t1 Q26534 50.482 311 1.29e-107 325.0 sp|Q26534|CATL_SCHMA Cathepsin L OS=Schistosoma mansoni OX=6183 GN=CL1 PE=2 SV=1 g4638.t1 Q4J781 30.079 379 3.0400000000000003e-35 135.0 sp|Q4J781|ADH_SULAC NAD-dependent alcohol dehydrogenase OS=Sulfolobus acidocaldarius (strain ATCC 33909 / DSM 639 / JCM 8929 / NBRC 15157 / NCIMB 11770) OX=330779 GN=adh PE=3 SV=1 g4638.t2 Q4J781 30.079 379 3.0400000000000003e-35 135.0 sp|Q4J781|ADH_SULAC NAD-dependent alcohol dehydrogenase OS=Sulfolobus acidocaldarius (strain ATCC 33909 / DSM 639 / JCM 8929 / NBRC 15157 / NCIMB 11770) OX=330779 GN=adh PE=3 SV=1 g4638.t3 Q4J781 29.532 342 7.63e-29 117.0 sp|Q4J781|ADH_SULAC NAD-dependent alcohol dehydrogenase OS=Sulfolobus acidocaldarius (strain ATCC 33909 / DSM 639 / JCM 8929 / NBRC 15157 / NCIMB 11770) OX=330779 GN=adh PE=3 SV=1 g4639.t1 Q4J781 33.073 384 4.05e-41 151.0 sp|Q4J781|ADH_SULAC NAD-dependent alcohol dehydrogenase OS=Sulfolobus acidocaldarius (strain ATCC 33909 / DSM 639 / JCM 8929 / NBRC 15157 / NCIMB 11770) OX=330779 GN=adh PE=3 SV=1 g4640.t1 Q7M456 35.025 197 4.1699999999999996e-39 139.0 sp|Q7M456|RNOY_MAGGI Ribonuclease Oy OS=Magallana gigas OX=29159 PE=1 SV=1 g4644.t1 Q2KI52 33.84 263 1.49e-25 108.0 sp|Q2KI52|HYLS1_BOVIN Centriolar and ciliogenesis-associated protein HYLS1 OS=Bos taurus OX=9913 GN=HYLS1 PE=2 SV=1 g4645.t1 Q6DFF9 55.541 758 0.0 888.0 sp|Q6DFF9|MABP1_XENLA Mitogen-activated protein kinase-binding protein 1 OS=Xenopus laevis OX=8355 GN=mapkbp1 PE=2 SV=1 g4645.t2 Q6DFF9 55.541 758 0.0 888.0 sp|Q6DFF9|MABP1_XENLA Mitogen-activated protein kinase-binding protein 1 OS=Xenopus laevis OX=8355 GN=mapkbp1 PE=2 SV=1 g4648.t1 Q9GZT4 41.641 329 1.13e-75 245.0 sp|Q9GZT4|SRR_HUMAN Serine racemase OS=Homo sapiens OX=9606 GN=SRR PE=1 SV=1 SRR_HUMAN reviewed Serine racemase (EC 5.1.1.18) (D-serine ammonia-lyase) (D-serine dehydratase) (EC 4.3.1.18) (L-serine ammonia-lyase) (L-serine dehydratase) (EC 4.3.1.17) Homo sapiens (Human) GO:0000287; GO:0003941; GO:0005509; GO:0005524; GO:0005737; GO:0005829; GO:0006563; GO:0008721; GO:0009069; GO:0009410; GO:0016594; GO:0018114; GO:0030165; GO:0030170; GO:0030378; GO:0032496; GO:0042802; GO:0042803; GO:0042866; GO:0043025; GO:0045177; GO:0070178; GO:0070179; GO:1901986 D-serine biosynthetic process [GO:0070179]; D-serine metabolic process [GO:0070178]; L-serine metabolic process [GO:0006563]; pyruvate biosynthetic process [GO:0042866]; response to ketamine [GO:1901986]; response to lipopolysaccharide [GO:0032496]; response to xenobiotic stimulus [GO:0009410]; serine family amino acid metabolic process [GO:0009069] apical part of cell [GO:0045177]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; neuronal cell body [GO:0043025] ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; D-serine ammonia-lyase activity [GO:0008721]; glycine binding [GO:0016594]; identical protein binding [GO:0042802]; L-serine ammonia-lyase activity [GO:0003941]; magnesium ion binding [GO:0000287]; PDZ domain binding [GO:0030165]; protein homodimerization activity [GO:0042803]; pyridoxal phosphate binding [GO:0030170]; serine racemase activity [GO:0030378]; threonine racemase activity [GO:0018114] g4651.t1 Q8N5C6 45.879 813 0.0 693.0 sp|Q8N5C6|SRBD1_HUMAN S1 RNA-binding domain-containing protein 1 OS=Homo sapiens OX=9606 GN=SRBD1 PE=1 SV=2 g4654.t1 Q504Y2 40.054 367 4.29e-76 252.0 sp|Q504Y2|PKDCC_HUMAN Extracellular tyrosine-protein kinase PKDCC OS=Homo sapiens OX=9606 GN=PKDCC PE=1 SV=2 PKDCC_HUMAN reviewed Extracellular tyrosine-protein kinase PKDCC (EC 2.7.10.2) (Protein kinase domain-containing protein, cytoplasmic) (Protein kinase-like protein SgK493) (Sugen kinase 493) (Vertebrate lonesome kinase) Homo sapiens (Human) GO:0001501; GO:0004672; GO:0004715; GO:0005524; GO:0005576; GO:0005794; GO:0015031; GO:0018108; GO:0030154; GO:0030282; GO:0030501; GO:0032332; GO:0035108; GO:0035264; GO:0042997; GO:0048286; GO:0048566; GO:0060021 bone mineralization [GO:0030282]; cell differentiation [GO:0030154]; embryonic digestive tract development [GO:0048566]; limb morphogenesis [GO:0035108]; lung alveolus development [GO:0048286]; multicellular organism growth [GO:0035264]; negative regulation of Golgi to plasma membrane protein transport [GO:0042997]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of bone mineralization [GO:0030501]; positive regulation of chondrocyte differentiation [GO:0032332]; protein transport [GO:0015031]; roof of mouth development [GO:0060021]; skeletal system development [GO:0001501] extracellular region [GO:0005576]; Golgi apparatus [GO:0005794] ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein kinase activity [GO:0004672] g4655.t1 Q7ZWP1 30.973 452 1.03e-61 211.0 sp|Q7ZWP1|FRMD8_XENLA FERM domain-containing protein 8 OS=Xenopus laevis OX=8355 GN=frmd8 PE=2 SV=1 g4655.t2 Q9BZ67 31.591 440 2.49e-63 216.0 sp|Q9BZ67|FRMD8_HUMAN FERM domain-containing protein 8 OS=Homo sapiens OX=9606 GN=FRMD8 PE=1 SV=1 g4658.t1 Q8BJ05 46.259 147 1.7e-41 165.0 sp|Q8BJ05|ZC3HE_MOUSE Zinc finger CCCH domain-containing protein 14 OS=Mus musculus OX=10090 GN=Zc3h14 PE=1 SV=1 ZC3HE_MOUSE reviewed Zinc finger CCCH domain-containing protein 14 Mus musculus (Mouse) GO:0003730; GO:0005634; GO:0005730; GO:0005737; GO:0007283; GO:0008143; GO:0008270; GO:0016607; GO:0030154; GO:0032839; GO:0036002; GO:0043488; GO:0048255; GO:0160091; GO:1904115; GO:1990904 cell differentiation [GO:0030154]; mRNA stabilization [GO:0048255]; regulation of mRNA stability [GO:0043488]; spermatogenesis [GO:0007283]; spliceosome-depend formation of circular RNA [GO:0160091] axon cytoplasm [GO:1904115]; cytoplasm [GO:0005737]; dendrite cytoplasm [GO:0032839]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904] mRNA 3'-UTR binding [GO:0003730]; poly(A) binding [GO:0008143]; pre-mRNA binding [GO:0036002]; zinc ion binding [GO:0008270] g4658.t1 Q8BJ05 71.605 81 1.1700000000000001e-27 122.0 sp|Q8BJ05|ZC3HE_MOUSE Zinc finger CCCH domain-containing protein 14 OS=Mus musculus OX=10090 GN=Zc3h14 PE=1 SV=1 ZC3HE_MOUSE reviewed Zinc finger CCCH domain-containing protein 14 Mus musculus (Mouse) GO:0003730; GO:0005634; GO:0005730; GO:0005737; GO:0007283; GO:0008143; GO:0008270; GO:0016607; GO:0030154; GO:0032839; GO:0036002; GO:0043488; GO:0048255; GO:0160091; GO:1904115; GO:1990904 cell differentiation [GO:0030154]; mRNA stabilization [GO:0048255]; regulation of mRNA stability [GO:0043488]; spermatogenesis [GO:0007283]; spliceosome-depend formation of circular RNA [GO:0160091] axon cytoplasm [GO:1904115]; cytoplasm [GO:0005737]; dendrite cytoplasm [GO:0032839]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904] mRNA 3'-UTR binding [GO:0003730]; poly(A) binding [GO:0008143]; pre-mRNA binding [GO:0036002]; zinc ion binding [GO:0008270] g4659.t1 P51476 34.591 318 4.37e-66 219.0 sp|P51476|OPSP_COLLI Pinopsin OS=Columba livia OX=8932 PE=1 SV=1 g4661.t1 Q94126 63.158 76 6.630000000000001e-26 103.0 sp|Q94126|CES2_CAEEL Transcription factor ces-2 OS=Caenorhabditis elegans OX=6239 GN=ces-2 PE=1 SV=1 CES2_CAEEL reviewed Transcription factor ces-2 (Cell death specification protein 2) Caenorhabditis elegans GO:0000977; GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0006915; GO:0009887; GO:0042802; GO:0043068; GO:0045944; GO:0046982; GO:1990837 animal organ morphogenesis [GO:0009887]; apoptotic process [GO:0006915]; positive regulation of programmed cell death [GO:0043068]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; protein heterodimerization activity [GO:0046982]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837] g4664.t1 Q501S4 31.224 237 3.39e-29 113.0 sp|Q501S4|CSKMT_DANRE Citrate synthase-lysine N-methyltransferase CSKMT, mitochondrial OS=Danio rerio OX=7955 GN=cskmt PE=2 SV=2 CSKMT_DANRE reviewed Citrate synthase-lysine N-methyltransferase CSKMT, mitochondrial (CS-KMT) (EC 2.1.1.-) (Methyltransferase-like protein 12, mitochondrial) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005739; GO:0006479; GO:0016278; GO:0016279; GO:0018023; GO:0018026; GO:0018027 peptidyl-lysine dimethylation [GO:0018027]; peptidyl-lysine monomethylation [GO:0018026]; peptidyl-lysine trimethylation [GO:0018023]; protein methylation [GO:0006479] mitochondrion [GO:0005739] lysine N-methyltransferase activity [GO:0016278]; protein-lysine N-methyltransferase activity [GO:0016279] g4666.t1 Q99NB1 58.699 615 0.0 756.0 sp|Q99NB1|ACS2L_MOUSE Acetyl-coenzyme A synthetase 2-like, mitochondrial OS=Mus musculus OX=10090 GN=Acss1 PE=1 SV=1 ACS2L_MOUSE reviewed Acetyl-coenzyme A synthetase 2-like, mitochondrial (EC 6.2.1.1) (Acetate--CoA ligase 2) (Acetyl-CoA synthetase 2) (AceCS2) (Acyl-CoA synthetase short-chain family member 1) (Propionate--CoA ligase) (EC 6.2.1.17) Mus musculus (Mouse) GO:0003987; GO:0005524; GO:0005739; GO:0005759; GO:0006085; GO:0016208; GO:0019413; GO:0019427; GO:0019542; GO:0050218 acetate biosynthetic process [GO:0019413]; acetyl-CoA biosynthetic process [GO:0006085]; acetyl-CoA biosynthetic process from acetate [GO:0019427]; propionate biosynthetic process [GO:0019542] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] acetate-CoA ligase activity [GO:0003987]; AMP binding [GO:0016208]; ATP binding [GO:0005524]; propionate-CoA ligase activity [GO:0050218] g4667.t1 Q868Z9 42.396 651 4.86e-145 502.0 sp|Q868Z9|PPN_DROME Papilin OS=Drosophila melanogaster OX=7227 GN=Ppn PE=1 SV=2 PPN_DROME reviewed Papilin Drosophila melanogaster (Fruit fly) GO:0004867; GO:0005201; GO:0005576; GO:0005604; GO:0030198 extracellular matrix organization [GO:0030198] basement membrane [GO:0005604]; extracellular region [GO:0005576] extracellular matrix structural constituent [GO:0005201]; serine-type endopeptidase inhibitor activity [GO:0004867] g4667.t1 Q868Z9 34.474 380 1.98e-57 224.0 sp|Q868Z9|PPN_DROME Papilin OS=Drosophila melanogaster OX=7227 GN=Ppn PE=1 SV=2 PPN_DROME reviewed Papilin Drosophila melanogaster (Fruit fly) GO:0004867; GO:0005201; GO:0005576; GO:0005604; GO:0030198 extracellular matrix organization [GO:0030198] basement membrane [GO:0005604]; extracellular region [GO:0005576] extracellular matrix structural constituent [GO:0005201]; serine-type endopeptidase inhibitor activity [GO:0004867] g4667.t1 Q868Z9 33.041 342 3.11e-45 184.0 sp|Q868Z9|PPN_DROME Papilin OS=Drosophila melanogaster OX=7227 GN=Ppn PE=1 SV=2 PPN_DROME reviewed Papilin Drosophila melanogaster (Fruit fly) GO:0004867; GO:0005201; GO:0005576; GO:0005604; GO:0030198 extracellular matrix organization [GO:0030198] basement membrane [GO:0005604]; extracellular region [GO:0005576] extracellular matrix structural constituent [GO:0005201]; serine-type endopeptidase inhibitor activity [GO:0004867] g4667.t1 Q868Z9 35.202 321 4.34e-43 177.0 sp|Q868Z9|PPN_DROME Papilin OS=Drosophila melanogaster OX=7227 GN=Ppn PE=1 SV=2 PPN_DROME reviewed Papilin Drosophila melanogaster (Fruit fly) GO:0004867; GO:0005201; GO:0005576; GO:0005604; GO:0030198 extracellular matrix organization [GO:0030198] basement membrane [GO:0005604]; extracellular region [GO:0005576] extracellular matrix structural constituent [GO:0005201]; serine-type endopeptidase inhibitor activity [GO:0004867] g4667.t1 Q868Z9 30.211 331 1.65e-39 166.0 sp|Q868Z9|PPN_DROME Papilin OS=Drosophila melanogaster OX=7227 GN=Ppn PE=1 SV=2 PPN_DROME reviewed Papilin Drosophila melanogaster (Fruit fly) GO:0004867; GO:0005201; GO:0005576; GO:0005604; GO:0030198 extracellular matrix organization [GO:0030198] basement membrane [GO:0005604]; extracellular region [GO:0005576] extracellular matrix structural constituent [GO:0005201]; serine-type endopeptidase inhibitor activity [GO:0004867] g4667.t1 Q868Z9 31.741 293 3.45e-32 142.0 sp|Q868Z9|PPN_DROME Papilin OS=Drosophila melanogaster OX=7227 GN=Ppn PE=1 SV=2 PPN_DROME reviewed Papilin Drosophila melanogaster (Fruit fly) GO:0004867; GO:0005201; GO:0005576; GO:0005604; GO:0030198 extracellular matrix organization [GO:0030198] basement membrane [GO:0005604]; extracellular region [GO:0005576] extracellular matrix structural constituent [GO:0005201]; serine-type endopeptidase inhibitor activity [GO:0004867] g4668.t1 A4IGL7 33.449 287 1.4100000000000001e-36 152.0 sp|A4IGL7|PXDN_XENTR Peroxidasin OS=Xenopus tropicalis OX=8364 GN=pxdn PE=2 SV=1 PXDN_XENTR reviewed Peroxidasin (EC 1.11.2.-) [Cleaved into: PXDN active fragment] Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0001525; GO:0004601; GO:0005604; GO:0005783; GO:0006979; GO:0007155; GO:0009986; GO:0016684; GO:0020037; GO:0031012; GO:0042744; GO:0046872; GO:0051260; GO:0070207; GO:0070831; GO:0071711 angiogenesis [GO:0001525]; basement membrane assembly [GO:0070831]; basement membrane organization [GO:0071711]; cell adhesion [GO:0007155]; hydrogen peroxide catabolic process [GO:0042744]; protein homooligomerization [GO:0051260]; protein homotrimerization [GO:0070207]; response to oxidative stress [GO:0006979] basement membrane [GO:0005604]; cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; extracellular matrix [GO:0031012] heme binding [GO:0020037]; metal ion binding [GO:0046872]; oxidoreductase activity, acting on peroxide as acceptor [GO:0016684]; peroxidase activity [GO:0004601] g4668.t1 A4IGL7 32.364 275 3.02e-32 139.0 sp|A4IGL7|PXDN_XENTR Peroxidasin OS=Xenopus tropicalis OX=8364 GN=pxdn PE=2 SV=1 PXDN_XENTR reviewed Peroxidasin (EC 1.11.2.-) [Cleaved into: PXDN active fragment] Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0001525; GO:0004601; GO:0005604; GO:0005783; GO:0006979; GO:0007155; GO:0009986; GO:0016684; GO:0020037; GO:0031012; GO:0042744; GO:0046872; GO:0051260; GO:0070207; GO:0070831; GO:0071711 angiogenesis [GO:0001525]; basement membrane assembly [GO:0070831]; basement membrane organization [GO:0071711]; cell adhesion [GO:0007155]; hydrogen peroxide catabolic process [GO:0042744]; protein homooligomerization [GO:0051260]; protein homotrimerization [GO:0070207]; response to oxidative stress [GO:0006979] basement membrane [GO:0005604]; cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; extracellular matrix [GO:0031012] heme binding [GO:0020037]; metal ion binding [GO:0046872]; oxidoreductase activity, acting on peroxide as acceptor [GO:0016684]; peroxidase activity [GO:0004601] g4670.t1 P86397 45.802 131 3.9e-37 130.0 sp|P86397|HTD2_HUMAN Hydroxyacyl-thioester dehydratase type 2, mitochondrial OS=Homo sapiens OX=9606 GN=HTD2 PE=1 SV=1 HTD2_HUMAN reviewed Hydroxyacyl-thioester dehydratase type 2, mitochondrial (HsHTD2) (EC 4.2.1.59) (3-hydroxyacyl-[acyl-carrier-protein] dehydratase) Homo sapiens (Human) GO:0005730; GO:0005739; GO:0005759; GO:0006633; GO:0018812; GO:0019171; GO:0046949 fatty acid biosynthetic process [GO:0006633]; fatty-acyl-CoA biosynthetic process [GO:0046949] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleolus [GO:0005730] (3R)-hydroxyacyl-[acyl-carrier-protein] dehydratase activity [GO:0019171]; 3-hydroxyacyl-CoA dehydratase activity [GO:0018812] g4671.t1 A2ATD1 42.473 372 9.25e-66 224.0 sp|A2ATD1|ISM1_MOUSE Isthmin-1 OS=Mus musculus OX=10090 GN=Ism1 PE=1 SV=1 ISM1_MOUSE reviewed Isthmin-1 Mus musculus (Mouse) GO:0005576; GO:0016525 negative regulation of angiogenesis [GO:0016525] extracellular region [GO:0005576] g4672.t1 Q8C008 39.39 787 4.2e-160 486.0 sp|Q8C008|DZAN1_MOUSE Double zinc ribbon and ankyrin repeat-containing protein 1 OS=Mus musculus OX=10090 GN=Dzank1 PE=1 SV=2 g4674.t1 X1WEM4 42.308 806 1.8200000000000003e-157 482.0 sp|X1WEM4|TM63C_DANRE Osmosensitive cation channel TMEM63C OS=Danio rerio OX=7955 GN=tmem63c PE=3 SV=1 g4674.t2 X1WEM4 42.066 813 2.12e-156 480.0 sp|X1WEM4|TM63C_DANRE Osmosensitive cation channel TMEM63C OS=Danio rerio OX=7955 GN=tmem63c PE=3 SV=1 g4677.t1 Q14997 53.348 448 1.59e-155 488.0 sp|Q14997|PSME4_HUMAN Proteasome activator complex subunit 4 OS=Homo sapiens OX=9606 GN=PSME4 PE=1 SV=2 PSME4_HUMAN reviewed Proteasome activator complex subunit 4 (Proteasome activator PA200) (Protein BLM10 homolog) (Blm10) (hBlm10) Homo sapiens (Human) GO:0005634; GO:0005654; GO:0005829; GO:0006281; GO:0006974; GO:0010499; GO:0016504; GO:0016607; GO:0035092; GO:0070628; GO:1990111 DNA damage response [GO:0006974]; DNA repair [GO:0006281]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; sperm DNA condensation [GO:0035092] cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spermatoproteasome complex [GO:1990111] peptidase activator activity [GO:0016504]; proteasome binding [GO:0070628] g4678.t1 F1MKX4 38.115 244 2.34e-38 145.0 sp|F1MKX4|PSME4_BOVIN Proteasome activator complex subunit 4 OS=Bos taurus OX=9913 GN=PSME4 PE=1 SV=1 g4679.t1 F1MKX4 44.518 301 3.56e-78 262.0 sp|F1MKX4|PSME4_BOVIN Proteasome activator complex subunit 4 OS=Bos taurus OX=9913 GN=PSME4 PE=1 SV=1 g4680.t1 F1QFR9 58.791 182 6.36e-63 214.0 sp|F1QFR9|PSM4A_DANRE Proteasome activator complex subunit 4A OS=Danio rerio OX=7955 GN=psme4a PE=3 SV=2 g4681.t1 Q6NRP2 57.751 329 4.29e-99 323.0 sp|Q6NRP2|PSME4_XENLA Proteasome activator complex subunit 4 OS=Xenopus laevis OX=8355 GN=psme4 PE=2 SV=1 g4682.t1 Q28FK7 53.333 90 3.9800000000000003e-29 103.0 sp|Q28FK7|ACYP1_XENTR Acylphosphatase-1 OS=Xenopus tropicalis OX=8364 GN=acyp1 PE=3 SV=1 g4683.t1 Q9UBQ5 61.574 216 3.17e-97 285.0 sp|Q9UBQ5|EIF3K_HUMAN Eukaryotic translation initiation factor 3 subunit K OS=Homo sapiens OX=9606 GN=EIF3K PE=1 SV=1 EIF3K_HUMAN reviewed Eukaryotic translation initiation factor 3 subunit K (eIF3k) (Eukaryotic translation initiation factor 3 subunit 12) (Muscle-specific gene M9 protein) (PLAC-24) (eIF-3 p25) (eIF-3 p28) Homo sapiens (Human) GO:0001732; GO:0003723; GO:0003743; GO:0005634; GO:0005829; GO:0005852; GO:0006413; GO:0006446; GO:0016020; GO:0016282; GO:0033290; GO:0043022 formation of cytoplasmic translation initiation complex [GO:0001732]; regulation of translational initiation [GO:0006446]; translational initiation [GO:0006413] cytosol [GO:0005829]; eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; membrane [GO:0016020]; nucleus [GO:0005634] ribosome binding [GO:0043022]; RNA binding [GO:0003723]; translation initiation factor activity [GO:0003743] g4684.t1 Q64425 31.373 306 1.26e-40 152.0 sp|Q64425|LIPP_MYOCO Pancreatic triacylglycerol lipase (Fragment) OS=Myocastor coypus OX=10157 GN=PNLIP PE=2 SV=1 g4685.t1 P43141 24.839 310 8.4e-21 95.5 sp|P43141|ADB4C_MELGA Beta-4C adrenergic receptor OS=Meleagris gallopavo OX=9103 GN=ADRB4C PE=2 SV=1 g4686.t1 Q6GNT7 50.92 489 4.63e-145 445.0 sp|Q6GNT7|GOGA5_XENLA Golgin subfamily A member 5 OS=Xenopus laevis OX=8355 GN=golga5 PE=2 SV=1 g4687.t1 Q5M9F5 67.857 252 6.18e-112 342.0 sp|Q5M9F5|DPH6_RAT Diphthine--ammonia ligase OS=Rattus norvegicus OX=10116 GN=Dph6 PE=2 SV=1 g4688.t1 P48766 68.953 277 6.49e-118 364.0 sp|P48766|NAC1_CAVPO Sodium/calcium exchanger 1 OS=Cavia porcellus OX=10141 GN=SLC8A1 PE=2 SV=1 g4689.t1 P57103 53.288 593 0.0 615.0 sp|P57103|NAC3_HUMAN Sodium/calcium exchanger 3 OS=Homo sapiens OX=9606 GN=SLC8A3 PE=1 SV=2 NAC3_HUMAN reviewed Sodium/calcium exchanger 3 (Na(+)/Ca(2+)-exchange protein 3) (Solute carrier family 8 member 3) Homo sapiens (Human) GO:0001669; GO:0002244; GO:0005432; GO:0005516; GO:0005654; GO:0005741; GO:0005789; GO:0005813; GO:0005829; GO:0005874; GO:0005886; GO:0006811; GO:0006851; GO:0006874; GO:0007154; GO:0007611; GO:0007612; GO:0007613; GO:0014069; GO:0014819; GO:0015630; GO:0016528; GO:0021537; GO:0030424; GO:0030425; GO:0031594; GO:0035725; GO:0042383; GO:0042552; GO:0043025; GO:0043197; GO:0043204; GO:0043679; GO:0045202; GO:0045211; GO:0046872; GO:0048471; GO:0048709; GO:0050808; GO:0051560; GO:0060291; GO:0060402; GO:0070161; GO:0070588; GO:0071320; GO:0071456; GO:0097229; GO:0098703; GO:0098794; GO:0098815; GO:1902532; GO:1903779; GO:1905060; GO:1990034 calcium ion export across plasma membrane [GO:1990034]; calcium ion import across plasma membrane [GO:0098703]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport into cytosol [GO:0060402]; cell communication [GO:0007154]; cellular response to cAMP [GO:0071320]; cellular response to hypoxia [GO:0071456]; hematopoietic progenitor cell differentiation [GO:0002244]; intracellular calcium ion homeostasis [GO:0006874]; learning [GO:0007612]; learning or memory [GO:0007611]; long-term synaptic potentiation [GO:0060291]; memory [GO:0007613]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrial calcium ion transmembrane transport [GO:0006851]; modulation of excitatory postsynaptic potential [GO:0098815]; monoatomic ion transport [GO:0006811]; myelination [GO:0042552]; negative regulation of intracellular signal transduction [GO:1902532]; oligodendrocyte differentiation [GO:0048709]; regulation of cardiac conduction [GO:1903779]; regulation of skeletal muscle contraction [GO:0014819]; sodium ion transmembrane transport [GO:0035725]; synapse organization [GO:0050808]; telencephalon development [GO:0021537] acrosomal vesicle [GO:0001669]; anchoring junction [GO:0070161]; axon [GO:0030424]; axon terminus [GO:0043679]; centrosome [GO:0005813]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; endoplasmic reticulum membrane [GO:0005789]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; mitochondrial outer membrane [GO:0005741]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; sarcoplasm [GO:0016528]; sperm end piece [GO:0097229]; synapse [GO:0045202] calcium:monoatomic cation antiporter activity involved in regulation of postsynaptic cytosolic calcium ion concentration [GO:1905060]; calcium:sodium antiporter activity [GO:0005432]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872] g4689.t2 P57103 53.355 626 0.0 632.0 sp|P57103|NAC3_HUMAN Sodium/calcium exchanger 3 OS=Homo sapiens OX=9606 GN=SLC8A3 PE=1 SV=2 NAC3_HUMAN reviewed Sodium/calcium exchanger 3 (Na(+)/Ca(2+)-exchange protein 3) (Solute carrier family 8 member 3) Homo sapiens (Human) GO:0001669; GO:0002244; GO:0005432; GO:0005516; GO:0005654; GO:0005741; GO:0005789; GO:0005813; GO:0005829; GO:0005874; GO:0005886; GO:0006811; GO:0006851; GO:0006874; GO:0007154; GO:0007611; GO:0007612; GO:0007613; GO:0014069; GO:0014819; GO:0015630; GO:0016528; GO:0021537; GO:0030424; GO:0030425; GO:0031594; GO:0035725; GO:0042383; GO:0042552; GO:0043025; GO:0043197; GO:0043204; GO:0043679; GO:0045202; GO:0045211; GO:0046872; GO:0048471; GO:0048709; GO:0050808; GO:0051560; GO:0060291; GO:0060402; GO:0070161; GO:0070588; GO:0071320; GO:0071456; GO:0097229; GO:0098703; GO:0098794; GO:0098815; GO:1902532; GO:1903779; GO:1905060; GO:1990034 calcium ion export across plasma membrane [GO:1990034]; calcium ion import across plasma membrane [GO:0098703]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport into cytosol [GO:0060402]; cell communication [GO:0007154]; cellular response to cAMP [GO:0071320]; cellular response to hypoxia [GO:0071456]; hematopoietic progenitor cell differentiation [GO:0002244]; intracellular calcium ion homeostasis [GO:0006874]; learning [GO:0007612]; learning or memory [GO:0007611]; long-term synaptic potentiation [GO:0060291]; memory [GO:0007613]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrial calcium ion transmembrane transport [GO:0006851]; modulation of excitatory postsynaptic potential [GO:0098815]; monoatomic ion transport [GO:0006811]; myelination [GO:0042552]; negative regulation of intracellular signal transduction [GO:1902532]; oligodendrocyte differentiation [GO:0048709]; regulation of cardiac conduction [GO:1903779]; regulation of skeletal muscle contraction [GO:0014819]; sodium ion transmembrane transport [GO:0035725]; synapse organization [GO:0050808]; telencephalon development [GO:0021537] acrosomal vesicle [GO:0001669]; anchoring junction [GO:0070161]; axon [GO:0030424]; axon terminus [GO:0043679]; centrosome [GO:0005813]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; endoplasmic reticulum membrane [GO:0005789]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; mitochondrial outer membrane [GO:0005741]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; sarcoplasm [GO:0016528]; sperm end piece [GO:0097229]; synapse [GO:0045202] calcium:monoatomic cation antiporter activity involved in regulation of postsynaptic cytosolic calcium ion concentration [GO:1905060]; calcium:sodium antiporter activity [GO:0005432]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872] g4691.t1 P49288 30.392 306 6.24e-24 103.0 sp|P49288|MTR1C_CHICK Melatonin receptor type 1C OS=Gallus gallus OX=9031 PE=2 SV=1 g4692.t1 Q24214 85.882 170 1.1599999999999999e-104 300.0 sp|Q24214|CANB2_DROME Calcineurin subunit B type 2 OS=Drosophila melanogaster OX=7227 GN=CanB2 PE=1 SV=2 CANB2_DROME reviewed Calcineurin subunit B type 2 (Protein phosphatase 2B regulatory subunit 2) (dCNB2) Drosophila melanogaster (Fruit fly) GO:0005509; GO:0005516; GO:0005955; GO:0007269; GO:0008021; GO:0008597; GO:0016192; GO:0019902; GO:0030431; GO:0045214; GO:0051321; GO:0097720 calcineurin-mediated signaling [GO:0097720]; meiotic cell cycle [GO:0051321]; neurotransmitter secretion [GO:0007269]; sarcomere organization [GO:0045214]; sleep [GO:0030431]; vesicle-mediated transport [GO:0016192] calcineurin complex [GO:0005955]; synaptic vesicle [GO:0008021] calcium ion binding [GO:0005509]; calcium-dependent protein serine/threonine phosphatase regulator activity [GO:0008597]; calmodulin binding [GO:0005516]; phosphatase binding [GO:0019902] g4693.t1 Q7SX99 72.436 468 0.0 683.0 sp|Q7SX99|FUMH_DANRE Fumarate hydratase, mitochondrial OS=Danio rerio OX=7955 GN=fh PE=2 SV=1 FUMH_DANRE reviewed Fumarate hydratase, mitochondrial (Fumarase) (EC 4.2.1.2) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000050; GO:0000821; GO:0004333; GO:0005634; GO:0005694; GO:0005739; GO:0005829; GO:0006099; GO:0006106; GO:0006108; GO:0006281; GO:0006974; GO:2001034 DNA damage response [GO:0006974]; DNA repair [GO:0006281]; fumarate metabolic process [GO:0006106]; malate metabolic process [GO:0006108]; positive regulation of double-strand break repair via nonhomologous end joining [GO:2001034]; regulation of arginine metabolic process [GO:0000821]; tricarboxylic acid cycle [GO:0006099]; urea cycle [GO:0000050] chromosome [GO:0005694]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634] fumarate hydratase activity [GO:0004333] g4694.t1 Q96DM1 26.617 541 3.17e-39 157.0 sp|Q96DM1|PGBD4_HUMAN PiggyBac transposable element-derived protein 4 OS=Homo sapiens OX=9606 GN=PGBD4 PE=1 SV=3 g4695.t1 P08842 47.81 548 8.62e-175 511.0 sp|P08842|STS_HUMAN Steryl-sulfatase OS=Homo sapiens OX=9606 GN=STS PE=1 SV=2 STS_HUMAN reviewed Steryl-sulfatase (EC 3.1.6.2) (Arylsulfatase C) (ASC) (Estrone sulfatase) (Steroid sulfatase) (Steryl-sulfate sulfohydrolase) Homo sapiens (Human) GO:0004065; GO:0004773; GO:0005764; GO:0005768; GO:0005783; GO:0005788; GO:0005789; GO:0005794; GO:0005886; GO:0006706; GO:0007565; GO:0008484; GO:0008544; GO:0016020; GO:0043231; GO:0046872 epidermis development [GO:0008544]; female pregnancy [GO:0007565]; steroid catabolic process [GO:0006706] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]; membrane [GO:0016020]; plasma membrane [GO:0005886] arylsulfatase activity [GO:0004065]; metal ion binding [GO:0046872]; steryl-sulfatase activity [GO:0004773]; sulfuric ester hydrolase activity [GO:0008484] g4697.t1 P08842 48.326 478 1.5699999999999998e-137 412.0 sp|P08842|STS_HUMAN Steryl-sulfatase OS=Homo sapiens OX=9606 GN=STS PE=1 SV=2 STS_HUMAN reviewed Steryl-sulfatase (EC 3.1.6.2) (Arylsulfatase C) (ASC) (Estrone sulfatase) (Steroid sulfatase) (Steryl-sulfate sulfohydrolase) Homo sapiens (Human) GO:0004065; GO:0004773; GO:0005764; GO:0005768; GO:0005783; GO:0005788; GO:0005789; GO:0005794; GO:0005886; GO:0006706; GO:0007565; GO:0008484; GO:0008544; GO:0016020; GO:0043231; GO:0046872 epidermis development [GO:0008544]; female pregnancy [GO:0007565]; steroid catabolic process [GO:0006706] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]; membrane [GO:0016020]; plasma membrane [GO:0005886] arylsulfatase activity [GO:0004065]; metal ion binding [GO:0046872]; steryl-sulfatase activity [GO:0004773]; sulfuric ester hydrolase activity [GO:0008484] g4703.t1 Q9C0G6 39.473 2275 0.0 1591.0 sp|Q9C0G6|DYH6_HUMAN Dynein axonemal heavy chain 6 OS=Homo sapiens OX=9606 GN=DNAH6 PE=1 SV=3 g4703.t1 Q9C0G6 56.624 468 4.9e-152 538.0 sp|Q9C0G6|DYH6_HUMAN Dynein axonemal heavy chain 6 OS=Homo sapiens OX=9606 GN=DNAH6 PE=1 SV=3 g4703.t1 Q9C0G6 32.419 401 3.03e-54 216.0 sp|Q9C0G6|DYH6_HUMAN Dynein axonemal heavy chain 6 OS=Homo sapiens OX=9606 GN=DNAH6 PE=1 SV=3 g4704.t1 Q9C0G6 32.0 850 6.630000000000001e-132 442.0 sp|Q9C0G6|DYH6_HUMAN Dynein axonemal heavy chain 6 OS=Homo sapiens OX=9606 GN=DNAH6 PE=1 SV=3 g4707.t1 Q5SPW0 45.408 969 0.0 818.0 sp|Q5SPW0|VPS54_MOUSE Vacuolar protein sorting-associated protein 54 OS=Mus musculus OX=10090 GN=Vps54 PE=1 SV=1 VPS54_MOUSE reviewed Vacuolar protein sorting-associated protein 54 (Tumor antigen SLP-8p homolog) Mus musculus (Mouse) GO:0000938; GO:0001701; GO:0005654; GO:0005737; GO:0005739; GO:0005794; GO:0005802; GO:0005829; GO:0006309; GO:0006622; GO:0006623; GO:0006874; GO:0006896; GO:0006941; GO:0007005; GO:0007033; GO:0007041; GO:0007274; GO:0007519; GO:0008104; GO:0010467; GO:0010992; GO:0014004; GO:0016020; GO:0019905; GO:0022904; GO:0030149; GO:0034394; GO:0035108; GO:0035128; GO:0035249; GO:0040008; GO:0042147; GO:0045047; GO:0045202; GO:0046677; GO:0048471; GO:0048515; GO:0048630; GO:0048708; GO:0048812; GO:0048872; GO:0048873; GO:0050881; GO:0051402; GO:0051592; GO:0051932; GO:0051938; GO:0060052; GO:0060173; GO:0061744; GO:0070493; GO:0071393; GO:0090119; GO:0097049; GO:0097719; GO:0150076; GO:2000672 apoptotic DNA fragmentation [GO:0006309]; astrocyte differentiation [GO:0048708]; cellular response to progesterone stimulus [GO:0071393]; gene expression [GO:0010467]; Golgi to vacuole transport [GO:0006896]; homeostasis of number of cells [GO:0048872]; homeostasis of number of cells within a tissue [GO:0048873]; in utero embryonic development [GO:0001701]; intracellular calcium ion homeostasis [GO:0006874]; intracellular protein localization [GO:0008104]; L-glutamate import [GO:0051938]; limb development [GO:0060173]; limb morphogenesis [GO:0035108]; lysosomal transport [GO:0007041]; microglia differentiation [GO:0014004]; mitochondrion organization [GO:0007005]; motor behavior [GO:0061744]; motor neuron apoptotic process [GO:0097049]; musculoskeletal movement [GO:0050881]; negative regulation of motor neuron apoptotic process [GO:2000672]; neural tissue regeneration [GO:0097719]; neurofilament cytoskeleton organization [GO:0060052]; neuroinflammatory response [GO:0150076]; neuromuscular synaptic transmission [GO:0007274]; neuron apoptotic process [GO:0051402]; neuron projection morphogenesis [GO:0048812]; post-embryonic forelimb morphogenesis [GO:0035128]; protein localization to cell surface [GO:0034394]; protein targeting to ER [GO:0045047]; protein targeting to lysosome [GO:0006622]; protein targeting to vacuole [GO:0006623]; regulation of growth [GO:0040008]; respiratory electron transport chain [GO:0022904]; response to antibiotic [GO:0046677]; response to calcium ion [GO:0051592]; retrograde transport, endosome to Golgi [GO:0042147]; skeletal muscle tissue development [GO:0007519]; skeletal muscle tissue growth [GO:0048630]; spermatid differentiation [GO:0048515]; sphingolipid catabolic process [GO:0030149]; striated muscle contraction [GO:0006941]; synaptic transmission, GABAergic [GO:0051932]; synaptic transmission, glutamatergic [GO:0035249]; thrombin-activated receptor signaling pathway [GO:0070493]; ubiquitin recycling [GO:0010992]; vacuole organization [GO:0007033]; vesicle-mediated cholesterol transport [GO:0090119] cytoplasm [GO:0005737]; cytosol [GO:0005829]; GARP complex [GO:0000938]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; synapse [GO:0045202]; trans-Golgi network [GO:0005802] syntaxin binding [GO:0019905] g4708.t1 Q8IWV8 37.969 719 2.63e-148 476.0 sp|Q8IWV8|UBR2_HUMAN E3 ubiquitin-protein ligase UBR2 OS=Homo sapiens OX=9606 GN=UBR2 PE=1 SV=1 UBR2_HUMAN reviewed E3 ubiquitin-protein ligase UBR2 (EC 2.3.2.27) (N-recognin-2) (Ubiquitin-protein ligase E3-alpha-2) (Ubiquitin-protein ligase E3-alpha-II) Homo sapiens (Human) GO:0000151; GO:0000785; GO:0005634; GO:0005737; GO:0005829; GO:0007131; GO:0007140; GO:0007141; GO:0007283; GO:0008270; GO:0010526; GO:0016567; GO:0031507; GO:0032007; GO:0043161; GO:0050862; GO:0061630; GO:0070534; GO:0070728; GO:0071233; GO:0071596; GO:0141053 cellular response to L-leucine [GO:0071233]; heterochromatin formation [GO:0031507]; male meiosis I [GO:0007141]; male meiotic nuclear division [GO:0007140]; negative regulation of TOR signaling [GO:0032007]; positive regulation of T cell receptor signaling pathway [GO:0050862]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K63-linked ubiquitination [GO:0070534]; protein ubiquitination [GO:0016567]; reciprocal meiotic recombination [GO:0007131]; spermatogenesis [GO:0007283]; transposable element silencing [GO:0010526]; ubiquitin-dependent protein catabolic process via the N-end rule pathway [GO:0071596] chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151] histone H2A ubiquitin ligase activity [GO:0141053]; L-leucine binding [GO:0070728]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] g4709.t1 Q8IWV8 44.792 1056 0.0 847.0 sp|Q8IWV8|UBR2_HUMAN E3 ubiquitin-protein ligase UBR2 OS=Homo sapiens OX=9606 GN=UBR2 PE=1 SV=1 UBR2_HUMAN reviewed E3 ubiquitin-protein ligase UBR2 (EC 2.3.2.27) (N-recognin-2) (Ubiquitin-protein ligase E3-alpha-2) (Ubiquitin-protein ligase E3-alpha-II) Homo sapiens (Human) GO:0000151; GO:0000785; GO:0005634; GO:0005737; GO:0005829; GO:0007131; GO:0007140; GO:0007141; GO:0007283; GO:0008270; GO:0010526; GO:0016567; GO:0031507; GO:0032007; GO:0043161; GO:0050862; GO:0061630; GO:0070534; GO:0070728; GO:0071233; GO:0071596; GO:0141053 cellular response to L-leucine [GO:0071233]; heterochromatin formation [GO:0031507]; male meiosis I [GO:0007141]; male meiotic nuclear division [GO:0007140]; negative regulation of TOR signaling [GO:0032007]; positive regulation of T cell receptor signaling pathway [GO:0050862]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K63-linked ubiquitination [GO:0070534]; protein ubiquitination [GO:0016567]; reciprocal meiotic recombination [GO:0007131]; spermatogenesis [GO:0007283]; transposable element silencing [GO:0010526]; ubiquitin-dependent protein catabolic process via the N-end rule pathway [GO:0071596] chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151] histone H2A ubiquitin ligase activity [GO:0141053]; L-leucine binding [GO:0070728]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] g4714.t1 Q96MB7 38.129 278 3.0999999999999995e-54 184.0 sp|Q96MB7|HARB1_HUMAN Putative nuclease HARBI1 OS=Homo sapiens OX=9606 GN=HARBI1 PE=1 SV=1 HARB1_HUMAN reviewed Putative nuclease HARBI1 (EC 3.1.-.-) (Harbinger transposase-derived nuclease) Homo sapiens (Human) GO:0004518; GO:0005634; GO:0005829; GO:0005886; GO:0016787; GO:0034451; GO:0046872 centriolar satellite [GO:0034451]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886] hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]; nuclease activity [GO:0004518] g4720.t1 Q9NVF7 48.636 220 6.8e-60 199.0 sp|Q9NVF7|FBX28_HUMAN F-box only protein 28 OS=Homo sapiens OX=9606 GN=FBXO28 PE=1 SV=1 FBX28_HUMAN reviewed F-box only protein 28 Homo sapiens (Human) GO:0000209; GO:0000776; GO:0042802 protein polyubiquitination [GO:0000209] kinetochore [GO:0000776] identical protein binding [GO:0042802] g4722.t1 Q5RFQ0 73.134 201 7.240000000000001e-103 298.0 sp|Q5RFQ0|FCF1_PONAB rRNA-processing protein FCF1 homolog OS=Pongo abelii OX=9601 GN=FCF1 PE=2 SV=1 g4723.t1 O15033 46.232 690 0.0 598.0 sp|O15033|AREL1_HUMAN Apoptosis-resistant E3 ubiquitin protein ligase 1 OS=Homo sapiens OX=9606 GN=AREL1 PE=1 SV=3 AREL1_HUMAN reviewed Apoptosis-resistant E3 ubiquitin protein ligase 1 (EC 2.3.2.26) (Apoptosis-resistant HECT-type E3 ubiquitin transferase 1) Homo sapiens (Human) GO:0004842; GO:0005737; GO:0005829; GO:0006511; GO:0006915; GO:0016567; GO:0043066; GO:0050727; GO:0061630; GO:0070979; GO:1990390 apoptotic process [GO:0006915]; negative regulation of apoptotic process [GO:0043066]; protein K11-linked ubiquitination [GO:0070979]; protein K33-linked ubiquitination [GO:1990390]; protein ubiquitination [GO:0016567]; regulation of inflammatory response [GO:0050727]; ubiquitin-dependent protein catabolic process [GO:0006511] cytoplasm [GO:0005737]; cytosol [GO:0005829] ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842] g4724.t1 Q8CHG5 76.316 76 1.14e-36 132.0 sp|Q8CHG5|AREL1_MOUSE Apoptosis-resistant E3 ubiquitin protein ligase 1 OS=Mus musculus OX=10090 GN=Arel1 PE=1 SV=2 AREL1_MOUSE reviewed Apoptosis-resistant E3 ubiquitin protein ligase 1 (EC 2.3.2.26) (Apoptosis-resistant HECT-type E3 ubiquitin transferase 1) Mus musculus (Mouse) GO:0004842; GO:0005737; GO:0005829; GO:0006511; GO:0006915; GO:0016567; GO:0043066; GO:0050727; GO:0061630; GO:0070979; GO:1990390 apoptotic process [GO:0006915]; negative regulation of apoptotic process [GO:0043066]; protein K11-linked ubiquitination [GO:0070979]; protein K33-linked ubiquitination [GO:1990390]; protein ubiquitination [GO:0016567]; regulation of inflammatory response [GO:0050727]; ubiquitin-dependent protein catabolic process [GO:0006511] cytoplasm [GO:0005737]; cytosol [GO:0005829] ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842] g4725.t1 Q7PYT9 45.455 363 1.4699999999999998e-104 325.0 sp|Q7PYT9|MALT_ANOGA Salivary alpha-glucosidase OS=Anopheles gambiae OX=7165 GN=MAL1 PE=1 SV=3 g4725.t2 Q7PYT9 47.242 417 2.73e-133 401.0 sp|Q7PYT9|MALT_ANOGA Salivary alpha-glucosidase OS=Anopheles gambiae OX=7165 GN=MAL1 PE=1 SV=3 g4726.t1 Q91WV7 36.136 678 2.13e-120 377.0 sp|Q91WV7|SLC31_MOUSE Amino acid transporter heavy chain SLC3A1 OS=Mus musculus OX=10090 GN=Slc3a1 PE=1 SV=1 SLC31_MOUSE reviewed Amino acid transporter heavy chain SLC3A1 (D2) (Neutral and basic amino acid transport protein) (NBAT) (Solute carrier family 3 member 1) (b(0,+)-type amino acid transporter-related heavy chain) (rBAT) Mus musculus (Mouse) GO:0005743; GO:0005774; GO:0005975; GO:0006865; GO:0010467; GO:0015810; GO:0015811; GO:0015813; GO:0016324; GO:0031526; GO:0044877; GO:0046872; GO:0046982 amino acid transport [GO:0006865]; aspartate transmembrane transport [GO:0015810]; carbohydrate metabolic process [GO:0005975]; gene expression [GO:0010467]; L-cystine transport [GO:0015811]; L-glutamate transmembrane transport [GO:0015813] apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; mitochondrial inner membrane [GO:0005743]; vacuolar membrane [GO:0005774] metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]; protein-containing complex binding [GO:0044877] g4730.t1 Q96T55 33.468 248 5.07e-34 134.0 sp|Q96T55|KCNKG_HUMAN Potassium channel subfamily K member 16 OS=Homo sapiens OX=9606 GN=KCNK16 PE=1 SV=1 KCNKG_HUMAN reviewed Potassium channel subfamily K member 16 (2P domain potassium channel Talk-1) (TWIK-related alkaline pH-activated K(+) channel 1) (TALK-1) Homo sapiens (Human) GO:0005267; GO:0005743; GO:0005789; GO:0005886; GO:0006813; GO:0015271; GO:0022841; GO:0032469; GO:0034702; GO:0042802; GO:0046872; GO:0046982; GO:0051279; GO:0061178; GO:0071805; GO:0086011; GO:0098900 endoplasmic reticulum calcium ion homeostasis [GO:0032469]; membrane repolarization during action potential [GO:0086011]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; regulation of action potential [GO:0098900]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]; regulation of release of sequestered calcium ion into cytosol [GO:0051279] endoplasmic reticulum membrane [GO:0005789]; mitochondrial inner membrane [GO:0005743]; monoatomic ion channel complex [GO:0034702]; plasma membrane [GO:0005886] identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; outward rectifier potassium channel activity [GO:0015271]; potassium channel activity [GO:0005267]; potassium ion leak channel activity [GO:0022841]; protein heterodimerization activity [GO:0046982] g4731.t1 Q5R6P6 52.899 138 1.03e-37 128.0 sp|Q5R6P6|GMFB_PONAB Glia maturation factor beta OS=Pongo abelii OX=9601 GN=GMFB PE=2 SV=3 g4733.t1 Q561P5 74.154 739 0.0 1168.0 sp|Q561P5|MCM5_XENTR DNA replication licensing factor mcm5 OS=Xenopus tropicalis OX=8364 GN=mcm5 PE=2 SV=1 MCM5_XENTR reviewed DNA replication licensing factor mcm5 (EC 3.6.4.12) Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0000727; GO:0000785; GO:0003678; GO:0003688; GO:0003697; GO:0005524; GO:0005634; GO:0006270; GO:0016887; GO:0030174; GO:0042555; GO:0044786; GO:0071162 cell cycle DNA replication [GO:0044786]; DNA replication initiation [GO:0006270]; double-strand break repair via break-induced replication [GO:0000727]; regulation of DNA-templated DNA replication initiation [GO:0030174] chromatin [GO:0000785]; CMG complex [GO:0071162]; MCM complex [GO:0042555]; nucleus [GO:0005634] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA helicase activity [GO:0003678]; DNA replication origin binding [GO:0003688]; single-stranded DNA binding [GO:0003697] g4736.t1 Q9BX10 62.329 438 0.0 546.0 sp|Q9BX10|GTPB2_HUMAN GTP-binding protein 2 OS=Homo sapiens OX=9606 GN=GTPBP2 PE=1 SV=1 GTPB2_HUMAN reviewed GTP-binding protein 2 Homo sapiens (Human) GO:0003924; GO:0005525; GO:0005576; GO:0006414; GO:0031093; GO:0042802; GO:0070966; GO:0072344; GO:1904678 nuclear-transcribed mRNA catabolic process, no-go decay [GO:0070966]; rescue of stalled ribosome [GO:0072344]; translational elongation [GO:0006414] extracellular region [GO:0005576]; platelet alpha granule lumen [GO:0031093] alpha-aminoacyl-tRNA binding [GO:1904678]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802] g4737.t1 Q5ZHS3 55.797 138 2.1300000000000002e-47 153.0 sp|Q5ZHS3|C1D_CHICK Nuclear nucleic acid-binding protein C1D OS=Gallus gallus OX=9031 GN=C1D PE=2 SV=1 g4739.t1 Q6AYJ1 47.069 597 0.0 575.0 sp|Q6AYJ1|RECQ1_RAT ATP-dependent DNA helicase Q1 OS=Rattus norvegicus OX=10116 GN=Recql PE=1 SV=1 RECQ1_RAT reviewed ATP-dependent DNA helicase Q1 (EC 5.6.2.4) (DNA 3'-5' helicase Q1) (DNA-dependent ATPase Q1) (RecQ protein-like 1) Rattus norvegicus (Rat) GO:0000724; GO:0003678; GO:0005524; GO:0005634; GO:0005654; GO:0005694; GO:0005737; GO:0006260; GO:0009378; GO:0016887; GO:0031297; GO:0036121; GO:0043138; GO:0046872; GO:1990814 DNA replication [GO:0006260]; double-strand break repair via homologous recombination [GO:0000724]; replication fork processing [GO:0031297] chromosome [GO:0005694]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] 3'-5' DNA helicase activity [GO:0043138]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA helicase activity [GO:0003678]; DNA/DNA annealing activity [GO:1990814]; double-stranded DNA helicase activity [GO:0036121]; four-way junction helicase activity [GO:0009378]; metal ion binding [GO:0046872] g4741.t1 O42282 34.951 309 8.62e-54 192.0 sp|O42282|RDS2_CHICK Photoreceptor outer segment membrane glycoprotein 2 OS=Gallus gallus OX=9031 PE=2 SV=1 g4744.t1 O75445 33.016 1469 0.0 704.0 sp|O75445|USH2A_HUMAN Usherin OS=Homo sapiens OX=9606 GN=USH2A PE=1 SV=3 USH2A_HUMAN reviewed Usherin (Usher syndrome type IIa protein) (Usher syndrome type-2A protein) Homo sapiens (Human) GO:0001917; GO:0002141; GO:0002142; GO:0005518; GO:0005576; GO:0005604; GO:0005737; GO:0007601; GO:0007605; GO:0016324; GO:0017022; GO:0032391; GO:0032421; GO:0035315; GO:0036064; GO:0042491; GO:0042802; GO:0045184; GO:0045494; GO:0048496; GO:0050953; GO:0051649; GO:0060113; GO:0060171; GO:1990075; GO:1990696 establishment of localization in cell [GO:0051649]; establishment of protein localization [GO:0045184]; hair cell differentiation [GO:0035315]; inner ear auditory receptor cell differentiation [GO:0042491]; inner ear receptor cell differentiation [GO:0060113]; maintenance of animal organ identity [GO:0048496]; photoreceptor cell maintenance [GO:0045494]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601] apical plasma membrane [GO:0016324]; basement membrane [GO:0005604]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; periciliary membrane compartment [GO:1990075]; photoreceptor connecting cilium [GO:0032391]; photoreceptor inner segment [GO:0001917]; stereocilia ankle link [GO:0002141]; stereocilia ankle link complex [GO:0002142]; stereocilium bundle [GO:0032421]; stereocilium membrane [GO:0060171]; USH2 complex [GO:1990696] collagen binding [GO:0005518]; identical protein binding [GO:0042802]; myosin binding [GO:0017022] g4744.t1 O75445 42.563 874 0.0 694.0 sp|O75445|USH2A_HUMAN Usherin OS=Homo sapiens OX=9606 GN=USH2A PE=1 SV=3 USH2A_HUMAN reviewed Usherin (Usher syndrome type IIa protein) (Usher syndrome type-2A protein) Homo sapiens (Human) GO:0001917; GO:0002141; GO:0002142; GO:0005518; GO:0005576; GO:0005604; GO:0005737; GO:0007601; GO:0007605; GO:0016324; GO:0017022; GO:0032391; GO:0032421; GO:0035315; GO:0036064; GO:0042491; GO:0042802; GO:0045184; GO:0045494; GO:0048496; GO:0050953; GO:0051649; GO:0060113; GO:0060171; GO:1990075; GO:1990696 establishment of localization in cell [GO:0051649]; establishment of protein localization [GO:0045184]; hair cell differentiation [GO:0035315]; inner ear auditory receptor cell differentiation [GO:0042491]; inner ear receptor cell differentiation [GO:0060113]; maintenance of animal organ identity [GO:0048496]; photoreceptor cell maintenance [GO:0045494]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601] apical plasma membrane [GO:0016324]; basement membrane [GO:0005604]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; periciliary membrane compartment [GO:1990075]; photoreceptor connecting cilium [GO:0032391]; photoreceptor inner segment [GO:0001917]; stereocilia ankle link [GO:0002141]; stereocilia ankle link complex [GO:0002142]; stereocilium bundle [GO:0032421]; stereocilium membrane [GO:0060171]; USH2 complex [GO:1990696] collagen binding [GO:0005518]; identical protein binding [GO:0042802]; myosin binding [GO:0017022] g4745.t1 O75445 52.5 160 2.94e-49 173.0 sp|O75445|USH2A_HUMAN Usherin OS=Homo sapiens OX=9606 GN=USH2A PE=1 SV=3 USH2A_HUMAN reviewed Usherin (Usher syndrome type IIa protein) (Usher syndrome type-2A protein) Homo sapiens (Human) GO:0001917; GO:0002141; GO:0002142; GO:0005518; GO:0005576; GO:0005604; GO:0005737; GO:0007601; GO:0007605; GO:0016324; GO:0017022; GO:0032391; GO:0032421; GO:0035315; GO:0036064; GO:0042491; GO:0042802; GO:0045184; GO:0045494; GO:0048496; GO:0050953; GO:0051649; GO:0060113; GO:0060171; GO:1990075; GO:1990696 establishment of localization in cell [GO:0051649]; establishment of protein localization [GO:0045184]; hair cell differentiation [GO:0035315]; inner ear auditory receptor cell differentiation [GO:0042491]; inner ear receptor cell differentiation [GO:0060113]; maintenance of animal organ identity [GO:0048496]; photoreceptor cell maintenance [GO:0045494]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601] apical plasma membrane [GO:0016324]; basement membrane [GO:0005604]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; periciliary membrane compartment [GO:1990075]; photoreceptor connecting cilium [GO:0032391]; photoreceptor inner segment [GO:0001917]; stereocilia ankle link [GO:0002141]; stereocilia ankle link complex [GO:0002142]; stereocilium bundle [GO:0032421]; stereocilium membrane [GO:0060171]; USH2 complex [GO:1990696] collagen binding [GO:0005518]; identical protein binding [GO:0042802]; myosin binding [GO:0017022] g4745.t1 O75445 37.162 148 8.03e-22 94.7 sp|O75445|USH2A_HUMAN Usherin OS=Homo sapiens OX=9606 GN=USH2A PE=1 SV=3 USH2A_HUMAN reviewed Usherin (Usher syndrome type IIa protein) (Usher syndrome type-2A protein) Homo sapiens (Human) GO:0001917; GO:0002141; GO:0002142; GO:0005518; GO:0005576; GO:0005604; GO:0005737; GO:0007601; GO:0007605; GO:0016324; GO:0017022; GO:0032391; GO:0032421; GO:0035315; GO:0036064; GO:0042491; GO:0042802; GO:0045184; GO:0045494; GO:0048496; GO:0050953; GO:0051649; GO:0060113; GO:0060171; GO:1990075; GO:1990696 establishment of localization in cell [GO:0051649]; establishment of protein localization [GO:0045184]; hair cell differentiation [GO:0035315]; inner ear auditory receptor cell differentiation [GO:0042491]; inner ear receptor cell differentiation [GO:0060113]; maintenance of animal organ identity [GO:0048496]; photoreceptor cell maintenance [GO:0045494]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601] apical plasma membrane [GO:0016324]; basement membrane [GO:0005604]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; periciliary membrane compartment [GO:1990075]; photoreceptor connecting cilium [GO:0032391]; photoreceptor inner segment [GO:0001917]; stereocilia ankle link [GO:0002141]; stereocilia ankle link complex [GO:0002142]; stereocilium bundle [GO:0032421]; stereocilium membrane [GO:0060171]; USH2 complex [GO:1990696] collagen binding [GO:0005518]; identical protein binding [GO:0042802]; myosin binding [GO:0017022] g4746.t1 O75445 39.906 1907 0.0 1345.0 sp|O75445|USH2A_HUMAN Usherin OS=Homo sapiens OX=9606 GN=USH2A PE=1 SV=3 USH2A_HUMAN reviewed Usherin (Usher syndrome type IIa protein) (Usher syndrome type-2A protein) Homo sapiens (Human) GO:0001917; GO:0002141; GO:0002142; GO:0005518; GO:0005576; GO:0005604; GO:0005737; GO:0007601; GO:0007605; GO:0016324; GO:0017022; GO:0032391; GO:0032421; GO:0035315; GO:0036064; GO:0042491; GO:0042802; GO:0045184; GO:0045494; GO:0048496; GO:0050953; GO:0051649; GO:0060113; GO:0060171; GO:1990075; GO:1990696 establishment of localization in cell [GO:0051649]; establishment of protein localization [GO:0045184]; hair cell differentiation [GO:0035315]; inner ear auditory receptor cell differentiation [GO:0042491]; inner ear receptor cell differentiation [GO:0060113]; maintenance of animal organ identity [GO:0048496]; photoreceptor cell maintenance [GO:0045494]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601] apical plasma membrane [GO:0016324]; basement membrane [GO:0005604]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; periciliary membrane compartment [GO:1990075]; photoreceptor connecting cilium [GO:0032391]; photoreceptor inner segment [GO:0001917]; stereocilia ankle link [GO:0002141]; stereocilia ankle link complex [GO:0002142]; stereocilium bundle [GO:0032421]; stereocilium membrane [GO:0060171]; USH2 complex [GO:1990696] collagen binding [GO:0005518]; identical protein binding [GO:0042802]; myosin binding [GO:0017022] g4746.t1 O75445 30.287 766 2.11e-75 284.0 sp|O75445|USH2A_HUMAN Usherin OS=Homo sapiens OX=9606 GN=USH2A PE=1 SV=3 USH2A_HUMAN reviewed Usherin (Usher syndrome type IIa protein) (Usher syndrome type-2A protein) Homo sapiens (Human) GO:0001917; GO:0002141; GO:0002142; GO:0005518; GO:0005576; GO:0005604; GO:0005737; GO:0007601; GO:0007605; GO:0016324; GO:0017022; GO:0032391; GO:0032421; GO:0035315; GO:0036064; GO:0042491; GO:0042802; GO:0045184; GO:0045494; GO:0048496; GO:0050953; GO:0051649; GO:0060113; GO:0060171; GO:1990075; GO:1990696 establishment of localization in cell [GO:0051649]; establishment of protein localization [GO:0045184]; hair cell differentiation [GO:0035315]; inner ear auditory receptor cell differentiation [GO:0042491]; inner ear receptor cell differentiation [GO:0060113]; maintenance of animal organ identity [GO:0048496]; photoreceptor cell maintenance [GO:0045494]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601] apical plasma membrane [GO:0016324]; basement membrane [GO:0005604]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; periciliary membrane compartment [GO:1990075]; photoreceptor connecting cilium [GO:0032391]; photoreceptor inner segment [GO:0001917]; stereocilia ankle link [GO:0002141]; stereocilia ankle link complex [GO:0002142]; stereocilium bundle [GO:0032421]; stereocilium membrane [GO:0060171]; USH2 complex [GO:1990696] collagen binding [GO:0005518]; identical protein binding [GO:0042802]; myosin binding [GO:0017022] g4746.t1 O75445 28.132 878 1.41e-74 281.0 sp|O75445|USH2A_HUMAN Usherin OS=Homo sapiens OX=9606 GN=USH2A PE=1 SV=3 USH2A_HUMAN reviewed Usherin (Usher syndrome type IIa protein) (Usher syndrome type-2A protein) Homo sapiens (Human) GO:0001917; GO:0002141; GO:0002142; GO:0005518; GO:0005576; GO:0005604; GO:0005737; GO:0007601; GO:0007605; GO:0016324; GO:0017022; GO:0032391; GO:0032421; GO:0035315; GO:0036064; GO:0042491; GO:0042802; GO:0045184; GO:0045494; GO:0048496; GO:0050953; GO:0051649; GO:0060113; GO:0060171; GO:1990075; GO:1990696 establishment of localization in cell [GO:0051649]; establishment of protein localization [GO:0045184]; hair cell differentiation [GO:0035315]; inner ear auditory receptor cell differentiation [GO:0042491]; inner ear receptor cell differentiation [GO:0060113]; maintenance of animal organ identity [GO:0048496]; photoreceptor cell maintenance [GO:0045494]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601] apical plasma membrane [GO:0016324]; basement membrane [GO:0005604]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; periciliary membrane compartment [GO:1990075]; photoreceptor connecting cilium [GO:0032391]; photoreceptor inner segment [GO:0001917]; stereocilia ankle link [GO:0002141]; stereocilia ankle link complex [GO:0002142]; stereocilium bundle [GO:0032421]; stereocilium membrane [GO:0060171]; USH2 complex [GO:1990696] collagen binding [GO:0005518]; identical protein binding [GO:0042802]; myosin binding [GO:0017022] g4746.t1 O75445 28.156 895 5.5e-72 273.0 sp|O75445|USH2A_HUMAN Usherin OS=Homo sapiens OX=9606 GN=USH2A PE=1 SV=3 USH2A_HUMAN reviewed Usherin (Usher syndrome type IIa protein) (Usher syndrome type-2A protein) Homo sapiens (Human) GO:0001917; GO:0002141; GO:0002142; GO:0005518; GO:0005576; GO:0005604; GO:0005737; GO:0007601; GO:0007605; GO:0016324; GO:0017022; GO:0032391; GO:0032421; GO:0035315; GO:0036064; GO:0042491; GO:0042802; GO:0045184; GO:0045494; GO:0048496; GO:0050953; GO:0051649; GO:0060113; GO:0060171; GO:1990075; GO:1990696 establishment of localization in cell [GO:0051649]; establishment of protein localization [GO:0045184]; hair cell differentiation [GO:0035315]; inner ear auditory receptor cell differentiation [GO:0042491]; inner ear receptor cell differentiation [GO:0060113]; maintenance of animal organ identity [GO:0048496]; photoreceptor cell maintenance [GO:0045494]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601] apical plasma membrane [GO:0016324]; basement membrane [GO:0005604]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; periciliary membrane compartment [GO:1990075]; photoreceptor connecting cilium [GO:0032391]; photoreceptor inner segment [GO:0001917]; stereocilia ankle link [GO:0002141]; stereocilia ankle link complex [GO:0002142]; stereocilium bundle [GO:0032421]; stereocilium membrane [GO:0060171]; USH2 complex [GO:1990696] collagen binding [GO:0005518]; identical protein binding [GO:0042802]; myosin binding [GO:0017022] g4746.t1 O75445 28.447 805 9.9e-58 226.0 sp|O75445|USH2A_HUMAN Usherin OS=Homo sapiens OX=9606 GN=USH2A PE=1 SV=3 USH2A_HUMAN reviewed Usherin (Usher syndrome type IIa protein) (Usher syndrome type-2A protein) Homo sapiens (Human) GO:0001917; GO:0002141; GO:0002142; GO:0005518; GO:0005576; GO:0005604; GO:0005737; GO:0007601; GO:0007605; GO:0016324; GO:0017022; GO:0032391; GO:0032421; GO:0035315; GO:0036064; GO:0042491; GO:0042802; GO:0045184; GO:0045494; GO:0048496; GO:0050953; GO:0051649; GO:0060113; GO:0060171; GO:1990075; GO:1990696 establishment of localization in cell [GO:0051649]; establishment of protein localization [GO:0045184]; hair cell differentiation [GO:0035315]; inner ear auditory receptor cell differentiation [GO:0042491]; inner ear receptor cell differentiation [GO:0060113]; maintenance of animal organ identity [GO:0048496]; photoreceptor cell maintenance [GO:0045494]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601] apical plasma membrane [GO:0016324]; basement membrane [GO:0005604]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; periciliary membrane compartment [GO:1990075]; photoreceptor connecting cilium [GO:0032391]; photoreceptor inner segment [GO:0001917]; stereocilia ankle link [GO:0002141]; stereocilia ankle link complex [GO:0002142]; stereocilium bundle [GO:0032421]; stereocilium membrane [GO:0060171]; USH2 complex [GO:1990696] collagen binding [GO:0005518]; identical protein binding [GO:0042802]; myosin binding [GO:0017022] g4746.t1 O75445 28.755 699 1.18e-56 223.0 sp|O75445|USH2A_HUMAN Usherin OS=Homo sapiens OX=9606 GN=USH2A PE=1 SV=3 USH2A_HUMAN reviewed Usherin (Usher syndrome type IIa protein) (Usher syndrome type-2A protein) Homo sapiens (Human) GO:0001917; GO:0002141; GO:0002142; GO:0005518; GO:0005576; GO:0005604; GO:0005737; GO:0007601; GO:0007605; GO:0016324; GO:0017022; GO:0032391; GO:0032421; GO:0035315; GO:0036064; GO:0042491; GO:0042802; GO:0045184; GO:0045494; GO:0048496; GO:0050953; GO:0051649; GO:0060113; GO:0060171; GO:1990075; GO:1990696 establishment of localization in cell [GO:0051649]; establishment of protein localization [GO:0045184]; hair cell differentiation [GO:0035315]; inner ear auditory receptor cell differentiation [GO:0042491]; inner ear receptor cell differentiation [GO:0060113]; maintenance of animal organ identity [GO:0048496]; photoreceptor cell maintenance [GO:0045494]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601] apical plasma membrane [GO:0016324]; basement membrane [GO:0005604]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; periciliary membrane compartment [GO:1990075]; photoreceptor connecting cilium [GO:0032391]; photoreceptor inner segment [GO:0001917]; stereocilia ankle link [GO:0002141]; stereocilia ankle link complex [GO:0002142]; stereocilium bundle [GO:0032421]; stereocilium membrane [GO:0060171]; USH2 complex [GO:1990696] collagen binding [GO:0005518]; identical protein binding [GO:0042802]; myosin binding [GO:0017022] g4746.t1 O75445 28.215 762 2.52e-56 221.0 sp|O75445|USH2A_HUMAN Usherin OS=Homo sapiens OX=9606 GN=USH2A PE=1 SV=3 USH2A_HUMAN reviewed Usherin (Usher syndrome type IIa protein) (Usher syndrome type-2A protein) Homo sapiens (Human) GO:0001917; GO:0002141; GO:0002142; GO:0005518; GO:0005576; GO:0005604; GO:0005737; GO:0007601; GO:0007605; GO:0016324; GO:0017022; GO:0032391; GO:0032421; GO:0035315; GO:0036064; GO:0042491; GO:0042802; GO:0045184; GO:0045494; GO:0048496; GO:0050953; GO:0051649; GO:0060113; GO:0060171; GO:1990075; GO:1990696 establishment of localization in cell [GO:0051649]; establishment of protein localization [GO:0045184]; hair cell differentiation [GO:0035315]; inner ear auditory receptor cell differentiation [GO:0042491]; inner ear receptor cell differentiation [GO:0060113]; maintenance of animal organ identity [GO:0048496]; photoreceptor cell maintenance [GO:0045494]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601] apical plasma membrane [GO:0016324]; basement membrane [GO:0005604]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; periciliary membrane compartment [GO:1990075]; photoreceptor connecting cilium [GO:0032391]; photoreceptor inner segment [GO:0001917]; stereocilia ankle link [GO:0002141]; stereocilia ankle link complex [GO:0002142]; stereocilium bundle [GO:0032421]; stereocilium membrane [GO:0060171]; USH2 complex [GO:1990696] collagen binding [GO:0005518]; identical protein binding [GO:0042802]; myosin binding [GO:0017022] g4746.t1 O75445 27.307 791 3.67e-55 218.0 sp|O75445|USH2A_HUMAN Usherin OS=Homo sapiens OX=9606 GN=USH2A PE=1 SV=3 USH2A_HUMAN reviewed Usherin (Usher syndrome type IIa protein) (Usher syndrome type-2A protein) Homo sapiens (Human) GO:0001917; GO:0002141; GO:0002142; GO:0005518; GO:0005576; GO:0005604; GO:0005737; GO:0007601; GO:0007605; GO:0016324; GO:0017022; GO:0032391; GO:0032421; GO:0035315; GO:0036064; GO:0042491; GO:0042802; GO:0045184; GO:0045494; GO:0048496; GO:0050953; GO:0051649; GO:0060113; GO:0060171; GO:1990075; GO:1990696 establishment of localization in cell [GO:0051649]; establishment of protein localization [GO:0045184]; hair cell differentiation [GO:0035315]; inner ear auditory receptor cell differentiation [GO:0042491]; inner ear receptor cell differentiation [GO:0060113]; maintenance of animal organ identity [GO:0048496]; photoreceptor cell maintenance [GO:0045494]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601] apical plasma membrane [GO:0016324]; basement membrane [GO:0005604]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; periciliary membrane compartment [GO:1990075]; photoreceptor connecting cilium [GO:0032391]; photoreceptor inner segment [GO:0001917]; stereocilia ankle link [GO:0002141]; stereocilia ankle link complex [GO:0002142]; stereocilium bundle [GO:0032421]; stereocilium membrane [GO:0060171]; USH2 complex [GO:1990696] collagen binding [GO:0005518]; identical protein binding [GO:0042802]; myosin binding [GO:0017022] g4746.t1 O75445 30.49 469 2.74e-41 172.0 sp|O75445|USH2A_HUMAN Usherin OS=Homo sapiens OX=9606 GN=USH2A PE=1 SV=3 USH2A_HUMAN reviewed Usherin (Usher syndrome type IIa protein) (Usher syndrome type-2A protein) Homo sapiens (Human) GO:0001917; GO:0002141; GO:0002142; GO:0005518; GO:0005576; GO:0005604; GO:0005737; GO:0007601; GO:0007605; GO:0016324; GO:0017022; GO:0032391; GO:0032421; GO:0035315; GO:0036064; GO:0042491; GO:0042802; GO:0045184; GO:0045494; GO:0048496; GO:0050953; GO:0051649; GO:0060113; GO:0060171; GO:1990075; GO:1990696 establishment of localization in cell [GO:0051649]; establishment of protein localization [GO:0045184]; hair cell differentiation [GO:0035315]; inner ear auditory receptor cell differentiation [GO:0042491]; inner ear receptor cell differentiation [GO:0060113]; maintenance of animal organ identity [GO:0048496]; photoreceptor cell maintenance [GO:0045494]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601] apical plasma membrane [GO:0016324]; basement membrane [GO:0005604]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; periciliary membrane compartment [GO:1990075]; photoreceptor connecting cilium [GO:0032391]; photoreceptor inner segment [GO:0001917]; stereocilia ankle link [GO:0002141]; stereocilia ankle link complex [GO:0002142]; stereocilium bundle [GO:0032421]; stereocilium membrane [GO:0060171]; USH2 complex [GO:1990696] collagen binding [GO:0005518]; identical protein binding [GO:0042802]; myosin binding [GO:0017022] g4746.t1 O75445 24.536 701 1.24e-39 166.0 sp|O75445|USH2A_HUMAN Usherin OS=Homo sapiens OX=9606 GN=USH2A PE=1 SV=3 USH2A_HUMAN reviewed Usherin (Usher syndrome type IIa protein) (Usher syndrome type-2A protein) Homo sapiens (Human) GO:0001917; GO:0002141; GO:0002142; GO:0005518; GO:0005576; GO:0005604; GO:0005737; GO:0007601; GO:0007605; GO:0016324; GO:0017022; GO:0032391; GO:0032421; GO:0035315; GO:0036064; GO:0042491; GO:0042802; GO:0045184; GO:0045494; GO:0048496; GO:0050953; GO:0051649; GO:0060113; GO:0060171; GO:1990075; GO:1990696 establishment of localization in cell [GO:0051649]; establishment of protein localization [GO:0045184]; hair cell differentiation [GO:0035315]; inner ear auditory receptor cell differentiation [GO:0042491]; inner ear receptor cell differentiation [GO:0060113]; maintenance of animal organ identity [GO:0048496]; photoreceptor cell maintenance [GO:0045494]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601] apical plasma membrane [GO:0016324]; basement membrane [GO:0005604]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; periciliary membrane compartment [GO:1990075]; photoreceptor connecting cilium [GO:0032391]; photoreceptor inner segment [GO:0001917]; stereocilia ankle link [GO:0002141]; stereocilia ankle link complex [GO:0002142]; stereocilium bundle [GO:0032421]; stereocilium membrane [GO:0060171]; USH2 complex [GO:1990696] collagen binding [GO:0005518]; identical protein binding [GO:0042802]; myosin binding [GO:0017022] g4746.t1 O75445 25.289 692 2.16e-38 162.0 sp|O75445|USH2A_HUMAN Usherin OS=Homo sapiens OX=9606 GN=USH2A PE=1 SV=3 USH2A_HUMAN reviewed Usherin (Usher syndrome type IIa protein) (Usher syndrome type-2A protein) Homo sapiens (Human) GO:0001917; GO:0002141; GO:0002142; GO:0005518; GO:0005576; GO:0005604; GO:0005737; GO:0007601; GO:0007605; GO:0016324; GO:0017022; GO:0032391; GO:0032421; GO:0035315; GO:0036064; GO:0042491; GO:0042802; GO:0045184; GO:0045494; GO:0048496; GO:0050953; GO:0051649; GO:0060113; GO:0060171; GO:1990075; GO:1990696 establishment of localization in cell [GO:0051649]; establishment of protein localization [GO:0045184]; hair cell differentiation [GO:0035315]; inner ear auditory receptor cell differentiation [GO:0042491]; inner ear receptor cell differentiation [GO:0060113]; maintenance of animal organ identity [GO:0048496]; photoreceptor cell maintenance [GO:0045494]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601] apical plasma membrane [GO:0016324]; basement membrane [GO:0005604]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; periciliary membrane compartment [GO:1990075]; photoreceptor connecting cilium [GO:0032391]; photoreceptor inner segment [GO:0001917]; stereocilia ankle link [GO:0002141]; stereocilia ankle link complex [GO:0002142]; stereocilium bundle [GO:0032421]; stereocilium membrane [GO:0060171]; USH2 complex [GO:1990696] collagen binding [GO:0005518]; identical protein binding [GO:0042802]; myosin binding [GO:0017022] g4746.t1 O75445 27.023 692 1.87e-36 156.0 sp|O75445|USH2A_HUMAN Usherin OS=Homo sapiens OX=9606 GN=USH2A PE=1 SV=3 USH2A_HUMAN reviewed Usherin (Usher syndrome type IIa protein) (Usher syndrome type-2A protein) Homo sapiens (Human) GO:0001917; GO:0002141; GO:0002142; GO:0005518; GO:0005576; GO:0005604; GO:0005737; GO:0007601; GO:0007605; GO:0016324; GO:0017022; GO:0032391; GO:0032421; GO:0035315; GO:0036064; GO:0042491; GO:0042802; GO:0045184; GO:0045494; GO:0048496; GO:0050953; GO:0051649; GO:0060113; GO:0060171; GO:1990075; GO:1990696 establishment of localization in cell [GO:0051649]; establishment of protein localization [GO:0045184]; hair cell differentiation [GO:0035315]; inner ear auditory receptor cell differentiation [GO:0042491]; inner ear receptor cell differentiation [GO:0060113]; maintenance of animal organ identity [GO:0048496]; photoreceptor cell maintenance [GO:0045494]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601] apical plasma membrane [GO:0016324]; basement membrane [GO:0005604]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; periciliary membrane compartment [GO:1990075]; photoreceptor connecting cilium [GO:0032391]; photoreceptor inner segment [GO:0001917]; stereocilia ankle link [GO:0002141]; stereocilia ankle link complex [GO:0002142]; stereocilium bundle [GO:0032421]; stereocilium membrane [GO:0060171]; USH2 complex [GO:1990696] collagen binding [GO:0005518]; identical protein binding [GO:0042802]; myosin binding [GO:0017022] g4746.t1 O75445 29.801 453 4.77e-32 142.0 sp|O75445|USH2A_HUMAN Usherin OS=Homo sapiens OX=9606 GN=USH2A PE=1 SV=3 USH2A_HUMAN reviewed Usherin (Usher syndrome type IIa protein) (Usher syndrome type-2A protein) Homo sapiens (Human) GO:0001917; GO:0002141; GO:0002142; GO:0005518; GO:0005576; GO:0005604; GO:0005737; GO:0007601; GO:0007605; GO:0016324; GO:0017022; GO:0032391; GO:0032421; GO:0035315; GO:0036064; GO:0042491; GO:0042802; GO:0045184; GO:0045494; GO:0048496; GO:0050953; GO:0051649; GO:0060113; GO:0060171; GO:1990075; GO:1990696 establishment of localization in cell [GO:0051649]; establishment of protein localization [GO:0045184]; hair cell differentiation [GO:0035315]; inner ear auditory receptor cell differentiation [GO:0042491]; inner ear receptor cell differentiation [GO:0060113]; maintenance of animal organ identity [GO:0048496]; photoreceptor cell maintenance [GO:0045494]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601] apical plasma membrane [GO:0016324]; basement membrane [GO:0005604]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; periciliary membrane compartment [GO:1990075]; photoreceptor connecting cilium [GO:0032391]; photoreceptor inner segment [GO:0001917]; stereocilia ankle link [GO:0002141]; stereocilia ankle link complex [GO:0002142]; stereocilium bundle [GO:0032421]; stereocilium membrane [GO:0060171]; USH2 complex [GO:1990696] collagen binding [GO:0005518]; identical protein binding [GO:0042802]; myosin binding [GO:0017022] g4746.t1 O75445 28.719 484 6.1399999999999995e-30 134.0 sp|O75445|USH2A_HUMAN Usherin OS=Homo sapiens OX=9606 GN=USH2A PE=1 SV=3 USH2A_HUMAN reviewed Usherin (Usher syndrome type IIa protein) (Usher syndrome type-2A protein) Homo sapiens (Human) GO:0001917; GO:0002141; GO:0002142; GO:0005518; GO:0005576; GO:0005604; GO:0005737; GO:0007601; GO:0007605; GO:0016324; GO:0017022; GO:0032391; GO:0032421; GO:0035315; GO:0036064; GO:0042491; GO:0042802; GO:0045184; GO:0045494; GO:0048496; GO:0050953; GO:0051649; GO:0060113; GO:0060171; GO:1990075; GO:1990696 establishment of localization in cell [GO:0051649]; establishment of protein localization [GO:0045184]; hair cell differentiation [GO:0035315]; inner ear auditory receptor cell differentiation [GO:0042491]; inner ear receptor cell differentiation [GO:0060113]; maintenance of animal organ identity [GO:0048496]; photoreceptor cell maintenance [GO:0045494]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601] apical plasma membrane [GO:0016324]; basement membrane [GO:0005604]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; periciliary membrane compartment [GO:1990075]; photoreceptor connecting cilium [GO:0032391]; photoreceptor inner segment [GO:0001917]; stereocilia ankle link [GO:0002141]; stereocilia ankle link complex [GO:0002142]; stereocilium bundle [GO:0032421]; stereocilium membrane [GO:0060171]; USH2 complex [GO:1990696] collagen binding [GO:0005518]; identical protein binding [GO:0042802]; myosin binding [GO:0017022] g4746.t1 O75445 29.178 377 1.52e-28 130.0 sp|O75445|USH2A_HUMAN Usherin OS=Homo sapiens OX=9606 GN=USH2A PE=1 SV=3 USH2A_HUMAN reviewed Usherin (Usher syndrome type IIa protein) (Usher syndrome type-2A protein) Homo sapiens (Human) GO:0001917; GO:0002141; GO:0002142; GO:0005518; GO:0005576; GO:0005604; GO:0005737; GO:0007601; GO:0007605; GO:0016324; GO:0017022; GO:0032391; GO:0032421; GO:0035315; GO:0036064; GO:0042491; GO:0042802; GO:0045184; GO:0045494; GO:0048496; GO:0050953; GO:0051649; GO:0060113; GO:0060171; GO:1990075; GO:1990696 establishment of localization in cell [GO:0051649]; establishment of protein localization [GO:0045184]; hair cell differentiation [GO:0035315]; inner ear auditory receptor cell differentiation [GO:0042491]; inner ear receptor cell differentiation [GO:0060113]; maintenance of animal organ identity [GO:0048496]; photoreceptor cell maintenance [GO:0045494]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601] apical plasma membrane [GO:0016324]; basement membrane [GO:0005604]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; periciliary membrane compartment [GO:1990075]; photoreceptor connecting cilium [GO:0032391]; photoreceptor inner segment [GO:0001917]; stereocilia ankle link [GO:0002141]; stereocilia ankle link complex [GO:0002142]; stereocilium bundle [GO:0032421]; stereocilium membrane [GO:0060171]; USH2 complex [GO:1990696] collagen binding [GO:0005518]; identical protein binding [GO:0042802]; myosin binding [GO:0017022] g4746.t1 O75445 28.0 475 3.74e-28 129.0 sp|O75445|USH2A_HUMAN Usherin OS=Homo sapiens OX=9606 GN=USH2A PE=1 SV=3 USH2A_HUMAN reviewed Usherin (Usher syndrome type IIa protein) (Usher syndrome type-2A protein) Homo sapiens (Human) GO:0001917; GO:0002141; GO:0002142; GO:0005518; GO:0005576; GO:0005604; GO:0005737; GO:0007601; GO:0007605; GO:0016324; GO:0017022; GO:0032391; GO:0032421; GO:0035315; GO:0036064; GO:0042491; GO:0042802; GO:0045184; GO:0045494; GO:0048496; GO:0050953; GO:0051649; GO:0060113; GO:0060171; GO:1990075; GO:1990696 establishment of localization in cell [GO:0051649]; establishment of protein localization [GO:0045184]; hair cell differentiation [GO:0035315]; inner ear auditory receptor cell differentiation [GO:0042491]; inner ear receptor cell differentiation [GO:0060113]; maintenance of animal organ identity [GO:0048496]; photoreceptor cell maintenance [GO:0045494]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601] apical plasma membrane [GO:0016324]; basement membrane [GO:0005604]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; periciliary membrane compartment [GO:1990075]; photoreceptor connecting cilium [GO:0032391]; photoreceptor inner segment [GO:0001917]; stereocilia ankle link [GO:0002141]; stereocilia ankle link complex [GO:0002142]; stereocilium bundle [GO:0032421]; stereocilium membrane [GO:0060171]; USH2 complex [GO:1990696] collagen binding [GO:0005518]; identical protein binding [GO:0042802]; myosin binding [GO:0017022] g4746.t1 O75445 25.881 653 8.35e-25 117.0 sp|O75445|USH2A_HUMAN Usherin OS=Homo sapiens OX=9606 GN=USH2A PE=1 SV=3 USH2A_HUMAN reviewed Usherin (Usher syndrome type IIa protein) (Usher syndrome type-2A protein) Homo sapiens (Human) GO:0001917; GO:0002141; GO:0002142; GO:0005518; GO:0005576; GO:0005604; GO:0005737; GO:0007601; GO:0007605; GO:0016324; GO:0017022; GO:0032391; GO:0032421; GO:0035315; GO:0036064; GO:0042491; GO:0042802; GO:0045184; GO:0045494; GO:0048496; GO:0050953; GO:0051649; GO:0060113; GO:0060171; GO:1990075; GO:1990696 establishment of localization in cell [GO:0051649]; establishment of protein localization [GO:0045184]; hair cell differentiation [GO:0035315]; inner ear auditory receptor cell differentiation [GO:0042491]; inner ear receptor cell differentiation [GO:0060113]; maintenance of animal organ identity [GO:0048496]; photoreceptor cell maintenance [GO:0045494]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601] apical plasma membrane [GO:0016324]; basement membrane [GO:0005604]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; periciliary membrane compartment [GO:1990075]; photoreceptor connecting cilium [GO:0032391]; photoreceptor inner segment [GO:0001917]; stereocilia ankle link [GO:0002141]; stereocilia ankle link complex [GO:0002142]; stereocilium bundle [GO:0032421]; stereocilium membrane [GO:0060171]; USH2 complex [GO:1990696] collagen binding [GO:0005518]; identical protein binding [GO:0042802]; myosin binding [GO:0017022] g4746.t2 O75445 39.543 1927 0.0 1337.0 sp|O75445|USH2A_HUMAN Usherin OS=Homo sapiens OX=9606 GN=USH2A PE=1 SV=3 USH2A_HUMAN reviewed Usherin (Usher syndrome type IIa protein) (Usher syndrome type-2A protein) Homo sapiens (Human) GO:0001917; GO:0002141; GO:0002142; GO:0005518; GO:0005576; GO:0005604; GO:0005737; GO:0007601; GO:0007605; GO:0016324; GO:0017022; GO:0032391; GO:0032421; GO:0035315; GO:0036064; GO:0042491; GO:0042802; GO:0045184; GO:0045494; GO:0048496; GO:0050953; GO:0051649; GO:0060113; GO:0060171; GO:1990075; GO:1990696 establishment of localization in cell [GO:0051649]; establishment of protein localization [GO:0045184]; hair cell differentiation [GO:0035315]; inner ear auditory receptor cell differentiation [GO:0042491]; inner ear receptor cell differentiation [GO:0060113]; maintenance of animal organ identity [GO:0048496]; photoreceptor cell maintenance [GO:0045494]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601] apical plasma membrane [GO:0016324]; basement membrane [GO:0005604]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; periciliary membrane compartment [GO:1990075]; photoreceptor connecting cilium [GO:0032391]; photoreceptor inner segment [GO:0001917]; stereocilia ankle link [GO:0002141]; stereocilia ankle link complex [GO:0002142]; stereocilium bundle [GO:0032421]; stereocilium membrane [GO:0060171]; USH2 complex [GO:1990696] collagen binding [GO:0005518]; identical protein binding [GO:0042802]; myosin binding [GO:0017022] g4746.t2 O75445 30.287 766 1.5e-75 285.0 sp|O75445|USH2A_HUMAN Usherin OS=Homo sapiens OX=9606 GN=USH2A PE=1 SV=3 USH2A_HUMAN reviewed Usherin (Usher syndrome type IIa protein) (Usher syndrome type-2A protein) Homo sapiens (Human) GO:0001917; GO:0002141; GO:0002142; GO:0005518; GO:0005576; GO:0005604; GO:0005737; GO:0007601; GO:0007605; GO:0016324; GO:0017022; GO:0032391; GO:0032421; GO:0035315; GO:0036064; GO:0042491; GO:0042802; GO:0045184; GO:0045494; GO:0048496; GO:0050953; GO:0051649; GO:0060113; GO:0060171; GO:1990075; GO:1990696 establishment of localization in cell [GO:0051649]; establishment of protein localization [GO:0045184]; hair cell differentiation [GO:0035315]; inner ear auditory receptor cell differentiation [GO:0042491]; inner ear receptor cell differentiation [GO:0060113]; maintenance of animal organ identity [GO:0048496]; photoreceptor cell maintenance [GO:0045494]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601] apical plasma membrane [GO:0016324]; basement membrane [GO:0005604]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; periciliary membrane compartment [GO:1990075]; photoreceptor connecting cilium [GO:0032391]; photoreceptor inner segment [GO:0001917]; stereocilia ankle link [GO:0002141]; stereocilia ankle link complex [GO:0002142]; stereocilium bundle [GO:0032421]; stereocilium membrane [GO:0060171]; USH2 complex [GO:1990696] collagen binding [GO:0005518]; identical protein binding [GO:0042802]; myosin binding [GO:0017022] g4746.t2 O75445 28.132 878 1.1599999999999999e-74 282.0 sp|O75445|USH2A_HUMAN Usherin OS=Homo sapiens OX=9606 GN=USH2A PE=1 SV=3 USH2A_HUMAN reviewed Usherin (Usher syndrome type IIa protein) (Usher syndrome type-2A protein) Homo sapiens (Human) GO:0001917; GO:0002141; GO:0002142; GO:0005518; GO:0005576; GO:0005604; GO:0005737; GO:0007601; GO:0007605; GO:0016324; GO:0017022; GO:0032391; GO:0032421; GO:0035315; GO:0036064; GO:0042491; GO:0042802; GO:0045184; GO:0045494; GO:0048496; GO:0050953; GO:0051649; GO:0060113; GO:0060171; GO:1990075; GO:1990696 establishment of localization in cell [GO:0051649]; establishment of protein localization [GO:0045184]; hair cell differentiation [GO:0035315]; inner ear auditory receptor cell differentiation [GO:0042491]; inner ear receptor cell differentiation [GO:0060113]; maintenance of animal organ identity [GO:0048496]; photoreceptor cell maintenance [GO:0045494]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601] apical plasma membrane [GO:0016324]; basement membrane [GO:0005604]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; periciliary membrane compartment [GO:1990075]; photoreceptor connecting cilium [GO:0032391]; photoreceptor inner segment [GO:0001917]; stereocilia ankle link [GO:0002141]; stereocilia ankle link complex [GO:0002142]; stereocilium bundle [GO:0032421]; stereocilium membrane [GO:0060171]; USH2 complex [GO:1990696] collagen binding [GO:0005518]; identical protein binding [GO:0042802]; myosin binding [GO:0017022] g4746.t2 O75445 28.156 895 3.48e-72 273.0 sp|O75445|USH2A_HUMAN Usherin OS=Homo sapiens OX=9606 GN=USH2A PE=1 SV=3 USH2A_HUMAN reviewed Usherin (Usher syndrome type IIa protein) (Usher syndrome type-2A protein) Homo sapiens (Human) GO:0001917; GO:0002141; GO:0002142; GO:0005518; GO:0005576; GO:0005604; GO:0005737; GO:0007601; GO:0007605; GO:0016324; GO:0017022; GO:0032391; GO:0032421; GO:0035315; GO:0036064; GO:0042491; GO:0042802; GO:0045184; GO:0045494; GO:0048496; GO:0050953; GO:0051649; GO:0060113; GO:0060171; GO:1990075; GO:1990696 establishment of localization in cell [GO:0051649]; establishment of protein localization [GO:0045184]; hair cell differentiation [GO:0035315]; inner ear auditory receptor cell differentiation [GO:0042491]; inner ear receptor cell differentiation [GO:0060113]; maintenance of animal organ identity [GO:0048496]; photoreceptor cell maintenance [GO:0045494]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601] apical plasma membrane [GO:0016324]; basement membrane [GO:0005604]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; periciliary membrane compartment [GO:1990075]; photoreceptor connecting cilium [GO:0032391]; photoreceptor inner segment [GO:0001917]; stereocilia ankle link [GO:0002141]; stereocilia ankle link complex [GO:0002142]; stereocilium bundle [GO:0032421]; stereocilium membrane [GO:0060171]; USH2 complex [GO:1990696] collagen binding [GO:0005518]; identical protein binding [GO:0042802]; myosin binding [GO:0017022] g4746.t2 O75445 28.447 805 6.88e-58 227.0 sp|O75445|USH2A_HUMAN Usherin OS=Homo sapiens OX=9606 GN=USH2A PE=1 SV=3 USH2A_HUMAN reviewed Usherin (Usher syndrome type IIa protein) (Usher syndrome type-2A protein) Homo sapiens (Human) GO:0001917; GO:0002141; GO:0002142; GO:0005518; GO:0005576; GO:0005604; GO:0005737; GO:0007601; GO:0007605; GO:0016324; GO:0017022; GO:0032391; GO:0032421; GO:0035315; GO:0036064; GO:0042491; GO:0042802; GO:0045184; GO:0045494; GO:0048496; GO:0050953; GO:0051649; GO:0060113; GO:0060171; GO:1990075; GO:1990696 establishment of localization in cell [GO:0051649]; establishment of protein localization [GO:0045184]; hair cell differentiation [GO:0035315]; inner ear auditory receptor cell differentiation [GO:0042491]; inner ear receptor cell differentiation [GO:0060113]; maintenance of animal organ identity [GO:0048496]; photoreceptor cell maintenance [GO:0045494]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601] apical plasma membrane [GO:0016324]; basement membrane [GO:0005604]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; periciliary membrane compartment [GO:1990075]; photoreceptor connecting cilium [GO:0032391]; photoreceptor inner segment [GO:0001917]; stereocilia ankle link [GO:0002141]; stereocilia ankle link complex [GO:0002142]; stereocilium bundle [GO:0032421]; stereocilium membrane [GO:0060171]; USH2 complex [GO:1990696] collagen binding [GO:0005518]; identical protein binding [GO:0042802]; myosin binding [GO:0017022] g4746.t2 O75445 28.755 699 7.92e-57 223.0 sp|O75445|USH2A_HUMAN Usherin OS=Homo sapiens OX=9606 GN=USH2A PE=1 SV=3 USH2A_HUMAN reviewed Usherin (Usher syndrome type IIa protein) (Usher syndrome type-2A protein) Homo sapiens (Human) GO:0001917; GO:0002141; GO:0002142; GO:0005518; GO:0005576; GO:0005604; GO:0005737; GO:0007601; GO:0007605; GO:0016324; GO:0017022; GO:0032391; GO:0032421; GO:0035315; GO:0036064; GO:0042491; GO:0042802; GO:0045184; GO:0045494; GO:0048496; GO:0050953; GO:0051649; GO:0060113; GO:0060171; GO:1990075; GO:1990696 establishment of localization in cell [GO:0051649]; establishment of protein localization [GO:0045184]; hair cell differentiation [GO:0035315]; inner ear auditory receptor cell differentiation [GO:0042491]; inner ear receptor cell differentiation [GO:0060113]; maintenance of animal organ identity [GO:0048496]; photoreceptor cell maintenance [GO:0045494]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601] apical plasma membrane [GO:0016324]; basement membrane [GO:0005604]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; periciliary membrane compartment [GO:1990075]; photoreceptor connecting cilium [GO:0032391]; photoreceptor inner segment [GO:0001917]; stereocilia ankle link [GO:0002141]; stereocilia ankle link complex [GO:0002142]; stereocilium bundle [GO:0032421]; stereocilium membrane [GO:0060171]; USH2 complex [GO:1990696] collagen binding [GO:0005518]; identical protein binding [GO:0042802]; myosin binding [GO:0017022] g4746.t2 O75445 28.215 762 1.62e-56 222.0 sp|O75445|USH2A_HUMAN Usherin OS=Homo sapiens OX=9606 GN=USH2A PE=1 SV=3 USH2A_HUMAN reviewed Usherin (Usher syndrome type IIa protein) (Usher syndrome type-2A protein) Homo sapiens (Human) GO:0001917; GO:0002141; GO:0002142; GO:0005518; GO:0005576; GO:0005604; GO:0005737; GO:0007601; GO:0007605; GO:0016324; GO:0017022; GO:0032391; GO:0032421; GO:0035315; GO:0036064; GO:0042491; GO:0042802; GO:0045184; GO:0045494; GO:0048496; GO:0050953; GO:0051649; GO:0060113; GO:0060171; GO:1990075; GO:1990696 establishment of localization in cell [GO:0051649]; establishment of protein localization [GO:0045184]; hair cell differentiation [GO:0035315]; inner ear auditory receptor cell differentiation [GO:0042491]; inner ear receptor cell differentiation [GO:0060113]; maintenance of animal organ identity [GO:0048496]; photoreceptor cell maintenance [GO:0045494]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601] apical plasma membrane [GO:0016324]; basement membrane [GO:0005604]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; periciliary membrane compartment [GO:1990075]; photoreceptor connecting cilium [GO:0032391]; photoreceptor inner segment [GO:0001917]; stereocilia ankle link [GO:0002141]; stereocilia ankle link complex [GO:0002142]; stereocilium bundle [GO:0032421]; stereocilium membrane [GO:0060171]; USH2 complex [GO:1990696] collagen binding [GO:0005518]; identical protein binding [GO:0042802]; myosin binding [GO:0017022] g4746.t2 O75445 27.307 791 1.88e-55 219.0 sp|O75445|USH2A_HUMAN Usherin OS=Homo sapiens OX=9606 GN=USH2A PE=1 SV=3 USH2A_HUMAN reviewed Usherin (Usher syndrome type IIa protein) (Usher syndrome type-2A protein) Homo sapiens (Human) GO:0001917; GO:0002141; GO:0002142; GO:0005518; GO:0005576; GO:0005604; GO:0005737; GO:0007601; GO:0007605; GO:0016324; GO:0017022; GO:0032391; GO:0032421; GO:0035315; GO:0036064; GO:0042491; GO:0042802; GO:0045184; GO:0045494; GO:0048496; GO:0050953; GO:0051649; GO:0060113; GO:0060171; GO:1990075; GO:1990696 establishment of localization in cell [GO:0051649]; establishment of protein localization [GO:0045184]; hair cell differentiation [GO:0035315]; inner ear auditory receptor cell differentiation [GO:0042491]; inner ear receptor cell differentiation [GO:0060113]; maintenance of animal organ identity [GO:0048496]; photoreceptor cell maintenance [GO:0045494]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601] apical plasma membrane [GO:0016324]; basement membrane [GO:0005604]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; periciliary membrane compartment [GO:1990075]; photoreceptor connecting cilium [GO:0032391]; photoreceptor inner segment [GO:0001917]; stereocilia ankle link [GO:0002141]; stereocilia ankle link complex [GO:0002142]; stereocilium bundle [GO:0032421]; stereocilium membrane [GO:0060171]; USH2 complex [GO:1990696] collagen binding [GO:0005518]; identical protein binding [GO:0042802]; myosin binding [GO:0017022] g4746.t2 O75445 30.49 469 2.13e-41 172.0 sp|O75445|USH2A_HUMAN Usherin OS=Homo sapiens OX=9606 GN=USH2A PE=1 SV=3 USH2A_HUMAN reviewed Usherin (Usher syndrome type IIa protein) (Usher syndrome type-2A protein) Homo sapiens (Human) GO:0001917; GO:0002141; GO:0002142; GO:0005518; GO:0005576; GO:0005604; GO:0005737; GO:0007601; GO:0007605; GO:0016324; GO:0017022; GO:0032391; GO:0032421; GO:0035315; GO:0036064; GO:0042491; GO:0042802; GO:0045184; GO:0045494; GO:0048496; GO:0050953; GO:0051649; GO:0060113; GO:0060171; GO:1990075; GO:1990696 establishment of localization in cell [GO:0051649]; establishment of protein localization [GO:0045184]; hair cell differentiation [GO:0035315]; inner ear auditory receptor cell differentiation [GO:0042491]; inner ear receptor cell differentiation [GO:0060113]; maintenance of animal organ identity [GO:0048496]; photoreceptor cell maintenance [GO:0045494]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601] apical plasma membrane [GO:0016324]; basement membrane [GO:0005604]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; periciliary membrane compartment [GO:1990075]; photoreceptor connecting cilium [GO:0032391]; photoreceptor inner segment [GO:0001917]; stereocilia ankle link [GO:0002141]; stereocilia ankle link complex [GO:0002142]; stereocilium bundle [GO:0032421]; stereocilium membrane [GO:0060171]; USH2 complex [GO:1990696] collagen binding [GO:0005518]; identical protein binding [GO:0042802]; myosin binding [GO:0017022] g4746.t2 O75445 24.536 701 9.7e-40 167.0 sp|O75445|USH2A_HUMAN Usherin OS=Homo sapiens OX=9606 GN=USH2A PE=1 SV=3 USH2A_HUMAN reviewed Usherin (Usher syndrome type IIa protein) (Usher syndrome type-2A protein) Homo sapiens (Human) GO:0001917; GO:0002141; GO:0002142; GO:0005518; GO:0005576; GO:0005604; GO:0005737; GO:0007601; GO:0007605; GO:0016324; GO:0017022; GO:0032391; GO:0032421; GO:0035315; GO:0036064; GO:0042491; GO:0042802; GO:0045184; GO:0045494; GO:0048496; GO:0050953; GO:0051649; GO:0060113; GO:0060171; GO:1990075; GO:1990696 establishment of localization in cell [GO:0051649]; establishment of protein localization [GO:0045184]; hair cell differentiation [GO:0035315]; inner ear auditory receptor cell differentiation [GO:0042491]; inner ear receptor cell differentiation [GO:0060113]; maintenance of animal organ identity [GO:0048496]; photoreceptor cell maintenance [GO:0045494]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601] apical plasma membrane [GO:0016324]; basement membrane [GO:0005604]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; periciliary membrane compartment [GO:1990075]; photoreceptor connecting cilium [GO:0032391]; photoreceptor inner segment [GO:0001917]; stereocilia ankle link [GO:0002141]; stereocilia ankle link complex [GO:0002142]; stereocilium bundle [GO:0032421]; stereocilium membrane [GO:0060171]; USH2 complex [GO:1990696] collagen binding [GO:0005518]; identical protein binding [GO:0042802]; myosin binding [GO:0017022] g4746.t2 O75445 25.289 692 1.58e-38 163.0 sp|O75445|USH2A_HUMAN Usherin OS=Homo sapiens OX=9606 GN=USH2A PE=1 SV=3 USH2A_HUMAN reviewed Usherin (Usher syndrome type IIa protein) (Usher syndrome type-2A protein) Homo sapiens (Human) GO:0001917; GO:0002141; GO:0002142; GO:0005518; GO:0005576; GO:0005604; GO:0005737; GO:0007601; GO:0007605; GO:0016324; GO:0017022; GO:0032391; GO:0032421; GO:0035315; GO:0036064; GO:0042491; GO:0042802; GO:0045184; GO:0045494; GO:0048496; GO:0050953; GO:0051649; GO:0060113; GO:0060171; GO:1990075; GO:1990696 establishment of localization in cell [GO:0051649]; establishment of protein localization [GO:0045184]; hair cell differentiation [GO:0035315]; inner ear auditory receptor cell differentiation [GO:0042491]; inner ear receptor cell differentiation [GO:0060113]; maintenance of animal organ identity [GO:0048496]; photoreceptor cell maintenance [GO:0045494]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601] apical plasma membrane [GO:0016324]; basement membrane [GO:0005604]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; periciliary membrane compartment [GO:1990075]; photoreceptor connecting cilium [GO:0032391]; photoreceptor inner segment [GO:0001917]; stereocilia ankle link [GO:0002141]; stereocilia ankle link complex [GO:0002142]; stereocilium bundle [GO:0032421]; stereocilium membrane [GO:0060171]; USH2 complex [GO:1990696] collagen binding [GO:0005518]; identical protein binding [GO:0042802]; myosin binding [GO:0017022] g4746.t2 O75445 26.879 692 1.4100000000000001e-36 156.0 sp|O75445|USH2A_HUMAN Usherin OS=Homo sapiens OX=9606 GN=USH2A PE=1 SV=3 USH2A_HUMAN reviewed Usherin (Usher syndrome type IIa protein) (Usher syndrome type-2A protein) Homo sapiens (Human) GO:0001917; GO:0002141; GO:0002142; GO:0005518; GO:0005576; GO:0005604; GO:0005737; GO:0007601; GO:0007605; GO:0016324; GO:0017022; GO:0032391; GO:0032421; GO:0035315; GO:0036064; GO:0042491; GO:0042802; GO:0045184; GO:0045494; GO:0048496; GO:0050953; GO:0051649; GO:0060113; GO:0060171; GO:1990075; GO:1990696 establishment of localization in cell [GO:0051649]; establishment of protein localization [GO:0045184]; hair cell differentiation [GO:0035315]; inner ear auditory receptor cell differentiation [GO:0042491]; inner ear receptor cell differentiation [GO:0060113]; maintenance of animal organ identity [GO:0048496]; photoreceptor cell maintenance [GO:0045494]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601] apical plasma membrane [GO:0016324]; basement membrane [GO:0005604]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; periciliary membrane compartment [GO:1990075]; photoreceptor connecting cilium [GO:0032391]; photoreceptor inner segment [GO:0001917]; stereocilia ankle link [GO:0002141]; stereocilia ankle link complex [GO:0002142]; stereocilium bundle [GO:0032421]; stereocilium membrane [GO:0060171]; USH2 complex [GO:1990696] collagen binding [GO:0005518]; identical protein binding [GO:0042802]; myosin binding [GO:0017022] g4746.t2 O75445 29.801 453 3.9e-32 142.0 sp|O75445|USH2A_HUMAN Usherin OS=Homo sapiens OX=9606 GN=USH2A PE=1 SV=3 USH2A_HUMAN reviewed Usherin (Usher syndrome type IIa protein) (Usher syndrome type-2A protein) Homo sapiens (Human) GO:0001917; GO:0002141; GO:0002142; GO:0005518; GO:0005576; GO:0005604; GO:0005737; GO:0007601; GO:0007605; GO:0016324; GO:0017022; GO:0032391; GO:0032421; GO:0035315; GO:0036064; GO:0042491; GO:0042802; GO:0045184; GO:0045494; GO:0048496; GO:0050953; GO:0051649; GO:0060113; GO:0060171; GO:1990075; GO:1990696 establishment of localization in cell [GO:0051649]; establishment of protein localization [GO:0045184]; hair cell differentiation [GO:0035315]; inner ear auditory receptor cell differentiation [GO:0042491]; inner ear receptor cell differentiation [GO:0060113]; maintenance of animal organ identity [GO:0048496]; photoreceptor cell maintenance [GO:0045494]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601] apical plasma membrane [GO:0016324]; basement membrane [GO:0005604]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; periciliary membrane compartment [GO:1990075]; photoreceptor connecting cilium [GO:0032391]; photoreceptor inner segment [GO:0001917]; stereocilia ankle link [GO:0002141]; stereocilia ankle link complex [GO:0002142]; stereocilium bundle [GO:0032421]; stereocilium membrane [GO:0060171]; USH2 complex [GO:1990696] collagen binding [GO:0005518]; identical protein binding [GO:0042802]; myosin binding [GO:0017022] g4746.t2 O75445 28.719 484 4.4199999999999995e-30 135.0 sp|O75445|USH2A_HUMAN Usherin OS=Homo sapiens OX=9606 GN=USH2A PE=1 SV=3 USH2A_HUMAN reviewed Usherin (Usher syndrome type IIa protein) (Usher syndrome type-2A protein) Homo sapiens (Human) GO:0001917; GO:0002141; GO:0002142; GO:0005518; GO:0005576; GO:0005604; GO:0005737; GO:0007601; GO:0007605; GO:0016324; GO:0017022; GO:0032391; GO:0032421; GO:0035315; GO:0036064; GO:0042491; GO:0042802; GO:0045184; GO:0045494; GO:0048496; GO:0050953; GO:0051649; GO:0060113; GO:0060171; GO:1990075; GO:1990696 establishment of localization in cell [GO:0051649]; establishment of protein localization [GO:0045184]; hair cell differentiation [GO:0035315]; inner ear auditory receptor cell differentiation [GO:0042491]; inner ear receptor cell differentiation [GO:0060113]; maintenance of animal organ identity [GO:0048496]; photoreceptor cell maintenance [GO:0045494]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601] apical plasma membrane [GO:0016324]; basement membrane [GO:0005604]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; periciliary membrane compartment [GO:1990075]; photoreceptor connecting cilium [GO:0032391]; photoreceptor inner segment [GO:0001917]; stereocilia ankle link [GO:0002141]; stereocilia ankle link complex [GO:0002142]; stereocilium bundle [GO:0032421]; stereocilium membrane [GO:0060171]; USH2 complex [GO:1990696] collagen binding [GO:0005518]; identical protein binding [GO:0042802]; myosin binding [GO:0017022] g4746.t2 O75445 29.178 377 1.43e-28 130.0 sp|O75445|USH2A_HUMAN Usherin OS=Homo sapiens OX=9606 GN=USH2A PE=1 SV=3 USH2A_HUMAN reviewed Usherin (Usher syndrome type IIa protein) (Usher syndrome type-2A protein) Homo sapiens (Human) GO:0001917; GO:0002141; GO:0002142; GO:0005518; GO:0005576; GO:0005604; GO:0005737; GO:0007601; GO:0007605; GO:0016324; GO:0017022; GO:0032391; GO:0032421; GO:0035315; GO:0036064; GO:0042491; GO:0042802; GO:0045184; GO:0045494; GO:0048496; GO:0050953; GO:0051649; GO:0060113; GO:0060171; GO:1990075; GO:1990696 establishment of localization in cell [GO:0051649]; establishment of protein localization [GO:0045184]; hair cell differentiation [GO:0035315]; inner ear auditory receptor cell differentiation [GO:0042491]; inner ear receptor cell differentiation [GO:0060113]; maintenance of animal organ identity [GO:0048496]; photoreceptor cell maintenance [GO:0045494]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601] apical plasma membrane [GO:0016324]; basement membrane [GO:0005604]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; periciliary membrane compartment [GO:1990075]; photoreceptor connecting cilium [GO:0032391]; photoreceptor inner segment [GO:0001917]; stereocilia ankle link [GO:0002141]; stereocilia ankle link complex [GO:0002142]; stereocilium bundle [GO:0032421]; stereocilium membrane [GO:0060171]; USH2 complex [GO:1990696] collagen binding [GO:0005518]; identical protein binding [GO:0042802]; myosin binding [GO:0017022] g4746.t2 O75445 28.0 475 2.69e-28 129.0 sp|O75445|USH2A_HUMAN Usherin OS=Homo sapiens OX=9606 GN=USH2A PE=1 SV=3 USH2A_HUMAN reviewed Usherin (Usher syndrome type IIa protein) (Usher syndrome type-2A protein) Homo sapiens (Human) GO:0001917; GO:0002141; GO:0002142; GO:0005518; GO:0005576; GO:0005604; GO:0005737; GO:0007601; GO:0007605; GO:0016324; GO:0017022; GO:0032391; GO:0032421; GO:0035315; GO:0036064; GO:0042491; GO:0042802; GO:0045184; GO:0045494; GO:0048496; GO:0050953; GO:0051649; GO:0060113; GO:0060171; GO:1990075; GO:1990696 establishment of localization in cell [GO:0051649]; establishment of protein localization [GO:0045184]; hair cell differentiation [GO:0035315]; inner ear auditory receptor cell differentiation [GO:0042491]; inner ear receptor cell differentiation [GO:0060113]; maintenance of animal organ identity [GO:0048496]; photoreceptor cell maintenance [GO:0045494]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601] apical plasma membrane [GO:0016324]; basement membrane [GO:0005604]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; periciliary membrane compartment [GO:1990075]; photoreceptor connecting cilium [GO:0032391]; photoreceptor inner segment [GO:0001917]; stereocilia ankle link [GO:0002141]; stereocilia ankle link complex [GO:0002142]; stereocilium bundle [GO:0032421]; stereocilium membrane [GO:0060171]; USH2 complex [GO:1990696] collagen binding [GO:0005518]; identical protein binding [GO:0042802]; myosin binding [GO:0017022] g4746.t2 O75445 25.466 644 6.69e-25 118.0 sp|O75445|USH2A_HUMAN Usherin OS=Homo sapiens OX=9606 GN=USH2A PE=1 SV=3 USH2A_HUMAN reviewed Usherin (Usher syndrome type IIa protein) (Usher syndrome type-2A protein) Homo sapiens (Human) GO:0001917; GO:0002141; GO:0002142; GO:0005518; GO:0005576; GO:0005604; GO:0005737; GO:0007601; GO:0007605; GO:0016324; GO:0017022; GO:0032391; GO:0032421; GO:0035315; GO:0036064; GO:0042491; GO:0042802; GO:0045184; GO:0045494; GO:0048496; GO:0050953; GO:0051649; GO:0060113; GO:0060171; GO:1990075; GO:1990696 establishment of localization in cell [GO:0051649]; establishment of protein localization [GO:0045184]; hair cell differentiation [GO:0035315]; inner ear auditory receptor cell differentiation [GO:0042491]; inner ear receptor cell differentiation [GO:0060113]; maintenance of animal organ identity [GO:0048496]; photoreceptor cell maintenance [GO:0045494]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601] apical plasma membrane [GO:0016324]; basement membrane [GO:0005604]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; periciliary membrane compartment [GO:1990075]; photoreceptor connecting cilium [GO:0032391]; photoreceptor inner segment [GO:0001917]; stereocilia ankle link [GO:0002141]; stereocilia ankle link complex [GO:0002142]; stereocilium bundle [GO:0032421]; stereocilium membrane [GO:0060171]; USH2 complex [GO:1990696] collagen binding [GO:0005518]; identical protein binding [GO:0042802]; myosin binding [GO:0017022] g4746.t3 O75445 39.627 1928 0.0 1340.0 sp|O75445|USH2A_HUMAN Usherin OS=Homo sapiens OX=9606 GN=USH2A PE=1 SV=3 USH2A_HUMAN reviewed Usherin (Usher syndrome type IIa protein) (Usher syndrome type-2A protein) Homo sapiens (Human) GO:0001917; GO:0002141; GO:0002142; GO:0005518; GO:0005576; GO:0005604; GO:0005737; GO:0007601; GO:0007605; GO:0016324; GO:0017022; GO:0032391; GO:0032421; GO:0035315; GO:0036064; GO:0042491; GO:0042802; GO:0045184; GO:0045494; GO:0048496; GO:0050953; GO:0051649; GO:0060113; GO:0060171; GO:1990075; GO:1990696 establishment of localization in cell [GO:0051649]; establishment of protein localization [GO:0045184]; hair cell differentiation [GO:0035315]; inner ear auditory receptor cell differentiation [GO:0042491]; inner ear receptor cell differentiation [GO:0060113]; maintenance of animal organ identity [GO:0048496]; photoreceptor cell maintenance [GO:0045494]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601] apical plasma membrane [GO:0016324]; basement membrane [GO:0005604]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; periciliary membrane compartment [GO:1990075]; photoreceptor connecting cilium [GO:0032391]; photoreceptor inner segment [GO:0001917]; stereocilia ankle link [GO:0002141]; stereocilia ankle link complex [GO:0002142]; stereocilium bundle [GO:0032421]; stereocilium membrane [GO:0060171]; USH2 complex [GO:1990696] collagen binding [GO:0005518]; identical protein binding [GO:0042802]; myosin binding [GO:0017022] g4746.t3 O75445 30.287 766 1.48e-75 285.0 sp|O75445|USH2A_HUMAN Usherin OS=Homo sapiens OX=9606 GN=USH2A PE=1 SV=3 USH2A_HUMAN reviewed Usherin (Usher syndrome type IIa protein) (Usher syndrome type-2A protein) Homo sapiens (Human) GO:0001917; GO:0002141; GO:0002142; GO:0005518; GO:0005576; GO:0005604; GO:0005737; GO:0007601; GO:0007605; GO:0016324; GO:0017022; GO:0032391; GO:0032421; GO:0035315; GO:0036064; GO:0042491; GO:0042802; GO:0045184; GO:0045494; GO:0048496; GO:0050953; GO:0051649; GO:0060113; GO:0060171; GO:1990075; GO:1990696 establishment of localization in cell [GO:0051649]; establishment of protein localization [GO:0045184]; hair cell differentiation [GO:0035315]; inner ear auditory receptor cell differentiation [GO:0042491]; inner ear receptor cell differentiation [GO:0060113]; maintenance of animal organ identity [GO:0048496]; photoreceptor cell maintenance [GO:0045494]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601] apical plasma membrane [GO:0016324]; basement membrane [GO:0005604]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; periciliary membrane compartment [GO:1990075]; photoreceptor connecting cilium [GO:0032391]; photoreceptor inner segment [GO:0001917]; stereocilia ankle link [GO:0002141]; stereocilia ankle link complex [GO:0002142]; stereocilium bundle [GO:0032421]; stereocilium membrane [GO:0060171]; USH2 complex [GO:1990696] collagen binding [GO:0005518]; identical protein binding [GO:0042802]; myosin binding [GO:0017022] g4746.t3 O75445 28.132 878 1.2199999999999999e-74 281.0 sp|O75445|USH2A_HUMAN Usherin OS=Homo sapiens OX=9606 GN=USH2A PE=1 SV=3 USH2A_HUMAN reviewed Usherin (Usher syndrome type IIa protein) (Usher syndrome type-2A protein) Homo sapiens (Human) GO:0001917; GO:0002141; GO:0002142; GO:0005518; GO:0005576; GO:0005604; GO:0005737; GO:0007601; GO:0007605; GO:0016324; GO:0017022; GO:0032391; GO:0032421; GO:0035315; GO:0036064; GO:0042491; GO:0042802; GO:0045184; GO:0045494; GO:0048496; GO:0050953; GO:0051649; GO:0060113; GO:0060171; GO:1990075; GO:1990696 establishment of localization in cell [GO:0051649]; establishment of protein localization [GO:0045184]; hair cell differentiation [GO:0035315]; inner ear auditory receptor cell differentiation [GO:0042491]; inner ear receptor cell differentiation [GO:0060113]; maintenance of animal organ identity [GO:0048496]; photoreceptor cell maintenance [GO:0045494]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601] apical plasma membrane [GO:0016324]; basement membrane [GO:0005604]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; periciliary membrane compartment [GO:1990075]; photoreceptor connecting cilium [GO:0032391]; photoreceptor inner segment [GO:0001917]; stereocilia ankle link [GO:0002141]; stereocilia ankle link complex [GO:0002142]; stereocilium bundle [GO:0032421]; stereocilium membrane [GO:0060171]; USH2 complex [GO:1990696] collagen binding [GO:0005518]; identical protein binding [GO:0042802]; myosin binding [GO:0017022] g4746.t3 O75445 28.156 895 3.61e-72 273.0 sp|O75445|USH2A_HUMAN Usherin OS=Homo sapiens OX=9606 GN=USH2A PE=1 SV=3 USH2A_HUMAN reviewed Usherin (Usher syndrome type IIa protein) (Usher syndrome type-2A protein) Homo sapiens (Human) GO:0001917; GO:0002141; GO:0002142; GO:0005518; GO:0005576; GO:0005604; GO:0005737; GO:0007601; GO:0007605; GO:0016324; GO:0017022; GO:0032391; GO:0032421; GO:0035315; GO:0036064; GO:0042491; GO:0042802; GO:0045184; GO:0045494; GO:0048496; GO:0050953; GO:0051649; GO:0060113; GO:0060171; GO:1990075; GO:1990696 establishment of localization in cell [GO:0051649]; establishment of protein localization [GO:0045184]; hair cell differentiation [GO:0035315]; inner ear auditory receptor cell differentiation [GO:0042491]; inner ear receptor cell differentiation [GO:0060113]; maintenance of animal organ identity [GO:0048496]; photoreceptor cell maintenance [GO:0045494]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601] apical plasma membrane [GO:0016324]; basement membrane [GO:0005604]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; periciliary membrane compartment [GO:1990075]; photoreceptor connecting cilium [GO:0032391]; photoreceptor inner segment [GO:0001917]; stereocilia ankle link [GO:0002141]; stereocilia ankle link complex [GO:0002142]; stereocilium bundle [GO:0032421]; stereocilium membrane [GO:0060171]; USH2 complex [GO:1990696] collagen binding [GO:0005518]; identical protein binding [GO:0042802]; myosin binding [GO:0017022] g4746.t3 O75445 28.447 805 7.320000000000001e-58 226.0 sp|O75445|USH2A_HUMAN Usherin OS=Homo sapiens OX=9606 GN=USH2A PE=1 SV=3 USH2A_HUMAN reviewed Usherin (Usher syndrome type IIa protein) (Usher syndrome type-2A protein) Homo sapiens (Human) GO:0001917; GO:0002141; GO:0002142; GO:0005518; GO:0005576; GO:0005604; GO:0005737; GO:0007601; GO:0007605; GO:0016324; GO:0017022; GO:0032391; GO:0032421; GO:0035315; GO:0036064; GO:0042491; GO:0042802; GO:0045184; GO:0045494; GO:0048496; GO:0050953; GO:0051649; GO:0060113; GO:0060171; GO:1990075; GO:1990696 establishment of localization in cell [GO:0051649]; establishment of protein localization [GO:0045184]; hair cell differentiation [GO:0035315]; inner ear auditory receptor cell differentiation [GO:0042491]; inner ear receptor cell differentiation [GO:0060113]; maintenance of animal organ identity [GO:0048496]; photoreceptor cell maintenance [GO:0045494]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601] apical plasma membrane [GO:0016324]; basement membrane [GO:0005604]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; periciliary membrane compartment [GO:1990075]; photoreceptor connecting cilium [GO:0032391]; photoreceptor inner segment [GO:0001917]; stereocilia ankle link [GO:0002141]; stereocilia ankle link complex [GO:0002142]; stereocilium bundle [GO:0032421]; stereocilium membrane [GO:0060171]; USH2 complex [GO:1990696] collagen binding [GO:0005518]; identical protein binding [GO:0042802]; myosin binding [GO:0017022] g4746.t3 O75445 28.755 699 8.500000000000001e-57 223.0 sp|O75445|USH2A_HUMAN Usherin OS=Homo sapiens OX=9606 GN=USH2A PE=1 SV=3 USH2A_HUMAN reviewed Usherin (Usher syndrome type IIa protein) (Usher syndrome type-2A protein) Homo sapiens (Human) GO:0001917; GO:0002141; GO:0002142; GO:0005518; GO:0005576; GO:0005604; GO:0005737; GO:0007601; GO:0007605; GO:0016324; GO:0017022; GO:0032391; GO:0032421; GO:0035315; GO:0036064; GO:0042491; GO:0042802; GO:0045184; GO:0045494; GO:0048496; GO:0050953; GO:0051649; GO:0060113; GO:0060171; GO:1990075; GO:1990696 establishment of localization in cell [GO:0051649]; establishment of protein localization [GO:0045184]; hair cell differentiation [GO:0035315]; inner ear auditory receptor cell differentiation [GO:0042491]; inner ear receptor cell differentiation [GO:0060113]; maintenance of animal organ identity [GO:0048496]; photoreceptor cell maintenance [GO:0045494]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601] apical plasma membrane [GO:0016324]; basement membrane [GO:0005604]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; periciliary membrane compartment [GO:1990075]; photoreceptor connecting cilium [GO:0032391]; photoreceptor inner segment [GO:0001917]; stereocilia ankle link [GO:0002141]; stereocilia ankle link complex [GO:0002142]; stereocilium bundle [GO:0032421]; stereocilium membrane [GO:0060171]; USH2 complex [GO:1990696] collagen binding [GO:0005518]; identical protein binding [GO:0042802]; myosin binding [GO:0017022] g4746.t3 O75445 28.215 762 1.6500000000000001e-56 222.0 sp|O75445|USH2A_HUMAN Usherin OS=Homo sapiens OX=9606 GN=USH2A PE=1 SV=3 USH2A_HUMAN reviewed Usherin (Usher syndrome type IIa protein) (Usher syndrome type-2A protein) Homo sapiens (Human) GO:0001917; GO:0002141; GO:0002142; GO:0005518; GO:0005576; GO:0005604; GO:0005737; GO:0007601; GO:0007605; GO:0016324; GO:0017022; GO:0032391; GO:0032421; GO:0035315; GO:0036064; GO:0042491; GO:0042802; GO:0045184; GO:0045494; GO:0048496; GO:0050953; GO:0051649; GO:0060113; GO:0060171; GO:1990075; GO:1990696 establishment of localization in cell [GO:0051649]; establishment of protein localization [GO:0045184]; hair cell differentiation [GO:0035315]; inner ear auditory receptor cell differentiation [GO:0042491]; inner ear receptor cell differentiation [GO:0060113]; maintenance of animal organ identity [GO:0048496]; photoreceptor cell maintenance [GO:0045494]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601] apical plasma membrane [GO:0016324]; basement membrane [GO:0005604]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; periciliary membrane compartment [GO:1990075]; photoreceptor connecting cilium [GO:0032391]; photoreceptor inner segment [GO:0001917]; stereocilia ankle link [GO:0002141]; stereocilia ankle link complex [GO:0002142]; stereocilium bundle [GO:0032421]; stereocilium membrane [GO:0060171]; USH2 complex [GO:1990696] collagen binding [GO:0005518]; identical protein binding [GO:0042802]; myosin binding [GO:0017022] g4746.t3 O75445 27.307 791 1.97e-55 219.0 sp|O75445|USH2A_HUMAN Usherin OS=Homo sapiens OX=9606 GN=USH2A PE=1 SV=3 USH2A_HUMAN reviewed Usherin (Usher syndrome type IIa protein) (Usher syndrome type-2A protein) Homo sapiens (Human) GO:0001917; GO:0002141; GO:0002142; GO:0005518; GO:0005576; GO:0005604; GO:0005737; GO:0007601; GO:0007605; GO:0016324; GO:0017022; GO:0032391; GO:0032421; GO:0035315; GO:0036064; GO:0042491; GO:0042802; GO:0045184; GO:0045494; GO:0048496; GO:0050953; GO:0051649; GO:0060113; GO:0060171; GO:1990075; GO:1990696 establishment of localization in cell [GO:0051649]; establishment of protein localization [GO:0045184]; hair cell differentiation [GO:0035315]; inner ear auditory receptor cell differentiation [GO:0042491]; inner ear receptor cell differentiation [GO:0060113]; maintenance of animal organ identity [GO:0048496]; photoreceptor cell maintenance [GO:0045494]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601] apical plasma membrane [GO:0016324]; basement membrane [GO:0005604]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; periciliary membrane compartment [GO:1990075]; photoreceptor connecting cilium [GO:0032391]; photoreceptor inner segment [GO:0001917]; stereocilia ankle link [GO:0002141]; stereocilia ankle link complex [GO:0002142]; stereocilium bundle [GO:0032421]; stereocilium membrane [GO:0060171]; USH2 complex [GO:1990696] collagen binding [GO:0005518]; identical protein binding [GO:0042802]; myosin binding [GO:0017022] g4746.t3 O75445 30.49 469 2.23e-41 172.0 sp|O75445|USH2A_HUMAN Usherin OS=Homo sapiens OX=9606 GN=USH2A PE=1 SV=3 USH2A_HUMAN reviewed Usherin (Usher syndrome type IIa protein) (Usher syndrome type-2A protein) Homo sapiens (Human) GO:0001917; GO:0002141; GO:0002142; GO:0005518; GO:0005576; GO:0005604; GO:0005737; GO:0007601; GO:0007605; GO:0016324; GO:0017022; GO:0032391; GO:0032421; GO:0035315; GO:0036064; GO:0042491; GO:0042802; GO:0045184; GO:0045494; GO:0048496; GO:0050953; GO:0051649; GO:0060113; GO:0060171; GO:1990075; GO:1990696 establishment of localization in cell [GO:0051649]; establishment of protein localization [GO:0045184]; hair cell differentiation [GO:0035315]; inner ear auditory receptor cell differentiation [GO:0042491]; inner ear receptor cell differentiation [GO:0060113]; maintenance of animal organ identity [GO:0048496]; photoreceptor cell maintenance [GO:0045494]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601] apical plasma membrane [GO:0016324]; basement membrane [GO:0005604]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; periciliary membrane compartment [GO:1990075]; photoreceptor connecting cilium [GO:0032391]; photoreceptor inner segment [GO:0001917]; stereocilia ankle link [GO:0002141]; stereocilia ankle link complex [GO:0002142]; stereocilium bundle [GO:0032421]; stereocilium membrane [GO:0060171]; USH2 complex [GO:1990696] collagen binding [GO:0005518]; identical protein binding [GO:0042802]; myosin binding [GO:0017022] g4746.t3 O75445 24.536 701 1.02e-39 167.0 sp|O75445|USH2A_HUMAN Usherin OS=Homo sapiens OX=9606 GN=USH2A PE=1 SV=3 USH2A_HUMAN reviewed Usherin (Usher syndrome type IIa protein) (Usher syndrome type-2A protein) Homo sapiens (Human) GO:0001917; GO:0002141; GO:0002142; GO:0005518; GO:0005576; GO:0005604; GO:0005737; GO:0007601; GO:0007605; GO:0016324; GO:0017022; GO:0032391; GO:0032421; GO:0035315; GO:0036064; GO:0042491; GO:0042802; GO:0045184; GO:0045494; GO:0048496; GO:0050953; GO:0051649; GO:0060113; GO:0060171; GO:1990075; GO:1990696 establishment of localization in cell [GO:0051649]; establishment of protein localization [GO:0045184]; hair cell differentiation [GO:0035315]; inner ear auditory receptor cell differentiation [GO:0042491]; inner ear receptor cell differentiation [GO:0060113]; maintenance of animal organ identity [GO:0048496]; photoreceptor cell maintenance [GO:0045494]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601] apical plasma membrane [GO:0016324]; basement membrane [GO:0005604]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; periciliary membrane compartment [GO:1990075]; photoreceptor connecting cilium [GO:0032391]; photoreceptor inner segment [GO:0001917]; stereocilia ankle link [GO:0002141]; stereocilia ankle link complex [GO:0002142]; stereocilium bundle [GO:0032421]; stereocilium membrane [GO:0060171]; USH2 complex [GO:1990696] collagen binding [GO:0005518]; identical protein binding [GO:0042802]; myosin binding [GO:0017022] g4746.t3 O75445 25.289 692 1.69e-38 163.0 sp|O75445|USH2A_HUMAN Usherin OS=Homo sapiens OX=9606 GN=USH2A PE=1 SV=3 USH2A_HUMAN reviewed Usherin (Usher syndrome type IIa protein) (Usher syndrome type-2A protein) Homo sapiens (Human) GO:0001917; GO:0002141; GO:0002142; GO:0005518; GO:0005576; GO:0005604; GO:0005737; GO:0007601; GO:0007605; GO:0016324; GO:0017022; GO:0032391; GO:0032421; GO:0035315; GO:0036064; GO:0042491; GO:0042802; GO:0045184; GO:0045494; GO:0048496; GO:0050953; GO:0051649; GO:0060113; GO:0060171; GO:1990075; GO:1990696 establishment of localization in cell [GO:0051649]; establishment of protein localization [GO:0045184]; hair cell differentiation [GO:0035315]; inner ear auditory receptor cell differentiation [GO:0042491]; inner ear receptor cell differentiation [GO:0060113]; maintenance of animal organ identity [GO:0048496]; photoreceptor cell maintenance [GO:0045494]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601] apical plasma membrane [GO:0016324]; basement membrane [GO:0005604]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; periciliary membrane compartment [GO:1990075]; photoreceptor connecting cilium [GO:0032391]; photoreceptor inner segment [GO:0001917]; stereocilia ankle link [GO:0002141]; stereocilia ankle link complex [GO:0002142]; stereocilium bundle [GO:0032421]; stereocilium membrane [GO:0060171]; USH2 complex [GO:1990696] collagen binding [GO:0005518]; identical protein binding [GO:0042802]; myosin binding [GO:0017022] g4746.t3 O75445 26.879 692 1.5300000000000002e-36 156.0 sp|O75445|USH2A_HUMAN Usherin OS=Homo sapiens OX=9606 GN=USH2A PE=1 SV=3 USH2A_HUMAN reviewed Usherin (Usher syndrome type IIa protein) (Usher syndrome type-2A protein) Homo sapiens (Human) GO:0001917; GO:0002141; GO:0002142; GO:0005518; GO:0005576; GO:0005604; GO:0005737; GO:0007601; GO:0007605; GO:0016324; GO:0017022; GO:0032391; GO:0032421; GO:0035315; GO:0036064; GO:0042491; GO:0042802; GO:0045184; GO:0045494; GO:0048496; GO:0050953; GO:0051649; GO:0060113; GO:0060171; GO:1990075; GO:1990696 establishment of localization in cell [GO:0051649]; establishment of protein localization [GO:0045184]; hair cell differentiation [GO:0035315]; inner ear auditory receptor cell differentiation [GO:0042491]; inner ear receptor cell differentiation [GO:0060113]; maintenance of animal organ identity [GO:0048496]; photoreceptor cell maintenance [GO:0045494]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601] apical plasma membrane [GO:0016324]; basement membrane [GO:0005604]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; periciliary membrane compartment [GO:1990075]; photoreceptor connecting cilium [GO:0032391]; photoreceptor inner segment [GO:0001917]; stereocilia ankle link [GO:0002141]; stereocilia ankle link complex [GO:0002142]; stereocilium bundle [GO:0032421]; stereocilium membrane [GO:0060171]; USH2 complex [GO:1990696] collagen binding [GO:0005518]; identical protein binding [GO:0042802]; myosin binding [GO:0017022] g4746.t3 O75445 29.801 453 3.97e-32 142.0 sp|O75445|USH2A_HUMAN Usherin OS=Homo sapiens OX=9606 GN=USH2A PE=1 SV=3 USH2A_HUMAN reviewed Usherin (Usher syndrome type IIa protein) (Usher syndrome type-2A protein) Homo sapiens (Human) GO:0001917; GO:0002141; GO:0002142; GO:0005518; GO:0005576; GO:0005604; GO:0005737; GO:0007601; GO:0007605; GO:0016324; GO:0017022; GO:0032391; GO:0032421; GO:0035315; GO:0036064; GO:0042491; GO:0042802; GO:0045184; GO:0045494; GO:0048496; GO:0050953; GO:0051649; GO:0060113; GO:0060171; GO:1990075; GO:1990696 establishment of localization in cell [GO:0051649]; establishment of protein localization [GO:0045184]; hair cell differentiation [GO:0035315]; inner ear auditory receptor cell differentiation [GO:0042491]; inner ear receptor cell differentiation [GO:0060113]; maintenance of animal organ identity [GO:0048496]; photoreceptor cell maintenance [GO:0045494]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601] apical plasma membrane [GO:0016324]; basement membrane [GO:0005604]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; periciliary membrane compartment [GO:1990075]; photoreceptor connecting cilium [GO:0032391]; photoreceptor inner segment [GO:0001917]; stereocilia ankle link [GO:0002141]; stereocilia ankle link complex [GO:0002142]; stereocilium bundle [GO:0032421]; stereocilium membrane [GO:0060171]; USH2 complex [GO:1990696] collagen binding [GO:0005518]; identical protein binding [GO:0042802]; myosin binding [GO:0017022] g4746.t3 O75445 28.719 484 4.5699999999999995e-30 135.0 sp|O75445|USH2A_HUMAN Usherin OS=Homo sapiens OX=9606 GN=USH2A PE=1 SV=3 USH2A_HUMAN reviewed Usherin (Usher syndrome type IIa protein) (Usher syndrome type-2A protein) Homo sapiens (Human) GO:0001917; GO:0002141; GO:0002142; GO:0005518; GO:0005576; GO:0005604; GO:0005737; GO:0007601; GO:0007605; GO:0016324; GO:0017022; GO:0032391; GO:0032421; GO:0035315; GO:0036064; GO:0042491; GO:0042802; GO:0045184; GO:0045494; GO:0048496; GO:0050953; GO:0051649; GO:0060113; GO:0060171; GO:1990075; GO:1990696 establishment of localization in cell [GO:0051649]; establishment of protein localization [GO:0045184]; hair cell differentiation [GO:0035315]; inner ear auditory receptor cell differentiation [GO:0042491]; inner ear receptor cell differentiation [GO:0060113]; maintenance of animal organ identity [GO:0048496]; photoreceptor cell maintenance [GO:0045494]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601] apical plasma membrane [GO:0016324]; basement membrane [GO:0005604]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; periciliary membrane compartment [GO:1990075]; photoreceptor connecting cilium [GO:0032391]; photoreceptor inner segment [GO:0001917]; stereocilia ankle link [GO:0002141]; stereocilia ankle link complex [GO:0002142]; stereocilium bundle [GO:0032421]; stereocilium membrane [GO:0060171]; USH2 complex [GO:1990696] collagen binding [GO:0005518]; identical protein binding [GO:0042802]; myosin binding [GO:0017022] g4746.t3 O75445 29.178 377 1.43e-28 130.0 sp|O75445|USH2A_HUMAN Usherin OS=Homo sapiens OX=9606 GN=USH2A PE=1 SV=3 USH2A_HUMAN reviewed Usherin (Usher syndrome type IIa protein) (Usher syndrome type-2A protein) Homo sapiens (Human) GO:0001917; GO:0002141; GO:0002142; GO:0005518; GO:0005576; GO:0005604; GO:0005737; GO:0007601; GO:0007605; GO:0016324; GO:0017022; GO:0032391; GO:0032421; GO:0035315; GO:0036064; GO:0042491; GO:0042802; GO:0045184; GO:0045494; GO:0048496; GO:0050953; GO:0051649; GO:0060113; GO:0060171; GO:1990075; GO:1990696 establishment of localization in cell [GO:0051649]; establishment of protein localization [GO:0045184]; hair cell differentiation [GO:0035315]; inner ear auditory receptor cell differentiation [GO:0042491]; inner ear receptor cell differentiation [GO:0060113]; maintenance of animal organ identity [GO:0048496]; photoreceptor cell maintenance [GO:0045494]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601] apical plasma membrane [GO:0016324]; basement membrane [GO:0005604]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; periciliary membrane compartment [GO:1990075]; photoreceptor connecting cilium [GO:0032391]; photoreceptor inner segment [GO:0001917]; stereocilia ankle link [GO:0002141]; stereocilia ankle link complex [GO:0002142]; stereocilium bundle [GO:0032421]; stereocilium membrane [GO:0060171]; USH2 complex [GO:1990696] collagen binding [GO:0005518]; identical protein binding [GO:0042802]; myosin binding [GO:0017022] g4746.t3 O75445 28.0 475 2.83e-28 129.0 sp|O75445|USH2A_HUMAN Usherin OS=Homo sapiens OX=9606 GN=USH2A PE=1 SV=3 USH2A_HUMAN reviewed Usherin (Usher syndrome type IIa protein) (Usher syndrome type-2A protein) Homo sapiens (Human) GO:0001917; GO:0002141; GO:0002142; GO:0005518; GO:0005576; GO:0005604; GO:0005737; GO:0007601; GO:0007605; GO:0016324; GO:0017022; GO:0032391; GO:0032421; GO:0035315; GO:0036064; GO:0042491; GO:0042802; GO:0045184; GO:0045494; GO:0048496; GO:0050953; GO:0051649; GO:0060113; GO:0060171; GO:1990075; GO:1990696 establishment of localization in cell [GO:0051649]; establishment of protein localization [GO:0045184]; hair cell differentiation [GO:0035315]; inner ear auditory receptor cell differentiation [GO:0042491]; inner ear receptor cell differentiation [GO:0060113]; maintenance of animal organ identity [GO:0048496]; photoreceptor cell maintenance [GO:0045494]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601] apical plasma membrane [GO:0016324]; basement membrane [GO:0005604]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; periciliary membrane compartment [GO:1990075]; photoreceptor connecting cilium [GO:0032391]; photoreceptor inner segment [GO:0001917]; stereocilia ankle link [GO:0002141]; stereocilia ankle link complex [GO:0002142]; stereocilium bundle [GO:0032421]; stereocilium membrane [GO:0060171]; USH2 complex [GO:1990696] collagen binding [GO:0005518]; identical protein binding [GO:0042802]; myosin binding [GO:0017022] g4746.t3 O75445 25.881 653 6.82e-25 118.0 sp|O75445|USH2A_HUMAN Usherin OS=Homo sapiens OX=9606 GN=USH2A PE=1 SV=3 USH2A_HUMAN reviewed Usherin (Usher syndrome type IIa protein) (Usher syndrome type-2A protein) Homo sapiens (Human) GO:0001917; GO:0002141; GO:0002142; GO:0005518; GO:0005576; GO:0005604; GO:0005737; GO:0007601; GO:0007605; GO:0016324; GO:0017022; GO:0032391; GO:0032421; GO:0035315; GO:0036064; GO:0042491; GO:0042802; GO:0045184; GO:0045494; GO:0048496; GO:0050953; GO:0051649; GO:0060113; GO:0060171; GO:1990075; GO:1990696 establishment of localization in cell [GO:0051649]; establishment of protein localization [GO:0045184]; hair cell differentiation [GO:0035315]; inner ear auditory receptor cell differentiation [GO:0042491]; inner ear receptor cell differentiation [GO:0060113]; maintenance of animal organ identity [GO:0048496]; photoreceptor cell maintenance [GO:0045494]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601] apical plasma membrane [GO:0016324]; basement membrane [GO:0005604]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; periciliary membrane compartment [GO:1990075]; photoreceptor connecting cilium [GO:0032391]; photoreceptor inner segment [GO:0001917]; stereocilia ankle link [GO:0002141]; stereocilia ankle link complex [GO:0002142]; stereocilium bundle [GO:0032421]; stereocilium membrane [GO:0060171]; USH2 complex [GO:1990696] collagen binding [GO:0005518]; identical protein binding [GO:0042802]; myosin binding [GO:0017022] g4747.t1 O75445 35.457 832 1.3699999999999998e-106 363.0 sp|O75445|USH2A_HUMAN Usherin OS=Homo sapiens OX=9606 GN=USH2A PE=1 SV=3 USH2A_HUMAN reviewed Usherin (Usher syndrome type IIa protein) (Usher syndrome type-2A protein) Homo sapiens (Human) GO:0001917; GO:0002141; GO:0002142; GO:0005518; GO:0005576; GO:0005604; GO:0005737; GO:0007601; GO:0007605; GO:0016324; GO:0017022; GO:0032391; GO:0032421; GO:0035315; GO:0036064; GO:0042491; GO:0042802; GO:0045184; GO:0045494; GO:0048496; GO:0050953; GO:0051649; GO:0060113; GO:0060171; GO:1990075; GO:1990696 establishment of localization in cell [GO:0051649]; establishment of protein localization [GO:0045184]; hair cell differentiation [GO:0035315]; inner ear auditory receptor cell differentiation [GO:0042491]; inner ear receptor cell differentiation [GO:0060113]; maintenance of animal organ identity [GO:0048496]; photoreceptor cell maintenance [GO:0045494]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601] apical plasma membrane [GO:0016324]; basement membrane [GO:0005604]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; periciliary membrane compartment [GO:1990075]; photoreceptor connecting cilium [GO:0032391]; photoreceptor inner segment [GO:0001917]; stereocilia ankle link [GO:0002141]; stereocilia ankle link complex [GO:0002142]; stereocilium bundle [GO:0032421]; stereocilium membrane [GO:0060171]; USH2 complex [GO:1990696] collagen binding [GO:0005518]; identical protein binding [GO:0042802]; myosin binding [GO:0017022] g4747.t1 O75445 28.707 526 1.91e-46 184.0 sp|O75445|USH2A_HUMAN Usherin OS=Homo sapiens OX=9606 GN=USH2A PE=1 SV=3 USH2A_HUMAN reviewed Usherin (Usher syndrome type IIa protein) (Usher syndrome type-2A protein) Homo sapiens (Human) GO:0001917; GO:0002141; GO:0002142; GO:0005518; GO:0005576; GO:0005604; GO:0005737; GO:0007601; GO:0007605; GO:0016324; GO:0017022; GO:0032391; GO:0032421; GO:0035315; GO:0036064; GO:0042491; GO:0042802; GO:0045184; GO:0045494; GO:0048496; GO:0050953; GO:0051649; GO:0060113; GO:0060171; GO:1990075; GO:1990696 establishment of localization in cell [GO:0051649]; establishment of protein localization [GO:0045184]; hair cell differentiation [GO:0035315]; inner ear auditory receptor cell differentiation [GO:0042491]; inner ear receptor cell differentiation [GO:0060113]; maintenance of animal organ identity [GO:0048496]; photoreceptor cell maintenance [GO:0045494]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601] apical plasma membrane [GO:0016324]; basement membrane [GO:0005604]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; periciliary membrane compartment [GO:1990075]; photoreceptor connecting cilium [GO:0032391]; photoreceptor inner segment [GO:0001917]; stereocilia ankle link [GO:0002141]; stereocilia ankle link complex [GO:0002142]; stereocilium bundle [GO:0032421]; stereocilium membrane [GO:0060171]; USH2 complex [GO:1990696] collagen binding [GO:0005518]; identical protein binding [GO:0042802]; myosin binding [GO:0017022] g4747.t1 O75445 26.719 640 2.9e-45 180.0 sp|O75445|USH2A_HUMAN Usherin OS=Homo sapiens OX=9606 GN=USH2A PE=1 SV=3 USH2A_HUMAN reviewed Usherin (Usher syndrome type IIa protein) (Usher syndrome type-2A protein) Homo sapiens (Human) GO:0001917; GO:0002141; GO:0002142; GO:0005518; GO:0005576; GO:0005604; GO:0005737; GO:0007601; GO:0007605; GO:0016324; GO:0017022; GO:0032391; GO:0032421; GO:0035315; GO:0036064; GO:0042491; GO:0042802; GO:0045184; GO:0045494; GO:0048496; GO:0050953; GO:0051649; GO:0060113; GO:0060171; GO:1990075; GO:1990696 establishment of localization in cell [GO:0051649]; establishment of protein localization [GO:0045184]; hair cell differentiation [GO:0035315]; inner ear auditory receptor cell differentiation [GO:0042491]; inner ear receptor cell differentiation [GO:0060113]; maintenance of animal organ identity [GO:0048496]; photoreceptor cell maintenance [GO:0045494]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601] apical plasma membrane [GO:0016324]; basement membrane [GO:0005604]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; periciliary membrane compartment [GO:1990075]; photoreceptor connecting cilium [GO:0032391]; photoreceptor inner segment [GO:0001917]; stereocilia ankle link [GO:0002141]; stereocilia ankle link complex [GO:0002142]; stereocilium bundle [GO:0032421]; stereocilium membrane [GO:0060171]; USH2 complex [GO:1990696] collagen binding [GO:0005518]; identical protein binding [GO:0042802]; myosin binding [GO:0017022] g4747.t1 O75445 26.05 595 1.0600000000000001e-44 178.0 sp|O75445|USH2A_HUMAN Usherin OS=Homo sapiens OX=9606 GN=USH2A PE=1 SV=3 USH2A_HUMAN reviewed Usherin (Usher syndrome type IIa protein) (Usher syndrome type-2A protein) Homo sapiens (Human) GO:0001917; GO:0002141; GO:0002142; GO:0005518; GO:0005576; GO:0005604; GO:0005737; GO:0007601; GO:0007605; GO:0016324; GO:0017022; GO:0032391; GO:0032421; GO:0035315; GO:0036064; GO:0042491; GO:0042802; GO:0045184; GO:0045494; GO:0048496; GO:0050953; GO:0051649; GO:0060113; GO:0060171; GO:1990075; GO:1990696 establishment of localization in cell [GO:0051649]; establishment of protein localization [GO:0045184]; hair cell differentiation [GO:0035315]; inner ear auditory receptor cell differentiation [GO:0042491]; inner ear receptor cell differentiation [GO:0060113]; maintenance of animal organ identity [GO:0048496]; photoreceptor cell maintenance [GO:0045494]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601] apical plasma membrane [GO:0016324]; basement membrane [GO:0005604]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; periciliary membrane compartment [GO:1990075]; photoreceptor connecting cilium [GO:0032391]; photoreceptor inner segment [GO:0001917]; stereocilia ankle link [GO:0002141]; stereocilia ankle link complex [GO:0002142]; stereocilium bundle [GO:0032421]; stereocilium membrane [GO:0060171]; USH2 complex [GO:1990696] collagen binding [GO:0005518]; identical protein binding [GO:0042802]; myosin binding [GO:0017022] g4747.t1 O75445 26.573 572 2.03e-44 177.0 sp|O75445|USH2A_HUMAN Usherin OS=Homo sapiens OX=9606 GN=USH2A PE=1 SV=3 USH2A_HUMAN reviewed Usherin (Usher syndrome type IIa protein) (Usher syndrome type-2A protein) Homo sapiens (Human) GO:0001917; GO:0002141; GO:0002142; GO:0005518; GO:0005576; GO:0005604; GO:0005737; GO:0007601; GO:0007605; GO:0016324; GO:0017022; GO:0032391; GO:0032421; GO:0035315; GO:0036064; GO:0042491; GO:0042802; GO:0045184; GO:0045494; GO:0048496; GO:0050953; GO:0051649; GO:0060113; GO:0060171; GO:1990075; GO:1990696 establishment of localization in cell [GO:0051649]; establishment of protein localization [GO:0045184]; hair cell differentiation [GO:0035315]; inner ear auditory receptor cell differentiation [GO:0042491]; inner ear receptor cell differentiation [GO:0060113]; maintenance of animal organ identity [GO:0048496]; photoreceptor cell maintenance [GO:0045494]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601] apical plasma membrane [GO:0016324]; basement membrane [GO:0005604]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; periciliary membrane compartment [GO:1990075]; photoreceptor connecting cilium [GO:0032391]; photoreceptor inner segment [GO:0001917]; stereocilia ankle link [GO:0002141]; stereocilia ankle link complex [GO:0002142]; stereocilium bundle [GO:0032421]; stereocilium membrane [GO:0060171]; USH2 complex [GO:1990696] collagen binding [GO:0005518]; identical protein binding [GO:0042802]; myosin binding [GO:0017022] g4747.t1 O75445 27.707 628 1.56e-43 175.0 sp|O75445|USH2A_HUMAN Usherin OS=Homo sapiens OX=9606 GN=USH2A PE=1 SV=3 USH2A_HUMAN reviewed Usherin (Usher syndrome type IIa protein) (Usher syndrome type-2A protein) Homo sapiens (Human) GO:0001917; GO:0002141; GO:0002142; GO:0005518; GO:0005576; GO:0005604; GO:0005737; GO:0007601; GO:0007605; GO:0016324; GO:0017022; GO:0032391; GO:0032421; GO:0035315; GO:0036064; GO:0042491; GO:0042802; GO:0045184; GO:0045494; GO:0048496; GO:0050953; GO:0051649; GO:0060113; GO:0060171; GO:1990075; GO:1990696 establishment of localization in cell [GO:0051649]; establishment of protein localization [GO:0045184]; hair cell differentiation [GO:0035315]; inner ear auditory receptor cell differentiation [GO:0042491]; inner ear receptor cell differentiation [GO:0060113]; maintenance of animal organ identity [GO:0048496]; photoreceptor cell maintenance [GO:0045494]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601] apical plasma membrane [GO:0016324]; basement membrane [GO:0005604]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; periciliary membrane compartment [GO:1990075]; photoreceptor connecting cilium [GO:0032391]; photoreceptor inner segment [GO:0001917]; stereocilia ankle link [GO:0002141]; stereocilia ankle link complex [GO:0002142]; stereocilium bundle [GO:0032421]; stereocilium membrane [GO:0060171]; USH2 complex [GO:1990696] collagen binding [GO:0005518]; identical protein binding [GO:0042802]; myosin binding [GO:0017022] g4747.t1 O75445 25.199 627 2.1699999999999998e-42 171.0 sp|O75445|USH2A_HUMAN Usherin OS=Homo sapiens OX=9606 GN=USH2A PE=1 SV=3 USH2A_HUMAN reviewed Usherin (Usher syndrome type IIa protein) (Usher syndrome type-2A protein) Homo sapiens (Human) GO:0001917; GO:0002141; GO:0002142; GO:0005518; GO:0005576; GO:0005604; GO:0005737; GO:0007601; GO:0007605; GO:0016324; GO:0017022; GO:0032391; GO:0032421; GO:0035315; GO:0036064; GO:0042491; GO:0042802; GO:0045184; GO:0045494; GO:0048496; GO:0050953; GO:0051649; GO:0060113; GO:0060171; GO:1990075; GO:1990696 establishment of localization in cell [GO:0051649]; establishment of protein localization [GO:0045184]; hair cell differentiation [GO:0035315]; inner ear auditory receptor cell differentiation [GO:0042491]; inner ear receptor cell differentiation [GO:0060113]; maintenance of animal organ identity [GO:0048496]; photoreceptor cell maintenance [GO:0045494]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601] apical plasma membrane [GO:0016324]; basement membrane [GO:0005604]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; periciliary membrane compartment [GO:1990075]; photoreceptor connecting cilium [GO:0032391]; photoreceptor inner segment [GO:0001917]; stereocilia ankle link [GO:0002141]; stereocilia ankle link complex [GO:0002142]; stereocilium bundle [GO:0032421]; stereocilium membrane [GO:0060171]; USH2 complex [GO:1990696] collagen binding [GO:0005518]; identical protein binding [GO:0042802]; myosin binding [GO:0017022] g4747.t1 O75445 25.903 637 5.7099999999999995e-42 170.0 sp|O75445|USH2A_HUMAN Usherin OS=Homo sapiens OX=9606 GN=USH2A PE=1 SV=3 USH2A_HUMAN reviewed Usherin (Usher syndrome type IIa protein) (Usher syndrome type-2A protein) Homo sapiens (Human) GO:0001917; GO:0002141; GO:0002142; GO:0005518; GO:0005576; GO:0005604; GO:0005737; GO:0007601; GO:0007605; GO:0016324; GO:0017022; GO:0032391; GO:0032421; GO:0035315; GO:0036064; GO:0042491; GO:0042802; GO:0045184; GO:0045494; GO:0048496; GO:0050953; GO:0051649; GO:0060113; GO:0060171; GO:1990075; GO:1990696 establishment of localization in cell [GO:0051649]; establishment of protein localization [GO:0045184]; hair cell differentiation [GO:0035315]; inner ear auditory receptor cell differentiation [GO:0042491]; inner ear receptor cell differentiation [GO:0060113]; maintenance of animal organ identity [GO:0048496]; photoreceptor cell maintenance [GO:0045494]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601] apical plasma membrane [GO:0016324]; basement membrane [GO:0005604]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; periciliary membrane compartment [GO:1990075]; photoreceptor connecting cilium [GO:0032391]; photoreceptor inner segment [GO:0001917]; stereocilia ankle link [GO:0002141]; stereocilia ankle link complex [GO:0002142]; stereocilium bundle [GO:0032421]; stereocilium membrane [GO:0060171]; USH2 complex [GO:1990696] collagen binding [GO:0005518]; identical protein binding [GO:0042802]; myosin binding [GO:0017022] g4747.t1 O75445 26.736 576 4.51e-41 167.0 sp|O75445|USH2A_HUMAN Usherin OS=Homo sapiens OX=9606 GN=USH2A PE=1 SV=3 USH2A_HUMAN reviewed Usherin (Usher syndrome type IIa protein) (Usher syndrome type-2A protein) Homo sapiens (Human) GO:0001917; GO:0002141; GO:0002142; GO:0005518; GO:0005576; GO:0005604; GO:0005737; GO:0007601; GO:0007605; GO:0016324; GO:0017022; GO:0032391; GO:0032421; GO:0035315; GO:0036064; GO:0042491; GO:0042802; GO:0045184; GO:0045494; GO:0048496; GO:0050953; GO:0051649; GO:0060113; GO:0060171; GO:1990075; GO:1990696 establishment of localization in cell [GO:0051649]; establishment of protein localization [GO:0045184]; hair cell differentiation [GO:0035315]; inner ear auditory receptor cell differentiation [GO:0042491]; inner ear receptor cell differentiation [GO:0060113]; maintenance of animal organ identity [GO:0048496]; photoreceptor cell maintenance [GO:0045494]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601] apical plasma membrane [GO:0016324]; basement membrane [GO:0005604]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; periciliary membrane compartment [GO:1990075]; photoreceptor connecting cilium [GO:0032391]; photoreceptor inner segment [GO:0001917]; stereocilia ankle link [GO:0002141]; stereocilia ankle link complex [GO:0002142]; stereocilium bundle [GO:0032421]; stereocilium membrane [GO:0060171]; USH2 complex [GO:1990696] collagen binding [GO:0005518]; identical protein binding [GO:0042802]; myosin binding [GO:0017022] g4747.t1 O75445 31.818 286 1.12e-35 150.0 sp|O75445|USH2A_HUMAN Usherin OS=Homo sapiens OX=9606 GN=USH2A PE=1 SV=3 USH2A_HUMAN reviewed Usherin (Usher syndrome type IIa protein) (Usher syndrome type-2A protein) Homo sapiens (Human) GO:0001917; GO:0002141; GO:0002142; GO:0005518; GO:0005576; GO:0005604; GO:0005737; GO:0007601; GO:0007605; GO:0016324; GO:0017022; GO:0032391; GO:0032421; GO:0035315; GO:0036064; GO:0042491; GO:0042802; GO:0045184; GO:0045494; GO:0048496; GO:0050953; GO:0051649; GO:0060113; GO:0060171; GO:1990075; GO:1990696 establishment of localization in cell [GO:0051649]; establishment of protein localization [GO:0045184]; hair cell differentiation [GO:0035315]; inner ear auditory receptor cell differentiation [GO:0042491]; inner ear receptor cell differentiation [GO:0060113]; maintenance of animal organ identity [GO:0048496]; photoreceptor cell maintenance [GO:0045494]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601] apical plasma membrane [GO:0016324]; basement membrane [GO:0005604]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; periciliary membrane compartment [GO:1990075]; photoreceptor connecting cilium [GO:0032391]; photoreceptor inner segment [GO:0001917]; stereocilia ankle link [GO:0002141]; stereocilia ankle link complex [GO:0002142]; stereocilium bundle [GO:0032421]; stereocilium membrane [GO:0060171]; USH2 complex [GO:1990696] collagen binding [GO:0005518]; identical protein binding [GO:0042802]; myosin binding [GO:0017022] g4747.t1 O75445 25.213 587 4.43e-35 148.0 sp|O75445|USH2A_HUMAN Usherin OS=Homo sapiens OX=9606 GN=USH2A PE=1 SV=3 USH2A_HUMAN reviewed Usherin (Usher syndrome type IIa protein) (Usher syndrome type-2A protein) Homo sapiens (Human) GO:0001917; GO:0002141; GO:0002142; GO:0005518; GO:0005576; GO:0005604; GO:0005737; GO:0007601; GO:0007605; GO:0016324; GO:0017022; GO:0032391; GO:0032421; GO:0035315; GO:0036064; GO:0042491; GO:0042802; GO:0045184; GO:0045494; GO:0048496; GO:0050953; GO:0051649; GO:0060113; GO:0060171; GO:1990075; GO:1990696 establishment of localization in cell [GO:0051649]; establishment of protein localization [GO:0045184]; hair cell differentiation [GO:0035315]; inner ear auditory receptor cell differentiation [GO:0042491]; inner ear receptor cell differentiation [GO:0060113]; maintenance of animal organ identity [GO:0048496]; photoreceptor cell maintenance [GO:0045494]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601] apical plasma membrane [GO:0016324]; basement membrane [GO:0005604]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; periciliary membrane compartment [GO:1990075]; photoreceptor connecting cilium [GO:0032391]; photoreceptor inner segment [GO:0001917]; stereocilia ankle link [GO:0002141]; stereocilia ankle link complex [GO:0002142]; stereocilium bundle [GO:0032421]; stereocilium membrane [GO:0060171]; USH2 complex [GO:1990696] collagen binding [GO:0005518]; identical protein binding [GO:0042802]; myosin binding [GO:0017022] g4747.t1 O75445 26.582 553 9.900000000000001e-35 147.0 sp|O75445|USH2A_HUMAN Usherin OS=Homo sapiens OX=9606 GN=USH2A PE=1 SV=3 USH2A_HUMAN reviewed Usherin (Usher syndrome type IIa protein) (Usher syndrome type-2A protein) Homo sapiens (Human) GO:0001917; GO:0002141; GO:0002142; GO:0005518; GO:0005576; GO:0005604; GO:0005737; GO:0007601; GO:0007605; GO:0016324; GO:0017022; GO:0032391; GO:0032421; GO:0035315; GO:0036064; GO:0042491; GO:0042802; GO:0045184; GO:0045494; GO:0048496; GO:0050953; GO:0051649; GO:0060113; GO:0060171; GO:1990075; GO:1990696 establishment of localization in cell [GO:0051649]; establishment of protein localization [GO:0045184]; hair cell differentiation [GO:0035315]; inner ear auditory receptor cell differentiation [GO:0042491]; inner ear receptor cell differentiation [GO:0060113]; maintenance of animal organ identity [GO:0048496]; photoreceptor cell maintenance [GO:0045494]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601] apical plasma membrane [GO:0016324]; basement membrane [GO:0005604]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; periciliary membrane compartment [GO:1990075]; photoreceptor connecting cilium [GO:0032391]; photoreceptor inner segment [GO:0001917]; stereocilia ankle link [GO:0002141]; stereocilia ankle link complex [GO:0002142]; stereocilium bundle [GO:0032421]; stereocilium membrane [GO:0060171]; USH2 complex [GO:1990696] collagen binding [GO:0005518]; identical protein binding [GO:0042802]; myosin binding [GO:0017022] g4747.t1 O75445 26.182 592 2.73e-31 136.0 sp|O75445|USH2A_HUMAN Usherin OS=Homo sapiens OX=9606 GN=USH2A PE=1 SV=3 USH2A_HUMAN reviewed Usherin (Usher syndrome type IIa protein) (Usher syndrome type-2A protein) Homo sapiens (Human) GO:0001917; GO:0002141; GO:0002142; GO:0005518; GO:0005576; GO:0005604; GO:0005737; GO:0007601; GO:0007605; GO:0016324; GO:0017022; GO:0032391; GO:0032421; GO:0035315; GO:0036064; GO:0042491; GO:0042802; GO:0045184; GO:0045494; GO:0048496; GO:0050953; GO:0051649; GO:0060113; GO:0060171; GO:1990075; GO:1990696 establishment of localization in cell [GO:0051649]; establishment of protein localization [GO:0045184]; hair cell differentiation [GO:0035315]; inner ear auditory receptor cell differentiation [GO:0042491]; inner ear receptor cell differentiation [GO:0060113]; maintenance of animal organ identity [GO:0048496]; photoreceptor cell maintenance [GO:0045494]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601] apical plasma membrane [GO:0016324]; basement membrane [GO:0005604]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; periciliary membrane compartment [GO:1990075]; photoreceptor connecting cilium [GO:0032391]; photoreceptor inner segment [GO:0001917]; stereocilia ankle link [GO:0002141]; stereocilia ankle link complex [GO:0002142]; stereocilium bundle [GO:0032421]; stereocilium membrane [GO:0060171]; USH2 complex [GO:1990696] collagen binding [GO:0005518]; identical protein binding [GO:0042802]; myosin binding [GO:0017022] g4747.t1 O75445 27.115 461 6.4e-29 129.0 sp|O75445|USH2A_HUMAN Usherin OS=Homo sapiens OX=9606 GN=USH2A PE=1 SV=3 USH2A_HUMAN reviewed Usherin (Usher syndrome type IIa protein) (Usher syndrome type-2A protein) Homo sapiens (Human) GO:0001917; GO:0002141; GO:0002142; GO:0005518; GO:0005576; GO:0005604; GO:0005737; GO:0007601; GO:0007605; GO:0016324; GO:0017022; GO:0032391; GO:0032421; GO:0035315; GO:0036064; GO:0042491; GO:0042802; GO:0045184; GO:0045494; GO:0048496; GO:0050953; GO:0051649; GO:0060113; GO:0060171; GO:1990075; GO:1990696 establishment of localization in cell [GO:0051649]; establishment of protein localization [GO:0045184]; hair cell differentiation [GO:0035315]; inner ear auditory receptor cell differentiation [GO:0042491]; inner ear receptor cell differentiation [GO:0060113]; maintenance of animal organ identity [GO:0048496]; photoreceptor cell maintenance [GO:0045494]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601] apical plasma membrane [GO:0016324]; basement membrane [GO:0005604]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; periciliary membrane compartment [GO:1990075]; photoreceptor connecting cilium [GO:0032391]; photoreceptor inner segment [GO:0001917]; stereocilia ankle link [GO:0002141]; stereocilia ankle link complex [GO:0002142]; stereocilium bundle [GO:0032421]; stereocilium membrane [GO:0060171]; USH2 complex [GO:1990696] collagen binding [GO:0005518]; identical protein binding [GO:0042802]; myosin binding [GO:0017022] g4747.t1 O75445 32.117 274 8.44e-26 119.0 sp|O75445|USH2A_HUMAN Usherin OS=Homo sapiens OX=9606 GN=USH2A PE=1 SV=3 USH2A_HUMAN reviewed Usherin (Usher syndrome type IIa protein) (Usher syndrome type-2A protein) Homo sapiens (Human) GO:0001917; GO:0002141; GO:0002142; GO:0005518; GO:0005576; GO:0005604; GO:0005737; GO:0007601; GO:0007605; GO:0016324; GO:0017022; GO:0032391; GO:0032421; GO:0035315; GO:0036064; GO:0042491; GO:0042802; GO:0045184; GO:0045494; GO:0048496; GO:0050953; GO:0051649; GO:0060113; GO:0060171; GO:1990075; GO:1990696 establishment of localization in cell [GO:0051649]; establishment of protein localization [GO:0045184]; hair cell differentiation [GO:0035315]; inner ear auditory receptor cell differentiation [GO:0042491]; inner ear receptor cell differentiation [GO:0060113]; maintenance of animal organ identity [GO:0048496]; photoreceptor cell maintenance [GO:0045494]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601] apical plasma membrane [GO:0016324]; basement membrane [GO:0005604]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; periciliary membrane compartment [GO:1990075]; photoreceptor connecting cilium [GO:0032391]; photoreceptor inner segment [GO:0001917]; stereocilia ankle link [GO:0002141]; stereocilia ankle link complex [GO:0002142]; stereocilium bundle [GO:0032421]; stereocilium membrane [GO:0060171]; USH2 complex [GO:1990696] collagen binding [GO:0005518]; identical protein binding [GO:0042802]; myosin binding [GO:0017022] g4747.t1 O75445 30.675 326 4.05e-22 107.0 sp|O75445|USH2A_HUMAN Usherin OS=Homo sapiens OX=9606 GN=USH2A PE=1 SV=3 USH2A_HUMAN reviewed Usherin (Usher syndrome type IIa protein) (Usher syndrome type-2A protein) Homo sapiens (Human) GO:0001917; GO:0002141; GO:0002142; GO:0005518; GO:0005576; GO:0005604; GO:0005737; GO:0007601; GO:0007605; GO:0016324; GO:0017022; GO:0032391; GO:0032421; GO:0035315; GO:0036064; GO:0042491; GO:0042802; GO:0045184; GO:0045494; GO:0048496; GO:0050953; GO:0051649; GO:0060113; GO:0060171; GO:1990075; GO:1990696 establishment of localization in cell [GO:0051649]; establishment of protein localization [GO:0045184]; hair cell differentiation [GO:0035315]; inner ear auditory receptor cell differentiation [GO:0042491]; inner ear receptor cell differentiation [GO:0060113]; maintenance of animal organ identity [GO:0048496]; photoreceptor cell maintenance [GO:0045494]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601] apical plasma membrane [GO:0016324]; basement membrane [GO:0005604]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; periciliary membrane compartment [GO:1990075]; photoreceptor connecting cilium [GO:0032391]; photoreceptor inner segment [GO:0001917]; stereocilia ankle link [GO:0002141]; stereocilia ankle link complex [GO:0002142]; stereocilium bundle [GO:0032421]; stereocilium membrane [GO:0060171]; USH2 complex [GO:1990696] collagen binding [GO:0005518]; identical protein binding [GO:0042802]; myosin binding [GO:0017022] g4747.t2 O75445 35.216 832 9.250000000000001e-107 364.0 sp|O75445|USH2A_HUMAN Usherin OS=Homo sapiens OX=9606 GN=USH2A PE=1 SV=3 USH2A_HUMAN reviewed Usherin (Usher syndrome type IIa protein) (Usher syndrome type-2A protein) Homo sapiens (Human) GO:0001917; GO:0002141; GO:0002142; GO:0005518; GO:0005576; GO:0005604; GO:0005737; GO:0007601; GO:0007605; GO:0016324; GO:0017022; GO:0032391; GO:0032421; GO:0035315; GO:0036064; GO:0042491; GO:0042802; GO:0045184; GO:0045494; GO:0048496; GO:0050953; GO:0051649; GO:0060113; GO:0060171; GO:1990075; GO:1990696 establishment of localization in cell [GO:0051649]; establishment of protein localization [GO:0045184]; hair cell differentiation [GO:0035315]; inner ear auditory receptor cell differentiation [GO:0042491]; inner ear receptor cell differentiation [GO:0060113]; maintenance of animal organ identity [GO:0048496]; photoreceptor cell maintenance [GO:0045494]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601] apical plasma membrane [GO:0016324]; basement membrane [GO:0005604]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; periciliary membrane compartment [GO:1990075]; photoreceptor connecting cilium [GO:0032391]; photoreceptor inner segment [GO:0001917]; stereocilia ankle link [GO:0002141]; stereocilia ankle link complex [GO:0002142]; stereocilium bundle [GO:0032421]; stereocilium membrane [GO:0060171]; USH2 complex [GO:1990696] collagen binding [GO:0005518]; identical protein binding [GO:0042802]; myosin binding [GO:0017022] g4747.t2 O75445 28.707 526 2.4599999999999997e-46 184.0 sp|O75445|USH2A_HUMAN Usherin OS=Homo sapiens OX=9606 GN=USH2A PE=1 SV=3 USH2A_HUMAN reviewed Usherin (Usher syndrome type IIa protein) (Usher syndrome type-2A protein) Homo sapiens (Human) GO:0001917; GO:0002141; GO:0002142; GO:0005518; GO:0005576; GO:0005604; GO:0005737; GO:0007601; GO:0007605; GO:0016324; GO:0017022; GO:0032391; GO:0032421; GO:0035315; GO:0036064; GO:0042491; GO:0042802; GO:0045184; GO:0045494; GO:0048496; GO:0050953; GO:0051649; GO:0060113; GO:0060171; GO:1990075; GO:1990696 establishment of localization in cell [GO:0051649]; establishment of protein localization [GO:0045184]; hair cell differentiation [GO:0035315]; inner ear auditory receptor cell differentiation [GO:0042491]; inner ear receptor cell differentiation [GO:0060113]; maintenance of animal organ identity [GO:0048496]; photoreceptor cell maintenance [GO:0045494]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601] apical plasma membrane [GO:0016324]; basement membrane [GO:0005604]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; periciliary membrane compartment [GO:1990075]; photoreceptor connecting cilium [GO:0032391]; photoreceptor inner segment [GO:0001917]; stereocilia ankle link [GO:0002141]; stereocilia ankle link complex [GO:0002142]; stereocilium bundle [GO:0032421]; stereocilium membrane [GO:0060171]; USH2 complex [GO:1990696] collagen binding [GO:0005518]; identical protein binding [GO:0042802]; myosin binding [GO:0017022] g4747.t2 O75445 26.719 640 4.53e-45 180.0 sp|O75445|USH2A_HUMAN Usherin OS=Homo sapiens OX=9606 GN=USH2A PE=1 SV=3 USH2A_HUMAN reviewed Usherin (Usher syndrome type IIa protein) (Usher syndrome type-2A protein) Homo sapiens (Human) GO:0001917; GO:0002141; GO:0002142; GO:0005518; GO:0005576; GO:0005604; GO:0005737; GO:0007601; GO:0007605; GO:0016324; GO:0017022; GO:0032391; GO:0032421; GO:0035315; GO:0036064; GO:0042491; GO:0042802; GO:0045184; GO:0045494; GO:0048496; GO:0050953; GO:0051649; GO:0060113; GO:0060171; GO:1990075; GO:1990696 establishment of localization in cell [GO:0051649]; establishment of protein localization [GO:0045184]; hair cell differentiation [GO:0035315]; inner ear auditory receptor cell differentiation [GO:0042491]; inner ear receptor cell differentiation [GO:0060113]; maintenance of animal organ identity [GO:0048496]; photoreceptor cell maintenance [GO:0045494]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601] apical plasma membrane [GO:0016324]; basement membrane [GO:0005604]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; periciliary membrane compartment [GO:1990075]; photoreceptor connecting cilium [GO:0032391]; photoreceptor inner segment [GO:0001917]; stereocilia ankle link [GO:0002141]; stereocilia ankle link complex [GO:0002142]; stereocilium bundle [GO:0032421]; stereocilium membrane [GO:0060171]; USH2 complex [GO:1990696] collagen binding [GO:0005518]; identical protein binding [GO:0042802]; myosin binding [GO:0017022] g4747.t2 O75445 26.05 595 1.65e-44 178.0 sp|O75445|USH2A_HUMAN Usherin OS=Homo sapiens OX=9606 GN=USH2A PE=1 SV=3 USH2A_HUMAN reviewed Usherin (Usher syndrome type IIa protein) (Usher syndrome type-2A protein) Homo sapiens (Human) GO:0001917; GO:0002141; GO:0002142; GO:0005518; GO:0005576; GO:0005604; GO:0005737; GO:0007601; GO:0007605; GO:0016324; GO:0017022; GO:0032391; GO:0032421; GO:0035315; GO:0036064; GO:0042491; GO:0042802; GO:0045184; GO:0045494; GO:0048496; GO:0050953; GO:0051649; GO:0060113; GO:0060171; GO:1990075; GO:1990696 establishment of localization in cell [GO:0051649]; establishment of protein localization [GO:0045184]; hair cell differentiation [GO:0035315]; inner ear auditory receptor cell differentiation [GO:0042491]; inner ear receptor cell differentiation [GO:0060113]; maintenance of animal organ identity [GO:0048496]; photoreceptor cell maintenance [GO:0045494]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601] apical plasma membrane [GO:0016324]; basement membrane [GO:0005604]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; periciliary membrane compartment [GO:1990075]; photoreceptor connecting cilium [GO:0032391]; photoreceptor inner segment [GO:0001917]; stereocilia ankle link [GO:0002141]; stereocilia ankle link complex [GO:0002142]; stereocilium bundle [GO:0032421]; stereocilium membrane [GO:0060171]; USH2 complex [GO:1990696] collagen binding [GO:0005518]; identical protein binding [GO:0042802]; myosin binding [GO:0017022] g4747.t2 O75445 26.573 572 2.72e-44 177.0 sp|O75445|USH2A_HUMAN Usherin OS=Homo sapiens OX=9606 GN=USH2A PE=1 SV=3 USH2A_HUMAN reviewed Usherin (Usher syndrome type IIa protein) (Usher syndrome type-2A protein) Homo sapiens (Human) GO:0001917; GO:0002141; GO:0002142; GO:0005518; GO:0005576; GO:0005604; GO:0005737; GO:0007601; GO:0007605; GO:0016324; GO:0017022; GO:0032391; GO:0032421; GO:0035315; GO:0036064; GO:0042491; GO:0042802; GO:0045184; GO:0045494; GO:0048496; GO:0050953; GO:0051649; GO:0060113; GO:0060171; GO:1990075; GO:1990696 establishment of localization in cell [GO:0051649]; establishment of protein localization [GO:0045184]; hair cell differentiation [GO:0035315]; inner ear auditory receptor cell differentiation [GO:0042491]; inner ear receptor cell differentiation [GO:0060113]; maintenance of animal organ identity [GO:0048496]; photoreceptor cell maintenance [GO:0045494]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601] apical plasma membrane [GO:0016324]; basement membrane [GO:0005604]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; periciliary membrane compartment [GO:1990075]; photoreceptor connecting cilium [GO:0032391]; photoreceptor inner segment [GO:0001917]; stereocilia ankle link [GO:0002141]; stereocilia ankle link complex [GO:0002142]; stereocilium bundle [GO:0032421]; stereocilium membrane [GO:0060171]; USH2 complex [GO:1990696] collagen binding [GO:0005518]; identical protein binding [GO:0042802]; myosin binding [GO:0017022] g4747.t2 O75445 27.707 628 2.3400000000000003e-43 174.0 sp|O75445|USH2A_HUMAN Usherin OS=Homo sapiens OX=9606 GN=USH2A PE=1 SV=3 USH2A_HUMAN reviewed Usherin (Usher syndrome type IIa protein) (Usher syndrome type-2A protein) Homo sapiens (Human) GO:0001917; GO:0002141; GO:0002142; GO:0005518; GO:0005576; GO:0005604; GO:0005737; GO:0007601; GO:0007605; GO:0016324; GO:0017022; GO:0032391; GO:0032421; GO:0035315; GO:0036064; GO:0042491; GO:0042802; GO:0045184; GO:0045494; GO:0048496; GO:0050953; GO:0051649; GO:0060113; GO:0060171; GO:1990075; GO:1990696 establishment of localization in cell [GO:0051649]; establishment of protein localization [GO:0045184]; hair cell differentiation [GO:0035315]; inner ear auditory receptor cell differentiation [GO:0042491]; inner ear receptor cell differentiation [GO:0060113]; maintenance of animal organ identity [GO:0048496]; photoreceptor cell maintenance [GO:0045494]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601] apical plasma membrane [GO:0016324]; basement membrane [GO:0005604]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; periciliary membrane compartment [GO:1990075]; photoreceptor connecting cilium [GO:0032391]; photoreceptor inner segment [GO:0001917]; stereocilia ankle link [GO:0002141]; stereocilia ankle link complex [GO:0002142]; stereocilium bundle [GO:0032421]; stereocilium membrane [GO:0060171]; USH2 complex [GO:1990696] collagen binding [GO:0005518]; identical protein binding [GO:0042802]; myosin binding [GO:0017022] g4747.t2 O75445 25.199 627 2.7899999999999998e-42 171.0 sp|O75445|USH2A_HUMAN Usherin OS=Homo sapiens OX=9606 GN=USH2A PE=1 SV=3 USH2A_HUMAN reviewed Usherin (Usher syndrome type IIa protein) (Usher syndrome type-2A protein) Homo sapiens (Human) GO:0001917; GO:0002141; GO:0002142; GO:0005518; GO:0005576; GO:0005604; GO:0005737; GO:0007601; GO:0007605; GO:0016324; GO:0017022; GO:0032391; GO:0032421; GO:0035315; GO:0036064; GO:0042491; GO:0042802; GO:0045184; GO:0045494; GO:0048496; GO:0050953; GO:0051649; GO:0060113; GO:0060171; GO:1990075; GO:1990696 establishment of localization in cell [GO:0051649]; establishment of protein localization [GO:0045184]; hair cell differentiation [GO:0035315]; inner ear auditory receptor cell differentiation [GO:0042491]; inner ear receptor cell differentiation [GO:0060113]; maintenance of animal organ identity [GO:0048496]; photoreceptor cell maintenance [GO:0045494]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601] apical plasma membrane [GO:0016324]; basement membrane [GO:0005604]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; periciliary membrane compartment [GO:1990075]; photoreceptor connecting cilium [GO:0032391]; photoreceptor inner segment [GO:0001917]; stereocilia ankle link [GO:0002141]; stereocilia ankle link complex [GO:0002142]; stereocilium bundle [GO:0032421]; stereocilium membrane [GO:0060171]; USH2 complex [GO:1990696] collagen binding [GO:0005518]; identical protein binding [GO:0042802]; myosin binding [GO:0017022] g4747.t2 O75445 25.903 637 7.399999999999999e-42 170.0 sp|O75445|USH2A_HUMAN Usherin OS=Homo sapiens OX=9606 GN=USH2A PE=1 SV=3 USH2A_HUMAN reviewed Usherin (Usher syndrome type IIa protein) (Usher syndrome type-2A protein) Homo sapiens (Human) GO:0001917; GO:0002141; GO:0002142; GO:0005518; GO:0005576; GO:0005604; GO:0005737; GO:0007601; GO:0007605; GO:0016324; GO:0017022; GO:0032391; GO:0032421; GO:0035315; GO:0036064; GO:0042491; GO:0042802; GO:0045184; GO:0045494; GO:0048496; GO:0050953; GO:0051649; GO:0060113; GO:0060171; GO:1990075; GO:1990696 establishment of localization in cell [GO:0051649]; establishment of protein localization [GO:0045184]; hair cell differentiation [GO:0035315]; inner ear auditory receptor cell differentiation [GO:0042491]; inner ear receptor cell differentiation [GO:0060113]; maintenance of animal organ identity [GO:0048496]; photoreceptor cell maintenance [GO:0045494]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601] apical plasma membrane [GO:0016324]; basement membrane [GO:0005604]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; periciliary membrane compartment [GO:1990075]; photoreceptor connecting cilium [GO:0032391]; photoreceptor inner segment [GO:0001917]; stereocilia ankle link [GO:0002141]; stereocilia ankle link complex [GO:0002142]; stereocilium bundle [GO:0032421]; stereocilium membrane [GO:0060171]; USH2 complex [GO:1990696] collagen binding [GO:0005518]; identical protein binding [GO:0042802]; myosin binding [GO:0017022] g4747.t2 O75445 26.736 576 6.53e-41 167.0 sp|O75445|USH2A_HUMAN Usherin OS=Homo sapiens OX=9606 GN=USH2A PE=1 SV=3 USH2A_HUMAN reviewed Usherin (Usher syndrome type IIa protein) (Usher syndrome type-2A protein) Homo sapiens (Human) GO:0001917; GO:0002141; GO:0002142; GO:0005518; GO:0005576; GO:0005604; GO:0005737; GO:0007601; GO:0007605; GO:0016324; GO:0017022; GO:0032391; GO:0032421; GO:0035315; GO:0036064; GO:0042491; GO:0042802; GO:0045184; GO:0045494; GO:0048496; GO:0050953; GO:0051649; GO:0060113; GO:0060171; GO:1990075; GO:1990696 establishment of localization in cell [GO:0051649]; establishment of protein localization [GO:0045184]; hair cell differentiation [GO:0035315]; inner ear auditory receptor cell differentiation [GO:0042491]; inner ear receptor cell differentiation [GO:0060113]; maintenance of animal organ identity [GO:0048496]; photoreceptor cell maintenance [GO:0045494]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601] apical plasma membrane [GO:0016324]; basement membrane [GO:0005604]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; periciliary membrane compartment [GO:1990075]; photoreceptor connecting cilium [GO:0032391]; photoreceptor inner segment [GO:0001917]; stereocilia ankle link [GO:0002141]; stereocilia ankle link complex [GO:0002142]; stereocilium bundle [GO:0032421]; stereocilium membrane [GO:0060171]; USH2 complex [GO:1990696] collagen binding [GO:0005518]; identical protein binding [GO:0042802]; myosin binding [GO:0017022] g4747.t2 O75445 31.818 286 1.16e-35 150.0 sp|O75445|USH2A_HUMAN Usherin OS=Homo sapiens OX=9606 GN=USH2A PE=1 SV=3 USH2A_HUMAN reviewed Usherin (Usher syndrome type IIa protein) (Usher syndrome type-2A protein) Homo sapiens (Human) GO:0001917; GO:0002141; GO:0002142; GO:0005518; GO:0005576; GO:0005604; GO:0005737; GO:0007601; GO:0007605; GO:0016324; GO:0017022; GO:0032391; GO:0032421; GO:0035315; GO:0036064; GO:0042491; GO:0042802; GO:0045184; GO:0045494; GO:0048496; GO:0050953; GO:0051649; GO:0060113; GO:0060171; GO:1990075; GO:1990696 establishment of localization in cell [GO:0051649]; establishment of protein localization [GO:0045184]; hair cell differentiation [GO:0035315]; inner ear auditory receptor cell differentiation [GO:0042491]; inner ear receptor cell differentiation [GO:0060113]; maintenance of animal organ identity [GO:0048496]; photoreceptor cell maintenance [GO:0045494]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601] apical plasma membrane [GO:0016324]; basement membrane [GO:0005604]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; periciliary membrane compartment [GO:1990075]; photoreceptor connecting cilium [GO:0032391]; photoreceptor inner segment [GO:0001917]; stereocilia ankle link [GO:0002141]; stereocilia ankle link complex [GO:0002142]; stereocilium bundle [GO:0032421]; stereocilium membrane [GO:0060171]; USH2 complex [GO:1990696] collagen binding [GO:0005518]; identical protein binding [GO:0042802]; myosin binding [GO:0017022] g4747.t2 O75445 25.213 587 6.220000000000001e-35 148.0 sp|O75445|USH2A_HUMAN Usherin OS=Homo sapiens OX=9606 GN=USH2A PE=1 SV=3 USH2A_HUMAN reviewed Usherin (Usher syndrome type IIa protein) (Usher syndrome type-2A protein) Homo sapiens (Human) GO:0001917; GO:0002141; GO:0002142; GO:0005518; GO:0005576; GO:0005604; GO:0005737; GO:0007601; GO:0007605; GO:0016324; GO:0017022; GO:0032391; GO:0032421; GO:0035315; GO:0036064; GO:0042491; GO:0042802; GO:0045184; GO:0045494; GO:0048496; GO:0050953; GO:0051649; GO:0060113; GO:0060171; GO:1990075; GO:1990696 establishment of localization in cell [GO:0051649]; establishment of protein localization [GO:0045184]; hair cell differentiation [GO:0035315]; inner ear auditory receptor cell differentiation [GO:0042491]; inner ear receptor cell differentiation [GO:0060113]; maintenance of animal organ identity [GO:0048496]; photoreceptor cell maintenance [GO:0045494]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601] apical plasma membrane [GO:0016324]; basement membrane [GO:0005604]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; periciliary membrane compartment [GO:1990075]; photoreceptor connecting cilium [GO:0032391]; photoreceptor inner segment [GO:0001917]; stereocilia ankle link [GO:0002141]; stereocilia ankle link complex [GO:0002142]; stereocilium bundle [GO:0032421]; stereocilium membrane [GO:0060171]; USH2 complex [GO:1990696] collagen binding [GO:0005518]; identical protein binding [GO:0042802]; myosin binding [GO:0017022] g4747.t2 O75445 26.582 553 1.33e-34 147.0 sp|O75445|USH2A_HUMAN Usherin OS=Homo sapiens OX=9606 GN=USH2A PE=1 SV=3 USH2A_HUMAN reviewed Usherin (Usher syndrome type IIa protein) (Usher syndrome type-2A protein) Homo sapiens (Human) GO:0001917; GO:0002141; GO:0002142; GO:0005518; GO:0005576; GO:0005604; GO:0005737; GO:0007601; GO:0007605; GO:0016324; GO:0017022; GO:0032391; GO:0032421; GO:0035315; GO:0036064; GO:0042491; GO:0042802; GO:0045184; GO:0045494; GO:0048496; GO:0050953; GO:0051649; GO:0060113; GO:0060171; GO:1990075; GO:1990696 establishment of localization in cell [GO:0051649]; establishment of protein localization [GO:0045184]; hair cell differentiation [GO:0035315]; inner ear auditory receptor cell differentiation [GO:0042491]; inner ear receptor cell differentiation [GO:0060113]; maintenance of animal organ identity [GO:0048496]; photoreceptor cell maintenance [GO:0045494]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601] apical plasma membrane [GO:0016324]; basement membrane [GO:0005604]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; periciliary membrane compartment [GO:1990075]; photoreceptor connecting cilium [GO:0032391]; photoreceptor inner segment [GO:0001917]; stereocilia ankle link [GO:0002141]; stereocilia ankle link complex [GO:0002142]; stereocilium bundle [GO:0032421]; stereocilium membrane [GO:0060171]; USH2 complex [GO:1990696] collagen binding [GO:0005518]; identical protein binding [GO:0042802]; myosin binding [GO:0017022] g4747.t2 O75445 26.182 592 3.5500000000000004e-31 136.0 sp|O75445|USH2A_HUMAN Usherin OS=Homo sapiens OX=9606 GN=USH2A PE=1 SV=3 USH2A_HUMAN reviewed Usherin (Usher syndrome type IIa protein) (Usher syndrome type-2A protein) Homo sapiens (Human) GO:0001917; GO:0002141; GO:0002142; GO:0005518; GO:0005576; GO:0005604; GO:0005737; GO:0007601; GO:0007605; GO:0016324; GO:0017022; GO:0032391; GO:0032421; GO:0035315; GO:0036064; GO:0042491; GO:0042802; GO:0045184; GO:0045494; GO:0048496; GO:0050953; GO:0051649; GO:0060113; GO:0060171; GO:1990075; GO:1990696 establishment of localization in cell [GO:0051649]; establishment of protein localization [GO:0045184]; hair cell differentiation [GO:0035315]; inner ear auditory receptor cell differentiation [GO:0042491]; inner ear receptor cell differentiation [GO:0060113]; maintenance of animal organ identity [GO:0048496]; photoreceptor cell maintenance [GO:0045494]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601] apical plasma membrane [GO:0016324]; basement membrane [GO:0005604]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; periciliary membrane compartment [GO:1990075]; photoreceptor connecting cilium [GO:0032391]; photoreceptor inner segment [GO:0001917]; stereocilia ankle link [GO:0002141]; stereocilia ankle link complex [GO:0002142]; stereocilium bundle [GO:0032421]; stereocilium membrane [GO:0060171]; USH2 complex [GO:1990696] collagen binding [GO:0005518]; identical protein binding [GO:0042802]; myosin binding [GO:0017022] g4747.t2 O75445 27.115 461 7.14e-29 129.0 sp|O75445|USH2A_HUMAN Usherin OS=Homo sapiens OX=9606 GN=USH2A PE=1 SV=3 USH2A_HUMAN reviewed Usherin (Usher syndrome type IIa protein) (Usher syndrome type-2A protein) Homo sapiens (Human) GO:0001917; GO:0002141; GO:0002142; GO:0005518; GO:0005576; GO:0005604; GO:0005737; GO:0007601; GO:0007605; GO:0016324; GO:0017022; GO:0032391; GO:0032421; GO:0035315; GO:0036064; GO:0042491; GO:0042802; GO:0045184; GO:0045494; GO:0048496; GO:0050953; GO:0051649; GO:0060113; GO:0060171; GO:1990075; GO:1990696 establishment of localization in cell [GO:0051649]; establishment of protein localization [GO:0045184]; hair cell differentiation [GO:0035315]; inner ear auditory receptor cell differentiation [GO:0042491]; inner ear receptor cell differentiation [GO:0060113]; maintenance of animal organ identity [GO:0048496]; photoreceptor cell maintenance [GO:0045494]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601] apical plasma membrane [GO:0016324]; basement membrane [GO:0005604]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; periciliary membrane compartment [GO:1990075]; photoreceptor connecting cilium [GO:0032391]; photoreceptor inner segment [GO:0001917]; stereocilia ankle link [GO:0002141]; stereocilia ankle link complex [GO:0002142]; stereocilium bundle [GO:0032421]; stereocilium membrane [GO:0060171]; USH2 complex [GO:1990696] collagen binding [GO:0005518]; identical protein binding [GO:0042802]; myosin binding [GO:0017022] g4747.t2 O75445 25.763 524 1.9100000000000003e-27 124.0 sp|O75445|USH2A_HUMAN Usherin OS=Homo sapiens OX=9606 GN=USH2A PE=1 SV=3 USH2A_HUMAN reviewed Usherin (Usher syndrome type IIa protein) (Usher syndrome type-2A protein) Homo sapiens (Human) GO:0001917; GO:0002141; GO:0002142; GO:0005518; GO:0005576; GO:0005604; GO:0005737; GO:0007601; GO:0007605; GO:0016324; GO:0017022; GO:0032391; GO:0032421; GO:0035315; GO:0036064; GO:0042491; GO:0042802; GO:0045184; GO:0045494; GO:0048496; GO:0050953; GO:0051649; GO:0060113; GO:0060171; GO:1990075; GO:1990696 establishment of localization in cell [GO:0051649]; establishment of protein localization [GO:0045184]; hair cell differentiation [GO:0035315]; inner ear auditory receptor cell differentiation [GO:0042491]; inner ear receptor cell differentiation [GO:0060113]; maintenance of animal organ identity [GO:0048496]; photoreceptor cell maintenance [GO:0045494]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601] apical plasma membrane [GO:0016324]; basement membrane [GO:0005604]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; periciliary membrane compartment [GO:1990075]; photoreceptor connecting cilium [GO:0032391]; photoreceptor inner segment [GO:0001917]; stereocilia ankle link [GO:0002141]; stereocilia ankle link complex [GO:0002142]; stereocilium bundle [GO:0032421]; stereocilium membrane [GO:0060171]; USH2 complex [GO:1990696] collagen binding [GO:0005518]; identical protein binding [GO:0042802]; myosin binding [GO:0017022] g4747.t2 O75445 32.117 274 1.01e-25 118.0 sp|O75445|USH2A_HUMAN Usherin OS=Homo sapiens OX=9606 GN=USH2A PE=1 SV=3 USH2A_HUMAN reviewed Usherin (Usher syndrome type IIa protein) (Usher syndrome type-2A protein) Homo sapiens (Human) GO:0001917; GO:0002141; GO:0002142; GO:0005518; GO:0005576; GO:0005604; GO:0005737; GO:0007601; GO:0007605; GO:0016324; GO:0017022; GO:0032391; GO:0032421; GO:0035315; GO:0036064; GO:0042491; GO:0042802; GO:0045184; GO:0045494; GO:0048496; GO:0050953; GO:0051649; GO:0060113; GO:0060171; GO:1990075; GO:1990696 establishment of localization in cell [GO:0051649]; establishment of protein localization [GO:0045184]; hair cell differentiation [GO:0035315]; inner ear auditory receptor cell differentiation [GO:0042491]; inner ear receptor cell differentiation [GO:0060113]; maintenance of animal organ identity [GO:0048496]; photoreceptor cell maintenance [GO:0045494]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601] apical plasma membrane [GO:0016324]; basement membrane [GO:0005604]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; periciliary membrane compartment [GO:1990075]; photoreceptor connecting cilium [GO:0032391]; photoreceptor inner segment [GO:0001917]; stereocilia ankle link [GO:0002141]; stereocilia ankle link complex [GO:0002142]; stereocilium bundle [GO:0032421]; stereocilium membrane [GO:0060171]; USH2 complex [GO:1990696] collagen binding [GO:0005518]; identical protein binding [GO:0042802]; myosin binding [GO:0017022] g4747.t2 O75445 30.675 326 4.64e-22 106.0 sp|O75445|USH2A_HUMAN Usherin OS=Homo sapiens OX=9606 GN=USH2A PE=1 SV=3 USH2A_HUMAN reviewed Usherin (Usher syndrome type IIa protein) (Usher syndrome type-2A protein) Homo sapiens (Human) GO:0001917; GO:0002141; GO:0002142; GO:0005518; GO:0005576; GO:0005604; GO:0005737; GO:0007601; GO:0007605; GO:0016324; GO:0017022; GO:0032391; GO:0032421; GO:0035315; GO:0036064; GO:0042491; GO:0042802; GO:0045184; GO:0045494; GO:0048496; GO:0050953; GO:0051649; GO:0060113; GO:0060171; GO:1990075; GO:1990696 establishment of localization in cell [GO:0051649]; establishment of protein localization [GO:0045184]; hair cell differentiation [GO:0035315]; inner ear auditory receptor cell differentiation [GO:0042491]; inner ear receptor cell differentiation [GO:0060113]; maintenance of animal organ identity [GO:0048496]; photoreceptor cell maintenance [GO:0045494]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601] apical plasma membrane [GO:0016324]; basement membrane [GO:0005604]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; periciliary membrane compartment [GO:1990075]; photoreceptor connecting cilium [GO:0032391]; photoreceptor inner segment [GO:0001917]; stereocilia ankle link [GO:0002141]; stereocilia ankle link complex [GO:0002142]; stereocilium bundle [GO:0032421]; stereocilium membrane [GO:0060171]; USH2 complex [GO:1990696] collagen binding [GO:0005518]; identical protein binding [GO:0042802]; myosin binding [GO:0017022] g4748.t1 Q8BFX3 67.375 518 0.0 702.0 sp|Q8BFX3|KCTD3_MOUSE BTB/POZ domain-containing protein KCTD3 OS=Mus musculus OX=10090 GN=Kctd3 PE=1 SV=1 g4749.t1 Q6P7W2 77.143 70 1.0600000000000001e-29 112.0 sp|Q6P7W2|SHKB1_MOUSE SH3KBP1-binding protein 1 OS=Mus musculus OX=10090 GN=Shkbp1 PE=1 SV=1 SHKB1_MOUSE reviewed SH3KBP1-binding protein 1 (SETA-binding protein 1) Mus musculus (Mouse) GO:0005764; GO:0042802; GO:0045742; GO:0051260 positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; protein homooligomerization [GO:0051260] lysosome [GO:0005764] identical protein binding [GO:0042802] g4750.t1 Q8N5I4 35.563 284 1.2900000000000001e-37 138.0 sp|Q8N5I4|DHRSX_HUMAN Polyprenol dehydrogenase OS=Homo sapiens OX=9606 GN=DHRSX PE=1 SV=2 DHRSX_HUMAN reviewed Polyprenol dehydrogenase (EC 1.1.1.441) (DHRSXY) (Dehydrogenase/reductase SDR family member on chromosome X) (Dolichal reductase) Homo sapiens (Human) GO:0005576; GO:0005789; GO:0005811; GO:0008106; GO:0010508; GO:0043048; GO:0160196; GO:0160197 dolichyl monophosphate biosynthetic process [GO:0043048]; positive regulation of autophagy [GO:0010508] endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; lipid droplet [GO:0005811] alcohol dehydrogenase (NADP+) activity [GO:0008106]; dolichal reductase (NADPH) activity [GO:0160197]; polyprenol dehydrogenase (NAD+) activity [GO:0160196] g4751.t1 O35218 56.806 551 0.0 570.0 sp|O35218|CPSF2_MOUSE Cleavage and polyadenylation specificity factor subunit 2 OS=Mus musculus OX=10090 GN=Cpsf2 PE=1 SV=1 g4752.t1 Q9P2I0 63.333 150 1.15e-57 193.0 sp|Q9P2I0|CPSF2_HUMAN Cleavage and polyadenylation specificity factor subunit 2 OS=Homo sapiens OX=9606 GN=CPSF2 PE=1 SV=2 CPSF2_HUMAN reviewed Cleavage and polyadenylation specificity factor subunit 2 (Cleavage and polyadenylation specificity factor 100 kDa subunit) (CPSF 100 kDa subunit) Homo sapiens (Human) GO:0003723; GO:0005654; GO:0005847; GO:0006398; GO:0016020; GO:0098794; GO:0098978 mRNA 3'-end processing by stem-loop binding and cleavage [GO:0006398] glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; nucleoplasm [GO:0005654]; postsynapse [GO:0098794] RNA binding [GO:0003723] g4756.t1 P91809 89.95 199 1.1e-127 367.0 sp|P91809|TBP_STRPU TATA-box-binding protein OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g4757.t1 Q8NHU2 49.837 307 1.48e-94 307.0 sp|Q8NHU2|CFA61_HUMAN Cilia- and flagella-associated protein 61 OS=Homo sapiens OX=9606 GN=CFAP61 PE=1 SV=3 g4758.t1 Q8NHU2 49.465 467 7.36e-137 441.0 sp|Q8NHU2|CFA61_HUMAN Cilia- and flagella-associated protein 61 OS=Homo sapiens OX=9606 GN=CFAP61 PE=1 SV=3 g4758.t1 Q8NHU2 51.464 239 2.4e-68 251.0 sp|Q8NHU2|CFA61_HUMAN Cilia- and flagella-associated protein 61 OS=Homo sapiens OX=9606 GN=CFAP61 PE=1 SV=3 g4759.t1 P63155 72.646 669 0.0 1008.0 sp|P63155|CRNL1_RAT Crooked neck-like protein 1 OS=Rattus norvegicus OX=10116 GN=Crnkl1 PE=2 SV=1 g4760.t1 Q5XI89 25.968 439 3.3399999999999997e-25 113.0 sp|Q5XI89|NXPE4_RAT NXPE family member 4 OS=Rattus norvegicus OX=10116 GN=Nxpe4 PE=2 SV=1 g4761.t1 P49219 28.529 340 1.0500000000000001e-32 129.0 sp|P49219|MTR1C_XENLA Melatonin receptor type 1C OS=Xenopus laevis OX=8355 GN=mtnr1c PE=2 SV=1 g4762.t1 Q9WTQ1 74.419 344 3.56e-171 526.0 sp|Q9WTQ1|KPCD1_RAT Serine/threonine-protein kinase D1 OS=Rattus norvegicus OX=10116 GN=Prkd1 PE=1 SV=2 KPCD1_RAT reviewed Serine/threonine-protein kinase D1 (EC 2.7.11.13) (Protein kinase C mu type) (Protein kinase D) (nPKC-D1) (nPKC-mu) Rattus norvegicus (Rat) GO:0000421; GO:0001525; GO:0001938; GO:0004672; GO:0004674; GO:0004697; GO:0005080; GO:0005524; GO:0005634; GO:0005737; GO:0005794; GO:0005802; GO:0005829; GO:0005886; GO:0005911; GO:0005938; GO:0006915; GO:0006954; GO:0007030; GO:0007200; GO:0007399; GO:0008270; GO:0010508; GO:0010595; GO:0010628; GO:0010837; GO:0010976; GO:0014723; GO:0016020; GO:0016301; GO:0030018; GO:0030154; GO:0031072; GO:0034198; GO:0034599; GO:0035556; GO:0035924; GO:0042307; GO:0042802; GO:0043123; GO:0043536; GO:0044331; GO:0045087; GO:0045669; GO:0045766; GO:0045793; GO:0045944; GO:0046777; GO:0046827; GO:0048010; GO:0048193; GO:0048471; GO:0050829; GO:0051092; GO:0051279; GO:0051897; GO:0060298; GO:0070633; GO:0071447; GO:0071873; GO:0071874; GO:0090277; GO:0106310; GO:0141038; GO:1900227; GO:1904385; GO:1904628; GO:1990859; GO:2001028 angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; cell differentiation [GO:0030154]; cell-cell adhesion mediated by cadherin [GO:0044331]; cellular response to amino acid starvation [GO:0034198]; cellular response to angiotensin [GO:1904385]; cellular response to endothelin [GO:1990859]; cellular response to hydroperoxide [GO:0071447]; cellular response to norepinephrine stimulus [GO:0071874]; cellular response to oxidative stress [GO:0034599]; cellular response to phorbol 13-acetate 12-myristate [GO:1904628]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; defense response to Gram-negative bacterium [GO:0050829]; Golgi organization [GO:0007030]; Golgi vesicle transport [GO:0048193]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; intracellular signal transduction [GO:0035556]; nervous system development [GO:0007399]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of angiogenesis [GO:0045766]; positive regulation of autophagy [GO:0010508]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of cell size [GO:0045793]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron projection development [GO:0010976]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of NLRP3 inflammasome complex assembly [GO:1900227]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of peptide hormone secretion [GO:0090277]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein autophosphorylation [GO:0046777]; regulation of keratinocyte proliferation [GO:0010837]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; regulation of skeletal muscle contraction by modulation of calcium ion sensitivity of myofibril [GO:0014723]; response to norepinephrine [GO:0071873]; transepithelial transport [GO:0070633]; vascular endothelial growth factor receptor signaling pathway [GO:0048010] autophagosome membrane [GO:0000421]; cell cortex [GO:0005938]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]; Z disc [GO:0030018] ATP binding [GO:0005524]; diacylglycerol-dependent serine/threonine kinase activity [GO:0004697]; heat shock protein binding [GO:0031072]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; phosphatidylinositol 3-kinase activator activity [GO:0141038]; protein kinase activity [GO:0004672]; protein kinase C binding [GO:0005080]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; zinc ion binding [GO:0008270] g4762.t1 Q9WTQ1 47.059 510 2.2499999999999997e-138 440.0 sp|Q9WTQ1|KPCD1_RAT Serine/threonine-protein kinase D1 OS=Rattus norvegicus OX=10116 GN=Prkd1 PE=1 SV=2 KPCD1_RAT reviewed Serine/threonine-protein kinase D1 (EC 2.7.11.13) (Protein kinase C mu type) (Protein kinase D) (nPKC-D1) (nPKC-mu) Rattus norvegicus (Rat) GO:0000421; GO:0001525; GO:0001938; GO:0004672; GO:0004674; GO:0004697; GO:0005080; GO:0005524; GO:0005634; GO:0005737; GO:0005794; GO:0005802; GO:0005829; GO:0005886; GO:0005911; GO:0005938; GO:0006915; GO:0006954; GO:0007030; GO:0007200; GO:0007399; GO:0008270; GO:0010508; GO:0010595; GO:0010628; GO:0010837; GO:0010976; GO:0014723; GO:0016020; GO:0016301; GO:0030018; GO:0030154; GO:0031072; GO:0034198; GO:0034599; GO:0035556; GO:0035924; GO:0042307; GO:0042802; GO:0043123; GO:0043536; GO:0044331; GO:0045087; GO:0045669; GO:0045766; GO:0045793; GO:0045944; GO:0046777; GO:0046827; GO:0048010; GO:0048193; GO:0048471; GO:0050829; GO:0051092; GO:0051279; GO:0051897; GO:0060298; GO:0070633; GO:0071447; GO:0071873; GO:0071874; GO:0090277; GO:0106310; GO:0141038; GO:1900227; GO:1904385; GO:1904628; GO:1990859; GO:2001028 angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; cell differentiation [GO:0030154]; cell-cell adhesion mediated by cadherin [GO:0044331]; cellular response to amino acid starvation [GO:0034198]; cellular response to angiotensin [GO:1904385]; cellular response to endothelin [GO:1990859]; cellular response to hydroperoxide [GO:0071447]; cellular response to norepinephrine stimulus [GO:0071874]; cellular response to oxidative stress [GO:0034599]; cellular response to phorbol 13-acetate 12-myristate [GO:1904628]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; defense response to Gram-negative bacterium [GO:0050829]; Golgi organization [GO:0007030]; Golgi vesicle transport [GO:0048193]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; intracellular signal transduction [GO:0035556]; nervous system development [GO:0007399]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of angiogenesis [GO:0045766]; positive regulation of autophagy [GO:0010508]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of cell size [GO:0045793]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron projection development [GO:0010976]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of NLRP3 inflammasome complex assembly [GO:1900227]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of peptide hormone secretion [GO:0090277]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein autophosphorylation [GO:0046777]; regulation of keratinocyte proliferation [GO:0010837]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; regulation of skeletal muscle contraction by modulation of calcium ion sensitivity of myofibril [GO:0014723]; response to norepinephrine [GO:0071873]; transepithelial transport [GO:0070633]; vascular endothelial growth factor receptor signaling pathway [GO:0048010] autophagosome membrane [GO:0000421]; cell cortex [GO:0005938]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]; Z disc [GO:0030018] ATP binding [GO:0005524]; diacylglycerol-dependent serine/threonine kinase activity [GO:0004697]; heat shock protein binding [GO:0031072]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; phosphatidylinositol 3-kinase activator activity [GO:0141038]; protein kinase activity [GO:0004672]; protein kinase C binding [GO:0005080]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; zinc ion binding [GO:0008270] g4763.t1 Q7ZT47 66.327 196 5.37e-93 272.0 sp|Q7ZT47|PSF1_XENLA DNA replication complex GINS protein PSF1 OS=Xenopus laevis OX=8355 GN=gins1 PE=1 SV=1 PSF1_XENLA reviewed DNA replication complex GINS protein PSF1 (GINS complex subunit 1) Xenopus laevis (African clawed frog) GO:0000811; GO:0003682; GO:0006260; GO:0071162; GO:1902983 DNA replication [GO:0006260]; DNA strand elongation involved in mitotic DNA replication [GO:1902983] CMG complex [GO:0071162]; GINS complex [GO:0000811] chromatin binding [GO:0003682] g4764.t1 Q9VYD7 62.667 75 6.1799999999999995e-28 100.0 sp|Q9VYD7|TIM9_DROME Mitochondrial import inner membrane translocase subunit Tim9 OS=Drosophila melanogaster OX=7227 GN=Tim9a PE=3 SV=1 g4765.t1 Q55E31 60.406 197 8.959999999999999e-82 248.0 sp|Q55E31|RB32B_DICDI Ras-related protein Rab-32B OS=Dictyostelium discoideum OX=44689 GN=rab32B PE=3 SV=1 RB32B_DICDI reviewed Ras-related protein Rab-32B Dictyostelium discoideum (Social amoeba) GO:0003924; GO:0005525; GO:0005802; GO:0006886; GO:0012505; GO:0016192; GO:0032438; GO:0042470 intracellular protein transport [GO:0006886]; melanosome organization [GO:0032438]; vesicle-mediated transport [GO:0016192] endomembrane system [GO:0012505]; melanosome [GO:0042470]; trans-Golgi network [GO:0005802] GTP binding [GO:0005525]; GTPase activity [GO:0003924] g4766.t1 P49802 57.054 482 0.0 561.0 sp|P49802|RGS7_HUMAN Regulator of G-protein signaling 7 OS=Homo sapiens OX=9606 GN=RGS7 PE=1 SV=3 RGS7_HUMAN reviewed Regulator of G-protein signaling 7 (RGS7) Homo sapiens (Human) GO:0001965; GO:0003924; GO:0005096; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0007186; GO:0031681; GO:0035556; GO:0042734; GO:0043005; GO:0043547; GO:0044292; GO:0045211; GO:0045744; GO:0051286; GO:0060078; GO:0098978 G protein-coupled receptor signaling pathway [GO:0007186]; intracellular signal transduction [GO:0035556]; negative regulation of G protein-coupled receptor signaling pathway [GO:0045744]; positive regulation of GTPase activity [GO:0043547]; regulation of postsynaptic membrane potential [GO:0060078] cell tip [GO:0051286]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite terminus [GO:0044292]; glutamatergic synapse [GO:0098978]; neuron projection [GO:0043005]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734] G-protein alpha-subunit binding [GO:0001965]; G-protein beta-subunit binding [GO:0031681]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924] g4766.t2 O46470 57.35 483 0.0 563.0 sp|O46470|RGS7_BOVIN Regulator of G-protein signaling 7 OS=Bos taurus OX=9913 GN=RGS7 PE=1 SV=1 g4766.t3 O46470 58.316 475 0.0 568.0 sp|O46470|RGS7_BOVIN Regulator of G-protein signaling 7 OS=Bos taurus OX=9913 GN=RGS7 PE=1 SV=1 g4767.t1 Q6DGZ0 46.642 268 2.21e-52 174.0 sp|Q6DGZ0|GPT11_DANRE G patch domain-containing protein 11 OS=Danio rerio OX=7955 GN=gpatch11 PE=2 SV=1 g4767.t2 Q6DGZ0 46.816 267 1.96e-52 174.0 sp|Q6DGZ0|GPT11_DANRE G patch domain-containing protein 11 OS=Danio rerio OX=7955 GN=gpatch11 PE=2 SV=1 g4768.t1 P26884 55.909 220 5.840000000000001e-59 188.0 sp|P26884|FKBP3_BOVIN Peptidyl-prolyl cis-trans isomerase FKBP3 OS=Bos taurus OX=9913 GN=FKBP3 PE=1 SV=2 g4769.t1 Q92753 54.878 82 4.7399999999999997e-23 106.0 sp|Q92753|RORB_HUMAN Nuclear receptor ROR-beta OS=Homo sapiens OX=9606 GN=RORB PE=1 SV=3 RORB_HUMAN reviewed Nuclear receptor ROR-beta (Nuclear receptor RZR-beta) (Nuclear receptor subfamily 1 group F member 2) (Retinoid-related orphan receptor-beta) Homo sapiens (Human) GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0003700; GO:0004879; GO:0005634; GO:0005654; GO:0006355; GO:0006357; GO:0007601; GO:0008270; GO:0008502; GO:0035881; GO:0042462; GO:0042752; GO:0045668; GO:0045892; GO:0045893; GO:0045944; GO:0046548; GO:0046549; GO:0048511; GO:0060041; GO:0071300; GO:1990837 amacrine cell differentiation [GO:0035881]; cellular response to retinoic acid [GO:0071300]; eye photoreceptor cell development [GO:0042462]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of osteoblast differentiation [GO:0045668]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of circadian rhythm [GO:0042752]; regulation of DNA-templated transcription [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; retina development in camera-type eye [GO:0060041]; retinal cone cell development [GO:0046549]; retinal rod cell development [GO:0046548]; rhythmic process [GO:0048511]; visual perception [GO:0007601] chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; melatonin receptor activity [GO:0008502]; nuclear receptor activity [GO:0004879]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; zinc ion binding [GO:0008270] g4769.t2 Q92753 54.878 82 4.76e-23 106.0 sp|Q92753|RORB_HUMAN Nuclear receptor ROR-beta OS=Homo sapiens OX=9606 GN=RORB PE=1 SV=3 RORB_HUMAN reviewed Nuclear receptor ROR-beta (Nuclear receptor RZR-beta) (Nuclear receptor subfamily 1 group F member 2) (Retinoid-related orphan receptor-beta) Homo sapiens (Human) GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0003700; GO:0004879; GO:0005634; GO:0005654; GO:0006355; GO:0006357; GO:0007601; GO:0008270; GO:0008502; GO:0035881; GO:0042462; GO:0042752; GO:0045668; GO:0045892; GO:0045893; GO:0045944; GO:0046548; GO:0046549; GO:0048511; GO:0060041; GO:0071300; GO:1990837 amacrine cell differentiation [GO:0035881]; cellular response to retinoic acid [GO:0071300]; eye photoreceptor cell development [GO:0042462]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of osteoblast differentiation [GO:0045668]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of circadian rhythm [GO:0042752]; regulation of DNA-templated transcription [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; retina development in camera-type eye [GO:0060041]; retinal cone cell development [GO:0046549]; retinal rod cell development [GO:0046548]; rhythmic process [GO:0048511]; visual perception [GO:0007601] chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; melatonin receptor activity [GO:0008502]; nuclear receptor activity [GO:0004879]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; zinc ion binding [GO:0008270] g4771.t1 F1QJF4 63.415 82 1.01e-25 115.0 sp|F1QJF4|RORAB_DANRE Nuclear receptor ROR-alpha B OS=Danio rerio OX=7955 GN=rorab PE=2 SV=1 g4772.t1 Q6PAV8 47.126 174 7.8e-41 157.0 sp|Q6PAV8|MACD2_XENLA ADP-ribose glycohydrolase MACROD2 OS=Xenopus laevis OX=8355 GN=macrod2 PE=2 SV=1 MACD2_XENLA reviewed ADP-ribose glycohydrolase MACROD2 (MACRO domain-containing protein 2) (O-acetyl-ADP-ribose deacetylase MACROD2) (EC 3.5.1.-) ([Protein ADP-ribosylaspartate] hydrolase MACROD2) (EC 3.2.2.-) ([Protein ADP-ribosylglutamate] hydrolase MACROD2) (EC 3.2.2.-) Xenopus laevis (African clawed frog) GO:0005634; GO:0005654; GO:0006974; GO:0016798; GO:0042278; GO:0051725; GO:0061463; GO:0140291; GO:0140293 DNA damage response [GO:0006974]; peptidyl-glutamate ADP-deribosylation [GO:0140291]; protein de-ADP-ribosylation [GO:0051725]; purine nucleoside metabolic process [GO:0042278] nucleoplasm [GO:0005654]; nucleus [GO:0005634] ADP-ribosylglutamate hydrolase activity [GO:0140293]; hydrolase activity, acting on glycosyl bonds [GO:0016798]; O-acetyl-ADP-ribose deacetylase activity [GO:0061463] g4773.t1 P15086 36.73 422 4.6e-93 290.0 sp|P15086|CBPB1_HUMAN Carboxypeptidase B OS=Homo sapiens OX=9606 GN=CPB1 PE=1 SV=4 CBPB1_HUMAN reviewed Carboxypeptidase B (EC 3.4.17.2) (Pancreas-specific protein) (PASP) Homo sapiens (Human) GO:0004180; GO:0004181; GO:0005615; GO:0006508; GO:0008270; GO:0031410 proteolysis [GO:0006508] cytoplasmic vesicle [GO:0031410]; extracellular space [GO:0005615] carboxypeptidase activity [GO:0004180]; metallocarboxypeptidase activity [GO:0004181]; zinc ion binding [GO:0008270] g4774.t1 Q6P8K8 36.765 408 2.77e-77 249.0 sp|Q6P8K8|CBPA4_MOUSE Carboxypeptidase A4 OS=Mus musculus OX=10090 GN=Cpa4 PE=2 SV=2 g4775.t1 Q9H6P5 49.479 384 1.6e-118 353.0 sp|Q9H6P5|TASP1_HUMAN Threonine aspartase 1 OS=Homo sapiens OX=9606 GN=TASP1 PE=1 SV=1 TASP1_HUMAN reviewed Threonine aspartase 1 (Taspase-1) (EC 3.4.25.-) [Cleaved into: Threonine aspartase subunit alpha; Threonine aspartase subunit beta] Homo sapiens (Human) GO:0004298; GO:0005737; GO:0005829; GO:0006508; GO:0042802; GO:0045893; GO:0051604 positive regulation of DNA-templated transcription [GO:0045893]; protein maturation [GO:0051604]; proteolysis [GO:0006508] cytoplasm [GO:0005737]; cytosol [GO:0005829] identical protein binding [GO:0042802]; threonine-type endopeptidase activity [GO:0004298] g4778.t1 Q14746 43.708 739 0.0 575.0 sp|Q14746|COG2_HUMAN Conserved oligomeric Golgi complex subunit 2 OS=Homo sapiens OX=9606 GN=COG2 PE=1 SV=1 g4780.t1 Q5R4T7 33.566 572 1.03e-98 315.0 sp|Q5R4T7|MKKS_PONAB Molecular chaperone MKKS OS=Pongo abelii OX=9601 GN=MKKS PE=2 SV=2 g4781.t1 Q6P0F9 32.208 385 4.52e-40 149.0 sp|Q6P0F9|INS1A_DANRE Insulinoma-associated protein 1a OS=Danio rerio OX=7955 GN=insm1a PE=2 SV=1 INS1A_DANRE reviewed Insulinoma-associated protein 1a (Insulinoma-associated 1-like protein a) (Zinc finger protein IA-1a) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000122; GO:0000978; GO:0000981; GO:0001227; GO:0003309; GO:0003310; GO:0003700; GO:0005634; GO:0008270; GO:0010564; GO:0017053; GO:0021522; GO:0030182; GO:0031490; GO:0035677; GO:0042670; GO:0043565; GO:0043697; GO:0045892; GO:0048920; GO:0060221; GO:0060290; GO:0070654 cell dedifferentiation [GO:0043697]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron differentiation [GO:0030182]; pancreatic A cell differentiation [GO:0003310]; posterior lateral line neuromast hair cell development [GO:0035677]; posterior lateral line neuromast primordium migration [GO:0048920]; regulation of cell cycle process [GO:0010564]; retinal cone cell differentiation [GO:0042670]; retinal rod cell differentiation [GO:0060221]; sensory epithelium regeneration [GO:0070654]; spinal cord motor neuron differentiation [GO:0021522]; transdifferentiation [GO:0060290]; type B pancreatic cell differentiation [GO:0003309] nucleus [GO:0005634]; transcription repressor complex [GO:0017053] chromatin DNA binding [GO:0031490]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270] g4782.t1 Q06HQ7 47.337 338 6.06e-92 308.0 sp|Q06HQ7|PLB1_MONDO Phospholipase B1, membrane-associated OS=Monodelphis domestica OX=13616 GN=PLB1 PE=2 SV=1 g4782.t1 Q06HQ7 42.073 328 2.1900000000000002e-79 272.0 sp|Q06HQ7|PLB1_MONDO Phospholipase B1, membrane-associated OS=Monodelphis domestica OX=13616 GN=PLB1 PE=2 SV=1 g4782.t1 Q06HQ7 44.379 338 7.67e-78 267.0 sp|Q06HQ7|PLB1_MONDO Phospholipase B1, membrane-associated OS=Monodelphis domestica OX=13616 GN=PLB1 PE=2 SV=1 g4783.t1 P62142 89.024 328 0.0 618.0 sp|P62142|PP1B_RAT Serine/threonine-protein phosphatase PP1-beta catalytic subunit OS=Rattus norvegicus OX=10116 GN=Ppp1cb PE=1 SV=3 PP1B_RAT reviewed Serine/threonine-protein phosphatase PP1-beta catalytic subunit (PP-1B) (EC 3.1.3.16) (EC 3.1.3.53) Rattus norvegicus (Rat) GO:0000164; GO:0000781; GO:0004721; GO:0004722; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0005977; GO:0005979; GO:0005981; GO:0016791; GO:0017018; GO:0019901; GO:0030155; GO:0032922; GO:0042587; GO:0042752; GO:0043153; GO:0046872; GO:0050115; GO:0051301; GO:0072357 cell division [GO:0051301]; circadian regulation of gene expression [GO:0032922]; entrainment of circadian clock by photoperiod [GO:0043153]; glycogen metabolic process [GO:0005977]; regulation of cell adhesion [GO:0030155]; regulation of circadian rhythm [GO:0042752]; regulation of glycogen biosynthetic process [GO:0005979]; regulation of glycogen catabolic process [GO:0005981] chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; glycogen granule [GO:0042587]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein phosphatase type 1 complex [GO:0000164]; PTW/PP1 phosphatase complex [GO:0072357] metal ion binding [GO:0046872]; myosin phosphatase activity [GO:0017018]; myosin-light-chain-phosphatase activity [GO:0050115]; phosphatase activity [GO:0016791]; phosphoprotein phosphatase activity [GO:0004721]; protein kinase binding [GO:0019901]; protein serine/threonine phosphatase activity [GO:0004722] g4784.t1 P49962 69.737 76 1.17e-35 118.0 sp|P49962|SRP09_MOUSE Signal recognition particle 9 kDa protein OS=Mus musculus OX=10090 GN=Srp9 PE=1 SV=2 g4787.t1 Q8N8S7 70.408 98 9.599999999999999e-38 147.0 sp|Q8N8S7|ENAH_HUMAN Protein enabled homolog OS=Homo sapiens OX=9606 GN=ENAH PE=1 SV=2 ENAH_HUMAN reviewed Protein enabled homolog Homo sapiens (Human) GO:0003779; GO:0005522; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0007411; GO:0008154; GO:0017124; GO:0030027; GO:0030175; GO:0050699; GO:0070358; GO:0098794; GO:0098982; GO:0099188 actin polymerization or depolymerization [GO:0008154]; actin polymerization-dependent cell motility [GO:0070358]; axon guidance [GO:0007411]; postsynaptic cytoskeleton organization [GO:0099188] cytoskeleton [GO:0005856]; cytosol [GO:0005829]; filopodium [GO:0030175]; focal adhesion [GO:0005925]; GABA-ergic synapse [GO:0098982]; lamellipodium [GO:0030027]; plasma membrane [GO:0005886]; postsynapse [GO:0098794] actin binding [GO:0003779]; profilin binding [GO:0005522]; SH3 domain binding [GO:0017124]; WW domain binding [GO:0050699] g4789.t1 Q14739 42.811 619 9.86e-138 416.0 sp|Q14739|LBR_HUMAN Delta(14)-sterol reductase LBR OS=Homo sapiens OX=9606 GN=LBR PE=1 SV=2 LBR_HUMAN reviewed Delta(14)-sterol reductase LBR (Delta-14-SR) (EC 1.3.1.70) (3-beta-hydroxysterol Delta (14)-reductase) (C-14 sterol reductase) (C14SR) (Integral nuclear envelope inner membrane protein) (LMN2R) (Lamin-B receptor) (Sterol C14-reductase) Homo sapiens (Human) GO:0001650; GO:0003677; GO:0003723; GO:0005521; GO:0005634; GO:0005635; GO:0005637; GO:0005652; GO:0005654; GO:0005737; GO:0005789; GO:0006695; GO:0016020; GO:0030223; GO:0031965; GO:0050613; GO:0060816; GO:0070087; GO:0070402; GO:0140463 cholesterol biosynthetic process [GO:0006695]; neutrophil differentiation [GO:0030223]; random inactivation of X chromosome [GO:0060816] cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; fibrillar center [GO:0001650]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear inner membrane [GO:0005637]; nuclear lamina [GO:0005652]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] chromatin-protein adaptor activity [GO:0140463]; chromo shadow domain binding [GO:0070087]; Delta14-sterol reductase activity [GO:0050613]; DNA binding [GO:0003677]; lamin binding [GO:0005521]; NADPH binding [GO:0070402]; RNA binding [GO:0003723] g4790.t1 P23913 53.922 408 2.33e-140 419.0 sp|P23913|LBR_CHICK Delta(14)-sterol reductase LBR OS=Gallus gallus OX=9031 GN=LBR PE=1 SV=1 g4791.t1 P10079 35.286 700 7.79e-88 310.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g4791.t1 P10079 35.753 730 2.11e-87 308.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g4791.t1 P10079 34.894 705 5.12e-81 290.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g4791.t1 P10079 36.215 671 2.01e-77 280.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g4791.t1 P10079 29.903 826 5.05e-65 243.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g4792.t1 P46531 40.87 230 2.91e-33 133.0 sp|P46531|NOTC1_HUMAN Neurogenic locus notch homolog protein 1 OS=Homo sapiens OX=9606 GN=NOTCH1 PE=1 SV=4 NOTC1_HUMAN reviewed Neurogenic locus notch homolog protein 1 (Notch 1) (hN1) (Translocation-associated notch protein TAN-1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Homo sapiens (Human) GO:0000122; GO:0000139; GO:0001554; GO:0001669; GO:0001701; GO:0001837; GO:0001889; GO:0001947; GO:0002040; GO:0002052; GO:0002085; GO:0002193; GO:0002437; GO:0003151; GO:0003157; GO:0003160; GO:0003162; GO:0003169; GO:0003180; GO:0003181; GO:0003182; GO:0003184; GO:0003192; GO:0003198; GO:0003203; GO:0003207; GO:0003208; GO:0003209; GO:0003213; GO:0003214; GO:0003219; GO:0003222; GO:0003241; GO:0003252; GO:0003270; GO:0003273; GO:0003332; GO:0003344; GO:0003713; GO:0004857; GO:0004888; GO:0005112; GO:0005509; GO:0005576; GO:0005634; GO:0005654; GO:0005789; GO:0005829; GO:0005886; GO:0005912; GO:0006355; GO:0006357; GO:0006366; GO:0006606; GO:0006955; GO:0006959; GO:0007219; GO:0007221; GO:0007283; GO:0007368; GO:0007386; GO:0007411; GO:0007440; GO:0007492; GO:0007507; GO:0008284; GO:0008285; GO:0009912; GO:0009957; GO:0009986; GO:0010008; GO:0010614; GO:0010628; GO:0010629; GO:0010667; GO:0010812; GO:0010832; GO:0014031; GO:0014807; GO:0016324; GO:0017156; GO:0019899; GO:0021515; GO:0021915; GO:0021953; GO:0030163; GO:0030216; GO:0030279; GO:0030324; GO:0030335; GO:0030513; GO:0030514; GO:0030900; GO:0031069; GO:0031100; GO:0031490; GO:0031902; GO:0032495; GO:0032496; GO:0032966; GO:0035116; GO:0035148; GO:0035914; GO:0035924; GO:0042246; GO:0042670; GO:0042802; GO:0043086; GO:0043235; GO:0045070; GO:0045603; GO:0045608; GO:0045618; GO:0045662; GO:0045668; GO:0045747; GO:0045892; GO:0045893; GO:0045944; GO:0045955; GO:0046427; GO:0046533; GO:0046579; GO:0048103; GO:0048708; GO:0048709; GO:0048711; GO:0048715; GO:0048754; GO:0048873; GO:0050673; GO:0050679; GO:0050680; GO:0050768; GO:0051152; GO:0055008; GO:0060038; GO:0060045; GO:0060253; GO:0060271; GO:0060317; GO:0060354; GO:0060379; GO:0060411; GO:0060412; GO:0060528; GO:0060740; GO:0060768; GO:0060842; GO:0060843; GO:0060948; GO:0060956; GO:0060979; GO:0060982; GO:0061101; GO:0061344; GO:0061384; GO:0062043; GO:0070168; GO:0070374; GO:0070986; GO:0071228; GO:0071372; GO:0071456; GO:0072017; GO:0072044; GO:0072091; GO:0072144; GO:0072148; GO:0072538; GO:0090051; GO:0090090; GO:0097150; GO:0097400; GO:0098685; GO:0098839; GO:0098978; GO:0099565; GO:0120163; GO:0140537; GO:1901201; GO:1902263; GO:1902339; GO:1903849; GO:2000048; GO:2000737; GO:2000811; GO:2000974; GO:2001027 animal organ regeneration [GO:0031100]; aortic valve morphogenesis [GO:0003180]; apoptotic process involved in embryonic digit morphogenesis [GO:1902263]; arterial endothelial cell differentiation [GO:0060842]; astrocyte differentiation [GO:0048708]; atrioventricular node development [GO:0003162]; atrioventricular valve morphogenesis [GO:0003181]; auditory receptor cell fate commitment [GO:0009912]; axon guidance [GO:0007411]; branching morphogenesis of an epithelial tube [GO:0048754]; calcium-ion regulated exocytosis [GO:0017156]; cardiac atrium morphogenesis [GO:0003209]; cardiac chamber formation [GO:0003207]; cardiac epithelial to mesenchymal transition [GO:0060317]; cardiac left ventricle morphogenesis [GO:0003214]; cardiac muscle cell myoblast differentiation [GO:0060379]; cardiac muscle cell proliferation [GO:0060038]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac right atrium morphogenesis [GO:0003213]; cardiac right ventricle formation [GO:0003219]; cardiac septum morphogenesis [GO:0060411]; cardiac vascular smooth muscle cell development [GO:0060948]; cardiac ventricle morphogenesis [GO:0003208]; cell differentiation in spinal cord [GO:0021515]; cell migration involved in endocardial cushion formation [GO:0003273]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to hypoxia [GO:0071456]; cellular response to tumor cell [GO:0071228]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; central nervous system neuron differentiation [GO:0021953]; chemical synaptic transmission, postsynaptic [GO:0099565]; cilium assembly [GO:0060271]; collecting duct development [GO:0072044]; compartment pattern specification [GO:0007386]; coronary artery morphogenesis [GO:0060982]; coronary sinus valve morphogenesis [GO:0003182]; coronary vein morphogenesis [GO:0003169]; determination of left/right symmetry [GO:0007368]; distal tubule development [GO:0072017]; embryonic hindlimb morphogenesis [GO:0035116]; endocardial cell differentiation [GO:0060956]; endocardial cushion morphogenesis [GO:0003203]; endocardium development [GO:0003157]; endocardium morphogenesis [GO:0003160]; endoderm development [GO:0007492]; epidermal cell fate specification [GO:0009957]; epithelial cell fate commitment [GO:0072148]; epithelial cell proliferation [GO:0050673]; epithelial to mesenchymal transition [GO:0001837]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; forebrain development [GO:0030900]; foregut morphogenesis [GO:0007440]; glomerular mesangial cell development [GO:0072144]; growth involved in heart morphogenesis [GO:0003241]; hair follicle morphogenesis [GO:0031069]; heart development [GO:0007507]; heart looping [GO:0001947]; heart trabecula morphogenesis [GO:0061384]; homeostasis of number of cells within a tissue [GO:0048873]; humoral immune response [GO:0006959]; immune response [GO:0006955]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; inhibition of neuroepithelial cell differentiation [GO:0002085]; interleukin-17-mediated signaling pathway [GO:0097400]; keratinocyte differentiation [GO:0030216]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; lung development [GO:0030324]; luteolysis [GO:0001554]; mesenchymal cell development [GO:0014031]; mitral valve formation [GO:0003192]; negative regulation of anoikis [GO:2000811]; negative regulation of biomineral tissue development [GO:0070168]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of catalytic activity [GO:0043086]; negative regulation of cell adhesion molecule production [GO:0060354]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell proliferation involved in heart valve morphogenesis [GO:0003252]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of collagen biosynthetic process [GO:0032966]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of endothelial cell chemotaxis [GO:2001027]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of extracellular matrix constituent secretion [GO:0003332]; negative regulation of gene expression [GO:0010629]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of inner ear auditory receptor cell differentiation [GO:0045608]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of neurogenesis [GO:0050768]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of ossification [GO:0030279]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of photoreceptor cell differentiation [GO:0046533]; negative regulation of pro-B cell differentiation [GO:2000974]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural tube development [GO:0021915]; neuroendocrine cell differentiation [GO:0061101]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; Notch signaling pathway involved in regulation of secondary heart field cardioblast proliferation [GO:0003270]; oligodendrocyte differentiation [GO:0048709]; outflow tract morphogenesis [GO:0003151]; pericardium morphogenesis [GO:0003344]; positive regulation of aorta morphogenesis [GO:1903849]; positive regulation of apoptotic process involved in morphogenesis [GO:1902339]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cardiac epithelial to mesenchymal transition [GO:0062043]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of smooth muscle cell differentiation [GO:0051152]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription of Notch receptor target [GO:0007221]; positive regulation of viral genome replication [GO:0045070]; prostate gland epithelium morphogenesis [GO:0060740]; protein catabolic process [GO:0030163]; protein import into nucleus [GO:0006606]; pulmonary valve morphogenesis [GO:0003184]; regulation of cell adhesion involved in heart morphogenesis [GO:0061344]; regulation of DNA-templated transcription [GO:0006355]; regulation of epithelial cell proliferation involved in prostate gland development [GO:0060768]; regulation of extracellular matrix assembly [GO:1901201]; regulation of somitogenesis [GO:0014807]; regulation of stem cell proliferation [GO:0072091]; regulation of transcription by RNA polymerase II [GO:0006357]; response to lipopolysaccharide [GO:0032496]; response to muramyl dipeptide [GO:0032495]; retinal cone cell differentiation [GO:0042670]; secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development [GO:0060528]; skeletal muscle cell differentiation [GO:0035914]; somatic stem cell division [GO:0048103]; spermatogenesis [GO:0007283]; sprouting angiogenesis [GO:0002040]; T-helper 17 type immune response [GO:0072538]; tissue regeneration [GO:0042246]; transcription by RNA polymerase II [GO:0006366]; tube formation [GO:0035148]; vasculogenesis involved in coronary vascular morphogenesis [GO:0060979]; venous endothelial cell differentiation [GO:0060843]; ventricular septum morphogenesis [GO:0060412]; ventricular trabecula myocardium morphogenesis [GO:0003222] acrosomal vesicle [GO:0001669]; adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; late endosome membrane [GO:0031902]; MAML1-RBP-Jkappa- ICN1 complex [GO:0002193]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; receptor complex [GO:0043235]; Schaffer collateral - CA1 synapse [GO:0098685] calcium ion binding [GO:0005509]; chromatin DNA binding [GO:0031490]; enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; identical protein binding [GO:0042802]; Notch binding [GO:0005112]; transcription coactivator activity [GO:0003713]; transcription regulator activator activity [GO:0140537]; transmembrane signaling receptor activity [GO:0004888] g4792.t1 P46531 45.455 33 2.91e-33 30.8 sp|P46531|NOTC1_HUMAN Neurogenic locus notch homolog protein 1 OS=Homo sapiens OX=9606 GN=NOTCH1 PE=1 SV=4 NOTC1_HUMAN reviewed Neurogenic locus notch homolog protein 1 (Notch 1) (hN1) (Translocation-associated notch protein TAN-1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Homo sapiens (Human) GO:0000122; GO:0000139; GO:0001554; GO:0001669; GO:0001701; GO:0001837; GO:0001889; GO:0001947; GO:0002040; GO:0002052; GO:0002085; GO:0002193; GO:0002437; GO:0003151; GO:0003157; GO:0003160; GO:0003162; GO:0003169; GO:0003180; GO:0003181; GO:0003182; GO:0003184; GO:0003192; GO:0003198; GO:0003203; GO:0003207; GO:0003208; GO:0003209; GO:0003213; GO:0003214; GO:0003219; GO:0003222; GO:0003241; GO:0003252; GO:0003270; GO:0003273; GO:0003332; GO:0003344; GO:0003713; GO:0004857; GO:0004888; GO:0005112; GO:0005509; GO:0005576; GO:0005634; GO:0005654; GO:0005789; GO:0005829; GO:0005886; GO:0005912; GO:0006355; GO:0006357; GO:0006366; GO:0006606; GO:0006955; GO:0006959; GO:0007219; GO:0007221; GO:0007283; GO:0007368; GO:0007386; GO:0007411; GO:0007440; GO:0007492; GO:0007507; GO:0008284; GO:0008285; GO:0009912; GO:0009957; GO:0009986; GO:0010008; GO:0010614; GO:0010628; GO:0010629; GO:0010667; GO:0010812; GO:0010832; GO:0014031; GO:0014807; GO:0016324; GO:0017156; GO:0019899; GO:0021515; GO:0021915; GO:0021953; GO:0030163; GO:0030216; GO:0030279; GO:0030324; GO:0030335; GO:0030513; GO:0030514; GO:0030900; GO:0031069; GO:0031100; GO:0031490; GO:0031902; GO:0032495; GO:0032496; GO:0032966; GO:0035116; GO:0035148; GO:0035914; GO:0035924; GO:0042246; GO:0042670; GO:0042802; GO:0043086; GO:0043235; GO:0045070; GO:0045603; GO:0045608; GO:0045618; GO:0045662; GO:0045668; GO:0045747; GO:0045892; GO:0045893; GO:0045944; GO:0045955; GO:0046427; GO:0046533; GO:0046579; GO:0048103; GO:0048708; GO:0048709; GO:0048711; GO:0048715; GO:0048754; GO:0048873; GO:0050673; GO:0050679; GO:0050680; GO:0050768; GO:0051152; GO:0055008; GO:0060038; GO:0060045; GO:0060253; GO:0060271; GO:0060317; GO:0060354; GO:0060379; GO:0060411; GO:0060412; GO:0060528; GO:0060740; GO:0060768; GO:0060842; GO:0060843; GO:0060948; GO:0060956; GO:0060979; GO:0060982; GO:0061101; GO:0061344; GO:0061384; GO:0062043; GO:0070168; GO:0070374; GO:0070986; GO:0071228; GO:0071372; GO:0071456; GO:0072017; GO:0072044; GO:0072091; GO:0072144; GO:0072148; GO:0072538; GO:0090051; GO:0090090; GO:0097150; GO:0097400; GO:0098685; GO:0098839; GO:0098978; GO:0099565; GO:0120163; GO:0140537; GO:1901201; GO:1902263; GO:1902339; GO:1903849; GO:2000048; GO:2000737; GO:2000811; GO:2000974; GO:2001027 animal organ regeneration [GO:0031100]; aortic valve morphogenesis [GO:0003180]; apoptotic process involved in embryonic digit morphogenesis [GO:1902263]; arterial endothelial cell differentiation [GO:0060842]; astrocyte differentiation [GO:0048708]; atrioventricular node development [GO:0003162]; atrioventricular valve morphogenesis [GO:0003181]; auditory receptor cell fate commitment [GO:0009912]; axon guidance [GO:0007411]; branching morphogenesis of an epithelial tube [GO:0048754]; calcium-ion regulated exocytosis [GO:0017156]; cardiac atrium morphogenesis [GO:0003209]; cardiac chamber formation [GO:0003207]; cardiac epithelial to mesenchymal transition [GO:0060317]; cardiac left ventricle morphogenesis [GO:0003214]; cardiac muscle cell myoblast differentiation [GO:0060379]; cardiac muscle cell proliferation [GO:0060038]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac right atrium morphogenesis [GO:0003213]; cardiac right ventricle formation [GO:0003219]; cardiac septum morphogenesis [GO:0060411]; cardiac vascular smooth muscle cell development [GO:0060948]; cardiac ventricle morphogenesis [GO:0003208]; cell differentiation in spinal cord [GO:0021515]; cell migration involved in endocardial cushion formation [GO:0003273]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to hypoxia [GO:0071456]; cellular response to tumor cell [GO:0071228]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; central nervous system neuron differentiation [GO:0021953]; chemical synaptic transmission, postsynaptic [GO:0099565]; cilium assembly [GO:0060271]; collecting duct development [GO:0072044]; compartment pattern specification [GO:0007386]; coronary artery morphogenesis [GO:0060982]; coronary sinus valve morphogenesis [GO:0003182]; coronary vein morphogenesis [GO:0003169]; determination of left/right symmetry [GO:0007368]; distal tubule development [GO:0072017]; embryonic hindlimb morphogenesis [GO:0035116]; endocardial cell differentiation [GO:0060956]; endocardial cushion morphogenesis [GO:0003203]; endocardium development [GO:0003157]; endocardium morphogenesis [GO:0003160]; endoderm development [GO:0007492]; epidermal cell fate specification [GO:0009957]; epithelial cell fate commitment [GO:0072148]; epithelial cell proliferation [GO:0050673]; epithelial to mesenchymal transition [GO:0001837]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; forebrain development [GO:0030900]; foregut morphogenesis [GO:0007440]; glomerular mesangial cell development [GO:0072144]; growth involved in heart morphogenesis [GO:0003241]; hair follicle morphogenesis [GO:0031069]; heart development [GO:0007507]; heart looping [GO:0001947]; heart trabecula morphogenesis [GO:0061384]; homeostasis of number of cells within a tissue [GO:0048873]; humoral immune response [GO:0006959]; immune response [GO:0006955]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; inhibition of neuroepithelial cell differentiation [GO:0002085]; interleukin-17-mediated signaling pathway [GO:0097400]; keratinocyte differentiation [GO:0030216]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; lung development [GO:0030324]; luteolysis [GO:0001554]; mesenchymal cell development [GO:0014031]; mitral valve formation [GO:0003192]; negative regulation of anoikis [GO:2000811]; negative regulation of biomineral tissue development [GO:0070168]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of catalytic activity [GO:0043086]; negative regulation of cell adhesion molecule production [GO:0060354]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell proliferation involved in heart valve morphogenesis [GO:0003252]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of collagen biosynthetic process [GO:0032966]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of endothelial cell chemotaxis [GO:2001027]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of extracellular matrix constituent secretion [GO:0003332]; negative regulation of gene expression [GO:0010629]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of inner ear auditory receptor cell differentiation [GO:0045608]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of neurogenesis [GO:0050768]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of ossification [GO:0030279]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of photoreceptor cell differentiation [GO:0046533]; negative regulation of pro-B cell differentiation [GO:2000974]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural tube development [GO:0021915]; neuroendocrine cell differentiation [GO:0061101]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; Notch signaling pathway involved in regulation of secondary heart field cardioblast proliferation [GO:0003270]; oligodendrocyte differentiation [GO:0048709]; outflow tract morphogenesis [GO:0003151]; pericardium morphogenesis [GO:0003344]; positive regulation of aorta morphogenesis [GO:1903849]; positive regulation of apoptotic process involved in morphogenesis [GO:1902339]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cardiac epithelial to mesenchymal transition [GO:0062043]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of smooth muscle cell differentiation [GO:0051152]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription of Notch receptor target [GO:0007221]; positive regulation of viral genome replication [GO:0045070]; prostate gland epithelium morphogenesis [GO:0060740]; protein catabolic process [GO:0030163]; protein import into nucleus [GO:0006606]; pulmonary valve morphogenesis [GO:0003184]; regulation of cell adhesion involved in heart morphogenesis [GO:0061344]; regulation of DNA-templated transcription [GO:0006355]; regulation of epithelial cell proliferation involved in prostate gland development [GO:0060768]; regulation of extracellular matrix assembly [GO:1901201]; regulation of somitogenesis [GO:0014807]; regulation of stem cell proliferation [GO:0072091]; regulation of transcription by RNA polymerase II [GO:0006357]; response to lipopolysaccharide [GO:0032496]; response to muramyl dipeptide [GO:0032495]; retinal cone cell differentiation [GO:0042670]; secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development [GO:0060528]; skeletal muscle cell differentiation [GO:0035914]; somatic stem cell division [GO:0048103]; spermatogenesis [GO:0007283]; sprouting angiogenesis [GO:0002040]; T-helper 17 type immune response [GO:0072538]; tissue regeneration [GO:0042246]; transcription by RNA polymerase II [GO:0006366]; tube formation [GO:0035148]; vasculogenesis involved in coronary vascular morphogenesis [GO:0060979]; venous endothelial cell differentiation [GO:0060843]; ventricular septum morphogenesis [GO:0060412]; ventricular trabecula myocardium morphogenesis [GO:0003222] acrosomal vesicle [GO:0001669]; adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; late endosome membrane [GO:0031902]; MAML1-RBP-Jkappa- ICN1 complex [GO:0002193]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; receptor complex [GO:0043235]; Schaffer collateral - CA1 synapse [GO:0098685] calcium ion binding [GO:0005509]; chromatin DNA binding [GO:0031490]; enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; identical protein binding [GO:0042802]; Notch binding [GO:0005112]; transcription coactivator activity [GO:0003713]; transcription regulator activator activity [GO:0140537]; transmembrane signaling receptor activity [GO:0004888] g4792.t1 P46531 38.863 211 1.91e-26 112.0 sp|P46531|NOTC1_HUMAN Neurogenic locus notch homolog protein 1 OS=Homo sapiens OX=9606 GN=NOTCH1 PE=1 SV=4 NOTC1_HUMAN reviewed Neurogenic locus notch homolog protein 1 (Notch 1) (hN1) (Translocation-associated notch protein TAN-1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Homo sapiens (Human) GO:0000122; GO:0000139; GO:0001554; GO:0001669; GO:0001701; GO:0001837; GO:0001889; GO:0001947; GO:0002040; GO:0002052; GO:0002085; GO:0002193; GO:0002437; GO:0003151; GO:0003157; GO:0003160; GO:0003162; GO:0003169; GO:0003180; GO:0003181; GO:0003182; GO:0003184; GO:0003192; GO:0003198; GO:0003203; GO:0003207; GO:0003208; GO:0003209; GO:0003213; GO:0003214; GO:0003219; GO:0003222; GO:0003241; GO:0003252; GO:0003270; GO:0003273; GO:0003332; GO:0003344; GO:0003713; GO:0004857; GO:0004888; GO:0005112; GO:0005509; GO:0005576; GO:0005634; GO:0005654; GO:0005789; GO:0005829; GO:0005886; GO:0005912; GO:0006355; GO:0006357; GO:0006366; GO:0006606; GO:0006955; GO:0006959; GO:0007219; GO:0007221; GO:0007283; GO:0007368; GO:0007386; GO:0007411; GO:0007440; GO:0007492; GO:0007507; GO:0008284; GO:0008285; GO:0009912; GO:0009957; GO:0009986; GO:0010008; GO:0010614; GO:0010628; GO:0010629; GO:0010667; GO:0010812; GO:0010832; GO:0014031; GO:0014807; GO:0016324; GO:0017156; GO:0019899; GO:0021515; GO:0021915; GO:0021953; GO:0030163; GO:0030216; GO:0030279; GO:0030324; GO:0030335; GO:0030513; GO:0030514; GO:0030900; GO:0031069; GO:0031100; GO:0031490; GO:0031902; GO:0032495; GO:0032496; GO:0032966; GO:0035116; GO:0035148; GO:0035914; GO:0035924; GO:0042246; GO:0042670; GO:0042802; GO:0043086; GO:0043235; GO:0045070; GO:0045603; GO:0045608; GO:0045618; GO:0045662; GO:0045668; GO:0045747; GO:0045892; GO:0045893; GO:0045944; GO:0045955; GO:0046427; GO:0046533; GO:0046579; GO:0048103; GO:0048708; GO:0048709; GO:0048711; GO:0048715; GO:0048754; GO:0048873; GO:0050673; GO:0050679; GO:0050680; GO:0050768; GO:0051152; GO:0055008; GO:0060038; GO:0060045; GO:0060253; GO:0060271; GO:0060317; GO:0060354; GO:0060379; GO:0060411; GO:0060412; GO:0060528; GO:0060740; GO:0060768; GO:0060842; GO:0060843; GO:0060948; GO:0060956; GO:0060979; GO:0060982; GO:0061101; GO:0061344; GO:0061384; GO:0062043; GO:0070168; GO:0070374; GO:0070986; GO:0071228; GO:0071372; GO:0071456; GO:0072017; GO:0072044; GO:0072091; GO:0072144; GO:0072148; GO:0072538; GO:0090051; GO:0090090; GO:0097150; GO:0097400; GO:0098685; GO:0098839; GO:0098978; GO:0099565; GO:0120163; GO:0140537; GO:1901201; GO:1902263; GO:1902339; GO:1903849; GO:2000048; GO:2000737; GO:2000811; GO:2000974; GO:2001027 animal organ regeneration [GO:0031100]; aortic valve morphogenesis [GO:0003180]; apoptotic process involved in embryonic digit morphogenesis [GO:1902263]; arterial endothelial cell differentiation [GO:0060842]; astrocyte differentiation [GO:0048708]; atrioventricular node development [GO:0003162]; atrioventricular valve morphogenesis [GO:0003181]; auditory receptor cell fate commitment [GO:0009912]; axon guidance [GO:0007411]; branching morphogenesis of an epithelial tube [GO:0048754]; calcium-ion regulated exocytosis [GO:0017156]; cardiac atrium morphogenesis [GO:0003209]; cardiac chamber formation [GO:0003207]; cardiac epithelial to mesenchymal transition [GO:0060317]; cardiac left ventricle morphogenesis [GO:0003214]; cardiac muscle cell myoblast differentiation [GO:0060379]; cardiac muscle cell proliferation [GO:0060038]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac right atrium morphogenesis [GO:0003213]; cardiac right ventricle formation [GO:0003219]; cardiac septum morphogenesis [GO:0060411]; cardiac vascular smooth muscle cell development [GO:0060948]; cardiac ventricle morphogenesis [GO:0003208]; cell differentiation in spinal cord [GO:0021515]; cell migration involved in endocardial cushion formation [GO:0003273]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to hypoxia [GO:0071456]; cellular response to tumor cell [GO:0071228]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; central nervous system neuron differentiation [GO:0021953]; chemical synaptic transmission, postsynaptic [GO:0099565]; cilium assembly [GO:0060271]; collecting duct development [GO:0072044]; compartment pattern specification [GO:0007386]; coronary artery morphogenesis [GO:0060982]; coronary sinus valve morphogenesis [GO:0003182]; coronary vein morphogenesis [GO:0003169]; determination of left/right symmetry [GO:0007368]; distal tubule development [GO:0072017]; embryonic hindlimb morphogenesis [GO:0035116]; endocardial cell differentiation [GO:0060956]; endocardial cushion morphogenesis [GO:0003203]; endocardium development [GO:0003157]; endocardium morphogenesis [GO:0003160]; endoderm development [GO:0007492]; epidermal cell fate specification [GO:0009957]; epithelial cell fate commitment [GO:0072148]; epithelial cell proliferation [GO:0050673]; epithelial to mesenchymal transition [GO:0001837]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; forebrain development [GO:0030900]; foregut morphogenesis [GO:0007440]; glomerular mesangial cell development [GO:0072144]; growth involved in heart morphogenesis [GO:0003241]; hair follicle morphogenesis [GO:0031069]; heart development [GO:0007507]; heart looping [GO:0001947]; heart trabecula morphogenesis [GO:0061384]; homeostasis of number of cells within a tissue [GO:0048873]; humoral immune response [GO:0006959]; immune response [GO:0006955]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; inhibition of neuroepithelial cell differentiation [GO:0002085]; interleukin-17-mediated signaling pathway [GO:0097400]; keratinocyte differentiation [GO:0030216]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; lung development [GO:0030324]; luteolysis [GO:0001554]; mesenchymal cell development [GO:0014031]; mitral valve formation [GO:0003192]; negative regulation of anoikis [GO:2000811]; negative regulation of biomineral tissue development [GO:0070168]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of catalytic activity [GO:0043086]; negative regulation of cell adhesion molecule production [GO:0060354]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell proliferation involved in heart valve morphogenesis [GO:0003252]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of collagen biosynthetic process [GO:0032966]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of endothelial cell chemotaxis [GO:2001027]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of extracellular matrix constituent secretion [GO:0003332]; negative regulation of gene expression [GO:0010629]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of inner ear auditory receptor cell differentiation [GO:0045608]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of neurogenesis [GO:0050768]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of ossification [GO:0030279]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of photoreceptor cell differentiation [GO:0046533]; negative regulation of pro-B cell differentiation [GO:2000974]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural tube development [GO:0021915]; neuroendocrine cell differentiation [GO:0061101]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; Notch signaling pathway involved in regulation of secondary heart field cardioblast proliferation [GO:0003270]; oligodendrocyte differentiation [GO:0048709]; outflow tract morphogenesis [GO:0003151]; pericardium morphogenesis [GO:0003344]; positive regulation of aorta morphogenesis [GO:1903849]; positive regulation of apoptotic process involved in morphogenesis [GO:1902339]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cardiac epithelial to mesenchymal transition [GO:0062043]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of smooth muscle cell differentiation [GO:0051152]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription of Notch receptor target [GO:0007221]; positive regulation of viral genome replication [GO:0045070]; prostate gland epithelium morphogenesis [GO:0060740]; protein catabolic process [GO:0030163]; protein import into nucleus [GO:0006606]; pulmonary valve morphogenesis [GO:0003184]; regulation of cell adhesion involved in heart morphogenesis [GO:0061344]; regulation of DNA-templated transcription [GO:0006355]; regulation of epithelial cell proliferation involved in prostate gland development [GO:0060768]; regulation of extracellular matrix assembly [GO:1901201]; regulation of somitogenesis [GO:0014807]; regulation of stem cell proliferation [GO:0072091]; regulation of transcription by RNA polymerase II [GO:0006357]; response to lipopolysaccharide [GO:0032496]; response to muramyl dipeptide [GO:0032495]; retinal cone cell differentiation [GO:0042670]; secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development [GO:0060528]; skeletal muscle cell differentiation [GO:0035914]; somatic stem cell division [GO:0048103]; spermatogenesis [GO:0007283]; sprouting angiogenesis [GO:0002040]; T-helper 17 type immune response [GO:0072538]; tissue regeneration [GO:0042246]; transcription by RNA polymerase II [GO:0006366]; tube formation [GO:0035148]; vasculogenesis involved in coronary vascular morphogenesis [GO:0060979]; venous endothelial cell differentiation [GO:0060843]; ventricular septum morphogenesis [GO:0060412]; ventricular trabecula myocardium morphogenesis [GO:0003222] acrosomal vesicle [GO:0001669]; adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; late endosome membrane [GO:0031902]; MAML1-RBP-Jkappa- ICN1 complex [GO:0002193]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; receptor complex [GO:0043235]; Schaffer collateral - CA1 synapse [GO:0098685] calcium ion binding [GO:0005509]; chromatin DNA binding [GO:0031490]; enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; identical protein binding [GO:0042802]; Notch binding [GO:0005112]; transcription coactivator activity [GO:0003713]; transcription regulator activator activity [GO:0140537]; transmembrane signaling receptor activity [GO:0004888] g4792.t1 P46531 48.485 33 1.91e-26 28.9 sp|P46531|NOTC1_HUMAN Neurogenic locus notch homolog protein 1 OS=Homo sapiens OX=9606 GN=NOTCH1 PE=1 SV=4 NOTC1_HUMAN reviewed Neurogenic locus notch homolog protein 1 (Notch 1) (hN1) (Translocation-associated notch protein TAN-1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Homo sapiens (Human) GO:0000122; GO:0000139; GO:0001554; GO:0001669; GO:0001701; GO:0001837; GO:0001889; GO:0001947; GO:0002040; GO:0002052; GO:0002085; GO:0002193; GO:0002437; GO:0003151; GO:0003157; GO:0003160; GO:0003162; GO:0003169; GO:0003180; GO:0003181; GO:0003182; GO:0003184; GO:0003192; GO:0003198; GO:0003203; GO:0003207; GO:0003208; GO:0003209; GO:0003213; GO:0003214; GO:0003219; GO:0003222; GO:0003241; GO:0003252; GO:0003270; GO:0003273; GO:0003332; GO:0003344; GO:0003713; GO:0004857; GO:0004888; GO:0005112; GO:0005509; GO:0005576; GO:0005634; GO:0005654; GO:0005789; GO:0005829; GO:0005886; GO:0005912; GO:0006355; GO:0006357; GO:0006366; GO:0006606; GO:0006955; GO:0006959; GO:0007219; GO:0007221; GO:0007283; GO:0007368; GO:0007386; GO:0007411; GO:0007440; GO:0007492; GO:0007507; GO:0008284; GO:0008285; GO:0009912; GO:0009957; GO:0009986; GO:0010008; GO:0010614; GO:0010628; GO:0010629; GO:0010667; GO:0010812; GO:0010832; GO:0014031; GO:0014807; GO:0016324; GO:0017156; GO:0019899; GO:0021515; GO:0021915; GO:0021953; GO:0030163; GO:0030216; GO:0030279; GO:0030324; GO:0030335; GO:0030513; GO:0030514; GO:0030900; GO:0031069; GO:0031100; GO:0031490; GO:0031902; GO:0032495; GO:0032496; GO:0032966; GO:0035116; GO:0035148; GO:0035914; GO:0035924; GO:0042246; GO:0042670; GO:0042802; GO:0043086; GO:0043235; GO:0045070; GO:0045603; GO:0045608; GO:0045618; GO:0045662; GO:0045668; GO:0045747; GO:0045892; GO:0045893; GO:0045944; GO:0045955; GO:0046427; GO:0046533; GO:0046579; GO:0048103; GO:0048708; GO:0048709; GO:0048711; GO:0048715; GO:0048754; GO:0048873; GO:0050673; GO:0050679; GO:0050680; GO:0050768; GO:0051152; GO:0055008; GO:0060038; GO:0060045; GO:0060253; GO:0060271; GO:0060317; GO:0060354; GO:0060379; GO:0060411; GO:0060412; GO:0060528; GO:0060740; GO:0060768; GO:0060842; GO:0060843; GO:0060948; GO:0060956; GO:0060979; GO:0060982; GO:0061101; GO:0061344; GO:0061384; GO:0062043; GO:0070168; GO:0070374; GO:0070986; GO:0071228; GO:0071372; GO:0071456; GO:0072017; GO:0072044; GO:0072091; GO:0072144; GO:0072148; GO:0072538; GO:0090051; GO:0090090; GO:0097150; GO:0097400; GO:0098685; GO:0098839; GO:0098978; GO:0099565; GO:0120163; GO:0140537; GO:1901201; GO:1902263; GO:1902339; GO:1903849; GO:2000048; GO:2000737; GO:2000811; GO:2000974; GO:2001027 animal organ regeneration [GO:0031100]; aortic valve morphogenesis [GO:0003180]; apoptotic process involved in embryonic digit morphogenesis [GO:1902263]; arterial endothelial cell differentiation [GO:0060842]; astrocyte differentiation [GO:0048708]; atrioventricular node development [GO:0003162]; atrioventricular valve morphogenesis [GO:0003181]; auditory receptor cell fate commitment [GO:0009912]; axon guidance [GO:0007411]; branching morphogenesis of an epithelial tube [GO:0048754]; calcium-ion regulated exocytosis [GO:0017156]; cardiac atrium morphogenesis [GO:0003209]; cardiac chamber formation [GO:0003207]; cardiac epithelial to mesenchymal transition [GO:0060317]; cardiac left ventricle morphogenesis [GO:0003214]; cardiac muscle cell myoblast differentiation [GO:0060379]; cardiac muscle cell proliferation [GO:0060038]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac right atrium morphogenesis [GO:0003213]; cardiac right ventricle formation [GO:0003219]; cardiac septum morphogenesis [GO:0060411]; cardiac vascular smooth muscle cell development [GO:0060948]; cardiac ventricle morphogenesis [GO:0003208]; cell differentiation in spinal cord [GO:0021515]; cell migration involved in endocardial cushion formation [GO:0003273]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to hypoxia [GO:0071456]; cellular response to tumor cell [GO:0071228]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; central nervous system neuron differentiation [GO:0021953]; chemical synaptic transmission, postsynaptic [GO:0099565]; cilium assembly [GO:0060271]; collecting duct development [GO:0072044]; compartment pattern specification [GO:0007386]; coronary artery morphogenesis [GO:0060982]; coronary sinus valve morphogenesis [GO:0003182]; coronary vein morphogenesis [GO:0003169]; determination of left/right symmetry [GO:0007368]; distal tubule development [GO:0072017]; embryonic hindlimb morphogenesis [GO:0035116]; endocardial cell differentiation [GO:0060956]; endocardial cushion morphogenesis [GO:0003203]; endocardium development [GO:0003157]; endocardium morphogenesis [GO:0003160]; endoderm development [GO:0007492]; epidermal cell fate specification [GO:0009957]; epithelial cell fate commitment [GO:0072148]; epithelial cell proliferation [GO:0050673]; epithelial to mesenchymal transition [GO:0001837]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; forebrain development [GO:0030900]; foregut morphogenesis [GO:0007440]; glomerular mesangial cell development [GO:0072144]; growth involved in heart morphogenesis [GO:0003241]; hair follicle morphogenesis [GO:0031069]; heart development [GO:0007507]; heart looping [GO:0001947]; heart trabecula morphogenesis [GO:0061384]; homeostasis of number of cells within a tissue [GO:0048873]; humoral immune response [GO:0006959]; immune response [GO:0006955]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; inhibition of neuroepithelial cell differentiation [GO:0002085]; interleukin-17-mediated signaling pathway [GO:0097400]; keratinocyte differentiation [GO:0030216]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; lung development [GO:0030324]; luteolysis [GO:0001554]; mesenchymal cell development [GO:0014031]; mitral valve formation [GO:0003192]; negative regulation of anoikis [GO:2000811]; negative regulation of biomineral tissue development [GO:0070168]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of catalytic activity [GO:0043086]; negative regulation of cell adhesion molecule production [GO:0060354]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell proliferation involved in heart valve morphogenesis [GO:0003252]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of collagen biosynthetic process [GO:0032966]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of endothelial cell chemotaxis [GO:2001027]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of extracellular matrix constituent secretion [GO:0003332]; negative regulation of gene expression [GO:0010629]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of inner ear auditory receptor cell differentiation [GO:0045608]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of neurogenesis [GO:0050768]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of ossification [GO:0030279]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of photoreceptor cell differentiation [GO:0046533]; negative regulation of pro-B cell differentiation [GO:2000974]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural tube development [GO:0021915]; neuroendocrine cell differentiation [GO:0061101]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; Notch signaling pathway involved in regulation of secondary heart field cardioblast proliferation [GO:0003270]; oligodendrocyte differentiation [GO:0048709]; outflow tract morphogenesis [GO:0003151]; pericardium morphogenesis [GO:0003344]; positive regulation of aorta morphogenesis [GO:1903849]; positive regulation of apoptotic process involved in morphogenesis [GO:1902339]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cardiac epithelial to mesenchymal transition [GO:0062043]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of smooth muscle cell differentiation [GO:0051152]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription of Notch receptor target [GO:0007221]; positive regulation of viral genome replication [GO:0045070]; prostate gland epithelium morphogenesis [GO:0060740]; protein catabolic process [GO:0030163]; protein import into nucleus [GO:0006606]; pulmonary valve morphogenesis [GO:0003184]; regulation of cell adhesion involved in heart morphogenesis [GO:0061344]; regulation of DNA-templated transcription [GO:0006355]; regulation of epithelial cell proliferation involved in prostate gland development [GO:0060768]; regulation of extracellular matrix assembly [GO:1901201]; regulation of somitogenesis [GO:0014807]; regulation of stem cell proliferation [GO:0072091]; regulation of transcription by RNA polymerase II [GO:0006357]; response to lipopolysaccharide [GO:0032496]; response to muramyl dipeptide [GO:0032495]; retinal cone cell differentiation [GO:0042670]; secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development [GO:0060528]; skeletal muscle cell differentiation [GO:0035914]; somatic stem cell division [GO:0048103]; spermatogenesis [GO:0007283]; sprouting angiogenesis [GO:0002040]; T-helper 17 type immune response [GO:0072538]; tissue regeneration [GO:0042246]; transcription by RNA polymerase II [GO:0006366]; tube formation [GO:0035148]; vasculogenesis involved in coronary vascular morphogenesis [GO:0060979]; venous endothelial cell differentiation [GO:0060843]; ventricular septum morphogenesis [GO:0060412]; ventricular trabecula myocardium morphogenesis [GO:0003222] acrosomal vesicle [GO:0001669]; adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; late endosome membrane [GO:0031902]; MAML1-RBP-Jkappa- ICN1 complex [GO:0002193]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; receptor complex [GO:0043235]; Schaffer collateral - CA1 synapse [GO:0098685] calcium ion binding [GO:0005509]; chromatin DNA binding [GO:0031490]; enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; identical protein binding [GO:0042802]; Notch binding [GO:0005112]; transcription coactivator activity [GO:0003713]; transcription regulator activator activity [GO:0140537]; transmembrane signaling receptor activity [GO:0004888] g4792.t1 P46531 34.579 214 1.23e-24 109.0 sp|P46531|NOTC1_HUMAN Neurogenic locus notch homolog protein 1 OS=Homo sapiens OX=9606 GN=NOTCH1 PE=1 SV=4 NOTC1_HUMAN reviewed Neurogenic locus notch homolog protein 1 (Notch 1) (hN1) (Translocation-associated notch protein TAN-1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Homo sapiens (Human) GO:0000122; GO:0000139; GO:0001554; GO:0001669; GO:0001701; GO:0001837; GO:0001889; GO:0001947; GO:0002040; GO:0002052; GO:0002085; GO:0002193; GO:0002437; GO:0003151; GO:0003157; GO:0003160; GO:0003162; GO:0003169; GO:0003180; GO:0003181; GO:0003182; GO:0003184; GO:0003192; GO:0003198; GO:0003203; GO:0003207; GO:0003208; GO:0003209; GO:0003213; GO:0003214; GO:0003219; GO:0003222; GO:0003241; GO:0003252; GO:0003270; GO:0003273; GO:0003332; GO:0003344; GO:0003713; GO:0004857; GO:0004888; GO:0005112; GO:0005509; GO:0005576; GO:0005634; GO:0005654; GO:0005789; GO:0005829; GO:0005886; GO:0005912; GO:0006355; GO:0006357; GO:0006366; GO:0006606; GO:0006955; GO:0006959; GO:0007219; GO:0007221; GO:0007283; GO:0007368; GO:0007386; GO:0007411; GO:0007440; GO:0007492; GO:0007507; GO:0008284; GO:0008285; GO:0009912; GO:0009957; GO:0009986; GO:0010008; GO:0010614; GO:0010628; GO:0010629; GO:0010667; GO:0010812; GO:0010832; GO:0014031; GO:0014807; GO:0016324; GO:0017156; GO:0019899; GO:0021515; GO:0021915; GO:0021953; GO:0030163; GO:0030216; GO:0030279; GO:0030324; GO:0030335; GO:0030513; GO:0030514; GO:0030900; GO:0031069; GO:0031100; GO:0031490; GO:0031902; GO:0032495; GO:0032496; GO:0032966; GO:0035116; GO:0035148; GO:0035914; GO:0035924; GO:0042246; GO:0042670; GO:0042802; GO:0043086; GO:0043235; GO:0045070; GO:0045603; GO:0045608; GO:0045618; GO:0045662; GO:0045668; GO:0045747; GO:0045892; GO:0045893; GO:0045944; GO:0045955; GO:0046427; GO:0046533; GO:0046579; GO:0048103; GO:0048708; GO:0048709; GO:0048711; GO:0048715; GO:0048754; GO:0048873; GO:0050673; GO:0050679; GO:0050680; GO:0050768; GO:0051152; GO:0055008; GO:0060038; GO:0060045; GO:0060253; GO:0060271; GO:0060317; GO:0060354; GO:0060379; GO:0060411; GO:0060412; GO:0060528; GO:0060740; GO:0060768; GO:0060842; GO:0060843; GO:0060948; GO:0060956; GO:0060979; GO:0060982; GO:0061101; GO:0061344; GO:0061384; GO:0062043; GO:0070168; GO:0070374; GO:0070986; GO:0071228; GO:0071372; GO:0071456; GO:0072017; GO:0072044; GO:0072091; GO:0072144; GO:0072148; GO:0072538; GO:0090051; GO:0090090; GO:0097150; GO:0097400; GO:0098685; GO:0098839; GO:0098978; GO:0099565; GO:0120163; GO:0140537; GO:1901201; GO:1902263; GO:1902339; GO:1903849; GO:2000048; GO:2000737; GO:2000811; GO:2000974; GO:2001027 animal organ regeneration [GO:0031100]; aortic valve morphogenesis [GO:0003180]; apoptotic process involved in embryonic digit morphogenesis [GO:1902263]; arterial endothelial cell differentiation [GO:0060842]; astrocyte differentiation [GO:0048708]; atrioventricular node development [GO:0003162]; atrioventricular valve morphogenesis [GO:0003181]; auditory receptor cell fate commitment [GO:0009912]; axon guidance [GO:0007411]; branching morphogenesis of an epithelial tube [GO:0048754]; calcium-ion regulated exocytosis [GO:0017156]; cardiac atrium morphogenesis [GO:0003209]; cardiac chamber formation [GO:0003207]; cardiac epithelial to mesenchymal transition [GO:0060317]; cardiac left ventricle morphogenesis [GO:0003214]; cardiac muscle cell myoblast differentiation [GO:0060379]; cardiac muscle cell proliferation [GO:0060038]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac right atrium morphogenesis [GO:0003213]; cardiac right ventricle formation [GO:0003219]; cardiac septum morphogenesis [GO:0060411]; cardiac vascular smooth muscle cell development [GO:0060948]; cardiac ventricle morphogenesis [GO:0003208]; cell differentiation in spinal cord [GO:0021515]; cell migration involved in endocardial cushion formation [GO:0003273]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to hypoxia [GO:0071456]; cellular response to tumor cell [GO:0071228]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; central nervous system neuron differentiation [GO:0021953]; chemical synaptic transmission, postsynaptic [GO:0099565]; cilium assembly [GO:0060271]; collecting duct development [GO:0072044]; compartment pattern specification [GO:0007386]; coronary artery morphogenesis [GO:0060982]; coronary sinus valve morphogenesis [GO:0003182]; coronary vein morphogenesis [GO:0003169]; determination of left/right symmetry [GO:0007368]; distal tubule development [GO:0072017]; embryonic hindlimb morphogenesis [GO:0035116]; endocardial cell differentiation [GO:0060956]; endocardial cushion morphogenesis [GO:0003203]; endocardium development [GO:0003157]; endocardium morphogenesis [GO:0003160]; endoderm development [GO:0007492]; epidermal cell fate specification [GO:0009957]; epithelial cell fate commitment [GO:0072148]; epithelial cell proliferation [GO:0050673]; epithelial to mesenchymal transition [GO:0001837]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; forebrain development [GO:0030900]; foregut morphogenesis [GO:0007440]; glomerular mesangial cell development [GO:0072144]; growth involved in heart morphogenesis [GO:0003241]; hair follicle morphogenesis [GO:0031069]; heart development [GO:0007507]; heart looping [GO:0001947]; heart trabecula morphogenesis [GO:0061384]; homeostasis of number of cells within a tissue [GO:0048873]; humoral immune response [GO:0006959]; immune response [GO:0006955]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; inhibition of neuroepithelial cell differentiation [GO:0002085]; interleukin-17-mediated signaling pathway [GO:0097400]; keratinocyte differentiation [GO:0030216]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; lung development [GO:0030324]; luteolysis [GO:0001554]; mesenchymal cell development [GO:0014031]; mitral valve formation [GO:0003192]; negative regulation of anoikis [GO:2000811]; negative regulation of biomineral tissue development [GO:0070168]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of catalytic activity [GO:0043086]; negative regulation of cell adhesion molecule production [GO:0060354]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell proliferation involved in heart valve morphogenesis [GO:0003252]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of collagen biosynthetic process [GO:0032966]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of endothelial cell chemotaxis [GO:2001027]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of extracellular matrix constituent secretion [GO:0003332]; negative regulation of gene expression [GO:0010629]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of inner ear auditory receptor cell differentiation [GO:0045608]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of neurogenesis [GO:0050768]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of ossification [GO:0030279]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of photoreceptor cell differentiation [GO:0046533]; negative regulation of pro-B cell differentiation [GO:2000974]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural tube development [GO:0021915]; neuroendocrine cell differentiation [GO:0061101]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; Notch signaling pathway involved in regulation of secondary heart field cardioblast proliferation [GO:0003270]; oligodendrocyte differentiation [GO:0048709]; outflow tract morphogenesis [GO:0003151]; pericardium morphogenesis [GO:0003344]; positive regulation of aorta morphogenesis [GO:1903849]; positive regulation of apoptotic process involved in morphogenesis [GO:1902339]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cardiac epithelial to mesenchymal transition [GO:0062043]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of smooth muscle cell differentiation [GO:0051152]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription of Notch receptor target [GO:0007221]; positive regulation of viral genome replication [GO:0045070]; prostate gland epithelium morphogenesis [GO:0060740]; protein catabolic process [GO:0030163]; protein import into nucleus [GO:0006606]; pulmonary valve morphogenesis [GO:0003184]; regulation of cell adhesion involved in heart morphogenesis [GO:0061344]; regulation of DNA-templated transcription [GO:0006355]; regulation of epithelial cell proliferation involved in prostate gland development [GO:0060768]; regulation of extracellular matrix assembly [GO:1901201]; regulation of somitogenesis [GO:0014807]; regulation of stem cell proliferation [GO:0072091]; regulation of transcription by RNA polymerase II [GO:0006357]; response to lipopolysaccharide [GO:0032496]; response to muramyl dipeptide [GO:0032495]; retinal cone cell differentiation [GO:0042670]; secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development [GO:0060528]; skeletal muscle cell differentiation [GO:0035914]; somatic stem cell division [GO:0048103]; spermatogenesis [GO:0007283]; sprouting angiogenesis [GO:0002040]; T-helper 17 type immune response [GO:0072538]; tissue regeneration [GO:0042246]; transcription by RNA polymerase II [GO:0006366]; tube formation [GO:0035148]; vasculogenesis involved in coronary vascular morphogenesis [GO:0060979]; venous endothelial cell differentiation [GO:0060843]; ventricular septum morphogenesis [GO:0060412]; ventricular trabecula myocardium morphogenesis [GO:0003222] acrosomal vesicle [GO:0001669]; adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; late endosome membrane [GO:0031902]; MAML1-RBP-Jkappa- ICN1 complex [GO:0002193]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; receptor complex [GO:0043235]; Schaffer collateral - CA1 synapse [GO:0098685] calcium ion binding [GO:0005509]; chromatin DNA binding [GO:0031490]; enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; identical protein binding [GO:0042802]; Notch binding [GO:0005112]; transcription coactivator activity [GO:0003713]; transcription regulator activator activity [GO:0140537]; transmembrane signaling receptor activity [GO:0004888] g4792.t1 P46531 41.379 29 1.23e-24 25.8 sp|P46531|NOTC1_HUMAN Neurogenic locus notch homolog protein 1 OS=Homo sapiens OX=9606 GN=NOTCH1 PE=1 SV=4 NOTC1_HUMAN reviewed Neurogenic locus notch homolog protein 1 (Notch 1) (hN1) (Translocation-associated notch protein TAN-1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Homo sapiens (Human) GO:0000122; GO:0000139; GO:0001554; GO:0001669; GO:0001701; GO:0001837; GO:0001889; GO:0001947; GO:0002040; GO:0002052; GO:0002085; GO:0002193; GO:0002437; GO:0003151; GO:0003157; GO:0003160; GO:0003162; GO:0003169; GO:0003180; GO:0003181; GO:0003182; GO:0003184; GO:0003192; GO:0003198; GO:0003203; GO:0003207; GO:0003208; GO:0003209; GO:0003213; GO:0003214; GO:0003219; GO:0003222; GO:0003241; GO:0003252; GO:0003270; GO:0003273; GO:0003332; GO:0003344; GO:0003713; GO:0004857; GO:0004888; GO:0005112; GO:0005509; GO:0005576; GO:0005634; GO:0005654; GO:0005789; GO:0005829; GO:0005886; GO:0005912; GO:0006355; GO:0006357; GO:0006366; GO:0006606; GO:0006955; GO:0006959; GO:0007219; GO:0007221; GO:0007283; GO:0007368; GO:0007386; GO:0007411; GO:0007440; GO:0007492; GO:0007507; GO:0008284; GO:0008285; GO:0009912; GO:0009957; GO:0009986; GO:0010008; GO:0010614; GO:0010628; GO:0010629; GO:0010667; GO:0010812; GO:0010832; GO:0014031; GO:0014807; GO:0016324; GO:0017156; GO:0019899; GO:0021515; GO:0021915; GO:0021953; GO:0030163; GO:0030216; GO:0030279; GO:0030324; GO:0030335; GO:0030513; GO:0030514; GO:0030900; GO:0031069; GO:0031100; GO:0031490; GO:0031902; GO:0032495; GO:0032496; GO:0032966; GO:0035116; GO:0035148; GO:0035914; GO:0035924; GO:0042246; GO:0042670; GO:0042802; GO:0043086; GO:0043235; GO:0045070; GO:0045603; GO:0045608; GO:0045618; GO:0045662; GO:0045668; GO:0045747; GO:0045892; GO:0045893; GO:0045944; GO:0045955; GO:0046427; GO:0046533; GO:0046579; GO:0048103; GO:0048708; GO:0048709; GO:0048711; GO:0048715; GO:0048754; GO:0048873; GO:0050673; GO:0050679; GO:0050680; GO:0050768; GO:0051152; GO:0055008; GO:0060038; GO:0060045; GO:0060253; GO:0060271; GO:0060317; GO:0060354; GO:0060379; GO:0060411; GO:0060412; GO:0060528; GO:0060740; GO:0060768; GO:0060842; GO:0060843; GO:0060948; GO:0060956; GO:0060979; GO:0060982; GO:0061101; GO:0061344; GO:0061384; GO:0062043; GO:0070168; GO:0070374; GO:0070986; GO:0071228; GO:0071372; GO:0071456; GO:0072017; GO:0072044; GO:0072091; GO:0072144; GO:0072148; GO:0072538; GO:0090051; GO:0090090; GO:0097150; GO:0097400; GO:0098685; GO:0098839; GO:0098978; GO:0099565; GO:0120163; GO:0140537; GO:1901201; GO:1902263; GO:1902339; GO:1903849; GO:2000048; GO:2000737; GO:2000811; GO:2000974; GO:2001027 animal organ regeneration [GO:0031100]; aortic valve morphogenesis [GO:0003180]; apoptotic process involved in embryonic digit morphogenesis [GO:1902263]; arterial endothelial cell differentiation [GO:0060842]; astrocyte differentiation [GO:0048708]; atrioventricular node development [GO:0003162]; atrioventricular valve morphogenesis [GO:0003181]; auditory receptor cell fate commitment [GO:0009912]; axon guidance [GO:0007411]; branching morphogenesis of an epithelial tube [GO:0048754]; calcium-ion regulated exocytosis [GO:0017156]; cardiac atrium morphogenesis [GO:0003209]; cardiac chamber formation [GO:0003207]; cardiac epithelial to mesenchymal transition [GO:0060317]; cardiac left ventricle morphogenesis [GO:0003214]; cardiac muscle cell myoblast differentiation [GO:0060379]; cardiac muscle cell proliferation [GO:0060038]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac right atrium morphogenesis [GO:0003213]; cardiac right ventricle formation [GO:0003219]; cardiac septum morphogenesis [GO:0060411]; cardiac vascular smooth muscle cell development [GO:0060948]; cardiac ventricle morphogenesis [GO:0003208]; cell differentiation in spinal cord [GO:0021515]; cell migration involved in endocardial cushion formation [GO:0003273]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to hypoxia [GO:0071456]; cellular response to tumor cell [GO:0071228]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; central nervous system neuron differentiation [GO:0021953]; chemical synaptic transmission, postsynaptic [GO:0099565]; cilium assembly [GO:0060271]; collecting duct development [GO:0072044]; compartment pattern specification [GO:0007386]; coronary artery morphogenesis [GO:0060982]; coronary sinus valve morphogenesis [GO:0003182]; coronary vein morphogenesis [GO:0003169]; determination of left/right symmetry [GO:0007368]; distal tubule development [GO:0072017]; embryonic hindlimb morphogenesis [GO:0035116]; endocardial cell differentiation [GO:0060956]; endocardial cushion morphogenesis [GO:0003203]; endocardium development [GO:0003157]; endocardium morphogenesis [GO:0003160]; endoderm development [GO:0007492]; epidermal cell fate specification [GO:0009957]; epithelial cell fate commitment [GO:0072148]; epithelial cell proliferation [GO:0050673]; epithelial to mesenchymal transition [GO:0001837]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; forebrain development [GO:0030900]; foregut morphogenesis [GO:0007440]; glomerular mesangial cell development [GO:0072144]; growth involved in heart morphogenesis [GO:0003241]; hair follicle morphogenesis [GO:0031069]; heart development [GO:0007507]; heart looping [GO:0001947]; heart trabecula morphogenesis [GO:0061384]; homeostasis of number of cells within a tissue [GO:0048873]; humoral immune response [GO:0006959]; immune response [GO:0006955]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; inhibition of neuroepithelial cell differentiation [GO:0002085]; interleukin-17-mediated signaling pathway [GO:0097400]; keratinocyte differentiation [GO:0030216]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; lung development [GO:0030324]; luteolysis [GO:0001554]; mesenchymal cell development [GO:0014031]; mitral valve formation [GO:0003192]; negative regulation of anoikis [GO:2000811]; negative regulation of biomineral tissue development [GO:0070168]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of catalytic activity [GO:0043086]; negative regulation of cell adhesion molecule production [GO:0060354]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell proliferation involved in heart valve morphogenesis [GO:0003252]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of collagen biosynthetic process [GO:0032966]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of endothelial cell chemotaxis [GO:2001027]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of extracellular matrix constituent secretion [GO:0003332]; negative regulation of gene expression [GO:0010629]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of inner ear auditory receptor cell differentiation [GO:0045608]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of neurogenesis [GO:0050768]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of ossification [GO:0030279]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of photoreceptor cell differentiation [GO:0046533]; negative regulation of pro-B cell differentiation [GO:2000974]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural tube development [GO:0021915]; neuroendocrine cell differentiation [GO:0061101]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; Notch signaling pathway involved in regulation of secondary heart field cardioblast proliferation [GO:0003270]; oligodendrocyte differentiation [GO:0048709]; outflow tract morphogenesis [GO:0003151]; pericardium morphogenesis [GO:0003344]; positive regulation of aorta morphogenesis [GO:1903849]; positive regulation of apoptotic process involved in morphogenesis [GO:1902339]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cardiac epithelial to mesenchymal transition [GO:0062043]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of smooth muscle cell differentiation [GO:0051152]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription of Notch receptor target [GO:0007221]; positive regulation of viral genome replication [GO:0045070]; prostate gland epithelium morphogenesis [GO:0060740]; protein catabolic process [GO:0030163]; protein import into nucleus [GO:0006606]; pulmonary valve morphogenesis [GO:0003184]; regulation of cell adhesion involved in heart morphogenesis [GO:0061344]; regulation of DNA-templated transcription [GO:0006355]; regulation of epithelial cell proliferation involved in prostate gland development [GO:0060768]; regulation of extracellular matrix assembly [GO:1901201]; regulation of somitogenesis [GO:0014807]; regulation of stem cell proliferation [GO:0072091]; regulation of transcription by RNA polymerase II [GO:0006357]; response to lipopolysaccharide [GO:0032496]; response to muramyl dipeptide [GO:0032495]; retinal cone cell differentiation [GO:0042670]; secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development [GO:0060528]; skeletal muscle cell differentiation [GO:0035914]; somatic stem cell division [GO:0048103]; spermatogenesis [GO:0007283]; sprouting angiogenesis [GO:0002040]; T-helper 17 type immune response [GO:0072538]; tissue regeneration [GO:0042246]; transcription by RNA polymerase II [GO:0006366]; tube formation [GO:0035148]; vasculogenesis involved in coronary vascular morphogenesis [GO:0060979]; venous endothelial cell differentiation [GO:0060843]; ventricular septum morphogenesis [GO:0060412]; ventricular trabecula myocardium morphogenesis [GO:0003222] acrosomal vesicle [GO:0001669]; adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; late endosome membrane [GO:0031902]; MAML1-RBP-Jkappa- ICN1 complex [GO:0002193]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; receptor complex [GO:0043235]; Schaffer collateral - CA1 synapse [GO:0098685] calcium ion binding [GO:0005509]; chromatin DNA binding [GO:0031490]; enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; identical protein binding [GO:0042802]; Notch binding [GO:0005112]; transcription coactivator activity [GO:0003713]; transcription regulator activator activity [GO:0140537]; transmembrane signaling receptor activity [GO:0004888] g4792.t1 P46531 35.814 215 9.159999999999999e-24 107.0 sp|P46531|NOTC1_HUMAN Neurogenic locus notch homolog protein 1 OS=Homo sapiens OX=9606 GN=NOTCH1 PE=1 SV=4 NOTC1_HUMAN reviewed Neurogenic locus notch homolog protein 1 (Notch 1) (hN1) (Translocation-associated notch protein TAN-1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Homo sapiens (Human) GO:0000122; GO:0000139; GO:0001554; GO:0001669; GO:0001701; GO:0001837; GO:0001889; GO:0001947; GO:0002040; GO:0002052; GO:0002085; GO:0002193; GO:0002437; GO:0003151; GO:0003157; GO:0003160; GO:0003162; GO:0003169; GO:0003180; GO:0003181; GO:0003182; GO:0003184; GO:0003192; GO:0003198; GO:0003203; GO:0003207; GO:0003208; GO:0003209; GO:0003213; GO:0003214; GO:0003219; GO:0003222; GO:0003241; GO:0003252; GO:0003270; GO:0003273; GO:0003332; GO:0003344; GO:0003713; GO:0004857; GO:0004888; GO:0005112; GO:0005509; GO:0005576; GO:0005634; GO:0005654; GO:0005789; GO:0005829; GO:0005886; GO:0005912; GO:0006355; GO:0006357; GO:0006366; GO:0006606; GO:0006955; GO:0006959; GO:0007219; GO:0007221; GO:0007283; GO:0007368; GO:0007386; GO:0007411; GO:0007440; GO:0007492; GO:0007507; GO:0008284; GO:0008285; GO:0009912; GO:0009957; GO:0009986; GO:0010008; GO:0010614; GO:0010628; GO:0010629; GO:0010667; GO:0010812; GO:0010832; GO:0014031; GO:0014807; GO:0016324; GO:0017156; GO:0019899; GO:0021515; GO:0021915; GO:0021953; GO:0030163; GO:0030216; GO:0030279; GO:0030324; GO:0030335; GO:0030513; GO:0030514; GO:0030900; GO:0031069; GO:0031100; GO:0031490; GO:0031902; GO:0032495; GO:0032496; GO:0032966; GO:0035116; GO:0035148; GO:0035914; GO:0035924; GO:0042246; GO:0042670; GO:0042802; GO:0043086; GO:0043235; GO:0045070; GO:0045603; GO:0045608; GO:0045618; GO:0045662; GO:0045668; GO:0045747; GO:0045892; GO:0045893; GO:0045944; GO:0045955; GO:0046427; GO:0046533; GO:0046579; GO:0048103; GO:0048708; GO:0048709; GO:0048711; GO:0048715; GO:0048754; GO:0048873; GO:0050673; GO:0050679; GO:0050680; GO:0050768; GO:0051152; GO:0055008; GO:0060038; GO:0060045; GO:0060253; GO:0060271; GO:0060317; GO:0060354; GO:0060379; GO:0060411; GO:0060412; GO:0060528; GO:0060740; GO:0060768; GO:0060842; GO:0060843; GO:0060948; GO:0060956; GO:0060979; GO:0060982; GO:0061101; GO:0061344; GO:0061384; GO:0062043; GO:0070168; GO:0070374; GO:0070986; GO:0071228; GO:0071372; GO:0071456; GO:0072017; GO:0072044; GO:0072091; GO:0072144; GO:0072148; GO:0072538; GO:0090051; GO:0090090; GO:0097150; GO:0097400; GO:0098685; GO:0098839; GO:0098978; GO:0099565; GO:0120163; GO:0140537; GO:1901201; GO:1902263; GO:1902339; GO:1903849; GO:2000048; GO:2000737; GO:2000811; GO:2000974; GO:2001027 animal organ regeneration [GO:0031100]; aortic valve morphogenesis [GO:0003180]; apoptotic process involved in embryonic digit morphogenesis [GO:1902263]; arterial endothelial cell differentiation [GO:0060842]; astrocyte differentiation [GO:0048708]; atrioventricular node development [GO:0003162]; atrioventricular valve morphogenesis [GO:0003181]; auditory receptor cell fate commitment [GO:0009912]; axon guidance [GO:0007411]; branching morphogenesis of an epithelial tube [GO:0048754]; calcium-ion regulated exocytosis [GO:0017156]; cardiac atrium morphogenesis [GO:0003209]; cardiac chamber formation [GO:0003207]; cardiac epithelial to mesenchymal transition [GO:0060317]; cardiac left ventricle morphogenesis [GO:0003214]; cardiac muscle cell myoblast differentiation [GO:0060379]; cardiac muscle cell proliferation [GO:0060038]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac right atrium morphogenesis [GO:0003213]; cardiac right ventricle formation [GO:0003219]; cardiac septum morphogenesis [GO:0060411]; cardiac vascular smooth muscle cell development [GO:0060948]; cardiac ventricle morphogenesis [GO:0003208]; cell differentiation in spinal cord [GO:0021515]; cell migration involved in endocardial cushion formation [GO:0003273]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to hypoxia [GO:0071456]; cellular response to tumor cell [GO:0071228]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; central nervous system neuron differentiation [GO:0021953]; chemical synaptic transmission, postsynaptic [GO:0099565]; cilium assembly [GO:0060271]; collecting duct development [GO:0072044]; compartment pattern specification [GO:0007386]; coronary artery morphogenesis [GO:0060982]; coronary sinus valve morphogenesis [GO:0003182]; coronary vein morphogenesis [GO:0003169]; determination of left/right symmetry [GO:0007368]; distal tubule development [GO:0072017]; embryonic hindlimb morphogenesis [GO:0035116]; endocardial cell differentiation [GO:0060956]; endocardial cushion morphogenesis [GO:0003203]; endocardium development [GO:0003157]; endocardium morphogenesis [GO:0003160]; endoderm development [GO:0007492]; epidermal cell fate specification [GO:0009957]; epithelial cell fate commitment [GO:0072148]; epithelial cell proliferation [GO:0050673]; epithelial to mesenchymal transition [GO:0001837]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; forebrain development [GO:0030900]; foregut morphogenesis [GO:0007440]; glomerular mesangial cell development [GO:0072144]; growth involved in heart morphogenesis [GO:0003241]; hair follicle morphogenesis [GO:0031069]; heart development [GO:0007507]; heart looping [GO:0001947]; heart trabecula morphogenesis [GO:0061384]; homeostasis of number of cells within a tissue [GO:0048873]; humoral immune response [GO:0006959]; immune response [GO:0006955]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; inhibition of neuroepithelial cell differentiation [GO:0002085]; interleukin-17-mediated signaling pathway [GO:0097400]; keratinocyte differentiation [GO:0030216]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; lung development [GO:0030324]; luteolysis [GO:0001554]; mesenchymal cell development [GO:0014031]; mitral valve formation [GO:0003192]; negative regulation of anoikis [GO:2000811]; negative regulation of biomineral tissue development [GO:0070168]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of catalytic activity [GO:0043086]; negative regulation of cell adhesion molecule production [GO:0060354]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell proliferation involved in heart valve morphogenesis [GO:0003252]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of collagen biosynthetic process [GO:0032966]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of endothelial cell chemotaxis [GO:2001027]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of extracellular matrix constituent secretion [GO:0003332]; negative regulation of gene expression [GO:0010629]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of inner ear auditory receptor cell differentiation [GO:0045608]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of neurogenesis [GO:0050768]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of ossification [GO:0030279]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of photoreceptor cell differentiation [GO:0046533]; negative regulation of pro-B cell differentiation [GO:2000974]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural tube development [GO:0021915]; neuroendocrine cell differentiation [GO:0061101]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; Notch signaling pathway involved in regulation of secondary heart field cardioblast proliferation [GO:0003270]; oligodendrocyte differentiation [GO:0048709]; outflow tract morphogenesis [GO:0003151]; pericardium morphogenesis [GO:0003344]; positive regulation of aorta morphogenesis [GO:1903849]; positive regulation of apoptotic process involved in morphogenesis [GO:1902339]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cardiac epithelial to mesenchymal transition [GO:0062043]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of smooth muscle cell differentiation [GO:0051152]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription of Notch receptor target [GO:0007221]; positive regulation of viral genome replication [GO:0045070]; prostate gland epithelium morphogenesis [GO:0060740]; protein catabolic process [GO:0030163]; protein import into nucleus [GO:0006606]; pulmonary valve morphogenesis [GO:0003184]; regulation of cell adhesion involved in heart morphogenesis [GO:0061344]; regulation of DNA-templated transcription [GO:0006355]; regulation of epithelial cell proliferation involved in prostate gland development [GO:0060768]; regulation of extracellular matrix assembly [GO:1901201]; regulation of somitogenesis [GO:0014807]; regulation of stem cell proliferation [GO:0072091]; regulation of transcription by RNA polymerase II [GO:0006357]; response to lipopolysaccharide [GO:0032496]; response to muramyl dipeptide [GO:0032495]; retinal cone cell differentiation [GO:0042670]; secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development [GO:0060528]; skeletal muscle cell differentiation [GO:0035914]; somatic stem cell division [GO:0048103]; spermatogenesis [GO:0007283]; sprouting angiogenesis [GO:0002040]; T-helper 17 type immune response [GO:0072538]; tissue regeneration [GO:0042246]; transcription by RNA polymerase II [GO:0006366]; tube formation [GO:0035148]; vasculogenesis involved in coronary vascular morphogenesis [GO:0060979]; venous endothelial cell differentiation [GO:0060843]; ventricular septum morphogenesis [GO:0060412]; ventricular trabecula myocardium morphogenesis [GO:0003222] acrosomal vesicle [GO:0001669]; adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; late endosome membrane [GO:0031902]; MAML1-RBP-Jkappa- ICN1 complex [GO:0002193]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; receptor complex [GO:0043235]; Schaffer collateral - CA1 synapse [GO:0098685] calcium ion binding [GO:0005509]; chromatin DNA binding [GO:0031490]; enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; identical protein binding [GO:0042802]; Notch binding [GO:0005112]; transcription coactivator activity [GO:0003713]; transcription regulator activator activity [GO:0140537]; transmembrane signaling receptor activity [GO:0004888] g4792.t1 P46531 35.714 210 6.0400000000000005e-22 102.0 sp|P46531|NOTC1_HUMAN Neurogenic locus notch homolog protein 1 OS=Homo sapiens OX=9606 GN=NOTCH1 PE=1 SV=4 NOTC1_HUMAN reviewed Neurogenic locus notch homolog protein 1 (Notch 1) (hN1) (Translocation-associated notch protein TAN-1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Homo sapiens (Human) GO:0000122; GO:0000139; GO:0001554; GO:0001669; GO:0001701; GO:0001837; GO:0001889; GO:0001947; GO:0002040; GO:0002052; GO:0002085; GO:0002193; GO:0002437; GO:0003151; GO:0003157; GO:0003160; GO:0003162; GO:0003169; GO:0003180; GO:0003181; GO:0003182; GO:0003184; GO:0003192; GO:0003198; GO:0003203; GO:0003207; GO:0003208; GO:0003209; GO:0003213; GO:0003214; GO:0003219; GO:0003222; GO:0003241; GO:0003252; GO:0003270; GO:0003273; GO:0003332; GO:0003344; GO:0003713; GO:0004857; GO:0004888; GO:0005112; GO:0005509; GO:0005576; GO:0005634; GO:0005654; GO:0005789; GO:0005829; GO:0005886; GO:0005912; GO:0006355; GO:0006357; GO:0006366; GO:0006606; GO:0006955; GO:0006959; GO:0007219; GO:0007221; GO:0007283; GO:0007368; GO:0007386; GO:0007411; GO:0007440; GO:0007492; GO:0007507; GO:0008284; GO:0008285; GO:0009912; GO:0009957; GO:0009986; GO:0010008; GO:0010614; GO:0010628; GO:0010629; GO:0010667; GO:0010812; GO:0010832; GO:0014031; GO:0014807; GO:0016324; GO:0017156; GO:0019899; GO:0021515; GO:0021915; GO:0021953; GO:0030163; GO:0030216; GO:0030279; GO:0030324; GO:0030335; GO:0030513; GO:0030514; GO:0030900; GO:0031069; GO:0031100; GO:0031490; GO:0031902; GO:0032495; GO:0032496; GO:0032966; GO:0035116; GO:0035148; GO:0035914; GO:0035924; GO:0042246; GO:0042670; GO:0042802; GO:0043086; GO:0043235; GO:0045070; GO:0045603; GO:0045608; GO:0045618; GO:0045662; GO:0045668; GO:0045747; GO:0045892; GO:0045893; GO:0045944; GO:0045955; GO:0046427; GO:0046533; GO:0046579; GO:0048103; GO:0048708; GO:0048709; GO:0048711; GO:0048715; GO:0048754; GO:0048873; GO:0050673; GO:0050679; GO:0050680; GO:0050768; GO:0051152; GO:0055008; GO:0060038; GO:0060045; GO:0060253; GO:0060271; GO:0060317; GO:0060354; GO:0060379; GO:0060411; GO:0060412; GO:0060528; GO:0060740; GO:0060768; GO:0060842; GO:0060843; GO:0060948; GO:0060956; GO:0060979; GO:0060982; GO:0061101; GO:0061344; GO:0061384; GO:0062043; GO:0070168; GO:0070374; GO:0070986; GO:0071228; GO:0071372; GO:0071456; GO:0072017; GO:0072044; GO:0072091; GO:0072144; GO:0072148; GO:0072538; GO:0090051; GO:0090090; GO:0097150; GO:0097400; GO:0098685; GO:0098839; GO:0098978; GO:0099565; GO:0120163; GO:0140537; GO:1901201; GO:1902263; GO:1902339; GO:1903849; GO:2000048; GO:2000737; GO:2000811; GO:2000974; GO:2001027 animal organ regeneration [GO:0031100]; aortic valve morphogenesis [GO:0003180]; apoptotic process involved in embryonic digit morphogenesis [GO:1902263]; arterial endothelial cell differentiation [GO:0060842]; astrocyte differentiation [GO:0048708]; atrioventricular node development [GO:0003162]; atrioventricular valve morphogenesis [GO:0003181]; auditory receptor cell fate commitment [GO:0009912]; axon guidance [GO:0007411]; branching morphogenesis of an epithelial tube [GO:0048754]; calcium-ion regulated exocytosis [GO:0017156]; cardiac atrium morphogenesis [GO:0003209]; cardiac chamber formation [GO:0003207]; cardiac epithelial to mesenchymal transition [GO:0060317]; cardiac left ventricle morphogenesis [GO:0003214]; cardiac muscle cell myoblast differentiation [GO:0060379]; cardiac muscle cell proliferation [GO:0060038]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac right atrium morphogenesis [GO:0003213]; cardiac right ventricle formation [GO:0003219]; cardiac septum morphogenesis [GO:0060411]; cardiac vascular smooth muscle cell development [GO:0060948]; cardiac ventricle morphogenesis [GO:0003208]; cell differentiation in spinal cord [GO:0021515]; cell migration involved in endocardial cushion formation [GO:0003273]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to hypoxia [GO:0071456]; cellular response to tumor cell [GO:0071228]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; central nervous system neuron differentiation [GO:0021953]; chemical synaptic transmission, postsynaptic [GO:0099565]; cilium assembly [GO:0060271]; collecting duct development [GO:0072044]; compartment pattern specification [GO:0007386]; coronary artery morphogenesis [GO:0060982]; coronary sinus valve morphogenesis [GO:0003182]; coronary vein morphogenesis [GO:0003169]; determination of left/right symmetry [GO:0007368]; distal tubule development [GO:0072017]; embryonic hindlimb morphogenesis [GO:0035116]; endocardial cell differentiation [GO:0060956]; endocardial cushion morphogenesis [GO:0003203]; endocardium development [GO:0003157]; endocardium morphogenesis [GO:0003160]; endoderm development [GO:0007492]; epidermal cell fate specification [GO:0009957]; epithelial cell fate commitment [GO:0072148]; epithelial cell proliferation [GO:0050673]; epithelial to mesenchymal transition [GO:0001837]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; forebrain development [GO:0030900]; foregut morphogenesis [GO:0007440]; glomerular mesangial cell development [GO:0072144]; growth involved in heart morphogenesis [GO:0003241]; hair follicle morphogenesis [GO:0031069]; heart development [GO:0007507]; heart looping [GO:0001947]; heart trabecula morphogenesis [GO:0061384]; homeostasis of number of cells within a tissue [GO:0048873]; humoral immune response [GO:0006959]; immune response [GO:0006955]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; inhibition of neuroepithelial cell differentiation [GO:0002085]; interleukin-17-mediated signaling pathway [GO:0097400]; keratinocyte differentiation [GO:0030216]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; lung development [GO:0030324]; luteolysis [GO:0001554]; mesenchymal cell development [GO:0014031]; mitral valve formation [GO:0003192]; negative regulation of anoikis [GO:2000811]; negative regulation of biomineral tissue development [GO:0070168]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of catalytic activity [GO:0043086]; negative regulation of cell adhesion molecule production [GO:0060354]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell proliferation involved in heart valve morphogenesis [GO:0003252]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of collagen biosynthetic process [GO:0032966]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of endothelial cell chemotaxis [GO:2001027]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of extracellular matrix constituent secretion [GO:0003332]; negative regulation of gene expression [GO:0010629]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of inner ear auditory receptor cell differentiation [GO:0045608]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of neurogenesis [GO:0050768]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of ossification [GO:0030279]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of photoreceptor cell differentiation [GO:0046533]; negative regulation of pro-B cell differentiation [GO:2000974]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural tube development [GO:0021915]; neuroendocrine cell differentiation [GO:0061101]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; Notch signaling pathway involved in regulation of secondary heart field cardioblast proliferation [GO:0003270]; oligodendrocyte differentiation [GO:0048709]; outflow tract morphogenesis [GO:0003151]; pericardium morphogenesis [GO:0003344]; positive regulation of aorta morphogenesis [GO:1903849]; positive regulation of apoptotic process involved in morphogenesis [GO:1902339]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cardiac epithelial to mesenchymal transition [GO:0062043]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of smooth muscle cell differentiation [GO:0051152]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription of Notch receptor target [GO:0007221]; positive regulation of viral genome replication [GO:0045070]; prostate gland epithelium morphogenesis [GO:0060740]; protein catabolic process [GO:0030163]; protein import into nucleus [GO:0006606]; pulmonary valve morphogenesis [GO:0003184]; regulation of cell adhesion involved in heart morphogenesis [GO:0061344]; regulation of DNA-templated transcription [GO:0006355]; regulation of epithelial cell proliferation involved in prostate gland development [GO:0060768]; regulation of extracellular matrix assembly [GO:1901201]; regulation of somitogenesis [GO:0014807]; regulation of stem cell proliferation [GO:0072091]; regulation of transcription by RNA polymerase II [GO:0006357]; response to lipopolysaccharide [GO:0032496]; response to muramyl dipeptide [GO:0032495]; retinal cone cell differentiation [GO:0042670]; secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development [GO:0060528]; skeletal muscle cell differentiation [GO:0035914]; somatic stem cell division [GO:0048103]; spermatogenesis [GO:0007283]; sprouting angiogenesis [GO:0002040]; T-helper 17 type immune response [GO:0072538]; tissue regeneration [GO:0042246]; transcription by RNA polymerase II [GO:0006366]; tube formation [GO:0035148]; vasculogenesis involved in coronary vascular morphogenesis [GO:0060979]; venous endothelial cell differentiation [GO:0060843]; ventricular septum morphogenesis [GO:0060412]; ventricular trabecula myocardium morphogenesis [GO:0003222] acrosomal vesicle [GO:0001669]; adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; late endosome membrane [GO:0031902]; MAML1-RBP-Jkappa- ICN1 complex [GO:0002193]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; receptor complex [GO:0043235]; Schaffer collateral - CA1 synapse [GO:0098685] calcium ion binding [GO:0005509]; chromatin DNA binding [GO:0031490]; enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; identical protein binding [GO:0042802]; Notch binding [GO:0005112]; transcription coactivator activity [GO:0003713]; transcription regulator activator activity [GO:0140537]; transmembrane signaling receptor activity [GO:0004888] g4792.t1 P46531 35.16 219 6.56e-22 102.0 sp|P46531|NOTC1_HUMAN Neurogenic locus notch homolog protein 1 OS=Homo sapiens OX=9606 GN=NOTCH1 PE=1 SV=4 NOTC1_HUMAN reviewed Neurogenic locus notch homolog protein 1 (Notch 1) (hN1) (Translocation-associated notch protein TAN-1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Homo sapiens (Human) GO:0000122; GO:0000139; GO:0001554; GO:0001669; GO:0001701; GO:0001837; GO:0001889; GO:0001947; GO:0002040; GO:0002052; GO:0002085; GO:0002193; GO:0002437; GO:0003151; GO:0003157; GO:0003160; GO:0003162; GO:0003169; GO:0003180; GO:0003181; GO:0003182; GO:0003184; GO:0003192; GO:0003198; GO:0003203; GO:0003207; GO:0003208; GO:0003209; GO:0003213; GO:0003214; GO:0003219; GO:0003222; GO:0003241; GO:0003252; GO:0003270; GO:0003273; GO:0003332; GO:0003344; GO:0003713; GO:0004857; GO:0004888; GO:0005112; GO:0005509; GO:0005576; GO:0005634; GO:0005654; GO:0005789; GO:0005829; GO:0005886; GO:0005912; GO:0006355; GO:0006357; GO:0006366; GO:0006606; GO:0006955; GO:0006959; GO:0007219; GO:0007221; GO:0007283; GO:0007368; GO:0007386; GO:0007411; GO:0007440; GO:0007492; GO:0007507; GO:0008284; GO:0008285; GO:0009912; GO:0009957; GO:0009986; GO:0010008; GO:0010614; GO:0010628; GO:0010629; GO:0010667; GO:0010812; GO:0010832; GO:0014031; GO:0014807; GO:0016324; GO:0017156; GO:0019899; GO:0021515; GO:0021915; GO:0021953; GO:0030163; GO:0030216; GO:0030279; GO:0030324; GO:0030335; GO:0030513; GO:0030514; GO:0030900; GO:0031069; GO:0031100; GO:0031490; GO:0031902; GO:0032495; GO:0032496; GO:0032966; GO:0035116; GO:0035148; GO:0035914; GO:0035924; GO:0042246; GO:0042670; GO:0042802; GO:0043086; GO:0043235; GO:0045070; GO:0045603; GO:0045608; GO:0045618; GO:0045662; GO:0045668; GO:0045747; GO:0045892; GO:0045893; GO:0045944; GO:0045955; GO:0046427; GO:0046533; GO:0046579; GO:0048103; GO:0048708; GO:0048709; GO:0048711; GO:0048715; GO:0048754; GO:0048873; GO:0050673; GO:0050679; GO:0050680; GO:0050768; GO:0051152; GO:0055008; GO:0060038; GO:0060045; GO:0060253; GO:0060271; GO:0060317; GO:0060354; GO:0060379; GO:0060411; GO:0060412; GO:0060528; GO:0060740; GO:0060768; GO:0060842; GO:0060843; GO:0060948; GO:0060956; GO:0060979; GO:0060982; GO:0061101; GO:0061344; GO:0061384; GO:0062043; GO:0070168; GO:0070374; GO:0070986; GO:0071228; GO:0071372; GO:0071456; GO:0072017; GO:0072044; GO:0072091; GO:0072144; GO:0072148; GO:0072538; GO:0090051; GO:0090090; GO:0097150; GO:0097400; GO:0098685; GO:0098839; GO:0098978; GO:0099565; GO:0120163; GO:0140537; GO:1901201; GO:1902263; GO:1902339; GO:1903849; GO:2000048; GO:2000737; GO:2000811; GO:2000974; GO:2001027 animal organ regeneration [GO:0031100]; aortic valve morphogenesis [GO:0003180]; apoptotic process involved in embryonic digit morphogenesis [GO:1902263]; arterial endothelial cell differentiation [GO:0060842]; astrocyte differentiation [GO:0048708]; atrioventricular node development [GO:0003162]; atrioventricular valve morphogenesis [GO:0003181]; auditory receptor cell fate commitment [GO:0009912]; axon guidance [GO:0007411]; branching morphogenesis of an epithelial tube [GO:0048754]; calcium-ion regulated exocytosis [GO:0017156]; cardiac atrium morphogenesis [GO:0003209]; cardiac chamber formation [GO:0003207]; cardiac epithelial to mesenchymal transition [GO:0060317]; cardiac left ventricle morphogenesis [GO:0003214]; cardiac muscle cell myoblast differentiation [GO:0060379]; cardiac muscle cell proliferation [GO:0060038]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac right atrium morphogenesis [GO:0003213]; cardiac right ventricle formation [GO:0003219]; cardiac septum morphogenesis [GO:0060411]; cardiac vascular smooth muscle cell development [GO:0060948]; cardiac ventricle morphogenesis [GO:0003208]; cell differentiation in spinal cord [GO:0021515]; cell migration involved in endocardial cushion formation [GO:0003273]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to hypoxia [GO:0071456]; cellular response to tumor cell [GO:0071228]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; central nervous system neuron differentiation [GO:0021953]; chemical synaptic transmission, postsynaptic [GO:0099565]; cilium assembly [GO:0060271]; collecting duct development [GO:0072044]; compartment pattern specification [GO:0007386]; coronary artery morphogenesis [GO:0060982]; coronary sinus valve morphogenesis [GO:0003182]; coronary vein morphogenesis [GO:0003169]; determination of left/right symmetry [GO:0007368]; distal tubule development [GO:0072017]; embryonic hindlimb morphogenesis [GO:0035116]; endocardial cell differentiation [GO:0060956]; endocardial cushion morphogenesis [GO:0003203]; endocardium development [GO:0003157]; endocardium morphogenesis [GO:0003160]; endoderm development [GO:0007492]; epidermal cell fate specification [GO:0009957]; epithelial cell fate commitment [GO:0072148]; epithelial cell proliferation [GO:0050673]; epithelial to mesenchymal transition [GO:0001837]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; forebrain development [GO:0030900]; foregut morphogenesis [GO:0007440]; glomerular mesangial cell development [GO:0072144]; growth involved in heart morphogenesis [GO:0003241]; hair follicle morphogenesis [GO:0031069]; heart development [GO:0007507]; heart looping [GO:0001947]; heart trabecula morphogenesis [GO:0061384]; homeostasis of number of cells within a tissue [GO:0048873]; humoral immune response [GO:0006959]; immune response [GO:0006955]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; inhibition of neuroepithelial cell differentiation [GO:0002085]; interleukin-17-mediated signaling pathway [GO:0097400]; keratinocyte differentiation [GO:0030216]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; lung development [GO:0030324]; luteolysis [GO:0001554]; mesenchymal cell development [GO:0014031]; mitral valve formation [GO:0003192]; negative regulation of anoikis [GO:2000811]; negative regulation of biomineral tissue development [GO:0070168]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of catalytic activity [GO:0043086]; negative regulation of cell adhesion molecule production [GO:0060354]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell proliferation involved in heart valve morphogenesis [GO:0003252]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of collagen biosynthetic process [GO:0032966]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of endothelial cell chemotaxis [GO:2001027]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of extracellular matrix constituent secretion [GO:0003332]; negative regulation of gene expression [GO:0010629]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of inner ear auditory receptor cell differentiation [GO:0045608]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of neurogenesis [GO:0050768]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of ossification [GO:0030279]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of photoreceptor cell differentiation [GO:0046533]; negative regulation of pro-B cell differentiation [GO:2000974]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural tube development [GO:0021915]; neuroendocrine cell differentiation [GO:0061101]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; Notch signaling pathway involved in regulation of secondary heart field cardioblast proliferation [GO:0003270]; oligodendrocyte differentiation [GO:0048709]; outflow tract morphogenesis [GO:0003151]; pericardium morphogenesis [GO:0003344]; positive regulation of aorta morphogenesis [GO:1903849]; positive regulation of apoptotic process involved in morphogenesis [GO:1902339]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cardiac epithelial to mesenchymal transition [GO:0062043]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of smooth muscle cell differentiation [GO:0051152]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription of Notch receptor target [GO:0007221]; positive regulation of viral genome replication [GO:0045070]; prostate gland epithelium morphogenesis [GO:0060740]; protein catabolic process [GO:0030163]; protein import into nucleus [GO:0006606]; pulmonary valve morphogenesis [GO:0003184]; regulation of cell adhesion involved in heart morphogenesis [GO:0061344]; regulation of DNA-templated transcription [GO:0006355]; regulation of epithelial cell proliferation involved in prostate gland development [GO:0060768]; regulation of extracellular matrix assembly [GO:1901201]; regulation of somitogenesis [GO:0014807]; regulation of stem cell proliferation [GO:0072091]; regulation of transcription by RNA polymerase II [GO:0006357]; response to lipopolysaccharide [GO:0032496]; response to muramyl dipeptide [GO:0032495]; retinal cone cell differentiation [GO:0042670]; secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development [GO:0060528]; skeletal muscle cell differentiation [GO:0035914]; somatic stem cell division [GO:0048103]; spermatogenesis [GO:0007283]; sprouting angiogenesis [GO:0002040]; T-helper 17 type immune response [GO:0072538]; tissue regeneration [GO:0042246]; transcription by RNA polymerase II [GO:0006366]; tube formation [GO:0035148]; vasculogenesis involved in coronary vascular morphogenesis [GO:0060979]; venous endothelial cell differentiation [GO:0060843]; ventricular septum morphogenesis [GO:0060412]; ventricular trabecula myocardium morphogenesis [GO:0003222] acrosomal vesicle [GO:0001669]; adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; late endosome membrane [GO:0031902]; MAML1-RBP-Jkappa- ICN1 complex [GO:0002193]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; receptor complex [GO:0043235]; Schaffer collateral - CA1 synapse [GO:0098685] calcium ion binding [GO:0005509]; chromatin DNA binding [GO:0031490]; enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; identical protein binding [GO:0042802]; Notch binding [GO:0005112]; transcription coactivator activity [GO:0003713]; transcription regulator activator activity [GO:0140537]; transmembrane signaling receptor activity [GO:0004888] g4792.t1 P46531 31.132 212 1.4800000000000002e-21 96.7 sp|P46531|NOTC1_HUMAN Neurogenic locus notch homolog protein 1 OS=Homo sapiens OX=9606 GN=NOTCH1 PE=1 SV=4 NOTC1_HUMAN reviewed Neurogenic locus notch homolog protein 1 (Notch 1) (hN1) (Translocation-associated notch protein TAN-1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Homo sapiens (Human) GO:0000122; GO:0000139; GO:0001554; GO:0001669; GO:0001701; GO:0001837; GO:0001889; GO:0001947; GO:0002040; GO:0002052; GO:0002085; GO:0002193; GO:0002437; GO:0003151; GO:0003157; GO:0003160; GO:0003162; GO:0003169; GO:0003180; GO:0003181; GO:0003182; GO:0003184; GO:0003192; GO:0003198; GO:0003203; GO:0003207; GO:0003208; GO:0003209; GO:0003213; GO:0003214; GO:0003219; GO:0003222; GO:0003241; GO:0003252; GO:0003270; GO:0003273; GO:0003332; GO:0003344; GO:0003713; GO:0004857; GO:0004888; GO:0005112; GO:0005509; GO:0005576; GO:0005634; GO:0005654; GO:0005789; GO:0005829; GO:0005886; GO:0005912; GO:0006355; GO:0006357; GO:0006366; GO:0006606; GO:0006955; GO:0006959; GO:0007219; GO:0007221; GO:0007283; GO:0007368; GO:0007386; GO:0007411; GO:0007440; GO:0007492; GO:0007507; GO:0008284; GO:0008285; GO:0009912; GO:0009957; GO:0009986; GO:0010008; GO:0010614; GO:0010628; GO:0010629; GO:0010667; GO:0010812; GO:0010832; GO:0014031; GO:0014807; GO:0016324; GO:0017156; GO:0019899; GO:0021515; GO:0021915; GO:0021953; GO:0030163; GO:0030216; GO:0030279; GO:0030324; GO:0030335; GO:0030513; GO:0030514; GO:0030900; GO:0031069; GO:0031100; GO:0031490; GO:0031902; GO:0032495; GO:0032496; GO:0032966; GO:0035116; GO:0035148; GO:0035914; GO:0035924; GO:0042246; GO:0042670; GO:0042802; GO:0043086; GO:0043235; GO:0045070; GO:0045603; GO:0045608; GO:0045618; GO:0045662; GO:0045668; GO:0045747; GO:0045892; GO:0045893; GO:0045944; GO:0045955; GO:0046427; GO:0046533; GO:0046579; GO:0048103; GO:0048708; GO:0048709; GO:0048711; GO:0048715; GO:0048754; GO:0048873; GO:0050673; GO:0050679; GO:0050680; GO:0050768; GO:0051152; GO:0055008; GO:0060038; GO:0060045; GO:0060253; GO:0060271; GO:0060317; GO:0060354; GO:0060379; GO:0060411; GO:0060412; GO:0060528; GO:0060740; GO:0060768; GO:0060842; GO:0060843; GO:0060948; GO:0060956; GO:0060979; GO:0060982; GO:0061101; GO:0061344; GO:0061384; GO:0062043; GO:0070168; GO:0070374; GO:0070986; GO:0071228; GO:0071372; GO:0071456; GO:0072017; GO:0072044; GO:0072091; GO:0072144; GO:0072148; GO:0072538; GO:0090051; GO:0090090; GO:0097150; GO:0097400; GO:0098685; GO:0098839; GO:0098978; GO:0099565; GO:0120163; GO:0140537; GO:1901201; GO:1902263; GO:1902339; GO:1903849; GO:2000048; GO:2000737; GO:2000811; GO:2000974; GO:2001027 animal organ regeneration [GO:0031100]; aortic valve morphogenesis [GO:0003180]; apoptotic process involved in embryonic digit morphogenesis [GO:1902263]; arterial endothelial cell differentiation [GO:0060842]; astrocyte differentiation [GO:0048708]; atrioventricular node development [GO:0003162]; atrioventricular valve morphogenesis [GO:0003181]; auditory receptor cell fate commitment [GO:0009912]; axon guidance [GO:0007411]; branching morphogenesis of an epithelial tube [GO:0048754]; calcium-ion regulated exocytosis [GO:0017156]; cardiac atrium morphogenesis [GO:0003209]; cardiac chamber formation [GO:0003207]; cardiac epithelial to mesenchymal transition [GO:0060317]; cardiac left ventricle morphogenesis [GO:0003214]; cardiac muscle cell myoblast differentiation [GO:0060379]; cardiac muscle cell proliferation [GO:0060038]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac right atrium morphogenesis [GO:0003213]; cardiac right ventricle formation [GO:0003219]; cardiac septum morphogenesis [GO:0060411]; cardiac vascular smooth muscle cell development [GO:0060948]; cardiac ventricle morphogenesis [GO:0003208]; cell differentiation in spinal cord [GO:0021515]; cell migration involved in endocardial cushion formation [GO:0003273]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to hypoxia [GO:0071456]; cellular response to tumor cell [GO:0071228]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; central nervous system neuron differentiation [GO:0021953]; chemical synaptic transmission, postsynaptic [GO:0099565]; cilium assembly [GO:0060271]; collecting duct development [GO:0072044]; compartment pattern specification [GO:0007386]; coronary artery morphogenesis [GO:0060982]; coronary sinus valve morphogenesis [GO:0003182]; coronary vein morphogenesis [GO:0003169]; determination of left/right symmetry [GO:0007368]; distal tubule development [GO:0072017]; embryonic hindlimb morphogenesis [GO:0035116]; endocardial cell differentiation [GO:0060956]; endocardial cushion morphogenesis [GO:0003203]; endocardium development [GO:0003157]; endocardium morphogenesis [GO:0003160]; endoderm development [GO:0007492]; epidermal cell fate specification [GO:0009957]; epithelial cell fate commitment [GO:0072148]; epithelial cell proliferation [GO:0050673]; epithelial to mesenchymal transition [GO:0001837]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; forebrain development [GO:0030900]; foregut morphogenesis [GO:0007440]; glomerular mesangial cell development [GO:0072144]; growth involved in heart morphogenesis [GO:0003241]; hair follicle morphogenesis [GO:0031069]; heart development [GO:0007507]; heart looping [GO:0001947]; heart trabecula morphogenesis [GO:0061384]; homeostasis of number of cells within a tissue [GO:0048873]; humoral immune response [GO:0006959]; immune response [GO:0006955]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; inhibition of neuroepithelial cell differentiation [GO:0002085]; interleukin-17-mediated signaling pathway [GO:0097400]; keratinocyte differentiation [GO:0030216]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; lung development [GO:0030324]; luteolysis [GO:0001554]; mesenchymal cell development [GO:0014031]; mitral valve formation [GO:0003192]; negative regulation of anoikis [GO:2000811]; negative regulation of biomineral tissue development [GO:0070168]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of catalytic activity [GO:0043086]; negative regulation of cell adhesion molecule production [GO:0060354]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell proliferation involved in heart valve morphogenesis [GO:0003252]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of collagen biosynthetic process [GO:0032966]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of endothelial cell chemotaxis [GO:2001027]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of extracellular matrix constituent secretion [GO:0003332]; negative regulation of gene expression [GO:0010629]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of inner ear auditory receptor cell differentiation [GO:0045608]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of neurogenesis [GO:0050768]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of ossification [GO:0030279]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of photoreceptor cell differentiation [GO:0046533]; negative regulation of pro-B cell differentiation [GO:2000974]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural tube development [GO:0021915]; neuroendocrine cell differentiation [GO:0061101]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; Notch signaling pathway involved in regulation of secondary heart field cardioblast proliferation [GO:0003270]; oligodendrocyte differentiation [GO:0048709]; outflow tract morphogenesis [GO:0003151]; pericardium morphogenesis [GO:0003344]; positive regulation of aorta morphogenesis [GO:1903849]; positive regulation of apoptotic process involved in morphogenesis [GO:1902339]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cardiac epithelial to mesenchymal transition [GO:0062043]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of smooth muscle cell differentiation [GO:0051152]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription of Notch receptor target [GO:0007221]; positive regulation of viral genome replication [GO:0045070]; prostate gland epithelium morphogenesis [GO:0060740]; protein catabolic process [GO:0030163]; protein import into nucleus [GO:0006606]; pulmonary valve morphogenesis [GO:0003184]; regulation of cell adhesion involved in heart morphogenesis [GO:0061344]; regulation of DNA-templated transcription [GO:0006355]; regulation of epithelial cell proliferation involved in prostate gland development [GO:0060768]; regulation of extracellular matrix assembly [GO:1901201]; regulation of somitogenesis [GO:0014807]; regulation of stem cell proliferation [GO:0072091]; regulation of transcription by RNA polymerase II [GO:0006357]; response to lipopolysaccharide [GO:0032496]; response to muramyl dipeptide [GO:0032495]; retinal cone cell differentiation [GO:0042670]; secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development [GO:0060528]; skeletal muscle cell differentiation [GO:0035914]; somatic stem cell division [GO:0048103]; spermatogenesis [GO:0007283]; sprouting angiogenesis [GO:0002040]; T-helper 17 type immune response [GO:0072538]; tissue regeneration [GO:0042246]; transcription by RNA polymerase II [GO:0006366]; tube formation [GO:0035148]; vasculogenesis involved in coronary vascular morphogenesis [GO:0060979]; venous endothelial cell differentiation [GO:0060843]; ventricular septum morphogenesis [GO:0060412]; ventricular trabecula myocardium morphogenesis [GO:0003222] acrosomal vesicle [GO:0001669]; adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; late endosome membrane [GO:0031902]; MAML1-RBP-Jkappa- ICN1 complex [GO:0002193]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; receptor complex [GO:0043235]; Schaffer collateral - CA1 synapse [GO:0098685] calcium ion binding [GO:0005509]; chromatin DNA binding [GO:0031490]; enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; identical protein binding [GO:0042802]; Notch binding [GO:0005112]; transcription coactivator activity [GO:0003713]; transcription regulator activator activity [GO:0140537]; transmembrane signaling receptor activity [GO:0004888] g4792.t1 P46531 42.857 28 1.4800000000000002e-21 28.5 sp|P46531|NOTC1_HUMAN Neurogenic locus notch homolog protein 1 OS=Homo sapiens OX=9606 GN=NOTCH1 PE=1 SV=4 NOTC1_HUMAN reviewed Neurogenic locus notch homolog protein 1 (Notch 1) (hN1) (Translocation-associated notch protein TAN-1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Homo sapiens (Human) GO:0000122; GO:0000139; GO:0001554; GO:0001669; GO:0001701; GO:0001837; GO:0001889; GO:0001947; GO:0002040; GO:0002052; GO:0002085; GO:0002193; GO:0002437; GO:0003151; GO:0003157; GO:0003160; GO:0003162; GO:0003169; GO:0003180; GO:0003181; GO:0003182; GO:0003184; GO:0003192; GO:0003198; GO:0003203; GO:0003207; GO:0003208; GO:0003209; GO:0003213; GO:0003214; GO:0003219; GO:0003222; GO:0003241; GO:0003252; GO:0003270; GO:0003273; GO:0003332; GO:0003344; GO:0003713; GO:0004857; GO:0004888; GO:0005112; GO:0005509; GO:0005576; GO:0005634; GO:0005654; GO:0005789; GO:0005829; GO:0005886; GO:0005912; GO:0006355; GO:0006357; GO:0006366; GO:0006606; GO:0006955; GO:0006959; GO:0007219; GO:0007221; GO:0007283; GO:0007368; GO:0007386; GO:0007411; GO:0007440; GO:0007492; GO:0007507; GO:0008284; GO:0008285; GO:0009912; GO:0009957; GO:0009986; GO:0010008; GO:0010614; GO:0010628; GO:0010629; GO:0010667; GO:0010812; GO:0010832; GO:0014031; GO:0014807; GO:0016324; GO:0017156; GO:0019899; GO:0021515; GO:0021915; GO:0021953; GO:0030163; GO:0030216; GO:0030279; GO:0030324; GO:0030335; GO:0030513; GO:0030514; GO:0030900; GO:0031069; GO:0031100; GO:0031490; GO:0031902; GO:0032495; GO:0032496; GO:0032966; GO:0035116; GO:0035148; GO:0035914; GO:0035924; GO:0042246; GO:0042670; GO:0042802; GO:0043086; GO:0043235; GO:0045070; GO:0045603; GO:0045608; GO:0045618; GO:0045662; GO:0045668; GO:0045747; GO:0045892; GO:0045893; GO:0045944; GO:0045955; GO:0046427; GO:0046533; GO:0046579; GO:0048103; GO:0048708; GO:0048709; GO:0048711; GO:0048715; GO:0048754; GO:0048873; GO:0050673; GO:0050679; GO:0050680; GO:0050768; GO:0051152; GO:0055008; GO:0060038; GO:0060045; GO:0060253; GO:0060271; GO:0060317; GO:0060354; GO:0060379; GO:0060411; GO:0060412; GO:0060528; GO:0060740; GO:0060768; GO:0060842; GO:0060843; GO:0060948; GO:0060956; GO:0060979; GO:0060982; GO:0061101; GO:0061344; GO:0061384; GO:0062043; GO:0070168; GO:0070374; GO:0070986; GO:0071228; GO:0071372; GO:0071456; GO:0072017; GO:0072044; GO:0072091; GO:0072144; GO:0072148; GO:0072538; GO:0090051; GO:0090090; GO:0097150; GO:0097400; GO:0098685; GO:0098839; GO:0098978; GO:0099565; GO:0120163; GO:0140537; GO:1901201; GO:1902263; GO:1902339; GO:1903849; GO:2000048; GO:2000737; GO:2000811; GO:2000974; GO:2001027 animal organ regeneration [GO:0031100]; aortic valve morphogenesis [GO:0003180]; apoptotic process involved in embryonic digit morphogenesis [GO:1902263]; arterial endothelial cell differentiation [GO:0060842]; astrocyte differentiation [GO:0048708]; atrioventricular node development [GO:0003162]; atrioventricular valve morphogenesis [GO:0003181]; auditory receptor cell fate commitment [GO:0009912]; axon guidance [GO:0007411]; branching morphogenesis of an epithelial tube [GO:0048754]; calcium-ion regulated exocytosis [GO:0017156]; cardiac atrium morphogenesis [GO:0003209]; cardiac chamber formation [GO:0003207]; cardiac epithelial to mesenchymal transition [GO:0060317]; cardiac left ventricle morphogenesis [GO:0003214]; cardiac muscle cell myoblast differentiation [GO:0060379]; cardiac muscle cell proliferation [GO:0060038]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac right atrium morphogenesis [GO:0003213]; cardiac right ventricle formation [GO:0003219]; cardiac septum morphogenesis [GO:0060411]; cardiac vascular smooth muscle cell development [GO:0060948]; cardiac ventricle morphogenesis [GO:0003208]; cell differentiation in spinal cord [GO:0021515]; cell migration involved in endocardial cushion formation [GO:0003273]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to hypoxia [GO:0071456]; cellular response to tumor cell [GO:0071228]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; central nervous system neuron differentiation [GO:0021953]; chemical synaptic transmission, postsynaptic [GO:0099565]; cilium assembly [GO:0060271]; collecting duct development [GO:0072044]; compartment pattern specification [GO:0007386]; coronary artery morphogenesis [GO:0060982]; coronary sinus valve morphogenesis [GO:0003182]; coronary vein morphogenesis [GO:0003169]; determination of left/right symmetry [GO:0007368]; distal tubule development [GO:0072017]; embryonic hindlimb morphogenesis [GO:0035116]; endocardial cell differentiation [GO:0060956]; endocardial cushion morphogenesis [GO:0003203]; endocardium development [GO:0003157]; endocardium morphogenesis [GO:0003160]; endoderm development [GO:0007492]; epidermal cell fate specification [GO:0009957]; epithelial cell fate commitment [GO:0072148]; epithelial cell proliferation [GO:0050673]; epithelial to mesenchymal transition [GO:0001837]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; forebrain development [GO:0030900]; foregut morphogenesis [GO:0007440]; glomerular mesangial cell development [GO:0072144]; growth involved in heart morphogenesis [GO:0003241]; hair follicle morphogenesis [GO:0031069]; heart development [GO:0007507]; heart looping [GO:0001947]; heart trabecula morphogenesis [GO:0061384]; homeostasis of number of cells within a tissue [GO:0048873]; humoral immune response [GO:0006959]; immune response [GO:0006955]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; inhibition of neuroepithelial cell differentiation [GO:0002085]; interleukin-17-mediated signaling pathway [GO:0097400]; keratinocyte differentiation [GO:0030216]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; lung development [GO:0030324]; luteolysis [GO:0001554]; mesenchymal cell development [GO:0014031]; mitral valve formation [GO:0003192]; negative regulation of anoikis [GO:2000811]; negative regulation of biomineral tissue development [GO:0070168]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of catalytic activity [GO:0043086]; negative regulation of cell adhesion molecule production [GO:0060354]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell proliferation involved in heart valve morphogenesis [GO:0003252]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of collagen biosynthetic process [GO:0032966]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of endothelial cell chemotaxis [GO:2001027]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of extracellular matrix constituent secretion [GO:0003332]; negative regulation of gene expression [GO:0010629]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of inner ear auditory receptor cell differentiation [GO:0045608]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of neurogenesis [GO:0050768]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of ossification [GO:0030279]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of photoreceptor cell differentiation [GO:0046533]; negative regulation of pro-B cell differentiation [GO:2000974]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural tube development [GO:0021915]; neuroendocrine cell differentiation [GO:0061101]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; Notch signaling pathway involved in regulation of secondary heart field cardioblast proliferation [GO:0003270]; oligodendrocyte differentiation [GO:0048709]; outflow tract morphogenesis [GO:0003151]; pericardium morphogenesis [GO:0003344]; positive regulation of aorta morphogenesis [GO:1903849]; positive regulation of apoptotic process involved in morphogenesis [GO:1902339]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cardiac epithelial to mesenchymal transition [GO:0062043]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of smooth muscle cell differentiation [GO:0051152]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription of Notch receptor target [GO:0007221]; positive regulation of viral genome replication [GO:0045070]; prostate gland epithelium morphogenesis [GO:0060740]; protein catabolic process [GO:0030163]; protein import into nucleus [GO:0006606]; pulmonary valve morphogenesis [GO:0003184]; regulation of cell adhesion involved in heart morphogenesis [GO:0061344]; regulation of DNA-templated transcription [GO:0006355]; regulation of epithelial cell proliferation involved in prostate gland development [GO:0060768]; regulation of extracellular matrix assembly [GO:1901201]; regulation of somitogenesis [GO:0014807]; regulation of stem cell proliferation [GO:0072091]; regulation of transcription by RNA polymerase II [GO:0006357]; response to lipopolysaccharide [GO:0032496]; response to muramyl dipeptide [GO:0032495]; retinal cone cell differentiation [GO:0042670]; secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development [GO:0060528]; skeletal muscle cell differentiation [GO:0035914]; somatic stem cell division [GO:0048103]; spermatogenesis [GO:0007283]; sprouting angiogenesis [GO:0002040]; T-helper 17 type immune response [GO:0072538]; tissue regeneration [GO:0042246]; transcription by RNA polymerase II [GO:0006366]; tube formation [GO:0035148]; vasculogenesis involved in coronary vascular morphogenesis [GO:0060979]; venous endothelial cell differentiation [GO:0060843]; ventricular septum morphogenesis [GO:0060412]; ventricular trabecula myocardium morphogenesis [GO:0003222] acrosomal vesicle [GO:0001669]; adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; late endosome membrane [GO:0031902]; MAML1-RBP-Jkappa- ICN1 complex [GO:0002193]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; receptor complex [GO:0043235]; Schaffer collateral - CA1 synapse [GO:0098685] calcium ion binding [GO:0005509]; chromatin DNA binding [GO:0031490]; enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; identical protein binding [GO:0042802]; Notch binding [GO:0005112]; transcription coactivator activity [GO:0003713]; transcription regulator activator activity [GO:0140537]; transmembrane signaling receptor activity [GO:0004888] g4794.t1 Q9CQE8 52.049 244 6.82e-84 253.0 sp|Q9CQE8|RTRAF_MOUSE RNA transcription, translation and transport factor protein OS=Mus musculus OX=10090 GN=RTRAF PE=1 SV=1 g4795.t1 A1Z877 30.027 1109 5.940000000000001e-129 436.0 sp|A1Z877|NDG_DROME Nidogen OS=Drosophila melanogaster OX=7227 GN=Ndg PE=1 SV=1 NDG_DROME reviewed Nidogen (Entactin) Drosophila melanogaster (Fruit fly) GO:0005201; GO:0005509; GO:0005604; GO:0005615; GO:0007160; GO:0071711; GO:0110011; GO:2001197 basement membrane assembly involved in embryonic body morphogenesis [GO:2001197]; basement membrane organization [GO:0071711]; cell-matrix adhesion [GO:0007160]; regulation of basement membrane organization [GO:0110011] basement membrane [GO:0005604]; extracellular space [GO:0005615] calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201] g4795.t2 A1Z877 30.084 1077 2.9600000000000003e-123 419.0 sp|A1Z877|NDG_DROME Nidogen OS=Drosophila melanogaster OX=7227 GN=Ndg PE=1 SV=1 NDG_DROME reviewed Nidogen (Entactin) Drosophila melanogaster (Fruit fly) GO:0005201; GO:0005509; GO:0005604; GO:0005615; GO:0007160; GO:0071711; GO:0110011; GO:2001197 basement membrane assembly involved in embryonic body morphogenesis [GO:2001197]; basement membrane organization [GO:0071711]; cell-matrix adhesion [GO:0007160]; regulation of basement membrane organization [GO:0110011] basement membrane [GO:0005604]; extracellular space [GO:0005615] calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201] g4800.t1 Q91981 48.754 281 2.48e-41 148.0 sp|Q91981|OTX2_DANRE Homeobox protein OTX2 OS=Danio rerio OX=7955 GN=otx2 PE=2 SV=1 g4802.t1 Q69ZW3 54.825 228 1.75e-67 251.0 sp|Q69ZW3|EHBP1_MOUSE EH domain-binding protein 1 OS=Mus musculus OX=10090 GN=Ehbp1 PE=1 SV=3 EHBP1_MOUSE reviewed EH domain-binding protein 1 Mus musculus (Mouse) GO:0005654; GO:0005768; GO:0005829; GO:0005886; GO:0006897; GO:0015031 endocytosis [GO:0006897]; protein transport [GO:0015031] cytosol [GO:0005829]; endosome [GO:0005768]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] g4802.t1 Q69ZW3 55.333 150 5.86e-44 177.0 sp|Q69ZW3|EHBP1_MOUSE EH domain-binding protein 1 OS=Mus musculus OX=10090 GN=Ehbp1 PE=1 SV=3 EHBP1_MOUSE reviewed EH domain-binding protein 1 Mus musculus (Mouse) GO:0005654; GO:0005768; GO:0005829; GO:0005886; GO:0006897; GO:0015031 endocytosis [GO:0006897]; protein transport [GO:0015031] cytosol [GO:0005829]; endosome [GO:0005768]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] g4802.t1 Q69ZW3 50.222 225 2.07e-36 153.0 sp|Q69ZW3|EHBP1_MOUSE EH domain-binding protein 1 OS=Mus musculus OX=10090 GN=Ehbp1 PE=1 SV=3 EHBP1_MOUSE reviewed EH domain-binding protein 1 Mus musculus (Mouse) GO:0005654; GO:0005768; GO:0005829; GO:0005886; GO:0006897; GO:0015031 endocytosis [GO:0006897]; protein transport [GO:0015031] cytosol [GO:0005829]; endosome [GO:0005768]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] g4806.t1 Q6NUP7 50.765 654 0.0 655.0 sp|Q6NUP7|PP4R4_HUMAN Serine/threonine-protein phosphatase 4 regulatory subunit 4 OS=Homo sapiens OX=9606 GN=PPP4R4 PE=1 SV=1 PP4R4_HUMAN reviewed Serine/threonine-protein phosphatase 4 regulatory subunit 4 Homo sapiens (Human) GO:0001835; GO:0004864; GO:0004865; GO:0005737; GO:0005829; GO:0005929; GO:0008287; GO:0019888; GO:0036064 blastocyst hatching [GO:0001835] ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; protein serine/threonine phosphatase complex [GO:0008287] protein phosphatase inhibitor activity [GO:0004864]; protein phosphatase regulator activity [GO:0019888]; protein serine/threonine phosphatase inhibitor activity [GO:0004865] g4806.t2 Q6NUP7 50.765 654 0.0 655.0 sp|Q6NUP7|PP4R4_HUMAN Serine/threonine-protein phosphatase 4 regulatory subunit 4 OS=Homo sapiens OX=9606 GN=PPP4R4 PE=1 SV=1 PP4R4_HUMAN reviewed Serine/threonine-protein phosphatase 4 regulatory subunit 4 Homo sapiens (Human) GO:0001835; GO:0004864; GO:0004865; GO:0005737; GO:0005829; GO:0005929; GO:0008287; GO:0019888; GO:0036064 blastocyst hatching [GO:0001835] ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; protein serine/threonine phosphatase complex [GO:0008287] protein phosphatase inhibitor activity [GO:0004864]; protein phosphatase regulator activity [GO:0019888]; protein serine/threonine phosphatase inhibitor activity [GO:0004865] g4806.t3 Q6NUP7 50.765 654 0.0 657.0 sp|Q6NUP7|PP4R4_HUMAN Serine/threonine-protein phosphatase 4 regulatory subunit 4 OS=Homo sapiens OX=9606 GN=PPP4R4 PE=1 SV=1 PP4R4_HUMAN reviewed Serine/threonine-protein phosphatase 4 regulatory subunit 4 Homo sapiens (Human) GO:0001835; GO:0004864; GO:0004865; GO:0005737; GO:0005829; GO:0005929; GO:0008287; GO:0019888; GO:0036064 blastocyst hatching [GO:0001835] ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; protein serine/threonine phosphatase complex [GO:0008287] protein phosphatase inhibitor activity [GO:0004864]; protein phosphatase regulator activity [GO:0019888]; protein serine/threonine phosphatase inhibitor activity [GO:0004865] g4807.t1 Q6ZQ93 36.025 322 3.0499999999999997e-55 202.0 sp|Q6ZQ93|UBP34_MOUSE Ubiquitin carboxyl-terminal hydrolase 34 OS=Mus musculus OX=10090 GN=Usp34 PE=1 SV=3 g4808.t1 Q3B7D2 59.167 240 4.44e-102 310.0 sp|Q3B7D2|SPTC2_RAT Serine palmitoyltransferase 2 OS=Rattus norvegicus OX=10116 GN=Sptlc2 PE=1 SV=1 SPTC2_RAT reviewed Serine palmitoyltransferase 2 (EC 2.3.1.50) (Long chain base biosynthesis protein 2) (LCB 2) (Serine-palmitoyl-CoA transferase 2) (SPT 2) Rattus norvegicus (Rat) GO:0004758; GO:0005789; GO:0006686; GO:0017059; GO:0030148; GO:0030170; GO:0035902; GO:0046511; GO:0046512; GO:0046513; GO:0060612; GO:1904504 adipose tissue development [GO:0060612]; ceramide biosynthetic process [GO:0046513]; positive regulation of lipophagy [GO:1904504]; response to immobilization stress [GO:0035902]; sphinganine biosynthetic process [GO:0046511]; sphingolipid biosynthetic process [GO:0030148]; sphingomyelin biosynthetic process [GO:0006686]; sphingosine biosynthetic process [GO:0046512] endoplasmic reticulum membrane [GO:0005789]; serine palmitoyltransferase complex [GO:0017059] pyridoxal phosphate binding [GO:0030170]; serine C-palmitoyltransferase activity [GO:0004758] g4809.t1 Q5ND34 33.333 1047 9.050000000000001e-144 494.0 sp|Q5ND34|WDR81_MOUSE WD repeat-containing protein 81 OS=Mus musculus OX=10090 GN=Wdr81 PE=1 SV=2 WDR81_MOUSE reviewed WD repeat-containing protein 81 Mus musculus (Mouse) GO:0000421; GO:0005739; GO:0005765; GO:0005829; GO:0006511; GO:0007005; GO:0010008; GO:0031901; GO:0031902; GO:0035014; GO:0035973; GO:0045022; GO:0050821; GO:0070530; GO:0141039 aggrephagy [GO:0035973]; early endosome to late endosome transport [GO:0045022]; mitochondrion organization [GO:0007005]; protein stabilization [GO:0050821]; ubiquitin-dependent protein catabolic process [GO:0006511] autophagosome membrane [GO:0000421]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endosome membrane [GO:0010008]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; mitochondrion [GO:0005739] K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; phosphatidylinositol 3-kinase inhibitor activity [GO:0141039]; phosphatidylinositol 3-kinase regulator activity [GO:0035014] g4810.t1 Q24498 62.319 207 2.4e-78 258.0 sp|Q24498|RYR_DROME Ryanodine receptor OS=Drosophila melanogaster OX=7227 GN=RyR PE=1 SV=3 RYR_DROME reviewed Ryanodine receptor (Ryanodine receptor 44F) Drosophila melanogaster (Fruit fly) GO:0005219; GO:0005262; GO:0006816; GO:0006874; GO:0006936; GO:0015279; GO:0016020; GO:0033017; GO:0035206; GO:0051209; GO:0060047; GO:0070588; GO:0072347 calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; heart contraction [GO:0060047]; intracellular calcium ion homeostasis [GO:0006874]; muscle contraction [GO:0006936]; regulation of hemocyte proliferation [GO:0035206]; release of sequestered calcium ion into cytosol [GO:0051209]; response to anesthetic [GO:0072347] membrane [GO:0016020]; sarcoplasmic reticulum membrane [GO:0033017] calcium channel activity [GO:0005262]; ryanodine-sensitive calcium-release channel activity [GO:0005219]; store-operated calcium channel activity [GO:0015279] g4811.t1 O14980 70.94 117 3.76e-53 182.0 sp|O14980|XPO1_HUMAN Exportin-1 OS=Homo sapiens OX=9606 GN=XPO1 PE=1 SV=1 g4817.t1 P24263 36.413 184 3.32e-33 130.0 sp|P24263|ACTD_PHYPO Actin, spherule isoform OS=Physarum polycephalum OX=5791 GN=ARDD PE=2 SV=2 g4818.t1 P24902 41.358 162 9.53e-35 122.0 sp|P24902|ACT_PINCO Actin (Fragment) OS=Pinus contorta OX=3339 PE=3 SV=1 g4823.t1 Q8BUV3 36.425 442 1.75e-72 246.0 sp|Q8BUV3|GEPH_MOUSE Gephyrin OS=Mus musculus OX=10090 GN=Gphn PE=1 SV=2 GEPH_MOUSE reviewed Gephyrin [Includes: Molybdopterin adenylyltransferase (MPT adenylyltransferase) (EC 2.7.7.75) (Domain G); Molybdopterin molybdenumtransferase (MPT Mo-transferase) (EC 2.10.1.1) (Domain E) (Mo insertase)] Mus musculus (Mouse) GO:0005102; GO:0005524; GO:0005737; GO:0005829; GO:0005856; GO:0006777; GO:0007529; GO:0008092; GO:0008940; GO:0009898; GO:0010038; GO:0014069; GO:0019897; GO:0030425; GO:0030674; GO:0032324; GO:0042802; GO:0043025; GO:0043197; GO:0043546; GO:0045184; GO:0045202; GO:0045211; GO:0046872; GO:0051932; GO:0060077; GO:0060090; GO:0061598; GO:0061599; GO:0072579; GO:0097060; GO:0097112; GO:0098690; GO:0098794; GO:0098982; GO:0099091; GO:0099572; GO:0099645 establishment of protein localization [GO:0045184]; establishment of synaptic specificity at neuromuscular junction [GO:0007529]; gamma-aminobutyric acid receptor clustering [GO:0097112]; glycine receptor clustering [GO:0072579]; Mo-molybdopterin cofactor biosynthetic process [GO:0006777]; molybdopterin cofactor biosynthetic process [GO:0032324]; neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0099645]; response to metal ion [GO:0010038]; synaptic transmission, GABAergic [GO:0051932] cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; extrinsic component of plasma membrane [GO:0019897]; GABA-ergic synapse [GO:0098982]; glycinergic synapse [GO:0098690]; inhibitory synapse [GO:0060077]; neuronal cell body [GO:0043025]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; postsynaptic specialization [GO:0099572]; postsynaptic specialization, intracellular component [GO:0099091]; synapse [GO:0045202]; synaptic membrane [GO:0097060] ATP binding [GO:0005524]; cytoskeletal protein binding [GO:0008092]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; molecular adaptor activity [GO:0060090]; molybdopterin adenylyltransferase activity [GO:0061598]; molybdopterin cofactor binding [GO:0043546]; molybdopterin molybdotransferase activity [GO:0061599]; nitrate reductase activity [GO:0008940]; protein-macromolecule adaptor activity [GO:0030674]; signaling receptor binding [GO:0005102] g4823.t1 Q8BUV3 60.563 142 2.3099999999999997e-48 180.0 sp|Q8BUV3|GEPH_MOUSE Gephyrin OS=Mus musculus OX=10090 GN=Gphn PE=1 SV=2 GEPH_MOUSE reviewed Gephyrin [Includes: Molybdopterin adenylyltransferase (MPT adenylyltransferase) (EC 2.7.7.75) (Domain G); Molybdopterin molybdenumtransferase (MPT Mo-transferase) (EC 2.10.1.1) (Domain E) (Mo insertase)] Mus musculus (Mouse) GO:0005102; GO:0005524; GO:0005737; GO:0005829; GO:0005856; GO:0006777; GO:0007529; GO:0008092; GO:0008940; GO:0009898; GO:0010038; GO:0014069; GO:0019897; GO:0030425; GO:0030674; GO:0032324; GO:0042802; GO:0043025; GO:0043197; GO:0043546; GO:0045184; GO:0045202; GO:0045211; GO:0046872; GO:0051932; GO:0060077; GO:0060090; GO:0061598; GO:0061599; GO:0072579; GO:0097060; GO:0097112; GO:0098690; GO:0098794; GO:0098982; GO:0099091; GO:0099572; GO:0099645 establishment of protein localization [GO:0045184]; establishment of synaptic specificity at neuromuscular junction [GO:0007529]; gamma-aminobutyric acid receptor clustering [GO:0097112]; glycine receptor clustering [GO:0072579]; Mo-molybdopterin cofactor biosynthetic process [GO:0006777]; molybdopterin cofactor biosynthetic process [GO:0032324]; neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0099645]; response to metal ion [GO:0010038]; synaptic transmission, GABAergic [GO:0051932] cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; extrinsic component of plasma membrane [GO:0019897]; GABA-ergic synapse [GO:0098982]; glycinergic synapse [GO:0098690]; inhibitory synapse [GO:0060077]; neuronal cell body [GO:0043025]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; postsynaptic specialization [GO:0099572]; postsynaptic specialization, intracellular component [GO:0099091]; synapse [GO:0045202]; synaptic membrane [GO:0097060] ATP binding [GO:0005524]; cytoskeletal protein binding [GO:0008092]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; molecular adaptor activity [GO:0060090]; molybdopterin adenylyltransferase activity [GO:0061598]; molybdopterin cofactor binding [GO:0043546]; molybdopterin molybdotransferase activity [GO:0061599]; nitrate reductase activity [GO:0008940]; protein-macromolecule adaptor activity [GO:0030674]; signaling receptor binding [GO:0005102] g4824.t1 Q4S2L4 57.971 69 1.1199999999999999e-23 90.1 sp|Q4S2L4|DNPH1_TETNG 5-hydroxymethyl-dUMP N-hydrolase OS=Tetraodon nigroviridis OX=99883 GN=dnph1 PE=3 SV=2 g4825.t1 Q9NQX3 56.216 185 1.6399999999999998e-67 222.0 sp|Q9NQX3|GEPH_HUMAN Gephyrin OS=Homo sapiens OX=9606 GN=GPHN PE=1 SV=1 GEPH_HUMAN reviewed Gephyrin [Includes: Molybdopterin adenylyltransferase (MPT adenylyltransferase) (EC 2.7.7.75) (Domain G); Molybdopterin molybdenumtransferase (MPT Mo-transferase) (EC 2.10.1.1) (Domain E) (Mo insertase)] Homo sapiens (Human) GO:0005102; GO:0005524; GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0006777; GO:0007416; GO:0007529; GO:0008940; GO:0009898; GO:0010038; GO:0014069; GO:0030425; GO:0030674; GO:0042802; GO:0043197; GO:0043546; GO:0045184; GO:0045211; GO:0046872; GO:0060077; GO:0061598; GO:0061599; GO:0072579; GO:0097060; GO:0097112; GO:0098690; GO:0098982; GO:0099091; GO:0099572; GO:0099645 establishment of protein localization [GO:0045184]; establishment of synaptic specificity at neuromuscular junction [GO:0007529]; gamma-aminobutyric acid receptor clustering [GO:0097112]; glycine receptor clustering [GO:0072579]; Mo-molybdopterin cofactor biosynthetic process [GO:0006777]; neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0099645]; response to metal ion [GO:0010038]; synapse assembly [GO:0007416] cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; GABA-ergic synapse [GO:0098982]; glycinergic synapse [GO:0098690]; inhibitory synapse [GO:0060077]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; postsynaptic specialization [GO:0099572]; postsynaptic specialization, intracellular component [GO:0099091]; synaptic membrane [GO:0097060] ATP binding [GO:0005524]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; molybdopterin adenylyltransferase activity [GO:0061598]; molybdopterin cofactor binding [GO:0043546]; molybdopterin molybdotransferase activity [GO:0061599]; nitrate reductase activity [GO:0008940]; protein-macromolecule adaptor activity [GO:0030674]; signaling receptor binding [GO:0005102] g4831.t1 Q54KD0 24.835 1063 2.8299999999999998e-74 279.0 sp|Q54KD0|Y7407_DICDI TPR repeat-containing protein DDB_G0287407 OS=Dictyostelium discoideum OX=44689 GN=DDB_G0287407 PE=4 SV=1 g4834.t1 Q9Y6A2 37.917 480 6.59e-107 331.0 sp|Q9Y6A2|CP46A_HUMAN Cholesterol 24-hydroxylase OS=Homo sapiens OX=9606 GN=CYP46A1 PE=1 SV=1 g4835.t1 Q9Y6A2 38.413 479 3.05e-102 319.0 sp|Q9Y6A2|CP46A_HUMAN Cholesterol 24-hydroxylase OS=Homo sapiens OX=9606 GN=CYP46A1 PE=1 SV=1 g4838.t1 A5D6U8 60.817 416 0.0 520.0 sp|A5D6U8|ACP7_DANRE Acid phosphatase type 7 OS=Danio rerio OX=7955 GN=acp7 PE=2 SV=1 ACP7_DANRE reviewed Acid phosphatase type 7 (EC 3.1.3.2) (Purple acid phosphatase long form) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0003993; GO:0005576; GO:0046872 extracellular region [GO:0005576] acid phosphatase activity [GO:0003993]; metal ion binding [GO:0046872] g4839.t1 A5D6U8 56.881 436 7.07e-174 496.0 sp|A5D6U8|ACP7_DANRE Acid phosphatase type 7 OS=Danio rerio OX=7955 GN=acp7 PE=2 SV=1 ACP7_DANRE reviewed Acid phosphatase type 7 (EC 3.1.3.2) (Purple acid phosphatase long form) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0003993; GO:0005576; GO:0046872 extracellular region [GO:0005576] acid phosphatase activity [GO:0003993]; metal ion binding [GO:0046872] g4840.t1 P60881 62.871 202 1.89e-84 251.0 sp|P60881|SNP25_RAT Synaptosomal-associated protein 25 OS=Rattus norvegicus OX=10116 GN=Snap25 PE=1 SV=1 SNP25_RAT reviewed Synaptosomal-associated protein 25 (SNAP-25) (Super protein) (SUP) (Synaptosomal-associated 25 kDa protein) Rattus norvegicus (Rat) GO:0000149; GO:0001917; GO:0005249; GO:0005484; GO:0005737; GO:0005768; GO:0005802; GO:0005856; GO:0005886; GO:0005938; GO:0006887; GO:0007269; GO:0007409; GO:0007616; GO:0007626; GO:0008021; GO:0008076; GO:0008289; GO:0008306; GO:0010975; GO:0015629; GO:0016020; GO:0016079; GO:0016082; GO:0016197; GO:0017022; GO:0017075; GO:0019904; GO:0030027; GO:0030073; GO:0030175; GO:0030182; GO:0030424; GO:0030426; GO:0031083; GO:0031201; GO:0031340; GO:0031629; GO:0031915; GO:0031982; GO:0032024; GO:0035493; GO:0036477; GO:0042734; GO:0043005; GO:0043025; GO:0043195; GO:0044295; GO:0044325; GO:0045202; GO:0046887; GO:0048306; GO:0048471; GO:0048791; GO:0051649; GO:0051963; GO:0060291; GO:0070032; GO:0070033; GO:0070044; GO:0070201; GO:0097470; GO:0098693; GO:0098888; GO:0098978; GO:0099525; GO:1903296; GO:1990926 associative learning [GO:0008306]; axonogenesis [GO:0007409]; calcium ion-regulated exocytosis of neurotransmitter [GO:0048791]; endosomal transport [GO:0016197]; establishment of localization in cell [GO:0051649]; exocytosis [GO:0006887]; insulin secretion [GO:0030073]; locomotory behavior [GO:0007626]; long-term memory [GO:0007616]; long-term synaptic potentiation [GO:0060291]; neuron differentiation [GO:0030182]; neurotransmitter secretion [GO:0007269]; positive regulation of glutamate secretion, neurotransmission [GO:1903296]; positive regulation of hormone secretion [GO:0046887]; positive regulation of insulin secretion [GO:0032024]; positive regulation of synaptic plasticity [GO:0031915]; positive regulation of vesicle fusion [GO:0031340]; presynaptic dense core vesicle exocytosis [GO:0099525]; regulation of establishment of protein localization [GO:0070201]; regulation of neuron projection development [GO:0010975]; regulation of synapse assembly [GO:0051963]; regulation of synaptic vesicle cycle [GO:0098693]; short-term synaptic potentiation [GO:1990926]; SNARE complex assembly [GO:0035493]; synaptic vesicle exocytosis [GO:0016079]; synaptic vesicle fusion to presynaptic active zone membrane [GO:0031629]; synaptic vesicle priming [GO:0016082] actin cytoskeleton [GO:0015629]; axon [GO:0030424]; axonal growth cone [GO:0044295]; BLOC-1 complex [GO:0031083]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; endosome [GO:0005768]; extrinsic component of presynaptic membrane [GO:0098888]; filopodium [GO:0030175]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; membrane [GO:0016020]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; photoreceptor inner segment [GO:0001917]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; ribbon synapse [GO:0097470]; SNARE complex [GO:0031201]; somatodendritic compartment [GO:0036477]; synapse [GO:0045202]; synaptic vesicle [GO:0008021]; synaptobrevin 2-SNAP-25-syntaxin-1a complex [GO:0070044]; synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex [GO:0070032]; synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex [GO:0070033]; terminal bouton [GO:0043195]; trans-Golgi network [GO:0005802]; vesicle [GO:0031982]; voltage-gated potassium channel complex [GO:0008076] calcium-dependent protein binding [GO:0048306]; lipid binding [GO:0008289]; myosin binding [GO:0017022]; protein domain specific binding [GO:0019904]; SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]; syntaxin-1 binding [GO:0017075]; transmembrane transporter binding [GO:0044325]; voltage-gated potassium channel activity [GO:0005249] g4841.t1 Q6DEL2 61.728 567 0.0 690.0 sp|Q6DEL2|CLPT1_DANRE Putative lipid scramblase CLPTM1 OS=Danio rerio OX=7955 GN=clptm1 PE=2 SV=1 g4842.t1 Q8K2P6 46.043 139 1.1899999999999998e-42 144.0 sp|Q8K2P6|RFESD_MOUSE Rieske domain-containing protein OS=Mus musculus OX=10090 GN=Rfesd PE=1 SV=1 g4844.t1 O95861 54.723 307 1.27e-106 316.0 sp|O95861|BPNT1_HUMAN 3'(2'),5'-bisphosphate nucleotidase 1 OS=Homo sapiens OX=9606 GN=BPNT1 PE=1 SV=1 BPNT1_HUMAN reviewed 3'(2'),5'-bisphosphate nucleotidase 1 (EC 3.1.3.7) (3'-phosphoadenosine 5'-phosphate phosphatase) (PAP phosphatase) (Bisphosphate 3'-nucleotidase 1) (BPntase 1) (HsPIP) (Inositol-polyphosphate 1-phosphatase) (EC 3.1.3.57) Homo sapiens (Human) GO:0004441; GO:0005739; GO:0005829; GO:0006139; GO:0007399; GO:0008441; GO:0046854; GO:0046872; GO:0050427 3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; nervous system development [GO:0007399]; nucleobase-containing compound metabolic process [GO:0006139]; phosphatidylinositol phosphate biosynthetic process [GO:0046854] cytosol [GO:0005829]; mitochondrion [GO:0005739] 3'(2'),5'-bisphosphate nucleotidase activity [GO:0008441]; inositol-1,4-bisphosphate 1-phosphatase activity [GO:0004441]; metal ion binding [GO:0046872] g4846.t1 Q0V9S9 55.19 790 0.0 756.0 sp|Q0V9S9|DRC7_XENTR Dynein regulatory complex subunit 7 OS=Xenopus tropicalis OX=8364 GN=drc7 PE=2 SV=1 g4847.t1 Q5F3K0 41.646 814 0.0 605.0 sp|Q5F3K0|TTC27_CHICK Tetratricopeptide repeat protein 27 OS=Gallus gallus OX=9031 GN=TTC27 PE=2 SV=1 g4848.t1 Q6GNT9 61.356 295 4.79e-130 374.0 sp|Q6GNT9|MEMO1_XENLA Protein MEMO1 OS=Xenopus laevis OX=8355 GN=memo1 PE=2 SV=1 g4849.t1 Q9N0F1 76.744 258 3.27e-135 400.0 sp|Q9N0F1|ODO2_PIG Dihydrolipoyllysine-residue succinyltransferase component of 2-oxoglutarate dehydrogenase complex, mitochondrial OS=Sus scrofa OX=9823 GN=DLST PE=1 SV=1 g4851.t1 P48437 61.0 200 1.41e-71 251.0 sp|P48437|PROX1_MOUSE Prospero homeobox protein 1 OS=Mus musculus OX=10090 GN=Prox1 PE=1 SV=2 g4851.t2 P48437 40.93 430 1.46e-72 254.0 sp|P48437|PROX1_MOUSE Prospero homeobox protein 1 OS=Mus musculus OX=10090 GN=Prox1 PE=1 SV=2 g4852.t1 Q8VHF0 55.396 834 0.0 822.0 sp|Q8VHF0|MARK3_RAT MAP/microtubule affinity-regulating kinase 3 OS=Rattus norvegicus OX=10116 GN=Mark3 PE=1 SV=1 MARK3_RAT reviewed MAP/microtubule affinity-regulating kinase 3 (EC 2.7.11.1) Rattus norvegicus (Rat) GO:0000226; GO:0001764; GO:0004674; GO:0005524; GO:0005737; GO:0005886; GO:0006468; GO:0010389; GO:0019903; GO:0030425; GO:0035331; GO:0035556; GO:0050321; GO:0106310; GO:1900181 intracellular signal transduction [GO:0035556]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of hippo signaling [GO:0035331]; negative regulation of protein localization to nucleus [GO:1900181]; neuron migration [GO:0001764]; protein phosphorylation [GO:0006468]; regulation of G2/M transition of mitotic cell cycle [GO:0010389] cytoplasm [GO:0005737]; dendrite [GO:0030425]; plasma membrane [GO:0005886] ATP binding [GO:0005524]; protein phosphatase binding [GO:0019903]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; tau-protein kinase activity [GO:0050321] g4852.t2 Q8VHF0 55.569 826 0.0 821.0 sp|Q8VHF0|MARK3_RAT MAP/microtubule affinity-regulating kinase 3 OS=Rattus norvegicus OX=10116 GN=Mark3 PE=1 SV=1 MARK3_RAT reviewed MAP/microtubule affinity-regulating kinase 3 (EC 2.7.11.1) Rattus norvegicus (Rat) GO:0000226; GO:0001764; GO:0004674; GO:0005524; GO:0005737; GO:0005886; GO:0006468; GO:0010389; GO:0019903; GO:0030425; GO:0035331; GO:0035556; GO:0050321; GO:0106310; GO:1900181 intracellular signal transduction [GO:0035556]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of hippo signaling [GO:0035331]; negative regulation of protein localization to nucleus [GO:1900181]; neuron migration [GO:0001764]; protein phosphorylation [GO:0006468]; regulation of G2/M transition of mitotic cell cycle [GO:0010389] cytoplasm [GO:0005737]; dendrite [GO:0030425]; plasma membrane [GO:0005886] ATP binding [GO:0005524]; protein phosphatase binding [GO:0019903]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; tau-protein kinase activity [GO:0050321] g4852.t3 Q8VHF0 55.69 826 0.0 821.0 sp|Q8VHF0|MARK3_RAT MAP/microtubule affinity-regulating kinase 3 OS=Rattus norvegicus OX=10116 GN=Mark3 PE=1 SV=1 MARK3_RAT reviewed MAP/microtubule affinity-regulating kinase 3 (EC 2.7.11.1) Rattus norvegicus (Rat) GO:0000226; GO:0001764; GO:0004674; GO:0005524; GO:0005737; GO:0005886; GO:0006468; GO:0010389; GO:0019903; GO:0030425; GO:0035331; GO:0035556; GO:0050321; GO:0106310; GO:1900181 intracellular signal transduction [GO:0035556]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of hippo signaling [GO:0035331]; negative regulation of protein localization to nucleus [GO:1900181]; neuron migration [GO:0001764]; protein phosphorylation [GO:0006468]; regulation of G2/M transition of mitotic cell cycle [GO:0010389] cytoplasm [GO:0005737]; dendrite [GO:0030425]; plasma membrane [GO:0005886] ATP binding [GO:0005524]; protein phosphatase binding [GO:0019903]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; tau-protein kinase activity [GO:0050321] g4852.t4 Q8VHF0 56.574 829 0.0 838.0 sp|Q8VHF0|MARK3_RAT MAP/microtubule affinity-regulating kinase 3 OS=Rattus norvegicus OX=10116 GN=Mark3 PE=1 SV=1 MARK3_RAT reviewed MAP/microtubule affinity-regulating kinase 3 (EC 2.7.11.1) Rattus norvegicus (Rat) GO:0000226; GO:0001764; GO:0004674; GO:0005524; GO:0005737; GO:0005886; GO:0006468; GO:0010389; GO:0019903; GO:0030425; GO:0035331; GO:0035556; GO:0050321; GO:0106310; GO:1900181 intracellular signal transduction [GO:0035556]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of hippo signaling [GO:0035331]; negative regulation of protein localization to nucleus [GO:1900181]; neuron migration [GO:0001764]; protein phosphorylation [GO:0006468]; regulation of G2/M transition of mitotic cell cycle [GO:0010389] cytoplasm [GO:0005737]; dendrite [GO:0030425]; plasma membrane [GO:0005886] ATP binding [GO:0005524]; protein phosphatase binding [GO:0019903]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; tau-protein kinase activity [GO:0050321] g4853.t1 Q9CXE6 43.169 366 5.28e-90 277.0 sp|Q9CXE6|XRCC3_MOUSE DNA repair protein XRCC3 OS=Mus musculus OX=10090 GN=Xrcc3 PE=2 SV=1 g4854.t1 Q9H2M9 56.43 381 1.03e-127 401.0 sp|Q9H2M9|RBGPR_HUMAN Rab3 GTPase-activating protein non-catalytic subunit OS=Homo sapiens OX=9606 GN=RAB3GAP2 PE=1 SV=1 RBGPR_HUMAN reviewed Rab3 GTPase-activating protein non-catalytic subunit (RGAP-iso) (Rab3 GTPase-activating protein 150 kDa subunit) (Rab3-GAP p150) (Rab3-GAP150) (Rab3-GAP regulatory subunit) Homo sapiens (Human) GO:0005096; GO:0005776; GO:0005789; GO:0005829; GO:0005886; GO:0006886; GO:0008047; GO:0016236; GO:0030234; GO:0031267; GO:0032991; GO:0042734; GO:0043087; GO:0097051; GO:0099536; GO:1903061; GO:1903373; GO:2000786 establishment of protein localization to endoplasmic reticulum membrane [GO:0097051]; intracellular protein transport [GO:0006886]; macroautophagy [GO:0016236]; positive regulation of autophagosome assembly [GO:2000786]; positive regulation of endoplasmic reticulum tubular network organization [GO:1903373]; positive regulation of protein lipidation [GO:1903061]; regulation of GTPase activity [GO:0043087]; synaptic signaling [GO:0099536] autophagosome [GO:0005776]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; protein-containing complex [GO:0032991] enzyme activator activity [GO:0008047]; enzyme regulator activity [GO:0030234]; GTPase activator activity [GO:0005096]; small GTPase binding [GO:0031267] g4858.t2 Q56R14 29.855 345 9.26e-23 104.0 sp|Q56R14|TRI33_XENLA E3 ubiquitin-protein ligase TRIM33 OS=Xenopus laevis OX=8355 GN=trim33 PE=1 SV=1 TRI33_XENLA reviewed E3 ubiquitin-protein ligase TRIM33 (EC 2.3.2.27) (Ectodermin) (RING-type E3 ubiquitin transferase TRIM33) (Transcription intermediary factor 1-gamma) (TIF1-gamma) (Tripartite motif-containing protein 33) Xenopus laevis (African clawed frog) GO:0000785; GO:0003677; GO:0005634; GO:0005654; GO:0008270; GO:0016567; GO:0061630 protein ubiquitination [GO:0016567] chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] DNA binding [GO:0003677]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] g4861.t1 M9PH32 26.502 283 3.7400000000000006e-27 115.0 sp|M9PH32|MEI26_DROME Protein meiotic P26 OS=Drosophila melanogaster OX=7227 GN=mei-P26 PE=1 SV=1 MEI26_DROME reviewed Protein meiotic P26 Drosophila melanogaster (Fruit fly) GO:0004842; GO:0005737; GO:0008270; GO:0016567; GO:0036464 protein ubiquitination [GO:0016567] cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464] ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] g4862.t1 Q8BMG7 35.45 1055 6.92e-171 540.0 sp|Q8BMG7|RBGPR_MOUSE Rab3 GTPase-activating protein non-catalytic subunit OS=Mus musculus OX=10090 GN=Rab3gap2 PE=1 SV=2 RBGPR_MOUSE reviewed Rab3 GTPase-activating protein non-catalytic subunit (Rab3 GTPase-activating protein 150 kDa subunit) (Rab3-GAP p150) (Rab3-GAP150) (Rab3-GAP regulatory subunit) Mus musculus (Mouse) GO:0005096; GO:0005776; GO:0005783; GO:0005829; GO:0005886; GO:0016236; GO:0030234; GO:0031267; GO:0032991; GO:0042734; GO:0043087; GO:0097051; GO:0099536; GO:1903061; GO:1903373; GO:2000786 establishment of protein localization to endoplasmic reticulum membrane [GO:0097051]; macroautophagy [GO:0016236]; positive regulation of autophagosome assembly [GO:2000786]; positive regulation of endoplasmic reticulum tubular network organization [GO:1903373]; positive regulation of protein lipidation [GO:1903061]; regulation of GTPase activity [GO:0043087]; synaptic signaling [GO:0099536] autophagosome [GO:0005776]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; protein-containing complex [GO:0032991] enzyme regulator activity [GO:0030234]; GTPase activator activity [GO:0005096]; small GTPase binding [GO:0031267] g4863.t1 Q6DCW7 43.953 339 7.33e-78 248.0 sp|Q6DCW7|G137B_XENLA Integral membrane protein GPR137B OS=Xenopus laevis OX=8355 GN=gpr137b PE=2 SV=1 g4867.t1 Q64LD2 41.176 136 1.28e-34 128.0 sp|Q64LD2|WDR25_HUMAN WD repeat-containing protein 25 OS=Homo sapiens OX=9606 GN=WDR25 PE=1 SV=3 WDR25_HUMAN reviewed WD repeat-containing protein 25 Homo sapiens (Human) g4870.t1 P17248 74.684 395 0.0 644.0 sp|P17248|SYWC_BOVIN Tryptophan--tRNA ligase, cytoplasmic OS=Bos taurus OX=9913 GN=WARS1 PE=1 SV=3 g4871.t1 Q60676 66.667 495 0.0 711.0 sp|Q60676|PPP5_MOUSE Serine/threonine-protein phosphatase 5 OS=Mus musculus OX=10090 GN=Ppp5c PE=1 SV=3 PPP5_MOUSE reviewed Serine/threonine-protein phosphatase 5 (PP5) (EC 3.1.3.16) (Protein phosphatase T) (PPT) Mus musculus (Mouse) GO:0001965; GO:0003723; GO:0004721; GO:0004722; GO:0005524; GO:0005634; GO:0005829; GO:0005886; GO:0008017; GO:0010288; GO:0016791; GO:0030291; GO:0030544; GO:0031072; GO:0031435; GO:0032991; GO:0042802; GO:0043025; GO:0043066; GO:0043204; GO:0043278; GO:0043409; GO:0043531; GO:0044877; GO:0046872; GO:0051879; GO:0070262; GO:0070301; GO:0071276; GO:0101031; GO:1904550; GO:1990635; GO:2000324 cellular response to cadmium ion [GO:0071276]; cellular response to hydrogen peroxide [GO:0070301]; negative regulation of apoptotic process [GO:0043066]; negative regulation of MAPK cascade [GO:0043409]; peptidyl-serine dephosphorylation [GO:0070262]; positive regulation of nuclear receptor-mediated glucocorticoid signaling pathway [GO:2000324]; response to arachidonate [GO:1904550]; response to lead ion [GO:0010288]; response to morphine [GO:0043278] cytosol [GO:0005829]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; protein folding chaperone complex [GO:0101031]; protein-containing complex [GO:0032991]; proximal dendrite [GO:1990635] ADP binding [GO:0043531]; ATP binding [GO:0005524]; G-protein alpha-subunit binding [GO:0001965]; heat shock protein binding [GO:0031072]; Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; microtubule binding [GO:0008017]; mitogen-activated protein kinase kinase kinase binding [GO:0031435]; phosphatase activity [GO:0016791]; phosphoprotein phosphatase activity [GO:0004721]; protein serine/threonine kinase inhibitor activity [GO:0030291]; protein serine/threonine phosphatase activity [GO:0004722]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723] g4872.t1 Q9CQA9 59.574 188 8.49e-64 198.0 sp|Q9CQA9|NTPCR_MOUSE Cancer-related nucleoside-triphosphatase homolog OS=Mus musculus OX=10090 GN=Ntpcr PE=1 SV=1 g4873.t1 Q8N9N7 52.521 238 4.21e-78 237.0 sp|Q8N9N7|LRC57_HUMAN Leucine-rich repeat-containing protein 57 OS=Homo sapiens OX=9606 GN=LRRC57 PE=1 SV=1 g4875.t1 P51589 45.85 253 1.3500000000000001e-73 236.0 sp|P51589|CP2J2_HUMAN Cytochrome P450 2J2 OS=Homo sapiens OX=9606 GN=CYP2J2 PE=1 SV=2 CP2J2_HUMAN reviewed Cytochrome P450 2J2 (EC 1.14.14.-) (Albendazole monooxygenase (hydroxylating)) (EC 1.14.14.74) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Arachidonic acid epoxygenase) (CYPIIJ2) (Hydroperoxy icosatetraenoate isomerase) (EC 5.4.4.7) Homo sapiens (Human) GO:0004497; GO:0005506; GO:0005737; GO:0005789; GO:0006082; GO:0006631; GO:0006690; GO:0006805; GO:0008016; GO:0008392; GO:0008404; GO:0008405; GO:0016712; GO:0016853; GO:0019373; GO:0020037; GO:0043651; GO:0070062; GO:0071614; GO:0106255; GO:0106301 epoxygenase P450 pathway [GO:0019373]; fatty acid metabolic process [GO:0006631]; icosanoid metabolic process [GO:0006690]; linoleic acid metabolic process [GO:0043651]; organic acid metabolic process [GO:0006082]; regulation of heart contraction [GO:0008016]; xenobiotic metabolic process [GO:0006805] cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062] arachidonate 11,12-epoxygenase activity [GO:0008405]; arachidonate 14,15-epoxygenase activity [GO:0008404]; arachidonate 5,6-epoxygenase activity [GO:0106301]; arachidonate epoxygenase activity [GO:0008392]; heme binding [GO:0020037]; hydroperoxy icosatetraenoate isomerase activity [GO:0106255]; iron ion binding [GO:0005506]; isomerase activity [GO:0016853]; linoleic acid epoxygenase activity [GO:0071614]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712] g4876.t1 O54750 40.698 172 9.219999999999999e-38 139.0 sp|O54750|CP2J6_MOUSE Cytochrome P450 2J6 OS=Mus musculus OX=10090 GN=Cyp2j6 PE=2 SV=2 g4878.t1 P70627 46.264 696 0.0 632.0 sp|P70627|FOLH1_RAT Glutamate carboxypeptidase 2 OS=Rattus norvegicus OX=10116 GN=Folh1 PE=1 SV=1 g4879.t1 P38584 51.1 409 2.2299999999999997e-140 408.0 sp|P38584|TTL_BOVIN Tubulin--tyrosine ligase OS=Bos taurus OX=9913 GN=TTL PE=1 SV=1 g4880.t1 Q07352 46.698 212 2.73e-49 172.0 sp|Q07352|TISB_HUMAN mRNA decay activator protein ZFP36L1 OS=Homo sapiens OX=9606 GN=ZFP36L1 PE=1 SV=1 TISB_HUMAN reviewed mRNA decay activator protein ZFP36L1 (Butyrate response factor 1) (EGF-response factor 1) (ERF-1) (TPA-induced sequence 11b) (Zinc finger protein 36, C3H1 type-like 1) (ZFP36-like 1) Homo sapiens (Human) GO:0000165; GO:0000288; GO:0000932; GO:0001570; GO:0003342; GO:0003677; GO:0003723; GO:0003729; GO:0005634; GO:0005737; GO:0005829; GO:0006397; GO:0006417; GO:0006915; GO:0007507; GO:0008270; GO:0008283; GO:0009611; GO:0010468; GO:0010837; GO:0021915; GO:0031086; GO:0031440; GO:0032869; GO:0033077; GO:0035264; GO:0035925; GO:0038066; GO:0043488; GO:0043491; GO:0044344; GO:0045577; GO:0045600; GO:0045616; GO:0045647; GO:0045657; GO:0045661; GO:0048382; GO:0051028; GO:0060710; GO:0061158; GO:0070371; GO:0071320; GO:0071356; GO:0071364; GO:0071375; GO:0071385; GO:0071456; GO:0071472; GO:0071560; GO:0071889; GO:0072091; GO:0097403; GO:1900153; GO:1901991; GO:1902172; GO:1904582; GO:1990904 3'-UTR-mediated mRNA destabilization [GO:0061158]; apoptotic process [GO:0006915]; cell population proliferation [GO:0008283]; cellular response to cAMP [GO:0071320]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to glucocorticoid stimulus [GO:0071385]; cellular response to hypoxia [GO:0071456]; cellular response to insulin stimulus [GO:0032869]; cellular response to peptide hormone stimulus [GO:0071375]; cellular response to raffinose [GO:0097403]; cellular response to salt stress [GO:0071472]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cellular response to tumor necrosis factor [GO:0071356]; chorio-allantoic fusion [GO:0060710]; ERK1 and ERK2 cascade [GO:0070371]; heart development [GO:0007507]; MAPK cascade [GO:0000165]; mesendoderm development [GO:0048382]; mRNA processing [GO:0006397]; mRNA transport [GO:0051028]; multicellular organism growth [GO:0035264]; negative regulation of erythrocyte differentiation [GO:0045647]; negative regulation of mitotic cell cycle phase transition [GO:1901991]; neural tube development [GO:0021915]; nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:0000288]; nuclear-transcribed mRNA catabolic process, deadenylation-independent decay [GO:0031086]; p38MAPK cascade [GO:0038066]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of intracellular mRNA localization [GO:1904582]; positive regulation of monocyte differentiation [GO:0045657]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; proepicardium development [GO:0003342]; regulation of B cell differentiation [GO:0045577]; regulation of gene expression [GO:0010468]; regulation of keratinocyte apoptotic process [GO:1902172]; regulation of keratinocyte differentiation [GO:0045616]; regulation of keratinocyte proliferation [GO:0010837]; regulation of mRNA 3'-end processing [GO:0031440]; regulation of mRNA stability [GO:0043488]; regulation of myoblast differentiation [GO:0045661]; regulation of stem cell proliferation [GO:0072091]; regulation of translation [GO:0006417]; response to wounding [GO:0009611]; T cell differentiation in thymus [GO:0033077]; vasculogenesis [GO:0001570] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; P-body [GO:0000932]; ribonucleoprotein complex [GO:1990904] 14-3-3 protein binding [GO:0071889]; DNA binding [GO:0003677]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270] g4882.t1 O15315 53.107 354 9.64e-133 388.0 sp|O15315|RA51B_HUMAN DNA repair protein RAD51 homolog 2 OS=Homo sapiens OX=9606 GN=RAD51B PE=1 SV=2 g4887.t1 Q6UXS0 38.667 150 1.4e-28 107.0 sp|Q6UXS0|CL19A_HUMAN C-type lectin domain family 19 member A OS=Homo sapiens OX=9606 GN=CLEC19A PE=1 SV=2 g4889.t1 Q0P4W3 42.714 199 4.5599999999999997e-48 171.0 sp|Q0P4W3|RMD2_XENTR Regulator of microtubule dynamics protein 2 OS=Xenopus tropicalis OX=8364 GN=rmdn2 PE=2 SV=1 g4890.t1 Q6PBT6 63.855 83 2.19e-36 121.0 sp|Q6PBT6|GFRP_DANRE GTP cyclohydrolase 1 feedback regulatory protein OS=Danio rerio OX=7955 GN=gchfr PE=3 SV=1 g4890.t2 Q6PBT6 59.756 82 1.27e-32 111.0 sp|Q6PBT6|GFRP_DANRE GTP cyclohydrolase 1 feedback regulatory protein OS=Danio rerio OX=7955 GN=gchfr PE=3 SV=1 g4891.t1 Q2KI83 50.871 287 4.07e-78 246.0 sp|Q2KI83|DJC17_BOVIN DnaJ homolog subfamily C member 17 OS=Bos taurus OX=9913 GN=DNAJC17 PE=2 SV=1 g4892.t1 P34885 51.449 138 1.13e-31 123.0 sp|P34885|KPC1B_CAEEL Protein kinase C-like 1B OS=Caenorhabditis elegans OX=6239 GN=pkc-1 PE=1 SV=2 KPC1B_CAEEL reviewed Protein kinase C-like 1B (PKC1B) (EC 2.7.11.13) Caenorhabditis elegans GO:0000165; GO:0004674; GO:0004697; GO:0005524; GO:0005856; GO:0006468; GO:0006935; GO:0007218; GO:0007269; GO:0007606; GO:0007635; GO:0008270; GO:0008306; GO:0016020; GO:0016079; GO:0035556; GO:0040012; GO:0040024; GO:0043005; GO:0048009; GO:0050893; GO:0050920; GO:0050927; GO:0050975; GO:0098793; GO:0098981; GO:0099161; GO:0106310; GO:1902074; GO:1990504; GO:2001024 associative learning [GO:0008306]; chemosensory behavior [GO:0007635]; chemotaxis [GO:0006935]; dauer larval development [GO:0040024]; dense core granule exocytosis [GO:1990504]; insulin-like growth factor receptor signaling pathway [GO:0048009]; intracellular signal transduction [GO:0035556]; MAPK cascade [GO:0000165]; negative regulation of response to drug [GO:2001024]; neuropeptide signaling pathway [GO:0007218]; neurotransmitter secretion [GO:0007269]; positive regulation of positive chemotaxis [GO:0050927]; protein phosphorylation [GO:0006468]; regulation of chemotaxis [GO:0050920]; regulation of locomotion [GO:0040012]; regulation of presynaptic dense core granule exocytosis [GO:0099161]; response to salt [GO:1902074]; sensory perception of chemical stimulus [GO:0007606]; sensory perception of touch [GO:0050975]; sensory processing [GO:0050893]; synaptic vesicle exocytosis [GO:0016079] cholinergic synapse [GO:0098981]; cytoskeleton [GO:0005856]; membrane [GO:0016020]; neuron projection [GO:0043005]; presynapse [GO:0098793] ATP binding [GO:0005524]; diacylglycerol-dependent serine/threonine kinase activity [GO:0004697]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; zinc ion binding [GO:0008270] g4893.t1 Q6ZUK4 35.028 177 4.8500000000000006e-27 112.0 sp|Q6ZUK4|TMM26_HUMAN Transmembrane protein 26 OS=Homo sapiens OX=9606 GN=TMEM26 PE=1 SV=1 g4896.t1 Q6ZUK4 32.971 276 7.98e-39 144.0 sp|Q6ZUK4|TMM26_HUMAN Transmembrane protein 26 OS=Homo sapiens OX=9606 GN=TMEM26 PE=1 SV=1 g4901.t1 O35680 67.176 131 5.58e-53 167.0 sp|O35680|RT12_MOUSE Small ribosomal subunit protein uS12m OS=Mus musculus OX=10090 GN=Mrps12 PE=1 SV=1 g4903.t1 Q2HJ46 47.482 139 1.4800000000000001e-33 138.0 sp|Q2HJ46|RNF8_BOVIN E3 ubiquitin-protein ligase RNF8 OS=Bos taurus OX=9913 GN=RNF8 PE=2 SV=1 RNF8_BOVIN reviewed E3 ubiquitin-protein ligase RNF8 (EC 2.3.2.27) (RING finger protein 8) (RING-type E3 ubiquitin transferase RNF8) Bos taurus (Bovine) GO:0000151; GO:0000781; GO:0003682; GO:0005634; GO:0005737; GO:0005829; GO:0006302; GO:0006303; GO:0006511; GO:0006974; GO:0008270; GO:0010212; GO:0030496; GO:0034244; GO:0035092; GO:0035861; GO:0040029; GO:0042393; GO:0042803; GO:0043130; GO:0045190; GO:0045739; GO:0051301; GO:0061630; GO:0070534; GO:0070936; GO:0085020; GO:0140861; GO:1905168 cell division [GO:0051301]; DNA damage response [GO:0006974]; DNA repair-dependent chromatin remodeling [GO:0140861]; double-strand break repair [GO:0006302]; double-strand break repair via nonhomologous end joining [GO:0006303]; epigenetic regulation of gene expression [GO:0040029]; isotype switching [GO:0045190]; negative regulation of transcription elongation by RNA polymerase II [GO:0034244]; positive regulation of DNA repair [GO:0045739]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; protein K48-linked ubiquitination [GO:0070936]; protein K6-linked ubiquitination [GO:0085020]; protein K63-linked ubiquitination [GO:0070534]; response to ionizing radiation [GO:0010212]; sperm DNA condensation [GO:0035092]; ubiquitin-dependent protein catabolic process [GO:0006511] chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; midbody [GO:0030496]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; ubiquitin ligase complex [GO:0000151] chromatin binding [GO:0003682]; histone binding [GO:0042393]; protein homodimerization activity [GO:0042803]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] g4903.t1 Q2HJ46 40.833 120 1.57e-21 102.0 sp|Q2HJ46|RNF8_BOVIN E3 ubiquitin-protein ligase RNF8 OS=Bos taurus OX=9913 GN=RNF8 PE=2 SV=1 RNF8_BOVIN reviewed E3 ubiquitin-protein ligase RNF8 (EC 2.3.2.27) (RING finger protein 8) (RING-type E3 ubiquitin transferase RNF8) Bos taurus (Bovine) GO:0000151; GO:0000781; GO:0003682; GO:0005634; GO:0005737; GO:0005829; GO:0006302; GO:0006303; GO:0006511; GO:0006974; GO:0008270; GO:0010212; GO:0030496; GO:0034244; GO:0035092; GO:0035861; GO:0040029; GO:0042393; GO:0042803; GO:0043130; GO:0045190; GO:0045739; GO:0051301; GO:0061630; GO:0070534; GO:0070936; GO:0085020; GO:0140861; GO:1905168 cell division [GO:0051301]; DNA damage response [GO:0006974]; DNA repair-dependent chromatin remodeling [GO:0140861]; double-strand break repair [GO:0006302]; double-strand break repair via nonhomologous end joining [GO:0006303]; epigenetic regulation of gene expression [GO:0040029]; isotype switching [GO:0045190]; negative regulation of transcription elongation by RNA polymerase II [GO:0034244]; positive regulation of DNA repair [GO:0045739]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; protein K48-linked ubiquitination [GO:0070936]; protein K6-linked ubiquitination [GO:0085020]; protein K63-linked ubiquitination [GO:0070534]; response to ionizing radiation [GO:0010212]; sperm DNA condensation [GO:0035092]; ubiquitin-dependent protein catabolic process [GO:0006511] chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; midbody [GO:0030496]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; ubiquitin ligase complex [GO:0000151] chromatin binding [GO:0003682]; histone binding [GO:0042393]; protein homodimerization activity [GO:0042803]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] g4904.t1 A7SAZ1 36.875 160 1.1300000000000001e-32 117.0 sp|A7SAZ1|U669_NEMVE UPF0669 protein v1g209471 OS=Nematostella vectensis OX=45351 GN=v1g209471 PE=3 SV=1 g4905.t1 Q61555 30.682 1672 9.920000000000001e-166 569.0 sp|Q61555|FBN2_MOUSE Fibrillin-2 OS=Mus musculus OX=10090 GN=Fbn2 PE=1 SV=2 FBN2_MOUSE reviewed Fibrillin-2 [Cleaved into: Placensin] Mus musculus (Mouse) GO:0001527; GO:0001890; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0005615; GO:0006006; GO:0030326; GO:0030501; GO:0031012; GO:0035108; GO:0035583; GO:0042593; GO:0043010; GO:0045669; GO:0048048; GO:0060346; GO:1901163 bone trabecula formation [GO:0060346]; camera-type eye development [GO:0043010]; embryonic eye morphogenesis [GO:0048048]; embryonic limb morphogenesis [GO:0030326]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; limb morphogenesis [GO:0035108]; placenta development [GO:0001890]; positive regulation of bone mineralization [GO:0030501]; positive regulation of osteoblast differentiation [GO:0045669]; regulation of trophoblast cell migration [GO:1901163]; sequestering of TGFbeta in extracellular matrix [GO:0035583] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; microfibril [GO:0001527] calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; hormone activity [GO:0005179] g4905.t1 Q61555 29.803 1473 1.24e-131 464.0 sp|Q61555|FBN2_MOUSE Fibrillin-2 OS=Mus musculus OX=10090 GN=Fbn2 PE=1 SV=2 FBN2_MOUSE reviewed Fibrillin-2 [Cleaved into: Placensin] Mus musculus (Mouse) GO:0001527; GO:0001890; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0005615; GO:0006006; GO:0030326; GO:0030501; GO:0031012; GO:0035108; GO:0035583; GO:0042593; GO:0043010; GO:0045669; GO:0048048; GO:0060346; GO:1901163 bone trabecula formation [GO:0060346]; camera-type eye development [GO:0043010]; embryonic eye morphogenesis [GO:0048048]; embryonic limb morphogenesis [GO:0030326]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; limb morphogenesis [GO:0035108]; placenta development [GO:0001890]; positive regulation of bone mineralization [GO:0030501]; positive regulation of osteoblast differentiation [GO:0045669]; regulation of trophoblast cell migration [GO:1901163]; sequestering of TGFbeta in extracellular matrix [GO:0035583] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; microfibril [GO:0001527] calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; hormone activity [GO:0005179] g4905.t1 Q61555 29.329 1640 4.09e-125 444.0 sp|Q61555|FBN2_MOUSE Fibrillin-2 OS=Mus musculus OX=10090 GN=Fbn2 PE=1 SV=2 FBN2_MOUSE reviewed Fibrillin-2 [Cleaved into: Placensin] Mus musculus (Mouse) GO:0001527; GO:0001890; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0005615; GO:0006006; GO:0030326; GO:0030501; GO:0031012; GO:0035108; GO:0035583; GO:0042593; GO:0043010; GO:0045669; GO:0048048; GO:0060346; GO:1901163 bone trabecula formation [GO:0060346]; camera-type eye development [GO:0043010]; embryonic eye morphogenesis [GO:0048048]; embryonic limb morphogenesis [GO:0030326]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; limb morphogenesis [GO:0035108]; placenta development [GO:0001890]; positive regulation of bone mineralization [GO:0030501]; positive regulation of osteoblast differentiation [GO:0045669]; regulation of trophoblast cell migration [GO:1901163]; sequestering of TGFbeta in extracellular matrix [GO:0035583] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; microfibril [GO:0001527] calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; hormone activity [GO:0005179] g4905.t1 Q61555 28.39 1416 1.19e-114 411.0 sp|Q61555|FBN2_MOUSE Fibrillin-2 OS=Mus musculus OX=10090 GN=Fbn2 PE=1 SV=2 FBN2_MOUSE reviewed Fibrillin-2 [Cleaved into: Placensin] Mus musculus (Mouse) GO:0001527; GO:0001890; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0005615; GO:0006006; GO:0030326; GO:0030501; GO:0031012; GO:0035108; GO:0035583; GO:0042593; GO:0043010; GO:0045669; GO:0048048; GO:0060346; GO:1901163 bone trabecula formation [GO:0060346]; camera-type eye development [GO:0043010]; embryonic eye morphogenesis [GO:0048048]; embryonic limb morphogenesis [GO:0030326]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; limb morphogenesis [GO:0035108]; placenta development [GO:0001890]; positive regulation of bone mineralization [GO:0030501]; positive regulation of osteoblast differentiation [GO:0045669]; regulation of trophoblast cell migration [GO:1901163]; sequestering of TGFbeta in extracellular matrix [GO:0035583] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; microfibril [GO:0001527] calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; hormone activity [GO:0005179] g4905.t1 Q61555 30.374 1284 1.0599999999999999e-111 401.0 sp|Q61555|FBN2_MOUSE Fibrillin-2 OS=Mus musculus OX=10090 GN=Fbn2 PE=1 SV=2 FBN2_MOUSE reviewed Fibrillin-2 [Cleaved into: Placensin] Mus musculus (Mouse) GO:0001527; GO:0001890; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0005615; GO:0006006; GO:0030326; GO:0030501; GO:0031012; GO:0035108; GO:0035583; GO:0042593; GO:0043010; GO:0045669; GO:0048048; GO:0060346; GO:1901163 bone trabecula formation [GO:0060346]; camera-type eye development [GO:0043010]; embryonic eye morphogenesis [GO:0048048]; embryonic limb morphogenesis [GO:0030326]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; limb morphogenesis [GO:0035108]; placenta development [GO:0001890]; positive regulation of bone mineralization [GO:0030501]; positive regulation of osteoblast differentiation [GO:0045669]; regulation of trophoblast cell migration [GO:1901163]; sequestering of TGFbeta in extracellular matrix [GO:0035583] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; microfibril [GO:0001527] calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; hormone activity [GO:0005179] g4905.t1 Q61555 29.233 1382 3.08e-108 390.0 sp|Q61555|FBN2_MOUSE Fibrillin-2 OS=Mus musculus OX=10090 GN=Fbn2 PE=1 SV=2 FBN2_MOUSE reviewed Fibrillin-2 [Cleaved into: Placensin] Mus musculus (Mouse) GO:0001527; GO:0001890; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0005615; GO:0006006; GO:0030326; GO:0030501; GO:0031012; GO:0035108; GO:0035583; GO:0042593; GO:0043010; GO:0045669; GO:0048048; GO:0060346; GO:1901163 bone trabecula formation [GO:0060346]; camera-type eye development [GO:0043010]; embryonic eye morphogenesis [GO:0048048]; embryonic limb morphogenesis [GO:0030326]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; limb morphogenesis [GO:0035108]; placenta development [GO:0001890]; positive regulation of bone mineralization [GO:0030501]; positive regulation of osteoblast differentiation [GO:0045669]; regulation of trophoblast cell migration [GO:1901163]; sequestering of TGFbeta in extracellular matrix [GO:0035583] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; microfibril [GO:0001527] calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; hormone activity [GO:0005179] g4905.t1 Q61555 27.327 1010 6.2399999999999996e-83 308.0 sp|Q61555|FBN2_MOUSE Fibrillin-2 OS=Mus musculus OX=10090 GN=Fbn2 PE=1 SV=2 FBN2_MOUSE reviewed Fibrillin-2 [Cleaved into: Placensin] Mus musculus (Mouse) GO:0001527; GO:0001890; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0005615; GO:0006006; GO:0030326; GO:0030501; GO:0031012; GO:0035108; GO:0035583; GO:0042593; GO:0043010; GO:0045669; GO:0048048; GO:0060346; GO:1901163 bone trabecula formation [GO:0060346]; camera-type eye development [GO:0043010]; embryonic eye morphogenesis [GO:0048048]; embryonic limb morphogenesis [GO:0030326]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; limb morphogenesis [GO:0035108]; placenta development [GO:0001890]; positive regulation of bone mineralization [GO:0030501]; positive regulation of osteoblast differentiation [GO:0045669]; regulation of trophoblast cell migration [GO:1901163]; sequestering of TGFbeta in extracellular matrix [GO:0035583] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; microfibril [GO:0001527] calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; hormone activity [GO:0005179] g4905.t1 Q61555 32.831 597 2.1600000000000002e-57 225.0 sp|Q61555|FBN2_MOUSE Fibrillin-2 OS=Mus musculus OX=10090 GN=Fbn2 PE=1 SV=2 FBN2_MOUSE reviewed Fibrillin-2 [Cleaved into: Placensin] Mus musculus (Mouse) GO:0001527; GO:0001890; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0005615; GO:0006006; GO:0030326; GO:0030501; GO:0031012; GO:0035108; GO:0035583; GO:0042593; GO:0043010; GO:0045669; GO:0048048; GO:0060346; GO:1901163 bone trabecula formation [GO:0060346]; camera-type eye development [GO:0043010]; embryonic eye morphogenesis [GO:0048048]; embryonic limb morphogenesis [GO:0030326]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; limb morphogenesis [GO:0035108]; placenta development [GO:0001890]; positive regulation of bone mineralization [GO:0030501]; positive regulation of osteoblast differentiation [GO:0045669]; regulation of trophoblast cell migration [GO:1901163]; sequestering of TGFbeta in extracellular matrix [GO:0035583] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; microfibril [GO:0001527] calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; hormone activity [GO:0005179] g4905.t1 Q61555 33.191 470 8.07e-47 190.0 sp|Q61555|FBN2_MOUSE Fibrillin-2 OS=Mus musculus OX=10090 GN=Fbn2 PE=1 SV=2 FBN2_MOUSE reviewed Fibrillin-2 [Cleaved into: Placensin] Mus musculus (Mouse) GO:0001527; GO:0001890; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0005615; GO:0006006; GO:0030326; GO:0030501; GO:0031012; GO:0035108; GO:0035583; GO:0042593; GO:0043010; GO:0045669; GO:0048048; GO:0060346; GO:1901163 bone trabecula formation [GO:0060346]; camera-type eye development [GO:0043010]; embryonic eye morphogenesis [GO:0048048]; embryonic limb morphogenesis [GO:0030326]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; limb morphogenesis [GO:0035108]; placenta development [GO:0001890]; positive regulation of bone mineralization [GO:0030501]; positive regulation of osteoblast differentiation [GO:0045669]; regulation of trophoblast cell migration [GO:1901163]; sequestering of TGFbeta in extracellular matrix [GO:0035583] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; microfibril [GO:0001527] calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; hormone activity [GO:0005179] g4905.t2 Q61555 30.732 1653 2.04e-163 562.0 sp|Q61555|FBN2_MOUSE Fibrillin-2 OS=Mus musculus OX=10090 GN=Fbn2 PE=1 SV=2 FBN2_MOUSE reviewed Fibrillin-2 [Cleaved into: Placensin] Mus musculus (Mouse) GO:0001527; GO:0001890; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0005615; GO:0006006; GO:0030326; GO:0030501; GO:0031012; GO:0035108; GO:0035583; GO:0042593; GO:0043010; GO:0045669; GO:0048048; GO:0060346; GO:1901163 bone trabecula formation [GO:0060346]; camera-type eye development [GO:0043010]; embryonic eye morphogenesis [GO:0048048]; embryonic limb morphogenesis [GO:0030326]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; limb morphogenesis [GO:0035108]; placenta development [GO:0001890]; positive regulation of bone mineralization [GO:0030501]; positive regulation of osteoblast differentiation [GO:0045669]; regulation of trophoblast cell migration [GO:1901163]; sequestering of TGFbeta in extracellular matrix [GO:0035583] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; microfibril [GO:0001527] calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; hormone activity [GO:0005179] g4905.t2 Q61555 30.307 1597 3.06e-153 531.0 sp|Q61555|FBN2_MOUSE Fibrillin-2 OS=Mus musculus OX=10090 GN=Fbn2 PE=1 SV=2 FBN2_MOUSE reviewed Fibrillin-2 [Cleaved into: Placensin] Mus musculus (Mouse) GO:0001527; GO:0001890; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0005615; GO:0006006; GO:0030326; GO:0030501; GO:0031012; GO:0035108; GO:0035583; GO:0042593; GO:0043010; GO:0045669; GO:0048048; GO:0060346; GO:1901163 bone trabecula formation [GO:0060346]; camera-type eye development [GO:0043010]; embryonic eye morphogenesis [GO:0048048]; embryonic limb morphogenesis [GO:0030326]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; limb morphogenesis [GO:0035108]; placenta development [GO:0001890]; positive regulation of bone mineralization [GO:0030501]; positive regulation of osteoblast differentiation [GO:0045669]; regulation of trophoblast cell migration [GO:1901163]; sequestering of TGFbeta in extracellular matrix [GO:0035583] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; microfibril [GO:0001527] calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; hormone activity [GO:0005179] g4905.t2 Q61555 30.11 1458 6.959999999999999e-134 471.0 sp|Q61555|FBN2_MOUSE Fibrillin-2 OS=Mus musculus OX=10090 GN=Fbn2 PE=1 SV=2 FBN2_MOUSE reviewed Fibrillin-2 [Cleaved into: Placensin] Mus musculus (Mouse) GO:0001527; GO:0001890; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0005615; GO:0006006; GO:0030326; GO:0030501; GO:0031012; GO:0035108; GO:0035583; GO:0042593; GO:0043010; GO:0045669; GO:0048048; GO:0060346; GO:1901163 bone trabecula formation [GO:0060346]; camera-type eye development [GO:0043010]; embryonic eye morphogenesis [GO:0048048]; embryonic limb morphogenesis [GO:0030326]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; limb morphogenesis [GO:0035108]; placenta development [GO:0001890]; positive regulation of bone mineralization [GO:0030501]; positive regulation of osteoblast differentiation [GO:0045669]; regulation of trophoblast cell migration [GO:1901163]; sequestering of TGFbeta in extracellular matrix [GO:0035583] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; microfibril [GO:0001527] calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; hormone activity [GO:0005179] g4905.t2 Q61555 29.149 1633 9.98e-125 442.0 sp|Q61555|FBN2_MOUSE Fibrillin-2 OS=Mus musculus OX=10090 GN=Fbn2 PE=1 SV=2 FBN2_MOUSE reviewed Fibrillin-2 [Cleaved into: Placensin] Mus musculus (Mouse) GO:0001527; GO:0001890; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0005615; GO:0006006; GO:0030326; GO:0030501; GO:0031012; GO:0035108; GO:0035583; GO:0042593; GO:0043010; GO:0045669; GO:0048048; GO:0060346; GO:1901163 bone trabecula formation [GO:0060346]; camera-type eye development [GO:0043010]; embryonic eye morphogenesis [GO:0048048]; embryonic limb morphogenesis [GO:0030326]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; limb morphogenesis [GO:0035108]; placenta development [GO:0001890]; positive regulation of bone mineralization [GO:0030501]; positive regulation of osteoblast differentiation [GO:0045669]; regulation of trophoblast cell migration [GO:1901163]; sequestering of TGFbeta in extracellular matrix [GO:0035583] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; microfibril [GO:0001527] calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; hormone activity [GO:0005179] g4905.t2 Q61555 28.042 1512 3.55e-115 412.0 sp|Q61555|FBN2_MOUSE Fibrillin-2 OS=Mus musculus OX=10090 GN=Fbn2 PE=1 SV=2 FBN2_MOUSE reviewed Fibrillin-2 [Cleaved into: Placensin] Mus musculus (Mouse) GO:0001527; GO:0001890; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0005615; GO:0006006; GO:0030326; GO:0030501; GO:0031012; GO:0035108; GO:0035583; GO:0042593; GO:0043010; GO:0045669; GO:0048048; GO:0060346; GO:1901163 bone trabecula formation [GO:0060346]; camera-type eye development [GO:0043010]; embryonic eye morphogenesis [GO:0048048]; embryonic limb morphogenesis [GO:0030326]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; limb morphogenesis [GO:0035108]; placenta development [GO:0001890]; positive regulation of bone mineralization [GO:0030501]; positive regulation of osteoblast differentiation [GO:0045669]; regulation of trophoblast cell migration [GO:1901163]; sequestering of TGFbeta in extracellular matrix [GO:0035583] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; microfibril [GO:0001527] calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; hormone activity [GO:0005179] g4905.t2 Q61555 29.688 1344 2.78e-114 409.0 sp|Q61555|FBN2_MOUSE Fibrillin-2 OS=Mus musculus OX=10090 GN=Fbn2 PE=1 SV=2 FBN2_MOUSE reviewed Fibrillin-2 [Cleaved into: Placensin] Mus musculus (Mouse) GO:0001527; GO:0001890; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0005615; GO:0006006; GO:0030326; GO:0030501; GO:0031012; GO:0035108; GO:0035583; GO:0042593; GO:0043010; GO:0045669; GO:0048048; GO:0060346; GO:1901163 bone trabecula formation [GO:0060346]; camera-type eye development [GO:0043010]; embryonic eye morphogenesis [GO:0048048]; embryonic limb morphogenesis [GO:0030326]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; limb morphogenesis [GO:0035108]; placenta development [GO:0001890]; positive regulation of bone mineralization [GO:0030501]; positive regulation of osteoblast differentiation [GO:0045669]; regulation of trophoblast cell migration [GO:1901163]; sequestering of TGFbeta in extracellular matrix [GO:0035583] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; microfibril [GO:0001527] calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; hormone activity [GO:0005179] g4905.t2 Q61555 33.117 462 7.1e-45 184.0 sp|Q61555|FBN2_MOUSE Fibrillin-2 OS=Mus musculus OX=10090 GN=Fbn2 PE=1 SV=2 FBN2_MOUSE reviewed Fibrillin-2 [Cleaved into: Placensin] Mus musculus (Mouse) GO:0001527; GO:0001890; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0005615; GO:0006006; GO:0030326; GO:0030501; GO:0031012; GO:0035108; GO:0035583; GO:0042593; GO:0043010; GO:0045669; GO:0048048; GO:0060346; GO:1901163 bone trabecula formation [GO:0060346]; camera-type eye development [GO:0043010]; embryonic eye morphogenesis [GO:0048048]; embryonic limb morphogenesis [GO:0030326]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; limb morphogenesis [GO:0035108]; placenta development [GO:0001890]; positive regulation of bone mineralization [GO:0030501]; positive regulation of osteoblast differentiation [GO:0045669]; regulation of trophoblast cell migration [GO:1901163]; sequestering of TGFbeta in extracellular matrix [GO:0035583] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; microfibril [GO:0001527] calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; hormone activity [GO:0005179] g4905.t3 Q61555 29.778 1575 1.0399999999999999e-147 513.0 sp|Q61555|FBN2_MOUSE Fibrillin-2 OS=Mus musculus OX=10090 GN=Fbn2 PE=1 SV=2 FBN2_MOUSE reviewed Fibrillin-2 [Cleaved into: Placensin] Mus musculus (Mouse) GO:0001527; GO:0001890; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0005615; GO:0006006; GO:0030326; GO:0030501; GO:0031012; GO:0035108; GO:0035583; GO:0042593; GO:0043010; GO:0045669; GO:0048048; GO:0060346; GO:1901163 bone trabecula formation [GO:0060346]; camera-type eye development [GO:0043010]; embryonic eye morphogenesis [GO:0048048]; embryonic limb morphogenesis [GO:0030326]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; limb morphogenesis [GO:0035108]; placenta development [GO:0001890]; positive regulation of bone mineralization [GO:0030501]; positive regulation of osteoblast differentiation [GO:0045669]; regulation of trophoblast cell migration [GO:1901163]; sequestering of TGFbeta in extracellular matrix [GO:0035583] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; microfibril [GO:0001527] calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; hormone activity [GO:0005179] g4905.t3 Q61555 31.131 1468 2.94e-143 500.0 sp|Q61555|FBN2_MOUSE Fibrillin-2 OS=Mus musculus OX=10090 GN=Fbn2 PE=1 SV=2 FBN2_MOUSE reviewed Fibrillin-2 [Cleaved into: Placensin] Mus musculus (Mouse) GO:0001527; GO:0001890; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0005615; GO:0006006; GO:0030326; GO:0030501; GO:0031012; GO:0035108; GO:0035583; GO:0042593; GO:0043010; GO:0045669; GO:0048048; GO:0060346; GO:1901163 bone trabecula formation [GO:0060346]; camera-type eye development [GO:0043010]; embryonic eye morphogenesis [GO:0048048]; embryonic limb morphogenesis [GO:0030326]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; limb morphogenesis [GO:0035108]; placenta development [GO:0001890]; positive regulation of bone mineralization [GO:0030501]; positive regulation of osteoblast differentiation [GO:0045669]; regulation of trophoblast cell migration [GO:1901163]; sequestering of TGFbeta in extracellular matrix [GO:0035583] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; microfibril [GO:0001527] calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; hormone activity [GO:0005179] g4905.t3 Q61555 30.014 1406 1.19e-134 473.0 sp|Q61555|FBN2_MOUSE Fibrillin-2 OS=Mus musculus OX=10090 GN=Fbn2 PE=1 SV=2 FBN2_MOUSE reviewed Fibrillin-2 [Cleaved into: Placensin] Mus musculus (Mouse) GO:0001527; GO:0001890; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0005615; GO:0006006; GO:0030326; GO:0030501; GO:0031012; GO:0035108; GO:0035583; GO:0042593; GO:0043010; GO:0045669; GO:0048048; GO:0060346; GO:1901163 bone trabecula formation [GO:0060346]; camera-type eye development [GO:0043010]; embryonic eye morphogenesis [GO:0048048]; embryonic limb morphogenesis [GO:0030326]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; limb morphogenesis [GO:0035108]; placenta development [GO:0001890]; positive regulation of bone mineralization [GO:0030501]; positive regulation of osteoblast differentiation [GO:0045669]; regulation of trophoblast cell migration [GO:1901163]; sequestering of TGFbeta in extracellular matrix [GO:0035583] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; microfibril [GO:0001527] calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; hormone activity [GO:0005179] g4905.t3 Q61555 29.578 1447 8.95e-127 449.0 sp|Q61555|FBN2_MOUSE Fibrillin-2 OS=Mus musculus OX=10090 GN=Fbn2 PE=1 SV=2 FBN2_MOUSE reviewed Fibrillin-2 [Cleaved into: Placensin] Mus musculus (Mouse) GO:0001527; GO:0001890; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0005615; GO:0006006; GO:0030326; GO:0030501; GO:0031012; GO:0035108; GO:0035583; GO:0042593; GO:0043010; GO:0045669; GO:0048048; GO:0060346; GO:1901163 bone trabecula formation [GO:0060346]; camera-type eye development [GO:0043010]; embryonic eye morphogenesis [GO:0048048]; embryonic limb morphogenesis [GO:0030326]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; limb morphogenesis [GO:0035108]; placenta development [GO:0001890]; positive regulation of bone mineralization [GO:0030501]; positive regulation of osteoblast differentiation [GO:0045669]; regulation of trophoblast cell migration [GO:1901163]; sequestering of TGFbeta in extracellular matrix [GO:0035583] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; microfibril [GO:0001527] calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; hormone activity [GO:0005179] g4905.t3 Q61555 28.449 1399 8.300000000000001e-110 395.0 sp|Q61555|FBN2_MOUSE Fibrillin-2 OS=Mus musculus OX=10090 GN=Fbn2 PE=1 SV=2 FBN2_MOUSE reviewed Fibrillin-2 [Cleaved into: Placensin] Mus musculus (Mouse) GO:0001527; GO:0001890; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0005615; GO:0006006; GO:0030326; GO:0030501; GO:0031012; GO:0035108; GO:0035583; GO:0042593; GO:0043010; GO:0045669; GO:0048048; GO:0060346; GO:1901163 bone trabecula formation [GO:0060346]; camera-type eye development [GO:0043010]; embryonic eye morphogenesis [GO:0048048]; embryonic limb morphogenesis [GO:0030326]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; limb morphogenesis [GO:0035108]; placenta development [GO:0001890]; positive regulation of bone mineralization [GO:0030501]; positive regulation of osteoblast differentiation [GO:0045669]; regulation of trophoblast cell migration [GO:1901163]; sequestering of TGFbeta in extracellular matrix [GO:0035583] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; microfibril [GO:0001527] calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; hormone activity [GO:0005179] g4905.t3 Q61555 28.928 1203 8.7e-99 360.0 sp|Q61555|FBN2_MOUSE Fibrillin-2 OS=Mus musculus OX=10090 GN=Fbn2 PE=1 SV=2 FBN2_MOUSE reviewed Fibrillin-2 [Cleaved into: Placensin] Mus musculus (Mouse) GO:0001527; GO:0001890; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0005615; GO:0006006; GO:0030326; GO:0030501; GO:0031012; GO:0035108; GO:0035583; GO:0042593; GO:0043010; GO:0045669; GO:0048048; GO:0060346; GO:1901163 bone trabecula formation [GO:0060346]; camera-type eye development [GO:0043010]; embryonic eye morphogenesis [GO:0048048]; embryonic limb morphogenesis [GO:0030326]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; limb morphogenesis [GO:0035108]; placenta development [GO:0001890]; positive regulation of bone mineralization [GO:0030501]; positive regulation of osteoblast differentiation [GO:0045669]; regulation of trophoblast cell migration [GO:1901163]; sequestering of TGFbeta in extracellular matrix [GO:0035583] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; microfibril [GO:0001527] calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; hormone activity [GO:0005179] g4905.t3 Q61555 29.865 740 3.47e-69 263.0 sp|Q61555|FBN2_MOUSE Fibrillin-2 OS=Mus musculus OX=10090 GN=Fbn2 PE=1 SV=2 FBN2_MOUSE reviewed Fibrillin-2 [Cleaved into: Placensin] Mus musculus (Mouse) GO:0001527; GO:0001890; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0005615; GO:0006006; GO:0030326; GO:0030501; GO:0031012; GO:0035108; GO:0035583; GO:0042593; GO:0043010; GO:0045669; GO:0048048; GO:0060346; GO:1901163 bone trabecula formation [GO:0060346]; camera-type eye development [GO:0043010]; embryonic eye morphogenesis [GO:0048048]; embryonic limb morphogenesis [GO:0030326]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; limb morphogenesis [GO:0035108]; placenta development [GO:0001890]; positive regulation of bone mineralization [GO:0030501]; positive regulation of osteoblast differentiation [GO:0045669]; regulation of trophoblast cell migration [GO:1901163]; sequestering of TGFbeta in extracellular matrix [GO:0035583] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; microfibril [GO:0001527] calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; hormone activity [GO:0005179] g4905.t3 Q61555 30.499 541 3.98e-44 181.0 sp|Q61555|FBN2_MOUSE Fibrillin-2 OS=Mus musculus OX=10090 GN=Fbn2 PE=1 SV=2 FBN2_MOUSE reviewed Fibrillin-2 [Cleaved into: Placensin] Mus musculus (Mouse) GO:0001527; GO:0001890; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0005615; GO:0006006; GO:0030326; GO:0030501; GO:0031012; GO:0035108; GO:0035583; GO:0042593; GO:0043010; GO:0045669; GO:0048048; GO:0060346; GO:1901163 bone trabecula formation [GO:0060346]; camera-type eye development [GO:0043010]; embryonic eye morphogenesis [GO:0048048]; embryonic limb morphogenesis [GO:0030326]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; limb morphogenesis [GO:0035108]; placenta development [GO:0001890]; positive regulation of bone mineralization [GO:0030501]; positive regulation of osteoblast differentiation [GO:0045669]; regulation of trophoblast cell migration [GO:1901163]; sequestering of TGFbeta in extracellular matrix [GO:0035583] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; microfibril [GO:0001527] calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; hormone activity [GO:0005179] g4906.t1 Q8JHI6 46.97 132 4.3e-33 118.0 sp|Q8JHI6|MED29_DANRE Mediator of RNA polymerase II transcription subunit 29 OS=Danio rerio OX=7955 GN=med29 PE=2 SV=1 g4907.t1 Q4U0S5 61.93 373 1.86e-162 475.0 sp|Q4U0S5|PAF1_DANRE RNA polymerase II-associated factor 1 homolog OS=Danio rerio OX=7955 GN=paf1 PE=1 SV=1 PAF1_DANRE reviewed RNA polymerase II-associated factor 1 homolog (PD2-like protein) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000122; GO:0000993; GO:0003682; GO:0005634; GO:0006368; GO:0007507; GO:0014032; GO:0016593 heart development [GO:0007507]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural crest cell development [GO:0014032]; transcription elongation by RNA polymerase II [GO:0006368] Cdc73/Paf1 complex [GO:0016593]; nucleus [GO:0005634] chromatin binding [GO:0003682]; RNA polymerase II complex binding [GO:0000993] g4908.t1 L7YAI7 39.594 394 1.35e-90 284.0 sp|L7YAI7|B4GA1_DANRE Beta-1,4-glucuronyltransferase 1 OS=Danio rerio OX=7955 GN=b4gat1 PE=1 SV=1 B4GA1_DANRE reviewed Beta-1,4-glucuronyltransferase 1 (EC 2.4.1.-) (I-beta-1,3-N-acetylglucosaminyltransferase) (N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase) (Poly-N-acetyllactosamine extension enzyme) (UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 1) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000139; GO:0005794; GO:0015020; GO:0035269; GO:0046872; GO:0055001 muscle cell development [GO:0055001]; protein O-linked glycosylation via mannose [GO:0035269] Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139] glucuronosyltransferase activity [GO:0015020]; metal ion binding [GO:0046872] g4911.t1 Q7SIC1 40.0 120 9.72e-22 95.1 sp|Q7SIC1|FUCL_ANGAN Fucolectin OS=Anguilla anguilla OX=7936 PE=1 SV=1 FUCL_ANGAN reviewed Fucolectin Anguilla anguilla (European freshwater eel) (Muraena anguilla) GO:0001868; GO:0005509; GO:0005576; GO:0010185; GO:0030246; GO:0042806; GO:0045088 regulation of cellular defense response [GO:0010185]; regulation of complement activation, lectin pathway [GO:0001868]; regulation of innate immune response [GO:0045088] extracellular region [GO:0005576] calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; fucose binding [GO:0042806] g4912.t1 P09848 49.58 476 9.23e-145 459.0 sp|P09848|LPH_HUMAN Lactase/phlorizin hydrolase OS=Homo sapiens OX=9606 GN=LCT PE=1 SV=3 LPH_HUMAN reviewed Lactase/phlorizin hydrolase (Lactase/glycosylceramidase) [Includes: Lactase (EC 3.2.1.108); Glycosylceramidase (EC 3.2.1.62) (Phlorizin hydrolase)] Homo sapiens (Human) GO:0000016; GO:0004336; GO:0004348; GO:0005886; GO:0005990; GO:0008422; GO:0042803; GO:0046477; GO:0080079; GO:0098591; GO:0140749; GO:1901733; GO:2000892 cellobiose catabolic process [GO:2000892]; glycosylceramide catabolic process [GO:0046477]; lactose catabolic process [GO:0005990]; quercetin catabolic process [GO:1901733] external side of apical plasma membrane [GO:0098591]; plasma membrane [GO:0005886] beta-glucosidase activity [GO:0008422]; cellobiose glucosidase activity [GO:0080079]; galactosylceramidase activity [GO:0004336]; glucosylceramidase activity [GO:0004348]; lactase activity [GO:0000016]; phlorizin hydrolase activity [GO:0140749]; protein homodimerization activity [GO:0042803] g4912.t1 P09848 45.474 475 1.52e-132 426.0 sp|P09848|LPH_HUMAN Lactase/phlorizin hydrolase OS=Homo sapiens OX=9606 GN=LCT PE=1 SV=3 LPH_HUMAN reviewed Lactase/phlorizin hydrolase (Lactase/glycosylceramidase) [Includes: Lactase (EC 3.2.1.108); Glycosylceramidase (EC 3.2.1.62) (Phlorizin hydrolase)] Homo sapiens (Human) GO:0000016; GO:0004336; GO:0004348; GO:0005886; GO:0005990; GO:0008422; GO:0042803; GO:0046477; GO:0080079; GO:0098591; GO:0140749; GO:1901733; GO:2000892 cellobiose catabolic process [GO:2000892]; glycosylceramide catabolic process [GO:0046477]; lactose catabolic process [GO:0005990]; quercetin catabolic process [GO:1901733] external side of apical plasma membrane [GO:0098591]; plasma membrane [GO:0005886] beta-glucosidase activity [GO:0008422]; cellobiose glucosidase activity [GO:0080079]; galactosylceramidase activity [GO:0004336]; glucosylceramidase activity [GO:0004348]; lactase activity [GO:0000016]; phlorizin hydrolase activity [GO:0140749]; protein homodimerization activity [GO:0042803] g4912.t1 P09848 40.08 499 1.89e-108 357.0 sp|P09848|LPH_HUMAN Lactase/phlorizin hydrolase OS=Homo sapiens OX=9606 GN=LCT PE=1 SV=3 LPH_HUMAN reviewed Lactase/phlorizin hydrolase (Lactase/glycosylceramidase) [Includes: Lactase (EC 3.2.1.108); Glycosylceramidase (EC 3.2.1.62) (Phlorizin hydrolase)] Homo sapiens (Human) GO:0000016; GO:0004336; GO:0004348; GO:0005886; GO:0005990; GO:0008422; GO:0042803; GO:0046477; GO:0080079; GO:0098591; GO:0140749; GO:1901733; GO:2000892 cellobiose catabolic process [GO:2000892]; glycosylceramide catabolic process [GO:0046477]; lactose catabolic process [GO:0005990]; quercetin catabolic process [GO:1901733] external side of apical plasma membrane [GO:0098591]; plasma membrane [GO:0005886] beta-glucosidase activity [GO:0008422]; cellobiose glucosidase activity [GO:0080079]; galactosylceramidase activity [GO:0004336]; glucosylceramidase activity [GO:0004348]; lactase activity [GO:0000016]; phlorizin hydrolase activity [GO:0140749]; protein homodimerization activity [GO:0042803] g4913.t1 P09848 51.22 287 1.34e-99 324.0 sp|P09848|LPH_HUMAN Lactase/phlorizin hydrolase OS=Homo sapiens OX=9606 GN=LCT PE=1 SV=3 LPH_HUMAN reviewed Lactase/phlorizin hydrolase (Lactase/glycosylceramidase) [Includes: Lactase (EC 3.2.1.108); Glycosylceramidase (EC 3.2.1.62) (Phlorizin hydrolase)] Homo sapiens (Human) GO:0000016; GO:0004336; GO:0004348; GO:0005886; GO:0005990; GO:0008422; GO:0042803; GO:0046477; GO:0080079; GO:0098591; GO:0140749; GO:1901733; GO:2000892 cellobiose catabolic process [GO:2000892]; glycosylceramide catabolic process [GO:0046477]; lactose catabolic process [GO:0005990]; quercetin catabolic process [GO:1901733] external side of apical plasma membrane [GO:0098591]; plasma membrane [GO:0005886] beta-glucosidase activity [GO:0008422]; cellobiose glucosidase activity [GO:0080079]; galactosylceramidase activity [GO:0004336]; glucosylceramidase activity [GO:0004348]; lactase activity [GO:0000016]; phlorizin hydrolase activity [GO:0140749]; protein homodimerization activity [GO:0042803] g4913.t1 P09848 49.815 271 3.11e-90 297.0 sp|P09848|LPH_HUMAN Lactase/phlorizin hydrolase OS=Homo sapiens OX=9606 GN=LCT PE=1 SV=3 LPH_HUMAN reviewed Lactase/phlorizin hydrolase (Lactase/glycosylceramidase) [Includes: Lactase (EC 3.2.1.108); Glycosylceramidase (EC 3.2.1.62) (Phlorizin hydrolase)] Homo sapiens (Human) GO:0000016; GO:0004336; GO:0004348; GO:0005886; GO:0005990; GO:0008422; GO:0042803; GO:0046477; GO:0080079; GO:0098591; GO:0140749; GO:1901733; GO:2000892 cellobiose catabolic process [GO:2000892]; glycosylceramide catabolic process [GO:0046477]; lactose catabolic process [GO:0005990]; quercetin catabolic process [GO:1901733] external side of apical plasma membrane [GO:0098591]; plasma membrane [GO:0005886] beta-glucosidase activity [GO:0008422]; cellobiose glucosidase activity [GO:0080079]; galactosylceramidase activity [GO:0004336]; glucosylceramidase activity [GO:0004348]; lactase activity [GO:0000016]; phlorizin hydrolase activity [GO:0140749]; protein homodimerization activity [GO:0042803] g4913.t1 P09848 47.482 278 5.2e-86 285.0 sp|P09848|LPH_HUMAN Lactase/phlorizin hydrolase OS=Homo sapiens OX=9606 GN=LCT PE=1 SV=3 LPH_HUMAN reviewed Lactase/phlorizin hydrolase (Lactase/glycosylceramidase) [Includes: Lactase (EC 3.2.1.108); Glycosylceramidase (EC 3.2.1.62) (Phlorizin hydrolase)] Homo sapiens (Human) GO:0000016; GO:0004336; GO:0004348; GO:0005886; GO:0005990; GO:0008422; GO:0042803; GO:0046477; GO:0080079; GO:0098591; GO:0140749; GO:1901733; GO:2000892 cellobiose catabolic process [GO:2000892]; glycosylceramide catabolic process [GO:0046477]; lactose catabolic process [GO:0005990]; quercetin catabolic process [GO:1901733] external side of apical plasma membrane [GO:0098591]; plasma membrane [GO:0005886] beta-glucosidase activity [GO:0008422]; cellobiose glucosidase activity [GO:0080079]; galactosylceramidase activity [GO:0004336]; glucosylceramidase activity [GO:0004348]; lactase activity [GO:0000016]; phlorizin hydrolase activity [GO:0140749]; protein homodimerization activity [GO:0042803] g4915.t1 Q6UWM7 48.361 488 1.99e-160 471.0 sp|Q6UWM7|LCTL_HUMAN Lactase-like protein OS=Homo sapiens OX=9606 GN=LCTL PE=1 SV=2 g4916.t1 Q9CRA8 56.731 208 5.1500000000000005e-80 242.0 sp|Q9CRA8|EXOS5_MOUSE Exosome complex component RRP46 OS=Mus musculus OX=10090 GN=Exosc5 PE=1 SV=1 EXOS5_MOUSE reviewed Exosome complex component RRP46 (Exosome component 5) (Ribosomal RNA-processing protein 46) Mus musculus (Mouse) GO:0000176; GO:0000177; GO:0000178; GO:0000791; GO:0003677; GO:0003723; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0006364; GO:0006396; GO:0006401; GO:0006402; GO:0016075; GO:0034475; GO:0045006; GO:0051607; GO:0071028; GO:0071051; GO:0101019 defense response to virus [GO:0051607]; DNA deamination [GO:0045006]; mRNA catabolic process [GO:0006402]; nuclear mRNA surveillance [GO:0071028]; poly(A)-dependent snoRNA 3'-end processing [GO:0071051]; RNA catabolic process [GO:0006401]; RNA processing [GO:0006396]; rRNA catabolic process [GO:0016075]; rRNA processing [GO:0006364]; U4 snRNA 3'-end processing [GO:0034475] cytoplasmic exosome (RNase complex) [GO:0000177]; cytosol [GO:0005829]; euchromatin [GO:0000791]; exosome (RNase complex) [GO:0000178]; nuclear exosome (RNase complex) [GO:0000176]; nucleolar exosome (RNase complex) [GO:0101019]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] DNA binding [GO:0003677]; RNA binding [GO:0003723] g4917.t1 P30044 57.143 161 3.17e-61 192.0 sp|P30044|PRDX5_HUMAN Peroxiredoxin-5, mitochondrial OS=Homo sapiens OX=9606 GN=PRDX5 PE=1 SV=4 PRDX5_HUMAN reviewed Peroxiredoxin-5, mitochondrial (EC 1.11.1.24) (Alu corepressor 1) (Antioxidant enzyme B166) (AOEB166) (Liver tissue 2D-page spot 71B) (PLP) (Peroxiredoxin V) (Prx-V) (Peroxisomal antioxidant enzyme) (TPx type VI) (Thioredoxin peroxidase PMP20) (Thioredoxin-dependent peroxiredoxin 5) Homo sapiens (Human) GO:0001016; GO:0004601; GO:0005102; GO:0005615; GO:0005634; GO:0005737; GO:0005739; GO:0005759; GO:0005777; GO:0005782; GO:0005829; GO:0006954; GO:0006979; GO:0008379; GO:0016209; GO:0016480; GO:0031410; GO:0032967; GO:0034599; GO:0034614; GO:0042744; GO:0042802; GO:0043027; GO:0043066; GO:0043231; GO:0045454; GO:0048471; GO:0051354; GO:0060785; GO:0070062; GO:0072541; GO:2001057 cell redox homeostasis [GO:0045454]; cellular response to oxidative stress [GO:0034599]; cellular response to reactive oxygen species [GO:0034614]; hydrogen peroxide catabolic process [GO:0042744]; inflammatory response [GO:0006954]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidoreductase activity [GO:0051354]; negative regulation of transcription by RNA polymerase III [GO:0016480]; positive regulation of collagen biosynthetic process [GO:0032967]; reactive nitrogen species metabolic process [GO:2001057]; regulation of apoptosis involved in tissue homeostasis [GO:0060785]; response to oxidative stress [GO:0006979] cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777] antioxidant activity [GO:0016209]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; identical protein binding [GO:0042802]; peroxidase activity [GO:0004601]; peroxynitrite reductase activity [GO:0072541]; RNA polymerase III transcription regulatory region sequence-specific DNA binding [GO:0001016]; signaling receptor binding [GO:0005102]; thioredoxin peroxidase activity [GO:0008379] g4921.t1 Q8IYD8 51.872 748 0.0 736.0 sp|Q8IYD8|FANCM_HUMAN Fanconi anemia group M protein OS=Homo sapiens OX=9606 GN=FANCM PE=1 SV=2 g4930.t1 Q0VC73 43.827 324 9.39e-83 270.0 sp|Q0VC73|KTU_BOVIN Protein kintoun OS=Bos taurus OX=9913 GN=DNAAF2 PE=2 SV=2 KTU_BOVIN reviewed Protein kintoun (Dynein assembly factor 2, axonemal) Bos taurus (Bovine) GO:0001701; GO:0003351; GO:0005576; GO:0005654; GO:0005730; GO:0005737; GO:0005794; GO:0005829; GO:0032526; GO:0036064; GO:0036158; GO:0036159; GO:0051649; GO:0060285; GO:0061966; GO:0070286; GO:0101031; GO:0120293 axonemal dynein complex assembly [GO:0070286]; cilium-dependent cell motility [GO:0060285]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; establishment of left/right asymmetry [GO:0061966]; establishment of localization in cell [GO:0051649]; in utero embryonic development [GO:0001701]; inner dynein arm assembly [GO:0036159]; outer dynein arm assembly [GO:0036158]; response to retinoic acid [GO:0032526] ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dynein axonemal particle [GO:0120293]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; protein folding chaperone complex [GO:0101031] g4930.t2 Q0VC73 40.23 174 3.05e-26 108.0 sp|Q0VC73|KTU_BOVIN Protein kintoun OS=Bos taurus OX=9913 GN=DNAAF2 PE=2 SV=2 KTU_BOVIN reviewed Protein kintoun (Dynein assembly factor 2, axonemal) Bos taurus (Bovine) GO:0001701; GO:0003351; GO:0005576; GO:0005654; GO:0005730; GO:0005737; GO:0005794; GO:0005829; GO:0032526; GO:0036064; GO:0036158; GO:0036159; GO:0051649; GO:0060285; GO:0061966; GO:0070286; GO:0101031; GO:0120293 axonemal dynein complex assembly [GO:0070286]; cilium-dependent cell motility [GO:0060285]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; establishment of left/right asymmetry [GO:0061966]; establishment of localization in cell [GO:0051649]; in utero embryonic development [GO:0001701]; inner dynein arm assembly [GO:0036159]; outer dynein arm assembly [GO:0036158]; response to retinoic acid [GO:0032526] ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dynein axonemal particle [GO:0120293]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; protein folding chaperone complex [GO:0101031] g4931.t1 Q6ZUK4 33.23 322 5.920000000000001e-43 155.0 sp|Q6ZUK4|TMM26_HUMAN Transmembrane protein 26 OS=Homo sapiens OX=9606 GN=TMEM26 PE=1 SV=1 g4933.t1 Q6ZUK4 32.225 391 3.2e-51 180.0 sp|Q6ZUK4|TMM26_HUMAN Transmembrane protein 26 OS=Homo sapiens OX=9606 GN=TMEM26 PE=1 SV=1 g4935.t1 Q6ZUK4 35.537 242 6.29e-35 132.0 sp|Q6ZUK4|TMM26_HUMAN Transmembrane protein 26 OS=Homo sapiens OX=9606 GN=TMEM26 PE=1 SV=1 g4937.t1 Q08C93 35.262 363 5.879999999999999e-81 255.0 sp|Q08C93|ABD12_DANRE Lysophosphatidylserine lipase ABHD12 OS=Danio rerio OX=7955 GN=abhd12 PE=2 SV=1 ABD12_DANRE reviewed Lysophosphatidylserine lipase ABHD12 (EC 3.1.-.-) (2-arachidonoylglycerol hydrolase ABHD12) (Abhydrolase domain-containing protein 12) (Monoacylglycerol lipase ABHD12) (EC 3.1.1.23) (Oxidized phosphatidylserine lipase ABHD12) (EC 3.1.-.-) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0004620; GO:0004622; GO:0005789; GO:0006660; GO:0009395; GO:0010842; GO:0016020; GO:0036269; GO:0042552; GO:0043010; GO:0046464; GO:0047372; GO:0048899; GO:0048919; GO:0052651; GO:0120560 acylglycerol catabolic process [GO:0046464]; anterior lateral line development [GO:0048899]; camera-type eye development [GO:0043010]; monoacylglycerol catabolic process [GO:0052651]; myelination [GO:0042552]; phosphatidylserine catabolic process [GO:0006660]; phospholipid catabolic process [GO:0009395]; posterior lateral line neuromast development [GO:0048919]; retina layer formation [GO:0010842]; swimming behavior [GO:0036269] endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020] monoacylglycerol lipase activity [GO:0047372]; phosphatidylcholine lysophospholipase activity [GO:0004622]; phosphatidylserine lysophospholipase activity [GO:0120560]; phospholipase activity [GO:0004620] g4938.t1 Q60452 75.0 760 0.0 1178.0 sp|Q60452|ERCC2_CRIGR General transcription and DNA repair factor IIH helicase subunit XPD OS=Cricetulus griseus OX=10029 GN=ERCC2 PE=1 SV=1 g4939.t1 Q99LC9 43.972 846 0.0 595.0 sp|Q99LC9|PEX6_MOUSE Peroxisomal ATPase PEX6 OS=Mus musculus OX=10090 GN=Pex6 PE=1 SV=1 g4940.t1 Q9ERS1 51.667 420 1.51e-137 404.0 sp|Q9ERS1|KCNKC_RAT Potassium channel subfamily K member 12 OS=Rattus norvegicus OX=10116 GN=Kcnk12 PE=2 SV=1 g4941.t1 D4AR77 25.963 597 2.1e-22 107.0 sp|D4AR77|A6907_ARTBC Uncharacterized secreted protein ARB_06907 OS=Arthroderma benhamiae (strain ATCC MYA-4681 / CBS 112371) OX=663331 GN=ARB_06907 PE=1 SV=2 g4942.t1 P47990 60.287 209 6.93e-78 256.0 sp|P47990|XDH_CHICK Xanthine dehydrogenase/oxidase OS=Gallus gallus OX=9031 GN=XDH PE=1 SV=1 g4943.t1 P47990 55.459 1145 0.0 1256.0 sp|P47990|XDH_CHICK Xanthine dehydrogenase/oxidase OS=Gallus gallus OX=9031 GN=XDH PE=1 SV=1 g4944.t1 Q56P03 32.039 309 3.1899999999999998e-24 102.0 sp|Q56P03|EAPP_HUMAN E2F-associated phosphoprotein OS=Homo sapiens OX=9606 GN=EAPP PE=1 SV=4 EAPP_HUMAN reviewed E2F-associated phosphoprotein (EAPP) Homo sapiens (Human) GO:0005634; GO:0005654; GO:0005737; GO:0008284; GO:0016607; GO:0032968; GO:0034244 negative regulation of transcription elongation by RNA polymerase II [GO:0034244]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of transcription elongation by RNA polymerase II [GO:0032968] cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] g4944.t2 Q56P03 32.792 308 1.31e-24 103.0 sp|Q56P03|EAPP_HUMAN E2F-associated phosphoprotein OS=Homo sapiens OX=9606 GN=EAPP PE=1 SV=4 EAPP_HUMAN reviewed E2F-associated phosphoprotein (EAPP) Homo sapiens (Human) GO:0005634; GO:0005654; GO:0005737; GO:0008284; GO:0016607; GO:0032968; GO:0034244 negative regulation of transcription elongation by RNA polymerase II [GO:0034244]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of transcription elongation by RNA polymerase II [GO:0032968] cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] g4945.t1 Q6DCX5 29.712 451 5.88e-55 193.0 sp|Q6DCX5|PCFT_XENLA Proton-coupled folate transporter OS=Xenopus laevis OX=8355 GN=slc46a1 PE=2 SV=1 PCFT_XENLA reviewed Proton-coupled folate transporter (Heme carrier protein 1) (Solute carrier family 46 member 1) Xenopus laevis (African clawed frog) GO:0005542; GO:0005768; GO:0005886; GO:0010008; GO:0015293; GO:0015350; GO:0016323; GO:0016324; GO:0022857; GO:0055085 transmembrane transport [GO:0055085] apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; endosome [GO:0005768]; endosome membrane [GO:0010008]; plasma membrane [GO:0005886] folic acid binding [GO:0005542]; methotrexate transmembrane transporter activity [GO:0015350]; symporter activity [GO:0015293]; transmembrane transporter activity [GO:0022857] g4946.t1 A1A4Q2 59.394 165 3.2999999999999995e-67 205.0 sp|A1A4Q2|PRXD1_BOVIN Prolyl-tRNA synthetase associated domain-containing protein 1 OS=Bos taurus OX=9913 GN=PRORSD1 PE=2 SV=1 g4948.t1 Q5F3L1 67.218 665 0.0 936.0 sp|Q5F3L1|KS6A5_CHICK Ribosomal protein S6 kinase alpha-5 OS=Gallus gallus OX=9031 GN=RPS6KA5 PE=2 SV=1 KS6A5_CHICK reviewed Ribosomal protein S6 kinase alpha-5 (S6K-alpha-5) (EC 2.7.11.1) Gallus gallus (Chicken) GO:0000287; GO:0004674; GO:0004713; GO:0005524; GO:0005654; GO:0005737; GO:0006355; GO:0035175; GO:0038202; GO:0043687; GO:0044022; GO:0044024; GO:0045892; GO:0045944; GO:0070498; GO:0099175; GO:0106310 interleukin-1-mediated signaling pathway [GO:0070498]; negative regulation of DNA-templated transcription [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; post-translational protein modification [GO:0043687]; regulation of DNA-templated transcription [GO:0006355]; regulation of postsynapse organization [GO:0099175]; TORC1 signaling [GO:0038202] cytoplasm [GO:0005737]; nucleoplasm [GO:0005654] ATP binding [GO:0005524]; histone H2AS1 kinase activity [GO:0044024]; histone H3S10 kinase activity [GO:0035175]; histone H3S28 kinase activity [GO:0044022]; magnesium ion binding [GO:0000287]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713] g4949.t1 Q3SZE9 40.491 326 5.510000000000001e-79 248.0 sp|Q3SZE9|TBCC_BOVIN Tubulin-specific chaperone C OS=Bos taurus OX=9913 GN=TBCC PE=2 SV=1 g4950.t1 Q4JIJ3 69.85 1267 0.0 1858.0 sp|Q4JIJ3|METH_BOVIN Methionine synthase OS=Bos taurus OX=9913 GN=MTR PE=2 SV=1 METH_BOVIN reviewed Methionine synthase (MS) (EC 2.1.1.13) (5-methyltetrahydrofolate--homocysteine methyltransferase) (Cobalamin-dependent methionine synthase) (Vitamin-B12 dependent methionine synthase) Bos taurus (Bovine) GO:0005829; GO:0008270; GO:0008705; GO:0009086; GO:0031419; GO:0032259; GO:0046653; GO:0050667 homocysteine metabolic process [GO:0050667]; methionine biosynthetic process [GO:0009086]; methylation [GO:0032259]; tetrahydrofolate metabolic process [GO:0046653] cytosol [GO:0005829] cobalamin binding [GO:0031419]; methionine synthase activity [GO:0008705]; zinc ion binding [GO:0008270] g4953.t1 Q5VTY9 31.463 499 8.070000000000001e-73 243.0 sp|Q5VTY9|HHAT_HUMAN Protein-cysteine N-palmitoyltransferase HHAT OS=Homo sapiens OX=9606 GN=HHAT PE=1 SV=1 HHAT_HUMAN reviewed Protein-cysteine N-palmitoyltransferase HHAT (EC 2.3.1.-) (Hedgehog acyltransferase) (Melanoma antigen recognized by T-cells 2) (MART-2) (Skinny hedgehog protein 1) Homo sapiens (Human) GO:0000139; GO:0005525; GO:0005783; GO:0005789; GO:0005794; GO:0007224; GO:0008374; GO:0016409; GO:0018009 N-terminal peptidyl-L-cysteine N-palmitoylation [GO:0018009]; smoothened signaling pathway [GO:0007224] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139] GTP binding [GO:0005525]; O-acyltransferase activity [GO:0008374]; palmitoyltransferase activity [GO:0016409] g4957.t1 Q9BRZ2 28.223 287 4.82e-28 119.0 sp|Q9BRZ2|TRI56_HUMAN E3 ubiquitin-protein ligase TRIM56 OS=Homo sapiens OX=9606 GN=TRIM56 PE=1 SV=3 g4958.t1 Q8MQW8 32.891 377 1.01e-44 181.0 sp|Q8MQW8|SPRI_DROME Protein sprint OS=Drosophila melanogaster OX=7227 GN=spri PE=2 SV=3 SPRI_DROME reviewed Protein sprint (SH2 poly-proline-containing Ras-interactor protein) Drosophila melanogaster (Fruit fly) GO:0005085; GO:0005096; GO:0005829; GO:0005938; GO:0007165; GO:0016192; GO:0019901; GO:0030139; GO:0030971; GO:0031267; GO:0032483; GO:0048260; GO:0048675; GO:1903688 axon extension [GO:0048675]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of receptor-mediated endocytosis [GO:0048260]; regulation of Rab protein signal transduction [GO:0032483]; signal transduction [GO:0007165]; vesicle-mediated transport [GO:0016192] cell cortex [GO:0005938]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139] GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; protein kinase binding [GO:0019901]; receptor tyrosine kinase binding [GO:0030971]; small GTPase binding [GO:0031267] g4959.t1 P16473 38.204 657 6.8e-136 427.0 sp|P16473|TSHR_HUMAN Thyrotropin receptor OS=Homo sapiens OX=9606 GN=TSHR PE=1 SV=3 TSHR_HUMAN reviewed Thyrotropin receptor (Thyroid-stimulating hormone receptor) (TSH-R) Homo sapiens (Human) GO:0004930; GO:0004996; GO:0005886; GO:0007166; GO:0007186; GO:0007187; GO:0007189; GO:0007267; GO:0008284; GO:0008528; GO:0009755; GO:0009986; GO:0016323; GO:0038023; GO:0038194; GO:0043235; GO:0044877; GO:0120162; GO:1904588; GO:1905229 adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; cell-cell signaling [GO:0007267]; cellular response to glycoprotein [GO:1904588]; cellular response to thyrotropin-releasing hormone [GO:1905229]; G protein-coupled receptor signaling pathway [GO:0007186]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; hormone-mediated signaling pathway [GO:0009755]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cold-induced thermogenesis [GO:0120162]; thyroid-stimulating hormone signaling pathway [GO:0038194] basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] G protein-coupled peptide receptor activity [GO:0008528]; G protein-coupled receptor activity [GO:0004930]; protein-containing complex binding [GO:0044877]; signaling receptor activity [GO:0038023]; thyroid-stimulating hormone receptor activity [GO:0004996] g4961.t1 O43683 41.667 336 2.68e-69 259.0 sp|O43683|BUB1_HUMAN Mitotic checkpoint serine/threonine-protein kinase BUB1 OS=Homo sapiens OX=9606 GN=BUB1 PE=1 SV=1 BUB1_HUMAN reviewed Mitotic checkpoint serine/threonine-protein kinase BUB1 (hBUB1) (EC 2.7.11.1) (BUB1A) Homo sapiens (Human) GO:0000776; GO:0000940; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005829; GO:0006915; GO:0007059; GO:0007063; GO:0007094; GO:0016020; GO:0051301; GO:0051754; GO:0051983; GO:0106310; GO:0140995; GO:2000720 apoptotic process [GO:0006915]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; meiotic sister chromatid cohesion, centromeric [GO:0051754]; mitotic spindle assembly checkpoint signaling [GO:0007094]; positive regulation of maintenance of mitotic sister chromatid cohesion, centromeric [GO:2000720]; regulation of chromosome segregation [GO:0051983]; regulation of sister chromatid cohesion [GO:0007063] cytosol [GO:0005829]; kinetochore [GO:0000776]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; outer kinetochore [GO:0000940] ATP binding [GO:0005524]; histone H2A kinase activity [GO:0140995]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g4962.t1 Q9QX66 45.885 401 4.0399999999999997e-106 322.0 sp|Q9QX66|DPF1_MOUSE Zinc finger protein neuro-d4 OS=Mus musculus OX=10090 GN=Dpf1 PE=1 SV=2 DPF1_MOUSE reviewed Zinc finger protein neuro-d4 (BRG1-associated factor 45B) (BAF45B) (D4, zinc and double PHD fingers family 1) Mus musculus (Mouse) GO:0000785; GO:0005654; GO:0005737; GO:0006338; GO:0006357; GO:0007399; GO:0008270; GO:0030071; GO:0045597; GO:0070316; GO:0071565; GO:1990837; GO:2000045; GO:2000781; GO:2000819 chromatin remodeling [GO:0006338]; nervous system development [GO:0007399]; positive regulation of cell differentiation [GO:0045597]; positive regulation of double-strand break repair [GO:2000781]; regulation of G0 to G1 transition [GO:0070316]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; regulation of nucleotide-excision repair [GO:2000819]; regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; cytoplasm [GO:0005737]; nBAF complex [GO:0071565]; nucleoplasm [GO:0005654] sequence-specific double-stranded DNA binding [GO:1990837]; zinc ion binding [GO:0008270] g4963.t1 Q8TCS8 63.661 743 0.0 912.0 sp|Q8TCS8|PNPT1_HUMAN Polyribonucleotide nucleotidyltransferase 1, mitochondrial OS=Homo sapiens OX=9606 GN=PNPT1 PE=1 SV=2 PNPT1_HUMAN reviewed Polyribonucleotide nucleotidyltransferase 1, mitochondrial (EC 2.7.7.8) (3'-5' RNA exonuclease OLD35) (PNPase old-35) (Polynucleotide phosphorylase 1) (PNPase 1) (Polynucleotide phosphorylase-like protein) Homo sapiens (Human) GO:0000175; GO:0000957; GO:0000958; GO:0000962; GO:0000964; GO:0000965; GO:0003723; GO:0004654; GO:0005737; GO:0005739; GO:0005758; GO:0005759; GO:0005789; GO:0005829; GO:0005840; GO:0006397; GO:0006401; GO:0006402; GO:0007005; GO:0008266; GO:0034046; GO:0034599; GO:0035198; GO:0035458; GO:0035927; GO:0035928; GO:0042802; GO:0043457; GO:0045025; GO:0051260; GO:0051591; GO:0060416; GO:0061014; GO:0070207; GO:0071042; GO:0097222; GO:0097421; GO:2000627; GO:2000772 cellular response to interferon-beta [GO:0035458]; cellular response to oxidative stress [GO:0034599]; liver regeneration [GO:0097421]; mitochondrial mRNA catabolic process [GO:0000958]; mitochondrial mRNA polyadenylation [GO:0097222]; mitochondrial RNA 3'-end processing [GO:0000965]; mitochondrial RNA 5'-end processing [GO:0000964]; mitochondrial RNA catabolic process [GO:0000957]; mitochondrion organization [GO:0007005]; mRNA catabolic process [GO:0006402]; mRNA processing [GO:0006397]; nuclear polyadenylation-dependent mRNA catabolic process [GO:0071042]; positive regulation of miRNA catabolic process [GO:2000627]; positive regulation of mitochondrial RNA catabolic process [GO:0000962]; positive regulation of mRNA catabolic process [GO:0061014]; protein homooligomerization [GO:0051260]; protein homotrimerization [GO:0070207]; regulation of cellular respiration [GO:0043457]; regulation of cellular senescence [GO:2000772]; response to cAMP [GO:0051591]; response to growth hormone [GO:0060416]; RNA catabolic process [GO:0006401]; RNA import into mitochondrion [GO:0035927]; rRNA import into mitochondrion [GO:0035928] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; mitochondrial degradosome [GO:0045025]; mitochondrial intermembrane space [GO:0005758]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ribosome [GO:0005840] 3'-5'-RNA exonuclease activity [GO:0000175]; identical protein binding [GO:0042802]; miRNA binding [GO:0035198]; poly(G) binding [GO:0034046]; poly(U) RNA binding [GO:0008266]; polyribonucleotide nucleotidyltransferase activity [GO:0004654]; RNA binding [GO:0003723] g4966.t1 Q5RFJ6 49.515 412 1.26e-127 386.0 sp|Q5RFJ6|GALT7_PONAB N-acetylgalactosaminyltransferase 7 OS=Pongo abelii OX=9601 GN=GALNT7 PE=2 SV=1 g4966.t2 Q5RFJ6 50.0 412 1.63e-127 386.0 sp|Q5RFJ6|GALT7_PONAB N-acetylgalactosaminyltransferase 7 OS=Pongo abelii OX=9601 GN=GALNT7 PE=2 SV=1 g4966.t3 Q5RFJ6 46.358 453 6.27e-122 373.0 sp|Q5RFJ6|GALT7_PONAB N-acetylgalactosaminyltransferase 7 OS=Pongo abelii OX=9601 GN=GALNT7 PE=2 SV=1 g4967.t1 Q5RFJ6 35.971 139 9.08e-25 102.0 sp|Q5RFJ6|GALT7_PONAB N-acetylgalactosaminyltransferase 7 OS=Pongo abelii OX=9601 GN=GALNT7 PE=2 SV=1 g4969.t1 P47816 46.243 346 7.42e-88 271.0 sp|P47816|PDCD2_RAT Programmed cell death protein 2 OS=Rattus norvegicus OX=10116 GN=Pdcd2 PE=2 SV=2 g4970.t1 Q5EAR5 52.688 186 1.2e-66 207.0 sp|Q5EAR5|TRPT1_DANRE tRNA 2'-phosphotransferase 1 OS=Danio rerio OX=7955 GN=trpt1 PE=2 SV=2 g4971.t1 Q9JMK0 39.13 230 5.1499999999999994e-52 181.0 sp|Q9JMK0|B4GT5_MOUSE Beta-1,4-galactosyltransferase 5 OS=Mus musculus OX=10090 GN=B4galt5 PE=1 SV=2 B4GT5_MOUSE reviewed Beta-1,4-galactosyltransferase 5 (Beta-1,4-GalTase 5) (Beta4Gal-T5) (b4Gal-T5) (EC 2.4.1.-) (Beta-1,4-GalT II) (Glucosylceramide beta-1,4-galactosyltransferase) (EC 2.4.1.274) (Lactosylceramide synthase) (LacCer synthase) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 5) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 5) Mus musculus (Mouse) GO:0001574; GO:0003945; GO:0005794; GO:0005975; GO:0008489; GO:0009101; GO:0021955; GO:0022010; GO:0030311; GO:0031647; GO:0032580; GO:0040019; GO:0042551; GO:0046872 carbohydrate metabolic process [GO:0005975]; central nervous system myelination [GO:0022010]; central nervous system neuron axonogenesis [GO:0021955]; ganglioside biosynthetic process [GO:0001574]; glycoprotein biosynthetic process [GO:0009101]; neuron maturation [GO:0042551]; poly-N-acetyllactosamine biosynthetic process [GO:0030311]; positive regulation of embryonic development [GO:0040019]; regulation of protein stability [GO:0031647] Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580] metal ion binding [GO:0046872]; N-acetyllactosamine synthase activity [GO:0003945]; UDP-galactose:glucosylceramide beta-1,4-galactosyltransferase activity [GO:0008489] g4972.t1 P0DV84 34.542 1213 6.24e-149 503.0 sp|P0DV84|ALK_CANLF ALK tyrosine kinase receptor OS=Canis lupus familiaris OX=9615 GN=ALK PE=3 SV=1 ALK_CANLF reviewed ALK tyrosine kinase receptor (EC 2.7.10.1) Canis lupus familiaris (Dog) (Canis familiaris) GO:0004714; GO:0005524; GO:0005886; GO:0006950; GO:0007169; GO:0008201; GO:0021766; GO:0030298; GO:0030534; GO:0036269; GO:0042127; GO:0042802; GO:0043235; GO:0045664; GO:0050995; GO:0060159; GO:0090648; GO:0097009; GO:1900006 adult behavior [GO:0030534]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; energy homeostasis [GO:0097009]; hippocampus development [GO:0021766]; negative regulation of lipid catabolic process [GO:0050995]; positive regulation of dendrite development [GO:1900006]; regulation of cell population proliferation [GO:0042127]; regulation of dopamine receptor signaling pathway [GO:0060159]; regulation of neuron differentiation [GO:0045664]; response to environmental enrichment [GO:0090648]; response to stress [GO:0006950]; swimming behavior [GO:0036269] plasma membrane [GO:0005886]; receptor complex [GO:0043235] ATP binding [GO:0005524]; heparin binding [GO:0008201]; identical protein binding [GO:0042802]; receptor signaling protein tyrosine kinase activator activity [GO:0030298]; transmembrane receptor protein tyrosine kinase activity [GO:0004714] g4973.t1 P36514 36.73 471 9.47e-95 301.0 sp|P36514|UD2C1_RABIT UDP-glucuronosyltransferase 2C1 (Fragment) OS=Oryctolagus cuniculus OX=9986 GN=UGT2C1 PE=2 SV=1 g4974.t1 O43741 65.641 195 6.76e-91 273.0 sp|O43741|AAKB2_HUMAN 5'-AMP-activated protein kinase subunit beta-2 OS=Homo sapiens OX=9606 GN=PRKAB2 PE=1 SV=1 AAKB2_HUMAN reviewed 5'-AMP-activated protein kinase subunit beta-2 (AMPK subunit beta-2) Homo sapiens (Human) GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006633; GO:0007165; GO:0019901; GO:0031588; GO:0031669; GO:0120162 cellular response to nutrient levels [GO:0031669]; fatty acid biosynthetic process [GO:0006633]; positive regulation of cold-induced thermogenesis [GO:0120162]; signal transduction [GO:0007165] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleotide-activated protein kinase complex [GO:0031588]; nucleus [GO:0005634] protein kinase binding [GO:0019901] g4979.t1 P27653 83.333 72 2.7599999999999997e-38 137.0 sp|P27653|C1TC_RAT C-1-tetrahydrofolate synthase, cytoplasmic OS=Rattus norvegicus OX=10116 GN=Mthfd1 PE=1 SV=3 C1TC_RAT reviewed C-1-tetrahydrofolate synthase, cytoplasmic (C1-THF synthase) [Includes: Methylenetetrahydrofolate dehydrogenase (EC 1.5.1.5); Methenyltetrahydrofolate cyclohydrolase (EC 3.5.4.9); Formyltetrahydrofolate synthetase (EC 6.3.4.3)] Rattus norvegicus (Rat) GO:0001780; GO:0001843; GO:0004329; GO:0004477; GO:0004488; GO:0005524; GO:0005829; GO:0006164; GO:0006555; GO:0006730; GO:0007507; GO:0009086; GO:0009152; GO:0009257; GO:0019346; GO:0035713; GO:0035999; GO:0046655; GO:0061053 10-formyltetrahydrofolate biosynthetic process [GO:0009257]; folic acid metabolic process [GO:0046655]; heart development [GO:0007507]; methionine biosynthetic process [GO:0009086]; methionine metabolic process [GO:0006555]; neural tube closure [GO:0001843]; neutrophil homeostasis [GO:0001780]; one-carbon metabolic process [GO:0006730]; purine nucleotide biosynthetic process [GO:0006164]; purine ribonucleotide biosynthetic process [GO:0009152]; response to nitrogen dioxide [GO:0035713]; somite development [GO:0061053]; tetrahydrofolate interconversion [GO:0035999]; transsulfuration [GO:0019346] cytosol [GO:0005829] ATP binding [GO:0005524]; formate-tetrahydrofolate ligase activity [GO:0004329]; methenyltetrahydrofolate cyclohydrolase activity [GO:0004477]; methylenetetrahydrofolate dehydrogenase (NADP+) activity [GO:0004488] g4980.t1 P11586 68.638 778 0.0 1048.0 sp|P11586|C1TC_HUMAN C-1-tetrahydrofolate synthase, cytoplasmic OS=Homo sapiens OX=9606 GN=MTHFD1 PE=1 SV=4 C1TC_HUMAN reviewed C-1-tetrahydrofolate synthase, cytoplasmic (C1-THF synthase) (Epididymis secretory sperm binding protein) [Cleaved into: C-1-tetrahydrofolate synthase, cytoplasmic, N-terminally processed] [Includes: Methylenetetrahydrofolate dehydrogenase (EC 1.5.1.5); Methenyltetrahydrofolate cyclohydrolase (EC 3.5.4.9); Formyltetrahydrofolate synthetase (EC 6.3.4.3)] Homo sapiens (Human) GO:0001780; GO:0001843; GO:0004329; GO:0004477; GO:0004488; GO:0005524; GO:0005739; GO:0005829; GO:0006164; GO:0006555; GO:0007507; GO:0009086; GO:0009152; GO:0009257; GO:0016020; GO:0019346; GO:0035999; GO:0046655; GO:0048702; GO:0048703; GO:0061053; GO:0070062 10-formyltetrahydrofolate biosynthetic process [GO:0009257]; embryonic neurocranium morphogenesis [GO:0048702]; embryonic viscerocranium morphogenesis [GO:0048703]; folic acid metabolic process [GO:0046655]; heart development [GO:0007507]; methionine biosynthetic process [GO:0009086]; methionine metabolic process [GO:0006555]; neural tube closure [GO:0001843]; neutrophil homeostasis [GO:0001780]; purine nucleotide biosynthetic process [GO:0006164]; purine ribonucleotide biosynthetic process [GO:0009152]; somite development [GO:0061053]; tetrahydrofolate interconversion [GO:0035999]; transsulfuration [GO:0019346] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; mitochondrion [GO:0005739] ATP binding [GO:0005524]; formate-tetrahydrofolate ligase activity [GO:0004329]; methenyltetrahydrofolate cyclohydrolase activity [GO:0004477]; methylenetetrahydrofolate dehydrogenase (NADP+) activity [GO:0004488] g4982.t1 Q6PBM1 65.217 138 3.21e-64 196.0 sp|Q6PBM1|GLRX5_DANRE Glutaredoxin-related protein 5, mitochondrial OS=Danio rerio OX=7955 GN=glrx5 PE=2 SV=1 GLRX5_DANRE reviewed Glutaredoxin-related protein 5, mitochondrial (Monothiol glutaredoxin-5) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005737; GO:0005739; GO:0005759; GO:0016226; GO:0030097; GO:0046872; GO:0051537 hemopoiesis [GO:0030097]; iron-sulfur cluster assembly [GO:0016226] cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] 2 iron, 2 sulfur cluster binding [GO:0051537]; metal ion binding [GO:0046872] g4983.t1 O76536 28.043 649 9.3e-33 141.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g4983.t1 O76536 27.15 593 3.31e-32 140.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g4983.t1 O76536 26.215 576 3.9900000000000004e-32 139.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g4983.t1 O76536 25.366 615 4.4599999999999996e-23 110.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g4991.t1 Q32PI6 54.545 198 1.4e-55 184.0 sp|Q32PI6|RM04_BOVIN Large ribosomal subunit protein uL4m OS=Bos taurus OX=9913 GN=MRPL4 PE=1 SV=1 g4992.t1 Q6DCX5 26.667 450 1.02e-32 133.0 sp|Q6DCX5|PCFT_XENLA Proton-coupled folate transporter OS=Xenopus laevis OX=8355 GN=slc46a1 PE=2 SV=1 PCFT_XENLA reviewed Proton-coupled folate transporter (Heme carrier protein 1) (Solute carrier family 46 member 1) Xenopus laevis (African clawed frog) GO:0005542; GO:0005768; GO:0005886; GO:0010008; GO:0015293; GO:0015350; GO:0016323; GO:0016324; GO:0022857; GO:0055085 transmembrane transport [GO:0055085] apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; endosome [GO:0005768]; endosome membrane [GO:0010008]; plasma membrane [GO:0005886] folic acid binding [GO:0005542]; methotrexate transmembrane transporter activity [GO:0015350]; symporter activity [GO:0015293]; transmembrane transporter activity [GO:0022857] g4993.t1 Q8AWW5 35.547 1069 0.0 579.0 sp|Q8AWW5|CRIM1_CHICK Cysteine-rich motor neuron 1 protein OS=Gallus gallus OX=9031 GN=CRIM1 PE=2 SV=1 g4994.t1 Q7SXW6 82.995 394 0.0 683.0 sp|Q7SXW6|ARP2A_DANRE Actin-related protein 2-A OS=Danio rerio OX=7955 GN=actr2a PE=2 SV=1 g4995.t1 Q9Y253 48.807 461 3.12e-149 457.0 sp|Q9Y253|POLH_HUMAN DNA polymerase eta OS=Homo sapiens OX=9606 GN=POLH PE=1 SV=1 POLH_HUMAN reviewed DNA polymerase eta (EC 2.7.7.7) (RAD30 homolog A) (Xeroderma pigmentosum variant type protein) Homo sapiens (Human) GO:0000731; GO:0003684; GO:0003887; GO:0005634; GO:0005654; GO:0005657; GO:0005829; GO:0006260; GO:0006281; GO:0006282; GO:0006290; GO:0008270; GO:0009314; GO:0010225; GO:0035861; GO:0042276; GO:0070987; GO:0071494 cellular response to UV-C [GO:0071494]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA synthesis involved in DNA repair [GO:0000731]; error-free translesion synthesis [GO:0070987]; error-prone translesion synthesis [GO:0042276]; pyrimidine dimer repair [GO:0006290]; regulation of DNA repair [GO:0006282]; response to radiation [GO:0009314]; response to UV-C [GO:0010225] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; replication fork [GO:0005657]; site of double-strand break [GO:0035861] damaged DNA binding [GO:0003684]; DNA-directed DNA polymerase activity [GO:0003887]; zinc ion binding [GO:0008270] g4996.t1 O95267 56.828 227 2.1399999999999998e-84 278.0 sp|O95267|GRP1_HUMAN RAS guanyl-releasing protein 1 OS=Homo sapiens OX=9606 GN=RASGRP1 PE=1 SV=2 g4997.t1 Q8IV61 46.154 299 3.6199999999999996e-82 265.0 sp|Q8IV61|GRP3_HUMAN Ras guanyl-releasing protein 3 OS=Homo sapiens OX=9606 GN=RASGRP3 PE=1 SV=1 GRP3_HUMAN reviewed Ras guanyl-releasing protein 3 (Calcium and DAG-regulated guanine nucleotide exchange factor III) (Guanine nucleotide exchange factor for Rap1) Homo sapiens (Human) GO:0000165; GO:0005085; GO:0005096; GO:0005509; GO:0005886; GO:0007264; GO:0007265; GO:0008270; GO:0019900; GO:0019992; GO:0031267; GO:0032045; GO:0048471 MAPK cascade [GO:0000165]; Ras protein signal transduction [GO:0007265]; small GTPase-mediated signal transduction [GO:0007264] guanyl-nucleotide exchange factor complex [GO:0032045]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; diacylglycerol binding [GO:0019992]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; kinase binding [GO:0019900]; small GTPase binding [GO:0031267]; zinc ion binding [GO:0008270] g5000.t1 Q9TU19 43.689 515 1.9599999999999998e-138 430.0 sp|Q9TU19|NPHP1_CANLF Nephrocystin-1 (Fragment) OS=Canis lupus familiaris OX=9615 GN=NPHP1 PE=1 SV=1 g5001.t1 Q5RE15 67.293 266 2.28e-120 348.0 sp|Q5RE15|PSMD8_PONAB 26S proteasome non-ATPase regulatory subunit 8 (Fragment) OS=Pongo abelii OX=9601 GN=PSMD8 PE=2 SV=2 PSMD8_PONAB reviewed 26S proteasome non-ATPase regulatory subunit 8 (26S proteasome regulatory subunit RPN12) Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0005634; GO:0005829; GO:0008541; GO:0022624; GO:0043161 proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161] cytosol [GO:0005829]; nucleus [GO:0005634]; proteasome accessory complex [GO:0022624]; proteasome regulatory particle, lid subcomplex [GO:0008541] g5002.t1 P62334 89.717 389 0.0 723.0 sp|P62334|PRS10_MOUSE 26S proteasome regulatory subunit 10B OS=Mus musculus OX=10090 GN=Psmc6 PE=1 SV=1 g5003.t1 Q99N87 54.277 339 6.609999999999999e-120 358.0 sp|Q99N87|RT05_MOUSE Small ribosomal subunit protein uS5m OS=Mus musculus OX=10090 GN=Mrps5 PE=1 SV=1 g5005.t1 P53569 45.035 715 0.0 631.0 sp|P53569|CEBPZ_MOUSE CCAAT/enhancer-binding protein zeta OS=Mus musculus OX=10090 GN=Cebpz PE=1 SV=2 g5006.t1 Q14919 73.737 99 1.41e-46 156.0 sp|Q14919|NC2A_HUMAN Dr1-associated corepressor OS=Homo sapiens OX=9606 GN=DRAP1 PE=1 SV=3 NC2A_HUMAN reviewed Dr1-associated corepressor (Dr1-associated protein 1) (Negative cofactor 2-alpha) (NC2-alpha) Homo sapiens (Human) GO:0000122; GO:0001046; GO:0001091; GO:0005634; GO:0006366; GO:0016251; GO:0017025; GO:0017054; GO:0042802; GO:0046982; GO:0090575 negative regulation of transcription by RNA polymerase II [GO:0000122]; transcription by RNA polymerase II [GO:0006366] negative cofactor 2 complex [GO:0017054]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575] core promoter sequence-specific DNA binding [GO:0001046]; identical protein binding [GO:0042802]; protein heterodimerization activity [GO:0046982]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; RNA polymerase II general transcription initiation factor binding [GO:0001091]; TBP-class protein binding [GO:0017025] g5011.t1 P78540 47.214 341 1.23e-106 320.0 sp|P78540|ARGI2_HUMAN Arginase-2, mitochondrial OS=Homo sapiens OX=9606 GN=ARG2 PE=1 SV=1 ARGI2_HUMAN reviewed Arginase-2, mitochondrial (EC 3.5.3.1) (Arginase II) (Kidney-type arginase) (Non-hepatic arginase) (Type II arginase) Homo sapiens (Human) GO:0000050; GO:0001657; GO:0002250; GO:0002829; GO:0004053; GO:0005737; GO:0005739; GO:0005759; GO:0006525; GO:0006809; GO:0006941; GO:0030145; GO:0032651; GO:0032696; GO:0032700; GO:0032720; GO:0045087; GO:0071641; GO:0071644; GO:0071650; GO:1900425; GO:1903426; GO:1905403; GO:2000562; GO:2000774 adaptive immune response [GO:0002250]; arginine metabolic process [GO:0006525]; innate immune response [GO:0045087]; negative regulation of activated CD8-positive, alpha-beta T cell apoptotic process [GO:1905403]; negative regulation of CD4-positive, alpha-beta T cell proliferation [GO:2000562]; negative regulation of chemokine (C-C motif) ligand 4 production [GO:0071644]; negative regulation of chemokine (C-C motif) ligand 5 production [GO:0071650]; negative regulation of defense response to bacterium [GO:1900425]; negative regulation of interleukin-13 production [GO:0032696]; negative regulation of interleukin-17 production [GO:0032700]; negative regulation of macrophage inflammatory protein 1 alpha production [GO:0071641]; negative regulation of tumor necrosis factor production [GO:0032720]; negative regulation of type 2 immune response [GO:0002829]; nitric oxide biosynthetic process [GO:0006809]; positive regulation of cellular senescence [GO:2000774]; regulation of interleukin-1 beta production [GO:0032651]; regulation of reactive oxygen species biosynthetic process [GO:1903426]; striated muscle contraction [GO:0006941]; urea cycle [GO:0000050]; ureteric bud development [GO:0001657] cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] arginase activity [GO:0004053]; manganese ion binding [GO:0030145] g5012.t1 F1MT22 28.638 426 5.38e-22 104.0 sp|F1MT22|LGR5_BOVIN Leucine-rich repeat-containing G-protein coupled receptor 5 OS=Bos taurus OX=9913 GN=LGR5 PE=3 SV=2 g5013.t1 P58682 29.098 787 5.21e-53 204.0 sp|P58682|TLR8_MOUSE Toll-like receptor 8 OS=Mus musculus OX=10090 GN=Tlr8 PE=1 SV=2 TLR8_MOUSE reviewed Toll-like receptor 8 (CD antigen CD288) Mus musculus (Mouse) GO:0002224; GO:0002718; GO:0003677; GO:0003725; GO:0003727; GO:0005764; GO:0005783; GO:0005886; GO:0006954; GO:0007249; GO:0009615; GO:0009897; GO:0010008; GO:0032009; GO:0032695; GO:0032727; GO:0032728; GO:0032729; GO:0032731; GO:0032755; GO:0032757; GO:0034158; GO:0038187; GO:0042802; GO:0043123; GO:0045087; GO:0045089; GO:0051607; GO:0071260 canonical NF-kappaB signal transduction [GO:0007249]; cellular response to mechanical stimulus [GO:0071260]; defense response to virus [GO:0051607]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; negative regulation of interleukin-12 production [GO:0032695]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of innate immune response [GO:0045089]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of type II interferon production [GO:0032729]; regulation of cytokine production involved in immune response [GO:0002718]; response to virus [GO:0009615]; toll-like receptor 8 signaling pathway [GO:0034158]; toll-like receptor signaling pathway [GO:0002224] early phagosome [GO:0032009]; endoplasmic reticulum [GO:0005783]; endosome membrane [GO:0010008]; external side of plasma membrane [GO:0009897]; lysosome [GO:0005764]; plasma membrane [GO:0005886] DNA binding [GO:0003677]; double-stranded RNA binding [GO:0003725]; identical protein binding [GO:0042802]; pattern recognition receptor activity [GO:0038187]; single-stranded RNA binding [GO:0003727] g5023.t1 Q8WV16 48.341 211 3.7e-56 194.0 sp|Q8WV16|DCAF4_HUMAN DDB1- and CUL4-associated factor 4 OS=Homo sapiens OX=9606 GN=DCAF4 PE=1 SV=3 DCAF4_HUMAN reviewed DDB1- and CUL4-associated factor 4 (WD repeat-containing protein 21A) Homo sapiens (Human) GO:0005654; GO:0016567; GO:0080008 protein ubiquitination [GO:0016567] Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; nucleoplasm [GO:0005654] g5024.t1 A5PJS2 53.696 257 3.6e-90 271.0 sp|A5PJS2|S5A1_BOVIN 3-oxo-5-alpha-steroid 4-dehydrogenase 1 OS=Bos taurus OX=9913 GN=SRD5A1 PE=2 SV=1 S5A1_BOVIN reviewed 3-oxo-5-alpha-steroid 4-dehydrogenase 1 (EC 1.3.1.22) (SR type 1) (Steroid 5-alpha-reductase 1) (S5AR 1) Bos taurus (Bovine) GO:0003865; GO:0005789; GO:0006702; GO:0008584; GO:0030154; GO:0043025; GO:0047751 androgen biosynthetic process [GO:0006702]; cell differentiation [GO:0030154]; male gonad development [GO:0008584] endoplasmic reticulum membrane [GO:0005789]; neuronal cell body [GO:0043025] 3-oxo-5-alpha-steroid 4-dehydrogenase (NADP+) activity [GO:0047751]; 3-oxo-5-alpha-steroid 4-dehydrogenase activity [GO:0003865] g5027.t1 P49701 44.068 118 9.04e-25 111.0 sp|P49701|VDR_COTJA Vitamin D3 receptor OS=Coturnix japonica OX=93934 GN=VDR PE=2 SV=1 g5028.t1 Q9HAT8 64.951 408 0.0 541.0 sp|Q9HAT8|PELI2_HUMAN E3 ubiquitin-protein ligase pellino homolog 2 OS=Homo sapiens OX=9606 GN=PELI2 PE=1 SV=1 PELI2_HUMAN reviewed E3 ubiquitin-protein ligase pellino homolog 2 (Pellino-2) (EC 2.3.2.27) (RING-type E3 ubiquitin transferase pellino homolog 2) Homo sapiens (Human) GO:0000209; GO:0001934; GO:0005829; GO:0008592; GO:0034450; GO:0043123; GO:0043410; GO:0061630 positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of protein phosphorylation [GO:0001934]; protein polyubiquitination [GO:0000209]; regulation of Toll signaling pathway [GO:0008592] cytosol [GO:0005829] ubiquitin protein ligase activity [GO:0061630]; ubiquitin-ubiquitin ligase activity [GO:0034450] g5031.t1 Q0VC16 28.962 549 2.4399999999999998e-45 182.0 sp|Q0VC16|TGO1_BOVIN Transport and Golgi organization protein 1 homolog OS=Bos taurus OX=9913 GN=MIA3 PE=2 SV=2 TGO1_BOVIN reviewed Transport and Golgi organization protein 1 homolog (TANGO1) Bos taurus (Bovine) GO:0005789; GO:0006887; GO:0006888; GO:0007029; GO:0009306; GO:0015031; GO:0016020; GO:0035459; GO:0038024; GO:0042953; GO:0048731; GO:0070971; GO:0070973; GO:0090110 COPII-coated vesicle cargo loading [GO:0090110]; endoplasmic reticulum organization [GO:0007029]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; exocytosis [GO:0006887]; lipoprotein transport [GO:0042953]; protein localization to endoplasmic reticulum exit site [GO:0070973]; protein secretion [GO:0009306]; protein transport [GO:0015031]; system development [GO:0048731]; vesicle cargo loading [GO:0035459] endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020] cargo receptor activity [GO:0038024] g5031.t2 Q0VC16 28.962 549 3.37e-44 174.0 sp|Q0VC16|TGO1_BOVIN Transport and Golgi organization protein 1 homolog OS=Bos taurus OX=9913 GN=MIA3 PE=2 SV=2 TGO1_BOVIN reviewed Transport and Golgi organization protein 1 homolog (TANGO1) Bos taurus (Bovine) GO:0005789; GO:0006887; GO:0006888; GO:0007029; GO:0009306; GO:0015031; GO:0016020; GO:0035459; GO:0038024; GO:0042953; GO:0048731; GO:0070971; GO:0070973; GO:0090110 COPII-coated vesicle cargo loading [GO:0090110]; endoplasmic reticulum organization [GO:0007029]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; exocytosis [GO:0006887]; lipoprotein transport [GO:0042953]; protein localization to endoplasmic reticulum exit site [GO:0070973]; protein secretion [GO:0009306]; protein transport [GO:0015031]; system development [GO:0048731]; vesicle cargo loading [GO:0035459] endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020] cargo receptor activity [GO:0038024] g5031.t3 Q0VC16 29.456 533 6.259999999999999e-45 176.0 sp|Q0VC16|TGO1_BOVIN Transport and Golgi organization protein 1 homolog OS=Bos taurus OX=9913 GN=MIA3 PE=2 SV=2 TGO1_BOVIN reviewed Transport and Golgi organization protein 1 homolog (TANGO1) Bos taurus (Bovine) GO:0005789; GO:0006887; GO:0006888; GO:0007029; GO:0009306; GO:0015031; GO:0016020; GO:0035459; GO:0038024; GO:0042953; GO:0048731; GO:0070971; GO:0070973; GO:0090110 COPII-coated vesicle cargo loading [GO:0090110]; endoplasmic reticulum organization [GO:0007029]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; exocytosis [GO:0006887]; lipoprotein transport [GO:0042953]; protein localization to endoplasmic reticulum exit site [GO:0070973]; protein secretion [GO:0009306]; protein transport [GO:0015031]; system development [GO:0048731]; vesicle cargo loading [GO:0035459] endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020] cargo receptor activity [GO:0038024] g5034.t1 O88454 37.109 256 2.73e-38 147.0 sp|O88454|KCNK4_MOUSE Potassium channel subfamily K member 4 OS=Mus musculus OX=10090 GN=Kcnk4 PE=1 SV=1 KCNK4_MOUSE reviewed Potassium channel subfamily K member 4 (TWIK-related arachidonic acid-stimulated potassium channel protein) (TRAAK) Mus musculus (Mouse) GO:0005267; GO:0005886; GO:0015271; GO:0019228; GO:0019233; GO:0022841; GO:0033268; GO:0034705; GO:0042802; GO:0046872; GO:0050951; GO:0050976; GO:0071260; GO:0071398; GO:0071468; GO:0071469; GO:0071502; GO:0071805; GO:0097604; GO:0098782; GO:1904551; GO:1990478 cellular response to acidic pH [GO:0071468]; cellular response to alkaline pH [GO:0071469]; cellular response to arachidonate [GO:1904551]; cellular response to fatty acid [GO:0071398]; cellular response to mechanical stimulus [GO:0071260]; cellular response to temperature stimulus [GO:0071502]; detection of mechanical stimulus involved in sensory perception of touch [GO:0050976]; neuronal action potential [GO:0019228]; potassium ion transmembrane transport [GO:0071805]; response to ultrasound [GO:1990478]; sensory perception of pain [GO:0019233]; sensory perception of temperature stimulus [GO:0050951] node of Ranvier [GO:0033268]; plasma membrane [GO:0005886]; potassium channel complex [GO:0034705] identical protein binding [GO:0042802]; mechanosensitive potassium channel activity [GO:0098782]; metal ion binding [GO:0046872]; outward rectifier potassium channel activity [GO:0015271]; potassium channel activity [GO:0005267]; potassium ion leak channel activity [GO:0022841]; temperature-gated cation channel activity [GO:0097604] g5037.t1 Q7TNC6 58.517 499 3.52e-143 478.0 sp|Q7TNC6|KI26B_MOUSE Kinesin-like protein KIF26B OS=Mus musculus OX=10090 GN=Kif26b PE=1 SV=3 KI26B_MOUSE reviewed Kinesin-like protein KIF26B Mus musculus (Mouse) GO:0003777; GO:0005524; GO:0005737; GO:0005874; GO:0007018; GO:0008017; GO:0022409; GO:0030010; GO:0072092 establishment of cell polarity [GO:0030010]; microtubule-based movement [GO:0007018]; positive regulation of cell-cell adhesion [GO:0022409]; ureteric bud invasion [GO:0072092] cytoplasm [GO:0005737]; microtubule [GO:0005874] ATP binding [GO:0005524]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777] g5040.t1 Q60803 39.33 567 9.67e-127 387.0 sp|Q60803|TRAF3_MOUSE TNF receptor-associated factor 3 OS=Mus musculus OX=10090 GN=Traf3 PE=1 SV=2 g5041.t1 Q26613 64.019 642 0.0 862.0 sp|Q26613|EMAP_STRPU 77 kDa echinoderm microtubule-associated protein OS=Strongylocentrotus purpuratus OX=7668 GN=EMAP PE=2 SV=1 g5041.t2 Q26613 63.404 664 0.0 877.0 sp|Q26613|EMAP_STRPU 77 kDa echinoderm microtubule-associated protein OS=Strongylocentrotus purpuratus OX=7668 GN=EMAP PE=2 SV=1 g5042.t1 Q3T0E5 41.912 408 2.74e-101 309.0 sp|Q3T0E5|APMAP_BOVIN Adipocyte plasma membrane-associated protein OS=Bos taurus OX=9913 GN=APMAP PE=2 SV=1 g5043.t1 Q6P0D1 50.474 422 7.45e-142 422.0 sp|Q6P0D1|ZNT6_DANRE Zinc transporter 6 OS=Danio rerio OX=7955 GN=slc30a6 PE=2 SV=1 g5045.t1 P09599 28.228 333 2.8099999999999998e-24 106.0 sp|P09599|PHL1_BACCE Sphingomyelinase C OS=Bacillus cereus OX=1396 GN=sph PE=3 SV=1 g5046.t1 Q9CWT6 40.119 506 2.83e-108 337.0 sp|Q9CWT6|DDX28_MOUSE Probable ATP-dependent RNA helicase DDX28 OS=Mus musculus OX=10090 GN=Ddx28 PE=2 SV=2 DDX28_MOUSE reviewed Probable ATP-dependent RNA helicase DDX28 (EC 3.6.4.13) (Mitochondrial DEAD box protein 28) Mus musculus (Mouse) GO:0003724; GO:0005524; GO:0005654; GO:0005730; GO:0005739; GO:0005829; GO:0016887; GO:0019843; GO:0035770; GO:0042645; GO:1902775 mitochondrial large ribosomal subunit assembly [GO:1902775] cytosol [GO:0005829]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; ribonucleoprotein granule [GO:0035770] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; RNA helicase activity [GO:0003724]; rRNA binding [GO:0019843] g5048.t1 Q5RDU7 85.345 116 9.98e-72 213.0 sp|Q5RDU7|YPEL5_PONAB Protein yippee-like 5 OS=Pongo abelii OX=9601 GN=YPEL5 PE=2 SV=1 g5050.t1 Q4VAC9 43.735 407 2.63e-96 344.0 sp|Q4VAC9|PKHG3_MOUSE Pleckstrin homology domain-containing family G member 3 OS=Mus musculus OX=10090 GN=Plekhg3 PE=1 SV=2 PKHG3_MOUSE reviewed Pleckstrin homology domain-containing family G member 3 (PH domain-containing family G member 3) Mus musculus (Mouse) GO:0003779; GO:0005085; GO:0005829; GO:0005856; GO:0030334; GO:0031267; GO:2000114 regulation of cell migration [GO:0030334]; regulation of establishment of cell polarity [GO:2000114] cytoskeleton [GO:0005856]; cytosol [GO:0005829] actin binding [GO:0003779]; guanyl-nucleotide exchange factor activity [GO:0005085]; small GTPase binding [GO:0031267] g5053.t1 P23506 61.321 106 2.2399999999999998e-38 134.0 sp|P23506|PIMT_MOUSE Protein-L-isoaspartate(D-aspartate) O-methyltransferase OS=Mus musculus OX=10090 GN=Pcmt1 PE=1 SV=3 g5054.t1 P16157 28.475 590 2.4099999999999998e-46 186.0 sp|P16157|ANK1_HUMAN Ankyrin-1 OS=Homo sapiens OX=9606 GN=ANK1 PE=1 SV=3 ANK1_HUMAN reviewed Ankyrin-1 (ANK-1) (Ankyrin-R) (Erythrocyte ankyrin) Homo sapiens (Human) GO:0005198; GO:0005200; GO:0005829; GO:0005856; GO:0005886; GO:0006887; GO:0006888; GO:0007010; GO:0007165; GO:0008093; GO:0009898; GO:0014731; GO:0016323; GO:0016529; GO:0019899; GO:0019903; GO:0030018; GO:0030507; GO:0030673; GO:0031430; GO:0042383; GO:0043005; GO:0044325; GO:0045199; GO:0045211; GO:0051117; GO:0072659; GO:0170014 cytoskeleton organization [GO:0007010]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; exocytosis [GO:0006887]; maintenance of epithelial cell apical/basal polarity [GO:0045199]; protein localization to plasma membrane [GO:0072659]; signal transduction [GO:0007165] ankyrin-1 complex [GO:0170014]; axolemma [GO:0030673]; basolateral plasma membrane [GO:0016323]; cytoplasmic side of plasma membrane [GO:0009898]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; M band [GO:0031430]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; sarcoplasmic reticulum [GO:0016529]; spectrin-associated cytoskeleton [GO:0014731]; Z disc [GO:0030018] ATPase binding [GO:0051117]; cytoskeletal anchor activity [GO:0008093]; enzyme binding [GO:0019899]; protein phosphatase binding [GO:0019903]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]; structural molecule activity [GO:0005198]; transmembrane transporter binding [GO:0044325] g5054.t1 P16157 26.846 596 4.9199999999999996e-40 165.0 sp|P16157|ANK1_HUMAN Ankyrin-1 OS=Homo sapiens OX=9606 GN=ANK1 PE=1 SV=3 ANK1_HUMAN reviewed Ankyrin-1 (ANK-1) (Ankyrin-R) (Erythrocyte ankyrin) Homo sapiens (Human) GO:0005198; GO:0005200; GO:0005829; GO:0005856; GO:0005886; GO:0006887; GO:0006888; GO:0007010; GO:0007165; GO:0008093; GO:0009898; GO:0014731; GO:0016323; GO:0016529; GO:0019899; GO:0019903; GO:0030018; GO:0030507; GO:0030673; GO:0031430; GO:0042383; GO:0043005; GO:0044325; GO:0045199; GO:0045211; GO:0051117; GO:0072659; GO:0170014 cytoskeleton organization [GO:0007010]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; exocytosis [GO:0006887]; maintenance of epithelial cell apical/basal polarity [GO:0045199]; protein localization to plasma membrane [GO:0072659]; signal transduction [GO:0007165] ankyrin-1 complex [GO:0170014]; axolemma [GO:0030673]; basolateral plasma membrane [GO:0016323]; cytoplasmic side of plasma membrane [GO:0009898]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; M band [GO:0031430]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; sarcoplasmic reticulum [GO:0016529]; spectrin-associated cytoskeleton [GO:0014731]; Z disc [GO:0030018] ATPase binding [GO:0051117]; cytoskeletal anchor activity [GO:0008093]; enzyme binding [GO:0019899]; protein phosphatase binding [GO:0019903]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]; structural molecule activity [GO:0005198]; transmembrane transporter binding [GO:0044325] g5054.t1 P16157 28.222 613 6.26e-40 165.0 sp|P16157|ANK1_HUMAN Ankyrin-1 OS=Homo sapiens OX=9606 GN=ANK1 PE=1 SV=3 ANK1_HUMAN reviewed Ankyrin-1 (ANK-1) (Ankyrin-R) (Erythrocyte ankyrin) Homo sapiens (Human) GO:0005198; GO:0005200; GO:0005829; GO:0005856; GO:0005886; GO:0006887; GO:0006888; GO:0007010; GO:0007165; GO:0008093; GO:0009898; GO:0014731; GO:0016323; GO:0016529; GO:0019899; GO:0019903; GO:0030018; GO:0030507; GO:0030673; GO:0031430; GO:0042383; GO:0043005; GO:0044325; GO:0045199; GO:0045211; GO:0051117; GO:0072659; GO:0170014 cytoskeleton organization [GO:0007010]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; exocytosis [GO:0006887]; maintenance of epithelial cell apical/basal polarity [GO:0045199]; protein localization to plasma membrane [GO:0072659]; signal transduction [GO:0007165] ankyrin-1 complex [GO:0170014]; axolemma [GO:0030673]; basolateral plasma membrane [GO:0016323]; cytoplasmic side of plasma membrane [GO:0009898]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; M band [GO:0031430]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; sarcoplasmic reticulum [GO:0016529]; spectrin-associated cytoskeleton [GO:0014731]; Z disc [GO:0030018] ATPase binding [GO:0051117]; cytoskeletal anchor activity [GO:0008093]; enzyme binding [GO:0019899]; protein phosphatase binding [GO:0019903]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]; structural molecule activity [GO:0005198]; transmembrane transporter binding [GO:0044325] g5054.t1 P16157 25.932 617 1.95e-37 157.0 sp|P16157|ANK1_HUMAN Ankyrin-1 OS=Homo sapiens OX=9606 GN=ANK1 PE=1 SV=3 ANK1_HUMAN reviewed Ankyrin-1 (ANK-1) (Ankyrin-R) (Erythrocyte ankyrin) Homo sapiens (Human) GO:0005198; GO:0005200; GO:0005829; GO:0005856; GO:0005886; GO:0006887; GO:0006888; GO:0007010; GO:0007165; GO:0008093; GO:0009898; GO:0014731; GO:0016323; GO:0016529; GO:0019899; GO:0019903; GO:0030018; GO:0030507; GO:0030673; GO:0031430; GO:0042383; GO:0043005; GO:0044325; GO:0045199; GO:0045211; GO:0051117; GO:0072659; GO:0170014 cytoskeleton organization [GO:0007010]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; exocytosis [GO:0006887]; maintenance of epithelial cell apical/basal polarity [GO:0045199]; protein localization to plasma membrane [GO:0072659]; signal transduction [GO:0007165] ankyrin-1 complex [GO:0170014]; axolemma [GO:0030673]; basolateral plasma membrane [GO:0016323]; cytoplasmic side of plasma membrane [GO:0009898]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; M band [GO:0031430]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; sarcoplasmic reticulum [GO:0016529]; spectrin-associated cytoskeleton [GO:0014731]; Z disc [GO:0030018] ATPase binding [GO:0051117]; cytoskeletal anchor activity [GO:0008093]; enzyme binding [GO:0019899]; protein phosphatase binding [GO:0019903]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]; structural molecule activity [GO:0005198]; transmembrane transporter binding [GO:0044325] g5054.t1 P16157 26.369 493 7.49e-27 122.0 sp|P16157|ANK1_HUMAN Ankyrin-1 OS=Homo sapiens OX=9606 GN=ANK1 PE=1 SV=3 ANK1_HUMAN reviewed Ankyrin-1 (ANK-1) (Ankyrin-R) (Erythrocyte ankyrin) Homo sapiens (Human) GO:0005198; GO:0005200; GO:0005829; GO:0005856; GO:0005886; GO:0006887; GO:0006888; GO:0007010; GO:0007165; GO:0008093; GO:0009898; GO:0014731; GO:0016323; GO:0016529; GO:0019899; GO:0019903; GO:0030018; GO:0030507; GO:0030673; GO:0031430; GO:0042383; GO:0043005; GO:0044325; GO:0045199; GO:0045211; GO:0051117; GO:0072659; GO:0170014 cytoskeleton organization [GO:0007010]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; exocytosis [GO:0006887]; maintenance of epithelial cell apical/basal polarity [GO:0045199]; protein localization to plasma membrane [GO:0072659]; signal transduction [GO:0007165] ankyrin-1 complex [GO:0170014]; axolemma [GO:0030673]; basolateral plasma membrane [GO:0016323]; cytoplasmic side of plasma membrane [GO:0009898]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; M band [GO:0031430]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; sarcoplasmic reticulum [GO:0016529]; spectrin-associated cytoskeleton [GO:0014731]; Z disc [GO:0030018] ATPase binding [GO:0051117]; cytoskeletal anchor activity [GO:0008093]; enzyme binding [GO:0019899]; protein phosphatase binding [GO:0019903]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]; structural molecule activity [GO:0005198]; transmembrane transporter binding [GO:0044325] g5054.t1 P16157 27.729 458 2.3599999999999998e-23 111.0 sp|P16157|ANK1_HUMAN Ankyrin-1 OS=Homo sapiens OX=9606 GN=ANK1 PE=1 SV=3 ANK1_HUMAN reviewed Ankyrin-1 (ANK-1) (Ankyrin-R) (Erythrocyte ankyrin) Homo sapiens (Human) GO:0005198; GO:0005200; GO:0005829; GO:0005856; GO:0005886; GO:0006887; GO:0006888; GO:0007010; GO:0007165; GO:0008093; GO:0009898; GO:0014731; GO:0016323; GO:0016529; GO:0019899; GO:0019903; GO:0030018; GO:0030507; GO:0030673; GO:0031430; GO:0042383; GO:0043005; GO:0044325; GO:0045199; GO:0045211; GO:0051117; GO:0072659; GO:0170014 cytoskeleton organization [GO:0007010]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; exocytosis [GO:0006887]; maintenance of epithelial cell apical/basal polarity [GO:0045199]; protein localization to plasma membrane [GO:0072659]; signal transduction [GO:0007165] ankyrin-1 complex [GO:0170014]; axolemma [GO:0030673]; basolateral plasma membrane [GO:0016323]; cytoplasmic side of plasma membrane [GO:0009898]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; M band [GO:0031430]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; sarcoplasmic reticulum [GO:0016529]; spectrin-associated cytoskeleton [GO:0014731]; Z disc [GO:0030018] ATPase binding [GO:0051117]; cytoskeletal anchor activity [GO:0008093]; enzyme binding [GO:0019899]; protein phosphatase binding [GO:0019903]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]; structural molecule activity [GO:0005198]; transmembrane transporter binding [GO:0044325] g5056.t1 Q9I8C7 34.675 323 2.55e-68 227.0 sp|Q9I8C7|ACH10_CHICK Neuronal acetylcholine receptor subunit alpha-10 OS=Gallus gallus OX=9031 GN=CHRNA10 PE=3 SV=1 ACH10_CHICK reviewed Neuronal acetylcholine receptor subunit alpha-10 (Alpha 10 nAChR) (Nicotinic acetylcholine receptor subunit alpha-10) (NACHR alpha-10) Gallus gallus (Chicken) GO:0005231; GO:0005262; GO:0005886; GO:0005892; GO:0007268; GO:0022848; GO:0022850; GO:0034220; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0050910; GO:1902495; GO:1904315 chemical synaptic transmission [GO:0007268]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; monoatomic ion transmembrane transport [GO:0034220]; regulation of membrane potential [GO:0042391] acetylcholine-gated channel complex [GO:0005892]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; transmembrane transporter complex [GO:1902495] acetylcholine-gated monoatomic cation-selective channel activity [GO:0022848]; calcium channel activity [GO:0005262]; excitatory extracellular ligand-gated monoatomic ion channel activity [GO:0005231]; serotonin-gated monoatomic cation channel activity [GO:0022850]; transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315] g5057.t1 Q96LQ0 34.456 386 1.47e-57 198.0 sp|Q96LQ0|PPR36_HUMAN Protein phosphatase 1 regulatory subunit 36 OS=Homo sapiens OX=9606 GN=PPP1R36 PE=1 SV=1 g5058.t1 Q32M08 63.3 297 2.49e-137 397.0 sp|Q32M08|DUS4L_MOUSE tRNA-dihydrouridine(20a/20b) synthase [NAD(P)+]-like OS=Mus musculus OX=10090 GN=Dus4l PE=2 SV=1 g5059.t1 Q8N801 40.952 210 6.11e-36 131.0 sp|Q8N801|STPG4_HUMAN Protein STPG4 OS=Homo sapiens OX=9606 GN=STPG4 PE=1 SV=2 g5060.t1 Q5CB03 55.285 246 8.09e-83 256.0 sp|Q5CB03|B3GA1_CANLF Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 1 OS=Canis lupus familiaris OX=9615 GN=B3GAT1 PE=2 SV=1 B3GA1_CANLF reviewed Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 1 (EC 2.4.1.135) (Beta-1,3-glucuronyltransferase 1) (Glucuronosyltransferase P) (GlcAT-P) (UDP-GlcUA:glycoprotein beta-1,3-glucuronyltransferase) (GlcUAT-P) Canis lupus familiaris (Dog) (Canis familiaris) GO:0000139; GO:0005576; GO:0005789; GO:0005975; GO:0015018; GO:0046872; GO:0050650 carbohydrate metabolic process [GO:0005975]; chondroitin sulfate proteoglycan biosynthetic process [GO:0050650] endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; Golgi membrane [GO:0000139] galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity [GO:0015018]; metal ion binding [GO:0046872] g5061.t1 O35815 47.988 323 1.2799999999999999e-95 290.0 sp|O35815|ATX3_RAT Ataxin-3 OS=Rattus norvegicus OX=10116 GN=Atxn3 PE=1 SV=1 g5062.t1 P51955 48.975 488 9.47e-153 444.0 sp|P51955|NEK2_HUMAN Serine/threonine-protein kinase Nek2 OS=Homo sapiens OX=9606 GN=NEK2 PE=1 SV=1 NEK2_HUMAN reviewed Serine/threonine-protein kinase Nek2 (EC 2.7.11.1) (HSPK 21) (Never in mitosis A-related kinase 2) (NimA-related protein kinase 2) (NimA-like protein kinase 1) Homo sapiens (Human) GO:0000278; GO:0000776; GO:0000794; GO:0000922; GO:0001824; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005813; GO:0005829; GO:0005874; GO:0005886; GO:0005929; GO:0007059; GO:0007088; GO:0019903; GO:0030496; GO:0032206; GO:0032991; GO:0036064; GO:0045171; GO:0046602; GO:0046872; GO:0051225; GO:0051299; GO:0051301; GO:0051321; GO:0051988; GO:0090307; GO:0106310; GO:1903126 blastocyst development [GO:0001824]; cell division [GO:0051301]; centrosome separation [GO:0051299]; chromosome segregation [GO:0007059]; meiotic cell cycle [GO:0051321]; mitotic cell cycle [GO:0000278]; mitotic spindle assembly [GO:0090307]; negative regulation of centriole-centriole cohesion [GO:1903126]; positive regulation of telomere maintenance [GO:0032206]; regulation of attachment of spindle microtubules to kinetochore [GO:0051988]; regulation of mitotic centrosome separation [GO:0046602]; regulation of mitotic nuclear division [GO:0007088]; spindle assembly [GO:0051225] centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; condensed nuclear chromosome [GO:0000794]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intercellular bridge [GO:0045171]; kinetochore [GO:0000776]; microtubule [GO:0005874]; midbody [GO:0030496]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; spindle pole [GO:0000922] ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein phosphatase binding [GO:0019903]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g5065.t1 O46606 41.433 712 6.25e-174 524.0 sp|O46606|DDHD1_BOVIN Phospholipase DDHD1 OS=Bos taurus OX=9913 GN=DDHD1 PE=1 SV=1 g5067.t1 Q5R806 49.565 345 3.5800000000000003e-103 309.0 sp|Q5R806|PTGR2_PONAB Prostaglandin reductase 2 OS=Pongo abelii OX=9601 GN=PTGR2 PE=2 SV=2 PTGR2_PONAB reviewed Prostaglandin reductase 2 (PRG-2) (EC 1.3.1.48) (15-oxoprostaglandin 13-reductase) Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0005737; GO:0006693; GO:0047522 prostaglandin metabolic process [GO:0006693] cytoplasm [GO:0005737] 15-oxoprostaglandin 13-reductase [NAD(P)+] activity [GO:0047522] g5070.t1 Q1L9A2 42.857 147 2.26e-40 136.0 sp|Q1L9A2|OPA3_DANRE Optic atrophy 3 protein homolog OS=Danio rerio OX=7955 GN=opa3 PE=3 SV=1 OPA3_DANRE reviewed Optic atrophy 3 protein homolog Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005739; GO:0007626; GO:0019216; GO:0031413; GO:0050881 locomotory behavior [GO:0007626]; musculoskeletal movement [GO:0050881]; regulation of buoyancy [GO:0031413]; regulation of lipid metabolic process [GO:0019216] mitochondrion [GO:0005739] g5071.t1 Q9Y6R9 46.853 286 1.01e-69 235.0 sp|Q9Y6R9|CCD61_HUMAN Centrosomal protein CCDC61 OS=Homo sapiens OX=9606 GN=CCDC61 PE=1 SV=3 CCD61_HUMAN reviewed Centrosomal protein CCDC61 (Coiled-coil domain-containing protein 61) (VFL3 homolog) Homo sapiens (Human) GO:0005813; GO:0005815; GO:0008017; GO:0030030; GO:0034451; GO:0036064; GO:0042802; GO:0090307; GO:0098534; GO:0120103 cell projection organization [GO:0030030]; centriole assembly [GO:0098534]; mitotic spindle assembly [GO:0090307] centriolar satellite [GO:0034451]; centriolar subdistal appendage [GO:0120103]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; microtubule organizing center [GO:0005815] identical protein binding [GO:0042802]; microtubule binding [GO:0008017] g5072.t1 P70627 45.248 705 0.0 585.0 sp|P70627|FOLH1_RAT Glutamate carboxypeptidase 2 OS=Rattus norvegicus OX=10116 GN=Folh1 PE=1 SV=1 g5073.t1 Q0Z7W6 47.531 162 3.1099999999999996e-52 171.0 sp|Q0Z7W6|TMX1_BOVIN Thioredoxin-related transmembrane protein 1 OS=Bos taurus OX=9913 GN=TMX1 PE=2 SV=1 TMX1_BOVIN reviewed Thioredoxin-related transmembrane protein 1 (Protein disulfide-isomerase TMX1) (EC 5.3.4.1) (Thioredoxin domain-containing protein 1) Bos taurus (Bovine) GO:0003756; GO:0004857; GO:0005576; GO:0005789; GO:0010868; GO:0012505; GO:0015035; GO:0015036; GO:0019432; GO:0031966; GO:0034976; GO:0044233; GO:0051924; GO:0090331; GO:1904294 negative regulation of platelet aggregation [GO:0090331]; negative regulation of triglyceride biosynthetic process [GO:0010868]; positive regulation of ERAD pathway [GO:1904294]; regulation of calcium ion transport [GO:0051924]; response to endoplasmic reticulum stress [GO:0034976]; triglyceride biosynthetic process [GO:0019432] endomembrane system [GO:0012505]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; mitochondria-associated endoplasmic reticulum membrane contact site [GO:0044233]; mitochondrial membrane [GO:0031966] disulfide oxidoreductase activity [GO:0015036]; enzyme inhibitor activity [GO:0004857]; protein disulfide isomerase activity [GO:0003756]; protein-disulfide reductase activity [GO:0015035] g5077.t1 Q8NDG6 40.869 1358 0.0 979.0 sp|Q8NDG6|TDRD9_HUMAN ATP-dependent RNA helicase TDRD9 OS=Homo sapiens OX=9606 GN=TDRD9 PE=1 SV=3 TDRD9_HUMAN reviewed ATP-dependent RNA helicase TDRD9 (EC 3.6.4.13) (Tudor domain-containing protein 9) Homo sapiens (Human) GO:0003723; GO:0003724; GO:0004386; GO:0005524; GO:0005634; GO:0005737; GO:0007140; GO:0007141; GO:0007283; GO:0009566; GO:0016887; GO:0030154; GO:0034587; GO:0071547; GO:0141006; GO:0141196 cell differentiation [GO:0030154]; fertilization [GO:0009566]; male meiosis I [GO:0007141]; male meiotic nuclear division [GO:0007140]; piRNA processing [GO:0034587]; spermatogenesis [GO:0007283]; transposable element silencing by piRNA-mediated DNA methylation [GO:0141196]; transposable element silencing by piRNA-mediated heterochromatin formation [GO:0141006] cytoplasm [GO:0005737]; nucleus [GO:0005634]; piP-body [GO:0071547] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; helicase activity [GO:0004386]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724] g5078.t1 Q8WXD5 39.623 159 9.090000000000001e-32 115.0 sp|Q8WXD5|GEMI6_HUMAN Gem-associated protein 6 OS=Homo sapiens OX=9606 GN=GEMIN6 PE=1 SV=1 GEMI6_HUMAN reviewed Gem-associated protein 6 (Gemin-6) (SIP2) Homo sapiens (Human) GO:0000245; GO:0000387; GO:0000398; GO:0003723; GO:0005654; GO:0005737; GO:0005829; GO:0016604; GO:0032797; GO:0034719; GO:0097504 mRNA splicing, via spliceosome [GO:0000398]; spliceosomal complex assembly [GO:0000245]; spliceosomal snRNP assembly [GO:0000387] cytoplasm [GO:0005737]; cytosol [GO:0005829]; Gemini of Cajal bodies [GO:0097504]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; SMN complex [GO:0032797]; SMN-Sm protein complex [GO:0034719] RNA binding [GO:0003723] g5079.t1 Q6P158 50.226 1326 0.0 1151.0 sp|Q6P158|DHX57_HUMAN Putative ATP-dependent RNA helicase DHX57 OS=Homo sapiens OX=9606 GN=DHX57 PE=1 SV=2 DHX57_HUMAN reviewed Putative ATP-dependent RNA helicase DHX57 (EC 3.6.4.13) (DEAH box protein 57) Homo sapiens (Human) GO:0003723; GO:0003724; GO:0004386; GO:0005524; GO:0008270; GO:0016887; GO:0045727; GO:0070063 positive regulation of translation [GO:0045727] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; helicase activity [GO:0004386]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; RNA polymerase binding [GO:0070063]; zinc ion binding [GO:0008270] g5080.t1 Q5RD94 54.0 150 2.36e-47 159.0 sp|Q5RD94|MED6_PONAB Mediator of RNA polymerase II transcription subunit 6 OS=Pongo abelii OX=9601 GN=MED6 PE=2 SV=1 MED6_PONAB reviewed Mediator of RNA polymerase II transcription subunit 6 (Mediator complex subunit 6) Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0003712; GO:0005654; GO:0006357; GO:0016592 regulation of transcription by RNA polymerase II [GO:0006357] mediator complex [GO:0016592]; nucleoplasm [GO:0005654] transcription coregulator activity [GO:0003712] g5083.t1 Q8R4P9 62.5 88 4.45e-31 119.0 sp|Q8R4P9|MRP7_MOUSE ATP-binding cassette sub-family C member 10 OS=Mus musculus OX=10090 GN=Abcc10 PE=1 SV=1 MRP7_MOUSE reviewed ATP-binding cassette sub-family C member 10 (EC 7.6.2.2) (EC 7.6.2.3) (Multidrug resistance-associated protein 7) Mus musculus (Mouse) GO:0005524; GO:0005886; GO:0006691; GO:0006869; GO:0008559; GO:0009925; GO:0015431; GO:0015711; GO:0016323; GO:0016887; GO:0055085; GO:0071716; GO:0140359 leukotriene metabolic process [GO:0006691]; leukotriene transport [GO:0071716]; lipid transport [GO:0006869]; organic anion transport [GO:0015711]; transmembrane transport [GO:0055085] basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; plasma membrane [GO:0005886] ABC-type glutathione S-conjugate transporter activity [GO:0015431]; ABC-type transporter activity [GO:0140359]; ABC-type xenobiotic transporter activity [GO:0008559]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887] g5085.t1 Q8R4P9 57.756 303 7.96e-106 341.0 sp|Q8R4P9|MRP7_MOUSE ATP-binding cassette sub-family C member 10 OS=Mus musculus OX=10090 GN=Abcc10 PE=1 SV=1 MRP7_MOUSE reviewed ATP-binding cassette sub-family C member 10 (EC 7.6.2.2) (EC 7.6.2.3) (Multidrug resistance-associated protein 7) Mus musculus (Mouse) GO:0005524; GO:0005886; GO:0006691; GO:0006869; GO:0008559; GO:0009925; GO:0015431; GO:0015711; GO:0016323; GO:0016887; GO:0055085; GO:0071716; GO:0140359 leukotriene metabolic process [GO:0006691]; leukotriene transport [GO:0071716]; lipid transport [GO:0006869]; organic anion transport [GO:0015711]; transmembrane transport [GO:0055085] basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; plasma membrane [GO:0005886] ABC-type glutathione S-conjugate transporter activity [GO:0015431]; ABC-type transporter activity [GO:0140359]; ABC-type xenobiotic transporter activity [GO:0008559]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887] g5086.t1 Q5T3U5 45.678 856 0.0 676.0 sp|Q5T3U5|MRP7_HUMAN ATP-binding cassette sub-family C member 10 OS=Homo sapiens OX=9606 GN=ABCC10 PE=1 SV=1 MRP7_HUMAN reviewed ATP-binding cassette sub-family C member 10 (EC 7.6.2.2) (EC 7.6.2.3) (Multidrug resistance-associated protein 7) Homo sapiens (Human) GO:0005524; GO:0005765; GO:0005886; GO:0006691; GO:0006869; GO:0008559; GO:0009925; GO:0015431; GO:0015711; GO:0016323; GO:0016887; GO:0043225; GO:0055085; GO:0071716; GO:0140359 leukotriene metabolic process [GO:0006691]; leukotriene transport [GO:0071716]; lipid transport [GO:0006869]; organic anion transport [GO:0015711]; transmembrane transport [GO:0055085] basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886] ABC-type glutathione S-conjugate transporter activity [GO:0015431]; ABC-type transporter activity [GO:0140359]; ABC-type xenobiotic transporter activity [GO:0008559]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled inorganic anion transmembrane transporter activity [GO:0043225] g5088.t1 P29147 45.833 264 1.08e-80 254.0 sp|P29147|BDH_RAT D-beta-hydroxybutyrate dehydrogenase, mitochondrial OS=Rattus norvegicus OX=10116 GN=Bdh1 PE=1 SV=2 BDH_RAT reviewed D-beta-hydroxybutyrate dehydrogenase, mitochondrial (EC 1.1.1.30) (3-hydroxybutyrate dehydrogenase) (BDH) Rattus norvegicus (Rat) GO:0001889; GO:0003858; GO:0005543; GO:0005739; GO:0005743; GO:0005759; GO:0007584; GO:0008202; GO:0009410; GO:0009636; GO:0009725; GO:0032355; GO:0032868; GO:0042594; GO:0045471; GO:0046686; GO:0051412; GO:0060416; GO:0060612; GO:0099617 adipose tissue development [GO:0060612]; liver development [GO:0001889]; response to cadmium ion [GO:0046686]; response to corticosterone [GO:0051412]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to growth hormone [GO:0060416]; response to hormone [GO:0009725]; response to insulin [GO:0032868]; response to nutrient [GO:0007584]; response to starvation [GO:0042594]; response to toxic substance [GO:0009636]; response to xenobiotic stimulus [GO:0009410]; steroid metabolic process [GO:0008202] matrix side of mitochondrial inner membrane [GO:0099617]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] 3-hydroxybutyrate dehydrogenase activity [GO:0003858]; phospholipid binding [GO:0005543] g5092.t1 Q7T2B0 42.127 724 2.91e-171 512.0 sp|Q7T2B0|CTL4_DANRE Choline transporter-like protein 4 OS=Danio rerio OX=7955 GN=slc44a4 PE=2 SV=1 CTL4_DANRE reviewed Choline transporter-like protein 4 (Solute carrier family 44 member 4) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005886; GO:0008292; GO:0015220; GO:0015297; GO:0015871; GO:0016324; GO:0030307; GO:0030974; GO:0032475; GO:0035675; GO:0048840; GO:0061526; GO:0090422 acetylcholine biosynthetic process [GO:0008292]; acetylcholine secretion [GO:0061526]; choline transport [GO:0015871]; neuromast hair cell development [GO:0035675]; otolith development [GO:0048840]; otolith formation [GO:0032475]; positive regulation of cell growth [GO:0030307]; thiamine pyrophosphate transmembrane transport [GO:0030974] apical plasma membrane [GO:0016324]; plasma membrane [GO:0005886] antiporter activity [GO:0015297]; choline transmembrane transporter activity [GO:0015220]; thiamine pyrophosphate transmembrane transporter activity [GO:0090422] g5093.t1 Q8K212 41.076 409 1.3599999999999998e-91 312.0 sp|Q8K212|PACS1_MOUSE Phosphofurin acidic cluster sorting protein 1 OS=Mus musculus OX=10090 GN=Pacs1 PE=1 SV=2 PACS1_MOUSE reviewed Phosphofurin acidic cluster sorting protein 1 (PACS-1) Mus musculus (Mouse) GO:0002260; GO:0005794; GO:0030137; GO:0034067; GO:0044325; GO:0048471; GO:0072659 lymphocyte homeostasis [GO:0002260]; protein localization to Golgi apparatus [GO:0034067]; protein localization to plasma membrane [GO:0072659] COPI-coated vesicle [GO:0030137]; Golgi apparatus [GO:0005794]; perinuclear region of cytoplasm [GO:0048471] transmembrane transporter binding [GO:0044325] g5093.t1 Q8K212 55.159 252 2.67e-57 215.0 sp|Q8K212|PACS1_MOUSE Phosphofurin acidic cluster sorting protein 1 OS=Mus musculus OX=10090 GN=Pacs1 PE=1 SV=2 PACS1_MOUSE reviewed Phosphofurin acidic cluster sorting protein 1 (PACS-1) Mus musculus (Mouse) GO:0002260; GO:0005794; GO:0030137; GO:0034067; GO:0044325; GO:0048471; GO:0072659 lymphocyte homeostasis [GO:0002260]; protein localization to Golgi apparatus [GO:0034067]; protein localization to plasma membrane [GO:0072659] COPI-coated vesicle [GO:0030137]; Golgi apparatus [GO:0005794]; perinuclear region of cytoplasm [GO:0048471] transmembrane transporter binding [GO:0044325] g5093.t2 Q8K212 41.076 409 1.56e-91 312.0 sp|Q8K212|PACS1_MOUSE Phosphofurin acidic cluster sorting protein 1 OS=Mus musculus OX=10090 GN=Pacs1 PE=1 SV=2 PACS1_MOUSE reviewed Phosphofurin acidic cluster sorting protein 1 (PACS-1) Mus musculus (Mouse) GO:0002260; GO:0005794; GO:0030137; GO:0034067; GO:0044325; GO:0048471; GO:0072659 lymphocyte homeostasis [GO:0002260]; protein localization to Golgi apparatus [GO:0034067]; protein localization to plasma membrane [GO:0072659] COPI-coated vesicle [GO:0030137]; Golgi apparatus [GO:0005794]; perinuclear region of cytoplasm [GO:0048471] transmembrane transporter binding [GO:0044325] g5093.t2 Q8K212 56.048 248 7.67e-59 220.0 sp|Q8K212|PACS1_MOUSE Phosphofurin acidic cluster sorting protein 1 OS=Mus musculus OX=10090 GN=Pacs1 PE=1 SV=2 PACS1_MOUSE reviewed Phosphofurin acidic cluster sorting protein 1 (PACS-1) Mus musculus (Mouse) GO:0002260; GO:0005794; GO:0030137; GO:0034067; GO:0044325; GO:0048471; GO:0072659 lymphocyte homeostasis [GO:0002260]; protein localization to Golgi apparatus [GO:0034067]; protein localization to plasma membrane [GO:0072659] COPI-coated vesicle [GO:0030137]; Golgi apparatus [GO:0005794]; perinuclear region of cytoplasm [GO:0048471] transmembrane transporter binding [GO:0044325] g5093.t3 Q8K212 41.076 409 1.79e-91 312.0 sp|Q8K212|PACS1_MOUSE Phosphofurin acidic cluster sorting protein 1 OS=Mus musculus OX=10090 GN=Pacs1 PE=1 SV=2 PACS1_MOUSE reviewed Phosphofurin acidic cluster sorting protein 1 (PACS-1) Mus musculus (Mouse) GO:0002260; GO:0005794; GO:0030137; GO:0034067; GO:0044325; GO:0048471; GO:0072659 lymphocyte homeostasis [GO:0002260]; protein localization to Golgi apparatus [GO:0034067]; protein localization to plasma membrane [GO:0072659] COPI-coated vesicle [GO:0030137]; Golgi apparatus [GO:0005794]; perinuclear region of cytoplasm [GO:0048471] transmembrane transporter binding [GO:0044325] g5093.t3 Q8K212 53.668 259 8.42e-57 214.0 sp|Q8K212|PACS1_MOUSE Phosphofurin acidic cluster sorting protein 1 OS=Mus musculus OX=10090 GN=Pacs1 PE=1 SV=2 PACS1_MOUSE reviewed Phosphofurin acidic cluster sorting protein 1 (PACS-1) Mus musculus (Mouse) GO:0002260; GO:0005794; GO:0030137; GO:0034067; GO:0044325; GO:0048471; GO:0072659 lymphocyte homeostasis [GO:0002260]; protein localization to Golgi apparatus [GO:0034067]; protein localization to plasma membrane [GO:0072659] COPI-coated vesicle [GO:0030137]; Golgi apparatus [GO:0005794]; perinuclear region of cytoplasm [GO:0048471] transmembrane transporter binding [GO:0044325] g5096.t1 Q28C74 34.396 878 3.39e-165 496.0 sp|Q28C74|LPPRC_XENTR Leucine-rich PPR motif-containing protein, mitochondrial OS=Xenopus tropicalis OX=8364 GN=lrpprc PE=2 SV=1 g5096.t1 Q28C74 63.636 77 3.39e-165 109.0 sp|Q28C74|LPPRC_XENTR Leucine-rich PPR motif-containing protein, mitochondrial OS=Xenopus tropicalis OX=8364 GN=lrpprc PE=2 SV=1 g5097.t1 Q98KK0 29.38 371 2.23e-49 174.0 sp|Q98KK0|BODG_RHILO Probable gamma-butyrobetaine dioxygenase OS=Mesorhizobium japonicum (strain LMG 29417 / CECT 9101 / MAFF 303099) OX=266835 GN=mll1440 PE=3 SV=1 g5098.t1 Q86VK4 63.924 158 1.91e-69 236.0 sp|Q86VK4|ZN410_HUMAN Zinc finger protein 410 OS=Homo sapiens OX=9606 GN=ZNF410 PE=1 SV=2 ZN410_HUMAN reviewed Zinc finger protein 410 (Another partner for ARF 1) Homo sapiens (Human) GO:0000978; GO:0003700; GO:0003712; GO:0005634; GO:0005694; GO:0006357; GO:0008270; GO:0010629; GO:0045944; GO:1990837 negative regulation of gene expression [GO:0010629]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357] chromosome [GO:0005694]; nucleus [GO:0005634] DNA-binding transcription factor activity [GO:0003700]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription coregulator activity [GO:0003712]; zinc ion binding [GO:0008270] g5102.t1 O88466 31.622 370 3.22e-44 181.0 sp|O88466|ZN106_MOUSE Zinc finger protein 106 OS=Mus musculus OX=10090 GN=Znf106 PE=1 SV=3 ZN106_MOUSE reviewed Zinc finger protein 106 (Zfp-106) (H3a minor histocompatibility antigen) (Son of insulin receptor mutant) (Zinc finger protein 474) Mus musculus (Mouse) GO:0003723; GO:0005730; GO:0005829; GO:0008270; GO:0008286; GO:0016020; GO:0016607; GO:0017124 insulin receptor signaling pathway [GO:0008286] cytosol [GO:0005829]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleolus [GO:0005730] RNA binding [GO:0003723]; SH3 domain binding [GO:0017124]; zinc ion binding [GO:0008270] g5104.t1 O60306 61.818 110 1.36e-41 149.0 sp|O60306|AQR_HUMAN RNA helicase aquarius OS=Homo sapiens OX=9606 GN=AQR PE=1 SV=4 AQR_HUMAN reviewed RNA helicase aquarius (EC 3.6.4.13) (Intron-binding protein of 160 kDa) (IBP160) Homo sapiens (Human) GO:0000398; GO:0003723; GO:0003727; GO:0003729; GO:0005524; GO:0005634; GO:0005654; GO:0016020; GO:0016887; GO:0034458; GO:0071007; GO:0071013 mRNA splicing, via spliceosome [GO:0000398] catalytic step 2 spliceosome [GO:0071013]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U2-type catalytic step 2 spliceosome [GO:0071007] 3'-5' RNA helicase activity [GO:0034458]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; single-stranded RNA binding [GO:0003727] g5105.t1 O60306 74.51 1224 0.0 1853.0 sp|O60306|AQR_HUMAN RNA helicase aquarius OS=Homo sapiens OX=9606 GN=AQR PE=1 SV=4 AQR_HUMAN reviewed RNA helicase aquarius (EC 3.6.4.13) (Intron-binding protein of 160 kDa) (IBP160) Homo sapiens (Human) GO:0000398; GO:0003723; GO:0003727; GO:0003729; GO:0005524; GO:0005634; GO:0005654; GO:0016020; GO:0016887; GO:0034458; GO:0071007; GO:0071013 mRNA splicing, via spliceosome [GO:0000398] catalytic step 2 spliceosome [GO:0071013]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U2-type catalytic step 2 spliceosome [GO:0071007] 3'-5' RNA helicase activity [GO:0034458]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; single-stranded RNA binding [GO:0003727] g5108.t1 Q7M3K2 25.287 522 1.96e-39 160.0 sp|Q7M3K2|PELET_DROME Transposable element P transposase OS=Drosophila melanogaster OX=7227 GN=T PE=1 SV=2 g5109.t1 Q9D0V8 36.19 210 3.35e-40 141.0 sp|Q9D0V8|CINP_MOUSE Cyclin-dependent kinase 2-interacting protein OS=Mus musculus OX=10090 GN=Cinp PE=2 SV=1 g5111.t1 Q7ZWG6 25.607 453 1.53e-23 106.0 sp|Q7ZWG6|PCFT_DANRE Proton-coupled folate transporter OS=Danio rerio OX=7955 GN=slc46a1 PE=2 SV=1 PCFT_DANRE reviewed Proton-coupled folate transporter (Solute carrier family 46 member 1) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005542; GO:0005768; GO:0005886; GO:0010008; GO:0015293; GO:0015350; GO:0016323; GO:0016324; GO:0022857; GO:0055085 transmembrane transport [GO:0055085] apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; endosome [GO:0005768]; endosome membrane [GO:0010008]; plasma membrane [GO:0005886] folic acid binding [GO:0005542]; methotrexate transmembrane transporter activity [GO:0015350]; symporter activity [GO:0015293]; transmembrane transporter activity [GO:0022857] g5113.t1 A0JNI5 55.46 348 3.49e-80 270.0 sp|A0JNI5|CLASR_BOVIN CLK4-associating serine/arginine rich protein OS=Bos taurus OX=9913 GN=CLASRP PE=2 SV=1 CLASR_BOVIN reviewed CLK4-associating serine/arginine rich protein (Splicing factor, arginine/serine-rich 16) Bos taurus (Bovine) GO:0005634; GO:0006397; GO:0008380 mRNA processing [GO:0006397]; RNA splicing [GO:0008380] nucleus [GO:0005634] g5115.t1 Q61321 61.429 210 1.87e-87 288.0 sp|Q61321|SIX4_MOUSE Homeobox protein SIX4 OS=Mus musculus OX=10090 GN=Six4 PE=1 SV=1 SIX4_MOUSE reviewed Homeobox protein SIX4 (Sine oculis homeobox homolog 4) (Skeletal muscle-specific ARE-binding protein AREC3) Mus musculus (Mouse) GO:0000978; GO:0000981; GO:0001228; GO:0003677; GO:0003700; GO:0005634; GO:0005667; GO:0005737; GO:0006357; GO:0007519; GO:0008582; GO:0008584; GO:0010468; GO:0030238; GO:0030910; GO:0032880; GO:0034504; GO:0042472; GO:0043066; GO:0043524; GO:0043565; GO:0043586; GO:0045214; GO:0045892; GO:0045893; GO:0045944; GO:0046661; GO:0048538; GO:0048699; GO:0048701; GO:0048704; GO:0050678; GO:0051451; GO:0060037; GO:0061055; GO:0061197; GO:0061551; GO:0072075; GO:0072095; GO:0072107; GO:0090190; GO:0098528; GO:1902725; GO:1990837 embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic skeletal system morphogenesis [GO:0048704]; fungiform papilla morphogenesis [GO:0061197]; generation of neurons [GO:0048699]; inner ear morphogenesis [GO:0042472]; male gonad development [GO:0008584]; male sex determination [GO:0030238]; male sex differentiation [GO:0046661]; metanephric mesenchyme development [GO:0072075]; myoblast migration [GO:0051451]; myotome development [GO:0061055]; negative regulation of apoptotic process [GO:0043066]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of satellite cell differentiation [GO:1902725]; olfactory placode formation [GO:0030910]; pharyngeal system development [GO:0060037]; positive regulation of branching involved in ureteric bud morphogenesis [GO:0090190]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of ureteric bud formation [GO:0072107]; protein localization to nucleus [GO:0034504]; regulation of branch elongation involved in ureteric bud branching [GO:0072095]; regulation of epithelial cell proliferation [GO:0050678]; regulation of gene expression [GO:0010468]; regulation of protein localization [GO:0032880]; regulation of synaptic assembly at neuromuscular junction [GO:0008582]; regulation of transcription by RNA polymerase II [GO:0006357]; sarcomere organization [GO:0045214]; skeletal muscle fiber differentiation [GO:0098528]; skeletal muscle tissue development [GO:0007519]; thymus development [GO:0048538]; tongue development [GO:0043586]; trigeminal ganglion development [GO:0061551] cytoplasm [GO:0005737]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667] DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837] g5117.t1 Q6NZ04 65.798 307 4.72e-127 367.0 sp|Q6NZ04|SIX1B_DANRE Homeobox protein six1b OS=Danio rerio OX=7955 GN=six1b PE=1 SV=1 SIX1B_DANRE reviewed Homeobox protein six1b (Homeobox protein six1a) (Sine oculis homeobox homolog 1a) (Sine oculis homeobox homolog 1b) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000978; GO:0000981; GO:0002074; GO:0005634; GO:0005667; GO:0005737; GO:0006357; GO:0006915; GO:0014857; GO:0021984; GO:0043282; GO:0048741; GO:0048839; GO:0048935; GO:0051146 adenohypophysis development [GO:0021984]; apoptotic process [GO:0006915]; chordate pharyngeal muscle development [GO:0043282]; extraocular skeletal muscle development [GO:0002074]; inner ear development [GO:0048839]; peripheral nervous system neuron development [GO:0048935]; regulation of skeletal muscle cell proliferation [GO:0014857]; regulation of transcription by RNA polymerase II [GO:0006357]; skeletal muscle fiber development [GO:0048741]; striated muscle cell differentiation [GO:0051146] cytoplasm [GO:0005737]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667] DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978] g5122.t1 O95475 90.11 182 3.14e-116 337.0 sp|O95475|SIX6_HUMAN Homeobox protein SIX6 OS=Homo sapiens OX=9606 GN=SIX6 PE=1 SV=2 SIX6_HUMAN reviewed Homeobox protein SIX6 (Homeodomain protein OPTX2) (Optic homeobox 2) (Sine oculis homeobox homolog 6) Homo sapiens (Human) GO:0000785; GO:0000978; GO:0000981; GO:0001654; GO:0005634; GO:0005667; GO:0006357; GO:0007601; GO:0009887; GO:1990837 animal organ morphogenesis [GO:0009887]; eye development [GO:0001654]; regulation of transcription by RNA polymerase II [GO:0006357]; visual perception [GO:0007601] chromatin [GO:0000785]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667] DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837] g5128.t1 Q9H165 79.381 97 1.84e-44 166.0 sp|Q9H165|BC11A_HUMAN BCL11 transcription factor A OS=Homo sapiens OX=9606 GN=BCL11A PE=1 SV=2 BC11A_HUMAN reviewed BCL11 transcription factor A (B-cell CLL/lymphoma 11A) (B-cell lymphoma/leukemia 11A) (BCL-11A) (COUP-TF-interacting protein 1) (Ecotropic viral integration site 9 protein homolog) (EVI-9) (Zinc finger protein 856) Homo sapiens (Human) GO:0000122; GO:0000978; GO:0001067; GO:0001227; GO:0003700; GO:0003712; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006357; GO:0008270; GO:0010628; GO:0010976; GO:0010977; GO:0016363; GO:0016514; GO:0016925; GO:0019901; GO:0030517; GO:0032463; GO:0042382; GO:0042803; GO:0045944; GO:0046982; GO:0048671; GO:0048672; GO:0050773; GO:0098794; GO:0140297; GO:1903860; GO:1904800; GO:1905232; GO:2000171; GO:2000173 cellular response to L-glutamate [GO:1905232]; negative regulation of axon extension [GO:0030517]; negative regulation of branching morphogenesis of a nerve [GO:2000173]; negative regulation of collateral sprouting [GO:0048671]; negative regulation of dendrite development [GO:2000171]; negative regulation of dendrite extension [GO:1903860]; negative regulation of neuron projection development [GO:0010977]; negative regulation of neuron remodeling [GO:1904800]; negative regulation of protein homooligomerization [GO:0032463]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of collateral sprouting [GO:0048672]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron projection development [GO:0010976]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein sumoylation [GO:0016925]; regulation of dendrite development [GO:0050773]; regulation of transcription by RNA polymerase II [GO:0006357] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; paraspeckles [GO:0042382]; postsynapse [GO:0098794]; SWI/SNF complex [GO:0016514] DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor binding [GO:0140297]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription coregulator activity [GO:0003712]; transcription regulatory region nucleic acid binding [GO:0001067]; zinc ion binding [GO:0008270] g5135.t1 A2ARS0 39.024 164 5.81e-33 132.0 sp|A2ARS0|ANR63_MOUSE Ankyrin repeat domain-containing protein 63 OS=Mus musculus OX=10090 GN=Ankrd63 PE=1 SV=1 g5138.t1 Q6ZUK4 35.03 334 3.44e-43 156.0 sp|Q6ZUK4|TMM26_HUMAN Transmembrane protein 26 OS=Homo sapiens OX=9606 GN=TMEM26 PE=1 SV=1 g5139.t1 Q5SP90 64.382 744 0.0 982.0 sp|Q5SP90|PP4R3_DANRE Serine/threonine-protein phosphatase 4 regulatory subunit 3 OS=Danio rerio OX=7955 GN=smek1 PE=1 SV=1 g5139.t2 Q5SP90 64.382 744 0.0 982.0 sp|Q5SP90|PP4R3_DANRE Serine/threonine-protein phosphatase 4 regulatory subunit 3 OS=Danio rerio OX=7955 GN=smek1 PE=1 SV=1 g5139.t3 Q5SP90 64.161 745 0.0 978.0 sp|Q5SP90|PP4R3_DANRE Serine/threonine-protein phosphatase 4 regulatory subunit 3 OS=Danio rerio OX=7955 GN=smek1 PE=1 SV=1 g5140.t1 Q8C6E0 30.37 405 5.480000000000001e-43 157.0 sp|Q8C6E0|CFA36_MOUSE Cilia- and flagella-associated protein 36 OS=Mus musculus OX=10090 GN=Cfap36 PE=1 SV=1 g5140.t2 Q28IH8 38.889 180 1e-38 145.0 sp|Q28IH8|CFA36_XENTR Cilia- and flagella-associated protein 36 OS=Xenopus tropicalis OX=8364 GN=cfap36 PE=2 SV=2 g5140.t3 Q8C6E0 31.51 384 3.25e-45 162.0 sp|Q8C6E0|CFA36_MOUSE Cilia- and flagella-associated protein 36 OS=Mus musculus OX=10090 GN=Cfap36 PE=1 SV=1 g5142.t1 C0Q7V5 46.26 361 9.27e-114 339.0 sp|C0Q7V5|PHNW_SALPC 2-aminoethylphosphonate--pyruvate transaminase OS=Salmonella paratyphi C (strain RKS4594) OX=476213 GN=phnW PE=3 SV=1 g5142.t2 C0Q7V5 46.26 361 8.4e-112 335.0 sp|C0Q7V5|PHNW_SALPC 2-aminoethylphosphonate--pyruvate transaminase OS=Salmonella paratyphi C (strain RKS4594) OX=476213 GN=phnW PE=3 SV=1 g5143.t1 P25788 74.39 246 1.74e-135 385.0 sp|P25788|PSA3_HUMAN Proteasome subunit alpha type-3 OS=Homo sapiens OX=9606 GN=PSMA3 PE=1 SV=2 PSA3_HUMAN reviewed Proteasome subunit alpha type-3 (Macropain subunit C8) (Multicatalytic endopeptidase complex subunit C8) (Proteasome component C8) (Proteasome subunit alpha-7) (alpha-7) Homo sapiens (Human) GO:0000502; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005839; GO:0019773; GO:0031625; GO:0043161; GO:0070062 proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; proteasome core complex [GO:0005839]; proteasome core complex, alpha-subunit complex [GO:0019773] ubiquitin protein ligase binding [GO:0031625] g5145.t1 Q6ZNE5 39.186 393 3.15e-71 238.0 sp|Q6ZNE5|BAKOR_HUMAN Beclin 1-associated autophagy-related key regulator OS=Homo sapiens OX=9606 GN=ATG14 PE=1 SV=1 BAKOR_HUMAN reviewed Beclin 1-associated autophagy-related key regulator (Barkor) (Autophagy-related protein 14-like protein) (Atg14L) Homo sapiens (Human) GO:0000045; GO:0000407; GO:0000421; GO:0000423; GO:0001933; GO:0001934; GO:0005776; GO:0005789; GO:0005829; GO:0005930; GO:0006622; GO:0008333; GO:0009267; GO:0010608; GO:0016236; GO:0016240; GO:0016241; GO:0034045; GO:0035014; GO:0035032; GO:0036092; GO:0042149; GO:0043491; GO:0043495; GO:0044233; GO:0045022; GO:0045087; GO:0045335; GO:0051020; GO:0051607; GO:0061635; GO:0090207; GO:0097352; GO:0097629; GO:0097632; GO:0098780; GO:0141039 autophagosome assembly [GO:0000045]; autophagosome maturation [GO:0097352]; autophagosome membrane docking [GO:0016240]; cellular response to glucose starvation [GO:0042149]; cellular response to starvation [GO:0009267]; defense response to virus [GO:0051607]; early endosome to late endosome transport [GO:0045022]; endosome to lysosome transport [GO:0008333]; innate immune response [GO:0045087]; macroautophagy [GO:0016236]; mitophagy [GO:0000423]; negative regulation of protein phosphorylation [GO:0001933]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; phosphatidylinositol-3-phosphate biosynthetic process [GO:0036092]; positive regulation of protein phosphorylation [GO:0001934]; post-transcriptional regulation of gene expression [GO:0010608]; protein targeting to lysosome [GO:0006622]; regulation of macroautophagy [GO:0016241]; regulation of protein complex stability [GO:0061635]; regulation of triglyceride metabolic process [GO:0090207]; response to mitochondrial depolarisation [GO:0098780] autophagosome [GO:0005776]; autophagosome membrane [GO:0000421]; axoneme [GO:0005930]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; extrinsic component of omegasome membrane [GO:0097629]; extrinsic component of phagophore assembly site membrane [GO:0097632]; mitochondria-associated endoplasmic reticulum membrane contact site [GO:0044233]; phagocytic vesicle [GO:0045335]; phagophore assembly site [GO:0000407]; phagophore assembly site membrane [GO:0034045]; phosphatidylinositol 3-kinase complex, class III [GO:0035032] GTPase binding [GO:0051020]; phosphatidylinositol 3-kinase inhibitor activity [GO:0141039]; phosphatidylinositol 3-kinase regulator activity [GO:0035014]; protein-membrane adaptor activity [GO:0043495] g5146.t1 Q7ZW41 90.698 172 1.95e-114 325.0 sp|Q7ZW41|RPB7_DANRE DNA-directed RNA polymerase II subunit RPB7 OS=Danio rerio OX=7955 GN=polr2g PE=2 SV=1 RPB7_DANRE reviewed DNA-directed RNA polymerase II subunit RPB7 (RNA polymerase II subunit B7) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000932; GO:0000956; GO:0003697; GO:0003727; GO:0005634; GO:0005665; GO:0006366; GO:0006367; GO:0031369; GO:0045948; GO:0060213 nuclear-transcribed mRNA catabolic process [GO:0000956]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; positive regulation of translational initiation [GO:0045948]; transcription by RNA polymerase II [GO:0006366]; transcription initiation at RNA polymerase II promoter [GO:0006367] nucleus [GO:0005634]; P-body [GO:0000932]; RNA polymerase II, core complex [GO:0005665] single-stranded DNA binding [GO:0003697]; single-stranded RNA binding [GO:0003727]; translation initiation factor binding [GO:0031369] g5147.t1 Q5ZKL5 36.989 611 1.56e-103 337.0 sp|Q5ZKL5|PPCEL_CHICK Prolyl endopeptidase-like OS=Gallus gallus OX=9031 GN=PREPL PE=2 SV=1 g5148.t1 Q8C0V9 41.231 325 1.31e-76 263.0 sp|Q8C0V9|FRMD6_MOUSE FERM domain-containing protein 6 OS=Mus musculus OX=10090 GN=Frmd6 PE=1 SV=2 g5149.t1 Q8VDL4 34.346 428 4.06e-59 205.0 sp|Q8VDL4|ADPGK_MOUSE ADP-dependent glucokinase OS=Mus musculus OX=10090 GN=Adpgk PE=1 SV=2 ADPGK_MOUSE reviewed ADP-dependent glucokinase (ADP-GK) (ADPGK) (EC 2.7.1.147) Mus musculus (Mouse) GO:0005576; GO:0005783; GO:0006006; GO:0006096; GO:0043843; GO:0046872 glucose metabolic process [GO:0006006]; glycolytic process [GO:0006096] endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576] ADP-specific glucokinase activity [GO:0043843]; metal ion binding [GO:0046872] g5152.t1 A1DWM3 30.4 250 2.75e-27 120.0 sp|A1DWM3|MFSD6_PIG Major facilitator superfamily domain-containing protein 6 OS=Sus scrofa OX=9823 GN=MFSD6 PE=2 SV=1 g5153.t1 Q9H1A4 45.357 1960 0.0 1607.0 sp|Q9H1A4|APC1_HUMAN Anaphase-promoting complex subunit 1 OS=Homo sapiens OX=9606 GN=ANAPC1 PE=1 SV=1 g5153.t2 Q9H1A4 45.726 1907 0.0 1589.0 sp|Q9H1A4|APC1_HUMAN Anaphase-promoting complex subunit 1 OS=Homo sapiens OX=9606 GN=ANAPC1 PE=1 SV=1 g5154.t1 Q9D1D4 63.981 211 1.52e-88 263.0 sp|Q9D1D4|TMEDA_MOUSE Transmembrane emp24 domain-containing protein 10 OS=Mus musculus OX=10090 GN=Tmed10 PE=1 SV=1 TMEDA_MOUSE reviewed Transmembrane emp24 domain-containing protein 10 (Protein Tmed10) (21 kDa transmembrane-trafficking protein) (Transmembrane protein Tmp21) (p24 family protein delta-1) (p24delta1) Mus musculus (Mouse) GO:0000139; GO:0005783; GO:0005789; GO:0005793; GO:0005794; GO:0005801; GO:0005886; GO:0006886; GO:0006888; GO:0006890; GO:0007030; GO:0008320; GO:0016020; GO:0019905; GO:0030134; GO:0030137; GO:0030140; GO:0030658; GO:0030667; GO:0032732; GO:0033116; GO:0035964; GO:0042470; GO:0042589; GO:0044877; GO:0045055; GO:0048199; GO:0050714; GO:0070765; GO:0106272; GO:0106273; GO:1902003 COPI-coated vesicle budding [GO:0035964]; cytosol to ERGIC protein transport [GO:0106273]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; intracellular protein transport [GO:0006886]; positive regulation of interleukin-1 production [GO:0032732]; positive regulation of protein secretion [GO:0050714]; protein localization to ERGIC [GO:0106272]; regulated exocytosis [GO:0045055]; regulation of amyloid-beta formation [GO:1902003]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; vesicle targeting, to, from or within Golgi [GO:0048199] cis-Golgi network [GO:0005801]; COPI-coated vesicle [GO:0030137]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; gamma-secretase complex [GO:0070765]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; melanosome [GO:0042470]; membrane [GO:0016020]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; trans-Golgi network transport vesicle [GO:0030140]; transport vesicle membrane [GO:0030658]; zymogen granule membrane [GO:0042589] protein transmembrane transporter activity [GO:0008320]; protein-containing complex binding [GO:0044877]; syntaxin binding [GO:0019905] g5154.t2 Q9D1D4 65.403 211 1.09e-93 275.0 sp|Q9D1D4|TMEDA_MOUSE Transmembrane emp24 domain-containing protein 10 OS=Mus musculus OX=10090 GN=Tmed10 PE=1 SV=1 TMEDA_MOUSE reviewed Transmembrane emp24 domain-containing protein 10 (Protein Tmed10) (21 kDa transmembrane-trafficking protein) (Transmembrane protein Tmp21) (p24 family protein delta-1) (p24delta1) Mus musculus (Mouse) GO:0000139; GO:0005783; GO:0005789; GO:0005793; GO:0005794; GO:0005801; GO:0005886; GO:0006886; GO:0006888; GO:0006890; GO:0007030; GO:0008320; GO:0016020; GO:0019905; GO:0030134; GO:0030137; GO:0030140; GO:0030658; GO:0030667; GO:0032732; GO:0033116; GO:0035964; GO:0042470; GO:0042589; GO:0044877; GO:0045055; GO:0048199; GO:0050714; GO:0070765; GO:0106272; GO:0106273; GO:1902003 COPI-coated vesicle budding [GO:0035964]; cytosol to ERGIC protein transport [GO:0106273]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; intracellular protein transport [GO:0006886]; positive regulation of interleukin-1 production [GO:0032732]; positive regulation of protein secretion [GO:0050714]; protein localization to ERGIC [GO:0106272]; regulated exocytosis [GO:0045055]; regulation of amyloid-beta formation [GO:1902003]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; vesicle targeting, to, from or within Golgi [GO:0048199] cis-Golgi network [GO:0005801]; COPI-coated vesicle [GO:0030137]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; gamma-secretase complex [GO:0070765]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; melanosome [GO:0042470]; membrane [GO:0016020]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; trans-Golgi network transport vesicle [GO:0030140]; transport vesicle membrane [GO:0030658]; zymogen granule membrane [GO:0042589] protein transmembrane transporter activity [GO:0008320]; protein-containing complex binding [GO:0044877]; syntaxin binding [GO:0019905] g5154.t3 Q9D1D4 58.159 239 5.17e-88 262.0 sp|Q9D1D4|TMEDA_MOUSE Transmembrane emp24 domain-containing protein 10 OS=Mus musculus OX=10090 GN=Tmed10 PE=1 SV=1 TMEDA_MOUSE reviewed Transmembrane emp24 domain-containing protein 10 (Protein Tmed10) (21 kDa transmembrane-trafficking protein) (Transmembrane protein Tmp21) (p24 family protein delta-1) (p24delta1) Mus musculus (Mouse) GO:0000139; GO:0005783; GO:0005789; GO:0005793; GO:0005794; GO:0005801; GO:0005886; GO:0006886; GO:0006888; GO:0006890; GO:0007030; GO:0008320; GO:0016020; GO:0019905; GO:0030134; GO:0030137; GO:0030140; GO:0030658; GO:0030667; GO:0032732; GO:0033116; GO:0035964; GO:0042470; GO:0042589; GO:0044877; GO:0045055; GO:0048199; GO:0050714; GO:0070765; GO:0106272; GO:0106273; GO:1902003 COPI-coated vesicle budding [GO:0035964]; cytosol to ERGIC protein transport [GO:0106273]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; intracellular protein transport [GO:0006886]; positive regulation of interleukin-1 production [GO:0032732]; positive regulation of protein secretion [GO:0050714]; protein localization to ERGIC [GO:0106272]; regulated exocytosis [GO:0045055]; regulation of amyloid-beta formation [GO:1902003]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; vesicle targeting, to, from or within Golgi [GO:0048199] cis-Golgi network [GO:0005801]; COPI-coated vesicle [GO:0030137]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; gamma-secretase complex [GO:0070765]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; melanosome [GO:0042470]; membrane [GO:0016020]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; trans-Golgi network transport vesicle [GO:0030140]; transport vesicle membrane [GO:0030658]; zymogen granule membrane [GO:0042589] protein transmembrane transporter activity [GO:0008320]; protein-containing complex binding [GO:0044877]; syntaxin binding [GO:0019905] g5155.t1 Q8TD19 50.675 815 0.0 748.0 sp|Q8TD19|NEK9_HUMAN Serine/threonine-protein kinase Nek9 OS=Homo sapiens OX=9606 GN=NEK9 PE=1 SV=2 NEK9_HUMAN reviewed Serine/threonine-protein kinase Nek9 (EC 2.7.11.38) (Nercc1 kinase) (Never in mitosis A-related kinase 9) (NimA-related protein kinase 9) (NimA-related kinase 8) (Nek8) Homo sapiens (Human) GO:0000278; GO:0004674; GO:0005524; GO:0005634; GO:0005829; GO:0007346; GO:0019901; GO:0030295; GO:0046872; GO:0051301; GO:0106310 cell division [GO:0051301]; mitotic cell cycle [GO:0000278]; regulation of mitotic cell cycle [GO:0007346] cytosol [GO:0005829]; nucleus [GO:0005634] ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase activator activity [GO:0030295]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g5159.t1 Q6AYP4 44.138 145 4.15e-31 132.0 sp|Q6AYP4|ZC21C_RAT Zinc finger C2HC domain-containing protein 1C OS=Rattus norvegicus OX=10116 GN=Zc2hc1c PE=2 SV=1 g5160.t1 Q9UHC1 48.07 285 3.6499999999999998e-84 280.0 sp|Q9UHC1|MLH3_HUMAN DNA mismatch repair protein Mlh3 OS=Homo sapiens OX=9606 GN=MLH3 PE=1 SV=3 MLH3_HUMAN reviewed DNA mismatch repair protein Mlh3 (MutL protein homolog 3) Homo sapiens (Human) GO:0000795; GO:0001673; GO:0003682; GO:0003696; GO:0005524; GO:0005634; GO:0005654; GO:0005712; GO:0006298; GO:0007130; GO:0007131; GO:0007140; GO:0007144; GO:0008104; GO:0016887; GO:0019237; GO:0030983; GO:0032300; GO:0140664 female meiosis I [GO:0007144]; intracellular protein localization [GO:0008104]; male meiotic nuclear division [GO:0007140]; mismatch repair [GO:0006298]; reciprocal meiotic recombination [GO:0007131]; synaptonemal complex assembly [GO:0007130] chiasma [GO:0005712]; male germ cell nucleus [GO:0001673]; mismatch repair complex [GO:0032300]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; synaptonemal complex [GO:0000795] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent DNA damage sensor activity [GO:0140664]; centromeric DNA binding [GO:0019237]; chromatin binding [GO:0003682]; mismatched DNA binding [GO:0030983]; satellite DNA binding [GO:0003696] g5161.t1 Q9UHC1 33.787 441 6.3199999999999995e-62 238.0 sp|Q9UHC1|MLH3_HUMAN DNA mismatch repair protein Mlh3 OS=Homo sapiens OX=9606 GN=MLH3 PE=1 SV=3 MLH3_HUMAN reviewed DNA mismatch repair protein Mlh3 (MutL protein homolog 3) Homo sapiens (Human) GO:0000795; GO:0001673; GO:0003682; GO:0003696; GO:0005524; GO:0005634; GO:0005654; GO:0005712; GO:0006298; GO:0007130; GO:0007131; GO:0007140; GO:0007144; GO:0008104; GO:0016887; GO:0019237; GO:0030983; GO:0032300; GO:0140664 female meiosis I [GO:0007144]; intracellular protein localization [GO:0008104]; male meiotic nuclear division [GO:0007140]; mismatch repair [GO:0006298]; reciprocal meiotic recombination [GO:0007131]; synaptonemal complex assembly [GO:0007130] chiasma [GO:0005712]; male germ cell nucleus [GO:0001673]; mismatch repair complex [GO:0032300]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; synaptonemal complex [GO:0000795] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent DNA damage sensor activity [GO:0140664]; centromeric DNA binding [GO:0019237]; chromatin binding [GO:0003682]; mismatched DNA binding [GO:0030983]; satellite DNA binding [GO:0003696] g5163.t1 Q16667 43.627 204 6.05e-50 165.0 sp|Q16667|CDKN3_HUMAN Cyclin-dependent kinase inhibitor 3 OS=Homo sapiens OX=9606 GN=CDKN3 PE=1 SV=1 CDKN3_HUMAN reviewed Cyclin-dependent kinase inhibitor 3 (EC 3.1.3.16) (EC 3.1.3.48) (CDK2-associated dual-specificity phosphatase) (Cyclin-dependent kinase interactor 1) (Cyclin-dependent kinase-interacting protein 2) (Kinase-associated phosphatase) Homo sapiens (Human) GO:0000079; GO:0000082; GO:0004722; GO:0004725; GO:0005634; GO:0005737; GO:0005829; GO:0008138; GO:0008285; GO:0048471; GO:0051726 G1/S transition of mitotic cell cycle [GO:0000082]; negative regulation of cell population proliferation [GO:0008285]; regulation of cell cycle [GO:0051726]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471] protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138] g5164.t1 F1MNN4 31.834 289 7.59e-42 168.0 sp|F1MNN4|FBXW7_BOVIN F-box/WD repeat-containing protein 7 OS=Bos taurus OX=9913 GN=FBXW7 PE=1 SV=3 FBXW7_BOVIN reviewed F-box/WD repeat-containing protein 7 (F-box and WD-40 domain-containing protein 7) Bos taurus (Bovine) GO:0001944; GO:0005634; GO:0005654; GO:0005694; GO:0005737; GO:0006281; GO:0006974; GO:0007062; GO:0007346; GO:0010629; GO:0010992; GO:0019005; GO:0030332; GO:0031146; GO:0031398; GO:0031625; GO:0042752; GO:0042802; GO:0043130; GO:0043161; GO:0045944; GO:0050816; GO:0070534; GO:0097027; GO:1901524; GO:1901800; GO:1903378; GO:1903955; GO:1990452; GO:1990756; GO:2000059; GO:2000060; GO:2001205 DNA damage response [GO:0006974]; DNA repair [GO:0006281]; negative regulation of gene expression [GO:0010629]; negative regulation of osteoclast development [GO:2001205]; negative regulation of ubiquitin-dependent protein catabolic process [GO:2000059]; positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway [GO:1903378]; positive regulation of proteasomal protein catabolic process [GO:1901800]; positive regulation of protein targeting to mitochondrion [GO:1903955]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K63-linked ubiquitination [GO:0070534]; regulation of circadian rhythm [GO:0042752]; regulation of mitophagy [GO:1901524]; regulation of mitotic cell cycle [GO:0007346]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; sister chromatid cohesion [GO:0007062]; ubiquitin recycling [GO:0010992]; vasculature development [GO:0001944] chromosome [GO:0005694]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Parkin-FBXW7-Cul1 ubiquitin ligase complex [GO:1990452]; SCF ubiquitin ligase complex [GO:0019005] cyclin binding [GO:0030332]; identical protein binding [GO:0042802]; phosphothreonine residue binding [GO:0050816]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-like ligase-substrate adaptor activity [GO:1990756]; ubiquitin-protein transferase activator activity [GO:0097027] g5164.t1 F1MNN4 33.094 278 3.92e-41 166.0 sp|F1MNN4|FBXW7_BOVIN F-box/WD repeat-containing protein 7 OS=Bos taurus OX=9913 GN=FBXW7 PE=1 SV=3 FBXW7_BOVIN reviewed F-box/WD repeat-containing protein 7 (F-box and WD-40 domain-containing protein 7) Bos taurus (Bovine) GO:0001944; GO:0005634; GO:0005654; GO:0005694; GO:0005737; GO:0006281; GO:0006974; GO:0007062; GO:0007346; GO:0010629; GO:0010992; GO:0019005; GO:0030332; GO:0031146; GO:0031398; GO:0031625; GO:0042752; GO:0042802; GO:0043130; GO:0043161; GO:0045944; GO:0050816; GO:0070534; GO:0097027; GO:1901524; GO:1901800; GO:1903378; GO:1903955; GO:1990452; GO:1990756; GO:2000059; GO:2000060; GO:2001205 DNA damage response [GO:0006974]; DNA repair [GO:0006281]; negative regulation of gene expression [GO:0010629]; negative regulation of osteoclast development [GO:2001205]; negative regulation of ubiquitin-dependent protein catabolic process [GO:2000059]; positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway [GO:1903378]; positive regulation of proteasomal protein catabolic process [GO:1901800]; positive regulation of protein targeting to mitochondrion [GO:1903955]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K63-linked ubiquitination [GO:0070534]; regulation of circadian rhythm [GO:0042752]; regulation of mitophagy [GO:1901524]; regulation of mitotic cell cycle [GO:0007346]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; sister chromatid cohesion [GO:0007062]; ubiquitin recycling [GO:0010992]; vasculature development [GO:0001944] chromosome [GO:0005694]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Parkin-FBXW7-Cul1 ubiquitin ligase complex [GO:1990452]; SCF ubiquitin ligase complex [GO:0019005] cyclin binding [GO:0030332]; identical protein binding [GO:0042802]; phosphothreonine residue binding [GO:0050816]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-like ligase-substrate adaptor activity [GO:1990756]; ubiquitin-protein transferase activator activity [GO:0097027] g5165.t1 P21274 46.774 372 1.93e-105 320.0 sp|P21274|BMP2_MOUSE Bone morphogenetic protein 2 OS=Mus musculus OX=10090 GN=Bmp2 PE=1 SV=3 BMP2_MOUSE reviewed Bone morphogenetic protein 2 (BMP-2) (Bone morphogenetic protein 2A) (BMP-2A) Mus musculus (Mouse) GO:0000122; GO:0001649; GO:0001658; GO:0001666; GO:0001701; GO:0001837; GO:0002062; GO:0003007; GO:0003129; GO:0003133; GO:0003176; GO:0003181; GO:0003203; GO:0003210; GO:0003272; GO:0003331; GO:0005125; GO:0005576; GO:0005615; GO:0005886; GO:0005929; GO:0006029; GO:0006355; GO:0006954; GO:0007179; GO:0007219; GO:0007507; GO:0008083; GO:0008284; GO:0008285; GO:0009617; GO:0009887; GO:0009986; GO:0010467; GO:0010628; GO:0010629; GO:0010718; GO:0010894; GO:0014898; GO:0019211; GO:0019904; GO:0021537; GO:0021978; GO:0030177; GO:0030282; GO:0030316; GO:0030335; GO:0030501; GO:0030509; GO:0030512; GO:0031648; GO:0031982; GO:0032348; GO:0032991; GO:0033690; GO:0035051; GO:0035054; GO:0035360; GO:0036305; GO:0039706; GO:0042475; GO:0042482; GO:0042487; GO:0042802; GO:0043065; GO:0043410; GO:0043539; GO:0043569; GO:0045165; GO:0045597; GO:0045599; GO:0045600; GO:0045666; GO:0045669; GO:0045778; GO:0045786; GO:0045892; GO:0045893; GO:0045944; GO:0048018; GO:0048662; GO:0048711; GO:0048762; GO:0048839; GO:0050769; GO:0051042; GO:0055007; GO:0055008; GO:0060039; GO:0060128; GO:0060129; GO:0060317; GO:0060348; GO:0060391; GO:0060426; GO:0060485; GO:0061036; GO:0070374; GO:0070700; GO:0070724; GO:0071363; GO:0071773; GO:0072138; GO:0090090; GO:0150005; GO:1900159; GO:1900745; GO:1901331; GO:1902895; GO:1905072; GO:1905222; GO:2000065; GO:2000726 ameloblast differentiation [GO:0036305]; animal organ morphogenesis [GO:0009887]; aortic valve development [GO:0003176]; atrioventricular canal morphogenesis [GO:1905222]; atrioventricular valve morphogenesis [GO:0003181]; BMP signaling pathway [GO:0030509]; bone development [GO:0060348]; bone mineralization [GO:0030282]; branching involved in ureteric bud morphogenesis [GO:0001658]; cardiac atrium formation [GO:0003210]; cardiac epithelial to mesenchymal transition [GO:0060317]; cardiac jelly development [GO:1905072]; cardiac muscle cell differentiation [GO:0055007]; cardiac muscle hypertrophy in response to stress [GO:0014898]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiocyte differentiation [GO:0035051]; cell fate commitment [GO:0045165]; cellular response to BMP stimulus [GO:0071773]; cellular response to growth factor stimulus [GO:0071363]; chondrocyte differentiation [GO:0002062]; corticotropin hormone secreting cell differentiation [GO:0060128]; embryonic heart tube anterior/posterior pattern specification [GO:0035054]; endocardial cushion formation [GO:0003272]; endocardial cushion morphogenesis [GO:0003203]; endodermal-mesodermal cell signaling [GO:0003133]; epithelial to mesenchymal transition [GO:0001837]; gene expression [GO:0010467]; heart development [GO:0007507]; heart induction [GO:0003129]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; inflammatory response [GO:0006954]; inner ear development [GO:0048839]; lung vasculature development [GO:0060426]; mesenchymal cell differentiation [GO:0048762]; mesenchymal cell proliferation involved in ureteric bud development [GO:0072138]; mesenchyme development [GO:0060485]; negative regulation of aldosterone biosynthetic process [GO:0032348]; negative regulation of calcium-independent cell-cell adhesion [GO:0051042]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cardiac muscle cell differentiation [GO:2000726]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cortisol biosynthetic process [GO:2000065]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of gene expression [GO:0010629]; negative regulation of insulin-like growth factor receptor signaling pathway [GO:0043569]; negative regulation of smooth muscle cell proliferation [GO:0048662]; negative regulation of steroid biosynthetic process [GO:0010894]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; Notch signaling pathway [GO:0007219]; odontogenesis of dentin-containing tooth [GO:0042475]; osteoblast differentiation [GO:0001649]; osteoclast differentiation [GO:0030316]; pericardium development [GO:0060039]; positive regulation of apoptotic process [GO:0043065]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of bone mineralization [GO:0030501]; positive regulation of bone mineralization involved in bone maturation [GO:1900159]; positive regulation of cartilage development [GO:0061036]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of extracellular matrix constituent secretion [GO:0003331]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of gene expression [GO:0010628]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of neurogenesis [GO:0050769]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of odontoblast differentiation [GO:1901331]; positive regulation of odontogenesis [GO:0042482]; positive regulation of ossification [GO:0045778]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of osteoblast proliferation [GO:0033690]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of peroxisome proliferator activated receptor signaling pathway [GO:0035360]; positive regulation of SMAD protein signal transduction [GO:0060391]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of Wnt signaling pathway [GO:0030177]; protein destabilization [GO:0031648]; proteoglycan metabolic process [GO:0006029]; regulation of DNA-templated transcription [GO:0006355]; regulation of odontogenesis of dentin-containing tooth [GO:0042487]; response to bacterium [GO:0009617]; response to hypoxia [GO:0001666]; telencephalon development [GO:0021537]; telencephalon regionalization [GO:0021978]; thyroid-stimulating hormone-secreting cell differentiation [GO:0060129]; transforming growth factor beta receptor signaling pathway [GO:0007179] BMP receptor complex [GO:0070724]; cell surface [GO:0009986]; cilium [GO:0005929]; enzyme activator complex [GO:0150005]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; vesicle [GO:0031982] BMP receptor binding [GO:0070700]; co-receptor binding [GO:0039706]; cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; identical protein binding [GO:0042802]; phosphatase activator activity [GO:0019211]; protein domain specific binding [GO:0019904]; protein serine/threonine kinase activator activity [GO:0043539]; receptor ligand activity [GO:0048018] g5166.t1 P48970 57.988 169 1.73e-63 208.0 sp|P48970|UNIV_STRPU Univin OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=2 g5169.t1 D2IYS2 41.617 334 1.14e-72 258.0 sp|D2IYS2|TORSO_BOMMO Tyrosine-protein kinase receptor torso OS=Bombyx mori OX=7091 GN=tor PE=1 SV=1 g5171.t1 Q5UQN4 34.595 185 2.2300000000000003e-27 105.0 sp|Q5UQN4|YL432_MIMIV Uncharacterized protein L432 OS=Acanthamoeba polyphaga mimivirus OX=212035 GN=MIMI_L432 PE=4 SV=1 g5172.t1 P0DKB4 61.963 326 7.58e-146 417.0 sp|P0DKB4|T3HPD_SACKO Trans-L-3-hydroxyproline dehydratase OS=Saccoglossus kowalevskii OX=10224 GN=l3hypdh PE=1 SV=1 g5176.t1 Q5SPH9 63.492 126 3.1999999999999998e-55 178.0 sp|Q5SPH9|RT10_DANRE Small ribosomal subunit protein uS10m OS=Danio rerio OX=7955 GN=mrps10 PE=3 SV=1 g5177.t1 Q8T888 70.202 198 6.01e-90 265.0 sp|Q8T888|DNAL1_CIOIN Dynein axonemal light chain 1 OS=Ciona intestinalis OX=7719 GN=DNAL1 PE=2 SV=1 g5178.t1 Q0GGX2 32.012 328 1.93e-36 148.0 sp|Q0GGX2|ZN541_MOUSE Zinc finger protein 541 OS=Mus musculus OX=10090 GN=Znf541 PE=1 SV=1 ZN541_MOUSE reviewed Zinc finger protein 541 (Spermatogenic cell HDAC-interacting protein 1) Mus musculus (Mouse) GO:0000118; GO:0003714; GO:0005634; GO:0005667; GO:0006355; GO:0006357; GO:0007140; GO:0007283; GO:0008270; GO:0030154; GO:0045892; GO:0045893 cell differentiation [GO:0030154]; male meiotic nuclear division [GO:0007140]; negative regulation of DNA-templated transcription [GO:0045892]; positive regulation of DNA-templated transcription [GO:0045893]; regulation of DNA-templated transcription [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283] histone deacetylase complex [GO:0000118]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667] transcription corepressor activity [GO:0003714]; zinc ion binding [GO:0008270] g5179.t1 Q9H0D2 61.176 85 6.9e-27 123.0 sp|Q9H0D2|ZN541_HUMAN Zinc finger protein 541 OS=Homo sapiens OX=9606 GN=ZNF541 PE=1 SV=3 ZN541_HUMAN reviewed Zinc finger protein 541 Homo sapiens (Human) GO:0000118; GO:0003714; GO:0005634; GO:0005667; GO:0006355; GO:0006357; GO:0007140; GO:0007283; GO:0008270; GO:0030154; GO:0045892; GO:0045893 cell differentiation [GO:0030154]; male meiotic nuclear division [GO:0007140]; negative regulation of DNA-templated transcription [GO:0045892]; positive regulation of DNA-templated transcription [GO:0045893]; regulation of DNA-templated transcription [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283] histone deacetylase complex [GO:0000118]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667] transcription corepressor activity [GO:0003714]; zinc ion binding [GO:0008270] g5180.t1 Q8NHH9 61.02 490 0.0 609.0 sp|Q8NHH9|ATLA2_HUMAN Atlastin-2 OS=Homo sapiens OX=9606 GN=ATL2 PE=1 SV=2 ATLA2_HUMAN reviewed Atlastin-2 (ATL-2) (EC 3.6.5.-) (ADP-ribosylation factor-like protein 6-interacting protein 2) Homo sapiens (Human) GO:0003924; GO:0005525; GO:0005783; GO:0005789; GO:0007029; GO:0016020; GO:0016320; GO:0046872; GO:0051260; GO:0098826; GO:0140523; GO:1990809 endoplasmic reticulum membrane fusion [GO:0016320]; endoplasmic reticulum organization [GO:0007029]; endoplasmic reticulum tubular network membrane organization [GO:1990809]; protein homooligomerization [GO:0051260] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum tubular network membrane [GO:0098826]; membrane [GO:0016020] GTP binding [GO:0005525]; GTPase activity [GO:0003924]; GTPase-dependent fusogenic activity [GO:0140523]; metal ion binding [GO:0046872] g5181.t1 Q96DM1 29.602 402 2.4899999999999998e-39 155.0 sp|Q96DM1|PGBD4_HUMAN PiggyBac transposable element-derived protein 4 OS=Homo sapiens OX=9606 GN=PGBD4 PE=1 SV=3 g5183.t1 Q5JTD7 55.046 218 1.02e-67 219.0 sp|Q5JTD7|LRC73_HUMAN Leucine-rich repeat-containing protein 73 OS=Homo sapiens OX=9606 GN=LRRC73 PE=1 SV=1 g5184.t1 Q8BGC3 27.018 285 8e-23 102.0 sp|Q8BGC3|MOT12_MOUSE Monocarboxylate transporter 12 OS=Mus musculus OX=10090 GN=Slc16a12 PE=1 SV=1 g5185.t1 Q9WVK8 38.542 480 3.7799999999999997e-104 323.0 sp|Q9WVK8|CP46A_MOUSE Cholesterol 24-hydroxylase OS=Mus musculus OX=10090 GN=Cyp46a1 PE=1 SV=1 CP46A_MOUSE reviewed Cholesterol 24-hydroxylase (CH24H) (EC 1.14.14.25) (Cholesterol 24-monooxygenase) (Cholesterol 24S-hydroxylase) (Cytochrome P450 46A1) Mus musculus (Mouse) GO:0005506; GO:0005789; GO:0006707; GO:0006805; GO:0008395; GO:0020037; GO:0030425; GO:0033781; GO:0042448; GO:0050649; GO:0062184; GO:0098793; GO:0098794; GO:1900271; GO:1903044 cholesterol catabolic process [GO:0006707]; progesterone metabolic process [GO:0042448]; protein localization to membrane raft [GO:1903044]; regulation of long-term synaptic potentiation [GO:1900271]; xenobiotic metabolic process [GO:0006805] dendrite [GO:0030425]; endoplasmic reticulum membrane [GO:0005789]; postsynapse [GO:0098794]; presynapse [GO:0098793] cholesterol 24-hydroxylase activity [GO:0033781]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; steroid hydroxylase activity [GO:0008395]; testosterone 16-beta-hydroxylase activity [GO:0062184]; testosterone 6-beta-hydroxylase activity [GO:0050649] g5188.t1 Q4R7U8 46.602 309 9.48e-86 263.0 sp|Q4R7U8|ASGL1_MACFA Isoaspartyl peptidase/L-asparaginase OS=Macaca fascicularis OX=9541 GN=ASRGL1 PE=2 SV=1 ASGL1_MACFA reviewed Isoaspartyl peptidase/L-asparaginase (EC 3.4.19.5) (EC 3.5.1.1) (Asparaginase-like protein 1) (Beta-aspartyl-peptidase) (Isoaspartyl dipeptidase) (L-asparagine amidohydrolase) [Cleaved into: Isoaspartyl peptidase/L-asparaginase alpha chain; Isoaspartyl peptidase/L-asparaginase beta chain] Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey) GO:0001917; GO:0004067; GO:0005737; GO:0006508; GO:0008798; GO:0033345 L-asparagine catabolic process via L-aspartate [GO:0033345]; proteolysis [GO:0006508] cytoplasm [GO:0005737]; photoreceptor inner segment [GO:0001917] asparaginase activity [GO:0004067]; beta-aspartyl-peptidase activity [GO:0008798] g5191.t1 P33497 40.924 303 1.63e-77 250.0 sp|P33497|RYK_AVIR3 Tyrosine-protein kinase transforming protein RYK OS=Avian retrovirus RPL30 OX=31671 GN=V-RYK PE=2 SV=1 g5192.t1 O59701 57.576 330 8.82e-136 394.0 sp|O59701|CYSK_SCHPO Cysteine synthase 1 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) OX=284812 GN=cys11 PE=1 SV=1 g5192.t2 O59701 57.576 330 1.29e-135 393.0 sp|O59701|CYSK_SCHPO Cysteine synthase 1 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) OX=284812 GN=cys11 PE=1 SV=1 g5196.t1 Q90YM5 30.824 279 2.95e-33 130.0 sp|Q90YM5|OSTA_LEUER Organic solute transporter subunit alpha OS=Leucoraja erinaceus OX=7782 GN=slc51a PE=1 SV=1 OSTA_LEUER reviewed Organic solute transporter subunit alpha (OST-alpha) (Solute carrier family 51 subunit alpha) Leucoraja erinaceus (Little skate) (Raja erinacea) GO:0005789; GO:0005886; GO:0015721; GO:0016020; GO:0032991; GO:0042803; GO:0046982 bile acid and bile salt transport [GO:0015721] endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803] g5199.t1 Q0IID7 38.905 347 1.83e-68 228.0 sp|Q0IID7|DUS10_BOVIN Dual specificity protein phosphatase 10 OS=Bos taurus OX=9913 GN=DUSP10 PE=2 SV=1 DUS10_BOVIN reviewed Dual specificity protein phosphatase 10 (EC 3.1.3.16) (EC 3.1.3.48) Bos taurus (Bovine) GO:0002819; GO:0004722; GO:0005654; GO:0005737; GO:0005829; GO:0007165; GO:0008330; GO:0008432; GO:0010633; GO:0017017; GO:0032496; GO:0032873; GO:0033549; GO:0033550; GO:0045591; GO:0046329; GO:0048273; GO:0048709; GO:0050680; GO:0051403; GO:0060266; GO:0070373; GO:0090335; GO:1903753; GO:1905042 negative regulation of epithelial cell migration [GO:0010633]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of epithelium regeneration [GO:1905042]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of JNK cascade [GO:0046329]; negative regulation of p38MAPK cascade [GO:1903753]; negative regulation of respiratory burst involved in inflammatory response [GO:0060266]; negative regulation of stress-activated MAPK cascade [GO:0032873]; oligodendrocyte differentiation [GO:0048709]; positive regulation of regulatory T cell differentiation [GO:0045591]; regulation of adaptive immune response [GO:0002819]; regulation of brown fat cell differentiation [GO:0090335]; response to lipopolysaccharide [GO:0032496]; signal transduction [GO:0007165]; stress-activated MAPK cascade [GO:0051403] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654] JUN kinase binding [GO:0008432]; MAP kinase phosphatase activity [GO:0033549]; MAP kinase tyrosine phosphatase activity [GO:0033550]; MAP kinase tyrosine/serine/threonine phosphatase activity [GO:0017017]; mitogen-activated protein kinase p38 binding [GO:0048273]; protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine/threonine phosphatase activity [GO:0008330] g5200.t1 Q6NXP6 29.558 362 3.04e-53 182.0 sp|Q6NXP6|NXRD1_HUMAN NADP-dependent oxidoreductase domain-containing protein 1 OS=Homo sapiens OX=9606 GN=NOXRED1 PE=1 SV=2 g5202.t1 Q5IS76 28.713 303 2.22e-30 124.0 sp|Q5IS76|ACHA6_PANTR Neuronal acetylcholine receptor subunit alpha-6 OS=Pan troglodytes OX=9598 GN=CHRNA6 PE=2 SV=1 ACHA6_PANTR reviewed Neuronal acetylcholine receptor subunit alpha-6 Pan troglodytes (Chimpanzee) GO:0005886; GO:0005892; GO:0007165; GO:0007271; GO:0007274; GO:0007399; GO:0014059; GO:0015464; GO:0022848; GO:0034220; GO:0034703; GO:0035094; GO:0035095; GO:0042734; GO:0043005; GO:0045202; GO:0045211; GO:0051899; GO:0060084; GO:0095500; GO:0098691; GO:0098878; GO:0099171 acetylcholine receptor signaling pathway [GO:0095500]; behavioral response to nicotine [GO:0035095]; membrane depolarization [GO:0051899]; monoatomic ion transmembrane transport [GO:0034220]; nervous system development [GO:0007399]; neuromuscular synaptic transmission [GO:0007274]; presynaptic modulation of chemical synaptic transmission [GO:0099171]; regulation of dopamine secretion [GO:0014059]; response to nicotine [GO:0035094]; signal transduction [GO:0007165]; synaptic transmission involved in micturition [GO:0060084]; synaptic transmission, cholinergic [GO:0007271] acetylcholine-gated channel complex [GO:0005892]; cation channel complex [GO:0034703]; dopaminergic synapse [GO:0098691]; neuron projection [GO:0043005]; neurotransmitter receptor complex [GO:0098878]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; synapse [GO:0045202] acetylcholine receptor activity [GO:0015464]; acetylcholine-gated monoatomic cation-selective channel activity [GO:0022848] g5203.t1 Q5IS76 30.258 271 1.02e-28 120.0 sp|Q5IS76|ACHA6_PANTR Neuronal acetylcholine receptor subunit alpha-6 OS=Pan troglodytes OX=9598 GN=CHRNA6 PE=2 SV=1 ACHA6_PANTR reviewed Neuronal acetylcholine receptor subunit alpha-6 Pan troglodytes (Chimpanzee) GO:0005886; GO:0005892; GO:0007165; GO:0007271; GO:0007274; GO:0007399; GO:0014059; GO:0015464; GO:0022848; GO:0034220; GO:0034703; GO:0035094; GO:0035095; GO:0042734; GO:0043005; GO:0045202; GO:0045211; GO:0051899; GO:0060084; GO:0095500; GO:0098691; GO:0098878; GO:0099171 acetylcholine receptor signaling pathway [GO:0095500]; behavioral response to nicotine [GO:0035095]; membrane depolarization [GO:0051899]; monoatomic ion transmembrane transport [GO:0034220]; nervous system development [GO:0007399]; neuromuscular synaptic transmission [GO:0007274]; presynaptic modulation of chemical synaptic transmission [GO:0099171]; regulation of dopamine secretion [GO:0014059]; response to nicotine [GO:0035094]; signal transduction [GO:0007165]; synaptic transmission involved in micturition [GO:0060084]; synaptic transmission, cholinergic [GO:0007271] acetylcholine-gated channel complex [GO:0005892]; cation channel complex [GO:0034703]; dopaminergic synapse [GO:0098691]; neuron projection [GO:0043005]; neurotransmitter receptor complex [GO:0098878]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; synapse [GO:0045202] acetylcholine receptor activity [GO:0015464]; acetylcholine-gated monoatomic cation-selective channel activity [GO:0022848] g5206.t1 A2AVA0 22.222 1368 1.45e-37 159.0 sp|A2AVA0|SVEP1_MOUSE Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 OS=Mus musculus OX=10090 GN=Svep1 PE=1 SV=1 SVEP1_MOUSE reviewed Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 (Polydom) Mus musculus (Mouse) GO:0001945; GO:0003017; GO:0003682; GO:0005178; GO:0005509; GO:0005576; GO:0005615; GO:0005634; GO:0005737; GO:0008544; GO:0010467; GO:0010572; GO:0016020; GO:0016477; GO:0031012; GO:0036303; GO:0045906; GO:0048014; GO:0090136; GO:0098640; GO:0120193 cell migration [GO:0016477]; epidermis development [GO:0008544]; epithelial cell-cell adhesion [GO:0090136]; gene expression [GO:0010467]; lymph circulation [GO:0003017]; lymph vessel development [GO:0001945]; lymph vessel morphogenesis [GO:0036303]; negative regulation of vasoconstriction [GO:0045906]; positive regulation of platelet activation [GO:0010572]; Tie signaling pathway [GO:0048014]; tight junction organization [GO:0120193] cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; nucleus [GO:0005634] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; integrin binding [GO:0005178]; integrin binding involved in cell-matrix adhesion [GO:0098640] g5206.t1 A2AVA0 29.048 420 7.39e-32 140.0 sp|A2AVA0|SVEP1_MOUSE Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 OS=Mus musculus OX=10090 GN=Svep1 PE=1 SV=1 SVEP1_MOUSE reviewed Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 (Polydom) Mus musculus (Mouse) GO:0001945; GO:0003017; GO:0003682; GO:0005178; GO:0005509; GO:0005576; GO:0005615; GO:0005634; GO:0005737; GO:0008544; GO:0010467; GO:0010572; GO:0016020; GO:0016477; GO:0031012; GO:0036303; GO:0045906; GO:0048014; GO:0090136; GO:0098640; GO:0120193 cell migration [GO:0016477]; epidermis development [GO:0008544]; epithelial cell-cell adhesion [GO:0090136]; gene expression [GO:0010467]; lymph circulation [GO:0003017]; lymph vessel development [GO:0001945]; lymph vessel morphogenesis [GO:0036303]; negative regulation of vasoconstriction [GO:0045906]; positive regulation of platelet activation [GO:0010572]; Tie signaling pathway [GO:0048014]; tight junction organization [GO:0120193] cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; nucleus [GO:0005634] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; integrin binding [GO:0005178]; integrin binding involved in cell-matrix adhesion [GO:0098640] g5206.t1 A2AVA0 22.758 1037 1.7700000000000002e-27 126.0 sp|A2AVA0|SVEP1_MOUSE Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 OS=Mus musculus OX=10090 GN=Svep1 PE=1 SV=1 SVEP1_MOUSE reviewed Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 (Polydom) Mus musculus (Mouse) GO:0001945; GO:0003017; GO:0003682; GO:0005178; GO:0005509; GO:0005576; GO:0005615; GO:0005634; GO:0005737; GO:0008544; GO:0010467; GO:0010572; GO:0016020; GO:0016477; GO:0031012; GO:0036303; GO:0045906; GO:0048014; GO:0090136; GO:0098640; GO:0120193 cell migration [GO:0016477]; epidermis development [GO:0008544]; epithelial cell-cell adhesion [GO:0090136]; gene expression [GO:0010467]; lymph circulation [GO:0003017]; lymph vessel development [GO:0001945]; lymph vessel morphogenesis [GO:0036303]; negative regulation of vasoconstriction [GO:0045906]; positive regulation of platelet activation [GO:0010572]; Tie signaling pathway [GO:0048014]; tight junction organization [GO:0120193] cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; nucleus [GO:0005634] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; integrin binding [GO:0005178]; integrin binding involved in cell-matrix adhesion [GO:0098640] g5206.t1 A2AVA0 27.7 426 2e-26 123.0 sp|A2AVA0|SVEP1_MOUSE Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 OS=Mus musculus OX=10090 GN=Svep1 PE=1 SV=1 SVEP1_MOUSE reviewed Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 (Polydom) Mus musculus (Mouse) GO:0001945; GO:0003017; GO:0003682; GO:0005178; GO:0005509; GO:0005576; GO:0005615; GO:0005634; GO:0005737; GO:0008544; GO:0010467; GO:0010572; GO:0016020; GO:0016477; GO:0031012; GO:0036303; GO:0045906; GO:0048014; GO:0090136; GO:0098640; GO:0120193 cell migration [GO:0016477]; epidermis development [GO:0008544]; epithelial cell-cell adhesion [GO:0090136]; gene expression [GO:0010467]; lymph circulation [GO:0003017]; lymph vessel development [GO:0001945]; lymph vessel morphogenesis [GO:0036303]; negative regulation of vasoconstriction [GO:0045906]; positive regulation of platelet activation [GO:0010572]; Tie signaling pathway [GO:0048014]; tight junction organization [GO:0120193] cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; nucleus [GO:0005634] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; integrin binding [GO:0005178]; integrin binding involved in cell-matrix adhesion [GO:0098640] g5206.t1 A2AVA0 26.168 428 8.38e-22 107.0 sp|A2AVA0|SVEP1_MOUSE Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 OS=Mus musculus OX=10090 GN=Svep1 PE=1 SV=1 SVEP1_MOUSE reviewed Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 (Polydom) Mus musculus (Mouse) GO:0001945; GO:0003017; GO:0003682; GO:0005178; GO:0005509; GO:0005576; GO:0005615; GO:0005634; GO:0005737; GO:0008544; GO:0010467; GO:0010572; GO:0016020; GO:0016477; GO:0031012; GO:0036303; GO:0045906; GO:0048014; GO:0090136; GO:0098640; GO:0120193 cell migration [GO:0016477]; epidermis development [GO:0008544]; epithelial cell-cell adhesion [GO:0090136]; gene expression [GO:0010467]; lymph circulation [GO:0003017]; lymph vessel development [GO:0001945]; lymph vessel morphogenesis [GO:0036303]; negative regulation of vasoconstriction [GO:0045906]; positive regulation of platelet activation [GO:0010572]; Tie signaling pathway [GO:0048014]; tight junction organization [GO:0120193] cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; nucleus [GO:0005634] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; integrin binding [GO:0005178]; integrin binding involved in cell-matrix adhesion [GO:0098640] g5207.t1 Q4LDE5 40.854 164 2.1100000000000002e-29 117.0 sp|Q4LDE5|SVEP1_HUMAN Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 OS=Homo sapiens OX=9606 GN=SVEP1 PE=1 SV=3 SVEP1_HUMAN reviewed Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 (CCP module-containing protein 22) (Polydom) (Selectin-like osteoblast-derived protein) (SEL-OB) (Serologically defined breast cancer antigen NY-BR-38) Homo sapiens (Human) GO:0003017; GO:0003682; GO:0005178; GO:0005509; GO:0005576; GO:0005615; GO:0005634; GO:0005737; GO:0008544; GO:0010467; GO:0010572; GO:0016020; GO:0036303; GO:0045906; GO:0048014; GO:0098640; GO:0120193 epidermis development [GO:0008544]; gene expression [GO:0010467]; lymph circulation [GO:0003017]; lymph vessel morphogenesis [GO:0036303]; negative regulation of vasoconstriction [GO:0045906]; positive regulation of platelet activation [GO:0010572]; Tie signaling pathway [GO:0048014]; tight junction organization [GO:0120193] cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; nucleus [GO:0005634] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; integrin binding [GO:0005178]; integrin binding involved in cell-matrix adhesion [GO:0098640] g5208.t1 P10079 40.768 807 0.0 605.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g5208.t1 P10079 42.083 720 0.0 580.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g5208.t1 P10079 42.659 722 1.67e-176 556.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g5208.t1 P10079 43.338 683 1.26e-171 544.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g5208.t1 P10079 44.3 307 6.56e-72 266.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g5208.t1 P10079 35.814 430 2.29e-61 233.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g5208.t2 P10079 38.032 376 3.41e-68 251.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g5208.t2 P10079 37.5 376 1.43e-65 243.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g5208.t2 P10079 36.658 371 1.4500000000000001e-65 243.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g5208.t2 P10079 33.333 432 1.69e-65 243.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g5208.t2 P10079 36.17 376 2.57e-62 233.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g5208.t2 P10079 36.436 376 3.2e-61 230.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g5208.t2 P10079 42.105 266 1.3599999999999998e-52 204.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g5208.t2 P10079 36.137 321 2.75e-51 200.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g5212.t1 A0A1D5NSM8 30.235 1108 8.58e-120 432.0 sp|A0A1D5NSM8|SVEP1_DANRE Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 OS=Danio rerio OX=7955 GN=svep1 PE=1 SV=1 SVEP1_DANRE reviewed Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 (Polydom) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001945; GO:0005509; GO:0005576; GO:0005634; GO:0005737; GO:0008544; GO:0009913; GO:0016020; GO:0016477; GO:0036303; GO:0090136 cell migration [GO:0016477]; epidermal cell differentiation [GO:0009913]; epidermis development [GO:0008544]; epithelial cell-cell adhesion [GO:0090136]; lymph vessel development [GO:0001945]; lymph vessel morphogenesis [GO:0036303] cytoplasm [GO:0005737]; extracellular region [GO:0005576]; membrane [GO:0016020]; nucleus [GO:0005634] calcium ion binding [GO:0005509] g5212.t1 A0A1D5NSM8 31.081 518 2.82e-64 249.0 sp|A0A1D5NSM8|SVEP1_DANRE Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 OS=Danio rerio OX=7955 GN=svep1 PE=1 SV=1 SVEP1_DANRE reviewed Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 (Polydom) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001945; GO:0005509; GO:0005576; GO:0005634; GO:0005737; GO:0008544; GO:0009913; GO:0016020; GO:0016477; GO:0036303; GO:0090136 cell migration [GO:0016477]; epidermal cell differentiation [GO:0009913]; epidermis development [GO:0008544]; epithelial cell-cell adhesion [GO:0090136]; lymph vessel development [GO:0001945]; lymph vessel morphogenesis [GO:0036303] cytoplasm [GO:0005737]; extracellular region [GO:0005576]; membrane [GO:0016020]; nucleus [GO:0005634] calcium ion binding [GO:0005509] g5212.t1 A0A1D5NSM8 21.964 1293 7.05e-38 162.0 sp|A0A1D5NSM8|SVEP1_DANRE Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 OS=Danio rerio OX=7955 GN=svep1 PE=1 SV=1 SVEP1_DANRE reviewed Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 (Polydom) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001945; GO:0005509; GO:0005576; GO:0005634; GO:0005737; GO:0008544; GO:0009913; GO:0016020; GO:0016477; GO:0036303; GO:0090136 cell migration [GO:0016477]; epidermal cell differentiation [GO:0009913]; epidermis development [GO:0008544]; epithelial cell-cell adhesion [GO:0090136]; lymph vessel development [GO:0001945]; lymph vessel morphogenesis [GO:0036303] cytoplasm [GO:0005737]; extracellular region [GO:0005576]; membrane [GO:0016020]; nucleus [GO:0005634] calcium ion binding [GO:0005509] g5212.t1 A0A1D5NSM8 23.561 1112 2.85e-36 156.0 sp|A0A1D5NSM8|SVEP1_DANRE Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 OS=Danio rerio OX=7955 GN=svep1 PE=1 SV=1 SVEP1_DANRE reviewed Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 (Polydom) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001945; GO:0005509; GO:0005576; GO:0005634; GO:0005737; GO:0008544; GO:0009913; GO:0016020; GO:0016477; GO:0036303; GO:0090136 cell migration [GO:0016477]; epidermal cell differentiation [GO:0009913]; epidermis development [GO:0008544]; epithelial cell-cell adhesion [GO:0090136]; lymph vessel development [GO:0001945]; lymph vessel morphogenesis [GO:0036303] cytoplasm [GO:0005737]; extracellular region [GO:0005576]; membrane [GO:0016020]; nucleus [GO:0005634] calcium ion binding [GO:0005509] g5212.t1 A0A1D5NSM8 21.662 1468 7.590000000000001e-27 125.0 sp|A0A1D5NSM8|SVEP1_DANRE Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 OS=Danio rerio OX=7955 GN=svep1 PE=1 SV=1 SVEP1_DANRE reviewed Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 (Polydom) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001945; GO:0005509; GO:0005576; GO:0005634; GO:0005737; GO:0008544; GO:0009913; GO:0016020; GO:0016477; GO:0036303; GO:0090136 cell migration [GO:0016477]; epidermal cell differentiation [GO:0009913]; epidermis development [GO:0008544]; epithelial cell-cell adhesion [GO:0090136]; lymph vessel development [GO:0001945]; lymph vessel morphogenesis [GO:0036303] cytoplasm [GO:0005737]; extracellular region [GO:0005576]; membrane [GO:0016020]; nucleus [GO:0005634] calcium ion binding [GO:0005509] g5215.t1 Q4LDE5 34.074 540 1.4500000000000001e-77 288.0 sp|Q4LDE5|SVEP1_HUMAN Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 OS=Homo sapiens OX=9606 GN=SVEP1 PE=1 SV=3 SVEP1_HUMAN reviewed Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 (CCP module-containing protein 22) (Polydom) (Selectin-like osteoblast-derived protein) (SEL-OB) (Serologically defined breast cancer antigen NY-BR-38) Homo sapiens (Human) GO:0003017; GO:0003682; GO:0005178; GO:0005509; GO:0005576; GO:0005615; GO:0005634; GO:0005737; GO:0008544; GO:0010467; GO:0010572; GO:0016020; GO:0036303; GO:0045906; GO:0048014; GO:0098640; GO:0120193 epidermis development [GO:0008544]; gene expression [GO:0010467]; lymph circulation [GO:0003017]; lymph vessel morphogenesis [GO:0036303]; negative regulation of vasoconstriction [GO:0045906]; positive regulation of platelet activation [GO:0010572]; Tie signaling pathway [GO:0048014]; tight junction organization [GO:0120193] cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; nucleus [GO:0005634] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; integrin binding [GO:0005178]; integrin binding involved in cell-matrix adhesion [GO:0098640] g5215.t1 Q4LDE5 30.253 671 5.67e-74 276.0 sp|Q4LDE5|SVEP1_HUMAN Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 OS=Homo sapiens OX=9606 GN=SVEP1 PE=1 SV=3 SVEP1_HUMAN reviewed Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 (CCP module-containing protein 22) (Polydom) (Selectin-like osteoblast-derived protein) (SEL-OB) (Serologically defined breast cancer antigen NY-BR-38) Homo sapiens (Human) GO:0003017; GO:0003682; GO:0005178; GO:0005509; GO:0005576; GO:0005615; GO:0005634; GO:0005737; GO:0008544; GO:0010467; GO:0010572; GO:0016020; GO:0036303; GO:0045906; GO:0048014; GO:0098640; GO:0120193 epidermis development [GO:0008544]; gene expression [GO:0010467]; lymph circulation [GO:0003017]; lymph vessel morphogenesis [GO:0036303]; negative regulation of vasoconstriction [GO:0045906]; positive regulation of platelet activation [GO:0010572]; Tie signaling pathway [GO:0048014]; tight junction organization [GO:0120193] cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; nucleus [GO:0005634] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; integrin binding [GO:0005178]; integrin binding involved in cell-matrix adhesion [GO:0098640] g5223.t1 Q96S38 40.26 231 5.8e-38 158.0 sp|Q96S38|KS6C1_HUMAN Ribosomal protein S6 kinase delta-1 OS=Homo sapiens OX=9606 GN=RPS6KC1 PE=1 SV=2 KS6C1_HUMAN reviewed Ribosomal protein S6 kinase delta-1 (S6K-delta-1) (EC 2.7.11.1) (52 kDa ribosomal protein S6 kinase) (Ribosomal S6 kinase-like protein with two PSK domains 118 kDa protein) (SPHK1-binding protein) Homo sapiens (Human) GO:0004674; GO:0005524; GO:0005764; GO:0005768; GO:0005769; GO:0007165; GO:0016020; GO:0035091; GO:0106310 signal transduction [GO:0007165] early endosome [GO:0005769]; endosome [GO:0005768]; lysosome [GO:0005764]; membrane [GO:0016020] ATP binding [GO:0005524]; phosphatidylinositol binding [GO:0035091]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g5223.t1 Q96S38 52.713 129 5.29e-29 129.0 sp|Q96S38|KS6C1_HUMAN Ribosomal protein S6 kinase delta-1 OS=Homo sapiens OX=9606 GN=RPS6KC1 PE=1 SV=2 KS6C1_HUMAN reviewed Ribosomal protein S6 kinase delta-1 (S6K-delta-1) (EC 2.7.11.1) (52 kDa ribosomal protein S6 kinase) (Ribosomal S6 kinase-like protein with two PSK domains 118 kDa protein) (SPHK1-binding protein) Homo sapiens (Human) GO:0004674; GO:0005524; GO:0005764; GO:0005768; GO:0005769; GO:0007165; GO:0016020; GO:0035091; GO:0106310 signal transduction [GO:0007165] early endosome [GO:0005769]; endosome [GO:0005768]; lysosome [GO:0005764]; membrane [GO:0016020] ATP binding [GO:0005524]; phosphatidylinositol binding [GO:0035091]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g5224.t1 Q96S38 50.0 186 8.2e-58 202.0 sp|Q96S38|KS6C1_HUMAN Ribosomal protein S6 kinase delta-1 OS=Homo sapiens OX=9606 GN=RPS6KC1 PE=1 SV=2 KS6C1_HUMAN reviewed Ribosomal protein S6 kinase delta-1 (S6K-delta-1) (EC 2.7.11.1) (52 kDa ribosomal protein S6 kinase) (Ribosomal S6 kinase-like protein with two PSK domains 118 kDa protein) (SPHK1-binding protein) Homo sapiens (Human) GO:0004674; GO:0005524; GO:0005764; GO:0005768; GO:0005769; GO:0007165; GO:0016020; GO:0035091; GO:0106310 signal transduction [GO:0007165] early endosome [GO:0005769]; endosome [GO:0005768]; lysosome [GO:0005764]; membrane [GO:0016020] ATP binding [GO:0005524]; phosphatidylinositol binding [GO:0035091]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g5225.t1 A0JMY4 42.437 476 3.24e-120 368.0 sp|A0JMY4|BBOF1_XENLA Basal body-orientation factor 1 OS=Xenopus laevis OX=8355 GN=ccdc176 PE=2 SV=1 BBOF1_XENLA reviewed Basal body-orientation factor 1 (Coiled-coil domain-containing protein 176) Xenopus laevis (African clawed frog) GO:0036064; GO:0044458 motile cilium assembly [GO:0044458] ciliary basal body [GO:0036064] g5226.t1 A0JPI9 41.687 415 1.08e-100 319.0 sp|A0JPI9|LR74A_RAT Leucine-rich repeat-containing protein 74A OS=Rattus norvegicus OX=10116 GN=Lrrc74a PE=2 SV=1 g5226.t2 A0JPI9 41.546 414 6.28e-101 316.0 sp|A0JPI9|LR74A_RAT Leucine-rich repeat-containing protein 74A OS=Rattus norvegicus OX=10116 GN=Lrrc74a PE=2 SV=1 g5227.t1 Q0IIS3 37.195 164 8.77e-32 120.0 sp|Q0IIS3|EPHX3_XENTR Epoxide hydrolase 3 OS=Xenopus tropicalis OX=8364 GN=ephx3 PE=2 SV=1 g5228.t1 Q8IUS5 45.695 151 8.92e-41 142.0 sp|Q8IUS5|EPHX4_HUMAN Epoxide hydrolase 4 OS=Homo sapiens OX=9606 GN=EPHX4 PE=1 SV=2 g5230.t1 Q5ZL91 42.259 956 0.0 708.0 sp|Q5ZL91|INT7_CHICK Integrator complex subunit 7 OS=Gallus gallus OX=9031 GN=INTS7 PE=2 SV=1 INT7_CHICK reviewed Integrator complex subunit 7 (Int7) Gallus gallus (Chicken) GO:0005634; GO:0005694; GO:0005737; GO:0006974; GO:0032039; GO:0034472; GO:0160232; GO:0160240 DNA damage response [GO:0006974]; RNA polymerase II transcription initiation surveillance [GO:0160240]; snRNA 3'-end processing [GO:0034472] chromosome [GO:0005694]; cytoplasm [GO:0005737]; INTAC complex [GO:0160232]; integrator complex [GO:0032039]; nucleus [GO:0005634] g5231.t1 Q6P1W0 41.379 522 2.05e-100 330.0 sp|Q6P1W0|DTL_XENTR Denticleless protein homolog OS=Xenopus tropicalis OX=8364 GN=dtl PE=1 SV=1 DTL_XENTR reviewed Denticleless protein homolog Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0000209; GO:0005634; GO:0005694; GO:0005813; GO:0006260; GO:0006511; GO:0006513; GO:0006974; GO:0007095; GO:0009411; GO:0019985; GO:0030674; GO:0031464; GO:0031465; GO:0031490; GO:0043161; GO:0048511; GO:0051726; GO:2000060 DNA damage response [GO:0006974]; DNA replication [GO:0006260]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; regulation of cell cycle [GO:0051726]; response to UV [GO:0009411]; rhythmic process [GO:0048511]; translesion synthesis [GO:0019985]; ubiquitin-dependent protein catabolic process [GO:0006511] centrosome [GO:0005813]; chromosome [GO:0005694]; Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]; Cul4B-RING E3 ubiquitin ligase complex [GO:0031465]; nucleus [GO:0005634] chromatin DNA binding [GO:0031490]; protein-macromolecule adaptor activity [GO:0030674] g5232.t1 Q28D01 63.746 582 0.0 732.0 sp|Q28D01|WDR26_XENTR WD repeat-containing protein 26 OS=Xenopus tropicalis OX=8364 GN=wdr26 PE=2 SV=2 g5233.t1 Q6ZQL4 36.913 596 8.89e-106 338.0 sp|Q6ZQL4|WDR43_MOUSE WD repeat-containing protein 43 OS=Mus musculus OX=10090 GN=Wdr43 PE=1 SV=2 WDR43_MOUSE reviewed WD repeat-containing protein 43 Mus musculus (Mouse) GO:0000462; GO:0000785; GO:0000993; GO:0001650; GO:0003711; GO:0003723; GO:0005654; GO:0005730; GO:0032040; GO:0034243; GO:0042274; GO:0045943; GO:2000036; GO:2000234 maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; positive regulation of rRNA processing [GO:2000234]; positive regulation of transcription by RNA polymerase I [GO:0045943]; regulation of stem cell population maintenance [GO:2000036]; regulation of transcription elongation by RNA polymerase II [GO:0034243]; ribosomal small subunit biogenesis [GO:0042274] chromatin [GO:0000785]; fibrillar center [GO:0001650]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; small-subunit processome [GO:0032040] RNA binding [GO:0003723]; RNA polymerase II complex binding [GO:0000993]; transcription elongation factor activity [GO:0003711] g5235.t1 Q7T0V2 50.413 121 7.56e-35 118.0 sp|Q7T0V2|LTR3A_XENLA Ragulator complex protein LAMTOR3-A OS=Xenopus laevis OX=8355 GN=lamtor3-a PE=2 SV=1 g5236.t1 Q498L0 38.421 190 2.9e-31 138.0 sp|Q498L0|C170B_XENLA Centrosomal protein of 170 kDa protein B OS=Xenopus laevis OX=8355 GN=cep170b PE=2 SV=1 g5236.t3 A0JM08 57.303 89 5.7699999999999996e-30 115.0 sp|A0JM08|C170B_XENTR Centrosomal protein of 170 kDa protein B OS=Xenopus tropicalis OX=8364 GN=cep170b PE=2 SV=1 g5237.t1 Q8CC12 35.494 1003 4.63e-121 412.0 sp|Q8CC12|CDAN1_MOUSE Codanin-1 OS=Mus musculus OX=10090 GN=Cdan1 PE=1 SV=2 CDAN1_MOUSE reviewed Codanin-1 Mus musculus (Mouse) GO:0000902; GO:0001701; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0006325; GO:0006998; GO:0008104; GO:0010467; GO:0012505; GO:0031507; GO:0048469; GO:0051170; GO:0060319 cell maturation [GO:0048469]; cell morphogenesis [GO:0000902]; chromatin organization [GO:0006325]; gene expression [GO:0010467]; heterochromatin formation [GO:0031507]; import into nucleus [GO:0051170]; in utero embryonic development [GO:0001701]; intracellular protein localization [GO:0008104]; nuclear envelope organization [GO:0006998]; primitive erythrocyte differentiation [GO:0060319] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; nucleus [GO:0005634]; plasma membrane [GO:0005886] g5239.t1 Q75J93 36.602 724 9.05e-131 416.0 sp|Q75J93|CPAS1_DICDI Circularly permutated Ras protein 1 OS=Dictyostelium discoideum OX=44689 GN=cpras1 PE=3 SV=1 g5240.t1 Q8CFN2 52.326 172 1.4800000000000001e-58 186.0 sp|Q8CFN2|CDC42_RAT Cell division control protein 42 homolog OS=Rattus norvegicus OX=10116 GN=Cdc42 PE=1 SV=2 CDC42_RAT reviewed Cell division control protein 42 homolog (EC 3.6.5.2) Rattus norvegicus (Rat) GO:0000139; GO:0000322; GO:0002040; GO:0003015; GO:0003161; GO:0003253; GO:0003924; GO:0003925; GO:0005525; GO:0005737; GO:0005813; GO:0005829; GO:0005886; GO:0005911; GO:0006897; GO:0006911; GO:0007015; GO:0007030; GO:0007088; GO:0007097; GO:0007165; GO:0007229; GO:0007264; GO:0008104; GO:0009749; GO:0010591; GO:0010592; GO:0016020; GO:0017119; GO:0017157; GO:0019901; GO:0030010; GO:0030036; GO:0030141; GO:0030175; GO:0030307; GO:0030335; GO:0030425; GO:0030496; GO:0030742; GO:0031252; GO:0031256; GO:0031258; GO:0031274; GO:0031333; GO:0031435; GO:0031996; GO:0032427; GO:0032467; GO:0032956; GO:0032991; GO:0034191; GO:0034329; GO:0034332; GO:0035050; GO:0035088; GO:0036336; GO:0036464; GO:0038189; GO:0042802; GO:0042995; GO:0043005; GO:0043025; GO:0043410; GO:0043525; GO:0045177; GO:0045198; GO:0045335; GO:0045740; GO:0046330; GO:0046847; GO:0048549; GO:0048664; GO:0051233; GO:0051489; GO:0051491; GO:0051492; GO:0051496; GO:0051647; GO:0051649; GO:0051683; GO:0051835; GO:0051897; GO:0051988; GO:0060047; GO:0060501; GO:0060661; GO:0060997; GO:0061630; GO:0071346; GO:0071944; GO:0072384; GO:0072686; GO:0086101; GO:0090135; GO:0090316; GO:0098685; GO:0098794; GO:0098978; GO:0099159; GO:0099175; GO:1900026 actin cytoskeleton organization [GO:0030036]; actin filament branching [GO:0090135]; actin filament organization [GO:0007015]; adherens junction organization [GO:0034332]; cardiac conduction system development [GO:0003161]; cardiac neural crest cell migration involved in outflow tract morphogenesis [GO:0003253]; cell junction assembly [GO:0034329]; cellular response to type II interferon [GO:0071346]; dendritic cell migration [GO:0036336]; dendritic spine morphogenesis [GO:0060997]; embryonic heart tube development [GO:0035050]; endocytosis [GO:0006897]; endothelin receptor signaling pathway involved in heart process [GO:0086101]; establishment of cell polarity [GO:0030010]; establishment of epithelial cell apical/basal polarity [GO:0045198]; establishment of Golgi localization [GO:0051683]; establishment of localization in cell [GO:0051649]; establishment or maintenance of apical/basal cell polarity [GO:0035088]; filopodium assembly [GO:0046847]; Golgi organization [GO:0007030]; heart contraction [GO:0060047]; heart process [GO:0003015]; integrin-mediated signaling pathway [GO:0007229]; intracellular protein localization [GO:0008104]; negative regulation of protein-containing complex assembly [GO:0031333]; neuron fate determination [GO:0048664]; neuropilin signaling pathway [GO:0038189]; nuclear migration [GO:0007097]; nucleus localization [GO:0051647]; organelle transport along microtubule [GO:0072384]; phagocytosis, engulfment [GO:0006911]; positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; positive regulation of cytokinesis [GO:0032467]; positive regulation of DNA replication [GO:0045740]; positive regulation of epithelial cell proliferation involved in lung morphogenesis [GO:0060501]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of JNK cascade [GO:0046330]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of pinocytosis [GO:0048549]; positive regulation of pseudopodium assembly [GO:0031274]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; positive regulation of synapse structural plasticity [GO:0051835]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of attachment of spindle microtubules to kinetochore [GO:0051988]; regulation of exocytosis [GO:0017157]; regulation of filopodium assembly [GO:0051489]; regulation of lamellipodium assembly [GO:0010591]; regulation of mitotic nuclear division [GO:0007088]; regulation of modification of postsynaptic structure [GO:0099159]; regulation of postsynapse organization [GO:0099175]; regulation of stress fiber assembly [GO:0051492]; response to glucose [GO:0009749]; signal transduction [GO:0007165]; small GTPase-mediated signal transduction [GO:0007264]; sprouting angiogenesis [GO:0002040]; submandibular salivary gland formation [GO:0060661] apical part of cell [GO:0045177]; cell leading edge [GO:0031252]; cell periphery [GO:0071944]; cell projection [GO:0042995]; cell-cell junction [GO:0005911]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; dendrite [GO:0030425]; filopodium [GO:0030175]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; Golgi transport complex [GO:0017119]; lamellipodium membrane [GO:0031258]; leading edge membrane [GO:0031256]; membrane [GO:0016020]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; protein-containing complex [GO:0032991]; Schaffer collateral - CA1 synapse [GO:0098685]; secretory granule [GO:0030141]; spindle midzone [GO:0051233]; storage vacuole [GO:0000322] apolipoprotein A-I receptor binding [GO:0034191]; G protein activity [GO:0003925]; GBD domain binding [GO:0032427]; GTP binding [GO:0005525]; GTP-dependent protein binding [GO:0030742]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; mitogen-activated protein kinase kinase kinase binding [GO:0031435]; protein kinase binding [GO:0019901]; thioesterase binding [GO:0031996]; ubiquitin protein ligase activity [GO:0061630] g5241.t1 Q95M12 48.798 416 1.13e-138 407.0 sp|Q95M12|LGMN_BOVIN Legumain OS=Bos taurus OX=9913 GN=LGMN PE=1 SV=1 LGMN_BOVIN reviewed Legumain (EC 3.4.22.34) (Asparaginyl endopeptidase) (Protease, cysteine 1) Bos taurus (Bovine) GO:0003014; GO:0004197; GO:0005764; GO:0006508; GO:0006624; GO:0019886; GO:0032801; GO:0043202; GO:0051603; GO:1901185 antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; negative regulation of ERBB signaling pathway [GO:1901185]; proteolysis [GO:0006508]; proteolysis involved in protein catabolic process [GO:0051603]; receptor catabolic process [GO:0032801]; renal system process [GO:0003014]; vacuolar protein processing [GO:0006624] lysosomal lumen [GO:0043202]; lysosome [GO:0005764] cysteine-type endopeptidase activity [GO:0004197] g5258.t1 Q08CA1 42.262 336 7.99e-84 261.0 sp|Q08CA1|GDPP1_DANRE GDP-D-glucose phosphorylase 1 OS=Danio rerio OX=7955 GN=gdpgp1 PE=2 SV=1 g5259.t1 Q803U7 47.738 442 3.24e-130 416.0 sp|Q803U7|EXO1_DANRE Exonuclease 1 OS=Danio rerio OX=7955 GN=exo1 PE=2 SV=1 EXO1_DANRE reviewed Exonuclease 1 (EC 3.1.-.-) (Exonuclease I) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0003677; GO:0005634; GO:0006298; GO:0006310; GO:0017108; GO:0035312; GO:0045145; GO:0046872; GO:0048256 DNA recombination [GO:0006310]; mismatch repair [GO:0006298] nucleus [GO:0005634] 5'-3' DNA exonuclease activity [GO:0035312]; 5'-flap endonuclease activity [GO:0017108]; DNA binding [GO:0003677]; flap endonuclease activity [GO:0048256]; metal ion binding [GO:0046872]; single-stranded DNA 5'-3' DNA exonuclease activity [GO:0045145] g5259.t2 Q803U7 47.738 442 3.32e-130 416.0 sp|Q803U7|EXO1_DANRE Exonuclease 1 OS=Danio rerio OX=7955 GN=exo1 PE=2 SV=1 EXO1_DANRE reviewed Exonuclease 1 (EC 3.1.-.-) (Exonuclease I) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0003677; GO:0005634; GO:0006298; GO:0006310; GO:0017108; GO:0035312; GO:0045145; GO:0046872; GO:0048256 DNA recombination [GO:0006310]; mismatch repair [GO:0006298] nucleus [GO:0005634] 5'-3' DNA exonuclease activity [GO:0035312]; 5'-flap endonuclease activity [GO:0017108]; DNA binding [GO:0003677]; flap endonuclease activity [GO:0048256]; metal ion binding [GO:0046872]; single-stranded DNA 5'-3' DNA exonuclease activity [GO:0045145] g5260.t1 Q5M7T4 65.143 175 7.82e-60 193.0 sp|Q5M7T4|YIPF4_RAT Protein YIPF4 OS=Rattus norvegicus OX=10116 GN=Yipf4 PE=2 SV=1 g5262.t1 Q5HZE0 50.694 288 2.1e-84 261.0 sp|Q5HZE0|S2529_RAT Mitochondrial basic amino acids transporter OS=Rattus norvegicus OX=10116 GN=Slc25a29 PE=2 SV=1 S2529_RAT reviewed Mitochondrial basic amino acids transporter (Carnitine/acylcarnitine translocase-like) (CACT-like) (Mitochondrial carnitine/acylcarnitine carrier protein CACL) (Mitochondrial ornithine transporter 3) (Solute carrier family 25 member 29) Rattus norvegicus (Rat) GO:0005289; GO:0005292; GO:0005739; GO:0005743; GO:0015174; GO:0015227; GO:0015822; GO:0089709; GO:1902616; GO:1903401; GO:1903826; GO:1990575 L-arginine transmembrane transport [GO:1903826]; L-histidine transmembrane transport [GO:0089709]; L-lysine transmembrane transport [GO:1903401]; mitochondrial L-ornithine transmembrane transport [GO:1990575]; O-acyl-L-carnitine transmembrane transport [GO:1902616]; ornithine transport [GO:0015822] mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739] basic amino acid transmembrane transporter activity [GO:0015174]; high-affinity L-arginine transmembrane transporter activity [GO:0005289]; high-affinity lysine transmembrane transporter activity [GO:0005292]; O-acyl-L-carnitine transmembrane transporter activity [GO:0015227] g5264.t1 P25490 62.757 341 6.43e-113 338.0 sp|P25490|TYY1_HUMAN Transcriptional repressor protein YY1 OS=Homo sapiens OX=9606 GN=YY1 PE=1 SV=2 TYY1_HUMAN reviewed Transcriptional repressor protein YY1 (Delta transcription factor) (INO80 complex subunit S) (NF-E1) (Yin and yang 1) (YY-1) Homo sapiens (Human) GO:0000122; GO:0000400; GO:0000723; GO:0000724; GO:0000785; GO:0000976; GO:0000978; GO:0000981; GO:0000987; GO:0001217; GO:0001227; GO:0001228; GO:0003677; GO:0003682; GO:0003723; GO:0005634; GO:0005654; GO:0005667; GO:0005677; GO:0006275; GO:0006282; GO:0006338; GO:0006357; GO:0006403; GO:0006974; GO:0007283; GO:0008270; GO:0009952; GO:0010225; GO:0010628; GO:0010629; GO:0016363; GO:0030183; GO:0031011; GO:0031519; GO:0032688; GO:0033044; GO:0034644; GO:0034696; GO:0045739; GO:0045893; GO:0045944; GO:0045995; GO:0046332; GO:0048593; GO:0051726; GO:0060382; GO:0061052; GO:0071347; GO:0071707; GO:0140297; GO:1902894; GO:1904507; GO:1990837 anterior/posterior pattern specification [GO:0009952]; B cell differentiation [GO:0030183]; camera-type eye morphogenesis [GO:0048593]; cellular response to interleukin-1 [GO:0071347]; cellular response to UV [GO:0034644]; chromatin remodeling [GO:0006338]; DNA damage response [GO:0006974]; double-strand break repair via homologous recombination [GO:0000724]; immunoglobulin heavy chain V-D-J recombination [GO:0071707]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of gene expression [GO:0010629]; negative regulation of interferon-beta production [GO:0032688]; negative regulation of miRNA transcription [GO:1902894]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of DNA repair [GO:0045739]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of gene expression [GO:0010628]; positive regulation of telomere maintenance in response to DNA damage [GO:1904507]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell cycle [GO:0051726]; regulation of chromosome organization [GO:0033044]; regulation of DNA repair [GO:0006282]; regulation of DNA replication [GO:0006275]; regulation of DNA strand elongation [GO:0060382]; regulation of embryonic development [GO:0045995]; regulation of transcription by RNA polymerase II [GO:0006357]; response to prostaglandin F [GO:0034696]; response to UV-C [GO:0010225]; RNA localization [GO:0006403]; spermatogenesis [GO:0007283]; telomere maintenance [GO:0000723] chromatin [GO:0000785]; chromatin silencing complex [GO:0005677]; Ino80 complex [GO:0031011]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; transcription regulator complex [GO:0005667] chromatin binding [GO:0003682]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription factor binding [GO:0140297]; DNA-binding transcription repressor activity [GO:0001217]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; four-way junction DNA binding [GO:0000400]; RNA binding [GO:0003723]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; SMAD binding [GO:0046332]; transcription cis-regulatory region binding [GO:0000976]; zinc ion binding [GO:0008270] g5264.t2 P25490 62.099 343 6.969999999999999e-111 333.0 sp|P25490|TYY1_HUMAN Transcriptional repressor protein YY1 OS=Homo sapiens OX=9606 GN=YY1 PE=1 SV=2 TYY1_HUMAN reviewed Transcriptional repressor protein YY1 (Delta transcription factor) (INO80 complex subunit S) (NF-E1) (Yin and yang 1) (YY-1) Homo sapiens (Human) GO:0000122; GO:0000400; GO:0000723; GO:0000724; GO:0000785; GO:0000976; GO:0000978; GO:0000981; GO:0000987; GO:0001217; GO:0001227; GO:0001228; GO:0003677; GO:0003682; GO:0003723; GO:0005634; GO:0005654; GO:0005667; GO:0005677; GO:0006275; GO:0006282; GO:0006338; GO:0006357; GO:0006403; GO:0006974; GO:0007283; GO:0008270; GO:0009952; GO:0010225; GO:0010628; GO:0010629; GO:0016363; GO:0030183; GO:0031011; GO:0031519; GO:0032688; GO:0033044; GO:0034644; GO:0034696; GO:0045739; GO:0045893; GO:0045944; GO:0045995; GO:0046332; GO:0048593; GO:0051726; GO:0060382; GO:0061052; GO:0071347; GO:0071707; GO:0140297; GO:1902894; GO:1904507; GO:1990837 anterior/posterior pattern specification [GO:0009952]; B cell differentiation [GO:0030183]; camera-type eye morphogenesis [GO:0048593]; cellular response to interleukin-1 [GO:0071347]; cellular response to UV [GO:0034644]; chromatin remodeling [GO:0006338]; DNA damage response [GO:0006974]; double-strand break repair via homologous recombination [GO:0000724]; immunoglobulin heavy chain V-D-J recombination [GO:0071707]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of gene expression [GO:0010629]; negative regulation of interferon-beta production [GO:0032688]; negative regulation of miRNA transcription [GO:1902894]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of DNA repair [GO:0045739]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of gene expression [GO:0010628]; positive regulation of telomere maintenance in response to DNA damage [GO:1904507]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell cycle [GO:0051726]; regulation of chromosome organization [GO:0033044]; regulation of DNA repair [GO:0006282]; regulation of DNA replication [GO:0006275]; regulation of DNA strand elongation [GO:0060382]; regulation of embryonic development [GO:0045995]; regulation of transcription by RNA polymerase II [GO:0006357]; response to prostaglandin F [GO:0034696]; response to UV-C [GO:0010225]; RNA localization [GO:0006403]; spermatogenesis [GO:0007283]; telomere maintenance [GO:0000723] chromatin [GO:0000785]; chromatin silencing complex [GO:0005677]; Ino80 complex [GO:0031011]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; transcription regulator complex [GO:0005667] chromatin binding [GO:0003682]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription factor binding [GO:0140297]; DNA-binding transcription repressor activity [GO:0001217]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; four-way junction DNA binding [GO:0000400]; RNA binding [GO:0003723]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; SMAD binding [GO:0046332]; transcription cis-regulatory region binding [GO:0000976]; zinc ion binding [GO:0008270] g5266.t1 Q94515 55.652 115 8.730000000000001e-37 130.0 sp|Q94515|DEGS1_DROME Sphingolipid delta(4)-desaturase DES1 OS=Drosophila melanogaster OX=7227 GN=ifc PE=1 SV=1 DEGS1_DROME reviewed Sphingolipid delta(4)-desaturase DES1 (EC 1.14.19.17) (Degenerative spermatocyte homolog 1) (DES-1) (Dihydroceramide desaturase-1) Drosophila melanogaster (Fruit fly) GO:0005739; GO:0005770; GO:0005783; GO:0005789; GO:0042284; GO:0046513; GO:1904503 ceramide biosynthetic process [GO:0046513]; negative regulation of lipophagy [GO:1904503] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; late endosome [GO:0005770]; mitochondrion [GO:0005739] sphingolipid delta-4 desaturase activity [GO:0042284] g5267.t1 Q6QHC5 61.538 104 6.6200000000000005e-43 145.0 sp|Q6QHC5|DEGS2_HUMAN Sphingolipid delta(4)-desaturase/C4-monooxygenase DES2 OS=Homo sapiens OX=9606 GN=DEGS2 PE=1 SV=2 DEGS2_HUMAN reviewed Sphingolipid delta(4)-desaturase/C4-monooxygenase DES2 (EC 1.14.18.5) (EC 1.14.19.17) (Degenerative spermatocyte homolog 2) (Sphingolipid 4-desaturase) (Sphingolipid C4-monooxygenase) Homo sapiens (Human) GO:0005789; GO:0006667; GO:0030148; GO:0042284; GO:0046513; GO:0102772 ceramide biosynthetic process [GO:0046513]; sphinganine metabolic process [GO:0006667]; sphingolipid biosynthetic process [GO:0030148] endoplasmic reticulum membrane [GO:0005789] sphingolipid C4-monooxygenase activity [GO:0102772]; sphingolipid delta-4 desaturase activity [GO:0042284] g5268.t1 Q6IQ97 41.011 178 2.1399999999999997e-48 170.0 sp|Q6IQ97|RBM41_DANRE RNA-binding protein 4.1 OS=Danio rerio OX=7955 GN=rbm4.1 PE=1 SV=1 g5270.t1 Q642T7 50.088 571 0.0 576.0 sp|Q642T7|UTP25_XENTR U3 small nucleolar RNA-associated protein 25 homolog OS=Xenopus tropicalis OX=8364 GN=utp25 PE=2 SV=1 g5271.t1 Q0P6H9 45.908 501 2.7e-146 441.0 sp|Q0P6H9|TMM62_HUMAN Transmembrane protein 62 OS=Homo sapiens OX=9606 GN=TMEM62 PE=1 SV=1 g5272.t1 Q8N128 53.922 102 6.410000000000001e-31 114.0 sp|Q8N128|F177A_HUMAN Protein FAM177A1 OS=Homo sapiens OX=9606 GN=FAM177A1 PE=1 SV=1 F177A_HUMAN reviewed Protein FAM177A1 Homo sapiens (Human) GO:0005794 Golgi apparatus [GO:0005794] g5273.t1 B2RYG6 62.302 252 3.61e-107 314.0 sp|B2RYG6|OTUB1_RAT Ubiquitin thioesterase OTUB1 OS=Rattus norvegicus OX=10116 GN=Otub1 PE=1 SV=1 OTUB1_RAT reviewed Ubiquitin thioesterase OTUB1 (EC 3.4.19.12) (Deubiquitinating enzyme OTUB1) (OTU domain-containing ubiquitin aldehyde-binding protein 1) (Otubain-1) (Ubiquitin-specific-processing protease OTUB1) Rattus norvegicus (Rat) GO:0002250; GO:0004843; GO:0005737; GO:0006281; GO:0006974; GO:0016579; GO:0019784; GO:0031625; GO:0031669; GO:0038202; GO:0043130; GO:0043161; GO:0055105; GO:0071108; GO:0071347; GO:1904262; GO:1904263; GO:2000780 adaptive immune response [GO:0002250]; cellular response to interleukin-1 [GO:0071347]; cellular response to nutrient levels [GO:0031669]; DNA damage response [GO:0006974]; DNA repair [GO:0006281]; negative regulation of double-strand break repair [GO:2000780]; negative regulation of TORC1 signaling [GO:1904262]; positive regulation of TORC1 signaling [GO:1904263]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deubiquitination [GO:0016579]; protein K48-linked deubiquitination [GO:0071108]; TORC1 signaling [GO:0038202] cytoplasm [GO:0005737] cysteine-type deubiquitinase activity [GO:0004843]; deNEDDylase activity [GO:0019784]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase inhibitor activity [GO:0055105] g5274.t1 O15381 52.105 879 0.0 805.0 sp|O15381|NVL_HUMAN Nuclear valosin-containing protein-like OS=Homo sapiens OX=9606 GN=NVL PE=1 SV=1 NVL_HUMAN reviewed Nuclear valosin-containing protein-like (NVLp) (Nuclear VCP-like protein) Homo sapiens (Human) GO:0003723; GO:0005524; GO:0005634; GO:0005654; GO:0005697; GO:0005730; GO:0006364; GO:0016020; GO:0016887; GO:0032092; GO:0032206; GO:0042254; GO:0042273; GO:1904749; GO:1905323; GO:1990275 positive regulation of protein binding [GO:0032092]; positive regulation of telomere maintenance [GO:0032206]; regulation of protein localization to nucleolus [GO:1904749]; ribosomal large subunit biogenesis [GO:0042273]; ribosome biogenesis [GO:0042254]; rRNA processing [GO:0006364]; telomerase holoenzyme complex assembly [GO:1905323] membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; telomerase holoenzyme complex [GO:0005697] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; preribosome binding [GO:1990275]; RNA binding [GO:0003723] g5275.t1 Q90YC0 56.109 442 8.69e-167 478.0 sp|Q90YC0|EF1G_CARAU Elongation factor 1-gamma OS=Carassius auratus OX=7957 GN=eef1g PE=2 SV=1 g5275.t2 Q68FR6 47.444 489 1.21e-148 434.0 sp|Q68FR6|EF1G_RAT Elongation factor 1-gamma OS=Rattus norvegicus OX=10116 GN=Eef1g PE=2 SV=3 EF1G_RAT reviewed Elongation factor 1-gamma (EF-1-gamma) (eEF-1B gamma) Rattus norvegicus (Rat) GO:0003746; GO:0005634; GO:0005737; GO:0005783; GO:0006414; GO:0009615 response to virus [GO:0009615]; translational elongation [GO:0006414] cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634] translation elongation factor activity [GO:0003746] g5280.t1 Q3U2J5 46.127 284 2.5100000000000002e-80 249.0 sp|Q3U2J5|CMKMT_MOUSE Calmodulin-lysine N-methyltransferase OS=Mus musculus OX=10090 GN=Camkmt PE=1 SV=1 g5282.t1 Q8BKU8 45.187 374 1.04e-91 295.0 sp|Q8BKU8|TM87B_MOUSE Transmembrane protein 87B OS=Mus musculus OX=10090 GN=Tmem87b PE=2 SV=1 g5283.t1 Q6P116 51.688 385 3.3100000000000005e-129 390.0 sp|Q6P116|RCOR2_DANRE REST corepressor 2 OS=Danio rerio OX=7955 GN=rcor2 PE=2 SV=1 g5285.t1 Q5RCS8 78.218 202 6.96e-104 303.0 sp|Q5RCS8|VATD_PONAB V-type proton ATPase subunit D OS=Pongo abelii OX=9601 GN=ATP6V1D PE=2 SV=1 g5286.t1 Q1LWJ6 47.826 230 1.64e-65 205.0 sp|Q1LWJ6|ARPIN_DANRE Arpin OS=Danio rerio OX=7955 GN=arpin PE=2 SV=1 ARPIN_DANRE reviewed Arpin Danio rerio (Zebrafish) (Brachydanio rerio) GO:0030027; GO:0030336; GO:0033058; GO:0051126 directional locomotion [GO:0033058]; negative regulation of actin nucleation [GO:0051126]; negative regulation of cell migration [GO:0030336] lamellipodium [GO:0030027] g5287.t1 Q10471 71.171 444 0.0 691.0 sp|Q10471|GALT2_HUMAN Polypeptide N-acetylgalactosaminyltransferase 2 OS=Homo sapiens OX=9606 GN=GALNT2 PE=1 SV=1 GALT2_HUMAN reviewed Polypeptide N-acetylgalactosaminyltransferase 2 (EC 2.4.1.41) (Polypeptide GalNAc transferase 2) (GalNAc-T2) (pp-GaNTase 2) (Protein-UDP acetylgalactosaminyltransferase 2) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 2) [Cleaved into: Polypeptide N-acetylgalactosaminyltransferase 2 soluble form] Homo sapiens (Human) GO:0000139; GO:0002639; GO:0004653; GO:0005576; GO:0005789; GO:0005794; GO:0005795; GO:0006493; GO:0016020; GO:0016266; GO:0030145; GO:0030246; GO:0032580; GO:0048471; GO:0051604 positive regulation of immunoglobulin production [GO:0002639]; protein maturation [GO:0051604]; protein O-linked glycosylation [GO:0006493]; protein O-linked glycosylation via N-acetyl-galactosamine [GO:0016266] endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471] carbohydrate binding [GO:0030246]; manganese ion binding [GO:0030145]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653] g5290.t1 A0A3Q7ZPG5 56.757 333 1.27e-87 268.0 sp|A0A3Q7ZPG5|S39A9_MICUN Zinc transporter ZIP9 OS=Micropogonias undulatus OX=29154 GN=slc39a9 PE=1 SV=1 S39A9_MICUN reviewed Zinc transporter ZIP9 (ZIP-9) (Solute carrier family 39 member 9) (Zrt- and Irt-like protein 9) Micropogonias undulatus (Atlantic croaker) GO:0004930; GO:0005385; GO:0005497; GO:0005634; GO:0005739; GO:0005794; GO:0005886; GO:0006882; GO:0048471; GO:0071577 intracellular zinc ion homeostasis [GO:0006882]; zinc ion transmembrane transport [GO:0071577] Golgi apparatus [GO:0005794]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886] androgen binding [GO:0005497]; G protein-coupled receptor activity [GO:0004930]; zinc ion transmembrane transporter activity [GO:0005385] g5291.t1 Q93104 65.0 100 6.7e-45 143.0 sp|Q93104|ERH_AEDAE Enhancer of rudimentary homolog OS=Aedes aegypti OX=7159 PE=3 SV=1 g5292.t1 Q9DFZ4 53.097 113 4.53e-40 132.0 sp|Q9DFZ4|CHUR_XENLA Protein Churchill OS=Xenopus laevis OX=8355 GN=churc1 PE=3 SV=1 g5293.t1 Q8CE96 41.034 290 1.3e-59 208.0 sp|Q8CE96|TRM6_MOUSE tRNA (adenine(58)-N(1))-methyltransferase non-catalytic subunit TRM6 OS=Mus musculus OX=10090 GN=Trmt6 PE=1 SV=1 g5293.t1 Q8CE96 46.078 102 9.23e-25 111.0 sp|Q8CE96|TRM6_MOUSE tRNA (adenine(58)-N(1))-methyltransferase non-catalytic subunit TRM6 OS=Mus musculus OX=10090 GN=Trmt6 PE=1 SV=1 g5296.t1 Q9UI42 28.371 356 4.1800000000000005e-21 98.6 sp|Q9UI42|CBPA4_HUMAN Carboxypeptidase A4 OS=Homo sapiens OX=9606 GN=CPA4 PE=1 SV=2 CBPA4_HUMAN reviewed Carboxypeptidase A4 (EC 3.4.17.-) (Carboxypeptidase A3) Homo sapiens (Human) GO:0004181; GO:0005615; GO:0006508; GO:0008270; GO:0042447; GO:0043171 hormone catabolic process [GO:0042447]; peptide catabolic process [GO:0043171]; proteolysis [GO:0006508] extracellular space [GO:0005615] metallocarboxypeptidase activity [GO:0004181]; zinc ion binding [GO:0008270] g5297.t1 Q5PQZ3 62.857 455 0.0 536.0 sp|Q5PQZ3|ZNT9_DANRE Proton-coupled zinc antiporter SLC30A9, mitochondrial OS=Danio rerio OX=7955 GN=slc30a9 PE=2 SV=1 ZNT9_DANRE reviewed Proton-coupled zinc antiporter SLC30A9, mitochondrial (Solute carrier family 30 member 9) (Zinc transporter 9) (ZnT-9) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005385; GO:0005634; GO:0005783; GO:0006829; GO:0006882; GO:0010821; GO:0015297; GO:0031410; GO:0031966 intracellular zinc ion homeostasis [GO:0006882]; regulation of mitochondrion organization [GO:0010821]; zinc ion transport [GO:0006829] cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum [GO:0005783]; mitochondrial membrane [GO:0031966]; nucleus [GO:0005634] antiporter activity [GO:0015297]; zinc ion transmembrane transporter activity [GO:0005385] g5298.t1 Q90Y54 44.598 1083 0.0 955.0 sp|Q90Y54|JAG1B_DANRE Protein jagged-1b OS=Danio rerio OX=7955 GN=jag1b PE=2 SV=1 JAG1B_DANRE reviewed Protein jagged-1b (Jagged1b) (Jagged3) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001889; GO:0005112; GO:0005509; GO:0005886; GO:0007219; GO:0009913; GO:0009953; GO:0016020; GO:0030878; GO:0031016; GO:0031017; GO:0031101; GO:0032474; GO:0035622; GO:0042472; GO:0048752; GO:0060117; GO:0060325; GO:0060351; GO:0060872; GO:0061008; GO:1904888 auditory receptor cell development [GO:0060117]; cartilage development involved in endochondral bone morphogenesis [GO:0060351]; cranial skeletal system development [GO:1904888]; dorsal/ventral pattern formation [GO:0009953]; epidermal cell differentiation [GO:0009913]; exocrine pancreas development [GO:0031017]; face morphogenesis [GO:0060325]; fin regeneration [GO:0031101]; hepaticobiliary system development [GO:0061008]; inner ear morphogenesis [GO:0042472]; intrahepatic bile duct development [GO:0035622]; liver development [GO:0001889]; Notch signaling pathway [GO:0007219]; otolith morphogenesis [GO:0032474]; pancreas development [GO:0031016]; semicircular canal development [GO:0060872]; semicircular canal morphogenesis [GO:0048752]; thyroid gland development [GO:0030878] membrane [GO:0016020]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; Notch binding [GO:0005112] g5300.t1 Q5RDB5 75.694 144 7.650000000000001e-56 174.0 sp|Q5RDB5|CNIH1_PONAB Protein cornichon homolog 1 OS=Pongo abelii OX=9601 GN=CNIH1 PE=2 SV=1 CNIH1_PONAB reviewed Protein cornichon homolog 1 (CNIH-1) (Cornichon family AMPA receptor auxiliary protein 1) (Protein cornichon homolog) Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0000139; GO:0005789; GO:0016192 vesicle-mediated transport [GO:0016192] endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139] g5301.t1 Q60954 63.613 393 4.56e-144 421.0 sp|Q60954|MEIS1_MOUSE Homeobox protein Meis1 OS=Mus musculus OX=10090 GN=Meis1 PE=1 SV=1 MEIS1_MOUSE reviewed Homeobox protein Meis1 (Myeloid ecotropic viral integration site 1) Mus musculus (Mouse) GO:0000978; GO:0000981; GO:0001228; GO:0001525; GO:0001654; GO:0002089; GO:0003677; GO:0003682; GO:0005634; GO:0005654; GO:0005667; GO:0006355; GO:0006357; GO:0007420; GO:0007626; GO:0008284; GO:0009880; GO:0009887; GO:0030097; GO:0035855; GO:0043565; GO:0045638; GO:0045665; GO:0045944; GO:0048514; GO:0060216; GO:0061049 angiogenesis [GO:0001525]; animal organ morphogenesis [GO:0009887]; blood vessel morphogenesis [GO:0048514]; brain development [GO:0007420]; cell growth involved in cardiac muscle cell development [GO:0061049]; definitive hemopoiesis [GO:0060216]; embryonic pattern specification [GO:0009880]; eye development [GO:0001654]; hemopoiesis [GO:0030097]; lens morphogenesis in camera-type eye [GO:0002089]; locomotory behavior [GO:0007626]; megakaryocyte development [GO:0035855]; negative regulation of myeloid cell differentiation [GO:0045638]; negative regulation of neuron differentiation [GO:0045665]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA-templated transcription [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357] nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667] chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565] g5301.t2 Q60954 63.855 415 7.84e-154 447.0 sp|Q60954|MEIS1_MOUSE Homeobox protein Meis1 OS=Mus musculus OX=10090 GN=Meis1 PE=1 SV=1 MEIS1_MOUSE reviewed Homeobox protein Meis1 (Myeloid ecotropic viral integration site 1) Mus musculus (Mouse) GO:0000978; GO:0000981; GO:0001228; GO:0001525; GO:0001654; GO:0002089; GO:0003677; GO:0003682; GO:0005634; GO:0005654; GO:0005667; GO:0006355; GO:0006357; GO:0007420; GO:0007626; GO:0008284; GO:0009880; GO:0009887; GO:0030097; GO:0035855; GO:0043565; GO:0045638; GO:0045665; GO:0045944; GO:0048514; GO:0060216; GO:0061049 angiogenesis [GO:0001525]; animal organ morphogenesis [GO:0009887]; blood vessel morphogenesis [GO:0048514]; brain development [GO:0007420]; cell growth involved in cardiac muscle cell development [GO:0061049]; definitive hemopoiesis [GO:0060216]; embryonic pattern specification [GO:0009880]; eye development [GO:0001654]; hemopoiesis [GO:0030097]; lens morphogenesis in camera-type eye [GO:0002089]; locomotory behavior [GO:0007626]; megakaryocyte development [GO:0035855]; negative regulation of myeloid cell differentiation [GO:0045638]; negative regulation of neuron differentiation [GO:0045665]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA-templated transcription [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357] nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667] chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565] g5310.t1 Q0VD42 35.776 232 4.76e-40 142.0 sp|Q0VD42|TLCD5_BOVIN TLC domain-containing protein 5 OS=Bos taurus OX=9913 GN=TLCD5 PE=2 SV=1 g5311.t1 Q8C0T9 32.649 925 8.54e-135 462.0 sp|Q8C0T9|ADCYA_MOUSE Adenylate cyclase type 10 OS=Mus musculus OX=10090 GN=Adcy10 PE=1 SV=2 ADCYA_MOUSE reviewed Adenylate cyclase type 10 (EC 4.6.1.1) (Germ cell soluble adenylyl cyclase) (sAC) (Testicular soluble adenylyl cyclase) Mus musculus (Mouse) GO:0000287; GO:0003351; GO:0004016; GO:0005524; GO:0005576; GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0005856; GO:0005929; GO:0006007; GO:0006171; GO:0007283; GO:0010613; GO:0010666; GO:0010917; GO:0016020; GO:0016324; GO:0030145; GO:0030424; GO:0030425; GO:0030426; GO:0035556; GO:0043025; GO:0043065; GO:0045177; GO:0045178; GO:0045773; GO:0045778; GO:0045819; GO:0048471; GO:0051117; GO:0051901; GO:0060306; GO:0071890; GO:0090724; GO:0097450; GO:0106028; GO:0106135; GO:1901524; GO:1903378; GO:1903427; GO:1903428; GO:1903955; GO:1905461; GO:1990138; GO:1990535; GO:1990544; GO:2001171; GO:2001244 cAMP biosynthetic process [GO:0006171]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; glucose catabolic process [GO:0006007]; intracellular signal transduction [GO:0035556]; mitochondrial ATP transmembrane transport [GO:1990544]; negative regulation of cardiac muscle cell contraction [GO:0106135]; negative regulation of mitochondrial membrane potential [GO:0010917]; negative regulation of reactive oxygen species biosynthetic process [GO:1903427]; neuron projection extension [GO:1990138]; neuron projection maintenance [GO:1990535]; neuron projection retraction [GO:0106028]; positive regulation of apoptotic process [GO:0043065]; positive regulation of ATP biosynthetic process [GO:2001171]; positive regulation of axon extension [GO:0045773]; positive regulation of cardiac muscle cell apoptotic process [GO:0010666]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of glycogen catabolic process [GO:0045819]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; positive regulation of mitochondrial depolarization [GO:0051901]; positive regulation of ossification [GO:0045778]; positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway [GO:1903378]; positive regulation of protein targeting to mitochondrion [GO:1903955]; positive regulation of reactive oxygen species biosynthetic process [GO:1903428]; positive regulation of vascular associated smooth muscle cell apoptotic process [GO:1905461]; regulation of membrane repolarization [GO:0060306]; regulation of mitophagy [GO:1901524]; spermatogenesis [GO:0007283] apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; astrocyte end-foot [GO:0097450]; axon [GO:0030424]; basal part of cell [GO:0045178]; central region of growth cone [GO:0090724]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dendrite [GO:0030425]; extracellular region [GO:0005576]; growth cone [GO:0030426]; membrane [GO:0016020]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471] adenylate cyclase activity [GO:0004016]; ATP binding [GO:0005524]; ATPase binding [GO:0051117]; bicarbonate binding [GO:0071890]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145] g5311.t1 Q8C0T9 23.235 439 8.25e-22 107.0 sp|Q8C0T9|ADCYA_MOUSE Adenylate cyclase type 10 OS=Mus musculus OX=10090 GN=Adcy10 PE=1 SV=2 ADCYA_MOUSE reviewed Adenylate cyclase type 10 (EC 4.6.1.1) (Germ cell soluble adenylyl cyclase) (sAC) (Testicular soluble adenylyl cyclase) Mus musculus (Mouse) GO:0000287; GO:0003351; GO:0004016; GO:0005524; GO:0005576; GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0005856; GO:0005929; GO:0006007; GO:0006171; GO:0007283; GO:0010613; GO:0010666; GO:0010917; GO:0016020; GO:0016324; GO:0030145; GO:0030424; GO:0030425; GO:0030426; GO:0035556; GO:0043025; GO:0043065; GO:0045177; GO:0045178; GO:0045773; GO:0045778; GO:0045819; GO:0048471; GO:0051117; GO:0051901; GO:0060306; GO:0071890; GO:0090724; GO:0097450; GO:0106028; GO:0106135; GO:1901524; GO:1903378; GO:1903427; GO:1903428; GO:1903955; GO:1905461; GO:1990138; GO:1990535; GO:1990544; GO:2001171; GO:2001244 cAMP biosynthetic process [GO:0006171]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; glucose catabolic process [GO:0006007]; intracellular signal transduction [GO:0035556]; mitochondrial ATP transmembrane transport [GO:1990544]; negative regulation of cardiac muscle cell contraction [GO:0106135]; negative regulation of mitochondrial membrane potential [GO:0010917]; negative regulation of reactive oxygen species biosynthetic process [GO:1903427]; neuron projection extension [GO:1990138]; neuron projection maintenance [GO:1990535]; neuron projection retraction [GO:0106028]; positive regulation of apoptotic process [GO:0043065]; positive regulation of ATP biosynthetic process [GO:2001171]; positive regulation of axon extension [GO:0045773]; positive regulation of cardiac muscle cell apoptotic process [GO:0010666]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of glycogen catabolic process [GO:0045819]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; positive regulation of mitochondrial depolarization [GO:0051901]; positive regulation of ossification [GO:0045778]; positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway [GO:1903378]; positive regulation of protein targeting to mitochondrion [GO:1903955]; positive regulation of reactive oxygen species biosynthetic process [GO:1903428]; positive regulation of vascular associated smooth muscle cell apoptotic process [GO:1905461]; regulation of membrane repolarization [GO:0060306]; regulation of mitophagy [GO:1901524]; spermatogenesis [GO:0007283] apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; astrocyte end-foot [GO:0097450]; axon [GO:0030424]; basal part of cell [GO:0045178]; central region of growth cone [GO:0090724]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dendrite [GO:0030425]; extracellular region [GO:0005576]; growth cone [GO:0030426]; membrane [GO:0016020]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471] adenylate cyclase activity [GO:0004016]; ATP binding [GO:0005524]; ATPase binding [GO:0051117]; bicarbonate binding [GO:0071890]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145] g5312.t1 Q9ULB1 37.124 1064 0.0 692.0 sp|Q9ULB1|NRX1A_HUMAN Neurexin-1 OS=Homo sapiens OX=9606 GN=NRXN1 PE=1 SV=1 g5312.t1 Q9ULB1 24.184 889 7.36e-51 201.0 sp|Q9ULB1|NRX1A_HUMAN Neurexin-1 OS=Homo sapiens OX=9606 GN=NRXN1 PE=1 SV=1 g5312.t2 A1XQY1 34.814 1261 0.0 724.0 sp|A1XQY1|NR3BA_DANRE Neurexin-3b OS=Danio rerio OX=7955 GN=nrxn3b PE=2 SV=1 g5312.t2 A1XQY1 24.914 871 2.68e-50 200.0 sp|A1XQY1|NR3BA_DANRE Neurexin-3b OS=Danio rerio OX=7955 GN=nrxn3b PE=2 SV=1 g5314.t1 F4IYM4 30.691 492 4.72e-66 237.0 sp|F4IYM4|DEX1_ARATH Protein DEFECTIVE IN EXINE FORMATION 1 OS=Arabidopsis thaliana OX=3702 GN=DEX1 PE=2 SV=1 DEX1_ARATH reviewed Protein DEFECTIVE IN EXINE FORMATION 1 Arabidopsis thaliana (Mouse-ear cress) GO:0000137; GO:0005509; GO:0005783; GO:0005829; GO:0005886; GO:0010208; GO:0010584; GO:0016020; GO:0071555 cell wall organization [GO:0071555]; pollen exine formation [GO:0010584]; pollen wall assembly [GO:0010208] cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi cis cisterna [GO:0000137]; membrane [GO:0016020]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509] g5315.t1 B6NXD5 48.459 357 6.34e-117 347.0 sp|B6NXD5|BABA2_BRAFL BRISC and BRCA1-A complex member 2 OS=Branchiostoma floridae OX=7739 GN=BABAM2 PE=3 SV=1 BABA2_BRAFL reviewed BRISC and BRCA1-A complex member 2 (BRCA1-A complex subunit BRE) (BRCA1/BRCA2-containing complex subunit 45) (Brain and reproductive organ-expressed protein) Branchiostoma floridae (Florida lancelet) (Amphioxus) GO:0005634; GO:0005737; GO:0006302; GO:0006325; GO:0006915; GO:0007095; GO:0010212; GO:0031593; GO:0045739; GO:0051301; GO:0070531; GO:0070552 apoptotic process [GO:0006915]; cell division [GO:0051301]; chromatin organization [GO:0006325]; double-strand break repair [GO:0006302]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; positive regulation of DNA repair [GO:0045739]; response to ionizing radiation [GO:0010212] BRCA1-A complex [GO:0070531]; BRISC complex [GO:0070552]; cytoplasm [GO:0005737]; nucleus [GO:0005634] polyubiquitin modification-dependent protein binding [GO:0031593] g5317.t1 O35790 42.105 247 9.88e-65 205.0 sp|O35790|PIGL_RAT N-acetylglucosaminyl-phosphatidylinositol de-N-acetylase OS=Rattus norvegicus OX=10116 GN=Pigl PE=1 SV=1 g5318.t1 Q5FWF7 31.481 162 1.11e-22 91.3 sp|Q5FWF7|FBX48_HUMAN F-box only protein 48 OS=Homo sapiens OX=9606 GN=FBXO48 PE=1 SV=1 g5321.t1 A0A1D5NSM8 35.664 143 6.28e-22 105.0 sp|A0A1D5NSM8|SVEP1_DANRE Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 OS=Danio rerio OX=7955 GN=svep1 PE=1 SV=1 SVEP1_DANRE reviewed Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 (Polydom) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001945; GO:0005509; GO:0005576; GO:0005634; GO:0005737; GO:0008544; GO:0009913; GO:0016020; GO:0016477; GO:0036303; GO:0090136 cell migration [GO:0016477]; epidermal cell differentiation [GO:0009913]; epidermis development [GO:0008544]; epithelial cell-cell adhesion [GO:0090136]; lymph vessel development [GO:0001945]; lymph vessel morphogenesis [GO:0036303] cytoplasm [GO:0005737]; extracellular region [GO:0005576]; membrane [GO:0016020]; nucleus [GO:0005634] calcium ion binding [GO:0005509] g5322.t1 A0A1D5NSM8 29.263 434 9.13e-39 163.0 sp|A0A1D5NSM8|SVEP1_DANRE Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 OS=Danio rerio OX=7955 GN=svep1 PE=1 SV=1 SVEP1_DANRE reviewed Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 (Polydom) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001945; GO:0005509; GO:0005576; GO:0005634; GO:0005737; GO:0008544; GO:0009913; GO:0016020; GO:0016477; GO:0036303; GO:0090136 cell migration [GO:0016477]; epidermal cell differentiation [GO:0009913]; epidermis development [GO:0008544]; epithelial cell-cell adhesion [GO:0090136]; lymph vessel development [GO:0001945]; lymph vessel morphogenesis [GO:0036303] cytoplasm [GO:0005737]; extracellular region [GO:0005576]; membrane [GO:0016020]; nucleus [GO:0005634] calcium ion binding [GO:0005509] g5326.t1 P10079 40.554 397 6.0100000000000004e-80 271.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g5326.t1 P10079 34.356 489 5.3100000000000003e-79 268.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g5326.t1 P10079 40.263 380 7.480000000000001e-79 268.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g5326.t1 P10079 37.028 397 1.33e-76 261.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g5326.t1 P10079 37.626 396 8.4e-72 248.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g5326.t1 P10079 43.448 290 5.990000000000001e-59 212.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g5326.t1 P10079 40.086 232 1.7100000000000001e-43 167.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g5327.t1 Q4LDE5 29.158 463 3.21e-37 159.0 sp|Q4LDE5|SVEP1_HUMAN Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 OS=Homo sapiens OX=9606 GN=SVEP1 PE=1 SV=3 SVEP1_HUMAN reviewed Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 (CCP module-containing protein 22) (Polydom) (Selectin-like osteoblast-derived protein) (SEL-OB) (Serologically defined breast cancer antigen NY-BR-38) Homo sapiens (Human) GO:0003017; GO:0003682; GO:0005178; GO:0005509; GO:0005576; GO:0005615; GO:0005634; GO:0005737; GO:0008544; GO:0010467; GO:0010572; GO:0016020; GO:0036303; GO:0045906; GO:0048014; GO:0098640; GO:0120193 epidermis development [GO:0008544]; gene expression [GO:0010467]; lymph circulation [GO:0003017]; lymph vessel morphogenesis [GO:0036303]; negative regulation of vasoconstriction [GO:0045906]; positive regulation of platelet activation [GO:0010572]; Tie signaling pathway [GO:0048014]; tight junction organization [GO:0120193] cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; nucleus [GO:0005634] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; integrin binding [GO:0005178]; integrin binding involved in cell-matrix adhesion [GO:0098640] g5327.t1 Q4LDE5 26.382 398 1.21e-22 110.0 sp|Q4LDE5|SVEP1_HUMAN Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 OS=Homo sapiens OX=9606 GN=SVEP1 PE=1 SV=3 SVEP1_HUMAN reviewed Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 (CCP module-containing protein 22) (Polydom) (Selectin-like osteoblast-derived protein) (SEL-OB) (Serologically defined breast cancer antigen NY-BR-38) Homo sapiens (Human) GO:0003017; GO:0003682; GO:0005178; GO:0005509; GO:0005576; GO:0005615; GO:0005634; GO:0005737; GO:0008544; GO:0010467; GO:0010572; GO:0016020; GO:0036303; GO:0045906; GO:0048014; GO:0098640; GO:0120193 epidermis development [GO:0008544]; gene expression [GO:0010467]; lymph circulation [GO:0003017]; lymph vessel morphogenesis [GO:0036303]; negative regulation of vasoconstriction [GO:0045906]; positive regulation of platelet activation [GO:0010572]; Tie signaling pathway [GO:0048014]; tight junction organization [GO:0120193] cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; nucleus [GO:0005634] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; integrin binding [GO:0005178]; integrin binding involved in cell-matrix adhesion [GO:0098640] g5327.t1 Q4LDE5 24.961 649 1.57e-22 110.0 sp|Q4LDE5|SVEP1_HUMAN Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 OS=Homo sapiens OX=9606 GN=SVEP1 PE=1 SV=3 SVEP1_HUMAN reviewed Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 (CCP module-containing protein 22) (Polydom) (Selectin-like osteoblast-derived protein) (SEL-OB) (Serologically defined breast cancer antigen NY-BR-38) Homo sapiens (Human) GO:0003017; GO:0003682; GO:0005178; GO:0005509; GO:0005576; GO:0005615; GO:0005634; GO:0005737; GO:0008544; GO:0010467; GO:0010572; GO:0016020; GO:0036303; GO:0045906; GO:0048014; GO:0098640; GO:0120193 epidermis development [GO:0008544]; gene expression [GO:0010467]; lymph circulation [GO:0003017]; lymph vessel morphogenesis [GO:0036303]; negative regulation of vasoconstriction [GO:0045906]; positive regulation of platelet activation [GO:0010572]; Tie signaling pathway [GO:0048014]; tight junction organization [GO:0120193] cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; nucleus [GO:0005634] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; integrin binding [GO:0005178]; integrin binding involved in cell-matrix adhesion [GO:0098640] g5338.t1 P23253 24.668 527 1.61e-28 125.0 sp|P23253|TCNA_TRYCR Sialidase OS=Trypanosoma cruzi OX=5693 GN=TCNA PE=2 SV=1 g5338.t1 P23253 24.668 527 3.05e-28 124.0 sp|P23253|TCNA_TRYCR Sialidase OS=Trypanosoma cruzi OX=5693 GN=TCNA PE=2 SV=1 g5338.t1 P23253 24.668 527 2.0900000000000003e-27 121.0 sp|P23253|TCNA_TRYCR Sialidase OS=Trypanosoma cruzi OX=5693 GN=TCNA PE=2 SV=1 g5338.t1 P23253 24.853 511 3.2200000000000004e-27 120.0 sp|P23253|TCNA_TRYCR Sialidase OS=Trypanosoma cruzi OX=5693 GN=TCNA PE=2 SV=1 g5338.t1 P23253 25.0 504 5.7e-24 110.0 sp|P23253|TCNA_TRYCR Sialidase OS=Trypanosoma cruzi OX=5693 GN=TCNA PE=2 SV=1 g5339.t1 Q96MB7 30.522 249 1.47e-26 112.0 sp|Q96MB7|HARB1_HUMAN Putative nuclease HARBI1 OS=Homo sapiens OX=9606 GN=HARBI1 PE=1 SV=1 HARB1_HUMAN reviewed Putative nuclease HARBI1 (EC 3.1.-.-) (Harbinger transposase-derived nuclease) Homo sapiens (Human) GO:0004518; GO:0005634; GO:0005829; GO:0005886; GO:0016787; GO:0034451; GO:0046872 centriolar satellite [GO:0034451]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886] hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]; nuclease activity [GO:0004518] g20092.t1 O43818 51.304 345 1.3e-114 346.0 sp|O43818|U3IP2_HUMAN U3 small nucleolar RNA-interacting protein 2 OS=Homo sapiens OX=9606 GN=RRP9 PE=1 SV=1 U3IP2_HUMAN reviewed U3 small nucleolar RNA-interacting protein 2 (RRP9 homolog) (U3 small nucleolar ribonucleoprotein-associated 55 kDa protein) (U3 snoRNP-associated 55 kDa protein) (U3-55K) Homo sapiens (Human) GO:0003723; GO:0005654; GO:0005730; GO:0006364; GO:0030515; GO:0031428; GO:0032040; GO:0034511; GO:0042274 ribosomal small subunit biogenesis [GO:0042274]; rRNA processing [GO:0006364] box C/D methylation guide snoRNP complex [GO:0031428]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; small-subunit processome [GO:0032040] RNA binding [GO:0003723]; snoRNA binding [GO:0030515]; U3 snoRNA binding [GO:0034511] g20093.t1 Q02543 70.455 176 5.38e-86 253.0 sp|Q02543|RL18A_HUMAN Large ribosomal subunit protein eL20 OS=Homo sapiens OX=9606 GN=RPL18A PE=1 SV=2 RL18A_HUMAN reviewed Large ribosomal subunit protein eL20 (60S ribosomal protein L18a) Homo sapiens (Human) GO:0002181; GO:0003723; GO:0003735; GO:0005737; GO:0005829; GO:0006412; GO:0014069; GO:0016020; GO:0022625; GO:0022626 cytoplasmic translation [GO:0002181]; translation [GO:0006412] cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; membrane [GO:0016020]; postsynaptic density [GO:0014069] RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735] g20094.t1 Q8JZN5 61.214 593 0.0 744.0 sp|Q8JZN5|ACAD9_MOUSE Complex I assembly factor ACAD9, mitochondrial OS=Mus musculus OX=10090 GN=Acad9 PE=1 SV=2 ACAD9_MOUSE reviewed Complex I assembly factor ACAD9, mitochondrial (Acyl-CoA dehydrogenase family member 9) (ACAD-9) (EC 1.3.8.7, EC 1.3.8.8) Mus musculus (Mouse) GO:0001676; GO:0003995; GO:0004466; GO:0005634; GO:0005739; GO:0005743; GO:0030425; GO:0031966; GO:0032981; GO:0046395; GO:0050660; GO:0051791; GO:0070991 carboxylic acid catabolic process [GO:0046395]; long-chain fatty acid metabolic process [GO:0001676]; medium-chain fatty acid metabolic process [GO:0051791]; mitochondrial respiratory chain complex I assembly [GO:0032981] dendrite [GO:0030425]; mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; nucleus [GO:0005634] acyl-CoA dehydrogenase activity [GO:0003995]; flavin adenine dinucleotide binding [GO:0050660]; long-chain fatty acyl-CoA dehydrogenase activity [GO:0004466]; medium-chain fatty acyl-CoA dehydrogenase activity [GO:0070991] g20095.t1 Q5XI64 39.344 305 1.3100000000000001e-73 234.0 sp|Q5XI64|ABHD6_RAT Monoacylglycerol lipase ABHD6 OS=Rattus norvegicus OX=10116 GN=Abhd6 PE=1 SV=1 ABHD6_RAT reviewed Monoacylglycerol lipase ABHD6 (EC 3.1.1.23) (2-arachidonoylglycerol hydrolase) (Abhydrolase domain-containing protein 6) Rattus norvegicus (Rat) GO:0004620; GO:0005739; GO:0005765; GO:0009395; GO:0016020; GO:0030336; GO:0031902; GO:0031966; GO:0032281; GO:0045211; GO:0046464; GO:0046889; GO:0047372; GO:0052651; GO:0060292; GO:0098978; GO:0098982; GO:0099178; GO:0120163; GO:2000124; GO:2001311 acylglycerol catabolic process [GO:0046464]; long-term synaptic depression [GO:0060292]; lysobisphosphatidic acid metabolic process [GO:2001311]; monoacylglycerol catabolic process [GO:0052651]; negative regulation of cell migration [GO:0030336]; negative regulation of cold-induced thermogenesis [GO:0120163]; phospholipid catabolic process [GO:0009395]; positive regulation of lipid biosynthetic process [GO:0046889]; regulation of endocannabinoid signaling pathway [GO:2000124]; regulation of retrograde trans-synaptic signaling by endocanabinoid [GO:0099178] AMPA glutamate receptor complex [GO:0032281]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; postsynaptic membrane [GO:0045211] monoacylglycerol lipase activity [GO:0047372]; phospholipase activity [GO:0004620] g20096.t1 Q5U3U3 54.967 453 1.73e-177 517.0 sp|Q5U3U3|CPT2_DANRE Carnitine O-palmitoyltransferase 2, mitochondrial OS=Danio rerio OX=7955 GN=cpt2 PE=2 SV=2 CPT2_DANRE reviewed Carnitine O-palmitoyltransferase 2, mitochondrial (EC 2.3.1.21) (Carnitine palmitoyltransferase II) (CPT II) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0004095; GO:0005739; GO:0005743; GO:0006635; GO:0008458; GO:0015909 fatty acid beta-oxidation [GO:0006635]; long-chain fatty acid transport [GO:0015909] mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739] carnitine O-octanoyltransferase activity [GO:0008458]; carnitine O-palmitoyltransferase activity [GO:0004095] g20098.t1 Q7ZXE1 40.972 144 1.25e-28 112.0 sp|Q7ZXE1|CPT2_XENLA Carnitine O-palmitoyltransferase 2, mitochondrial OS=Xenopus laevis OX=8355 GN=cpt2 PE=2 SV=1 CPT2_XENLA reviewed Carnitine O-palmitoyltransferase 2, mitochondrial (EC 2.3.1.21) (Carnitine palmitoyltransferase II) (CPT II) Xenopus laevis (African clawed frog) GO:0004095; GO:0005739; GO:0005743; GO:0006635; GO:0008458; GO:0015909 fatty acid beta-oxidation [GO:0006635]; long-chain fatty acid transport [GO:0015909] mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739] carnitine O-octanoyltransferase activity [GO:0008458]; carnitine O-palmitoyltransferase activity [GO:0004095] g20099.t1 Q6P2K3 40.842 404 1.2300000000000001e-79 276.0 sp|Q6P2K3|CF20D_MOUSE Protein CFAP20DC OS=Mus musculus OX=10090 GN=Cfap20dc PE=2 SV=2 g20101.t1 Q96SB4 75.362 207 7.31e-107 345.0 sp|Q96SB4|SRPK1_HUMAN SRSF protein kinase 1 OS=Homo sapiens OX=9606 GN=SRPK1 PE=1 SV=2 SRPK1_HUMAN reviewed SRSF protein kinase 1 (EC 2.7.11.1) (SFRS protein kinase 1) (Serine/arginine-rich protein-specific kinase 1) (SR-protein-specific kinase 1) Homo sapiens (Human) GO:0000245; GO:0000287; GO:0000785; GO:0003723; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0006468; GO:0007059; GO:0008380; GO:0016363; GO:0016607; GO:0035092; GO:0035556; GO:0045070; GO:0045071; GO:0045087; GO:0048024; GO:0050684; GO:0106310 chromosome segregation [GO:0007059]; innate immune response [GO:0045087]; intracellular signal transduction [GO:0035556]; negative regulation of viral genome replication [GO:0045071]; positive regulation of viral genome replication [GO:0045070]; protein phosphorylation [GO:0006468]; regulation of mRNA processing [GO:0050684]; regulation of mRNA splicing, via spliceosome [GO:0048024]; RNA splicing [GO:0008380]; sperm DNA condensation [GO:0035092]; spliceosomal complex assembly [GO:0000245] chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886] ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; RNA binding [GO:0003723] g20101.t1 Q96SB4 62.694 193 2.67e-78 269.0 sp|Q96SB4|SRPK1_HUMAN SRSF protein kinase 1 OS=Homo sapiens OX=9606 GN=SRPK1 PE=1 SV=2 SRPK1_HUMAN reviewed SRSF protein kinase 1 (EC 2.7.11.1) (SFRS protein kinase 1) (Serine/arginine-rich protein-specific kinase 1) (SR-protein-specific kinase 1) Homo sapiens (Human) GO:0000245; GO:0000287; GO:0000785; GO:0003723; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0006468; GO:0007059; GO:0008380; GO:0016363; GO:0016607; GO:0035092; GO:0035556; GO:0045070; GO:0045071; GO:0045087; GO:0048024; GO:0050684; GO:0106310 chromosome segregation [GO:0007059]; innate immune response [GO:0045087]; intracellular signal transduction [GO:0035556]; negative regulation of viral genome replication [GO:0045071]; positive regulation of viral genome replication [GO:0045070]; protein phosphorylation [GO:0006468]; regulation of mRNA processing [GO:0050684]; regulation of mRNA splicing, via spliceosome [GO:0048024]; RNA splicing [GO:0008380]; sperm DNA condensation [GO:0035092]; spliceosomal complex assembly [GO:0000245] chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886] ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; RNA binding [GO:0003723] g20101.t2 Q96SB4 75.362 207 1e-106 345.0 sp|Q96SB4|SRPK1_HUMAN SRSF protein kinase 1 OS=Homo sapiens OX=9606 GN=SRPK1 PE=1 SV=2 SRPK1_HUMAN reviewed SRSF protein kinase 1 (EC 2.7.11.1) (SFRS protein kinase 1) (Serine/arginine-rich protein-specific kinase 1) (SR-protein-specific kinase 1) Homo sapiens (Human) GO:0000245; GO:0000287; GO:0000785; GO:0003723; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0006468; GO:0007059; GO:0008380; GO:0016363; GO:0016607; GO:0035092; GO:0035556; GO:0045070; GO:0045071; GO:0045087; GO:0048024; GO:0050684; GO:0106310 chromosome segregation [GO:0007059]; innate immune response [GO:0045087]; intracellular signal transduction [GO:0035556]; negative regulation of viral genome replication [GO:0045071]; positive regulation of viral genome replication [GO:0045070]; protein phosphorylation [GO:0006468]; regulation of mRNA processing [GO:0050684]; regulation of mRNA splicing, via spliceosome [GO:0048024]; RNA splicing [GO:0008380]; sperm DNA condensation [GO:0035092]; spliceosomal complex assembly [GO:0000245] chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886] ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; RNA binding [GO:0003723] g20101.t2 Q96SB4 62.694 193 3.33e-78 269.0 sp|Q96SB4|SRPK1_HUMAN SRSF protein kinase 1 OS=Homo sapiens OX=9606 GN=SRPK1 PE=1 SV=2 SRPK1_HUMAN reviewed SRSF protein kinase 1 (EC 2.7.11.1) (SFRS protein kinase 1) (Serine/arginine-rich protein-specific kinase 1) (SR-protein-specific kinase 1) Homo sapiens (Human) GO:0000245; GO:0000287; GO:0000785; GO:0003723; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0006468; GO:0007059; GO:0008380; GO:0016363; GO:0016607; GO:0035092; GO:0035556; GO:0045070; GO:0045071; GO:0045087; GO:0048024; GO:0050684; GO:0106310 chromosome segregation [GO:0007059]; innate immune response [GO:0045087]; intracellular signal transduction [GO:0035556]; negative regulation of viral genome replication [GO:0045071]; positive regulation of viral genome replication [GO:0045070]; protein phosphorylation [GO:0006468]; regulation of mRNA processing [GO:0050684]; regulation of mRNA splicing, via spliceosome [GO:0048024]; RNA splicing [GO:0008380]; sperm DNA condensation [GO:0035092]; spliceosomal complex assembly [GO:0000245] chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886] ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; RNA binding [GO:0003723] g20103.t1 Q66KD5 52.289 415 1.6499999999999998e-114 343.0 sp|Q66KD5|ING3_XENTR Inhibitor of growth protein 3 OS=Xenopus tropicalis OX=8364 GN=ing3 PE=2 SV=1 g20105.t1 Q9TT91 42.857 399 4.67e-111 342.0 sp|Q9TT91|MKRN1_NOTEU E3 ubiquitin-protein ligase makorin-1 OS=Notamacropus eugenii OX=9315 GN=MKRN1 PE=2 SV=1 g20106.t1 Q9WUN2 38.757 756 2.74e-161 501.0 sp|Q9WUN2|TBK1_MOUSE Serine/threonine-protein kinase TBK1 OS=Mus musculus OX=10090 GN=Tbk1 PE=1 SV=1 TBK1_MOUSE reviewed Serine/threonine-protein kinase TBK1 (EC 2.7.11.1) (T2K) (TANK-binding kinase 1) Mus musculus (Mouse) GO:0002181; GO:0002218; GO:0002753; GO:0003676; GO:0004674; GO:0005524; GO:0005654; GO:0005737; GO:0005829; GO:0006468; GO:0006606; GO:0009299; GO:0010468; GO:0010508; GO:0010629; GO:0016239; GO:0018105; GO:0018107; GO:0019903; GO:0031669; GO:0032479; GO:0032481; GO:0032727; GO:0032728; GO:0034142; GO:0038202; GO:0038203; GO:0042802; GO:0043123; GO:0043491; GO:0044565; GO:0045087; GO:0045944; GO:0045948; GO:0050830; GO:0051219; GO:0051897; GO:0060340; GO:0061470; GO:0061629; GO:0106310; GO:0140374; GO:0140896; GO:1904262; GO:1904263; GO:1904417; GO:1904515 activation of innate immune response [GO:0002218]; antiviral innate immune response [GO:0140374]; cellular response to nutrient levels [GO:0031669]; cGAS/STING signaling pathway [GO:0140896]; cytoplasmic pattern recognition receptor signaling pathway [GO:0002753]; cytoplasmic translation [GO:0002181]; defense response to Gram-positive bacterium [GO:0050830]; dendritic cell proliferation [GO:0044565]; innate immune response [GO:0045087]; mRNA transcription [GO:0009299]; negative regulation of gene expression [GO:0010629]; negative regulation of TORC1 signaling [GO:1904262]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; positive regulation of autophagy [GO:0010508]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of macroautophagy [GO:0016239]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of TORC1 signaling [GO:1904263]; positive regulation of TORC2 signaling [GO:1904515]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of translational initiation [GO:0045948]; positive regulation of type I interferon production [GO:0032481]; positive regulation of type I interferon-mediated signaling pathway [GO:0060340]; positive regulation of xenophagy [GO:1904417]; protein import into nucleus [GO:0006606]; protein phosphorylation [GO:0006468]; regulation of gene expression [GO:0010468]; regulation of type I interferon production [GO:0032479]; T follicular helper cell differentiation [GO:0061470]; toll-like receptor 4 signaling pathway [GO:0034142]; TORC1 signaling [GO:0038202]; TORC2 signaling [GO:0038203] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654] ATP binding [GO:0005524]; identical protein binding [GO:0042802]; nucleic acid binding [GO:0003676]; phosphoprotein binding [GO:0051219]; protein phosphatase binding [GO:0019903]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629] g20107.t1 E7F654 31.967 610 9.860000000000001e-72 256.0 sp|E7F654|NOL9_DANRE Polynucleotide 5'-hydroxyl-kinase NOL9 OS=Danio rerio OX=7955 GN=nol9 PE=3 SV=1 g20111.t1 A8MWY0 39.085 962 0.0 689.0 sp|A8MWY0|ELAP2_HUMAN Endosome/lysosome-associated apoptosis and autophagy regulator family member 2 OS=Homo sapiens OX=9606 GN=ELAPOR2 PE=1 SV=2 ELAP2_HUMAN reviewed Endosome/lysosome-associated apoptosis and autophagy regulator family member 2 (Estrogen-induced gene 121-like protein) (hEIG121L) Homo sapiens (Human) GO:0005886; GO:0016020; GO:0030513; GO:0045684; GO:0051961; GO:0070700 negative regulation of nervous system development [GO:0051961]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of epidermis development [GO:0045684] membrane [GO:0016020]; plasma membrane [GO:0005886] BMP receptor binding [GO:0070700] g20111.t2 A8MWY0 39.226 956 0.0 689.0 sp|A8MWY0|ELAP2_HUMAN Endosome/lysosome-associated apoptosis and autophagy regulator family member 2 OS=Homo sapiens OX=9606 GN=ELAPOR2 PE=1 SV=2 ELAP2_HUMAN reviewed Endosome/lysosome-associated apoptosis and autophagy regulator family member 2 (Estrogen-induced gene 121-like protein) (hEIG121L) Homo sapiens (Human) GO:0005886; GO:0016020; GO:0030513; GO:0045684; GO:0051961; GO:0070700 negative regulation of nervous system development [GO:0051961]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of epidermis development [GO:0045684] membrane [GO:0016020]; plasma membrane [GO:0005886] BMP receptor binding [GO:0070700] g20112.t1 A8Y5T1 48.171 164 2.8e-50 162.0 sp|A8Y5T1|CF276_DANRE Protein CFAP276 OS=Danio rerio OX=7955 GN=cfap276 PE=3 SV=1 g20113.t1 Q9H1D0 27.133 586 1.67e-42 170.0 sp|Q9H1D0|TRPV6_HUMAN Transient receptor potential cation channel subfamily V member 6 OS=Homo sapiens OX=9606 GN=TRPV6 PE=1 SV=3 g20117.t1 P69478 33.466 251 9.89e-38 139.0 sp|P69478|CHSTB_RAT Carbohydrate sulfotransferase 11 OS=Rattus norvegicus OX=10116 GN=Chst11 PE=1 SV=1 CHSTB_RAT reviewed Carbohydrate sulfotransferase 11 (EC 2.8.2.5) (Chondroitin 4-O-sulfotransferase 1) (Chondroitin 4-sulfotransferase 1) (C4S-1) (C4ST-1) (C4ST1) Rattus norvegicus (Rat) GO:0000139; GO:0001537; GO:0001701; GO:0002063; GO:0007585; GO:0008146; GO:0009791; GO:0016051; GO:0030166; GO:0030326; GO:0030512; GO:0033037; GO:0036342; GO:0042127; GO:0042733; GO:0043066; GO:0047756; GO:0048589; GO:0048703; GO:0048704; GO:0050650; GO:0050654; GO:0050659; GO:0051216 carbohydrate biosynthetic process [GO:0016051]; cartilage development [GO:0051216]; chondrocyte development [GO:0002063]; chondroitin sulfate proteoglycan biosynthetic process [GO:0050650]; chondroitin sulfate proteoglycan metabolic process [GO:0050654]; developmental growth [GO:0048589]; embryonic digit morphogenesis [GO:0042733]; embryonic limb morphogenesis [GO:0030326]; embryonic skeletal system morphogenesis [GO:0048704]; embryonic viscerocranium morphogenesis [GO:0048703]; in utero embryonic development [GO:0001701]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; polysaccharide localization [GO:0033037]; post-anal tail morphogenesis [GO:0036342]; post-embryonic development [GO:0009791]; proteoglycan biosynthetic process [GO:0030166]; regulation of cell population proliferation [GO:0042127]; respiratory gaseous exchange by respiratory system [GO:0007585] Golgi membrane [GO:0000139] chondroitin 4-sulfotransferase activity [GO:0047756]; dermatan 4-sulfotransferase activity [GO:0001537]; N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity [GO:0050659]; sulfotransferase activity [GO:0008146] g20118.t1 Q805E5 32.155 283 8.270000000000001e-36 134.0 sp|Q805E5|CHSTE_DANRE Carbohydrate sulfotransferase 14 OS=Danio rerio OX=7955 GN=chst14 PE=2 SV=1 CHSTE_DANRE reviewed Carbohydrate sulfotransferase 14 (EC 2.8.2.-) (Dermatan 4-sulfotransferase 1) (D4ST-1) (zD4ST-1) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000139; GO:0001537; GO:0008146; GO:0016051; GO:0050655 carbohydrate biosynthetic process [GO:0016051]; dermatan sulfate proteoglycan metabolic process [GO:0050655] Golgi membrane [GO:0000139] dermatan 4-sulfotransferase activity [GO:0001537]; sulfotransferase activity [GO:0008146] g20120.t1 Q805E5 29.329 283 1.38e-31 123.0 sp|Q805E5|CHSTE_DANRE Carbohydrate sulfotransferase 14 OS=Danio rerio OX=7955 GN=chst14 PE=2 SV=1 CHSTE_DANRE reviewed Carbohydrate sulfotransferase 14 (EC 2.8.2.-) (Dermatan 4-sulfotransferase 1) (D4ST-1) (zD4ST-1) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000139; GO:0001537; GO:0008146; GO:0016051; GO:0050655 carbohydrate biosynthetic process [GO:0016051]; dermatan sulfate proteoglycan metabolic process [GO:0050655] Golgi membrane [GO:0000139] dermatan 4-sulfotransferase activity [GO:0001537]; sulfotransferase activity [GO:0008146] g20124.t1 Q9NQA5 25.193 389 2.28e-27 120.0 sp|Q9NQA5|TRPV5_HUMAN Transient receptor potential cation channel subfamily V member 5 OS=Homo sapiens OX=9606 GN=TRPV5 PE=1 SV=3 TRPV5_HUMAN reviewed Transient receptor potential cation channel subfamily V member 5 (TrpV5) (Calcium transport protein 2) (CaT2) (Epithelial calcium channel 1) (ECaC) (ECaC1) (Osm-9-like TRP channel 3) (OTRPC3) Homo sapiens (Human) GO:0005262; GO:0005516; GO:0005886; GO:0006816; GO:0016324; GO:0034704; GO:0035809; GO:0046872; GO:0051289; GO:0055074; GO:0060402; GO:0070588; GO:0098703 calcium ion homeostasis [GO:0055074]; calcium ion import across plasma membrane [GO:0098703]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; calcium ion transport into cytosol [GO:0060402]; protein homotetramerization [GO:0051289]; regulation of urine volume [GO:0035809] apical plasma membrane [GO:0016324]; calcium channel complex [GO:0034704]; plasma membrane [GO:0005886] calcium channel activity [GO:0005262]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872] g20125.t1 Q96GS4 44.118 102 1.81e-25 108.0 sp|Q96GS4|BORC6_HUMAN BLOC-1-related complex subunit 6 OS=Homo sapiens OX=9606 GN=BORCS6 PE=1 SV=2 g20125.t2 Q96GS4 35.673 171 4.0700000000000005e-27 113.0 sp|Q96GS4|BORC6_HUMAN BLOC-1-related complex subunit 6 OS=Homo sapiens OX=9606 GN=BORCS6 PE=1 SV=2 g20127.t1 Q9FWW6 38.545 275 3.3099999999999997e-52 180.0 sp|Q9FWW6|GSXL1_ARATH Flavin-containing monooxygenase FMO GS-OX-like 1 OS=Arabidopsis thaliana OX=3702 GN=At1g12160 PE=2 SV=1 g20128.t1 Q9C8U0 38.875 391 8.12e-81 259.0 sp|Q9C8U0|GSXL5_ARATH Flavin-containing monooxygenase FMO GS-OX-like 5 OS=Arabidopsis thaliana OX=3702 GN=At1g63370 PE=2 SV=2 g20129.t1 Q9C8U0 39.386 391 4.75e-81 258.0 sp|Q9C8U0|GSXL5_ARATH Flavin-containing monooxygenase FMO GS-OX-like 5 OS=Arabidopsis thaliana OX=3702 GN=At1g63370 PE=2 SV=2 g20130.t1 Q9JJ46 40.639 219 1.2799999999999999e-52 172.0 sp|Q9JJ46|EBP_RAT 3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase OS=Rattus norvegicus OX=10116 GN=Ebp PE=1 SV=3 EBP_RAT reviewed 3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase (EC 5.3.3.5) (Cholestenol Delta-isomerase) (Cholesterol-5,6-epoxide hydrolase subunit EBP) (EC 3.3.2.11) (Delta(8)-Delta(7) sterol isomerase) (D8-D7 sterol isomerase) (Emopamil-binding protein) (Sterol 8-isomerase) Rattus norvegicus (Rat) GO:0000247; GO:0004769; GO:0005635; GO:0005783; GO:0005789; GO:0006695; GO:0008203; GO:0016126; GO:0016863; GO:0030097; GO:0031410; GO:0031965; GO:0033489; GO:0033490; GO:0033963; GO:0042802; GO:0043931; GO:0047750 cholesterol biosynthetic process [GO:0006695]; cholesterol biosynthetic process via desmosterol [GO:0033489]; cholesterol biosynthetic process via lathosterol [GO:0033490]; cholesterol metabolic process [GO:0008203]; hemopoiesis [GO:0030097]; ossification involved in bone maturation [GO:0043931]; sterol biosynthetic process [GO:0016126] cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965] C-8 sterol isomerase activity [GO:0000247]; cholestenol delta-isomerase activity [GO:0047750]; cholesterol-5,6-oxide hydrolase activity [GO:0033963]; identical protein binding [GO:0042802]; intramolecular oxidoreductase activity, transposing C=C bonds [GO:0016863]; steroid Delta-isomerase activity [GO:0004769] g20131.t1 Q60490 42.986 221 1.21e-58 188.0 sp|Q60490|EBP_CAVPO 3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase OS=Cavia porcellus OX=10141 GN=EBP PE=1 SV=3 g20132.t1 Q60490 43.056 216 8.08e-56 181.0 sp|Q60490|EBP_CAVPO 3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase OS=Cavia porcellus OX=10141 GN=EBP PE=1 SV=3 g20133.t1 P70245 39.035 228 1.0599999999999999e-48 162.0 sp|P70245|EBP_MOUSE 3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase OS=Mus musculus OX=10090 GN=Ebp PE=1 SV=3 EBP_MOUSE reviewed 3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase (EC 5.3.3.5) (Cholestenol Delta-isomerase) (Cholesterol-5,6-epoxide hydrolase subunit EBP) (EC 3.3.2.11) (Delta(8)-Delta(7) sterol isomerase) (D8-D7 sterol isomerase) (Emopamil-binding protein) Mus musculus (Mouse) GO:0000247; GO:0004769; GO:0005635; GO:0005783; GO:0005789; GO:0006695; GO:0016126; GO:0016863; GO:0030097; GO:0031410; GO:0031965; GO:0033489; GO:0033490; GO:0033963; GO:0042802; GO:0043931; GO:0047750 cholesterol biosynthetic process [GO:0006695]; cholesterol biosynthetic process via desmosterol [GO:0033489]; cholesterol biosynthetic process via lathosterol [GO:0033490]; hemopoiesis [GO:0030097]; ossification involved in bone maturation [GO:0043931]; sterol biosynthetic process [GO:0016126] cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965] C-8 sterol isomerase activity [GO:0000247]; cholestenol delta-isomerase activity [GO:0047750]; cholesterol-5,6-oxide hydrolase activity [GO:0033963]; identical protein binding [GO:0042802]; intramolecular oxidoreductase activity, transposing C=C bonds [GO:0016863]; steroid Delta-isomerase activity [GO:0004769] g20134.t1 Q5F3N6 42.838 740 1.0800000000000001e-161 487.0 sp|Q5F3N6|BAP1_CHICK Ubiquitin carboxyl-terminal hydrolase BAP1 OS=Gallus gallus OX=9031 GN=BAP1 PE=2 SV=1 BAP1_CHICK reviewed Ubiquitin carboxyl-terminal hydrolase BAP1 (EC 3.4.19.12) (BRCA1-associated protein 1) Gallus gallus (Chicken) GO:0001558; GO:0003682; GO:0004843; GO:0005634; GO:0005737; GO:0006511; GO:0016579; GO:0031507; GO:0035517; GO:0045892; GO:0051726; GO:0071108 heterochromatin formation [GO:0031507]; negative regulation of DNA-templated transcription [GO:0045892]; protein deubiquitination [GO:0016579]; protein K48-linked deubiquitination [GO:0071108]; regulation of cell cycle [GO:0051726]; regulation of cell growth [GO:0001558]; ubiquitin-dependent protein catabolic process [GO:0006511] cytoplasm [GO:0005737]; nucleus [GO:0005634]; PR-DUB complex [GO:0035517] chromatin binding [GO:0003682]; cysteine-type deubiquitinase activity [GO:0004843] g20136.t1 P30531 52.305 629 0.0 686.0 sp|P30531|SC6A1_HUMAN Sodium- and chloride-dependent GABA transporter 1 OS=Homo sapiens OX=9606 GN=SLC6A1 PE=1 SV=2 SC6A1_HUMAN reviewed Sodium- and chloride-dependent GABA transporter 1 (GAT-1) (Solute carrier family 6 member 1) Homo sapiens (Human) GO:0005332; GO:0005886; GO:0006865; GO:0007268; GO:0007613; GO:0008306; GO:0009986; GO:0015185; GO:0015378; GO:0016020; GO:0030424; GO:0035725; GO:0043025; GO:0046872; GO:0050808; GO:0051936; GO:0051939; GO:0098658; GO:0098719; GO:0098793; GO:0098982; GO:0150104; GO:1902476 amino acid transport [GO:0006865]; associative learning [GO:0008306]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; gamma-aminobutyric acid import [GO:0051939]; gamma-aminobutyric acid reuptake [GO:0051936]; inorganic anion import across plasma membrane [GO:0098658]; memory [GO:0007613]; sodium ion import across plasma membrane [GO:0098719]; sodium ion transmembrane transport [GO:0035725]; synapse organization [GO:0050808]; transport across blood-brain barrier [GO:0150104] axon [GO:0030424]; cell surface [GO:0009986]; GABA-ergic synapse [GO:0098982]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; presynapse [GO:0098793] gamma-aminobutyric acid transmembrane transporter activity [GO:0015185]; gamma-aminobutyric acid:sodium:chloride symporter activity [GO:0005332]; metal ion binding [GO:0046872]; sodium:chloride symporter activity [GO:0015378] g20137.t1 Q91178 30.556 432 4.24e-49 176.0 sp|Q91178|GPRX_ORYLA Probable G-protein coupled receptor (Fragment) OS=Oryzias latipes OX=8090 PE=3 SV=1 g20141.t1 Q96DM1 33.141 519 2.4e-80 267.0 sp|Q96DM1|PGBD4_HUMAN PiggyBac transposable element-derived protein 4 OS=Homo sapiens OX=9606 GN=PGBD4 PE=1 SV=3 g20142.t1 Q9WUV0 59.637 441 0.0 538.0 sp|Q9WUV0|ORC5_MOUSE Origin recognition complex subunit 5 OS=Mus musculus OX=10090 GN=Orc5 PE=2 SV=1 g20143.t1 P82451 36.487 1617 0.0 1005.0 sp|P82451|ABCC9_RABIT ATP-binding cassette sub-family C member 9 OS=Oryctolagus cuniculus OX=9986 GN=ABCC9 PE=2 SV=1 g20144.t1 Q09428 33.279 1220 1.89e-176 571.0 sp|Q09428|ABCC8_HUMAN ATP-binding cassette sub-family C member 8 OS=Homo sapiens OX=9606 GN=ABCC8 PE=1 SV=6 ABCC8_HUMAN reviewed ATP-binding cassette sub-family C member 8 (Sulfonylurea receptor 1) Homo sapiens (Human) GO:0001508; GO:0001678; GO:0005267; GO:0005524; GO:0005886; GO:0006813; GO:0007565; GO:0007613; GO:0008281; GO:0008282; GO:0008542; GO:0009268; GO:0009410; GO:0010043; GO:0010989; GO:0015272; GO:0016525; GO:0016887; GO:0019829; GO:0030672; GO:0031004; GO:0031669; GO:0032496; GO:0032760; GO:0032868; GO:0035774; GO:0042383; GO:0042734; GO:0043268; GO:0043531; GO:0044325; GO:0046676; GO:0046872; GO:0050796; GO:0050905; GO:0055085; GO:0060253; GO:0061535; GO:0061855; GO:0071805; GO:0098662; GO:0140359; GO:1900721; GO:1905075; GO:1905604; GO:1990573 action potential [GO:0001508]; cellular response to nutrient levels [GO:0031669]; female pregnancy [GO:0007565]; glutamate secretion, neurotransmission [GO:0061535]; inorganic cation transmembrane transport [GO:0098662]; intracellular glucose homeostasis [GO:0001678]; memory [GO:0007613]; negative regulation of angiogenesis [GO:0016525]; negative regulation of blood-brain barrier permeability [GO:1905604]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of insulin secretion [GO:0046676]; negative regulation of low-density lipoprotein particle clearance [GO:0010989]; negative regulation of neuroblast migration [GO:0061855]; neuromuscular process [GO:0050905]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of potassium ion transport [GO:0043268]; positive regulation of tight junction disassembly [GO:1905075]; positive regulation of tumor necrosis factor production [GO:0032760]; positive regulation of uterine smooth muscle relaxation [GO:1900721]; potassium ion import across plasma membrane [GO:1990573]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; regulation of insulin secretion [GO:0050796]; response to insulin [GO:0032868]; response to lipopolysaccharide [GO:0032496]; response to pH [GO:0009268]; response to xenobiotic stimulus [GO:0009410]; response to zinc ion [GO:0010043]; transmembrane transport [GO:0055085]; visual learning [GO:0008542] inward rectifying potassium channel [GO:0008282]; plasma membrane [GO:0005886]; potassium ion-transporting ATPase complex [GO:0031004]; presynaptic membrane [GO:0042734]; sarcolemma [GO:0042383]; synaptic vesicle membrane [GO:0030672] ABC-type transporter activity [GO:0140359]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-activated inward rectifier potassium channel activity [GO:0015272]; ATPase-coupled monoatomic cation transmembrane transporter activity [GO:0019829]; metal ion binding [GO:0046872]; potassium channel activity [GO:0005267]; sulfonylurea receptor activity [GO:0008281]; transmembrane transporter binding [GO:0044325] g20144.t1 Q09428 41.104 163 1.62e-32 120.0 sp|Q09428|ABCC8_HUMAN ATP-binding cassette sub-family C member 8 OS=Homo sapiens OX=9606 GN=ABCC8 PE=1 SV=6 ABCC8_HUMAN reviewed ATP-binding cassette sub-family C member 8 (Sulfonylurea receptor 1) Homo sapiens (Human) GO:0001508; GO:0001678; GO:0005267; GO:0005524; GO:0005886; GO:0006813; GO:0007565; GO:0007613; GO:0008281; GO:0008282; GO:0008542; GO:0009268; GO:0009410; GO:0010043; GO:0010989; GO:0015272; GO:0016525; GO:0016887; GO:0019829; GO:0030672; GO:0031004; GO:0031669; GO:0032496; GO:0032760; GO:0032868; GO:0035774; GO:0042383; GO:0042734; GO:0043268; GO:0043531; GO:0044325; GO:0046676; GO:0046872; GO:0050796; GO:0050905; GO:0055085; GO:0060253; GO:0061535; GO:0061855; GO:0071805; GO:0098662; GO:0140359; GO:1900721; GO:1905075; GO:1905604; GO:1990573 action potential [GO:0001508]; cellular response to nutrient levels [GO:0031669]; female pregnancy [GO:0007565]; glutamate secretion, neurotransmission [GO:0061535]; inorganic cation transmembrane transport [GO:0098662]; intracellular glucose homeostasis [GO:0001678]; memory [GO:0007613]; negative regulation of angiogenesis [GO:0016525]; negative regulation of blood-brain barrier permeability [GO:1905604]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of insulin secretion [GO:0046676]; negative regulation of low-density lipoprotein particle clearance [GO:0010989]; negative regulation of neuroblast migration [GO:0061855]; neuromuscular process [GO:0050905]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of potassium ion transport [GO:0043268]; positive regulation of tight junction disassembly [GO:1905075]; positive regulation of tumor necrosis factor production [GO:0032760]; positive regulation of uterine smooth muscle relaxation [GO:1900721]; potassium ion import across plasma membrane [GO:1990573]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; regulation of insulin secretion [GO:0050796]; response to insulin [GO:0032868]; response to lipopolysaccharide [GO:0032496]; response to pH [GO:0009268]; response to xenobiotic stimulus [GO:0009410]; response to zinc ion [GO:0010043]; transmembrane transport [GO:0055085]; visual learning [GO:0008542] inward rectifying potassium channel [GO:0008282]; plasma membrane [GO:0005886]; potassium ion-transporting ATPase complex [GO:0031004]; presynaptic membrane [GO:0042734]; sarcolemma [GO:0042383]; synaptic vesicle membrane [GO:0030672] ABC-type transporter activity [GO:0140359]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-activated inward rectifier potassium channel activity [GO:0015272]; ATPase-coupled monoatomic cation transmembrane transporter activity [GO:0019829]; metal ion binding [GO:0046872]; potassium channel activity [GO:0005267]; sulfonylurea receptor activity [GO:0008281]; transmembrane transporter binding [GO:0044325] g20144.t1 Q09428 70.37 27 1.62e-32 43.9 sp|Q09428|ABCC8_HUMAN ATP-binding cassette sub-family C member 8 OS=Homo sapiens OX=9606 GN=ABCC8 PE=1 SV=6 ABCC8_HUMAN reviewed ATP-binding cassette sub-family C member 8 (Sulfonylurea receptor 1) Homo sapiens (Human) GO:0001508; GO:0001678; GO:0005267; GO:0005524; GO:0005886; GO:0006813; GO:0007565; GO:0007613; GO:0008281; GO:0008282; GO:0008542; GO:0009268; GO:0009410; GO:0010043; GO:0010989; GO:0015272; GO:0016525; GO:0016887; GO:0019829; GO:0030672; GO:0031004; GO:0031669; GO:0032496; GO:0032760; GO:0032868; GO:0035774; GO:0042383; GO:0042734; GO:0043268; GO:0043531; GO:0044325; GO:0046676; GO:0046872; GO:0050796; GO:0050905; GO:0055085; GO:0060253; GO:0061535; GO:0061855; GO:0071805; GO:0098662; GO:0140359; GO:1900721; GO:1905075; GO:1905604; GO:1990573 action potential [GO:0001508]; cellular response to nutrient levels [GO:0031669]; female pregnancy [GO:0007565]; glutamate secretion, neurotransmission [GO:0061535]; inorganic cation transmembrane transport [GO:0098662]; intracellular glucose homeostasis [GO:0001678]; memory [GO:0007613]; negative regulation of angiogenesis [GO:0016525]; negative regulation of blood-brain barrier permeability [GO:1905604]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of insulin secretion [GO:0046676]; negative regulation of low-density lipoprotein particle clearance [GO:0010989]; negative regulation of neuroblast migration [GO:0061855]; neuromuscular process [GO:0050905]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of potassium ion transport [GO:0043268]; positive regulation of tight junction disassembly [GO:1905075]; positive regulation of tumor necrosis factor production [GO:0032760]; positive regulation of uterine smooth muscle relaxation [GO:1900721]; potassium ion import across plasma membrane [GO:1990573]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; regulation of insulin secretion [GO:0050796]; response to insulin [GO:0032868]; response to lipopolysaccharide [GO:0032496]; response to pH [GO:0009268]; response to xenobiotic stimulus [GO:0009410]; response to zinc ion [GO:0010043]; transmembrane transport [GO:0055085]; visual learning [GO:0008542] inward rectifying potassium channel [GO:0008282]; plasma membrane [GO:0005886]; potassium ion-transporting ATPase complex [GO:0031004]; presynaptic membrane [GO:0042734]; sarcolemma [GO:0042383]; synaptic vesicle membrane [GO:0030672] ABC-type transporter activity [GO:0140359]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-activated inward rectifier potassium channel activity [GO:0015272]; ATPase-coupled monoatomic cation transmembrane transporter activity [GO:0019829]; metal ion binding [GO:0046872]; potassium channel activity [GO:0005267]; sulfonylurea receptor activity [GO:0008281]; transmembrane transporter binding [GO:0044325] g20145.t1 Q09429 35.924 1634 0.0 934.0 sp|Q09429|ABCC8_RAT ATP-binding cassette sub-family C member 8 OS=Rattus norvegicus OX=10116 GN=Abcc8 PE=1 SV=4 ABCC8_RAT reviewed ATP-binding cassette sub-family C member 8 (Sulfonylurea receptor 1) Rattus norvegicus (Rat) GO:0001508; GO:0001678; GO:0005267; GO:0005524; GO:0005886; GO:0007565; GO:0007613; GO:0008281; GO:0008282; GO:0008542; GO:0009268; GO:0009410; GO:0010043; GO:0010989; GO:0016525; GO:0016887; GO:0019829; GO:0030672; GO:0031669; GO:0032496; GO:0032760; GO:0032868; GO:0032991; GO:0035774; GO:0042383; GO:0042734; GO:0043268; GO:0043531; GO:0044325; GO:0046676; GO:0046872; GO:0050768; GO:0050905; GO:0055085; GO:0060253; GO:0061535; GO:0061855; GO:0140359; GO:1900721; GO:1905075; GO:1905604; GO:1990573 action potential [GO:0001508]; cellular response to nutrient levels [GO:0031669]; female pregnancy [GO:0007565]; glutamate secretion, neurotransmission [GO:0061535]; intracellular glucose homeostasis [GO:0001678]; memory [GO:0007613]; negative regulation of angiogenesis [GO:0016525]; negative regulation of blood-brain barrier permeability [GO:1905604]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of insulin secretion [GO:0046676]; negative regulation of low-density lipoprotein particle clearance [GO:0010989]; negative regulation of neuroblast migration [GO:0061855]; negative regulation of neurogenesis [GO:0050768]; neuromuscular process [GO:0050905]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of potassium ion transport [GO:0043268]; positive regulation of tight junction disassembly [GO:1905075]; positive regulation of tumor necrosis factor production [GO:0032760]; positive regulation of uterine smooth muscle relaxation [GO:1900721]; potassium ion import across plasma membrane [GO:1990573]; response to insulin [GO:0032868]; response to lipopolysaccharide [GO:0032496]; response to pH [GO:0009268]; response to xenobiotic stimulus [GO:0009410]; response to zinc ion [GO:0010043]; transmembrane transport [GO:0055085]; visual learning [GO:0008542] inward rectifying potassium channel [GO:0008282]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; protein-containing complex [GO:0032991]; sarcolemma [GO:0042383]; synaptic vesicle membrane [GO:0030672] ABC-type transporter activity [GO:0140359]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled monoatomic cation transmembrane transporter activity [GO:0019829]; metal ion binding [GO:0046872]; potassium channel activity [GO:0005267]; sulfonylurea receptor activity [GO:0008281]; transmembrane transporter binding [GO:0044325] g20146.t1 Q96ME1 31.591 440 7.650000000000001e-47 181.0 sp|Q96ME1|FXL18_HUMAN F-box/LRR-repeat protein 18 OS=Homo sapiens OX=9606 GN=FBXL18 PE=1 SV=3 g20147.t1 Q09429 37.25 1600 0.0 884.0 sp|Q09429|ABCC8_RAT ATP-binding cassette sub-family C member 8 OS=Rattus norvegicus OX=10116 GN=Abcc8 PE=1 SV=4 ABCC8_RAT reviewed ATP-binding cassette sub-family C member 8 (Sulfonylurea receptor 1) Rattus norvegicus (Rat) GO:0001508; GO:0001678; GO:0005267; GO:0005524; GO:0005886; GO:0007565; GO:0007613; GO:0008281; GO:0008282; GO:0008542; GO:0009268; GO:0009410; GO:0010043; GO:0010989; GO:0016525; GO:0016887; GO:0019829; GO:0030672; GO:0031669; GO:0032496; GO:0032760; GO:0032868; GO:0032991; GO:0035774; GO:0042383; GO:0042734; GO:0043268; GO:0043531; GO:0044325; GO:0046676; GO:0046872; GO:0050768; GO:0050905; GO:0055085; GO:0060253; GO:0061535; GO:0061855; GO:0140359; GO:1900721; GO:1905075; GO:1905604; GO:1990573 action potential [GO:0001508]; cellular response to nutrient levels [GO:0031669]; female pregnancy [GO:0007565]; glutamate secretion, neurotransmission [GO:0061535]; intracellular glucose homeostasis [GO:0001678]; memory [GO:0007613]; negative regulation of angiogenesis [GO:0016525]; negative regulation of blood-brain barrier permeability [GO:1905604]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of insulin secretion [GO:0046676]; negative regulation of low-density lipoprotein particle clearance [GO:0010989]; negative regulation of neuroblast migration [GO:0061855]; negative regulation of neurogenesis [GO:0050768]; neuromuscular process [GO:0050905]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of potassium ion transport [GO:0043268]; positive regulation of tight junction disassembly [GO:1905075]; positive regulation of tumor necrosis factor production [GO:0032760]; positive regulation of uterine smooth muscle relaxation [GO:1900721]; potassium ion import across plasma membrane [GO:1990573]; response to insulin [GO:0032868]; response to lipopolysaccharide [GO:0032496]; response to pH [GO:0009268]; response to xenobiotic stimulus [GO:0009410]; response to zinc ion [GO:0010043]; transmembrane transport [GO:0055085]; visual learning [GO:0008542] inward rectifying potassium channel [GO:0008282]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; protein-containing complex [GO:0032991]; sarcolemma [GO:0042383]; synaptic vesicle membrane [GO:0030672] ABC-type transporter activity [GO:0140359]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled monoatomic cation transmembrane transporter activity [GO:0019829]; metal ion binding [GO:0046872]; potassium channel activity [GO:0005267]; sulfonylurea receptor activity [GO:0008281]; transmembrane transporter binding [GO:0044325] g20148.t1 Q09YN8 41.753 194 8.500000000000001e-47 165.0 sp|Q09YN8|TES_RABIT Testin OS=Oryctolagus cuniculus OX=9986 GN=TES PE=3 SV=1 g20149.t1 A1Z6W3 51.613 155 9.94e-62 209.0 sp|A1Z6W3|PRIC1_DROME Protein prickle OS=Drosophila melanogaster OX=7227 GN=pk PE=1 SV=1 PRIC1_DROME reviewed Protein prickle (Protein spiny legs) Drosophila melanogaster (Fruit fly) GO:0001736; GO:0001737; GO:0001738; GO:0005737; GO:0005829; GO:0005886; GO:0007163; GO:0007164; GO:0008270; GO:0009948; GO:0016318; GO:0030424; GO:0030951; GO:0042067; GO:0045184; GO:0045185; GO:0045773; GO:0098930; GO:1902669 anterior/posterior axis specification [GO:0009948]; axonal transport [GO:0098930]; establishment of imaginal disc-derived wing hair orientation [GO:0001737]; establishment of ommatidial planar polarity [GO:0042067]; establishment of planar polarity [GO:0001736]; establishment of protein localization [GO:0045184]; establishment of tissue polarity [GO:0007164]; establishment or maintenance of cell polarity [GO:0007163]; establishment or maintenance of microtubule cytoskeleton polarity [GO:0030951]; maintenance of protein location [GO:0045185]; morphogenesis of a polarized epithelium [GO:0001738]; ommatidial rotation [GO:0016318]; positive regulation of axon extension [GO:0045773]; positive regulation of axon guidance [GO:1902669] axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886] zinc ion binding [GO:0008270] g20150.t1 Q62717 68.968 1173 0.0 1677.0 sp|Q62717|CAPS1_RAT Calcium-dependent secretion activator 1 OS=Rattus norvegicus OX=10116 GN=Cadps PE=1 SV=1 g20150.t2 Q62717 68.501 1181 0.0 1671.0 sp|Q62717|CAPS1_RAT Calcium-dependent secretion activator 1 OS=Rattus norvegicus OX=10116 GN=Cadps PE=1 SV=1 g20152.t1 P53459 73.373 169 5.84e-90 270.0 sp|P53459|ACT6_DIBDE Actin-6 (Fragment) OS=Dibothriocephalus dendriticus OX=28845 GN=ACT6 PE=2 SV=1 g20153.t1 O00338 38.356 292 8.98e-67 214.0 sp|O00338|ST1C2_HUMAN Sulfotransferase 1C2 OS=Homo sapiens OX=9606 GN=SULT1C2 PE=1 SV=1 ST1C2_HUMAN reviewed Sulfotransferase 1C2 (ST1C2) (EC 2.8.2.1) (Sulfotransferase 1C1) (SULT1C#1) (humSULTC2) Homo sapiens (Human) GO:0004062; GO:0005737; GO:0005739; GO:0005764; GO:0005829; GO:0008146; GO:0009308; GO:0051922; GO:0051923 amine metabolic process [GO:0009308]; sulfation [GO:0051923] cytoplasm [GO:0005737]; cytosol [GO:0005829]; lysosome [GO:0005764]; mitochondrion [GO:0005739] aryl sulfotransferase activity [GO:0004062]; cholesterol sulfotransferase activity [GO:0051922]; sulfotransferase activity [GO:0008146] g20161.t1 Q8MJJ7 52.922 308 6.19e-110 327.0 sp|Q8MJJ7|DCPS_BOVIN m7GpppX diphosphatase OS=Bos taurus OX=9913 GN=DCPS PE=2 SV=1 g20164.t1 Q9D1H9 43.846 130 1.43e-27 107.0 sp|Q9D1H9|MFAP4_MOUSE Microfibril-associated glycoprotein 4 OS=Mus musculus OX=10090 GN=Mfap4 PE=1 SV=1 g20169.t1 Q5FWU8 53.488 430 1.22e-178 509.0 sp|Q5FWU8|ZMY10_XENLA Zinc finger MYND domain-containing protein 10 OS=Xenopus laevis OX=8355 GN=zmynd10 PE=2 SV=1 ZMY10_XENLA reviewed Zinc finger MYND domain-containing protein 10 Xenopus laevis (African clawed frog) GO:0005737; GO:0008270; GO:0016324; GO:0034451; GO:0036158; GO:0036159; GO:0044458; GO:0120293; GO:1905505 inner dynein arm assembly [GO:0036159]; motile cilium assembly [GO:0044458]; outer dynein arm assembly [GO:0036158]; positive regulation of motile cilium assembly [GO:1905505] apical plasma membrane [GO:0016324]; centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; dynein axonemal particle [GO:0120293] zinc ion binding [GO:0008270] g20170.t1 O35083 37.356 174 2.7799999999999996e-23 98.6 sp|O35083|PLCA_MOUSE 1-acyl-sn-glycerol-3-phosphate acyltransferase alpha OS=Mus musculus OX=10090 GN=Agpat1 PE=1 SV=1 PLCA_MOUSE reviewed 1-acyl-sn-glycerol-3-phosphate acyltransferase alpha (EC 2.3.1.51) (1-acylglycerol-3-phosphate O-acyltransferase 1) (1-AGP acyltransferase 1) (1-AGPAT 1) (Lysophosphatidic acid acyltransferase alpha) (LPAAT-alpha) Mus musculus (Mouse) GO:0001819; GO:0003841; GO:0005783; GO:0005789; GO:0006654; GO:0016024 CDP-diacylglycerol biosynthetic process [GO:0016024]; phosphatidic acid biosynthetic process [GO:0006654]; positive regulation of cytokine production [GO:0001819] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789] 1-acylglycerol-3-phosphate O-acyltransferase activity [GO:0003841] g20171.t1 Q86UL8 39.201 551 3.17e-81 299.0 sp|Q86UL8|MAGI2_HUMAN Membrane-associated guanylate kinase, WW and PDZ domain-containing protein 2 OS=Homo sapiens OX=9606 GN=MAGI2 PE=1 SV=3 MAGI2_HUMAN reviewed Membrane-associated guanylate kinase, WW and PDZ domain-containing protein 2 (Atrophin-1-interacting protein 1) (AIP-1) (Atrophin-1-interacting protein A) (Membrane-associated guanylate kinase inverted 2) (MAGI-2) Homo sapiens (Human) GO:0001750; GO:0001917; GO:0002092; GO:0005634; GO:0005737; GO:0005770; GO:0005813; GO:0005814; GO:0005886; GO:0005911; GO:0005923; GO:0007165; GO:0007399; GO:0008285; GO:0010976; GO:0014069; GO:0019902; GO:0030159; GO:0030336; GO:0030425; GO:0031697; GO:0032926; GO:0032991; GO:0036057; GO:0038180; GO:0043113; GO:0045202; GO:0046332; GO:0048471; GO:0051898; GO:0060071; GO:0060395; GO:0070699; GO:0072015; GO:0072583; GO:0097546; GO:1990090 cellular response to nerve growth factor stimulus [GO:1990090]; clathrin-dependent endocytosis [GO:0072583]; negative regulation of activin receptor signaling pathway [GO:0032926]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051898]; nerve growth factor signaling pathway [GO:0038180]; nervous system development [GO:0007399]; podocyte development [GO:0072015]; positive regulation of neuron projection development [GO:0010976]; positive regulation of receptor internalization [GO:0002092]; receptor clustering [GO:0043113]; signal transduction [GO:0007165]; SMAD protein signal transduction [GO:0060395]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071] bicellular tight junction [GO:0005923]; cell-cell junction [GO:0005911]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary base [GO:0097546]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; late endosome [GO:0005770]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; photoreceptor inner segment [GO:0001917]; photoreceptor outer segment [GO:0001750]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; protein-containing complex [GO:0032991]; slit diaphragm [GO:0036057]; synapse [GO:0045202] beta-1 adrenergic receptor binding [GO:0031697]; phosphatase binding [GO:0019902]; signaling receptor complex adaptor activity [GO:0030159]; SMAD binding [GO:0046332]; type II activin receptor binding [GO:0070699] g20171.t1 Q86UL8 41.729 266 2.4699999999999998e-42 174.0 sp|Q86UL8|MAGI2_HUMAN Membrane-associated guanylate kinase, WW and PDZ domain-containing protein 2 OS=Homo sapiens OX=9606 GN=MAGI2 PE=1 SV=3 MAGI2_HUMAN reviewed Membrane-associated guanylate kinase, WW and PDZ domain-containing protein 2 (Atrophin-1-interacting protein 1) (AIP-1) (Atrophin-1-interacting protein A) (Membrane-associated guanylate kinase inverted 2) (MAGI-2) Homo sapiens (Human) GO:0001750; GO:0001917; GO:0002092; GO:0005634; GO:0005737; GO:0005770; GO:0005813; GO:0005814; GO:0005886; GO:0005911; GO:0005923; GO:0007165; GO:0007399; GO:0008285; GO:0010976; GO:0014069; GO:0019902; GO:0030159; GO:0030336; GO:0030425; GO:0031697; GO:0032926; GO:0032991; GO:0036057; GO:0038180; GO:0043113; GO:0045202; GO:0046332; GO:0048471; GO:0051898; GO:0060071; GO:0060395; GO:0070699; GO:0072015; GO:0072583; GO:0097546; GO:1990090 cellular response to nerve growth factor stimulus [GO:1990090]; clathrin-dependent endocytosis [GO:0072583]; negative regulation of activin receptor signaling pathway [GO:0032926]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051898]; nerve growth factor signaling pathway [GO:0038180]; nervous system development [GO:0007399]; podocyte development [GO:0072015]; positive regulation of neuron projection development [GO:0010976]; positive regulation of receptor internalization [GO:0002092]; receptor clustering [GO:0043113]; signal transduction [GO:0007165]; SMAD protein signal transduction [GO:0060395]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071] bicellular tight junction [GO:0005923]; cell-cell junction [GO:0005911]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary base [GO:0097546]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; late endosome [GO:0005770]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; photoreceptor inner segment [GO:0001917]; photoreceptor outer segment [GO:0001750]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; protein-containing complex [GO:0032991]; slit diaphragm [GO:0036057]; synapse [GO:0045202] beta-1 adrenergic receptor binding [GO:0031697]; phosphatase binding [GO:0019902]; signaling receptor complex adaptor activity [GO:0030159]; SMAD binding [GO:0046332]; type II activin receptor binding [GO:0070699] g20171.t2 O88382 39.362 564 2.48e-80 295.0 sp|O88382|MAGI2_RAT Membrane-associated guanylate kinase, WW and PDZ domain-containing protein 2 OS=Rattus norvegicus OX=10116 GN=Magi2 PE=1 SV=1 g20171.t2 O88382 41.86 258 4.3599999999999993e-42 173.0 sp|O88382|MAGI2_RAT Membrane-associated guanylate kinase, WW and PDZ domain-containing protein 2 OS=Rattus norvegicus OX=10116 GN=Magi2 PE=1 SV=1 g20172.t1 Q8VC12 71.746 676 0.0 1005.0 sp|Q8VC12|HUTU_MOUSE Urocanate hydratase OS=Mus musculus OX=10090 GN=Uroc1 PE=1 SV=2 g20173.t1 P42357 65.728 639 0.0 837.0 sp|P42357|HUTH_HUMAN Histidine ammonia-lyase OS=Homo sapiens OX=9606 GN=HAL PE=1 SV=1 HUTH_HUMAN reviewed Histidine ammonia-lyase (Histidase) (EC 4.3.1.3) Homo sapiens (Human) GO:0004397; GO:0005829; GO:0006548; GO:0019556; GO:0019557 L-histidine catabolic process [GO:0006548]; L-histidine catabolic process to glutamate and formamide [GO:0019556]; L-histidine catabolic process to glutamate and formate [GO:0019557] cytosol [GO:0005829] histidine ammonia-lyase activity [GO:0004397] g20175.t1 Q4V8E5 38.372 430 1.83e-67 224.0 sp|Q4V8E5|MFSD3_RAT Major facilitator superfamily domain-containing protein 3 OS=Rattus norvegicus OX=10116 GN=Mfsd3 PE=2 SV=1 g20176.t1 Q498T4 61.111 252 3.29e-93 282.0 sp|Q498T4|RM02_RAT Large ribosomal subunit protein uL2m OS=Rattus norvegicus OX=10116 GN=Mrpl2 PE=2 SV=1 g20177.t1 Q5RCP3 78.125 96 2.91e-51 159.0 sp|Q5RCP3|LSM8_PONAB U6 snRNA-associated Sm-like protein LSm8 OS=Pongo abelii OX=9601 GN=LSM8 PE=3 SV=3 LSM8_PONAB reviewed U6 snRNA-associated Sm-like protein LSm8 Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0000398; GO:0003729; GO:0005634; GO:0005688; GO:0046540; GO:0071005; GO:0120115 mRNA splicing, via spliceosome [GO:0000398] Lsm2-8 complex [GO:0120115]; nucleus [GO:0005634]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U6 snRNP [GO:0005688] mRNA binding [GO:0003729] g20178.t1 E2RQ08 53.713 579 0.0 581.0 sp|E2RQ08|RPN1_CANLF Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit 1 OS=Canis lupus familiaris OX=9615 GN=RPN1 PE=1 SV=1 RPN1_CANLF reviewed Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit 1 (Ribophorin I) (RPN-I) (Ribophorin-1) Canis lupus familiaris (Dog) (Canis familiaris) GO:0005791; GO:0005829; GO:0008250; GO:0009101; GO:0018279; GO:0160226; GO:0160227 glycoprotein biosynthetic process [GO:0009101]; protein N-linked glycosylation via asparagine [GO:0018279] cytosol [GO:0005829]; oligosaccharyltransferase complex [GO:0008250]; oligosaccharyltransferase complex A [GO:0160226]; oligosaccharyltransferase complex B [GO:0160227]; rough endoplasmic reticulum [GO:0005791] g20179.t1 Q91YE6 60.991 928 0.0 1130.0 sp|Q91YE6|IPO9_MOUSE Importin-9 OS=Mus musculus OX=10090 GN=Ipo9 PE=1 SV=3 IPO9_MOUSE reviewed Importin-9 (Imp9) (Importin-9a) (Imp9a) (Importin-9b) (Imp9b) (Ran-binding protein 9) (RanBP9) Mus musculus (Mouse) GO:0005635; GO:0005654; GO:0005737; GO:0005829; GO:0006606; GO:0010498; GO:0031144; GO:0031267; GO:0042254; GO:0042393; GO:0050821; GO:0061608; GO:0140713 proteasomal protein catabolic process [GO:0010498]; proteasome localization [GO:0031144]; protein import into nucleus [GO:0006606]; protein stabilization [GO:0050821]; ribosome biogenesis [GO:0042254] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654] histone binding [GO:0042393]; histone chaperone activity [GO:0140713]; nuclear import signal receptor activity [GO:0061608]; small GTPase binding [GO:0031267] g20181.t1 Q1RMT8 40.535 486 5.81e-83 268.0 sp|Q1RMT8|IRAK4_BOVIN Interleukin-1 receptor-associated kinase 4 OS=Bos taurus OX=9913 GN=IRAK4 PE=2 SV=1 IRAK4_BOVIN reviewed Interleukin-1 receptor-associated kinase 4 (IRAK-4) (EC 2.7.11.1) Bos taurus (Bovine) GO:0000287; GO:0002446; GO:0004674; GO:0005149; GO:0005524; GO:0005634; GO:0005737; GO:0005886; GO:0008063; GO:0009986; GO:0019221; GO:0019901; GO:0031663; GO:0034142; GO:0035556; GO:0038061; GO:0038172; GO:0043123; GO:0045087; GO:0070498; GO:0106310; GO:1990266 cytokine-mediated signaling pathway [GO:0019221]; innate immune response [GO:0045087]; interleukin-1-mediated signaling pathway [GO:0070498]; interleukin-33-mediated signaling pathway [GO:0038172]; intracellular signal transduction [GO:0035556]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; neutrophil mediated immunity [GO:0002446]; neutrophil migration [GO:1990266]; non-canonical NF-kappaB signal transduction [GO:0038061]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; Toll signaling pathway [GO:0008063]; toll-like receptor 4 signaling pathway [GO:0034142] cell surface [GO:0009986]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886] ATP binding [GO:0005524]; interleukin-1 receptor binding [GO:0005149]; magnesium ion binding [GO:0000287]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g20183.t1 P70266 62.132 441 0.0 535.0 sp|P70266|F261_MOUSE 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 1 OS=Mus musculus OX=10090 GN=Pfkfb1 PE=1 SV=2 g20183.t2 P07953 62.022 445 0.0 548.0 sp|P07953|F261_RAT 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 1 OS=Rattus norvegicus OX=10116 GN=Pfkfb1 PE=1 SV=3 F261_RAT reviewed 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 1 (6PF-2-K/Fru-2,6-P2ase 1) (PFK/FBPase 1) (6PF-2-K/Fru-2,6-P2ase liver isozyme) [Includes: 6-phosphofructo-2-kinase (EC 2.7.1.105); Fructose-2,6-bisphosphatase (EC 3.1.3.46)] Rattus norvegicus (Rat) GO:0003873; GO:0004331; GO:0005524; GO:0005829; GO:0006000; GO:0006003; GO:0006094; GO:0006096; GO:0019900; GO:0031100; GO:0032868; GO:0033762; GO:0042594; GO:0042802; GO:0043540; GO:0046835; GO:0051384; GO:0051591; GO:0070095; GO:1904539; GO:1904540 animal organ regeneration [GO:0031100]; carbohydrate phosphorylation [GO:0046835]; fructose 2,6-bisphosphate metabolic process [GO:0006003]; fructose metabolic process [GO:0006000]; gluconeogenesis [GO:0006094]; glycolytic process [GO:0006096]; negative regulation of glycolytic process through fructose-6-phosphate [GO:1904539]; positive regulation of glycolytic process through fructose-6-phosphate [GO:1904540]; response to cAMP [GO:0051591]; response to glucagon [GO:0033762]; response to glucocorticoid [GO:0051384]; response to insulin [GO:0032868]; response to starvation [GO:0042594] 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase complex [GO:0043540]; cytosol [GO:0005829] 6-phosphofructo-2-kinase activity [GO:0003873]; ATP binding [GO:0005524]; fructose-2,6-bisphosphate 2-phosphatase activity [GO:0004331]; fructose-6-phosphate binding [GO:0070095]; identical protein binding [GO:0042802]; kinase binding [GO:0019900] g20183.t3 P70266 63.426 432 0.0 543.0 sp|P70266|F261_MOUSE 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 1 OS=Mus musculus OX=10090 GN=Pfkfb1 PE=1 SV=2 g20183.t4 P70266 63.953 430 0.0 545.0 sp|P70266|F261_MOUSE 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 1 OS=Mus musculus OX=10090 GN=Pfkfb1 PE=1 SV=2 g20186.t1 P82451 45.413 436 1.58e-112 365.0 sp|P82451|ABCC9_RABIT ATP-binding cassette sub-family C member 9 OS=Oryctolagus cuniculus OX=9986 GN=ABCC9 PE=2 SV=1 g20187.t1 Q09428 33.517 1635 0.0 827.0 sp|Q09428|ABCC8_HUMAN ATP-binding cassette sub-family C member 8 OS=Homo sapiens OX=9606 GN=ABCC8 PE=1 SV=6 ABCC8_HUMAN reviewed ATP-binding cassette sub-family C member 8 (Sulfonylurea receptor 1) Homo sapiens (Human) GO:0001508; GO:0001678; GO:0005267; GO:0005524; GO:0005886; GO:0006813; GO:0007565; GO:0007613; GO:0008281; GO:0008282; GO:0008542; GO:0009268; GO:0009410; GO:0010043; GO:0010989; GO:0015272; GO:0016525; GO:0016887; GO:0019829; GO:0030672; GO:0031004; GO:0031669; GO:0032496; GO:0032760; GO:0032868; GO:0035774; GO:0042383; GO:0042734; GO:0043268; GO:0043531; GO:0044325; GO:0046676; GO:0046872; GO:0050796; GO:0050905; GO:0055085; GO:0060253; GO:0061535; GO:0061855; GO:0071805; GO:0098662; GO:0140359; GO:1900721; GO:1905075; GO:1905604; GO:1990573 action potential [GO:0001508]; cellular response to nutrient levels [GO:0031669]; female pregnancy [GO:0007565]; glutamate secretion, neurotransmission [GO:0061535]; inorganic cation transmembrane transport [GO:0098662]; intracellular glucose homeostasis [GO:0001678]; memory [GO:0007613]; negative regulation of angiogenesis [GO:0016525]; negative regulation of blood-brain barrier permeability [GO:1905604]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of insulin secretion [GO:0046676]; negative regulation of low-density lipoprotein particle clearance [GO:0010989]; negative regulation of neuroblast migration [GO:0061855]; neuromuscular process [GO:0050905]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of potassium ion transport [GO:0043268]; positive regulation of tight junction disassembly [GO:1905075]; positive regulation of tumor necrosis factor production [GO:0032760]; positive regulation of uterine smooth muscle relaxation [GO:1900721]; potassium ion import across plasma membrane [GO:1990573]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; regulation of insulin secretion [GO:0050796]; response to insulin [GO:0032868]; response to lipopolysaccharide [GO:0032496]; response to pH [GO:0009268]; response to xenobiotic stimulus [GO:0009410]; response to zinc ion [GO:0010043]; transmembrane transport [GO:0055085]; visual learning [GO:0008542] inward rectifying potassium channel [GO:0008282]; plasma membrane [GO:0005886]; potassium ion-transporting ATPase complex [GO:0031004]; presynaptic membrane [GO:0042734]; sarcolemma [GO:0042383]; synaptic vesicle membrane [GO:0030672] ABC-type transporter activity [GO:0140359]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-activated inward rectifier potassium channel activity [GO:0015272]; ATPase-coupled monoatomic cation transmembrane transporter activity [GO:0019829]; metal ion binding [GO:0046872]; potassium channel activity [GO:0005267]; sulfonylurea receptor activity [GO:0008281]; transmembrane transporter binding [GO:0044325] g20187.t2 Q09428 33.476 1637 0.0 821.0 sp|Q09428|ABCC8_HUMAN ATP-binding cassette sub-family C member 8 OS=Homo sapiens OX=9606 GN=ABCC8 PE=1 SV=6 ABCC8_HUMAN reviewed ATP-binding cassette sub-family C member 8 (Sulfonylurea receptor 1) Homo sapiens (Human) GO:0001508; GO:0001678; GO:0005267; GO:0005524; GO:0005886; GO:0006813; GO:0007565; GO:0007613; GO:0008281; GO:0008282; GO:0008542; GO:0009268; GO:0009410; GO:0010043; GO:0010989; GO:0015272; GO:0016525; GO:0016887; GO:0019829; GO:0030672; GO:0031004; GO:0031669; GO:0032496; GO:0032760; GO:0032868; GO:0035774; GO:0042383; GO:0042734; GO:0043268; GO:0043531; GO:0044325; GO:0046676; GO:0046872; GO:0050796; GO:0050905; GO:0055085; GO:0060253; GO:0061535; GO:0061855; GO:0071805; GO:0098662; GO:0140359; GO:1900721; GO:1905075; GO:1905604; GO:1990573 action potential [GO:0001508]; cellular response to nutrient levels [GO:0031669]; female pregnancy [GO:0007565]; glutamate secretion, neurotransmission [GO:0061535]; inorganic cation transmembrane transport [GO:0098662]; intracellular glucose homeostasis [GO:0001678]; memory [GO:0007613]; negative regulation of angiogenesis [GO:0016525]; negative regulation of blood-brain barrier permeability [GO:1905604]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of insulin secretion [GO:0046676]; negative regulation of low-density lipoprotein particle clearance [GO:0010989]; negative regulation of neuroblast migration [GO:0061855]; neuromuscular process [GO:0050905]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of potassium ion transport [GO:0043268]; positive regulation of tight junction disassembly [GO:1905075]; positive regulation of tumor necrosis factor production [GO:0032760]; positive regulation of uterine smooth muscle relaxation [GO:1900721]; potassium ion import across plasma membrane [GO:1990573]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; regulation of insulin secretion [GO:0050796]; response to insulin [GO:0032868]; response to lipopolysaccharide [GO:0032496]; response to pH [GO:0009268]; response to xenobiotic stimulus [GO:0009410]; response to zinc ion [GO:0010043]; transmembrane transport [GO:0055085]; visual learning [GO:0008542] inward rectifying potassium channel [GO:0008282]; plasma membrane [GO:0005886]; potassium ion-transporting ATPase complex [GO:0031004]; presynaptic membrane [GO:0042734]; sarcolemma [GO:0042383]; synaptic vesicle membrane [GO:0030672] ABC-type transporter activity [GO:0140359]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-activated inward rectifier potassium channel activity [GO:0015272]; ATPase-coupled monoatomic cation transmembrane transporter activity [GO:0019829]; metal ion binding [GO:0046872]; potassium channel activity [GO:0005267]; sulfonylurea receptor activity [GO:0008281]; transmembrane transporter binding [GO:0044325] g20188.t1 Q08830 39.738 229 7.5e-36 140.0 sp|Q08830|FGL1_HUMAN Fibrinogen-like protein 1 OS=Homo sapiens OX=9606 GN=FGL1 PE=1 SV=3 FGL1_HUMAN reviewed Fibrinogen-like protein 1 (HP-041) (Hepassocin) (HPS) (Hepatocyte-derived fibrinogen-related protein 1) (HFREP-1) (Liver fibrinogen-related protein 1) (LFIRE-1) Homo sapiens (Human) GO:0002250; GO:0005576; GO:0005577; GO:0005615; GO:0005886; GO:0007596; GO:0048018; GO:0050776; GO:0050860; GO:0050868; GO:0072574 adaptive immune response [GO:0002250]; blood coagulation [GO:0007596]; hepatocyte proliferation [GO:0072574]; negative regulation of T cell activation [GO:0050868]; negative regulation of T cell receptor signaling pathway [GO:0050860]; regulation of immune response [GO:0050776] extracellular region [GO:0005576]; extracellular space [GO:0005615]; fibrinogen complex [GO:0005577]; plasma membrane [GO:0005886] receptor ligand activity [GO:0048018] g20188.t1 Q08830 29.839 248 6.360000000000001e-21 97.8 sp|Q08830|FGL1_HUMAN Fibrinogen-like protein 1 OS=Homo sapiens OX=9606 GN=FGL1 PE=1 SV=3 FGL1_HUMAN reviewed Fibrinogen-like protein 1 (HP-041) (Hepassocin) (HPS) (Hepatocyte-derived fibrinogen-related protein 1) (HFREP-1) (Liver fibrinogen-related protein 1) (LFIRE-1) Homo sapiens (Human) GO:0002250; GO:0005576; GO:0005577; GO:0005615; GO:0005886; GO:0007596; GO:0048018; GO:0050776; GO:0050860; GO:0050868; GO:0072574 adaptive immune response [GO:0002250]; blood coagulation [GO:0007596]; hepatocyte proliferation [GO:0072574]; negative regulation of T cell activation [GO:0050868]; negative regulation of T cell receptor signaling pathway [GO:0050860]; regulation of immune response [GO:0050776] extracellular region [GO:0005576]; extracellular space [GO:0005615]; fibrinogen complex [GO:0005577]; plasma membrane [GO:0005886] receptor ligand activity [GO:0048018] g20190.t1 Q15075 36.615 650 5.18e-59 220.0 sp|Q15075|EEA1_HUMAN Early endosome antigen 1 OS=Homo sapiens OX=9606 GN=EEA1 PE=1 SV=2 EEA1_HUMAN reviewed Early endosome antigen 1 (Endosome-associated protein p162) (Zinc finger FYVE domain-containing protein 2) Homo sapiens (Human) GO:0005516; GO:0005545; GO:0005769; GO:0005829; GO:0006897; GO:0006906; GO:0008270; GO:0016189; GO:0030742; GO:0031901; GO:0042803; GO:0044308; GO:0044788; GO:0045022; GO:0055037; GO:0070062; GO:0098685; GO:0098830; GO:0098842; GO:0098978; GO:0099565 chemical synaptic transmission, postsynaptic [GO:0099565]; early endosome to late endosome transport [GO:0045022]; endocytosis [GO:0006897]; host-mediated perturbation of viral process [GO:0044788]; synaptic vesicle to endosome fusion [GO:0016189]; vesicle fusion [GO:0006906] axonal spine [GO:0044308]; cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; postsynaptic early endosome [GO:0098842]; presynaptic endosome [GO:0098830]; recycling endosome [GO:0055037]; Schaffer collateral - CA1 synapse [GO:0098685] 1-phosphatidylinositol binding [GO:0005545]; calmodulin binding [GO:0005516]; GTP-dependent protein binding [GO:0030742]; protein homodimerization activity [GO:0042803]; zinc ion binding [GO:0008270] g20191.t1 Q15075 66.667 177 7.379999999999999e-74 258.0 sp|Q15075|EEA1_HUMAN Early endosome antigen 1 OS=Homo sapiens OX=9606 GN=EEA1 PE=1 SV=2 EEA1_HUMAN reviewed Early endosome antigen 1 (Endosome-associated protein p162) (Zinc finger FYVE domain-containing protein 2) Homo sapiens (Human) GO:0005516; GO:0005545; GO:0005769; GO:0005829; GO:0006897; GO:0006906; GO:0008270; GO:0016189; GO:0030742; GO:0031901; GO:0042803; GO:0044308; GO:0044788; GO:0045022; GO:0055037; GO:0070062; GO:0098685; GO:0098830; GO:0098842; GO:0098978; GO:0099565 chemical synaptic transmission, postsynaptic [GO:0099565]; early endosome to late endosome transport [GO:0045022]; endocytosis [GO:0006897]; host-mediated perturbation of viral process [GO:0044788]; synaptic vesicle to endosome fusion [GO:0016189]; vesicle fusion [GO:0006906] axonal spine [GO:0044308]; cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; postsynaptic early endosome [GO:0098842]; presynaptic endosome [GO:0098830]; recycling endosome [GO:0055037]; Schaffer collateral - CA1 synapse [GO:0098685] 1-phosphatidylinositol binding [GO:0005545]; calmodulin binding [GO:0005516]; GTP-dependent protein binding [GO:0030742]; protein homodimerization activity [GO:0042803]; zinc ion binding [GO:0008270] g20197.t1 Q96M69 45.261 517 1.7e-150 460.0 sp|Q96M69|LRGUK_HUMAN Leucine-rich repeat and guanylate kinase domain-containing protein OS=Homo sapiens OX=9606 GN=LRGUK PE=1 SV=1 g20198.t1 Q925U4 62.132 544 0.0 708.0 sp|Q925U4|EDEM1_MOUSE ER degradation-enhancing alpha-mannosidase-like protein 1 OS=Mus musculus OX=10090 GN=Edem1 PE=1 SV=1 g20199.t1 Q9W2N0 50.612 245 1.12e-92 278.0 sp|Q9W2N0|CAPZA_DROME F-actin-capping protein subunit alpha OS=Drosophila melanogaster OX=7227 GN=cpa PE=1 SV=1 CAPZA_DROME reviewed F-actin-capping protein subunit alpha Drosophila melanogaster (Fruit fly) GO:0007015; GO:0007294; GO:0008290; GO:0010591; GO:0016324; GO:0030018; GO:0030036; GO:0030837; GO:0030863; GO:0035220; GO:0046329; GO:0046982; GO:0051015; GO:0051016; GO:0051489; GO:0051490; GO:0051491; GO:0071203; GO:0140591 actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; barbed-end actin filament capping [GO:0051016]; germarium-derived oocyte fate determination [GO:0007294]; negative regulation of actin filament polymerization [GO:0030837]; negative regulation of filopodium assembly [GO:0051490]; negative regulation of JNK cascade [GO:0046329]; nuclear envelope budding [GO:0140591]; positive regulation of filopodium assembly [GO:0051491]; regulation of filopodium assembly [GO:0051489]; regulation of lamellipodium assembly [GO:0010591]; wing disc development [GO:0035220] apical plasma membrane [GO:0016324]; cortical cytoskeleton [GO:0030863]; F-actin capping protein complex [GO:0008290]; WASH complex [GO:0071203]; Z disc [GO:0030018] actin filament binding [GO:0051015]; protein heterodimerization activity [GO:0046982] g20204.t1 Q9H6U8 60.917 545 0.0 664.0 sp|Q9H6U8|ALG9_HUMAN Alpha-1,2-mannosyltransferase ALG9 OS=Homo sapiens OX=9606 GN=ALG9 PE=1 SV=2 g20205.t1 Q4R4R4 40.805 174 1.26e-44 149.0 sp|Q4R4R4|PRAF3_MACFA PRA1 family protein 3 OS=Macaca fascicularis OX=9541 GN=ARL6IP5 PE=2 SV=1 g20207.t1 P52825 45.266 338 7.17e-90 289.0 sp|P52825|CPT2_MOUSE Carnitine O-palmitoyltransferase 2, mitochondrial OS=Mus musculus OX=10090 GN=Cpt2 PE=1 SV=2 CPT2_MOUSE reviewed Carnitine O-palmitoyltransferase 2, mitochondrial (EC 2.3.1.21) (Carnitine palmitoyltransferase II) (CPT II) Mus musculus (Mouse) GO:0001676; GO:0001701; GO:0004095; GO:0005654; GO:0005730; GO:0005739; GO:0005743; GO:0005759; GO:0006635; GO:0006853; GO:0008458; GO:0009437; GO:0016746; GO:0120162 carnitine metabolic process [GO:0009437]; carnitine shuttle [GO:0006853]; fatty acid beta-oxidation [GO:0006635]; in utero embryonic development [GO:0001701]; long-chain fatty acid metabolic process [GO:0001676]; positive regulation of cold-induced thermogenesis [GO:0120162] mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654] acyltransferase activity [GO:0016746]; carnitine O-octanoyltransferase activity [GO:0008458]; carnitine O-palmitoyltransferase activity [GO:0004095] g20208.t1 Q7ZXE1 46.729 107 7.1e-22 92.4 sp|Q7ZXE1|CPT2_XENLA Carnitine O-palmitoyltransferase 2, mitochondrial OS=Xenopus laevis OX=8355 GN=cpt2 PE=2 SV=1 CPT2_XENLA reviewed Carnitine O-palmitoyltransferase 2, mitochondrial (EC 2.3.1.21) (Carnitine palmitoyltransferase II) (CPT II) Xenopus laevis (African clawed frog) GO:0004095; GO:0005739; GO:0005743; GO:0006635; GO:0008458; GO:0015909 fatty acid beta-oxidation [GO:0006635]; long-chain fatty acid transport [GO:0015909] mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739] carnitine O-octanoyltransferase activity [GO:0008458]; carnitine O-palmitoyltransferase activity [GO:0004095] g20209.t1 Q7ZXE1 41.176 374 1.17e-88 283.0 sp|Q7ZXE1|CPT2_XENLA Carnitine O-palmitoyltransferase 2, mitochondrial OS=Xenopus laevis OX=8355 GN=cpt2 PE=2 SV=1 CPT2_XENLA reviewed Carnitine O-palmitoyltransferase 2, mitochondrial (EC 2.3.1.21) (Carnitine palmitoyltransferase II) (CPT II) Xenopus laevis (African clawed frog) GO:0004095; GO:0005739; GO:0005743; GO:0006635; GO:0008458; GO:0015909 fatty acid beta-oxidation [GO:0006635]; long-chain fatty acid transport [GO:0015909] mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739] carnitine O-octanoyltransferase activity [GO:0008458]; carnitine O-palmitoyltransferase activity [GO:0004095] g20210.t1 P18886 40.625 192 1.04e-28 115.0 sp|P18886|CPT2_RAT Carnitine O-palmitoyltransferase 2, mitochondrial OS=Rattus norvegicus OX=10116 GN=Cpt2 PE=1 SV=1 CPT2_RAT reviewed Carnitine O-palmitoyltransferase 2, mitochondrial (EC 2.3.1.21) (Carnitine palmitoyltransferase II) (CPT II) Rattus norvegicus (Rat) GO:0001676; GO:0001701; GO:0004095; GO:0005654; GO:0005730; GO:0005739; GO:0005743; GO:0005759; GO:0006635; GO:0006853; GO:0008458; GO:0009437; GO:0015909; GO:0016746; GO:0070542; GO:0120162 carnitine metabolic process [GO:0009437]; carnitine shuttle [GO:0006853]; fatty acid beta-oxidation [GO:0006635]; in utero embryonic development [GO:0001701]; long-chain fatty acid metabolic process [GO:0001676]; long-chain fatty acid transport [GO:0015909]; positive regulation of cold-induced thermogenesis [GO:0120162]; response to fatty acid [GO:0070542] mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654] acyltransferase activity [GO:0016746]; carnitine O-octanoyltransferase activity [GO:0008458]; carnitine O-palmitoyltransferase activity [GO:0004095] g20211.t1 P52825 45.42 262 3.9100000000000005e-71 234.0 sp|P52825|CPT2_MOUSE Carnitine O-palmitoyltransferase 2, mitochondrial OS=Mus musculus OX=10090 GN=Cpt2 PE=1 SV=2 CPT2_MOUSE reviewed Carnitine O-palmitoyltransferase 2, mitochondrial (EC 2.3.1.21) (Carnitine palmitoyltransferase II) (CPT II) Mus musculus (Mouse) GO:0001676; GO:0001701; GO:0004095; GO:0005654; GO:0005730; GO:0005739; GO:0005743; GO:0005759; GO:0006635; GO:0006853; GO:0008458; GO:0009437; GO:0016746; GO:0120162 carnitine metabolic process [GO:0009437]; carnitine shuttle [GO:0006853]; fatty acid beta-oxidation [GO:0006635]; in utero embryonic development [GO:0001701]; long-chain fatty acid metabolic process [GO:0001676]; positive regulation of cold-induced thermogenesis [GO:0120162] mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654] acyltransferase activity [GO:0016746]; carnitine O-octanoyltransferase activity [GO:0008458]; carnitine O-palmitoyltransferase activity [GO:0004095] g20217.t1 Q6P4X5 39.683 189 2e-24 102.0 sp|Q6P4X5|CPT2_XENTR Carnitine O-palmitoyltransferase 2, mitochondrial OS=Xenopus tropicalis OX=8364 GN=cpt2 PE=2 SV=1 CPT2_XENTR reviewed Carnitine O-palmitoyltransferase 2, mitochondrial (EC 2.3.1.21) (Carnitine palmitoyltransferase II) (CPT II) Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0004095; GO:0005739; GO:0005743; GO:0006635; GO:0008458; GO:0015909 fatty acid beta-oxidation [GO:0006635]; long-chain fatty acid transport [GO:0015909] mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739] carnitine O-octanoyltransferase activity [GO:0008458]; carnitine O-palmitoyltransferase activity [GO:0004095] g20218.t1 Q6P4X5 46.032 630 0.0 559.0 sp|Q6P4X5|CPT2_XENTR Carnitine O-palmitoyltransferase 2, mitochondrial OS=Xenopus tropicalis OX=8364 GN=cpt2 PE=2 SV=1 CPT2_XENTR reviewed Carnitine O-palmitoyltransferase 2, mitochondrial (EC 2.3.1.21) (Carnitine palmitoyltransferase II) (CPT II) Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0004095; GO:0005739; GO:0005743; GO:0006635; GO:0008458; GO:0015909 fatty acid beta-oxidation [GO:0006635]; long-chain fatty acid transport [GO:0015909] mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739] carnitine O-octanoyltransferase activity [GO:0008458]; carnitine O-palmitoyltransferase activity [GO:0004095] g20219.t1 Q99PV3 62.741 518 0.0 698.0 sp|Q99PV3|MKLN1_RAT Muskelin OS=Rattus norvegicus OX=10116 GN=Mkln1 PE=1 SV=1 MKLN1_RAT reviewed Muskelin Rattus norvegicus (Rat) GO:0000151; GO:0001726; GO:0002090; GO:0005654; GO:0005737; GO:0005829; GO:0005938; GO:0007160; GO:0008360; GO:0030036; GO:0042802; GO:0042803; GO:0098895; GO:0098968; GO:0098982; GO:0099003; GO:0099164 actin cytoskeleton organization [GO:0030036]; cell-matrix adhesion [GO:0007160]; neurotransmitter receptor transport postsynaptic membrane to endosome [GO:0098968]; regulation of cell shape [GO:0008360]; regulation of receptor internalization [GO:0002090]; vesicle-mediated transport in synapse [GO:0099003] cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; GABA-ergic synapse [GO:0098982]; nucleoplasm [GO:0005654]; postsynaptic endosome membrane [GO:0098895]; postsynaptic specialization membrane of symmetric synapse [GO:0099164]; ruffle [GO:0001726]; ubiquitin ligase complex [GO:0000151] identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803] g20220.t1 Q9UL63 53.968 126 1.49e-36 135.0 sp|Q9UL63|MKLN1_HUMAN Muskelin OS=Homo sapiens OX=9606 GN=MKLN1 PE=1 SV=2 g20222.t1 P70389 27.826 575 1.0900000000000001e-36 148.0 sp|P70389|ALS_MOUSE Insulin-like growth factor-binding protein complex acid labile subunit OS=Mus musculus OX=10090 GN=Igfals PE=1 SV=1 g20225.t1 Q58A42 37.398 615 2.05e-113 355.0 sp|Q58A42|DD3_DICDI Protein DD3-3 OS=Dictyostelium discoideum OX=44689 GN=DD3-3 PE=2 SV=1 DD3_DICDI reviewed Protein DD3-3 Dictyostelium discoideum (Social amoeba) GO:0016020 membrane [GO:0016020] g20226.t1 Q58A42 33.184 669 7.7e-87 287.0 sp|Q58A42|DD3_DICDI Protein DD3-3 OS=Dictyostelium discoideum OX=44689 GN=DD3-3 PE=2 SV=1 DD3_DICDI reviewed Protein DD3-3 Dictyostelium discoideum (Social amoeba) GO:0016020 membrane [GO:0016020] g20227.t1 Q58A42 37.736 636 5.28e-103 328.0 sp|Q58A42|DD3_DICDI Protein DD3-3 OS=Dictyostelium discoideum OX=44689 GN=DD3-3 PE=2 SV=1 DD3_DICDI reviewed Protein DD3-3 Dictyostelium discoideum (Social amoeba) GO:0016020 membrane [GO:0016020] g20228.t1 Q58A42 30.343 613 2.17e-68 236.0 sp|Q58A42|DD3_DICDI Protein DD3-3 OS=Dictyostelium discoideum OX=44689 GN=DD3-3 PE=2 SV=1 DD3_DICDI reviewed Protein DD3-3 Dictyostelium discoideum (Social amoeba) GO:0016020 membrane [GO:0016020] g20232.t1 Q0VCM2 32.677 254 2e-39 141.0 sp|Q0VCM2|TM187_BOVIN Transmembrane protein 187 OS=Bos taurus OX=9913 GN=TMEM187 PE=2 SV=1 g20233.t1 Q9R0M0 28.764 817 5.13e-71 265.0 sp|Q9R0M0|CELR2_MOUSE Cadherin EGF LAG seven-pass G-type receptor 2 OS=Mus musculus OX=10090 GN=Celsr2 PE=1 SV=3 g20233.t1 Q9R0M0 34.686 271 5.1e-29 130.0 sp|Q9R0M0|CELR2_MOUSE Cadherin EGF LAG seven-pass G-type receptor 2 OS=Mus musculus OX=10090 GN=Celsr2 PE=1 SV=3 g20233.t1 Q9R0M0 30.597 268 4.53e-24 114.0 sp|Q9R0M0|CELR2_MOUSE Cadherin EGF LAG seven-pass G-type receptor 2 OS=Mus musculus OX=10090 GN=Celsr2 PE=1 SV=3 g20233.t1 Q9R0M0 29.6 250 9.13e-24 113.0 sp|Q9R0M0|CELR2_MOUSE Cadherin EGF LAG seven-pass G-type receptor 2 OS=Mus musculus OX=10090 GN=Celsr2 PE=1 SV=3 g20237.t1 Q6NWG4 56.318 277 6.54e-107 318.0 sp|Q6NWG4|ANM6_DANRE Protein arginine N-methyltransferase 6 OS=Danio rerio OX=7955 GN=prmt6 PE=2 SV=2 ANM6_DANRE reviewed Protein arginine N-methyltransferase 6 (EC 2.1.1.319) (Histone-arginine N-methyltransferase PRMT6) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000785; GO:0005634; GO:0006281; GO:0006338; GO:0006355; GO:0008757; GO:0010629; GO:0016274; GO:0021782; GO:0032259; GO:0035241; GO:0035242; GO:0042054; GO:0042393; GO:0044020; GO:0045892; GO:0060041; GO:0070611; GO:0070612; GO:2000059 chromatin remodeling [GO:0006338]; DNA repair [GO:0006281]; glial cell development [GO:0021782]; methylation [GO:0032259]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of gene expression [GO:0010629]; negative regulation of ubiquitin-dependent protein catabolic process [GO:2000059]; regulation of DNA-templated transcription [GO:0006355]; retina development in camera-type eye [GO:0060041] chromatin [GO:0000785]; nucleus [GO:0005634] histone binding [GO:0042393]; histone H2AR3 methyltransferase activity [GO:0070612]; histone H3R2 methyltransferase activity [GO:0070611]; histone H4R3 methyltransferase activity [GO:0044020]; histone methyltransferase activity [GO:0042054]; protein-arginine N-methyltransferase activity [GO:0016274]; protein-arginine omega-N asymmetric methyltransferase activity [GO:0035242]; protein-arginine omega-N monomethyltransferase activity [GO:0035241]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757] g20242.t1 D8VNS8 44.292 219 1.4900000000000001e-43 157.0 sp|D8VNS8|FCNV2_CERRY Ryncolin-2 OS=Cerberus rynchops OX=46267 PE=1 SV=1 g20243.t1 P34908 49.872 780 0.0 675.0 sp|P34908|BRAF_COTJA Serine/threonine-protein kinase B-raf OS=Coturnix japonica OX=93934 GN=BRAF PE=2 SV=1 g20244.t1 Q0P5L5 61.337 344 1.69e-154 444.0 sp|Q0P5L5|SUMF1_BOVIN Formylglycine-generating enzyme OS=Bos taurus OX=9913 GN=SUMF1 PE=2 SV=1 SUMF1_BOVIN reviewed Formylglycine-generating enzyme (FGE) (EC 1.8.3.7) (C-alpha-formylglycine-generating enzyme 1) (Sulfatase-modifying factor 1) Bos taurus (Bovine) GO:0005783; GO:0005788; GO:0018158; GO:0042802; GO:0043687; GO:0120147; GO:1903135 post-translational protein modification [GO:0043687]; protein oxidation [GO:0018158] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788] cupric ion binding [GO:1903135]; formylglycine-generating oxidase activity [GO:0120147]; identical protein binding [GO:0042802] g20245.t1 Q8WSR4 95.455 176 5.38e-110 360.0 sp|Q8WSR4|ITPR_PATPE Inositol 1,4,5-trisphosphate receptor OS=Patiria pectinifera OX=7594 GN=IP3R PE=1 SV=1 g20246.t1 Q8WSR4 80.832 2572 0.0 3865.0 sp|Q8WSR4|ITPR_PATPE Inositol 1,4,5-trisphosphate receptor OS=Patiria pectinifera OX=7594 GN=IP3R PE=1 SV=1 g20246.t2 Q8WSR4 81.729 2545 0.0 3880.0 sp|Q8WSR4|ITPR_PATPE Inositol 1,4,5-trisphosphate receptor OS=Patiria pectinifera OX=7594 GN=IP3R PE=1 SV=1 g20246.t3 Q8WSR4 80.465 2022 0.0 2998.0 sp|Q8WSR4|ITPR_PATPE Inositol 1,4,5-trisphosphate receptor OS=Patiria pectinifera OX=7594 GN=IP3R PE=1 SV=1 g20251.t1 O75051 38.681 1895 0.0 1226.0 sp|O75051|PLXA2_HUMAN Plexin-A2 OS=Homo sapiens OX=9606 GN=PLXNA2 PE=1 SV=4 PLXA2_HUMAN reviewed Plexin-A2 (Semaphorin receptor OCT) Homo sapiens (Human) GO:0001756; GO:0002116; GO:0005886; GO:0007416; GO:0017154; GO:0021915; GO:0021935; GO:0030334; GO:0042802; GO:0051642; GO:0060037; GO:0060174; GO:0071526 centrosome localization [GO:0051642]; cerebellar granule cell precursor tangential migration [GO:0021935]; limb bud formation [GO:0060174]; neural tube development [GO:0021915]; pharyngeal system development [GO:0060037]; regulation of cell migration [GO:0030334]; semaphorin-plexin signaling pathway [GO:0071526]; somitogenesis [GO:0001756]; synapse assembly [GO:0007416] plasma membrane [GO:0005886]; semaphorin receptor complex [GO:0002116] identical protein binding [GO:0042802]; semaphorin receptor activity [GO:0017154] g20252.t1 O60285 45.745 376 6.31e-97 314.0 sp|O60285|NUAK1_HUMAN NUAK family SNF1-like kinase 1 OS=Homo sapiens OX=9606 GN=NUAK1 PE=1 SV=1 NUAK1_HUMAN reviewed NUAK family SNF1-like kinase 1 (EC 2.7.11.1) (AMPK-related protein kinase 5) (ARK5) (Omphalocele kinase 1) Homo sapiens (Human) GO:0001650; GO:0002039; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0006468; GO:0006974; GO:0007155; GO:0015630; GO:0030155; GO:0042127; GO:0046872; GO:0106310; GO:1901796; GO:2000772 cell adhesion [GO:0007155]; DNA damage response [GO:0006974]; protein phosphorylation [GO:0006468]; regulation of cell adhesion [GO:0030155]; regulation of cell population proliferation [GO:0042127]; regulation of cellular senescence [GO:2000772]; regulation of signal transduction by p53 class mediator [GO:1901796] cytoplasm [GO:0005737]; fibrillar center [GO:0001650]; microtubule cytoskeleton [GO:0015630]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] ATP binding [GO:0005524]; metal ion binding [GO:0046872]; p53 binding [GO:0002039]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g20253.t1 E1BSI0 47.716 197 2.8999999999999998e-52 180.0 sp|E1BSI0|PARP3_CHICK Protein mono-ADP-ribosyltransferase PARP3 OS=Gallus gallus OX=9031 GN=PARP3 PE=1 SV=2 PARP3_CHICK reviewed Protein mono-ADP-ribosyltransferase PARP3 (cPARP3) (EC 2.4.2.-) (ADP-ribosyltransferase diphtheria toxin-like 3) (ARTD3) (DNA ADP-ribosyltransferase PARP3) (EC 2.4.2.-) (NAD(+) ADP-ribosyltransferase 3) (ADPRT-3) Gallus gallus (Chicken) GO:0003950; GO:0005730; GO:0005813; GO:0005814; GO:0006302; GO:0016779; GO:0035861; GO:0051053; GO:0140804; GO:0140806; GO:0140807 double-strand break repair [GO:0006302]; negative regulation of DNA metabolic process [GO:0051053] centriole [GO:0005814]; centrosome [GO:0005813]; nucleolus [GO:0005730]; site of double-strand break [GO:0035861] NAD+ poly-ADP-ribosyltransferase activity [GO:0003950]; NAD+-protein-aspartate ADP-ribosyltransferase activity [GO:0140806]; NAD+-protein-glutamate ADP-ribosyltransferase activity [GO:0140807]; NAD+-protein-lysine ADP-ribosyltransferase activity [GO:0140804]; nucleotidyltransferase activity [GO:0016779] g20254.t1 E1BSI0 56.746 252 6.519999999999999e-91 281.0 sp|E1BSI0|PARP3_CHICK Protein mono-ADP-ribosyltransferase PARP3 OS=Gallus gallus OX=9031 GN=PARP3 PE=1 SV=2 PARP3_CHICK reviewed Protein mono-ADP-ribosyltransferase PARP3 (cPARP3) (EC 2.4.2.-) (ADP-ribosyltransferase diphtheria toxin-like 3) (ARTD3) (DNA ADP-ribosyltransferase PARP3) (EC 2.4.2.-) (NAD(+) ADP-ribosyltransferase 3) (ADPRT-3) Gallus gallus (Chicken) GO:0003950; GO:0005730; GO:0005813; GO:0005814; GO:0006302; GO:0016779; GO:0035861; GO:0051053; GO:0140804; GO:0140806; GO:0140807 double-strand break repair [GO:0006302]; negative regulation of DNA metabolic process [GO:0051053] centriole [GO:0005814]; centrosome [GO:0005813]; nucleolus [GO:0005730]; site of double-strand break [GO:0035861] NAD+ poly-ADP-ribosyltransferase activity [GO:0003950]; NAD+-protein-aspartate ADP-ribosyltransferase activity [GO:0140806]; NAD+-protein-glutamate ADP-ribosyltransferase activity [GO:0140807]; NAD+-protein-lysine ADP-ribosyltransferase activity [GO:0140804]; nucleotidyltransferase activity [GO:0016779] g20256.t1 Q708S6 37.696 191 2.07e-41 149.0 sp|Q708S6|ASI1C_DANRE Acid-sensing ion channel 1C OS=Danio rerio OX=7955 GN=asic1c PE=1 SV=1 ASI1C_DANRE reviewed Acid-sensing ion channel 1C (ASIC1-C) (Acid-sensing ion channel 1.3-C) (Amiloride-sensitive cation channel 2-C, neuronal-C) (ZASIC1.3) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005261; GO:0005886; GO:0007269; GO:0015280; GO:0030425; GO:0035725; GO:0045211; GO:0071467; GO:0098793; GO:0098978; GO:0160128 cellular response to pH [GO:0071467]; neurotransmitter secretion [GO:0007269]; sodium ion transmembrane transport [GO:0035725] dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynapse [GO:0098793] ligand-gated sodium channel activity [GO:0015280]; monoatomic cation channel activity [GO:0005261]; pH-gated monoatomic ion channel activity [GO:0160128] g20257.t1 Q5E9U6 49.148 352 1.6200000000000001e-109 335.0 sp|Q5E9U6|WNT16_BOVIN Protein Wnt-16 OS=Bos taurus OX=9913 GN=WNT16 PE=2 SV=1 g20258.t1 A0NLY7 31.754 211 6.199999999999999e-24 101.0 sp|A0NLY7|ISAHY_ROSAI Isatin hydrolase OS=Roseibium aggregatum (strain ATCC 25650 / DSM 13394 / JCM 20685 / NBRC 16684 / NCIMB 2208 / IAM 12614 / B1) OX=384765 GN=SIAM614_09648 PE=1 SV=1 ISAHY_ROSAI reviewed Isatin hydrolase (EC 3.5.2.20) (Isatin amidohydrolase) (Isatin hydrolase isoform b) (IH-b) Roseibium aggregatum (strain ATCC 25650 / DSM 13394 / JCM 20685 / NBRC 16684 / NCIMB 2208 / IAM 12614 / B1) (Stappia aggregata) GO:0004061; GO:0016812; GO:0019441; GO:0030145 L-tryptophan catabolic process to kynurenine [GO:0019441] arylformamidase activity [GO:0004061]; hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides [GO:0016812]; manganese ion binding [GO:0030145] g20260.t1 A0NLY7 31.754 211 3.55e-24 101.0 sp|A0NLY7|ISAHY_ROSAI Isatin hydrolase OS=Roseibium aggregatum (strain ATCC 25650 / DSM 13394 / JCM 20685 / NBRC 16684 / NCIMB 2208 / IAM 12614 / B1) OX=384765 GN=SIAM614_09648 PE=1 SV=1 ISAHY_ROSAI reviewed Isatin hydrolase (EC 3.5.2.20) (Isatin amidohydrolase) (Isatin hydrolase isoform b) (IH-b) Roseibium aggregatum (strain ATCC 25650 / DSM 13394 / JCM 20685 / NBRC 16684 / NCIMB 2208 / IAM 12614 / B1) (Stappia aggregata) GO:0004061; GO:0016812; GO:0019441; GO:0030145 L-tryptophan catabolic process to kynurenine [GO:0019441] arylformamidase activity [GO:0004061]; hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides [GO:0016812]; manganese ion binding [GO:0030145] g20262.t1 Q02650 78.571 126 4.7e-65 214.0 sp|Q02650|PAX5_MOUSE Paired box protein Pax-5 OS=Mus musculus OX=10090 GN=Pax5 PE=1 SV=1 g20263.t1 A4D0V7 42.251 471 1.89e-114 383.0 sp|A4D0V7|CPED1_HUMAN Cadherin-like and PC-esterase domain-containing protein 1 OS=Homo sapiens OX=9606 GN=CPED1 PE=1 SV=1 CPED1_HUMAN reviewed Cadherin-like and PC-esterase domain-containing protein 1 Homo sapiens (Human) GO:0005783 endoplasmic reticulum [GO:0005783] g20265.t1 O18738 35.766 411 2.29e-46 183.0 sp|O18738|DAG1_BOVIN Dystroglycan 1 OS=Bos taurus OX=9913 GN=DAG1 PE=1 SV=1 DAG1_BOVIN reviewed Dystroglycan 1 (Dystroglycan) (Dystrophin-associated glycoprotein 1) [Cleaved into: Alpha-dystroglycan (Alpha-DG); Beta-dystroglycan (Beta-DG)] Bos taurus (Bovine) GO:0002009; GO:0005055; GO:0005509; GO:0005576; GO:0005604; GO:0005615; GO:0005654; GO:0005856; GO:0005886; GO:0007411; GO:0016011; GO:0016020; GO:0016203; GO:0021675; GO:0035022; GO:0042383; GO:0043236; GO:0045211; GO:1904862 axon guidance [GO:0007411]; inhibitory synapse assembly [GO:1904862]; morphogenesis of an epithelium [GO:0002009]; muscle attachment [GO:0016203]; nerve development [GO:0021675]; positive regulation of Rac protein signal transduction [GO:0035022] basement membrane [GO:0005604]; cytoskeleton [GO:0005856]; dystroglycan complex [GO:0016011]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383] calcium ion binding [GO:0005509]; laminin binding [GO:0043236]; laminin receptor activity [GO:0005055] g20265.t1 O18738 32.331 266 2.4099999999999997e-34 145.0 sp|O18738|DAG1_BOVIN Dystroglycan 1 OS=Bos taurus OX=9913 GN=DAG1 PE=1 SV=1 DAG1_BOVIN reviewed Dystroglycan 1 (Dystroglycan) (Dystrophin-associated glycoprotein 1) [Cleaved into: Alpha-dystroglycan (Alpha-DG); Beta-dystroglycan (Beta-DG)] Bos taurus (Bovine) GO:0002009; GO:0005055; GO:0005509; GO:0005576; GO:0005604; GO:0005615; GO:0005654; GO:0005856; GO:0005886; GO:0007411; GO:0016011; GO:0016020; GO:0016203; GO:0021675; GO:0035022; GO:0042383; GO:0043236; GO:0045211; GO:1904862 axon guidance [GO:0007411]; inhibitory synapse assembly [GO:1904862]; morphogenesis of an epithelium [GO:0002009]; muscle attachment [GO:0016203]; nerve development [GO:0021675]; positive regulation of Rac protein signal transduction [GO:0035022] basement membrane [GO:0005604]; cytoskeleton [GO:0005856]; dystroglycan complex [GO:0016011]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383] calcium ion binding [GO:0005509]; laminin binding [GO:0043236]; laminin receptor activity [GO:0005055] g20267.t1 Q08BL7 42.661 511 5.22e-124 376.0 sp|Q08BL7|GLCTK_DANRE Glycerate kinase OS=Danio rerio OX=7955 GN=glyctk PE=2 SV=1 g20268.t1 A0FKN5 38.024 739 1.2499999999999999e-135 421.0 sp|A0FKN5|S26A5_CHICK Prestin OS=Gallus gallus OX=9031 GN=SLC26A5 PE=1 SV=1 S26A5_CHICK reviewed Prestin (Solute carrier family 26 member 5) Gallus gallus (Chicken) GO:0005886; GO:0046872; GO:0160044; GO:0160046 plasma membrane [GO:0005886] metal ion binding [GO:0046872]; oxalate:chloride antiporter activity [GO:0160046]; sulfate:chloride antiporter activity [GO:0160044] g20268.t2 A0FKN5 38.024 739 4.43e-135 420.0 sp|A0FKN5|S26A5_CHICK Prestin OS=Gallus gallus OX=9031 GN=SLC26A5 PE=1 SV=1 S26A5_CHICK reviewed Prestin (Solute carrier family 26 member 5) Gallus gallus (Chicken) GO:0005886; GO:0046872; GO:0160044; GO:0160046 plasma membrane [GO:0005886] metal ion binding [GO:0046872]; oxalate:chloride antiporter activity [GO:0160046]; sulfate:chloride antiporter activity [GO:0160044] g20269.t1 Q9V4A7 30.403 694 1.29e-78 290.0 sp|Q9V4A7|PLXB_DROME Plexin-B OS=Drosophila melanogaster OX=7227 GN=PlexB PE=1 SV=2 PLXB_DROME reviewed Plexin-B Drosophila melanogaster (Fruit fly) GO:0002116; GO:0005886; GO:0007162; GO:0007411; GO:0007416; GO:0008045; GO:0008360; GO:0017154; GO:0030334; GO:0030425; GO:0050772; GO:0070593; GO:0071526; GO:0071678; GO:0097374 axon guidance [GO:0007411]; dendrite self-avoidance [GO:0070593]; motor neuron axon guidance [GO:0008045]; negative regulation of cell adhesion [GO:0007162]; olfactory bulb axon guidance [GO:0071678]; positive regulation of axonogenesis [GO:0050772]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; semaphorin-plexin signaling pathway [GO:0071526]; sensory neuron axon guidance [GO:0097374]; synapse assembly [GO:0007416] dendrite [GO:0030425]; plasma membrane [GO:0005886]; semaphorin receptor complex [GO:0002116] semaphorin receptor activity [GO:0017154] g20270.t1 Q8CCC3 37.778 360 8.6e-51 190.0 sp|Q8CCC3|CL056_MOUSE Uncharacterized protein C12orf56 homolog OS=Mus musculus OX=10090 PE=2 SV=1 g20271.t1 Q9Y4C4 31.321 265 2.54e-30 129.0 sp|Q9Y4C4|MFHA1_HUMAN Malignant fibrous histiocytoma-amplified sequence 1 OS=Homo sapiens OX=9606 GN=MFHAS1 PE=1 SV=2 MFHA1_HUMAN reviewed Malignant fibrous histiocytoma-amplified sequence 1 (Malignant fibrous histiocytoma-amplified sequence with leucine-rich tandem repeats 1) Homo sapiens (Human) GO:0005525; GO:0005737; GO:0006954; GO:0030218; GO:0031625; GO:0034121; GO:0034136; GO:0034137; GO:0034144; GO:0035556; GO:0043030; GO:0045087; GO:0046330; GO:0050728; GO:0051721; GO:0051897; GO:0070374; GO:1900181; GO:1900745 erythrocyte differentiation [GO:0030218]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; intracellular signal transduction [GO:0035556]; negative regulation of inflammatory response [GO:0050728]; negative regulation of protein localization to nucleus [GO:1900181]; negative regulation of toll-like receptor 2 signaling pathway [GO:0034136]; negative regulation of toll-like receptor 4 signaling pathway [GO:0034144]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of JNK cascade [GO:0046330]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of toll-like receptor 2 signaling pathway [GO:0034137]; regulation of macrophage activation [GO:0043030]; regulation of toll-like receptor signaling pathway [GO:0034121] cytoplasm [GO:0005737] GTP binding [GO:0005525]; protein phosphatase 2A binding [GO:0051721]; ubiquitin protein ligase binding [GO:0031625] g20272.t1 Q8IZF6 34.406 404 1.54e-49 200.0 sp|Q8IZF6|AGRG4_HUMAN Adhesion G-protein coupled receptor G4 OS=Homo sapiens OX=9606 GN=ADGRG4 PE=1 SV=2 AGRG4_HUMAN reviewed Adhesion G-protein coupled receptor G4 (G-protein coupled receptor 112) [Cleaved into: Adhesion G-protein coupled receptor G4, N-terminal fragment (ADGRG4 N-terminal fragment); Adhesion G-protein coupled receptor G4, C-terminal fragment (ADGRG4 C-terminal fragment)] Homo sapiens (Human) GO:0004930; GO:0005886; GO:0007166; GO:0007186; GO:0007189; GO:0016020 adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186] membrane [GO:0016020]; plasma membrane [GO:0005886] G protein-coupled receptor activity [GO:0004930] g20272.t2 Q8IZF6 34.406 404 1.48e-49 200.0 sp|Q8IZF6|AGRG4_HUMAN Adhesion G-protein coupled receptor G4 OS=Homo sapiens OX=9606 GN=ADGRG4 PE=1 SV=2 AGRG4_HUMAN reviewed Adhesion G-protein coupled receptor G4 (G-protein coupled receptor 112) [Cleaved into: Adhesion G-protein coupled receptor G4, N-terminal fragment (ADGRG4 N-terminal fragment); Adhesion G-protein coupled receptor G4, C-terminal fragment (ADGRG4 C-terminal fragment)] Homo sapiens (Human) GO:0004930; GO:0005886; GO:0007166; GO:0007186; GO:0007189; GO:0016020 adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186] membrane [GO:0016020]; plasma membrane [GO:0005886] G protein-coupled receptor activity [GO:0004930] g20273.t1 P21856 58.036 448 1.7100000000000001e-161 466.0 sp|P21856|GDIA_BOVIN Rab GDP dissociation inhibitor alpha OS=Bos taurus OX=9913 GN=GDI1 PE=1 SV=1 GDIA_BOVIN reviewed Rab GDP dissociation inhibitor alpha (Rab GDI alpha) (Guanosine diphosphate dissociation inhibitor 1) (GDI-1) (SMG p25A GDI) Bos taurus (Bovine) GO:0005093; GO:0005096; GO:0005794; GO:0005829; GO:0015031; GO:0016192; GO:0032482; GO:0050771; GO:0090315 negative regulation of axonogenesis [GO:0050771]; negative regulation of protein targeting to membrane [GO:0090315]; protein transport [GO:0015031]; Rab protein signal transduction [GO:0032482]; vesicle-mediated transport [GO:0016192] cytosol [GO:0005829]; Golgi apparatus [GO:0005794] GTPase activator activity [GO:0005096]; Rab GDP-dissociation inhibitor activity [GO:0005093] g20274.t1 Q63563 43.894 909 0.0 739.0 sp|Q63563|ABCC9_RAT ATP-binding cassette sub-family C member 9 OS=Rattus norvegicus OX=10116 GN=Abcc9 PE=1 SV=1 g20274.t1 Q63563 30.269 446 1.13e-49 198.0 sp|Q63563|ABCC9_RAT ATP-binding cassette sub-family C member 9 OS=Rattus norvegicus OX=10116 GN=Abcc9 PE=1 SV=1 g20276.t1 Q9BY76 39.303 201 5.05e-30 117.0 sp|Q9BY76|ANGL4_HUMAN Angiopoietin-related protein 4 OS=Homo sapiens OX=9606 GN=ANGPTL4 PE=1 SV=2 ANGL4_HUMAN reviewed Angiopoietin-related protein 4 (Angiopoietin-like protein 4) (Hepatic fibrinogen/angiopoietin-related protein) (HFARP) [Cleaved into: ANGPTL4 N-terminal chain; ANGPTL4 C-terminal chain] Homo sapiens (Human) GO:0001525; GO:0001666; GO:0004857; GO:0005576; GO:0005615; GO:0006629; GO:0007596; GO:0010903; GO:0035473; GO:0042802; GO:0043066; GO:0043335; GO:0045717; GO:0045766; GO:0055102; GO:0070328; GO:0072562; GO:0072577; GO:0090318; GO:2000352 angiogenesis [GO:0001525]; blood coagulation [GO:0007596]; endothelial cell apoptotic process [GO:0072577]; lipid metabolic process [GO:0006629]; negative regulation of apoptotic process [GO:0043066]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of fatty acid biosynthetic process [GO:0045717]; negative regulation of very-low-density lipoprotein particle remodeling [GO:0010903]; positive regulation of angiogenesis [GO:0045766]; protein unfolding [GO:0043335]; regulation of chylomicron remodeling [GO:0090318]; response to hypoxia [GO:0001666]; triglyceride homeostasis [GO:0070328] blood microparticle [GO:0072562]; extracellular region [GO:0005576]; extracellular space [GO:0005615] enzyme inhibitor activity [GO:0004857]; identical protein binding [GO:0042802]; lipase binding [GO:0035473]; lipase inhibitor activity [GO:0055102] g20278.t1 Q9WTS8 46.154 182 1.26e-40 145.0 sp|Q9WTS8|FCN1_RAT Ficolin-1 OS=Rattus norvegicus OX=10116 GN=Fcn1 PE=2 SV=2 FCN1_RAT reviewed Ficolin-1 (Collagen/fibrinogen domain-containing protein 1) (Ficolin-A) (Ficolin-alpha) (M-ficolin) Rattus norvegicus (Rat) GO:0001867; GO:0002752; GO:0003823; GO:0005102; GO:0005581; GO:0005615; GO:0005886; GO:0007186; GO:0030246; GO:0032757; GO:0033691; GO:0038187; GO:0046872; GO:0097367; GO:0106139 cell surface pattern recognition receptor signaling pathway [GO:0002752]; complement activation, lectin pathway [GO:0001867]; G protein-coupled receptor signaling pathway [GO:0007186]; positive regulation of interleukin-8 production [GO:0032757] collagen trimer [GO:0005581]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; symbiont cell surface [GO:0106139] antigen binding [GO:0003823]; carbohydrate binding [GO:0030246]; carbohydrate derivative binding [GO:0097367]; metal ion binding [GO:0046872]; pattern recognition receptor activity [GO:0038187]; sialic acid binding [GO:0033691]; signaling receptor binding [GO:0005102] g20281.t1 P82451 38.303 1603 0.0 1014.0 sp|P82451|ABCC9_RABIT ATP-binding cassette sub-family C member 9 OS=Oryctolagus cuniculus OX=9986 GN=ABCC9 PE=2 SV=1 g20283.t1 E9Q9W4 38.482 382 9.13e-80 261.0 sp|E9Q9W4|S27A6_MOUSE Long-chain fatty acid transport protein 6 OS=Mus musculus OX=10090 GN=Slc27a6 PE=1 SV=1 S27A6_MOUSE reviewed Long-chain fatty acid transport protein 6 (FATP-6) (Fatty acid transport protein 6) (Arachidonate--CoA ligase) (EC 6.2.1.15) (Fatty-acid-coenzyme A ligase, very long-chain 2) (Long-chain-fatty-acid--CoA ligase) (EC 6.2.1.3) (Solute carrier family 27 member 6) (Very long-chain acyl-CoA synthetase homolog 1) (VLACS2) (VLCSH1) (mVLCS-H1) (EC 6.2.1.-) Mus musculus (Mouse) GO:0000166; GO:0001676; GO:0004467; GO:0005324; GO:0005783; GO:0005789; GO:0005886; GO:0031957; GO:0042383; GO:0044539; GO:0047676 long-chain fatty acid import into cell [GO:0044539]; long-chain fatty acid metabolic process [GO:0001676] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383] arachidonate-CoA ligase activity [GO:0047676]; long-chain fatty acid transmembrane transporter activity [GO:0005324]; long-chain fatty acid-CoA ligase activity [GO:0004467]; nucleotide binding [GO:0000166]; very long-chain fatty acid-CoA ligase activity [GO:0031957] g20284.t1 E9Q9W4 56.494 154 1.27e-53 181.0 sp|E9Q9W4|S27A6_MOUSE Long-chain fatty acid transport protein 6 OS=Mus musculus OX=10090 GN=Slc27a6 PE=1 SV=1 S27A6_MOUSE reviewed Long-chain fatty acid transport protein 6 (FATP-6) (Fatty acid transport protein 6) (Arachidonate--CoA ligase) (EC 6.2.1.15) (Fatty-acid-coenzyme A ligase, very long-chain 2) (Long-chain-fatty-acid--CoA ligase) (EC 6.2.1.3) (Solute carrier family 27 member 6) (Very long-chain acyl-CoA synthetase homolog 1) (VLACS2) (VLCSH1) (mVLCS-H1) (EC 6.2.1.-) Mus musculus (Mouse) GO:0000166; GO:0001676; GO:0004467; GO:0005324; GO:0005783; GO:0005789; GO:0005886; GO:0031957; GO:0042383; GO:0044539; GO:0047676 long-chain fatty acid import into cell [GO:0044539]; long-chain fatty acid metabolic process [GO:0001676] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383] arachidonate-CoA ligase activity [GO:0047676]; long-chain fatty acid transmembrane transporter activity [GO:0005324]; long-chain fatty acid-CoA ligase activity [GO:0004467]; nucleotide binding [GO:0000166]; very long-chain fatty acid-CoA ligase activity [GO:0031957] g20285.t1 Q9CX98 39.509 448 4.05e-109 337.0 sp|Q9CX98|CP2U1_MOUSE Cytochrome P450 2U1 OS=Mus musculus OX=10090 GN=Cyp2u1 PE=2 SV=2 CP2U1_MOUSE reviewed Cytochrome P450 2U1 (Long-chain fatty acid omega-monooxygenase) (EC 1.14.14.80) Mus musculus (Mouse) GO:0005506; GO:0005737; GO:0005743; GO:0005789; GO:0006082; GO:0006805; GO:0008202; GO:0008395; GO:0016712; GO:0020037; GO:0052869; GO:0097267; GO:0102033 omega-hydroxylase P450 pathway [GO:0097267]; organic acid metabolic process [GO:0006082]; steroid metabolic process [GO:0008202]; xenobiotic metabolic process [GO:0006805] cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; mitochondrial inner membrane [GO:0005743] arachidonate omega-hydroxylase activity [GO:0052869]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; long-chain fatty acid omega-hydroxylase activity [GO:0102033]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; steroid hydroxylase activity [GO:0008395] g20287.t1 Q9CX98 40.157 381 1.43e-94 300.0 sp|Q9CX98|CP2U1_MOUSE Cytochrome P450 2U1 OS=Mus musculus OX=10090 GN=Cyp2u1 PE=2 SV=2 CP2U1_MOUSE reviewed Cytochrome P450 2U1 (Long-chain fatty acid omega-monooxygenase) (EC 1.14.14.80) Mus musculus (Mouse) GO:0005506; GO:0005737; GO:0005743; GO:0005789; GO:0006082; GO:0006805; GO:0008202; GO:0008395; GO:0016712; GO:0020037; GO:0052869; GO:0097267; GO:0102033 omega-hydroxylase P450 pathway [GO:0097267]; organic acid metabolic process [GO:0006082]; steroid metabolic process [GO:0008202]; xenobiotic metabolic process [GO:0006805] cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; mitochondrial inner membrane [GO:0005743] arachidonate omega-hydroxylase activity [GO:0052869]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; long-chain fatty acid omega-hydroxylase activity [GO:0102033]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; steroid hydroxylase activity [GO:0008395] g20288.t1 Q7Z449 37.4 500 5.579999999999999e-115 352.0 sp|Q7Z449|CP2U1_HUMAN Cytochrome P450 2U1 OS=Homo sapiens OX=9606 GN=CYP2U1 PE=1 SV=1 CP2U1_HUMAN reviewed Cytochrome P450 2U1 (Long-chain fatty acid omega-monooxygenase) (EC 1.14.14.80) Homo sapiens (Human) GO:0004497; GO:0005506; GO:0005737; GO:0005743; GO:0005789; GO:0006082; GO:0006805; GO:0008202; GO:0008395; GO:0016712; GO:0020037; GO:0052869; GO:0097267; GO:0102033; GO:1903604 cytochrome metabolic process [GO:1903604]; omega-hydroxylase P450 pathway [GO:0097267]; organic acid metabolic process [GO:0006082]; steroid metabolic process [GO:0008202]; xenobiotic metabolic process [GO:0006805] cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; mitochondrial inner membrane [GO:0005743] arachidonate omega-hydroxylase activity [GO:0052869]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; long-chain fatty acid omega-hydroxylase activity [GO:0102033]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; steroid hydroxylase activity [GO:0008395] g20289.t1 Q7Z449 39.184 490 1.08e-123 375.0 sp|Q7Z449|CP2U1_HUMAN Cytochrome P450 2U1 OS=Homo sapiens OX=9606 GN=CYP2U1 PE=1 SV=1 CP2U1_HUMAN reviewed Cytochrome P450 2U1 (Long-chain fatty acid omega-monooxygenase) (EC 1.14.14.80) Homo sapiens (Human) GO:0004497; GO:0005506; GO:0005737; GO:0005743; GO:0005789; GO:0006082; GO:0006805; GO:0008202; GO:0008395; GO:0016712; GO:0020037; GO:0052869; GO:0097267; GO:0102033; GO:1903604 cytochrome metabolic process [GO:1903604]; omega-hydroxylase P450 pathway [GO:0097267]; organic acid metabolic process [GO:0006082]; steroid metabolic process [GO:0008202]; xenobiotic metabolic process [GO:0006805] cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; mitochondrial inner membrane [GO:0005743] arachidonate omega-hydroxylase activity [GO:0052869]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; long-chain fatty acid omega-hydroxylase activity [GO:0102033]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; steroid hydroxylase activity [GO:0008395] g20290.t1 Q9CX98 40.769 390 1.2300000000000001e-103 319.0 sp|Q9CX98|CP2U1_MOUSE Cytochrome P450 2U1 OS=Mus musculus OX=10090 GN=Cyp2u1 PE=2 SV=2 CP2U1_MOUSE reviewed Cytochrome P450 2U1 (Long-chain fatty acid omega-monooxygenase) (EC 1.14.14.80) Mus musculus (Mouse) GO:0005506; GO:0005737; GO:0005743; GO:0005789; GO:0006082; GO:0006805; GO:0008202; GO:0008395; GO:0016712; GO:0020037; GO:0052869; GO:0097267; GO:0102033 omega-hydroxylase P450 pathway [GO:0097267]; organic acid metabolic process [GO:0006082]; steroid metabolic process [GO:0008202]; xenobiotic metabolic process [GO:0006805] cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; mitochondrial inner membrane [GO:0005743] arachidonate omega-hydroxylase activity [GO:0052869]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; long-chain fatty acid omega-hydroxylase activity [GO:0102033]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; steroid hydroxylase activity [GO:0008395] g20291.t1 Q0IIF9 40.0 495 2.0400000000000002e-117 359.0 sp|Q0IIF9|CP2U1_BOVIN Cytochrome P450 2U1 OS=Bos taurus OX=9913 GN=CYP2U1 PE=2 SV=1 CP2U1_BOVIN reviewed Cytochrome P450 2U1 (Long-chain fatty acid omega-monooxygenase) (EC 1.14.14.80) Bos taurus (Bovine) GO:0005506; GO:0005737; GO:0005743; GO:0005789; GO:0006082; GO:0006805; GO:0008202; GO:0008395; GO:0016712; GO:0020037; GO:0052869; GO:0102033 organic acid metabolic process [GO:0006082]; steroid metabolic process [GO:0008202]; xenobiotic metabolic process [GO:0006805] cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; mitochondrial inner membrane [GO:0005743] arachidonate omega-hydroxylase activity [GO:0052869]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; long-chain fatty acid omega-hydroxylase activity [GO:0102033]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; steroid hydroxylase activity [GO:0008395] g20294.t1 Q7Z449 39.014 487 1.68e-120 366.0 sp|Q7Z449|CP2U1_HUMAN Cytochrome P450 2U1 OS=Homo sapiens OX=9606 GN=CYP2U1 PE=1 SV=1 CP2U1_HUMAN reviewed Cytochrome P450 2U1 (Long-chain fatty acid omega-monooxygenase) (EC 1.14.14.80) Homo sapiens (Human) GO:0004497; GO:0005506; GO:0005737; GO:0005743; GO:0005789; GO:0006082; GO:0006805; GO:0008202; GO:0008395; GO:0016712; GO:0020037; GO:0052869; GO:0097267; GO:0102033; GO:1903604 cytochrome metabolic process [GO:1903604]; omega-hydroxylase P450 pathway [GO:0097267]; organic acid metabolic process [GO:0006082]; steroid metabolic process [GO:0008202]; xenobiotic metabolic process [GO:0006805] cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; mitochondrial inner membrane [GO:0005743] arachidonate omega-hydroxylase activity [GO:0052869]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; long-chain fatty acid omega-hydroxylase activity [GO:0102033]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; steroid hydroxylase activity [GO:0008395] g20296.t1 Q7Z449 36.382 492 2.34e-107 332.0 sp|Q7Z449|CP2U1_HUMAN Cytochrome P450 2U1 OS=Homo sapiens OX=9606 GN=CYP2U1 PE=1 SV=1 CP2U1_HUMAN reviewed Cytochrome P450 2U1 (Long-chain fatty acid omega-monooxygenase) (EC 1.14.14.80) Homo sapiens (Human) GO:0004497; GO:0005506; GO:0005737; GO:0005743; GO:0005789; GO:0006082; GO:0006805; GO:0008202; GO:0008395; GO:0016712; GO:0020037; GO:0052869; GO:0097267; GO:0102033; GO:1903604 cytochrome metabolic process [GO:1903604]; omega-hydroxylase P450 pathway [GO:0097267]; organic acid metabolic process [GO:0006082]; steroid metabolic process [GO:0008202]; xenobiotic metabolic process [GO:0006805] cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; mitochondrial inner membrane [GO:0005743] arachidonate omega-hydroxylase activity [GO:0052869]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; long-chain fatty acid omega-hydroxylase activity [GO:0102033]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; steroid hydroxylase activity [GO:0008395] g20297.t1 Q9QXF7 39.03 474 2.73e-116 354.0 sp|Q9QXF7|CP2J4_RAT Cytochrome P450 2J4 OS=Rattus norvegicus OX=10116 GN=CYP2J4 PE=1 SV=1 g20298.t1 Q7Z449 37.892 446 3.43e-96 303.0 sp|Q7Z449|CP2U1_HUMAN Cytochrome P450 2U1 OS=Homo sapiens OX=9606 GN=CYP2U1 PE=1 SV=1 CP2U1_HUMAN reviewed Cytochrome P450 2U1 (Long-chain fatty acid omega-monooxygenase) (EC 1.14.14.80) Homo sapiens (Human) GO:0004497; GO:0005506; GO:0005737; GO:0005743; GO:0005789; GO:0006082; GO:0006805; GO:0008202; GO:0008395; GO:0016712; GO:0020037; GO:0052869; GO:0097267; GO:0102033; GO:1903604 cytochrome metabolic process [GO:1903604]; omega-hydroxylase P450 pathway [GO:0097267]; organic acid metabolic process [GO:0006082]; steroid metabolic process [GO:0008202]; xenobiotic metabolic process [GO:0006805] cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; mitochondrial inner membrane [GO:0005743] arachidonate omega-hydroxylase activity [GO:0052869]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; long-chain fatty acid omega-hydroxylase activity [GO:0102033]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; steroid hydroxylase activity [GO:0008395] g20299.t1 O60706 39.949 1582 0.0 1074.0 sp|O60706|ABCC9_HUMAN ATP-binding cassette sub-family C member 9 OS=Homo sapiens OX=9606 GN=ABCC9 PE=1 SV=2 ABCC9_HUMAN reviewed ATP-binding cassette sub-family C member 9 (Sulfonylurea receptor 2) Homo sapiens (Human) GO:0000165; GO:0001508; GO:0001666; GO:0003007; GO:0005267; GO:0005524; GO:0005739; GO:0005886; GO:0006357; GO:0007005; GO:0007519; GO:0008281; GO:0008282; GO:0010467; GO:0014823; GO:0015459; GO:0016887; GO:0019395; GO:0019829; GO:0030017; GO:0031004; GO:0033198; GO:0035865; GO:0042311; GO:0042383; GO:0042542; GO:0042626; GO:0043066; GO:0043225; GO:0043627; GO:0044325; GO:0044877; GO:0045333; GO:0045776; GO:0046034; GO:0048144; GO:0051607; GO:0055085; GO:0060976; GO:0061337; GO:0062197; GO:0071277; GO:0071318; GO:0071466; GO:0071805; GO:0072592; GO:0086003; GO:0098655; GO:0098662; GO:0099104; GO:0140359; GO:0150104; GO:1901379; GO:1901652; GO:1903409; GO:1904880; GO:1990573 action potential [GO:0001508]; ATP metabolic process [GO:0046034]; cardiac conduction [GO:0061337]; cardiac muscle cell contraction [GO:0086003]; cellular respiration [GO:0045333]; cellular response to ATP [GO:0071318]; cellular response to calcium ion [GO:0071277]; cellular response to chemical stress [GO:0062197]; cellular response to potassium ion [GO:0035865]; cellular response to xenobiotic stimulus [GO:0071466]; coronary vasculature development [GO:0060976]; defense response to virus [GO:0051607]; fatty acid oxidation [GO:0019395]; fibroblast proliferation [GO:0048144]; gene expression [GO:0010467]; heart morphogenesis [GO:0003007]; inorganic cation transmembrane transport [GO:0098662]; MAPK cascade [GO:0000165]; mitochondrion organization [GO:0007005]; monoatomic cation transmembrane transport [GO:0098655]; negative regulation of apoptotic process [GO:0043066]; negative regulation of blood pressure [GO:0045776]; oxygen metabolic process [GO:0072592]; potassium ion import across plasma membrane [GO:1990573]; potassium ion transmembrane transport [GO:0071805]; reactive oxygen species biosynthetic process [GO:1903409]; regulation of potassium ion transmembrane transport [GO:1901379]; regulation of transcription by RNA polymerase II [GO:0006357]; response to activity [GO:0014823]; response to ATP [GO:0033198]; response to estrogen [GO:0043627]; response to hydrogen peroxide [GO:0042542]; response to hydrogen sulfide [GO:1904880]; response to hypoxia [GO:0001666]; response to peptide [GO:1901652]; skeletal muscle tissue development [GO:0007519]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104]; vasodilation [GO:0042311] inward rectifying potassium channel [GO:0008282]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; potassium ion-transporting ATPase complex [GO:0031004]; sarcolemma [GO:0042383]; sarcomere [GO:0030017] ABC-type transporter activity [GO:0140359]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled inorganic anion transmembrane transporter activity [GO:0043225]; ATPase-coupled monoatomic cation transmembrane transporter activity [GO:0019829]; ATPase-coupled transmembrane transporter activity [GO:0042626]; potassium channel activator activity [GO:0099104]; potassium channel activity [GO:0005267]; potassium channel regulator activity [GO:0015459]; protein-containing complex binding [GO:0044877]; sulfonylurea receptor activity [GO:0008281]; transmembrane transporter binding [GO:0044325] g20300.t1 O60706 38.976 1601 0.0 1053.0 sp|O60706|ABCC9_HUMAN ATP-binding cassette sub-family C member 9 OS=Homo sapiens OX=9606 GN=ABCC9 PE=1 SV=2 ABCC9_HUMAN reviewed ATP-binding cassette sub-family C member 9 (Sulfonylurea receptor 2) Homo sapiens (Human) GO:0000165; GO:0001508; GO:0001666; GO:0003007; GO:0005267; GO:0005524; GO:0005739; GO:0005886; GO:0006357; GO:0007005; GO:0007519; GO:0008281; GO:0008282; GO:0010467; GO:0014823; GO:0015459; GO:0016887; GO:0019395; GO:0019829; GO:0030017; GO:0031004; GO:0033198; GO:0035865; GO:0042311; GO:0042383; GO:0042542; GO:0042626; GO:0043066; GO:0043225; GO:0043627; GO:0044325; GO:0044877; GO:0045333; GO:0045776; GO:0046034; GO:0048144; GO:0051607; GO:0055085; GO:0060976; GO:0061337; GO:0062197; GO:0071277; GO:0071318; GO:0071466; GO:0071805; GO:0072592; GO:0086003; GO:0098655; GO:0098662; GO:0099104; GO:0140359; GO:0150104; GO:1901379; GO:1901652; GO:1903409; GO:1904880; GO:1990573 action potential [GO:0001508]; ATP metabolic process [GO:0046034]; cardiac conduction [GO:0061337]; cardiac muscle cell contraction [GO:0086003]; cellular respiration [GO:0045333]; cellular response to ATP [GO:0071318]; cellular response to calcium ion [GO:0071277]; cellular response to chemical stress [GO:0062197]; cellular response to potassium ion [GO:0035865]; cellular response to xenobiotic stimulus [GO:0071466]; coronary vasculature development [GO:0060976]; defense response to virus [GO:0051607]; fatty acid oxidation [GO:0019395]; fibroblast proliferation [GO:0048144]; gene expression [GO:0010467]; heart morphogenesis [GO:0003007]; inorganic cation transmembrane transport [GO:0098662]; MAPK cascade [GO:0000165]; mitochondrion organization [GO:0007005]; monoatomic cation transmembrane transport [GO:0098655]; negative regulation of apoptotic process [GO:0043066]; negative regulation of blood pressure [GO:0045776]; oxygen metabolic process [GO:0072592]; potassium ion import across plasma membrane [GO:1990573]; potassium ion transmembrane transport [GO:0071805]; reactive oxygen species biosynthetic process [GO:1903409]; regulation of potassium ion transmembrane transport [GO:1901379]; regulation of transcription by RNA polymerase II [GO:0006357]; response to activity [GO:0014823]; response to ATP [GO:0033198]; response to estrogen [GO:0043627]; response to hydrogen peroxide [GO:0042542]; response to hydrogen sulfide [GO:1904880]; response to hypoxia [GO:0001666]; response to peptide [GO:1901652]; skeletal muscle tissue development [GO:0007519]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104]; vasodilation [GO:0042311] inward rectifying potassium channel [GO:0008282]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; potassium ion-transporting ATPase complex [GO:0031004]; sarcolemma [GO:0042383]; sarcomere [GO:0030017] ABC-type transporter activity [GO:0140359]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled inorganic anion transmembrane transporter activity [GO:0043225]; ATPase-coupled monoatomic cation transmembrane transporter activity [GO:0019829]; ATPase-coupled transmembrane transporter activity [GO:0042626]; potassium channel activator activity [GO:0099104]; potassium channel activity [GO:0005267]; potassium channel regulator activity [GO:0015459]; protein-containing complex binding [GO:0044877]; sulfonylurea receptor activity [GO:0008281]; transmembrane transporter binding [GO:0044325] g20301.t1 Q5RCN7 35.054 465 2.35e-76 255.0 sp|Q5RCN7|MFD4A_PONAB Major facilitator superfamily domain-containing protein 4A OS=Pongo abelii OX=9601 GN=MFSD4A PE=2 SV=1 g20302.t1 Q3ZC71 45.055 91 2.55e-29 103.0 sp|Q3ZC71|DPM3_BOVIN Dolichol-phosphate mannosyltransferase subunit 3 OS=Bos taurus OX=9913 GN=DPM3 PE=3 SV=1 g20302.t2 Q3ZC71 45.055 91 5.58e-27 101.0 sp|Q3ZC71|DPM3_BOVIN Dolichol-phosphate mannosyltransferase subunit 3 OS=Bos taurus OX=9913 GN=DPM3 PE=3 SV=1 g20305.t1 Q3SZ71 79.227 414 0.0 714.0 sp|Q3SZ71|MPPB_BOVIN Mitochondrial-processing peptidase subunit beta OS=Bos taurus OX=9913 GN=PMPCB PE=2 SV=1 MPPB_BOVIN reviewed Mitochondrial-processing peptidase subunit beta (EC 3.4.24.64) (Beta-MPP) Bos taurus (Bovine) GO:0004222; GO:0005739; GO:0005759; GO:0006627; GO:0009003; GO:0046872 protein processing involved in protein targeting to mitochondrion [GO:0006627] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; signal peptidase activity [GO:0009003] g20306.t1 Q6BEA0 30.04 496 1.58e-51 191.0 sp|Q6BEA0|PLXA4_DANRE Plexin-A4 OS=Danio rerio OX=7955 GN=plxna4 PE=2 SV=1 PLXA4_DANRE reviewed Plexin-A4 Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001763; GO:0002116; GO:0005886; GO:0007411; GO:0007414; GO:0007416; GO:0016020; GO:0017154; GO:0030334; GO:0071526 axon guidance [GO:0007411]; axonal defasciculation [GO:0007414]; morphogenesis of a branching structure [GO:0001763]; regulation of cell migration [GO:0030334]; semaphorin-plexin signaling pathway [GO:0071526]; synapse assembly [GO:0007416] membrane [GO:0016020]; plasma membrane [GO:0005886]; semaphorin receptor complex [GO:0002116] semaphorin receptor activity [GO:0017154] g20307.t1 Q9V4A7 32.039 206 2.3999999999999998e-28 115.0 sp|Q9V4A7|PLXB_DROME Plexin-B OS=Drosophila melanogaster OX=7227 GN=PlexB PE=1 SV=2 PLXB_DROME reviewed Plexin-B Drosophila melanogaster (Fruit fly) GO:0002116; GO:0005886; GO:0007162; GO:0007411; GO:0007416; GO:0008045; GO:0008360; GO:0017154; GO:0030334; GO:0030425; GO:0050772; GO:0070593; GO:0071526; GO:0071678; GO:0097374 axon guidance [GO:0007411]; dendrite self-avoidance [GO:0070593]; motor neuron axon guidance [GO:0008045]; negative regulation of cell adhesion [GO:0007162]; olfactory bulb axon guidance [GO:0071678]; positive regulation of axonogenesis [GO:0050772]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; semaphorin-plexin signaling pathway [GO:0071526]; sensory neuron axon guidance [GO:0097374]; synapse assembly [GO:0007416] dendrite [GO:0030425]; plasma membrane [GO:0005886]; semaphorin receptor complex [GO:0002116] semaphorin receptor activity [GO:0017154] g20308.t1 Q8CJH3 33.486 1093 4.7e-179 578.0 sp|Q8CJH3|PLXB1_MOUSE Plexin-B1 OS=Mus musculus OX=10090 GN=Plxnb1 PE=1 SV=2 PLXB1_MOUSE reviewed Plexin-B1 Mus musculus (Mouse) GO:0002116; GO:0005886; GO:0007162; GO:0007416; GO:0008360; GO:0017154; GO:0030334; GO:0032794; GO:0033689; GO:0035025; GO:0043547; GO:0043931; GO:0045211; GO:0048812; GO:0050772; GO:0051493; GO:0051897; GO:0071526; GO:0098978; GO:1904862 inhibitory synapse assembly [GO:1904862]; negative regulation of cell adhesion [GO:0007162]; negative regulation of osteoblast proliferation [GO:0033689]; neuron projection morphogenesis [GO:0048812]; ossification involved in bone maturation [GO:0043931]; positive regulation of axonogenesis [GO:0050772]; positive regulation of GTPase activity [GO:0043547]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of Rho protein signal transduction [GO:0035025]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; regulation of cytoskeleton organization [GO:0051493]; semaphorin-plexin signaling pathway [GO:0071526]; synapse assembly [GO:0007416] glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; semaphorin receptor complex [GO:0002116] GTPase activating protein binding [GO:0032794]; semaphorin receptor activity [GO:0017154] g20310.t1 P35832 30.719 459 3.55e-47 186.0 sp|P35832|PTP99_DROME Tyrosine-protein phosphatase 99A OS=Drosophila melanogaster OX=7227 GN=Ptp99A PE=2 SV=2 g20311.t1 Q62656 45.913 416 4.41e-120 397.0 sp|Q62656|PTPRZ_RAT Receptor-type tyrosine-protein phosphatase zeta OS=Rattus norvegicus OX=10116 GN=Ptprz1 PE=1 SV=1 g20311.t1 Q62656 28.571 259 4.35e-25 115.0 sp|Q62656|PTPRZ_RAT Receptor-type tyrosine-protein phosphatase zeta OS=Rattus norvegicus OX=10116 GN=Ptprz1 PE=1 SV=1 g20312.t1 Q5RC19 45.687 313 2.2999999999999998e-89 283.0 sp|Q5RC19|ACOX1_PONAB Peroxisomal acyl-coenzyme A oxidase 1 OS=Pongo abelii OX=9601 GN=ACOX1 PE=2 SV=2 ACOX1_PONAB reviewed Peroxisomal acyl-coenzyme A oxidase 1 (AOX) (EC 1.3.3.6) (Palmitoyl-CoA oxidase) (Peroxisomal fatty acyl-CoA oxidase) (Straight-chain acyl-CoA oxidase) [Cleaved into: Peroxisomal acyl-CoA oxidase 1, A chain; Peroxisomal acyl-CoA oxidase 1, B chain; Peroxisomal acyl-CoA oxidase 1, C chain] Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0003997; GO:0005504; GO:0005777; GO:0005778; GO:0005782; GO:0006091; GO:0006629; GO:0006636; GO:0006693; GO:0007283; GO:0009062; GO:0019395; GO:0030165; GO:0036109; GO:0042759; GO:0042803; GO:0050665; GO:0055088; GO:0071949; GO:0140493; GO:1901570 alpha-linolenic acid metabolic process [GO:0036109]; fatty acid catabolic process [GO:0009062]; fatty acid derivative biosynthetic process [GO:1901570]; fatty acid oxidation [GO:0019395]; generation of precursor metabolites and energy [GO:0006091]; hydrogen peroxide biosynthetic process [GO:0050665]; lipid homeostasis [GO:0055088]; lipid metabolic process [GO:0006629]; long-chain fatty acid biosynthetic process [GO:0042759]; prostaglandin metabolic process [GO:0006693]; spermatogenesis [GO:0007283]; unsaturated fatty acid biosynthetic process [GO:0006636]; very long-chain fatty acid beta-oxidation [GO:0140493] peroxisomal matrix [GO:0005782]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777] acyl-CoA oxidase activity [GO:0003997]; FAD binding [GO:0071949]; fatty acid binding [GO:0005504]; PDZ domain binding [GO:0030165]; protein homodimerization activity [GO:0042803] g20313.t1 Q8HYL8 30.769 234 1.3e-27 112.0 sp|Q8HYL8|ACOX1_PHACI Peroxisomal acyl-coenzyme A oxidase 1 OS=Phascolarctos cinereus OX=38626 GN=ACOX1 PE=1 SV=2 g20314.t1 Q9JJJ7 44.0 450 7.9e-115 349.0 sp|Q9JJJ7|PORCN_MOUSE Protein-serine O-palmitoleoyltransferase porcupine OS=Mus musculus OX=10090 GN=Porcn PE=1 SV=1 PORCN_MOUSE reviewed Protein-serine O-palmitoleoyltransferase porcupine (mPORC) (EC 2.3.1.250) Mus musculus (Mouse) GO:0005783; GO:0005789; GO:0006497; GO:0008374; GO:0009100; GO:0016020; GO:0016055; GO:0017147; GO:0030258; GO:0032281; GO:0045234; GO:0061355; GO:0098978; GO:0099072; GO:1990698 glycoprotein metabolic process [GO:0009100]; lipid modification [GO:0030258]; protein lipidation [GO:0006497]; protein palmitoleylation [GO:0045234]; regulation of postsynaptic membrane neurotransmitter receptor levels [GO:0099072]; Wnt protein secretion [GO:0061355]; Wnt signaling pathway [GO:0016055] AMPA glutamate receptor complex [GO:0032281]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020] O-acyltransferase activity [GO:0008374]; palmitoleoyltransferase activity [GO:1990698]; Wnt-protein binding [GO:0017147] g20315.t1 A0FKN5 40.498 321 4.58e-71 237.0 sp|A0FKN5|S26A5_CHICK Prestin OS=Gallus gallus OX=9031 GN=SLC26A5 PE=1 SV=1 S26A5_CHICK reviewed Prestin (Solute carrier family 26 member 5) Gallus gallus (Chicken) GO:0005886; GO:0046872; GO:0160044; GO:0160046 plasma membrane [GO:0005886] metal ion binding [GO:0046872]; oxalate:chloride antiporter activity [GO:0160046]; sulfate:chloride antiporter activity [GO:0160044] g20316.t1 Q17232 23.404 423 9.56e-22 101.0 sp|Q17232|OAR_BOMMO Octopamine receptor OS=Bombyx mori OX=7091 PE=2 SV=1 g20317.t1 D7PC76 39.831 354 1.31e-76 254.0 sp|D7PC76|S26A5_TURTR Prestin OS=Tursiops truncatus OX=9739 GN=SLC26A5 PE=1 SV=1 S26A5_TURTR reviewed Prestin (Solute carrier family 26 member 5) Tursiops truncatus (Atlantic bottle-nosed dolphin) (Delphinus truncatus) GO:0005886; GO:0007605; GO:0008271; GO:0008360; GO:0099129 cochlear outer hair cell electromotile response [GO:0099129]; regulation of cell shape [GO:0008360]; sensory perception of sound [GO:0007605] plasma membrane [GO:0005886] secondary active sulfate transmembrane transporter activity [GO:0008271] g20319.t1 Q16881 59.16 595 0.0 701.0 sp|Q16881|TRXR1_HUMAN Thioredoxin reductase 1, cytoplasmic OS=Homo sapiens OX=9606 GN=TXNRD1 PE=1 SV=3 g20320.t1 B7ZCC9 34.232 371 8.66e-46 182.0 sp|B7ZCC9|AGRG4_MOUSE Adhesion G-protein coupled receptor G4 OS=Mus musculus OX=10090 GN=Adgrg4 PE=3 SV=1 AGRG4_MOUSE reviewed Adhesion G-protein coupled receptor G4 (G-protein coupled receptor 112) [Cleaved into: Adhesion G-protein coupled receptor G4, N-terminal fragment (ADGRG4 N-terminal fragment); Adhesion G-protein coupled receptor G4, C-terminal fragment (ADGRG4 C-terminal fragment)] Mus musculus (Mouse) GO:0004930; GO:0005886; GO:0007166; GO:0007186; GO:0007189 adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186] plasma membrane [GO:0005886] G protein-coupled receptor activity [GO:0004930] g20320.t2 B7ZCC9 34.232 371 1.8299999999999998e-46 182.0 sp|B7ZCC9|AGRG4_MOUSE Adhesion G-protein coupled receptor G4 OS=Mus musculus OX=10090 GN=Adgrg4 PE=3 SV=1 AGRG4_MOUSE reviewed Adhesion G-protein coupled receptor G4 (G-protein coupled receptor 112) [Cleaved into: Adhesion G-protein coupled receptor G4, N-terminal fragment (ADGRG4 N-terminal fragment); Adhesion G-protein coupled receptor G4, C-terminal fragment (ADGRG4 C-terminal fragment)] Mus musculus (Mouse) GO:0004930; GO:0005886; GO:0007166; GO:0007186; GO:0007189 adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186] plasma membrane [GO:0005886] G protein-coupled receptor activity [GO:0004930] g20321.t1 Q8IZF6 29.16 631 1.1099999999999999e-54 215.0 sp|Q8IZF6|AGRG4_HUMAN Adhesion G-protein coupled receptor G4 OS=Homo sapiens OX=9606 GN=ADGRG4 PE=1 SV=2 AGRG4_HUMAN reviewed Adhesion G-protein coupled receptor G4 (G-protein coupled receptor 112) [Cleaved into: Adhesion G-protein coupled receptor G4, N-terminal fragment (ADGRG4 N-terminal fragment); Adhesion G-protein coupled receptor G4, C-terminal fragment (ADGRG4 C-terminal fragment)] Homo sapiens (Human) GO:0004930; GO:0005886; GO:0007166; GO:0007186; GO:0007189; GO:0016020 adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186] membrane [GO:0016020]; plasma membrane [GO:0005886] G protein-coupled receptor activity [GO:0004930] g20322.t1 Q8CJ12 28.697 568 1.43e-43 177.0 sp|Q8CJ12|AGRG2_MOUSE Adhesion G-protein coupled receptor G2 OS=Mus musculus OX=10090 GN=Adgrg2 PE=1 SV=1 AGRG2_MOUSE reviewed Adhesion G-protein coupled receptor G2 (G-protein coupled receptor 64) (Mouse epididymis-specific protein 6) (Me6) [Cleaved into: Adhesion G-protein coupled receptor G2, N-terminal fragment (ADGRG2 N-terminal fragment); Adhesion G-protein coupled receptor G2, C-terminal fragment (ADGRG2 C-terminal fragment)] Mus musculus (Mouse) GO:0004930; GO:0005829; GO:0005886; GO:0007166; GO:0007186; GO:0007189; GO:0007200; GO:0007286; GO:0016324 adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; spermatid development [GO:0007286] apical plasma membrane [GO:0016324]; cytosol [GO:0005829]; plasma membrane [GO:0005886] G protein-coupled receptor activity [GO:0004930] g20323.t1 Q6N075 34.158 404 1.1799999999999999e-61 210.0 sp|Q6N075|MFSD5_HUMAN Molybdate-anion transporter OS=Homo sapiens OX=9606 GN=MFSD5 PE=1 SV=2 MFSD5_HUMAN reviewed Solute carrier family 61 member 1 (Major facilitator superfamily domain-containing protein 5) (Molybdate transporter 2 homolog) (hsMOT2) (Molybdate-anion transporter) Homo sapiens (Human) GO:0005886; GO:0006811; GO:0015098; GO:0015689; GO:0016020; GO:0032094; GO:0042594 molybdate ion transport [GO:0015689]; monoatomic ion transport [GO:0006811]; response to food [GO:0032094]; response to starvation [GO:0042594] membrane [GO:0016020]; plasma membrane [GO:0005886] molybdate ion transmembrane transporter activity [GO:0015098] g20326.t1 Q8CFG5 30.351 313 8.440000000000001e-29 126.0 sp|Q8CFG5|CA2D3_RAT Voltage-dependent calcium channel subunit alpha-2/delta-3 OS=Rattus norvegicus OX=10116 GN=Cacna2d3 PE=1 SV=1 CA2D3_RAT reviewed Voltage-dependent calcium channel subunit alpha-2/delta-3 (Voltage-gated calcium channel subunit alpha-2/delta-3) [Cleaved into: Voltage-dependent calcium channel subunit alpha-2-3; Voltage-dependent calcium channel subunit delta-3] Rattus norvegicus (Rat) GO:0005245; GO:0005246; GO:0005891; GO:0006816; GO:0046872; GO:0048787; GO:0098982; GO:0099174; GO:1990314 calcium ion transport [GO:0006816]; cellular response to insulin-like growth factor stimulus [GO:1990314]; regulation of presynapse organization [GO:0099174] GABA-ergic synapse [GO:0098982]; presynaptic active zone membrane [GO:0048787]; voltage-gated calcium channel complex [GO:0005891] calcium channel regulator activity [GO:0005246]; metal ion binding [GO:0046872]; voltage-gated calcium channel activity [GO:0005245] g20328.t1 Q14AI6 32.99 291 2.2100000000000002e-29 119.0 sp|Q14AI6|RUSD3_MOUSE Mitochondrial mRNA pseudouridine synthase Rpusd3 OS=Mus musculus OX=10090 GN=Rpusd3 PE=2 SV=1 g20329.t1 P30676 79.825 114 3.65e-54 177.0 sp|P30676|GNAI_PATPE Guanine nucleotide-binding protein G(i) subunit alpha OS=Patiria pectinifera OX=7594 PE=1 SV=3 g20330.t1 P30676 97.845 232 4.3599999999999995e-170 475.0 sp|P30676|GNAI_PATPE Guanine nucleotide-binding protein G(i) subunit alpha OS=Patiria pectinifera OX=7594 PE=1 SV=3 g20331.t1 P51593 83.291 395 0.0 746.0 sp|P51593|HUWE1_RAT E3 ubiquitin-protein ligase HUWE1 OS=Rattus norvegicus OX=10116 GN=Huwe1 PE=1 SV=3 g20331.t1 P51593 42.755 421 1.69e-52 207.0 sp|P51593|HUWE1_RAT E3 ubiquitin-protein ligase HUWE1 OS=Rattus norvegicus OX=10116 GN=Huwe1 PE=1 SV=3 g20331.t2 P51593 83.291 395 0.0 746.0 sp|P51593|HUWE1_RAT E3 ubiquitin-protein ligase HUWE1 OS=Rattus norvegicus OX=10116 GN=Huwe1 PE=1 SV=3 g20331.t2 P51593 43.468 421 4.2099999999999995e-55 215.0 sp|P51593|HUWE1_RAT E3 ubiquitin-protein ligase HUWE1 OS=Rattus norvegicus OX=10116 GN=Huwe1 PE=1 SV=3 g20332.t1 Q7Z6Z7 63.043 1334 0.0 1603.0 sp|Q7Z6Z7|HUWE1_HUMAN E3 ubiquitin-protein ligase HUWE1 OS=Homo sapiens OX=9606 GN=HUWE1 PE=1 SV=3 HUWE1_HUMAN reviewed E3 ubiquitin-protein ligase HUWE1 (EC 2.3.2.26) (ARF-binding protein 1) (ARF-BP1) (HECT, UBA and WWE domain-containing protein 1) (HECT-type E3 ubiquitin transferase HUWE1) (Homologous to E6AP carboxyl terminus homologous protein 9) (HectH9) (Large structure of UREB1) (LASU1) (Mcl-1 ubiquitin ligase E3) (Mule) (Upstream regulatory element-binding protein 1) (URE-B1) (URE-binding protein 1) Homo sapiens (Human) GO:0000139; GO:0000209; GO:0003677; GO:0003723; GO:0004842; GO:0005576; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0006284; GO:0006511; GO:0006513; GO:0007030; GO:0010637; GO:0016020; GO:0030154; GO:0031398; GO:0032922; GO:0034450; GO:0034774; GO:0035359; GO:0043123; GO:0043161; GO:0061025; GO:0061630; GO:0070062; GO:0070936; GO:0097225; GO:0097228; GO:0097229; GO:0140852; GO:0141198; GO:1903955; GO:1904813; GO:1905091 base-excision repair [GO:0006284]; cell differentiation [GO:0030154]; circadian regulation of gene expression [GO:0032922]; Golgi organization [GO:0007030]; membrane fusion [GO:0061025]; negative regulation of mitochondrial fusion [GO:0010637]; negative regulation of peroxisome proliferator activated receptor signaling pathway [GO:0035359]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of protein targeting to mitochondrion [GO:1903955]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of type 2 mitophagy [GO:1905091]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein branched polyubiquitination [GO:0141198]; protein K48-linked ubiquitination [GO:0070936]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; secretory granule lumen [GO:0034774]; sperm end piece [GO:0097229]; sperm midpiece [GO:0097225]; sperm principal piece [GO:0097228] DNA binding [GO:0003677]; histone ubiquitin ligase activity [GO:0140852]; RNA binding [GO:0003723]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; ubiquitin-ubiquitin ligase activity [GO:0034450] g20332.t1 Q7Z6Z7 44.2 1000 0.0 677.0 sp|Q7Z6Z7|HUWE1_HUMAN E3 ubiquitin-protein ligase HUWE1 OS=Homo sapiens OX=9606 GN=HUWE1 PE=1 SV=3 HUWE1_HUMAN reviewed E3 ubiquitin-protein ligase HUWE1 (EC 2.3.2.26) (ARF-binding protein 1) (ARF-BP1) (HECT, UBA and WWE domain-containing protein 1) (HECT-type E3 ubiquitin transferase HUWE1) (Homologous to E6AP carboxyl terminus homologous protein 9) (HectH9) (Large structure of UREB1) (LASU1) (Mcl-1 ubiquitin ligase E3) (Mule) (Upstream regulatory element-binding protein 1) (URE-B1) (URE-binding protein 1) Homo sapiens (Human) GO:0000139; GO:0000209; GO:0003677; GO:0003723; GO:0004842; GO:0005576; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0006284; GO:0006511; GO:0006513; GO:0007030; GO:0010637; GO:0016020; GO:0030154; GO:0031398; GO:0032922; GO:0034450; GO:0034774; GO:0035359; GO:0043123; GO:0043161; GO:0061025; GO:0061630; GO:0070062; GO:0070936; GO:0097225; GO:0097228; GO:0097229; GO:0140852; GO:0141198; GO:1903955; GO:1904813; GO:1905091 base-excision repair [GO:0006284]; cell differentiation [GO:0030154]; circadian regulation of gene expression [GO:0032922]; Golgi organization [GO:0007030]; membrane fusion [GO:0061025]; negative regulation of mitochondrial fusion [GO:0010637]; negative regulation of peroxisome proliferator activated receptor signaling pathway [GO:0035359]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of protein targeting to mitochondrion [GO:1903955]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of type 2 mitophagy [GO:1905091]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein branched polyubiquitination [GO:0141198]; protein K48-linked ubiquitination [GO:0070936]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; secretory granule lumen [GO:0034774]; sperm end piece [GO:0097229]; sperm midpiece [GO:0097225]; sperm principal piece [GO:0097228] DNA binding [GO:0003677]; histone ubiquitin ligase activity [GO:0140852]; RNA binding [GO:0003723]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; ubiquitin-ubiquitin ligase activity [GO:0034450] g20332.t2 Q7Z6Z7 63.043 1334 0.0 1601.0 sp|Q7Z6Z7|HUWE1_HUMAN E3 ubiquitin-protein ligase HUWE1 OS=Homo sapiens OX=9606 GN=HUWE1 PE=1 SV=3 HUWE1_HUMAN reviewed E3 ubiquitin-protein ligase HUWE1 (EC 2.3.2.26) (ARF-binding protein 1) (ARF-BP1) (HECT, UBA and WWE domain-containing protein 1) (HECT-type E3 ubiquitin transferase HUWE1) (Homologous to E6AP carboxyl terminus homologous protein 9) (HectH9) (Large structure of UREB1) (LASU1) (Mcl-1 ubiquitin ligase E3) (Mule) (Upstream regulatory element-binding protein 1) (URE-B1) (URE-binding protein 1) Homo sapiens (Human) GO:0000139; GO:0000209; GO:0003677; GO:0003723; GO:0004842; GO:0005576; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0006284; GO:0006511; GO:0006513; GO:0007030; GO:0010637; GO:0016020; GO:0030154; GO:0031398; GO:0032922; GO:0034450; GO:0034774; GO:0035359; GO:0043123; GO:0043161; GO:0061025; GO:0061630; GO:0070062; GO:0070936; GO:0097225; GO:0097228; GO:0097229; GO:0140852; GO:0141198; GO:1903955; GO:1904813; GO:1905091 base-excision repair [GO:0006284]; cell differentiation [GO:0030154]; circadian regulation of gene expression [GO:0032922]; Golgi organization [GO:0007030]; membrane fusion [GO:0061025]; negative regulation of mitochondrial fusion [GO:0010637]; negative regulation of peroxisome proliferator activated receptor signaling pathway [GO:0035359]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of protein targeting to mitochondrion [GO:1903955]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of type 2 mitophagy [GO:1905091]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein branched polyubiquitination [GO:0141198]; protein K48-linked ubiquitination [GO:0070936]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; secretory granule lumen [GO:0034774]; sperm end piece [GO:0097229]; sperm midpiece [GO:0097225]; sperm principal piece [GO:0097228] DNA binding [GO:0003677]; histone ubiquitin ligase activity [GO:0140852]; RNA binding [GO:0003723]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; ubiquitin-ubiquitin ligase activity [GO:0034450] g20332.t2 Q7Z6Z7 44.2 1000 0.0 676.0 sp|Q7Z6Z7|HUWE1_HUMAN E3 ubiquitin-protein ligase HUWE1 OS=Homo sapiens OX=9606 GN=HUWE1 PE=1 SV=3 HUWE1_HUMAN reviewed E3 ubiquitin-protein ligase HUWE1 (EC 2.3.2.26) (ARF-binding protein 1) (ARF-BP1) (HECT, UBA and WWE domain-containing protein 1) (HECT-type E3 ubiquitin transferase HUWE1) (Homologous to E6AP carboxyl terminus homologous protein 9) (HectH9) (Large structure of UREB1) (LASU1) (Mcl-1 ubiquitin ligase E3) (Mule) (Upstream regulatory element-binding protein 1) (URE-B1) (URE-binding protein 1) Homo sapiens (Human) GO:0000139; GO:0000209; GO:0003677; GO:0003723; GO:0004842; GO:0005576; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0006284; GO:0006511; GO:0006513; GO:0007030; GO:0010637; GO:0016020; GO:0030154; GO:0031398; GO:0032922; GO:0034450; GO:0034774; GO:0035359; GO:0043123; GO:0043161; GO:0061025; GO:0061630; GO:0070062; GO:0070936; GO:0097225; GO:0097228; GO:0097229; GO:0140852; GO:0141198; GO:1903955; GO:1904813; GO:1905091 base-excision repair [GO:0006284]; cell differentiation [GO:0030154]; circadian regulation of gene expression [GO:0032922]; Golgi organization [GO:0007030]; membrane fusion [GO:0061025]; negative regulation of mitochondrial fusion [GO:0010637]; negative regulation of peroxisome proliferator activated receptor signaling pathway [GO:0035359]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of protein targeting to mitochondrion [GO:1903955]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of type 2 mitophagy [GO:1905091]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein branched polyubiquitination [GO:0141198]; protein K48-linked ubiquitination [GO:0070936]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; secretory granule lumen [GO:0034774]; sperm end piece [GO:0097229]; sperm midpiece [GO:0097225]; sperm principal piece [GO:0097228] DNA binding [GO:0003677]; histone ubiquitin ligase activity [GO:0140852]; RNA binding [GO:0003723]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; ubiquitin-ubiquitin ligase activity [GO:0034450] g20337.t1 Q8WXK3 46.332 259 2.58e-78 241.0 sp|Q8WXK3|ASB13_HUMAN Ankyrin repeat and SOCS box protein 13 OS=Homo sapiens OX=9606 GN=ASB13 PE=1 SV=2 ASB13_HUMAN reviewed Ankyrin repeat and SOCS box protein 13 (ASB-13) Homo sapiens (Human) GO:0005829; GO:0016567; GO:0035556 intracellular signal transduction [GO:0035556]; protein ubiquitination [GO:0016567] cytosol [GO:0005829] g20338.t1 Q9UK61 40.672 268 2.2999999999999997e-42 175.0 sp|Q9UK61|TASOR_HUMAN Protein TASOR OS=Homo sapiens OX=9606 GN=TASOR PE=1 SV=3 g20350.t1 Q4R6T7 50.235 637 0.0 622.0 sp|Q4R6T7|IQUB_MACFA IQ motif and ubiquitin-like domain-containing protein OS=Macaca fascicularis OX=9541 GN=IQUB PE=2 SV=2 IQUB_MACFA reviewed IQ motif and ubiquitin-like domain-containing protein Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey) GO:0001534; GO:0001669; GO:0007618; GO:0030317; GO:0036126; GO:0060271; GO:0097729 cilium assembly [GO:0060271]; flagellated sperm motility [GO:0030317]; mating [GO:0007618] 9+2 motile cilium [GO:0097729]; acrosomal vesicle [GO:0001669]; radial spoke [GO:0001534]; sperm flagellum [GO:0036126] g20351.t1 Q6ZR08 60.357 1738 0.0 1996.0 sp|Q6ZR08|DYH12_HUMAN Dynein axonemal heavy chain 12 OS=Homo sapiens OX=9606 GN=DNAH12 PE=1 SV=2 DYH12_HUMAN reviewed Dynein axonemal heavy chain 12 (Axonemal beta dynein heavy chain 12) (Axonemal dynein heavy chain 12-like protein) (Axonemal dynein heavy chain 7-like protein) (Ciliary dynein heavy chain 12) (Dynein axonemal heavy chain 7-like) (Dynein heavy chain domain-containing protein 2) Homo sapiens (Human) GO:0005524; GO:0005858; GO:0005874; GO:0007286; GO:0007288; GO:0008569; GO:0036126; GO:0045505; GO:0051959; GO:0070286 axonemal dynein complex assembly [GO:0070286]; sperm axoneme assembly [GO:0007288]; spermatid development [GO:0007286] axonemal dynein complex [GO:0005858]; microtubule [GO:0005874]; sperm flagellum [GO:0036126] ATP binding [GO:0005524]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; minus-end-directed microtubule motor activity [GO:0008569] g20352.t1 Q8WXX0 58.547 1790 0.0 2038.0 sp|Q8WXX0|DYH7_HUMAN Dynein axonemal heavy chain 7 OS=Homo sapiens OX=9606 GN=DNAH7 PE=1 SV=2 DYH7_HUMAN reviewed Dynein axonemal heavy chain 7 (Axonemal beta dynein heavy chain 7) (Ciliary dynein heavy chain 7) (Dynein heavy chain-like protein 2) (hDHC2) Homo sapiens (Human) GO:0003341; GO:0003777; GO:0005509; GO:0005524; GO:0005858; GO:0005874; GO:0005929; GO:0008569; GO:0036156; GO:0036159; GO:0045505; GO:0051959; GO:0060285; GO:0060294; GO:0097729 cilium movement [GO:0003341]; cilium movement involved in cell motility [GO:0060294]; cilium-dependent cell motility [GO:0060285]; inner dynein arm assembly [GO:0036159] 9+2 motile cilium [GO:0097729]; axonemal dynein complex [GO:0005858]; cilium [GO:0005929]; inner dynein arm [GO:0036156]; microtubule [GO:0005874] ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]; minus-end-directed microtubule motor activity [GO:0008569] g20353.t1 Q3V0Q1 71.377 276 4.3499999999999997e-135 426.0 sp|Q3V0Q1|DYH12_MOUSE Dynein axonemal heavy chain 12 OS=Mus musculus OX=10090 GN=Dnah12 PE=1 SV=2 DYH12_MOUSE reviewed Dynein axonemal heavy chain 12 (Axonemal beta dynein heavy chain 12) (Axonemal dynein heavy chain 12-like protein) (Axonemal dynein heavy chain 7-like protein) (Ciliary dynein heavy chain 12) Mus musculus (Mouse) GO:0005524; GO:0005874; GO:0007286; GO:0007288; GO:0008569; GO:0016567; GO:0036126; GO:0036156; GO:0045505; GO:0051959; GO:0060294; GO:0097729 cilium movement involved in cell motility [GO:0060294]; protein ubiquitination [GO:0016567]; sperm axoneme assembly [GO:0007288]; spermatid development [GO:0007286] 9+2 motile cilium [GO:0097729]; inner dynein arm [GO:0036156]; microtubule [GO:0005874]; sperm flagellum [GO:0036126] ATP binding [GO:0005524]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; minus-end-directed microtubule motor activity [GO:0008569] g20354.t1 O54715 27.211 441 1.88e-33 134.0 sp|O54715|VAS1_RAT V-type proton ATPase subunit S1 OS=Rattus norvegicus OX=10116 GN=Atp6ap1 PE=1 SV=1 VAS1_RAT reviewed V-type proton ATPase subunit S1 (V-ATPase subunit S1) (C7-1 protein) (V-ATPase Ac45 subunit) (V-ATPase S1 accessory protein) (Vacuolar proton pump subunit S1) Rattus norvegicus (Rat) GO:0001671; GO:0005789; GO:0006879; GO:0010008; GO:0016020; GO:0030641; GO:0030665; GO:0030672; GO:0031267; GO:0033116; GO:0033176; GO:0036035; GO:0036295; GO:0097401; GO:0099638; GO:0141109 cellular response to increased oxygen levels [GO:0036295]; endosome to plasma membrane protein transport [GO:0099638]; intracellular iron ion homeostasis [GO:0006879]; osteoclast development [GO:0036035]; regulation of cellular pH [GO:0030641]; synaptic vesicle lumen acidification [GO:0097401] clathrin-coated vesicle membrane [GO:0030665]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; endosome membrane [GO:0010008]; membrane [GO:0016020]; proton-transporting V-type ATPase complex [GO:0033176]; synaptic vesicle membrane [GO:0030672] ATPase activator activity [GO:0001671]; small GTPase binding [GO:0031267]; transporter activator activity [GO:0141109] g20355.t1 Q86FP7 93.662 142 1.57e-92 267.0 sp|Q86FP7|RS23_DERVA Small ribosomal subunit protein uS12 OS=Dermacentor variabilis OX=34621 GN=RpS23 PE=2 SV=1 g20356.t1 Q9Z0V7 56.805 169 1.64e-59 184.0 sp|Q9Z0V7|TI17B_MOUSE Mitochondrial import inner membrane translocase subunit Tim17-B OS=Mus musculus OX=10090 GN=Timm17b PE=1 SV=1 g20357.t1 Q9NS91 57.955 88 1.55e-31 119.0 sp|Q9NS91|RAD18_HUMAN E3 ubiquitin-protein ligase RAD18 OS=Homo sapiens OX=9606 GN=RAD18 PE=1 SV=2 g20358.t1 Q9NS91 39.521 167 4.97e-28 121.0 sp|Q9NS91|RAD18_HUMAN E3 ubiquitin-protein ligase RAD18 OS=Homo sapiens OX=9606 GN=RAD18 PE=1 SV=2 g20359.t1 Q6GMH0 57.31 342 4.9699999999999997e-135 391.0 sp|Q6GMH0|PRP18_DANRE Pre-mRNA-splicing factor 18 OS=Danio rerio OX=7955 GN=prpf18 PE=2 SV=1 g20360.t1 Q3UHX0 41.921 229 1.3299999999999999e-46 182.0 sp|Q3UHX0|NOL8_MOUSE Nucleolar protein 8 OS=Mus musculus OX=10090 GN=Nol8 PE=1 SV=2 g20362.t1 O57382 28.475 295 3.21e-34 132.0 sp|O57382|TLL2_XENLA Tolloid-like protein 2 OS=Xenopus laevis OX=8355 GN=tll2 PE=2 SV=1 g20362.t1 O57382 32.273 220 4.58e-30 120.0 sp|O57382|TLL2_XENLA Tolloid-like protein 2 OS=Xenopus laevis OX=8355 GN=tll2 PE=2 SV=1 g20362.t1 O57382 26.923 234 5.630000000000001e-27 112.0 sp|O57382|TLL2_XENLA Tolloid-like protein 2 OS=Xenopus laevis OX=8355 GN=tll2 PE=2 SV=1 g20363.t1 O88281 40.12 167 3.21e-27 109.0 sp|O88281|MEGF6_RAT Multiple epidermal growth factor-like domains protein 6 OS=Rattus norvegicus OX=10116 GN=Megf6 PE=1 SV=1 g20363.t1 O88281 44.118 34 3.21e-27 34.3 sp|O88281|MEGF6_RAT Multiple epidermal growth factor-like domains protein 6 OS=Rattus norvegicus OX=10116 GN=Megf6 PE=1 SV=1 g20363.t1 O88281 36.628 172 7.78e-25 93.6 sp|O88281|MEGF6_RAT Multiple epidermal growth factor-like domains protein 6 OS=Rattus norvegicus OX=10116 GN=Megf6 PE=1 SV=1 g20363.t1 O88281 48.649 37 7.78e-25 42.0 sp|O88281|MEGF6_RAT Multiple epidermal growth factor-like domains protein 6 OS=Rattus norvegicus OX=10116 GN=Megf6 PE=1 SV=1 g20364.t1 P98133 35.378 489 1.57e-64 232.0 sp|P98133|FBN1_BOVIN Fibrillin-1 OS=Bos taurus OX=9913 GN=FBN1 PE=1 SV=2 g20364.t1 P98133 36.919 409 1.27e-59 218.0 sp|P98133|FBN1_BOVIN Fibrillin-1 OS=Bos taurus OX=9913 GN=FBN1 PE=1 SV=2 g20364.t1 P98133 34.874 476 5.72e-57 210.0 sp|P98133|FBN1_BOVIN Fibrillin-1 OS=Bos taurus OX=9913 GN=FBN1 PE=1 SV=2 g20364.t1 P98133 34.161 483 6.84e-50 189.0 sp|P98133|FBN1_BOVIN Fibrillin-1 OS=Bos taurus OX=9913 GN=FBN1 PE=1 SV=2 g20364.t1 P98133 33.333 486 7.98e-49 186.0 sp|P98133|FBN1_BOVIN Fibrillin-1 OS=Bos taurus OX=9913 GN=FBN1 PE=1 SV=2 g20364.t1 P98133 32.514 529 1.76e-48 185.0 sp|P98133|FBN1_BOVIN Fibrillin-1 OS=Bos taurus OX=9913 GN=FBN1 PE=1 SV=2 g20364.t1 P98133 32.129 498 2.36e-47 181.0 sp|P98133|FBN1_BOVIN Fibrillin-1 OS=Bos taurus OX=9913 GN=FBN1 PE=1 SV=2 g20364.t1 P98133 33.871 434 2.38e-47 181.0 sp|P98133|FBN1_BOVIN Fibrillin-1 OS=Bos taurus OX=9913 GN=FBN1 PE=1 SV=2 g20364.t1 P98133 32.857 490 5.550000000000001e-47 180.0 sp|P98133|FBN1_BOVIN Fibrillin-1 OS=Bos taurus OX=9913 GN=FBN1 PE=1 SV=2 g20364.t1 P98133 31.176 510 2.87e-43 169.0 sp|P98133|FBN1_BOVIN Fibrillin-1 OS=Bos taurus OX=9913 GN=FBN1 PE=1 SV=2 g20364.t1 P98133 31.942 479 1.54e-41 164.0 sp|P98133|FBN1_BOVIN Fibrillin-1 OS=Bos taurus OX=9913 GN=FBN1 PE=1 SV=2 g20364.t1 P98133 30.02 503 6.840000000000001e-36 147.0 sp|P98133|FBN1_BOVIN Fibrillin-1 OS=Bos taurus OX=9913 GN=FBN1 PE=1 SV=2 g20364.t1 P98133 29.231 520 1.4899999999999998e-30 131.0 sp|P98133|FBN1_BOVIN Fibrillin-1 OS=Bos taurus OX=9913 GN=FBN1 PE=1 SV=2 g20364.t1 P98133 32.873 362 3.56e-30 130.0 sp|P98133|FBN1_BOVIN Fibrillin-1 OS=Bos taurus OX=9913 GN=FBN1 PE=1 SV=2 g20364.t1 P98133 28.571 546 5.8e-30 129.0 sp|P98133|FBN1_BOVIN Fibrillin-1 OS=Bos taurus OX=9913 GN=FBN1 PE=1 SV=2 g20364.t1 P98133 29.103 457 1.2000000000000002e-27 122.0 sp|P98133|FBN1_BOVIN Fibrillin-1 OS=Bos taurus OX=9913 GN=FBN1 PE=1 SV=2 g20370.t1 Q9H8X2 28.947 494 1.26e-56 199.0 sp|Q9H8X2|IPPK_HUMAN Inositol-pentakisphosphate 2-kinase OS=Homo sapiens OX=9606 GN=IPPK PE=1 SV=1 g20371.t1 P34743 58.333 120 1.35e-39 135.0 sp|P34743|BTG1_CHICK Protein BTG1 OS=Gallus gallus OX=9031 GN=BTG1 PE=2 SV=1 g20372.t1 Q9JMD2 79.268 82 1.02e-39 147.0 sp|Q9JMD2|SMBT1_RAT Scm-like with four MBT domains protein 1 OS=Rattus norvegicus OX=10116 GN=Sfmbt1 PE=1 SV=2 g20373.t1 Q5VUG0 45.645 620 3.42e-168 530.0 sp|Q5VUG0|SMBT2_HUMAN Scm-like with four MBT domains protein 2 OS=Homo sapiens OX=9606 GN=SFMBT2 PE=1 SV=1 SMBT2_HUMAN reviewed Scm-like with four MBT domains protein 2 (Scm-like with 4 MBT domains protein 2) Homo sapiens (Human) GO:0003682; GO:0003714; GO:0005634; GO:0005654; GO:0005829; GO:0010629; GO:0016235; GO:0016604; GO:0016607; GO:0042393; GO:0045892 negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of gene expression [GO:0010629] aggresome [GO:0016235]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] chromatin binding [GO:0003682]; histone binding [GO:0042393]; transcription corepressor activity [GO:0003714] g20377.t1 Q641G7 90.476 168 3.3e-111 316.0 sp|Q641G7|ARPC4_XENLA Actin-related protein 2/3 complex subunit 4 OS=Xenopus laevis OX=8355 GN=arpc4 PE=1 SV=1 g20384.t1 Q55GQ5 58.182 110 4.5799999999999996e-38 133.0 sp|Q55GQ5|SODC1_DICDI Superoxide dismutase [Cu-Zn] 1 OS=Dictyostelium discoideum OX=44689 GN=sodA PE=2 SV=1 SODC1_DICDI reviewed Superoxide dismutase [Cu-Zn] 1 (EC 1.15.1.1) Dictyostelium discoideum (Social amoeba) GO:0004784; GO:0005507; GO:0006801; GO:0006979; GO:0009617; GO:0019430; GO:0031012; GO:0031152; GO:0042542; GO:0045335; GO:0046686; GO:1904643 aggregation involved in sorocarp development [GO:0031152]; removal of superoxide radicals [GO:0019430]; response to bacterium [GO:0009617]; response to cadmium ion [GO:0046686]; response to curcumin [GO:1904643]; response to hydrogen peroxide [GO:0042542]; response to oxidative stress [GO:0006979]; superoxide metabolic process [GO:0006801] extracellular matrix [GO:0031012]; phagocytic vesicle [GO:0045335] copper ion binding [GO:0005507]; superoxide dismutase activity [GO:0004784] g20386.t1 P41340 77.273 374 0.0 624.0 sp|P41340|ACT3_LIMPO Actin-3 OS=Limulus polyphemus OX=6850 PE=1 SV=1 g20387.t1 P12716 84.759 374 0.0 690.0 sp|P12716|ACTC_PISOC Actin, cytoplasmic OS=Pisaster ochraceus OX=7612 PE=3 SV=1 g20388.t1 Q9Z2Z6 47.841 301 4.69e-85 260.0 sp|Q9Z2Z6|MCAT_MOUSE Mitochondrial carnitine/acylcarnitine carrier protein OS=Mus musculus OX=10090 GN=Slc25a20 PE=1 SV=1 MCAT_MOUSE reviewed Mitochondrial carnitine/acylcarnitine carrier protein (Carnitine/acylcarnitine translocase) (CAC) (CACT) (mCAC) (Solute carrier family 25 member 20) Mus musculus (Mouse) GO:0001701; GO:0005476; GO:0005739; GO:0005740; GO:0005743; GO:0005829; GO:0006839; GO:0006853; GO:0015227; GO:1902603 carnitine shuttle [GO:0006853]; carnitine transmembrane transport [GO:1902603]; in utero embryonic development [GO:0001701]; mitochondrial transport [GO:0006839] cytosol [GO:0005829]; mitochondrial envelope [GO:0005740]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739] carnitine:O-acyl-L-carnitine antiporter activity [GO:0005476]; O-acyl-L-carnitine transmembrane transporter activity [GO:0015227] g20389.t1 P28337 56.43 381 3.46e-149 431.0 sp|P28337|GCST_CHICK Aminomethyltransferase, mitochondrial OS=Gallus gallus OX=9031 GN=AMT PE=1 SV=2 g20398.t1 B0BNF9 51.791 363 4.0200000000000003e-116 344.0 sp|B0BNF9|HAOX1_RAT 2-Hydroxyacid oxidase 1 OS=Rattus norvegicus OX=10116 GN=Hao1 PE=1 SV=1 HAOX1_RAT reviewed 2-Hydroxyacid oxidase 1 (HAOX1) (EC 1.1.3.15) (Glycolate oxidase) (GOX) (Glyoxylate oxidase) (EC 1.2.3.5) Rattus norvegicus (Rat) GO:0001561; GO:0003973; GO:0005777; GO:0005782; GO:0006545; GO:0006979; GO:0010181; GO:0046296; GO:0047969 fatty acid alpha-oxidation [GO:0001561]; glycine biosynthetic process [GO:0006545]; glycolate catabolic process [GO:0046296]; response to oxidative stress [GO:0006979] peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777] (S)-2-hydroxy-acid oxidase activity [GO:0003973]; FMN binding [GO:0010181]; glyoxylate oxidase activity [GO:0047969] g20399.t1 B0BNF9 55.242 248 5.47e-78 244.0 sp|B0BNF9|HAOX1_RAT 2-Hydroxyacid oxidase 1 OS=Rattus norvegicus OX=10116 GN=Hao1 PE=1 SV=1 HAOX1_RAT reviewed 2-Hydroxyacid oxidase 1 (HAOX1) (EC 1.1.3.15) (Glycolate oxidase) (GOX) (Glyoxylate oxidase) (EC 1.2.3.5) Rattus norvegicus (Rat) GO:0001561; GO:0003973; GO:0005777; GO:0005782; GO:0006545; GO:0006979; GO:0010181; GO:0046296; GO:0047969 fatty acid alpha-oxidation [GO:0001561]; glycine biosynthetic process [GO:0006545]; glycolate catabolic process [GO:0046296]; response to oxidative stress [GO:0006979] peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777] (S)-2-hydroxy-acid oxidase activity [GO:0003973]; FMN binding [GO:0010181]; glyoxylate oxidase activity [GO:0047969] g20400.t1 Q99JW2 52.513 398 8.58e-150 433.0 sp|Q99JW2|ACY1_MOUSE Aminoacylase-1 OS=Mus musculus OX=10090 GN=Acy1 PE=1 SV=1 g20401.t1 Q6DGG1 41.038 212 8.23e-52 171.0 sp|Q6DGG1|ABHEB_RAT Putative protein-lysine deacylase ABHD14B OS=Rattus norvegicus OX=10116 GN=Abhd14b PE=2 SV=1 ABHEB_RAT reviewed Putative protein-lysine deacylase ABHD14B (EC 2.3.1.-) (Alpha/beta hydrolase domain-containing protein 14B) (Abhydrolase domain-containing protein 14B) Rattus norvegicus (Rat) GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0016787; GO:0045944; GO:0061733 positive regulation of transcription by RNA polymerase II [GO:0045944] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] hydrolase activity [GO:0016787]; protein-lysine-acetyltransferase activity [GO:0061733] g20402.t1 Q98SN7 64.634 328 9.72e-162 463.0 sp|Q98SN7|WNT2B_CHICK Protein Wnt-2b OS=Gallus gallus OX=9031 GN=WNT2B PE=1 SV=1 g20405.t1 O43592 50.364 961 0.0 1014.0 sp|O43592|XPOT_HUMAN Exportin-T OS=Homo sapiens OX=9606 GN=XPOT PE=1 SV=2 XPOT_HUMAN reviewed Exportin-T (Exportin(tRNA)) (tRNA exportin) Homo sapiens (Human) GO:0000049; GO:0005643; GO:0005654; GO:0005737; GO:0005829; GO:0006409; GO:0006886; GO:0016363; GO:0031267; GO:0071528 intracellular protein transport [GO:0006886]; tRNA export from nucleus [GO:0006409]; tRNA re-export from nucleus [GO:0071528] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear matrix [GO:0016363]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654] small GTPase binding [GO:0031267]; tRNA binding [GO:0000049] g20406.t1 Q9UHD2 37.006 708 1.29e-148 455.0 sp|Q9UHD2|TBK1_HUMAN Serine/threonine-protein kinase TBK1 OS=Homo sapiens OX=9606 GN=TBK1 PE=1 SV=1 TBK1_HUMAN reviewed Serine/threonine-protein kinase TBK1 (EC 2.7.11.1) (NF-kappa-B-activating kinase) (T2K) (TANK-binding kinase 1) Homo sapiens (Human) GO:0002218; GO:0002753; GO:0003676; GO:0004672; GO:0004674; GO:0005524; GO:0005654; GO:0005737; GO:0005829; GO:0006468; GO:0006954; GO:0007249; GO:0009615; GO:0010508; GO:0010629; GO:0016236; GO:0016239; GO:0018105; GO:0018107; GO:0019903; GO:0032479; GO:0032481; GO:0032727; GO:0032728; GO:0034142; GO:0042802; GO:0043123; GO:0044565; GO:0045087; GO:0045944; GO:0050830; GO:0051219; GO:0051607; GO:0060337; GO:0060340; GO:0061470; GO:0061629; GO:0106310; GO:0140374; GO:0140896; GO:1902554; GO:1904262; GO:1904263; GO:1904417; GO:1904515 activation of innate immune response [GO:0002218]; antiviral innate immune response [GO:0140374]; canonical NF-kappaB signal transduction [GO:0007249]; cGAS/STING signaling pathway [GO:0140896]; cytoplasmic pattern recognition receptor signaling pathway [GO:0002753]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; dendritic cell proliferation [GO:0044565]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; macroautophagy [GO:0016236]; negative regulation of gene expression [GO:0010629]; negative regulation of TORC1 signaling [GO:1904262]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of autophagy [GO:0010508]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of macroautophagy [GO:0016239]; positive regulation of TORC1 signaling [GO:1904263]; positive regulation of TORC2 signaling [GO:1904515]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of type I interferon production [GO:0032481]; positive regulation of type I interferon-mediated signaling pathway [GO:0060340]; positive regulation of xenophagy [GO:1904417]; protein phosphorylation [GO:0006468]; regulation of type I interferon production [GO:0032479]; response to virus [GO:0009615]; T follicular helper cell differentiation [GO:0061470]; toll-like receptor 4 signaling pathway [GO:0034142]; type I interferon-mediated signaling pathway [GO:0060337] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; serine/threonine protein kinase complex [GO:1902554] ATP binding [GO:0005524]; identical protein binding [GO:0042802]; nucleic acid binding [GO:0003676]; phosphoprotein binding [GO:0051219]; protein kinase activity [GO:0004672]; protein phosphatase binding [GO:0019903]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629] g20407.t1 Q8BIK6 35.638 376 3.28e-57 207.0 sp|Q8BIK6|TMPS7_MOUSE Transmembrane protease serine 7 OS=Mus musculus OX=10090 GN=Tmprss7 PE=1 SV=3 TMPS7_MOUSE reviewed Transmembrane protease serine 7 (EC 3.4.21.-) (Matriptase-3) Mus musculus (Mouse) GO:0004252; GO:0005886; GO:0006508; GO:0008236 proteolysis [GO:0006508] plasma membrane [GO:0005886] serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236] g20409.t1 Q3UG20 40.094 641 5.06e-94 342.0 sp|Q3UG20|KMT2E_MOUSE Inactive histone-lysine N-methyltransferase 2E OS=Mus musculus OX=10090 GN=Kmt2e PE=1 SV=2 KMT2E_MOUSE reviewed Inactive histone-lysine N-methyltransferase 2E (Inactive lysine N-methyltransferase 2E) (Myeloid/lymphoid or mixed-lineage leukemia protein 5 homolog) Mus musculus (Mouse) GO:0000785; GO:0000791; GO:0002446; GO:0003713; GO:0005634; GO:0005654; GO:0005813; GO:0006355; GO:0008270; GO:0016604; GO:0016607; GO:0019899; GO:0030218; GO:0032991; GO:0034967; GO:0040029; GO:0042119; GO:0042800; GO:0045893; GO:0048384; GO:0070210; GO:0140002; GO:1900087 epigenetic regulation of gene expression [GO:0040029]; erythrocyte differentiation [GO:0030218]; neutrophil activation [GO:0042119]; neutrophil mediated immunity [GO:0002446]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; regulation of DNA-templated transcription [GO:0006355]; retinoic acid receptor signaling pathway [GO:0048384] centrosome [GO:0005813]; chromatin [GO:0000785]; euchromatin [GO:0000791]; nuclear body [GO:0016604]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; Rpd3L-Expanded complex [GO:0070210]; Set3 complex [GO:0034967] enzyme binding [GO:0019899]; histone H3K4 methyltransferase activity [GO:0042800]; histone H3K4me3 reader activity [GO:0140002]; transcription coactivator activity [GO:0003713]; zinc ion binding [GO:0008270] g20409.t2 Q3UG20 40.094 641 4.49e-94 342.0 sp|Q3UG20|KMT2E_MOUSE Inactive histone-lysine N-methyltransferase 2E OS=Mus musculus OX=10090 GN=Kmt2e PE=1 SV=2 KMT2E_MOUSE reviewed Inactive histone-lysine N-methyltransferase 2E (Inactive lysine N-methyltransferase 2E) (Myeloid/lymphoid or mixed-lineage leukemia protein 5 homolog) Mus musculus (Mouse) GO:0000785; GO:0000791; GO:0002446; GO:0003713; GO:0005634; GO:0005654; GO:0005813; GO:0006355; GO:0008270; GO:0016604; GO:0016607; GO:0019899; GO:0030218; GO:0032991; GO:0034967; GO:0040029; GO:0042119; GO:0042800; GO:0045893; GO:0048384; GO:0070210; GO:0140002; GO:1900087 epigenetic regulation of gene expression [GO:0040029]; erythrocyte differentiation [GO:0030218]; neutrophil activation [GO:0042119]; neutrophil mediated immunity [GO:0002446]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; regulation of DNA-templated transcription [GO:0006355]; retinoic acid receptor signaling pathway [GO:0048384] centrosome [GO:0005813]; chromatin [GO:0000785]; euchromatin [GO:0000791]; nuclear body [GO:0016604]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; Rpd3L-Expanded complex [GO:0070210]; Set3 complex [GO:0034967] enzyme binding [GO:0019899]; histone H3K4 methyltransferase activity [GO:0042800]; histone H3K4me3 reader activity [GO:0140002]; transcription coactivator activity [GO:0003713]; zinc ion binding [GO:0008270] g20409.t3 Q3UG20 39.441 644 7.139999999999999e-94 342.0 sp|Q3UG20|KMT2E_MOUSE Inactive histone-lysine N-methyltransferase 2E OS=Mus musculus OX=10090 GN=Kmt2e PE=1 SV=2 KMT2E_MOUSE reviewed Inactive histone-lysine N-methyltransferase 2E (Inactive lysine N-methyltransferase 2E) (Myeloid/lymphoid or mixed-lineage leukemia protein 5 homolog) Mus musculus (Mouse) GO:0000785; GO:0000791; GO:0002446; GO:0003713; GO:0005634; GO:0005654; GO:0005813; GO:0006355; GO:0008270; GO:0016604; GO:0016607; GO:0019899; GO:0030218; GO:0032991; GO:0034967; GO:0040029; GO:0042119; GO:0042800; GO:0045893; GO:0048384; GO:0070210; GO:0140002; GO:1900087 epigenetic regulation of gene expression [GO:0040029]; erythrocyte differentiation [GO:0030218]; neutrophil activation [GO:0042119]; neutrophil mediated immunity [GO:0002446]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; regulation of DNA-templated transcription [GO:0006355]; retinoic acid receptor signaling pathway [GO:0048384] centrosome [GO:0005813]; chromatin [GO:0000785]; euchromatin [GO:0000791]; nuclear body [GO:0016604]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; Rpd3L-Expanded complex [GO:0070210]; Set3 complex [GO:0034967] enzyme binding [GO:0019899]; histone H3K4 methyltransferase activity [GO:0042800]; histone H3K4me3 reader activity [GO:0140002]; transcription coactivator activity [GO:0003713]; zinc ion binding [GO:0008270] g20410.t1 O95786 32.479 585 1.2999999999999998e-74 261.0 sp|O95786|RIGI_HUMAN Antiviral innate immune response receptor RIG-I OS=Homo sapiens OX=9606 GN=RIGI PE=1 SV=2 RIGI_HUMAN reviewed Antiviral innate immune response receptor RIG-I (ATP-dependent RNA helicase DDX58) (EC 3.6.4.13) (DEAD box protein 58) (RIG-I-like receptor 1) (RLR-1) (RNA sensor RIG-I) (Retinoic acid-inducible gene 1 protein) (RIG-1) (Retinoic acid-inducible gene I protein) (RIG-I) Homo sapiens (Human) GO:0002230; GO:0002735; GO:0002753; GO:0003690; GO:0003724; GO:0003725; GO:0003727; GO:0005524; GO:0005525; GO:0005737; GO:0005829; GO:0005923; GO:0008270; GO:0009597; GO:0009615; GO:0010467; GO:0010628; GO:0015629; GO:0016887; GO:0030334; GO:0031625; GO:0032587; GO:0032725; GO:0032727; GO:0032728; GO:0032755; GO:0032757; GO:0032760; GO:0034344; GO:0038187; GO:0039529; GO:0042802; GO:0043330; GO:0045087; GO:0045944; GO:0051607; GO:0060760; GO:0071360; GO:0140374; GO:1990904 antiviral innate immune response [GO:0140374]; cellular response to exogenous dsRNA [GO:0071360]; cytoplasmic pattern recognition receptor signaling pathway [GO:0002753]; defense response to virus [GO:0051607]; detection of virus [GO:0009597]; gene expression [GO:0010467]; innate immune response [GO:0045087]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of gene expression [GO:0010628]; positive regulation of granulocyte macrophage colony-stimulating factor production [GO:0032725]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of myeloid dendritic cell cytokine production [GO:0002735]; positive regulation of response to cytokine stimulus [GO:0060760]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]; regulation of cell migration [GO:0030334]; regulation of type III interferon production [GO:0034344]; response to exogenous dsRNA [GO:0043330]; response to virus [GO:0009615]; RIG-I signaling pathway [GO:0039529] actin cytoskeleton [GO:0015629]; bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; ribonucleoprotein complex [GO:1990904]; ruffle membrane [GO:0032587] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; double-stranded DNA binding [GO:0003690]; double-stranded RNA binding [GO:0003725]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; pattern recognition receptor activity [GO:0038187]; RNA helicase activity [GO:0003724]; single-stranded RNA binding [GO:0003727]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270] g20412.t1 O95786 34.146 615 6.68e-80 283.0 sp|O95786|RIGI_HUMAN Antiviral innate immune response receptor RIG-I OS=Homo sapiens OX=9606 GN=RIGI PE=1 SV=2 RIGI_HUMAN reviewed Antiviral innate immune response receptor RIG-I (ATP-dependent RNA helicase DDX58) (EC 3.6.4.13) (DEAD box protein 58) (RIG-I-like receptor 1) (RLR-1) (RNA sensor RIG-I) (Retinoic acid-inducible gene 1 protein) (RIG-1) (Retinoic acid-inducible gene I protein) (RIG-I) Homo sapiens (Human) GO:0002230; GO:0002735; GO:0002753; GO:0003690; GO:0003724; GO:0003725; GO:0003727; GO:0005524; GO:0005525; GO:0005737; GO:0005829; GO:0005923; GO:0008270; GO:0009597; GO:0009615; GO:0010467; GO:0010628; GO:0015629; GO:0016887; GO:0030334; GO:0031625; GO:0032587; GO:0032725; GO:0032727; GO:0032728; GO:0032755; GO:0032757; GO:0032760; GO:0034344; GO:0038187; GO:0039529; GO:0042802; GO:0043330; GO:0045087; GO:0045944; GO:0051607; GO:0060760; GO:0071360; GO:0140374; GO:1990904 antiviral innate immune response [GO:0140374]; cellular response to exogenous dsRNA [GO:0071360]; cytoplasmic pattern recognition receptor signaling pathway [GO:0002753]; defense response to virus [GO:0051607]; detection of virus [GO:0009597]; gene expression [GO:0010467]; innate immune response [GO:0045087]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of gene expression [GO:0010628]; positive regulation of granulocyte macrophage colony-stimulating factor production [GO:0032725]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of myeloid dendritic cell cytokine production [GO:0002735]; positive regulation of response to cytokine stimulus [GO:0060760]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]; regulation of cell migration [GO:0030334]; regulation of type III interferon production [GO:0034344]; response to exogenous dsRNA [GO:0043330]; response to virus [GO:0009615]; RIG-I signaling pathway [GO:0039529] actin cytoskeleton [GO:0015629]; bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; ribonucleoprotein complex [GO:1990904]; ruffle membrane [GO:0032587] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; double-stranded DNA binding [GO:0003690]; double-stranded RNA binding [GO:0003725]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; pattern recognition receptor activity [GO:0038187]; RNA helicase activity [GO:0003724]; single-stranded RNA binding [GO:0003727]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270] g20413.t1 Q9WV52 29.474 380 9.349999999999999e-46 163.0 sp|Q9WV52|PLEK2_MOUSE Pleckstrin-2 OS=Mus musculus OX=10090 GN=Plek2 PE=1 SV=1 PLEK2_MOUSE reviewed Pleckstrin-2 Mus musculus (Mouse) GO:0005856; GO:0005886; GO:0016020; GO:0030036; GO:0031258; GO:0031346; GO:0032266; GO:0035556; GO:0043325; GO:0080025; GO:0120034 actin cytoskeleton organization [GO:0030036]; intracellular signal transduction [GO:0035556]; positive regulation of cell projection organization [GO:0031346]; positive regulation of plasma membrane bounded cell projection assembly [GO:0120034] cytoskeleton [GO:0005856]; lamellipodium membrane [GO:0031258]; membrane [GO:0016020]; plasma membrane [GO:0005886] phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-3-phosphate binding [GO:0032266] g20414.t1 O42260 42.424 264 3.0500000000000005e-64 205.0 sp|O42260|GEMI2_XENLA Gem-associated protein 2 OS=Xenopus laevis OX=8355 GN=gemin2 PE=2 SV=1 g20417.t1 P16395 31.818 198 8.809999999999999e-23 108.0 sp|P16395|ACM1_DROME Muscarinic acetylcholine receptor DM1 OS=Drosophila melanogaster OX=7227 GN=mAChR-A PE=2 SV=2 g20421.t1 Q6ZMW2 27.616 344 1.34e-33 142.0 sp|Q6ZMW2|ZN782_HUMAN Zinc finger protein 782 OS=Homo sapiens OX=9606 GN=ZNF782 PE=1 SV=1 g20421.t1 Q6ZMW2 24.367 316 4.68e-24 112.0 sp|Q6ZMW2|ZN782_HUMAN Zinc finger protein 782 OS=Homo sapiens OX=9606 GN=ZNF782 PE=1 SV=1 g20423.t1 Q8BLJ3 46.795 312 1.38e-90 276.0 sp|Q8BLJ3|PLCX3_MOUSE PI-PLC X domain-containing protein 3 OS=Mus musculus OX=10090 GN=Plcxd3 PE=1 SV=1 g20424.t1 Q1T7C1 44.444 117 3.32e-24 101.0 sp|Q1T7C1|CENPK_CHICK Centromere protein K OS=Gallus gallus OX=9031 GN=CENPK PE=1 SV=1 g20425.t1 Q5BJN5 71.818 110 1.13e-50 162.0 sp|Q5BJN5|MIA40_RAT Mitochondrial intermembrane space import and assembly protein 40 OS=Rattus norvegicus OX=10116 GN=Chchd4 PE=2 SV=1 MIA40_RAT reviewed Mitochondrial intermembrane space import and assembly protein 40 (Coiled-coil-helix-coiled-coil-helix domain-containing protein 4) Rattus norvegicus (Rat) GO:0005739; GO:0005758; GO:0015035; GO:0033108; GO:0034599; GO:0043504; GO:0045041; GO:0046825; GO:0051604; GO:0072655; GO:0160203; GO:1901857; GO:1990830 cellular response to leukemia inhibitory factor [GO:1990830]; cellular response to oxidative stress [GO:0034599]; establishment of protein localization to mitochondrion [GO:0072655]; mitochondrial disulfide relay system [GO:0160203]; mitochondrial DNA repair [GO:0043504]; mitochondrial respiratory chain complex assembly [GO:0033108]; positive regulation of cellular respiration [GO:1901857]; protein import into mitochondrial intermembrane space [GO:0045041]; protein maturation [GO:0051604]; regulation of protein export from nucleus [GO:0046825] mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739] protein-disulfide reductase activity [GO:0015035] g20426.t1 Q8WMS0 54.286 350 1.8700000000000002e-107 323.0 sp|Q8WMS0|S35A2_CANLF UDP-galactose translocator OS=Canis lupus familiaris OX=9615 GN=SLC35A2 PE=2 SV=2 g20428.t1 A8WIP6 82.44 336 0.0 580.0 sp|A8WIP6|CDK20_DANRE Cyclin-dependent kinase 20 OS=Danio rerio OX=7955 GN=cdk20 PE=2 SV=1 CDK20_DANRE reviewed Cyclin-dependent kinase 20 (EC 2.7.11.22) (Cell cycle-related kinase) (Cell division protein kinase 20) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0004674; GO:0004693; GO:0005524; GO:0005634; GO:0005737; GO:0005929; GO:0051301; GO:0060271; GO:0106310 cell division [GO:0051301]; cilium assembly [GO:0060271] cilium [GO:0005929]; cytoplasm [GO:0005737]; nucleus [GO:0005634] ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g20432.t1 Q9MYM7 32.384 281 7.23e-50 175.0 sp|Q9MYM7|B3GT1_PONPY Beta-1,3-galactosyltransferase 1 OS=Pongo pygmaeus OX=9600 GN=B3GALT1 PE=3 SV=1 g20434.t1 Q5D0E6 34.05 279 6.8500000000000005e-37 147.0 sp|Q5D0E6|DALD3_HUMAN DALR anticodon-binding domain-containing protein 3 OS=Homo sapiens OX=9606 GN=DALRD3 PE=1 SV=2 DALD3_HUMAN reviewed DALR anticodon-binding domain-containing protein 3 Homo sapiens (Human) GO:0000049; GO:0004814; GO:0005524; GO:0006420; GO:0106217 arginyl-tRNA aminoacylation [GO:0006420]; tRNA C3-cytosine methylation [GO:0106217] arginine-tRNA ligase activity [GO:0004814]; ATP binding [GO:0005524]; tRNA binding [GO:0000049] g20435.t1 Q9EPW2 62.121 132 7.779999999999999e-48 171.0 sp|Q9EPW2|KLF15_MOUSE Krueppel-like factor 15 OS=Mus musculus OX=10090 GN=Klf15 PE=1 SV=1 KLF15_MOUSE reviewed Krueppel-like factor 15 (Cardiovascular Krueppel-like factor) Mus musculus (Mouse) GO:0000976; GO:0000977; GO:0000978; GO:0000981; GO:0001228; GO:0001678; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0006357; GO:0008270; GO:0010001; GO:0010468; GO:0014898; GO:0016607; GO:0030111; GO:0032868; GO:0032966; GO:0045893; GO:0045944; GO:0046326; GO:0071635; GO:0072112; GO:1990837; GO:1990859; GO:2000757 cardiac muscle hypertrophy in response to stress [GO:0014898]; cellular response to endothelin [GO:1990859]; glial cell differentiation [GO:0010001]; intracellular glucose homeostasis [GO:0001678]; negative regulation of collagen biosynthetic process [GO:0032966]; negative regulation of peptidyl-lysine acetylation [GO:2000757]; negative regulation of transforming growth factor beta production [GO:0071635]; podocyte differentiation [GO:0072112]; positive regulation of D-glucose import [GO:0046326]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of Wnt signaling pathway [GO:0030111]; response to insulin [GO:0032868] nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]; zinc ion binding [GO:0008270] g20436.t1 Q494V2 44.521 584 2.03e-114 357.0 sp|Q494V2|CP100_HUMAN Cilia- and flagella-associated protein 100 OS=Homo sapiens OX=9606 GN=CFAP100 PE=1 SV=1 CP100_HUMAN reviewed Cilia- and flagella-associated protein 100 (Coiled-coil domain-containing protein 37) Homo sapiens (Human) GO:0003341; GO:0031514; GO:0036064; GO:0036159; GO:0070840; GO:0097545 cilium movement [GO:0003341]; inner dynein arm assembly [GO:0036159] axonemal doublet microtubule [GO:0097545]; ciliary basal body [GO:0036064]; motile cilium [GO:0031514] dynein complex binding [GO:0070840] g20437.t1 A7RX26 61.557 424 0.0 559.0 sp|A7RX26|HUTI_NEMVE Probable imidazolonepropionase OS=Nematostella vectensis OX=45351 GN=amdhd1 PE=3 SV=1 HUTI_NEMVE reviewed Probable imidazolonepropionase (EC 3.5.2.7) (Amidohydrolase domain-containing protein 1 homolog) Nematostella vectensis (Starlet sea anemone) GO:0005737; GO:0006548; GO:0019556; GO:0019557; GO:0046872; GO:0050480 L-histidine catabolic process [GO:0006548]; L-histidine catabolic process to glutamate and formamide [GO:0019556]; L-histidine catabolic process to glutamate and formate [GO:0019557] cytoplasm [GO:0005737] imidazolonepropionase activity [GO:0050480]; metal ion binding [GO:0046872] g20441.t1 Q6NU27 52.913 206 4.33e-71 218.0 sp|Q6NU27|I4E3B_XENLA Eukaryotic translation initiation factor 4E type 3-B OS=Xenopus laevis OX=8355 GN=eif4e3-b PE=2 SV=1 g20443.t1 Q80VW5 34.468 235 1.15e-26 120.0 sp|Q80VW5|WHRN_MOUSE Whirlin OS=Mus musculus OX=10090 GN=Whrn PE=1 SV=3 g20445.t1 Q6ZV73 55.45 422 9.35e-147 487.0 sp|Q6ZV73|FGD6_HUMAN FYVE, RhoGEF and PH domain-containing protein 6 OS=Homo sapiens OX=9606 GN=FGD6 PE=1 SV=2 FGD6_HUMAN reviewed FYVE, RhoGEF and PH domain-containing protein 6 (Zinc finger FYVE domain-containing protein 24) Homo sapiens (Human) GO:0001726; GO:0005085; GO:0005737; GO:0005794; GO:0005856; GO:0007010; GO:0008270; GO:0008360; GO:0030027; GO:0030036; GO:0031267; GO:0043087; GO:0046847 actin cytoskeleton organization [GO:0030036]; cytoskeleton organization [GO:0007010]; filopodium assembly [GO:0046847]; regulation of cell shape [GO:0008360]; regulation of GTPase activity [GO:0043087] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; Golgi apparatus [GO:0005794]; lamellipodium [GO:0030027]; ruffle [GO:0001726] guanyl-nucleotide exchange factor activity [GO:0005085]; small GTPase binding [GO:0031267]; zinc ion binding [GO:0008270] g20448.t1 A7RK30 51.752 371 1.07e-114 340.0 sp|A7RK30|QORL2_NEMVE Quinone oxidoreductase-like protein 2 homolog OS=Nematostella vectensis OX=45351 GN=v1g238856 PE=3 SV=1 g20451.t1 O88387 41.603 524 1.75e-116 375.0 sp|O88387|FGD4_RAT FYVE, RhoGEF and PH domain-containing protein 4 OS=Rattus norvegicus OX=10116 GN=Fgd4 PE=1 SV=1 FGD4_RAT reviewed FYVE, RhoGEF and PH domain-containing protein 4 (Actin filament-binding protein frabin) (FGD1-related F-actin-binding protein) Rattus norvegicus (Rat) GO:0003779; GO:0005085; GO:0005737; GO:0005856; GO:0007010; GO:0008270; GO:0008360; GO:0030027; GO:0030032; GO:0030035; GO:0030175; GO:0043507; GO:0046330; GO:0046847; GO:0051015 cytoskeleton organization [GO:0007010]; filopodium assembly [GO:0046847]; lamellipodium assembly [GO:0030032]; microspike assembly [GO:0030035]; positive regulation of JNK cascade [GO:0046330]; positive regulation of JUN kinase activity [GO:0043507]; regulation of cell shape [GO:0008360] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; filopodium [GO:0030175]; lamellipodium [GO:0030027] actin binding [GO:0003779]; actin filament binding [GO:0051015]; guanyl-nucleotide exchange factor activity [GO:0005085]; zinc ion binding [GO:0008270] g20451.t2 O88387 41.603 524 1.87e-117 377.0 sp|O88387|FGD4_RAT FYVE, RhoGEF and PH domain-containing protein 4 OS=Rattus norvegicus OX=10116 GN=Fgd4 PE=1 SV=1 FGD4_RAT reviewed FYVE, RhoGEF and PH domain-containing protein 4 (Actin filament-binding protein frabin) (FGD1-related F-actin-binding protein) Rattus norvegicus (Rat) GO:0003779; GO:0005085; GO:0005737; GO:0005856; GO:0007010; GO:0008270; GO:0008360; GO:0030027; GO:0030032; GO:0030035; GO:0030175; GO:0043507; GO:0046330; GO:0046847; GO:0051015 cytoskeleton organization [GO:0007010]; filopodium assembly [GO:0046847]; lamellipodium assembly [GO:0030032]; microspike assembly [GO:0030035]; positive regulation of JNK cascade [GO:0046330]; positive regulation of JUN kinase activity [GO:0043507]; regulation of cell shape [GO:0008360] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; filopodium [GO:0030175]; lamellipodium [GO:0030027] actin binding [GO:0003779]; actin filament binding [GO:0051015]; guanyl-nucleotide exchange factor activity [GO:0005085]; zinc ion binding [GO:0008270] g20452.t1 P62597 32.543 464 7.19e-56 211.0 sp|P62597|POTE1_CHICK Protection of telomeres protein 1 OS=Gallus gallus OX=9031 GN=POT1 PE=1 SV=1 g20453.t1 Q5R8H3 47.755 245 7.91e-58 186.0 sp|Q5R8H3|BAP31_PONAB B-cell receptor-associated protein 31 OS=Pongo abelii OX=9601 GN=BCAP31 PE=2 SV=3 BAP31_PONAB reviewed B-cell receptor-associated protein 31 (BCR-associated protein 31) (Bap31) Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0005789; GO:0006886; GO:0006888; GO:0006915; GO:0033116; GO:0070973 apoptotic process [GO:0006915]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886]; protein localization to endoplasmic reticulum exit site [GO:0070973] endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116] g20455.t1 Q9CQM0 38.686 137 3.54e-31 113.0 sp|Q9CQM0|NICN1_MOUSE Nicolin-1 OS=Mus musculus OX=10090 GN=Nicn1 PE=1 SV=1 g20457.t1 B5X5D0 41.837 98 5.68e-24 92.8 sp|B5X5D0|PIRC1_SALSA Piercer of microtubule wall 1 protein OS=Salmo salar OX=8030 GN=pierce1 PE=2 SV=1 g20458.t1 Q3MII6 53.431 408 5.01e-131 405.0 sp|Q3MII6|TBC25_HUMAN TBC1 domain family member 25 OS=Homo sapiens OX=9606 GN=TBC1D25 PE=1 SV=2 TBC25_HUMAN reviewed TBC1 domain family member 25 Homo sapiens (Human) GO:0005096; GO:0005776; GO:0006914; GO:0031410; GO:1901096 autophagy [GO:0006914]; regulation of autophagosome maturation [GO:1901096] autophagosome [GO:0005776]; cytoplasmic vesicle [GO:0031410] GTPase activator activity [GO:0005096] g20459.t1 P15848 53.846 234 3.52e-67 218.0 sp|P15848|ARSB_HUMAN Arylsulfatase B OS=Homo sapiens OX=9606 GN=ARSB PE=1 SV=1 ARSB_HUMAN reviewed Arylsulfatase B (ASB) (EC 3.1.6.12) (N-acetylgalactosamine-4-sulfatase) (G4S) Homo sapiens (Human) GO:0003943; GO:0004065; GO:0005576; GO:0005764; GO:0005788; GO:0006914; GO:0007040; GO:0007041; GO:0007584; GO:0008484; GO:0009268; GO:0009986; GO:0010632; GO:0010976; GO:0030207; GO:0035578; GO:0043202; GO:0043627; GO:0046872; GO:0051597; GO:0061580; GO:0070062; GO:1904813 autophagy [GO:0006914]; chondroitin sulfate proteoglycan catabolic process [GO:0030207]; colon epithelial cell migration [GO:0061580]; lysosomal transport [GO:0007041]; lysosome organization [GO:0007040]; positive regulation of neuron projection development [GO:0010976]; regulation of epithelial cell migration [GO:0010632]; response to estrogen [GO:0043627]; response to methylmercury [GO:0051597]; response to nutrient [GO:0007584]; response to pH [GO:0009268] azurophil granule lumen [GO:0035578]; cell surface [GO:0009986]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764] arylsulfatase activity [GO:0004065]; metal ion binding [GO:0046872]; N-acetylgalactosamine-4-sulfatase activity [GO:0003943]; sulfuric ester hydrolase activity [GO:0008484] g20460.t1 P50429 60.232 259 4.72e-102 311.0 sp|P50429|ARSB_MOUSE Arylsulfatase B OS=Mus musculus OX=10090 GN=Arsb PE=1 SV=3 ARSB_MOUSE reviewed Arylsulfatase B (ASB) (EC 3.1.6.12) (N-acetylgalactosamine-4-sulfatase) (G4S) Mus musculus (Mouse) GO:0003943; GO:0004065; GO:0005764; GO:0006914; GO:0007584; GO:0008484; GO:0009268; GO:0009986; GO:0010632; GO:0010976; GO:0030207; GO:0030209; GO:0043627; GO:0043890; GO:0046872; GO:0051597; GO:0061580; GO:0097065 anterior head development [GO:0097065]; autophagy [GO:0006914]; chondroitin sulfate proteoglycan catabolic process [GO:0030207]; colon epithelial cell migration [GO:0061580]; dermatan sulfate proteoglycan catabolic process [GO:0030209]; positive regulation of neuron projection development [GO:0010976]; regulation of epithelial cell migration [GO:0010632]; response to estrogen [GO:0043627]; response to methylmercury [GO:0051597]; response to nutrient [GO:0007584]; response to pH [GO:0009268] cell surface [GO:0009986]; lysosome [GO:0005764] arylsulfatase activity [GO:0004065]; metal ion binding [GO:0046872]; N-acetylgalactosamine-4-sulfatase activity [GO:0003943]; N-acetylgalactosamine-6-sulfatase activity [GO:0043890]; sulfuric ester hydrolase activity [GO:0008484] g20460.t2 P50429 55.665 203 3.68e-66 215.0 sp|P50429|ARSB_MOUSE Arylsulfatase B OS=Mus musculus OX=10090 GN=Arsb PE=1 SV=3 ARSB_MOUSE reviewed Arylsulfatase B (ASB) (EC 3.1.6.12) (N-acetylgalactosamine-4-sulfatase) (G4S) Mus musculus (Mouse) GO:0003943; GO:0004065; GO:0005764; GO:0006914; GO:0007584; GO:0008484; GO:0009268; GO:0009986; GO:0010632; GO:0010976; GO:0030207; GO:0030209; GO:0043627; GO:0043890; GO:0046872; GO:0051597; GO:0061580; GO:0097065 anterior head development [GO:0097065]; autophagy [GO:0006914]; chondroitin sulfate proteoglycan catabolic process [GO:0030207]; colon epithelial cell migration [GO:0061580]; dermatan sulfate proteoglycan catabolic process [GO:0030209]; positive regulation of neuron projection development [GO:0010976]; regulation of epithelial cell migration [GO:0010632]; response to estrogen [GO:0043627]; response to methylmercury [GO:0051597]; response to nutrient [GO:0007584]; response to pH [GO:0009268] cell surface [GO:0009986]; lysosome [GO:0005764] arylsulfatase activity [GO:0004065]; metal ion binding [GO:0046872]; N-acetylgalactosamine-4-sulfatase activity [GO:0003943]; N-acetylgalactosamine-6-sulfatase activity [GO:0043890]; sulfuric ester hydrolase activity [GO:0008484] g20461.t1 P15848 57.315 499 0.0 531.0 sp|P15848|ARSB_HUMAN Arylsulfatase B OS=Homo sapiens OX=9606 GN=ARSB PE=1 SV=1 ARSB_HUMAN reviewed Arylsulfatase B (ASB) (EC 3.1.6.12) (N-acetylgalactosamine-4-sulfatase) (G4S) Homo sapiens (Human) GO:0003943; GO:0004065; GO:0005576; GO:0005764; GO:0005788; GO:0006914; GO:0007040; GO:0007041; GO:0007584; GO:0008484; GO:0009268; GO:0009986; GO:0010632; GO:0010976; GO:0030207; GO:0035578; GO:0043202; GO:0043627; GO:0046872; GO:0051597; GO:0061580; GO:0070062; GO:1904813 autophagy [GO:0006914]; chondroitin sulfate proteoglycan catabolic process [GO:0030207]; colon epithelial cell migration [GO:0061580]; lysosomal transport [GO:0007041]; lysosome organization [GO:0007040]; positive regulation of neuron projection development [GO:0010976]; regulation of epithelial cell migration [GO:0010632]; response to estrogen [GO:0043627]; response to methylmercury [GO:0051597]; response to nutrient [GO:0007584]; response to pH [GO:0009268] azurophil granule lumen [GO:0035578]; cell surface [GO:0009986]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764] arylsulfatase activity [GO:0004065]; metal ion binding [GO:0046872]; N-acetylgalactosamine-4-sulfatase activity [GO:0003943]; sulfuric ester hydrolase activity [GO:0008484] g20463.t1 Q9HCS2 38.289 491 6.81e-125 378.0 sp|Q9HCS2|CP4FC_HUMAN Cytochrome P450 4F12 OS=Homo sapiens OX=9606 GN=CYP4F12 PE=1 SV=3 CP4FC_HUMAN reviewed Cytochrome P450 4F12 (EC 1.14.14.1) (CYPIVF12) Homo sapiens (Human) GO:0000038; GO:0001676; GO:0003091; GO:0003095; GO:0004497; GO:0005506; GO:0005737; GO:0005789; GO:0006631; GO:0006805; GO:0008392; GO:0016324; GO:0018685; GO:0019369; GO:0019373; GO:0020037; GO:0036101; GO:0042360; GO:0042361; GO:0042376; GO:0043231; GO:0050051; GO:0055078 arachidonate metabolic process [GO:0019369]; epoxygenase P450 pathway [GO:0019373]; fatty acid metabolic process [GO:0006631]; leukotriene B4 catabolic process [GO:0036101]; long-chain fatty acid metabolic process [GO:0001676]; menaquinone catabolic process [GO:0042361]; phylloquinone catabolic process [GO:0042376]; pressure natriuresis [GO:0003095]; renal water homeostasis [GO:0003091]; sodium ion homeostasis [GO:0055078]; very long-chain fatty acid metabolic process [GO:0000038]; vitamin E metabolic process [GO:0042360]; xenobiotic metabolic process [GO:0006805] apical plasma membrane [GO:0016324]; cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231] alkane 1-monooxygenase activity [GO:0018685]; arachidonate epoxygenase activity [GO:0008392]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; leukotriene-B4 20-monooxygenase activity [GO:0050051]; monooxygenase activity [GO:0004497] g20464.t1 Q5RGE6 43.416 486 1.1e-111 342.0 sp|Q5RGE6|HSP7E_DANRE Heat shock 70 kDa protein 14 OS=Danio rerio OX=7955 GN=hspa14 PE=2 SV=1 g20465.t1 Q295V5 55.814 172 5.1699999999999994e-42 142.0 sp|Q295V5|ARMET_DROPS Mesencephalic astrocyte-derived neurotrophic factor homolog OS=Drosophila pseudoobscura pseudoobscura OX=46245 GN=Manf PE=3 SV=1 g20468.t1 Q9UP83 61.634 808 0.0 964.0 sp|Q9UP83|COG5_HUMAN Conserved oligomeric Golgi complex subunit 5 OS=Homo sapiens OX=9606 GN=COG5 PE=1 SV=4 COG5_HUMAN reviewed Conserved oligomeric Golgi complex subunit 5 (COG complex subunit 5) (13S Golgi transport complex 90 kDa subunit) (GTC-90) (Component of oligomeric Golgi complex 5) (Golgi transport complex 1) Homo sapiens (Human) GO:0000139; GO:0000301; GO:0005654; GO:0005794; GO:0005829; GO:0006891; GO:0007030; GO:0015031; GO:0016020; GO:0017119; GO:0032588; GO:0048219 Golgi organization [GO:0007030]; inter-Golgi cisterna vesicle-mediated transport [GO:0048219]; intra-Golgi vesicle-mediated transport [GO:0006891]; protein transport [GO:0015031]; retrograde transport, vesicle recycling within Golgi [GO:0000301] cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi transport complex [GO:0017119]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; trans-Golgi network membrane [GO:0032588] g20469.t1 Q99MV5 39.533 1113 0.0 698.0 sp|Q99MV5|M10L1_MOUSE RNA helicase Mov10l1 OS=Mus musculus OX=10090 GN=Mov10l1 PE=1 SV=1 M10L1_MOUSE reviewed RNA helicase Mov10l1 (EC 3.6.4.13) (Cardiac helicase activated by MEF2 protein) (Cardiac-specific RNA helicase) (Moloney leukemia virus 10-like protein 1 homolog) (MOV10-like protein 1 homolog) Mus musculus (Mouse) GO:0003723; GO:0003724; GO:0005524; GO:0005829; GO:0007140; GO:0007141; GO:0007283; GO:0016887; GO:0030154; GO:0034584; GO:0034587; GO:0035194; GO:0043186; GO:0045786; GO:0071546; GO:0141196 cell differentiation [GO:0030154]; male meiosis I [GO:0007141]; male meiotic nuclear division [GO:0007140]; negative regulation of cell cycle [GO:0045786]; piRNA processing [GO:0034587]; regulatory ncRNA-mediated post-transcriptional gene silencing [GO:0035194]; spermatogenesis [GO:0007283]; transposable element silencing by piRNA-mediated DNA methylation [GO:0141196] cytosol [GO:0005829]; P granule [GO:0043186]; pi-body [GO:0071546] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; piRNA binding [GO:0034584]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724] g20470.t1 O95376 57.639 432 0.0 541.0 sp|O95376|ARI2_HUMAN E3 ubiquitin-protein ligase ARIH2 OS=Homo sapiens OX=9606 GN=ARIH2 PE=1 SV=1 g20470.t2 O95376 57.639 432 0.0 541.0 sp|O95376|ARI2_HUMAN E3 ubiquitin-protein ligase ARIH2 OS=Homo sapiens OX=9606 GN=ARIH2 PE=1 SV=1 g20473.t1 Q6PCB5 63.068 352 1.38e-165 498.0 sp|Q6PCB5|RSBNL_HUMAN Lysine-specific demethylase RSBN1L OS=Homo sapiens OX=9606 GN=RSBN1L PE=1 SV=2 g20474.t1 P11029 65.463 2270 0.0 3038.0 sp|P11029|ACAC_CHICK Acetyl-CoA carboxylase OS=Gallus gallus OX=9031 GN=ACAC PE=1 SV=1 g20474.t2 P11029 65.463 2270 0.0 3037.0 sp|P11029|ACAC_CHICK Acetyl-CoA carboxylase OS=Gallus gallus OX=9031 GN=ACAC PE=1 SV=1 g20475.t1 Q5I0M0 44.275 262 2.44e-69 220.0 sp|Q5I0M0|SETMR_RAT Histone-lysine N-methyltransferase SETMAR OS=Rattus norvegicus OX=10116 GN=Setmar PE=2 SV=1 SETMR_RAT reviewed Histone-lysine N-methyltransferase SETMAR (EC 2.1.1.357) (SET domain and mariner transposase fusion protein homolog) Rattus norvegicus (Rat) GO:0000014; GO:0000729; GO:0000793; GO:0003677; GO:0003690; GO:0003697; GO:0004519; GO:0005634; GO:0005730; GO:0006303; GO:0006308; GO:0008270; GO:0008283; GO:0015074; GO:0031297; GO:0032259; GO:0035861; GO:0042054; GO:0042800; GO:0042803; GO:0044547; GO:0044774; GO:0045814; GO:0045892; GO:0046975; GO:0140954; GO:2001034; GO:2001251 cell population proliferation [GO:0008283]; DNA catabolic process [GO:0006308]; DNA double-strand break processing [GO:0000729]; DNA integration [GO:0015074]; double-strand break repair via nonhomologous end joining [GO:0006303]; methylation [GO:0032259]; mitotic DNA integrity checkpoint signaling [GO:0044774]; negative regulation of chromosome organization [GO:2001251]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of gene expression, epigenetic [GO:0045814]; positive regulation of double-strand break repair via nonhomologous end joining [GO:2001034]; replication fork processing [GO:0031297] condensed chromosome [GO:0000793]; nucleolus [GO:0005730]; nucleus [GO:0005634]; site of double-strand break [GO:0035861] DNA binding [GO:0003677]; DNA topoisomerase binding [GO:0044547]; double-stranded DNA binding [GO:0003690]; endonuclease activity [GO:0004519]; histone H3K36 dimethyltransferase activity [GO:0140954]; histone H3K36 methyltransferase activity [GO:0046975]; histone H3K4 methyltransferase activity [GO:0042800]; histone methyltransferase activity [GO:0042054]; protein homodimerization activity [GO:0042803]; single-stranded DNA binding [GO:0003697]; single-stranded DNA endodeoxyribonuclease activity [GO:0000014]; zinc ion binding [GO:0008270] g20476.t1 Q9EQU5 47.737 243 1.9899999999999998e-69 220.0 sp|Q9EQU5|SET_MOUSE Protein SET OS=Mus musculus OX=10090 GN=Set PE=1 SV=1 SET_MOUSE reviewed Protein SET (Phosphatase 2A inhibitor I2PP2A) (I-2PP2A) (Template-activating factor I) (TAF-I) Mus musculus (Mouse) GO:0000785; GO:0003677; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0005783; GO:0005811; GO:0005829; GO:0006334; GO:0032991; GO:0042393; GO:0043524; GO:0045892; GO:0048471 negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of neuron apoptotic process [GO:0043524]; nucleosome assembly [GO:0006334] chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; lipid droplet [GO:0005811]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991] chromatin binding [GO:0003682]; DNA binding [GO:0003677]; histone binding [GO:0042393] g20478.t1 Q5XGI3 35.108 695 1.2600000000000001e-117 367.0 sp|Q5XGI3|FBXL5_XENTR F-box/LRR-repeat protein 5 OS=Xenopus tropicalis OX=8364 GN=fbxl5 PE=2 SV=1 g20479.t1 Q5ZIU3 63.035 514 0.0 653.0 sp|Q5ZIU3|DYRK2_CHICK Dual specificity tyrosine-phosphorylation-regulated kinase 2 OS=Gallus gallus OX=9031 GN=DYRK2 PE=2 SV=1 DYRK2_CHICK reviewed Dual specificity tyrosine-phosphorylation-regulated kinase 2 (EC 2.7.12.1) Gallus gallus (Chicken) GO:0000287; GO:0004674; GO:0004712; GO:0004713; GO:0005524; GO:0005634; GO:0005737; GO:0005856; GO:0006468; GO:0030145; GO:0032991; GO:0042771; GO:0045725; GO:0106310 intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; positive regulation of glycogen biosynthetic process [GO:0045725]; protein phosphorylation [GO:0006468] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; nucleus [GO:0005634]; protein-containing complex [GO:0032991] ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713] g20480.t1 P47897 61.049 629 0.0 812.0 sp|P47897|SYQ_HUMAN Glutamine--tRNA ligase OS=Homo sapiens OX=9606 GN=QARS1 PE=1 SV=1 SYQ_HUMAN reviewed Glutamine--tRNA ligase (EC 6.1.1.18) (Glutaminyl-tRNA synthetase) (GlnRS) Homo sapiens (Human) GO:0004819; GO:0004860; GO:0005524; GO:0005737; GO:0005759; GO:0005829; GO:0006418; GO:0006425; GO:0007420; GO:0017101; GO:0019901; GO:0032873; GO:0032991; GO:0045892; GO:2001234 brain development [GO:0007420]; glutaminyl-tRNA aminoacylation [GO:0006425]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of stress-activated MAPK cascade [GO:0032873]; tRNA aminoacylation for protein translation [GO:0006418] aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; protein-containing complex [GO:0032991] ATP binding [GO:0005524]; glutamine-tRNA ligase activity [GO:0004819]; protein kinase binding [GO:0019901]; protein kinase inhibitor activity [GO:0004860] g20481.t1 Q3MHH4 65.556 90 1.11e-33 125.0 sp|Q3MHH4|SYQ_BOVIN Glutamine--tRNA ligase OS=Bos taurus OX=9913 GN=QARS1 PE=2 SV=1 SYQ_BOVIN reviewed Glutamine--tRNA ligase (EC 6.1.1.18) (Glutaminyl-tRNA synthetase) (GlnRS) Bos taurus (Bovine) GO:0004819; GO:0004860; GO:0005524; GO:0005737; GO:0005829; GO:0006425; GO:0007420; GO:0017101; GO:0019901; GO:0032873; GO:0045892; GO:2001234 brain development [GO:0007420]; glutaminyl-tRNA aminoacylation [GO:0006425]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of stress-activated MAPK cascade [GO:0032873] aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytoplasm [GO:0005737]; cytosol [GO:0005829] ATP binding [GO:0005524]; glutamine-tRNA ligase activity [GO:0004819]; protein kinase binding [GO:0019901]; protein kinase inhibitor activity [GO:0004860] g20482.t1 Q9N0P9 63.636 264 1.89e-122 359.0 sp|Q9N0P9|PIM1_BOVIN Serine/threonine-protein kinase pim-1 OS=Bos taurus OX=9913 GN=PIM1 PE=2 SV=1 g20483.t1 F6S215 26.399 947 2.8700000000000003e-88 304.0 sp|F6S215|AP5B1_XENTR AP-5 complex subunit beta-1 OS=Xenopus tropicalis OX=8364 GN=ap5b1 PE=3 SV=1 g20484.t1 A0JNK6 52.475 101 1.11e-34 119.0 sp|A0JNK6|TM243_BOVIN Transmembrane protein 243 OS=Bos taurus OX=9913 GN=TMEM243 PE=3 SV=1 g20486.t1 Q32PH7 49.74 384 6.83e-125 369.0 sp|Q32PH7|SUV92_BOVIN Histone-lysine N-methyltransferase SUV39H2 OS=Bos taurus OX=9913 GN=SUV39H2 PE=2 SV=1 SUV92_BOVIN reviewed Histone-lysine N-methyltransferase SUV39H2 (EC 2.1.1.-) (Suppressor of variegation 3-9 homolog 2) (Su(var)3-9 homolog 2) Bos taurus (Bovine) GO:0000775; GO:0000976; GO:0005634; GO:0007623; GO:0008270; GO:0030154; GO:0032259; GO:0045814; GO:0045892; GO:0046974; GO:0140949 cell differentiation [GO:0030154]; circadian rhythm [GO:0007623]; methylation [GO:0032259]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of gene expression, epigenetic [GO:0045814] chromosome, centromeric region [GO:0000775]; nucleus [GO:0005634] histone H3K9 methyltransferase activity [GO:0046974]; histone H3K9 trimethyltransferase activity [GO:0140949]; transcription cis-regulatory region binding [GO:0000976]; zinc ion binding [GO:0008270] g20488.t1 Q96MG7 42.534 221 1.17e-50 172.0 sp|Q96MG7|NSE3_HUMAN Non-structural maintenance of chromosomes element 3 homolog OS=Homo sapiens OX=9606 GN=NSMCE3 PE=1 SV=1 NSE3_HUMAN reviewed Non-structural maintenance of chromosomes element 3 homolog (Non-SMC element 3 homolog) (Hepatocellular carcinoma-associated protein 4) (MAGE-G1 antigen) (Melanoma-associated antigen G1) (Necdin-like protein 2) Homo sapiens (Human) GO:0000122; GO:0000724; GO:0000781; GO:0005634; GO:0005654; GO:0005737; GO:0006281; GO:0016925; GO:0030915; GO:0031398; GO:0032204; GO:0034644; GO:0046983; GO:0071478; GO:0072711; GO:0140588 cellular response to hydroxyurea [GO:0072711]; cellular response to radiation [GO:0071478]; cellular response to UV [GO:0034644]; chromatin looping [GO:0140588]; DNA repair [GO:0006281]; double-strand break repair via homologous recombination [GO:0000724]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of protein ubiquitination [GO:0031398]; protein sumoylation [GO:0016925]; regulation of telomere maintenance [GO:0032204] chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Smc5-Smc6 complex [GO:0030915] protein dimerization activity [GO:0046983] g20489.t1 Q6DFN1 61.871 139 9.429999999999999e-62 192.0 sp|Q6DFN1|NDUF3_XENTR NADH dehydrogenase [ubiquinone] 1 alpha subcomplex assembly factor 3 OS=Xenopus tropicalis OX=8364 GN=ndufaf3 PE=2 SV=1 g20490.t1 Q86TL2 46.939 245 8.25e-72 226.0 sp|Q86TL2|STIMA_HUMAN Store-operated calcium entry regulator STIMATE OS=Homo sapiens OX=9606 GN=STIMATE PE=1 SV=1 STIMA_HUMAN reviewed Store-operated calcium entry regulator STIMATE (STIM-activating enhancer encoded by TMEM110) (Transmembrane protein 110) Homo sapiens (Human) GO:0002115; GO:0005246; GO:0005789; GO:0016020; GO:0032237; GO:0032541; GO:0140268 activation of store-operated calcium channel activity [GO:0032237]; store-operated calcium entry [GO:0002115] cortical endoplasmic reticulum [GO:0032541]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-plasma membrane contact site [GO:0140268]; membrane [GO:0016020] calcium channel regulator activity [GO:0005246] g20491.t1 D3ZN95 78.229 271 1.24e-139 437.0 sp|D3ZN95|HCFC1_RAT Host cell factor 1 OS=Rattus norvegicus OX=10116 GN=Hcfc1 PE=1 SV=1 HCFC1_RAT reviewed Host cell factor 1 (HCF) (HCF-1) (C1 factor) [Cleaved into: HCF N-terminal chain 1; HCF N-terminal chain 2; HCF N-terminal chain 3; HCF N-terminal chain 4; HCF N-terminal chain 5; HCF N-terminal chain 6; HCF C-terminal chain 1; HCF C-terminal chain 2; HCF C-terminal chain 3; HCF C-terminal chain 4; HCF C-terminal chain 5; HCF C-terminal chain 6] Rattus norvegicus (Rat) GO:0000122; GO:0000123; GO:0000228; GO:0000978; GO:0001835; GO:0003682; GO:0003713; GO:0005634; GO:0005654; GO:0005737; GO:0006338; GO:0006355; GO:0010628; GO:0019046; GO:0030424; GO:0030425; GO:0030674; GO:0031490; GO:0032991; GO:0035097; GO:0035774; GO:0042802; GO:0043025; GO:0043254; GO:0044545; GO:0044665; GO:0045893; GO:0045944; GO:0048188; GO:0050821; GO:0071339; GO:0140297 blastocyst hatching [GO:0001835]; chromatin remodeling [GO:0006338]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of gene expression [GO:0010628]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein stabilization [GO:0050821]; regulation of DNA-templated transcription [GO:0006355]; regulation of protein-containing complex assembly [GO:0043254]; release from viral latency [GO:0019046] axon [GO:0030424]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; histone acetyltransferase complex [GO:0000123]; histone methyltransferase complex [GO:0035097]; MLL1 complex [GO:0071339]; MLL1/2 complex [GO:0044665]; neuronal cell body [GO:0043025]; NSL complex [GO:0044545]; nuclear chromosome [GO:0000228]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; Set1C/COMPASS complex [GO:0048188] chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; DNA-binding transcription factor binding [GO:0140297]; identical protein binding [GO:0042802]; protein-macromolecule adaptor activity [GO:0030674]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription coactivator activity [GO:0003713] g20492.t1 Q61191 61.475 244 2.83e-85 306.0 sp|Q61191|HCFC1_MOUSE Host cell factor 1 OS=Mus musculus OX=10090 GN=Hcfc1 PE=1 SV=2 HCFC1_MOUSE reviewed Host cell factor 1 (HCF) (HCF-1) (C1 factor) [Cleaved into: HCF N-terminal chain 1; HCF N-terminal chain 2; HCF N-terminal chain 3; HCF N-terminal chain 4; HCF N-terminal chain 5; HCF N-terminal chain 6; HCF C-terminal chain 1; HCF C-terminal chain 2; HCF C-terminal chain 3; HCF C-terminal chain 4; HCF C-terminal chain 5; HCF C-terminal chain 6] Mus musculus (Mouse) GO:0000122; GO:0000123; GO:0000228; GO:0000978; GO:0001835; GO:0003682; GO:0003713; GO:0005634; GO:0005654; GO:0005737; GO:0006338; GO:0006355; GO:0010628; GO:0019046; GO:0030424; GO:0030425; GO:0030674; GO:0031012; GO:0031490; GO:0032991; GO:0035097; GO:0035774; GO:0042802; GO:0043025; GO:0043254; GO:0044545; GO:0044665; GO:0045893; GO:0045944; GO:0048188; GO:0050821; GO:0071339; GO:0140297 blastocyst hatching [GO:0001835]; chromatin remodeling [GO:0006338]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of gene expression [GO:0010628]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein stabilization [GO:0050821]; regulation of DNA-templated transcription [GO:0006355]; regulation of protein-containing complex assembly [GO:0043254]; release from viral latency [GO:0019046] axon [GO:0030424]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; extracellular matrix [GO:0031012]; histone acetyltransferase complex [GO:0000123]; histone methyltransferase complex [GO:0035097]; MLL1 complex [GO:0071339]; MLL1/2 complex [GO:0044665]; neuronal cell body [GO:0043025]; NSL complex [GO:0044545]; nuclear chromosome [GO:0000228]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; Set1C/COMPASS complex [GO:0048188] chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; DNA-binding transcription factor binding [GO:0140297]; identical protein binding [GO:0042802]; protein-macromolecule adaptor activity [GO:0030674]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription coactivator activity [GO:0003713] g20493.t1 Q8BIE6 48.998 549 1.1e-161 511.0 sp|Q8BIE6|FRM4A_MOUSE FERM domain-containing protein 4A OS=Mus musculus OX=10090 GN=Frmd4a PE=1 SV=2 FRM4A_MOUSE reviewed FERM domain-containing protein 4A Mus musculus (Mouse) GO:0005737; GO:0005856; GO:0005912; GO:0005923; GO:0030674; GO:0050709; GO:0050714; GO:0090162 establishment of epithelial cell polarity [GO:0090162]; negative regulation of protein secretion [GO:0050709]; positive regulation of protein secretion [GO:0050714] adherens junction [GO:0005912]; bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856] protein-macromolecule adaptor activity [GO:0030674] g20495.t1 Q5ZKY2 63.501 337 7.720000000000001e-133 397.0 sp|Q5ZKY2|ATG7_CHICK Ubiquitin-like modifier-activating enzyme ATG7 OS=Gallus gallus OX=9031 GN=ATG7 PE=2 SV=1 ATG7_CHICK reviewed Ubiquitin-like modifier-activating enzyme ATG7 (ATG12-activating enzyme E1 ATG7) (Autophagy-related protein 7) (APG7-like) Gallus gallus (Chicken) GO:0000045; GO:0000407; GO:0000423; GO:0005737; GO:0006914; GO:0006995; GO:0009896; GO:0015031; GO:0019778; GO:0019779; GO:0032446; GO:0034727; GO:0042752; GO:0042981; GO:0048511; GO:0060255; GO:0080090 autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; cellular response to nitrogen starvation [GO:0006995]; mitophagy [GO:0000423]; piecemeal microautophagy of the nucleus [GO:0034727]; positive regulation of catabolic process [GO:0009896]; protein modification by small protein conjugation [GO:0032446]; protein transport [GO:0015031]; regulation of apoptotic process [GO:0042981]; regulation of circadian rhythm [GO:0042752]; regulation of macromolecule metabolic process [GO:0060255]; regulation of primary metabolic process [GO:0080090]; rhythmic process [GO:0048511] cytoplasm [GO:0005737]; phagophore assembly site [GO:0000407] Atg12 activating enzyme activity [GO:0019778]; Atg8 activating enzyme activity [GO:0019779] g20496.t1 Q5ZKY2 60.44 91 1.1100000000000001e-29 114.0 sp|Q5ZKY2|ATG7_CHICK Ubiquitin-like modifier-activating enzyme ATG7 OS=Gallus gallus OX=9031 GN=ATG7 PE=2 SV=1 ATG7_CHICK reviewed Ubiquitin-like modifier-activating enzyme ATG7 (ATG12-activating enzyme E1 ATG7) (Autophagy-related protein 7) (APG7-like) Gallus gallus (Chicken) GO:0000045; GO:0000407; GO:0000423; GO:0005737; GO:0006914; GO:0006995; GO:0009896; GO:0015031; GO:0019778; GO:0019779; GO:0032446; GO:0034727; GO:0042752; GO:0042981; GO:0048511; GO:0060255; GO:0080090 autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; cellular response to nitrogen starvation [GO:0006995]; mitophagy [GO:0000423]; piecemeal microautophagy of the nucleus [GO:0034727]; positive regulation of catabolic process [GO:0009896]; protein modification by small protein conjugation [GO:0032446]; protein transport [GO:0015031]; regulation of apoptotic process [GO:0042981]; regulation of circadian rhythm [GO:0042752]; regulation of macromolecule metabolic process [GO:0060255]; regulation of primary metabolic process [GO:0080090]; rhythmic process [GO:0048511] cytoplasm [GO:0005737]; phagophore assembly site [GO:0000407] Atg12 activating enzyme activity [GO:0019778]; Atg8 activating enzyme activity [GO:0019779] g20497.t1 Q5ZKY2 58.659 179 1.65e-66 220.0 sp|Q5ZKY2|ATG7_CHICK Ubiquitin-like modifier-activating enzyme ATG7 OS=Gallus gallus OX=9031 GN=ATG7 PE=2 SV=1 ATG7_CHICK reviewed Ubiquitin-like modifier-activating enzyme ATG7 (ATG12-activating enzyme E1 ATG7) (Autophagy-related protein 7) (APG7-like) Gallus gallus (Chicken) GO:0000045; GO:0000407; GO:0000423; GO:0005737; GO:0006914; GO:0006995; GO:0009896; GO:0015031; GO:0019778; GO:0019779; GO:0032446; GO:0034727; GO:0042752; GO:0042981; GO:0048511; GO:0060255; GO:0080090 autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; cellular response to nitrogen starvation [GO:0006995]; mitophagy [GO:0000423]; piecemeal microautophagy of the nucleus [GO:0034727]; positive regulation of catabolic process [GO:0009896]; protein modification by small protein conjugation [GO:0032446]; protein transport [GO:0015031]; regulation of apoptotic process [GO:0042981]; regulation of circadian rhythm [GO:0042752]; regulation of macromolecule metabolic process [GO:0060255]; regulation of primary metabolic process [GO:0080090]; rhythmic process [GO:0048511] cytoplasm [GO:0005737]; phagophore assembly site [GO:0000407] Atg12 activating enzyme activity [GO:0019778]; Atg8 activating enzyme activity [GO:0019779] g20516.t1 Q9I918 40.705 312 5.67e-76 245.0 sp|Q9I918|GP173_DANRE Probable G-protein coupled receptor 173 OS=Danio rerio OX=7955 GN=gpr173 PE=3 SV=1 g20520.t1 P46023 35.129 854 1.04e-150 504.0 sp|P46023|GR101_LYMST G-protein coupled receptor GRL101 OS=Lymnaea stagnalis OX=6523 PE=2 SV=1 g20520.t1 P46023 28.261 368 7.150000000000001e-21 105.0 sp|P46023|GR101_LYMST G-protein coupled receptor GRL101 OS=Lymnaea stagnalis OX=6523 PE=2 SV=1 g20521.t1 Q66H84 68.915 341 7.96e-175 494.0 sp|Q66H84|MAPK3_RAT MAP kinase-activated protein kinase 3 OS=Rattus norvegicus OX=10116 GN=Mapkapk3 PE=2 SV=1 MAPK3_RAT reviewed MAP kinase-activated protein kinase 3 (MAPK-activated protein kinase 3) (MAPKAP kinase 3) (MAPKAP-K3) (MAPKAPK-3) (MK-3) (EC 2.7.11.1) Rattus norvegicus (Rat) GO:0000165; GO:0002224; GO:0004674; GO:0004683; GO:0005516; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0009931; GO:0032496; GO:0034097; GO:0035556; GO:0044351; GO:0051019; GO:0106310 intracellular signal transduction [GO:0035556]; macropinocytosis [GO:0044351]; MAPK cascade [GO:0000165]; response to cytokine [GO:0034097]; response to lipopolysaccharide [GO:0032496]; toll-like receptor signaling pathway [GO:0002224] cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] ATP binding [GO:0005524]; calcium-dependent protein serine/threonine kinase activity [GO:0009931]; calcium/calmodulin-dependent protein kinase activity [GO:0004683]; calmodulin binding [GO:0005516]; mitogen-activated protein kinase binding [GO:0051019]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g20522.t1 Q6PHZ5 42.261 575 4.87e-114 370.0 sp|Q6PHZ5|RB15B_MOUSE Putative RNA-binding protein 15B OS=Mus musculus OX=10090 GN=Rbm15b PE=1 SV=2 RB15B_MOUSE reviewed Putative RNA-binding protein 15B (RNA-binding motif protein 15B) Mus musculus (Mouse) GO:0000381; GO:0001510; GO:0003723; GO:0003729; GO:0005634; GO:0005635; GO:0005654; GO:0006397; GO:0006406; GO:0008380; GO:0009048; GO:0016607; GO:0036396 dosage compensation by inactivation of X chromosome [GO:0009048]; mRNA export from nucleus [GO:0006406]; mRNA processing [GO:0006397]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA methylation [GO:0001510]; RNA splicing [GO:0008380] nuclear envelope [GO:0005635]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA N6-methyladenosine methyltransferase complex [GO:0036396] mRNA binding [GO:0003729]; RNA binding [GO:0003723] g20523.t1 Q8IZD9 37.417 1649 0.0 1054.0 sp|Q8IZD9|DOCK3_HUMAN Dedicator of cytokinesis protein 3 OS=Homo sapiens OX=9606 GN=DOCK3 PE=1 SV=1 DOCK3_HUMAN reviewed Dedicator of cytokinesis protein 3 (Modifier of cell adhesion) (PS binding protein) (PBP) (Presenilin-binding protein) Homo sapiens (Human) GO:0005085; GO:0005096; GO:0005737; GO:0005829; GO:0005886; GO:0007264; GO:0017124; GO:0031267; GO:0048011; GO:0051056 neurotrophin TRK receptor signaling pathway [GO:0048011]; regulation of small GTPase mediated signal transduction [GO:0051056]; small GTPase-mediated signal transduction [GO:0007264] cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886] GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; SH3 domain binding [GO:0017124]; small GTPase binding [GO:0031267] g20523.t2 Q8IZD9 37.791 1630 0.0 1059.0 sp|Q8IZD9|DOCK3_HUMAN Dedicator of cytokinesis protein 3 OS=Homo sapiens OX=9606 GN=DOCK3 PE=1 SV=1 DOCK3_HUMAN reviewed Dedicator of cytokinesis protein 3 (Modifier of cell adhesion) (PS binding protein) (PBP) (Presenilin-binding protein) Homo sapiens (Human) GO:0005085; GO:0005096; GO:0005737; GO:0005829; GO:0005886; GO:0007264; GO:0017124; GO:0031267; GO:0048011; GO:0051056 neurotrophin TRK receptor signaling pathway [GO:0048011]; regulation of small GTPase mediated signal transduction [GO:0051056]; small GTPase-mediated signal transduction [GO:0007264] cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886] GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; SH3 domain binding [GO:0017124]; small GTPase binding [GO:0031267] g20523.t3 Q8IZD9 37.791 1630 0.0 1060.0 sp|Q8IZD9|DOCK3_HUMAN Dedicator of cytokinesis protein 3 OS=Homo sapiens OX=9606 GN=DOCK3 PE=1 SV=1 DOCK3_HUMAN reviewed Dedicator of cytokinesis protein 3 (Modifier of cell adhesion) (PS binding protein) (PBP) (Presenilin-binding protein) Homo sapiens (Human) GO:0005085; GO:0005096; GO:0005737; GO:0005829; GO:0005886; GO:0007264; GO:0017124; GO:0031267; GO:0048011; GO:0051056 neurotrophin TRK receptor signaling pathway [GO:0048011]; regulation of small GTPase mediated signal transduction [GO:0051056]; small GTPase-mediated signal transduction [GO:0007264] cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886] GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; SH3 domain binding [GO:0017124]; small GTPase binding [GO:0031267] g20527.t1 Q9NRM2 46.715 411 1.17e-122 367.0 sp|Q9NRM2|ZN277_HUMAN Zinc finger protein 277 OS=Homo sapiens OX=9606 GN=ZNF277 PE=1 SV=2 g20528.t1 Q5RAU6 64.865 74 7.840000000000001e-29 100.0 sp|Q5RAU6|KISHB_PONAB Protein kish-B OS=Pongo abelii OX=9601 GN=TMEM167B PE=3 SV=1 g20531.t1 Q96HN2 80.909 440 0.0 773.0 sp|Q96HN2|SAHH3_HUMAN Adenosylhomocysteinase 3 OS=Homo sapiens OX=9606 GN=AHCYL2 PE=1 SV=1 SAHH3_HUMAN reviewed Adenosylhomocysteinase 3 (AdoHcyase 3) (EC 3.13.2.1) (IP(3)Rs binding protein released with IP(3) 2) (IRBIT2) (Long-IRBIT) (S-adenosyl-L-homocysteine hydrolase 3) (S-adenosylhomocysteine hydrolase-like protein 2) Homo sapiens (Human) GO:0005829; GO:0006730; GO:0016787; GO:0033353; GO:0043005 one-carbon metabolic process [GO:0006730]; S-adenosylmethionine cycle [GO:0033353] cytosol [GO:0005829]; neuron projection [GO:0043005] hydrolase activity [GO:0016787] g20532.t1 Q04073 75.817 306 8.34e-152 444.0 sp|Q04073|P3A2_STRPU DNA-binding protein P3A2 OS=Strongylocentrotus purpuratus OX=7668 PE=1 SV=1 g20537.t1 Q8NFZ0 40.409 391 6.38e-76 273.0 sp|Q8NFZ0|FBH1_HUMAN F-box DNA helicase 1 OS=Homo sapiens OX=9606 GN=FBH1 PE=1 SV=2 FBH1_HUMAN reviewed F-box DNA helicase 1 (hFBH1) (EC 5.6.2.4) (DNA 3'-5' helicase 1) (F-box only protein 18) Homo sapiens (Human) GO:0000724; GO:0000785; GO:0001934; GO:0003678; GO:0003690; GO:0003697; GO:0005524; GO:0005634; GO:0006281; GO:0006308; GO:0006974; GO:0015616; GO:0016567; GO:0016887; GO:0019005; GO:0031297; GO:0043138; GO:0072429; GO:1902231; GO:2000042 DNA catabolic process [GO:0006308]; DNA damage response [GO:0006974]; DNA repair [GO:0006281]; double-strand break repair via homologous recombination [GO:0000724]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage [GO:1902231]; positive regulation of protein phosphorylation [GO:0001934]; protein ubiquitination [GO:0016567]; replication fork processing [GO:0031297]; response to intra-S DNA damage checkpoint signaling [GO:0072429] chromatin [GO:0000785]; nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005] 3'-5' DNA helicase activity [GO:0043138]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA helicase activity [GO:0003678]; DNA translocase activity [GO:0015616]; double-stranded DNA binding [GO:0003690]; single-stranded DNA binding [GO:0003697] g20537.t1 Q8NFZ0 43.454 359 2.11e-74 268.0 sp|Q8NFZ0|FBH1_HUMAN F-box DNA helicase 1 OS=Homo sapiens OX=9606 GN=FBH1 PE=1 SV=2 FBH1_HUMAN reviewed F-box DNA helicase 1 (hFBH1) (EC 5.6.2.4) (DNA 3'-5' helicase 1) (F-box only protein 18) Homo sapiens (Human) GO:0000724; GO:0000785; GO:0001934; GO:0003678; GO:0003690; GO:0003697; GO:0005524; GO:0005634; GO:0006281; GO:0006308; GO:0006974; GO:0015616; GO:0016567; GO:0016887; GO:0019005; GO:0031297; GO:0043138; GO:0072429; GO:1902231; GO:2000042 DNA catabolic process [GO:0006308]; DNA damage response [GO:0006974]; DNA repair [GO:0006281]; double-strand break repair via homologous recombination [GO:0000724]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage [GO:1902231]; positive regulation of protein phosphorylation [GO:0001934]; protein ubiquitination [GO:0016567]; replication fork processing [GO:0031297]; response to intra-S DNA damage checkpoint signaling [GO:0072429] chromatin [GO:0000785]; nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005] 3'-5' DNA helicase activity [GO:0043138]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA helicase activity [GO:0003678]; DNA translocase activity [GO:0015616]; double-stranded DNA binding [GO:0003690]; single-stranded DNA binding [GO:0003697] g20538.t1 Q8NFZ0 36.86 293 1.3200000000000001e-36 147.0 sp|Q8NFZ0|FBH1_HUMAN F-box DNA helicase 1 OS=Homo sapiens OX=9606 GN=FBH1 PE=1 SV=2 FBH1_HUMAN reviewed F-box DNA helicase 1 (hFBH1) (EC 5.6.2.4) (DNA 3'-5' helicase 1) (F-box only protein 18) Homo sapiens (Human) GO:0000724; GO:0000785; GO:0001934; GO:0003678; GO:0003690; GO:0003697; GO:0005524; GO:0005634; GO:0006281; GO:0006308; GO:0006974; GO:0015616; GO:0016567; GO:0016887; GO:0019005; GO:0031297; GO:0043138; GO:0072429; GO:1902231; GO:2000042 DNA catabolic process [GO:0006308]; DNA damage response [GO:0006974]; DNA repair [GO:0006281]; double-strand break repair via homologous recombination [GO:0000724]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage [GO:1902231]; positive regulation of protein phosphorylation [GO:0001934]; protein ubiquitination [GO:0016567]; replication fork processing [GO:0031297]; response to intra-S DNA damage checkpoint signaling [GO:0072429] chromatin [GO:0000785]; nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005] 3'-5' DNA helicase activity [GO:0043138]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA helicase activity [GO:0003678]; DNA translocase activity [GO:0015616]; double-stranded DNA binding [GO:0003690]; single-stranded DNA binding [GO:0003697] g20542.t1 Q8NFZ0 36.68 488 5.33e-82 278.0 sp|Q8NFZ0|FBH1_HUMAN F-box DNA helicase 1 OS=Homo sapiens OX=9606 GN=FBH1 PE=1 SV=2 FBH1_HUMAN reviewed F-box DNA helicase 1 (hFBH1) (EC 5.6.2.4) (DNA 3'-5' helicase 1) (F-box only protein 18) Homo sapiens (Human) GO:0000724; GO:0000785; GO:0001934; GO:0003678; GO:0003690; GO:0003697; GO:0005524; GO:0005634; GO:0006281; GO:0006308; GO:0006974; GO:0015616; GO:0016567; GO:0016887; GO:0019005; GO:0031297; GO:0043138; GO:0072429; GO:1902231; GO:2000042 DNA catabolic process [GO:0006308]; DNA damage response [GO:0006974]; DNA repair [GO:0006281]; double-strand break repair via homologous recombination [GO:0000724]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage [GO:1902231]; positive regulation of protein phosphorylation [GO:0001934]; protein ubiquitination [GO:0016567]; replication fork processing [GO:0031297]; response to intra-S DNA damage checkpoint signaling [GO:0072429] chromatin [GO:0000785]; nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005] 3'-5' DNA helicase activity [GO:0043138]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA helicase activity [GO:0003678]; DNA translocase activity [GO:0015616]; double-stranded DNA binding [GO:0003690]; single-stranded DNA binding [GO:0003697] g20543.t1 F1ND48 47.761 134 2.62e-31 122.0 sp|F1ND48|FBH1_CHICK F-box DNA helicase 1 OS=Gallus gallus OX=9031 GN=FBH1 PE=2 SV=2 FBH1_CHICK reviewed F-box DNA helicase 1 (EC 5.6.2.4) (DNA 3'-5' helicase 1) (F-box only protein 18) Gallus gallus (Chicken) GO:0000724; GO:0000785; GO:0003678; GO:0003690; GO:0003697; GO:0005524; GO:0005634; GO:0006974; GO:0016567; GO:0016887; GO:0019005; GO:0031297; GO:0043138; GO:2000042 DNA damage response [GO:0006974]; double-strand break repair via homologous recombination [GO:0000724]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; protein ubiquitination [GO:0016567]; replication fork processing [GO:0031297] chromatin [GO:0000785]; nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005] 3'-5' DNA helicase activity [GO:0043138]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA helicase activity [GO:0003678]; double-stranded DNA binding [GO:0003690]; single-stranded DNA binding [GO:0003697] g20544.t1 A2AS55 41.573 356 6.65e-80 250.0 sp|A2AS55|ANR16_MOUSE Ankyrin repeat domain-containing protein 16 OS=Mus musculus OX=10090 GN=Ankrd16 PE=1 SV=1 ANR16_MOUSE reviewed Ankyrin repeat domain-containing protein 16 Mus musculus (Mouse) GO:0005634; GO:0005737; GO:0006400 tRNA modification [GO:0006400] cytoplasm [GO:0005737]; nucleus [GO:0005634] g20545.t1 Q16635 53.488 258 1.5500000000000002e-88 267.0 sp|Q16635|TAZ_HUMAN Tafazzin OS=Homo sapiens OX=9606 GN=TAFAZZIN PE=1 SV=2 g20554.t1 A4IHS0 36.808 307 1.57e-51 183.0 sp|A4IHS0|TM10C_XENTR tRNA methyltransferase 10 homolog C OS=Xenopus tropicalis OX=8364 GN=trmt10c PE=2 SV=1 TM10C_XENTR reviewed tRNA methyltransferase 10 homolog C (Mitochondrial ribonuclease P protein 1) (Mitochondrial RNase P protein 1) (RNA (guanine-9-)-methyltransferase domain-containing protein 1) (mRNA methyladenosine-N(1)-methyltransferase) (EC 2.1.1.-) (tRNA (adenine(9)-N(1))-methyltransferase) (EC 2.1.1.218) (tRNA (guanine(9)-N(1))-methyltransferase) (EC 2.1.1.221) Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0000049; GO:0005634; GO:0005654; GO:0005739; GO:0006397; GO:0032259; GO:0042645; GO:0052905; GO:0070131; GO:0090646; GO:0097745; GO:0160106 methylation [GO:0032259]; mitochondrial tRNA 5'-end processing [GO:0097745]; mitochondrial tRNA processing [GO:0090646]; mRNA processing [GO:0006397]; positive regulation of mitochondrial translation [GO:0070131] mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] tRNA (adenine(9)-N1)-methyltransferase activity [GO:0160106]; tRNA (guanosine(9)-N1)-methyltransferase activity [GO:0052905]; tRNA binding [GO:0000049] g20555.t1 Q8BUH1 76.51 149 2.54e-83 244.0 sp|Q8BUH1|TXN4B_MOUSE Thioredoxin-like protein 4B OS=Mus musculus OX=10090 GN=Txnl4b PE=2 SV=2 g20556.t1 Q6DJI9 57.642 229 4.96e-69 214.0 sp|Q6DJI9|ZCRB1_XENLA Zinc finger CCHC-type and RNA-binding motif-containing protein 1 OS=Xenopus laevis OX=8355 GN=zcrb1 PE=2 SV=1 g20557.t1 A7RKF6 86.083 503 0.0 911.0 sp|A7RKF6|RTCB_NEMVE RNA-splicing ligase RtcB homolog OS=Nematostella vectensis OX=45351 GN=v1g198406 PE=3 SV=1 RTCB_NEMVE reviewed RNA-splicing ligase RtcB homolog (EC 6.5.1.8) (3'-phosphate/5'-hydroxy nucleic acid ligase) Nematostella vectensis (Starlet sea anemone) GO:0005525; GO:0005634; GO:0006388; GO:0046872; GO:0072669; GO:0170057 tRNA splicing, via endonucleolytic cleavage and ligation [GO:0006388] nucleus [GO:0005634]; tRNA-splicing ligase complex [GO:0072669] GTP binding [GO:0005525]; metal ion binding [GO:0046872]; RNA ligase (GTP) activity [GO:0170057] g20563.t1 P57772 59.265 599 0.0 660.0 sp|P57772|SELB_HUMAN Selenocysteine-specific elongation factor OS=Homo sapiens OX=9606 GN=EEFSEC PE=1 SV=4 SELB_HUMAN reviewed Selenocysteine-specific elongation factor (EC 3.6.5.-) (Elongation factor sec) (Eukaryotic elongation factor, selenocysteine-tRNA-specific) Homo sapiens (Human) GO:0000049; GO:0001514; GO:0003746; GO:0003924; GO:0005525; GO:0005634; GO:0005737; GO:0035368; GO:0043021; GO:1990904 selenocysteine incorporation [GO:0001514] cytoplasm [GO:0005737]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904] GTP binding [GO:0005525]; GTPase activity [GO:0003924]; ribonucleoprotein complex binding [GO:0043021]; selenocysteine insertion sequence binding [GO:0035368]; translation elongation factor activity [GO:0003746]; tRNA binding [GO:0000049] g20565.t1 A6H8Y1 47.826 92 4.3e-22 97.8 sp|A6H8Y1|BDP1_HUMAN Transcription factor TFIIIB component B'' homolog OS=Homo sapiens OX=9606 GN=BDP1 PE=1 SV=3 BDP1_HUMAN reviewed Transcription factor TFIIIB component B'' homolog (Transcription factor IIIB 150) (TFIIIB150) (Transcription factor-like nuclear regulator) Homo sapiens (Human) GO:0000126; GO:0001156; GO:0005654; GO:0070898 RNA polymerase III preinitiation complex assembly [GO:0070898] nucleoplasm [GO:0005654]; transcription factor TFIIIB complex [GO:0000126] TFIIIC-class transcription factor complex binding [GO:0001156] g20569.t1 Q9H1K0 32.821 521 1.4800000000000002e-70 243.0 sp|Q9H1K0|RBNS5_HUMAN Rabenosyn-5 OS=Homo sapiens OX=9606 GN=RBSN PE=1 SV=2 RBNS5_HUMAN reviewed Rabenosyn-5 (110 kDa protein) (FYVE finger-containing Rab5 effector protein rabenosyn-5) (RAB effector RBSN) (Zinc finger FYVE domain-containing protein 20) Homo sapiens (Human) GO:0005768; GO:0005769; GO:0005829; GO:0005886; GO:0008270; GO:0010008; GO:0015031; GO:0016197; GO:0031267; GO:0031901; GO:0032266; GO:0034498; GO:0070062; GO:0090160; GO:1903358 early endosome to Golgi transport [GO:0034498]; endosomal transport [GO:0016197]; Golgi to lysosome transport [GO:0090160]; protein transport [GO:0015031]; regulation of Golgi organization [GO:1903358] cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; plasma membrane [GO:0005886] phosphatidylinositol-3-phosphate binding [GO:0032266]; small GTPase binding [GO:0031267]; zinc ion binding [GO:0008270] g20571.t1 Q95LL3 70.833 72 1.59e-29 115.0 sp|Q95LL3|TB22B_MACFA TBC1 domain family member 22B OS=Macaca fascicularis OX=9541 GN=TBC1D22B PE=2 SV=1 g20572.t1 Q9NU19 49.762 420 6.87e-131 389.0 sp|Q9NU19|TB22B_HUMAN TBC1 domain family member 22B OS=Homo sapiens OX=9606 GN=TBC1D22B PE=1 SV=3 TB22B_HUMAN reviewed TBC1 domain family member 22B Homo sapiens (Human) GO:0005096; GO:0005794; GO:0071889 Golgi apparatus [GO:0005794] 14-3-3 protein binding [GO:0071889]; GTPase activator activity [GO:0005096] g20573.t1 Q55C17 35.079 191 8.88e-26 106.0 sp|Q55C17|TECR_DICDI Very-long-chain enoyl-CoA reductase OS=Dictyostelium discoideum OX=44689 GN=gpsn2 PE=3 SV=1 g20574.t1 Q8TCT0 42.944 496 2.91e-130 394.0 sp|Q8TCT0|CERK1_HUMAN Ceramide kinase OS=Homo sapiens OX=9606 GN=CERK PE=1 SV=1 CERK1_HUMAN reviewed Ceramide kinase (hCERK) (EC 2.7.1.138) (Acylsphingosine kinase) (Lipid kinase 4) (LK4) Homo sapiens (Human) GO:0000287; GO:0001729; GO:0005524; GO:0005737; GO:0005886; GO:0006672; GO:0006688; GO:0016020 ceramide metabolic process [GO:0006672]; glycosphingolipid biosynthetic process [GO:0006688] cytoplasm [GO:0005737]; membrane [GO:0016020]; plasma membrane [GO:0005886] ATP binding [GO:0005524]; ceramide kinase activity [GO:0001729]; magnesium ion binding [GO:0000287] g20575.t1 Q00612 70.124 482 0.0 753.0 sp|Q00612|G6PD1_MOUSE Glucose-6-phosphate 1-dehydrogenase X OS=Mus musculus OX=10090 GN=G6pdx PE=1 SV=3 G6PD1_MOUSE reviewed Glucose-6-phosphate 1-dehydrogenase X (G6PD) (EC 1.-.-.-) (EC 1.1.1.49) Mus musculus (Mouse) GO:0001998; GO:0002033; GO:0004345; GO:0005536; GO:0005737; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006741; GO:0006749; GO:0006979; GO:0009051; GO:0009898; GO:0019322; GO:0030246; GO:0034451; GO:0034599; GO:0040014; GO:0042802; GO:0042803; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0048821; GO:0050661; GO:0051156; GO:0061052; GO:1904879; GO:2000378 angiotensin-mediated vasoconstriction involved in regulation of systemic arterial blood pressure [GO:0001998]; angiotensin-mediated vasodilation involved in regulation of systemic arterial blood pressure [GO:0002033]; cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte development [GO:0048821]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADP+ biosynthetic process [GO:0006741]; NADP+ metabolic process [GO:0006739]; NADPH regeneration [GO:0006740]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of multicellular organism growth [GO:0040014]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to oxidative stress [GO:0006979]; ribose phosphate biosynthetic process [GO:0046390] centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829] carbohydrate binding [GO:0030246]; D-glucose binding [GO:0005536]; glucose-6-phosphate dehydrogenase activity [GO:0004345]; identical protein binding [GO:0042802]; NADP binding [GO:0050661]; protein homodimerization activity [GO:0042803] g20576.t1 Q6UXH1 48.673 226 9.49e-58 191.0 sp|Q6UXH1|CREL2_HUMAN Protein disulfide isomerase CRELD2 OS=Homo sapiens OX=9606 GN=CRELD2 PE=1 SV=1 CREL2_HUMAN reviewed Protein disulfide isomerase CRELD2 (EC 5.3.4.1) (Cysteine-rich with EGF-like domain protein 2) Homo sapiens (Human) GO:0003756; GO:0005509; GO:0005615; GO:0005783; GO:0005794 endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794] calcium ion binding [GO:0005509]; protein disulfide isomerase activity [GO:0003756] g20578.t1 O60706 42.222 900 0.0 711.0 sp|O60706|ABCC9_HUMAN ATP-binding cassette sub-family C member 9 OS=Homo sapiens OX=9606 GN=ABCC9 PE=1 SV=2 ABCC9_HUMAN reviewed ATP-binding cassette sub-family C member 9 (Sulfonylurea receptor 2) Homo sapiens (Human) GO:0000165; GO:0001508; GO:0001666; GO:0003007; GO:0005267; GO:0005524; GO:0005739; GO:0005886; GO:0006357; GO:0007005; GO:0007519; GO:0008281; GO:0008282; GO:0010467; GO:0014823; GO:0015459; GO:0016887; GO:0019395; GO:0019829; GO:0030017; GO:0031004; GO:0033198; GO:0035865; GO:0042311; GO:0042383; GO:0042542; GO:0042626; GO:0043066; GO:0043225; GO:0043627; GO:0044325; GO:0044877; GO:0045333; GO:0045776; GO:0046034; GO:0048144; GO:0051607; GO:0055085; GO:0060976; GO:0061337; GO:0062197; GO:0071277; GO:0071318; GO:0071466; GO:0071805; GO:0072592; GO:0086003; GO:0098655; GO:0098662; GO:0099104; GO:0140359; GO:0150104; GO:1901379; GO:1901652; GO:1903409; GO:1904880; GO:1990573 action potential [GO:0001508]; ATP metabolic process [GO:0046034]; cardiac conduction [GO:0061337]; cardiac muscle cell contraction [GO:0086003]; cellular respiration [GO:0045333]; cellular response to ATP [GO:0071318]; cellular response to calcium ion [GO:0071277]; cellular response to chemical stress [GO:0062197]; cellular response to potassium ion [GO:0035865]; cellular response to xenobiotic stimulus [GO:0071466]; coronary vasculature development [GO:0060976]; defense response to virus [GO:0051607]; fatty acid oxidation [GO:0019395]; fibroblast proliferation [GO:0048144]; gene expression [GO:0010467]; heart morphogenesis [GO:0003007]; inorganic cation transmembrane transport [GO:0098662]; MAPK cascade [GO:0000165]; mitochondrion organization [GO:0007005]; monoatomic cation transmembrane transport [GO:0098655]; negative regulation of apoptotic process [GO:0043066]; negative regulation of blood pressure [GO:0045776]; oxygen metabolic process [GO:0072592]; potassium ion import across plasma membrane [GO:1990573]; potassium ion transmembrane transport [GO:0071805]; reactive oxygen species biosynthetic process [GO:1903409]; regulation of potassium ion transmembrane transport [GO:1901379]; regulation of transcription by RNA polymerase II [GO:0006357]; response to activity [GO:0014823]; response to ATP [GO:0033198]; response to estrogen [GO:0043627]; response to hydrogen peroxide [GO:0042542]; response to hydrogen sulfide [GO:1904880]; response to hypoxia [GO:0001666]; response to peptide [GO:1901652]; skeletal muscle tissue development [GO:0007519]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104]; vasodilation [GO:0042311] inward rectifying potassium channel [GO:0008282]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; potassium ion-transporting ATPase complex [GO:0031004]; sarcolemma [GO:0042383]; sarcomere [GO:0030017] ABC-type transporter activity [GO:0140359]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled inorganic anion transmembrane transporter activity [GO:0043225]; ATPase-coupled monoatomic cation transmembrane transporter activity [GO:0019829]; ATPase-coupled transmembrane transporter activity [GO:0042626]; potassium channel activator activity [GO:0099104]; potassium channel activity [GO:0005267]; potassium channel regulator activity [GO:0015459]; protein-containing complex binding [GO:0044877]; sulfonylurea receptor activity [GO:0008281]; transmembrane transporter binding [GO:0044325] g20579.t1 P82451 31.25 576 1.1e-69 248.0 sp|P82451|ABCC9_RABIT ATP-binding cassette sub-family C member 9 OS=Oryctolagus cuniculus OX=9986 GN=ABCC9 PE=2 SV=1 g20580.t1 O60706 42.25 800 0.0 642.0 sp|O60706|ABCC9_HUMAN ATP-binding cassette sub-family C member 9 OS=Homo sapiens OX=9606 GN=ABCC9 PE=1 SV=2 ABCC9_HUMAN reviewed ATP-binding cassette sub-family C member 9 (Sulfonylurea receptor 2) Homo sapiens (Human) GO:0000165; GO:0001508; GO:0001666; GO:0003007; GO:0005267; GO:0005524; GO:0005739; GO:0005886; GO:0006357; GO:0007005; GO:0007519; GO:0008281; GO:0008282; GO:0010467; GO:0014823; GO:0015459; GO:0016887; GO:0019395; GO:0019829; GO:0030017; GO:0031004; GO:0033198; GO:0035865; GO:0042311; GO:0042383; GO:0042542; GO:0042626; GO:0043066; GO:0043225; GO:0043627; GO:0044325; GO:0044877; GO:0045333; GO:0045776; GO:0046034; GO:0048144; GO:0051607; GO:0055085; GO:0060976; GO:0061337; GO:0062197; GO:0071277; GO:0071318; GO:0071466; GO:0071805; GO:0072592; GO:0086003; GO:0098655; GO:0098662; GO:0099104; GO:0140359; GO:0150104; GO:1901379; GO:1901652; GO:1903409; GO:1904880; GO:1990573 action potential [GO:0001508]; ATP metabolic process [GO:0046034]; cardiac conduction [GO:0061337]; cardiac muscle cell contraction [GO:0086003]; cellular respiration [GO:0045333]; cellular response to ATP [GO:0071318]; cellular response to calcium ion [GO:0071277]; cellular response to chemical stress [GO:0062197]; cellular response to potassium ion [GO:0035865]; cellular response to xenobiotic stimulus [GO:0071466]; coronary vasculature development [GO:0060976]; defense response to virus [GO:0051607]; fatty acid oxidation [GO:0019395]; fibroblast proliferation [GO:0048144]; gene expression [GO:0010467]; heart morphogenesis [GO:0003007]; inorganic cation transmembrane transport [GO:0098662]; MAPK cascade [GO:0000165]; mitochondrion organization [GO:0007005]; monoatomic cation transmembrane transport [GO:0098655]; negative regulation of apoptotic process [GO:0043066]; negative regulation of blood pressure [GO:0045776]; oxygen metabolic process [GO:0072592]; potassium ion import across plasma membrane [GO:1990573]; potassium ion transmembrane transport [GO:0071805]; reactive oxygen species biosynthetic process [GO:1903409]; regulation of potassium ion transmembrane transport [GO:1901379]; regulation of transcription by RNA polymerase II [GO:0006357]; response to activity [GO:0014823]; response to ATP [GO:0033198]; response to estrogen [GO:0043627]; response to hydrogen peroxide [GO:0042542]; response to hydrogen sulfide [GO:1904880]; response to hypoxia [GO:0001666]; response to peptide [GO:1901652]; skeletal muscle tissue development [GO:0007519]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104]; vasodilation [GO:0042311] inward rectifying potassium channel [GO:0008282]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; potassium ion-transporting ATPase complex [GO:0031004]; sarcolemma [GO:0042383]; sarcomere [GO:0030017] ABC-type transporter activity [GO:0140359]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled inorganic anion transmembrane transporter activity [GO:0043225]; ATPase-coupled monoatomic cation transmembrane transporter activity [GO:0019829]; ATPase-coupled transmembrane transporter activity [GO:0042626]; potassium channel activator activity [GO:0099104]; potassium channel activity [GO:0005267]; potassium channel regulator activity [GO:0015459]; protein-containing complex binding [GO:0044877]; sulfonylurea receptor activity [GO:0008281]; transmembrane transporter binding [GO:0044325] g20581.t1 P82451 32.425 771 2.3299999999999998e-98 338.0 sp|P82451|ABCC9_RABIT ATP-binding cassette sub-family C member 9 OS=Oryctolagus cuniculus OX=9986 GN=ABCC9 PE=2 SV=1 g20581.t2 P82451 32.425 771 4.14e-99 340.0 sp|P82451|ABCC9_RABIT ATP-binding cassette sub-family C member 9 OS=Oryctolagus cuniculus OX=9986 GN=ABCC9 PE=2 SV=1 g20582.t1 Q63563 38.176 1590 0.0 989.0 sp|Q63563|ABCC9_RAT ATP-binding cassette sub-family C member 9 OS=Rattus norvegicus OX=10116 GN=Abcc9 PE=1 SV=1 g20583.t1 O44126 26.071 280 3.56e-30 118.0 sp|O44126|LEG1_HAECO 32 kDa beta-galactoside-binding lectin OS=Haemonchus contortus OX=6289 GN=GAL-1 PE=1 SV=1 g20584.t1 Q29611 46.89 418 8.67e-117 351.0 sp|Q29611|CLN3_CANLF Battenin OS=Canis lupus familiaris OX=9615 GN=CLN3 PE=3 SV=1 CLN3_CANLF reviewed Battenin (Protein CLN3) Canis lupus familiaris (Dog) (Canis familiaris) GO:0000139; GO:0005634; GO:0005737; GO:0005764; GO:0005765; GO:0005769; GO:0005770; GO:0005783; GO:0005789; GO:0005794; GO:0005795; GO:0005802; GO:0005829; GO:0005886; GO:0005901; GO:0006898; GO:0007040; GO:0007042; GO:0007611; GO:0008021; GO:0009992; GO:0010762; GO:0016020; GO:0031901; GO:0032228; GO:0035752; GO:0036359; GO:0042987; GO:0042998; GO:0043005; GO:0043066; GO:0044754; GO:0044857; GO:0045121; GO:0046474; GO:0046836; GO:0047496; GO:0048172; GO:0048549; GO:0051493; GO:0051861; GO:0051966; GO:0055037; GO:0061909; GO:0070613; GO:0090160; GO:0090384; GO:0090385; GO:0106049; GO:0120146; GO:1900079; GO:1901096; GO:1903076; GO:1903826; GO:1905146; GO:1905162; GO:1905244; GO:2001288 amyloid precursor protein catabolic process [GO:0042987]; autophagosome-lysosome fusion [GO:0061909]; glycerophospholipid biosynthetic process [GO:0046474]; glycolipid transport [GO:0046836]; Golgi to lysosome transport [GO:0090160]; intracellular water homeostasis [GO:0009992]; L-arginine transmembrane transport [GO:1903826]; learning or memory [GO:0007611]; lysosomal lumen acidification [GO:0007042]; lysosomal lumen pH elevation [GO:0035752]; lysosomal protein catabolic process [GO:1905146]; lysosome organization [GO:0007040]; negative regulation of apoptotic process [GO:0043066]; phagosome-lysosome docking [GO:0090384]; phagosome-lysosome fusion [GO:0090385]; plasma membrane raft organization [GO:0044857]; positive regulation of caveolin-mediated endocytosis [GO:2001288]; positive regulation of Golgi to plasma membrane protein transport [GO:0042998]; positive regulation of pinocytosis [GO:0048549]; receptor-mediated endocytosis [GO:0006898]; regulation of arginine biosynthetic process [GO:1900079]; regulation of autophagosome maturation [GO:1901096]; regulation of cellular response to osmotic stress [GO:0106049]; regulation of cytoskeleton organization [GO:0051493]; regulation of fibroblast migration [GO:0010762]; regulation of modification of synaptic structure [GO:1905244]; regulation of phagosome maturation [GO:1905162]; regulation of protein localization to plasma membrane [GO:1903076]; regulation of protein processing [GO:0070613]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; regulation of synaptic transmission, GABAergic [GO:0032228]; regulation of synaptic transmission, glutamatergic [GO:0051966]; renal potassium excretion [GO:0036359]; vesicle transport along microtubule [GO:0047496] autolysosome [GO:0044754]; caveola [GO:0005901]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; membrane raft [GO:0045121]; neuron projection [GO:0043005]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; synaptic vesicle [GO:0008021]; trans-Golgi network [GO:0005802] glycolipid binding [GO:0051861]; sulfatide binding [GO:0120146] g20585.t1 Q7SXW4 76.552 145 3.79e-78 235.0 sp|Q7SXW4|EMC3_DANRE ER membrane protein complex subunit 3 OS=Danio rerio OX=7955 GN=emc3 PE=2 SV=1 g20586.t1 Q7L0Y3 37.829 304 6.6e-61 206.0 sp|Q7L0Y3|TM10C_HUMAN tRNA methyltransferase 10 homolog C OS=Homo sapiens OX=9606 GN=TRMT10C PE=1 SV=2 TM10C_HUMAN reviewed tRNA methyltransferase 10 homolog C (HBV pre-S2 trans-regulated protein 2) (Mitochondrial ribonuclease P protein 1) (Mitochondrial RNase P protein 1) (RNA (guanine-9-)-methyltransferase domain-containing protein 1) (Renal carcinoma antigen NY-REN-49) (mRNA methyladenosine-N(1)-methyltransferase) (EC 2.1.1.-) (tRNA (adenine(9)-N(1))-methyltransferase) (EC 2.1.1.218) (tRNA (guanine(9)-N(1))-methyltransferase) (EC 2.1.1.221) Homo sapiens (Human) GO:0000049; GO:0000964; GO:0003723; GO:0005634; GO:0005654; GO:0005739; GO:0005759; GO:0006397; GO:0030678; GO:0042645; GO:0042802; GO:0043527; GO:0052905; GO:0070131; GO:0070901; GO:0090646; GO:0097745; GO:0160106; GO:1990180 mitochondrial RNA 5'-end processing [GO:0000964]; mitochondrial tRNA 3'-end processing [GO:1990180]; mitochondrial tRNA 5'-end processing [GO:0097745]; mitochondrial tRNA methylation [GO:0070901]; mitochondrial tRNA processing [GO:0090646]; mRNA processing [GO:0006397]; positive regulation of mitochondrial translation [GO:0070131] mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrial ribonuclease P complex [GO:0030678]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; tRNA methyltransferase complex [GO:0043527] identical protein binding [GO:0042802]; RNA binding [GO:0003723]; tRNA (adenine(9)-N1)-methyltransferase activity [GO:0160106]; tRNA (guanosine(9)-N1)-methyltransferase activity [GO:0052905]; tRNA binding [GO:0000049] g20587.t1 Q8BR07 39.074 842 4.77e-156 477.0 sp|Q8BR07|BICD1_MOUSE Protein bicaudal D homolog 1 OS=Mus musculus OX=10090 GN=Bicd1 PE=1 SV=2 BICD1_MOUSE reviewed Protein bicaudal D homolog 1 (Bic-D 1) Mus musculus (Mouse) GO:0005794; GO:0005802; GO:0005813; GO:0005829; GO:0008093; GO:0016020; GO:0019068; GO:0019901; GO:0031267; GO:0031410; GO:0031871; GO:0034063; GO:0034452; GO:0045505; GO:0048260; GO:0048471; GO:0070507; GO:0070840; GO:0072385; GO:0072393; GO:0099503; GO:1900737; GO:1904781 microtubule anchoring at microtubule organizing center [GO:0072393]; minus-end-directed organelle transport along microtubule [GO:0072385]; negative regulation of phospholipase C-activating G protein-coupled receptor signaling pathway [GO:1900737]; positive regulation of protein localization to centrosome [GO:1904781]; positive regulation of receptor-mediated endocytosis [GO:0048260]; regulation of microtubule cytoskeleton organization [GO:0070507]; stress granule assembly [GO:0034063]; virion assembly [GO:0019068] centrosome [GO:0005813]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; secretory vesicle [GO:0099503]; trans-Golgi network [GO:0005802] cytoskeletal anchor activity [GO:0008093]; dynactin binding [GO:0034452]; dynein complex binding [GO:0070840]; dynein intermediate chain binding [GO:0045505]; protein kinase binding [GO:0019901]; proteinase activated receptor binding [GO:0031871]; small GTPase binding [GO:0031267] g20588.t1 A7S1L6 60.237 337 2.4000000000000002e-144 417.0 sp|A7S1L6|FUCT1_NEMVE GDP-fucose transporter 1 OS=Nematostella vectensis OX=45351 GN=slc35c1 PE=3 SV=1 FUCT1_NEMVE reviewed GDP-fucose transporter 1 (Solute carrier family 35 member C1 homolog) Nematostella vectensis (Starlet sea anemone) GO:0000139; GO:0005457; GO:0005794; GO:0015297; GO:0036085 GDP-fucose import into Golgi lumen [GO:0036085] Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139] antiporter activity [GO:0015297]; GDP-fucose transmembrane transporter activity [GO:0005457] g20589.t1 Q9FN03 32.187 407 2.84e-49 186.0 sp|Q9FN03|UVR8_ARATH Ultraviolet-B receptor UVR8 OS=Arabidopsis thaliana OX=3702 GN=UVR8 PE=1 SV=1 UVR8_ARATH reviewed Ultraviolet-B receptor UVR8 (Protein UV-B RESISTANCE 8) (RCC1 domain-containing protein UVR8) Arabidopsis thaliana (Mouse-ear cress) GO:0000785; GO:0003682; GO:0005085; GO:0005634; GO:0005829; GO:0009411; GO:0009536; GO:0009649; GO:0009881; GO:0010224; GO:0042802; GO:0042803 entrainment of circadian clock [GO:0009649]; response to UV [GO:0009411]; response to UV-B [GO:0010224] chromatin [GO:0000785]; cytosol [GO:0005829]; nucleus [GO:0005634]; plastid [GO:0009536] chromatin binding [GO:0003682]; guanyl-nucleotide exchange factor activity [GO:0005085]; identical protein binding [GO:0042802]; photoreceptor activity [GO:0009881]; protein homodimerization activity [GO:0042803] g20589.t1 Q9FN03 38.571 210 5.51e-32 134.0 sp|Q9FN03|UVR8_ARATH Ultraviolet-B receptor UVR8 OS=Arabidopsis thaliana OX=3702 GN=UVR8 PE=1 SV=1 UVR8_ARATH reviewed Ultraviolet-B receptor UVR8 (Protein UV-B RESISTANCE 8) (RCC1 domain-containing protein UVR8) Arabidopsis thaliana (Mouse-ear cress) GO:0000785; GO:0003682; GO:0005085; GO:0005634; GO:0005829; GO:0009411; GO:0009536; GO:0009649; GO:0009881; GO:0010224; GO:0042802; GO:0042803 entrainment of circadian clock [GO:0009649]; response to UV [GO:0009411]; response to UV-B [GO:0010224] chromatin [GO:0000785]; cytosol [GO:0005829]; nucleus [GO:0005634]; plastid [GO:0009536] chromatin binding [GO:0003682]; guanyl-nucleotide exchange factor activity [GO:0005085]; identical protein binding [GO:0042802]; photoreceptor activity [GO:0009881]; protein homodimerization activity [GO:0042803] g20590.t1 O60706 34.16 1613 0.0 845.0 sp|O60706|ABCC9_HUMAN ATP-binding cassette sub-family C member 9 OS=Homo sapiens OX=9606 GN=ABCC9 PE=1 SV=2 ABCC9_HUMAN reviewed ATP-binding cassette sub-family C member 9 (Sulfonylurea receptor 2) Homo sapiens (Human) GO:0000165; GO:0001508; GO:0001666; GO:0003007; GO:0005267; GO:0005524; GO:0005739; GO:0005886; GO:0006357; GO:0007005; GO:0007519; GO:0008281; GO:0008282; GO:0010467; GO:0014823; GO:0015459; GO:0016887; GO:0019395; GO:0019829; GO:0030017; GO:0031004; GO:0033198; GO:0035865; GO:0042311; GO:0042383; GO:0042542; GO:0042626; GO:0043066; GO:0043225; GO:0043627; GO:0044325; GO:0044877; GO:0045333; GO:0045776; GO:0046034; GO:0048144; GO:0051607; GO:0055085; GO:0060976; GO:0061337; GO:0062197; GO:0071277; GO:0071318; GO:0071466; GO:0071805; GO:0072592; GO:0086003; GO:0098655; GO:0098662; GO:0099104; GO:0140359; GO:0150104; GO:1901379; GO:1901652; GO:1903409; GO:1904880; GO:1990573 action potential [GO:0001508]; ATP metabolic process [GO:0046034]; cardiac conduction [GO:0061337]; cardiac muscle cell contraction [GO:0086003]; cellular respiration [GO:0045333]; cellular response to ATP [GO:0071318]; cellular response to calcium ion [GO:0071277]; cellular response to chemical stress [GO:0062197]; cellular response to potassium ion [GO:0035865]; cellular response to xenobiotic stimulus [GO:0071466]; coronary vasculature development [GO:0060976]; defense response to virus [GO:0051607]; fatty acid oxidation [GO:0019395]; fibroblast proliferation [GO:0048144]; gene expression [GO:0010467]; heart morphogenesis [GO:0003007]; inorganic cation transmembrane transport [GO:0098662]; MAPK cascade [GO:0000165]; mitochondrion organization [GO:0007005]; monoatomic cation transmembrane transport [GO:0098655]; negative regulation of apoptotic process [GO:0043066]; negative regulation of blood pressure [GO:0045776]; oxygen metabolic process [GO:0072592]; potassium ion import across plasma membrane [GO:1990573]; potassium ion transmembrane transport [GO:0071805]; reactive oxygen species biosynthetic process [GO:1903409]; regulation of potassium ion transmembrane transport [GO:1901379]; regulation of transcription by RNA polymerase II [GO:0006357]; response to activity [GO:0014823]; response to ATP [GO:0033198]; response to estrogen [GO:0043627]; response to hydrogen peroxide [GO:0042542]; response to hydrogen sulfide [GO:1904880]; response to hypoxia [GO:0001666]; response to peptide [GO:1901652]; skeletal muscle tissue development [GO:0007519]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104]; vasodilation [GO:0042311] inward rectifying potassium channel [GO:0008282]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; potassium ion-transporting ATPase complex [GO:0031004]; sarcolemma [GO:0042383]; sarcomere [GO:0030017] ABC-type transporter activity [GO:0140359]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled inorganic anion transmembrane transporter activity [GO:0043225]; ATPase-coupled monoatomic cation transmembrane transporter activity [GO:0019829]; ATPase-coupled transmembrane transporter activity [GO:0042626]; potassium channel activator activity [GO:0099104]; potassium channel activity [GO:0005267]; potassium channel regulator activity [GO:0015459]; protein-containing complex binding [GO:0044877]; sulfonylurea receptor activity [GO:0008281]; transmembrane transporter binding [GO:0044325] g20590.t2 O60706 34.098 1613 0.0 865.0 sp|O60706|ABCC9_HUMAN ATP-binding cassette sub-family C member 9 OS=Homo sapiens OX=9606 GN=ABCC9 PE=1 SV=2 ABCC9_HUMAN reviewed ATP-binding cassette sub-family C member 9 (Sulfonylurea receptor 2) Homo sapiens (Human) GO:0000165; GO:0001508; GO:0001666; GO:0003007; GO:0005267; GO:0005524; GO:0005739; GO:0005886; GO:0006357; GO:0007005; GO:0007519; GO:0008281; GO:0008282; GO:0010467; GO:0014823; GO:0015459; GO:0016887; GO:0019395; GO:0019829; GO:0030017; GO:0031004; GO:0033198; GO:0035865; GO:0042311; GO:0042383; GO:0042542; GO:0042626; GO:0043066; GO:0043225; GO:0043627; GO:0044325; GO:0044877; GO:0045333; GO:0045776; GO:0046034; GO:0048144; GO:0051607; GO:0055085; GO:0060976; GO:0061337; GO:0062197; GO:0071277; GO:0071318; GO:0071466; GO:0071805; GO:0072592; GO:0086003; GO:0098655; GO:0098662; GO:0099104; GO:0140359; GO:0150104; GO:1901379; GO:1901652; GO:1903409; GO:1904880; GO:1990573 action potential [GO:0001508]; ATP metabolic process [GO:0046034]; cardiac conduction [GO:0061337]; cardiac muscle cell contraction [GO:0086003]; cellular respiration [GO:0045333]; cellular response to ATP [GO:0071318]; cellular response to calcium ion [GO:0071277]; cellular response to chemical stress [GO:0062197]; cellular response to potassium ion [GO:0035865]; cellular response to xenobiotic stimulus [GO:0071466]; coronary vasculature development [GO:0060976]; defense response to virus [GO:0051607]; fatty acid oxidation [GO:0019395]; fibroblast proliferation [GO:0048144]; gene expression [GO:0010467]; heart morphogenesis [GO:0003007]; inorganic cation transmembrane transport [GO:0098662]; MAPK cascade [GO:0000165]; mitochondrion organization [GO:0007005]; monoatomic cation transmembrane transport [GO:0098655]; negative regulation of apoptotic process [GO:0043066]; negative regulation of blood pressure [GO:0045776]; oxygen metabolic process [GO:0072592]; potassium ion import across plasma membrane [GO:1990573]; potassium ion transmembrane transport [GO:0071805]; reactive oxygen species biosynthetic process [GO:1903409]; regulation of potassium ion transmembrane transport [GO:1901379]; regulation of transcription by RNA polymerase II [GO:0006357]; response to activity [GO:0014823]; response to ATP [GO:0033198]; response to estrogen [GO:0043627]; response to hydrogen peroxide [GO:0042542]; response to hydrogen sulfide [GO:1904880]; response to hypoxia [GO:0001666]; response to peptide [GO:1901652]; skeletal muscle tissue development [GO:0007519]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104]; vasodilation [GO:0042311] inward rectifying potassium channel [GO:0008282]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; potassium ion-transporting ATPase complex [GO:0031004]; sarcolemma [GO:0042383]; sarcomere [GO:0030017] ABC-type transporter activity [GO:0140359]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled inorganic anion transmembrane transporter activity [GO:0043225]; ATPase-coupled monoatomic cation transmembrane transporter activity [GO:0019829]; ATPase-coupled transmembrane transporter activity [GO:0042626]; potassium channel activator activity [GO:0099104]; potassium channel activity [GO:0005267]; potassium channel regulator activity [GO:0015459]; protein-containing complex binding [GO:0044877]; sulfonylurea receptor activity [GO:0008281]; transmembrane transporter binding [GO:0044325] g20591.t1 Q9NY47 34.316 1052 0.0 572.0 sp|Q9NY47|CA2D2_HUMAN Voltage-dependent calcium channel subunit alpha-2/delta-2 OS=Homo sapiens OX=9606 GN=CACNA2D2 PE=1 SV=2 g20591.t2 Q9NY47 34.82 1054 0.0 586.0 sp|Q9NY47|CA2D2_HUMAN Voltage-dependent calcium channel subunit alpha-2/delta-2 OS=Homo sapiens OX=9606 GN=CACNA2D2 PE=1 SV=2 g20591.t3 Q9NY47 34.557 1062 0.0 579.0 sp|Q9NY47|CA2D2_HUMAN Voltage-dependent calcium channel subunit alpha-2/delta-2 OS=Homo sapiens OX=9606 GN=CACNA2D2 PE=1 SV=2 g20593.t1 Q920B6 32.301 226 9.23e-33 131.0 sp|Q920B6|KCNK2_RAT Potassium channel subfamily K member 2 OS=Rattus norvegicus OX=10116 GN=Kcnk2 PE=1 SV=1 g20594.t1 Q6P799 68.116 483 0.0 681.0 sp|Q6P799|SYSC_RAT Serine--tRNA ligase, cytoplasmic OS=Rattus norvegicus OX=10116 GN=Sars1 PE=1 SV=3 SYSC_RAT reviewed Serine--tRNA ligase, cytoplasmic (EC 6.1.1.11) (Seryl-tRNA synthetase) (SerRS) (Seryl-tRNA(Ser/Sec) synthetase) Rattus norvegicus (Rat) GO:0000049; GO:0000122; GO:0000978; GO:0001514; GO:0002181; GO:0004828; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006400; GO:0006434; GO:0016525; GO:0019899; GO:0042803; GO:0060090; GO:0098619; GO:1904046 cytoplasmic translation [GO:0002181]; negative regulation of angiogenesis [GO:0016525]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of vascular endothelial growth factor production [GO:1904046]; selenocysteine incorporation [GO:0001514]; seryl-tRNA aminoacylation [GO:0006434]; tRNA modification [GO:0006400] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634] ATP binding [GO:0005524]; enzyme binding [GO:0019899]; molecular adaptor activity [GO:0060090]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; selenocysteine-tRNA ligase activity [GO:0098619]; serine-tRNA ligase activity [GO:0004828]; tRNA binding [GO:0000049] g20598.t1 Q7RTX9 34.518 197 1.01e-28 115.0 sp|Q7RTX9|MOT14_HUMAN Monocarboxylate transporter 14 OS=Homo sapiens OX=9606 GN=SLC16A14 PE=1 SV=1 g20599.t1 O15374 23.26 503 7.55e-37 146.0 sp|O15374|MOT5_HUMAN Monocarboxylate transporter 5 OS=Homo sapiens OX=9606 GN=SLC16A4 PE=1 SV=1 g20604.t1 P09960 55.611 606 0.0 698.0 sp|P09960|LKHA4_HUMAN Leukotriene A-4 hydrolase OS=Homo sapiens OX=9606 GN=LTA4H PE=1 SV=2 LKHA4_HUMAN reviewed Leukotriene A-4 hydrolase (LTA-4 hydrolase) (EC 3.3.2.6) (Leukotriene A(4) hydrolase) (Tripeptide aminopeptidase LTA4H) (EC 3.4.11.4) Homo sapiens (Human) GO:0003723; GO:0004177; GO:0004301; GO:0004463; GO:0005576; GO:0005634; GO:0005654; GO:0005829; GO:0006508; GO:0006629; GO:0008233; GO:0008270; GO:0010043; GO:0019370; GO:0043171; GO:0043434; GO:0045148; GO:0060509; GO:0070006; GO:0070062; GO:1904724; GO:1904813 leukotriene biosynthetic process [GO:0019370]; lipid metabolic process [GO:0006629]; peptide catabolic process [GO:0043171]; proteolysis [GO:0006508]; response to peptide hormone [GO:0043434]; response to zinc ion [GO:0010043]; type I pneumocyte differentiation [GO:0060509] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; tertiary granule lumen [GO:1904724] aminopeptidase activity [GO:0004177]; epoxide hydrolase activity [GO:0004301]; leukotriene-A4 hydrolase activity [GO:0004463]; metalloaminopeptidase activity [GO:0070006]; peptidase activity [GO:0008233]; RNA binding [GO:0003723]; tripeptide aminopeptidase activity [GO:0045148]; zinc ion binding [GO:0008270] g20607.t1 Q9H816 50.584 257 4.89e-88 274.0 sp|Q9H816|DCR1B_HUMAN 5' exonuclease Apollo OS=Homo sapiens OX=9606 GN=DCLRE1B PE=1 SV=1 g20610.t1 A7Z063 59.075 281 1.18e-106 328.0 sp|A7Z063|WASH1_BOVIN WASH complex subunit 1 OS=Bos taurus OX=9913 GN=WASHC1 PE=1 SV=1 WASH1_BOVIN reviewed WASH complex subunit 1 (WAS protein family homolog 1) Bos taurus (Bovine) GO:0003779; GO:0005769; GO:0005770; GO:0005776; GO:0005814; GO:0005829; GO:0006887; GO:0015031; GO:0016197; GO:0031901; GO:0032456; GO:0034314; GO:0042147; GO:0043014; GO:0043015; GO:0055037; GO:0055038; GO:0071203 Arp2/3 complex-mediated actin nucleation [GO:0034314]; endocytic recycling [GO:0032456]; endosomal transport [GO:0016197]; exocytosis [GO:0006887]; protein transport [GO:0015031]; retrograde transport, endosome to Golgi [GO:0042147] autophagosome [GO:0005776]; centriole [GO:0005814]; cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; late endosome [GO:0005770]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; WASH complex [GO:0071203] actin binding [GO:0003779]; alpha-tubulin binding [GO:0043014]; gamma-tubulin binding [GO:0043015] g20611.t1 Q8N0U4 27.095 358 3.6000000000000003e-29 120.0 sp|Q8N0U4|F185A_HUMAN Protein FAM185A OS=Homo sapiens OX=9606 GN=FAM185A PE=1 SV=3 g20612.t1 Q640L2 50.518 483 1.56e-150 442.0 sp|Q640L2|SPX3_XENLA Sugar phosphate exchanger 3 OS=Xenopus laevis OX=8355 GN=slc37a3 PE=2 SV=1 g20613.t1 Q6DEZ2 42.891 844 0.0 662.0 sp|Q6DEZ2|F120A_XENTR Constitutive coactivator of PPAR-gamma-like protein 1 homolog OS=Xenopus tropicalis OX=8364 GN=fam120a PE=2 SV=1 g20619.t1 E7F7V7 28.71 310 2.7200000000000002e-21 96.3 sp|E7F7V7|GAL2B_DANRE Galanin receptor 2b OS=Danio rerio OX=7955 GN=galr2b PE=2 SV=1 g20641.t1 Q9UDR5 59.236 157 9.51e-51 178.0 sp|Q9UDR5|AASS_HUMAN Alpha-aminoadipic semialdehyde synthase, mitochondrial OS=Homo sapiens OX=9606 GN=AASS PE=1 SV=1 AASS_HUMAN reviewed Alpha-aminoadipic semialdehyde synthase, mitochondrial (LKR/SDH) [Includes: Lysine ketoglutarate reductase (LKR) (LOR) (EC 1.5.1.8); Saccharopine dehydrogenase (SDH) (EC 1.5.1.9)] Homo sapiens (Human) GO:0000122; GO:0003714; GO:0004753; GO:0004754; GO:0005634; GO:0005737; GO:0005739; GO:0005759; GO:0005829; GO:0006554; GO:0019878; GO:0033512; GO:0042393; GO:0047130; GO:0047131 L-lysine catabolic process to acetyl-CoA via saccharopine [GO:0033512]; lysine biosynthetic process via aminoadipic acid [GO:0019878]; lysine catabolic process [GO:0006554]; negative regulation of transcription by RNA polymerase II [GO:0000122] cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleus [GO:0005634] histone binding [GO:0042393]; saccharopine dehydrogenase (NAD+, L-glutamate-forming) activity [GO:0047131]; saccharopine dehydrogenase (NAD+, L-lysine-forming) activity [GO:0004754]; saccharopine dehydrogenase (NADP+, L-lysine-forming) activity [GO:0047130]; saccharopine dehydrogenase activity [GO:0004753]; transcription corepressor activity [GO:0003714] g20657.t1 A2VCW9 57.143 245 3.7e-86 278.0 sp|A2VCW9|AASS_RAT Alpha-aminoadipic semialdehyde synthase, mitochondrial OS=Rattus norvegicus OX=10116 GN=Aass PE=2 SV=1 AASS_RAT reviewed Alpha-aminoadipic semialdehyde synthase, mitochondrial (LKR/SDH) [Includes: Lysine ketoglutarate reductase (LKR) (LOR) (EC 1.5.1.8); Saccharopine dehydrogenase (SDH) (EC 1.5.1.9)] Rattus norvegicus (Rat) GO:0004753; GO:0005737; GO:0005739; GO:0006554; GO:0019477; GO:0019878; GO:0033512; GO:0047130; GO:0047131 L-lysine catabolic process [GO:0019477]; L-lysine catabolic process to acetyl-CoA via saccharopine [GO:0033512]; lysine biosynthetic process via aminoadipic acid [GO:0019878]; lysine catabolic process [GO:0006554] cytoplasm [GO:0005737]; mitochondrion [GO:0005739] saccharopine dehydrogenase (NAD+, L-glutamate-forming) activity [GO:0047131]; saccharopine dehydrogenase (NADP+, L-lysine-forming) activity [GO:0047130]; saccharopine dehydrogenase activity [GO:0004753] g20657.t2 A2VCW9 54.902 255 1.92e-85 276.0 sp|A2VCW9|AASS_RAT Alpha-aminoadipic semialdehyde synthase, mitochondrial OS=Rattus norvegicus OX=10116 GN=Aass PE=2 SV=1 AASS_RAT reviewed Alpha-aminoadipic semialdehyde synthase, mitochondrial (LKR/SDH) [Includes: Lysine ketoglutarate reductase (LKR) (LOR) (EC 1.5.1.8); Saccharopine dehydrogenase (SDH) (EC 1.5.1.9)] Rattus norvegicus (Rat) GO:0004753; GO:0005737; GO:0005739; GO:0006554; GO:0019477; GO:0019878; GO:0033512; GO:0047130; GO:0047131 L-lysine catabolic process [GO:0019477]; L-lysine catabolic process to acetyl-CoA via saccharopine [GO:0033512]; lysine biosynthetic process via aminoadipic acid [GO:0019878]; lysine catabolic process [GO:0006554] cytoplasm [GO:0005737]; mitochondrion [GO:0005739] saccharopine dehydrogenase (NAD+, L-glutamate-forming) activity [GO:0047131]; saccharopine dehydrogenase (NADP+, L-lysine-forming) activity [GO:0047130]; saccharopine dehydrogenase activity [GO:0004753] g20664.t1 A8E657 50.615 895 0.0 907.0 sp|A8E657|AASS_BOVIN Alpha-aminoadipic semialdehyde synthase, mitochondrial OS=Bos taurus OX=9913 GN=AASS PE=2 SV=1 AASS_BOVIN reviewed Alpha-aminoadipic semialdehyde synthase, mitochondrial (LKR/SDH) [Includes: Lysine ketoglutarate reductase (LKR) (LOR) (EC 1.5.1.8); Saccharopine dehydrogenase (SDH) (EC 1.5.1.9)] Bos taurus (Bovine) GO:0004753; GO:0005737; GO:0005739; GO:0006554; GO:0019878; GO:0033512; GO:0047130; GO:0047131 L-lysine catabolic process to acetyl-CoA via saccharopine [GO:0033512]; lysine biosynthetic process via aminoadipic acid [GO:0019878]; lysine catabolic process [GO:0006554] cytoplasm [GO:0005737]; mitochondrion [GO:0005739] saccharopine dehydrogenase (NAD+, L-glutamate-forming) activity [GO:0047131]; saccharopine dehydrogenase (NADP+, L-lysine-forming) activity [GO:0047130]; saccharopine dehydrogenase activity [GO:0004753] g20664.t2 A8E657 50.847 885 0.0 907.0 sp|A8E657|AASS_BOVIN Alpha-aminoadipic semialdehyde synthase, mitochondrial OS=Bos taurus OX=9913 GN=AASS PE=2 SV=1 AASS_BOVIN reviewed Alpha-aminoadipic semialdehyde synthase, mitochondrial (LKR/SDH) [Includes: Lysine ketoglutarate reductase (LKR) (LOR) (EC 1.5.1.8); Saccharopine dehydrogenase (SDH) (EC 1.5.1.9)] Bos taurus (Bovine) GO:0004753; GO:0005737; GO:0005739; GO:0006554; GO:0019878; GO:0033512; GO:0047130; GO:0047131 L-lysine catabolic process to acetyl-CoA via saccharopine [GO:0033512]; lysine biosynthetic process via aminoadipic acid [GO:0019878]; lysine catabolic process [GO:0006554] cytoplasm [GO:0005737]; mitochondrion [GO:0005739] saccharopine dehydrogenase (NAD+, L-glutamate-forming) activity [GO:0047131]; saccharopine dehydrogenase (NADP+, L-lysine-forming) activity [GO:0047130]; saccharopine dehydrogenase activity [GO:0004753] g20665.t1 Q8K339 57.778 405 2.64e-142 413.0 sp|Q8K339|KIN17_MOUSE DNA/RNA-binding protein KIN17 OS=Mus musculus OX=10090 GN=Kin PE=1 SV=1 KIN17_MOUSE reviewed DNA/RNA-binding protein KIN17 (Binding to curved DNA) (KIN, antigenic determinant of recA protein) Mus musculus (Mouse) GO:0003690; GO:0003723; GO:0005634; GO:0005654; GO:0005829; GO:0006260; GO:0006281; GO:0006310; GO:0006397; GO:0006974; GO:0008270; GO:0016363; GO:0032991 DNA damage response [GO:0006974]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; mRNA processing [GO:0006397] cytosol [GO:0005829]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991] double-stranded DNA binding [GO:0003690]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270] g20674.t1 P02469 40.164 1830 0.0 1321.0 sp|P02469|LAMB1_MOUSE Laminin subunit beta-1 OS=Mus musculus OX=10090 GN=Lamb1 PE=1 SV=3 LAMB1_MOUSE reviewed Laminin subunit beta-1 (Laminin B1 chain) (Laminin-1 subunit beta) (Laminin-10 subunit beta) (Laminin-12 subunit beta) (Laminin-2 subunit beta) (Laminin-6 subunit beta) (Laminin-8 subunit beta) Mus musculus (Mouse) GO:0005178; GO:0005201; GO:0005576; GO:0005604; GO:0005606; GO:0005607; GO:0005615; GO:0005634; GO:0007162; GO:0007411; GO:0007566; GO:0007611; GO:0009887; GO:0009888; GO:0016477; GO:0019899; GO:0021812; GO:0030335; GO:0031012; GO:0031175; GO:0034446; GO:0035987; GO:0042476; GO:0043208; GO:0043256; GO:0043257; GO:0043259; GO:0045785; GO:0048018; GO:0048471; GO:0051149; GO:0070831; GO:0098637; GO:0110011; GO:1904395; GO:2001046 animal organ morphogenesis [GO:0009887]; axon guidance [GO:0007411]; basement membrane assembly [GO:0070831]; cell migration [GO:0016477]; embryo implantation [GO:0007566]; endodermal cell differentiation [GO:0035987]; learning or memory [GO:0007611]; negative regulation of cell adhesion [GO:0007162]; neuron projection development [GO:0031175]; neuronal-glial interaction involved in cerebral cortex radial glia guided migration [GO:0021812]; odontogenesis [GO:0042476]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cell migration [GO:0030335]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of muscle cell differentiation [GO:0051149]; positive regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904395]; regulation of basement membrane organization [GO:0110011]; substrate adhesion-dependent cell spreading [GO:0034446]; tissue development [GO:0009888] basement membrane [GO:0005604]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; laminin complex [GO:0043256]; laminin-1 complex [GO:0005606]; laminin-10 complex [GO:0043259]; laminin-2 complex [GO:0005607]; laminin-8 complex [GO:0043257]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein complex involved in cell-matrix adhesion [GO:0098637] enzyme binding [GO:0019899]; extracellular matrix structural constituent [GO:0005201]; glycosphingolipid binding [GO:0043208]; integrin binding [GO:0005178]; receptor ligand activity [GO:0048018] g20676.t1 Q8BH65 61.982 555 0.0 695.0 sp|Q8BH65|DEN6A_MOUSE Protein DENND6A OS=Mus musculus OX=10090 GN=Dennd6a PE=1 SV=1 g20677.t1 Q5XGY1 47.572 803 0.0 664.0 sp|Q5XGY1|TSR1_XENLA Pre-rRNA-processing protein TSR1 homolog OS=Xenopus laevis OX=8355 GN=tsr1 PE=2 SV=1 g20679.t1 P13676 48.333 720 0.0 629.0 sp|P13676|ACPH_RAT Acylamino-acid-releasing enzyme OS=Rattus norvegicus OX=10116 GN=Apeh PE=1 SV=1 ACPH_RAT reviewed Acylamino-acid-releasing enzyme (AARE) (EC 3.4.19.1) (Acyl-peptide hydrolase) (APH) (Acylaminoacyl-peptidase) (fMet aminopeptidase) (fMAP) Rattus norvegicus (Rat) GO:0004252; GO:0005829; GO:0006508; GO:0008242; GO:0031965; GO:0042802; GO:0050435 amyloid-beta metabolic process [GO:0050435]; proteolysis [GO:0006508] cytosol [GO:0005829]; nuclear membrane [GO:0031965] identical protein binding [GO:0042802]; omega peptidase activity [GO:0008242]; serine-type endopeptidase activity [GO:0004252] g20680.t1 A2A3K4 62.5 272 5.56e-120 382.0 sp|A2A3K4|PTPC1_HUMAN Protein tyrosine phosphatase domain-containing protein 1 OS=Homo sapiens OX=9606 GN=PTPDC1 PE=1 SV=1 g20681.t1 Q6P2S7 34.728 717 5.04e-108 377.0 sp|Q6P2S7|TTC41_HUMAN Putative tetratricopeptide repeat protein 41 OS=Homo sapiens OX=9606 GN=TTC41P PE=5 SV=3 g20681.t2 Q6P2S7 34.728 717 5.04e-108 377.0 sp|Q6P2S7|TTC41_HUMAN Putative tetratricopeptide repeat protein 41 OS=Homo sapiens OX=9606 GN=TTC41P PE=5 SV=3 g20681.t3 Q6P2S7 34.728 717 1.01e-107 377.0 sp|Q6P2S7|TTC41_HUMAN Putative tetratricopeptide repeat protein 41 OS=Homo sapiens OX=9606 GN=TTC41P PE=5 SV=3 g20682.t1 Q2T9W2 42.004 469 9.52e-107 332.0 sp|Q2T9W2|THUM3_BOVIN tRNA (guanine(6)-N(2))-methyltransferase THUMP3 OS=Bos taurus OX=9913 GN=THUMPD3 PE=2 SV=1 g20686.t1 Q5S007 39.172 1450 0.0 923.0 sp|Q5S007|LRRK2_HUMAN Leucine-rich repeat serine/threonine-protein kinase 2 OS=Homo sapiens OX=9606 GN=LRRK2 PE=1 SV=2 LRRK2_HUMAN reviewed Leucine-rich repeat serine/threonine-protein kinase 2 (EC 2.7.11.1) (EC 3.6.5.-) (Dardarin) Homo sapiens (Human) GO:0000139; GO:0000149; GO:0000165; GO:0000287; GO:0003779; GO:0003924; GO:0004672; GO:0004674; GO:0004706; GO:0004709; GO:0005096; GO:0005524; GO:0005525; GO:0005615; GO:0005654; GO:0005737; GO:0005739; GO:0005741; GO:0005743; GO:0005759; GO:0005764; GO:0005768; GO:0005783; GO:0005789; GO:0005794; GO:0005798; GO:0005802; GO:0005829; GO:0005886; GO:0005902; GO:0006468; GO:0006606; GO:0006897; GO:0006914; GO:0006979; GO:0007005; GO:0007029; GO:0007030; GO:0007040; GO:0007254; GO:0007266; GO:0007283; GO:0007528; GO:0008017; GO:0008104; GO:0008340; GO:0009267; GO:0010506; GO:0010508; GO:0010955; GO:0010977; GO:0014041; GO:0015631; GO:0016242; GO:0016301; GO:0017075; GO:0019722; GO:0021756; GO:0021772; GO:0022028; GO:0030159; GO:0030276; GO:0030424; GO:0030425; GO:0030426; GO:0030672; GO:0031267; GO:0031344; GO:0031398; GO:0031410; GO:0031647; GO:0031965; GO:0031966; GO:0032436; GO:0032473; GO:0032760; GO:0032839; GO:0034211; GO:0034260; GO:0034599; GO:0034614; GO:0035542; GO:0035556; GO:0035564; GO:0035640; GO:0035641; GO:0035751; GO:0036064; GO:0036479; GO:0039706; GO:0040012; GO:0042391; GO:0042802; GO:0042803; GO:0043005; GO:0043025; GO:0043068; GO:0043195; GO:0043204; GO:0043410; GO:0044325; GO:0044753; GO:0044754; GO:0045335; GO:0045746; GO:0046039; GO:0046777; GO:0048312; GO:0048812; GO:0051018; GO:0051646; GO:0051900; GO:0051966; GO:0060070; GO:0060079; GO:0060159; GO:0060161; GO:0060628; GO:0060828; GO:0061001; GO:0070062; GO:0070585; GO:0070971; GO:0070973; GO:0071287; GO:0090140; GO:0090263; GO:0090394; GO:0097413; GO:0097487; GO:0098794; GO:0098978; GO:0099400; GO:0099523; GO:0106310; GO:0140058; GO:0141161; GO:1900242; GO:1900244; GO:1901030; GO:1902236; GO:1902499; GO:1902692; GO:1902803; GO:1902823; GO:1902902; GO:1903215; GO:1903217; GO:1903351; GO:1903980; GO:1904644; GO:1904713; GO:1904887; GO:1905279; GO:1905289; GO:1905504; GO:1990904; GO:1990909; GO:2000172; GO:2000300; GO:2000377 autophagy [GO:0006914]; calcium-mediated signaling [GO:0019722]; canonical Wnt signaling pathway [GO:0060070]; cellular response to curcumin [GO:1904644]; cellular response to dopamine [GO:1903351]; cellular response to manganese ion [GO:0071287]; cellular response to oxidative stress [GO:0034599]; cellular response to reactive oxygen species [GO:0034614]; cellular response to starvation [GO:0009267]; determination of adult lifespan [GO:0008340]; endocytosis [GO:0006897]; endoplasmic reticulum organization [GO:0007029]; excitatory postsynaptic potential [GO:0060079]; exploration behavior [GO:0035640]; Golgi organization [GO:0007030]; GTP metabolic process [GO:0046039]; intracellular distribution of mitochondria [GO:0048312]; intracellular protein localization [GO:0008104]; intracellular signal transduction [GO:0035556]; JNK cascade [GO:0007254]; locomotory exploration behavior [GO:0035641]; lysosome organization [GO:0007040]; MAPK cascade [GO:0000165]; mitochondrion localization [GO:0051646]; mitochondrion organization [GO:0007005]; negative regulation of autophagosome assembly [GO:1902902]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]; negative regulation of excitatory postsynaptic potential [GO:0090394]; negative regulation of GTPase activity [GO:0034260]; negative regulation of late endosome to lysosome transport [GO:1902823]; negative regulation of macroautophagy [GO:0016242]; negative regulation of motile cilium assembly [GO:1905504]; negative regulation of neuron projection development [GO:0010977]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of protein processing [GO:0010955]; negative regulation of protein processing involved in protein targeting to mitochondrion [GO:1903217]; negative regulation of protein targeting to mitochondrion [GO:1903215]; neuromuscular junction development [GO:0007528]; neuron projection arborization [GO:0140058]; neuron projection morphogenesis [GO:0048812]; olfactory bulb development [GO:0021772]; positive regulation of autophagy [GO:0010508]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of dopamine receptor signaling pathway [GO:0060161]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of microglial cell activation [GO:1903980]; positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901030]; positive regulation of programmed cell death [GO:0043068]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein autoubiquitination [GO:1902499]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of synaptic vesicle endocytosis [GO:1900244]; positive regulation of tumor necrosis factor production [GO:0032760]; protein autophosphorylation [GO:0046777]; protein import into nucleus [GO:0006606]; protein localization to endoplasmic reticulum exit site [GO:0070973]; protein localization to mitochondrion [GO:0070585]; protein phosphorylation [GO:0006468]; regulation of autophagy [GO:0010506]; regulation of branching morphogenesis of a nerve [GO:2000172]; regulation of CAMKK-AMPK signaling cascade [GO:1905289]; regulation of cAMP/PKA signal transduction [GO:0141161]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of cell projection organization [GO:0031344]; regulation of dendritic spine morphogenesis [GO:0061001]; regulation of dopamine receptor signaling pathway [GO:0060159]; regulation of ER to Golgi vesicle-mediated transport [GO:0060628]; regulation of kidney size [GO:0035564]; regulation of locomotion [GO:0040012]; regulation of lysosomal lumen pH [GO:0035751]; regulation of membrane potential [GO:0042391]; regulation of mitochondrial depolarization [GO:0051900]; regulation of mitochondrial fission [GO:0090140]; regulation of neuroblast proliferation [GO:1902692]; regulation of neuron maturation [GO:0014041]; regulation of protein stability [GO:0031647]; regulation of reactive oxygen species metabolic process [GO:2000377]; regulation of retrograde transport, endosome to Golgi [GO:1905279]; regulation of SNARE complex assembly [GO:0035542]; regulation of synaptic transmission, glutamatergic [GO:0051966]; regulation of synaptic vesicle endocytosis [GO:1900242]; regulation of synaptic vesicle exocytosis [GO:2000300]; regulation of synaptic vesicle transport [GO:1902803]; response to oxidative stress [GO:0006979]; Rho protein signal transduction [GO:0007266]; spermatogenesis [GO:0007283]; striatum development [GO:0021756]; tangential migration from the subventricular zone to the olfactory bulb [GO:0022028]; Wnt signalosome assembly [GO:1904887] amphisome [GO:0044753]; autolysosome [GO:0044754]; axon [GO:0030424]; caveola neck [GO:0099400]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytoplasmic side of mitochondrial outer membrane [GO:0032473]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendrite cytoplasm [GO:0032839]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi-associated vesicle [GO:0005798]; growth cone [GO:0030426]; Lewy body [GO:0097413]; lysosome [GO:0005764]; microvillus [GO:0005902]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial membrane [GO:0031966]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; multivesicular body, internal vesicle [GO:0097487]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; perikaryon [GO:0043204]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; presynaptic cytosol [GO:0099523]; ribonucleoprotein complex [GO:1990904]; synaptic vesicle membrane [GO:0030672]; terminal bouton [GO:0043195]; trans-Golgi network [GO:0005802]; Wnt signalosome [GO:1990909] actin binding [GO:0003779]; ATP binding [GO:0005524]; beta-catenin destruction complex binding [GO:1904713]; clathrin binding [GO:0030276]; co-receptor binding [GO:0039706]; GTP binding [GO:0005525]; GTP-dependent protein kinase activity [GO:0034211]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; JUN kinase kinase kinase activity [GO:0004706]; kinase activity [GO:0016301]; magnesium ion binding [GO:0000287]; MAP kinase kinase kinase activity [GO:0004709]; microtubule binding [GO:0008017]; peroxidase inhibitor activity [GO:0036479]; protein homodimerization activity [GO:0042803]; protein kinase A binding [GO:0051018]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; signaling receptor complex adaptor activity [GO:0030159]; small GTPase binding [GO:0031267]; SNARE binding [GO:0000149]; syntaxin-1 binding [GO:0017075]; transmembrane transporter binding [GO:0044325]; tubulin binding [GO:0015631] g20686.t1 Q5S007 22.993 822 2.1299999999999997e-42 176.0 sp|Q5S007|LRRK2_HUMAN Leucine-rich repeat serine/threonine-protein kinase 2 OS=Homo sapiens OX=9606 GN=LRRK2 PE=1 SV=2 LRRK2_HUMAN reviewed Leucine-rich repeat serine/threonine-protein kinase 2 (EC 2.7.11.1) (EC 3.6.5.-) (Dardarin) Homo sapiens (Human) GO:0000139; GO:0000149; GO:0000165; GO:0000287; GO:0003779; GO:0003924; GO:0004672; GO:0004674; GO:0004706; GO:0004709; GO:0005096; GO:0005524; GO:0005525; GO:0005615; GO:0005654; GO:0005737; GO:0005739; GO:0005741; GO:0005743; GO:0005759; GO:0005764; GO:0005768; GO:0005783; GO:0005789; GO:0005794; GO:0005798; GO:0005802; GO:0005829; GO:0005886; GO:0005902; GO:0006468; GO:0006606; GO:0006897; GO:0006914; GO:0006979; GO:0007005; GO:0007029; GO:0007030; GO:0007040; GO:0007254; GO:0007266; GO:0007283; GO:0007528; GO:0008017; GO:0008104; GO:0008340; GO:0009267; GO:0010506; GO:0010508; GO:0010955; GO:0010977; GO:0014041; GO:0015631; GO:0016242; GO:0016301; GO:0017075; GO:0019722; GO:0021756; GO:0021772; GO:0022028; GO:0030159; GO:0030276; GO:0030424; GO:0030425; GO:0030426; GO:0030672; GO:0031267; GO:0031344; GO:0031398; GO:0031410; GO:0031647; GO:0031965; GO:0031966; GO:0032436; GO:0032473; GO:0032760; GO:0032839; GO:0034211; GO:0034260; GO:0034599; GO:0034614; GO:0035542; GO:0035556; GO:0035564; GO:0035640; GO:0035641; GO:0035751; GO:0036064; GO:0036479; GO:0039706; GO:0040012; GO:0042391; GO:0042802; GO:0042803; GO:0043005; GO:0043025; GO:0043068; GO:0043195; GO:0043204; GO:0043410; GO:0044325; GO:0044753; GO:0044754; GO:0045335; GO:0045746; GO:0046039; GO:0046777; GO:0048312; GO:0048812; GO:0051018; GO:0051646; GO:0051900; GO:0051966; GO:0060070; GO:0060079; GO:0060159; GO:0060161; GO:0060628; GO:0060828; GO:0061001; GO:0070062; GO:0070585; GO:0070971; GO:0070973; GO:0071287; GO:0090140; GO:0090263; GO:0090394; GO:0097413; GO:0097487; GO:0098794; GO:0098978; GO:0099400; GO:0099523; GO:0106310; GO:0140058; GO:0141161; GO:1900242; GO:1900244; GO:1901030; GO:1902236; GO:1902499; GO:1902692; GO:1902803; GO:1902823; GO:1902902; GO:1903215; GO:1903217; GO:1903351; GO:1903980; GO:1904644; GO:1904713; GO:1904887; GO:1905279; GO:1905289; GO:1905504; GO:1990904; GO:1990909; GO:2000172; GO:2000300; GO:2000377 autophagy [GO:0006914]; calcium-mediated signaling [GO:0019722]; canonical Wnt signaling pathway [GO:0060070]; cellular response to curcumin [GO:1904644]; cellular response to dopamine [GO:1903351]; cellular response to manganese ion [GO:0071287]; cellular response to oxidative stress [GO:0034599]; cellular response to reactive oxygen species [GO:0034614]; cellular response to starvation [GO:0009267]; determination of adult lifespan [GO:0008340]; endocytosis [GO:0006897]; endoplasmic reticulum organization [GO:0007029]; excitatory postsynaptic potential [GO:0060079]; exploration behavior [GO:0035640]; Golgi organization [GO:0007030]; GTP metabolic process [GO:0046039]; intracellular distribution of mitochondria [GO:0048312]; intracellular protein localization [GO:0008104]; intracellular signal transduction [GO:0035556]; JNK cascade [GO:0007254]; locomotory exploration behavior [GO:0035641]; lysosome organization [GO:0007040]; MAPK cascade [GO:0000165]; mitochondrion localization [GO:0051646]; mitochondrion organization [GO:0007005]; negative regulation of autophagosome assembly [GO:1902902]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]; negative regulation of excitatory postsynaptic potential [GO:0090394]; negative regulation of GTPase activity [GO:0034260]; negative regulation of late endosome to lysosome transport [GO:1902823]; negative regulation of macroautophagy [GO:0016242]; negative regulation of motile cilium assembly [GO:1905504]; negative regulation of neuron projection development [GO:0010977]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of protein processing [GO:0010955]; negative regulation of protein processing involved in protein targeting to mitochondrion [GO:1903217]; negative regulation of protein targeting to mitochondrion [GO:1903215]; neuromuscular junction development [GO:0007528]; neuron projection arborization [GO:0140058]; neuron projection morphogenesis [GO:0048812]; olfactory bulb development [GO:0021772]; positive regulation of autophagy [GO:0010508]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of dopamine receptor signaling pathway [GO:0060161]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of microglial cell activation [GO:1903980]; positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901030]; positive regulation of programmed cell death [GO:0043068]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein autoubiquitination [GO:1902499]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of synaptic vesicle endocytosis [GO:1900244]; positive regulation of tumor necrosis factor production [GO:0032760]; protein autophosphorylation [GO:0046777]; protein import into nucleus [GO:0006606]; protein localization to endoplasmic reticulum exit site [GO:0070973]; protein localization to mitochondrion [GO:0070585]; protein phosphorylation [GO:0006468]; regulation of autophagy [GO:0010506]; regulation of branching morphogenesis of a nerve [GO:2000172]; regulation of CAMKK-AMPK signaling cascade [GO:1905289]; regulation of cAMP/PKA signal transduction [GO:0141161]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of cell projection organization [GO:0031344]; regulation of dendritic spine morphogenesis [GO:0061001]; regulation of dopamine receptor signaling pathway [GO:0060159]; regulation of ER to Golgi vesicle-mediated transport [GO:0060628]; regulation of kidney size [GO:0035564]; regulation of locomotion [GO:0040012]; regulation of lysosomal lumen pH [GO:0035751]; regulation of membrane potential [GO:0042391]; regulation of mitochondrial depolarization [GO:0051900]; regulation of mitochondrial fission [GO:0090140]; regulation of neuroblast proliferation [GO:1902692]; regulation of neuron maturation [GO:0014041]; regulation of protein stability [GO:0031647]; regulation of reactive oxygen species metabolic process [GO:2000377]; regulation of retrograde transport, endosome to Golgi [GO:1905279]; regulation of SNARE complex assembly [GO:0035542]; regulation of synaptic transmission, glutamatergic [GO:0051966]; regulation of synaptic vesicle endocytosis [GO:1900242]; regulation of synaptic vesicle exocytosis [GO:2000300]; regulation of synaptic vesicle transport [GO:1902803]; response to oxidative stress [GO:0006979]; Rho protein signal transduction [GO:0007266]; spermatogenesis [GO:0007283]; striatum development [GO:0021756]; tangential migration from the subventricular zone to the olfactory bulb [GO:0022028]; Wnt signalosome assembly [GO:1904887] amphisome [GO:0044753]; autolysosome [GO:0044754]; axon [GO:0030424]; caveola neck [GO:0099400]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytoplasmic side of mitochondrial outer membrane [GO:0032473]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendrite cytoplasm [GO:0032839]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi-associated vesicle [GO:0005798]; growth cone [GO:0030426]; Lewy body [GO:0097413]; lysosome [GO:0005764]; microvillus [GO:0005902]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial membrane [GO:0031966]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; multivesicular body, internal vesicle [GO:0097487]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; perikaryon [GO:0043204]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; presynaptic cytosol [GO:0099523]; ribonucleoprotein complex [GO:1990904]; synaptic vesicle membrane [GO:0030672]; terminal bouton [GO:0043195]; trans-Golgi network [GO:0005802]; Wnt signalosome [GO:1990909] actin binding [GO:0003779]; ATP binding [GO:0005524]; beta-catenin destruction complex binding [GO:1904713]; clathrin binding [GO:0030276]; co-receptor binding [GO:0039706]; GTP binding [GO:0005525]; GTP-dependent protein kinase activity [GO:0034211]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; JUN kinase kinase kinase activity [GO:0004706]; kinase activity [GO:0016301]; magnesium ion binding [GO:0000287]; MAP kinase kinase kinase activity [GO:0004709]; microtubule binding [GO:0008017]; peroxidase inhibitor activity [GO:0036479]; protein homodimerization activity [GO:0042803]; protein kinase A binding [GO:0051018]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; signaling receptor complex adaptor activity [GO:0030159]; small GTPase binding [GO:0031267]; SNARE binding [GO:0000149]; syntaxin-1 binding [GO:0017075]; transmembrane transporter binding [GO:0044325]; tubulin binding [GO:0015631] g20687.t1 Q9UPS8 27.365 592 4.78e-46 187.0 sp|Q9UPS8|ANR26_HUMAN Ankyrin repeat domain-containing protein 26 OS=Homo sapiens OX=9606 GN=ANKRD26 PE=1 SV=4 ANR26_HUMAN reviewed Ankyrin repeat domain-containing protein 26 Homo sapiens (Human) GO:0005813; GO:0045599 negative regulation of fat cell differentiation [GO:0045599] centrosome [GO:0005813] g20687.t1 Q9UPS8 46.667 165 1.87e-34 149.0 sp|Q9UPS8|ANR26_HUMAN Ankyrin repeat domain-containing protein 26 OS=Homo sapiens OX=9606 GN=ANKRD26 PE=1 SV=4 ANR26_HUMAN reviewed Ankyrin repeat domain-containing protein 26 Homo sapiens (Human) GO:0005813; GO:0045599 negative regulation of fat cell differentiation [GO:0045599] centrosome [GO:0005813] g20688.t1 Q32LH4 43.182 132 5.47e-33 121.0 sp|Q32LH4|NIT1_BOVIN Deaminated glutathione amidase OS=Bos taurus OX=9913 GN=NIT1 PE=2 SV=1 g20689.t1 Q32LH4 65.854 123 3.59e-53 172.0 sp|Q32LH4|NIT1_BOVIN Deaminated glutathione amidase OS=Bos taurus OX=9913 GN=NIT1 PE=2 SV=1 g20693.t1 Q921A2 48.415 347 2.22e-78 255.0 sp|Q921A2|MYCT_RAT Proton myo-inositol cotransporter OS=Rattus norvegicus OX=10116 GN=Slc2a13 PE=1 SV=2 MYCT_RAT reviewed Proton myo-inositol cotransporter (H(+)-myo-inositol cotransporter) (Hmit) (H(+)-myo-inositol symporter) (Solute carrier family 2 member 13) Rattus norvegicus (Rat) GO:0002020; GO:0005365; GO:0005366; GO:0005737; GO:0005794; GO:0005886; GO:0015798; GO:0016020; GO:0016324; GO:0030426; GO:0031090; GO:0042995; GO:0044297; GO:0051117; GO:0055085; GO:0071944; GO:0097450; GO:1902004 myo-inositol transport [GO:0015798]; positive regulation of amyloid-beta formation [GO:1902004]; transmembrane transport [GO:0055085] apical plasma membrane [GO:0016324]; astrocyte end-foot [GO:0097450]; cell body [GO:0044297]; cell periphery [GO:0071944]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; growth cone [GO:0030426]; membrane [GO:0016020]; organelle membrane [GO:0031090]; plasma membrane [GO:0005886] ATPase binding [GO:0051117]; myo-inositol transmembrane transporter activity [GO:0005365]; myo-inositol:proton symporter activity [GO:0005366]; protease binding [GO:0002020] g20696.t1 Q17LW0 49.8 500 9.37e-147 471.0 sp|Q17LW0|MYO7A_AEDAE Myosin-VIIa OS=Aedes aegypti OX=7159 GN=ck PE=3 SV=1 MYO7A_AEDAE reviewed Myosin-VIIa (Protein crinkled) Aedes aegypti (Yellowfever mosquito) (Culex aegypti) GO:0000146; GO:0003779; GO:0005524; GO:0005737; GO:0005902; GO:0007605; GO:0008407; GO:0016461; GO:0030048; GO:0032027; GO:0035317; GO:0045177; GO:0048800; GO:0071944 actin filament-based movement [GO:0030048]; antennal morphogenesis [GO:0048800]; chaeta morphogenesis [GO:0008407]; imaginal disc-derived wing hair organization [GO:0035317]; sensory perception of sound [GO:0007605] apical part of cell [GO:0045177]; cell periphery [GO:0071944]; cytoplasm [GO:0005737]; microvillus [GO:0005902]; unconventional myosin complex [GO:0016461] actin binding [GO:0003779]; ATP binding [GO:0005524]; microfilament motor activity [GO:0000146]; myosin light chain binding [GO:0032027] g20696.t1 Q17LW0 27.96 397 1.74e-26 119.0 sp|Q17LW0|MYO7A_AEDAE Myosin-VIIa OS=Aedes aegypti OX=7159 GN=ck PE=3 SV=1 MYO7A_AEDAE reviewed Myosin-VIIa (Protein crinkled) Aedes aegypti (Yellowfever mosquito) (Culex aegypti) GO:0000146; GO:0003779; GO:0005524; GO:0005737; GO:0005902; GO:0007605; GO:0008407; GO:0016461; GO:0030048; GO:0032027; GO:0035317; GO:0045177; GO:0048800; GO:0071944 actin filament-based movement [GO:0030048]; antennal morphogenesis [GO:0048800]; chaeta morphogenesis [GO:0008407]; imaginal disc-derived wing hair organization [GO:0035317]; sensory perception of sound [GO:0007605] apical part of cell [GO:0045177]; cell periphery [GO:0071944]; cytoplasm [GO:0005737]; microvillus [GO:0005902]; unconventional myosin complex [GO:0016461] actin binding [GO:0003779]; ATP binding [GO:0005524]; microfilament motor activity [GO:0000146]; myosin light chain binding [GO:0032027] g20696.t2 Q17LW0 50.0 498 1.7999999999999998e-147 473.0 sp|Q17LW0|MYO7A_AEDAE Myosin-VIIa OS=Aedes aegypti OX=7159 GN=ck PE=3 SV=1 MYO7A_AEDAE reviewed Myosin-VIIa (Protein crinkled) Aedes aegypti (Yellowfever mosquito) (Culex aegypti) GO:0000146; GO:0003779; GO:0005524; GO:0005737; GO:0005902; GO:0007605; GO:0008407; GO:0016461; GO:0030048; GO:0032027; GO:0035317; GO:0045177; GO:0048800; GO:0071944 actin filament-based movement [GO:0030048]; antennal morphogenesis [GO:0048800]; chaeta morphogenesis [GO:0008407]; imaginal disc-derived wing hair organization [GO:0035317]; sensory perception of sound [GO:0007605] apical part of cell [GO:0045177]; cell periphery [GO:0071944]; cytoplasm [GO:0005737]; microvillus [GO:0005902]; unconventional myosin complex [GO:0016461] actin binding [GO:0003779]; ATP binding [GO:0005524]; microfilament motor activity [GO:0000146]; myosin light chain binding [GO:0032027] g20696.t2 Q17LW0 27.342 395 6.4e-26 117.0 sp|Q17LW0|MYO7A_AEDAE Myosin-VIIa OS=Aedes aegypti OX=7159 GN=ck PE=3 SV=1 MYO7A_AEDAE reviewed Myosin-VIIa (Protein crinkled) Aedes aegypti (Yellowfever mosquito) (Culex aegypti) GO:0000146; GO:0003779; GO:0005524; GO:0005737; GO:0005902; GO:0007605; GO:0008407; GO:0016461; GO:0030048; GO:0032027; GO:0035317; GO:0045177; GO:0048800; GO:0071944 actin filament-based movement [GO:0030048]; antennal morphogenesis [GO:0048800]; chaeta morphogenesis [GO:0008407]; imaginal disc-derived wing hair organization [GO:0035317]; sensory perception of sound [GO:0007605] apical part of cell [GO:0045177]; cell periphery [GO:0071944]; cytoplasm [GO:0005737]; microvillus [GO:0005902]; unconventional myosin complex [GO:0016461] actin binding [GO:0003779]; ATP binding [GO:0005524]; microfilament motor activity [GO:0000146]; myosin light chain binding [GO:0032027] g20697.t1 Q9BH05 47.589 643 0.0 578.0 sp|Q9BH05|THNS1_MACFA Threonine synthase-like 1 OS=Macaca fascicularis OX=9541 GN=THNSL1 PE=2 SV=1 g20702.t1 Q5E980 35.714 448 3.3000000000000003e-99 308.0 sp|Q5E980|CP20A_BOVIN Cytochrome P450 20A1 OS=Bos taurus OX=9913 GN=CYP20A1 PE=2 SV=1 g20703.t1 O53532 33.728 338 3.1599999999999997e-46 171.0 sp|O53532|Y2258_MYCTU S-adenosylmethionine-dependent methyltransferase Rv2258c OS=Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv) OX=83332 GN=Rv2258c PE=1 SV=1 g20703.t1 O53532 29.859 355 2.3e-36 144.0 sp|O53532|Y2258_MYCTU S-adenosylmethionine-dependent methyltransferase Rv2258c OS=Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv) OX=83332 GN=Rv2258c PE=1 SV=1 g20704.t1 P0CH95 56.926 462 0.0 570.0 sp|P0CH95|PHF8_DANRE Histone lysine demethylase PHF8 OS=Danio rerio OX=7955 GN=phf8 PE=1 SV=1 PHF8_DANRE reviewed Histone lysine demethylase PHF8 (EC 1.14.11.-) (EC 1.14.11.65) (PHD finger protein 8) (zPHF8) ([histone H3]-dimethyl-L-lysine(9) demethylase PHF8) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000082; GO:0003682; GO:0003712; GO:0005730; GO:0006338; GO:0006357; GO:0007420; GO:0008270; GO:0032452; GO:0032454; GO:0035575; GO:0042472; GO:0043523; GO:0045893; GO:0045943; GO:0048703; GO:0048922; GO:0051864; GO:0060319; GO:0061188; GO:0071558; GO:0140002; GO:0140680; GO:0140683 brain development [GO:0007420]; chromatin remodeling [GO:0006338]; embryonic viscerocranium morphogenesis [GO:0048703]; G1/S transition of mitotic cell cycle [GO:0000082]; inner ear morphogenesis [GO:0042472]; negative regulation of rDNA heterochromatin formation [GO:0061188]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase I [GO:0045943]; posterior lateral line neuromast deposition [GO:0048922]; primitive erythrocyte differentiation [GO:0060319]; regulation of neuron apoptotic process [GO:0043523]; regulation of transcription by RNA polymerase II [GO:0006357] nucleolus [GO:0005730] chromatin binding [GO:0003682]; histone demethylase activity [GO:0032452]; histone H3K27me2/H3K27me3 demethylase activity [GO:0071558]; histone H3K36 demethylase activity [GO:0051864]; histone H3K36me/H3K36me2 demethylase activity [GO:0140680]; histone H3K4me3 reader activity [GO:0140002]; histone H3K9 demethylase activity [GO:0032454]; histone H3K9me/H3K9me2 demethylase activity [GO:0140683]; histone H4K20 demethylase activity [GO:0035575]; transcription coregulator activity [GO:0003712]; zinc ion binding [GO:0008270] g20704.t2 P0CH95 58.278 453 0.0 575.0 sp|P0CH95|PHF8_DANRE Histone lysine demethylase PHF8 OS=Danio rerio OX=7955 GN=phf8 PE=1 SV=1 PHF8_DANRE reviewed Histone lysine demethylase PHF8 (EC 1.14.11.-) (EC 1.14.11.65) (PHD finger protein 8) (zPHF8) ([histone H3]-dimethyl-L-lysine(9) demethylase PHF8) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000082; GO:0003682; GO:0003712; GO:0005730; GO:0006338; GO:0006357; GO:0007420; GO:0008270; GO:0032452; GO:0032454; GO:0035575; GO:0042472; GO:0043523; GO:0045893; GO:0045943; GO:0048703; GO:0048922; GO:0051864; GO:0060319; GO:0061188; GO:0071558; GO:0140002; GO:0140680; GO:0140683 brain development [GO:0007420]; chromatin remodeling [GO:0006338]; embryonic viscerocranium morphogenesis [GO:0048703]; G1/S transition of mitotic cell cycle [GO:0000082]; inner ear morphogenesis [GO:0042472]; negative regulation of rDNA heterochromatin formation [GO:0061188]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase I [GO:0045943]; posterior lateral line neuromast deposition [GO:0048922]; primitive erythrocyte differentiation [GO:0060319]; regulation of neuron apoptotic process [GO:0043523]; regulation of transcription by RNA polymerase II [GO:0006357] nucleolus [GO:0005730] chromatin binding [GO:0003682]; histone demethylase activity [GO:0032452]; histone H3K27me2/H3K27me3 demethylase activity [GO:0071558]; histone H3K36 demethylase activity [GO:0051864]; histone H3K36me/H3K36me2 demethylase activity [GO:0140680]; histone H3K4me3 reader activity [GO:0140002]; histone H3K9 demethylase activity [GO:0032454]; histone H3K9me/H3K9me2 demethylase activity [GO:0140683]; histone H4K20 demethylase activity [GO:0035575]; transcription coregulator activity [GO:0003712]; zinc ion binding [GO:0008270] g20705.t1 Q1LXK4 31.175 587 1.05e-74 259.0 sp|Q1LXK4|M10B1_DANRE Putative helicase mov-10-B.1 OS=Danio rerio OX=7955 GN=mov10b.1 PE=2 SV=2 g20706.t1 P23249 49.184 429 4.2699999999999997e-134 412.0 sp|P23249|MOV10_MOUSE Putative helicase MOV-10 OS=Mus musculus OX=10090 GN=Mov10 PE=1 SV=2 MOV10_MOUSE reviewed Putative helicase MOV-10 (EC 3.6.4.13) (Moloney leukemia virus 10 protein) Mus musculus (Mouse) GO:0000932; GO:0003723; GO:0005524; GO:0005634; GO:0005829; GO:0010494; GO:0010526; GO:0016887; GO:0032574; GO:0035194; GO:0035195; GO:0035279; GO:0036464; GO:0043186; GO:0051607; GO:0061014; GO:0061158; GO:0141008; GO:0150011 3'-UTR-mediated mRNA destabilization [GO:0061158]; defense response to virus [GO:0051607]; miRNA-mediated gene silencing by mRNA destabilization [GO:0035279]; miRNA-mediated post-transcriptional gene silencing [GO:0035195]; positive regulation of mRNA catabolic process [GO:0061014]; regulation of neuron projection arborization [GO:0150011]; regulatory ncRNA-mediated post-transcriptional gene silencing [GO:0035194]; transposable element silencing [GO:0010526]; transposable element silencing by mRNA destabilization [GO:0141008] cytoplasmic ribonucleoprotein granule [GO:0036464]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; nucleus [GO:0005634]; P granule [GO:0043186]; P-body [GO:0000932] 5'-3' RNA helicase activity [GO:0032574]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; RNA binding [GO:0003723] g20707.t1 Q91502 48.736 554 2.82e-161 481.0 sp|Q91502|SC6A8_TORMA Creatine transporter OS=Torpedo marmorata OX=7788 PE=2 SV=1 g20713.t1 B0JZG0 47.611 586 5.55e-174 512.0 sp|B0JZG0|S23A2_XENTR Solute carrier family 23 member 2 OS=Xenopus tropicalis OX=8364 GN=slc23a2 PE=2 SV=1 g20715.t1 B0JZG0 47.993 548 5.2300000000000004e-173 508.0 sp|B0JZG0|S23A2_XENTR Solute carrier family 23 member 2 OS=Xenopus tropicalis OX=8364 GN=slc23a2 PE=2 SV=1 g20718.t1 Q9HC24 53.556 239 1.35e-77 236.0 sp|Q9HC24|LFG4_HUMAN Protein lifeguard 4 OS=Homo sapiens OX=9606 GN=TMBIM4 PE=1 SV=3 LFG4_HUMAN reviewed Protein lifeguard 4 (Golgi anti-apoptotic protein) (Protein S1R) (Transmembrane BAX inhibitor motif-containing protein 4) (Z-protein) Homo sapiens (Human) GO:0000139; GO:0005262; GO:0005789; GO:0005795; GO:0006915; GO:0007626; GO:0016020; GO:0030968; GO:0043066; GO:0043524; GO:0050848 apoptotic process [GO:0006915]; endoplasmic reticulum unfolded protein response [GO:0030968]; locomotory behavior [GO:0007626]; negative regulation of apoptotic process [GO:0043066]; negative regulation of neuron apoptotic process [GO:0043524]; regulation of calcium-mediated signaling [GO:0050848] endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; membrane [GO:0016020] calcium channel activity [GO:0005262] g20719.t1 P21158 39.583 144 5.53e-23 95.1 sp|P21158|CSGA_MYXXA C-signal OS=Myxococcus xanthus OX=34 GN=csgA PE=1 SV=1 g20728.t1 Q63481 50.246 203 2.1499999999999998e-67 208.0 sp|Q63481|RAB7L_RAT Ras-related protein Rab-7L1 OS=Rattus norvegicus OX=10116 GN=Rab29 PE=1 SV=1 g20729.t1 A8WGF4 71.345 1190 0.0 1842.0 sp|A8WGF4|IF122_XENTR Intraflagellar transport protein 122 homolog OS=Xenopus tropicalis OX=8364 GN=ift122 PE=2 SV=1 g20730.t1 Q640R7 88.372 172 7.35e-98 284.0 sp|Q640R7|RAP1B_XENTR Ras-related protein Rap-1b OS=Xenopus tropicalis OX=8364 GN=rap1b PE=2 SV=1 g20731.t1 F1MNN4 36.795 443 6.49e-81 278.0 sp|F1MNN4|FBXW7_BOVIN F-box/WD repeat-containing protein 7 OS=Bos taurus OX=9913 GN=FBXW7 PE=1 SV=3 FBXW7_BOVIN reviewed F-box/WD repeat-containing protein 7 (F-box and WD-40 domain-containing protein 7) Bos taurus (Bovine) GO:0001944; GO:0005634; GO:0005654; GO:0005694; GO:0005737; GO:0006281; GO:0006974; GO:0007062; GO:0007346; GO:0010629; GO:0010992; GO:0019005; GO:0030332; GO:0031146; GO:0031398; GO:0031625; GO:0042752; GO:0042802; GO:0043130; GO:0043161; GO:0045944; GO:0050816; GO:0070534; GO:0097027; GO:1901524; GO:1901800; GO:1903378; GO:1903955; GO:1990452; GO:1990756; GO:2000059; GO:2000060; GO:2001205 DNA damage response [GO:0006974]; DNA repair [GO:0006281]; negative regulation of gene expression [GO:0010629]; negative regulation of osteoclast development [GO:2001205]; negative regulation of ubiquitin-dependent protein catabolic process [GO:2000059]; positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway [GO:1903378]; positive regulation of proteasomal protein catabolic process [GO:1901800]; positive regulation of protein targeting to mitochondrion [GO:1903955]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K63-linked ubiquitination [GO:0070534]; regulation of circadian rhythm [GO:0042752]; regulation of mitophagy [GO:1901524]; regulation of mitotic cell cycle [GO:0007346]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; sister chromatid cohesion [GO:0007062]; ubiquitin recycling [GO:0010992]; vasculature development [GO:0001944] chromosome [GO:0005694]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Parkin-FBXW7-Cul1 ubiquitin ligase complex [GO:1990452]; SCF ubiquitin ligase complex [GO:0019005] cyclin binding [GO:0030332]; identical protein binding [GO:0042802]; phosphothreonine residue binding [GO:0050816]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-like ligase-substrate adaptor activity [GO:1990756]; ubiquitin-protein transferase activator activity [GO:0097027] g20737.t1 Q9Y2M2 32.733 333 1.8699999999999998e-69 227.0 sp|Q9Y2M2|SSUH2_HUMAN Protein SSUH2 homolog OS=Homo sapiens OX=9606 GN=SSUH2 PE=1 SV=2 g20738.t1 Q3U2V3 35.254 295 4.17e-48 167.0 sp|Q3U2V3|NUD18_MOUSE 8-oxo-dGDP phosphatase NUDT18 OS=Mus musculus OX=10090 GN=Nudt18 PE=1 SV=1 NUD18_MOUSE reviewed 8-oxo-dGDP phosphatase NUDT18 (EC 3.6.1.58) (EC 3.6.1.68) (EC 3.6.1.76) (2-hydroxy-dADP phosphatase) (7,8-dihydro-8-oxoguanine phosphatase) (Nucleoside diphosphate-linked moiety X motif 18) (Nudix motif 18) Mus musculus (Mouse) GO:0044715; GO:0044716; GO:0044717; GO:0046057; GO:0046067; GO:0046712; GO:0046872; GO:0106405 dADP catabolic process [GO:0046057]; dGDP catabolic process [GO:0046067]; GDP catabolic process [GO:0046712] 8-hydroxy-dADP phosphatase activity [GO:0044717]; 8-oxo-dGDP phosphatase activity [GO:0044715]; 8-oxo-GDP phosphatase activity [GO:0044716]; isoprenoid diphosphate phosphatase activity [GO:0106405]; metal ion binding [GO:0046872] g20739.t1 Q09428 29.102 512 2.62e-56 206.0 sp|Q09428|ABCC8_HUMAN ATP-binding cassette sub-family C member 8 OS=Homo sapiens OX=9606 GN=ABCC8 PE=1 SV=6 ABCC8_HUMAN reviewed ATP-binding cassette sub-family C member 8 (Sulfonylurea receptor 1) Homo sapiens (Human) GO:0001508; GO:0001678; GO:0005267; GO:0005524; GO:0005886; GO:0006813; GO:0007565; GO:0007613; GO:0008281; GO:0008282; GO:0008542; GO:0009268; GO:0009410; GO:0010043; GO:0010989; GO:0015272; GO:0016525; GO:0016887; GO:0019829; GO:0030672; GO:0031004; GO:0031669; GO:0032496; GO:0032760; GO:0032868; GO:0035774; GO:0042383; GO:0042734; GO:0043268; GO:0043531; GO:0044325; GO:0046676; GO:0046872; GO:0050796; GO:0050905; GO:0055085; GO:0060253; GO:0061535; GO:0061855; GO:0071805; GO:0098662; GO:0140359; GO:1900721; GO:1905075; GO:1905604; GO:1990573 action potential [GO:0001508]; cellular response to nutrient levels [GO:0031669]; female pregnancy [GO:0007565]; glutamate secretion, neurotransmission [GO:0061535]; inorganic cation transmembrane transport [GO:0098662]; intracellular glucose homeostasis [GO:0001678]; memory [GO:0007613]; negative regulation of angiogenesis [GO:0016525]; negative regulation of blood-brain barrier permeability [GO:1905604]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of insulin secretion [GO:0046676]; negative regulation of low-density lipoprotein particle clearance [GO:0010989]; negative regulation of neuroblast migration [GO:0061855]; neuromuscular process [GO:0050905]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of potassium ion transport [GO:0043268]; positive regulation of tight junction disassembly [GO:1905075]; positive regulation of tumor necrosis factor production [GO:0032760]; positive regulation of uterine smooth muscle relaxation [GO:1900721]; potassium ion import across plasma membrane [GO:1990573]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; regulation of insulin secretion [GO:0050796]; response to insulin [GO:0032868]; response to lipopolysaccharide [GO:0032496]; response to pH [GO:0009268]; response to xenobiotic stimulus [GO:0009410]; response to zinc ion [GO:0010043]; transmembrane transport [GO:0055085]; visual learning [GO:0008542] inward rectifying potassium channel [GO:0008282]; plasma membrane [GO:0005886]; potassium ion-transporting ATPase complex [GO:0031004]; presynaptic membrane [GO:0042734]; sarcolemma [GO:0042383]; synaptic vesicle membrane [GO:0030672] ABC-type transporter activity [GO:0140359]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-activated inward rectifier potassium channel activity [GO:0015272]; ATPase-coupled monoatomic cation transmembrane transporter activity [GO:0019829]; metal ion binding [GO:0046872]; potassium channel activity [GO:0005267]; sulfonylurea receptor activity [GO:0008281]; transmembrane transporter binding [GO:0044325] g20740.t1 P70170 42.522 1023 0.0 717.0 sp|P70170|ABCC9_MOUSE ATP-binding cassette sub-family C member 9 OS=Mus musculus OX=10090 GN=Abcc9 PE=1 SV=2 g20741.t1 Q9Y291 60.377 106 4.41e-29 103.0 sp|Q9Y291|RT33_HUMAN Small ribosomal subunit protein mS33 OS=Homo sapiens OX=9606 GN=MRPS33 PE=1 SV=1 g20742.t1 Q6PHU5 37.29 775 4.01e-165 502.0 sp|Q6PHU5|SORT_MOUSE Sortilin OS=Mus musculus OX=10090 GN=Sort1 PE=1 SV=1 SORT_MOUSE reviewed Sortilin (Neurotensin receptor 3) (NTR3) (mNTR3) Mus musculus (Mouse) GO:0001503; GO:0005764; GO:0005765; GO:0005769; GO:0005789; GO:0005794; GO:0005829; GO:0005886; GO:0005905; GO:0006622; GO:0006895; GO:0006897; GO:0007186; GO:0007218; GO:0008333; GO:0008625; GO:0009986; GO:0010008; GO:0010465; GO:0010468; GO:0014902; GO:0016020; GO:0016050; GO:0019899; GO:0030136; GO:0030140; GO:0030379; GO:0030425; GO:0030659; GO:0031410; GO:0031965; GO:0032509; GO:0032580; GO:0032868; GO:0043025; GO:0045599; GO:0046323; GO:0048011; GO:0048227; GO:0048406; GO:0048471; GO:0090160; GO:0099558; GO:0150053; GO:1904037; GO:1905394 D-glucose import [GO:0046323]; endocytosis [GO:0006897]; endosome to lysosome transport [GO:0008333]; endosome transport via multivesicular body sorting pathway [GO:0032509]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; G protein-coupled receptor signaling pathway [GO:0007186]; Golgi to endosome transport [GO:0006895]; Golgi to lysosome transport [GO:0090160]; maintenance of synapse structure [GO:0099558]; myotube differentiation [GO:0014902]; negative regulation of fat cell differentiation [GO:0045599]; neuropeptide signaling pathway [GO:0007218]; neurotrophin TRK receptor signaling pathway [GO:0048011]; ossification [GO:0001503]; plasma membrane to endosome transport [GO:0048227]; positive regulation of epithelial cell apoptotic process [GO:1904037]; protein targeting to lysosome [GO:0006622]; regulation of gene expression [GO:0010468]; response to insulin [GO:0032868]; vesicle organization [GO:0016050] cell surface [GO:0009986]; cerebellar climbing fiber to Purkinje cell synapse [GO:0150053]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; cytoplasmic vesicle [GO:0031410]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; dendrite [GO:0030425]; early endosome [GO:0005769]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; nuclear membrane [GO:0031965]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; trans-Golgi network transport vesicle [GO:0030140] enzyme binding [GO:0019899]; nerve growth factor binding [GO:0048406]; nerve growth factor receptor activity [GO:0010465]; neurotensin receptor activity, non-G protein-coupled [GO:0030379]; retromer complex binding [GO:1905394] g20743.t1 G3V9D0 60.556 360 1e-167 479.0 sp|G3V9D0|PGLT1_RAT Protein O-glucosyltransferase 1 OS=Rattus norvegicus OX=10116 GN=Poglut1 PE=3 SV=1 PGLT1_RAT reviewed Protein O-glucosyltransferase 1 (EC 2.4.1.376) (O-glucosyltransferase Rumi homolog) (Protein O-xylosyltransferase) (EC 2.4.2.63) Rattus norvegicus (Rat) GO:0001756; GO:0005783; GO:0005788; GO:0006493; GO:0007369; GO:0008593; GO:0010470; GO:0012505; GO:0035251; GO:0035252; GO:0045747; GO:0046527; GO:0048318; GO:0048339; GO:0060537; GO:0072359; GO:0140561; GO:0140562; GO:0180059; GO:0180064 axial mesoderm development [GO:0048318]; circulatory system development [GO:0072359]; gastrulation [GO:0007369]; muscle tissue development [GO:0060537]; paraxial mesoderm development [GO:0048339]; positive regulation of Notch signaling pathway [GO:0045747]; protein O-linked glycosylation [GO:0006493]; protein O-linked glycosylation via glucose [GO:0180059]; protein O-linked glycosylation via xylose [GO:0180064]; regulation of gastrulation [GO:0010470]; regulation of Notch signaling pathway [GO:0008593]; somitogenesis [GO:0001756] endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788] EGF-domain serine glucosyltransferase activity [GO:0140561]; EGF-domain serine xylosyltransferase activity [GO:0140562]; glucosyltransferase activity [GO:0046527]; UDP-glucosyltransferase activity [GO:0035251]; UDP-xylosyltransferase activity [GO:0035252] g20747.t1 Q3MHX1 50.0 182 3.22e-53 171.0 sp|Q3MHX1|COMD7_BOVIN COMM domain-containing protein 7 OS=Bos taurus OX=9913 GN=COMMD7 PE=2 SV=1 g20748.t1 Q9GLY5 31.481 918 2.67e-122 397.0 sp|Q9GLY5|ITIH3_RABIT Inter-alpha-trypsin inhibitor heavy chain H3 OS=Oryctolagus cuniculus OX=9986 GN=ITIH3 PE=2 SV=1 g20749.t1 Q9GLY5 34.0 550 2.56e-93 322.0 sp|Q9GLY5|ITIH3_RABIT Inter-alpha-trypsin inhibitor heavy chain H3 OS=Oryctolagus cuniculus OX=9986 GN=ITIH3 PE=2 SV=1 g20749.t1 Q9GLY5 36.744 430 8.36e-71 258.0 sp|Q9GLY5|ITIH3_RABIT Inter-alpha-trypsin inhibitor heavy chain H3 OS=Oryctolagus cuniculus OX=9986 GN=ITIH3 PE=2 SV=1 g20749.t2 Q9GLY5 34.623 491 1.4699999999999998e-82 290.0 sp|Q9GLY5|ITIH3_RABIT Inter-alpha-trypsin inhibitor heavy chain H3 OS=Oryctolagus cuniculus OX=9986 GN=ITIH3 PE=2 SV=1 g20749.t2 Q9GLY5 36.744 430 4.1200000000000005e-71 258.0 sp|Q9GLY5|ITIH3_RABIT Inter-alpha-trypsin inhibitor heavy chain H3 OS=Oryctolagus cuniculus OX=9986 GN=ITIH3 PE=2 SV=1 g20751.t1 P97279 29.945 905 3.82e-107 370.0 sp|P97279|ITIH2_MESAU Inter-alpha-trypsin inhibitor heavy chain H2 OS=Mesocricetus auratus OX=10036 GN=ITIH2 PE=1 SV=1 g20751.t1 P97279 31.424 576 1.08e-80 292.0 sp|P97279|ITIH2_MESAU Inter-alpha-trypsin inhibitor heavy chain H2 OS=Mesocricetus auratus OX=10036 GN=ITIH2 PE=1 SV=1 g20751.t1 P97279 29.661 590 7.330000000000001e-79 286.0 sp|P97279|ITIH2_MESAU Inter-alpha-trypsin inhibitor heavy chain H2 OS=Mesocricetus auratus OX=10036 GN=ITIH2 PE=1 SV=1 g20755.t1 Q9DCM0 56.275 247 1.05e-97 292.0 sp|Q9DCM0|ETHE1_MOUSE Persulfide dioxygenase ETHE1, mitochondrial OS=Mus musculus OX=10090 GN=Ethe1 PE=1 SV=2 ETHE1_MOUSE reviewed Persulfide dioxygenase ETHE1, mitochondrial (EC 1.13.11.18) (Ethylmalonic encephalopathy protein 1 homolog) (Hepatoma subtracted clone one protein) (Sulfur dioxygenase ETHE1) Mus musculus (Mouse) GO:0005506; GO:0005654; GO:0005737; GO:0005739; GO:0005759; GO:0006749; GO:0042802; GO:0050313; GO:0070813 glutathione metabolic process [GO:0006749]; hydrogen sulfide metabolic process [GO:0070813] cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654] identical protein binding [GO:0042802]; iron ion binding [GO:0005506]; sulfur dioxygenase activity [GO:0050313] g20756.t1 Q5FVB0 35.279 394 1.9899999999999998e-62 214.0 sp|Q5FVB0|ATX10_XENTR Ataxin-10 OS=Xenopus tropicalis OX=8364 GN=atxn10 PE=2 SV=1 g20757.t1 Q3L254 64.327 342 1.32e-171 484.0 sp|Q3L254|WNT7B_CHICK Protein Wnt-7b OS=Gallus gallus OX=9031 GN=WNT7B PE=2 SV=1 g20762.t1 Q8IPH9 35.22 318 1.25e-44 167.0 sp|Q8IPH9|SLOB_DROME Slowpoke-binding protein OS=Drosophila melanogaster OX=7227 GN=Slob PE=1 SV=2 SLOB_DROME reviewed Slowpoke-binding protein Drosophila melanogaster (Fruit fly) GO:0004672; GO:0005737; GO:0007274; GO:0042391; GO:0042594; GO:0045202; GO:0050804 modulation of chemical synaptic transmission [GO:0050804]; neuromuscular synaptic transmission [GO:0007274]; regulation of membrane potential [GO:0042391]; response to starvation [GO:0042594] cytoplasm [GO:0005737]; synapse [GO:0045202] protein kinase activity [GO:0004672] g20764.t1 Q5R9S8 40.852 399 2.6100000000000002e-105 320.0 sp|Q5R9S8|TMM43_PONAB Transmembrane protein 43 OS=Pongo abelii OX=9601 GN=TMEM43 PE=2 SV=1 g20765.t1 P56581 62.911 213 6.41e-86 279.0 sp|P56581|TDG_MOUSE G/T mismatch-specific thymine DNA glycosylase OS=Mus musculus OX=10090 GN=Tdg PE=1 SV=2 TDG_MOUSE reviewed G/T mismatch-specific thymine DNA glycosylase (EC 3.2.2.29) (C-JUN leucine zipper interactive protein JZA-3) (Thymine-DNA glycosylase) Mus musculus (Mouse) GO:0000122; GO:0000287; GO:0003676; GO:0003677; GO:0003690; GO:0003712; GO:0004844; GO:0005080; GO:0005524; GO:0005634; GO:0005654; GO:0005886; GO:0006284; GO:0006285; GO:0008263; GO:0016605; GO:0019104; GO:0019904; GO:0030983; GO:0031402; GO:0031404; GO:0032183; GO:0040029; GO:0043739; GO:0045995; GO:0140297; GO:0141016 base-excision repair [GO:0006284]; base-excision repair, AP site formation [GO:0006285]; epigenetic regulation of gene expression [GO:0040029]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of embryonic development [GO:0045995] nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; PML body [GO:0016605] ATP binding [GO:0005524]; chloride ion binding [GO:0031404]; DNA binding [GO:0003677]; DNA N-glycosylase activity [GO:0019104]; DNA-binding transcription factor binding [GO:0140297]; double-stranded DNA binding [GO:0003690]; G/T mismatch-specific thymine-DNA glycosylase activity [GO:0141016]; G/U mismatch-specific uracil-DNA glycosylase activity [GO:0043739]; magnesium ion binding [GO:0000287]; mismatched DNA binding [GO:0030983]; nucleic acid binding [GO:0003676]; protein domain specific binding [GO:0019904]; protein kinase C binding [GO:0005080]; pyrimidine-specific mismatch base pair DNA N-glycosylase activity [GO:0008263]; sodium ion binding [GO:0031402]; SUMO binding [GO:0032183]; transcription coregulator activity [GO:0003712]; uracil DNA N-glycosylase activity [GO:0004844] g20766.t1 Q8BSQ9 45.386 1463 0.0 1115.0 sp|Q8BSQ9|PB1_MOUSE Protein polybromo-1 OS=Mus musculus OX=10090 GN=Pbrm1 PE=1 SV=4 PB1_MOUSE reviewed Protein polybromo-1 (BRG1-associated factor 180) (BAF180) Mus musculus (Mouse) GO:0000776; GO:0000785; GO:0001825; GO:0001890; GO:0001974; GO:0003007; GO:0003349; GO:0003677; GO:0003682; GO:0005634; GO:0005654; GO:0006338; GO:0006357; GO:0006368; GO:0007507; GO:0008285; GO:0016363; GO:0016514; GO:0016586; GO:0030071; GO:0045582; GO:0045597; GO:0045663; GO:0045893; GO:0060948; GO:0060979; GO:0060999; GO:0070316; GO:2000045; GO:2000781; GO:2000819 blastocyst formation [GO:0001825]; blood vessel remodeling [GO:0001974]; cardiac vascular smooth muscle cell development [GO:0060948]; chromatin remodeling [GO:0006338]; epicardium-derived cardiac endothelial cell differentiation [GO:0003349]; heart development [GO:0007507]; heart morphogenesis [GO:0003007]; negative regulation of cell population proliferation [GO:0008285]; placenta development [GO:0001890]; positive regulation of cell differentiation [GO:0045597]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of T cell differentiation [GO:0045582]; regulation of G0 to G1 transition [GO:0070316]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; regulation of nucleotide-excision repair [GO:2000819]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription elongation by RNA polymerase II [GO:0006368]; vasculogenesis involved in coronary vascular morphogenesis [GO:0060979] chromatin [GO:0000785]; kinetochore [GO:0000776]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RSC-type complex [GO:0016586]; SWI/SNF complex [GO:0016514] chromatin binding [GO:0003682]; DNA binding [GO:0003677] g20767.t1 Q3T0J9 54.155 349 1.1000000000000002e-129 396.0 sp|Q3T0J9|GNL3L_BOVIN Guanine nucleotide-binding protein-like 3-like protein OS=Bos taurus OX=9913 GN=GNL3L PE=2 SV=1 g20768.t1 Q96DM1 33.141 519 4.97e-80 269.0 sp|Q96DM1|PGBD4_HUMAN PiggyBac transposable element-derived protein 4 OS=Homo sapiens OX=9606 GN=PGBD4 PE=1 SV=3 g20770.t1 Q13825 61.654 266 4.69e-102 304.0 sp|Q13825|AUHM_HUMAN Methylglutaconyl-CoA hydratase, mitochondrial OS=Homo sapiens OX=9606 GN=AUH PE=1 SV=1 AUHM_HUMAN reviewed Methylglutaconyl-CoA hydratase, mitochondrial (3-MG-CoA hydratase) (EC 4.2.1.18) (AU-specific RNA-binding enoyl-CoA hydratase) (AU-binding protein/enoyl-CoA hydratase) (Itaconyl-CoA hydratase) (EC 4.2.1.56) Homo sapiens (Human) GO:0003730; GO:0004300; GO:0004490; GO:0005739; GO:0005759; GO:0006552; GO:0006635; GO:0050011 fatty acid beta-oxidation [GO:0006635]; L-leucine catabolic process [GO:0006552] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] enoyl-CoA hydratase activity [GO:0004300]; itaconyl-CoA hydratase activity [GO:0050011]; methylglutaconyl-CoA hydratase activity [GO:0004490]; mRNA 3'-UTR binding [GO:0003730] g20771.t1 Q9H0J4 27.604 192 2.53e-25 106.0 sp|Q9H0J4|QRIC2_HUMAN Glutamine-rich protein 2 OS=Homo sapiens OX=9606 GN=QRICH2 PE=1 SV=1 QRIC2_HUMAN reviewed Glutamine-rich protein 2 Homo sapiens (Human) GO:0005737; GO:0030031; GO:0030317; GO:0031965; GO:0036126; GO:2000059 cell projection assembly [GO:0030031]; flagellated sperm motility [GO:0030317]; negative regulation of ubiquitin-dependent protein catabolic process [GO:2000059] cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; sperm flagellum [GO:0036126] g20771.t1 Q9H0J4 27.586 203 1.12e-24 105.0 sp|Q9H0J4|QRIC2_HUMAN Glutamine-rich protein 2 OS=Homo sapiens OX=9606 GN=QRICH2 PE=1 SV=1 QRIC2_HUMAN reviewed Glutamine-rich protein 2 Homo sapiens (Human) GO:0005737; GO:0030031; GO:0030317; GO:0031965; GO:0036126; GO:2000059 cell projection assembly [GO:0030031]; flagellated sperm motility [GO:0030317]; negative regulation of ubiquitin-dependent protein catabolic process [GO:2000059] cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; sperm flagellum [GO:0036126] g20771.t1 Q9H0J4 26.19 210 2.94e-22 97.8 sp|Q9H0J4|QRIC2_HUMAN Glutamine-rich protein 2 OS=Homo sapiens OX=9606 GN=QRICH2 PE=1 SV=1 QRIC2_HUMAN reviewed Glutamine-rich protein 2 Homo sapiens (Human) GO:0005737; GO:0030031; GO:0030317; GO:0031965; GO:0036126; GO:2000059 cell projection assembly [GO:0030031]; flagellated sperm motility [GO:0030317]; negative regulation of ubiquitin-dependent protein catabolic process [GO:2000059] cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; sperm flagellum [GO:0036126] g20772.t1 Q9H0J4 27.461 193 1.8999999999999998e-23 105.0 sp|Q9H0J4|QRIC2_HUMAN Glutamine-rich protein 2 OS=Homo sapiens OX=9606 GN=QRICH2 PE=1 SV=1 QRIC2_HUMAN reviewed Glutamine-rich protein 2 Homo sapiens (Human) GO:0005737; GO:0030031; GO:0030317; GO:0031965; GO:0036126; GO:2000059 cell projection assembly [GO:0030031]; flagellated sperm motility [GO:0030317]; negative regulation of ubiquitin-dependent protein catabolic process [GO:2000059] cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; sperm flagellum [GO:0036126] g20772.t1 Q9H0J4 27.586 203 4.9499999999999994e-23 104.0 sp|Q9H0J4|QRIC2_HUMAN Glutamine-rich protein 2 OS=Homo sapiens OX=9606 GN=QRICH2 PE=1 SV=1 QRIC2_HUMAN reviewed Glutamine-rich protein 2 Homo sapiens (Human) GO:0005737; GO:0030031; GO:0030317; GO:0031965; GO:0036126; GO:2000059 cell projection assembly [GO:0030031]; flagellated sperm motility [GO:0030317]; negative regulation of ubiquitin-dependent protein catabolic process [GO:2000059] cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; sperm flagellum [GO:0036126] g20781.t1 Q08874 42.105 399 1.54e-74 248.0 sp|Q08874|MITF_MOUSE Microphthalmia-associated transcription factor OS=Mus musculus OX=10090 GN=Mitf PE=1 SV=4 g20782.t1 Q8VD46 38.854 157 2.0700000000000002e-26 110.0 sp|Q8VD46|ASZ1_MOUSE Ankyrin repeat, SAM and basic leucine zipper domain-containing protein 1 OS=Mus musculus OX=10090 GN=Asz1 PE=1 SV=2 ASZ1_MOUSE reviewed Ankyrin repeat, SAM and basic leucine zipper domain-containing protein 1 (Germ cell-specific ankyrin, SAM and basic leucine zipper domain-containing protein) Mus musculus (Mouse) GO:0005737; GO:0005829; GO:0007140; GO:0007281; GO:0007283; GO:0010526; GO:0031047; GO:0071546 germ cell development [GO:0007281]; male meiotic nuclear division [GO:0007140]; regulatory ncRNA-mediated gene silencing [GO:0031047]; spermatogenesis [GO:0007283]; transposable element silencing [GO:0010526] cytoplasm [GO:0005737]; cytosol [GO:0005829]; pi-body [GO:0071546] g20787.t1 O02751 36.872 179 4.88e-32 126.0 sp|O02751|CFDP2_BOVIN Craniofacial development protein 2 OS=Bos taurus OX=9913 GN=CFDP2 PE=1 SV=2 g20788.t1 O61443 50.413 121 2.49e-36 137.0 sp|O61443|MK38B_DROME Mitogen-activated protein kinase p38b OS=Drosophila melanogaster OX=7227 GN=p38b PE=1 SV=1 g20789.t1 Q9DGE2 78.704 216 9.8e-119 345.0 sp|Q9DGE2|MK14A_DANRE Mitogen-activated protein kinase 14A OS=Danio rerio OX=7955 GN=mapk14a PE=1 SV=1 MK14A_DANRE reviewed Mitogen-activated protein kinase 14A (MAP kinase 14A) (MAPK 14A) (EC 2.7.11.24) (Mitogen-activated protein kinase p38a) (MAP kinase p38a) (zp38a) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001756; GO:0004674; GO:0004707; GO:0005524; GO:0005634; GO:0005737; GO:0006357; GO:0010831; GO:0031647; GO:0034644; GO:0035556; GO:0038066; GO:0040016; GO:0045663; GO:0048696; GO:0106310; GO:1901741 cellular response to UV [GO:0034644]; embryonic cleavage [GO:0040016]; intracellular signal transduction [GO:0035556]; p38MAPK cascade [GO:0038066]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of myoblast fusion [GO:1901741]; positive regulation of myotube differentiation [GO:0010831]; regulation of collateral sprouting in absence of injury [GO:0048696]; regulation of protein stability [GO:0031647]; regulation of transcription by RNA polymerase II [GO:0006357]; somitogenesis [GO:0001756] cytoplasm [GO:0005737]; nucleus [GO:0005634] ATP binding [GO:0005524]; MAP kinase activity [GO:0004707]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g20791.t1 Q99315 28.522 575 4.3899999999999997e-48 191.0 sp|Q99315|YG31B_YEAST Transposon Ty3-G Gag-Pol polyprotein OS=Saccharomyces cerevisiae (strain ATCC 204508 / S288c) OX=559292 GN=TY3B-G PE=1 SV=3 g20801.t1 P62311 84.314 102 7.65e-42 135.0 sp|P62311|LSM3_MOUSE U6 snRNA-associated Sm-like protein LSm3 OS=Mus musculus OX=10090 GN=Lsm3 PE=1 SV=2 g20803.t1 Q96AA3 51.769 537 6.51e-163 477.0 sp|Q96AA3|RFT1_HUMAN Man(5)GlcNAc(2)-PP-dolichol translocation protein RFT1 OS=Homo sapiens OX=9606 GN=RFT1 PE=1 SV=1 RFT1_HUMAN reviewed Man(5)GlcNAc(2)-PP-dolichol translocation protein RFT1 (Protein RFT1 homolog) Homo sapiens (Human) GO:0005789; GO:0006487; GO:0006488; GO:0034202; GO:0034203 dolichol-linked oligosaccharide biosynthetic process [GO:0006488]; glycolipid translocation [GO:0034203]; protein N-linked glycosylation [GO:0006487] endoplasmic reticulum membrane [GO:0005789] glycolipid floppase activity [GO:0034202] g20805.t1 Q1RMH9 55.337 609 1.04e-167 495.0 sp|Q1RMH9|DNJC2_BOVIN DnaJ homolog subfamily C member 2 OS=Bos taurus OX=9913 GN=DNAJC2 PE=2 SV=1 DNJC2_BOVIN reviewed DnaJ homolog subfamily C member 2 (Zuotin-related factor 1) Bos taurus (Bovine) GO:0003682; GO:0005634; GO:0005829; GO:0006450; GO:0030544; GO:0042393; GO:0043022; GO:0045893; GO:0051083; GO:0061649 'de novo' cotranslational protein folding [GO:0051083]; positive regulation of DNA-templated transcription [GO:0045893]; regulation of translational fidelity [GO:0006450] cytosol [GO:0005829]; nucleus [GO:0005634] chromatin binding [GO:0003682]; histone binding [GO:0042393]; Hsp70 protein binding [GO:0030544]; ribosome binding [GO:0043022]; ubiquitin-modified histone reader activity [GO:0061649] g20807.t1 Q3SZB5 32.571 175 4.4199999999999994e-23 93.6 sp|Q3SZB5|VMA22_BOVIN Vacuolar ATPase assembly protein VMA22 OS=Bos taurus OX=9913 GN=VMA22 PE=2 SV=1 g20808.t1 Q8BX57 57.174 453 0.0 556.0 sp|Q8BX57|PXK_MOUSE PX domain-containing protein kinase-like protein OS=Mus musculus OX=10090 GN=Pxk PE=1 SV=2 g20808.t2 Q8BX57 57.174 453 0.0 557.0 sp|Q8BX57|PXK_MOUSE PX domain-containing protein kinase-like protein OS=Mus musculus OX=10090 GN=Pxk PE=1 SV=2 g20809.t1 P11966 70.554 343 0.0 514.0 sp|P11966|ODPB_BOVIN Pyruvate dehydrogenase E1 component subunit beta, mitochondrial OS=Bos taurus OX=9913 GN=PDHB PE=1 SV=2 g20810.t1 Q8VEM8 77.532 316 7.54e-178 501.0 sp|Q8VEM8|S25A3_MOUSE Solute carrier family 25 member 3 OS=Mus musculus OX=10090 GN=Slc25a3 PE=1 SV=1 g20812.t1 F1QF89 45.328 717 0.0 628.0 sp|F1QF89|POMT1_DANRE Protein O-mannosyl-transferase 1 OS=Danio rerio OX=7955 GN=pomt1 PE=1 SV=1 POMT1_DANRE reviewed Protein O-mannosyl-transferase 1 (EC 2.4.1.109) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0004169; GO:0005783; GO:0005789; GO:0035269; GO:0042478; GO:0048742 protein O-linked glycosylation via mannose [GO:0035269]; regulation of eye photoreceptor cell development [GO:0042478]; regulation of skeletal muscle fiber development [GO:0048742] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789] dolichyl-phosphate-mannose-protein mannosyltransferase activity [GO:0004169] g20813.t1 P18294 72.137 585 0.0 879.0 sp|P18294|KCRF_STRPU Creatine kinase, flagellar OS=Strongylocentrotus purpuratus OX=7668 PE=1 SV=1 g20813.t1 P18294 65.535 589 0.0 799.0 sp|P18294|KCRF_STRPU Creatine kinase, flagellar OS=Strongylocentrotus purpuratus OX=7668 PE=1 SV=1 g20813.t1 P18294 69.041 365 1.74e-176 535.0 sp|P18294|KCRF_STRPU Creatine kinase, flagellar OS=Strongylocentrotus purpuratus OX=7668 PE=1 SV=1 g20814.t1 P18294 76.033 484 0.0 792.0 sp|P18294|KCRF_STRPU Creatine kinase, flagellar OS=Strongylocentrotus purpuratus OX=7668 PE=1 SV=1 g20814.t1 P18294 68.041 485 0.0 684.0 sp|P18294|KCRF_STRPU Creatine kinase, flagellar OS=Strongylocentrotus purpuratus OX=7668 PE=1 SV=1 g20814.t1 P18294 72.853 361 0.0 577.0 sp|P18294|KCRF_STRPU Creatine kinase, flagellar OS=Strongylocentrotus purpuratus OX=7668 PE=1 SV=1 g20814.t1 P18294 74.775 111 8.47e-45 172.0 sp|P18294|KCRF_STRPU Creatine kinase, flagellar OS=Strongylocentrotus purpuratus OX=7668 PE=1 SV=1 g20815.t1 Q9UKG1 40.262 688 1.82e-154 471.0 sp|Q9UKG1|DP13A_HUMAN DCC-interacting protein 13-alpha OS=Homo sapiens OX=9606 GN=APPL1 PE=1 SV=1 g20816.t1 Q6C7A6 50.0 300 6.64e-92 280.0 sp|Q6C7A6|NBP35_YARLI Cytosolic Fe-S cluster assembly factor NBP35 OS=Yarrowia lipolytica (strain CLIB 122 / E 150) OX=284591 GN=NBP35 PE=3 SV=1 g20819.t1 A1L1M4 43.871 155 7.79e-37 146.0 sp|A1L1M4|P4R2B_DANRE Serine/threonine-protein phosphatase 4 regulatory subunit 2-B OS=Danio rerio OX=7955 GN=ppp4r2b PE=1 SV=2 g20820.t1 Q91ZT8 38.043 276 3.9399999999999996e-45 158.0 sp|Q91ZT8|ASB9_MOUSE Ankyrin repeat and SOCS box protein 9 OS=Mus musculus OX=10090 GN=Asb9 PE=1 SV=2 g20821.t1 Q91ZT8 37.594 266 3.2999999999999997e-46 160.0 sp|Q91ZT8|ASB9_MOUSE Ankyrin repeat and SOCS box protein 9 OS=Mus musculus OX=10090 GN=Asb9 PE=1 SV=2 g20821.t2 Q8WWX0 39.394 264 1.03e-46 162.0 sp|Q8WWX0|ASB5_HUMAN Ankyrin repeat and SOCS box protein 5 OS=Homo sapiens OX=9606 GN=ASB5 PE=1 SV=1 g20822.t1 Q5ZLX4 49.476 382 1.6600000000000002e-125 375.0 sp|Q5ZLX4|ARHG3_CHICK Rho guanine nucleotide exchange factor 3 OS=Gallus gallus OX=9031 GN=Arhgef3 PE=2 SV=1 g20822.t2 Q5ZLX4 48.558 416 3.61e-134 400.0 sp|Q5ZLX4|ARHG3_CHICK Rho guanine nucleotide exchange factor 3 OS=Gallus gallus OX=9031 GN=Arhgef3 PE=2 SV=1 g20822.t3 Q5ZLX4 48.333 420 2.87e-134 400.0 sp|Q5ZLX4|ARHG3_CHICK Rho guanine nucleotide exchange factor 3 OS=Gallus gallus OX=9031 GN=Arhgef3 PE=2 SV=1 g20822.t4 Q5ZLX4 45.598 443 9.43e-129 387.0 sp|Q5ZLX4|ARHG3_CHICK Rho guanine nucleotide exchange factor 3 OS=Gallus gallus OX=9031 GN=Arhgef3 PE=2 SV=1 g20824.t1 Q5XFW8 76.623 308 4.03e-180 503.0 sp|Q5XFW8|SEC13_RAT Protein SEC13 homolog OS=Rattus norvegicus OX=10116 GN=Sec13 PE=1 SV=1 SEC13_RAT reviewed Protein SEC13 homolog (GATOR2 complex protein SEC13) (SEC13-like protein 1) Rattus norvegicus (Rat) GO:0000776; GO:0005198; GO:0005635; GO:0005643; GO:0005654; GO:0005765; GO:0005789; GO:0006606; GO:0006888; GO:0030127; GO:0031080; GO:0031669; GO:0032008; GO:0032527; GO:0032991; GO:0042802; GO:0051028; GO:0061700; GO:0072659; GO:0090110; GO:0090114; GO:1904263 cellular response to nutrient levels [GO:0031669]; COPII-coated vesicle budding [GO:0090114]; COPII-coated vesicle cargo loading [GO:0090110]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; mRNA transport [GO:0051028]; positive regulation of TOR signaling [GO:0032008]; positive regulation of TORC1 signaling [GO:1904263]; protein exit from endoplasmic reticulum [GO:0032527]; protein import into nucleus [GO:0006606]; protein localization to plasma membrane [GO:0072659] COPII vesicle coat [GO:0030127]; endoplasmic reticulum membrane [GO:0005789]; GATOR2 complex [GO:0061700]; kinetochore [GO:0000776]; lysosomal membrane [GO:0005765]; nuclear envelope [GO:0005635]; nuclear pore [GO:0005643]; nuclear pore outer ring [GO:0031080]; nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991] identical protein binding [GO:0042802]; structural molecule activity [GO:0005198] g20825.t1 O35161 41.789 2527 0.0 1939.0 sp|O35161|CELR1_MOUSE Cadherin EGF LAG seven-pass G-type receptor 1 OS=Mus musculus OX=10090 GN=Celsr1 PE=1 SV=3 CELR1_MOUSE reviewed Cadherin EGF LAG seven-pass G-type receptor 1 Mus musculus (Mouse) GO:0001736; GO:0001764; GO:0001843; GO:0001942; GO:0004930; GO:0005509; GO:0005654; GO:0005886; GO:0005912; GO:0007156; GO:0007166; GO:0007266; GO:0007409; GO:0007626; GO:0009952; GO:0016020; GO:0032956; GO:0042060; GO:0042249; GO:0042472; GO:0044331; GO:0045176; GO:0048105; GO:0060488; GO:0060489; GO:0060490; GO:0090251; GO:0097475 anterior/posterior pattern specification [GO:0009952]; apical protein localization [GO:0045176]; axonogenesis [GO:0007409]; cell surface receptor signaling pathway [GO:0007166]; cell-cell adhesion mediated by cadherin [GO:0044331]; establishment of body hair planar orientation [GO:0048105]; establishment of planar polarity [GO:0001736]; establishment of planar polarity of embryonic epithelium [GO:0042249]; hair follicle development [GO:0001942]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; inner ear morphogenesis [GO:0042472]; lateral sprouting involved in lung morphogenesis [GO:0060490]; locomotory behavior [GO:0007626]; motor neuron migration [GO:0097475]; neural tube closure [GO:0001843]; neuron migration [GO:0001764]; orthogonal dichotomous subdivision of terminal units involved in lung branching morphogenesis [GO:0060488]; planar dichotomous subdivision of terminal units involved in lung branching morphogenesis [GO:0060489]; protein localization involved in establishment of planar polarity [GO:0090251]; regulation of actin cytoskeleton organization [GO:0032956]; Rho protein signal transduction [GO:0007266]; wound healing [GO:0042060] adherens junction [GO:0005912]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; G protein-coupled receptor activity [GO:0004930] g20825.t2 O35161 41.789 2527 0.0 1939.0 sp|O35161|CELR1_MOUSE Cadherin EGF LAG seven-pass G-type receptor 1 OS=Mus musculus OX=10090 GN=Celsr1 PE=1 SV=3 CELR1_MOUSE reviewed Cadherin EGF LAG seven-pass G-type receptor 1 Mus musculus (Mouse) GO:0001736; GO:0001764; GO:0001843; GO:0001942; GO:0004930; GO:0005509; GO:0005654; GO:0005886; GO:0005912; GO:0007156; GO:0007166; GO:0007266; GO:0007409; GO:0007626; GO:0009952; GO:0016020; GO:0032956; GO:0042060; GO:0042249; GO:0042472; GO:0044331; GO:0045176; GO:0048105; GO:0060488; GO:0060489; GO:0060490; GO:0090251; GO:0097475 anterior/posterior pattern specification [GO:0009952]; apical protein localization [GO:0045176]; axonogenesis [GO:0007409]; cell surface receptor signaling pathway [GO:0007166]; cell-cell adhesion mediated by cadherin [GO:0044331]; establishment of body hair planar orientation [GO:0048105]; establishment of planar polarity [GO:0001736]; establishment of planar polarity of embryonic epithelium [GO:0042249]; hair follicle development [GO:0001942]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; inner ear morphogenesis [GO:0042472]; lateral sprouting involved in lung morphogenesis [GO:0060490]; locomotory behavior [GO:0007626]; motor neuron migration [GO:0097475]; neural tube closure [GO:0001843]; neuron migration [GO:0001764]; orthogonal dichotomous subdivision of terminal units involved in lung branching morphogenesis [GO:0060488]; planar dichotomous subdivision of terminal units involved in lung branching morphogenesis [GO:0060489]; protein localization involved in establishment of planar polarity [GO:0090251]; regulation of actin cytoskeleton organization [GO:0032956]; Rho protein signal transduction [GO:0007266]; wound healing [GO:0042060] adherens junction [GO:0005912]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; G protein-coupled receptor activity [GO:0004930] g20826.t1 P53500 33.596 381 6.99e-57 204.0 sp|P53500|ACT_CYAM1 Actin OS=Cyanidioschyzon merolae (strain NIES-3377 / 10D) OX=280699 GN=CYME_CMM237C PE=3 SV=1 g20827.t1 B0G143 47.651 298 5.289999999999999e-89 270.0 sp|B0G143|UCPB_DICDI Mitochondrial substrate carrier family protein ucpB OS=Dictyostelium discoideum OX=44689 GN=ucpB PE=3 SV=1 g20828.t1 E7FDW2 52.459 305 5.23e-90 294.0 sp|E7FDW2|PZR3B_DANRE E3 ubiquitin-protein ligase PDZRN3-B OS=Danio rerio OX=7955 GN=pdzrn3b PE=1 SV=1 g20829.t1 Q9UPQ7 42.895 380 3.13e-56 214.0 sp|Q9UPQ7|PZRN3_HUMAN E3 ubiquitin-protein ligase PDZRN3 OS=Homo sapiens OX=9606 GN=PDZRN3 PE=1 SV=2 g20829.t1 Q9UPQ7 50.505 198 3.13e-48 189.0 sp|Q9UPQ7|PZRN3_HUMAN E3 ubiquitin-protein ligase PDZRN3 OS=Homo sapiens OX=9606 GN=PDZRN3 PE=1 SV=2 g20830.t1 P41148 68.975 751 0.0 938.0 sp|P41148|ENPL_CANLF Endoplasmin OS=Canis lupus familiaris OX=9615 GN=HSP90B1 PE=1 SV=1 g20832.t1 Q86XH1 48.499 833 0.0 630.0 sp|Q86XH1|DRC11_HUMAN Dynein regulatory complex protein 11 OS=Homo sapiens OX=9606 GN=IQCA1 PE=1 SV=1 g20832.t2 Q86XH1 48.626 837 0.0 637.0 sp|Q86XH1|DRC11_HUMAN Dynein regulatory complex protein 11 OS=Homo sapiens OX=9606 GN=IQCA1 PE=1 SV=1 g20833.t1 Q4G017 45.103 439 4.31e-102 358.0 sp|Q4G017|NISCH_RAT Nischarin OS=Rattus norvegicus OX=10116 GN=Nisch PE=2 SV=2 NISCH_RAT reviewed Nischarin (Imidazoline receptor 1) (I-1) (IR1) (Imidazoline-1 receptor) (I1R) Rattus norvegicus (Rat) GO:0005178; GO:0005654; GO:0005737; GO:0005769; GO:0005829; GO:0005886; GO:0006006; GO:0006915; GO:0008217; GO:0015630; GO:0016601; GO:0030036; GO:0030336; GO:0032228; GO:0035091; GO:0042802; GO:0045171; GO:0048243; GO:0055037 actin cytoskeleton organization [GO:0030036]; apoptotic process [GO:0006915]; glucose metabolic process [GO:0006006]; negative regulation of cell migration [GO:0030336]; norepinephrine secretion [GO:0048243]; Rac protein signal transduction [GO:0016601]; regulation of blood pressure [GO:0008217]; regulation of synaptic transmission, GABAergic [GO:0032228] cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; intercellular bridge [GO:0045171]; microtubule cytoskeleton [GO:0015630]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037] identical protein binding [GO:0042802]; integrin binding [GO:0005178]; phosphatidylinositol binding [GO:0035091] g20833.t1 Q4G017 29.425 435 2.95e-40 167.0 sp|Q4G017|NISCH_RAT Nischarin OS=Rattus norvegicus OX=10116 GN=Nisch PE=2 SV=2 NISCH_RAT reviewed Nischarin (Imidazoline receptor 1) (I-1) (IR1) (Imidazoline-1 receptor) (I1R) Rattus norvegicus (Rat) GO:0005178; GO:0005654; GO:0005737; GO:0005769; GO:0005829; GO:0005886; GO:0006006; GO:0006915; GO:0008217; GO:0015630; GO:0016601; GO:0030036; GO:0030336; GO:0032228; GO:0035091; GO:0042802; GO:0045171; GO:0048243; GO:0055037 actin cytoskeleton organization [GO:0030036]; apoptotic process [GO:0006915]; glucose metabolic process [GO:0006006]; negative regulation of cell migration [GO:0030336]; norepinephrine secretion [GO:0048243]; Rac protein signal transduction [GO:0016601]; regulation of blood pressure [GO:0008217]; regulation of synaptic transmission, GABAergic [GO:0032228] cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; intercellular bridge [GO:0045171]; microtubule cytoskeleton [GO:0015630]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037] identical protein binding [GO:0042802]; integrin binding [GO:0005178]; phosphatidylinositol binding [GO:0035091] g20834.t1 Q9D581 36.22 127 3.1799999999999998e-24 93.6 sp|Q9D581|EFC10_MOUSE EF-hand calcium-binding domain-containing protein 10 OS=Mus musculus OX=10090 GN=Efcab10 PE=1 SV=1 g20835.t1 Q8VEL2 45.666 646 6.29e-159 474.0 sp|Q8VEL2|MTMRE_MOUSE Phosphatidylinositol-3,5-bisphosphate 3-phosphatase MTMR14 OS=Mus musculus OX=10090 GN=Mtmr14 PE=1 SV=2 MTMRE_MOUSE reviewed Phosphatidylinositol-3,5-bisphosphate 3-phosphatase MTMR14 (EC 3.1.3.95) (Myotubularin-related protein 14) (Phosphatidylinositol-3-phosphate phosphatase) (mJumpy) Mus musculus (Mouse) GO:0001726; GO:0004438; GO:0048471; GO:0052629 perinuclear region of cytoplasm [GO:0048471]; ruffle [GO:0001726] phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity [GO:0052629]; phosphatidylinositol-3-phosphate phosphatase activity [GO:0004438] g20836.t1 O75648 54.293 396 1.22e-153 443.0 sp|O75648|MTU1_HUMAN Mitochondrial tRNA-specific 2-thiouridylase 1 OS=Homo sapiens OX=9606 GN=TRMU PE=1 SV=2 g20837.t1 P09215 52.525 693 0.0 683.0 sp|P09215|KPCD_RAT Protein kinase C delta type OS=Rattus norvegicus OX=10116 GN=Prkcd PE=1 SV=1 g20841.t1 Q14BN4 59.487 390 5.05e-135 431.0 sp|Q14BN4|SLMAP_HUMAN Sarcolemmal membrane-associated protein OS=Homo sapiens OX=9606 GN=SLMAP PE=1 SV=1 g20841.t2 Q14BN4 57.209 215 1.47e-51 199.0 sp|Q14BN4|SLMAP_HUMAN Sarcolemmal membrane-associated protein OS=Homo sapiens OX=9606 GN=SLMAP PE=1 SV=1 g20845.t1 Q8BJA2 57.112 464 1.3e-158 466.0 sp|Q8BJA2|S41A1_MOUSE Solute carrier family 41 member 1 OS=Mus musculus OX=10090 GN=Slc41a1 PE=2 SV=1 S41A1_MOUSE reviewed Solute carrier family 41 member 1 Mus musculus (Mouse) GO:0005886; GO:0010961; GO:0015095; GO:0015693; GO:0016323; GO:0022857; GO:0022890; GO:0030001; GO:0032991; GO:0061768; GO:0071286; GO:1903830 cellular response to magnesium ion [GO:0071286]; intracellular magnesium ion homeostasis [GO:0010961]; magnesium ion transmembrane transport [GO:1903830]; magnesium ion transport [GO:0015693]; metal ion transport [GO:0030001] basolateral plasma membrane [GO:0016323]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] inorganic cation transmembrane transporter activity [GO:0022890]; magnesium ion transmembrane transporter activity [GO:0015095]; magnesium:sodium antiporter activity [GO:0061768]; transmembrane transporter activity [GO:0022857] g20848.t1 Q6PI26 47.743 421 1.2100000000000002e-132 407.0 sp|Q6PI26|SHQ1_HUMAN Protein SHQ1 homolog OS=Homo sapiens OX=9606 GN=SHQ1 PE=1 SV=2 SHQ1_HUMAN reviewed Protein SHQ1 homolog Homo sapiens (Human) GO:0000493; GO:0005654; GO:0005737; GO:0005829; GO:0022618; GO:0051082; GO:0060765; GO:0090671; GO:1904263 box H/ACA snoRNP assembly [GO:0000493]; positive regulation of TORC1 signaling [GO:1904263]; protein-RNA complex assembly [GO:0022618]; regulation of androgen receptor signaling pathway [GO:0060765]; telomerase RNA localization to Cajal body [GO:0090671] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654] unfolded protein binding [GO:0051082] g20850.t1 F1RBC8 55.985 259 2.5e-101 317.0 sp|F1RBC8|ABCD1_DANRE ATP-binding cassette sub-family D member 1 OS=Danio rerio OX=7955 GN=abcd1 PE=2 SV=1 ABCD1_DANRE reviewed ATP-binding cassette sub-family D member 1 (EC 3.1.2.-) (EC 7.6.2.-) (Adrenoleukodystrophy protein) (ALDP) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000038; GO:0005324; GO:0005524; GO:0005777; GO:0005778; GO:0006635; GO:0007031; GO:0014003; GO:0015910; GO:0016887; GO:0030301; GO:0030325; GO:0031643; GO:0036269; GO:0042626; GO:0042760; GO:0047617; GO:0052817; GO:0061744; GO:0140359 adrenal gland development [GO:0030325]; cholesterol transport [GO:0030301]; fatty acid beta-oxidation [GO:0006635]; long-chain fatty acid import into peroxisome [GO:0015910]; motor behavior [GO:0061744]; oligodendrocyte development [GO:0014003]; peroxisome organization [GO:0007031]; positive regulation of myelination [GO:0031643]; swimming behavior [GO:0036269]; very long-chain fatty acid catabolic process [GO:0042760]; very long-chain fatty acid metabolic process [GO:0000038] peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777] ABC-type transporter activity [GO:0140359]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; fatty acyl-CoA hydrolase activity [GO:0047617]; long-chain fatty acid transmembrane transporter activity [GO:0005324]; very long-chain fatty acyl-CoA hydrolase activity [GO:0052817] g20851.t1 Q9UBJ2 63.457 405 2.1699999999999997e-180 523.0 sp|Q9UBJ2|ABCD2_HUMAN ATP-binding cassette sub-family D member 2 OS=Homo sapiens OX=9606 GN=ABCD2 PE=1 SV=1 ABCD2_HUMAN reviewed ATP-binding cassette sub-family D member 2 (EC 3.1.2.-) (EC 7.6.2.-) (Adrenoleukodystrophy-like 1) (Adrenoleukodystrophy-related protein) (hALDR) Homo sapiens (Human) GO:0000038; GO:0005324; GO:0005524; GO:0005777; GO:0005778; GO:0005829; GO:0006635; GO:0006636; GO:0007031; GO:0009617; GO:0015605; GO:0015910; GO:0015932; GO:0016887; GO:0032000; GO:0036109; GO:0042626; GO:0042759; GO:0042760; GO:0042803; GO:0042887; GO:0043217; GO:0043651; GO:0046982; GO:0047617; GO:0140359; GO:1900016; GO:1901570; GO:1901682; GO:1903427; GO:1990535; GO:2001280 alpha-linolenic acid metabolic process [GO:0036109]; fatty acid beta-oxidation [GO:0006635]; fatty acid derivative biosynthetic process [GO:1901570]; linoleic acid metabolic process [GO:0043651]; long-chain fatty acid biosynthetic process [GO:0042759]; long-chain fatty acid import into peroxisome [GO:0015910]; myelin maintenance [GO:0043217]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of reactive oxygen species biosynthetic process [GO:1903427]; neuron projection maintenance [GO:1990535]; peroxisome organization [GO:0007031]; positive regulation of fatty acid beta-oxidation [GO:0032000]; positive regulation of unsaturated fatty acid biosynthetic process [GO:2001280]; response to bacterium [GO:0009617]; unsaturated fatty acid biosynthetic process [GO:0006636]; very long-chain fatty acid catabolic process [GO:0042760]; very long-chain fatty acid metabolic process [GO:0000038] cytosol [GO:0005829]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777] ABC-type transporter activity [GO:0140359]; amide transmembrane transporter activity [GO:0042887]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; fatty acyl-CoA hydrolase activity [GO:0047617]; long-chain fatty acid transmembrane transporter activity [GO:0005324]; nucleobase-containing compound transmembrane transporter activity [GO:0015932]; organophosphate ester transmembrane transporter activity [GO:0015605]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; sulfur compound transmembrane transporter activity [GO:1901682] g20852.t1 P31646 57.592 573 0.0 640.0 sp|P31646|S6A13_RAT Sodium- and chloride-dependent GABA transporter 2 OS=Rattus norvegicus OX=10116 GN=Slc6a13 PE=1 SV=1 S6A13_RAT reviewed Sodium- and chloride-dependent GABA transporter 2 (GAT-2) (Solute carrier family 6 member 13) Rattus norvegicus (Rat) GO:0005283; GO:0005308; GO:0005332; GO:0005369; GO:0005886; GO:0006836; GO:0006865; GO:0008028; GO:0015171; GO:0015185; GO:0015718; GO:0015734; GO:0015881; GO:0016323; GO:0016597; GO:0035725; GO:0042995; GO:0051939; GO:0089718 amino acid import across plasma membrane [GO:0089718]; amino acid transport [GO:0006865]; creatine transmembrane transport [GO:0015881]; gamma-aminobutyric acid import [GO:0051939]; monocarboxylic acid transport [GO:0015718]; neurotransmitter transport [GO:0006836]; sodium ion transmembrane transport [GO:0035725]; taurine transmembrane transport [GO:0015734] basolateral plasma membrane [GO:0016323]; cell projection [GO:0042995]; plasma membrane [GO:0005886] amino acid binding [GO:0016597]; amino acid transmembrane transporter activity [GO:0015171]; amino acid:sodium symporter activity [GO:0005283]; creatine transmembrane transporter activity [GO:0005308]; gamma-aminobutyric acid transmembrane transporter activity [GO:0015185]; gamma-aminobutyric acid:sodium:chloride symporter activity [GO:0005332]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; taurine:sodium symporter activity [GO:0005369] g20852.t2 P31646 57.592 573 0.0 640.0 sp|P31646|S6A13_RAT Sodium- and chloride-dependent GABA transporter 2 OS=Rattus norvegicus OX=10116 GN=Slc6a13 PE=1 SV=1 S6A13_RAT reviewed Sodium- and chloride-dependent GABA transporter 2 (GAT-2) (Solute carrier family 6 member 13) Rattus norvegicus (Rat) GO:0005283; GO:0005308; GO:0005332; GO:0005369; GO:0005886; GO:0006836; GO:0006865; GO:0008028; GO:0015171; GO:0015185; GO:0015718; GO:0015734; GO:0015881; GO:0016323; GO:0016597; GO:0035725; GO:0042995; GO:0051939; GO:0089718 amino acid import across plasma membrane [GO:0089718]; amino acid transport [GO:0006865]; creatine transmembrane transport [GO:0015881]; gamma-aminobutyric acid import [GO:0051939]; monocarboxylic acid transport [GO:0015718]; neurotransmitter transport [GO:0006836]; sodium ion transmembrane transport [GO:0035725]; taurine transmembrane transport [GO:0015734] basolateral plasma membrane [GO:0016323]; cell projection [GO:0042995]; plasma membrane [GO:0005886] amino acid binding [GO:0016597]; amino acid transmembrane transporter activity [GO:0015171]; amino acid:sodium symporter activity [GO:0005283]; creatine transmembrane transporter activity [GO:0005308]; gamma-aminobutyric acid transmembrane transporter activity [GO:0015185]; gamma-aminobutyric acid:sodium:chloride symporter activity [GO:0005332]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; taurine:sodium symporter activity [GO:0005369] g20857.t1 P31646 54.029 546 0.0 557.0 sp|P31646|S6A13_RAT Sodium- and chloride-dependent GABA transporter 2 OS=Rattus norvegicus OX=10116 GN=Slc6a13 PE=1 SV=1 S6A13_RAT reviewed Sodium- and chloride-dependent GABA transporter 2 (GAT-2) (Solute carrier family 6 member 13) Rattus norvegicus (Rat) GO:0005283; GO:0005308; GO:0005332; GO:0005369; GO:0005886; GO:0006836; GO:0006865; GO:0008028; GO:0015171; GO:0015185; GO:0015718; GO:0015734; GO:0015881; GO:0016323; GO:0016597; GO:0035725; GO:0042995; GO:0051939; GO:0089718 amino acid import across plasma membrane [GO:0089718]; amino acid transport [GO:0006865]; creatine transmembrane transport [GO:0015881]; gamma-aminobutyric acid import [GO:0051939]; monocarboxylic acid transport [GO:0015718]; neurotransmitter transport [GO:0006836]; sodium ion transmembrane transport [GO:0035725]; taurine transmembrane transport [GO:0015734] basolateral plasma membrane [GO:0016323]; cell projection [GO:0042995]; plasma membrane [GO:0005886] amino acid binding [GO:0016597]; amino acid transmembrane transporter activity [GO:0015171]; amino acid:sodium symporter activity [GO:0005283]; creatine transmembrane transporter activity [GO:0005308]; gamma-aminobutyric acid transmembrane transporter activity [GO:0015185]; gamma-aminobutyric acid:sodium:chloride symporter activity [GO:0005332]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; taurine:sodium symporter activity [GO:0005369] g20859.t1 Q9D4D4 62.46 618 0.0 801.0 sp|Q9D4D4|TKTL2_MOUSE Transketolase-like protein 2 OS=Mus musculus OX=10090 GN=Tktl2 PE=1 SV=1 g20859.t2 Q9D4D4 62.704 614 0.0 797.0 sp|Q9D4D4|TKTL2_MOUSE Transketolase-like protein 2 OS=Mus musculus OX=10090 GN=Tktl2 PE=1 SV=1 g20868.t1 Q9Y493 31.111 450 4.16e-65 235.0 sp|Q9Y493|ZAN_HUMAN Zonadhesin OS=Homo sapiens OX=9606 GN=ZAN PE=2 SV=5 g20868.t1 Q9Y493 33.407 452 1.77e-59 219.0 sp|Q9Y493|ZAN_HUMAN Zonadhesin OS=Homo sapiens OX=9606 GN=ZAN PE=2 SV=5 g20868.t1 Q9Y493 29.885 435 5.33e-56 208.0 sp|Q9Y493|ZAN_HUMAN Zonadhesin OS=Homo sapiens OX=9606 GN=ZAN PE=2 SV=5 g20868.t1 Q9Y493 32.892 453 1.86e-53 201.0 sp|Q9Y493|ZAN_HUMAN Zonadhesin OS=Homo sapiens OX=9606 GN=ZAN PE=2 SV=5 g20869.t1 Q9Y493 31.982 444 1.1899999999999999e-45 184.0 sp|Q9Y493|ZAN_HUMAN Zonadhesin OS=Homo sapiens OX=9606 GN=ZAN PE=2 SV=5 g20869.t1 Q9Y493 31.729 457 7.599999999999999e-42 172.0 sp|Q9Y493|ZAN_HUMAN Zonadhesin OS=Homo sapiens OX=9606 GN=ZAN PE=2 SV=5 g20869.t1 Q9Y493 30.334 389 1.09e-31 139.0 sp|Q9Y493|ZAN_HUMAN Zonadhesin OS=Homo sapiens OX=9606 GN=ZAN PE=2 SV=5 g20869.t1 Q9Y493 30.0 490 1.59e-27 125.0 sp|Q9Y493|ZAN_HUMAN Zonadhesin OS=Homo sapiens OX=9606 GN=ZAN PE=2 SV=5 g20869.t1 Q9Y493 29.216 510 3.0699999999999998e-24 114.0 sp|Q9Y493|ZAN_HUMAN Zonadhesin OS=Homo sapiens OX=9606 GN=ZAN PE=2 SV=5 g20869.t2 Q9Y493 28.68 394 5.09e-43 164.0 sp|Q9Y493|ZAN_HUMAN Zonadhesin OS=Homo sapiens OX=9606 GN=ZAN PE=2 SV=5 g20869.t2 Q9Y493 28.606 409 2.87e-41 159.0 sp|Q9Y493|ZAN_HUMAN Zonadhesin OS=Homo sapiens OX=9606 GN=ZAN PE=2 SV=5 g20869.t2 Q9Y493 26.301 365 3.7400000000000005e-32 132.0 sp|Q9Y493|ZAN_HUMAN Zonadhesin OS=Homo sapiens OX=9606 GN=ZAN PE=2 SV=5 g20869.t2 Q9Y493 29.642 307 2.42e-31 129.0 sp|Q9Y493|ZAN_HUMAN Zonadhesin OS=Homo sapiens OX=9606 GN=ZAN PE=2 SV=5 g20874.t1 A0A8I6GM68 47.425 835 0.0 758.0 sp|A0A8I6GM68|HDAC6_RAT Protein deacetylase HDAC6 OS=Rattus norvegicus OX=10116 GN=Hdac6 PE=3 SV=1 HDAC6_RAT reviewed Protein deacetylase HDAC6 (EC 3.5.1.-) (E3 ubiquitin-protein ligase HDAC6) (EC 2.3.2.-) (Tubulin-lysine deacetylase HDAC6) (EC 3.5.1.-) Rattus norvegicus (Rat) GO:0000118; GO:0000153; GO:0000209; GO:0000978; GO:0001222; GO:0001975; GO:0003779; GO:0004407; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005874; GO:0005875; GO:0005901; GO:0006511; GO:0006515; GO:0006886; GO:0007015; GO:0007026; GO:0007173; GO:0008013; GO:0008017; GO:0008270; GO:0010634; GO:0010727; GO:0010821; GO:0010977; GO:0015630; GO:0016234; GO:0016235; GO:0016241; GO:0019213; GO:0019896; GO:0019899; GO:0030182; GO:0030424; GO:0030425; GO:0031252; GO:0031333; GO:0031593; GO:0031625; GO:0031647; GO:0031648; GO:0032418; GO:0032461; GO:0032984; GO:0032991; GO:0033148; GO:0033558; GO:0035902; GO:0035967; GO:0035973; GO:0036064; GO:0036479; GO:0042030; GO:0042826; GO:0042903; GO:0043005; GO:0043014; GO:0043025; GO:0043130; GO:0043131; GO:0043162; GO:0043204; GO:0043242; GO:0045598; GO:0045814; GO:0045861; GO:0048156; GO:0048471; GO:0048487; GO:0048668; GO:0048843; GO:0050775; GO:0051412; GO:0051646; GO:0051787; GO:0051788; GO:0051879; GO:0051968; GO:0060997; GO:0061523; GO:0061630; GO:0061734; GO:0070201; GO:0070301; GO:0070507; GO:0070840; GO:0070842; GO:0070845; GO:0071211; GO:0071218; GO:0071374; GO:0071548; GO:0140694; GO:1900409; GO:1904056; GO:1904115; GO:1905091; GO:1905336 actin filament organization [GO:0007015]; aggrephagy [GO:0035973]; aggresome assembly [GO:0070842]; axonal transport of mitochondrion [GO:0019896]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to misfolded protein [GO:0071218]; cellular response to parathyroid hormone stimulus [GO:0071374]; cellular response to topologically incorrect protein [GO:0035967]; cilium disassembly [GO:0061523]; collateral sprouting [GO:0048668]; dendritic spine morphogenesis [GO:0060997]; epidermal growth factor receptor signaling pathway [GO:0007173]; erythrocyte enucleation [GO:0043131]; intracellular protein transport [GO:0006886]; lysosome localization [GO:0032418]; membraneless organelle assembly [GO:0140694]; mitochondrion localization [GO:0051646]; negative regulation of aggrephagy [GO:1905336]; negative regulation of axon extension involved in axon guidance [GO:0048843]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of hydrogen peroxide metabolic process [GO:0010727]; negative regulation of microtubule depolymerization [GO:0007026]; negative regulation of neuron projection development [GO:0010977]; negative regulation of protein-containing complex assembly [GO:0031333]; negative regulation of protein-containing complex disassembly [GO:0043242]; negative regulation of proteolysis [GO:0045861]; neuron differentiation [GO:0030182]; polyubiquitinated misfolded protein transport [GO:0070845]; positive regulation of cellular response to oxidative stress [GO:1900409]; positive regulation of cholangiocyte proliferation [GO:1904056]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of intracellular estrogen receptor signaling pathway [GO:0033148]; positive regulation of protein oligomerization [GO:0032461]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; positive regulation of type 2 mitophagy [GO:1905091]; protein destabilization [GO:0031648]; protein polyubiquitination [GO:0000209]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; protein targeting to vacuole involved in autophagy [GO:0071211]; protein-containing complex disassembly [GO:0032984]; regulation of establishment of protein localization [GO:0070201]; regulation of fat cell differentiation [GO:0045598]; regulation of macroautophagy [GO:0016241]; regulation of microtubule cytoskeleton organization [GO:0070507]; regulation of mitochondrion organization [GO:0010821]; regulation of protein stability [GO:0031647]; response to amphetamine [GO:0001975]; response to corticosterone [GO:0051412]; response to dexamethasone [GO:0071548]; response to immobilization stress [GO:0035902]; response to misfolded protein [GO:0051788]; type 2 mitophagy [GO:0061734]; ubiquitin-dependent protein catabolic process [GO:0006511]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162] aggresome [GO:0016235]; axon [GO:0030424]; axon cytoplasm [GO:1904115]; caveola [GO:0005901]; cell leading edge [GO:0031252]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytoplasmic ubiquitin ligase complex [GO:0000153]; cytosol [GO:0005829]; dendrite [GO:0030425]; histone deacetylase complex [GO:0000118]; inclusion body [GO:0016234]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; microtubule cytoskeleton [GO:0015630]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991] actin binding [GO:0003779]; alpha-tubulin binding [GO:0043014]; ATPase inhibitor activity [GO:0042030]; beta-catenin binding [GO:0008013]; beta-tubulin binding [GO:0048487]; deacetylase activity [GO:0019213]; dynein complex binding [GO:0070840]; enzyme binding [GO:0019899]; histone deacetylase activity [GO:0004407]; histone deacetylase binding [GO:0042826]; Hsp90 protein binding [GO:0051879]; microtubule binding [GO:0008017]; misfolded protein binding [GO:0051787]; peroxidase inhibitor activity [GO:0036479]; polyubiquitin modification-dependent protein binding [GO:0031593]; protein lysine deacetylase activity [GO:0033558]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; tau protein binding [GO:0048156]; transcription corepressor binding [GO:0001222]; tubulin deacetylase activity [GO:0042903]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270] g20874.t1 A0A8I6GM68 45.274 402 2.34e-103 351.0 sp|A0A8I6GM68|HDAC6_RAT Protein deacetylase HDAC6 OS=Rattus norvegicus OX=10116 GN=Hdac6 PE=3 SV=1 HDAC6_RAT reviewed Protein deacetylase HDAC6 (EC 3.5.1.-) (E3 ubiquitin-protein ligase HDAC6) (EC 2.3.2.-) (Tubulin-lysine deacetylase HDAC6) (EC 3.5.1.-) Rattus norvegicus (Rat) GO:0000118; GO:0000153; GO:0000209; GO:0000978; GO:0001222; GO:0001975; GO:0003779; GO:0004407; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005874; GO:0005875; GO:0005901; GO:0006511; GO:0006515; GO:0006886; GO:0007015; GO:0007026; GO:0007173; GO:0008013; GO:0008017; GO:0008270; GO:0010634; GO:0010727; GO:0010821; GO:0010977; GO:0015630; GO:0016234; GO:0016235; GO:0016241; GO:0019213; GO:0019896; GO:0019899; GO:0030182; GO:0030424; GO:0030425; GO:0031252; GO:0031333; GO:0031593; GO:0031625; GO:0031647; GO:0031648; GO:0032418; GO:0032461; GO:0032984; GO:0032991; GO:0033148; GO:0033558; GO:0035902; GO:0035967; GO:0035973; GO:0036064; GO:0036479; GO:0042030; GO:0042826; GO:0042903; GO:0043005; GO:0043014; GO:0043025; GO:0043130; GO:0043131; GO:0043162; GO:0043204; GO:0043242; GO:0045598; GO:0045814; GO:0045861; GO:0048156; GO:0048471; GO:0048487; GO:0048668; GO:0048843; GO:0050775; GO:0051412; GO:0051646; GO:0051787; GO:0051788; GO:0051879; GO:0051968; GO:0060997; GO:0061523; GO:0061630; GO:0061734; GO:0070201; GO:0070301; GO:0070507; GO:0070840; GO:0070842; GO:0070845; GO:0071211; GO:0071218; GO:0071374; GO:0071548; GO:0140694; GO:1900409; GO:1904056; GO:1904115; GO:1905091; GO:1905336 actin filament organization [GO:0007015]; aggrephagy [GO:0035973]; aggresome assembly [GO:0070842]; axonal transport of mitochondrion [GO:0019896]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to misfolded protein [GO:0071218]; cellular response to parathyroid hormone stimulus [GO:0071374]; cellular response to topologically incorrect protein [GO:0035967]; cilium disassembly [GO:0061523]; collateral sprouting [GO:0048668]; dendritic spine morphogenesis [GO:0060997]; epidermal growth factor receptor signaling pathway [GO:0007173]; erythrocyte enucleation [GO:0043131]; intracellular protein transport [GO:0006886]; lysosome localization [GO:0032418]; membraneless organelle assembly [GO:0140694]; mitochondrion localization [GO:0051646]; negative regulation of aggrephagy [GO:1905336]; negative regulation of axon extension involved in axon guidance [GO:0048843]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of hydrogen peroxide metabolic process [GO:0010727]; negative regulation of microtubule depolymerization [GO:0007026]; negative regulation of neuron projection development [GO:0010977]; negative regulation of protein-containing complex assembly [GO:0031333]; negative regulation of protein-containing complex disassembly [GO:0043242]; negative regulation of proteolysis [GO:0045861]; neuron differentiation [GO:0030182]; polyubiquitinated misfolded protein transport [GO:0070845]; positive regulation of cellular response to oxidative stress [GO:1900409]; positive regulation of cholangiocyte proliferation [GO:1904056]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of intracellular estrogen receptor signaling pathway [GO:0033148]; positive regulation of protein oligomerization [GO:0032461]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; positive regulation of type 2 mitophagy [GO:1905091]; protein destabilization [GO:0031648]; protein polyubiquitination [GO:0000209]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; protein targeting to vacuole involved in autophagy [GO:0071211]; protein-containing complex disassembly [GO:0032984]; regulation of establishment of protein localization [GO:0070201]; regulation of fat cell differentiation [GO:0045598]; regulation of macroautophagy [GO:0016241]; regulation of microtubule cytoskeleton organization [GO:0070507]; regulation of mitochondrion organization [GO:0010821]; regulation of protein stability [GO:0031647]; response to amphetamine [GO:0001975]; response to corticosterone [GO:0051412]; response to dexamethasone [GO:0071548]; response to immobilization stress [GO:0035902]; response to misfolded protein [GO:0051788]; type 2 mitophagy [GO:0061734]; ubiquitin-dependent protein catabolic process [GO:0006511]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162] aggresome [GO:0016235]; axon [GO:0030424]; axon cytoplasm [GO:1904115]; caveola [GO:0005901]; cell leading edge [GO:0031252]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytoplasmic ubiquitin ligase complex [GO:0000153]; cytosol [GO:0005829]; dendrite [GO:0030425]; histone deacetylase complex [GO:0000118]; inclusion body [GO:0016234]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; microtubule cytoskeleton [GO:0015630]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991] actin binding [GO:0003779]; alpha-tubulin binding [GO:0043014]; ATPase inhibitor activity [GO:0042030]; beta-catenin binding [GO:0008013]; beta-tubulin binding [GO:0048487]; deacetylase activity [GO:0019213]; dynein complex binding [GO:0070840]; enzyme binding [GO:0019899]; histone deacetylase activity [GO:0004407]; histone deacetylase binding [GO:0042826]; Hsp90 protein binding [GO:0051879]; microtubule binding [GO:0008017]; misfolded protein binding [GO:0051787]; peroxidase inhibitor activity [GO:0036479]; polyubiquitin modification-dependent protein binding [GO:0031593]; protein lysine deacetylase activity [GO:0033558]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; tau protein binding [GO:0048156]; transcription corepressor binding [GO:0001222]; tubulin deacetylase activity [GO:0042903]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270] g20874.t1 A0A8I6GM68 41.463 410 1.1099999999999999e-94 327.0 sp|A0A8I6GM68|HDAC6_RAT Protein deacetylase HDAC6 OS=Rattus norvegicus OX=10116 GN=Hdac6 PE=3 SV=1 HDAC6_RAT reviewed Protein deacetylase HDAC6 (EC 3.5.1.-) (E3 ubiquitin-protein ligase HDAC6) (EC 2.3.2.-) (Tubulin-lysine deacetylase HDAC6) (EC 3.5.1.-) Rattus norvegicus (Rat) GO:0000118; GO:0000153; GO:0000209; GO:0000978; GO:0001222; GO:0001975; GO:0003779; GO:0004407; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005874; GO:0005875; GO:0005901; GO:0006511; GO:0006515; GO:0006886; GO:0007015; GO:0007026; GO:0007173; GO:0008013; GO:0008017; GO:0008270; GO:0010634; GO:0010727; GO:0010821; GO:0010977; GO:0015630; GO:0016234; GO:0016235; GO:0016241; GO:0019213; GO:0019896; GO:0019899; GO:0030182; GO:0030424; GO:0030425; GO:0031252; GO:0031333; GO:0031593; GO:0031625; GO:0031647; GO:0031648; GO:0032418; GO:0032461; GO:0032984; GO:0032991; GO:0033148; GO:0033558; GO:0035902; GO:0035967; GO:0035973; GO:0036064; GO:0036479; GO:0042030; GO:0042826; GO:0042903; GO:0043005; GO:0043014; GO:0043025; GO:0043130; GO:0043131; GO:0043162; GO:0043204; GO:0043242; GO:0045598; GO:0045814; GO:0045861; GO:0048156; GO:0048471; GO:0048487; GO:0048668; GO:0048843; GO:0050775; GO:0051412; GO:0051646; GO:0051787; GO:0051788; GO:0051879; GO:0051968; GO:0060997; GO:0061523; GO:0061630; GO:0061734; GO:0070201; GO:0070301; GO:0070507; GO:0070840; GO:0070842; GO:0070845; GO:0071211; GO:0071218; GO:0071374; GO:0071548; GO:0140694; GO:1900409; GO:1904056; GO:1904115; GO:1905091; GO:1905336 actin filament organization [GO:0007015]; aggrephagy [GO:0035973]; aggresome assembly [GO:0070842]; axonal transport of mitochondrion [GO:0019896]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to misfolded protein [GO:0071218]; cellular response to parathyroid hormone stimulus [GO:0071374]; cellular response to topologically incorrect protein [GO:0035967]; cilium disassembly [GO:0061523]; collateral sprouting [GO:0048668]; dendritic spine morphogenesis [GO:0060997]; epidermal growth factor receptor signaling pathway [GO:0007173]; erythrocyte enucleation [GO:0043131]; intracellular protein transport [GO:0006886]; lysosome localization [GO:0032418]; membraneless organelle assembly [GO:0140694]; mitochondrion localization [GO:0051646]; negative regulation of aggrephagy [GO:1905336]; negative regulation of axon extension involved in axon guidance [GO:0048843]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of hydrogen peroxide metabolic process [GO:0010727]; negative regulation of microtubule depolymerization [GO:0007026]; negative regulation of neuron projection development [GO:0010977]; negative regulation of protein-containing complex assembly [GO:0031333]; negative regulation of protein-containing complex disassembly [GO:0043242]; negative regulation of proteolysis [GO:0045861]; neuron differentiation [GO:0030182]; polyubiquitinated misfolded protein transport [GO:0070845]; positive regulation of cellular response to oxidative stress [GO:1900409]; positive regulation of cholangiocyte proliferation [GO:1904056]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of intracellular estrogen receptor signaling pathway [GO:0033148]; positive regulation of protein oligomerization [GO:0032461]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; positive regulation of type 2 mitophagy [GO:1905091]; protein destabilization [GO:0031648]; protein polyubiquitination [GO:0000209]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; protein targeting to vacuole involved in autophagy [GO:0071211]; protein-containing complex disassembly [GO:0032984]; regulation of establishment of protein localization [GO:0070201]; regulation of fat cell differentiation [GO:0045598]; regulation of macroautophagy [GO:0016241]; regulation of microtubule cytoskeleton organization [GO:0070507]; regulation of mitochondrion organization [GO:0010821]; regulation of protein stability [GO:0031647]; response to amphetamine [GO:0001975]; response to corticosterone [GO:0051412]; response to dexamethasone [GO:0071548]; response to immobilization stress [GO:0035902]; response to misfolded protein [GO:0051788]; type 2 mitophagy [GO:0061734]; ubiquitin-dependent protein catabolic process [GO:0006511]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162] aggresome [GO:0016235]; axon [GO:0030424]; axon cytoplasm [GO:1904115]; caveola [GO:0005901]; cell leading edge [GO:0031252]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytoplasmic ubiquitin ligase complex [GO:0000153]; cytosol [GO:0005829]; dendrite [GO:0030425]; histone deacetylase complex [GO:0000118]; inclusion body [GO:0016234]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; microtubule cytoskeleton [GO:0015630]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991] actin binding [GO:0003779]; alpha-tubulin binding [GO:0043014]; ATPase inhibitor activity [GO:0042030]; beta-catenin binding [GO:0008013]; beta-tubulin binding [GO:0048487]; deacetylase activity [GO:0019213]; dynein complex binding [GO:0070840]; enzyme binding [GO:0019899]; histone deacetylase activity [GO:0004407]; histone deacetylase binding [GO:0042826]; Hsp90 protein binding [GO:0051879]; microtubule binding [GO:0008017]; misfolded protein binding [GO:0051787]; peroxidase inhibitor activity [GO:0036479]; polyubiquitin modification-dependent protein binding [GO:0031593]; protein lysine deacetylase activity [GO:0033558]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; tau protein binding [GO:0048156]; transcription corepressor binding [GO:0001222]; tubulin deacetylase activity [GO:0042903]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270] g20874.t2 A0A8I6GM68 46.55 855 0.0 750.0 sp|A0A8I6GM68|HDAC6_RAT Protein deacetylase HDAC6 OS=Rattus norvegicus OX=10116 GN=Hdac6 PE=3 SV=1 HDAC6_RAT reviewed Protein deacetylase HDAC6 (EC 3.5.1.-) (E3 ubiquitin-protein ligase HDAC6) (EC 2.3.2.-) (Tubulin-lysine deacetylase HDAC6) (EC 3.5.1.-) Rattus norvegicus (Rat) GO:0000118; GO:0000153; GO:0000209; GO:0000978; GO:0001222; GO:0001975; GO:0003779; GO:0004407; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005874; GO:0005875; GO:0005901; GO:0006511; GO:0006515; GO:0006886; GO:0007015; GO:0007026; GO:0007173; GO:0008013; GO:0008017; GO:0008270; GO:0010634; GO:0010727; GO:0010821; GO:0010977; GO:0015630; GO:0016234; GO:0016235; GO:0016241; GO:0019213; GO:0019896; GO:0019899; GO:0030182; GO:0030424; GO:0030425; GO:0031252; GO:0031333; GO:0031593; GO:0031625; GO:0031647; GO:0031648; GO:0032418; GO:0032461; GO:0032984; GO:0032991; GO:0033148; GO:0033558; GO:0035902; GO:0035967; GO:0035973; GO:0036064; GO:0036479; GO:0042030; GO:0042826; GO:0042903; GO:0043005; GO:0043014; GO:0043025; GO:0043130; GO:0043131; GO:0043162; GO:0043204; GO:0043242; GO:0045598; GO:0045814; GO:0045861; GO:0048156; GO:0048471; GO:0048487; GO:0048668; GO:0048843; GO:0050775; GO:0051412; GO:0051646; GO:0051787; GO:0051788; GO:0051879; GO:0051968; GO:0060997; GO:0061523; GO:0061630; GO:0061734; GO:0070201; GO:0070301; GO:0070507; GO:0070840; GO:0070842; GO:0070845; GO:0071211; GO:0071218; GO:0071374; GO:0071548; GO:0140694; GO:1900409; GO:1904056; GO:1904115; GO:1905091; GO:1905336 actin filament organization [GO:0007015]; aggrephagy [GO:0035973]; aggresome assembly [GO:0070842]; axonal transport of mitochondrion [GO:0019896]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to misfolded protein [GO:0071218]; cellular response to parathyroid hormone stimulus [GO:0071374]; cellular response to topologically incorrect protein [GO:0035967]; cilium disassembly [GO:0061523]; collateral sprouting [GO:0048668]; dendritic spine morphogenesis [GO:0060997]; epidermal growth factor receptor signaling pathway [GO:0007173]; erythrocyte enucleation [GO:0043131]; intracellular protein transport [GO:0006886]; lysosome localization [GO:0032418]; membraneless organelle assembly [GO:0140694]; mitochondrion localization [GO:0051646]; negative regulation of aggrephagy [GO:1905336]; negative regulation of axon extension involved in axon guidance [GO:0048843]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of hydrogen peroxide metabolic process [GO:0010727]; negative regulation of microtubule depolymerization [GO:0007026]; negative regulation of neuron projection development [GO:0010977]; negative regulation of protein-containing complex assembly [GO:0031333]; negative regulation of protein-containing complex disassembly [GO:0043242]; negative regulation of proteolysis [GO:0045861]; neuron differentiation [GO:0030182]; polyubiquitinated misfolded protein transport [GO:0070845]; positive regulation of cellular response to oxidative stress [GO:1900409]; positive regulation of cholangiocyte proliferation [GO:1904056]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of intracellular estrogen receptor signaling pathway [GO:0033148]; positive regulation of protein oligomerization [GO:0032461]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; positive regulation of type 2 mitophagy [GO:1905091]; protein destabilization [GO:0031648]; protein polyubiquitination [GO:0000209]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; protein targeting to vacuole involved in autophagy [GO:0071211]; protein-containing complex disassembly [GO:0032984]; regulation of establishment of protein localization [GO:0070201]; regulation of fat cell differentiation [GO:0045598]; regulation of macroautophagy [GO:0016241]; regulation of microtubule cytoskeleton organization [GO:0070507]; regulation of mitochondrion organization [GO:0010821]; regulation of protein stability [GO:0031647]; response to amphetamine [GO:0001975]; response to corticosterone [GO:0051412]; response to dexamethasone [GO:0071548]; response to immobilization stress [GO:0035902]; response to misfolded protein [GO:0051788]; type 2 mitophagy [GO:0061734]; ubiquitin-dependent protein catabolic process [GO:0006511]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162] aggresome [GO:0016235]; axon [GO:0030424]; axon cytoplasm [GO:1904115]; caveola [GO:0005901]; cell leading edge [GO:0031252]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytoplasmic ubiquitin ligase complex [GO:0000153]; cytosol [GO:0005829]; dendrite [GO:0030425]; histone deacetylase complex [GO:0000118]; inclusion body [GO:0016234]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; microtubule cytoskeleton [GO:0015630]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991] actin binding [GO:0003779]; alpha-tubulin binding [GO:0043014]; ATPase inhibitor activity [GO:0042030]; beta-catenin binding [GO:0008013]; beta-tubulin binding [GO:0048487]; deacetylase activity [GO:0019213]; dynein complex binding [GO:0070840]; enzyme binding [GO:0019899]; histone deacetylase activity [GO:0004407]; histone deacetylase binding [GO:0042826]; Hsp90 protein binding [GO:0051879]; microtubule binding [GO:0008017]; misfolded protein binding [GO:0051787]; peroxidase inhibitor activity [GO:0036479]; polyubiquitin modification-dependent protein binding [GO:0031593]; protein lysine deacetylase activity [GO:0033558]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; tau protein binding [GO:0048156]; transcription corepressor binding [GO:0001222]; tubulin deacetylase activity [GO:0042903]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270] g20876.t1 Q29J90 26.748 329 2.16e-38 147.0 sp|Q29J90|MOODY_DROPS G-protein coupled receptor moody OS=Drosophila pseudoobscura pseudoobscura OX=46245 GN=moody PE=3 SV=2 MOODY_DROPS reviewed G-protein coupled receptor moody Drosophila pseudoobscura pseudoobscura (Fruit fly) GO:0004930; GO:0005886; GO:0007186; GO:0008366; GO:0048148 axon ensheathment [GO:0008366]; behavioral response to cocaine [GO:0048148]; G protein-coupled receptor signaling pathway [GO:0007186] plasma membrane [GO:0005886] G protein-coupled receptor activity [GO:0004930] g20877.t1 Q9UBN7 54.955 111 1.8800000000000002e-29 118.0 sp|Q9UBN7|HDAC6_HUMAN Protein deacetylase HDAC6 OS=Homo sapiens OX=9606 GN=HDAC6 PE=1 SV=2 HDAC6_HUMAN reviewed Protein deacetylase HDAC6 (EC 3.5.1.-) (E3 ubiquitin-protein ligase HDAC6) (EC 2.3.2.-) (Tubulin-lysine deacetylase HDAC6) (EC 3.5.1.-) Homo sapiens (Human) GO:0000118; GO:0000153; GO:0000209; GO:0000978; GO:0001222; GO:0003779; GO:0004407; GO:0005634; GO:0005654; GO:0005737; GO:0005771; GO:0005813; GO:0005829; GO:0005874; GO:0005875; GO:0005901; GO:0006476; GO:0006515; GO:0006886; GO:0007015; GO:0007026; GO:0007173; GO:0008013; GO:0008017; GO:0008270; GO:0010506; GO:0010634; GO:0010727; GO:0016234; GO:0016235; GO:0016241; GO:0019213; GO:0019896; GO:0019899; GO:0030424; GO:0030425; GO:0031252; GO:0031333; GO:0031593; GO:0031625; GO:0031647; GO:0031648; GO:0032418; GO:0032461; GO:0032984; GO:0033148; GO:0033558; GO:0034605; GO:0035967; GO:0036064; GO:0036479; GO:0042030; GO:0042826; GO:0042903; GO:0043014; GO:0043130; GO:0043131; GO:0043162; GO:0043204; GO:0043242; GO:0045598; GO:0045814; GO:0045861; GO:0045892; GO:0048156; GO:0048471; GO:0048487; GO:0048668; GO:0051787; GO:0051788; GO:0051879; GO:0060271; GO:0060632; GO:0060765; GO:0060997; GO:0061523; GO:0061630; GO:0061734; GO:0070201; GO:0070301; GO:0070840; GO:0070842; GO:0070845; GO:0071218; GO:0090042; GO:1903146; GO:1904115; GO:1905091; GO:1905336 actin filament organization [GO:0007015]; aggresome assembly [GO:0070842]; axonal transport of mitochondrion [GO:0019896]; cellular response to heat [GO:0034605]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to misfolded protein [GO:0071218]; cellular response to topologically incorrect protein [GO:0035967]; cilium assembly [GO:0060271]; cilium disassembly [GO:0061523]; collateral sprouting [GO:0048668]; dendritic spine morphogenesis [GO:0060997]; epidermal growth factor receptor signaling pathway [GO:0007173]; erythrocyte enucleation [GO:0043131]; intracellular protein transport [GO:0006886]; lysosome localization [GO:0032418]; negative regulation of aggrephagy [GO:1905336]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of hydrogen peroxide metabolic process [GO:0010727]; negative regulation of microtubule depolymerization [GO:0007026]; negative regulation of protein-containing complex assembly [GO:0031333]; negative regulation of protein-containing complex disassembly [GO:0043242]; negative regulation of proteolysis [GO:0045861]; polyubiquitinated misfolded protein transport [GO:0070845]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of intracellular estrogen receptor signaling pathway [GO:0033148]; positive regulation of protein oligomerization [GO:0032461]; positive regulation of type 2 mitophagy [GO:1905091]; protein deacetylation [GO:0006476]; protein destabilization [GO:0031648]; protein polyubiquitination [GO:0000209]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; protein-containing complex disassembly [GO:0032984]; regulation of androgen receptor signaling pathway [GO:0060765]; regulation of autophagy [GO:0010506]; regulation of autophagy of mitochondrion [GO:1903146]; regulation of establishment of protein localization [GO:0070201]; regulation of fat cell differentiation [GO:0045598]; regulation of macroautophagy [GO:0016241]; regulation of microtubule-based movement [GO:0060632]; regulation of protein stability [GO:0031647]; response to misfolded protein [GO:0051788]; tubulin deacetylation [GO:0090042]; type 2 mitophagy [GO:0061734]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162] aggresome [GO:0016235]; axon [GO:0030424]; axon cytoplasm [GO:1904115]; caveola [GO:0005901]; cell leading edge [GO:0031252]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytoplasmic ubiquitin ligase complex [GO:0000153]; cytosol [GO:0005829]; dendrite [GO:0030425]; histone deacetylase complex [GO:0000118]; inclusion body [GO:0016234]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471] actin binding [GO:0003779]; alpha-tubulin binding [GO:0043014]; ATPase inhibitor activity [GO:0042030]; beta-catenin binding [GO:0008013]; beta-tubulin binding [GO:0048487]; deacetylase activity [GO:0019213]; dynein complex binding [GO:0070840]; enzyme binding [GO:0019899]; histone deacetylase activity [GO:0004407]; histone deacetylase binding [GO:0042826]; Hsp90 protein binding [GO:0051879]; microtubule binding [GO:0008017]; misfolded protein binding [GO:0051787]; peroxidase inhibitor activity [GO:0036479]; polyubiquitin modification-dependent protein binding [GO:0031593]; protein lysine deacetylase activity [GO:0033558]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; tau protein binding [GO:0048156]; transcription corepressor binding [GO:0001222]; tubulin deacetylase activity [GO:0042903]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270] g20879.t1 O95243 76.154 130 1.6000000000000002e-70 228.0 sp|O95243|MBD4_HUMAN Methyl-CpG-binding domain protein 4 OS=Homo sapiens OX=9606 GN=MBD4 PE=1 SV=1 g20879.t2 O95243 76.154 130 6.08e-71 230.0 sp|O95243|MBD4_HUMAN Methyl-CpG-binding domain protein 4 OS=Homo sapiens OX=9606 GN=MBD4 PE=1 SV=1 g20880.t1 P46058 31.034 348 1.74e-39 148.0 sp|P46058|EDSP_CYNPY Epidermal differentiation-specific protein OS=Cynops pyrrhogaster OX=8330 PE=2 SV=1 g20881.t1 Q9ULI1 28.244 917 3.5e-97 351.0 sp|Q9ULI1|NWD2_HUMAN NACHT and WD repeat domain-containing protein 2 OS=Homo sapiens OX=9606 GN=NWD2 PE=1 SV=3 g20882.t1 Q5ZKD7 41.963 1039 0.0 694.0 sp|Q5ZKD7|MOV10_CHICK Putative helicase MOV-10 OS=Gallus gallus OX=9031 GN=MOV10 PE=2 SV=1 MOV10_CHICK reviewed Putative helicase MOV-10 (EC 3.6.4.13) Gallus gallus (Chicken) GO:0000932; GO:0003723; GO:0005524; GO:0005634; GO:0005829; GO:0010494; GO:0010526; GO:0016887; GO:0032574; GO:0035194; GO:0035195; GO:0035279; GO:0036464; GO:0043186; GO:0061014; GO:0061158; GO:0150011 3'-UTR-mediated mRNA destabilization [GO:0061158]; miRNA-mediated gene silencing by mRNA destabilization [GO:0035279]; miRNA-mediated post-transcriptional gene silencing [GO:0035195]; positive regulation of mRNA catabolic process [GO:0061014]; regulation of neuron projection arborization [GO:0150011]; regulatory ncRNA-mediated post-transcriptional gene silencing [GO:0035194]; transposable element silencing [GO:0010526] cytoplasmic ribonucleoprotein granule [GO:0036464]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; nucleus [GO:0005634]; P granule [GO:0043186]; P-body [GO:0000932] 5'-3' RNA helicase activity [GO:0032574]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; RNA binding [GO:0003723] g20884.t1 Q8HXG5 35.294 170 9.15e-22 89.4 sp|Q8HXG5|NDUBB_BOVIN NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 11, mitochondrial OS=Bos taurus OX=9913 GN=NDUFB11 PE=1 SV=2 g20885.t1 W0LYS5 72.168 309 2.65e-169 478.0 sp|W0LYS5|CAMKI_MACNP Calcium/calmodulin-dependent protein kinase type 1 OS=Macrobrachium nipponense OX=159736 GN=CaMKI PE=2 SV=1 g20893.t1 P20488 33.333 213 4.5e-27 109.0 sp|P20488|SYPH_BOVIN Synaptophysin OS=Bos taurus OX=9913 GN=SYP PE=1 SV=3 SYPH_BOVIN reviewed Synaptophysin (Major synaptic vesicle protein p38) Bos taurus (Bovine) GO:0006897; GO:0030136; GO:0030672; GO:0042584; GO:0042802; GO:0043005; GO:0045920; GO:0048168; GO:0048786; GO:0051020; GO:2000474 endocytosis [GO:0006897]; negative regulation of exocytosis [GO:0045920]; regulation of neuronal synaptic plasticity [GO:0048168]; regulation of opioid receptor signaling pathway [GO:2000474] chromaffin granule membrane [GO:0042584]; clathrin-coated vesicle [GO:0030136]; neuron projection [GO:0043005]; presynaptic active zone [GO:0048786]; synaptic vesicle membrane [GO:0030672] GTPase binding [GO:0051020]; identical protein binding [GO:0042802] g20894.t1 P53590 69.321 427 0.0 559.0 sp|P53590|SUCB2_PIG Succinate--CoA ligase [GDP-forming] subunit beta, mitochondrial (Fragment) OS=Sus scrofa OX=9823 GN=SUCLG2 PE=1 SV=2 g20895.t1 Q8R431 42.491 273 3.5e-78 242.0 sp|Q8R431|MGLL_RAT Monoglyceride lipase OS=Rattus norvegicus OX=10116 GN=Mgll PE=1 SV=1 MGLL_RAT reviewed Monoglyceride lipase (MGL) (EC 3.1.1.23) (Monoacylglycerol lipase) (MAGL) Rattus norvegicus (Rat) GO:0005811; GO:0005829; GO:0006633; GO:0009966; GO:0016020; GO:0016787; GO:0019369; GO:0019433; GO:0030424; GO:0030516; GO:0042803; GO:0043196; GO:0045202; GO:0045471; GO:0045907; GO:0046464; GO:0047372; GO:0050727; GO:0051930; GO:0052651; GO:0060292; GO:0098688; GO:0098793; GO:0099178; GO:0150053; GO:2000124 acylglycerol catabolic process [GO:0046464]; arachidonate metabolic process [GO:0019369]; fatty acid biosynthetic process [GO:0006633]; long-term synaptic depression [GO:0060292]; monoacylglycerol catabolic process [GO:0052651]; positive regulation of vasoconstriction [GO:0045907]; regulation of axon extension [GO:0030516]; regulation of endocannabinoid signaling pathway [GO:2000124]; regulation of inflammatory response [GO:0050727]; regulation of retrograde trans-synaptic signaling by endocanabinoid [GO:0099178]; regulation of sensory perception of pain [GO:0051930]; regulation of signal transduction [GO:0009966]; response to ethanol [GO:0045471]; triglyceride catabolic process [GO:0019433] axon [GO:0030424]; cerebellar climbing fiber to Purkinje cell synapse [GO:0150053]; cytosol [GO:0005829]; lipid droplet [GO:0005811]; membrane [GO:0016020]; parallel fiber to Purkinje cell synapse [GO:0098688]; presynapse [GO:0098793]; synapse [GO:0045202]; varicosity [GO:0043196] hydrolase activity [GO:0016787]; monoacylglycerol lipase activity [GO:0047372]; protein homodimerization activity [GO:0042803] g20897.t1 Q5XIU1 46.948 213 2.56e-55 186.0 sp|Q5XIU1|ABTB1_RAT Ankyrin repeat and BTB/POZ domain-containing protein 1 OS=Rattus norvegicus OX=10116 GN=Abtb1 PE=2 SV=1 g20898.t1 Q99LJ2 59.559 136 5.79e-51 171.0 sp|Q99LJ2|ABTB1_MOUSE Ankyrin repeat and BTB/POZ domain-containing protein 1 OS=Mus musculus OX=10090 GN=Abtb1 PE=2 SV=1 g20900.t1 Q9JKS6 51.667 120 6.130000000000001e-35 131.0 sp|Q9JKS6|PCLO_RAT Protein piccolo OS=Rattus norvegicus OX=10116 GN=Pclo PE=1 SV=1 PCLO_RAT reviewed Protein piccolo (Aczonin) (Multidomain presynaptic cytomatrix protein) Rattus norvegicus (Rat) GO:0001222; GO:0005509; GO:0005522; GO:0005544; GO:0005798; GO:0005802; GO:0007010; GO:0008270; GO:0014069; GO:0016080; GO:0017157; GO:0030073; GO:0030424; GO:0030425; GO:0030426; GO:0031594; GO:0035418; GO:0043025; GO:0043195; GO:0044316; GO:0044317; GO:0045202; GO:0048471; GO:0048786; GO:0048788; GO:0050808; GO:0051036; GO:0060077; GO:0097091; GO:0097470; GO:0098688; GO:0098815; GO:0098831; GO:0098882; GO:0098978; GO:0098982; GO:0099140; GO:1903423; GO:1904071; GO:1904666 cytoskeleton organization [GO:0007010]; insulin secretion [GO:0030073]; modulation of excitatory postsynaptic potential [GO:0098815]; positive regulation of synaptic vesicle recycling [GO:1903423]; presynaptic actin cytoskeleton organization [GO:0099140]; presynaptic active zone assembly [GO:1904071]; protein localization to synapse [GO:0035418]; regulation of endosome size [GO:0051036]; regulation of exocytosis [GO:0017157]; regulation of ubiquitin protein ligase activity [GO:1904666]; synapse organization [GO:0050808]; synaptic vesicle clustering [GO:0097091]; synaptic vesicle targeting [GO:0016080] axon [GO:0030424]; cone cell pedicle [GO:0044316]; cytoskeleton of presynaptic active zone [GO:0048788]; dendrite [GO:0030425]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; Golgi-associated vesicle [GO:0005798]; growth cone [GO:0030426]; inhibitory synapse [GO:0060077]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; parallel fiber to Purkinje cell synapse [GO:0098688]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic density [GO:0014069]; presynaptic active zone [GO:0048786]; presynaptic active zone cytoplasmic component [GO:0098831]; ribbon synapse [GO:0097470]; rod spherule [GO:0044317]; synapse [GO:0045202]; terminal bouton [GO:0043195]; trans-Golgi network [GO:0005802] calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; profilin binding [GO:0005522]; structural constituent of presynaptic active zone [GO:0098882]; transcription corepressor binding [GO:0001222]; zinc ion binding [GO:0008270] g20902.t1 Q9PU36 38.483 356 4.64e-60 234.0 sp|Q9PU36|PCLO_CHICK Protein piccolo (Fragment) OS=Gallus gallus OX=9031 GN=PCLO PE=2 SV=1 g20906.t1 Q9UKK9 50.526 190 6.88e-65 203.0 sp|Q9UKK9|NUDT5_HUMAN ADP-sugar pyrophosphatase OS=Homo sapiens OX=9606 GN=NUDT5 PE=1 SV=1 NUDT5_HUMAN reviewed ADP-sugar pyrophosphatase (EC 3.6.1.13) (8-oxo-dGDP phosphatase) (EC 3.6.1.58) (Nuclear ATP-synthesis protein NUDIX5) (EC 2.7.7.96) (Nucleoside diphosphate-linked moiety X motif 5) (Nudix motif 5) (hNUDT5) (YSA1H) Homo sapiens (Human) GO:0000287; GO:0005634; GO:0005829; GO:0006338; GO:0006753; GO:0009117; GO:0009191; GO:0016779; GO:0019144; GO:0019303; GO:0019693; GO:0030515; GO:0042802; GO:0042803; GO:0044715; GO:0047631; GO:0055086; GO:0070062; GO:1990966 ATP generation from poly-ADP-D-ribose [GO:1990966]; chromatin remodeling [GO:0006338]; D-ribose catabolic process [GO:0019303]; nucleobase-containing small molecule metabolic process [GO:0055086]; nucleoside phosphate metabolic process [GO:0006753]; nucleotide metabolic process [GO:0009117]; ribonucleoside diphosphate catabolic process [GO:0009191]; ribose phosphate metabolic process [GO:0019693] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634] 8-oxo-dGDP phosphatase activity [GO:0044715]; ADP-ribose diphosphatase activity [GO:0047631]; ADP-sugar diphosphatase activity [GO:0019144]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; nucleotidyltransferase activity [GO:0016779]; protein homodimerization activity [GO:0042803]; snoRNA binding [GO:0030515] g20910.t1 P80146 49.194 372 3.41e-112 336.0 sp|P80146|SEPR_THESR Extracellular serine proteinase OS=Thermus sp. (strain Rt41A) OX=32063 PE=1 SV=3 g20911.t1 Q8AY32 84.177 474 0.0 811.0 sp|Q8AY32|SC61A_GADOC Protein transport protein Sec61 subunit alpha OS=Gadus ogac OX=8052 GN=sec61a PE=2 SV=3 g20913.t1 P23824 49.282 418 3.83e-101 314.0 sp|P23824|GATA2_CHICK GATA-binding factor 2 OS=Gallus gallus OX=9031 GN=GATA2 PE=2 SV=1 g20917.t1 P80146 50.131 383 4.9000000000000005e-117 348.0 sp|P80146|SEPR_THESR Extracellular serine proteinase OS=Thermus sp. (strain Rt41A) OX=32063 PE=1 SV=3 g20919.t1 P80146 50.269 372 8.52e-117 348.0 sp|P80146|SEPR_THESR Extracellular serine proteinase OS=Thermus sp. (strain Rt41A) OX=32063 PE=1 SV=3 g20922.t1 Q5E985 38.372 344 3.04e-84 270.0 sp|Q5E985|HYAL1_BOVIN Hyaluronidase-1 OS=Bos taurus OX=9913 GN=HYAL1 PE=2 SV=1 HYAL1_BOVIN reviewed Hyaluronidase-1 (Hyal-1) (EC 3.2.1.35) (Hyaluronoglucosaminidase-1) Bos taurus (Bovine) GO:0000302; GO:0004415; GO:0005615; GO:0005764; GO:0005975; GO:0006954; GO:0009615; GO:0030212; GO:0030214; GO:0030307; GO:0030308; GO:0031410; GO:0036117; GO:0036120; GO:0045766; GO:0045785; GO:0046677; GO:0051216; GO:0071347; GO:0071467; GO:0071493; GO:1900106 carbohydrate metabolic process [GO:0005975]; cartilage development [GO:0051216]; cellular response to interleukin-1 [GO:0071347]; cellular response to pH [GO:0071467]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; cellular response to UV-B [GO:0071493]; hyaluronan catabolic process [GO:0030214]; hyaluronan metabolic process [GO:0030212]; inflammatory response [GO:0006954]; negative regulation of cell growth [GO:0030308]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cell growth [GO:0030307]; positive regulation of hyaluranon cable assembly [GO:1900106]; response to antibiotic [GO:0046677]; response to reactive oxygen species [GO:0000302]; response to virus [GO:0009615] cytoplasmic vesicle [GO:0031410]; extracellular space [GO:0005615]; hyaluranon cable [GO:0036117]; lysosome [GO:0005764] hyalurononglucosaminidase activity [GO:0004415] g20923.t1 P80146 48.077 312 9.899999999999999e-84 263.0 sp|P80146|SEPR_THESR Extracellular serine proteinase OS=Thermus sp. (strain Rt41A) OX=32063 PE=1 SV=3 g20924.t1 Q5R4J5 31.93 285 1.27e-28 119.0 sp|Q5R4J5|SYT1_PONAB Synaptotagmin-1 OS=Pongo abelii OX=9601 GN=SYT1 PE=2 SV=1 SYT1_PONAB reviewed Synaptotagmin-1 (Synaptotagmin I) (SytI) Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0000149; GO:0001786; GO:0005509; GO:0005544; GO:0005886; GO:0030154; GO:0030276; GO:0030424; GO:0030669; GO:0030672; GO:0031045; GO:0042584; GO:0048488; GO:0048791; GO:1903235; GO:1903861 calcium ion-regulated exocytosis of neurotransmitter [GO:0048791]; cell differentiation [GO:0030154]; positive regulation of calcium ion-dependent exocytosis of neurotransmitter [GO:1903235]; positive regulation of dendrite extension [GO:1903861]; synaptic vesicle endocytosis [GO:0048488] axon [GO:0030424]; chromaffin granule membrane [GO:0042584]; clathrin-coated endocytic vesicle membrane [GO:0030669]; dense core granule [GO:0031045]; plasma membrane [GO:0005886]; synaptic vesicle membrane [GO:0030672] calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; clathrin binding [GO:0030276]; phosphatidylserine binding [GO:0001786]; SNARE binding [GO:0000149] g20927.t1 Q9D8N6 37.297 185 1.55e-23 98.6 sp|Q9D8N6|LIN37_MOUSE Protein lin-37 homolog OS=Mus musculus OX=10090 GN=Lin37 PE=1 SV=1 g20929.t1 Q9HA90 35.156 256 5.820000000000001e-31 127.0 sp|Q9HA90|EFCC1_HUMAN EF-hand and coiled-coil domain-containing protein 1 OS=Homo sapiens OX=9606 GN=EFCC1 PE=1 SV=2 g20930.t1 Q6NWG4 44.518 301 8.18e-89 273.0 sp|Q6NWG4|ANM6_DANRE Protein arginine N-methyltransferase 6 OS=Danio rerio OX=7955 GN=prmt6 PE=2 SV=2 ANM6_DANRE reviewed Protein arginine N-methyltransferase 6 (EC 2.1.1.319) (Histone-arginine N-methyltransferase PRMT6) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000785; GO:0005634; GO:0006281; GO:0006338; GO:0006355; GO:0008757; GO:0010629; GO:0016274; GO:0021782; GO:0032259; GO:0035241; GO:0035242; GO:0042054; GO:0042393; GO:0044020; GO:0045892; GO:0060041; GO:0070611; GO:0070612; GO:2000059 chromatin remodeling [GO:0006338]; DNA repair [GO:0006281]; glial cell development [GO:0021782]; methylation [GO:0032259]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of gene expression [GO:0010629]; negative regulation of ubiquitin-dependent protein catabolic process [GO:2000059]; regulation of DNA-templated transcription [GO:0006355]; retina development in camera-type eye [GO:0060041] chromatin [GO:0000785]; nucleus [GO:0005634] histone binding [GO:0042393]; histone H2AR3 methyltransferase activity [GO:0070612]; histone H3R2 methyltransferase activity [GO:0070611]; histone H4R3 methyltransferase activity [GO:0044020]; histone methyltransferase activity [GO:0042054]; protein-arginine N-methyltransferase activity [GO:0016274]; protein-arginine omega-N asymmetric methyltransferase activity [GO:0035242]; protein-arginine omega-N monomethyltransferase activity [GO:0035241]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757] g20931.t1 Q8VI56 41.333 150 3.2600000000000004e-27 117.0 sp|Q8VI56|LRP4_MOUSE Low-density lipoprotein receptor-related protein 4 OS=Mus musculus OX=10090 GN=Lrp4 PE=1 SV=3 LRP4_MOUSE reviewed Low-density lipoprotein receptor-related protein 4 (LRP-4) (LDLR dan) Mus musculus (Mouse) GO:0001822; GO:0001942; GO:0005509; GO:0005886; GO:0006897; GO:0007167; GO:0008104; GO:0009953; GO:0009954; GO:0009986; GO:0014069; GO:0015026; GO:0016055; GO:0030279; GO:0030326; GO:0030425; GO:0030971; GO:0031594; GO:0034185; GO:0035022; GO:0042475; GO:0042733; GO:0042803; GO:0043025; GO:0043113; GO:0044853; GO:0045202; GO:0048699; GO:0048813; GO:0050771; GO:0050808; GO:0051124; GO:0060173; GO:0071340; GO:0090090; GO:0097060; GO:0097104; GO:0097105; GO:0097110; GO:0150052; GO:0150094; GO:1901631; GO:1904395 amyloid-beta clearance by cellular catabolic process [GO:0150094]; dendrite morphogenesis [GO:0048813]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; embryonic limb morphogenesis [GO:0030326]; endocytosis [GO:0006897]; enzyme-linked receptor protein signaling pathway [GO:0007167]; generation of neurons [GO:0048699]; hair follicle development [GO:0001942]; intracellular protein localization [GO:0008104]; kidney development [GO:0001822]; limb development [GO:0060173]; negative regulation of axonogenesis [GO:0050771]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of ossification [GO:0030279]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of presynaptic membrane organization [GO:1901631]; positive regulation of Rac protein signal transduction [GO:0035022]; positive regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904395]; postsynaptic membrane assembly [GO:0097104]; presynaptic membrane assembly [GO:0097105]; proximal/distal pattern formation [GO:0009954]; receptor clustering [GO:0043113]; regulation of postsynapse assembly [GO:0150052]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; synapse organization [GO:0050808]; synaptic assembly at neuromuscular junction [GO:0051124]; Wnt signaling pathway [GO:0016055] cell surface [GO:0009986]; dendrite [GO:0030425]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic density [GO:0014069]; synapse [GO:0045202]; synaptic membrane [GO:0097060] apolipoprotein binding [GO:0034185]; calcium ion binding [GO:0005509]; coreceptor activity [GO:0015026]; protein homodimerization activity [GO:0042803]; receptor tyrosine kinase binding [GO:0030971]; scaffold protein binding [GO:0097110] g20931.t1 Q8VI56 37.778 180 4.29e-24 108.0 sp|Q8VI56|LRP4_MOUSE Low-density lipoprotein receptor-related protein 4 OS=Mus musculus OX=10090 GN=Lrp4 PE=1 SV=3 LRP4_MOUSE reviewed Low-density lipoprotein receptor-related protein 4 (LRP-4) (LDLR dan) Mus musculus (Mouse) GO:0001822; GO:0001942; GO:0005509; GO:0005886; GO:0006897; GO:0007167; GO:0008104; GO:0009953; GO:0009954; GO:0009986; GO:0014069; GO:0015026; GO:0016055; GO:0030279; GO:0030326; GO:0030425; GO:0030971; GO:0031594; GO:0034185; GO:0035022; GO:0042475; GO:0042733; GO:0042803; GO:0043025; GO:0043113; GO:0044853; GO:0045202; GO:0048699; GO:0048813; GO:0050771; GO:0050808; GO:0051124; GO:0060173; GO:0071340; GO:0090090; GO:0097060; GO:0097104; GO:0097105; GO:0097110; GO:0150052; GO:0150094; GO:1901631; GO:1904395 amyloid-beta clearance by cellular catabolic process [GO:0150094]; dendrite morphogenesis [GO:0048813]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; embryonic limb morphogenesis [GO:0030326]; endocytosis [GO:0006897]; enzyme-linked receptor protein signaling pathway [GO:0007167]; generation of neurons [GO:0048699]; hair follicle development [GO:0001942]; intracellular protein localization [GO:0008104]; kidney development [GO:0001822]; limb development [GO:0060173]; negative regulation of axonogenesis [GO:0050771]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of ossification [GO:0030279]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of presynaptic membrane organization [GO:1901631]; positive regulation of Rac protein signal transduction [GO:0035022]; positive regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904395]; postsynaptic membrane assembly [GO:0097104]; presynaptic membrane assembly [GO:0097105]; proximal/distal pattern formation [GO:0009954]; receptor clustering [GO:0043113]; regulation of postsynapse assembly [GO:0150052]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; synapse organization [GO:0050808]; synaptic assembly at neuromuscular junction [GO:0051124]; Wnt signaling pathway [GO:0016055] cell surface [GO:0009986]; dendrite [GO:0030425]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic density [GO:0014069]; synapse [GO:0045202]; synaptic membrane [GO:0097060] apolipoprotein binding [GO:0034185]; calcium ion binding [GO:0005509]; coreceptor activity [GO:0015026]; protein homodimerization activity [GO:0042803]; receptor tyrosine kinase binding [GO:0030971]; scaffold protein binding [GO:0097110] g20931.t1 Q8VI56 35.326 184 1.1199999999999999e-23 107.0 sp|Q8VI56|LRP4_MOUSE Low-density lipoprotein receptor-related protein 4 OS=Mus musculus OX=10090 GN=Lrp4 PE=1 SV=3 LRP4_MOUSE reviewed Low-density lipoprotein receptor-related protein 4 (LRP-4) (LDLR dan) Mus musculus (Mouse) GO:0001822; GO:0001942; GO:0005509; GO:0005886; GO:0006897; GO:0007167; GO:0008104; GO:0009953; GO:0009954; GO:0009986; GO:0014069; GO:0015026; GO:0016055; GO:0030279; GO:0030326; GO:0030425; GO:0030971; GO:0031594; GO:0034185; GO:0035022; GO:0042475; GO:0042733; GO:0042803; GO:0043025; GO:0043113; GO:0044853; GO:0045202; GO:0048699; GO:0048813; GO:0050771; GO:0050808; GO:0051124; GO:0060173; GO:0071340; GO:0090090; GO:0097060; GO:0097104; GO:0097105; GO:0097110; GO:0150052; GO:0150094; GO:1901631; GO:1904395 amyloid-beta clearance by cellular catabolic process [GO:0150094]; dendrite morphogenesis [GO:0048813]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; embryonic limb morphogenesis [GO:0030326]; endocytosis [GO:0006897]; enzyme-linked receptor protein signaling pathway [GO:0007167]; generation of neurons [GO:0048699]; hair follicle development [GO:0001942]; intracellular protein localization [GO:0008104]; kidney development [GO:0001822]; limb development [GO:0060173]; negative regulation of axonogenesis [GO:0050771]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of ossification [GO:0030279]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of presynaptic membrane organization [GO:1901631]; positive regulation of Rac protein signal transduction [GO:0035022]; positive regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904395]; postsynaptic membrane assembly [GO:0097104]; presynaptic membrane assembly [GO:0097105]; proximal/distal pattern formation [GO:0009954]; receptor clustering [GO:0043113]; regulation of postsynapse assembly [GO:0150052]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; synapse organization [GO:0050808]; synaptic assembly at neuromuscular junction [GO:0051124]; Wnt signaling pathway [GO:0016055] cell surface [GO:0009986]; dendrite [GO:0030425]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic density [GO:0014069]; synapse [GO:0045202]; synaptic membrane [GO:0097060] apolipoprotein binding [GO:0034185]; calcium ion binding [GO:0005509]; coreceptor activity [GO:0015026]; protein homodimerization activity [GO:0042803]; receptor tyrosine kinase binding [GO:0030971]; scaffold protein binding [GO:0097110] g20931.t1 Q8VI56 35.897 156 1.13e-21 101.0 sp|Q8VI56|LRP4_MOUSE Low-density lipoprotein receptor-related protein 4 OS=Mus musculus OX=10090 GN=Lrp4 PE=1 SV=3 LRP4_MOUSE reviewed Low-density lipoprotein receptor-related protein 4 (LRP-4) (LDLR dan) Mus musculus (Mouse) GO:0001822; GO:0001942; GO:0005509; GO:0005886; GO:0006897; GO:0007167; GO:0008104; GO:0009953; GO:0009954; GO:0009986; GO:0014069; GO:0015026; GO:0016055; GO:0030279; GO:0030326; GO:0030425; GO:0030971; GO:0031594; GO:0034185; GO:0035022; GO:0042475; GO:0042733; GO:0042803; GO:0043025; GO:0043113; GO:0044853; GO:0045202; GO:0048699; GO:0048813; GO:0050771; GO:0050808; GO:0051124; GO:0060173; GO:0071340; GO:0090090; GO:0097060; GO:0097104; GO:0097105; GO:0097110; GO:0150052; GO:0150094; GO:1901631; GO:1904395 amyloid-beta clearance by cellular catabolic process [GO:0150094]; dendrite morphogenesis [GO:0048813]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; embryonic limb morphogenesis [GO:0030326]; endocytosis [GO:0006897]; enzyme-linked receptor protein signaling pathway [GO:0007167]; generation of neurons [GO:0048699]; hair follicle development [GO:0001942]; intracellular protein localization [GO:0008104]; kidney development [GO:0001822]; limb development [GO:0060173]; negative regulation of axonogenesis [GO:0050771]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of ossification [GO:0030279]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of presynaptic membrane organization [GO:1901631]; positive regulation of Rac protein signal transduction [GO:0035022]; positive regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904395]; postsynaptic membrane assembly [GO:0097104]; presynaptic membrane assembly [GO:0097105]; proximal/distal pattern formation [GO:0009954]; receptor clustering [GO:0043113]; regulation of postsynapse assembly [GO:0150052]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; synapse organization [GO:0050808]; synaptic assembly at neuromuscular junction [GO:0051124]; Wnt signaling pathway [GO:0016055] cell surface [GO:0009986]; dendrite [GO:0030425]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic density [GO:0014069]; synapse [GO:0045202]; synaptic membrane [GO:0097060] apolipoprotein binding [GO:0034185]; calcium ion binding [GO:0005509]; coreceptor activity [GO:0015026]; protein homodimerization activity [GO:0042803]; receptor tyrosine kinase binding [GO:0030971]; scaffold protein binding [GO:0097110] g20932.t1 O75581 31.496 508 1.83e-67 253.0 sp|O75581|LRP6_HUMAN Low-density lipoprotein receptor-related protein 6 OS=Homo sapiens OX=9606 GN=LRP6 PE=1 SV=2 LRP6_HUMAN reviewed Low-density lipoprotein receptor-related protein 6 (LRP-6) Homo sapiens (Human) GO:0005041; GO:0005102; GO:0005109; GO:0005576; GO:0005783; GO:0005886; GO:0006897; GO:0007204; GO:0007268; GO:0007399; GO:0009986; GO:0014029; GO:0014033; GO:0015026; GO:0016055; GO:0017147; GO:0019210; GO:0019534; GO:0030291; GO:0031410; GO:0031901; GO:0034392; GO:0042802; GO:0042803; GO:0042813; GO:0043025; GO:0043434; GO:0045121; GO:0045202; GO:0045787; GO:0045893; GO:0045944; GO:0060070; GO:0071397; GO:0071542; GO:0072659; GO:0098609; GO:1904948; GO:1990851; GO:1990909 canonical Wnt signaling pathway [GO:0060070]; cell-cell adhesion [GO:0098609]; cellular response to cholesterol [GO:0071397]; chemical synaptic transmission [GO:0007268]; dopaminergic neuron differentiation [GO:0071542]; endocytosis [GO:0006897]; midbrain dopaminergic neuron differentiation [GO:1904948]; negative regulation of smooth muscle cell apoptotic process [GO:0034392]; nervous system development [GO:0007399]; neural crest cell differentiation [GO:0014033]; neural crest formation [GO:0014029]; positive regulation of cell cycle [GO:0045787]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein localization to plasma membrane [GO:0072659]; response to peptide hormone [GO:0043434]; Wnt signaling pathway [GO:0016055] cell surface [GO:0009986]; cytoplasmic vesicle [GO:0031410]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; membrane raft [GO:0045121]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; synapse [GO:0045202]; Wnt signalosome [GO:1990909]; Wnt-Frizzled-LRP5/6 complex [GO:1990851] coreceptor activity [GO:0015026]; frizzled binding [GO:0005109]; identical protein binding [GO:0042802]; kinase inhibitor activity [GO:0019210]; low-density lipoprotein particle receptor activity [GO:0005041]; protein homodimerization activity [GO:0042803]; protein serine/threonine kinase inhibitor activity [GO:0030291]; signaling receptor binding [GO:0005102]; toxin transmembrane transporter activity [GO:0019534]; Wnt receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147] g20932.t1 O75581 30.609 624 1.2800000000000001e-64 244.0 sp|O75581|LRP6_HUMAN Low-density lipoprotein receptor-related protein 6 OS=Homo sapiens OX=9606 GN=LRP6 PE=1 SV=2 LRP6_HUMAN reviewed Low-density lipoprotein receptor-related protein 6 (LRP-6) Homo sapiens (Human) GO:0005041; GO:0005102; GO:0005109; GO:0005576; GO:0005783; GO:0005886; GO:0006897; GO:0007204; GO:0007268; GO:0007399; GO:0009986; GO:0014029; GO:0014033; GO:0015026; GO:0016055; GO:0017147; GO:0019210; GO:0019534; GO:0030291; GO:0031410; GO:0031901; GO:0034392; GO:0042802; GO:0042803; GO:0042813; GO:0043025; GO:0043434; GO:0045121; GO:0045202; GO:0045787; GO:0045893; GO:0045944; GO:0060070; GO:0071397; GO:0071542; GO:0072659; GO:0098609; GO:1904948; GO:1990851; GO:1990909 canonical Wnt signaling pathway [GO:0060070]; cell-cell adhesion [GO:0098609]; cellular response to cholesterol [GO:0071397]; chemical synaptic transmission [GO:0007268]; dopaminergic neuron differentiation [GO:0071542]; endocytosis [GO:0006897]; midbrain dopaminergic neuron differentiation [GO:1904948]; negative regulation of smooth muscle cell apoptotic process [GO:0034392]; nervous system development [GO:0007399]; neural crest cell differentiation [GO:0014033]; neural crest formation [GO:0014029]; positive regulation of cell cycle [GO:0045787]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein localization to plasma membrane [GO:0072659]; response to peptide hormone [GO:0043434]; Wnt signaling pathway [GO:0016055] cell surface [GO:0009986]; cytoplasmic vesicle [GO:0031410]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; membrane raft [GO:0045121]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; synapse [GO:0045202]; Wnt signalosome [GO:1990909]; Wnt-Frizzled-LRP5/6 complex [GO:1990851] coreceptor activity [GO:0015026]; frizzled binding [GO:0005109]; identical protein binding [GO:0042802]; kinase inhibitor activity [GO:0019210]; low-density lipoprotein particle receptor activity [GO:0005041]; protein homodimerization activity [GO:0042803]; protein serine/threonine kinase inhibitor activity [GO:0030291]; signaling receptor binding [GO:0005102]; toxin transmembrane transporter activity [GO:0019534]; Wnt receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147] g20932.t1 O75581 29.336 467 1.34e-51 202.0 sp|O75581|LRP6_HUMAN Low-density lipoprotein receptor-related protein 6 OS=Homo sapiens OX=9606 GN=LRP6 PE=1 SV=2 LRP6_HUMAN reviewed Low-density lipoprotein receptor-related protein 6 (LRP-6) Homo sapiens (Human) GO:0005041; GO:0005102; GO:0005109; GO:0005576; GO:0005783; GO:0005886; GO:0006897; GO:0007204; GO:0007268; GO:0007399; GO:0009986; GO:0014029; GO:0014033; GO:0015026; GO:0016055; GO:0017147; GO:0019210; GO:0019534; GO:0030291; GO:0031410; GO:0031901; GO:0034392; GO:0042802; GO:0042803; GO:0042813; GO:0043025; GO:0043434; GO:0045121; GO:0045202; GO:0045787; GO:0045893; GO:0045944; GO:0060070; GO:0071397; GO:0071542; GO:0072659; GO:0098609; GO:1904948; GO:1990851; GO:1990909 canonical Wnt signaling pathway [GO:0060070]; cell-cell adhesion [GO:0098609]; cellular response to cholesterol [GO:0071397]; chemical synaptic transmission [GO:0007268]; dopaminergic neuron differentiation [GO:0071542]; endocytosis [GO:0006897]; midbrain dopaminergic neuron differentiation [GO:1904948]; negative regulation of smooth muscle cell apoptotic process [GO:0034392]; nervous system development [GO:0007399]; neural crest cell differentiation [GO:0014033]; neural crest formation [GO:0014029]; positive regulation of cell cycle [GO:0045787]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein localization to plasma membrane [GO:0072659]; response to peptide hormone [GO:0043434]; Wnt signaling pathway [GO:0016055] cell surface [GO:0009986]; cytoplasmic vesicle [GO:0031410]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; membrane raft [GO:0045121]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; synapse [GO:0045202]; Wnt signalosome [GO:1990909]; Wnt-Frizzled-LRP5/6 complex [GO:1990851] coreceptor activity [GO:0015026]; frizzled binding [GO:0005109]; identical protein binding [GO:0042802]; kinase inhibitor activity [GO:0019210]; low-density lipoprotein particle receptor activity [GO:0005041]; protein homodimerization activity [GO:0042803]; protein serine/threonine kinase inhibitor activity [GO:0030291]; signaling receptor binding [GO:0005102]; toxin transmembrane transporter activity [GO:0019534]; Wnt receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147] g20945.t1 C6KFA3 28.71 620 1.2e-58 225.0 sp|C6KFA3|AGRG6_DANRE Adhesion G-protein coupled receptor G6 OS=Danio rerio OX=7955 GN=adgrg6 PE=1 SV=1 AGRG6_DANRE reviewed Adhesion G-protein coupled receptor G6 (G-protein coupled receptor 126) [Cleaved into: Adhesion G-protein coupled receptor G6, N-terminal fragment (ADGRG6 N-terminal fragment) (ADGRG6-NTF); Adhesion G-protein coupled receptor G6, C-terminal fragment (ADGRG6 C-terminal fragment) (ADGRG6-CTF)] Danio rerio (Zebrafish) (Brachydanio rerio) GO:0004930; GO:0005518; GO:0005886; GO:0007166; GO:0007188; GO:0007189; GO:0007193; GO:0007507; GO:0014037; GO:0022011; GO:0030500; GO:0042552; GO:0043236; GO:0043583; GO:0050840; GO:0051216; GO:0060347 adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; cartilage development [GO:0051216]; cell surface receptor signaling pathway [GO:0007166]; ear development [GO:0043583]; heart development [GO:0007507]; heart trabecula formation [GO:0060347]; myelination [GO:0042552]; myelination in peripheral nervous system [GO:0022011]; regulation of bone mineralization [GO:0030500]; Schwann cell differentiation [GO:0014037] plasma membrane [GO:0005886] collagen binding [GO:0005518]; extracellular matrix binding [GO:0050840]; G protein-coupled receptor activity [GO:0004930]; laminin binding [GO:0043236] g20950.t1 Q8NHV4 39.909 441 6.21e-96 314.0 sp|Q8NHV4|NEDD1_HUMAN Protein NEDD1 OS=Homo sapiens OX=9606 GN=NEDD1 PE=1 SV=1 NEDD1_HUMAN reviewed Protein NEDD1 (Neural precursor cell expressed developmentally down-regulated protein 1) (NEDD-1) Homo sapiens (Human) GO:0000242; GO:0000278; GO:0000922; GO:0001650; GO:0005654; GO:0005737; GO:0005813; GO:0005814; GO:0005829; GO:0007020; GO:0036064; GO:0043015; GO:0045177; GO:0051301 cell division [GO:0051301]; microtubule nucleation [GO:0007020]; mitotic cell cycle [GO:0000278] apical part of cell [GO:0045177]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; pericentriolar material [GO:0000242]; spindle pole [GO:0000922] gamma-tubulin binding [GO:0043015] g20950.t2 Q8NHV4 39.909 441 2.8e-96 314.0 sp|Q8NHV4|NEDD1_HUMAN Protein NEDD1 OS=Homo sapiens OX=9606 GN=NEDD1 PE=1 SV=1 NEDD1_HUMAN reviewed Protein NEDD1 (Neural precursor cell expressed developmentally down-regulated protein 1) (NEDD-1) Homo sapiens (Human) GO:0000242; GO:0000278; GO:0000922; GO:0001650; GO:0005654; GO:0005737; GO:0005813; GO:0005814; GO:0005829; GO:0007020; GO:0036064; GO:0043015; GO:0045177; GO:0051301 cell division [GO:0051301]; microtubule nucleation [GO:0007020]; mitotic cell cycle [GO:0000278] apical part of cell [GO:0045177]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; pericentriolar material [GO:0000242]; spindle pole [GO:0000922] gamma-tubulin binding [GO:0043015] g20951.t1 Q9VQ56 82.011 189 4.0699999999999996e-111 343.0 sp|Q9VQ56|ERM_DROME Fez family zinc finger protein erm OS=Drosophila melanogaster OX=7227 GN=erm PE=1 SV=2 ERM_DROME reviewed Fez family zinc finger protein erm (Earmuff) Drosophila melanogaster (Fruit fly) GO:0000976; GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0007406; GO:0007412; GO:0008270; GO:0010628; GO:0010629; GO:0019827; GO:0043025; GO:0043565; GO:0043697; GO:0044295; GO:0045666; GO:0045892; GO:0050767; GO:0060385; GO:0072499; GO:1902692; GO:1902843 axon target recognition [GO:0007412]; axonogenesis involved in innervation [GO:0060385]; cell dedifferentiation [GO:0043697]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of gene expression [GO:0010629]; negative regulation of neuroblast proliferation [GO:0007406]; photoreceptor cell axon guidance [GO:0072499]; positive regulation of gene expression [GO:0010628]; positive regulation of netrin-activated signaling pathway [GO:1902843]; positive regulation of neuron differentiation [GO:0045666]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of transcription by RNA polymerase II [GO:0006357]; stem cell population maintenance [GO:0019827] axonal growth cone [GO:0044295]; neuronal cell body [GO:0043025]; nucleus [GO:0005634] DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription cis-regulatory region binding [GO:0000976]; zinc ion binding [GO:0008270] g20953.t1 Q9V3G7 71.722 389 0.0 586.0 sp|Q9V3G7|PSMD6_DROME 26S proteasome non-ATPase regulatory subunit 6 OS=Drosophila melanogaster OX=7227 GN=Rpn7 PE=2 SV=1 g20954.t1 P82669 53.503 157 4.2500000000000006e-59 184.0 sp|P82669|RT25_BOVIN Small ribosomal subunit protein mS25 OS=Bos taurus OX=9913 GN=MRPS25 PE=1 SV=2 g20956.t1 Q8NEE6 39.704 675 1.13e-156 479.0 sp|Q8NEE6|FXL13_HUMAN F-box and leucine-rich repeat protein 13 OS=Homo sapiens OX=9606 GN=FBXL13 PE=1 SV=3 FXL13_HUMAN reviewed F-box and leucine-rich repeat protein 13 (Dynein regulatory complex subunit 6) (F-box/LRR-repeat protein 13) Homo sapiens (Human) GO:0005813; GO:0005829; GO:0019005; GO:0031146 SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146] centrosome [GO:0005813]; cytosol [GO:0005829]; SCF ubiquitin ligase complex [GO:0019005] g20956.t2 Q8NEE6 39.704 675 2.1800000000000002e-156 479.0 sp|Q8NEE6|FXL13_HUMAN F-box and leucine-rich repeat protein 13 OS=Homo sapiens OX=9606 GN=FBXL13 PE=1 SV=3 FXL13_HUMAN reviewed F-box and leucine-rich repeat protein 13 (Dynein regulatory complex subunit 6) (F-box/LRR-repeat protein 13) Homo sapiens (Human) GO:0005813; GO:0005829; GO:0019005; GO:0031146 SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146] centrosome [GO:0005813]; cytosol [GO:0005829]; SCF ubiquitin ligase complex [GO:0019005] g20959.t1 Q6AZD4 61.224 98 3.52e-35 134.0 sp|Q6AZD4|IMP2L_DANRE Mitochondrial inner membrane protease subunit 2 OS=Danio rerio OX=7955 GN=immp2l PE=2 SV=1 IMP2L_DANRE reviewed Mitochondrial inner membrane protease subunit 2 (EC 3.4.21.-) (IMP2-like protein) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0004175; GO:0004252; GO:0006465; GO:0006627; GO:0042720 protein processing involved in protein targeting to mitochondrion [GO:0006627]; signal peptide processing [GO:0006465] mitochondrial inner membrane peptidase complex [GO:0042720] endopeptidase activity [GO:0004175]; serine-type endopeptidase activity [GO:0004252] g20959.t2 Q6AZD4 63.333 90 4.07e-32 126.0 sp|Q6AZD4|IMP2L_DANRE Mitochondrial inner membrane protease subunit 2 OS=Danio rerio OX=7955 GN=immp2l PE=2 SV=1 IMP2L_DANRE reviewed Mitochondrial inner membrane protease subunit 2 (EC 3.4.21.-) (IMP2-like protein) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0004175; GO:0004252; GO:0006465; GO:0006627; GO:0042720 protein processing involved in protein targeting to mitochondrion [GO:0006627]; signal peptide processing [GO:0006465] mitochondrial inner membrane peptidase complex [GO:0042720] endopeptidase activity [GO:0004175]; serine-type endopeptidase activity [GO:0004252] g20961.t1 Q9D8U8 29.744 390 7.28e-24 105.0 sp|Q9D8U8|SNX5_MOUSE Sorting nexin-5 OS=Mus musculus OX=10090 GN=Snx5 PE=1 SV=1 SNX5_MOUSE reviewed Sorting nexin-5 Mus musculus (Mouse) GO:0001726; GO:0001891; GO:0005768; GO:0005829; GO:0005903; GO:0006886; GO:0006907; GO:0007174; GO:0009898; GO:0010314; GO:0030904; GO:0031748; GO:0034452; GO:0035091; GO:0042147; GO:0045776; GO:0045893; GO:0046628; GO:0048471; GO:0070273; GO:0070685; GO:0080025; GO:0097422; GO:0098559 epidermal growth factor catabolic process [GO:0007174]; intracellular protein transport [GO:0006886]; negative regulation of blood pressure [GO:0045776]; pinocytosis [GO:0006907]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of insulin receptor signaling pathway [GO:0046628]; retrograde transport, endosome to Golgi [GO:0042147] brush border [GO:0005903]; cytoplasmic side of early endosome membrane [GO:0098559]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; endosome [GO:0005768]; macropinocytic cup [GO:0070685]; perinuclear region of cytoplasm [GO:0048471]; phagocytic cup [GO:0001891]; retromer complex [GO:0030904]; ruffle [GO:0001726]; tubular endosome [GO:0097422] D1 dopamine receptor binding [GO:0031748]; dynactin binding [GO:0034452]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-4-phosphate binding [GO:0070273]; phosphatidylinositol-5-phosphate binding [GO:0010314] g20963.t1 Q68FS3 30.785 497 1.2600000000000001e-37 149.0 sp|Q68FS3|FBX7_RAT F-box only protein 7 OS=Rattus norvegicus OX=10116 GN=Fbxo7 PE=2 SV=1 FBX7_RAT reviewed F-box only protein 7 Rattus norvegicus (Rat) GO:0000151; GO:0000422; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0006511; GO:0006626; GO:0010975; GO:0016567; GO:0019005; GO:0019901; GO:0030098; GO:0031625; GO:0031647; GO:0032991; GO:0040012; GO:0043130; GO:0043161; GO:0043524; GO:0045620; GO:0046982; GO:0070936; GO:0097409; GO:0097414; GO:0097462; GO:1901526; GO:1903377; GO:1903599; GO:1990037; GO:1990038; GO:1990756; GO:2000134 autophagy of mitochondrion [GO:0000422]; lymphocyte differentiation [GO:0030098]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of lymphocyte differentiation [GO:0045620]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway [GO:1903377]; positive regulation of autophagy of mitochondrion [GO:1903599]; positive regulation of mitophagy [GO:1901526]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K48-linked ubiquitination [GO:0070936]; protein targeting to mitochondrion [GO:0006626]; protein ubiquitination [GO:0016567]; regulation of locomotion [GO:0040012]; regulation of neuron projection development [GO:0010975]; regulation of protein stability [GO:0031647]; ubiquitin-dependent protein catabolic process [GO:0006511] classical Lewy body [GO:0097414]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; glial cytoplasmic inclusion [GO:0097409]; Lewy body core [GO:1990037]; Lewy body corona [GO:1990038]; Lewy neurite [GO:0097462]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; SCF ubiquitin ligase complex [GO:0019005]; ubiquitin ligase complex [GO:0000151] protein heterodimerization activity [GO:0046982]; protein kinase binding [GO:0019901]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-like ligase-substrate adaptor activity [GO:1990756] g20964.t1 Q6QM28 48.057 283 1.3e-80 253.0 sp|Q6QM28|SYN_HELPO Synapsin OS=Helix pomatia OX=6536 GN=SYN PE=1 SV=1 g20965.t1 P26652 30.808 198 1.68e-22 96.3 sp|P26652|TIMP3_CHICK Metalloproteinase inhibitor 3 OS=Gallus gallus OX=9031 GN=TIMP3 PE=1 SV=2 g20974.t1 P26652 31.527 203 1.0000000000000001e-21 92.8 sp|P26652|TIMP3_CHICK Metalloproteinase inhibitor 3 OS=Gallus gallus OX=9031 GN=TIMP3 PE=1 SV=2 g20975.t1 O70441 47.5 240 9.33e-68 222.0 sp|O70441|SYN3_RAT Synapsin-3 OS=Rattus norvegicus OX=10116 GN=Syn3 PE=1 SV=1 g20977.t1 P0CC00 64.348 115 3.48e-48 152.0 sp|P0CC00|NDUA5_PONPY NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5 OS=Pongo pygmaeus OX=9600 GN=NDUFA5 PE=3 SV=1 g20979.t1 Q9Y6G3 47.244 127 1.06e-28 105.0 sp|Q9Y6G3|RM42_HUMAN Large ribosomal subunit protein mL42 OS=Homo sapiens OX=9606 GN=MRPL42 PE=1 SV=1 g20980.t1 Q04832 40.323 248 1.5e-34 127.0 sp|Q04832|HEXP_LEIMA DNA-binding protein HEXBP OS=Leishmania major OX=5664 GN=HEXBP PE=4 SV=1 g20980.t1 Q04832 43.556 225 2.71e-34 127.0 sp|Q04832|HEXP_LEIMA DNA-binding protein HEXBP OS=Leishmania major OX=5664 GN=HEXBP PE=4 SV=1 g20980.t1 Q04832 38.919 185 1.34e-26 107.0 sp|Q04832|HEXP_LEIMA DNA-binding protein HEXBP OS=Leishmania major OX=5664 GN=HEXBP PE=4 SV=1 g20980.t1 Q04832 37.791 172 7.16e-21 91.7 sp|Q04832|HEXP_LEIMA DNA-binding protein HEXBP OS=Leishmania major OX=5664 GN=HEXBP PE=4 SV=1 g20980.t2 Q04832 44.393 214 2.19e-38 137.0 sp|Q04832|HEXP_LEIMA DNA-binding protein HEXBP OS=Leishmania major OX=5664 GN=HEXBP PE=4 SV=1 g20980.t2 Q04832 45.161 217 2.93e-34 127.0 sp|Q04832|HEXP_LEIMA DNA-binding protein HEXBP OS=Leishmania major OX=5664 GN=HEXBP PE=4 SV=1 g20980.t2 Q04832 44.792 192 6.080000000000001e-27 107.0 sp|Q04832|HEXP_LEIMA DNA-binding protein HEXBP OS=Leishmania major OX=5664 GN=HEXBP PE=4 SV=1 g20980.t2 Q04832 38.919 185 1.25e-26 107.0 sp|Q04832|HEXP_LEIMA DNA-binding protein HEXBP OS=Leishmania major OX=5664 GN=HEXBP PE=4 SV=1 g20980.t2 Q04832 37.791 172 6.72e-21 91.7 sp|Q04832|HEXP_LEIMA DNA-binding protein HEXBP OS=Leishmania major OX=5664 GN=HEXBP PE=4 SV=1 g20981.t1 Q04832 29.457 258 6.800000000000001e-29 114.0 sp|Q04832|HEXP_LEIMA DNA-binding protein HEXBP OS=Leishmania major OX=5664 GN=HEXBP PE=4 SV=1 g20981.t1 Q04832 30.233 258 2.7000000000000004e-26 107.0 sp|Q04832|HEXP_LEIMA DNA-binding protein HEXBP OS=Leishmania major OX=5664 GN=HEXBP PE=4 SV=1 g20981.t1 Q04832 36.667 180 2.75e-26 107.0 sp|Q04832|HEXP_LEIMA DNA-binding protein HEXBP OS=Leishmania major OX=5664 GN=HEXBP PE=4 SV=1 g20981.t1 Q04832 33.971 209 1.35e-22 97.4 sp|Q04832|HEXP_LEIMA DNA-binding protein HEXBP OS=Leishmania major OX=5664 GN=HEXBP PE=4 SV=1 g20982.t1 Q71SG7 37.838 370 1.15e-72 235.0 sp|Q71SG7|GCNT4_DANRE Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase 4 OS=Danio rerio OX=7955 GN=gcnt4 PE=2 SV=2 g20985.t1 Q8R2S9 56.41 585 0.0 672.0 sp|Q8R2S9|ARP8_MOUSE Actin-related protein 8 OS=Mus musculus OX=10090 GN=Actr8 PE=2 SV=1 ARP8_MOUSE reviewed Actin-related protein 8 Mus musculus (Mouse) GO:0000723; GO:0005524; GO:0005634; GO:0005654; GO:0005813; GO:0006275; GO:0006282; GO:0006302; GO:0006310; GO:0006338; GO:0006355; GO:0031011; GO:0033044; GO:0045739; GO:0045893; GO:0045995; GO:0051301; GO:0051726; GO:0060382; GO:1904507 cell division [GO:0051301]; chromatin remodeling [GO:0006338]; DNA recombination [GO:0006310]; double-strand break repair [GO:0006302]; positive regulation of DNA repair [GO:0045739]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of telomere maintenance in response to DNA damage [GO:1904507]; regulation of cell cycle [GO:0051726]; regulation of chromosome organization [GO:0033044]; regulation of DNA repair [GO:0006282]; regulation of DNA replication [GO:0006275]; regulation of DNA strand elongation [GO:0060382]; regulation of DNA-templated transcription [GO:0006355]; regulation of embryonic development [GO:0045995]; telomere maintenance [GO:0000723] centrosome [GO:0005813]; Ino80 complex [GO:0031011]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] ATP binding [GO:0005524] g20986.t1 P42768 50.0 140 3.97e-40 154.0 sp|P42768|WASP_HUMAN Actin nucleation-promoting factor WAS OS=Homo sapiens OX=9606 GN=WAS PE=1 SV=4 WASP_HUMAN reviewed Actin nucleation-promoting factor WAS (Wiskott-Aldrich syndrome protein) (WASp) Homo sapiens (Human) GO:0002625; GO:0003779; GO:0005634; GO:0005829; GO:0005884; GO:0005886; GO:0005911; GO:0006952; GO:0006955; GO:0007596; GO:0008064; GO:0008154; GO:0008544; GO:0010591; GO:0012506; GO:0015629; GO:0016197; GO:0017124; GO:0019901; GO:0030041; GO:0030048; GO:0030695; GO:0031267; GO:0032488; GO:0035861; GO:0042110; GO:0042802; GO:0043274; GO:0045335; GO:0045944; GO:0051492; GO:0051497; GO:0065003; GO:0070062; GO:0071346; GO:1905168; GO:2000146 actin filament polymerization [GO:0030041]; actin filament-based movement [GO:0030048]; actin polymerization or depolymerization [GO:0008154]; blood coagulation [GO:0007596]; Cdc42 protein signal transduction [GO:0032488]; cellular response to type II interferon [GO:0071346]; defense response [GO:0006952]; endosomal transport [GO:0016197]; epidermis development [GO:0008544]; immune response [GO:0006955]; negative regulation of cell motility [GO:2000146]; negative regulation of stress fiber assembly [GO:0051497]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein-containing complex assembly [GO:0065003]; regulation of actin polymerization or depolymerization [GO:0008064]; regulation of lamellipodium assembly [GO:0010591]; regulation of stress fiber assembly [GO:0051492]; regulation of T cell antigen processing and presentation [GO:0002625]; T cell activation [GO:0042110] actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; cell-cell junction [GO:0005911]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; site of double-strand break [GO:0035861]; vesicle membrane [GO:0012506] actin binding [GO:0003779]; GTPase regulator activity [GO:0030695]; identical protein binding [GO:0042802]; phospholipase binding [GO:0043274]; protein kinase binding [GO:0019901]; SH3 domain binding [GO:0017124]; small GTPase binding [GO:0031267] g20986.t2 P42768 41.534 313 7e-63 216.0 sp|P42768|WASP_HUMAN Actin nucleation-promoting factor WAS OS=Homo sapiens OX=9606 GN=WAS PE=1 SV=4 WASP_HUMAN reviewed Actin nucleation-promoting factor WAS (Wiskott-Aldrich syndrome protein) (WASp) Homo sapiens (Human) GO:0002625; GO:0003779; GO:0005634; GO:0005829; GO:0005884; GO:0005886; GO:0005911; GO:0006952; GO:0006955; GO:0007596; GO:0008064; GO:0008154; GO:0008544; GO:0010591; GO:0012506; GO:0015629; GO:0016197; GO:0017124; GO:0019901; GO:0030041; GO:0030048; GO:0030695; GO:0031267; GO:0032488; GO:0035861; GO:0042110; GO:0042802; GO:0043274; GO:0045335; GO:0045944; GO:0051492; GO:0051497; GO:0065003; GO:0070062; GO:0071346; GO:1905168; GO:2000146 actin filament polymerization [GO:0030041]; actin filament-based movement [GO:0030048]; actin polymerization or depolymerization [GO:0008154]; blood coagulation [GO:0007596]; Cdc42 protein signal transduction [GO:0032488]; cellular response to type II interferon [GO:0071346]; defense response [GO:0006952]; endosomal transport [GO:0016197]; epidermis development [GO:0008544]; immune response [GO:0006955]; negative regulation of cell motility [GO:2000146]; negative regulation of stress fiber assembly [GO:0051497]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein-containing complex assembly [GO:0065003]; regulation of actin polymerization or depolymerization [GO:0008064]; regulation of lamellipodium assembly [GO:0010591]; regulation of stress fiber assembly [GO:0051492]; regulation of T cell antigen processing and presentation [GO:0002625]; T cell activation [GO:0042110] actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; cell-cell junction [GO:0005911]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; site of double-strand break [GO:0035861]; vesicle membrane [GO:0012506] actin binding [GO:0003779]; GTPase regulator activity [GO:0030695]; identical protein binding [GO:0042802]; phospholipase binding [GO:0043274]; protein kinase binding [GO:0019901]; SH3 domain binding [GO:0017124]; small GTPase binding [GO:0031267] g20987.t1 P25207 61.677 167 1.2999999999999999e-61 193.0 sp|P25207|NFYB_CHICK Nuclear transcription factor Y subunit beta OS=Gallus gallus OX=9031 GN=NFYB PE=2 SV=2 g20987.t2 P25207 59.884 172 4.400000000000001e-59 187.0 sp|P25207|NFYB_CHICK Nuclear transcription factor Y subunit beta OS=Gallus gallus OX=9031 GN=NFYB PE=2 SV=2 g20989.t1 Q9I8E6 74.078 868 0.0 1255.0 sp|Q9I8E6|COPG2_TAKRU Coatomer subunit gamma-2 OS=Takifugu rubripes OX=31033 GN=copg2 PE=3 SV=1 g20990.t1 Q9SA71 28.842 423 3.9499999999999996e-30 125.0 sp|Q9SA71|GLPT3_ARATH Putative glycerol-3-phosphate transporter 3 OS=Arabidopsis thaliana OX=3702 GN=At1g30560 PE=3 SV=1 g20992.t1 B2GUB3 48.558 624 0.0 596.0 sp|B2GUB3|TTLL3_XENTR Tubulin tyrosine ligase 3 OS=Xenopus tropicalis OX=8364 GN=ttll3 PE=1 SV=1 TTLL3_XENTR reviewed Tubulin tyrosine ligase 3 (EC 6.3.2.-) (Tubulin--tyrosine ligase protein 3) Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0005524; GO:0005874; GO:0005930; GO:0018094; GO:0046872; GO:0070736 protein polyglycylation [GO:0018094] axoneme [GO:0005930]; microtubule [GO:0005874] ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein-glycine ligase activity, initiating [GO:0070736] g20992.t2 B2GUB3 48.558 624 0.0 596.0 sp|B2GUB3|TTLL3_XENTR Tubulin tyrosine ligase 3 OS=Xenopus tropicalis OX=8364 GN=ttll3 PE=1 SV=1 TTLL3_XENTR reviewed Tubulin tyrosine ligase 3 (EC 6.3.2.-) (Tubulin--tyrosine ligase protein 3) Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0005524; GO:0005874; GO:0005930; GO:0018094; GO:0046872; GO:0070736 protein polyglycylation [GO:0018094] axoneme [GO:0005930]; microtubule [GO:0005874] ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein-glycine ligase activity, initiating [GO:0070736] g20993.t1 Q9DC53 63.705 529 0.0 724.0 sp|Q9DC53|CPNE8_MOUSE Copine-8 OS=Mus musculus OX=10090 GN=Cpne8 PE=2 SV=3 g20994.t1 Q5BKT4 41.86 473 4.37e-124 372.0 sp|Q5BKT4|AG10A_HUMAN Dol-P-Glc:Glc(2)Man(9)GlcNAc(2)-PP-Dol alpha-1,2-glucosyltransferase OS=Homo sapiens OX=9606 GN=ALG10 PE=1 SV=1 AG10A_HUMAN reviewed Dol-P-Glc:Glc(2)Man(9)GlcNAc(2)-PP-Dol alpha-1,2-glucosyltransferase A (EC 2.4.1.256) (Alpha-1,2-glucosyltransferase ALG10-A) (Alpha-2-glucosyltransferase ALG10-A) (Asparagine-linked glycosylation protein 10 homolog A) Homo sapiens (Human) GO:0005783; GO:0005789; GO:0006487; GO:0006488; GO:0106073 dolichol-linked oligosaccharide biosynthetic process [GO:0006488]; protein N-linked glycosylation [GO:0006487] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789] dolichyl pyrophosphate Glc2Man9GlcNAc2 alpha-1,2-glucosyltransferase activity [GO:0106073] g20995.t1 Q8QZZ7 43.103 174 1.2999999999999999e-46 153.0 sp|Q8QZZ7|TPRKB_MOUSE EKC/KEOPS complex subunit Tprkb OS=Mus musculus OX=10090 GN=Tprkb PE=1 SV=1 g20996.t1 Q9VKV8 81.865 193 2.64e-121 344.0 sp|Q9VKV8|CFA20_DROME Cilia- and flagella-associated protein 20 OS=Drosophila melanogaster OX=7227 GN=Bug22 PE=1 SV=1 CFA20_DROME reviewed Cilia- and flagella-associated protein 20 (Basal body up-regulated protein 22) Drosophila melanogaster (Fruit fly) GO:0000398; GO:0005634; GO:0005730; GO:0005814; GO:0005879; GO:0005929; GO:0007288; GO:0007291; GO:0018094; GO:0031514; GO:0036064; GO:0036126; GO:0040011; GO:0044782; GO:0060271; GO:0060296; GO:0071011; GO:0071013; GO:1902093; GO:2000147 cilium assembly [GO:0060271]; cilium organization [GO:0044782]; locomotion [GO:0040011]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of cell motility [GO:2000147]; positive regulation of flagellated sperm motility [GO:1902093]; protein polyglycylation [GO:0018094]; regulation of cilium beat frequency involved in ciliary motility [GO:0060296]; sperm axoneme assembly [GO:0007288]; sperm individualization [GO:0007291] axonemal microtubule [GO:0005879]; catalytic step 2 spliceosome [GO:0071013]; centriole [GO:0005814]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; motile cilium [GO:0031514]; nucleolus [GO:0005730]; nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; sperm flagellum [GO:0036126] g20997.t1 Q91XA8 35.447 347 2.7600000000000003e-64 211.0 sp|Q91XA8|KLD8A_MOUSE Kelch domain-containing protein 8A OS=Mus musculus OX=10090 GN=Klhdc8a PE=2 SV=1 g21012.t1 Q1JP73 51.94 335 9.78e-127 370.0 sp|Q1JP73|QNG1_BOVIN Queuosine 5'-phosphate N-glycosylase/hydrolase OS=Bos taurus OX=9913 GN=QNG1 PE=2 SV=1 g21013.t1 Q93075 45.896 268 1.21e-78 279.0 sp|Q93075|TATD2_HUMAN 3'-5' RNA nuclease TATDN2 OS=Homo sapiens OX=9606 GN=TATDN2 PE=1 SV=2 g21014.t1 Q8WWW0 38.384 297 2.96e-62 213.0 sp|Q8WWW0|RASF5_HUMAN Ras association domain-containing protein 5 OS=Homo sapiens OX=9606 GN=RASSF5 PE=1 SV=1 RASF5_HUMAN reviewed Ras association domain-containing protein 5 (New ras effector 1) (Regulator for cell adhesion and polarization enriched in lymphoid tissues) (RAPL) Homo sapiens (Human) GO:0005634; GO:0005737; GO:0005874; GO:0006915; GO:0007165; GO:0008270; GO:0031398; GO:0042802; GO:0046651; GO:0050672; GO:1900180 apoptotic process [GO:0006915]; lymphocyte proliferation [GO:0046651]; negative regulation of lymphocyte proliferation [GO:0050672]; positive regulation of protein ubiquitination [GO:0031398]; regulation of protein localization to nucleus [GO:1900180]; signal transduction [GO:0007165] cytoplasm [GO:0005737]; microtubule [GO:0005874]; nucleus [GO:0005634] identical protein binding [GO:0042802]; zinc ion binding [GO:0008270] g21016.t1 Q63ZY7 55.319 141 5.52e-51 163.0 sp|Q63ZY7|UXT_RAT Protein UXT OS=Rattus norvegicus OX=10116 GN=Uxt PE=2 SV=1 g21017.t1 Q6P643 61.497 187 1.66e-76 232.0 sp|Q6P643|THOC7_XENTR THO complex subunit 7 homolog OS=Xenopus tropicalis OX=8364 GN=thoc7 PE=2 SV=1 g21021.t1 A2RV80 35.409 514 5.05e-88 288.0 sp|A2RV80|GRAM4_XENLA GRAM domain-containing protein 4 OS=Xenopus laevis OX=8355 GN=gramd4 PE=2 SV=1 g21023.t1 Q5RGV1 73.84 539 0.0 816.0 sp|Q5RGV1|IMDH3_DANRE Inosine-5'-monophosphate dehydrogenase 1b OS=Danio rerio OX=7955 GN=impdh1b PE=2 SV=1 g21023.t2 Q5RGV1 77.027 518 0.0 828.0 sp|Q5RGV1|IMDH3_DANRE Inosine-5'-monophosphate dehydrogenase 1b OS=Danio rerio OX=7955 GN=impdh1b PE=2 SV=1 g21025.t1 O18404 69.231 234 1.33e-121 350.0 sp|O18404|HCD2_DROME 3-hydroxyacyl-CoA dehydrogenase type-2 OS=Drosophila melanogaster OX=7227 GN=scu PE=1 SV=1 HCD2_DROME reviewed 3-hydroxyacyl-CoA dehydrogenase type-2 (EC 1.1.1.35) (17-beta-hydroxysteroid dehydrogenase 10) (17-beta-HSD 10) (EC 1.1.1.51, EC 1.1.1.62) (3-hydroxyacyl-CoA dehydrogenase type II) (Hydroxysteroid dehydrogenase) (EC 1.1.1.-, EC 1.1.1.53) (Mitochondrial ribonuclease P protein 2) (Mitochondrial RNase P protein 2) (Scully protein) (Type II HADH) Drosophila melanogaster (Fruit fly) GO:0003857; GO:0004303; GO:0005739; GO:0005759; GO:0006631; GO:0006637; GO:0008202; GO:0008205; GO:0008209; GO:0008210; GO:0030678; GO:0044594; GO:0047015; GO:0047035; GO:0047044; GO:0090646; GO:0097745; GO:0106282; GO:0106283; GO:0140040 acyl-CoA metabolic process [GO:0006637]; androgen metabolic process [GO:0008209]; ecdysone metabolic process [GO:0008205]; estrogen metabolic process [GO:0008210]; fatty acid metabolic process [GO:0006631]; mitochondrial polycistronic RNA processing [GO:0140040]; mitochondrial tRNA 5'-end processing [GO:0097745]; mitochondrial tRNA processing [GO:0090646]; steroid metabolic process [GO:0008202] mitochondrial matrix [GO:0005759]; mitochondrial ribonuclease P complex [GO:0030678]; mitochondrion [GO:0005739] (3S)-3-hydroxyacyl-CoA dehydrogenase (NAD+) activity [GO:0003857]; 17-beta-hydroxysteroid dehydrogenase (NAD+) activity [GO:0044594]; 3-hydroxy-2-methylbutyryl-CoA dehydrogenase activity [GO:0047015]; androstan-3-alpha,17-beta-diol dehydrogenase (NAD+) activity [GO:0047044]; estradiol 17-beta-dehydrogenase [NAD(P)+] activity [GO:0004303]; isoursodeoxycholate 7-beta-dehydrogenase (NAD+) activity [GO:0106282]; testosterone dehydrogenase (NAD+) activity [GO:0047035]; ursodeoxycholate 7-beta-dehydrogenase (NAD+) activity [GO:0106283] g21026.t1 O73775 36.612 549 1.41e-84 288.0 sp|O73775|FBLN1_CHICK Fibulin-1 OS=Gallus gallus OX=9031 GN=FBLN1 PE=2 SV=2 g21026.t1 O73775 31.56 564 1.26e-55 207.0 sp|O73775|FBLN1_CHICK Fibulin-1 OS=Gallus gallus OX=9031 GN=FBLN1 PE=2 SV=2 g21026.t1 O73775 34.043 282 5.9699999999999996e-24 111.0 sp|O73775|FBLN1_CHICK Fibulin-1 OS=Gallus gallus OX=9031 GN=FBLN1 PE=2 SV=2 g21026.t2 P37889 30.472 827 1.28e-87 308.0 sp|P37889|FBLN2_MOUSE Fibulin-2 OS=Mus musculus OX=10090 GN=Fbln2 PE=1 SV=2 g21028.t1 Q9CU62 63.936 1245 0.0 1431.0 sp|Q9CU62|SMC1A_MOUSE Structural maintenance of chromosomes protein 1A OS=Mus musculus OX=10090 GN=Smc1a PE=1 SV=4 SMC1A_MOUSE reviewed Structural maintenance of chromosomes protein 1A (SMC protein 1A) (SMC-1-alpha) (SMC-1A) (Chromosome segregation protein SmcB) (Sb1.8) Mus musculus (Mouse) GO:0000776; GO:0000795; GO:0000800; GO:0003677; GO:0003682; GO:0005524; GO:0005634; GO:0005654; GO:0005829; GO:0006281; GO:0007062; GO:0008278; GO:0009314; GO:0016363; GO:0016887; GO:0019827; GO:0030892; GO:0030893; GO:0036033; GO:0046982; GO:0051301; GO:0051321; GO:0072423; GO:0090307; GO:0097431 cell division [GO:0051301]; DNA repair [GO:0006281]; meiotic cell cycle [GO:0051321]; mitotic spindle assembly [GO:0090307]; response to DNA damage checkpoint signaling [GO:0072423]; response to radiation [GO:0009314]; sister chromatid cohesion [GO:0007062]; stem cell population maintenance [GO:0019827] cohesin complex [GO:0008278]; cytosol [GO:0005829]; kinetochore [GO:0000776]; lateral element [GO:0000800]; meiotic cohesin complex [GO:0030893]; mitotic cohesin complex [GO:0030892]; mitotic spindle pole [GO:0097431]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; synaptonemal complex [GO:0000795] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; mediator complex binding [GO:0036033]; protein heterodimerization activity [GO:0046982] g21029.t1 Q90X38 41.527 537 3.84e-111 344.0 sp|Q90X38|GPKOW_DANRE G-patch domain and KOW motifs-containing protein OS=Danio rerio OX=7955 GN=gpkow PE=2 SV=2 g21030.t1 Q62186 47.02 151 6.82e-49 159.0 sp|Q62186|SSRD_MOUSE Translocon-associated protein subunit delta OS=Mus musculus OX=10090 GN=Ssr4 PE=1 SV=1 g21031.t1 P35831 50.166 301 5.369999999999999e-95 322.0 sp|P35831|PTN12_MOUSE Tyrosine-protein phosphatase non-receptor type 12 OS=Mus musculus OX=10090 GN=Ptpn12 PE=1 SV=3 PTN12_MOUSE reviewed Tyrosine-protein phosphatase non-receptor type 12 (EC 3.1.3.48) (MPTP-PEST) (Protein-tyrosine phosphatase P19) (P19-PTP) Mus musculus (Mouse) GO:0002102; GO:0004721; GO:0004725; GO:0004726; GO:0005634; GO:0005737; GO:0005829; GO:0005925; GO:0017124; GO:0035335; GO:0042058; GO:0042246; GO:0071364 cellular response to epidermal growth factor stimulus [GO:0071364]; peptidyl-tyrosine dephosphorylation [GO:0035335]; regulation of epidermal growth factor receptor signaling pathway [GO:0042058]; tissue regeneration [GO:0042246] cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; nucleus [GO:0005634]; podosome [GO:0002102] non-membrane spanning protein tyrosine phosphatase activity [GO:0004726]; phosphoprotein phosphatase activity [GO:0004721]; protein tyrosine phosphatase activity [GO:0004725]; SH3 domain binding [GO:0017124] g21032.t1 Q8W485 40.0 115 6.24e-22 91.7 sp|Q8W485|Y5010_ARATH Uncharacterized protein At5g50100, chloroplastic OS=Arabidopsis thaliana OX=3702 GN=At5g50100 PE=1 SV=1 g21033.t1 Q6UXM1 44.386 766 0.0 655.0 sp|Q6UXM1|LRIG3_HUMAN Leucine-rich repeats and immunoglobulin-like domains protein 3 OS=Homo sapiens OX=9606 GN=LRIG3 PE=1 SV=1 LRIG3_HUMAN reviewed Leucine-rich repeats and immunoglobulin-like domains protein 3 (LIG-3) Homo sapiens (Human) GO:0005615; GO:0005886; GO:0007605; GO:0030659; GO:0032474; GO:0038023 otolith morphogenesis [GO:0032474]; sensory perception of sound [GO:0007605] cytoplasmic vesicle membrane [GO:0030659]; extracellular space [GO:0005615]; plasma membrane [GO:0005886] signaling receptor activity [GO:0038023] g21035.t1 Q8BGC3 26.28 293 3.81e-22 100.0 sp|Q8BGC3|MOT12_MOUSE Monocarboxylate transporter 12 OS=Mus musculus OX=10090 GN=Slc16a12 PE=1 SV=1 g21041.t1 Q3T052 40.136 588 9.99e-123 400.0 sp|Q3T052|ITIH4_BOVIN Inter-alpha-trypsin inhibitor heavy chain H4 OS=Bos taurus OX=9913 GN=ITIH4 PE=1 SV=1 ITIH4_BOVIN reviewed Inter-alpha-trypsin inhibitor heavy chain H4 (ITI heavy chain H4) (ITI-HC4) (Inter-alpha-inhibitor heavy chain 4) Bos taurus (Bovine) GO:0004867; GO:0005576; GO:0006953; GO:0030212 acute-phase response [GO:0006953]; hyaluronan metabolic process [GO:0030212] extracellular region [GO:0005576] serine-type endopeptidase inhibitor activity [GO:0004867] g21041.t3 Q3T052 40.136 588 1.14e-122 400.0 sp|Q3T052|ITIH4_BOVIN Inter-alpha-trypsin inhibitor heavy chain H4 OS=Bos taurus OX=9913 GN=ITIH4 PE=1 SV=1 ITIH4_BOVIN reviewed Inter-alpha-trypsin inhibitor heavy chain H4 (ITI heavy chain H4) (ITI-HC4) (Inter-alpha-inhibitor heavy chain 4) Bos taurus (Bovine) GO:0004867; GO:0005576; GO:0006953; GO:0030212 acute-phase response [GO:0006953]; hyaluronan metabolic process [GO:0030212] extracellular region [GO:0005576] serine-type endopeptidase inhibitor activity [GO:0004867] g21041.t4 Q3T052 40.136 588 3.43e-122 400.0 sp|Q3T052|ITIH4_BOVIN Inter-alpha-trypsin inhibitor heavy chain H4 OS=Bos taurus OX=9913 GN=ITIH4 PE=1 SV=1 ITIH4_BOVIN reviewed Inter-alpha-trypsin inhibitor heavy chain H4 (ITI heavy chain H4) (ITI-HC4) (Inter-alpha-inhibitor heavy chain 4) Bos taurus (Bovine) GO:0004867; GO:0005576; GO:0006953; GO:0030212 acute-phase response [GO:0006953]; hyaluronan metabolic process [GO:0030212] extracellular region [GO:0005576] serine-type endopeptidase inhibitor activity [GO:0004867] g21041.t5 Q3T052 40.136 588 3.1200000000000003e-122 400.0 sp|Q3T052|ITIH4_BOVIN Inter-alpha-trypsin inhibitor heavy chain H4 OS=Bos taurus OX=9913 GN=ITIH4 PE=1 SV=1 ITIH4_BOVIN reviewed Inter-alpha-trypsin inhibitor heavy chain H4 (ITI heavy chain H4) (ITI-HC4) (Inter-alpha-inhibitor heavy chain 4) Bos taurus (Bovine) GO:0004867; GO:0005576; GO:0006953; GO:0030212 acute-phase response [GO:0006953]; hyaluronan metabolic process [GO:0030212] extracellular region [GO:0005576] serine-type endopeptidase inhibitor activity [GO:0004867] g21041.t6 Q3T052 40.136 588 1.37e-122 400.0 sp|Q3T052|ITIH4_BOVIN Inter-alpha-trypsin inhibitor heavy chain H4 OS=Bos taurus OX=9913 GN=ITIH4 PE=1 SV=1 ITIH4_BOVIN reviewed Inter-alpha-trypsin inhibitor heavy chain H4 (ITI heavy chain H4) (ITI-HC4) (Inter-alpha-inhibitor heavy chain 4) Bos taurus (Bovine) GO:0004867; GO:0005576; GO:0006953; GO:0030212 acute-phase response [GO:0006953]; hyaluronan metabolic process [GO:0030212] extracellular region [GO:0005576] serine-type endopeptidase inhibitor activity [GO:0004867] g21041.t7 Q3T052 40.136 588 1.39e-122 400.0 sp|Q3T052|ITIH4_BOVIN Inter-alpha-trypsin inhibitor heavy chain H4 OS=Bos taurus OX=9913 GN=ITIH4 PE=1 SV=1 ITIH4_BOVIN reviewed Inter-alpha-trypsin inhibitor heavy chain H4 (ITI heavy chain H4) (ITI-HC4) (Inter-alpha-inhibitor heavy chain 4) Bos taurus (Bovine) GO:0004867; GO:0005576; GO:0006953; GO:0030212 acute-phase response [GO:0006953]; hyaluronan metabolic process [GO:0030212] extracellular region [GO:0005576] serine-type endopeptidase inhibitor activity [GO:0004867] g21041.t8 Q3T052 40.448 581 1.07e-125 403.0 sp|Q3T052|ITIH4_BOVIN Inter-alpha-trypsin inhibitor heavy chain H4 OS=Bos taurus OX=9913 GN=ITIH4 PE=1 SV=1 ITIH4_BOVIN reviewed Inter-alpha-trypsin inhibitor heavy chain H4 (ITI heavy chain H4) (ITI-HC4) (Inter-alpha-inhibitor heavy chain 4) Bos taurus (Bovine) GO:0004867; GO:0005576; GO:0006953; GO:0030212 acute-phase response [GO:0006953]; hyaluronan metabolic process [GO:0030212] extracellular region [GO:0005576] serine-type endopeptidase inhibitor activity [GO:0004867] g21042.t1 P97280 34.928 836 3.34e-139 442.0 sp|P97280|ITIH3_MESAU Inter-alpha-trypsin inhibitor heavy chain H3 OS=Mesocricetus auratus OX=10036 GN=ITIH3 PE=1 SV=1 g21043.t1 Q9GLY5 32.968 913 2.6600000000000002e-130 419.0 sp|Q9GLY5|ITIH3_RABIT Inter-alpha-trypsin inhibitor heavy chain H3 OS=Oryctolagus cuniculus OX=9986 GN=ITIH3 PE=2 SV=1 g21045.t1 Q8IUX8 43.307 254 5.75e-50 190.0 sp|Q8IUX8|EGFL6_HUMAN Epidermal growth factor-like protein 6 OS=Homo sapiens OX=9606 GN=EGFL6 PE=1 SV=1 EGFL6_HUMAN reviewed Epidermal growth factor-like protein 6 (EGF-like protein 6) (MAM and EGF domains-containing gene protein) Homo sapiens (Human) GO:0005178; GO:0005509; GO:0005604; GO:0005615; GO:0007155; GO:0010811; GO:0016020; GO:0030154; GO:0030198 cell adhesion [GO:0007155]; cell differentiation [GO:0030154]; extracellular matrix organization [GO:0030198]; positive regulation of cell-substrate adhesion [GO:0010811] basement membrane [GO:0005604]; extracellular space [GO:0005615]; membrane [GO:0016020] calcium ion binding [GO:0005509]; integrin binding [GO:0005178] g21045.t2 Q8IUX8 42.802 257 2.92e-50 191.0 sp|Q8IUX8|EGFL6_HUMAN Epidermal growth factor-like protein 6 OS=Homo sapiens OX=9606 GN=EGFL6 PE=1 SV=1 EGFL6_HUMAN reviewed Epidermal growth factor-like protein 6 (EGF-like protein 6) (MAM and EGF domains-containing gene protein) Homo sapiens (Human) GO:0005178; GO:0005509; GO:0005604; GO:0005615; GO:0007155; GO:0010811; GO:0016020; GO:0030154; GO:0030198 cell adhesion [GO:0007155]; cell differentiation [GO:0030154]; extracellular matrix organization [GO:0030198]; positive regulation of cell-substrate adhesion [GO:0010811] basement membrane [GO:0005604]; extracellular space [GO:0005615]; membrane [GO:0016020] calcium ion binding [GO:0005509]; integrin binding [GO:0005178] g21047.t1 Q9D0W5 76.712 73 6.9000000000000004e-43 101.0 sp|Q9D0W5|PPIL1_MOUSE Peptidyl-prolyl cis-trans isomerase-like 1 OS=Mus musculus OX=10090 GN=Ppil1 PE=1 SV=1 PPIL1_MOUSE reviewed Peptidyl-prolyl cis-trans isomerase-like 1 (PPIase) (EC 5.2.1.8) (Rotamase PPIL1) Mus musculus (Mouse) GO:0000398; GO:0000413; GO:0003755; GO:0005634; GO:0006457; GO:0071007; GO:0071013; GO:0097718; GO:1990403 embryonic brain development [GO:1990403]; mRNA splicing, via spliceosome [GO:0000398]; protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413] catalytic step 2 spliceosome [GO:0071013]; nucleus [GO:0005634]; U2-type catalytic step 2 spliceosome [GO:0071007] disordered domain specific binding [GO:0097718]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755] g21047.t1 Q9D0W5 71.429 56 6.9000000000000004e-43 92.8 sp|Q9D0W5|PPIL1_MOUSE Peptidyl-prolyl cis-trans isomerase-like 1 OS=Mus musculus OX=10090 GN=Ppil1 PE=1 SV=1 PPIL1_MOUSE reviewed Peptidyl-prolyl cis-trans isomerase-like 1 (PPIase) (EC 5.2.1.8) (Rotamase PPIL1) Mus musculus (Mouse) GO:0000398; GO:0000413; GO:0003755; GO:0005634; GO:0006457; GO:0071007; GO:0071013; GO:0097718; GO:1990403 embryonic brain development [GO:1990403]; mRNA splicing, via spliceosome [GO:0000398]; protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413] catalytic step 2 spliceosome [GO:0071013]; nucleus [GO:0005634]; U2-type catalytic step 2 spliceosome [GO:0071007] disordered domain specific binding [GO:0097718]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755] g21048.t1 Q9N2B0 44.33 194 1.61e-49 183.0 sp|Q9N2B0|HRH1_PONPY Histamine H1 receptor OS=Pongo pygmaeus OX=9600 GN=HRH1 PE=3 SV=1 g21048.t1 Q9N2B0 56.044 91 1.5e-29 126.0 sp|Q9N2B0|HRH1_PONPY Histamine H1 receptor OS=Pongo pygmaeus OX=9600 GN=HRH1 PE=3 SV=1 g21051.t1 Q96LD8 50.962 208 2.13e-62 196.0 sp|Q96LD8|SENP8_HUMAN Sentrin-specific protease 8 OS=Homo sapiens OX=9606 GN=SENP8 PE=1 SV=1 SENP8_HUMAN reviewed Sentrin-specific protease 8 (EC 3.4.22.-) (Deneddylase-1) (NEDD8-specific protease 1) (Protease, cysteine 2) (Sentrin/SUMO-specific protease SENP8) Homo sapiens (Human) GO:0000338; GO:0005829; GO:0006508; GO:0008234; GO:0016579; GO:0019784; GO:0043687 post-translational protein modification [GO:0043687]; protein deneddylation [GO:0000338]; protein deubiquitination [GO:0016579]; proteolysis [GO:0006508] cytosol [GO:0005829] cysteine-type peptidase activity [GO:0008234]; deNEDDylase activity [GO:0019784] g21054.t1 Q2HJA9 48.227 282 4.02e-71 224.0 sp|Q2HJA9|PHLP_BOVIN Phosducin-like protein OS=Bos taurus OX=9913 GN=PDCL PE=2 SV=1 g21060.t1 Q3UXZ9 58.531 803 0.0 850.0 sp|Q3UXZ9|KDM5A_MOUSE Lysine-specific demethylase 5A OS=Mus musculus OX=10090 GN=Kdm5a PE=1 SV=2 KDM5A_MOUSE reviewed Lysine-specific demethylase 5A (EC 1.14.11.67) (Histone demethylase JARID1A) (Jumonji/ARID domain-containing protein 1A) (Retinoblastoma-binding protein 2) (RBBP-2) ([histone H3]-trimethyl-L-lysine(4) demethylase 5A) Mus musculus (Mouse) GO:0000122; GO:0000785; GO:0000976; GO:0003677; GO:0003682; GO:0003713; GO:0004857; GO:0005634; GO:0005654; GO:0005730; GO:0006338; GO:0006355; GO:0007283; GO:0008270; GO:0008584; GO:0031490; GO:0032453; GO:0032922; GO:0032993; GO:0034647; GO:0042393; GO:0045893; GO:0140718 chromatin remodeling [GO:0006338]; circadian regulation of gene expression [GO:0032922]; facultative heterochromatin formation [GO:0140718]; male gonad development [GO:0008584]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of DNA-templated transcription [GO:0045893]; regulation of DNA-templated transcription [GO:0006355]; spermatogenesis [GO:0007283] chromatin [GO:0000785]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-DNA complex [GO:0032993] chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; DNA binding [GO:0003677]; enzyme inhibitor activity [GO:0004857]; histone binding [GO:0042393]; histone H3K4 demethylase activity [GO:0032453]; histone H3K4me/H3K4me2/H3K4me3 demethylase activity [GO:0034647]; transcription cis-regulatory region binding [GO:0000976]; transcription coactivator activity [GO:0003713]; zinc ion binding [GO:0008270] g21060.t2 Q3UXZ9 58.025 810 0.0 847.0 sp|Q3UXZ9|KDM5A_MOUSE Lysine-specific demethylase 5A OS=Mus musculus OX=10090 GN=Kdm5a PE=1 SV=2 KDM5A_MOUSE reviewed Lysine-specific demethylase 5A (EC 1.14.11.67) (Histone demethylase JARID1A) (Jumonji/ARID domain-containing protein 1A) (Retinoblastoma-binding protein 2) (RBBP-2) ([histone H3]-trimethyl-L-lysine(4) demethylase 5A) Mus musculus (Mouse) GO:0000122; GO:0000785; GO:0000976; GO:0003677; GO:0003682; GO:0003713; GO:0004857; GO:0005634; GO:0005654; GO:0005730; GO:0006338; GO:0006355; GO:0007283; GO:0008270; GO:0008584; GO:0031490; GO:0032453; GO:0032922; GO:0032993; GO:0034647; GO:0042393; GO:0045893; GO:0140718 chromatin remodeling [GO:0006338]; circadian regulation of gene expression [GO:0032922]; facultative heterochromatin formation [GO:0140718]; male gonad development [GO:0008584]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of DNA-templated transcription [GO:0045893]; regulation of DNA-templated transcription [GO:0006355]; spermatogenesis [GO:0007283] chromatin [GO:0000785]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-DNA complex [GO:0032993] chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; DNA binding [GO:0003677]; enzyme inhibitor activity [GO:0004857]; histone binding [GO:0042393]; histone H3K4 demethylase activity [GO:0032453]; histone H3K4me/H3K4me2/H3K4me3 demethylase activity [GO:0034647]; transcription cis-regulatory region binding [GO:0000976]; transcription coactivator activity [GO:0003713]; zinc ion binding [GO:0008270] g21061.t1 Q30DN6 58.925 521 0.0 624.0 sp|Q30DN6|KDM5D_CANLF Lysine-specific demethylase 5D OS=Canis lupus familiaris OX=9615 GN=KDM5D PE=2 SV=1 KDM5D_CANLF reviewed Lysine-specific demethylase 5D (EC 1.14.11.67) (Histone demethylase JARID1D) (Jumonji/ARID domain-containing protein 1D) (Protein SmcY) ([histone H3]-trimethyl-L-lysine(4) demethylase 5D) Canis lupus familiaris (Dog) (Canis familiaris) GO:0000785; GO:0003677; GO:0005634; GO:0005654; GO:0006338; GO:0006355; GO:0008270; GO:0034647 chromatin remodeling [GO:0006338]; regulation of DNA-templated transcription [GO:0006355] chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] DNA binding [GO:0003677]; histone H3K4me/H3K4me2/H3K4me3 demethylase activity [GO:0034647]; zinc ion binding [GO:0008270] g21068.t1 Q6DFC2 52.342 491 2.54e-161 469.0 sp|Q6DFC2|CCD77_XENLA Coiled-coil domain-containing protein 77 OS=Xenopus laevis OX=8355 GN=ccdc77 PE=2 SV=1 g21069.t1 A0A0G2JUG7 51.376 436 1.6800000000000001e-118 398.0 sp|A0A0G2JUG7|IQEC1_RAT IQ motif and SEC7 domain-containing protein 1 OS=Rattus norvegicus OX=10116 GN=Iqsec1 PE=1 SV=1 IQEC1_RAT reviewed IQ motif and SEC7 domain-containing protein 1 Rattus norvegicus (Rat) GO:0005085; GO:0005654; GO:0005813; GO:0005829; GO:0008021; GO:0008289; GO:0019901; GO:0030036; GO:0032012; GO:0051549; GO:0051965; GO:0060996; GO:0098685; GO:0098978; GO:0099092; GO:0099149; GO:0099170; GO:0120183 actin cytoskeleton organization [GO:0030036]; dendritic spine development [GO:0060996]; positive regulation of focal adhesion disassembly [GO:0120183]; positive regulation of keratinocyte migration [GO:0051549]; positive regulation of synapse assembly [GO:0051965]; postsynaptic modulation of chemical synaptic transmission [GO:0099170]; regulation of ARF protein signal transduction [GO:0032012]; regulation of postsynaptic neurotransmitter receptor internalization [GO:0099149] centrosome [GO:0005813]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; nucleoplasm [GO:0005654]; postsynaptic density, intracellular component [GO:0099092]; Schaffer collateral - CA1 synapse [GO:0098685]; synaptic vesicle [GO:0008021] guanyl-nucleotide exchange factor activity [GO:0005085]; lipid binding [GO:0008289]; protein kinase binding [GO:0019901] g21074.t1 O70497 57.037 135 5.1000000000000005e-43 147.0 sp|O70497|FCN2_MOUSE Ficolin-2 OS=Mus musculus OX=10090 GN=Fcn2 PE=2 SV=2 g21074.t2 O70497 53.939 165 5.880000000000001e-47 161.0 sp|O70497|FCN2_MOUSE Ficolin-2 OS=Mus musculus OX=10090 GN=Fcn2 PE=2 SV=2 g21076.t1 Q9Y2U8 41.7 494 3.38e-108 357.0 sp|Q9Y2U8|MAN1_HUMAN Inner nuclear membrane protein Man1 OS=Homo sapiens OX=9606 GN=LEMD3 PE=1 SV=2 MAN1_HUMAN reviewed Inner nuclear membrane protein Man1 (LEM domain-containing protein 3) Homo sapiens (Human) GO:0003677; GO:0005637; GO:0016020; GO:0030512; GO:0030514; GO:0031965; GO:0032926; GO:1990446 negative regulation of activin receptor signaling pathway [GO:0032926]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512] membrane [GO:0016020]; nuclear inner membrane [GO:0005637]; nuclear membrane [GO:0031965] DNA binding [GO:0003677]; U1 snRNP binding [GO:1990446] g21079.t1 Q6ZR37 35.912 362 2.5200000000000003e-72 257.0 sp|Q6ZR37|PKHG7_HUMAN Pleckstrin homology domain-containing family G member 7 OS=Homo sapiens OX=9606 GN=PLEKHG7 PE=1 SV=2 PKHG7_HUMAN reviewed Pleckstrin homology domain-containing family G member 7 (PH domain-containing family G member 7) Homo sapiens (Human) GO:0005085; GO:0007266 Rho protein signal transduction [GO:0007266] guanyl-nucleotide exchange factor activity [GO:0005085] g21090.t1 Q68ED2 49.035 881 0.0 817.0 sp|Q68ED2|GRM7_MOUSE Metabotropic glutamate receptor 7 OS=Mus musculus OX=10090 GN=Grm7 PE=1 SV=1 GRM7_MOUSE reviewed Metabotropic glutamate receptor 7 (mGluR7) Mus musculus (Mouse) GO:0001640; GO:0001642; GO:0001661; GO:0001662; GO:0005245; GO:0005246; GO:0005509; GO:0005516; GO:0005886; GO:0005938; GO:0007193; GO:0007196; GO:0007216; GO:0007268; GO:0007605; GO:0007613; GO:0007614; GO:0008066; GO:0008306; GO:0009986; GO:0010855; GO:0014050; GO:0016020; GO:0016595; GO:0019226; GO:0030165; GO:0030424; GO:0030425; GO:0030534; GO:0032279; GO:0032991; GO:0033555; GO:0042734; GO:0042802; GO:0043025; GO:0043195; GO:0043198; GO:0043235; GO:0043524; GO:0043679; GO:0045211; GO:0046983; GO:0048306; GO:0048786; GO:0048787; GO:0050877; GO:0051966; GO:0061564; GO:0070905; GO:0098978; GO:0098982; GO:0099171 adenylate cyclase-inhibiting G protein-coupled glutamate receptor signaling pathway [GO:0007196]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; adult behavior [GO:0030534]; associative learning [GO:0008306]; axon development [GO:0061564]; behavioral fear response [GO:0001662]; chemical synaptic transmission [GO:0007268]; conditioned taste aversion [GO:0001661]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; memory [GO:0007613]; multicellular organismal response to stress [GO:0033555]; negative regulation of glutamate secretion [GO:0014050]; negative regulation of neuron apoptotic process [GO:0043524]; nervous system process [GO:0050877]; presynaptic modulation of chemical synaptic transmission [GO:0099171]; regulation of synaptic transmission, glutamatergic [GO:0051966]; sensory perception of sound [GO:0007605]; short-term memory [GO:0007614]; transmission of nerve impulse [GO:0019226] asymmetric synapse [GO:0032279]; axon [GO:0030424]; axon terminus [GO:0043679]; cell cortex [GO:0005938]; cell surface [GO:0009986]; dendrite [GO:0030425]; dendritic shaft [GO:0043198]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic active zone [GO:0048786]; presynaptic active zone membrane [GO:0048787]; presynaptic membrane [GO:0042734]; protein-containing complex [GO:0032991]; receptor complex [GO:0043235]; terminal bouton [GO:0043195] adenylate cyclase inhibiting G protein-coupled glutamate receptor activity [GO:0001640]; adenylate cyclase inhibitor activity [GO:0010855]; calcium channel regulator activity [GO:0005246]; calcium ion binding [GO:0005509]; calcium-dependent protein binding [GO:0048306]; calmodulin binding [GO:0005516]; glutamate binding [GO:0016595]; glutamate receptor activity [GO:0008066]; group III metabotropic glutamate receptor activity [GO:0001642]; identical protein binding [GO:0042802]; PDZ domain binding [GO:0030165]; protein dimerization activity [GO:0046983]; serine binding [GO:0070905]; voltage-gated calcium channel activity [GO:0005245] g21090.t2 Q68ED2 49.035 881 0.0 817.0 sp|Q68ED2|GRM7_MOUSE Metabotropic glutamate receptor 7 OS=Mus musculus OX=10090 GN=Grm7 PE=1 SV=1 GRM7_MOUSE reviewed Metabotropic glutamate receptor 7 (mGluR7) Mus musculus (Mouse) GO:0001640; GO:0001642; GO:0001661; GO:0001662; GO:0005245; GO:0005246; GO:0005509; GO:0005516; GO:0005886; GO:0005938; GO:0007193; GO:0007196; GO:0007216; GO:0007268; GO:0007605; GO:0007613; GO:0007614; GO:0008066; GO:0008306; GO:0009986; GO:0010855; GO:0014050; GO:0016020; GO:0016595; GO:0019226; GO:0030165; GO:0030424; GO:0030425; GO:0030534; GO:0032279; GO:0032991; GO:0033555; GO:0042734; GO:0042802; GO:0043025; GO:0043195; GO:0043198; GO:0043235; GO:0043524; GO:0043679; GO:0045211; GO:0046983; GO:0048306; GO:0048786; GO:0048787; GO:0050877; GO:0051966; GO:0061564; GO:0070905; GO:0098978; GO:0098982; GO:0099171 adenylate cyclase-inhibiting G protein-coupled glutamate receptor signaling pathway [GO:0007196]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; adult behavior [GO:0030534]; associative learning [GO:0008306]; axon development [GO:0061564]; behavioral fear response [GO:0001662]; chemical synaptic transmission [GO:0007268]; conditioned taste aversion [GO:0001661]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; memory [GO:0007613]; multicellular organismal response to stress [GO:0033555]; negative regulation of glutamate secretion [GO:0014050]; negative regulation of neuron apoptotic process [GO:0043524]; nervous system process [GO:0050877]; presynaptic modulation of chemical synaptic transmission [GO:0099171]; regulation of synaptic transmission, glutamatergic [GO:0051966]; sensory perception of sound [GO:0007605]; short-term memory [GO:0007614]; transmission of nerve impulse [GO:0019226] asymmetric synapse [GO:0032279]; axon [GO:0030424]; axon terminus [GO:0043679]; cell cortex [GO:0005938]; cell surface [GO:0009986]; dendrite [GO:0030425]; dendritic shaft [GO:0043198]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic active zone [GO:0048786]; presynaptic active zone membrane [GO:0048787]; presynaptic membrane [GO:0042734]; protein-containing complex [GO:0032991]; receptor complex [GO:0043235]; terminal bouton [GO:0043195] adenylate cyclase inhibiting G protein-coupled glutamate receptor activity [GO:0001640]; adenylate cyclase inhibitor activity [GO:0010855]; calcium channel regulator activity [GO:0005246]; calcium ion binding [GO:0005509]; calcium-dependent protein binding [GO:0048306]; calmodulin binding [GO:0005516]; glutamate binding [GO:0016595]; glutamate receptor activity [GO:0008066]; group III metabotropic glutamate receptor activity [GO:0001642]; identical protein binding [GO:0042802]; PDZ domain binding [GO:0030165]; protein dimerization activity [GO:0046983]; serine binding [GO:0070905]; voltage-gated calcium channel activity [GO:0005245] g21092.t1 Q14832 53.528 822 0.0 892.0 sp|Q14832|GRM3_HUMAN Metabotropic glutamate receptor 3 OS=Homo sapiens OX=9606 GN=GRM3 PE=1 SV=2 GRM3_HUMAN reviewed Metabotropic glutamate receptor 3 (mGluR3) Homo sapiens (Human) GO:0001641; GO:0004930; GO:0005246; GO:0005886; GO:0007194; GO:0007216; GO:0007268; GO:0008066; GO:0010467; GO:0014069; GO:0030424; GO:0033554; GO:0042734; GO:0043197; GO:0045211; GO:0051966; GO:0097110; GO:0097449; GO:0098978; GO:0099170 cellular response to stress [GO:0033554]; chemical synaptic transmission [GO:0007268]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; gene expression [GO:0010467]; negative regulation of adenylate cyclase activity [GO:0007194]; postsynaptic modulation of chemical synaptic transmission [GO:0099170]; regulation of synaptic transmission, glutamatergic [GO:0051966] astrocyte projection [GO:0097449]; axon [GO:0030424]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734] calcium channel regulator activity [GO:0005246]; G protein-coupled receptor activity [GO:0004930]; glutamate receptor activity [GO:0008066]; group II metabotropic glutamate receptor activity [GO:0001641]; scaffold protein binding [GO:0097110] g21093.t1 P50579 81.301 369 0.0 648.0 sp|P50579|MAP2_HUMAN Methionine aminopeptidase 2 OS=Homo sapiens OX=9606 GN=METAP2 PE=1 SV=1 MAP2_HUMAN reviewed Methionine aminopeptidase 2 (MAP 2) (MetAP 2) (EC 3.4.11.18) (Initiation factor 2-associated 67 kDa glycoprotein) (p67) (p67eIF2) (Peptidase M) Homo sapiens (Human) GO:0003723; GO:0004177; GO:0004239; GO:0005737; GO:0005829; GO:0005886; GO:0006446; GO:0008235; GO:0016485; GO:0046872; GO:0070006 protein processing [GO:0016485]; regulation of translational initiation [GO:0006446] cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886] aminopeptidase activity [GO:0004177]; initiator methionyl aminopeptidase activity [GO:0004239]; metal ion binding [GO:0046872]; metalloaminopeptidase activity [GO:0070006]; metalloexopeptidase activity [GO:0008235]; RNA binding [GO:0003723] g21097.t1 P21333 51.101 863 0.0 843.0 sp|P21333|FLNA_HUMAN Filamin-A OS=Homo sapiens OX=9606 GN=FLNA PE=1 SV=4 FLNA_HUMAN reviewed Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Alpha-filamin) (Endothelial actin-binding protein) (Filamin-1) (Non-muscle filamin) Homo sapiens (Human) GO:0001664; GO:0002102; GO:0003723; GO:0005576; GO:0005634; GO:0005730; GO:0005737; GO:0005829; GO:0005884; GO:0005886; GO:0005911; GO:0005925; GO:0007195; GO:0007597; GO:0010572; GO:0015459; GO:0015629; GO:0016020; GO:0016479; GO:0019900; GO:0021943; GO:0021987; GO:0030018; GO:0030036; GO:0030334; GO:0030426; GO:0030863; GO:0031267; GO:0031523; GO:0032233; GO:0034394; GO:0034988; GO:0035855; GO:0042177; GO:0042307; GO:0042789; GO:0042803; GO:0043066; GO:0043113; GO:0043123; GO:0043198; GO:0043204; GO:0043433; GO:0044319; GO:0044325; GO:0045184; GO:0045296; GO:0046332; GO:0048471; GO:0050821; GO:0051015; GO:0051020; GO:0051209; GO:0051764; GO:0060271; GO:0070062; GO:0070527; GO:0071526; GO:0072659; GO:0090042; GO:0090307; GO:0097368; GO:0097440; GO:0098794; GO:0098978; GO:0140297; GO:0140311; GO:1900026; GO:1901381; GO:1902396; GO:1905000; GO:1905031; GO:1990779; GO:2000179; GO:2001046; GO:2001224 actin crosslink formation [GO:0051764]; actin cytoskeleton organization [GO:0030036]; adenylate cyclase-inhibiting dopamine receptor signaling pathway [GO:0007195]; blood coagulation, intrinsic pathway [GO:0007597]; cerebral cortex development [GO:0021987]; cilium assembly [GO:0060271]; establishment of protein localization [GO:0045184]; establishment of Sertoli cell barrier [GO:0097368]; formation of radial glial scaffolds [GO:0021943]; megakaryocyte development [GO:0035855]; mitotic spindle assembly [GO:0090307]; mRNA transcription by RNA polymerase II [GO:0042789]; negative regulation of apoptotic process [GO:0043066]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of transcription by RNA polymerase I [GO:0016479]; platelet aggregation [GO:0070527]; positive regulation of actin filament bundle assembly [GO:0032233]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of neuron migration [GO:2001224]; positive regulation of platelet activation [GO:0010572]; positive regulation of potassium ion transmembrane transport [GO:1901381]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; protein localization to bicellular tight junction [GO:1902396]; protein localization to cell surface [GO:0034394]; protein localization to plasma membrane [GO:0072659]; protein stabilization [GO:0050821]; receptor clustering [GO:0043113]; regulation of cell migration [GO:0030334]; regulation of membrane repolarization during atrial cardiac muscle cell action potential [GO:1905000]; regulation of membrane repolarization during cardiac muscle cell action potential [GO:1905031]; release of sequestered calcium ion into cytosol [GO:0051209]; semaphorin-plexin signaling pathway [GO:0071526]; tubulin deacetylation [GO:0090042]; wound healing, spreading of cells [GO:0044319] actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; apical dendrite [GO:0097440]; cell-cell junction [GO:0005911]; cortical cytoskeleton [GO:0030863]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic shaft [GO:0043198]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; glycoprotein Ib-IX-V complex [GO:1990779]; growth cone [GO:0030426]; membrane [GO:0016020]; Myb complex [GO:0031523]; nucleolus [GO:0005730]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; podosome [GO:0002102]; postsynapse [GO:0098794]; Z disc [GO:0030018] actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; DNA-binding transcription factor binding [GO:0140297]; Fc-gamma receptor I complex binding [GO:0034988]; G protein-coupled receptor binding [GO:0001664]; GTPase binding [GO:0051020]; kinase binding [GO:0019900]; potassium channel regulator activity [GO:0015459]; protein homodimerization activity [GO:0042803]; protein sequestering activity [GO:0140311]; RNA binding [GO:0003723]; SMAD binding [GO:0046332]; small GTPase binding [GO:0031267]; transmembrane transporter binding [GO:0044325] g21097.t1 P21333 50.685 803 0.0 759.0 sp|P21333|FLNA_HUMAN Filamin-A OS=Homo sapiens OX=9606 GN=FLNA PE=1 SV=4 FLNA_HUMAN reviewed Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Alpha-filamin) (Endothelial actin-binding protein) (Filamin-1) (Non-muscle filamin) Homo sapiens (Human) GO:0001664; GO:0002102; GO:0003723; GO:0005576; GO:0005634; GO:0005730; GO:0005737; GO:0005829; GO:0005884; GO:0005886; GO:0005911; GO:0005925; GO:0007195; GO:0007597; GO:0010572; GO:0015459; GO:0015629; GO:0016020; GO:0016479; GO:0019900; GO:0021943; GO:0021987; GO:0030018; GO:0030036; GO:0030334; GO:0030426; GO:0030863; GO:0031267; GO:0031523; GO:0032233; GO:0034394; GO:0034988; GO:0035855; GO:0042177; GO:0042307; GO:0042789; GO:0042803; GO:0043066; GO:0043113; GO:0043123; GO:0043198; GO:0043204; GO:0043433; GO:0044319; GO:0044325; GO:0045184; GO:0045296; GO:0046332; GO:0048471; GO:0050821; GO:0051015; GO:0051020; GO:0051209; GO:0051764; GO:0060271; GO:0070062; GO:0070527; GO:0071526; GO:0072659; GO:0090042; GO:0090307; GO:0097368; GO:0097440; GO:0098794; GO:0098978; GO:0140297; GO:0140311; GO:1900026; GO:1901381; GO:1902396; GO:1905000; GO:1905031; GO:1990779; GO:2000179; GO:2001046; GO:2001224 actin crosslink formation [GO:0051764]; actin cytoskeleton organization [GO:0030036]; adenylate cyclase-inhibiting dopamine receptor signaling pathway [GO:0007195]; blood coagulation, intrinsic pathway [GO:0007597]; cerebral cortex development [GO:0021987]; cilium assembly [GO:0060271]; establishment of protein localization [GO:0045184]; establishment of Sertoli cell barrier [GO:0097368]; formation of radial glial scaffolds [GO:0021943]; megakaryocyte development [GO:0035855]; mitotic spindle assembly [GO:0090307]; mRNA transcription by RNA polymerase II [GO:0042789]; negative regulation of apoptotic process [GO:0043066]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of transcription by RNA polymerase I [GO:0016479]; platelet aggregation [GO:0070527]; positive regulation of actin filament bundle assembly [GO:0032233]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of neuron migration [GO:2001224]; positive regulation of platelet activation [GO:0010572]; positive regulation of potassium ion transmembrane transport [GO:1901381]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; protein localization to bicellular tight junction [GO:1902396]; protein localization to cell surface [GO:0034394]; protein localization to plasma membrane [GO:0072659]; protein stabilization [GO:0050821]; receptor clustering [GO:0043113]; regulation of cell migration [GO:0030334]; regulation of membrane repolarization during atrial cardiac muscle cell action potential [GO:1905000]; regulation of membrane repolarization during cardiac muscle cell action potential [GO:1905031]; release of sequestered calcium ion into cytosol [GO:0051209]; semaphorin-plexin signaling pathway [GO:0071526]; tubulin deacetylation [GO:0090042]; wound healing, spreading of cells [GO:0044319] actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; apical dendrite [GO:0097440]; cell-cell junction [GO:0005911]; cortical cytoskeleton [GO:0030863]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic shaft [GO:0043198]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; glycoprotein Ib-IX-V complex [GO:1990779]; growth cone [GO:0030426]; membrane [GO:0016020]; Myb complex [GO:0031523]; nucleolus [GO:0005730]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; podosome [GO:0002102]; postsynapse [GO:0098794]; Z disc [GO:0030018] actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; DNA-binding transcription factor binding [GO:0140297]; Fc-gamma receptor I complex binding [GO:0034988]; G protein-coupled receptor binding [GO:0001664]; GTPase binding [GO:0051020]; kinase binding [GO:0019900]; potassium channel regulator activity [GO:0015459]; protein homodimerization activity [GO:0042803]; protein sequestering activity [GO:0140311]; RNA binding [GO:0003723]; SMAD binding [GO:0046332]; small GTPase binding [GO:0031267]; transmembrane transporter binding [GO:0044325] g21097.t1 P21333 42.577 815 0.0 521.0 sp|P21333|FLNA_HUMAN Filamin-A OS=Homo sapiens OX=9606 GN=FLNA PE=1 SV=4 FLNA_HUMAN reviewed Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Alpha-filamin) (Endothelial actin-binding protein) (Filamin-1) (Non-muscle filamin) Homo sapiens (Human) GO:0001664; GO:0002102; GO:0003723; GO:0005576; GO:0005634; GO:0005730; GO:0005737; GO:0005829; GO:0005884; GO:0005886; GO:0005911; GO:0005925; GO:0007195; GO:0007597; GO:0010572; GO:0015459; GO:0015629; GO:0016020; GO:0016479; GO:0019900; GO:0021943; GO:0021987; GO:0030018; GO:0030036; GO:0030334; GO:0030426; GO:0030863; GO:0031267; GO:0031523; GO:0032233; GO:0034394; GO:0034988; GO:0035855; GO:0042177; GO:0042307; GO:0042789; GO:0042803; GO:0043066; GO:0043113; GO:0043123; GO:0043198; GO:0043204; GO:0043433; GO:0044319; GO:0044325; GO:0045184; GO:0045296; GO:0046332; GO:0048471; GO:0050821; GO:0051015; GO:0051020; GO:0051209; GO:0051764; GO:0060271; GO:0070062; GO:0070527; GO:0071526; GO:0072659; GO:0090042; GO:0090307; GO:0097368; GO:0097440; GO:0098794; GO:0098978; GO:0140297; GO:0140311; GO:1900026; GO:1901381; GO:1902396; GO:1905000; GO:1905031; GO:1990779; GO:2000179; GO:2001046; GO:2001224 actin crosslink formation [GO:0051764]; actin cytoskeleton organization [GO:0030036]; adenylate cyclase-inhibiting dopamine receptor signaling pathway [GO:0007195]; blood coagulation, intrinsic pathway [GO:0007597]; cerebral cortex development [GO:0021987]; cilium assembly [GO:0060271]; establishment of protein localization [GO:0045184]; establishment of Sertoli cell barrier [GO:0097368]; formation of radial glial scaffolds [GO:0021943]; megakaryocyte development [GO:0035855]; mitotic spindle assembly [GO:0090307]; mRNA transcription by RNA polymerase II [GO:0042789]; negative regulation of apoptotic process [GO:0043066]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of transcription by RNA polymerase I [GO:0016479]; platelet aggregation [GO:0070527]; positive regulation of actin filament bundle assembly [GO:0032233]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of neuron migration [GO:2001224]; positive regulation of platelet activation [GO:0010572]; positive regulation of potassium ion transmembrane transport [GO:1901381]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; protein localization to bicellular tight junction [GO:1902396]; protein localization to cell surface [GO:0034394]; protein localization to plasma membrane [GO:0072659]; protein stabilization [GO:0050821]; receptor clustering [GO:0043113]; regulation of cell migration [GO:0030334]; regulation of membrane repolarization during atrial cardiac muscle cell action potential [GO:1905000]; regulation of membrane repolarization during cardiac muscle cell action potential [GO:1905031]; release of sequestered calcium ion into cytosol [GO:0051209]; semaphorin-plexin signaling pathway [GO:0071526]; tubulin deacetylation [GO:0090042]; wound healing, spreading of cells [GO:0044319] actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; apical dendrite [GO:0097440]; cell-cell junction [GO:0005911]; cortical cytoskeleton [GO:0030863]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic shaft [GO:0043198]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; glycoprotein Ib-IX-V complex [GO:1990779]; growth cone [GO:0030426]; membrane [GO:0016020]; Myb complex [GO:0031523]; nucleolus [GO:0005730]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; podosome [GO:0002102]; postsynapse [GO:0098794]; Z disc [GO:0030018] actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; DNA-binding transcription factor binding [GO:0140297]; Fc-gamma receptor I complex binding [GO:0034988]; G protein-coupled receptor binding [GO:0001664]; GTPase binding [GO:0051020]; kinase binding [GO:0019900]; potassium channel regulator activity [GO:0015459]; protein homodimerization activity [GO:0042803]; protein sequestering activity [GO:0140311]; RNA binding [GO:0003723]; SMAD binding [GO:0046332]; small GTPase binding [GO:0031267]; transmembrane transporter binding [GO:0044325] g21097.t1 P21333 28.449 819 0.0 229.0 sp|P21333|FLNA_HUMAN Filamin-A OS=Homo sapiens OX=9606 GN=FLNA PE=1 SV=4 FLNA_HUMAN reviewed Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Alpha-filamin) (Endothelial actin-binding protein) (Filamin-1) (Non-muscle filamin) Homo sapiens (Human) GO:0001664; GO:0002102; GO:0003723; GO:0005576; GO:0005634; GO:0005730; GO:0005737; GO:0005829; GO:0005884; GO:0005886; GO:0005911; GO:0005925; GO:0007195; GO:0007597; GO:0010572; GO:0015459; GO:0015629; GO:0016020; GO:0016479; GO:0019900; GO:0021943; GO:0021987; GO:0030018; GO:0030036; GO:0030334; GO:0030426; GO:0030863; GO:0031267; GO:0031523; GO:0032233; GO:0034394; GO:0034988; GO:0035855; GO:0042177; GO:0042307; GO:0042789; GO:0042803; GO:0043066; GO:0043113; GO:0043123; GO:0043198; GO:0043204; GO:0043433; GO:0044319; GO:0044325; GO:0045184; GO:0045296; GO:0046332; GO:0048471; GO:0050821; GO:0051015; GO:0051020; GO:0051209; GO:0051764; GO:0060271; GO:0070062; GO:0070527; GO:0071526; GO:0072659; GO:0090042; GO:0090307; GO:0097368; GO:0097440; GO:0098794; GO:0098978; GO:0140297; GO:0140311; GO:1900026; GO:1901381; GO:1902396; GO:1905000; GO:1905031; GO:1990779; GO:2000179; GO:2001046; GO:2001224 actin crosslink formation [GO:0051764]; actin cytoskeleton organization [GO:0030036]; adenylate cyclase-inhibiting dopamine receptor signaling pathway [GO:0007195]; blood coagulation, intrinsic pathway [GO:0007597]; cerebral cortex development [GO:0021987]; cilium assembly [GO:0060271]; establishment of protein localization [GO:0045184]; establishment of Sertoli cell barrier [GO:0097368]; formation of radial glial scaffolds [GO:0021943]; megakaryocyte development [GO:0035855]; mitotic spindle assembly [GO:0090307]; mRNA transcription by RNA polymerase II [GO:0042789]; negative regulation of apoptotic process [GO:0043066]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of transcription by RNA polymerase I [GO:0016479]; platelet aggregation [GO:0070527]; positive regulation of actin filament bundle assembly [GO:0032233]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of neuron migration [GO:2001224]; positive regulation of platelet activation [GO:0010572]; positive regulation of potassium ion transmembrane transport [GO:1901381]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; protein localization to bicellular tight junction [GO:1902396]; protein localization to cell surface [GO:0034394]; protein localization to plasma membrane [GO:0072659]; protein stabilization [GO:0050821]; receptor clustering [GO:0043113]; regulation of cell migration [GO:0030334]; regulation of membrane repolarization during atrial cardiac muscle cell action potential [GO:1905000]; regulation of membrane repolarization during cardiac muscle cell action potential [GO:1905031]; release of sequestered calcium ion into cytosol [GO:0051209]; semaphorin-plexin signaling pathway [GO:0071526]; tubulin deacetylation [GO:0090042]; wound healing, spreading of cells [GO:0044319] actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; apical dendrite [GO:0097440]; cell-cell junction [GO:0005911]; cortical cytoskeleton [GO:0030863]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic shaft [GO:0043198]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; glycoprotein Ib-IX-V complex [GO:1990779]; growth cone [GO:0030426]; membrane [GO:0016020]; Myb complex [GO:0031523]; nucleolus [GO:0005730]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; podosome [GO:0002102]; postsynapse [GO:0098794]; Z disc [GO:0030018] actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; DNA-binding transcription factor binding [GO:0140297]; Fc-gamma receptor I complex binding [GO:0034988]; G protein-coupled receptor binding [GO:0001664]; GTPase binding [GO:0051020]; kinase binding [GO:0019900]; potassium channel regulator activity [GO:0015459]; protein homodimerization activity [GO:0042803]; protein sequestering activity [GO:0140311]; RNA binding [GO:0003723]; SMAD binding [GO:0046332]; small GTPase binding [GO:0031267]; transmembrane transporter binding [GO:0044325] g21097.t1 P21333 30.216 556 0.0 191.0 sp|P21333|FLNA_HUMAN Filamin-A OS=Homo sapiens OX=9606 GN=FLNA PE=1 SV=4 FLNA_HUMAN reviewed Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Alpha-filamin) (Endothelial actin-binding protein) (Filamin-1) (Non-muscle filamin) Homo sapiens (Human) GO:0001664; GO:0002102; GO:0003723; GO:0005576; GO:0005634; GO:0005730; GO:0005737; GO:0005829; GO:0005884; GO:0005886; GO:0005911; GO:0005925; GO:0007195; GO:0007597; GO:0010572; GO:0015459; GO:0015629; GO:0016020; GO:0016479; GO:0019900; GO:0021943; GO:0021987; GO:0030018; GO:0030036; GO:0030334; GO:0030426; GO:0030863; GO:0031267; GO:0031523; GO:0032233; GO:0034394; GO:0034988; GO:0035855; GO:0042177; GO:0042307; GO:0042789; GO:0042803; GO:0043066; GO:0043113; GO:0043123; GO:0043198; GO:0043204; GO:0043433; GO:0044319; GO:0044325; GO:0045184; GO:0045296; GO:0046332; GO:0048471; GO:0050821; GO:0051015; GO:0051020; GO:0051209; GO:0051764; GO:0060271; GO:0070062; GO:0070527; GO:0071526; GO:0072659; GO:0090042; GO:0090307; GO:0097368; GO:0097440; GO:0098794; GO:0098978; GO:0140297; GO:0140311; GO:1900026; GO:1901381; GO:1902396; GO:1905000; GO:1905031; GO:1990779; GO:2000179; GO:2001046; GO:2001224 actin crosslink formation [GO:0051764]; actin cytoskeleton organization [GO:0030036]; adenylate cyclase-inhibiting dopamine receptor signaling pathway [GO:0007195]; blood coagulation, intrinsic pathway [GO:0007597]; cerebral cortex development [GO:0021987]; cilium assembly [GO:0060271]; establishment of protein localization [GO:0045184]; establishment of Sertoli cell barrier [GO:0097368]; formation of radial glial scaffolds [GO:0021943]; megakaryocyte development [GO:0035855]; mitotic spindle assembly [GO:0090307]; mRNA transcription by RNA polymerase II [GO:0042789]; negative regulation of apoptotic process [GO:0043066]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of transcription by RNA polymerase I [GO:0016479]; platelet aggregation [GO:0070527]; positive regulation of actin filament bundle assembly [GO:0032233]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of neuron migration [GO:2001224]; positive regulation of platelet activation [GO:0010572]; positive regulation of potassium ion transmembrane transport [GO:1901381]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; protein localization to bicellular tight junction [GO:1902396]; protein localization to cell surface [GO:0034394]; protein localization to plasma membrane [GO:0072659]; protein stabilization [GO:0050821]; receptor clustering [GO:0043113]; regulation of cell migration [GO:0030334]; regulation of membrane repolarization during atrial cardiac muscle cell action potential [GO:1905000]; regulation of membrane repolarization during cardiac muscle cell action potential [GO:1905031]; release of sequestered calcium ion into cytosol [GO:0051209]; semaphorin-plexin signaling pathway [GO:0071526]; tubulin deacetylation [GO:0090042]; wound healing, spreading of cells [GO:0044319] actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; apical dendrite [GO:0097440]; cell-cell junction [GO:0005911]; cortical cytoskeleton [GO:0030863]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic shaft [GO:0043198]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; glycoprotein Ib-IX-V complex [GO:1990779]; growth cone [GO:0030426]; membrane [GO:0016020]; Myb complex [GO:0031523]; nucleolus [GO:0005730]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; podosome [GO:0002102]; postsynapse [GO:0098794]; Z disc [GO:0030018] actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; DNA-binding transcription factor binding [GO:0140297]; Fc-gamma receptor I complex binding [GO:0034988]; G protein-coupled receptor binding [GO:0001664]; GTPase binding [GO:0051020]; kinase binding [GO:0019900]; potassium channel regulator activity [GO:0015459]; protein homodimerization activity [GO:0042803]; protein sequestering activity [GO:0140311]; RNA binding [GO:0003723]; SMAD binding [GO:0046332]; small GTPase binding [GO:0031267]; transmembrane transporter binding [GO:0044325] g21097.t1 P21333 45.902 61 0.0 55.1 sp|P21333|FLNA_HUMAN Filamin-A OS=Homo sapiens OX=9606 GN=FLNA PE=1 SV=4 FLNA_HUMAN reviewed Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Alpha-filamin) (Endothelial actin-binding protein) (Filamin-1) (Non-muscle filamin) Homo sapiens (Human) GO:0001664; GO:0002102; GO:0003723; GO:0005576; GO:0005634; GO:0005730; GO:0005737; GO:0005829; GO:0005884; GO:0005886; GO:0005911; GO:0005925; GO:0007195; GO:0007597; GO:0010572; GO:0015459; GO:0015629; GO:0016020; GO:0016479; GO:0019900; GO:0021943; GO:0021987; GO:0030018; GO:0030036; GO:0030334; GO:0030426; GO:0030863; GO:0031267; GO:0031523; GO:0032233; GO:0034394; GO:0034988; GO:0035855; GO:0042177; GO:0042307; GO:0042789; GO:0042803; GO:0043066; GO:0043113; GO:0043123; GO:0043198; GO:0043204; GO:0043433; GO:0044319; GO:0044325; GO:0045184; GO:0045296; GO:0046332; GO:0048471; GO:0050821; GO:0051015; GO:0051020; GO:0051209; GO:0051764; GO:0060271; GO:0070062; GO:0070527; GO:0071526; GO:0072659; GO:0090042; GO:0090307; GO:0097368; GO:0097440; GO:0098794; GO:0098978; GO:0140297; GO:0140311; GO:1900026; GO:1901381; GO:1902396; GO:1905000; GO:1905031; GO:1990779; GO:2000179; GO:2001046; GO:2001224 actin crosslink formation [GO:0051764]; actin cytoskeleton organization [GO:0030036]; adenylate cyclase-inhibiting dopamine receptor signaling pathway [GO:0007195]; blood coagulation, intrinsic pathway [GO:0007597]; cerebral cortex development [GO:0021987]; cilium assembly [GO:0060271]; establishment of protein localization [GO:0045184]; establishment of Sertoli cell barrier [GO:0097368]; formation of radial glial scaffolds [GO:0021943]; megakaryocyte development [GO:0035855]; mitotic spindle assembly [GO:0090307]; mRNA transcription by RNA polymerase II [GO:0042789]; negative regulation of apoptotic process [GO:0043066]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of transcription by RNA polymerase I [GO:0016479]; platelet aggregation [GO:0070527]; positive regulation of actin filament bundle assembly [GO:0032233]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of neuron migration [GO:2001224]; positive regulation of platelet activation [GO:0010572]; positive regulation of potassium ion transmembrane transport [GO:1901381]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; protein localization to bicellular tight junction [GO:1902396]; protein localization to cell surface [GO:0034394]; protein localization to plasma membrane [GO:0072659]; protein stabilization [GO:0050821]; receptor clustering [GO:0043113]; regulation of cell migration [GO:0030334]; regulation of membrane repolarization during atrial cardiac muscle cell action potential [GO:1905000]; regulation of membrane repolarization during cardiac muscle cell action potential [GO:1905031]; release of sequestered calcium ion into cytosol [GO:0051209]; semaphorin-plexin signaling pathway [GO:0071526]; tubulin deacetylation [GO:0090042]; wound healing, spreading of cells [GO:0044319] actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; apical dendrite [GO:0097440]; cell-cell junction [GO:0005911]; cortical cytoskeleton [GO:0030863]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic shaft [GO:0043198]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; glycoprotein Ib-IX-V complex [GO:1990779]; growth cone [GO:0030426]; membrane [GO:0016020]; Myb complex [GO:0031523]; nucleolus [GO:0005730]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; podosome [GO:0002102]; postsynapse [GO:0098794]; Z disc [GO:0030018] actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; DNA-binding transcription factor binding [GO:0140297]; Fc-gamma receptor I complex binding [GO:0034988]; G protein-coupled receptor binding [GO:0001664]; GTPase binding [GO:0051020]; kinase binding [GO:0019900]; potassium channel regulator activity [GO:0015459]; protein homodimerization activity [GO:0042803]; protein sequestering activity [GO:0140311]; RNA binding [GO:0003723]; SMAD binding [GO:0046332]; small GTPase binding [GO:0031267]; transmembrane transporter binding [GO:0044325] g21097.t1 P21333 46.512 43 0.0 39.3 sp|P21333|FLNA_HUMAN Filamin-A OS=Homo sapiens OX=9606 GN=FLNA PE=1 SV=4 FLNA_HUMAN reviewed Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Alpha-filamin) (Endothelial actin-binding protein) (Filamin-1) (Non-muscle filamin) Homo sapiens (Human) GO:0001664; GO:0002102; GO:0003723; GO:0005576; GO:0005634; GO:0005730; GO:0005737; GO:0005829; GO:0005884; GO:0005886; GO:0005911; GO:0005925; GO:0007195; GO:0007597; GO:0010572; GO:0015459; GO:0015629; GO:0016020; GO:0016479; GO:0019900; GO:0021943; GO:0021987; GO:0030018; GO:0030036; GO:0030334; GO:0030426; GO:0030863; GO:0031267; GO:0031523; GO:0032233; GO:0034394; GO:0034988; GO:0035855; GO:0042177; GO:0042307; GO:0042789; GO:0042803; GO:0043066; GO:0043113; GO:0043123; GO:0043198; GO:0043204; GO:0043433; GO:0044319; GO:0044325; GO:0045184; GO:0045296; GO:0046332; GO:0048471; GO:0050821; GO:0051015; GO:0051020; GO:0051209; GO:0051764; GO:0060271; GO:0070062; GO:0070527; GO:0071526; GO:0072659; GO:0090042; GO:0090307; GO:0097368; GO:0097440; GO:0098794; GO:0098978; GO:0140297; GO:0140311; GO:1900026; GO:1901381; GO:1902396; GO:1905000; GO:1905031; GO:1990779; GO:2000179; GO:2001046; GO:2001224 actin crosslink formation [GO:0051764]; actin cytoskeleton organization [GO:0030036]; adenylate cyclase-inhibiting dopamine receptor signaling pathway [GO:0007195]; blood coagulation, intrinsic pathway [GO:0007597]; cerebral cortex development [GO:0021987]; cilium assembly [GO:0060271]; establishment of protein localization [GO:0045184]; establishment of Sertoli cell barrier [GO:0097368]; formation of radial glial scaffolds [GO:0021943]; megakaryocyte development [GO:0035855]; mitotic spindle assembly [GO:0090307]; mRNA transcription by RNA polymerase II [GO:0042789]; negative regulation of apoptotic process [GO:0043066]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of transcription by RNA polymerase I [GO:0016479]; platelet aggregation [GO:0070527]; positive regulation of actin filament bundle assembly [GO:0032233]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of neuron migration [GO:2001224]; positive regulation of platelet activation [GO:0010572]; positive regulation of potassium ion transmembrane transport [GO:1901381]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; protein localization to bicellular tight junction [GO:1902396]; protein localization to cell surface [GO:0034394]; protein localization to plasma membrane [GO:0072659]; protein stabilization [GO:0050821]; receptor clustering [GO:0043113]; regulation of cell migration [GO:0030334]; regulation of membrane repolarization during atrial cardiac muscle cell action potential [GO:1905000]; regulation of membrane repolarization during cardiac muscle cell action potential [GO:1905031]; release of sequestered calcium ion into cytosol [GO:0051209]; semaphorin-plexin signaling pathway [GO:0071526]; tubulin deacetylation [GO:0090042]; wound healing, spreading of cells [GO:0044319] actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; apical dendrite [GO:0097440]; cell-cell junction [GO:0005911]; cortical cytoskeleton [GO:0030863]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic shaft [GO:0043198]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; glycoprotein Ib-IX-V complex [GO:1990779]; growth cone [GO:0030426]; membrane [GO:0016020]; Myb complex [GO:0031523]; nucleolus [GO:0005730]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; podosome [GO:0002102]; postsynapse [GO:0098794]; Z disc [GO:0030018] actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; DNA-binding transcription factor binding [GO:0140297]; Fc-gamma receptor I complex binding [GO:0034988]; G protein-coupled receptor binding [GO:0001664]; GTPase binding [GO:0051020]; kinase binding [GO:0019900]; potassium channel regulator activity [GO:0015459]; protein homodimerization activity [GO:0042803]; protein sequestering activity [GO:0140311]; RNA binding [GO:0003723]; SMAD binding [GO:0046332]; small GTPase binding [GO:0031267]; transmembrane transporter binding [GO:0044325] g21097.t1 P21333 26.071 840 1.04e-108 204.0 sp|P21333|FLNA_HUMAN Filamin-A OS=Homo sapiens OX=9606 GN=FLNA PE=1 SV=4 FLNA_HUMAN reviewed Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Alpha-filamin) (Endothelial actin-binding protein) (Filamin-1) (Non-muscle filamin) Homo sapiens (Human) GO:0001664; GO:0002102; GO:0003723; GO:0005576; GO:0005634; GO:0005730; GO:0005737; GO:0005829; GO:0005884; GO:0005886; GO:0005911; GO:0005925; GO:0007195; GO:0007597; GO:0010572; GO:0015459; GO:0015629; GO:0016020; GO:0016479; GO:0019900; GO:0021943; GO:0021987; GO:0030018; GO:0030036; GO:0030334; GO:0030426; GO:0030863; GO:0031267; GO:0031523; GO:0032233; GO:0034394; GO:0034988; GO:0035855; GO:0042177; GO:0042307; GO:0042789; GO:0042803; GO:0043066; GO:0043113; GO:0043123; GO:0043198; GO:0043204; GO:0043433; GO:0044319; GO:0044325; GO:0045184; GO:0045296; GO:0046332; GO:0048471; GO:0050821; GO:0051015; GO:0051020; GO:0051209; GO:0051764; GO:0060271; GO:0070062; GO:0070527; GO:0071526; GO:0072659; GO:0090042; GO:0090307; GO:0097368; GO:0097440; GO:0098794; GO:0098978; GO:0140297; GO:0140311; GO:1900026; GO:1901381; GO:1902396; GO:1905000; GO:1905031; GO:1990779; GO:2000179; GO:2001046; GO:2001224 actin crosslink formation [GO:0051764]; actin cytoskeleton organization [GO:0030036]; adenylate cyclase-inhibiting dopamine receptor signaling pathway [GO:0007195]; blood coagulation, intrinsic pathway [GO:0007597]; cerebral cortex development [GO:0021987]; cilium assembly [GO:0060271]; establishment of protein localization [GO:0045184]; establishment of Sertoli cell barrier [GO:0097368]; formation of radial glial scaffolds [GO:0021943]; megakaryocyte development [GO:0035855]; mitotic spindle assembly [GO:0090307]; mRNA transcription by RNA polymerase II [GO:0042789]; negative regulation of apoptotic process [GO:0043066]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of transcription by RNA polymerase I [GO:0016479]; platelet aggregation [GO:0070527]; positive regulation of actin filament bundle assembly [GO:0032233]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of neuron migration [GO:2001224]; positive regulation of platelet activation [GO:0010572]; positive regulation of potassium ion transmembrane transport [GO:1901381]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; protein localization to bicellular tight junction [GO:1902396]; protein localization to cell surface [GO:0034394]; protein localization to plasma membrane [GO:0072659]; protein stabilization [GO:0050821]; receptor clustering [GO:0043113]; regulation of cell migration [GO:0030334]; regulation of membrane repolarization during atrial cardiac muscle cell action potential [GO:1905000]; regulation of membrane repolarization during cardiac muscle cell action potential [GO:1905031]; release of sequestered calcium ion into cytosol [GO:0051209]; semaphorin-plexin signaling pathway [GO:0071526]; tubulin deacetylation [GO:0090042]; wound healing, spreading of cells [GO:0044319] actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; apical dendrite [GO:0097440]; cell-cell junction [GO:0005911]; cortical cytoskeleton [GO:0030863]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic shaft [GO:0043198]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; glycoprotein Ib-IX-V complex [GO:1990779]; growth cone [GO:0030426]; membrane [GO:0016020]; Myb complex [GO:0031523]; nucleolus [GO:0005730]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; podosome [GO:0002102]; postsynapse [GO:0098794]; Z disc [GO:0030018] actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; DNA-binding transcription factor binding [GO:0140297]; Fc-gamma receptor I complex binding [GO:0034988]; G protein-coupled receptor binding [GO:0001664]; GTPase binding [GO:0051020]; kinase binding [GO:0019900]; potassium channel regulator activity [GO:0015459]; protein homodimerization activity [GO:0042803]; protein sequestering activity [GO:0140311]; RNA binding [GO:0003723]; SMAD binding [GO:0046332]; small GTPase binding [GO:0031267]; transmembrane transporter binding [GO:0044325] g21097.t1 P21333 30.375 507 1.04e-108 191.0 sp|P21333|FLNA_HUMAN Filamin-A OS=Homo sapiens OX=9606 GN=FLNA PE=1 SV=4 FLNA_HUMAN reviewed Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Alpha-filamin) (Endothelial actin-binding protein) (Filamin-1) (Non-muscle filamin) Homo sapiens (Human) GO:0001664; GO:0002102; GO:0003723; GO:0005576; GO:0005634; GO:0005730; GO:0005737; GO:0005829; GO:0005884; GO:0005886; GO:0005911; GO:0005925; GO:0007195; GO:0007597; GO:0010572; GO:0015459; GO:0015629; GO:0016020; GO:0016479; GO:0019900; GO:0021943; GO:0021987; GO:0030018; GO:0030036; GO:0030334; GO:0030426; GO:0030863; GO:0031267; GO:0031523; GO:0032233; GO:0034394; GO:0034988; GO:0035855; GO:0042177; GO:0042307; GO:0042789; GO:0042803; GO:0043066; GO:0043113; GO:0043123; GO:0043198; GO:0043204; GO:0043433; GO:0044319; GO:0044325; GO:0045184; GO:0045296; GO:0046332; GO:0048471; GO:0050821; GO:0051015; GO:0051020; GO:0051209; GO:0051764; GO:0060271; GO:0070062; GO:0070527; GO:0071526; GO:0072659; GO:0090042; GO:0090307; GO:0097368; GO:0097440; GO:0098794; GO:0098978; GO:0140297; GO:0140311; GO:1900026; GO:1901381; GO:1902396; GO:1905000; GO:1905031; GO:1990779; GO:2000179; GO:2001046; GO:2001224 actin crosslink formation [GO:0051764]; actin cytoskeleton organization [GO:0030036]; adenylate cyclase-inhibiting dopamine receptor signaling pathway [GO:0007195]; blood coagulation, intrinsic pathway [GO:0007597]; cerebral cortex development [GO:0021987]; cilium assembly [GO:0060271]; establishment of protein localization [GO:0045184]; establishment of Sertoli cell barrier [GO:0097368]; formation of radial glial scaffolds [GO:0021943]; megakaryocyte development [GO:0035855]; mitotic spindle assembly [GO:0090307]; mRNA transcription by RNA polymerase II [GO:0042789]; negative regulation of apoptotic process [GO:0043066]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of transcription by RNA polymerase I [GO:0016479]; platelet aggregation [GO:0070527]; positive regulation of actin filament bundle assembly [GO:0032233]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of neuron migration [GO:2001224]; positive regulation of platelet activation [GO:0010572]; positive regulation of potassium ion transmembrane transport [GO:1901381]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; protein localization to bicellular tight junction [GO:1902396]; protein localization to cell surface [GO:0034394]; protein localization to plasma membrane [GO:0072659]; protein stabilization [GO:0050821]; receptor clustering [GO:0043113]; regulation of cell migration [GO:0030334]; regulation of membrane repolarization during atrial cardiac muscle cell action potential [GO:1905000]; regulation of membrane repolarization during cardiac muscle cell action potential [GO:1905031]; release of sequestered calcium ion into cytosol [GO:0051209]; semaphorin-plexin signaling pathway [GO:0071526]; tubulin deacetylation [GO:0090042]; wound healing, spreading of cells [GO:0044319] actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; apical dendrite [GO:0097440]; cell-cell junction [GO:0005911]; cortical cytoskeleton [GO:0030863]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic shaft [GO:0043198]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; glycoprotein Ib-IX-V complex [GO:1990779]; growth cone [GO:0030426]; membrane [GO:0016020]; Myb complex [GO:0031523]; nucleolus [GO:0005730]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; podosome [GO:0002102]; postsynapse [GO:0098794]; Z disc [GO:0030018] actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; DNA-binding transcription factor binding [GO:0140297]; Fc-gamma receptor I complex binding [GO:0034988]; G protein-coupled receptor binding [GO:0001664]; GTPase binding [GO:0051020]; kinase binding [GO:0019900]; potassium channel regulator activity [GO:0015459]; protein homodimerization activity [GO:0042803]; protein sequestering activity [GO:0140311]; RNA binding [GO:0003723]; SMAD binding [GO:0046332]; small GTPase binding [GO:0031267]; transmembrane transporter binding [GO:0044325] g21097.t1 P21333 36.364 55 1.04e-108 45.1 sp|P21333|FLNA_HUMAN Filamin-A OS=Homo sapiens OX=9606 GN=FLNA PE=1 SV=4 FLNA_HUMAN reviewed Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Alpha-filamin) (Endothelial actin-binding protein) (Filamin-1) (Non-muscle filamin) Homo sapiens (Human) GO:0001664; GO:0002102; GO:0003723; GO:0005576; GO:0005634; GO:0005730; GO:0005737; GO:0005829; GO:0005884; GO:0005886; GO:0005911; GO:0005925; GO:0007195; GO:0007597; GO:0010572; GO:0015459; GO:0015629; GO:0016020; GO:0016479; GO:0019900; GO:0021943; GO:0021987; GO:0030018; GO:0030036; GO:0030334; GO:0030426; GO:0030863; GO:0031267; GO:0031523; GO:0032233; GO:0034394; GO:0034988; GO:0035855; GO:0042177; GO:0042307; GO:0042789; GO:0042803; GO:0043066; GO:0043113; GO:0043123; GO:0043198; GO:0043204; GO:0043433; GO:0044319; GO:0044325; GO:0045184; GO:0045296; GO:0046332; GO:0048471; GO:0050821; GO:0051015; GO:0051020; GO:0051209; GO:0051764; GO:0060271; GO:0070062; GO:0070527; GO:0071526; GO:0072659; GO:0090042; GO:0090307; GO:0097368; GO:0097440; GO:0098794; GO:0098978; GO:0140297; GO:0140311; GO:1900026; GO:1901381; GO:1902396; GO:1905000; GO:1905031; GO:1990779; GO:2000179; GO:2001046; GO:2001224 actin crosslink formation [GO:0051764]; actin cytoskeleton organization [GO:0030036]; adenylate cyclase-inhibiting dopamine receptor signaling pathway [GO:0007195]; blood coagulation, intrinsic pathway [GO:0007597]; cerebral cortex development [GO:0021987]; cilium assembly [GO:0060271]; establishment of protein localization [GO:0045184]; establishment of Sertoli cell barrier [GO:0097368]; formation of radial glial scaffolds [GO:0021943]; megakaryocyte development [GO:0035855]; mitotic spindle assembly [GO:0090307]; mRNA transcription by RNA polymerase II [GO:0042789]; negative regulation of apoptotic process [GO:0043066]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of transcription by RNA polymerase I [GO:0016479]; platelet aggregation [GO:0070527]; positive regulation of actin filament bundle assembly [GO:0032233]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of neuron migration [GO:2001224]; positive regulation of platelet activation [GO:0010572]; positive regulation of potassium ion transmembrane transport [GO:1901381]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; protein localization to bicellular tight junction [GO:1902396]; protein localization to cell surface [GO:0034394]; protein localization to plasma membrane [GO:0072659]; protein stabilization [GO:0050821]; receptor clustering [GO:0043113]; regulation of cell migration [GO:0030334]; regulation of membrane repolarization during atrial cardiac muscle cell action potential [GO:1905000]; regulation of membrane repolarization during cardiac muscle cell action potential [GO:1905031]; release of sequestered calcium ion into cytosol [GO:0051209]; semaphorin-plexin signaling pathway [GO:0071526]; tubulin deacetylation [GO:0090042]; wound healing, spreading of cells [GO:0044319] actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; apical dendrite [GO:0097440]; cell-cell junction [GO:0005911]; cortical cytoskeleton [GO:0030863]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic shaft [GO:0043198]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; glycoprotein Ib-IX-V complex [GO:1990779]; growth cone [GO:0030426]; membrane [GO:0016020]; Myb complex [GO:0031523]; nucleolus [GO:0005730]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; podosome [GO:0002102]; postsynapse [GO:0098794]; Z disc [GO:0030018] actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; DNA-binding transcription factor binding [GO:0140297]; Fc-gamma receptor I complex binding [GO:0034988]; G protein-coupled receptor binding [GO:0001664]; GTPase binding [GO:0051020]; kinase binding [GO:0019900]; potassium channel regulator activity [GO:0015459]; protein homodimerization activity [GO:0042803]; protein sequestering activity [GO:0140311]; RNA binding [GO:0003723]; SMAD binding [GO:0046332]; small GTPase binding [GO:0031267]; transmembrane transporter binding [GO:0044325] g21097.t1 P21333 28.652 890 4.11e-80 300.0 sp|P21333|FLNA_HUMAN Filamin-A OS=Homo sapiens OX=9606 GN=FLNA PE=1 SV=4 FLNA_HUMAN reviewed Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Alpha-filamin) (Endothelial actin-binding protein) (Filamin-1) (Non-muscle filamin) Homo sapiens (Human) GO:0001664; GO:0002102; GO:0003723; GO:0005576; GO:0005634; GO:0005730; GO:0005737; GO:0005829; GO:0005884; GO:0005886; GO:0005911; GO:0005925; GO:0007195; GO:0007597; GO:0010572; GO:0015459; GO:0015629; GO:0016020; GO:0016479; GO:0019900; GO:0021943; GO:0021987; GO:0030018; GO:0030036; GO:0030334; GO:0030426; GO:0030863; GO:0031267; GO:0031523; GO:0032233; GO:0034394; GO:0034988; GO:0035855; GO:0042177; GO:0042307; GO:0042789; GO:0042803; GO:0043066; GO:0043113; GO:0043123; GO:0043198; GO:0043204; GO:0043433; GO:0044319; GO:0044325; GO:0045184; GO:0045296; GO:0046332; GO:0048471; GO:0050821; GO:0051015; GO:0051020; GO:0051209; GO:0051764; GO:0060271; GO:0070062; GO:0070527; GO:0071526; GO:0072659; GO:0090042; GO:0090307; GO:0097368; GO:0097440; GO:0098794; GO:0098978; GO:0140297; GO:0140311; GO:1900026; GO:1901381; GO:1902396; GO:1905000; GO:1905031; GO:1990779; GO:2000179; GO:2001046; GO:2001224 actin crosslink formation [GO:0051764]; actin cytoskeleton organization [GO:0030036]; adenylate cyclase-inhibiting dopamine receptor signaling pathway [GO:0007195]; blood coagulation, intrinsic pathway [GO:0007597]; cerebral cortex development [GO:0021987]; cilium assembly [GO:0060271]; establishment of protein localization [GO:0045184]; establishment of Sertoli cell barrier [GO:0097368]; formation of radial glial scaffolds [GO:0021943]; megakaryocyte development [GO:0035855]; mitotic spindle assembly [GO:0090307]; mRNA transcription by RNA polymerase II [GO:0042789]; negative regulation of apoptotic process [GO:0043066]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of transcription by RNA polymerase I [GO:0016479]; platelet aggregation [GO:0070527]; positive regulation of actin filament bundle assembly [GO:0032233]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of neuron migration [GO:2001224]; positive regulation of platelet activation [GO:0010572]; positive regulation of potassium ion transmembrane transport [GO:1901381]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; protein localization to bicellular tight junction [GO:1902396]; protein localization to cell surface [GO:0034394]; protein localization to plasma membrane [GO:0072659]; protein stabilization [GO:0050821]; receptor clustering [GO:0043113]; regulation of cell migration [GO:0030334]; regulation of membrane repolarization during atrial cardiac muscle cell action potential [GO:1905000]; regulation of membrane repolarization during cardiac muscle cell action potential [GO:1905031]; release of sequestered calcium ion into cytosol [GO:0051209]; semaphorin-plexin signaling pathway [GO:0071526]; tubulin deacetylation [GO:0090042]; wound healing, spreading of cells [GO:0044319] actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; apical dendrite [GO:0097440]; cell-cell junction [GO:0005911]; cortical cytoskeleton [GO:0030863]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic shaft [GO:0043198]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; glycoprotein Ib-IX-V complex [GO:1990779]; growth cone [GO:0030426]; membrane [GO:0016020]; Myb complex [GO:0031523]; nucleolus [GO:0005730]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; podosome [GO:0002102]; postsynapse [GO:0098794]; Z disc [GO:0030018] actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; DNA-binding transcription factor binding [GO:0140297]; Fc-gamma receptor I complex binding [GO:0034988]; G protein-coupled receptor binding [GO:0001664]; GTPase binding [GO:0051020]; kinase binding [GO:0019900]; potassium channel regulator activity [GO:0015459]; protein homodimerization activity [GO:0042803]; protein sequestering activity [GO:0140311]; RNA binding [GO:0003723]; SMAD binding [GO:0046332]; small GTPase binding [GO:0031267]; transmembrane transporter binding [GO:0044325] g21097.t1 P21333 33.061 735 1.0000000000000001e-77 293.0 sp|P21333|FLNA_HUMAN Filamin-A OS=Homo sapiens OX=9606 GN=FLNA PE=1 SV=4 FLNA_HUMAN reviewed Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Alpha-filamin) (Endothelial actin-binding protein) (Filamin-1) (Non-muscle filamin) Homo sapiens (Human) GO:0001664; GO:0002102; GO:0003723; GO:0005576; GO:0005634; GO:0005730; GO:0005737; GO:0005829; GO:0005884; GO:0005886; GO:0005911; GO:0005925; GO:0007195; GO:0007597; GO:0010572; GO:0015459; GO:0015629; GO:0016020; GO:0016479; GO:0019900; GO:0021943; GO:0021987; GO:0030018; GO:0030036; GO:0030334; GO:0030426; GO:0030863; GO:0031267; GO:0031523; GO:0032233; GO:0034394; GO:0034988; GO:0035855; GO:0042177; GO:0042307; GO:0042789; GO:0042803; GO:0043066; GO:0043113; GO:0043123; GO:0043198; GO:0043204; GO:0043433; GO:0044319; GO:0044325; GO:0045184; GO:0045296; GO:0046332; GO:0048471; GO:0050821; GO:0051015; GO:0051020; GO:0051209; GO:0051764; GO:0060271; GO:0070062; GO:0070527; GO:0071526; GO:0072659; GO:0090042; GO:0090307; GO:0097368; GO:0097440; GO:0098794; GO:0098978; GO:0140297; GO:0140311; GO:1900026; GO:1901381; GO:1902396; GO:1905000; GO:1905031; GO:1990779; GO:2000179; GO:2001046; GO:2001224 actin crosslink formation [GO:0051764]; actin cytoskeleton organization [GO:0030036]; adenylate cyclase-inhibiting dopamine receptor signaling pathway [GO:0007195]; blood coagulation, intrinsic pathway [GO:0007597]; cerebral cortex development [GO:0021987]; cilium assembly [GO:0060271]; establishment of protein localization [GO:0045184]; establishment of Sertoli cell barrier [GO:0097368]; formation of radial glial scaffolds [GO:0021943]; megakaryocyte development [GO:0035855]; mitotic spindle assembly [GO:0090307]; mRNA transcription by RNA polymerase II [GO:0042789]; negative regulation of apoptotic process [GO:0043066]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of transcription by RNA polymerase I [GO:0016479]; platelet aggregation [GO:0070527]; positive regulation of actin filament bundle assembly [GO:0032233]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of neuron migration [GO:2001224]; positive regulation of platelet activation [GO:0010572]; positive regulation of potassium ion transmembrane transport [GO:1901381]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; protein localization to bicellular tight junction [GO:1902396]; protein localization to cell surface [GO:0034394]; protein localization to plasma membrane [GO:0072659]; protein stabilization [GO:0050821]; receptor clustering [GO:0043113]; regulation of cell migration [GO:0030334]; regulation of membrane repolarization during atrial cardiac muscle cell action potential [GO:1905000]; regulation of membrane repolarization during cardiac muscle cell action potential [GO:1905031]; release of sequestered calcium ion into cytosol [GO:0051209]; semaphorin-plexin signaling pathway [GO:0071526]; tubulin deacetylation [GO:0090042]; wound healing, spreading of cells [GO:0044319] actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; apical dendrite [GO:0097440]; cell-cell junction [GO:0005911]; cortical cytoskeleton [GO:0030863]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic shaft [GO:0043198]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; glycoprotein Ib-IX-V complex [GO:1990779]; growth cone [GO:0030426]; membrane [GO:0016020]; Myb complex [GO:0031523]; nucleolus [GO:0005730]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; podosome [GO:0002102]; postsynapse [GO:0098794]; Z disc [GO:0030018] actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; DNA-binding transcription factor binding [GO:0140297]; Fc-gamma receptor I complex binding [GO:0034988]; G protein-coupled receptor binding [GO:0001664]; GTPase binding [GO:0051020]; kinase binding [GO:0019900]; potassium channel regulator activity [GO:0015459]; protein homodimerization activity [GO:0042803]; protein sequestering activity [GO:0140311]; RNA binding [GO:0003723]; SMAD binding [GO:0046332]; small GTPase binding [GO:0031267]; transmembrane transporter binding [GO:0044325] g21097.t1 P21333 30.519 829 5.959999999999999e-68 248.0 sp|P21333|FLNA_HUMAN Filamin-A OS=Homo sapiens OX=9606 GN=FLNA PE=1 SV=4 FLNA_HUMAN reviewed Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Alpha-filamin) (Endothelial actin-binding protein) (Filamin-1) (Non-muscle filamin) Homo sapiens (Human) GO:0001664; GO:0002102; GO:0003723; GO:0005576; GO:0005634; GO:0005730; GO:0005737; GO:0005829; GO:0005884; GO:0005886; GO:0005911; GO:0005925; GO:0007195; GO:0007597; GO:0010572; GO:0015459; GO:0015629; GO:0016020; GO:0016479; GO:0019900; GO:0021943; GO:0021987; GO:0030018; GO:0030036; GO:0030334; GO:0030426; GO:0030863; GO:0031267; GO:0031523; GO:0032233; GO:0034394; GO:0034988; GO:0035855; GO:0042177; GO:0042307; GO:0042789; GO:0042803; GO:0043066; GO:0043113; GO:0043123; GO:0043198; GO:0043204; GO:0043433; GO:0044319; GO:0044325; GO:0045184; GO:0045296; GO:0046332; GO:0048471; GO:0050821; GO:0051015; GO:0051020; GO:0051209; GO:0051764; GO:0060271; GO:0070062; GO:0070527; GO:0071526; GO:0072659; GO:0090042; GO:0090307; GO:0097368; GO:0097440; GO:0098794; GO:0098978; GO:0140297; GO:0140311; GO:1900026; GO:1901381; GO:1902396; GO:1905000; GO:1905031; GO:1990779; GO:2000179; GO:2001046; GO:2001224 actin crosslink formation [GO:0051764]; actin cytoskeleton organization [GO:0030036]; adenylate cyclase-inhibiting dopamine receptor signaling pathway [GO:0007195]; blood coagulation, intrinsic pathway [GO:0007597]; cerebral cortex development [GO:0021987]; cilium assembly [GO:0060271]; establishment of protein localization [GO:0045184]; establishment of Sertoli cell barrier [GO:0097368]; formation of radial glial scaffolds [GO:0021943]; megakaryocyte development [GO:0035855]; mitotic spindle assembly [GO:0090307]; mRNA transcription by RNA polymerase II [GO:0042789]; negative regulation of apoptotic process [GO:0043066]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of transcription by RNA polymerase I [GO:0016479]; platelet aggregation [GO:0070527]; positive regulation of actin filament bundle assembly [GO:0032233]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of neuron migration [GO:2001224]; positive regulation of platelet activation [GO:0010572]; positive regulation of potassium ion transmembrane transport [GO:1901381]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; protein localization to bicellular tight junction [GO:1902396]; protein localization to cell surface [GO:0034394]; protein localization to plasma membrane [GO:0072659]; protein stabilization [GO:0050821]; receptor clustering [GO:0043113]; regulation of cell migration [GO:0030334]; regulation of membrane repolarization during atrial cardiac muscle cell action potential [GO:1905000]; regulation of membrane repolarization during cardiac muscle cell action potential [GO:1905031]; release of sequestered calcium ion into cytosol [GO:0051209]; semaphorin-plexin signaling pathway [GO:0071526]; tubulin deacetylation [GO:0090042]; wound healing, spreading of cells [GO:0044319] actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; apical dendrite [GO:0097440]; cell-cell junction [GO:0005911]; cortical cytoskeleton [GO:0030863]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic shaft [GO:0043198]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; glycoprotein Ib-IX-V complex [GO:1990779]; growth cone [GO:0030426]; membrane [GO:0016020]; Myb complex [GO:0031523]; nucleolus [GO:0005730]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; podosome [GO:0002102]; postsynapse [GO:0098794]; Z disc [GO:0030018] actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; DNA-binding transcription factor binding [GO:0140297]; Fc-gamma receptor I complex binding [GO:0034988]; G protein-coupled receptor binding [GO:0001664]; GTPase binding [GO:0051020]; kinase binding [GO:0019900]; potassium channel regulator activity [GO:0015459]; protein homodimerization activity [GO:0042803]; protein sequestering activity [GO:0140311]; RNA binding [GO:0003723]; SMAD binding [GO:0046332]; small GTPase binding [GO:0031267]; transmembrane transporter binding [GO:0044325] g21097.t1 P21333 36.957 46 5.959999999999999e-68 35.8 sp|P21333|FLNA_HUMAN Filamin-A OS=Homo sapiens OX=9606 GN=FLNA PE=1 SV=4 FLNA_HUMAN reviewed Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Alpha-filamin) (Endothelial actin-binding protein) (Filamin-1) (Non-muscle filamin) Homo sapiens (Human) GO:0001664; GO:0002102; GO:0003723; GO:0005576; GO:0005634; GO:0005730; GO:0005737; GO:0005829; GO:0005884; GO:0005886; GO:0005911; GO:0005925; GO:0007195; GO:0007597; GO:0010572; GO:0015459; GO:0015629; GO:0016020; GO:0016479; GO:0019900; GO:0021943; GO:0021987; GO:0030018; GO:0030036; GO:0030334; GO:0030426; GO:0030863; GO:0031267; GO:0031523; GO:0032233; GO:0034394; GO:0034988; GO:0035855; GO:0042177; GO:0042307; GO:0042789; GO:0042803; GO:0043066; GO:0043113; GO:0043123; GO:0043198; GO:0043204; GO:0043433; GO:0044319; GO:0044325; GO:0045184; GO:0045296; GO:0046332; GO:0048471; GO:0050821; GO:0051015; GO:0051020; GO:0051209; GO:0051764; GO:0060271; GO:0070062; GO:0070527; GO:0071526; GO:0072659; GO:0090042; GO:0090307; GO:0097368; GO:0097440; GO:0098794; GO:0098978; GO:0140297; GO:0140311; GO:1900026; GO:1901381; GO:1902396; GO:1905000; GO:1905031; GO:1990779; GO:2000179; GO:2001046; GO:2001224 actin crosslink formation [GO:0051764]; actin cytoskeleton organization [GO:0030036]; adenylate cyclase-inhibiting dopamine receptor signaling pathway [GO:0007195]; blood coagulation, intrinsic pathway [GO:0007597]; cerebral cortex development [GO:0021987]; cilium assembly [GO:0060271]; establishment of protein localization [GO:0045184]; establishment of Sertoli cell barrier [GO:0097368]; formation of radial glial scaffolds [GO:0021943]; megakaryocyte development [GO:0035855]; mitotic spindle assembly [GO:0090307]; mRNA transcription by RNA polymerase II [GO:0042789]; negative regulation of apoptotic process [GO:0043066]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of transcription by RNA polymerase I [GO:0016479]; platelet aggregation [GO:0070527]; positive regulation of actin filament bundle assembly [GO:0032233]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of neuron migration [GO:2001224]; positive regulation of platelet activation [GO:0010572]; positive regulation of potassium ion transmembrane transport [GO:1901381]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; protein localization to bicellular tight junction [GO:1902396]; protein localization to cell surface [GO:0034394]; protein localization to plasma membrane [GO:0072659]; protein stabilization [GO:0050821]; receptor clustering [GO:0043113]; regulation of cell migration [GO:0030334]; regulation of membrane repolarization during atrial cardiac muscle cell action potential [GO:1905000]; regulation of membrane repolarization during cardiac muscle cell action potential [GO:1905031]; release of sequestered calcium ion into cytosol [GO:0051209]; semaphorin-plexin signaling pathway [GO:0071526]; tubulin deacetylation [GO:0090042]; wound healing, spreading of cells [GO:0044319] actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; apical dendrite [GO:0097440]; cell-cell junction [GO:0005911]; cortical cytoskeleton [GO:0030863]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic shaft [GO:0043198]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; glycoprotein Ib-IX-V complex [GO:1990779]; growth cone [GO:0030426]; membrane [GO:0016020]; Myb complex [GO:0031523]; nucleolus [GO:0005730]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; podosome [GO:0002102]; postsynapse [GO:0098794]; Z disc [GO:0030018] actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; DNA-binding transcription factor binding [GO:0140297]; Fc-gamma receptor I complex binding [GO:0034988]; G protein-coupled receptor binding [GO:0001664]; GTPase binding [GO:0051020]; kinase binding [GO:0019900]; potassium channel regulator activity [GO:0015459]; protein homodimerization activity [GO:0042803]; protein sequestering activity [GO:0140311]; RNA binding [GO:0003723]; SMAD binding [GO:0046332]; small GTPase binding [GO:0031267]; transmembrane transporter binding [GO:0044325] g21097.t1 P21333 28.941 812 5.02e-67 257.0 sp|P21333|FLNA_HUMAN Filamin-A OS=Homo sapiens OX=9606 GN=FLNA PE=1 SV=4 FLNA_HUMAN reviewed Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Alpha-filamin) (Endothelial actin-binding protein) (Filamin-1) (Non-muscle filamin) Homo sapiens (Human) GO:0001664; GO:0002102; GO:0003723; GO:0005576; GO:0005634; GO:0005730; GO:0005737; GO:0005829; GO:0005884; GO:0005886; GO:0005911; GO:0005925; GO:0007195; GO:0007597; GO:0010572; GO:0015459; GO:0015629; GO:0016020; GO:0016479; GO:0019900; GO:0021943; GO:0021987; GO:0030018; GO:0030036; GO:0030334; GO:0030426; GO:0030863; GO:0031267; GO:0031523; GO:0032233; GO:0034394; GO:0034988; GO:0035855; GO:0042177; GO:0042307; GO:0042789; GO:0042803; GO:0043066; GO:0043113; GO:0043123; GO:0043198; GO:0043204; GO:0043433; GO:0044319; GO:0044325; GO:0045184; GO:0045296; GO:0046332; GO:0048471; GO:0050821; GO:0051015; GO:0051020; GO:0051209; GO:0051764; GO:0060271; GO:0070062; GO:0070527; GO:0071526; GO:0072659; GO:0090042; GO:0090307; GO:0097368; GO:0097440; GO:0098794; GO:0098978; GO:0140297; GO:0140311; GO:1900026; GO:1901381; GO:1902396; GO:1905000; GO:1905031; GO:1990779; GO:2000179; GO:2001046; GO:2001224 actin crosslink formation [GO:0051764]; actin cytoskeleton organization [GO:0030036]; adenylate cyclase-inhibiting dopamine receptor signaling pathway [GO:0007195]; blood coagulation, intrinsic pathway [GO:0007597]; cerebral cortex development [GO:0021987]; cilium assembly [GO:0060271]; establishment of protein localization [GO:0045184]; establishment of Sertoli cell barrier [GO:0097368]; formation of radial glial scaffolds [GO:0021943]; megakaryocyte development [GO:0035855]; mitotic spindle assembly [GO:0090307]; mRNA transcription by RNA polymerase II [GO:0042789]; negative regulation of apoptotic process [GO:0043066]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of transcription by RNA polymerase I [GO:0016479]; platelet aggregation [GO:0070527]; positive regulation of actin filament bundle assembly [GO:0032233]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of neuron migration [GO:2001224]; positive regulation of platelet activation [GO:0010572]; positive regulation of potassium ion transmembrane transport [GO:1901381]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; protein localization to bicellular tight junction [GO:1902396]; protein localization to cell surface [GO:0034394]; protein localization to plasma membrane [GO:0072659]; protein stabilization [GO:0050821]; receptor clustering [GO:0043113]; regulation of cell migration [GO:0030334]; regulation of membrane repolarization during atrial cardiac muscle cell action potential [GO:1905000]; regulation of membrane repolarization during cardiac muscle cell action potential [GO:1905031]; release of sequestered calcium ion into cytosol [GO:0051209]; semaphorin-plexin signaling pathway [GO:0071526]; tubulin deacetylation [GO:0090042]; wound healing, spreading of cells [GO:0044319] actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; apical dendrite [GO:0097440]; cell-cell junction [GO:0005911]; cortical cytoskeleton [GO:0030863]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic shaft [GO:0043198]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; glycoprotein Ib-IX-V complex [GO:1990779]; growth cone [GO:0030426]; membrane [GO:0016020]; Myb complex [GO:0031523]; nucleolus [GO:0005730]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; podosome [GO:0002102]; postsynapse [GO:0098794]; Z disc [GO:0030018] actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; DNA-binding transcription factor binding [GO:0140297]; Fc-gamma receptor I complex binding [GO:0034988]; G protein-coupled receptor binding [GO:0001664]; GTPase binding [GO:0051020]; kinase binding [GO:0019900]; potassium channel regulator activity [GO:0015459]; protein homodimerization activity [GO:0042803]; protein sequestering activity [GO:0140311]; RNA binding [GO:0003723]; SMAD binding [GO:0046332]; small GTPase binding [GO:0031267]; transmembrane transporter binding [GO:0044325] g21097.t1 P21333 29.916 829 2.83e-65 237.0 sp|P21333|FLNA_HUMAN Filamin-A OS=Homo sapiens OX=9606 GN=FLNA PE=1 SV=4 FLNA_HUMAN reviewed Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Alpha-filamin) (Endothelial actin-binding protein) (Filamin-1) (Non-muscle filamin) Homo sapiens (Human) GO:0001664; GO:0002102; GO:0003723; GO:0005576; GO:0005634; GO:0005730; GO:0005737; GO:0005829; GO:0005884; GO:0005886; GO:0005911; GO:0005925; GO:0007195; GO:0007597; GO:0010572; GO:0015459; GO:0015629; GO:0016020; GO:0016479; GO:0019900; GO:0021943; GO:0021987; GO:0030018; GO:0030036; GO:0030334; GO:0030426; GO:0030863; GO:0031267; GO:0031523; GO:0032233; GO:0034394; GO:0034988; GO:0035855; GO:0042177; GO:0042307; GO:0042789; GO:0042803; GO:0043066; GO:0043113; GO:0043123; GO:0043198; GO:0043204; GO:0043433; GO:0044319; GO:0044325; GO:0045184; GO:0045296; GO:0046332; GO:0048471; GO:0050821; GO:0051015; GO:0051020; GO:0051209; GO:0051764; GO:0060271; GO:0070062; GO:0070527; GO:0071526; GO:0072659; GO:0090042; GO:0090307; GO:0097368; GO:0097440; GO:0098794; GO:0098978; GO:0140297; GO:0140311; GO:1900026; GO:1901381; GO:1902396; GO:1905000; GO:1905031; GO:1990779; GO:2000179; GO:2001046; GO:2001224 actin crosslink formation [GO:0051764]; actin cytoskeleton organization [GO:0030036]; adenylate cyclase-inhibiting dopamine receptor signaling pathway [GO:0007195]; blood coagulation, intrinsic pathway [GO:0007597]; cerebral cortex development [GO:0021987]; cilium assembly [GO:0060271]; establishment of protein localization [GO:0045184]; establishment of Sertoli cell barrier [GO:0097368]; formation of radial glial scaffolds [GO:0021943]; megakaryocyte development [GO:0035855]; mitotic spindle assembly [GO:0090307]; mRNA transcription by RNA polymerase II [GO:0042789]; negative regulation of apoptotic process [GO:0043066]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of transcription by RNA polymerase I [GO:0016479]; platelet aggregation [GO:0070527]; positive regulation of actin filament bundle assembly [GO:0032233]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of neuron migration [GO:2001224]; positive regulation of platelet activation [GO:0010572]; positive regulation of potassium ion transmembrane transport [GO:1901381]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; protein localization to bicellular tight junction [GO:1902396]; protein localization to cell surface [GO:0034394]; protein localization to plasma membrane [GO:0072659]; protein stabilization [GO:0050821]; receptor clustering [GO:0043113]; regulation of cell migration [GO:0030334]; regulation of membrane repolarization during atrial cardiac muscle cell action potential [GO:1905000]; regulation of membrane repolarization during cardiac muscle cell action potential [GO:1905031]; release of sequestered calcium ion into cytosol [GO:0051209]; semaphorin-plexin signaling pathway [GO:0071526]; tubulin deacetylation [GO:0090042]; wound healing, spreading of cells [GO:0044319] actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; apical dendrite [GO:0097440]; cell-cell junction [GO:0005911]; cortical cytoskeleton [GO:0030863]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic shaft [GO:0043198]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; glycoprotein Ib-IX-V complex [GO:1990779]; growth cone [GO:0030426]; membrane [GO:0016020]; Myb complex [GO:0031523]; nucleolus [GO:0005730]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; podosome [GO:0002102]; postsynapse [GO:0098794]; Z disc [GO:0030018] actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; DNA-binding transcription factor binding [GO:0140297]; Fc-gamma receptor I complex binding [GO:0034988]; G protein-coupled receptor binding [GO:0001664]; GTPase binding [GO:0051020]; kinase binding [GO:0019900]; potassium channel regulator activity [GO:0015459]; protein homodimerization activity [GO:0042803]; protein sequestering activity [GO:0140311]; RNA binding [GO:0003723]; SMAD binding [GO:0046332]; small GTPase binding [GO:0031267]; transmembrane transporter binding [GO:0044325] g21097.t1 P21333 36.735 49 2.83e-65 37.7 sp|P21333|FLNA_HUMAN Filamin-A OS=Homo sapiens OX=9606 GN=FLNA PE=1 SV=4 FLNA_HUMAN reviewed Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Alpha-filamin) (Endothelial actin-binding protein) (Filamin-1) (Non-muscle filamin) Homo sapiens (Human) GO:0001664; GO:0002102; GO:0003723; GO:0005576; GO:0005634; GO:0005730; GO:0005737; GO:0005829; GO:0005884; GO:0005886; GO:0005911; GO:0005925; GO:0007195; GO:0007597; GO:0010572; GO:0015459; GO:0015629; GO:0016020; GO:0016479; GO:0019900; GO:0021943; GO:0021987; GO:0030018; GO:0030036; GO:0030334; GO:0030426; GO:0030863; GO:0031267; GO:0031523; GO:0032233; GO:0034394; GO:0034988; GO:0035855; GO:0042177; GO:0042307; GO:0042789; GO:0042803; GO:0043066; GO:0043113; GO:0043123; GO:0043198; GO:0043204; GO:0043433; GO:0044319; GO:0044325; GO:0045184; GO:0045296; GO:0046332; GO:0048471; GO:0050821; GO:0051015; GO:0051020; GO:0051209; GO:0051764; GO:0060271; GO:0070062; GO:0070527; GO:0071526; GO:0072659; GO:0090042; GO:0090307; GO:0097368; GO:0097440; GO:0098794; GO:0098978; GO:0140297; GO:0140311; GO:1900026; GO:1901381; GO:1902396; GO:1905000; GO:1905031; GO:1990779; GO:2000179; GO:2001046; GO:2001224 actin crosslink formation [GO:0051764]; actin cytoskeleton organization [GO:0030036]; adenylate cyclase-inhibiting dopamine receptor signaling pathway [GO:0007195]; blood coagulation, intrinsic pathway [GO:0007597]; cerebral cortex development [GO:0021987]; cilium assembly [GO:0060271]; establishment of protein localization [GO:0045184]; establishment of Sertoli cell barrier [GO:0097368]; formation of radial glial scaffolds [GO:0021943]; megakaryocyte development [GO:0035855]; mitotic spindle assembly [GO:0090307]; mRNA transcription by RNA polymerase II [GO:0042789]; negative regulation of apoptotic process [GO:0043066]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of transcription by RNA polymerase I [GO:0016479]; platelet aggregation [GO:0070527]; positive regulation of actin filament bundle assembly [GO:0032233]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of neuron migration [GO:2001224]; positive regulation of platelet activation [GO:0010572]; positive regulation of potassium ion transmembrane transport [GO:1901381]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; protein localization to bicellular tight junction [GO:1902396]; protein localization to cell surface [GO:0034394]; protein localization to plasma membrane [GO:0072659]; protein stabilization [GO:0050821]; receptor clustering [GO:0043113]; regulation of cell migration [GO:0030334]; regulation of membrane repolarization during atrial cardiac muscle cell action potential [GO:1905000]; regulation of membrane repolarization during cardiac muscle cell action potential [GO:1905031]; release of sequestered calcium ion into cytosol [GO:0051209]; semaphorin-plexin signaling pathway [GO:0071526]; tubulin deacetylation [GO:0090042]; wound healing, spreading of cells [GO:0044319] actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; apical dendrite [GO:0097440]; cell-cell junction [GO:0005911]; cortical cytoskeleton [GO:0030863]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic shaft [GO:0043198]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; glycoprotein Ib-IX-V complex [GO:1990779]; growth cone [GO:0030426]; membrane [GO:0016020]; Myb complex [GO:0031523]; nucleolus [GO:0005730]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; podosome [GO:0002102]; postsynapse [GO:0098794]; Z disc [GO:0030018] actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; DNA-binding transcription factor binding [GO:0140297]; Fc-gamma receptor I complex binding [GO:0034988]; G protein-coupled receptor binding [GO:0001664]; GTPase binding [GO:0051020]; kinase binding [GO:0019900]; potassium channel regulator activity [GO:0015459]; protein homodimerization activity [GO:0042803]; protein sequestering activity [GO:0140311]; RNA binding [GO:0003723]; SMAD binding [GO:0046332]; small GTPase binding [GO:0031267]; transmembrane transporter binding [GO:0044325] g21097.t1 P21333 32.194 556 3.46e-61 221.0 sp|P21333|FLNA_HUMAN Filamin-A OS=Homo sapiens OX=9606 GN=FLNA PE=1 SV=4 FLNA_HUMAN reviewed Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Alpha-filamin) (Endothelial actin-binding protein) (Filamin-1) (Non-muscle filamin) Homo sapiens (Human) GO:0001664; GO:0002102; GO:0003723; GO:0005576; GO:0005634; GO:0005730; GO:0005737; GO:0005829; GO:0005884; GO:0005886; GO:0005911; GO:0005925; GO:0007195; GO:0007597; GO:0010572; GO:0015459; GO:0015629; GO:0016020; GO:0016479; GO:0019900; GO:0021943; GO:0021987; GO:0030018; GO:0030036; GO:0030334; GO:0030426; GO:0030863; GO:0031267; GO:0031523; GO:0032233; GO:0034394; GO:0034988; GO:0035855; GO:0042177; GO:0042307; GO:0042789; GO:0042803; GO:0043066; GO:0043113; GO:0043123; GO:0043198; GO:0043204; GO:0043433; GO:0044319; GO:0044325; GO:0045184; GO:0045296; GO:0046332; GO:0048471; GO:0050821; GO:0051015; GO:0051020; GO:0051209; GO:0051764; GO:0060271; GO:0070062; GO:0070527; GO:0071526; GO:0072659; GO:0090042; GO:0090307; GO:0097368; GO:0097440; GO:0098794; GO:0098978; GO:0140297; GO:0140311; GO:1900026; GO:1901381; GO:1902396; GO:1905000; GO:1905031; GO:1990779; GO:2000179; GO:2001046; GO:2001224 actin crosslink formation [GO:0051764]; actin cytoskeleton organization [GO:0030036]; adenylate cyclase-inhibiting dopamine receptor signaling pathway [GO:0007195]; blood coagulation, intrinsic pathway [GO:0007597]; cerebral cortex development [GO:0021987]; cilium assembly [GO:0060271]; establishment of protein localization [GO:0045184]; establishment of Sertoli cell barrier [GO:0097368]; formation of radial glial scaffolds [GO:0021943]; megakaryocyte development [GO:0035855]; mitotic spindle assembly [GO:0090307]; mRNA transcription by RNA polymerase II [GO:0042789]; negative regulation of apoptotic process [GO:0043066]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of transcription by RNA polymerase I [GO:0016479]; platelet aggregation [GO:0070527]; positive regulation of actin filament bundle assembly [GO:0032233]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of neuron migration [GO:2001224]; positive regulation of platelet activation [GO:0010572]; positive regulation of potassium ion transmembrane transport [GO:1901381]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; protein localization to bicellular tight junction [GO:1902396]; protein localization to cell surface [GO:0034394]; protein localization to plasma membrane [GO:0072659]; protein stabilization [GO:0050821]; receptor clustering [GO:0043113]; regulation of cell migration [GO:0030334]; regulation of membrane repolarization during atrial cardiac muscle cell action potential [GO:1905000]; regulation of membrane repolarization during cardiac muscle cell action potential [GO:1905031]; release of sequestered calcium ion into cytosol [GO:0051209]; semaphorin-plexin signaling pathway [GO:0071526]; tubulin deacetylation [GO:0090042]; wound healing, spreading of cells [GO:0044319] actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; apical dendrite [GO:0097440]; cell-cell junction [GO:0005911]; cortical cytoskeleton [GO:0030863]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic shaft [GO:0043198]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; glycoprotein Ib-IX-V complex [GO:1990779]; growth cone [GO:0030426]; membrane [GO:0016020]; Myb complex [GO:0031523]; nucleolus [GO:0005730]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; podosome [GO:0002102]; postsynapse [GO:0098794]; Z disc [GO:0030018] actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; DNA-binding transcription factor binding [GO:0140297]; Fc-gamma receptor I complex binding [GO:0034988]; G protein-coupled receptor binding [GO:0001664]; GTPase binding [GO:0051020]; kinase binding [GO:0019900]; potassium channel regulator activity [GO:0015459]; protein homodimerization activity [GO:0042803]; protein sequestering activity [GO:0140311]; RNA binding [GO:0003723]; SMAD binding [GO:0046332]; small GTPase binding [GO:0031267]; transmembrane transporter binding [GO:0044325] g21097.t1 P21333 40.0 45 3.46e-61 39.3 sp|P21333|FLNA_HUMAN Filamin-A OS=Homo sapiens OX=9606 GN=FLNA PE=1 SV=4 FLNA_HUMAN reviewed Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Alpha-filamin) (Endothelial actin-binding protein) (Filamin-1) (Non-muscle filamin) Homo sapiens (Human) GO:0001664; GO:0002102; GO:0003723; GO:0005576; GO:0005634; GO:0005730; GO:0005737; GO:0005829; GO:0005884; GO:0005886; GO:0005911; GO:0005925; GO:0007195; GO:0007597; GO:0010572; GO:0015459; GO:0015629; GO:0016020; GO:0016479; GO:0019900; GO:0021943; GO:0021987; GO:0030018; GO:0030036; GO:0030334; GO:0030426; GO:0030863; GO:0031267; GO:0031523; GO:0032233; GO:0034394; GO:0034988; GO:0035855; GO:0042177; GO:0042307; GO:0042789; GO:0042803; GO:0043066; GO:0043113; GO:0043123; GO:0043198; GO:0043204; GO:0043433; GO:0044319; GO:0044325; GO:0045184; GO:0045296; GO:0046332; GO:0048471; GO:0050821; GO:0051015; GO:0051020; GO:0051209; GO:0051764; GO:0060271; GO:0070062; GO:0070527; GO:0071526; GO:0072659; GO:0090042; GO:0090307; GO:0097368; GO:0097440; GO:0098794; GO:0098978; GO:0140297; GO:0140311; GO:1900026; GO:1901381; GO:1902396; GO:1905000; GO:1905031; GO:1990779; GO:2000179; GO:2001046; GO:2001224 actin crosslink formation [GO:0051764]; actin cytoskeleton organization [GO:0030036]; adenylate cyclase-inhibiting dopamine receptor signaling pathway [GO:0007195]; blood coagulation, intrinsic pathway [GO:0007597]; cerebral cortex development [GO:0021987]; cilium assembly [GO:0060271]; establishment of protein localization [GO:0045184]; establishment of Sertoli cell barrier [GO:0097368]; formation of radial glial scaffolds [GO:0021943]; megakaryocyte development [GO:0035855]; mitotic spindle assembly [GO:0090307]; mRNA transcription by RNA polymerase II [GO:0042789]; negative regulation of apoptotic process [GO:0043066]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of transcription by RNA polymerase I [GO:0016479]; platelet aggregation [GO:0070527]; positive regulation of actin filament bundle assembly [GO:0032233]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of neuron migration [GO:2001224]; positive regulation of platelet activation [GO:0010572]; positive regulation of potassium ion transmembrane transport [GO:1901381]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; protein localization to bicellular tight junction [GO:1902396]; protein localization to cell surface [GO:0034394]; protein localization to plasma membrane [GO:0072659]; protein stabilization [GO:0050821]; receptor clustering [GO:0043113]; regulation of cell migration [GO:0030334]; regulation of membrane repolarization during atrial cardiac muscle cell action potential [GO:1905000]; regulation of membrane repolarization during cardiac muscle cell action potential [GO:1905031]; release of sequestered calcium ion into cytosol [GO:0051209]; semaphorin-plexin signaling pathway [GO:0071526]; tubulin deacetylation [GO:0090042]; wound healing, spreading of cells [GO:0044319] actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; apical dendrite [GO:0097440]; cell-cell junction [GO:0005911]; cortical cytoskeleton [GO:0030863]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic shaft [GO:0043198]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; glycoprotein Ib-IX-V complex [GO:1990779]; growth cone [GO:0030426]; membrane [GO:0016020]; Myb complex [GO:0031523]; nucleolus [GO:0005730]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; podosome [GO:0002102]; postsynapse [GO:0098794]; Z disc [GO:0030018] actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; DNA-binding transcription factor binding [GO:0140297]; Fc-gamma receptor I complex binding [GO:0034988]; G protein-coupled receptor binding [GO:0001664]; GTPase binding [GO:0051020]; kinase binding [GO:0019900]; potassium channel regulator activity [GO:0015459]; protein homodimerization activity [GO:0042803]; protein sequestering activity [GO:0140311]; RNA binding [GO:0003723]; SMAD binding [GO:0046332]; small GTPase binding [GO:0031267]; transmembrane transporter binding [GO:0044325] g21097.t1 P21333 26.335 824 2.08e-58 212.0 sp|P21333|FLNA_HUMAN Filamin-A OS=Homo sapiens OX=9606 GN=FLNA PE=1 SV=4 FLNA_HUMAN reviewed Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Alpha-filamin) (Endothelial actin-binding protein) (Filamin-1) (Non-muscle filamin) Homo sapiens (Human) GO:0001664; GO:0002102; GO:0003723; GO:0005576; GO:0005634; GO:0005730; GO:0005737; GO:0005829; GO:0005884; GO:0005886; GO:0005911; GO:0005925; GO:0007195; GO:0007597; GO:0010572; GO:0015459; GO:0015629; GO:0016020; GO:0016479; GO:0019900; GO:0021943; GO:0021987; GO:0030018; GO:0030036; GO:0030334; GO:0030426; GO:0030863; GO:0031267; GO:0031523; GO:0032233; GO:0034394; GO:0034988; GO:0035855; GO:0042177; GO:0042307; GO:0042789; GO:0042803; GO:0043066; GO:0043113; GO:0043123; GO:0043198; GO:0043204; GO:0043433; GO:0044319; GO:0044325; GO:0045184; GO:0045296; GO:0046332; GO:0048471; GO:0050821; GO:0051015; GO:0051020; GO:0051209; GO:0051764; GO:0060271; GO:0070062; GO:0070527; GO:0071526; GO:0072659; GO:0090042; GO:0090307; GO:0097368; GO:0097440; GO:0098794; GO:0098978; GO:0140297; GO:0140311; GO:1900026; GO:1901381; GO:1902396; GO:1905000; GO:1905031; GO:1990779; GO:2000179; GO:2001046; GO:2001224 actin crosslink formation [GO:0051764]; actin cytoskeleton organization [GO:0030036]; adenylate cyclase-inhibiting dopamine receptor signaling pathway [GO:0007195]; blood coagulation, intrinsic pathway [GO:0007597]; cerebral cortex development [GO:0021987]; cilium assembly [GO:0060271]; establishment of protein localization [GO:0045184]; establishment of Sertoli cell barrier [GO:0097368]; formation of radial glial scaffolds [GO:0021943]; megakaryocyte development [GO:0035855]; mitotic spindle assembly [GO:0090307]; mRNA transcription by RNA polymerase II [GO:0042789]; negative regulation of apoptotic process [GO:0043066]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of transcription by RNA polymerase I [GO:0016479]; platelet aggregation [GO:0070527]; positive regulation of actin filament bundle assembly [GO:0032233]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of neuron migration [GO:2001224]; positive regulation of platelet activation [GO:0010572]; positive regulation of potassium ion transmembrane transport [GO:1901381]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; protein localization to bicellular tight junction [GO:1902396]; protein localization to cell surface [GO:0034394]; protein localization to plasma membrane [GO:0072659]; protein stabilization [GO:0050821]; receptor clustering [GO:0043113]; regulation of cell migration [GO:0030334]; regulation of membrane repolarization during atrial cardiac muscle cell action potential [GO:1905000]; regulation of membrane repolarization during cardiac muscle cell action potential [GO:1905031]; release of sequestered calcium ion into cytosol [GO:0051209]; semaphorin-plexin signaling pathway [GO:0071526]; tubulin deacetylation [GO:0090042]; wound healing, spreading of cells [GO:0044319] actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; apical dendrite [GO:0097440]; cell-cell junction [GO:0005911]; cortical cytoskeleton [GO:0030863]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic shaft [GO:0043198]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; glycoprotein Ib-IX-V complex [GO:1990779]; growth cone [GO:0030426]; membrane [GO:0016020]; Myb complex [GO:0031523]; nucleolus [GO:0005730]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; podosome [GO:0002102]; postsynapse [GO:0098794]; Z disc [GO:0030018] actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; DNA-binding transcription factor binding [GO:0140297]; Fc-gamma receptor I complex binding [GO:0034988]; G protein-coupled receptor binding [GO:0001664]; GTPase binding [GO:0051020]; kinase binding [GO:0019900]; potassium channel regulator activity [GO:0015459]; protein homodimerization activity [GO:0042803]; protein sequestering activity [GO:0140311]; RNA binding [GO:0003723]; SMAD binding [GO:0046332]; small GTPase binding [GO:0031267]; transmembrane transporter binding [GO:0044325] g21097.t1 P21333 35.849 53 2.08e-58 39.7 sp|P21333|FLNA_HUMAN Filamin-A OS=Homo sapiens OX=9606 GN=FLNA PE=1 SV=4 FLNA_HUMAN reviewed Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Alpha-filamin) (Endothelial actin-binding protein) (Filamin-1) (Non-muscle filamin) Homo sapiens (Human) GO:0001664; GO:0002102; GO:0003723; GO:0005576; GO:0005634; GO:0005730; GO:0005737; GO:0005829; GO:0005884; GO:0005886; GO:0005911; GO:0005925; GO:0007195; GO:0007597; GO:0010572; GO:0015459; GO:0015629; GO:0016020; GO:0016479; GO:0019900; GO:0021943; GO:0021987; GO:0030018; GO:0030036; GO:0030334; GO:0030426; GO:0030863; GO:0031267; GO:0031523; GO:0032233; GO:0034394; GO:0034988; GO:0035855; GO:0042177; GO:0042307; GO:0042789; GO:0042803; GO:0043066; GO:0043113; GO:0043123; GO:0043198; GO:0043204; GO:0043433; GO:0044319; GO:0044325; GO:0045184; GO:0045296; GO:0046332; GO:0048471; GO:0050821; GO:0051015; GO:0051020; GO:0051209; GO:0051764; GO:0060271; GO:0070062; GO:0070527; GO:0071526; GO:0072659; GO:0090042; GO:0090307; GO:0097368; GO:0097440; GO:0098794; GO:0098978; GO:0140297; GO:0140311; GO:1900026; GO:1901381; GO:1902396; GO:1905000; GO:1905031; GO:1990779; GO:2000179; GO:2001046; GO:2001224 actin crosslink formation [GO:0051764]; actin cytoskeleton organization [GO:0030036]; adenylate cyclase-inhibiting dopamine receptor signaling pathway [GO:0007195]; blood coagulation, intrinsic pathway [GO:0007597]; cerebral cortex development [GO:0021987]; cilium assembly [GO:0060271]; establishment of protein localization [GO:0045184]; establishment of Sertoli cell barrier [GO:0097368]; formation of radial glial scaffolds [GO:0021943]; megakaryocyte development [GO:0035855]; mitotic spindle assembly [GO:0090307]; mRNA transcription by RNA polymerase II [GO:0042789]; negative regulation of apoptotic process [GO:0043066]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of transcription by RNA polymerase I [GO:0016479]; platelet aggregation [GO:0070527]; positive regulation of actin filament bundle assembly [GO:0032233]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of neuron migration [GO:2001224]; positive regulation of platelet activation [GO:0010572]; positive regulation of potassium ion transmembrane transport [GO:1901381]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; protein localization to bicellular tight junction [GO:1902396]; protein localization to cell surface [GO:0034394]; protein localization to plasma membrane [GO:0072659]; protein stabilization [GO:0050821]; receptor clustering [GO:0043113]; regulation of cell migration [GO:0030334]; regulation of membrane repolarization during atrial cardiac muscle cell action potential [GO:1905000]; regulation of membrane repolarization during cardiac muscle cell action potential [GO:1905031]; release of sequestered calcium ion into cytosol [GO:0051209]; semaphorin-plexin signaling pathway [GO:0071526]; tubulin deacetylation [GO:0090042]; wound healing, spreading of cells [GO:0044319] actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; apical dendrite [GO:0097440]; cell-cell junction [GO:0005911]; cortical cytoskeleton [GO:0030863]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic shaft [GO:0043198]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; glycoprotein Ib-IX-V complex [GO:1990779]; growth cone [GO:0030426]; membrane [GO:0016020]; Myb complex [GO:0031523]; nucleolus [GO:0005730]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; podosome [GO:0002102]; postsynapse [GO:0098794]; Z disc [GO:0030018] actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; DNA-binding transcription factor binding [GO:0140297]; Fc-gamma receptor I complex binding [GO:0034988]; G protein-coupled receptor binding [GO:0001664]; GTPase binding [GO:0051020]; kinase binding [GO:0019900]; potassium channel regulator activity [GO:0015459]; protein homodimerization activity [GO:0042803]; protein sequestering activity [GO:0140311]; RNA binding [GO:0003723]; SMAD binding [GO:0046332]; small GTPase binding [GO:0031267]; transmembrane transporter binding [GO:0044325] g21097.t1 P21333 29.188 764 8.21e-57 224.0 sp|P21333|FLNA_HUMAN Filamin-A OS=Homo sapiens OX=9606 GN=FLNA PE=1 SV=4 FLNA_HUMAN reviewed Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Alpha-filamin) (Endothelial actin-binding protein) (Filamin-1) (Non-muscle filamin) Homo sapiens (Human) GO:0001664; GO:0002102; GO:0003723; GO:0005576; GO:0005634; GO:0005730; GO:0005737; GO:0005829; GO:0005884; GO:0005886; GO:0005911; GO:0005925; GO:0007195; GO:0007597; GO:0010572; GO:0015459; GO:0015629; GO:0016020; GO:0016479; GO:0019900; GO:0021943; GO:0021987; GO:0030018; GO:0030036; GO:0030334; GO:0030426; GO:0030863; GO:0031267; GO:0031523; GO:0032233; GO:0034394; GO:0034988; GO:0035855; GO:0042177; GO:0042307; GO:0042789; GO:0042803; GO:0043066; GO:0043113; GO:0043123; GO:0043198; GO:0043204; GO:0043433; GO:0044319; GO:0044325; GO:0045184; GO:0045296; GO:0046332; GO:0048471; GO:0050821; GO:0051015; GO:0051020; GO:0051209; GO:0051764; GO:0060271; GO:0070062; GO:0070527; GO:0071526; GO:0072659; GO:0090042; GO:0090307; GO:0097368; GO:0097440; GO:0098794; GO:0098978; GO:0140297; GO:0140311; GO:1900026; GO:1901381; GO:1902396; GO:1905000; GO:1905031; GO:1990779; GO:2000179; GO:2001046; GO:2001224 actin crosslink formation [GO:0051764]; actin cytoskeleton organization [GO:0030036]; adenylate cyclase-inhibiting dopamine receptor signaling pathway [GO:0007195]; blood coagulation, intrinsic pathway [GO:0007597]; cerebral cortex development [GO:0021987]; cilium assembly [GO:0060271]; establishment of protein localization [GO:0045184]; establishment of Sertoli cell barrier [GO:0097368]; formation of radial glial scaffolds [GO:0021943]; megakaryocyte development [GO:0035855]; mitotic spindle assembly [GO:0090307]; mRNA transcription by RNA polymerase II [GO:0042789]; negative regulation of apoptotic process [GO:0043066]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of transcription by RNA polymerase I [GO:0016479]; platelet aggregation [GO:0070527]; positive regulation of actin filament bundle assembly [GO:0032233]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of neuron migration [GO:2001224]; positive regulation of platelet activation [GO:0010572]; positive regulation of potassium ion transmembrane transport [GO:1901381]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; protein localization to bicellular tight junction [GO:1902396]; protein localization to cell surface [GO:0034394]; protein localization to plasma membrane [GO:0072659]; protein stabilization [GO:0050821]; receptor clustering [GO:0043113]; regulation of cell migration [GO:0030334]; regulation of membrane repolarization during atrial cardiac muscle cell action potential [GO:1905000]; regulation of membrane repolarization during cardiac muscle cell action potential [GO:1905031]; release of sequestered calcium ion into cytosol [GO:0051209]; semaphorin-plexin signaling pathway [GO:0071526]; tubulin deacetylation [GO:0090042]; wound healing, spreading of cells [GO:0044319] actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; apical dendrite [GO:0097440]; cell-cell junction [GO:0005911]; cortical cytoskeleton [GO:0030863]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic shaft [GO:0043198]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; glycoprotein Ib-IX-V complex [GO:1990779]; growth cone [GO:0030426]; membrane [GO:0016020]; Myb complex [GO:0031523]; nucleolus [GO:0005730]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; podosome [GO:0002102]; postsynapse [GO:0098794]; Z disc [GO:0030018] actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; DNA-binding transcription factor binding [GO:0140297]; Fc-gamma receptor I complex binding [GO:0034988]; G protein-coupled receptor binding [GO:0001664]; GTPase binding [GO:0051020]; kinase binding [GO:0019900]; potassium channel regulator activity [GO:0015459]; protein homodimerization activity [GO:0042803]; protein sequestering activity [GO:0140311]; RNA binding [GO:0003723]; SMAD binding [GO:0046332]; small GTPase binding [GO:0031267]; transmembrane transporter binding [GO:0044325] g21097.t1 P21333 29.859 710 3.8899999999999995e-55 198.0 sp|P21333|FLNA_HUMAN Filamin-A OS=Homo sapiens OX=9606 GN=FLNA PE=1 SV=4 FLNA_HUMAN reviewed Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Alpha-filamin) (Endothelial actin-binding protein) (Filamin-1) (Non-muscle filamin) Homo sapiens (Human) GO:0001664; GO:0002102; GO:0003723; GO:0005576; GO:0005634; GO:0005730; GO:0005737; GO:0005829; GO:0005884; GO:0005886; GO:0005911; GO:0005925; GO:0007195; GO:0007597; GO:0010572; GO:0015459; GO:0015629; GO:0016020; GO:0016479; GO:0019900; GO:0021943; GO:0021987; GO:0030018; GO:0030036; GO:0030334; GO:0030426; GO:0030863; GO:0031267; GO:0031523; GO:0032233; GO:0034394; GO:0034988; GO:0035855; GO:0042177; GO:0042307; GO:0042789; GO:0042803; GO:0043066; GO:0043113; GO:0043123; GO:0043198; GO:0043204; GO:0043433; GO:0044319; GO:0044325; GO:0045184; GO:0045296; GO:0046332; GO:0048471; GO:0050821; GO:0051015; GO:0051020; GO:0051209; GO:0051764; GO:0060271; GO:0070062; GO:0070527; GO:0071526; GO:0072659; GO:0090042; GO:0090307; GO:0097368; GO:0097440; GO:0098794; GO:0098978; GO:0140297; GO:0140311; GO:1900026; GO:1901381; GO:1902396; GO:1905000; GO:1905031; GO:1990779; GO:2000179; GO:2001046; GO:2001224 actin crosslink formation [GO:0051764]; actin cytoskeleton organization [GO:0030036]; adenylate cyclase-inhibiting dopamine receptor signaling pathway [GO:0007195]; blood coagulation, intrinsic pathway [GO:0007597]; cerebral cortex development [GO:0021987]; cilium assembly [GO:0060271]; establishment of protein localization [GO:0045184]; establishment of Sertoli cell barrier [GO:0097368]; formation of radial glial scaffolds [GO:0021943]; megakaryocyte development [GO:0035855]; mitotic spindle assembly [GO:0090307]; mRNA transcription by RNA polymerase II [GO:0042789]; negative regulation of apoptotic process [GO:0043066]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of transcription by RNA polymerase I [GO:0016479]; platelet aggregation [GO:0070527]; positive regulation of actin filament bundle assembly [GO:0032233]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of neuron migration [GO:2001224]; positive regulation of platelet activation [GO:0010572]; positive regulation of potassium ion transmembrane transport [GO:1901381]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; protein localization to bicellular tight junction [GO:1902396]; protein localization to cell surface [GO:0034394]; protein localization to plasma membrane [GO:0072659]; protein stabilization [GO:0050821]; receptor clustering [GO:0043113]; regulation of cell migration [GO:0030334]; regulation of membrane repolarization during atrial cardiac muscle cell action potential [GO:1905000]; regulation of membrane repolarization during cardiac muscle cell action potential [GO:1905031]; release of sequestered calcium ion into cytosol [GO:0051209]; semaphorin-plexin signaling pathway [GO:0071526]; tubulin deacetylation [GO:0090042]; wound healing, spreading of cells [GO:0044319] actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; apical dendrite [GO:0097440]; cell-cell junction [GO:0005911]; cortical cytoskeleton [GO:0030863]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic shaft [GO:0043198]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; glycoprotein Ib-IX-V complex [GO:1990779]; growth cone [GO:0030426]; membrane [GO:0016020]; Myb complex [GO:0031523]; nucleolus [GO:0005730]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; podosome [GO:0002102]; postsynapse [GO:0098794]; Z disc [GO:0030018] actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; DNA-binding transcription factor binding [GO:0140297]; Fc-gamma receptor I complex binding [GO:0034988]; G protein-coupled receptor binding [GO:0001664]; GTPase binding [GO:0051020]; kinase binding [GO:0019900]; potassium channel regulator activity [GO:0015459]; protein homodimerization activity [GO:0042803]; protein sequestering activity [GO:0140311]; RNA binding [GO:0003723]; SMAD binding [GO:0046332]; small GTPase binding [GO:0031267]; transmembrane transporter binding [GO:0044325] g21097.t1 P21333 37.037 54 3.8899999999999995e-55 42.0 sp|P21333|FLNA_HUMAN Filamin-A OS=Homo sapiens OX=9606 GN=FLNA PE=1 SV=4 FLNA_HUMAN reviewed Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Alpha-filamin) (Endothelial actin-binding protein) (Filamin-1) (Non-muscle filamin) Homo sapiens (Human) GO:0001664; GO:0002102; GO:0003723; GO:0005576; GO:0005634; GO:0005730; GO:0005737; GO:0005829; GO:0005884; GO:0005886; GO:0005911; GO:0005925; GO:0007195; GO:0007597; GO:0010572; GO:0015459; GO:0015629; GO:0016020; GO:0016479; GO:0019900; GO:0021943; GO:0021987; GO:0030018; GO:0030036; GO:0030334; GO:0030426; GO:0030863; GO:0031267; GO:0031523; GO:0032233; GO:0034394; GO:0034988; GO:0035855; GO:0042177; GO:0042307; GO:0042789; GO:0042803; GO:0043066; GO:0043113; GO:0043123; GO:0043198; GO:0043204; GO:0043433; GO:0044319; GO:0044325; GO:0045184; GO:0045296; GO:0046332; GO:0048471; GO:0050821; GO:0051015; GO:0051020; GO:0051209; GO:0051764; GO:0060271; GO:0070062; GO:0070527; GO:0071526; GO:0072659; GO:0090042; GO:0090307; GO:0097368; GO:0097440; GO:0098794; GO:0098978; GO:0140297; GO:0140311; GO:1900026; GO:1901381; GO:1902396; GO:1905000; GO:1905031; GO:1990779; GO:2000179; GO:2001046; GO:2001224 actin crosslink formation [GO:0051764]; actin cytoskeleton organization [GO:0030036]; adenylate cyclase-inhibiting dopamine receptor signaling pathway [GO:0007195]; blood coagulation, intrinsic pathway [GO:0007597]; cerebral cortex development [GO:0021987]; cilium assembly [GO:0060271]; establishment of protein localization [GO:0045184]; establishment of Sertoli cell barrier [GO:0097368]; formation of radial glial scaffolds [GO:0021943]; megakaryocyte development [GO:0035855]; mitotic spindle assembly [GO:0090307]; mRNA transcription by RNA polymerase II [GO:0042789]; negative regulation of apoptotic process [GO:0043066]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of transcription by RNA polymerase I [GO:0016479]; platelet aggregation [GO:0070527]; positive regulation of actin filament bundle assembly [GO:0032233]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of neuron migration [GO:2001224]; positive regulation of platelet activation [GO:0010572]; positive regulation of potassium ion transmembrane transport [GO:1901381]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; protein localization to bicellular tight junction [GO:1902396]; protein localization to cell surface [GO:0034394]; protein localization to plasma membrane [GO:0072659]; protein stabilization [GO:0050821]; receptor clustering [GO:0043113]; regulation of cell migration [GO:0030334]; regulation of membrane repolarization during atrial cardiac muscle cell action potential [GO:1905000]; regulation of membrane repolarization during cardiac muscle cell action potential [GO:1905031]; release of sequestered calcium ion into cytosol [GO:0051209]; semaphorin-plexin signaling pathway [GO:0071526]; tubulin deacetylation [GO:0090042]; wound healing, spreading of cells [GO:0044319] actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; apical dendrite [GO:0097440]; cell-cell junction [GO:0005911]; cortical cytoskeleton [GO:0030863]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic shaft [GO:0043198]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; glycoprotein Ib-IX-V complex [GO:1990779]; growth cone [GO:0030426]; membrane [GO:0016020]; Myb complex [GO:0031523]; nucleolus [GO:0005730]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; podosome [GO:0002102]; postsynapse [GO:0098794]; Z disc [GO:0030018] actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; DNA-binding transcription factor binding [GO:0140297]; Fc-gamma receptor I complex binding [GO:0034988]; G protein-coupled receptor binding [GO:0001664]; GTPase binding [GO:0051020]; kinase binding [GO:0019900]; potassium channel regulator activity [GO:0015459]; protein homodimerization activity [GO:0042803]; protein sequestering activity [GO:0140311]; RNA binding [GO:0003723]; SMAD binding [GO:0046332]; small GTPase binding [GO:0031267]; transmembrane transporter binding [GO:0044325] g21097.t1 P21333 26.869 856 1.45e-50 203.0 sp|P21333|FLNA_HUMAN Filamin-A OS=Homo sapiens OX=9606 GN=FLNA PE=1 SV=4 FLNA_HUMAN reviewed Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Alpha-filamin) (Endothelial actin-binding protein) (Filamin-1) (Non-muscle filamin) Homo sapiens (Human) GO:0001664; GO:0002102; GO:0003723; GO:0005576; GO:0005634; GO:0005730; GO:0005737; GO:0005829; GO:0005884; GO:0005886; GO:0005911; GO:0005925; GO:0007195; GO:0007597; GO:0010572; GO:0015459; GO:0015629; GO:0016020; GO:0016479; GO:0019900; GO:0021943; GO:0021987; GO:0030018; GO:0030036; GO:0030334; GO:0030426; GO:0030863; GO:0031267; GO:0031523; GO:0032233; GO:0034394; GO:0034988; GO:0035855; GO:0042177; GO:0042307; GO:0042789; GO:0042803; GO:0043066; GO:0043113; GO:0043123; GO:0043198; GO:0043204; GO:0043433; GO:0044319; GO:0044325; GO:0045184; GO:0045296; GO:0046332; GO:0048471; GO:0050821; GO:0051015; GO:0051020; GO:0051209; GO:0051764; GO:0060271; GO:0070062; GO:0070527; GO:0071526; GO:0072659; GO:0090042; GO:0090307; GO:0097368; GO:0097440; GO:0098794; GO:0098978; GO:0140297; GO:0140311; GO:1900026; GO:1901381; GO:1902396; GO:1905000; GO:1905031; GO:1990779; GO:2000179; GO:2001046; GO:2001224 actin crosslink formation [GO:0051764]; actin cytoskeleton organization [GO:0030036]; adenylate cyclase-inhibiting dopamine receptor signaling pathway [GO:0007195]; blood coagulation, intrinsic pathway [GO:0007597]; cerebral cortex development [GO:0021987]; cilium assembly [GO:0060271]; establishment of protein localization [GO:0045184]; establishment of Sertoli cell barrier [GO:0097368]; formation of radial glial scaffolds [GO:0021943]; megakaryocyte development [GO:0035855]; mitotic spindle assembly [GO:0090307]; mRNA transcription by RNA polymerase II [GO:0042789]; negative regulation of apoptotic process [GO:0043066]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of transcription by RNA polymerase I [GO:0016479]; platelet aggregation [GO:0070527]; positive regulation of actin filament bundle assembly [GO:0032233]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of neuron migration [GO:2001224]; positive regulation of platelet activation [GO:0010572]; positive regulation of potassium ion transmembrane transport [GO:1901381]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; protein localization to bicellular tight junction [GO:1902396]; protein localization to cell surface [GO:0034394]; protein localization to plasma membrane [GO:0072659]; protein stabilization [GO:0050821]; receptor clustering [GO:0043113]; regulation of cell migration [GO:0030334]; regulation of membrane repolarization during atrial cardiac muscle cell action potential [GO:1905000]; regulation of membrane repolarization during cardiac muscle cell action potential [GO:1905031]; release of sequestered calcium ion into cytosol [GO:0051209]; semaphorin-plexin signaling pathway [GO:0071526]; tubulin deacetylation [GO:0090042]; wound healing, spreading of cells [GO:0044319] actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; apical dendrite [GO:0097440]; cell-cell junction [GO:0005911]; cortical cytoskeleton [GO:0030863]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic shaft [GO:0043198]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; glycoprotein Ib-IX-V complex [GO:1990779]; growth cone [GO:0030426]; membrane [GO:0016020]; Myb complex [GO:0031523]; nucleolus [GO:0005730]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; podosome [GO:0002102]; postsynapse [GO:0098794]; Z disc [GO:0030018] actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; DNA-binding transcription factor binding [GO:0140297]; Fc-gamma receptor I complex binding [GO:0034988]; G protein-coupled receptor binding [GO:0001664]; GTPase binding [GO:0051020]; kinase binding [GO:0019900]; potassium channel regulator activity [GO:0015459]; protein homodimerization activity [GO:0042803]; protein sequestering activity [GO:0140311]; RNA binding [GO:0003723]; SMAD binding [GO:0046332]; small GTPase binding [GO:0031267]; transmembrane transporter binding [GO:0044325] g21097.t1 P21333 28.29 813 4.71e-49 198.0 sp|P21333|FLNA_HUMAN Filamin-A OS=Homo sapiens OX=9606 GN=FLNA PE=1 SV=4 FLNA_HUMAN reviewed Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Alpha-filamin) (Endothelial actin-binding protein) (Filamin-1) (Non-muscle filamin) Homo sapiens (Human) GO:0001664; GO:0002102; GO:0003723; GO:0005576; GO:0005634; GO:0005730; GO:0005737; GO:0005829; GO:0005884; GO:0005886; GO:0005911; GO:0005925; GO:0007195; GO:0007597; GO:0010572; GO:0015459; GO:0015629; GO:0016020; GO:0016479; GO:0019900; GO:0021943; GO:0021987; GO:0030018; GO:0030036; GO:0030334; GO:0030426; GO:0030863; GO:0031267; GO:0031523; GO:0032233; GO:0034394; GO:0034988; GO:0035855; GO:0042177; GO:0042307; GO:0042789; GO:0042803; GO:0043066; GO:0043113; GO:0043123; GO:0043198; GO:0043204; GO:0043433; GO:0044319; GO:0044325; GO:0045184; GO:0045296; GO:0046332; GO:0048471; GO:0050821; GO:0051015; GO:0051020; GO:0051209; GO:0051764; GO:0060271; GO:0070062; GO:0070527; GO:0071526; GO:0072659; GO:0090042; GO:0090307; GO:0097368; GO:0097440; GO:0098794; GO:0098978; GO:0140297; GO:0140311; GO:1900026; GO:1901381; GO:1902396; GO:1905000; GO:1905031; GO:1990779; GO:2000179; GO:2001046; GO:2001224 actin crosslink formation [GO:0051764]; actin cytoskeleton organization [GO:0030036]; adenylate cyclase-inhibiting dopamine receptor signaling pathway [GO:0007195]; blood coagulation, intrinsic pathway [GO:0007597]; cerebral cortex development [GO:0021987]; cilium assembly [GO:0060271]; establishment of protein localization [GO:0045184]; establishment of Sertoli cell barrier [GO:0097368]; formation of radial glial scaffolds [GO:0021943]; megakaryocyte development [GO:0035855]; mitotic spindle assembly [GO:0090307]; mRNA transcription by RNA polymerase II [GO:0042789]; negative regulation of apoptotic process [GO:0043066]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of transcription by RNA polymerase I [GO:0016479]; platelet aggregation [GO:0070527]; positive regulation of actin filament bundle assembly [GO:0032233]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of neuron migration [GO:2001224]; positive regulation of platelet activation [GO:0010572]; positive regulation of potassium ion transmembrane transport [GO:1901381]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; protein localization to bicellular tight junction [GO:1902396]; protein localization to cell surface [GO:0034394]; protein localization to plasma membrane [GO:0072659]; protein stabilization [GO:0050821]; receptor clustering [GO:0043113]; regulation of cell migration [GO:0030334]; regulation of membrane repolarization during atrial cardiac muscle cell action potential [GO:1905000]; regulation of membrane repolarization during cardiac muscle cell action potential [GO:1905031]; release of sequestered calcium ion into cytosol [GO:0051209]; semaphorin-plexin signaling pathway [GO:0071526]; tubulin deacetylation [GO:0090042]; wound healing, spreading of cells [GO:0044319] actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; apical dendrite [GO:0097440]; cell-cell junction [GO:0005911]; cortical cytoskeleton [GO:0030863]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic shaft [GO:0043198]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; glycoprotein Ib-IX-V complex [GO:1990779]; growth cone [GO:0030426]; membrane [GO:0016020]; Myb complex [GO:0031523]; nucleolus [GO:0005730]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; podosome [GO:0002102]; postsynapse [GO:0098794]; Z disc [GO:0030018] actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; DNA-binding transcription factor binding [GO:0140297]; Fc-gamma receptor I complex binding [GO:0034988]; G protein-coupled receptor binding [GO:0001664]; GTPase binding [GO:0051020]; kinase binding [GO:0019900]; potassium channel regulator activity [GO:0015459]; protein homodimerization activity [GO:0042803]; protein sequestering activity [GO:0140311]; RNA binding [GO:0003723]; SMAD binding [GO:0046332]; small GTPase binding [GO:0031267]; transmembrane transporter binding [GO:0044325] g21097.t1 P21333 31.449 566 9.57e-47 191.0 sp|P21333|FLNA_HUMAN Filamin-A OS=Homo sapiens OX=9606 GN=FLNA PE=1 SV=4 FLNA_HUMAN reviewed Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Alpha-filamin) (Endothelial actin-binding protein) (Filamin-1) (Non-muscle filamin) Homo sapiens (Human) GO:0001664; GO:0002102; GO:0003723; GO:0005576; GO:0005634; GO:0005730; GO:0005737; GO:0005829; GO:0005884; GO:0005886; GO:0005911; GO:0005925; GO:0007195; GO:0007597; GO:0010572; GO:0015459; GO:0015629; GO:0016020; GO:0016479; GO:0019900; GO:0021943; GO:0021987; GO:0030018; GO:0030036; GO:0030334; GO:0030426; GO:0030863; GO:0031267; GO:0031523; GO:0032233; GO:0034394; GO:0034988; GO:0035855; GO:0042177; GO:0042307; GO:0042789; GO:0042803; GO:0043066; GO:0043113; GO:0043123; GO:0043198; GO:0043204; GO:0043433; GO:0044319; GO:0044325; GO:0045184; GO:0045296; GO:0046332; GO:0048471; GO:0050821; GO:0051015; GO:0051020; GO:0051209; GO:0051764; GO:0060271; GO:0070062; GO:0070527; GO:0071526; GO:0072659; GO:0090042; GO:0090307; GO:0097368; GO:0097440; GO:0098794; GO:0098978; GO:0140297; GO:0140311; GO:1900026; GO:1901381; GO:1902396; GO:1905000; GO:1905031; GO:1990779; GO:2000179; GO:2001046; GO:2001224 actin crosslink formation [GO:0051764]; actin cytoskeleton organization [GO:0030036]; adenylate cyclase-inhibiting dopamine receptor signaling pathway [GO:0007195]; blood coagulation, intrinsic pathway [GO:0007597]; cerebral cortex development [GO:0021987]; cilium assembly [GO:0060271]; establishment of protein localization [GO:0045184]; establishment of Sertoli cell barrier [GO:0097368]; formation of radial glial scaffolds [GO:0021943]; megakaryocyte development [GO:0035855]; mitotic spindle assembly [GO:0090307]; mRNA transcription by RNA polymerase II [GO:0042789]; negative regulation of apoptotic process [GO:0043066]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of transcription by RNA polymerase I [GO:0016479]; platelet aggregation [GO:0070527]; positive regulation of actin filament bundle assembly [GO:0032233]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of neuron migration [GO:2001224]; positive regulation of platelet activation [GO:0010572]; positive regulation of potassium ion transmembrane transport [GO:1901381]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; protein localization to bicellular tight junction [GO:1902396]; protein localization to cell surface [GO:0034394]; protein localization to plasma membrane [GO:0072659]; protein stabilization [GO:0050821]; receptor clustering [GO:0043113]; regulation of cell migration [GO:0030334]; regulation of membrane repolarization during atrial cardiac muscle cell action potential [GO:1905000]; regulation of membrane repolarization during cardiac muscle cell action potential [GO:1905031]; release of sequestered calcium ion into cytosol [GO:0051209]; semaphorin-plexin signaling pathway [GO:0071526]; tubulin deacetylation [GO:0090042]; wound healing, spreading of cells [GO:0044319] actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; apical dendrite [GO:0097440]; cell-cell junction [GO:0005911]; cortical cytoskeleton [GO:0030863]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic shaft [GO:0043198]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; glycoprotein Ib-IX-V complex [GO:1990779]; growth cone [GO:0030426]; membrane [GO:0016020]; Myb complex [GO:0031523]; nucleolus [GO:0005730]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; podosome [GO:0002102]; postsynapse [GO:0098794]; Z disc [GO:0030018] actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; DNA-binding transcription factor binding [GO:0140297]; Fc-gamma receptor I complex binding [GO:0034988]; G protein-coupled receptor binding [GO:0001664]; GTPase binding [GO:0051020]; kinase binding [GO:0019900]; potassium channel regulator activity [GO:0015459]; protein homodimerization activity [GO:0042803]; protein sequestering activity [GO:0140311]; RNA binding [GO:0003723]; SMAD binding [GO:0046332]; small GTPase binding [GO:0031267]; transmembrane transporter binding [GO:0044325] g21097.t1 P21333 31.25 496 1.58e-44 169.0 sp|P21333|FLNA_HUMAN Filamin-A OS=Homo sapiens OX=9606 GN=FLNA PE=1 SV=4 FLNA_HUMAN reviewed Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Alpha-filamin) (Endothelial actin-binding protein) (Filamin-1) (Non-muscle filamin) Homo sapiens (Human) GO:0001664; GO:0002102; GO:0003723; GO:0005576; GO:0005634; GO:0005730; GO:0005737; GO:0005829; GO:0005884; GO:0005886; GO:0005911; GO:0005925; GO:0007195; GO:0007597; GO:0010572; GO:0015459; GO:0015629; GO:0016020; GO:0016479; GO:0019900; GO:0021943; GO:0021987; GO:0030018; GO:0030036; GO:0030334; GO:0030426; GO:0030863; GO:0031267; GO:0031523; GO:0032233; GO:0034394; GO:0034988; GO:0035855; GO:0042177; GO:0042307; GO:0042789; GO:0042803; GO:0043066; GO:0043113; GO:0043123; GO:0043198; GO:0043204; GO:0043433; GO:0044319; GO:0044325; GO:0045184; GO:0045296; GO:0046332; GO:0048471; GO:0050821; GO:0051015; GO:0051020; GO:0051209; GO:0051764; GO:0060271; GO:0070062; GO:0070527; GO:0071526; GO:0072659; GO:0090042; GO:0090307; GO:0097368; GO:0097440; GO:0098794; GO:0098978; GO:0140297; GO:0140311; GO:1900026; GO:1901381; GO:1902396; GO:1905000; GO:1905031; GO:1990779; GO:2000179; GO:2001046; GO:2001224 actin crosslink formation [GO:0051764]; actin cytoskeleton organization [GO:0030036]; adenylate cyclase-inhibiting dopamine receptor signaling pathway [GO:0007195]; blood coagulation, intrinsic pathway [GO:0007597]; cerebral cortex development [GO:0021987]; cilium assembly [GO:0060271]; establishment of protein localization [GO:0045184]; establishment of Sertoli cell barrier [GO:0097368]; formation of radial glial scaffolds [GO:0021943]; megakaryocyte development [GO:0035855]; mitotic spindle assembly [GO:0090307]; mRNA transcription by RNA polymerase II [GO:0042789]; negative regulation of apoptotic process [GO:0043066]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of transcription by RNA polymerase I [GO:0016479]; platelet aggregation [GO:0070527]; positive regulation of actin filament bundle assembly [GO:0032233]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of neuron migration [GO:2001224]; positive regulation of platelet activation [GO:0010572]; positive regulation of potassium ion transmembrane transport [GO:1901381]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; protein localization to bicellular tight junction [GO:1902396]; protein localization to cell surface [GO:0034394]; protein localization to plasma membrane [GO:0072659]; protein stabilization [GO:0050821]; receptor clustering [GO:0043113]; regulation of cell migration [GO:0030334]; regulation of membrane repolarization during atrial cardiac muscle cell action potential [GO:1905000]; regulation of membrane repolarization during cardiac muscle cell action potential [GO:1905031]; release of sequestered calcium ion into cytosol [GO:0051209]; semaphorin-plexin signaling pathway [GO:0071526]; tubulin deacetylation [GO:0090042]; wound healing, spreading of cells [GO:0044319] actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; apical dendrite [GO:0097440]; cell-cell junction [GO:0005911]; cortical cytoskeleton [GO:0030863]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic shaft [GO:0043198]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; glycoprotein Ib-IX-V complex [GO:1990779]; growth cone [GO:0030426]; membrane [GO:0016020]; Myb complex [GO:0031523]; nucleolus [GO:0005730]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; podosome [GO:0002102]; postsynapse [GO:0098794]; Z disc [GO:0030018] actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; DNA-binding transcription factor binding [GO:0140297]; Fc-gamma receptor I complex binding [GO:0034988]; G protein-coupled receptor binding [GO:0001664]; GTPase binding [GO:0051020]; kinase binding [GO:0019900]; potassium channel regulator activity [GO:0015459]; protein homodimerization activity [GO:0042803]; protein sequestering activity [GO:0140311]; RNA binding [GO:0003723]; SMAD binding [GO:0046332]; small GTPase binding [GO:0031267]; transmembrane transporter binding [GO:0044325] g21097.t1 P21333 35.385 65 1.58e-44 36.2 sp|P21333|FLNA_HUMAN Filamin-A OS=Homo sapiens OX=9606 GN=FLNA PE=1 SV=4 FLNA_HUMAN reviewed Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Alpha-filamin) (Endothelial actin-binding protein) (Filamin-1) (Non-muscle filamin) Homo sapiens (Human) GO:0001664; GO:0002102; GO:0003723; GO:0005576; GO:0005634; GO:0005730; GO:0005737; GO:0005829; GO:0005884; GO:0005886; GO:0005911; GO:0005925; GO:0007195; GO:0007597; GO:0010572; GO:0015459; GO:0015629; GO:0016020; GO:0016479; GO:0019900; GO:0021943; GO:0021987; GO:0030018; GO:0030036; GO:0030334; GO:0030426; GO:0030863; GO:0031267; GO:0031523; GO:0032233; GO:0034394; GO:0034988; GO:0035855; GO:0042177; GO:0042307; GO:0042789; GO:0042803; GO:0043066; GO:0043113; GO:0043123; GO:0043198; GO:0043204; GO:0043433; GO:0044319; GO:0044325; GO:0045184; GO:0045296; GO:0046332; GO:0048471; GO:0050821; GO:0051015; GO:0051020; GO:0051209; GO:0051764; GO:0060271; GO:0070062; GO:0070527; GO:0071526; GO:0072659; GO:0090042; GO:0090307; GO:0097368; GO:0097440; GO:0098794; GO:0098978; GO:0140297; GO:0140311; GO:1900026; GO:1901381; GO:1902396; GO:1905000; GO:1905031; GO:1990779; GO:2000179; GO:2001046; GO:2001224 actin crosslink formation [GO:0051764]; actin cytoskeleton organization [GO:0030036]; adenylate cyclase-inhibiting dopamine receptor signaling pathway [GO:0007195]; blood coagulation, intrinsic pathway [GO:0007597]; cerebral cortex development [GO:0021987]; cilium assembly [GO:0060271]; establishment of protein localization [GO:0045184]; establishment of Sertoli cell barrier [GO:0097368]; formation of radial glial scaffolds [GO:0021943]; megakaryocyte development [GO:0035855]; mitotic spindle assembly [GO:0090307]; mRNA transcription by RNA polymerase II [GO:0042789]; negative regulation of apoptotic process [GO:0043066]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of transcription by RNA polymerase I [GO:0016479]; platelet aggregation [GO:0070527]; positive regulation of actin filament bundle assembly [GO:0032233]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of neuron migration [GO:2001224]; positive regulation of platelet activation [GO:0010572]; positive regulation of potassium ion transmembrane transport [GO:1901381]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; protein localization to bicellular tight junction [GO:1902396]; protein localization to cell surface [GO:0034394]; protein localization to plasma membrane [GO:0072659]; protein stabilization [GO:0050821]; receptor clustering [GO:0043113]; regulation of cell migration [GO:0030334]; regulation of membrane repolarization during atrial cardiac muscle cell action potential [GO:1905000]; regulation of membrane repolarization during cardiac muscle cell action potential [GO:1905031]; release of sequestered calcium ion into cytosol [GO:0051209]; semaphorin-plexin signaling pathway [GO:0071526]; tubulin deacetylation [GO:0090042]; wound healing, spreading of cells [GO:0044319] actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; apical dendrite [GO:0097440]; cell-cell junction [GO:0005911]; cortical cytoskeleton [GO:0030863]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic shaft [GO:0043198]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; glycoprotein Ib-IX-V complex [GO:1990779]; growth cone [GO:0030426]; membrane [GO:0016020]; Myb complex [GO:0031523]; nucleolus [GO:0005730]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; podosome [GO:0002102]; postsynapse [GO:0098794]; Z disc [GO:0030018] actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; DNA-binding transcription factor binding [GO:0140297]; Fc-gamma receptor I complex binding [GO:0034988]; G protein-coupled receptor binding [GO:0001664]; GTPase binding [GO:0051020]; kinase binding [GO:0019900]; potassium channel regulator activity [GO:0015459]; protein homodimerization activity [GO:0042803]; protein sequestering activity [GO:0140311]; RNA binding [GO:0003723]; SMAD binding [GO:0046332]; small GTPase binding [GO:0031267]; transmembrane transporter binding [GO:0044325] g21097.t1 P21333 30.072 552 9.69e-43 160.0 sp|P21333|FLNA_HUMAN Filamin-A OS=Homo sapiens OX=9606 GN=FLNA PE=1 SV=4 FLNA_HUMAN reviewed Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Alpha-filamin) (Endothelial actin-binding protein) (Filamin-1) (Non-muscle filamin) Homo sapiens (Human) GO:0001664; GO:0002102; GO:0003723; GO:0005576; GO:0005634; GO:0005730; GO:0005737; GO:0005829; GO:0005884; GO:0005886; GO:0005911; GO:0005925; GO:0007195; GO:0007597; GO:0010572; GO:0015459; GO:0015629; GO:0016020; GO:0016479; GO:0019900; GO:0021943; GO:0021987; GO:0030018; GO:0030036; GO:0030334; GO:0030426; GO:0030863; GO:0031267; GO:0031523; GO:0032233; GO:0034394; GO:0034988; GO:0035855; GO:0042177; GO:0042307; GO:0042789; GO:0042803; GO:0043066; GO:0043113; GO:0043123; GO:0043198; GO:0043204; GO:0043433; GO:0044319; GO:0044325; GO:0045184; GO:0045296; GO:0046332; GO:0048471; GO:0050821; GO:0051015; GO:0051020; GO:0051209; GO:0051764; GO:0060271; GO:0070062; GO:0070527; GO:0071526; GO:0072659; GO:0090042; GO:0090307; GO:0097368; GO:0097440; GO:0098794; GO:0098978; GO:0140297; GO:0140311; GO:1900026; GO:1901381; GO:1902396; GO:1905000; GO:1905031; GO:1990779; GO:2000179; GO:2001046; GO:2001224 actin crosslink formation [GO:0051764]; actin cytoskeleton organization [GO:0030036]; adenylate cyclase-inhibiting dopamine receptor signaling pathway [GO:0007195]; blood coagulation, intrinsic pathway [GO:0007597]; cerebral cortex development [GO:0021987]; cilium assembly [GO:0060271]; establishment of protein localization [GO:0045184]; establishment of Sertoli cell barrier [GO:0097368]; formation of radial glial scaffolds [GO:0021943]; megakaryocyte development [GO:0035855]; mitotic spindle assembly [GO:0090307]; mRNA transcription by RNA polymerase II [GO:0042789]; negative regulation of apoptotic process [GO:0043066]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of transcription by RNA polymerase I [GO:0016479]; platelet aggregation [GO:0070527]; positive regulation of actin filament bundle assembly [GO:0032233]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of neuron migration [GO:2001224]; positive regulation of platelet activation [GO:0010572]; positive regulation of potassium ion transmembrane transport [GO:1901381]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; protein localization to bicellular tight junction [GO:1902396]; protein localization to cell surface [GO:0034394]; protein localization to plasma membrane [GO:0072659]; protein stabilization [GO:0050821]; receptor clustering [GO:0043113]; regulation of cell migration [GO:0030334]; regulation of membrane repolarization during atrial cardiac muscle cell action potential [GO:1905000]; regulation of membrane repolarization during cardiac muscle cell action potential [GO:1905031]; release of sequestered calcium ion into cytosol [GO:0051209]; semaphorin-plexin signaling pathway [GO:0071526]; tubulin deacetylation [GO:0090042]; wound healing, spreading of cells [GO:0044319] actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; apical dendrite [GO:0097440]; cell-cell junction [GO:0005911]; cortical cytoskeleton [GO:0030863]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic shaft [GO:0043198]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; glycoprotein Ib-IX-V complex [GO:1990779]; growth cone [GO:0030426]; membrane [GO:0016020]; Myb complex [GO:0031523]; nucleolus [GO:0005730]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; podosome [GO:0002102]; postsynapse [GO:0098794]; Z disc [GO:0030018] actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; DNA-binding transcription factor binding [GO:0140297]; Fc-gamma receptor I complex binding [GO:0034988]; G protein-coupled receptor binding [GO:0001664]; GTPase binding [GO:0051020]; kinase binding [GO:0019900]; potassium channel regulator activity [GO:0015459]; protein homodimerization activity [GO:0042803]; protein sequestering activity [GO:0140311]; RNA binding [GO:0003723]; SMAD binding [GO:0046332]; small GTPase binding [GO:0031267]; transmembrane transporter binding [GO:0044325] g21097.t1 P21333 36.364 44 9.69e-43 38.9 sp|P21333|FLNA_HUMAN Filamin-A OS=Homo sapiens OX=9606 GN=FLNA PE=1 SV=4 FLNA_HUMAN reviewed Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Alpha-filamin) (Endothelial actin-binding protein) (Filamin-1) (Non-muscle filamin) Homo sapiens (Human) GO:0001664; GO:0002102; GO:0003723; GO:0005576; GO:0005634; GO:0005730; GO:0005737; GO:0005829; GO:0005884; GO:0005886; GO:0005911; GO:0005925; GO:0007195; GO:0007597; GO:0010572; GO:0015459; GO:0015629; GO:0016020; GO:0016479; GO:0019900; GO:0021943; GO:0021987; GO:0030018; GO:0030036; GO:0030334; GO:0030426; GO:0030863; GO:0031267; GO:0031523; GO:0032233; GO:0034394; GO:0034988; GO:0035855; GO:0042177; GO:0042307; GO:0042789; GO:0042803; GO:0043066; GO:0043113; GO:0043123; GO:0043198; GO:0043204; GO:0043433; GO:0044319; GO:0044325; GO:0045184; GO:0045296; GO:0046332; GO:0048471; GO:0050821; GO:0051015; GO:0051020; GO:0051209; GO:0051764; GO:0060271; GO:0070062; GO:0070527; GO:0071526; GO:0072659; GO:0090042; GO:0090307; GO:0097368; GO:0097440; GO:0098794; GO:0098978; GO:0140297; GO:0140311; GO:1900026; GO:1901381; GO:1902396; GO:1905000; GO:1905031; GO:1990779; GO:2000179; GO:2001046; GO:2001224 actin crosslink formation [GO:0051764]; actin cytoskeleton organization [GO:0030036]; adenylate cyclase-inhibiting dopamine receptor signaling pathway [GO:0007195]; blood coagulation, intrinsic pathway [GO:0007597]; cerebral cortex development [GO:0021987]; cilium assembly [GO:0060271]; establishment of protein localization [GO:0045184]; establishment of Sertoli cell barrier [GO:0097368]; formation of radial glial scaffolds [GO:0021943]; megakaryocyte development [GO:0035855]; mitotic spindle assembly [GO:0090307]; mRNA transcription by RNA polymerase II [GO:0042789]; negative regulation of apoptotic process [GO:0043066]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of transcription by RNA polymerase I [GO:0016479]; platelet aggregation [GO:0070527]; positive regulation of actin filament bundle assembly [GO:0032233]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of neuron migration [GO:2001224]; positive regulation of platelet activation [GO:0010572]; positive regulation of potassium ion transmembrane transport [GO:1901381]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; protein localization to bicellular tight junction [GO:1902396]; protein localization to cell surface [GO:0034394]; protein localization to plasma membrane [GO:0072659]; protein stabilization [GO:0050821]; receptor clustering [GO:0043113]; regulation of cell migration [GO:0030334]; regulation of membrane repolarization during atrial cardiac muscle cell action potential [GO:1905000]; regulation of membrane repolarization during cardiac muscle cell action potential [GO:1905031]; release of sequestered calcium ion into cytosol [GO:0051209]; semaphorin-plexin signaling pathway [GO:0071526]; tubulin deacetylation [GO:0090042]; wound healing, spreading of cells [GO:0044319] actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; apical dendrite [GO:0097440]; cell-cell junction [GO:0005911]; cortical cytoskeleton [GO:0030863]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic shaft [GO:0043198]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; glycoprotein Ib-IX-V complex [GO:1990779]; growth cone [GO:0030426]; membrane [GO:0016020]; Myb complex [GO:0031523]; nucleolus [GO:0005730]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; podosome [GO:0002102]; postsynapse [GO:0098794]; Z disc [GO:0030018] actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; DNA-binding transcription factor binding [GO:0140297]; Fc-gamma receptor I complex binding [GO:0034988]; G protein-coupled receptor binding [GO:0001664]; GTPase binding [GO:0051020]; kinase binding [GO:0019900]; potassium channel regulator activity [GO:0015459]; protein homodimerization activity [GO:0042803]; protein sequestering activity [GO:0140311]; RNA binding [GO:0003723]; SMAD binding [GO:0046332]; small GTPase binding [GO:0031267]; transmembrane transporter binding [GO:0044325] g21097.t1 P21333 28.743 501 4.1e-39 137.0 sp|P21333|FLNA_HUMAN Filamin-A OS=Homo sapiens OX=9606 GN=FLNA PE=1 SV=4 FLNA_HUMAN reviewed Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Alpha-filamin) (Endothelial actin-binding protein) (Filamin-1) (Non-muscle filamin) Homo sapiens (Human) GO:0001664; GO:0002102; GO:0003723; GO:0005576; GO:0005634; GO:0005730; GO:0005737; GO:0005829; GO:0005884; GO:0005886; GO:0005911; GO:0005925; GO:0007195; GO:0007597; GO:0010572; GO:0015459; GO:0015629; GO:0016020; GO:0016479; GO:0019900; GO:0021943; GO:0021987; GO:0030018; GO:0030036; GO:0030334; GO:0030426; GO:0030863; GO:0031267; GO:0031523; GO:0032233; GO:0034394; GO:0034988; GO:0035855; GO:0042177; GO:0042307; GO:0042789; GO:0042803; GO:0043066; GO:0043113; GO:0043123; GO:0043198; GO:0043204; GO:0043433; GO:0044319; GO:0044325; GO:0045184; GO:0045296; GO:0046332; GO:0048471; GO:0050821; GO:0051015; GO:0051020; GO:0051209; GO:0051764; GO:0060271; GO:0070062; GO:0070527; GO:0071526; GO:0072659; GO:0090042; GO:0090307; GO:0097368; GO:0097440; GO:0098794; GO:0098978; GO:0140297; GO:0140311; GO:1900026; GO:1901381; GO:1902396; GO:1905000; GO:1905031; GO:1990779; GO:2000179; GO:2001046; GO:2001224 actin crosslink formation [GO:0051764]; actin cytoskeleton organization [GO:0030036]; adenylate cyclase-inhibiting dopamine receptor signaling pathway [GO:0007195]; blood coagulation, intrinsic pathway [GO:0007597]; cerebral cortex development [GO:0021987]; cilium assembly [GO:0060271]; establishment of protein localization [GO:0045184]; establishment of Sertoli cell barrier [GO:0097368]; formation of radial glial scaffolds [GO:0021943]; megakaryocyte development [GO:0035855]; mitotic spindle assembly [GO:0090307]; mRNA transcription by RNA polymerase II [GO:0042789]; negative regulation of apoptotic process [GO:0043066]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of transcription by RNA polymerase I [GO:0016479]; platelet aggregation [GO:0070527]; positive regulation of actin filament bundle assembly [GO:0032233]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of neuron migration [GO:2001224]; positive regulation of platelet activation [GO:0010572]; positive regulation of potassium ion transmembrane transport [GO:1901381]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; protein localization to bicellular tight junction [GO:1902396]; protein localization to cell surface [GO:0034394]; protein localization to plasma membrane [GO:0072659]; protein stabilization [GO:0050821]; receptor clustering [GO:0043113]; regulation of cell migration [GO:0030334]; regulation of membrane repolarization during atrial cardiac muscle cell action potential [GO:1905000]; regulation of membrane repolarization during cardiac muscle cell action potential [GO:1905031]; release of sequestered calcium ion into cytosol [GO:0051209]; semaphorin-plexin signaling pathway [GO:0071526]; tubulin deacetylation [GO:0090042]; wound healing, spreading of cells [GO:0044319] actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; apical dendrite [GO:0097440]; cell-cell junction [GO:0005911]; cortical cytoskeleton [GO:0030863]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic shaft [GO:0043198]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; glycoprotein Ib-IX-V complex [GO:1990779]; growth cone [GO:0030426]; membrane [GO:0016020]; Myb complex [GO:0031523]; nucleolus [GO:0005730]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; podosome [GO:0002102]; postsynapse [GO:0098794]; Z disc [GO:0030018] actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; DNA-binding transcription factor binding [GO:0140297]; Fc-gamma receptor I complex binding [GO:0034988]; G protein-coupled receptor binding [GO:0001664]; GTPase binding [GO:0051020]; kinase binding [GO:0019900]; potassium channel regulator activity [GO:0015459]; protein homodimerization activity [GO:0042803]; protein sequestering activity [GO:0140311]; RNA binding [GO:0003723]; SMAD binding [GO:0046332]; small GTPase binding [GO:0031267]; transmembrane transporter binding [GO:0044325] g21097.t1 P21333 45.455 55 4.1e-39 49.7 sp|P21333|FLNA_HUMAN Filamin-A OS=Homo sapiens OX=9606 GN=FLNA PE=1 SV=4 FLNA_HUMAN reviewed Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Alpha-filamin) (Endothelial actin-binding protein) (Filamin-1) (Non-muscle filamin) Homo sapiens (Human) GO:0001664; GO:0002102; GO:0003723; GO:0005576; GO:0005634; GO:0005730; GO:0005737; GO:0005829; GO:0005884; GO:0005886; GO:0005911; GO:0005925; GO:0007195; GO:0007597; GO:0010572; GO:0015459; GO:0015629; GO:0016020; GO:0016479; GO:0019900; GO:0021943; GO:0021987; GO:0030018; GO:0030036; GO:0030334; GO:0030426; GO:0030863; GO:0031267; GO:0031523; GO:0032233; GO:0034394; GO:0034988; GO:0035855; GO:0042177; GO:0042307; GO:0042789; GO:0042803; GO:0043066; GO:0043113; GO:0043123; GO:0043198; GO:0043204; GO:0043433; GO:0044319; GO:0044325; GO:0045184; GO:0045296; GO:0046332; GO:0048471; GO:0050821; GO:0051015; GO:0051020; GO:0051209; GO:0051764; GO:0060271; GO:0070062; GO:0070527; GO:0071526; GO:0072659; GO:0090042; GO:0090307; GO:0097368; GO:0097440; GO:0098794; GO:0098978; GO:0140297; GO:0140311; GO:1900026; GO:1901381; GO:1902396; GO:1905000; GO:1905031; GO:1990779; GO:2000179; GO:2001046; GO:2001224 actin crosslink formation [GO:0051764]; actin cytoskeleton organization [GO:0030036]; adenylate cyclase-inhibiting dopamine receptor signaling pathway [GO:0007195]; blood coagulation, intrinsic pathway [GO:0007597]; cerebral cortex development [GO:0021987]; cilium assembly [GO:0060271]; establishment of protein localization [GO:0045184]; establishment of Sertoli cell barrier [GO:0097368]; formation of radial glial scaffolds [GO:0021943]; megakaryocyte development [GO:0035855]; mitotic spindle assembly [GO:0090307]; mRNA transcription by RNA polymerase II [GO:0042789]; negative regulation of apoptotic process [GO:0043066]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of transcription by RNA polymerase I [GO:0016479]; platelet aggregation [GO:0070527]; positive regulation of actin filament bundle assembly [GO:0032233]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of neuron migration [GO:2001224]; positive regulation of platelet activation [GO:0010572]; positive regulation of potassium ion transmembrane transport [GO:1901381]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; protein localization to bicellular tight junction [GO:1902396]; protein localization to cell surface [GO:0034394]; protein localization to plasma membrane [GO:0072659]; protein stabilization [GO:0050821]; receptor clustering [GO:0043113]; regulation of cell migration [GO:0030334]; regulation of membrane repolarization during atrial cardiac muscle cell action potential [GO:1905000]; regulation of membrane repolarization during cardiac muscle cell action potential [GO:1905031]; release of sequestered calcium ion into cytosol [GO:0051209]; semaphorin-plexin signaling pathway [GO:0071526]; tubulin deacetylation [GO:0090042]; wound healing, spreading of cells [GO:0044319] actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; apical dendrite [GO:0097440]; cell-cell junction [GO:0005911]; cortical cytoskeleton [GO:0030863]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic shaft [GO:0043198]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; glycoprotein Ib-IX-V complex [GO:1990779]; growth cone [GO:0030426]; membrane [GO:0016020]; Myb complex [GO:0031523]; nucleolus [GO:0005730]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; podosome [GO:0002102]; postsynapse [GO:0098794]; Z disc [GO:0030018] actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; DNA-binding transcription factor binding [GO:0140297]; Fc-gamma receptor I complex binding [GO:0034988]; G protein-coupled receptor binding [GO:0001664]; GTPase binding [GO:0051020]; kinase binding [GO:0019900]; potassium channel regulator activity [GO:0015459]; protein homodimerization activity [GO:0042803]; protein sequestering activity [GO:0140311]; RNA binding [GO:0003723]; SMAD binding [GO:0046332]; small GTPase binding [GO:0031267]; transmembrane transporter binding [GO:0044325] g21097.t1 P21333 27.872 470 3e-34 128.0 sp|P21333|FLNA_HUMAN Filamin-A OS=Homo sapiens OX=9606 GN=FLNA PE=1 SV=4 FLNA_HUMAN reviewed Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Alpha-filamin) (Endothelial actin-binding protein) (Filamin-1) (Non-muscle filamin) Homo sapiens (Human) GO:0001664; GO:0002102; GO:0003723; GO:0005576; GO:0005634; GO:0005730; GO:0005737; GO:0005829; GO:0005884; GO:0005886; GO:0005911; GO:0005925; GO:0007195; GO:0007597; GO:0010572; GO:0015459; GO:0015629; GO:0016020; GO:0016479; GO:0019900; GO:0021943; GO:0021987; GO:0030018; GO:0030036; GO:0030334; GO:0030426; GO:0030863; GO:0031267; GO:0031523; GO:0032233; GO:0034394; GO:0034988; GO:0035855; GO:0042177; GO:0042307; GO:0042789; GO:0042803; GO:0043066; GO:0043113; GO:0043123; GO:0043198; GO:0043204; GO:0043433; GO:0044319; GO:0044325; GO:0045184; GO:0045296; GO:0046332; GO:0048471; GO:0050821; GO:0051015; GO:0051020; GO:0051209; GO:0051764; GO:0060271; GO:0070062; GO:0070527; GO:0071526; GO:0072659; GO:0090042; GO:0090307; GO:0097368; GO:0097440; GO:0098794; GO:0098978; GO:0140297; GO:0140311; GO:1900026; GO:1901381; GO:1902396; GO:1905000; GO:1905031; GO:1990779; GO:2000179; GO:2001046; GO:2001224 actin crosslink formation [GO:0051764]; actin cytoskeleton organization [GO:0030036]; adenylate cyclase-inhibiting dopamine receptor signaling pathway [GO:0007195]; blood coagulation, intrinsic pathway [GO:0007597]; cerebral cortex development [GO:0021987]; cilium assembly [GO:0060271]; establishment of protein localization [GO:0045184]; establishment of Sertoli cell barrier [GO:0097368]; formation of radial glial scaffolds [GO:0021943]; megakaryocyte development [GO:0035855]; mitotic spindle assembly [GO:0090307]; mRNA transcription by RNA polymerase II [GO:0042789]; negative regulation of apoptotic process [GO:0043066]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of transcription by RNA polymerase I [GO:0016479]; platelet aggregation [GO:0070527]; positive regulation of actin filament bundle assembly [GO:0032233]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of neuron migration [GO:2001224]; positive regulation of platelet activation [GO:0010572]; positive regulation of potassium ion transmembrane transport [GO:1901381]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; protein localization to bicellular tight junction [GO:1902396]; protein localization to cell surface [GO:0034394]; protein localization to plasma membrane [GO:0072659]; protein stabilization [GO:0050821]; receptor clustering [GO:0043113]; regulation of cell migration [GO:0030334]; regulation of membrane repolarization during atrial cardiac muscle cell action potential [GO:1905000]; regulation of membrane repolarization during cardiac muscle cell action potential [GO:1905031]; release of sequestered calcium ion into cytosol [GO:0051209]; semaphorin-plexin signaling pathway [GO:0071526]; tubulin deacetylation [GO:0090042]; wound healing, spreading of cells [GO:0044319] actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; apical dendrite [GO:0097440]; cell-cell junction [GO:0005911]; cortical cytoskeleton [GO:0030863]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic shaft [GO:0043198]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; glycoprotein Ib-IX-V complex [GO:1990779]; growth cone [GO:0030426]; membrane [GO:0016020]; Myb complex [GO:0031523]; nucleolus [GO:0005730]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; podosome [GO:0002102]; postsynapse [GO:0098794]; Z disc [GO:0030018] actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; DNA-binding transcription factor binding [GO:0140297]; Fc-gamma receptor I complex binding [GO:0034988]; G protein-coupled receptor binding [GO:0001664]; GTPase binding [GO:0051020]; kinase binding [GO:0019900]; potassium channel regulator activity [GO:0015459]; protein homodimerization activity [GO:0042803]; protein sequestering activity [GO:0140311]; RNA binding [GO:0003723]; SMAD binding [GO:0046332]; small GTPase binding [GO:0031267]; transmembrane transporter binding [GO:0044325] g21097.t1 P21333 39.623 53 3e-34 42.7 sp|P21333|FLNA_HUMAN Filamin-A OS=Homo sapiens OX=9606 GN=FLNA PE=1 SV=4 FLNA_HUMAN reviewed Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Alpha-filamin) (Endothelial actin-binding protein) (Filamin-1) (Non-muscle filamin) Homo sapiens (Human) GO:0001664; GO:0002102; GO:0003723; GO:0005576; GO:0005634; GO:0005730; GO:0005737; GO:0005829; GO:0005884; GO:0005886; GO:0005911; GO:0005925; GO:0007195; GO:0007597; GO:0010572; GO:0015459; GO:0015629; GO:0016020; GO:0016479; GO:0019900; GO:0021943; GO:0021987; GO:0030018; GO:0030036; GO:0030334; GO:0030426; GO:0030863; GO:0031267; GO:0031523; GO:0032233; GO:0034394; GO:0034988; GO:0035855; GO:0042177; GO:0042307; GO:0042789; GO:0042803; GO:0043066; GO:0043113; GO:0043123; GO:0043198; GO:0043204; GO:0043433; GO:0044319; GO:0044325; GO:0045184; GO:0045296; GO:0046332; GO:0048471; GO:0050821; GO:0051015; GO:0051020; GO:0051209; GO:0051764; GO:0060271; GO:0070062; GO:0070527; GO:0071526; GO:0072659; GO:0090042; GO:0090307; GO:0097368; GO:0097440; GO:0098794; GO:0098978; GO:0140297; GO:0140311; GO:1900026; GO:1901381; GO:1902396; GO:1905000; GO:1905031; GO:1990779; GO:2000179; GO:2001046; GO:2001224 actin crosslink formation [GO:0051764]; actin cytoskeleton organization [GO:0030036]; adenylate cyclase-inhibiting dopamine receptor signaling pathway [GO:0007195]; blood coagulation, intrinsic pathway [GO:0007597]; cerebral cortex development [GO:0021987]; cilium assembly [GO:0060271]; establishment of protein localization [GO:0045184]; establishment of Sertoli cell barrier [GO:0097368]; formation of radial glial scaffolds [GO:0021943]; megakaryocyte development [GO:0035855]; mitotic spindle assembly [GO:0090307]; mRNA transcription by RNA polymerase II [GO:0042789]; negative regulation of apoptotic process [GO:0043066]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of transcription by RNA polymerase I [GO:0016479]; platelet aggregation [GO:0070527]; positive regulation of actin filament bundle assembly [GO:0032233]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of neuron migration [GO:2001224]; positive regulation of platelet activation [GO:0010572]; positive regulation of potassium ion transmembrane transport [GO:1901381]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; protein localization to bicellular tight junction [GO:1902396]; protein localization to cell surface [GO:0034394]; protein localization to plasma membrane [GO:0072659]; protein stabilization [GO:0050821]; receptor clustering [GO:0043113]; regulation of cell migration [GO:0030334]; regulation of membrane repolarization during atrial cardiac muscle cell action potential [GO:1905000]; regulation of membrane repolarization during cardiac muscle cell action potential [GO:1905031]; release of sequestered calcium ion into cytosol [GO:0051209]; semaphorin-plexin signaling pathway [GO:0071526]; tubulin deacetylation [GO:0090042]; wound healing, spreading of cells [GO:0044319] actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; apical dendrite [GO:0097440]; cell-cell junction [GO:0005911]; cortical cytoskeleton [GO:0030863]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic shaft [GO:0043198]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; glycoprotein Ib-IX-V complex [GO:1990779]; growth cone [GO:0030426]; membrane [GO:0016020]; Myb complex [GO:0031523]; nucleolus [GO:0005730]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; podosome [GO:0002102]; postsynapse [GO:0098794]; Z disc [GO:0030018] actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; DNA-binding transcription factor binding [GO:0140297]; Fc-gamma receptor I complex binding [GO:0034988]; G protein-coupled receptor binding [GO:0001664]; GTPase binding [GO:0051020]; kinase binding [GO:0019900]; potassium channel regulator activity [GO:0015459]; protein homodimerization activity [GO:0042803]; protein sequestering activity [GO:0140311]; RNA binding [GO:0003723]; SMAD binding [GO:0046332]; small GTPase binding [GO:0031267]; transmembrane transporter binding [GO:0044325] g21097.t1 P21333 30.465 430 9.19e-33 144.0 sp|P21333|FLNA_HUMAN Filamin-A OS=Homo sapiens OX=9606 GN=FLNA PE=1 SV=4 FLNA_HUMAN reviewed Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Alpha-filamin) (Endothelial actin-binding protein) (Filamin-1) (Non-muscle filamin) Homo sapiens (Human) GO:0001664; GO:0002102; GO:0003723; GO:0005576; GO:0005634; GO:0005730; GO:0005737; GO:0005829; GO:0005884; GO:0005886; GO:0005911; GO:0005925; GO:0007195; GO:0007597; GO:0010572; GO:0015459; GO:0015629; GO:0016020; GO:0016479; GO:0019900; GO:0021943; GO:0021987; GO:0030018; GO:0030036; GO:0030334; GO:0030426; GO:0030863; GO:0031267; GO:0031523; GO:0032233; GO:0034394; GO:0034988; GO:0035855; GO:0042177; GO:0042307; GO:0042789; GO:0042803; GO:0043066; GO:0043113; GO:0043123; GO:0043198; GO:0043204; GO:0043433; GO:0044319; GO:0044325; GO:0045184; GO:0045296; GO:0046332; GO:0048471; GO:0050821; GO:0051015; GO:0051020; GO:0051209; GO:0051764; GO:0060271; GO:0070062; GO:0070527; GO:0071526; GO:0072659; GO:0090042; GO:0090307; GO:0097368; GO:0097440; GO:0098794; GO:0098978; GO:0140297; GO:0140311; GO:1900026; GO:1901381; GO:1902396; GO:1905000; GO:1905031; GO:1990779; GO:2000179; GO:2001046; GO:2001224 actin crosslink formation [GO:0051764]; actin cytoskeleton organization [GO:0030036]; adenylate cyclase-inhibiting dopamine receptor signaling pathway [GO:0007195]; blood coagulation, intrinsic pathway [GO:0007597]; cerebral cortex development [GO:0021987]; cilium assembly [GO:0060271]; establishment of protein localization [GO:0045184]; establishment of Sertoli cell barrier [GO:0097368]; formation of radial glial scaffolds [GO:0021943]; megakaryocyte development [GO:0035855]; mitotic spindle assembly [GO:0090307]; mRNA transcription by RNA polymerase II [GO:0042789]; negative regulation of apoptotic process [GO:0043066]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of transcription by RNA polymerase I [GO:0016479]; platelet aggregation [GO:0070527]; positive regulation of actin filament bundle assembly [GO:0032233]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of neuron migration [GO:2001224]; positive regulation of platelet activation [GO:0010572]; positive regulation of potassium ion transmembrane transport [GO:1901381]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; protein localization to bicellular tight junction [GO:1902396]; protein localization to cell surface [GO:0034394]; protein localization to plasma membrane [GO:0072659]; protein stabilization [GO:0050821]; receptor clustering [GO:0043113]; regulation of cell migration [GO:0030334]; regulation of membrane repolarization during atrial cardiac muscle cell action potential [GO:1905000]; regulation of membrane repolarization during cardiac muscle cell action potential [GO:1905031]; release of sequestered calcium ion into cytosol [GO:0051209]; semaphorin-plexin signaling pathway [GO:0071526]; tubulin deacetylation [GO:0090042]; wound healing, spreading of cells [GO:0044319] actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; apical dendrite [GO:0097440]; cell-cell junction [GO:0005911]; cortical cytoskeleton [GO:0030863]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic shaft [GO:0043198]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; glycoprotein Ib-IX-V complex [GO:1990779]; growth cone [GO:0030426]; membrane [GO:0016020]; Myb complex [GO:0031523]; nucleolus [GO:0005730]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; podosome [GO:0002102]; postsynapse [GO:0098794]; Z disc [GO:0030018] actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; DNA-binding transcription factor binding [GO:0140297]; Fc-gamma receptor I complex binding [GO:0034988]; G protein-coupled receptor binding [GO:0001664]; GTPase binding [GO:0051020]; kinase binding [GO:0019900]; potassium channel regulator activity [GO:0015459]; protein homodimerization activity [GO:0042803]; protein sequestering activity [GO:0140311]; RNA binding [GO:0003723]; SMAD binding [GO:0046332]; small GTPase binding [GO:0031267]; transmembrane transporter binding [GO:0044325] g21097.t1 P21333 25.437 515 5.130000000000001e-32 128.0 sp|P21333|FLNA_HUMAN Filamin-A OS=Homo sapiens OX=9606 GN=FLNA PE=1 SV=4 FLNA_HUMAN reviewed Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Alpha-filamin) (Endothelial actin-binding protein) (Filamin-1) (Non-muscle filamin) Homo sapiens (Human) GO:0001664; GO:0002102; GO:0003723; GO:0005576; GO:0005634; GO:0005730; GO:0005737; GO:0005829; GO:0005884; GO:0005886; GO:0005911; GO:0005925; GO:0007195; GO:0007597; GO:0010572; GO:0015459; GO:0015629; GO:0016020; GO:0016479; GO:0019900; GO:0021943; GO:0021987; GO:0030018; GO:0030036; GO:0030334; GO:0030426; GO:0030863; GO:0031267; GO:0031523; GO:0032233; GO:0034394; GO:0034988; GO:0035855; GO:0042177; GO:0042307; GO:0042789; GO:0042803; GO:0043066; GO:0043113; GO:0043123; GO:0043198; GO:0043204; GO:0043433; GO:0044319; GO:0044325; GO:0045184; GO:0045296; GO:0046332; GO:0048471; GO:0050821; GO:0051015; GO:0051020; GO:0051209; GO:0051764; GO:0060271; GO:0070062; GO:0070527; GO:0071526; GO:0072659; GO:0090042; GO:0090307; GO:0097368; GO:0097440; GO:0098794; GO:0098978; GO:0140297; GO:0140311; GO:1900026; GO:1901381; GO:1902396; GO:1905000; GO:1905031; GO:1990779; GO:2000179; GO:2001046; GO:2001224 actin crosslink formation [GO:0051764]; actin cytoskeleton organization [GO:0030036]; adenylate cyclase-inhibiting dopamine receptor signaling pathway [GO:0007195]; blood coagulation, intrinsic pathway [GO:0007597]; cerebral cortex development [GO:0021987]; cilium assembly [GO:0060271]; establishment of protein localization [GO:0045184]; establishment of Sertoli cell barrier [GO:0097368]; formation of radial glial scaffolds [GO:0021943]; megakaryocyte development [GO:0035855]; mitotic spindle assembly [GO:0090307]; mRNA transcription by RNA polymerase II [GO:0042789]; negative regulation of apoptotic process [GO:0043066]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of transcription by RNA polymerase I [GO:0016479]; platelet aggregation [GO:0070527]; positive regulation of actin filament bundle assembly [GO:0032233]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of neuron migration [GO:2001224]; positive regulation of platelet activation [GO:0010572]; positive regulation of potassium ion transmembrane transport [GO:1901381]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; protein localization to bicellular tight junction [GO:1902396]; protein localization to cell surface [GO:0034394]; protein localization to plasma membrane [GO:0072659]; protein stabilization [GO:0050821]; receptor clustering [GO:0043113]; regulation of cell migration [GO:0030334]; regulation of membrane repolarization during atrial cardiac muscle cell action potential [GO:1905000]; regulation of membrane repolarization during cardiac muscle cell action potential [GO:1905031]; release of sequestered calcium ion into cytosol [GO:0051209]; semaphorin-plexin signaling pathway [GO:0071526]; tubulin deacetylation [GO:0090042]; wound healing, spreading of cells [GO:0044319] actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; apical dendrite [GO:0097440]; cell-cell junction [GO:0005911]; cortical cytoskeleton [GO:0030863]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic shaft [GO:0043198]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; glycoprotein Ib-IX-V complex [GO:1990779]; growth cone [GO:0030426]; membrane [GO:0016020]; Myb complex [GO:0031523]; nucleolus [GO:0005730]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; podosome [GO:0002102]; postsynapse [GO:0098794]; Z disc [GO:0030018] actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; DNA-binding transcription factor binding [GO:0140297]; Fc-gamma receptor I complex binding [GO:0034988]; G protein-coupled receptor binding [GO:0001664]; GTPase binding [GO:0051020]; kinase binding [GO:0019900]; potassium channel regulator activity [GO:0015459]; protein homodimerization activity [GO:0042803]; protein sequestering activity [GO:0140311]; RNA binding [GO:0003723]; SMAD binding [GO:0046332]; small GTPase binding [GO:0031267]; transmembrane transporter binding [GO:0044325] g21097.t1 P21333 38.889 54 5.130000000000001e-32 34.7 sp|P21333|FLNA_HUMAN Filamin-A OS=Homo sapiens OX=9606 GN=FLNA PE=1 SV=4 FLNA_HUMAN reviewed Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Alpha-filamin) (Endothelial actin-binding protein) (Filamin-1) (Non-muscle filamin) Homo sapiens (Human) GO:0001664; GO:0002102; GO:0003723; GO:0005576; GO:0005634; GO:0005730; GO:0005737; GO:0005829; GO:0005884; GO:0005886; GO:0005911; GO:0005925; GO:0007195; GO:0007597; GO:0010572; GO:0015459; GO:0015629; GO:0016020; GO:0016479; GO:0019900; GO:0021943; GO:0021987; GO:0030018; GO:0030036; GO:0030334; GO:0030426; GO:0030863; GO:0031267; GO:0031523; GO:0032233; GO:0034394; GO:0034988; GO:0035855; GO:0042177; GO:0042307; GO:0042789; GO:0042803; GO:0043066; GO:0043113; GO:0043123; GO:0043198; GO:0043204; GO:0043433; GO:0044319; GO:0044325; GO:0045184; GO:0045296; GO:0046332; GO:0048471; GO:0050821; GO:0051015; GO:0051020; GO:0051209; GO:0051764; GO:0060271; GO:0070062; GO:0070527; GO:0071526; GO:0072659; GO:0090042; GO:0090307; GO:0097368; GO:0097440; GO:0098794; GO:0098978; GO:0140297; GO:0140311; GO:1900026; GO:1901381; GO:1902396; GO:1905000; GO:1905031; GO:1990779; GO:2000179; GO:2001046; GO:2001224 actin crosslink formation [GO:0051764]; actin cytoskeleton organization [GO:0030036]; adenylate cyclase-inhibiting dopamine receptor signaling pathway [GO:0007195]; blood coagulation, intrinsic pathway [GO:0007597]; cerebral cortex development [GO:0021987]; cilium assembly [GO:0060271]; establishment of protein localization [GO:0045184]; establishment of Sertoli cell barrier [GO:0097368]; formation of radial glial scaffolds [GO:0021943]; megakaryocyte development [GO:0035855]; mitotic spindle assembly [GO:0090307]; mRNA transcription by RNA polymerase II [GO:0042789]; negative regulation of apoptotic process [GO:0043066]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of transcription by RNA polymerase I [GO:0016479]; platelet aggregation [GO:0070527]; positive regulation of actin filament bundle assembly [GO:0032233]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of neuron migration [GO:2001224]; positive regulation of platelet activation [GO:0010572]; positive regulation of potassium ion transmembrane transport [GO:1901381]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; protein localization to bicellular tight junction [GO:1902396]; protein localization to cell surface [GO:0034394]; protein localization to plasma membrane [GO:0072659]; protein stabilization [GO:0050821]; receptor clustering [GO:0043113]; regulation of cell migration [GO:0030334]; regulation of membrane repolarization during atrial cardiac muscle cell action potential [GO:1905000]; regulation of membrane repolarization during cardiac muscle cell action potential [GO:1905031]; release of sequestered calcium ion into cytosol [GO:0051209]; semaphorin-plexin signaling pathway [GO:0071526]; tubulin deacetylation [GO:0090042]; wound healing, spreading of cells [GO:0044319] actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; apical dendrite [GO:0097440]; cell-cell junction [GO:0005911]; cortical cytoskeleton [GO:0030863]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic shaft [GO:0043198]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; glycoprotein Ib-IX-V complex [GO:1990779]; growth cone [GO:0030426]; membrane [GO:0016020]; Myb complex [GO:0031523]; nucleolus [GO:0005730]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; podosome [GO:0002102]; postsynapse [GO:0098794]; Z disc [GO:0030018] actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; DNA-binding transcription factor binding [GO:0140297]; Fc-gamma receptor I complex binding [GO:0034988]; G protein-coupled receptor binding [GO:0001664]; GTPase binding [GO:0051020]; kinase binding [GO:0019900]; potassium channel regulator activity [GO:0015459]; protein homodimerization activity [GO:0042803]; protein sequestering activity [GO:0140311]; RNA binding [GO:0003723]; SMAD binding [GO:0046332]; small GTPase binding [GO:0031267]; transmembrane transporter binding [GO:0044325] g21097.t1 P21333 27.292 469 2.95e-31 139.0 sp|P21333|FLNA_HUMAN Filamin-A OS=Homo sapiens OX=9606 GN=FLNA PE=1 SV=4 FLNA_HUMAN reviewed Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Alpha-filamin) (Endothelial actin-binding protein) (Filamin-1) (Non-muscle filamin) Homo sapiens (Human) GO:0001664; GO:0002102; GO:0003723; GO:0005576; GO:0005634; GO:0005730; GO:0005737; GO:0005829; GO:0005884; GO:0005886; GO:0005911; GO:0005925; GO:0007195; GO:0007597; GO:0010572; GO:0015459; GO:0015629; GO:0016020; GO:0016479; GO:0019900; GO:0021943; GO:0021987; GO:0030018; GO:0030036; GO:0030334; GO:0030426; GO:0030863; GO:0031267; GO:0031523; GO:0032233; GO:0034394; GO:0034988; GO:0035855; GO:0042177; GO:0042307; GO:0042789; GO:0042803; GO:0043066; GO:0043113; GO:0043123; GO:0043198; GO:0043204; GO:0043433; GO:0044319; GO:0044325; GO:0045184; GO:0045296; GO:0046332; GO:0048471; GO:0050821; GO:0051015; GO:0051020; GO:0051209; GO:0051764; GO:0060271; GO:0070062; GO:0070527; GO:0071526; GO:0072659; GO:0090042; GO:0090307; GO:0097368; GO:0097440; GO:0098794; GO:0098978; GO:0140297; GO:0140311; GO:1900026; GO:1901381; GO:1902396; GO:1905000; GO:1905031; GO:1990779; GO:2000179; GO:2001046; GO:2001224 actin crosslink formation [GO:0051764]; actin cytoskeleton organization [GO:0030036]; adenylate cyclase-inhibiting dopamine receptor signaling pathway [GO:0007195]; blood coagulation, intrinsic pathway [GO:0007597]; cerebral cortex development [GO:0021987]; cilium assembly [GO:0060271]; establishment of protein localization [GO:0045184]; establishment of Sertoli cell barrier [GO:0097368]; formation of radial glial scaffolds [GO:0021943]; megakaryocyte development [GO:0035855]; mitotic spindle assembly [GO:0090307]; mRNA transcription by RNA polymerase II [GO:0042789]; negative regulation of apoptotic process [GO:0043066]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of transcription by RNA polymerase I [GO:0016479]; platelet aggregation [GO:0070527]; positive regulation of actin filament bundle assembly [GO:0032233]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of neuron migration [GO:2001224]; positive regulation of platelet activation [GO:0010572]; positive regulation of potassium ion transmembrane transport [GO:1901381]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; protein localization to bicellular tight junction [GO:1902396]; protein localization to cell surface [GO:0034394]; protein localization to plasma membrane [GO:0072659]; protein stabilization [GO:0050821]; receptor clustering [GO:0043113]; regulation of cell migration [GO:0030334]; regulation of membrane repolarization during atrial cardiac muscle cell action potential [GO:1905000]; regulation of membrane repolarization during cardiac muscle cell action potential [GO:1905031]; release of sequestered calcium ion into cytosol [GO:0051209]; semaphorin-plexin signaling pathway [GO:0071526]; tubulin deacetylation [GO:0090042]; wound healing, spreading of cells [GO:0044319] actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; apical dendrite [GO:0097440]; cell-cell junction [GO:0005911]; cortical cytoskeleton [GO:0030863]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic shaft [GO:0043198]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; glycoprotein Ib-IX-V complex [GO:1990779]; growth cone [GO:0030426]; membrane [GO:0016020]; Myb complex [GO:0031523]; nucleolus [GO:0005730]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; podosome [GO:0002102]; postsynapse [GO:0098794]; Z disc [GO:0030018] actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; DNA-binding transcription factor binding [GO:0140297]; Fc-gamma receptor I complex binding [GO:0034988]; G protein-coupled receptor binding [GO:0001664]; GTPase binding [GO:0051020]; kinase binding [GO:0019900]; potassium channel regulator activity [GO:0015459]; protein homodimerization activity [GO:0042803]; protein sequestering activity [GO:0140311]; RNA binding [GO:0003723]; SMAD binding [GO:0046332]; small GTPase binding [GO:0031267]; transmembrane transporter binding [GO:0044325] g21097.t1 P21333 24.453 503 2.7599999999999998e-30 127.0 sp|P21333|FLNA_HUMAN Filamin-A OS=Homo sapiens OX=9606 GN=FLNA PE=1 SV=4 FLNA_HUMAN reviewed Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Alpha-filamin) (Endothelial actin-binding protein) (Filamin-1) (Non-muscle filamin) Homo sapiens (Human) GO:0001664; GO:0002102; GO:0003723; GO:0005576; GO:0005634; GO:0005730; GO:0005737; GO:0005829; GO:0005884; GO:0005886; GO:0005911; GO:0005925; GO:0007195; GO:0007597; GO:0010572; GO:0015459; GO:0015629; GO:0016020; GO:0016479; GO:0019900; GO:0021943; GO:0021987; GO:0030018; GO:0030036; GO:0030334; GO:0030426; GO:0030863; GO:0031267; GO:0031523; GO:0032233; GO:0034394; GO:0034988; GO:0035855; GO:0042177; GO:0042307; GO:0042789; GO:0042803; GO:0043066; GO:0043113; GO:0043123; GO:0043198; GO:0043204; GO:0043433; GO:0044319; GO:0044325; GO:0045184; GO:0045296; GO:0046332; GO:0048471; GO:0050821; GO:0051015; GO:0051020; GO:0051209; GO:0051764; GO:0060271; GO:0070062; GO:0070527; GO:0071526; GO:0072659; GO:0090042; GO:0090307; GO:0097368; GO:0097440; GO:0098794; GO:0098978; GO:0140297; GO:0140311; GO:1900026; GO:1901381; GO:1902396; GO:1905000; GO:1905031; GO:1990779; GO:2000179; GO:2001046; GO:2001224 actin crosslink formation [GO:0051764]; actin cytoskeleton organization [GO:0030036]; adenylate cyclase-inhibiting dopamine receptor signaling pathway [GO:0007195]; blood coagulation, intrinsic pathway [GO:0007597]; cerebral cortex development [GO:0021987]; cilium assembly [GO:0060271]; establishment of protein localization [GO:0045184]; establishment of Sertoli cell barrier [GO:0097368]; formation of radial glial scaffolds [GO:0021943]; megakaryocyte development [GO:0035855]; mitotic spindle assembly [GO:0090307]; mRNA transcription by RNA polymerase II [GO:0042789]; negative regulation of apoptotic process [GO:0043066]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of transcription by RNA polymerase I [GO:0016479]; platelet aggregation [GO:0070527]; positive regulation of actin filament bundle assembly [GO:0032233]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of neuron migration [GO:2001224]; positive regulation of platelet activation [GO:0010572]; positive regulation of potassium ion transmembrane transport [GO:1901381]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; protein localization to bicellular tight junction [GO:1902396]; protein localization to cell surface [GO:0034394]; protein localization to plasma membrane [GO:0072659]; protein stabilization [GO:0050821]; receptor clustering [GO:0043113]; regulation of cell migration [GO:0030334]; regulation of membrane repolarization during atrial cardiac muscle cell action potential [GO:1905000]; regulation of membrane repolarization during cardiac muscle cell action potential [GO:1905031]; release of sequestered calcium ion into cytosol [GO:0051209]; semaphorin-plexin signaling pathway [GO:0071526]; tubulin deacetylation [GO:0090042]; wound healing, spreading of cells [GO:0044319] actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; apical dendrite [GO:0097440]; cell-cell junction [GO:0005911]; cortical cytoskeleton [GO:0030863]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic shaft [GO:0043198]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; glycoprotein Ib-IX-V complex [GO:1990779]; growth cone [GO:0030426]; membrane [GO:0016020]; Myb complex [GO:0031523]; nucleolus [GO:0005730]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; podosome [GO:0002102]; postsynapse [GO:0098794]; Z disc [GO:0030018] actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; DNA-binding transcription factor binding [GO:0140297]; Fc-gamma receptor I complex binding [GO:0034988]; G protein-coupled receptor binding [GO:0001664]; GTPase binding [GO:0051020]; kinase binding [GO:0019900]; potassium channel regulator activity [GO:0015459]; protein homodimerization activity [GO:0042803]; protein sequestering activity [GO:0140311]; RNA binding [GO:0003723]; SMAD binding [GO:0046332]; small GTPase binding [GO:0031267]; transmembrane transporter binding [GO:0044325] g21097.t1 P21333 33.333 54 2.7599999999999998e-30 30.0 sp|P21333|FLNA_HUMAN Filamin-A OS=Homo sapiens OX=9606 GN=FLNA PE=1 SV=4 FLNA_HUMAN reviewed Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Alpha-filamin) (Endothelial actin-binding protein) (Filamin-1) (Non-muscle filamin) Homo sapiens (Human) GO:0001664; GO:0002102; GO:0003723; GO:0005576; GO:0005634; GO:0005730; GO:0005737; GO:0005829; GO:0005884; GO:0005886; GO:0005911; GO:0005925; GO:0007195; GO:0007597; GO:0010572; GO:0015459; GO:0015629; GO:0016020; GO:0016479; GO:0019900; GO:0021943; GO:0021987; GO:0030018; GO:0030036; GO:0030334; GO:0030426; GO:0030863; GO:0031267; GO:0031523; GO:0032233; GO:0034394; GO:0034988; GO:0035855; GO:0042177; GO:0042307; GO:0042789; GO:0042803; GO:0043066; GO:0043113; GO:0043123; GO:0043198; GO:0043204; GO:0043433; GO:0044319; GO:0044325; GO:0045184; GO:0045296; GO:0046332; GO:0048471; GO:0050821; GO:0051015; GO:0051020; GO:0051209; GO:0051764; GO:0060271; GO:0070062; GO:0070527; GO:0071526; GO:0072659; GO:0090042; GO:0090307; GO:0097368; GO:0097440; GO:0098794; GO:0098978; GO:0140297; GO:0140311; GO:1900026; GO:1901381; GO:1902396; GO:1905000; GO:1905031; GO:1990779; GO:2000179; GO:2001046; GO:2001224 actin crosslink formation [GO:0051764]; actin cytoskeleton organization [GO:0030036]; adenylate cyclase-inhibiting dopamine receptor signaling pathway [GO:0007195]; blood coagulation, intrinsic pathway [GO:0007597]; cerebral cortex development [GO:0021987]; cilium assembly [GO:0060271]; establishment of protein localization [GO:0045184]; establishment of Sertoli cell barrier [GO:0097368]; formation of radial glial scaffolds [GO:0021943]; megakaryocyte development [GO:0035855]; mitotic spindle assembly [GO:0090307]; mRNA transcription by RNA polymerase II [GO:0042789]; negative regulation of apoptotic process [GO:0043066]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of transcription by RNA polymerase I [GO:0016479]; platelet aggregation [GO:0070527]; positive regulation of actin filament bundle assembly [GO:0032233]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of neuron migration [GO:2001224]; positive regulation of platelet activation [GO:0010572]; positive regulation of potassium ion transmembrane transport [GO:1901381]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; protein localization to bicellular tight junction [GO:1902396]; protein localization to cell surface [GO:0034394]; protein localization to plasma membrane [GO:0072659]; protein stabilization [GO:0050821]; receptor clustering [GO:0043113]; regulation of cell migration [GO:0030334]; regulation of membrane repolarization during atrial cardiac muscle cell action potential [GO:1905000]; regulation of membrane repolarization during cardiac muscle cell action potential [GO:1905031]; release of sequestered calcium ion into cytosol [GO:0051209]; semaphorin-plexin signaling pathway [GO:0071526]; tubulin deacetylation [GO:0090042]; wound healing, spreading of cells [GO:0044319] actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; apical dendrite [GO:0097440]; cell-cell junction [GO:0005911]; cortical cytoskeleton [GO:0030863]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic shaft [GO:0043198]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; glycoprotein Ib-IX-V complex [GO:1990779]; growth cone [GO:0030426]; membrane [GO:0016020]; Myb complex [GO:0031523]; nucleolus [GO:0005730]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; podosome [GO:0002102]; postsynapse [GO:0098794]; Z disc [GO:0030018] actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; DNA-binding transcription factor binding [GO:0140297]; Fc-gamma receptor I complex binding [GO:0034988]; G protein-coupled receptor binding [GO:0001664]; GTPase binding [GO:0051020]; kinase binding [GO:0019900]; potassium channel regulator activity [GO:0015459]; protein homodimerization activity [GO:0042803]; protein sequestering activity [GO:0140311]; RNA binding [GO:0003723]; SMAD binding [GO:0046332]; small GTPase binding [GO:0031267]; transmembrane transporter binding [GO:0044325] g21097.t1 P21333 26.17 577 1.18e-28 131.0 sp|P21333|FLNA_HUMAN Filamin-A OS=Homo sapiens OX=9606 GN=FLNA PE=1 SV=4 FLNA_HUMAN reviewed Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Alpha-filamin) (Endothelial actin-binding protein) (Filamin-1) (Non-muscle filamin) Homo sapiens (Human) GO:0001664; GO:0002102; GO:0003723; GO:0005576; GO:0005634; GO:0005730; GO:0005737; GO:0005829; GO:0005884; GO:0005886; GO:0005911; GO:0005925; GO:0007195; GO:0007597; GO:0010572; GO:0015459; GO:0015629; GO:0016020; GO:0016479; GO:0019900; GO:0021943; GO:0021987; GO:0030018; GO:0030036; GO:0030334; GO:0030426; GO:0030863; GO:0031267; GO:0031523; GO:0032233; GO:0034394; GO:0034988; GO:0035855; GO:0042177; GO:0042307; GO:0042789; GO:0042803; GO:0043066; GO:0043113; GO:0043123; GO:0043198; GO:0043204; GO:0043433; GO:0044319; GO:0044325; GO:0045184; GO:0045296; GO:0046332; GO:0048471; GO:0050821; GO:0051015; GO:0051020; GO:0051209; GO:0051764; GO:0060271; GO:0070062; GO:0070527; GO:0071526; GO:0072659; GO:0090042; GO:0090307; GO:0097368; GO:0097440; GO:0098794; GO:0098978; GO:0140297; GO:0140311; GO:1900026; GO:1901381; GO:1902396; GO:1905000; GO:1905031; GO:1990779; GO:2000179; GO:2001046; GO:2001224 actin crosslink formation [GO:0051764]; actin cytoskeleton organization [GO:0030036]; adenylate cyclase-inhibiting dopamine receptor signaling pathway [GO:0007195]; blood coagulation, intrinsic pathway [GO:0007597]; cerebral cortex development [GO:0021987]; cilium assembly [GO:0060271]; establishment of protein localization [GO:0045184]; establishment of Sertoli cell barrier [GO:0097368]; formation of radial glial scaffolds [GO:0021943]; megakaryocyte development [GO:0035855]; mitotic spindle assembly [GO:0090307]; mRNA transcription by RNA polymerase II [GO:0042789]; negative regulation of apoptotic process [GO:0043066]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of transcription by RNA polymerase I [GO:0016479]; platelet aggregation [GO:0070527]; positive regulation of actin filament bundle assembly [GO:0032233]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of neuron migration [GO:2001224]; positive regulation of platelet activation [GO:0010572]; positive regulation of potassium ion transmembrane transport [GO:1901381]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; protein localization to bicellular tight junction [GO:1902396]; protein localization to cell surface [GO:0034394]; protein localization to plasma membrane [GO:0072659]; protein stabilization [GO:0050821]; receptor clustering [GO:0043113]; regulation of cell migration [GO:0030334]; regulation of membrane repolarization during atrial cardiac muscle cell action potential [GO:1905000]; regulation of membrane repolarization during cardiac muscle cell action potential [GO:1905031]; release of sequestered calcium ion into cytosol [GO:0051209]; semaphorin-plexin signaling pathway [GO:0071526]; tubulin deacetylation [GO:0090042]; wound healing, spreading of cells [GO:0044319] actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; apical dendrite [GO:0097440]; cell-cell junction [GO:0005911]; cortical cytoskeleton [GO:0030863]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic shaft [GO:0043198]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; glycoprotein Ib-IX-V complex [GO:1990779]; growth cone [GO:0030426]; membrane [GO:0016020]; Myb complex [GO:0031523]; nucleolus [GO:0005730]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; podosome [GO:0002102]; postsynapse [GO:0098794]; Z disc [GO:0030018] actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; DNA-binding transcription factor binding [GO:0140297]; Fc-gamma receptor I complex binding [GO:0034988]; G protein-coupled receptor binding [GO:0001664]; GTPase binding [GO:0051020]; kinase binding [GO:0019900]; potassium channel regulator activity [GO:0015459]; protein homodimerization activity [GO:0042803]; protein sequestering activity [GO:0140311]; RNA binding [GO:0003723]; SMAD binding [GO:0046332]; small GTPase binding [GO:0031267]; transmembrane transporter binding [GO:0044325] g21097.t1 P21333 29.377 337 3.3000000000000004e-26 123.0 sp|P21333|FLNA_HUMAN Filamin-A OS=Homo sapiens OX=9606 GN=FLNA PE=1 SV=4 FLNA_HUMAN reviewed Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Alpha-filamin) (Endothelial actin-binding protein) (Filamin-1) (Non-muscle filamin) Homo sapiens (Human) GO:0001664; GO:0002102; GO:0003723; GO:0005576; GO:0005634; GO:0005730; GO:0005737; GO:0005829; GO:0005884; GO:0005886; GO:0005911; GO:0005925; GO:0007195; GO:0007597; GO:0010572; GO:0015459; GO:0015629; GO:0016020; GO:0016479; GO:0019900; GO:0021943; GO:0021987; GO:0030018; GO:0030036; GO:0030334; GO:0030426; GO:0030863; GO:0031267; GO:0031523; GO:0032233; GO:0034394; GO:0034988; GO:0035855; GO:0042177; GO:0042307; GO:0042789; GO:0042803; GO:0043066; GO:0043113; GO:0043123; GO:0043198; GO:0043204; GO:0043433; GO:0044319; GO:0044325; GO:0045184; GO:0045296; GO:0046332; GO:0048471; GO:0050821; GO:0051015; GO:0051020; GO:0051209; GO:0051764; GO:0060271; GO:0070062; GO:0070527; GO:0071526; GO:0072659; GO:0090042; GO:0090307; GO:0097368; GO:0097440; GO:0098794; GO:0098978; GO:0140297; GO:0140311; GO:1900026; GO:1901381; GO:1902396; GO:1905000; GO:1905031; GO:1990779; GO:2000179; GO:2001046; GO:2001224 actin crosslink formation [GO:0051764]; actin cytoskeleton organization [GO:0030036]; adenylate cyclase-inhibiting dopamine receptor signaling pathway [GO:0007195]; blood coagulation, intrinsic pathway [GO:0007597]; cerebral cortex development [GO:0021987]; cilium assembly [GO:0060271]; establishment of protein localization [GO:0045184]; establishment of Sertoli cell barrier [GO:0097368]; formation of radial glial scaffolds [GO:0021943]; megakaryocyte development [GO:0035855]; mitotic spindle assembly [GO:0090307]; mRNA transcription by RNA polymerase II [GO:0042789]; negative regulation of apoptotic process [GO:0043066]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of transcription by RNA polymerase I [GO:0016479]; platelet aggregation [GO:0070527]; positive regulation of actin filament bundle assembly [GO:0032233]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of neuron migration [GO:2001224]; positive regulation of platelet activation [GO:0010572]; positive regulation of potassium ion transmembrane transport [GO:1901381]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; protein localization to bicellular tight junction [GO:1902396]; protein localization to cell surface [GO:0034394]; protein localization to plasma membrane [GO:0072659]; protein stabilization [GO:0050821]; receptor clustering [GO:0043113]; regulation of cell migration [GO:0030334]; regulation of membrane repolarization during atrial cardiac muscle cell action potential [GO:1905000]; regulation of membrane repolarization during cardiac muscle cell action potential [GO:1905031]; release of sequestered calcium ion into cytosol [GO:0051209]; semaphorin-plexin signaling pathway [GO:0071526]; tubulin deacetylation [GO:0090042]; wound healing, spreading of cells [GO:0044319] actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; apical dendrite [GO:0097440]; cell-cell junction [GO:0005911]; cortical cytoskeleton [GO:0030863]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic shaft [GO:0043198]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; glycoprotein Ib-IX-V complex [GO:1990779]; growth cone [GO:0030426]; membrane [GO:0016020]; Myb complex [GO:0031523]; nucleolus [GO:0005730]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; podosome [GO:0002102]; postsynapse [GO:0098794]; Z disc [GO:0030018] actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; DNA-binding transcription factor binding [GO:0140297]; Fc-gamma receptor I complex binding [GO:0034988]; G protein-coupled receptor binding [GO:0001664]; GTPase binding [GO:0051020]; kinase binding [GO:0019900]; potassium channel regulator activity [GO:0015459]; protein homodimerization activity [GO:0042803]; protein sequestering activity [GO:0140311]; RNA binding [GO:0003723]; SMAD binding [GO:0046332]; small GTPase binding [GO:0031267]; transmembrane transporter binding [GO:0044325] g21097.t1 P21333 26.786 504 1.94e-25 120.0 sp|P21333|FLNA_HUMAN Filamin-A OS=Homo sapiens OX=9606 GN=FLNA PE=1 SV=4 FLNA_HUMAN reviewed Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Alpha-filamin) (Endothelial actin-binding protein) (Filamin-1) (Non-muscle filamin) Homo sapiens (Human) GO:0001664; GO:0002102; GO:0003723; GO:0005576; GO:0005634; GO:0005730; GO:0005737; GO:0005829; GO:0005884; GO:0005886; GO:0005911; GO:0005925; GO:0007195; GO:0007597; GO:0010572; GO:0015459; GO:0015629; GO:0016020; GO:0016479; GO:0019900; GO:0021943; GO:0021987; GO:0030018; GO:0030036; GO:0030334; GO:0030426; GO:0030863; GO:0031267; GO:0031523; GO:0032233; GO:0034394; GO:0034988; GO:0035855; GO:0042177; GO:0042307; GO:0042789; GO:0042803; GO:0043066; GO:0043113; GO:0043123; GO:0043198; GO:0043204; GO:0043433; GO:0044319; GO:0044325; GO:0045184; GO:0045296; GO:0046332; GO:0048471; GO:0050821; GO:0051015; GO:0051020; GO:0051209; GO:0051764; GO:0060271; GO:0070062; GO:0070527; GO:0071526; GO:0072659; GO:0090042; GO:0090307; GO:0097368; GO:0097440; GO:0098794; GO:0098978; GO:0140297; GO:0140311; GO:1900026; GO:1901381; GO:1902396; GO:1905000; GO:1905031; GO:1990779; GO:2000179; GO:2001046; GO:2001224 actin crosslink formation [GO:0051764]; actin cytoskeleton organization [GO:0030036]; adenylate cyclase-inhibiting dopamine receptor signaling pathway [GO:0007195]; blood coagulation, intrinsic pathway [GO:0007597]; cerebral cortex development [GO:0021987]; cilium assembly [GO:0060271]; establishment of protein localization [GO:0045184]; establishment of Sertoli cell barrier [GO:0097368]; formation of radial glial scaffolds [GO:0021943]; megakaryocyte development [GO:0035855]; mitotic spindle assembly [GO:0090307]; mRNA transcription by RNA polymerase II [GO:0042789]; negative regulation of apoptotic process [GO:0043066]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of transcription by RNA polymerase I [GO:0016479]; platelet aggregation [GO:0070527]; positive regulation of actin filament bundle assembly [GO:0032233]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of neuron migration [GO:2001224]; positive regulation of platelet activation [GO:0010572]; positive regulation of potassium ion transmembrane transport [GO:1901381]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; protein localization to bicellular tight junction [GO:1902396]; protein localization to cell surface [GO:0034394]; protein localization to plasma membrane [GO:0072659]; protein stabilization [GO:0050821]; receptor clustering [GO:0043113]; regulation of cell migration [GO:0030334]; regulation of membrane repolarization during atrial cardiac muscle cell action potential [GO:1905000]; regulation of membrane repolarization during cardiac muscle cell action potential [GO:1905031]; release of sequestered calcium ion into cytosol [GO:0051209]; semaphorin-plexin signaling pathway [GO:0071526]; tubulin deacetylation [GO:0090042]; wound healing, spreading of cells [GO:0044319] actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; apical dendrite [GO:0097440]; cell-cell junction [GO:0005911]; cortical cytoskeleton [GO:0030863]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic shaft [GO:0043198]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; glycoprotein Ib-IX-V complex [GO:1990779]; growth cone [GO:0030426]; membrane [GO:0016020]; Myb complex [GO:0031523]; nucleolus [GO:0005730]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; podosome [GO:0002102]; postsynapse [GO:0098794]; Z disc [GO:0030018] actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; DNA-binding transcription factor binding [GO:0140297]; Fc-gamma receptor I complex binding [GO:0034988]; G protein-coupled receptor binding [GO:0001664]; GTPase binding [GO:0051020]; kinase binding [GO:0019900]; potassium channel regulator activity [GO:0015459]; protein homodimerization activity [GO:0042803]; protein sequestering activity [GO:0140311]; RNA binding [GO:0003723]; SMAD binding [GO:0046332]; small GTPase binding [GO:0031267]; transmembrane transporter binding [GO:0044325] g21099.t1 A2AE42 41.27 189 5.8399999999999996e-46 155.0 sp|A2AE42|C56D1_MOUSE Probable transmembrane reductase CYB561D1 OS=Mus musculus OX=10090 GN=Cyb561d1 PE=2 SV=1 g21100.t1 Q9WUE4 57.258 372 9.72e-143 413.0 sp|Q9WUE4|NPRL2_MOUSE GATOR1 complex protein NPRL2 OS=Mus musculus OX=10090 GN=Nprl2 PE=1 SV=1 NPRL2_MOUSE reviewed GATOR1 complex protein NPRL2 (Gene 21 protein) (G21 protein) (Nitrogen permease regulator 2-like protein) (NPR2-like protein) Mus musculus (Mouse) GO:0002181; GO:0005096; GO:0005765; GO:0005774; GO:0010508; GO:0031669; GO:0034198; GO:0038202; GO:0045947; GO:0045948; GO:0061431; GO:0061462; GO:1904262; GO:1904263; GO:1990130 cellular response to amino acid starvation [GO:0034198]; cellular response to methionine [GO:0061431]; cellular response to nutrient levels [GO:0031669]; cytoplasmic translation [GO:0002181]; negative regulation of TORC1 signaling [GO:1904262]; negative regulation of translational initiation [GO:0045947]; positive regulation of autophagy [GO:0010508]; positive regulation of TORC1 signaling [GO:1904263]; positive regulation of translational initiation [GO:0045948]; protein localization to lysosome [GO:0061462]; TORC1 signaling [GO:0038202] GATOR1 complex [GO:1990130]; lysosomal membrane [GO:0005765]; vacuolar membrane [GO:0005774] GTPase activator activity [GO:0005096] g21101.t1 O62714 28.972 214 5.4300000000000006e-27 112.0 sp|O62714|CASR_PIG Extracellular calcium-sensing receptor OS=Sus scrofa OX=9823 GN=CASR PE=2 SV=3 g21102.t1 O62714 29.321 324 4.04e-37 144.0 sp|O62714|CASR_PIG Extracellular calcium-sensing receptor OS=Sus scrofa OX=9823 GN=CASR PE=2 SV=3 g21103.t1 P48442 31.086 267 3.38e-40 153.0 sp|P48442|CASR_RAT Extracellular calcium-sensing receptor OS=Rattus norvegicus OX=10116 GN=Casr PE=1 SV=1 CASR_RAT reviewed Extracellular calcium-sensing receptor (CaSR) (Parathyroid cell calcium-sensing receptor) (PCaR1) (RaKCaR) Rattus norvegicus (Rat) GO:0001503; GO:0002931; GO:0004930; GO:0005178; GO:0005509; GO:0005513; GO:0005886; GO:0006874; GO:0007186; GO:0007193; GO:0007200; GO:0007254; GO:0008284; GO:0009986; GO:0010038; GO:0010628; GO:0016323; GO:0016324; GO:0016597; GO:0019901; GO:0030424; GO:0032024; GO:0032782; GO:0035729; GO:0042311; GO:0042734; GO:0042802; GO:0042803; GO:0043025; GO:0043679; GO:0044325; GO:0045907; GO:0048754; GO:0050927; GO:0051592; GO:0051649; GO:0051924; GO:0060613; GO:0070374; GO:0071305; GO:0071333; GO:0071404; GO:0071456; GO:0071774; GO:0090280; GO:0098978; GO:0099505; GO:1900227; GO:1901653; GO:1902476 adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; bile acid secretion [GO:0032782]; branching morphogenesis of an epithelial tube [GO:0048754]; cellular response to glucose stimulus [GO:0071333]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cellular response to hypoxia [GO:0071456]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; cellular response to peptide [GO:1901653]; cellular response to vitamin D [GO:0071305]; chloride transmembrane transport [GO:1902476]; detection of calcium ion [GO:0005513]; establishment of localization in cell [GO:0051649]; fat pad development [GO:0060613]; G protein-coupled receptor signaling pathway [GO:0007186]; intracellular calcium ion homeostasis [GO:0006874]; JNK cascade [GO:0007254]; ossification [GO:0001503]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of calcium ion import [GO:0090280]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of insulin secretion [GO:0032024]; positive regulation of NLRP3 inflammasome complex assembly [GO:1900227]; positive regulation of positive chemotaxis [GO:0050927]; positive regulation of vasoconstriction [GO:0045907]; regulation of calcium ion transport [GO:0051924]; regulation of presynaptic membrane potential [GO:0099505]; response to calcium ion [GO:0051592]; response to fibroblast growth factor [GO:0071774]; response to ischemia [GO:0002931]; response to metal ion [GO:0010038]; vasodilation [GO:0042311] apical plasma membrane [GO:0016324]; axon [GO:0030424]; axon terminus [GO:0043679]; basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; glutamatergic synapse [GO:0098978]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734] amino acid binding [GO:0016597]; calcium ion binding [GO:0005509]; G protein-coupled receptor activity [GO:0004930]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; transmembrane transporter binding [GO:0044325] g21106.t1 A4IIA7 52.877 365 5.7e-119 354.0 sp|A4IIA7|SAMTR_XENTR S-adenosylmethionine sensor upstream of mTORC1 OS=Xenopus tropicalis OX=8364 GN=samtor PE=2 SV=1 g21108.t1 Q5W1J5 81.034 116 1.22e-61 214.0 sp|Q5W1J5|FOXP1_XENLA Forkhead box protein P1 OS=Xenopus laevis OX=8355 GN=foxp1 PE=1 SV=1 FOXP1_XENLA reviewed Forkhead box protein P1 (XlFoxP1) Xenopus laevis (African clawed frog) GO:0000122; GO:0000978; GO:0001222; GO:0001227; GO:0003677; GO:0005634; GO:0006357; GO:0008270; GO:0045892 negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] DNA binding [GO:0003677]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription corepressor binding [GO:0001222]; zinc ion binding [GO:0008270] g21108.t1 Q5W1J5 72.727 77 4.69e-33 135.0 sp|Q5W1J5|FOXP1_XENLA Forkhead box protein P1 OS=Xenopus laevis OX=8355 GN=foxp1 PE=1 SV=1 FOXP1_XENLA reviewed Forkhead box protein P1 (XlFoxP1) Xenopus laevis (African clawed frog) GO:0000122; GO:0000978; GO:0001222; GO:0001227; GO:0003677; GO:0005634; GO:0006357; GO:0008270; GO:0045892 negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] DNA binding [GO:0003677]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription corepressor binding [GO:0001222]; zinc ion binding [GO:0008270] g21108.t2 Q8IVH2 56.667 300 8.39e-101 319.0 sp|Q8IVH2|FOXP4_HUMAN Forkhead box protein P4 OS=Homo sapiens OX=9606 GN=FOXP4 PE=1 SV=1 FOXP4_HUMAN reviewed Forkhead box protein P4 (Fork head-related protein-like A) Homo sapiens (Human) GO:0000785; GO:0000978; GO:0000981; GO:0001227; GO:0005634; GO:0005654; GO:0005829; GO:0006357; GO:0008270 regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270] g21108.t3 Q8IVH2 57.534 292 1.51e-102 323.0 sp|Q8IVH2|FOXP4_HUMAN Forkhead box protein P4 OS=Homo sapiens OX=9606 GN=FOXP4 PE=1 SV=1 FOXP4_HUMAN reviewed Forkhead box protein P4 (Fork head-related protein-like A) Homo sapiens (Human) GO:0000785; GO:0000978; GO:0000981; GO:0001227; GO:0005634; GO:0005654; GO:0005829; GO:0006357; GO:0008270 regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270] g21110.t1 P07207 36.537 999 2.27e-148 498.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g21110.t1 P07207 34.339 1028 2.9399999999999997e-140 474.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g21110.t1 P07207 35.3 1034 1.6e-138 469.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g21110.t1 P07207 35.736 999 5.49e-134 455.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g21110.t1 P07207 35.923 991 1.69e-132 451.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g21110.t1 P07207 36.099 928 2.85e-128 438.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g21110.t1 P07207 34.578 1018 1.9399999999999998e-126 433.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g21110.t1 P07207 36.227 864 2.67e-121 418.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g21110.t1 P07207 34.035 808 6.509999999999999e-90 323.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g21110.t1 P07207 35.832 547 1.21e-78 289.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g21110.t1 P07207 34.726 694 3.0900000000000005e-70 263.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g21110.t2 P07207 36.044 996 9.73e-142 477.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g21110.t2 P07207 34.735 999 3.04e-140 473.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g21110.t2 P07207 34.236 1034 2.6999999999999997e-131 446.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g21110.t2 P07207 36.146 960 1.27e-130 444.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g21110.t2 P07207 36.314 917 3.6e-124 425.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g21110.t2 P07207 35.069 864 6.22e-115 398.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g21110.t2 P07207 33.995 806 8.61e-90 322.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g21110.t2 P07207 35.728 515 7.6e-74 273.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g21110.t2 P07207 34.726 694 7.460000000000001e-71 264.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g21110.t3 P07207 36.632 950 1.74e-140 473.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g21110.t3 P07207 34.635 999 2.26e-139 470.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g21110.t3 P07207 35.693 989 2.5200000000000003e-133 452.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g21110.t3 P07207 36.42 961 1.19e-130 444.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g21110.t3 P07207 34.612 991 7.34e-129 439.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g21110.t3 P07207 33.957 1016 1.27e-123 424.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g21110.t3 P07207 35.167 927 3.82e-121 416.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g21110.t3 P07207 32.128 968 1.86e-102 360.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g21110.t3 P07207 34.512 707 7.86e-97 343.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g21110.t3 P07207 33.747 806 5.12e-90 323.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g21110.t3 P07207 33.858 635 8.23e-87 313.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g21110.t3 P07207 36.049 405 1.9599999999999998e-48 193.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g21110.t3 P07207 30.853 457 6.12e-31 136.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g21110.t4 P07207 36.632 950 1.74e-140 473.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g21110.t4 P07207 34.635 999 2.26e-139 470.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g21110.t4 P07207 35.693 989 2.5200000000000003e-133 452.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g21110.t4 P07207 36.42 961 1.19e-130 444.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g21110.t4 P07207 34.612 991 7.34e-129 439.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g21110.t4 P07207 33.957 1016 1.27e-123 424.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g21110.t4 P07207 35.167 927 3.82e-121 416.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g21110.t4 P07207 32.128 968 1.86e-102 360.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g21110.t4 P07207 34.512 707 7.86e-97 343.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g21110.t4 P07207 33.747 806 5.12e-90 323.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g21110.t4 P07207 33.858 635 8.23e-87 313.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g21110.t4 P07207 36.049 405 1.9599999999999998e-48 193.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g21110.t4 P07207 30.853 457 6.12e-31 136.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g21111.t1 P97677 41.573 178 1.69e-31 124.0 sp|P97677|DLL1_RAT Delta-like protein 1 OS=Rattus norvegicus OX=10116 GN=Dll1 PE=1 SV=1 g21113.t1 Q6ZUG5 37.237 427 9.05e-96 308.0 sp|Q6ZUG5|YC006_HUMAN Uncharacterized protein FLJ43738 OS=Homo sapiens OX=9606 PE=1 SV=1 g21115.t1 Q8BRG8 41.088 533 7.63e-107 333.0 sp|Q8BRG8|TM209_MOUSE Transmembrane protein 209 OS=Mus musculus OX=10090 GN=Tmem209 PE=2 SV=1 g21118.t1 P22000 70.874 103 8.219999999999999e-48 152.0 sp|P22000|SAA2_RABIT Serum amyloid A-2 protein OS=Oryctolagus cuniculus OX=9986 GN=SAA2 PE=2 SV=1 g21119.t1 Q68Y81 37.646 943 0.0 592.0 sp|Q68Y81|FACD2_CHICK Fanconi anemia group D2 protein OS=Gallus gallus OX=9031 GN=FANCD2 PE=1 SV=1 g21120.t1 P22000 70.874 103 8.219999999999999e-48 152.0 sp|P22000|SAA2_RABIT Serum amyloid A-2 protein OS=Oryctolagus cuniculus OX=9986 GN=SAA2 PE=2 SV=1 g21121.t1 Q68Y81 36.453 406 2.27e-65 230.0 sp|Q68Y81|FACD2_CHICK Fanconi anemia group D2 protein OS=Gallus gallus OX=9031 GN=FANCD2 PE=1 SV=1 g21123.t1 Q9GLY5 36.194 909 8.140000000000001e-163 504.0 sp|Q9GLY5|ITIH3_RABIT Inter-alpha-trypsin inhibitor heavy chain H3 OS=Oryctolagus cuniculus OX=9986 GN=ITIH3 PE=2 SV=1 g21135.t1 Q9UQ52 31.883 988 3.33e-139 446.0 sp|Q9UQ52|CNTN6_HUMAN Contactin-6 OS=Homo sapiens OX=9606 GN=CNTN6 PE=1 SV=1 CNTN6_HUMAN reviewed Contactin-6 (Neural recognition molecule NB-3) (hNB-3) Homo sapiens (Human) GO:0005886; GO:0007155; GO:0007156; GO:0007219; GO:0007411; GO:0007417; GO:0030424; GO:0042734; GO:0045202; GO:0045747; GO:0050808; GO:0070593; GO:0098552; GO:0098632; GO:0098688 axon guidance [GO:0007411]; cell adhesion [GO:0007155]; central nervous system development [GO:0007417]; dendrite self-avoidance [GO:0070593]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; Notch signaling pathway [GO:0007219]; positive regulation of Notch signaling pathway [GO:0045747]; synapse organization [GO:0050808] axon [GO:0030424]; parallel fiber to Purkinje cell synapse [GO:0098688]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; side of membrane [GO:0098552]; synapse [GO:0045202] cell-cell adhesion mediator activity [GO:0098632] g21135.t2 Q9UQ52 31.1 1000 3.2199999999999997e-134 433.0 sp|Q9UQ52|CNTN6_HUMAN Contactin-6 OS=Homo sapiens OX=9606 GN=CNTN6 PE=1 SV=1 CNTN6_HUMAN reviewed Contactin-6 (Neural recognition molecule NB-3) (hNB-3) Homo sapiens (Human) GO:0005886; GO:0007155; GO:0007156; GO:0007219; GO:0007411; GO:0007417; GO:0030424; GO:0042734; GO:0045202; GO:0045747; GO:0050808; GO:0070593; GO:0098552; GO:0098632; GO:0098688 axon guidance [GO:0007411]; cell adhesion [GO:0007155]; central nervous system development [GO:0007417]; dendrite self-avoidance [GO:0070593]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; Notch signaling pathway [GO:0007219]; positive regulation of Notch signaling pathway [GO:0045747]; synapse organization [GO:0050808] axon [GO:0030424]; parallel fiber to Purkinje cell synapse [GO:0098688]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; side of membrane [GO:0098552]; synapse [GO:0045202] cell-cell adhesion mediator activity [GO:0098632] g21138.t1 P35331 31.197 1295 2.08e-151 493.0 sp|P35331|NRCAM_CHICK Neuronal cell adhesion molecule OS=Gallus gallus OX=9031 PE=1 SV=1 g21138.t2 P35331 31.42 1289 3.34e-153 497.0 sp|P35331|NRCAM_CHICK Neuronal cell adhesion molecule OS=Gallus gallus OX=9031 PE=1 SV=1 g21140.t1 Q16829 51.19 336 2.2e-102 312.0 sp|Q16829|DUS7_HUMAN Dual specificity protein phosphatase 7 OS=Homo sapiens OX=9606 GN=DUSP7 PE=1 SV=4 DUS7_HUMAN reviewed Dual specificity protein phosphatase 7 (EC 3.1.3.16) (EC 3.1.3.48) (Dual specificity protein phosphatase PYST2) Homo sapiens (Human) GO:0000165; GO:0004722; GO:0004725; GO:0005654; GO:0005737; GO:0005829; GO:0007165; GO:0008138; GO:0008330; GO:0017017; GO:0033550; GO:0035335; GO:0043407; GO:0070371; GO:0070373 ERK1 and ERK2 cascade [GO:0070371]; MAPK cascade [GO:0000165]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of MAP kinase activity [GO:0043407]; peptidyl-tyrosine dephosphorylation [GO:0035335]; signal transduction [GO:0007165] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654] MAP kinase tyrosine phosphatase activity [GO:0033550]; MAP kinase tyrosine/serine/threonine phosphatase activity [GO:0017017]; protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; protein tyrosine/threonine phosphatase activity [GO:0008330] g21141.t1 Q7T0P4 60.51 471 0.0 562.0 sp|Q7T0P4|POC1A_XENLA POC1 centriolar protein homolog A OS=Xenopus laevis OX=8355 GN=poc1a PE=1 SV=2 g21141.t2 A2CEH0 49.02 255 3.3300000000000003e-73 234.0 sp|A2CEH0|POC1B_DANRE POC1 centriolar protein homolog B OS=Danio rerio OX=7955 GN=poc1b PE=2 SV=1 POC1B_DANRE reviewed POC1 centriolar protein homolog B (WD repeat domain 51B) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001895; GO:0003014; GO:0005576; GO:0005814; GO:0007099; GO:0007507; GO:0007634; GO:0010842; GO:0036064; GO:0060271; GO:0060287 centriole replication [GO:0007099]; cilium assembly [GO:0060271]; epithelial cilium movement involved in determination of left/right asymmetry [GO:0060287]; heart development [GO:0007507]; optokinetic behavior [GO:0007634]; renal system process [GO:0003014]; retina homeostasis [GO:0001895]; retina layer formation [GO:0010842] centriole [GO:0005814]; ciliary basal body [GO:0036064]; extracellular region [GO:0005576] g21141.t3 Q28I85 81.443 194 3.14e-118 345.0 sp|Q28I85|POC1A_XENTR POC1 centriolar protein homolog A OS=Xenopus tropicalis OX=8364 GN=poc1a PE=2 SV=1 g21142.t1 Q5RB79 46.154 117 3.2500000000000004e-33 115.0 sp|Q5RB79|RPP14_PONAB Ribonuclease P protein subunit p14 OS=Pongo abelii OX=9601 GN=RPP14 PE=2 SV=3 g21146.t1 Q9NP80 48.932 468 8.11e-151 464.0 sp|Q9NP80|PLPL8_HUMAN Calcium-independent phospholipase A2-gamma OS=Homo sapiens OX=9606 GN=PNPLA8 PE=1 SV=1 PLPL8_HUMAN reviewed Calcium-independent phospholipase A2-gamma (EC 3.1.1.-) (EC 3.1.1.5) (Intracellular membrane-associated calcium-independent phospholipase A2 gamma) (iPLA2-gamma) (PNPLA-gamma) (Patatin-like phospholipase domain-containing protein 8) (iPLA2-2) Homo sapiens (Human) GO:0001516; GO:0004622; GO:0005524; GO:0005739; GO:0005777; GO:0005778; GO:0005789; GO:0006631; GO:0008970; GO:0016020; GO:0019369; GO:0031966; GO:0032048; GO:0034638; GO:0035556; GO:0043651; GO:0046338; GO:0047499; GO:0050482; GO:0055088; GO:0070328; GO:1900407 arachidonate metabolic process [GO:0019369]; arachidonate secretion [GO:0050482]; cardiolipin metabolic process [GO:0032048]; fatty acid metabolic process [GO:0006631]; intracellular signal transduction [GO:0035556]; linoleic acid metabolic process [GO:0043651]; lipid homeostasis [GO:0055088]; phosphatidylcholine catabolic process [GO:0034638]; phosphatidylethanolamine catabolic process [GO:0046338]; prostaglandin biosynthetic process [GO:0001516]; regulation of cellular response to oxidative stress [GO:1900407]; triglyceride homeostasis [GO:0070328] endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777] ATP binding [GO:0005524]; calcium-independent phospholipase A2 activity [GO:0047499]; phosphatidylcholine lysophospholipase activity [GO:0004622]; phospholipase A1 activity [GO:0008970] g21147.t1 Q2M389 67.257 1130 0.0 1567.0 sp|Q2M389|WASC4_HUMAN WASH complex subunit 4 OS=Homo sapiens OX=9606 GN=WASHC4 PE=1 SV=2 WASC4_HUMAN reviewed WASH complex subunit 4 (Strumpellin and WASH-interacting protein) (SWIP) (WASH complex subunit SWIP) Homo sapiens (Human) GO:0005654; GO:0005768; GO:0007032; GO:0015031; GO:0016197; GO:0031901; GO:0034315; GO:0050890; GO:0050905; GO:0061635; GO:0071203; GO:0140591; GO:0140894 cognition [GO:0050890]; endolysosomal toll-like receptor signaling pathway [GO:0140894]; endosomal transport [GO:0016197]; endosome organization [GO:0007032]; neuromuscular process [GO:0050905]; nuclear envelope budding [GO:0140591]; protein transport [GO:0015031]; regulation of Arp2/3 complex-mediated actin nucleation [GO:0034315]; regulation of protein complex stability [GO:0061635] early endosome membrane [GO:0031901]; endosome [GO:0005768]; nucleoplasm [GO:0005654]; WASH complex [GO:0071203] g21153.t1 P13154 35.028 354 1.0399999999999999e-45 167.0 sp|P13154|DHLE_GEOSE Leucine dehydrogenase OS=Geobacillus stearothermophilus OX=1422 GN=ldh PE=1 SV=3 g21153.t2 P13154 31.865 386 7.61e-46 168.0 sp|P13154|DHLE_GEOSE Leucine dehydrogenase OS=Geobacillus stearothermophilus OX=1422 GN=ldh PE=1 SV=3 g21154.t1 A6QR55 67.982 228 5.21e-103 330.0 sp|A6QR55|UBP4_BOVIN Ubiquitin carboxyl-terminal hydrolase 4 OS=Bos taurus OX=9913 GN=USP4 PE=2 SV=1 UBP4_BOVIN reviewed Ubiquitin carboxyl-terminal hydrolase 4 (EC 3.4.19.12) (Deubiquitinating enzyme 4) (Ubiquitin thioesterase 4) (Ubiquitin-specific-processing protease 4) Bos taurus (Bovine) GO:0000244; GO:0002181; GO:0004843; GO:0005634; GO:0005737; GO:0006508; GO:0009267; GO:0016579; GO:0031397; GO:0031647; GO:0031685; GO:0034394; GO:0038202; GO:0042802; GO:0045947; GO:0045948; GO:0046872; GO:1904262; GO:1904263 cellular response to starvation [GO:0009267]; cytoplasmic translation [GO:0002181]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of TORC1 signaling [GO:1904262]; negative regulation of translational initiation [GO:0045947]; positive regulation of TORC1 signaling [GO:1904263]; positive regulation of translational initiation [GO:0045948]; protein deubiquitination [GO:0016579]; protein localization to cell surface [GO:0034394]; proteolysis [GO:0006508]; regulation of protein stability [GO:0031647]; spliceosomal tri-snRNP complex assembly [GO:0000244]; TORC1 signaling [GO:0038202] cytoplasm [GO:0005737]; nucleus [GO:0005634] adenosine receptor binding [GO:0031685]; cysteine-type deubiquitinase activity [GO:0004843]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872] g21154.t1 A6QR55 73.134 134 3.99e-62 219.0 sp|A6QR55|UBP4_BOVIN Ubiquitin carboxyl-terminal hydrolase 4 OS=Bos taurus OX=9913 GN=USP4 PE=2 SV=1 UBP4_BOVIN reviewed Ubiquitin carboxyl-terminal hydrolase 4 (EC 3.4.19.12) (Deubiquitinating enzyme 4) (Ubiquitin thioesterase 4) (Ubiquitin-specific-processing protease 4) Bos taurus (Bovine) GO:0000244; GO:0002181; GO:0004843; GO:0005634; GO:0005737; GO:0006508; GO:0009267; GO:0016579; GO:0031397; GO:0031647; GO:0031685; GO:0034394; GO:0038202; GO:0042802; GO:0045947; GO:0045948; GO:0046872; GO:1904262; GO:1904263 cellular response to starvation [GO:0009267]; cytoplasmic translation [GO:0002181]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of TORC1 signaling [GO:1904262]; negative regulation of translational initiation [GO:0045947]; positive regulation of TORC1 signaling [GO:1904263]; positive regulation of translational initiation [GO:0045948]; protein deubiquitination [GO:0016579]; protein localization to cell surface [GO:0034394]; proteolysis [GO:0006508]; regulation of protein stability [GO:0031647]; spliceosomal tri-snRNP complex assembly [GO:0000244]; TORC1 signaling [GO:0038202] cytoplasm [GO:0005737]; nucleus [GO:0005634] adenosine receptor binding [GO:0031685]; cysteine-type deubiquitinase activity [GO:0004843]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872] g21155.t1 B2GUZ1 46.121 464 1.16e-121 381.0 sp|B2GUZ1|UBP4_RAT Ubiquitin carboxyl-terminal hydrolase 4 OS=Rattus norvegicus OX=10116 GN=Usp4 PE=1 SV=1 UBP4_RAT reviewed Ubiquitin carboxyl-terminal hydrolase 4 (EC 3.4.19.12) (Deubiquitinating enzyme 4) (Ubiquitin thioesterase 4) (Ubiquitin-specific-processing protease 4) Rattus norvegicus (Rat) GO:0000244; GO:0002181; GO:0004843; GO:0005634; GO:0005737; GO:0006508; GO:0009267; GO:0016579; GO:0031397; GO:0031647; GO:0031669; GO:0031685; GO:0034394; GO:0038202; GO:0042802; GO:0045947; GO:0045948; GO:0046872; GO:1904262; GO:1904263 cellular response to nutrient levels [GO:0031669]; cellular response to starvation [GO:0009267]; cytoplasmic translation [GO:0002181]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of TORC1 signaling [GO:1904262]; negative regulation of translational initiation [GO:0045947]; positive regulation of TORC1 signaling [GO:1904263]; positive regulation of translational initiation [GO:0045948]; protein deubiquitination [GO:0016579]; protein localization to cell surface [GO:0034394]; proteolysis [GO:0006508]; regulation of protein stability [GO:0031647]; spliceosomal tri-snRNP complex assembly [GO:0000244]; TORC1 signaling [GO:0038202] cytoplasm [GO:0005737]; nucleus [GO:0005634] adenosine receptor binding [GO:0031685]; cysteine-type deubiquitinase activity [GO:0004843]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872] g21156.t1 Q8BFQ4 70.794 315 8.76e-177 494.0 sp|Q8BFQ4|WDR82_MOUSE WD repeat-containing protein 82 OS=Mus musculus OX=10090 GN=Wdr82 PE=1 SV=1 WDR82_MOUSE reviewed WD repeat-containing protein 82 Mus musculus (Mouse) GO:0000781; GO:0000785; GO:0001111; GO:0003682; GO:0005634; GO:0005730; GO:0006353; GO:0010467; GO:0032785; GO:0032968; GO:0035097; GO:0048188; GO:0071027; GO:0072357; GO:0106222; GO:0110064; GO:0140744 DNA-templated transcription termination [GO:0006353]; gene expression [GO:0010467]; lncRNA catabolic process [GO:0110064]; negative regulation of DNA-templated transcription, elongation [GO:0032785]; negative regulation of lncRNA transcription [GO:0140744]; nuclear RNA surveillance [GO:0071027]; positive regulation of transcription elongation by RNA polymerase II [GO:0032968]; RNA polymerase II promoter clearance [GO:0001111] chromatin [GO:0000785]; chromosome, telomeric region [GO:0000781]; histone methyltransferase complex [GO:0035097]; nucleolus [GO:0005730]; nucleus [GO:0005634]; PTW/PP1 phosphatase complex [GO:0072357]; Set1C/COMPASS complex [GO:0048188] chromatin binding [GO:0003682]; lncRNA binding [GO:0106222] g21157.t1 Q5M821 44.885 479 1.51e-140 416.0 sp|Q5M821|PPM1H_RAT Protein phosphatase 1H OS=Rattus norvegicus OX=10116 GN=Ppm1h PE=1 SV=2 PPM1H_RAT reviewed Protein phosphatase 1H (EC 3.1.3.16) Rattus norvegicus (Rat) GO:0004721; GO:0004741; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0042802; GO:0045202; GO:0098978 cytoplasm [GO:0005737]; glutamatergic synapse [GO:0098978]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; synapse [GO:0045202] [pyruvate dehydrogenase (acetyl-transferring)]-phosphatase activity [GO:0004741]; identical protein binding [GO:0042802]; phosphoprotein phosphatase activity [GO:0004721] g21158.t1 Q96DB2 66.361 327 1.48e-154 444.0 sp|Q96DB2|HDA11_HUMAN Histone deacetylase 11 OS=Homo sapiens OX=9606 GN=HDAC11 PE=1 SV=1 HDA11_HUMAN reviewed Histone deacetylase 11 (HD11) (EC 3.5.1.98) Homo sapiens (Human) GO:0000118; GO:0004407; GO:0005634; GO:0005886; GO:0006325; GO:0040029; GO:0140297; GO:0141221 chromatin organization [GO:0006325]; epigenetic regulation of gene expression [GO:0040029] histone deacetylase complex [GO:0000118]; nucleus [GO:0005634]; plasma membrane [GO:0005886] DNA-binding transcription factor binding [GO:0140297]; histone deacetylase activity [GO:0004407]; histone deacetylase activity, hydrolytic mechanism [GO:0141221] g21159.t1 Q9H4K1 49.733 374 1.5300000000000002e-109 328.0 sp|Q9H4K1|RIBC2_HUMAN RIB43A-like with coiled-coils protein 2 OS=Homo sapiens OX=9606 GN=RIBC2 PE=1 SV=2 g21160.t1 Q9D1P0 60.0 170 5.58e-74 223.0 sp|Q9D1P0|RM13_MOUSE Large ribosomal subunit protein uL13m OS=Mus musculus OX=10090 GN=Mrpl13 PE=1 SV=1 g21162.t1 P00734 42.857 252 1.6000000000000002e-56 207.0 sp|P00734|THRB_HUMAN Prothrombin OS=Homo sapiens OX=9606 GN=F2 PE=1 SV=2 THRB_HUMAN reviewed Prothrombin (EC 3.4.21.5) (Coagulation factor II) [Cleaved into: Activation peptide fragment 1; Activation peptide fragment 2; Thrombin light chain; Thrombin heavy chain] Homo sapiens (Human) GO:0001530; GO:0004252; GO:0005102; GO:0005509; GO:0005576; GO:0005615; GO:0005788; GO:0005796; GO:0005886; GO:0006508; GO:0006953; GO:0007166; GO:0007596; GO:0008083; GO:0008201; GO:0008284; GO:0008360; GO:0009611; GO:0010544; GO:0030168; GO:0030193; GO:0030194; GO:0030195; GO:0030307; GO:0032024; GO:0032967; GO:0042730; GO:0045861; GO:0046427; GO:0048018; GO:0048712; GO:0051281; GO:0051480; GO:0051838; GO:0051897; GO:0051918; GO:0061844; GO:0070053; GO:0070062; GO:0070493; GO:0070945; GO:0072378; GO:0072562; GO:1900016; GO:1900182; GO:1900738; GO:1990806; GO:2000379 acute-phase response [GO:0006953]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; blood coagulation [GO:0007596]; blood coagulation, fibrin clot formation [GO:0072378]; cell surface receptor signaling pathway [GO:0007166]; cytolysis by host of symbiont cells [GO:0051838]; fibrinolysis [GO:0042730]; ligand-gated ion channel signaling pathway [GO:1990806]; negative regulation of astrocyte differentiation [GO:0048712]; negative regulation of blood coagulation [GO:0030195]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of fibrinolysis [GO:0051918]; negative regulation of platelet activation [GO:0010544]; negative regulation of proteolysis [GO:0045861]; neutrophil-mediated killing of gram-negative bacterium [GO:0070945]; platelet activation [GO:0030168]; positive regulation of blood coagulation [GO:0030194]; positive regulation of cell growth [GO:0030307]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of collagen biosynthetic process [GO:0032967]; positive regulation of insulin secretion [GO:0032024]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of phospholipase C-activating G protein-coupled receptor signaling pathway [GO:1900738]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; proteolysis [GO:0006508]; regulation of blood coagulation [GO:0030193]; regulation of cell shape [GO:0008360]; regulation of cytosolic calcium ion concentration [GO:0051480]; response to wounding [GO:0009611]; thrombin-activated receptor signaling pathway [GO:0070493] blood microparticle [GO:0072562]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; growth factor activity [GO:0008083]; heparin binding [GO:0008201]; lipopolysaccharide binding [GO:0001530]; receptor ligand activity [GO:0048018]; serine-type endopeptidase activity [GO:0004252]; signaling receptor binding [GO:0005102]; thrombospondin receptor activity [GO:0070053] g21163.t1 Q98SP7 67.036 722 0.0 961.0 sp|Q98SP7|BBS2_DANRE BBSome complex member BBS2 OS=Danio rerio OX=7955 GN=bbs2 PE=2 SV=1 g21164.t1 Q6ZUK4 38.047 297 2.26e-51 181.0 sp|Q6ZUK4|TMM26_HUMAN Transmembrane protein 26 OS=Homo sapiens OX=9606 GN=TMEM26 PE=1 SV=1 g21166.t1 Q0VG85 34.664 952 1.24e-137 459.0 sp|Q0VG85|CC162_MOUSE Coiled-coil domain-containing protein 162 OS=Mus musculus OX=10090 GN=Ccdc162 PE=1 SV=4 g21166.t2 Q0VG85 34.664 952 1.24e-137 459.0 sp|Q0VG85|CC162_MOUSE Coiled-coil domain-containing protein 162 OS=Mus musculus OX=10090 GN=Ccdc162 PE=1 SV=4 g21166.t3 Q0VG85 34.664 952 1.0199999999999999e-137 459.0 sp|Q0VG85|CC162_MOUSE Coiled-coil domain-containing protein 162 OS=Mus musculus OX=10090 GN=Ccdc162 PE=1 SV=4 g21168.t1 Q96PZ0 50.0 144 1.05e-46 166.0 sp|Q96PZ0|PUS7_HUMAN Pseudouridylate synthase 7 homolog OS=Homo sapiens OX=9606 GN=PUS7 PE=1 SV=2 PUS7_HUMAN reviewed Pseudouridylate synthase 7 homolog (EC 5.4.99.-) Homo sapiens (Human) GO:0001522; GO:0003723; GO:0005634; GO:0006397; GO:0008380; GO:0009982; GO:0017148; GO:0019899; GO:0031119; GO:0160150; GO:1902036; GO:1990481; GO:2000380 mRNA processing [GO:0006397]; mRNA pseudouridine synthesis [GO:1990481]; negative regulation of translation [GO:0017148]; pseudouridine synthesis [GO:0001522]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of mesoderm development [GO:2000380]; RNA splicing [GO:0008380]; tRNA pseudouridine synthesis [GO:0031119] nucleus [GO:0005634] enzyme binding [GO:0019899]; pseudouridine synthase activity [GO:0009982]; RNA binding [GO:0003723]; tRNA pseudouridine(13) synthase activity [GO:0160150] g21169.t1 Q91VU7 45.658 403 7.880000000000001e-117 363.0 sp|Q91VU7|PUS7_MOUSE Pseudouridylate synthase 7 homolog OS=Mus musculus OX=10090 GN=Pus7 PE=2 SV=2 PUS7_MOUSE reviewed Pseudouridylate synthase 7 homolog (EC 5.4.99.-) Mus musculus (Mouse) GO:0001522; GO:0003723; GO:0005634; GO:0006397; GO:0008380; GO:0009982; GO:0017148; GO:0019899; GO:0031119; GO:0160150; GO:1902036; GO:1990481; GO:2000380 mRNA processing [GO:0006397]; mRNA pseudouridine synthesis [GO:1990481]; negative regulation of translation [GO:0017148]; pseudouridine synthesis [GO:0001522]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of mesoderm development [GO:2000380]; RNA splicing [GO:0008380]; tRNA pseudouridine synthesis [GO:0031119] nucleus [GO:0005634] enzyme binding [GO:0019899]; pseudouridine synthase activity [GO:0009982]; RNA binding [GO:0003723]; tRNA pseudouridine(13) synthase activity [GO:0160150] g21177.t1 P55861 78.291 866 0.0 1346.0 sp|P55861|MCM2_XENLA DNA replication licensing factor mcm2 OS=Xenopus laevis OX=8355 GN=mcm2 PE=1 SV=2 g21178.t1 Q4V8X0 47.222 324 1.76e-80 255.0 sp|Q4V8X0|TPRA1_DANRE Transmembrane protein adipocyte-associated 1 homolog OS=Danio rerio OX=7955 GN=tpra1 PE=2 SV=1 g21182.t1 Q3SZL6 48.058 206 8.75e-55 192.0 sp|Q3SZL6|DCP1B_BOVIN mRNA-decapping enzyme 1B OS=Bos taurus OX=9913 GN=DCP1B PE=2 SV=1 g21183.t1 P15381 60.649 1695 0.0 1821.0 sp|P15381|CAC1C_RABIT Voltage-dependent L-type calcium channel subunit alpha-1C OS=Oryctolagus cuniculus OX=9986 GN=CACNA1C PE=1 SV=1 g21183.t2 P15381 60.129 1708 0.0 1815.0 sp|P15381|CAC1C_RABIT Voltage-dependent L-type calcium channel subunit alpha-1C OS=Oryctolagus cuniculus OX=9986 GN=CACNA1C PE=1 SV=1 g21187.t1 P0CF65 44.226 407 5.92e-113 342.0 sp|P0CF65|CRBN_CHICK Protein cereblon OS=Gallus gallus OX=9031 GN=CRBN PE=1 SV=1 g21188.t1 Q9UBS3 52.326 86 1.39e-22 95.1 sp|Q9UBS3|DNJB9_HUMAN DnaJ homolog subfamily B member 9 OS=Homo sapiens OX=9606 GN=DNAJB9 PE=1 SV=1 DNJB9_HUMAN reviewed DnaJ homolog subfamily B member 9 (Endoplasmic reticulum DNA J domain-containing protein 4) (ER-resident protein ERdj4) (ERdj4) (Microvascular endothelial differentiation gene 1 protein) (Mdg-1) Homo sapiens (Human) GO:0002639; GO:0005730; GO:0005737; GO:0005783; GO:0005788; GO:0005789; GO:0006986; GO:0030183; GO:0030544; GO:0034976; GO:0036503; GO:0051087; GO:0051787; GO:0070062; GO:1903895 B cell differentiation [GO:0030183]; ERAD pathway [GO:0036503]; negative regulation of IRE1-mediated unfolded protein response [GO:1903895]; positive regulation of immunoglobulin production [GO:0002639]; response to endoplasmic reticulum stress [GO:0034976]; response to unfolded protein [GO:0006986] cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; nucleolus [GO:0005730] Hsp70 protein binding [GO:0030544]; misfolded protein binding [GO:0051787]; protein-folding chaperone binding [GO:0051087] g21190.t1 O46421 37.709 419 1.3e-67 228.0 sp|O46421|EST1_MACFA Liver carboxylesterase 1 OS=Macaca fascicularis OX=9541 GN=CES1 PE=2 SV=1 g21192.t1 P47990 55.662 1351 0.0 1468.0 sp|P47990|XDH_CHICK Xanthine dehydrogenase/oxidase OS=Gallus gallus OX=9031 GN=XDH PE=1 SV=1 g21193.t1 P41252 71.488 484 0.0 734.0 sp|P41252|SYIC_HUMAN Isoleucine--tRNA ligase, cytoplasmic OS=Homo sapiens OX=9606 GN=IARS1 PE=1 SV=2 SYIC_HUMAN reviewed Isoleucine--tRNA ligase, cytoplasmic (EC 6.1.1.5) (Isoleucyl-tRNA synthetase) (IRS) (IleRS) Homo sapiens (Human) GO:0000049; GO:0001649; GO:0002161; GO:0004822; GO:0005524; GO:0005654; GO:0005737; GO:0005829; GO:0006418; GO:0006428; GO:0016020; GO:0017101; GO:0051020; GO:0070062 isoleucyl-tRNA aminoacylation [GO:0006428]; osteoblast differentiation [GO:0001649]; tRNA aminoacylation for protein translation [GO:0006418] aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleoplasm [GO:0005654] aminoacyl-tRNA deacylase activity [GO:0002161]; ATP binding [GO:0005524]; GTPase binding [GO:0051020]; isoleucine-tRNA ligase activity [GO:0004822]; tRNA binding [GO:0000049] g21194.t1 Q8BU30 58.559 666 0.0 789.0 sp|Q8BU30|SYIC_MOUSE Isoleucine--tRNA ligase, cytoplasmic OS=Mus musculus OX=10090 GN=Iars1 PE=1 SV=2 SYIC_MOUSE reviewed Isoleucine--tRNA ligase, cytoplasmic (EC 6.1.1.5) (Isoleucyl-tRNA synthetase) (IRS) (IleRS) Mus musculus (Mouse) GO:0000049; GO:0002161; GO:0004822; GO:0005524; GO:0005654; GO:0005737; GO:0005829; GO:0006428; GO:0017101; GO:0051020 isoleucyl-tRNA aminoacylation [GO:0006428] aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654] aminoacyl-tRNA deacylase activity [GO:0002161]; ATP binding [GO:0005524]; GTPase binding [GO:0051020]; isoleucine-tRNA ligase activity [GO:0004822]; tRNA binding [GO:0000049] g21195.t1 D3K0R6 62.154 938 0.0 1144.0 sp|D3K0R6|AT2B4_BOVIN Plasma membrane calcium-transporting ATPase 4 OS=Bos taurus OX=9913 GN=ATP2B4 PE=1 SV=2 AT2B4_BOVIN reviewed Plasma membrane calcium-transporting ATPase 4 (PMCA4) (EC 7.2.2.10) Bos taurus (Bovine) GO:0005388; GO:0005516; GO:0005524; GO:0005739; GO:0005886; GO:0006357; GO:0006874; GO:0010629; GO:0014832; GO:0016525; GO:0016887; GO:0030018; GO:0030315; GO:0030317; GO:0030346; GO:0036064; GO:0036126; GO:0036487; GO:0038060; GO:0043537; GO:0045019; GO:0045121; GO:0046872; GO:0050998; GO:0051480; GO:0051599; GO:0070885; GO:0071872; GO:0071878; GO:0098736; GO:1900082; GO:1901660; GO:1902548; GO:1902806; GO:1903078; GO:1903243; GO:1903249; GO:1905145 calcium ion export [GO:1901660]; cellular response to acetylcholine [GO:1905145]; cellular response to epinephrine stimulus [GO:0071872]; flagellated sperm motility [GO:0030317]; intracellular calcium ion homeostasis [GO:0006874]; negative regulation of adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071878]; negative regulation of angiogenesis [GO:0016525]; negative regulation of arginine catabolic process [GO:1900082]; negative regulation of blood vessel endothelial cell migration [GO:0043537]; negative regulation of calcineurin-NFAT signaling cascade [GO:0070885]; negative regulation of cardiac muscle hypertrophy in response to stress [GO:1903243]; negative regulation of cellular response to vascular endothelial growth factor stimulus [GO:1902548]; negative regulation of citrulline biosynthetic process [GO:1903249]; negative regulation of gene expression [GO:0010629]; negative regulation of nitric oxide biosynthetic process [GO:0045019]; negative regulation of the force of heart contraction [GO:0098736]; nitric oxide-cGMP-mediated signaling [GO:0038060]; positive regulation of protein localization to plasma membrane [GO:1903078]; regulation of cell cycle G1/S phase transition [GO:1902806]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of transcription by RNA polymerase II [GO:0006357]; response to hydrostatic pressure [GO:0051599]; urinary bladder smooth muscle contraction [GO:0014832] ciliary basal body [GO:0036064]; membrane raft [GO:0045121]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; sperm flagellum [GO:0036126]; T-tubule [GO:0030315]; Z disc [GO:0030018] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; nitric-oxide synthase binding [GO:0050998]; nitric-oxide synthase inhibitor activity [GO:0036487]; P-type calcium transporter activity [GO:0005388]; protein phosphatase 2B binding [GO:0030346] g21196.t1 Q64568 52.288 153 2.76e-36 133.0 sp|Q64568|AT2B3_RAT Plasma membrane calcium-transporting ATPase 3 OS=Rattus norvegicus OX=10116 GN=Atp2b3 PE=1 SV=2 g21196.t1 Q64568 61.538 26 2.76e-36 39.7 sp|Q64568|AT2B3_RAT Plasma membrane calcium-transporting ATPase 3 OS=Rattus norvegicus OX=10116 GN=Atp2b3 PE=1 SV=2 g21198.t1 Q29504 62.417 1059 0.0 1390.0 sp|Q29504|UBA1_RABIT Ubiquitin-like modifier-activating enzyme 1 OS=Oryctolagus cuniculus OX=9986 GN=UBA1 PE=1 SV=1 UBA1_RABIT reviewed Ubiquitin-like modifier-activating enzyme 1 (EC 6.2.1.45) (Ubiquitin-activating enzyme E1) Oryctolagus cuniculus (Rabbit) GO:0004839; GO:0005524; GO:0005634; GO:0005737; GO:0005739; GO:0006511; GO:0006974 DNA damage response [GO:0006974]; ubiquitin-dependent protein catabolic process [GO:0006511] cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleus [GO:0005634] ATP binding [GO:0005524]; ubiquitin activating enzyme activity [GO:0004839] g21199.t1 Q9NSC7 31.988 322 1.75e-36 144.0 sp|Q9NSC7|SIA7A_HUMAN Alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 1 OS=Homo sapiens OX=9606 GN=ST6GALNAC1 PE=1 SV=1 SIA7A_HUMAN reviewed Alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 1 (EC 2.4.3.3) (GalNAc alpha-2,6-sialyltransferase I) (ST6GalNAc I) (ST6GalNAc-I) (ST6GalNAcI) (hST6GalNAc-I) (Sialyltransferase 7A) (SIAT7-A) Homo sapiens (Human) GO:0000139; GO:0001665; GO:0008373; GO:0009101; GO:0009312; GO:0048874 glycoprotein biosynthetic process [GO:0009101]; host-mediated modulation of intestinal microbiota composition [GO:0048874]; oligosaccharide biosynthetic process [GO:0009312] Golgi membrane [GO:0000139] alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity [GO:0001665]; sialyltransferase activity [GO:0008373] g21201.t1 Q01361 36.632 475 2.0300000000000003e-73 242.0 sp|Q01361|CP2DE_BOVIN Cytochrome P450 2D14 OS=Bos taurus OX=9913 GN=CYP2D14 PE=2 SV=2 g21202.t1 O15992 41.551 361 1.03e-76 256.0 sp|O15992|KARG_ANTJA Arginine kinase OS=Anthopleura japonica OX=67755 PE=1 SV=1 g21202.t1 O15992 41.092 348 3.91e-74 249.0 sp|O15992|KARG_ANTJA Arginine kinase OS=Anthopleura japonica OX=67755 PE=1 SV=1 g21204.t1 Q5ZMP3 31.351 370 7.66e-55 190.0 sp|Q5ZMP3|T184C_CHICK Transmembrane protein 184C OS=Gallus gallus OX=9031 GN=TMEM184C PE=2 SV=1 g21205.t1 Q95218 40.506 237 8.479999999999999e-42 159.0 sp|Q95218|DMBT1_RABIT Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Oryctolagus cuniculus OX=9986 GN=Dmbt1 PE=1 SV=2 g21205.t1 Q95218 37.069 232 6.54e-37 144.0 sp|Q95218|DMBT1_RABIT Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Oryctolagus cuniculus OX=9986 GN=Dmbt1 PE=1 SV=2 g21205.t1 Q95218 37.069 232 5.270000000000001e-35 139.0 sp|Q95218|DMBT1_RABIT Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Oryctolagus cuniculus OX=9986 GN=Dmbt1 PE=1 SV=2 g21205.t1 Q95218 37.768 233 1.57e-32 132.0 sp|Q95218|DMBT1_RABIT Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Oryctolagus cuniculus OX=9986 GN=Dmbt1 PE=1 SV=2 g21206.t1 Q9UGM3 41.718 163 2.71e-22 100.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g21208.t1 Q3UJD6 43.354 948 0.0 738.0 sp|Q3UJD6|UBP19_MOUSE Ubiquitin carboxyl-terminal hydrolase 19 OS=Mus musculus OX=10090 GN=Usp19 PE=1 SV=1 UBP19_MOUSE reviewed Ubiquitin carboxyl-terminal hydrolase 19 (EC 3.4.19.12) (Deubiquitinating enzyme 19) (Ubiquitin thioesterase 19) (Ubiquitin-specific-processing protease 19) Mus musculus (Mouse) GO:0004843; GO:0005789; GO:0005829; GO:0008270; GO:0016579; GO:0031625; GO:0031647; GO:0034976; GO:0036503; GO:0048642; GO:0050821; GO:0051879; GO:0071108; GO:0090068; GO:1900037; GO:1901799; GO:1904292; GO:1990380 ERAD pathway [GO:0036503]; negative regulation of proteasomal protein catabolic process [GO:1901799]; negative regulation of skeletal muscle tissue development [GO:0048642]; positive regulation of cell cycle process [GO:0090068]; protein deubiquitination [GO:0016579]; protein K48-linked deubiquitination [GO:0071108]; protein stabilization [GO:0050821]; regulation of cellular response to hypoxia [GO:1900037]; regulation of ERAD pathway [GO:1904292]; regulation of protein stability [GO:0031647]; response to endoplasmic reticulum stress [GO:0034976] cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789] cysteine-type deubiquitinase activity [GO:0004843]; Hsp90 protein binding [GO:0051879]; K48-linked deubiquitinase activity [GO:1990380]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270] g21211.t1 Q96RW7 43.841 276 1.2600000000000001e-59 209.0 sp|Q96RW7|HMCN1_HUMAN Hemicentin-1 OS=Homo sapiens OX=9606 GN=HMCN1 PE=1 SV=2 HMCN1_HUMAN reviewed Hemicentin-1 (Fibulin-6) (FIBL-6) Homo sapiens (Human) GO:0005201; GO:0005509; GO:0005604; GO:0005737; GO:0005886; GO:0005912; GO:0005927; GO:0005938; GO:0007156; GO:0007157; GO:0007601; GO:0009617; GO:0030036; GO:0031012; GO:0032154; GO:0051301; GO:0070062; GO:0071711; GO:0098631 actin cytoskeleton organization [GO:0030036]; basement membrane organization [GO:0071711]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601] adherens junction [GO:0005912]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; muscle tendon junction [GO:0005927]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; cell adhesion mediator activity [GO:0098631]; extracellular matrix structural constituent [GO:0005201] g21211.t1 Q96RW7 42.336 274 7.38e-59 207.0 sp|Q96RW7|HMCN1_HUMAN Hemicentin-1 OS=Homo sapiens OX=9606 GN=HMCN1 PE=1 SV=2 HMCN1_HUMAN reviewed Hemicentin-1 (Fibulin-6) (FIBL-6) Homo sapiens (Human) GO:0005201; GO:0005509; GO:0005604; GO:0005737; GO:0005886; GO:0005912; GO:0005927; GO:0005938; GO:0007156; GO:0007157; GO:0007601; GO:0009617; GO:0030036; GO:0031012; GO:0032154; GO:0051301; GO:0070062; GO:0071711; GO:0098631 actin cytoskeleton organization [GO:0030036]; basement membrane organization [GO:0071711]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601] adherens junction [GO:0005912]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; muscle tendon junction [GO:0005927]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; cell adhesion mediator activity [GO:0098631]; extracellular matrix structural constituent [GO:0005201] g21211.t1 Q96RW7 42.194 237 2.73e-51 186.0 sp|Q96RW7|HMCN1_HUMAN Hemicentin-1 OS=Homo sapiens OX=9606 GN=HMCN1 PE=1 SV=2 HMCN1_HUMAN reviewed Hemicentin-1 (Fibulin-6) (FIBL-6) Homo sapiens (Human) GO:0005201; GO:0005509; GO:0005604; GO:0005737; GO:0005886; GO:0005912; GO:0005927; GO:0005938; GO:0007156; GO:0007157; GO:0007601; GO:0009617; GO:0030036; GO:0031012; GO:0032154; GO:0051301; GO:0070062; GO:0071711; GO:0098631 actin cytoskeleton organization [GO:0030036]; basement membrane organization [GO:0071711]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601] adherens junction [GO:0005912]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; muscle tendon junction [GO:0005927]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; cell adhesion mediator activity [GO:0098631]; extracellular matrix structural constituent [GO:0005201] g21211.t1 Q96RW7 42.045 176 1.18e-34 137.0 sp|Q96RW7|HMCN1_HUMAN Hemicentin-1 OS=Homo sapiens OX=9606 GN=HMCN1 PE=1 SV=2 HMCN1_HUMAN reviewed Hemicentin-1 (Fibulin-6) (FIBL-6) Homo sapiens (Human) GO:0005201; GO:0005509; GO:0005604; GO:0005737; GO:0005886; GO:0005912; GO:0005927; GO:0005938; GO:0007156; GO:0007157; GO:0007601; GO:0009617; GO:0030036; GO:0031012; GO:0032154; GO:0051301; GO:0070062; GO:0071711; GO:0098631 actin cytoskeleton organization [GO:0030036]; basement membrane organization [GO:0071711]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601] adherens junction [GO:0005912]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; muscle tendon junction [GO:0005927]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; cell adhesion mediator activity [GO:0098631]; extracellular matrix structural constituent [GO:0005201] g21211.t1 Q96RW7 43.548 124 8.56e-21 97.1 sp|Q96RW7|HMCN1_HUMAN Hemicentin-1 OS=Homo sapiens OX=9606 GN=HMCN1 PE=1 SV=2 HMCN1_HUMAN reviewed Hemicentin-1 (Fibulin-6) (FIBL-6) Homo sapiens (Human) GO:0005201; GO:0005509; GO:0005604; GO:0005737; GO:0005886; GO:0005912; GO:0005927; GO:0005938; GO:0007156; GO:0007157; GO:0007601; GO:0009617; GO:0030036; GO:0031012; GO:0032154; GO:0051301; GO:0070062; GO:0071711; GO:0098631 actin cytoskeleton organization [GO:0030036]; basement membrane organization [GO:0071711]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601] adherens junction [GO:0005912]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; muscle tendon junction [GO:0005927]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; cell adhesion mediator activity [GO:0098631]; extracellular matrix structural constituent [GO:0005201] g21212.t1 D3YXG0 41.695 295 1.12e-48 183.0 sp|D3YXG0|HMCN1_MOUSE Hemicentin-1 OS=Mus musculus OX=10090 GN=Hmcn1 PE=1 SV=1 HMCN1_MOUSE reviewed Hemicentin-1 (Fibulin-6) (FIBL-6) Mus musculus (Mouse) GO:0005509; GO:0005576; GO:0005604; GO:0005737; GO:0005886; GO:0005912; GO:0005927; GO:0005938; GO:0007156; GO:0007157; GO:0009617; GO:0030036; GO:0030054; GO:0031012; GO:0032154; GO:0051301; GO:0071711; GO:0098631 actin cytoskeleton organization [GO:0030036]; basement membrane organization [GO:0071711]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617] adherens junction [GO:0005912]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; muscle tendon junction [GO:0005927]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; cell adhesion mediator activity [GO:0098631] g21212.t1 D3YXG0 43.289 298 1.65e-44 171.0 sp|D3YXG0|HMCN1_MOUSE Hemicentin-1 OS=Mus musculus OX=10090 GN=Hmcn1 PE=1 SV=1 HMCN1_MOUSE reviewed Hemicentin-1 (Fibulin-6) (FIBL-6) Mus musculus (Mouse) GO:0005509; GO:0005576; GO:0005604; GO:0005737; GO:0005886; GO:0005912; GO:0005927; GO:0005938; GO:0007156; GO:0007157; GO:0009617; GO:0030036; GO:0030054; GO:0031012; GO:0032154; GO:0051301; GO:0071711; GO:0098631 actin cytoskeleton organization [GO:0030036]; basement membrane organization [GO:0071711]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617] adherens junction [GO:0005912]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; muscle tendon junction [GO:0005927]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; cell adhesion mediator activity [GO:0098631] g21212.t1 D3YXG0 41.026 234 1.6100000000000002e-32 135.0 sp|D3YXG0|HMCN1_MOUSE Hemicentin-1 OS=Mus musculus OX=10090 GN=Hmcn1 PE=1 SV=1 HMCN1_MOUSE reviewed Hemicentin-1 (Fibulin-6) (FIBL-6) Mus musculus (Mouse) GO:0005509; GO:0005576; GO:0005604; GO:0005737; GO:0005886; GO:0005912; GO:0005927; GO:0005938; GO:0007156; GO:0007157; GO:0009617; GO:0030036; GO:0030054; GO:0031012; GO:0032154; GO:0051301; GO:0071711; GO:0098631 actin cytoskeleton organization [GO:0030036]; basement membrane organization [GO:0071711]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617] adherens junction [GO:0005912]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; muscle tendon junction [GO:0005927]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; cell adhesion mediator activity [GO:0098631] g21213.t1 Q5G266 37.445 227 2.8e-38 150.0 sp|Q5G266|NETR_TRAPH Neurotrypsin OS=Trachypithecus phayrei OX=61618 GN=PRSS12 PE=3 SV=1 NETR_TRAPH reviewed Neurotrypsin (EC 3.4.21.-) (Serine protease 12) Trachypithecus phayrei (Phayre's leaf monkey) GO:0004252; GO:0005576; GO:0005886; GO:0006508; GO:0006887; GO:0030424; GO:0098793; GO:0098978 exocytosis [GO:0006887]; proteolysis [GO:0006508] axon [GO:0030424]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; presynapse [GO:0098793] serine-type endopeptidase activity [GO:0004252] g21213.t1 Q5G266 38.565 223 1.1500000000000001e-35 143.0 sp|Q5G266|NETR_TRAPH Neurotrypsin OS=Trachypithecus phayrei OX=61618 GN=PRSS12 PE=3 SV=1 NETR_TRAPH reviewed Neurotrypsin (EC 3.4.21.-) (Serine protease 12) Trachypithecus phayrei (Phayre's leaf monkey) GO:0004252; GO:0005576; GO:0005886; GO:0006508; GO:0006887; GO:0030424; GO:0098793; GO:0098978 exocytosis [GO:0006887]; proteolysis [GO:0006508] axon [GO:0030424]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; presynapse [GO:0098793] serine-type endopeptidase activity [GO:0004252] g21213.t1 Q5G266 33.641 217 6.56e-32 132.0 sp|Q5G266|NETR_TRAPH Neurotrypsin OS=Trachypithecus phayrei OX=61618 GN=PRSS12 PE=3 SV=1 NETR_TRAPH reviewed Neurotrypsin (EC 3.4.21.-) (Serine protease 12) Trachypithecus phayrei (Phayre's leaf monkey) GO:0004252; GO:0005576; GO:0005886; GO:0006508; GO:0006887; GO:0030424; GO:0098793; GO:0098978 exocytosis [GO:0006887]; proteolysis [GO:0006508] axon [GO:0030424]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; presynapse [GO:0098793] serine-type endopeptidase activity [GO:0004252] g21213.t2 Q5G266 37.054 224 1.65e-36 145.0 sp|Q5G266|NETR_TRAPH Neurotrypsin OS=Trachypithecus phayrei OX=61618 GN=PRSS12 PE=3 SV=1 NETR_TRAPH reviewed Neurotrypsin (EC 3.4.21.-) (Serine protease 12) Trachypithecus phayrei (Phayre's leaf monkey) GO:0004252; GO:0005576; GO:0005886; GO:0006508; GO:0006887; GO:0030424; GO:0098793; GO:0098978 exocytosis [GO:0006887]; proteolysis [GO:0006508] axon [GO:0030424]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; presynapse [GO:0098793] serine-type endopeptidase activity [GO:0004252] g21213.t2 Q5G266 36.842 228 3.76e-33 135.0 sp|Q5G266|NETR_TRAPH Neurotrypsin OS=Trachypithecus phayrei OX=61618 GN=PRSS12 PE=3 SV=1 NETR_TRAPH reviewed Neurotrypsin (EC 3.4.21.-) (Serine protease 12) Trachypithecus phayrei (Phayre's leaf monkey) GO:0004252; GO:0005576; GO:0005886; GO:0006508; GO:0006887; GO:0030424; GO:0098793; GO:0098978 exocytosis [GO:0006887]; proteolysis [GO:0006508] axon [GO:0030424]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; presynapse [GO:0098793] serine-type endopeptidase activity [GO:0004252] g21213.t2 Q5G266 33.019 212 1.2300000000000001e-29 125.0 sp|Q5G266|NETR_TRAPH Neurotrypsin OS=Trachypithecus phayrei OX=61618 GN=PRSS12 PE=3 SV=1 NETR_TRAPH reviewed Neurotrypsin (EC 3.4.21.-) (Serine protease 12) Trachypithecus phayrei (Phayre's leaf monkey) GO:0004252; GO:0005576; GO:0005886; GO:0006508; GO:0006887; GO:0030424; GO:0098793; GO:0098978 exocytosis [GO:0006887]; proteolysis [GO:0006508] axon [GO:0030424]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; presynapse [GO:0098793] serine-type endopeptidase activity [GO:0004252] g21215.t1 Q99MI1 43.012 830 5.350000000000001e-164 507.0 sp|Q99MI1|RB6I2_MOUSE ELKS/Rab6-interacting/CAST family member 1 OS=Mus musculus OX=10090 GN=Erc1 PE=1 SV=1 g21215.t2 Q99MI1 44.994 809 1.1299999999999999e-168 518.0 sp|Q99MI1|RB6I2_MOUSE ELKS/Rab6-interacting/CAST family member 1 OS=Mus musculus OX=10090 GN=Erc1 PE=1 SV=1 g21219.t1 Q8N1E6 68.798 391 0.0 553.0 sp|Q8N1E6|FXL14_HUMAN F-box/LRR-repeat protein 14 OS=Homo sapiens OX=9606 GN=FBXL14 PE=1 SV=1 FXL14_HUMAN reviewed F-box/LRR-repeat protein 14 (F-box and leucine-rich repeat protein 14) Homo sapiens (Human) GO:0004842; GO:0005737; GO:0005829; GO:0006511; GO:0019005; GO:0031146 SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; ubiquitin-dependent protein catabolic process [GO:0006511] cytoplasm [GO:0005737]; cytosol [GO:0005829]; SCF ubiquitin ligase complex [GO:0019005] ubiquitin-protein transferase activity [GO:0004842] g21220.t1 P33945 57.018 342 1.68e-137 397.0 sp|P33945|WNT5B_XENLA Protein Wnt-5b OS=Xenopus laevis OX=8355 GN=wnt5b PE=2 SV=2 g21221.t1 Q9Y6H3 40.777 206 1.7e-49 166.0 sp|Q9Y6H3|ATP23_HUMAN Mitochondrial inner membrane protease ATP23 homolog OS=Homo sapiens OX=9606 GN=ATP23 PE=1 SV=3 g21222.t1 Q90Z16 29.464 336 4.84e-25 114.0 sp|Q90Z16|OPTN_CHICK Optineurin OS=Gallus gallus OX=9031 GN=OPTN PE=1 SV=1 OPTN_CHICK reviewed Optineurin (Ag9-C5) (FIP-2) Gallus gallus (Chicken) GO:0005634; GO:0005737; GO:0005776; GO:0005794; GO:0006914; GO:0008270; GO:0034067; GO:0043122; GO:0048471; GO:0055037; GO:0070530; GO:0090161 autophagy [GO:0006914]; Golgi ribbon formation [GO:0090161]; protein localization to Golgi apparatus [GO:0034067]; regulation of canonical NF-kappaB signal transduction [GO:0043122] autophagosome [GO:0005776]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; recycling endosome [GO:0055037] K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; zinc ion binding [GO:0008270] g21222.t2 Q90Z16 29.464 336 4.11e-25 114.0 sp|Q90Z16|OPTN_CHICK Optineurin OS=Gallus gallus OX=9031 GN=OPTN PE=1 SV=1 OPTN_CHICK reviewed Optineurin (Ag9-C5) (FIP-2) Gallus gallus (Chicken) GO:0005634; GO:0005737; GO:0005776; GO:0005794; GO:0006914; GO:0008270; GO:0034067; GO:0043122; GO:0048471; GO:0055037; GO:0070530; GO:0090161 autophagy [GO:0006914]; Golgi ribbon formation [GO:0090161]; protein localization to Golgi apparatus [GO:0034067]; regulation of canonical NF-kappaB signal transduction [GO:0043122] autophagosome [GO:0005776]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; recycling endosome [GO:0055037] K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; zinc ion binding [GO:0008270] g21225.t1 Q6ZXC9 32.995 197 1.07e-26 116.0 sp|Q6ZXC9|SIA8D_BOVIN CMP-N-acetylneuraminate-poly-alpha-2,8-sialyltransferase OS=Bos taurus OX=9913 GN=ST8SIA4 PE=2 SV=1 g21228.t1 Q63563 33.129 1144 3.6499999999999994e-170 545.0 sp|Q63563|ABCC9_RAT ATP-binding cassette sub-family C member 9 OS=Rattus norvegicus OX=10116 GN=Abcc9 PE=1 SV=1 g21229.t1 O60706 50.688 436 2.19e-143 449.0 sp|O60706|ABCC9_HUMAN ATP-binding cassette sub-family C member 9 OS=Homo sapiens OX=9606 GN=ABCC9 PE=1 SV=2 ABCC9_HUMAN reviewed ATP-binding cassette sub-family C member 9 (Sulfonylurea receptor 2) Homo sapiens (Human) GO:0000165; GO:0001508; GO:0001666; GO:0003007; GO:0005267; GO:0005524; GO:0005739; GO:0005886; GO:0006357; GO:0007005; GO:0007519; GO:0008281; GO:0008282; GO:0010467; GO:0014823; GO:0015459; GO:0016887; GO:0019395; GO:0019829; GO:0030017; GO:0031004; GO:0033198; GO:0035865; GO:0042311; GO:0042383; GO:0042542; GO:0042626; GO:0043066; GO:0043225; GO:0043627; GO:0044325; GO:0044877; GO:0045333; GO:0045776; GO:0046034; GO:0048144; GO:0051607; GO:0055085; GO:0060976; GO:0061337; GO:0062197; GO:0071277; GO:0071318; GO:0071466; GO:0071805; GO:0072592; GO:0086003; GO:0098655; GO:0098662; GO:0099104; GO:0140359; GO:0150104; GO:1901379; GO:1901652; GO:1903409; GO:1904880; GO:1990573 action potential [GO:0001508]; ATP metabolic process [GO:0046034]; cardiac conduction [GO:0061337]; cardiac muscle cell contraction [GO:0086003]; cellular respiration [GO:0045333]; cellular response to ATP [GO:0071318]; cellular response to calcium ion [GO:0071277]; cellular response to chemical stress [GO:0062197]; cellular response to potassium ion [GO:0035865]; cellular response to xenobiotic stimulus [GO:0071466]; coronary vasculature development [GO:0060976]; defense response to virus [GO:0051607]; fatty acid oxidation [GO:0019395]; fibroblast proliferation [GO:0048144]; gene expression [GO:0010467]; heart morphogenesis [GO:0003007]; inorganic cation transmembrane transport [GO:0098662]; MAPK cascade [GO:0000165]; mitochondrion organization [GO:0007005]; monoatomic cation transmembrane transport [GO:0098655]; negative regulation of apoptotic process [GO:0043066]; negative regulation of blood pressure [GO:0045776]; oxygen metabolic process [GO:0072592]; potassium ion import across plasma membrane [GO:1990573]; potassium ion transmembrane transport [GO:0071805]; reactive oxygen species biosynthetic process [GO:1903409]; regulation of potassium ion transmembrane transport [GO:1901379]; regulation of transcription by RNA polymerase II [GO:0006357]; response to activity [GO:0014823]; response to ATP [GO:0033198]; response to estrogen [GO:0043627]; response to hydrogen peroxide [GO:0042542]; response to hydrogen sulfide [GO:1904880]; response to hypoxia [GO:0001666]; response to peptide [GO:1901652]; skeletal muscle tissue development [GO:0007519]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104]; vasodilation [GO:0042311] inward rectifying potassium channel [GO:0008282]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; potassium ion-transporting ATPase complex [GO:0031004]; sarcolemma [GO:0042383]; sarcomere [GO:0030017] ABC-type transporter activity [GO:0140359]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled inorganic anion transmembrane transporter activity [GO:0043225]; ATPase-coupled monoatomic cation transmembrane transporter activity [GO:0019829]; ATPase-coupled transmembrane transporter activity [GO:0042626]; potassium channel activator activity [GO:0099104]; potassium channel activity [GO:0005267]; potassium channel regulator activity [GO:0015459]; protein-containing complex binding [GO:0044877]; sulfonylurea receptor activity [GO:0008281]; transmembrane transporter binding [GO:0044325] g21230.t1 Q86UP9 40.594 202 2.54e-40 144.0 sp|Q86UP9|LHPL3_HUMAN LHFPL tetraspan subfamily member 3 protein OS=Homo sapiens OX=9606 GN=LHFPL3 PE=1 SV=3 g21231.t1 Q08830 37.154 253 6.720000000000001e-43 152.0 sp|Q08830|FGL1_HUMAN Fibrinogen-like protein 1 OS=Homo sapiens OX=9606 GN=FGL1 PE=1 SV=3 FGL1_HUMAN reviewed Fibrinogen-like protein 1 (HP-041) (Hepassocin) (HPS) (Hepatocyte-derived fibrinogen-related protein 1) (HFREP-1) (Liver fibrinogen-related protein 1) (LFIRE-1) Homo sapiens (Human) GO:0002250; GO:0005576; GO:0005577; GO:0005615; GO:0005886; GO:0007596; GO:0048018; GO:0050776; GO:0050860; GO:0050868; GO:0072574 adaptive immune response [GO:0002250]; blood coagulation [GO:0007596]; hepatocyte proliferation [GO:0072574]; negative regulation of T cell activation [GO:0050868]; negative regulation of T cell receptor signaling pathway [GO:0050860]; regulation of immune response [GO:0050776] extracellular region [GO:0005576]; extracellular space [GO:0005615]; fibrinogen complex [GO:0005577]; plasma membrane [GO:0005886] receptor ligand activity [GO:0048018] g21234.t1 Q60997 40.079 252 2.31e-34 137.0 sp|Q60997|DMBT1_MOUSE Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Mus musculus OX=10090 GN=Dmbt1 PE=1 SV=2 g21234.t1 Q60997 39.37 254 5.32e-34 136.0 sp|Q60997|DMBT1_MOUSE Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Mus musculus OX=10090 GN=Dmbt1 PE=1 SV=2 g21234.t1 Q60997 39.921 253 2.77e-33 134.0 sp|Q60997|DMBT1_MOUSE Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Mus musculus OX=10090 GN=Dmbt1 PE=1 SV=2 g21234.t1 Q60997 40.164 244 4.6500000000000004e-32 130.0 sp|Q60997|DMBT1_MOUSE Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Mus musculus OX=10090 GN=Dmbt1 PE=1 SV=2 g21234.t1 Q60997 38.34 253 6.61e-32 130.0 sp|Q60997|DMBT1_MOUSE Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Mus musculus OX=10090 GN=Dmbt1 PE=1 SV=2 g21235.t1 Q9UGM3 45.455 209 9.46e-39 152.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g21235.t1 Q9UGM3 42.174 230 1.96e-37 148.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g21235.t1 Q9UGM3 41.739 230 2.62e-37 148.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g21235.t1 Q9UGM3 41.739 230 1.55e-36 145.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g21235.t1 Q9UGM3 41.304 230 4.26e-36 144.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g21235.t1 Q9UGM3 40.084 237 8.62e-36 144.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g21235.t1 Q9UGM3 41.379 232 8.79e-36 144.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g21235.t1 Q9UGM3 40.948 232 1.46e-35 143.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g21235.t1 Q9UGM3 39.485 233 1.2499999999999999e-34 140.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g21236.t1 Q95218 42.92 226 3.61e-46 172.0 sp|Q95218|DMBT1_RABIT Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Oryctolagus cuniculus OX=9986 GN=Dmbt1 PE=1 SV=2 g21236.t1 Q95218 37.975 237 3.49e-39 152.0 sp|Q95218|DMBT1_RABIT Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Oryctolagus cuniculus OX=9986 GN=Dmbt1 PE=1 SV=2 g21236.t1 Q95218 37.19 242 1e-37 147.0 sp|Q95218|DMBT1_RABIT Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Oryctolagus cuniculus OX=9986 GN=Dmbt1 PE=1 SV=2 g21236.t1 Q95218 36.709 237 7.69e-35 139.0 sp|Q95218|DMBT1_RABIT Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Oryctolagus cuniculus OX=9986 GN=Dmbt1 PE=1 SV=2 g21236.t1 Q95218 37.069 232 6.15e-34 136.0 sp|Q95218|DMBT1_RABIT Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Oryctolagus cuniculus OX=9986 GN=Dmbt1 PE=1 SV=2 g21242.t1 Q52I78 58.439 474 0.0 545.0 sp|Q52I78|NAMPT_PIG Nicotinamide phosphoribosyltransferase OS=Sus scrofa OX=9823 GN=NAMPT PE=2 SV=2 NAMPT_PIG reviewed Nicotinamide phosphoribosyltransferase (NAmPRTase) (Nampt) (EC 2.4.2.12) (Pre-B-cell colony-enhancing factor 1 homolog) (PBEF) (Visfatin) Sus scrofa (Pig) GO:0005125; GO:0005615; GO:0005634; GO:0005737; GO:0009435; GO:0032922; GO:0042802; GO:0047280 circadian regulation of gene expression [GO:0032922]; NAD+ biosynthetic process [GO:0009435] cytoplasm [GO:0005737]; extracellular space [GO:0005615]; nucleus [GO:0005634] cytokine activity [GO:0005125]; identical protein binding [GO:0042802]; nicotinamide phosphoribosyltransferase activity [GO:0047280] g21243.t1 A7SMR0 62.637 91 1.57e-34 116.0 sp|A7SMR0|MEIG1_NEMVE Meiosis expressed gene 1 protein homolog OS=Nematostella vectensis OX=45351 GN=v1g237368 PE=3 SV=1 g21244.t1 Q9Z2U1 79.253 241 3.6099999999999997e-147 413.0 sp|Q9Z2U1|PSA5_MOUSE Proteasome subunit alpha type-5 OS=Mus musculus OX=10090 GN=Psma5 PE=1 SV=1 PSA5_MOUSE reviewed Proteasome subunit alpha type-5 (Macropain zeta chain) (Multicatalytic endopeptidase complex zeta chain) (Proteasome subunit alpha-5) (alpha-5) (Proteasome zeta chain) Mus musculus (Mouse) GO:0000502; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005839; GO:0019773; GO:0043161 proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; proteasome core complex [GO:0005839]; proteasome core complex, alpha-subunit complex [GO:0019773] g21245.t1 Q53B90 67.333 150 3.01e-74 224.0 sp|Q53B90|RAB43_RAT Ras-related protein Rab-43 OS=Rattus norvegicus OX=10116 GN=Rab43 PE=2 SV=1 RAB43_RAT reviewed Ras-related protein Rab-43 (EC 3.6.5.2) Rattus norvegicus (Rat) GO:0000045; GO:0000139; GO:0003924; GO:0003925; GO:0005525; GO:0005789; GO:0005794; GO:0006886; GO:0006888; GO:0007030; GO:0012505; GO:0030670; GO:0030672; GO:0033106; GO:0033116; GO:0035526; GO:0045335; GO:0071346; GO:0090382; GO:1903358 autophagosome assembly [GO:0000045]; cellular response to type II interferon [GO:0071346]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; intracellular protein transport [GO:0006886]; phagosome maturation [GO:0090382]; regulation of Golgi organization [GO:1903358]; retrograde transport, plasma membrane to Golgi [GO:0035526] cis-Golgi network membrane [GO:0033106]; endomembrane system [GO:0012505]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; synaptic vesicle membrane [GO:0030672] G protein activity [GO:0003925]; GTP binding [GO:0005525]; GTPase activity [GO:0003924] g21246.t1 Q91WM2 55.191 183 6.63e-65 211.0 sp|Q91WM2|HDHD5_MOUSE Haloacid dehalogenase-like hydrolase domain-containing 5 OS=Mus musculus OX=10090 GN=Hdhd5 PE=1 SV=1 g21247.t1 Q91WM2 59.048 105 1.6e-36 132.0 sp|Q91WM2|HDHD5_MOUSE Haloacid dehalogenase-like hydrolase domain-containing 5 OS=Mus musculus OX=10090 GN=Hdhd5 PE=1 SV=1 g21248.t1 Q6AYB3 71.93 285 4.2700000000000005e-124 358.0 sp|Q6AYB3|ISY1_RAT Pre-mRNA-splicing factor ISY1 homolog OS=Rattus norvegicus OX=10116 GN=Isy1 PE=2 SV=1 ISY1_RAT reviewed Pre-mRNA-splicing factor ISY1 homolog Rattus norvegicus (Rat) GO:0000350; GO:0000389; GO:0000398; GO:0000974; GO:0005634; GO:0071006; GO:0071013; GO:0071014; GO:0071020 generation of catalytic spliceosome for second transesterification step [GO:0000350]; mRNA 3'-splice site recognition [GO:0000389]; mRNA splicing, via spliceosome [GO:0000398] catalytic step 2 spliceosome [GO:0071013]; nucleus [GO:0005634]; post-mRNA release spliceosomal complex [GO:0071014]; post-spliceosomal complex [GO:0071020]; Prp19 complex [GO:0000974]; U2-type catalytic step 1 spliceosome [GO:0071006] g21249.t1 Q96G21 66.187 278 1.3399999999999999e-141 403.0 sp|Q96G21|IMP4_HUMAN U3 small nucleolar ribonucleoprotein protein IMP4 OS=Homo sapiens OX=9606 GN=IMP4 PE=1 SV=1 IMP4_HUMAN reviewed U3 small nucleolar ribonucleoprotein protein IMP4 (U3 snoRNP protein IMP4) (Brix domain-containing protein 4) Homo sapiens (Human) GO:0001650; GO:0005654; GO:0005730; GO:0006364; GO:0030490; GO:0030515; GO:0030684; GO:0032040; GO:0034457; GO:0042134; GO:0042274 maturation of SSU-rRNA [GO:0030490]; ribosomal small subunit biogenesis [GO:0042274]; rRNA processing [GO:0006364] fibrillar center [GO:0001650]; Mpp10 complex [GO:0034457]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; preribosome [GO:0030684]; small-subunit processome [GO:0032040] rRNA primary transcript binding [GO:0042134]; snoRNA binding [GO:0030515] g21253.t1 Q9QY36 93.684 95 5.2e-65 199.0 sp|Q9QY36|NAA10_MOUSE N-alpha-acetyltransferase 10 OS=Mus musculus OX=10090 GN=Naa10 PE=1 SV=1 g21256.t1 Q2HJM9 52.273 176 9.72e-62 197.0 sp|Q2HJM9|MEST_BOVIN Mesoderm-specific transcript homolog protein OS=Bos taurus OX=9913 GN=MEST PE=2 SV=2 MEST_BOVIN reviewed Mesoderm-specific transcript homolog protein (EC 3.-.-.-) (Paternally-expressed gene 1 protein) Bos taurus (Bovine) GO:0005783; GO:0005789; GO:0010561; GO:0016787; GO:0045444; GO:0048666; GO:0050767; GO:0090090; GO:0140650; GO:1903077 fat cell differentiation [GO:0045444]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of glycoprotein biosynthetic process [GO:0010561]; negative regulation of protein localization to plasma membrane [GO:1903077]; neuron development [GO:0048666]; radial glia-guided pyramidal neuron migration [GO:0140650]; regulation of neurogenesis [GO:0050767] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789] hydrolase activity [GO:0016787] g21256.t2 Q07646 47.931 290 4.22e-93 282.0 sp|Q07646|MEST_MOUSE Mesoderm-specific transcript protein OS=Mus musculus OX=10090 GN=Mest PE=2 SV=1 g21256.t3 Q07646 48.621 290 3.99e-96 290.0 sp|Q07646|MEST_MOUSE Mesoderm-specific transcript protein OS=Mus musculus OX=10090 GN=Mest PE=2 SV=1 g21257.t1 A0JPH7 50.163 307 5.4500000000000005e-87 270.0 sp|A0JPH7|CE41B_XENLA Centrosomal protein of 41 kDa B OS=Xenopus laevis OX=8355 GN=cep41-b PE=2 SV=1 g21258.t1 P05631 61.679 274 1.47e-112 329.0 sp|P05631|ATPG_BOVIN ATP synthase F(1) complex subunit gamma, mitochondrial OS=Bos taurus OX=9913 GN=ATP5F1C PE=1 SV=3 g21259.t1 B2RRD7 50.0 120 9.46e-28 111.0 sp|B2RRD7|BRPF1_MOUSE Peregrin OS=Mus musculus OX=10090 GN=Brpf1 PE=1 SV=1 BRPF1_MOUSE reviewed Peregrin (Bromodomain and PHD finger-containing protein 1) Mus musculus (Mouse) GO:0000123; GO:0001570; GO:0001841; GO:0003677; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0006338; GO:0006355; GO:0006357; GO:0008270; GO:0010698; GO:0035726; GO:0045893; GO:0048145; GO:0070776 chromatin remodeling [GO:0006338]; common myeloid progenitor cell proliferation [GO:0035726]; neural tube formation [GO:0001841]; positive regulation of DNA-templated transcription [GO:0045893]; regulation of DNA-templated transcription [GO:0006355]; regulation of fibroblast proliferation [GO:0048145]; regulation of transcription by RNA polymerase II [GO:0006357]; vasculogenesis [GO:0001570] cytoplasm [GO:0005737]; cytosol [GO:0005829]; histone acetyltransferase complex [GO:0000123]; MOZ/MORF histone acetyltransferase complex [GO:0070776]; nucleus [GO:0005634]; plasma membrane [GO:0005886] acetyltransferase activator activity [GO:0010698]; DNA binding [GO:0003677]; zinc ion binding [GO:0008270] g21260.t1 P55201 66.391 604 0.0 825.0 sp|P55201|BRPF1_HUMAN Peregrin OS=Homo sapiens OX=9606 GN=BRPF1 PE=1 SV=2 BRPF1_HUMAN reviewed Peregrin (Bromodomain and PHD finger-containing protein 1) (Protein Br140) Homo sapiens (Human) GO:0000123; GO:0003677; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0006338; GO:0006355; GO:0006357; GO:0008270; GO:0010698; GO:0045893; GO:0050793; GO:0070776; GO:1903706 chromatin remodeling [GO:0006338]; positive regulation of DNA-templated transcription [GO:0045893]; regulation of developmental process [GO:0050793]; regulation of DNA-templated transcription [GO:0006355]; regulation of hemopoiesis [GO:1903706]; regulation of transcription by RNA polymerase II [GO:0006357] cytoplasm [GO:0005737]; cytosol [GO:0005829]; histone acetyltransferase complex [GO:0000123]; MOZ/MORF histone acetyltransferase complex [GO:0070776]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886] acetyltransferase activator activity [GO:0010698]; DNA binding [GO:0003677]; zinc ion binding [GO:0008270] g21260.t2 P55201 66.391 604 0.0 827.0 sp|P55201|BRPF1_HUMAN Peregrin OS=Homo sapiens OX=9606 GN=BRPF1 PE=1 SV=2 BRPF1_HUMAN reviewed Peregrin (Bromodomain and PHD finger-containing protein 1) (Protein Br140) Homo sapiens (Human) GO:0000123; GO:0003677; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0006338; GO:0006355; GO:0006357; GO:0008270; GO:0010698; GO:0045893; GO:0050793; GO:0070776; GO:1903706 chromatin remodeling [GO:0006338]; positive regulation of DNA-templated transcription [GO:0045893]; regulation of developmental process [GO:0050793]; regulation of DNA-templated transcription [GO:0006355]; regulation of hemopoiesis [GO:1903706]; regulation of transcription by RNA polymerase II [GO:0006357] cytoplasm [GO:0005737]; cytosol [GO:0005829]; histone acetyltransferase complex [GO:0000123]; MOZ/MORF histone acetyltransferase complex [GO:0070776]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886] acetyltransferase activator activity [GO:0010698]; DNA binding [GO:0003677]; zinc ion binding [GO:0008270] g21261.t1 P55201 60.335 179 3.08e-58 209.0 sp|P55201|BRPF1_HUMAN Peregrin OS=Homo sapiens OX=9606 GN=BRPF1 PE=1 SV=2 BRPF1_HUMAN reviewed Peregrin (Bromodomain and PHD finger-containing protein 1) (Protein Br140) Homo sapiens (Human) GO:0000123; GO:0003677; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0006338; GO:0006355; GO:0006357; GO:0008270; GO:0010698; GO:0045893; GO:0050793; GO:0070776; GO:1903706 chromatin remodeling [GO:0006338]; positive regulation of DNA-templated transcription [GO:0045893]; regulation of developmental process [GO:0050793]; regulation of DNA-templated transcription [GO:0006355]; regulation of hemopoiesis [GO:1903706]; regulation of transcription by RNA polymerase II [GO:0006357] cytoplasm [GO:0005737]; cytosol [GO:0005829]; histone acetyltransferase complex [GO:0000123]; MOZ/MORF histone acetyltransferase complex [GO:0070776]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886] acetyltransferase activator activity [GO:0010698]; DNA binding [GO:0003677]; zinc ion binding [GO:0008270] g21261.t2 P55201 60.44 182 3.84e-58 209.0 sp|P55201|BRPF1_HUMAN Peregrin OS=Homo sapiens OX=9606 GN=BRPF1 PE=1 SV=2 BRPF1_HUMAN reviewed Peregrin (Bromodomain and PHD finger-containing protein 1) (Protein Br140) Homo sapiens (Human) GO:0000123; GO:0003677; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0006338; GO:0006355; GO:0006357; GO:0008270; GO:0010698; GO:0045893; GO:0050793; GO:0070776; GO:1903706 chromatin remodeling [GO:0006338]; positive regulation of DNA-templated transcription [GO:0045893]; regulation of developmental process [GO:0050793]; regulation of DNA-templated transcription [GO:0006355]; regulation of hemopoiesis [GO:1903706]; regulation of transcription by RNA polymerase II [GO:0006357] cytoplasm [GO:0005737]; cytosol [GO:0005829]; histone acetyltransferase complex [GO:0000123]; MOZ/MORF histone acetyltransferase complex [GO:0070776]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886] acetyltransferase activator activity [GO:0010698]; DNA binding [GO:0003677]; zinc ion binding [GO:0008270] g21262.t1 Q2QLC0 30.966 1408 6.1000000000000005e-173 554.0 sp|Q2QLC0|MET_PLEMO Hepatocyte growth factor receptor OS=Plecturocebus moloch OX=9523 GN=MET PE=3 SV=1 MET_PLEMO reviewed Hepatocyte growth factor receptor (HGF receptor) (EC 2.7.10.1) (HGF/SF receptor) (Proto-oncogene c-Met) (Scatter factor receptor) (SF receptor) (Tyrosine-protein kinase Met) Plecturocebus moloch (Dusky titi monkey) (Callicebus moloch) GO:0002116; GO:0004714; GO:0005524; GO:0005886; GO:0007169; GO:0010468; GO:0017154; GO:0048468; GO:0048513; GO:0050918; GO:0071526; GO:2001028 animal organ development [GO:0048513]; cell development [GO:0048468]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; positive chemotaxis [GO:0050918]; positive regulation of endothelial cell chemotaxis [GO:2001028]; regulation of gene expression [GO:0010468]; semaphorin-plexin signaling pathway [GO:0071526] plasma membrane [GO:0005886]; semaphorin receptor complex [GO:0002116] ATP binding [GO:0005524]; semaphorin receptor activity [GO:0017154]; transmembrane receptor protein tyrosine kinase activity [GO:0004714] g21262.t2 Q2QLC0 30.633 1407 1.11e-173 556.0 sp|Q2QLC0|MET_PLEMO Hepatocyte growth factor receptor OS=Plecturocebus moloch OX=9523 GN=MET PE=3 SV=1 MET_PLEMO reviewed Hepatocyte growth factor receptor (HGF receptor) (EC 2.7.10.1) (HGF/SF receptor) (Proto-oncogene c-Met) (Scatter factor receptor) (SF receptor) (Tyrosine-protein kinase Met) Plecturocebus moloch (Dusky titi monkey) (Callicebus moloch) GO:0002116; GO:0004714; GO:0005524; GO:0005886; GO:0007169; GO:0010468; GO:0017154; GO:0048468; GO:0048513; GO:0050918; GO:0071526; GO:2001028 animal organ development [GO:0048513]; cell development [GO:0048468]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; positive chemotaxis [GO:0050918]; positive regulation of endothelial cell chemotaxis [GO:2001028]; regulation of gene expression [GO:0010468]; semaphorin-plexin signaling pathway [GO:0071526] plasma membrane [GO:0005886]; semaphorin receptor complex [GO:0002116] ATP binding [GO:0005524]; semaphorin receptor activity [GO:0017154]; transmembrane receptor protein tyrosine kinase activity [GO:0004714] g21263.t1 P16056 31.308 1399 7.97e-175 560.0 sp|P16056|MET_MOUSE Hepatocyte growth factor receptor OS=Mus musculus OX=10090 GN=Met PE=1 SV=1 MET_MOUSE reviewed Hepatocyte growth factor receptor (HGF receptor) (EC 2.7.10.1) (HGF/SF receptor) (Proto-oncogene c-Met) (Scatter factor receptor) (SF receptor) (Tyrosine-protein kinase Met) Mus musculus (Mouse) GO:0000122; GO:0001764; GO:0001886; GO:0001889; GO:0001890; GO:0004672; GO:0004713; GO:0005008; GO:0005524; GO:0005615; GO:0005886; GO:0007169; GO:0007268; GO:0007420; GO:0007517; GO:0007519; GO:0008013; GO:0009925; GO:0010628; GO:0010629; GO:0010828; GO:0010976; GO:0014812; GO:0014902; GO:0016020; GO:0017154; GO:0019903; GO:0030182; GO:0030317; GO:0030425; GO:0030534; GO:0031016; GO:0031116; GO:0032675; GO:0035024; GO:0036126; GO:0042593; GO:0042802; GO:0043025; GO:0043235; GO:0043274; GO:0043410; GO:0043548; GO:0044877; GO:0045211; GO:0045740; GO:0045840; GO:0045944; GO:0048012; GO:0048754; GO:0050775; GO:0050804; GO:0050918; GO:0051450; GO:0051497; GO:0055013; GO:0060048; GO:0060076; GO:0060079; GO:0060665; GO:0061436; GO:0070495; GO:0071526; GO:0071635; GO:0072593; GO:0140677; GO:1900407; GO:1900745; GO:1901299; GO:2001028 adult behavior [GO:0030534]; brain development [GO:0007420]; branching morphogenesis of an epithelial tube [GO:0048754]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; chemical synaptic transmission [GO:0007268]; endothelial cell morphogenesis [GO:0001886]; establishment of skin barrier [GO:0061436]; excitatory postsynaptic potential [GO:0060079]; flagellated sperm motility [GO:0030317]; glucose homeostasis [GO:0042593]; hepatocyte growth factor receptor signaling pathway [GO:0048012]; liver development [GO:0001889]; modulation of chemical synaptic transmission [GO:0050804]; muscle cell migration [GO:0014812]; muscle organ development [GO:0007517]; myoblast proliferation [GO:0051450]; myotube differentiation [GO:0014902]; negative regulation of gene expression [GO:0010629]; negative regulation of hydrogen peroxide-mediated programmed cell death [GO:1901299]; negative regulation of Rho protein signal transduction [GO:0035024]; negative regulation of stress fiber assembly [GO:0051497]; negative regulation of thrombin-activated receptor signaling pathway [GO:0070495]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta production [GO:0071635]; neuron differentiation [GO:0030182]; neuron migration [GO:0001764]; pancreas development [GO:0031016]; placenta development [GO:0001890]; positive chemotaxis [GO:0050918]; positive regulation of D-glucose transmembrane transport [GO:0010828]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of DNA replication [GO:0045740]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of gene expression [GO:0010628]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of microtubule polymerization [GO:0031116]; positive regulation of mitotic nuclear division [GO:0045840]; positive regulation of neuron projection development [GO:0010976]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of transcription by RNA polymerase II [GO:0045944]; reactive oxygen species metabolic process [GO:0072593]; regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling [GO:0060665]; regulation of cellular response to oxidative stress [GO:1900407]; regulation of interleukin-6 production [GO:0032675]; semaphorin-plexin signaling pathway [GO:0071526]; skeletal muscle tissue development [GO:0007519] basal plasma membrane [GO:0009925]; dendrite [GO:0030425]; excitatory synapse [GO:0060076]; extracellular space [GO:0005615]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; receptor complex [GO:0043235]; sperm flagellum [GO:0036126] ATP binding [GO:0005524]; beta-catenin binding [GO:0008013]; hepatocyte growth factor receptor activity [GO:0005008]; identical protein binding [GO:0042802]; molecular function activator activity [GO:0140677]; phosphatidylinositol 3-kinase binding [GO:0043548]; phospholipase binding [GO:0043274]; protein kinase activity [GO:0004672]; protein phosphatase binding [GO:0019903]; protein tyrosine kinase activity [GO:0004713]; protein-containing complex binding [GO:0044877]; semaphorin receptor activity [GO:0017154] g21264.t1 Q9Y222 47.416 445 8.270000000000001e-129 402.0 sp|Q9Y222|DMTF1_HUMAN Cyclin-D-binding Myb-like transcription factor 1 OS=Homo sapiens OX=9606 GN=DMTF1 PE=1 SV=1 g21271.t1 Q8BW94 66.234 770 0.0 1003.0 sp|Q8BW94|DYH3_MOUSE Dynein axonemal heavy chain 3 OS=Mus musculus OX=10090 GN=Dnah3 PE=1 SV=2 g21271.t1 Q8BW94 65.043 575 0.0 790.0 sp|Q8BW94|DYH3_MOUSE Dynein axonemal heavy chain 3 OS=Mus musculus OX=10090 GN=Dnah3 PE=1 SV=2 g21271.t2 Q8BW94 64.803 787 0.0 993.0 sp|Q8BW94|DYH3_MOUSE Dynein axonemal heavy chain 3 OS=Mus musculus OX=10090 GN=Dnah3 PE=1 SV=2 g21271.t2 Q8BW94 65.043 575 0.0 790.0 sp|Q8BW94|DYH3_MOUSE Dynein axonemal heavy chain 3 OS=Mus musculus OX=10090 GN=Dnah3 PE=1 SV=2 g21272.t1 Q8TD57 63.746 1324 0.0 1773.0 sp|Q8TD57|DYH3_HUMAN Dynein axonemal heavy chain 3 OS=Homo sapiens OX=9606 GN=DNAH3 PE=1 SV=1 DYH3_HUMAN reviewed Dynein axonemal heavy chain 3 (Axonemal beta dynein heavy chain 3) (HsADHC3) (Ciliary dynein heavy chain 3) (Dnahc3-b) Homo sapiens (Human) GO:0003777; GO:0005524; GO:0005858; GO:0005874; GO:0008569; GO:0036156; GO:0036159; GO:0045505; GO:0051959; GO:0060285; GO:0060294; GO:0097729 cilium movement involved in cell motility [GO:0060294]; cilium-dependent cell motility [GO:0060285]; inner dynein arm assembly [GO:0036159] 9+2 motile cilium [GO:0097729]; axonemal dynein complex [GO:0005858]; inner dynein arm [GO:0036156]; microtubule [GO:0005874] ATP binding [GO:0005524]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]; minus-end-directed microtubule motor activity [GO:0008569] g21273.t1 Q8BW94 37.96 1196 0.0 738.0 sp|Q8BW94|DYH3_MOUSE Dynein axonemal heavy chain 3 OS=Mus musculus OX=10090 GN=Dnah3 PE=1 SV=2 g21280.t1 P78329 37.652 494 3.92e-103 320.0 sp|P78329|CP4F2_HUMAN Cytochrome P450 4F2 OS=Homo sapiens OX=9606 GN=CYP4F2 PE=1 SV=1 CP4F2_HUMAN reviewed Cytochrome P450 4F2 (EC 1.14.14.1) (20-hydroxyeicosatetraenoic acid synthase) (20-HETE synthase) (Arachidonic acid omega-hydroxylase) (CYPIVF2) (Cytochrome P450-LTB-omega) (Docosahexaenoic acid omega-hydroxylase) (EC 1.14.14.79) (Leukotriene-B(4) 20-monooxygenase 1) (Leukotriene-B(4) omega-hydroxylase 1) (EC 1.14.14.94) (Phylloquinone omega-hydroxylase CYP4F2) (EC 1.14.14.78) Homo sapiens (Human) GO:0000038; GO:0001676; GO:0003091; GO:0003095; GO:0004497; GO:0005506; GO:0005737; GO:0005789; GO:0006690; GO:0006691; GO:0006805; GO:0007596; GO:0008217; GO:0008392; GO:0010430; GO:0016324; GO:0016709; GO:0018685; GO:0019369; GO:0019373; GO:0020037; GO:0032304; GO:0032305; GO:0036101; GO:0042360; GO:0042361; GO:0042376; GO:0042377; GO:0043231; GO:0050051; GO:0052869; GO:0052871; GO:0055078; GO:0097258; GO:0097259; GO:0097267; GO:0102033 arachidonate metabolic process [GO:0019369]; blood coagulation [GO:0007596]; epoxygenase P450 pathway [GO:0019373]; fatty acid omega-oxidation [GO:0010430]; icosanoid metabolic process [GO:0006690]; leukotriene B4 catabolic process [GO:0036101]; leukotriene metabolic process [GO:0006691]; long-chain fatty acid metabolic process [GO:0001676]; menaquinone catabolic process [GO:0042361]; negative regulation of icosanoid secretion [GO:0032304]; omega-hydroxylase P450 pathway [GO:0097267]; phylloquinone catabolic process [GO:0042376]; positive regulation of icosanoid secretion [GO:0032305]; pressure natriuresis [GO:0003095]; regulation of blood pressure [GO:0008217]; renal water homeostasis [GO:0003091]; sodium ion homeostasis [GO:0055078]; very long-chain fatty acid metabolic process [GO:0000038]; vitamin E metabolic process [GO:0042360]; vitamin K catabolic process [GO:0042377]; xenobiotic metabolic process [GO:0006805] apical plasma membrane [GO:0016324]; cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231] 20-aldehyde-leukotriene B4 20-monooxygenase activity [GO:0097259]; 20-hydroxy-leukotriene B4 omega oxidase activity [GO:0097258]; alkane 1-monooxygenase activity [GO:0018685]; alpha-tocopherol omega-hydroxylase activity [GO:0052871]; arachidonate epoxygenase activity [GO:0008392]; arachidonate omega-hydroxylase activity [GO:0052869]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; leukotriene-B4 20-monooxygenase activity [GO:0050051]; long-chain fatty acid omega-hydroxylase activity [GO:0102033]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen [GO:0016709] g21280.t2 Q64462 33.209 536 8.42e-84 272.0 sp|Q64462|CP4B1_MOUSE Cytochrome P450 4B1 OS=Mus musculus OX=10090 GN=Cyp4b1 PE=1 SV=1 g21286.t1 Q6NT55 41.071 392 2.62e-105 323.0 sp|Q6NT55|CP4FN_HUMAN Ultra-long-chain fatty acid omega-hydroxylase OS=Homo sapiens OX=9606 GN=CYP4F22 PE=1 SV=1 CP4FN_HUMAN reviewed Ultra-long-chain fatty acid omega-hydroxylase (EC 1.14.14.177) (Cytochrome P450 4F22) Homo sapiens (Human) GO:0004497; GO:0005506; GO:0005789; GO:0006690; GO:0016705; GO:0020037; GO:0046513 ceramide biosynthetic process [GO:0046513]; icosanoid metabolic process [GO:0006690] endoplasmic reticulum membrane [GO:0005789] heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705] g21287.t1 Q7Z3G6 75.379 264 1.3e-150 455.0 sp|Q7Z3G6|PRIC2_HUMAN Prickle-like protein 2 OS=Homo sapiens OX=9606 GN=PRICKLE2 PE=1 SV=2 PRIC2_HUMAN reviewed Prickle-like protein 2 Homo sapiens (Human) GO:0001825; GO:0005634; GO:0005737; GO:0008270; GO:0014069; GO:0030424; GO:0030425; GO:0031965; GO:0043194; GO:0060071; GO:0099612 blastocyst formation [GO:0001825]; protein localization to axon [GO:0099612]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071] axon [GO:0030424]; axon initial segment [GO:0043194]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; postsynaptic density [GO:0014069] zinc ion binding [GO:0008270] g21291.t1 Q5RDH2 43.82 178 1.87e-34 134.0 sp|Q5RDH2|CT2NL_PONAB CTTNBP2 N-terminal-like protein OS=Pongo abelii OX=9601 GN=CTTNBP2NL PE=2 SV=1 g21292.t1 Q07DW4 35.741 263 3.65e-36 151.0 sp|Q07DW4|CTTB2_MUNRE Cortactin-binding protein 2 OS=Muntiacus reevesi OX=9886 GN=CTTNBP2 PE=3 SV=1 g21293.t1 Q2IBB2 31.45 407 5.03e-65 235.0 sp|Q2IBB2|CTTB2_RHIFE Cortactin-binding protein 2 OS=Rhinolophus ferrumequinum OX=59479 GN=CTTNBP2 PE=3 SV=1 g21294.t1 G5E8P0 36.916 856 6.46e-158 533.0 sp|G5E8P0|GCP6_MOUSE Gamma-tubulin complex component 6 OS=Mus musculus OX=10090 GN=Tubgcp6 PE=1 SV=1 g21294.t1 G5E8P0 51.654 393 3.54e-122 429.0 sp|G5E8P0|GCP6_MOUSE Gamma-tubulin complex component 6 OS=Mus musculus OX=10090 GN=Tubgcp6 PE=1 SV=1 g21295.t1 P10079 44.733 693 1.66e-175 575.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g21295.t1 P10079 40.489 573 2.97e-124 426.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g21295.t1 P10079 42.626 495 4.6e-112 389.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g21295.t1 P10079 42.623 427 7.579999999999999e-95 338.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g21295.t1 P10079 41.0 500 6.43e-87 314.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g21295.t2 P10079 44.733 693 1.66e-175 575.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g21295.t2 P10079 40.489 573 2.9800000000000004e-124 426.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g21295.t2 P10079 42.626 495 4.63e-112 389.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g21295.t2 P10079 42.623 427 7.62e-95 338.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g21295.t2 P10079 41.0 500 6.46e-87 314.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g21295.t3 P10079 38.837 860 4.52e-174 572.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g21295.t3 P10079 43.073 729 9.500000000000001e-167 550.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g21295.t3 P10079 41.0 500 4.83e-87 314.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g21295.t3 P10079 38.113 265 1.47e-37 159.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g21295.t3 P10079 46.018 113 8.980000000000001e-35 108.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g21295.t3 P10079 49.254 67 8.980000000000001e-35 64.3 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g21296.t1 P23249 50.0 516 5.6600000000000004e-167 500.0 sp|P23249|MOV10_MOUSE Putative helicase MOV-10 OS=Mus musculus OX=10090 GN=Mov10 PE=1 SV=2 MOV10_MOUSE reviewed Putative helicase MOV-10 (EC 3.6.4.13) (Moloney leukemia virus 10 protein) Mus musculus (Mouse) GO:0000932; GO:0003723; GO:0005524; GO:0005634; GO:0005829; GO:0010494; GO:0010526; GO:0016887; GO:0032574; GO:0035194; GO:0035195; GO:0035279; GO:0036464; GO:0043186; GO:0051607; GO:0061014; GO:0061158; GO:0141008; GO:0150011 3'-UTR-mediated mRNA destabilization [GO:0061158]; defense response to virus [GO:0051607]; miRNA-mediated gene silencing by mRNA destabilization [GO:0035279]; miRNA-mediated post-transcriptional gene silencing [GO:0035195]; positive regulation of mRNA catabolic process [GO:0061014]; regulation of neuron projection arborization [GO:0150011]; regulatory ncRNA-mediated post-transcriptional gene silencing [GO:0035194]; transposable element silencing [GO:0010526]; transposable element silencing by mRNA destabilization [GO:0141008] cytoplasmic ribonucleoprotein granule [GO:0036464]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; nucleus [GO:0005634]; P granule [GO:0043186]; P-body [GO:0000932] 5'-3' RNA helicase activity [GO:0032574]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; RNA binding [GO:0003723] g21297.t1 Q5ZKD7 28.381 451 5.27e-43 166.0 sp|Q5ZKD7|MOV10_CHICK Putative helicase MOV-10 OS=Gallus gallus OX=9031 GN=MOV10 PE=2 SV=1 MOV10_CHICK reviewed Putative helicase MOV-10 (EC 3.6.4.13) Gallus gallus (Chicken) GO:0000932; GO:0003723; GO:0005524; GO:0005634; GO:0005829; GO:0010494; GO:0010526; GO:0016887; GO:0032574; GO:0035194; GO:0035195; GO:0035279; GO:0036464; GO:0043186; GO:0061014; GO:0061158; GO:0150011 3'-UTR-mediated mRNA destabilization [GO:0061158]; miRNA-mediated gene silencing by mRNA destabilization [GO:0035279]; miRNA-mediated post-transcriptional gene silencing [GO:0035195]; positive regulation of mRNA catabolic process [GO:0061014]; regulation of neuron projection arborization [GO:0150011]; regulatory ncRNA-mediated post-transcriptional gene silencing [GO:0035194]; transposable element silencing [GO:0010526] cytoplasmic ribonucleoprotein granule [GO:0036464]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; nucleus [GO:0005634]; P granule [GO:0043186]; P-body [GO:0000932] 5'-3' RNA helicase activity [GO:0032574]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; RNA binding [GO:0003723] g21298.t1 E7F7V7 32.66 297 1.43e-21 97.1 sp|E7F7V7|GAL2B_DANRE Galanin receptor 2b OS=Danio rerio OX=7955 GN=galr2b PE=2 SV=1 g21299.t1 P23978 47.128 592 0.0 529.0 sp|P23978|SC6A1_RAT Sodium- and chloride-dependent GABA transporter 1 OS=Rattus norvegicus OX=10116 GN=Slc6a1 PE=1 SV=1 SC6A1_RAT reviewed Sodium- and chloride-dependent GABA transporter 1 (GAT-1) (Solute carrier family 6 member 1) Rattus norvegicus (Rat) GO:0005283; GO:0005332; GO:0005886; GO:0006865; GO:0007612; GO:0007613; GO:0008306; GO:0009410; GO:0009636; GO:0009744; GO:0009986; GO:0010288; GO:0014054; GO:0014074; GO:0015185; GO:0015378; GO:0030424; GO:0032229; GO:0032355; GO:0035725; GO:0042220; GO:0042734; GO:0042802; GO:0043025; GO:0045211; GO:0046872; GO:0050808; GO:0051592; GO:0051939; GO:0098658; GO:0098719; GO:0098810; GO:0098982; GO:1902476; GO:1904313 amino acid transport [GO:0006865]; associative learning [GO:0008306]; chloride transmembrane transport [GO:1902476]; gamma-aminobutyric acid import [GO:0051939]; inorganic anion import across plasma membrane [GO:0098658]; learning [GO:0007612]; memory [GO:0007613]; negative regulation of synaptic transmission, GABAergic [GO:0032229]; neurotransmitter reuptake [GO:0098810]; positive regulation of gamma-aminobutyric acid secretion [GO:0014054]; response to calcium ion [GO:0051592]; response to cocaine [GO:0042220]; response to estradiol [GO:0032355]; response to lead ion [GO:0010288]; response to methamphetamine hydrochloride [GO:1904313]; response to purine-containing compound [GO:0014074]; response to sucrose [GO:0009744]; response to toxic substance [GO:0009636]; response to xenobiotic stimulus [GO:0009410]; sodium ion import across plasma membrane [GO:0098719]; sodium ion transmembrane transport [GO:0035725]; synapse organization [GO:0050808] axon [GO:0030424]; cell surface [GO:0009986]; GABA-ergic synapse [GO:0098982]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734] amino acid:sodium symporter activity [GO:0005283]; gamma-aminobutyric acid transmembrane transporter activity [GO:0015185]; gamma-aminobutyric acid:sodium:chloride symporter activity [GO:0005332]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; sodium:chloride symporter activity [GO:0015378] g21300.t1 P30531 47.16 581 1.05e-175 517.0 sp|P30531|SC6A1_HUMAN Sodium- and chloride-dependent GABA transporter 1 OS=Homo sapiens OX=9606 GN=SLC6A1 PE=1 SV=2 SC6A1_HUMAN reviewed Sodium- and chloride-dependent GABA transporter 1 (GAT-1) (Solute carrier family 6 member 1) Homo sapiens (Human) GO:0005332; GO:0005886; GO:0006865; GO:0007268; GO:0007613; GO:0008306; GO:0009986; GO:0015185; GO:0015378; GO:0016020; GO:0030424; GO:0035725; GO:0043025; GO:0046872; GO:0050808; GO:0051936; GO:0051939; GO:0098658; GO:0098719; GO:0098793; GO:0098982; GO:0150104; GO:1902476 amino acid transport [GO:0006865]; associative learning [GO:0008306]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; gamma-aminobutyric acid import [GO:0051939]; gamma-aminobutyric acid reuptake [GO:0051936]; inorganic anion import across plasma membrane [GO:0098658]; memory [GO:0007613]; sodium ion import across plasma membrane [GO:0098719]; sodium ion transmembrane transport [GO:0035725]; synapse organization [GO:0050808]; transport across blood-brain barrier [GO:0150104] axon [GO:0030424]; cell surface [GO:0009986]; GABA-ergic synapse [GO:0098982]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; presynapse [GO:0098793] gamma-aminobutyric acid transmembrane transporter activity [GO:0015185]; gamma-aminobutyric acid:sodium:chloride symporter activity [GO:0005332]; metal ion binding [GO:0046872]; sodium:chloride symporter activity [GO:0015378] g21304.t1 E7F7V7 32.997 297 2.7400000000000004e-21 96.3 sp|E7F7V7|GAL2B_DANRE Galanin receptor 2b OS=Danio rerio OX=7955 GN=galr2b PE=2 SV=1 g21307.t1 E7F7V7 32.075 318 1.2800000000000001e-21 97.8 sp|E7F7V7|GAL2B_DANRE Galanin receptor 2b OS=Danio rerio OX=7955 GN=galr2b PE=2 SV=1 g21308.t1 P62321 88.0 75 7.46e-44 139.0 sp|P62321|RUXF_XENLA Small nuclear ribonucleoprotein F OS=Xenopus laevis OX=8355 GN=snrpf PE=3 SV=1 g21309.t1 Q9R0X0 50.495 202 5.84e-75 228.0 sp|Q9R0X0|MED20_MOUSE Mediator of RNA polymerase II transcription subunit 20 OS=Mus musculus OX=10090 GN=Med20 PE=1 SV=1 MED20_MOUSE reviewed Mediator of RNA polymerase II transcription subunit 20 (Mediator complex subunit 20) (TRF-proximal protein homolog) Mus musculus (Mouse) GO:0000151; GO:0003713; GO:0005634; GO:0005654; GO:0006357; GO:0016567; GO:0016592; GO:0032968; GO:0035914; GO:0051123; GO:0060261; GO:0070847 positive regulation of transcription elongation by RNA polymerase II [GO:0032968]; positive regulation of transcription initiation by RNA polymerase II [GO:0060261]; protein ubiquitination [GO:0016567]; regulation of transcription by RNA polymerase II [GO:0006357]; RNA polymerase II preinitiation complex assembly [GO:0051123]; skeletal muscle cell differentiation [GO:0035914] core mediator complex [GO:0070847]; mediator complex [GO:0016592]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151] transcription coactivator activity [GO:0003713] g21311.t1 Q8ND61 37.572 173 4.57e-25 114.0 sp|Q8ND61|CC020_HUMAN Uncharacterized protein C3orf20 OS=Homo sapiens OX=9606 GN=C3orf20 PE=1 SV=2 g21312.t1 Q5XI52 27.576 660 8.31e-31 133.0 sp|Q5XI52|VEZA_RAT Vezatin OS=Rattus norvegicus OX=10116 GN=Vezt PE=2 SV=1 VEZA_RAT reviewed Vezatin Rattus norvegicus (Rat) GO:0001669; GO:0002142; GO:0005634; GO:0005654; GO:0005829; GO:0005886; GO:0005912; GO:0017022; GO:0043009; GO:0060074; GO:0060171; GO:0098609; GO:0098794; GO:0098978 cell-cell adhesion [GO:0098609]; chordate embryonic development [GO:0043009]; synapse maturation [GO:0060074] acrosomal vesicle [GO:0001669]; adherens junction [GO:0005912]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; stereocilia ankle link complex [GO:0002142]; stereocilium membrane [GO:0060171] myosin binding [GO:0017022] g21313.t1 Q32KI9 44.685 508 3.1e-137 411.0 sp|Q32KI9|ARSI_MOUSE Arylsulfatase I OS=Mus musculus OX=10090 GN=Arsi PE=2 SV=1 g21319.t1 Q99LW6 59.459 111 3.04e-26 107.0 sp|Q99LW6|YAF2_MOUSE YY1-associated factor 2 OS=Mus musculus OX=10090 GN=Yaf2 PE=1 SV=1 g21320.t1 Q8R3A2 50.485 103 4.54e-33 114.0 sp|Q8R3A2|CDPF1_MOUSE Cysteine-rich DPF motif domain-containing protein 1 OS=Mus musculus OX=10090 GN=Cdpf1 PE=3 SV=2 g21325.t1 Q9DBB9 29.718 461 7.74e-37 147.0 sp|Q9DBB9|CPN2_MOUSE Carboxypeptidase N subunit 2 OS=Mus musculus OX=10090 GN=Cpn2 PE=1 SV=2 g21327.t1 Q96SD1 50.765 392 2.9e-122 380.0 sp|Q96SD1|DCR1C_HUMAN Protein artemis OS=Homo sapiens OX=9606 GN=DCLRE1C PE=1 SV=2 g21333.t1 Q9Z1J2 74.532 267 3.3800000000000002e-143 440.0 sp|Q9Z1J2|NEK4_MOUSE Serine/threonine-protein kinase Nek4 OS=Mus musculus OX=10090 GN=Nek4 PE=1 SV=1 g21333.t2 Q9Z1J2 74.532 267 4.33e-143 440.0 sp|Q9Z1J2|NEK4_MOUSE Serine/threonine-protein kinase Nek4 OS=Mus musculus OX=10090 GN=Nek4 PE=1 SV=1 g21334.t1 Q8CFG5 41.188 1061 0.0 809.0 sp|Q8CFG5|CA2D3_RAT Voltage-dependent calcium channel subunit alpha-2/delta-3 OS=Rattus norvegicus OX=10116 GN=Cacna2d3 PE=1 SV=1 CA2D3_RAT reviewed Voltage-dependent calcium channel subunit alpha-2/delta-3 (Voltage-gated calcium channel subunit alpha-2/delta-3) [Cleaved into: Voltage-dependent calcium channel subunit alpha-2-3; Voltage-dependent calcium channel subunit delta-3] Rattus norvegicus (Rat) GO:0005245; GO:0005246; GO:0005891; GO:0006816; GO:0046872; GO:0048787; GO:0098982; GO:0099174; GO:1990314 calcium ion transport [GO:0006816]; cellular response to insulin-like growth factor stimulus [GO:1990314]; regulation of presynapse organization [GO:0099174] GABA-ergic synapse [GO:0098982]; presynaptic active zone membrane [GO:0048787]; voltage-gated calcium channel complex [GO:0005891] calcium channel regulator activity [GO:0005246]; metal ion binding [GO:0046872]; voltage-gated calcium channel activity [GO:0005245] g21334.t2 Q8CFG5 46.87 687 0.0 630.0 sp|Q8CFG5|CA2D3_RAT Voltage-dependent calcium channel subunit alpha-2/delta-3 OS=Rattus norvegicus OX=10116 GN=Cacna2d3 PE=1 SV=1 CA2D3_RAT reviewed Voltage-dependent calcium channel subunit alpha-2/delta-3 (Voltage-gated calcium channel subunit alpha-2/delta-3) [Cleaved into: Voltage-dependent calcium channel subunit alpha-2-3; Voltage-dependent calcium channel subunit delta-3] Rattus norvegicus (Rat) GO:0005245; GO:0005246; GO:0005891; GO:0006816; GO:0046872; GO:0048787; GO:0098982; GO:0099174; GO:1990314 calcium ion transport [GO:0006816]; cellular response to insulin-like growth factor stimulus [GO:1990314]; regulation of presynapse organization [GO:0099174] GABA-ergic synapse [GO:0098982]; presynaptic active zone membrane [GO:0048787]; voltage-gated calcium channel complex [GO:0005891] calcium channel regulator activity [GO:0005246]; metal ion binding [GO:0046872]; voltage-gated calcium channel activity [GO:0005245] g21334.t2 Q8CFG5 31.806 371 5.89e-49 194.0 sp|Q8CFG5|CA2D3_RAT Voltage-dependent calcium channel subunit alpha-2/delta-3 OS=Rattus norvegicus OX=10116 GN=Cacna2d3 PE=1 SV=1 CA2D3_RAT reviewed Voltage-dependent calcium channel subunit alpha-2/delta-3 (Voltage-gated calcium channel subunit alpha-2/delta-3) [Cleaved into: Voltage-dependent calcium channel subunit alpha-2-3; Voltage-dependent calcium channel subunit delta-3] Rattus norvegicus (Rat) GO:0005245; GO:0005246; GO:0005891; GO:0006816; GO:0046872; GO:0048787; GO:0098982; GO:0099174; GO:1990314 calcium ion transport [GO:0006816]; cellular response to insulin-like growth factor stimulus [GO:1990314]; regulation of presynapse organization [GO:0099174] GABA-ergic synapse [GO:0098982]; presynaptic active zone membrane [GO:0048787]; voltage-gated calcium channel complex [GO:0005891] calcium channel regulator activity [GO:0005246]; metal ion binding [GO:0046872]; voltage-gated calcium channel activity [GO:0005245] g21336.t1 Q6DDT4 48.263 547 2.21e-158 465.0 sp|Q6DDT4|APEX2_XENLA DNA-(apurinic or apyrimidinic site) endonuclease 2 OS=Xenopus laevis OX=8355 GN=apex2.L PE=1 SV=1 APEX2_XENLA reviewed DNA-(apurinic or apyrimidinic site) endonuclease 2 (EC 3.1.11.2) Xenopus laevis (African clawed frog) GO:0003677; GO:0003906; GO:0005634; GO:0005694; GO:0005739; GO:0006284; GO:0008081; GO:0008270; GO:0008311 base-excision repair [GO:0006284] chromosome [GO:0005694]; mitochondrion [GO:0005739]; nucleus [GO:0005634] DNA binding [GO:0003677]; DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0003906]; double-stranded DNA 3'-5' DNA exonuclease activity [GO:0008311]; phosphoric diester hydrolase activity [GO:0008081]; zinc ion binding [GO:0008270] g21337.t1 P19221 41.502 253 6.76e-55 199.0 sp|P19221|THRB_MOUSE Prothrombin OS=Mus musculus OX=10090 GN=F2 PE=1 SV=1 THRB_MOUSE reviewed Prothrombin (EC 3.4.21.5) (Coagulation factor II) [Cleaved into: Activation peptide fragment 1; Activation peptide fragment 2; Thrombin light chain; Thrombin heavy chain] Mus musculus (Mouse) GO:0001530; GO:0004175; GO:0004252; GO:0005102; GO:0005509; GO:0005615; GO:0006508; GO:0006953; GO:0007166; GO:0007186; GO:0008201; GO:0008233; GO:0008284; GO:0008360; GO:0009611; GO:0009897; GO:0010468; GO:0030168; GO:0030194; GO:0030195; GO:0030307; GO:0031012; GO:0032967; GO:0042730; GO:0045861; GO:0048018; GO:0048712; GO:0051281; GO:0051480; GO:0051838; GO:0051897; GO:0061844; GO:0070053; GO:0070493; GO:0070945; GO:1900016; GO:1900182; GO:1900738; GO:2000379 acute-phase response [GO:0006953]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; cell surface receptor signaling pathway [GO:0007166]; cytolysis by host of symbiont cells [GO:0051838]; fibrinolysis [GO:0042730]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of astrocyte differentiation [GO:0048712]; negative regulation of blood coagulation [GO:0030195]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of proteolysis [GO:0045861]; neutrophil-mediated killing of gram-negative bacterium [GO:0070945]; platelet activation [GO:0030168]; positive regulation of blood coagulation [GO:0030194]; positive regulation of cell growth [GO:0030307]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of collagen biosynthetic process [GO:0032967]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of phospholipase C-activating G protein-coupled receptor signaling pathway [GO:1900738]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; proteolysis [GO:0006508]; regulation of cell shape [GO:0008360]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of gene expression [GO:0010468]; response to wounding [GO:0009611]; thrombin-activated receptor signaling pathway [GO:0070493] external side of plasma membrane [GO:0009897]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615] calcium ion binding [GO:0005509]; endopeptidase activity [GO:0004175]; heparin binding [GO:0008201]; lipopolysaccharide binding [GO:0001530]; peptidase activity [GO:0008233]; receptor ligand activity [GO:0048018]; serine-type endopeptidase activity [GO:0004252]; signaling receptor binding [GO:0005102]; thrombospondin receptor activity [GO:0070053] g21344.t1 Q7RTX9 31.602 231 1.0400000000000001e-31 128.0 sp|Q7RTX9|MOT14_HUMAN Monocarboxylate transporter 14 OS=Homo sapiens OX=9606 GN=SLC16A14 PE=1 SV=1 g21346.t1 Q5PQN4 27.429 638 1.38e-35 148.0 sp|Q5PQN4|MDM1_RAT Nuclear protein MDM1 OS=Rattus norvegicus OX=10116 GN=Mdm1 PE=1 SV=2 MDM1_RAT reviewed Nuclear protein MDM1 Rattus norvegicus (Rat) GO:0005634; GO:0005813; GO:0005814; GO:0005829; GO:0005874; GO:0008017; GO:0034451; GO:0046600; GO:0060041; GO:0097730 negative regulation of centriole replication [GO:0046600]; retina development in camera-type eye [GO:0060041] centriolar satellite [GO:0034451]; centriole [GO:0005814]; centrosome [GO:0005813]; cytosol [GO:0005829]; microtubule [GO:0005874]; non-motile cilium [GO:0097730]; nucleus [GO:0005634] microtubule binding [GO:0008017] g21347.t1 Q1JQ66 67.559 299 2.81e-128 375.0 sp|Q1JQ66|S35E3_DANRE Solute carrier family 35 member E3 OS=Danio rerio OX=7955 GN=slc35e3 PE=2 SV=1 g21349.t1 Q2PG37 46.526 331 4.2e-97 295.0 sp|Q2PG37|CD123_MACFA Translation initiation factor eIF2 assembly protein OS=Macaca fascicularis OX=9541 GN=CDC123 PE=2 SV=1 g21350.t1 Q28C33 52.862 594 0.0 599.0 sp|Q28C33|TBC30_XENTR TBC1 domain family member 30 OS=Xenopus tropicalis OX=8364 GN=tbc1d30 PE=2 SV=1 g21351.t1 P53634 51.481 439 1.9e-159 460.0 sp|P53634|CATC_HUMAN Dipeptidyl peptidase 1 OS=Homo sapiens OX=9606 GN=CTSC PE=1 SV=2 CATC_HUMAN reviewed Dipeptidyl peptidase 1 (EC 3.4.14.1) (Cathepsin C) (Cathepsin J) (Dipeptidyl peptidase I) (DPP-I) (DPPI) (Dipeptidyl transferase) [Cleaved into: Dipeptidyl peptidase 1 exclusion domain chain (Dipeptidyl peptidase I exclusion domain chain); Dipeptidyl peptidase 1 heavy chain (Dipeptidyl peptidase I heavy chain); Dipeptidyl peptidase 1 light chain (Dipeptidyl peptidase I light chain)] Homo sapiens (Human) GO:0001913; GO:0004197; GO:0004252; GO:0005576; GO:0005615; GO:0005654; GO:0005764; GO:0005788; GO:0005813; GO:0006508; GO:0006955; GO:0008234; GO:0008239; GO:0016020; GO:0016505; GO:0019902; GO:0030134; GO:0031012; GO:0031404; GO:0031642; GO:0033116; GO:0035578; GO:0042802; GO:0051087; GO:0051603; GO:0070062; GO:1903052; GO:1903980; GO:2001235 immune response [GO:0006955]; negative regulation of myelination [GO:0031642]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of microglial cell activation [GO:1903980]; positive regulation of proteolysis involved in protein catabolic process [GO:1903052]; proteolysis [GO:0006508]; proteolysis involved in protein catabolic process [GO:0051603]; T cell mediated cytotoxicity [GO:0001913] azurophil granule lumen [GO:0035578]; centrosome [GO:0005813]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; lysosome [GO:0005764]; membrane [GO:0016020]; nucleoplasm [GO:0005654] chloride ion binding [GO:0031404]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]; dipeptidyl-peptidase activity [GO:0008239]; identical protein binding [GO:0042802]; peptidase activator activity involved in apoptotic process [GO:0016505]; phosphatase binding [GO:0019902]; protein-folding chaperone binding [GO:0051087]; serine-type endopeptidase activity [GO:0004252] g21353.t1 Q9Y6I9 47.305 167 2.4099999999999998e-46 160.0 sp|Q9Y6I9|TX264_HUMAN Testis-expressed protein 264 OS=Homo sapiens OX=9606 GN=TEX264 PE=1 SV=1 TX264_HUMAN reviewed Testis-expressed protein 264 (Putative secreted protein Zsig11) Homo sapiens (Human) GO:0000421; GO:0005576; GO:0005634; GO:0005657; GO:0005783; GO:0005789; GO:0005829; GO:0031093; GO:0038023; GO:0061709; GO:0106300 protein-DNA covalent cross-linking repair [GO:0106300]; reticulophagy [GO:0061709] autophagosome membrane [GO:0000421]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; nucleus [GO:0005634]; platelet alpha granule lumen [GO:0031093]; replication fork [GO:0005657] signaling receptor activity [GO:0038023] g21359.t1 Q2HJC9 43.062 209 1.06e-39 140.0 sp|Q2HJC9|PQBP1_BOVIN Polyglutamine-binding protein 1 OS=Bos taurus OX=9913 GN=PQBP1 PE=2 SV=1 PQBP1_BOVIN reviewed Polyglutamine-binding protein 1 (PQBP-1) (Polyglutamine tract-binding protein 1) Bos taurus (Bovine) GO:0000380; GO:0002218; GO:0002230; GO:0003690; GO:0005737; GO:0016604; GO:0016607; GO:0031175; GO:0032481; GO:0043021; GO:0045087; GO:0051607; GO:0071360; GO:0120025 activation of innate immune response [GO:0002218]; alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to exogenous dsRNA [GO:0071360]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; neuron projection development [GO:0031175]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of type I interferon production [GO:0032481] cytoplasm [GO:0005737]; nuclear body [GO:0016604]; nuclear speck [GO:0016607]; plasma membrane bounded cell projection [GO:0120025] double-stranded DNA binding [GO:0003690]; ribonucleoprotein complex binding [GO:0043021] g21360.t1 Q26619 73.854 371 0.0 510.0 sp|Q26619|KAPR_STRPU cAMP-dependent protein kinase type II regulatory subunit OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g21360.t2 Q26619 69.018 397 3.4599999999999996e-176 498.0 sp|Q26619|KAPR_STRPU cAMP-dependent protein kinase type II regulatory subunit OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g21364.t1 Q96N23 32.192 1227 1.7500000000000002e-144 501.0 sp|Q96N23|CFA54_HUMAN Cilia- and flagella-associated protein 54 OS=Homo sapiens OX=9606 GN=CFAP54 PE=1 SV=3 g21364.t2 Q96N23 32.498 2874 0.0 1328.0 sp|Q96N23|CFA54_HUMAN Cilia- and flagella-associated protein 54 OS=Homo sapiens OX=9606 GN=CFAP54 PE=1 SV=3 g21364.t3 Q96N23 33.586 1581 0.0 851.0 sp|Q96N23|CFA54_HUMAN Cilia- and flagella-associated protein 54 OS=Homo sapiens OX=9606 GN=CFAP54 PE=1 SV=3 g21364.t4 Q96N23 32.859 1616 0.0 832.0 sp|Q96N23|CFA54_HUMAN Cilia- and flagella-associated protein 54 OS=Homo sapiens OX=9606 GN=CFAP54 PE=1 SV=3 g21365.t1 Q6NRW2 31.976 491 5.0200000000000004e-58 209.0 sp|Q6NRW2|SPDLB_XENLA Protein Spindly-B OS=Xenopus laevis OX=8355 GN=spdl1-b PE=2 SV=1 SPDLB_XENLA reviewed Protein Spindly-B (Coiled-coil domain-containing protein 99-B) (Spindle apparatus coiled-coil domain-containing protein 1-B) Xenopus laevis (African clawed frog) GO:0000132; GO:0000922; GO:0000940; GO:0005634; GO:0007080; GO:0007094; GO:0034501; GO:0043515; GO:0051301 cell division [GO:0051301]; establishment of mitotic spindle orientation [GO:0000132]; mitotic metaphase chromosome alignment [GO:0007080]; mitotic spindle assembly checkpoint signaling [GO:0007094]; protein localization to kinetochore [GO:0034501] nucleus [GO:0005634]; outer kinetochore [GO:0000940]; spindle pole [GO:0000922] kinetochore binding [GO:0043515] g21366.t1 A4GTP4 72.277 101 3.7e-43 160.0 sp|A4GTP4|ELK1_RAT ETS domain-containing protein Elk-1 OS=Rattus norvegicus OX=10116 GN=Elk1 PE=1 SV=1 ELK1_RAT reviewed ETS domain-containing protein Elk-1 Rattus norvegicus (Rat) GO:0000976; GO:0000978; GO:0000981; GO:0001228; GO:0001889; GO:0003682; GO:0003690; GO:0003700; GO:0005634; GO:0005654; GO:0006355; GO:0006357; GO:0009416; GO:0010467; GO:0030154; GO:0030324; GO:0030425; GO:0031966; GO:0036033; GO:0043025; GO:0043679; GO:0045471; GO:0045893; GO:0045944; GO:0061629; GO:0071394; GO:0071396; GO:0071480; GO:0071774; GO:0110088; GO:0140416; GO:0140537; GO:1990837 cell differentiation [GO:0030154]; cellular response to gamma radiation [GO:0071480]; cellular response to lipid [GO:0071396]; cellular response to testosterone stimulus [GO:0071394]; gene expression [GO:0010467]; hippocampal neuron apoptotic process [GO:0110088]; liver development [GO:0001889]; lung development [GO:0030324]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA-templated transcription [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; response to ethanol [GO:0045471]; response to fibroblast growth factor [GO:0071774]; response to light stimulus [GO:0009416] axon terminus [GO:0043679]; dendrite [GO:0030425]; mitochondrial membrane [GO:0031966]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; double-stranded DNA binding [GO:0003690]; mediator complex binding [GO:0036033]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]; transcription regulator activator activity [GO:0140537]; transcription regulator inhibitor activity [GO:0140416] g21367.t1 Q1L8I0 31.24 605 4.2999999999999996e-67 236.0 sp|Q1L8I0|PUS7L_DANRE Pseudouridylate synthase PUS7L OS=Danio rerio OX=7955 GN=pus7l PE=2 SV=1 g21368.t1 Q6P7G6 82.353 68 1.86e-36 120.0 sp|Q6P7G6|BRK1A_XENLA Probable protein BRICK1-A OS=Xenopus laevis OX=8355 GN=brk1-a PE=3 SV=1 g21371.t1 Q5EAW4 37.647 680 3.53e-105 350.0 sp|Q5EAW4|MCM10_XENLA Protein MCM10 homolog OS=Xenopus laevis OX=8355 GN=mcm10 PE=1 SV=2 MCM10_XENLA reviewed Protein MCM10 homolog Xenopus laevis (African clawed frog) GO:0003688; GO:0003697; GO:0005634; GO:0006270; GO:0006974; GO:0008270; GO:0043596 DNA damage response [GO:0006974]; DNA replication initiation [GO:0006270] nuclear replication fork [GO:0043596]; nucleus [GO:0005634] DNA replication origin binding [GO:0003688]; single-stranded DNA binding [GO:0003697]; zinc ion binding [GO:0008270] g21372.t1 Q9HAU5 64.08 451 0.0 649.0 sp|Q9HAU5|RENT2_HUMAN Regulator of nonsense transcripts 2 OS=Homo sapiens OX=9606 GN=UPF2 PE=1 SV=1 g21372.t1 Q9HAU5 49.471 378 1.7499999999999999e-115 389.0 sp|Q9HAU5|RENT2_HUMAN Regulator of nonsense transcripts 2 OS=Homo sapiens OX=9606 GN=UPF2 PE=1 SV=1 g21372.t2 Q9HAU5 64.08 451 0.0 649.0 sp|Q9HAU5|RENT2_HUMAN Regulator of nonsense transcripts 2 OS=Homo sapiens OX=9606 GN=UPF2 PE=1 SV=1 g21372.t2 Q9HAU5 49.471 378 3.2899999999999997e-113 389.0 sp|Q9HAU5|RENT2_HUMAN Regulator of nonsense transcripts 2 OS=Homo sapiens OX=9606 GN=UPF2 PE=1 SV=1 g21379.t1 A2AT37 42.424 165 4.3700000000000004e-27 109.0 sp|A2AT37|RENT2_MOUSE Regulator of nonsense transcripts 2 OS=Mus musculus OX=10090 GN=Upf2 PE=1 SV=1 RENT2_MOUSE reviewed Regulator of nonsense transcripts 2 (Up-frameshift suppressor 2 homolog) (Upf2) Mus musculus (Mouse) GO:0000184; GO:0001889; GO:0003723; GO:0005634; GO:0005737; GO:0005829; GO:0006986; GO:0031100; GO:0035145; GO:0036464; GO:0042162; GO:0048471 animal organ regeneration [GO:0031100]; liver development [GO:0001889]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; response to unfolded protein [GO:0006986] cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; exon-exon junction complex [GO:0035145]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471] RNA binding [GO:0003723]; telomeric DNA binding [GO:0042162] g21380.t1 Q6GL44 66.946 239 1.98e-114 353.0 sp|Q6GL44|OTUD5_XENTR OTU domain-containing protein 5 OS=Xenopus tropicalis OX=8364 GN=otud5 PE=2 SV=1 OTUD5_XENTR reviewed OTU domain-containing protein 5 (EC 3.4.19.12) (Deubiquitinating enzyme A) (DUBA) Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0001817; GO:0004843; GO:0006508; GO:0010629; GO:0030154; GO:0032496; GO:0050776; GO:0051241; GO:0061578; GO:0070536; GO:0071108; GO:0090090; GO:1904263; GO:1904515 cell differentiation [GO:0030154]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of gene expression [GO:0010629]; negative regulation of multicellular organismal process [GO:0051241]; positive regulation of TORC1 signaling [GO:1904263]; positive regulation of TORC2 signaling [GO:1904515]; protein K48-linked deubiquitination [GO:0071108]; protein K63-linked deubiquitination [GO:0070536]; proteolysis [GO:0006508]; regulation of cytokine production [GO:0001817]; regulation of immune response [GO:0050776]; response to lipopolysaccharide [GO:0032496] cysteine-type deubiquitinase activity [GO:0004843]; K63-linked deubiquitinase activity [GO:0061578] g21381.t1 Q8R4U0 34.348 1511 0.0 783.0 sp|Q8R4U0|STAB2_MOUSE Stabilin-2 OS=Mus musculus OX=10090 GN=Stab2 PE=1 SV=1 STAB2_MOUSE reviewed Stabilin-2 (Fasciclin, EGF-like, laminin-type EGF-like and link domain-containing scavenger receptor 2) (FEEL-2) [Cleaved into: Short form stabilin-2] Mus musculus (Mouse) GO:0005041; GO:0005044; GO:0005509; GO:0005540; GO:0005829; GO:0005886; GO:0006897; GO:0006898; GO:0007155; GO:0009897; GO:0030169; GO:0030214; GO:0038024; GO:0042742; GO:0050830 cell adhesion [GO:0007155]; defense response to bacterium [GO:0042742]; defense response to Gram-positive bacterium [GO:0050830]; endocytosis [GO:0006897]; hyaluronan catabolic process [GO:0030214]; receptor-mediated endocytosis [GO:0006898] cytosol [GO:0005829]; external side of plasma membrane [GO:0009897]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; cargo receptor activity [GO:0038024]; hyaluronic acid binding [GO:0005540]; low-density lipoprotein particle binding [GO:0030169]; low-density lipoprotein particle receptor activity [GO:0005041]; scavenger receptor activity [GO:0005044] g21381.t1 Q8R4U0 27.892 1409 1.3500000000000002e-129 451.0 sp|Q8R4U0|STAB2_MOUSE Stabilin-2 OS=Mus musculus OX=10090 GN=Stab2 PE=1 SV=1 STAB2_MOUSE reviewed Stabilin-2 (Fasciclin, EGF-like, laminin-type EGF-like and link domain-containing scavenger receptor 2) (FEEL-2) [Cleaved into: Short form stabilin-2] Mus musculus (Mouse) GO:0005041; GO:0005044; GO:0005509; GO:0005540; GO:0005829; GO:0005886; GO:0006897; GO:0006898; GO:0007155; GO:0009897; GO:0030169; GO:0030214; GO:0038024; GO:0042742; GO:0050830 cell adhesion [GO:0007155]; defense response to bacterium [GO:0042742]; defense response to Gram-positive bacterium [GO:0050830]; endocytosis [GO:0006897]; hyaluronan catabolic process [GO:0030214]; receptor-mediated endocytosis [GO:0006898] cytosol [GO:0005829]; external side of plasma membrane [GO:0009897]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; cargo receptor activity [GO:0038024]; hyaluronic acid binding [GO:0005540]; low-density lipoprotein particle binding [GO:0030169]; low-density lipoprotein particle receptor activity [GO:0005041]; scavenger receptor activity [GO:0005044] g21381.t1 Q8R4U0 31.837 958 4.73e-98 354.0 sp|Q8R4U0|STAB2_MOUSE Stabilin-2 OS=Mus musculus OX=10090 GN=Stab2 PE=1 SV=1 STAB2_MOUSE reviewed Stabilin-2 (Fasciclin, EGF-like, laminin-type EGF-like and link domain-containing scavenger receptor 2) (FEEL-2) [Cleaved into: Short form stabilin-2] Mus musculus (Mouse) GO:0005041; GO:0005044; GO:0005509; GO:0005540; GO:0005829; GO:0005886; GO:0006897; GO:0006898; GO:0007155; GO:0009897; GO:0030169; GO:0030214; GO:0038024; GO:0042742; GO:0050830 cell adhesion [GO:0007155]; defense response to bacterium [GO:0042742]; defense response to Gram-positive bacterium [GO:0050830]; endocytosis [GO:0006897]; hyaluronan catabolic process [GO:0030214]; receptor-mediated endocytosis [GO:0006898] cytosol [GO:0005829]; external side of plasma membrane [GO:0009897]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; cargo receptor activity [GO:0038024]; hyaluronic acid binding [GO:0005540]; low-density lipoprotein particle binding [GO:0030169]; low-density lipoprotein particle receptor activity [GO:0005041]; scavenger receptor activity [GO:0005044] g21382.t1 Q8WWQ8 38.346 665 1.44e-129 436.0 sp|Q8WWQ8|STAB2_HUMAN Stabilin-2 OS=Homo sapiens OX=9606 GN=STAB2 PE=1 SV=3 STAB2_HUMAN reviewed Stabilin-2 (FAS1 EGF-like and X-link domain-containing adhesion molecule 2) (Fasciclin, EGF-like, laminin-type EGF-like and link domain-containing scavenger receptor 2) (FEEL-2) (Hyaluronan receptor for endocytosis) [Cleaved into: 190 kDa form stabilin-2 (190 kDa hyaluronan receptor for endocytosis)] Homo sapiens (Human) GO:0001525; GO:0005041; GO:0005044; GO:0005509; GO:0005540; GO:0005829; GO:0005886; GO:0006897; GO:0006898; GO:0007155; GO:0009897; GO:0015035; GO:0030169; GO:0030214; GO:0030666; GO:0042742; GO:0050830 angiogenesis [GO:0001525]; cell adhesion [GO:0007155]; defense response to bacterium [GO:0042742]; defense response to Gram-positive bacterium [GO:0050830]; endocytosis [GO:0006897]; hyaluronan catabolic process [GO:0030214]; receptor-mediated endocytosis [GO:0006898] cytosol [GO:0005829]; endocytic vesicle membrane [GO:0030666]; external side of plasma membrane [GO:0009897]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; hyaluronic acid binding [GO:0005540]; low-density lipoprotein particle binding [GO:0030169]; low-density lipoprotein particle receptor activity [GO:0005041]; protein-disulfide reductase activity [GO:0015035]; scavenger receptor activity [GO:0005044] g21382.t1 Q8WWQ8 27.071 857 2.8499999999999997e-74 272.0 sp|Q8WWQ8|STAB2_HUMAN Stabilin-2 OS=Homo sapiens OX=9606 GN=STAB2 PE=1 SV=3 STAB2_HUMAN reviewed Stabilin-2 (FAS1 EGF-like and X-link domain-containing adhesion molecule 2) (Fasciclin, EGF-like, laminin-type EGF-like and link domain-containing scavenger receptor 2) (FEEL-2) (Hyaluronan receptor for endocytosis) [Cleaved into: 190 kDa form stabilin-2 (190 kDa hyaluronan receptor for endocytosis)] Homo sapiens (Human) GO:0001525; GO:0005041; GO:0005044; GO:0005509; GO:0005540; GO:0005829; GO:0005886; GO:0006897; GO:0006898; GO:0007155; GO:0009897; GO:0015035; GO:0030169; GO:0030214; GO:0030666; GO:0042742; GO:0050830 angiogenesis [GO:0001525]; cell adhesion [GO:0007155]; defense response to bacterium [GO:0042742]; defense response to Gram-positive bacterium [GO:0050830]; endocytosis [GO:0006897]; hyaluronan catabolic process [GO:0030214]; receptor-mediated endocytosis [GO:0006898] cytosol [GO:0005829]; endocytic vesicle membrane [GO:0030666]; external side of plasma membrane [GO:0009897]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; hyaluronic acid binding [GO:0005540]; low-density lipoprotein particle binding [GO:0030169]; low-density lipoprotein particle receptor activity [GO:0005041]; protein-disulfide reductase activity [GO:0015035]; scavenger receptor activity [GO:0005044] g21382.t1 Q8WWQ8 26.702 940 4.3600000000000005e-73 268.0 sp|Q8WWQ8|STAB2_HUMAN Stabilin-2 OS=Homo sapiens OX=9606 GN=STAB2 PE=1 SV=3 STAB2_HUMAN reviewed Stabilin-2 (FAS1 EGF-like and X-link domain-containing adhesion molecule 2) (Fasciclin, EGF-like, laminin-type EGF-like and link domain-containing scavenger receptor 2) (FEEL-2) (Hyaluronan receptor for endocytosis) [Cleaved into: 190 kDa form stabilin-2 (190 kDa hyaluronan receptor for endocytosis)] Homo sapiens (Human) GO:0001525; GO:0005041; GO:0005044; GO:0005509; GO:0005540; GO:0005829; GO:0005886; GO:0006897; GO:0006898; GO:0007155; GO:0009897; GO:0015035; GO:0030169; GO:0030214; GO:0030666; GO:0042742; GO:0050830 angiogenesis [GO:0001525]; cell adhesion [GO:0007155]; defense response to bacterium [GO:0042742]; defense response to Gram-positive bacterium [GO:0050830]; endocytosis [GO:0006897]; hyaluronan catabolic process [GO:0030214]; receptor-mediated endocytosis [GO:0006898] cytosol [GO:0005829]; endocytic vesicle membrane [GO:0030666]; external side of plasma membrane [GO:0009897]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; hyaluronic acid binding [GO:0005540]; low-density lipoprotein particle binding [GO:0030169]; low-density lipoprotein particle receptor activity [GO:0005041]; protein-disulfide reductase activity [GO:0015035]; scavenger receptor activity [GO:0005044] g21382.t1 Q8WWQ8 28.736 522 2.97e-35 150.0 sp|Q8WWQ8|STAB2_HUMAN Stabilin-2 OS=Homo sapiens OX=9606 GN=STAB2 PE=1 SV=3 STAB2_HUMAN reviewed Stabilin-2 (FAS1 EGF-like and X-link domain-containing adhesion molecule 2) (Fasciclin, EGF-like, laminin-type EGF-like and link domain-containing scavenger receptor 2) (FEEL-2) (Hyaluronan receptor for endocytosis) [Cleaved into: 190 kDa form stabilin-2 (190 kDa hyaluronan receptor for endocytosis)] Homo sapiens (Human) GO:0001525; GO:0005041; GO:0005044; GO:0005509; GO:0005540; GO:0005829; GO:0005886; GO:0006897; GO:0006898; GO:0007155; GO:0009897; GO:0015035; GO:0030169; GO:0030214; GO:0030666; GO:0042742; GO:0050830 angiogenesis [GO:0001525]; cell adhesion [GO:0007155]; defense response to bacterium [GO:0042742]; defense response to Gram-positive bacterium [GO:0050830]; endocytosis [GO:0006897]; hyaluronan catabolic process [GO:0030214]; receptor-mediated endocytosis [GO:0006898] cytosol [GO:0005829]; endocytic vesicle membrane [GO:0030666]; external side of plasma membrane [GO:0009897]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; hyaluronic acid binding [GO:0005540]; low-density lipoprotein particle binding [GO:0030169]; low-density lipoprotein particle receptor activity [GO:0005041]; protein-disulfide reductase activity [GO:0015035]; scavenger receptor activity [GO:0005044] g21382.t2 Q8WWQ8 33.985 665 1.39e-100 349.0 sp|Q8WWQ8|STAB2_HUMAN Stabilin-2 OS=Homo sapiens OX=9606 GN=STAB2 PE=1 SV=3 STAB2_HUMAN reviewed Stabilin-2 (FAS1 EGF-like and X-link domain-containing adhesion molecule 2) (Fasciclin, EGF-like, laminin-type EGF-like and link domain-containing scavenger receptor 2) (FEEL-2) (Hyaluronan receptor for endocytosis) [Cleaved into: 190 kDa form stabilin-2 (190 kDa hyaluronan receptor for endocytosis)] Homo sapiens (Human) GO:0001525; GO:0005041; GO:0005044; GO:0005509; GO:0005540; GO:0005829; GO:0005886; GO:0006897; GO:0006898; GO:0007155; GO:0009897; GO:0015035; GO:0030169; GO:0030214; GO:0030666; GO:0042742; GO:0050830 angiogenesis [GO:0001525]; cell adhesion [GO:0007155]; defense response to bacterium [GO:0042742]; defense response to Gram-positive bacterium [GO:0050830]; endocytosis [GO:0006897]; hyaluronan catabolic process [GO:0030214]; receptor-mediated endocytosis [GO:0006898] cytosol [GO:0005829]; endocytic vesicle membrane [GO:0030666]; external side of plasma membrane [GO:0009897]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; hyaluronic acid binding [GO:0005540]; low-density lipoprotein particle binding [GO:0030169]; low-density lipoprotein particle receptor activity [GO:0005041]; protein-disulfide reductase activity [GO:0015035]; scavenger receptor activity [GO:0005044] g21382.t2 Q8WWQ8 26.432 908 6.69e-57 218.0 sp|Q8WWQ8|STAB2_HUMAN Stabilin-2 OS=Homo sapiens OX=9606 GN=STAB2 PE=1 SV=3 STAB2_HUMAN reviewed Stabilin-2 (FAS1 EGF-like and X-link domain-containing adhesion molecule 2) (Fasciclin, EGF-like, laminin-type EGF-like and link domain-containing scavenger receptor 2) (FEEL-2) (Hyaluronan receptor for endocytosis) [Cleaved into: 190 kDa form stabilin-2 (190 kDa hyaluronan receptor for endocytosis)] Homo sapiens (Human) GO:0001525; GO:0005041; GO:0005044; GO:0005509; GO:0005540; GO:0005829; GO:0005886; GO:0006897; GO:0006898; GO:0007155; GO:0009897; GO:0015035; GO:0030169; GO:0030214; GO:0030666; GO:0042742; GO:0050830 angiogenesis [GO:0001525]; cell adhesion [GO:0007155]; defense response to bacterium [GO:0042742]; defense response to Gram-positive bacterium [GO:0050830]; endocytosis [GO:0006897]; hyaluronan catabolic process [GO:0030214]; receptor-mediated endocytosis [GO:0006898] cytosol [GO:0005829]; endocytic vesicle membrane [GO:0030666]; external side of plasma membrane [GO:0009897]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; hyaluronic acid binding [GO:0005540]; low-density lipoprotein particle binding [GO:0030169]; low-density lipoprotein particle receptor activity [GO:0005041]; protein-disulfide reductase activity [GO:0015035]; scavenger receptor activity [GO:0005044] g21382.t2 Q8WWQ8 25.408 858 4.980000000000001e-56 215.0 sp|Q8WWQ8|STAB2_HUMAN Stabilin-2 OS=Homo sapiens OX=9606 GN=STAB2 PE=1 SV=3 STAB2_HUMAN reviewed Stabilin-2 (FAS1 EGF-like and X-link domain-containing adhesion molecule 2) (Fasciclin, EGF-like, laminin-type EGF-like and link domain-containing scavenger receptor 2) (FEEL-2) (Hyaluronan receptor for endocytosis) [Cleaved into: 190 kDa form stabilin-2 (190 kDa hyaluronan receptor for endocytosis)] Homo sapiens (Human) GO:0001525; GO:0005041; GO:0005044; GO:0005509; GO:0005540; GO:0005829; GO:0005886; GO:0006897; GO:0006898; GO:0007155; GO:0009897; GO:0015035; GO:0030169; GO:0030214; GO:0030666; GO:0042742; GO:0050830 angiogenesis [GO:0001525]; cell adhesion [GO:0007155]; defense response to bacterium [GO:0042742]; defense response to Gram-positive bacterium [GO:0050830]; endocytosis [GO:0006897]; hyaluronan catabolic process [GO:0030214]; receptor-mediated endocytosis [GO:0006898] cytosol [GO:0005829]; endocytic vesicle membrane [GO:0030666]; external side of plasma membrane [GO:0009897]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; hyaluronic acid binding [GO:0005540]; low-density lipoprotein particle binding [GO:0030169]; low-density lipoprotein particle receptor activity [GO:0005041]; protein-disulfide reductase activity [GO:0015035]; scavenger receptor activity [GO:0005044] g21382.t2 Q8WWQ8 26.641 518 1.32e-21 105.0 sp|Q8WWQ8|STAB2_HUMAN Stabilin-2 OS=Homo sapiens OX=9606 GN=STAB2 PE=1 SV=3 STAB2_HUMAN reviewed Stabilin-2 (FAS1 EGF-like and X-link domain-containing adhesion molecule 2) (Fasciclin, EGF-like, laminin-type EGF-like and link domain-containing scavenger receptor 2) (FEEL-2) (Hyaluronan receptor for endocytosis) [Cleaved into: 190 kDa form stabilin-2 (190 kDa hyaluronan receptor for endocytosis)] Homo sapiens (Human) GO:0001525; GO:0005041; GO:0005044; GO:0005509; GO:0005540; GO:0005829; GO:0005886; GO:0006897; GO:0006898; GO:0007155; GO:0009897; GO:0015035; GO:0030169; GO:0030214; GO:0030666; GO:0042742; GO:0050830 angiogenesis [GO:0001525]; cell adhesion [GO:0007155]; defense response to bacterium [GO:0042742]; defense response to Gram-positive bacterium [GO:0050830]; endocytosis [GO:0006897]; hyaluronan catabolic process [GO:0030214]; receptor-mediated endocytosis [GO:0006898] cytosol [GO:0005829]; endocytic vesicle membrane [GO:0030666]; external side of plasma membrane [GO:0009897]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; hyaluronic acid binding [GO:0005540]; low-density lipoprotein particle binding [GO:0030169]; low-density lipoprotein particle receptor activity [GO:0005041]; protein-disulfide reductase activity [GO:0015035]; scavenger receptor activity [GO:0005044] g21383.t1 Q803T2 60.567 776 0.0 904.0 sp|Q803T2|STRP1_DANRE Striatin-interacting protein 1 homolog OS=Danio rerio OX=7955 GN=strip1 PE=1 SV=1 g21383.t2 Q803T2 60.567 776 0.0 905.0 sp|Q803T2|STRP1_DANRE Striatin-interacting protein 1 homolog OS=Danio rerio OX=7955 GN=strip1 PE=1 SV=1 g21386.t1 P09623 72.407 511 0.0 739.0 sp|P09623|DLDH_PIG Dihydrolipoyl dehydrogenase, mitochondrial OS=Sus scrofa OX=9823 GN=DLD PE=1 SV=1 DLDH_PIG reviewed Dihydrolipoyl dehydrogenase, mitochondrial (EC 1.8.1.4) (Dihydrolipoamide dehydrogenase) Sus scrofa (Pig) GO:0001669; GO:0004148; GO:0005634; GO:0005739; GO:0005759; GO:0006086; GO:0006103; GO:0031514; GO:0045252; GO:0045254; GO:0050660 2-oxoglutarate metabolic process [GO:0006103]; pyruvate decarboxylation to acetyl-CoA [GO:0006086] acrosomal vesicle [GO:0001669]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; motile cilium [GO:0031514]; nucleus [GO:0005634]; oxoglutarate dehydrogenase complex [GO:0045252]; pyruvate dehydrogenase complex [GO:0045254] dihydrolipoyl dehydrogenase (NADH) activity [GO:0004148]; flavin adenine dinucleotide binding [GO:0050660] g21387.t1 F4JEQ2 42.174 230 5.8e-51 188.0 sp|F4JEQ2|PBL23_ARATH Probable serine/threonine-protein kinase PBL23 OS=Arabidopsis thaliana OX=3702 GN=PBL23 PE=2 SV=1 PBL23_ARATH reviewed Probable serine/threonine-protein kinase PBL23 (EC 2.7.11.1) (PBS1-like protein 23) Arabidopsis thaliana (Mouse-ear cress) GO:0004672; GO:0004674; GO:0005524; GO:0005777; GO:0005886; GO:0006952; GO:0106310 defense response [GO:0006952] peroxisome [GO:0005777]; plasma membrane [GO:0005886] ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g21388.t1 B9FAF3 43.501 377 3.88e-86 301.0 sp|B9FAF3|KN14E_ORYSJ Kinesin-like protein KIN-14E OS=Oryza sativa subsp. japonica OX=39947 GN=KIN14E PE=2 SV=1 KN14E_ORYSJ reviewed Kinesin-like protein KIN-14E Oryza sativa subsp. japonica (Rice) GO:0003777; GO:0005524; GO:0005874; GO:0007017; GO:0007018; GO:0008017; GO:0015630 microtubule-based movement [GO:0007018]; microtubule-based process [GO:0007017] microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630] ATP binding [GO:0005524]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777] g21389.t1 Q7ZW46 60.119 336 1.23e-135 391.0 sp|Q7ZW46|S35B4_DANRE UDP-xylose and UDP-N-acetylglucosamine transporter OS=Danio rerio OX=7955 GN=slc35b4 PE=2 SV=1 g21389.t2 Q7ZW46 58.333 336 3.83e-127 369.0 sp|Q7ZW46|S35B4_DANRE UDP-xylose and UDP-N-acetylglucosamine transporter OS=Danio rerio OX=7955 GN=slc35b4 PE=2 SV=1 g21390.t1 O35831 60.204 294 4.58e-97 296.0 sp|O35831|CDK17_RAT Cyclin-dependent kinase 17 OS=Rattus norvegicus OX=10116 GN=Cdk17 PE=1 SV=1 CDK17_RAT reviewed Cyclin-dependent kinase 17 (EC 2.7.11.22) (Cell division protein kinase 17) (PCTAIRE-motif protein kinase 2) (Serine/threonine-protein kinase PCTAIRE-2) Rattus norvegicus (Rat) GO:0004693; GO:0005524; GO:0005634; GO:0005737; GO:0106310; GO:1901987 regulation of cell cycle phase transition [GO:1901987] cytoplasm [GO:0005737]; nucleus [GO:0005634] ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; protein serine kinase activity [GO:0106310] g21391.t1 O35832 88.0 75 7.75e-43 147.0 sp|O35832|CDK18_RAT Cyclin-dependent kinase 18 OS=Rattus norvegicus OX=10116 GN=Cdk18 PE=1 SV=1 g21392.t1 Q00536 55.634 142 9.67e-52 176.0 sp|Q00536|CDK16_HUMAN Cyclin-dependent kinase 16 OS=Homo sapiens OX=9606 GN=CDK16 PE=1 SV=1 CDK16_HUMAN reviewed Cyclin-dependent kinase 16 (EC 2.7.11.22) (Cell division protein kinase 16) (PCTAIRE-motif protein kinase 1) (Serine/threonine-protein kinase PCTAIRE-1) Homo sapiens (Human) GO:0000307; GO:0004674; GO:0004693; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0006468; GO:0006887; GO:0007283; GO:0008021; GO:0009898; GO:0010508; GO:0015630; GO:0030252; GO:0031175; GO:0043005; GO:0061178; GO:0106310; GO:1901987 exocytosis [GO:0006887]; growth hormone secretion [GO:0030252]; neuron projection development [GO:0031175]; positive regulation of autophagy [GO:0010508]; protein phosphorylation [GO:0006468]; regulation of cell cycle phase transition [GO:1901987]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]; spermatogenesis [GO:0007283] cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; microtubule cytoskeleton [GO:0015630]; neuron projection [GO:0043005]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; synaptic vesicle [GO:0008021] ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g21395.t1 Q5R7J6 86.667 150 6.850000000000001e-97 278.0 sp|Q5R7J6|UBE2N_PONAB Ubiquitin-conjugating enzyme E2 N OS=Pongo abelii OX=9601 GN=UBE2N PE=2 SV=1 UBE2N_PONAB reviewed Ubiquitin-conjugating enzyme E2 N (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme N) (Ubiquitin carrier protein N) (Ubiquitin-protein ligase N) Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0000151; GO:0004842; GO:0005524; GO:0006281; GO:0031372; GO:0061631; GO:0070534 DNA repair [GO:0006281]; protein K63-linked ubiquitination [GO:0070534] UBC13-MMS2 complex [GO:0031372]; ubiquitin ligase complex [GO:0000151] ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842] g21396.t1 Q80TR8 52.727 1155 0.0 1179.0 sp|Q80TR8|DCAF1_MOUSE DDB1- and CUL4-associated factor 1 OS=Mus musculus OX=10090 GN=Dcaf1 PE=1 SV=4 g21396.t1 Q80TR8 50.847 177 1.86e-51 204.0 sp|Q80TR8|DCAF1_MOUSE DDB1- and CUL4-associated factor 1 OS=Mus musculus OX=10090 GN=Dcaf1 PE=1 SV=4 g21397.t1 Q8F7W8 58.594 128 4.14e-51 164.0 sp|Q8F7W8|MSRB_LEPIN Peptide methionine sulfoxide reductase MsrB OS=Leptospira interrogans serogroup Icterohaemorrhagiae serovar Lai (strain 56601) OX=189518 GN=msrB PE=3 SV=3 g21397.t2 Q8F7W8 59.055 127 1.02e-51 164.0 sp|Q8F7W8|MSRB_LEPIN Peptide methionine sulfoxide reductase MsrB OS=Leptospira interrogans serogroup Icterohaemorrhagiae serovar Lai (strain 56601) OX=189518 GN=msrB PE=3 SV=3 g21397.t3 Q8F7W8 58.594 128 5.8699999999999994e-52 164.0 sp|Q8F7W8|MSRB_LEPIN Peptide methionine sulfoxide reductase MsrB OS=Leptospira interrogans serogroup Icterohaemorrhagiae serovar Lai (strain 56601) OX=189518 GN=msrB PE=3 SV=3 g21398.t1 P19182 48.058 412 9.03e-107 326.0 sp|P19182|IFRD1_MOUSE Interferon-related developmental regulator 1 OS=Mus musculus OX=10090 GN=Ifrd1 PE=1 SV=2 IFRD1_MOUSE reviewed Interferon-related developmental regulator 1 (Nerve growth factor-inducible protein PC4) (TPA-induced sequence 7) (TIS7 protein) Mus musculus (Mouse) GO:0005634; GO:0005737; GO:0006357; GO:0014706; GO:0016055; GO:0030517; GO:0042692; GO:0043403; GO:0045444; GO:0045944; GO:0048671; GO:0060612; GO:0061629 adipose tissue development [GO:0060612]; fat cell differentiation [GO:0045444]; muscle cell differentiation [GO:0042692]; negative regulation of axon extension [GO:0030517]; negative regulation of collateral sprouting [GO:0048671]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; skeletal muscle tissue regeneration [GO:0043403]; striated muscle tissue development [GO:0014706]; Wnt signaling pathway [GO:0016055] cytoplasm [GO:0005737]; nucleus [GO:0005634] RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629] g21399.t1 A2CI35 59.255 940 0.0 1112.0 sp|A2CI35|DUSTY_STRPU Dual serine/threonine and tyrosine protein kinase OS=Strongylocentrotus purpuratus OX=7668 GN=DSTYK PE=2 SV=1 g21405.t1 Q8WZA1 30.392 306 9.18e-29 120.0 sp|Q8WZA1|PMGT1_HUMAN Protein O-linked-mannose beta-1,2-N-acetylglucosaminyltransferase 1 OS=Homo sapiens OX=9606 GN=POMGNT1 PE=1 SV=2 PMGT1_HUMAN reviewed Protein O-linked-mannose beta-1,2-N-acetylglucosaminyltransferase 1 (POMGnT1) (EC 2.4.1.-) (UDP-GlcNAc:alpha-D-mannoside beta-1,2-N-acetylglucosaminyltransferase I.2) (GnT I.2) Homo sapiens (Human) GO:0000139; GO:0006493; GO:0007605; GO:0008375; GO:0010467; GO:0016020; GO:0016266; GO:0021542; GO:0030145; GO:0030246; GO:0035269; GO:0042552; GO:0047223; GO:0051674; GO:0071711; GO:0150103 basement membrane organization [GO:0071711]; dentate gyrus development [GO:0021542]; gene expression [GO:0010467]; localization of cell [GO:0051674]; myelination [GO:0042552]; protein O-linked glycosylation [GO:0006493]; protein O-linked glycosylation via mannose [GO:0035269]; protein O-linked glycosylation via N-acetyl-galactosamine [GO:0016266]; reactive gliosis [GO:0150103]; sensory perception of sound [GO:0007605] Golgi membrane [GO:0000139]; membrane [GO:0016020] acetylglucosaminyltransferase activity [GO:0008375]; beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity [GO:0047223]; carbohydrate binding [GO:0030246]; manganese ion binding [GO:0030145] g21407.t1 P51650 62.733 483 0.0 603.0 sp|P51650|SSDH_RAT Succinate-semialdehyde dehydrogenase, mitochondrial OS=Rattus norvegicus OX=10116 GN=Aldh5a1 PE=1 SV=2 SSDH_RAT reviewed Succinate-semialdehyde dehydrogenase, mitochondrial (SSADH) (EC 1.2.1.24) (Aldehyde dehydrogenase family 5 member A1) (NAD(+)-dependent succinic semialdehyde dehydrogenase) Rattus norvegicus (Rat) GO:0004777; GO:0005739; GO:0006105; GO:0006536; GO:0007417; GO:0009448; GO:0009450; GO:0009791; GO:0031406; GO:0042802; GO:0045202; GO:0051287; GO:0051932 central nervous system development [GO:0007417]; gamma-aminobutyric acid catabolic process [GO:0009450]; gamma-aminobutyric acid metabolic process [GO:0009448]; glutamate metabolic process [GO:0006536]; post-embryonic development [GO:0009791]; succinate metabolic process [GO:0006105]; synaptic transmission, GABAergic [GO:0051932] mitochondrion [GO:0005739]; synapse [GO:0045202] carboxylic acid binding [GO:0031406]; identical protein binding [GO:0042802]; NAD binding [GO:0051287]; succinate-semialdehyde dehydrogenase (NAD+) activity [GO:0004777] g21408.t1 Q9D8P7 46.316 95 6.310000000000001e-21 87.8 sp|Q9D8P7|TF3C6_MOUSE General transcription factor 3C polypeptide 6 OS=Mus musculus OX=10090 GN=Gtf3c6 PE=2 SV=1 g21409.t1 Q8JZX4 47.388 268 6.759999999999999e-60 206.0 sp|Q8JZX4|SPF45_MOUSE Splicing factor 45 OS=Mus musculus OX=10090 GN=Rbm17 PE=1 SV=1 g21409.t2 Q8JZX4 47.388 268 6.84e-60 206.0 sp|Q8JZX4|SPF45_MOUSE Splicing factor 45 OS=Mus musculus OX=10090 GN=Rbm17 PE=1 SV=1 g21410.t1 Q6NRK9 51.57 223 4.76e-87 261.0 sp|Q6NRK9|CCNQ_XENLA Cyclin-Q OS=Xenopus laevis OX=8355 GN=ccnq PE=2 SV=2 g21412.t1 Q26622 61.67 587 0.0 645.0 sp|Q26622|SHR2_STRPU Orphan steroid hormone receptor 2 OS=Strongylocentrotus purpuratus OX=7668 GN=SHR2 PE=1 SV=1 SHR2_STRPU reviewed Orphan steroid hormone receptor 2 (SpSHR2) Strongylocentrotus purpuratus (Purple sea urchin) GO:0000978; GO:0003677; GO:0004879; GO:0005634; GO:0005652; GO:0005737; GO:0006357; GO:0008270; GO:0030154; GO:0045177; GO:0048471 cell differentiation [GO:0030154]; regulation of transcription by RNA polymerase II [GO:0006357] apical part of cell [GO:0045177]; cytoplasm [GO:0005737]; nuclear lamina [GO:0005652]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471] DNA binding [GO:0003677]; nuclear receptor activity [GO:0004879]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270] g21412.t2 Q26622 61.383 593 0.0 647.0 sp|Q26622|SHR2_STRPU Orphan steroid hormone receptor 2 OS=Strongylocentrotus purpuratus OX=7668 GN=SHR2 PE=1 SV=1 SHR2_STRPU reviewed Orphan steroid hormone receptor 2 (SpSHR2) Strongylocentrotus purpuratus (Purple sea urchin) GO:0000978; GO:0003677; GO:0004879; GO:0005634; GO:0005652; GO:0005737; GO:0006357; GO:0008270; GO:0030154; GO:0045177; GO:0048471 cell differentiation [GO:0030154]; regulation of transcription by RNA polymerase II [GO:0006357] apical part of cell [GO:0045177]; cytoplasm [GO:0005737]; nuclear lamina [GO:0005652]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471] DNA binding [GO:0003677]; nuclear receptor activity [GO:0004879]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270] g21412.t3 Q26622 60.231 606 0.0 642.0 sp|Q26622|SHR2_STRPU Orphan steroid hormone receptor 2 OS=Strongylocentrotus purpuratus OX=7668 GN=SHR2 PE=1 SV=1 SHR2_STRPU reviewed Orphan steroid hormone receptor 2 (SpSHR2) Strongylocentrotus purpuratus (Purple sea urchin) GO:0000978; GO:0003677; GO:0004879; GO:0005634; GO:0005652; GO:0005737; GO:0006357; GO:0008270; GO:0030154; GO:0045177; GO:0048471 cell differentiation [GO:0030154]; regulation of transcription by RNA polymerase II [GO:0006357] apical part of cell [GO:0045177]; cytoplasm [GO:0005737]; nuclear lamina [GO:0005652]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471] DNA binding [GO:0003677]; nuclear receptor activity [GO:0004879]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270] g21412.t4 Q26622 61.551 593 0.0 652.0 sp|Q26622|SHR2_STRPU Orphan steroid hormone receptor 2 OS=Strongylocentrotus purpuratus OX=7668 GN=SHR2 PE=1 SV=1 SHR2_STRPU reviewed Orphan steroid hormone receptor 2 (SpSHR2) Strongylocentrotus purpuratus (Purple sea urchin) GO:0000978; GO:0003677; GO:0004879; GO:0005634; GO:0005652; GO:0005737; GO:0006357; GO:0008270; GO:0030154; GO:0045177; GO:0048471 cell differentiation [GO:0030154]; regulation of transcription by RNA polymerase II [GO:0006357] apical part of cell [GO:0045177]; cytoplasm [GO:0005737]; nuclear lamina [GO:0005652]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471] DNA binding [GO:0003677]; nuclear receptor activity [GO:0004879]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270] g21413.t1 Q08CY9 48.577 492 8.38e-161 471.0 sp|Q08CY9|EOGT_XENTR EGF domain-specific O-linked N-acetylglucosamine transferase OS=Xenopus tropicalis OX=8364 GN=eogt PE=2 SV=1 g21414.t1 P54281 30.906 618 8.34e-84 285.0 sp|P54281|CLCA1_BOVIN Calcium-activated chloride channel regulator 1 OS=Bos taurus OX=9913 PE=1 SV=1 g21417.t1 Q80TF4 29.155 343 5.290000000000001e-37 152.0 sp|Q80TF4|KLH13_MOUSE Kelch-like protein 13 OS=Mus musculus OX=10090 GN=Klhl13 PE=2 SV=3 g21417.t2 Q80TF4 29.155 343 4.19e-37 152.0 sp|Q80TF4|KLH13_MOUSE Kelch-like protein 13 OS=Mus musculus OX=10090 GN=Klhl13 PE=2 SV=3 g21423.t1 O88854 25.344 363 9.49e-21 95.5 sp|O88854|GALR2_MOUSE Galanin receptor type 2 OS=Mus musculus OX=10090 GN=Galr2 PE=2 SV=2 g21425.t1 O08726 28.66 321 9.430000000000001e-27 112.0 sp|O08726|GALR2_RAT Galanin receptor type 2 OS=Rattus norvegicus OX=10116 GN=Galr2 PE=2 SV=1 g21427.t1 Q6ZQY2 37.874 301 1.9799999999999997e-42 160.0 sp|Q6ZQY2|LR74B_HUMAN Leucine-rich repeat-containing protein 74B OS=Homo sapiens OX=9606 GN=LRRC74B PE=1 SV=3 g21428.t1 Q2KIA5 67.763 760 0.0 1019.0 sp|Q2KIA5|DNM1L_BOVIN Dynamin-1-like protein OS=Bos taurus OX=9913 GN=DNM1L PE=2 SV=1 DNM1L_BOVIN reviewed Dynamin-1-like protein (EC 3.6.5.5) Bos taurus (Bovine) GO:0000266; GO:0003924; GO:0005525; GO:0005737; GO:0005739; GO:0005741; GO:0005777; GO:0005783; GO:0005794; GO:0005829; GO:0005874; GO:0005903; GO:0005905; GO:0006816; GO:0006897; GO:0008017; GO:0008289; GO:0010468; GO:0016020; GO:0016559; GO:0030672; GO:0030742; GO:0031267; GO:0031625; GO:0032991; GO:0042802; GO:0042803; GO:0043653; GO:0048312; GO:0048471; GO:0048511; GO:0050714; GO:0051259; GO:0060047; GO:0070585; GO:0090023; GO:0090141; GO:0090149; GO:0099073; GO:0160040; GO:1900063; GO:1901524; GO:1903578 calcium ion transport [GO:0006816]; endocytosis [GO:0006897]; heart contraction [GO:0060047]; intracellular distribution of mitochondria [GO:0048312]; mitochondrial fission [GO:0000266]; mitochondrial fragmentation involved in apoptotic process [GO:0043653]; mitochondrial membrane fission [GO:0090149]; mitocytosis [GO:0160040]; peroxisome fission [GO:0016559]; positive regulation of mitochondrial fission [GO:0090141]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of protein secretion [GO:0050714]; protein complex oligomerization [GO:0051259]; protein localization to mitochondrion [GO:0070585]; regulation of ATP metabolic process [GO:1903578]; regulation of gene expression [GO:0010468]; regulation of mitophagy [GO:1901524]; regulation of peroxisome organization [GO:1900063]; rhythmic process [GO:0048511] brush border [GO:0005903]; clathrin-coated pit [GO:0005905]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; microtubule [GO:0005874]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; mitochondrion-derived vesicle [GO:0099073]; perinuclear region of cytoplasm [GO:0048471]; peroxisome [GO:0005777]; protein-containing complex [GO:0032991]; synaptic vesicle membrane [GO:0030672] GTP binding [GO:0005525]; GTP-dependent protein binding [GO:0030742]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; lipid binding [GO:0008289]; microtubule binding [GO:0008017]; protein homodimerization activity [GO:0042803]; small GTPase binding [GO:0031267]; ubiquitin protein ligase binding [GO:0031625] g21430.t1 Q12893 46.264 348 2.13e-100 304.0 sp|Q12893|TM115_HUMAN Transmembrane protein 115 OS=Homo sapiens OX=9606 GN=TMEM115 PE=1 SV=1 TM115_HUMAN reviewed Transmembrane protein 115 (Placental protein 6) (Protein PL6) Homo sapiens (Human) GO:0000139; GO:0005634; GO:0005794; GO:0006890; GO:0008285; GO:0015031; GO:0032580; GO:0042802 negative regulation of cell population proliferation [GO:0008285]; protein transport [GO:0015031]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890] Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; nucleus [GO:0005634] identical protein binding [GO:0042802] g21431.t1 O18373 62.366 372 1.0699999999999999e-172 489.0 sp|O18373|SPS1_DROME Inactive selenide, water dikinase-like protein OS=Drosophila melanogaster OX=7227 GN=Sps1 PE=2 SV=1 g21432.t1 O18373 56.032 373 7.19e-141 408.0 sp|O18373|SPS1_DROME Inactive selenide, water dikinase-like protein OS=Drosophila melanogaster OX=7227 GN=Sps1 PE=2 SV=1 g21433.t1 Q63505 29.853 546 2.1600000000000003e-58 227.0 sp|Q63505|TF3C1_RAT General transcription factor 3C polypeptide 1 OS=Rattus norvegicus OX=10116 GN=Gtf3c1 PE=1 SV=1 g21435.t1 Q12789 39.61 154 2.14e-26 107.0 sp|Q12789|TF3C1_HUMAN General transcription factor 3C polypeptide 1 OS=Homo sapiens OX=9606 GN=GTF3C1 PE=1 SV=4 TF3C1_HUMAN reviewed General transcription factor 3C polypeptide 1 (TF3C-alpha) (TFIIIC box B-binding subunit) (Transcription factor IIIC 220 kDa subunit) (TFIIIC 220 kDa subunit) (TFIIIC220) (Transcription factor IIIC subunit alpha) Homo sapiens (Human) GO:0000127; GO:0000995; GO:0003677; GO:0005654; GO:0005730; GO:0006383; GO:0006384; GO:0009303; GO:0009304; GO:0016020; GO:0042791; GO:0042797; GO:1990904 5S class rRNA transcription by RNA polymerase III [GO:0042791]; rRNA transcription [GO:0009303]; transcription by RNA polymerase III [GO:0006383]; transcription initiation at RNA polymerase III promoter [GO:0006384]; tRNA transcription [GO:0009304]; tRNA transcription by RNA polymerase III [GO:0042797] membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; ribonucleoprotein complex [GO:1990904]; transcription factor TFIIIC complex [GO:0000127] DNA binding [GO:0003677]; RNA polymerase III general transcription initiation factor activity [GO:0000995] g21438.t1 P62257 88.608 158 3.48e-105 302.0 sp|P62257|UBE2H_MOUSE Ubiquitin-conjugating enzyme E2 H OS=Mus musculus OX=10090 GN=Ube2h PE=1 SV=1 UBE2H_MOUSE reviewed Ubiquitin-conjugating enzyme E2 H (EC 2.3.2.23) ((E3-independent) E2 ubiquitin-conjugating enzyme H) (EC 2.3.2.24) (E2 ubiquitin-conjugating enzyme H) (UBCH2) (Ubiquitin carrier protein H) (Ubiquitin-conjugating enzyme E2-20K) (Ubiquitin-protein ligase H) Mus musculus (Mouse) GO:0000209; GO:0004842; GO:0005524; GO:0005634; GO:0006511; GO:0043161; GO:0061631; GO:0070936; GO:0070979 proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K11-linked ubiquitination [GO:0070979]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511] nucleus [GO:0005634] ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842] g21441.t1 Q6PID8 33.167 401 2.06e-66 227.0 sp|Q6PID8|KLD10_HUMAN Kelch domain-containing protein 10 OS=Homo sapiens OX=9606 GN=KLHDC10 PE=1 SV=1 KLD10_HUMAN reviewed Kelch domain-containing protein 10 Homo sapiens (Human) GO:0005654; GO:0005737; GO:0016567; GO:0031462; GO:0032874; GO:0072344; GO:0140627; GO:1990756 positive regulation of stress-activated MAPK cascade [GO:0032874]; protein ubiquitination [GO:0016567]; rescue of stalled ribosome [GO:0072344]; ubiquitin-dependent protein catabolic process via the C-end degron rule pathway [GO:0140627] Cul2-RING ubiquitin ligase complex [GO:0031462]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654] ubiquitin-like ligase-substrate adaptor activity [GO:1990756] g21442.t1 Q8VXZ0 31.686 344 1.06e-39 147.0 sp|Q8VXZ0|NUD20_ARATH Nudix hydrolase 20, chloroplastic OS=Arabidopsis thaliana OX=3702 GN=NUDT20 PE=2 SV=1 g21442.t2 Q8VXZ0 32.765 293 3.04e-39 144.0 sp|Q8VXZ0|NUD20_ARATH Nudix hydrolase 20, chloroplastic OS=Arabidopsis thaliana OX=3702 GN=NUDT20 PE=2 SV=1 g21444.t1 Q9P2N4 31.041 1018 2.61e-127 427.0 sp|Q9P2N4|ATS9_HUMAN A disintegrin and metalloproteinase with thrombospondin motifs 9 OS=Homo sapiens OX=9606 GN=ADAMTS9 PE=1 SV=4 ATS9_HUMAN reviewed A disintegrin and metalloproteinase with thrombospondin motifs 9 (ADAM-TS 9) (ADAM-TS9) (ADAMTS-9) (EC 3.4.24.-) Homo sapiens (Human) GO:0002088; GO:0003179; GO:0003229; GO:0004222; GO:0005615; GO:0005783; GO:0006508; GO:0008237; GO:0008270; GO:0009617; GO:0009986; GO:0010596; GO:0015031; GO:0016192; GO:0030198; GO:0030318; GO:0031012; GO:0035909; GO:0045636; GO:0048593; GO:0061303; GO:0090673; GO:1903671 aorta morphogenesis [GO:0035909]; camera-type eye morphogenesis [GO:0048593]; cornea development in camera-type eye [GO:0061303]; endothelial cell-matrix adhesion [GO:0090673]; extracellular matrix organization [GO:0030198]; heart valve morphogenesis [GO:0003179]; lens development in camera-type eye [GO:0002088]; melanocyte differentiation [GO:0030318]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of sprouting angiogenesis [GO:1903671]; positive regulation of melanocyte differentiation [GO:0045636]; protein transport [GO:0015031]; proteolysis [GO:0006508]; response to bacterium [GO:0009617]; ventricular cardiac muscle tissue development [GO:0003229]; vesicle-mediated transport [GO:0016192] cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615] metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; zinc ion binding [GO:0008270] g21444.t1 Q9P2N4 28.776 629 1.84e-43 176.0 sp|Q9P2N4|ATS9_HUMAN A disintegrin and metalloproteinase with thrombospondin motifs 9 OS=Homo sapiens OX=9606 GN=ADAMTS9 PE=1 SV=4 ATS9_HUMAN reviewed A disintegrin and metalloproteinase with thrombospondin motifs 9 (ADAM-TS 9) (ADAM-TS9) (ADAMTS-9) (EC 3.4.24.-) Homo sapiens (Human) GO:0002088; GO:0003179; GO:0003229; GO:0004222; GO:0005615; GO:0005783; GO:0006508; GO:0008237; GO:0008270; GO:0009617; GO:0009986; GO:0010596; GO:0015031; GO:0016192; GO:0030198; GO:0030318; GO:0031012; GO:0035909; GO:0045636; GO:0048593; GO:0061303; GO:0090673; GO:1903671 aorta morphogenesis [GO:0035909]; camera-type eye morphogenesis [GO:0048593]; cornea development in camera-type eye [GO:0061303]; endothelial cell-matrix adhesion [GO:0090673]; extracellular matrix organization [GO:0030198]; heart valve morphogenesis [GO:0003179]; lens development in camera-type eye [GO:0002088]; melanocyte differentiation [GO:0030318]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of sprouting angiogenesis [GO:1903671]; positive regulation of melanocyte differentiation [GO:0045636]; protein transport [GO:0015031]; proteolysis [GO:0006508]; response to bacterium [GO:0009617]; ventricular cardiac muscle tissue development [GO:0003229]; vesicle-mediated transport [GO:0016192] cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615] metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; zinc ion binding [GO:0008270] g21444.t1 Q9P2N4 28.571 532 5.19e-39 162.0 sp|Q9P2N4|ATS9_HUMAN A disintegrin and metalloproteinase with thrombospondin motifs 9 OS=Homo sapiens OX=9606 GN=ADAMTS9 PE=1 SV=4 ATS9_HUMAN reviewed A disintegrin and metalloproteinase with thrombospondin motifs 9 (ADAM-TS 9) (ADAM-TS9) (ADAMTS-9) (EC 3.4.24.-) Homo sapiens (Human) GO:0002088; GO:0003179; GO:0003229; GO:0004222; GO:0005615; GO:0005783; GO:0006508; GO:0008237; GO:0008270; GO:0009617; GO:0009986; GO:0010596; GO:0015031; GO:0016192; GO:0030198; GO:0030318; GO:0031012; GO:0035909; GO:0045636; GO:0048593; GO:0061303; GO:0090673; GO:1903671 aorta morphogenesis [GO:0035909]; camera-type eye morphogenesis [GO:0048593]; cornea development in camera-type eye [GO:0061303]; endothelial cell-matrix adhesion [GO:0090673]; extracellular matrix organization [GO:0030198]; heart valve morphogenesis [GO:0003179]; lens development in camera-type eye [GO:0002088]; melanocyte differentiation [GO:0030318]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of sprouting angiogenesis [GO:1903671]; positive regulation of melanocyte differentiation [GO:0045636]; protein transport [GO:0015031]; proteolysis [GO:0006508]; response to bacterium [GO:0009617]; ventricular cardiac muscle tissue development [GO:0003229]; vesicle-mediated transport [GO:0016192] cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615] metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; zinc ion binding [GO:0008270] g21446.t1 Q9P2N4 42.253 1465 0.0 1156.0 sp|Q9P2N4|ATS9_HUMAN A disintegrin and metalloproteinase with thrombospondin motifs 9 OS=Homo sapiens OX=9606 GN=ADAMTS9 PE=1 SV=4 ATS9_HUMAN reviewed A disintegrin and metalloproteinase with thrombospondin motifs 9 (ADAM-TS 9) (ADAM-TS9) (ADAMTS-9) (EC 3.4.24.-) Homo sapiens (Human) GO:0002088; GO:0003179; GO:0003229; GO:0004222; GO:0005615; GO:0005783; GO:0006508; GO:0008237; GO:0008270; GO:0009617; GO:0009986; GO:0010596; GO:0015031; GO:0016192; GO:0030198; GO:0030318; GO:0031012; GO:0035909; GO:0045636; GO:0048593; GO:0061303; GO:0090673; GO:1903671 aorta morphogenesis [GO:0035909]; camera-type eye morphogenesis [GO:0048593]; cornea development in camera-type eye [GO:0061303]; endothelial cell-matrix adhesion [GO:0090673]; extracellular matrix organization [GO:0030198]; heart valve morphogenesis [GO:0003179]; lens development in camera-type eye [GO:0002088]; melanocyte differentiation [GO:0030318]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of sprouting angiogenesis [GO:1903671]; positive regulation of melanocyte differentiation [GO:0045636]; protein transport [GO:0015031]; proteolysis [GO:0006508]; response to bacterium [GO:0009617]; ventricular cardiac muscle tissue development [GO:0003229]; vesicle-mediated transport [GO:0016192] cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615] metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; zinc ion binding [GO:0008270] g21446.t1 Q9P2N4 30.441 749 2.37e-87 319.0 sp|Q9P2N4|ATS9_HUMAN A disintegrin and metalloproteinase with thrombospondin motifs 9 OS=Homo sapiens OX=9606 GN=ADAMTS9 PE=1 SV=4 ATS9_HUMAN reviewed A disintegrin and metalloproteinase with thrombospondin motifs 9 (ADAM-TS 9) (ADAM-TS9) (ADAMTS-9) (EC 3.4.24.-) Homo sapiens (Human) GO:0002088; GO:0003179; GO:0003229; GO:0004222; GO:0005615; GO:0005783; GO:0006508; GO:0008237; GO:0008270; GO:0009617; GO:0009986; GO:0010596; GO:0015031; GO:0016192; GO:0030198; GO:0030318; GO:0031012; GO:0035909; GO:0045636; GO:0048593; GO:0061303; GO:0090673; GO:1903671 aorta morphogenesis [GO:0035909]; camera-type eye morphogenesis [GO:0048593]; cornea development in camera-type eye [GO:0061303]; endothelial cell-matrix adhesion [GO:0090673]; extracellular matrix organization [GO:0030198]; heart valve morphogenesis [GO:0003179]; lens development in camera-type eye [GO:0002088]; melanocyte differentiation [GO:0030318]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of sprouting angiogenesis [GO:1903671]; positive regulation of melanocyte differentiation [GO:0045636]; protein transport [GO:0015031]; proteolysis [GO:0006508]; response to bacterium [GO:0009617]; ventricular cardiac muscle tissue development [GO:0003229]; vesicle-mediated transport [GO:0016192] cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615] metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; zinc ion binding [GO:0008270] g21446.t1 Q9P2N4 32.38 769 1.04e-86 317.0 sp|Q9P2N4|ATS9_HUMAN A disintegrin and metalloproteinase with thrombospondin motifs 9 OS=Homo sapiens OX=9606 GN=ADAMTS9 PE=1 SV=4 ATS9_HUMAN reviewed A disintegrin and metalloproteinase with thrombospondin motifs 9 (ADAM-TS 9) (ADAM-TS9) (ADAMTS-9) (EC 3.4.24.-) Homo sapiens (Human) GO:0002088; GO:0003179; GO:0003229; GO:0004222; GO:0005615; GO:0005783; GO:0006508; GO:0008237; GO:0008270; GO:0009617; GO:0009986; GO:0010596; GO:0015031; GO:0016192; GO:0030198; GO:0030318; GO:0031012; GO:0035909; GO:0045636; GO:0048593; GO:0061303; GO:0090673; GO:1903671 aorta morphogenesis [GO:0035909]; camera-type eye morphogenesis [GO:0048593]; cornea development in camera-type eye [GO:0061303]; endothelial cell-matrix adhesion [GO:0090673]; extracellular matrix organization [GO:0030198]; heart valve morphogenesis [GO:0003179]; lens development in camera-type eye [GO:0002088]; melanocyte differentiation [GO:0030318]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of sprouting angiogenesis [GO:1903671]; positive regulation of melanocyte differentiation [GO:0045636]; protein transport [GO:0015031]; proteolysis [GO:0006508]; response to bacterium [GO:0009617]; ventricular cardiac muscle tissue development [GO:0003229]; vesicle-mediated transport [GO:0016192] cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615] metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; zinc ion binding [GO:0008270] g21446.t1 Q9P2N4 32.199 382 9.139999999999999e-42 172.0 sp|Q9P2N4|ATS9_HUMAN A disintegrin and metalloproteinase with thrombospondin motifs 9 OS=Homo sapiens OX=9606 GN=ADAMTS9 PE=1 SV=4 ATS9_HUMAN reviewed A disintegrin and metalloproteinase with thrombospondin motifs 9 (ADAM-TS 9) (ADAM-TS9) (ADAMTS-9) (EC 3.4.24.-) Homo sapiens (Human) GO:0002088; GO:0003179; GO:0003229; GO:0004222; GO:0005615; GO:0005783; GO:0006508; GO:0008237; GO:0008270; GO:0009617; GO:0009986; GO:0010596; GO:0015031; GO:0016192; GO:0030198; GO:0030318; GO:0031012; GO:0035909; GO:0045636; GO:0048593; GO:0061303; GO:0090673; GO:1903671 aorta morphogenesis [GO:0035909]; camera-type eye morphogenesis [GO:0048593]; cornea development in camera-type eye [GO:0061303]; endothelial cell-matrix adhesion [GO:0090673]; extracellular matrix organization [GO:0030198]; heart valve morphogenesis [GO:0003179]; lens development in camera-type eye [GO:0002088]; melanocyte differentiation [GO:0030318]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of sprouting angiogenesis [GO:1903671]; positive regulation of melanocyte differentiation [GO:0045636]; protein transport [GO:0015031]; proteolysis [GO:0006508]; response to bacterium [GO:0009617]; ventricular cardiac muscle tissue development [GO:0003229]; vesicle-mediated transport [GO:0016192] cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615] metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; zinc ion binding [GO:0008270] g21446.t1 Q9P2N4 34.118 255 1.9e-26 122.0 sp|Q9P2N4|ATS9_HUMAN A disintegrin and metalloproteinase with thrombospondin motifs 9 OS=Homo sapiens OX=9606 GN=ADAMTS9 PE=1 SV=4 ATS9_HUMAN reviewed A disintegrin and metalloproteinase with thrombospondin motifs 9 (ADAM-TS 9) (ADAM-TS9) (ADAMTS-9) (EC 3.4.24.-) Homo sapiens (Human) GO:0002088; GO:0003179; GO:0003229; GO:0004222; GO:0005615; GO:0005783; GO:0006508; GO:0008237; GO:0008270; GO:0009617; GO:0009986; GO:0010596; GO:0015031; GO:0016192; GO:0030198; GO:0030318; GO:0031012; GO:0035909; GO:0045636; GO:0048593; GO:0061303; GO:0090673; GO:1903671 aorta morphogenesis [GO:0035909]; camera-type eye morphogenesis [GO:0048593]; cornea development in camera-type eye [GO:0061303]; endothelial cell-matrix adhesion [GO:0090673]; extracellular matrix organization [GO:0030198]; heart valve morphogenesis [GO:0003179]; lens development in camera-type eye [GO:0002088]; melanocyte differentiation [GO:0030318]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of sprouting angiogenesis [GO:1903671]; positive regulation of melanocyte differentiation [GO:0045636]; protein transport [GO:0015031]; proteolysis [GO:0006508]; response to bacterium [GO:0009617]; ventricular cardiac muscle tissue development [GO:0003229]; vesicle-mediated transport [GO:0016192] cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615] metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; zinc ion binding [GO:0008270] g21446.t2 Q9P2N4 41.496 1511 0.0 1162.0 sp|Q9P2N4|ATS9_HUMAN A disintegrin and metalloproteinase with thrombospondin motifs 9 OS=Homo sapiens OX=9606 GN=ADAMTS9 PE=1 SV=4 ATS9_HUMAN reviewed A disintegrin and metalloproteinase with thrombospondin motifs 9 (ADAM-TS 9) (ADAM-TS9) (ADAMTS-9) (EC 3.4.24.-) Homo sapiens (Human) GO:0002088; GO:0003179; GO:0003229; GO:0004222; GO:0005615; GO:0005783; GO:0006508; GO:0008237; GO:0008270; GO:0009617; GO:0009986; GO:0010596; GO:0015031; GO:0016192; GO:0030198; GO:0030318; GO:0031012; GO:0035909; GO:0045636; GO:0048593; GO:0061303; GO:0090673; GO:1903671 aorta morphogenesis [GO:0035909]; camera-type eye morphogenesis [GO:0048593]; cornea development in camera-type eye [GO:0061303]; endothelial cell-matrix adhesion [GO:0090673]; extracellular matrix organization [GO:0030198]; heart valve morphogenesis [GO:0003179]; lens development in camera-type eye [GO:0002088]; melanocyte differentiation [GO:0030318]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of sprouting angiogenesis [GO:1903671]; positive regulation of melanocyte differentiation [GO:0045636]; protein transport [GO:0015031]; proteolysis [GO:0006508]; response to bacterium [GO:0009617]; ventricular cardiac muscle tissue development [GO:0003229]; vesicle-mediated transport [GO:0016192] cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615] metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; zinc ion binding [GO:0008270] g21446.t2 Q9P2N4 30.441 749 1.09e-87 320.0 sp|Q9P2N4|ATS9_HUMAN A disintegrin and metalloproteinase with thrombospondin motifs 9 OS=Homo sapiens OX=9606 GN=ADAMTS9 PE=1 SV=4 ATS9_HUMAN reviewed A disintegrin and metalloproteinase with thrombospondin motifs 9 (ADAM-TS 9) (ADAM-TS9) (ADAMTS-9) (EC 3.4.24.-) Homo sapiens (Human) GO:0002088; GO:0003179; GO:0003229; GO:0004222; GO:0005615; GO:0005783; GO:0006508; GO:0008237; GO:0008270; GO:0009617; GO:0009986; GO:0010596; GO:0015031; GO:0016192; GO:0030198; GO:0030318; GO:0031012; GO:0035909; GO:0045636; GO:0048593; GO:0061303; GO:0090673; GO:1903671 aorta morphogenesis [GO:0035909]; camera-type eye morphogenesis [GO:0048593]; cornea development in camera-type eye [GO:0061303]; endothelial cell-matrix adhesion [GO:0090673]; extracellular matrix organization [GO:0030198]; heart valve morphogenesis [GO:0003179]; lens development in camera-type eye [GO:0002088]; melanocyte differentiation [GO:0030318]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of sprouting angiogenesis [GO:1903671]; positive regulation of melanocyte differentiation [GO:0045636]; protein transport [GO:0015031]; proteolysis [GO:0006508]; response to bacterium [GO:0009617]; ventricular cardiac muscle tissue development [GO:0003229]; vesicle-mediated transport [GO:0016192] cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615] metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; zinc ion binding [GO:0008270] g21446.t2 Q9P2N4 32.38 769 4.43e-87 318.0 sp|Q9P2N4|ATS9_HUMAN A disintegrin and metalloproteinase with thrombospondin motifs 9 OS=Homo sapiens OX=9606 GN=ADAMTS9 PE=1 SV=4 ATS9_HUMAN reviewed A disintegrin and metalloproteinase with thrombospondin motifs 9 (ADAM-TS 9) (ADAM-TS9) (ADAMTS-9) (EC 3.4.24.-) Homo sapiens (Human) GO:0002088; GO:0003179; GO:0003229; GO:0004222; GO:0005615; GO:0005783; GO:0006508; GO:0008237; GO:0008270; GO:0009617; GO:0009986; GO:0010596; GO:0015031; GO:0016192; GO:0030198; GO:0030318; GO:0031012; GO:0035909; GO:0045636; GO:0048593; GO:0061303; GO:0090673; GO:1903671 aorta morphogenesis [GO:0035909]; camera-type eye morphogenesis [GO:0048593]; cornea development in camera-type eye [GO:0061303]; endothelial cell-matrix adhesion [GO:0090673]; extracellular matrix organization [GO:0030198]; heart valve morphogenesis [GO:0003179]; lens development in camera-type eye [GO:0002088]; melanocyte differentiation [GO:0030318]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of sprouting angiogenesis [GO:1903671]; positive regulation of melanocyte differentiation [GO:0045636]; protein transport [GO:0015031]; proteolysis [GO:0006508]; response to bacterium [GO:0009617]; ventricular cardiac muscle tissue development [GO:0003229]; vesicle-mediated transport [GO:0016192] cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615] metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; zinc ion binding [GO:0008270] g21446.t2 Q9P2N4 32.461 382 6.029999999999999e-42 173.0 sp|Q9P2N4|ATS9_HUMAN A disintegrin and metalloproteinase with thrombospondin motifs 9 OS=Homo sapiens OX=9606 GN=ADAMTS9 PE=1 SV=4 ATS9_HUMAN reviewed A disintegrin and metalloproteinase with thrombospondin motifs 9 (ADAM-TS 9) (ADAM-TS9) (ADAMTS-9) (EC 3.4.24.-) Homo sapiens (Human) GO:0002088; GO:0003179; GO:0003229; GO:0004222; GO:0005615; GO:0005783; GO:0006508; GO:0008237; GO:0008270; GO:0009617; GO:0009986; GO:0010596; GO:0015031; GO:0016192; GO:0030198; GO:0030318; GO:0031012; GO:0035909; GO:0045636; GO:0048593; GO:0061303; GO:0090673; GO:1903671 aorta morphogenesis [GO:0035909]; camera-type eye morphogenesis [GO:0048593]; cornea development in camera-type eye [GO:0061303]; endothelial cell-matrix adhesion [GO:0090673]; extracellular matrix organization [GO:0030198]; heart valve morphogenesis [GO:0003179]; lens development in camera-type eye [GO:0002088]; melanocyte differentiation [GO:0030318]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of sprouting angiogenesis [GO:1903671]; positive regulation of melanocyte differentiation [GO:0045636]; protein transport [GO:0015031]; proteolysis [GO:0006508]; response to bacterium [GO:0009617]; ventricular cardiac muscle tissue development [GO:0003229]; vesicle-mediated transport [GO:0016192] cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615] metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; zinc ion binding [GO:0008270] g21446.t2 Q9P2N4 34.118 255 1.61e-26 122.0 sp|Q9P2N4|ATS9_HUMAN A disintegrin and metalloproteinase with thrombospondin motifs 9 OS=Homo sapiens OX=9606 GN=ADAMTS9 PE=1 SV=4 ATS9_HUMAN reviewed A disintegrin and metalloproteinase with thrombospondin motifs 9 (ADAM-TS 9) (ADAM-TS9) (ADAMTS-9) (EC 3.4.24.-) Homo sapiens (Human) GO:0002088; GO:0003179; GO:0003229; GO:0004222; GO:0005615; GO:0005783; GO:0006508; GO:0008237; GO:0008270; GO:0009617; GO:0009986; GO:0010596; GO:0015031; GO:0016192; GO:0030198; GO:0030318; GO:0031012; GO:0035909; GO:0045636; GO:0048593; GO:0061303; GO:0090673; GO:1903671 aorta morphogenesis [GO:0035909]; camera-type eye morphogenesis [GO:0048593]; cornea development in camera-type eye [GO:0061303]; endothelial cell-matrix adhesion [GO:0090673]; extracellular matrix organization [GO:0030198]; heart valve morphogenesis [GO:0003179]; lens development in camera-type eye [GO:0002088]; melanocyte differentiation [GO:0030318]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of sprouting angiogenesis [GO:1903671]; positive regulation of melanocyte differentiation [GO:0045636]; protein transport [GO:0015031]; proteolysis [GO:0006508]; response to bacterium [GO:0009617]; ventricular cardiac muscle tissue development [GO:0003229]; vesicle-mediated transport [GO:0016192] cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615] metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; zinc ion binding [GO:0008270] g21447.t1 Q9P2N4 35.028 177 3.410000000000001e-21 95.5 sp|Q9P2N4|ATS9_HUMAN A disintegrin and metalloproteinase with thrombospondin motifs 9 OS=Homo sapiens OX=9606 GN=ADAMTS9 PE=1 SV=4 ATS9_HUMAN reviewed A disintegrin and metalloproteinase with thrombospondin motifs 9 (ADAM-TS 9) (ADAM-TS9) (ADAMTS-9) (EC 3.4.24.-) Homo sapiens (Human) GO:0002088; GO:0003179; GO:0003229; GO:0004222; GO:0005615; GO:0005783; GO:0006508; GO:0008237; GO:0008270; GO:0009617; GO:0009986; GO:0010596; GO:0015031; GO:0016192; GO:0030198; GO:0030318; GO:0031012; GO:0035909; GO:0045636; GO:0048593; GO:0061303; GO:0090673; GO:1903671 aorta morphogenesis [GO:0035909]; camera-type eye morphogenesis [GO:0048593]; cornea development in camera-type eye [GO:0061303]; endothelial cell-matrix adhesion [GO:0090673]; extracellular matrix organization [GO:0030198]; heart valve morphogenesis [GO:0003179]; lens development in camera-type eye [GO:0002088]; melanocyte differentiation [GO:0030318]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of sprouting angiogenesis [GO:1903671]; positive regulation of melanocyte differentiation [GO:0045636]; protein transport [GO:0015031]; proteolysis [GO:0006508]; response to bacterium [GO:0009617]; ventricular cardiac muscle tissue development [GO:0003229]; vesicle-mediated transport [GO:0016192] cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615] metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; zinc ion binding [GO:0008270] g21448.t1 F1R4Y7 35.958 673 5.71e-116 366.0 sp|F1R4Y7|CEP83_DANRE Centrosomal protein of 83 kDa OS=Danio rerio OX=7955 GN=cep83 PE=3 SV=2 g21449.t1 B0S5N4 35.545 1733 0.0 914.0 sp|B0S5N4|PLXA3_DANRE Plexin A3 OS=Danio rerio OX=7955 GN=plxna3 PE=2 SV=2 PLXA3_DANRE reviewed Plexin A3 Danio rerio (Zebrafish) (Brachydanio rerio) GO:0002116; GO:0003205; GO:0005886; GO:0007416; GO:0008045; GO:0016020; GO:0017154; GO:0030334; GO:0042802; GO:0048675; GO:0048696; GO:0048755; GO:0060272; GO:0071526 axon extension [GO:0048675]; branching morphogenesis of a nerve [GO:0048755]; cardiac chamber development [GO:0003205]; embryonic skeletal joint morphogenesis [GO:0060272]; motor neuron axon guidance [GO:0008045]; regulation of cell migration [GO:0030334]; regulation of collateral sprouting in absence of injury [GO:0048696]; semaphorin-plexin signaling pathway [GO:0071526]; synapse assembly [GO:0007416] membrane [GO:0016020]; plasma membrane [GO:0005886]; semaphorin receptor complex [GO:0002116] identical protein binding [GO:0042802]; semaphorin receptor activity [GO:0017154] g21450.t1 A8E0R9 53.96 202 4.21e-71 238.0 sp|A8E0R9|GRIP2_XENLA Glutamate receptor-interacting protein 2 OS=Xenopus laevis OX=8355 GN=grip2 PE=2 SV=2 GRIP2_XENLA reviewed Glutamate receptor-interacting protein 2 (xGRIP2) (xGRIP2.1) Xenopus laevis (African clawed frog) GO:0005737; GO:0005938; GO:0007281; GO:0008354; GO:0032019; GO:0045495; GO:0098887 germ cell development [GO:0007281]; germ cell migration [GO:0008354]; neurotransmitter receptor transport, endosome to postsynaptic membrane [GO:0098887] cell cortex [GO:0005938]; cytoplasm [GO:0005737]; mitochondrial cloud [GO:0032019]; pole plasm [GO:0045495] g21451.t1 Q6DIK0 47.932 532 3.24e-146 452.0 sp|Q6DIK0|INT13_XENTR Integrator complex subunit 13 OS=Xenopus tropicalis OX=8364 GN=ints13 PE=2 SV=1 INT13_XENTR reviewed Integrator complex subunit 13 (Cell cycle regulator Mat89Bb homolog) (Germ cell tumor 1) (Protein asunder homolog) (Sarcoma antigen NY-SAR-95) Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0005634; GO:0005737; GO:0007346; GO:0030317; GO:0032039; GO:0051301; GO:0051642; GO:0080154; GO:0160232; GO:0160240 cell division [GO:0051301]; centrosome localization [GO:0051642]; flagellated sperm motility [GO:0030317]; regulation of fertilization [GO:0080154]; regulation of mitotic cell cycle [GO:0007346]; RNA polymerase II transcription initiation surveillance [GO:0160240] cytoplasm [GO:0005737]; INTAC complex [GO:0160232]; integrator complex [GO:0032039]; nucleus [GO:0005634] g21452.t1 Q6BEA0 29.946 1112 5.03e-120 411.0 sp|Q6BEA0|PLXA4_DANRE Plexin-A4 OS=Danio rerio OX=7955 GN=plxna4 PE=2 SV=1 PLXA4_DANRE reviewed Plexin-A4 Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001763; GO:0002116; GO:0005886; GO:0007411; GO:0007414; GO:0007416; GO:0016020; GO:0017154; GO:0030334; GO:0071526 axon guidance [GO:0007411]; axonal defasciculation [GO:0007414]; morphogenesis of a branching structure [GO:0001763]; regulation of cell migration [GO:0030334]; semaphorin-plexin signaling pathway [GO:0071526]; synapse assembly [GO:0007416] membrane [GO:0016020]; plasma membrane [GO:0005886]; semaphorin receptor complex [GO:0002116] semaphorin receptor activity [GO:0017154] g21452.t2 Q6BEA0 28.316 1176 1.17e-107 376.0 sp|Q6BEA0|PLXA4_DANRE Plexin-A4 OS=Danio rerio OX=7955 GN=plxna4 PE=2 SV=1 PLXA4_DANRE reviewed Plexin-A4 Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001763; GO:0002116; GO:0005886; GO:0007411; GO:0007414; GO:0007416; GO:0016020; GO:0017154; GO:0030334; GO:0071526 axon guidance [GO:0007411]; axonal defasciculation [GO:0007414]; morphogenesis of a branching structure [GO:0001763]; regulation of cell migration [GO:0030334]; semaphorin-plexin signaling pathway [GO:0071526]; synapse assembly [GO:0007416] membrane [GO:0016020]; plasma membrane [GO:0005886]; semaphorin receptor complex [GO:0002116] semaphorin receptor activity [GO:0017154] g21454.t1 Q94K49 32.302 291 2.33e-41 152.0 sp|Q94K49|ALP1_ARATH Protein ANTAGONIST OF LIKE HETEROCHROMATIN PROTEIN 1 OS=Arabidopsis thaliana OX=3702 GN=ALP1 PE=1 SV=1 ALP1_ARATH reviewed Protein ANTAGONIST OF LIKE HETEROCHROMATIN PROTEIN 1 (EC 3.1.-.-) Arabidopsis thaliana (Mouse-ear cress) GO:0003682; GO:0004518; GO:0005634; GO:0016787; GO:0035098; GO:0035102; GO:0040029; GO:0046872 epigenetic regulation of gene expression [GO:0040029] ESC/E(Z) complex [GO:0035098]; nucleus [GO:0005634]; PRC1 complex [GO:0035102] chromatin binding [GO:0003682]; hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]; nuclease activity [GO:0004518] g21455.t1 Q9HCM2 28.71 1233 5.32e-121 419.0 sp|Q9HCM2|PLXA4_HUMAN Plexin-A4 OS=Homo sapiens OX=9606 GN=PLXNA4 PE=1 SV=4 PLXA4_HUMAN reviewed Plexin-A4 Homo sapiens (Human) GO:0002116; GO:0005886; GO:0007411; GO:0007416; GO:0008045; GO:0017154; GO:0021612; GO:0021615; GO:0021637; GO:0021644; GO:0021784; GO:0021785; GO:0021793; GO:0021960; GO:0030334; GO:0035050; GO:0048485; GO:0048841; GO:0050923; GO:0071526; GO:0097492; GO:0099558; GO:0150053 anterior commissure morphogenesis [GO:0021960]; axon guidance [GO:0007411]; branchiomotor neuron axon guidance [GO:0021785]; chemorepulsion of branchiomotor axon [GO:0021793]; embryonic heart tube development [GO:0035050]; facial nerve structural organization [GO:0021612]; glossopharyngeal nerve morphogenesis [GO:0021615]; maintenance of synapse structure [GO:0099558]; motor neuron axon guidance [GO:0008045]; postganglionic parasympathetic fiber development [GO:0021784]; regulation of axon extension involved in axon guidance [GO:0048841]; regulation of cell migration [GO:0030334]; regulation of negative chemotaxis [GO:0050923]; semaphorin-plexin signaling pathway [GO:0071526]; sympathetic nervous system development [GO:0048485]; sympathetic neuron axon guidance [GO:0097492]; synapse assembly [GO:0007416]; trigeminal nerve structural organization [GO:0021637]; vagus nerve morphogenesis [GO:0021644] cerebellar climbing fiber to Purkinje cell synapse [GO:0150053]; plasma membrane [GO:0005886]; semaphorin receptor complex [GO:0002116] semaphorin receptor activity [GO:0017154] g21457.t1 P70206 29.511 1003 1.02e-96 349.0 sp|P70206|PLXA1_MOUSE Plexin-A1 OS=Mus musculus OX=10090 GN=Plxna1 PE=1 SV=1 PLXA1_MOUSE reviewed Plexin-A1 (Plex 1) (Plexin-1) Mus musculus (Mouse) GO:0002116; GO:0002291; GO:0005654; GO:0005829; GO:0005886; GO:0007416; GO:0014910; GO:0016020; GO:0017154; GO:0021628; GO:0021828; GO:0030334; GO:0045202; GO:0060666; GO:0071526; GO:0097485; GO:0098978; GO:1990138 dichotomous subdivision of terminal units involved in salivary gland branching [GO:0060666]; gonadotrophin-releasing hormone neuronal migration to the hypothalamus [GO:0021828]; neuron projection extension [GO:1990138]; neuron projection guidance [GO:0097485]; olfactory nerve formation [GO:0021628]; regulation of cell migration [GO:0030334]; regulation of smooth muscle cell migration [GO:0014910]; semaphorin-plexin signaling pathway [GO:0071526]; synapse assembly [GO:0007416]; T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell [GO:0002291] cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; semaphorin receptor complex [GO:0002116]; synapse [GO:0045202] semaphorin receptor activity [GO:0017154] g21457.t1 P70206 28.033 717 3.8299999999999995e-67 255.0 sp|P70206|PLXA1_MOUSE Plexin-A1 OS=Mus musculus OX=10090 GN=Plxna1 PE=1 SV=1 PLXA1_MOUSE reviewed Plexin-A1 (Plex 1) (Plexin-1) Mus musculus (Mouse) GO:0002116; GO:0002291; GO:0005654; GO:0005829; GO:0005886; GO:0007416; GO:0014910; GO:0016020; GO:0017154; GO:0021628; GO:0021828; GO:0030334; GO:0045202; GO:0060666; GO:0071526; GO:0097485; GO:0098978; GO:1990138 dichotomous subdivision of terminal units involved in salivary gland branching [GO:0060666]; gonadotrophin-releasing hormone neuronal migration to the hypothalamus [GO:0021828]; neuron projection extension [GO:1990138]; neuron projection guidance [GO:0097485]; olfactory nerve formation [GO:0021628]; regulation of cell migration [GO:0030334]; regulation of smooth muscle cell migration [GO:0014910]; semaphorin-plexin signaling pathway [GO:0071526]; synapse assembly [GO:0007416]; T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell [GO:0002291] cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; semaphorin receptor complex [GO:0002116]; synapse [GO:0045202] semaphorin receptor activity [GO:0017154] g21460.t1 O43157 40.244 164 2.66e-37 142.0 sp|O43157|PLXB1_HUMAN Plexin-B1 OS=Homo sapiens OX=9606 GN=PLXNB1 PE=1 SV=3 PLXB1_HUMAN reviewed Plexin-B1 (Semaphorin receptor SEP) Homo sapiens (Human) GO:0002116; GO:0004888; GO:0005096; GO:0005576; GO:0005886; GO:0007162; GO:0007416; GO:0008360; GO:0016477; GO:0017154; GO:0030215; GO:0030334; GO:0032794; GO:0033689; GO:0035025; GO:0035556; GO:0043547; GO:0043931; GO:0045211; GO:0048812; GO:0050772; GO:0051493; GO:0051897; GO:0071526; GO:0098978; GO:1904862 cell migration [GO:0016477]; inhibitory synapse assembly [GO:1904862]; intracellular signal transduction [GO:0035556]; negative regulation of cell adhesion [GO:0007162]; negative regulation of osteoblast proliferation [GO:0033689]; neuron projection morphogenesis [GO:0048812]; ossification involved in bone maturation [GO:0043931]; positive regulation of axonogenesis [GO:0050772]; positive regulation of GTPase activity [GO:0043547]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of Rho protein signal transduction [GO:0035025]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; regulation of cytoskeleton organization [GO:0051493]; semaphorin-plexin signaling pathway [GO:0071526]; synapse assembly [GO:0007416] extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; semaphorin receptor complex [GO:0002116] GTPase activating protein binding [GO:0032794]; GTPase activator activity [GO:0005096]; semaphorin receptor activity [GO:0017154]; semaphorin receptor binding [GO:0030215]; transmembrane signaling receptor activity [GO:0004888] g21461.t1 Q9V4A7 29.243 1043 3.08e-104 372.0 sp|Q9V4A7|PLXB_DROME Plexin-B OS=Drosophila melanogaster OX=7227 GN=PlexB PE=1 SV=2 PLXB_DROME reviewed Plexin-B Drosophila melanogaster (Fruit fly) GO:0002116; GO:0005886; GO:0007162; GO:0007411; GO:0007416; GO:0008045; GO:0008360; GO:0017154; GO:0030334; GO:0030425; GO:0050772; GO:0070593; GO:0071526; GO:0071678; GO:0097374 axon guidance [GO:0007411]; dendrite self-avoidance [GO:0070593]; motor neuron axon guidance [GO:0008045]; negative regulation of cell adhesion [GO:0007162]; olfactory bulb axon guidance [GO:0071678]; positive regulation of axonogenesis [GO:0050772]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; semaphorin-plexin signaling pathway [GO:0071526]; sensory neuron axon guidance [GO:0097374]; synapse assembly [GO:0007416] dendrite [GO:0030425]; plasma membrane [GO:0005886]; semaphorin receptor complex [GO:0002116] semaphorin receptor activity [GO:0017154] g21461.t1 Q9V4A7 30.737 475 2.71e-49 197.0 sp|Q9V4A7|PLXB_DROME Plexin-B OS=Drosophila melanogaster OX=7227 GN=PlexB PE=1 SV=2 PLXB_DROME reviewed Plexin-B Drosophila melanogaster (Fruit fly) GO:0002116; GO:0005886; GO:0007162; GO:0007411; GO:0007416; GO:0008045; GO:0008360; GO:0017154; GO:0030334; GO:0030425; GO:0050772; GO:0070593; GO:0071526; GO:0071678; GO:0097374 axon guidance [GO:0007411]; dendrite self-avoidance [GO:0070593]; motor neuron axon guidance [GO:0008045]; negative regulation of cell adhesion [GO:0007162]; olfactory bulb axon guidance [GO:0071678]; positive regulation of axonogenesis [GO:0050772]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; semaphorin-plexin signaling pathway [GO:0071526]; sensory neuron axon guidance [GO:0097374]; synapse assembly [GO:0007416] dendrite [GO:0030425]; plasma membrane [GO:0005886]; semaphorin receptor complex [GO:0002116] semaphorin receptor activity [GO:0017154] g21462.t1 Q9ULL4 34.61 783 1.1499999999999999e-131 436.0 sp|Q9ULL4|PLXB3_HUMAN Plexin-B3 OS=Homo sapiens OX=9606 GN=PLXNB3 PE=1 SV=2 PLXB3_HUMAN reviewed Plexin-B3 Homo sapiens (Human) GO:0001938; GO:0002116; GO:0005886; GO:0007156; GO:0007162; GO:0007416; GO:0008360; GO:0009986; GO:0010593; GO:0010976; GO:0017154; GO:0019904; GO:0030336; GO:0034260; GO:0050772; GO:0050918; GO:0051022; GO:0060326; GO:0071526; GO:0098632 cell chemotaxis [GO:0060326]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell adhesion [GO:0007162]; negative regulation of cell migration [GO:0030336]; negative regulation of GTPase activity [GO:0034260]; negative regulation of lamellipodium assembly [GO:0010593]; positive chemotaxis [GO:0050918]; positive regulation of axonogenesis [GO:0050772]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of neuron projection development [GO:0010976]; regulation of cell shape [GO:0008360]; semaphorin-plexin signaling pathway [GO:0071526]; synapse assembly [GO:0007416] cell surface [GO:0009986]; plasma membrane [GO:0005886]; semaphorin receptor complex [GO:0002116] cell-cell adhesion mediator activity [GO:0098632]; protein domain specific binding [GO:0019904]; Rho GDP-dissociation inhibitor binding [GO:0051022]; semaphorin receptor activity [GO:0017154] g21465.t1 Q80UG2 29.619 1023 1.03e-113 390.0 sp|Q80UG2|PLXA4_MOUSE Plexin-A4 OS=Mus musculus OX=10090 GN=Plxna4 PE=1 SV=3 PLXA4_MOUSE reviewed Plexin-A4 Mus musculus (Mouse) GO:0002116; GO:0005886; GO:0007399; GO:0007411; GO:0007416; GO:0008045; GO:0017154; GO:0021602; GO:0021610; GO:0021612; GO:0021615; GO:0021636; GO:0021637; GO:0021644; GO:0021784; GO:0021785; GO:0021793; GO:0021960; GO:0030334; GO:0035050; GO:0048485; GO:0048812; GO:0048841; GO:0050923; GO:0071526; GO:0097492; GO:0099558; GO:0150053 anterior commissure morphogenesis [GO:0021960]; axon guidance [GO:0007411]; branchiomotor neuron axon guidance [GO:0021785]; chemorepulsion of branchiomotor axon [GO:0021793]; cranial nerve morphogenesis [GO:0021602]; embryonic heart tube development [GO:0035050]; facial nerve morphogenesis [GO:0021610]; facial nerve structural organization [GO:0021612]; glossopharyngeal nerve morphogenesis [GO:0021615]; maintenance of synapse structure [GO:0099558]; motor neuron axon guidance [GO:0008045]; nervous system development [GO:0007399]; neuron projection morphogenesis [GO:0048812]; postganglionic parasympathetic fiber development [GO:0021784]; regulation of axon extension involved in axon guidance [GO:0048841]; regulation of cell migration [GO:0030334]; regulation of negative chemotaxis [GO:0050923]; semaphorin-plexin signaling pathway [GO:0071526]; sympathetic nervous system development [GO:0048485]; sympathetic neuron axon guidance [GO:0097492]; synapse assembly [GO:0007416]; trigeminal nerve morphogenesis [GO:0021636]; trigeminal nerve structural organization [GO:0021637]; vagus nerve morphogenesis [GO:0021644] cerebellar climbing fiber to Purkinje cell synapse [GO:0150053]; plasma membrane [GO:0005886]; semaphorin receptor complex [GO:0002116] semaphorin receptor activity [GO:0017154] g21466.t1 Q9V4A7 28.051 631 1.42e-64 236.0 sp|Q9V4A7|PLXB_DROME Plexin-B OS=Drosophila melanogaster OX=7227 GN=PlexB PE=1 SV=2 PLXB_DROME reviewed Plexin-B Drosophila melanogaster (Fruit fly) GO:0002116; GO:0005886; GO:0007162; GO:0007411; GO:0007416; GO:0008045; GO:0008360; GO:0017154; GO:0030334; GO:0030425; GO:0050772; GO:0070593; GO:0071526; GO:0071678; GO:0097374 axon guidance [GO:0007411]; dendrite self-avoidance [GO:0070593]; motor neuron axon guidance [GO:0008045]; negative regulation of cell adhesion [GO:0007162]; olfactory bulb axon guidance [GO:0071678]; positive regulation of axonogenesis [GO:0050772]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; semaphorin-plexin signaling pathway [GO:0071526]; sensory neuron axon guidance [GO:0097374]; synapse assembly [GO:0007416] dendrite [GO:0030425]; plasma membrane [GO:0005886]; semaphorin receptor complex [GO:0002116] semaphorin receptor activity [GO:0017154] g21467.t1 Q8CJH3 32.069 923 6.1e-130 434.0 sp|Q8CJH3|PLXB1_MOUSE Plexin-B1 OS=Mus musculus OX=10090 GN=Plxnb1 PE=1 SV=2 PLXB1_MOUSE reviewed Plexin-B1 Mus musculus (Mouse) GO:0002116; GO:0005886; GO:0007162; GO:0007416; GO:0008360; GO:0017154; GO:0030334; GO:0032794; GO:0033689; GO:0035025; GO:0043547; GO:0043931; GO:0045211; GO:0048812; GO:0050772; GO:0051493; GO:0051897; GO:0071526; GO:0098978; GO:1904862 inhibitory synapse assembly [GO:1904862]; negative regulation of cell adhesion [GO:0007162]; negative regulation of osteoblast proliferation [GO:0033689]; neuron projection morphogenesis [GO:0048812]; ossification involved in bone maturation [GO:0043931]; positive regulation of axonogenesis [GO:0050772]; positive regulation of GTPase activity [GO:0043547]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of Rho protein signal transduction [GO:0035025]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; regulation of cytoskeleton organization [GO:0051493]; semaphorin-plexin signaling pathway [GO:0071526]; synapse assembly [GO:0007416] glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; semaphorin receptor complex [GO:0002116] GTPase activating protein binding [GO:0032794]; semaphorin receptor activity [GO:0017154] g21469.t1 Q80UG2 29.089 1241 4.0500000000000005e-124 428.0 sp|Q80UG2|PLXA4_MOUSE Plexin-A4 OS=Mus musculus OX=10090 GN=Plxna4 PE=1 SV=3 PLXA4_MOUSE reviewed Plexin-A4 Mus musculus (Mouse) GO:0002116; GO:0005886; GO:0007399; GO:0007411; GO:0007416; GO:0008045; GO:0017154; GO:0021602; GO:0021610; GO:0021612; GO:0021615; GO:0021636; GO:0021637; GO:0021644; GO:0021784; GO:0021785; GO:0021793; GO:0021960; GO:0030334; GO:0035050; GO:0048485; GO:0048812; GO:0048841; GO:0050923; GO:0071526; GO:0097492; GO:0099558; GO:0150053 anterior commissure morphogenesis [GO:0021960]; axon guidance [GO:0007411]; branchiomotor neuron axon guidance [GO:0021785]; chemorepulsion of branchiomotor axon [GO:0021793]; cranial nerve morphogenesis [GO:0021602]; embryonic heart tube development [GO:0035050]; facial nerve morphogenesis [GO:0021610]; facial nerve structural organization [GO:0021612]; glossopharyngeal nerve morphogenesis [GO:0021615]; maintenance of synapse structure [GO:0099558]; motor neuron axon guidance [GO:0008045]; nervous system development [GO:0007399]; neuron projection morphogenesis [GO:0048812]; postganglionic parasympathetic fiber development [GO:0021784]; regulation of axon extension involved in axon guidance [GO:0048841]; regulation of cell migration [GO:0030334]; regulation of negative chemotaxis [GO:0050923]; semaphorin-plexin signaling pathway [GO:0071526]; sympathetic nervous system development [GO:0048485]; sympathetic neuron axon guidance [GO:0097492]; synapse assembly [GO:0007416]; trigeminal nerve morphogenesis [GO:0021636]; trigeminal nerve structural organization [GO:0021637]; vagus nerve morphogenesis [GO:0021644] cerebellar climbing fiber to Purkinje cell synapse [GO:0150053]; plasma membrane [GO:0005886]; semaphorin receptor complex [GO:0002116] semaphorin receptor activity [GO:0017154] g21470.t1 Q9V4A7 29.278 526 1.06e-55 209.0 sp|Q9V4A7|PLXB_DROME Plexin-B OS=Drosophila melanogaster OX=7227 GN=PlexB PE=1 SV=2 PLXB_DROME reviewed Plexin-B Drosophila melanogaster (Fruit fly) GO:0002116; GO:0005886; GO:0007162; GO:0007411; GO:0007416; GO:0008045; GO:0008360; GO:0017154; GO:0030334; GO:0030425; GO:0050772; GO:0070593; GO:0071526; GO:0071678; GO:0097374 axon guidance [GO:0007411]; dendrite self-avoidance [GO:0070593]; motor neuron axon guidance [GO:0008045]; negative regulation of cell adhesion [GO:0007162]; olfactory bulb axon guidance [GO:0071678]; positive regulation of axonogenesis [GO:0050772]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; semaphorin-plexin signaling pathway [GO:0071526]; sensory neuron axon guidance [GO:0097374]; synapse assembly [GO:0007416] dendrite [GO:0030425]; plasma membrane [GO:0005886]; semaphorin receptor complex [GO:0002116] semaphorin receptor activity [GO:0017154] g21471.t1 Q6NZW8 91.257 183 5.28e-126 356.0 sp|Q6NZW8|AR8BA_DANRE ADP-ribosylation factor-like protein 8B-A OS=Danio rerio OX=7955 GN=arl8ba PE=2 SV=1 g21472.t1 Q9ULL4 35.971 139 1.15e-22 97.8 sp|Q9ULL4|PLXB3_HUMAN Plexin-B3 OS=Homo sapiens OX=9606 GN=PLXNB3 PE=1 SV=2 PLXB3_HUMAN reviewed Plexin-B3 Homo sapiens (Human) GO:0001938; GO:0002116; GO:0005886; GO:0007156; GO:0007162; GO:0007416; GO:0008360; GO:0009986; GO:0010593; GO:0010976; GO:0017154; GO:0019904; GO:0030336; GO:0034260; GO:0050772; GO:0050918; GO:0051022; GO:0060326; GO:0071526; GO:0098632 cell chemotaxis [GO:0060326]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell adhesion [GO:0007162]; negative regulation of cell migration [GO:0030336]; negative regulation of GTPase activity [GO:0034260]; negative regulation of lamellipodium assembly [GO:0010593]; positive chemotaxis [GO:0050918]; positive regulation of axonogenesis [GO:0050772]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of neuron projection development [GO:0010976]; regulation of cell shape [GO:0008360]; semaphorin-plexin signaling pathway [GO:0071526]; synapse assembly [GO:0007416] cell surface [GO:0009986]; plasma membrane [GO:0005886]; semaphorin receptor complex [GO:0002116] cell-cell adhesion mediator activity [GO:0098632]; protein domain specific binding [GO:0019904]; Rho GDP-dissociation inhibitor binding [GO:0051022]; semaphorin receptor activity [GO:0017154] g21473.t1 Q9V4A7 28.235 340 3.97e-23 105.0 sp|Q9V4A7|PLXB_DROME Plexin-B OS=Drosophila melanogaster OX=7227 GN=PlexB PE=1 SV=2 PLXB_DROME reviewed Plexin-B Drosophila melanogaster (Fruit fly) GO:0002116; GO:0005886; GO:0007162; GO:0007411; GO:0007416; GO:0008045; GO:0008360; GO:0017154; GO:0030334; GO:0030425; GO:0050772; GO:0070593; GO:0071526; GO:0071678; GO:0097374 axon guidance [GO:0007411]; dendrite self-avoidance [GO:0070593]; motor neuron axon guidance [GO:0008045]; negative regulation of cell adhesion [GO:0007162]; olfactory bulb axon guidance [GO:0071678]; positive regulation of axonogenesis [GO:0050772]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; semaphorin-plexin signaling pathway [GO:0071526]; sensory neuron axon guidance [GO:0097374]; synapse assembly [GO:0007416] dendrite [GO:0030425]; plasma membrane [GO:0005886]; semaphorin receptor complex [GO:0002116] semaphorin receptor activity [GO:0017154] g21474.t1 Q9V4A7 27.714 350 8.910000000000001e-27 117.0 sp|Q9V4A7|PLXB_DROME Plexin-B OS=Drosophila melanogaster OX=7227 GN=PlexB PE=1 SV=2 PLXB_DROME reviewed Plexin-B Drosophila melanogaster (Fruit fly) GO:0002116; GO:0005886; GO:0007162; GO:0007411; GO:0007416; GO:0008045; GO:0008360; GO:0017154; GO:0030334; GO:0030425; GO:0050772; GO:0070593; GO:0071526; GO:0071678; GO:0097374 axon guidance [GO:0007411]; dendrite self-avoidance [GO:0070593]; motor neuron axon guidance [GO:0008045]; negative regulation of cell adhesion [GO:0007162]; olfactory bulb axon guidance [GO:0071678]; positive regulation of axonogenesis [GO:0050772]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; semaphorin-plexin signaling pathway [GO:0071526]; sensory neuron axon guidance [GO:0097374]; synapse assembly [GO:0007416] dendrite [GO:0030425]; plasma membrane [GO:0005886]; semaphorin receptor complex [GO:0002116] semaphorin receptor activity [GO:0017154] g21475.t1 Q9HCM2 28.909 339 7.300000000000001e-27 117.0 sp|Q9HCM2|PLXA4_HUMAN Plexin-A4 OS=Homo sapiens OX=9606 GN=PLXNA4 PE=1 SV=4 PLXA4_HUMAN reviewed Plexin-A4 Homo sapiens (Human) GO:0002116; GO:0005886; GO:0007411; GO:0007416; GO:0008045; GO:0017154; GO:0021612; GO:0021615; GO:0021637; GO:0021644; GO:0021784; GO:0021785; GO:0021793; GO:0021960; GO:0030334; GO:0035050; GO:0048485; GO:0048841; GO:0050923; GO:0071526; GO:0097492; GO:0099558; GO:0150053 anterior commissure morphogenesis [GO:0021960]; axon guidance [GO:0007411]; branchiomotor neuron axon guidance [GO:0021785]; chemorepulsion of branchiomotor axon [GO:0021793]; embryonic heart tube development [GO:0035050]; facial nerve structural organization [GO:0021612]; glossopharyngeal nerve morphogenesis [GO:0021615]; maintenance of synapse structure [GO:0099558]; motor neuron axon guidance [GO:0008045]; postganglionic parasympathetic fiber development [GO:0021784]; regulation of axon extension involved in axon guidance [GO:0048841]; regulation of cell migration [GO:0030334]; regulation of negative chemotaxis [GO:0050923]; semaphorin-plexin signaling pathway [GO:0071526]; sympathetic nervous system development [GO:0048485]; sympathetic neuron axon guidance [GO:0097492]; synapse assembly [GO:0007416]; trigeminal nerve structural organization [GO:0021637]; vagus nerve morphogenesis [GO:0021644] cerebellar climbing fiber to Purkinje cell synapse [GO:0150053]; plasma membrane [GO:0005886]; semaphorin receptor complex [GO:0002116] semaphorin receptor activity [GO:0017154] g21476.t1 Q9V4A7 27.419 310 6.0000000000000006e-21 98.2 sp|Q9V4A7|PLXB_DROME Plexin-B OS=Drosophila melanogaster OX=7227 GN=PlexB PE=1 SV=2 PLXB_DROME reviewed Plexin-B Drosophila melanogaster (Fruit fly) GO:0002116; GO:0005886; GO:0007162; GO:0007411; GO:0007416; GO:0008045; GO:0008360; GO:0017154; GO:0030334; GO:0030425; GO:0050772; GO:0070593; GO:0071526; GO:0071678; GO:0097374 axon guidance [GO:0007411]; dendrite self-avoidance [GO:0070593]; motor neuron axon guidance [GO:0008045]; negative regulation of cell adhesion [GO:0007162]; olfactory bulb axon guidance [GO:0071678]; positive regulation of axonogenesis [GO:0050772]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; semaphorin-plexin signaling pathway [GO:0071526]; sensory neuron axon guidance [GO:0097374]; synapse assembly [GO:0007416] dendrite [GO:0030425]; plasma membrane [GO:0005886]; semaphorin receptor complex [GO:0002116] semaphorin receptor activity [GO:0017154] g21477.t1 Q9V4A7 27.907 344 3.63e-25 112.0 sp|Q9V4A7|PLXB_DROME Plexin-B OS=Drosophila melanogaster OX=7227 GN=PlexB PE=1 SV=2 PLXB_DROME reviewed Plexin-B Drosophila melanogaster (Fruit fly) GO:0002116; GO:0005886; GO:0007162; GO:0007411; GO:0007416; GO:0008045; GO:0008360; GO:0017154; GO:0030334; GO:0030425; GO:0050772; GO:0070593; GO:0071526; GO:0071678; GO:0097374 axon guidance [GO:0007411]; dendrite self-avoidance [GO:0070593]; motor neuron axon guidance [GO:0008045]; negative regulation of cell adhesion [GO:0007162]; olfactory bulb axon guidance [GO:0071678]; positive regulation of axonogenesis [GO:0050772]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; semaphorin-plexin signaling pathway [GO:0071526]; sensory neuron axon guidance [GO:0097374]; synapse assembly [GO:0007416] dendrite [GO:0030425]; plasma membrane [GO:0005886]; semaphorin receptor complex [GO:0002116] semaphorin receptor activity [GO:0017154] g21481.t1 Q9V4A7 26.733 808 3.98e-60 233.0 sp|Q9V4A7|PLXB_DROME Plexin-B OS=Drosophila melanogaster OX=7227 GN=PlexB PE=1 SV=2 PLXB_DROME reviewed Plexin-B Drosophila melanogaster (Fruit fly) GO:0002116; GO:0005886; GO:0007162; GO:0007411; GO:0007416; GO:0008045; GO:0008360; GO:0017154; GO:0030334; GO:0030425; GO:0050772; GO:0070593; GO:0071526; GO:0071678; GO:0097374 axon guidance [GO:0007411]; dendrite self-avoidance [GO:0070593]; motor neuron axon guidance [GO:0008045]; negative regulation of cell adhesion [GO:0007162]; olfactory bulb axon guidance [GO:0071678]; positive regulation of axonogenesis [GO:0050772]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; semaphorin-plexin signaling pathway [GO:0071526]; sensory neuron axon guidance [GO:0097374]; synapse assembly [GO:0007416] dendrite [GO:0030425]; plasma membrane [GO:0005886]; semaphorin receptor complex [GO:0002116] semaphorin receptor activity [GO:0017154] g21481.t1 Q9V4A7 28.03 528 5.7e-40 167.0 sp|Q9V4A7|PLXB_DROME Plexin-B OS=Drosophila melanogaster OX=7227 GN=PlexB PE=1 SV=2 PLXB_DROME reviewed Plexin-B Drosophila melanogaster (Fruit fly) GO:0002116; GO:0005886; GO:0007162; GO:0007411; GO:0007416; GO:0008045; GO:0008360; GO:0017154; GO:0030334; GO:0030425; GO:0050772; GO:0070593; GO:0071526; GO:0071678; GO:0097374 axon guidance [GO:0007411]; dendrite self-avoidance [GO:0070593]; motor neuron axon guidance [GO:0008045]; negative regulation of cell adhesion [GO:0007162]; olfactory bulb axon guidance [GO:0071678]; positive regulation of axonogenesis [GO:0050772]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; semaphorin-plexin signaling pathway [GO:0071526]; sensory neuron axon guidance [GO:0097374]; synapse assembly [GO:0007416] dendrite [GO:0030425]; plasma membrane [GO:0005886]; semaphorin receptor complex [GO:0002116] semaphorin receptor activity [GO:0017154] g21481.t1 Q9V4A7 28.308 325 3.7799999999999994e-23 112.0 sp|Q9V4A7|PLXB_DROME Plexin-B OS=Drosophila melanogaster OX=7227 GN=PlexB PE=1 SV=2 PLXB_DROME reviewed Plexin-B Drosophila melanogaster (Fruit fly) GO:0002116; GO:0005886; GO:0007162; GO:0007411; GO:0007416; GO:0008045; GO:0008360; GO:0017154; GO:0030334; GO:0030425; GO:0050772; GO:0070593; GO:0071526; GO:0071678; GO:0097374 axon guidance [GO:0007411]; dendrite self-avoidance [GO:0070593]; motor neuron axon guidance [GO:0008045]; negative regulation of cell adhesion [GO:0007162]; olfactory bulb axon guidance [GO:0071678]; positive regulation of axonogenesis [GO:0050772]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; semaphorin-plexin signaling pathway [GO:0071526]; sensory neuron axon guidance [GO:0097374]; synapse assembly [GO:0007416] dendrite [GO:0030425]; plasma membrane [GO:0005886]; semaphorin receptor complex [GO:0002116] semaphorin receptor activity [GO:0017154] g21482.t1 Q80UG2 31.731 416 1.3099999999999998e-55 214.0 sp|Q80UG2|PLXA4_MOUSE Plexin-A4 OS=Mus musculus OX=10090 GN=Plxna4 PE=1 SV=3 PLXA4_MOUSE reviewed Plexin-A4 Mus musculus (Mouse) GO:0002116; GO:0005886; GO:0007399; GO:0007411; GO:0007416; GO:0008045; GO:0017154; GO:0021602; GO:0021610; GO:0021612; GO:0021615; GO:0021636; GO:0021637; GO:0021644; GO:0021784; GO:0021785; GO:0021793; GO:0021960; GO:0030334; GO:0035050; GO:0048485; GO:0048812; GO:0048841; GO:0050923; GO:0071526; GO:0097492; GO:0099558; GO:0150053 anterior commissure morphogenesis [GO:0021960]; axon guidance [GO:0007411]; branchiomotor neuron axon guidance [GO:0021785]; chemorepulsion of branchiomotor axon [GO:0021793]; cranial nerve morphogenesis [GO:0021602]; embryonic heart tube development [GO:0035050]; facial nerve morphogenesis [GO:0021610]; facial nerve structural organization [GO:0021612]; glossopharyngeal nerve morphogenesis [GO:0021615]; maintenance of synapse structure [GO:0099558]; motor neuron axon guidance [GO:0008045]; nervous system development [GO:0007399]; neuron projection morphogenesis [GO:0048812]; postganglionic parasympathetic fiber development [GO:0021784]; regulation of axon extension involved in axon guidance [GO:0048841]; regulation of cell migration [GO:0030334]; regulation of negative chemotaxis [GO:0050923]; semaphorin-plexin signaling pathway [GO:0071526]; sympathetic nervous system development [GO:0048485]; sympathetic neuron axon guidance [GO:0097492]; synapse assembly [GO:0007416]; trigeminal nerve morphogenesis [GO:0021636]; trigeminal nerve structural organization [GO:0021637]; vagus nerve morphogenesis [GO:0021644] cerebellar climbing fiber to Purkinje cell synapse [GO:0150053]; plasma membrane [GO:0005886]; semaphorin receptor complex [GO:0002116] semaphorin receptor activity [GO:0017154] g21482.t1 Q80UG2 26.556 482 8.340000000000001e-32 138.0 sp|Q80UG2|PLXA4_MOUSE Plexin-A4 OS=Mus musculus OX=10090 GN=Plxna4 PE=1 SV=3 PLXA4_MOUSE reviewed Plexin-A4 Mus musculus (Mouse) GO:0002116; GO:0005886; GO:0007399; GO:0007411; GO:0007416; GO:0008045; GO:0017154; GO:0021602; GO:0021610; GO:0021612; GO:0021615; GO:0021636; GO:0021637; GO:0021644; GO:0021784; GO:0021785; GO:0021793; GO:0021960; GO:0030334; GO:0035050; GO:0048485; GO:0048812; GO:0048841; GO:0050923; GO:0071526; GO:0097492; GO:0099558; GO:0150053 anterior commissure morphogenesis [GO:0021960]; axon guidance [GO:0007411]; branchiomotor neuron axon guidance [GO:0021785]; chemorepulsion of branchiomotor axon [GO:0021793]; cranial nerve morphogenesis [GO:0021602]; embryonic heart tube development [GO:0035050]; facial nerve morphogenesis [GO:0021610]; facial nerve structural organization [GO:0021612]; glossopharyngeal nerve morphogenesis [GO:0021615]; maintenance of synapse structure [GO:0099558]; motor neuron axon guidance [GO:0008045]; nervous system development [GO:0007399]; neuron projection morphogenesis [GO:0048812]; postganglionic parasympathetic fiber development [GO:0021784]; regulation of axon extension involved in axon guidance [GO:0048841]; regulation of cell migration [GO:0030334]; regulation of negative chemotaxis [GO:0050923]; semaphorin-plexin signaling pathway [GO:0071526]; sympathetic nervous system development [GO:0048485]; sympathetic neuron axon guidance [GO:0097492]; synapse assembly [GO:0007416]; trigeminal nerve morphogenesis [GO:0021636]; trigeminal nerve structural organization [GO:0021637]; vagus nerve morphogenesis [GO:0021644] cerebellar climbing fiber to Purkinje cell synapse [GO:0150053]; plasma membrane [GO:0005886]; semaphorin receptor complex [GO:0002116] semaphorin receptor activity [GO:0017154] g21483.t1 O43157 31.929 617 5.86e-76 278.0 sp|O43157|PLXB1_HUMAN Plexin-B1 OS=Homo sapiens OX=9606 GN=PLXNB1 PE=1 SV=3 PLXB1_HUMAN reviewed Plexin-B1 (Semaphorin receptor SEP) Homo sapiens (Human) GO:0002116; GO:0004888; GO:0005096; GO:0005576; GO:0005886; GO:0007162; GO:0007416; GO:0008360; GO:0016477; GO:0017154; GO:0030215; GO:0030334; GO:0032794; GO:0033689; GO:0035025; GO:0035556; GO:0043547; GO:0043931; GO:0045211; GO:0048812; GO:0050772; GO:0051493; GO:0051897; GO:0071526; GO:0098978; GO:1904862 cell migration [GO:0016477]; inhibitory synapse assembly [GO:1904862]; intracellular signal transduction [GO:0035556]; negative regulation of cell adhesion [GO:0007162]; negative regulation of osteoblast proliferation [GO:0033689]; neuron projection morphogenesis [GO:0048812]; ossification involved in bone maturation [GO:0043931]; positive regulation of axonogenesis [GO:0050772]; positive regulation of GTPase activity [GO:0043547]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of Rho protein signal transduction [GO:0035025]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; regulation of cytoskeleton organization [GO:0051493]; semaphorin-plexin signaling pathway [GO:0071526]; synapse assembly [GO:0007416] extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; semaphorin receptor complex [GO:0002116] GTPase activating protein binding [GO:0032794]; GTPase activator activity [GO:0005096]; semaphorin receptor activity [GO:0017154]; semaphorin receptor binding [GO:0030215]; transmembrane signaling receptor activity [GO:0004888] g21483.t1 O43157 32.319 263 1.2600000000000001e-35 151.0 sp|O43157|PLXB1_HUMAN Plexin-B1 OS=Homo sapiens OX=9606 GN=PLXNB1 PE=1 SV=3 PLXB1_HUMAN reviewed Plexin-B1 (Semaphorin receptor SEP) Homo sapiens (Human) GO:0002116; GO:0004888; GO:0005096; GO:0005576; GO:0005886; GO:0007162; GO:0007416; GO:0008360; GO:0016477; GO:0017154; GO:0030215; GO:0030334; GO:0032794; GO:0033689; GO:0035025; GO:0035556; GO:0043547; GO:0043931; GO:0045211; GO:0048812; GO:0050772; GO:0051493; GO:0051897; GO:0071526; GO:0098978; GO:1904862 cell migration [GO:0016477]; inhibitory synapse assembly [GO:1904862]; intracellular signal transduction [GO:0035556]; negative regulation of cell adhesion [GO:0007162]; negative regulation of osteoblast proliferation [GO:0033689]; neuron projection morphogenesis [GO:0048812]; ossification involved in bone maturation [GO:0043931]; positive regulation of axonogenesis [GO:0050772]; positive regulation of GTPase activity [GO:0043547]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of Rho protein signal transduction [GO:0035025]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; regulation of cytoskeleton organization [GO:0051493]; semaphorin-plexin signaling pathway [GO:0071526]; synapse assembly [GO:0007416] extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; semaphorin receptor complex [GO:0002116] GTPase activating protein binding [GO:0032794]; GTPase activator activity [GO:0005096]; semaphorin receptor activity [GO:0017154]; semaphorin receptor binding [GO:0030215]; transmembrane signaling receptor activity [GO:0004888] g21483.t2 O43157 31.929 617 6.22e-76 279.0 sp|O43157|PLXB1_HUMAN Plexin-B1 OS=Homo sapiens OX=9606 GN=PLXNB1 PE=1 SV=3 PLXB1_HUMAN reviewed Plexin-B1 (Semaphorin receptor SEP) Homo sapiens (Human) GO:0002116; GO:0004888; GO:0005096; GO:0005576; GO:0005886; GO:0007162; GO:0007416; GO:0008360; GO:0016477; GO:0017154; GO:0030215; GO:0030334; GO:0032794; GO:0033689; GO:0035025; GO:0035556; GO:0043547; GO:0043931; GO:0045211; GO:0048812; GO:0050772; GO:0051493; GO:0051897; GO:0071526; GO:0098978; GO:1904862 cell migration [GO:0016477]; inhibitory synapse assembly [GO:1904862]; intracellular signal transduction [GO:0035556]; negative regulation of cell adhesion [GO:0007162]; negative regulation of osteoblast proliferation [GO:0033689]; neuron projection morphogenesis [GO:0048812]; ossification involved in bone maturation [GO:0043931]; positive regulation of axonogenesis [GO:0050772]; positive regulation of GTPase activity [GO:0043547]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of Rho protein signal transduction [GO:0035025]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; regulation of cytoskeleton organization [GO:0051493]; semaphorin-plexin signaling pathway [GO:0071526]; synapse assembly [GO:0007416] extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; semaphorin receptor complex [GO:0002116] GTPase activating protein binding [GO:0032794]; GTPase activator activity [GO:0005096]; semaphorin receptor activity [GO:0017154]; semaphorin receptor binding [GO:0030215]; transmembrane signaling receptor activity [GO:0004888] g21483.t2 O43157 32.319 263 1.04e-35 152.0 sp|O43157|PLXB1_HUMAN Plexin-B1 OS=Homo sapiens OX=9606 GN=PLXNB1 PE=1 SV=3 PLXB1_HUMAN reviewed Plexin-B1 (Semaphorin receptor SEP) Homo sapiens (Human) GO:0002116; GO:0004888; GO:0005096; GO:0005576; GO:0005886; GO:0007162; GO:0007416; GO:0008360; GO:0016477; GO:0017154; GO:0030215; GO:0030334; GO:0032794; GO:0033689; GO:0035025; GO:0035556; GO:0043547; GO:0043931; GO:0045211; GO:0048812; GO:0050772; GO:0051493; GO:0051897; GO:0071526; GO:0098978; GO:1904862 cell migration [GO:0016477]; inhibitory synapse assembly [GO:1904862]; intracellular signal transduction [GO:0035556]; negative regulation of cell adhesion [GO:0007162]; negative regulation of osteoblast proliferation [GO:0033689]; neuron projection morphogenesis [GO:0048812]; ossification involved in bone maturation [GO:0043931]; positive regulation of axonogenesis [GO:0050772]; positive regulation of GTPase activity [GO:0043547]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of Rho protein signal transduction [GO:0035025]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; regulation of cytoskeleton organization [GO:0051493]; semaphorin-plexin signaling pathway [GO:0071526]; synapse assembly [GO:0007416] extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; semaphorin receptor complex [GO:0002116] GTPase activating protein binding [GO:0032794]; GTPase activator activity [GO:0005096]; semaphorin receptor activity [GO:0017154]; semaphorin receptor binding [GO:0030215]; transmembrane signaling receptor activity [GO:0004888] g21485.t1 O43772 60.403 298 4e-121 351.0 sp|O43772|MCAT_HUMAN Mitochondrial carnitine/acylcarnitine carrier protein OS=Homo sapiens OX=9606 GN=SLC25A20 PE=1 SV=1 MCAT_HUMAN reviewed Mitochondrial carnitine/acylcarnitine carrier protein (Carnitine/acylcarnitine translocase) (CAC) (CACT) (Solute carrier family 25 member 20) Homo sapiens (Human) GO:0001701; GO:0005476; GO:0005739; GO:0005740; GO:0005743; GO:0005829; GO:0006839; GO:0006853; GO:0015227; GO:1902603 carnitine shuttle [GO:0006853]; carnitine transmembrane transport [GO:1902603]; in utero embryonic development [GO:0001701]; mitochondrial transport [GO:0006839] cytosol [GO:0005829]; mitochondrial envelope [GO:0005740]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739] carnitine:O-acyl-L-carnitine antiporter activity [GO:0005476]; O-acyl-L-carnitine transmembrane transporter activity [GO:0015227] g21486.t1 Q9DGD1 39.379 419 1.21e-102 317.0 sp|Q9DGD1|MGT4C_CHICK Alpha-1,6-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase OS=Gallus gallus OX=9031 GN=MGAT4C PE=1 SV=1 g21489.t1 P82451 47.027 185 1.51e-46 174.0 sp|P82451|ABCC9_RABIT ATP-binding cassette sub-family C member 9 OS=Oryctolagus cuniculus OX=9986 GN=ABCC9 PE=2 SV=1 g21493.t1 Q7RTX9 40.909 198 5.750000000000001e-29 125.0 sp|Q7RTX9|MOT14_HUMAN Monocarboxylate transporter 14 OS=Homo sapiens OX=9606 GN=SLC16A14 PE=1 SV=1 g21494.t1 Q7ZWB2 42.958 142 2e-35 123.0 sp|Q7ZWB2|UBL4A_DANRE Ubiquitin-like protein 4A OS=Danio rerio OX=7955 GN=ubl4a PE=2 SV=1 g21496.t1 Q7ZY86 40.398 703 1.37e-180 534.0 sp|Q7ZY86|TM168_XENLA Transmembrane protein 168 OS=Xenopus laevis OX=8355 GN=tmem168 PE=2 SV=1 g21498.t1 Q7ZY86 30.218 321 8.18e-39 149.0 sp|Q7ZY86|TM168_XENLA Transmembrane protein 168 OS=Xenopus laevis OX=8355 GN=tmem168 PE=2 SV=1 g21501.t1 Q8NA31 37.433 374 5.2e-59 220.0 sp|Q8NA31|TERB1_HUMAN Telomere repeats-binding bouquet formation protein 1 OS=Homo sapiens OX=9606 GN=TERB1 PE=1 SV=3 TERB1_HUMAN reviewed Telomere repeats-binding bouquet formation protein 1 (Coiled-coil domain-containing protein 79) Homo sapiens (Human) GO:0000781; GO:0005635; GO:0005637; GO:0007129; GO:0045141; GO:0070187; GO:0070197; GO:1990918 double-strand break repair involved in meiotic recombination [GO:1990918]; homologous chromosome pairing at meiosis [GO:0007129]; meiotic attachment of telomere to nuclear envelope [GO:0070197]; meiotic telomere clustering [GO:0045141] chromosome, telomeric region [GO:0000781]; nuclear envelope [GO:0005635]; nuclear inner membrane [GO:0005637]; shelterin complex [GO:0070187] g21501.t2 Q8NA31 37.433 374 5.18e-59 220.0 sp|Q8NA31|TERB1_HUMAN Telomere repeats-binding bouquet formation protein 1 OS=Homo sapiens OX=9606 GN=TERB1 PE=1 SV=3 TERB1_HUMAN reviewed Telomere repeats-binding bouquet formation protein 1 (Coiled-coil domain-containing protein 79) Homo sapiens (Human) GO:0000781; GO:0005635; GO:0005637; GO:0007129; GO:0045141; GO:0070187; GO:0070197; GO:1990918 double-strand break repair involved in meiotic recombination [GO:1990918]; homologous chromosome pairing at meiosis [GO:0007129]; meiotic attachment of telomere to nuclear envelope [GO:0070197]; meiotic telomere clustering [GO:0045141] chromosome, telomeric region [GO:0000781]; nuclear envelope [GO:0005635]; nuclear inner membrane [GO:0005637]; shelterin complex [GO:0070187] g21502.t1 O15457 50.969 826 0.0 782.0 sp|O15457|MSH4_HUMAN MutS protein homolog 4 OS=Homo sapiens OX=9606 GN=MSH4 PE=1 SV=2 MSH4_HUMAN reviewed MutS protein homolog 4 (hMSH4) Homo sapiens (Human) GO:0000795; GO:0001541; GO:0003677; GO:0003690; GO:0005524; GO:0005634; GO:0005694; GO:0005713; GO:0006298; GO:0007129; GO:0007131; GO:0007283; GO:0007292; GO:0030983; GO:0140664 female gamete generation [GO:0007292]; homologous chromosome pairing at meiosis [GO:0007129]; mismatch repair [GO:0006298]; ovarian follicle development [GO:0001541]; reciprocal meiotic recombination [GO:0007131]; spermatogenesis [GO:0007283] chromosome [GO:0005694]; nucleus [GO:0005634]; recombination nodule [GO:0005713]; synaptonemal complex [GO:0000795] ATP binding [GO:0005524]; ATP-dependent DNA damage sensor activity [GO:0140664]; DNA binding [GO:0003677]; double-stranded DNA binding [GO:0003690]; mismatched DNA binding [GO:0030983] g21503.t1 Q7Z6B7 36.216 798 1.33e-157 493.0 sp|Q7Z6B7|SRGP1_HUMAN SLIT-ROBO Rho GTPase-activating protein 1 OS=Homo sapiens OX=9606 GN=SRGAP1 PE=1 SV=1 SRGP1_HUMAN reviewed SLIT-ROBO Rho GTPase-activating protein 1 (srGAP1) (Rho GTPase-activating protein 13) Homo sapiens (Human) GO:0005096; GO:0005829; GO:0007266; GO:0007399; GO:0016477; GO:0030336; GO:0031267; GO:0051963 cell migration [GO:0016477]; negative regulation of cell migration [GO:0030336]; nervous system development [GO:0007399]; regulation of synapse assembly [GO:0051963]; Rho protein signal transduction [GO:0007266] cytosol [GO:0005829] GTPase activator activity [GO:0005096]; small GTPase binding [GO:0031267] g21504.t1 A6QL50 45.865 133 6.62e-41 137.0 sp|A6QL50|FA72A_BOVIN Protein FAM72A OS=Bos taurus OX=9913 GN=FAM72A PE=1 SV=1 g21505.t1 Q08CD5 39.551 445 3.4e-111 337.0 sp|Q08CD5|RXLT1_DANRE Ribitol-5-phosphate xylosyltransferase 1 OS=Danio rerio OX=7955 GN=rxylt1 PE=2 SV=2 RXLT1_DANRE reviewed Ribitol-5-phosphate xylosyltransferase 1 (EC 2.4.2.61) (Transmembrane protein 5) (UDP-D-xylose:ribitol-5-phosphate beta1,4-xylosyltransferase) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000139; GO:0005794; GO:0035269; GO:0120053 protein O-linked glycosylation via mannose [GO:0035269] Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139] ribitol beta-1,4-xylosyltransferase activity [GO:0120053] g21506.t1 Q568K9 68.129 342 2.84e-143 411.0 sp|Q568K9|FA50A_DANRE Protein FAM50A OS=Danio rerio OX=7955 GN=fam50a PE=2 SV=1 FA50A_DANRE reviewed Protein FAM50A Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005634; GO:0006325; GO:0006397; GO:0007417; GO:0008380; GO:0048024; GO:0048701 central nervous system development [GO:0007417]; chromatin organization [GO:0006325]; embryonic cranial skeleton morphogenesis [GO:0048701]; mRNA processing [GO:0006397]; regulation of mRNA splicing, via spliceosome [GO:0048024]; RNA splicing [GO:0008380] nucleus [GO:0005634] g21507.t1 P51644 82.486 177 5.54e-110 314.0 sp|P51644|ARF4_XENLA ADP-ribosylation factor 4 OS=Xenopus laevis OX=8355 GN=arf4 PE=1 SV=2 g21508.t1 B9EJI9 45.0 160 1.59e-27 110.0 sp|B9EJI9|T229A_MOUSE Transmembrane protein 229A OS=Mus musculus OX=10090 GN=Tmem229a PE=2 SV=1 g21510.t1 P0C218 62.087 393 1.0299999999999999e-171 505.0 sp|P0C218|DDX20_DANRE Probable ATP-dependent RNA helicase DDX20 OS=Danio rerio OX=7955 GN=ddx20 PE=3 SV=1 g21511.t1 Q12792 42.424 231 1.43e-60 197.0 sp|Q12792|TWF1_HUMAN Twinfilin-1 OS=Homo sapiens OX=9606 GN=TWF1 PE=1 SV=3 g21512.t1 Q5ZM35 57.746 71 3.6200000000000004e-21 87.8 sp|Q5ZM35|TWF2_CHICK Twinfilin-2 OS=Gallus gallus OX=9031 GN=TWF2 PE=1 SV=1 g21513.t1 Q5XK94 43.868 212 3.45e-49 164.0 sp|Q5XK94|TIDC1_XENLA Complex I assembly factor TIMMDC1, mitochondrial OS=Xenopus laevis OX=8355 GN=timmdc1 PE=2 SV=1 g21514.t1 P70501 44.147 299 1.1e-46 184.0 sp|P70501|RBM10_RAT RNA-binding protein 10 OS=Rattus norvegicus OX=10116 GN=Rbm10 PE=1 SV=1 RBM10_RAT reviewed RNA-binding protein 10 (RNA-binding motif protein 10) (RNA-binding protein S1-1) Rattus norvegicus (Rat) GO:0000122; GO:0000398; GO:0003723; GO:0003727; GO:0005634; GO:0005730; GO:0008270; GO:0008285; GO:0016607; GO:0032991; GO:0035198; GO:0042802; GO:0048025; GO:0048255; GO:0060379; GO:0061052; GO:0070935; GO:1900119; GO:1904706; GO:1905459; GO:1905461; GO:2000204 3'-UTR-mediated mRNA stabilization [GO:0070935]; cardiac muscle cell myoblast differentiation [GO:0060379]; mRNA splicing, via spliceosome [GO:0000398]; mRNA stabilization [GO:0048255]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; negative regulation of ribosomal large subunit export from nucleus [GO:2000204]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of vascular associated smooth muscle cell proliferation [GO:1904706]; positive regulation of execution phase of apoptosis [GO:1900119]; positive regulation of vascular associated smooth muscle cell apoptotic process [GO:1905461]; regulation of vascular associated smooth muscle cell apoptotic process [GO:1905459] nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleus [GO:0005634]; protein-containing complex [GO:0032991] identical protein binding [GO:0042802]; miRNA binding [GO:0035198]; RNA binding [GO:0003723]; single-stranded RNA binding [GO:0003727]; zinc ion binding [GO:0008270] g21514.t1 P70501 31.25 240 5.2600000000000004e-33 141.0 sp|P70501|RBM10_RAT RNA-binding protein 10 OS=Rattus norvegicus OX=10116 GN=Rbm10 PE=1 SV=1 RBM10_RAT reviewed RNA-binding protein 10 (RNA-binding motif protein 10) (RNA-binding protein S1-1) Rattus norvegicus (Rat) GO:0000122; GO:0000398; GO:0003723; GO:0003727; GO:0005634; GO:0005730; GO:0008270; GO:0008285; GO:0016607; GO:0032991; GO:0035198; GO:0042802; GO:0048025; GO:0048255; GO:0060379; GO:0061052; GO:0070935; GO:1900119; GO:1904706; GO:1905459; GO:1905461; GO:2000204 3'-UTR-mediated mRNA stabilization [GO:0070935]; cardiac muscle cell myoblast differentiation [GO:0060379]; mRNA splicing, via spliceosome [GO:0000398]; mRNA stabilization [GO:0048255]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; negative regulation of ribosomal large subunit export from nucleus [GO:2000204]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of vascular associated smooth muscle cell proliferation [GO:1904706]; positive regulation of execution phase of apoptosis [GO:1900119]; positive regulation of vascular associated smooth muscle cell apoptotic process [GO:1905461]; regulation of vascular associated smooth muscle cell apoptotic process [GO:1905459] nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleus [GO:0005634]; protein-containing complex [GO:0032991] identical protein binding [GO:0042802]; miRNA binding [GO:0035198]; RNA binding [GO:0003723]; single-stranded RNA binding [GO:0003727]; zinc ion binding [GO:0008270] g21514.t2 P70501 44.147 299 6.88e-47 184.0 sp|P70501|RBM10_RAT RNA-binding protein 10 OS=Rattus norvegicus OX=10116 GN=Rbm10 PE=1 SV=1 RBM10_RAT reviewed RNA-binding protein 10 (RNA-binding motif protein 10) (RNA-binding protein S1-1) Rattus norvegicus (Rat) GO:0000122; GO:0000398; GO:0003723; GO:0003727; GO:0005634; GO:0005730; GO:0008270; GO:0008285; GO:0016607; GO:0032991; GO:0035198; GO:0042802; GO:0048025; GO:0048255; GO:0060379; GO:0061052; GO:0070935; GO:1900119; GO:1904706; GO:1905459; GO:1905461; GO:2000204 3'-UTR-mediated mRNA stabilization [GO:0070935]; cardiac muscle cell myoblast differentiation [GO:0060379]; mRNA splicing, via spliceosome [GO:0000398]; mRNA stabilization [GO:0048255]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; negative regulation of ribosomal large subunit export from nucleus [GO:2000204]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of vascular associated smooth muscle cell proliferation [GO:1904706]; positive regulation of execution phase of apoptosis [GO:1900119]; positive regulation of vascular associated smooth muscle cell apoptotic process [GO:1905461]; regulation of vascular associated smooth muscle cell apoptotic process [GO:1905459] nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleus [GO:0005634]; protein-containing complex [GO:0032991] identical protein binding [GO:0042802]; miRNA binding [GO:0035198]; RNA binding [GO:0003723]; single-stranded RNA binding [GO:0003727]; zinc ion binding [GO:0008270] g21514.t2 P70501 31.25 240 5.07e-33 141.0 sp|P70501|RBM10_RAT RNA-binding protein 10 OS=Rattus norvegicus OX=10116 GN=Rbm10 PE=1 SV=1 RBM10_RAT reviewed RNA-binding protein 10 (RNA-binding motif protein 10) (RNA-binding protein S1-1) Rattus norvegicus (Rat) GO:0000122; GO:0000398; GO:0003723; GO:0003727; GO:0005634; GO:0005730; GO:0008270; GO:0008285; GO:0016607; GO:0032991; GO:0035198; GO:0042802; GO:0048025; GO:0048255; GO:0060379; GO:0061052; GO:0070935; GO:1900119; GO:1904706; GO:1905459; GO:1905461; GO:2000204 3'-UTR-mediated mRNA stabilization [GO:0070935]; cardiac muscle cell myoblast differentiation [GO:0060379]; mRNA splicing, via spliceosome [GO:0000398]; mRNA stabilization [GO:0048255]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; negative regulation of ribosomal large subunit export from nucleus [GO:2000204]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of vascular associated smooth muscle cell proliferation [GO:1904706]; positive regulation of execution phase of apoptosis [GO:1900119]; positive regulation of vascular associated smooth muscle cell apoptotic process [GO:1905461]; regulation of vascular associated smooth muscle cell apoptotic process [GO:1905459] nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleus [GO:0005634]; protein-containing complex [GO:0032991] identical protein binding [GO:0042802]; miRNA binding [GO:0035198]; RNA binding [GO:0003723]; single-stranded RNA binding [GO:0003727]; zinc ion binding [GO:0008270] g21514.t3 P70501 44.147 299 6.920000000000001e-47 184.0 sp|P70501|RBM10_RAT RNA-binding protein 10 OS=Rattus norvegicus OX=10116 GN=Rbm10 PE=1 SV=1 RBM10_RAT reviewed RNA-binding protein 10 (RNA-binding motif protein 10) (RNA-binding protein S1-1) Rattus norvegicus (Rat) GO:0000122; GO:0000398; GO:0003723; GO:0003727; GO:0005634; GO:0005730; GO:0008270; GO:0008285; GO:0016607; GO:0032991; GO:0035198; GO:0042802; GO:0048025; GO:0048255; GO:0060379; GO:0061052; GO:0070935; GO:1900119; GO:1904706; GO:1905459; GO:1905461; GO:2000204 3'-UTR-mediated mRNA stabilization [GO:0070935]; cardiac muscle cell myoblast differentiation [GO:0060379]; mRNA splicing, via spliceosome [GO:0000398]; mRNA stabilization [GO:0048255]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; negative regulation of ribosomal large subunit export from nucleus [GO:2000204]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of vascular associated smooth muscle cell proliferation [GO:1904706]; positive regulation of execution phase of apoptosis [GO:1900119]; positive regulation of vascular associated smooth muscle cell apoptotic process [GO:1905461]; regulation of vascular associated smooth muscle cell apoptotic process [GO:1905459] nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleus [GO:0005634]; protein-containing complex [GO:0032991] identical protein binding [GO:0042802]; miRNA binding [GO:0035198]; RNA binding [GO:0003723]; single-stranded RNA binding [GO:0003727]; zinc ion binding [GO:0008270] g21514.t3 P70501 31.25 240 5.09e-33 141.0 sp|P70501|RBM10_RAT RNA-binding protein 10 OS=Rattus norvegicus OX=10116 GN=Rbm10 PE=1 SV=1 RBM10_RAT reviewed RNA-binding protein 10 (RNA-binding motif protein 10) (RNA-binding protein S1-1) Rattus norvegicus (Rat) GO:0000122; GO:0000398; GO:0003723; GO:0003727; GO:0005634; GO:0005730; GO:0008270; GO:0008285; GO:0016607; GO:0032991; GO:0035198; GO:0042802; GO:0048025; GO:0048255; GO:0060379; GO:0061052; GO:0070935; GO:1900119; GO:1904706; GO:1905459; GO:1905461; GO:2000204 3'-UTR-mediated mRNA stabilization [GO:0070935]; cardiac muscle cell myoblast differentiation [GO:0060379]; mRNA splicing, via spliceosome [GO:0000398]; mRNA stabilization [GO:0048255]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; negative regulation of ribosomal large subunit export from nucleus [GO:2000204]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of vascular associated smooth muscle cell proliferation [GO:1904706]; positive regulation of execution phase of apoptosis [GO:1900119]; positive regulation of vascular associated smooth muscle cell apoptotic process [GO:1905461]; regulation of vascular associated smooth muscle cell apoptotic process [GO:1905459] nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleus [GO:0005634]; protein-containing complex [GO:0032991] identical protein binding [GO:0042802]; miRNA binding [GO:0035198]; RNA binding [GO:0003723]; single-stranded RNA binding [GO:0003727]; zinc ion binding [GO:0008270] g21514.t4 P70501 43.96 298 5.79e-48 186.0 sp|P70501|RBM10_RAT RNA-binding protein 10 OS=Rattus norvegicus OX=10116 GN=Rbm10 PE=1 SV=1 RBM10_RAT reviewed RNA-binding protein 10 (RNA-binding motif protein 10) (RNA-binding protein S1-1) Rattus norvegicus (Rat) GO:0000122; GO:0000398; GO:0003723; GO:0003727; GO:0005634; GO:0005730; GO:0008270; GO:0008285; GO:0016607; GO:0032991; GO:0035198; GO:0042802; GO:0048025; GO:0048255; GO:0060379; GO:0061052; GO:0070935; GO:1900119; GO:1904706; GO:1905459; GO:1905461; GO:2000204 3'-UTR-mediated mRNA stabilization [GO:0070935]; cardiac muscle cell myoblast differentiation [GO:0060379]; mRNA splicing, via spliceosome [GO:0000398]; mRNA stabilization [GO:0048255]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; negative regulation of ribosomal large subunit export from nucleus [GO:2000204]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of vascular associated smooth muscle cell proliferation [GO:1904706]; positive regulation of execution phase of apoptosis [GO:1900119]; positive regulation of vascular associated smooth muscle cell apoptotic process [GO:1905461]; regulation of vascular associated smooth muscle cell apoptotic process [GO:1905459] nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleus [GO:0005634]; protein-containing complex [GO:0032991] identical protein binding [GO:0042802]; miRNA binding [GO:0035198]; RNA binding [GO:0003723]; single-stranded RNA binding [GO:0003727]; zinc ion binding [GO:0008270] g21516.t1 Q5RK00 36.626 243 2.78e-43 152.0 sp|Q5RK00|RM46_RAT Large ribosomal subunit protein mL46 OS=Rattus norvegicus OX=10116 GN=Mrpl46 PE=2 SV=1 g21517.t1 Q9P0U4 63.504 274 5.01e-123 384.0 sp|Q9P0U4|CXXC1_HUMAN CXXC-type zinc finger protein 1 OS=Homo sapiens OX=9606 GN=CXXC1 PE=1 SV=2 CXXC1_HUMAN reviewed CXXC-type zinc finger protein 1 (CpG-binding protein) (PHD finger and CXXC domain-containing protein 1) Homo sapiens (Human) GO:0000987; GO:0005634; GO:0005654; GO:0005829; GO:0006355; GO:0008270; GO:0016363; GO:0016607; GO:0035097; GO:0045322; GO:0045893; GO:0048188; GO:0140002 positive regulation of DNA-templated transcription [GO:0045893]; regulation of DNA-templated transcription [GO:0006355] cytosol [GO:0005829]; histone methyltransferase complex [GO:0035097]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Set1C/COMPASS complex [GO:0048188] cis-regulatory region sequence-specific DNA binding [GO:0000987]; histone H3K4me3 reader activity [GO:0140002]; unmethylated CpG binding [GO:0045322]; zinc ion binding [GO:0008270] g21518.t1 Q9GZR2 56.019 216 4.8300000000000006e-70 238.0 sp|Q9GZR2|REXO4_HUMAN RNA exonuclease 4 OS=Homo sapiens OX=9606 GN=REXO4 PE=1 SV=2 REXO4_HUMAN reviewed RNA exonuclease 4 (EC 3.1.-.-) (Exonuclease XPMC2) (Prevents mitotic catastrophe 2 protein homolog) (hPMC2) Homo sapiens (Human) GO:0003690; GO:0003697; GO:0003723; GO:0004519; GO:0004527; GO:0005634; GO:0005654; GO:0005730; GO:0006281; GO:0006308; GO:0006355; GO:0006364; GO:0006396; GO:0008408; GO:0016607 DNA catabolic process [GO:0006308]; DNA repair [GO:0006281]; regulation of DNA-templated transcription [GO:0006355]; RNA processing [GO:0006396]; rRNA processing [GO:0006364] nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] 3'-5' exonuclease activity [GO:0008408]; double-stranded DNA binding [GO:0003690]; endonuclease activity [GO:0004519]; exonuclease activity [GO:0004527]; RNA binding [GO:0003723]; single-stranded DNA binding [GO:0003697] g21521.t1 P11714 32.879 514 6.91e-77 253.0 sp|P11714|CP2D9_MOUSE Cytochrome P450 2D9 OS=Mus musculus OX=10090 GN=Cyp2d9 PE=1 SV=2 g21522.t1 P11714 31.323 514 1.4300000000000002e-73 245.0 sp|P11714|CP2D9_MOUSE Cytochrome P450 2D9 OS=Mus musculus OX=10090 GN=Cyp2d9 PE=1 SV=2 g21523.t1 P11714 30.934 514 4.96e-73 243.0 sp|P11714|CP2D9_MOUSE Cytochrome P450 2D9 OS=Mus musculus OX=10090 GN=Cyp2d9 PE=1 SV=2 g21524.t1 P11714 28.772 285 2.89e-27 115.0 sp|P11714|CP2D9_MOUSE Cytochrome P450 2D9 OS=Mus musculus OX=10090 GN=Cyp2d9 PE=1 SV=2 g21525.t1 Q4V8D1 40.0 145 8.67e-35 129.0 sp|Q4V8D1|CP2U1_RAT Cytochrome P450 2U1 OS=Rattus norvegicus OX=10116 GN=Cyp2u1 PE=1 SV=1 CP2U1_RAT reviewed Cytochrome P450 2U1 (Long-chain fatty acid omega-monooxygenase) (EC 1.14.14.80) Rattus norvegicus (Rat) GO:0005506; GO:0005737; GO:0005743; GO:0005789; GO:0006082; GO:0006805; GO:0008202; GO:0008395; GO:0016712; GO:0020037; GO:0052869; GO:0097267; GO:0102033 omega-hydroxylase P450 pathway [GO:0097267]; organic acid metabolic process [GO:0006082]; steroid metabolic process [GO:0008202]; xenobiotic metabolic process [GO:0006805] cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; mitochondrial inner membrane [GO:0005743] arachidonate omega-hydroxylase activity [GO:0052869]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; long-chain fatty acid omega-hydroxylase activity [GO:0102033]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; steroid hydroxylase activity [GO:0008395] g21526.t1 P17560 54.897 388 4.89e-162 464.0 sp|P17560|RENBP_PIG N-acylglucosamine 2-epimerase OS=Sus scrofa OX=9823 GN=RENBP PE=1 SV=2 g21527.t1 P82343 51.938 387 3.92e-139 417.0 sp|P82343|RENBP_MOUSE N-acylglucosamine 2-epimerase OS=Mus musculus OX=10090 GN=Renbp PE=1 SV=4 RENBP_MOUSE reviewed N-acylglucosamine 2-epimerase (AGE) (EC 5.1.3.8) (GlcNAc 2-epimerase) (N-acetyl-D-glucosamine 2-epimerase) (Renin-binding protein) (RnBP) Mus musculus (Mouse) GO:0004857; GO:0005524; GO:0005975; GO:0006044; GO:0006051; GO:0017076; GO:0019262; GO:0030414; GO:0042802; GO:0050121 carbohydrate metabolic process [GO:0005975]; N-acetylglucosamine metabolic process [GO:0006044]; N-acetylmannosamine metabolic process [GO:0006051]; N-acetylneuraminate catabolic process [GO:0019262] ATP binding [GO:0005524]; enzyme inhibitor activity [GO:0004857]; identical protein binding [GO:0042802]; N-acylglucosamine 2-epimerase activity [GO:0050121]; peptidase inhibitor activity [GO:0030414]; purine nucleotide binding [GO:0017076] g21527.t2 P82343 51.938 387 1.06e-142 414.0 sp|P82343|RENBP_MOUSE N-acylglucosamine 2-epimerase OS=Mus musculus OX=10090 GN=Renbp PE=1 SV=4 RENBP_MOUSE reviewed N-acylglucosamine 2-epimerase (AGE) (EC 5.1.3.8) (GlcNAc 2-epimerase) (N-acetyl-D-glucosamine 2-epimerase) (Renin-binding protein) (RnBP) Mus musculus (Mouse) GO:0004857; GO:0005524; GO:0005975; GO:0006044; GO:0006051; GO:0017076; GO:0019262; GO:0030414; GO:0042802; GO:0050121 carbohydrate metabolic process [GO:0005975]; N-acetylglucosamine metabolic process [GO:0006044]; N-acetylmannosamine metabolic process [GO:0006051]; N-acetylneuraminate catabolic process [GO:0019262] ATP binding [GO:0005524]; enzyme inhibitor activity [GO:0004857]; identical protein binding [GO:0042802]; N-acylglucosamine 2-epimerase activity [GO:0050121]; peptidase inhibitor activity [GO:0030414]; purine nucleotide binding [GO:0017076] g21529.t1 Q149M9 28.993 1321 5.1e-150 499.0 sp|Q149M9|NWD1_HUMAN NACHT domain- and WD repeat-containing protein 1 OS=Homo sapiens OX=9606 GN=NWD1 PE=1 SV=3 g21530.t1 Q8VD04 37.278 676 1e-84 293.0 sp|Q8VD04|GRAP1_MOUSE GRIP1-associated protein 1 OS=Mus musculus OX=10090 GN=Gripap1 PE=1 SV=1 GRAP1_MOUSE reviewed GRIP1-associated protein 1 (GRASP-1) (HCMV-interacting protein) [Cleaved into: GRASP-1 C-terminal chain (30kDa C-terminus form)] Mus musculus (Mouse) GO:0005085; GO:0005654; GO:0005829; GO:0015031; GO:0030424; GO:0030425; GO:0035255; GO:0042734; GO:0042802; GO:0043025; GO:0055038; GO:0098685; GO:0098978; GO:0098998; GO:0099152; GO:0099158; GO:1903828; GO:1903910 negative regulation of protein localization [GO:1903828]; negative regulation of receptor clustering [GO:1903910]; protein transport [GO:0015031]; regulation of neurotransmitter receptor transport, endosome to postsynaptic membrane [GO:0099152]; regulation of recycling endosome localization within postsynapse [GO:0099158] axon [GO:0030424]; cytosol [GO:0005829]; dendrite [GO:0030425]; extrinsic component of postsynaptic early endosome membrane [GO:0098998]; glutamatergic synapse [GO:0098978]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; presynaptic membrane [GO:0042734]; recycling endosome membrane [GO:0055038]; Schaffer collateral - CA1 synapse [GO:0098685] guanyl-nucleotide exchange factor activity [GO:0005085]; identical protein binding [GO:0042802]; ionotropic glutamate receptor binding [GO:0035255] g21530.t1 Q8VD04 65.546 119 7.84e-28 124.0 sp|Q8VD04|GRAP1_MOUSE GRIP1-associated protein 1 OS=Mus musculus OX=10090 GN=Gripap1 PE=1 SV=1 GRAP1_MOUSE reviewed GRIP1-associated protein 1 (GRASP-1) (HCMV-interacting protein) [Cleaved into: GRASP-1 C-terminal chain (30kDa C-terminus form)] Mus musculus (Mouse) GO:0005085; GO:0005654; GO:0005829; GO:0015031; GO:0030424; GO:0030425; GO:0035255; GO:0042734; GO:0042802; GO:0043025; GO:0055038; GO:0098685; GO:0098978; GO:0098998; GO:0099152; GO:0099158; GO:1903828; GO:1903910 negative regulation of protein localization [GO:1903828]; negative regulation of receptor clustering [GO:1903910]; protein transport [GO:0015031]; regulation of neurotransmitter receptor transport, endosome to postsynaptic membrane [GO:0099152]; regulation of recycling endosome localization within postsynapse [GO:0099158] axon [GO:0030424]; cytosol [GO:0005829]; dendrite [GO:0030425]; extrinsic component of postsynaptic early endosome membrane [GO:0098998]; glutamatergic synapse [GO:0098978]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; presynaptic membrane [GO:0042734]; recycling endosome membrane [GO:0055038]; Schaffer collateral - CA1 synapse [GO:0098685] guanyl-nucleotide exchange factor activity [GO:0005085]; identical protein binding [GO:0042802]; ionotropic glutamate receptor binding [GO:0035255] g21530.t2 Q9JHZ4 37.358 704 3.09e-86 298.0 sp|Q9JHZ4|GRAP1_RAT GRIP1-associated protein 1 OS=Rattus norvegicus OX=10116 GN=Gripap1 PE=1 SV=1 GRAP1_RAT reviewed GRIP1-associated protein 1 (GRASP-1) [Cleaved into: GRASP-1 C-terminal chain (30kDa C-terminus form)] Rattus norvegicus (Rat) GO:0005085; GO:0005654; GO:0005829; GO:0015031; GO:0030424; GO:0030425; GO:0035255; GO:0042734; GO:0042802; GO:0043025; GO:0055038; GO:0098685; GO:0098978; GO:0098998; GO:0099152; GO:0099158; GO:1903828; GO:1903910 negative regulation of protein localization [GO:1903828]; negative regulation of receptor clustering [GO:1903910]; protein transport [GO:0015031]; regulation of neurotransmitter receptor transport, endosome to postsynaptic membrane [GO:0099152]; regulation of recycling endosome localization within postsynapse [GO:0099158] axon [GO:0030424]; cytosol [GO:0005829]; dendrite [GO:0030425]; extrinsic component of postsynaptic early endosome membrane [GO:0098998]; glutamatergic synapse [GO:0098978]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; presynaptic membrane [GO:0042734]; recycling endosome membrane [GO:0055038]; Schaffer collateral - CA1 synapse [GO:0098685] guanyl-nucleotide exchange factor activity [GO:0005085]; identical protein binding [GO:0042802]; ionotropic glutamate receptor binding [GO:0035255] g21530.t2 Q9JHZ4 65.546 119 6.26e-28 125.0 sp|Q9JHZ4|GRAP1_RAT GRIP1-associated protein 1 OS=Rattus norvegicus OX=10116 GN=Gripap1 PE=1 SV=1 GRAP1_RAT reviewed GRIP1-associated protein 1 (GRASP-1) [Cleaved into: GRASP-1 C-terminal chain (30kDa C-terminus form)] Rattus norvegicus (Rat) GO:0005085; GO:0005654; GO:0005829; GO:0015031; GO:0030424; GO:0030425; GO:0035255; GO:0042734; GO:0042802; GO:0043025; GO:0055038; GO:0098685; GO:0098978; GO:0098998; GO:0099152; GO:0099158; GO:1903828; GO:1903910 negative regulation of protein localization [GO:1903828]; negative regulation of receptor clustering [GO:1903910]; protein transport [GO:0015031]; regulation of neurotransmitter receptor transport, endosome to postsynaptic membrane [GO:0099152]; regulation of recycling endosome localization within postsynapse [GO:0099158] axon [GO:0030424]; cytosol [GO:0005829]; dendrite [GO:0030425]; extrinsic component of postsynaptic early endosome membrane [GO:0098998]; glutamatergic synapse [GO:0098978]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; presynaptic membrane [GO:0042734]; recycling endosome membrane [GO:0055038]; Schaffer collateral - CA1 synapse [GO:0098685] guanyl-nucleotide exchange factor activity [GO:0005085]; identical protein binding [GO:0042802]; ionotropic glutamate receptor binding [GO:0035255] g21531.t1 P17971 62.882 229 2.07e-97 298.0 sp|P17971|KCNAL_DROME Potassium voltage-gated channel protein Shal OS=Drosophila melanogaster OX=7227 GN=Shal PE=1 SV=2 g21532.t1 P17971 61.392 158 1.03e-23 103.0 sp|P17971|KCNAL_DROME Potassium voltage-gated channel protein Shal OS=Drosophila melanogaster OX=7227 GN=Shal PE=1 SV=2 g21532.t2 P17971 70.803 137 2.61e-28 116.0 sp|P17971|KCNAL_DROME Potassium voltage-gated channel protein Shal OS=Drosophila melanogaster OX=7227 GN=Shal PE=1 SV=2 g21533.t1 Q1KZG4 54.198 131 3e-41 137.0 sp|Q1KZG4|FHIT_BOVIN Bis(5'-adenosyl)-triphosphatase OS=Bos taurus OX=9913 GN=FHIT PE=2 SV=1 FHIT_BOVIN reviewed Bis(5'-adenosyl)-triphosphatase (EC 3.6.1.29) (AP3A hydrolase) (AP3Aase) (Adenosine 5'-monophosphoramidase FHIT) (EC 3.9.1.-) (Adenylylsulfatase) (EC 3.6.2.1) (Adenylylsulfate-ammonia adenylyltransferase) (EC 2.7.7.51) (Diadenosine 5',5'''-P1,P3-triphosphate hydrolase) (Dinucleosidetriphosphatase) (Fragile histidine triad protein) Bos taurus (Bovine) GO:0000166; GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0005886; GO:0006163; GO:0015964; GO:0031625; GO:0032435; GO:0043530; GO:0047352; GO:0047627; GO:0047710; GO:0072332 diadenosine triphosphate catabolic process [GO:0015964]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; purine nucleotide metabolic process [GO:0006163] cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886] adenosine 5'-monophosphoramidase activity [GO:0043530]; adenylylsulfatase activity [GO:0047627]; adenylylsulfate-ammonia adenylyltransferase activity [GO:0047352]; bis(5'-adenosyl)-triphosphatase activity [GO:0047710]; nucleotide binding [GO:0000166]; ubiquitin protein ligase binding [GO:0031625] g21535.t1 Q9HCJ2 33.333 390 1.6399999999999999e-40 162.0 sp|Q9HCJ2|LRC4C_HUMAN Leucine-rich repeat-containing protein 4C OS=Homo sapiens OX=9606 GN=LRRC4C PE=1 SV=1 LRC4C_HUMAN reviewed Leucine-rich repeat-containing protein 4C (Netrin-G1 ligand) (NGL-1) Homo sapiens (Human) GO:0005615; GO:0005886; GO:0016020; GO:0050770; GO:0050804; GO:0050839; GO:0098632; GO:0098685; GO:0098839; GO:0098978; GO:0099560 modulation of chemical synaptic transmission [GO:0050804]; regulation of axonogenesis [GO:0050770]; synaptic membrane adhesion [GO:0099560] extracellular space [GO:0005615]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; Schaffer collateral - CA1 synapse [GO:0098685] cell adhesion molecule binding [GO:0050839]; cell-cell adhesion mediator activity [GO:0098632] g21536.t1 Q3B7H2 50.606 330 9.48e-102 305.0 sp|Q3B7H2|TAM41_DANRE Phosphatidate cytidylyltransferase, mitochondrial OS=Danio rerio OX=7955 GN=tamm41 PE=2 SV=1 g21545.t1 O60706 36.558 1540 0.0 887.0 sp|O60706|ABCC9_HUMAN ATP-binding cassette sub-family C member 9 OS=Homo sapiens OX=9606 GN=ABCC9 PE=1 SV=2 ABCC9_HUMAN reviewed ATP-binding cassette sub-family C member 9 (Sulfonylurea receptor 2) Homo sapiens (Human) GO:0000165; GO:0001508; GO:0001666; GO:0003007; GO:0005267; GO:0005524; GO:0005739; GO:0005886; GO:0006357; GO:0007005; GO:0007519; GO:0008281; GO:0008282; GO:0010467; GO:0014823; GO:0015459; GO:0016887; GO:0019395; GO:0019829; GO:0030017; GO:0031004; GO:0033198; GO:0035865; GO:0042311; GO:0042383; GO:0042542; GO:0042626; GO:0043066; GO:0043225; GO:0043627; GO:0044325; GO:0044877; GO:0045333; GO:0045776; GO:0046034; GO:0048144; GO:0051607; GO:0055085; GO:0060976; GO:0061337; GO:0062197; GO:0071277; GO:0071318; GO:0071466; GO:0071805; GO:0072592; GO:0086003; GO:0098655; GO:0098662; GO:0099104; GO:0140359; GO:0150104; GO:1901379; GO:1901652; GO:1903409; GO:1904880; GO:1990573 action potential [GO:0001508]; ATP metabolic process [GO:0046034]; cardiac conduction [GO:0061337]; cardiac muscle cell contraction [GO:0086003]; cellular respiration [GO:0045333]; cellular response to ATP [GO:0071318]; cellular response to calcium ion [GO:0071277]; cellular response to chemical stress [GO:0062197]; cellular response to potassium ion [GO:0035865]; cellular response to xenobiotic stimulus [GO:0071466]; coronary vasculature development [GO:0060976]; defense response to virus [GO:0051607]; fatty acid oxidation [GO:0019395]; fibroblast proliferation [GO:0048144]; gene expression [GO:0010467]; heart morphogenesis [GO:0003007]; inorganic cation transmembrane transport [GO:0098662]; MAPK cascade [GO:0000165]; mitochondrion organization [GO:0007005]; monoatomic cation transmembrane transport [GO:0098655]; negative regulation of apoptotic process [GO:0043066]; negative regulation of blood pressure [GO:0045776]; oxygen metabolic process [GO:0072592]; potassium ion import across plasma membrane [GO:1990573]; potassium ion transmembrane transport [GO:0071805]; reactive oxygen species biosynthetic process [GO:1903409]; regulation of potassium ion transmembrane transport [GO:1901379]; regulation of transcription by RNA polymerase II [GO:0006357]; response to activity [GO:0014823]; response to ATP [GO:0033198]; response to estrogen [GO:0043627]; response to hydrogen peroxide [GO:0042542]; response to hydrogen sulfide [GO:1904880]; response to hypoxia [GO:0001666]; response to peptide [GO:1901652]; skeletal muscle tissue development [GO:0007519]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104]; vasodilation [GO:0042311] inward rectifying potassium channel [GO:0008282]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; potassium ion-transporting ATPase complex [GO:0031004]; sarcolemma [GO:0042383]; sarcomere [GO:0030017] ABC-type transporter activity [GO:0140359]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled inorganic anion transmembrane transporter activity [GO:0043225]; ATPase-coupled monoatomic cation transmembrane transporter activity [GO:0019829]; ATPase-coupled transmembrane transporter activity [GO:0042626]; potassium channel activator activity [GO:0099104]; potassium channel activity [GO:0005267]; potassium channel regulator activity [GO:0015459]; protein-containing complex binding [GO:0044877]; sulfonylurea receptor activity [GO:0008281]; transmembrane transporter binding [GO:0044325] g21546.t1 O60706 25.294 340 3.33e-21 99.8 sp|O60706|ABCC9_HUMAN ATP-binding cassette sub-family C member 9 OS=Homo sapiens OX=9606 GN=ABCC9 PE=1 SV=2 ABCC9_HUMAN reviewed ATP-binding cassette sub-family C member 9 (Sulfonylurea receptor 2) Homo sapiens (Human) GO:0000165; GO:0001508; GO:0001666; GO:0003007; GO:0005267; GO:0005524; GO:0005739; GO:0005886; GO:0006357; GO:0007005; GO:0007519; GO:0008281; GO:0008282; GO:0010467; GO:0014823; GO:0015459; GO:0016887; GO:0019395; GO:0019829; GO:0030017; GO:0031004; GO:0033198; GO:0035865; GO:0042311; GO:0042383; GO:0042542; GO:0042626; GO:0043066; GO:0043225; GO:0043627; GO:0044325; GO:0044877; GO:0045333; GO:0045776; GO:0046034; GO:0048144; GO:0051607; GO:0055085; GO:0060976; GO:0061337; GO:0062197; GO:0071277; GO:0071318; GO:0071466; GO:0071805; GO:0072592; GO:0086003; GO:0098655; GO:0098662; GO:0099104; GO:0140359; GO:0150104; GO:1901379; GO:1901652; GO:1903409; GO:1904880; GO:1990573 action potential [GO:0001508]; ATP metabolic process [GO:0046034]; cardiac conduction [GO:0061337]; cardiac muscle cell contraction [GO:0086003]; cellular respiration [GO:0045333]; cellular response to ATP [GO:0071318]; cellular response to calcium ion [GO:0071277]; cellular response to chemical stress [GO:0062197]; cellular response to potassium ion [GO:0035865]; cellular response to xenobiotic stimulus [GO:0071466]; coronary vasculature development [GO:0060976]; defense response to virus [GO:0051607]; fatty acid oxidation [GO:0019395]; fibroblast proliferation [GO:0048144]; gene expression [GO:0010467]; heart morphogenesis [GO:0003007]; inorganic cation transmembrane transport [GO:0098662]; MAPK cascade [GO:0000165]; mitochondrion organization [GO:0007005]; monoatomic cation transmembrane transport [GO:0098655]; negative regulation of apoptotic process [GO:0043066]; negative regulation of blood pressure [GO:0045776]; oxygen metabolic process [GO:0072592]; potassium ion import across plasma membrane [GO:1990573]; potassium ion transmembrane transport [GO:0071805]; reactive oxygen species biosynthetic process [GO:1903409]; regulation of potassium ion transmembrane transport [GO:1901379]; regulation of transcription by RNA polymerase II [GO:0006357]; response to activity [GO:0014823]; response to ATP [GO:0033198]; response to estrogen [GO:0043627]; response to hydrogen peroxide [GO:0042542]; response to hydrogen sulfide [GO:1904880]; response to hypoxia [GO:0001666]; response to peptide [GO:1901652]; skeletal muscle tissue development [GO:0007519]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104]; vasodilation [GO:0042311] inward rectifying potassium channel [GO:0008282]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; potassium ion-transporting ATPase complex [GO:0031004]; sarcolemma [GO:0042383]; sarcomere [GO:0030017] ABC-type transporter activity [GO:0140359]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled inorganic anion transmembrane transporter activity [GO:0043225]; ATPase-coupled monoatomic cation transmembrane transporter activity [GO:0019829]; ATPase-coupled transmembrane transporter activity [GO:0042626]; potassium channel activator activity [GO:0099104]; potassium channel activity [GO:0005267]; potassium channel regulator activity [GO:0015459]; protein-containing complex binding [GO:0044877]; sulfonylurea receptor activity [GO:0008281]; transmembrane transporter binding [GO:0044325] g21547.t1 P70170 41.535 1199 0.0 841.0 sp|P70170|ABCC9_MOUSE ATP-binding cassette sub-family C member 9 OS=Mus musculus OX=10090 GN=Abcc9 PE=1 SV=2 g21548.t1 P78509 42.433 3502 0.0 2785.0 sp|P78509|RELN_HUMAN Reelin OS=Homo sapiens OX=9606 GN=RELN PE=1 SV=3 RELN_HUMAN reviewed Reelin (EC 3.4.21.-) Homo sapiens (Human) GO:0000902; GO:0001764; GO:0005576; GO:0005615; GO:0005737; GO:0005886; GO:0006508; GO:0007155; GO:0007411; GO:0007417; GO:0007420; GO:0007616; GO:0007626; GO:0008236; GO:0008306; GO:0010001; GO:0010468; GO:0010976; GO:0016358; GO:0021511; GO:0021517; GO:0021766; GO:0021800; GO:0021819; GO:0030425; GO:0031012; GO:0032008; GO:0035418; GO:0038026; GO:0043005; GO:0045664; GO:0046872; GO:0048018; GO:0048265; GO:0050795; GO:0050804; GO:0051057; GO:0051897; GO:0051968; GO:0060019; GO:0060025; GO:0060291; GO:0061003; GO:0070325; GO:0070326; GO:0090129; GO:0097107; GO:0097114; GO:0097119; GO:0097120; GO:0097477; GO:0110157; GO:1900273; GO:1902078; GO:1904936; GO:2000463; GO:2001222 associative learning [GO:0008306]; axon guidance [GO:0007411]; brain development [GO:0007420]; cell adhesion [GO:0007155]; cell morphogenesis [GO:0000902]; central nervous system development [GO:0007417]; cerebral cortex tangential migration [GO:0021800]; dendrite development [GO:0016358]; glial cell differentiation [GO:0010001]; hippocampus development [GO:0021766]; interneuron migration [GO:1904936]; lateral motor column neuron migration [GO:0097477]; layer formation in cerebral cortex [GO:0021819]; locomotory behavior [GO:0007626]; long-term memory [GO:0007616]; long-term synaptic potentiation [GO:0060291]; modulation of chemical synaptic transmission [GO:0050804]; neuron migration [GO:0001764]; NMDA glutamate receptor clustering [GO:0097114]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of lateral motor column neuron migration [GO:1902078]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of neuron projection development [GO:0010976]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of small GTPase mediated signal transduction [GO:0051057]; positive regulation of synapse maturation [GO:0090129]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; positive regulation of TOR signaling [GO:0032008]; postsynaptic density assembly [GO:0097107]; postsynaptic density protein 95 clustering [GO:0097119]; protein localization to synapse [GO:0035418]; proteolysis [GO:0006508]; radial glial cell differentiation [GO:0060019]; receptor localization to synapse [GO:0097120]; reelin-mediated signaling pathway [GO:0038026]; regulation of behavior [GO:0050795]; regulation of gene expression [GO:0010468]; regulation of neuron differentiation [GO:0045664]; regulation of neuron migration [GO:2001222]; regulation of synaptic activity [GO:0060025]; response to pain [GO:0048265]; spinal cord patterning [GO:0021511]; ventral spinal cord development [GO:0021517] cytoplasm [GO:0005737]; dendrite [GO:0030425]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; reelin complex [GO:0110157] lipoprotein particle receptor binding [GO:0070325]; metal ion binding [GO:0046872]; receptor ligand activity [GO:0048018]; serine-type peptidase activity [GO:0008236]; very-low-density lipoprotein particle receptor binding [GO:0070326] g21548.t1 P78509 32.898 1073 4.49e-149 528.0 sp|P78509|RELN_HUMAN Reelin OS=Homo sapiens OX=9606 GN=RELN PE=1 SV=3 RELN_HUMAN reviewed Reelin (EC 3.4.21.-) Homo sapiens (Human) GO:0000902; GO:0001764; GO:0005576; GO:0005615; GO:0005737; GO:0005886; GO:0006508; GO:0007155; GO:0007411; GO:0007417; GO:0007420; GO:0007616; GO:0007626; GO:0008236; GO:0008306; GO:0010001; GO:0010468; GO:0010976; GO:0016358; GO:0021511; GO:0021517; GO:0021766; GO:0021800; GO:0021819; GO:0030425; GO:0031012; GO:0032008; GO:0035418; GO:0038026; GO:0043005; GO:0045664; GO:0046872; GO:0048018; GO:0048265; GO:0050795; GO:0050804; GO:0051057; GO:0051897; GO:0051968; GO:0060019; GO:0060025; GO:0060291; GO:0061003; GO:0070325; GO:0070326; GO:0090129; GO:0097107; GO:0097114; GO:0097119; GO:0097120; GO:0097477; GO:0110157; GO:1900273; GO:1902078; GO:1904936; GO:2000463; GO:2001222 associative learning [GO:0008306]; axon guidance [GO:0007411]; brain development [GO:0007420]; cell adhesion [GO:0007155]; cell morphogenesis [GO:0000902]; central nervous system development [GO:0007417]; cerebral cortex tangential migration [GO:0021800]; dendrite development [GO:0016358]; glial cell differentiation [GO:0010001]; hippocampus development [GO:0021766]; interneuron migration [GO:1904936]; lateral motor column neuron migration [GO:0097477]; layer formation in cerebral cortex [GO:0021819]; locomotory behavior [GO:0007626]; long-term memory [GO:0007616]; long-term synaptic potentiation [GO:0060291]; modulation of chemical synaptic transmission [GO:0050804]; neuron migration [GO:0001764]; NMDA glutamate receptor clustering [GO:0097114]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of lateral motor column neuron migration [GO:1902078]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of neuron projection development [GO:0010976]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of small GTPase mediated signal transduction [GO:0051057]; positive regulation of synapse maturation [GO:0090129]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; positive regulation of TOR signaling [GO:0032008]; postsynaptic density assembly [GO:0097107]; postsynaptic density protein 95 clustering [GO:0097119]; protein localization to synapse [GO:0035418]; proteolysis [GO:0006508]; radial glial cell differentiation [GO:0060019]; receptor localization to synapse [GO:0097120]; reelin-mediated signaling pathway [GO:0038026]; regulation of behavior [GO:0050795]; regulation of gene expression [GO:0010468]; regulation of neuron differentiation [GO:0045664]; regulation of neuron migration [GO:2001222]; regulation of synaptic activity [GO:0060025]; response to pain [GO:0048265]; spinal cord patterning [GO:0021511]; ventral spinal cord development [GO:0021517] cytoplasm [GO:0005737]; dendrite [GO:0030425]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; reelin complex [GO:0110157] lipoprotein particle receptor binding [GO:0070325]; metal ion binding [GO:0046872]; receptor ligand activity [GO:0048018]; serine-type peptidase activity [GO:0008236]; very-low-density lipoprotein particle receptor binding [GO:0070326] g21557.t1 Q58DF3 52.244 312 3.71e-88 279.0 sp|Q58DF3|TRABD_BOVIN TraB domain-containing protein OS=Bos taurus OX=9913 GN=TRABD PE=2 SV=1 g21558.t1 Q9CX98 45.259 232 7.94e-68 220.0 sp|Q9CX98|CP2U1_MOUSE Cytochrome P450 2U1 OS=Mus musculus OX=10090 GN=Cyp2u1 PE=2 SV=2 CP2U1_MOUSE reviewed Cytochrome P450 2U1 (Long-chain fatty acid omega-monooxygenase) (EC 1.14.14.80) Mus musculus (Mouse) GO:0005506; GO:0005737; GO:0005743; GO:0005789; GO:0006082; GO:0006805; GO:0008202; GO:0008395; GO:0016712; GO:0020037; GO:0052869; GO:0097267; GO:0102033 omega-hydroxylase P450 pathway [GO:0097267]; organic acid metabolic process [GO:0006082]; steroid metabolic process [GO:0008202]; xenobiotic metabolic process [GO:0006805] cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; mitochondrial inner membrane [GO:0005743] arachidonate omega-hydroxylase activity [GO:0052869]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; long-chain fatty acid omega-hydroxylase activity [GO:0102033]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; steroid hydroxylase activity [GO:0008395] g21559.t1 O54750 50.0 86 3.86e-27 106.0 sp|O54750|CP2J6_MOUSE Cytochrome P450 2J6 OS=Mus musculus OX=10090 GN=Cyp2j6 PE=2 SV=2 g21560.t1 Q58CN9 58.416 303 1.1000000000000001e-132 385.0 sp|Q58CN9|NAPEP_BOVIN N-acyl-phosphatidylethanolamine-hydrolyzing phospholipase D OS=Bos taurus OX=9913 GN=NAPEPLD PE=2 SV=1 NAPEP_BOVIN reviewed N-acyl-phosphatidylethanolamine-hydrolyzing phospholipase D (N-acyl phosphatidylethanolamine phospholipase D) (NAPE-PLD) (NAPE-hydrolyzing phospholipase D) (EC 3.1.4.54) Bos taurus (Bovine) GO:0000139; GO:0001659; GO:0005635; GO:0005654; GO:0005737; GO:0005769; GO:0005794; GO:0008270; GO:0009395; GO:0031901; GO:0043005; GO:0043025; GO:0048874; GO:0050729; GO:0070290; GO:0070291; GO:0070292; GO:0090336 host-mediated modulation of intestinal microbiota composition [GO:0048874]; N-acylethanolamine metabolic process [GO:0070291]; N-acylphosphatidylethanolamine metabolic process [GO:0070292]; phospholipid catabolic process [GO:0009395]; positive regulation of brown fat cell differentiation [GO:0090336]; positive regulation of inflammatory response [GO:0050729]; temperature homeostasis [GO:0001659] cytoplasm [GO:0005737]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654] N-acylphosphatidylethanolamine-specific phospholipase D activity [GO:0070290]; zinc ion binding [GO:0008270] g21564.t1 Q7Z3U7 58.933 1181 0.0 1305.0 sp|Q7Z3U7|MON2_HUMAN Protein MON2 homolog OS=Homo sapiens OX=9606 GN=MON2 PE=1 SV=3 MON2_HUMAN reviewed Protein MON2 homolog (Protein SF21) Homo sapiens (Human) GO:0005085; GO:0005829; GO:0006895; GO:0015031; GO:0031901; GO:0070062 Golgi to endosome transport [GO:0006895]; protein transport [GO:0015031] cytosol [GO:0005829]; early endosome membrane [GO:0031901]; extracellular exosome [GO:0070062] guanyl-nucleotide exchange factor activity [GO:0005085] g21565.t1 Q7Z3U7 50.996 502 2.82e-154 486.0 sp|Q7Z3U7|MON2_HUMAN Protein MON2 homolog OS=Homo sapiens OX=9606 GN=MON2 PE=1 SV=3 MON2_HUMAN reviewed Protein MON2 homolog (Protein SF21) Homo sapiens (Human) GO:0005085; GO:0005829; GO:0006895; GO:0015031; GO:0031901; GO:0070062 Golgi to endosome transport [GO:0006895]; protein transport [GO:0015031] cytosol [GO:0005829]; early endosome membrane [GO:0031901]; extracellular exosome [GO:0070062] guanyl-nucleotide exchange factor activity [GO:0005085] g21565.t2 Q7Z3U7 52.567 487 2.8e-156 490.0 sp|Q7Z3U7|MON2_HUMAN Protein MON2 homolog OS=Homo sapiens OX=9606 GN=MON2 PE=1 SV=3 MON2_HUMAN reviewed Protein MON2 homolog (Protein SF21) Homo sapiens (Human) GO:0005085; GO:0005829; GO:0006895; GO:0015031; GO:0031901; GO:0070062 Golgi to endosome transport [GO:0006895]; protein transport [GO:0015031] cytosol [GO:0005829]; early endosome membrane [GO:0031901]; extracellular exosome [GO:0070062] guanyl-nucleotide exchange factor activity [GO:0005085] g21566.t1 Q9PSX7 84.043 188 2.0099999999999999e-115 329.0 sp|Q9PSX7|RHOC_CHICK Rho-related GTP-binding protein RhoC OS=Gallus gallus OX=9031 GN=RHOC PE=1 SV=1 g21567.t1 P01122 89.062 192 1.02e-121 345.0 sp|P01122|RHO_APLCA Ras-like GTP-binding protein RHO OS=Aplysia californica OX=6500 GN=RHO PE=2 SV=1 g21569.t1 Q6NW85 31.313 198 4.47e-21 100.0 sp|Q6NW85|ARI1L_DANRE E3 ubiquitin-protein ligase arih1l OS=Danio rerio OX=7955 GN=arih1l PE=2 SV=1 ARI1L_DANRE reviewed E3 ubiquitin-protein ligase arih1l (EC 2.3.2.31) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000151; GO:0004842; GO:0005634; GO:0005737; GO:0006511; GO:0008270; GO:0016567; GO:0031624; GO:0061630 protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511] cytoplasm [GO:0005737]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151] ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] g21570.t1 Q68EQ1 71.944 360 0.0 532.0 sp|Q68EQ1|GMPPB_XENTR Mannose-1-phosphate guanylyltransferase catalytic subunit beta OS=Xenopus tropicalis OX=8364 GN=gmppb PE=2 SV=1 g21571.t1 Q5F489 48.387 186 4.2799999999999995e-46 183.0 sp|Q5F489|TAF3_CHICK Transcription initiation factor TFIID subunit 3 OS=Gallus gallus OX=9031 GN=TAF3 PE=2 SV=1 g21572.t1 Q7ZVX6 65.463 443 0.0 585.0 sp|Q7ZVX6|UBA3_DANRE NEDD8-activating enzyme E1 catalytic subunit OS=Danio rerio OX=7955 GN=uba3 PE=2 SV=1 UBA3_DANRE reviewed NEDD8-activating enzyme E1 catalytic subunit (EC 6.2.1.64) (NEDD8-activating enzyme E1C) (Ubiquitin-activating enzyme E1C) (Ubiquitin-like modifier-activating enzyme 3) (Ubiquitin-activating enzyme 3) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005524; GO:0005634; GO:0005737; GO:0019781; GO:0045116 protein neddylation [GO:0045116] cytoplasm [GO:0005737]; nucleus [GO:0005634] ATP binding [GO:0005524]; NEDD8 activating enzyme activity [GO:0019781] g21573.t1 Q3KRG3 39.062 128 3.49e-30 112.0 sp|Q3KRG3|TSR2_DANRE Pre-rRNA-processing protein TSR2 homolog OS=Danio rerio OX=7955 GN=tsr2 PE=2 SV=1 g21574.t1 Q9BV10 44.221 199 1.4099999999999999e-40 147.0 sp|Q9BV10|ALG12_HUMAN Dol-P-Man:Man(7)GlcNAc(2)-PP-Dol alpha-1,6-mannosyltransferase OS=Homo sapiens OX=9606 GN=ALG12 PE=1 SV=1 g21575.t1 Q8VDB2 49.333 225 1.2800000000000001e-64 202.0 sp|Q8VDB2|ALG12_MOUSE Dol-P-Man:Man(7)GlcNAc(2)-PP-Dol alpha-1,6-mannosyltransferase OS=Mus musculus OX=10090 GN=Alg12 PE=2 SV=2 g21575.t1 Q8VDB2 82.857 35 1.2800000000000001e-64 65.9 sp|Q8VDB2|ALG12_MOUSE Dol-P-Man:Man(7)GlcNAc(2)-PP-Dol alpha-1,6-mannosyltransferase OS=Mus musculus OX=10090 GN=Alg12 PE=2 SV=2 g21576.t1 Q5E9Q3 42.714 199 1.6e-25 108.0 sp|Q5E9Q3|MITOK_BOVIN Mitochondrial potassium channel OS=Bos taurus OX=9913 GN=CCDC51 PE=2 SV=1 g21577.t1 Q9YHT4 53.819 576 0.0 600.0 sp|Q9YHT4|HEM0_DANRE 5-aminolevulinate synthase, erythroid-specific, mitochondrial OS=Danio rerio OX=7955 GN=alas2 PE=2 SV=1 g21577.t2 Q9YHT4 53.472 576 0.0 602.0 sp|Q9YHT4|HEM0_DANRE 5-aminolevulinate synthase, erythroid-specific, mitochondrial OS=Danio rerio OX=7955 GN=alas2 PE=2 SV=1 g21578.t1 O60706 37.787 1609 0.0 1046.0 sp|O60706|ABCC9_HUMAN ATP-binding cassette sub-family C member 9 OS=Homo sapiens OX=9606 GN=ABCC9 PE=1 SV=2 ABCC9_HUMAN reviewed ATP-binding cassette sub-family C member 9 (Sulfonylurea receptor 2) Homo sapiens (Human) GO:0000165; GO:0001508; GO:0001666; GO:0003007; GO:0005267; GO:0005524; GO:0005739; GO:0005886; GO:0006357; GO:0007005; GO:0007519; GO:0008281; GO:0008282; GO:0010467; GO:0014823; GO:0015459; GO:0016887; GO:0019395; GO:0019829; GO:0030017; GO:0031004; GO:0033198; GO:0035865; GO:0042311; GO:0042383; GO:0042542; GO:0042626; GO:0043066; GO:0043225; GO:0043627; GO:0044325; GO:0044877; GO:0045333; GO:0045776; GO:0046034; GO:0048144; GO:0051607; GO:0055085; GO:0060976; GO:0061337; GO:0062197; GO:0071277; GO:0071318; GO:0071466; GO:0071805; GO:0072592; GO:0086003; GO:0098655; GO:0098662; GO:0099104; GO:0140359; GO:0150104; GO:1901379; GO:1901652; GO:1903409; GO:1904880; GO:1990573 action potential [GO:0001508]; ATP metabolic process [GO:0046034]; cardiac conduction [GO:0061337]; cardiac muscle cell contraction [GO:0086003]; cellular respiration [GO:0045333]; cellular response to ATP [GO:0071318]; cellular response to calcium ion [GO:0071277]; cellular response to chemical stress [GO:0062197]; cellular response to potassium ion [GO:0035865]; cellular response to xenobiotic stimulus [GO:0071466]; coronary vasculature development [GO:0060976]; defense response to virus [GO:0051607]; fatty acid oxidation [GO:0019395]; fibroblast proliferation [GO:0048144]; gene expression [GO:0010467]; heart morphogenesis [GO:0003007]; inorganic cation transmembrane transport [GO:0098662]; MAPK cascade [GO:0000165]; mitochondrion organization [GO:0007005]; monoatomic cation transmembrane transport [GO:0098655]; negative regulation of apoptotic process [GO:0043066]; negative regulation of blood pressure [GO:0045776]; oxygen metabolic process [GO:0072592]; potassium ion import across plasma membrane [GO:1990573]; potassium ion transmembrane transport [GO:0071805]; reactive oxygen species biosynthetic process [GO:1903409]; regulation of potassium ion transmembrane transport [GO:1901379]; regulation of transcription by RNA polymerase II [GO:0006357]; response to activity [GO:0014823]; response to ATP [GO:0033198]; response to estrogen [GO:0043627]; response to hydrogen peroxide [GO:0042542]; response to hydrogen sulfide [GO:1904880]; response to hypoxia [GO:0001666]; response to peptide [GO:1901652]; skeletal muscle tissue development [GO:0007519]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104]; vasodilation [GO:0042311] inward rectifying potassium channel [GO:0008282]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; potassium ion-transporting ATPase complex [GO:0031004]; sarcolemma [GO:0042383]; sarcomere [GO:0030017] ABC-type transporter activity [GO:0140359]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled inorganic anion transmembrane transporter activity [GO:0043225]; ATPase-coupled monoatomic cation transmembrane transporter activity [GO:0019829]; ATPase-coupled transmembrane transporter activity [GO:0042626]; potassium channel activator activity [GO:0099104]; potassium channel activity [GO:0005267]; potassium channel regulator activity [GO:0015459]; protein-containing complex binding [GO:0044877]; sulfonylurea receptor activity [GO:0008281]; transmembrane transporter binding [GO:0044325] g21579.t1 P82451 38.391 1529 0.0 1045.0 sp|P82451|ABCC9_RABIT ATP-binding cassette sub-family C member 9 OS=Oryctolagus cuniculus OX=9986 GN=ABCC9 PE=2 SV=1 g21581.t1 Q09428 61.806 144 1.45e-51 181.0 sp|Q09428|ABCC8_HUMAN ATP-binding cassette sub-family C member 8 OS=Homo sapiens OX=9606 GN=ABCC8 PE=1 SV=6 ABCC8_HUMAN reviewed ATP-binding cassette sub-family C member 8 (Sulfonylurea receptor 1) Homo sapiens (Human) GO:0001508; GO:0001678; GO:0005267; GO:0005524; GO:0005886; GO:0006813; GO:0007565; GO:0007613; GO:0008281; GO:0008282; GO:0008542; GO:0009268; GO:0009410; GO:0010043; GO:0010989; GO:0015272; GO:0016525; GO:0016887; GO:0019829; GO:0030672; GO:0031004; GO:0031669; GO:0032496; GO:0032760; GO:0032868; GO:0035774; GO:0042383; GO:0042734; GO:0043268; GO:0043531; GO:0044325; GO:0046676; GO:0046872; GO:0050796; GO:0050905; GO:0055085; GO:0060253; GO:0061535; GO:0061855; GO:0071805; GO:0098662; GO:0140359; GO:1900721; GO:1905075; GO:1905604; GO:1990573 action potential [GO:0001508]; cellular response to nutrient levels [GO:0031669]; female pregnancy [GO:0007565]; glutamate secretion, neurotransmission [GO:0061535]; inorganic cation transmembrane transport [GO:0098662]; intracellular glucose homeostasis [GO:0001678]; memory [GO:0007613]; negative regulation of angiogenesis [GO:0016525]; negative regulation of blood-brain barrier permeability [GO:1905604]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of insulin secretion [GO:0046676]; negative regulation of low-density lipoprotein particle clearance [GO:0010989]; negative regulation of neuroblast migration [GO:0061855]; neuromuscular process [GO:0050905]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of potassium ion transport [GO:0043268]; positive regulation of tight junction disassembly [GO:1905075]; positive regulation of tumor necrosis factor production [GO:0032760]; positive regulation of uterine smooth muscle relaxation [GO:1900721]; potassium ion import across plasma membrane [GO:1990573]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; regulation of insulin secretion [GO:0050796]; response to insulin [GO:0032868]; response to lipopolysaccharide [GO:0032496]; response to pH [GO:0009268]; response to xenobiotic stimulus [GO:0009410]; response to zinc ion [GO:0010043]; transmembrane transport [GO:0055085]; visual learning [GO:0008542] inward rectifying potassium channel [GO:0008282]; plasma membrane [GO:0005886]; potassium ion-transporting ATPase complex [GO:0031004]; presynaptic membrane [GO:0042734]; sarcolemma [GO:0042383]; synaptic vesicle membrane [GO:0030672] ABC-type transporter activity [GO:0140359]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-activated inward rectifier potassium channel activity [GO:0015272]; ATPase-coupled monoatomic cation transmembrane transporter activity [GO:0019829]; metal ion binding [GO:0046872]; potassium channel activity [GO:0005267]; sulfonylurea receptor activity [GO:0008281]; transmembrane transporter binding [GO:0044325] g21582.t1 P70170 38.366 1603 0.0 1055.0 sp|P70170|ABCC9_MOUSE ATP-binding cassette sub-family C member 9 OS=Mus musculus OX=10090 GN=Abcc9 PE=1 SV=2 g21586.t1 P62597 40.52 269 2.4099999999999998e-46 177.0 sp|P62597|POTE1_CHICK Protection of telomeres protein 1 OS=Gallus gallus OX=9031 GN=POT1 PE=1 SV=1 g21588.t1 Q08BB2 46.171 444 6.23e-134 400.0 sp|Q08BB2|P2012_DANRE N-fatty-acyl-amino acid synthase/hydrolase PM20D1.2 OS=Danio rerio OX=7955 GN=pm20d1.2 PE=2 SV=1 P2012_DANRE reviewed N-fatty-acyl-amino acid synthase/hydrolase PM20D1.2 (EC 3.5.1.114) (EC 3.5.1.14) (Peptidase M20 domain-containing protein 1.2) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0004046; GO:0004181; GO:0005615; GO:0006508; GO:0006520; GO:0006629; GO:0006631; GO:0016811; GO:0016829; GO:0022904; GO:0043604; GO:0043605; GO:0046872; GO:0097009; GO:1990845 adaptive thermogenesis [GO:1990845]; amide biosynthetic process [GO:0043604]; amide catabolic process [GO:0043605]; amino acid metabolic process [GO:0006520]; energy homeostasis [GO:0097009]; fatty acid metabolic process [GO:0006631]; lipid metabolic process [GO:0006629]; proteolysis [GO:0006508]; respiratory electron transport chain [GO:0022904] extracellular space [GO:0005615] aminoacylase activity [GO:0004046]; hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides [GO:0016811]; lyase activity [GO:0016829]; metal ion binding [GO:0046872]; metallocarboxypeptidase activity [GO:0004181] g21589.t1 Q55E58 29.25 400 2.46e-27 124.0 sp|Q55E58|PATS1_DICDI Probable serine/threonine-protein kinase pats1 OS=Dictyostelium discoideum OX=44689 GN=pats1 PE=3 SV=1 PATS1_DICDI reviewed Probable serine/threonine-protein kinase pats1 (EC 2.7.11.1) (Protein associated with the transduction of signal 1) Dictyostelium discoideum (Social amoeba) GO:0000281; GO:0004438; GO:0004674; GO:0004721; GO:0005524; GO:0005525; GO:0005737; GO:0005829; GO:0016020; GO:0042641; GO:0046856; GO:0099139; GO:0106310 cheating during chimeric sorocarp development [GO:0099139]; mitotic cytokinesis [GO:0000281]; phosphatidylinositol dephosphorylation [GO:0046856] actomyosin [GO:0042641]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020] ATP binding [GO:0005524]; GTP binding [GO:0005525]; phosphatidylinositol-3-phosphate phosphatase activity [GO:0004438]; phosphoprotein phosphatase activity [GO:0004721]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g21590.t1 Q3SY69 68.95 905 0.0 1295.0 sp|Q3SY69|AL1L2_HUMAN Mitochondrial 10-formyltetrahydrofolate dehydrogenase OS=Homo sapiens OX=9606 GN=ALDH1L2 PE=1 SV=2 AL1L2_HUMAN reviewed Mitochondrial 10-formyltetrahydrofolate dehydrogenase (Mitochondrial 10-FTHFDH) (mtFDH) (EC 1.5.1.6) (Aldehyde dehydrogenase family 1 member L2) Homo sapiens (Human) GO:0004029; GO:0005654; GO:0005739; GO:0005759; GO:0006635; GO:0006730; GO:0006740; GO:0009258; GO:0016155; GO:0046655; GO:0070062 10-formyltetrahydrofolate catabolic process [GO:0009258]; fatty acid beta-oxidation [GO:0006635]; folic acid metabolic process [GO:0046655]; NADPH regeneration [GO:0006740]; one-carbon metabolic process [GO:0006730] extracellular exosome [GO:0070062]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654] aldehyde dehydrogenase (NAD+) activity [GO:0004029]; formyltetrahydrofolate dehydrogenase activity [GO:0016155] g21593.t1 F1R332 26.543 324 1.45e-22 101.0 sp|F1R332|GAL2A_DANRE Galanin receptor 2a OS=Danio rerio OX=7955 GN=galr2a PE=2 SV=2 g21594.t1 Q58CP0 57.979 376 3.8299999999999998e-140 408.0 sp|Q58CP0|IDH3G_BOVIN Isocitrate dehydrogenase [NAD] subunit gamma, mitochondrial OS=Bos taurus OX=9913 GN=IDH3G PE=2 SV=1 g21595.t1 P82349 29.932 294 6.32e-25 103.0 sp|P82349|SGCB_MOUSE Beta-sarcoglycan OS=Mus musculus OX=10090 GN=Sgcb PE=1 SV=1 SGCB_MOUSE reviewed Beta-sarcoglycan (Beta-SG) (43 kDa dystrophin-associated glycoprotein) (43DAG) Mus musculus (Mouse) GO:0005856; GO:0005886; GO:0007517; GO:0009749; GO:0010467; GO:0016010; GO:0016011; GO:0016012; GO:0042383; GO:0042593; GO:0044381; GO:0055001; GO:0055013; GO:0061024; GO:0097084 cardiac muscle cell development [GO:0055013]; gene expression [GO:0010467]; glucose homeostasis [GO:0042593]; glucose import in response to insulin stimulus [GO:0044381]; membrane organization [GO:0061024]; muscle cell development [GO:0055001]; muscle organ development [GO:0007517]; response to glucose [GO:0009749]; vascular associated smooth muscle cell development [GO:0097084] cytoskeleton [GO:0005856]; dystroglycan complex [GO:0016011]; dystrophin-associated glycoprotein complex [GO:0016010]; plasma membrane [GO:0005886]; sarcoglycan complex [GO:0016012]; sarcolemma [GO:0042383] g21595.t2 P82349 32.881 295 7.760000000000001e-29 114.0 sp|P82349|SGCB_MOUSE Beta-sarcoglycan OS=Mus musculus OX=10090 GN=Sgcb PE=1 SV=1 SGCB_MOUSE reviewed Beta-sarcoglycan (Beta-SG) (43 kDa dystrophin-associated glycoprotein) (43DAG) Mus musculus (Mouse) GO:0005856; GO:0005886; GO:0007517; GO:0009749; GO:0010467; GO:0016010; GO:0016011; GO:0016012; GO:0042383; GO:0042593; GO:0044381; GO:0055001; GO:0055013; GO:0061024; GO:0097084 cardiac muscle cell development [GO:0055013]; gene expression [GO:0010467]; glucose homeostasis [GO:0042593]; glucose import in response to insulin stimulus [GO:0044381]; membrane organization [GO:0061024]; muscle cell development [GO:0055001]; muscle organ development [GO:0007517]; response to glucose [GO:0009749]; vascular associated smooth muscle cell development [GO:0097084] cytoskeleton [GO:0005856]; dystroglycan complex [GO:0016011]; dystrophin-associated glycoprotein complex [GO:0016010]; plasma membrane [GO:0005886]; sarcoglycan complex [GO:0016012]; sarcolemma [GO:0042383] g16326.t1 Q96KV7 33.52 179 1.74e-23 96.7 sp|Q96KV7|WDR90_HUMAN WD repeat-containing protein 90 OS=Homo sapiens OX=9606 GN=WDR90 PE=1 SV=2 g16326.t1 Q96KV7 42.857 28 1.74e-23 33.5 sp|Q96KV7|WDR90_HUMAN WD repeat-containing protein 90 OS=Homo sapiens OX=9606 GN=WDR90 PE=1 SV=2 g16337.t1 A0JP70 31.892 185 2.0100000000000003e-27 109.0 sp|A0JP70|WDR90_XENTR WD repeat-containing protein 90 OS=Xenopus tropicalis OX=8364 GN=wdr90 PE=2 SV=1 g16340.t1 P10079 37.625 598 1.68e-87 298.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g16340.t1 P10079 37.553 474 4.25e-76 266.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g16340.t1 P10079 36.096 543 9.72e-75 263.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g16340.t1 P10079 36.559 372 3.7399999999999995e-52 197.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g16340.t1 P10079 39.871 311 1.21e-49 190.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g16340.t1 P10079 44.91 167 7.58e-34 142.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g16340.t1 P10079 47.333 150 1.02e-31 135.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g16340.t1 P10079 45.783 166 1.9600000000000001e-31 134.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g16340.t1 P10079 44.231 156 3.5000000000000003e-31 134.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g16340.t1 P10079 45.395 152 9.91e-31 132.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g16340.t1 P10079 46.154 156 8.5e-30 129.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g16340.t1 P10079 40.0 170 2.1400000000000002e-29 128.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g16340.t1 P10079 42.169 166 2.5100000000000002e-29 128.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g16340.t1 P10079 44.375 160 3.63e-28 124.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g16340.t1 P10079 44.371 151 5.45e-28 124.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g16340.t1 P10079 40.698 172 6.28e-27 120.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g16340.t1 P10079 41.29 155 6.76e-26 117.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g16341.t1 P07207 39.111 900 0.0 600.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g16341.t1 P07207 37.09 976 0.0 588.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g16341.t1 P07207 39.709 894 1.63e-178 575.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g16341.t1 P07207 37.379 931 2.8999999999999997e-176 569.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g16341.t1 P07207 36.728 923 6.74e-160 522.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g16341.t1 P07207 34.921 882 8.18e-137 455.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g16341.t1 P07207 37.532 778 4.19e-136 453.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g16341.t1 P07207 34.396 910 4.4e-136 453.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g16341.t2 P07207 39.573 983 0.0 666.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g16341.t2 P07207 38.166 1014 0.0 659.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g16341.t2 P07207 38.936 1053 0.0 652.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g16341.t2 P07207 38.081 1032 0.0 650.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g16341.t2 P07207 38.872 1011 0.0 632.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g16341.t2 P07207 39.381 904 0.0 604.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g16341.t2 P07207 35.905 972 4.92e-164 538.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g16341.t2 P07207 37.14 902 5.94e-156 515.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g16341.t2 P07207 37.666 754 1.05e-142 476.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g16341.t2 P07207 36.037 641 4.64e-91 323.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g16343.t1 P10079 40.741 621 1.63e-121 394.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g16343.t1 P10079 39.677 620 4.7999999999999996e-119 388.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g16343.t1 P10079 37.296 614 1.3900000000000002e-110 365.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g16343.t1 P10079 38.111 593 3.35e-106 353.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g16343.t1 P10079 39.425 487 3.95e-87 301.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g16343.t1 P10079 36.077 571 1.42e-80 283.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g16344.t1 Q3V096 50.81 494 1.46e-157 461.0 sp|Q3V096|ANR42_MOUSE Ankyrin repeat domain-containing protein 42 OS=Mus musculus OX=10090 GN=Ankrd42 PE=1 SV=1 g16345.t1 Q07192 70.807 322 2.38e-168 481.0 sp|Q07192|MP2K2_XENLA Dual specificity mitogen-activated protein kinase kinase 2 (Fragment) OS=Xenopus laevis OX=8355 GN=map2k2 PE=1 SV=1 g16346.t1 Q8R481 36.033 605 1.0999999999999999e-91 304.0 sp|Q8R481|PERL_MESAU Lactoperoxidase OS=Mesocricetus auratus OX=10036 GN=LPO PE=1 SV=1 PERL_MESAU reviewed Lactoperoxidase (LPO) (EC 1.11.1.7) (Lacrimal gland peroxidase) Mesocricetus auratus (Golden hamster) GO:0001580; GO:0004601; GO:0005615; GO:0005737; GO:0006979; GO:0016323; GO:0020037; GO:0036393; GO:0042742; GO:0046872; GO:0140825 defense response to bacterium [GO:0042742]; detection of chemical stimulus involved in sensory perception of bitter taste [GO:0001580]; response to oxidative stress [GO:0006979] basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; extracellular space [GO:0005615] heme binding [GO:0020037]; lactoperoxidase activity [GO:0140825]; metal ion binding [GO:0046872]; peroxidase activity [GO:0004601]; thiocyanate peroxidase activity [GO:0036393] g16347.t1 G5EG78 35.897 585 2.36e-99 337.0 sp|G5EG78|PXDN2_CAEEL Peroxidasin homolog pxn-2 OS=Caenorhabditis elegans OX=6239 GN=pxn-2 PE=1 SV=1 PXDN2_CAEEL reviewed Peroxidasin homolog pxn-2 (EC 1.11.2.-) Caenorhabditis elegans GO:0004601; GO:0005604; GO:0005615; GO:0006979; GO:0007411; GO:0010172; GO:0016203; GO:0020037; GO:0046872; GO:0048681; GO:0071711; GO:0110011 axon guidance [GO:0007411]; basement membrane organization [GO:0071711]; embryonic body morphogenesis [GO:0010172]; muscle attachment [GO:0016203]; negative regulation of axon regeneration [GO:0048681]; regulation of basement membrane organization [GO:0110011]; response to oxidative stress [GO:0006979] basement membrane [GO:0005604]; extracellular space [GO:0005615] heme binding [GO:0020037]; metal ion binding [GO:0046872]; peroxidase activity [GO:0004601] g16348.t1 Q9D8W5 67.483 449 0.0 609.0 sp|Q9D8W5|PSD12_MOUSE 26S proteasome non-ATPase regulatory subunit 12 OS=Mus musculus OX=10090 GN=Psmd12 PE=1 SV=4 PSD12_MOUSE reviewed 26S proteasome non-ATPase regulatory subunit 12 (26S proteasome regulatory subunit RPN5) (26S proteasome regulatory subunit p55) Mus musculus (Mouse) GO:0000502; GO:0005737; GO:0005838; GO:0008541; GO:0022624 cytoplasm [GO:0005737]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; proteasome regulatory particle [GO:0005838]; proteasome regulatory particle, lid subcomplex [GO:0008541] g16351.t1 Q53FZ2 58.942 548 0.0 696.0 sp|Q53FZ2|ACSM3_HUMAN Acyl-coenzyme A synthetase ACSM3, mitochondrial OS=Homo sapiens OX=9606 GN=ACSM3 PE=1 SV=2 ACSM3_HUMAN reviewed Acyl-coenzyme A synthetase ACSM3, mitochondrial (EC 6.2.1.2) (Acyl-CoA synthetase medium-chain family member 3) (Butyrate--CoA ligase 3) (Butyryl-coenzyme A synthetase 3) (Middle-chain acyl-CoA synthetase 3) (Propionate--CoA ligase) (EC 6.2.1.17) (Protein SA homolog) Homo sapiens (Human) GO:0004321; GO:0005524; GO:0005739; GO:0005759; GO:0006633; GO:0006637; GO:0008217; GO:0015645; GO:0018729; GO:0031956; GO:0042632; GO:0043759; GO:0046872; GO:0050218 acyl-CoA metabolic process [GO:0006637]; cholesterol homeostasis [GO:0042632]; fatty acid biosynthetic process [GO:0006633]; regulation of blood pressure [GO:0008217] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] 2-methylbutanoate-CoA ligase activity [GO:0043759]; ATP binding [GO:0005524]; fatty acid ligase activity [GO:0015645]; fatty-acyl-CoA synthase activity [GO:0004321]; medium-chain fatty acid-CoA ligase activity [GO:0031956]; metal ion binding [GO:0046872]; propionate CoA-transferase activity [GO:0018729]; propionate-CoA ligase activity [GO:0050218] g16352.t1 Q8IYS1 44.11 399 1.24e-77 250.0 sp|Q8IYS1|P20D2_HUMAN Xaa-Arg dipeptidase OS=Homo sapiens OX=9606 GN=PM20D2 PE=1 SV=2 g16353.t1 A3KG59 42.172 396 2.44e-79 254.0 sp|A3KG59|P20D2_MOUSE Xaa-Arg dipeptidase OS=Mus musculus OX=10090 GN=Pm20d2 PE=1 SV=1 P20D2_MOUSE reviewed Xaa-Arg dipeptidase (EC 3.4.13.4) Mus musculus (Mouse) GO:0004180; GO:0005654; GO:0006508; GO:0016805; GO:0042802; GO:0051246 proteolysis [GO:0006508]; regulation of protein metabolic process [GO:0051246] nucleoplasm [GO:0005654] carboxypeptidase activity [GO:0004180]; dipeptidase activity [GO:0016805]; identical protein binding [GO:0042802] g16353.t2 A3KG59 46.927 358 1.24e-86 274.0 sp|A3KG59|P20D2_MOUSE Xaa-Arg dipeptidase OS=Mus musculus OX=10090 GN=Pm20d2 PE=1 SV=1 P20D2_MOUSE reviewed Xaa-Arg dipeptidase (EC 3.4.13.4) Mus musculus (Mouse) GO:0004180; GO:0005654; GO:0006508; GO:0016805; GO:0042802; GO:0051246 proteolysis [GO:0006508]; regulation of protein metabolic process [GO:0051246] nucleoplasm [GO:0005654] carboxypeptidase activity [GO:0004180]; dipeptidase activity [GO:0016805]; identical protein binding [GO:0042802] g16354.t1 Q5PNP1 38.66 776 4.5500000000000005e-166 506.0 sp|Q5PNP1|SNX14_DANRE Sorting nexin-14 OS=Danio rerio OX=7955 GN=snx14 PE=2 SV=3 SNX14_DANRE reviewed Sorting nexin-14 Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005764; GO:0005765; GO:0005770; GO:0006914; GO:0021680; GO:0030425; GO:0030902; GO:0031902; GO:0035091; GO:0080025; GO:0097352 autophagosome maturation [GO:0097352]; autophagy [GO:0006914]; cerebellar Purkinje cell layer development [GO:0021680]; hindbrain development [GO:0030902] dendrite [GO:0030425]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764] phosphatidylinositol binding [GO:0035091]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025] g16356.t1 Q17QR8 34.875 281 9.96e-51 176.0 sp|Q17QR8|HARB1_BOVIN Putative nuclease HARBI1 OS=Bos taurus OX=9913 GN=HARBI1 PE=2 SV=1 g16358.t1 Q8QGX4 56.075 321 1.3000000000000002e-109 353.0 sp|Q8QGX4|PRKDC_CHICK DNA-dependent protein kinase catalytic subunit OS=Gallus gallus OX=9031 GN=PRKDC PE=2 SV=1 g16359.t1 Q8QGX4 41.411 3557 0.0 2622.0 sp|Q8QGX4|PRKDC_CHICK DNA-dependent protein kinase catalytic subunit OS=Gallus gallus OX=9031 GN=PRKDC PE=2 SV=1 g16360.t1 Q9DEI1 36.694 248 8.26e-36 138.0 sp|Q9DEI1|PRKDC_XENLA DNA-dependent protein kinase catalytic subunit OS=Xenopus laevis OX=8355 GN=prkdc PE=2 SV=1 g16361.t1 Q7YR75 47.205 161 1.04e-33 122.0 sp|Q7YR75|RM12_BOVIN Large ribosomal subunit protein bL12m OS=Bos taurus OX=9913 GN=MRPL12 PE=1 SV=1 g16364.t1 Q9UKN7 29.758 867 6.89e-127 448.0 sp|Q9UKN7|MYO15_HUMAN Unconventional myosin-XV OS=Homo sapiens OX=9606 GN=MYO15A PE=1 SV=2 MYO15_HUMAN reviewed Unconventional myosin-XV (Unconventional myosin-15) Homo sapiens (Human) GO:0000146; GO:0005516; GO:0005524; GO:0005737; GO:0006897; GO:0007015; GO:0007605; GO:0007626; GO:0009416; GO:0015629; GO:0016020; GO:0016459; GO:0032420; GO:0042472; GO:0051015; GO:0070062; GO:0098858 actin filament organization [GO:0007015]; endocytosis [GO:0006897]; inner ear morphogenesis [GO:0042472]; locomotory behavior [GO:0007626]; response to light stimulus [GO:0009416]; sensory perception of sound [GO:0007605] actin cytoskeleton [GO:0015629]; actin-based cell projection [GO:0098858]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; myosin complex [GO:0016459]; stereocilium [GO:0032420] actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146] g16364.t1 Q9UKN7 41.667 204 9.48e-41 170.0 sp|Q9UKN7|MYO15_HUMAN Unconventional myosin-XV OS=Homo sapiens OX=9606 GN=MYO15A PE=1 SV=2 MYO15_HUMAN reviewed Unconventional myosin-XV (Unconventional myosin-15) Homo sapiens (Human) GO:0000146; GO:0005516; GO:0005524; GO:0005737; GO:0006897; GO:0007015; GO:0007605; GO:0007626; GO:0009416; GO:0015629; GO:0016020; GO:0016459; GO:0032420; GO:0042472; GO:0051015; GO:0070062; GO:0098858 actin filament organization [GO:0007015]; endocytosis [GO:0006897]; inner ear morphogenesis [GO:0042472]; locomotory behavior [GO:0007626]; response to light stimulus [GO:0009416]; sensory perception of sound [GO:0007605] actin cytoskeleton [GO:0015629]; actin-based cell projection [GO:0098858]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; myosin complex [GO:0016459]; stereocilium [GO:0032420] actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146] g16364.t2 Q9UKN7 29.758 867 1.2999999999999998e-126 448.0 sp|Q9UKN7|MYO15_HUMAN Unconventional myosin-XV OS=Homo sapiens OX=9606 GN=MYO15A PE=1 SV=2 MYO15_HUMAN reviewed Unconventional myosin-XV (Unconventional myosin-15) Homo sapiens (Human) GO:0000146; GO:0005516; GO:0005524; GO:0005737; GO:0006897; GO:0007015; GO:0007605; GO:0007626; GO:0009416; GO:0015629; GO:0016020; GO:0016459; GO:0032420; GO:0042472; GO:0051015; GO:0070062; GO:0098858 actin filament organization [GO:0007015]; endocytosis [GO:0006897]; inner ear morphogenesis [GO:0042472]; locomotory behavior [GO:0007626]; response to light stimulus [GO:0009416]; sensory perception of sound [GO:0007605] actin cytoskeleton [GO:0015629]; actin-based cell projection [GO:0098858]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; myosin complex [GO:0016459]; stereocilium [GO:0032420] actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146] g16364.t2 Q9UKN7 41.667 204 1.01e-40 170.0 sp|Q9UKN7|MYO15_HUMAN Unconventional myosin-XV OS=Homo sapiens OX=9606 GN=MYO15A PE=1 SV=2 MYO15_HUMAN reviewed Unconventional myosin-XV (Unconventional myosin-15) Homo sapiens (Human) GO:0000146; GO:0005516; GO:0005524; GO:0005737; GO:0006897; GO:0007015; GO:0007605; GO:0007626; GO:0009416; GO:0015629; GO:0016020; GO:0016459; GO:0032420; GO:0042472; GO:0051015; GO:0070062; GO:0098858 actin filament organization [GO:0007015]; endocytosis [GO:0006897]; inner ear morphogenesis [GO:0042472]; locomotory behavior [GO:0007626]; response to light stimulus [GO:0009416]; sensory perception of sound [GO:0007605] actin cytoskeleton [GO:0015629]; actin-based cell projection [GO:0098858]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; myosin complex [GO:0016459]; stereocilium [GO:0032420] actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146] g16366.t1 Q9QZZ4 43.787 338 2.55e-97 319.0 sp|Q9QZZ4|MYO15_MOUSE Unconventional myosin-XV OS=Mus musculus OX=10090 GN=Myo15a PE=1 SV=2 MYO15_MOUSE reviewed Unconventional myosin-XV (Unconventional myosin-15) Mus musculus (Mouse) GO:0000146; GO:0005524; GO:0005737; GO:0005829; GO:0006897; GO:0007015; GO:0007605; GO:0007626; GO:0009416; GO:0015629; GO:0016020; GO:0016459; GO:0032420; GO:0032421; GO:0042472; GO:0051015; GO:0098858 actin filament organization [GO:0007015]; endocytosis [GO:0006897]; inner ear morphogenesis [GO:0042472]; locomotory behavior [GO:0007626]; response to light stimulus [GO:0009416]; sensory perception of sound [GO:0007605] actin cytoskeleton [GO:0015629]; actin-based cell projection [GO:0098858]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; myosin complex [GO:0016459]; stereocilium [GO:0032420]; stereocilium bundle [GO:0032421] actin filament binding [GO:0051015]; ATP binding [GO:0005524]; microfilament motor activity [GO:0000146] g16368.t1 Q9UKN7 58.0 250 7.07e-89 293.0 sp|Q9UKN7|MYO15_HUMAN Unconventional myosin-XV OS=Homo sapiens OX=9606 GN=MYO15A PE=1 SV=2 MYO15_HUMAN reviewed Unconventional myosin-XV (Unconventional myosin-15) Homo sapiens (Human) GO:0000146; GO:0005516; GO:0005524; GO:0005737; GO:0006897; GO:0007015; GO:0007605; GO:0007626; GO:0009416; GO:0015629; GO:0016020; GO:0016459; GO:0032420; GO:0042472; GO:0051015; GO:0070062; GO:0098858 actin filament organization [GO:0007015]; endocytosis [GO:0006897]; inner ear morphogenesis [GO:0042472]; locomotory behavior [GO:0007626]; response to light stimulus [GO:0009416]; sensory perception of sound [GO:0007605] actin cytoskeleton [GO:0015629]; actin-based cell projection [GO:0098858]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; myosin complex [GO:0016459]; stereocilium [GO:0032420] actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146] g16371.t1 Q2KIA4 62.191 283 6.719999999999999e-128 371.0 sp|Q2KIA4|SCD5_BOVIN Stearoyl-CoA desaturase 5 OS=Bos taurus OX=9913 GN=SCD5 PE=2 SV=1 SCD5_BOVIN reviewed Stearoyl-CoA desaturase 5 (EC 1.14.19.1) (Acyl-CoA-desaturase 4) (Stearoyl-CoA 9-desaturase) Bos taurus (Bovine) GO:0004768; GO:0005506; GO:0005789; GO:0006636; GO:0016491; GO:0032896 unsaturated fatty acid biosynthetic process [GO:0006636] endoplasmic reticulum membrane [GO:0005789] iron ion binding [GO:0005506]; oxidoreductase activity [GO:0016491]; palmitoyl-CoA 9-desaturase activity [GO:0032896]; stearoyl-CoA 9-desaturase activity [GO:0004768] g16373.t1 Q9UIG8 30.151 597 1.54e-76 268.0 sp|Q9UIG8|SO3A1_HUMAN Solute carrier organic anion transporter family member 3A1 OS=Homo sapiens OX=9606 GN=SLCO3A1 PE=1 SV=3 g16373.t2 Q9UIG8 30.083 605 1.34e-77 271.0 sp|Q9UIG8|SO3A1_HUMAN Solute carrier organic anion transporter family member 3A1 OS=Homo sapiens OX=9606 GN=SLCO3A1 PE=1 SV=3 g16374.t1 Q5QQ57 47.613 733 0.0 744.0 sp|Q5QQ57|XYLT1_PANTR Xylosyltransferase 1 OS=Pan troglodytes OX=9598 GN=XYLT1 PE=2 SV=1 XYLT1_PANTR reviewed Xylosyltransferase 1 (EC 2.4.2.26) (Peptide O-xylosyltransferase 1) (Xylosyltransferase I) Pan troglodytes (Chimpanzee) GO:0000137; GO:0000139; GO:0005615; GO:0015012; GO:0030158; GO:0030166; GO:0043931; GO:0046872; GO:0048706; GO:0050650 chondroitin sulfate proteoglycan biosynthetic process [GO:0050650]; embryonic skeletal system development [GO:0048706]; heparan sulfate proteoglycan biosynthetic process [GO:0015012]; ossification involved in bone maturation [GO:0043931]; proteoglycan biosynthetic process [GO:0030166] extracellular space [GO:0005615]; Golgi cis cisterna [GO:0000137]; Golgi membrane [GO:0000139] metal ion binding [GO:0046872]; protein xylosyltransferase activity [GO:0030158] g16374.t2 Q5QQ57 46.972 743 0.0 736.0 sp|Q5QQ57|XYLT1_PANTR Xylosyltransferase 1 OS=Pan troglodytes OX=9598 GN=XYLT1 PE=2 SV=1 XYLT1_PANTR reviewed Xylosyltransferase 1 (EC 2.4.2.26) (Peptide O-xylosyltransferase 1) (Xylosyltransferase I) Pan troglodytes (Chimpanzee) GO:0000137; GO:0000139; GO:0005615; GO:0015012; GO:0030158; GO:0030166; GO:0043931; GO:0046872; GO:0048706; GO:0050650 chondroitin sulfate proteoglycan biosynthetic process [GO:0050650]; embryonic skeletal system development [GO:0048706]; heparan sulfate proteoglycan biosynthetic process [GO:0015012]; ossification involved in bone maturation [GO:0043931]; proteoglycan biosynthetic process [GO:0030166] extracellular space [GO:0005615]; Golgi cis cisterna [GO:0000137]; Golgi membrane [GO:0000139] metal ion binding [GO:0046872]; protein xylosyltransferase activity [GO:0030158] g16377.t1 Q66JJ3 42.566 343 8.090000000000001e-88 271.0 sp|Q66JJ3|ADPRM_XENTR Manganese-dependent ADP-ribose/CDP-alcohol diphosphatase OS=Xenopus tropicalis OX=8364 GN=adprm PE=2 SV=1 g16377.t2 Q66JJ3 42.566 343 7.120000000000001e-88 271.0 sp|Q66JJ3|ADPRM_XENTR Manganese-dependent ADP-ribose/CDP-alcohol diphosphatase OS=Xenopus tropicalis OX=8364 GN=adprm PE=2 SV=1 g16379.t1 Q6GV29 60.618 259 1.58e-115 339.0 sp|Q6GV29|QTGAL_RAT Queuosine-tRNA galactosyltransferase OS=Rattus norvegicus OX=10116 GN=B3gntl1 PE=1 SV=1 QTGAL_RAT reviewed Queuosine-tRNA galactosyltransferase (QTGAL) (EC 2.4.1.-) (UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase-like protein 1) (BGnT-like protein 1) (Beta1,3-N-acetylglucosaminyltransferase-like protein 1) (Beta3Gn-T-like protein 1) (Beta3GnTL1) Rattus norvegicus (Rat) GO:0005737; GO:0006400; GO:0006417; GO:0141125 regulation of translation [GO:0006417]; tRNA modification [GO:0006400] cytoplasm [GO:0005737] tRNA-queuosine(34) galactosyltransferase activity [GO:0141125] g16380.t1 Q5HZV9 29.693 293 1.41e-27 117.0 sp|Q5HZV9|PP1R7_RAT Protein phosphatase 1 regulatory subunit 7 OS=Rattus norvegicus OX=10116 GN=Ppp1r7 PE=1 SV=1 g16381.t1 P10079 38.265 392 3.01e-70 243.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g16381.t1 P10079 44.813 241 6.55e-56 202.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g16381.t1 P10079 43.154 241 1.01e-51 190.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g16381.t1 P10079 43.568 241 1.65e-51 190.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g16381.t1 P10079 42.51 247 2.04e-51 189.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g16381.t1 P10079 43.568 241 1.13e-49 184.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g16381.t1 P10079 40.072 277 7.000000000000001e-47 176.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g16381.t1 P10079 39.357 249 2.36e-45 172.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g16381.t1 P10079 41.048 229 4.51e-44 168.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g16382.t1 Q8BWQ6 55.263 988 0.0 1100.0 sp|Q8BWQ6|VP35L_MOUSE VPS35 endosomal protein-sorting factor-like OS=Mus musculus OX=10090 GN=Vps35l PE=1 SV=2 g16386.t1 Q9UBX3 61.786 280 4.86e-120 348.0 sp|Q9UBX3|DIC_HUMAN Mitochondrial dicarboxylate carrier OS=Homo sapiens OX=9606 GN=SLC25A10 PE=1 SV=2 DIC_HUMAN reviewed Mitochondrial dicarboxylate carrier (DIC) (Solute carrier family 25 member 10) Homo sapiens (Human) GO:0005310; GO:0005634; GO:0005654; GO:0005739; GO:0005743; GO:0006094; GO:0006811; GO:0006835; GO:0006869; GO:0015116; GO:0015117; GO:0015131; GO:0015140; GO:0015141; GO:0015297; GO:0015709; GO:0015729; GO:0035435; GO:0046166; GO:0070221; GO:0071422; GO:0071423; GO:1902358 dicarboxylic acid transport [GO:0006835]; gluconeogenesis [GO:0006094]; glyceraldehyde-3-phosphate biosynthetic process [GO:0046166]; lipid transport [GO:0006869]; malate transmembrane transport [GO:0071423]; monoatomic ion transport [GO:0006811]; oxaloacetate transport [GO:0015729]; phosphate ion transmembrane transport [GO:0035435]; succinate transmembrane transport [GO:0071422]; sulfate transmembrane transport [GO:1902358]; sulfide oxidation, using sulfide:quinone oxidoreductase [GO:0070221]; thiosulfate transport [GO:0015709] mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] antiporter activity [GO:0015297]; dicarboxylic acid transmembrane transporter activity [GO:0005310]; malate transmembrane transporter activity [GO:0015140]; oxaloacetate transmembrane transporter activity [GO:0015131]; succinate transmembrane transporter activity [GO:0015141]; sulfate transmembrane transporter activity [GO:0015116]; thiosulfate transmembrane transporter activity [GO:0015117] g16397.t1 Q4W5Z4 44.444 765 0.0 665.0 sp|Q4W5Z4|DNM3A_CHICK DNA (cytosine-5)-methyltransferase 3A OS=Gallus gallus OX=9031 GN=DNMT3A PE=2 SV=1 DNM3A_CHICK reviewed DNA (cytosine-5)-methyltransferase 3A (Dnmt3a) (EC 2.1.1.37) (Cysteine methyltransferase DNMT3A) (EC 2.1.1.-) Gallus gallus (Chicken) GO:0000791; GO:0001046; GO:0003886; GO:0005634; GO:0005737; GO:0008270; GO:0009408; GO:0016363; GO:0032259; GO:0044027; GO:0045892; GO:0071774; GO:0106363 methylation [GO:0032259]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of gene expression via chromosomal CpG island methylation [GO:0044027]; response to fibroblast growth factor [GO:0071774]; response to heat [GO:0009408] cytoplasm [GO:0005737]; euchromatin [GO:0000791]; nuclear matrix [GO:0016363]; nucleus [GO:0005634] core promoter sequence-specific DNA binding [GO:0001046]; DNA (cytosine-5-)-methyltransferase activity [GO:0003886]; protein-cysteine methyltransferase activity [GO:0106363]; zinc ion binding [GO:0008270] g16400.t1 Q6NVU2 71.854 302 7.02e-157 444.0 sp|Q6NVU2|PPIG_XENTR Serine/threonine-protein phosphatase PP1-gamma catalytic subunit OS=Xenopus tropicalis OX=8364 GN=ppp1cc PE=2 SV=1 PPIG_XENTR reviewed Serine/threonine-protein phosphatase PP1-gamma catalytic subunit (PP-1G) (EC 3.1.3.16) Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0000776; GO:0004722; GO:0005634; GO:0005730; GO:0005737; GO:0005739; GO:0005815; GO:0005977; GO:0006470; GO:0007084; GO:0016607; GO:0030496; GO:0032154; GO:0042752; GO:0046872; GO:0051301 cell division [GO:0051301]; glycogen metabolic process [GO:0005977]; mitotic nuclear membrane reassembly [GO:0007084]; protein dephosphorylation [GO:0006470]; regulation of circadian rhythm [GO:0042752] cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; kinetochore [GO:0000776]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]; mitochondrion [GO:0005739]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleus [GO:0005634] metal ion binding [GO:0046872]; protein serine/threonine phosphatase activity [GO:0004722] g16401.t1 Q1LV50 26.871 294 1.29e-24 103.0 sp|Q1LV50|CENPP_DANRE Centromere protein P OS=Danio rerio OX=7955 GN=cenpp PE=2 SV=1 g16403.t1 Q8AXX8 41.713 362 7.23e-68 226.0 sp|Q8AXX8|SOX10_XENLA Transcription factor Sox-10 OS=Xenopus laevis OX=8355 GN=sox10 PE=1 SV=1 SOX10_XENLA reviewed Transcription factor Sox-10 (SRY (sex determining region Y)-box 10) Xenopus laevis (African clawed frog) GO:0000122; GO:0000978; GO:0000981; GO:0001755; GO:0002009; GO:0003677; GO:0003700; GO:0005634; GO:0005737; GO:0007422; GO:0014003; GO:0014029; GO:0016055; GO:0019899; GO:0022010; GO:0030318; GO:0045893; GO:0048484; GO:0048709 central nervous system myelination [GO:0022010]; enteric nervous system development [GO:0048484]; melanocyte differentiation [GO:0030318]; morphogenesis of an epithelium [GO:0002009]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural crest cell migration [GO:0001755]; neural crest formation [GO:0014029]; oligodendrocyte development [GO:0014003]; oligodendrocyte differentiation [GO:0048709]; peripheral nervous system development [GO:0007422]; positive regulation of DNA-templated transcription [GO:0045893]; Wnt signaling pathway [GO:0016055] cytoplasm [GO:0005737]; nucleus [GO:0005634] DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; enzyme binding [GO:0019899]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978] g16404.t1 Q6P6S2 65.889 343 1.11e-137 397.0 sp|Q6P6S2|S39AB_RAT Zinc transporter ZIP11 OS=Rattus norvegicus OX=10116 GN=Slc39a11 PE=2 SV=1 g16405.t1 Q803V5 52.012 323 1.01e-117 342.0 sp|Q803V5|LST8_DANRE Target of rapamycin complex subunit lst8 OS=Danio rerio OX=7955 GN=mlst8 PE=2 SV=1 g16406.t1 Q9D0P8 46.364 110 9.700000000000001e-31 110.0 sp|Q9D0P8|IFT27_MOUSE Intraflagellar transport protein 27 homolog OS=Mus musculus OX=10090 GN=Ift27 PE=1 SV=1 IFT27_MOUSE reviewed Intraflagellar transport protein 27 homolog (Putative GTP-binding protein RAY-like) (Rab-like protein 4) Mus musculus (Mouse) GO:0000139; GO:0001822; GO:0003924; GO:0005525; GO:0005634; GO:0005737; GO:0005794; GO:0005813; GO:0005929; GO:0006886; GO:0007224; GO:0007283; GO:0016192; GO:0030992; GO:0035720; GO:0036126; GO:0042073; GO:0060122; GO:0060271; GO:0090102; GO:0097225; GO:0097228 cilium assembly [GO:0060271]; cochlea development [GO:0090102]; inner ear receptor cell stereocilium organization [GO:0060122]; intracellular protein transport [GO:0006886]; intraciliary anterograde transport [GO:0035720]; intraciliary transport [GO:0042073]; kidney development [GO:0001822]; smoothened signaling pathway [GO:0007224]; spermatogenesis [GO:0007283]; vesicle-mediated transport [GO:0016192] centrosome [GO:0005813]; cilium [GO:0005929]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; intraciliary transport particle B [GO:0030992]; nucleus [GO:0005634]; sperm flagellum [GO:0036126]; sperm midpiece [GO:0097225]; sperm principal piece [GO:0097228] GTP binding [GO:0005525]; GTPase activity [GO:0003924] g16407.t1 Q5R6R5 55.33 394 1.76e-156 451.0 sp|Q5R6R5|NEUA_PONAB N-acylneuraminate cytidylyltransferase OS=Pongo abelii OX=9601 GN=CMAS PE=2 SV=1 g16408.t1 Q6NV34 57.401 277 3.95e-120 349.0 sp|Q6NV34|DECR2_DANRE Peroxisomal 2,4-dienoyl-CoA reductase [(3E)-enoyl-CoA-producing] OS=Danio rerio OX=7955 GN=decr2 PE=2 SV=1 DECR2_DANRE reviewed Peroxisomal 2,4-dienoyl-CoA reductase [(3E)-enoyl-CoA-producing] (EC 1.3.1.124) (2,4-dienoyl-CoA reductase 2) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005777; GO:0005778; GO:0006631; GO:0008670; GO:0009062 fatty acid catabolic process [GO:0009062]; fatty acid metabolic process [GO:0006631] peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777] 2,4-dienoyl-CoA reductase (NADPH) activity [GO:0008670] g16409.t1 Q9D3R3 59.848 132 1.01e-44 157.0 sp|Q9D3R3|CEP72_MOUSE Centrosomal protein of 72 kDa OS=Mus musculus OX=10090 GN=Cep72 PE=1 SV=3 CEP72_MOUSE reviewed Centrosomal protein of 72 kDa (Cep72) Mus musculus (Mouse) GO:0005813; GO:0005829; GO:0007051; GO:0007099; GO:0033566; GO:0034451; GO:0036064; GO:0042802; GO:1904779 centriole replication [GO:0007099]; gamma-tubulin complex localization [GO:0033566]; regulation of protein localization to centrosome [GO:1904779]; spindle organization [GO:0007051] centriolar satellite [GO:0034451]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytosol [GO:0005829] identical protein binding [GO:0042802] g16413.t1 Q6PJ21 35.545 211 1.04e-35 132.0 sp|Q6PJ21|SPSB3_HUMAN SPRY domain-containing SOCS box protein 3 OS=Homo sapiens OX=9606 GN=SPSB3 PE=1 SV=2 SPSB3_HUMAN reviewed SPRY domain-containing SOCS box protein 3 (SSB-3) Homo sapiens (Human) GO:0005634; GO:0005829; GO:0010719; GO:0019005; GO:0031466; GO:0043161; GO:0070936; GO:0160049; GO:1990756 negative regulation of cGAS/STING signaling pathway [GO:0160049]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K48-linked ubiquitination [GO:0070936] Cul5-RING ubiquitin ligase complex [GO:0031466]; cytosol [GO:0005829]; nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005] ubiquitin-like ligase-substrate adaptor activity [GO:1990756] g16414.t1 Q8IWF2 51.613 620 0.0 649.0 sp|Q8IWF2|FXRD2_HUMAN FAD-dependent oxidoreductase domain-containing protein 2 OS=Homo sapiens OX=9606 GN=FOXRED2 PE=1 SV=1 FXRD2_HUMAN reviewed FAD-dependent oxidoreductase domain-containing protein 2 (Endoplasmic reticulum flavoprotein associated with degradation) Homo sapiens (Human) GO:0004497; GO:0005788; GO:0036503; GO:0050660 ERAD pathway [GO:0036503] endoplasmic reticulum lumen [GO:0005788] flavin adenine dinucleotide binding [GO:0050660]; monooxygenase activity [GO:0004497] g16417.t1 F5H4B4 35.326 184 6.79e-29 124.0 sp|F5H4B4|F227A_HUMAN Protein FAM227A OS=Homo sapiens OX=9606 GN=FAM227A PE=1 SV=1 g16417.t2 F5H4B4 35.326 184 5.710000000000001e-29 124.0 sp|F5H4B4|F227A_HUMAN Protein FAM227A OS=Homo sapiens OX=9606 GN=FAM227A PE=1 SV=1 g16418.t1 Q96RY7 63.095 168 1.88e-73 244.0 sp|Q96RY7|IF140_HUMAN Intraflagellar transport protein 140 homolog OS=Homo sapiens OX=9606 GN=IFT140 PE=1 SV=1 IF140_HUMAN reviewed Intraflagellar transport protein 140 homolog (WD and tetratricopeptide repeats protein 2) Homo sapiens (Human) GO:0005654; GO:0005739; GO:0005813; GO:0005814; GO:0005929; GO:0005930; GO:0007368; GO:0007507; GO:0008589; GO:0021532; GO:0030991; GO:0031076; GO:0032391; GO:0035721; GO:0035845; GO:0036064; GO:0042733; GO:0048701; GO:0060271; GO:0061512; GO:0097542; GO:0120199; GO:1902017; GO:1905515; GO:1990403 cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; embryonic brain development [GO:1990403]; embryonic camera-type eye development [GO:0031076]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic digit morphogenesis [GO:0042733]; heart development [GO:0007507]; intraciliary retrograde transport [GO:0035721]; neural tube patterning [GO:0021532]; non-motile cilium assembly [GO:1905515]; photoreceptor cell outer segment organization [GO:0035845]; protein localization to cilium [GO:0061512]; regulation of cilium assembly [GO:1902017]; regulation of smoothened signaling pathway [GO:0008589] axoneme [GO:0005930]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary tip [GO:0097542]; cilium [GO:0005929]; cone photoreceptor outer segment [GO:0120199]; intraciliary transport particle A [GO:0030991]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; photoreceptor connecting cilium [GO:0032391] g16419.t1 E9PY46 62.366 93 4.47e-39 115.0 sp|E9PY46|IF140_MOUSE Intraflagellar transport protein 140 homolog OS=Mus musculus OX=10090 GN=Ift140 PE=1 SV=1 IF140_MOUSE reviewed Intraflagellar transport protein 140 homolog (WD and tetratricopeptide repeats protein 2) Mus musculus (Mouse) GO:0001750; GO:0005654; GO:0005739; GO:0005813; GO:0005814; GO:0005929; GO:0005930; GO:0007368; GO:0007507; GO:0008589; GO:0021532; GO:0030991; GO:0031076; GO:0032391; GO:0035108; GO:0035721; GO:0035845; GO:0036064; GO:0042073; GO:0042733; GO:0048701; GO:0060271; GO:0061512; GO:0097730; GO:1902017; GO:1905515; GO:1990403 cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; embryonic brain development [GO:1990403]; embryonic camera-type eye development [GO:0031076]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic digit morphogenesis [GO:0042733]; heart development [GO:0007507]; intraciliary retrograde transport [GO:0035721]; intraciliary transport [GO:0042073]; limb morphogenesis [GO:0035108]; neural tube patterning [GO:0021532]; non-motile cilium assembly [GO:1905515]; photoreceptor cell outer segment organization [GO:0035845]; protein localization to cilium [GO:0061512]; regulation of cilium assembly [GO:1902017]; regulation of smoothened signaling pathway [GO:0008589] axoneme [GO:0005930]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; intraciliary transport particle A [GO:0030991]; mitochondrion [GO:0005739]; non-motile cilium [GO:0097730]; nucleoplasm [GO:0005654]; photoreceptor connecting cilium [GO:0032391]; photoreceptor outer segment [GO:0001750] g16419.t1 E9PY46 85.294 34 4.47e-39 65.9 sp|E9PY46|IF140_MOUSE Intraflagellar transport protein 140 homolog OS=Mus musculus OX=10090 GN=Ift140 PE=1 SV=1 IF140_MOUSE reviewed Intraflagellar transport protein 140 homolog (WD and tetratricopeptide repeats protein 2) Mus musculus (Mouse) GO:0001750; GO:0005654; GO:0005739; GO:0005813; GO:0005814; GO:0005929; GO:0005930; GO:0007368; GO:0007507; GO:0008589; GO:0021532; GO:0030991; GO:0031076; GO:0032391; GO:0035108; GO:0035721; GO:0035845; GO:0036064; GO:0042073; GO:0042733; GO:0048701; GO:0060271; GO:0061512; GO:0097730; GO:1902017; GO:1905515; GO:1990403 cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; embryonic brain development [GO:1990403]; embryonic camera-type eye development [GO:0031076]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic digit morphogenesis [GO:0042733]; heart development [GO:0007507]; intraciliary retrograde transport [GO:0035721]; intraciliary transport [GO:0042073]; limb morphogenesis [GO:0035108]; neural tube patterning [GO:0021532]; non-motile cilium assembly [GO:1905515]; photoreceptor cell outer segment organization [GO:0035845]; protein localization to cilium [GO:0061512]; regulation of cilium assembly [GO:1902017]; regulation of smoothened signaling pathway [GO:0008589] axoneme [GO:0005930]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; intraciliary transport particle A [GO:0030991]; mitochondrion [GO:0005739]; non-motile cilium [GO:0097730]; nucleoplasm [GO:0005654]; photoreceptor connecting cilium [GO:0032391]; photoreceptor outer segment [GO:0001750] g16420.t1 E9PY46 51.953 845 0.0 904.0 sp|E9PY46|IF140_MOUSE Intraflagellar transport protein 140 homolog OS=Mus musculus OX=10090 GN=Ift140 PE=1 SV=1 IF140_MOUSE reviewed Intraflagellar transport protein 140 homolog (WD and tetratricopeptide repeats protein 2) Mus musculus (Mouse) GO:0001750; GO:0005654; GO:0005739; GO:0005813; GO:0005814; GO:0005929; GO:0005930; GO:0007368; GO:0007507; GO:0008589; GO:0021532; GO:0030991; GO:0031076; GO:0032391; GO:0035108; GO:0035721; GO:0035845; GO:0036064; GO:0042073; GO:0042733; GO:0048701; GO:0060271; GO:0061512; GO:0097730; GO:1902017; GO:1905515; GO:1990403 cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; embryonic brain development [GO:1990403]; embryonic camera-type eye development [GO:0031076]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic digit morphogenesis [GO:0042733]; heart development [GO:0007507]; intraciliary retrograde transport [GO:0035721]; intraciliary transport [GO:0042073]; limb morphogenesis [GO:0035108]; neural tube patterning [GO:0021532]; non-motile cilium assembly [GO:1905515]; photoreceptor cell outer segment organization [GO:0035845]; protein localization to cilium [GO:0061512]; regulation of cilium assembly [GO:1902017]; regulation of smoothened signaling pathway [GO:0008589] axoneme [GO:0005930]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; intraciliary transport particle A [GO:0030991]; mitochondrion [GO:0005739]; non-motile cilium [GO:0097730]; nucleoplasm [GO:0005654]; photoreceptor connecting cilium [GO:0032391]; photoreceptor outer segment [GO:0001750] g16420.t2 E9PY46 50.81 864 0.0 893.0 sp|E9PY46|IF140_MOUSE Intraflagellar transport protein 140 homolog OS=Mus musculus OX=10090 GN=Ift140 PE=1 SV=1 IF140_MOUSE reviewed Intraflagellar transport protein 140 homolog (WD and tetratricopeptide repeats protein 2) Mus musculus (Mouse) GO:0001750; GO:0005654; GO:0005739; GO:0005813; GO:0005814; GO:0005929; GO:0005930; GO:0007368; GO:0007507; GO:0008589; GO:0021532; GO:0030991; GO:0031076; GO:0032391; GO:0035108; GO:0035721; GO:0035845; GO:0036064; GO:0042073; GO:0042733; GO:0048701; GO:0060271; GO:0061512; GO:0097730; GO:1902017; GO:1905515; GO:1990403 cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; embryonic brain development [GO:1990403]; embryonic camera-type eye development [GO:0031076]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic digit morphogenesis [GO:0042733]; heart development [GO:0007507]; intraciliary retrograde transport [GO:0035721]; intraciliary transport [GO:0042073]; limb morphogenesis [GO:0035108]; neural tube patterning [GO:0021532]; non-motile cilium assembly [GO:1905515]; photoreceptor cell outer segment organization [GO:0035845]; protein localization to cilium [GO:0061512]; regulation of cilium assembly [GO:1902017]; regulation of smoothened signaling pathway [GO:0008589] axoneme [GO:0005930]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; intraciliary transport particle A [GO:0030991]; mitochondrion [GO:0005739]; non-motile cilium [GO:0097730]; nucleoplasm [GO:0005654]; photoreceptor connecting cilium [GO:0032391]; photoreceptor outer segment [GO:0001750] g16421.t1 E9PY46 41.126 231 5.28e-55 193.0 sp|E9PY46|IF140_MOUSE Intraflagellar transport protein 140 homolog OS=Mus musculus OX=10090 GN=Ift140 PE=1 SV=1 IF140_MOUSE reviewed Intraflagellar transport protein 140 homolog (WD and tetratricopeptide repeats protein 2) Mus musculus (Mouse) GO:0001750; GO:0005654; GO:0005739; GO:0005813; GO:0005814; GO:0005929; GO:0005930; GO:0007368; GO:0007507; GO:0008589; GO:0021532; GO:0030991; GO:0031076; GO:0032391; GO:0035108; GO:0035721; GO:0035845; GO:0036064; GO:0042073; GO:0042733; GO:0048701; GO:0060271; GO:0061512; GO:0097730; GO:1902017; GO:1905515; GO:1990403 cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; embryonic brain development [GO:1990403]; embryonic camera-type eye development [GO:0031076]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic digit morphogenesis [GO:0042733]; heart development [GO:0007507]; intraciliary retrograde transport [GO:0035721]; intraciliary transport [GO:0042073]; limb morphogenesis [GO:0035108]; neural tube patterning [GO:0021532]; non-motile cilium assembly [GO:1905515]; photoreceptor cell outer segment organization [GO:0035845]; protein localization to cilium [GO:0061512]; regulation of cilium assembly [GO:1902017]; regulation of smoothened signaling pathway [GO:0008589] axoneme [GO:0005930]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; intraciliary transport particle A [GO:0030991]; mitochondrion [GO:0005739]; non-motile cilium [GO:0097730]; nucleoplasm [GO:0005654]; photoreceptor connecting cilium [GO:0032391]; photoreceptor outer segment [GO:0001750] g16422.t1 Q8MJK1 55.118 127 2.3400000000000003e-21 85.9 sp|Q8MJK1|CBY1_BOVIN Protein chibby homolog 1 OS=Bos taurus OX=9913 GN=CBY1 PE=2 SV=1 g16424.t1 P33095 91.538 130 9.790000000000001e-88 254.0 sp|P33095|RS15A_STRPU Small ribosomal subunit protein uS8 OS=Strongylocentrotus purpuratus OX=7668 GN=RPS15A PE=2 SV=3 g16427.t1 A7MCS3 28.98 245 1.61e-30 93.6 sp|A7MCS3|CP089_DANRE UPF0764 protein C16orf89 homolog OS=Danio rerio OX=7955 PE=2 SV=2 g16427.t1 A7MCS3 50.0 50 1.61e-30 61.2 sp|A7MCS3|CP089_DANRE UPF0764 protein C16orf89 homolog OS=Danio rerio OX=7955 PE=2 SV=2 g16429.t1 A2RTY3 28.896 308 9.189999999999999e-30 129.0 sp|A2RTY3|HEAT9_HUMAN Protein HEATR9 OS=Homo sapiens OX=9606 GN=HEATR9 PE=1 SV=2 g16430.t1 Q8IUX7 37.349 166 7.819999999999999e-24 103.0 sp|Q8IUX7|AEBP1_HUMAN Adipocyte enhancer-binding protein 1 OS=Homo sapiens OX=9606 GN=AEBP1 PE=1 SV=1 AEBP1_HUMAN reviewed Adipocyte enhancer-binding protein 1 (AE-binding protein 1) (Aortic carboxypeptidase-like protein) Homo sapiens (Human) GO:0000122; GO:0000977; GO:0001227; GO:0004180; GO:0005516; GO:0005518; GO:0005576; GO:0005615; GO:0005634; GO:0005737; GO:0006355; GO:0006508; GO:0008270; GO:0031012; GO:0070062; GO:1904026 negative regulation of transcription by RNA polymerase II [GO:0000122]; proteolysis [GO:0006508]; regulation of collagen fibril organization [GO:1904026]; regulation of DNA-templated transcription [GO:0006355] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; nucleus [GO:0005634] calmodulin binding [GO:0005516]; carboxypeptidase activity [GO:0004180]; collagen binding [GO:0005518]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; zinc ion binding [GO:0008270] g16430.t2 A2RUV9 38.065 155 1.4e-22 97.1 sp|A2RUV9|AEBP1_RAT Adipocyte enhancer-binding protein 1 OS=Rattus norvegicus OX=10116 GN=Aebp1 PE=2 SV=1 AEBP1_RAT reviewed Adipocyte enhancer-binding protein 1 (AE-binding protein 1) (Aortic carboxypeptidase-like protein) Rattus norvegicus (Rat) GO:0000122; GO:0000977; GO:0001227; GO:0004180; GO:0005516; GO:0005518; GO:0005576; GO:0006355; GO:0006508; GO:0008270; GO:1904026 negative regulation of transcription by RNA polymerase II [GO:0000122]; proteolysis [GO:0006508]; regulation of collagen fibril organization [GO:1904026]; regulation of DNA-templated transcription [GO:0006355] extracellular region [GO:0005576] calmodulin binding [GO:0005516]; carboxypeptidase activity [GO:0004180]; collagen binding [GO:0005518]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; zinc ion binding [GO:0008270] g16432.t1 P21956 32.508 323 9.2e-38 145.0 sp|P21956|MFGM_MOUSE Lactadherin OS=Mus musculus OX=10090 GN=Mfge8 PE=1 SV=3 MFGM_MOUSE reviewed Lactadherin (MFGM) (Milk fat globule-EGF factor 8) (MFG-E8) (SED1) (Sperm surface protein SP47) (MP47) Mus musculus (Mouse) GO:0001525; GO:0001786; GO:0002080; GO:0005178; GO:0005615; GO:0006910; GO:0006911; GO:0007155; GO:0007338; GO:0008429; GO:0009897; GO:0031012; GO:0043277; GO:0050766 angiogenesis [GO:0001525]; apoptotic cell clearance [GO:0043277]; cell adhesion [GO:0007155]; phagocytosis, engulfment [GO:0006911]; phagocytosis, recognition [GO:0006910]; positive regulation of phagocytosis [GO:0050766]; single fertilization [GO:0007338] acrosomal membrane [GO:0002080]; external side of plasma membrane [GO:0009897]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615] integrin binding [GO:0005178]; phosphatidylethanolamine binding [GO:0008429]; phosphatidylserine binding [GO:0001786] g16434.t1 B7ZCC9 27.326 516 1.39e-34 149.0 sp|B7ZCC9|AGRG4_MOUSE Adhesion G-protein coupled receptor G4 OS=Mus musculus OX=10090 GN=Adgrg4 PE=3 SV=1 AGRG4_MOUSE reviewed Adhesion G-protein coupled receptor G4 (G-protein coupled receptor 112) [Cleaved into: Adhesion G-protein coupled receptor G4, N-terminal fragment (ADGRG4 N-terminal fragment); Adhesion G-protein coupled receptor G4, C-terminal fragment (ADGRG4 C-terminal fragment)] Mus musculus (Mouse) GO:0004930; GO:0005886; GO:0007166; GO:0007186; GO:0007189 adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186] plasma membrane [GO:0005886] G protein-coupled receptor activity [GO:0004930] g16434.t2 O76536 30.278 971 2.7299999999999996e-42 173.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g16434.t2 O76536 30.03 999 5.49e-39 163.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g16434.t2 O76536 28.832 985 8.12e-30 133.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g16434.t2 O76536 30.062 642 5.6e-25 117.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g16436.t1 Q58DC0 41.958 286 2.86e-76 238.0 sp|Q58DC0|CPPED_BOVIN Serine/threonine-protein phosphatase CPPED1 OS=Bos taurus OX=9913 GN=CPPED1 PE=2 SV=1 g16437.t2 Q8CJ11 31.473 448 4.41e-55 209.0 sp|Q8CJ11|AGRG2_RAT Adhesion G-protein coupled receptor G2 OS=Rattus norvegicus OX=10116 GN=Adgrg2 PE=1 SV=1 AGRG2_RAT reviewed Adhesion G-protein coupled receptor G2 (G-protein coupled receptor 64) (Rat epididymis-specific protein 6) (Re6) [Cleaved into: Adhesion G-protein coupled receptor G2, N-terminal fragment (ADGRG2 N-terminal fragment); Adhesion G-protein coupled receptor G2, C-terminal fragment (ADGRG2 C-terminal fragment)] Rattus norvegicus (Rat) GO:0004930; GO:0005829; GO:0005886; GO:0007166; GO:0007186; GO:0007189; GO:0007200; GO:0007286; GO:0016324 adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; spermatid development [GO:0007286] apical plasma membrane [GO:0016324]; cytosol [GO:0005829]; plasma membrane [GO:0005886] G protein-coupled receptor activity [GO:0004930] g16437.t3 Q8CJ11 31.473 448 3.47e-54 209.0 sp|Q8CJ11|AGRG2_RAT Adhesion G-protein coupled receptor G2 OS=Rattus norvegicus OX=10116 GN=Adgrg2 PE=1 SV=1 AGRG2_RAT reviewed Adhesion G-protein coupled receptor G2 (G-protein coupled receptor 64) (Rat epididymis-specific protein 6) (Re6) [Cleaved into: Adhesion G-protein coupled receptor G2, N-terminal fragment (ADGRG2 N-terminal fragment); Adhesion G-protein coupled receptor G2, C-terminal fragment (ADGRG2 C-terminal fragment)] Rattus norvegicus (Rat) GO:0004930; GO:0005829; GO:0005886; GO:0007166; GO:0007186; GO:0007189; GO:0007200; GO:0007286; GO:0016324 adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; spermatid development [GO:0007286] apical plasma membrane [GO:0016324]; cytosol [GO:0005829]; plasma membrane [GO:0005886] G protein-coupled receptor activity [GO:0004930] g16438.t1 Q8CJ11 28.795 448 1.56e-44 177.0 sp|Q8CJ11|AGRG2_RAT Adhesion G-protein coupled receptor G2 OS=Rattus norvegicus OX=10116 GN=Adgrg2 PE=1 SV=1 AGRG2_RAT reviewed Adhesion G-protein coupled receptor G2 (G-protein coupled receptor 64) (Rat epididymis-specific protein 6) (Re6) [Cleaved into: Adhesion G-protein coupled receptor G2, N-terminal fragment (ADGRG2 N-terminal fragment); Adhesion G-protein coupled receptor G2, C-terminal fragment (ADGRG2 C-terminal fragment)] Rattus norvegicus (Rat) GO:0004930; GO:0005829; GO:0005886; GO:0007166; GO:0007186; GO:0007189; GO:0007200; GO:0007286; GO:0016324 adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; spermatid development [GO:0007286] apical plasma membrane [GO:0016324]; cytosol [GO:0005829]; plasma membrane [GO:0005886] G protein-coupled receptor activity [GO:0004930] g16439.t1 Q8CJ11 32.96 446 8.089999999999999e-52 197.0 sp|Q8CJ11|AGRG2_RAT Adhesion G-protein coupled receptor G2 OS=Rattus norvegicus OX=10116 GN=Adgrg2 PE=1 SV=1 AGRG2_RAT reviewed Adhesion G-protein coupled receptor G2 (G-protein coupled receptor 64) (Rat epididymis-specific protein 6) (Re6) [Cleaved into: Adhesion G-protein coupled receptor G2, N-terminal fragment (ADGRG2 N-terminal fragment); Adhesion G-protein coupled receptor G2, C-terminal fragment (ADGRG2 C-terminal fragment)] Rattus norvegicus (Rat) GO:0004930; GO:0005829; GO:0005886; GO:0007166; GO:0007186; GO:0007189; GO:0007200; GO:0007286; GO:0016324 adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; spermatid development [GO:0007286] apical plasma membrane [GO:0016324]; cytosol [GO:0005829]; plasma membrane [GO:0005886] G protein-coupled receptor activity [GO:0004930] g16443.t1 Q8CJ11 31.696 448 1.42e-55 213.0 sp|Q8CJ11|AGRG2_RAT Adhesion G-protein coupled receptor G2 OS=Rattus norvegicus OX=10116 GN=Adgrg2 PE=1 SV=1 AGRG2_RAT reviewed Adhesion G-protein coupled receptor G2 (G-protein coupled receptor 64) (Rat epididymis-specific protein 6) (Re6) [Cleaved into: Adhesion G-protein coupled receptor G2, N-terminal fragment (ADGRG2 N-terminal fragment); Adhesion G-protein coupled receptor G2, C-terminal fragment (ADGRG2 C-terminal fragment)] Rattus norvegicus (Rat) GO:0004930; GO:0005829; GO:0005886; GO:0007166; GO:0007186; GO:0007189; GO:0007200; GO:0007286; GO:0016324 adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; spermatid development [GO:0007286] apical plasma membrane [GO:0016324]; cytosol [GO:0005829]; plasma membrane [GO:0005886] G protein-coupled receptor activity [GO:0004930] g16445.t1 Q8TER0 40.212 189 3e-36 139.0 sp|Q8TER0|SNED1_HUMAN Sushi, nidogen and EGF-like domain-containing protein 1 OS=Homo sapiens OX=9606 GN=SNED1 PE=1 SV=2 g16447.t1 B7ZCC9 26.636 657 7.28e-52 199.0 sp|B7ZCC9|AGRG4_MOUSE Adhesion G-protein coupled receptor G4 OS=Mus musculus OX=10090 GN=Adgrg4 PE=3 SV=1 AGRG4_MOUSE reviewed Adhesion G-protein coupled receptor G4 (G-protein coupled receptor 112) [Cleaved into: Adhesion G-protein coupled receptor G4, N-terminal fragment (ADGRG4 N-terminal fragment); Adhesion G-protein coupled receptor G4, C-terminal fragment (ADGRG4 C-terminal fragment)] Mus musculus (Mouse) GO:0004930; GO:0005886; GO:0007166; GO:0007186; GO:0007189 adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186] plasma membrane [GO:0005886] G protein-coupled receptor activity [GO:0004930] g16448.t1 Q8TER0 36.782 174 7.06e-28 114.0 sp|Q8TER0|SNED1_HUMAN Sushi, nidogen and EGF-like domain-containing protein 1 OS=Homo sapiens OX=9606 GN=SNED1 PE=1 SV=2 g16450.t1 P98074 39.231 260 2.87e-39 160.0 sp|P98074|ENTK_PIG Enteropeptidase OS=Sus scrofa OX=9823 GN=TMPRSS15 PE=1 SV=1 g16451.t1 P10079 48.73 1102 0.0 1018.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g16451.t2 P10079 48.425 1111 0.0 1011.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g16452.t1 P07207 43.988 1389 0.0 1048.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g16452.t1 P07207 42.733 1376 0.0 1042.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g16452.t1 P07207 41.875 1483 0.0 1011.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g16452.t1 P07207 42.004 1407 0.0 985.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g16452.t1 P07207 40.897 1450 0.0 985.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g16452.t1 P07207 40.434 1521 0.0 975.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g16452.t1 P07207 42.482 1370 0.0 962.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g16452.t1 P07207 42.24 973 0.0 773.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g16452.t1 P07207 37.571 354 1.08e-46 190.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g16453.t1 O42430 38.477 486 2.2e-121 370.0 sp|O42430|CP1A1_LIMLI Cytochrome P450 1A1 OS=Limanda limanda OX=27771 GN=cyp1a1 PE=2 SV=1 g16453.t2 O42430 41.429 210 1.99e-47 168.0 sp|O42430|CP1A1_LIMLI Cytochrome P450 1A1 OS=Limanda limanda OX=27771 GN=cyp1a1 PE=2 SV=1 g16454.t1 O42430 41.614 471 1.4000000000000001e-123 373.0 sp|O42430|CP1A1_LIMLI Cytochrome P450 1A1 OS=Limanda limanda OX=27771 GN=cyp1a1 PE=2 SV=1 g16457.t1 P23965 43.506 154 1.2400000000000001e-43 148.0 sp|P23965|ECI1_RAT Enoyl-CoA delta isomerase 1, mitochondrial OS=Rattus norvegicus OX=10116 GN=Eci1 PE=1 SV=1 g16459.t1 P42125 55.026 189 1.99e-75 232.0 sp|P42125|ECI1_MOUSE Enoyl-CoA delta isomerase 1, mitochondrial OS=Mus musculus OX=10090 GN=Eci1 PE=1 SV=2 ECI1_MOUSE reviewed Enoyl-CoA delta isomerase 1, mitochondrial (EC 5.3.3.8) (3,2-trans-enoyl-CoA isomerase) (Delta(3),Delta(2)-enoyl-CoA isomerase) (D3,D2-enoyl-CoA isomerase) (Dodecenoyl-CoA isomerase) Mus musculus (Mouse) GO:0004165; GO:0005739; GO:0005743; GO:0005759; GO:0006635; GO:0016863; GO:0042802 fatty acid beta-oxidation [GO:0006635] mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] delta(3)-delta(2)-enoyl-CoA isomerase activity [GO:0004165]; identical protein binding [GO:0042802]; intramolecular oxidoreductase activity, transposing C=C bonds [GO:0016863] g16460.t1 P42125 41.494 241 1.4400000000000001e-64 206.0 sp|P42125|ECI1_MOUSE Enoyl-CoA delta isomerase 1, mitochondrial OS=Mus musculus OX=10090 GN=Eci1 PE=1 SV=2 ECI1_MOUSE reviewed Enoyl-CoA delta isomerase 1, mitochondrial (EC 5.3.3.8) (3,2-trans-enoyl-CoA isomerase) (Delta(3),Delta(2)-enoyl-CoA isomerase) (D3,D2-enoyl-CoA isomerase) (Dodecenoyl-CoA isomerase) Mus musculus (Mouse) GO:0004165; GO:0005739; GO:0005743; GO:0005759; GO:0006635; GO:0016863; GO:0042802 fatty acid beta-oxidation [GO:0006635] mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] delta(3)-delta(2)-enoyl-CoA isomerase activity [GO:0004165]; identical protein binding [GO:0042802]; intramolecular oxidoreductase activity, transposing C=C bonds [GO:0016863] g16462.t1 A0JP70 51.774 1099 0.0 1133.0 sp|A0JP70|WDR90_XENTR WD repeat-containing protein 90 OS=Xenopus tropicalis OX=8364 GN=wdr90 PE=2 SV=1 g16462.t1 A0JP70 46.19 420 5.75e-105 375.0 sp|A0JP70|WDR90_XENTR WD repeat-containing protein 90 OS=Xenopus tropicalis OX=8364 GN=wdr90 PE=2 SV=1 g16462.t2 A0JP70 51.727 1100 0.0 1132.0 sp|A0JP70|WDR90_XENTR WD repeat-containing protein 90 OS=Xenopus tropicalis OX=8364 GN=wdr90 PE=2 SV=1 g16462.t2 A0JP70 46.19 420 6.44e-105 375.0 sp|A0JP70|WDR90_XENTR WD repeat-containing protein 90 OS=Xenopus tropicalis OX=8364 GN=wdr90 PE=2 SV=1 g16463.t1 A0JP70 47.59 166 7.870000000000001e-47 167.0 sp|A0JP70|WDR90_XENTR WD repeat-containing protein 90 OS=Xenopus tropicalis OX=8364 GN=wdr90 PE=2 SV=1 g16469.t1 P62994 63.084 214 5.82e-96 281.0 sp|P62994|GRB2_RAT Growth factor receptor-bound protein 2 OS=Rattus norvegicus OX=10116 GN=Grb2 PE=1 SV=1 GRB2_RAT reviewed Growth factor receptor-bound protein 2 (Adapter protein GRB2) (Protein Ash) (SH2/SH3 adapter GRB2) Rattus norvegicus (Rat) GO:0001784; GO:0005068; GO:0005091; GO:0005154; GO:0005168; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005794; GO:0005813; GO:0005829; GO:0005886; GO:0005911; GO:0005938; GO:0007165; GO:0007173; GO:0007265; GO:0008180; GO:0008286; GO:0008543; GO:0012506; GO:0014044; GO:0016020; GO:0017124; GO:0019899; GO:0019901; GO:0019903; GO:0019904; GO:0030036; GO:0030674; GO:0030838; GO:0031295; GO:0031623; GO:0032991; GO:0035987; GO:0042059; GO:0042110; GO:0042267; GO:0042552; GO:0042770; GO:0042802; GO:0043408; GO:0043560; GO:0044877; GO:0045953; GO:0046875; GO:0048009; GO:0048646; GO:0050853; GO:0051219; GO:0060670; GO:0070436; GO:0071479; GO:0098793; GO:2000379 actin cytoskeleton organization [GO:0030036]; anatomical structure formation involved in morphogenesis [GO:0048646]; B cell receptor signaling pathway [GO:0050853]; branching involved in labyrinthine layer morphogenesis [GO:0060670]; cellular response to ionizing radiation [GO:0071479]; endodermal cell differentiation [GO:0035987]; epidermal growth factor receptor signaling pathway [GO:0007173]; fibroblast growth factor receptor signaling pathway [GO:0008543]; insulin receptor signaling pathway [GO:0008286]; insulin-like growth factor receptor signaling pathway [GO:0048009]; myelination [GO:0042552]; natural killer cell mediated cytotoxicity [GO:0042267]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of natural killer cell mediated cytotoxicity [GO:0045953]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; Ras protein signal transduction [GO:0007265]; receptor internalization [GO:0031623]; regulation of MAPK cascade [GO:0043408]; Schwann cell development [GO:0014044]; signal transduction [GO:0007165]; signal transduction in response to DNA damage [GO:0042770]; T cell activation [GO:0042110]; T cell costimulation [GO:0031295] cell cortex [GO:0005938]; cell-cell junction [GO:0005911]; centrosome [GO:0005813]; COP9 signalosome [GO:0008180]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; Grb2-EGFR complex [GO:0070436]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; protein-containing complex [GO:0032991]; vesicle membrane [GO:0012506] enzyme binding [GO:0019899]; ephrin receptor binding [GO:0046875]; epidermal growth factor receptor binding [GO:0005154]; guanyl-nucleotide exchange factor adaptor activity [GO:0005091]; identical protein binding [GO:0042802]; insulin receptor substrate binding [GO:0043560]; neurotrophin TRKA receptor binding [GO:0005168]; phosphoprotein binding [GO:0051219]; phosphotyrosine residue binding [GO:0001784]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; protein phosphatase binding [GO:0019903]; protein-containing complex binding [GO:0044877]; protein-macromolecule adaptor activity [GO:0030674]; SH3 domain binding [GO:0017124]; transmembrane receptor protein tyrosine kinase adaptor activity [GO:0005068] g16470.t1 Q60631 52.752 218 9.759999999999999e-74 225.0 sp|Q60631|GRB2_MOUSE Growth factor receptor-bound protein 2 OS=Mus musculus OX=10090 GN=Grb2 PE=1 SV=1 GRB2_MOUSE reviewed Growth factor receptor-bound protein 2 (Adapter protein GRB2) (SH2/SH3 adapter GRB2) Mus musculus (Mouse) GO:0001784; GO:0005068; GO:0005091; GO:0005154; GO:0005168; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005794; GO:0005813; GO:0005829; GO:0005886; GO:0005911; GO:0005938; GO:0007165; GO:0007173; GO:0007265; GO:0008180; GO:0008286; GO:0008543; GO:0012506; GO:0014044; GO:0016020; GO:0017124; GO:0019899; GO:0019901; GO:0019903; GO:0019904; GO:0030036; GO:0030154; GO:0030674; GO:0030838; GO:0031295; GO:0031623; GO:0032991; GO:0038133; GO:0042110; GO:0042267; GO:0042552; GO:0042770; GO:0042802; GO:0043408; GO:0043560; GO:0044877; GO:0045953; GO:0046875; GO:0048009; GO:0048646; GO:0050853; GO:0051219; GO:0060090; GO:0060670; GO:0070436; GO:0071479; GO:0098793; GO:2000379 actin cytoskeleton organization [GO:0030036]; anatomical structure formation involved in morphogenesis [GO:0048646]; B cell receptor signaling pathway [GO:0050853]; branching involved in labyrinthine layer morphogenesis [GO:0060670]; cell differentiation [GO:0030154]; cellular response to ionizing radiation [GO:0071479]; epidermal growth factor receptor signaling pathway [GO:0007173]; ERBB2-ERBB3 signaling pathway [GO:0038133]; fibroblast growth factor receptor signaling pathway [GO:0008543]; insulin receptor signaling pathway [GO:0008286]; insulin-like growth factor receptor signaling pathway [GO:0048009]; myelination [GO:0042552]; natural killer cell mediated cytotoxicity [GO:0042267]; negative regulation of natural killer cell mediated cytotoxicity [GO:0045953]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; Ras protein signal transduction [GO:0007265]; receptor internalization [GO:0031623]; regulation of MAPK cascade [GO:0043408]; Schwann cell development [GO:0014044]; signal transduction [GO:0007165]; signal transduction in response to DNA damage [GO:0042770]; T cell activation [GO:0042110]; T cell costimulation [GO:0031295] cell cortex [GO:0005938]; cell-cell junction [GO:0005911]; centrosome [GO:0005813]; COP9 signalosome [GO:0008180]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; Grb2-EGFR complex [GO:0070436]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; protein-containing complex [GO:0032991]; vesicle membrane [GO:0012506] enzyme binding [GO:0019899]; ephrin receptor binding [GO:0046875]; epidermal growth factor receptor binding [GO:0005154]; guanyl-nucleotide exchange factor adaptor activity [GO:0005091]; identical protein binding [GO:0042802]; insulin receptor substrate binding [GO:0043560]; molecular adaptor activity [GO:0060090]; neurotrophin TRKA receptor binding [GO:0005168]; phosphoprotein binding [GO:0051219]; phosphotyrosine residue binding [GO:0001784]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; protein phosphatase binding [GO:0019903]; protein-containing complex binding [GO:0044877]; protein-macromolecule adaptor activity [GO:0030674]; SH3 domain binding [GO:0017124]; transmembrane receptor protein tyrosine kinase adaptor activity [GO:0005068] g16471.t1 O14981 55.847 1907 0.0 1909.0 sp|O14981|BTAF1_HUMAN TATA-binding protein-associated factor 172 OS=Homo sapiens OX=9606 GN=BTAF1 PE=1 SV=2 g16473.t1 Q12767 36.327 490 1.7e-65 239.0 sp|Q12767|TMM94_HUMAN Transmembrane protein 94 OS=Homo sapiens OX=9606 GN=TMEM94 PE=1 SV=1 TMM94_HUMAN reviewed Transmembrane protein 94 (Endoplasmic reticulum magnesium ATPase) Homo sapiens (Human) GO:0005789; GO:0010961; GO:0015444; GO:0160176 intracellular magnesium ion homeostasis [GO:0010961]; magnesium ion transport from cytosol to endoplasmic reticulum [GO:0160176] endoplasmic reticulum membrane [GO:0005789] P-type magnesium transporter activity [GO:0015444] g16474.t1 Q498Z6 58.025 162 6.5e-65 202.0 sp|Q498Z6|RT07_DANRE Small ribosomal subunit protein uS7m OS=Danio rerio OX=7955 GN=mrps7 PE=2 SV=1 g16475.t1 Q9JMK2 70.449 423 0.0 590.0 sp|Q9JMK2|KC1E_MOUSE Casein kinase I isoform epsilon OS=Mus musculus OX=10090 GN=Csnk1e PE=1 SV=2 KC1E_MOUSE reviewed Casein kinase I isoform epsilon (CKI-epsilon) (CKIe) (EC 2.7.11.1) Mus musculus (Mouse) GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006468; GO:0006897; GO:0007165; GO:0007623; GO:0008104; GO:0030177; GO:0030178; GO:0030426; GO:0032436; GO:0032880; GO:0032922; GO:0035567; GO:0042752; GO:0043025; GO:0048512; GO:0051058; GO:0060070; GO:0090263; GO:0106310; GO:1902004; GO:1990090; GO:1990904; GO:2000052 canonical Wnt signaling pathway [GO:0060070]; cellular response to nerve growth factor stimulus [GO:1990090]; circadian behavior [GO:0048512]; circadian regulation of gene expression [GO:0032922]; circadian rhythm [GO:0007623]; endocytosis [GO:0006897]; intracellular protein localization [GO:0008104]; negative regulation of small GTPase mediated signal transduction [GO:0051058]; negative regulation of Wnt signaling pathway [GO:0030178]; non-canonical Wnt signaling pathway [GO:0035567]; positive regulation of amyloid-beta formation [GO:1902004]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of non-canonical Wnt signaling pathway [GO:2000052]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of Wnt signaling pathway [GO:0030177]; protein phosphorylation [GO:0006468]; regulation of circadian rhythm [GO:0042752]; regulation of protein localization [GO:0032880]; signal transduction [GO:0007165] cytoplasm [GO:0005737]; cytosol [GO:0005829]; growth cone [GO:0030426]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904] ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g16475.t2 Q5ZLL1 88.963 299 0.0 580.0 sp|Q5ZLL1|KC1E_CHICK Casein kinase I isoform epsilon OS=Gallus gallus OX=9031 GN=CSNK1E PE=2 SV=2 KC1E_CHICK reviewed Casein kinase I isoform epsilon (CKI-epsilon) (CKIe) (EC 2.7.11.1) Gallus gallus (Chicken) GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0006468; GO:0006897; GO:0007165; GO:0032436; GO:0048511; GO:0090263; GO:0106310 endocytosis [GO:0006897]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein phosphorylation [GO:0006468]; rhythmic process [GO:0048511]; signal transduction [GO:0007165] cytoplasm [GO:0005737]; nucleus [GO:0005634] ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g16479.t1 P56404 37.069 232 2.24e-43 149.0 sp|P56404|AQP8_MOUSE Aquaporin-8 OS=Mus musculus OX=10090 GN=Aqp8 PE=1 SV=1 AQP8_MOUSE reviewed Aquaporin-8 (AQP-8) Mus musculus (Mouse) GO:0005739; GO:0005743; GO:0005790; GO:0005886; GO:0006833; GO:0008519; GO:0015250; GO:0015264; GO:0015265; GO:0015722; GO:0015840; GO:0015843; GO:0016323; GO:0016324; GO:0030183; GO:0030868; GO:0031526; GO:0031966; GO:0035377; GO:0045177; GO:0045540; GO:0046691; GO:0071320; GO:0072488; GO:0072489; GO:0080170; GO:0097708; GO:0140157; GO:1990748 ammonium import across plasma membrane [GO:0140157]; ammonium transmembrane transport [GO:0072488]; B cell differentiation [GO:0030183]; canalicular bile acid transport [GO:0015722]; cellular detoxification [GO:1990748]; cellular response to cAMP [GO:0071320]; hydrogen peroxide transmembrane transport [GO:0080170]; methylammonium transmembrane transport [GO:0072489]; methylammonium transport [GO:0015843]; regulation of cholesterol biosynthetic process [GO:0045540]; transepithelial water transport [GO:0035377]; urea transport [GO:0015840]; water transport [GO:0006833] apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; brush border membrane [GO:0031526]; intracellular canaliculus [GO:0046691]; intracellular vesicle [GO:0097708]; mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; smooth endoplasmic reticulum [GO:0005790]; smooth endoplasmic reticulum membrane [GO:0030868] ammonium channel activity [GO:0008519]; methylammonium channel activity [GO:0015264]; urea channel activity [GO:0015265]; water channel activity [GO:0015250] g16480.t1 Q03468 49.395 1075 0.0 935.0 sp|Q03468|ERCC6_HUMAN DNA excision repair protein ERCC-6 OS=Homo sapiens OX=9606 GN=ERCC6 PE=1 SV=1 ERCC6_HUMAN reviewed DNA excision repair protein ERCC-6 (EC 3.6.4.-) (ATP-dependent helicase ERCC6) (Cockayne syndrome protein CSB) Homo sapiens (Human) GO:0000012; GO:0000077; GO:0000303; GO:0003677; GO:0003682; GO:0004386; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0006281; GO:0006283; GO:0006284; GO:0006290; GO:0006338; GO:0006362; GO:0006366; GO:0006979; GO:0007254; GO:0008023; GO:0008094; GO:0008630; GO:0009636; GO:0010165; GO:0010224; GO:0010332; GO:0016887; GO:0022008; GO:0030182; GO:0030296; GO:0031175; GO:0032784; GO:0032786; GO:0034243; GO:0035264; GO:0042262; GO:0045494; GO:0045739; GO:0045943; GO:0045944; GO:0045945; GO:0060261; GO:0070063; GO:0071168; GO:0090734; GO:0097680; GO:0110016; GO:0140463; GO:0140658; GO:0140664; GO:1905168; GO:2001033 base-excision repair [GO:0006284]; chromatin remodeling [GO:0006338]; DNA damage checkpoint signaling [GO:0000077]; DNA protection [GO:0042262]; DNA repair [GO:0006281]; double-strand break repair via classical nonhomologous end joining [GO:0097680]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; JNK cascade [GO:0007254]; multicellular organism growth [GO:0035264]; negative regulation of double-strand break repair via nonhomologous end joining [GO:2001033]; neurogenesis [GO:0022008]; neuron differentiation [GO:0030182]; neuron projection development [GO:0031175]; photoreceptor cell maintenance [GO:0045494]; positive regulation of DNA repair [GO:0045739]; positive regulation of DNA-templated transcription, elongation [GO:0032786]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of transcription by RNA polymerase I [GO:0045943]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription by RNA polymerase III [GO:0045945]; positive regulation of transcription initiation by RNA polymerase II [GO:0060261]; protein localization to chromatin [GO:0071168]; pyrimidine dimer repair [GO:0006290]; regulation of DNA-templated transcription elongation [GO:0032784]; regulation of transcription elongation by RNA polymerase II [GO:0034243]; response to gamma radiation [GO:0010332]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]; response to toxic substance [GO:0009636]; response to UV-B [GO:0010224]; response to X-ray [GO:0010165]; single strand break repair [GO:0000012]; transcription by RNA polymerase II [GO:0006366]; transcription elongation by RNA polymerase I [GO:0006362]; transcription-coupled nucleotide-excision repair [GO:0006283] B-WICH complex [GO:0110016]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of DNA damage [GO:0090734]; transcription elongation factor complex [GO:0008023] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent activity, acting on DNA [GO:0008094]; ATP-dependent chromatin remodeler activity [GO:0140658]; ATP-dependent DNA damage sensor activity [GO:0140664]; chromatin binding [GO:0003682]; chromatin-protein adaptor activity [GO:0140463]; DNA binding [GO:0003677]; helicase activity [GO:0004386]; protein tyrosine kinase activator activity [GO:0030296]; RNA polymerase binding [GO:0070063] g16482.t1 Q56FC8 87.143 70 5.910000000000001e-37 121.0 sp|Q56FC8|RL38_LYSTE Large ribosomal subunit protein eL38 OS=Lysiphlebus testaceipes OX=77504 GN=RpL38 PE=3 SV=1 g16483.t1 G3M4F8 27.078 373 1.98e-33 132.0 sp|G3M4F8|OCTB2_CHISP Octopamine receptor beta-2R OS=Chilo suppressalis OX=168631 GN=OA2B2 PE=2 SV=1 OCTB2_CHISP reviewed Octopamine receptor beta-2R (CsOA2B2) Chilo suppressalis (Asiatic rice borer moth) GO:0004989; GO:0005886; GO:0007189; GO:0008226; GO:0016020; GO:0043410; GO:0071418; GO:0071880; GO:0071927; GO:0071928 adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cellular response to amine stimulus [GO:0071418]; octopamine signaling pathway [GO:0071927]; positive regulation of MAPK cascade [GO:0043410]; tyramine signaling pathway [GO:0071928] membrane [GO:0016020]; plasma membrane [GO:0005886] octopamine receptor activity [GO:0004989]; tyramine receptor activity [GO:0008226] g16485.t1 P04047 64.641 181 5.55e-83 249.0 sp|P04047|KITH_CHICK Thymidine kinase, cytosolic OS=Gallus gallus OX=9031 GN=TK1 PE=1 SV=1 g16488.t1 O70201 52.459 122 1.08e-45 149.0 sp|O70201|BIRC5_MOUSE Baculoviral IAP repeat-containing protein 5 OS=Mus musculus OX=10090 GN=Birc5 PE=1 SV=1 BIRC5_MOUSE reviewed Baculoviral IAP repeat-containing protein 5 (Apoptosis inhibitor 4) (Apoptosis inhibitor survivin) (TIAP) Mus musculus (Mouse) GO:0000086; GO:0000226; GO:0000228; GO:0000278; GO:0000281; GO:0000775; GO:0000776; GO:0004869; GO:0005634; GO:0005737; GO:0005814; GO:0005829; GO:0005876; GO:0005881; GO:0006915; GO:0007052; GO:0007094; GO:0007127; GO:0007346; GO:0008017; GO:0008270; GO:0015630; GO:0015631; GO:0016324; GO:0019899; GO:0030496; GO:0031021; GO:0031267; GO:0031398; GO:0031503; GO:0031536; GO:0032133; GO:0032991; GO:0042802; GO:0042803; GO:0043027; GO:0043066; GO:0043524; GO:0045787; GO:0045892; GO:0045931; GO:0046982; GO:0050000; GO:0051087; GO:0051256; GO:0051301; GO:0051726; GO:0061178; GO:0061469; GO:0061630; GO:0090267; GO:1901970; GO:1902425; GO:1903490; GO:1990713 apoptotic process [GO:0006915]; cell division [GO:0051301]; chromosome localization [GO:0050000]; G2/M transition of mitotic cell cycle [GO:0000086]; meiosis I [GO:0007127]; microtubule cytoskeleton organization [GO:0000226]; mitotic cell cycle [GO:0000278]; mitotic cytokinesis [GO:0000281]; mitotic spindle assembly checkpoint signaling [GO:0007094]; mitotic spindle midzone assembly [GO:0051256]; mitotic spindle organization [GO:0007052]; negative regulation of apoptotic process [GO:0043066]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of neuron apoptotic process [GO:0043524]; positive regulation of attachment of mitotic spindle microtubules to kinetochore [GO:1902425]; positive regulation of cell cycle [GO:0045787]; positive regulation of exit from mitosis [GO:0031536]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; positive regulation of mitotic cytokinesis [GO:1903490]; positive regulation of mitotic sister chromatid separation [GO:1901970]; positive regulation of protein ubiquitination [GO:0031398]; protein-containing complex localization [GO:0031503]; regulation of cell cycle [GO:0051726]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]; regulation of mitotic cell cycle [GO:0007346]; regulation of type B pancreatic cell proliferation [GO:0061469] apical plasma membrane [GO:0016324]; centriole [GO:0005814]; chromosome passenger complex [GO:0032133]; chromosome, centromeric region [GO:0000775]; cytoplasm [GO:0005737]; cytoplasmic microtubule [GO:0005881]; cytosol [GO:0005829]; interphase microtubule organizing center [GO:0031021]; kinetochore [GO:0000776]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; nuclear chromosome [GO:0000228]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; spindle microtubule [GO:0005876]; survivin complex [GO:1990713] cysteine-type endopeptidase inhibitor activity [GO:0004869]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; protein-folding chaperone binding [GO:0051087]; small GTPase binding [GO:0031267]; tubulin binding [GO:0015631]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] g16491.t1 B2GV72 51.481 270 4.11e-96 286.0 sp|B2GV72|CRB3_RAT Carbonyl reductase [NADPH] 3 OS=Rattus norvegicus OX=10116 GN=Cbr3 PE=1 SV=1 CRB3_RAT reviewed Carbonyl reductase [NADPH] 3 (EC 1.1.1.184) (Monomeric carbonyl reductase 3) (Quinone reductase CBR3) (EC 1.6.5.10) Rattus norvegicus (Rat) GO:0000253; GO:0004090; GO:0005654; GO:0005829; GO:0008753; GO:0042376; GO:0050890; GO:0070402 cognition [GO:0050890]; phylloquinone catabolic process [GO:0042376] cytosol [GO:0005829]; nucleoplasm [GO:0005654] 3-beta-hydroxysteroid 3-dehydrogenase (NADP+) activity [GO:0000253]; carbonyl reductase (NADPH) activity [GO:0004090]; NADPH binding [GO:0070402]; NADPH dehydrogenase (quinone) activity [GO:0008753] g16492.t1 B2GV72 49.071 269 3.1199999999999997e-89 269.0 sp|B2GV72|CRB3_RAT Carbonyl reductase [NADPH] 3 OS=Rattus norvegicus OX=10116 GN=Cbr3 PE=1 SV=1 CRB3_RAT reviewed Carbonyl reductase [NADPH] 3 (EC 1.1.1.184) (Monomeric carbonyl reductase 3) (Quinone reductase CBR3) (EC 1.6.5.10) Rattus norvegicus (Rat) GO:0000253; GO:0004090; GO:0005654; GO:0005829; GO:0008753; GO:0042376; GO:0050890; GO:0070402 cognition [GO:0050890]; phylloquinone catabolic process [GO:0042376] cytosol [GO:0005829]; nucleoplasm [GO:0005654] 3-beta-hydroxysteroid 3-dehydrogenase (NADP+) activity [GO:0000253]; carbonyl reductase (NADPH) activity [GO:0004090]; NADPH binding [GO:0070402]; NADPH dehydrogenase (quinone) activity [GO:0008753] g16495.t1 Q0VA03 44.64 681 0.0 555.0 sp|Q0VA03|SUZ12_XENTR Polycomb protein suz12 OS=Xenopus tropicalis OX=8364 GN=suz12 PE=2 SV=1 g16496.t1 Q9BUU2 45.339 236 8.72e-50 174.0 sp|Q9BUU2|MET22_HUMAN Methyltransferase-like protein 22 OS=Homo sapiens OX=9606 GN=METTL22 PE=1 SV=2 MET22_HUMAN reviewed Methyltransferase-like protein 22 (EC 2.1.1.-) Homo sapiens (Human) GO:0005634; GO:0005654; GO:0005730; GO:0006479; GO:0008276; GO:0016279; GO:0031072; GO:0032991 protein methylation [GO:0006479] nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991] heat shock protein binding [GO:0031072]; protein methyltransferase activity [GO:0008276]; protein-lysine N-methyltransferase activity [GO:0016279] g16497.t1 Q8BS45 69.489 567 0.0 772.0 sp|Q8BS45|IFT56_MOUSE Intraflagellar transport protein 56 OS=Mus musculus OX=10090 GN=Ift56 PE=1 SV=1 IFT56_MOUSE reviewed Intraflagellar transport protein 56 (Protein hop-sterile) (Tetratricopeptide repeat protein 26) (TPR repeat protein 26) Mus musculus (Mouse) GO:0005813; GO:0005929; GO:0007224; GO:0007286; GO:0008594; GO:0015031; GO:0030992; GO:0035082; GO:0035720; GO:0035735; GO:0036064; GO:0042073; GO:0046530; GO:0060271; GO:0061512; GO:0097546; GO:0120170; GO:1905198 axoneme assembly [GO:0035082]; cilium assembly [GO:0060271]; intraciliary anterograde transport [GO:0035720]; intraciliary transport [GO:0042073]; intraciliary transport involved in cilium assembly [GO:0035735]; manchette assembly [GO:1905198]; photoreceptor cell differentiation [GO:0046530]; photoreceptor cell morphogenesis [GO:0008594]; protein localization to cilium [GO:0061512]; protein transport [GO:0015031]; smoothened signaling pathway [GO:0007224]; spermatid development [GO:0007286] centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary base [GO:0097546]; cilium [GO:0005929]; intraciliary transport particle B [GO:0030992] intraciliary transport particle B binding [GO:0120170] g16497.t2 Q8BS45 71.3 554 0.0 764.0 sp|Q8BS45|IFT56_MOUSE Intraflagellar transport protein 56 OS=Mus musculus OX=10090 GN=Ift56 PE=1 SV=1 IFT56_MOUSE reviewed Intraflagellar transport protein 56 (Protein hop-sterile) (Tetratricopeptide repeat protein 26) (TPR repeat protein 26) Mus musculus (Mouse) GO:0005813; GO:0005929; GO:0007224; GO:0007286; GO:0008594; GO:0015031; GO:0030992; GO:0035082; GO:0035720; GO:0035735; GO:0036064; GO:0042073; GO:0046530; GO:0060271; GO:0061512; GO:0097546; GO:0120170; GO:1905198 axoneme assembly [GO:0035082]; cilium assembly [GO:0060271]; intraciliary anterograde transport [GO:0035720]; intraciliary transport [GO:0042073]; intraciliary transport involved in cilium assembly [GO:0035735]; manchette assembly [GO:1905198]; photoreceptor cell differentiation [GO:0046530]; photoreceptor cell morphogenesis [GO:0008594]; protein localization to cilium [GO:0061512]; protein transport [GO:0015031]; smoothened signaling pathway [GO:0007224]; spermatid development [GO:0007286] centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary base [GO:0097546]; cilium [GO:0005929]; intraciliary transport particle B [GO:0030992] intraciliary transport particle B binding [GO:0120170] g16500.t1 Q8NFG4 46.644 581 2.8400000000000004e-169 495.0 sp|Q8NFG4|FLCN_HUMAN Folliculin OS=Homo sapiens OX=9606 GN=FLCN PE=1 SV=1 FLCN_HUMAN reviewed Folliculin (BHD skin lesion fibrofolliculoma protein) (Birt-Hogg-Dube syndrome protein) Homo sapiens (Human) GO:0000122; GO:0001701; GO:0004857; GO:0005096; GO:0005634; GO:0005737; GO:0005764; GO:0005765; GO:0005813; GO:0005829; GO:0005886; GO:0005929; GO:0007043; GO:0007179; GO:0009267; GO:0010508; GO:0019899; GO:0030097; GO:0030511; GO:0031929; GO:0032006; GO:0032007; GO:0032008; GO:0032418; GO:0034198; GO:0035024; GO:0035556; GO:0043065; GO:0043491; GO:0044877; GO:0045820; GO:0046578; GO:0050673; GO:0050680; GO:0051898; GO:0070371; GO:0070373; GO:0072111; GO:0072686; GO:0097009; GO:0097193; GO:0120163; GO:1901723; GO:1901874; GO:1903444; GO:1904263; GO:1905672; GO:1990877; GO:2000973; GO:2001244 cell proliferation involved in kidney development [GO:0072111]; cell-cell junction assembly [GO:0007043]; cellular response to amino acid starvation [GO:0034198]; cellular response to starvation [GO:0009267]; energy homeostasis [GO:0097009]; epithelial cell proliferation [GO:0050673]; ERK1 and ERK2 cascade [GO:0070371]; hemopoiesis [GO:0030097]; in utero embryonic development [GO:0001701]; intracellular signal transduction [GO:0035556]; intrinsic apoptotic signaling pathway [GO:0097193]; lysosome localization [GO:0032418]; negative regulation of brown fat cell differentiation [GO:1903444]; negative regulation of cell proliferation involved in kidney development [GO:1901723]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of glycolytic process [GO:0045820]; negative regulation of lysosome organization [GO:1905672]; negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051898]; negative regulation of post-translational protein modification [GO:1901874]; negative regulation of Rho protein signal transduction [GO:0035024]; negative regulation of TOR signaling [GO:0032007]; negative regulation of transcription by RNA polymerase II [GO:0000122]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; positive regulation of apoptotic process [GO:0043065]; positive regulation of autophagy [GO:0010508]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; positive regulation of TOR signaling [GO:0032008]; positive regulation of TORC1 signaling [GO:1904263]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; regulation of pro-B cell differentiation [GO:2000973]; regulation of Ras protein signal transduction [GO:0046578]; regulation of TOR signaling [GO:0032006]; TOR signaling [GO:0031929]; transforming growth factor beta receptor signaling pathway [GO:0007179] centrosome [GO:0005813]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; FNIP-folliculin RagC/D GAP [GO:1990877]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]; plasma membrane [GO:0005886] enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; GTPase activator activity [GO:0005096]; protein-containing complex binding [GO:0044877] g16509.t1 Q7Z442 28.073 659 3.16e-69 265.0 sp|Q7Z442|PK1L2_HUMAN Polycystin-1-like protein 2 OS=Homo sapiens OX=9606 GN=PKD1L2 PE=1 SV=5 PK1L2_HUMAN reviewed Polycystin-1-like protein 2 (Polycystin-1L2) (PC1-like 2 protein) (Polycystic kidney disease protein 1-like 2) Homo sapiens (Human) GO:0005262; GO:0005509; GO:0016020; GO:0030246; GO:0050982 detection of mechanical stimulus [GO:0050982] membrane [GO:0016020] calcium channel activity [GO:0005262]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246] g16509.t1 Q7Z442 32.456 570 8.09e-63 244.0 sp|Q7Z442|PK1L2_HUMAN Polycystin-1-like protein 2 OS=Homo sapiens OX=9606 GN=PKD1L2 PE=1 SV=5 PK1L2_HUMAN reviewed Polycystin-1-like protein 2 (Polycystin-1L2) (PC1-like 2 protein) (Polycystic kidney disease protein 1-like 2) Homo sapiens (Human) GO:0005262; GO:0005509; GO:0016020; GO:0030246; GO:0050982 detection of mechanical stimulus [GO:0050982] membrane [GO:0016020] calcium channel activity [GO:0005262]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246] g16510.t1 P14604 66.312 282 1.0899999999999999e-134 386.0 sp|P14604|ECHM_RAT Enoyl-CoA hydratase, mitochondrial OS=Rattus norvegicus OX=10116 GN=Echs1 PE=1 SV=1 ECHM_RAT reviewed Enoyl-CoA hydratase, mitochondrial (mECH) (mECH1) (EC 4.2.1.17) (EC 5.3.3.8) (Enoyl-CoA hydratase 1) (ECHS1) (Short-chain enoyl-CoA hydratase) (SCEH) Rattus norvegicus (Rat) GO:0004165; GO:0004300; GO:0005739; GO:0005759; GO:0006635; GO:0043956; GO:0120092 fatty acid beta-oxidation [GO:0006635] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] (2E)-butenoyl-CoA hydratase activity [GO:0120092]; 3-hydroxypropionyl-CoA dehydratase activity [GO:0043956]; delta(3)-delta(2)-enoyl-CoA isomerase activity [GO:0004165]; enoyl-CoA hydratase activity [GO:0004300] g16511.t1 Q5R7W0 65.432 81 3.6400000000000004e-32 117.0 sp|Q5R7W0|WIPI3_PONAB WD repeat domain phosphoinositide-interacting protein 3 OS=Pongo abelii OX=9601 GN=WDR45B PE=2 SV=1 g16512.t1 Q5ZL16 68.142 226 1.22e-96 286.0 sp|Q5ZL16|WIPI3_CHICK WD repeat domain phosphoinositide-interacting protein 3 OS=Gallus gallus OX=9031 GN=WDR45B PE=2 SV=1 WIPI3_CHICK reviewed WD repeat domain phosphoinositide-interacting protein 3 (WIPI-3) (WD repeat-containing protein 45B) Gallus gallus (Chicken) GO:0000045; GO:0000407; GO:0000422; GO:0000425; GO:0005764; GO:0005829; GO:0009267; GO:0030674; GO:0032266; GO:0034045; GO:0034497; GO:0044804; GO:0061723; GO:0080025 autophagosome assembly [GO:0000045]; autophagy of mitochondrion [GO:0000422]; cellular response to starvation [GO:0009267]; glycophagy [GO:0061723]; nucleophagy [GO:0044804]; pexophagy [GO:0000425]; protein localization to phagophore assembly site [GO:0034497] cytosol [GO:0005829]; lysosome [GO:0005764]; phagophore assembly site [GO:0000407]; phagophore assembly site membrane [GO:0034045] phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-3-phosphate binding [GO:0032266]; protein-macromolecule adaptor activity [GO:0030674] g16513.t1 Q13231 48.802 459 2.3199999999999998e-150 440.0 sp|Q13231|CHIT1_HUMAN Chitotriosidase-1 OS=Homo sapiens OX=9606 GN=CHIT1 PE=1 SV=1 g16519.t1 Q13231 52.756 381 4.81e-112 348.0 sp|Q13231|CHIT1_HUMAN Chitotriosidase-1 OS=Homo sapiens OX=9606 GN=CHIT1 PE=1 SV=1 g16521.t1 O96530 39.881 336 4.7099999999999995e-53 199.0 sp|O96530|HYAL_LYTVA Hyalin (Fragment) OS=Lytechinus variegatus OX=7654 PE=2 SV=1 g16521.t1 O96530 39.721 287 1.54e-44 174.0 sp|O96530|HYAL_LYTVA Hyalin (Fragment) OS=Lytechinus variegatus OX=7654 PE=2 SV=1 g16521.t1 O96530 37.061 313 1.1e-33 141.0 sp|O96530|HYAL_LYTVA Hyalin (Fragment) OS=Lytechinus variegatus OX=7654 PE=2 SV=1 g16521.t1 O96530 38.889 216 1.63e-29 129.0 sp|O96530|HYAL_LYTVA Hyalin (Fragment) OS=Lytechinus variegatus OX=7654 PE=2 SV=1 g16522.t1 C6KFA3 24.5 600 1.9e-41 168.0 sp|C6KFA3|AGRG6_DANRE Adhesion G-protein coupled receptor G6 OS=Danio rerio OX=7955 GN=adgrg6 PE=1 SV=1 AGRG6_DANRE reviewed Adhesion G-protein coupled receptor G6 (G-protein coupled receptor 126) [Cleaved into: Adhesion G-protein coupled receptor G6, N-terminal fragment (ADGRG6 N-terminal fragment) (ADGRG6-NTF); Adhesion G-protein coupled receptor G6, C-terminal fragment (ADGRG6 C-terminal fragment) (ADGRG6-CTF)] Danio rerio (Zebrafish) (Brachydanio rerio) GO:0004930; GO:0005518; GO:0005886; GO:0007166; GO:0007188; GO:0007189; GO:0007193; GO:0007507; GO:0014037; GO:0022011; GO:0030500; GO:0042552; GO:0043236; GO:0043583; GO:0050840; GO:0051216; GO:0060347 adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; cartilage development [GO:0051216]; cell surface receptor signaling pathway [GO:0007166]; ear development [GO:0043583]; heart development [GO:0007507]; heart trabecula formation [GO:0060347]; myelination [GO:0042552]; myelination in peripheral nervous system [GO:0022011]; regulation of bone mineralization [GO:0030500]; Schwann cell differentiation [GO:0014037] plasma membrane [GO:0005886] collagen binding [GO:0005518]; extracellular matrix binding [GO:0050840]; G protein-coupled receptor activity [GO:0004930]; laminin binding [GO:0043236] g16526.t1 O76536 31.704 716 2.78e-71 263.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g16526.t1 O76536 31.454 674 6.83e-65 244.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g16526.t1 O76536 31.487 632 3.13e-63 239.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g16526.t1 O76536 30.189 636 1.7899999999999999e-62 236.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g16526.t1 O76536 29.508 671 1.1e-56 218.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g16526.t1 O76536 29.967 614 4.13e-50 197.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g16526.t2 O76536 32.869 718 4.66e-75 275.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g16526.t2 O76536 31.579 722 1.3e-66 249.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g16526.t2 O76536 31.61 677 1.9899999999999998e-62 236.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g16526.t2 O76536 30.163 673 7.29e-59 225.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g16526.t2 O76536 31.23 618 4.44e-53 207.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g16526.t2 O76536 31.407 519 2.3099999999999997e-52 205.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g16528.t1 Q5R1W5 81.053 95 4.6399999999999994e-48 161.0 sp|Q5R1W5|SRSF2_PANTR Serine/arginine-rich splicing factor 2 OS=Pan troglodytes OX=9598 GN=SRSF2 PE=2 SV=3 g16529.t1 Q5F364 45.841 1106 0.0 951.0 sp|Q5F364|MRP1_CHICK Multidrug resistance-associated protein 1 OS=Gallus gallus OX=9031 GN=ABCC1 PE=2 SV=1 MRP1_CHICK reviewed Multidrug resistance-associated protein 1 (EC 7.6.2.2) (ATP-binding cassette sub-family C member 1) (Glutathione-S-conjugate-translocating ATPase ABCC1) (EC 7.6.2.3) (Leukotriene C(4) transporter) (LTC4 transporter) Gallus gallus (Chicken) GO:0005524; GO:0005886; GO:0006869; GO:0008559; GO:0015431; GO:0016323; GO:0016887; GO:0034634; GO:0034775; GO:0042908; GO:0046943; GO:0070729 cyclic nucleotide transport [GO:0070729]; glutathione transmembrane transport [GO:0034775]; lipid transport [GO:0006869]; xenobiotic transport [GO:0042908] basolateral plasma membrane [GO:0016323]; plasma membrane [GO:0005886] ABC-type glutathione S-conjugate transporter activity [GO:0015431]; ABC-type xenobiotic transporter activity [GO:0008559]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; carboxylic acid transmembrane transporter activity [GO:0046943]; glutathione transmembrane transporter activity [GO:0034634] g16530.t1 O15438 64.964 411 0.0 552.0 sp|O15438|MRP3_HUMAN ATP-binding cassette sub-family C member 3 OS=Homo sapiens OX=9606 GN=ABCC3 PE=1 SV=3 MRP3_HUMAN reviewed ATP-binding cassette sub-family C member 3 (EC 7.6.2.-) (EC 7.6.2.2) (EC 7.6.2.3) (Canalicular multispecific organic anion transporter 2) (Multi-specific organic anion transporter D) (MOAT-D) (Multidrug resistance-associated protein 3) Homo sapiens (Human) GO:0005524; GO:0005886; GO:0006805; GO:0006855; GO:0008559; GO:0009925; GO:0015164; GO:0015431; GO:0015432; GO:0015721; GO:0016323; GO:0016887; GO:0036064; GO:0042626; GO:0042908; GO:0042910; GO:0043225; GO:0055085; GO:0071714; GO:0071716; GO:0140359; GO:0150104 bile acid and bile salt transport [GO:0015721]; leukotriene transport [GO:0071716]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104]; xenobiotic metabolic process [GO:0006805]; xenobiotic transmembrane transport [GO:0006855]; xenobiotic transport [GO:0042908] basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; ciliary basal body [GO:0036064]; plasma membrane [GO:0005886] ABC-type bile acid transporter activity [GO:0015432]; ABC-type glutathione S-conjugate transporter activity [GO:0015431]; ABC-type transporter activity [GO:0140359]; ABC-type xenobiotic transporter activity [GO:0008559]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled inorganic anion transmembrane transporter activity [GO:0043225]; ATPase-coupled transmembrane transporter activity [GO:0042626]; glucuronoside transmembrane transporter activity [GO:0015164]; icosanoid transmembrane transporter activity [GO:0071714]; xenobiotic transmembrane transporter activity [GO:0042910] g16533.t1 Q9NQZ8 31.604 212 1.2699999999999999e-23 107.0 sp|Q9NQZ8|ZNF71_HUMAN Endothelial zinc finger protein induced by tumor necrosis factor alpha OS=Homo sapiens OX=9606 GN=ZNF71 PE=1 SV=1 ZNF71_HUMAN reviewed Endothelial zinc finger protein induced by tumor necrosis factor alpha (Zinc finger protein 71) Homo sapiens (Human) GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0008270 regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270] g16533.t1 Q9NQZ8 30.583 206 8.82e-21 99.0 sp|Q9NQZ8|ZNF71_HUMAN Endothelial zinc finger protein induced by tumor necrosis factor alpha OS=Homo sapiens OX=9606 GN=ZNF71 PE=1 SV=1 ZNF71_HUMAN reviewed Endothelial zinc finger protein induced by tumor necrosis factor alpha (Zinc finger protein 71) Homo sapiens (Human) GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0008270 regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270] g16534.t1 O43345 25.133 1130 3.83e-55 215.0 sp|O43345|ZN208_HUMAN Zinc finger protein 208 OS=Homo sapiens OX=9606 GN=ZNF208 PE=1 SV=2 g16534.t1 O43345 23.973 1047 5.4399999999999995e-48 192.0 sp|O43345|ZN208_HUMAN Zinc finger protein 208 OS=Homo sapiens OX=9606 GN=ZNF208 PE=1 SV=2 g16534.t1 O43345 22.326 1066 7.440000000000001e-37 156.0 sp|O43345|ZN208_HUMAN Zinc finger protein 208 OS=Homo sapiens OX=9606 GN=ZNF208 PE=1 SV=2 g16536.t1 Q5F364 46.714 1552 0.0 1372.0 sp|Q5F364|MRP1_CHICK Multidrug resistance-associated protein 1 OS=Gallus gallus OX=9031 GN=ABCC1 PE=2 SV=1 MRP1_CHICK reviewed Multidrug resistance-associated protein 1 (EC 7.6.2.2) (ATP-binding cassette sub-family C member 1) (Glutathione-S-conjugate-translocating ATPase ABCC1) (EC 7.6.2.3) (Leukotriene C(4) transporter) (LTC4 transporter) Gallus gallus (Chicken) GO:0005524; GO:0005886; GO:0006869; GO:0008559; GO:0015431; GO:0016323; GO:0016887; GO:0034634; GO:0034775; GO:0042908; GO:0046943; GO:0070729 cyclic nucleotide transport [GO:0070729]; glutathione transmembrane transport [GO:0034775]; lipid transport [GO:0006869]; xenobiotic transport [GO:0042908] basolateral plasma membrane [GO:0016323]; plasma membrane [GO:0005886] ABC-type glutathione S-conjugate transporter activity [GO:0015431]; ABC-type xenobiotic transporter activity [GO:0008559]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; carboxylic acid transmembrane transporter activity [GO:0046943]; glutathione transmembrane transporter activity [GO:0034634] g16537.t1 O14562 64.912 228 9.78e-107 318.0 sp|O14562|UBFD1_HUMAN Ubiquitin domain-containing protein UBFD1 OS=Homo sapiens OX=9606 GN=UBFD1 PE=1 SV=2 g16537.t2 O14562 64.912 228 1.27e-106 318.0 sp|O14562|UBFD1_HUMAN Ubiquitin domain-containing protein UBFD1 OS=Homo sapiens OX=9606 GN=UBFD1 PE=1 SV=2 g16538.t1 Q24K03 38.558 319 5.12e-65 211.0 sp|Q24K03|THUM1_BOVIN THUMP domain-containing protein 1 OS=Bos taurus OX=9913 GN=THUMPD1 PE=2 SV=1 g16540.t1 Q7RTU9 27.972 572 4.1799999999999995e-52 200.0 sp|Q7RTU9|STRC_HUMAN Stereocilin OS=Homo sapiens OX=9606 GN=STRC PE=2 SV=1 STRC_HUMAN reviewed Stereocilin Homo sapiens (Human) GO:0007160; GO:0008104; GO:0009986; GO:0032426; GO:0050910; GO:0060088; GO:0060091 auditory receptor cell stereocilium organization [GO:0060088]; cell-matrix adhesion [GO:0007160]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; intracellular protein localization [GO:0008104] cell surface [GO:0009986]; kinocilium [GO:0060091]; stereocilium tip [GO:0032426] g16543.t1 Q8I7P9 33.039 566 2.8999999999999997e-84 302.0 sp|Q8I7P9|POL5_DROME Retrovirus-related Pol polyprotein from transposon opus OS=Drosophila melanogaster OX=7227 GN=pol PE=4 SV=1 g16544.t1 Q9U7D5 27.155 232 1.17e-22 102.0 sp|Q9U7D5|ACM3_CAEEL Muscarinic acetylcholine receptor gar-3 OS=Caenorhabditis elegans OX=6239 GN=gar-3 PE=1 SV=2 g16547.t1 P51799 58.564 724 0.0 773.0 sp|P51799|CLCN7_RAT H(+)/Cl(-) exchange transporter 7 OS=Rattus norvegicus OX=10116 GN=Clcn7 PE=2 SV=1 g16548.t1 Q01850 30.425 447 6.2300000000000005e-37 143.0 sp|Q01850|CDR2_HUMAN Cerebellar degeneration-related protein 2 OS=Homo sapiens OX=9606 GN=CDR2 PE=1 SV=2 CDR2_HUMAN reviewed Cerebellar degeneration-related protein 2 (Major Yo paraneoplastic antigen) (Paraneoplastic cerebellar degeneration-associated antigen) Homo sapiens (Human) GO:0005737 cytoplasm [GO:0005737] g16551.t1 Q96DM1 28.681 523 7.919999999999999e-48 179.0 sp|Q96DM1|PGBD4_HUMAN PiggyBac transposable element-derived protein 4 OS=Homo sapiens OX=9606 GN=PGBD4 PE=1 SV=3 g16556.t1 F8WK50 60.047 1279 0.0 1392.0 sp|F8WK50|FLII_DANRE Protein flightless-1 homolog OS=Danio rerio OX=7955 GN=flii PE=1 SV=1 g16557.t1 Q9BTV6 41.372 481 2.86e-102 317.0 sp|Q9BTV6|DPH7_HUMAN Diphthine methyltransferase OS=Homo sapiens OX=9606 GN=DPH7 PE=1 SV=2 g16564.t1 F1QAM1 38.889 126 3.8800000000000006e-27 108.0 sp|F1QAM1|ZDHC4_DANRE Palmitoyltransferase ZDHHC4 OS=Danio rerio OX=7955 GN=zdhhc4 PE=2 SV=1 g16566.t1 P54922 56.78 354 1.1900000000000002e-132 385.0 sp|P54922|ADPRH_HUMAN ADP-ribosylhydrolase ARH1 OS=Homo sapiens OX=9606 GN=ADPRH PE=1 SV=1 ADPRH_HUMAN reviewed ADP-ribosylhydrolase ARH1 (EC 3.2.2.19) (ADP-ribose-L-arginine cleaving enzyme) ([Protein ADP-ribosylarginine] hydrolase) (ADP-ribosylarginine hydrolase) (hARH1) Homo sapiens (Human) GO:0000287; GO:0003875; GO:0005615; GO:0030955; GO:0036211; GO:0051725 protein de-ADP-ribosylation [GO:0051725]; protein modification process [GO:0036211] extracellular space [GO:0005615] ADP-ribosylarginine hydrolase activity [GO:0003875]; magnesium ion binding [GO:0000287]; potassium ion binding [GO:0030955] g16567.t1 P54922 47.855 303 2.08e-76 238.0 sp|P54922|ADPRH_HUMAN ADP-ribosylhydrolase ARH1 OS=Homo sapiens OX=9606 GN=ADPRH PE=1 SV=1 ADPRH_HUMAN reviewed ADP-ribosylhydrolase ARH1 (EC 3.2.2.19) (ADP-ribose-L-arginine cleaving enzyme) ([Protein ADP-ribosylarginine] hydrolase) (ADP-ribosylarginine hydrolase) (hARH1) Homo sapiens (Human) GO:0000287; GO:0003875; GO:0005615; GO:0030955; GO:0036211; GO:0051725 protein de-ADP-ribosylation [GO:0051725]; protein modification process [GO:0036211] extracellular space [GO:0005615] ADP-ribosylarginine hydrolase activity [GO:0003875]; magnesium ion binding [GO:0000287]; potassium ion binding [GO:0030955] g16569.t1 Q95108 40.994 161 6.03e-41 137.0 sp|Q95108|THIOM_BOVIN Thioredoxin, mitochondrial OS=Bos taurus OX=9913 GN=TXN2 PE=1 SV=2 g16570.t1 Q90YS3 89.732 224 6.45e-151 426.0 sp|Q90YS3|RS2_ICTPU Small ribosomal subunit protein uS5 OS=Ictalurus punctatus OX=7998 GN=rps2 PE=2 SV=1 g16571.t1 Q8IV36 69.24 842 0.0 1160.0 sp|Q8IV36|HID1_HUMAN Protein HID1 OS=Homo sapiens OX=9606 GN=HID1 PE=1 SV=1 HID1_HUMAN reviewed Protein HID1 (Down-regulated in multiple cancers 1) (HID1 domain-containing protein) (Protein hid-1 homolog) Homo sapiens (Human) GO:0000138; GO:0005737; GO:0005794; GO:0005797; GO:0005829; GO:0005881; GO:0009749; GO:0016020; GO:0030070; GO:0042144; GO:0061792; GO:0070062; GO:0098548 insulin processing [GO:0030070]; response to glucose [GO:0009749]; secretory granule maturation [GO:0061792]; vacuole fusion, non-autophagic [GO:0042144] cytoplasm [GO:0005737]; cytoplasmic microtubule [GO:0005881]; cytoplasmic side of Golgi membrane [GO:0098548]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi medial cisterna [GO:0005797]; Golgi trans cisterna [GO:0000138]; membrane [GO:0016020] g16571.t2 Q8IV36 69.048 840 0.0 1154.0 sp|Q8IV36|HID1_HUMAN Protein HID1 OS=Homo sapiens OX=9606 GN=HID1 PE=1 SV=1 HID1_HUMAN reviewed Protein HID1 (Down-regulated in multiple cancers 1) (HID1 domain-containing protein) (Protein hid-1 homolog) Homo sapiens (Human) GO:0000138; GO:0005737; GO:0005794; GO:0005797; GO:0005829; GO:0005881; GO:0009749; GO:0016020; GO:0030070; GO:0042144; GO:0061792; GO:0070062; GO:0098548 insulin processing [GO:0030070]; response to glucose [GO:0009749]; secretory granule maturation [GO:0061792]; vacuole fusion, non-autophagic [GO:0042144] cytoplasm [GO:0005737]; cytoplasmic microtubule [GO:0005881]; cytoplasmic side of Golgi membrane [GO:0098548]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi medial cisterna [GO:0005797]; Golgi trans cisterna [GO:0000138]; membrane [GO:0016020] g16572.t1 U3JAG9 56.066 610 2.81e-155 497.0 sp|U3JAG9|CP131_DANRE Centrosomal protein of 131 kDa OS=Danio rerio OX=7955 GN=cep131 PE=1 SV=1 CP131_DANRE reviewed Centrosomal protein of 131 kDa (5-azacytidine-induced protein 1) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000775; GO:0001669; GO:0005576; GO:0005929; GO:0010824; GO:0030154; GO:0032402; GO:0034451; GO:0035721; GO:0035735; GO:0050953; GO:0060271; GO:0060287; GO:0070121; GO:0090317 cell differentiation [GO:0030154]; cilium assembly [GO:0060271]; epithelial cilium movement involved in determination of left/right asymmetry [GO:0060287]; intraciliary retrograde transport [GO:0035721]; intraciliary transport involved in cilium assembly [GO:0035735]; Kupffer's vesicle development [GO:0070121]; melanosome transport [GO:0032402]; negative regulation of intracellular protein transport [GO:0090317]; regulation of centrosome duplication [GO:0010824]; sensory perception of light stimulus [GO:0050953] acrosomal vesicle [GO:0001669]; centriolar satellite [GO:0034451]; chromosome, centromeric region [GO:0000775]; cilium [GO:0005929]; extracellular region [GO:0005576] g16574.t1 Q8K0V4 69.057 265 2.11e-111 361.0 sp|Q8K0V4|CNOT3_MOUSE CCR4-NOT transcription complex subunit 3 OS=Mus musculus OX=10090 GN=Cnot3 PE=1 SV=1 CNOT3_MOUSE reviewed CCR4-NOT transcription complex subunit 3 (CCR4-associated factor 3) Mus musculus (Mouse) GO:0000289; GO:0000932; GO:0001829; GO:0005634; GO:0005829; GO:0006355; GO:0006402; GO:0006417; GO:0007368; GO:0010467; GO:0030014; GO:0030015; GO:0031047; GO:0033147; GO:0120162; GO:2000036 determination of left/right symmetry [GO:0007368]; gene expression [GO:0010467]; mRNA catabolic process [GO:0006402]; negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; positive regulation of cold-induced thermogenesis [GO:0120162]; regulation of DNA-templated transcription [GO:0006355]; regulation of stem cell population maintenance [GO:2000036]; regulation of translation [GO:0006417]; regulatory ncRNA-mediated gene silencing [GO:0031047]; trophectodermal cell differentiation [GO:0001829] CCR4-NOT complex [GO:0030014]; CCR4-NOT core complex [GO:0030015]; cytosol [GO:0005829]; nucleus [GO:0005634]; P-body [GO:0000932] g16574.t1 Q8K0V4 79.394 165 1.87e-88 300.0 sp|Q8K0V4|CNOT3_MOUSE CCR4-NOT transcription complex subunit 3 OS=Mus musculus OX=10090 GN=Cnot3 PE=1 SV=1 CNOT3_MOUSE reviewed CCR4-NOT transcription complex subunit 3 (CCR4-associated factor 3) Mus musculus (Mouse) GO:0000289; GO:0000932; GO:0001829; GO:0005634; GO:0005829; GO:0006355; GO:0006402; GO:0006417; GO:0007368; GO:0010467; GO:0030014; GO:0030015; GO:0031047; GO:0033147; GO:0120162; GO:2000036 determination of left/right symmetry [GO:0007368]; gene expression [GO:0010467]; mRNA catabolic process [GO:0006402]; negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; positive regulation of cold-induced thermogenesis [GO:0120162]; regulation of DNA-templated transcription [GO:0006355]; regulation of stem cell population maintenance [GO:2000036]; regulation of translation [GO:0006417]; regulatory ncRNA-mediated gene silencing [GO:0031047]; trophectodermal cell differentiation [GO:0001829] CCR4-NOT complex [GO:0030014]; CCR4-NOT core complex [GO:0030015]; cytosol [GO:0005829]; nucleus [GO:0005634]; P-body [GO:0000932] g16574.t2 Q8K0V4 75.0 244 1.01e-116 374.0 sp|Q8K0V4|CNOT3_MOUSE CCR4-NOT transcription complex subunit 3 OS=Mus musculus OX=10090 GN=Cnot3 PE=1 SV=1 CNOT3_MOUSE reviewed CCR4-NOT transcription complex subunit 3 (CCR4-associated factor 3) Mus musculus (Mouse) GO:0000289; GO:0000932; GO:0001829; GO:0005634; GO:0005829; GO:0006355; GO:0006402; GO:0006417; GO:0007368; GO:0010467; GO:0030014; GO:0030015; GO:0031047; GO:0033147; GO:0120162; GO:2000036 determination of left/right symmetry [GO:0007368]; gene expression [GO:0010467]; mRNA catabolic process [GO:0006402]; negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; positive regulation of cold-induced thermogenesis [GO:0120162]; regulation of DNA-templated transcription [GO:0006355]; regulation of stem cell population maintenance [GO:2000036]; regulation of translation [GO:0006417]; regulatory ncRNA-mediated gene silencing [GO:0031047]; trophectodermal cell differentiation [GO:0001829] CCR4-NOT complex [GO:0030014]; CCR4-NOT core complex [GO:0030015]; cytosol [GO:0005829]; nucleus [GO:0005634]; P-body [GO:0000932] g16574.t2 Q8K0V4 79.394 165 5.1699999999999996e-89 301.0 sp|Q8K0V4|CNOT3_MOUSE CCR4-NOT transcription complex subunit 3 OS=Mus musculus OX=10090 GN=Cnot3 PE=1 SV=1 CNOT3_MOUSE reviewed CCR4-NOT transcription complex subunit 3 (CCR4-associated factor 3) Mus musculus (Mouse) GO:0000289; GO:0000932; GO:0001829; GO:0005634; GO:0005829; GO:0006355; GO:0006402; GO:0006417; GO:0007368; GO:0010467; GO:0030014; GO:0030015; GO:0031047; GO:0033147; GO:0120162; GO:2000036 determination of left/right symmetry [GO:0007368]; gene expression [GO:0010467]; mRNA catabolic process [GO:0006402]; negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; positive regulation of cold-induced thermogenesis [GO:0120162]; regulation of DNA-templated transcription [GO:0006355]; regulation of stem cell population maintenance [GO:2000036]; regulation of translation [GO:0006417]; regulatory ncRNA-mediated gene silencing [GO:0031047]; trophectodermal cell differentiation [GO:0001829] CCR4-NOT complex [GO:0030014]; CCR4-NOT core complex [GO:0030015]; cytosol [GO:0005829]; nucleus [GO:0005634]; P-body [GO:0000932] g16574.t3 Q8K0V4 75.0 244 2.18e-116 374.0 sp|Q8K0V4|CNOT3_MOUSE CCR4-NOT transcription complex subunit 3 OS=Mus musculus OX=10090 GN=Cnot3 PE=1 SV=1 CNOT3_MOUSE reviewed CCR4-NOT transcription complex subunit 3 (CCR4-associated factor 3) Mus musculus (Mouse) GO:0000289; GO:0000932; GO:0001829; GO:0005634; GO:0005829; GO:0006355; GO:0006402; GO:0006417; GO:0007368; GO:0010467; GO:0030014; GO:0030015; GO:0031047; GO:0033147; GO:0120162; GO:2000036 determination of left/right symmetry [GO:0007368]; gene expression [GO:0010467]; mRNA catabolic process [GO:0006402]; negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; positive regulation of cold-induced thermogenesis [GO:0120162]; regulation of DNA-templated transcription [GO:0006355]; regulation of stem cell population maintenance [GO:2000036]; regulation of translation [GO:0006417]; regulatory ncRNA-mediated gene silencing [GO:0031047]; trophectodermal cell differentiation [GO:0001829] CCR4-NOT complex [GO:0030014]; CCR4-NOT core complex [GO:0030015]; cytosol [GO:0005829]; nucleus [GO:0005634]; P-body [GO:0000932] g16574.t3 Q8K0V4 79.394 165 9.26e-89 300.0 sp|Q8K0V4|CNOT3_MOUSE CCR4-NOT transcription complex subunit 3 OS=Mus musculus OX=10090 GN=Cnot3 PE=1 SV=1 CNOT3_MOUSE reviewed CCR4-NOT transcription complex subunit 3 (CCR4-associated factor 3) Mus musculus (Mouse) GO:0000289; GO:0000932; GO:0001829; GO:0005634; GO:0005829; GO:0006355; GO:0006402; GO:0006417; GO:0007368; GO:0010467; GO:0030014; GO:0030015; GO:0031047; GO:0033147; GO:0120162; GO:2000036 determination of left/right symmetry [GO:0007368]; gene expression [GO:0010467]; mRNA catabolic process [GO:0006402]; negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; positive regulation of cold-induced thermogenesis [GO:0120162]; regulation of DNA-templated transcription [GO:0006355]; regulation of stem cell population maintenance [GO:2000036]; regulation of translation [GO:0006417]; regulatory ncRNA-mediated gene silencing [GO:0031047]; trophectodermal cell differentiation [GO:0001829] CCR4-NOT complex [GO:0030014]; CCR4-NOT core complex [GO:0030015]; cytosol [GO:0005829]; nucleus [GO:0005634]; P-body [GO:0000932] g16574.t4 Q8K0V4 75.0 244 1.34e-116 374.0 sp|Q8K0V4|CNOT3_MOUSE CCR4-NOT transcription complex subunit 3 OS=Mus musculus OX=10090 GN=Cnot3 PE=1 SV=1 CNOT3_MOUSE reviewed CCR4-NOT transcription complex subunit 3 (CCR4-associated factor 3) Mus musculus (Mouse) GO:0000289; GO:0000932; GO:0001829; GO:0005634; GO:0005829; GO:0006355; GO:0006402; GO:0006417; GO:0007368; GO:0010467; GO:0030014; GO:0030015; GO:0031047; GO:0033147; GO:0120162; GO:2000036 determination of left/right symmetry [GO:0007368]; gene expression [GO:0010467]; mRNA catabolic process [GO:0006402]; negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; positive regulation of cold-induced thermogenesis [GO:0120162]; regulation of DNA-templated transcription [GO:0006355]; regulation of stem cell population maintenance [GO:2000036]; regulation of translation [GO:0006417]; regulatory ncRNA-mediated gene silencing [GO:0031047]; trophectodermal cell differentiation [GO:0001829] CCR4-NOT complex [GO:0030014]; CCR4-NOT core complex [GO:0030015]; cytosol [GO:0005829]; nucleus [GO:0005634]; P-body [GO:0000932] g16574.t4 Q8K0V4 79.394 165 5e-89 300.0 sp|Q8K0V4|CNOT3_MOUSE CCR4-NOT transcription complex subunit 3 OS=Mus musculus OX=10090 GN=Cnot3 PE=1 SV=1 CNOT3_MOUSE reviewed CCR4-NOT transcription complex subunit 3 (CCR4-associated factor 3) Mus musculus (Mouse) GO:0000289; GO:0000932; GO:0001829; GO:0005634; GO:0005829; GO:0006355; GO:0006402; GO:0006417; GO:0007368; GO:0010467; GO:0030014; GO:0030015; GO:0031047; GO:0033147; GO:0120162; GO:2000036 determination of left/right symmetry [GO:0007368]; gene expression [GO:0010467]; mRNA catabolic process [GO:0006402]; negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; positive regulation of cold-induced thermogenesis [GO:0120162]; regulation of DNA-templated transcription [GO:0006355]; regulation of stem cell population maintenance [GO:2000036]; regulation of translation [GO:0006417]; regulatory ncRNA-mediated gene silencing [GO:0031047]; trophectodermal cell differentiation [GO:0001829] CCR4-NOT complex [GO:0030014]; CCR4-NOT core complex [GO:0030015]; cytosol [GO:0005829]; nucleus [GO:0005634]; P-body [GO:0000932] g16575.t1 Q60414 30.547 311 5.38e-33 130.0 sp|Q60414|NTCP2_CRIGR Ileal sodium/bile acid cotransporter OS=Cricetulus griseus OX=10029 GN=SLC10A2 PE=1 SV=1 g16577.t1 F8J2D3 48.752 521 4.5700000000000005e-166 485.0 sp|F8J2D3|PLB_DRYCN Phospholipase-B 81 OS=Drysdalia coronoides OX=66186 PE=1 SV=1 g16580.t1 Q5ZIE8 52.427 103 5.49e-28 114.0 sp|Q5ZIE8|MCAF1_CHICK Activating transcription factor 7-interacting protein 1 OS=Gallus gallus OX=9031 GN=ATF7IP PE=2 SV=1 g16584.t1 B1AK53 36.0 250 3.13e-25 114.0 sp|B1AK53|ESPN_HUMAN Espin OS=Homo sapiens OX=9606 GN=ESPN PE=1 SV=1 ESPN_HUMAN reviewed Espin (Autosomal recessive deafness type 36 protein) (Ectoplasmic specialization protein) Homo sapiens (Human) GO:0005737; GO:0005902; GO:0005903; GO:0007605; GO:0017124; GO:0030034; GO:0031941; GO:0032420; GO:0032426; GO:0051015; GO:0051017 actin filament bundle assembly [GO:0051017]; microvillar actin bundle assembly [GO:0030034]; sensory perception of sound [GO:0007605] brush border [GO:0005903]; cytoplasm [GO:0005737]; filamentous actin [GO:0031941]; microvillus [GO:0005902]; stereocilium [GO:0032420]; stereocilium tip [GO:0032426] actin filament binding [GO:0051015]; SH3 domain binding [GO:0017124] g16585.t1 P0C1H5 91.111 90 5.63e-58 178.0 sp|P0C1H5|H2B7_CHICK Histone H2B 7 OS=Gallus gallus OX=9031 GN=H2B-VII PE=1 SV=2 H2B7_CHICK reviewed Histone H2B 7 (H2B VII) Gallus gallus (Chicken) GO:0000786; GO:0003677; GO:0005634; GO:0030527; GO:0044877; GO:0046982 nucleosome [GO:0000786]; nucleus [GO:0005634] DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; protein-containing complex binding [GO:0044877]; structural constituent of chromatin [GO:0030527] g16586.t1 P58873 38.095 147 1.15e-22 97.8 sp|P58873|RHBL3_MOUSE Rhomboid-related protein 3 OS=Mus musculus OX=10090 GN=Rhbdl3 PE=2 SV=1 g16586.t2 P58872 38.814 371 4.9099999999999995e-82 261.0 sp|P58872|RHBL3_HUMAN Rhomboid-related protein 3 OS=Homo sapiens OX=9606 GN=RHBDL3 PE=1 SV=1 g16592.t1 P29506 73.333 75 4.64e-32 121.0 sp|P29506|UNC4_CAEEL Homeobox protein unc-4 OS=Caenorhabditis elegans OX=6239 GN=unc-4 PE=1 SV=2 UNC4_CAEEL reviewed Homeobox protein unc-4 (Homeobox protein ceh-4) (Uncoordinated protein 4) Caenorhabditis elegans GO:0000122; GO:0000977; GO:0000981; GO:0001708; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0007400; GO:0007416; GO:0008039; GO:0030424; GO:0040011; GO:0048489; GO:0048666; GO:0050770; GO:0050803; GO:0050807; GO:0090090 cell fate specification [GO:0001708]; locomotion [GO:0040011]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuroblast fate determination [GO:0007400]; neuron development [GO:0048666]; regulation of axonogenesis [GO:0050770]; regulation of DNA-templated transcription [GO:0006355]; regulation of synapse organization [GO:0050807]; regulation of synapse structure or activity [GO:0050803]; regulation of transcription by RNA polymerase II [GO:0006357]; synapse assembly [GO:0007416]; synaptic target recognition [GO:0008039]; synaptic vesicle transport [GO:0048489] axon [GO:0030424]; nucleus [GO:0005634] DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977] g16594.t1 O08934 85.0 80 7.01e-41 155.0 sp|O08934|UNC4_MOUSE Homeobox protein unc-4 homolog OS=Mus musculus OX=10090 GN=Uncx PE=2 SV=2 UNC4_MOUSE reviewed Homeobox protein unc-4 homolog (Homeobox protein Uncx4.1) Mus musculus (Mouse) GO:0000981; GO:0001502; GO:0005634; GO:0007389; GO:0010468; GO:0021516; GO:0021889; GO:0035726; GO:0045595; GO:1990837 cartilage condensation [GO:0001502]; common myeloid progenitor cell proliferation [GO:0035726]; dorsal spinal cord development [GO:0021516]; olfactory bulb interneuron differentiation [GO:0021889]; pattern specification process [GO:0007389]; regulation of cell differentiation [GO:0045595]; regulation of gene expression [GO:0010468] nucleus [GO:0005634] DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific double-stranded DNA binding [GO:1990837] g16597.t1 P21265 72.822 482 0.0 762.0 sp|P21265|PUR8_CHICK Adenylosuccinate lyase OS=Gallus gallus OX=9031 GN=ADSL PE=2 SV=2 g16598.t1 Q949P2 48.286 700 0.0 633.0 sp|Q949P2|COPDA_ARATH Probable cytosolic oligopeptidase A OS=Arabidopsis thaliana OX=3702 GN=CYOP PE=1 SV=1 COPDA_ARATH reviewed Probable cytosolic oligopeptidase A (EC 3.4.24.70) (Thimet metalloendopeptidase 2) (Zincin-like metalloproteases family protein 2) Arabidopsis thaliana (Mouse-ear cress) GO:0004222; GO:0005829; GO:0005886; GO:0006508; GO:0006518; GO:0046872; GO:0048046 peptide metabolic process [GO:0006518]; proteolysis [GO:0006508] apoplast [GO:0048046]; cytosol [GO:0005829]; plasma membrane [GO:0005886] metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222] g16601.t1 E7FC72 41.342 745 0.0 545.0 sp|E7FC72|EXOC7_DANRE Exocyst complex component 7 OS=Danio rerio OX=7955 GN=exoc7 PE=3 SV=2 g16601.t2 E7FC72 42.483 725 0.0 556.0 sp|E7FC72|EXOC7_DANRE Exocyst complex component 7 OS=Danio rerio OX=7955 GN=exoc7 PE=3 SV=2 g16602.t1 Q14344 60.556 360 2.4000000000000002e-160 457.0 sp|Q14344|GNA13_HUMAN Guanine nucleotide-binding protein subunit alpha-13 OS=Homo sapiens OX=9606 GN=GNA13 PE=1 SV=2 g16603.t1 Q1LZ96 61.29 248 2.8100000000000003e-109 321.0 sp|Q1LZ96|ATPF2_BOVIN ATP synthase mitochondrial F1 complex assembly factor 2 OS=Bos taurus OX=9913 GN=ATPAF2 PE=2 SV=1 g16604.t1 Q9CPY6 78.5 200 1.3e-118 338.0 sp|Q9CPY6|GID4_MOUSE Glucose-induced degradation protein 4 homolog OS=Mus musculus OX=10090 GN=Gid4 PE=1 SV=1 g16608.t1 Q9XUE6 56.223 233 1.52e-94 280.0 sp|Q9XUE6|PMM_CAEEL Probable phosphomannomutase OS=Caenorhabditis elegans OX=6239 GN=F52B11.2 PE=3 SV=2 g16609.t1 Q63430 47.115 104 4.2400000000000005e-21 86.3 sp|Q63430|CSDC2_RAT Cold shock domain-containing protein C2 OS=Rattus norvegicus OX=10116 GN=Csdc2 PE=1 SV=3 g16611.t1 P30937 41.155 277 1.1e-60 204.0 sp|P30937|SSR4_RAT Somatostatin receptor type 4 OS=Rattus norvegicus OX=10116 GN=Sstr4 PE=1 SV=1 SSR4_RAT reviewed Somatostatin receptor type 4 (SS-4-R) (SS4-R) (SS4R) Rattus norvegicus (Rat) GO:0004994; GO:0005886; GO:0007218; GO:0016477; GO:0030900; GO:0042923; GO:0043005; GO:0070374; GO:0071385; GO:0090238; GO:0106072 cell migration [GO:0016477]; cellular response to glucocorticoid stimulus [GO:0071385]; forebrain development [GO:0030900]; negative regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0106072]; neuropeptide signaling pathway [GO:0007218]; positive regulation of arachidonate secretion [GO:0090238]; positive regulation of ERK1 and ERK2 cascade [GO:0070374] neuron projection [GO:0043005]; plasma membrane [GO:0005886] neuropeptide binding [GO:0042923]; somatostatin receptor activity [GO:0004994] g16612.t1 Q5ZHY5 59.286 280 2.26e-117 342.0 sp|Q5ZHY5|CHIP_CHICK E3 ubiquitin-protein ligase CHIP OS=Gallus gallus OX=9031 GN=STUB1 PE=2 SV=1 CHIP_CHICK reviewed E3 ubiquitin-protein ligase CHIP (EC 2.3.2.27) (RING-type E3 ubiquitin transferase CHIP) (STIP1 homology and U box-containing protein 1) Gallus gallus (Chicken) GO:0000209; GO:0004842; GO:0005634; GO:0005737; GO:0005739; GO:0006281; GO:0006511; GO:0006515; GO:0007165; GO:0030018; GO:0034450; GO:0042803; GO:0043161; GO:0045862; GO:0051087; GO:0061630; GO:0071218 cellular response to misfolded protein [GO:0071218]; DNA repair [GO:0006281]; positive regulation of proteolysis [GO:0045862]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; signal transduction [GO:0007165]; ubiquitin-dependent protein catabolic process [GO:0006511] cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; Z disc [GO:0030018] protein homodimerization activity [GO:0042803]; protein-folding chaperone binding [GO:0051087]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; ubiquitin-ubiquitin ligase activity [GO:0034450] g16613.t1 O05218 33.465 505 6.8e-75 250.0 sp|O05218|YWRD_BACSU Glutathione hydrolase-like YwrD proenzyme OS=Bacillus subtilis (strain 168) OX=224308 GN=ywrD PE=1 SV=1 g16614.t1 Q5MJ12 65.365 384 2.0099999999999998e-180 518.0 sp|Q5MJ12|FXL16_RAT F-box/LRR-repeat protein 16 OS=Rattus norvegicus OX=10116 GN=Fbxl16 PE=2 SV=1 g16620.t1 Q9Y535 73.786 206 2.32e-111 320.0 sp|Q9Y535|RPC8_HUMAN DNA-directed RNA polymerase III subunit RPC8 OS=Homo sapiens OX=9606 GN=POLR3H PE=1 SV=1 RPC8_HUMAN reviewed DNA-directed RNA polymerase III subunit RPC8 (RNA polymerase III subunit C8) (DNA-directed RNA polymerase III subunit H) (RNA polymerase III subunit 22.9 kDa subunit) (RPC22.9) Homo sapiens (Human) GO:0003677; GO:0003899; GO:0005654; GO:0005666; GO:0005813; GO:0005829; GO:0006139; GO:0006383; GO:0006384; GO:0045087; GO:0051607 defense response to virus [GO:0051607]; innate immune response [GO:0045087]; nucleobase-containing compound metabolic process [GO:0006139]; transcription by RNA polymerase III [GO:0006383]; transcription initiation at RNA polymerase III promoter [GO:0006384] centrosome [GO:0005813]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; RNA polymerase III complex [GO:0005666] DNA binding [GO:0003677]; DNA-directed RNA polymerase activity [GO:0003899] g16625.t1 Q9C0B0 53.905 525 1.7200000000000002e-166 504.0 sp|Q9C0B0|UNK_HUMAN RING finger protein unkempt homolog OS=Homo sapiens OX=9606 GN=UNK PE=1 SV=2 UNK_HUMAN reviewed RING finger protein unkempt homolog (Zinc finger CCCH domain-containing protein 5) Homo sapiens (Human) GO:0001701; GO:0001764; GO:0003723; GO:0005737; GO:0008270; GO:0043022; GO:0048667; GO:1990715; GO:2000766 cell morphogenesis involved in neuron differentiation [GO:0048667]; in utero embryonic development [GO:0001701]; negative regulation of cytoplasmic translation [GO:2000766]; neuron migration [GO:0001764] cytoplasm [GO:0005737] mRNA CDS binding [GO:1990715]; ribosome binding [GO:0043022]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270] g16625.t1 Q9C0B0 34.463 177 8.3e-21 101.0 sp|Q9C0B0|UNK_HUMAN RING finger protein unkempt homolog OS=Homo sapiens OX=9606 GN=UNK PE=1 SV=2 UNK_HUMAN reviewed RING finger protein unkempt homolog (Zinc finger CCCH domain-containing protein 5) Homo sapiens (Human) GO:0001701; GO:0001764; GO:0003723; GO:0005737; GO:0008270; GO:0043022; GO:0048667; GO:1990715; GO:2000766 cell morphogenesis involved in neuron differentiation [GO:0048667]; in utero embryonic development [GO:0001701]; negative regulation of cytoplasmic translation [GO:2000766]; neuron migration [GO:0001764] cytoplasm [GO:0005737] mRNA CDS binding [GO:1990715]; ribosome binding [GO:0043022]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270] g16625.t2 Q9C0B0 52.82 532 5.74e-163 495.0 sp|Q9C0B0|UNK_HUMAN RING finger protein unkempt homolog OS=Homo sapiens OX=9606 GN=UNK PE=1 SV=2 UNK_HUMAN reviewed RING finger protein unkempt homolog (Zinc finger CCCH domain-containing protein 5) Homo sapiens (Human) GO:0001701; GO:0001764; GO:0003723; GO:0005737; GO:0008270; GO:0043022; GO:0048667; GO:1990715; GO:2000766 cell morphogenesis involved in neuron differentiation [GO:0048667]; in utero embryonic development [GO:0001701]; negative regulation of cytoplasmic translation [GO:2000766]; neuron migration [GO:0001764] cytoplasm [GO:0005737] mRNA CDS binding [GO:1990715]; ribosome binding [GO:0043022]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270] g16625.t2 Q9C0B0 34.463 177 7.44e-21 102.0 sp|Q9C0B0|UNK_HUMAN RING finger protein unkempt homolog OS=Homo sapiens OX=9606 GN=UNK PE=1 SV=2 UNK_HUMAN reviewed RING finger protein unkempt homolog (Zinc finger CCCH domain-containing protein 5) Homo sapiens (Human) GO:0001701; GO:0001764; GO:0003723; GO:0005737; GO:0008270; GO:0043022; GO:0048667; GO:1990715; GO:2000766 cell morphogenesis involved in neuron differentiation [GO:0048667]; in utero embryonic development [GO:0001701]; negative regulation of cytoplasmic translation [GO:2000766]; neuron migration [GO:0001764] cytoplasm [GO:0005737] mRNA CDS binding [GO:1990715]; ribosome binding [GO:0043022]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270] g16625.t3 Q9C0B0 53.626 524 5.540000000000001e-166 503.0 sp|Q9C0B0|UNK_HUMAN RING finger protein unkempt homolog OS=Homo sapiens OX=9606 GN=UNK PE=1 SV=2 UNK_HUMAN reviewed RING finger protein unkempt homolog (Zinc finger CCCH domain-containing protein 5) Homo sapiens (Human) GO:0001701; GO:0001764; GO:0003723; GO:0005737; GO:0008270; GO:0043022; GO:0048667; GO:1990715; GO:2000766 cell morphogenesis involved in neuron differentiation [GO:0048667]; in utero embryonic development [GO:0001701]; negative regulation of cytoplasmic translation [GO:2000766]; neuron migration [GO:0001764] cytoplasm [GO:0005737] mRNA CDS binding [GO:1990715]; ribosome binding [GO:0043022]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270] g16625.t3 Q9C0B0 34.463 177 8.28e-21 101.0 sp|Q9C0B0|UNK_HUMAN RING finger protein unkempt homolog OS=Homo sapiens OX=9606 GN=UNK PE=1 SV=2 UNK_HUMAN reviewed RING finger protein unkempt homolog (Zinc finger CCCH domain-containing protein 5) Homo sapiens (Human) GO:0001701; GO:0001764; GO:0003723; GO:0005737; GO:0008270; GO:0043022; GO:0048667; GO:1990715; GO:2000766 cell morphogenesis involved in neuron differentiation [GO:0048667]; in utero embryonic development [GO:0001701]; negative regulation of cytoplasmic translation [GO:2000766]; neuron migration [GO:0001764] cytoplasm [GO:0005737] mRNA CDS binding [GO:1990715]; ribosome binding [GO:0043022]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270] g16626.t1 B5DF45 31.95 482 2.72e-63 216.0 sp|B5DF45|TRAF6_RAT TNF receptor-associated factor 6 OS=Rattus norvegicus OX=10116 GN=Traf6 PE=2 SV=1 TRAF6_RAT reviewed TNF receptor-associated factor 6 (EC 2.3.2.27) (E3 ubiquitin-protein ligase TRAF6) (RING-type E3 ubiquitin transferase TRAF6) Rattus norvegicus (Rat) GO:0000045; GO:0000122; GO:0000209; GO:0001503; GO:0001701; GO:0001843; GO:0002637; GO:0002726; GO:0002753; GO:0002931; GO:0004842; GO:0005164; GO:0005634; GO:0005737; GO:0005811; GO:0005829; GO:0005886; GO:0005938; GO:0006955; GO:0006974; GO:0007165; GO:0007249; GO:0007254; GO:0007416; GO:0008270; GO:0009299; GO:0009887; GO:0009898; GO:0016567; GO:0019221; GO:0019886; GO:0023035; GO:0030316; GO:0030674; GO:0031624; GO:0031663; GO:0031666; GO:0032481; GO:0032735; GO:0032743; GO:0032755; GO:0032991; GO:0033209; GO:0034142; GO:0034450; GO:0035591; GO:0035631; GO:0038061; GO:0038172; GO:0038173; GO:0042088; GO:0042102; GO:0042475; GO:0042742; GO:0042802; GO:0042826; GO:0042981; GO:0043011; GO:0043122; GO:0043123; GO:0043124; GO:0043422; GO:0045087; GO:0045453; GO:0045672; GO:0045892; GO:0045944; GO:0046330; GO:0046849; GO:0048468; GO:0048471; GO:0048661; GO:0050852; GO:0051092; GO:0051865; GO:0061630; GO:0070301; GO:0070498; GO:0070534; GO:0070555; GO:0070936; GO:0071222; GO:0071345; GO:0097400; GO:0098696; GO:0098794; GO:0098978; GO:0140252; GO:0140374; GO:0141198; GO:1904385; GO:1904996 animal organ morphogenesis [GO:0009887]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; antiviral innate immune response [GO:0140374]; autophagosome assembly [GO:0000045]; bone remodeling [GO:0046849]; bone resorption [GO:0045453]; canonical NF-kappaB signal transduction [GO:0007249]; CD40 signaling pathway [GO:0023035]; cell development [GO:0048468]; cellular response to angiotensin [GO:1904385]; cellular response to cytokine stimulus [GO:0071345]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to lipopolysaccharide [GO:0071222]; cytokine-mediated signaling pathway [GO:0019221]; cytoplasmic pattern recognition receptor signaling pathway [GO:0002753]; defense response to bacterium [GO:0042742]; DNA damage response [GO:0006974]; immune response [GO:0006955]; in utero embryonic development [GO:0001701]; innate immune response [GO:0045087]; interleukin-1-mediated signaling pathway [GO:0070498]; interleukin-17-mediated signaling pathway [GO:0097400]; interleukin-17A-mediated signaling pathway [GO:0038173]; interleukin-33-mediated signaling pathway [GO:0038172]; JNK cascade [GO:0007254]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; mRNA transcription [GO:0009299]; myeloid dendritic cell differentiation [GO:0043011]; negative regulation of canonical NF-kappaB signal transduction [GO:0043124]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural tube closure [GO:0001843]; non-canonical NF-kappaB signal transduction [GO:0038061]; odontogenesis of dentin-containing tooth [GO:0042475]; ossification [GO:0001503]; osteoclast differentiation [GO:0030316]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of JNK cascade [GO:0046330]; positive regulation of leukocyte adhesion to vascular endothelial cell [GO:1904996]; positive regulation of lipopolysaccharide-mediated signaling pathway [GO:0031666]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of T cell cytokine production [GO:0002726]; positive regulation of T cell proliferation [GO:0042102]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of type I interferon production [GO:0032481]; protein autoubiquitination [GO:0051865]; protein branched polyubiquitination [GO:0141198]; protein K48-linked ubiquitination [GO:0070936]; protein K63-linked ubiquitination [GO:0070534]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of apoptotic process [GO:0042981]; regulation of canonical NF-kappaB signal transduction [GO:0043122]; regulation of immunoglobulin production [GO:0002637]; regulation of neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0098696]; regulation protein catabolic process at postsynapse [GO:0140252]; response to interleukin-1 [GO:0070555]; response to ischemia [GO:0002931]; signal transduction [GO:0007165]; synapse assembly [GO:0007416]; T cell receptor signaling pathway [GO:0050852]; T-helper 1 type immune response [GO:0042088]; toll-like receptor 4 signaling pathway [GO:0034142]; tumor necrosis factor-mediated signaling pathway [GO:0033209] CD40 receptor complex [GO:0035631]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; lipid droplet [GO:0005811]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; protein-containing complex [GO:0032991] histone deacetylase binding [GO:0042826]; identical protein binding [GO:0042802]; protein kinase B binding [GO:0043422]; protein-macromolecule adaptor activity [GO:0030674]; signaling adaptor activity [GO:0035591]; tumor necrosis factor receptor binding [GO:0005164]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; ubiquitin-ubiquitin ligase activity [GO:0034450]; zinc ion binding [GO:0008270] g16629.t1 Q13472 64.847 751 0.0 1028.0 sp|Q13472|TOP3A_HUMAN DNA topoisomerase 3-alpha OS=Homo sapiens OX=9606 GN=TOP3A PE=1 SV=1 g16629.t2 Q13472 64.847 751 0.0 1028.0 sp|Q13472|TOP3A_HUMAN DNA topoisomerase 3-alpha OS=Homo sapiens OX=9606 GN=TOP3A PE=1 SV=1 g16630.t1 B9EKI3 43.919 740 5.58e-163 515.0 sp|B9EKI3|TMF1_MOUSE TATA element modulatory factor OS=Mus musculus OX=10090 GN=Tmf1 PE=1 SV=2 TMF1_MOUSE reviewed TATA element modulatory factor (TMF) (Androgen receptor coactivator 160 kDa protein) (Androgen receptor-associated protein of 160 kDa) Mus musculus (Mouse) GO:0000139; GO:0001675; GO:0001819; GO:0003677; GO:0003713; GO:0005634; GO:0005783; GO:0005794; GO:0007286; GO:0007289; GO:0008584; GO:0010629; GO:0030317; GO:0030521; GO:0032275; GO:0033327; GO:0042742; GO:0043066; GO:0045944; GO:0050681; GO:0061136; GO:2000845 acrosome assembly [GO:0001675]; androgen receptor signaling pathway [GO:0030521]; defense response to bacterium [GO:0042742]; flagellated sperm motility [GO:0030317]; Leydig cell differentiation [GO:0033327]; luteinizing hormone secretion [GO:0032275]; male gonad development [GO:0008584]; negative regulation of apoptotic process [GO:0043066]; negative regulation of gene expression [GO:0010629]; positive regulation of cytokine production [GO:0001819]; positive regulation of testosterone secretion [GO:2000845]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of proteasomal protein catabolic process [GO:0061136]; spermatid development [GO:0007286]; spermatid nucleus differentiation [GO:0007289] endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; nucleus [GO:0005634] DNA binding [GO:0003677]; nuclear androgen receptor binding [GO:0050681]; transcription coactivator activity [GO:0003713] g16631.t1 P13620 50.323 155 1.18e-44 147.0 sp|P13620|ATP5H_BOVIN ATP synthase peripheral stalk subunit d, mitochondrial OS=Bos taurus OX=9913 GN=ATP5PD PE=1 SV=2 g16632.t1 C3Z724 72.487 189 2.12e-101 295.0 sp|C3Z724|UBE2S_BRAFL Ubiquitin-conjugating enzyme E2 S OS=Branchiostoma floridae OX=7739 GN=BRAFLDRAFT_259979 PE=3 SV=1 UBE2S_BRAFL reviewed Ubiquitin-conjugating enzyme E2 S (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme S) (Ubiquitin carrier protein S) (Ubiquitin-protein ligase S) Branchiostoma floridae (Florida lancelet) (Amphioxus) GO:0000209; GO:0005524; GO:0005634; GO:0005680; GO:0006511; GO:0010458; GO:0010994; GO:0031145; GO:0051301; GO:0061631; GO:0070979; GO:1904668 anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell division [GO:0051301]; exit from mitosis [GO:0010458]; free ubiquitin chain polymerization [GO:0010994]; positive regulation of ubiquitin protein ligase activity [GO:1904668]; protein K11-linked ubiquitination [GO:0070979]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511] anaphase-promoting complex [GO:0005680]; nucleus [GO:0005634] ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631] g16633.t1 Q9ULH7 44.91 167 2.1900000000000002e-29 130.0 sp|Q9ULH7|MRTFB_HUMAN Myocardin-related transcription factor B OS=Homo sapiens OX=9606 GN=MRTFB PE=1 SV=3 MRTFB_HUMAN reviewed Myocardin-related transcription factor B (MRTF-B) (MKL/myocardin-like protein 2) (Megakaryoblastic leukemia 2) Homo sapiens (Human) GO:0003713; GO:0005634; GO:0005737; GO:0007517; GO:0045296; GO:0045844; GO:0045944; GO:0051145; GO:0098793; GO:0098794; GO:0098978; GO:0099159; GO:1902895 muscle organ development [GO:0007517]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of striated muscle tissue development [GO:0045844]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of modification of postsynaptic structure [GO:0099159]; smooth muscle cell differentiation [GO:0051145] cytoplasm [GO:0005737]; glutamatergic synapse [GO:0098978]; nucleus [GO:0005634]; postsynapse [GO:0098794]; presynapse [GO:0098793] cadherin binding [GO:0045296]; transcription coactivator activity [GO:0003713] g16635.t1 Q5R9G1 57.339 218 4.9e-81 251.0 sp|Q5R9G1|DCNL3_PONAB DCN1-like protein 3 OS=Pongo abelii OX=9601 GN=DCUN1D3 PE=2 SV=1 DCNL3_PONAB reviewed DCN1-like protein 3 (DCNL3) (DCUN1 domain-containing protein 3) (Defective in cullin neddylation protein 1-like protein 3) Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0000151; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0010225; GO:0010332; GO:0010564; GO:0030308; GO:0031624; GO:0032182; GO:0043065; GO:0045116; GO:0048471; GO:0097602; GO:2000134; GO:2000434; GO:2000435; GO:2000436 negative regulation of cell growth [GO:0030308]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of protein neddylation [GO:2000435]; positive regulation of apoptotic process [GO:0043065]; positive regulation of protein neddylation [GO:2000436]; protein neddylation [GO:0045116]; regulation of cell cycle process [GO:0010564]; regulation of protein neddylation [GO:2000434]; response to gamma radiation [GO:0010332]; response to UV-C [GO:0010225] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; ubiquitin ligase complex [GO:0000151] cullin family protein binding [GO:0097602]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin-like protein binding [GO:0032182] g16636.t1 Q2TA38 52.899 414 1.86e-145 426.0 sp|Q2TA38|TEKT4_BOVIN Tektin-4 OS=Bos taurus OX=9913 GN=TEKT4 PE=1 SV=1 TEKT4_BOVIN reviewed Tektin-4 Bos taurus (Bovine) GO:0005879; GO:0015630; GO:0030317; GO:0036126; GO:0060271; GO:0060294; GO:0060378; GO:0097225; GO:0097228; GO:0160111 cilium assembly [GO:0060271]; cilium movement involved in cell motility [GO:0060294]; flagellated sperm motility [GO:0030317]; regulation of brood size [GO:0060378] axonemal A tubule inner sheath [GO:0160111]; axonemal microtubule [GO:0005879]; microtubule cytoskeleton [GO:0015630]; sperm flagellum [GO:0036126]; sperm midpiece [GO:0097225]; sperm principal piece [GO:0097228] g16637.t1 Q9DCS9 44.755 143 1.38e-32 116.0 sp|Q9DCS9|NDUBA_MOUSE NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 10 OS=Mus musculus OX=10090 GN=Ndufb10 PE=1 SV=3 g16638.t1 P27659 87.013 77 3.5699999999999996e-42 144.0 sp|P27659|RL3_MOUSE Large ribosomal subunit protein uL3 OS=Mus musculus OX=10090 GN=Rpl3 PE=1 SV=3 RL3_MOUSE reviewed Large ribosomal subunit protein uL3 (60S ribosomal protein L3) (J1 protein) Mus musculus (Mouse) GO:0002181; GO:0003723; GO:0003735; GO:0005730; GO:0005737; GO:0005829; GO:0005840; GO:0006412; GO:0008097; GO:0022625; GO:0022626; GO:0032991; GO:0045202; GO:0071353 cellular response to interleukin-4 [GO:0071353]; cytoplasmic translation [GO:0002181]; translation [GO:0006412] cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; nucleolus [GO:0005730]; protein-containing complex [GO:0032991]; ribosome [GO:0005840]; synapse [GO:0045202] 5S rRNA binding [GO:0008097]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735] g16639.t1 P27659 75.41 305 9.58e-162 459.0 sp|P27659|RL3_MOUSE Large ribosomal subunit protein uL3 OS=Mus musculus OX=10090 GN=Rpl3 PE=1 SV=3 RL3_MOUSE reviewed Large ribosomal subunit protein uL3 (60S ribosomal protein L3) (J1 protein) Mus musculus (Mouse) GO:0002181; GO:0003723; GO:0003735; GO:0005730; GO:0005737; GO:0005829; GO:0005840; GO:0006412; GO:0008097; GO:0022625; GO:0022626; GO:0032991; GO:0045202; GO:0071353 cellular response to interleukin-4 [GO:0071353]; cytoplasmic translation [GO:0002181]; translation [GO:0006412] cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; nucleolus [GO:0005730]; protein-containing complex [GO:0032991]; ribosome [GO:0005840]; synapse [GO:0045202] 5S rRNA binding [GO:0008097]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735] g16641.t1 Q58EA2 51.852 216 2.2099999999999997e-54 179.0 sp|Q58EA2|THO4A_XENLA THO complex subunit 4-A OS=Xenopus laevis OX=8355 GN=alyref-a PE=2 SV=1 g16642.t1 Q4R4J0 53.297 182 2.1700000000000002e-64 200.0 sp|Q4R4J0|GDIR1_MACFA Rho GDP-dissociation inhibitor 1 OS=Macaca fascicularis OX=9541 GN=ARHGDIA PE=2 SV=1 GDIR1_MACFA reviewed Rho GDP-dissociation inhibitor 1 (Rho GDI 1) (Rho-GDI alpha) Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey) GO:0005094; GO:0005096; GO:0005829; GO:0007266; GO:0016020; GO:0071526 Rho protein signal transduction [GO:0007266]; semaphorin-plexin signaling pathway [GO:0071526] cytosol [GO:0005829]; membrane [GO:0016020] GTPase activator activity [GO:0005096]; Rho GDP-dissociation inhibitor activity [GO:0005094] g16644.t1 Q9TU03 49.505 202 1.5399999999999999e-55 178.0 sp|Q9TU03|GDIR2_BOVIN Rho GDP-dissociation inhibitor 2 OS=Bos taurus OX=9913 GN=ARHGDIB PE=2 SV=3 g16645.t1 Q17770 49.772 438 4.95e-137 407.0 sp|Q17770|PDI2_CAEEL Protein disulfide-isomerase 2 OS=Caenorhabditis elegans OX=6239 GN=pdi-2 PE=1 SV=1 PDI2_CAEEL reviewed Protein disulfide-isomerase 2 (EC 5.3.4.1) (PDI 1) (Prolyl 4-hydroxylase subunit beta-2) Caenorhabditis elegans GO:0003756; GO:0003810; GO:0005783; GO:0005788; GO:0006457; GO:0016222; GO:0030968; GO:0034976; GO:0036498 endoplasmic reticulum unfolded protein response [GO:0030968]; IRE1-mediated unfolded protein response [GO:0036498]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; procollagen-proline 4-dioxygenase complex [GO:0016222] protein disulfide isomerase activity [GO:0003756]; protein-glutamine gamma-glutamyltransferase activity [GO:0003810] g16648.t1 P84185 94.947 376 0.0 759.0 sp|P84185|ACT5C_ANOGA Actin-5C OS=Anopheles gambiae OX=7165 GN=Act5C PE=2 SV=1 g16649.t1 B2GUN4 38.413 794 1.05e-169 559.0 sp|B2GUN4|MARF1_XENTR Meiosis regulator and mRNA stability factor 1 OS=Xenopus tropicalis OX=8364 GN=marf1 PE=2 SV=1 g16649.t1 B2GUN4 58.678 242 1.08e-81 301.0 sp|B2GUN4|MARF1_XENTR Meiosis regulator and mRNA stability factor 1 OS=Xenopus tropicalis OX=8364 GN=marf1 PE=2 SV=1 g16649.t2 B2GUN4 38.413 794 9.929999999999999e-170 559.0 sp|B2GUN4|MARF1_XENTR Meiosis regulator and mRNA stability factor 1 OS=Xenopus tropicalis OX=8364 GN=marf1 PE=2 SV=1 g16649.t2 B2GUN4 56.202 258 7.03e-82 302.0 sp|B2GUN4|MARF1_XENTR Meiosis regulator and mRNA stability factor 1 OS=Xenopus tropicalis OX=8364 GN=marf1 PE=2 SV=1 g16651.t1 Q7SXI6 54.007 287 1.35e-81 254.0 sp|Q7SXI6|NDL1A_DANRE Nuclear distribution protein nudE-like 1-A OS=Danio rerio OX=7955 GN=ndel1a PE=2 SV=1 g16653.t1 Q6P7A9 51.155 866 0.0 917.0 sp|Q6P7A9|LYAG_RAT Lysosomal alpha-glucosidase OS=Rattus norvegicus OX=10116 GN=Gaa PE=2 SV=1 LYAG_RAT reviewed Lysosomal alpha-glucosidase (EC 3.2.1.20) (Acid maltase) Rattus norvegicus (Rat) GO:0002026; GO:0002086; GO:0003007; GO:0004558; GO:0005764; GO:0005765; GO:0005977; GO:0005980; GO:0006941; GO:0007040; GO:0007626; GO:0009888; GO:0016020; GO:0030246; GO:0035904; GO:0043181; GO:0046716; GO:0050884; GO:0050885; GO:0060048; GO:0061723; GO:0090599; GO:0120282 aorta development [GO:0035904]; cardiac muscle contraction [GO:0060048]; diaphragm contraction [GO:0002086]; glycogen catabolic process [GO:0005980]; glycogen metabolic process [GO:0005977]; glycophagy [GO:0061723]; heart morphogenesis [GO:0003007]; locomotory behavior [GO:0007626]; lysosome organization [GO:0007040]; muscle cell cellular homeostasis [GO:0046716]; neuromuscular process controlling balance [GO:0050885]; neuromuscular process controlling posture [GO:0050884]; regulation of the force of heart contraction [GO:0002026]; striated muscle contraction [GO:0006941]; tissue development [GO:0009888]; vacuolar sequestering [GO:0043181] autolysosome lumen [GO:0120282]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020] alpha-1,4-glucosidase activity [GO:0004558]; alpha-glucosidase activity [GO:0090599]; carbohydrate binding [GO:0030246] g16653.t2 P70699 50.577 866 0.0 913.0 sp|P70699|LYAG_MOUSE Lysosomal alpha-glucosidase OS=Mus musculus OX=10090 GN=Gaa PE=1 SV=2 LYAG_MOUSE reviewed Lysosomal alpha-glucosidase (EC 3.2.1.20) (Acid maltase) Mus musculus (Mouse) GO:0002026; GO:0002086; GO:0003007; GO:0004558; GO:0005764; GO:0005765; GO:0005977; GO:0005980; GO:0006941; GO:0007040; GO:0007626; GO:0009888; GO:0016020; GO:0030246; GO:0035904; GO:0043181; GO:0043896; GO:0046716; GO:0050884; GO:0050885; GO:0060048; GO:0061723; GO:0090599; GO:0120282 aorta development [GO:0035904]; cardiac muscle contraction [GO:0060048]; diaphragm contraction [GO:0002086]; glycogen catabolic process [GO:0005980]; glycogen metabolic process [GO:0005977]; glycophagy [GO:0061723]; heart morphogenesis [GO:0003007]; locomotory behavior [GO:0007626]; lysosome organization [GO:0007040]; muscle cell cellular homeostasis [GO:0046716]; neuromuscular process controlling balance [GO:0050885]; neuromuscular process controlling posture [GO:0050884]; regulation of the force of heart contraction [GO:0002026]; striated muscle contraction [GO:0006941]; tissue development [GO:0009888]; vacuolar sequestering [GO:0043181] autolysosome lumen [GO:0120282]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020] alpha-1,4-glucosidase activity [GO:0004558]; alpha-glucosidase activity [GO:0090599]; carbohydrate binding [GO:0030246]; glucan 1,6-alpha-glucosidase activity [GO:0043896] g16653.t3 P70699 48.889 900 0.0 902.0 sp|P70699|LYAG_MOUSE Lysosomal alpha-glucosidase OS=Mus musculus OX=10090 GN=Gaa PE=1 SV=2 LYAG_MOUSE reviewed Lysosomal alpha-glucosidase (EC 3.2.1.20) (Acid maltase) Mus musculus (Mouse) GO:0002026; GO:0002086; GO:0003007; GO:0004558; GO:0005764; GO:0005765; GO:0005977; GO:0005980; GO:0006941; GO:0007040; GO:0007626; GO:0009888; GO:0016020; GO:0030246; GO:0035904; GO:0043181; GO:0043896; GO:0046716; GO:0050884; GO:0050885; GO:0060048; GO:0061723; GO:0090599; GO:0120282 aorta development [GO:0035904]; cardiac muscle contraction [GO:0060048]; diaphragm contraction [GO:0002086]; glycogen catabolic process [GO:0005980]; glycogen metabolic process [GO:0005977]; glycophagy [GO:0061723]; heart morphogenesis [GO:0003007]; locomotory behavior [GO:0007626]; lysosome organization [GO:0007040]; muscle cell cellular homeostasis [GO:0046716]; neuromuscular process controlling balance [GO:0050885]; neuromuscular process controlling posture [GO:0050884]; regulation of the force of heart contraction [GO:0002026]; striated muscle contraction [GO:0006941]; tissue development [GO:0009888]; vacuolar sequestering [GO:0043181] autolysosome lumen [GO:0120282]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020] alpha-1,4-glucosidase activity [GO:0004558]; alpha-glucosidase activity [GO:0090599]; carbohydrate binding [GO:0030246]; glucan 1,6-alpha-glucosidase activity [GO:0043896] g16653.t4 P70699 48.132 910 0.0 894.0 sp|P70699|LYAG_MOUSE Lysosomal alpha-glucosidase OS=Mus musculus OX=10090 GN=Gaa PE=1 SV=2 LYAG_MOUSE reviewed Lysosomal alpha-glucosidase (EC 3.2.1.20) (Acid maltase) Mus musculus (Mouse) GO:0002026; GO:0002086; GO:0003007; GO:0004558; GO:0005764; GO:0005765; GO:0005977; GO:0005980; GO:0006941; GO:0007040; GO:0007626; GO:0009888; GO:0016020; GO:0030246; GO:0035904; GO:0043181; GO:0043896; GO:0046716; GO:0050884; GO:0050885; GO:0060048; GO:0061723; GO:0090599; GO:0120282 aorta development [GO:0035904]; cardiac muscle contraction [GO:0060048]; diaphragm contraction [GO:0002086]; glycogen catabolic process [GO:0005980]; glycogen metabolic process [GO:0005977]; glycophagy [GO:0061723]; heart morphogenesis [GO:0003007]; locomotory behavior [GO:0007626]; lysosome organization [GO:0007040]; muscle cell cellular homeostasis [GO:0046716]; neuromuscular process controlling balance [GO:0050885]; neuromuscular process controlling posture [GO:0050884]; regulation of the force of heart contraction [GO:0002026]; striated muscle contraction [GO:0006941]; tissue development [GO:0009888]; vacuolar sequestering [GO:0043181] autolysosome lumen [GO:0120282]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020] alpha-1,4-glucosidase activity [GO:0004558]; alpha-glucosidase activity [GO:0090599]; carbohydrate binding [GO:0030246]; glucan 1,6-alpha-glucosidase activity [GO:0043896] g16655.t1 Q501J6 73.536 461 0.0 710.0 sp|Q501J6|DDX17_MOUSE Probable ATP-dependent RNA helicase DDX17 OS=Mus musculus OX=10090 GN=Ddx17 PE=1 SV=1 DDX17_MOUSE reviewed Probable ATP-dependent RNA helicase DDX17 (EC 3.6.4.13) (DEAD box protein 17) Mus musculus (Mouse) GO:0000380; GO:0000381; GO:0001837; GO:0002376; GO:0003713; GO:0003724; GO:0003729; GO:0005524; GO:0005634; GO:0005730; GO:0005737; GO:0005829; GO:0006357; GO:0006364; GO:0010467; GO:0010586; GO:0016607; GO:0016887; GO:0030520; GO:0030521; GO:0031047; GO:0031490; GO:0045445; GO:0045944; GO:0051607; GO:0061614; GO:0106222; GO:1990904; GO:2001014 alternative mRNA splicing, via spliceosome [GO:0000380]; androgen receptor signaling pathway [GO:0030521]; defense response to virus [GO:0051607]; epithelial to mesenchymal transition [GO:0001837]; estrogen receptor signaling pathway [GO:0030520]; gene expression [GO:0010467]; immune system process [GO:0002376]; miRNA metabolic process [GO:0010586]; miRNA transcription [GO:0061614]; myoblast differentiation [GO:0045445]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of skeletal muscle cell differentiation [GO:2001014]; regulation of transcription by RNA polymerase II [GO:0006357]; regulatory ncRNA-mediated gene silencing [GO:0031047]; rRNA processing [GO:0006364] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; chromatin DNA binding [GO:0031490]; lncRNA binding [GO:0106222]; mRNA binding [GO:0003729]; RNA helicase activity [GO:0003724]; transcription coactivator activity [GO:0003713] g16655.t2 Q501J6 72.821 390 0.0 593.0 sp|Q501J6|DDX17_MOUSE Probable ATP-dependent RNA helicase DDX17 OS=Mus musculus OX=10090 GN=Ddx17 PE=1 SV=1 DDX17_MOUSE reviewed Probable ATP-dependent RNA helicase DDX17 (EC 3.6.4.13) (DEAD box protein 17) Mus musculus (Mouse) GO:0000380; GO:0000381; GO:0001837; GO:0002376; GO:0003713; GO:0003724; GO:0003729; GO:0005524; GO:0005634; GO:0005730; GO:0005737; GO:0005829; GO:0006357; GO:0006364; GO:0010467; GO:0010586; GO:0016607; GO:0016887; GO:0030520; GO:0030521; GO:0031047; GO:0031490; GO:0045445; GO:0045944; GO:0051607; GO:0061614; GO:0106222; GO:1990904; GO:2001014 alternative mRNA splicing, via spliceosome [GO:0000380]; androgen receptor signaling pathway [GO:0030521]; defense response to virus [GO:0051607]; epithelial to mesenchymal transition [GO:0001837]; estrogen receptor signaling pathway [GO:0030520]; gene expression [GO:0010467]; immune system process [GO:0002376]; miRNA metabolic process [GO:0010586]; miRNA transcription [GO:0061614]; myoblast differentiation [GO:0045445]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of skeletal muscle cell differentiation [GO:2001014]; regulation of transcription by RNA polymerase II [GO:0006357]; regulatory ncRNA-mediated gene silencing [GO:0031047]; rRNA processing [GO:0006364] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; chromatin DNA binding [GO:0031490]; lncRNA binding [GO:0106222]; mRNA binding [GO:0003729]; RNA helicase activity [GO:0003724]; transcription coactivator activity [GO:0003713] g16655.t3 Q501J6 68.235 85 1.31e-26 115.0 sp|Q501J6|DDX17_MOUSE Probable ATP-dependent RNA helicase DDX17 OS=Mus musculus OX=10090 GN=Ddx17 PE=1 SV=1 DDX17_MOUSE reviewed Probable ATP-dependent RNA helicase DDX17 (EC 3.6.4.13) (DEAD box protein 17) Mus musculus (Mouse) GO:0000380; GO:0000381; GO:0001837; GO:0002376; GO:0003713; GO:0003724; GO:0003729; GO:0005524; GO:0005634; GO:0005730; GO:0005737; GO:0005829; GO:0006357; GO:0006364; GO:0010467; GO:0010586; GO:0016607; GO:0016887; GO:0030520; GO:0030521; GO:0031047; GO:0031490; GO:0045445; GO:0045944; GO:0051607; GO:0061614; GO:0106222; GO:1990904; GO:2001014 alternative mRNA splicing, via spliceosome [GO:0000380]; androgen receptor signaling pathway [GO:0030521]; defense response to virus [GO:0051607]; epithelial to mesenchymal transition [GO:0001837]; estrogen receptor signaling pathway [GO:0030520]; gene expression [GO:0010467]; immune system process [GO:0002376]; miRNA metabolic process [GO:0010586]; miRNA transcription [GO:0061614]; myoblast differentiation [GO:0045445]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of skeletal muscle cell differentiation [GO:2001014]; regulation of transcription by RNA polymerase II [GO:0006357]; regulatory ncRNA-mediated gene silencing [GO:0031047]; rRNA processing [GO:0006364] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; chromatin DNA binding [GO:0031490]; lncRNA binding [GO:0106222]; mRNA binding [GO:0003729]; RNA helicase activity [GO:0003724]; transcription coactivator activity [GO:0003713] g16660.t1 Q5R7A2 52.273 440 4.2300000000000006e-157 455.0 sp|Q5R7A2|ALG1_PONAB Chitobiosyldiphosphodolichol beta-mannosyltransferase OS=Pongo abelii OX=9601 GN=ALG1 PE=2 SV=1 g16661.t1 Q9JHS3 75.2 125 2.56e-59 181.0 sp|Q9JHS3|LTOR2_MOUSE Ragulator complex protein LAMTOR2 OS=Mus musculus OX=10090 GN=Lamtor2 PE=1 SV=1 LTOR2_MOUSE reviewed Ragulator complex protein LAMTOR2 (Endosomal adaptor protein p14) (Late endosomal/lysosomal Mp1-interacting protein) (Late endosomal/lysosomal adaptor and MAPK and MTOR activator 2) (Mitogen-activated protein-binding protein-interacting protein) (Roadblock domain-containing protein 3) Mus musculus (Mouse) GO:0001558; GO:0005085; GO:0005765; GO:0005770; GO:0008104; GO:0010761; GO:0031902; GO:0032008; GO:0038202; GO:0043410; GO:0060090; GO:0071230; GO:0071986; GO:0150116; GO:1902414; GO:1904263; GO:1990877 cellular response to amino acid stimulus [GO:0071230]; fibroblast migration [GO:0010761]; intracellular protein localization [GO:0008104]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of TOR signaling [GO:0032008]; positive regulation of TORC1 signaling [GO:1904263]; protein localization to cell junction [GO:1902414]; regulation of cell growth [GO:0001558]; regulation of cell-substrate junction organization [GO:0150116]; TORC1 signaling [GO:0038202] FNIP-folliculin RagC/D GAP [GO:1990877]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; Ragulator complex [GO:0071986] guanyl-nucleotide exchange factor activity [GO:0005085]; molecular adaptor activity [GO:0060090] g16666.t1 Q96DM1 27.155 232 4.4e-21 98.6 sp|Q96DM1|PGBD4_HUMAN PiggyBac transposable element-derived protein 4 OS=Homo sapiens OX=9606 GN=PGBD4 PE=1 SV=3 g16669.t1 P20004 73.677 775 0.0 1163.0 sp|P20004|ACON_BOVIN Aconitate hydratase, mitochondrial OS=Bos taurus OX=9913 GN=ACO2 PE=1 SV=4 ACON_BOVIN reviewed Aconitate hydratase, mitochondrial (Aconitase) (EC 4.2.1.3) (Citrate hydro-lyase) Bos taurus (Bovine) GO:0003994; GO:0005506; GO:0005739; GO:0005829; GO:0006099; GO:0006101; GO:0008198; GO:0051538; GO:0051539 citrate metabolic process [GO:0006101]; tricarboxylic acid cycle [GO:0006099] cytosol [GO:0005829]; mitochondrion [GO:0005739] 3 iron, 4 sulfur cluster binding [GO:0051538]; 4 iron, 4 sulfur cluster binding [GO:0051539]; aconitate hydratase activity [GO:0003994]; ferrous iron binding [GO:0008198]; iron ion binding [GO:0005506] g16671.t1 Q8BFY6 51.25 160 1.4700000000000001e-56 185.0 sp|Q8BFY6|PEF1_MOUSE Peflin OS=Mus musculus OX=10090 GN=Pef1 PE=1 SV=1 PEF1_MOUSE reviewed Peflin (PEF protein with a long N-terminal hydrophobic domain) (Penta-EF hand domain-containing protein 1) Mus musculus (Mouse) GO:0005509; GO:0005737; GO:0005783; GO:0006888; GO:0014029; GO:0014032; GO:0030127; GO:0031463; GO:0042802; GO:0046982; GO:0046983; GO:0048208; GO:0048306; GO:0051592; GO:1902527; GO:1990756 COPII vesicle coating [GO:0048208]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; neural crest cell development [GO:0014032]; neural crest formation [GO:0014029]; positive regulation of protein monoubiquitination [GO:1902527]; response to calcium ion [GO:0051592] COPII vesicle coat [GO:0030127]; Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783] calcium ion binding [GO:0005509]; calcium-dependent protein binding [GO:0048306]; identical protein binding [GO:0042802]; protein dimerization activity [GO:0046983]; protein heterodimerization activity [GO:0046982]; ubiquitin-like ligase-substrate adaptor activity [GO:1990756] g16672.t1 Q96D21 45.596 193 8.29e-49 164.0 sp|Q96D21|RHES_HUMAN GTP-binding protein Rhes OS=Homo sapiens OX=9606 GN=RASD2 PE=1 SV=1 RHES_HUMAN reviewed GTP-binding protein Rhes (Ras homolog enriched in striatum) (Tumor endothelial marker 2) Homo sapiens (Human) GO:0001963; GO:0003924; GO:0005525; GO:0005886; GO:0007165; GO:0007626; GO:0031681; GO:0033235; GO:0045202; GO:0051897 locomotory behavior [GO:0007626]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of protein sumoylation [GO:0033235]; signal transduction [GO:0007165]; synaptic transmission, dopaminergic [GO:0001963] plasma membrane [GO:0005886]; synapse [GO:0045202] G-protein beta-subunit binding [GO:0031681]; GTP binding [GO:0005525]; GTPase activity [GO:0003924] g16673.t1 Q6ZQT0 28.986 138 2.72e-25 101.0 sp|Q6ZQT0|YD023_HUMAN Putative uncharacterized protein FLJ45035 OS=Homo sapiens OX=9606 PE=5 SV=1 g16673.t1 Q6ZQT0 28.986 138 2.72e-25 101.0 sp|Q6ZQT0|YD023_HUMAN Putative uncharacterized protein FLJ45035 OS=Homo sapiens OX=9606 PE=5 SV=1 g16673.t1 Q6ZQT0 28.986 138 2.72e-25 101.0 sp|Q6ZQT0|YD023_HUMAN Putative uncharacterized protein FLJ45035 OS=Homo sapiens OX=9606 PE=5 SV=1 g16673.t1 Q6ZQT0 28.986 138 2.72e-25 101.0 sp|Q6ZQT0|YD023_HUMAN Putative uncharacterized protein FLJ45035 OS=Homo sapiens OX=9606 PE=5 SV=1 g16673.t1 Q6ZQT0 28.986 138 2.72e-25 101.0 sp|Q6ZQT0|YD023_HUMAN Putative uncharacterized protein FLJ45035 OS=Homo sapiens OX=9606 PE=5 SV=1 g16673.t1 Q6ZQT0 28.986 138 2.72e-25 101.0 sp|Q6ZQT0|YD023_HUMAN Putative uncharacterized protein FLJ45035 OS=Homo sapiens OX=9606 PE=5 SV=1 g16673.t1 Q6ZQT0 29.197 137 4.33e-25 100.0 sp|Q6ZQT0|YD023_HUMAN Putative uncharacterized protein FLJ45035 OS=Homo sapiens OX=9606 PE=5 SV=1 g16673.t1 Q6ZQT0 28.986 138 4.86e-25 100.0 sp|Q6ZQT0|YD023_HUMAN Putative uncharacterized protein FLJ45035 OS=Homo sapiens OX=9606 PE=5 SV=1 g16673.t1 Q6ZQT0 28.986 138 4.86e-25 100.0 sp|Q6ZQT0|YD023_HUMAN Putative uncharacterized protein FLJ45035 OS=Homo sapiens OX=9606 PE=5 SV=1 g16673.t1 Q6ZQT0 28.986 138 4.86e-25 100.0 sp|Q6ZQT0|YD023_HUMAN Putative uncharacterized protein FLJ45035 OS=Homo sapiens OX=9606 PE=5 SV=1 g16673.t1 Q6ZQT0 28.986 138 4.86e-25 100.0 sp|Q6ZQT0|YD023_HUMAN Putative uncharacterized protein FLJ45035 OS=Homo sapiens OX=9606 PE=5 SV=1 g16673.t1 Q6ZQT0 28.986 138 4.86e-25 100.0 sp|Q6ZQT0|YD023_HUMAN Putative uncharacterized protein FLJ45035 OS=Homo sapiens OX=9606 PE=5 SV=1 g16673.t1 Q6ZQT0 28.986 138 4.86e-25 100.0 sp|Q6ZQT0|YD023_HUMAN Putative uncharacterized protein FLJ45035 OS=Homo sapiens OX=9606 PE=5 SV=1 g16674.t1 Q8N8E3 41.814 794 1.37e-171 523.0 sp|Q8N8E3|CE112_HUMAN Centrosomal protein of 112 kDa OS=Homo sapiens OX=9606 GN=CEP112 PE=1 SV=2 CE112_HUMAN reviewed Centrosomal protein of 112 kDa (Cep112) (Coiled-coil domain-containing protein 46) Homo sapiens (Human) GO:0005813; GO:0005886; GO:0060077; GO:0097120; GO:0140693 receptor localization to synapse [GO:0097120] centrosome [GO:0005813]; inhibitory synapse [GO:0060077]; plasma membrane [GO:0005886] molecular condensate scaffold activity [GO:0140693] g16675.t1 Q5PR68 44.516 155 1.27e-22 97.4 sp|Q5PR68|CE112_MOUSE Centrosomal protein of 112 kDa OS=Mus musculus OX=10090 GN=Cep112 PE=2 SV=2 CE112_MOUSE reviewed Centrosomal protein of 112 kDa (Cep112) (Coiled-coil domain-containing protein 46) Mus musculus (Mouse) GO:0005813; GO:0005886; GO:0060077; GO:0097120 receptor localization to synapse [GO:0097120] centrosome [GO:0005813]; inhibitory synapse [GO:0060077]; plasma membrane [GO:0005886] g16676.t1 Q3UIA2 43.07 469 7.7e-128 402.0 sp|Q3UIA2|RHG17_MOUSE Rho GTPase-activating protein 17 OS=Mus musculus OX=10090 GN=Arhgap17 PE=1 SV=1 g16676.t2 Q68EM7 42.977 477 1.36e-126 402.0 sp|Q68EM7|RHG17_HUMAN Rho GTPase-activating protein 17 OS=Homo sapiens OX=9606 GN=ARHGAP17 PE=1 SV=1 RHG17_HUMAN reviewed Rho GTPase-activating protein 17 (Rho-type GTPase-activating protein 17) (RhoGAP interacting with CIP4 homologs protein 1) (RICH-1) Homo sapiens (Human) GO:0005096; GO:0005829; GO:0005886; GO:0005923; GO:0007165; GO:0017124; GO:0032956; GO:0035020; GO:0051058 negative regulation of small GTPase mediated signal transduction [GO:0051058]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of Rac protein signal transduction [GO:0035020]; signal transduction [GO:0007165] bicellular tight junction [GO:0005923]; cytosol [GO:0005829]; plasma membrane [GO:0005886] GTPase activator activity [GO:0005096]; SH3 domain binding [GO:0017124] g16677.t1 Q5XGE0 53.147 286 3.3799999999999997e-90 275.0 sp|Q5XGE0|OGFD3_XENTR 2-oxoglutarate and iron-dependent oxygenase domain-containing protein 3 OS=Xenopus tropicalis OX=8364 GN=ogfod3 PE=2 SV=1 g16685.t1 A2RUV0 33.204 1551 9.620000000000001e-173 601.0 sp|A2RUV0|NOTC1_XENTR Neurogenic locus notch homolog protein 1 OS=Xenopus tropicalis OX=8364 GN=notch1 PE=1 SV=2 NOTC1_XENTR reviewed Neurogenic locus notch homolog protein 1 (Notch 1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0001525; GO:0005509; GO:0005634; GO:0005886; GO:0006355; GO:0007219; GO:0007411; GO:0009986; GO:0038023; GO:0043235; GO:0050793; GO:0060271; GO:0061314 angiogenesis [GO:0001525]; axon guidance [GO:0007411]; cilium assembly [GO:0060271]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; regulation of developmental process [GO:0050793]; regulation of DNA-templated transcription [GO:0006355] cell surface [GO:0009986]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; signaling receptor activity [GO:0038023] g16685.t1 A2RUV0 34.101 1519 1.21e-170 594.0 sp|A2RUV0|NOTC1_XENTR Neurogenic locus notch homolog protein 1 OS=Xenopus tropicalis OX=8364 GN=notch1 PE=1 SV=2 NOTC1_XENTR reviewed Neurogenic locus notch homolog protein 1 (Notch 1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0001525; GO:0005509; GO:0005634; GO:0005886; GO:0006355; GO:0007219; GO:0007411; GO:0009986; GO:0038023; GO:0043235; GO:0050793; GO:0060271; GO:0061314 angiogenesis [GO:0001525]; axon guidance [GO:0007411]; cilium assembly [GO:0060271]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; regulation of developmental process [GO:0050793]; regulation of DNA-templated transcription [GO:0006355] cell surface [GO:0009986]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; signaling receptor activity [GO:0038023] g16685.t1 A2RUV0 32.868 1576 2.1200000000000003e-166 581.0 sp|A2RUV0|NOTC1_XENTR Neurogenic locus notch homolog protein 1 OS=Xenopus tropicalis OX=8364 GN=notch1 PE=1 SV=2 NOTC1_XENTR reviewed Neurogenic locus notch homolog protein 1 (Notch 1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0001525; GO:0005509; GO:0005634; GO:0005886; GO:0006355; GO:0007219; GO:0007411; GO:0009986; GO:0038023; GO:0043235; GO:0050793; GO:0060271; GO:0061314 angiogenesis [GO:0001525]; axon guidance [GO:0007411]; cilium assembly [GO:0060271]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; regulation of developmental process [GO:0050793]; regulation of DNA-templated transcription [GO:0006355] cell surface [GO:0009986]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; signaling receptor activity [GO:0038023] g16685.t1 A2RUV0 31.689 1622 3.3900000000000004e-163 571.0 sp|A2RUV0|NOTC1_XENTR Neurogenic locus notch homolog protein 1 OS=Xenopus tropicalis OX=8364 GN=notch1 PE=1 SV=2 NOTC1_XENTR reviewed Neurogenic locus notch homolog protein 1 (Notch 1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0001525; GO:0005509; GO:0005634; GO:0005886; GO:0006355; GO:0007219; GO:0007411; GO:0009986; GO:0038023; GO:0043235; GO:0050793; GO:0060271; GO:0061314 angiogenesis [GO:0001525]; axon guidance [GO:0007411]; cilium assembly [GO:0060271]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; regulation of developmental process [GO:0050793]; regulation of DNA-templated transcription [GO:0006355] cell surface [GO:0009986]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; signaling receptor activity [GO:0038023] g16685.t1 A2RUV0 32.724 1641 5.1e-160 561.0 sp|A2RUV0|NOTC1_XENTR Neurogenic locus notch homolog protein 1 OS=Xenopus tropicalis OX=8364 GN=notch1 PE=1 SV=2 NOTC1_XENTR reviewed Neurogenic locus notch homolog protein 1 (Notch 1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0001525; GO:0005509; GO:0005634; GO:0005886; GO:0006355; GO:0007219; GO:0007411; GO:0009986; GO:0038023; GO:0043235; GO:0050793; GO:0060271; GO:0061314 angiogenesis [GO:0001525]; axon guidance [GO:0007411]; cilium assembly [GO:0060271]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; regulation of developmental process [GO:0050793]; regulation of DNA-templated transcription [GO:0006355] cell surface [GO:0009986]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; signaling receptor activity [GO:0038023] g16685.t1 A2RUV0 33.174 1468 1.8e-156 550.0 sp|A2RUV0|NOTC1_XENTR Neurogenic locus notch homolog protein 1 OS=Xenopus tropicalis OX=8364 GN=notch1 PE=1 SV=2 NOTC1_XENTR reviewed Neurogenic locus notch homolog protein 1 (Notch 1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0001525; GO:0005509; GO:0005634; GO:0005886; GO:0006355; GO:0007219; GO:0007411; GO:0009986; GO:0038023; GO:0043235; GO:0050793; GO:0060271; GO:0061314 angiogenesis [GO:0001525]; axon guidance [GO:0007411]; cilium assembly [GO:0060271]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; regulation of developmental process [GO:0050793]; regulation of DNA-templated transcription [GO:0006355] cell surface [GO:0009986]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; signaling receptor activity [GO:0038023] g16685.t1 A2RUV0 31.351 1547 1.36e-153 540.0 sp|A2RUV0|NOTC1_XENTR Neurogenic locus notch homolog protein 1 OS=Xenopus tropicalis OX=8364 GN=notch1 PE=1 SV=2 NOTC1_XENTR reviewed Neurogenic locus notch homolog protein 1 (Notch 1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0001525; GO:0005509; GO:0005634; GO:0005886; GO:0006355; GO:0007219; GO:0007411; GO:0009986; GO:0038023; GO:0043235; GO:0050793; GO:0060271; GO:0061314 angiogenesis [GO:0001525]; axon guidance [GO:0007411]; cilium assembly [GO:0060271]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; regulation of developmental process [GO:0050793]; regulation of DNA-templated transcription [GO:0006355] cell surface [GO:0009986]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; signaling receptor activity [GO:0038023] g16685.t1 A2RUV0 35.065 1309 7.1299999999999995e-146 516.0 sp|A2RUV0|NOTC1_XENTR Neurogenic locus notch homolog protein 1 OS=Xenopus tropicalis OX=8364 GN=notch1 PE=1 SV=2 NOTC1_XENTR reviewed Neurogenic locus notch homolog protein 1 (Notch 1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0001525; GO:0005509; GO:0005634; GO:0005886; GO:0006355; GO:0007219; GO:0007411; GO:0009986; GO:0038023; GO:0043235; GO:0050793; GO:0060271; GO:0061314 angiogenesis [GO:0001525]; axon guidance [GO:0007411]; cilium assembly [GO:0060271]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; regulation of developmental process [GO:0050793]; regulation of DNA-templated transcription [GO:0006355] cell surface [GO:0009986]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; signaling receptor activity [GO:0038023] g16685.t1 A2RUV0 31.53 1516 2.4800000000000002e-145 514.0 sp|A2RUV0|NOTC1_XENTR Neurogenic locus notch homolog protein 1 OS=Xenopus tropicalis OX=8364 GN=notch1 PE=1 SV=2 NOTC1_XENTR reviewed Neurogenic locus notch homolog protein 1 (Notch 1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0001525; GO:0005509; GO:0005634; GO:0005886; GO:0006355; GO:0007219; GO:0007411; GO:0009986; GO:0038023; GO:0043235; GO:0050793; GO:0060271; GO:0061314 angiogenesis [GO:0001525]; axon guidance [GO:0007411]; cilium assembly [GO:0060271]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; regulation of developmental process [GO:0050793]; regulation of DNA-templated transcription [GO:0006355] cell surface [GO:0009986]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; signaling receptor activity [GO:0038023] g16685.t1 A2RUV0 31.429 1505 6.4e-135 481.0 sp|A2RUV0|NOTC1_XENTR Neurogenic locus notch homolog protein 1 OS=Xenopus tropicalis OX=8364 GN=notch1 PE=1 SV=2 NOTC1_XENTR reviewed Neurogenic locus notch homolog protein 1 (Notch 1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0001525; GO:0005509; GO:0005634; GO:0005886; GO:0006355; GO:0007219; GO:0007411; GO:0009986; GO:0038023; GO:0043235; GO:0050793; GO:0060271; GO:0061314 angiogenesis [GO:0001525]; axon guidance [GO:0007411]; cilium assembly [GO:0060271]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; regulation of developmental process [GO:0050793]; regulation of DNA-templated transcription [GO:0006355] cell surface [GO:0009986]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; signaling receptor activity [GO:0038023] g16685.t1 A2RUV0 31.289 1451 3.1500000000000005e-132 472.0 sp|A2RUV0|NOTC1_XENTR Neurogenic locus notch homolog protein 1 OS=Xenopus tropicalis OX=8364 GN=notch1 PE=1 SV=2 NOTC1_XENTR reviewed Neurogenic locus notch homolog protein 1 (Notch 1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0001525; GO:0005509; GO:0005634; GO:0005886; GO:0006355; GO:0007219; GO:0007411; GO:0009986; GO:0038023; GO:0043235; GO:0050793; GO:0060271; GO:0061314 angiogenesis [GO:0001525]; axon guidance [GO:0007411]; cilium assembly [GO:0060271]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; regulation of developmental process [GO:0050793]; regulation of DNA-templated transcription [GO:0006355] cell surface [GO:0009986]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; signaling receptor activity [GO:0038023] g16685.t1 A2RUV0 32.571 1400 2.2000000000000003e-129 462.0 sp|A2RUV0|NOTC1_XENTR Neurogenic locus notch homolog protein 1 OS=Xenopus tropicalis OX=8364 GN=notch1 PE=1 SV=2 NOTC1_XENTR reviewed Neurogenic locus notch homolog protein 1 (Notch 1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0001525; GO:0005509; GO:0005634; GO:0005886; GO:0006355; GO:0007219; GO:0007411; GO:0009986; GO:0038023; GO:0043235; GO:0050793; GO:0060271; GO:0061314 angiogenesis [GO:0001525]; axon guidance [GO:0007411]; cilium assembly [GO:0060271]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; regulation of developmental process [GO:0050793]; regulation of DNA-templated transcription [GO:0006355] cell surface [GO:0009986]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; signaling receptor activity [GO:0038023] g16685.t1 A2RUV0 34.289 1012 2.2200000000000002e-103 378.0 sp|A2RUV0|NOTC1_XENTR Neurogenic locus notch homolog protein 1 OS=Xenopus tropicalis OX=8364 GN=notch1 PE=1 SV=2 NOTC1_XENTR reviewed Neurogenic locus notch homolog protein 1 (Notch 1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0001525; GO:0005509; GO:0005634; GO:0005886; GO:0006355; GO:0007219; GO:0007411; GO:0009986; GO:0038023; GO:0043235; GO:0050793; GO:0060271; GO:0061314 angiogenesis [GO:0001525]; axon guidance [GO:0007411]; cilium assembly [GO:0060271]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; regulation of developmental process [GO:0050793]; regulation of DNA-templated transcription [GO:0006355] cell surface [GO:0009986]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; signaling receptor activity [GO:0038023] g16688.t1 B6VQA1 71.429 70 2.32e-25 104.0 sp|B6VQA1|DIMM_DROME Protein dimmed OS=Drosophila melanogaster OX=7227 GN=dimm PE=1 SV=1 DIMM_DROME reviewed Protein dimmed Drosophila melanogaster (Fruit fly) GO:0000981; GO:0002793; GO:0005634; GO:0005737; GO:0006355; GO:0007419; GO:0007423; GO:0045944; GO:0046887; GO:0046983; GO:0061101; GO:0061564; GO:0070888 axon development [GO:0061564]; neuroendocrine cell differentiation [GO:0061101]; positive regulation of hormone secretion [GO:0046887]; positive regulation of peptide secretion [GO:0002793]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA-templated transcription [GO:0006355]; sensory organ development [GO:0007423]; ventral cord development [GO:0007419] cytoplasm [GO:0005737]; nucleus [GO:0005634] DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; E-box binding [GO:0070888]; protein dimerization activity [GO:0046983] g16690.t1 Q9Y3A4 40.426 188 8.399999999999999e-42 145.0 sp|Q9Y3A4|RRP7A_HUMAN Ribosomal RNA-processing protein 7 homolog A OS=Homo sapiens OX=9606 GN=RRP7A PE=1 SV=2 g16691.t1 Q96N11 33.083 399 8.829999999999999e-46 167.0 sp|Q96N11|INT15_HUMAN Integrator complex subunit 15 OS=Homo sapiens OX=9606 GN=INTS15 PE=1 SV=1 INT15_HUMAN reviewed Integrator complex subunit 15 Homo sapiens (Human) GO:0000398; GO:0001654; GO:0005634; GO:0005694; GO:0007420; GO:0032039; GO:0160232; GO:0160240 brain development [GO:0007420]; eye development [GO:0001654]; mRNA splicing, via spliceosome [GO:0000398]; RNA polymerase II transcription initiation surveillance [GO:0160240] chromosome [GO:0005694]; INTAC complex [GO:0160232]; integrator complex [GO:0032039]; nucleus [GO:0005634] g16692.t1 O35548 30.528 511 1.59e-60 212.0 sp|O35548|MMP16_RAT Matrix metalloproteinase-16 OS=Rattus norvegicus OX=10116 GN=Mmp16 PE=2 SV=1 MMP16_RAT reviewed Matrix metalloproteinase-16 (MMP-16) (EC 3.4.24.-) (Membrane-type matrix metalloproteinase 3) (MT-MMP 3) (MTMMP3) (Membrane-type-3 matrix metalloproteinase) (MT3-MMP) (MT3MMP) Rattus norvegicus (Rat) GO:0001501; GO:0001503; GO:0001958; GO:0004222; GO:0005615; GO:0005886; GO:0006508; GO:0008270; GO:0016485; GO:0030198; GO:0030574; GO:0031012; GO:0035988; GO:0048701; GO:0060348; GO:0070006; GO:0097094; GO:1990834 bone development [GO:0060348]; chondrocyte proliferation [GO:0035988]; collagen catabolic process [GO:0030574]; craniofacial suture morphogenesis [GO:0097094]; embryonic cranial skeleton morphogenesis [GO:0048701]; endochondral ossification [GO:0001958]; extracellular matrix organization [GO:0030198]; ossification [GO:0001503]; protein processing [GO:0016485]; proteolysis [GO:0006508]; response to odorant [GO:1990834]; skeletal system development [GO:0001501] extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; plasma membrane [GO:0005886] metalloaminopeptidase activity [GO:0070006]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270] g16693.t1 Q9CWG1 41.04 173 1.85e-34 134.0 sp|Q9CWG1|GLIP1_MOUSE Glioma pathogenesis-related protein 1 OS=Mus musculus OX=10090 GN=Glipr1 PE=2 SV=1 g16694.t1 Q6UWM5 38.0 200 5.01e-37 138.0 sp|Q6UWM5|GPRL1_HUMAN GLIPR1-like protein 1 OS=Homo sapiens OX=9606 GN=GLIPR1L1 PE=1 SV=2 g16695.t1 O77656 33.333 435 1.25e-59 207.0 sp|O77656|MMP13_BOVIN Collagenase 3 OS=Bos taurus OX=9913 GN=MMP13 PE=2 SV=1 g16696.t1 O77656 31.275 502 3.0900000000000003e-58 204.0 sp|O77656|MMP13_BOVIN Collagenase 3 OS=Bos taurus OX=9913 GN=MMP13 PE=2 SV=1 g16699.t1 P13943 39.474 418 1.84e-81 265.0 sp|P13943|MMP1_RABIT Interstitial collagenase OS=Oryctolagus cuniculus OX=9986 GN=MMP1 PE=2 SV=1 g16700.t1 Q9R0S2 33.012 518 9.68e-68 233.0 sp|Q9R0S2|MMP24_MOUSE Matrix metalloproteinase-24 OS=Mus musculus OX=10090 GN=Mmp24 PE=1 SV=2 MMP24_MOUSE reviewed Matrix metalloproteinase-24 (MMP-24) (EC 3.4.24.-) (Matrix metalloproteinase-21) (MMP-21) (Membrane-type matrix metalloproteinase 5) (MT-MMP 5) (MTMMP5) (Membrane-type-5 matrix metalloproteinase) (MT5-MMP) (MT5MMP) [Cleaved into: Processed matrix metalloproteinase-24] Mus musculus (Mouse) GO:0004222; GO:0005615; GO:0005886; GO:0006508; GO:0008270; GO:0010001; GO:0030198; GO:0030574; GO:0031012; GO:0032588; GO:0044331; GO:0045296; GO:0050965; GO:0097150; GO:0098742 cell-cell adhesion mediated by cadherin [GO:0044331]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; collagen catabolic process [GO:0030574]; detection of temperature stimulus involved in sensory perception of pain [GO:0050965]; extracellular matrix organization [GO:0030198]; glial cell differentiation [GO:0010001]; neuronal stem cell population maintenance [GO:0097150]; proteolysis [GO:0006508] extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; trans-Golgi network membrane [GO:0032588] cadherin binding [GO:0045296]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270] g16705.t1 Q6P1R4 55.824 455 7.85e-177 510.0 sp|Q6P1R4|DUS1L_HUMAN tRNA-dihydrouridine(16/17) synthase [NAD(P)(+)]-like OS=Homo sapiens OX=9606 GN=DUS1L PE=1 SV=1 DUS1L_HUMAN reviewed tRNA-dihydrouridine(16/17) synthase [NAD(P)(+)]-like (EC 1.3.1.88) (tRNA-dihydrouridine synthase 1-like) Homo sapiens (Human) GO:0002943; GO:0005634; GO:0005737; GO:0017150; GO:0050660; GO:0102262; GO:0102263 tRNA dihydrouridine synthesis [GO:0002943] cytoplasm [GO:0005737]; nucleus [GO:0005634] flavin adenine dinucleotide binding [GO:0050660]; tRNA dihydrouridine synthase activity [GO:0017150]; tRNA-dihydrouridine16 synthase activity [GO:0102262]; tRNA-dihydrouridine17 synthase activity [GO:0102263] g16712.t1 Q5I012 42.857 154 1.16e-37 140.0 sp|Q5I012|S38AA_MOUSE Solute carrier family 38 member 10 OS=Mus musculus OX=10090 GN=Slc38a10 PE=1 SV=2 S38AA_MOUSE reviewed Solute carrier family 38 member 10 (Amino acid transporter SLC38A10) Mus musculus (Mouse) GO:0003333; GO:0005794; GO:0015179; GO:0016020; GO:0060348 amino acid transmembrane transport [GO:0003333]; bone development [GO:0060348] Golgi apparatus [GO:0005794]; membrane [GO:0016020] L-amino acid transmembrane transporter activity [GO:0015179] g16713.t1 Q5RC98 44.811 212 2.91e-49 185.0 sp|Q5RC98|S38AA_PONAB Solute carrier family 38 member 10 OS=Pongo abelii OX=9601 GN=SLC38A10 PE=2 SV=1 g16713.t2 Q9HBR0 44.811 212 2.87e-49 185.0 sp|Q9HBR0|S38AA_HUMAN Solute carrier family 38 member 10 OS=Homo sapiens OX=9606 GN=SLC38A10 PE=1 SV=2 g16717.t1 A4FUW8 36.325 234 7.799999999999999e-42 157.0 sp|A4FUW8|TXD11_BOVIN Thioredoxin domain-containing protein 11 OS=Bos taurus OX=9913 GN=TXNDC11 PE=2 SV=1 g16722.t1 P49285 32.955 264 7.27e-32 125.0 sp|P49285|MTR1A_CHICK Melatonin receptor type 1A OS=Gallus gallus OX=9031 PE=2 SV=1 g16723.t1 Q5R8W6 64.53 234 1.49e-104 321.0 sp|Q5R8W6|LC7L3_PONAB Luc7-like protein 3 OS=Pongo abelii OX=9601 GN=LUC7L3 PE=2 SV=1 LC7L3_PONAB reviewed Luc7-like protein 3 (Cisplatin resistance-associated-overexpressed protein) Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0003677; GO:0003729; GO:0005634; GO:0005685; GO:0006376; GO:0008380; GO:0016607 mRNA splice site recognition [GO:0006376]; RNA splicing [GO:0008380] nuclear speck [GO:0016607]; nucleus [GO:0005634]; U1 snRNP [GO:0005685] DNA binding [GO:0003677]; mRNA binding [GO:0003729] g16724.t1 O54983 50.327 306 6.279999999999999e-91 279.0 sp|O54983|CRYM_MOUSE Ketimine reductase mu-crystallin OS=Mus musculus OX=10090 GN=Crym PE=1 SV=1 CRYM_MOUSE reviewed Ketimine reductase mu-crystallin (EC 1.5.1.25) (1-piperideine-2-carboxylate/1-pyrroline-2-carboxylate reductase) (P2C/Pyr2C reductase) (EC 1.5.1.1) (NADP-regulated thyroid-hormone-binding protein) Mus musculus (Mouse) GO:0000122; GO:0003714; GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0006839; GO:0007605; GO:0042403; GO:0042562; GO:0042803; GO:0047125; GO:0047127; GO:0050241; GO:0050661; GO:0070324; GO:0070327 mitochondrial transport [GO:0006839]; negative regulation of transcription by RNA polymerase II [GO:0000122]; sensory perception of sound [GO:0007605]; thyroid hormone metabolic process [GO:0042403]; thyroid hormone transport [GO:0070327] cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634] delta1-piperideine-2-carboxylate reductase activity [GO:0047125]; hormone binding [GO:0042562]; NADP binding [GO:0050661]; protein homodimerization activity [GO:0042803]; pyrroline-2-carboxylate reductase activity [GO:0050241]; thiomorpholine-carboxylate dehydrogenase activity [GO:0047127]; thyroid hormone binding [GO:0070324]; transcription corepressor activity [GO:0003714] g16728.t1 P60670 45.148 237 6.519999999999999e-67 196.0 sp|P60670|NPL4_MOUSE Nuclear protein localization protein 4 homolog OS=Mus musculus OX=10090 GN=Nploc4 PE=1 SV=3 NPL4_MOUSE reviewed Nuclear protein localization protein 4 homolog (Protein NPL4) Mus musculus (Mouse) GO:0005634; GO:0005783; GO:0005829; GO:0006511; GO:0007030; GO:0008270; GO:0030970; GO:0031625; GO:0032480; GO:0034098; GO:0036435; GO:0036501; GO:0036503; GO:0039536; GO:0042175; GO:0043130; GO:0043161; GO:0044877; GO:0051117; GO:0070530 ERAD pathway [GO:0036503]; Golgi organization [GO:0007030]; negative regulation of RIG-I signaling pathway [GO:0039536]; negative regulation of type I interferon production [GO:0032480]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; retrograde protein transport, ER to cytosol [GO:0030970]; ubiquitin-dependent protein catabolic process [GO:0006511] cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nuclear outer membrane-endoplasmic reticulum membrane network [GO:0042175]; nucleus [GO:0005634]; UFD1-NPL4 complex [GO:0036501]; VCP-NPL4-UFD1 AAA ATPase complex [GO:0034098] ATPase binding [GO:0051117]; K48-linked polyubiquitin modification-dependent protein binding [GO:0036435]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; protein-containing complex binding [GO:0044877]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270] g16728.t1 P60670 71.429 49 6.519999999999999e-67 80.1 sp|P60670|NPL4_MOUSE Nuclear protein localization protein 4 homolog OS=Mus musculus OX=10090 GN=Nploc4 PE=1 SV=3 NPL4_MOUSE reviewed Nuclear protein localization protein 4 homolog (Protein NPL4) Mus musculus (Mouse) GO:0005634; GO:0005783; GO:0005829; GO:0006511; GO:0007030; GO:0008270; GO:0030970; GO:0031625; GO:0032480; GO:0034098; GO:0036435; GO:0036501; GO:0036503; GO:0039536; GO:0042175; GO:0043130; GO:0043161; GO:0044877; GO:0051117; GO:0070530 ERAD pathway [GO:0036503]; Golgi organization [GO:0007030]; negative regulation of RIG-I signaling pathway [GO:0039536]; negative regulation of type I interferon production [GO:0032480]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; retrograde protein transport, ER to cytosol [GO:0030970]; ubiquitin-dependent protein catabolic process [GO:0006511] cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nuclear outer membrane-endoplasmic reticulum membrane network [GO:0042175]; nucleus [GO:0005634]; UFD1-NPL4 complex [GO:0036501]; VCP-NPL4-UFD1 AAA ATPase complex [GO:0034098] ATPase binding [GO:0051117]; K48-linked polyubiquitin modification-dependent protein binding [GO:0036435]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; protein-containing complex binding [GO:0044877]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270] g16729.t1 Q9VBP9 51.266 316 4.31e-112 341.0 sp|Q9VBP9|NPL4_DROME Nuclear protein localization protein 4 homolog OS=Drosophila melanogaster OX=7227 GN=Npl4 PE=1 SV=3 NPL4_DROME reviewed Nuclear protein localization protein 4 homolog Drosophila melanogaster (Fruit fly) GO:0005634; GO:0005654; GO:0005829; GO:0006511; GO:0008270; GO:0031625; GO:0043130; GO:0043161; GO:0045879; GO:0071795; GO:0098586 cellular response to virus [GO:0098586]; negative regulation of smoothened signaling pathway [GO:0045879]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; ubiquitin-dependent protein catabolic process [GO:0006511] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] K11-linked polyubiquitin modification-dependent protein binding [GO:0071795]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270] g16746.t1 P97288 35.632 348 1.63e-51 179.0 sp|P97288|5HT4R_MOUSE 5-hydroxytryptamine receptor 4 OS=Mus musculus OX=10090 GN=Htr4 PE=1 SV=3 5HT4R_MOUSE reviewed 5-hydroxytryptamine receptor 4 (5-HT-4) (5-HT4) (Serotonin receptor 4) Mus musculus (Mouse) GO:0004993; GO:0005737; GO:0005886; GO:0007186; GO:0007187; GO:0007189; GO:0007192; GO:0007198; GO:0007214; GO:0007268; GO:0010008; GO:0016020; GO:0030277; GO:0030425; GO:0030594; GO:0032098; GO:0051378; GO:0070254; GO:0098794; GO:0098978; GO:0099589; GO:0120056; GO:0150052 adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-activating serotonin receptor signaling pathway [GO:0007192]; adenylate cyclase-inhibiting serotonin receptor signaling pathway [GO:0007198]; chemical synaptic transmission [GO:0007268]; G protein-coupled receptor signaling pathway [GO:0007186]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; gamma-aminobutyric acid signaling pathway [GO:0007214]; large intestinal transit [GO:0120056]; maintenance of gastrointestinal epithelium [GO:0030277]; mucus secretion [GO:0070254]; regulation of appetite [GO:0032098]; regulation of postsynapse assembly [GO:0150052] cytoplasm [GO:0005737]; dendrite [GO:0030425]; endosome membrane [GO:0010008]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; plasma membrane [GO:0005886]; postsynapse [GO:0098794] G protein-coupled serotonin receptor activity [GO:0004993]; neurotransmitter receptor activity [GO:0030594]; serotonin binding [GO:0051378]; serotonin receptor activity [GO:0099589] g16749.t1 Q7Z6L1 43.831 616 3.72e-167 535.0 sp|Q7Z6L1|TCPR1_HUMAN Tectonin beta-propeller repeat-containing protein 1 OS=Homo sapiens OX=9606 GN=TECPR1 PE=1 SV=1 TCPR1_HUMAN reviewed Tectonin beta-propeller repeat-containing protein 1 Homo sapiens (Human) GO:0000421; GO:0005654; GO:0005765; GO:0006914; GO:0016236; GO:0031410; GO:0032266; GO:0032991; GO:0097352; GO:1901096 autophagosome maturation [GO:0097352]; autophagy [GO:0006914]; macroautophagy [GO:0016236]; regulation of autophagosome maturation [GO:1901096] autophagosome membrane [GO:0000421]; cytoplasmic vesicle [GO:0031410]; lysosomal membrane [GO:0005765]; nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991] phosphatidylinositol-3-phosphate binding [GO:0032266] g16749.t1 Q7Z6L1 47.545 387 1.2600000000000001e-86 311.0 sp|Q7Z6L1|TCPR1_HUMAN Tectonin beta-propeller repeat-containing protein 1 OS=Homo sapiens OX=9606 GN=TECPR1 PE=1 SV=1 TCPR1_HUMAN reviewed Tectonin beta-propeller repeat-containing protein 1 Homo sapiens (Human) GO:0000421; GO:0005654; GO:0005765; GO:0006914; GO:0016236; GO:0031410; GO:0032266; GO:0032991; GO:0097352; GO:1901096 autophagosome maturation [GO:0097352]; autophagy [GO:0006914]; macroautophagy [GO:0016236]; regulation of autophagosome maturation [GO:1901096] autophagosome membrane [GO:0000421]; cytoplasmic vesicle [GO:0031410]; lysosomal membrane [GO:0005765]; nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991] phosphatidylinositol-3-phosphate binding [GO:0032266] g16749.t1 Q7Z6L1 29.462 353 2.3e-30 134.0 sp|Q7Z6L1|TCPR1_HUMAN Tectonin beta-propeller repeat-containing protein 1 OS=Homo sapiens OX=9606 GN=TECPR1 PE=1 SV=1 TCPR1_HUMAN reviewed Tectonin beta-propeller repeat-containing protein 1 Homo sapiens (Human) GO:0000421; GO:0005654; GO:0005765; GO:0006914; GO:0016236; GO:0031410; GO:0032266; GO:0032991; GO:0097352; GO:1901096 autophagosome maturation [GO:0097352]; autophagy [GO:0006914]; macroautophagy [GO:0016236]; regulation of autophagosome maturation [GO:1901096] autophagosome membrane [GO:0000421]; cytoplasmic vesicle [GO:0031410]; lysosomal membrane [GO:0005765]; nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991] phosphatidylinositol-3-phosphate binding [GO:0032266] g16749.t1 Q7Z6L1 30.867 392 3.47e-30 134.0 sp|Q7Z6L1|TCPR1_HUMAN Tectonin beta-propeller repeat-containing protein 1 OS=Homo sapiens OX=9606 GN=TECPR1 PE=1 SV=1 TCPR1_HUMAN reviewed Tectonin beta-propeller repeat-containing protein 1 Homo sapiens (Human) GO:0000421; GO:0005654; GO:0005765; GO:0006914; GO:0016236; GO:0031410; GO:0032266; GO:0032991; GO:0097352; GO:1901096 autophagosome maturation [GO:0097352]; autophagy [GO:0006914]; macroautophagy [GO:0016236]; regulation of autophagosome maturation [GO:1901096] autophagosome membrane [GO:0000421]; cytoplasmic vesicle [GO:0031410]; lysosomal membrane [GO:0005765]; nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991] phosphatidylinositol-3-phosphate binding [GO:0032266] g16749.t2 Q7Z6L1 43.648 614 2.01e-165 531.0 sp|Q7Z6L1|TCPR1_HUMAN Tectonin beta-propeller repeat-containing protein 1 OS=Homo sapiens OX=9606 GN=TECPR1 PE=1 SV=1 TCPR1_HUMAN reviewed Tectonin beta-propeller repeat-containing protein 1 Homo sapiens (Human) GO:0000421; GO:0005654; GO:0005765; GO:0006914; GO:0016236; GO:0031410; GO:0032266; GO:0032991; GO:0097352; GO:1901096 autophagosome maturation [GO:0097352]; autophagy [GO:0006914]; macroautophagy [GO:0016236]; regulation of autophagosome maturation [GO:1901096] autophagosome membrane [GO:0000421]; cytoplasmic vesicle [GO:0031410]; lysosomal membrane [GO:0005765]; nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991] phosphatidylinositol-3-phosphate binding [GO:0032266] g16749.t2 Q7Z6L1 47.545 387 1.1e-86 312.0 sp|Q7Z6L1|TCPR1_HUMAN Tectonin beta-propeller repeat-containing protein 1 OS=Homo sapiens OX=9606 GN=TECPR1 PE=1 SV=1 TCPR1_HUMAN reviewed Tectonin beta-propeller repeat-containing protein 1 Homo sapiens (Human) GO:0000421; GO:0005654; GO:0005765; GO:0006914; GO:0016236; GO:0031410; GO:0032266; GO:0032991; GO:0097352; GO:1901096 autophagosome maturation [GO:0097352]; autophagy [GO:0006914]; macroautophagy [GO:0016236]; regulation of autophagosome maturation [GO:1901096] autophagosome membrane [GO:0000421]; cytoplasmic vesicle [GO:0031410]; lysosomal membrane [GO:0005765]; nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991] phosphatidylinositol-3-phosphate binding [GO:0032266] g16749.t2 Q7Z6L1 29.462 353 2.14e-30 134.0 sp|Q7Z6L1|TCPR1_HUMAN Tectonin beta-propeller repeat-containing protein 1 OS=Homo sapiens OX=9606 GN=TECPR1 PE=1 SV=1 TCPR1_HUMAN reviewed Tectonin beta-propeller repeat-containing protein 1 Homo sapiens (Human) GO:0000421; GO:0005654; GO:0005765; GO:0006914; GO:0016236; GO:0031410; GO:0032266; GO:0032991; GO:0097352; GO:1901096 autophagosome maturation [GO:0097352]; autophagy [GO:0006914]; macroautophagy [GO:0016236]; regulation of autophagosome maturation [GO:1901096] autophagosome membrane [GO:0000421]; cytoplasmic vesicle [GO:0031410]; lysosomal membrane [GO:0005765]; nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991] phosphatidylinositol-3-phosphate binding [GO:0032266] g16749.t2 Q7Z6L1 30.867 392 3.06e-30 134.0 sp|Q7Z6L1|TCPR1_HUMAN Tectonin beta-propeller repeat-containing protein 1 OS=Homo sapiens OX=9606 GN=TECPR1 PE=1 SV=1 TCPR1_HUMAN reviewed Tectonin beta-propeller repeat-containing protein 1 Homo sapiens (Human) GO:0000421; GO:0005654; GO:0005765; GO:0006914; GO:0016236; GO:0031410; GO:0032266; GO:0032991; GO:0097352; GO:1901096 autophagosome maturation [GO:0097352]; autophagy [GO:0006914]; macroautophagy [GO:0016236]; regulation of autophagosome maturation [GO:1901096] autophagosome membrane [GO:0000421]; cytoplasmic vesicle [GO:0031410]; lysosomal membrane [GO:0005765]; nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991] phosphatidylinositol-3-phosphate binding [GO:0032266] g16750.t1 Q922B6 63.79 591 0.0 776.0 sp|Q922B6|TRAF7_MOUSE E3 ubiquitin-protein ligase TRAF7 OS=Mus musculus OX=10090 GN=Traf7 PE=1 SV=1 TRAF7_MOUSE reviewed E3 ubiquitin-protein ligase TRAF7 (EC 2.3.2.-) (EC 2.3.2.27) (RING-type E3 ubiquitin transferase TRAF7) (TNF receptor-associated factor 7) Mus musculus (Mouse) GO:0000122; GO:0000151; GO:0004842; GO:0005634; GO:0005829; GO:0005886; GO:0006357; GO:0006915; GO:0007249; GO:0008270; GO:0016567; GO:0031410; GO:0032880; GO:0033235; GO:0035519; GO:0043410; GO:0043525; GO:0048471; GO:0061630; GO:0070372; GO:0071354; GO:2000060; GO:2001235 apoptotic process [GO:0006915]; canonical NF-kappaB signal transduction [GO:0007249]; cellular response to interleukin-6 [GO:0071354]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of protein sumoylation [GO:0033235]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; protein K29-linked ubiquitination [GO:0035519]; protein ubiquitination [GO:0016567]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of protein localization [GO:0032880]; regulation of transcription by RNA polymerase II [GO:0006357] cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; ubiquitin ligase complex [GO:0000151] ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] g16753.t1 Q54IT3 35.256 468 9.18e-83 268.0 sp|Q54IT3|AOFA_DICDI Probable flavin-containing monoamine oxidase A OS=Dictyostelium discoideum OX=44689 GN=maoA PE=3 SV=1 g16754.t1 Q5R454 36.095 169 4.58e-25 100.0 sp|Q5R454|AR6P1_PONAB ADP-ribosylation factor-like protein 6-interacting protein 1 OS=Pongo abelii OX=9601 GN=ARL6IP1 PE=2 SV=1 g16756.t1 A7RJI7 56.344 465 0.0 546.0 sp|A7RJI7|CCZ1_NEMVE Vacuolar fusion protein CCZ1 homolog OS=Nematostella vectensis OX=45351 GN=v1g238755 PE=3 SV=1 g16758.t1 Q54IT3 29.323 532 6.68e-69 233.0 sp|Q54IT3|AOFA_DICDI Probable flavin-containing monoamine oxidase A OS=Dictyostelium discoideum OX=44689 GN=maoA PE=3 SV=1 g16760.t1 Q9NVU0 42.511 701 0.0 544.0 sp|Q9NVU0|RPC5_HUMAN DNA-directed RNA polymerase III subunit RPC5 OS=Homo sapiens OX=9606 GN=POLR3E PE=1 SV=1 g16761.t1 Q14197 49.721 179 3.0400000000000002e-56 180.0 sp|Q14197|ICT1_HUMAN Large ribosomal subunit protein mL62 OS=Homo sapiens OX=9606 GN=MRPL58 PE=1 SV=1 ICT1_HUMAN reviewed Large ribosomal subunit protein mL62 (39S ribosomal protein L58, mitochondrial) (MRP-L58) (Digestion substraction 1) (DS-1) (Immature colon carcinoma transcript 1 protein) (Peptidyl-tRNA hydrolase ICT1, mitochondrial) (EC 3.1.1.29) Homo sapiens (Human) GO:0004045; GO:0005654; GO:0005739; GO:0005743; GO:0005759; GO:0005762; GO:0005886; GO:0016150; GO:0032543; GO:0070126; GO:0072344 mitochondrial translation [GO:0032543]; mitochondrial translational termination [GO:0070126]; rescue of stalled ribosome [GO:0072344] mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] peptidyl-tRNA hydrolase activity [GO:0004045]; translation release factor activity, codon nonspecific [GO:0016150] g16762.t1 Q2TAC2 40.281 499 1.3700000000000001e-86 303.0 sp|Q2TAC2|CCD57_HUMAN Coiled-coil domain-containing protein 57 OS=Homo sapiens OX=9606 GN=CCDC57 PE=1 SV=3 CCD57_HUMAN reviewed Coiled-coil domain-containing protein 57 Homo sapiens (Human) GO:0000086; GO:0005813; GO:0005814; GO:0005876; GO:0007020; GO:0007099; GO:0034451; GO:0045931; GO:0060271 centriole replication [GO:0007099]; cilium assembly [GO:0060271]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule nucleation [GO:0007020]; positive regulation of mitotic cell cycle [GO:0045931] centriolar satellite [GO:0034451]; centriole [GO:0005814]; centrosome [GO:0005813]; spindle microtubule [GO:0005876] g16763.t1 P97259 45.171 673 0.0 574.0 sp|P97259|MGT5A_CRIGR Alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase A OS=Cricetulus griseus OX=10029 GN=MGAT5 PE=1 SV=1 g16764.t1 P97259 46.569 685 0.0 567.0 sp|P97259|MGT5A_CRIGR Alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase A OS=Cricetulus griseus OX=10029 GN=MGAT5 PE=1 SV=1 g16767.t1 O43299 31.979 763 1.13e-121 388.0 sp|O43299|AP5Z1_HUMAN AP-5 complex subunit zeta-1 OS=Homo sapiens OX=9606 GN=AP5Z1 PE=1 SV=2 AP5Z1_HUMAN reviewed AP-5 complex subunit zeta-1 (Adaptor-related protein complex 5 zeta subunit) (Zeta5) Homo sapiens (Human) GO:0000045; GO:0000724; GO:0005634; GO:0005654; GO:0005737; GO:0005764; GO:0005770; GO:0006886; GO:0007030; GO:0007040; GO:0010467; GO:0016192; GO:0016197; GO:0016607; GO:0030119; GO:0034499; GO:0044599; GO:0061564; GO:1905146 autophagosome assembly [GO:0000045]; axon development [GO:0061564]; double-strand break repair via homologous recombination [GO:0000724]; endosomal transport [GO:0016197]; gene expression [GO:0010467]; Golgi organization [GO:0007030]; intracellular protein transport [GO:0006886]; late endosome to Golgi transport [GO:0034499]; lysosomal protein catabolic process [GO:1905146]; lysosome organization [GO:0007040]; vesicle-mediated transport [GO:0016192] AP-5 adaptor complex [GO:0044599]; AP-type membrane coat adaptor complex [GO:0030119]; cytoplasm [GO:0005737]; late endosome [GO:0005770]; lysosome [GO:0005764]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] g16768.t1 Q16960 87.13 575 0.0 1016.0 sp|Q16960|DYI3_HELCR Dynein intermediate chain 3, ciliary OS=Heliocidaris crassispina OX=1043166 PE=2 SV=1 g16772.t1 Q9VVH9 32.932 249 1.4100000000000001e-33 133.0 sp|Q9VVH9|SO74D_DROME Solute carrier organic anion transporter family member 74D OS=Drosophila melanogaster OX=7227 GN=Oatp74D PE=2 SV=2 SO74D_DROME reviewed Solute carrier organic anion transporter family member 74D (Ecdysone Importer) (EcI) (Organic anion transporting polypeptide 74D) Drosophila melanogaster (Fruit fly) GO:0002164; GO:0005886; GO:0006811; GO:0008514; GO:0015347; GO:0015711; GO:0016323; GO:0035076; GO:0043252; GO:0055085 ecdysone receptor signaling pathway [GO:0035076]; larval development [GO:0002164]; monoatomic ion transport [GO:0006811]; organic anion transport [GO:0015711]; sodium-independent organic anion transport [GO:0043252]; transmembrane transport [GO:0055085] basolateral plasma membrane [GO:0016323]; plasma membrane [GO:0005886] organic anion transmembrane transporter activity [GO:0008514]; sodium-independent organic anion transmembrane transporter activity [GO:0015347] g16773.t1 Q92959 30.877 285 6.1599999999999995e-34 135.0 sp|Q92959|SO2A1_HUMAN Solute carrier organic anion transporter family member 2A1 OS=Homo sapiens OX=9606 GN=SLCO2A1 PE=1 SV=2 SO2A1_HUMAN reviewed Solute carrier organic anion transporter family member 2A1 (SLCO2A1) (OATP2A1) (PHOAR2) (Prostaglandin transporter) (PGT) (Solute carrier family 21 member 2) (SLC21A2) Homo sapiens (Human) GO:0005319; GO:0005764; GO:0005886; GO:0006869; GO:0009925; GO:0015132; GO:0015347; GO:0015732; GO:0016020; GO:0016323; GO:0043252 lipid transport [GO:0006869]; prostaglandin transport [GO:0015732]; sodium-independent organic anion transport [GO:0043252] basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; lysosome [GO:0005764]; membrane [GO:0016020]; plasma membrane [GO:0005886] lipid transporter activity [GO:0005319]; prostaglandin transmembrane transporter activity [GO:0015132]; sodium-independent organic anion transmembrane transporter activity [GO:0015347] g16775.t1 O75689 46.245 253 2.7099999999999998e-74 234.0 sp|O75689|ADAP1_HUMAN Arf-GAP with dual PH domain-containing protein 1 OS=Homo sapiens OX=9606 GN=ADAP1 PE=1 SV=2 ADAP1_HUMAN reviewed Arf-GAP with dual PH domain-containing protein 1 (Centaurin-alpha-1) (Cnt-a1) (Putative MAPK-activating protein PM25) Homo sapiens (Human) GO:0005096; GO:0005547; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0007166; GO:0008270; GO:0043087; GO:0043533; GO:1902936 cell surface receptor signaling pathway [GO:0007166]; regulation of GTPase activity [GO:0043087] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886] GTPase activator activity [GO:0005096]; inositol 1,3,4,5 tetrakisphosphate binding [GO:0043533]; phosphatidylinositol bisphosphate binding [GO:1902936]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; zinc ion binding [GO:0008270] g16777.t1 A7SLC8 56.497 177 1.6299999999999998e-67 208.0 sp|A7SLC8|NAT9_NEMVE N-acetyltransferase 9-like protein OS=Nematostella vectensis OX=45351 GN=nat9 PE=3 SV=1 g16778.t1 Q9W107 49.576 472 4.51e-170 490.0 sp|Q9W107|SYYM_DROME Tyrosine--tRNA ligase, mitochondrial OS=Drosophila melanogaster OX=7227 GN=TyrRS-m PE=2 SV=1 g16779.t1 Q4G0X9 43.008 851 0.0 618.0 sp|Q4G0X9|CCD40_HUMAN Coiled-coil domain-containing protein 40 OS=Homo sapiens OX=9606 GN=CCDC40 PE=1 SV=2 CCD40_HUMAN reviewed Coiled-coil domain-containing protein 40 Homo sapiens (Human) GO:0001947; GO:0003341; GO:0003351; GO:0003356; GO:0005576; GO:0005737; GO:0005929; GO:0005930; GO:0030317; GO:0030324; GO:0031514; GO:0035082; GO:0035469; GO:0036159; GO:0044458; GO:0044782; GO:0060287; GO:0061512; GO:0070286; GO:0071907; GO:0071910 axonemal dynein complex assembly [GO:0070286]; axoneme assembly [GO:0035082]; cilium movement [GO:0003341]; cilium organization [GO:0044782]; determination of digestive tract left/right asymmetry [GO:0071907]; determination of liver left/right asymmetry [GO:0071910]; determination of pancreatic left/right asymmetry [GO:0035469]; epithelial cilium movement involved in determination of left/right asymmetry [GO:0060287]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; flagellated sperm motility [GO:0030317]; heart looping [GO:0001947]; inner dynein arm assembly [GO:0036159]; lung development [GO:0030324]; motile cilium assembly [GO:0044458]; protein localization to cilium [GO:0061512]; regulation of cilium beat frequency [GO:0003356] axoneme [GO:0005930]; cilium [GO:0005929]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; motile cilium [GO:0031514] g16780.t1 Q8TBP0 58.65 474 0.0 587.0 sp|Q8TBP0|TBC16_HUMAN TBC1 domain family member 16 OS=Homo sapiens OX=9606 GN=TBC1D16 PE=1 SV=1 g16781.t1 Q9Y140 56.391 266 1.83e-102 306.0 sp|Q9Y140|DHRS7_DROME Dehydrogenase/reductase SDR family protein 7-like OS=Drosophila melanogaster OX=7227 GN=CG7601 PE=2 SV=1 g16782.t1 A6H8I0 63.636 506 0.0 612.0 sp|A6H8I0|UBP22_DANRE Ubiquitin carboxyl-terminal hydrolase 22 OS=Danio rerio OX=7955 GN=usp22 PE=2 SV=1 UBP22_DANRE reviewed Ubiquitin carboxyl-terminal hydrolase 22 (EC 3.4.19.12) (Deubiquitinating enzyme 22) (Ubiquitin thioesterase 22) (Ubiquitin-specific-processing protease 22) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0004843; GO:0005634; GO:0006325; GO:0006508; GO:0008270; GO:0016579 chromatin organization [GO:0006325]; protein deubiquitination [GO:0016579]; proteolysis [GO:0006508] nucleus [GO:0005634] cysteine-type deubiquitinase activity [GO:0004843]; zinc ion binding [GO:0008270] g16783.t1 Q9C0C9 59.091 220 1.7800000000000002e-79 276.0 sp|Q9C0C9|UBE2O_HUMAN (E3-independent) E2 ubiquitin-conjugating enzyme OS=Homo sapiens OX=9606 GN=UBE2O PE=1 SV=3 UBE2O_HUMAN reviewed (E3-independent) E2 ubiquitin-conjugating enzyme (EC 2.3.2.24) (E2/E3 hybrid ubiquitin-protein ligase UBE2O) (Ubiquitin carrier protein O) (Ubiquitin-conjugating enzyme E2 O) (Ubiquitin-conjugating enzyme E2 of 230 kDa) (Ubiquitin-conjugating enzyme E2-230K) (Ubiquitin-protein ligase O) Homo sapiens (Human) GO:0003723; GO:0004842; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006513; GO:0016604; GO:0030513; GO:0042147; GO:0061630; GO:0061631; GO:0070534 positive regulation of BMP signaling pathway [GO:0030513]; protein K63-linked ubiquitination [GO:0070534]; protein monoubiquitination [GO:0006513]; retrograde transport, endosome to Golgi [GO:0042147] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] ATP binding [GO:0005524]; RNA binding [GO:0003723]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842] g16784.t1 Q6ZPJ3 37.294 303 1.0899999999999999e-41 170.0 sp|Q6ZPJ3|UBE2O_MOUSE (E3-independent) E2 ubiquitin-conjugating enzyme UBE2O OS=Mus musculus OX=10090 GN=Ube2o PE=1 SV=3 UBE2O_MOUSE reviewed (E3-independent) E2 ubiquitin-conjugating enzyme UBE2O (EC 2.3.2.24) (E2/E3 hybrid ubiquitin-protein ligase UBE2O) (Ubiquitin carrier protein O) (Ubiquitin-conjugating enzyme E2 O) (Ubiquitin-conjugating enzyme E2 of 230 kDa) (Ubiquitin-conjugating enzyme E2-230K) (Ubiquitin-protein ligase O) Mus musculus (Mouse) GO:0004842; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006513; GO:0016604; GO:0030513; GO:0042147; GO:0061630; GO:0061631; GO:0070534 positive regulation of BMP signaling pathway [GO:0030513]; protein K63-linked ubiquitination [GO:0070534]; protein monoubiquitination [GO:0006513]; retrograde transport, endosome to Golgi [GO:0042147] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842] g16784.t1 Q6ZPJ3 46.212 132 2.8e-25 117.0 sp|Q6ZPJ3|UBE2O_MOUSE (E3-independent) E2 ubiquitin-conjugating enzyme UBE2O OS=Mus musculus OX=10090 GN=Ube2o PE=1 SV=3 UBE2O_MOUSE reviewed (E3-independent) E2 ubiquitin-conjugating enzyme UBE2O (EC 2.3.2.24) (E2/E3 hybrid ubiquitin-protein ligase UBE2O) (Ubiquitin carrier protein O) (Ubiquitin-conjugating enzyme E2 O) (Ubiquitin-conjugating enzyme E2 of 230 kDa) (Ubiquitin-conjugating enzyme E2-230K) (Ubiquitin-protein ligase O) Mus musculus (Mouse) GO:0004842; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006513; GO:0016604; GO:0030513; GO:0042147; GO:0061630; GO:0061631; GO:0070534 positive regulation of BMP signaling pathway [GO:0030513]; protein K63-linked ubiquitination [GO:0070534]; protein monoubiquitination [GO:0006513]; retrograde transport, endosome to Golgi [GO:0042147] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842] g16785.t1 Q924Z6 56.19 1155 0.0 1292.0 sp|Q924Z6|XPO6_MOUSE Exportin-6 OS=Mus musculus OX=10090 GN=Xpo6 PE=1 SV=2 g16786.t1 Q9D4I2 27.197 1206 2e-98 345.0 sp|Q9D4I2|MEII1_MOUSE Meiosis inhibitor protein 1 OS=Mus musculus OX=10090 GN=Mei1 PE=2 SV=4 MEII1_MOUSE reviewed Meiosis inhibitor protein 1 (Meiosis defective protein 1) Mus musculus (Mouse) GO:0000212; GO:0007127; GO:0007141; GO:0007276; GO:0007283; GO:0007286; GO:0040038; GO:0045141; GO:0048477; GO:0051321 gamete generation [GO:0007276]; male meiosis I [GO:0007141]; meiosis I [GO:0007127]; meiotic cell cycle [GO:0051321]; meiotic spindle organization [GO:0000212]; meiotic telomere clustering [GO:0045141]; oogenesis [GO:0048477]; polar body extrusion after meiotic divisions [GO:0040038]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283] g16787.t1 P24733 57.702 1915 0.0 2013.0 sp|P24733|MYS_ARGIR Myosin heavy chain, striated muscle OS=Argopecten irradians OX=31199 PE=1 SV=1 g16787.t2 F1PT61 59.964 1099 0.0 1309.0 sp|F1PT61|MYH16_CANLF Myosin-16 OS=Canis lupus familiaris OX=9615 GN=MYH16 PE=3 SV=2 g16787.t2 F1PT61 51.813 772 0.0 658.0 sp|F1PT61|MYH16_CANLF Myosin-16 OS=Canis lupus familiaris OX=9615 GN=MYH16 PE=3 SV=2 g16791.t1 Q9QZS6 38.214 280 1.79e-50 176.0 sp|Q9QZS6|HS3SB_MOUSE Heparan sulfate glucosamine 3-O-sulfotransferase 3B1 OS=Mus musculus OX=10090 GN=Hs3st3b1 PE=2 SV=2 g16793.t1 Q8CHU3 52.273 264 7.38e-72 242.0 sp|Q8CHU3|EPN2_MOUSE Epsin-2 OS=Mus musculus OX=10090 GN=Epn2 PE=1 SV=1 EPN2_MOUSE reviewed Epsin-2 (EPS-15-interacting protein 2) (Intersectin-EH-binding protein 2) (Ibp2) Mus musculus (Mouse) GO:0001701; GO:0005543; GO:0005768; GO:0005886; GO:0006897; GO:0007219; GO:0030100; GO:0030125; GO:0030128; GO:0030276; GO:0030948; GO:0045747; GO:0048568; GO:0098843; GO:1903671 embryonic organ development [GO:0048568]; endocytosis [GO:0006897]; in utero embryonic development [GO:0001701]; negative regulation of sprouting angiogenesis [GO:1903671]; negative regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030948]; Notch signaling pathway [GO:0007219]; positive regulation of Notch signaling pathway [GO:0045747]; regulation of endocytosis [GO:0030100] clathrin coat of endocytic vesicle [GO:0030128]; clathrin vesicle coat [GO:0030125]; endosome [GO:0005768]; plasma membrane [GO:0005886]; postsynaptic endocytic zone [GO:0098843] clathrin binding [GO:0030276]; phospholipid binding [GO:0005543] g16798.t1 Q9EPT5 31.882 643 3.1e-77 263.0 sp|Q9EPT5|SO2A1_MOUSE Solute carrier organic anion transporter family member 2A1 OS=Mus musculus OX=10090 GN=Slco2a1 PE=1 SV=2 SO2A1_MOUSE reviewed Solute carrier organic anion transporter family member 2A1 (SLCO2A1) (OATP2A1) (PHOAR2) (Prostaglandin transporter) (PGT) (Solute carrier family 21 member 2) (SLC21A2) Mus musculus (Mouse) GO:0005764; GO:0005886; GO:0009925; GO:0015132; GO:0015347; GO:0015732; GO:0016323; GO:0043252 prostaglandin transport [GO:0015732]; sodium-independent organic anion transport [GO:0043252] basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; lysosome [GO:0005764]; plasma membrane [GO:0005886] prostaglandin transmembrane transporter activity [GO:0015132]; sodium-independent organic anion transmembrane transporter activity [GO:0015347] g16799.t1 Q3T122 66.171 538 0.0 725.0 sp|Q3T122|EIF3D_BOVIN Eukaryotic translation initiation factor 3 subunit D OS=Bos taurus OX=9913 GN=EIF3D PE=2 SV=1 EIF3D_BOVIN reviewed Eukaryotic translation initiation factor 3 subunit D (eIF3d) (Eukaryotic translation initiation factor 3 subunit 7) (eIF-3-zeta) Bos taurus (Bovine) GO:0001732; GO:0002191; GO:0003723; GO:0003743; GO:0005852; GO:0006413; GO:0016282; GO:0033290; GO:0045202; GO:0071541; GO:0075522; GO:0075525; GO:0098808 cap-dependent translational initiation [GO:0002191]; formation of cytoplasmic translation initiation complex [GO:0001732]; IRES-dependent viral translational initiation [GO:0075522]; translational initiation [GO:0006413]; viral translational termination-reinitiation [GO:0075525] eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; eukaryotic translation initiation factor 3 complex, eIF3m [GO:0071541]; synapse [GO:0045202] mRNA cap binding [GO:0098808]; RNA binding [GO:0003723]; translation initiation factor activity [GO:0003743] g16802.t1 Q96GE4 47.347 245 3.0099999999999997e-68 239.0 sp|Q96GE4|CEP95_HUMAN Centrosomal protein of 95 kDa OS=Homo sapiens OX=9606 GN=CEP95 PE=1 SV=1 CEP95_HUMAN reviewed Centrosomal protein of 95 kDa (Cep95) (Coiled-coil domain-containing protein 45) Homo sapiens (Human) GO:0000922; GO:0005813 centrosome [GO:0005813]; spindle pole [GO:0000922] g16806.t1 Q923D5 54.857 175 9.88e-39 153.0 sp|Q923D5|WBP11_MOUSE WW domain-binding protein 11 OS=Mus musculus OX=10090 GN=Wbp11 PE=1 SV=2 WBP11_MOUSE reviewed WW domain-binding protein 11 (WBP-11) (Splicing factor that interacts with PQBP-1 and PP1) Mus musculus (Mouse) GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006364; GO:0006397; GO:0008380; GO:0016607; GO:0019888; GO:0050699 mRNA processing [GO:0006397]; RNA splicing [GO:0008380]; rRNA processing [GO:0006364] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] protein phosphatase regulator activity [GO:0019888]; WW domain binding [GO:0050699] g16808.t1 F1R8Z9 46.914 243 9.31e-56 204.0 sp|F1R8Z9|FXJ1B_DANRE Forkhead box protein J1-B OS=Danio rerio OX=7955 GN=foxj1b PE=2 SV=1 FXJ1B_DANRE reviewed Forkhead box protein J1-B Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000978; GO:0000981; GO:0001947; GO:0003146; GO:0005634; GO:0006357; GO:0007368; GO:0044458; GO:0060088; GO:0060271 auditory receptor cell stereocilium organization [GO:0060088]; cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; heart jogging [GO:0003146]; heart looping [GO:0001947]; motile cilium assembly [GO:0044458]; regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978] g16809.t1 B3EWZ3 35.62 379 6.17e-54 204.0 sp|B3EWZ3|CADN_ACRMI Coadhesin (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g16809.t1 B3EWZ3 30.352 369 3.34e-34 144.0 sp|B3EWZ3|CADN_ACRMI Coadhesin (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g16809.t1 B3EWZ3 33.051 236 3.68e-26 119.0 sp|B3EWZ3|CADN_ACRMI Coadhesin (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g16810.t1 P51688 51.919 495 0.0 551.0 sp|P51688|SPHM_HUMAN N-sulphoglucosamine sulphohydrolase OS=Homo sapiens OX=9606 GN=SGSH PE=1 SV=1 SPHM_HUMAN reviewed N-sulphoglucosamine sulphohydrolase (EC 3.10.1.1) (Sulfoglucosamine sulfamidase) (Sulphamidase) Homo sapiens (Human) GO:0005764; GO:0006027; GO:0008340; GO:0008484; GO:0016250; GO:0030200; GO:0043202; GO:0046872; GO:0061744; GO:0070062 determination of adult lifespan [GO:0008340]; glycosaminoglycan catabolic process [GO:0006027]; heparan sulfate proteoglycan catabolic process [GO:0030200]; motor behavior [GO:0061744] extracellular exosome [GO:0070062]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764] metal ion binding [GO:0046872]; N-sulfoglucosamine sulfohydrolase activity [GO:0016250]; sulfuric ester hydrolase activity [GO:0008484] g16810.t2 P51688 50.806 496 0.0 543.0 sp|P51688|SPHM_HUMAN N-sulphoglucosamine sulphohydrolase OS=Homo sapiens OX=9606 GN=SGSH PE=1 SV=1 SPHM_HUMAN reviewed N-sulphoglucosamine sulphohydrolase (EC 3.10.1.1) (Sulfoglucosamine sulfamidase) (Sulphamidase) Homo sapiens (Human) GO:0005764; GO:0006027; GO:0008340; GO:0008484; GO:0016250; GO:0030200; GO:0043202; GO:0046872; GO:0061744; GO:0070062 determination of adult lifespan [GO:0008340]; glycosaminoglycan catabolic process [GO:0006027]; heparan sulfate proteoglycan catabolic process [GO:0030200]; motor behavior [GO:0061744] extracellular exosome [GO:0070062]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764] metal ion binding [GO:0046872]; N-sulfoglucosamine sulfohydrolase activity [GO:0016250]; sulfuric ester hydrolase activity [GO:0008484] g16810.t3 P51688 46.801 547 0.0 523.0 sp|P51688|SPHM_HUMAN N-sulphoglucosamine sulphohydrolase OS=Homo sapiens OX=9606 GN=SGSH PE=1 SV=1 SPHM_HUMAN reviewed N-sulphoglucosamine sulphohydrolase (EC 3.10.1.1) (Sulfoglucosamine sulfamidase) (Sulphamidase) Homo sapiens (Human) GO:0005764; GO:0006027; GO:0008340; GO:0008484; GO:0016250; GO:0030200; GO:0043202; GO:0046872; GO:0061744; GO:0070062 determination of adult lifespan [GO:0008340]; glycosaminoglycan catabolic process [GO:0006027]; heparan sulfate proteoglycan catabolic process [GO:0030200]; motor behavior [GO:0061744] extracellular exosome [GO:0070062]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764] metal ion binding [GO:0046872]; N-sulfoglucosamine sulfohydrolase activity [GO:0016250]; sulfuric ester hydrolase activity [GO:0008484] g16814.t1 Q3U3N6 30.608 477 5.35e-36 147.0 sp|Q3U3N6|AP4AT_MOUSE AP-4 complex accessory subunit Tepsin OS=Mus musculus OX=10090 GN=Tepsin PE=2 SV=1 g16816.t1 Q96Q15 31.567 1698 0.0 687.0 sp|Q96Q15|SMG1_HUMAN Serine/threonine-protein kinase SMG1 OS=Homo sapiens OX=9606 GN=SMG1 PE=1 SV=3 SMG1_HUMAN reviewed Serine/threonine-protein kinase SMG1 (SMG-1) (hSMG-1) (EC 2.7.11.1) (Lambda/iota protein kinase C-interacting protein) (Lambda-interacting protein) (Nonsense mediated mRNA decay-associated PI3K-related kinase SMG1) Homo sapiens (Human) GO:0000184; GO:0003723; GO:0004672; GO:0004674; GO:0004697; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006281; GO:0006406; GO:0006974; GO:0018105; GO:0032204; GO:0033391; GO:0042162; GO:0046777; GO:0046854; GO:0046872; GO:0106310 DNA damage response [GO:0006974]; DNA repair [GO:0006281]; mRNA export from nucleus [GO:0006406]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; peptidyl-serine phosphorylation [GO:0018105]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; protein autophosphorylation [GO:0046777]; regulation of telomere maintenance [GO:0032204] chromatoid body [GO:0033391]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] ATP binding [GO:0005524]; diacylglycerol-dependent serine/threonine kinase activity [GO:0004697]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; RNA binding [GO:0003723]; telomeric DNA binding [GO:0042162] g16817.t1 Q8BKX6 40.498 1926 0.0 1360.0 sp|Q8BKX6|SMG1_MOUSE Serine/threonine-protein kinase SMG1 OS=Mus musculus OX=10090 GN=Smg1 PE=1 SV=3 SMG1_MOUSE reviewed Serine/threonine-protein kinase SMG1 (SMG-1) (EC 2.7.11.1) (Lambda/iota protein kinase C-interacting protein) (Lambda-interacting protein) (Nonsense mediated mRNA decay-associated PI3K-related kinase SMG1) Mus musculus (Mouse) GO:0000184; GO:0004674; GO:0004697; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0006281; GO:0006974; GO:0032204; GO:0033391; GO:0042162; GO:0046854; GO:0046872; GO:0106310 DNA damage response [GO:0006974]; DNA repair [GO:0006281]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; regulation of telomere maintenance [GO:0032204] chromatoid body [GO:0033391]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] ATP binding [GO:0005524]; diacylglycerol-dependent serine/threonine kinase activity [GO:0004697]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; telomeric DNA binding [GO:0042162] g16821.t1 Q99447 61.828 372 1.78e-166 475.0 sp|Q99447|PCY2_HUMAN Ethanolamine-phosphate cytidylyltransferase OS=Homo sapiens OX=9606 GN=PCYT2 PE=1 SV=1 PCY2_HUMAN reviewed Ethanolamine-phosphate cytidylyltransferase (EC 2.7.7.14) (CTP:phosphoethanolamine cytidylyltransferase) (Phosphorylethanolamine transferase) Homo sapiens (Human) GO:0004306; GO:0005737; GO:0005789; GO:0006646; GO:0008654 phosphatidylethanolamine biosynthetic process [GO:0006646]; phospholipid biosynthetic process [GO:0008654] cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789] ethanolamine-phosphate cytidylyltransferase activity [GO:0004306] g16824.t1 Q8N122 80.578 623 0.0 1069.0 sp|Q8N122|RPTOR_HUMAN Regulatory-associated protein of mTOR OS=Homo sapiens OX=9606 GN=RPTOR PE=1 SV=1 g16825.t1 Q8K4Q0 47.518 564 9.59e-165 509.0 sp|Q8K4Q0|RPTOR_MOUSE Regulatory-associated protein of mTOR OS=Mus musculus OX=10090 GN=Rptor PE=1 SV=1 RPTOR_MOUSE reviewed Regulatory-associated protein of mTOR (Raptor) (p150 target of rapamycin (TOR)-scaffold protein) Mus musculus (Mouse) GO:0000045; GO:0001558; GO:0001932; GO:0001938; GO:0002181; GO:0005654; GO:0005737; GO:0005764; GO:0005765; GO:0005829; GO:0006974; GO:0008361; GO:0009267; GO:0009410; GO:0010494; GO:0010506; GO:0010507; GO:0019901; GO:0030291; GO:0030295; GO:0030307; GO:0030425; GO:0030674; GO:0031267; GO:0031669; GO:0031929; GO:0031931; GO:0032008; GO:0035176; GO:0038202; GO:0043025; GO:0044877; GO:0045672; GO:0045821; GO:0045945; GO:0045947; GO:0045948; GO:0046676; GO:0046889; GO:0061462; GO:0071230; GO:0071233; GO:0071333; GO:0071456; GO:0071470; GO:0071889; GO:0140767; GO:1900087; GO:1901331; GO:1902554; GO:1904263; GO:1905857 autophagosome assembly [GO:0000045]; cellular response to amino acid stimulus [GO:0071230]; cellular response to glucose stimulus [GO:0071333]; cellular response to hypoxia [GO:0071456]; cellular response to L-leucine [GO:0071233]; cellular response to nutrient levels [GO:0031669]; cellular response to osmotic stress [GO:0071470]; cellular response to starvation [GO:0009267]; cytoplasmic translation [GO:0002181]; DNA damage response [GO:0006974]; negative regulation of autophagy [GO:0010507]; negative regulation of insulin secretion [GO:0046676]; negative regulation of translational initiation [GO:0045947]; positive regulation of cell growth [GO:0030307]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of glycolytic process [GO:0045821]; positive regulation of lipid biosynthetic process [GO:0046889]; positive regulation of odontoblast differentiation [GO:1901331]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of pentose-phosphate shunt [GO:1905857]; positive regulation of TOR signaling [GO:0032008]; positive regulation of TORC1 signaling [GO:1904263]; positive regulation of transcription by RNA polymerase III [GO:0045945]; positive regulation of translational initiation [GO:0045948]; protein localization to lysosome [GO:0061462]; regulation of autophagy [GO:0010506]; regulation of cell growth [GO:0001558]; regulation of cell size [GO:0008361]; regulation of protein phosphorylation [GO:0001932]; response to xenobiotic stimulus [GO:0009410]; social behavior [GO:0035176]; TOR signaling [GO:0031929]; TORC1 signaling [GO:0038202] cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; dendrite [GO:0030425]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; serine/threonine protein kinase complex [GO:1902554]; TORC1 complex [GO:0031931] 14-3-3 protein binding [GO:0071889]; enzyme-substrate adaptor activity [GO:0140767]; protein kinase activator activity [GO:0030295]; protein kinase binding [GO:0019901]; protein serine/threonine kinase inhibitor activity [GO:0030291]; protein-containing complex binding [GO:0044877]; protein-macromolecule adaptor activity [GO:0030674]; small GTPase binding [GO:0031267] g16826.t1 Q9UI43 47.393 211 1.4500000000000002e-70 219.0 sp|Q9UI43|MRM2_HUMAN rRNA methyltransferase 2, mitochondrial OS=Homo sapiens OX=9606 GN=MRM2 PE=1 SV=1 MRM2_HUMAN reviewed rRNA methyltransferase 2, mitochondrial (EC 2.1.1.-) (16S rRNA (uridine(1369)-2'-O)-methyltransferase) (16S rRNA [Um1369] 2'-O-methyltransferase) (Protein ftsJ homolog 2) Homo sapiens (Human) GO:0000451; GO:0001510; GO:0005730; GO:0005739; GO:0005759; GO:0006364; GO:0008650; GO:0031167; GO:1902775 mitochondrial large ribosomal subunit assembly [GO:1902775]; RNA methylation [GO:0001510]; rRNA 2'-O-methylation [GO:0000451]; rRNA methylation [GO:0031167]; rRNA processing [GO:0006364] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleolus [GO:0005730] rRNA (uridine-2'-O-)-methyltransferase activity [GO:0008650] g16828.t1 Q1T7B9 35.758 165 7.240000000000001e-29 108.0 sp|Q1T7B9|CENPM_CHICK Centromere protein M OS=Gallus gallus OX=9031 GN=CENPM PE=1 SV=1 g16848.t1 O75636 35.676 185 3.49e-22 95.5 sp|O75636|FCN3_HUMAN Ficolin-3 OS=Homo sapiens OX=9606 GN=FCN3 PE=1 SV=2 FCN3_HUMAN reviewed Ficolin-3 (Collagen/fibrinogen domain-containing lectin 3 p35) (Collagen/fibrinogen domain-containing protein 3) (H-ficolin) (Hakata antigen) Homo sapiens (Human) GO:0001867; GO:0002752; GO:0003823; GO:0005102; GO:0005576; GO:0005581; GO:0005615; GO:0006508; GO:0006956; GO:0009897; GO:0030246; GO:0038187; GO:0043654; GO:0046597; GO:0046872; GO:0051607; GO:0072562; GO:0097367; GO:0106139; GO:1902679; GO:1903028; GO:1905370 cell surface pattern recognition receptor signaling pathway [GO:0002752]; complement activation [GO:0006956]; complement activation, lectin pathway [GO:0001867]; defense response to virus [GO:0051607]; host-mediated suppression of symbiont invasion [GO:0046597]; negative regulation of RNA biosynthetic process [GO:1902679]; positive regulation of opsonization [GO:1903028]; proteolysis [GO:0006508]; recognition of apoptotic cell [GO:0043654] blood microparticle [GO:0072562]; collagen trimer [GO:0005581]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; serine-type endopeptidase complex [GO:1905370]; symbiont cell surface [GO:0106139] antigen binding [GO:0003823]; carbohydrate binding [GO:0030246]; carbohydrate derivative binding [GO:0097367]; metal ion binding [GO:0046872]; pattern recognition receptor activity [GO:0038187]; signaling receptor binding [GO:0005102] g16850.t1 P97819 39.268 820 0.0 549.0 sp|P97819|PLPL9_MOUSE 85/88 kDa calcium-independent phospholipase A2 OS=Mus musculus OX=10090 GN=Pla2g6 PE=1 SV=3 PLPL9_MOUSE reviewed 85/88 kDa calcium-independent phospholipase A2 (CaI-PLA2) (EC 3.1.1.4) (2-lysophosphatidylcholine acylhydrolase) (EC 3.1.1.5) (Group VI phospholipase A2) (GVI PLA2) (Intracellular membrane-associated calcium-independent phospholipase A2 beta) (iPLA2-beta) (Palmitoyl-CoA hydrolase) (EC 3.1.2.2) (Patatin-like phospholipase domain-containing protein 9) (PNPLA9) Mus musculus (Mouse) GO:0003847; GO:0004622; GO:0005516; GO:0005615; GO:0005739; GO:0005886; GO:0006935; GO:0007204; GO:0007613; GO:0014832; GO:0015630; GO:0016607; GO:0017171; GO:0019731; GO:0019901; GO:0031143; GO:0034638; GO:0034976; GO:0035774; GO:0035965; GO:0042311; GO:0042802; GO:0043008; GO:0045921; GO:0046338; GO:0046469; GO:0046473; GO:0047499; GO:0051967; GO:0052816; GO:0090200; GO:0090238; GO:1902533; GO:2000304 antibacterial humoral response [GO:0019731]; cardiolipin acyl-chain remodeling [GO:0035965]; chemotaxis [GO:0006935]; memory [GO:0007613]; negative regulation of synaptic transmission, glutamatergic [GO:0051967]; phosphatidic acid metabolic process [GO:0046473]; phosphatidylcholine catabolic process [GO:0034638]; phosphatidylethanolamine catabolic process [GO:0046338]; platelet activating factor metabolic process [GO:0046469]; positive regulation of arachidonate secretion [GO:0090238]; positive regulation of ceramide biosynthetic process [GO:2000304]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of exocytosis [GO:0045921]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of intracellular signal transduction [GO:1902533]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; response to endoplasmic reticulum stress [GO:0034976]; urinary bladder smooth muscle contraction [GO:0014832]; vasodilation [GO:0042311] extracellular space [GO:0005615]; microtubule cytoskeleton [GO:0015630]; mitochondrion [GO:0005739]; nuclear speck [GO:0016607]; plasma membrane [GO:0005886]; pseudopodium [GO:0031143] 1-alkyl-2-acetylglycerophosphocholine esterase activity [GO:0003847]; ATP-dependent protein binding [GO:0043008]; calcium-independent phospholipase A2 activity [GO:0047499]; calmodulin binding [GO:0005516]; identical protein binding [GO:0042802]; long-chain fatty acyl-CoA hydrolase activity [GO:0052816]; phosphatidylcholine lysophospholipase activity [GO:0004622]; protein kinase binding [GO:0019901]; serine hydrolase activity [GO:0017171] g16861.t1 Q0P5C0 58.453 556 0.0 661.0 sp|Q0P5C0|LMF1_BOVIN Lipase maturation factor 1 OS=Bos taurus OX=9913 GN=LMF1 PE=2 SV=1 g16865.t1 A1L251 37.518 677 8.11e-113 357.0 sp|A1L251|ENASE_DANRE Cytosolic endo-beta-N-acetylglucosaminidase OS=Danio rerio OX=7955 GN=engase PE=2 SV=1 g16867.t1 P70236 61.329 331 4.13e-143 410.0 sp|P70236|MP2K6_MOUSE Dual specificity mitogen-activated protein kinase kinase 6 OS=Mus musculus OX=10090 GN=Map2k6 PE=1 SV=1 MP2K6_MOUSE reviewed Dual specificity mitogen-activated protein kinase kinase 6 (MAP kinase kinase 6) (MAPKK 6) (EC 2.7.12.2) (MAPK/ERK kinase 6) (MEK 6) (SAPKK3) Mus musculus (Mouse) GO:0000165; GO:0001649; GO:0004674; GO:0004708; GO:0004713; GO:0005524; GO:0005654; GO:0005829; GO:0005856; GO:0006915; GO:0019901; GO:0031098; GO:0032308; GO:0038066; GO:0042802; GO:0043065; GO:0043410; GO:0051403; GO:0051604; GO:0060048; GO:0060348; GO:0070269; GO:0071493; GO:0106310; GO:0120163; GO:1904784 apoptotic process [GO:0006915]; bone development [GO:0060348]; cardiac muscle contraction [GO:0060048]; cellular response to UV-B [GO:0071493]; MAPK cascade [GO:0000165]; negative regulation of cold-induced thermogenesis [GO:0120163]; NLRP1 inflammasome complex assembly [GO:1904784]; osteoblast differentiation [GO:0001649]; p38MAPK cascade [GO:0038066]; positive regulation of apoptotic process [GO:0043065]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of prostaglandin secretion [GO:0032308]; protein maturation [GO:0051604]; pyroptotic inflammatory response [GO:0070269]; stress-activated MAPK cascade [GO:0051403]; stress-activated protein kinase signaling cascade [GO:0031098] cytoskeleton [GO:0005856]; cytosol [GO:0005829]; nucleoplasm [GO:0005654] ATP binding [GO:0005524]; identical protein binding [GO:0042802]; MAP kinase kinase activity [GO:0004708]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713] g16868.t1 Q6GPA5 30.597 402 5.900000000000001e-47 172.0 sp|Q6GPA5|TTYH3_XENLA Protein tweety homolog 3 OS=Xenopus laevis OX=8355 GN=ttyh3 PE=2 SV=1 g16874.t1 A6H8I2 69.314 743 0.0 1080.0 sp|A6H8I2|SGSM3_XENLA Small G protein signaling modulator 3 homolog OS=Xenopus laevis OX=8355 GN=sgsm3 PE=2 SV=1 g16879.t1 Q49B96 67.059 85 1.09e-34 117.0 sp|Q49B96|COX19_HUMAN Cytochrome c oxidase assembly protein COX19 OS=Homo sapiens OX=9606 GN=COX19 PE=1 SV=1 COX19_HUMAN reviewed Cytochrome c oxidase assembly protein COX19 (hCOX19) Homo sapiens (Human) GO:0005739; GO:0005758; GO:0005829; GO:0006878; GO:0033617 intracellular copper ion homeostasis [GO:0006878]; mitochondrial respiratory chain complex IV assembly [GO:0033617] cytosol [GO:0005829]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739] g16880.t1 Q4KM51 31.987 297 4e-41 150.0 sp|Q4KM51|TEFM_RAT Transcription elongation factor, mitochondrial OS=Rattus norvegicus OX=10116 GN=Tefm PE=2 SV=1 g16881.t1 A8Y5H7 54.933 750 0.0 811.0 sp|A8Y5H7|S14L1_MOUSE SEC14-like protein 1 OS=Mus musculus OX=10090 GN=Sec14l1 PE=1 SV=1 S14L1_MOUSE reviewed SEC14-like protein 1 Mus musculus (Mouse) GO:0002753; GO:0005654; GO:0005737; GO:0005794; GO:0005829; GO:0015871; GO:0039532; GO:0039536; GO:0039552; GO:0045087; GO:0140311 choline transport [GO:0015871]; cytoplasmic pattern recognition receptor signaling pathway [GO:0002753]; innate immune response [GO:0045087]; negative regulation of cytoplasmic pattern recognition receptor signaling pathway [GO:0039532]; negative regulation of RIG-I signaling pathway [GO:0039536] cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654] protein sequestering activity [GO:0140311]; RIG-I binding [GO:0039552] g16882.t1 Q8NCG7 34.207 687 5.1600000000000004e-121 377.0 sp|Q8NCG7|DGLB_HUMAN Diacylglycerol lipase-beta OS=Homo sapiens OX=9606 GN=DAGLB PE=1 SV=2 DGLB_HUMAN reviewed Diacylglycerol lipase-beta (DAGL-beta) (DGL-beta) (EC 3.1.1.116) (KCCR13L) (PUFA-specific triacylglycerol lipase) (EC 3.1.1.3) (Sn1-specific diacylglycerol lipase beta) Homo sapiens (Human) GO:0001516; GO:0004806; GO:0005654; GO:0005765; GO:0005886; GO:0006640; GO:0007405; GO:0010898; GO:0016298; GO:0019369; GO:0022008; GO:0046340; GO:0046872; GO:0047372; GO:0050727; GO:1901696 arachidonate metabolic process [GO:0019369]; cannabinoid biosynthetic process [GO:1901696]; diacylglycerol catabolic process [GO:0046340]; monoacylglycerol biosynthetic process [GO:0006640]; neuroblast proliferation [GO:0007405]; neurogenesis [GO:0022008]; positive regulation of triglyceride catabolic process [GO:0010898]; prostaglandin biosynthetic process [GO:0001516]; regulation of inflammatory response [GO:0050727] lysosomal membrane [GO:0005765]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] lipase activity [GO:0016298]; metal ion binding [GO:0046872]; monoacylglycerol lipase activity [GO:0047372]; triacylglycerol lipase activity [GO:0004806] g16883.t1 Q7T076 36.019 211 4.37e-31 125.0 sp|Q7T076|LSM11_XENLA U7 snRNA-associated Sm-like protein LSm11 OS=Xenopus laevis OX=8355 GN=lsm11 PE=2 SV=1 g16883.t2 Q7T076 36.019 211 4.25e-31 124.0 sp|Q7T076|LSM11_XENLA U7 snRNA-associated Sm-like protein LSm11 OS=Xenopus laevis OX=8355 GN=lsm11 PE=2 SV=1 g16884.t1 P0CW27 35.802 243 2.04e-30 122.0 sp|P0CW27|CC166_HUMAN Coiled-coil domain-containing protein 166 OS=Homo sapiens OX=9606 GN=CCDC166 PE=1 SV=1 g16885.t1 Q10002 51.601 281 9.54e-103 318.0 sp|Q10002|APN1_CAEEL Apurinic-apyrimidinic endonuclease OS=Caenorhabditis elegans OX=6239 GN=apn-1 PE=2 SV=2 APN1_CAEEL reviewed Apurinic-apyrimidinic endonuclease (AP endonuclease) (EC 3.1.21.-) Caenorhabditis elegans GO:0003677; GO:0003906; GO:0005634; GO:0005739; GO:0006284; GO:0008081; GO:0008270; GO:0008311; GO:0017005 base-excision repair [GO:0006284] mitochondrion [GO:0005739]; nucleus [GO:0005634] 3'-tyrosyl-DNA phosphodiesterase activity [GO:0017005]; DNA binding [GO:0003677]; DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0003906]; double-stranded DNA 3'-5' DNA exonuclease activity [GO:0008311]; phosphoric diester hydrolase activity [GO:0008081]; zinc ion binding [GO:0008270] g16887.t1 Q8BJQ2 39.597 149 2.3e-26 115.0 sp|Q8BJQ2|UBP1_MOUSE Ubiquitin carboxyl-terminal hydrolase 1 OS=Mus musculus OX=10090 GN=Usp1 PE=1 SV=1 UBP1_MOUSE reviewed Ubiquitin carboxyl-terminal hydrolase 1 (EC 3.4.19.12) (Deubiquitinating enzyme 1) (Ubiquitin thioesterase 1) (Ubiquitin-specific-processing protease 1) [Cleaved into: Ubiquitin carboxyl-terminal hydrolase 1, N-terminal fragment] Mus musculus (Mouse) GO:0001501; GO:0004197; GO:0004843; GO:0005634; GO:0005654; GO:0005829; GO:0006281; GO:0006282; GO:0006508; GO:0007259; GO:0008233; GO:0009411; GO:0016579; GO:0031647; GO:0035520; GO:0046427 cell surface receptor signaling pathway via JAK-STAT [GO:0007259]; DNA repair [GO:0006281]; monoubiquitinated protein deubiquitination [GO:0035520]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; protein deubiquitination [GO:0016579]; proteolysis [GO:0006508]; regulation of DNA repair [GO:0006282]; regulation of protein stability [GO:0031647]; response to UV [GO:0009411]; skeletal system development [GO:0001501] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cysteine-type deubiquitinase activity [GO:0004843]; cysteine-type endopeptidase activity [GO:0004197]; peptidase activity [GO:0008233] g16888.t1 Q8BJQ2 47.179 195 2.35e-40 154.0 sp|Q8BJQ2|UBP1_MOUSE Ubiquitin carboxyl-terminal hydrolase 1 OS=Mus musculus OX=10090 GN=Usp1 PE=1 SV=1 UBP1_MOUSE reviewed Ubiquitin carboxyl-terminal hydrolase 1 (EC 3.4.19.12) (Deubiquitinating enzyme 1) (Ubiquitin thioesterase 1) (Ubiquitin-specific-processing protease 1) [Cleaved into: Ubiquitin carboxyl-terminal hydrolase 1, N-terminal fragment] Mus musculus (Mouse) GO:0001501; GO:0004197; GO:0004843; GO:0005634; GO:0005654; GO:0005829; GO:0006281; GO:0006282; GO:0006508; GO:0007259; GO:0008233; GO:0009411; GO:0016579; GO:0031647; GO:0035520; GO:0046427 cell surface receptor signaling pathway via JAK-STAT [GO:0007259]; DNA repair [GO:0006281]; monoubiquitinated protein deubiquitination [GO:0035520]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; protein deubiquitination [GO:0016579]; proteolysis [GO:0006508]; regulation of DNA repair [GO:0006282]; regulation of protein stability [GO:0031647]; response to UV [GO:0009411]; skeletal system development [GO:0001501] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cysteine-type deubiquitinase activity [GO:0004843]; cysteine-type endopeptidase activity [GO:0004197]; peptidase activity [GO:0008233] g16889.t1 A4IHR1 81.144 647 0.0 1077.0 sp|A4IHR1|IT70A_XENTR Intraflagellar transport protein 70A OS=Xenopus tropicalis OX=8364 GN=ift70a PE=2 SV=1 g16891.t1 Q9UJY5 55.362 345 1.2600000000000001e-117 371.0 sp|Q9UJY5|GGA1_HUMAN ADP-ribosylation factor-binding protein GGA1 OS=Homo sapiens OX=9606 GN=GGA1 PE=1 SV=1 g16891.t1 Q9UJY5 57.971 138 8.34e-41 162.0 sp|Q9UJY5|GGA1_HUMAN ADP-ribosylation factor-binding protein GGA1 OS=Homo sapiens OX=9606 GN=GGA1 PE=1 SV=1 g16898.t1 P49815 52.459 305 4.27e-98 334.0 sp|P49815|TSC2_HUMAN Tuberin OS=Homo sapiens OX=9606 GN=TSC2 PE=1 SV=2 TSC2_HUMAN reviewed Tuberin (Tuberous sclerosis 2 protein) Homo sapiens (Human) GO:0001843; GO:0005096; GO:0005634; GO:0005737; GO:0005764; GO:0005765; GO:0005794; GO:0005829; GO:0006606; GO:0006897; GO:0007507; GO:0008104; GO:0008285; GO:0009267; GO:0014069; GO:0016020; GO:0016192; GO:0016239; GO:0019902; GO:0030100; GO:0030178; GO:0031267; GO:0032007; GO:0033596; GO:0042803; GO:0043276; GO:0046626; GO:0046627; GO:0048471; GO:0050918; GO:0051056; GO:0051726; GO:0051879; GO:0051898; GO:1901525; GO:1904262 anoikis [GO:0043276]; cellular response to starvation [GO:0009267]; endocytosis [GO:0006897]; heart development [GO:0007507]; intracellular protein localization [GO:0008104]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of mitophagy [GO:1901525]; negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051898]; negative regulation of TOR signaling [GO:0032007]; negative regulation of TORC1 signaling [GO:1904262]; negative regulation of Wnt signaling pathway [GO:0030178]; neural tube closure [GO:0001843]; positive chemotaxis [GO:0050918]; positive regulation of macroautophagy [GO:0016239]; protein import into nucleus [GO:0006606]; regulation of cell cycle [GO:0051726]; regulation of endocytosis [GO:0030100]; regulation of insulin receptor signaling pathway [GO:0046626]; regulation of small GTPase mediated signal transduction [GO:0051056]; vesicle-mediated transport [GO:0016192] cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic density [GO:0014069]; TSC1-TSC2 complex [GO:0033596] GTPase activator activity [GO:0005096]; Hsp90 protein binding [GO:0051879]; phosphatase binding [GO:0019902]; protein homodimerization activity [GO:0042803]; small GTPase binding [GO:0031267] g16911.t1 P49816 42.228 1203 0.0 866.0 sp|P49816|TSC2_RAT Tuberin OS=Rattus norvegicus OX=10116 GN=Tsc2 PE=1 SV=1 TSC2_RAT reviewed Tuberin (Tuberous sclerosis 2 protein homolog) Rattus norvegicus (Rat) GO:0001666; GO:0001822; GO:0001843; GO:0002181; GO:0005096; GO:0005634; GO:0005737; GO:0005764; GO:0005765; GO:0005794; GO:0005829; GO:0005901; GO:0006606; GO:0007507; GO:0008104; GO:0008285; GO:0009267; GO:0010508; GO:0010719; GO:0010763; GO:0010976; GO:0014069; GO:0016020; GO:0016239; GO:0016242; GO:0019902; GO:0030010; GO:0030030; GO:0030100; GO:0030178; GO:0030425; GO:0030426; GO:0030889; GO:0031267; GO:0031669; GO:0032007; GO:0032869; GO:0033596; GO:0034394; GO:0035176; GO:0036446; GO:0038202; GO:0042130; GO:0042803; GO:0042995; GO:0043025; GO:0043276; GO:0044861; GO:0044877; GO:0045202; GO:0045785; GO:0045792; GO:0045944; GO:0045947; GO:0045948; GO:0046323; GO:0046626; GO:0046627; GO:0046628; GO:0048147; GO:0048471; GO:0048550; GO:0048771; GO:0050680; GO:0050771; GO:0050918; GO:0051056; GO:0051726; GO:0051879; GO:0051898; GO:0060999; GO:0071889; GO:0072014; GO:0097709; GO:0098976; GO:0098977; GO:0098978; GO:0099175; GO:1904262; GO:1904263; GO:1905563 anoikis [GO:0043276]; cell projection organization [GO:0030030]; cellular response to insulin stimulus [GO:0032869]; cellular response to nutrient levels [GO:0031669]; cellular response to starvation [GO:0009267]; connective tissue replacement [GO:0097709]; cytoplasmic translation [GO:0002181]; D-glucose import [GO:0046323]; establishment of cell polarity [GO:0030010]; excitatory chemical synaptic transmission [GO:0098976]; heart development [GO:0007507]; inhibitory chemical synaptic transmission [GO:0098977]; intracellular protein localization [GO:0008104]; kidney development [GO:0001822]; myofibroblast differentiation [GO:0036446]; negative regulation of axonogenesis [GO:0050771]; negative regulation of B cell proliferation [GO:0030889]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell size [GO:0045792]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of macroautophagy [GO:0016242]; negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051898]; negative regulation of pinocytosis [GO:0048550]; negative regulation of T cell proliferation [GO:0042130]; negative regulation of TOR signaling [GO:0032007]; negative regulation of TORC1 signaling [GO:1904262]; negative regulation of translational initiation [GO:0045947]; negative regulation of vascular endothelial cell proliferation [GO:1905563]; negative regulation of Wnt signaling pathway [GO:0030178]; neural tube closure [GO:0001843]; positive chemotaxis [GO:0050918]; positive regulation of autophagy [GO:0010508]; positive regulation of cell adhesion [GO:0045785]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of macroautophagy [GO:0016239]; positive regulation of neuron projection development [GO:0010976]; positive regulation of TORC1 signaling [GO:1904263]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of translational initiation [GO:0045948]; protein import into nucleus [GO:0006606]; protein localization to cell surface [GO:0034394]; protein transport into plasma membrane raft [GO:0044861]; proximal tubule development [GO:0072014]; regulation of cell cycle [GO:0051726]; regulation of endocytosis [GO:0030100]; regulation of insulin receptor signaling pathway [GO:0046626]; regulation of postsynapse organization [GO:0099175]; regulation of small GTPase mediated signal transduction [GO:0051056]; response to hypoxia [GO:0001666]; social behavior [GO:0035176]; tissue remodeling [GO:0048771]; TORC1 signaling [GO:0038202] caveola [GO:0005901]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; growth cone [GO:0030426]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic density [GO:0014069]; synapse [GO:0045202]; TSC1-TSC2 complex [GO:0033596] 14-3-3 protein binding [GO:0071889]; GTPase activator activity [GO:0005096]; Hsp90 protein binding [GO:0051879]; phosphatase binding [GO:0019902]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; small GTPase binding [GO:0031267] g16912.t1 Q5REH1 73.684 361 0.0 574.0 sp|Q5REH1|PICK1_PONAB PRKCA-binding protein OS=Pongo abelii OX=9601 GN=PICK1 PE=2 SV=1 PICK1_PONAB reviewed PRKCA-binding protein (Protein interacting with C kinase 1) (Protein kinase C-alpha-binding protein) Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0002092; GO:0005080; GO:0005543; GO:0005856; GO:0005886; GO:0006886; GO:0008021; GO:0014069; GO:0019904; GO:0021782; GO:0032588; GO:0034316; GO:0036294; GO:0042149; GO:0043005; GO:0043113; GO:0046872; GO:0048471; GO:0051015; GO:0060292; GO:0071933; GO:0097061; GO:0097062; GO:0098842 cellular response to decreased oxygen levels [GO:0036294]; cellular response to glucose starvation [GO:0042149]; dendritic spine maintenance [GO:0097062]; dendritic spine organization [GO:0097061]; glial cell development [GO:0021782]; intracellular protein transport [GO:0006886]; long-term synaptic depression [GO:0060292]; negative regulation of Arp2/3 complex-mediated actin nucleation [GO:0034316]; positive regulation of receptor internalization [GO:0002092]; receptor clustering [GO:0043113] cytoskeleton [GO:0005856]; neuron projection [GO:0043005]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic early endosome [GO:0098842]; synaptic vesicle [GO:0008021]; trans-Golgi network membrane [GO:0032588] actin filament binding [GO:0051015]; Arp2/3 complex binding [GO:0071933]; metal ion binding [GO:0046872]; phospholipid binding [GO:0005543]; protein domain specific binding [GO:0019904]; protein kinase C binding [GO:0005080] g16912.t2 Q5REH1 73.569 367 0.0 583.0 sp|Q5REH1|PICK1_PONAB PRKCA-binding protein OS=Pongo abelii OX=9601 GN=PICK1 PE=2 SV=1 PICK1_PONAB reviewed PRKCA-binding protein (Protein interacting with C kinase 1) (Protein kinase C-alpha-binding protein) Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0002092; GO:0005080; GO:0005543; GO:0005856; GO:0005886; GO:0006886; GO:0008021; GO:0014069; GO:0019904; GO:0021782; GO:0032588; GO:0034316; GO:0036294; GO:0042149; GO:0043005; GO:0043113; GO:0046872; GO:0048471; GO:0051015; GO:0060292; GO:0071933; GO:0097061; GO:0097062; GO:0098842 cellular response to decreased oxygen levels [GO:0036294]; cellular response to glucose starvation [GO:0042149]; dendritic spine maintenance [GO:0097062]; dendritic spine organization [GO:0097061]; glial cell development [GO:0021782]; intracellular protein transport [GO:0006886]; long-term synaptic depression [GO:0060292]; negative regulation of Arp2/3 complex-mediated actin nucleation [GO:0034316]; positive regulation of receptor internalization [GO:0002092]; receptor clustering [GO:0043113] cytoskeleton [GO:0005856]; neuron projection [GO:0043005]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic early endosome [GO:0098842]; synaptic vesicle [GO:0008021]; trans-Golgi network membrane [GO:0032588] actin filament binding [GO:0051015]; Arp2/3 complex binding [GO:0071933]; metal ion binding [GO:0046872]; phospholipid binding [GO:0005543]; protein domain specific binding [GO:0019904]; protein kinase C binding [GO:0005080] g16912.t3 Q5REH1 73.95 357 0.0 568.0 sp|Q5REH1|PICK1_PONAB PRKCA-binding protein OS=Pongo abelii OX=9601 GN=PICK1 PE=2 SV=1 PICK1_PONAB reviewed PRKCA-binding protein (Protein interacting with C kinase 1) (Protein kinase C-alpha-binding protein) Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0002092; GO:0005080; GO:0005543; GO:0005856; GO:0005886; GO:0006886; GO:0008021; GO:0014069; GO:0019904; GO:0021782; GO:0032588; GO:0034316; GO:0036294; GO:0042149; GO:0043005; GO:0043113; GO:0046872; GO:0048471; GO:0051015; GO:0060292; GO:0071933; GO:0097061; GO:0097062; GO:0098842 cellular response to decreased oxygen levels [GO:0036294]; cellular response to glucose starvation [GO:0042149]; dendritic spine maintenance [GO:0097062]; dendritic spine organization [GO:0097061]; glial cell development [GO:0021782]; intracellular protein transport [GO:0006886]; long-term synaptic depression [GO:0060292]; negative regulation of Arp2/3 complex-mediated actin nucleation [GO:0034316]; positive regulation of receptor internalization [GO:0002092]; receptor clustering [GO:0043113] cytoskeleton [GO:0005856]; neuron projection [GO:0043005]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic early endosome [GO:0098842]; synaptic vesicle [GO:0008021]; trans-Golgi network membrane [GO:0032588] actin filament binding [GO:0051015]; Arp2/3 complex binding [GO:0071933]; metal ion binding [GO:0046872]; phospholipid binding [GO:0005543]; protein domain specific binding [GO:0019904]; protein kinase C binding [GO:0005080] g16913.t1 O15229 55.862 435 9.419999999999999e-176 504.0 sp|O15229|KMO_HUMAN Kynurenine 3-monooxygenase OS=Homo sapiens OX=9606 GN=KMO PE=1 SV=2 KMO_HUMAN reviewed Kynurenine 3-monooxygenase (EC 1.14.13.9) (Kynurenine 3-hydroxylase) Homo sapiens (Human) GO:0004502; GO:0005615; GO:0005739; GO:0005741; GO:0005829; GO:0006569; GO:0009651; GO:0016174; GO:0019674; GO:0019805; GO:0034276; GO:0034354; GO:0043420; GO:0050660; GO:0070189; GO:0071222; GO:0071347; GO:0071949; GO:0097052; GO:1903296 'de novo' NAD+ biosynthetic process from L-tryptophan [GO:0034354]; anthranilate metabolic process [GO:0043420]; cellular response to interleukin-1 [GO:0071347]; cellular response to lipopolysaccharide [GO:0071222]; kynurenic acid biosynthetic process [GO:0034276]; kynurenine metabolic process [GO:0070189]; L-kynurenine metabolic process [GO:0097052]; L-tryptophan catabolic process [GO:0006569]; NAD+ metabolic process [GO:0019674]; positive regulation of glutamate secretion, neurotransmission [GO:1903296]; quinolinate biosynthetic process [GO:0019805]; response to salt stress [GO:0009651] cytosol [GO:0005829]; extracellular space [GO:0005615]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739] FAD binding [GO:0071949]; flavin adenine dinucleotide binding [GO:0050660]; kynurenine 3-monooxygenase activity [GO:0004502]; NAD(P)H oxidase H2O2-forming activity [GO:0016174] g16923.t1 Q96RT1 32.836 402 7.76e-42 167.0 sp|Q96RT1|ERBIN_HUMAN Erbin OS=Homo sapiens OX=9606 GN=ERBIN PE=1 SV=2 g16923.t1 Q96RT1 32.603 365 1.58e-36 151.0 sp|Q96RT1|ERBIN_HUMAN Erbin OS=Homo sapiens OX=9606 GN=ERBIN PE=1 SV=2 g16924.t1 Q24524 35.385 520 4.42e-91 290.0 sp|Q24524|SING_DROME Protein singed OS=Drosophila melanogaster OX=7227 GN=sn PE=1 SV=1 SING_DROME reviewed Protein singed Drosophila melanogaster (Fruit fly) GO:0003779; GO:0005737; GO:0007163; GO:0008407; GO:0009913; GO:0015629; GO:0016358; GO:0016477; GO:0030034; GO:0030036; GO:0030674; GO:0035017; GO:0035099; GO:0035317; GO:0042060; GO:0043005; GO:0043025; GO:0046847; GO:0048477; GO:0048800; GO:0048812; GO:0051015; GO:0051017 actin cytoskeleton organization [GO:0030036]; actin filament bundle assembly [GO:0051017]; antennal morphogenesis [GO:0048800]; cell migration [GO:0016477]; chaeta morphogenesis [GO:0008407]; cuticle pattern formation [GO:0035017]; dendrite development [GO:0016358]; epidermal cell differentiation [GO:0009913]; establishment or maintenance of cell polarity [GO:0007163]; filopodium assembly [GO:0046847]; hemocyte migration [GO:0035099]; imaginal disc-derived wing hair organization [GO:0035317]; microvillar actin bundle assembly [GO:0030034]; neuron projection morphogenesis [GO:0048812]; oogenesis [GO:0048477]; wound healing [GO:0042060] actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025] actin binding [GO:0003779]; actin filament binding [GO:0051015]; protein-macromolecule adaptor activity [GO:0030674] g16925.t1 Q6NU40 45.286 594 5.1200000000000005e-143 442.0 sp|Q6NU40|CTF18_XENLA Chromosome transmission fidelity protein 18 homolog OS=Xenopus laevis OX=8355 GN=chtf18 PE=2 SV=1 g16927.t1 Q08C69 49.167 240 7.490000000000001e-79 244.0 sp|Q08C69|RUSD1_DANRE RNA pseudouridylate synthase domain-containing protein 1 OS=Danio rerio OX=7955 GN=rpusd1 PE=2 SV=1 g16928.t1 Q62867 49.653 288 2.7200000000000002e-99 298.0 sp|Q62867|GGH_RAT Gamma-glutamyl hydrolase OS=Rattus norvegicus OX=10116 GN=Ggh PE=1 SV=1 GGH_RAT reviewed Gamma-glutamyl hydrolase (EC 3.4.19.9) (Conjugase) (GH) (Gamma-Glu-X carboxypeptidase) Rattus norvegicus (Rat) GO:0005615; GO:0005764; GO:0005773; GO:0009410; GO:0010043; GO:0032868; GO:0034722; GO:0042470; GO:0045471; GO:0046900 response to ethanol [GO:0045471]; response to insulin [GO:0032868]; response to xenobiotic stimulus [GO:0009410]; response to zinc ion [GO:0010043]; tetrahydrofolylpolyglutamate metabolic process [GO:0046900] extracellular space [GO:0005615]; lysosome [GO:0005764]; melanosome [GO:0042470]; vacuole [GO:0005773] gamma-glutamyl-peptidase activity [GO:0034722] g16930.t1 Q8K448 34.032 811 2.01e-122 427.0 sp|Q8K448|ABCA5_MOUSE Cholesterol transporter ABCA5 OS=Mus musculus OX=10090 GN=Abca5 PE=1 SV=2 ABCA5_MOUSE reviewed Cholesterol transporter ABCA5 (EC 7.6.2.-) (ATP-binding cassette sub-family A member 5) Mus musculus (Mouse) GO:0000139; GO:0005319; GO:0005524; GO:0005764; GO:0005765; GO:0005770; GO:0005886; GO:0006869; GO:0008203; GO:0010745; GO:0010874; GO:0016887; GO:0031902; GO:0033344; GO:0034375; GO:0042626; GO:0042632; GO:0043691; GO:0140359; GO:1903064 cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; high-density lipoprotein particle remodeling [GO:0034375]; lipid transport [GO:0006869]; negative regulation of macrophage derived foam cell differentiation [GO:0010745]; positive regulation of reverse cholesterol transport [GO:1903064]; regulation of cholesterol efflux [GO:0010874]; reverse cholesterol transport [GO:0043691] Golgi membrane [GO:0000139]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; plasma membrane [GO:0005886] ABC-type transporter activity [GO:0140359]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; lipid transporter activity [GO:0005319] g16930.t1 Q8K448 32.081 745 8.88e-96 346.0 sp|Q8K448|ABCA5_MOUSE Cholesterol transporter ABCA5 OS=Mus musculus OX=10090 GN=Abca5 PE=1 SV=2 ABCA5_MOUSE reviewed Cholesterol transporter ABCA5 (EC 7.6.2.-) (ATP-binding cassette sub-family A member 5) Mus musculus (Mouse) GO:0000139; GO:0005319; GO:0005524; GO:0005764; GO:0005765; GO:0005770; GO:0005886; GO:0006869; GO:0008203; GO:0010745; GO:0010874; GO:0016887; GO:0031902; GO:0033344; GO:0034375; GO:0042626; GO:0042632; GO:0043691; GO:0140359; GO:1903064 cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; high-density lipoprotein particle remodeling [GO:0034375]; lipid transport [GO:0006869]; negative regulation of macrophage derived foam cell differentiation [GO:0010745]; positive regulation of reverse cholesterol transport [GO:1903064]; regulation of cholesterol efflux [GO:0010874]; reverse cholesterol transport [GO:0043691] Golgi membrane [GO:0000139]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; plasma membrane [GO:0005886] ABC-type transporter activity [GO:0140359]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; lipid transporter activity [GO:0005319] g16930.t1 Q8K448 30.488 410 1.48e-49 198.0 sp|Q8K448|ABCA5_MOUSE Cholesterol transporter ABCA5 OS=Mus musculus OX=10090 GN=Abca5 PE=1 SV=2 ABCA5_MOUSE reviewed Cholesterol transporter ABCA5 (EC 7.6.2.-) (ATP-binding cassette sub-family A member 5) Mus musculus (Mouse) GO:0000139; GO:0005319; GO:0005524; GO:0005764; GO:0005765; GO:0005770; GO:0005886; GO:0006869; GO:0008203; GO:0010745; GO:0010874; GO:0016887; GO:0031902; GO:0033344; GO:0034375; GO:0042626; GO:0042632; GO:0043691; GO:0140359; GO:1903064 cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; high-density lipoprotein particle remodeling [GO:0034375]; lipid transport [GO:0006869]; negative regulation of macrophage derived foam cell differentiation [GO:0010745]; positive regulation of reverse cholesterol transport [GO:1903064]; regulation of cholesterol efflux [GO:0010874]; reverse cholesterol transport [GO:0043691] Golgi membrane [GO:0000139]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; plasma membrane [GO:0005886] ABC-type transporter activity [GO:0140359]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; lipid transporter activity [GO:0005319] g16930.t1 Q8K448 32.803 314 1.16e-43 179.0 sp|Q8K448|ABCA5_MOUSE Cholesterol transporter ABCA5 OS=Mus musculus OX=10090 GN=Abca5 PE=1 SV=2 ABCA5_MOUSE reviewed Cholesterol transporter ABCA5 (EC 7.6.2.-) (ATP-binding cassette sub-family A member 5) Mus musculus (Mouse) GO:0000139; GO:0005319; GO:0005524; GO:0005764; GO:0005765; GO:0005770; GO:0005886; GO:0006869; GO:0008203; GO:0010745; GO:0010874; GO:0016887; GO:0031902; GO:0033344; GO:0034375; GO:0042626; GO:0042632; GO:0043691; GO:0140359; GO:1903064 cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; high-density lipoprotein particle remodeling [GO:0034375]; lipid transport [GO:0006869]; negative regulation of macrophage derived foam cell differentiation [GO:0010745]; positive regulation of reverse cholesterol transport [GO:1903064]; regulation of cholesterol efflux [GO:0010874]; reverse cholesterol transport [GO:0043691] Golgi membrane [GO:0000139]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; plasma membrane [GO:0005886] ABC-type transporter activity [GO:0140359]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; lipid transporter activity [GO:0005319] g16931.t1 Q9Y272 54.682 267 2.5e-89 270.0 sp|Q9Y272|RASD1_HUMAN Dexamethasone-induced Ras-related protein 1 OS=Homo sapiens OX=9606 GN=RASD1 PE=1 SV=1 RASD1_HUMAN reviewed Dexamethasone-induced Ras-related protein 1 (Activator of G-protein signaling 1) Homo sapiens (Human) GO:0003924; GO:0005525; GO:0005634; GO:0005737; GO:0005886; GO:0007165; GO:0007186; GO:0007263; GO:0016529; GO:0031681; GO:0045892; GO:0048471 G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of DNA-templated transcription [GO:0045892]; nitric oxide mediated signal transduction [GO:0007263]; signal transduction [GO:0007165] cytoplasm [GO:0005737]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; sarcoplasmic reticulum [GO:0016529] G-protein beta-subunit binding [GO:0031681]; GTP binding [GO:0005525]; GTPase activity [GO:0003924] g16934.t1 O61231 80.282 213 4.15e-131 370.0 sp|O61231|RL10_DROME Large ribosomal subunit protein uL16 OS=Drosophila melanogaster OX=7227 GN=RpL10 PE=1 SV=1 g16935.t1 Q8N5I4 33.968 315 3.0100000000000004e-32 131.0 sp|Q8N5I4|DHRSX_HUMAN Polyprenol dehydrogenase OS=Homo sapiens OX=9606 GN=DHRSX PE=1 SV=2 DHRSX_HUMAN reviewed Polyprenol dehydrogenase (EC 1.1.1.441) (DHRSXY) (Dehydrogenase/reductase SDR family member on chromosome X) (Dolichal reductase) Homo sapiens (Human) GO:0005576; GO:0005789; GO:0005811; GO:0008106; GO:0010508; GO:0043048; GO:0160196; GO:0160197 dolichyl monophosphate biosynthetic process [GO:0043048]; positive regulation of autophagy [GO:0010508] endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; lipid droplet [GO:0005811] alcohol dehydrogenase (NADP+) activity [GO:0008106]; dolichal reductase (NADPH) activity [GO:0160197]; polyprenol dehydrogenase (NAD+) activity [GO:0160196] g16936.t1 P27463 59.504 484 0.0 574.0 sp|P27463|AL1A1_CHICK Aldehyde dehydrogenase 1A1 OS=Gallus gallus OX=9031 GN=ALDH1A1 PE=2 SV=1 g16937.t1 Q66HF8 59.794 97 9.85e-29 110.0 sp|Q66HF8|AL1B1_RAT Aldehyde dehydrogenase X, mitochondrial OS=Rattus norvegicus OX=10116 GN=Aldh1b1 PE=1 SV=1 AL1B1_RAT reviewed Aldehyde dehydrogenase X, mitochondrial (EC 1.2.1.3) (Aldehyde dehydrogenase family 1 member B1) Rattus norvegicus (Rat) GO:0004029; GO:0005654; GO:0005739; GO:0005759; GO:0005829; GO:0006068; GO:0006081; GO:0048732; GO:0110095 aldehyde metabolic process [GO:0006081]; cellular detoxification of aldehyde [GO:0110095]; ethanol catabolic process [GO:0006068]; gland development [GO:0048732] cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654] aldehyde dehydrogenase (NAD+) activity [GO:0004029] g16938.t1 P27463 61.364 308 1.62e-135 396.0 sp|P27463|AL1A1_CHICK Aldehyde dehydrogenase 1A1 OS=Gallus gallus OX=9031 GN=ALDH1A1 PE=2 SV=1 g16942.t1 P48550 36.242 149 1.3200000000000001e-33 127.0 sp|P48550|KCNJ6_RAT G protein-activated inward rectifier potassium channel 2 OS=Rattus norvegicus OX=10116 GN=Kcnj6 PE=1 SV=1 KCNJ6_RAT reviewed G protein-activated inward rectifier potassium channel 2 (GIRK-2) (BIR1) (Inward rectifier K(+) channel Kir3.2) (KATP-2) (Potassium channel, inwardly rectifying subfamily J member 6) Rattus norvegicus (Rat) GO:0001965; GO:0005242; GO:0005267; GO:0005886; GO:0009986; GO:0015467; GO:0016020; GO:0030424; GO:0030425; GO:0032809; GO:0034765; GO:0042734; GO:0051602; GO:0071315; GO:0098688; GO:0098793; GO:0098794; GO:0099508; GO:1902937; GO:1990573 cellular response to morphine [GO:0071315]; potassium ion import across plasma membrane [GO:1990573]; regulation of monoatomic ion transmembrane transport [GO:0034765]; response to electrical stimulus [GO:0051602] axon [GO:0030424]; cell surface [GO:0009986]; dendrite [GO:0030425]; inward rectifier potassium channel complex [GO:1902937]; membrane [GO:0016020]; neuronal cell body membrane [GO:0032809]; parallel fiber to Purkinje cell synapse [GO:0098688]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; presynapse [GO:0098793]; presynaptic membrane [GO:0042734] G-protein activated inward rectifier potassium channel activity [GO:0015467]; G-protein alpha-subunit binding [GO:0001965]; inward rectifier potassium channel activity [GO:0005242]; potassium channel activity [GO:0005267]; voltage-gated monoatomic ion channel activity involved in regulation of presynaptic membrane potential [GO:0099508] g16943.t1 P52189 49.219 128 3.52e-35 130.0 sp|P52189|KCNJ4_MOUSE Inward rectifier potassium channel 4 OS=Mus musculus OX=10090 GN=Kcnj4 PE=1 SV=1 KCNJ4_MOUSE reviewed Inward rectifier potassium channel 4 (Inward rectifier K(+) channel Kir2.3) (IRK-3) (Potassium channel, inwardly rectifying subfamily J member 4) Mus musculus (Mouse) GO:0005242; GO:0005886; GO:0016323; GO:0030165; GO:0030425; GO:0030659; GO:0034702; GO:0034765; GO:0043025; GO:0045211; GO:0098978; GO:1990573 potassium ion import across plasma membrane [GO:1990573]; regulation of monoatomic ion transmembrane transport [GO:0034765] basolateral plasma membrane [GO:0016323]; cytoplasmic vesicle membrane [GO:0030659]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; monoatomic ion channel complex [GO:0034702]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211] inward rectifier potassium channel activity [GO:0005242]; PDZ domain binding [GO:0030165] g16944.t1 F1NHE9 46.631 371 2.29e-100 311.0 sp|F1NHE9|KCJ12_CHICK ATP-sensitive inward rectifier potassium channel 12 OS=Gallus gallus OX=9031 GN=KCNJ12 PE=1 SV=1 KCJ12_CHICK reviewed ATP-sensitive inward rectifier potassium channel 12 (Inward rectifier K(+) channel Kir2.2) (Potassium channel, inwardly rectifying subfamily J member 12) Gallus gallus (Chicken) GO:0005242; GO:0005886; GO:0006813; GO:0016020; GO:0030315; GO:0034702; GO:0034765; GO:0042802; GO:0051289; GO:1990573 potassium ion import across plasma membrane [GO:1990573]; potassium ion transport [GO:0006813]; protein homotetramerization [GO:0051289]; regulation of monoatomic ion transmembrane transport [GO:0034765] membrane [GO:0016020]; monoatomic ion channel complex [GO:0034702]; plasma membrane [GO:0005886]; T-tubule [GO:0030315] identical protein binding [GO:0042802]; inward rectifier potassium channel activity [GO:0005242] g16945.t1 Q4TZY1 50.382 393 1.9e-123 371.0 sp|Q4TZY1|KCJ12_BOVIN ATP-sensitive inward rectifier potassium channel 12 OS=Bos taurus OX=9913 GN=KCNJ12 PE=2 SV=1 KCJ12_BOVIN reviewed ATP-sensitive inward rectifier potassium channel 12 (Potassium channel, inwardly rectifying subfamily J member 12) Bos taurus (Bovine) GO:0005242; GO:0005886; GO:0006813; GO:0016020; GO:0034702; GO:0034765; GO:0046872; GO:0051289; GO:1990573 potassium ion import across plasma membrane [GO:1990573]; potassium ion transport [GO:0006813]; protein homotetramerization [GO:0051289]; regulation of monoatomic ion transmembrane transport [GO:0034765] membrane [GO:0016020]; monoatomic ion channel complex [GO:0034702]; plasma membrane [GO:0005886] inward rectifier potassium channel activity [GO:0005242]; metal ion binding [GO:0046872] g16946.t1 Q8TDG4 51.551 838 0.0 837.0 sp|Q8TDG4|HELQ_HUMAN Helicase POLQ-like OS=Homo sapiens OX=9606 GN=HELQ PE=1 SV=2 HELQ_HUMAN reviewed Helicase POLQ-like (EC 5.6.2.4) (Mus308-like helicase) (POLQ-like helicase) Homo sapiens (Human) GO:0000724; GO:0003677; GO:0005524; GO:0005634; GO:0010792; GO:0016887; GO:0045003; GO:0090734; GO:0097681; GO:1905168; GO:1990518 DNA double-strand break processing involved in repair via single-strand annealing [GO:0010792]; double-strand break repair via alternative nonhomologous end joining [GO:0097681]; double-strand break repair via homologous recombination [GO:0000724]; double-strand break repair via synthesis-dependent strand annealing [GO:0045003]; positive regulation of double-strand break repair via homologous recombination [GO:1905168] nucleus [GO:0005634]; site of DNA damage [GO:0090734] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA binding [GO:0003677]; single-stranded 3'-5' DNA helicase activity [GO:1990518] g16947.t1 Q9Y383 66.957 230 2.23e-98 301.0 sp|Q9Y383|LC7L2_HUMAN Putative RNA-binding protein Luc7-like 2 OS=Homo sapiens OX=9606 GN=LUC7L2 PE=1 SV=2 LC7L2_HUMAN reviewed Putative RNA-binding protein Luc7-like 2 Homo sapiens (Human) GO:0003723; GO:0003729; GO:0005685; GO:0006376; GO:0016607; GO:0019899; GO:0071004 mRNA splice site recognition [GO:0006376] nuclear speck [GO:0016607]; U1 snRNP [GO:0005685]; U2-type prespliceosome [GO:0071004] enzyme binding [GO:0019899]; mRNA binding [GO:0003729]; RNA binding [GO:0003723] g16948.t1 Q575T0 34.211 152 1.3e-22 92.8 sp|Q575T0|CYGB1_ORYLA Cytoglobin-1 OS=Oryzias latipes OX=8090 GN=cygb1 PE=2 SV=1 CYGB1_ORYLA reviewed Cytoglobin-1 (Nitric oxygen dioxygenase CYGB) (EC 1.14.12.-) (Nitrite reductase CYGB) (EC 1.7.-.-) (Pseudoperoxidase CYGB) (EC 1.11.1.-) (Superoxide dismutase CYGB) (EC 1.15.1.1) Oryzias latipes (Japanese rice fish) (Japanese killifish) GO:0004784; GO:0005506; GO:0005634; GO:0005737; GO:0015671; GO:0016491; GO:0019430; GO:0019825; GO:0020037; GO:0046210; GO:0098809; GO:0141118 nitric oxide catabolic process [GO:0046210]; oxygen transport [GO:0015671]; removal of superoxide radicals [GO:0019430] cytoplasm [GO:0005737]; nucleus [GO:0005634] heme binding [GO:0020037]; iron ion binding [GO:0005506]; nitric oxide dioxygenase activity, heme protein as donor [GO:0141118]; nitrite reductase activity [GO:0098809]; oxidoreductase activity [GO:0016491]; oxygen binding [GO:0019825]; superoxide dismutase activity [GO:0004784] g16948.t2 Q575T0 34.211 152 1.74e-22 92.4 sp|Q575T0|CYGB1_ORYLA Cytoglobin-1 OS=Oryzias latipes OX=8090 GN=cygb1 PE=2 SV=1 CYGB1_ORYLA reviewed Cytoglobin-1 (Nitric oxygen dioxygenase CYGB) (EC 1.14.12.-) (Nitrite reductase CYGB) (EC 1.7.-.-) (Pseudoperoxidase CYGB) (EC 1.11.1.-) (Superoxide dismutase CYGB) (EC 1.15.1.1) Oryzias latipes (Japanese rice fish) (Japanese killifish) GO:0004784; GO:0005506; GO:0005634; GO:0005737; GO:0015671; GO:0016491; GO:0019430; GO:0019825; GO:0020037; GO:0046210; GO:0098809; GO:0141118 nitric oxide catabolic process [GO:0046210]; oxygen transport [GO:0015671]; removal of superoxide radicals [GO:0019430] cytoplasm [GO:0005737]; nucleus [GO:0005634] heme binding [GO:0020037]; iron ion binding [GO:0005506]; nitric oxide dioxygenase activity, heme protein as donor [GO:0141118]; nitrite reductase activity [GO:0098809]; oxidoreductase activity [GO:0016491]; oxygen binding [GO:0019825]; superoxide dismutase activity [GO:0004784] g16949.t1 Q8TAC2 58.286 175 6.1e-73 220.0 sp|Q8TAC2|JOS2_HUMAN Josephin-2 OS=Homo sapiens OX=9606 GN=JOSD2 PE=1 SV=1 JOS2_HUMAN reviewed Josephin-2 (EC 3.4.19.12) (Josephin domain-containing protein 2) Homo sapiens (Human) GO:0004843; GO:0005829; GO:0006508; GO:0016579 protein deubiquitination [GO:0016579]; proteolysis [GO:0006508] cytosol [GO:0005829] cysteine-type deubiquitinase activity [GO:0004843] g16950.t1 P80147 52.227 494 0.0 547.0 sp|P80147|GABT_PIG 4-aminobutyrate aminotransferase, mitochondrial OS=Sus scrofa OX=9823 GN=ABAT PE=1 SV=2 GABT_PIG reviewed 4-aminobutyrate aminotransferase, mitochondrial (EC 2.6.1.19) ((S)-3-amino-2-methylpropionate transaminase) (EC 2.6.1.22) (GABA aminotransferase) (GABA-AT) (Gamma-amino-N-butyrate transaminase) (GABA transaminase) (GABA-T) (L-AIBAT) Sus scrofa (Pig) GO:0005739; GO:0005759; GO:0005829; GO:0009450; GO:0030170; GO:0032144; GO:0032145; GO:0034386; GO:0042802; GO:0042803; GO:0046872; GO:0047298; GO:0050877; GO:0051537 gamma-aminobutyric acid catabolic process [GO:0009450]; nervous system process [GO:0050877] 4-aminobutyrate transaminase complex [GO:0032144]; cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] (S)-3-amino-2-methylpropionate transaminase activity [GO:0047298]; 2 iron, 2 sulfur cluster binding [GO:0051537]; 4-aminobutyrate:2-oxoglutarate transaminase activity [GO:0034386]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; pyridoxal phosphate binding [GO:0030170]; succinate-semialdehyde dehydrogenase binding [GO:0032145] g16951.t1 P80404 57.422 256 3.62e-106 321.0 sp|P80404|GABT_HUMAN 4-aminobutyrate aminotransferase, mitochondrial OS=Homo sapiens OX=9606 GN=ABAT PE=1 SV=3 GABT_HUMAN reviewed 4-aminobutyrate aminotransferase, mitochondrial (EC 2.6.1.19) ((S)-3-amino-2-methylpropionate transaminase) (EC 2.6.1.22) (GABA aminotransferase) (GABA-AT) (Gamma-amino-N-butyrate transaminase) (GABA transaminase) (GABA-T) (L-AIBAT) Homo sapiens (Human) GO:0001666; GO:0005739; GO:0005759; GO:0007620; GO:0007626; GO:0009410; GO:0009448; GO:0009449; GO:0009450; GO:0010039; GO:0014053; GO:0021549; GO:0030170; GO:0031652; GO:0032024; GO:0032144; GO:0032145; GO:0033602; GO:0034386; GO:0035094; GO:0035640; GO:0042220; GO:0042802; GO:0045471; GO:0045776; GO:0045964; GO:0046872; GO:0047298; GO:0050877; GO:0051536; GO:0070474; GO:0097151; GO:1902722; GO:1904450 cerebellum development [GO:0021549]; copulation [GO:0007620]; exploration behavior [GO:0035640]; gamma-aminobutyric acid biosynthetic process [GO:0009449]; gamma-aminobutyric acid catabolic process [GO:0009450]; gamma-aminobutyric acid metabolic process [GO:0009448]; locomotory behavior [GO:0007626]; negative regulation of blood pressure [GO:0045776]; negative regulation of dopamine secretion [GO:0033602]; negative regulation of gamma-aminobutyric acid secretion [GO:0014053]; nervous system process [GO:0050877]; positive regulation of aspartate secretion [GO:1904450]; positive regulation of dopamine metabolic process [GO:0045964]; positive regulation of heat generation [GO:0031652]; positive regulation of inhibitory postsynaptic potential [GO:0097151]; positive regulation of insulin secretion [GO:0032024]; positive regulation of prolactin secretion [GO:1902722]; positive regulation of uterine smooth muscle contraction [GO:0070474]; response to cocaine [GO:0042220]; response to ethanol [GO:0045471]; response to hypoxia [GO:0001666]; response to iron ion [GO:0010039]; response to nicotine [GO:0035094]; response to xenobiotic stimulus [GO:0009410] 4-aminobutyrate transaminase complex [GO:0032144]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] (S)-3-amino-2-methylpropionate transaminase activity [GO:0047298]; 4-aminobutyrate:2-oxoglutarate transaminase activity [GO:0034386]; identical protein binding [GO:0042802]; iron-sulfur cluster binding [GO:0051536]; metal ion binding [GO:0046872]; pyridoxal phosphate binding [GO:0030170]; succinate-semialdehyde dehydrogenase binding [GO:0032145] g16952.t1 P80147 49.761 209 1.15e-72 231.0 sp|P80147|GABT_PIG 4-aminobutyrate aminotransferase, mitochondrial OS=Sus scrofa OX=9823 GN=ABAT PE=1 SV=2 GABT_PIG reviewed 4-aminobutyrate aminotransferase, mitochondrial (EC 2.6.1.19) ((S)-3-amino-2-methylpropionate transaminase) (EC 2.6.1.22) (GABA aminotransferase) (GABA-AT) (Gamma-amino-N-butyrate transaminase) (GABA transaminase) (GABA-T) (L-AIBAT) Sus scrofa (Pig) GO:0005739; GO:0005759; GO:0005829; GO:0009450; GO:0030170; GO:0032144; GO:0032145; GO:0034386; GO:0042802; GO:0042803; GO:0046872; GO:0047298; GO:0050877; GO:0051537 gamma-aminobutyric acid catabolic process [GO:0009450]; nervous system process [GO:0050877] 4-aminobutyrate transaminase complex [GO:0032144]; cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] (S)-3-amino-2-methylpropionate transaminase activity [GO:0047298]; 2 iron, 2 sulfur cluster binding [GO:0051537]; 4-aminobutyrate:2-oxoglutarate transaminase activity [GO:0034386]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; pyridoxal phosphate binding [GO:0030170]; succinate-semialdehyde dehydrogenase binding [GO:0032145] g16954.t1 Q3UHC0 66.234 77 2.1700000000000002e-26 120.0 sp|Q3UHC0|TNR6C_MOUSE Trinucleotide repeat-containing gene 6C protein OS=Mus musculus OX=10090 GN=Tnrc6c PE=1 SV=2 TNR6C_MOUSE reviewed Trinucleotide repeat-containing gene 6C protein Mus musculus (Mouse) GO:0000932; GO:0001706; GO:0003723; GO:0005654; GO:0005829; GO:0006417; GO:0007179; GO:0007492; GO:0035162; GO:0035195; GO:0048568; GO:0060213; GO:0060430; GO:0060964; GO:1900153 embryonic hemopoiesis [GO:0035162]; embryonic organ development [GO:0048568]; endoderm development [GO:0007492]; endoderm formation [GO:0001706]; lung saccule development [GO:0060430]; miRNA-mediated post-transcriptional gene silencing [GO:0035195]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; regulation of miRNA-mediated gene silencing [GO:0060964]; regulation of translation [GO:0006417]; transforming growth factor beta receptor signaling pathway [GO:0007179] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; P-body [GO:0000932] RNA binding [GO:0003723] g16957.t1 O75832 51.584 221 1.6899999999999999e-74 228.0 sp|O75832|PSD10_HUMAN 26S proteasome non-ATPase regulatory subunit 10 OS=Homo sapiens OX=9606 GN=PSMD10 PE=1 SV=1 g16958.t1 Q8BQ47 46.569 204 9.09e-56 182.0 sp|Q8BQ47|CNPY4_MOUSE Protein canopy homolog 4 OS=Mus musculus OX=10090 GN=Cnpy4 PE=1 SV=1 g16959.t1 Q6ZQW0 37.406 401 1.1800000000000002e-79 254.0 sp|Q6ZQW0|I23O2_HUMAN Indoleamine 2,3-dioxygenase 2 OS=Homo sapiens OX=9606 GN=IDO2 PE=1 SV=5 I23O2_HUMAN reviewed Indoleamine 2,3-dioxygenase 2 (IDO-2) (EC 1.13.11.-) (Indoleamine 2,3-dioxygenase-like protein 1) (Indoleamine-pyrrole 2,3-dioxygenase-like protein 1) Homo sapiens (Human) GO:0002376; GO:0004833; GO:0005737; GO:0005829; GO:0019441; GO:0020037; GO:0033754; GO:0034354; GO:0046872 'de novo' NAD+ biosynthetic process from L-tryptophan [GO:0034354]; immune system process [GO:0002376]; L-tryptophan catabolic process to kynurenine [GO:0019441] cytoplasm [GO:0005737]; cytosol [GO:0005829] heme binding [GO:0020037]; indoleamine 2,3-dioxygenase activity [GO:0033754]; L-tryptophan 2,3-dioxygenase activity [GO:0004833]; metal ion binding [GO:0046872] g16960.t1 Q90889 49.315 146 7.3e-40 135.0 sp|Q90889|MAFG_CHICK Transcription factor MafG OS=Gallus gallus OX=9031 GN=MAFG PE=3 SV=1 g16961.t1 Q6PDG8 53.269 413 2.92e-163 479.0 sp|Q6PDG8|MON1A_MOUSE Vacuolar fusion protein MON1 homolog A OS=Mus musculus OX=10090 GN=Mon1a PE=1 SV=3 MON1A_MOUSE reviewed Vacuolar fusion protein MON1 homolog A Mus musculus (Mouse) GO:0005085; GO:0006623; GO:0006879; GO:0009306; GO:0015031; GO:0016192; GO:0035658 intracellular iron ion homeostasis [GO:0006879]; protein secretion [GO:0009306]; protein targeting to vacuole [GO:0006623]; protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192] Mon1-Ccz1 complex [GO:0035658] guanyl-nucleotide exchange factor activity [GO:0005085] g16962.t1 Q14166 43.387 620 5.73e-163 483.0 sp|Q14166|TTL12_HUMAN Tubulin--tyrosine ligase-like protein 12 OS=Homo sapiens OX=9606 GN=TTLL12 PE=1 SV=2 g16964.t1 Q9HAS0 32.468 385 4.2099999999999995e-52 182.0 sp|Q9HAS0|NJMU_HUMAN Protein Njmu-R1 OS=Homo sapiens OX=9606 GN=C17orf75 PE=1 SV=2 g16965.t1 B0BMX9 44.512 164 1.3200000000000001e-33 128.0 sp|B0BMX9|MEIOB_RAT Meiosis-specific with OB domain-containing protein OS=Rattus norvegicus OX=10116 GN=Meiob PE=2 SV=1 MEIOB_RAT reviewed Meiosis-specific with OB domain-containing protein (EC 3.1.-.-) Rattus norvegicus (Rat) GO:0000712; GO:0000724; GO:0003682; GO:0003697; GO:0005634; GO:0005694; GO:0005737; GO:0007129; GO:0007140; GO:0007141; GO:0007144; GO:0008310; GO:0009566 double-strand break repair via homologous recombination [GO:0000724]; female meiosis I [GO:0007144]; fertilization [GO:0009566]; homologous chromosome pairing at meiosis [GO:0007129]; male meiosis I [GO:0007141]; male meiotic nuclear division [GO:0007140]; resolution of meiotic recombination intermediates [GO:0000712] chromosome [GO:0005694]; cytoplasm [GO:0005737]; nucleus [GO:0005634] chromatin binding [GO:0003682]; single-stranded DNA 3'-5' DNA exonuclease activity [GO:0008310]; single-stranded DNA binding [GO:0003697] g16966.t1 B0BMX9 45.788 273 1.25e-67 220.0 sp|B0BMX9|MEIOB_RAT Meiosis-specific with OB domain-containing protein OS=Rattus norvegicus OX=10116 GN=Meiob PE=2 SV=1 MEIOB_RAT reviewed Meiosis-specific with OB domain-containing protein (EC 3.1.-.-) Rattus norvegicus (Rat) GO:0000712; GO:0000724; GO:0003682; GO:0003697; GO:0005634; GO:0005694; GO:0005737; GO:0007129; GO:0007140; GO:0007141; GO:0007144; GO:0008310; GO:0009566 double-strand break repair via homologous recombination [GO:0000724]; female meiosis I [GO:0007144]; fertilization [GO:0009566]; homologous chromosome pairing at meiosis [GO:0007129]; male meiosis I [GO:0007141]; male meiotic nuclear division [GO:0007140]; resolution of meiotic recombination intermediates [GO:0000712] chromosome [GO:0005694]; cytoplasm [GO:0005737]; nucleus [GO:0005634] chromatin binding [GO:0003682]; single-stranded DNA 3'-5' DNA exonuclease activity [GO:0008310]; single-stranded DNA binding [GO:0003697] g16967.t1 Q06248 76.48 642 0.0 1011.0 sp|Q06248|HSP74_PARLI Heat shock 70 kDa protein IV OS=Paracentrotus lividus OX=7656 GN=HSP70IV PE=3 SV=1 g16967.t2 Q06248 74.407 590 0.0 899.0 sp|Q06248|HSP74_PARLI Heat shock 70 kDa protein IV OS=Paracentrotus lividus OX=7656 GN=HSP70IV PE=3 SV=1 g16971.t1 P83871 100.0 110 5.63e-76 222.0 sp|P83871|PHF5A_RAT PHD finger-like domain-containing protein 5A OS=Rattus norvegicus OX=10116 GN=Phf5a PE=2 SV=1 PHF5A_RAT reviewed PHD finger-like domain-containing protein 5A (PHD finger-like domain protein 5A) (Splicing factor 3B-associated 14 kDa protein) (SF3b14b) Rattus norvegicus (Rat) GO:0000398; GO:0003677; GO:0003723; GO:0005634; GO:0005654; GO:0005684; GO:0005686; GO:0005689; GO:0008270; GO:0016363; GO:0016607; GO:0045893; GO:0048863; GO:0071005; GO:0071011 mRNA splicing, via spliceosome [GO:0000398]; positive regulation of DNA-templated transcription [GO:0045893]; stem cell differentiation [GO:0048863] nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; U12-type spliceosomal complex [GO:0005689]; U2 snRNP [GO:0005686]; U2-type precatalytic spliceosome [GO:0071005]; U2-type spliceosomal complex [GO:0005684] DNA binding [GO:0003677]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270] g16972.t1 P19217 41.418 268 1.99e-65 211.0 sp|P19217|ST1E1_BOVIN Sulfotransferase 1E1 OS=Bos taurus OX=9913 GN=SULT1E1 PE=1 SV=1 ST1E1_BOVIN reviewed Sulfotransferase 1E1 (ST1E1) (EC 2.8.2.4) (Estrogen sulfotransferase) (Sulfotransferase, estrogen-preferring) Bos taurus (Bovine) GO:0004062; GO:0004304; GO:0005496; GO:0005737; GO:0005829; GO:0008210; GO:0050294; GO:0051923 estrogen metabolic process [GO:0008210]; sulfation [GO:0051923] cytoplasm [GO:0005737]; cytosol [GO:0005829] aryl sulfotransferase activity [GO:0004062]; estrone sulfotransferase activity [GO:0004304]; steroid binding [GO:0005496]; steroid sulfotransferase activity [GO:0050294] g16973.t1 Q95JD5 34.532 278 2.84e-51 173.0 sp|Q95JD5|ST1B1_CANLF Sulfotransferase 1B1 OS=Canis lupus familiaris OX=9615 GN=SULT1B1 PE=1 SV=1 g16974.t1 Q7SXM7 67.329 453 0.0 556.0 sp|Q7SXM7|PRP31_DANRE U4/U6 small nuclear ribonucleoprotein Prp31 OS=Danio rerio OX=7955 GN=prpf31 PE=2 SV=1 PRP31_DANRE reviewed U4/U6 small nuclear ribonucleoprotein Prp31 (Pre-mRNA-processing factor 31) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000244; GO:0000381; GO:0000398; GO:0005634; GO:0005687; GO:0005690; GO:0015030; GO:0016607; GO:0030622; GO:0046540; GO:0060041; GO:0071005; GO:0071011; GO:0071339; GO:0097526 mRNA splicing, via spliceosome [GO:0000398]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; retina development in camera-type eye [GO:0060041]; spliceosomal tri-snRNP complex assembly [GO:0000244] Cajal body [GO:0015030]; MLL1 complex [GO:0071339]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; spliceosomal tri-snRNP complex [GO:0097526]; U2-type precatalytic spliceosome [GO:0071005]; U4 snRNP [GO:0005687]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U4atac snRNP [GO:0005690] U4atac snRNA binding [GO:0030622] g16975.t1 Q75T13 38.682 592 4.87e-133 414.0 sp|Q75T13|PGAP1_HUMAN GPI inositol-deacylase OS=Homo sapiens OX=9606 GN=PGAP1 PE=1 SV=1 PGAP1_HUMAN reviewed GPI inositol-deacylase (EC 3.1.-.-) (Post-GPI attachment to proteins factor 1) (hPGAP1) Homo sapiens (Human) GO:0005783; GO:0005789; GO:0006506; GO:0007605; GO:0009880; GO:0009948; GO:0015031; GO:0016255; GO:0016788; GO:0021871; GO:0050185; GO:0160215; GO:1902953 anterior/posterior axis specification [GO:0009948]; attachment of GPI anchor to protein [GO:0016255]; embryonic pattern specification [GO:0009880]; forebrain regionalization [GO:0021871]; GPI anchor biosynthetic process [GO:0006506]; positive regulation of ER to Golgi vesicle-mediated transport [GO:1902953]; protein transport [GO:0015031]; sensory perception of sound [GO:0007605] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789] deacylase activity [GO:0160215]; hydrolase activity, acting on ester bonds [GO:0016788]; phosphatidylinositol deacylase activity [GO:0050185] g16975.t2 Q75T13 37.838 592 3.4800000000000003e-129 404.0 sp|Q75T13|PGAP1_HUMAN GPI inositol-deacylase OS=Homo sapiens OX=9606 GN=PGAP1 PE=1 SV=1 PGAP1_HUMAN reviewed GPI inositol-deacylase (EC 3.1.-.-) (Post-GPI attachment to proteins factor 1) (hPGAP1) Homo sapiens (Human) GO:0005783; GO:0005789; GO:0006506; GO:0007605; GO:0009880; GO:0009948; GO:0015031; GO:0016255; GO:0016788; GO:0021871; GO:0050185; GO:0160215; GO:1902953 anterior/posterior axis specification [GO:0009948]; attachment of GPI anchor to protein [GO:0016255]; embryonic pattern specification [GO:0009880]; forebrain regionalization [GO:0021871]; GPI anchor biosynthetic process [GO:0006506]; positive regulation of ER to Golgi vesicle-mediated transport [GO:1902953]; protein transport [GO:0015031]; sensory perception of sound [GO:0007605] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789] deacylase activity [GO:0160215]; hydrolase activity, acting on ester bonds [GO:0016788]; phosphatidylinositol deacylase activity [GO:0050185] g16978.t1 O95497 39.423 520 4.42e-107 333.0 sp|O95497|VNN1_HUMAN Pantetheinase OS=Homo sapiens OX=9606 GN=VNN1 PE=1 SV=2 VNN1_HUMAN reviewed Pantetheinase (EC 3.5.1.92) (Pantetheine hydrolase) (Tiff66) (Vascular non-inflammatory molecule 1) (Vanin-1) Homo sapiens (Human) GO:0002526; GO:0002544; GO:0005576; GO:0005886; GO:0006954; GO:0006979; GO:0015938; GO:0015939; GO:0016020; GO:0017159; GO:0033089; GO:0035577; GO:0045087; GO:0098552; GO:0098609; GO:1902177 acute inflammatory response [GO:0002526]; cell-cell adhesion [GO:0098609]; chronic inflammatory response [GO:0002544]; coenzyme A catabolic process [GO:0015938]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; pantothenate metabolic process [GO:0015939]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of T cell differentiation in thymus [GO:0033089]; response to oxidative stress [GO:0006979] azurophil granule membrane [GO:0035577]; extracellular region [GO:0005576]; membrane [GO:0016020]; plasma membrane [GO:0005886]; side of membrane [GO:0098552] pantetheine hydrolase activity [GO:0017159] g16979.t1 Q99LI8 52.896 518 2.29e-145 449.0 sp|Q99LI8|HGS_MOUSE Hepatocyte growth factor-regulated tyrosine kinase substrate OS=Mus musculus OX=10090 GN=Hgs PE=1 SV=2 HGS_MOUSE reviewed Hepatocyte growth factor-regulated tyrosine kinase substrate Mus musculus (Mouse) GO:0005737; GO:0005764; GO:0005768; GO:0005769; GO:0005829; GO:0006622; GO:0008270; GO:0008333; GO:0010324; GO:0010628; GO:0010642; GO:0016525; GO:0019904; GO:0030141; GO:0030948; GO:0031623; GO:0031901; GO:0032456; GO:0032585; GO:0033565; GO:0035091; GO:0042802; GO:0043130; GO:0044389; GO:0046426; GO:0072657; GO:0140036; GO:1903543 endocytic recycling [GO:0032456]; endosome to lysosome transport [GO:0008333]; membrane invagination [GO:0010324]; negative regulation of angiogenesis [GO:0016525]; negative regulation of platelet-derived growth factor receptor signaling pathway [GO:0010642]; negative regulation of receptor signaling pathway via JAK-STAT [GO:0046426]; negative regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030948]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of gene expression [GO:0010628]; protein localization to membrane [GO:0072657]; protein targeting to lysosome [GO:0006622]; receptor internalization [GO:0031623] cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; ESCRT-0 complex [GO:0033565]; lysosome [GO:0005764]; multivesicular body membrane [GO:0032585]; secretory granule [GO:0030141] identical protein binding [GO:0042802]; phosphatidylinositol binding [GO:0035091]; protein domain specific binding [GO:0019904]; ubiquitin binding [GO:0043130]; ubiquitin-like protein ligase binding [GO:0044389]; ubiquitin-modified protein reader activity [GO:0140036]; zinc ion binding [GO:0008270] g16979.t2 Q99LI8 52.896 518 2.24e-145 448.0 sp|Q99LI8|HGS_MOUSE Hepatocyte growth factor-regulated tyrosine kinase substrate OS=Mus musculus OX=10090 GN=Hgs PE=1 SV=2 HGS_MOUSE reviewed Hepatocyte growth factor-regulated tyrosine kinase substrate Mus musculus (Mouse) GO:0005737; GO:0005764; GO:0005768; GO:0005769; GO:0005829; GO:0006622; GO:0008270; GO:0008333; GO:0010324; GO:0010628; GO:0010642; GO:0016525; GO:0019904; GO:0030141; GO:0030948; GO:0031623; GO:0031901; GO:0032456; GO:0032585; GO:0033565; GO:0035091; GO:0042802; GO:0043130; GO:0044389; GO:0046426; GO:0072657; GO:0140036; GO:1903543 endocytic recycling [GO:0032456]; endosome to lysosome transport [GO:0008333]; membrane invagination [GO:0010324]; negative regulation of angiogenesis [GO:0016525]; negative regulation of platelet-derived growth factor receptor signaling pathway [GO:0010642]; negative regulation of receptor signaling pathway via JAK-STAT [GO:0046426]; negative regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030948]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of gene expression [GO:0010628]; protein localization to membrane [GO:0072657]; protein targeting to lysosome [GO:0006622]; receptor internalization [GO:0031623] cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; ESCRT-0 complex [GO:0033565]; lysosome [GO:0005764]; multivesicular body membrane [GO:0032585]; secretory granule [GO:0030141] identical protein binding [GO:0042802]; phosphatidylinositol binding [GO:0035091]; protein domain specific binding [GO:0019904]; ubiquitin binding [GO:0043130]; ubiquitin-like protein ligase binding [GO:0044389]; ubiquitin-modified protein reader activity [GO:0140036]; zinc ion binding [GO:0008270] g16979.t3 Q99LI8 52.794 519 2.4499999999999997e-146 451.0 sp|Q99LI8|HGS_MOUSE Hepatocyte growth factor-regulated tyrosine kinase substrate OS=Mus musculus OX=10090 GN=Hgs PE=1 SV=2 HGS_MOUSE reviewed Hepatocyte growth factor-regulated tyrosine kinase substrate Mus musculus (Mouse) GO:0005737; GO:0005764; GO:0005768; GO:0005769; GO:0005829; GO:0006622; GO:0008270; GO:0008333; GO:0010324; GO:0010628; GO:0010642; GO:0016525; GO:0019904; GO:0030141; GO:0030948; GO:0031623; GO:0031901; GO:0032456; GO:0032585; GO:0033565; GO:0035091; GO:0042802; GO:0043130; GO:0044389; GO:0046426; GO:0072657; GO:0140036; GO:1903543 endocytic recycling [GO:0032456]; endosome to lysosome transport [GO:0008333]; membrane invagination [GO:0010324]; negative regulation of angiogenesis [GO:0016525]; negative regulation of platelet-derived growth factor receptor signaling pathway [GO:0010642]; negative regulation of receptor signaling pathway via JAK-STAT [GO:0046426]; negative regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030948]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of gene expression [GO:0010628]; protein localization to membrane [GO:0072657]; protein targeting to lysosome [GO:0006622]; receptor internalization [GO:0031623] cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; ESCRT-0 complex [GO:0033565]; lysosome [GO:0005764]; multivesicular body membrane [GO:0032585]; secretory granule [GO:0030141] identical protein binding [GO:0042802]; phosphatidylinositol binding [GO:0035091]; protein domain specific binding [GO:0019904]; ubiquitin binding [GO:0043130]; ubiquitin-like protein ligase binding [GO:0044389]; ubiquitin-modified protein reader activity [GO:0140036]; zinc ion binding [GO:0008270] g16980.t1 Q0P5N6 43.503 177 7.19e-42 142.0 sp|Q0P5N6|ARL16_HUMAN ADP-ribosylation factor-like protein 16 OS=Homo sapiens OX=9606 GN=ARL16 PE=1 SV=1 ARL16_HUMAN reviewed ADP-ribosylation factor-like protein 16 Homo sapiens (Human) GO:0003924; GO:0005525; GO:0005737 cytoplasm [GO:0005737] GTP binding [GO:0005525]; GTPase activity [GO:0003924] g16982.t1 G3C7W6 47.358 492 3.42e-131 397.0 sp|G3C7W6|S2611_CAVPO Sodium-independent sulfate anion transporter OS=Cavia porcellus OX=10141 GN=Slc26a11 PE=2 SV=1 S2611_CAVPO reviewed Sodium-independent sulfate anion transporter (Solute carrier family 26 member 11) Cavia porcellus (Guinea pig) GO:0005254; GO:0005654; GO:0005765; GO:0005783; GO:0005794; GO:0005886; GO:0008271; GO:0016323; GO:0016324; GO:0019532; GO:0140900; GO:1902358 oxalate transport [GO:0019532]; sulfate transmembrane transport [GO:1902358] apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; lysosomal membrane [GO:0005765]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] chloride channel activity [GO:0005254]; chloride:bicarbonate antiporter activity [GO:0140900]; secondary active sulfate transmembrane transporter activity [GO:0008271] g16983.t1 Q7Z6J9 38.235 170 2.33e-26 110.0 sp|Q7Z6J9|SEN54_HUMAN tRNA-splicing endonuclease subunit Sen54 OS=Homo sapiens OX=9606 GN=TSEN54 PE=1 SV=3 SEN54_HUMAN reviewed tRNA-splicing endonuclease subunit Sen54 (SEN54 homolog) (HsSEN54) (tRNA-intron endonuclease Sen54) Homo sapiens (Human) GO:0000214; GO:0000379; GO:0005654; GO:0005730; GO:0006388; GO:0006397 mRNA processing [GO:0006397]; tRNA splicing, via endonucleolytic cleavage and ligation [GO:0006388]; tRNA-type intron splice site recognition and cleavage [GO:0000379] nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; tRNA-intron endonuclease complex [GO:0000214] g16988.t1 O60303 50.0 790 0.0 739.0 sp|O60303|KATIP_HUMAN Katanin-interacting protein OS=Homo sapiens OX=9606 GN=KATNIP PE=1 SV=4 KATIP_HUMAN reviewed Katanin-interacting protein Homo sapiens (Human) GO:0005615; GO:0005654; GO:0005886; GO:0005929; GO:0005930; GO:0008017; GO:0015631; GO:0034451; GO:0036064; GO:0090660; GO:0097546; GO:0097729; GO:0120170; GO:1905504 cerebrospinal fluid circulation [GO:0090660]; negative regulation of motile cilium assembly [GO:1905504] 9+2 motile cilium [GO:0097729]; axoneme [GO:0005930]; centriolar satellite [GO:0034451]; ciliary basal body [GO:0036064]; ciliary base [GO:0097546]; cilium [GO:0005929]; extracellular space [GO:0005615]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] intraciliary transport particle B binding [GO:0120170]; microtubule binding [GO:0008017]; tubulin binding [GO:0015631] g16989.t1 Q7YRK6 62.069 87 3.85e-36 120.0 sp|Q7YRK6|CX6B1_CARSF Cytochrome c oxidase subunit 6B1 OS=Carlito syrichta OX=1868482 GN=COX6B1 PE=3 SV=3 g16990.t1 Q7ZXX2 50.644 776 0.0 709.0 sp|Q7ZXX2|KIF19_XENLA Kinesin-like protein KIF19 OS=Xenopus laevis OX=8355 GN=kif19 PE=2 SV=1 g16991.t1 Q495M9 53.378 148 1.2e-50 180.0 sp|Q495M9|USH1G_HUMAN pre-mRNA splicing regulator USH1G OS=Homo sapiens OX=9606 GN=USH1G PE=1 SV=1 USH1G_HUMAN reviewed pre-mRNA splicing regulator USH1G (Scaffold protein containing ankyrin repeats and SAM domain) (Usher syndrome type-1G protein) Homo sapiens (Human) GO:0001917; GO:0005813; GO:0005829; GO:0005886; GO:0007605; GO:0015030; GO:0015629; GO:0016607; GO:0030507; GO:0032391; GO:0036064; GO:0042472; GO:0042802; GO:0045494; GO:0050953; GO:0050957; GO:0060122; GO:0097546; GO:0097733; GO:2000369 equilibrioception [GO:0050957]; inner ear morphogenesis [GO:0042472]; inner ear receptor cell stereocilium organization [GO:0060122]; photoreceptor cell maintenance [GO:0045494]; regulation of clathrin-dependent endocytosis [GO:2000369]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605] actin cytoskeleton [GO:0015629]; Cajal body [GO:0015030]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary base [GO:0097546]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; photoreceptor cell cilium [GO:0097733]; photoreceptor connecting cilium [GO:0032391]; photoreceptor inner segment [GO:0001917]; plasma membrane [GO:0005886] identical protein binding [GO:0042802]; spectrin binding [GO:0030507] g16997.t1 Q61879 63.087 1937 0.0 2233.0 sp|Q61879|MYH10_MOUSE Myosin-10 OS=Mus musculus OX=10090 GN=Myh10 PE=1 SV=2 g17001.t1 Q9DBV3 52.285 1094 0.0 1113.0 sp|Q9DBV3|DHX34_MOUSE Probable ATP-dependent RNA helicase DHX34 OS=Mus musculus OX=10090 GN=Dhx34 PE=1 SV=2 DHX34_MOUSE reviewed Probable ATP-dependent RNA helicase DHX34 (EC 3.6.4.13) (DEAH box protein 34) (DExH-box helicase 34) Mus musculus (Mouse) GO:0000184; GO:0000956; GO:0003723; GO:0003724; GO:0004386; GO:0005524; GO:0016887; GO:0042327; GO:0044877; GO:2000623 negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:2000623]; nuclear-transcribed mRNA catabolic process [GO:0000956]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; positive regulation of phosphorylation [GO:0042327] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; helicase activity [GO:0004386]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724] g17003.t1 P55039 78.797 349 0.0 599.0 sp|P55039|DRG2_HUMAN Developmentally-regulated GTP-binding protein 2 OS=Homo sapiens OX=9606 GN=DRG2 PE=1 SV=1 DRG2_HUMAN reviewed Developmentally-regulated GTP-binding protein 2 (DRG-2) (Translation factor GTPase DRG2) (TRAFAC GTPase DRG2) (EC 3.6.5.-) Homo sapiens (Human) GO:0002181; GO:0003723; GO:0003924; GO:0005525; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007165; GO:0016020; GO:0046872 cytoplasmic translation [GO:0002181]; signal transduction [GO:0007165] cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; RNA binding [GO:0003723] g17004.t1 Q6NWH5 69.481 154 5.84e-78 233.0 sp|Q6NWH5|TMM11_DANRE Transmembrane protein 11, mitochondrial OS=Danio rerio OX=7955 GN=tmem11 PE=2 SV=1 g17005.t1 Q9D5E4 70.732 82 9.29e-34 124.0 sp|Q9D5E4|DRC3_MOUSE Dynein regulatory complex subunit 3 OS=Mus musculus OX=10090 GN=Drc3 PE=1 SV=1 DRC3_MOUSE reviewed Dynein regulatory complex subunit 3 (Leucine-rich repeat-containing protein 48) Mus musculus (Mouse) GO:0005737; GO:0005929; GO:0005930; GO:0036126; GO:0097545 axonemal doublet microtubule [GO:0097545]; axoneme [GO:0005930]; cilium [GO:0005929]; cytoplasm [GO:0005737]; sperm flagellum [GO:0036126] g17006.t1 Q9D5E4 44.131 426 1.45e-109 335.0 sp|Q9D5E4|DRC3_MOUSE Dynein regulatory complex subunit 3 OS=Mus musculus OX=10090 GN=Drc3 PE=1 SV=1 DRC3_MOUSE reviewed Dynein regulatory complex subunit 3 (Leucine-rich repeat-containing protein 48) Mus musculus (Mouse) GO:0005737; GO:0005929; GO:0005930; GO:0036126; GO:0097545 axonemal doublet microtubule [GO:0097545]; axoneme [GO:0005930]; cilium [GO:0005929]; cytoplasm [GO:0005737]; sperm flagellum [GO:0036126] g17008.t1 A0ZSK3 34.977 426 2.1e-76 263.0 sp|A0ZSK3|STXA_SYNVE Neoverrucotoxin subunit alpha OS=Synanceia verrucosa OX=51996 PE=1 SV=1 STXA_SYNVE reviewed Neoverrucotoxin subunit alpha (NeoVTX subunit alpha) Synanceia verrucosa (Reef stonefish) GO:0005576; GO:0031640; GO:0090729 killing of cells of another organism [GO:0031640] extracellular region [GO:0005576] toxin activity [GO:0090729] g17010.t1 Q14344 60.556 360 1.26e-156 447.0 sp|Q14344|GNA13_HUMAN Guanine nucleotide-binding protein subunit alpha-13 OS=Homo sapiens OX=9606 GN=GNA13 PE=1 SV=2 g17015.t1 Q5ZL55 66.48 179 1.1699999999999999e-60 191.0 sp|Q5ZL55|CHMP6_CHICK Charged multivesicular body protein 6 OS=Gallus gallus OX=9031 GN=CHMP6 PE=2 SV=3 g17016.t1 Q58CS8 52.209 249 1.0800000000000001e-88 270.0 sp|Q58CS8|GNPTG_BOVIN N-acetylglucosamine-1-phosphotransferase subunit gamma OS=Bos taurus OX=9913 GN=GNPTG PE=1 SV=4 GNPTG_BOVIN reviewed N-acetylglucosamine-1-phosphotransferase subunit gamma (GlcNAc-1-phosphotransferase subunit gamma) (UDP-N-acetylglucosamine-1-phosphotransferase subunit gamma) Bos taurus (Bovine) GO:0005576; GO:0005794; GO:0042803; GO:0046835 carbohydrate phosphorylation [GO:0046835] extracellular region [GO:0005576]; Golgi apparatus [GO:0005794] protein homodimerization activity [GO:0042803] g17017.t1 Q92186 33.48 227 1.1e-32 129.0 sp|Q92186|SIA8B_HUMAN Alpha-2,8-sialyltransferase 8B OS=Homo sapiens OX=9606 GN=ST8SIA2 PE=1 SV=1 SIA8B_HUMAN reviewed Alpha-2,8-sialyltransferase 8B (EC 2.4.3.-) (Sialyltransferase 8B) (SIAT8-B) (Sialyltransferase St8Sia II) (ST8SiaII) (Sialyltransferase X) (STX) Homo sapiens (Human) GO:0000139; GO:0000166; GO:0001574; GO:0003828; GO:0005576; GO:0005654; GO:0005769; GO:0005794; GO:0005829; GO:0005886; GO:0005975; GO:0006491; GO:0007399; GO:0009101; GO:0009311; GO:0033691; GO:0036211; GO:0042220; GO:0043525; GO:0048471; GO:0051965; GO:0055037; GO:0097503; GO:1990138 carbohydrate metabolic process [GO:0005975]; ganglioside biosynthetic process [GO:0001574]; glycoprotein biosynthetic process [GO:0009101]; N-glycan processing [GO:0006491]; nervous system development [GO:0007399]; neuron projection extension [GO:1990138]; oligosaccharide metabolic process [GO:0009311]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of synapse assembly [GO:0051965]; protein modification process [GO:0036211]; response to cocaine [GO:0042220]; sialylation [GO:0097503] cytosol [GO:0005829]; early endosome [GO:0005769]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037] alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity [GO:0003828]; nucleotide binding [GO:0000166]; sialic acid binding [GO:0033691] g17018.t1 P61643 34.978 223 1.0600000000000001e-35 137.0 sp|P61643|SIA8B_PANTR Alpha-2,8-sialyltransferase 8B OS=Pan troglodytes OX=9598 GN=ST8SIA2 PE=2 SV=1 g17020.t1 G3M4F8 27.576 330 5.2e-29 119.0 sp|G3M4F8|OCTB2_CHISP Octopamine receptor beta-2R OS=Chilo suppressalis OX=168631 GN=OA2B2 PE=2 SV=1 OCTB2_CHISP reviewed Octopamine receptor beta-2R (CsOA2B2) Chilo suppressalis (Asiatic rice borer moth) GO:0004989; GO:0005886; GO:0007189; GO:0008226; GO:0016020; GO:0043410; GO:0071418; GO:0071880; GO:0071927; GO:0071928 adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cellular response to amine stimulus [GO:0071418]; octopamine signaling pathway [GO:0071927]; positive regulation of MAPK cascade [GO:0043410]; tyramine signaling pathway [GO:0071928] membrane [GO:0016020]; plasma membrane [GO:0005886] octopamine receptor activity [GO:0004989]; tyramine receptor activity [GO:0008226] g17021.t1 G3M4F8 27.301 326 2.07e-27 115.0 sp|G3M4F8|OCTB2_CHISP Octopamine receptor beta-2R OS=Chilo suppressalis OX=168631 GN=OA2B2 PE=2 SV=1 OCTB2_CHISP reviewed Octopamine receptor beta-2R (CsOA2B2) Chilo suppressalis (Asiatic rice borer moth) GO:0004989; GO:0005886; GO:0007189; GO:0008226; GO:0016020; GO:0043410; GO:0071418; GO:0071880; GO:0071927; GO:0071928 adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cellular response to amine stimulus [GO:0071418]; octopamine signaling pathway [GO:0071927]; positive regulation of MAPK cascade [GO:0043410]; tyramine signaling pathway [GO:0071928] membrane [GO:0016020]; plasma membrane [GO:0005886] octopamine receptor activity [GO:0004989]; tyramine receptor activity [GO:0008226] g17022.t1 Q27433 67.547 265 2.1800000000000002e-103 313.0 sp|Q27433|MEC2_CAEEL Mechanosensory protein 2 OS=Caenorhabditis elegans OX=6239 GN=mec-2 PE=1 SV=1 MEC2_CAEEL reviewed Mechanosensory protein 2 Caenorhabditis elegans GO:0005272; GO:0005886; GO:0006813; GO:0007638; GO:0008200; GO:0009612; GO:0015485; GO:0032589; GO:0043005; GO:0050976; GO:1905789; GO:1905792 detection of mechanical stimulus involved in sensory perception of touch [GO:0050976]; mechanosensory behavior [GO:0007638]; positive regulation of detection of mechanical stimulus involved in sensory perception of touch [GO:1905789]; positive regulation of mechanosensory behavior [GO:1905792]; potassium ion transport [GO:0006813]; response to mechanical stimulus [GO:0009612] neuron projection [GO:0043005]; neuron projection membrane [GO:0032589]; plasma membrane [GO:0005886] cholesterol binding [GO:0015485]; ion channel inhibitor activity [GO:0008200]; sodium channel activity [GO:0005272] g17023.t1 P07511 69.499 459 0.0 651.0 sp|P07511|GLYC_RABIT Serine hydroxymethyltransferase, cytosolic OS=Oryctolagus cuniculus OX=9986 GN=SHMT1 PE=1 SV=2 g17024.t1 Q4G061 65.471 669 0.0 961.0 sp|Q4G061|EIF3B_RAT Eukaryotic translation initiation factor 3 subunit B OS=Rattus norvegicus OX=10116 GN=Eif3b PE=1 SV=1 EIF3B_RAT reviewed Eukaryotic translation initiation factor 3 subunit B (eIF3b) (Eukaryotic translation initiation factor 3 subunit 9) (eIF-3-eta) Rattus norvegicus (Rat) GO:0001732; GO:0003723; GO:0003743; GO:0005852; GO:0006413; GO:0006446; GO:0010494; GO:0016282; GO:0031369; GO:0033290; GO:0045202; GO:0071541; GO:0075522; GO:0075525 formation of cytoplasmic translation initiation complex [GO:0001732]; IRES-dependent viral translational initiation [GO:0075522]; regulation of translational initiation [GO:0006446]; translational initiation [GO:0006413]; viral translational termination-reinitiation [GO:0075525] cytoplasmic stress granule [GO:0010494]; eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; eukaryotic translation initiation factor 3 complex, eIF3m [GO:0071541]; synapse [GO:0045202] RNA binding [GO:0003723]; translation initiation factor activity [GO:0003743]; translation initiation factor binding [GO:0031369] g17025.t1 Q27433 71.318 258 1.02e-105 318.0 sp|Q27433|MEC2_CAEEL Mechanosensory protein 2 OS=Caenorhabditis elegans OX=6239 GN=mec-2 PE=1 SV=1 MEC2_CAEEL reviewed Mechanosensory protein 2 Caenorhabditis elegans GO:0005272; GO:0005886; GO:0006813; GO:0007638; GO:0008200; GO:0009612; GO:0015485; GO:0032589; GO:0043005; GO:0050976; GO:1905789; GO:1905792 detection of mechanical stimulus involved in sensory perception of touch [GO:0050976]; mechanosensory behavior [GO:0007638]; positive regulation of detection of mechanical stimulus involved in sensory perception of touch [GO:1905789]; positive regulation of mechanosensory behavior [GO:1905792]; potassium ion transport [GO:0006813]; response to mechanical stimulus [GO:0009612] neuron projection [GO:0043005]; neuron projection membrane [GO:0032589]; plasma membrane [GO:0005886] cholesterol binding [GO:0015485]; ion channel inhibitor activity [GO:0008200]; sodium channel activity [GO:0005272] g17027.t1 Q27433 65.035 286 5.27e-103 312.0 sp|Q27433|MEC2_CAEEL Mechanosensory protein 2 OS=Caenorhabditis elegans OX=6239 GN=mec-2 PE=1 SV=1 MEC2_CAEEL reviewed Mechanosensory protein 2 Caenorhabditis elegans GO:0005272; GO:0005886; GO:0006813; GO:0007638; GO:0008200; GO:0009612; GO:0015485; GO:0032589; GO:0043005; GO:0050976; GO:1905789; GO:1905792 detection of mechanical stimulus involved in sensory perception of touch [GO:0050976]; mechanosensory behavior [GO:0007638]; positive regulation of detection of mechanical stimulus involved in sensory perception of touch [GO:1905789]; positive regulation of mechanosensory behavior [GO:1905792]; potassium ion transport [GO:0006813]; response to mechanical stimulus [GO:0009612] neuron projection [GO:0043005]; neuron projection membrane [GO:0032589]; plasma membrane [GO:0005886] cholesterol binding [GO:0015485]; ion channel inhibitor activity [GO:0008200]; sodium channel activity [GO:0005272] g17028.t1 Q27433 67.647 272 9.99e-102 308.0 sp|Q27433|MEC2_CAEEL Mechanosensory protein 2 OS=Caenorhabditis elegans OX=6239 GN=mec-2 PE=1 SV=1 MEC2_CAEEL reviewed Mechanosensory protein 2 Caenorhabditis elegans GO:0005272; GO:0005886; GO:0006813; GO:0007638; GO:0008200; GO:0009612; GO:0015485; GO:0032589; GO:0043005; GO:0050976; GO:1905789; GO:1905792 detection of mechanical stimulus involved in sensory perception of touch [GO:0050976]; mechanosensory behavior [GO:0007638]; positive regulation of detection of mechanical stimulus involved in sensory perception of touch [GO:1905789]; positive regulation of mechanosensory behavior [GO:1905792]; potassium ion transport [GO:0006813]; response to mechanical stimulus [GO:0009612] neuron projection [GO:0043005]; neuron projection membrane [GO:0032589]; plasma membrane [GO:0005886] cholesterol binding [GO:0015485]; ion channel inhibitor activity [GO:0008200]; sodium channel activity [GO:0005272] g17029.t1 Q22165 61.905 252 4.04e-86 264.0 sp|Q22165|STO4_CAEEL Stomatin-4 OS=Caenorhabditis elegans OX=6239 GN=sto-4 PE=3 SV=2 g17030.t1 Q27433 71.937 253 7.25e-108 323.0 sp|Q27433|MEC2_CAEEL Mechanosensory protein 2 OS=Caenorhabditis elegans OX=6239 GN=mec-2 PE=1 SV=1 MEC2_CAEEL reviewed Mechanosensory protein 2 Caenorhabditis elegans GO:0005272; GO:0005886; GO:0006813; GO:0007638; GO:0008200; GO:0009612; GO:0015485; GO:0032589; GO:0043005; GO:0050976; GO:1905789; GO:1905792 detection of mechanical stimulus involved in sensory perception of touch [GO:0050976]; mechanosensory behavior [GO:0007638]; positive regulation of detection of mechanical stimulus involved in sensory perception of touch [GO:1905789]; positive regulation of mechanosensory behavior [GO:1905792]; potassium ion transport [GO:0006813]; response to mechanical stimulus [GO:0009612] neuron projection [GO:0043005]; neuron projection membrane [GO:0032589]; plasma membrane [GO:0005886] cholesterol binding [GO:0015485]; ion channel inhibitor activity [GO:0008200]; sodium channel activity [GO:0005272] g17031.t1 G3M4F8 35.179 307 5.4e-55 189.0 sp|G3M4F8|OCTB2_CHISP Octopamine receptor beta-2R OS=Chilo suppressalis OX=168631 GN=OA2B2 PE=2 SV=1 OCTB2_CHISP reviewed Octopamine receptor beta-2R (CsOA2B2) Chilo suppressalis (Asiatic rice borer moth) GO:0004989; GO:0005886; GO:0007189; GO:0008226; GO:0016020; GO:0043410; GO:0071418; GO:0071880; GO:0071927; GO:0071928 adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cellular response to amine stimulus [GO:0071418]; octopamine signaling pathway [GO:0071927]; positive regulation of MAPK cascade [GO:0043410]; tyramine signaling pathway [GO:0071928] membrane [GO:0016020]; plasma membrane [GO:0005886] octopamine receptor activity [GO:0004989]; tyramine receptor activity [GO:0008226] g17033.t1 O95639 55.477 283 4.18e-112 328.0 sp|O95639|CPSF4_HUMAN Cleavage and polyadenylation specificity factor subunit 4 OS=Homo sapiens OX=9606 GN=CPSF4 PE=1 SV=1 CPSF4_HUMAN reviewed Cleavage and polyadenylation specificity factor subunit 4 (Cleavage and polyadenylation specificity factor 30 kDa subunit) (CPSF 30 kDa subunit) (NS1 effector domain-binding protein 1) (Neb-1) (No arches homolog) Homo sapiens (Human) GO:0003723; GO:0005654; GO:0005847; GO:0006397; GO:0008270; GO:1990837 mRNA processing [GO:0006397] mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; nucleoplasm [GO:0005654] RNA binding [GO:0003723]; sequence-specific double-stranded DNA binding [GO:1990837]; zinc ion binding [GO:0008270] g17034.t1 Q9H633 45.652 138 1.12e-31 113.0 sp|Q9H633|RPP21_HUMAN Ribonuclease P protein subunit p21 OS=Homo sapiens OX=9606 GN=RPP21 PE=1 SV=1 g17035.t1 Q8CFY5 52.381 315 1.41e-100 311.0 sp|Q8CFY5|COX10_MOUSE Protoheme IX farnesyltransferase, mitochondrial OS=Mus musculus OX=10090 GN=Cox10 PE=2 SV=1 COX10_MOUSE reviewed Protoheme IX farnesyltransferase, mitochondrial (EC 2.5.1.141) (Heme O synthase) Mus musculus (Mouse) GO:0000266; GO:0002521; GO:0004311; GO:0005730; GO:0005739; GO:0005759; GO:0005829; GO:0006629; GO:0006784; GO:0007005; GO:0008495; GO:0008535; GO:0009060; GO:0017004; GO:0031966; GO:0035264; GO:0055070; GO:0070069 aerobic respiration [GO:0009060]; copper ion homeostasis [GO:0055070]; cytochrome complex assembly [GO:0017004]; heme A biosynthetic process [GO:0006784]; leukocyte differentiation [GO:0002521]; lipid metabolic process [GO:0006629]; mitochondrial fission [GO:0000266]; mitochondrion organization [GO:0007005]; multicellular organism growth [GO:0035264]; respiratory chain complex IV assembly [GO:0008535] cytochrome complex [GO:0070069]; cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; nucleolus [GO:0005730] geranylgeranyl diphosphate synthase activity [GO:0004311]; protoheme IX farnesyltransferase activity [GO:0008495] g17036.t1 P49013 35.082 305 1.93e-49 176.0 sp|P49013|FBP3_STRPU Fibropellin-3 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF3 PE=1 SV=1 g17036.t1 P49013 45.312 128 4.9799999999999996e-23 103.0 sp|P49013|FBP3_STRPU Fibropellin-3 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF3 PE=1 SV=1 g17037.t1 P10079 50.894 615 0.0 570.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g17037.t1 P10079 47.854 629 0.0 561.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g17037.t1 P10079 48.73 630 0.0 560.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g17037.t1 P10079 49.126 629 0.0 560.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g17037.t1 P10079 46.52 589 5.19e-158 484.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g17037.t1 P10079 52.814 462 4.38e-143 446.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g17037.t1 P10079 36.795 674 2.75e-111 362.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g17038.t1 P10079 40.95 779 3.26e-167 520.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g17038.t1 P10079 38.06 804 1.18e-138 445.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g17038.t1 P10079 46.543 376 1.48e-102 348.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g17038.t1 P10079 45.0 340 2.1199999999999998e-89 311.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g17038.t1 P10079 33.844 588 2.69e-76 274.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g17038.t1 P10079 41.076 409 2.2399999999999998e-67 248.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g17038.t1 P10079 39.055 402 2.3499999999999997e-67 248.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g17038.t1 P10079 40.764 314 1.47e-53 207.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g17038.t1 P10079 40.317 315 3.15e-51 199.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g17045.t1 A7RUD5 69.565 69 1.08e-28 107.0 sp|A7RUD5|NUBP1_NEMVE Cytosolic Fe-S cluster assembly factor NUBP1 homolog OS=Nematostella vectensis OX=45351 GN=v1g236650 PE=3 SV=1 NUBP1_NEMVE reviewed Cytosolic Fe-S cluster assembly factor NUBP1 homolog Nematostella vectensis (Starlet sea anemone) GO:0005524; GO:0005829; GO:0016226; GO:0046872; GO:0051536; GO:0051539; GO:0140663 iron-sulfur cluster assembly [GO:0016226] cytosol [GO:0005829] 4 iron, 4 sulfur cluster binding [GO:0051539]; ATP binding [GO:0005524]; ATP-dependent FeS chaperone activity [GO:0140663]; iron-sulfur cluster binding [GO:0051536]; metal ion binding [GO:0046872] g17053.t1 Q6P298 82.305 243 8.28e-153 431.0 sp|Q6P298|NUBP1_DANRE Cytosolic Fe-S cluster assembly factor nubp1 OS=Danio rerio OX=7955 GN=nubp1 PE=2 SV=2 NUBP1_DANRE reviewed Cytosolic Fe-S cluster assembly factor nubp1 (Nucleotide-binding protein 1) (NBP 1) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005524; GO:0005829; GO:0016226; GO:0046872; GO:0051536; GO:0051539; GO:0140663 iron-sulfur cluster assembly [GO:0016226] cytosol [GO:0005829] 4 iron, 4 sulfur cluster binding [GO:0051539]; ATP binding [GO:0005524]; ATP-dependent FeS chaperone activity [GO:0140663]; iron-sulfur cluster binding [GO:0051536]; metal ion binding [GO:0046872] g17058.t1 Q7TN88 43.75 208 1.05e-45 176.0 sp|Q7TN88|PK1L2_MOUSE Polycystin-1-like protein 2 OS=Mus musculus OX=10090 GN=Pkd1l2 PE=2 SV=1 PK1L2_MOUSE reviewed Polycystin-1-like protein 2 (Polycystin-1L2) (PC1-like 2 protein) (Polycystic kidney disease protein 1-like 2) Mus musculus (Mouse) GO:0001965; GO:0005262; GO:0005509; GO:0016020; GO:0030246; GO:0050982 detection of mechanical stimulus [GO:0050982] membrane [GO:0016020] calcium channel activity [GO:0005262]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; G-protein alpha-subunit binding [GO:0001965] g17060.t1 A2A259 30.539 501 5.13e-69 243.0 sp|A2A259|PK2L1_MOUSE Polycystin-2-like protein 1 OS=Mus musculus OX=10090 GN=Pkd2l1 PE=1 SV=1 PK2L1_MOUSE reviewed Polycystin-2-like protein 1 (Polycystin-2L1) (Polycystic kidney disease 2-like 1 protein) (Polycystin-2 homolog) Mus musculus (Mouse) GO:0001581; GO:0005227; GO:0005261; GO:0005262; GO:0005272; GO:0005509; GO:0005783; GO:0005829; GO:0005886; GO:0006812; GO:0007224; GO:0008092; GO:0009415; GO:0015269; GO:0015629; GO:0016020; GO:0031410; GO:0034703; GO:0034704; GO:0035725; GO:0042802; GO:0043235; GO:0044325; GO:0050912; GO:0050915; GO:0050982; GO:0051262; GO:0051289; GO:0051371; GO:0051393; GO:0060170; GO:0071467; GO:0071468; GO:0071805; GO:0097730; GO:0098655; GO:0098662; GO:0160128; GO:1990760 cellular response to acidic pH [GO:0071468]; cellular response to pH [GO:0071467]; detection of chemical stimulus involved in sensory perception of sour taste [GO:0001581]; detection of chemical stimulus involved in sensory perception of taste [GO:0050912]; detection of mechanical stimulus [GO:0050982]; inorganic cation transmembrane transport [GO:0098662]; monoatomic cation transmembrane transport [GO:0098655]; monoatomic cation transport [GO:0006812]; potassium ion transmembrane transport [GO:0071805]; protein homotetramerization [GO:0051289]; protein tetramerization [GO:0051262]; response to water [GO:0009415]; sensory perception of sour taste [GO:0050915]; smoothened signaling pathway [GO:0007224]; sodium ion transmembrane transport [GO:0035725] actin cytoskeleton [GO:0015629]; calcium channel complex [GO:0034704]; cation channel complex [GO:0034703]; ciliary membrane [GO:0060170]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; membrane [GO:0016020]; non-motile cilium [GO:0097730]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] alpha-actinin binding [GO:0051393]; calcium channel activity [GO:0005262]; calcium ion binding [GO:0005509]; calcium-activated cation channel activity [GO:0005227]; calcium-activated potassium channel activity [GO:0015269]; cytoskeletal protein binding [GO:0008092]; identical protein binding [GO:0042802]; monoatomic cation channel activity [GO:0005261]; muscle alpha-actinin binding [GO:0051371]; osmolarity-sensing monoatomic cation channel activity [GO:1990760]; pH-gated monoatomic ion channel activity [GO:0160128]; sodium channel activity [GO:0005272]; transmembrane transporter binding [GO:0044325] g17061.t1 Q7TN88 39.106 358 1.81e-76 289.0 sp|Q7TN88|PK1L2_MOUSE Polycystin-1-like protein 2 OS=Mus musculus OX=10090 GN=Pkd1l2 PE=2 SV=1 PK1L2_MOUSE reviewed Polycystin-1-like protein 2 (Polycystin-1L2) (PC1-like 2 protein) (Polycystic kidney disease protein 1-like 2) Mus musculus (Mouse) GO:0001965; GO:0005262; GO:0005509; GO:0016020; GO:0030246; GO:0050982 detection of mechanical stimulus [GO:0050982] membrane [GO:0016020] calcium channel activity [GO:0005262]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; G-protein alpha-subunit binding [GO:0001965] g17061.t1 Q7TN88 27.727 660 3.42e-69 265.0 sp|Q7TN88|PK1L2_MOUSE Polycystin-1-like protein 2 OS=Mus musculus OX=10090 GN=Pkd1l2 PE=2 SV=1 PK1L2_MOUSE reviewed Polycystin-1-like protein 2 (Polycystin-1L2) (PC1-like 2 protein) (Polycystic kidney disease protein 1-like 2) Mus musculus (Mouse) GO:0001965; GO:0005262; GO:0005509; GO:0016020; GO:0030246; GO:0050982 detection of mechanical stimulus [GO:0050982] membrane [GO:0016020] calcium channel activity [GO:0005262]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; G-protein alpha-subunit binding [GO:0001965] g17066.t1 A6H782 51.515 495 1.9499999999999999e-178 513.0 sp|A6H782|TEKT3_BOVIN Tektin-3 OS=Bos taurus OX=9913 GN=TEKT3 PE=1 SV=1 TEKT3_BOVIN reviewed Tektin-3 Bos taurus (Bovine) GO:0001669; GO:0002080; GO:0002081; GO:0005879; GO:0015630; GO:0030317; GO:0036126; GO:0060271; GO:0060294; GO:0060378; GO:0160111 cilium assembly [GO:0060271]; cilium movement involved in cell motility [GO:0060294]; flagellated sperm motility [GO:0030317]; regulation of brood size [GO:0060378] acrosomal membrane [GO:0002080]; acrosomal vesicle [GO:0001669]; axonemal A tubule inner sheath [GO:0160111]; axonemal microtubule [GO:0005879]; microtubule cytoskeleton [GO:0015630]; outer acrosomal membrane [GO:0002081]; sperm flagellum [GO:0036126] g17067.t1 Q5RAM2 37.297 370 8.46e-66 219.0 sp|Q5RAM2|ERR3_PONAB Estrogen-related receptor gamma OS=Pongo abelii OX=9601 GN=ESRRG PE=2 SV=1 g17068.t1 Q5RAM2 28.571 203 6.9e-23 99.4 sp|Q5RAM2|ERR3_PONAB Estrogen-related receptor gamma OS=Pongo abelii OX=9601 GN=ESRRG PE=2 SV=1 g17069.t1 Q6QMY5 46.324 136 2.0500000000000003e-37 135.0 sp|Q6QMY5|ERR1_CANLF Steroid hormone receptor ERR1 OS=Canis lupus familiaris OX=9615 GN=ESRRA PE=2 SV=1 g17071.t1 Q6INH1 53.034 379 8.729999999999999e-138 421.0 sp|Q6INH1|RN157_XENLA E3 ubiquitin ligase Rnf157 OS=Xenopus laevis OX=8355 GN=rnf157 PE=2 SV=1 g17072.t1 Q8TB05 59.292 113 4.83e-25 97.1 sp|Q8TB05|UBAD1_HUMAN UBA-like domain-containing protein 1 OS=Homo sapiens OX=9606 GN=UBALD1 PE=1 SV=1 g17076.t1 Q7ZXV8 87.778 90 2.1e-52 187.0 sp|Q7ZXV8|ZN207_XENLA BUB3-interacting and GLEBS motif-containing protein ZNF207 OS=Xenopus laevis OX=8355 GN=znf207 PE=1 SV=1 ZN207_XENLA reviewed BUB3-interacting and GLEBS motif-containing protein ZNF207 (BuGZ) (xBuGZ) (Zinc finger protein 207) Xenopus laevis (African clawed frog) GO:0000070; GO:0000776; GO:0001578; GO:0005634; GO:0005819; GO:0005874; GO:0007094; GO:0008017; GO:0008270; GO:0008608; GO:0046785; GO:0050821; GO:0051301; GO:0051983; GO:0090307; GO:1990047 attachment of spindle microtubules to kinetochore [GO:0008608]; cell division [GO:0051301]; microtubule bundle formation [GO:0001578]; microtubule polymerization [GO:0046785]; mitotic sister chromatid segregation [GO:0000070]; mitotic spindle assembly [GO:0090307]; mitotic spindle assembly checkpoint signaling [GO:0007094]; protein stabilization [GO:0050821]; regulation of chromosome segregation [GO:0051983] kinetochore [GO:0000776]; microtubule [GO:0005874]; nucleus [GO:0005634]; spindle [GO:0005819]; spindle matrix [GO:1990047] microtubule binding [GO:0008017]; zinc ion binding [GO:0008270] g17078.t1 A0A0G2K1Q8 46.365 1747 0.0 1495.0 sp|A0A0G2K1Q8|ABCA3_RAT Phospholipid-transporting ATPase ABCA3 OS=Rattus norvegicus OX=10116 GN=Abca3 PE=1 SV=1 ABCA3_RAT reviewed Phospholipid-transporting ATPase ABCA3 (EC 7.6.2.1) (ATP-binding cassette sub-family A member 3) (Xenobiotic-transporting ATPase ABCA3) (EC 7.6.2.2) [Cleaved into: 150 Kda mature form] Rattus norvegicus (Rat) GO:0005319; GO:0005524; GO:0005765; GO:0005770; GO:0005886; GO:0006855; GO:0006869; GO:0008559; GO:0010875; GO:0015914; GO:0016887; GO:0030324; GO:0030659; GO:0032368; GO:0032464; GO:0032585; GO:0042599; GO:0042626; GO:0042908; GO:0043129; GO:0046470; GO:0046471; GO:0046618; GO:0046890; GO:0051384; GO:0055091; GO:0097208; GO:0097232; GO:0097233; GO:0120019; GO:0140345; GO:0150172; GO:1902995; GO:2001140 lipid transport [GO:0006869]; lung development [GO:0030324]; phosphatidylcholine metabolic process [GO:0046470]; phosphatidylglycerol metabolic process [GO:0046471]; phospholipid homeostasis [GO:0055091]; phospholipid transport [GO:0015914]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of phospholipid efflux [GO:1902995]; positive regulation of phospholipid transport [GO:2001140]; positive regulation of protein homooligomerization [GO:0032464]; regulation of lipid biosynthetic process [GO:0046890]; regulation of lipid transport [GO:0032368]; regulation of phosphatidylcholine metabolic process [GO:0150172]; response to glucocorticoid [GO:0051384]; surfactant homeostasis [GO:0043129]; xenobiotic export from cell [GO:0046618]; xenobiotic transmembrane transport [GO:0006855]; xenobiotic transport [GO:0042908] alveolar lamellar body [GO:0097208]; alveolar lamellar body membrane [GO:0097233]; cytoplasmic vesicle membrane [GO:0030659]; lamellar body [GO:0042599]; lamellar body membrane [GO:0097232]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; multivesicular body membrane [GO:0032585]; plasma membrane [GO:0005886] ABC-type xenobiotic transporter activity [GO:0008559]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; lipid transporter activity [GO:0005319]; phosphatidylcholine flippase activity [GO:0140345]; phosphatidylcholine transfer activity [GO:0120019] g17080.t1 Q3U4H6 48.571 105 2.83e-26 105.0 sp|Q3U4H6|HEXD_MOUSE Hexosaminidase D OS=Mus musculus OX=10090 GN=Hexd PE=1 SV=1 HEXD_MOUSE reviewed Hexosaminidase D (EC 3.2.1.52) (Beta-N-acetylhexosaminidase) (Beta-hexosaminidase D) (Hexosaminidase domain-containing protein) (N-acetyl-beta-galactosaminidase) Mus musculus (Mouse) GO:0004563; GO:0005634; GO:0005737; GO:0005975; GO:0015929; GO:1903561 carbohydrate metabolic process [GO:0005975] cytoplasm [GO:0005737]; extracellular vesicle [GO:1903561]; nucleus [GO:0005634] beta-N-acetylhexosaminidase activity [GO:0004563]; hexosaminidase activity [GO:0015929] g17081.t1 Q3U4H6 34.722 288 7.800000000000001e-27 112.0 sp|Q3U4H6|HEXD_MOUSE Hexosaminidase D OS=Mus musculus OX=10090 GN=Hexd PE=1 SV=1 HEXD_MOUSE reviewed Hexosaminidase D (EC 3.2.1.52) (Beta-N-acetylhexosaminidase) (Beta-hexosaminidase D) (Hexosaminidase domain-containing protein) (N-acetyl-beta-galactosaminidase) Mus musculus (Mouse) GO:0004563; GO:0005634; GO:0005737; GO:0005975; GO:0015929; GO:1903561 carbohydrate metabolic process [GO:0005975] cytoplasm [GO:0005737]; extracellular vesicle [GO:1903561]; nucleus [GO:0005634] beta-N-acetylhexosaminidase activity [GO:0004563]; hexosaminidase activity [GO:0015929] g17083.t1 Q7T2A5 66.135 564 0.0 729.0 sp|Q7T2A5|EIF3L_DANRE Eukaryotic translation initiation factor 3 subunit L OS=Danio rerio OX=7955 GN=eif3l PE=2 SV=1 g17084.t1 Q8HXY0 68.047 338 2.0199999999999998e-140 404.0 sp|Q8HXY0|ETFA_MACFA Electron transfer flavoprotein subunit alpha, mitochondrial OS=Macaca fascicularis OX=9541 GN=ETFA PE=2 SV=1 g17086.t1 P56213 52.941 136 7.21e-47 153.0 sp|P56213|ALR_MOUSE FAD-linked sulfhydryl oxidase ALR OS=Mus musculus OX=10090 GN=Gfer PE=1 SV=2 ALR_MOUSE reviewed FAD-linked sulfhydryl oxidase ALR (EC 1.8.3.2) (Augmenter of liver regeneration) Mus musculus (Mouse) GO:0001889; GO:0005615; GO:0005739; GO:0005758; GO:0005829; GO:0008083; GO:0015035; GO:0016971; GO:0043066; GO:0045953; GO:0050660; GO:0097421; GO:0160203; GO:2000573 liver development [GO:0001889]; liver regeneration [GO:0097421]; mitochondrial disulfide relay system [GO:0160203]; negative regulation of apoptotic process [GO:0043066]; negative regulation of natural killer cell mediated cytotoxicity [GO:0045953]; positive regulation of DNA biosynthetic process [GO:2000573] cytosol [GO:0005829]; extracellular space [GO:0005615]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739] flavin adenine dinucleotide binding [GO:0050660]; flavin-dependent sulfhydryl oxidase activity [GO:0016971]; growth factor activity [GO:0008083]; protein-disulfide reductase activity [GO:0015035] g17087.t1 F1NQJ3 56.195 452 1.55e-168 514.0 sp|F1NQJ3|PMS2_CHICK Mismatch repair endonuclease PMS2 OS=Gallus gallus OX=9031 GN=PMS2 PE=2 SV=3 PMS2_CHICK reviewed Mismatch repair endonuclease PMS2 (EC 3.1.-.-) (DNA mismatch repair protein PMS2) (PMS1 protein homolog 2) Gallus gallus (Chicken) GO:0003697; GO:0004519; GO:0005524; GO:0005654; GO:0005829; GO:0006298; GO:0007095; GO:0016446; GO:0016447; GO:0016887; GO:0030890; GO:0032138; GO:0032389; GO:0032407; GO:0048298; GO:0048304; GO:0140664 mismatch repair [GO:0006298]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of isotype switching to IgA isotypes [GO:0048298]; positive regulation of isotype switching to IgG isotypes [GO:0048304]; somatic hypermutation of immunoglobulin genes [GO:0016446]; somatic recombination of immunoglobulin gene segments [GO:0016447] cytosol [GO:0005829]; MutLalpha complex [GO:0032389]; nucleoplasm [GO:0005654] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent DNA damage sensor activity [GO:0140664]; endonuclease activity [GO:0004519]; MutSalpha complex binding [GO:0032407]; single base insertion or deletion binding [GO:0032138]; single-stranded DNA binding [GO:0003697] g17087.t1 F1NQJ3 62.304 191 2.87e-70 253.0 sp|F1NQJ3|PMS2_CHICK Mismatch repair endonuclease PMS2 OS=Gallus gallus OX=9031 GN=PMS2 PE=2 SV=3 PMS2_CHICK reviewed Mismatch repair endonuclease PMS2 (EC 3.1.-.-) (DNA mismatch repair protein PMS2) (PMS1 protein homolog 2) Gallus gallus (Chicken) GO:0003697; GO:0004519; GO:0005524; GO:0005654; GO:0005829; GO:0006298; GO:0007095; GO:0016446; GO:0016447; GO:0016887; GO:0030890; GO:0032138; GO:0032389; GO:0032407; GO:0048298; GO:0048304; GO:0140664 mismatch repair [GO:0006298]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of isotype switching to IgA isotypes [GO:0048298]; positive regulation of isotype switching to IgG isotypes [GO:0048304]; somatic hypermutation of immunoglobulin genes [GO:0016446]; somatic recombination of immunoglobulin gene segments [GO:0016447] cytosol [GO:0005829]; MutLalpha complex [GO:0032389]; nucleoplasm [GO:0005654] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent DNA damage sensor activity [GO:0140664]; endonuclease activity [GO:0004519]; MutSalpha complex binding [GO:0032407]; single base insertion or deletion binding [GO:0032138]; single-stranded DNA binding [GO:0003697] g17090.t1 Q9BZE9 46.243 173 1.02e-40 160.0 sp|Q9BZE9|ASPC1_HUMAN Tether containing UBX domain for GLUT4 OS=Homo sapiens OX=9606 GN=ASPSCR1 PE=1 SV=1 ASPC1_HUMAN reviewed Tether containing UBX domain for GLUT4 (Alveolar soft part sarcoma chromosomal region candidate gene 1 protein) (Alveolar soft part sarcoma locus) (Renal papillary cell carcinoma protein 17) (UBX domain-containing protein 9) Homo sapiens (Human) GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0006886; GO:0009898; GO:0012505; GO:0012506; GO:0031401; GO:0033116; GO:0042593; GO:0046324; GO:0048471 glucose homeostasis [GO:0042593]; intracellular protein transport [GO:0006886]; positive regulation of protein modification process [GO:0031401]; regulation of D-glucose import [GO:0046324] cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; vesicle membrane [GO:0012506] g17090.t1 Q9BZE9 45.752 153 9.1e-31 130.0 sp|Q9BZE9|ASPC1_HUMAN Tether containing UBX domain for GLUT4 OS=Homo sapiens OX=9606 GN=ASPSCR1 PE=1 SV=1 ASPC1_HUMAN reviewed Tether containing UBX domain for GLUT4 (Alveolar soft part sarcoma chromosomal region candidate gene 1 protein) (Alveolar soft part sarcoma locus) (Renal papillary cell carcinoma protein 17) (UBX domain-containing protein 9) Homo sapiens (Human) GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0006886; GO:0009898; GO:0012505; GO:0012506; GO:0031401; GO:0033116; GO:0042593; GO:0046324; GO:0048471 glucose homeostasis [GO:0042593]; intracellular protein transport [GO:0006886]; positive regulation of protein modification process [GO:0031401]; regulation of D-glucose import [GO:0046324] cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; vesicle membrane [GO:0012506] g17091.t1 Q99758 43.495 1791 0.0 1428.0 sp|Q99758|ABCA3_HUMAN Phospholipid-transporting ATPase ABCA3 OS=Homo sapiens OX=9606 GN=ABCA3 PE=1 SV=2 ABCA3_HUMAN reviewed Phospholipid-transporting ATPase ABCA3 (EC 7.6.2.1) (ABC-C transporter) (ATP-binding cassette sub-family A member 3) (ATP-binding cassette transporter 3) (ATP-binding cassette 3) (Xenobiotic-transporting ATPase ABCA3) (EC 7.6.2.2) [Cleaved into: 150 Kda mature form] Homo sapiens (Human) GO:0005319; GO:0005524; GO:0005615; GO:0005765; GO:0005770; GO:0005886; GO:0006855; GO:0006869; GO:0008559; GO:0009410; GO:0010875; GO:0015914; GO:0016887; GO:0030324; GO:0030659; GO:0032464; GO:0032585; GO:0042599; GO:0042626; GO:0042908; GO:0043129; GO:0046470; GO:0046471; GO:0046618; GO:0046890; GO:0051384; GO:0055091; GO:0070925; GO:0097208; GO:0097232; GO:0097233; GO:0120019; GO:0140345; GO:0150172; GO:1902995; GO:2001140 lipid transport [GO:0006869]; lung development [GO:0030324]; organelle assembly [GO:0070925]; phosphatidylcholine metabolic process [GO:0046470]; phosphatidylglycerol metabolic process [GO:0046471]; phospholipid homeostasis [GO:0055091]; phospholipid transport [GO:0015914]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of phospholipid efflux [GO:1902995]; positive regulation of phospholipid transport [GO:2001140]; positive regulation of protein homooligomerization [GO:0032464]; regulation of lipid biosynthetic process [GO:0046890]; regulation of phosphatidylcholine metabolic process [GO:0150172]; response to glucocorticoid [GO:0051384]; response to xenobiotic stimulus [GO:0009410]; surfactant homeostasis [GO:0043129]; xenobiotic export from cell [GO:0046618]; xenobiotic transmembrane transport [GO:0006855]; xenobiotic transport [GO:0042908] alveolar lamellar body [GO:0097208]; alveolar lamellar body membrane [GO:0097233]; cytoplasmic vesicle membrane [GO:0030659]; extracellular space [GO:0005615]; lamellar body [GO:0042599]; lamellar body membrane [GO:0097232]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; multivesicular body membrane [GO:0032585]; plasma membrane [GO:0005886] ABC-type xenobiotic transporter activity [GO:0008559]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; lipid transporter activity [GO:0005319]; phosphatidylcholine flippase activity [GO:0140345]; phosphatidylcholine transfer activity [GO:0120019] g17091.t1 Q99758 34.667 300 3.24e-45 184.0 sp|Q99758|ABCA3_HUMAN Phospholipid-transporting ATPase ABCA3 OS=Homo sapiens OX=9606 GN=ABCA3 PE=1 SV=2 ABCA3_HUMAN reviewed Phospholipid-transporting ATPase ABCA3 (EC 7.6.2.1) (ABC-C transporter) (ATP-binding cassette sub-family A member 3) (ATP-binding cassette transporter 3) (ATP-binding cassette 3) (Xenobiotic-transporting ATPase ABCA3) (EC 7.6.2.2) [Cleaved into: 150 Kda mature form] Homo sapiens (Human) GO:0005319; GO:0005524; GO:0005615; GO:0005765; GO:0005770; GO:0005886; GO:0006855; GO:0006869; GO:0008559; GO:0009410; GO:0010875; GO:0015914; GO:0016887; GO:0030324; GO:0030659; GO:0032464; GO:0032585; GO:0042599; GO:0042626; GO:0042908; GO:0043129; GO:0046470; GO:0046471; GO:0046618; GO:0046890; GO:0051384; GO:0055091; GO:0070925; GO:0097208; GO:0097232; GO:0097233; GO:0120019; GO:0140345; GO:0150172; GO:1902995; GO:2001140 lipid transport [GO:0006869]; lung development [GO:0030324]; organelle assembly [GO:0070925]; phosphatidylcholine metabolic process [GO:0046470]; phosphatidylglycerol metabolic process [GO:0046471]; phospholipid homeostasis [GO:0055091]; phospholipid transport [GO:0015914]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of phospholipid efflux [GO:1902995]; positive regulation of phospholipid transport [GO:2001140]; positive regulation of protein homooligomerization [GO:0032464]; regulation of lipid biosynthetic process [GO:0046890]; regulation of phosphatidylcholine metabolic process [GO:0150172]; response to glucocorticoid [GO:0051384]; response to xenobiotic stimulus [GO:0009410]; surfactant homeostasis [GO:0043129]; xenobiotic export from cell [GO:0046618]; xenobiotic transmembrane transport [GO:0006855]; xenobiotic transport [GO:0042908] alveolar lamellar body [GO:0097208]; alveolar lamellar body membrane [GO:0097233]; cytoplasmic vesicle membrane [GO:0030659]; extracellular space [GO:0005615]; lamellar body [GO:0042599]; lamellar body membrane [GO:0097232]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; multivesicular body membrane [GO:0032585]; plasma membrane [GO:0005886] ABC-type xenobiotic transporter activity [GO:0008559]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; lipid transporter activity [GO:0005319]; phosphatidylcholine flippase activity [GO:0140345]; phosphatidylcholine transfer activity [GO:0120019] g17092.t1 O00338 42.268 291 2.5200000000000003e-72 228.0 sp|O00338|ST1C2_HUMAN Sulfotransferase 1C2 OS=Homo sapiens OX=9606 GN=SULT1C2 PE=1 SV=1 ST1C2_HUMAN reviewed Sulfotransferase 1C2 (ST1C2) (EC 2.8.2.1) (Sulfotransferase 1C1) (SULT1C#1) (humSULTC2) Homo sapiens (Human) GO:0004062; GO:0005737; GO:0005739; GO:0005764; GO:0005829; GO:0008146; GO:0009308; GO:0051922; GO:0051923 amine metabolic process [GO:0009308]; sulfation [GO:0051923] cytoplasm [GO:0005737]; cytosol [GO:0005829]; lysosome [GO:0005764]; mitochondrion [GO:0005739] aryl sulfotransferase activity [GO:0004062]; cholesterol sulfotransferase activity [GO:0051922]; sulfotransferase activity [GO:0008146] g17094.t1 Q9WUW8 44.516 155 8.440000000000001e-35 125.0 sp|Q9WUW8|ST1C2_RAT Sulfotransferase 1C2 OS=Rattus norvegicus OX=10116 GN=Sult1c2 PE=1 SV=2 ST1C2_RAT reviewed Sulfotransferase 1C2 (ST1C2) (rSULT1C2) (EC 2.8.2.1) (Sulfotransferase K1) Rattus norvegicus (Rat) GO:0004062; GO:0005737; GO:0005739; GO:0005764; GO:0051922; GO:0051923 sulfation [GO:0051923] cytoplasm [GO:0005737]; lysosome [GO:0005764]; mitochondrion [GO:0005739] aryl sulfotransferase activity [GO:0004062]; cholesterol sulfotransferase activity [GO:0051922] g17095.t1 O75897 35.458 251 4.08e-49 167.0 sp|O75897|ST1C4_HUMAN Sulfotransferase 1C4 OS=Homo sapiens OX=9606 GN=SULT1C4 PE=1 SV=2 ST1C4_HUMAN reviewed Sulfotransferase 1C4 (ST1C4) (EC 2.8.2.1) (Sulfotransferase 1C2) (SULT1C#2) Homo sapiens (Human) GO:0004062; GO:0005737; GO:0005829; GO:0006068; GO:0006805; GO:0008146; GO:0009812; GO:0044598; GO:0050427; GO:0051923 3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; doxorubicin metabolic process [GO:0044598]; ethanol catabolic process [GO:0006068]; flavonoid metabolic process [GO:0009812]; sulfation [GO:0051923]; xenobiotic metabolic process [GO:0006805] cytoplasm [GO:0005737]; cytosol [GO:0005829] aryl sulfotransferase activity [GO:0004062]; sulfotransferase activity [GO:0008146] g17096.t1 O00338 36.082 291 2.54e-62 202.0 sp|O00338|ST1C2_HUMAN Sulfotransferase 1C2 OS=Homo sapiens OX=9606 GN=SULT1C2 PE=1 SV=1 ST1C2_HUMAN reviewed Sulfotransferase 1C2 (ST1C2) (EC 2.8.2.1) (Sulfotransferase 1C1) (SULT1C#1) (humSULTC2) Homo sapiens (Human) GO:0004062; GO:0005737; GO:0005739; GO:0005764; GO:0005829; GO:0008146; GO:0009308; GO:0051922; GO:0051923 amine metabolic process [GO:0009308]; sulfation [GO:0051923] cytoplasm [GO:0005737]; cytosol [GO:0005829]; lysosome [GO:0005764]; mitochondrion [GO:0005739] aryl sulfotransferase activity [GO:0004062]; cholesterol sulfotransferase activity [GO:0051922]; sulfotransferase activity [GO:0008146] g17097.t1 O00338 35.64 289 4.79e-61 199.0 sp|O00338|ST1C2_HUMAN Sulfotransferase 1C2 OS=Homo sapiens OX=9606 GN=SULT1C2 PE=1 SV=1 ST1C2_HUMAN reviewed Sulfotransferase 1C2 (ST1C2) (EC 2.8.2.1) (Sulfotransferase 1C1) (SULT1C#1) (humSULTC2) Homo sapiens (Human) GO:0004062; GO:0005737; GO:0005739; GO:0005764; GO:0005829; GO:0008146; GO:0009308; GO:0051922; GO:0051923 amine metabolic process [GO:0009308]; sulfation [GO:0051923] cytoplasm [GO:0005737]; cytosol [GO:0005829]; lysosome [GO:0005764]; mitochondrion [GO:0005739] aryl sulfotransferase activity [GO:0004062]; cholesterol sulfotransferase activity [GO:0051922]; sulfotransferase activity [GO:0008146] g17097.t2 O00338 35.64 289 4.79e-61 199.0 sp|O00338|ST1C2_HUMAN Sulfotransferase 1C2 OS=Homo sapiens OX=9606 GN=SULT1C2 PE=1 SV=1 ST1C2_HUMAN reviewed Sulfotransferase 1C2 (ST1C2) (EC 2.8.2.1) (Sulfotransferase 1C1) (SULT1C#1) (humSULTC2) Homo sapiens (Human) GO:0004062; GO:0005737; GO:0005739; GO:0005764; GO:0005829; GO:0008146; GO:0009308; GO:0051922; GO:0051923 amine metabolic process [GO:0009308]; sulfation [GO:0051923] cytoplasm [GO:0005737]; cytosol [GO:0005829]; lysosome [GO:0005764]; mitochondrion [GO:0005739] aryl sulfotransferase activity [GO:0004062]; cholesterol sulfotransferase activity [GO:0051922]; sulfotransferase activity [GO:0008146] g17098.t1 P19217 38.745 271 1.11e-62 203.0 sp|P19217|ST1E1_BOVIN Sulfotransferase 1E1 OS=Bos taurus OX=9913 GN=SULT1E1 PE=1 SV=1 ST1E1_BOVIN reviewed Sulfotransferase 1E1 (ST1E1) (EC 2.8.2.4) (Estrogen sulfotransferase) (Sulfotransferase, estrogen-preferring) Bos taurus (Bovine) GO:0004062; GO:0004304; GO:0005496; GO:0005737; GO:0005829; GO:0008210; GO:0050294; GO:0051923 estrogen metabolic process [GO:0008210]; sulfation [GO:0051923] cytoplasm [GO:0005737]; cytosol [GO:0005829] aryl sulfotransferase activity [GO:0004062]; estrone sulfotransferase activity [GO:0004304]; steroid binding [GO:0005496]; steroid sulfotransferase activity [GO:0050294] g17099.t1 P19217 40.23 261 8.49e-62 201.0 sp|P19217|ST1E1_BOVIN Sulfotransferase 1E1 OS=Bos taurus OX=9913 GN=SULT1E1 PE=1 SV=1 ST1E1_BOVIN reviewed Sulfotransferase 1E1 (ST1E1) (EC 2.8.2.4) (Estrogen sulfotransferase) (Sulfotransferase, estrogen-preferring) Bos taurus (Bovine) GO:0004062; GO:0004304; GO:0005496; GO:0005737; GO:0005829; GO:0008210; GO:0050294; GO:0051923 estrogen metabolic process [GO:0008210]; sulfation [GO:0051923] cytoplasm [GO:0005737]; cytosol [GO:0005829] aryl sulfotransferase activity [GO:0004062]; estrone sulfotransferase activity [GO:0004304]; steroid binding [GO:0005496]; steroid sulfotransferase activity [GO:0050294] g17100.t1 O95453 50.193 518 4.87e-180 528.0 sp|O95453|PARN_HUMAN Poly(A)-specific ribonuclease PARN OS=Homo sapiens OX=9606 GN=PARN PE=1 SV=1 g17108.t1 Q9QXV1 70.312 64 3.17e-22 103.0 sp|Q9QXV1|CBX8_MOUSE Chromobox protein homolog 8 OS=Mus musculus OX=10090 GN=Cbx8 PE=1 SV=1 CBX8_MOUSE reviewed Chromobox protein homolog 8 (Polycomb 3 homolog) (Pc3) (mPc3) Mus musculus (Mouse) GO:0000122; GO:0000785; GO:0000792; GO:0003682; GO:0003727; GO:0005634; GO:0005654; GO:0008284; GO:0031507; GO:0031519; GO:0032967; GO:0035102; GO:0045739; GO:0061628; GO:0070301; GO:0097027 cellular response to hydrogen peroxide [GO:0070301]; heterochromatin formation [GO:0031507]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of collagen biosynthetic process [GO:0032967]; positive regulation of DNA repair [GO:0045739] chromatin [GO:0000785]; heterochromatin [GO:0000792]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; PRC1 complex [GO:0035102] chromatin binding [GO:0003682]; histone H3K27me3 reader activity [GO:0061628]; single-stranded RNA binding [GO:0003727]; ubiquitin-protein transferase activator activity [GO:0097027] g17109.t1 Q7TN88 29.71 690 2.69e-68 261.0 sp|Q7TN88|PK1L2_MOUSE Polycystin-1-like protein 2 OS=Mus musculus OX=10090 GN=Pkd1l2 PE=2 SV=1 PK1L2_MOUSE reviewed Polycystin-1-like protein 2 (Polycystin-1L2) (PC1-like 2 protein) (Polycystic kidney disease protein 1-like 2) Mus musculus (Mouse) GO:0001965; GO:0005262; GO:0005509; GO:0016020; GO:0030246; GO:0050982 detection of mechanical stimulus [GO:0050982] membrane [GO:0016020] calcium channel activity [GO:0005262]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; G-protein alpha-subunit binding [GO:0001965] g17109.t1 Q7TN88 31.536 371 5.74e-42 175.0 sp|Q7TN88|PK1L2_MOUSE Polycystin-1-like protein 2 OS=Mus musculus OX=10090 GN=Pkd1l2 PE=2 SV=1 PK1L2_MOUSE reviewed Polycystin-1-like protein 2 (Polycystin-1L2) (PC1-like 2 protein) (Polycystic kidney disease protein 1-like 2) Mus musculus (Mouse) GO:0001965; GO:0005262; GO:0005509; GO:0016020; GO:0030246; GO:0050982 detection of mechanical stimulus [GO:0050982] membrane [GO:0016020] calcium channel activity [GO:0005262]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; G-protein alpha-subunit binding [GO:0001965] g17111.t1 Q9NZS9 39.518 415 1.27e-96 299.0 sp|Q9NZS9|BFAR_HUMAN Bifunctional apoptosis regulator OS=Homo sapiens OX=9606 GN=BFAR PE=1 SV=1 BFAR_HUMAN reviewed Bifunctional apoptosis regulator (EC 2.3.2.27) (RING finger protein 47) Homo sapiens (Human) GO:0000209; GO:0005783; GO:0005789; GO:0005886; GO:0006511; GO:0006915; GO:0008270; GO:0016020; GO:0030674; GO:0043066; GO:0043161; GO:0051865; GO:0061630; GO:0070534; GO:0070936; GO:0089720; GO:1903895 apoptotic process [GO:0006915]; negative regulation of apoptotic process [GO:0043066]; negative regulation of IRE1-mediated unfolded protein response [GO:1903895]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein K48-linked ubiquitination [GO:0070936]; protein K63-linked ubiquitination [GO:0070534]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; plasma membrane [GO:0005886] caspase binding [GO:0089720]; protein-macromolecule adaptor activity [GO:0030674]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] g17112.t1 Q5U4T9 43.187 477 7.61e-125 374.0 sp|Q5U4T9|MBOA7_XENLA Membrane-bound acylglycerophosphatidylinositol O-acyltransferase mboat7 OS=Xenopus laevis OX=8355 GN=mboat7 PE=2 SV=1 MBOA7_XENLA reviewed Membrane-bound acylglycerophosphatidylinositol O-acyltransferase mboat7 (EC 2.3.1.-) (Leukocyte receptor cluster member 4) (Lysophospholipid acyltransferase 7) (LPLAT 7) (Membrane-bound O-acyltransferase domain-containing protein 7) (O-acyltransferase domain-containing protein 7) Xenopus laevis (African clawed frog) GO:0005789; GO:0006661; GO:0008374; GO:0016020; GO:0030258; GO:0036149; GO:0036151; GO:0044233; GO:0071617; GO:0090207 lipid modification [GO:0030258]; phosphatidylcholine acyl-chain remodeling [GO:0036151]; phosphatidylinositol acyl-chain remodeling [GO:0036149]; phosphatidylinositol biosynthetic process [GO:0006661]; regulation of triglyceride metabolic process [GO:0090207] endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; mitochondria-associated endoplasmic reticulum membrane contact site [GO:0044233] lysophospholipid acyltransferase activity [GO:0071617]; O-acyltransferase activity [GO:0008374] g17113.t1 Q5U4T9 38.085 470 9.95e-84 268.0 sp|Q5U4T9|MBOA7_XENLA Membrane-bound acylglycerophosphatidylinositol O-acyltransferase mboat7 OS=Xenopus laevis OX=8355 GN=mboat7 PE=2 SV=1 MBOA7_XENLA reviewed Membrane-bound acylglycerophosphatidylinositol O-acyltransferase mboat7 (EC 2.3.1.-) (Leukocyte receptor cluster member 4) (Lysophospholipid acyltransferase 7) (LPLAT 7) (Membrane-bound O-acyltransferase domain-containing protein 7) (O-acyltransferase domain-containing protein 7) Xenopus laevis (African clawed frog) GO:0005789; GO:0006661; GO:0008374; GO:0016020; GO:0030258; GO:0036149; GO:0036151; GO:0044233; GO:0071617; GO:0090207 lipid modification [GO:0030258]; phosphatidylcholine acyl-chain remodeling [GO:0036151]; phosphatidylinositol acyl-chain remodeling [GO:0036149]; phosphatidylinositol biosynthetic process [GO:0006661]; regulation of triglyceride metabolic process [GO:0090207] endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; mitochondria-associated endoplasmic reticulum membrane contact site [GO:0044233] lysophospholipid acyltransferase activity [GO:0071617]; O-acyltransferase activity [GO:0008374] g17121.t1 A2APV2 36.148 379 5.160000000000001e-66 239.0 sp|A2APV2|FMNL2_MOUSE Formin-like protein 2 OS=Mus musculus OX=10090 GN=Fmnl2 PE=1 SV=2 g17126.t1 Q9M146 26.578 301 2.9e-25 107.0 sp|Q9M146|MGP4_ARATH UDP-D-xylose:L-fucose alpha-1,3-D-xylosyltransferase MGP4 OS=Arabidopsis thaliana OX=3702 GN=MGP4 PE=2 SV=1 MGP4_ARATH reviewed UDP-D-xylose:L-fucose alpha-1,3-D-xylosyltransferase MGP4 (EC 2.4.2.-) (Protein MALE GAMETOPHYTE DEFECTIVE 4) (Rhamnogalacturonan xylosyltransferase MGP4) Arabidopsis thaliana (Mouse-ear cress) GO:0000138; GO:0000139; GO:0005794; GO:0010306; GO:0035252; GO:0042285; GO:0048868 pollen tube development [GO:0048868]; rhamnogalacturonan II biosynthetic process [GO:0010306] Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi trans cisterna [GO:0000138] UDP-xylosyltransferase activity [GO:0035252]; xylosyltransferase activity [GO:0042285] g17127.t1 Q920A5 54.808 416 3.6100000000000004e-148 432.0 sp|Q920A5|RISC_MOUSE Retinoid-inducible serine carboxypeptidase OS=Mus musculus OX=10090 GN=Scpep1 PE=1 SV=2 g17129.t1 Q9UNK0 39.367 221 2.3299999999999998e-38 136.0 sp|Q9UNK0|STX8_HUMAN Syntaxin-8 OS=Homo sapiens OX=9606 GN=STX8 PE=1 SV=2 STX8_HUMAN reviewed Syntaxin-8 Homo sapiens (Human) GO:0000149; GO:0005484; GO:0005768; GO:0005769; GO:0005770; GO:0005783; GO:0005802; GO:0005886; GO:0006886; GO:0006906; GO:0012505; GO:0019869; GO:0019905; GO:0031201; GO:0031625; GO:0031982; GO:0045022; GO:0045335; GO:0048278; GO:0048471; GO:0055037; GO:0071346; GO:1903076 cellular response to type II interferon [GO:0071346]; early endosome to late endosome transport [GO:0045022]; intracellular protein transport [GO:0006886]; regulation of protein localization to plasma membrane [GO:1903076]; vesicle docking [GO:0048278]; vesicle fusion [GO:0006906] early endosome [GO:0005769]; endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; late endosome [GO:0005770]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; SNARE complex [GO:0031201]; trans-Golgi network [GO:0005802]; vesicle [GO:0031982] chloride channel inhibitor activity [GO:0019869]; SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905]; ubiquitin protein ligase binding [GO:0031625] g17130.t1 Q90922 64.433 582 0.0 790.0 sp|Q90922|NET1_CHICK Netrin-1 OS=Gallus gallus OX=9031 GN=NTN1 PE=1 SV=1 NET1_CHICK reviewed Netrin-1 Gallus gallus (Chicken) GO:0005576; GO:0005604; GO:0005654; GO:0005829; GO:0006930; GO:0007097; GO:0007265; GO:0014009; GO:0015629; GO:0030517; GO:0032488; GO:0033564; GO:0042472; GO:0045773; GO:0051963; GO:0060252; GO:0061643; GO:0071944; GO:0097475; GO:0098609; GO:0098978; GO:1903975; GO:2000147 anterior/posterior axon guidance [GO:0033564]; Cdc42 protein signal transduction [GO:0032488]; cell-cell adhesion [GO:0098609]; chemorepulsion of axon [GO:0061643]; glial cell proliferation [GO:0014009]; inner ear morphogenesis [GO:0042472]; motor neuron migration [GO:0097475]; negative regulation of axon extension [GO:0030517]; nuclear migration [GO:0007097]; positive regulation of axon extension [GO:0045773]; positive regulation of cell motility [GO:2000147]; positive regulation of glial cell proliferation [GO:0060252]; Ras protein signal transduction [GO:0007265]; regulation of glial cell migration [GO:1903975]; regulation of synapse assembly [GO:0051963]; substrate-dependent cell migration, cell extension [GO:0006930] actin cytoskeleton [GO:0015629]; basement membrane [GO:0005604]; cell periphery [GO:0071944]; cytosol [GO:0005829]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; nucleoplasm [GO:0005654] g17130.t2 Q90922 62.647 597 0.0 783.0 sp|Q90922|NET1_CHICK Netrin-1 OS=Gallus gallus OX=9031 GN=NTN1 PE=1 SV=1 NET1_CHICK reviewed Netrin-1 Gallus gallus (Chicken) GO:0005576; GO:0005604; GO:0005654; GO:0005829; GO:0006930; GO:0007097; GO:0007265; GO:0014009; GO:0015629; GO:0030517; GO:0032488; GO:0033564; GO:0042472; GO:0045773; GO:0051963; GO:0060252; GO:0061643; GO:0071944; GO:0097475; GO:0098609; GO:0098978; GO:1903975; GO:2000147 anterior/posterior axon guidance [GO:0033564]; Cdc42 protein signal transduction [GO:0032488]; cell-cell adhesion [GO:0098609]; chemorepulsion of axon [GO:0061643]; glial cell proliferation [GO:0014009]; inner ear morphogenesis [GO:0042472]; motor neuron migration [GO:0097475]; negative regulation of axon extension [GO:0030517]; nuclear migration [GO:0007097]; positive regulation of axon extension [GO:0045773]; positive regulation of cell motility [GO:2000147]; positive regulation of glial cell proliferation [GO:0060252]; Ras protein signal transduction [GO:0007265]; regulation of glial cell migration [GO:1903975]; regulation of synapse assembly [GO:0051963]; substrate-dependent cell migration, cell extension [GO:0006930] actin cytoskeleton [GO:0015629]; basement membrane [GO:0005604]; cell periphery [GO:0071944]; cytosol [GO:0005829]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; nucleoplasm [GO:0005654] g17132.t1 Q7JQ32 41.547 1112 0.0 773.0 sp|Q7JQ32|GC76C_DROME Receptor-type guanylate cyclase Gyc76C OS=Drosophila melanogaster OX=7227 GN=Gyc76C PE=1 SV=1 GC76C_DROME reviewed Receptor-type guanylate cyclase Gyc76C (EC 4.6.1.2) (DrGC-1) Drosophila melanogaster (Fruit fly) GO:0001653; GO:0004383; GO:0005524; GO:0005525; GO:0005886; GO:0006182; GO:0007168; GO:0007411; GO:0007428; GO:0007435; GO:0007526; GO:0008045; GO:0009651; GO:0016199; GO:0030198; GO:0030215; GO:0030510; GO:0035556; GO:0038023; GO:0046872; GO:0050830 axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; cGMP biosynthetic process [GO:0006182]; defense response to Gram-positive bacterium [GO:0050830]; extracellular matrix organization [GO:0030198]; intracellular signal transduction [GO:0035556]; larval somatic muscle development [GO:0007526]; motor neuron axon guidance [GO:0008045]; primary branching, open tracheal system [GO:0007428]; receptor guanylyl cyclase signaling pathway [GO:0007168]; regulation of BMP signaling pathway [GO:0030510]; response to salt stress [GO:0009651]; salivary gland morphogenesis [GO:0007435] plasma membrane [GO:0005886] ATP binding [GO:0005524]; GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; metal ion binding [GO:0046872]; peptide receptor activity [GO:0001653]; semaphorin receptor binding [GO:0030215]; signaling receptor activity [GO:0038023] g17134.t1 Q07553 42.733 1039 0.0 758.0 sp|Q07553|GCY3E_DROME Guanylate cyclase 32E OS=Drosophila melanogaster OX=7227 GN=Gyc32E PE=1 SV=4 g17136.t1 P82861 56.701 388 7.14e-155 451.0 sp|P82861|ADRO_SALFO NADPH:adrenodoxin oxidoreductase, mitochondrial OS=Salvelinus fontinalis OX=8038 GN=fdxr PE=2 SV=1 g17138.t1 P04323 40.741 162 1.4599999999999998e-23 100.0 sp|P04323|POL3_DROME Retrovirus-related Pol polyprotein from transposon 17.6 OS=Drosophila melanogaster OX=7227 GN=pol PE=4 SV=1 g17138.t2 P04323 39.294 425 6.74e-75 257.0 sp|P04323|POL3_DROME Retrovirus-related Pol polyprotein from transposon 17.6 OS=Drosophila melanogaster OX=7227 GN=pol PE=4 SV=1 g17141.t1 Q6DFD7 68.984 187 1.57e-97 284.0 sp|Q6DFD7|B9D1_XENLA B9 domain-containing protein 1 OS=Xenopus laevis OX=8355 GN=b9d1 PE=2 SV=1 g17145.t1 Q9Z2A0 62.979 470 0.0 604.0 sp|Q9Z2A0|PDPK1_MOUSE 3-phosphoinositide-dependent protein kinase 1 OS=Mus musculus OX=10090 GN=Pdpk1 PE=1 SV=2 PDPK1_MOUSE reviewed 3-phosphoinositide-dependent protein kinase 1 (mPDK1) (EC 2.7.11.1) Mus musculus (Mouse) GO:0003323; GO:0004674; GO:0004676; GO:0005158; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0005925; GO:0006972; GO:0007165; GO:0007173; GO:0008286; GO:0010594; GO:0010667; GO:0014069; GO:0016004; GO:0016477; GO:0019722; GO:0019901; GO:0030512; GO:0031410; GO:0034122; GO:0035556; GO:0042995; GO:0043122; GO:0043204; GO:0043274; GO:0043304; GO:0043491; GO:0043524; GO:0043536; GO:0048009; GO:0048041; GO:0051281; GO:0051897; GO:0071364; GO:0097191; GO:0106310; GO:1903078; GO:1903672; GO:1905564; GO:2000352 calcium-mediated signaling [GO:0019722]; cell migration [GO:0016477]; cellular response to epidermal growth factor stimulus [GO:0071364]; epidermal growth factor receptor signaling pathway [GO:0007173]; extrinsic apoptotic signaling pathway [GO:0097191]; focal adhesion assembly [GO:0048041]; hyperosmotic response [GO:0006972]; insulin receptor signaling pathway [GO:0008286]; insulin-like growth factor receptor signaling pathway [GO:0048009]; intracellular signal transduction [GO:0035556]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of toll-like receptor signaling pathway [GO:0034122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; positive regulation of sprouting angiogenesis [GO:1903672]; positive regulation of vascular endothelial cell proliferation [GO:1905564]; regulation of canonical NF-kappaB signal transduction [GO:0043122]; regulation of endothelial cell migration [GO:0010594]; regulation of mast cell degranulation [GO:0043304]; signal transduction [GO:0007165]; type B pancreatic cell development [GO:0003323] cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; nucleus [GO:0005634]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069] 3-phosphoinositide-dependent protein kinase activity [GO:0004676]; ATP binding [GO:0005524]; insulin receptor binding [GO:0005158]; phospholipase activator activity [GO:0016004]; phospholipase binding [GO:0043274]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g17145.t2 Q9Z2A0 62.979 470 0.0 605.0 sp|Q9Z2A0|PDPK1_MOUSE 3-phosphoinositide-dependent protein kinase 1 OS=Mus musculus OX=10090 GN=Pdpk1 PE=1 SV=2 PDPK1_MOUSE reviewed 3-phosphoinositide-dependent protein kinase 1 (mPDK1) (EC 2.7.11.1) Mus musculus (Mouse) GO:0003323; GO:0004674; GO:0004676; GO:0005158; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0005925; GO:0006972; GO:0007165; GO:0007173; GO:0008286; GO:0010594; GO:0010667; GO:0014069; GO:0016004; GO:0016477; GO:0019722; GO:0019901; GO:0030512; GO:0031410; GO:0034122; GO:0035556; GO:0042995; GO:0043122; GO:0043204; GO:0043274; GO:0043304; GO:0043491; GO:0043524; GO:0043536; GO:0048009; GO:0048041; GO:0051281; GO:0051897; GO:0071364; GO:0097191; GO:0106310; GO:1903078; GO:1903672; GO:1905564; GO:2000352 calcium-mediated signaling [GO:0019722]; cell migration [GO:0016477]; cellular response to epidermal growth factor stimulus [GO:0071364]; epidermal growth factor receptor signaling pathway [GO:0007173]; extrinsic apoptotic signaling pathway [GO:0097191]; focal adhesion assembly [GO:0048041]; hyperosmotic response [GO:0006972]; insulin receptor signaling pathway [GO:0008286]; insulin-like growth factor receptor signaling pathway [GO:0048009]; intracellular signal transduction [GO:0035556]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of toll-like receptor signaling pathway [GO:0034122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; positive regulation of sprouting angiogenesis [GO:1903672]; positive regulation of vascular endothelial cell proliferation [GO:1905564]; regulation of canonical NF-kappaB signal transduction [GO:0043122]; regulation of endothelial cell migration [GO:0010594]; regulation of mast cell degranulation [GO:0043304]; signal transduction [GO:0007165]; type B pancreatic cell development [GO:0003323] cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; nucleus [GO:0005634]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069] 3-phosphoinositide-dependent protein kinase activity [GO:0004676]; ATP binding [GO:0005524]; insulin receptor binding [GO:0005158]; phospholipase activator activity [GO:0016004]; phospholipase binding [GO:0043274]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g17146.t1 A5PKG7 81.959 194 3.17e-109 317.0 sp|A5PKG7|KCTD5_BOVIN BTB/POZ domain-containing protein KCTD5 OS=Bos taurus OX=9913 GN=KCTD5 PE=2 SV=1 g17147.t1 Q9D6D0 66.225 302 2.03e-142 409.0 sp|Q9D6D0|UCP4_MOUSE Mitochondrial uncoupling protein 4 OS=Mus musculus OX=10090 GN=Slc25a27 PE=2 SV=1 UCP4_MOUSE reviewed Mitochondrial uncoupling protein 4 (UCP 4) (Solute carrier family 25, member 27) Mus musculus (Mouse) GO:0005739; GO:0005743; GO:0008284; GO:0009409; GO:0010917; GO:0015078; GO:0015108; GO:0022857; GO:0035356; GO:0042803; GO:0043005; GO:0043025; GO:0043066; GO:0043524; GO:0045177; GO:0046324; GO:0048839; GO:0051562 inner ear development [GO:0048839]; intracellular triglyceride homeostasis [GO:0035356]; negative regulation of apoptotic process [GO:0043066]; negative regulation of mitochondrial calcium ion concentration [GO:0051562]; negative regulation of mitochondrial membrane potential [GO:0010917]; negative regulation of neuron apoptotic process [GO:0043524]; positive regulation of cell population proliferation [GO:0008284]; regulation of D-glucose import [GO:0046324]; response to cold [GO:0009409] apical part of cell [GO:0045177]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025] chloride transmembrane transporter activity [GO:0015108]; protein homodimerization activity [GO:0042803]; proton transmembrane transporter activity [GO:0015078]; transmembrane transporter activity [GO:0022857] g17148.t1 Q12788 51.546 679 0.0 725.0 sp|Q12788|TBL3_HUMAN Transducin beta-like protein 3 OS=Homo sapiens OX=9606 GN=TBL3 PE=1 SV=2 TBL3_HUMAN reviewed Transducin beta-like protein 3 (WD repeat-containing protein SAZD) Homo sapiens (Human) GO:0000472; GO:0000480; GO:0003723; GO:0005654; GO:0005730; GO:0030686; GO:0032040; GO:0034511; GO:0042274 endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000480]; endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000472]; ribosomal small subunit biogenesis [GO:0042274] 90S preribosome [GO:0030686]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; small-subunit processome [GO:0032040] RNA binding [GO:0003723]; U3 snoRNA binding [GO:0034511] g17152.t1 Q9UPQ7 37.766 188 4.83e-31 127.0 sp|Q9UPQ7|PZRN3_HUMAN E3 ubiquitin-protein ligase PDZRN3 OS=Homo sapiens OX=9606 GN=PDZRN3 PE=1 SV=2 g17153.t1 Q9UPQ7 35.849 212 5.73e-30 129.0 sp|Q9UPQ7|PZRN3_HUMAN E3 ubiquitin-protein ligase PDZRN3 OS=Homo sapiens OX=9606 GN=PDZRN3 PE=1 SV=2 g17159.t1 Q96QE3 36.585 287 6.37e-22 103.0 sp|Q96QE3|ATAD5_HUMAN ATPase family AAA domain-containing protein 5 OS=Homo sapiens OX=9606 GN=ATAD5 PE=1 SV=4 ATAD5_HUMAN reviewed ATPase family AAA domain-containing protein 5 (Chromosome fragility-associated gene 1 protein) Homo sapiens (Human) GO:0003677; GO:0005524; GO:0005634; GO:0008283; GO:0016887; GO:0030890; GO:0031391; GO:0033260; GO:0042770; GO:0042771; GO:0045190; GO:0045740; GO:0048304; GO:0061860; GO:1901990; GO:1902166; GO:1902751 cell population proliferation [GO:0008283]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; isotype switching [GO:0045190]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:1902166]; nuclear DNA replication [GO:0033260]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of cell cycle G2/M phase transition [GO:1902751]; positive regulation of DNA replication [GO:0045740]; positive regulation of isotype switching to IgG isotypes [GO:0048304]; regulation of mitotic cell cycle phase transition [GO:1901990]; signal transduction in response to DNA damage [GO:0042770] Elg1 RFC-like complex [GO:0031391]; nucleus [GO:0005634] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA binding [GO:0003677]; DNA clamp unloader activity [GO:0061860] g17161.t1 A7SE07 76.339 224 8.86e-129 369.0 sp|A7SE07|NUBP2_NEMVE Cytosolic Fe-S cluster assembly factor NUBP2 homolog OS=Nematostella vectensis OX=45351 GN=v1g229988 PE=3 SV=1 g17164.t1 Q9UBX8 53.913 230 2.12e-84 267.0 sp|Q9UBX8|B4GT6_HUMAN Beta-1,4-galactosyltransferase 6 OS=Homo sapiens OX=9606 GN=B4GALT6 PE=1 SV=1 B4GT6_HUMAN reviewed Beta-1,4-galactosyltransferase 6 (Beta-1,4-GalTase 6) (Beta4Gal-T6) (b4Gal-T6) (EC 2.4.1.-) (Glucosylceramide beta-1,4-galactosyltransferase) (EC 2.4.1.274) (Lactosylceramide synthase) (LacCer synthase) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 6) (UDP-Gal:glucosylceramide beta-1,4-galactosyltransferase) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 6) Homo sapiens (Human) GO:0000139; GO:0001572; GO:0001574; GO:0005794; GO:0005975; GO:0006688; GO:0008378; GO:0008489; GO:0021955; GO:0022010; GO:0032580; GO:0042551; GO:0046872 carbohydrate metabolic process [GO:0005975]; central nervous system myelination [GO:0022010]; central nervous system neuron axonogenesis [GO:0021955]; ganglioside biosynthetic process [GO:0001574]; glycosphingolipid biosynthetic process [GO:0006688]; lactosylceramide biosynthetic process [GO:0001572]; neuron maturation [GO:0042551] Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139] galactosyltransferase activity [GO:0008378]; metal ion binding [GO:0046872]; UDP-galactose:glucosylceramide beta-1,4-galactosyltransferase activity [GO:0008489] g17166.t1 Q29RR0 70.833 216 2.1e-112 325.0 sp|Q29RR0|RAB26_BOVIN Ras-related protein Rab-26 OS=Bos taurus OX=9913 GN=RAB26 PE=2 SV=1 RAB26_BOVIN reviewed Ras-related protein Rab-26 (EC 3.6.5.2) Bos taurus (Bovine) GO:0000139; GO:0003924; GO:0003925; GO:0005525; GO:0005802; GO:0005886; GO:0007193; GO:0016192; GO:0017157; GO:0019002; GO:0030667; GO:0030672; GO:0031985; GO:0035272; GO:0043001; GO:0045055; GO:0046872; GO:0140251 adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; exocrine system development [GO:0035272]; Golgi to plasma membrane protein transport [GO:0043001]; regulated exocytosis [GO:0045055]; regulation of exocytosis [GO:0017157]; regulation protein catabolic process at presynapse [GO:0140251]; vesicle-mediated transport [GO:0016192] Golgi cisterna [GO:0031985]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; synaptic vesicle membrane [GO:0030672]; trans-Golgi network [GO:0005802] G protein activity [GO:0003925]; GMP binding [GO:0019002]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872] g17167.t1 Q6GR34 60.241 166 8.12e-53 168.0 sp|Q6GR34|CP52A_XENLA Uncharacterized protein C16orf52 homolog A OS=Xenopus laevis OX=8355 PE=2 SV=1 g17168.t1 Q99PD4 62.568 366 3e-169 479.0 sp|Q99PD4|ARC1A_RAT Actin-related protein 2/3 complex subunit 1A OS=Rattus norvegicus OX=10116 GN=Arpc1a PE=2 SV=1 g17169.t1 P25325 42.049 283 2.97e-87 266.0 sp|P25325|THTM_HUMAN 3-mercaptopyruvate sulfurtransferase OS=Homo sapiens OX=9606 GN=MPST PE=1 SV=3 THTM_HUMAN reviewed 3-mercaptopyruvate sulfurtransferase (MST) (EC 2.8.1.2) Homo sapiens (Human) GO:0000098; GO:0001822; GO:0001889; GO:0004792; GO:0005739; GO:0005759; GO:0009440; GO:0009636; GO:0016783; GO:0016784; GO:0019346; GO:0021510; GO:0042802; GO:0043005; GO:0045202; GO:0070062; GO:0070814 cyanate catabolic process [GO:0009440]; hydrogen sulfide biosynthetic process [GO:0070814]; kidney development [GO:0001822]; liver development [GO:0001889]; response to toxic substance [GO:0009636]; spinal cord development [GO:0021510]; sulfur amino acid catabolic process [GO:0000098]; transsulfuration [GO:0019346] extracellular exosome [GO:0070062]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; synapse [GO:0045202] 3-mercaptopyruvate sulfurtransferase activity [GO:0016784]; identical protein binding [GO:0042802]; sulfurtransferase activity [GO:0016783]; thiosulfate-cyanide sulfurtransferase activity [GO:0004792] g17170.t1 P97532 42.564 195 4.88e-57 187.0 sp|P97532|THTM_RAT 3-mercaptopyruvate sulfurtransferase OS=Rattus norvegicus OX=10116 GN=Mpst PE=1 SV=3 g17171.t1 P02285 98.901 91 9e-61 185.0 sp|P02285|H2B_MARGL Histone H2B, sperm OS=Marthasterias glacialis OX=7609 PE=1 SV=2 g17172.t1 P02269 99.029 103 1.21e-68 205.0 sp|P02269|H2A_ASTRU Histone H2A OS=Asterias rubens OX=7604 PE=1 SV=2 g17173.t1 P69079 100.0 136 1.54e-95 274.0 sp|P69079|H3_STRDR Histone H3, embryonic OS=Strongylocentrotus droebachiensis OX=7671 PE=2 SV=2 g17174.t1 P62783 100.0 82 2.27e-53 165.0 sp|P62783|H4_STRPU Histone H4 OS=Strongylocentrotus purpuratus OX=7668 PE=3 SV=2 g17175.t1 Q28CA0 65.354 254 1.76e-121 353.0 sp|Q28CA0|PITC1_XENTR Cytoplasmic phosphatidylinositol transfer protein 1 OS=Xenopus tropicalis OX=8364 GN=pitpnc1 PE=2 SV=1 g17176.t1 O94817 63.83 94 6.4e-45 145.0 sp|O94817|ATG12_HUMAN Ubiquitin-like protein ATG12 OS=Homo sapiens OX=9606 GN=ATG12 PE=1 SV=1 ATG12_HUMAN reviewed Ubiquitin-like protein ATG12 (Autophagy-related protein 12) (APG12-like) Homo sapiens (Human) GO:0000045; GO:0000421; GO:0000422; GO:0005654; GO:0005776; GO:0005829; GO:0016236; GO:0030670; GO:0031386; GO:0032480; GO:0032991; GO:0034045; GO:0034274; GO:0034727; GO:0045824; GO:0050687; GO:0061723; GO:0097352; GO:1901096; GO:1904973; GO:1990234 autophagosome assembly [GO:0000045]; autophagosome maturation [GO:0097352]; autophagy of mitochondrion [GO:0000422]; glycophagy [GO:0061723]; macroautophagy [GO:0016236]; negative regulation of defense response to virus [GO:0050687]; negative regulation of innate immune response [GO:0045824]; negative regulation of type I interferon production [GO:0032480]; piecemeal microautophagy of the nucleus [GO:0034727]; positive regulation of viral translation [GO:1904973]; regulation of autophagosome maturation [GO:1901096] Atg12-Atg5-Atg16 complex [GO:0034274]; autophagosome [GO:0005776]; autophagosome membrane [GO:0000421]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; phagocytic vesicle membrane [GO:0030670]; phagophore assembly site membrane [GO:0034045]; protein-containing complex [GO:0032991]; transferase complex [GO:1990234] protein tag activity [GO:0031386] g17177.t1 E1BKF9 56.23 610 0.0 729.0 sp|E1BKF9|CFA52_BOVIN Cilia- and flagella-associated protein 52 OS=Bos taurus OX=9913 GN=CFAP52 PE=1 SV=1 g17180.t1 O04287 54.255 94 1.72e-27 100.0 sp|O04287|FKB12_VICFA Peptidyl-prolyl cis-trans isomerase FKBP12 OS=Vicia faba OX=3906 GN=FKBP12 PE=1 SV=1 g17184.t1 Q5R864 58.505 535 0.0 665.0 sp|Q5R864|DHX40_PONAB Probable ATP-dependent RNA helicase DHX40 OS=Pongo abelii OX=9601 GN=DHX40 PE=2 SV=1 g17185.t1 Q8BTN6 48.077 104 2.73e-25 112.0 sp|Q8BTN6|LENG9_MOUSE Leukocyte receptor cluster member 9 OS=Mus musculus OX=10090 GN=Leng9 PE=2 SV=1 g17186.t1 Q91175 33.787 367 2.5e-46 167.0 sp|Q91175|ADA1A_ORYLA Alpha-1A adrenergic receptor OS=Oryzias latipes OX=8090 GN=adra1a PE=3 SV=1 ADA1A_ORYLA reviewed Alpha-1A adrenergic receptor (Alpha-1A adrenoreceptor) (Alpha-1A adrenoceptor) (MAR1) Oryzias latipes (Japanese rice fish) (Japanese killifish) GO:0004937; GO:0005886; GO:0007200; GO:0007204; GO:0007267; GO:0010613; GO:0043410; GO:0071880 adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; cell-cell signaling [GO:0007267]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of MAPK cascade [GO:0043410] plasma membrane [GO:0005886] alpha1-adrenergic receptor activity [GO:0004937] g17187.t1 O43808 56.066 305 1.3500000000000002e-110 326.0 sp|O43808|PM34_HUMAN Peroxisomal membrane protein PMP34 OS=Homo sapiens OX=9606 GN=SLC25A17 PE=1 SV=1 PM34_HUMAN reviewed Peroxisomal membrane protein PMP34 (34 kDa peroxisomal membrane protein) (Solute carrier family 25 member 17) Homo sapiens (Human) GO:0000295; GO:0001561; GO:0005347; GO:0005777; GO:0005778; GO:0005829; GO:0006635; GO:0015217; GO:0015228; GO:0015230; GO:0015297; GO:0015867; GO:0015908; GO:0016020; GO:0044610; GO:0051087; GO:0051724; GO:0080122; GO:1901679 ATP transport [GO:0015867]; fatty acid alpha-oxidation [GO:0001561]; fatty acid beta-oxidation [GO:0006635]; fatty acid transport [GO:0015908]; nucleotide transmembrane transport [GO:1901679] cytosol [GO:0005829]; membrane [GO:0016020]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777] adenine nucleotide transmembrane transporter activity [GO:0000295]; ADP transmembrane transporter activity [GO:0015217]; AMP transmembrane transporter activity [GO:0080122]; antiporter activity [GO:0015297]; ATP transmembrane transporter activity [GO:0005347]; coenzyme A transmembrane transporter activity [GO:0015228]; FAD transmembrane transporter activity [GO:0015230]; FMN transmembrane transporter activity [GO:0044610]; NAD transmembrane transporter activity [GO:0051724]; protein-folding chaperone binding [GO:0051087] g17188.t1 Q9JHN8 53.922 102 2.2100000000000002e-35 124.0 sp|Q9JHN8|WHR1_MOUSE Winged helix repair factor 1 OS=Mus musculus OX=10090 GN=Whr1 PE=2 SV=2 g17190.t1 Q09575 45.192 104 1.38e-25 102.0 sp|Q09575|YRD6_CAEEL Uncharacterized protein K02A2.6 OS=Caenorhabditis elegans OX=6239 GN=K02A2.6 PE=4 SV=1 g17191.t1 O70348 43.526 363 3.19e-96 298.0 sp|O70348|DXO_MOUSE Decapping and exoribonuclease protein OS=Mus musculus OX=10090 GN=Dxo PE=1 SV=2 DXO_MOUSE reviewed Decapping and exoribonuclease protein (DXO) (EC 3.6.1.-) (5'-3' exoribonuclease DXO) (EC 3.1.13.-) (Dom-3 homolog Z) (NAD-capped RNA hydrolase DXO) (DeNADding enzyme DXO) (EC 3.6.1.-) Mus musculus (Mouse) GO:0000166; GO:0000287; GO:0000956; GO:0003729; GO:0005634; GO:0005654; GO:0005829; GO:0005886; GO:0006402; GO:0008409; GO:0034353; GO:0050779; GO:0071028; GO:0090304; GO:0110152; GO:0110155 mRNA catabolic process [GO:0006402]; NAD-cap decapping [GO:0110155]; nuclear mRNA surveillance [GO:0071028]; nuclear-transcribed mRNA catabolic process [GO:0000956]; nucleic acid metabolic process [GO:0090304]; RNA destabilization [GO:0050779] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886] 5'-3' exonuclease activity [GO:0008409]; magnesium ion binding [GO:0000287]; mRNA 5'-diphosphatase activity [GO:0034353]; mRNA binding [GO:0003729]; nucleotide binding [GO:0000166]; RNA NAD+-cap (NAD+-forming) hydrolase activity [GO:0110152] g17192.t1 Q9V7A7 32.778 360 1.83e-40 149.0 sp|Q9V7A7|GPAN1_DROME G patch domain and ankyrin repeat-containing protein 1 homolog OS=Drosophila melanogaster OX=7227 GN=CG8152 PE=2 SV=1 g17193.t1 Q9D5W8 34.361 227 5.75e-48 162.0 sp|Q9D5W8|TEX47_MOUSE Testis-expressed protein 47 OS=Mus musculus OX=10090 GN=Tex47 PE=2 SV=1 g17197.t1 O75127 42.274 563 1.29e-120 380.0 sp|O75127|PTCD1_HUMAN Pentatricopeptide repeat-containing protein 1, mitochondrial OS=Homo sapiens OX=9606 GN=PTCD1 PE=1 SV=2 PTCD1_HUMAN reviewed Pentatricopeptide repeat-containing protein 1, mitochondrial Homo sapiens (Human) GO:0000049; GO:0003723; GO:0005739; GO:0005759; GO:0032543; GO:0042780 mitochondrial translation [GO:0032543]; tRNA 3'-end processing [GO:0042780] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] RNA binding [GO:0003723]; tRNA binding [GO:0000049] g17198.t1 Q9XZV3 55.153 359 2.85e-145 418.0 sp|Q9XZV3|GNAO_GEOCY Guanine nucleotide-binding protein G(o) subunit alpha OS=Geodia cydonium OX=6047 PE=2 SV=3 g17202.t1 P31319 71.615 384 0.0 568.0 sp|P31319|KAPR_APLCA cAMP-dependent protein kinase regulatory subunit OS=Aplysia californica OX=6500 PE=2 SV=2 g17203.t1 Q8CBY3 55.556 216 2.86e-57 214.0 sp|Q8CBY3|LENG8_MOUSE Leukocyte receptor cluster member 8 homolog OS=Mus musculus OX=10090 GN=Leng8 PE=1 SV=1 g17206.t1 Q60631 54.487 156 3.33e-49 166.0 sp|Q60631|GRB2_MOUSE Growth factor receptor-bound protein 2 OS=Mus musculus OX=10090 GN=Grb2 PE=1 SV=1 GRB2_MOUSE reviewed Growth factor receptor-bound protein 2 (Adapter protein GRB2) (SH2/SH3 adapter GRB2) Mus musculus (Mouse) GO:0001784; GO:0005068; GO:0005091; GO:0005154; GO:0005168; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005794; GO:0005813; GO:0005829; GO:0005886; GO:0005911; GO:0005938; GO:0007165; GO:0007173; GO:0007265; GO:0008180; GO:0008286; GO:0008543; GO:0012506; GO:0014044; GO:0016020; GO:0017124; GO:0019899; GO:0019901; GO:0019903; GO:0019904; GO:0030036; GO:0030154; GO:0030674; GO:0030838; GO:0031295; GO:0031623; GO:0032991; GO:0038133; GO:0042110; GO:0042267; GO:0042552; GO:0042770; GO:0042802; GO:0043408; GO:0043560; GO:0044877; GO:0045953; GO:0046875; GO:0048009; GO:0048646; GO:0050853; GO:0051219; GO:0060090; GO:0060670; GO:0070436; GO:0071479; GO:0098793; GO:2000379 actin cytoskeleton organization [GO:0030036]; anatomical structure formation involved in morphogenesis [GO:0048646]; B cell receptor signaling pathway [GO:0050853]; branching involved in labyrinthine layer morphogenesis [GO:0060670]; cell differentiation [GO:0030154]; cellular response to ionizing radiation [GO:0071479]; epidermal growth factor receptor signaling pathway [GO:0007173]; ERBB2-ERBB3 signaling pathway [GO:0038133]; fibroblast growth factor receptor signaling pathway [GO:0008543]; insulin receptor signaling pathway [GO:0008286]; insulin-like growth factor receptor signaling pathway [GO:0048009]; myelination [GO:0042552]; natural killer cell mediated cytotoxicity [GO:0042267]; negative regulation of natural killer cell mediated cytotoxicity [GO:0045953]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; Ras protein signal transduction [GO:0007265]; receptor internalization [GO:0031623]; regulation of MAPK cascade [GO:0043408]; Schwann cell development [GO:0014044]; signal transduction [GO:0007165]; signal transduction in response to DNA damage [GO:0042770]; T cell activation [GO:0042110]; T cell costimulation [GO:0031295] cell cortex [GO:0005938]; cell-cell junction [GO:0005911]; centrosome [GO:0005813]; COP9 signalosome [GO:0008180]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; Grb2-EGFR complex [GO:0070436]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; protein-containing complex [GO:0032991]; vesicle membrane [GO:0012506] enzyme binding [GO:0019899]; ephrin receptor binding [GO:0046875]; epidermal growth factor receptor binding [GO:0005154]; guanyl-nucleotide exchange factor adaptor activity [GO:0005091]; identical protein binding [GO:0042802]; insulin receptor substrate binding [GO:0043560]; molecular adaptor activity [GO:0060090]; neurotrophin TRKA receptor binding [GO:0005168]; phosphoprotein binding [GO:0051219]; phosphotyrosine residue binding [GO:0001784]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; protein phosphatase binding [GO:0019903]; protein-containing complex binding [GO:0044877]; protein-macromolecule adaptor activity [GO:0030674]; SH3 domain binding [GO:0017124]; transmembrane receptor protein tyrosine kinase adaptor activity [GO:0005068] g17207.t1 D3ZEN0 41.311 305 8.14e-59 223.0 sp|D3ZEN0|MILK2_RAT MICAL-like protein 2 OS=Rattus norvegicus OX=10116 GN=Micall2 PE=1 SV=2 MILK2_RAT reviewed MICAL-like protein 2 (Junctional Rab13-binding protein) (Molecule interacting with CasL-like 2) (MICAL-L2) Rattus norvegicus (Rat) GO:0001725; GO:0005886; GO:0005911; GO:0005923; GO:0030036; GO:0030041; GO:0031005; GO:0031175; GO:0031267; GO:0032432; GO:0032456; GO:0032482; GO:0034446; GO:0042805; GO:0043005; GO:0046872; GO:0051015; GO:0055037; GO:0070830; GO:0097750 actin cytoskeleton organization [GO:0030036]; actin filament polymerization [GO:0030041]; bicellular tight junction assembly [GO:0070830]; endocytic recycling [GO:0032456]; endosome membrane tubulation [GO:0097750]; neuron projection development [GO:0031175]; Rab protein signal transduction [GO:0032482]; substrate adhesion-dependent cell spreading [GO:0034446] actin filament bundle [GO:0032432]; bicellular tight junction [GO:0005923]; cell-cell junction [GO:0005911]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; stress fiber [GO:0001725] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; filamin binding [GO:0031005]; metal ion binding [GO:0046872]; small GTPase binding [GO:0031267] g17208.t1 Q5RB75 33.514 370 6.45e-56 189.0 sp|Q5RB75|NUDC3_PONAB NudC domain-containing protein 3 OS=Pongo abelii OX=9601 GN=NUDCD3 PE=2 SV=1 g17209.t1 Q8HY87 41.026 780 0.0 580.0 sp|Q8HY87|RNZ2_MACFA Zinc phosphodiesterase ELAC protein 2 OS=Macaca fascicularis OX=9541 GN=ELAC2 PE=2 SV=1 g17210.t1 Q12830 52.941 221 2.9799999999999998e-52 205.0 sp|Q12830|BPTF_HUMAN Nucleosome-remodeling factor subunit BPTF OS=Homo sapiens OX=9606 GN=BPTF PE=1 SV=3 g17215.t1 Q12830 41.711 374 6.98e-77 266.0 sp|Q12830|BPTF_HUMAN Nucleosome-remodeling factor subunit BPTF OS=Homo sapiens OX=9606 GN=BPTF PE=1 SV=3 g17217.t1 Q12830 58.453 349 1.01e-136 444.0 sp|Q12830|BPTF_HUMAN Nucleosome-remodeling factor subunit BPTF OS=Homo sapiens OX=9606 GN=BPTF PE=1 SV=3 g17218.t1 Q9WVM7 38.82 322 1.03e-46 162.0 sp|Q9WVM7|AIMP2_CRIGR Aminoacyl tRNA synthase complex-interacting multifunctional protein 2 OS=Cricetulus griseus OX=10029 GN=AIMP2 PE=2 SV=1 g17221.t1 Q6ZMW2 43.191 257 2.27e-61 209.0 sp|Q6ZMW2|ZN782_HUMAN Zinc finger protein 782 OS=Homo sapiens OX=9606 GN=ZNF782 PE=1 SV=1 g17221.t1 Q6ZMW2 41.245 257 1.92e-57 199.0 sp|Q6ZMW2|ZN782_HUMAN Zinc finger protein 782 OS=Homo sapiens OX=9606 GN=ZNF782 PE=1 SV=1 g17221.t1 Q6ZMW2 41.518 224 4.2099999999999995e-55 192.0 sp|Q6ZMW2|ZN782_HUMAN Zinc finger protein 782 OS=Homo sapiens OX=9606 GN=ZNF782 PE=1 SV=1 g17221.t1 Q6ZMW2 37.5 256 5.68e-48 173.0 sp|Q6ZMW2|ZN782_HUMAN Zinc finger protein 782 OS=Homo sapiens OX=9606 GN=ZNF782 PE=1 SV=1 g17221.t1 Q6ZMW2 45.614 171 7.15e-45 164.0 sp|Q6ZMW2|ZN782_HUMAN Zinc finger protein 782 OS=Homo sapiens OX=9606 GN=ZNF782 PE=1 SV=1 g17221.t1 Q6ZMW2 35.628 247 4.7e-43 159.0 sp|Q6ZMW2|ZN782_HUMAN Zinc finger protein 782 OS=Homo sapiens OX=9606 GN=ZNF782 PE=1 SV=1 g17221.t1 Q6ZMW2 34.694 245 1.6099999999999998e-38 147.0 sp|Q6ZMW2|ZN782_HUMAN Zinc finger protein 782 OS=Homo sapiens OX=9606 GN=ZNF782 PE=1 SV=1 g17222.t1 Q9D0M1 68.919 74 2.16e-32 117.0 sp|Q9D0M1|KPRA_MOUSE Phosphoribosyl pyrophosphate synthase-associated protein 1 OS=Mus musculus OX=10090 GN=Prpsap1 PE=1 SV=1 g17223.t1 Q5ZL26 67.347 147 4.47e-75 212.0 sp|Q5ZL26|KPRB_CHICK Phosphoribosyl pyrophosphate synthase-associated protein 2 OS=Gallus gallus OX=9031 GN=PRPSAP2 PE=2 SV=1 g17223.t1 Q5ZL26 83.673 49 4.47e-75 90.1 sp|Q5ZL26|KPRB_CHICK Phosphoribosyl pyrophosphate synthase-associated protein 2 OS=Gallus gallus OX=9031 GN=PRPSAP2 PE=2 SV=1 g17224.t1 A7M7B9 65.044 226 5.94e-114 337.0 sp|A7M7B9|NTH_CHICK Endonuclease III-like protein 1 OS=Gallus gallus OX=9031 GN=NTHL1 PE=2 SV=1 NTH_CHICK reviewed Endonuclease III-like protein 1 (EC 3.2.2.-) (EC 4.2.99.18) (Bifunctional DNA N-glycosylase/DNA-(apurinic or apyrimidinic site) lyase) (DNA glycosylase/AP lyase) Gallus gallus (Chicken) GO:0000703; GO:0003677; GO:0003906; GO:0005634; GO:0005739; GO:0006285; GO:0006289; GO:0046872; GO:0051539; GO:0140078 base-excision repair, AP site formation [GO:0006285]; nucleotide-excision repair [GO:0006289] mitochondrion [GO:0005739]; nucleus [GO:0005634] 4 iron, 4 sulfur cluster binding [GO:0051539]; class I DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0140078]; DNA binding [GO:0003677]; DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0003906]; metal ion binding [GO:0046872]; oxidized pyrimidine nucleobase lesion DNA N-glycosylase activity [GO:0000703] g17225.t1 Q7Z5N4 37.888 483 6.6e-98 318.0 sp|Q7Z5N4|SDK1_HUMAN Protein sidekick-1 OS=Homo sapiens OX=9606 GN=SDK1 PE=1 SV=3 SDK1_HUMAN reviewed Protein sidekick-1 Homo sapiens (Human) GO:0005886; GO:0007156; GO:0007416; GO:0010842; GO:0042802; GO:0045202; GO:0048148; GO:0060998 behavioral response to cocaine [GO:0048148]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; regulation of dendritic spine development [GO:0060998]; retina layer formation [GO:0010842]; synapse assembly [GO:0007416] plasma membrane [GO:0005886]; synapse [GO:0045202] identical protein binding [GO:0042802] g17225.t1 Q7Z5N4 29.801 151 6.6e-98 57.8 sp|Q7Z5N4|SDK1_HUMAN Protein sidekick-1 OS=Homo sapiens OX=9606 GN=SDK1 PE=1 SV=3 SDK1_HUMAN reviewed Protein sidekick-1 Homo sapiens (Human) GO:0005886; GO:0007156; GO:0007416; GO:0010842; GO:0042802; GO:0045202; GO:0048148; GO:0060998 behavioral response to cocaine [GO:0048148]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; regulation of dendritic spine development [GO:0060998]; retina layer formation [GO:0010842]; synapse assembly [GO:0007416] plasma membrane [GO:0005886]; synapse [GO:0045202] identical protein binding [GO:0042802] g17225.t1 Q7Z5N4 45.455 33 6.6e-98 26.9 sp|Q7Z5N4|SDK1_HUMAN Protein sidekick-1 OS=Homo sapiens OX=9606 GN=SDK1 PE=1 SV=3 SDK1_HUMAN reviewed Protein sidekick-1 Homo sapiens (Human) GO:0005886; GO:0007156; GO:0007416; GO:0010842; GO:0042802; GO:0045202; GO:0048148; GO:0060998 behavioral response to cocaine [GO:0048148]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; regulation of dendritic spine development [GO:0060998]; retina layer formation [GO:0010842]; synapse assembly [GO:0007416] plasma membrane [GO:0005886]; synapse [GO:0045202] identical protein binding [GO:0042802] g17225.t1 Q7Z5N4 40.625 32 6.6e-98 21.2 sp|Q7Z5N4|SDK1_HUMAN Protein sidekick-1 OS=Homo sapiens OX=9606 GN=SDK1 PE=1 SV=3 SDK1_HUMAN reviewed Protein sidekick-1 Homo sapiens (Human) GO:0005886; GO:0007156; GO:0007416; GO:0010842; GO:0042802; GO:0045202; GO:0048148; GO:0060998 behavioral response to cocaine [GO:0048148]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; regulation of dendritic spine development [GO:0060998]; retina layer formation [GO:0010842]; synapse assembly [GO:0007416] plasma membrane [GO:0005886]; synapse [GO:0045202] identical protein binding [GO:0042802] g17225.t1 Q7Z5N4 32.258 465 7.08e-53 203.0 sp|Q7Z5N4|SDK1_HUMAN Protein sidekick-1 OS=Homo sapiens OX=9606 GN=SDK1 PE=1 SV=3 SDK1_HUMAN reviewed Protein sidekick-1 Homo sapiens (Human) GO:0005886; GO:0007156; GO:0007416; GO:0010842; GO:0042802; GO:0045202; GO:0048148; GO:0060998 behavioral response to cocaine [GO:0048148]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; regulation of dendritic spine development [GO:0060998]; retina layer formation [GO:0010842]; synapse assembly [GO:0007416] plasma membrane [GO:0005886]; synapse [GO:0045202] identical protein binding [GO:0042802] g17225.t1 Q7Z5N4 30.303 330 5.7599999999999994e-34 144.0 sp|Q7Z5N4|SDK1_HUMAN Protein sidekick-1 OS=Homo sapiens OX=9606 GN=SDK1 PE=1 SV=3 SDK1_HUMAN reviewed Protein sidekick-1 Homo sapiens (Human) GO:0005886; GO:0007156; GO:0007416; GO:0010842; GO:0042802; GO:0045202; GO:0048148; GO:0060998 behavioral response to cocaine [GO:0048148]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; regulation of dendritic spine development [GO:0060998]; retina layer formation [GO:0010842]; synapse assembly [GO:0007416] plasma membrane [GO:0005886]; synapse [GO:0045202] identical protein binding [GO:0042802] g17225.t2 Q7Z5N4 37.888 483 9.03e-98 318.0 sp|Q7Z5N4|SDK1_HUMAN Protein sidekick-1 OS=Homo sapiens OX=9606 GN=SDK1 PE=1 SV=3 SDK1_HUMAN reviewed Protein sidekick-1 Homo sapiens (Human) GO:0005886; GO:0007156; GO:0007416; GO:0010842; GO:0042802; GO:0045202; GO:0048148; GO:0060998 behavioral response to cocaine [GO:0048148]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; regulation of dendritic spine development [GO:0060998]; retina layer formation [GO:0010842]; synapse assembly [GO:0007416] plasma membrane [GO:0005886]; synapse [GO:0045202] identical protein binding [GO:0042802] g17225.t2 Q7Z5N4 29.801 151 9.03e-98 57.8 sp|Q7Z5N4|SDK1_HUMAN Protein sidekick-1 OS=Homo sapiens OX=9606 GN=SDK1 PE=1 SV=3 SDK1_HUMAN reviewed Protein sidekick-1 Homo sapiens (Human) GO:0005886; GO:0007156; GO:0007416; GO:0010842; GO:0042802; GO:0045202; GO:0048148; GO:0060998 behavioral response to cocaine [GO:0048148]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; regulation of dendritic spine development [GO:0060998]; retina layer formation [GO:0010842]; synapse assembly [GO:0007416] plasma membrane [GO:0005886]; synapse [GO:0045202] identical protein binding [GO:0042802] g17225.t2 Q7Z5N4 45.455 33 9.03e-98 26.9 sp|Q7Z5N4|SDK1_HUMAN Protein sidekick-1 OS=Homo sapiens OX=9606 GN=SDK1 PE=1 SV=3 SDK1_HUMAN reviewed Protein sidekick-1 Homo sapiens (Human) GO:0005886; GO:0007156; GO:0007416; GO:0010842; GO:0042802; GO:0045202; GO:0048148; GO:0060998 behavioral response to cocaine [GO:0048148]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; regulation of dendritic spine development [GO:0060998]; retina layer formation [GO:0010842]; synapse assembly [GO:0007416] plasma membrane [GO:0005886]; synapse [GO:0045202] identical protein binding [GO:0042802] g17225.t2 Q7Z5N4 40.625 32 9.03e-98 21.2 sp|Q7Z5N4|SDK1_HUMAN Protein sidekick-1 OS=Homo sapiens OX=9606 GN=SDK1 PE=1 SV=3 SDK1_HUMAN reviewed Protein sidekick-1 Homo sapiens (Human) GO:0005886; GO:0007156; GO:0007416; GO:0010842; GO:0042802; GO:0045202; GO:0048148; GO:0060998 behavioral response to cocaine [GO:0048148]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; regulation of dendritic spine development [GO:0060998]; retina layer formation [GO:0010842]; synapse assembly [GO:0007416] plasma membrane [GO:0005886]; synapse [GO:0045202] identical protein binding [GO:0042802] g17225.t2 Q7Z5N4 32.473 465 8.76e-53 203.0 sp|Q7Z5N4|SDK1_HUMAN Protein sidekick-1 OS=Homo sapiens OX=9606 GN=SDK1 PE=1 SV=3 SDK1_HUMAN reviewed Protein sidekick-1 Homo sapiens (Human) GO:0005886; GO:0007156; GO:0007416; GO:0010842; GO:0042802; GO:0045202; GO:0048148; GO:0060998 behavioral response to cocaine [GO:0048148]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; regulation of dendritic spine development [GO:0060998]; retina layer formation [GO:0010842]; synapse assembly [GO:0007416] plasma membrane [GO:0005886]; synapse [GO:0045202] identical protein binding [GO:0042802] g17225.t2 Q7Z5N4 30.303 330 7.04e-34 144.0 sp|Q7Z5N4|SDK1_HUMAN Protein sidekick-1 OS=Homo sapiens OX=9606 GN=SDK1 PE=1 SV=3 SDK1_HUMAN reviewed Protein sidekick-1 Homo sapiens (Human) GO:0005886; GO:0007156; GO:0007416; GO:0010842; GO:0042802; GO:0045202; GO:0048148; GO:0060998 behavioral response to cocaine [GO:0048148]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; regulation of dendritic spine development [GO:0060998]; retina layer formation [GO:0010842]; synapse assembly [GO:0007416] plasma membrane [GO:0005886]; synapse [GO:0045202] identical protein binding [GO:0042802] g17227.t1 Q6P8I6 70.526 190 1.48e-98 290.0 sp|Q6P8I6|COX11_MOUSE Cytochrome c oxidase assembly protein COX11, mitochondrial OS=Mus musculus OX=10090 GN=Cox11 PE=1 SV=1 COX11_MOUSE reviewed Cytochrome c oxidase assembly protein COX11, mitochondrial Mus musculus (Mouse) GO:0005507; GO:0005739; GO:0005743; GO:0006754; GO:0030003; GO:0032991 ATP biosynthetic process [GO:0006754]; intracellular monoatomic cation homeostasis [GO:0030003] mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; protein-containing complex [GO:0032991] copper ion binding [GO:0005507] g17228.t1 P97868 49.593 246 2.12e-60 234.0 sp|P97868|RBBP6_MOUSE E3 ubiquitin-protein ligase RBBP6 OS=Mus musculus OX=10090 GN=Rbbp6 PE=1 SV=5 g17230.t1 P42694 48.943 331 5.77e-97 322.0 sp|P42694|HELZ_HUMAN Probable helicase with zinc finger domain OS=Homo sapiens OX=9606 GN=HELZ PE=1 SV=2 HELZ_HUMAN reviewed ATP-dependent RNA helicase with zinc finger domain (EC 3.6.4.13) (Down-regulated in human cancers protein) Homo sapiens (Human) GO:0003723; GO:0004386; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0008270; GO:0008284; GO:0016020; GO:0016787; GO:0017148; GO:0035194; GO:0043186; GO:1900153; GO:1905762 negative regulation of translation [GO:0017148]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; regulatory ncRNA-mediated post-transcriptional gene silencing [GO:0035194] cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; P granule [GO:0043186] ATP binding [GO:0005524]; CCR4-NOT complex binding [GO:1905762]; helicase activity [GO:0004386]; hydrolase activity [GO:0016787]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270] g17231.t1 Q6NYU2 65.138 545 0.0 736.0 sp|Q6NYU2|HELZ_DANRE Probable helicase with zinc finger domain OS=Danio rerio OX=7955 GN=helz PE=2 SV=1 HELZ_DANRE reviewed ATP-dependent RNA helicase with zinc finger domain (EC 3.6.4.13) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0003677; GO:0003700; GO:0003723; GO:0004386; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0008270; GO:0008284; GO:0016787; GO:0017148; GO:0035194; GO:0043186; GO:1900153 negative regulation of translation [GO:0017148]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; regulatory ncRNA-mediated post-transcriptional gene silencing [GO:0035194] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; P granule [GO:0043186] ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; helicase activity [GO:0004386]; hydrolase activity [GO:0016787]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270] g17237.t1 A4VPC3 56.25 272 9.91e-97 289.0 sp|A4VPC3|ISPE_STUS1 4-diphosphocytidyl-2-C-methyl-D-erythritol kinase OS=Stutzerimonas stutzeri (strain A1501) OX=379731 GN=ispE PE=3 SV=1 g17239.t1 P23098 77.432 1316 0.0 2113.0 sp|P23098|DYHC_TRIGR Dynein beta chain, ciliary OS=Tripneustes gratilla OX=7673 PE=1 SV=1 g17240.t1 P39057 88.847 1058 0.0 1855.0 sp|P39057|DYHC_HELCR Dynein beta chain, ciliary OS=Heliocidaris crassispina OX=1043166 PE=1 SV=1 g17241.t1 P23098 80.62 258 4.8500000000000006e-144 450.0 sp|P23098|DYHC_TRIGR Dynein beta chain, ciliary OS=Tripneustes gratilla OX=7673 PE=1 SV=1 g17242.t1 P23098 80.0 535 0.0 759.0 sp|P23098|DYHC_TRIGR Dynein beta chain, ciliary OS=Tripneustes gratilla OX=7673 PE=1 SV=1 g17243.t1 P39057 88.332 1097 0.0 1967.0 sp|P39057|DYHC_HELCR Dynein beta chain, ciliary OS=Heliocidaris crassispina OX=1043166 PE=1 SV=1 g17246.t1 P49109 38.306 543 3.27e-127 394.0 sp|P49109|FMO5_CAVPO Flavin-containing monooxygenase 5 OS=Cavia porcellus OX=10141 GN=FMO5 PE=1 SV=2 g17247.t1 P53396 41.814 849 0.0 593.0 sp|P53396|ACLY_HUMAN ATP-citrate synthase OS=Homo sapiens OX=9606 GN=ACLY PE=1 SV=3 ACLY_HUMAN reviewed ATP-citrate synthase (EC 2.3.3.8) (ATP-citrate (pro-S-)-lyase) (ACL) (Citrate cleavage enzyme) Homo sapiens (Human) GO:0003878; GO:0005524; GO:0005576; GO:0005654; GO:0005829; GO:0006085; GO:0006101; GO:0006107; GO:0006633; GO:0006695; GO:0008610; GO:0015936; GO:0016020; GO:0035578; GO:0035869; GO:0036064; GO:0046872; GO:0070062; GO:0097228; GO:0110076; GO:1904813 acetyl-CoA biosynthetic process [GO:0006085]; cholesterol biosynthetic process [GO:0006695]; citrate metabolic process [GO:0006101]; coenzyme A metabolic process [GO:0015936]; fatty acid biosynthetic process [GO:0006633]; lipid biosynthetic process [GO:0008610]; negative regulation of ferroptosis [GO:0110076]; oxaloacetate metabolic process [GO:0006107] azurophil granule lumen [GO:0035578]; ciliary basal body [GO:0036064]; ciliary transition zone [GO:0035869]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; sperm principal piece [GO:0097228] ATP binding [GO:0005524]; ATP citrate synthase activity [GO:0003878]; metal ion binding [GO:0046872] g17251.t1 Q8R050 74.824 425 0.0 688.0 sp|Q8R050|ERF3A_MOUSE Eukaryotic peptide chain release factor GTP-binding subunit ERF3A OS=Mus musculus OX=10090 GN=Gspt1 PE=1 SV=2 ERF3A_MOUSE reviewed Eukaryotic peptide chain release factor GTP-binding subunit ERF3A (Eukaryotic peptide chain release factor subunit 3a) (eRF3a) (EC 3.6.5.-) (G1 to S phase transition protein 1 homolog) Mus musculus (Mouse) GO:0000184; GO:0003747; GO:0003924; GO:0005525; GO:0005737; GO:0006412; GO:0006415; GO:0006449; GO:0018444; GO:0022626; GO:0032790 nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; regulation of translational termination [GO:0006449]; ribosome disassembly [GO:0032790]; translation [GO:0006412]; translational termination [GO:0006415] cytoplasm [GO:0005737]; cytosolic ribosome [GO:0022626]; translation release factor complex [GO:0018444] GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation release factor activity [GO:0003747] g17253.t1 Q9FPH3 55.431 267 1.18e-102 306.0 sp|Q9FPH3|THA2_ARATH Probable low-specificity L-threonine aldolase 2 OS=Arabidopsis thaliana OX=3702 GN=THA2 PE=1 SV=1 g17254.t1 Q80U30 54.0 800 0.0 768.0 sp|Q80U30|CL16A_MOUSE Protein CLEC16A OS=Mus musculus OX=10090 GN=Clec16a PE=1 SV=2 CL16A_MOUSE reviewed Protein CLEC16A Mus musculus (Mouse) GO:0000423; GO:0005794; GO:0005829; GO:0007034; GO:0009267; GO:0016197; GO:0031648; GO:0031982; GO:0032434; GO:0032435; GO:0036020; GO:1901096; GO:1901097; GO:1901098; GO:1901525; GO:1904263 cellular response to starvation [GO:0009267]; endosomal transport [GO:0016197]; mitophagy [GO:0000423]; negative regulation of autophagosome maturation [GO:1901097]; negative regulation of mitophagy [GO:1901525]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; positive regulation of autophagosome maturation [GO:1901098]; positive regulation of TORC1 signaling [GO:1904263]; protein destabilization [GO:0031648]; regulation of autophagosome maturation [GO:1901096]; regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032434]; vacuolar transport [GO:0007034] cytosol [GO:0005829]; endolysosome membrane [GO:0036020]; Golgi apparatus [GO:0005794]; vesicle [GO:0031982] g17258.t1 O35717 40.741 189 3.3100000000000003e-35 127.0 sp|O35717|SOCS2_MOUSE Suppressor of cytokine signaling 2 OS=Mus musculus OX=10090 GN=Socs2 PE=1 SV=1 SOCS2_MOUSE reviewed Suppressor of cytokine signaling 2 (SOCS-2) Mus musculus (Mouse) GO:0005126; GO:0005131; GO:0005159; GO:0005737; GO:0007595; GO:0009968; GO:0016567; GO:0019221; GO:0031466; GO:0032355; GO:0032870; GO:0035556; GO:0038162; GO:0040014; GO:0040015; GO:0043161; GO:0045666; GO:0046426; GO:0060396; GO:0060397; GO:0060400; GO:0060749; GO:0140031; GO:1990756 cellular response to hormone stimulus [GO:0032870]; cytokine-mediated signaling pathway [GO:0019221]; erythropoietin-mediated signaling pathway [GO:0038162]; growth hormone receptor signaling pathway [GO:0060396]; growth hormone receptor signaling pathway via JAK-STAT [GO:0060397]; intracellular signal transduction [GO:0035556]; lactation [GO:0007595]; mammary gland alveolus development [GO:0060749]; negative regulation of growth hormone receptor signaling pathway [GO:0060400]; negative regulation of multicellular organism growth [GO:0040015]; negative regulation of receptor signaling pathway via JAK-STAT [GO:0046426]; negative regulation of signal transduction [GO:0009968]; positive regulation of neuron differentiation [GO:0045666]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of multicellular organism growth [GO:0040014]; response to estradiol [GO:0032355] Cul5-RING ubiquitin ligase complex [GO:0031466]; cytoplasm [GO:0005737] cytokine receptor binding [GO:0005126]; growth hormone receptor binding [GO:0005131]; insulin-like growth factor receptor binding [GO:0005159]; phosphorylation-dependent protein binding [GO:0140031]; ubiquitin-like ligase-substrate adaptor activity [GO:1990756] g17262.t1 A4FV97 37.838 259 1.48e-60 205.0 sp|A4FV97|RL1D1_BOVIN Ribosomal L1 domain-containing protein 1 OS=Bos taurus OX=9913 GN=RSL1D1 PE=2 SV=1 g17263.t1 Q5SUE8 41.6 125 3.75e-28 113.0 sp|Q5SUE8|ANR40_MOUSE Ankyrin repeat domain-containing protein 40 OS=Mus musculus OX=10090 GN=Ankrd40 PE=1 SV=1 g17263.t1 Q5SUE8 50.769 130 2.2e-23 100.0 sp|Q5SUE8|ANR40_MOUSE Ankyrin repeat domain-containing protein 40 OS=Mus musculus OX=10090 GN=Ankrd40 PE=1 SV=1 g17263.t2 Q6AI12 58.333 96 6.24e-25 102.0 sp|Q6AI12|ANR40_HUMAN Ankyrin repeat domain-containing protein 40 OS=Homo sapiens OX=9606 GN=ANKRD40 PE=1 SV=2 g17263.t2 Q6AI12 45.977 87 1.0300000000000001e-21 94.0 sp|Q6AI12|ANR40_HUMAN Ankyrin repeat domain-containing protein 40 OS=Homo sapiens OX=9606 GN=ANKRD40 PE=1 SV=2 g17264.t1 Q08CY4 38.341 832 2.89e-155 478.0 sp|Q08CY4|TELO2_XENTR Telomere length regulation protein TEL2 homolog OS=Xenopus tropicalis OX=8364 GN=telo2 PE=2 SV=1 g17266.t1 Q99XR4 26.667 330 8.31e-24 102.0 sp|Q99XR4|GLFT_STRP1 Glutamate formimidoyltransferase OS=Streptococcus pyogenes serotype M1 OX=301447 GN=M5005_Spy1772 PE=1 SV=1 g17267.t1 A1L2K1 25.667 300 2.56e-29 116.0 sp|A1L2K1|METRL_XENLA Meteorin-like protein OS=Xenopus laevis OX=8355 GN=metrnl PE=2 SV=1 g17272.t1 Q8C9A2 50.495 303 8.66e-98 295.0 sp|Q8C9A2|ENDOV_MOUSE Endonuclease V OS=Mus musculus OX=10090 GN=Endov PE=1 SV=2 ENDOV_MOUSE reviewed Endonuclease V (EC 3.1.26.-) Mus musculus (Mouse) GO:0000287; GO:0003677; GO:0003727; GO:0005730; GO:0005737; GO:0006281; GO:0010494; GO:0016888; GO:0016891 DNA repair [GO:0006281] cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; nucleolus [GO:0005730] DNA binding [GO:0003677]; DNA endonuclease activity, producing 5'-phosphomonoesters [GO:0016888]; magnesium ion binding [GO:0000287]; RNA endonuclease activity producing 5'-phosphomonoesters, hydrolytic mechanism [GO:0016891]; single-stranded RNA binding [GO:0003727] g17273.t1 Q9DCM4 75.728 103 8.35e-57 174.0 sp|Q9DCM4|DNAL4_MOUSE Dynein axonemal light chain 4 OS=Mus musculus OX=10090 GN=Dnal4 PE=3 SV=2 g17276.t1 Q08431 31.329 316 2.1200000000000001e-32 130.0 sp|Q08431|MFGM_HUMAN Lactadherin OS=Homo sapiens OX=9606 GN=MFGE8 PE=1 SV=3 MFGM_HUMAN reviewed Lactadherin (Breast epithelial antigen BA46) (HMFG) (MFGM) (Milk fat globule-EGF factor 8) (MFG-E8) (SED1) [Cleaved into: Lactadherin short form; Medin] Homo sapiens (Human) GO:0001525; GO:0001786; GO:0002080; GO:0005178; GO:0005576; GO:0005615; GO:0005788; GO:0007155; GO:0007338; GO:0009897; GO:0016020; GO:0031012; GO:0043277; GO:0070062; GO:1903561 angiogenesis [GO:0001525]; apoptotic cell clearance [GO:0043277]; cell adhesion [GO:0007155]; single fertilization [GO:0007338] acrosomal membrane [GO:0002080]; endoplasmic reticulum lumen [GO:0005788]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular vesicle [GO:1903561]; membrane [GO:0016020] integrin binding [GO:0005178]; phosphatidylserine binding [GO:0001786] g17276.t1 Q08431 28.571 343 1.71e-28 119.0 sp|Q08431|MFGM_HUMAN Lactadherin OS=Homo sapiens OX=9606 GN=MFGE8 PE=1 SV=3 MFGM_HUMAN reviewed Lactadherin (Breast epithelial antigen BA46) (HMFG) (MFGM) (Milk fat globule-EGF factor 8) (MFG-E8) (SED1) [Cleaved into: Lactadherin short form; Medin] Homo sapiens (Human) GO:0001525; GO:0001786; GO:0002080; GO:0005178; GO:0005576; GO:0005615; GO:0005788; GO:0007155; GO:0007338; GO:0009897; GO:0016020; GO:0031012; GO:0043277; GO:0070062; GO:1903561 angiogenesis [GO:0001525]; apoptotic cell clearance [GO:0043277]; cell adhesion [GO:0007155]; single fertilization [GO:0007338] acrosomal membrane [GO:0002080]; endoplasmic reticulum lumen [GO:0005788]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular vesicle [GO:1903561]; membrane [GO:0016020] integrin binding [GO:0005178]; phosphatidylserine binding [GO:0001786] g17276.t2 Q08431 31.329 316 6.62e-32 130.0 sp|Q08431|MFGM_HUMAN Lactadherin OS=Homo sapiens OX=9606 GN=MFGE8 PE=1 SV=3 MFGM_HUMAN reviewed Lactadherin (Breast epithelial antigen BA46) (HMFG) (MFGM) (Milk fat globule-EGF factor 8) (MFG-E8) (SED1) [Cleaved into: Lactadherin short form; Medin] Homo sapiens (Human) GO:0001525; GO:0001786; GO:0002080; GO:0005178; GO:0005576; GO:0005615; GO:0005788; GO:0007155; GO:0007338; GO:0009897; GO:0016020; GO:0031012; GO:0043277; GO:0070062; GO:1903561 angiogenesis [GO:0001525]; apoptotic cell clearance [GO:0043277]; cell adhesion [GO:0007155]; single fertilization [GO:0007338] acrosomal membrane [GO:0002080]; endoplasmic reticulum lumen [GO:0005788]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular vesicle [GO:1903561]; membrane [GO:0016020] integrin binding [GO:0005178]; phosphatidylserine binding [GO:0001786] g17276.t2 Q08431 28.571 343 3.72e-28 119.0 sp|Q08431|MFGM_HUMAN Lactadherin OS=Homo sapiens OX=9606 GN=MFGE8 PE=1 SV=3 MFGM_HUMAN reviewed Lactadherin (Breast epithelial antigen BA46) (HMFG) (MFGM) (Milk fat globule-EGF factor 8) (MFG-E8) (SED1) [Cleaved into: Lactadherin short form; Medin] Homo sapiens (Human) GO:0001525; GO:0001786; GO:0002080; GO:0005178; GO:0005576; GO:0005615; GO:0005788; GO:0007155; GO:0007338; GO:0009897; GO:0016020; GO:0031012; GO:0043277; GO:0070062; GO:1903561 angiogenesis [GO:0001525]; apoptotic cell clearance [GO:0043277]; cell adhesion [GO:0007155]; single fertilization [GO:0007338] acrosomal membrane [GO:0002080]; endoplasmic reticulum lumen [GO:0005788]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular vesicle [GO:1903561]; membrane [GO:0016020] integrin binding [GO:0005178]; phosphatidylserine binding [GO:0001786] g17285.t1 Q6UXY8 33.99 609 1.41e-85 299.0 sp|Q6UXY8|TMC5_HUMAN Transmembrane channel-like protein 5 OS=Homo sapiens OX=9606 GN=TMC5 PE=1 SV=3 g17286.t1 Q4R7U0 39.478 689 1.67e-146 448.0 sp|Q4R7U0|TMC7_MACFA Transmembrane channel-like protein 7 OS=Macaca fascicularis OX=9541 GN=TMC7 PE=2 SV=1 g17287.t1 Q32PC3 43.2 125 2.62e-26 100.0 sp|Q32PC3|RM27_BOVIN Large ribosomal subunit protein bL27m OS=Bos taurus OX=9913 GN=MRPL27 PE=1 SV=1 g17288.t1 Q9NYH9 38.651 608 8.5e-125 382.0 sp|Q9NYH9|UTP6_HUMAN U3 small nucleolar RNA-associated protein 6 homolog OS=Homo sapiens OX=9606 GN=UTP6 PE=1 SV=2 g17289.t1 Q9XT77 32.209 593 7.470000000000001e-80 268.0 sp|Q9XT77|SC5A6_RABIT Sodium-dependent multivitamin transporter OS=Oryctolagus cuniculus OX=9986 GN=SLC5A6 PE=2 SV=1 g17289.t2 Q9XT77 32.209 593 8.66e-80 268.0 sp|Q9XT77|SC5A6_RABIT Sodium-dependent multivitamin transporter OS=Oryctolagus cuniculus OX=9986 GN=SLC5A6 PE=2 SV=1 g17290.t1 O35625 38.929 280 3.35e-36 144.0 sp|O35625|AXIN1_MOUSE Axin-1 OS=Mus musculus OX=10090 GN=Axin1 PE=1 SV=3 AXIN1_MOUSE reviewed Axin-1 (Axis inhibition protein 1) (Protein Fused) Mus musculus (Mouse) GO:0000209; GO:0001701; GO:0002039; GO:0005102; GO:0005634; GO:0005730; GO:0005737; GO:0005794; GO:0005829; GO:0005886; GO:0005938; GO:0006913; GO:0006915; GO:0007605; GO:0008013; GO:0009950; GO:0009953; GO:0010629; GO:0015630; GO:0016055; GO:0016328; GO:0019899; GO:0019901; GO:0019904; GO:0030163; GO:0030178; GO:0030511; GO:0030877; GO:0031122; GO:0031398; GO:0031410; GO:0031625; GO:0032436; GO:0032991; GO:0034244; GO:0035591; GO:0036342; GO:0042802; GO:0042803; GO:0043161; GO:0043539; GO:0044725; GO:0045202; GO:0045599; GO:0045732; GO:0045860; GO:0046330; GO:0046332; GO:0048318; GO:0048320; GO:0048468; GO:0048471; GO:0051248; GO:0060070; GO:0060090; GO:0060322; GO:0060828; GO:0065003; GO:0070016; GO:0070411; GO:0070412; GO:0071944; GO:0090090; GO:0120283; GO:1904885; GO:1990756; GO:1990909; GO:2000060 apoptotic process [GO:0006915]; axial mesoderm development [GO:0048318]; axial mesoderm formation [GO:0048320]; beta-catenin destruction complex assembly [GO:1904885]; canonical Wnt signaling pathway [GO:0060070]; cell development [GO:0048468]; cytoplasmic microtubule organization [GO:0031122]; dorsal/ventral axis specification [GO:0009950]; dorsal/ventral pattern formation [GO:0009953]; epigenetic programming in the zygotic pronuclei [GO:0044725]; head development [GO:0060322]; in utero embryonic development [GO:0001701]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of gene expression [GO:0010629]; negative regulation of protein metabolic process [GO:0051248]; negative regulation of transcription elongation by RNA polymerase II [GO:0034244]; negative regulation of Wnt signaling pathway [GO:0030178]; nucleocytoplasmic transport [GO:0006913]; positive regulation of JNK cascade [GO:0046330]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; post-anal tail morphogenesis [GO:0036342]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein catabolic process [GO:0030163]; protein polyubiquitination [GO:0000209]; protein-containing complex assembly [GO:0065003]; regulation of canonical Wnt signaling pathway [GO:0060828]; sensory perception of sound [GO:0007605]; Wnt signaling pathway [GO:0016055] beta-catenin destruction complex [GO:0030877]; cell cortex [GO:0005938]; cell periphery [GO:0071944]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; lateral plasma membrane [GO:0016328]; microtubule cytoskeleton [GO:0015630]; nucleolus [GO:0005730]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; synapse [GO:0045202]; Wnt signalosome [GO:1990909] armadillo repeat domain binding [GO:0070016]; beta-catenin binding [GO:0008013]; enzyme binding [GO:0019899]; I-SMAD binding [GO:0070411]; identical protein binding [GO:0042802]; molecular adaptor activity [GO:0060090]; p53 binding [GO:0002039]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activator activity [GO:0043539]; protein serine/threonine kinase binding [GO:0120283]; R-SMAD binding [GO:0070412]; signaling adaptor activity [GO:0035591]; signaling receptor binding [GO:0005102]; SMAD binding [GO:0046332]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-like ligase-substrate adaptor activity [GO:1990756] g17290.t2 O35625 39.716 282 7.11e-36 143.0 sp|O35625|AXIN1_MOUSE Axin-1 OS=Mus musculus OX=10090 GN=Axin1 PE=1 SV=3 AXIN1_MOUSE reviewed Axin-1 (Axis inhibition protein 1) (Protein Fused) Mus musculus (Mouse) GO:0000209; GO:0001701; GO:0002039; GO:0005102; GO:0005634; GO:0005730; GO:0005737; GO:0005794; GO:0005829; GO:0005886; GO:0005938; GO:0006913; GO:0006915; GO:0007605; GO:0008013; GO:0009950; GO:0009953; GO:0010629; GO:0015630; GO:0016055; GO:0016328; GO:0019899; GO:0019901; GO:0019904; GO:0030163; GO:0030178; GO:0030511; GO:0030877; GO:0031122; GO:0031398; GO:0031410; GO:0031625; GO:0032436; GO:0032991; GO:0034244; GO:0035591; GO:0036342; GO:0042802; GO:0042803; GO:0043161; GO:0043539; GO:0044725; GO:0045202; GO:0045599; GO:0045732; GO:0045860; GO:0046330; GO:0046332; GO:0048318; GO:0048320; GO:0048468; GO:0048471; GO:0051248; GO:0060070; GO:0060090; GO:0060322; GO:0060828; GO:0065003; GO:0070016; GO:0070411; GO:0070412; GO:0071944; GO:0090090; GO:0120283; GO:1904885; GO:1990756; GO:1990909; GO:2000060 apoptotic process [GO:0006915]; axial mesoderm development [GO:0048318]; axial mesoderm formation [GO:0048320]; beta-catenin destruction complex assembly [GO:1904885]; canonical Wnt signaling pathway [GO:0060070]; cell development [GO:0048468]; cytoplasmic microtubule organization [GO:0031122]; dorsal/ventral axis specification [GO:0009950]; dorsal/ventral pattern formation [GO:0009953]; epigenetic programming in the zygotic pronuclei [GO:0044725]; head development [GO:0060322]; in utero embryonic development [GO:0001701]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of gene expression [GO:0010629]; negative regulation of protein metabolic process [GO:0051248]; negative regulation of transcription elongation by RNA polymerase II [GO:0034244]; negative regulation of Wnt signaling pathway [GO:0030178]; nucleocytoplasmic transport [GO:0006913]; positive regulation of JNK cascade [GO:0046330]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; post-anal tail morphogenesis [GO:0036342]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein catabolic process [GO:0030163]; protein polyubiquitination [GO:0000209]; protein-containing complex assembly [GO:0065003]; regulation of canonical Wnt signaling pathway [GO:0060828]; sensory perception of sound [GO:0007605]; Wnt signaling pathway [GO:0016055] beta-catenin destruction complex [GO:0030877]; cell cortex [GO:0005938]; cell periphery [GO:0071944]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; lateral plasma membrane [GO:0016328]; microtubule cytoskeleton [GO:0015630]; nucleolus [GO:0005730]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; synapse [GO:0045202]; Wnt signalosome [GO:1990909] armadillo repeat domain binding [GO:0070016]; beta-catenin binding [GO:0008013]; enzyme binding [GO:0019899]; I-SMAD binding [GO:0070411]; identical protein binding [GO:0042802]; molecular adaptor activity [GO:0060090]; p53 binding [GO:0002039]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activator activity [GO:0043539]; protein serine/threonine kinase binding [GO:0120283]; R-SMAD binding [GO:0070412]; signaling adaptor activity [GO:0035591]; signaling receptor binding [GO:0005102]; SMAD binding [GO:0046332]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-like ligase-substrate adaptor activity [GO:1990756] g17291.t1 O70239 38.028 426 1.76e-57 205.0 sp|O70239|AXIN1_RAT Axin-1 OS=Rattus norvegicus OX=10116 GN=Axin1 PE=1 SV=3 AXIN1_RAT reviewed Axin-1 (Axis inhibition protein 1) (rAxin) Rattus norvegicus (Rat) GO:0000209; GO:0001701; GO:0002039; GO:0005102; GO:0005634; GO:0005730; GO:0005737; GO:0005886; GO:0005938; GO:0006913; GO:0006915; GO:0007605; GO:0008013; GO:0009950; GO:0009953; GO:0010629; GO:0015630; GO:0016055; GO:0016328; GO:0019899; GO:0019901; GO:0019904; GO:0030163; GO:0030178; GO:0030511; GO:0030877; GO:0031122; GO:0031398; GO:0031410; GO:0031625; GO:0032436; GO:0032991; GO:0034244; GO:0035591; GO:0036342; GO:0042802; GO:0042803; GO:0043539; GO:0044725; GO:0045202; GO:0045599; GO:0045732; GO:0046330; GO:0046332; GO:0048318; GO:0048320; GO:0048468; GO:0048471; GO:0051248; GO:0060070; GO:0060090; GO:0060322; GO:0060828; GO:0065003; GO:0070016; GO:0070411; GO:0070412; GO:0071944; GO:0090090; GO:0120283; GO:1904885; GO:1905235; GO:1990756; GO:1990909; GO:2000060 apoptotic process [GO:0006915]; axial mesoderm development [GO:0048318]; axial mesoderm formation [GO:0048320]; beta-catenin destruction complex assembly [GO:1904885]; canonical Wnt signaling pathway [GO:0060070]; cell development [GO:0048468]; cytoplasmic microtubule organization [GO:0031122]; dorsal/ventral axis specification [GO:0009950]; dorsal/ventral pattern formation [GO:0009953]; epigenetic programming in the zygotic pronuclei [GO:0044725]; head development [GO:0060322]; in utero embryonic development [GO:0001701]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of gene expression [GO:0010629]; negative regulation of protein metabolic process [GO:0051248]; negative regulation of transcription elongation by RNA polymerase II [GO:0034244]; negative regulation of Wnt signaling pathway [GO:0030178]; nucleocytoplasmic transport [GO:0006913]; positive regulation of JNK cascade [GO:0046330]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; post-anal tail morphogenesis [GO:0036342]; protein catabolic process [GO:0030163]; protein polyubiquitination [GO:0000209]; protein-containing complex assembly [GO:0065003]; regulation of canonical Wnt signaling pathway [GO:0060828]; response to quercetin [GO:1905235]; sensory perception of sound [GO:0007605]; Wnt signaling pathway [GO:0016055] beta-catenin destruction complex [GO:0030877]; cell cortex [GO:0005938]; cell periphery [GO:0071944]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; lateral plasma membrane [GO:0016328]; microtubule cytoskeleton [GO:0015630]; nucleolus [GO:0005730]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; synapse [GO:0045202]; Wnt signalosome [GO:1990909] armadillo repeat domain binding [GO:0070016]; beta-catenin binding [GO:0008013]; enzyme binding [GO:0019899]; I-SMAD binding [GO:0070411]; identical protein binding [GO:0042802]; molecular adaptor activity [GO:0060090]; p53 binding [GO:0002039]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activator activity [GO:0043539]; protein serine/threonine kinase binding [GO:0120283]; R-SMAD binding [GO:0070412]; signaling adaptor activity [GO:0035591]; signaling receptor binding [GO:0005102]; SMAD binding [GO:0046332]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-like ligase-substrate adaptor activity [GO:1990756] g17292.t1 Q29S22 82.781 151 7.85e-88 268.0 sp|Q29S22|DDX47_BOVIN Probable ATP-dependent RNA helicase DDX47 OS=Bos taurus OX=9913 GN=DDX47 PE=2 SV=1 DDX47_BOVIN reviewed Probable ATP-dependent RNA helicase DDX47 (EC 3.6.4.13) (DEAD box protein 47) Bos taurus (Bovine) GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005730; GO:0006364; GO:0006397; GO:0008380; GO:0008625; GO:0016887 extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380]; rRNA processing [GO:0006364] nucleolus [GO:0005730]; nucleus [GO:0005634] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724] g17293.t1 Q29S22 73.43 207 3.59e-91 277.0 sp|Q29S22|DDX47_BOVIN Probable ATP-dependent RNA helicase DDX47 OS=Bos taurus OX=9913 GN=DDX47 PE=2 SV=1 DDX47_BOVIN reviewed Probable ATP-dependent RNA helicase DDX47 (EC 3.6.4.13) (DEAD box protein 47) Bos taurus (Bovine) GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005730; GO:0006364; GO:0006397; GO:0008380; GO:0008625; GO:0016887 extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380]; rRNA processing [GO:0006364] nucleolus [GO:0005730]; nucleus [GO:0005634] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724] g17296.t1 Q25378 74.379 644 0.0 1013.0 sp|Q25378|KPC1_LYTPI Protein kinase C OS=Lytechinus pictus OX=7653 GN=PKC1 PE=2 SV=1 g17297.t1 A6NCI4 43.66 694 0.0 577.0 sp|A6NCI4|VWA3A_HUMAN von Willebrand factor A domain-containing protein 3A OS=Homo sapiens OX=9606 GN=VWA3A PE=1 SV=3 g17297.t1 A6NCI4 36.339 366 0.0 254.0 sp|A6NCI4|VWA3A_HUMAN von Willebrand factor A domain-containing protein 3A OS=Homo sapiens OX=9606 GN=VWA3A PE=1 SV=3 g17297.t1 A6NCI4 67.568 37 0.0 63.2 sp|A6NCI4|VWA3A_HUMAN von Willebrand factor A domain-containing protein 3A OS=Homo sapiens OX=9606 GN=VWA3A PE=1 SV=3 g17297.t1 A6NCI4 72.0 25 0.0 39.7 sp|A6NCI4|VWA3A_HUMAN von Willebrand factor A domain-containing protein 3A OS=Homo sapiens OX=9606 GN=VWA3A PE=1 SV=3 g17297.t1 A6NCI4 25.641 390 1.86e-24 115.0 sp|A6NCI4|VWA3A_HUMAN von Willebrand factor A domain-containing protein 3A OS=Homo sapiens OX=9606 GN=VWA3A PE=1 SV=3 g17297.t2 A6NCI4 43.453 695 0.0 578.0 sp|A6NCI4|VWA3A_HUMAN von Willebrand factor A domain-containing protein 3A OS=Homo sapiens OX=9606 GN=VWA3A PE=1 SV=3 g17297.t2 A6NCI4 35.567 388 0.0 254.0 sp|A6NCI4|VWA3A_HUMAN von Willebrand factor A domain-containing protein 3A OS=Homo sapiens OX=9606 GN=VWA3A PE=1 SV=3 g17297.t2 A6NCI4 67.568 37 0.0 63.2 sp|A6NCI4|VWA3A_HUMAN von Willebrand factor A domain-containing protein 3A OS=Homo sapiens OX=9606 GN=VWA3A PE=1 SV=3 g17297.t2 A6NCI4 72.0 25 0.0 39.7 sp|A6NCI4|VWA3A_HUMAN von Willebrand factor A domain-containing protein 3A OS=Homo sapiens OX=9606 GN=VWA3A PE=1 SV=3 g17297.t2 A6NCI4 25.641 390 1.8e-24 115.0 sp|A6NCI4|VWA3A_HUMAN von Willebrand factor A domain-containing protein 3A OS=Homo sapiens OX=9606 GN=VWA3A PE=1 SV=3 g17300.t1 A2A870 32.054 443 2.53e-26 121.0 sp|A2A870|FBF1_MOUSE Fas-binding factor 1 OS=Mus musculus OX=10090 GN=Fbf1 PE=1 SV=1 g17305.t1 P21956 30.576 278 1.7499999999999999e-25 109.0 sp|P21956|MFGM_MOUSE Lactadherin OS=Mus musculus OX=10090 GN=Mfge8 PE=1 SV=3 MFGM_MOUSE reviewed Lactadherin (MFGM) (Milk fat globule-EGF factor 8) (MFG-E8) (SED1) (Sperm surface protein SP47) (MP47) Mus musculus (Mouse) GO:0001525; GO:0001786; GO:0002080; GO:0005178; GO:0005615; GO:0006910; GO:0006911; GO:0007155; GO:0007338; GO:0008429; GO:0009897; GO:0031012; GO:0043277; GO:0050766 angiogenesis [GO:0001525]; apoptotic cell clearance [GO:0043277]; cell adhesion [GO:0007155]; phagocytosis, engulfment [GO:0006911]; phagocytosis, recognition [GO:0006910]; positive regulation of phagocytosis [GO:0050766]; single fertilization [GO:0007338] acrosomal membrane [GO:0002080]; external side of plasma membrane [GO:0009897]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615] integrin binding [GO:0005178]; phosphatidylethanolamine binding [GO:0008429]; phosphatidylserine binding [GO:0001786] g17305.t2 P21956 30.576 278 1.03e-24 108.0 sp|P21956|MFGM_MOUSE Lactadherin OS=Mus musculus OX=10090 GN=Mfge8 PE=1 SV=3 MFGM_MOUSE reviewed Lactadherin (MFGM) (Milk fat globule-EGF factor 8) (MFG-E8) (SED1) (Sperm surface protein SP47) (MP47) Mus musculus (Mouse) GO:0001525; GO:0001786; GO:0002080; GO:0005178; GO:0005615; GO:0006910; GO:0006911; GO:0007155; GO:0007338; GO:0008429; GO:0009897; GO:0031012; GO:0043277; GO:0050766 angiogenesis [GO:0001525]; apoptotic cell clearance [GO:0043277]; cell adhesion [GO:0007155]; phagocytosis, engulfment [GO:0006911]; phagocytosis, recognition [GO:0006910]; positive regulation of phagocytosis [GO:0050766]; single fertilization [GO:0007338] acrosomal membrane [GO:0002080]; external side of plasma membrane [GO:0009897]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615] integrin binding [GO:0005178]; phosphatidylethanolamine binding [GO:0008429]; phosphatidylserine binding [GO:0001786] g17306.t1 Q55EX9 30.392 204 1.4399999999999997e-23 99.8 sp|Q55EX9|Y8948_DICDI Putative methyltransferase DDB_G0268948 OS=Dictyostelium discoideum OX=44689 GN=DDB_G0268948 PE=1 SV=2 g17308.t1 P36639 54.605 152 2.73e-45 148.0 sp|P36639|8ODP_HUMAN Oxidized purine nucleoside triphosphate hydrolase OS=Homo sapiens OX=9606 GN=NUDT1 PE=1 SV=4 8ODP_HUMAN reviewed Oxidized purine nucleoside triphosphate hydrolase (EC 3.6.1.56) (2-hydroxy-dATP diphosphatase) (7,8-dihydro-8-oxoguanine triphosphatase) (8-oxo-dGTPase) (Methylated purine nucleoside triphosphate hydrolase) (EC 3.6.1.-) (Nucleoside diphosphate-linked moiety X motif 1) (Nudix motif 1) Homo sapiens (Human) GO:0005634; GO:0005737; GO:0005739; GO:0005759; GO:0005829; GO:0006152; GO:0006281; GO:0006979; GO:0008413; GO:0008828; GO:0016818; GO:0030515; GO:0035539; GO:0042262; GO:0046872; GO:0047693; GO:0106377; GO:0106378; GO:0106431; GO:0106433 DNA protection [GO:0042262]; DNA repair [GO:0006281]; purine nucleoside catabolic process [GO:0006152]; response to oxidative stress [GO:0006979] cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleus [GO:0005634] 2-hydroxy-ATP hydrolase activity [GO:0106377]; 2-hydroxy-dATP hydrolase activity [GO:0106378]; 8-oxo-7,8-dihydrodeoxyguanosine triphosphate pyrophosphatase activity [GO:0035539]; 8-oxo-7,8-dihydroguanosine triphosphate pyrophosphatase activity [GO:0008413]; ATP diphosphatase activity [GO:0047693]; dATP diphosphatase activity [GO:0008828]; hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides [GO:0016818]; metal ion binding [GO:0046872]; N6-methyl-(d)ATP hydrolase activity [GO:0106431]; O6-methyl-dGTP hydrolase activity [GO:0106433]; snoRNA binding [GO:0030515] g17309.t1 Q6NRT5 70.44 477 0.0 640.0 sp|Q6NRT5|CSN1_XENLA COP9 signalosome complex subunit 1 OS=Xenopus laevis OX=8355 GN=csn1 PE=2 SV=1 g17311.t1 Q90YV0 77.128 188 7.1e-100 289.0 sp|Q90YV0|RL18_ICTPU Large ribosomal subunit protein eL18 OS=Ictalurus punctatus OX=7998 GN=rpl18 PE=2 SV=3 g17312.t1 Q2KIH4 45.19 343 1.15e-95 293.0 sp|Q2KIH4|RRS1_BOVIN Ribosome biogenesis regulatory protein homolog OS=Bos taurus OX=9913 GN=RRS1 PE=2 SV=1 g17313.t1 Q6ZXC9 38.565 223 3.07e-35 135.0 sp|Q6ZXC9|SIA8D_BOVIN CMP-N-acetylneuraminate-poly-alpha-2,8-sialyltransferase OS=Bos taurus OX=9913 GN=ST8SIA4 PE=2 SV=1 g17314.t1 G3C7W6 41.751 594 9.909999999999999e-137 414.0 sp|G3C7W6|S2611_CAVPO Sodium-independent sulfate anion transporter OS=Cavia porcellus OX=10141 GN=Slc26a11 PE=2 SV=1 S2611_CAVPO reviewed Sodium-independent sulfate anion transporter (Solute carrier family 26 member 11) Cavia porcellus (Guinea pig) GO:0005254; GO:0005654; GO:0005765; GO:0005783; GO:0005794; GO:0005886; GO:0008271; GO:0016323; GO:0016324; GO:0019532; GO:0140900; GO:1902358 oxalate transport [GO:0019532]; sulfate transmembrane transport [GO:1902358] apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; lysosomal membrane [GO:0005765]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] chloride channel activity [GO:0005254]; chloride:bicarbonate antiporter activity [GO:0140900]; secondary active sulfate transmembrane transporter activity [GO:0008271] g17314.t2 G3C7W6 41.333 600 5.08e-134 407.0 sp|G3C7W6|S2611_CAVPO Sodium-independent sulfate anion transporter OS=Cavia porcellus OX=10141 GN=Slc26a11 PE=2 SV=1 S2611_CAVPO reviewed Sodium-independent sulfate anion transporter (Solute carrier family 26 member 11) Cavia porcellus (Guinea pig) GO:0005254; GO:0005654; GO:0005765; GO:0005783; GO:0005794; GO:0005886; GO:0008271; GO:0016323; GO:0016324; GO:0019532; GO:0140900; GO:1902358 oxalate transport [GO:0019532]; sulfate transmembrane transport [GO:1902358] apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; lysosomal membrane [GO:0005765]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] chloride channel activity [GO:0005254]; chloride:bicarbonate antiporter activity [GO:0140900]; secondary active sulfate transmembrane transporter activity [GO:0008271] g17315.t1 Q8VIJ8 46.774 434 2.7000000000000003e-125 378.0 sp|Q8VIJ8|NPRL3_MOUSE GATOR1 complex protein NPRL3 OS=Mus musculus OX=10090 GN=Nprl3 PE=1 SV=1 g17316.t1 Q8VIJ8 54.167 96 1.95e-28 111.0 sp|Q8VIJ8|NPRL3_MOUSE GATOR1 complex protein NPRL3 OS=Mus musculus OX=10090 GN=Nprl3 PE=1 SV=1 g17319.t1 Q04841 44.074 270 3.11e-65 209.0 sp|Q04841|3MG_MOUSE DNA-3-methyladenine glycosylase OS=Mus musculus OX=10090 GN=Mpg PE=2 SV=3 3MG_MOUSE reviewed DNA-3-methyladenine glycosylase (EC 3.2.2.21) (3-alkyladenine DNA glycosylase) (3-methyladenine DNA glycosidase) (ADPG) (N-methylpurine-DNA glycosylase) Mus musculus (Mouse) GO:0003677; GO:0003905; GO:0005654; GO:0005829; GO:0006284; GO:0042645 base-excision repair [GO:0006284] cytosol [GO:0005829]; mitochondrial nucleoid [GO:0042645]; nucleoplasm [GO:0005654] alkylbase DNA N-glycosylase activity [GO:0003905]; DNA binding [GO:0003677] g17322.t1 Q6GMF8 55.072 414 1.54e-154 461.0 sp|Q6GMF8|RHDF1_DANRE Inactive rhomboid protein 1 OS=Danio rerio OX=7955 GN=rhbdf1 PE=2 SV=1 RHDF1_DANRE reviewed Inactive rhomboid protein 1 (iRhom1) (Rhomboid family member 1) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000139; GO:0005789; GO:0008283; GO:0015031; GO:0016477; GO:0019838; GO:0042058; GO:0050708; GO:0050709; GO:0061136 cell migration [GO:0016477]; cell population proliferation [GO:0008283]; negative regulation of protein secretion [GO:0050709]; protein transport [GO:0015031]; regulation of epidermal growth factor receptor signaling pathway [GO:0042058]; regulation of proteasomal protein catabolic process [GO:0061136]; regulation of protein secretion [GO:0050708] endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139] growth factor binding [GO:0019838] g17326.t1 Q6NVC5 58.264 599 0.0 722.0 sp|Q6NVC5|MIRO1_DANRE Mitochondrial Rho GTPase 1-A OS=Danio rerio OX=7955 GN=rhot1a PE=2 SV=1 MIRO1_DANRE reviewed Mitochondrial Rho GTPase 1-A (MIRO-1-A) (EC 3.6.5.-) (Ras homolog gene family member T1-A) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000287; GO:0003924; GO:0005509; GO:0005525; GO:0005739; GO:0005741; GO:0007005; GO:0016887; GO:0019003; GO:0019725; GO:0047497; GO:0097345 cellular homeostasis [GO:0019725]; mitochondrial outer membrane permeabilization [GO:0097345]; mitochondrion organization [GO:0007005]; mitochondrion transport along microtubule [GO:0047497] mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739] ATP hydrolysis activity [GO:0016887]; calcium ion binding [GO:0005509]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; magnesium ion binding [GO:0000287] g17326.t2 Q6NVC5 58.0 600 0.0 714.0 sp|Q6NVC5|MIRO1_DANRE Mitochondrial Rho GTPase 1-A OS=Danio rerio OX=7955 GN=rhot1a PE=2 SV=1 MIRO1_DANRE reviewed Mitochondrial Rho GTPase 1-A (MIRO-1-A) (EC 3.6.5.-) (Ras homolog gene family member T1-A) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000287; GO:0003924; GO:0005509; GO:0005525; GO:0005739; GO:0005741; GO:0007005; GO:0016887; GO:0019003; GO:0019725; GO:0047497; GO:0097345 cellular homeostasis [GO:0019725]; mitochondrial outer membrane permeabilization [GO:0097345]; mitochondrion organization [GO:0007005]; mitochondrion transport along microtubule [GO:0047497] mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739] ATP hydrolysis activity [GO:0016887]; calcium ion binding [GO:0005509]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; magnesium ion binding [GO:0000287] g17328.t1 Q9HAU4 70.5 200 5.33e-96 300.0 sp|Q9HAU4|SMUF2_HUMAN E3 ubiquitin-protein ligase SMURF2 OS=Homo sapiens OX=9606 GN=SMURF2 PE=1 SV=1 SMUF2_HUMAN reviewed E3 ubiquitin-protein ligase SMURF2 (hSMURF2) (EC 2.3.2.26) (HECT-type E3 ubiquitin transferase SMURF2) (SMAD ubiquitination regulatory factor 2) (SMAD-specific E3 ubiquitin-protein ligase 2) Homo sapiens (Human) GO:0000122; GO:0000151; GO:0004842; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0006511; GO:0016567; GO:0016607; GO:0017015; GO:0030512; GO:0030514; GO:0042802; GO:0043161; GO:0045121; GO:0045892; GO:0046332; GO:0060071; GO:0061630; GO:0090263; GO:0160020; GO:1901165 negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of ferroptosis [GO:0160020]; positive regulation of trophoblast cell migration [GO:1901165]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of transforming growth factor beta receptor signaling pathway [GO:0017015]; ubiquitin-dependent protein catabolic process [GO:0006511]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071] cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane raft [GO:0045121]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ubiquitin ligase complex [GO:0000151] identical protein binding [GO:0042802]; SMAD binding [GO:0046332]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842] g17329.t1 A9JRZ0 67.614 528 0.0 733.0 sp|A9JRZ0|SMUF2_DANRE E3 ubiquitin-protein ligase SMURF2 OS=Danio rerio OX=7955 GN=smurf2 PE=2 SV=1 SMUF2_DANRE reviewed E3 ubiquitin-protein ligase SMURF2 (EC 2.3.2.26) (HECT-type E3 ubiquitin transferase SMURF2) (SMAD ubiquitination regulatory factor 2) (SMAD-specific E3 ubiquitin-protein ligase 2) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0016567; GO:0030514; GO:0043161; GO:0045121; GO:0046332; GO:0061630 negative regulation of BMP signaling pathway [GO:0030514]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567] cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane raft [GO:0045121]; nucleus [GO:0005634]; plasma membrane [GO:0005886] SMAD binding [GO:0046332]; ubiquitin protein ligase activity [GO:0061630] g17330.t1 P78382 50.0 316 6.059999999999999e-94 285.0 sp|P78382|S35A1_HUMAN CMP-sialic acid transporter OS=Homo sapiens OX=9606 GN=SLC35A1 PE=1 SV=1 S35A1_HUMAN reviewed CMP-sialic acid transporter (CMP-SA-Tr) (CMP-Sia-Tr) (CST) (Solute carrier family 35 member A1) Homo sapiens (Human) GO:0000139; GO:0005456; GO:0005794; GO:0005886; GO:0005975; GO:0006054; GO:0006055; GO:0006493; GO:0015218; GO:0015297; GO:0015782; GO:0016020; GO:0036211 carbohydrate metabolic process [GO:0005975]; CMP-N-acetylneuraminate biosynthetic process [GO:0006055]; CMP-N-acetylneuraminate transmembrane transport [GO:0015782]; N-acetylneuraminate metabolic process [GO:0006054]; protein modification process [GO:0036211]; protein O-linked glycosylation [GO:0006493] Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; plasma membrane [GO:0005886] antiporter activity [GO:0015297]; CMP-N-acetylneuraminate transmembrane transporter activity [GO:0005456]; pyrimidine nucleotide transmembrane transporter activity [GO:0015218] g17331.t1 Q5SSH7 40.0 740 3.11e-156 509.0 sp|Q5SSH7|ZZEF1_MOUSE Zinc finger ZZ-type and EF-hand domain-containing protein 1 OS=Mus musculus OX=10090 GN=Zzef1 PE=1 SV=2 ZZEF1_MOUSE reviewed Zinc finger ZZ-type and EF-hand domain-containing protein 1 Mus musculus (Mouse) GO:0005509; GO:0007405; GO:0008270; GO:0008542; GO:0009986; GO:0016567; GO:0035249; GO:0042393; GO:0045202; GO:0048167; GO:0048786; GO:0061659; GO:0098794 neuroblast proliferation [GO:0007405]; protein ubiquitination [GO:0016567]; regulation of synaptic plasticity [GO:0048167]; synaptic transmission, glutamatergic [GO:0035249]; visual learning [GO:0008542] cell surface [GO:0009986]; postsynapse [GO:0098794]; presynaptic active zone [GO:0048786]; synapse [GO:0045202] calcium ion binding [GO:0005509]; histone binding [GO:0042393]; ubiquitin-like protein ligase activity [GO:0061659]; zinc ion binding [GO:0008270] g17332.t1 Q5SSH7 38.204 746 2.88e-127 453.0 sp|Q5SSH7|ZZEF1_MOUSE Zinc finger ZZ-type and EF-hand domain-containing protein 1 OS=Mus musculus OX=10090 GN=Zzef1 PE=1 SV=2 ZZEF1_MOUSE reviewed Zinc finger ZZ-type and EF-hand domain-containing protein 1 Mus musculus (Mouse) GO:0005509; GO:0007405; GO:0008270; GO:0008542; GO:0009986; GO:0016567; GO:0035249; GO:0042393; GO:0045202; GO:0048167; GO:0048786; GO:0061659; GO:0098794 neuroblast proliferation [GO:0007405]; protein ubiquitination [GO:0016567]; regulation of synaptic plasticity [GO:0048167]; synaptic transmission, glutamatergic [GO:0035249]; visual learning [GO:0008542] cell surface [GO:0009986]; postsynapse [GO:0098794]; presynaptic active zone [GO:0048786]; synapse [GO:0045202] calcium ion binding [GO:0005509]; histone binding [GO:0042393]; ubiquitin-like protein ligase activity [GO:0061659]; zinc ion binding [GO:0008270] g17332.t1 Q5SSH7 36.408 412 2.36e-71 271.0 sp|Q5SSH7|ZZEF1_MOUSE Zinc finger ZZ-type and EF-hand domain-containing protein 1 OS=Mus musculus OX=10090 GN=Zzef1 PE=1 SV=2 ZZEF1_MOUSE reviewed Zinc finger ZZ-type and EF-hand domain-containing protein 1 Mus musculus (Mouse) GO:0005509; GO:0007405; GO:0008270; GO:0008542; GO:0009986; GO:0016567; GO:0035249; GO:0042393; GO:0045202; GO:0048167; GO:0048786; GO:0061659; GO:0098794 neuroblast proliferation [GO:0007405]; protein ubiquitination [GO:0016567]; regulation of synaptic plasticity [GO:0048167]; synaptic transmission, glutamatergic [GO:0035249]; visual learning [GO:0008542] cell surface [GO:0009986]; postsynapse [GO:0098794]; presynaptic active zone [GO:0048786]; synapse [GO:0045202] calcium ion binding [GO:0005509]; histone binding [GO:0042393]; ubiquitin-like protein ligase activity [GO:0061659]; zinc ion binding [GO:0008270] g17332.t1 Q5SSH7 32.836 469 1.41e-55 219.0 sp|Q5SSH7|ZZEF1_MOUSE Zinc finger ZZ-type and EF-hand domain-containing protein 1 OS=Mus musculus OX=10090 GN=Zzef1 PE=1 SV=2 ZZEF1_MOUSE reviewed Zinc finger ZZ-type and EF-hand domain-containing protein 1 Mus musculus (Mouse) GO:0005509; GO:0007405; GO:0008270; GO:0008542; GO:0009986; GO:0016567; GO:0035249; GO:0042393; GO:0045202; GO:0048167; GO:0048786; GO:0061659; GO:0098794 neuroblast proliferation [GO:0007405]; protein ubiquitination [GO:0016567]; regulation of synaptic plasticity [GO:0048167]; synaptic transmission, glutamatergic [GO:0035249]; visual learning [GO:0008542] cell surface [GO:0009986]; postsynapse [GO:0098794]; presynaptic active zone [GO:0048786]; synapse [GO:0045202] calcium ion binding [GO:0005509]; histone binding [GO:0042393]; ubiquitin-like protein ligase activity [GO:0061659]; zinc ion binding [GO:0008270] g17332.t2 Q5SSH7 38.204 746 2.81e-127 453.0 sp|Q5SSH7|ZZEF1_MOUSE Zinc finger ZZ-type and EF-hand domain-containing protein 1 OS=Mus musculus OX=10090 GN=Zzef1 PE=1 SV=2 ZZEF1_MOUSE reviewed Zinc finger ZZ-type and EF-hand domain-containing protein 1 Mus musculus (Mouse) GO:0005509; GO:0007405; GO:0008270; GO:0008542; GO:0009986; GO:0016567; GO:0035249; GO:0042393; GO:0045202; GO:0048167; GO:0048786; GO:0061659; GO:0098794 neuroblast proliferation [GO:0007405]; protein ubiquitination [GO:0016567]; regulation of synaptic plasticity [GO:0048167]; synaptic transmission, glutamatergic [GO:0035249]; visual learning [GO:0008542] cell surface [GO:0009986]; postsynapse [GO:0098794]; presynaptic active zone [GO:0048786]; synapse [GO:0045202] calcium ion binding [GO:0005509]; histone binding [GO:0042393]; ubiquitin-like protein ligase activity [GO:0061659]; zinc ion binding [GO:0008270] g17332.t2 Q5SSH7 36.408 412 1.78e-71 271.0 sp|Q5SSH7|ZZEF1_MOUSE Zinc finger ZZ-type and EF-hand domain-containing protein 1 OS=Mus musculus OX=10090 GN=Zzef1 PE=1 SV=2 ZZEF1_MOUSE reviewed Zinc finger ZZ-type and EF-hand domain-containing protein 1 Mus musculus (Mouse) GO:0005509; GO:0007405; GO:0008270; GO:0008542; GO:0009986; GO:0016567; GO:0035249; GO:0042393; GO:0045202; GO:0048167; GO:0048786; GO:0061659; GO:0098794 neuroblast proliferation [GO:0007405]; protein ubiquitination [GO:0016567]; regulation of synaptic plasticity [GO:0048167]; synaptic transmission, glutamatergic [GO:0035249]; visual learning [GO:0008542] cell surface [GO:0009986]; postsynapse [GO:0098794]; presynaptic active zone [GO:0048786]; synapse [GO:0045202] calcium ion binding [GO:0005509]; histone binding [GO:0042393]; ubiquitin-like protein ligase activity [GO:0061659]; zinc ion binding [GO:0008270] g17332.t2 Q5SSH7 32.623 469 1.2099999999999998e-54 216.0 sp|Q5SSH7|ZZEF1_MOUSE Zinc finger ZZ-type and EF-hand domain-containing protein 1 OS=Mus musculus OX=10090 GN=Zzef1 PE=1 SV=2 ZZEF1_MOUSE reviewed Zinc finger ZZ-type and EF-hand domain-containing protein 1 Mus musculus (Mouse) GO:0005509; GO:0007405; GO:0008270; GO:0008542; GO:0009986; GO:0016567; GO:0035249; GO:0042393; GO:0045202; GO:0048167; GO:0048786; GO:0061659; GO:0098794 neuroblast proliferation [GO:0007405]; protein ubiquitination [GO:0016567]; regulation of synaptic plasticity [GO:0048167]; synaptic transmission, glutamatergic [GO:0035249]; visual learning [GO:0008542] cell surface [GO:0009986]; postsynapse [GO:0098794]; presynaptic active zone [GO:0048786]; synapse [GO:0045202] calcium ion binding [GO:0005509]; histone binding [GO:0042393]; ubiquitin-like protein ligase activity [GO:0061659]; zinc ion binding [GO:0008270] g17333.t1 Q54KD0 25.758 660 6.14e-58 223.0 sp|Q54KD0|Y7407_DICDI TPR repeat-containing protein DDB_G0287407 OS=Dictyostelium discoideum OX=44689 GN=DDB_G0287407 PE=4 SV=1 g17335.t1 Q9W740 35.802 162 2.68e-22 93.2 sp|Q9W740|NOGG2_DANRE Noggin-2 OS=Danio rerio OX=7955 GN=nog2 PE=2 SV=1 g17336.t1 Q2KJ28 55.024 209 7.62e-71 235.0 sp|Q2KJ28|PGPS1_BOVIN CDP-diacylglycerol--glycerol-3-phosphate 3-phosphatidyltransferase, mitochondrial OS=Bos taurus OX=9913 GN=PGS1 PE=2 SV=2 g17339.t1 Q6P823 99.265 136 1.43e-94 271.0 sp|Q6P823|H33_XENTR Histone H3.3 OS=Xenopus tropicalis OX=8364 GN=TGas113e22.1 PE=1 SV=3 H33_XENTR reviewed Histone H3.3 Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0000786; GO:0003677; GO:0005634; GO:0030527; GO:0046982 nucleosome [GO:0000786]; nucleus [GO:0005634] DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; structural constituent of chromatin [GO:0030527] g17350.t1 Q5XI13 56.667 420 8.77e-166 477.0 sp|Q5XI13|GRWD1_RAT Glutamate-rich WD repeat-containing protein 1 OS=Rattus norvegicus OX=10116 GN=Grwd1 PE=2 SV=1 g17351.t1 A2RRV9 62.687 134 1.08e-56 184.0 sp|A2RRV9|NARFL_DANRE Cytosolic Fe-S cluster assembly factor narfl OS=Danio rerio OX=7955 GN=narfl PE=2 SV=1 g17352.t1 A7SDA8 61.661 313 7.279999999999999e-136 395.0 sp|A7SDA8|NARF_NEMVE Probable cytosolic Fe-S cluster assembly factor v1g210509 OS=Nematostella vectensis OX=45351 GN=v1g210509 PE=3 SV=1 g17353.t1 P61214 54.271 199 9.97e-74 224.0 sp|P61214|ARL4A_RAT ADP-ribosylation factor-like protein 4A OS=Rattus norvegicus OX=10116 GN=Arl4a PE=2 SV=1 g17357.t1 Q3UHR0 65.644 163 4.01e-65 248.0 sp|Q3UHR0|BAHC1_MOUSE BAH and coiled-coil domain-containing protein 1 OS=Mus musculus OX=10090 GN=Bahcc1 PE=1 SV=2 g17357.t1 Q3UHR0 54.43 158 1.3299999999999999e-46 188.0 sp|Q3UHR0|BAHC1_MOUSE BAH and coiled-coil domain-containing protein 1 OS=Mus musculus OX=10090 GN=Bahcc1 PE=1 SV=2 g17358.t1 Q8IV35 27.83 212 1.89e-22 101.0 sp|Q8IV35|CF337_HUMAN Cilia- and flagella-associated protein 337 OS=Homo sapiens OX=9606 GN=CFAP337 PE=1 SV=2 g17361.t1 Q8IV35 26.733 505 8.74e-44 175.0 sp|Q8IV35|CF337_HUMAN Cilia- and flagella-associated protein 337 OS=Homo sapiens OX=9606 GN=CFAP337 PE=1 SV=2 g17362.t1 Q8R3P7 71.569 306 1.26e-141 414.0 sp|Q8R3P7|CLUA1_MOUSE Clusterin-associated protein 1 OS=Mus musculus OX=10090 GN=Cluap1 PE=1 SV=1 CLUA1_MOUSE reviewed Clusterin-associated protein 1 Mus musculus (Mouse) GO:0001843; GO:0001947; GO:0005654; GO:0005813; GO:0005815; GO:0005929; GO:0007224; GO:0015629; GO:0021508; GO:0030991; GO:0030992; GO:0035082; GO:0035720; GO:0042073; GO:0060271; GO:0060972; GO:0097542; GO:0097546 axoneme assembly [GO:0035082]; cilium assembly [GO:0060271]; floor plate formation [GO:0021508]; heart looping [GO:0001947]; intraciliary anterograde transport [GO:0035720]; intraciliary transport [GO:0042073]; left/right pattern formation [GO:0060972]; neural tube closure [GO:0001843]; smoothened signaling pathway [GO:0007224] actin cytoskeleton [GO:0015629]; centrosome [GO:0005813]; ciliary base [GO:0097546]; ciliary tip [GO:0097542]; cilium [GO:0005929]; intraciliary transport particle A [GO:0030991]; intraciliary transport particle B [GO:0030992]; microtubule organizing center [GO:0005815]; nucleoplasm [GO:0005654] g17363.t1 P42290 33.52 179 6.370000000000001e-21 94.7 sp|P42290|DRD5_XENLA D(1B) dopamine receptor OS=Xenopus laevis OX=8355 GN=drd5 PE=2 SV=1 g17367.t1 Q6PJ21 53.409 176 8.47e-57 193.0 sp|Q6PJ21|SPSB3_HUMAN SPRY domain-containing SOCS box protein 3 OS=Homo sapiens OX=9606 GN=SPSB3 PE=1 SV=2 SPSB3_HUMAN reviewed SPRY domain-containing SOCS box protein 3 (SSB-3) Homo sapiens (Human) GO:0005634; GO:0005829; GO:0010719; GO:0019005; GO:0031466; GO:0043161; GO:0070936; GO:0160049; GO:1990756 negative regulation of cGAS/STING signaling pathway [GO:0160049]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K48-linked ubiquitination [GO:0070936] Cul5-RING ubiquitin ligase complex [GO:0031466]; cytosol [GO:0005829]; nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005] ubiquitin-like ligase-substrate adaptor activity [GO:1990756] g17368.t1 Q5NVA9 42.627 373 1.68e-85 286.0 sp|Q5NVA9|EME1_PONAB Structure-specific endonuclease subunit EME1 OS=Pongo abelii OX=9601 GN=EME1 PE=3 SV=1 g17370.t1 A0JMW2 46.809 611 4.2e-174 518.0 sp|A0JMW2|DAAF5_XENLA Dynein axonemal assembly factor 5 OS=Xenopus laevis OX=8355 GN=dnaaf5 PE=2 SV=1 g17372.t1 Q5GFD5 55.172 203 9.98e-76 234.0 sp|Q5GFD5|HS3S6_MOUSE Heparan sulfate glucosamine 3-O-sulfotransferase 6 OS=Mus musculus OX=10090 GN=Hs3st6 PE=2 SV=1 HS3S6_MOUSE reviewed Heparan sulfate glucosamine 3-O-sulfotransferase 6 (EC 2.8.2.23) (Heparan sulfate D-glucosaminyl 3-O-sulfotransferase 6) (3-OST-6) (Heparan sulfate 3-O-sulfotransferase 6) Mus musculus (Mouse) GO:0000139; GO:0001835; GO:0008467; GO:0015012 blastocyst hatching [GO:0001835]; heparan sulfate proteoglycan biosynthetic process [GO:0015012] Golgi membrane [GO:0000139] [heparan sulfate]-glucosamine 3-sulfotransferase activity [GO:0008467] g17374.t1 Q29RM1 48.428 318 8.79e-100 299.0 sp|Q29RM1|TPC_BOVIN Mitochondrial thiamine pyrophosphate carrier OS=Bos taurus OX=9913 GN=SLC25A19 PE=2 SV=1 g17375.t1 Q9QZS6 32.979 282 3.0899999999999998e-40 152.0 sp|Q9QZS6|HS3SB_MOUSE Heparan sulfate glucosamine 3-O-sulfotransferase 3B1 OS=Mus musculus OX=10090 GN=Hs3st3b1 PE=2 SV=2 g17377.t1 O75899 29.508 732 1.19e-91 312.0 sp|O75899|GABR2_HUMAN Gamma-aminobutyric acid type B receptor subunit 2 OS=Homo sapiens OX=9606 GN=GABBR2 PE=1 SV=1 GABR2_HUMAN reviewed Gamma-aminobutyric acid type B receptor subunit 2 (GABA-B receptor 2) (GABA-B-R2) (GABA-BR2) (GABABR2) (Gb2) (G-protein coupled receptor 51) (HG20) Homo sapiens (Human) GO:0004888; GO:0004965; GO:0005737; GO:0005886; GO:0007186; GO:0007193; GO:0007194; GO:0007214; GO:0007268; GO:0038039; GO:0043005; GO:0045211; GO:0046982; GO:0051932; GO:0150099; GO:1902710; GO:1902712 adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; chemical synaptic transmission [GO:0007268]; G protein-coupled receptor signaling pathway [GO:0007186]; gamma-aminobutyric acid signaling pathway [GO:0007214]; negative regulation of adenylate cyclase activity [GO:0007194]; neuron-glial cell signaling [GO:0150099]; synaptic transmission, GABAergic [GO:0051932] cytoplasm [GO:0005737]; G protein-coupled GABA receptor complex [GO:1902712]; G protein-coupled receptor heterodimeric complex [GO:0038039]; GABA receptor complex [GO:1902710]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211] G protein-coupled GABA receptor activity [GO:0004965]; protein heterodimerization activity [GO:0046982]; transmembrane signaling receptor activity [GO:0004888] g17386.t1 P23004 41.084 443 1.67e-115 349.0 sp|P23004|QCR2_BOVIN Cytochrome b-c1 complex subunit 2, mitochondrial OS=Bos taurus OX=9913 GN=UQCRC2 PE=1 SV=2 g17389.t1 Q6P4M0 59.701 402 4.68e-162 468.0 sp|Q6P4M0|DHCR7_XENTR 7-dehydrocholesterol reductase OS=Xenopus tropicalis OX=8364 GN=dhcr7 PE=2 SV=1 g17393.t1 Q9QZB9 78.571 182 4.9e-107 307.0 sp|Q9QZB9|DCTN5_MOUSE Dynactin subunit 5 OS=Mus musculus OX=10090 GN=Dctn5 PE=1 SV=1 g17399.t1 Q5XGG5 40.65 615 2.01e-130 410.0 sp|Q5XGG5|CCNF_XENTR Cyclin-F OS=Xenopus tropicalis OX=8364 GN=ccnf PE=2 SV=1 CCNF_XENTR reviewed Cyclin-F Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0000082; GO:0000307; GO:0005634; GO:0005737; GO:0005814; GO:0005815; GO:0010826; GO:0016538; GO:0016567; GO:0019005; GO:0031146; GO:0048471; GO:0051301 cell division [GO:0051301]; G1/S transition of mitotic cell cycle [GO:0000082]; negative regulation of centrosome duplication [GO:0010826]; protein ubiquitination [GO:0016567]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146] centriole [GO:0005814]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; SCF ubiquitin ligase complex [GO:0019005] cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538] g17402.t1 Q8N957 41.081 555 1.05e-112 370.0 sp|Q8N957|ANKF1_HUMAN Ankyrin repeat and fibronectin type-III domain-containing protein 1 OS=Homo sapiens OX=9606 GN=ANKFN1 PE=1 SV=3 g17404.t1 Q6DJ08 58.156 282 3.69e-108 319.0 sp|Q6DJ08|S2538_XENTR Mitochondrial glycine transporter OS=Xenopus tropicalis OX=8364 GN=slc25a38 PE=2 SV=1 g17405.t1 Q5ZJ24 56.111 180 6.61e-61 189.0 sp|Q5ZJ24|CEP20_CHICK Centrosomal protein 20 OS=Gallus gallus OX=9031 GN=CEP20 PE=2 SV=1 CEP20_CHICK reviewed Centrosomal protein 20 (FGFR1OP N-terminal-like protein) (LisH domain-containing protein FOPNL) Gallus gallus (Chicken) GO:0005813; GO:0031514; GO:0034451; GO:0034453; GO:0036064; GO:0060271 cilium assembly [GO:0060271]; microtubule anchoring [GO:0034453] centriolar satellite [GO:0034451]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; motile cilium [GO:0031514] g17407.t1 Q00004 50.526 570 2.42e-178 521.0 sp|Q00004|SRP68_CANLF Signal recognition particle subunit SRP68 OS=Canis lupus familiaris OX=9615 GN=SRP68 PE=1 SV=1 g17408.t1 P51570 62.575 334 9.170000000000001e-133 388.0 sp|P51570|GALK1_HUMAN Galactokinase OS=Homo sapiens OX=9606 GN=GALK1 PE=1 SV=1 GALK1_HUMAN reviewed Galactokinase (EC 2.7.1.6) (Galactose kinase) Homo sapiens (Human) GO:0004335; GO:0005524; GO:0005534; GO:0005737; GO:0005829; GO:0006012; GO:0016020; GO:0019402; GO:0033499; GO:0061623; GO:0070062 galactitol metabolic process [GO:0019402]; galactose catabolic process via UDP-galactose, Leloir pathway [GO:0033499]; galactose metabolic process [GO:0006012]; glycolytic process from galactose [GO:0061623] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020] ATP binding [GO:0005524]; galactokinase activity [GO:0004335]; galactose binding [GO:0005534] g17409.t1 Q9D3S3 49.56 341 3.4e-105 348.0 sp|Q9D3S3|SNX29_MOUSE Sorting nexin-29 OS=Mus musculus OX=10090 GN=Snx29 PE=1 SV=2 g17409.t1 Q9D3S3 62.371 194 1.3099999999999999e-68 248.0 sp|Q9D3S3|SNX29_MOUSE Sorting nexin-29 OS=Mus musculus OX=10090 GN=Snx29 PE=1 SV=2 g17410.t1 D2XV59 72.084 523 0.0 692.0 sp|D2XV59|GTPB1_RAT GTP-binding protein 1 OS=Rattus norvegicus OX=10116 GN=Gtpbp1 PE=1 SV=1 GTPB1_RAT reviewed GTP-binding protein 1 (EC 3.6.5.3) Rattus norvegicus (Rat) GO:0000049; GO:0000177; GO:0002181; GO:0003746; GO:0003924; GO:0005525; GO:0005829; GO:0006414; GO:0046039; GO:0061014; GO:0071025; GO:1904678 cytoplasmic translation [GO:0002181]; GTP metabolic process [GO:0046039]; positive regulation of mRNA catabolic process [GO:0061014]; RNA surveillance [GO:0071025]; translational elongation [GO:0006414] cytoplasmic exosome (RNase complex) [GO:0000177]; cytosol [GO:0005829] alpha-aminoacyl-tRNA binding [GO:1904678]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]; tRNA binding [GO:0000049] g17411.t1 Q70CQ4 40.026 767 1.47e-169 535.0 sp|Q70CQ4|UBP31_HUMAN Ubiquitin carboxyl-terminal hydrolase 31 OS=Homo sapiens OX=9606 GN=USP31 PE=1 SV=2 UBP31_HUMAN reviewed Ubiquitin carboxyl-terminal hydrolase 31 (EC 3.4.19.12) (Deubiquitinating enzyme 31) (Ubiquitin thioesterase 31) (Ubiquitin-specific-processing protease 31) Homo sapiens (Human) GO:0004843; GO:0005634; GO:0006508; GO:0016579 protein deubiquitination [GO:0016579]; proteolysis [GO:0006508] nucleus [GO:0005634] cysteine-type deubiquitinase activity [GO:0004843] g17412.t1 Q3V2A7 37.875 367 2.49e-67 239.0 sp|Q3V2A7|QRIC2_MOUSE Glutamine-rich protein 2 OS=Mus musculus OX=10090 GN=Qrich2 PE=2 SV=1 QRIC2_MOUSE reviewed Glutamine-rich protein 2 Mus musculus (Mouse) GO:0005634; GO:0005737; GO:0030031; GO:0030317; GO:0031965; GO:0036126; GO:2000059 cell projection assembly [GO:0030031]; flagellated sperm motility [GO:0030317]; negative regulation of ubiquitin-dependent protein catabolic process [GO:2000059] cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; sperm flagellum [GO:0036126] g17413.t1 A2VD95 41.379 319 2.47e-78 248.0 sp|A2VD95|ECSIT_XENLA Evolutionarily conserved signaling intermediate in Toll pathway, mitochondrial OS=Xenopus laevis OX=8355 GN=ecsit PE=2 SV=1 g17414.t1 Q32KJ9 48.269 520 3.18e-171 497.0 sp|Q32KJ9|ARSG_RAT Arylsulfatase G OS=Rattus norvegicus OX=10116 GN=Arsg PE=2 SV=1 ARSG_RAT reviewed Arylsulfatase G (ASG) (EC 3.1.6.1) (N-sulfoglucosamine-3-sulfatase) (EC 3.1.6.15) Rattus norvegicus (Rat) GO:0004065; GO:0005615; GO:0005764; GO:0005783; GO:0006790; GO:0007040; GO:0010001; GO:0010467; GO:0033889; GO:0046872; GO:0048872; GO:0051402; GO:0060041 gene expression [GO:0010467]; glial cell differentiation [GO:0010001]; homeostasis of number of cells [GO:0048872]; lysosome organization [GO:0007040]; neuron apoptotic process [GO:0051402]; retina development in camera-type eye [GO:0060041]; sulfur compound metabolic process [GO:0006790] endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; lysosome [GO:0005764] arylsulfatase activity [GO:0004065]; metal ion binding [GO:0046872]; N-sulfoglucosamine-3-sulfatase activity [GO:0033889] g17415.t1 Q6KFX9 50.181 277 4.27e-86 266.0 sp|Q6KFX9|RFNG_DANRE Beta-1,3-N-acetylglucosaminyltransferase radical fringe OS=Danio rerio OX=7955 GN=rfng PE=2 SV=1 RFNG_DANRE reviewed Beta-1,3-N-acetylglucosaminyltransferase radical fringe (EC 2.4.1.222) (O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000139; GO:0007219; GO:0008593; GO:0021592; GO:0021654; GO:0030154; GO:0030902; GO:0033829; GO:0035284; GO:0046872 brain segmentation [GO:0035284]; cell differentiation [GO:0030154]; fourth ventricle development [GO:0021592]; hindbrain development [GO:0030902]; Notch signaling pathway [GO:0007219]; regulation of Notch signaling pathway [GO:0008593]; rhombomere boundary formation [GO:0021654] Golgi membrane [GO:0000139] metal ion binding [GO:0046872]; O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity [GO:0033829] g17417.t1 Q7TN88 29.875 559 1.33e-70 269.0 sp|Q7TN88|PK1L2_MOUSE Polycystin-1-like protein 2 OS=Mus musculus OX=10090 GN=Pkd1l2 PE=2 SV=1 PK1L2_MOUSE reviewed Polycystin-1-like protein 2 (Polycystin-1L2) (PC1-like 2 protein) (Polycystic kidney disease protein 1-like 2) Mus musculus (Mouse) GO:0001965; GO:0005262; GO:0005509; GO:0016020; GO:0030246; GO:0050982 detection of mechanical stimulus [GO:0050982] membrane [GO:0016020] calcium channel activity [GO:0005262]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; G-protein alpha-subunit binding [GO:0001965] g17417.t1 Q7TN88 28.457 622 7.65e-64 247.0 sp|Q7TN88|PK1L2_MOUSE Polycystin-1-like protein 2 OS=Mus musculus OX=10090 GN=Pkd1l2 PE=2 SV=1 PK1L2_MOUSE reviewed Polycystin-1-like protein 2 (Polycystin-1L2) (PC1-like 2 protein) (Polycystic kidney disease protein 1-like 2) Mus musculus (Mouse) GO:0001965; GO:0005262; GO:0005509; GO:0016020; GO:0030246; GO:0050982 detection of mechanical stimulus [GO:0050982] membrane [GO:0016020] calcium channel activity [GO:0005262]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; G-protein alpha-subunit binding [GO:0001965] g17419.t1 P21783 39.723 1586 0.0 1009.0 sp|P21783|NOTC1_XENLA Neurogenic locus notch homolog protein 1 OS=Xenopus laevis OX=8355 GN=notch1 PE=1 SV=3 g17419.t1 P21783 41.151 1373 0.0 965.0 sp|P21783|NOTC1_XENLA Neurogenic locus notch homolog protein 1 OS=Xenopus laevis OX=8355 GN=notch1 PE=1 SV=3 g17419.t1 P21783 40.404 1386 0.0 949.0 sp|P21783|NOTC1_XENLA Neurogenic locus notch homolog protein 1 OS=Xenopus laevis OX=8355 GN=notch1 PE=1 SV=3 g17419.t1 P21783 38.661 1539 0.0 942.0 sp|P21783|NOTC1_XENLA Neurogenic locus notch homolog protein 1 OS=Xenopus laevis OX=8355 GN=notch1 PE=1 SV=3 g17419.t1 P21783 40.559 1324 0.0 924.0 sp|P21783|NOTC1_XENLA Neurogenic locus notch homolog protein 1 OS=Xenopus laevis OX=8355 GN=notch1 PE=1 SV=3 g17419.t1 P21783 41.176 1275 0.0 899.0 sp|P21783|NOTC1_XENLA Neurogenic locus notch homolog protein 1 OS=Xenopus laevis OX=8355 GN=notch1 PE=1 SV=3 g17419.t1 P21783 40.826 1259 0.0 875.0 sp|P21783|NOTC1_XENLA Neurogenic locus notch homolog protein 1 OS=Xenopus laevis OX=8355 GN=notch1 PE=1 SV=3 g17419.t1 P21783 42.751 1207 0.0 872.0 sp|P21783|NOTC1_XENLA Neurogenic locus notch homolog protein 1 OS=Xenopus laevis OX=8355 GN=notch1 PE=1 SV=3 g17419.t1 P21783 40.714 953 0.0 626.0 sp|P21783|NOTC1_XENLA Neurogenic locus notch homolog protein 1 OS=Xenopus laevis OX=8355 GN=notch1 PE=1 SV=3 g17419.t1 P21783 37.032 721 5.56e-113 407.0 sp|P21783|NOTC1_XENLA Neurogenic locus notch homolog protein 1 OS=Xenopus laevis OX=8355 GN=notch1 PE=1 SV=3 g17419.t1 P21783 38.872 337 6.3000000000000004e-49 197.0 sp|P21783|NOTC1_XENLA Neurogenic locus notch homolog protein 1 OS=Xenopus laevis OX=8355 GN=notch1 PE=1 SV=3 g17419.t1 P21783 35.561 374 9.71e-48 194.0 sp|P21783|NOTC1_XENLA Neurogenic locus notch homolog protein 1 OS=Xenopus laevis OX=8355 GN=notch1 PE=1 SV=3 g17419.t1 P21783 38.462 325 4.76e-47 191.0 sp|P21783|NOTC1_XENLA Neurogenic locus notch homolog protein 1 OS=Xenopus laevis OX=8355 GN=notch1 PE=1 SV=3 g17419.t1 P21783 38.05 318 6.45e-47 191.0 sp|P21783|NOTC1_XENLA Neurogenic locus notch homolog protein 1 OS=Xenopus laevis OX=8355 GN=notch1 PE=1 SV=3 g17419.t1 P21783 36.31 336 1.91e-46 189.0 sp|P21783|NOTC1_XENLA Neurogenic locus notch homolog protein 1 OS=Xenopus laevis OX=8355 GN=notch1 PE=1 SV=3 g17419.t1 P21783 35.714 336 5.11e-46 188.0 sp|P21783|NOTC1_XENLA Neurogenic locus notch homolog protein 1 OS=Xenopus laevis OX=8355 GN=notch1 PE=1 SV=3 g17419.t1 P21783 34.536 388 1.6699999999999998e-45 186.0 sp|P21783|NOTC1_XENLA Neurogenic locus notch homolog protein 1 OS=Xenopus laevis OX=8355 GN=notch1 PE=1 SV=3 g17419.t1 P21783 35.417 336 1.84e-41 173.0 sp|P21783|NOTC1_XENLA Neurogenic locus notch homolog protein 1 OS=Xenopus laevis OX=8355 GN=notch1 PE=1 SV=3 g17419.t1 P21783 33.994 353 1.44e-40 170.0 sp|P21783|NOTC1_XENLA Neurogenic locus notch homolog protein 1 OS=Xenopus laevis OX=8355 GN=notch1 PE=1 SV=3 g17419.t1 P21783 38.154 325 1.7099999999999998e-40 170.0 sp|P21783|NOTC1_XENLA Neurogenic locus notch homolog protein 1 OS=Xenopus laevis OX=8355 GN=notch1 PE=1 SV=3 g17419.t1 P21783 35.849 318 3.0499999999999997e-40 169.0 sp|P21783|NOTC1_XENLA Neurogenic locus notch homolog protein 1 OS=Xenopus laevis OX=8355 GN=notch1 PE=1 SV=3 g17419.t1 P21783 34.324 370 1.76e-39 166.0 sp|P21783|NOTC1_XENLA Neurogenic locus notch homolog protein 1 OS=Xenopus laevis OX=8355 GN=notch1 PE=1 SV=3 g17419.t1 P21783 37.267 322 8.93e-37 157.0 sp|P21783|NOTC1_XENLA Neurogenic locus notch homolog protein 1 OS=Xenopus laevis OX=8355 GN=notch1 PE=1 SV=3 g17419.t1 P21783 32.584 356 1.3200000000000001e-33 147.0 sp|P21783|NOTC1_XENLA Neurogenic locus notch homolog protein 1 OS=Xenopus laevis OX=8355 GN=notch1 PE=1 SV=3 g17419.t2 P21783 39.723 1586 0.0 1010.0 sp|P21783|NOTC1_XENLA Neurogenic locus notch homolog protein 1 OS=Xenopus laevis OX=8355 GN=notch1 PE=1 SV=3 g17419.t2 P21783 41.151 1373 0.0 966.0 sp|P21783|NOTC1_XENLA Neurogenic locus notch homolog protein 1 OS=Xenopus laevis OX=8355 GN=notch1 PE=1 SV=3 g17419.t2 P21783 40.404 1386 0.0 950.0 sp|P21783|NOTC1_XENLA Neurogenic locus notch homolog protein 1 OS=Xenopus laevis OX=8355 GN=notch1 PE=1 SV=3 g17419.t2 P21783 38.791 1539 0.0 942.0 sp|P21783|NOTC1_XENLA Neurogenic locus notch homolog protein 1 OS=Xenopus laevis OX=8355 GN=notch1 PE=1 SV=3 g17419.t2 P21783 40.559 1324 0.0 925.0 sp|P21783|NOTC1_XENLA Neurogenic locus notch homolog protein 1 OS=Xenopus laevis OX=8355 GN=notch1 PE=1 SV=3 g17419.t2 P21783 41.176 1275 0.0 900.0 sp|P21783|NOTC1_XENLA Neurogenic locus notch homolog protein 1 OS=Xenopus laevis OX=8355 GN=notch1 PE=1 SV=3 g17419.t2 P21783 40.826 1259 0.0 875.0 sp|P21783|NOTC1_XENLA Neurogenic locus notch homolog protein 1 OS=Xenopus laevis OX=8355 GN=notch1 PE=1 SV=3 g17419.t2 P21783 42.751 1207 0.0 872.0 sp|P21783|NOTC1_XENLA Neurogenic locus notch homolog protein 1 OS=Xenopus laevis OX=8355 GN=notch1 PE=1 SV=3 g17419.t2 P21783 40.714 953 0.0 627.0 sp|P21783|NOTC1_XENLA Neurogenic locus notch homolog protein 1 OS=Xenopus laevis OX=8355 GN=notch1 PE=1 SV=3 g17419.t2 P21783 37.032 721 4.42e-113 408.0 sp|P21783|NOTC1_XENLA Neurogenic locus notch homolog protein 1 OS=Xenopus laevis OX=8355 GN=notch1 PE=1 SV=3 g17419.t2 P21783 38.872 337 6.61e-49 197.0 sp|P21783|NOTC1_XENLA Neurogenic locus notch homolog protein 1 OS=Xenopus laevis OX=8355 GN=notch1 PE=1 SV=3 g17419.t2 P21783 35.561 374 9.439999999999999e-48 194.0 sp|P21783|NOTC1_XENLA Neurogenic locus notch homolog protein 1 OS=Xenopus laevis OX=8355 GN=notch1 PE=1 SV=3 g17419.t2 P21783 38.462 325 4.48e-47 191.0 sp|P21783|NOTC1_XENLA Neurogenic locus notch homolog protein 1 OS=Xenopus laevis OX=8355 GN=notch1 PE=1 SV=3 g17419.t2 P21783 38.05 318 6.2200000000000005e-47 191.0 sp|P21783|NOTC1_XENLA Neurogenic locus notch homolog protein 1 OS=Xenopus laevis OX=8355 GN=notch1 PE=1 SV=3 g17419.t2 P21783 36.31 336 1.8899999999999998e-46 189.0 sp|P21783|NOTC1_XENLA Neurogenic locus notch homolog protein 1 OS=Xenopus laevis OX=8355 GN=notch1 PE=1 SV=3 g17419.t2 P21783 35.714 336 4.97e-46 188.0 sp|P21783|NOTC1_XENLA Neurogenic locus notch homolog protein 1 OS=Xenopus laevis OX=8355 GN=notch1 PE=1 SV=3 g17419.t2 P21783 34.536 388 1.62e-45 186.0 sp|P21783|NOTC1_XENLA Neurogenic locus notch homolog protein 1 OS=Xenopus laevis OX=8355 GN=notch1 PE=1 SV=3 g17419.t2 P21783 35.417 336 1.79e-41 173.0 sp|P21783|NOTC1_XENLA Neurogenic locus notch homolog protein 1 OS=Xenopus laevis OX=8355 GN=notch1 PE=1 SV=3 g17419.t2 P21783 33.994 353 1.27e-40 170.0 sp|P21783|NOTC1_XENLA Neurogenic locus notch homolog protein 1 OS=Xenopus laevis OX=8355 GN=notch1 PE=1 SV=3 g17419.t2 P21783 38.154 325 1.49e-40 170.0 sp|P21783|NOTC1_XENLA Neurogenic locus notch homolog protein 1 OS=Xenopus laevis OX=8355 GN=notch1 PE=1 SV=3 g17419.t2 P21783 35.849 318 2.95e-40 169.0 sp|P21783|NOTC1_XENLA Neurogenic locus notch homolog protein 1 OS=Xenopus laevis OX=8355 GN=notch1 PE=1 SV=3 g17419.t2 P21783 34.324 370 1.65e-39 166.0 sp|P21783|NOTC1_XENLA Neurogenic locus notch homolog protein 1 OS=Xenopus laevis OX=8355 GN=notch1 PE=1 SV=3 g17419.t2 P21783 36.957 322 8e-37 157.0 sp|P21783|NOTC1_XENLA Neurogenic locus notch homolog protein 1 OS=Xenopus laevis OX=8355 GN=notch1 PE=1 SV=3 g17419.t2 P21783 32.749 342 1.33e-33 147.0 sp|P21783|NOTC1_XENLA Neurogenic locus notch homolog protein 1 OS=Xenopus laevis OX=8355 GN=notch1 PE=1 SV=3 g17421.t1 B3EWZ6 41.76 1068 0.0 665.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g17421.t1 B3EWZ6 39.024 1107 0.0 635.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g17421.t1 B3EWZ6 40.237 1096 0.0 627.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g17421.t1 B3EWZ6 39.346 1070 0.0 614.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g17421.t1 B3EWZ6 38.894 1085 0.0 607.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g17421.t1 B3EWZ6 39.075 1103 5.499999999999999e-180 590.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g17421.t1 B3EWZ6 38.975 1093 7.59e-180 590.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g17421.t1 B3EWZ6 41.991 924 9.600000000000001e-166 549.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g17421.t1 B3EWZ6 33.035 1229 1.2100000000000002e-132 451.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g17421.t1 B3EWZ6 29.476 1374 1.47e-118 409.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g17421.t1 B3EWZ6 30.512 1288 2.5200000000000002e-117 406.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g17421.t1 B3EWZ6 30.335 1345 2.74e-117 406.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g17421.t1 B3EWZ6 28.56 1271 1.0299999999999999e-104 368.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g17421.t1 B3EWZ6 42.602 561 1.41e-95 340.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g17421.t1 B3EWZ6 29.791 1242 1.45e-87 316.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g17421.t1 B3EWZ6 28.478 920 4.4400000000000005e-66 250.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g17421.t1 B3EWZ6 32.802 439 4.9199999999999996e-40 166.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g17423.t1 O73792 59.091 132 7.26e-59 183.0 sp|O73792|TIE1_DANRE Tyrosine-protein kinase receptor Tie-1 (Fragment) OS=Danio rerio OX=7955 GN=tie1 PE=1 SV=1 g17424.t1 B3EWZ6 40.358 503 1.14e-76 280.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g17424.t1 B3EWZ6 40.695 489 9.85e-76 278.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g17424.t1 B3EWZ6 38.614 505 1.16e-75 277.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g17424.t1 B3EWZ6 40.254 472 6.4700000000000005e-75 275.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g17424.t1 B3EWZ6 37.888 483 4.99e-74 272.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g17424.t1 B3EWZ6 38.28 465 1.91e-67 252.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g17424.t1 B3EWZ6 37.645 518 1.05e-63 241.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g17424.t1 B3EWZ6 36.632 475 9.35e-63 238.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g17424.t1 B3EWZ6 36.57 484 6.280000000000001e-59 226.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g17424.t1 B3EWZ6 32.696 575 7.11e-59 226.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g17424.t1 B3EWZ6 37.975 474 4.0800000000000004e-58 223.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g17424.t1 B3EWZ6 31.365 542 1.4700000000000002e-47 190.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g17424.t1 B3EWZ6 30.88 557 8.71e-43 174.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g17424.t1 B3EWZ6 36.517 356 4.42e-40 166.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g17424.t1 B3EWZ6 43.931 173 9.49e-28 126.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g17424.t1 B3EWZ6 40.191 209 5.3199999999999996e-24 114.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g17424.t1 B3EWZ6 32.353 204 3.6999999999999997e-23 111.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g17424.t1 B3EWZ6 40.805 174 3.58e-22 107.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g17424.t1 B3EWZ6 32.8 250 5.9400000000000005e-21 103.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g17425.t1 P10079 39.672 731 1.54e-135 434.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g17425.t1 P10079 38.872 656 2.75e-117 386.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g17425.t1 P10079 36.289 609 9.16e-88 305.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g17425.t1 P10079 40.411 438 7.119999999999999e-83 291.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g17425.t1 P10079 40.712 393 1.0000000000000001e-72 263.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g17425.t1 P10079 36.913 447 1.72e-66 244.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g17425.t1 P10079 49.084 273 2.3200000000000002e-64 238.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g17425.t1 P10079 46.886 273 2.08e-57 218.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g17425.t1 P10079 44.803 279 9.270000000000001e-57 216.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g17425.t1 P10079 45.614 228 7.61e-45 179.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g17426.t1 Q80Z71 23.077 780 8.97e-26 119.0 sp|Q80Z71|TENN_MOUSE Tenascin-N OS=Mus musculus OX=10090 GN=Tnn PE=1 SV=2 TENN_MOUSE reviewed Tenascin-N (TN-N) (Tenascin-W) (TN-W) Mus musculus (Mouse) GO:0001764; GO:0002076; GO:0005178; GO:0005615; GO:0007160; GO:0007409; GO:0009986; GO:0010976; GO:0030155; GO:0030334; GO:0031012; GO:0042802; GO:0043005; GO:0043025; GO:0070593; GO:0090733; GO:0097442; GO:1903010; GO:1903672; GO:1905899; GO:1990026; GO:1990138; GO:2001223 axonogenesis [GO:0007409]; cell-matrix adhesion [GO:0007160]; dendrite self-avoidance [GO:0070593]; negative regulation of neuron migration [GO:2001223]; neuron migration [GO:0001764]; neuron projection extension [GO:1990138]; osteoblast development [GO:0002076]; positive regulation of neuron projection development [GO:0010976]; positive regulation of sprouting angiogenesis [GO:1903672]; regulation of bone development [GO:1903010]; regulation of cell adhesion [GO:0030155]; regulation of cell migration [GO:0030334]; regulation of smooth muscle tissue development [GO:1905899] CA3 pyramidal cell dendrite [GO:0097442]; cell surface [GO:0009986]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; hippocampal mossy fiber expansion [GO:1990026]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; tenascin complex [GO:0090733] identical protein binding [GO:0042802]; integrin binding [GO:0005178] g17426.t1 Q80Z71 24.009 908 1.1699999999999998e-23 112.0 sp|Q80Z71|TENN_MOUSE Tenascin-N OS=Mus musculus OX=10090 GN=Tnn PE=1 SV=2 TENN_MOUSE reviewed Tenascin-N (TN-N) (Tenascin-W) (TN-W) Mus musculus (Mouse) GO:0001764; GO:0002076; GO:0005178; GO:0005615; GO:0007160; GO:0007409; GO:0009986; GO:0010976; GO:0030155; GO:0030334; GO:0031012; GO:0042802; GO:0043005; GO:0043025; GO:0070593; GO:0090733; GO:0097442; GO:1903010; GO:1903672; GO:1905899; GO:1990026; GO:1990138; GO:2001223 axonogenesis [GO:0007409]; cell-matrix adhesion [GO:0007160]; dendrite self-avoidance [GO:0070593]; negative regulation of neuron migration [GO:2001223]; neuron migration [GO:0001764]; neuron projection extension [GO:1990138]; osteoblast development [GO:0002076]; positive regulation of neuron projection development [GO:0010976]; positive regulation of sprouting angiogenesis [GO:1903672]; regulation of bone development [GO:1903010]; regulation of cell adhesion [GO:0030155]; regulation of cell migration [GO:0030334]; regulation of smooth muscle tissue development [GO:1905899] CA3 pyramidal cell dendrite [GO:0097442]; cell surface [GO:0009986]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; hippocampal mossy fiber expansion [GO:1990026]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; tenascin complex [GO:0090733] identical protein binding [GO:0042802]; integrin binding [GO:0005178] g17427.t1 Q7ZX03 58.225 383 1.29e-133 409.0 sp|Q7ZX03|FOXK2_XENLA Forkhead box protein K2 OS=Xenopus laevis OX=8355 GN=foxk2 PE=2 SV=2 FOXK2_XENLA reviewed Forkhead box protein K2 (FoxK2) (Interleukin enhancer-binding factor 1) (ILF1) (xFoxK1) Xenopus laevis (African clawed frog) GO:0000287; GO:0000976; GO:0000978; GO:0000981; GO:0001227; GO:0001678; GO:0003677; GO:0003700; GO:0005634; GO:0005737; GO:0006355; GO:0006357; GO:0010507; GO:0010906; GO:0042594; GO:0043565; GO:0045892; GO:0045893; GO:0061621 canonical glycolysis [GO:0061621]; intracellular glucose homeostasis [GO:0001678]; negative regulation of autophagy [GO:0010507]; negative regulation of DNA-templated transcription [GO:0045892]; positive regulation of DNA-templated transcription [GO:0045893]; regulation of DNA-templated transcription [GO:0006355]; regulation of glucose metabolic process [GO:0010906]; regulation of transcription by RNA polymerase II [GO:0006357]; response to starvation [GO:0042594] cytoplasm [GO:0005737]; nucleus [GO:0005634] DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; magnesium ion binding [GO:0000287]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription cis-regulatory region binding [GO:0000976] g17428.t1 Q08DM7 68.151 292 3.44e-149 430.0 sp|Q08DM7|SEPT3_BOVIN Neuronal-specific septin-3 OS=Bos taurus OX=9913 GN=SEPTIN3 PE=2 SV=3 SEPT3_BOVIN reviewed Neuronal-specific septin-3 Bos taurus (Bovine) GO:0003924; GO:0005525; GO:0005940; GO:0008104; GO:0015630; GO:0031105; GO:0032153; GO:0060090; GO:0061640; GO:0098793 cytoskeleton-dependent cytokinesis [GO:0061640]; intracellular protein localization [GO:0008104] cell division site [GO:0032153]; microtubule cytoskeleton [GO:0015630]; presynapse [GO:0098793]; septin complex [GO:0031105]; septin ring [GO:0005940] GTP binding [GO:0005525]; GTPase activity [GO:0003924]; molecular adaptor activity [GO:0060090] g17429.t1 Q69Z89 30.425 848 5.65e-88 315.0 sp|Q69Z89|RADIL_MOUSE Ras-associating and dilute domain-containing protein OS=Mus musculus OX=10090 GN=Radil PE=1 SV=2 RADIL_MOUSE reviewed Ras-associating and dilute domain-containing protein Mus musculus (Mouse) GO:0001755; GO:0005874; GO:0007165; GO:0032991; GO:0034446; GO:0051020 neural crest cell migration [GO:0001755]; signal transduction [GO:0007165]; substrate adhesion-dependent cell spreading [GO:0034446] microtubule [GO:0005874]; protein-containing complex [GO:0032991] GTPase binding [GO:0051020] g17429.t1 Q69Z89 57.895 95 3.0099999999999997e-25 118.0 sp|Q69Z89|RADIL_MOUSE Ras-associating and dilute domain-containing protein OS=Mus musculus OX=10090 GN=Radil PE=1 SV=2 RADIL_MOUSE reviewed Ras-associating and dilute domain-containing protein Mus musculus (Mouse) GO:0001755; GO:0005874; GO:0007165; GO:0032991; GO:0034446; GO:0051020 neural crest cell migration [GO:0001755]; signal transduction [GO:0007165]; substrate adhesion-dependent cell spreading [GO:0034446] microtubule [GO:0005874]; protein-containing complex [GO:0032991] GTPase binding [GO:0051020] g17430.t1 Q9CQY7 46.018 226 1.83e-63 201.0 sp|Q9CQY7|PAQRB_MOUSE Monocyte to macrophage differentiation factor OS=Mus musculus OX=10090 GN=Mmd PE=2 SV=1 g17431.t1 Q9ERE6 55.556 144 2.02e-34 147.0 sp|Q9ERE6|MPRIP_RAT Myosin phosphatase Rho-interacting protein OS=Rattus norvegicus OX=10116 GN=Mprip PE=1 SV=1 g17431.t1 Q9ERE6 51.0 100 7.45e-25 116.0 sp|Q9ERE6|MPRIP_RAT Myosin phosphatase Rho-interacting protein OS=Rattus norvegicus OX=10116 GN=Mprip PE=1 SV=1 g17433.t1 Q80ZD1 44.796 442 1.59e-138 415.0 sp|Q80ZD1|RGS9_TAMST Regulator of G-protein signaling 9 OS=Tamias striatus OX=45474 PE=1 SV=1 g17434.t1 Q1JPJ9 38.344 326 3.07e-58 194.0 sp|Q1JPJ9|EF2KT_BOVIN Protein-lysine N-methyltransferase EEF2KMT OS=Bos taurus OX=9913 GN=EEF2KMT PE=2 SV=2 g17436.t1 Q6AYK1 63.75 80 6.75e-32 123.0 sp|Q6AYK1|RNPS1_RAT RNA-binding protein with serine-rich domain 1 OS=Rattus norvegicus OX=10116 GN=Rnps1 PE=2 SV=1 RNPS1_RAT reviewed RNA-binding protein with serine-rich domain 1 Rattus norvegicus (Rat) GO:0000184; GO:0000381; GO:0000398; GO:0003730; GO:0005634; GO:0005654; GO:0005737; GO:0016607; GO:0043065; GO:0048025; GO:0061574 mRNA splicing, via spliceosome [GO:0000398]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; positive regulation of apoptotic process [GO:0043065]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381] ASAP complex [GO:0061574]; cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] mRNA 3'-UTR binding [GO:0003730] g17437.t1 Q9EQY0 67.241 406 8.73e-175 535.0 sp|Q9EQY0|ERN1_MOUSE Serine/threonine-protein kinase/endoribonuclease IRE1 OS=Mus musculus OX=10090 GN=Ern1 PE=1 SV=1 ERN1_MOUSE reviewed Serine/threonine-protein kinase/endoribonuclease IRE1 (Endoplasmic reticulum-to-nucleus signaling 1) (Inositol-requiring protein 1) (Ire1-alpha) (IRE1a) [Includes: Serine/threonine-protein kinase (EC 2.7.11.1); Endoribonuclease (EC 3.1.26.-)] Mus musculus (Mouse) GO:0000287; GO:0001935; GO:0004519; GO:0004521; GO:0004674; GO:0005161; GO:0005524; GO:0005637; GO:0005737; GO:0005739; GO:0005783; GO:0005789; GO:0006468; GO:0010629; GO:0016787; GO:0019899; GO:0030544; GO:0030968; GO:0033120; GO:0034620; GO:0034976; GO:0035924; GO:0036498; GO:0042802; GO:0042803; GO:0043531; GO:0046330; GO:0046777; GO:0051082; GO:0051879; GO:0070054; GO:0070059; GO:0070301; GO:0071333; GO:0106310; GO:1900103; GO:1901142; GO:1904707; GO:1990597; GO:1990604; GO:1990630 cellular response to glucose stimulus [GO:0071333]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to unfolded protein [GO:0034620]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; endoplasmic reticulum unfolded protein response [GO:0030968]; endothelial cell proliferation [GO:0001935]; insulin metabolic process [GO:1901142]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; IRE1-mediated unfolded protein response [GO:0036498]; mRNA splicing, via endonucleolytic cleavage and ligation [GO:0070054]; negative regulation of gene expression [GO:0010629]; positive regulation of endoplasmic reticulum unfolded protein response [GO:1900103]; positive regulation of JNK cascade [GO:0046330]; positive regulation of RNA splicing [GO:0033120]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to endoplasmic reticulum stress [GO:0034976] AIP1-IRE1 complex [GO:1990597]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; IRE1-RACK1-PP2A complex [GO:1990630]; IRE1-TRAF2-ASK1 complex [GO:1990604]; mitochondrion [GO:0005739]; nuclear inner membrane [GO:0005637] ADP binding [GO:0043531]; ATP binding [GO:0005524]; endonuclease activity [GO:0004519]; enzyme binding [GO:0019899]; Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]; hydrolase activity [GO:0016787]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; platelet-derived growth factor receptor binding [GO:0005161]; protein homodimerization activity [GO:0042803]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; RNA endonuclease activity [GO:0004521]; unfolded protein binding [GO:0051082] g17437.t1 Q9EQY0 44.898 343 2.74e-77 275.0 sp|Q9EQY0|ERN1_MOUSE Serine/threonine-protein kinase/endoribonuclease IRE1 OS=Mus musculus OX=10090 GN=Ern1 PE=1 SV=1 ERN1_MOUSE reviewed Serine/threonine-protein kinase/endoribonuclease IRE1 (Endoplasmic reticulum-to-nucleus signaling 1) (Inositol-requiring protein 1) (Ire1-alpha) (IRE1a) [Includes: Serine/threonine-protein kinase (EC 2.7.11.1); Endoribonuclease (EC 3.1.26.-)] Mus musculus (Mouse) GO:0000287; GO:0001935; GO:0004519; GO:0004521; GO:0004674; GO:0005161; GO:0005524; GO:0005637; GO:0005737; GO:0005739; GO:0005783; GO:0005789; GO:0006468; GO:0010629; GO:0016787; GO:0019899; GO:0030544; GO:0030968; GO:0033120; GO:0034620; GO:0034976; GO:0035924; GO:0036498; GO:0042802; GO:0042803; GO:0043531; GO:0046330; GO:0046777; GO:0051082; GO:0051879; GO:0070054; GO:0070059; GO:0070301; GO:0071333; GO:0106310; GO:1900103; GO:1901142; GO:1904707; GO:1990597; GO:1990604; GO:1990630 cellular response to glucose stimulus [GO:0071333]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to unfolded protein [GO:0034620]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; endoplasmic reticulum unfolded protein response [GO:0030968]; endothelial cell proliferation [GO:0001935]; insulin metabolic process [GO:1901142]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; IRE1-mediated unfolded protein response [GO:0036498]; mRNA splicing, via endonucleolytic cleavage and ligation [GO:0070054]; negative regulation of gene expression [GO:0010629]; positive regulation of endoplasmic reticulum unfolded protein response [GO:1900103]; positive regulation of JNK cascade [GO:0046330]; positive regulation of RNA splicing [GO:0033120]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to endoplasmic reticulum stress [GO:0034976] AIP1-IRE1 complex [GO:1990597]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; IRE1-RACK1-PP2A complex [GO:1990630]; IRE1-TRAF2-ASK1 complex [GO:1990604]; mitochondrion [GO:0005739]; nuclear inner membrane [GO:0005637] ADP binding [GO:0043531]; ATP binding [GO:0005524]; endonuclease activity [GO:0004519]; enzyme binding [GO:0019899]; Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]; hydrolase activity [GO:0016787]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; platelet-derived growth factor receptor binding [GO:0005161]; protein homodimerization activity [GO:0042803]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; RNA endonuclease activity [GO:0004521]; unfolded protein binding [GO:0051082] g17438.t1 Q8IWB9 32.932 249 1.33e-26 120.0 sp|Q8IWB9|TEX2_HUMAN Testis-expressed protein 2 OS=Homo sapiens OX=9606 GN=TEX2 PE=1 SV=2 g17438.t2 Q8IWB9 61.94 134 5.2399999999999996e-48 170.0 sp|Q8IWB9|TEX2_HUMAN Testis-expressed protein 2 OS=Homo sapiens OX=9606 GN=TEX2 PE=1 SV=2 g17438.t3 Q8IWB9 38.991 436 1.85e-67 249.0 sp|Q8IWB9|TEX2_HUMAN Testis-expressed protein 2 OS=Homo sapiens OX=9606 GN=TEX2 PE=1 SV=2 g17439.t1 Q9NWF9 39.093 463 4.21e-85 302.0 sp|Q9NWF9|RN216_HUMAN E3 ubiquitin-protein ligase RNF216 OS=Homo sapiens OX=9606 GN=RNF216 PE=1 SV=3 g17440.t1 A4F5G6 51.19 252 5.33e-53 185.0 sp|A4F5G6|RFOX2_XENLA RNA binding protein fox-1 homolog 2 OS=Xenopus laevis OX=8355 GN=rbfox2 PE=1 SV=1 RFOX2_XENLA reviewed RNA binding protein fox-1 homolog 2 (Fox-1 homolog B) (RNA-binding motif protein 9) (RNA-binding protein 9) Xenopus laevis (African clawed frog) GO:0000381; GO:0003729; GO:0005634; GO:0005737; GO:0006397; GO:0007399; GO:0008380 mRNA processing [GO:0006397]; nervous system development [GO:0007399]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA splicing [GO:0008380] cytoplasm [GO:0005737]; nucleus [GO:0005634] mRNA binding [GO:0003729] g17440.t2 A4F5G6 50.388 258 1.97e-52 184.0 sp|A4F5G6|RFOX2_XENLA RNA binding protein fox-1 homolog 2 OS=Xenopus laevis OX=8355 GN=rbfox2 PE=1 SV=1 RFOX2_XENLA reviewed RNA binding protein fox-1 homolog 2 (Fox-1 homolog B) (RNA-binding motif protein 9) (RNA-binding protein 9) Xenopus laevis (African clawed frog) GO:0000381; GO:0003729; GO:0005634; GO:0005737; GO:0006397; GO:0007399; GO:0008380 mRNA processing [GO:0006397]; nervous system development [GO:0007399]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA splicing [GO:0008380] cytoplasm [GO:0005737]; nucleus [GO:0005634] mRNA binding [GO:0003729] g17440.t3 A4F5G6 50.0 258 2.7799999999999997e-52 183.0 sp|A4F5G6|RFOX2_XENLA RNA binding protein fox-1 homolog 2 OS=Xenopus laevis OX=8355 GN=rbfox2 PE=1 SV=1 RFOX2_XENLA reviewed RNA binding protein fox-1 homolog 2 (Fox-1 homolog B) (RNA-binding motif protein 9) (RNA-binding protein 9) Xenopus laevis (African clawed frog) GO:0000381; GO:0003729; GO:0005634; GO:0005737; GO:0006397; GO:0007399; GO:0008380 mRNA processing [GO:0006397]; nervous system development [GO:0007399]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA splicing [GO:0008380] cytoplasm [GO:0005737]; nucleus [GO:0005634] mRNA binding [GO:0003729] g17446.t1 Q8BKX1 37.687 268 2.11e-56 203.0 sp|Q8BKX1|BAIP2_MOUSE BAR/IMD domain-containing adapter protein 2 OS=Mus musculus OX=10090 GN=Baiap2 PE=1 SV=2 BAIP2_MOUSE reviewed BAR/IMD domain-containing adapter protein 2 (Brain-specific angiogenesis inhibitor 1-associated protein 2) (BAI-associated protein 2) (BAI1-associated protein 2) (Insulin receptor substrate protein of 53 kDa) (IRSp53) (Insulin receptor substrate p53) (Insulin receptor tyrosine kinase 53 kDa substrate) Mus musculus (Mouse) GO:0001221; GO:0001726; GO:0005654; GO:0005829; GO:0005874; GO:0005886; GO:0007009; GO:0007266; GO:0008093; GO:0008360; GO:0010976; GO:0014069; GO:0015629; GO:0016358; GO:0030027; GO:0030141; GO:0030165; GO:0030175; GO:0030674; GO:0030838; GO:0032956; GO:0035418; GO:0042060; GO:0042802; GO:0042803; GO:0043005; GO:0043025; GO:0043197; GO:0043198; GO:0044306; GO:0046847; GO:0048167; GO:0050804; GO:0051017; GO:0051764; GO:0060076; GO:0061003; GO:0061845; GO:0061846; GO:0070064; GO:0071364; GO:0097060; GO:0097110; GO:0098685; GO:0098793; GO:0098794; GO:0098978; GO:0099092; GO:0099175; GO:0099523; GO:0099524; GO:1905232; GO:1905274; GO:2000463 actin crosslink formation [GO:0051764]; actin filament bundle assembly [GO:0051017]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to L-glutamate [GO:1905232]; dendrite development [GO:0016358]; filopodium assembly [GO:0046847]; modulation of chemical synaptic transmission [GO:0050804]; plasma membrane organization [GO:0007009]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of neuron projection development [GO:0010976]; protein localization to synapse [GO:0035418]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell shape [GO:0008360]; regulation of modification of postsynaptic actin cytoskeleton [GO:1905274]; regulation of postsynapse organization [GO:0099175]; regulation of synaptic plasticity [GO:0048167]; Rho protein signal transduction [GO:0007266]; wound healing [GO:0042060] actin cytoskeleton [GO:0015629]; cytosol [GO:0005829]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; dendritic spine cytoplasm [GO:0061846]; excitatory synapse [GO:0060076]; filopodium [GO:0030175]; glutamatergic synapse [GO:0098978]; lamellipodium [GO:0030027]; microtubule [GO:0005874]; neuron projection [GO:0043005]; neuron projection branch point [GO:0061845]; neuron projection terminus [GO:0044306]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic cytosol [GO:0099524]; postsynaptic density [GO:0014069]; postsynaptic density, intracellular component [GO:0099092]; presynapse [GO:0098793]; presynaptic cytosol [GO:0099523]; ruffle [GO:0001726]; Schaffer collateral - CA1 synapse [GO:0098685]; secretory granule [GO:0030141]; synaptic membrane [GO:0097060] cytoskeletal anchor activity [GO:0008093]; identical protein binding [GO:0042802]; PDZ domain binding [GO:0030165]; proline-rich region binding [GO:0070064]; protein homodimerization activity [GO:0042803]; protein-macromolecule adaptor activity [GO:0030674]; scaffold protein binding [GO:0097110]; transcription coregulator binding [GO:0001221] g17446.t2 Q8BKX1 37.687 268 2.26e-56 203.0 sp|Q8BKX1|BAIP2_MOUSE BAR/IMD domain-containing adapter protein 2 OS=Mus musculus OX=10090 GN=Baiap2 PE=1 SV=2 BAIP2_MOUSE reviewed BAR/IMD domain-containing adapter protein 2 (Brain-specific angiogenesis inhibitor 1-associated protein 2) (BAI-associated protein 2) (BAI1-associated protein 2) (Insulin receptor substrate protein of 53 kDa) (IRSp53) (Insulin receptor substrate p53) (Insulin receptor tyrosine kinase 53 kDa substrate) Mus musculus (Mouse) GO:0001221; GO:0001726; GO:0005654; GO:0005829; GO:0005874; GO:0005886; GO:0007009; GO:0007266; GO:0008093; GO:0008360; GO:0010976; GO:0014069; GO:0015629; GO:0016358; GO:0030027; GO:0030141; GO:0030165; GO:0030175; GO:0030674; GO:0030838; GO:0032956; GO:0035418; GO:0042060; GO:0042802; GO:0042803; GO:0043005; GO:0043025; GO:0043197; GO:0043198; GO:0044306; GO:0046847; GO:0048167; GO:0050804; GO:0051017; GO:0051764; GO:0060076; GO:0061003; GO:0061845; GO:0061846; GO:0070064; GO:0071364; GO:0097060; GO:0097110; GO:0098685; GO:0098793; GO:0098794; GO:0098978; GO:0099092; GO:0099175; GO:0099523; GO:0099524; GO:1905232; GO:1905274; GO:2000463 actin crosslink formation [GO:0051764]; actin filament bundle assembly [GO:0051017]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to L-glutamate [GO:1905232]; dendrite development [GO:0016358]; filopodium assembly [GO:0046847]; modulation of chemical synaptic transmission [GO:0050804]; plasma membrane organization [GO:0007009]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of neuron projection development [GO:0010976]; protein localization to synapse [GO:0035418]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell shape [GO:0008360]; regulation of modification of postsynaptic actin cytoskeleton [GO:1905274]; regulation of postsynapse organization [GO:0099175]; regulation of synaptic plasticity [GO:0048167]; Rho protein signal transduction [GO:0007266]; wound healing [GO:0042060] actin cytoskeleton [GO:0015629]; cytosol [GO:0005829]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; dendritic spine cytoplasm [GO:0061846]; excitatory synapse [GO:0060076]; filopodium [GO:0030175]; glutamatergic synapse [GO:0098978]; lamellipodium [GO:0030027]; microtubule [GO:0005874]; neuron projection [GO:0043005]; neuron projection branch point [GO:0061845]; neuron projection terminus [GO:0044306]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic cytosol [GO:0099524]; postsynaptic density [GO:0014069]; postsynaptic density, intracellular component [GO:0099092]; presynapse [GO:0098793]; presynaptic cytosol [GO:0099523]; ruffle [GO:0001726]; Schaffer collateral - CA1 synapse [GO:0098685]; secretory granule [GO:0030141]; synaptic membrane [GO:0097060] cytoskeletal anchor activity [GO:0008093]; identical protein binding [GO:0042802]; PDZ domain binding [GO:0030165]; proline-rich region binding [GO:0070064]; protein homodimerization activity [GO:0042803]; protein-macromolecule adaptor activity [GO:0030674]; scaffold protein binding [GO:0097110]; transcription coregulator binding [GO:0001221] g17448.t1 Q6P963 57.237 152 3.26e-62 196.0 sp|Q6P963|GLO2_DANRE Hydroxyacylglutathione hydrolase, mitochondrial OS=Danio rerio OX=7955 GN=hagh PE=2 SV=2 GLO2_DANRE reviewed Hydroxyacylglutathione hydrolase, mitochondrial (EC 3.1.2.6) (Glyoxalase II) (Glx II) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0004416; GO:0005739; GO:0005759; GO:0006749; GO:0019243; GO:0046872 glutathione metabolic process [GO:0006749]; methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione [GO:0019243] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] hydroxyacylglutathione hydrolase activity [GO:0004416]; metal ion binding [GO:0046872] g17450.t1 Q0PV50 29.043 909 2.04e-78 276.0 sp|Q0PV50|TLR3_BOSTR Toll-like receptor 3 OS=Boselaphus tragocamelus OX=9917 GN=TLR3 PE=2 SV=1 TLR3_BOSTR reviewed Toll-like receptor 3 (CD antigen CD283) Boselaphus tragocamelus (Nilgai) GO:0002684; GO:0003723; GO:0004888; GO:0005769; GO:0005789; GO:0005886; GO:0010008; GO:0032722; GO:0032728; GO:0032755; GO:0035556; GO:0038187; GO:0043123; GO:0043330; GO:0045087; GO:0046330; GO:0051607; GO:0090594 defense response to virus [GO:0051607]; inflammatory response to wounding [GO:0090594]; innate immune response [GO:0045087]; intracellular signal transduction [GO:0035556]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of chemokine production [GO:0032722]; positive regulation of immune system process [GO:0002684]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of JNK cascade [GO:0046330]; response to exogenous dsRNA [GO:0043330] early endosome [GO:0005769]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; plasma membrane [GO:0005886] pattern recognition receptor activity [GO:0038187]; RNA binding [GO:0003723]; transmembrane signaling receptor activity [GO:0004888] g17451.t1 Q24562 61.765 408 3.9700000000000005e-169 484.0 sp|Q24562|U2AF2_DROME Splicing factor U2AF 50 kDa subunit OS=Drosophila melanogaster OX=7227 GN=U2af50 PE=1 SV=1 U2AF2_DROME reviewed Splicing factor U2AF 50 kDa subunit (U2 auxiliary factor 50 kDa subunit) (U2 snRNP auxiliary factor large subunit) Drosophila melanogaster (Fruit fly) GO:0000243; GO:0000245; GO:0000381; GO:0000398; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0005681; GO:0008187; GO:0008380; GO:0016607; GO:0030628; GO:0046833; GO:0051168; GO:0071004; GO:0071011; GO:0089701 mRNA splicing, via spliceosome [GO:0000398]; nuclear export [GO:0051168]; positive regulation of RNA export from nucleus [GO:0046833]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA splicing [GO:0008380]; spliceosomal complex assembly [GO:0000245] commitment complex [GO:0000243]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; spliceosomal complex [GO:0005681]; U2-type prespliceosome [GO:0071004]; U2AF complex [GO:0089701] mRNA binding [GO:0003729]; poly-pyrimidine tract binding [GO:0008187]; pre-mRNA 3'-splice site binding [GO:0030628]; RNA binding [GO:0003723] g17454.t1 Q7LHG5 30.686 919 1.65e-113 393.0 sp|Q7LHG5|YI31B_YEAST Transposon Ty3-I Gag-Pol polyprotein OS=Saccharomyces cerevisiae (strain ATCC 204508 / S288c) OX=559292 GN=TY3B-I PE=1 SV=2 YI31B_YEAST reviewed Transposon Ty3-I Gag-Pol polyprotein (Gag3-Pol3) (Transposon Ty3-2 TYA-TYB polyprotein) [Cleaved into: Capsid protein (CA) (p24); Spacer peptide p3; Nucleocapsid protein p11 (NC); Ty3 protease (PR) (EC 3.4.23.-) (p16); Spacer peptide J; Reverse transcriptase/ribonuclease H (RT) (RT-RH) (EC 2.7.7.49) (EC 2.7.7.7) (EC 3.1.26.4) (p55); Integrase p52 (IN); Integrase p49 (IN)] Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast) GO:0003677; GO:0003723; GO:0003887; GO:0003964; GO:0004190; GO:0004523; GO:0005524; GO:0005634; GO:0005737; GO:0006310; GO:0006508; GO:0008270; GO:0015074; GO:0075523 DNA integration [GO:0015074]; DNA recombination [GO:0006310]; proteolysis [GO:0006508]; viral translational frameshifting [GO:0075523] cytoplasm [GO:0005737]; nucleus [GO:0005634] aspartic-type endopeptidase activity [GO:0004190]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; RNA binding [GO:0003723]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; zinc ion binding [GO:0008270] g17459.t1 Q8K4Y7 54.088 318 8.410000000000001e-123 363.0 sp|Q8K4Y7|CANT1_RAT Soluble calcium-activated nucleotidase 1 OS=Rattus norvegicus OX=10116 GN=Cant1 PE=1 SV=1 CANT1_RAT reviewed Soluble calcium-activated nucleotidase 1 (SCAN-1) (EC 3.6.1.6) (Apyrase homolog) Rattus norvegicus (Rat) GO:0004382; GO:0005509; GO:0005789; GO:0005794; GO:0016020; GO:0030166; GO:0032580; GO:0042803; GO:0043262; GO:0045134 proteoglycan biosynthetic process [GO:0030166] endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; membrane [GO:0016020] ADP phosphatase activity [GO:0043262]; calcium ion binding [GO:0005509]; GDP phosphatase activity [GO:0004382]; protein homodimerization activity [GO:0042803]; UDP phosphatase activity [GO:0045134] g17460.t1 Q0MQA5 66.055 109 1.49e-50 159.0 sp|Q0MQA5|NDUA6_PANTR NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 6 OS=Pan troglodytes OX=9598 GN=NDUFA6 PE=2 SV=3 g17463.t1 Q9Y6D9 34.631 745 1.1300000000000001e-97 320.0 sp|Q9Y6D9|MD1L1_HUMAN Mitotic spindle assembly checkpoint protein MAD1 OS=Homo sapiens OX=9606 GN=MAD1L1 PE=1 SV=2 MD1L1_HUMAN reviewed Mitotic spindle assembly checkpoint protein MAD1 (Mitotic arrest deficient 1-like protein 1) (MAD1-like protein 1) (Mitotic checkpoint MAD1 protein homolog) (HsMAD1) (hMAD1) (Tax-binding protein 181) Homo sapiens (Human) GO:0000776; GO:0000922; GO:0005634; GO:0005635; GO:0005737; GO:0005813; GO:0005819; GO:0005829; GO:0007094; GO:0042130; GO:0042802; GO:0043515; GO:0044615; GO:0048538; GO:0051301; GO:0051315; GO:0072686; GO:0090235; GO:0090267; GO:1902426; GO:1990706; GO:1990728 attachment of mitotic spindle microtubules to kinetochore [GO:0051315]; cell division [GO:0051301]; deactivation of mitotic spindle assembly checkpoint [GO:1902426]; mitotic spindle assembly checkpoint signaling [GO:0007094]; negative regulation of T cell proliferation [GO:0042130]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; regulation of metaphase plate congression [GO:0090235]; thymus development [GO:0048538] centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; kinetochore [GO:0000776]; MAD1 complex [GO:1990706]; mitotic spindle [GO:0072686]; mitotic spindle assembly checkpoint MAD1-MAD2 complex [GO:1990728]; nuclear envelope [GO:0005635]; nuclear pore nuclear basket [GO:0044615]; nucleus [GO:0005634]; spindle [GO:0005819]; spindle pole [GO:0000922] identical protein binding [GO:0042802]; kinetochore binding [GO:0043515] g17466.t1 Q9JKF8 76.087 92 1.58e-45 150.0 sp|Q9JKF8|RASD1_RAT Dexamethasone-induced Ras-related protein 1 OS=Rattus norvegicus OX=10116 GN=Rasd1 PE=1 SV=1 RASD1_RAT reviewed Dexamethasone-induced Ras-related protein 1 Rattus norvegicus (Rat) GO:0003924; GO:0005525; GO:0005634; GO:0005737; GO:0005886; GO:0007165; GO:0007263; GO:0016529; GO:0031681; GO:0045892; GO:0048471 negative regulation of DNA-templated transcription [GO:0045892]; nitric oxide mediated signal transduction [GO:0007263]; signal transduction [GO:0007165] cytoplasm [GO:0005737]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; sarcoplasmic reticulum [GO:0016529] G-protein beta-subunit binding [GO:0031681]; GTP binding [GO:0005525]; GTPase activity [GO:0003924] g17467.t1 Q96D21 40.26 154 3.05e-28 109.0 sp|Q96D21|RHES_HUMAN GTP-binding protein Rhes OS=Homo sapiens OX=9606 GN=RASD2 PE=1 SV=1 RHES_HUMAN reviewed GTP-binding protein Rhes (Ras homolog enriched in striatum) (Tumor endothelial marker 2) Homo sapiens (Human) GO:0001963; GO:0003924; GO:0005525; GO:0005886; GO:0007165; GO:0007626; GO:0031681; GO:0033235; GO:0045202; GO:0051897 locomotory behavior [GO:0007626]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of protein sumoylation [GO:0033235]; signal transduction [GO:0007165]; synaptic transmission, dopaminergic [GO:0001963] plasma membrane [GO:0005886]; synapse [GO:0045202] G-protein beta-subunit binding [GO:0031681]; GTP binding [GO:0005525]; GTPase activity [GO:0003924] g17468.t1 P97765 51.128 133 7.48e-34 126.0 sp|P97765|WBP2_MOUSE WW domain-binding protein 2 OS=Mus musculus OX=10090 GN=Wbp2 PE=1 SV=1 g17469.t1 Q28CQ4 77.564 156 3.12e-92 268.0 sp|Q28CQ4|UBC9_XENTR SUMO-conjugating enzyme UBC9 OS=Xenopus tropicalis OX=8364 GN=ube2i PE=2 SV=1 UBC9_XENTR reviewed SUMO-conjugating enzyme UBC9 (EC 2.3.2.-) (RING-type E3 SUMO transferase UBC9) (SUMO-protein ligase) (Ubiquitin carrier protein 9) (Ubiquitin carrier protein I) (Ubiquitin-conjugating enzyme E2 I) (Ubiquitin-protein ligase I) Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0005524; GO:0005634; GO:0007059; GO:0016925; GO:0051301; GO:0061656 cell division [GO:0051301]; chromosome segregation [GO:0007059]; protein sumoylation [GO:0016925] nucleus [GO:0005634] ATP binding [GO:0005524]; SUMO conjugating enzyme activity [GO:0061656] g17476.t1 P33947 85.377 212 3.02e-126 358.0 sp|P33947|ERD22_HUMAN ER lumen protein-retaining receptor 2 OS=Homo sapiens OX=9606 GN=KDELR2 PE=1 SV=1 ERD22_HUMAN reviewed ER lumen protein-retaining receptor 2 (ERD2-like protein 1) (ELP-1) (KDEL endoplasmic reticulum protein retention receptor 2) (KDEL receptor 2) Homo sapiens (Human) GO:0000139; GO:0005046; GO:0005783; GO:0005789; GO:0005801; GO:0006621; GO:0006890; GO:0015031; GO:0016020; GO:0030133; GO:0030663; GO:0035437; GO:0046923 maintenance of protein localization in endoplasmic reticulum [GO:0035437]; protein retention in ER lumen [GO:0006621]; protein transport [GO:0015031]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890] cis-Golgi network [GO:0005801]; COPI-coated vesicle membrane [GO:0030663]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; transport vesicle [GO:0030133] ER retention sequence binding [GO:0046923]; KDEL sequence binding [GO:0005046] g17478.t1 Q9MYM7 37.45 251 6.060000000000001e-43 155.0 sp|Q9MYM7|B3GT1_PONPY Beta-1,3-galactosyltransferase 1 OS=Pongo pygmaeus OX=9600 GN=B3GALT1 PE=3 SV=1 g17481.t1 A3KPA3 61.453 179 6.14e-76 253.0 sp|A3KPA3|NAA60_DANRE N-alpha-acetyltransferase 60 OS=Danio rerio OX=7955 GN=naa60 PE=2 SV=1 NAA60_DANRE reviewed N-alpha-acetyltransferase 60 (EC 2.3.1.259) (Histone acetyltransferase type B protein 4) (HAT4) (EC 2.3.1.48) (N-acetyltransferase 15) (N-alpha-acetyltransferase F) (NatF) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000139; GO:0004402; GO:0004596; GO:0006334; GO:0006474; GO:0007059; GO:0008283; GO:0010485; GO:0017196; GO:0042803; GO:0120518 cell population proliferation [GO:0008283]; chromosome segregation [GO:0007059]; N-terminal peptidyl-methionine acetylation [GO:0017196]; N-terminal protein amino acid acetylation [GO:0006474]; nucleosome assembly [GO:0006334] Golgi membrane [GO:0000139] histone acetyltransferase activity [GO:0004402]; histone H4 acetyltransferase activity [GO:0010485]; protein homodimerization activity [GO:0042803]; protein N-terminal-methionine acetyltransferase activity [GO:0120518]; protein-N-terminal amino-acid acetyltransferase activity [GO:0004596] g17483.t1 Q4R9F7 47.594 187 1.6900000000000001e-43 173.0 sp|Q4R9F7|REXO5_MACFA RNA exonuclease 5 OS=Macaca fascicularis OX=9541 GN=REXO5 PE=2 SV=1 g17483.t2 Q4R9F7 47.594 187 2.3400000000000003e-43 173.0 sp|Q4R9F7|REXO5_MACFA RNA exonuclease 5 OS=Macaca fascicularis OX=9541 GN=REXO5 PE=2 SV=1 g17483.t3 Q4R9F7 47.594 187 2.17e-43 173.0 sp|Q4R9F7|REXO5_MACFA RNA exonuclease 5 OS=Macaca fascicularis OX=9541 GN=REXO5 PE=2 SV=1 g17483.t4 Q4R9F7 47.594 187 2.17e-43 173.0 sp|Q4R9F7|REXO5_MACFA RNA exonuclease 5 OS=Macaca fascicularis OX=9541 GN=REXO5 PE=2 SV=1 g17485.t1 P56489 23.934 305 3.6699999999999995e-24 104.0 sp|P56489|ACM1_MACMU Muscarinic acetylcholine receptor M1 OS=Macaca mulatta OX=9544 GN=CHRM1 PE=2 SV=1 g17486.t1 P04761 28.928 401 8.81e-53 187.0 sp|P04761|ACM1_PIG Muscarinic acetylcholine receptor M1 OS=Sus scrofa OX=9823 GN=CHRM1 PE=2 SV=1 g17487.t1 Q5HZL1 60.331 242 1.1e-99 318.0 sp|Q5HZL1|ERI2_XENLA ERI1 exoribonuclease 2 OS=Xenopus laevis OX=8355 GN=eri2 PE=2 SV=1 g17488.t1 Q7ZW63 26.018 442 3.68e-31 128.0 sp|Q7ZW63|NUF2_DANRE Kinetochore protein Nuf2 OS=Danio rerio OX=7955 GN=nuf2 PE=2 SV=1 g17489.t1 P06199 27.273 440 9.340000000000001e-56 196.0 sp|P06199|ACM2_PIG Muscarinic acetylcholine receptor M2 OS=Sus scrofa OX=9823 GN=CHRM2 PE=1 SV=1 g17490.t1 Q7SZE3 46.813 455 5.85e-132 417.0 sp|Q7SZE3|L2GL2_DANRE LLGL scribble cell polarity complex component 2 OS=Danio rerio OX=7955 GN=llgl2 PE=1 SV=1 L2GL2_DANRE reviewed LLGL scribble cell polarity complex component 2 (Lethal(2) giant larvae protein homolog 2) (Protein penner) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005096; GO:0005737; GO:0005886; GO:0006887; GO:0006893; GO:0007010; GO:0008285; GO:0008544; GO:0008593; GO:0008594; GO:0010719; GO:0030031; GO:0030336; GO:0030864; GO:0030866; GO:0031581; GO:0032878; GO:0043588; GO:0044458; GO:0045159; GO:0045682; GO:0048919; GO:0050680; GO:0051294; GO:0070121; GO:0098773 cell projection assembly [GO:0030031]; cortical actin cytoskeleton organization [GO:0030866]; cytoskeleton organization [GO:0007010]; epidermis development [GO:0008544]; establishment of spindle orientation [GO:0051294]; exocytosis [GO:0006887]; Golgi to plasma membrane transport [GO:0006893]; hemidesmosome assembly [GO:0031581]; Kupffer's vesicle development [GO:0070121]; motile cilium assembly [GO:0044458]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; photoreceptor cell morphogenesis [GO:0008594]; posterior lateral line neuromast development [GO:0048919]; regulation of epidermis development [GO:0045682]; regulation of establishment or maintenance of cell polarity [GO:0032878]; regulation of Notch signaling pathway [GO:0008593]; skin development [GO:0043588]; skin epidermis development [GO:0098773] cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886] GTPase activator activity [GO:0005096]; myosin II binding [GO:0045159] g17491.t1 Q5RCX2 47.989 373 3.04e-111 353.0 sp|Q5RCX2|L2GL2_PONAB LLGL scribble cell polarity complex component 2 OS=Pongo abelii OX=9601 GN=LLGL2 PE=2 SV=1 L2GL2_PONAB reviewed LLGL scribble cell polarity complex component 2 (Lethal(2) giant larvae protein homolog 2) Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0005096; GO:0005886; GO:0006887; GO:0006893; GO:0008593; GO:0030864; GO:0030866; GO:0032878; GO:0045159; GO:0051294; GO:0051301 cell division [GO:0051301]; cortical actin cytoskeleton organization [GO:0030866]; establishment of spindle orientation [GO:0051294]; exocytosis [GO:0006887]; Golgi to plasma membrane transport [GO:0006893]; regulation of establishment or maintenance of cell polarity [GO:0032878]; regulation of Notch signaling pathway [GO:0008593] cortical actin cytoskeleton [GO:0030864]; plasma membrane [GO:0005886] GTPase activator activity [GO:0005096]; myosin II binding [GO:0045159] g17491.t2 Q5RCX2 48.634 366 3.26e-112 355.0 sp|Q5RCX2|L2GL2_PONAB LLGL scribble cell polarity complex component 2 OS=Pongo abelii OX=9601 GN=LLGL2 PE=2 SV=1 L2GL2_PONAB reviewed LLGL scribble cell polarity complex component 2 (Lethal(2) giant larvae protein homolog 2) Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0005096; GO:0005886; GO:0006887; GO:0006893; GO:0008593; GO:0030864; GO:0030866; GO:0032878; GO:0045159; GO:0051294; GO:0051301 cell division [GO:0051301]; cortical actin cytoskeleton organization [GO:0030866]; establishment of spindle orientation [GO:0051294]; exocytosis [GO:0006887]; Golgi to plasma membrane transport [GO:0006893]; regulation of establishment or maintenance of cell polarity [GO:0032878]; regulation of Notch signaling pathway [GO:0008593] cortical actin cytoskeleton [GO:0030864]; plasma membrane [GO:0005886] GTPase activator activity [GO:0005096]; myosin II binding [GO:0045159] g17491.t3 Q5RCX2 46.842 380 2.3e-108 345.0 sp|Q5RCX2|L2GL2_PONAB LLGL scribble cell polarity complex component 2 OS=Pongo abelii OX=9601 GN=LLGL2 PE=2 SV=1 L2GL2_PONAB reviewed LLGL scribble cell polarity complex component 2 (Lethal(2) giant larvae protein homolog 2) Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0005096; GO:0005886; GO:0006887; GO:0006893; GO:0008593; GO:0030864; GO:0030866; GO:0032878; GO:0045159; GO:0051294; GO:0051301 cell division [GO:0051301]; cortical actin cytoskeleton organization [GO:0030866]; establishment of spindle orientation [GO:0051294]; exocytosis [GO:0006887]; Golgi to plasma membrane transport [GO:0006893]; regulation of establishment or maintenance of cell polarity [GO:0032878]; regulation of Notch signaling pathway [GO:0008593] cortical actin cytoskeleton [GO:0030864]; plasma membrane [GO:0005886] GTPase activator activity [GO:0005096]; myosin II binding [GO:0045159] g17492.t1 Q3LGD4 28.299 629 2e-50 187.0 sp|Q3LGD4|RFP4A_DANRE Rab11 family-interacting protein 4A OS=Danio rerio OX=7955 GN=rab11fip4a PE=2 SV=1 RFP4A_DANRE reviewed Rab11 family-interacting protein 4A (FIP4-Rab11) (Rab11-FIP4-A) (zRab11-FIP4-A) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005509; GO:0005768; GO:0030139; GO:0030496; GO:0031267; GO:0032154; GO:0032456; GO:0032465; GO:0042803; GO:0048592; GO:0051301; GO:0051726; GO:0055038 cell division [GO:0051301]; endocytic recycling [GO:0032456]; eye morphogenesis [GO:0048592]; regulation of cell cycle [GO:0051726]; regulation of cytokinesis [GO:0032465] cleavage furrow [GO:0032154]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; midbody [GO:0030496]; recycling endosome membrane [GO:0055038] calcium ion binding [GO:0005509]; protein homodimerization activity [GO:0042803]; small GTPase binding [GO:0031267] g17492.t2 Q3LGD4 28.84 638 2.89e-53 195.0 sp|Q3LGD4|RFP4A_DANRE Rab11 family-interacting protein 4A OS=Danio rerio OX=7955 GN=rab11fip4a PE=2 SV=1 RFP4A_DANRE reviewed Rab11 family-interacting protein 4A (FIP4-Rab11) (Rab11-FIP4-A) (zRab11-FIP4-A) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005509; GO:0005768; GO:0030139; GO:0030496; GO:0031267; GO:0032154; GO:0032456; GO:0032465; GO:0042803; GO:0048592; GO:0051301; GO:0051726; GO:0055038 cell division [GO:0051301]; endocytic recycling [GO:0032456]; eye morphogenesis [GO:0048592]; regulation of cell cycle [GO:0051726]; regulation of cytokinesis [GO:0032465] cleavage furrow [GO:0032154]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; midbody [GO:0030496]; recycling endosome membrane [GO:0055038] calcium ion binding [GO:0005509]; protein homodimerization activity [GO:0042803]; small GTPase binding [GO:0031267] g17492.t3 Q3LGD4 31.828 443 2.24e-42 166.0 sp|Q3LGD4|RFP4A_DANRE Rab11 family-interacting protein 4A OS=Danio rerio OX=7955 GN=rab11fip4a PE=2 SV=1 RFP4A_DANRE reviewed Rab11 family-interacting protein 4A (FIP4-Rab11) (Rab11-FIP4-A) (zRab11-FIP4-A) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005509; GO:0005768; GO:0030139; GO:0030496; GO:0031267; GO:0032154; GO:0032456; GO:0032465; GO:0042803; GO:0048592; GO:0051301; GO:0051726; GO:0055038 cell division [GO:0051301]; endocytic recycling [GO:0032456]; eye morphogenesis [GO:0048592]; regulation of cell cycle [GO:0051726]; regulation of cytokinesis [GO:0032465] cleavage furrow [GO:0032154]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; midbody [GO:0030496]; recycling endosome membrane [GO:0055038] calcium ion binding [GO:0005509]; protein homodimerization activity [GO:0042803]; small GTPase binding [GO:0031267] g17492.t4 Q3LGD4 31.304 460 8.16e-43 164.0 sp|Q3LGD4|RFP4A_DANRE Rab11 family-interacting protein 4A OS=Danio rerio OX=7955 GN=rab11fip4a PE=2 SV=1 RFP4A_DANRE reviewed Rab11 family-interacting protein 4A (FIP4-Rab11) (Rab11-FIP4-A) (zRab11-FIP4-A) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005509; GO:0005768; GO:0030139; GO:0030496; GO:0031267; GO:0032154; GO:0032456; GO:0032465; GO:0042803; GO:0048592; GO:0051301; GO:0051726; GO:0055038 cell division [GO:0051301]; endocytic recycling [GO:0032456]; eye morphogenesis [GO:0048592]; regulation of cell cycle [GO:0051726]; regulation of cytokinesis [GO:0032465] cleavage furrow [GO:0032154]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; midbody [GO:0030496]; recycling endosome membrane [GO:0055038] calcium ion binding [GO:0005509]; protein homodimerization activity [GO:0042803]; small GTPase binding [GO:0031267] g17494.t1 Q6P2X9 25.517 435 2.99e-23 105.0 sp|Q6P2X9|MOT12_XENTR Monocarboxylate transporter 12 OS=Xenopus tropicalis OX=8364 GN=slc16a12 PE=2 SV=1 g17496.t1 A1L272 48.261 460 2e-142 424.0 sp|A1L272|S29A4_DANRE Equilibrative nucleoside transporter 4 OS=Danio rerio OX=7955 GN=slc29a4 PE=2 SV=1 g17496.t2 A1L272 50.229 436 4.3799999999999996e-141 419.0 sp|A1L272|S29A4_DANRE Equilibrative nucleoside transporter 4 OS=Danio rerio OX=7955 GN=slc29a4 PE=2 SV=1 g17499.t1 Q8R480 49.158 594 0.0 567.0 sp|Q8R480|NUP85_MOUSE Nuclear pore complex protein Nup85 OS=Mus musculus OX=10090 GN=Nup85 PE=1 SV=1 NUP85_MOUSE reviewed Nuclear pore complex protein Nup85 (85 kDa nucleoporin) (FROUNT) (Nucleoporin Nup85) (Pericentrin-1) Mus musculus (Mouse) GO:0000776; GO:0005635; GO:0005643; GO:0005654; GO:0005737; GO:0005819; GO:0005829; GO:0005886; GO:0006406; GO:0006606; GO:0006913; GO:0006935; GO:0015629; GO:0017056; GO:0019221; GO:0030032; GO:0031080; GO:0031727; GO:0031965; GO:0036064; GO:0045893; GO:0048246; GO:0072006 chemotaxis [GO:0006935]; cytokine-mediated signaling pathway [GO:0019221]; lamellipodium assembly [GO:0030032]; macrophage chemotaxis [GO:0048246]; mRNA export from nucleus [GO:0006406]; nephron development [GO:0072006]; nucleocytoplasmic transport [GO:0006913]; positive regulation of DNA-templated transcription [GO:0045893]; protein import into nucleus [GO:0006606] actin cytoskeleton [GO:0015629]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; kinetochore [GO:0000776]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nuclear pore outer ring [GO:0031080]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; spindle [GO:0005819] CCR2 chemokine receptor binding [GO:0031727]; structural constituent of nuclear pore [GO:0017056] g17500.t1 P07992 67.15 207 3.95e-107 321.0 sp|P07992|ERCC1_HUMAN DNA excision repair protein ERCC-1 OS=Homo sapiens OX=9606 GN=ERCC1 PE=1 SV=1 ERCC1_HUMAN reviewed DNA excision repair protein ERCC-1 Homo sapiens (Human) GO:0000109; GO:0000110; GO:0000720; GO:0000781; GO:0001094; GO:0003684; GO:0003697; GO:0005654; GO:0005737; GO:0006281; GO:0006289; GO:0006303; GO:0006312; GO:0006949; GO:0006979; GO:0007283; GO:0008283; GO:0008340; GO:0008584; GO:0009650; GO:0010165; GO:0032205; GO:0035166; GO:0035264; GO:0036297; GO:0045190; GO:0048009; GO:0048477; GO:0060261; GO:0061819; GO:0070522; GO:0070914; GO:0090399; GO:0090656; GO:1904431; GO:1905765; GO:1990841 cell population proliferation [GO:0008283]; determination of adult lifespan [GO:0008340]; DNA repair [GO:0006281]; double-strand break repair via nonhomologous end joining [GO:0006303]; insulin-like growth factor receptor signaling pathway [GO:0048009]; interstrand cross-link repair [GO:0036297]; isotype switching [GO:0045190]; male gonad development [GO:0008584]; mitotic recombination [GO:0006312]; multicellular organism growth [GO:0035264]; negative regulation of protection from non-homologous end joining at telomere [GO:1905765]; negative regulation of telomere maintenance [GO:0032205]; nucleotide-excision repair [GO:0006289]; oogenesis [GO:0048477]; positive regulation of t-circle formation [GO:1904431]; positive regulation of transcription initiation by RNA polymerase II [GO:0060261]; post-embryonic hemopoiesis [GO:0035166]; pyrimidine dimer repair by nucleotide-excision repair [GO:0000720]; replicative senescence [GO:0090399]; response to oxidative stress [GO:0006979]; response to X-ray [GO:0010165]; spermatogenesis [GO:0007283]; syncytium formation [GO:0006949]; t-circle formation [GO:0090656]; telomeric DNA-containing double minutes formation [GO:0061819]; UV protection [GO:0009650]; UV-damage excision repair [GO:0070914] chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; ERCC4-ERCC1 complex [GO:0070522]; nucleoplasm [GO:0005654]; nucleotide-excision repair complex [GO:0000109]; nucleotide-excision repair factor 1 complex [GO:0000110] damaged DNA binding [GO:0003684]; promoter-specific chromatin binding [GO:1990841]; single-stranded DNA binding [GO:0003697]; TFIID-class transcription factor complex binding [GO:0001094] g17501.t1 Q5HZH2 51.55 258 7.32e-84 263.0 sp|Q5HZH2|TSR3_MOUSE 18S rRNA aminocarboxypropyltransferase OS=Mus musculus OX=10090 GN=Tsr3 PE=1 SV=1 g17502.t1 Q91Y25 55.825 206 2.69e-60 233.0 sp|Q91Y25|WASC2_CRIGR WASH complex subunit 2 OS=Cricetulus griseus OX=10029 GN=Washc2 PE=2 SV=1 g17508.t1 P08594 38.532 327 5.36e-53 186.0 sp|P08594|AQL1_THEAQ Aqualysin-1 OS=Thermus aquaticus OX=271 GN=pstI PE=1 SV=2 g17509.t1 Q29476 34.426 244 2.2799999999999998e-45 156.0 sp|Q29476|ST1A1_CANLF Sulfotransferase 1A1 OS=Canis lupus familiaris OX=9615 GN=SULT1A1 PE=1 SV=1 ST1A1_CANLF reviewed Sulfotransferase 1A1 (ST1A1) (EC 2.8.2.1) (Aryl sulfotransferase) (Phenol sulfotransferase) (Phenol-sulfating phenol sulfotransferase) (P-PST) Canis lupus familiaris (Dog) (Canis familiaris) GO:0004062; GO:0005737; GO:0008146; GO:0008202; GO:0042403; GO:0042420; GO:0050656; GO:0051923 dopamine catabolic process [GO:0042420]; steroid metabolic process [GO:0008202]; sulfation [GO:0051923]; thyroid hormone metabolic process [GO:0042403] cytoplasm [GO:0005737] 3'-phosphoadenosine 5'-phosphosulfate binding [GO:0050656]; aryl sulfotransferase activity [GO:0004062]; sulfotransferase activity [GO:0008146] g17511.t1 Q6PAX8 44.286 280 1.74e-62 200.0 sp|Q6PAX8|HAPR1_XENLA HUWE1-associated protein modifying stress responses OS=Xenopus laevis OX=8355 GN=hapstr1 PE=2 SV=1 g17512.t1 Q6U7I1 64.346 948 0.0 1261.0 sp|Q6U7I1|UBP7_CHICK Ubiquitin carboxyl-terminal hydrolase 7 OS=Gallus gallus OX=9031 GN=USP7 PE=2 SV=1 UBP7_CHICK reviewed Ubiquitin carboxyl-terminal hydrolase 7 (EC 3.4.19.12) (Deubiquitinating enzyme 7) (Ubiquitin thioesterase 7) (Ubiquitin-specific-processing protease 7) Gallus gallus (Chicken) GO:0004843; GO:0005634; GO:0005694; GO:0005829; GO:0006508; GO:0016579; GO:0016605; GO:0031647; GO:0051090 protein deubiquitination [GO:0016579]; proteolysis [GO:0006508]; regulation of DNA-binding transcription factor activity [GO:0051090]; regulation of protein stability [GO:0031647] chromosome [GO:0005694]; cytosol [GO:0005829]; nucleus [GO:0005634]; PML body [GO:0016605] cysteine-type deubiquitinase activity [GO:0004843] g17513.t1 Q93009 59.615 104 2.7700000000000004e-32 122.0 sp|Q93009|UBP7_HUMAN Ubiquitin carboxyl-terminal hydrolase 7 OS=Homo sapiens OX=9606 GN=USP7 PE=1 SV=2 UBP7_HUMAN reviewed Ubiquitin carboxyl-terminal hydrolase 7 (EC 3.4.19.12) (Deubiquitinating enzyme 7) (Herpesvirus-associated ubiquitin-specific protease) (Ubiquitin thioesterase 7) (Ubiquitin-specific-processing protease 7) Homo sapiens (Human) GO:0002039; GO:0004197; GO:0004843; GO:0005634; GO:0005654; GO:0005694; GO:0005829; GO:0006283; GO:0006307; GO:0006508; GO:0016567; GO:0016579; GO:0016604; GO:0016605; GO:0031647; GO:0032435; GO:0032991; GO:0035520; GO:0042752; GO:0044027; GO:0045721; GO:0048511; GO:0050821; GO:0051090; GO:0070203; GO:0075342; GO:0101005; GO:1901796; GO:1904262; GO:1904353; GO:1905279; GO:1990380 DNA alkylation repair [GO:0006307]; monoubiquitinated protein deubiquitination [GO:0035520]; negative regulation of gene expression via chromosomal CpG island methylation [GO:0044027]; negative regulation of gluconeogenesis [GO:0045721]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of TORC1 signaling [GO:1904262]; protein deubiquitination [GO:0016579]; protein stabilization [GO:0050821]; protein ubiquitination [GO:0016567]; proteolysis [GO:0006508]; regulation of circadian rhythm [GO:0042752]; regulation of DNA-binding transcription factor activity [GO:0051090]; regulation of establishment of protein localization to telomere [GO:0070203]; regulation of protein stability [GO:0031647]; regulation of retrograde transport, endosome to Golgi [GO:1905279]; regulation of signal transduction by p53 class mediator [GO:1901796]; regulation of telomere capping [GO:1904353]; rhythmic process [GO:0048511]; symbiont-mediated disruption of host cell PML body [GO:0075342]; transcription-coupled nucleotide-excision repair [GO:0006283] chromosome [GO:0005694]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; protein-containing complex [GO:0032991] cysteine-type deubiquitinase activity [GO:0004843]; cysteine-type endopeptidase activity [GO:0004197]; deubiquitinase activity [GO:0101005]; K48-linked deubiquitinase activity [GO:1990380]; p53 binding [GO:0002039] g17514.t1 Q9Y519 60.766 418 4.5100000000000005e-160 462.0 sp|Q9Y519|T184B_HUMAN Transmembrane protein 184B OS=Homo sapiens OX=9606 GN=TMEM184B PE=1 SV=2 g17515.t1 Q962X9 88.889 144 2.29e-96 276.0 sp|Q962X9|BUD31_BRABE Protein BUD31 homolog OS=Branchiostoma belcheri OX=7741 PE=2 SV=1 g17517.t1 Q5MJS3 60.519 347 1.26e-143 430.0 sp|Q5MJS3|FA20C_MOUSE Extracellular serine/threonine protein kinase FAM20C OS=Mus musculus OX=10090 GN=Fam20c PE=1 SV=1 FA20C_MOUSE reviewed Extracellular serine/threonine protein kinase FAM20C (EC 2.7.11.1) (Dentin matrix protein 4) (DMP-4) (Golgi-enriched fraction casein kinase) (GEF-CK) Mus musculus (Mouse) GO:0000139; GO:0001501; GO:0002020; GO:0004672; GO:0004674; GO:0005509; GO:0005524; GO:0005615; GO:0005654; GO:0005737; GO:0005783; GO:0005794; GO:0006468; GO:0030145; GO:0030501; GO:0031214; GO:0036179; GO:0040036; GO:0045669; GO:0051174; GO:0070166; GO:0071895; GO:0097187; GO:0106310 biomineral tissue development [GO:0031214]; dentinogenesis [GO:0097187]; enamel mineralization [GO:0070166]; odontoblast differentiation [GO:0071895]; osteoclast maturation [GO:0036179]; positive regulation of bone mineralization [GO:0030501]; positive regulation of osteoblast differentiation [GO:0045669]; protein phosphorylation [GO:0006468]; regulation of fibroblast growth factor receptor signaling pathway [GO:0040036]; regulation of phosphorus metabolic process [GO:0051174]; skeletal system development [GO:0001501] cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; nucleoplasm [GO:0005654] ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; manganese ion binding [GO:0030145]; protease binding [GO:0002020]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g17519.t1 Q8BYA0 52.129 1174 0.0 1114.0 sp|Q8BYA0|TBCD_MOUSE Tubulin-specific chaperone D OS=Mus musculus OX=10090 GN=Tbcd PE=1 SV=1 g17520.t1 G5E8K5 29.794 678 4.43e-51 195.0 sp|G5E8K5|ANK3_MOUSE Ankyrin-3 OS=Mus musculus OX=10090 GN=Ank3 PE=1 SV=1 ANK3_MOUSE reviewed Ankyrin-3 (ANK-3) (Ankyrin-G) Mus musculus (Mouse) GO:0000281; GO:0005200; GO:0005737; GO:0005764; GO:0005886; GO:0007009; GO:0007165; GO:0007409; GO:0007411; GO:0007528; GO:0008089; GO:0008092; GO:0009925; GO:0009986; GO:0010628; GO:0010650; GO:0010765; GO:0010960; GO:0014069; GO:0014704; GO:0014731; GO:0016020; GO:0016323; GO:0016328; GO:0016529; GO:0017080; GO:0019228; GO:0030018; GO:0030315; GO:0030424; GO:0030425; GO:0030507; GO:0030674; GO:0030951; GO:0031594; GO:0032507; GO:0033268; GO:0033270; GO:0034112; GO:0042383; GO:0043001; GO:0043034; GO:0043194; GO:0043266; GO:0044325; GO:0045162; GO:0045184; GO:0045202; GO:0045211; GO:0045296; GO:0045760; GO:0045806; GO:0045838; GO:0050808; GO:0061564; GO:0071286; GO:0071709; GO:0072659; GO:0072660; GO:0090314; GO:0098794; GO:0098978; GO:0099103; GO:0099159; GO:0099612; GO:0140031; GO:1900827; GO:1901224; GO:1902260; GO:1903533; GO:1903784; GO:1904115 anterograde axonal transport [GO:0008089]; axon development [GO:0061564]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; cellular response to magnesium ion [GO:0071286]; clustering of voltage-gated sodium channels [GO:0045162]; establishment of protein localization [GO:0045184]; establishment or maintenance of microtubule cytoskeleton polarity [GO:0030951]; Golgi to plasma membrane protein transport [GO:0043001]; magnesium ion homeostasis [GO:0010960]; maintenance of protein location in cell [GO:0032507]; maintenance of protein location in plasma membrane [GO:0072660]; membrane assembly [GO:0071709]; mitotic cytokinesis [GO:0000281]; negative regulation of delayed rectifier potassium channel activity [GO:1902260]; negative regulation of endocytosis [GO:0045806]; neuromuscular junction development [GO:0007528]; neuronal action potential [GO:0019228]; plasma membrane organization [GO:0007009]; positive regulation of action potential [GO:0045760]; positive regulation of cell communication by electrical coupling [GO:0010650]; positive regulation of gene expression [GO:0010628]; positive regulation of homotypic cell-cell adhesion [GO:0034112]; positive regulation of membrane depolarization during cardiac muscle cell action potential [GO:1900827]; positive regulation of membrane potential [GO:0045838]; positive regulation of non-canonical NF-kappaB signal transduction [GO:1901224]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of sodium ion import across plasma membrane [GO:1903784]; positive regulation of sodium ion transport [GO:0010765]; protein localization to axon [GO:0099612]; protein localization to plasma membrane [GO:0072659]; regulation of modification of postsynaptic structure [GO:0099159]; regulation of potassium ion transport [GO:0043266]; regulation of protein targeting [GO:1903533]; signal transduction [GO:0007165]; synapse organization [GO:0050808] axon [GO:0030424]; axon cytoplasm [GO:1904115]; axon initial segment [GO:0043194]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; costamere [GO:0043034]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; intercalated disc [GO:0014704]; lateral plasma membrane [GO:0016328]; lysosome [GO:0005764]; membrane [GO:0016020]; neuromuscular junction [GO:0031594]; node of Ranvier [GO:0033268]; paranode region of axon [GO:0033270]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; sarcoplasmic reticulum [GO:0016529]; spectrin-associated cytoskeleton [GO:0014731]; synapse [GO:0045202]; T-tubule [GO:0030315]; Z disc [GO:0030018] cadherin binding [GO:0045296]; channel activator activity [GO:0099103]; cytoskeletal protein binding [GO:0008092]; phosphorylation-dependent protein binding [GO:0140031]; protein-macromolecule adaptor activity [GO:0030674]; sodium channel regulator activity [GO:0017080]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]; transmembrane transporter binding [GO:0044325] g17520.t1 G5E8K5 30.017 583 1.44e-45 179.0 sp|G5E8K5|ANK3_MOUSE Ankyrin-3 OS=Mus musculus OX=10090 GN=Ank3 PE=1 SV=1 ANK3_MOUSE reviewed Ankyrin-3 (ANK-3) (Ankyrin-G) Mus musculus (Mouse) GO:0000281; GO:0005200; GO:0005737; GO:0005764; GO:0005886; GO:0007009; GO:0007165; GO:0007409; GO:0007411; GO:0007528; GO:0008089; GO:0008092; GO:0009925; GO:0009986; GO:0010628; GO:0010650; GO:0010765; GO:0010960; GO:0014069; GO:0014704; GO:0014731; GO:0016020; GO:0016323; GO:0016328; GO:0016529; GO:0017080; GO:0019228; GO:0030018; GO:0030315; GO:0030424; GO:0030425; GO:0030507; GO:0030674; GO:0030951; GO:0031594; GO:0032507; GO:0033268; GO:0033270; GO:0034112; GO:0042383; GO:0043001; GO:0043034; GO:0043194; GO:0043266; GO:0044325; GO:0045162; GO:0045184; GO:0045202; GO:0045211; GO:0045296; GO:0045760; GO:0045806; GO:0045838; GO:0050808; GO:0061564; GO:0071286; GO:0071709; GO:0072659; GO:0072660; GO:0090314; GO:0098794; GO:0098978; GO:0099103; GO:0099159; GO:0099612; GO:0140031; GO:1900827; GO:1901224; GO:1902260; GO:1903533; GO:1903784; GO:1904115 anterograde axonal transport [GO:0008089]; axon development [GO:0061564]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; cellular response to magnesium ion [GO:0071286]; clustering of voltage-gated sodium channels [GO:0045162]; establishment of protein localization [GO:0045184]; establishment or maintenance of microtubule cytoskeleton polarity [GO:0030951]; Golgi to plasma membrane protein transport [GO:0043001]; magnesium ion homeostasis [GO:0010960]; maintenance of protein location in cell [GO:0032507]; maintenance of protein location in plasma membrane [GO:0072660]; membrane assembly [GO:0071709]; mitotic cytokinesis [GO:0000281]; negative regulation of delayed rectifier potassium channel activity [GO:1902260]; negative regulation of endocytosis [GO:0045806]; neuromuscular junction development [GO:0007528]; neuronal action potential [GO:0019228]; plasma membrane organization [GO:0007009]; positive regulation of action potential [GO:0045760]; positive regulation of cell communication by electrical coupling [GO:0010650]; positive regulation of gene expression [GO:0010628]; positive regulation of homotypic cell-cell adhesion [GO:0034112]; positive regulation of membrane depolarization during cardiac muscle cell action potential [GO:1900827]; positive regulation of membrane potential [GO:0045838]; positive regulation of non-canonical NF-kappaB signal transduction [GO:1901224]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of sodium ion import across plasma membrane [GO:1903784]; positive regulation of sodium ion transport [GO:0010765]; protein localization to axon [GO:0099612]; protein localization to plasma membrane [GO:0072659]; regulation of modification of postsynaptic structure [GO:0099159]; regulation of potassium ion transport [GO:0043266]; regulation of protein targeting [GO:1903533]; signal transduction [GO:0007165]; synapse organization [GO:0050808] axon [GO:0030424]; axon cytoplasm [GO:1904115]; axon initial segment [GO:0043194]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; costamere [GO:0043034]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; intercalated disc [GO:0014704]; lateral plasma membrane [GO:0016328]; lysosome [GO:0005764]; membrane [GO:0016020]; neuromuscular junction [GO:0031594]; node of Ranvier [GO:0033268]; paranode region of axon [GO:0033270]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; sarcoplasmic reticulum [GO:0016529]; spectrin-associated cytoskeleton [GO:0014731]; synapse [GO:0045202]; T-tubule [GO:0030315]; Z disc [GO:0030018] cadherin binding [GO:0045296]; channel activator activity [GO:0099103]; cytoskeletal protein binding [GO:0008092]; phosphorylation-dependent protein binding [GO:0140031]; protein-macromolecule adaptor activity [GO:0030674]; sodium channel regulator activity [GO:0017080]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]; transmembrane transporter binding [GO:0044325] g17520.t1 G5E8K5 31.507 438 6.310000000000001e-35 146.0 sp|G5E8K5|ANK3_MOUSE Ankyrin-3 OS=Mus musculus OX=10090 GN=Ank3 PE=1 SV=1 ANK3_MOUSE reviewed Ankyrin-3 (ANK-3) (Ankyrin-G) Mus musculus (Mouse) GO:0000281; GO:0005200; GO:0005737; GO:0005764; GO:0005886; GO:0007009; GO:0007165; GO:0007409; GO:0007411; GO:0007528; GO:0008089; GO:0008092; GO:0009925; GO:0009986; GO:0010628; GO:0010650; GO:0010765; GO:0010960; GO:0014069; GO:0014704; GO:0014731; GO:0016020; GO:0016323; GO:0016328; GO:0016529; GO:0017080; GO:0019228; GO:0030018; GO:0030315; GO:0030424; GO:0030425; GO:0030507; GO:0030674; GO:0030951; GO:0031594; GO:0032507; GO:0033268; GO:0033270; GO:0034112; GO:0042383; GO:0043001; GO:0043034; GO:0043194; GO:0043266; GO:0044325; GO:0045162; GO:0045184; GO:0045202; GO:0045211; GO:0045296; GO:0045760; GO:0045806; GO:0045838; GO:0050808; GO:0061564; GO:0071286; GO:0071709; GO:0072659; GO:0072660; GO:0090314; GO:0098794; GO:0098978; GO:0099103; GO:0099159; GO:0099612; GO:0140031; GO:1900827; GO:1901224; GO:1902260; GO:1903533; GO:1903784; GO:1904115 anterograde axonal transport [GO:0008089]; axon development [GO:0061564]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; cellular response to magnesium ion [GO:0071286]; clustering of voltage-gated sodium channels [GO:0045162]; establishment of protein localization [GO:0045184]; establishment or maintenance of microtubule cytoskeleton polarity [GO:0030951]; Golgi to plasma membrane protein transport [GO:0043001]; magnesium ion homeostasis [GO:0010960]; maintenance of protein location in cell [GO:0032507]; maintenance of protein location in plasma membrane [GO:0072660]; membrane assembly [GO:0071709]; mitotic cytokinesis [GO:0000281]; negative regulation of delayed rectifier potassium channel activity [GO:1902260]; negative regulation of endocytosis [GO:0045806]; neuromuscular junction development [GO:0007528]; neuronal action potential [GO:0019228]; plasma membrane organization [GO:0007009]; positive regulation of action potential [GO:0045760]; positive regulation of cell communication by electrical coupling [GO:0010650]; positive regulation of gene expression [GO:0010628]; positive regulation of homotypic cell-cell adhesion [GO:0034112]; positive regulation of membrane depolarization during cardiac muscle cell action potential [GO:1900827]; positive regulation of membrane potential [GO:0045838]; positive regulation of non-canonical NF-kappaB signal transduction [GO:1901224]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of sodium ion import across plasma membrane [GO:1903784]; positive regulation of sodium ion transport [GO:0010765]; protein localization to axon [GO:0099612]; protein localization to plasma membrane [GO:0072659]; regulation of modification of postsynaptic structure [GO:0099159]; regulation of potassium ion transport [GO:0043266]; regulation of protein targeting [GO:1903533]; signal transduction [GO:0007165]; synapse organization [GO:0050808] axon [GO:0030424]; axon cytoplasm [GO:1904115]; axon initial segment [GO:0043194]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; costamere [GO:0043034]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; intercalated disc [GO:0014704]; lateral plasma membrane [GO:0016328]; lysosome [GO:0005764]; membrane [GO:0016020]; neuromuscular junction [GO:0031594]; node of Ranvier [GO:0033268]; paranode region of axon [GO:0033270]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; sarcoplasmic reticulum [GO:0016529]; spectrin-associated cytoskeleton [GO:0014731]; synapse [GO:0045202]; T-tubule [GO:0030315]; Z disc [GO:0030018] cadherin binding [GO:0045296]; channel activator activity [GO:0099103]; cytoskeletal protein binding [GO:0008092]; phosphorylation-dependent protein binding [GO:0140031]; protein-macromolecule adaptor activity [GO:0030674]; sodium channel regulator activity [GO:0017080]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]; transmembrane transporter binding [GO:0044325] g17520.t1 G5E8K5 29.275 386 1.24e-25 117.0 sp|G5E8K5|ANK3_MOUSE Ankyrin-3 OS=Mus musculus OX=10090 GN=Ank3 PE=1 SV=1 ANK3_MOUSE reviewed Ankyrin-3 (ANK-3) (Ankyrin-G) Mus musculus (Mouse) GO:0000281; GO:0005200; GO:0005737; GO:0005764; GO:0005886; GO:0007009; GO:0007165; GO:0007409; GO:0007411; GO:0007528; GO:0008089; GO:0008092; GO:0009925; GO:0009986; GO:0010628; GO:0010650; GO:0010765; GO:0010960; GO:0014069; GO:0014704; GO:0014731; GO:0016020; GO:0016323; GO:0016328; GO:0016529; GO:0017080; GO:0019228; GO:0030018; GO:0030315; GO:0030424; GO:0030425; GO:0030507; GO:0030674; GO:0030951; GO:0031594; GO:0032507; GO:0033268; GO:0033270; GO:0034112; GO:0042383; GO:0043001; GO:0043034; GO:0043194; GO:0043266; GO:0044325; GO:0045162; GO:0045184; GO:0045202; GO:0045211; GO:0045296; GO:0045760; GO:0045806; GO:0045838; GO:0050808; GO:0061564; GO:0071286; GO:0071709; GO:0072659; GO:0072660; GO:0090314; GO:0098794; GO:0098978; GO:0099103; GO:0099159; GO:0099612; GO:0140031; GO:1900827; GO:1901224; GO:1902260; GO:1903533; GO:1903784; GO:1904115 anterograde axonal transport [GO:0008089]; axon development [GO:0061564]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; cellular response to magnesium ion [GO:0071286]; clustering of voltage-gated sodium channels [GO:0045162]; establishment of protein localization [GO:0045184]; establishment or maintenance of microtubule cytoskeleton polarity [GO:0030951]; Golgi to plasma membrane protein transport [GO:0043001]; magnesium ion homeostasis [GO:0010960]; maintenance of protein location in cell [GO:0032507]; maintenance of protein location in plasma membrane [GO:0072660]; membrane assembly [GO:0071709]; mitotic cytokinesis [GO:0000281]; negative regulation of delayed rectifier potassium channel activity [GO:1902260]; negative regulation of endocytosis [GO:0045806]; neuromuscular junction development [GO:0007528]; neuronal action potential [GO:0019228]; plasma membrane organization [GO:0007009]; positive regulation of action potential [GO:0045760]; positive regulation of cell communication by electrical coupling [GO:0010650]; positive regulation of gene expression [GO:0010628]; positive regulation of homotypic cell-cell adhesion [GO:0034112]; positive regulation of membrane depolarization during cardiac muscle cell action potential [GO:1900827]; positive regulation of membrane potential [GO:0045838]; positive regulation of non-canonical NF-kappaB signal transduction [GO:1901224]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of sodium ion import across plasma membrane [GO:1903784]; positive regulation of sodium ion transport [GO:0010765]; protein localization to axon [GO:0099612]; protein localization to plasma membrane [GO:0072659]; regulation of modification of postsynaptic structure [GO:0099159]; regulation of potassium ion transport [GO:0043266]; regulation of protein targeting [GO:1903533]; signal transduction [GO:0007165]; synapse organization [GO:0050808] axon [GO:0030424]; axon cytoplasm [GO:1904115]; axon initial segment [GO:0043194]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; costamere [GO:0043034]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; intercalated disc [GO:0014704]; lateral plasma membrane [GO:0016328]; lysosome [GO:0005764]; membrane [GO:0016020]; neuromuscular junction [GO:0031594]; node of Ranvier [GO:0033268]; paranode region of axon [GO:0033270]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; sarcoplasmic reticulum [GO:0016529]; spectrin-associated cytoskeleton [GO:0014731]; synapse [GO:0045202]; T-tubule [GO:0030315]; Z disc [GO:0030018] cadherin binding [GO:0045296]; channel activator activity [GO:0099103]; cytoskeletal protein binding [GO:0008092]; phosphorylation-dependent protein binding [GO:0140031]; protein-macromolecule adaptor activity [GO:0030674]; sodium channel regulator activity [GO:0017080]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]; transmembrane transporter binding [GO:0044325] g17524.t1 P70549 37.573 857 3.7599999999999996e-142 445.0 sp|P70549|NAC3_RAT Sodium/calcium exchanger 3 OS=Rattus norvegicus OX=10116 GN=Slc8a3 PE=1 SV=1 NAC3_RAT reviewed Sodium/calcium exchanger 3 (Na(+)/Ca(2+)-exchange protein 3) (Solute carrier family 8 member 3) Rattus norvegicus (Rat) GO:0002244; GO:0005432; GO:0005516; GO:0005654; GO:0005741; GO:0005789; GO:0005813; GO:0005829; GO:0005874; GO:0005886; GO:0006814; GO:0006851; GO:0006874; GO:0007154; GO:0007611; GO:0007612; GO:0007613; GO:0014069; GO:0014819; GO:0015368; GO:0015630; GO:0016528; GO:0021537; GO:0030001; GO:0030424; GO:0030425; GO:0031594; GO:0035725; GO:0042383; GO:0042552; GO:0042995; GO:0043025; GO:0043197; GO:0043204; GO:0043679; GO:0045202; GO:0045211; GO:0046872; GO:0048471; GO:0048709; GO:0050808; GO:0051560; GO:0060291; GO:0060402; GO:0070161; GO:0070588; GO:0071320; GO:0071456; GO:0098703; GO:0098794; GO:0098815; GO:1902532; GO:1905060; GO:1990034 calcium ion export across plasma membrane [GO:1990034]; calcium ion import across plasma membrane [GO:0098703]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport into cytosol [GO:0060402]; cell communication [GO:0007154]; cellular response to cAMP [GO:0071320]; cellular response to hypoxia [GO:0071456]; hematopoietic progenitor cell differentiation [GO:0002244]; intracellular calcium ion homeostasis [GO:0006874]; learning [GO:0007612]; learning or memory [GO:0007611]; long-term synaptic potentiation [GO:0060291]; memory [GO:0007613]; metal ion transport [GO:0030001]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrial calcium ion transmembrane transport [GO:0006851]; modulation of excitatory postsynaptic potential [GO:0098815]; myelination [GO:0042552]; negative regulation of intracellular signal transduction [GO:1902532]; oligodendrocyte differentiation [GO:0048709]; regulation of skeletal muscle contraction [GO:0014819]; sodium ion transmembrane transport [GO:0035725]; sodium ion transport [GO:0006814]; synapse organization [GO:0050808]; telencephalon development [GO:0021537] anchoring junction [GO:0070161]; axon [GO:0030424]; axon terminus [GO:0043679]; cell projection [GO:0042995]; centrosome [GO:0005813]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; endoplasmic reticulum membrane [GO:0005789]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; mitochondrial outer membrane [GO:0005741]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; sarcoplasm [GO:0016528]; synapse [GO:0045202] calcium:monoatomic cation antiporter activity [GO:0015368]; calcium:monoatomic cation antiporter activity involved in regulation of postsynaptic cytosolic calcium ion concentration [GO:1905060]; calcium:sodium antiporter activity [GO:0005432]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872] g17525.t1 Q6P8E9 81.102 127 1.91e-63 192.0 sp|Q6P8E9|NH2L1_XENTR NHP2-like protein 1 OS=Xenopus tropicalis OX=8364 GN=snu13 PE=2 SV=1 NH2L1_XENTR reviewed NHP2-like protein 1 (High mobility group-like nuclear protein 2 homolog 1) (U4/U6.U5 small nuclear ribonucleoprotein SNU13) (U4/U6.U5 tri-snRNP 15.5 kDa protein) Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0000398; GO:0003723; GO:0005634; GO:0005690; GO:0005730; GO:0030490; GO:0030622; GO:0031428; GO:0032040; GO:0034512; GO:0042274; GO:0046540; GO:0071005; GO:0071011 maturation of SSU-rRNA [GO:0030490]; mRNA splicing, via spliceosome [GO:0000398]; ribosomal small subunit biogenesis [GO:0042274] box C/D methylation guide snoRNP complex [GO:0031428]; nucleolus [GO:0005730]; nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; small-subunit processome [GO:0032040]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U4atac snRNP [GO:0005690] box C/D sno(s)RNA binding [GO:0034512]; RNA binding [GO:0003723]; U4atac snRNA binding [GO:0030622] g17526.t1 Q14565 85.093 322 0.0 578.0 sp|Q14565|DMC1_HUMAN Meiotic recombination protein DMC1/LIM15 homolog OS=Homo sapiens OX=9606 GN=DMC1 PE=1 SV=2 g17527.t1 O94901 63.021 192 2.54e-73 265.0 sp|O94901|SUN1_HUMAN SUN domain-containing protein 1 OS=Homo sapiens OX=9606 GN=SUN1 PE=1 SV=4 g17537.t1 F1NV61 39.564 321 4.2700000000000006e-79 247.0 sp|F1NV61|CASP7_CHICK Caspase-7 OS=Gallus gallus OX=9031 GN=CASP7 PE=3 SV=2 CASP7_CHICK reviewed Caspase-7 (CASP-7) (EC 3.4.22.60) [Cleaved into: Caspase-7 subunit p20; Caspase-7 subunit p11] Gallus gallus (Chicken) GO:0003723; GO:0004190; GO:0004197; GO:0005615; GO:0005634; GO:0005737; GO:0005829; GO:0006508; GO:0006915; GO:0042742; GO:0043525; GO:0070227; GO:0097194; GO:1905686 apoptotic process [GO:0006915]; defense response to bacterium [GO:0042742]; execution phase of apoptosis [GO:0097194]; lymphocyte apoptotic process [GO:0070227]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of plasma membrane repair [GO:1905686]; proteolysis [GO:0006508] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; nucleus [GO:0005634] aspartic-type endopeptidase activity [GO:0004190]; cysteine-type endopeptidase activity [GO:0004197]; RNA binding [GO:0003723] g17538.t1 O94812 27.462 1107 3.61e-137 450.0 sp|O94812|BAIP3_HUMAN BAI1-associated protein 3 OS=Homo sapiens OX=9606 GN=BAIAP3 PE=1 SV=2 g17539.t1 Q5XX13 34.146 164 9.1e-28 114.0 sp|Q5XX13|FBW10_HUMAN F-box/WD repeat-containing protein 10 OS=Homo sapiens OX=9606 GN=FBXW10 PE=1 SV=2 FBW10_HUMAN reviewed F-box/WD repeat-containing protein 10 (F-box and WD-40 domain-containing protein 10) (Ubiquitin ligase-specificity factor) Homo sapiens (Human) GO:0005829 cytosol [GO:0005829] g17540.t1 Q5XX13 41.146 384 3.1e-93 321.0 sp|Q5XX13|FBW10_HUMAN F-box/WD repeat-containing protein 10 OS=Homo sapiens OX=9606 GN=FBXW10 PE=1 SV=2 FBW10_HUMAN reviewed F-box/WD repeat-containing protein 10 (F-box and WD-40 domain-containing protein 10) (Ubiquitin ligase-specificity factor) Homo sapiens (Human) GO:0005829 cytosol [GO:0005829] g17544.t1 A2RUV9 39.216 153 1.26e-24 101.0 sp|A2RUV9|AEBP1_RAT Adipocyte enhancer-binding protein 1 OS=Rattus norvegicus OX=10116 GN=Aebp1 PE=2 SV=1 AEBP1_RAT reviewed Adipocyte enhancer-binding protein 1 (AE-binding protein 1) (Aortic carboxypeptidase-like protein) Rattus norvegicus (Rat) GO:0000122; GO:0000977; GO:0001227; GO:0004180; GO:0005516; GO:0005518; GO:0005576; GO:0006355; GO:0006508; GO:0008270; GO:1904026 negative regulation of transcription by RNA polymerase II [GO:0000122]; proteolysis [GO:0006508]; regulation of collagen fibril organization [GO:1904026]; regulation of DNA-templated transcription [GO:0006355] extracellular region [GO:0005576] calmodulin binding [GO:0005516]; carboxypeptidase activity [GO:0004180]; collagen binding [GO:0005518]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; zinc ion binding [GO:0008270] g17551.t1 Q6PCQ0 28.325 579 7.62e-40 160.0 sp|Q6PCQ0|IQCE_MOUSE IQ domain-containing protein E OS=Mus musculus OX=10090 GN=Iqce PE=1 SV=1 IQCE_MOUSE reviewed IQ domain-containing protein E Mus musculus (Mouse) GO:0005739; GO:0008589; GO:0009898; GO:0035108; GO:0045944; GO:0060170; GO:0098797; GO:0120229 limb morphogenesis [GO:0035108]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein localization to motile cilium [GO:0120229]; regulation of smoothened signaling pathway [GO:0008589] ciliary membrane [GO:0060170]; cytoplasmic side of plasma membrane [GO:0009898]; mitochondrion [GO:0005739]; plasma membrane protein complex [GO:0098797] g17552.t1 Q3T0H0 49.679 312 2.43e-118 347.0 sp|Q3T0H0|LCMT1_BOVIN Leucine carboxyl methyltransferase 1 OS=Bos taurus OX=9913 GN=LCMT1 PE=2 SV=1 g17553.t1 Q8VHQ4 69.748 238 2.14e-118 343.0 sp|Q8VHQ4|RB40C_MOUSE Ras-related protein Rab-40C OS=Mus musculus OX=10090 GN=Rab40c PE=1 SV=1 RB40C_MOUSE reviewed Ras-related protein Rab-40C (EC 3.6.5.2) (SOCS box-containing protein RAR3) Mus musculus (Mouse) GO:0000139; GO:0003924; GO:0003925; GO:0005525; GO:0005768; GO:0005811; GO:0005829; GO:0005886; GO:0006887; GO:0008021; GO:0016477; GO:0016567; GO:0019003; GO:0031466; GO:0035556; GO:0043161; GO:0046872; GO:0048471; GO:0051894; GO:0051895; GO:0140042; GO:1990756 cell migration [GO:0016477]; exocytosis [GO:0006887]; intracellular signal transduction [GO:0035556]; lipid droplet formation [GO:0140042]; negative regulation of focal adhesion assembly [GO:0051895]; positive regulation of focal adhesion assembly [GO:0051894]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567] Cul5-RING ubiquitin ligase complex [GO:0031466]; cytosol [GO:0005829]; endosome [GO:0005768]; Golgi membrane [GO:0000139]; lipid droplet [GO:0005811]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; synaptic vesicle [GO:0008021] G protein activity [GO:0003925]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; ubiquitin-like ligase-substrate adaptor activity [GO:1990756] g17554.t1 Q6ICB0 56.604 159 8.72e-57 190.0 sp|Q6ICB0|DESI1_HUMAN Desumoylating isopeptidase 1 OS=Homo sapiens OX=9606 GN=DESI1 PE=1 SV=1 DESI1_HUMAN reviewed Desumoylating isopeptidase 1 (DeSI-1) (EC 3.4.-.-) (PPPDE peptidase domain-containing protein 2) (Palmitoyl protein thioesterase DESI1) (EC 3.1.2.22) (Polyubiquitinated substrate transporter) (POST) (S-depalmitoylase DESI1) Homo sapiens (Human) GO:0005634; GO:0005829; GO:0006508; GO:0006611; GO:0008474; GO:0016926; GO:0016929; GO:0032434; GO:0032991; GO:0042802; GO:0052816; GO:0061676 protein desumoylation [GO:0016926]; protein export from nucleus [GO:0006611]; proteolysis [GO:0006508]; regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032434] cytosol [GO:0005829]; nucleus [GO:0005634]; protein-containing complex [GO:0032991] deSUMOylase activity [GO:0016929]; identical protein binding [GO:0042802]; importin-alpha family protein binding [GO:0061676]; long-chain fatty acyl-CoA hydrolase activity [GO:0052816]; palmitoyl-(protein) hydrolase activity [GO:0008474] g17555.t1 P29314 90.0 170 7.89e-99 287.0 sp|P29314|RS9_RAT Small ribosomal subunit protein uS4 OS=Rattus norvegicus OX=10116 GN=Rps9 PE=1 SV=4 g17556.t1 Q9NZC3 45.42 262 2.31e-72 230.0 sp|Q9NZC3|GDE1_HUMAN Glycerophosphodiester phosphodiesterase 1 OS=Homo sapiens OX=9606 GN=GDE1 PE=1 SV=1 GDE1_HUMAN reviewed Glycerophosphodiester phosphodiesterase 1 (Glycerophosphoinositol glycerophosphodiesterase GDE1) (EC 3.1.4.44) (Lysophospholipase D GDE1) (EC 3.1.4.-) (Membrane-interacting protein of RGS16) (RGS16-interacting membrane protein) Homo sapiens (Human) GO:0004622; GO:0005886; GO:0006580; GO:0006629; GO:0006644; GO:0008889; GO:0016020; GO:0030659; GO:0046475; GO:0046872; GO:0047395; GO:0070291 ethanolamine metabolic process [GO:0006580]; glycerophospholipid catabolic process [GO:0046475]; lipid metabolic process [GO:0006629]; N-acylethanolamine metabolic process [GO:0070291]; phospholipid metabolic process [GO:0006644] cytoplasmic vesicle membrane [GO:0030659]; membrane [GO:0016020]; plasma membrane [GO:0005886] glycerophosphodiester phosphodiesterase activity [GO:0008889]; glycerophosphoinositol glycerophosphodiesterase activity [GO:0047395]; metal ion binding [GO:0046872]; phosphatidylcholine lysophospholipase activity [GO:0004622] g17557.t1 Q6P4S8 53.374 489 6.05e-160 506.0 sp|Q6P4S8|INT1_MOUSE Integrator complex subunit 1 OS=Mus musculus OX=10090 GN=Ints1 PE=1 SV=2 INT1_MOUSE reviewed Integrator complex subunit 1 (Int1) Mus musculus (Mouse) GO:0001832; GO:0001833; GO:0005634; GO:0007566; GO:0016180; GO:0031965; GO:0032039; GO:0034474; GO:0043066; GO:0160232; GO:0160240 blastocyst growth [GO:0001832]; embryo implantation [GO:0007566]; inner cell mass cell proliferation [GO:0001833]; negative regulation of apoptotic process [GO:0043066]; RNA polymerase II transcription initiation surveillance [GO:0160240]; snRNA processing [GO:0016180]; U2 snRNA 3'-end processing [GO:0034474] INTAC complex [GO:0160232]; integrator complex [GO:0032039]; nuclear membrane [GO:0031965]; nucleus [GO:0005634] g17558.t1 Q6P4S8 68.02 197 1.32e-84 276.0 sp|Q6P4S8|INT1_MOUSE Integrator complex subunit 1 OS=Mus musculus OX=10090 GN=Ints1 PE=1 SV=2 INT1_MOUSE reviewed Integrator complex subunit 1 (Int1) Mus musculus (Mouse) GO:0001832; GO:0001833; GO:0005634; GO:0007566; GO:0016180; GO:0031965; GO:0032039; GO:0034474; GO:0043066; GO:0160232; GO:0160240 blastocyst growth [GO:0001832]; embryo implantation [GO:0007566]; inner cell mass cell proliferation [GO:0001833]; negative regulation of apoptotic process [GO:0043066]; RNA polymerase II transcription initiation surveillance [GO:0160240]; snRNA processing [GO:0016180]; U2 snRNA 3'-end processing [GO:0034474] INTAC complex [GO:0160232]; integrator complex [GO:0032039]; nuclear membrane [GO:0031965]; nucleus [GO:0005634] g17559.t1 Q6P4S8 41.192 755 1.38e-136 467.0 sp|Q6P4S8|INT1_MOUSE Integrator complex subunit 1 OS=Mus musculus OX=10090 GN=Ints1 PE=1 SV=2 INT1_MOUSE reviewed Integrator complex subunit 1 (Int1) Mus musculus (Mouse) GO:0001832; GO:0001833; GO:0005634; GO:0007566; GO:0016180; GO:0031965; GO:0032039; GO:0034474; GO:0043066; GO:0160232; GO:0160240 blastocyst growth [GO:0001832]; embryo implantation [GO:0007566]; inner cell mass cell proliferation [GO:0001833]; negative regulation of apoptotic process [GO:0043066]; RNA polymerase II transcription initiation surveillance [GO:0160240]; snRNA processing [GO:0016180]; U2 snRNA 3'-end processing [GO:0034474] INTAC complex [GO:0160232]; integrator complex [GO:0032039]; nuclear membrane [GO:0031965]; nucleus [GO:0005634] g17559.t2 Q6P4S8 40.548 767 2.6700000000000002e-133 458.0 sp|Q6P4S8|INT1_MOUSE Integrator complex subunit 1 OS=Mus musculus OX=10090 GN=Ints1 PE=1 SV=2 INT1_MOUSE reviewed Integrator complex subunit 1 (Int1) Mus musculus (Mouse) GO:0001832; GO:0001833; GO:0005634; GO:0007566; GO:0016180; GO:0031965; GO:0032039; GO:0034474; GO:0043066; GO:0160232; GO:0160240 blastocyst growth [GO:0001832]; embryo implantation [GO:0007566]; inner cell mass cell proliferation [GO:0001833]; negative regulation of apoptotic process [GO:0043066]; RNA polymerase II transcription initiation surveillance [GO:0160240]; snRNA processing [GO:0016180]; U2 snRNA 3'-end processing [GO:0034474] INTAC complex [GO:0160232]; integrator complex [GO:0032039]; nuclear membrane [GO:0031965]; nucleus [GO:0005634] g17560.t1 Q6P4S8 37.582 612 7.32e-105 352.0 sp|Q6P4S8|INT1_MOUSE Integrator complex subunit 1 OS=Mus musculus OX=10090 GN=Ints1 PE=1 SV=2 INT1_MOUSE reviewed Integrator complex subunit 1 (Int1) Mus musculus (Mouse) GO:0001832; GO:0001833; GO:0005634; GO:0007566; GO:0016180; GO:0031965; GO:0032039; GO:0034474; GO:0043066; GO:0160232; GO:0160240 blastocyst growth [GO:0001832]; embryo implantation [GO:0007566]; inner cell mass cell proliferation [GO:0001833]; negative regulation of apoptotic process [GO:0043066]; RNA polymerase II transcription initiation surveillance [GO:0160240]; snRNA processing [GO:0016180]; U2 snRNA 3'-end processing [GO:0034474] INTAC complex [GO:0160232]; integrator complex [GO:0032039]; nuclear membrane [GO:0031965]; nucleus [GO:0005634] g17564.t1 Q96CN5 42.33 704 3.4500000000000004e-166 496.0 sp|Q96CN5|LRC45_HUMAN Leucine-rich repeat-containing protein 45 OS=Homo sapiens OX=9606 GN=LRRC45 PE=1 SV=1 LRC45_HUMAN reviewed Leucine-rich repeat-containing protein 45 Homo sapiens (Human) GO:0005813; GO:0005829; GO:0005886; GO:0036064; GO:0097225; GO:0097228 centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; sperm midpiece [GO:0097225]; sperm principal piece [GO:0097228] g17565.t1 Q6PFK1 56.506 269 2.88e-98 332.0 sp|Q6PFK1|ZN598_DANRE E3 ubiquitin-protein ligase ZNF598 OS=Danio rerio OX=7955 GN=znf598 PE=1 SV=2 g17565.t1 Q6PFK1 36.082 194 1.2699999999999999e-23 111.0 sp|Q6PFK1|ZN598_DANRE E3 ubiquitin-protein ligase ZNF598 OS=Danio rerio OX=7955 GN=znf598 PE=1 SV=2 g17566.t1 Q6RUV5 89.637 193 2.12e-125 354.0 sp|Q6RUV5|RAC1_RAT Ras-related C3 botulinum toxin substrate 1 OS=Rattus norvegicus OX=10116 GN=Rac1 PE=1 SV=1 RAC1_RAT reviewed Ras-related C3 botulinum toxin substrate 1 (EC 3.6.5.2) (p21-Rac1) Rattus norvegicus (Rat) GO:0000139; GO:0000242; GO:0001764; GO:0001891; GO:0001934; GO:0002093; GO:0002551; GO:0003015; GO:0003376; GO:0003382; GO:0003924; GO:0003925; GO:0005525; GO:0005634; GO:0005737; GO:0005802; GO:0005829; GO:0005856; GO:0005884; GO:0005886; GO:0005938; GO:0006897; GO:0006911; GO:0006935; GO:0006972; GO:0007010; GO:0007015; GO:0007155; GO:0007163; GO:0007167; GO:0007186; GO:0007264; GO:0007411; GO:0008045; GO:0008360; GO:0010591; GO:0010592; GO:0010595; GO:0010762; GO:0010764; GO:0010811; GO:0014041; GO:0016020; GO:0016358; GO:0016477; GO:0016601; GO:0019805; GO:0019899; GO:0019901; GO:0021799; GO:0021831; GO:0021894; GO:0022604; GO:0030027; GO:0030031; GO:0030032; GO:0030036; GO:0030041; GO:0030334; GO:0030425; GO:0030672; GO:0030742; GO:0030838; GO:0030865; GO:0030900; GO:0031116; GO:0031267; GO:0031410; GO:0031901; GO:0031996; GO:0032496; GO:0032587; GO:0032707; GO:0032956; GO:0034446; GO:0035567; GO:0035774; GO:0036464; GO:0042470; GO:0042554; GO:0042734; GO:0042826; GO:0042995; GO:0043020; GO:0043131; GO:0043652; GO:0044877; GO:0045211; GO:0045216; GO:0045428; GO:0045453; GO:0045740; GO:0046425; GO:0048012; GO:0048168; GO:0048532; GO:0048812; GO:0048813; GO:0048870; GO:0048873; GO:0051022; GO:0051117; GO:0051491; GO:0051492; GO:0051496; GO:0051668; GO:0051894; GO:0051897; GO:0051932; GO:0055038; GO:0060071; GO:0060091; GO:0060263; GO:0060326; GO:0060999; GO:0061344; GO:0070376; GO:0071260; GO:0071526; GO:0071542; GO:0072659; GO:0086098; GO:0090023; GO:0090103; GO:0097178; GO:0098794; GO:0098974; GO:0098978; GO:0098982; GO:0150052; GO:1900026; GO:1900029; GO:1900242; GO:1902622; GO:1903348; GO:1904395; GO:1904936; GO:1904948; GO:2000386; GO:2001222 actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; actin filament polymerization [GO:0030041]; anatomical structure arrangement [GO:0048532]; angiotensin-activated signaling pathway involved in heart process [GO:0086098]; auditory receptor cell morphogenesis [GO:0002093]; axon guidance [GO:0007411]; bone resorption [GO:0045453]; cell adhesion [GO:0007155]; cell chemotaxis [GO:0060326]; cell migration [GO:0016477]; cell motility [GO:0048870]; cell projection assembly [GO:0030031]; cell-cell junction organization [GO:0045216]; cellular response to mechanical stimulus [GO:0071260]; cerebral cortex GABAergic interneuron development [GO:0021894]; cerebral cortex radially oriented cell migration [GO:0021799]; chemotaxis [GO:0006935]; cochlea morphogenesis [GO:0090103]; cortical cytoskeleton organization [GO:0030865]; cytoskeleton organization [GO:0007010]; dendrite development [GO:0016358]; dendrite morphogenesis [GO:0048813]; dopaminergic neuron differentiation [GO:0071542]; embryonic olfactory bulb interneuron precursor migration [GO:0021831]; endocytosis [GO:0006897]; engulfment of apoptotic cell [GO:0043652]; enzyme-linked receptor protein signaling pathway [GO:0007167]; epithelial cell morphogenesis [GO:0003382]; erythrocyte enucleation [GO:0043131]; establishment or maintenance of cell polarity [GO:0007163]; forebrain development [GO:0030900]; G protein-coupled receptor signaling pathway [GO:0007186]; heart process [GO:0003015]; hepatocyte growth factor receptor signaling pathway [GO:0048012]; homeostasis of number of cells within a tissue [GO:0048873]; hyperosmotic response [GO:0006972]; interneuron migration [GO:1904936]; lamellipodium assembly [GO:0030032]; localization within membrane [GO:0051668]; mast cell chemotaxis [GO:0002551]; midbrain dopaminergic neuron differentiation [GO:1904948]; motor neuron axon guidance [GO:0008045]; negative regulation of fibroblast migration [GO:0010764]; negative regulation of interleukin-23 production [GO:0032707]; neuron migration [GO:0001764]; neuron projection morphogenesis [GO:0048812]; non-canonical Wnt signaling pathway [GO:0035567]; phagocytosis, engulfment [GO:0006911]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of bicellular tight junction assembly [GO:1903348]; positive regulation of cell-substrate adhesion [GO:0010811]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of DNA replication [GO:0045740]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of microtubule polymerization [GO:0031116]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of ovarian follicle development [GO:2000386]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of ruffle assembly [GO:1900029]; positive regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904395]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; postsynaptic actin cytoskeleton organization [GO:0098974]; protein localization to plasma membrane [GO:0072659]; quinolinate biosynthetic process [GO:0019805]; Rac protein signal transduction [GO:0016601]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell adhesion involved in heart morphogenesis [GO:0061344]; regulation of cell migration [GO:0030334]; regulation of cell morphogenesis [GO:0022604]; regulation of cell shape [GO:0008360]; regulation of ERK5 cascade [GO:0070376]; regulation of fibroblast migration [GO:0010762]; regulation of lamellipodium assembly [GO:0010591]; regulation of neuron maturation [GO:0014041]; regulation of neuron migration [GO:2001222]; regulation of neuronal synaptic plasticity [GO:0048168]; regulation of neutrophil migration [GO:1902622]; regulation of nitric oxide biosynthetic process [GO:0045428]; regulation of postsynapse assembly [GO:0150052]; regulation of receptor signaling pathway via JAK-STAT [GO:0046425]; regulation of respiratory burst [GO:0060263]; regulation of stress fiber assembly [GO:0051492]; regulation of synaptic vesicle endocytosis [GO:1900242]; response to lipopolysaccharide [GO:0032496]; ruffle assembly [GO:0097178]; semaphorin-plexin signaling pathway [GO:0071526]; small GTPase-mediated signal transduction [GO:0007264]; sphingosine-1-phosphate receptor signaling pathway [GO:0003376]; substrate adhesion-dependent cell spreading [GO:0034446]; superoxide anion generation [GO:0042554]; synaptic transmission, GABAergic [GO:0051932]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071] actin filament [GO:0005884]; cell cortex [GO:0005938]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dendrite [GO:0030425]; early endosome membrane [GO:0031901]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; kinocilium [GO:0060091]; lamellipodium [GO:0030027]; melanosome [GO:0042470]; membrane [GO:0016020]; NADPH oxidase complex [GO:0043020]; nucleus [GO:0005634]; pericentriolar material [GO:0000242]; phagocytic cup [GO:0001891]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; recycling endosome membrane [GO:0055038]; ruffle membrane [GO:0032587]; synaptic vesicle membrane [GO:0030672]; trans-Golgi network [GO:0005802] ATPase binding [GO:0051117]; enzyme binding [GO:0019899]; G protein activity [GO:0003925]; GTP binding [GO:0005525]; GTP-dependent protein binding [GO:0030742]; GTPase activity [GO:0003924]; histone deacetylase binding [GO:0042826]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; Rho GDP-dissociation inhibitor binding [GO:0051022]; small GTPase binding [GO:0031267]; thioesterase binding [GO:0031996] g17567.t1 Q6RUV5 85.876 177 1.3e-114 327.0 sp|Q6RUV5|RAC1_RAT Ras-related C3 botulinum toxin substrate 1 OS=Rattus norvegicus OX=10116 GN=Rac1 PE=1 SV=1 RAC1_RAT reviewed Ras-related C3 botulinum toxin substrate 1 (EC 3.6.5.2) (p21-Rac1) Rattus norvegicus (Rat) GO:0000139; GO:0000242; GO:0001764; GO:0001891; GO:0001934; GO:0002093; GO:0002551; GO:0003015; GO:0003376; GO:0003382; GO:0003924; GO:0003925; GO:0005525; GO:0005634; GO:0005737; GO:0005802; GO:0005829; GO:0005856; GO:0005884; GO:0005886; GO:0005938; GO:0006897; GO:0006911; GO:0006935; GO:0006972; GO:0007010; GO:0007015; GO:0007155; GO:0007163; GO:0007167; GO:0007186; GO:0007264; GO:0007411; GO:0008045; GO:0008360; GO:0010591; GO:0010592; GO:0010595; GO:0010762; GO:0010764; GO:0010811; GO:0014041; GO:0016020; GO:0016358; GO:0016477; GO:0016601; GO:0019805; GO:0019899; GO:0019901; GO:0021799; GO:0021831; GO:0021894; GO:0022604; GO:0030027; GO:0030031; GO:0030032; GO:0030036; GO:0030041; GO:0030334; GO:0030425; GO:0030672; GO:0030742; GO:0030838; GO:0030865; GO:0030900; GO:0031116; GO:0031267; GO:0031410; GO:0031901; GO:0031996; GO:0032496; GO:0032587; GO:0032707; GO:0032956; GO:0034446; GO:0035567; GO:0035774; GO:0036464; GO:0042470; GO:0042554; GO:0042734; GO:0042826; GO:0042995; GO:0043020; GO:0043131; GO:0043652; GO:0044877; GO:0045211; GO:0045216; GO:0045428; GO:0045453; GO:0045740; GO:0046425; GO:0048012; GO:0048168; GO:0048532; GO:0048812; GO:0048813; GO:0048870; GO:0048873; GO:0051022; GO:0051117; GO:0051491; GO:0051492; GO:0051496; GO:0051668; GO:0051894; GO:0051897; GO:0051932; GO:0055038; GO:0060071; GO:0060091; GO:0060263; GO:0060326; GO:0060999; GO:0061344; GO:0070376; GO:0071260; GO:0071526; GO:0071542; GO:0072659; GO:0086098; GO:0090023; GO:0090103; GO:0097178; GO:0098794; GO:0098974; GO:0098978; GO:0098982; GO:0150052; GO:1900026; GO:1900029; GO:1900242; GO:1902622; GO:1903348; GO:1904395; GO:1904936; GO:1904948; GO:2000386; GO:2001222 actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; actin filament polymerization [GO:0030041]; anatomical structure arrangement [GO:0048532]; angiotensin-activated signaling pathway involved in heart process [GO:0086098]; auditory receptor cell morphogenesis [GO:0002093]; axon guidance [GO:0007411]; bone resorption [GO:0045453]; cell adhesion [GO:0007155]; cell chemotaxis [GO:0060326]; cell migration [GO:0016477]; cell motility [GO:0048870]; cell projection assembly [GO:0030031]; cell-cell junction organization [GO:0045216]; cellular response to mechanical stimulus [GO:0071260]; cerebral cortex GABAergic interneuron development [GO:0021894]; cerebral cortex radially oriented cell migration [GO:0021799]; chemotaxis [GO:0006935]; cochlea morphogenesis [GO:0090103]; cortical cytoskeleton organization [GO:0030865]; cytoskeleton organization [GO:0007010]; dendrite development [GO:0016358]; dendrite morphogenesis [GO:0048813]; dopaminergic neuron differentiation [GO:0071542]; embryonic olfactory bulb interneuron precursor migration [GO:0021831]; endocytosis [GO:0006897]; engulfment of apoptotic cell [GO:0043652]; enzyme-linked receptor protein signaling pathway [GO:0007167]; epithelial cell morphogenesis [GO:0003382]; erythrocyte enucleation [GO:0043131]; establishment or maintenance of cell polarity [GO:0007163]; forebrain development [GO:0030900]; G protein-coupled receptor signaling pathway [GO:0007186]; heart process [GO:0003015]; hepatocyte growth factor receptor signaling pathway [GO:0048012]; homeostasis of number of cells within a tissue [GO:0048873]; hyperosmotic response [GO:0006972]; interneuron migration [GO:1904936]; lamellipodium assembly [GO:0030032]; localization within membrane [GO:0051668]; mast cell chemotaxis [GO:0002551]; midbrain dopaminergic neuron differentiation [GO:1904948]; motor neuron axon guidance [GO:0008045]; negative regulation of fibroblast migration [GO:0010764]; negative regulation of interleukin-23 production [GO:0032707]; neuron migration [GO:0001764]; neuron projection morphogenesis [GO:0048812]; non-canonical Wnt signaling pathway [GO:0035567]; phagocytosis, engulfment [GO:0006911]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of bicellular tight junction assembly [GO:1903348]; positive regulation of cell-substrate adhesion [GO:0010811]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of DNA replication [GO:0045740]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of microtubule polymerization [GO:0031116]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of ovarian follicle development [GO:2000386]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of ruffle assembly [GO:1900029]; positive regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904395]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; postsynaptic actin cytoskeleton organization [GO:0098974]; protein localization to plasma membrane [GO:0072659]; quinolinate biosynthetic process [GO:0019805]; Rac protein signal transduction [GO:0016601]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell adhesion involved in heart morphogenesis [GO:0061344]; regulation of cell migration [GO:0030334]; regulation of cell morphogenesis [GO:0022604]; regulation of cell shape [GO:0008360]; regulation of ERK5 cascade [GO:0070376]; regulation of fibroblast migration [GO:0010762]; regulation of lamellipodium assembly [GO:0010591]; regulation of neuron maturation [GO:0014041]; regulation of neuron migration [GO:2001222]; regulation of neuronal synaptic plasticity [GO:0048168]; regulation of neutrophil migration [GO:1902622]; regulation of nitric oxide biosynthetic process [GO:0045428]; regulation of postsynapse assembly [GO:0150052]; regulation of receptor signaling pathway via JAK-STAT [GO:0046425]; regulation of respiratory burst [GO:0060263]; regulation of stress fiber assembly [GO:0051492]; regulation of synaptic vesicle endocytosis [GO:1900242]; response to lipopolysaccharide [GO:0032496]; ruffle assembly [GO:0097178]; semaphorin-plexin signaling pathway [GO:0071526]; small GTPase-mediated signal transduction [GO:0007264]; sphingosine-1-phosphate receptor signaling pathway [GO:0003376]; substrate adhesion-dependent cell spreading [GO:0034446]; superoxide anion generation [GO:0042554]; synaptic transmission, GABAergic [GO:0051932]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071] actin filament [GO:0005884]; cell cortex [GO:0005938]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dendrite [GO:0030425]; early endosome membrane [GO:0031901]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; kinocilium [GO:0060091]; lamellipodium [GO:0030027]; melanosome [GO:0042470]; membrane [GO:0016020]; NADPH oxidase complex [GO:0043020]; nucleus [GO:0005634]; pericentriolar material [GO:0000242]; phagocytic cup [GO:0001891]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; recycling endosome membrane [GO:0055038]; ruffle membrane [GO:0032587]; synaptic vesicle membrane [GO:0030672]; trans-Golgi network [GO:0005802] ATPase binding [GO:0051117]; enzyme binding [GO:0019899]; G protein activity [GO:0003925]; GTP binding [GO:0005525]; GTP-dependent protein binding [GO:0030742]; GTPase activity [GO:0003924]; histone deacetylase binding [GO:0042826]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; Rho GDP-dissociation inhibitor binding [GO:0051022]; small GTPase binding [GO:0031267]; thioesterase binding [GO:0031996] g17568.t1 P29314 90.588 170 5.94e-100 290.0 sp|P29314|RS9_RAT Small ribosomal subunit protein uS4 OS=Rattus norvegicus OX=10116 GN=Rps9 PE=1 SV=4 g17569.t1 Q3TYD6 35.268 448 2.66e-74 264.0 sp|Q3TYD6|LMTK2_MOUSE Serine/threonine-protein kinase LMTK2 OS=Mus musculus OX=10090 GN=Lmtk2 PE=1 SV=3 LMTK2_MOUSE reviewed Serine/threonine-protein kinase LMTK2 (EC 2.7.11.1) (Brain-enriched kinase) (Lemur tyrosine kinase 2) Mus musculus (Mouse) GO:0001881; GO:0004672; GO:0004674; GO:0004864; GO:0005524; GO:0005737; GO:0005769; GO:0005794; GO:0007399; GO:0007411; GO:0016020; GO:0030426; GO:0032456; GO:0033572; GO:0043025; GO:0045022; GO:0048011; GO:0048471; GO:0055037; GO:0070853; GO:0106310 axon guidance [GO:0007411]; early endosome to late endosome transport [GO:0045022]; endocytic recycling [GO:0032456]; nervous system development [GO:0007399]; neurotrophin TRK receptor signaling pathway [GO:0048011]; receptor recycling [GO:0001881]; transferrin transport [GO:0033572] cytoplasm [GO:0005737]; early endosome [GO:0005769]; Golgi apparatus [GO:0005794]; growth cone [GO:0030426]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; recycling endosome [GO:0055037] ATP binding [GO:0005524]; myosin VI binding [GO:0070853]; protein kinase activity [GO:0004672]; protein phosphatase inhibitor activity [GO:0004864]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g17571.t1 Q6DKP5 53.395 324 3.2500000000000004e-124 366.0 sp|Q6DKP5|WDR13_PANTR WD repeat-containing protein 13 OS=Pan troglodytes OX=9598 GN=WDR13 PE=3 SV=1 g17572.t1 Q6DKP5 54.839 155 2.54e-38 138.0 sp|Q6DKP5|WDR13_PANTR WD repeat-containing protein 13 OS=Pan troglodytes OX=9598 GN=WDR13 PE=3 SV=1 g17573.t1 Q15438 71.465 396 0.0 584.0 sp|Q15438|CYH1_HUMAN Cytohesin-1 OS=Homo sapiens OX=9606 GN=CYTH1 PE=1 SV=1 CYH1_HUMAN reviewed Cytohesin-1 (PH, SEC7 and coiled-coil domain-containing protein 1) (SEC7 homolog B2-1) Homo sapiens (Human) GO:0000139; GO:0005085; GO:0005737; GO:0005829; GO:0005886; GO:0005912; GO:0005923; GO:0008289; GO:0009898; GO:0016192; GO:0030155; GO:0032012; GO:0090162 establishment of epithelial cell polarity [GO:0090162]; regulation of ARF protein signal transduction [GO:0032012]; regulation of cell adhesion [GO:0030155]; vesicle-mediated transport [GO:0016192] adherens junction [GO:0005912]; bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886] guanyl-nucleotide exchange factor activity [GO:0005085]; lipid binding [GO:0008289] g17574.t1 P97478 68.047 169 1.68e-63 198.0 sp|P97478|COQ7_MOUSE NADPH-dependent 3-demethoxyubiquinone 3-hydroxylase, mitochondrial OS=Mus musculus OX=10090 GN=Coq7 PE=1 SV=3 COQ7_MOUSE reviewed NADPH-dependent 3-demethoxyubiquinone 3-hydroxylase, mitochondrial (EC 1.14.13.253) (3-demethoxyubiquinone 3-hydroxylase (NADH)) (Timing protein clk-1 homolog) (Ubiquinone biosynthesis monooxygenase COQ7) Mus musculus (Mouse) GO:0000122; GO:0001701; GO:0001841; GO:0003682; GO:0005634; GO:0005739; GO:0005743; GO:0006744; GO:0006979; GO:0007005; GO:0008340; GO:0010468; GO:0016709; GO:0022008; GO:0022904; GO:0031314; GO:0034599; GO:0042775; GO:0045944; GO:0046872; GO:0110142; GO:0160224; GO:2000377 cellular response to oxidative stress [GO:0034599]; determination of adult lifespan [GO:0008340]; in utero embryonic development [GO:0001701]; mitochondrial ATP synthesis coupled electron transport [GO:0042775]; mitochondrion organization [GO:0007005]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural tube formation [GO:0001841]; neurogenesis [GO:0022008]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; regulation of reactive oxygen species metabolic process [GO:2000377]; respiratory electron transport chain [GO:0022904]; response to oxidative stress [GO:0006979]; ubiquinone biosynthetic process [GO:0006744] extrinsic component of mitochondrial inner membrane [GO:0031314]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; ubiquinone biosynthesis complex [GO:0110142] 3-demethoxyubiquinone 3-hydroxylase (NADH) activity [GO:0160224]; chromatin binding [GO:0003682]; metal ion binding [GO:0046872]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen [GO:0016709] g17588.t1 Q5M8C6 34.967 306 6.47e-44 156.0 sp|Q5M8C6|FGL1_RAT Fibrinogen-like protein 1 OS=Rattus norvegicus OX=10116 GN=Fgl1 PE=2 SV=1 FGL1_RAT reviewed Fibrinogen-like protein 1 Rattus norvegicus (Rat) GO:0002250; GO:0005576; GO:0005615; GO:0007596; GO:0008203; GO:0010906; GO:0035634; GO:0042802; GO:0048018; GO:0050776; GO:0050868; GO:0060612; GO:0072574 adaptive immune response [GO:0002250]; adipose tissue development [GO:0060612]; blood coagulation [GO:0007596]; cholesterol metabolic process [GO:0008203]; hepatocyte proliferation [GO:0072574]; negative regulation of T cell activation [GO:0050868]; regulation of glucose metabolic process [GO:0010906]; regulation of immune response [GO:0050776]; response to stilbenoid [GO:0035634] extracellular region [GO:0005576]; extracellular space [GO:0005615] identical protein binding [GO:0042802]; receptor ligand activity [GO:0048018] g17590.t1 A7MBI7 45.045 222 6.87e-63 200.0 sp|A7MBI7|COMT_BOVIN Catechol O-methyltransferase OS=Bos taurus OX=9913 GN=COMT PE=2 SV=1 COMT_BOVIN reviewed Catechol O-methyltransferase (EC 2.1.1.6) Bos taurus (Bovine) GO:0000287; GO:0005829; GO:0005886; GO:0006629; GO:0016020; GO:0016206; GO:0030424; GO:0030425; GO:0032259; GO:0032502; GO:0042417; GO:0042424 catecholamine catabolic process [GO:0042424]; developmental process [GO:0032502]; dopamine metabolic process [GO:0042417]; lipid metabolic process [GO:0006629]; methylation [GO:0032259] axon [GO:0030424]; cytosol [GO:0005829]; dendrite [GO:0030425]; membrane [GO:0016020]; plasma membrane [GO:0005886] catechol O-methyltransferase activity [GO:0016206]; magnesium ion binding [GO:0000287] g17592.t1 A7MBI7 46.667 210 2.32e-63 201.0 sp|A7MBI7|COMT_BOVIN Catechol O-methyltransferase OS=Bos taurus OX=9913 GN=COMT PE=2 SV=1 COMT_BOVIN reviewed Catechol O-methyltransferase (EC 2.1.1.6) Bos taurus (Bovine) GO:0000287; GO:0005829; GO:0005886; GO:0006629; GO:0016020; GO:0016206; GO:0030424; GO:0030425; GO:0032259; GO:0032502; GO:0042417; GO:0042424 catecholamine catabolic process [GO:0042424]; developmental process [GO:0032502]; dopamine metabolic process [GO:0042417]; lipid metabolic process [GO:0006629]; methylation [GO:0032259] axon [GO:0030424]; cytosol [GO:0005829]; dendrite [GO:0030425]; membrane [GO:0016020]; plasma membrane [GO:0005886] catechol O-methyltransferase activity [GO:0016206]; magnesium ion binding [GO:0000287] g17593.t1 P22734 45.07 213 6.46e-60 193.0 sp|P22734|COMT_RAT Catechol O-methyltransferase OS=Rattus norvegicus OX=10116 GN=Comt PE=1 SV=2 COMT_RAT reviewed Catechol O-methyltransferase (EC 2.1.1.6) Rattus norvegicus (Rat) GO:0000287; GO:0001662; GO:0001666; GO:0001822; GO:0001963; GO:0001964; GO:0001975; GO:0002001; GO:0005615; GO:0005829; GO:0005977; GO:0006584; GO:0006693; GO:0006950; GO:0006979; GO:0007565; GO:0007611; GO:0007612; GO:0007613; GO:0007614; GO:0008210; GO:0008217; GO:0008542; GO:0009266; GO:0009410; GO:0009611; GO:0009636; GO:0009712; GO:0010467; GO:0014046; GO:0016020; GO:0016036; GO:0016206; GO:0021696; GO:0030424; GO:0030425; GO:0031982; GO:0032094; GO:0032259; GO:0032496; GO:0032502; GO:0032835; GO:0033344; GO:0033555; GO:0034097; GO:0035264; GO:0035640; GO:0035812; GO:0042415; GO:0042417; GO:0042420; GO:0042424; GO:0042596; GO:0043197; GO:0043627; GO:0044297; GO:0045211; GO:0045963; GO:0046498; GO:0046500; GO:0046959; GO:0048243; GO:0048265; GO:0048662; GO:0050668; GO:0050890; GO:0050965; GO:0051412; GO:0060840; GO:0071314; GO:0071626; GO:0097018; GO:0097205; GO:0097333; GO:0097336; GO:0097386; GO:0098794; GO:0098978; GO:1902074; GO:1903350; GO:1903489; GO:1990776 artery development [GO:0060840]; behavioral fear response [GO:0001662]; catechol-containing compound metabolic process [GO:0009712]; catecholamine catabolic process [GO:0042424]; catecholamine metabolic process [GO:0006584]; cellular response to cocaine [GO:0071314]; cellular response to phosphate starvation [GO:0016036]; cerebellar cortex morphogenesis [GO:0021696]; cholesterol efflux [GO:0033344]; cognition [GO:0050890]; detection of temperature stimulus involved in sensory perception of pain [GO:0050965]; developmental process [GO:0032502]; dopamine catabolic process [GO:0042420]; dopamine metabolic process [GO:0042417]; dopamine secretion [GO:0014046]; estrogen metabolic process [GO:0008210]; exploration behavior [GO:0035640]; fear response [GO:0042596]; female pregnancy [GO:0007565]; gene expression [GO:0010467]; glomerulus development [GO:0032835]; glycogen metabolic process [GO:0005977]; habituation [GO:0046959]; kidney development [GO:0001822]; learning [GO:0007612]; learning or memory [GO:0007611]; mastication [GO:0071626]; memory [GO:0007613]; methylation [GO:0032259]; multicellular organism growth [GO:0035264]; multicellular organismal response to stress [GO:0033555]; negative regulation of dopamine metabolic process [GO:0045963]; negative regulation of smooth muscle cell proliferation [GO:0048662]; norepinephrine metabolic process [GO:0042415]; norepinephrine secretion [GO:0048243]; positive regulation of homocysteine metabolic process [GO:0050668]; positive regulation of lactation [GO:1903489]; prostaglandin metabolic process [GO:0006693]; regulation of blood pressure [GO:0008217]; renal albumin absorption [GO:0097018]; renal filtration [GO:0097205]; renal sodium excretion [GO:0035812]; renin secretion into blood stream [GO:0002001]; response to amphetamine [GO:0001975]; response to angiotensin [GO:1990776]; response to corticosterone [GO:0051412]; response to cytokine [GO:0034097]; response to dopamine [GO:1903350]; response to estrogen [GO:0043627]; response to food [GO:0032094]; response to hypoxia [GO:0001666]; response to lipopolysaccharide [GO:0032496]; response to olanzapine [GO:0097333]; response to oxidative stress [GO:0006979]; response to pain [GO:0048265]; response to risperidone [GO:0097336]; response to salt [GO:1902074]; response to stress [GO:0006950]; response to temperature stimulus [GO:0009266]; response to toxic substance [GO:0009636]; response to wounding [GO:0009611]; response to xenobiotic stimulus [GO:0009410]; S-adenosylhomocysteine metabolic process [GO:0046498]; S-adenosylmethionine metabolic process [GO:0046500]; short-term memory [GO:0007614]; startle response [GO:0001964]; synaptic transmission, dopaminergic [GO:0001963]; visual learning [GO:0008542] axon [GO:0030424]; cell body [GO:0044297]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; extracellular space [GO:0005615]; glial cell projection [GO:0097386]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; postsynapse [GO:0098794]; postsynaptic membrane [GO:0045211]; vesicle [GO:0031982] catechol O-methyltransferase activity [GO:0016206]; magnesium ion binding [GO:0000287] g17594.t1 Q7Z020 26.624 1093 4.749999999999999e-95 333.0 sp|Q7Z020|TRPA1_DROME Transient receptor potential cation channel subfamily A member 1 OS=Drosophila melanogaster OX=7227 GN=TrpA1 PE=1 SV=4 g17596.t1 B1AQJ2 48.156 461 2.45e-136 451.0 sp|B1AQJ2|UBP36_MOUSE Ubiquitin carboxyl-terminal hydrolase 36 OS=Mus musculus OX=10090 GN=Usp36 PE=1 SV=1 UBP36_MOUSE reviewed Ubiquitin carboxyl-terminal hydrolase 36 (EC 2.3.2.-) (EC 3.4.19.12) (Deubiquitinating enzyme 36) (Ubiquitin thioesterase 36) (Ubiquitin-specific-processing protease 36) Mus musculus (Mouse) GO:0003723; GO:0004843; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0006325; GO:0006508; GO:0007000; GO:0016242; GO:0016579; GO:0016607; GO:0016740; GO:0031647; GO:0042981; GO:0050821; GO:0140936; GO:1990380; GO:2000232 chromatin organization [GO:0006325]; negative regulation of macroautophagy [GO:0016242]; nucleolus organization [GO:0007000]; protein deubiquitination [GO:0016579]; protein stabilization [GO:0050821]; proteolysis [GO:0006508]; regulation of apoptotic process [GO:0042981]; regulation of protein stability [GO:0031647]; regulation of rRNA processing [GO:2000232] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cysteine-type deubiquitinase activity [GO:0004843]; histone H2B deubiquitinase activity [GO:0140936]; K48-linked deubiquitinase activity [GO:1990380]; RNA binding [GO:0003723]; transferase activity [GO:0016740] g17597.t1 Q0P595 61.656 326 9.769999999999999e-146 426.0 sp|Q0P595|SIR7_BOVIN NAD-dependent protein deacetylase sirtuin-7 OS=Bos taurus OX=9913 GN=SIRT7 PE=2 SV=1 SIR7_BOVIN reviewed NAD-dependent protein deacetylase sirtuin-7 (EC 2.3.1.286) (NAD-dependent protein deacylase sirtuin-7) (EC 2.3.1.-) (Regulatory protein SIR2 homolog 7) (SIR2-like protein 7) Bos taurus (Bovine) GO:0000122; GO:0000785; GO:0001649; GO:0003682; GO:0005634; GO:0005654; GO:0005730; GO:0005731; GO:0005737; GO:0006281; GO:0006357; GO:0006476; GO:0007129; GO:0009303; GO:0010526; GO:0010821; GO:0031397; GO:0034979; GO:0035861; GO:0036055; GO:0040029; GO:0045722; GO:0045943; GO:0046825; GO:0046872; GO:0061697; GO:0061698; GO:0062176; GO:0070403; GO:0097372; GO:0106230; GO:0106231; GO:0140861; GO:1901836; GO:2000234 DNA repair [GO:0006281]; DNA repair-dependent chromatin remodeling [GO:0140861]; epigenetic regulation of gene expression [GO:0040029]; homologous chromosome pairing at meiosis [GO:0007129]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of transcription by RNA polymerase II [GO:0000122]; osteoblast differentiation [GO:0001649]; positive regulation of gluconeogenesis [GO:0045722]; positive regulation of rRNA processing [GO:2000234]; positive regulation of transcription by RNA polymerase I [GO:0045943]; protein deacetylation [GO:0006476]; protein deglutarylation [GO:0061698]; protein depropionylation [GO:0106230]; R-loop processing [GO:0062176]; regulation of mitochondrion organization [GO:0010821]; regulation of protein export from nucleus [GO:0046825]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription of nucleolar large rRNA by RNA polymerase I [GO:1901836]; rRNA transcription [GO:0009303]; transposable element silencing [GO:0010526] chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleolus organizer region [GO:0005731]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of double-strand break [GO:0035861] chromatin binding [GO:0003682]; histone H3K18 deacetylase activity, NAD-dependent [GO:0097372]; metal ion binding [GO:0046872]; NAD+ binding [GO:0070403]; NAD-dependent protein lysine deacetylase activity [GO:0034979]; NAD-dependent protein-lysine depropionylase activity [GO:0106231]; protein-glutaryllysine deglutarylase activity [GO:0061697]; protein-succinyllysine desuccinylase activity [GO:0036055] g17598.t1 Q80YT5 47.405 578 0.0 543.0 sp|Q80YT5|SPT20_MOUSE Spermatogenesis-associated protein 20 OS=Mus musculus OX=10090 GN=Spata20 PE=1 SV=1 g17602.t1 Q8TB22 58.503 147 9e-41 152.0 sp|Q8TB22|SPT20_HUMAN Spermatogenesis-associated protein 20 OS=Homo sapiens OX=9606 GN=SPATA20 PE=1 SV=3 g17605.t1 O95180 61.957 644 3.95e-176 597.0 sp|O95180|CAC1H_HUMAN Voltage-dependent T-type calcium channel subunit alpha-1H OS=Homo sapiens OX=9606 GN=CACNA1H PE=1 SV=4 CAC1H_HUMAN reviewed Voltage-dependent T-type calcium channel subunit alpha-1H (Low-voltage-activated calcium channel alpha1 3.2 subunit) (Voltage-gated calcium channel subunit alpha Cav3.2) Homo sapiens (Human) GO:0005244; GO:0005245; GO:0005886; GO:0005891; GO:0006936; GO:0007517; GO:0007520; GO:0008016; GO:0008331; GO:0008332; GO:0016020; GO:0032342; GO:0032870; GO:0034651; GO:0035865; GO:0042391; GO:0046872; GO:0070509; GO:0097110; GO:0098662; GO:0098703; GO:2000344 aldosterone biosynthetic process [GO:0032342]; calcium ion import [GO:0070509]; calcium ion import across plasma membrane [GO:0098703]; cellular response to hormone stimulus [GO:0032870]; cellular response to potassium ion [GO:0035865]; cortisol biosynthetic process [GO:0034651]; inorganic cation transmembrane transport [GO:0098662]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; myoblast fusion [GO:0007520]; positive regulation of acrosome reaction [GO:2000344]; regulation of heart contraction [GO:0008016]; regulation of membrane potential [GO:0042391] membrane [GO:0016020]; plasma membrane [GO:0005886]; voltage-gated calcium channel complex [GO:0005891] high voltage-gated calcium channel activity [GO:0008331]; low voltage-gated calcium channel activity [GO:0008332]; metal ion binding [GO:0046872]; scaffold protein binding [GO:0097110]; voltage-gated calcium channel activity [GO:0005245]; voltage-gated monoatomic ion channel activity [GO:0005244] g17605.t1 O95180 73.361 244 6.48e-84 311.0 sp|O95180|CAC1H_HUMAN Voltage-dependent T-type calcium channel subunit alpha-1H OS=Homo sapiens OX=9606 GN=CACNA1H PE=1 SV=4 CAC1H_HUMAN reviewed Voltage-dependent T-type calcium channel subunit alpha-1H (Low-voltage-activated calcium channel alpha1 3.2 subunit) (Voltage-gated calcium channel subunit alpha Cav3.2) Homo sapiens (Human) GO:0005244; GO:0005245; GO:0005886; GO:0005891; GO:0006936; GO:0007517; GO:0007520; GO:0008016; GO:0008331; GO:0008332; GO:0016020; GO:0032342; GO:0032870; GO:0034651; GO:0035865; GO:0042391; GO:0046872; GO:0070509; GO:0097110; GO:0098662; GO:0098703; GO:2000344 aldosterone biosynthetic process [GO:0032342]; calcium ion import [GO:0070509]; calcium ion import across plasma membrane [GO:0098703]; cellular response to hormone stimulus [GO:0032870]; cellular response to potassium ion [GO:0035865]; cortisol biosynthetic process [GO:0034651]; inorganic cation transmembrane transport [GO:0098662]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; myoblast fusion [GO:0007520]; positive regulation of acrosome reaction [GO:2000344]; regulation of heart contraction [GO:0008016]; regulation of membrane potential [GO:0042391] membrane [GO:0016020]; plasma membrane [GO:0005886]; voltage-gated calcium channel complex [GO:0005891] high voltage-gated calcium channel activity [GO:0008331]; low voltage-gated calcium channel activity [GO:0008332]; metal ion binding [GO:0046872]; scaffold protein binding [GO:0097110]; voltage-gated calcium channel activity [GO:0005245]; voltage-gated monoatomic ion channel activity [GO:0005244] g17605.t1 O95180 53.056 360 7.6e-75 282.0 sp|O95180|CAC1H_HUMAN Voltage-dependent T-type calcium channel subunit alpha-1H OS=Homo sapiens OX=9606 GN=CACNA1H PE=1 SV=4 CAC1H_HUMAN reviewed Voltage-dependent T-type calcium channel subunit alpha-1H (Low-voltage-activated calcium channel alpha1 3.2 subunit) (Voltage-gated calcium channel subunit alpha Cav3.2) Homo sapiens (Human) GO:0005244; GO:0005245; GO:0005886; GO:0005891; GO:0006936; GO:0007517; GO:0007520; GO:0008016; GO:0008331; GO:0008332; GO:0016020; GO:0032342; GO:0032870; GO:0034651; GO:0035865; GO:0042391; GO:0046872; GO:0070509; GO:0097110; GO:0098662; GO:0098703; GO:2000344 aldosterone biosynthetic process [GO:0032342]; calcium ion import [GO:0070509]; calcium ion import across plasma membrane [GO:0098703]; cellular response to hormone stimulus [GO:0032870]; cellular response to potassium ion [GO:0035865]; cortisol biosynthetic process [GO:0034651]; inorganic cation transmembrane transport [GO:0098662]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; myoblast fusion [GO:0007520]; positive regulation of acrosome reaction [GO:2000344]; regulation of heart contraction [GO:0008016]; regulation of membrane potential [GO:0042391] membrane [GO:0016020]; plasma membrane [GO:0005886]; voltage-gated calcium channel complex [GO:0005891] high voltage-gated calcium channel activity [GO:0008331]; low voltage-gated calcium channel activity [GO:0008332]; metal ion binding [GO:0046872]; scaffold protein binding [GO:0097110]; voltage-gated calcium channel activity [GO:0005245]; voltage-gated monoatomic ion channel activity [GO:0005244] g17605.t2 O95180 61.957 644 2.7199999999999997e-176 597.0 sp|O95180|CAC1H_HUMAN Voltage-dependent T-type calcium channel subunit alpha-1H OS=Homo sapiens OX=9606 GN=CACNA1H PE=1 SV=4 CAC1H_HUMAN reviewed Voltage-dependent T-type calcium channel subunit alpha-1H (Low-voltage-activated calcium channel alpha1 3.2 subunit) (Voltage-gated calcium channel subunit alpha Cav3.2) Homo sapiens (Human) GO:0005244; GO:0005245; GO:0005886; GO:0005891; GO:0006936; GO:0007517; GO:0007520; GO:0008016; GO:0008331; GO:0008332; GO:0016020; GO:0032342; GO:0032870; GO:0034651; GO:0035865; GO:0042391; GO:0046872; GO:0070509; GO:0097110; GO:0098662; GO:0098703; GO:2000344 aldosterone biosynthetic process [GO:0032342]; calcium ion import [GO:0070509]; calcium ion import across plasma membrane [GO:0098703]; cellular response to hormone stimulus [GO:0032870]; cellular response to potassium ion [GO:0035865]; cortisol biosynthetic process [GO:0034651]; inorganic cation transmembrane transport [GO:0098662]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; myoblast fusion [GO:0007520]; positive regulation of acrosome reaction [GO:2000344]; regulation of heart contraction [GO:0008016]; regulation of membrane potential [GO:0042391] membrane [GO:0016020]; plasma membrane [GO:0005886]; voltage-gated calcium channel complex [GO:0005891] high voltage-gated calcium channel activity [GO:0008331]; low voltage-gated calcium channel activity [GO:0008332]; metal ion binding [GO:0046872]; scaffold protein binding [GO:0097110]; voltage-gated calcium channel activity [GO:0005245]; voltage-gated monoatomic ion channel activity [GO:0005244] g17605.t2 O95180 73.361 244 5.43e-84 311.0 sp|O95180|CAC1H_HUMAN Voltage-dependent T-type calcium channel subunit alpha-1H OS=Homo sapiens OX=9606 GN=CACNA1H PE=1 SV=4 CAC1H_HUMAN reviewed Voltage-dependent T-type calcium channel subunit alpha-1H (Low-voltage-activated calcium channel alpha1 3.2 subunit) (Voltage-gated calcium channel subunit alpha Cav3.2) Homo sapiens (Human) GO:0005244; GO:0005245; GO:0005886; GO:0005891; GO:0006936; GO:0007517; GO:0007520; GO:0008016; GO:0008331; GO:0008332; GO:0016020; GO:0032342; GO:0032870; GO:0034651; GO:0035865; GO:0042391; GO:0046872; GO:0070509; GO:0097110; GO:0098662; GO:0098703; GO:2000344 aldosterone biosynthetic process [GO:0032342]; calcium ion import [GO:0070509]; calcium ion import across plasma membrane [GO:0098703]; cellular response to hormone stimulus [GO:0032870]; cellular response to potassium ion [GO:0035865]; cortisol biosynthetic process [GO:0034651]; inorganic cation transmembrane transport [GO:0098662]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; myoblast fusion [GO:0007520]; positive regulation of acrosome reaction [GO:2000344]; regulation of heart contraction [GO:0008016]; regulation of membrane potential [GO:0042391] membrane [GO:0016020]; plasma membrane [GO:0005886]; voltage-gated calcium channel complex [GO:0005891] high voltage-gated calcium channel activity [GO:0008331]; low voltage-gated calcium channel activity [GO:0008332]; metal ion binding [GO:0046872]; scaffold protein binding [GO:0097110]; voltage-gated calcium channel activity [GO:0005245]; voltage-gated monoatomic ion channel activity [GO:0005244] g17605.t2 O95180 53.056 360 5.14e-75 282.0 sp|O95180|CAC1H_HUMAN Voltage-dependent T-type calcium channel subunit alpha-1H OS=Homo sapiens OX=9606 GN=CACNA1H PE=1 SV=4 CAC1H_HUMAN reviewed Voltage-dependent T-type calcium channel subunit alpha-1H (Low-voltage-activated calcium channel alpha1 3.2 subunit) (Voltage-gated calcium channel subunit alpha Cav3.2) Homo sapiens (Human) GO:0005244; GO:0005245; GO:0005886; GO:0005891; GO:0006936; GO:0007517; GO:0007520; GO:0008016; GO:0008331; GO:0008332; GO:0016020; GO:0032342; GO:0032870; GO:0034651; GO:0035865; GO:0042391; GO:0046872; GO:0070509; GO:0097110; GO:0098662; GO:0098703; GO:2000344 aldosterone biosynthetic process [GO:0032342]; calcium ion import [GO:0070509]; calcium ion import across plasma membrane [GO:0098703]; cellular response to hormone stimulus [GO:0032870]; cellular response to potassium ion [GO:0035865]; cortisol biosynthetic process [GO:0034651]; inorganic cation transmembrane transport [GO:0098662]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; myoblast fusion [GO:0007520]; positive regulation of acrosome reaction [GO:2000344]; regulation of heart contraction [GO:0008016]; regulation of membrane potential [GO:0042391] membrane [GO:0016020]; plasma membrane [GO:0005886]; voltage-gated calcium channel complex [GO:0005891] high voltage-gated calcium channel activity [GO:0008331]; low voltage-gated calcium channel activity [GO:0008332]; metal ion binding [GO:0046872]; scaffold protein binding [GO:0097110]; voltage-gated calcium channel activity [GO:0005245]; voltage-gated monoatomic ion channel activity [GO:0005244] g17605.t3 O95180 61.957 644 2.6e-176 598.0 sp|O95180|CAC1H_HUMAN Voltage-dependent T-type calcium channel subunit alpha-1H OS=Homo sapiens OX=9606 GN=CACNA1H PE=1 SV=4 CAC1H_HUMAN reviewed Voltage-dependent T-type calcium channel subunit alpha-1H (Low-voltage-activated calcium channel alpha1 3.2 subunit) (Voltage-gated calcium channel subunit alpha Cav3.2) Homo sapiens (Human) GO:0005244; GO:0005245; GO:0005886; GO:0005891; GO:0006936; GO:0007517; GO:0007520; GO:0008016; GO:0008331; GO:0008332; GO:0016020; GO:0032342; GO:0032870; GO:0034651; GO:0035865; GO:0042391; GO:0046872; GO:0070509; GO:0097110; GO:0098662; GO:0098703; GO:2000344 aldosterone biosynthetic process [GO:0032342]; calcium ion import [GO:0070509]; calcium ion import across plasma membrane [GO:0098703]; cellular response to hormone stimulus [GO:0032870]; cellular response to potassium ion [GO:0035865]; cortisol biosynthetic process [GO:0034651]; inorganic cation transmembrane transport [GO:0098662]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; myoblast fusion [GO:0007520]; positive regulation of acrosome reaction [GO:2000344]; regulation of heart contraction [GO:0008016]; regulation of membrane potential [GO:0042391] membrane [GO:0016020]; plasma membrane [GO:0005886]; voltage-gated calcium channel complex [GO:0005891] high voltage-gated calcium channel activity [GO:0008331]; low voltage-gated calcium channel activity [GO:0008332]; metal ion binding [GO:0046872]; scaffold protein binding [GO:0097110]; voltage-gated calcium channel activity [GO:0005245]; voltage-gated monoatomic ion channel activity [GO:0005244] g17605.t3 O95180 73.361 244 5.39e-84 311.0 sp|O95180|CAC1H_HUMAN Voltage-dependent T-type calcium channel subunit alpha-1H OS=Homo sapiens OX=9606 GN=CACNA1H PE=1 SV=4 CAC1H_HUMAN reviewed Voltage-dependent T-type calcium channel subunit alpha-1H (Low-voltage-activated calcium channel alpha1 3.2 subunit) (Voltage-gated calcium channel subunit alpha Cav3.2) Homo sapiens (Human) GO:0005244; GO:0005245; GO:0005886; GO:0005891; GO:0006936; GO:0007517; GO:0007520; GO:0008016; GO:0008331; GO:0008332; GO:0016020; GO:0032342; GO:0032870; GO:0034651; GO:0035865; GO:0042391; GO:0046872; GO:0070509; GO:0097110; GO:0098662; GO:0098703; GO:2000344 aldosterone biosynthetic process [GO:0032342]; calcium ion import [GO:0070509]; calcium ion import across plasma membrane [GO:0098703]; cellular response to hormone stimulus [GO:0032870]; cellular response to potassium ion [GO:0035865]; cortisol biosynthetic process [GO:0034651]; inorganic cation transmembrane transport [GO:0098662]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; myoblast fusion [GO:0007520]; positive regulation of acrosome reaction [GO:2000344]; regulation of heart contraction [GO:0008016]; regulation of membrane potential [GO:0042391] membrane [GO:0016020]; plasma membrane [GO:0005886]; voltage-gated calcium channel complex [GO:0005891] high voltage-gated calcium channel activity [GO:0008331]; low voltage-gated calcium channel activity [GO:0008332]; metal ion binding [GO:0046872]; scaffold protein binding [GO:0097110]; voltage-gated calcium channel activity [GO:0005245]; voltage-gated monoatomic ion channel activity [GO:0005244] g17605.t3 O95180 53.056 360 4.94e-75 282.0 sp|O95180|CAC1H_HUMAN Voltage-dependent T-type calcium channel subunit alpha-1H OS=Homo sapiens OX=9606 GN=CACNA1H PE=1 SV=4 CAC1H_HUMAN reviewed Voltage-dependent T-type calcium channel subunit alpha-1H (Low-voltage-activated calcium channel alpha1 3.2 subunit) (Voltage-gated calcium channel subunit alpha Cav3.2) Homo sapiens (Human) GO:0005244; GO:0005245; GO:0005886; GO:0005891; GO:0006936; GO:0007517; GO:0007520; GO:0008016; GO:0008331; GO:0008332; GO:0016020; GO:0032342; GO:0032870; GO:0034651; GO:0035865; GO:0042391; GO:0046872; GO:0070509; GO:0097110; GO:0098662; GO:0098703; GO:2000344 aldosterone biosynthetic process [GO:0032342]; calcium ion import [GO:0070509]; calcium ion import across plasma membrane [GO:0098703]; cellular response to hormone stimulus [GO:0032870]; cellular response to potassium ion [GO:0035865]; cortisol biosynthetic process [GO:0034651]; inorganic cation transmembrane transport [GO:0098662]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; myoblast fusion [GO:0007520]; positive regulation of acrosome reaction [GO:2000344]; regulation of heart contraction [GO:0008016]; regulation of membrane potential [GO:0042391] membrane [GO:0016020]; plasma membrane [GO:0005886]; voltage-gated calcium channel complex [GO:0005891] high voltage-gated calcium channel activity [GO:0008331]; low voltage-gated calcium channel activity [GO:0008332]; metal ion binding [GO:0046872]; scaffold protein binding [GO:0097110]; voltage-gated calcium channel activity [GO:0005245]; voltage-gated monoatomic ion channel activity [GO:0005244] g17605.t4 O95180 60.942 658 3.13e-176 598.0 sp|O95180|CAC1H_HUMAN Voltage-dependent T-type calcium channel subunit alpha-1H OS=Homo sapiens OX=9606 GN=CACNA1H PE=1 SV=4 CAC1H_HUMAN reviewed Voltage-dependent T-type calcium channel subunit alpha-1H (Low-voltage-activated calcium channel alpha1 3.2 subunit) (Voltage-gated calcium channel subunit alpha Cav3.2) Homo sapiens (Human) GO:0005244; GO:0005245; GO:0005886; GO:0005891; GO:0006936; GO:0007517; GO:0007520; GO:0008016; GO:0008331; GO:0008332; GO:0016020; GO:0032342; GO:0032870; GO:0034651; GO:0035865; GO:0042391; GO:0046872; GO:0070509; GO:0097110; GO:0098662; GO:0098703; GO:2000344 aldosterone biosynthetic process [GO:0032342]; calcium ion import [GO:0070509]; calcium ion import across plasma membrane [GO:0098703]; cellular response to hormone stimulus [GO:0032870]; cellular response to potassium ion [GO:0035865]; cortisol biosynthetic process [GO:0034651]; inorganic cation transmembrane transport [GO:0098662]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; myoblast fusion [GO:0007520]; positive regulation of acrosome reaction [GO:2000344]; regulation of heart contraction [GO:0008016]; regulation of membrane potential [GO:0042391] membrane [GO:0016020]; plasma membrane [GO:0005886]; voltage-gated calcium channel complex [GO:0005891] high voltage-gated calcium channel activity [GO:0008331]; low voltage-gated calcium channel activity [GO:0008332]; metal ion binding [GO:0046872]; scaffold protein binding [GO:0097110]; voltage-gated calcium channel activity [GO:0005245]; voltage-gated monoatomic ion channel activity [GO:0005244] g17605.t4 O95180 73.361 244 6.78e-84 311.0 sp|O95180|CAC1H_HUMAN Voltage-dependent T-type calcium channel subunit alpha-1H OS=Homo sapiens OX=9606 GN=CACNA1H PE=1 SV=4 CAC1H_HUMAN reviewed Voltage-dependent T-type calcium channel subunit alpha-1H (Low-voltage-activated calcium channel alpha1 3.2 subunit) (Voltage-gated calcium channel subunit alpha Cav3.2) Homo sapiens (Human) GO:0005244; GO:0005245; GO:0005886; GO:0005891; GO:0006936; GO:0007517; GO:0007520; GO:0008016; GO:0008331; GO:0008332; GO:0016020; GO:0032342; GO:0032870; GO:0034651; GO:0035865; GO:0042391; GO:0046872; GO:0070509; GO:0097110; GO:0098662; GO:0098703; GO:2000344 aldosterone biosynthetic process [GO:0032342]; calcium ion import [GO:0070509]; calcium ion import across plasma membrane [GO:0098703]; cellular response to hormone stimulus [GO:0032870]; cellular response to potassium ion [GO:0035865]; cortisol biosynthetic process [GO:0034651]; inorganic cation transmembrane transport [GO:0098662]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; myoblast fusion [GO:0007520]; positive regulation of acrosome reaction [GO:2000344]; regulation of heart contraction [GO:0008016]; regulation of membrane potential [GO:0042391] membrane [GO:0016020]; plasma membrane [GO:0005886]; voltage-gated calcium channel complex [GO:0005891] high voltage-gated calcium channel activity [GO:0008331]; low voltage-gated calcium channel activity [GO:0008332]; metal ion binding [GO:0046872]; scaffold protein binding [GO:0097110]; voltage-gated calcium channel activity [GO:0005245]; voltage-gated monoatomic ion channel activity [GO:0005244] g17605.t4 O95180 53.056 360 6.28e-75 282.0 sp|O95180|CAC1H_HUMAN Voltage-dependent T-type calcium channel subunit alpha-1H OS=Homo sapiens OX=9606 GN=CACNA1H PE=1 SV=4 CAC1H_HUMAN reviewed Voltage-dependent T-type calcium channel subunit alpha-1H (Low-voltage-activated calcium channel alpha1 3.2 subunit) (Voltage-gated calcium channel subunit alpha Cav3.2) Homo sapiens (Human) GO:0005244; GO:0005245; GO:0005886; GO:0005891; GO:0006936; GO:0007517; GO:0007520; GO:0008016; GO:0008331; GO:0008332; GO:0016020; GO:0032342; GO:0032870; GO:0034651; GO:0035865; GO:0042391; GO:0046872; GO:0070509; GO:0097110; GO:0098662; GO:0098703; GO:2000344 aldosterone biosynthetic process [GO:0032342]; calcium ion import [GO:0070509]; calcium ion import across plasma membrane [GO:0098703]; cellular response to hormone stimulus [GO:0032870]; cellular response to potassium ion [GO:0035865]; cortisol biosynthetic process [GO:0034651]; inorganic cation transmembrane transport [GO:0098662]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; myoblast fusion [GO:0007520]; positive regulation of acrosome reaction [GO:2000344]; regulation of heart contraction [GO:0008016]; regulation of membrane potential [GO:0042391] membrane [GO:0016020]; plasma membrane [GO:0005886]; voltage-gated calcium channel complex [GO:0005891] high voltage-gated calcium channel activity [GO:0008331]; low voltage-gated calcium channel activity [GO:0008332]; metal ion binding [GO:0046872]; scaffold protein binding [GO:0097110]; voltage-gated calcium channel activity [GO:0005245]; voltage-gated monoatomic ion channel activity [GO:0005244] g17607.t1 Q9JIA7 32.113 601 2.68e-77 259.0 sp|Q9JIA7|SPHK2_MOUSE Sphingosine kinase 2 OS=Mus musculus OX=10090 GN=Sphk2 PE=1 SV=2 SPHK2_MOUSE reviewed Sphingosine kinase 2 (SK 2) (SPK 2) (EC 2.7.1.91) Mus musculus (Mouse) GO:0000786; GO:0001568; GO:0002720; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005743; GO:0005765; GO:0005783; GO:0005829; GO:0005886; GO:0006669; GO:0006670; GO:0007420; GO:0007565; GO:0008284; GO:0008481; GO:0016020; GO:0030308; GO:0032736; GO:0032755; GO:0032760; GO:0033008; GO:0035556; GO:0038036; GO:0042393; GO:0043065; GO:0043122; GO:0043306; GO:0045815; GO:0046512; GO:1903426; GO:1904628; GO:1904959; GO:2000304; GO:2001169 blood vessel development [GO:0001568]; brain development [GO:0007420]; cellular response to phorbol 13-acetate 12-myristate [GO:1904628]; female pregnancy [GO:0007565]; intracellular signal transduction [GO:0035556]; negative regulation of cell growth [GO:0030308]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ceramide biosynthetic process [GO:2000304]; positive regulation of cytokine production involved in immune response [GO:0002720]; positive regulation of interleukin-13 production [GO:0032736]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of mast cell activation involved in immune response [GO:0033008]; positive regulation of mast cell degranulation [GO:0043306]; positive regulation of tumor necrosis factor production [GO:0032760]; regulation of ATP biosynthetic process [GO:2001169]; regulation of canonical NF-kappaB signal transduction [GO:0043122]; regulation of cytochrome-c oxidase activity [GO:1904959]; regulation of reactive oxygen species biosynthetic process [GO:1903426]; sphinganine-1-phosphate biosynthetic process [GO:0006669]; sphingosine biosynthetic process [GO:0046512]; sphingosine metabolic process [GO:0006670]; transcription initiation-coupled chromatin remodeling [GO:0045815] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634]; plasma membrane [GO:0005886] ATP binding [GO:0005524]; histone binding [GO:0042393]; sphingosine kinase activity [GO:0008481]; sphingosine-1-phosphate receptor activity [GO:0038036] g17610.t1 Q9JM55 46.392 97 1.75e-23 95.5 sp|Q9JM55|TOB2_MOUSE Protein Tob2 OS=Mus musculus OX=10090 GN=Tob2 PE=2 SV=1 g17612.t1 P51892 57.84 574 0.0 669.0 sp|P51892|DNLI1_XENLA DNA ligase 1 OS=Xenopus laevis OX=8355 GN=lig1 PE=2 SV=1 g17612.t2 P51892 58.239 704 0.0 829.0 sp|P51892|DNLI1_XENLA DNA ligase 1 OS=Xenopus laevis OX=8355 GN=lig1 PE=2 SV=1 g17613.t1 Q3TX08 45.113 532 2.24e-148 446.0 sp|Q3TX08|TRM1_MOUSE tRNA (guanine(26)-N(2))-dimethyltransferase OS=Mus musculus OX=10090 GN=Trmt1 PE=1 SV=3 g17614.t1 Q15262 39.099 555 4.4100000000000005e-117 404.0 sp|Q15262|PTPRK_HUMAN Receptor-type tyrosine-protein phosphatase kappa OS=Homo sapiens OX=9606 GN=PTPRK PE=1 SV=2 PTPRK_HUMAN reviewed Receptor-type tyrosine-protein phosphatase kappa (Protein-tyrosine phosphatase kappa) (R-PTP-kappa) (EC 3.1.3.48) Homo sapiens (Human) GO:0004725; GO:0005001; GO:0005814; GO:0005886; GO:0005911; GO:0005912; GO:0006470; GO:0007155; GO:0007165; GO:0007179; GO:0008013; GO:0008285; GO:0009986; GO:0010839; GO:0016020; GO:0016477; GO:0019901; GO:0030054; GO:0030336; GO:0031175; GO:0031256; GO:0034394; GO:0034614; GO:0034644; GO:0045295; GO:0045786; GO:0045892; GO:0048041; GO:0120212 cell adhesion [GO:0007155]; cell migration [GO:0016477]; cellular response to reactive oxygen species [GO:0034614]; cellular response to UV [GO:0034644]; focal adhesion assembly [GO:0048041]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of keratinocyte proliferation [GO:0010839]; neuron projection development [GO:0031175]; protein dephosphorylation [GO:0006470]; protein localization to cell surface [GO:0034394]; signal transduction [GO:0007165]; transforming growth factor beta receptor signaling pathway [GO:0007179] adherens junction [GO:0005912]; cell junction [GO:0030054]; cell surface [GO:0009986]; cell-cell junction [GO:0005911]; centriole [GO:0005814]; leading edge membrane [GO:0031256]; membrane [GO:0016020]; plasma membrane [GO:0005886]; sperm head-tail coupling apparatus [GO:0120212] beta-catenin binding [GO:0008013]; gamma-catenin binding [GO:0045295]; protein kinase binding [GO:0019901]; protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001] g17614.t1 Q15262 28.383 303 1.09e-22 110.0 sp|Q15262|PTPRK_HUMAN Receptor-type tyrosine-protein phosphatase kappa OS=Homo sapiens OX=9606 GN=PTPRK PE=1 SV=2 PTPRK_HUMAN reviewed Receptor-type tyrosine-protein phosphatase kappa (Protein-tyrosine phosphatase kappa) (R-PTP-kappa) (EC 3.1.3.48) Homo sapiens (Human) GO:0004725; GO:0005001; GO:0005814; GO:0005886; GO:0005911; GO:0005912; GO:0006470; GO:0007155; GO:0007165; GO:0007179; GO:0008013; GO:0008285; GO:0009986; GO:0010839; GO:0016020; GO:0016477; GO:0019901; GO:0030054; GO:0030336; GO:0031175; GO:0031256; GO:0034394; GO:0034614; GO:0034644; GO:0045295; GO:0045786; GO:0045892; GO:0048041; GO:0120212 cell adhesion [GO:0007155]; cell migration [GO:0016477]; cellular response to reactive oxygen species [GO:0034614]; cellular response to UV [GO:0034644]; focal adhesion assembly [GO:0048041]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of keratinocyte proliferation [GO:0010839]; neuron projection development [GO:0031175]; protein dephosphorylation [GO:0006470]; protein localization to cell surface [GO:0034394]; signal transduction [GO:0007165]; transforming growth factor beta receptor signaling pathway [GO:0007179] adherens junction [GO:0005912]; cell junction [GO:0030054]; cell surface [GO:0009986]; cell-cell junction [GO:0005911]; centriole [GO:0005814]; leading edge membrane [GO:0031256]; membrane [GO:0016020]; plasma membrane [GO:0005886]; sperm head-tail coupling apparatus [GO:0120212] beta-catenin binding [GO:0008013]; gamma-catenin binding [GO:0045295]; protein kinase binding [GO:0019901]; protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001] g17615.t1 Q06805 35.51 245 4.51e-40 159.0 sp|Q06805|TIE1_BOVIN Tyrosine-protein kinase receptor Tie-1 OS=Bos taurus OX=9913 GN=TIE1 PE=2 SV=1 g17618.t1 Q61241 36.039 308 2.57e-59 204.0 sp|Q61241|TSSK1_MOUSE Testis-specific serine/threonine-protein kinase 1 OS=Mus musculus OX=10090 GN=Tssk1b PE=1 SV=2 TSSK1_MOUSE reviewed Testis-specific serine/threonine-protein kinase 1 (TSK-1) (TSK1) (TSSK-1) (Testis-specific kinase 1) (EC 2.7.11.1) (Serine/threonine-protein kinase 22A) Mus musculus (Mouse) GO:0000287; GO:0001669; GO:0004674; GO:0005524; GO:0006468; GO:0007283; GO:0007286; GO:0018105; GO:0031514; GO:0044877; GO:0106310 peptidyl-serine phosphorylation [GO:0018105]; protein phosphorylation [GO:0006468]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283] acrosomal vesicle [GO:0001669]; motile cilium [GO:0031514] ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein-containing complex binding [GO:0044877] g17619.t1 O00418 46.296 540 3.95e-143 432.0 sp|O00418|EF2K_HUMAN Eukaryotic elongation factor 2 kinase OS=Homo sapiens OX=9606 GN=EEF2K PE=1 SV=2 EF2K_HUMAN reviewed Eukaryotic elongation factor 2 kinase (eEF-2 kinase) (eEF-2K) (EC 2.7.11.20) (Calcium/calmodulin-dependent eukaryotic elongation factor 2 kinase) Homo sapiens (Human) GO:0002931; GO:0004672; GO:0004686; GO:0005509; GO:0005516; GO:0005524; GO:0005737; GO:0005829; GO:0006414; GO:0008135; GO:0014069; GO:0031037; GO:0032869; GO:0043066; GO:0043197; GO:0045807; GO:0046777; GO:0051965; GO:0061003; GO:0071277; GO:0071320; GO:0071454; GO:0098978; GO:0140245; GO:1990416; GO:1990637 cellular response to anoxia [GO:0071454]; cellular response to brain-derived neurotrophic factor stimulus [GO:1990416]; cellular response to calcium ion [GO:0071277]; cellular response to cAMP [GO:0071320]; cellular response to insulin stimulus [GO:0032869]; myosin II filament disassembly [GO:0031037]; negative regulation of apoptotic process [GO:0043066]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of endocytosis [GO:0045807]; positive regulation of synapse assembly [GO:0051965]; protein autophosphorylation [GO:0046777]; regulation of translation at postsynapse [GO:0140245]; response to ischemia [GO:0002931]; response to prolactin [GO:1990637]; translational elongation [GO:0006414] cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; postsynaptic density [GO:0014069] ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; elongation factor-2 kinase activity [GO:0004686]; protein kinase activity [GO:0004672]; translation factor activity, RNA binding [GO:0008135] g17619.t2 O00418 46.269 536 4.48e-143 431.0 sp|O00418|EF2K_HUMAN Eukaryotic elongation factor 2 kinase OS=Homo sapiens OX=9606 GN=EEF2K PE=1 SV=2 EF2K_HUMAN reviewed Eukaryotic elongation factor 2 kinase (eEF-2 kinase) (eEF-2K) (EC 2.7.11.20) (Calcium/calmodulin-dependent eukaryotic elongation factor 2 kinase) Homo sapiens (Human) GO:0002931; GO:0004672; GO:0004686; GO:0005509; GO:0005516; GO:0005524; GO:0005737; GO:0005829; GO:0006414; GO:0008135; GO:0014069; GO:0031037; GO:0032869; GO:0043066; GO:0043197; GO:0045807; GO:0046777; GO:0051965; GO:0061003; GO:0071277; GO:0071320; GO:0071454; GO:0098978; GO:0140245; GO:1990416; GO:1990637 cellular response to anoxia [GO:0071454]; cellular response to brain-derived neurotrophic factor stimulus [GO:1990416]; cellular response to calcium ion [GO:0071277]; cellular response to cAMP [GO:0071320]; cellular response to insulin stimulus [GO:0032869]; myosin II filament disassembly [GO:0031037]; negative regulation of apoptotic process [GO:0043066]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of endocytosis [GO:0045807]; positive regulation of synapse assembly [GO:0051965]; protein autophosphorylation [GO:0046777]; regulation of translation at postsynapse [GO:0140245]; response to ischemia [GO:0002931]; response to prolactin [GO:1990637]; translational elongation [GO:0006414] cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; postsynaptic density [GO:0014069] ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; elongation factor-2 kinase activity [GO:0004686]; protein kinase activity [GO:0004672]; translation factor activity, RNA binding [GO:0008135] g17620.t1 O00418 54.545 77 5.980000000000001e-21 92.0 sp|O00418|EF2K_HUMAN Eukaryotic elongation factor 2 kinase OS=Homo sapiens OX=9606 GN=EEF2K PE=1 SV=2 EF2K_HUMAN reviewed Eukaryotic elongation factor 2 kinase (eEF-2 kinase) (eEF-2K) (EC 2.7.11.20) (Calcium/calmodulin-dependent eukaryotic elongation factor 2 kinase) Homo sapiens (Human) GO:0002931; GO:0004672; GO:0004686; GO:0005509; GO:0005516; GO:0005524; GO:0005737; GO:0005829; GO:0006414; GO:0008135; GO:0014069; GO:0031037; GO:0032869; GO:0043066; GO:0043197; GO:0045807; GO:0046777; GO:0051965; GO:0061003; GO:0071277; GO:0071320; GO:0071454; GO:0098978; GO:0140245; GO:1990416; GO:1990637 cellular response to anoxia [GO:0071454]; cellular response to brain-derived neurotrophic factor stimulus [GO:1990416]; cellular response to calcium ion [GO:0071277]; cellular response to cAMP [GO:0071320]; cellular response to insulin stimulus [GO:0032869]; myosin II filament disassembly [GO:0031037]; negative regulation of apoptotic process [GO:0043066]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of endocytosis [GO:0045807]; positive regulation of synapse assembly [GO:0051965]; protein autophosphorylation [GO:0046777]; regulation of translation at postsynapse [GO:0140245]; response to ischemia [GO:0002931]; response to prolactin [GO:1990637]; translational elongation [GO:0006414] cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; postsynaptic density [GO:0014069] ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; elongation factor-2 kinase activity [GO:0004686]; protein kinase activity [GO:0004672]; translation factor activity, RNA binding [GO:0008135] g17621.t1 Q5ZKJ5 28.571 434 7.97e-49 177.0 sp|Q5ZKJ5|MF13A_CHICK Transmembrane protein 180 OS=Gallus gallus OX=9031 GN=MFSD13A PE=2 SV=1 g17622.t1 Q9N126 41.176 272 3.4e-59 194.0 sp|Q9N126|RDH8_BOVIN Retinol dehydrogenase 8 OS=Bos taurus OX=9913 GN=RDH8 PE=1 SV=1 g17623.t1 Q8CF89 37.405 524 6.1099999999999996e-93 295.0 sp|Q8CF89|TAB1_MOUSE TGF-beta-activated kinase 1 and MAP3K7-binding protein 1 OS=Mus musculus OX=10090 GN=Tab1 PE=1 SV=2 TAB1_MOUSE reviewed TGF-beta-activated kinase 1 and MAP3K7-binding protein 1 (Mitogen-activated protein kinase kinase kinase 7-interacting protein 1) (TGF-beta-activated kinase 1-binding protein 1) (TAK1-binding protein 1) Mus musculus (Mouse) GO:0001701; GO:0003007; GO:0003279; GO:0004722; GO:0005737; GO:0005783; GO:0005789; GO:0005829; GO:0007165; GO:0007179; GO:0007249; GO:0019209; GO:0030324; GO:0032481; GO:0032527; GO:0032991; GO:0035904; GO:0038061; GO:0043410; GO:0043539; GO:0044877; GO:0048273; GO:0060090; GO:0060976; GO:0140896; GO:0141111 aorta development [GO:0035904]; canonical NF-kappaB signal transduction [GO:0007249]; cardiac septum development [GO:0003279]; cGAS/STING signaling pathway [GO:0140896]; coronary vasculature development [GO:0060976]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; lung development [GO:0030324]; non-canonical NF-kappaB signal transduction [GO:0038061]; positive regulation of cGAS/STING signaling pathway [GO:0141111]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of type I interferon production [GO:0032481]; protein exit from endoplasmic reticulum [GO:0032527]; signal transduction [GO:0007165]; transforming growth factor beta receptor signaling pathway [GO:0007179] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; protein-containing complex [GO:0032991] kinase activator activity [GO:0019209]; mitogen-activated protein kinase p38 binding [GO:0048273]; molecular adaptor activity [GO:0060090]; protein serine/threonine kinase activator activity [GO:0043539]; protein serine/threonine phosphatase activity [GO:0004722]; protein-containing complex binding [GO:0044877] g17624.t1 B5FYC7 55.556 117 3.97e-43 140.0 sp|B5FYC7|LYRM1_TAEGU LYR motif-containing protein 1 OS=Taeniopygia guttata OX=59729 GN=LYRM1 PE=2 SV=1 g17625.t1 Q8BW94 42.105 722 1.67e-165 531.0 sp|Q8BW94|DYH3_MOUSE Dynein axonemal heavy chain 3 OS=Mus musculus OX=10090 GN=Dnah3 PE=1 SV=2 g17626.t1 Q8TD57 71.074 3260 0.0 4778.0 sp|Q8TD57|DYH3_HUMAN Dynein axonemal heavy chain 3 OS=Homo sapiens OX=9606 GN=DNAH3 PE=1 SV=1 DYH3_HUMAN reviewed Dynein axonemal heavy chain 3 (Axonemal beta dynein heavy chain 3) (HsADHC3) (Ciliary dynein heavy chain 3) (Dnahc3-b) Homo sapiens (Human) GO:0003777; GO:0005524; GO:0005858; GO:0005874; GO:0008569; GO:0036156; GO:0036159; GO:0045505; GO:0051959; GO:0060285; GO:0060294; GO:0097729 cilium movement involved in cell motility [GO:0060294]; cilium-dependent cell motility [GO:0060285]; inner dynein arm assembly [GO:0036159] 9+2 motile cilium [GO:0097729]; axonemal dynein complex [GO:0005858]; inner dynein arm [GO:0036156]; microtubule [GO:0005874] ATP binding [GO:0005524]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]; minus-end-directed microtubule motor activity [GO:0008569] g17628.t1 Q8JHF2 42.765 311 4.72e-82 259.0 sp|Q8JHF2|LFNG_DANRE Beta-1,3-N-acetylglucosaminyltransferase lunatic fringe OS=Danio rerio OX=7955 GN=lfng PE=2 SV=2 LFNG_DANRE reviewed Beta-1,3-N-acetylglucosaminyltransferase lunatic fringe (EC 2.4.1.222) (O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000139; GO:0007219; GO:0007389; GO:0007399; GO:0008593; GO:0030154; GO:0031101; GO:0033829; GO:0045665; GO:0046872; GO:0055016 cell differentiation [GO:0030154]; fin regeneration [GO:0031101]; hypochord development [GO:0055016]; negative regulation of neuron differentiation [GO:0045665]; nervous system development [GO:0007399]; Notch signaling pathway [GO:0007219]; pattern specification process [GO:0007389]; regulation of Notch signaling pathway [GO:0008593] Golgi membrane [GO:0000139] metal ion binding [GO:0046872]; O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity [GO:0033829] g17628.t2 Q8JHF2 42.628 312 1.51e-81 258.0 sp|Q8JHF2|LFNG_DANRE Beta-1,3-N-acetylglucosaminyltransferase lunatic fringe OS=Danio rerio OX=7955 GN=lfng PE=2 SV=2 LFNG_DANRE reviewed Beta-1,3-N-acetylglucosaminyltransferase lunatic fringe (EC 2.4.1.222) (O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000139; GO:0007219; GO:0007389; GO:0007399; GO:0008593; GO:0030154; GO:0031101; GO:0033829; GO:0045665; GO:0046872; GO:0055016 cell differentiation [GO:0030154]; fin regeneration [GO:0031101]; hypochord development [GO:0055016]; negative regulation of neuron differentiation [GO:0045665]; nervous system development [GO:0007399]; Notch signaling pathway [GO:0007219]; pattern specification process [GO:0007389]; regulation of Notch signaling pathway [GO:0008593] Golgi membrane [GO:0000139] metal ion binding [GO:0046872]; O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity [GO:0033829] g17628.t3 Q8JHF2 42.765 311 3.2299999999999996e-82 259.0 sp|Q8JHF2|LFNG_DANRE Beta-1,3-N-acetylglucosaminyltransferase lunatic fringe OS=Danio rerio OX=7955 GN=lfng PE=2 SV=2 LFNG_DANRE reviewed Beta-1,3-N-acetylglucosaminyltransferase lunatic fringe (EC 2.4.1.222) (O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000139; GO:0007219; GO:0007389; GO:0007399; GO:0008593; GO:0030154; GO:0031101; GO:0033829; GO:0045665; GO:0046872; GO:0055016 cell differentiation [GO:0030154]; fin regeneration [GO:0031101]; hypochord development [GO:0055016]; negative regulation of neuron differentiation [GO:0045665]; nervous system development [GO:0007399]; Notch signaling pathway [GO:0007219]; pattern specification process [GO:0007389]; regulation of Notch signaling pathway [GO:0008593] Golgi membrane [GO:0000139] metal ion binding [GO:0046872]; O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity [GO:0033829] g17629.t1 Q1JPD8 39.801 201 1.02e-34 139.0 sp|Q1JPD8|S43A3_BOVIN Equilibrative nucleobase transporter 1 OS=Bos taurus OX=9913 GN=SLC43A3 PE=2 SV=1 g17629.t1 Q1JPD8 32.086 187 8.54e-22 102.0 sp|Q1JPD8|S43A3_BOVIN Equilibrative nucleobase transporter 1 OS=Bos taurus OX=9913 GN=SLC43A3 PE=2 SV=1 g17630.t1 Q66JG8 45.532 235 3.39e-56 190.0 sp|Q66JG8|ALKB5_XENTR RNA demethylase ALKBH5 OS=Xenopus tropicalis OX=8364 GN=alkbh5 PE=2 SV=1 ALKB5_XENTR reviewed RNA demethylase ALKBH5 (EC 1.14.11.53) (Alkylated DNA repair protein alkB homolog 5) (Alpha-ketoglutarate-dependent dioxygenase alkB homolog 5) Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0001666; GO:0005634; GO:0006397; GO:0006417; GO:0007283; GO:0010793; GO:0016607; GO:0016706; GO:0035515; GO:0042382; GO:0046872; GO:0050684; GO:0061157; GO:0140693; GO:0140694; GO:1990931 membraneless organelle assembly [GO:0140694]; mRNA destabilization [GO:0061157]; mRNA processing [GO:0006397]; regulation of mRNA export from nucleus [GO:0010793]; regulation of mRNA processing [GO:0050684]; regulation of translation [GO:0006417]; response to hypoxia [GO:0001666]; spermatogenesis [GO:0007283] nuclear speck [GO:0016607]; nucleus [GO:0005634]; paraspeckles [GO:0042382] 2-oxoglutarate-dependent dioxygenase activity [GO:0016706]; metal ion binding [GO:0046872]; molecular condensate scaffold activity [GO:0140693]; mRNA N6-methyladenosine dioxygenase activity [GO:1990931]; oxidative RNA demethylase activity [GO:0035515] g17631.t1 Q1LZC5 42.795 229 6.0199999999999996e-52 176.0 sp|Q1LZC5|ANR54_BOVIN Ankyrin repeat domain-containing protein 54 OS=Bos taurus OX=9913 GN=ANKRD54 PE=2 SV=1 ANR54_BOVIN reviewed Ankyrin repeat domain-containing protein 54 Bos taurus (Bovine) GO:0005634; GO:0005737; GO:0006913; GO:0019887; GO:0030496; GO:0044877; GO:0045648; GO:1902531 nucleocytoplasmic transport [GO:0006913]; positive regulation of erythrocyte differentiation [GO:0045648]; regulation of intracellular signal transduction [GO:1902531] cytoplasm [GO:0005737]; midbody [GO:0030496]; nucleus [GO:0005634] protein kinase regulator activity [GO:0019887]; protein-containing complex binding [GO:0044877] g17632.t1 Q9Y5X2 48.092 393 2.26e-134 400.0 sp|Q9Y5X2|SNX8_HUMAN Sorting nexin-8 OS=Homo sapiens OX=9606 GN=SNX8 PE=1 SV=1 g17634.t1 P38983 64.164 293 3.64e-130 375.0 sp|P38983|RSSA_RAT Small ribosomal subunit protein uS2 OS=Rattus norvegicus OX=10116 GN=Rpsa PE=1 SV=3 g17635.t1 Q66HY8 34.228 298 3.92e-40 154.0 sp|Q66HY8|PDXD1_DANRE Pyridoxal-dependent decarboxylase domain-containing protein 1 OS=Danio rerio OX=7955 GN=pdxdc1 PE=2 SV=1 g17636.t1 A7MBC2 48.953 382 1.7299999999999997e-126 388.0 sp|A7MBC2|PDXD1_BOVIN Pyridoxal-dependent decarboxylase domain-containing protein 1 OS=Bos taurus OX=9913 GN=PDXDC1 PE=2 SV=1 g17636.t2 Q6DF78 51.451 379 5.0300000000000003e-129 395.0 sp|Q6DF78|PDXD1_XENLA Pyridoxal-dependent decarboxylase domain-containing protein 1 OS=Xenopus laevis OX=8355 GN=pdxdc1 PE=2 SV=1 g17637.t1 Q5XGZ9 32.203 354 2.8000000000000002e-43 169.0 sp|Q5XGZ9|MF6LB_XENLA Major facilitator superfamily domain-containing protein 6-like protein B OS=Xenopus laevis OX=8355 GN=mfsd6l-b PE=2 SV=1 g17638.t1 Q68F62 34.132 167 1.72e-37 131.0 sp|Q68F62|MP17L_XENLA Mpv17-like protein OS=Xenopus laevis OX=8355 GN=mpv17l PE=2 SV=1 g17642.t1 P10079 41.568 421 2.0300000000000002e-71 251.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g17642.t1 P10079 37.277 448 5.4599999999999996e-67 239.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g17642.t1 P10079 39.813 427 3.22e-65 233.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g17642.t1 P10079 37.336 458 5.09e-64 230.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g17642.t1 P10079 40.052 387 2.8499999999999997e-61 222.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g17642.t2 P10079 40.052 382 2.17e-62 224.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g17642.t2 P10079 38.929 411 2.9899999999999998e-61 221.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g17642.t2 P10079 40.155 386 1.36e-60 219.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g17642.t2 P10079 38.743 382 3.3e-58 212.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g17642.t2 P10079 41.092 348 1.31e-57 211.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g17642.t2 P10079 38.619 391 3.9700000000000003e-56 206.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g17642.t3 P10079 40.052 382 3.4099999999999998e-62 224.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g17642.t3 P10079 38.929 411 6.18e-61 221.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g17642.t3 P10079 40.155 386 2.23e-60 219.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g17642.t3 P10079 38.743 382 5.5100000000000006e-58 213.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g17642.t3 P10079 41.092 348 2.0600000000000002e-57 211.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g17642.t3 P10079 38.619 391 6.47e-56 206.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g17643.t1 P07207 40.445 1214 0.0 853.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g17643.t1 P07207 39.203 1204 0.0 830.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g17643.t1 P07207 39.594 1182 0.0 786.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g17643.t1 P07207 39.75 1122 0.0 720.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g17643.t1 P07207 37.792 1114 0.0 683.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g17643.t1 P07207 31.677 483 4.9699999999999994e-48 193.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g17644.t1 Q9D8T4 57.292 192 1.61e-73 224.0 sp|Q9D8T4|TV23B_MOUSE Golgi apparatus membrane protein TVP23 homolog B OS=Mus musculus OX=10090 GN=Tvp23b PE=1 SV=1 g17645.t1 A8IW99 45.455 165 3.0499999999999996e-52 171.0 sp|A8IW99|PLD6_CHLRE Mitochondrial cardiolipin hydrolase OS=Chlamydomonas reinhardtii OX=3055 GN=CHLREDRAFT_190403 PE=3 SV=1 g17646.t1 O43934 49.556 450 2.8599999999999997e-134 397.0 sp|O43934|MFS11_HUMAN UNC93-like protein MFSD11 OS=Homo sapiens OX=9606 GN=MFSD11 PE=1 SV=2 g17648.t1 Q9D665 47.222 360 6.14e-112 336.0 sp|Q9D665|D42E1_MOUSE Short-chain dehydrogenase/reductase family 42E member 1 OS=Mus musculus OX=10090 GN=Sdr42e1 PE=1 SV=1 g17649.t1 Q9W6G7 33.81 420 1.6000000000000001e-75 246.0 sp|Q9W6G7|DPOG2_XENLA DNA polymerase subunit gamma-2, mitochondrial OS=Xenopus laevis OX=8355 GN=polg2 PE=1 SV=1 g17651.t1 C3YWU0 66.743 436 0.0 610.0 sp|C3YWU0|FUCO_BRAFL Alpha-L-fucosidase OS=Branchiostoma floridae OX=7739 GN=BRAFLDRAFT_56888 PE=3 SV=2 g17652.t1 C3YWU0 69.042 449 0.0 649.0 sp|C3YWU0|FUCO_BRAFL Alpha-L-fucosidase OS=Branchiostoma floridae OX=7739 GN=BRAFLDRAFT_56888 PE=3 SV=2 g17652.t2 C3YWU0 72.449 294 1.15e-155 446.0 sp|C3YWU0|FUCO_BRAFL Alpha-L-fucosidase OS=Branchiostoma floridae OX=7739 GN=BRAFLDRAFT_56888 PE=3 SV=2 g17652.t3 C3YWU0 65.217 230 2.53e-107 319.0 sp|C3YWU0|FUCO_BRAFL Alpha-L-fucosidase OS=Branchiostoma floridae OX=7739 GN=BRAFLDRAFT_56888 PE=3 SV=2 g17653.t1 C3YWU0 72.311 437 0.0 659.0 sp|C3YWU0|FUCO_BRAFL Alpha-L-fucosidase OS=Branchiostoma floridae OX=7739 GN=BRAFLDRAFT_56888 PE=3 SV=2 g17654.t1 C3YWU0 63.596 445 0.0 600.0 sp|C3YWU0|FUCO_BRAFL Alpha-L-fucosidase OS=Branchiostoma floridae OX=7739 GN=BRAFLDRAFT_56888 PE=3 SV=2 g17655.t1 Q6DJF8 53.571 168 3.49e-62 196.0 sp|Q6DJF8|MET23_XENLA Histone-arginine methyltransferase METTL23 OS=Xenopus laevis OX=8355 GN=mettl23 PE=2 SV=1 g17658.t1 Q90ZY4 43.561 264 5.72e-77 245.0 sp|Q90ZY4|SBK1_DANRE Serine/threonine-protein kinase SBK1 OS=Danio rerio OX=7955 GN=sbk1 PE=1 SV=1 SBK1_DANRE reviewed Serine/threonine-protein kinase SBK1 (EC 2.7.11.1) (Brain-specific protein kinase BSK146) (SH3 domain-binding kinase 1) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0004672; GO:0004674; GO:0005524; GO:0005737; GO:0106310 cytoplasm [GO:0005737] ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g17659.t1 Q920M7 58.154 325 1.33e-124 374.0 sp|Q920M7|SYT17_MOUSE Synaptotagmin-17 OS=Mus musculus OX=10090 GN=Syt17 PE=1 SV=1 g17660.t1 Q8BZ36 42.398 684 2.0500000000000002e-161 488.0 sp|Q8BZ36|RINT1_MOUSE RAD50-interacting protein 1 OS=Mus musculus OX=10090 GN=Rint1 PE=1 SV=2 g17660.t2 Q8BZ36 43.008 665 5.5e-164 493.0 sp|Q8BZ36|RINT1_MOUSE RAD50-interacting protein 1 OS=Mus musculus OX=10090 GN=Rint1 PE=1 SV=2 g17664.t1 E7F7V7 37.586 290 1.1899999999999999e-55 190.0 sp|E7F7V7|GAL2B_DANRE Galanin receptor 2b OS=Danio rerio OX=7955 GN=galr2b PE=2 SV=1 g17666.t1 Q8WXD9 52.586 348 2.45e-100 360.0 sp|Q8WXD9|CSKI1_HUMAN Caskin-1 OS=Homo sapiens OX=9606 GN=CASKIN1 PE=1 SV=1 g17666.t1 Q8WXD9 50.35 143 1.02e-41 172.0 sp|Q8WXD9|CSKI1_HUMAN Caskin-1 OS=Homo sapiens OX=9606 GN=CASKIN1 PE=1 SV=1 g17666.t2 Q8WXD9 52.586 348 1.82e-100 360.0 sp|Q8WXD9|CSKI1_HUMAN Caskin-1 OS=Homo sapiens OX=9606 GN=CASKIN1 PE=1 SV=1 g17666.t2 Q8WXD9 50.35 143 8.96e-42 173.0 sp|Q8WXD9|CSKI1_HUMAN Caskin-1 OS=Homo sapiens OX=9606 GN=CASKIN1 PE=1 SV=1 g17668.t1 Q9BQA9 38.889 162 1.11e-28 108.0 sp|Q9BQA9|CYBC1_HUMAN Cytochrome b-245 chaperone 1 OS=Homo sapiens OX=9606 GN=CYBC1 PE=1 SV=1 CYBC1_HUMAN reviewed Cytochrome b-245 chaperone 1 (Essential for reactive oxygen species protein) (Eros) Homo sapiens (Human) GO:0005783; GO:0005789; GO:0045087; GO:0045728 innate immune response [GO:0045087]; respiratory burst after phagocytosis [GO:0045728] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789] g17669.t1 P23610 47.076 342 8.54e-75 237.0 sp|P23610|HAP40_HUMAN 40-kDa huntingtin-associated protein OS=Homo sapiens OX=9606 GN=F8A1 PE=1 SV=2 HAP40_HUMAN reviewed 40-kDa huntingtin-associated protein (HAP40) (CpG island protein) (Factor VIII intron 22 protein) Homo sapiens (Human) GO:0005634; GO:0005769; GO:0016604; GO:0099518; GO:1901799 negative regulation of proteasomal protein catabolic process [GO:1901799]; vesicle cytoskeletal trafficking [GO:0099518] early endosome [GO:0005769]; nuclear body [GO:0016604]; nucleus [GO:0005634] g17670.t1 A4D2P6 37.968 374 8.75e-75 276.0 sp|A4D2P6|GRD2I_HUMAN Delphilin OS=Homo sapiens OX=9606 GN=GRID2IP PE=1 SV=2 GRD2I_HUMAN reviewed Delphilin (Glutamate receptor, ionotropic, delta 2-interacting protein 1) Homo sapiens (Human) GO:0045211; GO:0060292; GO:0098688; GO:0099072; GO:0099092; GO:0099566; GO:0150048 long-term synaptic depression [GO:0060292]; regulation of postsynaptic cytosolic calcium ion concentration [GO:0099566]; regulation of postsynaptic membrane neurotransmitter receptor levels [GO:0099072] cerebellar granule cell to Purkinje cell synapse [GO:0150048]; parallel fiber to Purkinje cell synapse [GO:0098688]; postsynaptic density, intracellular component [GO:0099092]; postsynaptic membrane [GO:0045211] g17670.t1 A4D2P6 39.301 229 1.51e-38 161.0 sp|A4D2P6|GRD2I_HUMAN Delphilin OS=Homo sapiens OX=9606 GN=GRID2IP PE=1 SV=2 GRD2I_HUMAN reviewed Delphilin (Glutamate receptor, ionotropic, delta 2-interacting protein 1) Homo sapiens (Human) GO:0045211; GO:0060292; GO:0098688; GO:0099072; GO:0099092; GO:0099566; GO:0150048 long-term synaptic depression [GO:0060292]; regulation of postsynaptic cytosolic calcium ion concentration [GO:0099566]; regulation of postsynaptic membrane neurotransmitter receptor levels [GO:0099072] cerebellar granule cell to Purkinje cell synapse [GO:0150048]; parallel fiber to Purkinje cell synapse [GO:0098688]; postsynaptic density, intracellular component [GO:0099092]; postsynaptic membrane [GO:0045211] g17670.t2 A4D2P6 37.968 374 8.7700000000000005e-75 276.0 sp|A4D2P6|GRD2I_HUMAN Delphilin OS=Homo sapiens OX=9606 GN=GRID2IP PE=1 SV=2 GRD2I_HUMAN reviewed Delphilin (Glutamate receptor, ionotropic, delta 2-interacting protein 1) Homo sapiens (Human) GO:0045211; GO:0060292; GO:0098688; GO:0099072; GO:0099092; GO:0099566; GO:0150048 long-term synaptic depression [GO:0060292]; regulation of postsynaptic cytosolic calcium ion concentration [GO:0099566]; regulation of postsynaptic membrane neurotransmitter receptor levels [GO:0099072] cerebellar granule cell to Purkinje cell synapse [GO:0150048]; parallel fiber to Purkinje cell synapse [GO:0098688]; postsynaptic density, intracellular component [GO:0099092]; postsynaptic membrane [GO:0045211] g17670.t2 A4D2P6 39.301 229 1.33e-38 161.0 sp|A4D2P6|GRD2I_HUMAN Delphilin OS=Homo sapiens OX=9606 GN=GRID2IP PE=1 SV=2 GRD2I_HUMAN reviewed Delphilin (Glutamate receptor, ionotropic, delta 2-interacting protein 1) Homo sapiens (Human) GO:0045211; GO:0060292; GO:0098688; GO:0099072; GO:0099092; GO:0099566; GO:0150048 long-term synaptic depression [GO:0060292]; regulation of postsynaptic cytosolic calcium ion concentration [GO:0099566]; regulation of postsynaptic membrane neurotransmitter receptor levels [GO:0099072] cerebellar granule cell to Purkinje cell synapse [GO:0150048]; parallel fiber to Purkinje cell synapse [GO:0098688]; postsynaptic density, intracellular component [GO:0099092]; postsynaptic membrane [GO:0045211] g17671.t1 A1Z3X3 57.322 239 6.74e-99 295.0 sp|A1Z3X3|GET4_ORYLA Golgi to ER traffic protein 4 homolog OS=Oryzias latipes OX=8090 GN=get4 PE=2 SV=1 g17672.t1 O93610 56.979 437 1.84e-170 489.0 sp|O93610|DPOD2_XENLA DNA polymerase delta subunit 2 OS=Xenopus laevis OX=8355 GN=pold2 PE=2 SV=1 g17674.t1 Q8N0W5 39.095 243 4.37e-38 139.0 sp|Q8N0W5|IQCK_HUMAN IQ domain-containing protein K OS=Homo sapiens OX=9606 GN=IQCK PE=1 SV=1 g17675.t1 Q8NE00 54.672 503 6.72e-177 509.0 sp|Q8NE00|TM104_HUMAN Transmembrane protein 104 OS=Homo sapiens OX=9606 GN=TMEM104 PE=1 SV=2 g17678.t1 Q1JP75 60.976 205 4.64e-89 265.0 sp|Q1JP75|DCXR_BOVIN L-xylulose reductase OS=Bos taurus OX=9913 GN=DCXR PE=2 SV=1 g17680.t1 Q9QYT7 46.479 284 1.18e-60 214.0 sp|Q9QYT7|PIGQ_MOUSE Phosphatidylinositol N-acetylglucosaminyltransferase subunit Q OS=Mus musculus OX=10090 GN=Pigq PE=1 SV=3 g17682.t1 Q5ZHN3 82.222 225 5.71e-122 363.0 sp|Q5ZHN3|WIPI2_CHICK WD repeat domain phosphoinositide-interacting protein 2 OS=Gallus gallus OX=9031 GN=WIPI2 PE=2 SV=1 g2059.t1 P09848 54.149 482 7.8e-172 534.0 sp|P09848|LPH_HUMAN Lactase/phlorizin hydrolase OS=Homo sapiens OX=9606 GN=LCT PE=1 SV=3 LPH_HUMAN reviewed Lactase/phlorizin hydrolase (Lactase/glycosylceramidase) [Includes: Lactase (EC 3.2.1.108); Glycosylceramidase (EC 3.2.1.62) (Phlorizin hydrolase)] Homo sapiens (Human) GO:0000016; GO:0004336; GO:0004348; GO:0005886; GO:0005990; GO:0008422; GO:0042803; GO:0046477; GO:0080079; GO:0098591; GO:0140749; GO:1901733; GO:2000892 cellobiose catabolic process [GO:2000892]; glycosylceramide catabolic process [GO:0046477]; lactose catabolic process [GO:0005990]; quercetin catabolic process [GO:1901733] external side of apical plasma membrane [GO:0098591]; plasma membrane [GO:0005886] beta-glucosidase activity [GO:0008422]; cellobiose glucosidase activity [GO:0080079]; galactosylceramidase activity [GO:0004336]; glucosylceramidase activity [GO:0004348]; lactase activity [GO:0000016]; phlorizin hydrolase activity [GO:0140749]; protein homodimerization activity [GO:0042803] g2059.t1 P09848 52.0 475 1.9600000000000003e-161 506.0 sp|P09848|LPH_HUMAN Lactase/phlorizin hydrolase OS=Homo sapiens OX=9606 GN=LCT PE=1 SV=3 LPH_HUMAN reviewed Lactase/phlorizin hydrolase (Lactase/glycosylceramidase) [Includes: Lactase (EC 3.2.1.108); Glycosylceramidase (EC 3.2.1.62) (Phlorizin hydrolase)] Homo sapiens (Human) GO:0000016; GO:0004336; GO:0004348; GO:0005886; GO:0005990; GO:0008422; GO:0042803; GO:0046477; GO:0080079; GO:0098591; GO:0140749; GO:1901733; GO:2000892 cellobiose catabolic process [GO:2000892]; glycosylceramide catabolic process [GO:0046477]; lactose catabolic process [GO:0005990]; quercetin catabolic process [GO:1901733] external side of apical plasma membrane [GO:0098591]; plasma membrane [GO:0005886] beta-glucosidase activity [GO:0008422]; cellobiose glucosidase activity [GO:0080079]; galactosylceramidase activity [GO:0004336]; glucosylceramidase activity [GO:0004348]; lactase activity [GO:0000016]; phlorizin hydrolase activity [GO:0140749]; protein homodimerization activity [GO:0042803] g2059.t1 P09848 44.672 488 2.08e-133 429.0 sp|P09848|LPH_HUMAN Lactase/phlorizin hydrolase OS=Homo sapiens OX=9606 GN=LCT PE=1 SV=3 LPH_HUMAN reviewed Lactase/phlorizin hydrolase (Lactase/glycosylceramidase) [Includes: Lactase (EC 3.2.1.108); Glycosylceramidase (EC 3.2.1.62) (Phlorizin hydrolase)] Homo sapiens (Human) GO:0000016; GO:0004336; GO:0004348; GO:0005886; GO:0005990; GO:0008422; GO:0042803; GO:0046477; GO:0080079; GO:0098591; GO:0140749; GO:1901733; GO:2000892 cellobiose catabolic process [GO:2000892]; glycosylceramide catabolic process [GO:0046477]; lactose catabolic process [GO:0005990]; quercetin catabolic process [GO:1901733] external side of apical plasma membrane [GO:0098591]; plasma membrane [GO:0005886] beta-glucosidase activity [GO:0008422]; cellobiose glucosidase activity [GO:0080079]; galactosylceramidase activity [GO:0004336]; glucosylceramidase activity [GO:0004348]; lactase activity [GO:0000016]; phlorizin hydrolase activity [GO:0140749]; protein homodimerization activity [GO:0042803] g2060.t1 O14841 64.28 1299 0.0 1628.0 sp|O14841|OPLA_HUMAN 5-oxoprolinase OS=Homo sapiens OX=9606 GN=OPLAH PE=1 SV=3 g2061.t1 Q7YRA3 70.464 237 6.3e-125 357.0 sp|Q7YRA3|EXOS4_BOVIN Exosome complex component RRP41 OS=Bos taurus OX=9913 GN=EXOSC4 PE=2 SV=3 g2062.t1 Q8AVJ2 50.649 154 4.39e-33 134.0 sp|Q8AVJ2|L14AB_XENLA Protein LSM14 homolog A-B OS=Xenopus laevis OX=8355 GN=lsm14a-b PE=2 SV=1 g2063.t1 Q9VKA4 27.562 566 2.03e-54 210.0 sp|Q9VKA4|Y1760_DROME Probable G-protein coupled receptor CG31760 OS=Drosophila melanogaster OX=7227 GN=CG31760 PE=1 SV=3 g2074.t1 Q9D411 50.508 295 3.48e-97 294.0 sp|Q9D411|TSSK4_MOUSE Testis-specific serine/threonine-protein kinase 4 OS=Mus musculus OX=10090 GN=Tssk4 PE=1 SV=1 TSSK4_MOUSE reviewed Testis-specific serine/threonine-protein kinase 4 (TSK-4) (TSSK-4) (Testis-specific kinase 4) (EC 2.7.11.1) Mus musculus (Mouse) GO:0000287; GO:0001669; GO:0004672; GO:0004674; GO:0005524; GO:0006468; GO:0007286; GO:0009566; GO:0018105; GO:0030317; GO:0031514; GO:0032793; GO:0036126; GO:0042802; GO:0042803; GO:0044877; GO:0106310; GO:1990443 fertilization [GO:0009566]; flagellated sperm motility [GO:0030317]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine autophosphorylation [GO:1990443]; positive regulation of CREB transcription factor activity [GO:0032793]; protein phosphorylation [GO:0006468]; spermatid development [GO:0007286] acrosomal vesicle [GO:0001669]; motile cilium [GO:0031514]; sperm flagellum [GO:0036126] ATP binding [GO:0005524]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein-containing complex binding [GO:0044877] g2075.t1 Q5R605 59.296 199 5.849999999999999e-68 209.0 sp|Q5R605|CHM1A_PONAB Charged multivesicular body protein 1a OS=Pongo abelii OX=9601 GN=CHMP1A PE=2 SV=1 CHM1A_PONAB reviewed Charged multivesicular body protein 1a (Chromatin-modifying protein 1a) (CHMP1a) Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0000776; GO:0001778; GO:0005643; GO:0005765; GO:0005828; GO:0007080; GO:0015031; GO:0016363; GO:0030496; GO:0031468; GO:0032585; GO:0039702; GO:0043162; GO:0046761; GO:0061952; GO:0071985; GO:0097352; GO:1901673; GO:1902774; GO:1904930 autophagosome maturation [GO:0097352]; late endosome to lysosome transport [GO:1902774]; midbody abscission [GO:0061952]; mitotic metaphase chromosome alignment [GO:0007080]; multivesicular body sorting pathway [GO:0071985]; nuclear membrane reassembly [GO:0031468]; plasma membrane repair [GO:0001778]; protein transport [GO:0015031]; regulation of mitotic spindle assembly [GO:1901673]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]; viral budding from plasma membrane [GO:0046761]; viral budding via host ESCRT complex [GO:0039702] amphisome membrane [GO:1904930]; kinetochore [GO:0000776]; kinetochore microtubule [GO:0005828]; lysosomal membrane [GO:0005765]; midbody [GO:0030496]; multivesicular body membrane [GO:0032585]; nuclear matrix [GO:0016363]; nuclear pore [GO:0005643] g2076.t1 Q3T042 53.171 205 9.25e-68 226.0 sp|Q3T042|NOB1_BOVIN RNA-binding protein NOB1 OS=Bos taurus OX=9913 GN=NOB1 PE=2 SV=1 g2076.t1 Q3T042 41.081 185 3.68e-33 133.0 sp|Q3T042|NOB1_BOVIN RNA-binding protein NOB1 OS=Bos taurus OX=9913 GN=NOB1 PE=2 SV=1 g2077.t1 Q99L45 59.012 344 1.8e-109 325.0 sp|Q99L45|IF2B_MOUSE Eukaryotic translation initiation factor 2 subunit 2 OS=Mus musculus OX=10090 GN=Eif2s2 PE=1 SV=1 IF2B_MOUSE reviewed Eukaryotic translation initiation factor 2 subunit 2 (Eukaryotic translation initiation factor 2 subunit beta) (eIF2-beta) Mus musculus (Mouse) GO:0001701; GO:0001731; GO:0002176; GO:0002183; GO:0003729; GO:0003743; GO:0005737; GO:0005829; GO:0005850; GO:0006413; GO:0008270; GO:0008584; GO:0031369; GO:0045202 cytoplasmic translational initiation [GO:0002183]; formation of translation preinitiation complex [GO:0001731]; in utero embryonic development [GO:0001701]; male germ cell proliferation [GO:0002176]; male gonad development [GO:0008584]; translational initiation [GO:0006413] cytoplasm [GO:0005737]; cytosol [GO:0005829]; eukaryotic translation initiation factor 2 complex [GO:0005850]; synapse [GO:0045202] mRNA binding [GO:0003729]; translation initiation factor activity [GO:0003743]; translation initiation factor binding [GO:0031369]; zinc ion binding [GO:0008270] g2078.t1 Q6YHK3 31.852 1485 0.0 649.0 sp|Q6YHK3|CD109_HUMAN CD109 antigen OS=Homo sapiens OX=9606 GN=CD109 PE=1 SV=2 CD109_HUMAN reviewed CD109 antigen (150 kDa TGF-beta-1-binding protein) (C3 and PZP-like alpha-2-macroglobulin domain-containing protein 7) (Platelet-specific Gov antigen) (p180) (r150) (CD antigen CD109) Homo sapiens (Human) GO:0001942; GO:0004867; GO:0005576; GO:0005615; GO:0005829; GO:0005886; GO:0009986; GO:0010839; GO:0030512; GO:0031092; GO:0043616; GO:0045616; GO:0061045; GO:0072089; GO:0072675; GO:0098552; GO:2000647 hair follicle development [GO:0001942]; keratinocyte proliferation [GO:0043616]; negative regulation of keratinocyte proliferation [GO:0010839]; negative regulation of stem cell proliferation [GO:2000647]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; negative regulation of wound healing [GO:0061045]; osteoclast fusion [GO:0072675]; regulation of keratinocyte differentiation [GO:0045616]; stem cell proliferation [GO:0072089] cell surface [GO:0009986]; cytosol [GO:0005829]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; platelet alpha granule membrane [GO:0031092]; side of membrane [GO:0098552] serine-type endopeptidase inhibitor activity [GO:0004867] g2078.t2 Q6YHK3 31.614 1493 0.0 637.0 sp|Q6YHK3|CD109_HUMAN CD109 antigen OS=Homo sapiens OX=9606 GN=CD109 PE=1 SV=2 CD109_HUMAN reviewed CD109 antigen (150 kDa TGF-beta-1-binding protein) (C3 and PZP-like alpha-2-macroglobulin domain-containing protein 7) (Platelet-specific Gov antigen) (p180) (r150) (CD antigen CD109) Homo sapiens (Human) GO:0001942; GO:0004867; GO:0005576; GO:0005615; GO:0005829; GO:0005886; GO:0009986; GO:0010839; GO:0030512; GO:0031092; GO:0043616; GO:0045616; GO:0061045; GO:0072089; GO:0072675; GO:0098552; GO:2000647 hair follicle development [GO:0001942]; keratinocyte proliferation [GO:0043616]; negative regulation of keratinocyte proliferation [GO:0010839]; negative regulation of stem cell proliferation [GO:2000647]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; negative regulation of wound healing [GO:0061045]; osteoclast fusion [GO:0072675]; regulation of keratinocyte differentiation [GO:0045616]; stem cell proliferation [GO:0072089] cell surface [GO:0009986]; cytosol [GO:0005829]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; platelet alpha granule membrane [GO:0031092]; side of membrane [GO:0098552] serine-type endopeptidase inhibitor activity [GO:0004867] g2084.t1 Q9NZJ4 27.974 454 2.2099999999999998e-30 128.0 sp|Q9NZJ4|SACS_HUMAN Sacsin OS=Homo sapiens OX=9606 GN=SACS PE=1 SV=2 g2085.t1 Q9NZJ4 28.091 2321 0.0 764.0 sp|Q9NZJ4|SACS_HUMAN Sacsin OS=Homo sapiens OX=9606 GN=SACS PE=1 SV=2 g2085.t1 Q9NZJ4 30.401 1694 0.0 667.0 sp|Q9NZJ4|SACS_HUMAN Sacsin OS=Homo sapiens OX=9606 GN=SACS PE=1 SV=2 g2085.t1 Q9NZJ4 31.973 441 1.9199999999999998e-42 177.0 sp|Q9NZJ4|SACS_HUMAN Sacsin OS=Homo sapiens OX=9606 GN=SACS PE=1 SV=2 g2085.t1 Q9NZJ4 29.079 478 3.38e-39 166.0 sp|Q9NZJ4|SACS_HUMAN Sacsin OS=Homo sapiens OX=9606 GN=SACS PE=1 SV=2 g2085.t1 Q9NZJ4 26.974 608 5.16e-35 152.0 sp|Q9NZJ4|SACS_HUMAN Sacsin OS=Homo sapiens OX=9606 GN=SACS PE=1 SV=2 g2087.t1 Q6INN8 40.26 154 2.7400000000000002e-27 110.0 sp|Q6INN8|SAMH1_XENLA Deoxynucleoside triphosphate triphosphohydrolase SAMHD1 OS=Xenopus laevis OX=8355 GN=samhd1 PE=1 SV=2 SAMH1_XENLA reviewed Deoxynucleoside triphosphate triphosphohydrolase SAMHD1 (dNTPase) (EC 3.1.5.-) Xenopus laevis (African clawed frog) GO:0000724; GO:0003676; GO:0003697; GO:0003723; GO:0005525; GO:0005634; GO:0006203; GO:0006974; GO:0008270; GO:0008832; GO:0009264; GO:0016446; GO:0016793; GO:0032567; GO:0035861; GO:0045087; GO:0045088; GO:0046061; GO:0051289; GO:0051607; GO:0060339; GO:0106375; GO:0110025 dATP catabolic process [GO:0046061]; defense response to virus [GO:0051607]; deoxyribonucleotide catabolic process [GO:0009264]; dGTP catabolic process [GO:0006203]; DNA damage response [GO:0006974]; DNA strand resection involved in replication fork processing [GO:0110025]; double-strand break repair via homologous recombination [GO:0000724]; innate immune response [GO:0045087]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; protein homotetramerization [GO:0051289]; regulation of innate immune response [GO:0045088]; somatic hypermutation of immunoglobulin genes [GO:0016446] nucleus [GO:0005634]; site of double-strand break [GO:0035861] deoxynucleoside triphosphate hydrolase activity [GO:0106375]; dGTP binding [GO:0032567]; dGTPase activity [GO:0008832]; GTP binding [GO:0005525]; nucleic acid binding [GO:0003676]; RNA binding [GO:0003723]; single-stranded DNA binding [GO:0003697]; triphosphoric monoester hydrolase activity [GO:0016793]; zinc ion binding [GO:0008270] g2088.t1 Q0VCA5 53.911 358 2.7200000000000003e-121 364.0 sp|Q0VCA5|SAMH1_BOVIN Deoxynucleoside triphosphate triphosphohydrolase SAMHD1 OS=Bos taurus OX=9913 GN=SAMHD1 PE=2 SV=1 SAMH1_BOVIN reviewed Deoxynucleoside triphosphate triphosphohydrolase SAMHD1 (dNTPase) (EC 3.1.5.-) Bos taurus (Bovine) GO:0000724; GO:0003676; GO:0003697; GO:0003723; GO:0005525; GO:0005634; GO:0006203; GO:0006974; GO:0008270; GO:0008832; GO:0009264; GO:0016446; GO:0016793; GO:0032567; GO:0035861; GO:0045087; GO:0045088; GO:0046061; GO:0051289; GO:0051607; GO:0060339; GO:0106375; GO:0110025 dATP catabolic process [GO:0046061]; defense response to virus [GO:0051607]; deoxyribonucleotide catabolic process [GO:0009264]; dGTP catabolic process [GO:0006203]; DNA damage response [GO:0006974]; DNA strand resection involved in replication fork processing [GO:0110025]; double-strand break repair via homologous recombination [GO:0000724]; innate immune response [GO:0045087]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; protein homotetramerization [GO:0051289]; regulation of innate immune response [GO:0045088]; somatic hypermutation of immunoglobulin genes [GO:0016446] nucleus [GO:0005634]; site of double-strand break [GO:0035861] deoxynucleoside triphosphate hydrolase activity [GO:0106375]; dGTP binding [GO:0032567]; dGTPase activity [GO:0008832]; GTP binding [GO:0005525]; nucleic acid binding [GO:0003676]; RNA binding [GO:0003723]; single-stranded DNA binding [GO:0003697]; triphosphoric monoester hydrolase activity [GO:0016793]; zinc ion binding [GO:0008270] g2089.t1 Q9JLC8 41.969 193 3.25e-35 135.0 sp|Q9JLC8|SACS_MOUSE Sacsin OS=Mus musculus OX=10090 GN=Sacs PE=1 SV=2 g2090.t1 Q9NZJ4 29.668 391 1.83e-26 117.0 sp|Q9NZJ4|SACS_HUMAN Sacsin OS=Homo sapiens OX=9606 GN=SACS PE=1 SV=2 g2091.t1 Q9JLC8 24.597 744 1.7099999999999998e-48 189.0 sp|Q9JLC8|SACS_MOUSE Sacsin OS=Mus musculus OX=10090 GN=Sacs PE=1 SV=2 g2094.t1 Q9NZJ4 30.975 523 1.11e-69 255.0 sp|Q9NZJ4|SACS_HUMAN Sacsin OS=Homo sapiens OX=9606 GN=SACS PE=1 SV=2 g2094.t1 Q9NZJ4 33.019 424 1.89e-40 166.0 sp|Q9NZJ4|SACS_HUMAN Sacsin OS=Homo sapiens OX=9606 GN=SACS PE=1 SV=2 g2094.t1 Q9NZJ4 28.024 496 2.59e-32 140.0 sp|Q9NZJ4|SACS_HUMAN Sacsin OS=Homo sapiens OX=9606 GN=SACS PE=1 SV=2 g2095.t1 Q9NZJ4 39.118 340 1.5099999999999998e-54 213.0 sp|Q9NZJ4|SACS_HUMAN Sacsin OS=Homo sapiens OX=9606 GN=SACS PE=1 SV=2 g2095.t1 Q9NZJ4 53.509 114 5.8e-31 136.0 sp|Q9NZJ4|SACS_HUMAN Sacsin OS=Homo sapiens OX=9606 GN=SACS PE=1 SV=2 g2097.t1 Q9JLC8 23.942 685 1.89e-38 157.0 sp|Q9JLC8|SACS_MOUSE Sacsin OS=Mus musculus OX=10090 GN=Sacs PE=1 SV=2 g2098.t1 Q9JLC8 29.213 445 3.71e-33 139.0 sp|Q9JLC8|SACS_MOUSE Sacsin OS=Mus musculus OX=10090 GN=Sacs PE=1 SV=2 g2099.t1 Q9NZJ4 32.099 405 6.79e-51 187.0 sp|Q9NZJ4|SACS_HUMAN Sacsin OS=Homo sapiens OX=9606 GN=SACS PE=1 SV=2 g2100.t1 Q9NZJ4 31.378 392 1.01e-58 213.0 sp|Q9NZJ4|SACS_HUMAN Sacsin OS=Homo sapiens OX=9606 GN=SACS PE=1 SV=2 g2100.t1 Q9NZJ4 35.556 315 2.8e-34 141.0 sp|Q9NZJ4|SACS_HUMAN Sacsin OS=Homo sapiens OX=9606 GN=SACS PE=1 SV=2 g2100.t1 Q9NZJ4 31.535 241 7.81e-24 109.0 sp|Q9NZJ4|SACS_HUMAN Sacsin OS=Homo sapiens OX=9606 GN=SACS PE=1 SV=2 g2101.t1 Q9NZJ4 31.634 1236 1.05e-147 496.0 sp|Q9NZJ4|SACS_HUMAN Sacsin OS=Homo sapiens OX=9606 GN=SACS PE=1 SV=2 g2101.t1 Q9NZJ4 31.448 442 2.58e-44 180.0 sp|Q9NZJ4|SACS_HUMAN Sacsin OS=Homo sapiens OX=9606 GN=SACS PE=1 SV=2 g2101.t1 Q9NZJ4 24.024 820 3.6699999999999997e-41 170.0 sp|Q9NZJ4|SACS_HUMAN Sacsin OS=Homo sapiens OX=9606 GN=SACS PE=1 SV=2 g2102.t1 Q9JLC8 23.706 599 8.839999999999999e-30 129.0 sp|Q9JLC8|SACS_MOUSE Sacsin OS=Mus musculus OX=10090 GN=Sacs PE=1 SV=2 g2104.t1 W5PLZ6 52.809 89 7.039999999999999e-23 95.1 sp|W5PLZ6|LPH_SHEEP Lactase/phlorizin hydrolase OS=Ovis aries OX=9940 GN=LCT PE=1 SV=1 g2105.t1 Q6UWM7 45.075 335 3.08e-88 277.0 sp|Q6UWM7|LCTL_HUMAN Lactase-like protein OS=Homo sapiens OX=9606 GN=LCTL PE=1 SV=2 g2106.t1 P85971 49.16 238 2.91e-71 221.0 sp|P85971|6PGL_RAT 6-phosphogluconolactonase OS=Rattus norvegicus OX=10116 GN=Pgls PE=1 SV=1 g2107.t1 Q9UHC3 30.155 451 2.46e-52 188.0 sp|Q9UHC3|ASIC3_HUMAN Acid-sensing ion channel 3 OS=Homo sapiens OX=9606 GN=ASIC3 PE=1 SV=2 g2110.t1 A5YKK6 58.189 806 0.0 872.0 sp|A5YKK6|CNOT1_HUMAN CCR4-NOT transcription complex subunit 1 OS=Homo sapiens OX=9606 GN=CNOT1 PE=1 SV=2 CNOT1_HUMAN reviewed CCR4-NOT transcription complex subunit 1 (CCR4-associated factor 1) (Negative regulator of transcription subunit 1 homolog) (NOT1H) (hNOT1) Homo sapiens (Human) GO:0000122; GO:0000288; GO:0000289; GO:0000932; GO:0001829; GO:0003723; GO:0005615; GO:0005634; GO:0005778; GO:0005829; GO:0010606; GO:0016020; GO:0017148; GO:0019904; GO:0030014; GO:0030015; GO:0030331; GO:0033147; GO:0035195; GO:0042974; GO:0048387; GO:0060090; GO:0060213; GO:0061014; GO:0070016; GO:1900153; GO:2000036 miRNA-mediated post-transcriptional gene silencing [GO:0035195]; negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; negative regulation of retinoic acid receptor signaling pathway [GO:0048387]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of translation [GO:0017148]; nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:0000288]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; positive regulation of cytoplasmic mRNA processing body assembly [GO:0010606]; positive regulation of mRNA catabolic process [GO:0061014]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; regulation of stem cell population maintenance [GO:2000036]; trophectodermal cell differentiation [GO:0001829] CCR4-NOT complex [GO:0030014]; CCR4-NOT core complex [GO:0030015]; cytosol [GO:0005829]; extracellular space [GO:0005615]; membrane [GO:0016020]; nucleus [GO:0005634]; P-body [GO:0000932]; peroxisomal membrane [GO:0005778] armadillo repeat domain binding [GO:0070016]; molecular adaptor activity [GO:0060090]; nuclear estrogen receptor binding [GO:0030331]; nuclear retinoic acid receptor binding [GO:0042974]; protein domain specific binding [GO:0019904]; RNA binding [GO:0003723] g2110.t2 A0JP85 60.931 773 0.0 899.0 sp|A0JP85|CNOT1_XENTR CCR4-NOT transcription complex subunit 1 OS=Xenopus tropicalis OX=8364 GN=cnot1 PE=2 SV=1 CNOT1_XENTR reviewed CCR4-NOT transcription complex subunit 1 (CCR4-associated factor 1) Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0000122; GO:0000288; GO:0000932; GO:0005634; GO:0010606; GO:0017148; GO:0030014; GO:0030015; GO:0030331; GO:0031047; GO:0033147; GO:0042974; GO:0048387; GO:0060090; GO:0060213; GO:1900153 negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; negative regulation of retinoic acid receptor signaling pathway [GO:0048387]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of translation [GO:0017148]; nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:0000288]; positive regulation of cytoplasmic mRNA processing body assembly [GO:0010606]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; regulatory ncRNA-mediated gene silencing [GO:0031047] CCR4-NOT complex [GO:0030014]; CCR4-NOT core complex [GO:0030015]; nucleus [GO:0005634]; P-body [GO:0000932] molecular adaptor activity [GO:0060090]; nuclear estrogen receptor binding [GO:0030331]; nuclear retinoic acid receptor binding [GO:0042974] g2111.t1 A0JP85 61.992 492 0.0 628.0 sp|A0JP85|CNOT1_XENTR CCR4-NOT transcription complex subunit 1 OS=Xenopus tropicalis OX=8364 GN=cnot1 PE=2 SV=1 CNOT1_XENTR reviewed CCR4-NOT transcription complex subunit 1 (CCR4-associated factor 1) Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0000122; GO:0000288; GO:0000932; GO:0005634; GO:0010606; GO:0017148; GO:0030014; GO:0030015; GO:0030331; GO:0031047; GO:0033147; GO:0042974; GO:0048387; GO:0060090; GO:0060213; GO:1900153 negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; negative regulation of retinoic acid receptor signaling pathway [GO:0048387]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of translation [GO:0017148]; nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:0000288]; positive regulation of cytoplasmic mRNA processing body assembly [GO:0010606]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; regulatory ncRNA-mediated gene silencing [GO:0031047] CCR4-NOT complex [GO:0030014]; CCR4-NOT core complex [GO:0030015]; nucleus [GO:0005634]; P-body [GO:0000932] molecular adaptor activity [GO:0060090]; nuclear estrogen receptor binding [GO:0030331]; nuclear retinoic acid receptor binding [GO:0042974] g2111.t1 A0JP85 71.642 268 2.03e-123 414.0 sp|A0JP85|CNOT1_XENTR CCR4-NOT transcription complex subunit 1 OS=Xenopus tropicalis OX=8364 GN=cnot1 PE=2 SV=1 CNOT1_XENTR reviewed CCR4-NOT transcription complex subunit 1 (CCR4-associated factor 1) Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0000122; GO:0000288; GO:0000932; GO:0005634; GO:0010606; GO:0017148; GO:0030014; GO:0030015; GO:0030331; GO:0031047; GO:0033147; GO:0042974; GO:0048387; GO:0060090; GO:0060213; GO:1900153 negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; negative regulation of retinoic acid receptor signaling pathway [GO:0048387]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of translation [GO:0017148]; nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:0000288]; positive regulation of cytoplasmic mRNA processing body assembly [GO:0010606]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; regulatory ncRNA-mediated gene silencing [GO:0031047] CCR4-NOT complex [GO:0030014]; CCR4-NOT core complex [GO:0030015]; nucleus [GO:0005634]; P-body [GO:0000932] molecular adaptor activity [GO:0060090]; nuclear estrogen receptor binding [GO:0030331]; nuclear retinoic acid receptor binding [GO:0042974] g2112.t1 A5YKK6 74.731 744 0.0 1159.0 sp|A5YKK6|CNOT1_HUMAN CCR4-NOT transcription complex subunit 1 OS=Homo sapiens OX=9606 GN=CNOT1 PE=1 SV=2 CNOT1_HUMAN reviewed CCR4-NOT transcription complex subunit 1 (CCR4-associated factor 1) (Negative regulator of transcription subunit 1 homolog) (NOT1H) (hNOT1) Homo sapiens (Human) GO:0000122; GO:0000288; GO:0000289; GO:0000932; GO:0001829; GO:0003723; GO:0005615; GO:0005634; GO:0005778; GO:0005829; GO:0010606; GO:0016020; GO:0017148; GO:0019904; GO:0030014; GO:0030015; GO:0030331; GO:0033147; GO:0035195; GO:0042974; GO:0048387; GO:0060090; GO:0060213; GO:0061014; GO:0070016; GO:1900153; GO:2000036 miRNA-mediated post-transcriptional gene silencing [GO:0035195]; negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; negative regulation of retinoic acid receptor signaling pathway [GO:0048387]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of translation [GO:0017148]; nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:0000288]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; positive regulation of cytoplasmic mRNA processing body assembly [GO:0010606]; positive regulation of mRNA catabolic process [GO:0061014]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; regulation of stem cell population maintenance [GO:2000036]; trophectodermal cell differentiation [GO:0001829] CCR4-NOT complex [GO:0030014]; CCR4-NOT core complex [GO:0030015]; cytosol [GO:0005829]; extracellular space [GO:0005615]; membrane [GO:0016020]; nucleus [GO:0005634]; P-body [GO:0000932]; peroxisomal membrane [GO:0005778] armadillo repeat domain binding [GO:0070016]; molecular adaptor activity [GO:0060090]; nuclear estrogen receptor binding [GO:0030331]; nuclear retinoic acid receptor binding [GO:0042974]; protein domain specific binding [GO:0019904]; RNA binding [GO:0003723] g2113.t1 Q09225 26.052 499 9.3e-34 142.0 sp|Q09225|NRF6_CAEEL Nose resistant to fluoxetine protein 6 OS=Caenorhabditis elegans OX=6239 GN=nrf-6 PE=1 SV=3 NRF6_CAEEL reviewed Nose resistant to fluoxetine protein 6 (Protein nrf-6) Caenorhabditis elegans GO:0006869; GO:0008289; GO:0016020; GO:0016747 lipid transport [GO:0006869] membrane [GO:0016020] acyltransferase activity, transferring groups other than amino-acyl groups [GO:0016747]; lipid binding [GO:0008289] g2114.t1 Q09225 28.289 707 6.05e-67 239.0 sp|Q09225|NRF6_CAEEL Nose resistant to fluoxetine protein 6 OS=Caenorhabditis elegans OX=6239 GN=nrf-6 PE=1 SV=3 NRF6_CAEEL reviewed Nose resistant to fluoxetine protein 6 (Protein nrf-6) Caenorhabditis elegans GO:0006869; GO:0008289; GO:0016020; GO:0016747 lipid transport [GO:0006869] membrane [GO:0016020] acyltransferase activity, transferring groups other than amino-acyl groups [GO:0016747]; lipid binding [GO:0008289] g2116.t1 Q09225 26.792 586 4.46e-39 157.0 sp|Q09225|NRF6_CAEEL Nose resistant to fluoxetine protein 6 OS=Caenorhabditis elegans OX=6239 GN=nrf-6 PE=1 SV=3 NRF6_CAEEL reviewed Nose resistant to fluoxetine protein 6 (Protein nrf-6) Caenorhabditis elegans GO:0006869; GO:0008289; GO:0016020; GO:0016747 lipid transport [GO:0006869] membrane [GO:0016020] acyltransferase activity, transferring groups other than amino-acyl groups [GO:0016747]; lipid binding [GO:0008289] g2117.t1 O76536 42.132 1163 0.0 693.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g2117.t1 O76536 40.894 1208 0.0 681.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g2117.t1 O76536 41.549 1059 0.0 634.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g2117.t1 O76536 39.083 1003 5.65e-159 531.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g2117.t1 O76536 40.649 893 6.039999999999999e-159 531.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g2117.t1 O76536 38.14 1054 1.97e-131 450.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g2117.t1 O76536 36.053 1054 4.6e-124 428.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g2117.t1 O76536 36.792 1041 1.3e-120 418.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g2117.t1 O76536 38.778 851 1.39e-113 397.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g2117.t1 O76536 36.345 985 8.23e-111 389.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g2117.t1 O76536 39.13 483 6.8e-69 260.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g2117.t2 O76536 41.64 1232 0.0 713.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g2117.t2 O76536 42.032 1142 0.0 697.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g2117.t2 O76536 40.363 1157 0.0 627.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g2117.t2 O76536 40.888 1059 0.0 625.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g2117.t2 O76536 40.426 893 5.17e-159 531.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g2117.t2 O76536 38.883 1003 3.0700000000000005e-157 526.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g2117.t2 O76536 38.14 1054 2.06e-131 450.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g2117.t2 O76536 36.053 1054 4.82e-124 428.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g2117.t2 O76536 36.792 1041 1.36e-120 418.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g2117.t2 O76536 38.778 851 1.45e-113 397.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g2117.t2 O76536 36.345 985 8.619999999999999e-111 389.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g2117.t2 O76536 39.13 483 8.4e-69 260.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g2117.t3 O76536 41.519 1185 0.0 712.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g2117.t3 O76536 42.013 1202 0.0 710.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g2117.t3 O76536 41.147 1186 0.0 700.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g2117.t3 O76536 41.808 1117 0.0 682.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g2117.t3 O76536 40.994 1127 0.0 651.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g2117.t3 O76536 39.877 978 9.330000000000001e-163 543.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g2117.t3 O76536 38.14 1054 2.21e-131 450.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g2117.t3 O76536 36.053 1054 5.15e-124 428.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g2117.t3 O76536 36.792 1041 1.46e-120 418.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g2117.t3 O76536 38.778 851 1.55e-113 397.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g2117.t3 O76536 36.345 985 9.21e-111 389.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g2117.t3 O76536 40.987 527 1.1600000000000001e-88 322.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g2117.t3 O76536 39.651 459 5.649999999999999e-68 257.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g2117.t4 O76536 42.37 1232 0.0 742.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g2117.t4 O76536 42.557 1142 0.0 708.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g2117.t4 O76536 41.227 1157 0.0 655.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g2117.t4 O76536 41.549 1059 0.0 640.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g2117.t4 O76536 41.433 893 8.3e-167 554.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g2117.t4 O76536 39.482 1003 3.43e-165 550.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g2117.t4 O76536 38.14 1054 2.08e-131 450.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g2117.t4 O76536 36.053 1054 4.850000000000001e-124 428.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g2117.t4 O76536 36.792 1041 1.3699999999999999e-120 418.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g2117.t4 O76536 38.778 851 1.46e-113 397.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g2117.t4 O76536 36.345 985 8.67e-111 389.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g2117.t4 O76536 39.13 483 4.81e-69 261.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g2117.t5 O76536 41.891 1227 0.0 717.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g2117.t5 O76536 41.108 1209 0.0 716.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g2117.t5 O76536 41.04 1211 0.0 709.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g2117.t5 O76536 41.594 1142 0.0 690.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g2117.t5 O76536 40.712 1152 0.0 657.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g2117.t5 O76536 39.877 978 1.48e-162 542.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g2117.t5 O76536 38.14 1054 2.2499999999999998e-131 450.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g2117.t5 O76536 36.053 1054 5.250000000000001e-124 428.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g2117.t5 O76536 36.792 1041 1.4799999999999999e-120 418.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g2117.t5 O76536 38.778 851 1.58e-113 397.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g2117.t5 O76536 36.345 985 9.38e-111 389.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g2117.t5 O76536 40.653 551 7.6199999999999995e-93 334.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g2117.t5 O76536 39.13 483 9.45e-69 260.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g2117.t6 O76536 41.998 1231 0.0 725.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g2117.t6 O76536 41.592 1231 0.0 716.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g2117.t6 O76536 41.108 1209 0.0 716.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g2117.t6 O76536 41.04 1211 0.0 709.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g2117.t6 O76536 41.119 1233 0.0 693.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g2117.t6 O76536 41.594 1142 0.0 690.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g2117.t6 O76536 39.629 1133 0.0 604.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g2117.t6 O76536 38.14 1054 2.44e-131 450.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g2117.t6 O76536 36.053 1054 5.700000000000001e-124 428.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g2117.t6 O76536 36.792 1041 1.61e-120 418.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g2117.t6 O76536 38.778 851 1.72e-113 397.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g2117.t6 O76536 36.345 985 1.02e-110 389.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g2117.t6 O76536 40.653 551 8.89e-93 334.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g2117.t6 O76536 39.13 483 1.1799999999999998e-68 259.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g2118.t1 O76536 35.638 564 1.23e-61 228.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g2118.t1 O76536 36.057 563 5.509999999999999e-60 223.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g2118.t1 O76536 33.798 574 1.92e-58 219.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g2118.t1 O76536 36.38 569 3.63e-58 218.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g2118.t1 O76536 32.632 570 2.16e-56 213.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g2118.t1 O76536 33.993 556 1.6999999999999998e-48 189.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g2119.t1 Q5R9W3 59.259 243 1.41e-102 301.0 sp|Q5R9W3|DERL1_PONAB Derlin-1 OS=Pongo abelii OX=9601 GN=DERL1 PE=2 SV=1 DERL1_PONAB reviewed Derlin-1 (Der1-like protein 1) Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0005047; GO:0005769; GO:0005770; GO:0030968; GO:0030970; GO:0031398; GO:0031625; GO:0031648; GO:0036502; GO:0036513; GO:0042288; GO:0042802; GO:0043161; GO:0044322; GO:0051117; GO:0071218; GO:1990381 cellular response to misfolded protein [GO:0071218]; endoplasmic reticulum unfolded protein response [GO:0030968]; positive regulation of protein ubiquitination [GO:0031398]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein destabilization [GO:0031648]; retrograde protein transport, ER to cytosol [GO:0030970] Derlin-1 retrotranslocation complex [GO:0036513]; Derlin-1-VIMP complex [GO:0036502]; early endosome [GO:0005769]; endoplasmic reticulum quality control compartment [GO:0044322]; late endosome [GO:0005770] ATPase binding [GO:0051117]; identical protein binding [GO:0042802]; MHC class I protein binding [GO:0042288]; signal recognition particle binding [GO:0005047]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-specific protease binding [GO:1990381] g2120.t1 Q6DEY8 53.958 1099 0.0 1202.0 sp|Q6DEY8|TBC31_XENTR TBC1 domain family member 31 OS=Xenopus tropicalis OX=8364 GN=tbc1d31 PE=2 SV=1 TBC31_XENTR reviewed TBC1 domain family member 31 Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0005813; GO:0034451; GO:0036064; GO:0060090; GO:0060271 cilium assembly [GO:0060271] centriolar satellite [GO:0034451]; centrosome [GO:0005813]; ciliary basal body [GO:0036064] molecular adaptor activity [GO:0060090] g2120.t2 Q6DEY8 54.429 1095 0.0 1203.0 sp|Q6DEY8|TBC31_XENTR TBC1 domain family member 31 OS=Xenopus tropicalis OX=8364 GN=tbc1d31 PE=2 SV=1 TBC31_XENTR reviewed TBC1 domain family member 31 Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0005813; GO:0034451; GO:0036064; GO:0060090; GO:0060271 cilium assembly [GO:0060271] centriolar satellite [GO:0034451]; centrosome [GO:0005813]; ciliary basal body [GO:0036064] molecular adaptor activity [GO:0060090] g2122.t1 Q8BGQ7 60.718 975 0.0 1201.0 sp|Q8BGQ7|SYAC_MOUSE Alanine--tRNA ligase, cytoplasmic OS=Mus musculus OX=10090 GN=Aars1 PE=1 SV=1 SYAC_MOUSE reviewed Alanine--tRNA ligase, cytoplasmic (EC 6.1.1.7) (Alanyl-tRNA synthetase) (AlaRS) (Protein lactyltransferase AARS1) (EC 6.-.-.-) (Protein sticky) (Sti) Mus musculus (Mouse) GO:0000049; GO:0002161; GO:0002196; GO:0004813; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006400; GO:0006419; GO:0008270; GO:0016597; GO:0021680; GO:0030330; GO:0035329; GO:0035332; GO:0043524; GO:0050885; GO:0050905; GO:0140018; GO:0141207; GO:1901797 alanyl-tRNA aminoacylation [GO:0006419]; cerebellar Purkinje cell layer development [GO:0021680]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; hippo signaling [GO:0035329]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of signal transduction by p53 class mediator [GO:1901797]; neuromuscular process [GO:0050905]; neuromuscular process controlling balance [GO:0050885]; positive regulation of hippo signaling [GO:0035332]; regulation of cytoplasmic translational fidelity [GO:0140018]; tRNA modification [GO:0006400] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634] alanine-tRNA ligase activity [GO:0004813]; amino acid binding [GO:0016597]; aminoacyl-tRNA deacylase activity [GO:0002161]; ATP binding [GO:0005524]; peptide lactyltransferase (ATP-dependent) activity [GO:0141207]; Ser-tRNA(Ala) deacylase activity [GO:0002196]; tRNA binding [GO:0000049]; zinc ion binding [GO:0008270] g2123.t1 A0A061ACU2 28.113 2369 0.0 651.0 sp|A0A061ACU2|PIEZ1_CAEEL Piezo-type mechanosensitive ion channel component 1 OS=Caenorhabditis elegans OX=6239 GN=pezo-1 PE=1 SV=1 PIEZ1_CAEEL reviewed Piezo-type mechanosensitive ion channel component 1 Caenorhabditis elegans GO:0005261; GO:0005886; GO:0008381; GO:0009612; GO:0030317; GO:0042391; GO:0050982; GO:0060279; GO:0071260; GO:0090727; GO:0098655 cellular response to mechanical stimulus [GO:0071260]; detection of mechanical stimulus [GO:0050982]; flagellated sperm motility [GO:0030317]; monoatomic cation transmembrane transport [GO:0098655]; positive regulation of brood size [GO:0090727]; positive regulation of ovulation [GO:0060279]; regulation of membrane potential [GO:0042391]; response to mechanical stimulus [GO:0009612] plasma membrane [GO:0005886] mechanosensitive monoatomic ion channel activity [GO:0008381]; monoatomic cation channel activity [GO:0005261] g2123.t2 A0A061ACU2 28.153 2355 0.0 655.0 sp|A0A061ACU2|PIEZ1_CAEEL Piezo-type mechanosensitive ion channel component 1 OS=Caenorhabditis elegans OX=6239 GN=pezo-1 PE=1 SV=1 PIEZ1_CAEEL reviewed Piezo-type mechanosensitive ion channel component 1 Caenorhabditis elegans GO:0005261; GO:0005886; GO:0008381; GO:0009612; GO:0030317; GO:0042391; GO:0050982; GO:0060279; GO:0071260; GO:0090727; GO:0098655 cellular response to mechanical stimulus [GO:0071260]; detection of mechanical stimulus [GO:0050982]; flagellated sperm motility [GO:0030317]; monoatomic cation transmembrane transport [GO:0098655]; positive regulation of brood size [GO:0090727]; positive regulation of ovulation [GO:0060279]; regulation of membrane potential [GO:0042391]; response to mechanical stimulus [GO:0009612] plasma membrane [GO:0005886] mechanosensitive monoatomic ion channel activity [GO:0008381]; monoatomic cation channel activity [GO:0005261] g2123.t3 A0A061ACU2 28.088 2364 0.0 650.0 sp|A0A061ACU2|PIEZ1_CAEEL Piezo-type mechanosensitive ion channel component 1 OS=Caenorhabditis elegans OX=6239 GN=pezo-1 PE=1 SV=1 PIEZ1_CAEEL reviewed Piezo-type mechanosensitive ion channel component 1 Caenorhabditis elegans GO:0005261; GO:0005886; GO:0008381; GO:0009612; GO:0030317; GO:0042391; GO:0050982; GO:0060279; GO:0071260; GO:0090727; GO:0098655 cellular response to mechanical stimulus [GO:0071260]; detection of mechanical stimulus [GO:0050982]; flagellated sperm motility [GO:0030317]; monoatomic cation transmembrane transport [GO:0098655]; positive regulation of brood size [GO:0090727]; positive regulation of ovulation [GO:0060279]; regulation of membrane potential [GO:0042391]; response to mechanical stimulus [GO:0009612] plasma membrane [GO:0005886] mechanosensitive monoatomic ion channel activity [GO:0008381]; monoatomic cation channel activity [GO:0005261] g2123.t4 A0A061ACU2 27.901 2387 0.0 651.0 sp|A0A061ACU2|PIEZ1_CAEEL Piezo-type mechanosensitive ion channel component 1 OS=Caenorhabditis elegans OX=6239 GN=pezo-1 PE=1 SV=1 PIEZ1_CAEEL reviewed Piezo-type mechanosensitive ion channel component 1 Caenorhabditis elegans GO:0005261; GO:0005886; GO:0008381; GO:0009612; GO:0030317; GO:0042391; GO:0050982; GO:0060279; GO:0071260; GO:0090727; GO:0098655 cellular response to mechanical stimulus [GO:0071260]; detection of mechanical stimulus [GO:0050982]; flagellated sperm motility [GO:0030317]; monoatomic cation transmembrane transport [GO:0098655]; positive regulation of brood size [GO:0090727]; positive regulation of ovulation [GO:0060279]; regulation of membrane potential [GO:0042391]; response to mechanical stimulus [GO:0009612] plasma membrane [GO:0005886] mechanosensitive monoatomic ion channel activity [GO:0008381]; monoatomic cation channel activity [GO:0005261] g2126.t1 P0DW91 51.549 355 1.02e-130 382.0 sp|P0DW91|ZTRF1_BOVIN Zinc finger TRAF-type-containing protein 1 OS=Bos taurus OX=9913 GN=ZFTRAF1 PE=3 SV=1 g2127.t1 A6QLP7 46.154 182 1.03e-44 156.0 sp|A6QLP7|SSRA_BOVIN Translocon-associated protein subunit alpha OS=Bos taurus OX=9913 GN=SSR1 PE=2 SV=1 g2128.t1 Q5RCM6 58.788 165 1.1499999999999999e-55 198.0 sp|Q5RCM6|SOCS6_PONAB Suppressor of cytokine signaling 6 OS=Pongo abelii OX=9601 GN=SOCS6 PE=2 SV=1 g2129.t1 Q5RJV0 39.785 186 9.4e-44 150.0 sp|Q5RJV0|COQ9_XENTR Ubiquinone biosynthesis protein COQ9, mitochondrial OS=Xenopus tropicalis OX=8364 GN=coq9 PE=2 SV=1 g2131.t1 Q9CWZ7 43.91 312 1.25e-83 258.0 sp|Q9CWZ7|SNAG_MOUSE Gamma-soluble NSF attachment protein OS=Mus musculus OX=10090 GN=Napg PE=1 SV=1 g2132.t1 Q5ZJX5 38.826 443 3.23e-95 298.0 sp|Q5ZJX5|MEAK7_CHICK MTOR-associated protein MEAK7 OS=Gallus gallus OX=9031 GN=MEAK7 PE=2 SV=1 MEAK7_CHICK reviewed MTOR-associated protein MEAK7 (MEAK7) (TBC/LysM-associated domain-containing protein 1) (TLD domain-containing protein 1) Gallus gallus (Chicken) GO:0005634; GO:0005737; GO:0005765; GO:0006979; GO:0016020; GO:0030334; GO:0031667; GO:0031929; GO:0032868; GO:0042127; GO:0043200; GO:0150032 positive regulation of protein localization to lysosome [GO:0150032]; regulation of cell migration [GO:0030334]; regulation of cell population proliferation [GO:0042127]; response to amino acid [GO:0043200]; response to insulin [GO:0032868]; response to nutrient levels [GO:0031667]; response to oxidative stress [GO:0006979]; TOR signaling [GO:0031929] cytoplasm [GO:0005737]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; nucleus [GO:0005634] g2133.t1 P58137 42.951 305 2.8e-76 239.0 sp|P58137|ACOT8_MOUSE Acyl-coenzyme A thioesterase 8 OS=Mus musculus OX=10090 GN=Acot8 PE=1 SV=1 ACOT8_MOUSE reviewed Acyl-coenzyme A thioesterase 8 (Acyl-CoA thioesterase 8) (EC 3.1.2.1) (EC 3.1.2.11) (EC 3.1.2.2) (EC 3.1.2.3) (EC 3.1.2.5) (Choloyl-coenzyme A thioesterase) (EC 3.1.2.27) (Peroxisomal acyl-CoA thioesterase 2) (PTE-2) (Peroxisomal acyl-coenzyme A thioester hydrolase 1) (PTE-1) (Peroxisomal long-chain acyl-CoA thioesterase 1) Mus musculus (Mouse) GO:0003986; GO:0004778; GO:0005739; GO:0005777; GO:0005782; GO:0006633; GO:0006637; GO:0009062; GO:0010561; GO:0016559; GO:0033882; GO:0043649; GO:0047603; GO:0047617; GO:0047994; GO:0052689; GO:0052815; GO:0052816 acyl-CoA metabolic process [GO:0006637]; dicarboxylic acid catabolic process [GO:0043649]; fatty acid biosynthetic process [GO:0006633]; fatty acid catabolic process [GO:0009062]; negative regulation of glycoprotein biosynthetic process [GO:0010561]; peroxisome fission [GO:0016559] mitochondrion [GO:0005739]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777] acetoacetyl-CoA hydrolase activity [GO:0047603]; acetyl-CoA hydrolase activity [GO:0003986]; carboxylic ester hydrolase activity [GO:0052689]; choloyl-CoA hydrolase activity [GO:0033882]; fatty acyl-CoA hydrolase activity [GO:0047617]; hydroxymethylglutaryl-CoA hydrolase activity [GO:0047994]; long-chain fatty acyl-CoA hydrolase activity [GO:0052816]; medium-chain fatty acyl-CoA hydrolase activity [GO:0052815]; succinyl-CoA hydrolase activity [GO:0004778] g2140.t1 Q5U4V2 32.997 297 6.97e-44 154.0 sp|Q5U4V2|HNMTA_XENLA Histamine N-methyltransferase A OS=Xenopus laevis OX=8355 GN=hnmt-a PE=2 SV=1 g2141.t1 Q5U4V2 31.293 294 4.86e-38 139.0 sp|Q5U4V2|HNMTA_XENLA Histamine N-methyltransferase A OS=Xenopus laevis OX=8355 GN=hnmt-a PE=2 SV=1 g2142.t1 Q6DC37 29.431 299 1.59e-41 148.0 sp|Q6DC37|HNMT_DANRE Histamine N-methyltransferase OS=Danio rerio OX=7955 GN=hnmt PE=2 SV=1 g2143.t1 Q5U4V2 32.886 298 9.94e-44 154.0 sp|Q5U4V2|HNMTA_XENLA Histamine N-methyltransferase A OS=Xenopus laevis OX=8355 GN=hnmt-a PE=2 SV=1 g2144.t1 Q0V9P1 32.432 296 7.879999999999999e-45 157.0 sp|Q0V9P1|HNMT_XENTR Histamine N-methyltransferase OS=Xenopus tropicalis OX=8364 GN=hnmt PE=2 SV=1 g2145.t1 Q5U4V2 35.354 297 4.5e-46 160.0 sp|Q5U4V2|HNMTA_XENLA Histamine N-methyltransferase A OS=Xenopus laevis OX=8355 GN=hnmt-a PE=2 SV=1 g2147.t1 Q6DC37 32.765 293 2.3300000000000002e-43 152.0 sp|Q6DC37|HNMT_DANRE Histamine N-methyltransferase OS=Danio rerio OX=7955 GN=hnmt PE=2 SV=1 g2148.t1 Q28DH9 67.356 677 0.0 899.0 sp|Q28DH9|CEP76_XENTR Centrosomal protein of 76 kDa OS=Xenopus tropicalis OX=8364 GN=cep76 PE=2 SV=1 g2151.t1 Q9H5Z1 67.194 695 0.0 909.0 sp|Q9H5Z1|DHX35_HUMAN Probable ATP-dependent RNA helicase DHX35 OS=Homo sapiens OX=9606 GN=DHX35 PE=1 SV=2 DHX35_HUMAN reviewed Probable ATP-dependent RNA helicase DHX35 (EC 3.6.4.13) (DEAH box protein 35) Homo sapiens (Human) GO:0000398; GO:0001701; GO:0003723; GO:0003724; GO:0004386; GO:0005524; GO:0005654; GO:0016887; GO:0071013 in utero embryonic development [GO:0001701]; mRNA splicing, via spliceosome [GO:0000398] catalytic step 2 spliceosome [GO:0071013]; nucleoplasm [GO:0005654] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; helicase activity [GO:0004386]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724] g2152.t1 Q9NX04 30.392 204 1.3100000000000002e-27 107.0 sp|Q9NX04|AIRIM_HUMAN AFG2-interacting ribosome maturation factor OS=Homo sapiens OX=9606 GN=AIRIM PE=1 SV=1 AIRIM_HUMAN reviewed AFG2-interacting ribosome maturation factor (Ribosome biogenesis protein C1orf109) Homo sapiens (Human) GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0042273 ribosomal large subunit biogenesis [GO:0042273] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] g2154.t1 Q9DE07 42.276 123 4.7399999999999997e-23 96.3 sp|Q9DE07|NBN_CHICK Nibrin OS=Gallus gallus OX=9031 GN=NBN PE=1 SV=1 NBN_CHICK reviewed Nibrin (Nijmegen breakage syndrome protein 1 homolog) Gallus gallus (Chicken) GO:0000723; GO:0000724; GO:0000729; GO:0000781; GO:0003684; GO:0005654; GO:0006302; GO:0007095; GO:0016605; GO:0030870; GO:0031848; GO:0035861; GO:0042405; GO:0043247; GO:0043539; GO:0048145; GO:0051321; GO:0062176; GO:0140031; GO:0140297; GO:0140463; GO:1990166 DNA double-strand break processing [GO:0000729]; double-strand break repair [GO:0006302]; double-strand break repair via homologous recombination [GO:0000724]; meiotic cell cycle [GO:0051321]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; protection from non-homologous end joining at telomere [GO:0031848]; protein localization to site of double-strand break [GO:1990166]; R-loop processing [GO:0062176]; regulation of fibroblast proliferation [GO:0048145]; telomere maintenance [GO:0000723]; telomere maintenance in response to DNA damage [GO:0043247] chromosome, telomeric region [GO:0000781]; Mre11 complex [GO:0030870]; nuclear inclusion body [GO:0042405]; nucleoplasm [GO:0005654]; PML body [GO:0016605]; site of double-strand break [GO:0035861] chromatin-protein adaptor activity [GO:0140463]; damaged DNA binding [GO:0003684]; DNA-binding transcription factor binding [GO:0140297]; phosphorylation-dependent protein binding [GO:0140031]; protein serine/threonine kinase activator activity [GO:0043539] g2155.t1 Q9JIL9 37.313 201 1.0499999999999999e-30 131.0 sp|Q9JIL9|NBN_RAT Nibrin OS=Rattus norvegicus OX=10116 GN=Nbn PE=1 SV=2 NBN_RAT reviewed Nibrin (Nijmegen breakage syndrome protein 1 homolog) Rattus norvegicus (Rat) GO:0000077; GO:0000723; GO:0000724; GO:0000729; GO:0000781; GO:0001701; GO:0001832; GO:0003684; GO:0005634; GO:0005654; GO:0005657; GO:0005730; GO:0005794; GO:0006302; GO:0007095; GO:0007405; GO:0008284; GO:0009410; GO:0016605; GO:0030870; GO:0031848; GO:0031860; GO:0032206; GO:0035861; GO:0042393; GO:0042405; GO:0043247; GO:0043539; GO:0045190; GO:0045665; GO:0046597; GO:0048145; GO:0050885; GO:0051321; GO:0062176; GO:0070533; GO:0090656; GO:0090737; GO:0097193; GO:0097681; GO:0110025; GO:0140031; GO:0140297; GO:0140463; GO:1904354; GO:1990166; GO:2000781 blastocyst growth [GO:0001832]; DNA damage checkpoint signaling [GO:0000077]; DNA double-strand break processing [GO:0000729]; DNA strand resection involved in replication fork processing [GO:0110025]; double-strand break repair [GO:0006302]; double-strand break repair via alternative nonhomologous end joining [GO:0097681]; double-strand break repair via homologous recombination [GO:0000724]; host-mediated suppression of symbiont invasion [GO:0046597]; in utero embryonic development [GO:0001701]; intrinsic apoptotic signaling pathway [GO:0097193]; isotype switching [GO:0045190]; meiotic cell cycle [GO:0051321]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of telomere capping [GO:1904354]; neuroblast proliferation [GO:0007405]; neuromuscular process controlling balance [GO:0050885]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of telomere maintenance [GO:0032206]; protection from non-homologous end joining at telomere [GO:0031848]; protein localization to site of double-strand break [GO:1990166]; R-loop processing [GO:0062176]; regulation of fibroblast proliferation [GO:0048145]; response to xenobiotic stimulus [GO:0009410]; t-circle formation [GO:0090656]; telomere maintenance [GO:0000723]; telomere maintenance in response to DNA damage [GO:0043247]; telomere maintenance via telomere trimming [GO:0090737]; telomeric 3' overhang formation [GO:0031860] BRCA1-C complex [GO:0070533]; chromosome, telomeric region [GO:0000781]; Golgi apparatus [GO:0005794]; Mre11 complex [GO:0030870]; nuclear inclusion body [GO:0042405]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; replication fork [GO:0005657]; site of double-strand break [GO:0035861] chromatin-protein adaptor activity [GO:0140463]; damaged DNA binding [GO:0003684]; DNA-binding transcription factor binding [GO:0140297]; histone binding [GO:0042393]; phosphorylation-dependent protein binding [GO:0140031]; protein serine/threonine kinase activator activity [GO:0043539] g2156.t1 Q9Y236 42.827 481 1.22e-116 356.0 sp|Q9Y236|OSGI2_HUMAN Oxidative stress-induced growth inhibitor 2 OS=Homo sapiens OX=9606 GN=OSGIN2 PE=1 SV=1 g2157.t1 Q9DAJ5 80.645 93 5.9899999999999995e-52 160.0 sp|Q9DAJ5|DLRB2_MOUSE Dynein light chain roadblock-type 2 OS=Mus musculus OX=10090 GN=Dynlrb2 PE=1 SV=1 g2158.t1 Q2T9Q1 62.411 282 4.14e-120 356.0 sp|Q2T9Q1|TBC20_BOVIN TBC1 domain family member 20 OS=Bos taurus OX=9913 GN=TBC1D20 PE=2 SV=1 TBC20_BOVIN reviewed TBC1 domain family member 20 Bos taurus (Bovine) GO:0000139; GO:0001675; GO:0005096; GO:0005789; GO:0006888; GO:0007030; GO:0019068; GO:0031267; GO:0031965; GO:0034389; GO:0044829; GO:0046726; GO:0070309; GO:0072520; GO:0090110; GO:1902953 acrosome assembly [GO:0001675]; COPII-coated vesicle cargo loading [GO:0090110]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; host-mediated activation of viral genome replication [GO:0044829]; lens fiber cell morphogenesis [GO:0070309]; lipid droplet organization [GO:0034389]; positive regulation by virus of viral protein levels in host cell [GO:0046726]; positive regulation of ER to Golgi vesicle-mediated transport [GO:1902953]; seminiferous tubule development [GO:0072520]; virion assembly [GO:0019068] endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; nuclear membrane [GO:0031965] GTPase activator activity [GO:0005096]; small GTPase binding [GO:0031267] g2160.t1 E7F4Z4 54.913 173 1.84e-59 210.0 sp|E7F4Z4|ZDHC1_DANRE Palmitoyltransferase ZDHHC1 OS=Danio rerio OX=7955 GN=zdhhc1 PE=2 SV=2 ZDHC1_DANRE reviewed Palmitoyltransferase ZDHHC1 (EC 2.3.1.225) (DHHC domain-containing protein 1) (Zinc finger DHHC domain-containing protein 1) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005783; GO:0005789; GO:0005794; GO:0006612; GO:0010008; GO:0019706; GO:0140374; GO:1900227 antiviral innate immune response [GO:0140374]; positive regulation of NLRP3 inflammasome complex assembly [GO:1900227]; protein targeting to membrane [GO:0006612] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794] protein-cysteine S-palmitoyltransferase activity [GO:0019706] g2160.t2 E7F4Z4 54.913 173 3.9500000000000004e-59 210.0 sp|E7F4Z4|ZDHC1_DANRE Palmitoyltransferase ZDHHC1 OS=Danio rerio OX=7955 GN=zdhhc1 PE=2 SV=2 ZDHC1_DANRE reviewed Palmitoyltransferase ZDHHC1 (EC 2.3.1.225) (DHHC domain-containing protein 1) (Zinc finger DHHC domain-containing protein 1) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005783; GO:0005789; GO:0005794; GO:0006612; GO:0010008; GO:0019706; GO:0140374; GO:1900227 antiviral innate immune response [GO:0140374]; positive regulation of NLRP3 inflammasome complex assembly [GO:1900227]; protein targeting to membrane [GO:0006612] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794] protein-cysteine S-palmitoyltransferase activity [GO:0019706] g2161.t1 E1BC52 42.466 219 2.11e-48 160.0 sp|E1BC52|CF418_BOVIN Cilia- and flagella-associated protein 418 OS=Bos taurus OX=9913 GN=CFAP418 PE=1 SV=1 g2162.t1 Q6GR45 82.787 244 1.55e-155 434.0 sp|Q6GR45|IF6_XENLA Eukaryotic translation initiation factor 6 OS=Xenopus laevis OX=8355 GN=eif6 PE=2 SV=1 g2164.t1 Q1H9T6 25.338 296 1.65e-22 107.0 sp|Q1H9T6|ZBT48_MOUSE Zinc finger and BTB domain-containing protein 48 OS=Mus musculus OX=10090 GN=Zbtb48 PE=1 SV=1 ZBT48_MOUSE reviewed Zinc finger and BTB domain-containing protein 48 (Krueppel-related zinc finger protein 3 homolog) (Telomere zinc finger-associated protein) (TZAP) Mus musculus (Mouse) GO:0000781; GO:0000976; GO:0000981; GO:0003691; GO:0003723; GO:0005634; GO:0006357; GO:0008270; GO:0010833; GO:0042802; GO:0043565; GO:0045893; GO:0051252 positive regulation of DNA-templated transcription [GO:0045893]; regulation of RNA metabolic process [GO:0051252]; regulation of transcription by RNA polymerase II [GO:0006357]; telomere maintenance via telomere lengthening [GO:0010833] chromosome, telomeric region [GO:0000781]; nucleus [GO:0005634] DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; double-stranded telomeric DNA binding [GO:0003691]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; sequence-specific DNA binding [GO:0043565]; transcription cis-regulatory region binding [GO:0000976]; zinc ion binding [GO:0008270] g2164.t2 Q1H9T6 25.338 296 1.65e-22 107.0 sp|Q1H9T6|ZBT48_MOUSE Zinc finger and BTB domain-containing protein 48 OS=Mus musculus OX=10090 GN=Zbtb48 PE=1 SV=1 ZBT48_MOUSE reviewed Zinc finger and BTB domain-containing protein 48 (Krueppel-related zinc finger protein 3 homolog) (Telomere zinc finger-associated protein) (TZAP) Mus musculus (Mouse) GO:0000781; GO:0000976; GO:0000981; GO:0003691; GO:0003723; GO:0005634; GO:0006357; GO:0008270; GO:0010833; GO:0042802; GO:0043565; GO:0045893; GO:0051252 positive regulation of DNA-templated transcription [GO:0045893]; regulation of RNA metabolic process [GO:0051252]; regulation of transcription by RNA polymerase II [GO:0006357]; telomere maintenance via telomere lengthening [GO:0010833] chromosome, telomeric region [GO:0000781]; nucleus [GO:0005634] DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; double-stranded telomeric DNA binding [GO:0003691]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; sequence-specific DNA binding [GO:0043565]; transcription cis-regulatory region binding [GO:0000976]; zinc ion binding [GO:0008270] g2166.t1 P07207 29.614 466 3.13e-36 154.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g2166.t1 P07207 28.935 432 1.8100000000000002e-29 132.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g2166.t1 P07207 30.097 412 1.5300000000000001e-27 126.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g2166.t1 P07207 28.14 430 2.04e-26 122.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g2166.t1 P07207 27.456 397 3.1799999999999997e-23 112.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g2167.t1 O76536 36.696 575 1.88e-68 248.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g2167.t1 O76536 35.192 574 6.99e-66 240.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g2167.t1 O76536 35.628 581 1.1199999999999999e-60 224.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g2167.t1 O76536 35.467 578 2.73e-60 223.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g2167.t1 O76536 34.662 577 1.41e-54 206.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g2167.t1 O76536 45.106 235 8.089999999999999e-45 177.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g2167.t1 O76536 35.381 472 2.1499999999999997e-42 169.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g2168.t1 Q9JM95 36.704 267 4.77e-50 171.0 sp|Q9JM95|SIA7F_MOUSE Alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 6 OS=Mus musculus OX=10090 GN=St6galnac6 PE=1 SV=1 g2169.t1 Q91XQ5 32.292 384 4.5199999999999995e-55 202.0 sp|Q91XQ5|CHSTF_MOUSE Carbohydrate sulfotransferase 15 OS=Mus musculus OX=10090 GN=Chst15 PE=2 SV=1 g2169.t1 Q91XQ5 37.269 271 8.09e-47 179.0 sp|Q91XQ5|CHSTF_MOUSE Carbohydrate sulfotransferase 15 OS=Mus musculus OX=10090 GN=Chst15 PE=2 SV=1 g2170.t1 Q6NTW6 63.308 526 0.0 661.0 sp|Q6NTW6|ULA1_XENLA NEDD8-activating enzyme E1 regulatory subunit OS=Xenopus laevis OX=8355 GN=nae1 PE=2 SV=1 g2171.t1 Q69BJ8 63.964 222 7.12e-109 318.0 sp|Q69BJ8|UCRI_LAGLA Cytochrome b-c1 complex subunit Rieske, mitochondrial OS=Lagothrix lagotricha OX=9519 GN=UQCRFS1 PE=3 SV=1 g2172.t1 Q86VM9 50.735 136 4.33e-25 116.0 sp|Q86VM9|ZCH18_HUMAN Zinc finger CCCH domain-containing protein 18 OS=Homo sapiens OX=9606 GN=ZC3H18 PE=1 SV=2 ZCH18_HUMAN reviewed Zinc finger CCCH domain-containing protein 18 (Nuclear protein NHN1) Homo sapiens (Human) GO:0003723; GO:0005654; GO:0008270; GO:0016607; GO:0030674; GO:0032991; GO:0050779; GO:0140262; GO:1990904 RNA destabilization [GO:0050779] nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991]; ribonucleoprotein complex [GO:1990904] mRNA cap binding complex binding [GO:0140262]; protein-macromolecule adaptor activity [GO:0030674]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270] g2177.t1 Q96T60 55.125 361 1.47e-144 438.0 sp|Q96T60|PNKP_HUMAN Bifunctional polynucleotide phosphatase/kinase OS=Homo sapiens OX=9606 GN=PNKP PE=1 SV=1 g2178.t1 Q3UHG7 60.614 391 2.41e-160 464.0 sp|Q3UHG7|DEN11_MOUSE DENN domain-containing protein 11 OS=Mus musculus OX=10090 GN=Dennd11 PE=2 SV=1 g2179.t1 Q3ZBF3 48.63 292 2.26e-101 307.0 sp|Q3ZBF3|RM38_BOVIN Large ribosomal subunit protein mL38 OS=Bos taurus OX=9913 GN=MRPL38 PE=1 SV=2 g2181.t1 Q5R881 62.26 469 0.0 590.0 sp|Q5R881|RSPRY_PONAB RING finger and SPRY domain-containing protein 1 OS=Pongo abelii OX=9601 GN=RSPRY1 PE=2 SV=1 g2184.t1 Q9UGM3 47.236 199 1.91e-37 150.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g2184.t1 Q9UGM3 42.411 224 1.08e-36 148.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g2184.t1 Q9UGM3 41.518 224 1.74e-36 147.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g2184.t1 Q9UGM3 40.708 226 1.74e-35 144.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g2184.t1 Q9UGM3 40.167 239 4.96e-35 143.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g2184.t1 Q9UGM3 40.708 226 5.75e-35 143.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g2184.t1 Q9UGM3 40.625 224 2.31e-34 141.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g2184.t1 Q9UGM3 40.625 224 2.31e-34 141.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g2184.t1 Q9UGM3 41.176 221 2.46e-34 141.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g2184.t1 Q9UGM3 43.694 222 4.62e-34 140.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g2184.t1 Q9UGM3 40.807 223 1.43e-33 139.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g2184.t1 Q9UGM3 40.179 224 2.7e-33 138.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g2184.t1 Q9UGM3 59.406 101 7.14e-29 124.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g2184.t1 Q9UGM3 61.29 93 8.78e-26 115.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g2185.t1 Q8BZE1 67.164 67 5.1300000000000004e-21 97.1 sp|Q8BZE1|DMBTL_MOUSE Putative DMBT1-like protein OS=Mus musculus OX=10090 GN=Cdcp3 PE=2 SV=2 g2186.t1 Q9UGM3 41.765 340 5.45e-65 230.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g2186.t1 Q9UGM3 39.167 360 1.06e-61 221.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g2186.t1 Q9UGM3 38.674 362 2.9699999999999998e-61 219.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g2186.t1 Q9UGM3 38.567 363 3.46e-61 219.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g2186.t1 Q9UGM3 39.612 361 4.03e-61 219.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g2186.t1 Q9UGM3 39.665 358 4.56e-61 219.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g2186.t1 Q9UGM3 39.665 358 6.239999999999999e-61 218.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g2186.t1 Q9UGM3 39.665 358 1.6e-60 217.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g2186.t1 Q9UGM3 40.0 345 1.99e-60 217.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g2186.t1 Q9UGM3 38.211 369 6.07e-60 215.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g2190.t1 P80146 40.053 377 1.11e-56 193.0 sp|P80146|SEPR_THESR Extracellular serine proteinase OS=Thermus sp. (strain Rt41A) OX=32063 PE=1 SV=3 g2191.t1 P80146 41.608 286 1.94e-45 164.0 sp|P80146|SEPR_THESR Extracellular serine proteinase OS=Thermus sp. (strain Rt41A) OX=32063 PE=1 SV=3 g2192.t1 P80146 39.788 377 1.45e-47 169.0 sp|P80146|SEPR_THESR Extracellular serine proteinase OS=Thermus sp. (strain Rt41A) OX=32063 PE=1 SV=3 g2193.t1 P80146 40.323 372 7.9e-64 212.0 sp|P80146|SEPR_THESR Extracellular serine proteinase OS=Thermus sp. (strain Rt41A) OX=32063 PE=1 SV=3 g2194.t1 Q91766 67.38 374 0.0 516.0 sp|Q91766|HNF4A_XENLA Hepatocyte nuclear factor 4-alpha OS=Xenopus laevis OX=8355 GN=hnf4a PE=2 SV=2 g2196.t1 Q0P6D2 32.888 374 2.83e-55 191.0 sp|Q0P6D2|DIK1C_HUMAN Divergent protein kinase domain 1C OS=Homo sapiens OX=9606 GN=DIPK1C PE=1 SV=3 DIK1C_HUMAN reviewed Divergent protein kinase domain 1C (Protein FAM69C) Homo sapiens (Human) GO:0005789 endoplasmic reticulum membrane [GO:0005789] g2197.t1 O08653 25.784 733 6.03e-41 168.0 sp|O08653|TEP1_RAT Telomerase protein component 1 OS=Rattus norvegicus OX=10116 GN=Tep1 PE=1 SV=1 g2198.t1 Q6GLK6 42.557 571 3.06e-128 389.0 sp|Q6GLK6|ACSF3_XENLA Malonate--CoA ligase ACSF3, mitochondrial OS=Xenopus laevis OX=8355 GN=acsf3 PE=2 SV=1 g2199.t1 Q3MHJ7 52.041 98 3.1400000000000002e-31 119.0 sp|Q3MHJ7|EEPD1_BOVIN Endonuclease/exonuclease/phosphatase family domain-containing protein 1 OS=Bos taurus OX=9913 GN=EEPD1 PE=2 SV=1 g2200.t1 Q7L9B9 32.209 326 2.08e-34 135.0 sp|Q7L9B9|EEPD1_HUMAN Endonuclease/exonuclease/phosphatase family domain-containing protein 1 OS=Homo sapiens OX=9606 GN=EEPD1 PE=1 SV=2 EEPD1_HUMAN reviewed Endonuclease/exonuclease/phosphatase family domain-containing protein 1 Homo sapiens (Human) GO:0003677; GO:0003824; GO:0005886; GO:0006281; GO:0010875 DNA repair [GO:0006281]; positive regulation of cholesterol efflux [GO:0010875] plasma membrane [GO:0005886] catalytic activity [GO:0003824]; DNA binding [GO:0003677] g2201.t1 O55131 69.267 423 0.0 530.0 sp|O55131|SEPT7_MOUSE Septin-7 OS=Mus musculus OX=10090 GN=Septin7 PE=1 SV=1 SEPT7_MOUSE reviewed Septin-7 (CDC10 protein homolog) Mus musculus (Mouse) GO:0000281; GO:0000776; GO:0001725; GO:0003924; GO:0005525; GO:0005634; GO:0005737; GO:0005819; GO:0005886; GO:0005930; GO:0005938; GO:0005940; GO:0007283; GO:0008104; GO:0015630; GO:0016020; GO:0016192; GO:0016476; GO:0030496; GO:0030865; GO:0031105; GO:0031270; GO:0031982; GO:0032153; GO:0032154; GO:0032156; GO:0032160; GO:0032991; GO:0042734; GO:0042802; GO:0043005; GO:0043209; GO:0043679; GO:0044297; GO:0045202; GO:0046323; GO:0048668; GO:0060090; GO:0060271; GO:0060997; GO:0061640; GO:0097227; GO:0098978; GO:0099173; GO:0099186; GO:0150050 cilium assembly [GO:0060271]; collateral sprouting [GO:0048668]; cortical cytoskeleton organization [GO:0030865]; cytoskeleton-dependent cytokinesis [GO:0061640]; D-glucose import [GO:0046323]; dendritic spine morphogenesis [GO:0060997]; intracellular protein localization [GO:0008104]; mitotic cytokinesis [GO:0000281]; postsynapse organization [GO:0099173]; pseudopodium retraction [GO:0031270]; regulation of embryonic cell shape [GO:0016476]; spermatogenesis [GO:0007283]; vesicle-mediated transport [GO:0016192] axon terminus [GO:0043679]; axoneme [GO:0005930]; cell body [GO:0044297]; cell cortex [GO:0005938]; cell division site [GO:0032153]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; glutamatergic synapse [GO:0098978]; kinetochore [GO:0000776]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; myelin sheath [GO:0043209]; neuron projection [GO:0043005]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic septin cytoskeleton [GO:0150050]; presynaptic membrane [GO:0042734]; protein-containing complex [GO:0032991]; septin complex [GO:0031105]; septin cytoskeleton [GO:0032156]; septin filament array [GO:0032160]; septin ring [GO:0005940]; sperm annulus [GO:0097227]; spindle [GO:0005819]; stress fiber [GO:0001725]; synapse [GO:0045202]; vesicle [GO:0031982] GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; molecular adaptor activity [GO:0060090]; structural constituent of postsynapse [GO:0099186] g2201.t2 O55131 70.192 416 0.0 533.0 sp|O55131|SEPT7_MOUSE Septin-7 OS=Mus musculus OX=10090 GN=Septin7 PE=1 SV=1 SEPT7_MOUSE reviewed Septin-7 (CDC10 protein homolog) Mus musculus (Mouse) GO:0000281; GO:0000776; GO:0001725; GO:0003924; GO:0005525; GO:0005634; GO:0005737; GO:0005819; GO:0005886; GO:0005930; GO:0005938; GO:0005940; GO:0007283; GO:0008104; GO:0015630; GO:0016020; GO:0016192; GO:0016476; GO:0030496; GO:0030865; GO:0031105; GO:0031270; GO:0031982; GO:0032153; GO:0032154; GO:0032156; GO:0032160; GO:0032991; GO:0042734; GO:0042802; GO:0043005; GO:0043209; GO:0043679; GO:0044297; GO:0045202; GO:0046323; GO:0048668; GO:0060090; GO:0060271; GO:0060997; GO:0061640; GO:0097227; GO:0098978; GO:0099173; GO:0099186; GO:0150050 cilium assembly [GO:0060271]; collateral sprouting [GO:0048668]; cortical cytoskeleton organization [GO:0030865]; cytoskeleton-dependent cytokinesis [GO:0061640]; D-glucose import [GO:0046323]; dendritic spine morphogenesis [GO:0060997]; intracellular protein localization [GO:0008104]; mitotic cytokinesis [GO:0000281]; postsynapse organization [GO:0099173]; pseudopodium retraction [GO:0031270]; regulation of embryonic cell shape [GO:0016476]; spermatogenesis [GO:0007283]; vesicle-mediated transport [GO:0016192] axon terminus [GO:0043679]; axoneme [GO:0005930]; cell body [GO:0044297]; cell cortex [GO:0005938]; cell division site [GO:0032153]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; glutamatergic synapse [GO:0098978]; kinetochore [GO:0000776]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; myelin sheath [GO:0043209]; neuron projection [GO:0043005]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic septin cytoskeleton [GO:0150050]; presynaptic membrane [GO:0042734]; protein-containing complex [GO:0032991]; septin complex [GO:0031105]; septin cytoskeleton [GO:0032156]; septin filament array [GO:0032160]; septin ring [GO:0005940]; sperm annulus [GO:0097227]; spindle [GO:0005819]; stress fiber [GO:0001725]; synapse [GO:0045202]; vesicle [GO:0031982] GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; molecular adaptor activity [GO:0060090]; structural constituent of postsynapse [GO:0099186] g2201.t3 O55131 74.25 400 0.0 536.0 sp|O55131|SEPT7_MOUSE Septin-7 OS=Mus musculus OX=10090 GN=Septin7 PE=1 SV=1 SEPT7_MOUSE reviewed Septin-7 (CDC10 protein homolog) Mus musculus (Mouse) GO:0000281; GO:0000776; GO:0001725; GO:0003924; GO:0005525; GO:0005634; GO:0005737; GO:0005819; GO:0005886; GO:0005930; GO:0005938; GO:0005940; GO:0007283; GO:0008104; GO:0015630; GO:0016020; GO:0016192; GO:0016476; GO:0030496; GO:0030865; GO:0031105; GO:0031270; GO:0031982; GO:0032153; GO:0032154; GO:0032156; GO:0032160; GO:0032991; GO:0042734; GO:0042802; GO:0043005; GO:0043209; GO:0043679; GO:0044297; GO:0045202; GO:0046323; GO:0048668; GO:0060090; GO:0060271; GO:0060997; GO:0061640; GO:0097227; GO:0098978; GO:0099173; GO:0099186; GO:0150050 cilium assembly [GO:0060271]; collateral sprouting [GO:0048668]; cortical cytoskeleton organization [GO:0030865]; cytoskeleton-dependent cytokinesis [GO:0061640]; D-glucose import [GO:0046323]; dendritic spine morphogenesis [GO:0060997]; intracellular protein localization [GO:0008104]; mitotic cytokinesis [GO:0000281]; postsynapse organization [GO:0099173]; pseudopodium retraction [GO:0031270]; regulation of embryonic cell shape [GO:0016476]; spermatogenesis [GO:0007283]; vesicle-mediated transport [GO:0016192] axon terminus [GO:0043679]; axoneme [GO:0005930]; cell body [GO:0044297]; cell cortex [GO:0005938]; cell division site [GO:0032153]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; glutamatergic synapse [GO:0098978]; kinetochore [GO:0000776]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; myelin sheath [GO:0043209]; neuron projection [GO:0043005]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic septin cytoskeleton [GO:0150050]; presynaptic membrane [GO:0042734]; protein-containing complex [GO:0032991]; septin complex [GO:0031105]; septin cytoskeleton [GO:0032156]; septin filament array [GO:0032160]; septin ring [GO:0005940]; sperm annulus [GO:0097227]; spindle [GO:0005819]; stress fiber [GO:0001725]; synapse [GO:0045202]; vesicle [GO:0031982] GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; molecular adaptor activity [GO:0060090]; structural constituent of postsynapse [GO:0099186] g2203.t1 A0A0X1KHF9 31.755 359 1.4600000000000001e-36 154.0 sp|A0A0X1KHF9|RPH_LISMF Rifampicin phosphotransferase OS=Listeria monocytogenes serotype 4b (strain F2365) OX=265669 GN=rph PE=1 SV=2 RPH_LISMF reviewed Rifampicin phosphotransferase (EC 2.7.9.6) (LmRPH) (Rifampin phosphotransferase) (RIF phosphotransferase) Listeria monocytogenes serotype 4b (strain F2365) GO:0005524; GO:0016301; GO:0046677 response to antibiotic [GO:0046677] ATP binding [GO:0005524]; kinase activity [GO:0016301] g2203.t1 A0A0X1KHF9 27.301 326 7.38e-26 119.0 sp|A0A0X1KHF9|RPH_LISMF Rifampicin phosphotransferase OS=Listeria monocytogenes serotype 4b (strain F2365) OX=265669 GN=rph PE=1 SV=2 RPH_LISMF reviewed Rifampicin phosphotransferase (EC 2.7.9.6) (LmRPH) (Rifampin phosphotransferase) (RIF phosphotransferase) Listeria monocytogenes serotype 4b (strain F2365) GO:0005524; GO:0016301; GO:0046677 response to antibiotic [GO:0046677] ATP binding [GO:0005524]; kinase activity [GO:0016301] g2206.t1 P35285 59.487 195 6.04e-84 249.0 sp|P35285|RB22A_MOUSE Ras-related protein Rab-22A OS=Mus musculus OX=10090 GN=Rab22a PE=1 SV=2 RB22A_MOUSE reviewed Ras-related protein Rab-22A (Rab-22) (EC 3.6.5.2) (Rab-14) Mus musculus (Mouse) GO:0001726; GO:0003924; GO:0003925; GO:0005525; GO:0005769; GO:0005770; GO:0005794; GO:0005886; GO:0006886; GO:0006897; GO:0007032; GO:0010008; GO:0012505; GO:0015629; GO:0019003; GO:0030670; GO:0045335; GO:0097494 endocytosis [GO:0006897]; endosome organization [GO:0007032]; intracellular protein transport [GO:0006886]; regulation of vesicle size [GO:0097494] actin cytoskeleton [GO:0015629]; early endosome [GO:0005769]; endomembrane system [GO:0012505]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; late endosome [GO:0005770]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; ruffle [GO:0001726] G protein activity [GO:0003925]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924] g2207.t1 Q9CQJ8 56.923 130 1.59e-48 157.0 sp|Q9CQJ8|NDUB9_MOUSE NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 9 OS=Mus musculus OX=10090 GN=Ndufb9 PE=1 SV=3 NDUB9_MOUSE reviewed NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 9 (Complex I-B22) (CI-B22) (NADH-ubiquinone oxidoreductase B22 subunit) Mus musculus (Mouse) GO:0005739; GO:0005743; GO:0006120; GO:0009060; GO:0042776; GO:0045271 aerobic respiration [GO:0009060]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; proton motive force-driven mitochondrial ATP synthesis [GO:0042776] mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; respiratory chain complex I [GO:0045271] g2208.t1 Q9H7H0 39.224 464 1.0600000000000001e-110 339.0 sp|Q9H7H0|MET17_HUMAN Ribosome assembly protein METTL17, mitochondrial OS=Homo sapiens OX=9606 GN=METTL17 PE=1 SV=1 g2210.t1 P54254 55.797 138 6.51e-41 165.0 sp|P54254|ATX1_MOUSE Ataxin-1 OS=Mus musculus OX=10090 GN=Atxn1 PE=1 SV=2 ATX1_MOUSE reviewed Ataxin-1 (Spinocerebellar ataxia type 1 protein homolog) Mus musculus (Mouse) GO:0000122; GO:0003677; GO:0003682; GO:0003723; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0007420; GO:0007612; GO:0007613; GO:0008266; GO:0008344; GO:0008542; GO:0016363; GO:0031208; GO:0032991; GO:0034046; GO:0035176; GO:0042405; GO:0042802; GO:0043569; GO:0045892; GO:0045944; GO:0048286; GO:0051168; GO:0060079; GO:0060252; GO:0098794 adult locomotory behavior [GO:0008344]; brain development [GO:0007420]; excitatory postsynaptic potential [GO:0060079]; learning [GO:0007612]; lung alveolus development [GO:0048286]; memory [GO:0007613]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of insulin-like growth factor receptor signaling pathway [GO:0043569]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nuclear export [GO:0051168]; positive regulation of glial cell proliferation [GO:0060252]; positive regulation of transcription by RNA polymerase II [GO:0045944]; social behavior [GO:0035176]; visual learning [GO:0008542] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear inclusion body [GO:0042405]; nuclear matrix [GO:0016363]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynapse [GO:0098794]; protein-containing complex [GO:0032991] chromatin binding [GO:0003682]; DNA binding [GO:0003677]; identical protein binding [GO:0042802]; poly(G) binding [GO:0034046]; poly(U) RNA binding [GO:0008266]; POZ domain binding [GO:0031208]; RNA binding [GO:0003723] g2211.t1 Q64012 50.602 83 1.9099999999999998e-23 99.0 sp|Q64012|RALY_MOUSE RNA-binding protein Raly OS=Mus musculus OX=10090 GN=Raly PE=1 SV=3 RALY_MOUSE reviewed RNA-binding protein Raly (Maternally-expressed hnRNP C-related protein) (hnRNP associated with lethal yellow protein) Mus musculus (Mouse) GO:0000122; GO:0003712; GO:0003723; GO:0005634; GO:0006397; GO:0008380; GO:0042632; GO:0071013 cholesterol homeostasis [GO:0042632]; mRNA processing [GO:0006397]; negative regulation of transcription by RNA polymerase II [GO:0000122]; RNA splicing [GO:0008380] catalytic step 2 spliceosome [GO:0071013]; nucleus [GO:0005634] RNA binding [GO:0003723]; transcription coregulator activity [GO:0003712] g2215.t1 Q95SS8 41.916 167 5.32e-29 114.0 sp|Q95SS8|TMM70_DROME Transmembrane protein 70 homolog, mitochondrial OS=Drosophila melanogaster OX=7227 GN=Tmem70 PE=1 SV=1 g2216.t1 Q58EX7 52.533 375 2.6700000000000002e-117 403.0 sp|Q58EX7|PKHG4_HUMAN Puratrophin-1 OS=Homo sapiens OX=9606 GN=PLEKHG4 PE=1 SV=1 PKHG4_HUMAN reviewed Puratrophin-1 (Pleckstrin homology domain-containing family G member 4) (PH domain-containing family G member 4) (Purkinje cell atrophy-associated protein 1) Homo sapiens (Human) GO:0005085; GO:0005737; GO:0005829; GO:0005886; GO:0007411; GO:0019898; GO:0051056 axon guidance [GO:0007411]; regulation of small GTPase mediated signal transduction [GO:0051056] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of membrane [GO:0019898]; plasma membrane [GO:0005886] guanyl-nucleotide exchange factor activity [GO:0005085] g2216.t1 Q58EX7 28.807 486 6.74e-43 176.0 sp|Q58EX7|PKHG4_HUMAN Puratrophin-1 OS=Homo sapiens OX=9606 GN=PLEKHG4 PE=1 SV=1 PKHG4_HUMAN reviewed Puratrophin-1 (Pleckstrin homology domain-containing family G member 4) (PH domain-containing family G member 4) (Purkinje cell atrophy-associated protein 1) Homo sapiens (Human) GO:0005085; GO:0005737; GO:0005829; GO:0005886; GO:0007411; GO:0019898; GO:0051056 axon guidance [GO:0007411]; regulation of small GTPase mediated signal transduction [GO:0051056] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of membrane [GO:0019898]; plasma membrane [GO:0005886] guanyl-nucleotide exchange factor activity [GO:0005085] g2218.t1 Q86UP3 43.953 1108 0.0 795.0 sp|Q86UP3|ZFHX4_HUMAN Zinc finger homeobox protein 4 OS=Homo sapiens OX=9606 GN=ZFHX4 PE=1 SV=1 ZFHX4_HUMAN reviewed Zinc finger homeobox protein 4 (Zinc finger homeodomain protein 4) (ZFH-4) Homo sapiens (Human) GO:0000785; GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0008270 regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; nucleus [GO:0005634] DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270] g2218.t1 Q86UP3 37.77 601 1.71e-86 322.0 sp|Q86UP3|ZFHX4_HUMAN Zinc finger homeobox protein 4 OS=Homo sapiens OX=9606 GN=ZFHX4 PE=1 SV=1 ZFHX4_HUMAN reviewed Zinc finger homeobox protein 4 (Zinc finger homeodomain protein 4) (ZFH-4) Homo sapiens (Human) GO:0000785; GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0008270 regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; nucleus [GO:0005634] DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270] g2218.t1 Q86UP3 38.754 289 2e-41 173.0 sp|Q86UP3|ZFHX4_HUMAN Zinc finger homeobox protein 4 OS=Homo sapiens OX=9606 GN=ZFHX4 PE=1 SV=1 ZFHX4_HUMAN reviewed Zinc finger homeobox protein 4 (Zinc finger homeodomain protein 4) (ZFH-4) Homo sapiens (Human) GO:0000785; GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0008270 regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; nucleus [GO:0005634] DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270] g2218.t1 Q86UP3 62.791 129 4.0700000000000004e-36 156.0 sp|Q86UP3|ZFHX4_HUMAN Zinc finger homeobox protein 4 OS=Homo sapiens OX=9606 GN=ZFHX4 PE=1 SV=1 ZFHX4_HUMAN reviewed Zinc finger homeobox protein 4 (Zinc finger homeodomain protein 4) (ZFH-4) Homo sapiens (Human) GO:0000785; GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0008270 regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; nucleus [GO:0005634] DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270] g2218.t1 Q86UP3 55.556 117 2.95e-31 140.0 sp|Q86UP3|ZFHX4_HUMAN Zinc finger homeobox protein 4 OS=Homo sapiens OX=9606 GN=ZFHX4 PE=1 SV=1 ZFHX4_HUMAN reviewed Zinc finger homeobox protein 4 (Zinc finger homeodomain protein 4) (ZFH-4) Homo sapiens (Human) GO:0000785; GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0008270 regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; nucleus [GO:0005634] DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270] g2221.t1 Q9BU02 32.599 227 5.44e-28 108.0 sp|Q9BU02|THTPA_HUMAN Thiamine-triphosphatase OS=Homo sapiens OX=9606 GN=THTPA PE=1 SV=3 THTPA_HUMAN reviewed Thiamine-triphosphatase (ThTPase) (EC 3.6.1.28) Homo sapiens (Human) GO:0000287; GO:0005829; GO:0006091; GO:0006772; GO:0009229; GO:0016311; GO:0016787; GO:0042357; GO:0050333 dephosphorylation [GO:0016311]; generation of precursor metabolites and energy [GO:0006091]; thiamine diphosphate biosynthetic process [GO:0009229]; thiamine diphosphate metabolic process [GO:0042357]; thiamine metabolic process [GO:0006772] cytosol [GO:0005829] hydrolase activity [GO:0016787]; magnesium ion binding [GO:0000287]; thiamine triphosphate phosphatase activity [GO:0050333] g2224.t1 Q924N4 57.609 1104 0.0 1222.0 sp|Q924N4|S12A6_MOUSE Solute carrier family 12 member 6 OS=Mus musculus OX=10090 GN=Slc12a6 PE=1 SV=2 g2224.t2 Q63632 58.68 1106 0.0 1225.0 sp|Q63632|S12A4_RAT Solute carrier family 12 member 4 OS=Rattus norvegicus OX=10116 GN=Slc12a4 PE=1 SV=1 g2224.t3 Q9UHW9 54.492 1180 0.0 1212.0 sp|Q9UHW9|S12A6_HUMAN Solute carrier family 12 member 6 OS=Homo sapiens OX=9606 GN=SLC12A6 PE=1 SV=2 g2225.t1 Q6JWR2 41.575 457 2.52e-102 315.0 sp|Q6JWR2|S38A7_RAT Sodium-coupled neutral amino acid transporter 7 OS=Rattus norvegicus OX=10116 GN=Slc38a7 PE=2 SV=1 S38A7_RAT reviewed Sodium-coupled neutral amino acid transporter 7 (Solute carrier family 38 member 7) Rattus norvegicus (Rat) GO:0003333; GO:0005765; GO:0006814; GO:0006867; GO:0006868; GO:0015182; GO:0015186; GO:0016020; GO:0030424; GO:0043025; GO:0140901; GO:0140902 amino acid transmembrane transport [GO:0003333]; asparagine transport [GO:0006867]; glutamine transport [GO:0006868]; sodium ion transport [GO:0006814] axon [GO:0030424]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; neuronal cell body [GO:0043025] L-asparagine transmembrane transporter activity [GO:0015182]; L-asparagine:sodium symporter activity [GO:0140901]; L-glutamine transmembrane transporter activity [GO:0015186]; L-glutamine:sodium symporter activity [GO:0140902] g2226.t1 P53990 60.804 199 1.91e-78 248.0 sp|P53990|IST1_HUMAN IST1 homolog OS=Homo sapiens OX=9606 GN=IST1 PE=1 SV=1 IST1_HUMAN reviewed IST1 homolog (hIST1) (Charged multivesicular body protein 8) (CHMP8) (Putative MAPK-activating protein PM28) Homo sapiens (Human) GO:0000785; GO:0005576; GO:0005635; GO:0005793; GO:0005813; GO:0005829; GO:0008104; GO:0015031; GO:0019904; GO:0030496; GO:0035578; GO:0036258; GO:0042802; GO:0044877; GO:0045184; GO:0045296; GO:0045862; GO:0048668; GO:0048672; GO:0051301; GO:0061640; GO:0061952; GO:0070062; GO:0090541; GO:0090543; GO:1904903 cell division [GO:0051301]; collateral sprouting [GO:0048668]; cytoskeleton-dependent cytokinesis [GO:0061640]; ESCRT III complex disassembly [GO:1904903]; establishment of protein localization [GO:0045184]; intracellular protein localization [GO:0008104]; midbody abscission [GO:0061952]; multivesicular body assembly [GO:0036258]; positive regulation of collateral sprouting [GO:0048672]; positive regulation of proteolysis [GO:0045862]; protein transport [GO:0015031] azurophil granule lumen [GO:0035578]; centrosome [GO:0005813]; chromatin [GO:0000785]; cytosol [GO:0005829]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; Flemming body [GO:0090543]; midbody [GO:0030496]; nuclear envelope [GO:0005635] cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; MIT domain binding [GO:0090541]; protein domain specific binding [GO:0019904]; protein-containing complex binding [GO:0044877] g2226.t2 P53990 60.804 199 6.27e-78 248.0 sp|P53990|IST1_HUMAN IST1 homolog OS=Homo sapiens OX=9606 GN=IST1 PE=1 SV=1 IST1_HUMAN reviewed IST1 homolog (hIST1) (Charged multivesicular body protein 8) (CHMP8) (Putative MAPK-activating protein PM28) Homo sapiens (Human) GO:0000785; GO:0005576; GO:0005635; GO:0005793; GO:0005813; GO:0005829; GO:0008104; GO:0015031; GO:0019904; GO:0030496; GO:0035578; GO:0036258; GO:0042802; GO:0044877; GO:0045184; GO:0045296; GO:0045862; GO:0048668; GO:0048672; GO:0051301; GO:0061640; GO:0061952; GO:0070062; GO:0090541; GO:0090543; GO:1904903 cell division [GO:0051301]; collateral sprouting [GO:0048668]; cytoskeleton-dependent cytokinesis [GO:0061640]; ESCRT III complex disassembly [GO:1904903]; establishment of protein localization [GO:0045184]; intracellular protein localization [GO:0008104]; midbody abscission [GO:0061952]; multivesicular body assembly [GO:0036258]; positive regulation of collateral sprouting [GO:0048672]; positive regulation of proteolysis [GO:0045862]; protein transport [GO:0015031] azurophil granule lumen [GO:0035578]; centrosome [GO:0005813]; chromatin [GO:0000785]; cytosol [GO:0005829]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; Flemming body [GO:0090543]; midbody [GO:0030496]; nuclear envelope [GO:0005635] cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; MIT domain binding [GO:0090541]; protein domain specific binding [GO:0019904]; protein-containing complex binding [GO:0044877] g2238.t1 Q8NEP9 29.514 288 1.28e-25 117.0 sp|Q8NEP9|ZN555_HUMAN Zinc finger protein 555 OS=Homo sapiens OX=9606 GN=ZNF555 PE=1 SV=4 g2238.t1 Q8NEP9 26.415 318 1.9300000000000001e-22 107.0 sp|Q8NEP9|ZN555_HUMAN Zinc finger protein 555 OS=Homo sapiens OX=9606 GN=ZNF555 PE=1 SV=4 g2239.t1 Q3UR97 30.924 249 7.1e-27 111.0 sp|Q3UR97|SNX21_MOUSE Sorting nexin-21 OS=Mus musculus OX=10090 GN=Snx21 PE=1 SV=1 g2241.t1 O88917 36.592 358 1.8199999999999998e-60 233.0 sp|O88917|AGRL1_RAT Adhesion G protein-coupled receptor L1 OS=Rattus norvegicus OX=10116 GN=Adgrl1 PE=1 SV=1 AGRL1_RAT reviewed Adhesion G protein-coupled receptor L1 (Calcium-independent alpha-latrotoxin receptor 1) (CIRL-1) (Latrophilin-1) Rattus norvegicus (Rat) GO:0004930; GO:0005886; GO:0007166; GO:0007186; GO:0015643; GO:0016524; GO:0030246; GO:0030424; GO:0030426; GO:0042734; GO:0043005; GO:0045202; GO:0050839; GO:0051965; GO:0098978 cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186]; positive regulation of synapse assembly [GO:0051965] axon [GO:0030424]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; synapse [GO:0045202] carbohydrate binding [GO:0030246]; cell adhesion molecule binding [GO:0050839]; G protein-coupled receptor activity [GO:0004930]; latrotoxin receptor activity [GO:0016524]; toxic substance binding [GO:0015643] g2241.t1 O88917 36.429 420 9.37e-57 221.0 sp|O88917|AGRL1_RAT Adhesion G protein-coupled receptor L1 OS=Rattus norvegicus OX=10116 GN=Adgrl1 PE=1 SV=1 AGRL1_RAT reviewed Adhesion G protein-coupled receptor L1 (Calcium-independent alpha-latrotoxin receptor 1) (CIRL-1) (Latrophilin-1) Rattus norvegicus (Rat) GO:0004930; GO:0005886; GO:0007166; GO:0007186; GO:0015643; GO:0016524; GO:0030246; GO:0030424; GO:0030426; GO:0042734; GO:0043005; GO:0045202; GO:0050839; GO:0051965; GO:0098978 cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186]; positive regulation of synapse assembly [GO:0051965] axon [GO:0030424]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; synapse [GO:0045202] carbohydrate binding [GO:0030246]; cell adhesion molecule binding [GO:0050839]; G protein-coupled receptor activity [GO:0004930]; latrotoxin receptor activity [GO:0016524]; toxic substance binding [GO:0015643] g2243.t1 Q02962 73.077 130 6.349999999999999e-61 206.0 sp|Q02962|PAX2_HUMAN Paired box protein Pax-2 OS=Homo sapiens OX=9606 GN=PAX2 PE=1 SV=4 PAX2_HUMAN reviewed Paired box protein Pax-2 Homo sapiens (Human) GO:0000785; GO:0000976; GO:0000978; GO:0000981; GO:0000987; GO:0001655; GO:0001658; GO:0001709; GO:0001823; GO:0001843; GO:0002072; GO:0003337; GO:0003406; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0005815; GO:0006357; GO:0007399; GO:0007409; GO:0007423; GO:0007501; GO:0007601; GO:0008134; GO:0010001; GO:0021554; GO:0021631; GO:0021633; GO:0021650; GO:0032991; GO:0032993; GO:0034451; GO:0035566; GO:0035799; GO:0039003; GO:0042472; GO:0043010; GO:0043066; GO:0043069; GO:0045892; GO:0045893; GO:0045944; GO:0048793; GO:0048854; GO:0048863; GO:0050679; GO:0060231; GO:0061360; GO:0071300; GO:0071333; GO:0072075; GO:0072108; GO:0072162; GO:0072179; GO:0072189; GO:0072205; GO:0072207; GO:0072221; GO:0072289; GO:0072300; GO:0072305; GO:0072307; GO:0090102; GO:0090103; GO:1900212; GO:1900215; GO:1900218; GO:1990837; GO:2000378; GO:2000594; GO:2000597 axonogenesis [GO:0007409]; brain morphogenesis [GO:0048854]; branching involved in ureteric bud morphogenesis [GO:0001658]; camera-type eye development [GO:0043010]; cell fate determination [GO:0001709]; cellular response to glucose stimulus [GO:0071333]; cellular response to retinoic acid [GO:0071300]; cochlea development [GO:0090102]; cochlea morphogenesis [GO:0090103]; glial cell differentiation [GO:0010001]; inner ear morphogenesis [GO:0042472]; mesenchymal to epithelial transition [GO:0060231]; mesenchymal to epithelial transition involved in metanephros morphogenesis [GO:0003337]; mesodermal cell fate specification [GO:0007501]; mesonephros development [GO:0001823]; metanephric collecting duct development [GO:0072205]; metanephric distal convoluted tubule development [GO:0072221]; metanephric epithelium development [GO:0072207]; metanephric mesenchymal cell differentiation [GO:0072162]; metanephric mesenchyme development [GO:0072075]; metanephric nephron tubule formation [GO:0072289]; negative regulation of apoptotic process [GO:0043066]; negative regulation of apoptotic process involved in metanephric collecting duct development [GO:1900215]; negative regulation of apoptotic process involved in metanephric nephron tubule development [GO:1900218]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis [GO:0072305]; negative regulation of mesenchymal cell apoptotic process involved in metanephros development [GO:1900212]; negative regulation of programmed cell death [GO:0043069]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; nephric duct formation [GO:0072179]; nervous system development [GO:0007399]; neural tube closure [GO:0001843]; optic chiasma development [GO:0061360]; optic cup morphogenesis involved in camera-type eye development [GO:0002072]; optic nerve development [GO:0021554]; optic nerve morphogenesis [GO:0021631]; optic nerve structural organization [GO:0021633]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis [GO:0072108]; positive regulation of metanephric DCT cell differentiation [GO:2000594]; positive regulation of metanephric glomerulus development [GO:0072300]; positive regulation of optic nerve formation [GO:2000597]; positive regulation of transcription by RNA polymerase II [GO:0045944]; pronephric field specification [GO:0039003]; pronephros development [GO:0048793]; regulation of metanephric nephron tubule epithelial cell differentiation [GO:0072307]; regulation of metanephros size [GO:0035566]; regulation of transcription by RNA polymerase II [GO:0006357]; retinal pigment epithelium development [GO:0003406]; sensory organ development [GO:0007423]; stem cell differentiation [GO:0048863]; ureter development [GO:0072189]; ureter maturation [GO:0035799]; urogenital system development [GO:0001655]; vestibulocochlear nerve formation [GO:0021650]; visual perception [GO:0007601] centriolar satellite [GO:0034451]; chromatin [GO:0000785]; microtubule organizing center [GO:0005815]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; protein-DNA complex [GO:0032993] cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]; transcription factor binding [GO:0008134] g2245.t1 A2A288 54.545 154 1.76e-51 184.0 sp|A2A288|ZC12D_HUMAN Probable ribonuclease ZC3H12D OS=Homo sapiens OX=9606 GN=ZC3H12D PE=1 SV=3 ZC12D_HUMAN reviewed Probable ribonuclease ZC3H12D (EC 3.1.-.-) (MCP-induced protein 4) (Transformed follicular lymphoma) (Zinc finger CCCH domain-containing protein 12D) (p34) Homo sapiens (Human) GO:0000932; GO:0003729; GO:0004521; GO:0005634; GO:0005654; GO:0005737; GO:0008270; GO:0016787; GO:0030308; GO:0036464; GO:0061158; GO:2000134 3'-UTR-mediated mRNA destabilization [GO:0061158]; negative regulation of cell growth [GO:0030308]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134] cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932] hydrolase activity [GO:0016787]; mRNA binding [GO:0003729]; RNA endonuclease activity [GO:0004521]; zinc ion binding [GO:0008270] g2246.t1 Q9NQQ7 51.07 327 9.46e-101 306.0 sp|Q9NQQ7|S35C2_HUMAN Solute carrier family 35 member C2 OS=Homo sapiens OX=9606 GN=SLC35C2 PE=1 SV=2 S35H1_HUMAN reviewed Solute carrier family 35 member H1 (Ovarian cancer-overexpressed gene 1 protein) (Solute carrier family 35 member C2) Homo sapiens (Human) GO:0005654; GO:0005793; GO:0005794; GO:0005801; GO:0010629; GO:0015297; GO:0015786; GO:0033116; GO:0036066; GO:0045747 negative regulation of gene expression [GO:0010629]; positive regulation of Notch signaling pathway [GO:0045747]; protein O-linked glycosylation via fucose [GO:0036066]; UDP-glucose transmembrane transport [GO:0015786] cis-Golgi network [GO:0005801]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654] antiporter activity [GO:0015297] g2247.t1 Q99KE8 47.04 321 2.19e-83 286.0 sp|Q99KE8|ZFP64_MOUSE Zinc finger protein 64 OS=Mus musculus OX=10090 GN=Zfp64 PE=1 SV=1 g2247.t1 Q99KE8 35.493 355 2.76e-51 195.0 sp|Q99KE8|ZFP64_MOUSE Zinc finger protein 64 OS=Mus musculus OX=10090 GN=Zfp64 PE=1 SV=1 g2249.t1 Q9NSC2 46.122 245 6.26e-51 202.0 sp|Q9NSC2|SALL1_HUMAN Sal-like protein 1 OS=Homo sapiens OX=9606 GN=SALL1 PE=1 SV=2 g2249.t1 Q9NSC2 55.474 137 2.1200000000000002e-33 145.0 sp|Q9NSC2|SALL1_HUMAN Sal-like protein 1 OS=Homo sapiens OX=9606 GN=SALL1 PE=1 SV=2 g2249.t1 Q9NSC2 59.843 127 1.31e-32 142.0 sp|Q9NSC2|SALL1_HUMAN Sal-like protein 1 OS=Homo sapiens OX=9606 GN=SALL1 PE=1 SV=2 g2249.t1 Q9NSC2 54.118 85 8.23e-24 114.0 sp|Q9NSC2|SALL1_HUMAN Sal-like protein 1 OS=Homo sapiens OX=9606 GN=SALL1 PE=1 SV=2 g2250.t1 Q8NI51 53.101 258 3.33e-89 304.0 sp|Q8NI51|CTCFL_HUMAN Transcriptional repressor CTCFL OS=Homo sapiens OX=9606 GN=CTCFL PE=1 SV=2 g2250.t1 Q8NI51 31.383 188 1.39e-25 117.0 sp|Q8NI51|CTCFL_HUMAN Transcriptional repressor CTCFL OS=Homo sapiens OX=9606 GN=CTCFL PE=1 SV=2 g2252.t1 Q61164 39.286 168 2.4300000000000003e-35 140.0 sp|Q61164|CTCF_MOUSE Transcriptional repressor CTCF OS=Mus musculus OX=10090 GN=Ctcf PE=1 SV=2 CTCF_MOUSE reviewed Transcriptional repressor CTCF (11-zinc finger protein) (CCCTC-binding factor) (CTCFL paralog) Mus musculus (Mouse) GO:0000122; GO:0000775; GO:0000793; GO:0000976; GO:0000978; GO:0000987; GO:0001221; GO:0001227; GO:0001651; GO:0001652; GO:0001701; GO:0003677; GO:0003682; GO:0003700; GO:0005634; GO:0005654; GO:0005730; GO:0006325; GO:0006346; GO:0006355; GO:0006357; GO:0007005; GO:0007059; GO:0007507; GO:0008270; GO:0008285; GO:0010467; GO:0010628; GO:0010629; GO:0040029; GO:0043035; GO:0043565; GO:0044027; GO:0045892; GO:0045893; GO:0045944; GO:0055007; GO:0055013; GO:0060816; GO:0071459; GO:0071514; GO:0140297; GO:0140587; GO:0140588; GO:1902895; GO:1990837 cardiac muscle cell development [GO:0055013]; cardiac muscle cell differentiation [GO:0055007]; chromatin looping [GO:0140588]; chromatin organization [GO:0006325]; chromosome segregation [GO:0007059]; DNA methylation-dependent constitutive heterochromatin formation [GO:0006346]; epigenetic regulation of gene expression [GO:0040029]; gene expression [GO:0010467]; genomic imprinting [GO:0071514]; heart development [GO:0007507]; in utero embryonic development [GO:0001701]; mitochondrion organization [GO:0007005]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of gene expression [GO:0010629]; negative regulation of gene expression via chromosomal CpG island methylation [GO:0044027]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of gene expression [GO:0010628]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein localization to chromosome, centromeric region [GO:0071459]; random inactivation of X chromosome [GO:0060816]; regulation of DNA-templated transcription [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357] chromosome, centromeric region [GO:0000775]; condensed chromosome [GO:0000793]; dense fibrillar component [GO:0001651]; granular component [GO:0001652]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] chromatin binding [GO:0003682]; chromatin insulator sequence binding [GO:0043035]; chromatin loop anchoring activity [GO:0140587]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor binding [GO:0140297]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]; transcription coregulator binding [GO:0001221]; zinc ion binding [GO:0008270] g2252.t1 Q61164 31.515 165 2.39e-23 105.0 sp|Q61164|CTCF_MOUSE Transcriptional repressor CTCF OS=Mus musculus OX=10090 GN=Ctcf PE=1 SV=2 CTCF_MOUSE reviewed Transcriptional repressor CTCF (11-zinc finger protein) (CCCTC-binding factor) (CTCFL paralog) Mus musculus (Mouse) GO:0000122; GO:0000775; GO:0000793; GO:0000976; GO:0000978; GO:0000987; GO:0001221; GO:0001227; GO:0001651; GO:0001652; GO:0001701; GO:0003677; GO:0003682; GO:0003700; GO:0005634; GO:0005654; GO:0005730; GO:0006325; GO:0006346; GO:0006355; GO:0006357; GO:0007005; GO:0007059; GO:0007507; GO:0008270; GO:0008285; GO:0010467; GO:0010628; GO:0010629; GO:0040029; GO:0043035; GO:0043565; GO:0044027; GO:0045892; GO:0045893; GO:0045944; GO:0055007; GO:0055013; GO:0060816; GO:0071459; GO:0071514; GO:0140297; GO:0140587; GO:0140588; GO:1902895; GO:1990837 cardiac muscle cell development [GO:0055013]; cardiac muscle cell differentiation [GO:0055007]; chromatin looping [GO:0140588]; chromatin organization [GO:0006325]; chromosome segregation [GO:0007059]; DNA methylation-dependent constitutive heterochromatin formation [GO:0006346]; epigenetic regulation of gene expression [GO:0040029]; gene expression [GO:0010467]; genomic imprinting [GO:0071514]; heart development [GO:0007507]; in utero embryonic development [GO:0001701]; mitochondrion organization [GO:0007005]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of gene expression [GO:0010629]; negative regulation of gene expression via chromosomal CpG island methylation [GO:0044027]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of gene expression [GO:0010628]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein localization to chromosome, centromeric region [GO:0071459]; random inactivation of X chromosome [GO:0060816]; regulation of DNA-templated transcription [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357] chromosome, centromeric region [GO:0000775]; condensed chromosome [GO:0000793]; dense fibrillar component [GO:0001651]; granular component [GO:0001652]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] chromatin binding [GO:0003682]; chromatin insulator sequence binding [GO:0043035]; chromatin loop anchoring activity [GO:0140587]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor binding [GO:0140297]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]; transcription coregulator binding [GO:0001221]; zinc ion binding [GO:0008270] g2253.t1 Q66JZ4 33.06 487 7.57e-78 254.0 sp|Q66JZ4|TCAIM_MOUSE T-cell activation inhibitor, mitochondrial OS=Mus musculus OX=10090 GN=TCAIM PE=1 SV=1 g2258.t1 Q8K298 36.784 454 5.96e-80 287.0 sp|Q8K298|ANLN_MOUSE Anillin OS=Mus musculus OX=10090 GN=Anln PE=1 SV=2 g2259.t1 Q9D600 62.963 108 1.4200000000000001e-43 143.0 sp|Q9D600|PSF2_MOUSE DNA replication complex GINS protein PSF2 OS=Mus musculus OX=10090 GN=Gins2 PE=1 SV=1 g2263.t1 Q9V4N3 49.383 81 5.7500000000000005e-21 85.5 sp|Q9V4N3|CYB5_DROME Cytochrome b5 OS=Drosophila melanogaster OX=7227 GN=Cyt-b5 PE=2 SV=1 g2264.t1 Q5ZK82 54.221 308 6.6e-113 348.0 sp|Q5ZK82|MPPE1_CHICK Metallophosphoesterase 1 OS=Gallus gallus OX=9031 GN=MPPE1 PE=2 SV=1 MPPE1_CHICK reviewed Metallophosphoesterase 1 (EC 3.1.-.-) (Post-GPI attachment to proteins factor 5) Gallus gallus (Chicken) GO:0006506; GO:0006888; GO:0030145; GO:0033116; GO:0062050; GO:0070971 endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; GPI anchor biosynthetic process [GO:0006506] endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116] GPI-mannose ethanolamine phosphate phosphodiesterase activity [GO:0062050]; manganese ion binding [GO:0030145] g2264.t2 Q5ZK82 54.221 308 6.78e-113 348.0 sp|Q5ZK82|MPPE1_CHICK Metallophosphoesterase 1 OS=Gallus gallus OX=9031 GN=MPPE1 PE=2 SV=1 MPPE1_CHICK reviewed Metallophosphoesterase 1 (EC 3.1.-.-) (Post-GPI attachment to proteins factor 5) Gallus gallus (Chicken) GO:0006506; GO:0006888; GO:0030145; GO:0033116; GO:0062050; GO:0070971 endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; GPI anchor biosynthetic process [GO:0006506] endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116] GPI-mannose ethanolamine phosphate phosphodiesterase activity [GO:0062050]; manganese ion binding [GO:0030145] g2265.t1 O16118 80.739 379 0.0 625.0 sp|O16118|GNAS_HOMAM Guanine nucleotide-binding protein G(s) subunit alpha OS=Homarus americanus OX=6706 PE=2 SV=1 g2266.t1 Q5U4Y8 69.817 328 3.6499999999999995e-172 488.0 sp|Q5U4Y8|SEH1_XENTR Nucleoporin SEH1 OS=Xenopus tropicalis OX=8364 GN=seh1l PE=2 SV=1 SEH1_XENTR reviewed Nucleoporin SEH1 (GATOR2 complex protein SEH1) (Nup107-160 subcomplex subunit seh1) Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0000776; GO:0005198; GO:0005765; GO:0006999; GO:0007080; GO:0015031; GO:0031080; GO:0031669; GO:0034198; GO:0035859; GO:0051028; GO:0051301; GO:0051315; GO:0061700; GO:1904263 attachment of mitotic spindle microtubules to kinetochore [GO:0051315]; cell division [GO:0051301]; cellular response to amino acid starvation [GO:0034198]; cellular response to nutrient levels [GO:0031669]; mitotic metaphase chromosome alignment [GO:0007080]; mRNA transport [GO:0051028]; nuclear pore organization [GO:0006999]; positive regulation of TORC1 signaling [GO:1904263]; protein transport [GO:0015031] GATOR2 complex [GO:0061700]; kinetochore [GO:0000776]; lysosomal membrane [GO:0005765]; nuclear pore outer ring [GO:0031080]; Seh1-associated complex [GO:0035859] structural molecule activity [GO:0005198] g2266.t2 Q5U4Y8 69.817 328 2.59e-172 488.0 sp|Q5U4Y8|SEH1_XENTR Nucleoporin SEH1 OS=Xenopus tropicalis OX=8364 GN=seh1l PE=2 SV=1 SEH1_XENTR reviewed Nucleoporin SEH1 (GATOR2 complex protein SEH1) (Nup107-160 subcomplex subunit seh1) Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0000776; GO:0005198; GO:0005765; GO:0006999; GO:0007080; GO:0015031; GO:0031080; GO:0031669; GO:0034198; GO:0035859; GO:0051028; GO:0051301; GO:0051315; GO:0061700; GO:1904263 attachment of mitotic spindle microtubules to kinetochore [GO:0051315]; cell division [GO:0051301]; cellular response to amino acid starvation [GO:0034198]; cellular response to nutrient levels [GO:0031669]; mitotic metaphase chromosome alignment [GO:0007080]; mRNA transport [GO:0051028]; nuclear pore organization [GO:0006999]; positive regulation of TORC1 signaling [GO:1904263]; protein transport [GO:0015031] GATOR2 complex [GO:0061700]; kinetochore [GO:0000776]; lysosomal membrane [GO:0005765]; nuclear pore outer ring [GO:0031080]; Seh1-associated complex [GO:0035859] structural molecule activity [GO:0005198] g2267.t1 Q9D0S4 37.255 306 1.25e-47 164.0 sp|Q9D0S4|NEUL2_MOUSE Neuralized-like protein 2 OS=Mus musculus OX=10090 GN=Neurl2 PE=1 SV=1 g2268.t1 Q9D0S4 37.255 306 1.25e-47 164.0 sp|Q9D0S4|NEUL2_MOUSE Neuralized-like protein 2 OS=Mus musculus OX=10090 GN=Neurl2 PE=1 SV=1 g2269.t1 Q6TGU2 67.179 195 3.14e-86 261.0 sp|Q6TGU2|SEH1_DANRE Nucleoporin SEH1 OS=Danio rerio OX=7955 GN=seh1l PE=2 SV=2 g2270.t1 Q14703 67.63 519 0.0 716.0 sp|Q14703|MBTP1_HUMAN Membrane-bound transcription factor site-1 protease OS=Homo sapiens OX=9606 GN=MBTPS1 PE=1 SV=1 MBTP1_HUMAN reviewed Membrane-bound transcription factor site-1 protease (EC 3.4.21.112) (Endopeptidase S1P) (Subtilisin/kexin-isozyme 1) (SKI-1) Homo sapiens (Human) GO:0000139; GO:0004252; GO:0005739; GO:0005788; GO:0005789; GO:0005794; GO:0005795; GO:0006508; GO:0006606; GO:0007040; GO:0007095; GO:0008203; GO:0016485; GO:0030968; GO:0031293; GO:0034976; GO:0036500; GO:0045540; GO:0051604; GO:0060627 ATF6-mediated unfolded protein response [GO:0036500]; cholesterol metabolic process [GO:0008203]; endoplasmic reticulum unfolded protein response [GO:0030968]; lysosome organization [GO:0007040]; membrane protein intracellular domain proteolysis [GO:0031293]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; protein import into nucleus [GO:0006606]; protein maturation [GO:0051604]; protein processing [GO:0016485]; proteolysis [GO:0006508]; regulation of cholesterol biosynthetic process [GO:0045540]; regulation of vesicle-mediated transport [GO:0060627]; response to endoplasmic reticulum stress [GO:0034976] endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; mitochondrion [GO:0005739] serine-type endopeptidase activity [GO:0004252] g2274.t1 Q5G267 26.076 395 3.24e-28 121.0 sp|Q5G267|NETR_MACMU Neurotrypsin OS=Macaca mulatta OX=9544 GN=PRSS12 PE=3 SV=1 NETR_MACMU reviewed Neurotrypsin (EC 3.4.21.-) (Serine protease 12) Macaca mulatta (Rhesus macaque) GO:0004252; GO:0005886; GO:0006508; GO:0006887; GO:0030424; GO:0030425; GO:0043083; GO:0043195; GO:0098978 exocytosis [GO:0006887]; proteolysis [GO:0006508] axon [GO:0030424]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; synaptic cleft [GO:0043083]; terminal bouton [GO:0043195] serine-type endopeptidase activity [GO:0004252] g2274.t1 Q5G267 30.114 352 1.64e-26 115.0 sp|Q5G267|NETR_MACMU Neurotrypsin OS=Macaca mulatta OX=9544 GN=PRSS12 PE=3 SV=1 NETR_MACMU reviewed Neurotrypsin (EC 3.4.21.-) (Serine protease 12) Macaca mulatta (Rhesus macaque) GO:0004252; GO:0005886; GO:0006508; GO:0006887; GO:0030424; GO:0030425; GO:0043083; GO:0043195; GO:0098978 exocytosis [GO:0006887]; proteolysis [GO:0006508] axon [GO:0030424]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; synaptic cleft [GO:0043083]; terminal bouton [GO:0043195] serine-type endopeptidase activity [GO:0004252] g2275.t1 Q8VI75 39.335 511 3.51e-88 295.0 sp|Q8VI75|IPO4_MOUSE Importin-4 OS=Mus musculus OX=10090 GN=Ipo4 PE=1 SV=1 g2276.t1 E9P860 29.976 417 1.49e-26 120.0 sp|E9P860|ZNFX1_CAEEL NFX1-type zinc finger-containing protein 1 homolog OS=Caenorhabditis elegans OX=6239 GN=znfx-1 PE=1 SV=1 ZNFX1_CAEEL reviewed NFX1-type zinc finger-containing protein 1 homolog (EC 3.6.4.13) Caenorhabditis elegans GO:0003723; GO:0003724; GO:0005524; GO:0005694; GO:0008270; GO:0016887; GO:0031048; GO:0031380; GO:0048471 regulatory ncRNA-mediated heterochromatin formation [GO:0031048] chromosome [GO:0005694]; nuclear RNA-directed RNA polymerase complex [GO:0031380]; perinuclear region of cytoplasm [GO:0048471] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; zinc ion binding [GO:0008270] g2277.t1 Q9P2E3 36.443 686 1.16e-107 370.0 sp|Q9P2E3|ZNFX1_HUMAN NFX1-type zinc finger-containing protein 1 OS=Homo sapiens OX=9606 GN=ZNFX1 PE=1 SV=2 ZNFX1_HUMAN reviewed NFX1-type zinc finger-containing protein 1 Homo sapiens (Human) GO:0002218; GO:0003723; GO:0004386; GO:0005741; GO:0008270; GO:0010494; GO:0031048; GO:0031380; GO:0042742; GO:0045071; GO:0045087; GO:0051607 activation of innate immune response [GO:0002218]; defense response to bacterium [GO:0042742]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; negative regulation of viral genome replication [GO:0045071]; regulatory ncRNA-mediated heterochromatin formation [GO:0031048] cytoplasmic stress granule [GO:0010494]; mitochondrial outer membrane [GO:0005741]; nuclear RNA-directed RNA polymerase complex [GO:0031380] helicase activity [GO:0004386]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270] g2278.t1 Q8R151 54.335 173 6.57e-46 164.0 sp|Q8R151|ZNFX1_MOUSE NFX1-type zinc finger-containing protein 1 OS=Mus musculus OX=10090 GN=Znfx1 PE=1 SV=3 ZNFX1_MOUSE reviewed NFX1-type zinc finger-containing protein 1 Mus musculus (Mouse) GO:0002218; GO:0003723; GO:0004386; GO:0005741; GO:0008270; GO:0010494; GO:0031048; GO:0031380; GO:0042742; GO:0045071; GO:0045087; GO:0051607 activation of innate immune response [GO:0002218]; defense response to bacterium [GO:0042742]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; negative regulation of viral genome replication [GO:0045071]; regulatory ncRNA-mediated heterochromatin formation [GO:0031048] cytoplasmic stress granule [GO:0010494]; mitochondrial outer membrane [GO:0005741]; nuclear RNA-directed RNA polymerase complex [GO:0031380] helicase activity [GO:0004386]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270] g2279.t1 Q8R151 43.976 332 3.03e-62 238.0 sp|Q8R151|ZNFX1_MOUSE NFX1-type zinc finger-containing protein 1 OS=Mus musculus OX=10090 GN=Znfx1 PE=1 SV=3 ZNFX1_MOUSE reviewed NFX1-type zinc finger-containing protein 1 Mus musculus (Mouse) GO:0002218; GO:0003723; GO:0004386; GO:0005741; GO:0008270; GO:0010494; GO:0031048; GO:0031380; GO:0042742; GO:0045071; GO:0045087; GO:0051607 activation of innate immune response [GO:0002218]; defense response to bacterium [GO:0042742]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; negative regulation of viral genome replication [GO:0045071]; regulatory ncRNA-mediated heterochromatin formation [GO:0031048] cytoplasmic stress granule [GO:0010494]; mitochondrial outer membrane [GO:0005741]; nuclear RNA-directed RNA polymerase complex [GO:0031380] helicase activity [GO:0004386]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270] g2280.t1 Q9P2E3 61.905 84 1.44e-29 113.0 sp|Q9P2E3|ZNFX1_HUMAN NFX1-type zinc finger-containing protein 1 OS=Homo sapiens OX=9606 GN=ZNFX1 PE=1 SV=2 ZNFX1_HUMAN reviewed NFX1-type zinc finger-containing protein 1 Homo sapiens (Human) GO:0002218; GO:0003723; GO:0004386; GO:0005741; GO:0008270; GO:0010494; GO:0031048; GO:0031380; GO:0042742; GO:0045071; GO:0045087; GO:0051607 activation of innate immune response [GO:0002218]; defense response to bacterium [GO:0042742]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; negative regulation of viral genome replication [GO:0045071]; regulatory ncRNA-mediated heterochromatin formation [GO:0031048] cytoplasmic stress granule [GO:0010494]; mitochondrial outer membrane [GO:0005741]; nuclear RNA-directed RNA polymerase complex [GO:0031380] helicase activity [GO:0004386]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270] g2282.t1 Q8R151 56.604 159 1.7900000000000001e-44 160.0 sp|Q8R151|ZNFX1_MOUSE NFX1-type zinc finger-containing protein 1 OS=Mus musculus OX=10090 GN=Znfx1 PE=1 SV=3 ZNFX1_MOUSE reviewed NFX1-type zinc finger-containing protein 1 Mus musculus (Mouse) GO:0002218; GO:0003723; GO:0004386; GO:0005741; GO:0008270; GO:0010494; GO:0031048; GO:0031380; GO:0042742; GO:0045071; GO:0045087; GO:0051607 activation of innate immune response [GO:0002218]; defense response to bacterium [GO:0042742]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; negative regulation of viral genome replication [GO:0045071]; regulatory ncRNA-mediated heterochromatin formation [GO:0031048] cytoplasmic stress granule [GO:0010494]; mitochondrial outer membrane [GO:0005741]; nuclear RNA-directed RNA polymerase complex [GO:0031380] helicase activity [GO:0004386]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270] g2285.t1 O43312 60.725 331 2.2800000000000002e-123 395.0 sp|O43312|MTSS1_HUMAN Protein MTSS 1 OS=Homo sapiens OX=9606 GN=MTSS1 PE=1 SV=2 MTSS1_HUMAN reviewed Protein MTSS 1 (Metastasis suppressor YGL-1) (Metastasis suppressor protein 1) (Missing in metastasis protein) Homo sapiens (Human) GO:0001726; GO:0003779; GO:0003785; GO:0005102; GO:0005543; GO:0005737; GO:0007009; GO:0007155; GO:0007169; GO:0009898; GO:0015629; GO:0030035; GO:0030036; GO:0030139; GO:0032233; GO:0034334; GO:0042802; GO:0050680; GO:0061333; GO:0071498; GO:0072102; GO:0072160; GO:2001013 actin cytoskeleton organization [GO:0030036]; adherens junction maintenance [GO:0034334]; cell adhesion [GO:0007155]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; cellular response to fluid shear stress [GO:0071498]; epithelial cell proliferation involved in renal tubule morphogenesis [GO:2001013]; glomerulus morphogenesis [GO:0072102]; microspike assembly [GO:0030035]; negative regulation of epithelial cell proliferation [GO:0050680]; nephron tubule epithelial cell differentiation [GO:0072160]; plasma membrane organization [GO:0007009]; positive regulation of actin filament bundle assembly [GO:0032233]; renal tubule morphogenesis [GO:0061333] actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; endocytic vesicle [GO:0030139]; ruffle [GO:0001726] actin binding [GO:0003779]; actin monomer binding [GO:0003785]; identical protein binding [GO:0042802]; phospholipid binding [GO:0005543]; signaling receptor binding [GO:0005102] g2285.t2 O43312 60.725 331 1.9400000000000002e-123 395.0 sp|O43312|MTSS1_HUMAN Protein MTSS 1 OS=Homo sapiens OX=9606 GN=MTSS1 PE=1 SV=2 MTSS1_HUMAN reviewed Protein MTSS 1 (Metastasis suppressor YGL-1) (Metastasis suppressor protein 1) (Missing in metastasis protein) Homo sapiens (Human) GO:0001726; GO:0003779; GO:0003785; GO:0005102; GO:0005543; GO:0005737; GO:0007009; GO:0007155; GO:0007169; GO:0009898; GO:0015629; GO:0030035; GO:0030036; GO:0030139; GO:0032233; GO:0034334; GO:0042802; GO:0050680; GO:0061333; GO:0071498; GO:0072102; GO:0072160; GO:2001013 actin cytoskeleton organization [GO:0030036]; adherens junction maintenance [GO:0034334]; cell adhesion [GO:0007155]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; cellular response to fluid shear stress [GO:0071498]; epithelial cell proliferation involved in renal tubule morphogenesis [GO:2001013]; glomerulus morphogenesis [GO:0072102]; microspike assembly [GO:0030035]; negative regulation of epithelial cell proliferation [GO:0050680]; nephron tubule epithelial cell differentiation [GO:0072160]; plasma membrane organization [GO:0007009]; positive regulation of actin filament bundle assembly [GO:0032233]; renal tubule morphogenesis [GO:0061333] actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; endocytic vesicle [GO:0030139]; ruffle [GO:0001726] actin binding [GO:0003779]; actin monomer binding [GO:0003785]; identical protein binding [GO:0042802]; phospholipid binding [GO:0005543]; signaling receptor binding [GO:0005102] g2285.t3 O43312 58.261 345 1.24e-119 385.0 sp|O43312|MTSS1_HUMAN Protein MTSS 1 OS=Homo sapiens OX=9606 GN=MTSS1 PE=1 SV=2 MTSS1_HUMAN reviewed Protein MTSS 1 (Metastasis suppressor YGL-1) (Metastasis suppressor protein 1) (Missing in metastasis protein) Homo sapiens (Human) GO:0001726; GO:0003779; GO:0003785; GO:0005102; GO:0005543; GO:0005737; GO:0007009; GO:0007155; GO:0007169; GO:0009898; GO:0015629; GO:0030035; GO:0030036; GO:0030139; GO:0032233; GO:0034334; GO:0042802; GO:0050680; GO:0061333; GO:0071498; GO:0072102; GO:0072160; GO:2001013 actin cytoskeleton organization [GO:0030036]; adherens junction maintenance [GO:0034334]; cell adhesion [GO:0007155]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; cellular response to fluid shear stress [GO:0071498]; epithelial cell proliferation involved in renal tubule morphogenesis [GO:2001013]; glomerulus morphogenesis [GO:0072102]; microspike assembly [GO:0030035]; negative regulation of epithelial cell proliferation [GO:0050680]; nephron tubule epithelial cell differentiation [GO:0072160]; plasma membrane organization [GO:0007009]; positive regulation of actin filament bundle assembly [GO:0032233]; renal tubule morphogenesis [GO:0061333] actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; endocytic vesicle [GO:0030139]; ruffle [GO:0001726] actin binding [GO:0003779]; actin monomer binding [GO:0003785]; identical protein binding [GO:0042802]; phospholipid binding [GO:0005543]; signaling receptor binding [GO:0005102] g2287.t1 Q8N0V3 36.923 195 7.02e-30 120.0 sp|Q8N0V3|RBFA_HUMAN Putative ribosome-binding factor A, mitochondrial OS=Homo sapiens OX=9606 GN=RBFA PE=1 SV=3 RBFA_HUMAN reviewed Putative ribosome-binding factor A, mitochondrial Homo sapiens (Human) GO:0005739; GO:0005759; GO:0006364; GO:0019843; GO:0043024; GO:0180026 mitochondrial small ribosomal subunit assembly [GO:0180026]; rRNA processing [GO:0006364] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] ribosomal small subunit binding [GO:0043024]; rRNA binding [GO:0019843] g2288.t1 Q5ZLG9 42.547 1013 0.0 732.0 sp|Q5ZLG9|WDR59_CHICK GATOR2 complex protein WDR59 OS=Gallus gallus OX=9031 GN=WDR59 PE=2 SV=1 WDR59_CHICK reviewed GATOR2 complex protein WDR59 Gallus gallus (Chicken) GO:0005765; GO:0005774; GO:0008270; GO:0031669; GO:0034198; GO:0035591; GO:0035859; GO:0061700; GO:1904263 cellular response to amino acid starvation [GO:0034198]; cellular response to nutrient levels [GO:0031669]; positive regulation of TORC1 signaling [GO:1904263] GATOR2 complex [GO:0061700]; lysosomal membrane [GO:0005765]; Seh1-associated complex [GO:0035859]; vacuolar membrane [GO:0005774] signaling adaptor activity [GO:0035591]; zinc ion binding [GO:0008270] g2291.t1 O88667 41.176 204 8.8e-36 134.0 sp|O88667|RAD_MOUSE GTP-binding protein RAD OS=Mus musculus OX=10090 GN=Rrad PE=1 SV=1 RAD_MOUSE reviewed GTP-binding protein RAD Mus musculus (Mouse) GO:0003924; GO:0005246; GO:0005516; GO:0005525; GO:0005886; GO:0030308; GO:0030315 negative regulation of cell growth [GO:0030308] plasma membrane [GO:0005886]; T-tubule [GO:0030315] calcium channel regulator activity [GO:0005246]; calmodulin binding [GO:0005516]; GTP binding [GO:0005525]; GTPase activity [GO:0003924] g2293.t1 P28651 56.41 273 1.9100000000000003e-110 324.0 sp|P28651|CAH8_MOUSE Carbonic anhydrase-related protein OS=Mus musculus OX=10090 GN=Ca8 PE=1 SV=5 g2293.t2 P28651 59.533 257 1.1299999999999999e-114 334.0 sp|P28651|CAH8_MOUSE Carbonic anhydrase-related protein OS=Mus musculus OX=10090 GN=Ca8 PE=1 SV=5 g2295.t1 Q503Z8 56.444 225 6.62e-72 240.0 sp|Q503Z8|IRX6A_DANRE Iroquois homeobox protein 6a OS=Danio rerio OX=7955 GN=irx6a PE=2 SV=1 g2297.t1 Q503Z8 78.218 101 1.8600000000000002e-43 162.0 sp|Q503Z8|IRX6A_DANRE Iroquois homeobox protein 6a OS=Danio rerio OX=7955 GN=irx6a PE=2 SV=1 g2300.t1 Q8K4C0 51.556 514 0.0 561.0 sp|Q8K4C0|FMO5_RAT Flavin-containing monooxygenase 5 OS=Rattus norvegicus OX=10116 GN=Fmo5 PE=1 SV=3 FMO5_RAT reviewed Flavin-containing monooxygenase 5 (FMO 5) (Dimethylaniline monooxygenase [N-oxide-forming] 5) (EC 1.14.13.8) (Dimethylaniline oxidase 5) (Hepatic flavin-containing monooxygenase 5) (NADPH oxidase) (EC 1.6.3.1) Rattus norvegicus (Rat) GO:0004497; GO:0004499; GO:0005783; GO:0005789; GO:0005829; GO:0006629; GO:0006805; GO:0016174; GO:0050660; GO:0050661; GO:0090181 lipid metabolic process [GO:0006629]; regulation of cholesterol metabolic process [GO:0090181]; xenobiotic metabolic process [GO:0006805] cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789] flavin adenine dinucleotide binding [GO:0050660]; monooxygenase activity [GO:0004497]; N,N-dimethylaniline monooxygenase activity [GO:0004499]; NAD(P)H oxidase H2O2-forming activity [GO:0016174]; NADP binding [GO:0050661] g2302.t1 Q9I9A7 41.935 434 6.9e-101 325.0 sp|Q9I9A7|CDT1_XENLA DNA replication factor Cdt1 OS=Xenopus laevis OX=8355 GN=cdt1 PE=1 SV=2 g2303.t1 P23975 59.002 561 0.0 612.0 sp|P23975|SC6A2_HUMAN Sodium-dependent noradrenaline transporter OS=Homo sapiens OX=9606 GN=SLC6A2 PE=1 SV=1 SC6A2_HUMAN reviewed Sodium-dependent noradrenaline transporter (Norepinephrine transporter) (NET) (Solute carrier family 6 member 2) Homo sapiens (Human) GO:0003779; GO:0005326; GO:0005328; GO:0005330; GO:0005334; GO:0005886; GO:0006836; GO:0006865; GO:0007268; GO:0008504; GO:0009410; GO:0009986; GO:0015844; GO:0015874; GO:0016020; GO:0030424; GO:0030672; GO:0032809; GO:0035725; GO:0042734; GO:0043014; GO:0046872; GO:0048265; GO:0048487; GO:0051583; GO:0051620; GO:0070050 amino acid transport [GO:0006865]; chemical synaptic transmission [GO:0007268]; dopamine uptake involved in synaptic transmission [GO:0051583]; monoamine transport [GO:0015844]; neuron cellular homeostasis [GO:0070050]; neurotransmitter transport [GO:0006836]; norepinephrine transport [GO:0015874]; norepinephrine uptake [GO:0051620]; response to pain [GO:0048265]; response to xenobiotic stimulus [GO:0009410]; sodium ion transmembrane transport [GO:0035725] axon [GO:0030424]; cell surface [GO:0009986]; membrane [GO:0016020]; neuronal cell body membrane [GO:0032809]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; synaptic vesicle membrane [GO:0030672] actin binding [GO:0003779]; alpha-tubulin binding [GO:0043014]; beta-tubulin binding [GO:0048487]; dopamine:sodium symporter activity [GO:0005330]; metal ion binding [GO:0046872]; monoamine transmembrane transporter activity [GO:0008504]; neurotransmitter transmembrane transporter activity [GO:0005326]; neurotransmitter:sodium symporter activity [GO:0005328]; norepinephrine:sodium symporter activity [GO:0005334] g2322.t1 Q9JLC8 33.161 968 1.0700000000000001e-129 435.0 sp|Q9JLC8|SACS_MOUSE Sacsin OS=Mus musculus OX=10090 GN=Sacs PE=1 SV=2 g2322.t1 Q9JLC8 32.805 442 3.75e-44 178.0 sp|Q9JLC8|SACS_MOUSE Sacsin OS=Mus musculus OX=10090 GN=Sacs PE=1 SV=2 g2322.t1 Q9JLC8 34.146 246 1.02e-27 125.0 sp|Q9JLC8|SACS_MOUSE Sacsin OS=Mus musculus OX=10090 GN=Sacs PE=1 SV=2 g2323.t1 Q9NZJ4 27.874 3566 0.0 1112.0 sp|Q9NZJ4|SACS_HUMAN Sacsin OS=Homo sapiens OX=9606 GN=SACS PE=1 SV=2 g2323.t1 Q9NZJ4 30.368 517 1.17e-44 184.0 sp|Q9NZJ4|SACS_HUMAN Sacsin OS=Homo sapiens OX=9606 GN=SACS PE=1 SV=2 g2323.t1 Q9NZJ4 30.303 462 6.1500000000000005e-43 179.0 sp|Q9NZJ4|SACS_HUMAN Sacsin OS=Homo sapiens OX=9606 GN=SACS PE=1 SV=2 g2323.t1 Q9NZJ4 27.546 599 4.51e-40 169.0 sp|Q9NZJ4|SACS_HUMAN Sacsin OS=Homo sapiens OX=9606 GN=SACS PE=1 SV=2 g2324.t1 Q9NZJ4 36.42 648 7.96e-106 356.0 sp|Q9NZJ4|SACS_HUMAN Sacsin OS=Homo sapiens OX=9606 GN=SACS PE=1 SV=2 g2324.t1 Q9NZJ4 32.805 442 2.3e-44 175.0 sp|Q9NZJ4|SACS_HUMAN Sacsin OS=Homo sapiens OX=9606 GN=SACS PE=1 SV=2 g2324.t1 Q9NZJ4 35.081 248 5.440000000000001e-26 118.0 sp|Q9NZJ4|SACS_HUMAN Sacsin OS=Homo sapiens OX=9606 GN=SACS PE=1 SV=2 g2337.t1 Q8WPD0 36.806 144 3.37e-24 96.3 sp|Q8WPD0|LECG_PATPE Alpha-N-acetylgalactosamine-specific lectin OS=Patiria pectinifera OX=7594 PE=1 SV=1 g2340.t1 Q8WPD0 33.562 146 4.53e-22 90.1 sp|Q8WPD0|LECG_PATPE Alpha-N-acetylgalactosamine-specific lectin OS=Patiria pectinifera OX=7594 PE=1 SV=1 g2341.t1 P98133 39.203 477 3.14e-63 245.0 sp|P98133|FBN1_BOVIN Fibrillin-1 OS=Bos taurus OX=9913 GN=FBN1 PE=1 SV=2 g2341.t1 P98133 34.221 526 1.01e-40 171.0 sp|P98133|FBN1_BOVIN Fibrillin-1 OS=Bos taurus OX=9913 GN=FBN1 PE=1 SV=2 g2341.t1 P98133 33.75 480 1.98e-38 163.0 sp|P98133|FBN1_BOVIN Fibrillin-1 OS=Bos taurus OX=9913 GN=FBN1 PE=1 SV=2 g2341.t1 P98133 33.333 438 1.56e-33 147.0 sp|P98133|FBN1_BOVIN Fibrillin-1 OS=Bos taurus OX=9913 GN=FBN1 PE=1 SV=2 g2341.t1 P98133 37.457 291 3.62e-33 145.0 sp|P98133|FBN1_BOVIN Fibrillin-1 OS=Bos taurus OX=9913 GN=FBN1 PE=1 SV=2 g2341.t1 P98133 31.459 569 6.35e-33 145.0 sp|P98133|FBN1_BOVIN Fibrillin-1 OS=Bos taurus OX=9913 GN=FBN1 PE=1 SV=2 g2341.t1 P98133 32.432 518 1.52e-29 134.0 sp|P98133|FBN1_BOVIN Fibrillin-1 OS=Bos taurus OX=9913 GN=FBN1 PE=1 SV=2 g2341.t1 P98133 30.787 445 4.55e-29 132.0 sp|P98133|FBN1_BOVIN Fibrillin-1 OS=Bos taurus OX=9913 GN=FBN1 PE=1 SV=2 g2341.t1 P98133 30.943 488 1.5e-26 124.0 sp|P98133|FBN1_BOVIN Fibrillin-1 OS=Bos taurus OX=9913 GN=FBN1 PE=1 SV=2 g2341.t1 P98133 29.522 481 7.76e-22 108.0 sp|P98133|FBN1_BOVIN Fibrillin-1 OS=Bos taurus OX=9913 GN=FBN1 PE=1 SV=2 g2341.t1 P98133 33.154 371 1.0900000000000001e-21 108.0 sp|P98133|FBN1_BOVIN Fibrillin-1 OS=Bos taurus OX=9913 GN=FBN1 PE=1 SV=2 g2341.t1 P98133 31.1 418 1.24e-21 108.0 sp|P98133|FBN1_BOVIN Fibrillin-1 OS=Bos taurus OX=9913 GN=FBN1 PE=1 SV=2 g2342.t1 P0C0T2 38.134 493 1.47e-93 316.0 sp|P0C0T2|ANKS6_RAT Ankyrin repeat and SAM domain-containing protein 6 OS=Rattus norvegicus OX=10116 GN=Anks6 PE=1 SV=2 ANKS6_RAT reviewed Ankyrin repeat and SAM domain-containing protein 6 (Polycystic kidney disease protein 1) (SamCystin) (Sterile alpha motif domain-containing protein 6) (SAM domain-containing protein 6) Rattus norvegicus (Rat) GO:0001701; GO:0001822; GO:0005737; GO:0007368; GO:0007507; GO:0042802; GO:0045087; GO:0097543 determination of left/right symmetry [GO:0007368]; heart development [GO:0007507]; in utero embryonic development [GO:0001701]; innate immune response [GO:0045087]; kidney development [GO:0001822] ciliary inversin compartment [GO:0097543]; cytoplasm [GO:0005737] identical protein binding [GO:0042802] g2346.t1 O08653 26.093 732 1.35e-46 187.0 sp|O08653|TEP1_RAT Telomerase protein component 1 OS=Rattus norvegicus OX=10116 GN=Tep1 PE=1 SV=1 g2347.t1 Q6GLK6 34.112 214 2.73e-29 119.0 sp|Q6GLK6|ACSF3_XENLA Malonate--CoA ligase ACSF3, mitochondrial OS=Xenopus laevis OX=8355 GN=acsf3 PE=2 SV=1 g2351.t1 O76536 36.039 308 5.500000000000001e-35 142.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g2351.t1 O76536 34.81 316 9.03e-33 135.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g2351.t1 O76536 36.027 297 4.1000000000000003e-29 124.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g2351.t1 O76536 31.367 373 1.05e-27 120.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g2351.t1 O76536 32.797 311 5.020000000000001e-27 118.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g2351.t1 O76536 33.333 306 1.92e-26 116.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g2351.t1 O76536 33.904 292 4.5000000000000005e-26 115.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g2351.t1 O76536 32.131 305 1.2699999999999999e-24 110.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g2354.t1 P11387 72.432 555 0.0 838.0 sp|P11387|TOP1_HUMAN DNA topoisomerase 1 OS=Homo sapiens OX=9606 GN=TOP1 PE=1 SV=2 TOP1_HUMAN reviewed DNA topoisomerase 1 (EC 5.6.2.1) (DNA topoisomerase I) Homo sapiens (Human) GO:0000932; GO:0000978; GO:0001650; GO:0001651; GO:0001673; GO:0003677; GO:0003682; GO:0003690; GO:0003697; GO:0003723; GO:0003917; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005694; GO:0005730; GO:0006260; GO:0006265; GO:0006338; GO:0007059; GO:0007623; GO:0008301; GO:0009266; GO:0009303; GO:0009410; GO:0010332; GO:0012501; GO:0019904; GO:0031100; GO:0031490; GO:0032922; GO:0032993; GO:0040016; GO:0043204; GO:0044877; GO:0051591; GO:0071373; GO:0097100; GO:0140693 animal organ regeneration [GO:0031100]; cellular response to luteinizing hormone stimulus [GO:0071373]; chromatin remodeling [GO:0006338]; chromosome segregation [GO:0007059]; circadian regulation of gene expression [GO:0032922]; circadian rhythm [GO:0007623]; DNA replication [GO:0006260]; DNA topological change [GO:0006265]; embryonic cleavage [GO:0040016]; programmed cell death [GO:0012501]; response to cAMP [GO:0051591]; response to gamma radiation [GO:0010332]; response to temperature stimulus [GO:0009266]; response to xenobiotic stimulus [GO:0009410]; rRNA transcription [GO:0009303] chromosome [GO:0005694]; dense fibrillar component [GO:0001651]; fibrillar center [GO:0001650]; male germ cell nucleus [GO:0001673]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; perikaryon [GO:0043204]; protein-DNA complex [GO:0032993] ATP binding [GO:0005524]; chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; DNA binding [GO:0003677]; DNA binding, bending [GO:0008301]; DNA topoisomerase type I (single strand cut, ATP-independent) activity [GO:0003917]; double-stranded DNA binding [GO:0003690]; molecular condensate scaffold activity [GO:0140693]; protein domain specific binding [GO:0019904]; protein serine/threonine kinase activity [GO:0004674]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; single-stranded DNA binding [GO:0003697]; supercoiled DNA binding [GO:0097100] g2355.t1 Q4R7K1 60.0 345 1.1399999999999999e-128 381.0 sp|Q4R7K1|MCES_MACFA mRNA cap guanine-N(7) methyltransferase OS=Macaca fascicularis OX=9541 GN=RNMT PE=2 SV=1 MCES_MACFA reviewed mRNA cap guanine-N(7) methyltransferase (EC 2.1.1.56) (RG7MT1) (mRNA (guanine-N(7))-methyltransferase) (mRNA cap methyltransferase) Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey) GO:0003723; GO:0004482; GO:0005634; GO:0006370; GO:0160130 7-methylguanosine mRNA capping [GO:0006370] mRNA cap methyltransferase RNMT:RAMAC complex [GO:0160130]; nucleus [GO:0005634] mRNA 5'-cap (guanine-N7-)-methyltransferase activity [GO:0004482]; RNA binding [GO:0003723] g2356.t1 H1UBN0 57.491 534 0.0 617.0 sp|H1UBN0|CPNE7_RAT Copine-7 OS=Rattus norvegicus OX=10116 GN=Cpne7 PE=1 SV=1 g2356.t2 H1UBN0 57.491 534 0.0 615.0 sp|H1UBN0|CPNE7_RAT Copine-7 OS=Rattus norvegicus OX=10116 GN=Cpne7 PE=1 SV=1 g2356.t3 H1UBN0 55.044 565 0.0 610.0 sp|H1UBN0|CPNE7_RAT Copine-7 OS=Rattus norvegicus OX=10116 GN=Cpne7 PE=1 SV=1 g2357.t1 Q92620 71.103 1052 0.0 1476.0 sp|Q92620|PRP16_HUMAN Pre-mRNA-splicing factor ATP-dependent RNA helicase PRP16 OS=Homo sapiens OX=9606 GN=DHX38 PE=1 SV=2 PRP16_HUMAN reviewed Pre-mRNA-splicing factor ATP-dependent RNA helicase PRP16 (EC 3.6.4.13) (ATP-dependent RNA helicase DHX38) (DEAH box protein 38) Homo sapiens (Human) GO:0000398; GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005654; GO:0005681; GO:0016020; GO:0016887; GO:0034458; GO:0071013 mRNA splicing, via spliceosome [GO:0000398] catalytic step 2 spliceosome [GO:0071013]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681] 3'-5' RNA helicase activity [GO:0034458]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724] g2358.t1 Q3KQF4 50.0 274 1.14e-80 251.0 sp|Q3KQF4|LRC69_XENLA Leucine-rich repeat-containing protein 69 OS=Xenopus laevis OX=8355 GN=lrrc69 PE=2 SV=1 g2359.t1 A7RRJ0 72.296 379 0.0 540.0 sp|A7RRJ0|FEN1_NEMVE Flap endonuclease 1 OS=Nematostella vectensis OX=45351 GN=FEN1 PE=3 SV=1 FEN1_NEMVE reviewed Flap endonuclease 1 (FEN-1) (EC 3.1.-.-) (Flap structure-specific endonuclease 1) Nematostella vectensis (Starlet sea anemone) GO:0000287; GO:0003677; GO:0004523; GO:0005634; GO:0005654; GO:0005730; GO:0005739; GO:0006284; GO:0008409; GO:0017108; GO:0030145; GO:0043137 base-excision repair [GO:0006284]; DNA replication, removal of RNA primer [GO:0043137] mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] 5'-3' exonuclease activity [GO:0008409]; 5'-flap endonuclease activity [GO:0017108]; DNA binding [GO:0003677]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; RNA-DNA hybrid ribonuclease activity [GO:0004523] g2360.t1 O95427 51.551 935 0.0 850.0 sp|O95427|PIGN_HUMAN GPI ethanolamine phosphate transferase 1 OS=Homo sapiens OX=9606 GN=PIGN PE=1 SV=1 PIGN_HUMAN reviewed GPI ethanolamine phosphate transferase 1 (EC 2.-.-.-) (GPI-ethanolamine transferase I) (GPI-ETI) (MCD4 homolog) (Phosphatidylinositol-glycan biosynthesis class N protein) (PIG-N) Homo sapiens (Human) GO:0005789; GO:0005829; GO:0005886; GO:0006506; GO:0016020; GO:0051377 GPI anchor biosynthetic process [GO:0006506] cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; plasma membrane [GO:0005886] mannose-ethanolamine phosphotransferase activity [GO:0051377] g2361.t1 Q13951 61.224 147 3.6000000000000005e-64 199.0 sp|Q13951|PEBB_HUMAN Core-binding factor subunit beta OS=Homo sapiens OX=9606 GN=CBFB PE=1 SV=2 g2361.t2 Q13951 61.224 147 1.65e-64 199.0 sp|Q13951|PEBB_HUMAN Core-binding factor subunit beta OS=Homo sapiens OX=9606 GN=CBFB PE=1 SV=2 g2362.t1 Q9WVM6 28.256 407 1.89e-37 154.0 sp|Q9WVM6|TLL2_MOUSE Tolloid-like protein 2 OS=Mus musculus OX=10090 GN=Tll2 PE=1 SV=1 g2362.t1 Q9WVM6 31.429 245 5.81e-29 127.0 sp|Q9WVM6|TLL2_MOUSE Tolloid-like protein 2 OS=Mus musculus OX=10090 GN=Tll2 PE=1 SV=1 g2362.t1 Q9WVM6 26.57 414 8.66e-28 123.0 sp|Q9WVM6|TLL2_MOUSE Tolloid-like protein 2 OS=Mus musculus OX=10090 GN=Tll2 PE=1 SV=1 g2363.t1 O00268 57.463 268 6.23e-78 281.0 sp|O00268|TAF4_HUMAN Transcription initiation factor TFIID subunit 4 OS=Homo sapiens OX=9606 GN=TAF4 PE=1 SV=2 TAF4_HUMAN reviewed Transcription initiation factor TFIID subunit 4 (RNA polymerase II TBP-associated factor subunit C) (TBP-associated factor 4) (Transcription initiation factor TFIID 130 kDa subunit) (TAF(II)130) (TAFII-130) (TAFII130) (Transcription initiation factor TFIID 135 kDa subunit) (TAF(II)135) (TAFII-135) (TAFII135) Homo sapiens (Human) GO:0000785; GO:0001541; GO:0001673; GO:0003677; GO:0005634; GO:0005654; GO:0005669; GO:0005829; GO:0006282; GO:0006352; GO:0006357; GO:0006366; GO:0006367; GO:0017162; GO:0032991; GO:0033276; GO:0042789; GO:0045893; GO:0046982; GO:0051123; GO:0060261; GO:0071339 DNA-templated transcription initiation [GO:0006352]; mRNA transcription by RNA polymerase II [GO:0042789]; ovarian follicle development [GO:0001541]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription initiation by RNA polymerase II [GO:0060261]; regulation of DNA repair [GO:0006282]; regulation of transcription by RNA polymerase II [GO:0006357]; RNA polymerase II preinitiation complex assembly [GO:0051123]; transcription by RNA polymerase II [GO:0006366]; transcription initiation at RNA polymerase II promoter [GO:0006367] chromatin [GO:0000785]; cytosol [GO:0005829]; male germ cell nucleus [GO:0001673]; MLL1 complex [GO:0071339]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcription factor TFIID complex [GO:0005669]; transcription factor TFTC complex [GO:0033276] aryl hydrocarbon receptor binding [GO:0017162]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982] g2363.t1 O00268 74.026 77 6.65e-28 125.0 sp|O00268|TAF4_HUMAN Transcription initiation factor TFIID subunit 4 OS=Homo sapiens OX=9606 GN=TAF4 PE=1 SV=2 TAF4_HUMAN reviewed Transcription initiation factor TFIID subunit 4 (RNA polymerase II TBP-associated factor subunit C) (TBP-associated factor 4) (Transcription initiation factor TFIID 130 kDa subunit) (TAF(II)130) (TAFII-130) (TAFII130) (Transcription initiation factor TFIID 135 kDa subunit) (TAF(II)135) (TAFII-135) (TAFII135) Homo sapiens (Human) GO:0000785; GO:0001541; GO:0001673; GO:0003677; GO:0005634; GO:0005654; GO:0005669; GO:0005829; GO:0006282; GO:0006352; GO:0006357; GO:0006366; GO:0006367; GO:0017162; GO:0032991; GO:0033276; GO:0042789; GO:0045893; GO:0046982; GO:0051123; GO:0060261; GO:0071339 DNA-templated transcription initiation [GO:0006352]; mRNA transcription by RNA polymerase II [GO:0042789]; ovarian follicle development [GO:0001541]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription initiation by RNA polymerase II [GO:0060261]; regulation of DNA repair [GO:0006282]; regulation of transcription by RNA polymerase II [GO:0006357]; RNA polymerase II preinitiation complex assembly [GO:0051123]; transcription by RNA polymerase II [GO:0006366]; transcription initiation at RNA polymerase II promoter [GO:0006367] chromatin [GO:0000785]; cytosol [GO:0005829]; male germ cell nucleus [GO:0001673]; MLL1 complex [GO:0071339]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcription factor TFIID complex [GO:0005669]; transcription factor TFTC complex [GO:0033276] aryl hydrocarbon receptor binding [GO:0017162]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982] g2368.t1 Q6DC02 61.712 222 2.78e-100 296.0 sp|Q6DC02|KCD15_DANRE BTB/POZ domain-containing protein kctd15 OS=Danio rerio OX=7955 GN=kctd15 PE=1 SV=1 KCD15_DANRE reviewed BTB/POZ domain-containing protein kctd15 (Potassium channel tetramerization domain-containing protein 15) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0003714; GO:0005654; GO:0007420; GO:0014033; GO:0045892; GO:0051260; GO:0060037; GO:0060070 brain development [GO:0007420]; canonical Wnt signaling pathway [GO:0060070]; negative regulation of DNA-templated transcription [GO:0045892]; neural crest cell differentiation [GO:0014033]; pharyngeal system development [GO:0060037]; protein homooligomerization [GO:0051260] nucleoplasm [GO:0005654] transcription corepressor activity [GO:0003714] g2370.t1 Q3MI05 43.016 451 3.79e-119 360.0 sp|Q3MI05|PPGB_BOVIN Lysosomal protective protein OS=Bos taurus OX=9913 GN=CTSA PE=2 SV=1 g2371.t1 P10619 47.265 457 7.11e-149 436.0 sp|P10619|PPGB_HUMAN Lysosomal protective protein OS=Homo sapiens OX=9606 GN=CTSA PE=1 SV=2 PPGB_HUMAN reviewed Lysosomal protective protein (EC 3.4.16.5) (Carboxypeptidase C) (Carboxypeptidase L) (Cathepsin A) (Protective protein cathepsin A) (PPCA) (Protective protein for beta-galactosidase) [Cleaved into: Lysosomal protective protein 32 kDa chain; Lysosomal protective protein 20 kDa chain] Homo sapiens (Human) GO:0004180; GO:0004185; GO:0005576; GO:0005764; GO:0005783; GO:0006508; GO:0006886; GO:0008047; GO:0016020; GO:0031647; GO:0035578; GO:0043202; GO:0070062; GO:1904714; GO:1904715 intracellular protein transport [GO:0006886]; negative regulation of chaperone-mediated autophagy [GO:1904715]; proteolysis [GO:0006508]; regulation of chaperone-mediated autophagy [GO:1904714]; regulation of protein stability [GO:0031647] azurophil granule lumen [GO:0035578]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764]; membrane [GO:0016020] carboxypeptidase activity [GO:0004180]; enzyme activator activity [GO:0008047]; serine-type carboxypeptidase activity [GO:0004185] g2372.t1 Q7TSH2 53.03 1056 0.0 1113.0 sp|Q7TSH2|KPBB_MOUSE Phosphorylase b kinase regulatory subunit beta OS=Mus musculus OX=10090 GN=Phkb PE=1 SV=1 g2373.t1 Q96I23 58.333 60 8.72e-22 85.9 sp|Q96I23|PREY_HUMAN Protein preY, mitochondrial OS=Homo sapiens OX=9606 GN=PYURF PE=1 SV=1 g2374.t1 A0A0R4IC37 55.747 174 1.7600000000000003e-58 200.0 sp|A0A0R4IC37|CPSF1_DANRE Cleavage and polyadenylation specificity factor subunit 1 OS=Danio rerio OX=7955 GN=cpsf1 PE=3 SV=2 g2376.t1 Q9H9E3 56.935 757 0.0 884.0 sp|Q9H9E3|COG4_HUMAN Conserved oligomeric Golgi complex subunit 4 OS=Homo sapiens OX=9606 GN=COG4 PE=1 SV=3 COG4_HUMAN reviewed Conserved oligomeric Golgi complex subunit 4 (COG complex subunit 4) (Component of oligomeric Golgi complex 4) Homo sapiens (Human) GO:0000139; GO:0000301; GO:0005829; GO:0006890; GO:0007030; GO:0015031; GO:0017119; GO:0032588; GO:0042802 Golgi organization [GO:0007030]; protein transport [GO:0015031]; retrograde transport, vesicle recycling within Golgi [GO:0000301]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890] cytosol [GO:0005829]; Golgi membrane [GO:0000139]; Golgi transport complex [GO:0017119]; trans-Golgi network membrane [GO:0032588] identical protein binding [GO:0042802] g2377.t1 Q921M3 82.759 957 0.0 1611.0 sp|Q921M3|SF3B3_MOUSE Splicing factor 3B subunit 3 OS=Mus musculus OX=10090 GN=Sf3b3 PE=1 SV=1 g2378.t1 Q1LVE8 78.423 241 1.84e-139 424.0 sp|Q1LVE8|SF3B3_DANRE Splicing factor 3B subunit 3 OS=Danio rerio OX=7955 GN=sf3b3 PE=2 SV=1 g2381.t1 Q9CR96 52.532 158 1.75e-53 170.0 sp|Q9CR96|TM208_MOUSE Transmembrane protein 208 OS=Mus musculus OX=10090 GN=Tmem208 PE=2 SV=1 g2382.t1 P20678 41.304 92 3e-22 81.3 sp|P20678|CP2H2_CHICK Cytochrome P450 2H2 OS=Gallus gallus OX=9031 GN=CYP2H2 PE=1 SV=1 g2382.t1 P20678 55.556 36 3e-22 44.7 sp|P20678|CP2H2_CHICK Cytochrome P450 2H2 OS=Gallus gallus OX=9031 GN=CYP2H2 PE=1 SV=1 g2383.t1 Q0IIF9 49.5 200 7.989999999999999e-67 217.0 sp|Q0IIF9|CP2U1_BOVIN Cytochrome P450 2U1 OS=Bos taurus OX=9913 GN=CYP2U1 PE=2 SV=1 CP2U1_BOVIN reviewed Cytochrome P450 2U1 (Long-chain fatty acid omega-monooxygenase) (EC 1.14.14.80) Bos taurus (Bovine) GO:0005506; GO:0005737; GO:0005743; GO:0005789; GO:0006082; GO:0006805; GO:0008202; GO:0008395; GO:0016712; GO:0020037; GO:0052869; GO:0102033 organic acid metabolic process [GO:0006082]; steroid metabolic process [GO:0008202]; xenobiotic metabolic process [GO:0006805] cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; mitochondrial inner membrane [GO:0005743] arachidonate omega-hydroxylase activity [GO:0052869]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; long-chain fatty acid omega-hydroxylase activity [GO:0102033]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; steroid hydroxylase activity [GO:0008395] g2385.t1 Q8K358 45.714 420 1.63e-110 335.0 sp|Q8K358|PIGU_MOUSE GPI-anchor transamidase component PIGU OS=Mus musculus OX=10090 GN=Pigu PE=1 SV=4 g2386.t1 Q5G267 39.437 213 6.08e-40 155.0 sp|Q5G267|NETR_MACMU Neurotrypsin OS=Macaca mulatta OX=9544 GN=PRSS12 PE=3 SV=1 NETR_MACMU reviewed Neurotrypsin (EC 3.4.21.-) (Serine protease 12) Macaca mulatta (Rhesus macaque) GO:0004252; GO:0005886; GO:0006508; GO:0006887; GO:0030424; GO:0030425; GO:0043083; GO:0043195; GO:0098978 exocytosis [GO:0006887]; proteolysis [GO:0006508] axon [GO:0030424]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; synaptic cleft [GO:0043083]; terminal bouton [GO:0043195] serine-type endopeptidase activity [GO:0004252] g2386.t1 Q5G267 43.564 202 2.78e-38 150.0 sp|Q5G267|NETR_MACMU Neurotrypsin OS=Macaca mulatta OX=9544 GN=PRSS12 PE=3 SV=1 NETR_MACMU reviewed Neurotrypsin (EC 3.4.21.-) (Serine protease 12) Macaca mulatta (Rhesus macaque) GO:0004252; GO:0005886; GO:0006508; GO:0006887; GO:0030424; GO:0030425; GO:0043083; GO:0043195; GO:0098978 exocytosis [GO:0006887]; proteolysis [GO:0006508] axon [GO:0030424]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; synaptic cleft [GO:0043083]; terminal bouton [GO:0043195] serine-type endopeptidase activity [GO:0004252] g2386.t1 Q5G267 33.333 243 9.240000000000001e-33 134.0 sp|Q5G267|NETR_MACMU Neurotrypsin OS=Macaca mulatta OX=9544 GN=PRSS12 PE=3 SV=1 NETR_MACMU reviewed Neurotrypsin (EC 3.4.21.-) (Serine protease 12) Macaca mulatta (Rhesus macaque) GO:0004252; GO:0005886; GO:0006508; GO:0006887; GO:0030424; GO:0030425; GO:0043083; GO:0043195; GO:0098978 exocytosis [GO:0006887]; proteolysis [GO:0006508] axon [GO:0030424]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; synaptic cleft [GO:0043083]; terminal bouton [GO:0043195] serine-type endopeptidase activity [GO:0004252] g2387.t1 Q29486 42.384 151 2.35e-41 123.0 sp|Q29486|PPBT_FELCA Alkaline phosphatase, tissue-nonspecific isozyme OS=Felis catus OX=9685 GN=ALPL PE=1 SV=1 PPBT_FELCA reviewed Alkaline phosphatase, tissue-nonspecific isozyme (AP-TNAP) (TNSALP) (EC 3.1.3.1) (Alkaline phosphatase liver/bone/kidney isozyme) (Phosphoamidase) (Phosphocreatine phosphatase) (EC 3.9.1.1) Felis catus (Cat) (Felis silvestris catus) GO:0004035; GO:0004427; GO:0005509; GO:0005758; GO:0005886; GO:0016311; GO:0016462; GO:0016887; GO:0030282; GO:0031966; GO:0033883; GO:0043262; GO:0050187; GO:0052732; GO:0098552; GO:0120162 bone mineralization [GO:0030282]; dephosphorylation [GO:0016311]; positive regulation of cold-induced thermogenesis [GO:0120162] mitochondrial intermembrane space [GO:0005758]; mitochondrial membrane [GO:0031966]; plasma membrane [GO:0005886]; side of membrane [GO:0098552] ADP phosphatase activity [GO:0043262]; alkaline phosphatase activity [GO:0004035]; ATP hydrolysis activity [GO:0016887]; calcium ion binding [GO:0005509]; inorganic diphosphate phosphatase activity [GO:0004427]; phosphoamidase activity [GO:0050187]; phosphoethanolamine phosphatase activity [GO:0052732]; pyridoxal phosphatase activity [GO:0033883]; pyrophosphatase activity [GO:0016462] g2387.t1 Q29486 70.732 41 2.35e-41 66.6 sp|Q29486|PPBT_FELCA Alkaline phosphatase, tissue-nonspecific isozyme OS=Felis catus OX=9685 GN=ALPL PE=1 SV=1 PPBT_FELCA reviewed Alkaline phosphatase, tissue-nonspecific isozyme (AP-TNAP) (TNSALP) (EC 3.1.3.1) (Alkaline phosphatase liver/bone/kidney isozyme) (Phosphoamidase) (Phosphocreatine phosphatase) (EC 3.9.1.1) Felis catus (Cat) (Felis silvestris catus) GO:0004035; GO:0004427; GO:0005509; GO:0005758; GO:0005886; GO:0016311; GO:0016462; GO:0016887; GO:0030282; GO:0031966; GO:0033883; GO:0043262; GO:0050187; GO:0052732; GO:0098552; GO:0120162 bone mineralization [GO:0030282]; dephosphorylation [GO:0016311]; positive regulation of cold-induced thermogenesis [GO:0120162] mitochondrial intermembrane space [GO:0005758]; mitochondrial membrane [GO:0031966]; plasma membrane [GO:0005886]; side of membrane [GO:0098552] ADP phosphatase activity [GO:0043262]; alkaline phosphatase activity [GO:0004035]; ATP hydrolysis activity [GO:0016887]; calcium ion binding [GO:0005509]; inorganic diphosphate phosphatase activity [GO:0004427]; phosphoamidase activity [GO:0050187]; phosphoethanolamine phosphatase activity [GO:0052732]; pyridoxal phosphatase activity [GO:0033883]; pyrophosphatase activity [GO:0016462] g2388.t1 P05186 50.187 267 2.98e-86 270.0 sp|P05186|PPBT_HUMAN Alkaline phosphatase, tissue-nonspecific isozyme OS=Homo sapiens OX=9606 GN=ALPL PE=1 SV=4 PPBT_HUMAN reviewed Alkaline phosphatase, tissue-nonspecific isozyme (AP-TNAP) (TNS-ALP) (TNSALP) (EC 3.1.3.1) (Alkaline phosphatase liver/bone/kidney isozyme) (Phosphoamidase) (Phosphocreatine phosphatase) (EC 3.9.1.1) Homo sapiens (Human) GO:0001501; GO:0001649; GO:0001958; GO:0003006; GO:0004035; GO:0004427; GO:0005509; GO:0005576; GO:0005758; GO:0005886; GO:0016020; GO:0016462; GO:0016887; GO:0019725; GO:0030282; GO:0031012; GO:0031966; GO:0032496; GO:0032868; GO:0033280; GO:0033883; GO:0034516; GO:0036005; GO:0042822; GO:0043262; GO:0046677; GO:0050187; GO:0051384; GO:0052732; GO:0055062; GO:0055074; GO:0070062; GO:0071529; GO:0098552; GO:0120162; GO:0140651; GO:0140928; GO:1904383 bone mineralization [GO:0030282]; calcium ion homeostasis [GO:0055074]; cellular homeostasis [GO:0019725]; cementum mineralization [GO:0071529]; developmental process involved in reproduction [GO:0003006]; endochondral ossification [GO:0001958]; futile creatine cycle [GO:0140651]; inhibition of non-skeletal tissue mineralization [GO:0140928]; osteoblast differentiation [GO:0001649]; phosphate ion homeostasis [GO:0055062]; positive regulation of cold-induced thermogenesis [GO:0120162]; pyridoxal phosphate metabolic process [GO:0042822]; response to antibiotic [GO:0046677]; response to glucocorticoid [GO:0051384]; response to insulin [GO:0032868]; response to lipopolysaccharide [GO:0032496]; response to macrophage colony-stimulating factor [GO:0036005]; response to sodium phosphate [GO:1904383]; response to vitamin B6 [GO:0034516]; response to vitamin D [GO:0033280]; skeletal system development [GO:0001501] extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; membrane [GO:0016020]; mitochondrial intermembrane space [GO:0005758]; mitochondrial membrane [GO:0031966]; plasma membrane [GO:0005886]; side of membrane [GO:0098552] ADP phosphatase activity [GO:0043262]; alkaline phosphatase activity [GO:0004035]; ATP hydrolysis activity [GO:0016887]; calcium ion binding [GO:0005509]; inorganic diphosphate phosphatase activity [GO:0004427]; phosphoamidase activity [GO:0050187]; phosphoethanolamine phosphatase activity [GO:0052732]; pyridoxal phosphatase activity [GO:0033883]; pyrophosphatase activity [GO:0016462] g2390.t1 Q9MYM7 39.85 133 1.13e-25 103.0 sp|Q9MYM7|B3GT1_PONPY Beta-1,3-galactosyltransferase 1 OS=Pongo pygmaeus OX=9600 GN=B3GALT1 PE=3 SV=1 g2391.t1 O75506 74.194 62 5.06e-26 94.4 sp|O75506|HSBP1_HUMAN Heat shock factor-binding protein 1 OS=Homo sapiens OX=9606 GN=HSBP1 PE=1 SV=1 HSBP1_HUMAN reviewed Heat shock factor-binding protein 1 (Nasopharyngeal carcinoma-associated antigen 13) (NPC-A-13) Homo sapiens (Human) GO:0000122; GO:0003714; GO:0005634; GO:0005654; GO:0005829; GO:0006936; GO:0019896; GO:0035987; GO:0042802; GO:0070370; GO:1904115 axonal transport of mitochondrion [GO:0019896]; cellular heat acclimation [GO:0070370]; endodermal cell differentiation [GO:0035987]; muscle contraction [GO:0006936]; negative regulation of transcription by RNA polymerase II [GO:0000122] axon cytoplasm [GO:1904115]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] identical protein binding [GO:0042802]; transcription corepressor activity [GO:0003714] g2393.t1 Q99L04 49.091 330 3.7100000000000003e-109 323.0 sp|Q99L04|DHRS1_MOUSE Dehydrogenase/reductase SDR family member 1 OS=Mus musculus OX=10090 GN=Dhrs1 PE=1 SV=1 g2394.t1 Q9BUB4 40.458 524 1.01e-116 356.0 sp|Q9BUB4|ADAT1_HUMAN tRNA-specific adenosine deaminase 1 OS=Homo sapiens OX=9606 GN=ADAT1 PE=1 SV=1 g2395.t1 Q99N11 50.0 170 3.47e-60 191.0 sp|Q99N11|DUS22_MOUSE Dual specificity protein phosphatase 22 OS=Mus musculus OX=10090 GN=Dusp22 PE=1 SV=1 DUS22_MOUSE reviewed Dual specificity protein phosphatase 22 (EC 3.1.3.16) (EC 3.1.3.48) (JNK pathway associated phosphatase) (JKAP) (Low molecular weight dual specificity phosphatase 2) (LMW-DSP2) Mus musculus (Mouse) GO:0000122; GO:0002710; GO:0004722; GO:0004725; GO:0004726; GO:0005737; GO:0005829; GO:0005886; GO:0007179; GO:0008138; GO:0030292; GO:0030336; GO:0031941; GO:0035556; GO:0042127; GO:0046330; GO:0050852; GO:0050860; GO:0050862; GO:0050868; GO:0051895; GO:0061851; GO:0070534; GO:0070936; GO:0071364; GO:1990782 cellular response to epidermal growth factor stimulus [GO:0071364]; intracellular signal transduction [GO:0035556]; negative regulation of cell migration [GO:0030336]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of T cell activation [GO:0050868]; negative regulation of T cell mediated immunity [GO:0002710]; negative regulation of T cell receptor signaling pathway [GO:0050860]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of JNK cascade [GO:0046330]; positive regulation of T cell receptor signaling pathway [GO:0050862]; protein K48-linked ubiquitination [GO:0070936]; protein K63-linked ubiquitination [GO:0070534]; regulation of cell population proliferation [GO:0042127]; T cell receptor signaling pathway [GO:0050852]; transforming growth factor beta receptor signaling pathway [GO:0007179] cytoplasm [GO:0005737]; cytosol [GO:0005829]; filamentous actin [GO:0031941]; leading edge of lamellipodium [GO:0061851]; plasma membrane [GO:0005886] non-membrane spanning protein tyrosine phosphatase activity [GO:0004726]; protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine kinase binding [GO:1990782]; protein tyrosine kinase inhibitor activity [GO:0030292]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138] g2396.t1 A2AV36 44.949 683 0.0 605.0 sp|A2AV36|ANM7_DANRE Protein arginine N-methyltransferase 7 OS=Danio rerio OX=7955 GN=prmt7 PE=2 SV=1 ANM7_DANRE reviewed Protein arginine N-methyltransferase 7 (EC 2.1.1.321) (Histone-arginine N-methyltransferase PRMT7) ([Myelin basic protein]-arginine N-methyltransferase PRMT7) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000387; GO:0005634; GO:0005829; GO:0006338; GO:0006355; GO:0007010; GO:0008757; GO:0016274; GO:0018216; GO:0035241; GO:0035243; GO:0042054; GO:0044020; GO:0071514 chromatin remodeling [GO:0006338]; cytoskeleton organization [GO:0007010]; genomic imprinting [GO:0071514]; peptidyl-arginine methylation [GO:0018216]; regulation of DNA-templated transcription [GO:0006355]; spliceosomal snRNP assembly [GO:0000387] cytosol [GO:0005829]; nucleus [GO:0005634] histone H4R3 methyltransferase activity [GO:0044020]; histone methyltransferase activity [GO:0042054]; protein-arginine N-methyltransferase activity [GO:0016274]; protein-arginine omega-N monomethyltransferase activity [GO:0035241]; protein-arginine omega-N symmetric methyltransferase activity [GO:0035243]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757] g2397.t1 Q0P570 60.814 393 3.47e-165 471.0 sp|Q0P570|MVD1_BOVIN Diphosphomevalonate decarboxylase OS=Bos taurus OX=9913 GN=MVD PE=2 SV=1 MVD1_BOVIN reviewed Diphosphomevalonate decarboxylase (EC 4.1.1.33) (Mevalonate (diphospho)decarboxylase) (MDDase) (Mevalonate pyrophosphate decarboxylase) Bos taurus (Bovine) GO:0004163; GO:0005524; GO:0005829; GO:0006695; GO:0008284; GO:0008299; GO:0019287; GO:0030544; GO:0042803 cholesterol biosynthetic process [GO:0006695]; isopentenyl diphosphate biosynthetic process, mevalonate pathway [GO:0019287]; isoprenoid biosynthetic process [GO:0008299]; positive regulation of cell population proliferation [GO:0008284] cytosol [GO:0005829] ATP binding [GO:0005524]; diphosphomevalonate decarboxylase activity [GO:0004163]; Hsp70 protein binding [GO:0030544]; protein homodimerization activity [GO:0042803] g2398.t1 A0JNH6 43.416 486 3.58e-108 339.0 sp|A0JNH6|C102A_BOVIN Coiled-coil domain-containing protein 102A OS=Bos taurus OX=9913 GN=CCDC102A PE=2 SV=1 g2399.t1 P47224 49.558 113 8.839999999999999e-34 118.0 sp|P47224|MSS4_HUMAN Guanine nucleotide exchange factor MSS4 OS=Homo sapiens OX=9606 GN=RABIF PE=1 SV=2 MSS4_HUMAN reviewed Guanine nucleotide exchange factor MSS4 (Rab-interacting factor) Homo sapiens (Human) GO:0005085; GO:0005829; GO:0006892; GO:0007264; GO:0008270; GO:0015031; GO:0016020; GO:0061025 membrane fusion [GO:0061025]; post-Golgi vesicle-mediated transport [GO:0006892]; protein transport [GO:0015031]; small GTPase-mediated signal transduction [GO:0007264] cytosol [GO:0005829]; membrane [GO:0016020] guanyl-nucleotide exchange factor activity [GO:0005085]; zinc ion binding [GO:0008270] g2400.t1 Q08048 43.972 141 1.1400000000000001e-21 104.0 sp|Q08048|HGF_MOUSE Hepatocyte growth factor OS=Mus musculus OX=10090 GN=Hgf PE=1 SV=1 HGF_MOUSE reviewed Hepatocyte growth factor (Hepatopoietin-A) (Scatter factor) (SF) [Cleaved into: Hepatocyte growth factor alpha chain; Hepatocyte growth factor beta chain] Mus musculus (Mouse) GO:0000902; GO:0001889; GO:0005102; GO:0005576; GO:0005615; GO:0006508; GO:0008083; GO:0030335; GO:0031643; GO:0032715; GO:0032733; GO:0035729; GO:0042056; GO:0042802; GO:0043066; GO:0043410; GO:0044877; GO:0045766; GO:0048012; GO:0050673; GO:0050728; GO:0051450; GO:0051897; GO:0060326; GO:0060665; GO:0070572; GO:0090201; GO:1900744; GO:1901299; GO:1902042; GO:2000573 cell chemotaxis [GO:0060326]; cell morphogenesis [GO:0000902]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; epithelial cell proliferation [GO:0050673]; hepatocyte growth factor receptor signaling pathway [GO:0048012]; liver development [GO:0001889]; myoblast proliferation [GO:0051450]; negative regulation of apoptotic process [GO:0043066]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; negative regulation of hydrogen peroxide-mediated programmed cell death [GO:1901299]; negative regulation of inflammatory response [GO:0050728]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell migration [GO:0030335]; positive regulation of DNA biosynthetic process [GO:2000573]; positive regulation of interleukin-10 production [GO:0032733]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of myelination [GO:0031643]; positive regulation of neuron projection regeneration [GO:0070572]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; proteolysis [GO:0006508]; regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling [GO:0060665]; regulation of p38MAPK cascade [GO:1900744] extracellular region [GO:0005576]; extracellular space [GO:0005615] chemoattractant activity [GO:0042056]; growth factor activity [GO:0008083]; identical protein binding [GO:0042802]; protein-containing complex binding [GO:0044877]; signaling receptor binding [GO:0005102] g2401.t1 O75351 69.321 427 0.0 567.0 sp|O75351|VPS4B_HUMAN Vacuolar protein sorting-associated protein 4B OS=Homo sapiens OX=9606 GN=VPS4B PE=1 SV=2 VPS4B_HUMAN reviewed Vacuolar protein sorting-associated protein 4B (EC 3.6.4.6) (Cell migration-inducing gene 1 protein) (Suppressor of K(+) transport growth defect 1) (Protein SKD1) Homo sapiens (Human) GO:0000922; GO:0001525; GO:0001778; GO:0005524; GO:0005634; GO:0005643; GO:0005737; GO:0005768; GO:0005813; GO:0005829; GO:0005886; GO:0006813; GO:0006914; GO:0006997; GO:0007033; GO:0007080; GO:0010008; GO:0010824; GO:0010971; GO:0015031; GO:0016197; GO:0016236; GO:0016887; GO:0030301; GO:0030496; GO:0031468; GO:0031902; GO:0032510; GO:0033993; GO:0036258; GO:0039702; GO:0042802; GO:0042803; GO:0043162; GO:0044877; GO:0046761; GO:0051261; GO:0060070; GO:0060856; GO:0061738; GO:0061764; GO:0061952; GO:0070062; GO:0071985; GO:0090148; GO:0090543; GO:0090611; GO:0097352; GO:1901673; GO:1903542; GO:1903543; GO:1903724; GO:1904903; GO:1904949 angiogenesis [GO:0001525]; autophagosome maturation [GO:0097352]; autophagy [GO:0006914]; canonical Wnt signaling pathway [GO:0060070]; cholesterol transport [GO:0030301]; endosomal transport [GO:0016197]; endosome to lysosome transport via multivesicular body sorting pathway [GO:0032510]; ESCRT III complex disassembly [GO:1904903]; establishment of blood-brain barrier [GO:0060856]; late endosomal microautophagy [GO:0061738]; late endosome to lysosome transport via multivesicular body sorting pathway [GO:0061764]; macroautophagy [GO:0016236]; membrane fission [GO:0090148]; midbody abscission [GO:0061952]; mitotic metaphase chromosome alignment [GO:0007080]; multivesicular body assembly [GO:0036258]; multivesicular body sorting pathway [GO:0071985]; negative regulation of exosomal secretion [GO:1903542]; nuclear membrane reassembly [GO:0031468]; nucleus organization [GO:0006997]; plasma membrane repair [GO:0001778]; positive regulation of centriole elongation [GO:1903724]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; potassium ion transport [GO:0006813]; protein depolymerization [GO:0051261]; protein transport [GO:0015031]; regulation of centrosome duplication [GO:0010824]; regulation of mitotic spindle assembly [GO:1901673]; response to lipid [GO:0033993]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]; ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway [GO:0090611]; vacuole organization [GO:0007033]; viral budding from plasma membrane [GO:0046761]; viral budding via host ESCRT complex [GO:0039702] ATPase complex [GO:1904949]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome [GO:0005768]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; Flemming body [GO:0090543]; late endosome membrane [GO:0031902]; midbody [GO:0030496]; nuclear pore [GO:0005643]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; spindle pole [GO:0000922] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877] g2402.t1 Q5R7G6 70.899 189 1.9099999999999997e-89 274.0 sp|Q5R7G6|PEPL1_PONAB Probable aminopeptidase NPEPL1 OS=Pongo abelii OX=9601 GN=NPEPL1 PE=3 SV=2 PEPL1_PONAB reviewed Probable aminopeptidase NPEPL1 (EC 3.4.11.-) (Aminopeptidase-like 1) Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0005737; GO:0006508; GO:0030145; GO:0070006 proteolysis [GO:0006508] cytoplasm [GO:0005737] manganese ion binding [GO:0030145]; metalloaminopeptidase activity [GO:0070006] g2403.t1 Q5R7G6 63.028 284 5.879999999999999e-104 317.0 sp|Q5R7G6|PEPL1_PONAB Probable aminopeptidase NPEPL1 OS=Pongo abelii OX=9601 GN=NPEPL1 PE=3 SV=2 PEPL1_PONAB reviewed Probable aminopeptidase NPEPL1 (EC 3.4.11.-) (Aminopeptidase-like 1) Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0005737; GO:0006508; GO:0030145; GO:0070006 proteolysis [GO:0006508] cytoplasm [GO:0005737] manganese ion binding [GO:0030145]; metalloaminopeptidase activity [GO:0070006] g2405.t1 O95363 58.852 418 3.95e-180 514.0 sp|O95363|SYFM_HUMAN Phenylalanine--tRNA ligase, mitochondrial OS=Homo sapiens OX=9606 GN=FARS2 PE=1 SV=1 SYFM_HUMAN reviewed Phenylalanine--tRNA ligase, mitochondrial (EC 6.1.1.20) (Phenylalanyl-tRNA synthetase) (PheRS) Homo sapiens (Human) GO:0000049; GO:0004826; GO:0005524; GO:0005737; GO:0005739; GO:0005759; GO:0006418; GO:0006432; GO:0008033 phenylalanyl-tRNA aminoacylation [GO:0006432]; tRNA aminoacylation for protein translation [GO:0006418]; tRNA processing [GO:0008033] cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] ATP binding [GO:0005524]; phenylalanine-tRNA ligase activity [GO:0004826]; tRNA binding [GO:0000049] g2407.t1 Q4R5S9 57.955 176 1.0800000000000001e-64 201.0 sp|Q4R5S9|PLD3B_MACFA PRELI domain containing protein 3B OS=Macaca fascicularis OX=9541 GN=PRELID3B PE=2 SV=1 g2408.t1 Q9UGM3 36.232 552 2.95e-84 292.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g2408.t1 Q9UGM3 37.548 522 8.8e-84 290.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g2408.t1 Q9UGM3 35.741 540 2.96e-81 283.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g2408.t1 Q9UGM3 37.127 536 4.53e-81 283.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g2408.t1 Q9UGM3 36.505 515 5.63e-81 282.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g2408.t1 Q9UGM3 38.71 403 1.1099999999999999e-61 226.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g2408.t1 Q9UGM3 32.869 502 3.1400000000000003e-59 218.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g2409.t1 Q9UGM3 36.071 560 1.2e-83 291.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g2409.t1 Q9UGM3 36.973 522 1.99e-83 290.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g2409.t1 Q9UGM3 36.794 549 5.23e-81 283.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g2409.t1 Q9UGM3 35.436 539 5.279999999999999e-81 283.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g2409.t1 Q9UGM3 36.454 502 1.12e-78 276.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g2409.t1 Q9UGM3 38.71 403 2.8199999999999997e-61 225.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g2409.t1 Q9UGM3 33.266 493 7.190000000000001e-59 218.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g2409.t1 Q9UGM3 38.603 272 8.190000000000001e-44 172.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g2410.t1 Q6Q0C0 34.053 602 1.21e-91 300.0 sp|Q6Q0C0|TRAF7_HUMAN E3 ubiquitin-protein ligase TRAF7 OS=Homo sapiens OX=9606 GN=TRAF7 PE=1 SV=1 TRAF7_HUMAN reviewed E3 ubiquitin-protein ligase TRAF7 (EC 2.3.2.-) (EC 2.3.2.27) (RING finger and WD repeat-containing protein 1) (RING finger protein 119) (RING-type E3 ubiquitin transferase TRAF7) (TNF receptor-associated factor 7) Homo sapiens (Human) GO:0000151; GO:0004842; GO:0005634; GO:0005886; GO:0006915; GO:0008270; GO:0016567; GO:0031410; GO:0035519; GO:0043410; GO:0043525; GO:0061630; GO:0070372; GO:2000060; GO:2001235 apoptotic process [GO:0006915]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; protein K29-linked ubiquitination [GO:0035519]; protein ubiquitination [GO:0016567]; regulation of ERK1 and ERK2 cascade [GO:0070372] cytoplasmic vesicle [GO:0031410]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ubiquitin ligase complex [GO:0000151] ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] g2412.t1 Q8TB40 51.943 283 1.76e-108 320.0 sp|Q8TB40|ABHD4_HUMAN (Lyso)-N-acylphosphatidylethanolamine lipase OS=Homo sapiens OX=9606 GN=ABHD4 PE=1 SV=1 ABHD4_HUMAN reviewed (Lyso)-N-acylphosphatidylethanolamine lipase (EC 3.1.1.-) (Alpha/beta hydrolase domain-containing protein 4) (Abhydrolase domain-containing protein 4) (Alpha/beta-hydrolase 4) Homo sapiens (Human) GO:0004622; GO:0005789; GO:0005811; GO:0006654; GO:0016042; GO:0016787; GO:0036152; GO:0042171; GO:0055088; GO:0070292 lipid catabolic process [GO:0016042]; lipid homeostasis [GO:0055088]; N-acylphosphatidylethanolamine metabolic process [GO:0070292]; phosphatidic acid biosynthetic process [GO:0006654]; phosphatidylethanolamine acyl-chain remodeling [GO:0036152] endoplasmic reticulum membrane [GO:0005789]; lipid droplet [GO:0005811] hydrolase activity [GO:0016787]; lysophosphatidic acid acyltransferase activity [GO:0042171]; phosphatidylcholine lysophospholipase activity [GO:0004622] g2413.t1 A0A8I3S9V6 56.589 129 2.69e-51 161.0 sp|A0A8I3S9V6|RCAF1_CANLF GEL complex subunit OPTI OS=Canis lupus familiaris OX=9615 GN=RAB5IF PE=1 SV=1 RCAF1_CANLF reviewed GEL complex subunit OPTI (Obligate partner of TMCO1 insertase) (Rab5-interacting protein) (RIP5) (Respirasome Complex Assembly Factor 1) (RCAF1) Canis lupus familiaris (Dog) (Canis familiaris) GO:0005743; GO:0005789; GO:0097250; GO:0160063; GO:0160064 mitochondrial respirasome assembly [GO:0097250]; multi-pass transmembrane protein insertion into ER membrane [GO:0160063] endoplasmic reticulum membrane [GO:0005789]; mitochondrial inner membrane [GO:0005743]; multi-pass translocon complex [GO:0160064] g2414.t1 P56616 43.646 181 1.8099999999999997e-48 157.0 sp|P56616|UBE2C_XENLA Ubiquitin-conjugating enzyme E2 C OS=Xenopus laevis OX=8355 GN=ube2c PE=1 SV=1 g2415.t1 P69566 55.167 629 0.0 657.0 sp|P69566|RANB9_MOUSE Ran-binding protein 9 OS=Mus musculus OX=10090 GN=Ranbp9 PE=1 SV=1 RANB9_MOUSE reviewed Ran-binding protein 9 (RanBP9) (B-cell antigen receptor Ig beta-associated protein 1) (IBAP-1) (Ran-binding protein M) (RanBPM) Mus musculus (Mouse) GO:0000151; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0007010; GO:0016604; GO:0019899; GO:0031267; GO:0070373; GO:1902993 cytoskeleton organization [GO:0007010]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; positive regulation of amyloid precursor protein catabolic process [GO:1902993] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ubiquitin ligase complex [GO:0000151] enzyme binding [GO:0019899]; small GTPase binding [GO:0031267] g2416.t1 Q2TAA8 35.443 711 5.74e-134 414.0 sp|Q2TAA8|TXIP1_HUMAN Translin-associated factor X-interacting protein 1 OS=Homo sapiens OX=9606 GN=TSNAXIP1 PE=1 SV=1 g2418.t1 Q32LE4 45.455 132 4.43e-33 118.0 sp|Q32LE4|GGCT_BOVIN Gamma-glutamylcyclotransferase OS=Bos taurus OX=9913 GN=GGCT PE=2 SV=1 g2419.t1 Q8VDC0 50.495 909 0.0 897.0 sp|Q8VDC0|SYLM_MOUSE Probable leucine--tRNA ligase, mitochondrial OS=Mus musculus OX=10090 GN=Lars2 PE=1 SV=1 g2420.t1 Q90Z10 71.134 194 6.87e-93 273.0 sp|Q90Z10|RL13_DANRE Large ribosomal subunit protein eL13 OS=Danio rerio OX=7955 GN=rpl13 PE=1 SV=3 g2424.t1 Q8RDT4 47.55 347 3.7200000000000003e-110 333.0 sp|Q8RDT4|MEGL_FUSNN L-methionine gamma-lyase OS=Fusobacterium nucleatum subsp. nucleatum (strain ATCC 25586 / DSM 15643 / BCRC 10681 / CIP 101130 / JCM 8532 / KCTC 2640 / LMG 13131 / VPI 4355) OX=190304 GN=FN1419 PE=1 SV=1 g2426.t1 Q9IBG7 28.41 887 1.01e-63 239.0 sp|Q9IBG7|KCP_XENLA Kielin/chordin-like protein OS=Xenopus laevis OX=8355 GN=kcp PE=2 SV=1 g2426.t1 Q9IBG7 28.554 816 1.15e-63 239.0 sp|Q9IBG7|KCP_XENLA Kielin/chordin-like protein OS=Xenopus laevis OX=8355 GN=kcp PE=2 SV=1 g2426.t1 Q9IBG7 30.296 845 6.720000000000001e-57 218.0 sp|Q9IBG7|KCP_XENLA Kielin/chordin-like protein OS=Xenopus laevis OX=8355 GN=kcp PE=2 SV=1 g2426.t1 Q9IBG7 28.417 834 1.86e-53 207.0 sp|Q9IBG7|KCP_XENLA Kielin/chordin-like protein OS=Xenopus laevis OX=8355 GN=kcp PE=2 SV=1 g2426.t1 Q9IBG7 28.689 610 4.83e-45 181.0 sp|Q9IBG7|KCP_XENLA Kielin/chordin-like protein OS=Xenopus laevis OX=8355 GN=kcp PE=2 SV=1 g2426.t1 Q9IBG7 25.133 943 2.7e-39 162.0 sp|Q9IBG7|KCP_XENLA Kielin/chordin-like protein OS=Xenopus laevis OX=8355 GN=kcp PE=2 SV=1 g2426.t1 Q9IBG7 27.41 664 3.8900000000000003e-32 139.0 sp|Q9IBG7|KCP_XENLA Kielin/chordin-like protein OS=Xenopus laevis OX=8355 GN=kcp PE=2 SV=1 g2428.t1 Q92636 44.457 911 0.0 754.0 sp|Q92636|FAN_HUMAN Protein FAN OS=Homo sapiens OX=9606 GN=NSMAF PE=1 SV=2 FAN_HUMAN reviewed Protein FAN (Factor associated with neutral sphingomyelinase activation) (Factor associated with N-SMase activation) Homo sapiens (Human) GO:0005737; GO:0005829; GO:0006672; GO:0007165; GO:0016020; GO:0033209; GO:0034250; GO:0045834; GO:1905038 ceramide metabolic process [GO:0006672]; positive regulation of amide metabolic process [GO:0034250]; positive regulation of lipid metabolic process [GO:0045834]; regulation of membrane lipid metabolic process [GO:1905038]; signal transduction [GO:0007165]; tumor necrosis factor-mediated signaling pathway [GO:0033209] cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020] g2429.t1 B5FZ63 76.842 95 3.28e-49 154.0 sp|B5FZ63|ENY2_TAEGU Transcription and mRNA export factor ENY2 OS=Taeniopygia guttata OX=59729 GN=ENY2 PE=3 SV=1 g2430.t1 Q9CWL8 59.895 571 0.0 657.0 sp|Q9CWL8|CTBL1_MOUSE Beta-catenin-like protein 1 OS=Mus musculus OX=10090 GN=Ctnnbl1 PE=1 SV=1 CTBL1_MOUSE reviewed Beta-catenin-like protein 1 (Nuclear-associated protein) (NAP) Mus musculus (Mouse) GO:0000398; GO:0000974; GO:0002250; GO:0005634; GO:0005654; GO:0005681; GO:0005813; GO:0005829; GO:0006915; GO:0016445; GO:0019899; GO:0043065 adaptive immune response [GO:0002250]; apoptotic process [GO:0006915]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of apoptotic process [GO:0043065]; somatic diversification of immunoglobulins [GO:0016445] centrosome [GO:0005813]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Prp19 complex [GO:0000974]; spliceosomal complex [GO:0005681] enzyme binding [GO:0019899] g2431.t1 O23300 28.641 206 1.98e-24 100.0 sp|O23300|ECI3_ARATH Enoyl-CoA delta isomerase 3 OS=Arabidopsis thaliana OX=3702 GN=ECI3 PE=1 SV=1 g2432.t1 Q9P2T1 77.035 344 0.0 565.0 sp|Q9P2T1|GMPR2_HUMAN GMP reductase 2 OS=Homo sapiens OX=9606 GN=GMPR2 PE=1 SV=1 g2433.t1 Q9VJ33 94.737 76 3.96e-35 117.0 sp|Q9VJ33|NEDD8_DROME Ubiquitin-like protein NEDD8 OS=Drosophila melanogaster OX=7227 GN=Nedd8 PE=1 SV=1 NEDD8_DROME reviewed Ubiquitin-like protein NEDD8 (Neddylin) Drosophila melanogaster (Fruit fly) GO:0005634; GO:0005737; GO:0008283; GO:0008589; GO:0019941; GO:0030162; GO:0030431; GO:0031386; GO:0031625; GO:0031647; GO:0036099; GO:0045116; GO:0045879; GO:0051438 cell population proliferation [GO:0008283]; female germ-line stem cell population maintenance [GO:0036099]; modification-dependent protein catabolic process [GO:0019941]; negative regulation of smoothened signaling pathway [GO:0045879]; protein neddylation [GO:0045116]; regulation of protein stability [GO:0031647]; regulation of proteolysis [GO:0030162]; regulation of smoothened signaling pathway [GO:0008589]; regulation of ubiquitin-protein transferase activity [GO:0051438]; sleep [GO:0030431] cytoplasm [GO:0005737]; nucleus [GO:0005634] protein tag activity [GO:0031386]; ubiquitin protein ligase binding [GO:0031625] g2434.t1 O08999 36.673 529 6.27e-66 244.0 sp|O08999|LTBP2_MOUSE Latent-transforming growth factor beta-binding protein 2 OS=Mus musculus OX=10090 GN=Ltbp2 PE=1 SV=2 g2434.t1 O08999 38.958 480 6.3e-59 223.0 sp|O08999|LTBP2_MOUSE Latent-transforming growth factor beta-binding protein 2 OS=Mus musculus OX=10090 GN=Ltbp2 PE=1 SV=2 g2434.t1 O08999 34.973 366 1.1100000000000001e-35 150.0 sp|O08999|LTBP2_MOUSE Latent-transforming growth factor beta-binding protein 2 OS=Mus musculus OX=10090 GN=Ltbp2 PE=1 SV=2 g2434.t1 O08999 31.519 441 3.01e-34 146.0 sp|O08999|LTBP2_MOUSE Latent-transforming growth factor beta-binding protein 2 OS=Mus musculus OX=10090 GN=Ltbp2 PE=1 SV=2 g2436.t1 Q5HYA8 42.638 978 0.0 729.0 sp|Q5HYA8|MKS3_HUMAN Meckelin OS=Homo sapiens OX=9606 GN=TMEM67 PE=1 SV=2 MKS3_HUMAN reviewed Meckelin (Meckel syndrome type 3 protein) (Transmembrane protein 67) Homo sapiens (Human) GO:0005789; GO:0005813; GO:0010826; GO:0030659; GO:0031005; GO:0035567; GO:0035869; GO:0036038; GO:0036503; GO:0051082; GO:0060170; GO:0060271 cilium assembly [GO:0060271]; ERAD pathway [GO:0036503]; negative regulation of centrosome duplication [GO:0010826]; non-canonical Wnt signaling pathway [GO:0035567] centrosome [GO:0005813]; ciliary membrane [GO:0060170]; ciliary transition zone [GO:0035869]; cytoplasmic vesicle membrane [GO:0030659]; endoplasmic reticulum membrane [GO:0005789]; MKS complex [GO:0036038] filamin binding [GO:0031005]; unfolded protein binding [GO:0051082] g2438.t1 Q60414 32.803 314 3.55e-28 117.0 sp|Q60414|NTCP2_CRIGR Ileal sodium/bile acid cotransporter OS=Cricetulus griseus OX=10029 GN=SLC10A2 PE=1 SV=1 g2439.t1 Q12908 36.26 262 8.74e-36 139.0 sp|Q12908|NTCP2_HUMAN Ileal sodium/bile acid cotransporter OS=Homo sapiens OX=9606 GN=SLC10A2 PE=1 SV=2 NTCP2_HUMAN reviewed Ileal sodium/bile acid cotransporter (Apical sodium-dependent bile acid transporter) (ASBT) (Ileal Na(+)/bile acid cotransporter) (Ileal sodium-dependent bile acid transporter) (IBAT) (ISBT) (Na(+)-dependent ileal bile acid transporter) (Sodium/taurocholate cotransporting polypeptide, ileal) (Solute carrier family 10 member 2) Homo sapiens (Human) GO:0005886; GO:0005902; GO:0008508; GO:0009617; GO:0015721; GO:0016324 bile acid and bile salt transport [GO:0015721]; response to bacterium [GO:0009617] apical plasma membrane [GO:0016324]; microvillus [GO:0005902]; plasma membrane [GO:0005886] bile acid:sodium symporter activity [GO:0008508] g2440.t1 P57709 65.733 893 0.0 1103.0 sp|P57709|AT2C1_BOVIN Calcium-transporting ATPase type 2C member 1 OS=Bos taurus OX=9913 GN=ATP2C1 PE=2 SV=1 g2441.t1 Q2HJF3 40.367 218 8.57e-45 152.0 sp|Q2HJF3|ORC6_BOVIN Origin recognition complex subunit 6 OS=Bos taurus OX=9913 GN=ORC6 PE=2 SV=1 g2442.t1 Q96RK4 68.949 409 0.0 584.0 sp|Q96RK4|BBS4_HUMAN BBSome complex member BBS4 OS=Homo sapiens OX=9606 GN=BBS4 PE=1 SV=2 BBS4_HUMAN reviewed BBSome complex member BBS4 (Bardet-Biedl syndrome 4 protein) Homo sapiens (Human) GO:0000226; GO:0000242; GO:0000281; GO:0001750; GO:0001764; GO:0001782; GO:0001843; GO:0001895; GO:0001917; GO:0001947; GO:0003085; GO:0005634; GO:0005813; GO:0005814; GO:0005829; GO:0005929; GO:0007098; GO:0007286; GO:0007601; GO:0007608; GO:0010467; GO:0010629; GO:0015031; GO:0016055; GO:0016358; GO:0019216; GO:0021591; GO:0021756; GO:0021766; GO:0021987; GO:0030534; GO:0030674; GO:0030837; GO:0031514; GO:0032391; GO:0032402; GO:0032465; GO:0034101; GO:0034451; GO:0034452; GO:0034454; GO:0034464; GO:0035176; GO:0035845; GO:0035869; GO:0036064; GO:0038108; GO:0040018; GO:0043014; GO:0045444; GO:0045494; GO:0045724; GO:0046548; GO:0048487; GO:0048854; GO:0050893; GO:0051457; GO:0051492; GO:0060170; GO:0060271; GO:0060296; GO:0060324; GO:0060613; GO:0061512; GO:0061629; GO:0071539; GO:0097730; GO:0120316; GO:1902855; GO:1903546; GO:1905515 adult behavior [GO:0030534]; B cell homeostasis [GO:0001782]; brain morphogenesis [GO:0048854]; centrosome cycle [GO:0007098]; cerebral cortex development [GO:0021987]; cilium assembly [GO:0060271]; dendrite development [GO:0016358]; erythrocyte homeostasis [GO:0034101]; face development [GO:0060324]; fat cell differentiation [GO:0045444]; fat pad development [GO:0060613]; gene expression [GO:0010467]; heart looping [GO:0001947]; hippocampus development [GO:0021766]; maintenance of protein location in nucleus [GO:0051457]; melanosome transport [GO:0032402]; microtubule anchoring at centrosome [GO:0034454]; microtubule cytoskeleton organization [GO:0000226]; mitotic cytokinesis [GO:0000281]; negative regulation of actin filament polymerization [GO:0030837]; negative regulation of appetite by leptin-mediated signaling pathway [GO:0038108]; negative regulation of gene expression [GO:0010629]; negative regulation of systemic arterial blood pressure [GO:0003085]; neural tube closure [GO:0001843]; neuron migration [GO:0001764]; non-motile cilium assembly [GO:1905515]; photoreceptor cell maintenance [GO:0045494]; photoreceptor cell outer segment organization [GO:0035845]; positive regulation of cilium assembly [GO:0045724]; positive regulation of multicellular organism growth [GO:0040018]; protein localization to centrosome [GO:0071539]; protein localization to cilium [GO:0061512]; protein localization to photoreceptor outer segment [GO:1903546]; protein transport [GO:0015031]; regulation of cilium beat frequency involved in ciliary motility [GO:0060296]; regulation of cytokinesis [GO:0032465]; regulation of lipid metabolic process [GO:0019216]; regulation of non-motile cilium assembly [GO:1902855]; regulation of stress fiber assembly [GO:0051492]; retina homeostasis [GO:0001895]; retinal rod cell development [GO:0046548]; sensory perception of smell [GO:0007608]; sensory processing [GO:0050893]; social behavior [GO:0035176]; sperm flagellum assembly [GO:0120316]; spermatid development [GO:0007286]; striatum development [GO:0021756]; ventricular system development [GO:0021591]; visual perception [GO:0007601]; Wnt signaling pathway [GO:0016055] BBSome [GO:0034464]; centriolar satellite [GO:0034451]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary membrane [GO:0060170]; ciliary transition zone [GO:0035869]; cilium [GO:0005929]; cytosol [GO:0005829]; motile cilium [GO:0031514]; non-motile cilium [GO:0097730]; nucleus [GO:0005634]; pericentriolar material [GO:0000242]; photoreceptor connecting cilium [GO:0032391]; photoreceptor inner segment [GO:0001917]; photoreceptor outer segment [GO:0001750] alpha-tubulin binding [GO:0043014]; beta-tubulin binding [GO:0048487]; dynactin binding [GO:0034452]; protein-macromolecule adaptor activity [GO:0030674]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629] g2443.t1 F1QWW8 49.679 312 4.58e-111 328.0 sp|F1QWW8|KDSR_DANRE 3-dehydrosphinganine reductase OS=Danio rerio OX=7955 GN=kdsr PE=1 SV=2 g2443.t2 F1QWW8 49.679 312 4.58e-111 328.0 sp|F1QWW8|KDSR_DANRE 3-dehydrosphinganine reductase OS=Danio rerio OX=7955 GN=kdsr PE=1 SV=2 g2446.t1 S4R2K0 49.724 181 1.1600000000000001e-57 184.0 sp|S4R2K0|DEFM_MOUSE Peptide deformylase, mitochondrial OS=Mus musculus OX=10090 GN=Pdf PE=3 SV=1 g2447.t1 Q2HJ57 47.183 142 1.4200000000000002e-35 123.0 sp|Q2HJ57|COTL1_BOVIN Coactosin-like protein OS=Bos taurus OX=9913 GN=COTL1 PE=2 SV=3 g2452.t1 P49013 41.085 129 2.75e-25 106.0 sp|P49013|FBP3_STRPU Fibropellin-3 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF3 PE=1 SV=1 g2453.t1 Q9WTR6 49.471 473 8.71e-156 455.0 sp|Q9WTR6|XCT_MOUSE Cystine/glutamate transporter OS=Mus musculus OX=10090 GN=Slc7a11 PE=1 SV=1 XCT_MOUSE reviewed Cystine/glutamate transporter (Amino acid transport system xc-) (Solute carrier family 7 member 11) (Subtle gray protein) (xCT) Mus musculus (Mouse) GO:0003333; GO:0005765; GO:0005886; GO:0006749; GO:0007420; GO:0008542; GO:0009636; GO:0009986; GO:0015179; GO:0015252; GO:0015327; GO:0015811; GO:0015813; GO:0016020; GO:0021591; GO:0021756; GO:0022840; GO:0030534; GO:0031526; GO:0031528; GO:0033029; GO:0033554; GO:0034599; GO:0034775; GO:0035752; GO:0042127; GO:0045177; GO:0048021; GO:0048286; GO:0050804; GO:0050807; GO:0051223; GO:0051775; GO:0060173; GO:0070527; GO:0090461; GO:0097449; GO:0098712; GO:0110076; GO:0140206; GO:0140924; GO:0140926; GO:1900407; GO:1901494; GO:1902600; GO:1903786; GO:1904717; GO:2000211 adult behavior [GO:0030534]; amino acid transmembrane transport [GO:0003333]; brain development [GO:0007420]; cellular response to oxidative stress [GO:0034599]; cellular response to stress [GO:0033554]; dipeptide import across plasma membrane [GO:0140206]; glutathione metabolic process [GO:0006749]; glutathione transmembrane transport [GO:0034775]; intracellular glutamate homeostasis [GO:0090461]; L-cystine transport [GO:0015811]; L-glutamate import across plasma membrane [GO:0098712]; L-glutamate transmembrane transport [GO:0015813]; L-kynurenine transmembrane transport [GO:0140924]; limb development [GO:0060173]; lung alveolus development [GO:0048286]; lysosomal lumen pH elevation [GO:0035752]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of ferroptosis [GO:0110076]; platelet aggregation [GO:0070527]; proton transmembrane transport [GO:1902600]; regulation of AMPA glutamate receptor clustering [GO:1904717]; regulation of cell population proliferation [GO:0042127]; regulation of cellular response to oxidative stress [GO:1900407]; regulation of cysteine metabolic process [GO:1901494]; regulation of glutamate metabolic process [GO:2000211]; regulation of glutathione biosynthetic process [GO:1903786]; regulation of melanin biosynthetic process [GO:0048021]; regulation of neutrophil apoptotic process [GO:0033029]; regulation of protein transport [GO:0051223]; regulation of synapse organization [GO:0050807]; response to redox state [GO:0051775]; response to toxic substance [GO:0009636]; striatum development [GO:0021756]; ventricular system development [GO:0021591]; visual learning [GO:0008542] apical part of cell [GO:0045177]; astrocyte projection [GO:0097449]; brush border membrane [GO:0031526]; cell surface [GO:0009986]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; microvillus membrane [GO:0031528]; plasma membrane [GO:0005886] cystine:glutamate antiporter activity [GO:0015327]; L-amino acid transmembrane transporter activity [GO:0015179]; L-kynurenine transmembrane transporter activity [GO:0140926]; leak channel activity [GO:0022840]; proton channel activity [GO:0015252] g2454.t1 Q9WTR6 45.726 468 1.17e-138 412.0 sp|Q9WTR6|XCT_MOUSE Cystine/glutamate transporter OS=Mus musculus OX=10090 GN=Slc7a11 PE=1 SV=1 XCT_MOUSE reviewed Cystine/glutamate transporter (Amino acid transport system xc-) (Solute carrier family 7 member 11) (Subtle gray protein) (xCT) Mus musculus (Mouse) GO:0003333; GO:0005765; GO:0005886; GO:0006749; GO:0007420; GO:0008542; GO:0009636; GO:0009986; GO:0015179; GO:0015252; GO:0015327; GO:0015811; GO:0015813; GO:0016020; GO:0021591; GO:0021756; GO:0022840; GO:0030534; GO:0031526; GO:0031528; GO:0033029; GO:0033554; GO:0034599; GO:0034775; GO:0035752; GO:0042127; GO:0045177; GO:0048021; GO:0048286; GO:0050804; GO:0050807; GO:0051223; GO:0051775; GO:0060173; GO:0070527; GO:0090461; GO:0097449; GO:0098712; GO:0110076; GO:0140206; GO:0140924; GO:0140926; GO:1900407; GO:1901494; GO:1902600; GO:1903786; GO:1904717; GO:2000211 adult behavior [GO:0030534]; amino acid transmembrane transport [GO:0003333]; brain development [GO:0007420]; cellular response to oxidative stress [GO:0034599]; cellular response to stress [GO:0033554]; dipeptide import across plasma membrane [GO:0140206]; glutathione metabolic process [GO:0006749]; glutathione transmembrane transport [GO:0034775]; intracellular glutamate homeostasis [GO:0090461]; L-cystine transport [GO:0015811]; L-glutamate import across plasma membrane [GO:0098712]; L-glutamate transmembrane transport [GO:0015813]; L-kynurenine transmembrane transport [GO:0140924]; limb development [GO:0060173]; lung alveolus development [GO:0048286]; lysosomal lumen pH elevation [GO:0035752]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of ferroptosis [GO:0110076]; platelet aggregation [GO:0070527]; proton transmembrane transport [GO:1902600]; regulation of AMPA glutamate receptor clustering [GO:1904717]; regulation of cell population proliferation [GO:0042127]; regulation of cellular response to oxidative stress [GO:1900407]; regulation of cysteine metabolic process [GO:1901494]; regulation of glutamate metabolic process [GO:2000211]; regulation of glutathione biosynthetic process [GO:1903786]; regulation of melanin biosynthetic process [GO:0048021]; regulation of neutrophil apoptotic process [GO:0033029]; regulation of protein transport [GO:0051223]; regulation of synapse organization [GO:0050807]; response to redox state [GO:0051775]; response to toxic substance [GO:0009636]; striatum development [GO:0021756]; ventricular system development [GO:0021591]; visual learning [GO:0008542] apical part of cell [GO:0045177]; astrocyte projection [GO:0097449]; brush border membrane [GO:0031526]; cell surface [GO:0009986]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; microvillus membrane [GO:0031528]; plasma membrane [GO:0005886] cystine:glutamate antiporter activity [GO:0015327]; L-amino acid transmembrane transporter activity [GO:0015179]; L-kynurenine transmembrane transporter activity [GO:0140926]; leak channel activity [GO:0022840]; proton channel activity [GO:0015252] g2455.t1 Q5RAG7 50.22 227 1.62e-71 229.0 sp|Q5RAG7|XCT_PONAB Cystine/glutamate transporter OS=Pongo abelii OX=9601 GN=SLC7A11 PE=2 SV=1 XCT_PONAB reviewed Cystine/glutamate transporter (Amino acid transport system xc-) (Solute carrier family 7 member 11) (xCT) Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0005765; GO:0005886; GO:0015252; GO:0015327; GO:0015811; GO:0015813; GO:0022840; GO:0031528; GO:0035752; GO:0110076; GO:0140924; GO:0140926; GO:1902600 L-cystine transport [GO:0015811]; L-glutamate transmembrane transport [GO:0015813]; L-kynurenine transmembrane transport [GO:0140924]; lysosomal lumen pH elevation [GO:0035752]; negative regulation of ferroptosis [GO:0110076]; proton transmembrane transport [GO:1902600] lysosomal membrane [GO:0005765]; microvillus membrane [GO:0031528]; plasma membrane [GO:0005886] cystine:glutamate antiporter activity [GO:0015327]; L-kynurenine transmembrane transporter activity [GO:0140926]; leak channel activity [GO:0022840]; proton channel activity [GO:0015252] g2455.t2 Q9WTR6 46.154 507 7.879999999999999e-146 430.0 sp|Q9WTR6|XCT_MOUSE Cystine/glutamate transporter OS=Mus musculus OX=10090 GN=Slc7a11 PE=1 SV=1 XCT_MOUSE reviewed Cystine/glutamate transporter (Amino acid transport system xc-) (Solute carrier family 7 member 11) (Subtle gray protein) (xCT) Mus musculus (Mouse) GO:0003333; GO:0005765; GO:0005886; GO:0006749; GO:0007420; GO:0008542; GO:0009636; GO:0009986; GO:0015179; GO:0015252; GO:0015327; GO:0015811; GO:0015813; GO:0016020; GO:0021591; GO:0021756; GO:0022840; GO:0030534; GO:0031526; GO:0031528; GO:0033029; GO:0033554; GO:0034599; GO:0034775; GO:0035752; GO:0042127; GO:0045177; GO:0048021; GO:0048286; GO:0050804; GO:0050807; GO:0051223; GO:0051775; GO:0060173; GO:0070527; GO:0090461; GO:0097449; GO:0098712; GO:0110076; GO:0140206; GO:0140924; GO:0140926; GO:1900407; GO:1901494; GO:1902600; GO:1903786; GO:1904717; GO:2000211 adult behavior [GO:0030534]; amino acid transmembrane transport [GO:0003333]; brain development [GO:0007420]; cellular response to oxidative stress [GO:0034599]; cellular response to stress [GO:0033554]; dipeptide import across plasma membrane [GO:0140206]; glutathione metabolic process [GO:0006749]; glutathione transmembrane transport [GO:0034775]; intracellular glutamate homeostasis [GO:0090461]; L-cystine transport [GO:0015811]; L-glutamate import across plasma membrane [GO:0098712]; L-glutamate transmembrane transport [GO:0015813]; L-kynurenine transmembrane transport [GO:0140924]; limb development [GO:0060173]; lung alveolus development [GO:0048286]; lysosomal lumen pH elevation [GO:0035752]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of ferroptosis [GO:0110076]; platelet aggregation [GO:0070527]; proton transmembrane transport [GO:1902600]; regulation of AMPA glutamate receptor clustering [GO:1904717]; regulation of cell population proliferation [GO:0042127]; regulation of cellular response to oxidative stress [GO:1900407]; regulation of cysteine metabolic process [GO:1901494]; regulation of glutamate metabolic process [GO:2000211]; regulation of glutathione biosynthetic process [GO:1903786]; regulation of melanin biosynthetic process [GO:0048021]; regulation of neutrophil apoptotic process [GO:0033029]; regulation of protein transport [GO:0051223]; regulation of synapse organization [GO:0050807]; response to redox state [GO:0051775]; response to toxic substance [GO:0009636]; striatum development [GO:0021756]; ventricular system development [GO:0021591]; visual learning [GO:0008542] apical part of cell [GO:0045177]; astrocyte projection [GO:0097449]; brush border membrane [GO:0031526]; cell surface [GO:0009986]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; microvillus membrane [GO:0031528]; plasma membrane [GO:0005886] cystine:glutamate antiporter activity [GO:0015327]; L-amino acid transmembrane transporter activity [GO:0015179]; L-kynurenine transmembrane transporter activity [GO:0140926]; leak channel activity [GO:0022840]; proton channel activity [GO:0015252] g2456.t1 Q9WTR6 47.689 476 1.03e-137 409.0 sp|Q9WTR6|XCT_MOUSE Cystine/glutamate transporter OS=Mus musculus OX=10090 GN=Slc7a11 PE=1 SV=1 XCT_MOUSE reviewed Cystine/glutamate transporter (Amino acid transport system xc-) (Solute carrier family 7 member 11) (Subtle gray protein) (xCT) Mus musculus (Mouse) GO:0003333; GO:0005765; GO:0005886; GO:0006749; GO:0007420; GO:0008542; GO:0009636; GO:0009986; GO:0015179; GO:0015252; GO:0015327; GO:0015811; GO:0015813; GO:0016020; GO:0021591; GO:0021756; GO:0022840; GO:0030534; GO:0031526; GO:0031528; GO:0033029; GO:0033554; GO:0034599; GO:0034775; GO:0035752; GO:0042127; GO:0045177; GO:0048021; GO:0048286; GO:0050804; GO:0050807; GO:0051223; GO:0051775; GO:0060173; GO:0070527; GO:0090461; GO:0097449; GO:0098712; GO:0110076; GO:0140206; GO:0140924; GO:0140926; GO:1900407; GO:1901494; GO:1902600; GO:1903786; GO:1904717; GO:2000211 adult behavior [GO:0030534]; amino acid transmembrane transport [GO:0003333]; brain development [GO:0007420]; cellular response to oxidative stress [GO:0034599]; cellular response to stress [GO:0033554]; dipeptide import across plasma membrane [GO:0140206]; glutathione metabolic process [GO:0006749]; glutathione transmembrane transport [GO:0034775]; intracellular glutamate homeostasis [GO:0090461]; L-cystine transport [GO:0015811]; L-glutamate import across plasma membrane [GO:0098712]; L-glutamate transmembrane transport [GO:0015813]; L-kynurenine transmembrane transport [GO:0140924]; limb development [GO:0060173]; lung alveolus development [GO:0048286]; lysosomal lumen pH elevation [GO:0035752]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of ferroptosis [GO:0110076]; platelet aggregation [GO:0070527]; proton transmembrane transport [GO:1902600]; regulation of AMPA glutamate receptor clustering [GO:1904717]; regulation of cell population proliferation [GO:0042127]; regulation of cellular response to oxidative stress [GO:1900407]; regulation of cysteine metabolic process [GO:1901494]; regulation of glutamate metabolic process [GO:2000211]; regulation of glutathione biosynthetic process [GO:1903786]; regulation of melanin biosynthetic process [GO:0048021]; regulation of neutrophil apoptotic process [GO:0033029]; regulation of protein transport [GO:0051223]; regulation of synapse organization [GO:0050807]; response to redox state [GO:0051775]; response to toxic substance [GO:0009636]; striatum development [GO:0021756]; ventricular system development [GO:0021591]; visual learning [GO:0008542] apical part of cell [GO:0045177]; astrocyte projection [GO:0097449]; brush border membrane [GO:0031526]; cell surface [GO:0009986]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; microvillus membrane [GO:0031528]; plasma membrane [GO:0005886] cystine:glutamate antiporter activity [GO:0015327]; L-amino acid transmembrane transporter activity [GO:0015179]; L-kynurenine transmembrane transporter activity [GO:0140926]; leak channel activity [GO:0022840]; proton channel activity [GO:0015252] g2458.t1 P16065 66.019 206 2.96e-75 257.0 sp|P16065|GCY_STRPU Speract receptor OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g2459.t1 Q7JQ32 28.953 487 3.71e-47 181.0 sp|Q7JQ32|GC76C_DROME Receptor-type guanylate cyclase Gyc76C OS=Drosophila melanogaster OX=7227 GN=Gyc76C PE=1 SV=1 GC76C_DROME reviewed Receptor-type guanylate cyclase Gyc76C (EC 4.6.1.2) (DrGC-1) Drosophila melanogaster (Fruit fly) GO:0001653; GO:0004383; GO:0005524; GO:0005525; GO:0005886; GO:0006182; GO:0007168; GO:0007411; GO:0007428; GO:0007435; GO:0007526; GO:0008045; GO:0009651; GO:0016199; GO:0030198; GO:0030215; GO:0030510; GO:0035556; GO:0038023; GO:0046872; GO:0050830 axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; cGMP biosynthetic process [GO:0006182]; defense response to Gram-positive bacterium [GO:0050830]; extracellular matrix organization [GO:0030198]; intracellular signal transduction [GO:0035556]; larval somatic muscle development [GO:0007526]; motor neuron axon guidance [GO:0008045]; primary branching, open tracheal system [GO:0007428]; receptor guanylyl cyclase signaling pathway [GO:0007168]; regulation of BMP signaling pathway [GO:0030510]; response to salt stress [GO:0009651]; salivary gland morphogenesis [GO:0007435] plasma membrane [GO:0005886] ATP binding [GO:0005524]; GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; metal ion binding [GO:0046872]; peptide receptor activity [GO:0001653]; semaphorin receptor binding [GO:0030215]; signaling receptor activity [GO:0038023] g2460.t1 Q07553 33.333 255 8.95e-34 139.0 sp|Q07553|GCY3E_DROME Guanylate cyclase 32E OS=Drosophila melanogaster OX=7227 GN=Gyc32E PE=1 SV=4 g2461.t1 Q7JQ32 28.807 486 1.41e-46 180.0 sp|Q7JQ32|GC76C_DROME Receptor-type guanylate cyclase Gyc76C OS=Drosophila melanogaster OX=7227 GN=Gyc76C PE=1 SV=1 GC76C_DROME reviewed Receptor-type guanylate cyclase Gyc76C (EC 4.6.1.2) (DrGC-1) Drosophila melanogaster (Fruit fly) GO:0001653; GO:0004383; GO:0005524; GO:0005525; GO:0005886; GO:0006182; GO:0007168; GO:0007411; GO:0007428; GO:0007435; GO:0007526; GO:0008045; GO:0009651; GO:0016199; GO:0030198; GO:0030215; GO:0030510; GO:0035556; GO:0038023; GO:0046872; GO:0050830 axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; cGMP biosynthetic process [GO:0006182]; defense response to Gram-positive bacterium [GO:0050830]; extracellular matrix organization [GO:0030198]; intracellular signal transduction [GO:0035556]; larval somatic muscle development [GO:0007526]; motor neuron axon guidance [GO:0008045]; primary branching, open tracheal system [GO:0007428]; receptor guanylyl cyclase signaling pathway [GO:0007168]; regulation of BMP signaling pathway [GO:0030510]; response to salt stress [GO:0009651]; salivary gland morphogenesis [GO:0007435] plasma membrane [GO:0005886] ATP binding [GO:0005524]; GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; metal ion binding [GO:0046872]; peptide receptor activity [GO:0001653]; semaphorin receptor binding [GO:0030215]; signaling receptor activity [GO:0038023] g2462.t1 P82252 50.962 104 2.02e-26 104.0 sp|P82252|BAT1_RAT b(0,+)-type amino acid transporter 1 OS=Rattus norvegicus OX=10116 GN=Slc7a9 PE=1 SV=1 BAT1_RAT reviewed b(0,+)-type amino acid transporter 1 (b(0,+)AT) (Glycoprotein-associated amino acid transporter b0,+AT1) (Solute carrier family 7 member 9) Rattus norvegicus (Rat) GO:0003333; GO:0005886; GO:0006865; GO:0015171; GO:0015175; GO:0015184; GO:0015297; GO:0015804; GO:0015811; GO:0016324; GO:0031526; GO:0042605; GO:0046982; GO:0180009 amino acid transmembrane transport [GO:0003333]; amino acid transport [GO:0006865]; L-cystine transport [GO:0015811]; neutral amino acid transport [GO:0015804] apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; plasma membrane [GO:0005886] amino acid transmembrane transporter activity [GO:0015171]; antiporter activity [GO:0015297]; broad specificity neutral L-amino acid:basic L-amino acid antiporter activity [GO:0180009]; L-cystine transmembrane transporter activity [GO:0015184]; neutral L-amino acid transmembrane transporter activity [GO:0015175]; peptide antigen binding [GO:0042605]; protein heterodimerization activity [GO:0046982] g2464.t1 Q9WTR6 48.109 476 4.66e-142 420.0 sp|Q9WTR6|XCT_MOUSE Cystine/glutamate transporter OS=Mus musculus OX=10090 GN=Slc7a11 PE=1 SV=1 XCT_MOUSE reviewed Cystine/glutamate transporter (Amino acid transport system xc-) (Solute carrier family 7 member 11) (Subtle gray protein) (xCT) Mus musculus (Mouse) GO:0003333; GO:0005765; GO:0005886; GO:0006749; GO:0007420; GO:0008542; GO:0009636; GO:0009986; GO:0015179; GO:0015252; GO:0015327; GO:0015811; GO:0015813; GO:0016020; GO:0021591; GO:0021756; GO:0022840; GO:0030534; GO:0031526; GO:0031528; GO:0033029; GO:0033554; GO:0034599; GO:0034775; GO:0035752; GO:0042127; GO:0045177; GO:0048021; GO:0048286; GO:0050804; GO:0050807; GO:0051223; GO:0051775; GO:0060173; GO:0070527; GO:0090461; GO:0097449; GO:0098712; GO:0110076; GO:0140206; GO:0140924; GO:0140926; GO:1900407; GO:1901494; GO:1902600; GO:1903786; GO:1904717; GO:2000211 adult behavior [GO:0030534]; amino acid transmembrane transport [GO:0003333]; brain development [GO:0007420]; cellular response to oxidative stress [GO:0034599]; cellular response to stress [GO:0033554]; dipeptide import across plasma membrane [GO:0140206]; glutathione metabolic process [GO:0006749]; glutathione transmembrane transport [GO:0034775]; intracellular glutamate homeostasis [GO:0090461]; L-cystine transport [GO:0015811]; L-glutamate import across plasma membrane [GO:0098712]; L-glutamate transmembrane transport [GO:0015813]; L-kynurenine transmembrane transport [GO:0140924]; limb development [GO:0060173]; lung alveolus development [GO:0048286]; lysosomal lumen pH elevation [GO:0035752]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of ferroptosis [GO:0110076]; platelet aggregation [GO:0070527]; proton transmembrane transport [GO:1902600]; regulation of AMPA glutamate receptor clustering [GO:1904717]; regulation of cell population proliferation [GO:0042127]; regulation of cellular response to oxidative stress [GO:1900407]; regulation of cysteine metabolic process [GO:1901494]; regulation of glutamate metabolic process [GO:2000211]; regulation of glutathione biosynthetic process [GO:1903786]; regulation of melanin biosynthetic process [GO:0048021]; regulation of neutrophil apoptotic process [GO:0033029]; regulation of protein transport [GO:0051223]; regulation of synapse organization [GO:0050807]; response to redox state [GO:0051775]; response to toxic substance [GO:0009636]; striatum development [GO:0021756]; ventricular system development [GO:0021591]; visual learning [GO:0008542] apical part of cell [GO:0045177]; astrocyte projection [GO:0097449]; brush border membrane [GO:0031526]; cell surface [GO:0009986]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; microvillus membrane [GO:0031528]; plasma membrane [GO:0005886] cystine:glutamate antiporter activity [GO:0015327]; L-amino acid transmembrane transporter activity [GO:0015179]; L-kynurenine transmembrane transporter activity [GO:0140926]; leak channel activity [GO:0022840]; proton channel activity [GO:0015252] g2467.t1 P57768 49.772 219 2.02e-65 215.0 sp|P57768|SNX16_HUMAN Sorting nexin-16 OS=Homo sapiens OX=9606 GN=SNX16 PE=1 SV=2 SNX16_HUMAN reviewed Sorting nexin-16 Homo sapiens (Human) GO:0001881; GO:0005764; GO:0005769; GO:0005770; GO:0006622; GO:0008333; GO:0010008; GO:0031901; GO:0031902; GO:0035091; GO:0042802; GO:0045022 early endosome to late endosome transport [GO:0045022]; endosome to lysosome transport [GO:0008333]; protein targeting to lysosome [GO:0006622]; receptor recycling [GO:0001881] early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endosome membrane [GO:0010008]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosome [GO:0005764] identical protein binding [GO:0042802]; phosphatidylinositol binding [GO:0035091] g2468.t1 Q8R151 43.643 1054 0.0 833.0 sp|Q8R151|ZNFX1_MOUSE NFX1-type zinc finger-containing protein 1 OS=Mus musculus OX=10090 GN=Znfx1 PE=1 SV=3 ZNFX1_MOUSE reviewed NFX1-type zinc finger-containing protein 1 Mus musculus (Mouse) GO:0002218; GO:0003723; GO:0004386; GO:0005741; GO:0008270; GO:0010494; GO:0031048; GO:0031380; GO:0042742; GO:0045071; GO:0045087; GO:0051607 activation of innate immune response [GO:0002218]; defense response to bacterium [GO:0042742]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; negative regulation of viral genome replication [GO:0045071]; regulatory ncRNA-mediated heterochromatin formation [GO:0031048] cytoplasmic stress granule [GO:0010494]; mitochondrial outer membrane [GO:0005741]; nuclear RNA-directed RNA polymerase complex [GO:0031380] helicase activity [GO:0004386]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270] g2468.t1 Q8R151 29.899 495 2.69e-51 204.0 sp|Q8R151|ZNFX1_MOUSE NFX1-type zinc finger-containing protein 1 OS=Mus musculus OX=10090 GN=Znfx1 PE=1 SV=3 ZNFX1_MOUSE reviewed NFX1-type zinc finger-containing protein 1 Mus musculus (Mouse) GO:0002218; GO:0003723; GO:0004386; GO:0005741; GO:0008270; GO:0010494; GO:0031048; GO:0031380; GO:0042742; GO:0045071; GO:0045087; GO:0051607 activation of innate immune response [GO:0002218]; defense response to bacterium [GO:0042742]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; negative regulation of viral genome replication [GO:0045071]; regulatory ncRNA-mediated heterochromatin formation [GO:0031048] cytoplasmic stress granule [GO:0010494]; mitochondrial outer membrane [GO:0005741]; nuclear RNA-directed RNA polymerase complex [GO:0031380] helicase activity [GO:0004386]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270] g2468.t1 Q8R151 42.991 214 4.950000000000001e-35 151.0 sp|Q8R151|ZNFX1_MOUSE NFX1-type zinc finger-containing protein 1 OS=Mus musculus OX=10090 GN=Znfx1 PE=1 SV=3 ZNFX1_MOUSE reviewed NFX1-type zinc finger-containing protein 1 Mus musculus (Mouse) GO:0002218; GO:0003723; GO:0004386; GO:0005741; GO:0008270; GO:0010494; GO:0031048; GO:0031380; GO:0042742; GO:0045071; GO:0045087; GO:0051607 activation of innate immune response [GO:0002218]; defense response to bacterium [GO:0042742]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; negative regulation of viral genome replication [GO:0045071]; regulatory ncRNA-mediated heterochromatin formation [GO:0031048] cytoplasmic stress granule [GO:0010494]; mitochondrial outer membrane [GO:0005741]; nuclear RNA-directed RNA polymerase complex [GO:0031380] helicase activity [GO:0004386]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270] g2469.t1 Q8R151 43.886 1014 0.0 789.0 sp|Q8R151|ZNFX1_MOUSE NFX1-type zinc finger-containing protein 1 OS=Mus musculus OX=10090 GN=Znfx1 PE=1 SV=3 ZNFX1_MOUSE reviewed NFX1-type zinc finger-containing protein 1 Mus musculus (Mouse) GO:0002218; GO:0003723; GO:0004386; GO:0005741; GO:0008270; GO:0010494; GO:0031048; GO:0031380; GO:0042742; GO:0045071; GO:0045087; GO:0051607 activation of innate immune response [GO:0002218]; defense response to bacterium [GO:0042742]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; negative regulation of viral genome replication [GO:0045071]; regulatory ncRNA-mediated heterochromatin formation [GO:0031048] cytoplasmic stress granule [GO:0010494]; mitochondrial outer membrane [GO:0005741]; nuclear RNA-directed RNA polymerase complex [GO:0031380] helicase activity [GO:0004386]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270] g2470.t1 Q9P2E3 28.986 552 3.01e-50 198.0 sp|Q9P2E3|ZNFX1_HUMAN NFX1-type zinc finger-containing protein 1 OS=Homo sapiens OX=9606 GN=ZNFX1 PE=1 SV=2 ZNFX1_HUMAN reviewed NFX1-type zinc finger-containing protein 1 Homo sapiens (Human) GO:0002218; GO:0003723; GO:0004386; GO:0005741; GO:0008270; GO:0010494; GO:0031048; GO:0031380; GO:0042742; GO:0045071; GO:0045087; GO:0051607 activation of innate immune response [GO:0002218]; defense response to bacterium [GO:0042742]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; negative regulation of viral genome replication [GO:0045071]; regulatory ncRNA-mediated heterochromatin formation [GO:0031048] cytoplasmic stress granule [GO:0010494]; mitochondrial outer membrane [GO:0005741]; nuclear RNA-directed RNA polymerase complex [GO:0031380] helicase activity [GO:0004386]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270] g2470.t1 Q9P2E3 42.188 192 2.38e-33 144.0 sp|Q9P2E3|ZNFX1_HUMAN NFX1-type zinc finger-containing protein 1 OS=Homo sapiens OX=9606 GN=ZNFX1 PE=1 SV=2 ZNFX1_HUMAN reviewed NFX1-type zinc finger-containing protein 1 Homo sapiens (Human) GO:0002218; GO:0003723; GO:0004386; GO:0005741; GO:0008270; GO:0010494; GO:0031048; GO:0031380; GO:0042742; GO:0045071; GO:0045087; GO:0051607 activation of innate immune response [GO:0002218]; defense response to bacterium [GO:0042742]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; negative regulation of viral genome replication [GO:0045071]; regulatory ncRNA-mediated heterochromatin formation [GO:0031048] cytoplasmic stress granule [GO:0010494]; mitochondrial outer membrane [GO:0005741]; nuclear RNA-directed RNA polymerase complex [GO:0031380] helicase activity [GO:0004386]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270] g2474.t1 O61585 55.108 695 0.0 777.0 sp|O61585|KTNB1_STRPU Katanin p80 WD40 repeat-containing subunit B1 OS=Strongylocentrotus purpuratus OX=7668 GN=KATNB1 PE=1 SV=1 g2475.t1 Q6P1X6 51.01 198 3.2600000000000004e-59 188.0 sp|Q6P1X6|CH082_HUMAN UPF0598 protein C8orf82 OS=Homo sapiens OX=9606 GN=C8orf82 PE=1 SV=2 g2476.t1 Q5RE48 52.824 301 2.21e-105 311.0 sp|Q5RE48|AKTIP_PONAB AKT-interacting protein OS=Pongo abelii OX=9601 GN=AKTIP PE=2 SV=1 AKTIP_PONAB reviewed AKT-interacting protein (Fused toes protein homolog) Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0005886; GO:0006915; GO:0007032; GO:0007040; GO:0008333; GO:0015031; GO:0030897; GO:0045022; GO:0070695; GO:1905719 apoptotic process [GO:0006915]; early endosome to late endosome transport [GO:0045022]; endosome organization [GO:0007032]; endosome to lysosome transport [GO:0008333]; lysosome organization [GO:0007040]; protein localization to perinuclear region of cytoplasm [GO:1905719]; protein transport [GO:0015031] FHF complex [GO:0070695]; HOPS complex [GO:0030897]; plasma membrane [GO:0005886] g2476.t2 Q5RE48 56.044 273 1.1999999999999999e-104 310.0 sp|Q5RE48|AKTIP_PONAB AKT-interacting protein OS=Pongo abelii OX=9601 GN=AKTIP PE=2 SV=1 AKTIP_PONAB reviewed AKT-interacting protein (Fused toes protein homolog) Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0005886; GO:0006915; GO:0007032; GO:0007040; GO:0008333; GO:0015031; GO:0030897; GO:0045022; GO:0070695; GO:1905719 apoptotic process [GO:0006915]; early endosome to late endosome transport [GO:0045022]; endosome organization [GO:0007032]; endosome to lysosome transport [GO:0008333]; lysosome organization [GO:0007040]; protein localization to perinuclear region of cytoplasm [GO:1905719]; protein transport [GO:0015031] FHF complex [GO:0070695]; HOPS complex [GO:0030897]; plasma membrane [GO:0005886] g2477.t1 Q8TEB1 51.789 475 0.0 531.0 sp|Q8TEB1|DCA11_HUMAN DDB1- and CUL4-associated factor 11 OS=Homo sapiens OX=9606 GN=DCAF11 PE=1 SV=1 DCA11_HUMAN reviewed DDB1- and CUL4-associated factor 11 (WD repeat-containing protein 23) Homo sapiens (Human) GO:0003016; GO:0005654; GO:0006979; GO:0007613; GO:0010467; GO:0016567; GO:0035640; GO:0043161; GO:0050821; GO:0080008 exploration behavior [GO:0035640]; gene expression [GO:0010467]; memory [GO:0007613]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein stabilization [GO:0050821]; protein ubiquitination [GO:0016567]; respiratory system process [GO:0003016]; response to oxidative stress [GO:0006979] Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; nucleoplasm [GO:0005654] g2479.t1 Q53S33 64.103 78 2.8100000000000002e-33 114.0 sp|Q53S33|BOLA3_HUMAN BolA-like protein 3 OS=Homo sapiens OX=9606 GN=BOLA3 PE=1 SV=1 BOLA3_HUMAN reviewed BolA-like protein 3 Homo sapiens (Human) GO:0005739; GO:0005759; GO:0005829; GO:0006006; GO:0006879; GO:0009249; GO:0016226; GO:0016604; GO:0045454; GO:0051604; GO:0097009; GO:1903442; GO:1990229; GO:1990845 adaptive thermogenesis [GO:1990845]; cell redox homeostasis [GO:0045454]; energy homeostasis [GO:0097009]; glucose metabolic process [GO:0006006]; intracellular iron ion homeostasis [GO:0006879]; iron-sulfur cluster assembly [GO:0016226]; protein lipoylation [GO:0009249]; protein maturation [GO:0051604]; response to lipoic acid [GO:1903442] cytosol [GO:0005829]; iron-sulfur cluster assembly complex [GO:1990229]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nuclear body [GO:0016604] g2483.t1 Q6DC37 31.488 289 4.93e-38 139.0 sp|Q6DC37|HNMT_DANRE Histamine N-methyltransferase OS=Danio rerio OX=7955 GN=hnmt PE=2 SV=1 g2485.t1 Q6UWM7 51.867 482 1.69e-164 493.0 sp|Q6UWM7|LCTL_HUMAN Lactase-like protein OS=Homo sapiens OX=9606 GN=LCTL PE=1 SV=2 g2486.t1 P85971 47.773 247 7.840000000000001e-70 218.0 sp|P85971|6PGL_RAT 6-phosphogluconolactonase OS=Rattus norvegicus OX=10116 GN=Pgls PE=1 SV=1 g2488.t1 A0JMQ0 60.386 621 0.0 730.0 sp|A0JMQ0|BOP1_DANRE Ribosome biogenesis protein bop1 OS=Danio rerio OX=7955 GN=bop1 PE=2 SV=1 g2489.t1 Q9NW15 36.604 265 7.86e-43 159.0 sp|Q9NW15|ANO10_HUMAN Anoctamin-10 OS=Homo sapiens OX=9606 GN=ANO10 PE=1 SV=2 g2490.t1 Q8BH79 48.077 312 1.57e-80 261.0 sp|Q8BH79|ANO10_MOUSE Anoctamin-10 OS=Mus musculus OX=10090 GN=Ano10 PE=1 SV=1 g2491.t1 A2VD92 62.753 741 0.0 886.0 sp|A2VD92|DDX1_XENLA ATP-dependent RNA helicase DDX1 OS=Xenopus laevis OX=8355 GN=ddx1 PE=2 SV=1 DDX1_XENLA reviewed ATP-dependent RNA helicase DDX1 (EC 3.6.4.13) (DEAD box protein 1) Xenopus laevis (African clawed frog) GO:0003677; GO:0003682; GO:0003712; GO:0003724; GO:0003729; GO:0004518; GO:0004527; GO:0005524; GO:0005634; GO:0005730; GO:0005737; GO:0005739; GO:0005829; GO:0006302; GO:0006364; GO:0006388; GO:0006397; GO:0008143; GO:0010494; GO:0016887; GO:0033677; GO:0072669 double-strand break repair [GO:0006302]; mRNA processing [GO:0006397]; rRNA processing [GO:0006364]; tRNA splicing, via endonucleolytic cleavage and ligation [GO:0006388] cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleus [GO:0005634]; tRNA-splicing ligase complex [GO:0072669] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA/RNA helicase activity [GO:0033677]; exonuclease activity [GO:0004527]; mRNA binding [GO:0003729]; nuclease activity [GO:0004518]; poly(A) binding [GO:0008143]; RNA helicase activity [GO:0003724]; transcription coregulator activity [GO:0003712] g2492.t1 Q5E9W3 58.29 386 3.4500000000000004e-161 461.0 sp|Q5E9W3|PYRD_BOVIN Dihydroorotate dehydrogenase (quinone), mitochondrial OS=Bos taurus OX=9913 GN=DHODH PE=1 SV=1 PYRD_BOVIN reviewed Dihydroorotate dehydrogenase (quinone), mitochondrial (DHOdehase) (EC 1.3.5.2) (Dihydroorotate oxidase) Bos taurus (Bovine) GO:0004152; GO:0005743; GO:0006207; GO:0009220; GO:0044205; GO:0106430 'de novo' pyrimidine nucleobase biosynthetic process [GO:0006207]; 'de novo' UMP biosynthetic process [GO:0044205]; pyrimidine ribonucleotide biosynthetic process [GO:0009220] mitochondrial inner membrane [GO:0005743] dihydroorotate dehydrogenase (quinone) activity [GO:0106430]; dihydroorotate dehydrogenase activity [GO:0004152] g2493.t1 Q9PTW9 86.758 219 7.909999999999999e-135 383.0 sp|Q9PTW9|PSA7_CARAU Proteasome subunit alpha type-7 OS=Carassius auratus OX=7957 GN=psma7 PE=2 SV=1 g2494.t1 P55115 29.56 477 1.2e-53 199.0 sp|P55115|NAS15_CAEEL Zinc metalloproteinase nas-15 OS=Caenorhabditis elegans OX=6239 GN=nas-15 PE=2 SV=2 g2494.t2 P55115 29.56 477 9.619999999999999e-54 200.0 sp|P55115|NAS15_CAEEL Zinc metalloproteinase nas-15 OS=Caenorhabditis elegans OX=6239 GN=nas-15 PE=2 SV=2 g2494.t3 P55115 29.56 477 7.04e-54 200.0 sp|P55115|NAS15_CAEEL Zinc metalloproteinase nas-15 OS=Caenorhabditis elegans OX=6239 GN=nas-15 PE=2 SV=2 g2495.t1 P55112 36.15 213 1.79e-43 153.0 sp|P55112|NAS4_CAEEL Zinc metalloproteinase nas-4 OS=Caenorhabditis elegans OX=6239 GN=nas-4 PE=2 SV=4 g2497.t1 Q63244 69.672 122 1.7199999999999998e-54 187.0 sp|Q63244|FOXQ1_RAT Forkhead box protein Q1 OS=Rattus norvegicus OX=10116 GN=Foxq1 PE=1 SV=3 g2498.t1 Q9UGV2 40.936 342 3.83e-86 269.0 sp|Q9UGV2|NDRG3_HUMAN Protein NDRG3 OS=Homo sapiens OX=9606 GN=NDRG3 PE=1 SV=2 g2499.t1 Q9BV94 60.259 541 0.0 673.0 sp|Q9BV94|EDEM2_HUMAN ER degradation-enhancing alpha-mannosidase-like protein 2 OS=Homo sapiens OX=9606 GN=EDEM2 PE=1 SV=2 g2502.t1 Q9Y6L7 33.333 240 6.99e-28 119.0 sp|Q9Y6L7|TLL2_HUMAN Tolloid-like protein 2 OS=Homo sapiens OX=9606 GN=TLL2 PE=1 SV=1 TLL2_HUMAN reviewed Tolloid-like protein 2 (EC 3.4.24.-) Homo sapiens (Human) GO:0004222; GO:0004252; GO:0005509; GO:0005576; GO:0005615; GO:0008270; GO:0009953; GO:0016485; GO:0030154; GO:0030199; GO:0048632 cell differentiation [GO:0030154]; collagen fibril organization [GO:0030199]; dorsal/ventral pattern formation [GO:0009953]; negative regulation of skeletal muscle tissue growth [GO:0048632]; protein processing [GO:0016485] extracellular region [GO:0005576]; extracellular space [GO:0005615] calcium ion binding [GO:0005509]; metalloendopeptidase activity [GO:0004222]; serine-type endopeptidase activity [GO:0004252]; zinc ion binding [GO:0008270] g2502.t1 Q9Y6L7 27.907 258 7.09e-22 101.0 sp|Q9Y6L7|TLL2_HUMAN Tolloid-like protein 2 OS=Homo sapiens OX=9606 GN=TLL2 PE=1 SV=1 TLL2_HUMAN reviewed Tolloid-like protein 2 (EC 3.4.24.-) Homo sapiens (Human) GO:0004222; GO:0004252; GO:0005509; GO:0005576; GO:0005615; GO:0008270; GO:0009953; GO:0016485; GO:0030154; GO:0030199; GO:0048632 cell differentiation [GO:0030154]; collagen fibril organization [GO:0030199]; dorsal/ventral pattern formation [GO:0009953]; negative regulation of skeletal muscle tissue growth [GO:0048632]; protein processing [GO:0016485] extracellular region [GO:0005576]; extracellular space [GO:0005615] calcium ion binding [GO:0005509]; metalloendopeptidase activity [GO:0004222]; serine-type endopeptidase activity [GO:0004252]; zinc ion binding [GO:0008270] g2503.t1 Q8K1T0 55.556 117 1.51e-34 126.0 sp|Q8K1T0|TMPS3_MOUSE Transmembrane protease serine 3 OS=Mus musculus OX=10090 GN=Tmprss3 PE=1 SV=2 TMPS3_MOUSE reviewed Transmembrane protease serine 3 (EC 3.4.21.-) Mus musculus (Mouse) GO:0004252; GO:0005783; GO:0005789; GO:0006508; GO:0006883; GO:0007605; GO:0008236; GO:0017080; GO:0043025 intracellular sodium ion homeostasis [GO:0006883]; proteolysis [GO:0006508]; sensory perception of sound [GO:0007605] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; neuronal cell body [GO:0043025] serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]; sodium channel regulator activity [GO:0017080] g2504.t1 P56812 56.667 120 6.78e-34 117.0 sp|P56812|PDCD5_MOUSE Programmed cell death protein 5 OS=Mus musculus OX=10090 GN=Pdcd5 PE=1 SV=3 g2505.t1 Q5ZKJ0 54.198 524 0.0 567.0 sp|Q5ZKJ0|CLP1L_CHICK Lipid scramblase CLPTM1L OS=Gallus gallus OX=9031 GN=CLPTM1L PE=2 SV=1 CLP1L_CHICK reviewed Lipid scramblase CLPTM1L (Cisplatin resistance-related protein 9) (CRR9p) (Cleft lip and palate transmembrane protein 1-like protein) (CLPTM1-like protein) Gallus gallus (Chicken) GO:0005789; GO:0006915; GO:0012505; GO:0016020; GO:0017128 apoptotic process [GO:0006915] endomembrane system [GO:0012505]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020] phospholipid scramblase activity [GO:0017128] g2506.t1 P00491 49.286 280 2.54e-99 296.0 sp|P00491|PNPH_HUMAN Purine nucleoside phosphorylase OS=Homo sapiens OX=9606 GN=PNP PE=1 SV=2 PNPH_HUMAN reviewed Purine nucleoside phosphorylase (PNP) (EC 2.4.2.1) (Inosine phosphorylase) (Inosine-guanosine phosphorylase) Homo sapiens (Human) GO:0000255; GO:0001882; GO:0002060; GO:0004731; GO:0005576; GO:0005737; GO:0005829; GO:0006139; GO:0006148; GO:0006149; GO:0006157; GO:0006166; GO:0006204; GO:0006738; GO:0006955; GO:0009165; GO:0009410; GO:0032743; GO:0034418; GO:0034774; GO:0042102; GO:0042301; GO:0042802; GO:0043101; GO:0046059; GO:0046638; GO:0047975; GO:0070062; GO:1904813 allantoin metabolic process [GO:0000255]; dAMP catabolic process [GO:0046059]; deoxyadenosine catabolic process [GO:0006157]; deoxyinosine catabolic process [GO:0006149]; immune response [GO:0006955]; IMP catabolic process [GO:0006204]; inosine catabolic process [GO:0006148]; nicotinamide riboside catabolic process [GO:0006738]; nucleobase-containing compound metabolic process [GO:0006139]; nucleotide biosynthetic process [GO:0009165]; positive regulation of alpha-beta T cell differentiation [GO:0046638]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of T cell proliferation [GO:0042102]; purine ribonucleoside salvage [GO:0006166]; purine-containing compound salvage [GO:0043101]; response to xenobiotic stimulus [GO:0009410]; urate biosynthetic process [GO:0034418] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; secretory granule lumen [GO:0034774] guanosine phosphorylase activity [GO:0047975]; identical protein binding [GO:0042802]; nucleoside binding [GO:0001882]; phosphate ion binding [GO:0042301]; purine nucleobase binding [GO:0002060]; purine-nucleoside phosphorylase activity [GO:0004731] g2509.t1 O46373 76.589 299 1.27e-160 452.0 sp|O46373|ADT1_RABIT ADP/ATP translocase 1 OS=Oryctolagus cuniculus OX=9986 GN=SLC25A4 PE=2 SV=3 g2510.t1 Q1HFZ0 43.203 537 4.21e-131 414.0 sp|Q1HFZ0|NSUN2_MOUSE RNA cytosine C(5)-methyltransferase NSUN2 OS=Mus musculus OX=10090 GN=Nsun2 PE=1 SV=2 NSUN2_MOUSE reviewed RNA cytosine C(5)-methyltransferase NSUN2 (EC 2.1.1.-) (Myc-induced SUN domain-containing protein) (Misu) (NOL1/NOP2/Sun domain family member 2) (mRNA cytosine C(5)-methyltransferase) (EC 2.1.1.-) (tRNA cytosine C(5)-methyltransferase) (EC 2.1.1.-, EC 2.1.1.203) Mus musculus (Mouse) GO:0000049; GO:0001701; GO:0005634; GO:0005730; GO:0005737; GO:0005739; GO:0005819; GO:0006397; GO:0007286; GO:0008033; GO:0010793; GO:0016428; GO:0030488; GO:0033313; GO:0033391; GO:0036416; GO:0048820; GO:0051301; GO:0062152; GO:0070062; GO:2000736 cell division [GO:0051301]; hair follicle maturation [GO:0048820]; in utero embryonic development [GO:0001701]; meiotic cell cycle checkpoint signaling [GO:0033313]; mRNA processing [GO:0006397]; regulation of mRNA export from nucleus [GO:0010793]; regulation of stem cell differentiation [GO:2000736]; spermatid development [GO:0007286]; tRNA methylation [GO:0030488]; tRNA processing [GO:0008033]; tRNA stabilization [GO:0036416] chromatoid body [GO:0033391]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleus [GO:0005634]; spindle [GO:0005819] mRNA (cytidine-5-)-methyltransferase activity [GO:0062152]; tRNA (cytidine-5-)-methyltransferase activity [GO:0016428]; tRNA binding [GO:0000049] g2510.t1 Q1HFZ0 51.031 194 5.42e-56 210.0 sp|Q1HFZ0|NSUN2_MOUSE RNA cytosine C(5)-methyltransferase NSUN2 OS=Mus musculus OX=10090 GN=Nsun2 PE=1 SV=2 NSUN2_MOUSE reviewed RNA cytosine C(5)-methyltransferase NSUN2 (EC 2.1.1.-) (Myc-induced SUN domain-containing protein) (Misu) (NOL1/NOP2/Sun domain family member 2) (mRNA cytosine C(5)-methyltransferase) (EC 2.1.1.-) (tRNA cytosine C(5)-methyltransferase) (EC 2.1.1.-, EC 2.1.1.203) Mus musculus (Mouse) GO:0000049; GO:0001701; GO:0005634; GO:0005730; GO:0005737; GO:0005739; GO:0005819; GO:0006397; GO:0007286; GO:0008033; GO:0010793; GO:0016428; GO:0030488; GO:0033313; GO:0033391; GO:0036416; GO:0048820; GO:0051301; GO:0062152; GO:0070062; GO:2000736 cell division [GO:0051301]; hair follicle maturation [GO:0048820]; in utero embryonic development [GO:0001701]; meiotic cell cycle checkpoint signaling [GO:0033313]; mRNA processing [GO:0006397]; regulation of mRNA export from nucleus [GO:0010793]; regulation of stem cell differentiation [GO:2000736]; spermatid development [GO:0007286]; tRNA methylation [GO:0030488]; tRNA processing [GO:0008033]; tRNA stabilization [GO:0036416] chromatoid body [GO:0033391]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleus [GO:0005634]; spindle [GO:0005819] mRNA (cytidine-5-)-methyltransferase activity [GO:0062152]; tRNA (cytidine-5-)-methyltransferase activity [GO:0016428]; tRNA binding [GO:0000049] g2510.t2 Q1HFZ0 43.599 539 5.46e-131 414.0 sp|Q1HFZ0|NSUN2_MOUSE RNA cytosine C(5)-methyltransferase NSUN2 OS=Mus musculus OX=10090 GN=Nsun2 PE=1 SV=2 NSUN2_MOUSE reviewed RNA cytosine C(5)-methyltransferase NSUN2 (EC 2.1.1.-) (Myc-induced SUN domain-containing protein) (Misu) (NOL1/NOP2/Sun domain family member 2) (mRNA cytosine C(5)-methyltransferase) (EC 2.1.1.-) (tRNA cytosine C(5)-methyltransferase) (EC 2.1.1.-, EC 2.1.1.203) Mus musculus (Mouse) GO:0000049; GO:0001701; GO:0005634; GO:0005730; GO:0005737; GO:0005739; GO:0005819; GO:0006397; GO:0007286; GO:0008033; GO:0010793; GO:0016428; GO:0030488; GO:0033313; GO:0033391; GO:0036416; GO:0048820; GO:0051301; GO:0062152; GO:0070062; GO:2000736 cell division [GO:0051301]; hair follicle maturation [GO:0048820]; in utero embryonic development [GO:0001701]; meiotic cell cycle checkpoint signaling [GO:0033313]; mRNA processing [GO:0006397]; regulation of mRNA export from nucleus [GO:0010793]; regulation of stem cell differentiation [GO:2000736]; spermatid development [GO:0007286]; tRNA methylation [GO:0030488]; tRNA processing [GO:0008033]; tRNA stabilization [GO:0036416] chromatoid body [GO:0033391]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleus [GO:0005634]; spindle [GO:0005819] mRNA (cytidine-5-)-methyltransferase activity [GO:0062152]; tRNA (cytidine-5-)-methyltransferase activity [GO:0016428]; tRNA binding [GO:0000049] g2510.t2 Q1HFZ0 51.031 194 4.48e-56 210.0 sp|Q1HFZ0|NSUN2_MOUSE RNA cytosine C(5)-methyltransferase NSUN2 OS=Mus musculus OX=10090 GN=Nsun2 PE=1 SV=2 NSUN2_MOUSE reviewed RNA cytosine C(5)-methyltransferase NSUN2 (EC 2.1.1.-) (Myc-induced SUN domain-containing protein) (Misu) (NOL1/NOP2/Sun domain family member 2) (mRNA cytosine C(5)-methyltransferase) (EC 2.1.1.-) (tRNA cytosine C(5)-methyltransferase) (EC 2.1.1.-, EC 2.1.1.203) Mus musculus (Mouse) GO:0000049; GO:0001701; GO:0005634; GO:0005730; GO:0005737; GO:0005739; GO:0005819; GO:0006397; GO:0007286; GO:0008033; GO:0010793; GO:0016428; GO:0030488; GO:0033313; GO:0033391; GO:0036416; GO:0048820; GO:0051301; GO:0062152; GO:0070062; GO:2000736 cell division [GO:0051301]; hair follicle maturation [GO:0048820]; in utero embryonic development [GO:0001701]; meiotic cell cycle checkpoint signaling [GO:0033313]; mRNA processing [GO:0006397]; regulation of mRNA export from nucleus [GO:0010793]; regulation of stem cell differentiation [GO:2000736]; spermatid development [GO:0007286]; tRNA methylation [GO:0030488]; tRNA processing [GO:0008033]; tRNA stabilization [GO:0036416] chromatoid body [GO:0033391]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleus [GO:0005634]; spindle [GO:0005819] mRNA (cytidine-5-)-methyltransferase activity [GO:0062152]; tRNA (cytidine-5-)-methyltransferase activity [GO:0016428]; tRNA binding [GO:0000049] g2512.t1 Q12908 32.68 153 2.8000000000000004e-21 92.0 sp|Q12908|NTCP2_HUMAN Ileal sodium/bile acid cotransporter OS=Homo sapiens OX=9606 GN=SLC10A2 PE=1 SV=2 NTCP2_HUMAN reviewed Ileal sodium/bile acid cotransporter (Apical sodium-dependent bile acid transporter) (ASBT) (Ileal Na(+)/bile acid cotransporter) (Ileal sodium-dependent bile acid transporter) (IBAT) (ISBT) (Na(+)-dependent ileal bile acid transporter) (Sodium/taurocholate cotransporting polypeptide, ileal) (Solute carrier family 10 member 2) Homo sapiens (Human) GO:0005886; GO:0005902; GO:0008508; GO:0009617; GO:0015721; GO:0016324 bile acid and bile salt transport [GO:0015721]; response to bacterium [GO:0009617] apical plasma membrane [GO:0016324]; microvillus [GO:0005902]; plasma membrane [GO:0005886] bile acid:sodium symporter activity [GO:0008508] g2513.t1 Q70EX6 40.972 144 9.399999999999999e-23 95.9 sp|Q70EX6|SOAT_RAT Sodium-dependent organic anion transporter OS=Rattus norvegicus OX=10116 GN=Slc10a6 PE=1 SV=1 SOAT_RAT reviewed Sodium-dependent organic anion transporter (Soat) (Solute carrier family 10 member 6) (SLC10A6) Rattus norvegicus (Rat) GO:0008508; GO:0015721; GO:0016020; GO:0043250; GO:0043251 bile acid and bile salt transport [GO:0015721]; sodium-dependent organic anion transport [GO:0043251] membrane [GO:0016020] bile acid:sodium symporter activity [GO:0008508]; sodium-dependent organic anion transmembrane transporter activity [GO:0043250] g2514.t1 Q9CXB2 41.049 324 5.85e-50 174.0 sp|Q9CXB2|SOAT_MOUSE Sodium-dependent organic anion transporter OS=Mus musculus OX=10090 GN=Slc10a6 PE=1 SV=1 SOAT_MOUSE reviewed Sodium-dependent organic anion transporter (SOAT) (Solute carrier family 10 member 6) (SLC10A6) Mus musculus (Mouse) GO:0008508; GO:0015721; GO:0016020; GO:0043250; GO:0043251 bile acid and bile salt transport [GO:0015721]; sodium-dependent organic anion transport [GO:0043251] membrane [GO:0016020] bile acid:sodium symporter activity [GO:0008508]; sodium-dependent organic anion transmembrane transporter activity [GO:0043250] g2516.t1 Q9NRH2 62.376 404 5.59e-176 526.0 sp|Q9NRH2|SNRK_HUMAN SNF-related serine/threonine-protein kinase OS=Homo sapiens OX=9606 GN=SNRK PE=1 SV=2 g2518.t1 Q13404 61.314 137 4.77e-58 180.0 sp|Q13404|UB2V1_HUMAN Ubiquitin-conjugating enzyme E2 variant 1 OS=Homo sapiens OX=9606 GN=UBE2V1 PE=1 SV=2 g2519.t1 Q5RAA9 34.862 218 6.969999999999999e-34 125.0 sp|Q5RAA9|NPS3A_PONAB Protein NipSnap homolog 3A OS=Pongo abelii OX=9601 GN=NIPSNAP3A PE=2 SV=1 g2520.t1 Q32KL2 62.637 273 6.68e-116 336.0 sp|Q32KL2|PSB5_BOVIN Proteasome subunit beta type-5 OS=Bos taurus OX=9913 GN=PSMB5 PE=1 SV=1 g2521.t1 Q8BZZ3 67.238 583 0.0 780.0 sp|Q8BZZ3|WWP1_MOUSE NEDD4-like E3 ubiquitin-protein ligase WWP1 OS=Mus musculus OX=10090 GN=Wwp1 PE=1 SV=2 WWP1_MOUSE reviewed NEDD4-like E3 ubiquitin-protein ligase WWP1 (EC 2.3.2.26) (HECT-type E3 ubiquitin transferase WWP1) (WW domain-containing protein 1) Mus musculus (Mouse) GO:0004842; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0016567; GO:0030217; GO:0030324; GO:0043161; GO:0045892; GO:0061630; GO:0070161 lung development [GO:0030324]; negative regulation of DNA-templated transcription [GO:0045892]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; T cell differentiation [GO:0030217] anchoring junction [GO:0070161]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886] ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842] g2530.t1 P23934 48.062 129 1.08e-34 119.0 sp|P23934|NDUS6_BOVIN NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial OS=Bos taurus OX=9913 GN=NDUFS6 PE=1 SV=2 g2532.t1 Q9C0G0 36.695 357 7e-59 218.0 sp|Q9C0G0|ZN407_HUMAN Zinc finger protein 407 OS=Homo sapiens OX=9606 GN=ZNF407 PE=1 SV=2 ZN407_HUMAN reviewed Zinc finger protein 407 Homo sapiens (Human) GO:0003677; GO:0005634; GO:0008270; GO:0045944 positive regulation of transcription by RNA polymerase II [GO:0045944] nucleus [GO:0005634] DNA binding [GO:0003677]; zinc ion binding [GO:0008270] g2533.t1 Q63244 48.624 109 2.95e-26 112.0 sp|Q63244|FOXQ1_RAT Forkhead box protein Q1 OS=Rattus norvegicus OX=10116 GN=Foxq1 PE=1 SV=3 g2537.t1 Q9QXA6 40.663 332 7.45e-65 216.0 sp|Q9QXA6|BAT1_MOUSE b(0,+)-type amino acid transporter 1 OS=Mus musculus OX=10090 GN=Slc7a9 PE=1 SV=1 BAT1_MOUSE reviewed b(0,+)-type amino acid transporter 1 (b(0,+)AT1) (Glycoprotein-associated amino acid transporter b0,+AT1) (Solute carrier family 7 member 9) Mus musculus (Mouse) GO:0003333; GO:0005886; GO:0006865; GO:0015171; GO:0015175; GO:0015184; GO:0015297; GO:0015804; GO:0015811; GO:0016324; GO:0031526; GO:0042605; GO:0046982; GO:0180009 amino acid transmembrane transport [GO:0003333]; amino acid transport [GO:0006865]; L-cystine transport [GO:0015811]; neutral amino acid transport [GO:0015804] apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; plasma membrane [GO:0005886] amino acid transmembrane transporter activity [GO:0015171]; antiporter activity [GO:0015297]; broad specificity neutral L-amino acid:basic L-amino acid antiporter activity [GO:0180009]; L-cystine transmembrane transporter activity [GO:0015184]; neutral L-amino acid transmembrane transporter activity [GO:0015175]; peptide antigen binding [GO:0042605]; protein heterodimerization activity [GO:0046982] g2540.t1 Q9N1R6 53.75 480 6.48e-143 423.0 sp|Q9N1R6|BAT1_RABIT b(0,+)-type amino acid transporter 1 OS=Oryctolagus cuniculus OX=9986 GN=SLC7A9 PE=2 SV=1 g2541.t1 P82251 56.009 466 3.7899999999999997e-165 479.0 sp|P82251|BAT1_HUMAN b(0,+)-type amino acid transporter 1 OS=Homo sapiens OX=9606 GN=SLC7A9 PE=1 SV=1 BAT1_HUMAN reviewed b(0,+)-type amino acid transporter 1 (b(0,+)AT1) (Glycoprotein-associated amino acid transporter b0,+AT1) (Solute carrier family 7 member 9) Homo sapiens (Human) GO:0003333; GO:0005886; GO:0015175; GO:0015184; GO:0015297; GO:0015804; GO:0015811; GO:0016324; GO:0031526; GO:0042605; GO:0046982; GO:0065003; GO:0180009 amino acid transmembrane transport [GO:0003333]; L-cystine transport [GO:0015811]; neutral amino acid transport [GO:0015804]; protein-containing complex assembly [GO:0065003] apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; plasma membrane [GO:0005886] antiporter activity [GO:0015297]; broad specificity neutral L-amino acid:basic L-amino acid antiporter activity [GO:0180009]; L-cystine transmembrane transporter activity [GO:0015184]; neutral L-amino acid transmembrane transporter activity [GO:0015175]; peptide antigen binding [GO:0042605]; protein heterodimerization activity [GO:0046982] g2543.t1 Q5R662 37.358 530 2.8e-91 310.0 sp|Q5R662|LRP12_PONAB Low-density lipoprotein receptor-related protein 12 OS=Pongo abelii OX=9601 GN=LRP12 PE=2 SV=2 LRP12_PONAB reviewed Low-density lipoprotein receptor-related protein 12 (LRP-12) Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0001764; GO:0005178; GO:0005886; GO:0005905; GO:0006897; GO:0007155; GO:0031175; GO:0033622; GO:0097021 cell adhesion [GO:0007155]; endocytosis [GO:0006897]; integrin activation [GO:0033622]; lymphocyte migration into lymphoid organs [GO:0097021]; neuron migration [GO:0001764]; neuron projection development [GO:0031175] clathrin-coated pit [GO:0005905]; plasma membrane [GO:0005886] integrin binding [GO:0005178] g2543.t2 Q8BUJ9 37.476 531 2.67e-90 308.0 sp|Q8BUJ9|LRP12_MOUSE Low-density lipoprotein receptor-related protein 12 OS=Mus musculus OX=10090 GN=Lrp12 PE=2 SV=2 LRP12_MOUSE reviewed Low-density lipoprotein receptor-related protein 12 (LRP-12) Mus musculus (Mouse) GO:0001764; GO:0005178; GO:0005886; GO:0005905; GO:0006897; GO:0007155; GO:0016477; GO:0031175; GO:0033622; GO:0097021 cell adhesion [GO:0007155]; cell migration [GO:0016477]; endocytosis [GO:0006897]; integrin activation [GO:0033622]; lymphocyte migration into lymphoid organs [GO:0097021]; neuron migration [GO:0001764]; neuron projection development [GO:0031175] clathrin-coated pit [GO:0005905]; plasma membrane [GO:0005886] integrin binding [GO:0005178] g2544.t1 Q62638 45.935 492 1.14e-146 460.0 sp|Q62638|GSLG1_RAT Golgi apparatus protein 1 OS=Rattus norvegicus OX=10116 GN=Glg1 PE=1 SV=1 g2544.t1 Q62638 22.423 553 2.76e-21 103.0 sp|Q62638|GSLG1_RAT Golgi apparatus protein 1 OS=Rattus norvegicus OX=10116 GN=Glg1 PE=1 SV=1 g2546.t1 Q02391 44.141 512 3.37e-141 437.0 sp|Q02391|GSLG1_CHICK Golgi apparatus protein 1 OS=Gallus gallus OX=9031 GN=GLG1 PE=1 SV=1 g2546.t1 Q02391 23.519 540 5.65e-28 122.0 sp|Q02391|GSLG1_CHICK Golgi apparatus protein 1 OS=Gallus gallus OX=9031 GN=GLG1 PE=1 SV=1 g2546.t1 Q02391 24.714 437 7.48e-25 112.0 sp|Q02391|GSLG1_CHICK Golgi apparatus protein 1 OS=Gallus gallus OX=9031 GN=GLG1 PE=1 SV=1 g2548.t1 Q9JIX5 68.966 783 0.0 1108.0 sp|Q9JIX5|CHD8_RAT Chromodomain-helicase-DNA-binding protein 8 OS=Rattus norvegicus OX=10116 GN=Chd8 PE=1 SV=2 CHD8_RAT reviewed ATP-dependent chromatin remodeler CHD8 (EC 3.6.4.-) (Axis duplication inhibitor) (Duplin) (Chromo domain-containing protein 8) (CHD-8) Rattus norvegicus (Rat) GO:0000122; GO:0000785; GO:0001701; GO:0001964; GO:0002039; GO:0003677; GO:0003678; GO:0003682; GO:0005524; GO:0005634; GO:0005654; GO:0006338; GO:0006397; GO:0007420; GO:0007616; GO:0008013; GO:0010468; GO:0016055; GO:0016887; GO:0030178; GO:0032991; GO:0035176; GO:0042393; GO:0043066; GO:0045892; GO:0045893; GO:0045944; GO:0045945; GO:0048565; GO:0060134; GO:0070016; GO:0071339; GO:0090090; GO:0140002; GO:0140658; GO:2000270 brain development [GO:0007420]; chromatin remodeling [GO:0006338]; digestive tract development [GO:0048565]; in utero embryonic development [GO:0001701]; long-term memory [GO:0007616]; mRNA processing [GO:0006397]; negative regulation of apoptotic process [GO:0043066]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of fibroblast apoptotic process [GO:2000270]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of Wnt signaling pathway [GO:0030178]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription by RNA polymerase III [GO:0045945]; prepulse inhibition [GO:0060134]; regulation of gene expression [GO:0010468]; social behavior [GO:0035176]; startle response [GO:0001964]; Wnt signaling pathway [GO:0016055] chromatin [GO:0000785]; MLL1 complex [GO:0071339]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991] armadillo repeat domain binding [GO:0070016]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent chromatin remodeler activity [GO:0140658]; beta-catenin binding [GO:0008013]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; histone binding [GO:0042393]; histone H3K4me3 reader activity [GO:0140002]; p53 binding [GO:0002039] g2549.t1 Q3L8U1 53.612 263 1.46e-77 259.0 sp|Q3L8U1|CHD9_HUMAN Chromodomain-helicase-DNA-binding protein 9 OS=Homo sapiens OX=9606 GN=CHD9 PE=1 SV=2 CHD9_HUMAN reviewed ATP-dependent chromatin remodeler CHD9 (EC 3.6.4.-) (Chromatin-related mesenchymal modulator) (CReMM) (Chromatin-remodeling factor CHROM1) (Chromo domain-containing protein 9) (CHD-9) (Kismet homolog 2) (PPAR-alpha-interacting complex protein 320 kDa) (Peroxisomal proliferator-activated receptor A-interacting complex 320 kDa protein) Homo sapiens (Human) GO:0003677; GO:0005524; GO:0005654; GO:0005829; GO:0006325; GO:0016887 chromatin organization [GO:0006325] cytosol [GO:0005829]; nucleoplasm [GO:0005654] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA binding [GO:0003677] g2550.t1 A2AJK6 43.983 241 5.539999999999999e-48 191.0 sp|A2AJK6|CHD7_MOUSE Chromodomain-helicase-DNA-binding protein 7 OS=Mus musculus OX=10090 GN=Chd7 PE=1 SV=1 CHD7_MOUSE reviewed ATP-dependent chromatin remodeler CHD7 (EC 3.6.4.-) (Chromo domain-containing protein 7) (CHD-7) Mus musculus (Mouse) GO:0000785; GO:0000978; GO:0001501; GO:0001568; GO:0001701; GO:0001974; GO:0003007; GO:0003222; GO:0003226; GO:0003677; GO:0003682; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0006338; GO:0006364; GO:0007417; GO:0007512; GO:0007605; GO:0007626; GO:0007628; GO:0008015; GO:0009617; GO:0010468; GO:0010880; GO:0016887; GO:0021545; GO:0021553; GO:0021772; GO:0030217; GO:0030540; GO:0035116; GO:0035904; GO:0035909; GO:0036302; GO:0040018; GO:0042048; GO:0042393; GO:0042471; GO:0042472; GO:0043009; GO:0043010; GO:0043584; GO:0045944; GO:0048752; GO:0048771; GO:0048806; GO:0048844; GO:0050767; GO:0050890; GO:0060021; GO:0060041; GO:0060123; GO:0060173; GO:0060324; GO:0060384; GO:0060411; GO:0060429; GO:0062009; GO:0140658; GO:1990841 adult heart development [GO:0007512]; adult walking behavior [GO:0007628]; aorta development [GO:0035904]; aorta morphogenesis [GO:0035909]; artery morphogenesis [GO:0048844]; atrioventricular canal development [GO:0036302]; blood circulation [GO:0008015]; blood vessel development [GO:0001568]; blood vessel remodeling [GO:0001974]; camera-type eye development [GO:0043010]; cardiac septum morphogenesis [GO:0060411]; central nervous system development [GO:0007417]; chordate embryonic development [GO:0043009]; chromatin remodeling [GO:0006338]; cognition [GO:0050890]; cranial nerve development [GO:0021545]; ear morphogenesis [GO:0042471]; embryonic hindlimb morphogenesis [GO:0035116]; epithelium development [GO:0060429]; face development [GO:0060324]; female genitalia development [GO:0030540]; genitalia development [GO:0048806]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; inner ear morphogenesis [GO:0042472]; innervation [GO:0060384]; limb development [GO:0060173]; locomotory behavior [GO:0007626]; nose development [GO:0043584]; olfactory behavior [GO:0042048]; olfactory bulb development [GO:0021772]; olfactory nerve development [GO:0021553]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; regulation of growth hormone secretion [GO:0060123]; regulation of neurogenesis [GO:0050767]; regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0010880]; response to bacterium [GO:0009617]; retina development in camera-type eye [GO:0060041]; right ventricular compact myocardium morphogenesis [GO:0003226]; roof of mouth development [GO:0060021]; rRNA processing [GO:0006364]; secondary palate development [GO:0062009]; semicircular canal morphogenesis [GO:0048752]; sensory perception of sound [GO:0007605]; skeletal system development [GO:0001501]; T cell differentiation [GO:0030217]; tissue remodeling [GO:0048771]; ventricular trabecula myocardium morphogenesis [GO:0003222] chromatin [GO:0000785]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent chromatin remodeler activity [GO:0140658]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; histone binding [GO:0042393]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978] g2552.t1 Q05975 91.981 212 6.59e-143 400.0 sp|Q05975|RAB2_LYMST Ras-related protein Rab-2 OS=Lymnaea stagnalis OX=6523 GN=RAB2 PE=2 SV=1 g2553.t1 Q4G112 40.945 127 1.5100000000000001e-22 103.0 sp|Q4G112|HSF5_HUMAN Heat shock factor protein 5 OS=Homo sapiens OX=9606 GN=HSF5 PE=1 SV=3 HSF5_HUMAN reviewed Heat shock factor protein 5 (HSF 5) (Heat shock transcription factor 5) (HSTF 5) Homo sapiens (Human) GO:0001216; GO:0001217; GO:0001741; GO:0005634; GO:0007140; GO:0007283; GO:0030154; GO:1990837 cell differentiation [GO:0030154]; male meiotic nuclear division [GO:0007140]; spermatogenesis [GO:0007283] nucleus [GO:0005634]; XY body [GO:0001741] DNA-binding transcription activator activity [GO:0001216]; DNA-binding transcription repressor activity [GO:0001217]; sequence-specific double-stranded DNA binding [GO:1990837] g2560.t1 P46413 42.48 379 4.9099999999999995e-90 283.0 sp|P46413|GSHB_RAT Glutathione synthetase OS=Rattus norvegicus OX=10116 GN=Gss PE=1 SV=1 GSHB_RAT reviewed Glutathione synthetase (GSH synthetase) (GSH-S) (EC 6.3.2.3) (Glutathione synthase) Rattus norvegicus (Rat) GO:0000287; GO:0004363; GO:0005524; GO:0005829; GO:0006750; GO:0009410; GO:0016594; GO:0031667; GO:0034612; GO:0042277; GO:0042802; GO:0042803; GO:0043200; GO:0043295; GO:0046686 glutathione biosynthetic process [GO:0006750]; response to amino acid [GO:0043200]; response to cadmium ion [GO:0046686]; response to nutrient levels [GO:0031667]; response to tumor necrosis factor [GO:0034612]; response to xenobiotic stimulus [GO:0009410] cytosol [GO:0005829] ATP binding [GO:0005524]; glutathione binding [GO:0043295]; glutathione synthase activity [GO:0004363]; glycine binding [GO:0016594]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; peptide binding [GO:0042277]; protein homodimerization activity [GO:0042803] g2563.t1 Q96EP0 33.158 190 3.48e-23 105.0 sp|Q96EP0|RNF31_HUMAN E3 ubiquitin-protein ligase RNF31 OS=Homo sapiens OX=9606 GN=RNF31 PE=1 SV=1 RNF31_HUMAN reviewed E3 ubiquitin-protein ligase RNF31 (EC 2.3.2.31) (HOIL-1-interacting protein) (HOIP) (RING finger protein 31) (RING-type E3 ubiquitin transferase RNF31) (Zinc in-between-RING-finger ubiquitin-associated domain protein) Homo sapiens (Human) GO:0000209; GO:0004842; GO:0005829; GO:0007249; GO:0008270; GO:0009898; GO:0023035; GO:0031625; GO:0035631; GO:0036435; GO:0042742; GO:0042802; GO:0043123; GO:0043124; GO:0043130; GO:0050852; GO:0051092; GO:0060546; GO:0061630; GO:0070530; GO:0071797; GO:0097039; GO:1903955; GO:1904417; GO:1990450 canonical NF-kappaB signal transduction [GO:0007249]; CD40 signaling pathway [GO:0023035]; defense response to bacterium [GO:0042742]; negative regulation of canonical NF-kappaB signal transduction [GO:0043124]; negative regulation of necroptotic process [GO:0060546]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of protein targeting to mitochondrion [GO:1903955]; positive regulation of xenophagy [GO:1904417]; protein linear polyubiquitination [GO:0097039]; protein polyubiquitination [GO:0000209]; T cell receptor signaling pathway [GO:0050852] CD40 receptor complex [GO:0035631]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; LUBAC complex [GO:0071797] identical protein binding [GO:0042802]; K48-linked polyubiquitin modification-dependent protein binding [GO:0036435]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; linear polyubiquitin binding [GO:1990450]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] g2565.t1 Q924T7 37.829 608 2.86e-110 367.0 sp|Q924T7|RNF31_MOUSE E3 ubiquitin-protein ligase RNF31 OS=Mus musculus OX=10090 GN=Rnf31 PE=1 SV=2 g2567.t1 O60669 27.612 402 1.7e-35 140.0 sp|O60669|MOT2_HUMAN Monocarboxylate transporter 2 OS=Homo sapiens OX=9606 GN=SLC16A7 PE=1 SV=2 MOT2_HUMAN reviewed Monocarboxylate transporter 2 (MCT 2) (Solute carrier family 16 member 7) Homo sapiens (Human) GO:0005477; GO:0005654; GO:0005829; GO:0005886; GO:0015129; GO:0015293; GO:0016323; GO:0035873; GO:0035879; GO:0042802; GO:0050833; GO:0098685; GO:0098686; GO:0098688; GO:0098839; GO:0098978; GO:0150104; GO:1901475 lactate transmembrane transport [GO:0035873]; plasma membrane lactate transport [GO:0035879]; pyruvate transmembrane transport [GO:1901475]; transport across blood-brain barrier [GO:0150104] basolateral plasma membrane [GO:0016323]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; nucleoplasm [GO:0005654]; parallel fiber to Purkinje cell synapse [GO:0098688]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; Schaffer collateral - CA1 synapse [GO:0098685] identical protein binding [GO:0042802]; lactate transmembrane transporter activity [GO:0015129]; pyruvate secondary active transmembrane transporter activity [GO:0005477]; pyruvate transmembrane transporter activity [GO:0050833]; symporter activity [GO:0015293] g2568.t1 Q9DAR0 42.478 113 8.45e-24 94.4 sp|Q9DAR0|CFA90_MOUSE Cilia- and flagella-associated protein 90 OS=Mus musculus OX=10090 GN=Cfap90 PE=1 SV=1 CFA90_MOUSE reviewed Cilia- and flagella-associated protein 90 (Y regulated sperm protein) Mus musculus (Mouse) GO:0005930; GO:0030317; GO:0036064; GO:0036126; GO:0160112 flagellated sperm motility [GO:0030317] axonemal B tubule inner sheath [GO:0160112]; axoneme [GO:0005930]; ciliary basal body [GO:0036064]; sperm flagellum [GO:0036126] g2572.t1 Q5R875 30.267 337 9.66e-58 193.0 sp|Q5R875|TMX3_PONAB Protein disulfide-isomerase TMX3 OS=Pongo abelii OX=9601 GN=TMX3 PE=2 SV=1 TMX3_PONAB reviewed Protein disulfide-isomerase TMX3 (EC 5.3.4.1) (Thioredoxin domain-containing protein 10) (Thioredoxin-related transmembrane protein 3) Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0003756; GO:0005789; GO:0009986 cell surface [GO:0009986]; endoplasmic reticulum membrane [GO:0005789] protein disulfide isomerase activity [GO:0003756] g2572.t1 Q5R875 70.37 27 9.66e-58 52.8 sp|Q5R875|TMX3_PONAB Protein disulfide-isomerase TMX3 OS=Pongo abelii OX=9601 GN=TMX3 PE=2 SV=1 TMX3_PONAB reviewed Protein disulfide-isomerase TMX3 (EC 5.3.4.1) (Thioredoxin domain-containing protein 10) (Thioredoxin-related transmembrane protein 3) Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0003756; GO:0005789; GO:0009986 cell surface [GO:0009986]; endoplasmic reticulum membrane [GO:0005789] protein disulfide isomerase activity [GO:0003756] g2573.t1 Q8IZU8 55.019 538 0.0 602.0 sp|Q8IZU8|DSEL_HUMAN Dermatan-sulfate epimerase-like protein OS=Homo sapiens OX=9606 GN=DSEL PE=1 SV=2 g2574.t1 Q8IZU8 29.058 499 9.37e-51 189.0 sp|Q8IZU8|DSEL_HUMAN Dermatan-sulfate epimerase-like protein OS=Homo sapiens OX=9606 GN=DSEL PE=1 SV=2 g2578.t1 Q5ZML6 42.236 161 3.31e-36 134.0 sp|Q5ZML6|F210A_CHICK Protein FAM210A OS=Gallus gallus OX=9031 GN=FAM210A PE=2 SV=1 g2583.t1 Q5R6C9 67.407 135 1.62e-53 168.0 sp|Q5R6C9|UB2V2_PONAB Ubiquitin-conjugating enzyme E2 variant 2 OS=Pongo abelii OX=9601 GN=UBE2V2 PE=2 SV=1 g2592.t1 Q8J025 45.238 252 9.87e-69 223.0 sp|Q8J025|APCD1_HUMAN Protein APCDD1 OS=Homo sapiens OX=9606 GN=APCDD1 PE=1 SV=1 APCD1_HUMAN reviewed Protein APCDD1 (Adenomatosis polyposis coli down-regulated 1 protein) Homo sapiens (Human) GO:0001942; GO:0005886; GO:0016055; GO:0017147; GO:0030178; GO:0042487; GO:0042802; GO:0043615 astrocyte cell migration [GO:0043615]; hair follicle development [GO:0001942]; negative regulation of Wnt signaling pathway [GO:0030178]; regulation of odontogenesis of dentin-containing tooth [GO:0042487]; Wnt signaling pathway [GO:0016055] plasma membrane [GO:0005886] identical protein binding [GO:0042802]; Wnt-protein binding [GO:0017147] g2593.t1 Q5R2I8 46.087 115 5.830000000000001e-26 105.0 sp|Q5R2I8|APCD1_CHICK Protein APCDD1 OS=Gallus gallus OX=9031 GN=APCDD1 PE=2 SV=1 g2593.t2 Q5R2I8 38.798 183 1.49e-34 130.0 sp|Q5R2I8|APCD1_CHICK Protein APCDD1 OS=Gallus gallus OX=9031 GN=APCDD1 PE=2 SV=1 g2596.t1 P91455 53.75 160 1.93e-58 184.0 sp|P91455|APT_CAEEL Adenine phosphoribosyltransferase OS=Caenorhabditis elegans OX=6239 GN=aprt-1 PE=2 SV=1 g2597.t1 Q810A5 48.0 350 1e-116 357.0 sp|Q810A5|MACA1_MOUSE Microtubule-associated tyrosine carboxypeptidase 1 OS=Mus musculus OX=10090 GN=Matcap1 PE=2 SV=1 g2598.t1 P78417 43.128 211 4.32e-50 167.0 sp|P78417|GSTO1_HUMAN Glutathione S-transferase omega-1 OS=Homo sapiens OX=9606 GN=GSTO1 PE=1 SV=2 GSTO1_HUMAN reviewed Glutathione S-transferase omega-1 (GSTO-1) (EC 2.5.1.18) (Glutathione S-transferase omega 1-1) (GSTO 1-1) (Glutathione-dependent dehydroascorbate reductase) (EC 1.8.5.1) (Monomethylarsonic acid reductase) (MMA(V) reductase) (EC 1.20.4.2) (S-(Phenacyl)glutathione reductase) (SPG-R) Homo sapiens (Human) GO:0004364; GO:0005737; GO:0005829; GO:0006749; GO:0010880; GO:0010881; GO:0014810; GO:0016491; GO:0019852; GO:0042178; GO:0045174; GO:0050610; GO:0051280; GO:0051281; GO:0070062; GO:0071243 cellular response to arsenic-containing substance [GO:0071243]; glutathione metabolic process [GO:0006749]; L-ascorbic acid metabolic process [GO:0019852]; negative regulation of release of sequestered calcium ion into cytosol [GO:0051280]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; positive regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion [GO:0014810]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0010880]; xenobiotic catabolic process [GO:0042178] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062] glutathione dehydrogenase (ascorbate) activity [GO:0045174]; glutathione transferase activity [GO:0004364]; methylarsonate reductase activity [GO:0050610]; oxidoreductase activity [GO:0016491] g2599.t1 Q8C190 46.512 215 4.38e-50 191.0 sp|Q8C190|VP9D1_MOUSE VPS9 domain-containing protein 1 OS=Mus musculus OX=10090 GN=Vps9d1 PE=1 SV=1 g2599.t1 Q8C190 37.349 332 4.4499999999999995e-45 176.0 sp|Q8C190|VP9D1_MOUSE VPS9 domain-containing protein 1 OS=Mus musculus OX=10090 GN=Vps9d1 PE=1 SV=1 g2600.t1 Q9CZX2 31.391 532 1.1700000000000001e-64 237.0 sp|Q9CZX2|CEP89_MOUSE Centrosomal protein of 89 kDa OS=Mus musculus OX=10090 GN=Cep89 PE=1 SV=1 CEP89_MOUSE reviewed Centrosomal protein of 89 kDa (Cep89) (Coiled-coil domain-containing protein 123) Mus musculus (Mouse) GO:0000922; GO:0005758; GO:0005813; GO:0005814; GO:0005829; GO:0005929; GO:0007005; GO:0007268; GO:0016604; GO:0031514; GO:0033617; GO:0036064; GO:0045202; GO:0060271; GO:0097539; GO:0097730; GO:1905515 chemical synaptic transmission [GO:0007268]; cilium assembly [GO:0060271]; mitochondrial respiratory chain complex IV assembly [GO:0033617]; mitochondrion organization [GO:0007005]; non-motile cilium assembly [GO:1905515] centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary transition fiber [GO:0097539]; cilium [GO:0005929]; cytosol [GO:0005829]; mitochondrial intermembrane space [GO:0005758]; motile cilium [GO:0031514]; non-motile cilium [GO:0097730]; nuclear body [GO:0016604]; spindle pole [GO:0000922]; synapse [GO:0045202] g2602.t1 Q96EV8 33.579 271 8.54e-41 150.0 sp|Q96EV8|DTBP1_HUMAN Dysbindin OS=Homo sapiens OX=9606 GN=DTNBP1 PE=1 SV=1 g2606.t1 Q63244 46.4 125 3.6600000000000004e-31 124.0 sp|Q63244|FOXQ1_RAT Forkhead box protein Q1 OS=Rattus norvegicus OX=10116 GN=Foxq1 PE=1 SV=3 g2610.t1 Q8K0C9 70.699 372 0.0 557.0 sp|Q8K0C9|GMDS_MOUSE GDP-mannose 4,6 dehydratase OS=Mus musculus OX=10090 GN=Gmds PE=1 SV=1 g2612.t1 Q12952 76.577 111 4.9600000000000004e-57 195.0 sp|Q12952|FOXL1_HUMAN Forkhead box protein L1 OS=Homo sapiens OX=9606 GN=FOXL1 PE=1 SV=2 FOXL1_HUMAN reviewed Forkhead box protein L1 (Forkhead-related protein FKHL11) (Forkhead-related transcription factor 7) (FREAC-7) Homo sapiens (Human) GO:0000785; GO:0000978; GO:0000981; GO:0003677; GO:0003700; GO:0005634; GO:0006357; GO:0007495; GO:0007507; GO:0008301; GO:0009653; GO:0030111; GO:0030154; GO:0030166; GO:0043565; GO:0061146 anatomical structure morphogenesis [GO:0009653]; cell differentiation [GO:0030154]; heart development [GO:0007507]; Peyer's patch morphogenesis [GO:0061146]; proteoglycan biosynthetic process [GO:0030166]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of Wnt signaling pathway [GO:0030111]; visceral mesoderm-endoderm interaction involved in midgut development [GO:0007495] chromatin [GO:0000785]; nucleus [GO:0005634] DNA binding [GO:0003677]; DNA binding, bending [GO:0008301]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565] g2616.t1 Q9PVY8 39.423 520 5.5e-77 252.0 sp|Q9PVY8|FXC2B_XENLA Forkhead box protein C2-B OS=Xenopus laevis OX=8355 GN=foxc2-b PE=2 SV=2 g2621.t1 Q9W707 93.966 116 6.67e-52 181.0 sp|Q9W707|FXF1B_XENLA Forkhead box protein F1-B OS=Xenopus laevis OX=8355 GN=foxf1-b PE=2 SV=1 g2622.t1 Q7TN88 34.647 609 6.39e-95 323.0 sp|Q7TN88|PK1L2_MOUSE Polycystin-1-like protein 2 OS=Mus musculus OX=10090 GN=Pkd1l2 PE=2 SV=1 PK1L2_MOUSE reviewed Polycystin-1-like protein 2 (Polycystin-1L2) (PC1-like 2 protein) (Polycystic kidney disease protein 1-like 2) Mus musculus (Mouse) GO:0001965; GO:0005262; GO:0005509; GO:0016020; GO:0030246; GO:0050982 detection of mechanical stimulus [GO:0050982] membrane [GO:0016020] calcium channel activity [GO:0005262]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; G-protein alpha-subunit binding [GO:0001965] g2623.t1 Q26627 28.739 1110 7.84e-107 379.0 sp|Q26627|SUREJ_STRPU Sperm receptor for egg jelly OS=Strongylocentrotus purpuratus OX=7668 GN=REJ PE=1 SV=1 SUREJ_STRPU reviewed Sperm receptor for egg jelly (suREJ) Strongylocentrotus purpuratus (Purple sea urchin) GO:0005262; GO:0005509; GO:0005886; GO:0016020; GO:0030246; GO:0050982 detection of mechanical stimulus [GO:0050982] membrane [GO:0016020]; plasma membrane [GO:0005886] calcium channel activity [GO:0005262]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246] g2627.t1 Q63244 50.0 100 3.6e-24 106.0 sp|Q63244|FOXQ1_RAT Forkhead box protein Q1 OS=Rattus norvegicus OX=10116 GN=Foxq1 PE=1 SV=3 g2628.t1 Q3UEG6 52.174 161 1.1600000000000001e-57 193.0 sp|Q3UEG6|AGT2_MOUSE Alanine--glyoxylate aminotransferase 2, mitochondrial OS=Mus musculus OX=10090 GN=Agxt2 PE=1 SV=1 AGT2_MOUSE reviewed Alanine--glyoxylate aminotransferase 2, mitochondrial (AGT 2) (EC 2.6.1.44) ((R)-3-amino-2-methylpropionate--pyruvate transaminase) (EC 2.6.1.40) (Beta-ALAAT II) (Beta-alanine-pyruvate aminotransferase) (EC 2.6.1.18) (D-3-aminoisobutyrate-pyruvate aminotransferase) (D-AIBAT) (D-beta-aminoisobutyrate-pyruvate aminotransferase) Mus musculus (Mouse) GO:0005739; GO:0008453; GO:0009436; GO:0016223; GO:0019265; GO:0019481; GO:0030170; GO:0045429; GO:0047305; GO:2001299 glycine biosynthetic process, by transamination of glyoxylate [GO:0019265]; glyoxylate catabolic process [GO:0009436]; L-alanine catabolic process, by transamination [GO:0019481]; N(omega),N(omega)-dimethyl-L-arginine catabolic process [GO:2001299]; positive regulation of nitric oxide biosynthetic process [GO:0045429] mitochondrion [GO:0005739] (R)-3-amino-2-methylpropionate-pyruvate transaminase activity [GO:0047305]; alanine-glyoxylate transaminase activity [GO:0008453]; beta-alanine:pyruvate transaminase activity [GO:0016223]; pyridoxal phosphate binding [GO:0030170] g2629.t1 Q17QF0 67.742 248 1.53e-119 353.0 sp|Q17QF0|AGT2_BOVIN Alanine--glyoxylate aminotransferase 2, mitochondrial OS=Bos taurus OX=9913 GN=AGXT2 PE=2 SV=1 AGT2_BOVIN reviewed Alanine--glyoxylate aminotransferase 2, mitochondrial (AGT 2) (EC 2.6.1.44) ((R)-3-amino-2-methylpropionate--pyruvate transaminase) (EC 2.6.1.40) (Beta-ALAAT II) (Beta-alanine-pyruvate aminotransferase) (EC 2.6.1.18) (D-3-aminoisobutyrate-pyruvate aminotransferase) (D-AIBAT) (D-beta-aminoisobutyrate-pyruvate aminotransferase) Bos taurus (Bovine) GO:0005739; GO:0008453; GO:0009436; GO:0016223; GO:0019481; GO:0030170; GO:0047305; GO:2001299 glyoxylate catabolic process [GO:0009436]; L-alanine catabolic process, by transamination [GO:0019481]; N(omega),N(omega)-dimethyl-L-arginine catabolic process [GO:2001299] mitochondrion [GO:0005739] (R)-3-amino-2-methylpropionate-pyruvate transaminase activity [GO:0047305]; alanine-glyoxylate transaminase activity [GO:0008453]; beta-alanine:pyruvate transaminase activity [GO:0016223]; pyridoxal phosphate binding [GO:0030170] g2630.t1 A7SXZ6 81.493 335 0.0 566.0 sp|A7SXZ6|OSGEP_NEMVE Probable tRNA N6-adenosine threonylcarbamoyltransferase OS=Nematostella vectensis OX=45351 GN=osgep PE=3 SV=1 g2632.t1 Q16880 37.297 370 1.03e-86 281.0 sp|Q16880|CGT_HUMAN 2-hydroxyacylsphingosine 1-beta-galactosyltransferase OS=Homo sapiens OX=9606 GN=UGT8 PE=1 SV=2 CGT_HUMAN reviewed 2-hydroxyacylsphingosine 1-beta-galactosyltransferase (EC 2.4.1.47) (Ceramide UDP-galactosyltransferase) (Cerebroside synthase) (UDP-galactose-ceramide galactosyltransferase) Homo sapiens (Human) GO:0002175; GO:0003851; GO:0005783; GO:0005789; GO:0006682; GO:0006688; GO:0007010; GO:0007417; GO:0007422; GO:0008489; GO:0030913; GO:0035902; GO:0048812; GO:0098553 central nervous system development [GO:0007417]; cytoskeleton organization [GO:0007010]; galactosylceramide biosynthetic process [GO:0006682]; glycosphingolipid biosynthetic process [GO:0006688]; neuron projection morphogenesis [GO:0048812]; paranodal junction assembly [GO:0030913]; peripheral nervous system development [GO:0007422]; protein localization to paranode region of axon [GO:0002175]; response to immobilization stress [GO:0035902] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; lumenal side of endoplasmic reticulum membrane [GO:0098553] N-acylsphingosine galactosyltransferase activity [GO:0003851]; UDP-galactose:glucosylceramide beta-1,4-galactosyltransferase activity [GO:0008489] g2632.t2 Q16880 37.297 370 1.33e-86 281.0 sp|Q16880|CGT_HUMAN 2-hydroxyacylsphingosine 1-beta-galactosyltransferase OS=Homo sapiens OX=9606 GN=UGT8 PE=1 SV=2 CGT_HUMAN reviewed 2-hydroxyacylsphingosine 1-beta-galactosyltransferase (EC 2.4.1.47) (Ceramide UDP-galactosyltransferase) (Cerebroside synthase) (UDP-galactose-ceramide galactosyltransferase) Homo sapiens (Human) GO:0002175; GO:0003851; GO:0005783; GO:0005789; GO:0006682; GO:0006688; GO:0007010; GO:0007417; GO:0007422; GO:0008489; GO:0030913; GO:0035902; GO:0048812; GO:0098553 central nervous system development [GO:0007417]; cytoskeleton organization [GO:0007010]; galactosylceramide biosynthetic process [GO:0006682]; glycosphingolipid biosynthetic process [GO:0006688]; neuron projection morphogenesis [GO:0048812]; paranodal junction assembly [GO:0030913]; peripheral nervous system development [GO:0007422]; protein localization to paranode region of axon [GO:0002175]; response to immobilization stress [GO:0035902] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; lumenal side of endoplasmic reticulum membrane [GO:0098553] N-acylsphingosine galactosyltransferase activity [GO:0003851]; UDP-galactose:glucosylceramide beta-1,4-galactosyltransferase activity [GO:0008489] g2642.t1 P10076 31.2 375 2.57e-49 184.0 sp|P10076|ZFP26_MOUSE Zinc finger protein 26 OS=Mus musculus OX=10090 GN=Zfp26 PE=2 SV=2 g2642.t1 P10076 33.333 354 2.63e-46 176.0 sp|P10076|ZFP26_MOUSE Zinc finger protein 26 OS=Mus musculus OX=10090 GN=Zfp26 PE=2 SV=2 g2642.t1 P10076 29.6 375 5.51e-46 175.0 sp|P10076|ZFP26_MOUSE Zinc finger protein 26 OS=Mus musculus OX=10090 GN=Zfp26 PE=2 SV=2 g2642.t1 P10076 30.726 358 4.43e-44 169.0 sp|P10076|ZFP26_MOUSE Zinc finger protein 26 OS=Mus musculus OX=10090 GN=Zfp26 PE=2 SV=2 g2642.t1 P10076 31.135 379 5.73e-44 169.0 sp|P10076|ZFP26_MOUSE Zinc finger protein 26 OS=Mus musculus OX=10090 GN=Zfp26 PE=2 SV=2 g2642.t1 P10076 30.127 395 3.9999999999999995e-42 164.0 sp|P10076|ZFP26_MOUSE Zinc finger protein 26 OS=Mus musculus OX=10090 GN=Zfp26 PE=2 SV=2 g2642.t1 P10076 30.925 346 2.39e-40 158.0 sp|P10076|ZFP26_MOUSE Zinc finger protein 26 OS=Mus musculus OX=10090 GN=Zfp26 PE=2 SV=2 g2642.t1 P10076 29.063 320 2.69e-33 137.0 sp|P10076|ZFP26_MOUSE Zinc finger protein 26 OS=Mus musculus OX=10090 GN=Zfp26 PE=2 SV=2 g2643.t1 Q96K83 33.424 368 1.97e-44 168.0 sp|Q96K83|ZN521_HUMAN Zinc finger protein 521 OS=Homo sapiens OX=9606 GN=ZNF521 PE=1 SV=1 ZN521_HUMAN reviewed Zinc finger protein 521 (Early hematopoietic zinc finger protein) (LYST-interacting protein 3) Homo sapiens (Human) GO:0003677; GO:0005634; GO:0005654; GO:0006357; GO:0008270; GO:0019904; GO:0048663 neuron fate commitment [GO:0048663]; regulation of transcription by RNA polymerase II [GO:0006357] nucleoplasm [GO:0005654]; nucleus [GO:0005634] DNA binding [GO:0003677]; protein domain specific binding [GO:0019904]; zinc ion binding [GO:0008270] g2645.t1 Q6ZMW2 36.897 290 1.6100000000000002e-47 174.0 sp|Q6ZMW2|ZN782_HUMAN Zinc finger protein 782 OS=Homo sapiens OX=9606 GN=ZNF782 PE=1 SV=1 g2645.t1 Q6ZMW2 33.818 275 1.49e-40 155.0 sp|Q6ZMW2|ZN782_HUMAN Zinc finger protein 782 OS=Homo sapiens OX=9606 GN=ZNF782 PE=1 SV=1 g2645.t1 Q6ZMW2 31.126 302 3.64e-33 134.0 sp|Q6ZMW2|ZN782_HUMAN Zinc finger protein 782 OS=Homo sapiens OX=9606 GN=ZNF782 PE=1 SV=1 g2645.t1 Q6ZMW2 31.624 234 4.37e-28 119.0 sp|Q6ZMW2|ZN782_HUMAN Zinc finger protein 782 OS=Homo sapiens OX=9606 GN=ZNF782 PE=1 SV=1 g2646.t1 Q2M1K9 29.826 1093 2.31e-133 439.0 sp|Q2M1K9|ZN423_HUMAN Zinc finger protein 423 OS=Homo sapiens OX=9606 GN=ZNF423 PE=1 SV=1 ZN423_HUMAN reviewed Zinc finger protein 423 (Olf1/EBF-associated zinc finger protein) (hOAZ) (Smad- and Olf-interacting zinc finger protein) Homo sapiens (Human) GO:0000978; GO:0000981; GO:0005634; GO:0005654; GO:0006355; GO:0007219; GO:0007399; GO:0008270; GO:0030154; GO:0030513; GO:0043565; GO:0045892; GO:0045893; GO:0061512; GO:0120163 cell differentiation [GO:0030154]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of DNA-templated transcription [GO:0045892]; nervous system development [GO:0007399]; Notch signaling pathway [GO:0007219]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of DNA-templated transcription [GO:0045893]; protein localization to cilium [GO:0061512]; regulation of DNA-templated transcription [GO:0006355] nucleoplasm [GO:0005654]; nucleus [GO:0005634] DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270] g2648.t1 O75845 47.17 265 8.25e-76 234.0 sp|O75845|SC5D_HUMAN Lathosterol oxidase OS=Homo sapiens OX=9606 GN=SC5D PE=1 SV=2 g2649.t1 O93477 78.372 430 0.0 700.0 sp|O93477|SAHHB_XENLA Adenosylhomocysteinase B OS=Xenopus laevis OX=8355 GN=ahcy-b PE=2 SV=1 g2650.t1 Q9W4P5 81.341 343 0.0 598.0 sp|Q9W4P5|VA0D1_DROME V-type proton ATPase subunit d 1 OS=Drosophila melanogaster OX=7227 GN=VhaAC39-1 PE=2 SV=1 g2651.t1 Q5RC80 73.333 180 4.12e-86 272.0 sp|Q5RC80|RBM39_PONAB RNA-binding protein 39 OS=Pongo abelii OX=9601 GN=RBM39 PE=2 SV=1 RBM39_PONAB reviewed RNA-binding protein 39 (RNA-binding motif protein 39) Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0003723; GO:0006397; GO:0008380; GO:0016607; GO:0032991; GO:0034451; GO:0048024; GO:0050733 mRNA processing [GO:0006397]; regulation of mRNA splicing, via spliceosome [GO:0048024]; RNA splicing [GO:0008380] centriolar satellite [GO:0034451]; nuclear speck [GO:0016607]; protein-containing complex [GO:0032991] RNA binding [GO:0003723]; RS domain binding [GO:0050733] g2651.t1 Q5RC80 66.981 106 1.86e-36 141.0 sp|Q5RC80|RBM39_PONAB RNA-binding protein 39 OS=Pongo abelii OX=9601 GN=RBM39 PE=2 SV=1 RBM39_PONAB reviewed RNA-binding protein 39 (RNA-binding motif protein 39) Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0003723; GO:0006397; GO:0008380; GO:0016607; GO:0032991; GO:0034451; GO:0048024; GO:0050733 mRNA processing [GO:0006397]; regulation of mRNA splicing, via spliceosome [GO:0048024]; RNA splicing [GO:0008380] centriolar satellite [GO:0034451]; nuclear speck [GO:0016607]; protein-containing complex [GO:0032991] RNA binding [GO:0003723]; RS domain binding [GO:0050733] g2653.t1 O75845 60.215 279 4.2700000000000005e-117 341.0 sp|O75845|SC5D_HUMAN Lathosterol oxidase OS=Homo sapiens OX=9606 GN=SC5D PE=1 SV=2 g2655.t1 Q08AE8 41.026 390 1.54e-82 283.0 sp|Q08AE8|SPIR1_HUMAN Protein spire homolog 1 OS=Homo sapiens OX=9606 GN=SPIRE1 PE=1 SV=3 SPIR1_HUMAN reviewed Protein spire homolog 1 (Spir-1) Homo sapiens (Human) GO:0003779; GO:0005654; GO:0005741; GO:0005829; GO:0005856; GO:0005886; GO:0005938; GO:0008017; GO:0015031; GO:0016192; GO:0030036; GO:0030659; GO:0036089; GO:0040038; GO:0045010; GO:0045087; GO:0046907; GO:0048193; GO:0048471; GO:0051295; GO:0051639; GO:0070649; GO:0090141; GO:2000781 actin cytoskeleton organization [GO:0030036]; actin filament network formation [GO:0051639]; actin nucleation [GO:0045010]; cleavage furrow formation [GO:0036089]; establishment of meiotic spindle localization [GO:0051295]; formin-nucleated actin cable assembly [GO:0070649]; Golgi vesicle transport [GO:0048193]; innate immune response [GO:0045087]; intracellular transport [GO:0046907]; polar body extrusion after meiotic divisions [GO:0040038]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of mitochondrial fission [GO:0090141]; protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192] cell cortex [GO:0005938]; cytoplasmic vesicle membrane [GO:0030659]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; mitochondrial outer membrane [GO:0005741]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886] actin binding [GO:0003779]; microtubule binding [GO:0008017] g2656.t1 O14662 59.032 310 8.71e-126 365.0 sp|O14662|STX16_HUMAN Syntaxin-16 OS=Homo sapiens OX=9606 GN=STX16 PE=1 SV=3 STX16_HUMAN reviewed Syntaxin-16 (Syn16) Homo sapiens (Human) GO:0000139; GO:0000149; GO:0005484; GO:0005737; GO:0005794; GO:0005802; GO:0005829; GO:0005925; GO:0006886; GO:0006906; GO:0012505; GO:0016020; GO:0019905; GO:0030672; GO:0031201; GO:0031985; GO:0032456; GO:0032588; GO:0042147; GO:0043231; GO:0048278; GO:0048471 endocytic recycling [GO:0032456]; intracellular protein transport [GO:0006886]; retrograde transport, endosome to Golgi [GO:0042147]; vesicle docking [GO:0048278]; vesicle fusion [GO:0006906] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; Golgi cisterna [GO:0031985]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; SNARE complex [GO:0031201]; synaptic vesicle membrane [GO:0030672]; trans-Golgi network [GO:0005802]; trans-Golgi network membrane [GO:0032588] SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905] g2657.t1 P80311 56.593 182 2.4999999999999997e-69 213.0 sp|P80311|PPIB_BOVIN Peptidyl-prolyl cis-trans isomerase B OS=Bos taurus OX=9913 GN=PPIB PE=1 SV=4 PPIB_BOVIN reviewed Peptidyl-prolyl cis-trans isomerase B (PPIase B) (EC 5.2.1.8) (Cyclophilin B) (Rotamase B) (S-cyclophilin) (SCYLP) Bos taurus (Bovine) GO:0003755; GO:0005654; GO:0005737; GO:0005788; GO:0006457; GO:0016018; GO:0030593; GO:0032991; GO:0034663; GO:0040018; GO:0042470; GO:0044829; GO:0048471; GO:0050821; GO:0060348; GO:0070063 bone development [GO:0060348]; host-mediated activation of viral genome replication [GO:0044829]; neutrophil chemotaxis [GO:0030593]; positive regulation of multicellular organism growth [GO:0040018]; protein folding [GO:0006457]; protein stabilization [GO:0050821] cytoplasm [GO:0005737]; endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum lumen [GO:0005788]; melanosome [GO:0042470]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991] cyclosporin A binding [GO:0016018]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; RNA polymerase binding [GO:0070063] g2658.t1 Q5ZIW2 47.286 700 0.0 587.0 sp|Q5ZIW2|CNO10_CHICK CCR4-NOT transcription complex subunit 10 OS=Gallus gallus OX=9031 GN=CNOT10 PE=1 SV=1 CNO10_CHICK reviewed CCR4-NOT transcription complex subunit 10 Gallus gallus (Chicken) GO:0005634; GO:0005829; GO:0006402; GO:0017148; GO:0030014; GO:0031047 mRNA catabolic process [GO:0006402]; negative regulation of translation [GO:0017148]; regulatory ncRNA-mediated gene silencing [GO:0031047] CCR4-NOT complex [GO:0030014]; cytosol [GO:0005829]; nucleus [GO:0005634] g2659.t1 Q9CYH5 50.407 369 4.5299999999999996e-138 401.0 sp|Q9CYH5|GFOD2_MOUSE Glucose-fructose oxidoreductase domain-containing protein 2 OS=Mus musculus OX=10090 GN=Gfod2 PE=2 SV=1 g2660.t1 Q9W625 48.264 288 7.92e-87 265.0 sp|Q9W625|IMPCT_XENLA Protein IMPACT OS=Xenopus laevis OX=8355 GN=impact PE=2 SV=1 g2661.t1 Q4R5P6 49.284 489 1.7599999999999998e-140 414.0 sp|Q4R5P6|DC1L2_MACFA Cytoplasmic dynein 1 light intermediate chain 2 OS=Macaca fascicularis OX=9541 GN=DYNC1LI2 PE=2 SV=1 DC1L2_MACFA reviewed Cytoplasmic dynein 1 light intermediate chain 2 (Dynein light intermediate chain 2, cytosolic) Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey) GO:0000226; GO:0005524; GO:0005813; GO:0005868; GO:0005874; GO:0007018; GO:0045504 microtubule cytoskeleton organization [GO:0000226]; microtubule-based movement [GO:0007018] centrosome [GO:0005813]; cytoplasmic dynein complex [GO:0005868]; microtubule [GO:0005874] ATP binding [GO:0005524]; dynein heavy chain binding [GO:0045504] g2662.t1 Q8NEM2 28.65 548 4.6799999999999996e-60 215.0 sp|Q8NEM2|SHCBP_HUMAN SHC SH2 domain-binding protein 1 OS=Homo sapiens OX=9606 GN=SHCBP1 PE=1 SV=3 g2663.t1 P47990 55.352 1364 0.0 1491.0 sp|P47990|XDH_CHICK Xanthine dehydrogenase/oxidase OS=Gallus gallus OX=9031 GN=XDH PE=1 SV=1 g2664.t1 Q8N0W3 46.883 1107 0.0 952.0 sp|Q8N0W3|FCSK_HUMAN L-fucose kinase OS=Homo sapiens OX=9606 GN=FCSK PE=1 SV=2 FCSK_HUMAN reviewed L-fucose kinase (Fucokinase) (EC 2.7.1.52) Homo sapiens (Human) GO:0005524; GO:0005829; GO:0042350; GO:0042352; GO:0046835; GO:0050201 carbohydrate phosphorylation [GO:0046835]; GDP-L-fucose biosynthetic process [GO:0042350]; GDP-L-fucose salvage [GO:0042352] cytosol [GO:0005829] ATP binding [GO:0005524]; fucokinase activity [GO:0050201] g2665.t1 Q5XH29 26.239 343 5.470000000000001e-29 118.0 sp|Q5XH29|CENNA_XENLA Centromere protein N-A OS=Xenopus laevis OX=8355 GN=cenpn-a PE=2 SV=2 g2671.t1 Q8BFT2 31.965 341 1.62e-49 173.0 sp|Q8BFT2|HAUS4_MOUSE HAUS augmin-like complex subunit 4 OS=Mus musculus OX=10090 GN=Haus4 PE=1 SV=1 g2672.t1 Q8NA66 27.553 421 1.94e-44 165.0 sp|Q8NA66|CNBD1_HUMAN Cyclic nucleotide-binding domain-containing protein 1 OS=Homo sapiens OX=9606 GN=CNBD1 PE=1 SV=1 g2673.t1 Q28181 41.308 581 2.83e-141 456.0 sp|Q28181|CNGB1_BOVIN Cyclic nucleotide-gated channel beta-1 OS=Bos taurus OX=9913 GN=CNGB1 PE=1 SV=1 CNGB1_BOVIN reviewed Cyclic nucleotide-gated channel beta-1 (CNG channel beta-1) (240 kDa protein of rod photoreceptor CNG-channel) (Cyclic nucleotide-gated cation channel 4) (CNG channel 4) (CNG-4) (CNG4) (Cyclic nucleotide-gated cation channel gamma) (Cyclic nucleotide-gated cation channel modulatory subunit) (Glutamic acid-rich protein) (GARP) Bos taurus (Bovine) GO:0001750; GO:0001895; GO:0005222; GO:0005223; GO:0005262; GO:0005272; GO:0005737; GO:0005886; GO:0006813; GO:0006814; GO:0006816; GO:0007601; GO:0007608; GO:0010628; GO:0017071; GO:0030552; GO:0030553; GO:0032991; GO:0042622; GO:0042802; GO:0042803; GO:0060090; GO:0098655; GO:0098804; GO:0120200; GO:0140313 calcium ion transport [GO:0006816]; monoatomic cation transmembrane transport [GO:0098655]; positive regulation of gene expression [GO:0010628]; potassium ion transport [GO:0006813]; retina homeostasis [GO:0001895]; sensory perception of smell [GO:0007608]; sodium ion transport [GO:0006814]; visual perception [GO:0007601] cytoplasm [GO:0005737]; intracellular cyclic nucleotide activated cation channel complex [GO:0017071]; non-motile cilium membrane [GO:0098804]; photoreceptor outer segment [GO:0001750]; photoreceptor outer segment membrane [GO:0042622]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; rod photoreceptor outer segment [GO:0120200] calcium channel activity [GO:0005262]; cAMP binding [GO:0030552]; cGMP binding [GO:0030553]; identical protein binding [GO:0042802]; intracellularly cAMP-activated cation channel activity [GO:0005222]; intracellularly cGMP-activated cation channel activity [GO:0005223]; molecular adaptor activity [GO:0060090]; molecular sequestering activity [GO:0140313]; protein homodimerization activity [GO:0042803]; sodium channel activity [GO:0005272] g2673.t2 Q28181 41.308 581 2.85e-140 461.0 sp|Q28181|CNGB1_BOVIN Cyclic nucleotide-gated channel beta-1 OS=Bos taurus OX=9913 GN=CNGB1 PE=1 SV=1 CNGB1_BOVIN reviewed Cyclic nucleotide-gated channel beta-1 (CNG channel beta-1) (240 kDa protein of rod photoreceptor CNG-channel) (Cyclic nucleotide-gated cation channel 4) (CNG channel 4) (CNG-4) (CNG4) (Cyclic nucleotide-gated cation channel gamma) (Cyclic nucleotide-gated cation channel modulatory subunit) (Glutamic acid-rich protein) (GARP) Bos taurus (Bovine) GO:0001750; GO:0001895; GO:0005222; GO:0005223; GO:0005262; GO:0005272; GO:0005737; GO:0005886; GO:0006813; GO:0006814; GO:0006816; GO:0007601; GO:0007608; GO:0010628; GO:0017071; GO:0030552; GO:0030553; GO:0032991; GO:0042622; GO:0042802; GO:0042803; GO:0060090; GO:0098655; GO:0098804; GO:0120200; GO:0140313 calcium ion transport [GO:0006816]; monoatomic cation transmembrane transport [GO:0098655]; positive regulation of gene expression [GO:0010628]; potassium ion transport [GO:0006813]; retina homeostasis [GO:0001895]; sensory perception of smell [GO:0007608]; sodium ion transport [GO:0006814]; visual perception [GO:0007601] cytoplasm [GO:0005737]; intracellular cyclic nucleotide activated cation channel complex [GO:0017071]; non-motile cilium membrane [GO:0098804]; photoreceptor outer segment [GO:0001750]; photoreceptor outer segment membrane [GO:0042622]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; rod photoreceptor outer segment [GO:0120200] calcium channel activity [GO:0005262]; cAMP binding [GO:0030552]; cGMP binding [GO:0030553]; identical protein binding [GO:0042802]; intracellularly cAMP-activated cation channel activity [GO:0005222]; intracellularly cGMP-activated cation channel activity [GO:0005223]; molecular adaptor activity [GO:0060090]; molecular sequestering activity [GO:0140313]; protein homodimerization activity [GO:0042803]; sodium channel activity [GO:0005272] g2675.t1 Q8MJY8 43.511 262 1.53e-73 228.0 sp|Q8MJY8|PGDH_MACFA 15-hydroxyprostaglandin dehydrogenase [NAD(+)] OS=Macaca fascicularis OX=9541 GN=HPGD PE=2 SV=1 PGDH_MACFA reviewed 15-hydroxyprostaglandin dehydrogenase [NAD(+)] (15-PGDH) (EC 1.1.1.141) (Eicosanoid/docosanoid dehydrogenase [NAD(+)]) (EC 1.1.1.-, EC 1.1.1.232) (Prostaglandin dehydrogenase 1) Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey) GO:0004957; GO:0005654; GO:0005737; GO:0005829; GO:0006693; GO:0007179; GO:0007565; GO:0007567; GO:0016323; GO:0016404; GO:0016616; GO:0030728; GO:0042802; GO:0045786; GO:0047034; GO:0051287; GO:0070403; GO:0070493; GO:0097070; GO:1905828 ductus arteriosus closure [GO:0097070]; female pregnancy [GO:0007565]; negative regulation of cell cycle [GO:0045786]; ovulation [GO:0030728]; parturition [GO:0007567]; prostaglandin metabolic process [GO:0006693]; regulation of prostaglandin catabolic process [GO:1905828]; thrombin-activated receptor signaling pathway [GO:0070493]; transforming growth factor beta receptor signaling pathway [GO:0007179] basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654] 15-hydroxyicosatetraenoate dehydrogenase activity [GO:0047034]; 15-hydroxyprostaglandin dehydrogenase (NAD+) activity [GO:0016404]; identical protein binding [GO:0042802]; NAD binding [GO:0051287]; NAD+ binding [GO:0070403]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]; prostaglandin E receptor activity [GO:0004957] g2678.t1 Q14159 27.171 714 9.62e-51 197.0 sp|Q14159|SPIDR_HUMAN DNA repair-scaffolding protein OS=Homo sapiens OX=9606 GN=SPIDR PE=1 SV=2 SPIDR_HUMAN reviewed DNA repair-scaffolding protein (Scaffolding protein involved in DNA repair) Homo sapiens (Human) GO:0000228; GO:0000724; GO:0005654; GO:0006974; GO:0010569; GO:0031334; GO:0070202; GO:0071479; GO:0072711; GO:0072757; GO:2000781 cellular response to camptothecin [GO:0072757]; cellular response to hydroxyurea [GO:0072711]; cellular response to ionizing radiation [GO:0071479]; DNA damage response [GO:0006974]; double-strand break repair via homologous recombination [GO:0000724]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of protein-containing complex assembly [GO:0031334]; regulation of double-strand break repair via homologous recombination [GO:0010569]; regulation of establishment of protein localization to chromosome [GO:0070202] nuclear chromosome [GO:0000228]; nucleoplasm [GO:0005654] g2680.t1 Q86WA6 50.593 253 1.31e-93 281.0 sp|Q86WA6|BPHL_HUMAN Serine hydrolase BPHL OS=Homo sapiens OX=9606 GN=BPHL PE=1 SV=1 BPHL_HUMAN reviewed Serine hydrolase BPHL (EC 3.1.-.-) (Biphenyl hydrolase-like protein) (Biphenyl hydrolase-related protein) (Bph-rp) (Breast epithelial mucin-associated antigen) (MCNAA) (L-homocysteine-thiolactonase BPHL) (Valacyclovir hydrolase) (VACVase) (Valacyclovirase) Homo sapiens (Human) GO:0005739; GO:0005741; GO:0006520; GO:0006805; GO:0009636; GO:0017171; GO:0046872; GO:0047658; GO:0050667 amino acid metabolic process [GO:0006520]; homocysteine metabolic process [GO:0050667]; response to toxic substance [GO:0009636]; xenobiotic metabolic process [GO:0006805] mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739] alpha-amino-acid esterase activity [GO:0047658]; metal ion binding [GO:0046872]; serine hydrolase activity [GO:0017171] g2681.t1 Q9DBI2 27.918 437 2.79e-29 127.0 sp|Q9DBI2|BBS10_MOUSE BBSome complex assembly protein BBS10 OS=Mus musculus OX=10090 GN=Bbs10 PE=2 SV=2 BBS10_MOUSE reviewed BBSome complex assembly protein BBS10 (Bardet-Biedl syndrome 10 protein homolog) Mus musculus (Mouse) GO:0005524; GO:0005929; GO:0006974; GO:0007601; GO:0008104; GO:0009416; GO:0019228; GO:0034976; GO:0042670; GO:0043254; GO:0043524; GO:0045494; GO:0046530; GO:0051131; GO:0060041; GO:0060221; GO:0061629; GO:1904390; GO:1905515 chaperone-mediated protein complex assembly [GO:0051131]; cone retinal bipolar cell differentiation [GO:1904390]; DNA damage response [GO:0006974]; intracellular protein localization [GO:0008104]; negative regulation of neuron apoptotic process [GO:0043524]; neuronal action potential [GO:0019228]; non-motile cilium assembly [GO:1905515]; photoreceptor cell differentiation [GO:0046530]; photoreceptor cell maintenance [GO:0045494]; regulation of protein-containing complex assembly [GO:0043254]; response to endoplasmic reticulum stress [GO:0034976]; response to light stimulus [GO:0009416]; retina development in camera-type eye [GO:0060041]; retinal cone cell differentiation [GO:0042670]; retinal rod cell differentiation [GO:0060221]; visual perception [GO:0007601] cilium [GO:0005929] ATP binding [GO:0005524]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629] g2683.t1 Q11205 51.101 227 2.45e-78 245.0 sp|Q11205|SIA4B_RAT CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 2 OS=Rattus norvegicus OX=10116 GN=St3gal2 PE=1 SV=1 SIA4B_RAT reviewed CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 2 (Alpha 2,3-ST 2) (Beta-galactoside alpha-2,3-sialyltransferase 2) (EC 2.4.3.4) (Gal-NAc6S) (Gal-beta-1,3-GalNAc-alpha-2,3-sialyltransferase) (Monosialoganglioside sialyltransferase) (EC 2.4.3.2) (ST3Gal II) (ST3GalII) (ST3GalA.2) (Sialyltransferase 4B) (SIAT4-B) Rattus norvegicus (Rat) GO:0000139; GO:0001574; GO:0001576; GO:0003836; GO:0005576; GO:0008373; GO:0009101; GO:0009247; GO:0009312; GO:0016020; GO:0032580; GO:0042803; GO:0047288; GO:0097503 ganglioside biosynthetic process [GO:0001574]; globoside biosynthetic process [GO:0001576]; glycolipid biosynthetic process [GO:0009247]; glycoprotein biosynthetic process [GO:0009101]; oligosaccharide biosynthetic process [GO:0009312]; sialylation [GO:0097503] extracellular region [GO:0005576]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; membrane [GO:0016020] beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminide alpha-2,3- sialyltransferase [GO:0047288]; beta-galactoside (CMP) alpha-2,3-sialyltransferase activity [GO:0003836]; protein homodimerization activity [GO:0042803]; sialyltransferase activity [GO:0008373] g2684.t1 B5XGE7 74.453 137 3.3300000000000002e-77 228.0 sp|B5XGE7|TPC2L_SALSA Trafficking protein particle complex subunit 2-like protein OS=Salmo salar OX=8030 GN=trappc2l PE=2 SV=1 g2685.t1 Q28165 73.585 159 7.62e-62 198.0 sp|Q28165|PABP2_BOVIN Polyadenylate-binding protein 2 OS=Bos taurus OX=9913 GN=PABPN1 PE=1 SV=3 PABP2_BOVIN reviewed Polyadenylate-binding protein 2 (PABP-2) (Poly(A)-binding protein 2) (Nuclear poly(A)-binding protein 1) (Poly(A)-binding protein II) (PABII) (Polyadenylate-binding nuclear protein 1) Bos taurus (Bovine) GO:0000165; GO:0005634; GO:0005737; GO:0006397; GO:0008143; GO:0016607; GO:0016973; GO:0042405; GO:0042802; GO:0070063; GO:0071222; GO:1904247; GO:1990904 cellular response to lipopolysaccharide [GO:0071222]; MAPK cascade [GO:0000165]; mRNA processing [GO:0006397]; poly(A)+ mRNA export from nucleus [GO:0016973]; positive regulation of polynucleotide adenylyltransferase activity [GO:1904247] cytoplasm [GO:0005737]; nuclear inclusion body [GO:0042405]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904] identical protein binding [GO:0042802]; poly(A) binding [GO:0008143]; RNA polymerase binding [GO:0070063] g2687.t1 P51665 78.521 284 1.09e-148 424.0 sp|P51665|PSMD7_HUMAN 26S proteasome non-ATPase regulatory subunit 7 OS=Homo sapiens OX=9606 GN=PSMD7 PE=1 SV=2 PSMD7_HUMAN reviewed 26S proteasome non-ATPase regulatory subunit 7 (26S proteasome regulatory subunit RPN8) (26S proteasome regulatory subunit S12) (Mov34 protein homolog) (Proteasome subunit p40) Homo sapiens (Human) GO:0000502; GO:0005576; GO:0005634; GO:0005654; GO:0005829; GO:0005838; GO:0016020; GO:0034774; GO:0042803; GO:0043161; GO:0070062; GO:1904813 proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; proteasome regulatory particle [GO:0005838]; secretory granule lumen [GO:0034774] protein homodimerization activity [GO:0042803] g2688.t1 O15943 34.564 2789 0.0 1199.0 sp|O15943|CADN_DROME Neural-cadherin OS=Drosophila melanogaster OX=7227 GN=CadN PE=1 SV=2 g2688.t1 O15943 24.91 1389 1.02e-46 191.0 sp|O15943|CADN_DROME Neural-cadherin OS=Drosophila melanogaster OX=7227 GN=CadN PE=1 SV=2 g2689.t1 Q1LUT1 42.5 560 2.08e-129 437.0 sp|Q1LUT1|EDC4_DANRE Enhancer of mRNA-decapping protein 4 OS=Danio rerio OX=7955 GN=edc4 PE=3 SV=1 g2689.t1 Q1LUT1 38.514 444 1.18e-76 283.0 sp|Q1LUT1|EDC4_DANRE Enhancer of mRNA-decapping protein 4 OS=Danio rerio OX=7955 GN=edc4 PE=3 SV=1 g2689.t2 Q1LUT1 42.5 560 2.87e-129 438.0 sp|Q1LUT1|EDC4_DANRE Enhancer of mRNA-decapping protein 4 OS=Danio rerio OX=7955 GN=edc4 PE=3 SV=1 g2689.t2 Q1LUT1 38.514 444 1.19e-76 283.0 sp|Q1LUT1|EDC4_DANRE Enhancer of mRNA-decapping protein 4 OS=Danio rerio OX=7955 GN=edc4 PE=3 SV=1 g2694.t1 Q86WA6 52.569 253 7.54e-101 300.0 sp|Q86WA6|BPHL_HUMAN Serine hydrolase BPHL OS=Homo sapiens OX=9606 GN=BPHL PE=1 SV=1 BPHL_HUMAN reviewed Serine hydrolase BPHL (EC 3.1.-.-) (Biphenyl hydrolase-like protein) (Biphenyl hydrolase-related protein) (Bph-rp) (Breast epithelial mucin-associated antigen) (MCNAA) (L-homocysteine-thiolactonase BPHL) (Valacyclovir hydrolase) (VACVase) (Valacyclovirase) Homo sapiens (Human) GO:0005739; GO:0005741; GO:0006520; GO:0006805; GO:0009636; GO:0017171; GO:0046872; GO:0047658; GO:0050667 amino acid metabolic process [GO:0006520]; homocysteine metabolic process [GO:0050667]; response to toxic substance [GO:0009636]; xenobiotic metabolic process [GO:0006805] mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739] alpha-amino-acid esterase activity [GO:0047658]; metal ion binding [GO:0046872]; serine hydrolase activity [GO:0017171] g2695.t1 Q0P5G1 39.551 445 4.37e-84 293.0 sp|Q0P5G1|TONSL_BOVIN Tonsoku-like protein OS=Bos taurus OX=9913 GN=TONSL PE=2 SV=1 g2696.t1 D4A615 57.447 141 3.65e-49 178.0 sp|D4A615|TONSL_RAT Tonsoku-like protein OS=Rattus norvegicus OX=10116 GN=Tonsl PE=3 SV=1 g2697.t1 A9JR78 48.357 426 8.59e-114 372.0 sp|A9JR78|TONSL_DANRE Tonsoku-like protein OS=Danio rerio OX=7955 GN=tonsl PE=2 SV=1 TONSL_DANRE reviewed Tonsoku-like protein (NF-kappa-B inhibitor-like protein 2) (Nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor-like 2) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000724; GO:0005737; GO:0031297; GO:0035861; GO:0042393; GO:0043596; GO:0140566 double-strand break repair via homologous recombination [GO:0000724]; replication fork processing [GO:0031297] cytoplasm [GO:0005737]; nuclear replication fork [GO:0043596]; site of double-strand break [GO:0035861] histone binding [GO:0042393]; histone reader activity [GO:0140566] g2698.t1 Q8IZ73 48.942 378 4.12e-123 380.0 sp|Q8IZ73|RUSD2_HUMAN Pseudouridylate synthase RPUSD2 OS=Homo sapiens OX=9606 GN=RPUSD2 PE=1 SV=2 g2701.t1 Q5JS54 54.867 113 4.6e-36 123.0 sp|Q5JS54|PSMG4_HUMAN Proteasome assembly chaperone 4 OS=Homo sapiens OX=9606 GN=PSMG4 PE=1 SV=2 g2703.t1 P86221 94.656 131 7.37e-91 268.0 sp|P86221|TBB4B_MESAU Tubulin beta-4B chain (Fragments) OS=Mesocricetus auratus OX=10036 GN=TUBB4B PE=1 SV=1 g2705.t1 P11833 99.296 284 0.0 595.0 sp|P11833|TBB_PARLI Tubulin beta chain OS=Paracentrotus lividus OX=7656 PE=2 SV=1 g2706.t1 P11833 91.973 299 0.0 526.0 sp|P11833|TBB_PARLI Tubulin beta chain OS=Paracentrotus lividus OX=7656 PE=2 SV=1 g2707.t1 P18699 98.529 68 8.96e-44 140.0 sp|P18699|TBB_LYMST Tubulin beta chain (Fragment) OS=Lymnaea stagnalis OX=6523 PE=2 SV=1 g2708.t1 P11833 99.302 430 0.0 858.0 sp|P11833|TBB_PARLI Tubulin beta chain OS=Paracentrotus lividus OX=7656 PE=2 SV=1 g2709.t1 P11833 98.372 430 0.0 851.0 sp|P11833|TBB_PARLI Tubulin beta chain OS=Paracentrotus lividus OX=7656 PE=2 SV=1 g2710.t1 P11833 98.837 430 0.0 853.0 sp|P11833|TBB_PARLI Tubulin beta chain OS=Paracentrotus lividus OX=7656 PE=2 SV=1 g2711.t1 P11833 99.07 430 0.0 857.0 sp|P11833|TBB_PARLI Tubulin beta chain OS=Paracentrotus lividus OX=7656 PE=2 SV=1 g2712.t1 P11833 99.534 429 0.0 858.0 sp|P11833|TBB_PARLI Tubulin beta chain OS=Paracentrotus lividus OX=7656 PE=2 SV=1 g2713.t1 Q4V8I4 52.507 379 8.059999999999999e-150 444.0 sp|Q4V8I4|DEFI8_RAT Differentially expressed in FDCP 8 homolog OS=Rattus norvegicus OX=10116 GN=Def8 PE=1 SV=1 g2713.t2 Q4V8I4 52.507 379 8.32e-150 444.0 sp|Q4V8I4|DEFI8_RAT Differentially expressed in FDCP 8 homolog OS=Rattus norvegicus OX=10116 GN=Def8 PE=1 SV=1 g2713.t3 Q4V8I4 50.126 397 6.0799999999999996e-146 435.0 sp|Q4V8I4|DEFI8_RAT Differentially expressed in FDCP 8 homolog OS=Rattus norvegicus OX=10116 GN=Def8 PE=1 SV=1 g2714.t1 Q7SZF1 32.87 216 9.429999999999999e-25 103.0 sp|Q7SZF1|CE022_DANRE UPF0489 protein C5orf22 homolog OS=Danio rerio OX=7955 GN=zgc:56556 PE=2 SV=1 g2715.t1 Q28H30 56.376 149 4.4299999999999996e-55 183.0 sp|Q28H30|CE022_XENTR UPF0489 protein C5orf22 homolog OS=Xenopus tropicalis OX=8364 GN=TEgg058p12.1 PE=2 SV=1 g2716.t1 Q5R698 56.577 631 0.0 765.0 sp|Q5R698|ANM5_PONAB Protein arginine N-methyltransferase 5 OS=Pongo abelii OX=9601 GN=PRMT5 PE=2 SV=3 ANM5_PONAB reviewed Protein arginine N-methyltransferase 5 (PRMT5) (EC 2.1.1.320) (Histone-arginine N-methyltransferase PRMT5) (Shk1 kinase-binding protein 1 homolog) (SKB1 homolog) Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0000387; GO:0003714; GO:0005634; GO:0005794; GO:0005829; GO:0006353; GO:0008327; GO:0016274; GO:0018216; GO:0032922; GO:0034709; GO:0035097; GO:0035243; GO:0042118; GO:0044020; GO:0070888; GO:0090161 circadian regulation of gene expression [GO:0032922]; DNA-templated transcription termination [GO:0006353]; endothelial cell activation [GO:0042118]; Golgi ribbon formation [GO:0090161]; peptidyl-arginine methylation [GO:0018216]; spliceosomal snRNP assembly [GO:0000387] cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; histone methyltransferase complex [GO:0035097]; methylosome [GO:0034709]; nucleus [GO:0005634] E-box binding [GO:0070888]; histone H4R3 methyltransferase activity [GO:0044020]; methyl-CpG binding [GO:0008327]; protein-arginine N-methyltransferase activity [GO:0016274]; protein-arginine omega-N symmetric methyltransferase activity [GO:0035243]; transcription corepressor activity [GO:0003714] g2717.t1 Q9HCJ6 48.958 384 9.29e-135 394.0 sp|Q9HCJ6|VAT1L_HUMAN Synaptic vesicle membrane protein VAT-1 homolog-like OS=Homo sapiens OX=9606 GN=VAT1L PE=1 SV=2 g2718.t1 Q5NDE3 42.533 529 6.19e-149 444.0 sp|Q5NDE3|PMGT2_TETNG Protein O-linked-mannose beta-1,4-N-acetylglucosaminyltransferase 2 OS=Tetraodon nigroviridis OX=99883 GN=pomgnt2 PE=2 SV=1 PMGT2_TETNG reviewed Protein O-linked-mannose beta-1,4-N-acetylglucosaminyltransferase 2 (POMGnT2) (EC 2.4.1.312) (Extracellular O-linked N-acetylglucosamine transferase-like) (Glycosyltransferase-like domain-containing protein 2) Tetraodon nigroviridis (Spotted green pufferfish) (Chelonodon nigroviridis) GO:0001764; GO:0005783; GO:0005789; GO:0006493; GO:0007420; GO:0008375; GO:0035269; GO:0055001; GO:0060041; GO:0097363 brain development [GO:0007420]; muscle cell development [GO:0055001]; neuron migration [GO:0001764]; protein O-linked glycosylation [GO:0006493]; protein O-linked glycosylation via mannose [GO:0035269]; retina development in camera-type eye [GO:0060041] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789] acetylglucosaminyltransferase activity [GO:0008375]; protein O-acetylglucosaminyltransferase activity [GO:0097363] g2720.t1 Q08999 50.0 280 2.64e-74 250.0 sp|Q08999|RBL2_HUMAN Retinoblastoma-like protein 2 OS=Homo sapiens OX=9606 GN=RBL2 PE=1 SV=3 RBL2_HUMAN reviewed Retinoblastoma-like protein 2 (130 kDa retinoblastoma-associated protein) (p130) (Retinoblastoma-related protein 2) (RBR-2) (pRb2) Homo sapiens (Human) GO:0000785; GO:0000977; GO:0005654; GO:0005667; GO:0005694; GO:0005730; GO:0005829; GO:0006325; GO:0006357; GO:0010629; GO:0030154; GO:0043550; GO:0070062; GO:1990841; GO:2000134 cell differentiation [GO:0030154]; chromatin organization [GO:0006325]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of gene expression [GO:0010629]; regulation of lipid kinase activity [GO:0043550]; regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; chromosome [GO:0005694]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; transcription regulator complex [GO:0005667] promoter-specific chromatin binding [GO:1990841]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977] g2721.t1 D3ZS28 56.221 651 0.0 732.0 sp|D3ZS28|RBL1_RAT Retinoblastoma-like protein 1 OS=Rattus norvegicus OX=10116 GN=Rbl1 PE=1 SV=4 g2723.t1 P35668 37.778 450 1.01e-98 305.0 sp|P35668|GSHB_XENLA Glutathione synthetase OS=Xenopus laevis OX=8355 GN=gss PE=2 SV=1 g2727.t1 O35049 30.601 183 5.81e-25 112.0 sp|O35049|NSMA2_RAT Sphingomyelin phosphodiesterase 3 OS=Rattus norvegicus OX=10116 GN=Smpd3 PE=1 SV=2 NSMA2_RAT reviewed Sphingomyelin phosphodiesterase 3 (EC 3.1.4.12) (Confluent 3Y1 cell-associated protein 1) (Neutral sphingomyelinase 2) (nSMase-2) (nSMase2) (Neutral sphingomyelinase II) Rattus norvegicus (Rat) GO:0000137; GO:0000139; GO:0001501; GO:0001503; GO:0001786; GO:0001958; GO:0002063; GO:0002244; GO:0002685; GO:0003433; GO:0004767; GO:0005576; GO:0005737; GO:0005794; GO:0005886; GO:0006665; GO:0006672; GO:0006684; GO:0006685; GO:0007165; GO:0008081; GO:0014824; GO:0015774; GO:0030072; GO:0030282; GO:0030324; GO:0030509; GO:0032963; GO:0034614; GO:0035264; GO:0042802; GO:0045429; GO:0045840; GO:0046872; GO:0048008; GO:0048286; GO:0048661; GO:0051216; GO:0051481; GO:0051898; GO:0060348; GO:0060541; GO:0061035; GO:0061751; GO:0070300; GO:0070301; GO:0070314; GO:0071286; GO:0071347; GO:0071356; GO:0071461; GO:0071897; GO:0085029; GO:0090494; GO:0090520; GO:0097187; GO:0098868; GO:0140014; GO:0140052; GO:1900125; GO:1900126; GO:1901224; GO:1901653; GO:1903543; GO:2000304 artery smooth muscle contraction [GO:0014824]; BMP signaling pathway [GO:0030509]; bone development [GO:0060348]; bone growth [GO:0098868]; bone mineralization [GO:0030282]; cartilage development [GO:0051216]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to interleukin-1 [GO:0071347]; cellular response to magnesium ion [GO:0071286]; cellular response to oxidised low-density lipoprotein particle stimulus [GO:0140052]; cellular response to peptide [GO:1901653]; cellular response to reactive oxygen species [GO:0034614]; cellular response to redox state [GO:0071461]; cellular response to tumor necrosis factor [GO:0071356]; ceramide metabolic process [GO:0006672]; chondrocyte development [GO:0002063]; chondrocyte development involved in endochondral bone morphogenesis [GO:0003433]; collagen metabolic process [GO:0032963]; dentinogenesis [GO:0097187]; DNA biosynthetic process [GO:0071897]; dopamine uptake [GO:0090494]; endochondral ossification [GO:0001958]; extracellular matrix assembly [GO:0085029]; G1 to G0 transition [GO:0070314]; hematopoietic progenitor cell differentiation [GO:0002244]; lung alveolus development [GO:0048286]; lung development [GO:0030324]; mitotic nuclear division [GO:0140014]; multicellular organism growth [GO:0035264]; negative regulation of cytosolic calcium ion concentration [GO:0051481]; negative regulation of hyaluronan biosynthetic process [GO:1900126]; negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051898]; ossification [GO:0001503]; peptide hormone secretion [GO:0030072]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; polysaccharide transport [GO:0015774]; positive regulation of ceramide biosynthetic process [GO:2000304]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of mitotic nuclear division [GO:0045840]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of non-canonical NF-kappaB signal transduction [GO:1901224]; positive regulation of smooth muscle cell proliferation [GO:0048661]; regulation of cartilage development [GO:0061035]; regulation of hyaluronan biosynthetic process [GO:1900125]; regulation of leukocyte migration [GO:0002685]; respiratory system development [GO:0060541]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; sphingolipid mediated signaling pathway [GO:0090520]; sphingolipid metabolic process [GO:0006665]; sphingomyelin catabolic process [GO:0006685]; sphingomyelin metabolic process [GO:0006684] cytoplasm [GO:0005737]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; Golgi cis cisterna [GO:0000137]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886] identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; neutral sphingomyelin phosphodiesterase activity [GO:0061751]; phosphatidic acid binding [GO:0070300]; phosphatidylserine binding [GO:0001786]; phosphoric diester hydrolase activity [GO:0008081]; sphingomyelin phosphodiesterase activity [GO:0004767] g2727.t1 O35049 42.857 133 2.86e-22 103.0 sp|O35049|NSMA2_RAT Sphingomyelin phosphodiesterase 3 OS=Rattus norvegicus OX=10116 GN=Smpd3 PE=1 SV=2 NSMA2_RAT reviewed Sphingomyelin phosphodiesterase 3 (EC 3.1.4.12) (Confluent 3Y1 cell-associated protein 1) (Neutral sphingomyelinase 2) (nSMase-2) (nSMase2) (Neutral sphingomyelinase II) Rattus norvegicus (Rat) GO:0000137; GO:0000139; GO:0001501; GO:0001503; GO:0001786; GO:0001958; GO:0002063; GO:0002244; GO:0002685; GO:0003433; GO:0004767; GO:0005576; GO:0005737; GO:0005794; GO:0005886; GO:0006665; GO:0006672; GO:0006684; GO:0006685; GO:0007165; GO:0008081; GO:0014824; GO:0015774; GO:0030072; GO:0030282; GO:0030324; GO:0030509; GO:0032963; GO:0034614; GO:0035264; GO:0042802; GO:0045429; GO:0045840; GO:0046872; GO:0048008; GO:0048286; GO:0048661; GO:0051216; GO:0051481; GO:0051898; GO:0060348; GO:0060541; GO:0061035; GO:0061751; GO:0070300; GO:0070301; GO:0070314; GO:0071286; GO:0071347; GO:0071356; GO:0071461; GO:0071897; GO:0085029; GO:0090494; GO:0090520; GO:0097187; GO:0098868; GO:0140014; GO:0140052; GO:1900125; GO:1900126; GO:1901224; GO:1901653; GO:1903543; GO:2000304 artery smooth muscle contraction [GO:0014824]; BMP signaling pathway [GO:0030509]; bone development [GO:0060348]; bone growth [GO:0098868]; bone mineralization [GO:0030282]; cartilage development [GO:0051216]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to interleukin-1 [GO:0071347]; cellular response to magnesium ion [GO:0071286]; cellular response to oxidised low-density lipoprotein particle stimulus [GO:0140052]; cellular response to peptide [GO:1901653]; cellular response to reactive oxygen species [GO:0034614]; cellular response to redox state [GO:0071461]; cellular response to tumor necrosis factor [GO:0071356]; ceramide metabolic process [GO:0006672]; chondrocyte development [GO:0002063]; chondrocyte development involved in endochondral bone morphogenesis [GO:0003433]; collagen metabolic process [GO:0032963]; dentinogenesis [GO:0097187]; DNA biosynthetic process [GO:0071897]; dopamine uptake [GO:0090494]; endochondral ossification [GO:0001958]; extracellular matrix assembly [GO:0085029]; G1 to G0 transition [GO:0070314]; hematopoietic progenitor cell differentiation [GO:0002244]; lung alveolus development [GO:0048286]; lung development [GO:0030324]; mitotic nuclear division [GO:0140014]; multicellular organism growth [GO:0035264]; negative regulation of cytosolic calcium ion concentration [GO:0051481]; negative regulation of hyaluronan biosynthetic process [GO:1900126]; negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051898]; ossification [GO:0001503]; peptide hormone secretion [GO:0030072]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; polysaccharide transport [GO:0015774]; positive regulation of ceramide biosynthetic process [GO:2000304]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of mitotic nuclear division [GO:0045840]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of non-canonical NF-kappaB signal transduction [GO:1901224]; positive regulation of smooth muscle cell proliferation [GO:0048661]; regulation of cartilage development [GO:0061035]; regulation of hyaluronan biosynthetic process [GO:1900125]; regulation of leukocyte migration [GO:0002685]; respiratory system development [GO:0060541]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; sphingolipid mediated signaling pathway [GO:0090520]; sphingolipid metabolic process [GO:0006665]; sphingomyelin catabolic process [GO:0006685]; sphingomyelin metabolic process [GO:0006684] cytoplasm [GO:0005737]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; Golgi cis cisterna [GO:0000137]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886] identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; neutral sphingomyelin phosphodiesterase activity [GO:0061751]; phosphatidic acid binding [GO:0070300]; phosphatidylserine binding [GO:0001786]; phosphoric diester hydrolase activity [GO:0008081]; sphingomyelin phosphodiesterase activity [GO:0004767] g2727.t2 O35049 30.601 183 5.81e-25 111.0 sp|O35049|NSMA2_RAT Sphingomyelin phosphodiesterase 3 OS=Rattus norvegicus OX=10116 GN=Smpd3 PE=1 SV=2 NSMA2_RAT reviewed Sphingomyelin phosphodiesterase 3 (EC 3.1.4.12) (Confluent 3Y1 cell-associated protein 1) (Neutral sphingomyelinase 2) (nSMase-2) (nSMase2) (Neutral sphingomyelinase II) Rattus norvegicus (Rat) GO:0000137; GO:0000139; GO:0001501; GO:0001503; GO:0001786; GO:0001958; GO:0002063; GO:0002244; GO:0002685; GO:0003433; GO:0004767; GO:0005576; GO:0005737; GO:0005794; GO:0005886; GO:0006665; GO:0006672; GO:0006684; GO:0006685; GO:0007165; GO:0008081; GO:0014824; GO:0015774; GO:0030072; GO:0030282; GO:0030324; GO:0030509; GO:0032963; GO:0034614; GO:0035264; GO:0042802; GO:0045429; GO:0045840; GO:0046872; GO:0048008; GO:0048286; GO:0048661; GO:0051216; GO:0051481; GO:0051898; GO:0060348; GO:0060541; GO:0061035; GO:0061751; GO:0070300; GO:0070301; GO:0070314; GO:0071286; GO:0071347; GO:0071356; GO:0071461; GO:0071897; GO:0085029; GO:0090494; GO:0090520; GO:0097187; GO:0098868; GO:0140014; GO:0140052; GO:1900125; GO:1900126; GO:1901224; GO:1901653; GO:1903543; GO:2000304 artery smooth muscle contraction [GO:0014824]; BMP signaling pathway [GO:0030509]; bone development [GO:0060348]; bone growth [GO:0098868]; bone mineralization [GO:0030282]; cartilage development [GO:0051216]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to interleukin-1 [GO:0071347]; cellular response to magnesium ion [GO:0071286]; cellular response to oxidised low-density lipoprotein particle stimulus [GO:0140052]; cellular response to peptide [GO:1901653]; cellular response to reactive oxygen species [GO:0034614]; cellular response to redox state [GO:0071461]; cellular response to tumor necrosis factor [GO:0071356]; ceramide metabolic process [GO:0006672]; chondrocyte development [GO:0002063]; chondrocyte development involved in endochondral bone morphogenesis [GO:0003433]; collagen metabolic process [GO:0032963]; dentinogenesis [GO:0097187]; DNA biosynthetic process [GO:0071897]; dopamine uptake [GO:0090494]; endochondral ossification [GO:0001958]; extracellular matrix assembly [GO:0085029]; G1 to G0 transition [GO:0070314]; hematopoietic progenitor cell differentiation [GO:0002244]; lung alveolus development [GO:0048286]; lung development [GO:0030324]; mitotic nuclear division [GO:0140014]; multicellular organism growth [GO:0035264]; negative regulation of cytosolic calcium ion concentration [GO:0051481]; negative regulation of hyaluronan biosynthetic process [GO:1900126]; negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051898]; ossification [GO:0001503]; peptide hormone secretion [GO:0030072]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; polysaccharide transport [GO:0015774]; positive regulation of ceramide biosynthetic process [GO:2000304]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of mitotic nuclear division [GO:0045840]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of non-canonical NF-kappaB signal transduction [GO:1901224]; positive regulation of smooth muscle cell proliferation [GO:0048661]; regulation of cartilage development [GO:0061035]; regulation of hyaluronan biosynthetic process [GO:1900125]; regulation of leukocyte migration [GO:0002685]; respiratory system development [GO:0060541]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; sphingolipid mediated signaling pathway [GO:0090520]; sphingolipid metabolic process [GO:0006665]; sphingomyelin catabolic process [GO:0006685]; sphingomyelin metabolic process [GO:0006684] cytoplasm [GO:0005737]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; Golgi cis cisterna [GO:0000137]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886] identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; neutral sphingomyelin phosphodiesterase activity [GO:0061751]; phosphatidic acid binding [GO:0070300]; phosphatidylserine binding [GO:0001786]; phosphoric diester hydrolase activity [GO:0008081]; sphingomyelin phosphodiesterase activity [GO:0004767] g2728.t1 Q7ZXR7 34.135 208 9.009999999999999e-23 107.0 sp|Q7ZXR7|UB10B_XENLA Ubiquitin carboxyl-terminal hydrolase 10-B OS=Xenopus laevis OX=8355 GN=usp10-b PE=2 SV=1 UB10B_XENLA reviewed Ubiquitin carboxyl-terminal hydrolase 10-B (EC 3.4.19.12) (Deubiquitinating enzyme 10-B) (Ubiquitin thioesterase 10-B) (Ubiquitin-specific-processing protease 10-B) Xenopus laevis (African clawed frog) GO:0002039; GO:0004197; GO:0004843; GO:0005634; GO:0005737; GO:0005769; GO:0005829; GO:0006281; GO:0006508; GO:0006914; GO:0006974; GO:0010506; GO:0016579; GO:0030330; GO:0031647; GO:0043124; GO:0044325; GO:0062030; GO:0071347; GO:0072344 autophagy [GO:0006914]; cellular response to interleukin-1 [GO:0071347]; DNA damage response [GO:0006974]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; DNA repair [GO:0006281]; negative regulation of canonical NF-kappaB signal transduction [GO:0043124]; negative regulation of stress granule assembly [GO:0062030]; protein deubiquitination [GO:0016579]; proteolysis [GO:0006508]; regulation of autophagy [GO:0010506]; regulation of protein stability [GO:0031647]; rescue of stalled ribosome [GO:0072344] cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; nucleus [GO:0005634] cysteine-type deubiquitinase activity [GO:0004843]; cysteine-type endopeptidase activity [GO:0004197]; p53 binding [GO:0002039]; transmembrane transporter binding [GO:0044325] g2729.t1 Q5ZJN4 71.429 70 2.55e-29 100.0 sp|Q5ZJN4|UBP10_CHICK Ubiquitin carboxyl-terminal hydrolase 10 OS=Gallus gallus OX=9031 GN=USP10 PE=2 SV=1 UBP10_CHICK reviewed Ubiquitin carboxyl-terminal hydrolase 10 (EC 3.4.19.12) (Deubiquitinating enzyme 10) (Ubiquitin thioesterase 10) (Ubiquitin-specific-processing protease 10) Gallus gallus (Chicken) GO:0002039; GO:0004197; GO:0004843; GO:0005634; GO:0005737; GO:0005769; GO:0005829; GO:0006281; GO:0006508; GO:0006914; GO:0006974; GO:0010506; GO:0016579; GO:0030330; GO:0031647; GO:0043124; GO:0044325; GO:0062030; GO:0071347; GO:0072344 autophagy [GO:0006914]; cellular response to interleukin-1 [GO:0071347]; DNA damage response [GO:0006974]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; DNA repair [GO:0006281]; negative regulation of canonical NF-kappaB signal transduction [GO:0043124]; negative regulation of stress granule assembly [GO:0062030]; protein deubiquitination [GO:0016579]; proteolysis [GO:0006508]; regulation of autophagy [GO:0010506]; regulation of protein stability [GO:0031647]; rescue of stalled ribosome [GO:0072344] cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; nucleus [GO:0005634] cysteine-type deubiquitinase activity [GO:0004843]; cysteine-type endopeptidase activity [GO:0004197]; p53 binding [GO:0002039]; transmembrane transporter binding [GO:0044325] g2729.t1 Q5ZJN4 56.41 39 2.55e-29 48.1 sp|Q5ZJN4|UBP10_CHICK Ubiquitin carboxyl-terminal hydrolase 10 OS=Gallus gallus OX=9031 GN=USP10 PE=2 SV=1 UBP10_CHICK reviewed Ubiquitin carboxyl-terminal hydrolase 10 (EC 3.4.19.12) (Deubiquitinating enzyme 10) (Ubiquitin thioesterase 10) (Ubiquitin-specific-processing protease 10) Gallus gallus (Chicken) GO:0002039; GO:0004197; GO:0004843; GO:0005634; GO:0005737; GO:0005769; GO:0005829; GO:0006281; GO:0006508; GO:0006914; GO:0006974; GO:0010506; GO:0016579; GO:0030330; GO:0031647; GO:0043124; GO:0044325; GO:0062030; GO:0071347; GO:0072344 autophagy [GO:0006914]; cellular response to interleukin-1 [GO:0071347]; DNA damage response [GO:0006974]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; DNA repair [GO:0006281]; negative regulation of canonical NF-kappaB signal transduction [GO:0043124]; negative regulation of stress granule assembly [GO:0062030]; protein deubiquitination [GO:0016579]; proteolysis [GO:0006508]; regulation of autophagy [GO:0010506]; regulation of protein stability [GO:0031647]; rescue of stalled ribosome [GO:0072344] cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; nucleus [GO:0005634] cysteine-type deubiquitinase activity [GO:0004843]; cysteine-type endopeptidase activity [GO:0004197]; p53 binding [GO:0002039]; transmembrane transporter binding [GO:0044325] g2730.t1 Q2NL57 56.122 98 1.1400000000000001e-33 125.0 sp|Q2NL57|UB10A_XENLA Ubiquitin carboxyl-terminal hydrolase 10-A OS=Xenopus laevis OX=8355 GN=usp10-a PE=2 SV=1 UB10A_XENLA reviewed Ubiquitin carboxyl-terminal hydrolase 10-A (EC 3.4.19.12) (Deubiquitinating enzyme 10-A) (Ubiquitin thioesterase 10-A) (Ubiquitin-specific-processing protease 10-A) Xenopus laevis (African clawed frog) GO:0002039; GO:0004197; GO:0004843; GO:0005634; GO:0005737; GO:0005769; GO:0005829; GO:0006281; GO:0006508; GO:0006914; GO:0006974; GO:0010506; GO:0016579; GO:0030330; GO:0031647; GO:0043124; GO:0044325; GO:0062030; GO:0071347; GO:0072344 autophagy [GO:0006914]; cellular response to interleukin-1 [GO:0071347]; DNA damage response [GO:0006974]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; DNA repair [GO:0006281]; negative regulation of canonical NF-kappaB signal transduction [GO:0043124]; negative regulation of stress granule assembly [GO:0062030]; protein deubiquitination [GO:0016579]; proteolysis [GO:0006508]; regulation of autophagy [GO:0010506]; regulation of protein stability [GO:0031647]; rescue of stalled ribosome [GO:0072344] cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; nucleus [GO:0005634] cysteine-type deubiquitinase activity [GO:0004843]; cysteine-type endopeptidase activity [GO:0004197]; p53 binding [GO:0002039]; transmembrane transporter binding [GO:0044325] g2731.t1 Q96KP1 40.504 953 0.0 665.0 sp|Q96KP1|EXOC2_HUMAN Exocyst complex component 2 OS=Homo sapiens OX=9606 GN=EXOC2 PE=1 SV=1 g2731.t2 Q96KP1 45.223 314 6.15e-76 254.0 sp|Q96KP1|EXOC2_HUMAN Exocyst complex component 2 OS=Homo sapiens OX=9606 GN=EXOC2 PE=1 SV=1 g2731.t3 O54921 38.11 635 4.6800000000000004e-130 417.0 sp|O54921|EXOC2_RAT Exocyst complex component 2 OS=Rattus norvegicus OX=10116 GN=Exoc2 PE=1 SV=1 g2733.t1 D3YXG0 43.045 381 4.34e-84 300.0 sp|D3YXG0|HMCN1_MOUSE Hemicentin-1 OS=Mus musculus OX=10090 GN=Hmcn1 PE=1 SV=1 HMCN1_MOUSE reviewed Hemicentin-1 (Fibulin-6) (FIBL-6) Mus musculus (Mouse) GO:0005509; GO:0005576; GO:0005604; GO:0005737; GO:0005886; GO:0005912; GO:0005927; GO:0005938; GO:0007156; GO:0007157; GO:0009617; GO:0030036; GO:0030054; GO:0031012; GO:0032154; GO:0051301; GO:0071711; GO:0098631 actin cytoskeleton organization [GO:0030036]; basement membrane organization [GO:0071711]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617] adherens junction [GO:0005912]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; muscle tendon junction [GO:0005927]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; cell adhesion mediator activity [GO:0098631] g2733.t1 D3YXG0 41.408 355 4.05e-79 285.0 sp|D3YXG0|HMCN1_MOUSE Hemicentin-1 OS=Mus musculus OX=10090 GN=Hmcn1 PE=1 SV=1 HMCN1_MOUSE reviewed Hemicentin-1 (Fibulin-6) (FIBL-6) Mus musculus (Mouse) GO:0005509; GO:0005576; GO:0005604; GO:0005737; GO:0005886; GO:0005912; GO:0005927; GO:0005938; GO:0007156; GO:0007157; GO:0009617; GO:0030036; GO:0030054; GO:0031012; GO:0032154; GO:0051301; GO:0071711; GO:0098631 actin cytoskeleton organization [GO:0030036]; basement membrane organization [GO:0071711]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617] adherens junction [GO:0005912]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; muscle tendon junction [GO:0005927]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; cell adhesion mediator activity [GO:0098631] g2736.t1 Q5I0D7 62.947 475 0.0 577.0 sp|Q5I0D7|PEPD_RAT Xaa-Pro dipeptidase OS=Rattus norvegicus OX=10116 GN=Pepd PE=2 SV=1 g2737.t1 Q6PLK3 53.209 483 0.0 538.0 sp|Q6PLK3|AOFB_PIG Amine oxidase [flavin-containing] B OS=Sus scrofa OX=9823 GN=MAOB PE=2 SV=3 AOFB_PIG reviewed Amine oxidase [flavin-containing] B (EC 1.4.3.21) (EC 1.4.3.4) (Monoamine oxidase type B) (MAO-B) Sus scrofa (Pig) GO:0005739; GO:0005741; GO:0006576; GO:0008131; GO:0050660; GO:0097621 biogenic amine metabolic process [GO:0006576] mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739] flavin adenine dinucleotide binding [GO:0050660]; monoamine oxidase activity [GO:0097621]; primary methylamine oxidase activity [GO:0008131] g2739.t1 P56945 28.617 933 2.43e-82 286.0 sp|P56945|BCAR1_HUMAN Breast cancer anti-estrogen resistance protein 1 OS=Homo sapiens OX=9606 GN=BCAR1 PE=1 SV=2 BCAR1_HUMAN reviewed Breast cancer anti-estrogen resistance protein 1 (CRK-associated substrate) (Cas scaffolding protein family member 1) (p130cas) Homo sapiens (Human) GO:0001558; GO:0001726; GO:0005737; GO:0005829; GO:0005925; GO:0007015; GO:0007155; GO:0007169; GO:0007173; GO:0007186; GO:0007229; GO:0008286; GO:0010595; GO:0015629; GO:0016020; GO:0016477; GO:0017124; GO:0019901; GO:0030027; GO:0030335; GO:0030424; GO:0035729; GO:0042981; GO:0048008; GO:0048010; GO:0048011; GO:0048012; GO:0050851; GO:0050852; GO:0050853; GO:0051301; GO:0060326; GO:0086100 actin filament organization [GO:0007015]; antigen receptor-mediated signaling pathway [GO:0050851]; B cell receptor signaling pathway [GO:0050853]; cell adhesion [GO:0007155]; cell chemotaxis [GO:0060326]; cell division [GO:0051301]; cell migration [GO:0016477]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; endothelin receptor signaling pathway [GO:0086100]; epidermal growth factor receptor signaling pathway [GO:0007173]; G protein-coupled receptor signaling pathway [GO:0007186]; hepatocyte growth factor receptor signaling pathway [GO:0048012]; insulin receptor signaling pathway [GO:0008286]; integrin-mediated signaling pathway [GO:0007229]; neurotrophin TRK receptor signaling pathway [GO:0048011]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of cell migration [GO:0030335]; positive regulation of endothelial cell migration [GO:0010595]; regulation of apoptotic process [GO:0042981]; regulation of cell growth [GO:0001558]; T cell receptor signaling pathway [GO:0050852]; vascular endothelial growth factor receptor signaling pathway [GO:0048010] actin cytoskeleton [GO:0015629]; axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; membrane [GO:0016020]; ruffle [GO:0001726] protein kinase binding [GO:0019901]; SH3 domain binding [GO:0017124] g2740.t1 A0A8J8 37.946 224 1.33e-34 134.0 sp|A0A8J8|ANGP2_CANLF Angiopoietin-2 OS=Canis lupus familiaris OX=9615 GN=ANGPT2 PE=2 SV=1 ANGP2_CANLF reviewed Angiopoietin-2 (ANG-2) Canis lupus familiaris (Dog) (Canis familiaris) GO:0001525; GO:0005615; GO:0007596; GO:0010467; GO:0010812; GO:0016525; GO:0030154; GO:0030195; GO:0030971; GO:0043537; GO:0046872; GO:0048014; GO:0048018; GO:0050820; GO:0050928 angiogenesis [GO:0001525]; blood coagulation [GO:0007596]; cell differentiation [GO:0030154]; gene expression [GO:0010467]; negative regulation of angiogenesis [GO:0016525]; negative regulation of blood coagulation [GO:0030195]; negative regulation of blood vessel endothelial cell migration [GO:0043537]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of positive chemotaxis [GO:0050928]; positive regulation of coagulation [GO:0050820]; Tie signaling pathway [GO:0048014] extracellular space [GO:0005615] metal ion binding [GO:0046872]; receptor ligand activity [GO:0048018]; receptor tyrosine kinase binding [GO:0030971] g2742.t1 Q2YDM5 39.791 191 4.8300000000000004e-37 130.0 sp|Q2YDM5|SMIP8_BOVIN Sperm microtubule inner protein 8 OS=Bos taurus OX=9913 GN=SPMIP8 PE=1 SV=2 g2744.t1 P12027 41.259 429 1.3399999999999998e-54 204.0 sp|P12027|PSGP_ONCMY Polysialoglycoprotein OS=Oncorhynchus mykiss OX=8022 PE=1 SV=2 g2744.t1 P12027 40.941 425 2.3999999999999998e-54 203.0 sp|P12027|PSGP_ONCMY Polysialoglycoprotein OS=Oncorhynchus mykiss OX=8022 PE=1 SV=2 g2744.t1 P12027 40.878 433 2.4199999999999997e-54 203.0 sp|P12027|PSGP_ONCMY Polysialoglycoprotein OS=Oncorhynchus mykiss OX=8022 PE=1 SV=2 g2744.t1 P12027 41.093 421 1.53e-53 201.0 sp|P12027|PSGP_ONCMY Polysialoglycoprotein OS=Oncorhynchus mykiss OX=8022 PE=1 SV=2 g2744.t1 P12027 40.647 433 2.47e-53 200.0 sp|P12027|PSGP_ONCMY Polysialoglycoprotein OS=Oncorhynchus mykiss OX=8022 PE=1 SV=2 g2744.t1 P12027 40.783 434 8.05e-53 199.0 sp|P12027|PSGP_ONCMY Polysialoglycoprotein OS=Oncorhynchus mykiss OX=8022 PE=1 SV=2 g2744.t1 P12027 40.802 424 1.94e-52 197.0 sp|P12027|PSGP_ONCMY Polysialoglycoprotein OS=Oncorhynchus mykiss OX=8022 PE=1 SV=2 g2744.t1 P12027 40.639 438 5.9299999999999995e-52 196.0 sp|P12027|PSGP_ONCMY Polysialoglycoprotein OS=Oncorhynchus mykiss OX=8022 PE=1 SV=2 g2744.t1 P12027 41.463 410 1.17e-51 195.0 sp|P12027|PSGP_ONCMY Polysialoglycoprotein OS=Oncorhynchus mykiss OX=8022 PE=1 SV=2 g2744.t1 P12027 40.0 440 1.73e-51 194.0 sp|P12027|PSGP_ONCMY Polysialoglycoprotein OS=Oncorhynchus mykiss OX=8022 PE=1 SV=2 g2744.t1 P12027 41.235 405 1.99e-49 189.0 sp|P12027|PSGP_ONCMY Polysialoglycoprotein OS=Oncorhynchus mykiss OX=8022 PE=1 SV=2 g2744.t1 P12027 40.38 421 3.18e-49 188.0 sp|P12027|PSGP_ONCMY Polysialoglycoprotein OS=Oncorhynchus mykiss OX=8022 PE=1 SV=2 g2744.t1 P12027 38.303 436 3e-48 185.0 sp|P12027|PSGP_ONCMY Polysialoglycoprotein OS=Oncorhynchus mykiss OX=8022 PE=1 SV=2 g2744.t1 P12027 38.849 417 3.86e-48 185.0 sp|P12027|PSGP_ONCMY Polysialoglycoprotein OS=Oncorhynchus mykiss OX=8022 PE=1 SV=2 g2744.t1 P12027 38.106 433 4.36e-48 184.0 sp|P12027|PSGP_ONCMY Polysialoglycoprotein OS=Oncorhynchus mykiss OX=8022 PE=1 SV=2 g2744.t1 P12027 37.963 432 6.04e-48 184.0 sp|P12027|PSGP_ONCMY Polysialoglycoprotein OS=Oncorhynchus mykiss OX=8022 PE=1 SV=2 g2744.t1 P12027 38.369 417 2.67e-47 182.0 sp|P12027|PSGP_ONCMY Polysialoglycoprotein OS=Oncorhynchus mykiss OX=8022 PE=1 SV=2 g2744.t1 P12027 38.588 425 1.02e-44 174.0 sp|P12027|PSGP_ONCMY Polysialoglycoprotein OS=Oncorhynchus mykiss OX=8022 PE=1 SV=2 g2744.t1 P12027 38.673 437 1.53e-44 174.0 sp|P12027|PSGP_ONCMY Polysialoglycoprotein OS=Oncorhynchus mykiss OX=8022 PE=1 SV=2 g2744.t1 P12027 37.907 430 1.4799999999999998e-42 168.0 sp|P12027|PSGP_ONCMY Polysialoglycoprotein OS=Oncorhynchus mykiss OX=8022 PE=1 SV=2 g2744.t1 P12027 38.242 421 2.36e-42 167.0 sp|P12027|PSGP_ONCMY Polysialoglycoprotein OS=Oncorhynchus mykiss OX=8022 PE=1 SV=2 g2744.t1 P12027 37.327 434 6.599999999999999e-42 166.0 sp|P12027|PSGP_ONCMY Polysialoglycoprotein OS=Oncorhynchus mykiss OX=8022 PE=1 SV=2 g2744.t1 P12027 37.441 422 9.43e-41 163.0 sp|P12027|PSGP_ONCMY Polysialoglycoprotein OS=Oncorhynchus mykiss OX=8022 PE=1 SV=2 g2744.t1 P12027 37.94 369 1.22e-39 159.0 sp|P12027|PSGP_ONCMY Polysialoglycoprotein OS=Oncorhynchus mykiss OX=8022 PE=1 SV=2 g2744.t1 P12027 36.49 433 8.57e-39 157.0 sp|P12027|PSGP_ONCMY Polysialoglycoprotein OS=Oncorhynchus mykiss OX=8022 PE=1 SV=2 g2744.t1 P12027 34.989 443 2.17e-35 147.0 sp|P12027|PSGP_ONCMY Polysialoglycoprotein OS=Oncorhynchus mykiss OX=8022 PE=1 SV=2 g2744.t1 P12027 34.824 425 9.33e-35 145.0 sp|P12027|PSGP_ONCMY Polysialoglycoprotein OS=Oncorhynchus mykiss OX=8022 PE=1 SV=2 g2744.t1 P12027 32.967 455 6.46e-31 133.0 sp|P12027|PSGP_ONCMY Polysialoglycoprotein OS=Oncorhynchus mykiss OX=8022 PE=1 SV=2 g2744.t1 P12027 32.594 451 1.64e-30 132.0 sp|P12027|PSGP_ONCMY Polysialoglycoprotein OS=Oncorhynchus mykiss OX=8022 PE=1 SV=2 g2750.t1 A6NE52 27.031 714 3.01e-83 301.0 sp|A6NE52|WDR97_HUMAN WD repeat-containing protein 97 OS=Homo sapiens OX=9606 GN=WDR97 PE=1 SV=2 g2750.t2 A6NE52 27.031 714 3.33e-83 301.0 sp|A6NE52|WDR97_HUMAN WD repeat-containing protein 97 OS=Homo sapiens OX=9606 GN=WDR97 PE=1 SV=2 g2750.t3 A6NE52 27.031 714 4.33e-83 301.0 sp|A6NE52|WDR97_HUMAN WD repeat-containing protein 97 OS=Homo sapiens OX=9606 GN=WDR97 PE=1 SV=2 g2751.t1 Q501L1 45.885 401 8.53e-99 304.0 sp|Q501L1|P20D2_XENTR Peptidase M20 domain-containing protein 2 OS=Xenopus tropicalis OX=8364 GN=pm20d2 PE=2 SV=1 g2752.t1 Q8BXQ2 40.85 306 3.07e-69 229.0 sp|Q8BXQ2|PIGT_MOUSE GPI-anchor transamidase component PIGT OS=Mus musculus OX=10090 GN=Pigt PE=1 SV=2 PIGT_MOUSE reviewed GPI-anchor transamidase component PIGT (Neuronal development-associated protein 7) (Phosphatidylinositol-glycan biosynthesis class T protein) Mus musculus (Mouse) GO:0005737; GO:0006506; GO:0016255; GO:0030182; GO:0031410; GO:0034235; GO:0042765; GO:0051402; GO:0180046 attachment of GPI anchor to protein [GO:0016255]; GPI anchor biosynthetic process [GO:0006506]; GPI anchored protein biosynthesis [GO:0180046]; neuron apoptotic process [GO:0051402]; neuron differentiation [GO:0030182] cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; GPI-anchor transamidase complex [GO:0042765] GPI anchor binding [GO:0034235] g2753.t1 Q8BXQ2 60.773 181 3.61e-70 227.0 sp|Q8BXQ2|PIGT_MOUSE GPI-anchor transamidase component PIGT OS=Mus musculus OX=10090 GN=Pigt PE=1 SV=2 PIGT_MOUSE reviewed GPI-anchor transamidase component PIGT (Neuronal development-associated protein 7) (Phosphatidylinositol-glycan biosynthesis class T protein) Mus musculus (Mouse) GO:0005737; GO:0006506; GO:0016255; GO:0030182; GO:0031410; GO:0034235; GO:0042765; GO:0051402; GO:0180046 attachment of GPI anchor to protein [GO:0016255]; GPI anchor biosynthetic process [GO:0006506]; GPI anchored protein biosynthesis [GO:0180046]; neuron apoptotic process [GO:0051402]; neuron differentiation [GO:0030182] cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; GPI-anchor transamidase complex [GO:0042765] GPI anchor binding [GO:0034235] g2757.t1 Q9VT00 33.882 608 2.12e-93 331.0 sp|Q9VT00|JARD2_DROME Jumonji, AT rich interactive domain protein 2 OS=Drosophila melanogaster OX=7227 GN=Jarid2 PE=1 SV=3 JARD2_DROME reviewed Jumonji, AT rich interactive domain protein 2 (Protein jumonji) (dJmj) Drosophila melanogaster (Fruit fly) GO:0000785; GO:0000791; GO:0003677; GO:0005634; GO:0005737; GO:0006338; GO:0010468; GO:0044877; GO:0045893 chromatin remodeling [GO:0006338]; positive regulation of DNA-templated transcription [GO:0045893]; regulation of gene expression [GO:0010468] chromatin [GO:0000785]; cytoplasm [GO:0005737]; euchromatin [GO:0000791]; nucleus [GO:0005634] DNA binding [GO:0003677]; protein-containing complex binding [GO:0044877] g2758.t1 Q9W603 63.558 933 0.0 1183.0 sp|Q9W603|SP16H_XENLA FACT complex subunit SPT16 OS=Xenopus laevis OX=8355 GN=supt16h PE=1 SV=2 g2759.t1 Q642A0 50.394 127 9.85e-28 102.0 sp|Q642A0|PDRG1_RAT p53 and DNA damage-regulated protein 1 OS=Rattus norvegicus OX=10116 GN=Pdrg1 PE=2 SV=2 g2760.t1 Q3SZH6 65.668 434 0.0 593.0 sp|Q3SZH6|TTLL9_BOVIN Probable tubulin polyglutamylase TTLL9 OS=Bos taurus OX=9913 GN=TTLL9 PE=2 SV=1 TTLL9_BOVIN reviewed Probable tubulin polyglutamylase TTLL9 (EC 6.3.2.-) (Tubulin--tyrosine ligase-like protein 9) Bos taurus (Bovine) GO:0000226; GO:0005524; GO:0005874; GO:0015631; GO:0030317; GO:0036064; GO:0046872; GO:0070740; GO:0106438 flagellated sperm motility [GO:0030317]; microtubule cytoskeleton organization [GO:0000226] ciliary basal body [GO:0036064]; microtubule [GO:0005874] ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein-glutamic acid ligase activity, elongating [GO:0106438]; tubulin binding [GO:0015631]; tubulin-glutamic acid ligase activity [GO:0070740] g2760.t2 Q3SZH6 65.337 401 0.0 548.0 sp|Q3SZH6|TTLL9_BOVIN Probable tubulin polyglutamylase TTLL9 OS=Bos taurus OX=9913 GN=TTLL9 PE=2 SV=1 TTLL9_BOVIN reviewed Probable tubulin polyglutamylase TTLL9 (EC 6.3.2.-) (Tubulin--tyrosine ligase-like protein 9) Bos taurus (Bovine) GO:0000226; GO:0005524; GO:0005874; GO:0015631; GO:0030317; GO:0036064; GO:0046872; GO:0070740; GO:0106438 flagellated sperm motility [GO:0030317]; microtubule cytoskeleton organization [GO:0000226] ciliary basal body [GO:0036064]; microtubule [GO:0005874] ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein-glutamic acid ligase activity, elongating [GO:0106438]; tubulin binding [GO:0015631]; tubulin-glutamic acid ligase activity [GO:0070740] g2761.t1 P13073 36.723 177 3.68e-33 118.0 sp|P13073|COX41_HUMAN Cytochrome c oxidase subunit 4 isoform 1, mitochondrial OS=Homo sapiens OX=9606 GN=COX4I1 PE=1 SV=1 COX41_HUMAN reviewed Cytochrome c oxidase subunit 4 isoform 1, mitochondrial (Cytochrome c oxidase polypeptide IV) (Cytochrome c oxidase subunit IV isoform 1) (COX IV-1) Homo sapiens (Human) GO:0004129; GO:0005654; GO:0005739; GO:0005743; GO:0005758; GO:0005829; GO:0006091; GO:0006123; GO:0007584; GO:0016020; GO:0031966; GO:0045277; GO:0045333 cellular respiration [GO:0045333]; generation of precursor metabolites and energy [GO:0006091]; mitochondrial electron transport, cytochrome c to oxygen [GO:0006123]; response to nutrient [GO:0007584] cytosol [GO:0005829]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; respiratory chain complex IV [GO:0045277] cytochrome-c oxidase activity [GO:0004129] g2763.t1 Q1LU86 48.077 260 5.680000000000001e-79 245.0 sp|Q1LU86|CBAR1_DANRE CBY1-interacting BAR domain-containing protein 1 OS=Danio rerio OX=7955 GN=cibar1 PE=2 SV=1 CBAR1_DANRE reviewed CBY1-interacting BAR domain-containing protein 1 Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005634; GO:0005737; GO:0005743; GO:0005814; GO:0005929; GO:0007007; GO:0007283; GO:0030154; GO:0035869; GO:0036064; GO:0045880; GO:0060271; GO:0097227; GO:0097546 cell differentiation [GO:0030154]; cilium assembly [GO:0060271]; inner mitochondrial membrane organization [GO:0007007]; positive regulation of smoothened signaling pathway [GO:0045880]; spermatogenesis [GO:0007283] centriole [GO:0005814]; ciliary basal body [GO:0036064]; ciliary base [GO:0097546]; ciliary transition zone [GO:0035869]; cilium [GO:0005929]; cytoplasm [GO:0005737]; mitochondrial inner membrane [GO:0005743]; nucleus [GO:0005634]; sperm annulus [GO:0097227] g2764.t1 Q9NTZ6 54.023 87 2.2100000000000003e-21 105.0 sp|Q9NTZ6|RBM12_HUMAN RNA-binding protein 12 OS=Homo sapiens OX=9606 GN=RBM12 PE=1 SV=1 g2765.t1 Q921G8 60.278 720 0.0 882.0 sp|Q921G8|GCP2_MOUSE Gamma-tubulin complex component 2 OS=Mus musculus OX=10090 GN=Tubgcp2 PE=1 SV=2 g2766.t1 Q921G8 45.865 133 2.5499999999999998e-23 99.4 sp|Q921G8|GCP2_MOUSE Gamma-tubulin complex component 2 OS=Mus musculus OX=10090 GN=Tubgcp2 PE=1 SV=2 g2768.t1 Q6DFF7 34.59 451 8.47e-76 251.0 sp|Q6DFF7|KLH25_XENLA Kelch-like protein 25 OS=Xenopus laevis OX=8355 GN=klhl25 PE=2 SV=1 g2773.t1 Q6DC53 38.552 511 4.18e-114 348.0 sp|Q6DC53|CTU2_DANRE Cytoplasmic tRNA 2-thiolation protein 2 OS=Danio rerio OX=7955 GN=ctu2 PE=2 SV=2 g2774.t1 O34313 25.466 483 1.1900000000000001e-32 140.0 sp|O34313|NTPES_BACSU Trifunctional nucleotide phosphoesterase protein YfkN OS=Bacillus subtilis (strain 168) OX=224308 GN=yfkN PE=1 SV=1 NTPES_BACSU reviewed Trifunctional nucleotide phosphoesterase protein YfkN [Includes: 2',3'-cyclic-nucleotide 2'-phosphodiesterase/3'-nucleotidase (EC 3.1.3.6) (EC 3.1.4.16); 5'-nucleotidase (EC 3.1.3.5)] Bacillus subtilis (strain 168) GO:0000166; GO:0008253; GO:0008254; GO:0008663; GO:0009166; GO:0030288; GO:0046872 nucleotide catabolic process [GO:0009166] outer membrane-bounded periplasmic space [GO:0030288] 2',3'-cyclic-nucleotide 2'-phosphodiesterase activity [GO:0008663]; 3'-nucleotidase activity [GO:0008254]; 5'-nucleotidase activity [GO:0008253]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166] g2777.t1 Q1RMQ3 51.449 138 2.75e-49 158.0 sp|Q1RMQ3|SYS1_BOVIN Protein SYS1 homolog OS=Bos taurus OX=9913 GN=SYS1 PE=2 SV=1 g2780.t1 Q6GM82 65.481 478 0.0 674.0 sp|Q6GM82|ALAT2_XENLA Alanine aminotransferase 2 OS=Xenopus laevis OX=8355 GN=gpt2 PE=2 SV=1 ALAT2_XENLA reviewed Alanine aminotransferase 2 (ALT2) (EC 2.6.1.2) (Glutamate pyruvate transaminase 2) (GPT 2) (Glutamic--alanine transaminase 2) (Glutamic--pyruvic transaminase 2) Xenopus laevis (African clawed frog) GO:0004021; GO:0005737; GO:0006103; GO:0030170; GO:0042851; GO:0042853 2-oxoglutarate metabolic process [GO:0006103]; L-alanine catabolic process [GO:0042853]; L-alanine metabolic process [GO:0042851] cytoplasm [GO:0005737] L-alanine:2-oxoglutarate aminotransferase activity [GO:0004021]; pyridoxal phosphate binding [GO:0030170] g2781.t1 Q5XG50 38.75 160 2.61e-22 90.5 sp|Q5XG50|CE087_XENLA UPF0547 protein C16orf87 homolog OS=Xenopus laevis OX=8355 PE=2 SV=1 g2782.t1 Q5ZKD9 30.31 452 2.72e-59 210.0 sp|Q5ZKD9|KLH20_CHICK Kelch-like protein 20 OS=Gallus gallus OX=9031 GN=KLHL20 PE=2 SV=1 KLH20_CHICK reviewed Kelch-like protein 20 Gallus gallus (Chicken) GO:0005737; GO:0005802; GO:0005829; GO:0006895; GO:0015031; GO:0016567; GO:0016605; GO:0019964; GO:0031463; GO:0043066; GO:0043161; GO:0048471; GO:1990390; GO:1990756 Golgi to endosome transport [GO:0006895]; negative regulation of apoptotic process [GO:0043066]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K33-linked ubiquitination [GO:1990390]; protein transport [GO:0015031]; protein ubiquitination [GO:0016567] Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; perinuclear region of cytoplasm [GO:0048471]; PML body [GO:0016605]; trans-Golgi network [GO:0005802] type II interferon binding [GO:0019964]; ubiquitin-like ligase-substrate adaptor activity [GO:1990756] g2784.t1 Q7YQK4 52.954 474 7.039999999999999e-146 429.0 sp|Q7YQK4|LAT1_RABIT Large neutral amino acids transporter small subunit 1 OS=Oryctolagus cuniculus OX=9986 GN=SLC7A5 PE=1 SV=1 g2788.t1 Q9WTR6 52.778 144 2.31e-42 149.0 sp|Q9WTR6|XCT_MOUSE Cystine/glutamate transporter OS=Mus musculus OX=10090 GN=Slc7a11 PE=1 SV=1 XCT_MOUSE reviewed Cystine/glutamate transporter (Amino acid transport system xc-) (Solute carrier family 7 member 11) (Subtle gray protein) (xCT) Mus musculus (Mouse) GO:0003333; GO:0005765; GO:0005886; GO:0006749; GO:0007420; GO:0008542; GO:0009636; GO:0009986; GO:0015179; GO:0015252; GO:0015327; GO:0015811; GO:0015813; GO:0016020; GO:0021591; GO:0021756; GO:0022840; GO:0030534; GO:0031526; GO:0031528; GO:0033029; GO:0033554; GO:0034599; GO:0034775; GO:0035752; GO:0042127; GO:0045177; GO:0048021; GO:0048286; GO:0050804; GO:0050807; GO:0051223; GO:0051775; GO:0060173; GO:0070527; GO:0090461; GO:0097449; GO:0098712; GO:0110076; GO:0140206; GO:0140924; GO:0140926; GO:1900407; GO:1901494; GO:1902600; GO:1903786; GO:1904717; GO:2000211 adult behavior [GO:0030534]; amino acid transmembrane transport [GO:0003333]; brain development [GO:0007420]; cellular response to oxidative stress [GO:0034599]; cellular response to stress [GO:0033554]; dipeptide import across plasma membrane [GO:0140206]; glutathione metabolic process [GO:0006749]; glutathione transmembrane transport [GO:0034775]; intracellular glutamate homeostasis [GO:0090461]; L-cystine transport [GO:0015811]; L-glutamate import across plasma membrane [GO:0098712]; L-glutamate transmembrane transport [GO:0015813]; L-kynurenine transmembrane transport [GO:0140924]; limb development [GO:0060173]; lung alveolus development [GO:0048286]; lysosomal lumen pH elevation [GO:0035752]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of ferroptosis [GO:0110076]; platelet aggregation [GO:0070527]; proton transmembrane transport [GO:1902600]; regulation of AMPA glutamate receptor clustering [GO:1904717]; regulation of cell population proliferation [GO:0042127]; regulation of cellular response to oxidative stress [GO:1900407]; regulation of cysteine metabolic process [GO:1901494]; regulation of glutamate metabolic process [GO:2000211]; regulation of glutathione biosynthetic process [GO:1903786]; regulation of melanin biosynthetic process [GO:0048021]; regulation of neutrophil apoptotic process [GO:0033029]; regulation of protein transport [GO:0051223]; regulation of synapse organization [GO:0050807]; response to redox state [GO:0051775]; response to toxic substance [GO:0009636]; striatum development [GO:0021756]; ventricular system development [GO:0021591]; visual learning [GO:0008542] apical part of cell [GO:0045177]; astrocyte projection [GO:0097449]; brush border membrane [GO:0031526]; cell surface [GO:0009986]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; microvillus membrane [GO:0031528]; plasma membrane [GO:0005886] cystine:glutamate antiporter activity [GO:0015327]; L-amino acid transmembrane transporter activity [GO:0015179]; L-kynurenine transmembrane transporter activity [GO:0140926]; leak channel activity [GO:0022840]; proton channel activity [GO:0015252] g2789.t1 Q9WTR6 51.903 289 2.76e-86 271.0 sp|Q9WTR6|XCT_MOUSE Cystine/glutamate transporter OS=Mus musculus OX=10090 GN=Slc7a11 PE=1 SV=1 XCT_MOUSE reviewed Cystine/glutamate transporter (Amino acid transport system xc-) (Solute carrier family 7 member 11) (Subtle gray protein) (xCT) Mus musculus (Mouse) GO:0003333; GO:0005765; GO:0005886; GO:0006749; GO:0007420; GO:0008542; GO:0009636; GO:0009986; GO:0015179; GO:0015252; GO:0015327; GO:0015811; GO:0015813; GO:0016020; GO:0021591; GO:0021756; GO:0022840; GO:0030534; GO:0031526; GO:0031528; GO:0033029; GO:0033554; GO:0034599; GO:0034775; GO:0035752; GO:0042127; GO:0045177; GO:0048021; GO:0048286; GO:0050804; GO:0050807; GO:0051223; GO:0051775; GO:0060173; GO:0070527; GO:0090461; GO:0097449; GO:0098712; GO:0110076; GO:0140206; GO:0140924; GO:0140926; GO:1900407; GO:1901494; GO:1902600; GO:1903786; GO:1904717; GO:2000211 adult behavior [GO:0030534]; amino acid transmembrane transport [GO:0003333]; brain development [GO:0007420]; cellular response to oxidative stress [GO:0034599]; cellular response to stress [GO:0033554]; dipeptide import across plasma membrane [GO:0140206]; glutathione metabolic process [GO:0006749]; glutathione transmembrane transport [GO:0034775]; intracellular glutamate homeostasis [GO:0090461]; L-cystine transport [GO:0015811]; L-glutamate import across plasma membrane [GO:0098712]; L-glutamate transmembrane transport [GO:0015813]; L-kynurenine transmembrane transport [GO:0140924]; limb development [GO:0060173]; lung alveolus development [GO:0048286]; lysosomal lumen pH elevation [GO:0035752]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of ferroptosis [GO:0110076]; platelet aggregation [GO:0070527]; proton transmembrane transport [GO:1902600]; regulation of AMPA glutamate receptor clustering [GO:1904717]; regulation of cell population proliferation [GO:0042127]; regulation of cellular response to oxidative stress [GO:1900407]; regulation of cysteine metabolic process [GO:1901494]; regulation of glutamate metabolic process [GO:2000211]; regulation of glutathione biosynthetic process [GO:1903786]; regulation of melanin biosynthetic process [GO:0048021]; regulation of neutrophil apoptotic process [GO:0033029]; regulation of protein transport [GO:0051223]; regulation of synapse organization [GO:0050807]; response to redox state [GO:0051775]; response to toxic substance [GO:0009636]; striatum development [GO:0021756]; ventricular system development [GO:0021591]; visual learning [GO:0008542] apical part of cell [GO:0045177]; astrocyte projection [GO:0097449]; brush border membrane [GO:0031526]; cell surface [GO:0009986]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; microvillus membrane [GO:0031528]; plasma membrane [GO:0005886] cystine:glutamate antiporter activity [GO:0015327]; L-amino acid transmembrane transporter activity [GO:0015179]; L-kynurenine transmembrane transporter activity [GO:0140926]; leak channel activity [GO:0022840]; proton channel activity [GO:0015252] g2790.t1 Q9N1Q0 69.799 149 5.26e-50 166.0 sp|Q9N1Q0|RSMB_NOTEU Small nuclear ribonucleoprotein-associated protein B' OS=Notamacropus eugenii OX=9315 GN=SNRPB PE=2 SV=1 g2791.t1 A5GFY4 65.766 555 0.0 799.0 sp|A5GFY4|NELFD_PIG Negative elongation factor D OS=Sus scrofa OX=9823 GN=NELFCD PE=3 SV=1 g2792.t1 A8WGA0 38.217 471 2.63e-115 356.0 sp|A8WGA0|C27C1_DANRE Cytochrome P450 27C1 OS=Danio rerio OX=7955 GN=cyp27c1 PE=1 SV=2 C27C1_DANRE reviewed Cytochrome P450 27C1 (EC 1.14.19.53) (All-trans retinol 3,4-desaturase) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001972; GO:0004497; GO:0005506; GO:0005739; GO:0006629; GO:0016020; GO:0020037; GO:0061896; GO:0061897; GO:0061898; GO:1904768 lipid metabolic process [GO:0006629] membrane [GO:0016020]; mitochondrion [GO:0005739] all-trans retinal 3,4-desaturase activity [GO:0061897]; all-trans retinoic acid 3,4-desaturase activity [GO:0061898]; all-trans retinol 3,4-desaturase activity [GO:0061896]; all-trans-retinol binding [GO:1904768]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; retinoic acid binding [GO:0001972] g2793.t1 P56395 48.062 129 4.4100000000000005e-31 110.0 sp|P56395|CYB5_MOUSE Cytochrome b5 OS=Mus musculus OX=10090 GN=Cyb5a PE=1 SV=2 CYB5_MOUSE reviewed Cytochrome b5 Mus musculus (Mouse) GO:0004768; GO:0005739; GO:0005783; GO:0005789; GO:0005829; GO:0006631; GO:0016020; GO:0019899; GO:0020037; GO:0046872 fatty acid metabolic process [GO:0006631] cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; mitochondrion [GO:0005739] enzyme binding [GO:0019899]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; stearoyl-CoA 9-desaturase activity [GO:0004768] g2794.t1 Q8QZR1 55.072 414 1.11e-173 496.0 sp|Q8QZR1|ATTY_MOUSE Tyrosine aminotransferase OS=Mus musculus OX=10090 GN=Tat PE=1 SV=1 g2802.t1 Q52KL1 37.405 262 2.9e-35 130.0 sp|Q52KL1|FITM2_DANRE Acyl-coenzyme A diphosphatase FITM2 OS=Danio rerio OX=7955 GN=fitm2 PE=2 SV=1 FITM2_DANRE reviewed Acyl-coenzyme A diphosphatase FITM2 (EC 3.6.1.-) (Fat storage-inducing transmembrane protein 2) (Fat-inducing protein 2) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0003323; GO:0005789; GO:0007010; GO:0008654; GO:0010945; GO:0017129; GO:0019915; GO:0019992; GO:0022604; GO:0031018; GO:0034389; GO:0036115; GO:0042593; GO:0055088; GO:0140042; GO:1990798 cytoskeleton organization [GO:0007010]; endocrine pancreas development [GO:0031018]; fatty-acyl-CoA catabolic process [GO:0036115]; glucose homeostasis [GO:0042593]; lipid droplet formation [GO:0140042]; lipid droplet organization [GO:0034389]; lipid homeostasis [GO:0055088]; lipid storage [GO:0019915]; pancreas regeneration [GO:1990798]; phospholipid biosynthetic process [GO:0008654]; regulation of cell morphogenesis [GO:0022604]; type B pancreatic cell development [GO:0003323] endoplasmic reticulum membrane [GO:0005789] coenzyme A diphosphatase activity [GO:0010945]; diacylglycerol binding [GO:0019992]; triglyceride binding [GO:0017129] g2803.t1 Q8TB36 33.333 294 3.8699999999999996e-42 152.0 sp|Q8TB36|GDAP1_HUMAN Ganglioside-induced differentiation-associated protein 1 OS=Homo sapiens OX=9606 GN=GDAP1 PE=1 SV=3 GDAP1_HUMAN reviewed Ganglioside-induced differentiation-associated protein 1 (GDAP1) Homo sapiens (Human) GO:0000266; GO:0005634; GO:0005739; GO:0005741; GO:0005778; GO:0005829; GO:0006626; GO:0008053; GO:0016020; GO:0032526; GO:0071305 cellular response to vitamin D [GO:0071305]; mitochondrial fission [GO:0000266]; mitochondrial fusion [GO:0008053]; protein targeting to mitochondrion [GO:0006626]; response to retinoic acid [GO:0032526] cytosol [GO:0005829]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; peroxisomal membrane [GO:0005778] g2804.t1 Q96S44 58.407 226 1.28e-90 270.0 sp|Q96S44|PRPK_HUMAN EKC/KEOPS complex subunit TP53RK OS=Homo sapiens OX=9606 GN=TP53RK PE=1 SV=2 PRPK_HUMAN reviewed EKC/KEOPS complex subunit TP53RK (EC 3.6.-.-) (Atypical serine/threonine protein kinase TP53RK) (Nori-2) (TP53-regulating kinase) (EC 2.7.11.1) (p53-related protein kinase) Homo sapiens (Human) GO:0000408; GO:0002039; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006468; GO:0008033; GO:0016787; GO:0070525; GO:0106310; GO:1901796 protein phosphorylation [GO:0006468]; regulation of signal transduction by p53 class mediator [GO:1901796]; tRNA processing [GO:0008033]; tRNA threonylcarbamoyladenosine metabolic process [GO:0070525] cytoplasm [GO:0005737]; cytosol [GO:0005829]; EKC/KEOPS complex [GO:0000408]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] ATP binding [GO:0005524]; hydrolase activity [GO:0016787]; p53 binding [GO:0002039]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g2805.t1 Q9GKX2 60.0 260 1.09e-102 302.0 sp|Q9GKX2|DHRS4_RABIT Dehydrogenase/reductase SDR family member 4 (Fragment) OS=Oryctolagus cuniculus OX=9986 GN=DHRS4 PE=1 SV=1 g2806.t1 Q9N0C5 49.756 205 1.23e-66 211.0 sp|Q9N0C5|KITM_MACFA Thymidine kinase 2, mitochondrial OS=Macaca fascicularis OX=9541 GN=TK2 PE=2 SV=1 g2807.t1 Q9N0C5 46.535 202 2.79e-66 209.0 sp|Q9N0C5|KITM_MACFA Thymidine kinase 2, mitochondrial OS=Macaca fascicularis OX=9541 GN=TK2 PE=2 SV=1 g2808.t1 Q9N0C5 46.97 198 1.2e-63 205.0 sp|Q9N0C5|KITM_MACFA Thymidine kinase 2, mitochondrial OS=Macaca fascicularis OX=9541 GN=TK2 PE=2 SV=1 g2809.t1 Q5XGW6 61.86 215 1.16e-62 197.0 sp|Q5XGW6|CHM4B_XENLA Charged multivesicular body protein 4b OS=Xenopus laevis OX=8355 GN=chmp4b PE=2 SV=1 g2811.t1 P05689 61.957 276 9.52e-125 362.0 sp|P05689|CATZ_BOVIN Cathepsin Z OS=Bos taurus OX=9913 GN=CTSZ PE=2 SV=2 g2812.t1 P08761 42.593 108 7.76e-22 89.4 sp|P08761|MSRA_DROME Peptide methionine sulfoxide reductase OS=Drosophila melanogaster OX=7227 GN=MsrA PE=1 SV=2 MSRA_DROME reviewed Peptide methionine sulfoxide reductase (EC 1.8.4.11) (Ecdysone-induced protein 28/29 kDa) (Methionine-S-sulfoxide reductase) (Peptide-methionine (S)-S-oxide reductase) Drosophila melanogaster (Fruit fly) GO:0000096; GO:0005737; GO:0005739; GO:0006979; GO:0008113; GO:0008340; GO:0033744; GO:0034599 cellular response to oxidative stress [GO:0034599]; determination of adult lifespan [GO:0008340]; response to oxidative stress [GO:0006979]; sulfur amino acid metabolic process [GO:0000096] cytoplasm [GO:0005737]; mitochondrion [GO:0005739] L-methionine:thioredoxin-disulfide S-oxidoreductase activity [GO:0033744]; peptide-methionine (S)-S-oxide reductase activity [GO:0008113] g2813.t1 P11183 43.03 165 2.66e-39 134.0 sp|P11183|GCSH_CHICK Glycine cleavage system H protein, mitochondrial OS=Gallus gallus OX=9031 GN=GCSH PE=1 SV=2 g2814.t1 Q6TEM9 40.315 444 5.7e-90 284.0 sp|Q6TEM9|MYLIA_DANRE E3 ubiquitin-protein ligase MYLIP-A OS=Danio rerio OX=7955 GN=mylipa PE=1 SV=2 MYLIA_DANRE reviewed E3 ubiquitin-protein ligase MYLIP-A (EC 2.3.2.27) (Myosin regulatory light chain-interacting protein A) (MIR-A) (RING-type E3 ubiquitin transferase MYLIP-A) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0004842; GO:0005737; GO:0005829; GO:0006511; GO:0007369; GO:0008270; GO:0016567; GO:0030178; GO:0061630 gastrulation [GO:0007369]; negative regulation of Wnt signaling pathway [GO:0030178]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511] cytoplasm [GO:0005737]; cytosol [GO:0005829] ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] g2815.t1 Q2KJI7 64.337 415 3.29e-178 517.0 sp|Q2KJI7|AFG32_BOVIN Mitochondrial inner membrane m-AAA protease component AFG3L2 OS=Bos taurus OX=9913 GN=AFG3L2 PE=2 SV=1 AFG32_BOVIN reviewed Mitochondrial inner membrane m-AAA protease component AFG3L2 (EC 3.4.24.-) (EC 3.6.-.-) (AFG3-like protein 2) Bos taurus (Bovine) GO:0004176; GO:0004222; GO:0005524; GO:0005743; GO:0005745; GO:0006508; GO:0007409; GO:0008237; GO:0008270; GO:0016485; GO:0016540; GO:0016887; GO:0030163; GO:0034982; GO:0036444; GO:0051560; GO:0072753; GO:0110097; GO:0140567; GO:0141164 axonogenesis [GO:0007409]; calcium import into the mitochondrion [GO:0036444]; cellular response to glutathione [GO:0072753]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrial protein processing [GO:0034982]; mitochondrial protein quality control [GO:0141164]; protein autoprocessing [GO:0016540]; protein catabolic process [GO:0030163]; protein processing [GO:0016485]; proteolysis [GO:0006508]; regulation of calcium import into the mitochondrion [GO:0110097] m-AAA complex [GO:0005745]; mitochondrial inner membrane [GO:0005743] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent peptidase activity [GO:0004176]; membrane protein dislocase activity [GO:0140567]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; zinc ion binding [GO:0008270] g2816.t1 Q2KJI7 59.873 157 1.94e-49 178.0 sp|Q2KJI7|AFG32_BOVIN Mitochondrial inner membrane m-AAA protease component AFG3L2 OS=Bos taurus OX=9913 GN=AFG3L2 PE=2 SV=1 AFG32_BOVIN reviewed Mitochondrial inner membrane m-AAA protease component AFG3L2 (EC 3.4.24.-) (EC 3.6.-.-) (AFG3-like protein 2) Bos taurus (Bovine) GO:0004176; GO:0004222; GO:0005524; GO:0005743; GO:0005745; GO:0006508; GO:0007409; GO:0008237; GO:0008270; GO:0016485; GO:0016540; GO:0016887; GO:0030163; GO:0034982; GO:0036444; GO:0051560; GO:0072753; GO:0110097; GO:0140567; GO:0141164 axonogenesis [GO:0007409]; calcium import into the mitochondrion [GO:0036444]; cellular response to glutathione [GO:0072753]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrial protein processing [GO:0034982]; mitochondrial protein quality control [GO:0141164]; protein autoprocessing [GO:0016540]; protein catabolic process [GO:0030163]; protein processing [GO:0016485]; proteolysis [GO:0006508]; regulation of calcium import into the mitochondrion [GO:0110097] m-AAA complex [GO:0005745]; mitochondrial inner membrane [GO:0005743] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent peptidase activity [GO:0004176]; membrane protein dislocase activity [GO:0140567]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; zinc ion binding [GO:0008270] g2818.t1 Q32L27 36.364 165 1.47e-22 99.8 sp|Q32L27|UB2Q2_BOVIN Ubiquitin-conjugating enzyme E2 Q2 OS=Bos taurus OX=9913 GN=UBE2Q2 PE=2 SV=1 g2819.t1 Q3TQF0 36.977 430 2.2399999999999997e-81 262.0 sp|Q3TQF0|FBX31_MOUSE F-box only protein 31 OS=Mus musculus OX=10090 GN=Fbxo31 PE=1 SV=1 FBX31_MOUSE reviewed F-box only protein 31 Mus musculus (Mouse) GO:0005737; GO:0005813; GO:0006974; GO:0016567; GO:0019005; GO:0030330; GO:0030332; GO:0031145; GO:0031146; GO:0031571; GO:0034599; GO:0038066; GO:0042770; GO:0043025; GO:0043161; GO:0046872; GO:0050775; GO:1901797; GO:1990756; GO:2001224 anaphase-promoting complex-dependent catabolic process [GO:0031145]; cellular response to oxidative stress [GO:0034599]; DNA damage response [GO:0006974]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; mitotic G1 DNA damage checkpoint signaling [GO:0031571]; negative regulation of signal transduction by p53 class mediator [GO:1901797]; p38MAPK cascade [GO:0038066]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of neuron migration [GO:2001224]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; signal transduction in response to DNA damage [GO:0042770] centrosome [GO:0005813]; cytoplasm [GO:0005737]; neuronal cell body [GO:0043025]; SCF ubiquitin ligase complex [GO:0019005] cyclin binding [GO:0030332]; metal ion binding [GO:0046872]; ubiquitin-like ligase-substrate adaptor activity [GO:1990756] g2820.t1 B2RYD2 44.092 694 0.0 547.0 sp|B2RYD2|ESRP1_RAT Epithelial splicing regulatory protein 1 OS=Rattus norvegicus OX=10116 GN=Esrp1 PE=2 SV=2 ESRP1_RAT reviewed Epithelial splicing regulatory protein 1 (RNA-binding motif protein 35A) (RNA-binding protein 35A) Rattus norvegicus (Rat) GO:0000380; GO:0003729; GO:0005634; GO:0005654; GO:0016604; GO:0042669; GO:0043484; GO:0050673; GO:0050679; GO:0060441; GO:0060445; GO:1990904 alternative mRNA splicing, via spliceosome [GO:0000380]; branching involved in salivary gland morphogenesis [GO:0060445]; epithelial cell proliferation [GO:0050673]; epithelial tube branching involved in lung morphogenesis [GO:0060441]; positive regulation of epithelial cell proliferation [GO:0050679]; regulation of inner ear auditory receptor cell fate specification [GO:0042669]; regulation of RNA splicing [GO:0043484] nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904] mRNA binding [GO:0003729] g2820.t2 B2RYD2 44.331 688 0.0 547.0 sp|B2RYD2|ESRP1_RAT Epithelial splicing regulatory protein 1 OS=Rattus norvegicus OX=10116 GN=Esrp1 PE=2 SV=2 ESRP1_RAT reviewed Epithelial splicing regulatory protein 1 (RNA-binding motif protein 35A) (RNA-binding protein 35A) Rattus norvegicus (Rat) GO:0000380; GO:0003729; GO:0005634; GO:0005654; GO:0016604; GO:0042669; GO:0043484; GO:0050673; GO:0050679; GO:0060441; GO:0060445; GO:1990904 alternative mRNA splicing, via spliceosome [GO:0000380]; branching involved in salivary gland morphogenesis [GO:0060445]; epithelial cell proliferation [GO:0050673]; epithelial tube branching involved in lung morphogenesis [GO:0060441]; positive regulation of epithelial cell proliferation [GO:0050679]; regulation of inner ear auditory receptor cell fate specification [GO:0042669]; regulation of RNA splicing [GO:0043484] nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904] mRNA binding [GO:0003729] g2822.t1 Q8BQM4 38.799 683 6.07e-115 362.0 sp|Q8BQM4|HEAT3_MOUSE HEAT repeat-containing protein 3 OS=Mus musculus OX=10090 GN=Heatr3 PE=1 SV=1 g2823.t1 Q9M571 53.77 504 4.93e-177 510.0 sp|Q9M571|PEAMT_SPIOL Phosphoethanolamine N-methyltransferase OS=Spinacia oleracea OX=3562 GN=PEAMT PE=1 SV=1 g2824.t1 P47863 36.818 220 9.02e-36 132.0 sp|P47863|AQP4_RAT Aquaporin-4 OS=Rattus norvegicus OX=10116 GN=Aqp4 PE=1 SV=1 g2825.t1 Q68F54 41.392 273 1.1400000000000001e-56 192.0 sp|Q68F54|FTO_XENLA Alpha-ketoglutarate-dependent dioxygenase FTO OS=Xenopus laevis OX=8355 GN=fto PE=2 SV=1 FTO_XENLA reviewed Alpha-ketoglutarate-dependent dioxygenase FTO (U6 small nuclear RNA (2'-O-methyladenosine-N(6)-)-demethylase FTO) (EC 1.14.11.-) (U6 small nuclear RNA N(6)-methyladenosine-demethylase FTO) (EC 1.14.11.-) (mRNA (2'-O-methyladenosine-N(6)-)-demethylase FTO) (m6A(m)-demethylase FTO) (EC 1.14.11.-) (mRNA N(6)-methyladenosine demethylase FTO) (EC 1.14.11.53) (tRNA N1-methyl adenine demethylase FTO) (EC 1.14.11.-) Xenopus laevis (African clawed frog) GO:0005634; GO:0005737; GO:0006307; GO:0008198; GO:0010883; GO:0016607; GO:0035515; GO:0035516; GO:0040014; GO:0042245; GO:0044458; GO:0061157; GO:1990931; GO:1990984 DNA alkylation repair [GO:0006307]; motile cilium assembly [GO:0044458]; mRNA destabilization [GO:0061157]; regulation of lipid storage [GO:0010883]; regulation of multicellular organism growth [GO:0040014]; RNA repair [GO:0042245] cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634] broad specificity oxidative DNA demethylase activity [GO:0035516]; ferrous iron binding [GO:0008198]; mRNA N6-methyladenosine dioxygenase activity [GO:1990931]; oxidative RNA demethylase activity [GO:0035515]; tRNA demethylase activity [GO:1990984] g2826.t1 Q2A121 33.171 205 3.64e-28 113.0 sp|Q2A121|FTO_RAT Alpha-ketoglutarate-dependent dioxygenase FTO OS=Rattus norvegicus OX=10116 GN=Fto PE=2 SV=1 FTO_RAT reviewed Alpha-ketoglutarate-dependent dioxygenase FTO (Fat mass and obesity-associated protein) (U6 small nuclear RNA (2'-O-methyladenosine-N(6)-)-demethylase FTO) (EC 1.14.11.-) (U6 small nuclear RNA N(6)-methyladenosine-demethylase FTO) (EC 1.14.11.-) (mRNA (2'-O-methyladenosine-N(6)-)-demethylase FTO) (m6A(m)-demethylase FTO) (EC 1.14.11.-) (mRNA N(6)-methyladenosine demethylase FTO) (EC 1.14.11.53) (tRNA N1-methyl adenine demethylase FTO) (EC 1.14.11.-) Rattus norvegicus (Rat) GO:0001649; GO:0001659; GO:0005634; GO:0005737; GO:0005829; GO:0006307; GO:0007507; GO:0008198; GO:0010883; GO:0016180; GO:0016607; GO:0016706; GO:0019233; GO:0031667; GO:0035515; GO:0035516; GO:0035774; GO:0040014; GO:0042245; GO:0043065; GO:0044065; GO:0051480; GO:0060612; GO:0061157; GO:0070350; GO:0090335; GO:1903925; GO:1903999; GO:1990931; GO:1990984 adipose tissue development [GO:0060612]; DNA alkylation repair [GO:0006307]; heart development [GO:0007507]; mRNA destabilization [GO:0061157]; negative regulation of eating behavior [GO:1903999]; osteoblast differentiation [GO:0001649]; positive regulation of apoptotic process [GO:0043065]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; regulation of brown fat cell differentiation [GO:0090335]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of lipid storage [GO:0010883]; regulation of multicellular organism growth [GO:0040014]; regulation of respiratory system process [GO:0044065]; regulation of white fat cell proliferation [GO:0070350]; response to bisphenol A [GO:1903925]; response to nutrient levels [GO:0031667]; RNA repair [GO:0042245]; sensory perception of pain [GO:0019233]; snRNA processing [GO:0016180]; temperature homeostasis [GO:0001659] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleus [GO:0005634] 2-oxoglutarate-dependent dioxygenase activity [GO:0016706]; broad specificity oxidative DNA demethylase activity [GO:0035516]; ferrous iron binding [GO:0008198]; mRNA N6-methyladenosine dioxygenase activity [GO:1990931]; oxidative RNA demethylase activity [GO:0035515]; tRNA demethylase activity [GO:1990984] g2827.t1 Q68CZ1 50.907 937 0.0 850.0 sp|Q68CZ1|FTM_HUMAN Protein fantom OS=Homo sapiens OX=9606 GN=RPGRIP1L PE=1 SV=2 FTM_HUMAN reviewed Protein fantom (Nephrocystin-8) (RPGR-interacting protein 1-like protein) (RPGRIP1-like protein) Homo sapiens (Human) GO:0001701; GO:0001736; GO:0001822; GO:0001889; GO:0005737; GO:0005813; GO:0005829; GO:0005886; GO:0005911; GO:0005923; GO:0005929; GO:0005930; GO:0007163; GO:0007368; GO:0008589; GO:0016607; GO:0021532; GO:0021549; GO:0021670; GO:0021772; GO:0022038; GO:0031870; GO:0032391; GO:0035115; GO:0035116; GO:0035869; GO:0036064; GO:0043584; GO:0045744; GO:0046548; GO:0060039; GO:0090102; GO:1905515 cerebellum development [GO:0021549]; cochlea development [GO:0090102]; corpus callosum development [GO:0022038]; determination of left/right symmetry [GO:0007368]; embryonic forelimb morphogenesis [GO:0035115]; embryonic hindlimb morphogenesis [GO:0035116]; establishment of planar polarity [GO:0001736]; establishment or maintenance of cell polarity [GO:0007163]; in utero embryonic development [GO:0001701]; kidney development [GO:0001822]; lateral ventricle development [GO:0021670]; liver development [GO:0001889]; negative regulation of G protein-coupled receptor signaling pathway [GO:0045744]; neural tube patterning [GO:0021532]; non-motile cilium assembly [GO:1905515]; nose development [GO:0043584]; olfactory bulb development [GO:0021772]; pericardium development [GO:0060039]; regulation of smoothened signaling pathway [GO:0008589]; retinal rod cell development [GO:0046548] axoneme [GO:0005930]; bicellular tight junction [GO:0005923]; cell-cell junction [GO:0005911]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary transition zone [GO:0035869]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; photoreceptor connecting cilium [GO:0032391]; plasma membrane [GO:0005886] thromboxane A2 receptor binding [GO:0031870] g2828.t1 Q6NRC9 45.559 608 1.04e-145 465.0 sp|Q6NRC9|LRCC1_XENLA Leucine-rich repeat and coiled-coil domain-containing protein 1 OS=Xenopus laevis OX=8355 GN=lrrcc1 PE=2 SV=1 g2828.t1 Q6NRC9 42.121 330 6.82e-57 218.0 sp|Q6NRC9|LRCC1_XENLA Leucine-rich repeat and coiled-coil domain-containing protein 1 OS=Xenopus laevis OX=8355 GN=lrrcc1 PE=2 SV=1 g2831.t1 Q6NRC9 43.213 361 1.9900000000000002e-72 253.0 sp|Q6NRC9|LRCC1_XENLA Leucine-rich repeat and coiled-coil domain-containing protein 1 OS=Xenopus laevis OX=8355 GN=lrrcc1 PE=2 SV=1 g2831.t2 Q6NRC9 43.213 361 7.26e-72 252.0 sp|Q6NRC9|LRCC1_XENLA Leucine-rich repeat and coiled-coil domain-containing protein 1 OS=Xenopus laevis OX=8355 GN=lrrcc1 PE=2 SV=1 g2834.t1 F1R8P4 39.631 434 2.05e-87 279.0 sp|F1R8P4|GLRA2_DANRE Glycine receptor subunit alpha-2 OS=Danio rerio OX=7955 GN=glra2 PE=3 SV=2 GLRA2_DANRE reviewed Glycine receptor subunit alpha-2 Danio rerio (Zebrafish) (Brachydanio rerio) GO:0004888; GO:0005231; GO:0005254; GO:0016594; GO:0022824; GO:0034707; GO:0042995; GO:0045211; GO:0046872; GO:1902476 chloride transmembrane transport [GO:1902476] cell projection [GO:0042995]; chloride channel complex [GO:0034707]; postsynaptic membrane [GO:0045211] chloride channel activity [GO:0005254]; excitatory extracellular ligand-gated monoatomic ion channel activity [GO:0005231]; glycine binding [GO:0016594]; metal ion binding [GO:0046872]; transmembrane signaling receptor activity [GO:0004888]; transmitter-gated monoatomic ion channel activity [GO:0022824] g2836.t1 Q5M882 50.394 127 3.16e-44 147.0 sp|Q5M882|RPP29_RAT Ribonuclease P protein subunit p29 OS=Rattus norvegicus OX=10116 GN=Pop4 PE=2 SV=1 g2837.t1 Q80TL1 47.81 525 2.59e-150 461.0 sp|Q80TL1|ADCY2_MOUSE Adenylate cyclase type 2 OS=Mus musculus OX=10090 GN=Adcy2 PE=1 SV=2 ADCY2_MOUSE reviewed Adenylate cyclase type 2 (EC 4.6.1.1) (ATP pyrophosphate-lyase 2) (Adenylate cyclase type II) (Adenylyl cyclase 2) Mus musculus (Mouse) GO:0000287; GO:0004016; GO:0005524; GO:0005737; GO:0005886; GO:0006171; GO:0007188; GO:0007189; GO:0008179; GO:0016020; GO:0030145; GO:0030425; GO:0031683; GO:0032991; GO:0035556; GO:0045121; GO:1904322 adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; cAMP biosynthetic process [GO:0006171]; cellular response to forskolin [GO:1904322]; intracellular signal transduction [GO:0035556] cytoplasm [GO:0005737]; dendrite [GO:0030425]; membrane [GO:0016020]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] adenylate cyclase activity [GO:0004016]; adenylate cyclase binding [GO:0008179]; ATP binding [GO:0005524]; G-protein beta/gamma-subunit complex binding [GO:0031683]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145] g2838.t1 Q08462 40.584 308 1.0300000000000001e-57 206.0 sp|Q08462|ADCY2_HUMAN Adenylate cyclase type 2 OS=Homo sapiens OX=9606 GN=ADCY2 PE=1 SV=5 ADCY2_HUMAN reviewed Adenylate cyclase type 2 (EC 4.6.1.1) (ATP pyrophosphate-lyase 2) (Adenylate cyclase type II) (Adenylyl cyclase 2) Homo sapiens (Human) GO:0000287; GO:0003091; GO:0004016; GO:0005524; GO:0005737; GO:0005886; GO:0006171; GO:0007188; GO:0007189; GO:0008179; GO:0016020; GO:0030145; GO:0030425; GO:0035556; GO:0045121; GO:0071377; GO:0097700; GO:1904322 adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; cAMP biosynthetic process [GO:0006171]; cellular response to forskolin [GO:1904322]; cellular response to glucagon stimulus [GO:0071377]; intracellular signal transduction [GO:0035556]; renal water homeostasis [GO:0003091]; vascular endothelial cell response to laminar fluid shear stress [GO:0097700] cytoplasm [GO:0005737]; dendrite [GO:0030425]; membrane [GO:0016020]; membrane raft [GO:0045121]; plasma membrane [GO:0005886] adenylate cyclase activity [GO:0004016]; adenylate cyclase binding [GO:0008179]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145] g2838.t2 Q08462 48.262 489 2.82e-140 446.0 sp|Q08462|ADCY2_HUMAN Adenylate cyclase type 2 OS=Homo sapiens OX=9606 GN=ADCY2 PE=1 SV=5 ADCY2_HUMAN reviewed Adenylate cyclase type 2 (EC 4.6.1.1) (ATP pyrophosphate-lyase 2) (Adenylate cyclase type II) (Adenylyl cyclase 2) Homo sapiens (Human) GO:0000287; GO:0003091; GO:0004016; GO:0005524; GO:0005737; GO:0005886; GO:0006171; GO:0007188; GO:0007189; GO:0008179; GO:0016020; GO:0030145; GO:0030425; GO:0035556; GO:0045121; GO:0071377; GO:0097700; GO:1904322 adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; cAMP biosynthetic process [GO:0006171]; cellular response to forskolin [GO:1904322]; cellular response to glucagon stimulus [GO:0071377]; intracellular signal transduction [GO:0035556]; renal water homeostasis [GO:0003091]; vascular endothelial cell response to laminar fluid shear stress [GO:0097700] cytoplasm [GO:0005737]; dendrite [GO:0030425]; membrane [GO:0016020]; membrane raft [GO:0045121]; plasma membrane [GO:0005886] adenylate cyclase activity [GO:0004016]; adenylate cyclase binding [GO:0008179]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145] g2839.t1 Q8BFR6 54.982 271 4.3200000000000004e-88 266.0 sp|Q8BFR6|ZFAN1_MOUSE AN1-type zinc finger protein 1 OS=Mus musculus OX=10090 GN=Zfand1 PE=1 SV=1 g2840.t1 Q1LXS2 43.223 273 2.21e-72 226.0 sp|Q1LXS2|PSMG2_DANRE Proteasome assembly chaperone 2 OS=Danio rerio OX=7955 GN=psmg2 PE=2 SV=1 g2841.t1 Q16822 64.067 359 1.2e-162 471.0 sp|Q16822|PCKGM_HUMAN Phosphoenolpyruvate carboxykinase [GTP], mitochondrial OS=Homo sapiens OX=9606 GN=PCK2 PE=1 SV=4 g2842.t1 A0A4X1UM84 66.887 151 2.2200000000000002e-66 217.0 sp|A0A4X1UM84|PCKGC_PIG Phosphoenolpyruvate carboxykinase, cytosolic [GTP] OS=Sus scrofa OX=9823 GN=PCK1 PE=1 SV=2 PCKGC_PIG reviewed Phosphoenolpyruvate carboxykinase, cytosolic [GTP] (PEPCK-C) (EC 4.1.1.32) (Serine-protein kinase PCK1) (EC 2.7.11.-) Sus scrofa (Pig) GO:0000287; GO:0004613; GO:0005525; GO:0005783; GO:0005829; GO:0006094; GO:0006107; GO:0006607; GO:0009617; GO:0010447; GO:0018105; GO:0030145; GO:0031406; GO:0032869; GO:0036316; GO:0043382; GO:0045542; GO:0045944; GO:0046166; GO:0046327; GO:0046890; GO:0051365; GO:0051604; GO:0071333; GO:0072350; GO:0106264 cellular response to glucose stimulus [GO:0071333]; cellular response to insulin stimulus [GO:0032869]; cellular response to potassium ion starvation [GO:0051365]; gluconeogenesis [GO:0006094]; glyceraldehyde-3-phosphate biosynthetic process [GO:0046166]; glycerol biosynthetic process from pyruvate [GO:0046327]; NLS-bearing protein import into nucleus [GO:0006607]; oxaloacetate metabolic process [GO:0006107]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of cholesterol biosynthetic process [GO:0045542]; positive regulation of memory T cell differentiation [GO:0043382]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein maturation [GO:0051604]; regulation of lipid biosynthetic process [GO:0046890]; response to acidic pH [GO:0010447]; response to bacterium [GO:0009617]; SREBP-SCAP complex retention in endoplasmic reticulum [GO:0036316]; tricarboxylic acid metabolic process [GO:0072350] cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783] carboxylic acid binding [GO:0031406]; GTP binding [GO:0005525]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; phosphoenolpyruvate carboxykinase (GTP) activity [GO:0004613]; protein serine kinase activity (using GTP as donor) [GO:0106264] g2843.t1 O13016 56.028 282 2.33e-110 333.0 sp|O13016|PTN1_CHICK Tyrosine-protein phosphatase non-receptor type 1 OS=Gallus gallus OX=9031 GN=PTPN1 PE=1 SV=1 g2843.t2 O13016 56.028 282 3.59e-110 334.0 sp|O13016|PTN1_CHICK Tyrosine-protein phosphatase non-receptor type 1 OS=Gallus gallus OX=9031 GN=PTPN1 PE=1 SV=1 g2845.t1 A1X158 35.214 514 9.789999999999999e-23 106.0 sp|A1X158|FP1V1_PERVI Foot protein 1 variant 1 OS=Perna viridis OX=73031 GN=fp-1 PE=1 SV=1 g2845.t1 A1X158 35.307 456 7.07e-21 100.0 sp|A1X158|FP1V1_PERVI Foot protein 1 variant 1 OS=Perna viridis OX=73031 GN=fp-1 PE=1 SV=1 g2846.t1 Q8R0A7 48.438 128 4.21e-33 132.0 sp|Q8R0A7|K0513_MOUSE Uncharacterized protein KIAA0513 OS=Mus musculus OX=10090 GN=Kiaa0513 PE=1 SV=1 g2846.t1 Q8R0A7 52.83 106 3.15e-28 119.0 sp|Q8R0A7|K0513_MOUSE Uncharacterized protein KIAA0513 OS=Mus musculus OX=10090 GN=Kiaa0513 PE=1 SV=1 g2847.t1 Q32PH2 31.759 381 5.28e-51 184.0 sp|Q32PH2|TM143_BOVIN Transmembrane protein 143 OS=Bos taurus OX=9913 GN=TMEM143 PE=2 SV=1 g2848.t1 Q6P9S1 33.75 160 1.1400000000000001e-21 104.0 sp|Q6P9S1|ATMIN_MOUSE ATM interactor OS=Mus musculus OX=10090 GN=Atmin PE=2 SV=2 ATMIN_MOUSE reviewed ATM interactor (ATM/ATR-substrate CHK2-interacting zinc finger protein) (ASCIZ) Mus musculus (Mouse) GO:0000976; GO:0000981; GO:0001228; GO:0005634; GO:0006357; GO:0006974; GO:0008270; GO:0010628; GO:0016604; GO:0044458; GO:0045893; GO:0045944; GO:0070840; GO:1902857 DNA damage response [GO:0006974]; motile cilium assembly [GO:0044458]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of gene expression [GO:0010628]; positive regulation of non-motile cilium assembly [GO:1902857]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357] nuclear body [GO:0016604]; nucleus [GO:0005634] DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; dynein complex binding [GO:0070840]; transcription cis-regulatory region binding [GO:0000976]; zinc ion binding [GO:0008270] g2850.t1 Q9QYJ0 61.687 415 4.04e-152 440.0 sp|Q9QYJ0|DNJA2_MOUSE DnaJ homolog subfamily A member 2 OS=Mus musculus OX=10090 GN=Dnaja2 PE=1 SV=1 g2851.t1 Q9JLV2 42.51 781 0.0 592.0 sp|Q9JLV2|TP4AP_MOUSE Short transient receptor potential channel 4-associated protein OS=Mus musculus OX=10090 GN=Trpc4ap PE=1 SV=2 TP4AP_MOUSE reviewed Short transient receptor potential channel 4-associated protein (Trp4-associated protein) (Trpc4-associated protein) (Protein TAP1) (Rabex-5/Rin2-interacting protein) (TNF-receptor ubiquitous scaffolding/signaling protein) (Protein TRUSS) Mus musculus (Mouse) GO:0005829; GO:0006511; GO:0016567; GO:0019902; GO:0031464; GO:0048471; GO:0048820; GO:0080008; GO:0140627; GO:1990756 hair follicle maturation [GO:0048820]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]; ubiquitin-dependent protein catabolic process via the C-end degron rule pathway [GO:0140627] Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]; cytosol [GO:0005829]; perinuclear region of cytoplasm [GO:0048471] phosphatase binding [GO:0019902]; ubiquitin-like ligase-substrate adaptor activity [GO:1990756] g2852.t1 Q5VZK9 44.471 841 0.0 712.0 sp|Q5VZK9|CARL1_HUMAN F-actin-uncapping protein LRRC16A OS=Homo sapiens OX=9606 GN=CARMIL1 PE=1 SV=1 CARL1_HUMAN reviewed F-actin-uncapping protein LRRC16A (CARMIL homolog) (Capping protein regulator and myosin 1 linker protein 1) (Capping protein, Arp2/3 and myosin-I linker homolog 1) (Capping protein, Arp2/3 and myosin-I linker protein 1) (Leucine-rich repeat-containing protein 16A) Homo sapiens (Human) GO:0005829; GO:0005886; GO:0007015; GO:0016477; GO:0016607; GO:0030027; GO:0030032; GO:0030335; GO:0030838; GO:0031252; GO:0031529; GO:0031941; GO:0034315; GO:0044351; GO:0044354; GO:0044877; GO:0046415; GO:0051496; GO:0051638; GO:0051639; GO:0070062; GO:1900026; GO:1902745; GO:2000813 actin filament network formation [GO:0051639]; actin filament organization [GO:0007015]; barbed-end actin filament uncapping [GO:0051638]; cell migration [GO:0016477]; lamellipodium assembly [GO:0030032]; macropinocytosis [GO:0044351]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell migration [GO:0030335]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; regulation of Arp2/3 complex-mediated actin nucleation [GO:0034315]; ruffle organization [GO:0031529]; urate metabolic process [GO:0046415] cell leading edge [GO:0031252]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; filamentous actin [GO:0031941]; lamellipodium [GO:0030027]; macropinosome [GO:0044354]; nuclear speck [GO:0016607]; plasma membrane [GO:0005886] protein-containing complex binding [GO:0044877] g2852.t2 Q5VZK9 44.471 841 0.0 711.0 sp|Q5VZK9|CARL1_HUMAN F-actin-uncapping protein LRRC16A OS=Homo sapiens OX=9606 GN=CARMIL1 PE=1 SV=1 CARL1_HUMAN reviewed F-actin-uncapping protein LRRC16A (CARMIL homolog) (Capping protein regulator and myosin 1 linker protein 1) (Capping protein, Arp2/3 and myosin-I linker homolog 1) (Capping protein, Arp2/3 and myosin-I linker protein 1) (Leucine-rich repeat-containing protein 16A) Homo sapiens (Human) GO:0005829; GO:0005886; GO:0007015; GO:0016477; GO:0016607; GO:0030027; GO:0030032; GO:0030335; GO:0030838; GO:0031252; GO:0031529; GO:0031941; GO:0034315; GO:0044351; GO:0044354; GO:0044877; GO:0046415; GO:0051496; GO:0051638; GO:0051639; GO:0070062; GO:1900026; GO:1902745; GO:2000813 actin filament network formation [GO:0051639]; actin filament organization [GO:0007015]; barbed-end actin filament uncapping [GO:0051638]; cell migration [GO:0016477]; lamellipodium assembly [GO:0030032]; macropinocytosis [GO:0044351]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell migration [GO:0030335]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; regulation of Arp2/3 complex-mediated actin nucleation [GO:0034315]; ruffle organization [GO:0031529]; urate metabolic process [GO:0046415] cell leading edge [GO:0031252]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; filamentous actin [GO:0031941]; lamellipodium [GO:0030027]; macropinosome [GO:0044354]; nuclear speck [GO:0016607]; plasma membrane [GO:0005886] protein-containing complex binding [GO:0044877] g2864.t1 Q9DB96 49.6 250 1.37e-66 214.0 sp|Q9DB96|NGDN_MOUSE Neuroguidin OS=Mus musculus OX=10090 GN=Ngdn PE=1 SV=1 NGDN_MOUSE reviewed Neuroguidin (EIF4E-binding protein) Mus musculus (Mouse) GO:0000462; GO:0000775; GO:0005654; GO:0005730; GO:0005739; GO:0030175; GO:0030424; GO:0030425; GO:0032040; GO:0042274; GO:0098794; GO:0098978; GO:0099170; GO:0140240; GO:0140245; GO:1903077 maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; negative regulation of protein localization to plasma membrane [GO:1903077]; postsynaptic modulation of chemical synaptic transmission [GO:0099170]; regulation of translation at postsynapse [GO:0140245]; ribosomal small subunit biogenesis [GO:0042274] axon [GO:0030424]; chromosome, centromeric region [GO:0000775]; dendrite [GO:0030425]; filopodium [GO:0030175]; glutamatergic synapse [GO:0098978]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; perforant pathway to dendrate granule cell synapse [GO:0140240]; postsynapse [GO:0098794]; small-subunit processome [GO:0032040] g2864.t2 Q2KII6 45.724 304 2.0000000000000002e-71 228.0 sp|Q2KII6|NGDN_BOVIN Neuroguidin OS=Bos taurus OX=9913 GN=NGDN PE=2 SV=1 NGDN_BOVIN reviewed Neuroguidin (EIF4E-binding protein) Bos taurus (Bovine) GO:0000462; GO:0000775; GO:0005654; GO:0005730; GO:0005739; GO:0006417; GO:0030175; GO:0030424; GO:0030425; GO:0032040; GO:0042274 maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; regulation of translation [GO:0006417]; ribosomal small subunit biogenesis [GO:0042274] axon [GO:0030424]; chromosome, centromeric region [GO:0000775]; dendrite [GO:0030425]; filopodium [GO:0030175]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; small-subunit processome [GO:0032040] g2865.t1 B5XB24 58.757 177 3.07e-71 216.0 sp|B5XB24|EMC4_SALSA ER membrane protein complex subunit 4 OS=Salmo salar OX=8030 GN=emc4 PE=2 SV=1 g2866.t1 Q8R1F9 36.579 380 1.21e-75 241.0 sp|Q8R1F9|RPP40_MOUSE Ribonuclease P protein subunit p40 OS=Mus musculus OX=10090 GN=Rpp40 PE=2 SV=2 g2867.t1 P51875 85.987 157 2.0099999999999998e-98 291.0 sp|P51875|GNAO_CAEEL Guanine nucleotide-binding protein G(o) subunit alpha OS=Caenorhabditis elegans OX=6239 GN=goa-1 PE=1 SV=3 GNAO_CAEEL reviewed Guanine nucleotide-binding protein G(o) subunit alpha Caenorhabditis elegans GO:0001664; GO:0003924; GO:0003925; GO:0005525; GO:0005737; GO:0005834; GO:0005938; GO:0006935; GO:0007186; GO:0007188; GO:0007212; GO:0009410; GO:0016907; GO:0019901; GO:0031683; GO:0032094; GO:0032223; GO:0040012; GO:0043051; GO:0043495; GO:0045202; GO:0046662; GO:0046872; GO:0048681; GO:0050829; GO:0051301; GO:0060259; GO:0120169; GO:1904014 adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; cell division [GO:0051301]; chemotaxis [GO:0006935]; defense response to Gram-negative bacterium [GO:0050829]; detection of cold stimulus involved in thermoception [GO:0120169]; G protein-coupled dopamine receptor signaling pathway [GO:0007212]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of axon regeneration [GO:0048681]; negative regulation of synaptic transmission, cholinergic [GO:0032223]; regulation of egg-laying behavior [GO:0046662]; regulation of feeding behavior [GO:0060259]; regulation of locomotion [GO:0040012]; regulation of nematode pharyngeal pumping [GO:0043051]; response to food [GO:0032094]; response to serotonin [GO:1904014]; response to xenobiotic stimulus [GO:0009410] cell cortex [GO:0005938]; cytoplasm [GO:0005737]; heterotrimeric G-protein complex [GO:0005834]; synapse [GO:0045202] G protein activity [GO:0003925]; G protein-coupled acetylcholine receptor activity [GO:0016907]; G protein-coupled receptor binding [GO:0001664]; G-protein beta/gamma-subunit complex binding [GO:0031683]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; protein kinase binding [GO:0019901]; protein-membrane adaptor activity [GO:0043495] g2868.t1 P10825 72.0 175 5.91e-88 265.0 sp|P10825|GNAO_XENLA Guanine nucleotide-binding protein G(o) subunit alpha OS=Xenopus laevis OX=8355 GN=gna0 PE=2 SV=5 g2869.t1 Q9VY77 60.748 321 9.909999999999999e-126 389.0 sp|Q9VY77|AJUBA_DROME LIM domain-containing protein jub OS=Drosophila melanogaster OX=7227 GN=jub PE=1 SV=3 AJUBA_DROME reviewed LIM domain-containing protein jub Drosophila melanogaster (Fruit fly) GO:0000278; GO:0000932; GO:0001666; GO:0003714; GO:0005634; GO:0005667; GO:0005912; GO:0006355; GO:0007010; GO:0030707; GO:0035331; GO:0045179; GO:0045572; GO:0046872; GO:0071539; GO:0140311 cytoskeleton organization [GO:0007010]; follicle cell of egg chamber development [GO:0030707]; mitotic cell cycle [GO:0000278]; negative regulation of hippo signaling [GO:0035331]; positive regulation of imaginal disc growth [GO:0045572]; protein localization to centrosome [GO:0071539]; regulation of DNA-templated transcription [GO:0006355]; response to hypoxia [GO:0001666] adherens junction [GO:0005912]; apical cortex [GO:0045179]; nucleus [GO:0005634]; P-body [GO:0000932]; transcription regulator complex [GO:0005667] metal ion binding [GO:0046872]; protein sequestering activity [GO:0140311]; transcription corepressor activity [GO:0003714] g2869.t2 Q9VY77 60.125 321 1.8e-122 380.0 sp|Q9VY77|AJUBA_DROME LIM domain-containing protein jub OS=Drosophila melanogaster OX=7227 GN=jub PE=1 SV=3 AJUBA_DROME reviewed LIM domain-containing protein jub Drosophila melanogaster (Fruit fly) GO:0000278; GO:0000932; GO:0001666; GO:0003714; GO:0005634; GO:0005667; GO:0005912; GO:0006355; GO:0007010; GO:0030707; GO:0035331; GO:0045179; GO:0045572; GO:0046872; GO:0071539; GO:0140311 cytoskeleton organization [GO:0007010]; follicle cell of egg chamber development [GO:0030707]; mitotic cell cycle [GO:0000278]; negative regulation of hippo signaling [GO:0035331]; positive regulation of imaginal disc growth [GO:0045572]; protein localization to centrosome [GO:0071539]; regulation of DNA-templated transcription [GO:0006355]; response to hypoxia [GO:0001666] adherens junction [GO:0005912]; apical cortex [GO:0045179]; nucleus [GO:0005634]; P-body [GO:0000932]; transcription regulator complex [GO:0005667] metal ion binding [GO:0046872]; protein sequestering activity [GO:0140311]; transcription corepressor activity [GO:0003714] g2870.t1 P12815 66.279 172 1.0199999999999999e-82 245.0 sp|P12815|PDCD6_MOUSE Programmed cell death protein 6 OS=Mus musculus OX=10090 GN=Pdcd6 PE=1 SV=2 PDCD6_MOUSE reviewed Programmed cell death protein 6 (ALG-257) (Apoptosis-linked gene 2 protein) (ALG-2) (PMP41) Mus musculus (Mouse) GO:0000287; GO:0001525; GO:0001938; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005783; GO:0005789; GO:0005829; GO:0006886; GO:0006888; GO:0006915; GO:0010595; GO:0014029; GO:0014032; GO:0030127; GO:0030674; GO:0030948; GO:0031410; GO:0031463; GO:0032007; GO:0034605; GO:0036324; GO:0042802; GO:0042803; GO:0043065; GO:0043495; GO:0045766; GO:0046982; GO:0046983; GO:0048208; GO:0048306; GO:0048471; GO:0051592; GO:0051898; GO:0070971; GO:1902527; GO:1990756 angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; cellular response to heat [GO:0034605]; COPII vesicle coating [GO:0048208]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886]; negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051898]; negative regulation of TOR signaling [GO:0032007]; negative regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030948]; neural crest cell development [GO:0014032]; neural crest formation [GO:0014029]; positive regulation of angiogenesis [GO:0045766]; positive regulation of apoptotic process [GO:0043065]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of protein monoubiquitination [GO:1902527]; response to calcium ion [GO:0051592]; vascular endothelial growth factor receptor-2 signaling pathway [GO:0036324] COPII vesicle coat [GO:0030127]; Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471] calcium ion binding [GO:0005509]; calcium-dependent protein binding [GO:0048306]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; protein dimerization activity [GO:0046983]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; protein-macromolecule adaptor activity [GO:0030674]; protein-membrane adaptor activity [GO:0043495]; ubiquitin-like ligase-substrate adaptor activity [GO:1990756] g2872.t1 Q06455 50.465 430 1.2000000000000002e-123 382.0 sp|Q06455|MTG8_HUMAN Protein CBFA2T1 OS=Homo sapiens OX=9606 GN=RUNX1T1 PE=1 SV=2 MTG8_HUMAN reviewed Protein CBFA2T1 (Cyclin-D-related protein) (Eight twenty one protein) (Protein ETO) (Protein MTG8) (Zinc finger MYND domain-containing protein 2) Homo sapiens (Human) GO:0003677; GO:0003714; GO:0005634; GO:0005654; GO:0006351; GO:0008270; GO:0016363; GO:0045599; GO:0045892; GO:0140297 DNA-templated transcription [GO:0006351]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of fat cell differentiation [GO:0045599] nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] DNA binding [GO:0003677]; DNA-binding transcription factor binding [GO:0140297]; transcription corepressor activity [GO:0003714]; zinc ion binding [GO:0008270] g2872.t2 Q06455 50.465 430 3.9600000000000003e-122 378.0 sp|Q06455|MTG8_HUMAN Protein CBFA2T1 OS=Homo sapiens OX=9606 GN=RUNX1T1 PE=1 SV=2 MTG8_HUMAN reviewed Protein CBFA2T1 (Cyclin-D-related protein) (Eight twenty one protein) (Protein ETO) (Protein MTG8) (Zinc finger MYND domain-containing protein 2) Homo sapiens (Human) GO:0003677; GO:0003714; GO:0005634; GO:0005654; GO:0006351; GO:0008270; GO:0016363; GO:0045599; GO:0045892; GO:0140297 DNA-templated transcription [GO:0006351]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of fat cell differentiation [GO:0045599] nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] DNA binding [GO:0003677]; DNA-binding transcription factor binding [GO:0140297]; transcription corepressor activity [GO:0003714]; zinc ion binding [GO:0008270] g2876.t1 Q5ZKP6 49.853 341 3.83e-120 354.0 sp|Q5ZKP6|ADA_CHICK Adenosine deaminase OS=Gallus gallus OX=9031 GN=ADA PE=2 SV=1 ADA_CHICK reviewed Adenosine deaminase (EC 3.5.4.4) (Adenosine aminohydrolase) Gallus gallus (Chicken) GO:0004000; GO:0005764; GO:0005829; GO:0006154; GO:0008270; GO:0009117; GO:0009168; GO:0009897; GO:0042110; GO:0043103; GO:0045187; GO:0046103; GO:0046936; GO:0060169; GO:0060205; GO:0070161 adenosine catabolic process [GO:0006154]; hypoxanthine salvage [GO:0043103]; inosine biosynthetic process [GO:0046103]; negative regulation of adenosine receptor signaling pathway [GO:0060169]; nucleotide metabolic process [GO:0009117]; purine ribonucleoside monophosphate biosynthetic process [GO:0009168]; regulation of circadian sleep/wake cycle, sleep [GO:0045187]; T cell activation [GO:0042110] anchoring junction [GO:0070161]; cytoplasmic vesicle lumen [GO:0060205]; cytosol [GO:0005829]; external side of plasma membrane [GO:0009897]; lysosome [GO:0005764] 2'-deoxyadenosine deaminase activity [GO:0046936]; adenosine deaminase activity [GO:0004000]; zinc ion binding [GO:0008270] g2879.t1 A1A4J6 65.178 1097 0.0 1480.0 sp|A1A4J6|ATP9B_BOVIN Probable phospholipid-transporting ATPase IIB OS=Bos taurus OX=9913 GN=ATP9B PE=2 SV=1 ATP9B_BOVIN reviewed Probable phospholipid-transporting ATPase IIB (EC 7.6.2.1) (ATPase class II type 9B) Bos taurus (Bovine) GO:0000287; GO:0005524; GO:0005768; GO:0005802; GO:0005886; GO:0006890; GO:0006897; GO:0016887; GO:0045332; GO:0048471; GO:0140326 endocytosis [GO:0006897]; phospholipid translocation [GO:0045332]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890] endosome [GO:0005768]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; magnesium ion binding [GO:0000287] g2879.t2 F1Q4S1 64.299 1112 0.0 1474.0 sp|F1Q4S1|ATP9B_DANRE Probable phospholipid-transporting ATPase IIB OS=Danio rerio OX=7955 GN=atp9b PE=3 SV=1 ATP9B_DANRE reviewed Probable phospholipid-transporting ATPase IIB (EC 7.6.2.1) (ATPase class II type 9B) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000287; GO:0005524; GO:0005768; GO:0005802; GO:0005886; GO:0006890; GO:0006897; GO:0016887; GO:0045332; GO:0140326 endocytosis [GO:0006897]; phospholipid translocation [GO:0045332]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890] endosome [GO:0005768]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; magnesium ion binding [GO:0000287] g2880.t1 Q92179 34.561 353 1.87e-54 192.0 sp|Q92179|CHST3_CHICK Carbohydrate sulfotransferase 3 OS=Gallus gallus OX=9031 GN=CHST3 PE=1 SV=1 g2881.t1 Q5PQY6 60.14 858 0.0 908.0 sp|Q5PQY6|LONP2_DANRE Lon protease homolog 2, peroxisomal OS=Danio rerio OX=7955 GN=lonp2 PE=2 SV=1 LONP2_DANRE reviewed Lon protease homolog 2, peroxisomal (EC 3.4.21.53) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0004176; GO:0004252; GO:0005524; GO:0005782; GO:0006515; GO:0006625; GO:0009653; GO:0016485; GO:0016558; GO:0016887 anatomical structure morphogenesis [GO:0009653]; protein import into peroxisome matrix [GO:0016558]; protein processing [GO:0016485]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; protein targeting to peroxisome [GO:0006625] peroxisomal matrix [GO:0005782] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent peptidase activity [GO:0004176]; serine-type endopeptidase activity [GO:0004252] g2881.t2 Q5PQY6 60.256 858 0.0 906.0 sp|Q5PQY6|LONP2_DANRE Lon protease homolog 2, peroxisomal OS=Danio rerio OX=7955 GN=lonp2 PE=2 SV=1 LONP2_DANRE reviewed Lon protease homolog 2, peroxisomal (EC 3.4.21.53) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0004176; GO:0004252; GO:0005524; GO:0005782; GO:0006515; GO:0006625; GO:0009653; GO:0016485; GO:0016558; GO:0016887 anatomical structure morphogenesis [GO:0009653]; protein import into peroxisome matrix [GO:0016558]; protein processing [GO:0016485]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; protein targeting to peroxisome [GO:0006625] peroxisomal matrix [GO:0005782] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent peptidase activity [GO:0004176]; serine-type endopeptidase activity [GO:0004252] g2883.t1 Q2LAM0 45.902 366 2.92e-104 314.0 sp|Q2LAM0|FA2H_RAT Fatty acid 2-hydroxylase OS=Rattus norvegicus OX=10116 GN=Fa2h PE=1 SV=2 FA2H_RAT reviewed Fatty acid 2-hydroxylase (EC 1.14.18.-) (Fatty acid alpha-hydroxylase) Rattus norvegicus (Rat) GO:0001949; GO:0005506; GO:0005783; GO:0005789; GO:0006631; GO:0006633; GO:0006679; GO:0006682; GO:0016020; GO:0020037; GO:0030258; GO:0032286; GO:0032287; GO:0042634; GO:0044857; GO:0046513; GO:0061436; GO:0080132; GO:0120520; GO:0120521; GO:1904002; GO:1904697 central nervous system myelin maintenance [GO:0032286]; ceramide biosynthetic process [GO:0046513]; establishment of skin barrier [GO:0061436]; fatty acid biosynthetic process [GO:0006633]; fatty acid metabolic process [GO:0006631]; galactosylceramide biosynthetic process [GO:0006682]; glucosylceramide biosynthetic process [GO:0006679]; lipid modification [GO:0030258]; peripheral nervous system myelin maintenance [GO:0032287]; plasma membrane raft organization [GO:0044857]; regulation of acinar cell proliferation [GO:1904697]; regulation of hair cycle [GO:0042634]; regulation of sebum secreting cell proliferation [GO:1904002]; sebaceous gland cell differentiation [GO:0001949] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020] 4-hydroxysphinganine ceramide fatty acyl 2-hydroxylase activity [GO:0120521]; fatty acid 2-hydroxylase activity [GO:0080132]; free fatty acid 2-hydroxylase activity [GO:0120520]; heme binding [GO:0020037]; iron ion binding [GO:0005506] g2885.t1 O95995 70.246 447 0.0 535.0 sp|O95995|DRC4_HUMAN Dynein regulatory complex subunit 4 OS=Homo sapiens OX=9606 GN=GAS8 PE=1 SV=1 DRC4_HUMAN reviewed Dynein regulatory complex subunit 4 (Growth arrest-specific protein 11) (GAS-11) (Growth arrest-specific protein 8) (GAS-8) Homo sapiens (Human) GO:0000226; GO:0003351; GO:0005576; GO:0005794; GO:0005829; GO:0005874; GO:0005886; GO:0005929; GO:0005930; GO:0007368; GO:0007420; GO:0008017; GO:0008285; GO:0030317; GO:0031267; GO:0031514; GO:0035082; GO:0036064; GO:0036126; GO:0044782; GO:0045880; GO:0051649; GO:0060294; GO:0061512; GO:0065003; GO:0097225; GO:0097228; GO:0097229; GO:1903566 axoneme assembly [GO:0035082]; brain development [GO:0007420]; cilium movement involved in cell motility [GO:0060294]; cilium organization [GO:0044782]; determination of left/right symmetry [GO:0007368]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; establishment of localization in cell [GO:0051649]; flagellated sperm motility [GO:0030317]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of protein localization to cilium [GO:1903566]; positive regulation of smoothened signaling pathway [GO:0045880]; protein localization to cilium [GO:0061512]; protein-containing complex assembly [GO:0065003] axoneme [GO:0005930]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytosol [GO:0005829]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; microtubule [GO:0005874]; motile cilium [GO:0031514]; plasma membrane [GO:0005886]; sperm end piece [GO:0097229]; sperm flagellum [GO:0036126]; sperm midpiece [GO:0097225]; sperm principal piece [GO:0097228] microtubule binding [GO:0008017]; small GTPase binding [GO:0031267] g2886.t1 Q6UXB8 40.437 183 4.41e-36 144.0 sp|Q6UXB8|PI16_HUMAN Peptidase inhibitor 16 OS=Homo sapiens OX=9606 GN=PI16 PE=1 SV=1 PI16_HUMAN reviewed Peptidase inhibitor 16 (PI-16) (Cysteine-rich secretory protein 9) (CRISP-9) (PSP94-binding protein) (CD antigen CD364) Homo sapiens (Human) GO:0005615; GO:0030414; GO:0061052 negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052] extracellular space [GO:0005615] peptidase inhibitor activity [GO:0030414] g2887.t1 Q8R4Y8 28.962 1937 4.0599999999999997e-168 576.0 sp|Q8R4Y8|RTTN_MOUSE Rotatin OS=Mus musculus OX=10090 GN=Rttn PE=1 SV=2 g2887.t1 Q8R4Y8 42.434 304 5.99e-49 197.0 sp|Q8R4Y8|RTTN_MOUSE Rotatin OS=Mus musculus OX=10090 GN=Rttn PE=1 SV=2 g2888.t1 Q6PKX4 49.541 218 1.96e-73 228.0 sp|Q6PKX4|DOK6_HUMAN Docking protein 6 OS=Homo sapiens OX=9606 GN=DOK6 PE=1 SV=1 DOK6_HUMAN reviewed Docking protein 6 (Downstream of tyrosine kinase 6) Homo sapiens (Human) GO:0005737; GO:0005829; GO:0007169 cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169] cytoplasm [GO:0005737]; cytosol [GO:0005829] g2890.t1 Q08CN9 54.601 163 4.25e-49 164.0 sp|Q08CN9|ZNRF2_DANRE E3 ubiquitin-protein ligase znrf2 OS=Danio rerio OX=7955 GN=znrf2 PE=2 SV=1 ZNRF2_DANRE reviewed E3 ubiquitin-protein ligase znrf2 (EC 2.3.2.27) (RING-type E3 ubiquitin transferase znrf2) (Zinc/RING finger protein 2) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005737; GO:0005765; GO:0008270; GO:0010008; GO:0016020; GO:0042734; GO:0043161; GO:0061630; GO:0070936 proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K48-linked ubiquitination [GO:0070936] cytoplasm [GO:0005737]; endosome membrane [GO:0010008]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; presynaptic membrane [GO:0042734] ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] g2891.t1 O04486 30.631 222 1.11e-26 105.0 sp|O04486|RAA2A_ARATH Ras-related protein RABA2a OS=Arabidopsis thaliana OX=3702 GN=RABA2A PE=2 SV=1 g2893.t1 Q0MQG7 67.382 233 2.3e-116 336.0 sp|Q0MQG7|NDUS3_GORGO NADH dehydrogenase [ubiquinone] iron-sulfur protein 3, mitochondrial OS=Gorilla gorilla gorilla OX=9595 GN=NDUFS3 PE=2 SV=1 g2893.t2 Q0MQG7 67.66 235 2.01e-118 342.0 sp|Q0MQG7|NDUS3_GORGO NADH dehydrogenase [ubiquinone] iron-sulfur protein 3, mitochondrial OS=Gorilla gorilla gorilla OX=9595 GN=NDUFS3 PE=2 SV=1 g2894.t1 Q3UMM4 72.321 336 0.0 513.0 sp|Q3UMM4|CDK10_MOUSE Cyclin-dependent kinase 10 OS=Mus musculus OX=10090 GN=Cdk10 PE=1 SV=1 CDK10_MOUSE reviewed Cyclin-dependent kinase 10 (EC 2.7.11.22) (Cell division protein kinase 10) Mus musculus (Mouse) GO:0000307; GO:0004674; GO:0004693; GO:0005524; GO:0005634; GO:0007346; GO:0018107; GO:0030030; GO:0032956; GO:0036064; GO:0043410; GO:0097472; GO:0106310; GO:1902018; GO:1902749 cell projection organization [GO:0030030]; negative regulation of cilium assembly [GO:1902018]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of MAPK cascade [GO:0043410]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell cycle G2/M phase transition [GO:1902749]; regulation of mitotic cell cycle [GO:0007346] ciliary basal body [GO:0036064]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; nucleus [GO:0005634] ATP binding [GO:0005524]; cyclin-dependent protein kinase activity [GO:0097472]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g2897.t1 Q54N00 26.913 379 7.430000000000001e-37 154.0 sp|Q54N00|FORH_DICDI Formin-H OS=Dictyostelium discoideum OX=44689 GN=forH PE=1 SV=1 FORH_DICDI reviewed Formin-H (Diaphanous-related formin dia2) (dDia2) Dictyostelium discoideum (Social amoeba) GO:0000281; GO:0000902; GO:0005522; GO:0005938; GO:0015629; GO:0030041; GO:0030175; GO:0030587; GO:0030838; GO:0030866; GO:0031254; GO:0031267; GO:0031268; GO:0031589; GO:0032433; GO:0045010; GO:0046847; GO:0048870; GO:0051015; GO:0051638; GO:0070060 'de novo' actin filament nucleation [GO:0070060]; actin filament polymerization [GO:0030041]; actin nucleation [GO:0045010]; barbed-end actin filament uncapping [GO:0051638]; cell morphogenesis [GO:0000902]; cell motility [GO:0048870]; cell-substrate adhesion [GO:0031589]; cortical actin cytoskeleton organization [GO:0030866]; filopodium assembly [GO:0046847]; mitotic cytokinesis [GO:0000281]; positive regulation of actin filament polymerization [GO:0030838]; pseudopodium organization [GO:0031268]; sorocarp development [GO:0030587] actin cytoskeleton [GO:0015629]; cell cortex [GO:0005938]; cell trailing edge [GO:0031254]; filopodium [GO:0030175]; filopodium tip [GO:0032433] actin filament binding [GO:0051015]; profilin binding [GO:0005522]; small GTPase binding [GO:0031267] g2909.t1 Q1ZXJ0 34.441 752 9.21e-99 330.0 sp|Q1ZXJ0|CLCD_DICDI Chloride channel protein D OS=Dictyostelium discoideum OX=44689 GN=clcD PE=3 SV=1 g2910.t1 Q96DM1 24.299 428 1.8800000000000002e-27 120.0 sp|Q96DM1|PGBD4_HUMAN PiggyBac transposable element-derived protein 4 OS=Homo sapiens OX=9606 GN=PGBD4 PE=1 SV=3 g2913.t1 Q9Z269 52.217 203 5.64e-69 215.0 sp|Q9Z269|VAPB_RAT Vesicle-associated membrane protein-associated protein B OS=Rattus norvegicus OX=10116 GN=Vapb PE=1 SV=3 VAPB_RAT reviewed Vesicle-associated membrane protein-associated protein B (VAMP-B) (VAMP-associated protein B) (VAP-B) Rattus norvegicus (Rat) GO:0005737; GO:0005783; GO:0005789; GO:0005794; GO:0005886; GO:0006874; GO:0006888; GO:0007029; GO:0008017; GO:0016020; GO:0019076; GO:0019899; GO:0030301; GO:0030968; GO:0033149; GO:0036498; GO:0042803; GO:0043495; GO:0044790; GO:0044828; GO:0044829; GO:0044830; GO:0045070; GO:0046725; GO:0046982; GO:0048487; GO:0061817; GO:0090114; GO:0090158; GO:0098793; GO:0098794; GO:0098978 cholesterol transport [GO:0030301]; COPII-coated vesicle budding [GO:0090114]; endoplasmic reticulum membrane organization [GO:0090158]; endoplasmic reticulum organization [GO:0007029]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; endoplasmic reticulum unfolded protein response [GO:0030968]; endoplasmic reticulum-plasma membrane tethering [GO:0061817]; host-mediated activation of viral genome replication [GO:0044829]; host-mediated perturbation of viral RNA genome replication [GO:0044830]; host-mediated suppression of viral genome replication [GO:0044828]; intracellular calcium ion homeostasis [GO:0006874]; IRE1-mediated unfolded protein response [GO:0036498]; negative regulation by virus of viral protein levels in host cell [GO:0046725]; positive regulation of viral genome replication [GO:0045070]; suppression of viral release by host [GO:0044790]; viral release from host cell [GO:0019076] cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; presynapse [GO:0098793] beta-tubulin binding [GO:0048487]; enzyme binding [GO:0019899]; FFAT motif binding [GO:0033149]; microtubule binding [GO:0008017]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; protein-membrane adaptor activity [GO:0043495] g2914.t1 Q5F389 59.606 406 2.21e-177 503.0 sp|Q5F389|WWOX_CHICK WW domain-containing oxidoreductase OS=Gallus gallus OX=9031 GN=WWOX PE=2 SV=2 WWOX_CHICK reviewed WW domain-containing oxidoreductase (EC 1.1.1.-) Gallus gallus (Chicken) GO:0001649; GO:0003713; GO:0005739; GO:0005764; GO:0005794; GO:0005829; GO:0005886; GO:0005902; GO:0016055; GO:0016491; GO:0019899; GO:0030178; GO:0045944; GO:0048705; GO:0071560; GO:0072332; GO:0090575; GO:0097191; GO:2001241 cellular response to transforming growth factor beta stimulus [GO:0071560]; extrinsic apoptotic signaling pathway [GO:0097191]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; negative regulation of Wnt signaling pathway [GO:0030178]; osteoblast differentiation [GO:0001649]; positive regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001241]; positive regulation of transcription by RNA polymerase II [GO:0045944]; skeletal system morphogenesis [GO:0048705]; Wnt signaling pathway [GO:0016055] cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; lysosome [GO:0005764]; microvillus [GO:0005902]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; RNA polymerase II transcription regulator complex [GO:0090575] enzyme binding [GO:0019899]; oxidoreductase activity [GO:0016491]; transcription coactivator activity [GO:0003713] g2914.t2 Q5F389 59.36 406 4.5e-175 498.0 sp|Q5F389|WWOX_CHICK WW domain-containing oxidoreductase OS=Gallus gallus OX=9031 GN=WWOX PE=2 SV=2 WWOX_CHICK reviewed WW domain-containing oxidoreductase (EC 1.1.1.-) Gallus gallus (Chicken) GO:0001649; GO:0003713; GO:0005739; GO:0005764; GO:0005794; GO:0005829; GO:0005886; GO:0005902; GO:0016055; GO:0016491; GO:0019899; GO:0030178; GO:0045944; GO:0048705; GO:0071560; GO:0072332; GO:0090575; GO:0097191; GO:2001241 cellular response to transforming growth factor beta stimulus [GO:0071560]; extrinsic apoptotic signaling pathway [GO:0097191]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; negative regulation of Wnt signaling pathway [GO:0030178]; osteoblast differentiation [GO:0001649]; positive regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001241]; positive regulation of transcription by RNA polymerase II [GO:0045944]; skeletal system morphogenesis [GO:0048705]; Wnt signaling pathway [GO:0016055] cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; lysosome [GO:0005764]; microvillus [GO:0005902]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; RNA polymerase II transcription regulator complex [GO:0090575] enzyme binding [GO:0019899]; oxidoreductase activity [GO:0016491]; transcription coactivator activity [GO:0003713] g2916.t1 Q8TE57 48.849 1173 0.0 1162.0 sp|Q8TE57|ATS16_HUMAN A disintegrin and metalloproteinase with thrombospondin motifs 16 OS=Homo sapiens OX=9606 GN=ADAMTS16 PE=1 SV=3 ATS16_HUMAN reviewed A disintegrin and metalloproteinase with thrombospondin motifs 16 (ADAM-TS 16) (ADAM-TS16) (ADAMTS-16) (EC 3.4.24.-) Homo sapiens (Human) GO:0001658; GO:0003073; GO:0004222; GO:0006508; GO:0030198; GO:0031012; GO:0046872; GO:0048232; GO:1902017 branching involved in ureteric bud morphogenesis [GO:0001658]; extracellular matrix organization [GO:0030198]; male gamete generation [GO:0048232]; proteolysis [GO:0006508]; regulation of cilium assembly [GO:1902017]; regulation of systemic arterial blood pressure [GO:0003073] extracellular matrix [GO:0031012] metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222] g2916.t2 Q8TE60 45.111 1166 0.0 1052.0 sp|Q8TE60|ATS18_HUMAN A disintegrin and metalloproteinase with thrombospondin motifs 18 OS=Homo sapiens OX=9606 GN=ADAMTS18 PE=1 SV=3 ATS18_HUMAN reviewed A disintegrin and metalloproteinase with thrombospondin motifs 18 (ADAM-TS 18) (ADAM-TS18) (ADAMTS-18) (EC 3.4.24.-) Homo sapiens (Human) GO:0001654; GO:0004222; GO:0006508; GO:0030198; GO:0031012; GO:0046872; GO:0090331 extracellular matrix organization [GO:0030198]; eye development [GO:0001654]; negative regulation of platelet aggregation [GO:0090331]; proteolysis [GO:0006508] extracellular matrix [GO:0031012] metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222] g2917.t1 Q75NR7 45.528 492 7.650000000000001e-123 419.0 sp|Q75NR7|RECQ4_MOUSE ATP-dependent DNA helicase Q4 OS=Mus musculus OX=10090 GN=Recql4 PE=2 SV=2 RECQ4_MOUSE reviewed ATP-dependent DNA helicase Q4 (EC 5.6.2.4) (DNA 3'-5' helicase RecQ4) (DNA helicase, RecQ-like type 4) (RecQ4) (RecQ protein-like 4) Mus musculus (Mouse) GO:0000405; GO:0000723; GO:0000724; GO:0000781; GO:0001501; GO:0005524; GO:0005634; GO:0005654; GO:0005694; GO:0005737; GO:0006260; GO:0008270; GO:0008284; GO:0009378; GO:0016887; GO:0032357; GO:0043138; GO:0043473; GO:0045875; GO:0048705; GO:0061820; GO:0061821 DNA replication [GO:0006260]; double-strand break repair via homologous recombination [GO:0000724]; negative regulation of sister chromatid cohesion [GO:0045875]; pigmentation [GO:0043473]; positive regulation of cell population proliferation [GO:0008284]; skeletal system development [GO:0001501]; skeletal system morphogenesis [GO:0048705]; telomere maintenance [GO:0000723]; telomeric D-loop disassembly [GO:0061820] chromosome [GO:0005694]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] 3'-5' DNA helicase activity [GO:0043138]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; bubble DNA binding [GO:0000405]; four-way junction helicase activity [GO:0009378]; oxidized purine DNA binding [GO:0032357]; telomeric D-loop binding [GO:0061821]; zinc ion binding [GO:0008270] g2917.t1 Q75NR7 52.973 370 3.46e-96 342.0 sp|Q75NR7|RECQ4_MOUSE ATP-dependent DNA helicase Q4 OS=Mus musculus OX=10090 GN=Recql4 PE=2 SV=2 RECQ4_MOUSE reviewed ATP-dependent DNA helicase Q4 (EC 5.6.2.4) (DNA 3'-5' helicase RecQ4) (DNA helicase, RecQ-like type 4) (RecQ4) (RecQ protein-like 4) Mus musculus (Mouse) GO:0000405; GO:0000723; GO:0000724; GO:0000781; GO:0001501; GO:0005524; GO:0005634; GO:0005654; GO:0005694; GO:0005737; GO:0006260; GO:0008270; GO:0008284; GO:0009378; GO:0016887; GO:0032357; GO:0043138; GO:0043473; GO:0045875; GO:0048705; GO:0061820; GO:0061821 DNA replication [GO:0006260]; double-strand break repair via homologous recombination [GO:0000724]; negative regulation of sister chromatid cohesion [GO:0045875]; pigmentation [GO:0043473]; positive regulation of cell population proliferation [GO:0008284]; skeletal system development [GO:0001501]; skeletal system morphogenesis [GO:0048705]; telomere maintenance [GO:0000723]; telomeric D-loop disassembly [GO:0061820] chromosome [GO:0005694]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] 3'-5' DNA helicase activity [GO:0043138]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; bubble DNA binding [GO:0000405]; four-way junction helicase activity [GO:0009378]; oxidized purine DNA binding [GO:0032357]; telomeric D-loop binding [GO:0061821]; zinc ion binding [GO:0008270] g2917.t2 Q75NR7 52.973 370 3.17e-99 344.0 sp|Q75NR7|RECQ4_MOUSE ATP-dependent DNA helicase Q4 OS=Mus musculus OX=10090 GN=Recql4 PE=2 SV=2 RECQ4_MOUSE reviewed ATP-dependent DNA helicase Q4 (EC 5.6.2.4) (DNA 3'-5' helicase RecQ4) (DNA helicase, RecQ-like type 4) (RecQ4) (RecQ protein-like 4) Mus musculus (Mouse) GO:0000405; GO:0000723; GO:0000724; GO:0000781; GO:0001501; GO:0005524; GO:0005634; GO:0005654; GO:0005694; GO:0005737; GO:0006260; GO:0008270; GO:0008284; GO:0009378; GO:0016887; GO:0032357; GO:0043138; GO:0043473; GO:0045875; GO:0048705; GO:0061820; GO:0061821 DNA replication [GO:0006260]; double-strand break repair via homologous recombination [GO:0000724]; negative regulation of sister chromatid cohesion [GO:0045875]; pigmentation [GO:0043473]; positive regulation of cell population proliferation [GO:0008284]; skeletal system development [GO:0001501]; skeletal system morphogenesis [GO:0048705]; telomere maintenance [GO:0000723]; telomeric D-loop disassembly [GO:0061820] chromosome [GO:0005694]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] 3'-5' DNA helicase activity [GO:0043138]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; bubble DNA binding [GO:0000405]; four-way junction helicase activity [GO:0009378]; oxidized purine DNA binding [GO:0032357]; telomeric D-loop binding [GO:0061821]; zinc ion binding [GO:0008270] g2918.t1 Q6PIP5 41.821 593 1.53e-150 449.0 sp|Q6PIP5|NUDC1_MOUSE NudC domain-containing protein 1 OS=Mus musculus OX=10090 GN=Nudcd1 PE=1 SV=2 g2920.t1 Q5RHR6 60.403 149 6.04e-49 171.0 sp|Q5RHR6|BROMI_DANRE Protein broad-minded OS=Danio rerio OX=7955 GN=tbc1d32 PE=3 SV=2 g2921.t1 Q5RHR6 39.28 1166 0.0 732.0 sp|Q5RHR6|BROMI_DANRE Protein broad-minded OS=Danio rerio OX=7955 GN=tbc1d32 PE=3 SV=2 g2925.t1 Q9D0M0 58.015 262 2.3e-106 314.0 sp|Q9D0M0|EXOS7_MOUSE Exosome complex exonuclease RRP42 OS=Mus musculus OX=10090 GN=Exosc7 PE=1 SV=2 g2926.t1 F1RE57 58.798 233 1.48e-86 263.0 sp|F1RE57|DHC3A_DANRE Palmitoyltransferase ZDHHC3-A OS=Danio rerio OX=7955 GN=zdhhc3a PE=1 SV=1 DHC3A_DANRE reviewed Palmitoyltransferase ZDHHC3-A (EC 2.3.1.225) (Acyltransferase ZDHHC3A) (EC 2.3.1.-) (Zinc finger DHHC domain-containing protein 3) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000139; GO:0005783; GO:0005794; GO:0006612; GO:0008277; GO:0016417; GO:0018230; GO:0018345; GO:0019705; GO:0019706; GO:0042803; GO:0072659; GO:0140439 peptidyl-L-cysteine S-palmitoylation [GO:0018230]; protein localization to plasma membrane [GO:0072659]; protein palmitoylation [GO:0018345]; protein targeting to membrane [GO:0006612]; regulation of G protein-coupled receptor signaling pathway [GO:0008277] endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139] protein homodimerization activity [GO:0042803]; protein-cysteine S-myristoyltransferase activity [GO:0019705]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]; protein-cysteine S-stearoyltransferase activity [GO:0140439]; S-acyltransferase activity [GO:0016417] g2928.t1 Q2TBR6 53.226 124 2.3800000000000002e-32 114.0 sp|Q2TBR6|PFD4_BOVIN Prefoldin subunit 4 OS=Bos taurus OX=9913 GN=PFDN4 PE=2 SV=1 g2929.t1 Q8NCC3 47.872 376 6.94e-117 350.0 sp|Q8NCC3|PAG15_HUMAN Lysosomal phospholipase A and acyltransferase OS=Homo sapiens OX=9606 GN=PLA2G15 PE=1 SV=2 PAG15_HUMAN reviewed Lysosomal phospholipase A and acyltransferase (EC 2.3.1.-) (EC 3.1.1.32) (EC 3.1.1.4) (1-O-acylceramide synthase) (ACS) (LCAT-like lysophospholipase) (LLPL) (EC 3.1.1.5) (Lysophospholipase 3) (Lysosomal phospholipase A2) (LPLA2) (Phospholipase A2 group XV) (PLA2G15) Homo sapiens (Human) GO:0004622; GO:0005543; GO:0005576; GO:0005615; GO:0005654; GO:0005764; GO:0006644; GO:0006650; GO:0006651; GO:0006658; GO:0006672; GO:0008270; GO:0008374; GO:0008970; GO:0009062; GO:0016020; GO:0016411; GO:0034638; GO:0046338; GO:0046470; GO:0046471; GO:0047499; GO:0070062 ceramide metabolic process [GO:0006672]; diacylglycerol biosynthetic process [GO:0006651]; fatty acid catabolic process [GO:0009062]; glycerophospholipid metabolic process [GO:0006650]; phosphatidylcholine catabolic process [GO:0034638]; phosphatidylcholine metabolic process [GO:0046470]; phosphatidylethanolamine catabolic process [GO:0046338]; phosphatidylglycerol metabolic process [GO:0046471]; phosphatidylserine metabolic process [GO:0006658]; phospholipid metabolic process [GO:0006644] extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; lysosome [GO:0005764]; membrane [GO:0016020]; nucleoplasm [GO:0005654] acylglycerol O-acyltransferase activity [GO:0016411]; calcium-independent phospholipase A2 activity [GO:0047499]; O-acyltransferase activity [GO:0008374]; phosphatidylcholine lysophospholipase activity [GO:0004622]; phospholipase A1 activity [GO:0008970]; phospholipid binding [GO:0005543]; zinc ion binding [GO:0008270] g2930.t1 P00125 68.1 279 2.11e-129 374.0 sp|P00125|CY1_BOVIN Cytochrome c1, heme protein, mitochondrial OS=Bos taurus OX=9913 GN=CYC1 PE=1 SV=2 g2931.t1 Q3T077 44.706 170 1.79e-34 122.0 sp|Q3T077|TPPP2_BOVIN Tubulin polymerization-promoting protein family member 2 OS=Bos taurus OX=9913 GN=TPPP2 PE=2 SV=1 g2932.t1 Q3T0Z5 43.82 178 9.639999999999999e-24 101.0 sp|Q3T0Z5|LENG1_BOVIN Leukocyte receptor cluster member 1 homolog OS=Bos taurus OX=9913 GN=LENG1 PE=2 SV=1 g2933.t1 Q96ME1 27.494 411 2.54e-26 118.0 sp|Q96ME1|FXL18_HUMAN F-box/LRR-repeat protein 18 OS=Homo sapiens OX=9606 GN=FBXL18 PE=1 SV=3 g2934.t1 Q92536 54.015 137 2.77e-40 155.0 sp|Q92536|YLAT2_HUMAN Y+L amino acid transporter 2 OS=Homo sapiens OX=9606 GN=SLC7A6 PE=1 SV=3 YLAT2_HUMAN reviewed Y+L amino acid transporter 2 (Cationic amino acid transporter, y+ system) (Solute carrier family 7 member 6) (y(+)L-type amino acid transporter 2) (Y+LAT2) (y+LAT-2) Homo sapiens (Human) GO:0003333; GO:0005886; GO:0006809; GO:0015171; GO:0015174; GO:0015179; GO:0015804; GO:0015820; GO:0015822; GO:0031460; GO:0034618; GO:0061459; GO:0106439; GO:1903826 amino acid transmembrane transport [GO:0003333]; glycine betaine transport [GO:0031460]; L-arginine transmembrane transport [GO:1903826]; L-leucine transport [GO:0015820]; neutral amino acid transport [GO:0015804]; nitric oxide biosynthetic process [GO:0006809]; ornithine transport [GO:0015822] plasma membrane [GO:0005886] amino acid transmembrane transporter activity [GO:0015171]; arginine binding [GO:0034618]; basic amino acid transmembrane transporter activity [GO:0015174]; L-amino acid transmembrane transporter activity [GO:0015179]; L-arginine transmembrane transporter activity [GO:0061459]; L-lysine:L-arginine antiporter activity [GO:0106439] g2935.t1 Q59I64 55.072 138 5.76e-35 131.0 sp|Q59I64|YLAT2_DANRE Y+L amino acid transporter 2 OS=Danio rerio OX=7955 GN=slc7a6 PE=2 SV=1 YLAT2_DANRE reviewed Y+L amino acid transporter 2 (Solute carrier family 7 member 6) (zfSlc7a6) (y(+)L-type amino acid transporter 2) (Y+LAT2) (y+LAT-2) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0003333; GO:0005886; GO:0006809; GO:0015179; GO:0015804; GO:0031460; GO:0034618; GO:0061459; GO:0106439; GO:1903826 amino acid transmembrane transport [GO:0003333]; glycine betaine transport [GO:0031460]; L-arginine transmembrane transport [GO:1903826]; neutral amino acid transport [GO:0015804]; nitric oxide biosynthetic process [GO:0006809] plasma membrane [GO:0005886] arginine binding [GO:0034618]; L-amino acid transmembrane transporter activity [GO:0015179]; L-arginine transmembrane transporter activity [GO:0061459]; L-lysine:L-arginine antiporter activity [GO:0106439] g2936.t1 Q8BGK6 49.197 498 4.8899999999999995e-146 432.0 sp|Q8BGK6|YLAT2_MOUSE Y+L amino acid transporter 2 OS=Mus musculus OX=10090 GN=Slc7a6 PE=1 SV=1 YLAT2_MOUSE reviewed Y+L amino acid transporter 2 (Solute carrier family 7 member 6) (y(+)L-type amino acid transporter 2) (Y+LAT2) (y+LAT-2) Mus musculus (Mouse) GO:0003333; GO:0005886; GO:0006809; GO:0015174; GO:0015179; GO:0015804; GO:0015820; GO:0015822; GO:0031460; GO:0034618; GO:0061459; GO:0106439; GO:1903826 amino acid transmembrane transport [GO:0003333]; glycine betaine transport [GO:0031460]; L-arginine transmembrane transport [GO:1903826]; L-leucine transport [GO:0015820]; neutral amino acid transport [GO:0015804]; nitric oxide biosynthetic process [GO:0006809]; ornithine transport [GO:0015822] plasma membrane [GO:0005886] arginine binding [GO:0034618]; basic amino acid transmembrane transporter activity [GO:0015174]; L-amino acid transmembrane transporter activity [GO:0015179]; L-arginine transmembrane transporter activity [GO:0061459]; L-lysine:L-arginine antiporter activity [GO:0106439] g2937.t1 O70378 40.876 137 2.12e-31 114.0 sp|O70378|EMC8_MOUSE ER membrane protein complex subunit 8 OS=Mus musculus OX=10090 GN=Emc8 PE=1 SV=1 g2939.t1 Q9D8B6 50.505 99 8.860000000000001e-27 108.0 sp|Q9D8B6|F210B_MOUSE Protein FAM210B, mitochondrial OS=Mus musculus OX=10090 GN=Fam210b PE=1 SV=3 F210B_MOUSE reviewed Protein FAM210B, mitochondrial Mus musculus (Mouse) GO:0005739; GO:0005741; GO:0006954; GO:0016020; GO:0030218; GO:0043249; GO:0043588; GO:0045648; GO:0048536; GO:0071392; GO:0072593 cellular response to estradiol stimulus [GO:0071392]; erythrocyte differentiation [GO:0030218]; erythrocyte maturation [GO:0043249]; inflammatory response [GO:0006954]; positive regulation of erythrocyte differentiation [GO:0045648]; reactive oxygen species metabolic process [GO:0072593]; skin development [GO:0043588]; spleen development [GO:0048536] membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739] g2940.t1 D7UQM5 69.586 411 0.0 522.0 sp|D7UQM5|AURK_PATPE Aurora kinase OS=Patiria pectinifera OX=7594 GN=aur PE=1 SV=1 AURK_PATPE reviewed Aurora kinase (EC 2.7.11.1) (ApAurora) Patiria pectinifera (Starfish) (Asterina pectinifera) GO:0000775; GO:0004674; GO:0005524; GO:0005634; GO:0005813; GO:0005819; GO:0030496; GO:0051301; GO:0051321; GO:0106310 cell division [GO:0051301]; meiotic cell cycle [GO:0051321] centrosome [GO:0005813]; chromosome, centromeric region [GO:0000775]; midbody [GO:0030496]; nucleus [GO:0005634]; spindle [GO:0005819] ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g2941.t1 Q32KH5 67.355 484 0.0 705.0 sp|Q32KH5|GALNS_CANLF N-acetylgalactosamine-6-sulfatase OS=Canis lupus familiaris OX=9615 GN=GALNS PE=2 SV=1 GALNS_CANLF reviewed N-acetylgalactosamine-6-sulfatase (EC 3.1.6.4) (Chondroitinsulfatase) (Chondroitinase) (Galactose-6-sulfate sulfatase) (N-acetylgalactosamine-6-sulfate sulfatase) (GalNAc6S sulfatase) Canis lupus familiaris (Dog) (Canis familiaris) GO:0004065; GO:0005764; GO:0043890; GO:0046872 lysosome [GO:0005764] arylsulfatase activity [GO:0004065]; metal ion binding [GO:0046872]; N-acetylgalactosamine-6-sulfatase activity [GO:0043890] g2941.t2 Q32KJ6 63.608 316 5.87e-151 437.0 sp|Q32KJ6|GALNS_RAT N-acetylgalactosamine-6-sulfatase OS=Rattus norvegicus OX=10116 GN=Galns PE=1 SV=1 GALNS_RAT reviewed N-acetylgalactosamine-6-sulfatase (EC 3.1.6.4) (Chondroitinsulfatase) (Chondroitinase) (Galactose-6-sulfate sulfatase) (N-acetylgalactosamine-6-sulfate sulfatase) (GalNAc6S sulfatase) Rattus norvegicus (Rat) GO:0004065; GO:0005764; GO:0008484; GO:0043890; GO:0046872 lysosome [GO:0005764] arylsulfatase activity [GO:0004065]; metal ion binding [GO:0046872]; N-acetylgalactosamine-6-sulfatase activity [GO:0043890]; sulfuric ester hydrolase activity [GO:0008484] g2941.t3 Q32KH5 67.961 206 6.26e-102 307.0 sp|Q32KH5|GALNS_CANLF N-acetylgalactosamine-6-sulfatase OS=Canis lupus familiaris OX=9615 GN=GALNS PE=2 SV=1 GALNS_CANLF reviewed N-acetylgalactosamine-6-sulfatase (EC 3.1.6.4) (Chondroitinsulfatase) (Chondroitinase) (Galactose-6-sulfate sulfatase) (N-acetylgalactosamine-6-sulfate sulfatase) (GalNAc6S sulfatase) Canis lupus familiaris (Dog) (Canis familiaris) GO:0004065; GO:0005764; GO:0043890; GO:0046872 lysosome [GO:0005764] arylsulfatase activity [GO:0004065]; metal ion binding [GO:0046872]; N-acetylgalactosamine-6-sulfatase activity [GO:0043890] g2941.t4 Q32KH5 65.287 314 2.4000000000000002e-154 446.0 sp|Q32KH5|GALNS_CANLF N-acetylgalactosamine-6-sulfatase OS=Canis lupus familiaris OX=9615 GN=GALNS PE=2 SV=1 GALNS_CANLF reviewed N-acetylgalactosamine-6-sulfatase (EC 3.1.6.4) (Chondroitinsulfatase) (Chondroitinase) (Galactose-6-sulfate sulfatase) (N-acetylgalactosamine-6-sulfate sulfatase) (GalNAc6S sulfatase) Canis lupus familiaris (Dog) (Canis familiaris) GO:0004065; GO:0005764; GO:0043890; GO:0046872 lysosome [GO:0005764] arylsulfatase activity [GO:0004065]; metal ion binding [GO:0046872]; N-acetylgalactosamine-6-sulfatase activity [GO:0043890] g2946.t1 O76536 29.04 396 1.3600000000000002e-27 120.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g2946.t1 O76536 30.252 357 6.28e-25 112.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g2946.t1 O76536 30.556 396 1.13e-24 112.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g2946.t1 O76536 30.612 343 5.74e-24 109.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g2946.t1 O76536 29.674 337 5.55e-23 106.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g2946.t1 O76536 32.389 247 2.36e-21 101.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g2946.t1 O76536 32.66 297 3.76e-21 101.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g2946.t1 O76536 32.09 268 6.72e-21 100.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g2947.t1 O76536 39.649 285 1.34e-37 148.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g2947.t1 O76536 38.832 291 5.32e-37 146.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g2947.t1 O76536 38.356 292 1.66e-34 139.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g2947.t1 O76536 38.816 304 4.2000000000000004e-32 132.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g2947.t1 O76536 37.063 286 4.4100000000000004e-32 132.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g2947.t1 O76536 37.662 308 2.67e-31 129.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g2947.t1 O76536 39.033 269 3.63e-31 129.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g2947.t1 O76536 35.417 288 2.67e-26 112.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g2947.t1 O76536 41.667 36 2.67e-26 28.1 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g2947.t1 O76536 37.367 281 6.64e-25 110.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g2948.t2 O76536 41.694 307 3.52e-47 173.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g2948.t2 O76536 41.368 307 3.62e-42 159.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g2948.t2 O76536 42.405 316 3.05e-41 156.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g2948.t2 O76536 42.071 309 1.3899999999999999e-40 154.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g2948.t2 O76536 42.089 316 4.5e-40 153.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g2948.t2 O76536 36.57 309 2.5500000000000002e-36 142.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g2948.t2 O76536 39.789 284 8.070000000000001e-35 137.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g2948.t2 O76536 40.727 275 1.45e-32 131.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g2948.t2 O76536 36.882 263 7.86e-29 120.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g2948.t3 O76536 41.155 277 7.249999999999999e-45 166.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g2948.t3 O76536 41.727 278 3.93e-41 155.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g2948.t3 O76536 40.86 279 9.159999999999999e-38 145.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g2948.t3 O76536 40.909 286 2.59e-37 144.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g2948.t3 O76536 35.125 279 2.87e-35 138.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g2948.t3 O76536 39.789 284 7.800000000000001e-35 137.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g2948.t3 O76536 37.857 280 1.15e-32 131.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g2948.t3 O76536 40.727 275 1.1800000000000001e-32 130.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g2948.t3 O76536 36.882 263 6.2e-29 120.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g2948.t3 O76536 42.718 206 3.5e-21 97.4 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g2954.t1 O76536 37.0 600 6.929999999999999e-55 214.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g2954.t1 O76536 37.891 607 7.76e-55 214.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g2954.t1 O76536 38.435 588 4.06e-54 211.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g2954.t1 O76536 36.066 610 7.449999999999999e-52 204.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g2954.t1 O76536 36.364 583 1.01e-50 201.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g2954.t1 O76536 37.417 604 5.54e-49 195.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g2954.t1 O76536 35.991 464 1.6500000000000001e-37 158.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g2954.t1 O76536 39.643 280 6.280000000000001e-37 156.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g2954.t1 O76536 37.525 501 2.77e-36 154.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g2954.t1 O76536 39.785 279 1.4900000000000001e-33 145.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g2954.t1 O76536 40.78 282 3.14e-32 140.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g2954.t1 O76536 38.545 275 2.39e-30 135.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g2954.t1 O76536 37.857 280 3.21e-26 121.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g2954.t1 O76536 37.143 280 2.68e-22 108.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g2956.t1 O76536 30.134 521 2.05e-25 115.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g2957.t1 O76536 36.842 1140 2.5e-165 533.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g2957.t1 O76536 35.98 1209 3.74e-160 520.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g2957.t1 O76536 35.363 1199 4.29e-154 503.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g2957.t1 O76536 37.298 1051 4.7e-143 473.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g2957.t1 O76536 36.417 1016 1.9e-141 469.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g2957.t2 O76536 37.16 1141 1.07e-165 536.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g2957.t2 O76536 36.146 1209 1.4400000000000001e-164 533.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g2957.t2 O76536 36.063 1209 5.52e-158 515.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g2957.t2 O76536 36.605 1131 4.67e-157 513.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g2957.t2 O76536 36.607 1120 1.6800000000000002e-144 479.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g2957.t2 O76536 36.22 1016 1.25e-140 468.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g2957.t3 O76536 37.215 1142 7.290000000000001e-169 546.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g2957.t3 O76536 35.815 1209 4.59e-160 523.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g2957.t3 O76536 36.538 1144 5.64e-159 520.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g2957.t3 O76536 36.142 1187 4.0200000000000004e-157 514.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g2957.t3 O76536 36.605 1131 1.4100000000000002e-156 513.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g2957.t3 O76536 36.607 1120 4.54e-144 479.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g2957.t3 O76536 36.095 1014 2.5e-138 463.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g2960.t1 Q08DZ2 76.393 377 0.0 626.0 sp|Q08DZ2|PRP4K_BOVIN Serine/threonine-protein kinase PRP4 homolog OS=Bos taurus OX=9913 GN=PRP4K PE=2 SV=1 PRP4K_BOVIN reviewed Serine/threonine-protein kinase PRP4 homolog (EC 2.7.11.1) (PRP4 pre-mRNA-processing factor 4 homolog) Bos taurus (Bovine) GO:0000244; GO:0000387; GO:0000776; GO:0004674; GO:0005524; GO:0005681; GO:0016607; GO:0045292; GO:0090266; GO:0106310 mRNA cis splicing, via spliceosome [GO:0045292]; regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090266]; spliceosomal snRNP assembly [GO:0000387]; spliceosomal tri-snRNP complex assembly [GO:0000244] kinetochore [GO:0000776]; nuclear speck [GO:0016607]; spliceosomal complex [GO:0005681] ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g2964.t1 Q6ZMY6 47.581 248 5.11e-74 237.0 sp|Q6ZMY6|WDR88_HUMAN WD repeat-containing protein 88 OS=Homo sapiens OX=9606 GN=WDR88 PE=1 SV=2 g2966.t1 Q5R9W1 68.156 179 9.000000000000001e-86 276.0 sp|Q5R9W1|MARH6_PONAB E3 ubiquitin-protein ligase MARCHF6 OS=Pongo abelii OX=9601 GN=MARCHF6 PE=2 SV=1 MARH6_PONAB reviewed E3 ubiquitin-protein ligase MARCHF6 (EC 2.3.2.27) (Membrane-associated RING finger protein 6) (Membrane-associated RING-CH protein VI) (MARCH-VI) (RING-type E3 ubiquitin transferase MARCH6) Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0005789; GO:0008270; GO:0016567; GO:0036503; GO:0043161; GO:0061630; GO:0070936 ERAD pathway [GO:0036503]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K48-linked ubiquitination [GO:0070936]; protein ubiquitination [GO:0016567] endoplasmic reticulum membrane [GO:0005789] ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] g2967.t1 Q6ZQ89 76.73 318 8.1e-148 446.0 sp|Q6ZQ89|MARH6_MOUSE E3 ubiquitin-protein ligase MARCHF6 OS=Mus musculus OX=10090 GN=Marchf6 PE=2 SV=2 g2968.t1 O60337 57.095 296 9.190000000000001e-86 281.0 sp|O60337|MARH6_HUMAN E3 ubiquitin-protein ligase MARCHF6 OS=Homo sapiens OX=9606 GN=MARCHF6 PE=1 SV=2 MARH6_HUMAN reviewed E3 ubiquitin-protein ligase MARCHF6 (EC 2.3.2.27) (Doa10 homolog) (Membrane-associated RING finger protein 6) (Membrane-associated RING-CH protein VI) (MARCH-VI) (Protein TEB-4) (RING finger protein 176) (RING-type E3 ubiquitin transferase MARCHF6) Homo sapiens (Human) GO:0000835; GO:0004842; GO:0005783; GO:0005789; GO:0008270; GO:0010498; GO:0016020; GO:0016567; GO:0019899; GO:0031624; GO:0036503; GO:0043161; GO:0044322; GO:0045541; GO:0061630; GO:0070936; GO:1904380; GO:1990381 endoplasmic reticulum mannose trimming [GO:1904380]; ERAD pathway [GO:0036503]; negative regulation of cholesterol biosynthetic process [GO:0045541]; proteasomal protein catabolic process [GO:0010498]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K48-linked ubiquitination [GO:0070936]; protein ubiquitination [GO:0016567] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum quality control compartment [GO:0044322]; ER ubiquitin ligase complex [GO:0000835]; membrane [GO:0016020] enzyme binding [GO:0019899]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; ubiquitin-specific protease binding [GO:1990381]; zinc ion binding [GO:0008270] g2969.t1 Q9BZ19 34.545 220 1.86e-23 106.0 sp|Q9BZ19|ANR60_HUMAN Ankyrin repeat domain-containing protein 60 OS=Homo sapiens OX=9606 GN=ANKRD60 PE=1 SV=3 g2976.t1 Q1LYL8 27.536 483 3.9500000000000003e-26 117.0 sp|Q1LYL8|ASTE1_DANRE Single-strand DNA endonuclease ASTE1 OS=Danio rerio OX=7955 GN=aste1a PE=2 SV=1 g2977.t1 Q5RCY5 39.674 184 3.2499999999999998e-28 114.0 sp|Q5RCY5|ASTE1_PONAB Single-strand DNA endonuclease ASTE1 OS=Pongo abelii OX=9601 GN=ASTE1 PE=2 SV=1 g2979.t1 Q1LYL8 30.361 527 2.18e-49 184.0 sp|Q1LYL8|ASTE1_DANRE Single-strand DNA endonuclease ASTE1 OS=Danio rerio OX=7955 GN=aste1a PE=2 SV=1 g2980.t1 Q8NG66 46.719 381 3.81e-121 380.0 sp|Q8NG66|NEK11_HUMAN Serine/threonine-protein kinase Nek11 OS=Homo sapiens OX=9606 GN=NEK11 PE=1 SV=2 NEK11_HUMAN reviewed Serine/threonine-protein kinase Nek11 (EC 2.7.11.1) (Never in mitosis A-related kinase 11) (NimA-related protein kinase 11) Homo sapiens (Human) GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0006468; GO:0031573; GO:0035556; GO:0046872; GO:0106310; GO:1901990 intracellular signal transduction [GO:0035556]; mitotic intra-S DNA damage checkpoint signaling [GO:0031573]; protein phosphorylation [GO:0006468]; regulation of mitotic cell cycle phase transition [GO:1901990] nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g2985.t1 Q91XU0 51.797 473 4.82e-158 472.0 sp|Q91XU0|WRIP1_MOUSE ATPase WRNIP1 OS=Mus musculus OX=10090 GN=Wrnip1 PE=1 SV=2 WRIP1_MOUSE reviewed ATPase WRNIP1 (EC 3.6.1.-) (Werner helicase-interacting protein 1) Mus musculus (Mouse) GO:0000731; GO:0000781; GO:0003677; GO:0005524; GO:0005634; GO:0006261; GO:0008047; GO:0008270; GO:0016887; GO:0017116; GO:0030174; GO:0042802; GO:0045087; GO:0048471 DNA synthesis involved in DNA repair [GO:0000731]; DNA-templated DNA replication [GO:0006261]; innate immune response [GO:0045087]; regulation of DNA-templated DNA replication initiation [GO:0030174] chromosome, telomeric region [GO:0000781]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA binding [GO:0003677]; enzyme activator activity [GO:0008047]; identical protein binding [GO:0042802]; single-stranded DNA helicase activity [GO:0017116]; zinc ion binding [GO:0008270] g2986.t1 Q9D486 43.819 728 0.0 566.0 sp|Q9D486|CMIP_MOUSE C-Maf-inducing protein OS=Mus musculus OX=10090 GN=Cmip PE=1 SV=3 g2987.t1 Q7TS63 29.327 416 5.53e-51 189.0 sp|Q7TS63|ZFAT_MOUSE Zinc finger protein ZFAT OS=Mus musculus OX=10090 GN=Zfat PE=1 SV=2 ZFAT_MOUSE reviewed Zinc finger protein ZFAT (Zinc finger protein 406) Mus musculus (Mouse) GO:0000978; GO:0000981; GO:0001228; GO:0002244; GO:0005634; GO:0005829; GO:0006355; GO:0008270; GO:0030097; GO:0060712 hematopoietic progenitor cell differentiation [GO:0002244]; hemopoiesis [GO:0030097]; regulation of DNA-templated transcription [GO:0006355]; spongiotrophoblast layer development [GO:0060712] cytosol [GO:0005829]; nucleus [GO:0005634] DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270] g2988.t1 Q9P243 38.182 110 6.5200000000000004e-21 95.5 sp|Q9P243|ZFAT_HUMAN Zinc finger protein ZFAT OS=Homo sapiens OX=9606 GN=ZFAT PE=1 SV=2 ZFAT_HUMAN reviewed Zinc finger protein ZFAT (Zinc finger gene in AITD susceptibility region) (Zinc finger protein 406) Homo sapiens (Human) GO:0000978; GO:0000981; GO:0001228; GO:0002244; GO:0005634; GO:0005829; GO:0006355; GO:0008270 hematopoietic progenitor cell differentiation [GO:0002244]; regulation of DNA-templated transcription [GO:0006355] cytosol [GO:0005829]; nucleus [GO:0005634] DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270] g2990.t1 Q71MB6 35.648 648 8.56e-125 390.0 sp|Q71MB6|SO4C1_RAT Solute carrier organic anion transporter family member 4C1 OS=Rattus norvegicus OX=10116 GN=Slco4c1 PE=1 SV=1 SO4C1_RAT reviewed Solute carrier organic anion transporter family member 4C1 (SLCO4C1) (Organic anion transporting polypeptide 4C1) (OATP4C1) (Solute carrier family 21 member 20) Rattus norvegicus (Rat) GO:0006811; GO:0007283; GO:0008514; GO:0015347; GO:0015711; GO:0016323; GO:0016324; GO:0030154; GO:0043252 cell differentiation [GO:0030154]; monoatomic ion transport [GO:0006811]; organic anion transport [GO:0015711]; sodium-independent organic anion transport [GO:0043252]; spermatogenesis [GO:0007283] apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323] organic anion transmembrane transporter activity [GO:0008514]; sodium-independent organic anion transmembrane transporter activity [GO:0015347] g2993.t1 Q66L58 51.064 141 4e-25 102.0 sp|Q66L58|VAC14_DANRE Protein VAC14 homolog OS=Danio rerio OX=7955 GN=vac14 PE=2 SV=1 g2996.t1 O34309 32.877 365 7.02e-45 180.0 sp|O34309|RPH_BACSU Rifampicin phosphotransferase OS=Bacillus subtilis (strain 168) OX=224308 GN=rph PE=3 SV=1 g2996.t1 O34309 28.0 300 3.19e-23 110.0 sp|O34309|RPH_BACSU Rifampicin phosphotransferase OS=Bacillus subtilis (strain 168) OX=224308 GN=rph PE=3 SV=1 g2998.t1 Q5FWL3 36.406 217 5.62e-32 123.0 sp|Q5FWL3|RNF41_XENLA E3 ubiquitin-protein ligase NRDP1 OS=Xenopus laevis OX=8355 GN=rnf41 PE=2 SV=1 g3001.t1 A2AIV2 35.395 760 3.27e-95 328.0 sp|A2AIV2|VIR_MOUSE Protein virilizer homolog OS=Mus musculus OX=10090 GN=Virma PE=1 SV=1 VIR_MOUSE reviewed Protein virilizer homolog Mus musculus (Mouse) GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006397; GO:0008380; GO:0016604; GO:0016607; GO:0036396 mRNA processing [GO:0006397]; RNA splicing [GO:0008380] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA N6-methyladenosine methyltransferase complex [GO:0036396] g3003.t1 A2AIV2 33.114 456 5.62e-60 228.0 sp|A2AIV2|VIR_MOUSE Protein virilizer homolog OS=Mus musculus OX=10090 GN=Virma PE=1 SV=1 VIR_MOUSE reviewed Protein virilizer homolog Mus musculus (Mouse) GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006397; GO:0008380; GO:0016604; GO:0016607; GO:0036396 mRNA processing [GO:0006397]; RNA splicing [GO:0008380] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA N6-methyladenosine methyltransferase complex [GO:0036396] g3003.t1 A2AIV2 51.938 129 3.8000000000000003e-29 130.0 sp|A2AIV2|VIR_MOUSE Protein virilizer homolog OS=Mus musculus OX=10090 GN=Virma PE=1 SV=1 VIR_MOUSE reviewed Protein virilizer homolog Mus musculus (Mouse) GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006397; GO:0008380; GO:0016604; GO:0016607; GO:0036396 mRNA processing [GO:0006397]; RNA splicing [GO:0008380] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA N6-methyladenosine methyltransferase complex [GO:0036396] g3005.t1 Q63185 44.231 260 1.01e-59 206.0 sp|Q63185|E2AK1_RAT Eukaryotic translation initiation factor 2-alpha kinase 1 OS=Rattus norvegicus OX=10116 GN=Eif2ak1 PE=1 SV=2 E2AK1_RAT reviewed Eukaryotic translation initiation factor 2-alpha kinase 1 (EC 2.7.11.1) (Heme-controlled repressor) (HCR) (Heme-regulated eukaryotic initiation factor eIF-2-alpha kinase) (Heme-regulated inhibitor) (Hemin-sensitive initiation factor 2-alpha kinase) Rattus norvegicus (Rat) GO:0000423; GO:0002526; GO:0004672; GO:0004694; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006413; GO:0006417; GO:0006446; GO:0006909; GO:0008285; GO:0017148; GO:0020037; GO:0030225; GO:0042803; GO:0046501; GO:0046777; GO:0046984; GO:0046986; GO:0051649; GO:0060586; GO:0070585; GO:0106310; GO:0140467; GO:0140468; GO:1901526; GO:1990641 acute inflammatory response [GO:0002526]; establishment of localization in cell [GO:0051649]; HRI-mediated signaling [GO:0140468]; integrated stress response signaling [GO:0140467]; macrophage differentiation [GO:0030225]; mitophagy [GO:0000423]; multicellular organismal-level iron ion homeostasis [GO:0060586]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of hemoglobin biosynthetic process [GO:0046986]; negative regulation of translation [GO:0017148]; phagocytosis [GO:0006909]; positive regulation of mitophagy [GO:1901526]; protein autophosphorylation [GO:0046777]; protein localization to mitochondrion [GO:0070585]; protoporphyrinogen IX metabolic process [GO:0046501]; regulation of hemoglobin biosynthetic process [GO:0046984]; regulation of translation [GO:0006417]; regulation of translational initiation [GO:0006446]; response to iron ion starvation [GO:1990641]; translational initiation [GO:0006413] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634] ATP binding [GO:0005524]; eukaryotic translation initiation factor 2alpha kinase activity [GO:0004694]; heme binding [GO:0020037]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310] g3006.t1 Q4R8E0 39.655 174 3.9900000000000006e-27 114.0 sp|Q4R8E0|E2AK1_MACFA Eukaryotic translation initiation factor 2-alpha kinase 1 OS=Macaca fascicularis OX=9541 GN=EIF2AK1 PE=2 SV=1 E2AK1_MACFA reviewed Eukaryotic translation initiation factor 2-alpha kinase 1 (EC 2.7.11.1) (Heme-regulated eukaryotic initiation factor eIF-2-alpha kinase) (Hemin-sensitive initiation factor 2-alpha kinase) Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey) GO:0004694; GO:0005524; GO:0005634; GO:0005737; GO:0017148; GO:0106310; GO:0140467; GO:0140468; GO:1901526 HRI-mediated signaling [GO:0140468]; integrated stress response signaling [GO:0140467]; negative regulation of translation [GO:0017148]; positive regulation of mitophagy [GO:1901526] cytoplasm [GO:0005737]; nucleus [GO:0005634] ATP binding [GO:0005524]; eukaryotic translation initiation factor 2alpha kinase activity [GO:0004694]; protein serine kinase activity [GO:0106310] g3007.t1 Q5U4I3 41.994 331 1.61e-81 254.0 sp|Q5U4I3|CCDB1_XENLA Cyclin-D1-binding protein 1 homolog OS=Xenopus laevis OX=8355 GN=ccndbp1 PE=2 SV=2 g3008.t1 E9Q876 35.63 1611 0.0 846.0 sp|E9Q876|ABCAC_MOUSE Glucosylceramide transporter ABCA12 OS=Mus musculus OX=10090 GN=Abca12 PE=1 SV=1 ABCAC_MOUSE reviewed Glucosylceramide transporter ABCA12 (EC 7.6.2.1) (ATP-binding cassette sub-family A member 12) Mus musculus (Mouse) GO:0000139; GO:0003336; GO:0005102; GO:0005319; GO:0005524; GO:0005737; GO:0005743; GO:0005829; GO:0005886; GO:0006672; GO:0006869; GO:0006886; GO:0010875; GO:0016887; GO:0030216; GO:0030658; GO:0031424; GO:0032379; GO:0032940; GO:0033700; GO:0034191; GO:0035627; GO:0042626; GO:0043129; GO:0045055; GO:0045616; GO:0048286; GO:0055088; GO:0061178; GO:0061436; GO:0072659; GO:0097209; GO:0097234; GO:0140326; GO:0140359; GO:2000010 ceramide metabolic process [GO:0006672]; ceramide transport [GO:0035627]; corneocyte desquamation [GO:0003336]; establishment of skin barrier [GO:0061436]; intracellular protein transport [GO:0006886]; keratinization [GO:0031424]; keratinocyte differentiation [GO:0030216]; lipid homeostasis [GO:0055088]; lipid transport [GO:0006869]; lung alveolus development [GO:0048286]; phospholipid efflux [GO:0033700]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of intracellular lipid transport [GO:0032379]; positive regulation of protein localization to cell surface [GO:2000010]; protein localization to plasma membrane [GO:0072659]; regulated exocytosis [GO:0045055]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]; regulation of keratinocyte differentiation [GO:0045616]; secretion by cell [GO:0032940]; surfactant homeostasis [GO:0043129] cytoplasm [GO:0005737]; cytosol [GO:0005829]; epidermal lamellar body [GO:0097209]; epidermal lamellar body membrane [GO:0097234]; Golgi membrane [GO:0000139]; mitochondrial inner membrane [GO:0005743]; plasma membrane [GO:0005886]; transport vesicle membrane [GO:0030658] ABC-type transporter activity [GO:0140359]; apolipoprotein A-I receptor binding [GO:0034191]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; ATPase-coupled transmembrane transporter activity [GO:0042626]; lipid transporter activity [GO:0005319]; signaling receptor binding [GO:0005102] g3009.t1 Q96NW4 41.149 644 4.77e-157 484.0 sp|Q96NW4|ANR27_HUMAN Ankyrin repeat domain-containing protein 27 OS=Homo sapiens OX=9606 GN=ANKRD27 PE=1 SV=2 g3009.t1 Q96NW4 32.083 240 1.49e-25 116.0 sp|Q96NW4|ANR27_HUMAN Ankyrin repeat domain-containing protein 27 OS=Homo sapiens OX=9606 GN=ANKRD27 PE=1 SV=2 g3010.t1 Q3UMR0 38.976 254 8.76e-36 149.0 sp|Q3UMR0|ANR27_MOUSE Ankyrin repeat domain-containing protein 27 OS=Mus musculus OX=10090 GN=Ankrd27 PE=1 SV=2 ANR27_MOUSE reviewed Ankyrin repeat domain-containing protein 27 (VPS9 domain-containing protein) (VPS9-ankyrin-repeat protein) Mus musculus (Mouse) GO:0000149; GO:0005085; GO:0005096; GO:0005764; GO:0005769; GO:0005770; GO:0005829; GO:0005886; GO:0010976; GO:0015031; GO:0030133; GO:0030659; GO:0031267; GO:0032456; GO:0035544; GO:0035646; GO:0042470; GO:0043005; GO:0045022; GO:0048812; GO:0050775; GO:0097422 early endosome to late endosome transport [GO:0045022]; endocytic recycling [GO:0032456]; endosome to melanosome transport [GO:0035646]; negative regulation of SNARE complex assembly [GO:0035544]; neuron projection morphogenesis [GO:0048812]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of neuron projection development [GO:0010976]; protein transport [GO:0015031] cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; early endosome [GO:0005769]; late endosome [GO:0005770]; lysosome [GO:0005764]; melanosome [GO:0042470]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; transport vesicle [GO:0030133]; tubular endosome [GO:0097422] GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; small GTPase binding [GO:0031267]; SNARE binding [GO:0000149] g3010.t1 Q3UMR0 34.211 190 1.81e-24 113.0 sp|Q3UMR0|ANR27_MOUSE Ankyrin repeat domain-containing protein 27 OS=Mus musculus OX=10090 GN=Ankrd27 PE=1 SV=2 ANR27_MOUSE reviewed Ankyrin repeat domain-containing protein 27 (VPS9 domain-containing protein) (VPS9-ankyrin-repeat protein) Mus musculus (Mouse) GO:0000149; GO:0005085; GO:0005096; GO:0005764; GO:0005769; GO:0005770; GO:0005829; GO:0005886; GO:0010976; GO:0015031; GO:0030133; GO:0030659; GO:0031267; GO:0032456; GO:0035544; GO:0035646; GO:0042470; GO:0043005; GO:0045022; GO:0048812; GO:0050775; GO:0097422 early endosome to late endosome transport [GO:0045022]; endocytic recycling [GO:0032456]; endosome to melanosome transport [GO:0035646]; negative regulation of SNARE complex assembly [GO:0035544]; neuron projection morphogenesis [GO:0048812]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of neuron projection development [GO:0010976]; protein transport [GO:0015031] cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; early endosome [GO:0005769]; late endosome [GO:0005770]; lysosome [GO:0005764]; melanosome [GO:0042470]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; transport vesicle [GO:0030133]; tubular endosome [GO:0097422] GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; small GTPase binding [GO:0031267]; SNARE binding [GO:0000149] g3012.t1 Q9VKA4 38.199 322 1.68e-58 210.0 sp|Q9VKA4|Y1760_DROME Probable G-protein coupled receptor CG31760 OS=Drosophila melanogaster OX=7227 GN=CG31760 PE=1 SV=3 g3016.t1 P36514 37.86 486 6.41e-92 293.0 sp|P36514|UD2C1_RABIT UDP-glucuronosyltransferase 2C1 (Fragment) OS=Oryctolagus cuniculus OX=9986 GN=UGT2C1 PE=2 SV=1 g3018.t1 Q5RFJ3 36.973 522 4.84e-94 301.0 sp|Q5RFJ3|UD2A3_PONAB UDP-glucuronosyltransferase 2A3 OS=Pongo abelii OX=9601 GN=UGT2A3 PE=2 SV=1 g3020.t1 Q5ZIW5 52.581 620 0.0 577.0 sp|Q5ZIW5|VAC14_CHICK Protein VAC14 homolog OS=Gallus gallus OX=9031 GN=VAC14 PE=2 SV=1 g3021.t1 Q68DL7 35.873 315 1.21e-66 237.0 sp|Q68DL7|CR063_HUMAN Uncharacterized protein C18orf63 OS=Homo sapiens OX=9606 GN=C18orf63 PE=1 SV=2 g3022.t1 E0CZ22 33.838 1123 0.0 621.0 sp|E0CZ22|MROH1_MOUSE Maestro heat-like repeat-containing protein family member 1 OS=Mus musculus OX=10090 GN=Mroh1 PE=2 SV=1 g3023.t1 Q8NDA8 45.187 509 1.31e-152 479.0 sp|Q8NDA8|MROH1_HUMAN Maestro heat-like repeat-containing protein family member 1 OS=Homo sapiens OX=9606 GN=MROH1 PE=1 SV=3 g3024.t1 O76536 42.735 351 1.8099999999999997e-52 194.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g3024.t1 O76536 38.109 349 4.83e-45 172.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g3024.t1 O76536 37.017 362 1.2199999999999999e-42 166.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g3024.t1 O76536 39.831 354 1.4099999999999999e-40 159.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g3024.t1 O76536 40.979 327 1.45e-39 156.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g3024.t1 O76536 37.36 356 1.54e-38 153.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g3024.t1 O76536 36.517 356 4.45e-38 152.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g3024.t1 O76536 37.538 333 1.48e-37 150.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g3024.t1 O76536 38.835 309 1.8200000000000001e-31 132.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g3025.t1 O76536 39.316 1170 7.79e-143 484.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g3025.t1 O76536 38.305 1180 3.58e-141 479.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g3025.t1 O76536 38.148 1177 1.46e-130 448.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g3025.t1 O76536 37.339 1165 1.13e-126 436.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g3025.t1 O76536 38.843 1089 3.14e-126 435.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g3025.t1 O76536 39.079 1108 1.06e-125 433.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g3025.t1 O76536 39.032 1012 1.81e-121 421.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g3025.t1 O76536 37.111 1156 1.46e-120 418.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g3025.t1 O76536 36.98 1179 1.49e-114 400.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g3025.t1 O76536 37.639 1169 2.32e-113 396.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g3025.t1 O76536 40.238 589 3.47e-70 265.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g3025.t1 O76536 42.923 431 1.23e-54 215.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g3026.t1 O96530 41.895 401 1.92e-61 214.0 sp|O96530|HYAL_LYTVA Hyalin (Fragment) OS=Lytechinus variegatus OX=7654 PE=2 SV=1 g3026.t1 O96530 47.742 310 2.7699999999999997e-60 211.0 sp|O96530|HYAL_LYTVA Hyalin (Fragment) OS=Lytechinus variegatus OX=7654 PE=2 SV=1 g3026.t1 O96530 50.325 308 5.16e-60 210.0 sp|O96530|HYAL_LYTVA Hyalin (Fragment) OS=Lytechinus variegatus OX=7654 PE=2 SV=1 g3026.t1 O96530 40.964 332 8.26e-51 185.0 sp|O96530|HYAL_LYTVA Hyalin (Fragment) OS=Lytechinus variegatus OX=7654 PE=2 SV=1 g3026.t1 O96530 47.458 236 5.62e-32 132.0 sp|O96530|HYAL_LYTVA Hyalin (Fragment) OS=Lytechinus variegatus OX=7654 PE=2 SV=1 g3027.t1 O76536 39.303 1033 2.3099999999999998e-135 461.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g3027.t1 O76536 38.447 1069 4.6e-124 428.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g3027.t1 O76536 39.164 909 5.83e-117 407.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g3027.t1 O76536 37.846 1012 6.520000000000001e-117 407.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g3027.t1 O76536 37.998 879 1.2e-81 300.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g3027.t1 O76536 37.358 878 9.850000000000001e-79 291.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g3027.t1 O76536 37.915 873 5.0299999999999995e-74 276.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g3027.t1 O76536 36.628 688 2.06e-56 220.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g3027.t1 O76536 37.011 562 1.24e-44 182.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g3029.t1 Q24K12 39.586 773 2.55e-133 423.0 sp|Q24K12|GPTC1_BOVIN G patch domain-containing protein 1 OS=Bos taurus OX=9913 GN=GPATCH1 PE=2 SV=1 g3030.t1 Q9UGM3 35.733 750 4.42e-114 384.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g3030.t1 Q9UGM3 35.332 767 3.95e-110 373.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g3030.t1 Q9UGM3 34.896 768 2e-109 370.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g3030.t1 Q9UGM3 35.364 755 6.4800000000000005e-109 369.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g3030.t1 Q9UGM3 34.766 768 2.72e-108 367.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g3030.t1 Q9UGM3 34.297 761 1.39e-107 365.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g3030.t1 Q9UGM3 35.906 635 1.41e-92 321.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g3030.t1 Q9UGM3 36.741 626 2.48e-92 320.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g3030.t1 Q9UGM3 30.971 381 5.84e-38 157.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g3030.t1 Q9UGM3 32.022 356 1.1700000000000001e-32 140.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g3036.t1 Q9BVG8 64.116 379 5.9500000000000005e-173 508.0 sp|Q9BVG8|KIFC3_HUMAN Kinesin-like protein KIFC3 OS=Homo sapiens OX=9606 GN=KIFC3 PE=1 SV=4 g3038.t1 Q6J1I7 51.208 207 9.65e-66 207.0 sp|Q6J1I7|RN166_RAT E3 ubiquitin-protein ligase RNF166 OS=Rattus norvegicus OX=10116 GN=Rnf166 PE=2 SV=1 g3040.t1 Q8TEP8 32.36 1233 1.09e-146 508.0 sp|Q8TEP8|CE192_HUMAN Centrosomal protein of 192 kDa OS=Homo sapiens OX=9606 GN=CEP192 PE=1 SV=3 CE192_HUMAN reviewed Centrosomal protein of 192 kDa (Cep192) (Cep192/SPD-2) Homo sapiens (Human) GO:0000242; GO:0005737; GO:0005813; GO:0005814; GO:0005829; GO:0007098; GO:0007099; GO:0009617; GO:0019902; GO:0071539; GO:0090222; GO:0090307; GO:0120098; GO:0120099 centriole replication [GO:0007099]; centrosome cycle [GO:0007098]; centrosome-templated microtubule nucleation [GO:0090222]; mitotic spindle assembly [GO:0090307]; protein localization to centrosome [GO:0071539]; response to bacterium [GO:0009617] centriole [GO:0005814]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; pericentriolar material [GO:0000242]; procentriole [GO:0120098]; procentriole replication complex [GO:0120099] phosphatase binding [GO:0019902] g3042.t1 Q9H1P6 41.606 137 4.13e-23 90.9 sp|Q9H1P6|CMIP1_HUMAN Ciliary microtubule inner protein 1 OS=Homo sapiens OX=9606 GN=CIMIP1 PE=1 SV=1 CMIP1_HUMAN reviewed Ciliary microtubule inner protein 1 Homo sapiens (Human) GO:0005929 cilium [GO:0005929] g3050.t1 Q969X6 35.364 673 4.8400000000000005e-129 399.0 sp|Q969X6|UTP4_HUMAN U3 small nucleolar RNA-associated protein 4 homolog OS=Homo sapiens OX=9606 GN=UTP4 PE=1 SV=1 UTP4_HUMAN reviewed U3 small nucleolar RNA-associated protein 4 homolog (Cirhin) (UTP4 small subunit processome component) Homo sapiens (Human) GO:0000462; GO:0001650; GO:0003723; GO:0005654; GO:0005694; GO:0005730; GO:0006355; GO:0030490; GO:0030686; GO:0032040; GO:0034455; GO:0042274 maturation of SSU-rRNA [GO:0030490]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; regulation of DNA-templated transcription [GO:0006355]; ribosomal small subunit biogenesis [GO:0042274] 90S preribosome [GO:0030686]; chromosome [GO:0005694]; fibrillar center [GO:0001650]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; small-subunit processome [GO:0032040]; t-UTP complex [GO:0034455] RNA binding [GO:0003723] g3051.t1 P0CG13 46.099 141 4.8200000000000006e-27 100.0 sp|P0CG13|CTF8_HUMAN Chromosome transmission fidelity protein 8 homolog OS=Homo sapiens OX=9606 GN=CHTF8 PE=1 SV=1 CTF8_HUMAN reviewed Chromosome transmission fidelity protein 8 homolog (hCTF8) Homo sapiens (Human) GO:0003677; GO:0005654; GO:0006260; GO:0007064; GO:0031390; GO:1900264 DNA replication [GO:0006260]; mitotic sister chromatid cohesion [GO:0007064]; positive regulation of DNA-directed DNA polymerase activity [GO:1900264] Ctf18 RFC-like complex [GO:0031390]; nucleoplasm [GO:0005654] DNA binding [GO:0003677] g3054.t1 Q6UWM5 41.243 177 1.49e-37 143.0 sp|Q6UWM5|GPRL1_HUMAN GLIPR1-like protein 1 OS=Homo sapiens OX=9606 GN=GLIPR1L1 PE=1 SV=2 g3055.t1 O70537 33.191 470 3.6300000000000005e-86 277.0 sp|O70537|CP3AV_MESAU Cytochrome P450 3A31 OS=Mesocricetus auratus OX=10036 GN=CYP3A31 PE=2 SV=1 g3058.t1 Q6UXB8 35.047 214 3.87e-34 139.0 sp|Q6UXB8|PI16_HUMAN Peptidase inhibitor 16 OS=Homo sapiens OX=9606 GN=PI16 PE=1 SV=1 PI16_HUMAN reviewed Peptidase inhibitor 16 (PI-16) (Cysteine-rich secretory protein 9) (CRISP-9) (PSP94-binding protein) (CD antigen CD364) Homo sapiens (Human) GO:0005615; GO:0030414; GO:0061052 negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052] extracellular space [GO:0005615] peptidase inhibitor activity [GO:0030414] g3059.t1 Q9ET66 39.766 171 5.35e-33 130.0 sp|Q9ET66|PI16_MOUSE Peptidase inhibitor 16 OS=Mus musculus OX=10090 GN=Pi16 PE=1 SV=2 PI16_MOUSE reviewed Peptidase inhibitor 16 (PI-16) (Cysteine-rich protease inhibitor) (CD antigen CD364) Mus musculus (Mouse) GO:0005615; GO:0030414; GO:0061052 negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052] extracellular space [GO:0005615] peptidase inhibitor activity [GO:0030414] g3060.t1 Q9ET66 38.587 184 3.14e-34 140.0 sp|Q9ET66|PI16_MOUSE Peptidase inhibitor 16 OS=Mus musculus OX=10090 GN=Pi16 PE=1 SV=2 PI16_MOUSE reviewed Peptidase inhibitor 16 (PI-16) (Cysteine-rich protease inhibitor) (CD antigen CD364) Mus musculus (Mouse) GO:0005615; GO:0030414; GO:0061052 negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052] extracellular space [GO:0005615] peptidase inhibitor activity [GO:0030414] g3061.t1 Q4AEH5 36.181 199 1.6200000000000002e-33 122.0 sp|Q4AEH5|GPX3_HYLLA Glutathione peroxidase 3 OS=Hylobates lar OX=9580 GN=GPX3 PE=2 SV=2 g3063.t1 Q29496 32.976 467 7.779999999999999e-91 289.0 sp|Q29496|CP3AO_SHEEP Cytochrome P450 3A24 OS=Ovis aries OX=9940 GN=CYP3A24 PE=2 SV=1 g3064.t1 Q29496 34.898 490 4.59e-90 287.0 sp|Q29496|CP3AO_SHEEP Cytochrome P450 3A24 OS=Ovis aries OX=9940 GN=CYP3A24 PE=2 SV=1 g3064.t2 Q29496 34.898 490 6.899999999999999e-90 287.0 sp|Q29496|CP3AO_SHEEP Cytochrome P450 3A24 OS=Ovis aries OX=9940 GN=CYP3A24 PE=2 SV=1 g3066.t1 B5X4H8 41.328 467 4.62e-86 276.0 sp|B5X4H8|RFT2_SALSA Riboflavin transporter 2 OS=Salmo salar OX=8030 GN=rft2 PE=2 SV=1 g3067.t1 Q6INN8 52.091 574 0.0 589.0 sp|Q6INN8|SAMH1_XENLA Deoxynucleoside triphosphate triphosphohydrolase SAMHD1 OS=Xenopus laevis OX=8355 GN=samhd1 PE=1 SV=2 SAMH1_XENLA reviewed Deoxynucleoside triphosphate triphosphohydrolase SAMHD1 (dNTPase) (EC 3.1.5.-) Xenopus laevis (African clawed frog) GO:0000724; GO:0003676; GO:0003697; GO:0003723; GO:0005525; GO:0005634; GO:0006203; GO:0006974; GO:0008270; GO:0008832; GO:0009264; GO:0016446; GO:0016793; GO:0032567; GO:0035861; GO:0045087; GO:0045088; GO:0046061; GO:0051289; GO:0051607; GO:0060339; GO:0106375; GO:0110025 dATP catabolic process [GO:0046061]; defense response to virus [GO:0051607]; deoxyribonucleotide catabolic process [GO:0009264]; dGTP catabolic process [GO:0006203]; DNA damage response [GO:0006974]; DNA strand resection involved in replication fork processing [GO:0110025]; double-strand break repair via homologous recombination [GO:0000724]; innate immune response [GO:0045087]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; protein homotetramerization [GO:0051289]; regulation of innate immune response [GO:0045088]; somatic hypermutation of immunoglobulin genes [GO:0016446] nucleus [GO:0005634]; site of double-strand break [GO:0035861] deoxynucleoside triphosphate hydrolase activity [GO:0106375]; dGTP binding [GO:0032567]; dGTPase activity [GO:0008832]; GTP binding [GO:0005525]; nucleic acid binding [GO:0003676]; RNA binding [GO:0003723]; single-stranded DNA binding [GO:0003697]; triphosphoric monoester hydrolase activity [GO:0016793]; zinc ion binding [GO:0008270] g3072.t1 Q4AEI0 42.391 184 2.3699999999999998e-42 147.0 sp|Q4AEI0|GPX2_PONPY Glutathione peroxidase 2 OS=Pongo pygmaeus OX=9600 GN=GPX2 PE=2 SV=2 g3073.t1 A2RT91 31.8 761 9.51e-95 329.0 sp|A2RT91|ANKAR_MOUSE Ankyrin and armadillo repeat-containing protein OS=Mus musculus OX=10090 GN=Ankar PE=2 SV=1 g3075.t1 P35816 42.902 317 5.35e-74 244.0 sp|P35816|PDP1_BOVIN [Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial OS=Bos taurus OX=9913 GN=PDP1 PE=1 SV=1 PDP1_BOVIN reviewed [Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial (PDP 1) (EC 3.1.3.43) (Protein phosphatase 2C) (PDPc) (Pyruvate dehydrogenase phosphatase catalytic subunit 1) (PDPC 1) Bos taurus (Bovine) GO:0000287; GO:0004741; GO:0005509; GO:0005739; GO:0016311; GO:0019910; GO:0045254 dephosphorylation [GO:0016311] mitochondrial pyruvate dehydrogenase (lipoamide) phosphatase complex [GO:0019910]; mitochondrion [GO:0005739]; pyruvate dehydrogenase complex [GO:0045254] [pyruvate dehydrogenase (acetyl-transferring)]-phosphatase activity [GO:0004741]; calcium ion binding [GO:0005509]; magnesium ion binding [GO:0000287] g3076.t1 Q9Y697 78.055 401 0.0 686.0 sp|Q9Y697|NFS1_HUMAN Cysteine desulfurase OS=Homo sapiens OX=9606 GN=NFS1 PE=1 SV=3 g3079.t1 Q2VLH6 30.154 325 1.9600000000000001e-31 130.0 sp|Q2VLH6|C163A_MOUSE Scavenger receptor cysteine-rich type 1 protein M130 OS=Mus musculus OX=10090 GN=Cd163 PE=1 SV=2 C163A_MOUSE reviewed Scavenger receptor cysteine-rich type 1 protein M130 (CD antigen CD163) [Cleaved into: Soluble CD163 (sCD163)] Mus musculus (Mouse) GO:0005044; GO:0005576; GO:0005737; GO:0005886; GO:0006953; GO:0009897; GO:0009986; GO:0097110 acute-phase response [GO:0006953] cell surface [GO:0009986]; cytoplasm [GO:0005737]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; plasma membrane [GO:0005886] scaffold protein binding [GO:0097110]; scavenger receptor activity [GO:0005044] g3079.t1 Q2VLH6 31.329 316 6.38e-26 113.0 sp|Q2VLH6|C163A_MOUSE Scavenger receptor cysteine-rich type 1 protein M130 OS=Mus musculus OX=10090 GN=Cd163 PE=1 SV=2 C163A_MOUSE reviewed Scavenger receptor cysteine-rich type 1 protein M130 (CD antigen CD163) [Cleaved into: Soluble CD163 (sCD163)] Mus musculus (Mouse) GO:0005044; GO:0005576; GO:0005737; GO:0005886; GO:0006953; GO:0009897; GO:0009986; GO:0097110 acute-phase response [GO:0006953] cell surface [GO:0009986]; cytoplasm [GO:0005737]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; plasma membrane [GO:0005886] scaffold protein binding [GO:0097110]; scavenger receptor activity [GO:0005044] g3079.t1 Q2VLH6 29.181 281 5.02e-21 99.0 sp|Q2VLH6|C163A_MOUSE Scavenger receptor cysteine-rich type 1 protein M130 OS=Mus musculus OX=10090 GN=Cd163 PE=1 SV=2 C163A_MOUSE reviewed Scavenger receptor cysteine-rich type 1 protein M130 (CD antigen CD163) [Cleaved into: Soluble CD163 (sCD163)] Mus musculus (Mouse) GO:0005044; GO:0005576; GO:0005737; GO:0005886; GO:0006953; GO:0009897; GO:0009986; GO:0097110 acute-phase response [GO:0006953] cell surface [GO:0009986]; cytoplasm [GO:0005737]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; plasma membrane [GO:0005886] scaffold protein binding [GO:0097110]; scavenger receptor activity [GO:0005044] g3080.t1 P41044 39.779 181 1.85e-32 121.0 sp|P41044|CAB32_DROME Calbindin-32 OS=Drosophila melanogaster OX=7227 GN=Cbp53E PE=2 SV=1 g3081.t1 Q64464 37.551 490 1.3399999999999999e-104 325.0 sp|Q64464|CP3AD_MOUSE Cytochrome P450 3A13 OS=Mus musculus OX=10090 GN=Cyp3a13 PE=1 SV=1 CP3AD_MOUSE reviewed Cytochrome P450 3A13 (EC 1.14.14.1) (CYPIIIA13) Mus musculus (Mouse) GO:0004497; GO:0005496; GO:0005506; GO:0005737; GO:0005789; GO:0008202; GO:0008395; GO:0008401; GO:0010628; GO:0016491; GO:0019899; GO:0020037; GO:0030343; GO:0034875; GO:0042908; GO:0050649; GO:0062181; GO:0070576; GO:0070989; GO:0101020; GO:0101021 oxidative demethylation [GO:0070989]; positive regulation of gene expression [GO:0010628]; steroid metabolic process [GO:0008202]; xenobiotic transport [GO:0042908] cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789] 1-alpha,25-dihydroxyvitamin D3 23-hydroxylase activity [GO:0062181]; caffeine oxidase activity [GO:0034875]; enzyme binding [GO:0019899]; estrogen 16-alpha-hydroxylase activity [GO:0101020]; estrogen 2-hydroxylase activity [GO:0101021]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity [GO:0016491]; retinoic acid 4-hydroxylase activity [GO:0008401]; steroid binding [GO:0005496]; steroid hydroxylase activity [GO:0008395]; testosterone 6-beta-hydroxylase activity [GO:0050649]; vitamin D 24-hydroxylase activity [GO:0070576]; vitamin D3 25-hydroxylase activity [GO:0030343] g3082.t1 P79401 36.802 519 1.48e-95 319.0 sp|P79401|CP3AT_PIG Cytochrome P450 3A29 OS=Sus scrofa OX=9823 GN=CYP3A29 PE=2 SV=1 g3087.t1 Q64464 39.501 481 6.69e-114 348.0 sp|Q64464|CP3AD_MOUSE Cytochrome P450 3A13 OS=Mus musculus OX=10090 GN=Cyp3a13 PE=1 SV=1 CP3AD_MOUSE reviewed Cytochrome P450 3A13 (EC 1.14.14.1) (CYPIIIA13) Mus musculus (Mouse) GO:0004497; GO:0005496; GO:0005506; GO:0005737; GO:0005789; GO:0008202; GO:0008395; GO:0008401; GO:0010628; GO:0016491; GO:0019899; GO:0020037; GO:0030343; GO:0034875; GO:0042908; GO:0050649; GO:0062181; GO:0070576; GO:0070989; GO:0101020; GO:0101021 oxidative demethylation [GO:0070989]; positive regulation of gene expression [GO:0010628]; steroid metabolic process [GO:0008202]; xenobiotic transport [GO:0042908] cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789] 1-alpha,25-dihydroxyvitamin D3 23-hydroxylase activity [GO:0062181]; caffeine oxidase activity [GO:0034875]; enzyme binding [GO:0019899]; estrogen 16-alpha-hydroxylase activity [GO:0101020]; estrogen 2-hydroxylase activity [GO:0101021]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity [GO:0016491]; retinoic acid 4-hydroxylase activity [GO:0008401]; steroid binding [GO:0005496]; steroid hydroxylase activity [GO:0008395]; testosterone 6-beta-hydroxylase activity [GO:0050649]; vitamin D 24-hydroxylase activity [GO:0070576]; vitamin D3 25-hydroxylase activity [GO:0030343] g3088.t1 Q64464 42.094 487 4.1499999999999996e-128 385.0 sp|Q64464|CP3AD_MOUSE Cytochrome P450 3A13 OS=Mus musculus OX=10090 GN=Cyp3a13 PE=1 SV=1 CP3AD_MOUSE reviewed Cytochrome P450 3A13 (EC 1.14.14.1) (CYPIIIA13) Mus musculus (Mouse) GO:0004497; GO:0005496; GO:0005506; GO:0005737; GO:0005789; GO:0008202; GO:0008395; GO:0008401; GO:0010628; GO:0016491; GO:0019899; GO:0020037; GO:0030343; GO:0034875; GO:0042908; GO:0050649; GO:0062181; GO:0070576; GO:0070989; GO:0101020; GO:0101021 oxidative demethylation [GO:0070989]; positive regulation of gene expression [GO:0010628]; steroid metabolic process [GO:0008202]; xenobiotic transport [GO:0042908] cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789] 1-alpha,25-dihydroxyvitamin D3 23-hydroxylase activity [GO:0062181]; caffeine oxidase activity [GO:0034875]; enzyme binding [GO:0019899]; estrogen 16-alpha-hydroxylase activity [GO:0101020]; estrogen 2-hydroxylase activity [GO:0101021]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity [GO:0016491]; retinoic acid 4-hydroxylase activity [GO:0008401]; steroid binding [GO:0005496]; steroid hydroxylase activity [GO:0008395]; testosterone 6-beta-hydroxylase activity [GO:0050649]; vitamin D 24-hydroxylase activity [GO:0070576]; vitamin D3 25-hydroxylase activity [GO:0030343] g3093.t2 Q5RAG7 29.268 287 5.93e-39 146.0 sp|Q5RAG7|XCT_PONAB Cystine/glutamate transporter OS=Pongo abelii OX=9601 GN=SLC7A11 PE=2 SV=1 XCT_PONAB reviewed Cystine/glutamate transporter (Amino acid transport system xc-) (Solute carrier family 7 member 11) (xCT) Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0005765; GO:0005886; GO:0015252; GO:0015327; GO:0015811; GO:0015813; GO:0022840; GO:0031528; GO:0035752; GO:0110076; GO:0140924; GO:0140926; GO:1902600 L-cystine transport [GO:0015811]; L-glutamate transmembrane transport [GO:0015813]; L-kynurenine transmembrane transport [GO:0140924]; lysosomal lumen pH elevation [GO:0035752]; negative regulation of ferroptosis [GO:0110076]; proton transmembrane transport [GO:1902600] lysosomal membrane [GO:0005765]; microvillus membrane [GO:0031528]; plasma membrane [GO:0005886] cystine:glutamate antiporter activity [GO:0015327]; L-kynurenine transmembrane transporter activity [GO:0140926]; leak channel activity [GO:0022840]; proton channel activity [GO:0015252] g3093.t3 Q9WTR6 29.184 490 8.16e-61 211.0 sp|Q9WTR6|XCT_MOUSE Cystine/glutamate transporter OS=Mus musculus OX=10090 GN=Slc7a11 PE=1 SV=1 XCT_MOUSE reviewed Cystine/glutamate transporter (Amino acid transport system xc-) (Solute carrier family 7 member 11) (Subtle gray protein) (xCT) Mus musculus (Mouse) GO:0003333; GO:0005765; GO:0005886; GO:0006749; GO:0007420; GO:0008542; GO:0009636; GO:0009986; GO:0015179; GO:0015252; GO:0015327; GO:0015811; GO:0015813; GO:0016020; GO:0021591; GO:0021756; GO:0022840; GO:0030534; GO:0031526; GO:0031528; GO:0033029; GO:0033554; GO:0034599; GO:0034775; GO:0035752; GO:0042127; GO:0045177; GO:0048021; GO:0048286; GO:0050804; GO:0050807; GO:0051223; GO:0051775; GO:0060173; GO:0070527; GO:0090461; GO:0097449; GO:0098712; GO:0110076; GO:0140206; GO:0140924; GO:0140926; GO:1900407; GO:1901494; GO:1902600; GO:1903786; GO:1904717; GO:2000211 adult behavior [GO:0030534]; amino acid transmembrane transport [GO:0003333]; brain development [GO:0007420]; cellular response to oxidative stress [GO:0034599]; cellular response to stress [GO:0033554]; dipeptide import across plasma membrane [GO:0140206]; glutathione metabolic process [GO:0006749]; glutathione transmembrane transport [GO:0034775]; intracellular glutamate homeostasis [GO:0090461]; L-cystine transport [GO:0015811]; L-glutamate import across plasma membrane [GO:0098712]; L-glutamate transmembrane transport [GO:0015813]; L-kynurenine transmembrane transport [GO:0140924]; limb development [GO:0060173]; lung alveolus development [GO:0048286]; lysosomal lumen pH elevation [GO:0035752]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of ferroptosis [GO:0110076]; platelet aggregation [GO:0070527]; proton transmembrane transport [GO:1902600]; regulation of AMPA glutamate receptor clustering [GO:1904717]; regulation of cell population proliferation [GO:0042127]; regulation of cellular response to oxidative stress [GO:1900407]; regulation of cysteine metabolic process [GO:1901494]; regulation of glutamate metabolic process [GO:2000211]; regulation of glutathione biosynthetic process [GO:1903786]; regulation of melanin biosynthetic process [GO:0048021]; regulation of neutrophil apoptotic process [GO:0033029]; regulation of protein transport [GO:0051223]; regulation of synapse organization [GO:0050807]; response to redox state [GO:0051775]; response to toxic substance [GO:0009636]; striatum development [GO:0021756]; ventricular system development [GO:0021591]; visual learning [GO:0008542] apical part of cell [GO:0045177]; astrocyte projection [GO:0097449]; brush border membrane [GO:0031526]; cell surface [GO:0009986]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; microvillus membrane [GO:0031528]; plasma membrane [GO:0005886] cystine:glutamate antiporter activity [GO:0015327]; L-amino acid transmembrane transporter activity [GO:0015179]; L-kynurenine transmembrane transporter activity [GO:0140926]; leak channel activity [GO:0022840]; proton channel activity [GO:0015252] g3094.t1 Q9EQH3 69.767 86 3.14e-38 137.0 sp|Q9EQH3|VPS35_MOUSE Vacuolar protein sorting-associated protein 35 OS=Mus musculus OX=10090 GN=Vps35 PE=1 SV=1 VPS35_MOUSE reviewed Vacuolar protein sorting-associated protein 35 (Maternal-embryonic 3) (Vesicle protein sorting 35) Mus musculus (Mouse) GO:0005737; GO:0005739; GO:0005764; GO:0005768; GO:0005769; GO:0005770; GO:0005829; GO:0006624; GO:0006886; GO:0007040; GO:0010008; GO:0010628; GO:0010629; GO:0010821; GO:0014069; GO:0016020; GO:0030904; GO:0030906; GO:0031647; GO:0031648; GO:0031748; GO:0032456; GO:0032463; GO:0036010; GO:0042147; GO:0043005; GO:0043025; GO:0043653; GO:0045056; GO:0045202; GO:0045732; GO:0048471; GO:0050728; GO:0050804; GO:0050882; GO:0051246; GO:0060161; GO:0061357; GO:0090128; GO:0090141; GO:0090263; GO:0090326; GO:0097422; GO:0098691; GO:0098793; GO:0098794; GO:0098887; GO:0098978; GO:0099073; GO:0099074; GO:0099639; GO:0150052; GO:1902823; GO:1902950; GO:1903181; GO:1903828; GO:1904377; GO:1905166; GO:2000331 endocytic recycling [GO:0032456]; intracellular protein transport [GO:0006886]; lysosome organization [GO:0007040]; mitochondrial fragmentation involved in apoptotic process [GO:0043653]; mitochondrion to lysosome vesicle-mediated transport [GO:0099074]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of gene expression [GO:0010629]; negative regulation of inflammatory response [GO:0050728]; negative regulation of late endosome to lysosome transport [GO:1902823]; negative regulation of lysosomal protein catabolic process [GO:1905166]; negative regulation of protein homooligomerization [GO:0032463]; negative regulation of protein localization [GO:1903828]; neurotransmitter receptor transport, endosome to plasma membrane [GO:0099639]; neurotransmitter receptor transport, endosome to postsynaptic membrane [GO:0098887]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of dopamine biosynthetic process [GO:1903181]; positive regulation of dopamine receptor signaling pathway [GO:0060161]; positive regulation of gene expression [GO:0010628]; positive regulation of locomotion involved in locomotory behavior [GO:0090326]; positive regulation of mitochondrial fission [GO:0090141]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein localization to cell periphery [GO:1904377]; positive regulation of Wnt protein secretion [GO:0061357]; protein destabilization [GO:0031648]; protein localization to endosome [GO:0036010]; regulation of dendritic spine maintenance [GO:1902950]; regulation of mitochondrion organization [GO:0010821]; regulation of postsynapse assembly [GO:0150052]; regulation of protein metabolic process [GO:0051246]; regulation of protein stability [GO:0031647]; regulation of synapse maturation [GO:0090128]; regulation of terminal button organization [GO:2000331]; retrograde transport, endosome to Golgi [GO:0042147]; transcytosis [GO:0045056]; vacuolar protein processing [GO:0006624]; voluntary musculoskeletal movement [GO:0050882] cytoplasm [GO:0005737]; cytosol [GO:0005829]; dopaminergic synapse [GO:0098691]; early endosome [GO:0005769]; endosome [GO:0005768]; endosome membrane [GO:0010008]; glutamatergic synapse [GO:0098978]; late endosome [GO:0005770]; lysosome [GO:0005764]; membrane [GO:0016020]; mitochondrion [GO:0005739]; mitochondrion-derived vesicle [GO:0099073]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; presynapse [GO:0098793]; retromer complex [GO:0030904]; retromer, cargo-selective complex [GO:0030906]; synapse [GO:0045202]; tubular endosome [GO:0097422] D1 dopamine receptor binding [GO:0031748] g3095.t1 Q2HJG5 69.42 690 0.0 952.0 sp|Q2HJG5|VPS35_BOVIN Vacuolar protein sorting-associated protein 35 OS=Bos taurus OX=9913 GN=VPS35 PE=2 SV=1 VPS35_BOVIN reviewed Vacuolar protein sorting-associated protein 35 (Vesicle protein sorting 35) Bos taurus (Bovine) GO:0005739; GO:0005764; GO:0005768; GO:0005769; GO:0005770; GO:0005829; GO:0006886; GO:0010008; GO:0010628; GO:0030904; GO:0030906; GO:0031647; GO:0031748; GO:0032456; GO:0036010; GO:0042147; GO:0043653; GO:0045056; GO:0045732; GO:0050728; GO:0060161; GO:0090141; GO:0097422; GO:0099073; GO:0099074; GO:0099639; GO:1902823; GO:1902950; GO:1904377; GO:2000331 endocytic recycling [GO:0032456]; intracellular protein transport [GO:0006886]; mitochondrial fragmentation involved in apoptotic process [GO:0043653]; mitochondrion to lysosome vesicle-mediated transport [GO:0099074]; negative regulation of inflammatory response [GO:0050728]; negative regulation of late endosome to lysosome transport [GO:1902823]; neurotransmitter receptor transport, endosome to plasma membrane [GO:0099639]; positive regulation of dopamine receptor signaling pathway [GO:0060161]; positive regulation of gene expression [GO:0010628]; positive regulation of mitochondrial fission [GO:0090141]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein localization to cell periphery [GO:1904377]; protein localization to endosome [GO:0036010]; regulation of dendritic spine maintenance [GO:1902950]; regulation of protein stability [GO:0031647]; regulation of terminal button organization [GO:2000331]; retrograde transport, endosome to Golgi [GO:0042147]; transcytosis [GO:0045056] cytosol [GO:0005829]; early endosome [GO:0005769]; endosome [GO:0005768]; endosome membrane [GO:0010008]; late endosome [GO:0005770]; lysosome [GO:0005764]; mitochondrion [GO:0005739]; mitochondrion-derived vesicle [GO:0099073]; retromer complex [GO:0030904]; retromer, cargo-selective complex [GO:0030906]; tubular endosome [GO:0097422] D1 dopamine receptor binding [GO:0031748] g3097.t1 Q8N987 42.47 332 8.04e-77 242.0 sp|Q8N987|NECA1_HUMAN N-terminal EF-hand calcium-binding protein 1 OS=Homo sapiens OX=9606 GN=NECAB1 PE=1 SV=1 NECA1_HUMAN reviewed N-terminal EF-hand calcium-binding protein 1 (EF-hand calcium-binding protein 1) (Neuronal calcium-binding protein 1) Homo sapiens (Human) GO:0001835; GO:0005509; GO:0005654; GO:0005737; GO:0005829; GO:0005929; GO:0042802; GO:0042984 blastocyst hatching [GO:0001835]; regulation of amyloid precursor protein biosynthetic process [GO:0042984] cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654] calcium ion binding [GO:0005509]; identical protein binding [GO:0042802] g3098.t1 Q9Y2R5 53.465 101 1.6e-36 125.0 sp|Q9Y2R5|RT17_HUMAN Small ribosomal subunit protein uS17m OS=Homo sapiens OX=9606 GN=MRPS17 PE=1 SV=1 g3099.t1 Q9Y5B0 49.533 321 3.24e-83 288.0 sp|Q9Y5B0|CTDP1_HUMAN RNA polymerase II subunit A C-terminal domain phosphatase OS=Homo sapiens OX=9606 GN=CTDP1 PE=1 SV=3 g3099.t1 Q9Y5B0 42.553 141 2.95e-28 125.0 sp|Q9Y5B0|CTDP1_HUMAN RNA polymerase II subunit A C-terminal domain phosphatase OS=Homo sapiens OX=9606 GN=CTDP1 PE=1 SV=3 g3100.t1 Q5EA18 31.013 316 1.27e-49 172.0 sp|Q5EA18|CENPL_BOVIN Centromere protein L OS=Bos taurus OX=9913 GN=CENPL PE=2 SV=1 g3101.t1 Q7ZT01 60.69 145 4.17e-63 195.0 sp|Q7ZT01|PSF3_XENLA DNA replication complex GINS protein PSF3 OS=Xenopus laevis OX=8355 GN=gins3 PE=1 SV=1 PSF3_XENLA reviewed DNA replication complex GINS protein PSF3 (GINS complex subunit 3) Xenopus laevis (African clawed frog) GO:0000811; GO:0003682; GO:0006260; GO:0071162; GO:1902975 DNA replication [GO:0006260]; mitotic DNA replication initiation [GO:1902975] CMG complex [GO:0071162]; GINS complex [GO:0000811] chromatin binding [GO:0003682] g3103.t1 A7YVD7 57.5 280 8.009999999999999e-115 338.0 sp|A7YVD7|NDUF6_BOVIN NADH dehydrogenase (ubiquinone) complex I, assembly factor 6 OS=Bos taurus OX=9913 GN=NDUFAF6 PE=2 SV=1 g3104.t1 Q28F67 70.238 420 0.0 652.0 sp|Q28F67|AATM_XENTR Aspartate aminotransferase, mitochondrial OS=Xenopus tropicalis OX=8364 GN=got2 PE=2 SV=1 AATM_XENTR reviewed Aspartate aminotransferase, mitochondrial (mAspAT) (EC 2.6.1.1) (EC 2.6.1.7) (Glutamate oxaloacetate transaminase 2) (Kynurenine aminotransferase 4) (Kynurenine aminotransferase IV) (Kynurenine--oxoglutarate transaminase 4) (Kynurenine--oxoglutarate transaminase IV) (Transaminase A) Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0004069; GO:0005739; GO:0005759; GO:0006103; GO:0006531; GO:0006533; GO:0006536; GO:0016212; GO:0030170 2-oxoglutarate metabolic process [GO:0006103]; aspartate metabolic process [GO:0006531]; glutamate metabolic process [GO:0006536]; L-aspartate catabolic process [GO:0006533] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] kynurenine-oxoglutarate transaminase activity [GO:0016212]; L-aspartate:2-oxoglutarate aminotransferase activity [GO:0004069]; pyridoxal phosphate binding [GO:0030170] g3106.t1 Q3ZBX6 46.026 302 1.48e-77 244.0 sp|Q3ZBX6|RM03_BOVIN Large ribosomal subunit protein uL3m OS=Bos taurus OX=9913 GN=MRPL3 PE=1 SV=1 g3107.t1 Q3TLD5 54.815 135 2.8499999999999997e-46 162.0 sp|Q3TLD5|RMP_MOUSE Unconventional prefoldin RPB5 interactor OS=Mus musculus OX=10090 GN=Uri1 PE=1 SV=2 RMP_MOUSE reviewed Unconventional prefoldin RPB5 interactor (Protein NNX3) (Protein phosphatase 1 regulatory subunit 19) (RNA polymerase II subunit 5-mediating protein) (RPB5-mediating protein) Mus musculus (Mouse) GO:0000122; GO:0000993; GO:0001558; GO:0003682; GO:0003714; GO:0004864; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0006357; GO:0009615; GO:0010923; GO:0019212; GO:0030425; GO:0042771; GO:0051219; GO:0071363; GO:0071383; GO:1990062; GO:2001243 cellular response to growth factor stimulus [GO:0071363]; cellular response to steroid hormone stimulus [GO:0071383]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of phosphatase activity [GO:0010923]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of cell growth [GO:0001558]; regulation of transcription by RNA polymerase II [GO:0006357]; response to virus [GO:0009615] cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RPAP3/R2TP/prefoldin-like complex [GO:1990062] chromatin binding [GO:0003682]; phosphatase inhibitor activity [GO:0019212]; phosphoprotein binding [GO:0051219]; protein phosphatase inhibitor activity [GO:0004864]; RNA polymerase II complex binding [GO:0000993]; transcription corepressor activity [GO:0003714] g3109.t1 P97697 52.593 270 9.66e-101 298.0 sp|P97697|IMPA1_RAT Inositol monophosphatase 1 OS=Rattus norvegicus OX=10116 GN=Impa1 PE=1 SV=2 IMPA1_RAT reviewed Inositol monophosphatase 1 (IMP 1) (IMPase 1) (EC 3.1.3.25) (D-galactose 1-phosphate phosphatase) (EC 3.1.3.94) (Inositol-1(or 4)-monophosphatase 1) (Lithium-sensitive myo-inositol monophosphatase A1) Rattus norvegicus (Rat) GO:0000287; GO:0004346; GO:0005737; GO:0006020; GO:0006021; GO:0006661; GO:0006796; GO:0007165; GO:0008877; GO:0008934; GO:0030145; GO:0030424; GO:0031403; GO:0042802; GO:0042803; GO:0043025; GO:0046854; GO:0047954; GO:0052832; GO:0052833; GO:0052834; GO:0103026 inositol biosynthetic process [GO:0006021]; inositol metabolic process [GO:0006020]; phosphate-containing compound metabolic process [GO:0006796]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; signal transduction [GO:0007165] axon [GO:0030424]; cytoplasm [GO:0005737]; neuronal cell body [GO:0043025] fructose-1-phosphatase activity [GO:0103026]; glucose-1-phosphatase activity [GO:0008877]; glucose-6-phosphatase activity [GO:0004346]; glycerol-2-phosphatase activity [GO:0047954]; identical protein binding [GO:0042802]; inositol monophosphate 1-phosphatase activity [GO:0008934]; inositol monophosphate 3-phosphatase activity [GO:0052832]; inositol monophosphate 4-phosphatase activity [GO:0052833]; inositol monophosphate phosphatase activity [GO:0052834]; lithium ion binding [GO:0031403]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; protein homodimerization activity [GO:0042803] g3110.t1 Q62280 74.359 78 3.18e-28 119.0 sp|Q62280|SSXT_MOUSE Protein SSXT OS=Mus musculus OX=10090 GN=Ss18 PE=1 SV=2 SSXT_MOUSE reviewed Protein SSXT (Protein SYT) (Synovial sarcoma-associated Ss18-alpha) Mus musculus (Mouse) GO:0000226; GO:0000785; GO:0000902; GO:0003713; GO:0005634; GO:0005654; GO:0006338; GO:0006357; GO:0007010; GO:0008284; GO:0009410; GO:0015630; GO:0016514; GO:0035556; GO:0045596; GO:0045944; GO:0048013; GO:0071564; GO:0097150; GO:0140288; GO:1902459 cell morphogenesis [GO:0000902]; chromatin remodeling [GO:0006338]; cytoskeleton organization [GO:0007010]; ephrin receptor signaling pathway [GO:0048013]; intracellular signal transduction [GO:0035556]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of cell differentiation [GO:0045596]; neuronal stem cell population maintenance [GO:0097150]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; response to xenobiotic stimulus [GO:0009410] chromatin [GO:0000785]; GBAF complex [GO:0140288]; microtubule cytoskeleton [GO:0015630]; npBAF complex [GO:0071564]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SWI/SNF complex [GO:0016514] transcription coactivator activity [GO:0003713] g3122.t1 Q9VU02 88.235 85 1.84e-50 159.0 sp|Q9VU02|SMD1_DROME Probable small nuclear ribonucleoprotein Sm D1 OS=Drosophila melanogaster OX=7227 GN=SmD1 PE=1 SV=1 g3123.t1 C3YFB4 46.945 311 5.2099999999999994e-67 215.0 sp|C3YFB4|DRE2_BRAFL Anamorsin homolog OS=Branchiostoma floridae OX=7739 GN=BRAFLDRAFT_58504 PE=3 SV=1 g3124.t1 E2RYF8 78.261 46 1.7100000000000003e-21 92.8 sp|E2RYF8|TPX2_PATPE Targeting protein for Xklp2 homolog OS=Patiria pectinifera OX=7594 GN=TPX2 PE=2 SV=1 g3125.t1 E2RYF8 60.0 85 1.2800000000000001e-22 95.9 sp|E2RYF8|TPX2_PATPE Targeting protein for Xklp2 homolog OS=Patiria pectinifera OX=7594 GN=TPX2 PE=2 SV=1 g3126.t1 E2RYF8 70.991 424 0.0 593.0 sp|E2RYF8|TPX2_PATPE Targeting protein for Xklp2 homolog OS=Patiria pectinifera OX=7594 GN=TPX2 PE=2 SV=1 g3130.t1 Q8R4D1 62.048 498 1.06e-175 514.0 sp|Q8R4D1|SL9A8_MOUSE Sodium/hydrogen exchanger 8 OS=Mus musculus OX=10090 GN=Slc9a8 PE=1 SV=1 SL9A8_MOUSE reviewed Sodium/hydrogen exchanger 8 (Na(+)/H(+) exchanger 8) (NHE-8) (Solute carrier family 9 member 8) Mus musculus (Mouse) GO:0000139; GO:0001669; GO:0001675; GO:0005794; GO:0006813; GO:0006814; GO:0015385; GO:0015386; GO:0016324; GO:0032585; GO:0032588; GO:0035725; GO:0051453; GO:0071805; GO:1902600; GO:1905526 acrosome assembly [GO:0001675]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; proton transmembrane transport [GO:1902600]; regulation of Golgi lumen acidification [GO:1905526]; regulation of intracellular pH [GO:0051453]; sodium ion transmembrane transport [GO:0035725]; sodium ion transport [GO:0006814] acrosomal vesicle [GO:0001669]; apical plasma membrane [GO:0016324]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; multivesicular body membrane [GO:0032585]; trans-Golgi network membrane [GO:0032588] potassium:proton antiporter activity [GO:0015386]; sodium:proton antiporter activity [GO:0015385] g3131.t1 Q5GFD5 34.783 276 4.52e-49 170.0 sp|Q5GFD5|HS3S6_MOUSE Heparan sulfate glucosamine 3-O-sulfotransferase 6 OS=Mus musculus OX=10090 GN=Hs3st6 PE=2 SV=1 HS3S6_MOUSE reviewed Heparan sulfate glucosamine 3-O-sulfotransferase 6 (EC 2.8.2.23) (Heparan sulfate D-glucosaminyl 3-O-sulfotransferase 6) (3-OST-6) (Heparan sulfate 3-O-sulfotransferase 6) Mus musculus (Mouse) GO:0000139; GO:0001835; GO:0008467; GO:0015012 blastocyst hatching [GO:0001835]; heparan sulfate proteoglycan biosynthetic process [GO:0015012] Golgi membrane [GO:0000139] [heparan sulfate]-glucosamine 3-sulfotransferase activity [GO:0008467] g3131.t2 Q5GFD5 34.783 276 1.38e-49 171.0 sp|Q5GFD5|HS3S6_MOUSE Heparan sulfate glucosamine 3-O-sulfotransferase 6 OS=Mus musculus OX=10090 GN=Hs3st6 PE=2 SV=1 HS3S6_MOUSE reviewed Heparan sulfate glucosamine 3-O-sulfotransferase 6 (EC 2.8.2.23) (Heparan sulfate D-glucosaminyl 3-O-sulfotransferase 6) (3-OST-6) (Heparan sulfate 3-O-sulfotransferase 6) Mus musculus (Mouse) GO:0000139; GO:0001835; GO:0008467; GO:0015012 blastocyst hatching [GO:0001835]; heparan sulfate proteoglycan biosynthetic process [GO:0015012] Golgi membrane [GO:0000139] [heparan sulfate]-glucosamine 3-sulfotransferase activity [GO:0008467] g3132.t1 Q5GFD5 34.783 276 7.66e-51 175.0 sp|Q5GFD5|HS3S6_MOUSE Heparan sulfate glucosamine 3-O-sulfotransferase 6 OS=Mus musculus OX=10090 GN=Hs3st6 PE=2 SV=1 HS3S6_MOUSE reviewed Heparan sulfate glucosamine 3-O-sulfotransferase 6 (EC 2.8.2.23) (Heparan sulfate D-glucosaminyl 3-O-sulfotransferase 6) (3-OST-6) (Heparan sulfate 3-O-sulfotransferase 6) Mus musculus (Mouse) GO:0000139; GO:0001835; GO:0008467; GO:0015012 blastocyst hatching [GO:0001835]; heparan sulfate proteoglycan biosynthetic process [GO:0015012] Golgi membrane [GO:0000139] [heparan sulfate]-glucosamine 3-sulfotransferase activity [GO:0008467] g3134.t1 Q9ET77 50.893 448 3.5e-125 397.0 sp|Q9ET77|JPH3_MOUSE Junctophilin-3 OS=Mus musculus OX=10090 GN=Jph3 PE=1 SV=1 JPH3_MOUSE reviewed Junctophilin-3 (JP-3) (Junctophilin type 3) Mus musculus (Mouse) GO:0005783; GO:0005789; GO:0005886; GO:0007612; GO:0007613; GO:0016020; GO:0030314; GO:0035640; GO:0040011; GO:0048167; GO:0048168; GO:0050885; GO:0060314 exploration behavior [GO:0035640]; learning [GO:0007612]; locomotion [GO:0040011]; memory [GO:0007613]; neuromuscular process controlling balance [GO:0050885]; regulation of neuronal synaptic plasticity [GO:0048168]; regulation of ryanodine-sensitive calcium-release channel activity [GO:0060314]; regulation of synaptic plasticity [GO:0048167] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; junctional membrane complex [GO:0030314]; membrane [GO:0016020]; plasma membrane [GO:0005886] g3134.t2 Q9GKY7 51.794 446 2.0500000000000001e-125 395.0 sp|Q9GKY7|JPH2_RABIT Junctophilin-2 OS=Oryctolagus cuniculus OX=9986 GN=JPH2 PE=2 SV=1 g3135.t1 Q92556 49.125 743 0.0 670.0 sp|Q92556|ELMO1_HUMAN Engulfment and cell motility protein 1 OS=Homo sapiens OX=9606 GN=ELMO1 PE=1 SV=2 ELMO1_HUMAN reviewed Engulfment and cell motility protein 1 (Protein ced-12 homolog) Homo sapiens (Human) GO:0005737; GO:0005829; GO:0005886; GO:0006911; GO:0006915; GO:0007015; GO:0016020; GO:0016601; GO:0017124; GO:0030036; GO:0032045; GO:0048870; GO:0098794; GO:0098978; GO:0150052 actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; apoptotic process [GO:0006915]; cell motility [GO:0048870]; phagocytosis, engulfment [GO:0006911]; Rac protein signal transduction [GO:0016601]; regulation of postsynapse assembly [GO:0150052] cytoplasm [GO:0005737]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; guanyl-nucleotide exchange factor complex [GO:0032045]; membrane [GO:0016020]; plasma membrane [GO:0005886]; postsynapse [GO:0098794] SH3 domain binding [GO:0017124] g3135.t2 Q92556 49.26 743 0.0 674.0 sp|Q92556|ELMO1_HUMAN Engulfment and cell motility protein 1 OS=Homo sapiens OX=9606 GN=ELMO1 PE=1 SV=2 ELMO1_HUMAN reviewed Engulfment and cell motility protein 1 (Protein ced-12 homolog) Homo sapiens (Human) GO:0005737; GO:0005829; GO:0005886; GO:0006911; GO:0006915; GO:0007015; GO:0016020; GO:0016601; GO:0017124; GO:0030036; GO:0032045; GO:0048870; GO:0098794; GO:0098978; GO:0150052 actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; apoptotic process [GO:0006915]; cell motility [GO:0048870]; phagocytosis, engulfment [GO:0006911]; Rac protein signal transduction [GO:0016601]; regulation of postsynapse assembly [GO:0150052] cytoplasm [GO:0005737]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; guanyl-nucleotide exchange factor complex [GO:0032045]; membrane [GO:0016020]; plasma membrane [GO:0005886]; postsynapse [GO:0098794] SH3 domain binding [GO:0017124] g3135.t3 Q92556 49.932 735 0.0 660.0 sp|Q92556|ELMO1_HUMAN Engulfment and cell motility protein 1 OS=Homo sapiens OX=9606 GN=ELMO1 PE=1 SV=2 ELMO1_HUMAN reviewed Engulfment and cell motility protein 1 (Protein ced-12 homolog) Homo sapiens (Human) GO:0005737; GO:0005829; GO:0005886; GO:0006911; GO:0006915; GO:0007015; GO:0016020; GO:0016601; GO:0017124; GO:0030036; GO:0032045; GO:0048870; GO:0098794; GO:0098978; GO:0150052 actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; apoptotic process [GO:0006915]; cell motility [GO:0048870]; phagocytosis, engulfment [GO:0006911]; Rac protein signal transduction [GO:0016601]; regulation of postsynapse assembly [GO:0150052] cytoplasm [GO:0005737]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; guanyl-nucleotide exchange factor complex [GO:0032045]; membrane [GO:0016020]; plasma membrane [GO:0005886]; postsynapse [GO:0098794] SH3 domain binding [GO:0017124] g3136.t1 Q9VTC4 75.893 112 1.61e-55 173.0 sp|Q9VTC4|GALL2_DROME MIP18 family protein galla-2 OS=Drosophila melanogaster OX=7227 GN=galla-2 PE=1 SV=1 g3137.t1 Q8N0Z6 48.38 432 4.1499999999999997e-141 413.0 sp|Q8N0Z6|TTC5_HUMAN Tetratricopeptide repeat protein 5 OS=Homo sapiens OX=9606 GN=TTC5 PE=1 SV=2 TTC5_HUMAN reviewed Tetratricopeptide repeat protein 5 (TPR repeat protein 5) (Stress-responsive activator of p300) (Protein Strap) Homo sapiens (Human) GO:0003677; GO:0003682; GO:0005654; GO:0005739; GO:0005759; GO:0005829; GO:0006281; GO:0006974; GO:0009267; GO:0031410; GO:0043022; GO:0045944; GO:0061014 cellular response to starvation [GO:0009267]; DNA damage response [GO:0006974]; DNA repair [GO:0006281]; positive regulation of mRNA catabolic process [GO:0061014]; positive regulation of transcription by RNA polymerase II [GO:0045944] cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654] chromatin binding [GO:0003682]; DNA binding [GO:0003677]; ribosome binding [GO:0043022] g3138.t1 Q8BGA9 42.975 363 1.41e-108 330.0 sp|Q8BGA9|OXA1L_MOUSE Mitochondrial inner membrane protein OXA1L OS=Mus musculus OX=10090 GN=Oxa1l PE=1 SV=1 OXA1L_MOUSE reviewed Mitochondrial inner membrane protein OXA1L (Oxidase assembly 1-like protein) (OXA1-like protein) Mus musculus (Mouse) GO:0005739; GO:0005743; GO:0009060; GO:0031966; GO:0032977; GO:0032979; GO:0032981; GO:0032991; GO:0033615; GO:0042803; GO:0051262; GO:0097177; GO:0141164 aerobic respiration [GO:0009060]; mitochondrial protein quality control [GO:0141164]; mitochondrial proton-transporting ATP synthase complex assembly [GO:0033615]; mitochondrial respiratory chain complex I assembly [GO:0032981]; protein insertion into mitochondrial inner membrane from matrix [GO:0032979]; protein tetramerization [GO:0051262] mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; protein-containing complex [GO:0032991] membrane insertase activity [GO:0032977]; mitochondrial ribosome binding [GO:0097177]; protein homodimerization activity [GO:0042803] g3140.t1 P10619 43.167 461 1.4599999999999998e-128 385.0 sp|P10619|PPGB_HUMAN Lysosomal protective protein OS=Homo sapiens OX=9606 GN=CTSA PE=1 SV=2 PPGB_HUMAN reviewed Lysosomal protective protein (EC 3.4.16.5) (Carboxypeptidase C) (Carboxypeptidase L) (Cathepsin A) (Protective protein cathepsin A) (PPCA) (Protective protein for beta-galactosidase) [Cleaved into: Lysosomal protective protein 32 kDa chain; Lysosomal protective protein 20 kDa chain] Homo sapiens (Human) GO:0004180; GO:0004185; GO:0005576; GO:0005764; GO:0005783; GO:0006508; GO:0006886; GO:0008047; GO:0016020; GO:0031647; GO:0035578; GO:0043202; GO:0070062; GO:1904714; GO:1904715 intracellular protein transport [GO:0006886]; negative regulation of chaperone-mediated autophagy [GO:1904715]; proteolysis [GO:0006508]; regulation of chaperone-mediated autophagy [GO:1904714]; regulation of protein stability [GO:0031647] azurophil granule lumen [GO:0035578]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764]; membrane [GO:0016020] carboxypeptidase activity [GO:0004180]; enzyme activator activity [GO:0008047]; serine-type carboxypeptidase activity [GO:0004185] g3142.t1 F1QXM5 63.774 461 0.0 574.0 sp|F1QXM5|LDHD_DANRE Probable D-lactate dehydrogenase, mitochondrial OS=Danio rerio OX=7955 GN=ldhd PE=2 SV=1 LDHD_DANRE reviewed D-lactate dehydrogenase, mitochondrial (DLD) (Lactate dehydrogenase D) (EC 1.1.98.-) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0004458; GO:0005739; GO:0008720; GO:0050660; GO:0071949; GO:0140170; GO:0140174; GO:1903457 lactate catabolic process [GO:1903457] mitochondrion [GO:0005739] (2R)-2-hydroxycarboxylate dehydrogenase activity [GO:0140174]; D-lactate dehydrogenase (cytochrome) activity [GO:0004458]; D-lactate dehydrogenase (FAD) activity [GO:0140170]; D-lactate dehydrogenase (NAD+) activity [GO:0008720]; FAD binding [GO:0071949]; flavin adenine dinucleotide binding [GO:0050660] g3143.t1 Q62737 51.969 127 6.79e-38 132.0 sp|Q62737|CY24A_RAT Cytochrome b-245 light chain OS=Rattus norvegicus OX=10116 GN=Cyba PE=1 SV=3 CY24A_RAT reviewed Cytochrome b-245 light chain (Cytochrome b(558) alpha chain) (Cytochrome b558 subunit alpha) (Neutrophil cytochrome b 22 kDa polypeptide) (Superoxide-generating NADPH oxidase light chain subunit) (p22 phagocyte B-cytochrome) (p22-phox) (p22phox) Rattus norvegicus (Rat) GO:0001666; GO:0001725; GO:0001938; GO:0003106; GO:0005737; GO:0005768; GO:0005886; GO:0005925; GO:0006801; GO:0006954; GO:0009055; GO:0009410; GO:0014823; GO:0014895; GO:0016175; GO:0016324; GO:0017004; GO:0017124; GO:0020037; GO:0030307; GO:0030425; GO:0031667; GO:0032755; GO:0032760; GO:0032930; GO:0034137; GO:0042554; GO:0043020; GO:0043025; GO:0045087; GO:0045730; GO:0045777; GO:0046872; GO:0046982; GO:0048661; GO:0050665; GO:0050766; GO:0051279; GO:0051649; GO:0070254; GO:0070257; GO:0070555; GO:0071260; GO:0071333; GO:0071356; GO:0071480; GO:0072593; GO:0097038; GO:1900426; GO:1903428; GO:1904044; GO:1904385; GO:1904628; GO:1904845 cellular response to angiotensin [GO:1904385]; cellular response to gamma radiation [GO:0071480]; cellular response to glucose stimulus [GO:0071333]; cellular response to L-glutamine [GO:1904845]; cellular response to mechanical stimulus [GO:0071260]; cellular response to phorbol 13-acetate 12-myristate [GO:1904628]; cellular response to tumor necrosis factor [GO:0071356]; cytochrome complex assembly [GO:0017004]; establishment of localization in cell [GO:0051649]; hydrogen peroxide biosynthetic process [GO:0050665]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; mucus secretion [GO:0070254]; negative regulation of glomerular filtration by angiotensin [GO:0003106]; positive regulation of blood pressure [GO:0045777]; positive regulation of cell growth [GO:0030307]; positive regulation of defense response to bacterium [GO:1900426]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of mucus secretion [GO:0070257]; positive regulation of phagocytosis [GO:0050766]; positive regulation of reactive oxygen species biosynthetic process [GO:1903428]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of superoxide anion generation [GO:0032930]; positive regulation of toll-like receptor 2 signaling pathway [GO:0034137]; positive regulation of tumor necrosis factor production [GO:0032760]; reactive oxygen species metabolic process [GO:0072593]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; respiratory burst [GO:0045730]; response to activity [GO:0014823]; response to aldosterone [GO:1904044]; response to hypoxia [GO:0001666]; response to interleukin-1 [GO:0070555]; response to nutrient levels [GO:0031667]; response to xenobiotic stimulus [GO:0009410]; smooth muscle hypertrophy [GO:0014895]; superoxide anion generation [GO:0042554]; superoxide metabolic process [GO:0006801] apical plasma membrane [GO:0016324]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; endosome [GO:0005768]; focal adhesion [GO:0005925]; NADPH oxidase complex [GO:0043020]; neuronal cell body [GO:0043025]; perinuclear endoplasmic reticulum [GO:0097038]; plasma membrane [GO:0005886]; stress fiber [GO:0001725] electron transfer activity [GO:0009055]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]; SH3 domain binding [GO:0017124]; superoxide-generating NAD(P)H oxidase activity [GO:0016175] g3144.t1 Q8BTH6 70.504 139 1.82e-61 204.0 sp|Q8BTH6|SCRT2_MOUSE Transcriptional repressor scratch 2 OS=Mus musculus OX=10090 GN=Scrt2 PE=2 SV=2 g3145.t1 Q7T3C6 68.103 232 1.52e-107 311.0 sp|Q7T3C6|CPSF5_DANRE Cleavage and polyadenylation specificity factor subunit 5 OS=Danio rerio OX=7955 GN=nudt21 PE=2 SV=1 g3155.t1 Q86U38 29.248 612 3.6e-70 245.0 sp|Q86U38|NOP9_HUMAN Nucleolar protein 9 OS=Homo sapiens OX=9606 GN=NOP9 PE=1 SV=1 g3156.t1 Q80W93 49.634 1366 0.0 1371.0 sp|Q80W93|HYDIN_MOUSE Hydrocephalus-inducing protein OS=Mus musculus OX=10090 GN=Hydin PE=1 SV=2 HYDIN_MOUSE reviewed Hydrocephalus-inducing protein (Protein Hy-3) Mus musculus (Mouse) GO:0002064; GO:0003341; GO:0005929; GO:0005930; GO:0007420; GO:0021591; GO:0036126; GO:0060438; GO:1904158; GO:1990716; GO:1990718 axonemal central apparatus assembly [GO:1904158]; brain development [GO:0007420]; cilium movement [GO:0003341]; epithelial cell development [GO:0002064]; trachea development [GO:0060438]; ventricular system development [GO:0021591] axonemal central apparatus [GO:1990716]; axonemal central pair projection [GO:1990718]; axoneme [GO:0005930]; cilium [GO:0005929]; sperm flagellum [GO:0036126] g3156.t1 Q80W93 40.876 1233 0.0 866.0 sp|Q80W93|HYDIN_MOUSE Hydrocephalus-inducing protein OS=Mus musculus OX=10090 GN=Hydin PE=1 SV=2 HYDIN_MOUSE reviewed Hydrocephalus-inducing protein (Protein Hy-3) Mus musculus (Mouse) GO:0002064; GO:0003341; GO:0005929; GO:0005930; GO:0007420; GO:0021591; GO:0036126; GO:0060438; GO:1904158; GO:1990716; GO:1990718 axonemal central apparatus assembly [GO:1904158]; brain development [GO:0007420]; cilium movement [GO:0003341]; epithelial cell development [GO:0002064]; trachea development [GO:0060438]; ventricular system development [GO:0021591] axonemal central apparatus [GO:1990716]; axonemal central pair projection [GO:1990718]; axoneme [GO:0005930]; cilium [GO:0005929]; sperm flagellum [GO:0036126] g3156.t1 Q80W93 49.474 380 2.8600000000000003e-103 378.0 sp|Q80W93|HYDIN_MOUSE Hydrocephalus-inducing protein OS=Mus musculus OX=10090 GN=Hydin PE=1 SV=2 HYDIN_MOUSE reviewed Hydrocephalus-inducing protein (Protein Hy-3) Mus musculus (Mouse) GO:0002064; GO:0003341; GO:0005929; GO:0005930; GO:0007420; GO:0021591; GO:0036126; GO:0060438; GO:1904158; GO:1990716; GO:1990718 axonemal central apparatus assembly [GO:1904158]; brain development [GO:0007420]; cilium movement [GO:0003341]; epithelial cell development [GO:0002064]; trachea development [GO:0060438]; ventricular system development [GO:0021591] axonemal central apparatus [GO:1990716]; axonemal central pair projection [GO:1990718]; axoneme [GO:0005930]; cilium [GO:0005929]; sperm flagellum [GO:0036126] g3156.t1 Q80W93 58.095 105 8.55e-27 125.0 sp|Q80W93|HYDIN_MOUSE Hydrocephalus-inducing protein OS=Mus musculus OX=10090 GN=Hydin PE=1 SV=2 HYDIN_MOUSE reviewed Hydrocephalus-inducing protein (Protein Hy-3) Mus musculus (Mouse) GO:0002064; GO:0003341; GO:0005929; GO:0005930; GO:0007420; GO:0021591; GO:0036126; GO:0060438; GO:1904158; GO:1990716; GO:1990718 axonemal central apparatus assembly [GO:1904158]; brain development [GO:0007420]; cilium movement [GO:0003341]; epithelial cell development [GO:0002064]; trachea development [GO:0060438]; ventricular system development [GO:0021591] axonemal central apparatus [GO:1990716]; axonemal central pair projection [GO:1990718]; axoneme [GO:0005930]; cilium [GO:0005929]; sperm flagellum [GO:0036126] g3156.t1 Q80W93 50.0 144 1e-25 122.0 sp|Q80W93|HYDIN_MOUSE Hydrocephalus-inducing protein OS=Mus musculus OX=10090 GN=Hydin PE=1 SV=2 HYDIN_MOUSE reviewed Hydrocephalus-inducing protein (Protein Hy-3) Mus musculus (Mouse) GO:0002064; GO:0003341; GO:0005929; GO:0005930; GO:0007420; GO:0021591; GO:0036126; GO:0060438; GO:1904158; GO:1990716; GO:1990718 axonemal central apparatus assembly [GO:1904158]; brain development [GO:0007420]; cilium movement [GO:0003341]; epithelial cell development [GO:0002064]; trachea development [GO:0060438]; ventricular system development [GO:0021591] axonemal central apparatus [GO:1990716]; axonemal central pair projection [GO:1990718]; axoneme [GO:0005930]; cilium [GO:0005929]; sperm flagellum [GO:0036126] g3157.t1 Q80W93 61.053 95 5.14e-32 133.0 sp|Q80W93|HYDIN_MOUSE Hydrocephalus-inducing protein OS=Mus musculus OX=10090 GN=Hydin PE=1 SV=2 HYDIN_MOUSE reviewed Hydrocephalus-inducing protein (Protein Hy-3) Mus musculus (Mouse) GO:0002064; GO:0003341; GO:0005929; GO:0005930; GO:0007420; GO:0021591; GO:0036126; GO:0060438; GO:1904158; GO:1990716; GO:1990718 axonemal central apparatus assembly [GO:1904158]; brain development [GO:0007420]; cilium movement [GO:0003341]; epithelial cell development [GO:0002064]; trachea development [GO:0060438]; ventricular system development [GO:0021591] axonemal central apparatus [GO:1990716]; axonemal central pair projection [GO:1990718]; axoneme [GO:0005930]; cilium [GO:0005929]; sperm flagellum [GO:0036126] g3157.t1 Q80W93 52.212 113 7.91e-31 130.0 sp|Q80W93|HYDIN_MOUSE Hydrocephalus-inducing protein OS=Mus musculus OX=10090 GN=Hydin PE=1 SV=2 HYDIN_MOUSE reviewed Hydrocephalus-inducing protein (Protein Hy-3) Mus musculus (Mouse) GO:0002064; GO:0003341; GO:0005929; GO:0005930; GO:0007420; GO:0021591; GO:0036126; GO:0060438; GO:1904158; GO:1990716; GO:1990718 axonemal central apparatus assembly [GO:1904158]; brain development [GO:0007420]; cilium movement [GO:0003341]; epithelial cell development [GO:0002064]; trachea development [GO:0060438]; ventricular system development [GO:0021591] axonemal central apparatus [GO:1990716]; axonemal central pair projection [GO:1990718]; axoneme [GO:0005930]; cilium [GO:0005929]; sperm flagellum [GO:0036126] g3158.t1 Q4G0P3 47.785 1061 0.0 972.0 sp|Q4G0P3|HYDIN_HUMAN Hydrocephalus-inducing protein homolog OS=Homo sapiens OX=9606 GN=HYDIN PE=1 SV=3 HYDIN_HUMAN reviewed Hydrocephalus-inducing protein homolog Homo sapiens (Human) GO:0002064; GO:0003341; GO:0005929; GO:0005930; GO:0021591; GO:0030036; GO:0036126; GO:0060438; GO:1904158; GO:1990716; GO:1990718 actin cytoskeleton organization [GO:0030036]; axonemal central apparatus assembly [GO:1904158]; cilium movement [GO:0003341]; epithelial cell development [GO:0002064]; trachea development [GO:0060438]; ventricular system development [GO:0021591] axonemal central apparatus [GO:1990716]; axonemal central pair projection [GO:1990718]; axoneme [GO:0005930]; cilium [GO:0005929]; sperm flagellum [GO:0036126] g3159.t1 Q9UGM3 31.749 1452 4.1200000000000004e-164 551.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g3159.t1 Q9UGM3 31.749 1452 2.13e-162 546.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g3159.t1 Q9UGM3 32.216 1313 4.58e-155 525.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g3159.t1 Q9UGM3 31.619 1322 9.36e-148 503.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g3159.t1 Q9UGM3 31.402 1070 2.63e-118 416.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g3159.t1 Q9UGM3 31.579 798 1.1800000000000001e-73 276.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g3159.t1 Q9UGM3 31.648 613 2.1400000000000002e-64 246.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g3159.t1 Q9UGM3 32.136 529 5.97e-53 209.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g3159.t2 Q9UGM3 30.236 1442 2.55e-142 486.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g3159.t2 Q9UGM3 31.118 1369 2.84e-138 474.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g3159.t2 Q9UGM3 30.09 1439 5.4e-135 464.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g3159.t2 Q9UGM3 30.536 1251 1.82e-124 433.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g3159.t2 Q9UGM3 31.071 1223 1.33e-121 424.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g3159.t2 Q9UGM3 29.633 1117 5.54e-102 364.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g3159.t2 Q9UGM3 28.659 977 5.75e-83 305.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g3159.t2 Q9UGM3 31.579 798 6.12e-74 276.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g3159.t2 Q9UGM3 32.136 529 4.37e-53 209.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g3159.t2 Q9UGM3 51.402 107 4.44e-22 108.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g3161.t1 Q16698 61.938 289 8.899999999999999e-108 321.0 sp|Q16698|DECR_HUMAN 2,4-dienoyl-CoA reductase [(3E)-enoyl-CoA-producing], mitochondrial OS=Homo sapiens OX=9606 GN=DECR1 PE=1 SV=1 g3162.t1 Q61085 47.009 585 1.83e-174 516.0 sp|Q61085|RHPN1_MOUSE Rhophilin-1 OS=Mus musculus OX=10090 GN=Rhpn1 PE=1 SV=2 RHPN1_MOUSE reviewed Rhophilin-1 (GTP-Rho-binding protein 1) Mus musculus (Mouse) GO:0001822; GO:0003094; GO:0005829; GO:0005886; GO:0007165; GO:0048041; GO:0051497; GO:0071944; GO:0097018; GO:0120039 focal adhesion assembly [GO:0048041]; glomerular filtration [GO:0003094]; kidney development [GO:0001822]; negative regulation of stress fiber assembly [GO:0051497]; plasma membrane bounded cell projection morphogenesis [GO:0120039]; renal albumin absorption [GO:0097018]; signal transduction [GO:0007165] cell periphery [GO:0071944]; cytosol [GO:0005829]; plasma membrane [GO:0005886] g3164.t1 Q9CXD6 37.815 238 3.630000000000001e-43 152.0 sp|Q9CXD6|MCUR1_MOUSE Mitochondrial calcium uniporter regulator 1 OS=Mus musculus OX=10090 GN=Mcur1 PE=1 SV=1 MCUR1_MOUSE reviewed Mitochondrial calcium uniporter regulator 1 (MCU regulator 1) (Coiled-coil domain-containing protein 90A, mitochondrial) Mus musculus (Mouse) GO:0005739; GO:0005743; GO:0006091; GO:0006851; GO:0008283; GO:0016477; GO:0030674; GO:0036444; GO:0044877; GO:0051291; GO:0051561; GO:0070509; GO:0070588 calcium import into the mitochondrion [GO:0036444]; calcium ion import [GO:0070509]; calcium ion transmembrane transport [GO:0070588]; cell migration [GO:0016477]; cell population proliferation [GO:0008283]; generation of precursor metabolites and energy [GO:0006091]; mitochondrial calcium ion transmembrane transport [GO:0006851]; positive regulation of mitochondrial calcium ion concentration [GO:0051561]; protein heterooligomerization [GO:0051291] mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739] protein-containing complex binding [GO:0044877]; protein-macromolecule adaptor activity [GO:0030674] g3165.t1 Q9UGM3 34.729 406 2.2599999999999998e-55 204.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g3165.t1 Q9UGM3 34.279 423 4.4499999999999994e-55 203.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g3165.t1 Q9UGM3 34.383 413 1.13e-53 199.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g3165.t1 Q9UGM3 36.043 369 1.9199999999999999e-53 198.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g3165.t1 Q9UGM3 34.456 386 1.6499999999999998e-52 195.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g3165.t1 Q9UGM3 34.536 388 2.6999999999999997e-52 194.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g3165.t1 Q9UGM3 33.681 383 1.25e-51 192.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g3165.t1 Q9UGM3 34.218 377 4.06e-51 191.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g3165.t1 Q9UGM3 33.676 389 2.75e-49 186.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g3166.t1 Q5G266 33.772 456 4.79e-55 202.0 sp|Q5G266|NETR_TRAPH Neurotrypsin OS=Trachypithecus phayrei OX=61618 GN=PRSS12 PE=3 SV=1 NETR_TRAPH reviewed Neurotrypsin (EC 3.4.21.-) (Serine protease 12) Trachypithecus phayrei (Phayre's leaf monkey) GO:0004252; GO:0005576; GO:0005886; GO:0006508; GO:0006887; GO:0030424; GO:0098793; GO:0098978 exocytosis [GO:0006887]; proteolysis [GO:0006508] axon [GO:0030424]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; presynapse [GO:0098793] serine-type endopeptidase activity [GO:0004252] g3167.t1 Q9UGM3 30.159 315 2.44e-28 110.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g3167.t1 Q9UGM3 87.5 16 2.44e-28 36.6 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g3167.t1 Q9UGM3 32.765 293 1.2000000000000002e-27 112.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g3167.t1 Q9UGM3 75.0 16 1.2000000000000002e-27 33.1 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g3167.t1 Q9UGM3 29.841 315 7.090000000000001e-27 109.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g3167.t1 Q9UGM3 75.0 16 7.090000000000001e-27 33.1 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g3167.t1 Q9UGM3 29.33 358 1.28e-25 111.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g3167.t1 Q9UGM3 30.0 310 4.1e-25 103.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g3167.t1 Q9UGM3 75.0 16 4.1e-25 33.1 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g3167.t1 Q9UGM3 30.526 285 1.36e-23 105.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g3167.t1 Q9UGM3 30.526 285 2.3399999999999997e-23 104.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g3167.t1 Q9UGM3 29.968 317 3.1299999999999994e-23 104.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g3168.t1 Q95218 41.204 216 2.89e-34 137.0 sp|Q95218|DMBT1_RABIT Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Oryctolagus cuniculus OX=9986 GN=Dmbt1 PE=1 SV=2 g3168.t1 Q95218 34.444 270 3.98e-28 119.0 sp|Q95218|DMBT1_RABIT Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Oryctolagus cuniculus OX=9986 GN=Dmbt1 PE=1 SV=2 g3173.t1 P61132 46.388 263 8.12e-85 266.0 sp|P61132|SIAT6_PANTR CMP-N-acetylneuraminate-beta-1,4-galactoside alpha-2,3-sialyltransferase OS=Pan troglodytes OX=9598 GN=ST3GAL3 PE=2 SV=1 g3173.t2 P61132 46.388 263 5.22e-85 266.0 sp|P61132|SIAT6_PANTR CMP-N-acetylneuraminate-beta-1,4-galactoside alpha-2,3-sialyltransferase OS=Pan troglodytes OX=9598 GN=ST3GAL3 PE=2 SV=1 g3173.t3 P61132 46.388 263 1.81e-85 266.0 sp|P61132|SIAT6_PANTR CMP-N-acetylneuraminate-beta-1,4-galactoside alpha-2,3-sialyltransferase OS=Pan troglodytes OX=9598 GN=ST3GAL3 PE=2 SV=1 g3174.t1 Q08BG1 48.731 197 7.84e-62 202.0 sp|Q08BG1|TMPPE_DANRE Transmembrane protein with metallophosphoesterase domain OS=Danio rerio OX=7955 GN=tmppe PE=2 SV=1 g3176.t1 Q9Z2A7 50.655 458 1.3e-150 442.0 sp|Q9Z2A7|DGAT1_MOUSE Diacylglycerol O-acyltransferase 1 OS=Mus musculus OX=10090 GN=Dgat1 PE=1 SV=1 DGAT1_MOUSE reviewed Diacylglycerol O-acyltransferase 1 (EC 2.3.1.20) (Acyl-CoA retinol O-fatty-acyltransferase) (ARAT) (Retinol O-fatty-acyltransferase) (EC 2.3.1.76) (Diglyceride acyltransferase) Mus musculus (Mouse) GO:0001523; GO:0003846; GO:0004144; GO:0005504; GO:0005789; GO:0006640; GO:0010867; GO:0016020; GO:0016746; GO:0019432; GO:0019915; GO:0019992; GO:0030073; GO:0034379; GO:0035336; GO:0042802; GO:0046321; GO:0046339; GO:0046486; GO:0050252; GO:0055089; GO:1901738; GO:1902224; GO:1903998; GO:1904729; GO:2000491 diacylglycerol metabolic process [GO:0046339]; fatty acid homeostasis [GO:0055089]; glycerolipid metabolic process [GO:0046486]; insulin secretion [GO:0030073]; ketone body metabolic process [GO:1902224]; lipid storage [GO:0019915]; long-chain fatty-acyl-CoA metabolic process [GO:0035336]; monoacylglycerol biosynthetic process [GO:0006640]; positive regulation of fatty acid oxidation [GO:0046321]; positive regulation of hepatic stellate cell activation [GO:2000491]; positive regulation of triglyceride biosynthetic process [GO:0010867]; regulation of eating behavior [GO:1903998]; regulation of intestinal lipid absorption [GO:1904729]; regulation of vitamin A metabolic process [GO:1901738]; retinoid metabolic process [GO:0001523]; triglyceride biosynthetic process [GO:0019432]; very-low-density lipoprotein particle assembly [GO:0034379] endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020] 2-acylglycerol O-acyltransferase activity [GO:0003846]; acyltransferase activity [GO:0016746]; diacylglycerol binding [GO:0019992]; diacylglycerol O-acyltransferase activity [GO:0004144]; fatty acid binding [GO:0005504]; identical protein binding [GO:0042802]; retinol O-fatty-acyltransferase activity [GO:0050252] g3177.t1 Q76LL6 66.462 325 1.2e-138 435.0 sp|Q76LL6|FHOD3_MOUSE FH1/FH2 domain-containing protein 3 OS=Mus musculus OX=10090 GN=Fhod3 PE=1 SV=1 g3179.t1 Q2V2M9 51.136 528 1.05e-155 523.0 sp|Q2V2M9|FHOD3_HUMAN FH1/FH2 domain-containing protein 3 OS=Homo sapiens OX=9606 GN=FHOD3 PE=1 SV=2 FHOD3_HUMAN reviewed FH1/FH2 domain-containing protein 3 (Formactin-2) (Formin homolog overexpressed in spleen 2) (hFHOS2) Homo sapiens (Human) GO:0005737; GO:0005856; GO:0007015; GO:0030018; GO:0045214; GO:0051015; GO:0051496; GO:0055003 actin filament organization [GO:0007015]; cardiac myofibril assembly [GO:0055003]; positive regulation of stress fiber assembly [GO:0051496]; sarcomere organization [GO:0045214] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; Z disc [GO:0030018] actin filament binding [GO:0051015] g3179.t2 Q2V2M9 51.136 528 7.020000000000001e-156 523.0 sp|Q2V2M9|FHOD3_HUMAN FH1/FH2 domain-containing protein 3 OS=Homo sapiens OX=9606 GN=FHOD3 PE=1 SV=2 FHOD3_HUMAN reviewed FH1/FH2 domain-containing protein 3 (Formactin-2) (Formin homolog overexpressed in spleen 2) (hFHOS2) Homo sapiens (Human) GO:0005737; GO:0005856; GO:0007015; GO:0030018; GO:0045214; GO:0051015; GO:0051496; GO:0055003 actin filament organization [GO:0007015]; cardiac myofibril assembly [GO:0055003]; positive regulation of stress fiber assembly [GO:0051496]; sarcomere organization [GO:0045214] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; Z disc [GO:0030018] actin filament binding [GO:0051015] g3180.t1 Q6PF45 32.321 461 1.71e-66 225.0 sp|Q6PF45|VIAAT_XENLA Vesicular inhibitory amino acid transporter OS=Xenopus laevis OX=8355 GN=slc32a1 PE=2 SV=1 g3181.t1 F7J220 38.441 372 1.77e-59 213.0 sp|F7J220|SRCR1_PATPE Scavenger receptor cysteine-rich domain superfamily protein OS=Patiria pectinifera OX=7594 GN=SRCR1 PE=1 SV=1 g3181.t1 F7J220 37.903 372 2.46e-57 207.0 sp|F7J220|SRCR1_PATPE Scavenger receptor cysteine-rich domain superfamily protein OS=Patiria pectinifera OX=7594 GN=SRCR1 PE=1 SV=1 g3181.t1 F7J220 36.043 369 1.2099999999999998e-54 199.0 sp|F7J220|SRCR1_PATPE Scavenger receptor cysteine-rich domain superfamily protein OS=Patiria pectinifera OX=7594 GN=SRCR1 PE=1 SV=1 g3181.t1 F7J220 40.377 265 1.28e-49 184.0 sp|F7J220|SRCR1_PATPE Scavenger receptor cysteine-rich domain superfamily protein OS=Patiria pectinifera OX=7594 GN=SRCR1 PE=1 SV=1 g3181.t1 F7J220 31.233 365 9.86e-39 152.0 sp|F7J220|SRCR1_PATPE Scavenger receptor cysteine-rich domain superfamily protein OS=Patiria pectinifera OX=7594 GN=SRCR1 PE=1 SV=1 g3181.t1 F7J220 46.875 160 8.6e-35 141.0 sp|F7J220|SRCR1_PATPE Scavenger receptor cysteine-rich domain superfamily protein OS=Patiria pectinifera OX=7594 GN=SRCR1 PE=1 SV=1 g3181.t1 F7J220 32.45 302 6.11e-34 138.0 sp|F7J220|SRCR1_PATPE Scavenger receptor cysteine-rich domain superfamily protein OS=Patiria pectinifera OX=7594 GN=SRCR1 PE=1 SV=1 g3182.t1 Q9UGM3 36.642 685 1.76e-108 363.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g3182.t1 Q9UGM3 35.185 702 5.63e-106 355.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g3182.t1 Q9UGM3 36.012 672 1.94e-104 351.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g3182.t1 Q9UGM3 38.657 551 1.97e-98 333.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g3182.t1 Q9UGM3 35.816 631 9.61e-94 320.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g3182.t1 Q9UGM3 32.037 643 1.6e-72 258.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g3183.t1 Q9UGM3 37.536 1388 0.0 704.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g3183.t1 Q9UGM3 41.641 963 1.25e-177 606.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g3183.t1 Q9UGM3 41.675 967 7.6100000000000005e-177 603.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g3183.t1 Q9UGM3 42.065 920 1.3e-172 591.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g3183.t1 Q9UGM3 34.375 1184 3.87e-151 526.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g3183.t1 Q9UGM3 40.455 880 7.77e-147 513.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g3183.t1 Q9UGM3 33.219 1168 3.03e-141 496.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g3183.t1 Q9UGM3 37.281 912 5.41e-136 479.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g3183.t1 Q9UGM3 30.457 1159 2.52e-113 407.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g3183.t1 Q9UGM3 31.657 1014 2.32e-102 372.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g3183.t1 Q9UGM3 40.93 215 1.32e-34 150.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g3183.t1 Q9UGM3 38.057 247 2.65e-34 149.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g3183.t1 Q9UGM3 38.961 231 1.53e-33 146.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g3183.t1 Q9UGM3 37.712 236 3.82e-33 145.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g3183.t1 Q9UGM3 37.395 238 3.99e-33 145.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g3183.t1 Q9UGM3 37.395 238 6.28e-33 144.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g3183.t1 Q9UGM3 37.238 239 6.66e-33 144.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g3183.t1 Q9UGM3 37.288 236 9.81e-33 144.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g3183.t1 Q9UGM3 37.288 236 1.2800000000000002e-32 144.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g3183.t1 Q9UGM3 37.288 236 1.34e-32 143.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g3183.t1 Q9UGM3 36.82 239 3.8e-32 142.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g3183.t1 Q9UGM3 37.662 231 4.35e-32 142.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g3183.t1 Q9UGM3 43.791 153 6.480000000000001e-27 125.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g3183.t1 Q9UGM3 42.581 155 4.41e-26 122.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g3183.t1 Q9UGM3 42.308 156 1.81e-25 120.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g3183.t2 Q9UGM3 35.132 1779 0.0 772.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g3183.t2 Q9UGM3 39.415 1025 2.2e-163 565.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g3183.t2 Q9UGM3 39.164 1029 6.61e-162 560.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g3183.t2 Q9UGM3 39.715 982 6.19e-160 554.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g3183.t2 Q9UGM3 34.375 1184 6.69e-151 526.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g3183.t2 Q9UGM3 33.219 1168 4.67e-141 496.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g3183.t2 Q9UGM3 39.931 864 1.1400000000000001e-132 470.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g3183.t2 Q9UGM3 34.908 974 9.890000000000001e-123 438.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g3183.t2 Q9UGM3 31.491 1140 3.0000000000000003e-117 421.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g3183.t2 Q9UGM3 31.657 1014 2.68e-102 372.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g3183.t2 Q9UGM3 40.93 215 1.47e-34 150.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g3183.t2 Q9UGM3 38.057 247 2.83e-34 149.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g3183.t2 Q9UGM3 38.961 231 1.66e-33 146.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g3183.t2 Q9UGM3 37.712 236 4.14e-33 145.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g3183.t2 Q9UGM3 37.395 238 4.21e-33 145.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g3183.t2 Q9UGM3 37.395 238 6.92e-33 144.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g3183.t2 Q9UGM3 37.238 239 7.41e-33 144.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g3183.t2 Q9UGM3 37.288 236 1.08e-32 144.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g3183.t2 Q9UGM3 37.288 236 1.4e-32 143.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g3183.t2 Q9UGM3 37.288 236 1.48e-32 143.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g3183.t2 Q9UGM3 36.82 239 4.0900000000000005e-32 142.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g3183.t2 Q9UGM3 37.662 231 4.71e-32 142.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g3183.t2 Q9UGM3 43.791 153 6.2900000000000006e-27 125.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g3183.t2 Q9UGM3 47.02 151 3.24e-26 122.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g3183.t2 Q9UGM3 42.581 155 4.3100000000000004e-26 122.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g3183.t2 Q9UGM3 42.308 156 1.79e-25 120.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g3184.t1 Q9UGM3 42.097 620 1.45e-127 416.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g3184.t1 Q9UGM3 41.997 631 1.67e-126 413.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g3184.t1 Q9UGM3 41.158 639 1.07e-124 408.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g3184.t1 Q9UGM3 41.946 596 2.35e-124 407.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g3184.t1 Q9UGM3 42.744 503 3.2900000000000004e-103 345.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g3184.t1 Q9UGM3 46.313 339 3.63e-78 273.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g3184.t1 Q9UGM3 35.583 326 5.33e-34 142.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g3184.t1 Q9UGM3 46.154 130 1.9499999999999997e-23 109.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g3185.t1 Q5G267 35.106 376 2.96e-56 198.0 sp|Q5G267|NETR_MACMU Neurotrypsin OS=Macaca mulatta OX=9544 GN=PRSS12 PE=3 SV=1 NETR_MACMU reviewed Neurotrypsin (EC 3.4.21.-) (Serine protease 12) Macaca mulatta (Rhesus macaque) GO:0004252; GO:0005886; GO:0006508; GO:0006887; GO:0030424; GO:0030425; GO:0043083; GO:0043195; GO:0098978 exocytosis [GO:0006887]; proteolysis [GO:0006508] axon [GO:0030424]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; synaptic cleft [GO:0043083]; terminal bouton [GO:0043195] serine-type endopeptidase activity [GO:0004252] g3185.t1 Q5G267 31.955 266 7.509999999999999e-34 135.0 sp|Q5G267|NETR_MACMU Neurotrypsin OS=Macaca mulatta OX=9544 GN=PRSS12 PE=3 SV=1 NETR_MACMU reviewed Neurotrypsin (EC 3.4.21.-) (Serine protease 12) Macaca mulatta (Rhesus macaque) GO:0004252; GO:0005886; GO:0006508; GO:0006887; GO:0030424; GO:0030425; GO:0043083; GO:0043195; GO:0098978 exocytosis [GO:0006887]; proteolysis [GO:0006508] axon [GO:0030424]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; synaptic cleft [GO:0043083]; terminal bouton [GO:0043195] serine-type endopeptidase activity [GO:0004252] g3185.t1 Q5G267 41.558 154 7.03e-33 132.0 sp|Q5G267|NETR_MACMU Neurotrypsin OS=Macaca mulatta OX=9544 GN=PRSS12 PE=3 SV=1 NETR_MACMU reviewed Neurotrypsin (EC 3.4.21.-) (Serine protease 12) Macaca mulatta (Rhesus macaque) GO:0004252; GO:0005886; GO:0006508; GO:0006887; GO:0030424; GO:0030425; GO:0043083; GO:0043195; GO:0098978 exocytosis [GO:0006887]; proteolysis [GO:0006508] axon [GO:0030424]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; synaptic cleft [GO:0043083]; terminal bouton [GO:0043195] serine-type endopeptidase activity [GO:0004252] g3191.t1 Q8C5T8 47.849 372 3.4199999999999996e-92 284.0 sp|Q8C5T8|CF263_MOUSE Cilia- and flagella-associated protein 263 OS=Mus musculus OX=10090 GN=Cfap263 PE=2 SV=1 g3192.t1 P28020 81.912 387 0.0 611.0 sp|P28020|CSK21_XENLA Casein kinase II subunit alpha OS=Xenopus laevis OX=8355 GN=csnk2a1 PE=2 SV=2 g3193.t1 Q8BTU1 94.241 191 8.03e-135 378.0 sp|Q8BTU1|CFA20_MOUSE Cilia- and flagella-associated protein 20 OS=Mus musculus OX=10090 GN=Cfap20 PE=1 SV=1 CFA20_MOUSE reviewed Cilia- and flagella-associated protein 20 (Gene trap locus 3 protein) Mus musculus (Mouse) GO:0005654; GO:0005814; GO:0005879; GO:0005929; GO:0018095; GO:0030317; GO:0031514; GO:0036064; GO:0036126; GO:0060271; GO:0060296; GO:0160112; GO:2000147; GO:2000253 cilium assembly [GO:0060271]; flagellated sperm motility [GO:0030317]; positive regulation of cell motility [GO:2000147]; positive regulation of feeding behavior [GO:2000253]; protein polyglutamylation [GO:0018095]; regulation of cilium beat frequency involved in ciliary motility [GO:0060296] axonemal B tubule inner sheath [GO:0160112]; axonemal microtubule [GO:0005879]; centriole [GO:0005814]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; motile cilium [GO:0031514]; nucleoplasm [GO:0005654]; sperm flagellum [GO:0036126] g3193.t2 Q8BTU1 93.264 193 1.4199999999999998e-134 379.0 sp|Q8BTU1|CFA20_MOUSE Cilia- and flagella-associated protein 20 OS=Mus musculus OX=10090 GN=Cfap20 PE=1 SV=1 CFA20_MOUSE reviewed Cilia- and flagella-associated protein 20 (Gene trap locus 3 protein) Mus musculus (Mouse) GO:0005654; GO:0005814; GO:0005879; GO:0005929; GO:0018095; GO:0030317; GO:0031514; GO:0036064; GO:0036126; GO:0060271; GO:0060296; GO:0160112; GO:2000147; GO:2000253 cilium assembly [GO:0060271]; flagellated sperm motility [GO:0030317]; positive regulation of cell motility [GO:2000147]; positive regulation of feeding behavior [GO:2000253]; protein polyglutamylation [GO:0018095]; regulation of cilium beat frequency involved in ciliary motility [GO:0060296] axonemal B tubule inner sheath [GO:0160112]; axonemal microtubule [GO:0005879]; centriole [GO:0005814]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; motile cilium [GO:0031514]; nucleoplasm [GO:0005654]; sperm flagellum [GO:0036126] g3194.t1 P16444 51.832 382 4.81e-136 399.0 sp|P16444|DPEP1_HUMAN Dipeptidase 1 OS=Homo sapiens OX=9606 GN=DPEP1 PE=1 SV=3 DPEP1_HUMAN reviewed Dipeptidase 1 (EC 3.4.13.19) (Beta-lactamase) (EC 3.5.2.6) (Dehydropeptidase-I) (Microsomal dipeptidase) (Renal dipeptidase) (hRDP) Homo sapiens (Human) GO:0005615; GO:0005654; GO:0005886; GO:0006508; GO:0006749; GO:0006751; GO:0006954; GO:0008235; GO:0008270; GO:0008800; GO:0016324; GO:0016805; GO:0016999; GO:0030054; GO:0030336; GO:0030593; GO:0031528; GO:0034235; GO:0045177; GO:0050667; GO:0070062; GO:0070573; GO:0071277; GO:0071732; GO:0072340; GO:0072341; GO:0098552; GO:1901749 antibiotic metabolic process [GO:0016999]; cellular response to calcium ion [GO:0071277]; cellular response to nitric oxide [GO:0071732]; glutathione catabolic process [GO:0006751]; glutathione metabolic process [GO:0006749]; homocysteine metabolic process [GO:0050667]; inflammatory response [GO:0006954]; lactam catabolic process [GO:0072340]; leukotriene D4 catabolic process [GO:1901749]; negative regulation of cell migration [GO:0030336]; neutrophil chemotaxis [GO:0030593]; proteolysis [GO:0006508] apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; cell junction [GO:0030054]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; microvillus membrane [GO:0031528]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; side of membrane [GO:0098552] beta-lactamase activity [GO:0008800]; dipeptidase activity [GO:0016805]; GPI anchor binding [GO:0034235]; metallodipeptidase activity [GO:0070573]; metalloexopeptidase activity [GO:0008235]; modified amino acid binding [GO:0072341]; zinc ion binding [GO:0008270] g3194.t2 P16444 51.832 382 1.3399999999999998e-134 395.0 sp|P16444|DPEP1_HUMAN Dipeptidase 1 OS=Homo sapiens OX=9606 GN=DPEP1 PE=1 SV=3 DPEP1_HUMAN reviewed Dipeptidase 1 (EC 3.4.13.19) (Beta-lactamase) (EC 3.5.2.6) (Dehydropeptidase-I) (Microsomal dipeptidase) (Renal dipeptidase) (hRDP) Homo sapiens (Human) GO:0005615; GO:0005654; GO:0005886; GO:0006508; GO:0006749; GO:0006751; GO:0006954; GO:0008235; GO:0008270; GO:0008800; GO:0016324; GO:0016805; GO:0016999; GO:0030054; GO:0030336; GO:0030593; GO:0031528; GO:0034235; GO:0045177; GO:0050667; GO:0070062; GO:0070573; GO:0071277; GO:0071732; GO:0072340; GO:0072341; GO:0098552; GO:1901749 antibiotic metabolic process [GO:0016999]; cellular response to calcium ion [GO:0071277]; cellular response to nitric oxide [GO:0071732]; glutathione catabolic process [GO:0006751]; glutathione metabolic process [GO:0006749]; homocysteine metabolic process [GO:0050667]; inflammatory response [GO:0006954]; lactam catabolic process [GO:0072340]; leukotriene D4 catabolic process [GO:1901749]; negative regulation of cell migration [GO:0030336]; neutrophil chemotaxis [GO:0030593]; proteolysis [GO:0006508] apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; cell junction [GO:0030054]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; microvillus membrane [GO:0031528]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; side of membrane [GO:0098552] beta-lactamase activity [GO:0008800]; dipeptidase activity [GO:0016805]; GPI anchor binding [GO:0034235]; metallodipeptidase activity [GO:0070573]; metalloexopeptidase activity [GO:0008235]; modified amino acid binding [GO:0072341]; zinc ion binding [GO:0008270] g3195.t1 P48416 34.916 358 4.5399999999999997e-60 205.0 sp|P48416|CP10_LYMST Cytochrome P450 10 OS=Lymnaea stagnalis OX=6523 GN=CYP10 PE=2 SV=1 g3200.t1 D3YXS5 45.081 559 1.9199999999999998e-147 454.0 sp|D3YXS5|KIF28_MOUSE Kinesin-like protein KIF28 OS=Mus musculus OX=10090 GN=Kif28 PE=3 SV=1 g3201.t1 B7ZC32 30.738 244 1.5299999999999999e-34 139.0 sp|B7ZC32|KIF28_HUMAN Kinesin-like protein KIF28P OS=Homo sapiens OX=9606 GN=KIF28P PE=3 SV=2 KIF28_HUMAN reviewed Kinesin-like protein KIF28P (Kinesin-like protein 6) Homo sapiens (Human) GO:0003777; GO:0005524; GO:0005737; GO:0005871; GO:0005874; GO:0007005; GO:0008017; GO:0016887; GO:0031966; GO:0047496; GO:0072384 mitochondrion organization [GO:0007005]; organelle transport along microtubule [GO:0072384]; vesicle transport along microtubule [GO:0047496] cytoplasm [GO:0005737]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; mitochondrial membrane [GO:0031966] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777] g3201.t2 B7ZC32 30.738 244 1.61e-34 138.0 sp|B7ZC32|KIF28_HUMAN Kinesin-like protein KIF28P OS=Homo sapiens OX=9606 GN=KIF28P PE=3 SV=2 KIF28_HUMAN reviewed Kinesin-like protein KIF28P (Kinesin-like protein 6) Homo sapiens (Human) GO:0003777; GO:0005524; GO:0005737; GO:0005871; GO:0005874; GO:0007005; GO:0008017; GO:0016887; GO:0031966; GO:0047496; GO:0072384 mitochondrion organization [GO:0007005]; organelle transport along microtubule [GO:0072384]; vesicle transport along microtubule [GO:0047496] cytoplasm [GO:0005737]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; mitochondrial membrane [GO:0031966] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777] g3206.t1 Q9NBX4 23.509 570 6.389999999999999e-23 107.0 sp|Q9NBX4|RTXE_DROME Probable RNA-directed DNA polymerase from transposon X-element OS=Drosophila melanogaster OX=7227 GN=X-element\ORF2 PE=3 SV=1 g3207.t1 Q9NQC7 44.356 505 1.87e-121 407.0 sp|Q9NQC7|CYLD_HUMAN Ubiquitin carboxyl-terminal hydrolase CYLD OS=Homo sapiens OX=9606 GN=CYLD PE=1 SV=1 CYLD_HUMAN reviewed Ubiquitin carboxyl-terminal hydrolase CYLD (EC 3.4.19.12) (Deubiquitinating enzyme CYLD) (Ubiquitin thioesterase CYLD) (Ubiquitin-specific-processing protease CYLD) Homo sapiens (Human) GO:0004843; GO:0005654; GO:0005813; GO:0005819; GO:0005829; GO:0005874; GO:0005886; GO:0006508; GO:0007346; GO:0008270; GO:0010803; GO:0016055; GO:0016579; GO:0019901; GO:0032088; GO:0032480; GO:0034451; GO:0035869; GO:0035872; GO:0036064; GO:0043124; GO:0043369; GO:0045087; GO:0045577; GO:0045582; GO:0046329; GO:0048471; GO:0048872; GO:0050727; GO:0050728; GO:0050862; GO:0060544; GO:0061578; GO:0061815; GO:0070064; GO:0070266; GO:0070507; GO:0070536; GO:0090090; GO:0097225; GO:0097228; GO:0097542; GO:1901026; GO:1901223; GO:1902017; GO:1903753; GO:1903829; GO:1990108; GO:1990380; GO:2000493; GO:2001238; GO:2001242 CD4-positive or CD8-positive, alpha-beta T cell lineage commitment [GO:0043369]; homeostasis of number of cells [GO:0048872]; innate immune response [GO:0045087]; necroptotic process [GO:0070266]; negative regulation of canonical NF-kappaB signal transduction [GO:0043124]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of inflammatory response [GO:0050728]; negative regulation of interleukin-18-mediated signaling pathway [GO:2000493]; negative regulation of JNK cascade [GO:0046329]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of non-canonical NF-kappaB signal transduction [GO:1901223]; negative regulation of p38MAPK cascade [GO:1903753]; negative regulation of type I interferon production [GO:0032480]; nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway [GO:0035872]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; positive regulation of protein localization [GO:1903829]; positive regulation of T cell differentiation [GO:0045582]; positive regulation of T cell receptor signaling pathway [GO:0050862]; protein deubiquitination [GO:0016579]; protein K63-linked deubiquitination [GO:0070536]; protein linear deubiquitination [GO:1990108]; proteolysis [GO:0006508]; regulation of B cell differentiation [GO:0045577]; regulation of cilium assembly [GO:1902017]; regulation of inflammatory response [GO:0050727]; regulation of intrinsic apoptotic signaling pathway [GO:2001242]; regulation of microtubule cytoskeleton organization [GO:0070507]; regulation of mitotic cell cycle [GO:0007346]; regulation of necroptotic process [GO:0060544]; regulation of tumor necrosis factor-mediated signaling pathway [GO:0010803]; ripoptosome assembly involved in necroptotic process [GO:1901026]; Wnt signaling pathway [GO:0016055] centriolar satellite [GO:0034451]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary tip [GO:0097542]; ciliary transition zone [GO:0035869]; cytosol [GO:0005829]; microtubule [GO:0005874]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; sperm midpiece [GO:0097225]; sperm principal piece [GO:0097228]; spindle [GO:0005819] cysteine-type deubiquitinase activity [GO:0004843]; K48-linked deubiquitinase activity [GO:1990380]; K63-linked deubiquitinase activity [GO:0061578]; Met1-linked polyubiquitin deubiquitinase activity [GO:0061815]; proline-rich region binding [GO:0070064]; protein kinase binding [GO:0019901]; zinc ion binding [GO:0008270] g3208.t1 Q6PGU2 54.583 240 1.8e-83 253.0 sp|Q6PGU2|MAF1_DANRE Repressor of RNA polymerase III transcription MAF1 homolog OS=Danio rerio OX=7955 GN=maf1 PE=2 SV=1 g3209.t1 A9JTG5 40.328 548 1.3600000000000002e-132 409.0 sp|A9JTG5|HOIL1_DANRE RanBP-type and C3HC4-type zinc finger-containing protein 1 OS=Danio rerio OX=7955 GN=rbck1 PE=2 SV=1 HOIL1_DANRE reviewed RanBP-type and C3HC4-type zinc finger-containing protein 1 (EC 2.3.2.31) (Heme-oxidized IRP2 ubiquitin ligase 1 homolog) (HOIL-1) (Heme-oxidized IRP2 ubiquitin transferase 1 homolog) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0004842; GO:0008270; GO:0042742; GO:0043123; GO:0043130; GO:0043161; GO:0048701; GO:0061630; GO:0071600; GO:0071797; GO:0097039 defense response to bacterium [GO:0042742]; embryonic cranial skeleton morphogenesis [GO:0048701]; otic vesicle morphogenesis [GO:0071600]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein linear polyubiquitination [GO:0097039] LUBAC complex [GO:0071797] ubiquitin binding [GO:0043130]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] g3209.t2 Q9BYM8 32.714 269 8.639999999999999e-24 107.0 sp|Q9BYM8|HOIL1_HUMAN RanBP-type and C3HC4-type zinc finger-containing protein 1 OS=Homo sapiens OX=9606 GN=RBCK1 PE=1 SV=2 HOIL1_HUMAN reviewed RanBP-type and C3HC4-type zinc finger-containing protein 1 (EC 2.3.2.31) (HBV-associated factor 4) (Heme-oxidized IRP2 ubiquitin ligase 1) (HOIL-1) (Hepatitis B virus X-associated protein 4) (RING finger protein 54) (RING-type E3 ubiquitin transferase HOIL-1) (Ubiquitin-conjugating enzyme 7-interacting protein 3) Homo sapiens (Human) GO:0000209; GO:0003713; GO:0004842; GO:0005829; GO:0007249; GO:0008270; GO:0032088; GO:0042742; GO:0042802; GO:0043123; GO:0043124; GO:0043130; GO:0043161; GO:0050852; GO:0051092; GO:0060546; GO:0061630; GO:0071797; GO:0097039; GO:0140311; GO:1901224; GO:1990757; GO:2001238 canonical NF-kappaB signal transduction [GO:0007249]; defense response to bacterium [GO:0042742]; negative regulation of canonical NF-kappaB signal transduction [GO:0043124]; negative regulation of necroptotic process [GO:0060546]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of non-canonical NF-kappaB signal transduction [GO:1901224]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein linear polyubiquitination [GO:0097039]; protein polyubiquitination [GO:0000209]; T cell receptor signaling pathway [GO:0050852] cytosol [GO:0005829]; LUBAC complex [GO:0071797] identical protein binding [GO:0042802]; protein sequestering activity [GO:0140311]; transcription coactivator activity [GO:0003713]; ubiquitin binding [GO:0043130]; ubiquitin ligase activator activity [GO:1990757]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] g3214.t1 G1SZ12 61.538 130 2.6599999999999998e-46 152.0 sp|G1SZ12|RL14_RABIT Large ribosomal subunit protein eL14 OS=Oryctolagus cuniculus OX=9986 GN=RPL14 PE=1 SV=1 g3215.t1 Q0VCJ8 53.237 139 2.6799999999999996e-42 146.0 sp|Q0VCJ8|METL9_BOVIN Protein-L-histidine N-pros-methyltransferase OS=Bos taurus OX=9913 GN=METTL9 PE=2 SV=1 METL9_BOVIN reviewed Protein-L-histidine N-pros-methyltransferase (EC 2.1.1.-) (Methyltransferase-like protein 9) Bos taurus (Bovine) GO:0005739; GO:0005783; GO:0032259; GO:0106370 methylation [GO:0032259] endoplasmic reticulum [GO:0005783]; mitochondrion [GO:0005739] protein-L-histidine N-pros-methyltransferase activity [GO:0106370] g3216.t1 Q9H1A3 52.5 80 3.23e-23 91.7 sp|Q9H1A3|METL9_HUMAN Protein-L-histidine N-pros-methyltransferase OS=Homo sapiens OX=9606 GN=METTL9 PE=1 SV=1 METL9_HUMAN reviewed Protein-L-histidine N-pros-methyltransferase (EC 2.1.1.-) (DORA reverse strand protein) (DREV) (DREV1) (Methyltransferase-like protein 9) (hMETTL9) Homo sapiens (Human) GO:0005739; GO:0005783; GO:0032259; GO:0106370 methylation [GO:0032259] endoplasmic reticulum [GO:0005783]; mitochondrion [GO:0005739] protein-L-histidine N-pros-methyltransferase activity [GO:0106370] g3216.t1 Q9H1A3 58.621 29 3.23e-23 36.6 sp|Q9H1A3|METL9_HUMAN Protein-L-histidine N-pros-methyltransferase OS=Homo sapiens OX=9606 GN=METTL9 PE=1 SV=1 METL9_HUMAN reviewed Protein-L-histidine N-pros-methyltransferase (EC 2.1.1.-) (DORA reverse strand protein) (DREV) (DREV1) (Methyltransferase-like protein 9) (hMETTL9) Homo sapiens (Human) GO:0005739; GO:0005783; GO:0032259; GO:0106370 methylation [GO:0032259] endoplasmic reticulum [GO:0005783]; mitochondrion [GO:0005739] protein-L-histidine N-pros-methyltransferase activity [GO:0106370] g3217.t1 Q8IXZ2 55.882 204 2.03e-64 238.0 sp|Q8IXZ2|ZC3H3_HUMAN Zinc finger CCCH domain-containing protein 3 OS=Homo sapiens OX=9606 GN=ZC3H3 PE=1 SV=3 ZC3H3_HUMAN reviewed Zinc finger CCCH domain-containing protein 3 (Smad-interacting CPSF-like factor) Homo sapiens (Human) GO:0003677; GO:0005634; GO:0005654; GO:0005847; GO:0008270; GO:0031124; GO:0032927; GO:0051028; GO:0070412 mRNA 3'-end processing [GO:0031124]; mRNA transport [GO:0051028]; positive regulation of activin receptor signaling pathway [GO:0032927] mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] DNA binding [GO:0003677]; R-SMAD binding [GO:0070412]; zinc ion binding [GO:0008270] g3218.t1 O57342 59.551 89 1.2400000000000001e-27 112.0 sp|O57342|MAFA_COTJA Transcription factor MafA OS=Coturnix japonica OX=93934 GN=MAFA PE=1 SV=1 g3222.t1 Q91W39 45.283 106 3.64e-22 105.0 sp|Q91W39|NCOA5_MOUSE Nuclear receptor coactivator 5 OS=Mus musculus OX=10090 GN=Ncoa5 PE=1 SV=1 g3223.t1 Q5M8F7 67.241 116 7.29e-48 152.0 sp|Q5M8F7|NEPR1_XENTR Nuclear envelope phosphatase-regulatory subunit 1 OS=Xenopus tropicalis OX=8364 GN=cnep1r1 PE=2 SV=1 g3224.t1 Q0VIA1 66.667 129 7.23e-60 184.0 sp|Q0VIA1|MED10_DANRE Mediator of RNA polymerase II transcription subunit 10 OS=Danio rerio OX=7955 GN=med10 PE=2 SV=1 MED10_DANRE reviewed Mediator of RNA polymerase II transcription subunit 10 (Mediator complex subunit 10) (Protein tennis match) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0003712; GO:0006357; GO:0007507; GO:0016055; GO:0016592; GO:0036302; GO:1905072 atrioventricular canal development [GO:0036302]; cardiac jelly development [GO:1905072]; heart development [GO:0007507]; regulation of transcription by RNA polymerase II [GO:0006357]; Wnt signaling pathway [GO:0016055] mediator complex [GO:0016592] transcription coregulator activity [GO:0003712] g3226.t1 P38529 50.579 259 6.840000000000001e-75 248.0 sp|P38529|HSF1_CHICK Heat shock factor protein 1 OS=Gallus gallus OX=9031 GN=HSF1 PE=1 SV=1 g3226.t2 P38529 50.579 259 7.770000000000001e-75 247.0 sp|P38529|HSF1_CHICK Heat shock factor protein 1 OS=Gallus gallus OX=9031 GN=HSF1 PE=1 SV=1 g3227.t1 O35604 41.412 1275 0.0 879.0 sp|O35604|NPC1_MOUSE NPC intracellular cholesterol transporter 1 OS=Mus musculus OX=10090 GN=Npc1 PE=1 SV=2 NPC1_MOUSE reviewed NPC intracellular cholesterol transporter 1 (Niemann-Pick C1 protein) Mus musculus (Mouse) GO:0001889; GO:0005576; GO:0005635; GO:0005764; GO:0005765; GO:0005768; GO:0005783; GO:0005794; GO:0005886; GO:0006897; GO:0006914; GO:0007041; GO:0007628; GO:0008203; GO:0008206; GO:0009410; GO:0010467; GO:0010878; GO:0012501; GO:0015485; GO:0015918; GO:0016020; GO:0016125; GO:0016242; GO:0022008; GO:0030299; GO:0030301; GO:0031579; GO:0031902; GO:0031982; GO:0032365; GO:0032367; GO:0033344; GO:0042632; GO:0045121; GO:0046686; GO:0046718; GO:0048471; GO:0071383; GO:0071404; GO:0090150; GO:0120020; GO:1904036; GO:1904262; GO:2000900 adult walking behavior [GO:0007628]; autophagy [GO:0006914]; bile acid metabolic process [GO:0008206]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; cellular response to steroid hormone stimulus [GO:0071383]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; cholesterol storage [GO:0010878]; cholesterol transport [GO:0030301]; cyclodextrin metabolic process [GO:2000900]; endocytosis [GO:0006897]; establishment of protein localization to membrane [GO:0090150]; gene expression [GO:0010467]; intestinal cholesterol absorption [GO:0030299]; intracellular cholesterol transport [GO:0032367]; intracellular lipid transport [GO:0032365]; liver development [GO:0001889]; lysosomal transport [GO:0007041]; membrane raft organization [GO:0031579]; negative regulation of epithelial cell apoptotic process [GO:1904036]; negative regulation of macroautophagy [GO:0016242]; negative regulation of TORC1 signaling [GO:1904262]; neurogenesis [GO:0022008]; programmed cell death [GO:0012501]; response to cadmium ion [GO:0046686]; response to xenobiotic stimulus [GO:0009410]; sterol metabolic process [GO:0016125]; sterol transport [GO:0015918]; symbiont entry into host cell [GO:0046718] endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; membrane raft [GO:0045121]; nuclear envelope [GO:0005635]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; vesicle [GO:0031982] cholesterol binding [GO:0015485]; cholesterol transfer activity [GO:0120020] g3228.t1 Q5I0I5 37.069 232 1.46e-47 162.0 sp|Q5I0I5|USB1_RAT U6 snRNA phosphodiesterase 1 OS=Rattus norvegicus OX=10116 GN=Usb1 PE=2 SV=1 g3229.t1 O96081 95.973 149 5.85e-101 289.0 sp|O96081|CALMB_HALRO Calmodulin-B OS=Halocynthia roretzi OX=7729 PE=3 SV=3 g3230.t1 Q8STF0 96.377 138 9.35e-94 271.0 sp|Q8STF0|CALM_STRIE Calmodulin OS=Strongylocentrotus intermedius OX=7667 PE=2 SV=3 g3231.t1 Q95NR9 98.649 148 5.2e-102 291.0 sp|Q95NR9|CALM_METSE Calmodulin OS=Metridium senile OX=6116 PE=1 SV=3 g3231.t2 Q8STF0 97.315 149 2.33e-101 290.0 sp|Q8STF0|CALM_STRIE Calmodulin OS=Strongylocentrotus intermedius OX=7667 PE=2 SV=3 g3232.t1 Q95NR9 97.987 149 4.3300000000000003e-103 294.0 sp|Q95NR9|CALM_METSE Calmodulin OS=Metridium senile OX=6116 PE=1 SV=3 g3233.t1 Q95NR9 98.658 149 2.34e-103 295.0 sp|Q95NR9|CALM_METSE Calmodulin OS=Metridium senile OX=6116 PE=1 SV=3 g3234.t1 P70665 40.951 547 4.920000000000001e-129 390.0 sp|P70665|SIAE_MOUSE Sialate O-acetylesterase OS=Mus musculus OX=10090 GN=Siae PE=1 SV=3 SIAE_MOUSE reviewed Sialate O-acetylesterase (SIAE) (EC 3.1.1.53) (Sialic acid-specific 9-O-acetylesterase) (Yolk sac protein 2) [Cleaved into: Sialate O-acetylesterase small subunit; Sialate O-acetylesterase large subunit] Mus musculus (Mouse) GO:0001681; GO:0002682; GO:0005764; GO:0005975; GO:0106330 carbohydrate metabolic process [GO:0005975]; regulation of immune system process [GO:0002682] lysosome [GO:0005764] sialate 9-O-acetylesterase activity [GO:0106330]; sialate O-acetylesterase activity [GO:0001681] g3235.t1 P55088 51.073 233 1.55e-70 223.0 sp|P55088|AQP4_MOUSE Aquaporin-4 OS=Mus musculus OX=10090 GN=Aqp4 PE=1 SV=2 g3236.t1 Q86YQ8 65.653 329 5.7100000000000006e-157 454.0 sp|Q86YQ8|CPNE8_HUMAN Copine-8 OS=Homo sapiens OX=9606 GN=CPNE8 PE=1 SV=2 g3237.t1 Q9HCH3 55.676 185 1.11e-68 222.0 sp|Q9HCH3|CPNE5_HUMAN Copine-5 OS=Homo sapiens OX=9606 GN=CPNE5 PE=1 SV=2 CPNE5_HUMAN reviewed Copine-5 (Copine V) Homo sapiens (Human) GO:0005544; GO:0005886; GO:0030154; GO:0043005; GO:0043204; GO:0046872; GO:0070062; GO:0071277; GO:1903861 cell differentiation [GO:0030154]; cellular response to calcium ion [GO:0071277]; positive regulation of dendrite extension [GO:1903861] extracellular exosome [GO:0070062]; neuron projection [GO:0043005]; perikaryon [GO:0043204]; plasma membrane [GO:0005886] calcium-dependent phospholipid binding [GO:0005544]; metal ion binding [GO:0046872] g3237.t2 Q9HCH3 57.838 185 1.87e-71 229.0 sp|Q9HCH3|CPNE5_HUMAN Copine-5 OS=Homo sapiens OX=9606 GN=CPNE5 PE=1 SV=2 CPNE5_HUMAN reviewed Copine-5 (Copine V) Homo sapiens (Human) GO:0005544; GO:0005886; GO:0030154; GO:0043005; GO:0043204; GO:0046872; GO:0070062; GO:0071277; GO:1903861 cell differentiation [GO:0030154]; cellular response to calcium ion [GO:0071277]; positive regulation of dendrite extension [GO:1903861] extracellular exosome [GO:0070062]; neuron projection [GO:0043005]; perikaryon [GO:0043204]; plasma membrane [GO:0005886] calcium-dependent phospholipid binding [GO:0005544]; metal ion binding [GO:0046872] g3238.t1 Q99P30 41.985 131 1.45e-22 92.4 sp|Q99P30|NUDT7_MOUSE Peroxisomal coenzyme A diphosphatase NUDT7 OS=Mus musculus OX=10090 GN=Nudt7 PE=1 SV=2 g3239.t1 Q9WV30 54.671 289 8.09e-93 317.0 sp|Q9WV30|NFAT5_MOUSE Nuclear factor of activated T-cells 5 OS=Mus musculus OX=10090 GN=Nfat5 PE=1 SV=2 g3239.t2 Q9WV30 54.671 289 2.19e-93 316.0 sp|Q9WV30|NFAT5_MOUSE Nuclear factor of activated T-cells 5 OS=Mus musculus OX=10090 GN=Nfat5 PE=1 SV=2 g3240.t1 Q86U44 58.333 504 0.0 584.0 sp|Q86U44|MTA70_HUMAN N(6)-adenosine-methyltransferase catalytic subunit METTL3 OS=Homo sapiens OX=9606 GN=METTL3 PE=1 SV=2 MTA70_HUMAN reviewed N(6)-adenosine-methyltransferase catalytic subunit METTL3 (EC 2.1.1.348) (Methyltransferase-like protein 3) (hMETTL3) (N(6)-adenosine-methyltransferase 70 kDa subunit) (MT-A70) Homo sapiens (Human) GO:0000398; GO:0001510; GO:0001734; GO:0003729; GO:0005634; GO:0005654; GO:0005794; GO:0005829; GO:0006397; GO:0006974; GO:0007283; GO:0007623; GO:0008173; GO:0009048; GO:0016556; GO:0016604; GO:0016607; GO:0019827; GO:0021861; GO:0031053; GO:0034644; GO:0036396; GO:0042063; GO:0045087; GO:0045580; GO:0045727; GO:0045746; GO:0046982; GO:0048477; GO:0051445; GO:0060339; GO:0061157; GO:0098508; GO:1902036; GO:1903679; GO:1904047 cellular response to UV [GO:0034644]; circadian rhythm [GO:0007623]; DNA damage response [GO:0006974]; dosage compensation by inactivation of X chromosome [GO:0009048]; endothelial to hematopoietic transition [GO:0098508]; forebrain radial glial cell differentiation [GO:0021861]; gliogenesis [GO:0042063]; innate immune response [GO:0045087]; mRNA destabilization [GO:0061157]; mRNA modification [GO:0016556]; mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; oogenesis [GO:0048477]; positive regulation of cap-independent translational initiation [GO:1903679]; positive regulation of translation [GO:0045727]; primary miRNA processing [GO:0031053]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of meiotic cell cycle [GO:0051445]; regulation of T cell differentiation [GO:0045580]; RNA methylation [GO:0001510]; spermatogenesis [GO:0007283]; stem cell population maintenance [GO:0019827] cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nuclear body [GO:0016604]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA N6-methyladenosine methyltransferase complex [GO:0036396] mRNA binding [GO:0003729]; mRNA m(6)A methyltransferase activity [GO:0001734]; protein heterodimerization activity [GO:0046982]; RNA methyltransferase activity [GO:0008173]; S-adenosyl-L-methionine binding [GO:1904047] g3241.t1 B7SBD2 47.082 257 2.07e-31 131.0 sp|B7SBD2|TOX3_RAT TOX high mobility group box family member 3 OS=Rattus norvegicus OX=10116 GN=Tox3 PE=1 SV=1 TOX3_RAT reviewed TOX high mobility group box family member 3 (Trinucleotide repeat-containing gene 9 protein) Rattus norvegicus (Rat) GO:0003682; GO:0003713; GO:0005634; GO:0005654; GO:0005829; GO:0006357; GO:0006915; GO:0019722; GO:0031490; GO:0042803; GO:0042981; GO:0043524; GO:0045893; GO:0045944; GO:0051219 apoptotic process [GO:0006915]; calcium-mediated signaling [GO:0019722]; negative regulation of neuron apoptotic process [GO:0043524]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of apoptotic process [GO:0042981]; regulation of transcription by RNA polymerase II [GO:0006357] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; phosphoprotein binding [GO:0051219]; protein homodimerization activity [GO:0042803]; transcription coactivator activity [GO:0003713] g3248.t1 Q64464 42.71 487 5.37e-135 403.0 sp|Q64464|CP3AD_MOUSE Cytochrome P450 3A13 OS=Mus musculus OX=10090 GN=Cyp3a13 PE=1 SV=1 CP3AD_MOUSE reviewed Cytochrome P450 3A13 (EC 1.14.14.1) (CYPIIIA13) Mus musculus (Mouse) GO:0004497; GO:0005496; GO:0005506; GO:0005737; GO:0005789; GO:0008202; GO:0008395; GO:0008401; GO:0010628; GO:0016491; GO:0019899; GO:0020037; GO:0030343; GO:0034875; GO:0042908; GO:0050649; GO:0062181; GO:0070576; GO:0070989; GO:0101020; GO:0101021 oxidative demethylation [GO:0070989]; positive regulation of gene expression [GO:0010628]; steroid metabolic process [GO:0008202]; xenobiotic transport [GO:0042908] cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789] 1-alpha,25-dihydroxyvitamin D3 23-hydroxylase activity [GO:0062181]; caffeine oxidase activity [GO:0034875]; enzyme binding [GO:0019899]; estrogen 16-alpha-hydroxylase activity [GO:0101020]; estrogen 2-hydroxylase activity [GO:0101021]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity [GO:0016491]; retinoic acid 4-hydroxylase activity [GO:0008401]; steroid binding [GO:0005496]; steroid hydroxylase activity [GO:0008395]; testosterone 6-beta-hydroxylase activity [GO:0050649]; vitamin D 24-hydroxylase activity [GO:0070576]; vitamin D3 25-hydroxylase activity [GO:0030343] g3253.t1 P22770 32.866 499 2.2399999999999998e-62 216.0 sp|P22770|ACHA7_CHICK Neuronal acetylcholine receptor subunit alpha-7 OS=Gallus gallus OX=9031 GN=CHRNA7 PE=1 SV=1 g3260.t1 Q9DGH0 35.938 192 6.49e-25 99.8 sp|Q9DGH0|TWS1A_DANRE Twisted gastrulation protein homolog 1-A OS=Danio rerio OX=7955 GN=twsg1a PE=2 SV=1 g3261.t1 O15063 27.593 511 7.69e-33 141.0 sp|O15063|GRRE1_HUMAN Granule associated Rac and RHOG effector protein 1 OS=Homo sapiens OX=9606 GN=GARRE1 PE=1 SV=2 g3263.t1 Q3ULF4 48.478 460 6.59e-132 410.0 sp|Q3ULF4|SPG7_MOUSE Mitochondrial inner membrane m-AAA protease component paraplegin OS=Mus musculus OX=10090 GN=Spg7 PE=1 SV=1 SPG7_MOUSE reviewed Mitochondrial inner membrane m-AAA protease component paraplegin (EC 3.4.24.-) (EC 3.6.-.-) (Paraplegin) (Spastic paraplegia 7 protein) Mus musculus (Mouse) GO:0004176; GO:0004222; GO:0005524; GO:0005739; GO:0005743; GO:0005745; GO:0005757; GO:0007005; GO:0007155; GO:0008089; GO:0008270; GO:0016887; GO:0030155; GO:0034982; GO:0036444; GO:0046902; GO:0110097; GO:1902686; GO:1904115 anterograde axonal transport [GO:0008089]; calcium import into the mitochondrion [GO:0036444]; cell adhesion [GO:0007155]; mitochondrial outer membrane permeabilization involved in programmed cell death [GO:1902686]; mitochondrial protein processing [GO:0034982]; mitochondrion organization [GO:0007005]; regulation of calcium import into the mitochondrion [GO:0110097]; regulation of cell adhesion [GO:0030155]; regulation of mitochondrial membrane permeability [GO:0046902] axon cytoplasm [GO:1904115]; m-AAA complex [GO:0005745]; mitochondrial inner membrane [GO:0005743]; mitochondrial permeability transition pore complex [GO:0005757]; mitochondrion [GO:0005739] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent peptidase activity [GO:0004176]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270] g3264.t1 Q6UB99 50.566 265 8.48e-59 227.0 sp|Q6UB99|ANR11_HUMAN Ankyrin repeat domain-containing protein 11 OS=Homo sapiens OX=9606 GN=ANKRD11 PE=1 SV=3 ANR11_HUMAN reviewed Ankyrin repeat domain-containing protein 11 (Ankyrin repeat-containing cofactor 1) Homo sapiens (Human) GO:0005634; GO:0005654; GO:0005829; GO:0042475; GO:0048705; GO:0060325 face morphogenesis [GO:0060325]; odontogenesis of dentin-containing tooth [GO:0042475]; skeletal system morphogenesis [GO:0048705] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] g3264.t1 Q6UB99 41.438 292 5.29e-55 215.0 sp|Q6UB99|ANR11_HUMAN Ankyrin repeat domain-containing protein 11 OS=Homo sapiens OX=9606 GN=ANKRD11 PE=1 SV=3 ANR11_HUMAN reviewed Ankyrin repeat domain-containing protein 11 (Ankyrin repeat-containing cofactor 1) Homo sapiens (Human) GO:0005634; GO:0005654; GO:0005829; GO:0042475; GO:0048705; GO:0060325 face morphogenesis [GO:0060325]; odontogenesis of dentin-containing tooth [GO:0042475]; skeletal system morphogenesis [GO:0048705] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] g3270.t1 Q13884 51.718 524 0.0 523.0 sp|Q13884|SNTB1_HUMAN Beta-1-syntrophin OS=Homo sapiens OX=9606 GN=SNTB1 PE=1 SV=3 SNTB1_HUMAN reviewed Beta-1-syntrophin (59 kDa dystrophin-associated protein A1 basic component 1) (DAPA1B) (BSYN2) (Syntrophin-2) (Tax interaction protein 43) (TIP-43) Homo sapiens (Human) GO:0003779; GO:0005198; GO:0005516; GO:0005856; GO:0005886; GO:0005925; GO:0006936; GO:0016010; GO:0030165; GO:0032991; GO:0042383; GO:0045202 muscle contraction [GO:0006936] cytoskeleton [GO:0005856]; dystrophin-associated glycoprotein complex [GO:0016010]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; sarcolemma [GO:0042383]; synapse [GO:0045202] actin binding [GO:0003779]; calmodulin binding [GO:0005516]; PDZ domain binding [GO:0030165]; structural molecule activity [GO:0005198] g3270.t2 Q13884 58.182 165 3.8e-62 204.0 sp|Q13884|SNTB1_HUMAN Beta-1-syntrophin OS=Homo sapiens OX=9606 GN=SNTB1 PE=1 SV=3 SNTB1_HUMAN reviewed Beta-1-syntrophin (59 kDa dystrophin-associated protein A1 basic component 1) (DAPA1B) (BSYN2) (Syntrophin-2) (Tax interaction protein 43) (TIP-43) Homo sapiens (Human) GO:0003779; GO:0005198; GO:0005516; GO:0005856; GO:0005886; GO:0005925; GO:0006936; GO:0016010; GO:0030165; GO:0032991; GO:0042383; GO:0045202 muscle contraction [GO:0006936] cytoskeleton [GO:0005856]; dystrophin-associated glycoprotein complex [GO:0016010]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; sarcolemma [GO:0042383]; synapse [GO:0045202] actin binding [GO:0003779]; calmodulin binding [GO:0005516]; PDZ domain binding [GO:0030165]; structural molecule activity [GO:0005198] g3271.t1 Q8IVS2 52.038 319 1.68e-121 363.0 sp|Q8IVS2|FABD_HUMAN Malonyl-CoA-acyl carrier protein transacylase, mitochondrial OS=Homo sapiens OX=9606 GN=MCAT PE=1 SV=2 FABD_HUMAN reviewed Malonyl-CoA-acyl carrier protein transacylase, mitochondrial (MCT) (EC 2.3.1.39) (Mitochondrial malonyl CoA:ACP acyltransferase) (Mitochondrial malonyltransferase) ([Acyl-carrier-protein] malonyltransferase) Homo sapiens (Human) GO:0003723; GO:0004314; GO:0005739; GO:0005759; GO:0006633; GO:0006635; GO:0140691; GO:0180026 fatty acid beta-oxidation [GO:0006635]; fatty acid biosynthetic process [GO:0006633]; mitochondrial small ribosomal subunit assembly [GO:0180026] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] [acyl-carrier-protein] S-malonyltransferase activity [GO:0004314]; RNA binding [GO:0003723]; RNA folding chaperone [GO:0140691] g3272.t1 Q68ED3 53.525 383 1.02e-123 386.0 sp|Q68ED3|PAPD5_MOUSE Terminal nucleotidyltransferase 4B OS=Mus musculus OX=10090 GN=Tent4b PE=1 SV=2 PAPD5_MOUSE reviewed Terminal nucleotidyltransferase 4B (Non-canonical poly(A) RNA polymerase PAPD5) (EC 2.7.7.19) (PAP-associated domain-containing protein 5) (Terminal guanylyltransferase) (EC 2.7.7.-) (Terminal uridylyltransferase 3) (TUTase 3) (Topoisomerase-related function protein 4-2) (TRF4-2) Mus musculus (Mouse) GO:0003677; GO:0003887; GO:0005524; GO:0005730; GO:0005737; GO:0005829; GO:0005886; GO:0006364; GO:0010587; GO:0031123; GO:0031124; GO:0031499; GO:0032211; GO:0033500; GO:0043634; GO:0046872; GO:0051301; GO:0060212; GO:0070034; GO:0070568; GO:0071044; GO:0071051; GO:1905870; GO:1990817 carbohydrate homeostasis [GO:0033500]; cell division [GO:0051301]; histone mRNA catabolic process [GO:0071044]; miRNA catabolic process [GO:0010587]; mRNA 3'-end processing [GO:0031124]; negative regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060212]; negative regulation of telomere maintenance via telomerase [GO:0032211]; poly(A)-dependent snoRNA 3'-end processing [GO:0071051]; polyadenylation-dependent ncRNA catabolic process [GO:0043634]; positive regulation of 3'-UTR-mediated mRNA stabilization [GO:1905870]; RNA 3'-end processing [GO:0031123]; rRNA processing [GO:0006364] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; TRAMP complex [GO:0031499] ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; guanylyltransferase activity [GO:0070568]; metal ion binding [GO:0046872]; poly(A) RNA polymerase activity [GO:1990817]; telomerase RNA binding [GO:0070034] g3273.t1 Q8BHL6 41.706 211 1.45e-53 175.0 sp|Q8BHL6|FAP24_MOUSE Fanconi anemia core complex-associated protein 24 OS=Mus musculus OX=10090 GN=Faap24 PE=2 SV=1 g3274.t1 Q5XK83 68.097 862 0.0 1195.0 sp|Q5XK83|MCM4A_XENLA DNA replication licensing factor mcm4-A OS=Xenopus laevis OX=8355 GN=mcm4-a PE=1 SV=1 MCM4A_XENLA reviewed DNA replication licensing factor mcm4-A (EC 3.6.4.12) (CDC21 homolog-A) (Minichromosome maintenance protein 4-A) (xMCM4-A) (P1-CDC21-A) (p98) Xenopus laevis (African clawed frog) GO:0000727; GO:0000785; GO:0003682; GO:0003697; GO:0005524; GO:0005634; GO:0006271; GO:0008270; GO:0016887; GO:0017116; GO:0030174; GO:0042555; GO:0044786; GO:0071162; GO:1902975 cell cycle DNA replication [GO:0044786]; DNA strand elongation involved in DNA replication [GO:0006271]; double-strand break repair via break-induced replication [GO:0000727]; mitotic DNA replication initiation [GO:1902975]; regulation of DNA-templated DNA replication initiation [GO:0030174] chromatin [GO:0000785]; CMG complex [GO:0071162]; MCM complex [GO:0042555]; nucleus [GO:0005634] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; chromatin binding [GO:0003682]; single-stranded DNA binding [GO:0003697]; single-stranded DNA helicase activity [GO:0017116]; zinc ion binding [GO:0008270] g3275.t1 D3ZVM4 54.795 803 0.0 860.0 sp|D3ZVM4|LIN41_RAT E3 ubiquitin-protein ligase TRIM71 OS=Rattus norvegicus OX=10116 GN=Trim71 PE=3 SV=1 LIN41_RAT reviewed E3 ubiquitin-protein ligase TRIM71 (EC 2.3.2.27) (Protein lin-41 homolog) (RING-type E3 ubiquitin transferase TRIM71) (Tripartite motif-containing protein 71) Rattus norvegicus (Rat) GO:0000082; GO:0000209; GO:0000932; GO:0001843; GO:0004842; GO:0008270; GO:0008543; GO:0010608; GO:0017148; GO:0021915; GO:0030371; GO:0035196; GO:0035198; GO:0035278; GO:0043161; GO:0051246; GO:0051865; GO:0060964; GO:0061158; GO:0061630; GO:0072089; GO:2000177; GO:2000637 3'-UTR-mediated mRNA destabilization [GO:0061158]; fibroblast growth factor receptor signaling pathway [GO:0008543]; G1/S transition of mitotic cell cycle [GO:0000082]; miRNA processing [GO:0035196]; miRNA-mediated gene silencing by inhibition of translation [GO:0035278]; negative regulation of translation [GO:0017148]; neural tube closure [GO:0001843]; neural tube development [GO:0021915]; positive regulation of miRNA-mediated gene silencing [GO:2000637]; post-transcriptional regulation of gene expression [GO:0010608]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein polyubiquitination [GO:0000209]; regulation of miRNA-mediated gene silencing [GO:0060964]; regulation of neural precursor cell proliferation [GO:2000177]; regulation of protein metabolic process [GO:0051246]; stem cell proliferation [GO:0072089] P-body [GO:0000932] miRNA binding [GO:0035198]; translation repressor activity [GO:0030371]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] g3276.t1 P97760 73.455 275 1.01e-147 417.0 sp|P97760|RPB3_MOUSE DNA-directed RNA polymerase II subunit RPB3 OS=Mus musculus OX=10090 GN=Polr2c PE=1 SV=2 g3277.t1 Q9CSU0 50.751 333 3.35e-100 301.0 sp|Q9CSU0|RPR1B_MOUSE Regulation of nuclear pre-mRNA domain-containing protein 1B OS=Mus musculus OX=10090 GN=Rprd1b PE=1 SV=2 g3278.t1 P06745 62.136 206 2.5e-80 253.0 sp|P06745|G6PI_MOUSE Glucose-6-phosphate isomerase OS=Mus musculus OX=10090 GN=Gpi PE=1 SV=4 g3279.t1 P08059 74.499 349 0.0 556.0 sp|P08059|G6PI_PIG Glucose-6-phosphate isomerase OS=Sus scrofa OX=9823 GN=GPI PE=1 SV=3 g3280.t1 Q5PPM8 52.332 193 2.1e-64 206.0 sp|Q5PPM8|PP4P1_RAT Type 1 phosphatidylinositol 4,5-bisphosphate 4-phosphatase OS=Rattus norvegicus OX=10116 GN=Pip4p1 PE=1 SV=1 PP4P1_RAT reviewed Type 1 phosphatidylinositol 4,5-bisphosphate 4-phosphatase (Type 1 PtdIns-4,5-P2 4-Ptase) (EC 3.1.3.78) (PtdIns-4,5-P2 4-Ptase I) (Transmembrane protein 55B) Rattus norvegicus (Rat) GO:0005765; GO:0005886; GO:0006991; GO:0008203; GO:0030670; GO:0031902; GO:0032418; GO:0034597; GO:0046856; GO:0070070; GO:1904263 cholesterol metabolic process [GO:0008203]; lysosome localization [GO:0032418]; phosphatidylinositol dephosphorylation [GO:0046856]; positive regulation of TORC1 signaling [GO:1904263]; proton-transporting V-type ATPase complex assembly [GO:0070070]; response to sterol depletion [GO:0006991] late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886] phosphatidylinositol-4,5-bisphosphate 4-phosphatase activity [GO:0034597] g3281.t1 Q9VSL3 32.203 236 8.78e-31 115.0 sp|Q9VSL3|SEPIA_DROME Pyrimidodiazepine synthase OS=Drosophila melanogaster OX=7227 GN=se PE=1 SV=1 SEPIA_DROME reviewed Pyrimidodiazepine synthase (EC 1.5.4.1) (Protein sepia) Drosophila melanogaster (Fruit fly) GO:0004364; GO:0004734; GO:0005737; GO:0006726; GO:0006728; GO:0006749; GO:0042803; GO:0045174 eye pigment biosynthetic process [GO:0006726]; glutathione metabolic process [GO:0006749]; pteridine biosynthetic process [GO:0006728] cytoplasm [GO:0005737] glutathione dehydrogenase (ascorbate) activity [GO:0045174]; glutathione transferase activity [GO:0004364]; protein homodimerization activity [GO:0042803]; pyrimidodiazepine synthase activity [GO:0004734] g3282.t1 Q9Y2L5 36.646 322 1.67e-60 212.0 sp|Q9Y2L5|TPPC8_HUMAN Trafficking protein particle complex subunit 8 OS=Homo sapiens OX=9606 GN=TRAPPC8 PE=1 SV=2 TPPC8_HUMAN reviewed Trafficking protein particle complex subunit 8 (Protein TRS85 homolog) Homo sapiens (Human) GO:0005737; GO:0005829; GO:0006888; GO:0007030; GO:0030008; GO:0032964; GO:0048208; GO:0099022; GO:1990072 collagen biosynthetic process [GO:0032964]; COPII vesicle coating [GO:0048208]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; vesicle tethering [GO:0099022] cytoplasm [GO:0005737]; cytosol [GO:0005829]; TRAPP complex [GO:0030008]; TRAPPIII protein complex [GO:1990072] g3283.t1 Q9Y2L5 38.525 1098 0.0 656.0 sp|Q9Y2L5|TPPC8_HUMAN Trafficking protein particle complex subunit 8 OS=Homo sapiens OX=9606 GN=TRAPPC8 PE=1 SV=2 TPPC8_HUMAN reviewed Trafficking protein particle complex subunit 8 (Protein TRS85 homolog) Homo sapiens (Human) GO:0005737; GO:0005829; GO:0006888; GO:0007030; GO:0030008; GO:0032964; GO:0048208; GO:0099022; GO:1990072 collagen biosynthetic process [GO:0032964]; COPII vesicle coating [GO:0048208]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; vesicle tethering [GO:0099022] cytoplasm [GO:0005737]; cytosol [GO:0005829]; TRAPP complex [GO:0030008]; TRAPPIII protein complex [GO:1990072] g3284.t1 Q5XHI2 50.667 150 1.48e-30 111.0 sp|Q5XHI2|K1143_XENLA Uncharacterized protein KIAA1143 homolog OS=Xenopus laevis OX=8355 PE=2 SV=1 g3285.t1 Q9GYZ0 47.248 1272 0.0 1027.0 sp|Q9GYZ0|KIF15_STRPU Kinesin-like protein KIF15 OS=Strongylocentrotus purpuratus OX=7668 GN=KIF15 PE=1 SV=1 g3286.t1 Q9GYZ0 46.032 126 1.58e-24 108.0 sp|Q9GYZ0|KIF15_STRPU Kinesin-like protein KIF15 OS=Strongylocentrotus purpuratus OX=7668 GN=KIF15 PE=1 SV=1 g3287.t1 Q1JQ93 83.265 245 5.3e-145 409.0 sp|Q1JQ93|DPM1_BOVIN Dolichol-phosphate mannosyltransferase subunit 1 OS=Bos taurus OX=9913 GN=DPM1 PE=2 SV=1 DPM1_BOVIN reviewed Dolichol-phosphate mannosyltransferase subunit 1 (EC 2.4.1.83) (Dolichol-phosphate mannose synthase subunit 1) (DPM synthase subunit 1) (Dolichyl-phosphate beta-D-mannosyltransferase subunit 1) (Mannose-P-dolichol synthase subunit 1) (MPD synthase subunit 1) Bos taurus (Bovine) GO:0004582; GO:0005789; GO:0006488; GO:0006506; GO:0035269; GO:0046872; GO:0180047 dolichol phosphate mannose biosynthetic process [GO:0180047]; dolichol-linked oligosaccharide biosynthetic process [GO:0006488]; GPI anchor biosynthetic process [GO:0006506]; protein O-linked glycosylation via mannose [GO:0035269] endoplasmic reticulum membrane [GO:0005789] dolichyl-phosphate beta-D-mannosyltransferase activity [GO:0004582]; metal ion binding [GO:0046872] g3288.t1 Q9NX74 54.756 431 1.09e-161 473.0 sp|Q9NX74|DUS2_HUMAN tRNA-dihydrouridine(20) synthase [NAD(P)+]-like OS=Homo sapiens OX=9606 GN=DUS2 PE=1 SV=1 DUS2_HUMAN reviewed tRNA-dihydrouridine(20) synthase [NAD(P)+]-like (EC 1.3.1.91) (Dihydrouridine synthase 2) (Up-regulated in lung cancer protein 8) (URLC8) (tRNA-dihydrouridine synthase 2-like) (hDUS2) Homo sapiens (Human) GO:0000049; GO:0002943; GO:0003725; GO:0004860; GO:0005737; GO:0005739; GO:0005783; GO:0005829; GO:0010181; GO:0017150; GO:0050660; GO:0070402; GO:0102264; GO:0140374 antiviral innate immune response [GO:0140374]; tRNA dihydrouridine synthesis [GO:0002943] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; mitochondrion [GO:0005739] double-stranded RNA binding [GO:0003725]; flavin adenine dinucleotide binding [GO:0050660]; FMN binding [GO:0010181]; NADPH binding [GO:0070402]; protein kinase inhibitor activity [GO:0004860]; tRNA binding [GO:0000049]; tRNA dihydrouridine synthase activity [GO:0017150]; tRNA-dihydrouridine20 synthase activity [GO:0102264] g3289.t1 Q502J0 48.337 511 2.9e-156 459.0 sp|Q502J0|PCAT2_DANRE Lysophosphatidylcholine acyltransferase 2 OS=Danio rerio OX=7955 GN=lpcat2 PE=2 SV=1 PCAT2_DANRE reviewed Lysophosphatidylcholine acyltransferase 2 (LPC acyltransferase 2) (LPCAT-2) (LysoPC acyltransferase 2) (EC 2.3.1.23) (1-acylglycerol-3-phosphate O-acyltransferase 11) (1-AGP acyltransferase 11) (1-AGPAT 11) (EC 2.3.1.51) (1-acylglycerophosphocholine O-acyltransferase) (1-alkenylglycerophosphocholine O-acyltransferase) (EC 2.3.1.25) (1-alkylglycerophosphocholine O-acetyltransferase) (EC 2.3.1.67) (Acyltransferase-like 1) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000139; GO:0003841; GO:0005509; GO:0005783; GO:0005789; GO:0005811; GO:0005886; GO:0008654; GO:0042171; GO:0047159; GO:0047184; GO:0047192 phospholipid biosynthetic process [GO:0008654] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; lipid droplet [GO:0005811]; plasma membrane [GO:0005886] 1-acylglycerol-3-phosphate O-acyltransferase activity [GO:0003841]; 1-acylglycerophosphocholine O-acyltransferase activity [GO:0047184]; 1-alkylglycerophosphocholine O-acetyltransferase activity [GO:0047192]; calcium ion binding [GO:0005509]; lysophosphatidic acid acyltransferase activity [GO:0042171]; plasmalogen synthase activity [GO:0047159] g3291.t1 O88554 55.241 353 5.15e-125 379.0 sp|O88554|PARP2_MOUSE Poly [ADP-ribose] polymerase 2 OS=Mus musculus OX=10090 GN=Parp2 PE=1 SV=3 PARP2_MOUSE reviewed Poly [ADP-ribose] polymerase 2 (PARP-2) (mPARP-2) (EC 2.4.2.30) (ADP-ribosyltransferase diphtheria toxin-like 2) (ARTD2) (DNA ADP-ribosyltransferase PARP2) (EC 2.4.2.-) (NAD(+) ADP-ribosyltransferase 2) (ADPRT-2) (Poly[ADP-ribose] synthase 2) (pADPRT-2) (Protein poly-ADP-ribosyltransferase PARP2) (EC 2.4.2.-) Mus musculus (Mouse) GO:0003682; GO:0003684; GO:0003950; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0006281; GO:0006284; GO:0006302; GO:0006974; GO:0016779; GO:0030592; GO:0031491; GO:0046697; GO:0061051; GO:0070212; GO:0070213; GO:0071168; GO:0072572; GO:0090649; GO:0090734; GO:0097191; GO:0110088; GO:0140294; GO:0140805; GO:0140806; GO:0140807; GO:0140861; GO:0160004; GO:1990404 base-excision repair [GO:0006284]; decidualization [GO:0046697]; DNA ADP-ribosylation [GO:0030592]; DNA damage response [GO:0006974]; DNA repair [GO:0006281]; DNA repair-dependent chromatin remodeling [GO:0140861]; double-strand break repair [GO:0006302]; extrinsic apoptotic signaling pathway [GO:0097191]; hippocampal neuron apoptotic process [GO:0110088]; positive regulation of cell growth involved in cardiac muscle cell development [GO:0061051]; protein auto-ADP-ribosylation [GO:0070213]; protein localization to chromatin [GO:0071168]; protein poly-ADP-ribosylation [GO:0070212]; response to oxygen-glucose deprivation [GO:0090649] cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of DNA damage [GO:0090734] chromatin binding [GO:0003682]; damaged DNA binding [GO:0003684]; NAD DNA ADP-ribosyltransferase activity [GO:0140294]; NAD+ poly-ADP-ribosyltransferase activity [GO:0003950]; NAD+-protein mono-ADP-ribosyltransferase activity [GO:1990404]; NAD+-protein-aspartate ADP-ribosyltransferase activity [GO:0140806]; NAD+-protein-glutamate ADP-ribosyltransferase activity [GO:0140807]; NAD+-protein-serine ADP-ribosyltransferase activity [GO:0140805]; nucleosome binding [GO:0031491]; nucleotidyltransferase activity [GO:0016779]; poly-ADP-D-ribose binding [GO:0072572]; poly-ADP-D-ribose modification-dependent protein binding [GO:0160004] g3292.t1 Q9UGN5 60.484 124 1.54e-33 125.0 sp|Q9UGN5|PARP2_HUMAN Poly [ADP-ribose] polymerase 2 OS=Homo sapiens OX=9606 GN=PARP2 PE=1 SV=2 PARP2_HUMAN reviewed Poly [ADP-ribose] polymerase 2 (PARP-2) (hPARP-2) (EC 2.4.2.30) (ADP-ribosyltransferase diphtheria toxin-like 2) (ARTD2) (DNA ADP-ribosyltransferase PARP2) (EC 2.4.2.-) (NAD(+) ADP-ribosyltransferase 2) (ADPRT-2) (Poly[ADP-ribose] synthase 2) (pADPRT-2) (Protein poly-ADP-ribosyltransferase PARP2) (EC 2.4.2.-) Homo sapiens (Human) GO:0003682; GO:0003684; GO:0003950; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0006281; GO:0006284; GO:0006302; GO:0006974; GO:0016779; GO:0030592; GO:0031491; GO:0046697; GO:0061051; GO:0070212; GO:0070213; GO:0072572; GO:0090649; GO:0090734; GO:0097191; GO:0110088; GO:0140294; GO:0140805; GO:0140806; GO:0140807; GO:0140861; GO:0160004; GO:1990404 base-excision repair [GO:0006284]; decidualization [GO:0046697]; DNA ADP-ribosylation [GO:0030592]; DNA damage response [GO:0006974]; DNA repair [GO:0006281]; DNA repair-dependent chromatin remodeling [GO:0140861]; double-strand break repair [GO:0006302]; extrinsic apoptotic signaling pathway [GO:0097191]; hippocampal neuron apoptotic process [GO:0110088]; positive regulation of cell growth involved in cardiac muscle cell development [GO:0061051]; protein auto-ADP-ribosylation [GO:0070213]; protein poly-ADP-ribosylation [GO:0070212]; response to oxygen-glucose deprivation [GO:0090649] cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of DNA damage [GO:0090734] chromatin binding [GO:0003682]; damaged DNA binding [GO:0003684]; NAD DNA ADP-ribosyltransferase activity [GO:0140294]; NAD+ poly-ADP-ribosyltransferase activity [GO:0003950]; NAD+-protein mono-ADP-ribosyltransferase activity [GO:1990404]; NAD+-protein-aspartate ADP-ribosyltransferase activity [GO:0140806]; NAD+-protein-glutamate ADP-ribosyltransferase activity [GO:0140807]; NAD+-protein-serine ADP-ribosyltransferase activity [GO:0140805]; nucleosome binding [GO:0031491]; nucleotidyltransferase activity [GO:0016779]; poly-ADP-D-ribose binding [GO:0072572]; poly-ADP-D-ribose modification-dependent protein binding [GO:0160004] g3293.t1 Q5RDW1 55.425 341 6.42e-108 326.0 sp|Q5RDW1|MTG2_PONAB Mitochondrial ribosome-associated GTPase 2 OS=Pongo abelii OX=9601 GN=MTG2 PE=2 SV=1 MTG2_PONAB reviewed Mitochondrial ribosome-associated GTPase 2 (GTP-binding protein 5) Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0000287; GO:0003924; GO:0005525; GO:0005743; GO:0005759; GO:0005761; GO:0044065; GO:0070129; GO:1902775 mitochondrial large ribosomal subunit assembly [GO:1902775]; regulation of mitochondrial translation [GO:0070129]; regulation of respiratory system process [GO:0044065] mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial ribosome [GO:0005761] GTP binding [GO:0005525]; GTPase activity [GO:0003924]; magnesium ion binding [GO:0000287] g3295.t1 Q9NUP1 38.926 149 5.59e-26 102.0 sp|Q9NUP1|BL1S4_HUMAN Biogenesis of lysosome-related organelles complex 1 subunit 4 OS=Homo sapiens OX=9606 GN=BLOC1S4 PE=1 SV=1 g3297.t1 A6H603 26.338 934 6.41e-73 267.0 sp|A6H603|NWD1_MOUSE NACHT domain- and WD repeat-containing protein 1 OS=Mus musculus OX=10090 GN=Nwd1 PE=2 SV=2 g3297.t2 A6H603 26.243 945 2.07e-70 259.0 sp|A6H603|NWD1_MOUSE NACHT domain- and WD repeat-containing protein 1 OS=Mus musculus OX=10090 GN=Nwd1 PE=2 SV=2 g3303.t1 Q62077 47.106 1244 0.0 1082.0 sp|Q62077|PLCG1_MOUSE 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 OS=Mus musculus OX=10090 GN=Plcg1 PE=1 SV=2 PLCG1_MOUSE reviewed 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 (EC 3.1.4.11) (Phosphoinositide phospholipase C-gamma-1) (Phospholipase C-gamma-1) (PLC-gamma-1) Mus musculus (Mouse) GO:0001701; GO:0001726; GO:0004435; GO:0004629; GO:0005085; GO:0005158; GO:0005168; GO:0005509; GO:0005737; GO:0005829; GO:0005886; GO:0005911; GO:0006816; GO:0007173; GO:0008180; GO:0010634; GO:0016477; GO:0019722; GO:0019901; GO:0030027; GO:0030136; GO:0030335; GO:0030971; GO:0031161; GO:0032587; GO:0032957; GO:0032959; GO:0035254; GO:0042995; GO:0043536; GO:0045766; GO:0045793; GO:0046488; GO:0048015; GO:0050429; GO:0050804; GO:0050852; GO:0051209; GO:0051219; GO:0051281; GO:0071364; GO:0090303; GO:0098685; GO:0098978; GO:0120548; GO:1904643; GO:1905564; GO:2000353 calcium ion transport [GO:0006816]; calcium-mediated signaling [GO:0019722]; cell migration [GO:0016477]; cellular response to epidermal growth factor stimulus [GO:0071364]; epidermal growth factor receptor signaling pathway [GO:0007173]; in utero embryonic development [GO:0001701]; inositol trisphosphate biosynthetic process [GO:0032959]; inositol trisphosphate metabolic process [GO:0032957]; modulation of chemical synaptic transmission [GO:0050804]; phosphatidylinositol catabolic process [GO:0031161]; phosphatidylinositol metabolic process [GO:0046488]; phosphatidylinositol-mediated signaling [GO:0048015]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of cell migration [GO:0030335]; positive regulation of cell size [GO:0045793]; positive regulation of endothelial cell apoptotic process [GO:2000353]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; positive regulation of vascular endothelial cell proliferation [GO:1905564]; positive regulation of wound healing [GO:0090303]; release of sequestered calcium ion into cytosol [GO:0051209]; response to curcumin [GO:1904643]; T cell receptor signaling pathway [GO:0050852] cell projection [GO:0042995]; cell-cell junction [GO:0005911]; clathrin-coated vesicle [GO:0030136]; COP9 signalosome [GO:0008180]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; lamellipodium [GO:0030027]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; ruffle membrane [GO:0032587]; Schaffer collateral - CA1 synapse [GO:0098685] calcium ion binding [GO:0005509]; calcium-dependent phospholipase C activity [GO:0050429]; glutamate receptor binding [GO:0035254]; guanyl-nucleotide exchange factor activity [GO:0005085]; insulin receptor binding [GO:0005158]; neurotrophin TRKA receptor binding [GO:0005168]; phosphatidylinositol phospholipase C activity [GO:0120548]; phosphatidylinositol-4,5-bisphosphate phospholipase C activity [GO:0004435]; phospholipase C activity [GO:0004629]; phosphoprotein binding [GO:0051219]; protein kinase binding [GO:0019901]; receptor tyrosine kinase binding [GO:0030971] g3303.t2 Q62077 47.352 642 0.0 593.0 sp|Q62077|PLCG1_MOUSE 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 OS=Mus musculus OX=10090 GN=Plcg1 PE=1 SV=2 PLCG1_MOUSE reviewed 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 (EC 3.1.4.11) (Phosphoinositide phospholipase C-gamma-1) (Phospholipase C-gamma-1) (PLC-gamma-1) Mus musculus (Mouse) GO:0001701; GO:0001726; GO:0004435; GO:0004629; GO:0005085; GO:0005158; GO:0005168; GO:0005509; GO:0005737; GO:0005829; GO:0005886; GO:0005911; GO:0006816; GO:0007173; GO:0008180; GO:0010634; GO:0016477; GO:0019722; GO:0019901; GO:0030027; GO:0030136; GO:0030335; GO:0030971; GO:0031161; GO:0032587; GO:0032957; GO:0032959; GO:0035254; GO:0042995; GO:0043536; GO:0045766; GO:0045793; GO:0046488; GO:0048015; GO:0050429; GO:0050804; GO:0050852; GO:0051209; GO:0051219; GO:0051281; GO:0071364; GO:0090303; GO:0098685; GO:0098978; GO:0120548; GO:1904643; GO:1905564; GO:2000353 calcium ion transport [GO:0006816]; calcium-mediated signaling [GO:0019722]; cell migration [GO:0016477]; cellular response to epidermal growth factor stimulus [GO:0071364]; epidermal growth factor receptor signaling pathway [GO:0007173]; in utero embryonic development [GO:0001701]; inositol trisphosphate biosynthetic process [GO:0032959]; inositol trisphosphate metabolic process [GO:0032957]; modulation of chemical synaptic transmission [GO:0050804]; phosphatidylinositol catabolic process [GO:0031161]; phosphatidylinositol metabolic process [GO:0046488]; phosphatidylinositol-mediated signaling [GO:0048015]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of cell migration [GO:0030335]; positive regulation of cell size [GO:0045793]; positive regulation of endothelial cell apoptotic process [GO:2000353]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; positive regulation of vascular endothelial cell proliferation [GO:1905564]; positive regulation of wound healing [GO:0090303]; release of sequestered calcium ion into cytosol [GO:0051209]; response to curcumin [GO:1904643]; T cell receptor signaling pathway [GO:0050852] cell projection [GO:0042995]; cell-cell junction [GO:0005911]; clathrin-coated vesicle [GO:0030136]; COP9 signalosome [GO:0008180]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; lamellipodium [GO:0030027]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; ruffle membrane [GO:0032587]; Schaffer collateral - CA1 synapse [GO:0098685] calcium ion binding [GO:0005509]; calcium-dependent phospholipase C activity [GO:0050429]; glutamate receptor binding [GO:0035254]; guanyl-nucleotide exchange factor activity [GO:0005085]; insulin receptor binding [GO:0005158]; neurotrophin TRKA receptor binding [GO:0005168]; phosphatidylinositol phospholipase C activity [GO:0120548]; phosphatidylinositol-4,5-bisphosphate phospholipase C activity [GO:0004435]; phospholipase C activity [GO:0004629]; phosphoprotein binding [GO:0051219]; protein kinase binding [GO:0019901]; receptor tyrosine kinase binding [GO:0030971] g3303.t2 Q62077 42.487 772 1.6900000000000002e-173 554.0 sp|Q62077|PLCG1_MOUSE 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 OS=Mus musculus OX=10090 GN=Plcg1 PE=1 SV=2 PLCG1_MOUSE reviewed 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 (EC 3.1.4.11) (Phosphoinositide phospholipase C-gamma-1) (Phospholipase C-gamma-1) (PLC-gamma-1) Mus musculus (Mouse) GO:0001701; GO:0001726; GO:0004435; GO:0004629; GO:0005085; GO:0005158; GO:0005168; GO:0005509; GO:0005737; GO:0005829; GO:0005886; GO:0005911; GO:0006816; GO:0007173; GO:0008180; GO:0010634; GO:0016477; GO:0019722; GO:0019901; GO:0030027; GO:0030136; GO:0030335; GO:0030971; GO:0031161; GO:0032587; GO:0032957; GO:0032959; GO:0035254; GO:0042995; GO:0043536; GO:0045766; GO:0045793; GO:0046488; GO:0048015; GO:0050429; GO:0050804; GO:0050852; GO:0051209; GO:0051219; GO:0051281; GO:0071364; GO:0090303; GO:0098685; GO:0098978; GO:0120548; GO:1904643; GO:1905564; GO:2000353 calcium ion transport [GO:0006816]; calcium-mediated signaling [GO:0019722]; cell migration [GO:0016477]; cellular response to epidermal growth factor stimulus [GO:0071364]; epidermal growth factor receptor signaling pathway [GO:0007173]; in utero embryonic development [GO:0001701]; inositol trisphosphate biosynthetic process [GO:0032959]; inositol trisphosphate metabolic process [GO:0032957]; modulation of chemical synaptic transmission [GO:0050804]; phosphatidylinositol catabolic process [GO:0031161]; phosphatidylinositol metabolic process [GO:0046488]; phosphatidylinositol-mediated signaling [GO:0048015]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of cell migration [GO:0030335]; positive regulation of cell size [GO:0045793]; positive regulation of endothelial cell apoptotic process [GO:2000353]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; positive regulation of vascular endothelial cell proliferation [GO:1905564]; positive regulation of wound healing [GO:0090303]; release of sequestered calcium ion into cytosol [GO:0051209]; response to curcumin [GO:1904643]; T cell receptor signaling pathway [GO:0050852] cell projection [GO:0042995]; cell-cell junction [GO:0005911]; clathrin-coated vesicle [GO:0030136]; COP9 signalosome [GO:0008180]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; lamellipodium [GO:0030027]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; ruffle membrane [GO:0032587]; Schaffer collateral - CA1 synapse [GO:0098685] calcium ion binding [GO:0005509]; calcium-dependent phospholipase C activity [GO:0050429]; glutamate receptor binding [GO:0035254]; guanyl-nucleotide exchange factor activity [GO:0005085]; insulin receptor binding [GO:0005158]; neurotrophin TRKA receptor binding [GO:0005168]; phosphatidylinositol phospholipase C activity [GO:0120548]; phosphatidylinositol-4,5-bisphosphate phospholipase C activity [GO:0004435]; phospholipase C activity [GO:0004629]; phosphoprotein binding [GO:0051219]; protein kinase binding [GO:0019901]; receptor tyrosine kinase binding [GO:0030971] g3304.t1 P68827 48.866 397 3.27e-112 348.0 sp|P68827|NAGPA_BOVIN N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase OS=Bos taurus OX=9913 GN=NAGPA PE=1 SV=2 g3307.t1 Q1NZ26 47.059 272 2.23e-80 247.0 sp|Q1NZ26|YSMU_CAEEL Uncharacterized protein F13E9.13, mitochondrial OS=Caenorhabditis elegans OX=6239 GN=F13E9.13 PE=3 SV=1 g3308.t1 O15995 59.9 399 1.2e-149 434.0 sp|O15995|CCNE_HEMPU G1/S-specific cyclin-E OS=Hemicentrotus pulcherrimus OX=7650 GN=CYCE PE=2 SV=1 g3313.t1 Q8WVE7 53.211 109 5e-31 110.0 sp|Q8WVE7|T170A_HUMAN Transmembrane protein 170A OS=Homo sapiens OX=9606 GN=TMEM170A PE=1 SV=1 T170A_HUMAN reviewed Transmembrane protein 170A Homo sapiens (Human) GO:0005635; GO:0005789; GO:0006998; GO:0051292; GO:0071786 endoplasmic reticulum tubular network organization [GO:0071786]; nuclear envelope organization [GO:0006998]; nuclear pore complex assembly [GO:0051292] endoplasmic reticulum membrane [GO:0005789]; nuclear envelope [GO:0005635] g3314.t1 Q8K215 55.0 80 5.1300000000000004e-26 95.1 sp|Q8K215|LYRM4_MOUSE LYR motif-containing protein 4 OS=Mus musculus OX=10090 GN=Lyrm4 PE=1 SV=1 g3315.t1 A5PLL7 41.732 254 2.04e-62 199.0 sp|A5PLL7|PEDS1_HUMAN Plasmanylethanolamine desaturase 1 OS=Homo sapiens OX=9606 GN=PEDS1 PE=1 SV=3 PEDS1_HUMAN reviewed Plasmanylethanolamine desaturase 1 (EC 1.14.19.77) (Transmembrane protein 189) Homo sapiens (Human) GO:0005783; GO:0005789; GO:0006631; GO:0008611; GO:0050207 ether lipid biosynthetic process [GO:0008611]; fatty acid metabolic process [GO:0006631] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789] plasmanylethanolamine desaturase activity [GO:0050207] g3316.t1 O43747 60.641 874 0.0 963.0 sp|O43747|AP1G1_HUMAN AP-1 complex subunit gamma-1 OS=Homo sapiens OX=9606 GN=AP1G1 PE=1 SV=5 AP1G1_HUMAN reviewed AP-1 complex subunit gamma-1 (Adaptor protein complex AP-1 subunit gamma-1) (Adaptor-related protein complex 1 subunit gamma-1) (Clathrin assembly protein complex 1 gamma-1 large chain) (Gamma-adaptin) (Gamma1-adaptin) (Golgi adaptor HA1/AP1 adaptin subunit gamma-1) Homo sapiens (Human) GO:0000139; GO:0005518; GO:0005737; GO:0005765; GO:0005769; GO:0005794; GO:0005829; GO:0005905; GO:0006886; GO:0006896; GO:0016020; GO:0016182; GO:0016192; GO:0019894; GO:0030121; GO:0030136; GO:0030659; GO:0030665; GO:0030742; GO:0031267; GO:0032438; GO:0032588; GO:0035615; GO:0035646; GO:0043323; GO:0045954; GO:0048471; GO:0048488; GO:0055037; GO:0060155; GO:0090160; GO:0098793; GO:0110010; GO:1903232 basolateral protein secretion [GO:0110010]; endosome to melanosome transport [GO:0035646]; Golgi to lysosome transport [GO:0090160]; Golgi to vacuole transport [GO:0006896]; intracellular protein transport [GO:0006886]; melanosome assembly [GO:1903232]; melanosome organization [GO:0032438]; platelet dense granule organization [GO:0060155]; positive regulation of natural killer cell degranulation [GO:0043323]; positive regulation of natural killer cell mediated cytotoxicity [GO:0045954]; synaptic vesicle budding from endosome [GO:0016182]; synaptic vesicle endocytosis [GO:0048488]; vesicle-mediated transport [GO:0016192] AP-1 adaptor complex [GO:0030121]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; clathrin-coated vesicle membrane [GO:0030665]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; early endosome [GO:0005769]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; presynapse [GO:0098793]; recycling endosome [GO:0055037]; trans-Golgi network membrane [GO:0032588] clathrin adaptor activity [GO:0035615]; collagen binding [GO:0005518]; GTP-dependent protein binding [GO:0030742]; kinesin binding [GO:0019894]; small GTPase binding [GO:0031267] g3316.t2 O43747 62.648 846 0.0 969.0 sp|O43747|AP1G1_HUMAN AP-1 complex subunit gamma-1 OS=Homo sapiens OX=9606 GN=AP1G1 PE=1 SV=5 AP1G1_HUMAN reviewed AP-1 complex subunit gamma-1 (Adaptor protein complex AP-1 subunit gamma-1) (Adaptor-related protein complex 1 subunit gamma-1) (Clathrin assembly protein complex 1 gamma-1 large chain) (Gamma-adaptin) (Gamma1-adaptin) (Golgi adaptor HA1/AP1 adaptin subunit gamma-1) Homo sapiens (Human) GO:0000139; GO:0005518; GO:0005737; GO:0005765; GO:0005769; GO:0005794; GO:0005829; GO:0005905; GO:0006886; GO:0006896; GO:0016020; GO:0016182; GO:0016192; GO:0019894; GO:0030121; GO:0030136; GO:0030659; GO:0030665; GO:0030742; GO:0031267; GO:0032438; GO:0032588; GO:0035615; GO:0035646; GO:0043323; GO:0045954; GO:0048471; GO:0048488; GO:0055037; GO:0060155; GO:0090160; GO:0098793; GO:0110010; GO:1903232 basolateral protein secretion [GO:0110010]; endosome to melanosome transport [GO:0035646]; Golgi to lysosome transport [GO:0090160]; Golgi to vacuole transport [GO:0006896]; intracellular protein transport [GO:0006886]; melanosome assembly [GO:1903232]; melanosome organization [GO:0032438]; platelet dense granule organization [GO:0060155]; positive regulation of natural killer cell degranulation [GO:0043323]; positive regulation of natural killer cell mediated cytotoxicity [GO:0045954]; synaptic vesicle budding from endosome [GO:0016182]; synaptic vesicle endocytosis [GO:0048488]; vesicle-mediated transport [GO:0016192] AP-1 adaptor complex [GO:0030121]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; clathrin-coated vesicle membrane [GO:0030665]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; early endosome [GO:0005769]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; presynapse [GO:0098793]; recycling endosome [GO:0055037]; trans-Golgi network membrane [GO:0032588] clathrin adaptor activity [GO:0035615]; collagen binding [GO:0005518]; GTP-dependent protein binding [GO:0030742]; kinesin binding [GO:0019894]; small GTPase binding [GO:0031267] g3317.t1 Q6DE14 50.369 407 5.83e-97 296.0 sp|Q6DE14|E2F4_XENLA Transcription factor E2F4 OS=Xenopus laevis OX=8355 GN=e2f4 PE=1 SV=1 E2F4_XENLA reviewed Transcription factor E2F4 (E2F-4) Xenopus laevis (African clawed frog) GO:0000978; GO:0000981; GO:0003700; GO:0006357; GO:0044458; GO:0045944; GO:0046983; GO:0090575; GO:0098534; GO:1903251 centriole assembly [GO:0098534]; motile cilium assembly [GO:0044458]; multi-ciliated epithelial cell differentiation [GO:1903251]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357] RNA polymerase II transcription regulator complex [GO:0090575] DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978] g3318.t1 P10079 34.454 238 2.6100000000000002e-31 127.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g3320.t1 Q17QH8 57.724 246 5.88e-96 286.0 sp|Q17QH8|D39U1_BOVIN Epimerase family protein SDR39U1 OS=Bos taurus OX=9913 GN=SDR39U1 PE=2 SV=1 g3321.t1 Q8C3S2 34.172 1033 1.86e-161 507.0 sp|Q8C3S2|TNG6_MOUSE Transport and Golgi organization protein 6 homolog OS=Mus musculus OX=10090 GN=Tango6 PE=1 SV=1 g3322.t1 Q9BYN7 62.025 79 1.19e-24 107.0 sp|Q9BYN7|ZN341_HUMAN Zinc finger protein 341 OS=Homo sapiens OX=9606 GN=ZNF341 PE=1 SV=2 ZN341_HUMAN reviewed Zinc finger protein 341 Homo sapiens (Human) GO:0000978; GO:0000981; GO:0001216; GO:0003677; GO:0005634; GO:0006355; GO:0008270 regulation of DNA-templated transcription [GO:0006355] nucleus [GO:0005634] DNA binding [GO:0003677]; DNA-binding transcription activator activity [GO:0001216]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270] g3323.t1 Q9BYN7 62.3 313 5.3099999999999994e-126 390.0 sp|Q9BYN7|ZN341_HUMAN Zinc finger protein 341 OS=Homo sapiens OX=9606 GN=ZNF341 PE=1 SV=2 ZN341_HUMAN reviewed Zinc finger protein 341 Homo sapiens (Human) GO:0000978; GO:0000981; GO:0001216; GO:0003677; GO:0005634; GO:0006355; GO:0008270 regulation of DNA-templated transcription [GO:0006355] nucleus [GO:0005634] DNA binding [GO:0003677]; DNA-binding transcription activator activity [GO:0001216]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270] g3324.t1 Q8VBU8 41.88 351 8.74e-74 243.0 sp|Q8VBU8|BANP_MOUSE Protein BANP OS=Mus musculus OX=10090 GN=Banp PE=1 SV=1 g3324.t2 Q0VCW3 42.135 356 2.3800000000000003e-73 240.0 sp|Q0VCW3|BANP_BOVIN Protein BANP OS=Bos taurus OX=9913 GN=BANP PE=2 SV=1 g3325.t1 Q9BYN7 31.228 285 1.04e-34 147.0 sp|Q9BYN7|ZN341_HUMAN Zinc finger protein 341 OS=Homo sapiens OX=9606 GN=ZNF341 PE=1 SV=2 ZN341_HUMAN reviewed Zinc finger protein 341 Homo sapiens (Human) GO:0000978; GO:0000981; GO:0001216; GO:0003677; GO:0005634; GO:0006355; GO:0008270 regulation of DNA-templated transcription [GO:0006355] nucleus [GO:0005634] DNA binding [GO:0003677]; DNA-binding transcription activator activity [GO:0001216]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270] g3326.t1 Q8TB96 41.475 610 1.63e-131 402.0 sp|Q8TB96|TIP_HUMAN T-cell immunomodulatory protein OS=Homo sapiens OX=9606 GN=ITFG1 PE=1 SV=1 g3327.t1 Q96GQ7 55.571 718 0.0 667.0 sp|Q96GQ7|DDX27_HUMAN Probable ATP-dependent RNA helicase DDX27 OS=Homo sapiens OX=9606 GN=DDX27 PE=1 SV=3 g3328.t1 Q9BYN7 30.33 455 2.1499999999999997e-54 205.0 sp|Q9BYN7|ZN341_HUMAN Zinc finger protein 341 OS=Homo sapiens OX=9606 GN=ZNF341 PE=1 SV=2 ZN341_HUMAN reviewed Zinc finger protein 341 Homo sapiens (Human) GO:0000978; GO:0000981; GO:0001216; GO:0003677; GO:0005634; GO:0006355; GO:0008270 regulation of DNA-templated transcription [GO:0006355] nucleus [GO:0005634] DNA binding [GO:0003677]; DNA-binding transcription activator activity [GO:0001216]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270] g3328.t2 Q9BYN7 30.396 454 3.35e-52 199.0 sp|Q9BYN7|ZN341_HUMAN Zinc finger protein 341 OS=Homo sapiens OX=9606 GN=ZNF341 PE=1 SV=2 ZN341_HUMAN reviewed Zinc finger protein 341 Homo sapiens (Human) GO:0000978; GO:0000981; GO:0001216; GO:0003677; GO:0005634; GO:0006355; GO:0008270 regulation of DNA-templated transcription [GO:0006355] nucleus [GO:0005634] DNA binding [GO:0003677]; DNA-binding transcription activator activity [GO:0001216]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270] g3330.t1 O57415 42.64 197 7.559999999999999e-48 181.0 sp|O57415|RREB1_CHICK Ras-responsive element-binding protein 1 OS=Gallus gallus OX=9031 GN=RREB1 PE=2 SV=2 g3331.t1 Q92766 40.467 257 2.5700000000000003e-47 181.0 sp|Q92766|RREB1_HUMAN Ras-responsive element-binding protein 1 OS=Homo sapiens OX=9606 GN=RREB1 PE=1 SV=3 g3332.t1 A4VCH0 58.065 589 0.0 726.0 sp|A4VCH0|SAC1A_DANRE Phosphatidylinositol-3-phosphatase SAC1-A OS=Danio rerio OX=7955 GN=sacm1la PE=2 SV=2 SAC1A_DANRE reviewed Phosphatidylinositol-3-phosphatase SAC1-A (EC 3.1.3.64) (Phosphatidylinositol-4-phosphate phosphatase) (Suppressor of actin mutations 1-like protein A) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000139; GO:0004438; GO:0005783; GO:0005789; GO:0016791; GO:0043812; GO:0046856; GO:0140268 phosphatidylinositol dephosphorylation [GO:0046856] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-plasma membrane contact site [GO:0140268]; Golgi membrane [GO:0000139] phosphatase activity [GO:0016791]; phosphatidylinositol-3-phosphate phosphatase activity [GO:0004438]; phosphatidylinositol-4-phosphate phosphatase activity [GO:0043812] g3332.t2 A4VCH0 57.895 589 0.0 721.0 sp|A4VCH0|SAC1A_DANRE Phosphatidylinositol-3-phosphatase SAC1-A OS=Danio rerio OX=7955 GN=sacm1la PE=2 SV=2 SAC1A_DANRE reviewed Phosphatidylinositol-3-phosphatase SAC1-A (EC 3.1.3.64) (Phosphatidylinositol-4-phosphate phosphatase) (Suppressor of actin mutations 1-like protein A) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000139; GO:0004438; GO:0005783; GO:0005789; GO:0016791; GO:0043812; GO:0046856; GO:0140268 phosphatidylinositol dephosphorylation [GO:0046856] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-plasma membrane contact site [GO:0140268]; Golgi membrane [GO:0000139] phosphatase activity [GO:0016791]; phosphatidylinositol-3-phosphate phosphatase activity [GO:0004438]; phosphatidylinositol-4-phosphate phosphatase activity [GO:0043812] g3333.t1 Q9PVZ4 41.638 293 4.59e-69 258.0 sp|Q9PVZ4|INSR_XENLA Insulin receptor OS=Xenopus laevis OX=8355 GN=insr PE=1 SV=1 g3335.t1 Q7ZV00 47.826 299 2.0600000000000002e-80 248.0 sp|Q7ZV00|OTU6B_DANRE Deubiquitinase OTUD6B OS=Danio rerio OX=7955 GN=otud6b PE=2 SV=1 g3336.t1 Q5NVK5 47.88 566 2.12e-160 471.0 sp|Q5NVK5|PGTA_PONAB Geranylgeranyl transferase type-2 subunit alpha OS=Pongo abelii OX=9601 GN=RABGGTA PE=2 SV=1 g3337.t1 Q1XG89 28.687 495 5.66e-45 181.0 sp|Q1XG89|TDR12_BOMMO Putative ATP-dependent RNA helicase TDRD12 OS=Bombyx mori OX=7091 GN=TDRD12 PE=1 SV=2 TDR12_BOMMO reviewed Putative ATP-dependent RNA helicase TDRD12 (EC 3.6.4.13) (RNA helicase-like protein) (Tudor domain-containing protein 12) (BmTdrd12) Bombyx mori (Silk moth) GO:0003676; GO:0003724; GO:0005524; GO:0005694; GO:0005829; GO:0007283; GO:0016887; GO:0031047; GO:0031965; GO:0042078; GO:0043186; GO:0051321; GO:1990923 germ-line stem cell division [GO:0042078]; meiotic cell cycle [GO:0051321]; regulatory ncRNA-mediated gene silencing [GO:0031047]; spermatogenesis [GO:0007283] chromosome [GO:0005694]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]; P granule [GO:0043186]; PET complex [GO:1990923] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; nucleic acid binding [GO:0003676]; RNA helicase activity [GO:0003724] g3338.t1 Q587J7 31.552 393 1.76e-51 188.0 sp|Q587J7|TDR12_HUMAN Putative ATP-dependent RNA helicase TDRD12 OS=Homo sapiens OX=9606 GN=TDRD12 PE=1 SV=2 TDR12_HUMAN reviewed Putative ATP-dependent RNA helicase TDRD12 (EC 3.6.4.13) (ES cell-associated transcript 8 protein) (Tudor domain-containing protein 12) Homo sapiens (Human) GO:0003676; GO:0003724; GO:0005524; GO:0007140; GO:0007283; GO:0009566; GO:0016887; GO:0034587; GO:0042078; GO:0141196; GO:1990923 fertilization [GO:0009566]; germ-line stem cell division [GO:0042078]; male meiotic nuclear division [GO:0007140]; piRNA processing [GO:0034587]; spermatogenesis [GO:0007283]; transposable element silencing by piRNA-mediated DNA methylation [GO:0141196] PET complex [GO:1990923] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; nucleic acid binding [GO:0003676]; RNA helicase activity [GO:0003724] g3339.t1 Q9CWU0 29.167 216 1.74e-23 108.0 sp|Q9CWU0|TDR12_MOUSE Putative ATP-dependent RNA helicase TDRD12 OS=Mus musculus OX=10090 GN=Tdrd12 PE=1 SV=2 TDR12_MOUSE reviewed Putative ATP-dependent RNA helicase TDRD12 (EC 3.6.4.13) (ES cell-associated transcript 8 protein) (Tudor domain-containing protein 12) Mus musculus (Mouse) GO:0003676; GO:0003724; GO:0005524; GO:0005829; GO:0007140; GO:0007283; GO:0009566; GO:0016887; GO:0034587; GO:0042078; GO:0141196; GO:1990923 fertilization [GO:0009566]; germ-line stem cell division [GO:0042078]; male meiotic nuclear division [GO:0007140]; piRNA processing [GO:0034587]; spermatogenesis [GO:0007283]; transposable element silencing by piRNA-mediated DNA methylation [GO:0141196] cytosol [GO:0005829]; PET complex [GO:1990923] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; nucleic acid binding [GO:0003676]; RNA helicase activity [GO:0003724] g3340.t1 Q3U145 41.872 203 1.64e-38 145.0 sp|Q3U145|TMM64_MOUSE Transmembrane protein 64 OS=Mus musculus OX=10090 GN=Tmem64 PE=1 SV=1 TMM64_MOUSE reviewed Transmembrane protein 64 Mus musculus (Mouse) GO:0005783; GO:0016020; GO:0045600; GO:0045668; GO:0045672; GO:0045780; GO:0051480; GO:0090090 negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of osteoblast differentiation [GO:0045668]; positive regulation of bone resorption [GO:0045780]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of osteoclast differentiation [GO:0045672]; regulation of cytosolic calcium ion concentration [GO:0051480] endoplasmic reticulum [GO:0005783]; membrane [GO:0016020] g3341.t1 Q0VCC1 60.09 223 2.67e-83 253.0 sp|Q0VCC1|S66A2_BOVIN Solute carrier family 66 member 2 OS=Bos taurus OX=9913 GN=SLC66A2 PE=2 SV=1 g3342.t1 Q3SZV6 50.898 167 4.1099999999999995e-40 140.0 sp|Q3SZV6|TIM21_BOVIN Mitochondrial import inner membrane translocase subunit Tim21 OS=Bos taurus OX=9913 GN=TIMM21 PE=2 SV=1 g3343.t1 A7MB75 47.302 315 3.2600000000000003e-103 308.0 sp|A7MB75|TM231_BOVIN Transmembrane protein 231 OS=Bos taurus OX=9913 GN=TMEM231 PE=2 SV=1 TM231_BOVIN reviewed Transmembrane protein 231 Bos taurus (Bovine) GO:0001701; GO:0001944; GO:0007224; GO:0032880; GO:0035869; GO:0036038; GO:0042733; GO:0043010; GO:0060170; GO:0060271; GO:0060563 camera-type eye development [GO:0043010]; cilium assembly [GO:0060271]; embryonic digit morphogenesis [GO:0042733]; in utero embryonic development [GO:0001701]; neuroepithelial cell differentiation [GO:0060563]; regulation of protein localization [GO:0032880]; smoothened signaling pathway [GO:0007224]; vasculature development [GO:0001944] ciliary membrane [GO:0060170]; ciliary transition zone [GO:0035869]; MKS complex [GO:0036038] g3344.t1 P60522 73.276 116 7.099999999999999e-60 182.0 sp|P60522|GBRL2_RAT Gamma-aminobutyric acid receptor-associated protein-like 2 OS=Rattus norvegicus OX=10116 GN=Gabarapl2 PE=3 SV=1 g3345.t1 A0A481NSZ4 30.851 470 1.5899999999999998e-68 230.0 sp|A0A481NSZ4|BPI_SEBSC Bactericidal permeability-increasing protein OS=Sebastes schlegelii OX=214486 GN=BPI PE=1 SV=1 BPI_SEBSC reviewed Bactericidal permeability-increasing protein (BPI) (Lipopolysaccharide-binding protein) (LBP) Sebastes schlegelii (Korean rockfish) GO:0005615; GO:0008289; GO:0042742; GO:0045087 defense response to bacterium [GO:0042742]; innate immune response [GO:0045087] extracellular space [GO:0005615] lipid binding [GO:0008289] g3346.t1 Q7XJJ7 35.035 568 1.08e-81 271.0 sp|Q7XJJ7|FAAH_ARATH Fatty acid amide hydrolase OS=Arabidopsis thaliana OX=3702 GN=FAAH PE=1 SV=1 g3348.t1 P17439 46.386 498 2.52e-159 466.0 sp|P17439|GBA1_MOUSE Lysosomal acid glucosylceramidase OS=Mus musculus OX=10090 GN=Gba1 PE=1 SV=1 GBA1_MOUSE reviewed Lysosomal acid glucosylceramidase (Lysosomal acid GCase) (EC 3.2.1.45) (Acid beta-glucosidase) (Beta-glucocerebrosidase) (Cholesterol glucosyltransferase) (SGTase) (EC 2.4.1.-) (Cholesteryl-beta-glucosidase) (EC 3.2.1.-) (D-glucosyl-N-acylsphingosine glucohydrolase) (Lysosomal cholesterol glycosyltransferase) (Lysosomal galactosylceramidase) (EC 3.2.1.46) (Lysosomal glycosylceramidase) Mus musculus (Mouse) GO:0000423; GO:0004336; GO:0004348; GO:0005102; GO:0005124; GO:0005615; GO:0005764; GO:0005765; GO:0005783; GO:0005794; GO:0005802; GO:0006678; GO:0006680; GO:0006914; GO:0007005; GO:0007040; GO:0007417; GO:0008203; GO:0008340; GO:0008422; GO:0009247; GO:0009267; GO:0009268; GO:0014004; GO:0016787; GO:0019882; GO:0019915; GO:0021694; GO:0021859; GO:0022904; GO:0023021; GO:0031333; GO:0032006; GO:0032436; GO:0032715; GO:0033077; GO:0033574; GO:0042391; GO:0043161; GO:0043202; GO:0043409; GO:0043524; GO:0043627; GO:0046512; GO:0046513; GO:0046527; GO:0048469; GO:0048854; GO:0048872; GO:0050295; GO:0050728; GO:0050877; GO:0050905; GO:0051246; GO:0051248; GO:0051402; GO:0061436; GO:0061518; GO:0061744; GO:0071356; GO:0071425; GO:0071548; GO:0072676; GO:0097066; GO:0098773; GO:1901805; GO:1903052; GO:1904457; GO:1905037; GO:1905091; GO:1905146 antigen processing and presentation [GO:0019882]; autophagosome organization [GO:1905037]; autophagy [GO:0006914]; beta-glucoside catabolic process [GO:1901805]; brain morphogenesis [GO:0048854]; cell maturation [GO:0048469]; cellular response to starvation [GO:0009267]; cellular response to tumor necrosis factor [GO:0071356]; central nervous system development [GO:0007417]; ceramide biosynthetic process [GO:0046513]; cerebellar Purkinje cell layer formation [GO:0021694]; cholesterol metabolic process [GO:0008203]; determination of adult lifespan [GO:0008340]; establishment of skin barrier [GO:0061436]; glucosylceramide catabolic process [GO:0006680]; glucosylceramide metabolic process [GO:0006678]; glycolipid biosynthetic process [GO:0009247]; hematopoietic stem cell proliferation [GO:0071425]; homeostasis of number of cells [GO:0048872]; lipid storage [GO:0019915]; lymphocyte migration [GO:0072676]; lysosomal protein catabolic process [GO:1905146]; lysosome organization [GO:0007040]; microglia differentiation [GO:0014004]; microglial cell proliferation [GO:0061518]; mitochondrion organization [GO:0007005]; mitophagy [GO:0000423]; motor behavior [GO:0061744]; negative regulation of inflammatory response [GO:0050728]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of protein metabolic process [GO:0051248]; negative regulation of protein-containing complex assembly [GO:0031333]; nervous system process [GO:0050877]; neuromuscular process [GO:0050905]; neuron apoptotic process [GO:0051402]; positive regulation of neuronal action potential [GO:1904457]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of proteolysis involved in protein catabolic process [GO:1903052]; positive regulation of type 2 mitophagy [GO:1905091]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; pyramidal neuron differentiation [GO:0021859]; regulation of membrane potential [GO:0042391]; regulation of protein metabolic process [GO:0051246]; regulation of TOR signaling [GO:0032006]; respiratory electron transport chain [GO:0022904]; response to dexamethasone [GO:0071548]; response to estrogen [GO:0043627]; response to pH [GO:0009268]; response to testosterone [GO:0033574]; response to thyroid hormone [GO:0097066]; skin epidermis development [GO:0098773]; sphingosine biosynthetic process [GO:0046512]; T cell differentiation in thymus [GO:0033077]; termination of signal transduction [GO:0023021] endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; trans-Golgi network [GO:0005802] beta-glucosidase activity [GO:0008422]; galactosylceramidase activity [GO:0004336]; glucosylceramidase activity [GO:0004348]; glucosyltransferase activity [GO:0046527]; hydrolase activity [GO:0016787]; scavenger receptor binding [GO:0005124]; signaling receptor binding [GO:0005102]; steryl-beta-glucosidase activity [GO:0050295] g3349.t1 Q70KH2 46.386 498 1.17e-151 447.0 sp|Q70KH2|GBA1_PIG Lysosomal acid glucosylceramidase OS=Sus scrofa OX=9823 GN=GBA1 PE=3 SV=1 g3350.t1 Q75QI0 46.341 123 7.800000000000001e-27 104.0 sp|Q75QI0|CFDP1_CHICK Craniofacial development protein 1 OS=Gallus gallus OX=9031 GN=CFDP1 PE=2 SV=1 g3351.t1 Q9R049 44.376 649 2.2900000000000003e-167 499.0 sp|Q9R049|AMFR_MOUSE E3 ubiquitin-protein ligase AMFR OS=Mus musculus OX=10090 GN=Amfr PE=1 SV=2 AMFR_MOUSE reviewed E3 ubiquitin-protein ligase AMFR (EC 2.3.2.36) (Autocrine motility factor receptor) (AMF receptor) (RING-type E3 ubiquitin transferase AMFR) Mus musculus (Mouse) GO:0000151; GO:0000166; GO:0000209; GO:0004842; GO:0005783; GO:0005789; GO:0005794; GO:0005829; GO:0005886; GO:0006511; GO:0007249; GO:0007611; GO:0008270; GO:0016055; GO:0030425; GO:0030426; GO:0030674; GO:0030968; GO:0032991; GO:0034450; GO:0036503; GO:0036513; GO:0038023; GO:0038061; GO:0042802; GO:0043025; GO:0043130; GO:0044314; GO:0048471; GO:0051087; GO:0051865; GO:0061630; GO:0070936; GO:0090090; GO:1904288; GO:1990381; GO:2000638 canonical NF-kappaB signal transduction [GO:0007249]; endoplasmic reticulum unfolded protein response [GO:0030968]; ERAD pathway [GO:0036503]; learning or memory [GO:0007611]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; non-canonical NF-kappaB signal transduction [GO:0038061]; protein autoubiquitination [GO:0051865]; protein K27-linked ubiquitination [GO:0044314]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; regulation of SREBP signaling pathway [GO:2000638]; ubiquitin-dependent protein catabolic process [GO:0006511]; Wnt signaling pathway [GO:0016055] cytosol [GO:0005829]; dendrite [GO:0030425]; Derlin-1 retrotranslocation complex [GO:0036513]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; growth cone [GO:0030426]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; ubiquitin ligase complex [GO:0000151] BAT3 complex binding [GO:1904288]; identical protein binding [GO:0042802]; nucleotide binding [GO:0000166]; protein-folding chaperone binding [GO:0051087]; protein-macromolecule adaptor activity [GO:0030674]; signaling receptor activity [GO:0038023]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; ubiquitin-specific protease binding [GO:1990381]; ubiquitin-ubiquitin ligase activity [GO:0034450]; zinc ion binding [GO:0008270] g3352.t1 Q9UL36 53.794 738 0.0 758.0 sp|Q9UL36|ZN236_HUMAN Zinc finger protein 236 OS=Homo sapiens OX=9606 GN=ZNF236 PE=1 SV=2 g3352.t1 Q9UL36 39.413 954 1.2e-162 548.0 sp|Q9UL36|ZN236_HUMAN Zinc finger protein 236 OS=Homo sapiens OX=9606 GN=ZNF236 PE=1 SV=2 g3352.t1 Q9UL36 38.17 317 6.85e-55 216.0 sp|Q9UL36|ZN236_HUMAN Zinc finger protein 236 OS=Homo sapiens OX=9606 GN=ZNF236 PE=1 SV=2 g3352.t1 Q9UL36 33.962 371 1.12e-52 209.0 sp|Q9UL36|ZN236_HUMAN Zinc finger protein 236 OS=Homo sapiens OX=9606 GN=ZNF236 PE=1 SV=2 g3352.t1 Q9UL36 58.088 136 3.850000000000001e-43 177.0 sp|Q9UL36|ZN236_HUMAN Zinc finger protein 236 OS=Homo sapiens OX=9606 GN=ZNF236 PE=1 SV=2 g3352.t1 Q9UL36 32.534 292 7.62e-33 144.0 sp|Q9UL36|ZN236_HUMAN Zinc finger protein 236 OS=Homo sapiens OX=9606 GN=ZNF236 PE=1 SV=2 g3352.t1 Q9UL36 50.0 152 9.98e-33 143.0 sp|Q9UL36|ZN236_HUMAN Zinc finger protein 236 OS=Homo sapiens OX=9606 GN=ZNF236 PE=1 SV=2 g3352.t1 Q9UL36 59.292 113 9.67e-32 140.0 sp|Q9UL36|ZN236_HUMAN Zinc finger protein 236 OS=Homo sapiens OX=9606 GN=ZNF236 PE=1 SV=2 g3352.t1 Q9UL36 30.928 291 3.16e-29 132.0 sp|Q9UL36|ZN236_HUMAN Zinc finger protein 236 OS=Homo sapiens OX=9606 GN=ZNF236 PE=1 SV=2 g3352.t1 Q9UL36 44.304 158 4.0000000000000003e-29 131.0 sp|Q9UL36|ZN236_HUMAN Zinc finger protein 236 OS=Homo sapiens OX=9606 GN=ZNF236 PE=1 SV=2 g3352.t1 Q9UL36 33.447 293 2.04e-28 129.0 sp|Q9UL36|ZN236_HUMAN Zinc finger protein 236 OS=Homo sapiens OX=9606 GN=ZNF236 PE=1 SV=2 g3356.t1 Q99M85 81.69 142 1.06e-83 259.0 sp|Q99M85|SCRT1_MOUSE Transcriptional repressor scratch 1 OS=Mus musculus OX=10090 GN=Scrt1 PE=1 SV=1 SCRT1_MOUSE reviewed Transcriptional repressor scratch 1 (Scratch homolog 1 zinc finger protein) (SCRT) (Scratch 1) (mScrt) Mus musculus (Mouse) GO:0000122; GO:0000977; GO:0000978; GO:0000981; GO:0001227; GO:0005634; GO:0006355; GO:0008270; GO:0016604; GO:0043565; GO:1990837; GO:2001222 negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of DNA-templated transcription [GO:0006355]; regulation of neuron migration [GO:2001222] nuclear body [GO:0016604]; nucleus [GO:0005634] DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; zinc ion binding [GO:0008270] g3358.t1 P05689 68.248 274 1.08e-135 389.0 sp|P05689|CATZ_BOVIN Cathepsin Z OS=Bos taurus OX=9913 GN=CTSZ PE=2 SV=2 g3363.t1 Q8VI02 55.589 331 1.71e-111 364.0 sp|Q8VI02|PP4R1_RAT Serine/threonine-protein phosphatase 4 regulatory subunit 1 OS=Rattus norvegicus OX=10116 GN=Ppp4r1 PE=1 SV=1 g3363.t1 Q8VI02 42.353 255 4.83e-46 181.0 sp|Q8VI02|PP4R1_RAT Serine/threonine-protein phosphatase 4 regulatory subunit 1 OS=Rattus norvegicus OX=10116 GN=Ppp4r1 PE=1 SV=1 g3364.t1 Q8TF05 55.429 175 2.04e-44 161.0 sp|Q8TF05|PP4R1_HUMAN Serine/threonine-protein phosphatase 4 regulatory subunit 1 OS=Homo sapiens OX=9606 GN=PPP4R1 PE=1 SV=1 g3365.t1 Q5RAH7 57.143 392 3.0099999999999997e-137 402.0 sp|Q5RAH7|PIGM_PONAB GPI alpha-1,4-mannosyltransferase I, catalytic subunit OS=Pongo abelii OX=9601 GN=PIGM PE=2 SV=1 g3368.t1 Q9BQ70 46.906 501 4.43e-136 417.0 sp|Q9BQ70|TCF25_HUMAN Ribosome quality control complex subunit TCF25 OS=Homo sapiens OX=9606 GN=TCF25 PE=1 SV=1 TCF25_HUMAN reviewed Ribosome quality control complex subunit TCF25 (Nuclear localized protein 1) (Transcription factor 25) (TCF-25) Homo sapiens (Human) GO:0005634; GO:0005829; GO:0061945; GO:0072344; GO:1990112 regulation of protein K48-linked ubiquitination [GO:0061945]; rescue of stalled ribosome [GO:0072344] cytosol [GO:0005829]; nucleus [GO:0005634]; RQC complex [GO:1990112] g3370.t1 P59114 55.047 634 0.0 696.0 sp|P59114|CAPAM_MOUSE mRNA (2'-O-methyladenosine-N(6)-)-methyltransferase OS=Mus musculus OX=10090 GN=Pcif1 PE=1 SV=1 CAPAM_MOUSE reviewed mRNA (2'-O-methyladenosine-N(6)-)-methyltransferase (EC 2.1.1.62) (Cap-specific adenosine methyltransferase) (CAPAM) (Phosphorylated CTD-interacting factor 1) Mus musculus (Mouse) GO:0005634; GO:0005654; GO:0006397; GO:0015630; GO:0016422; GO:0017148; GO:0032259; GO:0045171; GO:0045727; GO:0099122; GO:1904047; GO:1990269 methylation [GO:0032259]; mRNA processing [GO:0006397]; negative regulation of translation [GO:0017148]; positive regulation of translation [GO:0045727] intercellular bridge [GO:0045171]; microtubule cytoskeleton [GO:0015630]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity [GO:0016422]; RNA polymerase II C-terminal domain binding [GO:0099122]; RNA polymerase II C-terminal domain phosphoserine binding [GO:1990269]; S-adenosyl-L-methionine binding [GO:1904047] g3371.t1 Q6TDP4 33.563 581 1.07e-104 332.0 sp|Q6TDP4|KLH17_HUMAN Kelch-like protein 17 OS=Homo sapiens OX=9606 GN=KLHL17 PE=1 SV=1 g3373.t1 Q9UBX8 48.511 235 2.79e-68 223.0 sp|Q9UBX8|B4GT6_HUMAN Beta-1,4-galactosyltransferase 6 OS=Homo sapiens OX=9606 GN=B4GALT6 PE=1 SV=1 B4GT6_HUMAN reviewed Beta-1,4-galactosyltransferase 6 (Beta-1,4-GalTase 6) (Beta4Gal-T6) (b4Gal-T6) (EC 2.4.1.-) (Glucosylceramide beta-1,4-galactosyltransferase) (EC 2.4.1.274) (Lactosylceramide synthase) (LacCer synthase) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 6) (UDP-Gal:glucosylceramide beta-1,4-galactosyltransferase) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 6) Homo sapiens (Human) GO:0000139; GO:0001572; GO:0001574; GO:0005794; GO:0005975; GO:0006688; GO:0008378; GO:0008489; GO:0021955; GO:0022010; GO:0032580; GO:0042551; GO:0046872 carbohydrate metabolic process [GO:0005975]; central nervous system myelination [GO:0022010]; central nervous system neuron axonogenesis [GO:0021955]; ganglioside biosynthetic process [GO:0001574]; glycosphingolipid biosynthetic process [GO:0006688]; lactosylceramide biosynthetic process [GO:0001572]; neuron maturation [GO:0042551] Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139] galactosyltransferase activity [GO:0008378]; metal ion binding [GO:0046872]; UDP-galactose:glucosylceramide beta-1,4-galactosyltransferase activity [GO:0008489] g3374.t1 Q8NCN5 43.354 805 0.0 685.0 sp|Q8NCN5|PDPR_HUMAN Pyruvate dehydrogenase phosphatase regulatory subunit, mitochondrial OS=Homo sapiens OX=9606 GN=PDPR PE=1 SV=2 g3375.t1 Q3SA46 53.986 276 4.5e-82 257.0 sp|Q3SA46|TBX20_XENTR T-box transcription factor TBX20 OS=Xenopus tropicalis OX=8364 GN=tbx20 PE=2 SV=1 g3376.t1 Q9JMK0 52.569 253 1.2e-87 283.0 sp|Q9JMK0|B4GT5_MOUSE Beta-1,4-galactosyltransferase 5 OS=Mus musculus OX=10090 GN=B4galt5 PE=1 SV=2 B4GT5_MOUSE reviewed Beta-1,4-galactosyltransferase 5 (Beta-1,4-GalTase 5) (Beta4Gal-T5) (b4Gal-T5) (EC 2.4.1.-) (Beta-1,4-GalT II) (Glucosylceramide beta-1,4-galactosyltransferase) (EC 2.4.1.274) (Lactosylceramide synthase) (LacCer synthase) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 5) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 5) Mus musculus (Mouse) GO:0001574; GO:0003945; GO:0005794; GO:0005975; GO:0008489; GO:0009101; GO:0021955; GO:0022010; GO:0030311; GO:0031647; GO:0032580; GO:0040019; GO:0042551; GO:0046872 carbohydrate metabolic process [GO:0005975]; central nervous system myelination [GO:0022010]; central nervous system neuron axonogenesis [GO:0021955]; ganglioside biosynthetic process [GO:0001574]; glycoprotein biosynthetic process [GO:0009101]; neuron maturation [GO:0042551]; poly-N-acetyllactosamine biosynthetic process [GO:0030311]; positive regulation of embryonic development [GO:0040019]; regulation of protein stability [GO:0031647] Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580] metal ion binding [GO:0046872]; N-acetyllactosamine synthase activity [GO:0003945]; UDP-galactose:glucosylceramide beta-1,4-galactosyltransferase activity [GO:0008489] g3377.t1 Q9GKV7 27.664 441 1.1399999999999998e-52 188.0 sp|Q9GKV7|FBX15_MACFA F-box only protein 15 OS=Macaca fascicularis OX=9541 GN=FBXO15 PE=2 SV=1 g3378.t1 Q921E2 45.342 161 3.72e-48 159.0 sp|Q921E2|RAB31_MOUSE Ras-related protein Rab-31 OS=Mus musculus OX=10090 GN=Rab31 PE=1 SV=2 RAB31_MOUSE reviewed Ras-related protein Rab-31 (EC 3.6.5.2) Mus musculus (Mouse) GO:0001891; GO:0003924; GO:0003925; GO:0005525; GO:0005737; GO:0005769; GO:0005770; GO:0005794; GO:0005802; GO:0006886; GO:0006897; GO:0012505; GO:0019003; GO:0031623; GO:0032588; GO:0032869; GO:0036186; GO:0043001; GO:0045055; GO:0045335; GO:0046872; GO:0048193; GO:0060100; GO:0090382 cellular response to insulin stimulus [GO:0032869]; endocytosis [GO:0006897]; Golgi to plasma membrane protein transport [GO:0043001]; Golgi vesicle transport [GO:0048193]; intracellular protein transport [GO:0006886]; phagosome maturation [GO:0090382]; positive regulation of phagocytosis, engulfment [GO:0060100]; receptor internalization [GO:0031623]; regulated exocytosis [GO:0045055] cytoplasm [GO:0005737]; early endosome [GO:0005769]; early phagosome membrane [GO:0036186]; endomembrane system [GO:0012505]; Golgi apparatus [GO:0005794]; late endosome [GO:0005770]; phagocytic cup [GO:0001891]; phagocytic vesicle [GO:0045335]; trans-Golgi network [GO:0005802]; trans-Golgi network membrane [GO:0032588] G protein activity [GO:0003925]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872] g3380.t1 Q54RX9 44.643 168 1.12e-43 149.0 sp|Q54RX9|RAB5B_DICDI Putative ras-related protein Rab-5B OS=Dictyostelium discoideum OX=44689 GN=rab5B PE=5 SV=1 g3382.t1 Q9P260 42.52 381 2.1e-77 264.0 sp|Q9P260|RELCH_HUMAN RAB11-binding protein RELCH OS=Homo sapiens OX=9606 GN=RELCH PE=1 SV=2 g3383.t1 Q6P6Y1 54.483 580 0.0 612.0 sp|Q6P6Y1|RELCH_DANRE RAB11-binding protein RELCH homolog OS=Danio rerio OX=7955 GN=relch PE=2 SV=1 g3385.t1 O08654 57.757 419 4.1200000000000003e-169 483.0 sp|O08654|PHAF1_RAT Phagosome assembly factor 1 OS=Rattus norvegicus OX=10116 GN=Phaf1 PE=2 SV=1 g3386.t1 Q96FK6 42.47 332 2.22e-83 263.0 sp|Q96FK6|WDR89_HUMAN WD repeat-containing protein 89 OS=Homo sapiens OX=9606 GN=WDR89 PE=1 SV=1 g3387.t1 Q501V0 61.804 377 8.06e-164 469.0 sp|Q501V0|KPSH1_DANRE Serine/threonine-protein kinase H1 homolog OS=Danio rerio OX=7955 GN=pskh1 PE=2 SV=2 KPSH1_DANRE reviewed Serine/threonine-protein kinase H1 homolog (EC 2.7.11.1) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0004674; GO:0005524; GO:0005737; GO:0106310 cytoplasm [GO:0005737] ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g3388.t1 Q4V847 32.139 1005 2.63e-146 464.0 sp|Q4V847|INT8_XENLA Integrator complex subunit 8 OS=Xenopus laevis OX=8355 GN=ints8 PE=2 SV=1 g3391.t1 P23342 31.525 387 5.42e-61 205.0 sp|P23342|MSOX_BACSN Monomeric sarcosine oxidase OS=Bacillus sp. (strain NS-129) OX=1419 GN=soxA PE=1 SV=1 g3392.t1 Q9Z1F9 60.967 579 0.0 665.0 sp|Q9Z1F9|SAE2_MOUSE SUMO-activating enzyme subunit 2 OS=Mus musculus OX=10090 GN=Uba2 PE=1 SV=1 g3393.t1 Q8NCN5 46.262 856 0.0 783.0 sp|Q8NCN5|PDPR_HUMAN Pyruvate dehydrogenase phosphatase regulatory subunit, mitochondrial OS=Homo sapiens OX=9606 GN=PDPR PE=1 SV=2 g3394.t1 Q6NX12 50.966 828 0.0 839.0 sp|Q6NX12|NUP93_XENTR Nuclear pore complex protein Nup93 OS=Xenopus tropicalis OX=8364 GN=nup93 PE=2 SV=1 g3395.t1 Q5R9K8 58.219 146 5.62e-56 177.0 sp|Q5R9K8|AR2BP_PONAB ADP-ribosylation factor-like protein 2-binding protein OS=Pongo abelii OX=9601 GN=ARL2BP PE=2 SV=1 AR2BP_PONAB reviewed ADP-ribosylation factor-like protein 2-binding protein (ARF-like 2-binding protein) Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0003713; GO:0005654; GO:0005758; GO:0005813; GO:0005819; GO:0005829; GO:0030496; GO:0036064; GO:0042531; GO:0051457 maintenance of protein location in nucleus [GO:0051457]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531] centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytosol [GO:0005829]; midbody [GO:0030496]; mitochondrial intermembrane space [GO:0005758]; nucleoplasm [GO:0005654]; spindle [GO:0005819] transcription coactivator activity [GO:0003713] g3395.t2 Q5R9K8 58.219 146 5.96e-56 177.0 sp|Q5R9K8|AR2BP_PONAB ADP-ribosylation factor-like protein 2-binding protein OS=Pongo abelii OX=9601 GN=ARL2BP PE=2 SV=1 AR2BP_PONAB reviewed ADP-ribosylation factor-like protein 2-binding protein (ARF-like 2-binding protein) Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0003713; GO:0005654; GO:0005758; GO:0005813; GO:0005819; GO:0005829; GO:0030496; GO:0036064; GO:0042531; GO:0051457 maintenance of protein location in nucleus [GO:0051457]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531] centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytosol [GO:0005829]; midbody [GO:0030496]; mitochondrial intermembrane space [GO:0005758]; nucleoplasm [GO:0005654]; spindle [GO:0005819] transcription coactivator activity [GO:0003713] g3396.t1 Q8UWA5 49.621 264 3.5199999999999995e-82 250.0 sp|Q8UWA5|CAH2_PSEHK Carbonic anhydrase 2 OS=Pseudaspius hakonensis OX=3004147 GN=ca2 PE=2 SV=3 g3396.t2 Q8UWA5 49.627 268 2.14e-82 251.0 sp|Q8UWA5|CAH2_PSEHK Carbonic anhydrase 2 OS=Pseudaspius hakonensis OX=3004147 GN=ca2 PE=2 SV=3 g3398.t1 M0R8U1 51.878 559 0.0 606.0 sp|M0R8U1|DYH5_RAT Dynein axonemal heavy chain 5 (Fragment) OS=Rattus norvegicus OX=10116 GN=Dnah5 PE=1 SV=1 DYH5_RAT reviewed Dynein axonemal heavy chain 5 (Axonemal beta dynein heavy chain 5) (Ciliary dynein heavy chain 5) Rattus norvegicus (Rat) GO:0003341; GO:0003351; GO:0003777; GO:0005524; GO:0005576; GO:0005737; GO:0005858; GO:0005874; GO:0005930; GO:0007368; GO:0007507; GO:0008569; GO:0021670; GO:0030317; GO:0031514; GO:0036157; GO:0036158; GO:0045505; GO:0051649; GO:0051959; GO:0060271; GO:0060294; GO:0097386; GO:0097728; GO:0097729 cilium assembly [GO:0060271]; cilium movement [GO:0003341]; cilium movement involved in cell motility [GO:0060294]; determination of left/right symmetry [GO:0007368]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; establishment of localization in cell [GO:0051649]; flagellated sperm motility [GO:0030317]; heart development [GO:0007507]; lateral ventricle development [GO:0021670]; outer dynein arm assembly [GO:0036158] 9+0 motile cilium [GO:0097728]; 9+2 motile cilium [GO:0097729]; axonemal dynein complex [GO:0005858]; axoneme [GO:0005930]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; glial cell projection [GO:0097386]; microtubule [GO:0005874]; motile cilium [GO:0031514]; outer dynein arm [GO:0036157] ATP binding [GO:0005524]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]; minus-end-directed microtubule motor activity [GO:0008569] g8308.t1 Q5FWH7 35.204 392 1.1200000000000001e-58 207.0 sp|Q5FWH7|S39AC_MOUSE Zinc transporter ZIP12 OS=Mus musculus OX=10090 GN=Slc39a12 PE=1 SV=1 S39AC_MOUSE reviewed Zinc transporter ZIP12 (Solute carrier family 39 member 12) (Zrt- and Irt-like protein 12) (ZIP-12) Mus musculus (Mouse) GO:0001841; GO:0005385; GO:0005886; GO:0007165; GO:0010975; GO:0030003; GO:0031113; GO:0048471; GO:0071578; GO:0140410; GO:1903672; GO:1990138 intracellular monoatomic cation homeostasis [GO:0030003]; neural tube formation [GO:0001841]; neuron projection extension [GO:1990138]; positive regulation of sprouting angiogenesis [GO:1903672]; regulation of microtubule polymerization [GO:0031113]; regulation of neuron projection development [GO:0010975]; signal transduction [GO:0007165]; zinc ion import across plasma membrane [GO:0071578] perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886] monoatomic cation:bicarbonate symporter activity [GO:0140410]; zinc ion transmembrane transporter activity [GO:0005385] g8312.t1 Q5FWH7 43.434 99 3.5599999999999996e-23 95.9 sp|Q5FWH7|S39AC_MOUSE Zinc transporter ZIP12 OS=Mus musculus OX=10090 GN=Slc39a12 PE=1 SV=1 S39AC_MOUSE reviewed Zinc transporter ZIP12 (Solute carrier family 39 member 12) (Zrt- and Irt-like protein 12) (ZIP-12) Mus musculus (Mouse) GO:0001841; GO:0005385; GO:0005886; GO:0007165; GO:0010975; GO:0030003; GO:0031113; GO:0048471; GO:0071578; GO:0140410; GO:1903672; GO:1990138 intracellular monoatomic cation homeostasis [GO:0030003]; neural tube formation [GO:0001841]; neuron projection extension [GO:1990138]; positive regulation of sprouting angiogenesis [GO:1903672]; regulation of microtubule polymerization [GO:0031113]; regulation of neuron projection development [GO:0010975]; signal transduction [GO:0007165]; zinc ion import across plasma membrane [GO:0071578] perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886] monoatomic cation:bicarbonate symporter activity [GO:0140410]; zinc ion transmembrane transporter activity [GO:0005385] g8317.t1 Q6NZ07 51.494 569 2.19e-168 493.0 sp|Q6NZ07|NCLN_DANRE BOS complex subunit ncln OS=Danio rerio OX=7955 GN=ncln PE=2 SV=1 NCLN_DANRE reviewed BOS complex subunit ncln (Nicalin-1) (Nicastrin-like protein 1) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0003140; GO:0005789; GO:0009966; GO:0043022; GO:0048484; GO:0160063; GO:0160064; GO:1900108 determination of left/right asymmetry in lateral mesoderm [GO:0003140]; enteric nervous system development [GO:0048484]; multi-pass transmembrane protein insertion into ER membrane [GO:0160063]; negative regulation of nodal signaling pathway [GO:1900108]; regulation of signal transduction [GO:0009966] endoplasmic reticulum membrane [GO:0005789]; multi-pass translocon complex [GO:0160064] ribosome binding [GO:0043022] g8319.t1 Q6UXH8 43.575 179 3.58e-42 162.0 sp|Q6UXH8|CCBE1_HUMAN Collagen and calcium-binding EGF domain-containing protein 1 OS=Homo sapiens OX=9606 GN=CCBE1 PE=1 SV=1 CCBE1_HUMAN reviewed Collagen and calcium-binding EGF domain-containing protein 1 (Full of fluid protein homolog) Homo sapiens (Human) GO:0001946; GO:0002020; GO:0002040; GO:0003016; GO:0005509; GO:0005518; GO:0005581; GO:0005615; GO:0010575; GO:0010595; GO:0010954; GO:0030324; GO:0031012; GO:0045766; GO:0048845; GO:1900748; GO:1901492; GO:1904977 lung development [GO:0030324]; lymphangiogenesis [GO:0001946]; lymphatic endothelial cell migration [GO:1904977]; positive regulation of angiogenesis [GO:0045766]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of lymphangiogenesis [GO:1901492]; positive regulation of protein processing [GO:0010954]; positive regulation of vascular endothelial growth factor production [GO:0010575]; positive regulation of vascular endothelial growth factor signaling pathway [GO:1900748]; respiratory system process [GO:0003016]; sprouting angiogenesis [GO:0002040]; venous blood vessel morphogenesis [GO:0048845] collagen trimer [GO:0005581]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615] calcium ion binding [GO:0005509]; collagen binding [GO:0005518]; protease binding [GO:0002020] g8320.t1 A6NNX1 52.5 80 4.38e-24 90.9 sp|A6NNX1|RIAD1_HUMAN RIIa domain-containing protein 1 OS=Homo sapiens OX=9606 GN=RIIAD1 PE=1 SV=1 g8322.t1 O15973 30.225 311 4.49e-26 113.0 sp|O15973|OPSD1_MIZYE Rhodopsin, GQ-coupled OS=Mizuhopecten yessoensis OX=6573 GN=SCOP1 PE=1 SV=1 g8323.t1 P43141 30.449 312 7.49e-27 113.0 sp|P43141|ADB4C_MELGA Beta-4C adrenergic receptor OS=Meleagris gallopavo OX=9103 GN=ADRB4C PE=2 SV=1 g8324.t1 O15973 29.677 310 4.1800000000000003e-29 120.0 sp|O15973|OPSD1_MIZYE Rhodopsin, GQ-coupled OS=Mizuhopecten yessoensis OX=6573 GN=SCOP1 PE=1 SV=1 g8325.t1 O15973 31.02 245 6.28e-25 107.0 sp|O15973|OPSD1_MIZYE Rhodopsin, GQ-coupled OS=Mizuhopecten yessoensis OX=6573 GN=SCOP1 PE=1 SV=1 g8325.t2 O57422 28.477 302 1.33e-25 110.0 sp|O57422|OPN4B_XENLA Melanopsin-B OS=Xenopus laevis OX=8355 GN=opn4b PE=2 SV=1 g8326.t1 O15973 30.263 304 2.11e-31 127.0 sp|O15973|OPSD1_MIZYE Rhodopsin, GQ-coupled OS=Mizuhopecten yessoensis OX=6573 GN=SCOP1 PE=1 SV=1 g8330.t1 O15973 29.085 306 4.3500000000000006e-27 115.0 sp|O15973|OPSD1_MIZYE Rhodopsin, GQ-coupled OS=Mizuhopecten yessoensis OX=6573 GN=SCOP1 PE=1 SV=1 g8331.t1 O15973 30.137 292 4.0000000000000003e-29 120.0 sp|O15973|OPSD1_MIZYE Rhodopsin, GQ-coupled OS=Mizuhopecten yessoensis OX=6573 GN=SCOP1 PE=1 SV=1 g8332.t1 O15973 29.126 309 4.11e-25 110.0 sp|O15973|OPSD1_MIZYE Rhodopsin, GQ-coupled OS=Mizuhopecten yessoensis OX=6573 GN=SCOP1 PE=1 SV=1 g8335.t1 Q8JG64 55.246 467 1.4700000000000001e-167 485.0 sp|Q8JG64|PDIA3_CHICK Protein disulfide-isomerase A3 OS=Gallus gallus OX=9031 GN=PDIA3 PE=2 SV=1 PDIA3_CHICK reviewed Protein disulfide-isomerase A3 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 57) (ER protein 57) (ERp57) (Glucose-regulated thiol oxidoreductase 58 kDa protein) Gallus gallus (Chicken) GO:0002502; GO:0003756; GO:0005615; GO:0005783; GO:0005788; GO:0006457; GO:0009986; GO:0015035; GO:0034976; GO:0042470; GO:0042802; GO:0061779; GO:0070527; GO:0097191; GO:0098761; GO:0106222; GO:2001238 cellular response to interleukin-7 [GO:0098761]; extrinsic apoptotic signaling pathway [GO:0097191]; peptide antigen assembly with MHC class I protein complex [GO:0002502]; platelet aggregation [GO:0070527]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976] cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; extracellular space [GO:0005615]; melanosome [GO:0042470]; Tapasin-ERp57 complex [GO:0061779] identical protein binding [GO:0042802]; lncRNA binding [GO:0106222]; protein disulfide isomerase activity [GO:0003756]; protein-disulfide reductase activity [GO:0015035] g8337.t1 Q9DCA2 62.016 129 9.53e-40 139.0 sp|Q9DCA2|RT11_MOUSE Small ribosomal subunit protein uS11m OS=Mus musculus OX=10090 GN=Mrps11 PE=1 SV=2 g8339.t1 Q6DFB8 43.694 222 2.5499999999999998e-40 150.0 sp|Q6DFB8|TTC37_XENLA Tetratricopeptide repeat protein 37 OS=Xenopus laevis OX=8355 GN=ttc37 PE=2 SV=1 g8345.t1 Q6DFB8 40.646 1176 0.0 754.0 sp|Q6DFB8|TTC37_XENLA Tetratricopeptide repeat protein 37 OS=Xenopus laevis OX=8355 GN=ttc37 PE=2 SV=1 g8346.t1 Q8CH02 62.992 127 8.71e-51 174.0 sp|Q8CH02|SUGP1_MOUSE SURP and G-patch domain-containing protein 1 OS=Mus musculus OX=10090 GN=Sugp1 PE=1 SV=1 g8350.t1 Q9H511 34.686 271 2.34e-49 175.0 sp|Q9H511|KLH31_HUMAN Kelch-like protein 31 OS=Homo sapiens OX=9606 GN=KLHL31 PE=1 SV=1 g8352.t1 O53532 33.43 344 1.84e-55 188.0 sp|O53532|Y2258_MYCTU S-adenosylmethionine-dependent methyltransferase Rv2258c OS=Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv) OX=83332 GN=Rv2258c PE=1 SV=1 g8352.t2 O53532 33.43 344 1.82e-55 188.0 sp|O53532|Y2258_MYCTU S-adenosylmethionine-dependent methyltransferase Rv2258c OS=Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv) OX=83332 GN=Rv2258c PE=1 SV=1 g8357.t1 B2RUJ5 66.912 408 0.0 542.0 sp|B2RUJ5|APBA1_MOUSE Amyloid-beta A4 precursor protein-binding family A member 1 OS=Mus musculus OX=10090 GN=Apba1 PE=1 SV=2 APBA1_MOUSE reviewed Amyloid-beta A4 precursor protein-binding family A member 1 (Adapter protein X11alpha) (Neuron-specific X11 protein) (Neuronal Munc18-1-interacting protein 1) (Mint-1) Mus musculus (Mouse) GO:0001540; GO:0001701; GO:0005546; GO:0005634; GO:0005737; GO:0005794; GO:0005829; GO:0005886; GO:0006886; GO:0007268; GO:0007626; GO:0010468; GO:0014047; GO:0014051; GO:0016020; GO:0019901; GO:0030165; GO:0032991; GO:0035264; GO:0043197; GO:0044877; GO:0048471; GO:0048787; GO:0098685; GO:0098978; GO:0099171 chemical synaptic transmission [GO:0007268]; gamma-aminobutyric acid secretion [GO:0014051]; glutamate secretion [GO:0014047]; in utero embryonic development [GO:0001701]; intracellular protein transport [GO:0006886]; locomotory behavior [GO:0007626]; multicellular organism growth [GO:0035264]; presynaptic modulation of chemical synaptic transmission [GO:0099171]; regulation of gene expression [GO:0010468] cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; presynaptic active zone membrane [GO:0048787]; protein-containing complex [GO:0032991]; Schaffer collateral - CA1 synapse [GO:0098685] amyloid-beta binding [GO:0001540]; PDZ domain binding [GO:0030165]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877] g8357.t2 Q02410 66.667 408 0.0 537.0 sp|Q02410|APBA1_HUMAN Amyloid-beta A4 precursor protein-binding family A member 1 OS=Homo sapiens OX=9606 GN=APBA1 PE=1 SV=3 APBA1_HUMAN reviewed Amyloid-beta A4 precursor protein-binding family A member 1 (Adapter protein X11alpha) (Neuron-specific X11 protein) (Neuronal Munc18-1-interacting protein 1) (Mint-1) Homo sapiens (Human) GO:0001540; GO:0001701; GO:0005634; GO:0005737; GO:0005794; GO:0005829; GO:0005886; GO:0006886; GO:0007155; GO:0007268; GO:0007399; GO:0007626; GO:0008021; GO:0008088; GO:0010468; GO:0014047; GO:0014051; GO:0035264; GO:0043197; GO:0048471; GO:0048787; GO:0065003; GO:0098685; GO:0098978; GO:0099171 axo-dendritic transport [GO:0008088]; cell adhesion [GO:0007155]; chemical synaptic transmission [GO:0007268]; gamma-aminobutyric acid secretion [GO:0014051]; glutamate secretion [GO:0014047]; in utero embryonic development [GO:0001701]; intracellular protein transport [GO:0006886]; locomotory behavior [GO:0007626]; multicellular organism growth [GO:0035264]; nervous system development [GO:0007399]; presynaptic modulation of chemical synaptic transmission [GO:0099171]; protein-containing complex assembly [GO:0065003]; regulation of gene expression [GO:0010468] cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; presynaptic active zone membrane [GO:0048787]; Schaffer collateral - CA1 synapse [GO:0098685]; synaptic vesicle [GO:0008021] amyloid-beta binding [GO:0001540] g8358.t1 Q91044 39.88 830 5.1e-171 518.0 sp|Q91044|NTRK3_CHICK NT-3 growth factor receptor OS=Gallus gallus OX=9031 GN=NTRK3 PE=1 SV=2 NTRK3_CHICK reviewed NT-3 growth factor receptor (EC 2.7.10.1) (Neurotrophic tyrosine kinase receptor type 3) (TrkC tyrosine kinase) (Trk-C) Gallus gallus (Chicken) GO:0004714; GO:0005030; GO:0005524; GO:0005886; GO:0007169; GO:0007399; GO:0007507; GO:0010976; GO:0030154; GO:0030424; GO:0043121; GO:0043235; GO:0051897; GO:1990090 cell differentiation [GO:0030154]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; cellular response to nerve growth factor stimulus [GO:1990090]; heart development [GO:0007507]; nervous system development [GO:0007399]; positive regulation of neuron projection development [GO:0010976]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897] axon [GO:0030424]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] ATP binding [GO:0005524]; neurotrophin binding [GO:0043121]; neurotrophin receptor activity [GO:0005030]; transmembrane receptor protein tyrosine kinase activity [GO:0004714] g8359.t1 Q4U2V3 67.46 126 1.33e-50 187.0 sp|Q4U2V3|CBPC1_DANRE Cytosolic carboxypeptidase 1 OS=Danio rerio OX=7955 GN=agtpbp1 PE=2 SV=1 CBPC1_DANRE reviewed Cytosolic carboxypeptidase 1 (EC 3.4.17.-) (EC 3.4.17.24) (ATP/GTP-binding protein 1) (Protein deglutamylase CCP1) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001754; GO:0004181; GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0006508; GO:0007005; GO:0008270; GO:0015630; GO:0015631; GO:0021702; GO:0021772; GO:0033077; GO:0035609; GO:0035610; GO:0043009; GO:0050905 C-terminal protein deglutamylation [GO:0035609]; cerebellar Purkinje cell differentiation [GO:0021702]; chordate embryonic development [GO:0043009]; eye photoreceptor cell differentiation [GO:0001754]; mitochondrion organization [GO:0007005]; neuromuscular process [GO:0050905]; olfactory bulb development [GO:0021772]; protein side chain deglutamylation [GO:0035610]; proteolysis [GO:0006508]; T cell differentiation in thymus [GO:0033077] cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule cytoskeleton [GO:0015630]; mitochondrion [GO:0005739]; nucleus [GO:0005634] metallocarboxypeptidase activity [GO:0004181]; tubulin binding [GO:0015631]; zinc ion binding [GO:0008270] g8363.t1 Q9NBX4 23.939 589 3.94e-22 104.0 sp|Q9NBX4|RTXE_DROME Probable RNA-directed DNA polymerase from transposon X-element OS=Drosophila melanogaster OX=7227 GN=X-element\ORF2 PE=3 SV=1 g8365.t1 Q3UHC2 28.932 1825 1.72e-171 580.0 sp|Q3UHC2|LRRK1_MOUSE Leucine-rich repeat serine/threonine-protein kinase 1 OS=Mus musculus OX=10090 GN=Lrrk1 PE=1 SV=1 LRRK1_MOUSE reviewed Leucine-rich repeat serine/threonine-protein kinase 1 (EC 2.7.11.1) Mus musculus (Mouse) GO:0004672; GO:0004674; GO:0005524; GO:0005525; GO:0005737; GO:0005739; GO:0005829; GO:0005886; GO:0007165; GO:0036035; GO:0042802; GO:0045453; GO:0046872; GO:0090263; GO:0106310; GO:1902533 bone resorption [GO:0045453]; osteoclast development [GO:0036035]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of intracellular signal transduction [GO:1902533]; signal transduction [GO:0007165] cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886] ATP binding [GO:0005524]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g8367.t1 Q8N567 36.7 297 2.6899999999999998e-55 183.0 sp|Q8N567|ZCHC9_HUMAN Zinc finger CCHC domain-containing protein 9 OS=Homo sapiens OX=9606 GN=ZCCHC9 PE=1 SV=2 g8368.t1 Q8AY68 52.846 246 1.8199999999999998e-60 211.0 sp|Q8AY68|SHC1_XENLA SHC-transforming protein 1 OS=Xenopus laevis OX=8355 GN=shc1 PE=1 SV=2 g8368.t1 Q8AY68 65.347 101 2.92e-34 139.0 sp|Q8AY68|SHC1_XENLA SHC-transforming protein 1 OS=Xenopus laevis OX=8355 GN=shc1 PE=1 SV=2 g8369.t1 Q5VT52 37.363 273 1.86e-38 161.0 sp|Q5VT52|RPRD2_HUMAN Regulation of nuclear pre-mRNA domain-containing protein 2 OS=Homo sapiens OX=9606 GN=RPRD2 PE=1 SV=1 RPRD2_HUMAN reviewed Regulation of nuclear pre-mRNA domain-containing protein 2 Homo sapiens (Human) GO:0000993; GO:0005654; GO:0031124; GO:0097550; GO:0099122 mRNA 3'-end processing [GO:0031124] nucleoplasm [GO:0005654]; transcription preinitiation complex [GO:0097550] RNA polymerase II C-terminal domain binding [GO:0099122]; RNA polymerase II complex binding [GO:0000993] g8370.t1 Q6ZQ11 47.319 746 0.0 723.0 sp|Q6ZQ11|CHSS1_MOUSE Chondroitin sulfate synthase 1 OS=Mus musculus OX=10090 GN=Chsy1 PE=2 SV=2 g8372.t1 Q7Z2Z2 55.846 1146 0.0 1279.0 sp|Q7Z2Z2|EFL1_HUMAN Elongation factor-like GTPase 1 OS=Homo sapiens OX=9606 GN=EFL1 PE=1 SV=2 EFL1_HUMAN reviewed Elongation factor-like GTPase 1 (EC 3.6.5.-) (Elongation factor Tu GTP-binding domain-containing protein 1) (Elongation factor-like 1) (Protein FAM42A) Homo sapiens (Human) GO:0003746; GO:0003924; GO:0005525; GO:0005829; GO:0042256; GO:0043022; GO:0046039; GO:1990904 cytosolic ribosome assembly [GO:0042256]; GTP metabolic process [GO:0046039] cytosol [GO:0005829]; ribonucleoprotein complex [GO:1990904] GTP binding [GO:0005525]; GTPase activity [GO:0003924]; ribosome binding [GO:0043022]; translation elongation factor activity [GO:0003746] g8377.t1 Q9FHN8 45.974 385 3.95e-87 308.0 sp|Q9FHN8|KN14E_ARATH Kinesin-like protein KIN-14E OS=Arabidopsis thaliana OX=3702 GN=KIN14E PE=1 SV=1 KN14E_ARATH reviewed Kinesin-like protein KIN-14E (Kinesin-like calmodulin-binding protein) (Protein ZWICHEL) Arabidopsis thaliana (Mouse-ear cress) GO:0001578; GO:0003777; GO:0005509; GO:0005516; GO:0005524; GO:0005737; GO:0005856; GO:0005871; GO:0005874; GO:0007018; GO:0008017; GO:0008569; GO:0009524; GO:0010091; GO:0016491; GO:0016887; GO:0019901; GO:0042803; GO:0043531; GO:0043622; GO:0048629; GO:0051015; GO:0055028; GO:0072686 cortical microtubule organization [GO:0043622]; microtubule bundle formation [GO:0001578]; microtubule-based movement [GO:0007018]; trichome branching [GO:0010091]; trichome patterning [GO:0048629] cortical microtubule [GO:0055028]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; mitotic spindle [GO:0072686]; phragmoplast [GO:0009524] actin filament binding [GO:0051015]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; minus-end-directed microtubule motor activity [GO:0008569]; oxidoreductase activity [GO:0016491]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901] g8381.t1 Q6NTJ7 40.5 200 8.17e-41 140.0 sp|Q6NTJ7|SWET1_XENLA Sugar transporter SWEET1 OS=Xenopus laevis OX=8355 GN=slc50a1 PE=2 SV=1 g8382.t1 Q92546 50.518 386 2.14e-113 339.0 sp|Q92546|RGP1_HUMAN RAB6A-GEF complex partner protein 2 OS=Homo sapiens OX=9606 GN=RGP1 PE=1 SV=1 RGP1_HUMAN reviewed RAB6A-GEF complex partner protein 2 (Retrograde Golgi transport protein RGP1 homolog) Homo sapiens (Human) GO:0000139; GO:0005085; GO:0005829; GO:0005886; GO:0016020; GO:0031267; GO:0032588; GO:0032991; GO:0034066; GO:0042147; GO:0042177; GO:0043547 negative regulation of protein catabolic process [GO:0042177]; positive regulation of GTPase activity [GO:0043547]; retrograde transport, endosome to Golgi [GO:0042147] cytosol [GO:0005829]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; Ric1-Rgp1 guanyl-nucleotide exchange factor complex [GO:0034066]; trans-Golgi network membrane [GO:0032588] guanyl-nucleotide exchange factor activity [GO:0005085]; small GTPase binding [GO:0031267] g8386.t1 Q9I9M5 56.0 125 9.32e-35 142.0 sp|Q9I9M5|FZD1_XENLA Frizzled-1 OS=Xenopus laevis OX=8355 GN=fzd1 PE=1 SV=1 g8386.t1 Q9I9M5 56.0 125 9.32e-35 142.0 sp|Q9I9M5|FZD1_XENLA Frizzled-1 OS=Xenopus laevis OX=8355 GN=fzd1 PE=1 SV=1 g8386.t1 Q9I9M5 59.292 113 3.98e-33 137.0 sp|Q9I9M5|FZD1_XENLA Frizzled-1 OS=Xenopus laevis OX=8355 GN=fzd1 PE=1 SV=1 g8386.t1 Q9I9M5 54.4 125 1.4200000000000002e-32 135.0 sp|Q9I9M5|FZD1_XENLA Frizzled-1 OS=Xenopus laevis OX=8355 GN=fzd1 PE=1 SV=1 g8387.t1 Q8AVJ9 55.0 120 6.670000000000001e-35 134.0 sp|Q8AVJ9|FZD7B_XENLA Frizzled-7-B OS=Xenopus laevis OX=8355 GN=fzd7-b PE=1 SV=1 g8388.t1 P10079 38.703 478 4.04e-83 300.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g8388.t1 P10079 38.306 496 2.36e-82 298.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g8388.t1 P10079 37.787 479 8.6e-80 290.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g8388.t1 P10079 38.912 478 5.3900000000000004e-79 288.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g8388.t1 P10079 36.842 513 1.83e-78 286.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g8388.t1 P10079 39.0 400 4.62e-66 248.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g8388.t2 P10079 38.703 478 3.46e-83 300.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g8388.t2 P10079 38.306 496 2.03e-82 298.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g8388.t2 P10079 37.787 479 7.56e-80 290.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g8388.t2 P10079 38.912 478 4.7600000000000004e-79 288.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g8388.t2 P10079 36.842 513 1.62e-78 286.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g8388.t2 P10079 39.0 400 4.2600000000000004e-66 248.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g8388.t3 P10079 38.703 478 3.91e-83 300.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g8388.t3 P10079 38.306 496 2.28e-82 298.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g8388.t3 P10079 37.787 479 8.36e-80 290.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g8388.t3 P10079 38.912 478 5.25e-79 288.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g8388.t3 P10079 36.842 513 1.78e-78 286.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g8388.t3 P10079 39.0 400 4.54e-66 248.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g8388.t4 P10079 38.703 478 3.6499999999999998e-84 300.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g8388.t4 P10079 38.306 496 2.29e-83 298.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g8388.t4 P10079 37.787 479 1.06e-80 290.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g8388.t4 P10079 38.912 478 7.150000000000001e-80 288.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g8388.t4 P10079 36.842 513 2.5400000000000003e-79 286.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g8388.t4 P10079 39.0 400 1.5100000000000002e-66 248.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g8391.t1 A6H8Z2 50.0 108 4.1000000000000003e-32 123.0 sp|A6H8Z2|F221B_HUMAN Protein FAM221B OS=Homo sapiens OX=9606 GN=FAM221B PE=1 SV=2 F221B_HUMAN reviewed Protein FAM221B Homo sapiens (Human) g8392.t1 Q8R2Y3 42.041 245 5.98e-48 177.0 sp|Q8R2Y3|DOLK_MOUSE Dolichol kinase OS=Mus musculus OX=10090 GN=Dolk PE=1 SV=1 g8393.t1 A4IHW3 43.494 269 3.86e-62 202.0 sp|A4IHW3|S35A4_XENTR Probable UDP-sugar transporter protein SLC35A4 OS=Xenopus tropicalis OX=8364 GN=slc35a4 PE=2 SV=1 g8393.t2 A4IHW3 43.279 305 2.58e-71 227.0 sp|A4IHW3|S35A4_XENTR Probable UDP-sugar transporter protein SLC35A4 OS=Xenopus tropicalis OX=8364 GN=slc35a4 PE=2 SV=1 g8394.t1 Q5EAL3 33.01 206 1.59e-32 120.0 sp|Q5EAL3|SWET1_XENTR Sugar transporter SWEET1 OS=Xenopus tropicalis OX=8364 GN=slc50a1 PE=2 SV=1 g8395.t1 F1R7R1 46.115 399 5.45e-105 357.0 sp|F1R7R1|SMG5_DANRE Nonsense-mediated mRNA decay factor SMG5 OS=Danio rerio OX=7955 GN=smg5 PE=2 SV=1 g8395.t1 F1R7R1 30.488 492 1.16e-50 198.0 sp|F1R7R1|SMG5_DANRE Nonsense-mediated mRNA decay factor SMG5 OS=Danio rerio OX=7955 GN=smg5 PE=2 SV=1 g8399.t1 Q62441 66.292 801 0.0 929.0 sp|Q62441|TLE4_MOUSE Transducin-like enhancer protein 4 OS=Mus musculus OX=10090 GN=Tle4 PE=1 SV=4 TLE4_MOUSE reviewed Transducin-like enhancer protein 4 (Grg-4) (Groucho-related protein 4) Mus musculus (Mouse) GO:0000122; GO:0003682; GO:0003714; GO:0005634; GO:0005654; GO:0005667; GO:0016055; GO:0045892; GO:0090090; GO:0140297; GO:1990830; GO:1990907 cellular response to leukemia inhibitory factor [GO:1990830]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; Wnt signaling pathway [GO:0016055] beta-catenin-TCF complex [GO:1990907]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667] chromatin binding [GO:0003682]; DNA-binding transcription factor binding [GO:0140297]; transcription corepressor activity [GO:0003714] g8399.t2 Q62441 66.542 801 0.0 936.0 sp|Q62441|TLE4_MOUSE Transducin-like enhancer protein 4 OS=Mus musculus OX=10090 GN=Tle4 PE=1 SV=4 TLE4_MOUSE reviewed Transducin-like enhancer protein 4 (Grg-4) (Groucho-related protein 4) Mus musculus (Mouse) GO:0000122; GO:0003682; GO:0003714; GO:0005634; GO:0005654; GO:0005667; GO:0016055; GO:0045892; GO:0090090; GO:0140297; GO:1990830; GO:1990907 cellular response to leukemia inhibitory factor [GO:1990830]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; Wnt signaling pathway [GO:0016055] beta-catenin-TCF complex [GO:1990907]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667] chromatin binding [GO:0003682]; DNA-binding transcription factor binding [GO:0140297]; transcription corepressor activity [GO:0003714] g8401.t1 C0HBB2 31.888 392 9.65e-62 207.0 sp|C0HBB2|GLMP_SALSA Glycosylated lysosomal membrane protein OS=Salmo salar OX=8030 GN=glmp PE=2 SV=1 g8403.t1 P10079 34.183 471 1.63e-57 221.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g8403.t1 P10079 35.253 434 2.0999999999999997e-54 211.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g8403.t1 P10079 34.698 464 3.1199999999999996e-54 210.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g8403.t1 P10079 36.636 434 3.96e-54 210.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g8403.t1 P10079 33.871 434 4.77e-49 194.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g8403.t1 P10079 35.309 405 2.35e-46 185.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g8403.t1 P10079 36.812 345 3.12e-44 179.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g8403.t1 P10079 35.0 280 3.5600000000000003e-35 149.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g8403.t2 P10079 32.463 536 1.73e-58 224.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g8403.t2 P10079 33.973 521 6.27e-55 213.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g8403.t2 P10079 33.855 511 4.9099999999999994e-54 210.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g8403.t2 P10079 31.985 519 1.66e-52 205.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g8403.t2 P10079 33.114 456 1.3500000000000001e-47 189.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g8403.t2 P10079 35.55 391 3.9099999999999995e-46 185.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g8403.t2 P10079 33.639 327 1.97e-35 150.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g8403.t2 P10079 36.179 246 6.47e-25 116.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g8404.t1 Q8WND5 43.523 1374 0.0 1030.0 sp|Q8WND5|ELP1_RABIT Elongator complex protein 1 OS=Oryctolagus cuniculus OX=9986 GN=ELP1 PE=2 SV=1 g8405.t1 P70579 27.918 831 8.16e-93 315.0 sp|P70579|GRM8_RAT Metabotropic glutamate receptor 8 OS=Rattus norvegicus OX=10116 GN=Grm8 PE=1 SV=1 GRM8_RAT reviewed Metabotropic glutamate receptor 8 (mGluR8) Rattus norvegicus (Rat) GO:0001642; GO:0004930; GO:0005886; GO:0007193; GO:0007196; GO:0007216; GO:0007268; GO:0008066; GO:0019233; GO:0035249; GO:0042734; GO:0043025; GO:0045211; GO:0046928; GO:0048787; GO:0050966; GO:0051966; GO:0098978; GO:0098982; GO:0099171 adenylate cyclase-inhibiting G protein-coupled glutamate receptor signaling pathway [GO:0007196]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; chemical synaptic transmission [GO:0007268]; detection of mechanical stimulus involved in sensory perception of pain [GO:0050966]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; presynaptic modulation of chemical synaptic transmission [GO:0099171]; regulation of neurotransmitter secretion [GO:0046928]; regulation of synaptic transmission, glutamatergic [GO:0051966]; sensory perception of pain [GO:0019233]; synaptic transmission, glutamatergic [GO:0035249] GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic active zone membrane [GO:0048787]; presynaptic membrane [GO:0042734] G protein-coupled receptor activity [GO:0004930]; glutamate receptor activity [GO:0008066]; group III metabotropic glutamate receptor activity [GO:0001642] g8406.t1 Q8BKW4 53.089 437 1.7400000000000003e-160 466.0 sp|Q8BKW4|ZCHC4_MOUSE rRNA N(6)-adenosine-methyltransferase ZCCHC4 OS=Mus musculus OX=10090 GN=Zcchc4 PE=2 SV=1 g8418.t1 P22770 38.542 480 1.53e-90 288.0 sp|P22770|ACHA7_CHICK Neuronal acetylcholine receptor subunit alpha-7 OS=Gallus gallus OX=9031 GN=CHRNA7 PE=1 SV=1 g8420.t1 O93529 49.186 307 9.84e-80 248.0 sp|O93529|FOXB1_XENLA Forkhead box protein B1 OS=Xenopus laevis OX=8355 GN=foxb1 PE=2 SV=1 g8421.t1 Q96PS8 41.176 289 6.34e-81 250.0 sp|Q96PS8|AQP10_HUMAN Aquaporin-10 OS=Homo sapiens OX=9606 GN=AQP10 PE=1 SV=2 g8429.t1 Q868T3 33.546 313 1.29e-33 134.0 sp|Q868T3|CCAPR_DROME Cardioacceleratory peptide receptor OS=Drosophila melanogaster OX=7227 GN=CCAP-R PE=2 SV=4 g8432.t1 Q9VQG2 41.736 242 2.6499999999999997e-46 157.0 sp|Q9VQG2|APH1_DROME Gamma-secretase subunit Aph-1 OS=Drosophila melanogaster OX=7227 GN=aph-1 PE=1 SV=1 APH1_DROME reviewed Gamma-secretase subunit Aph-1 (Presenilin-stabilization factor) Drosophila melanogaster (Fruit fly) GO:0005770; GO:0005783; GO:0005886; GO:0006509; GO:0007219; GO:0007220; GO:0016485; GO:0030674; GO:0034205; GO:0035333; GO:0050821; GO:0055037; GO:0070765 amyloid-beta formation [GO:0034205]; membrane protein ectodomain proteolysis [GO:0006509]; Notch receptor processing [GO:0007220]; Notch receptor processing, ligand-dependent [GO:0035333]; Notch signaling pathway [GO:0007219]; protein processing [GO:0016485]; protein stabilization [GO:0050821] endoplasmic reticulum [GO:0005783]; gamma-secretase complex [GO:0070765]; late endosome [GO:0005770]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037] protein-macromolecule adaptor activity [GO:0030674] g8433.t1 Q5E9V4 38.356 219 1.67e-41 160.0 sp|Q5E9V4|MT25B_BOVIN Methyltransferase-like protein 25B OS=Bos taurus OX=9913 GN=METTL25B PE=2 SV=1 g8434.t1 Q7ZXZ2 42.748 262 2.7799999999999998e-67 220.0 sp|Q7ZXZ2|UTP15_XENLA U3 small nucleolar RNA-associated protein 15 homolog OS=Xenopus laevis OX=8355 GN=utp15 PE=2 SV=1 g8435.t1 Q5F3D7 54.091 220 2.04e-78 247.0 sp|Q5F3D7|UTP15_CHICK U3 small nucleolar RNA-associated protein 15 homolog OS=Gallus gallus OX=9031 GN=UTP15 PE=2 SV=1 g8440.t1 O00160 48.624 109 1.85e-21 92.0 sp|O00160|MYO1F_HUMAN Unconventional myosin-If OS=Homo sapiens OX=9606 GN=MYO1F PE=1 SV=3 MYO1F_HUMAN reviewed Unconventional myosin-If (Myosin-Ie) Homo sapiens (Human) GO:0000146; GO:0003779; GO:0005516; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0005902; GO:0006897; GO:0007015; GO:0015629; GO:0016461; GO:0051015 actin filament organization [GO:0007015]; endocytosis [GO:0006897] actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; microvillus [GO:0005902]; plasma membrane [GO:0005886]; unconventional myosin complex [GO:0016461] actin binding [GO:0003779]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146] g8441.t1 E9Q634 70.525 933 0.0 1392.0 sp|E9Q634|MYO1E_MOUSE Unconventional myosin-Ie OS=Mus musculus OX=10090 GN=Myo1e PE=1 SV=1 MYO1E_MOUSE reviewed Unconventional myosin-Ie (Unconventional myosin 1E) Mus musculus (Mouse) GO:0000146; GO:0001570; GO:0001701; GO:0001822; GO:0003094; GO:0005516; GO:0005524; GO:0005737; GO:0005856; GO:0005886; GO:0005902; GO:0005903; GO:0005912; GO:0006897; GO:0007015; GO:0015629; GO:0016459; GO:0016887; GO:0030097; GO:0032437; GO:0032835; GO:0032836; GO:0032991; GO:0035091; GO:0035166; GO:0044877; GO:0045334; GO:0048008; GO:0051015; GO:0072015 actin filament organization [GO:0007015]; endocytosis [GO:0006897]; glomerular basement membrane development [GO:0032836]; glomerular filtration [GO:0003094]; glomerulus development [GO:0032835]; hemopoiesis [GO:0030097]; in utero embryonic development [GO:0001701]; kidney development [GO:0001822]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; podocyte development [GO:0072015]; post-embryonic hemopoiesis [GO:0035166]; vasculogenesis [GO:0001570] actin cytoskeleton [GO:0015629]; adherens junction [GO:0005912]; brush border [GO:0005903]; clathrin-coated endocytic vesicle [GO:0045334]; cuticular plate [GO:0032437]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; microvillus [GO:0005902]; myosin complex [GO:0016459]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] actin filament binding [GO:0051015]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; phosphatidylinositol binding [GO:0035091]; protein-containing complex binding [GO:0044877] g8442.t1 Q03111 56.621 219 9.97e-71 244.0 sp|Q03111|ENL_HUMAN Protein ENL OS=Homo sapiens OX=9606 GN=MLLT1 PE=1 SV=2 ENL_HUMAN reviewed Protein ENL (Eleven-nineteen-leukeumia) (YEATS domain-containing protein 1) Homo sapiens (Human) GO:0001650; GO:0003682; GO:0005654; GO:0005829; GO:0008023; GO:0045893 positive regulation of DNA-templated transcription [GO:0045893] cytosol [GO:0005829]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; transcription elongation factor complex [GO:0008023] chromatin binding [GO:0003682] g8443.t1 P48768 34.4 500 1.3100000000000001e-65 244.0 sp|P48768|NAC2_RAT Sodium/calcium exchanger 2 OS=Rattus norvegicus OX=10116 GN=Slc8a2 PE=1 SV=1 g8443.t1 P48768 43.939 198 1.89e-40 166.0 sp|P48768|NAC2_RAT Sodium/calcium exchanger 2 OS=Rattus norvegicus OX=10116 GN=Slc8a2 PE=1 SV=1 g8447.t1 Q9JJZ6 81.633 98 8.44e-55 182.0 sp|Q9JJZ6|KLF13_MOUSE Krueppel-like factor 13 OS=Mus musculus OX=10090 GN=Klf13 PE=1 SV=2 KLF13_MOUSE reviewed Krueppel-like factor 13 (Basic transcription element-binding protein 3) (BTE-binding protein 3) (Erythroid transcription factor FKLF-2) (RANTES factor of late activated T-lymphocytes 1) (RFLAT-1) (Transcription factor BTEB3) Mus musculus (Mouse) GO:0000978; GO:0000981; GO:0001228; GO:0003677; GO:0005634; GO:0006357; GO:0006366; GO:0008270; GO:0008285; GO:0045647; GO:0045944; GO:1990837 negative regulation of cell population proliferation [GO:0008285]; negative regulation of erythrocyte differentiation [GO:0045647]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription by RNA polymerase II [GO:0006366] nucleus [GO:0005634] DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; zinc ion binding [GO:0008270] g8450.t1 Q5RE08 26.265 415 2.1600000000000003e-27 115.0 sp|Q5RE08|FBX22_PONAB F-box only protein 22 OS=Pongo abelii OX=9601 GN=FBXO22 PE=2 SV=1 g8451.t1 P55013 48.96 1058 0.0 828.0 sp|P55013|S12A2_SQUAC Solute carrier family 12 member 2 OS=Squalus acanthias OX=7797 GN=SLC12A2 PE=1 SV=1 g8458.t1 Q6AX44 56.579 76 2.05e-22 100.0 sp|Q6AX44|FBCDA_XENLA Fibrinogen C domain-containing protein 1-A OS=Xenopus laevis OX=8355 GN=fibcd1-a PE=2 SV=1 g8460.t1 P06276 35.635 449 2.05e-78 258.0 sp|P06276|CHLE_HUMAN Cholinesterase OS=Homo sapiens OX=9606 GN=BCHE PE=1 SV=1 CHLE_HUMAN reviewed Cholinesterase (EC 3.1.1.8) (Acylcholine acylhydrolase) (Butyrylcholine esterase) (Choline esterase II) (Pseudocholinesterase) Homo sapiens (Human) GO:0001540; GO:0003824; GO:0003990; GO:0004104; GO:0005576; GO:0005615; GO:0005641; GO:0005788; GO:0005886; GO:0006581; GO:0006805; GO:0007612; GO:0008285; GO:0014016; GO:0016486; GO:0016788; GO:0019695; GO:0019899; GO:0033265; GO:0042802; GO:0043279; GO:0050784; GO:0050805; GO:0051384; GO:0051593; GO:0072562 acetylcholine catabolic process [GO:0006581]; choline metabolic process [GO:0019695]; cocaine catabolic process [GO:0050784]; learning [GO:0007612]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of synaptic transmission [GO:0050805]; neuroblast differentiation [GO:0014016]; peptide hormone processing [GO:0016486]; response to alkaloid [GO:0043279]; response to folic acid [GO:0051593]; response to glucocorticoid [GO:0051384]; xenobiotic metabolic process [GO:0006805] blood microparticle [GO:0072562]; endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; nuclear envelope lumen [GO:0005641]; plasma membrane [GO:0005886] acetylcholinesterase activity [GO:0003990]; amyloid-beta binding [GO:0001540]; catalytic activity [GO:0003824]; choline binding [GO:0033265]; cholinesterase activity [GO:0004104]; enzyme binding [GO:0019899]; hydrolase activity, acting on ester bonds [GO:0016788]; identical protein binding [GO:0042802] g8462.t1 Q869C3 36.106 565 3e-100 323.0 sp|Q869C3|ACES_ANOGA Acetylcholinesterase OS=Anopheles gambiae OX=7165 GN=Ace PE=1 SV=3 g8464.t1 P22303 34.142 577 3.42e-76 256.0 sp|P22303|ACES_HUMAN Acetylcholinesterase OS=Homo sapiens OX=9606 GN=ACHE PE=1 SV=1 ACES_HUMAN reviewed Acetylcholinesterase (AChE) (EC 3.1.1.7) Homo sapiens (Human) GO:0001507; GO:0001540; GO:0001919; GO:0002076; GO:0003990; GO:0004104; GO:0005518; GO:0005576; GO:0005604; GO:0005615; GO:0005634; GO:0005794; GO:0005886; GO:0006581; GO:0007155; GO:0007399; GO:0007416; GO:0009986; GO:0016020; GO:0016787; GO:0017171; GO:0031594; GO:0031623; GO:0032223; GO:0042166; GO:0042803; GO:0042982; GO:0043083; GO:0043236; GO:0045202; GO:0048471; GO:0050714; GO:0060041; GO:0095500; GO:0098552; GO:0120162 acetylcholine catabolic process [GO:0006581]; acetylcholine catabolic process in synaptic cleft [GO:0001507]; acetylcholine receptor signaling pathway [GO:0095500]; amyloid precursor protein metabolic process [GO:0042982]; cell adhesion [GO:0007155]; negative regulation of synaptic transmission, cholinergic [GO:0032223]; nervous system development [GO:0007399]; osteoblast development [GO:0002076]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of protein secretion [GO:0050714]; receptor internalization [GO:0031623]; regulation of receptor recycling [GO:0001919]; retina development in camera-type eye [GO:0060041]; synapse assembly [GO:0007416] basement membrane [GO:0005604]; cell surface [GO:0009986]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; neuromuscular junction [GO:0031594]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; side of membrane [GO:0098552]; synapse [GO:0045202]; synaptic cleft [GO:0043083] acetylcholine binding [GO:0042166]; acetylcholinesterase activity [GO:0003990]; amyloid-beta binding [GO:0001540]; cholinesterase activity [GO:0004104]; collagen binding [GO:0005518]; hydrolase activity [GO:0016787]; laminin binding [GO:0043236]; protein homodimerization activity [GO:0042803]; serine hydrolase activity [GO:0017171] g8465.t1 Q869C3 38.681 561 4.9499999999999996e-102 328.0 sp|Q869C3|ACES_ANOGA Acetylcholinesterase OS=Anopheles gambiae OX=7165 GN=Ace PE=1 SV=3 g8468.t1 A1ZAX0 31.737 334 4.859999999999999e-42 156.0 sp|A1ZAX0|CCH1R_DROME Neuropeptide CCHamide-1 receptor OS=Drosophila melanogaster OX=7227 GN=CCHa1-R PE=2 SV=2 g8470.t1 P82924 30.556 432 1.0599999999999999e-53 187.0 sp|P82924|RT30_BOVIN Large ribosomal subunit protein mL65 OS=Bos taurus OX=9913 GN=MRPS30 PE=1 SV=4 g8471.t1 Q5XIG6 50.893 112 4.46e-39 140.0 sp|Q5XIG6|GALK2_RAT N-acetylgalactosamine kinase OS=Rattus norvegicus OX=10116 GN=Galk2 PE=2 SV=1 GALK2_RAT reviewed N-acetylgalactosamine kinase (EC 2.7.1.157) (GalNAc kinase) (Galactokinase 2) Rattus norvegicus (Rat) GO:0004335; GO:0005524; GO:0005829; GO:0006012; GO:0033858 galactose metabolic process [GO:0006012] cytosol [GO:0005829] ATP binding [GO:0005524]; galactokinase activity [GO:0004335]; N-acetylgalactosamine kinase activity [GO:0033858] g8472.t1 Q68FH4 57.877 292 2.9500000000000004e-122 361.0 sp|Q68FH4|GALK2_MOUSE N-acetylgalactosamine kinase OS=Mus musculus OX=10090 GN=Galk2 PE=1 SV=1 g8474.t1 Q96M60 34.459 296 2.8000000000000002e-43 163.0 sp|Q96M60|F227B_HUMAN Protein FAM227B OS=Homo sapiens OX=9606 GN=FAM227B PE=1 SV=2 g8475.t1 P41239 53.699 365 4.26e-136 399.0 sp|P41239|CSK_CHICK Tyrosine-protein kinase CSK OS=Gallus gallus OX=9031 GN=CSK PE=2 SV=1 g8476.t1 Q9H9E1 48.925 186 7.73e-55 184.0 sp|Q9H9E1|ANRA2_HUMAN Ankyrin repeat family A protein 2 OS=Homo sapiens OX=9606 GN=ANKRA2 PE=1 SV=1 g8477.t1 P15206 95.588 272 0.0 545.0 sp|P15206|CCNB_MARGL G2/mitotic-specific cyclin-B OS=Marthasterias glacialis OX=7609 PE=2 SV=1 g8478.t1 P15206 83.099 71 2.3700000000000002e-36 128.0 sp|P15206|CCNB_MARGL G2/mitotic-specific cyclin-B OS=Marthasterias glacialis OX=7609 PE=2 SV=1 g8479.t1 Q8NEF3 42.664 443 5.44e-97 303.0 sp|Q8NEF3|CC112_HUMAN Coiled-coil domain-containing protein 112 OS=Homo sapiens OX=9606 GN=CCDC112 PE=1 SV=2 g8480.t1 Q3V0Q6 38.22 191 8.4e-26 106.0 sp|Q3V0Q6|SPAG8_MOUSE Sperm-associated antigen 8 OS=Mus musculus OX=10090 GN=Spag8 PE=1 SV=1 SPAG8_MOUSE reviewed Sperm-associated antigen 8 (Sperm membrane protein 1) (SMP-1) (Sperm membrane protein BS-84) Mus musculus (Mouse) GO:0001669; GO:0005634; GO:0005654; GO:0005737; GO:0005815; GO:0005819; GO:0005829; GO:0005879; GO:0005929; GO:0007283; GO:0007338; GO:0008017; GO:0030154; GO:0030317; GO:0036126; GO:0045944; GO:0160111 cell differentiation [GO:0030154]; flagellated sperm motility [GO:0030317]; positive regulation of transcription by RNA polymerase II [GO:0045944]; single fertilization [GO:0007338]; spermatogenesis [GO:0007283] acrosomal vesicle [GO:0001669]; axonemal A tubule inner sheath [GO:0160111]; axonemal microtubule [GO:0005879]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule organizing center [GO:0005815]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; sperm flagellum [GO:0036126]; spindle [GO:0005819] microtubule binding [GO:0008017] g8481.t1 O88704 46.25 160 1.8699999999999998e-45 167.0 sp|O88704|HCN1_MOUSE Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1 OS=Mus musculus OX=10090 GN=Hcn1 PE=1 SV=1 HCN1_MOUSE reviewed Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1 (Brain cyclic nucleotide-gated channel 1) (BCNG-1) (Hyperpolarization-activated cation channel 2) (HAC-2) Mus musculus (Mouse) GO:0003254; GO:0005222; GO:0005248; GO:0005249; GO:0005546; GO:0005547; GO:0005886; GO:0009986; GO:0016323; GO:0019228; GO:0022843; GO:0030424; GO:0030425; GO:0030552; GO:0032590; GO:0035458; GO:0035725; GO:0036477; GO:0042391; GO:0042711; GO:0042802; GO:0043025; GO:0043198; GO:0043679; GO:0045176; GO:0045211; GO:0045759; GO:0046549; GO:0048787; GO:0051289; GO:0051592; GO:0051867; GO:0060078; GO:0071320; GO:0071805; GO:0097440; GO:0098855; GO:0098978; GO:0140232; GO:1902065; GO:1902630; GO:1902632 apical protein localization [GO:0045176]; cellular response to cAMP [GO:0071320]; cellular response to interferon-beta [GO:0035458]; general adaptation syndrome, behavioral process [GO:0051867]; maternal behavior [GO:0042711]; negative regulation of action potential [GO:0045759]; neuronal action potential [GO:0019228]; positive regulation of membrane hyperpolarization [GO:1902632]; potassium ion transmembrane transport [GO:0071805]; protein homotetramerization [GO:0051289]; regulation of membrane depolarization [GO:0003254]; regulation of membrane hyperpolarization [GO:1902630]; regulation of membrane potential [GO:0042391]; regulation of postsynaptic membrane potential [GO:0060078]; response to calcium ion [GO:0051592]; response to L-glutamate [GO:1902065]; retinal cone cell development [GO:0046549]; sodium ion transmembrane transport [GO:0035725] apical dendrite [GO:0097440]; axon [GO:0030424]; axon terminus [GO:0043679]; basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; dendrite [GO:0030425]; dendrite membrane [GO:0032590]; dendritic shaft [GO:0043198]; glutamatergic synapse [GO:0098978]; HCN channel complex [GO:0098855]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic active zone membrane [GO:0048787]; somatodendritic compartment [GO:0036477] cAMP binding [GO:0030552]; identical protein binding [GO:0042802]; intracellular cAMP-activated cation channel activity involved in regulation of presynaptic membrane potential [GO:0140232]; intracellularly cAMP-activated cation channel activity [GO:0005222]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; voltage-gated monoatomic cation channel activity [GO:0022843]; voltage-gated potassium channel activity [GO:0005249]; voltage-gated sodium channel activity [GO:0005248] g8482.t1 O88703 57.764 322 5.21e-134 405.0 sp|O88703|HCN2_MOUSE Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 2 OS=Mus musculus OX=10090 GN=Hcn2 PE=1 SV=1 HCN2_MOUSE reviewed Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 2 (Brain cyclic nucleotide-gated channel 2) (BCNG-2) (Hyperpolarization-activated cation channel 1) (HAC-1) Mus musculus (Mouse) GO:0003254; GO:0005222; GO:0005248; GO:0005249; GO:0005886; GO:0009410; GO:0016020; GO:0030165; GO:0030424; GO:0030425; GO:0030552; GO:0032590; GO:0035725; GO:0036477; GO:0042391; GO:0042802; GO:0043025; GO:0043198; GO:0044877; GO:0060090; GO:0071320; GO:0071321; GO:0071805; GO:0072488; GO:0098719; GO:0098855; GO:1904045; GO:1990573 ammonium transmembrane transport [GO:0072488]; cellular response to aldosterone [GO:1904045]; cellular response to cAMP [GO:0071320]; cellular response to cGMP [GO:0071321]; potassium ion import across plasma membrane [GO:1990573]; potassium ion transmembrane transport [GO:0071805]; regulation of membrane depolarization [GO:0003254]; regulation of membrane potential [GO:0042391]; response to xenobiotic stimulus [GO:0009410]; sodium ion import across plasma membrane [GO:0098719]; sodium ion transmembrane transport [GO:0035725] axon [GO:0030424]; dendrite [GO:0030425]; dendrite membrane [GO:0032590]; dendritic shaft [GO:0043198]; HCN channel complex [GO:0098855]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; somatodendritic compartment [GO:0036477] cAMP binding [GO:0030552]; identical protein binding [GO:0042802]; intracellularly cAMP-activated cation channel activity [GO:0005222]; molecular adaptor activity [GO:0060090]; PDZ domain binding [GO:0030165]; protein-containing complex binding [GO:0044877]; voltage-gated potassium channel activity [GO:0005249]; voltage-gated sodium channel activity [GO:0005248] g8485.t1 Q80ZD0 69.774 354 3.3300000000000005e-179 503.0 sp|Q80ZD0|GNB5_TAMST Guanine nucleotide-binding protein subunit beta-5 OS=Tamias striatus OX=45474 GN=GNB5 PE=2 SV=1 g8486.t1 A2A3L6 29.114 395 3.09e-26 118.0 sp|A2A3L6|TTC24_HUMAN Tetratricopeptide repeat protein 24 OS=Homo sapiens OX=9606 GN=TTC24 PE=1 SV=1 g8487.t1 P23438 60.526 190 5.46e-78 234.0 sp|P23438|SSRB_CANLF Translocon-associated protein subunit beta OS=Canis lupus familiaris OX=9615 GN=SSR2 PE=1 SV=1 g8489.t1 Q9NXD2 32.411 759 3.09e-115 371.0 sp|Q9NXD2|MTMRA_HUMAN Myotubularin-related protein 10 OS=Homo sapiens OX=9606 GN=MTMR10 PE=1 SV=3 g8489.t2 Q9NXD2 32.411 759 4.36e-115 371.0 sp|Q9NXD2|MTMRA_HUMAN Myotubularin-related protein 10 OS=Homo sapiens OX=9606 GN=MTMR10 PE=1 SV=3 g8489.t3 Q9NXD2 32.411 759 2.7299999999999997e-115 371.0 sp|Q9NXD2|MTMRA_HUMAN Myotubularin-related protein 10 OS=Homo sapiens OX=9606 GN=MTMR10 PE=1 SV=3 g8491.t1 Q9D0R2 72.018 679 0.0 1041.0 sp|Q9D0R2|SYTC_MOUSE Threonine--tRNA ligase 1, cytoplasmic OS=Mus musculus OX=10090 GN=Tars1 PE=1 SV=2 SYTC_MOUSE reviewed Threonine--tRNA ligase 1, cytoplasmic (EC 6.1.1.3) (Threonine--tRNA ligase, cytoplasmic) (Threonyl-tRNA synthetase) (ThrRS) (Threonyl-tRNA synthetase 1) Mus musculus (Mouse) GO:0004829; GO:0005524; GO:0005737; GO:0006435; GO:0008270; GO:0042802 threonyl-tRNA aminoacylation [GO:0006435] cytoplasm [GO:0005737] ATP binding [GO:0005524]; identical protein binding [GO:0042802]; threonine-tRNA ligase activity [GO:0004829]; zinc ion binding [GO:0008270] g8491.t2 Q9D0R2 72.018 679 0.0 1040.0 sp|Q9D0R2|SYTC_MOUSE Threonine--tRNA ligase 1, cytoplasmic OS=Mus musculus OX=10090 GN=Tars1 PE=1 SV=2 SYTC_MOUSE reviewed Threonine--tRNA ligase 1, cytoplasmic (EC 6.1.1.3) (Threonine--tRNA ligase, cytoplasmic) (Threonyl-tRNA synthetase) (ThrRS) (Threonyl-tRNA synthetase 1) Mus musculus (Mouse) GO:0004829; GO:0005524; GO:0005737; GO:0006435; GO:0008270; GO:0042802 threonyl-tRNA aminoacylation [GO:0006435] cytoplasm [GO:0005737] ATP binding [GO:0005524]; identical protein binding [GO:0042802]; threonine-tRNA ligase activity [GO:0004829]; zinc ion binding [GO:0008270] g8495.t1 Q90252 25.301 332 1.3100000000000002e-21 98.2 sp|Q90252|MTR_RHIMB Mesotocin receptor OS=Rhinella marina OX=8386 PE=2 SV=1 g8498.t1 Q9NR16 28.292 919 4.43e-61 232.0 sp|Q9NR16|C163B_HUMAN Scavenger receptor cysteine-rich type 1 protein M160 OS=Homo sapiens OX=9606 GN=CD163L1 PE=1 SV=2 g8498.t1 Q9NR16 38.889 342 4.0500000000000005e-43 175.0 sp|Q9NR16|C163B_HUMAN Scavenger receptor cysteine-rich type 1 protein M160 OS=Homo sapiens OX=9606 GN=CD163L1 PE=1 SV=2 g8498.t1 Q9NR16 31.065 338 8.609999999999999e-34 145.0 sp|Q9NR16|C163B_HUMAN Scavenger receptor cysteine-rich type 1 protein M160 OS=Homo sapiens OX=9606 GN=CD163L1 PE=1 SV=2 g8498.t2 Q9NR16 28.509 912 1.4899999999999999e-61 233.0 sp|Q9NR16|C163B_HUMAN Scavenger receptor cysteine-rich type 1 protein M160 OS=Homo sapiens OX=9606 GN=CD163L1 PE=1 SV=2 g8498.t2 Q9NR16 38.889 342 3.630000000000001e-43 175.0 sp|Q9NR16|C163B_HUMAN Scavenger receptor cysteine-rich type 1 protein M160 OS=Homo sapiens OX=9606 GN=CD163L1 PE=1 SV=2 g8498.t2 Q9NR16 30.523 344 8.75e-34 145.0 sp|Q9NR16|C163B_HUMAN Scavenger receptor cysteine-rich type 1 protein M160 OS=Homo sapiens OX=9606 GN=CD163L1 PE=1 SV=2 g8499.t1 Q9UGM3 54.128 109 7.72e-30 120.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g8499.t1 Q9UGM3 53.271 107 1.96e-28 116.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g8499.t1 Q9UGM3 50.877 114 3.85e-28 115.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g8499.t1 Q9UGM3 52.427 103 4.7999999999999995e-28 115.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g8499.t1 Q9UGM3 53.398 103 5.03e-28 115.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g8499.t1 Q9UGM3 53.398 103 7.68e-28 114.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g8499.t1 Q9UGM3 53.398 103 8.37e-28 114.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g8499.t1 Q9UGM3 53.398 103 1.09e-27 114.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g8499.t1 Q9UGM3 53.398 103 1.34e-27 113.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g8499.t1 Q9UGM3 53.398 103 1.5300000000000001e-27 113.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g8499.t1 Q9UGM3 53.398 103 1.5300000000000001e-27 113.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g8499.t1 Q9UGM3 53.398 103 1.8400000000000002e-27 113.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g8499.t1 Q9UGM3 53.398 103 1.8400000000000002e-27 113.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g8499.t1 Q9UGM3 45.536 112 3.5700000000000003e-22 98.2 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g8501.t1 O89026 34.383 381 3.18e-53 197.0 sp|O89026|ROBO1_MOUSE Roundabout homolog 1 OS=Mus musculus OX=10090 GN=Robo1 PE=1 SV=1 ROBO1_MOUSE reviewed Roundabout homolog 1 Mus musculus (Mouse) GO:0001822; GO:0002042; GO:0003129; GO:0003148; GO:0003180; GO:0003184; GO:0003272; GO:0003281; GO:0005737; GO:0005829; GO:0005886; GO:0005929; GO:0007156; GO:0007411; GO:0007507; GO:0008046; GO:0008285; GO:0009986; GO:0010628; GO:0010629; GO:0016199; GO:0021836; GO:0021891; GO:0030275; GO:0030336; GO:0030424; GO:0030425; GO:0030673; GO:0030949; GO:0033116; GO:0033600; GO:0035025; GO:0035385; GO:0035904; GO:0042802; GO:0043025; GO:0043410; GO:0045747; GO:0048814; GO:0050772; GO:0050925; GO:0051964; GO:0060412; GO:0060763; GO:0060976; GO:0070100; GO:1900748; GO:1990138 aorta development [GO:0035904]; aortic valve morphogenesis [GO:0003180]; axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; cell migration involved in sprouting angiogenesis [GO:0002042]; chemorepulsion involved in postnatal olfactory bulb interneuron migration [GO:0021836]; coronary vasculature development [GO:0060976]; endocardial cushion formation [GO:0003272]; heart development [GO:0007507]; heart induction [GO:0003129]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; kidney development [GO:0001822]; mammary duct terminal end bud growth [GO:0060763]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of chemokine-mediated signaling pathway [GO:0070100]; negative regulation of gene expression [GO:0010629]; negative regulation of mammary gland epithelial cell proliferation [GO:0033600]; negative regulation of negative chemotaxis [GO:0050925]; negative regulation of synapse assembly [GO:0051964]; neuron projection extension [GO:1990138]; olfactory bulb interneuron development [GO:0021891]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of axonogenesis [GO:0050772]; positive regulation of gene expression [GO:0010628]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of Rho protein signal transduction [GO:0035025]; positive regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030949]; positive regulation of vascular endothelial growth factor signaling pathway [GO:1900748]; pulmonary valve morphogenesis [GO:0003184]; regulation of dendrite morphogenesis [GO:0048814]; Roundabout signaling pathway [GO:0035385]; ventricular septum development [GO:0003281]; ventricular septum morphogenesis [GO:0060412] axolemma [GO:0030673]; axon [GO:0030424]; cell surface [GO:0009986]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886] axon guidance receptor activity [GO:0008046]; identical protein binding [GO:0042802]; LRR domain binding [GO:0030275] g8501.t1 O89026 32.99 291 1.43e-28 124.0 sp|O89026|ROBO1_MOUSE Roundabout homolog 1 OS=Mus musculus OX=10090 GN=Robo1 PE=1 SV=1 ROBO1_MOUSE reviewed Roundabout homolog 1 Mus musculus (Mouse) GO:0001822; GO:0002042; GO:0003129; GO:0003148; GO:0003180; GO:0003184; GO:0003272; GO:0003281; GO:0005737; GO:0005829; GO:0005886; GO:0005929; GO:0007156; GO:0007411; GO:0007507; GO:0008046; GO:0008285; GO:0009986; GO:0010628; GO:0010629; GO:0016199; GO:0021836; GO:0021891; GO:0030275; GO:0030336; GO:0030424; GO:0030425; GO:0030673; GO:0030949; GO:0033116; GO:0033600; GO:0035025; GO:0035385; GO:0035904; GO:0042802; GO:0043025; GO:0043410; GO:0045747; GO:0048814; GO:0050772; GO:0050925; GO:0051964; GO:0060412; GO:0060763; GO:0060976; GO:0070100; GO:1900748; GO:1990138 aorta development [GO:0035904]; aortic valve morphogenesis [GO:0003180]; axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; cell migration involved in sprouting angiogenesis [GO:0002042]; chemorepulsion involved in postnatal olfactory bulb interneuron migration [GO:0021836]; coronary vasculature development [GO:0060976]; endocardial cushion formation [GO:0003272]; heart development [GO:0007507]; heart induction [GO:0003129]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; kidney development [GO:0001822]; mammary duct terminal end bud growth [GO:0060763]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of chemokine-mediated signaling pathway [GO:0070100]; negative regulation of gene expression [GO:0010629]; negative regulation of mammary gland epithelial cell proliferation [GO:0033600]; negative regulation of negative chemotaxis [GO:0050925]; negative regulation of synapse assembly [GO:0051964]; neuron projection extension [GO:1990138]; olfactory bulb interneuron development [GO:0021891]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of axonogenesis [GO:0050772]; positive regulation of gene expression [GO:0010628]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of Rho protein signal transduction [GO:0035025]; positive regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030949]; positive regulation of vascular endothelial growth factor signaling pathway [GO:1900748]; pulmonary valve morphogenesis [GO:0003184]; regulation of dendrite morphogenesis [GO:0048814]; Roundabout signaling pathway [GO:0035385]; ventricular septum development [GO:0003281]; ventricular septum morphogenesis [GO:0060412] axolemma [GO:0030673]; axon [GO:0030424]; cell surface [GO:0009986]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886] axon guidance receptor activity [GO:0008046]; identical protein binding [GO:0042802]; LRR domain binding [GO:0030275] g8502.t1 Q8K4C0 45.693 534 3.31e-168 490.0 sp|Q8K4C0|FMO5_RAT Flavin-containing monooxygenase 5 OS=Rattus norvegicus OX=10116 GN=Fmo5 PE=1 SV=3 FMO5_RAT reviewed Flavin-containing monooxygenase 5 (FMO 5) (Dimethylaniline monooxygenase [N-oxide-forming] 5) (EC 1.14.13.8) (Dimethylaniline oxidase 5) (Hepatic flavin-containing monooxygenase 5) (NADPH oxidase) (EC 1.6.3.1) Rattus norvegicus (Rat) GO:0004497; GO:0004499; GO:0005783; GO:0005789; GO:0005829; GO:0006629; GO:0006805; GO:0016174; GO:0050660; GO:0050661; GO:0090181 lipid metabolic process [GO:0006629]; regulation of cholesterol metabolic process [GO:0090181]; xenobiotic metabolic process [GO:0006805] cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789] flavin adenine dinucleotide binding [GO:0050660]; monooxygenase activity [GO:0004497]; N,N-dimethylaniline monooxygenase activity [GO:0004499]; NAD(P)H oxidase H2O2-forming activity [GO:0016174]; NADP binding [GO:0050661] g8503.t1 Q6PC62 62.857 280 2.11e-136 392.0 sp|Q6PC62|SPG21_DANRE Maspardin OS=Danio rerio OX=7955 GN=spg21 PE=2 SV=1 g8506.t1 Q15751 57.143 98 2.0199999999999998e-38 122.0 sp|Q15751|HERC1_HUMAN Probable E3 ubiquitin-protein ligase HERC1 OS=Homo sapiens OX=9606 GN=HERC1 PE=1 SV=2 HERC1_HUMAN reviewed Probable E3 ubiquitin-protein ligase HERC1 (EC 2.3.2.26) (HECT domain and RCC1-like domain-containing protein 1) (HECT-type E3 ubiquitin transferase HERC1) (p532) (p619) Homo sapiens (Human) GO:0005085; GO:0005737; GO:0005794; GO:0005829; GO:0006914; GO:0010467; GO:0010507; GO:0016020; GO:0016567; GO:0021702; GO:0022038; GO:0030282; GO:0031175; GO:0046849; GO:0050885; GO:0061630 autophagy [GO:0006914]; bone mineralization [GO:0030282]; bone remodeling [GO:0046849]; cerebellar Purkinje cell differentiation [GO:0021702]; corpus callosum development [GO:0022038]; gene expression [GO:0010467]; negative regulation of autophagy [GO:0010507]; neuromuscular process controlling balance [GO:0050885]; neuron projection development [GO:0031175]; protein ubiquitination [GO:0016567] cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; membrane [GO:0016020] guanyl-nucleotide exchange factor activity [GO:0005085]; ubiquitin protein ligase activity [GO:0061630] g8506.t1 Q15751 55.556 45 2.0199999999999998e-38 57.0 sp|Q15751|HERC1_HUMAN Probable E3 ubiquitin-protein ligase HERC1 OS=Homo sapiens OX=9606 GN=HERC1 PE=1 SV=2 HERC1_HUMAN reviewed Probable E3 ubiquitin-protein ligase HERC1 (EC 2.3.2.26) (HECT domain and RCC1-like domain-containing protein 1) (HECT-type E3 ubiquitin transferase HERC1) (p532) (p619) Homo sapiens (Human) GO:0005085; GO:0005737; GO:0005794; GO:0005829; GO:0006914; GO:0010467; GO:0010507; GO:0016020; GO:0016567; GO:0021702; GO:0022038; GO:0030282; GO:0031175; GO:0046849; GO:0050885; GO:0061630 autophagy [GO:0006914]; bone mineralization [GO:0030282]; bone remodeling [GO:0046849]; cerebellar Purkinje cell differentiation [GO:0021702]; corpus callosum development [GO:0022038]; gene expression [GO:0010467]; negative regulation of autophagy [GO:0010507]; neuromuscular process controlling balance [GO:0050885]; neuron projection development [GO:0031175]; protein ubiquitination [GO:0016567] cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; membrane [GO:0016020] guanyl-nucleotide exchange factor activity [GO:0005085]; ubiquitin protein ligase activity [GO:0061630] g8507.t1 Q15751 62.436 1166 0.0 1246.0 sp|Q15751|HERC1_HUMAN Probable E3 ubiquitin-protein ligase HERC1 OS=Homo sapiens OX=9606 GN=HERC1 PE=1 SV=2 HERC1_HUMAN reviewed Probable E3 ubiquitin-protein ligase HERC1 (EC 2.3.2.26) (HECT domain and RCC1-like domain-containing protein 1) (HECT-type E3 ubiquitin transferase HERC1) (p532) (p619) Homo sapiens (Human) GO:0005085; GO:0005737; GO:0005794; GO:0005829; GO:0006914; GO:0010467; GO:0010507; GO:0016020; GO:0016567; GO:0021702; GO:0022038; GO:0030282; GO:0031175; GO:0046849; GO:0050885; GO:0061630 autophagy [GO:0006914]; bone mineralization [GO:0030282]; bone remodeling [GO:0046849]; cerebellar Purkinje cell differentiation [GO:0021702]; corpus callosum development [GO:0022038]; gene expression [GO:0010467]; negative regulation of autophagy [GO:0010507]; neuromuscular process controlling balance [GO:0050885]; neuron projection development [GO:0031175]; protein ubiquitination [GO:0016567] cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; membrane [GO:0016020] guanyl-nucleotide exchange factor activity [GO:0005085]; ubiquitin protein ligase activity [GO:0061630] g8507.t1 Q15751 38.573 757 1.91e-107 388.0 sp|Q15751|HERC1_HUMAN Probable E3 ubiquitin-protein ligase HERC1 OS=Homo sapiens OX=9606 GN=HERC1 PE=1 SV=2 HERC1_HUMAN reviewed Probable E3 ubiquitin-protein ligase HERC1 (EC 2.3.2.26) (HECT domain and RCC1-like domain-containing protein 1) (HECT-type E3 ubiquitin transferase HERC1) (p532) (p619) Homo sapiens (Human) GO:0005085; GO:0005737; GO:0005794; GO:0005829; GO:0006914; GO:0010467; GO:0010507; GO:0016020; GO:0016567; GO:0021702; GO:0022038; GO:0030282; GO:0031175; GO:0046849; GO:0050885; GO:0061630 autophagy [GO:0006914]; bone mineralization [GO:0030282]; bone remodeling [GO:0046849]; cerebellar Purkinje cell differentiation [GO:0021702]; corpus callosum development [GO:0022038]; gene expression [GO:0010467]; negative regulation of autophagy [GO:0010507]; neuromuscular process controlling balance [GO:0050885]; neuron projection development [GO:0031175]; protein ubiquitination [GO:0016567] cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; membrane [GO:0016020] guanyl-nucleotide exchange factor activity [GO:0005085]; ubiquitin protein ligase activity [GO:0061630] g8507.t1 Q15751 44.715 369 2.52e-76 287.0 sp|Q15751|HERC1_HUMAN Probable E3 ubiquitin-protein ligase HERC1 OS=Homo sapiens OX=9606 GN=HERC1 PE=1 SV=2 HERC1_HUMAN reviewed Probable E3 ubiquitin-protein ligase HERC1 (EC 2.3.2.26) (HECT domain and RCC1-like domain-containing protein 1) (HECT-type E3 ubiquitin transferase HERC1) (p532) (p619) Homo sapiens (Human) GO:0005085; GO:0005737; GO:0005794; GO:0005829; GO:0006914; GO:0010467; GO:0010507; GO:0016020; GO:0016567; GO:0021702; GO:0022038; GO:0030282; GO:0031175; GO:0046849; GO:0050885; GO:0061630 autophagy [GO:0006914]; bone mineralization [GO:0030282]; bone remodeling [GO:0046849]; cerebellar Purkinje cell differentiation [GO:0021702]; corpus callosum development [GO:0022038]; gene expression [GO:0010467]; negative regulation of autophagy [GO:0010507]; neuromuscular process controlling balance [GO:0050885]; neuron projection development [GO:0031175]; protein ubiquitination [GO:0016567] cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; membrane [GO:0016020] guanyl-nucleotide exchange factor activity [GO:0005085]; ubiquitin protein ligase activity [GO:0061630] g8510.t1 Q9UPW8 58.75 80 2.55e-28 111.0 sp|Q9UPW8|UN13A_HUMAN Protein unc-13 homolog A OS=Homo sapiens OX=9606 GN=UNC13A PE=1 SV=4 UN13A_HUMAN reviewed Protein unc-13 homolog A (Munc13-1) Homo sapiens (Human) GO:0005509; GO:0005516; GO:0005543; GO:0005886; GO:0007269; GO:0008270; GO:0016081; GO:0016082; GO:0017075; GO:0019992; GO:0030154; GO:0030672; GO:0031594; GO:0035249; GO:0042734; GO:0043005; GO:0043195; GO:0048786; GO:0051966; GO:0061789; GO:0099011; GO:1903861 cell differentiation [GO:0030154]; dense core granule priming [GO:0061789]; neuronal dense core vesicle exocytosis [GO:0099011]; neurotransmitter secretion [GO:0007269]; positive regulation of dendrite extension [GO:1903861]; regulation of synaptic transmission, glutamatergic [GO:0051966]; synaptic transmission, glutamatergic [GO:0035249]; synaptic vesicle docking [GO:0016081]; synaptic vesicle priming [GO:0016082] neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; presynaptic active zone [GO:0048786]; presynaptic membrane [GO:0042734]; synaptic vesicle membrane [GO:0030672]; terminal bouton [GO:0043195] calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; diacylglycerol binding [GO:0019992]; phospholipid binding [GO:0005543]; syntaxin-1 binding [GO:0017075]; zinc ion binding [GO:0008270] g8511.t1 Q4KUS2 77.519 129 2.01e-58 211.0 sp|Q4KUS2|UN13A_MOUSE Protein unc-13 homolog A OS=Mus musculus OX=10090 GN=Unc13a PE=1 SV=3 UN13A_MOUSE reviewed Protein unc-13 homolog A (Munc13-1) Mus musculus (Mouse) GO:0000149; GO:0001956; GO:0005509; GO:0005516; GO:0005543; GO:0005798; GO:0005886; GO:0007269; GO:0007528; GO:0008270; GO:0010807; GO:0016079; GO:0016081; GO:0016082; GO:0016188; GO:0017075; GO:0019904; GO:0019905; GO:0019992; GO:0030154; GO:0030424; GO:0030507; GO:0030672; GO:0031340; GO:0031594; GO:0031915; GO:0032991; GO:0035249; GO:0035493; GO:0042734; GO:0042802; GO:0043005; GO:0043195; GO:0044305; GO:0044877; GO:0045202; GO:0048172; GO:0048786; GO:0050435; GO:0060076; GO:0060291; GO:0060384; GO:0061789; GO:0097060; GO:0098793; GO:0098978; GO:0099011; GO:0150037; GO:1900451; GO:1902991; GO:1903861 amyloid-beta metabolic process [GO:0050435]; cell differentiation [GO:0030154]; dense core granule priming [GO:0061789]; innervation [GO:0060384]; long-term synaptic potentiation [GO:0060291]; neuromuscular junction development [GO:0007528]; neuronal dense core vesicle exocytosis [GO:0099011]; neurotransmitter secretion [GO:0007269]; positive regulation of dendrite extension [GO:1903861]; positive regulation of glutamate receptor signaling pathway [GO:1900451]; positive regulation of neurotransmitter secretion [GO:0001956]; positive regulation of synaptic plasticity [GO:0031915]; positive regulation of vesicle fusion [GO:0031340]; regulation of amyloid precursor protein catabolic process [GO:1902991]; regulation of calcium-dependent activation of synaptic vesicle fusion [GO:0150037]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; regulation of synaptic vesicle priming [GO:0010807]; SNARE complex assembly [GO:0035493]; synaptic transmission, glutamatergic [GO:0035249]; synaptic vesicle docking [GO:0016081]; synaptic vesicle exocytosis [GO:0016079]; synaptic vesicle maturation [GO:0016188]; synaptic vesicle priming [GO:0016082] axon [GO:0030424]; calyx of Held [GO:0044305]; excitatory synapse [GO:0060076]; glutamatergic synapse [GO:0098978]; Golgi-associated vesicle [GO:0005798]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; presynaptic active zone [GO:0048786]; presynaptic membrane [GO:0042734]; protein-containing complex [GO:0032991]; synapse [GO:0045202]; synaptic membrane [GO:0097060]; synaptic vesicle membrane [GO:0030672]; terminal bouton [GO:0043195] calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; diacylglycerol binding [GO:0019992]; identical protein binding [GO:0042802]; phospholipid binding [GO:0005543]; protein domain specific binding [GO:0019904]; protein-containing complex binding [GO:0044877]; SNARE binding [GO:0000149]; spectrin binding [GO:0030507]; syntaxin binding [GO:0019905]; syntaxin-1 binding [GO:0017075]; zinc ion binding [GO:0008270] g8511.t1 Q4KUS2 83.333 18 2.01e-58 38.1 sp|Q4KUS2|UN13A_MOUSE Protein unc-13 homolog A OS=Mus musculus OX=10090 GN=Unc13a PE=1 SV=3 UN13A_MOUSE reviewed Protein unc-13 homolog A (Munc13-1) Mus musculus (Mouse) GO:0000149; GO:0001956; GO:0005509; GO:0005516; GO:0005543; GO:0005798; GO:0005886; GO:0007269; GO:0007528; GO:0008270; GO:0010807; GO:0016079; GO:0016081; GO:0016082; GO:0016188; GO:0017075; GO:0019904; GO:0019905; GO:0019992; GO:0030154; GO:0030424; GO:0030507; GO:0030672; GO:0031340; GO:0031594; GO:0031915; GO:0032991; GO:0035249; GO:0035493; GO:0042734; GO:0042802; GO:0043005; GO:0043195; GO:0044305; GO:0044877; GO:0045202; GO:0048172; GO:0048786; GO:0050435; GO:0060076; GO:0060291; GO:0060384; GO:0061789; GO:0097060; GO:0098793; GO:0098978; GO:0099011; GO:0150037; GO:1900451; GO:1902991; GO:1903861 amyloid-beta metabolic process [GO:0050435]; cell differentiation [GO:0030154]; dense core granule priming [GO:0061789]; innervation [GO:0060384]; long-term synaptic potentiation [GO:0060291]; neuromuscular junction development [GO:0007528]; neuronal dense core vesicle exocytosis [GO:0099011]; neurotransmitter secretion [GO:0007269]; positive regulation of dendrite extension [GO:1903861]; positive regulation of glutamate receptor signaling pathway [GO:1900451]; positive regulation of neurotransmitter secretion [GO:0001956]; positive regulation of synaptic plasticity [GO:0031915]; positive regulation of vesicle fusion [GO:0031340]; regulation of amyloid precursor protein catabolic process [GO:1902991]; regulation of calcium-dependent activation of synaptic vesicle fusion [GO:0150037]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; regulation of synaptic vesicle priming [GO:0010807]; SNARE complex assembly [GO:0035493]; synaptic transmission, glutamatergic [GO:0035249]; synaptic vesicle docking [GO:0016081]; synaptic vesicle exocytosis [GO:0016079]; synaptic vesicle maturation [GO:0016188]; synaptic vesicle priming [GO:0016082] axon [GO:0030424]; calyx of Held [GO:0044305]; excitatory synapse [GO:0060076]; glutamatergic synapse [GO:0098978]; Golgi-associated vesicle [GO:0005798]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; presynaptic active zone [GO:0048786]; presynaptic membrane [GO:0042734]; protein-containing complex [GO:0032991]; synapse [GO:0045202]; synaptic membrane [GO:0097060]; synaptic vesicle membrane [GO:0030672]; terminal bouton [GO:0043195] calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; diacylglycerol binding [GO:0019992]; identical protein binding [GO:0042802]; phospholipid binding [GO:0005543]; protein domain specific binding [GO:0019904]; protein-containing complex binding [GO:0044877]; SNARE binding [GO:0000149]; spectrin binding [GO:0030507]; syntaxin binding [GO:0019905]; syntaxin-1 binding [GO:0017075]; zinc ion binding [GO:0008270] g8511.t1 Q4KUS2 56.842 190 2.9000000000000004e-56 211.0 sp|Q4KUS2|UN13A_MOUSE Protein unc-13 homolog A OS=Mus musculus OX=10090 GN=Unc13a PE=1 SV=3 UN13A_MOUSE reviewed Protein unc-13 homolog A (Munc13-1) Mus musculus (Mouse) GO:0000149; GO:0001956; GO:0005509; GO:0005516; GO:0005543; GO:0005798; GO:0005886; GO:0007269; GO:0007528; GO:0008270; GO:0010807; GO:0016079; GO:0016081; GO:0016082; GO:0016188; GO:0017075; GO:0019904; GO:0019905; GO:0019992; GO:0030154; GO:0030424; GO:0030507; GO:0030672; GO:0031340; GO:0031594; GO:0031915; GO:0032991; GO:0035249; GO:0035493; GO:0042734; GO:0042802; GO:0043005; GO:0043195; GO:0044305; GO:0044877; GO:0045202; GO:0048172; GO:0048786; GO:0050435; GO:0060076; GO:0060291; GO:0060384; GO:0061789; GO:0097060; GO:0098793; GO:0098978; GO:0099011; GO:0150037; GO:1900451; GO:1902991; GO:1903861 amyloid-beta metabolic process [GO:0050435]; cell differentiation [GO:0030154]; dense core granule priming [GO:0061789]; innervation [GO:0060384]; long-term synaptic potentiation [GO:0060291]; neuromuscular junction development [GO:0007528]; neuronal dense core vesicle exocytosis [GO:0099011]; neurotransmitter secretion [GO:0007269]; positive regulation of dendrite extension [GO:1903861]; positive regulation of glutamate receptor signaling pathway [GO:1900451]; positive regulation of neurotransmitter secretion [GO:0001956]; positive regulation of synaptic plasticity [GO:0031915]; positive regulation of vesicle fusion [GO:0031340]; regulation of amyloid precursor protein catabolic process [GO:1902991]; regulation of calcium-dependent activation of synaptic vesicle fusion [GO:0150037]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; regulation of synaptic vesicle priming [GO:0010807]; SNARE complex assembly [GO:0035493]; synaptic transmission, glutamatergic [GO:0035249]; synaptic vesicle docking [GO:0016081]; synaptic vesicle exocytosis [GO:0016079]; synaptic vesicle maturation [GO:0016188]; synaptic vesicle priming [GO:0016082] axon [GO:0030424]; calyx of Held [GO:0044305]; excitatory synapse [GO:0060076]; glutamatergic synapse [GO:0098978]; Golgi-associated vesicle [GO:0005798]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; presynaptic active zone [GO:0048786]; presynaptic membrane [GO:0042734]; protein-containing complex [GO:0032991]; synapse [GO:0045202]; synaptic membrane [GO:0097060]; synaptic vesicle membrane [GO:0030672]; terminal bouton [GO:0043195] calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; diacylglycerol binding [GO:0019992]; identical protein binding [GO:0042802]; phospholipid binding [GO:0005543]; protein domain specific binding [GO:0019904]; protein-containing complex binding [GO:0044877]; SNARE binding [GO:0000149]; spectrin binding [GO:0030507]; syntaxin binding [GO:0019905]; syntaxin-1 binding [GO:0017075]; zinc ion binding [GO:0008270] g8511.t2 Q4KUS2 77.519 129 2.08e-58 211.0 sp|Q4KUS2|UN13A_MOUSE Protein unc-13 homolog A OS=Mus musculus OX=10090 GN=Unc13a PE=1 SV=3 UN13A_MOUSE reviewed Protein unc-13 homolog A (Munc13-1) Mus musculus (Mouse) GO:0000149; GO:0001956; GO:0005509; GO:0005516; GO:0005543; GO:0005798; GO:0005886; GO:0007269; GO:0007528; GO:0008270; GO:0010807; GO:0016079; GO:0016081; GO:0016082; GO:0016188; GO:0017075; GO:0019904; GO:0019905; GO:0019992; GO:0030154; GO:0030424; GO:0030507; GO:0030672; GO:0031340; GO:0031594; GO:0031915; GO:0032991; GO:0035249; GO:0035493; GO:0042734; GO:0042802; GO:0043005; GO:0043195; GO:0044305; GO:0044877; GO:0045202; GO:0048172; GO:0048786; GO:0050435; GO:0060076; GO:0060291; GO:0060384; GO:0061789; GO:0097060; GO:0098793; GO:0098978; GO:0099011; GO:0150037; GO:1900451; GO:1902991; GO:1903861 amyloid-beta metabolic process [GO:0050435]; cell differentiation [GO:0030154]; dense core granule priming [GO:0061789]; innervation [GO:0060384]; long-term synaptic potentiation [GO:0060291]; neuromuscular junction development [GO:0007528]; neuronal dense core vesicle exocytosis [GO:0099011]; neurotransmitter secretion [GO:0007269]; positive regulation of dendrite extension [GO:1903861]; positive regulation of glutamate receptor signaling pathway [GO:1900451]; positive regulation of neurotransmitter secretion [GO:0001956]; positive regulation of synaptic plasticity [GO:0031915]; positive regulation of vesicle fusion [GO:0031340]; regulation of amyloid precursor protein catabolic process [GO:1902991]; regulation of calcium-dependent activation of synaptic vesicle fusion [GO:0150037]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; regulation of synaptic vesicle priming [GO:0010807]; SNARE complex assembly [GO:0035493]; synaptic transmission, glutamatergic [GO:0035249]; synaptic vesicle docking [GO:0016081]; synaptic vesicle exocytosis [GO:0016079]; synaptic vesicle maturation [GO:0016188]; synaptic vesicle priming [GO:0016082] axon [GO:0030424]; calyx of Held [GO:0044305]; excitatory synapse [GO:0060076]; glutamatergic synapse [GO:0098978]; Golgi-associated vesicle [GO:0005798]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; presynaptic active zone [GO:0048786]; presynaptic membrane [GO:0042734]; protein-containing complex [GO:0032991]; synapse [GO:0045202]; synaptic membrane [GO:0097060]; synaptic vesicle membrane [GO:0030672]; terminal bouton [GO:0043195] calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; diacylglycerol binding [GO:0019992]; identical protein binding [GO:0042802]; phospholipid binding [GO:0005543]; protein domain specific binding [GO:0019904]; protein-containing complex binding [GO:0044877]; SNARE binding [GO:0000149]; spectrin binding [GO:0030507]; syntaxin binding [GO:0019905]; syntaxin-1 binding [GO:0017075]; zinc ion binding [GO:0008270] g8511.t2 Q4KUS2 83.333 18 2.08e-58 38.1 sp|Q4KUS2|UN13A_MOUSE Protein unc-13 homolog A OS=Mus musculus OX=10090 GN=Unc13a PE=1 SV=3 UN13A_MOUSE reviewed Protein unc-13 homolog A (Munc13-1) Mus musculus (Mouse) GO:0000149; GO:0001956; GO:0005509; GO:0005516; GO:0005543; GO:0005798; GO:0005886; GO:0007269; GO:0007528; GO:0008270; GO:0010807; GO:0016079; GO:0016081; GO:0016082; GO:0016188; GO:0017075; GO:0019904; GO:0019905; GO:0019992; GO:0030154; GO:0030424; GO:0030507; GO:0030672; GO:0031340; GO:0031594; GO:0031915; GO:0032991; GO:0035249; GO:0035493; GO:0042734; GO:0042802; GO:0043005; GO:0043195; GO:0044305; GO:0044877; GO:0045202; GO:0048172; GO:0048786; GO:0050435; GO:0060076; GO:0060291; GO:0060384; GO:0061789; GO:0097060; GO:0098793; GO:0098978; GO:0099011; GO:0150037; GO:1900451; GO:1902991; GO:1903861 amyloid-beta metabolic process [GO:0050435]; cell differentiation [GO:0030154]; dense core granule priming [GO:0061789]; innervation [GO:0060384]; long-term synaptic potentiation [GO:0060291]; neuromuscular junction development [GO:0007528]; neuronal dense core vesicle exocytosis [GO:0099011]; neurotransmitter secretion [GO:0007269]; positive regulation of dendrite extension [GO:1903861]; positive regulation of glutamate receptor signaling pathway [GO:1900451]; positive regulation of neurotransmitter secretion [GO:0001956]; positive regulation of synaptic plasticity [GO:0031915]; positive regulation of vesicle fusion [GO:0031340]; regulation of amyloid precursor protein catabolic process [GO:1902991]; regulation of calcium-dependent activation of synaptic vesicle fusion [GO:0150037]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; regulation of synaptic vesicle priming [GO:0010807]; SNARE complex assembly [GO:0035493]; synaptic transmission, glutamatergic [GO:0035249]; synaptic vesicle docking [GO:0016081]; synaptic vesicle exocytosis [GO:0016079]; synaptic vesicle maturation [GO:0016188]; synaptic vesicle priming [GO:0016082] axon [GO:0030424]; calyx of Held [GO:0044305]; excitatory synapse [GO:0060076]; glutamatergic synapse [GO:0098978]; Golgi-associated vesicle [GO:0005798]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; presynaptic active zone [GO:0048786]; presynaptic membrane [GO:0042734]; protein-containing complex [GO:0032991]; synapse [GO:0045202]; synaptic membrane [GO:0097060]; synaptic vesicle membrane [GO:0030672]; terminal bouton [GO:0043195] calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; diacylglycerol binding [GO:0019992]; identical protein binding [GO:0042802]; phospholipid binding [GO:0005543]; protein domain specific binding [GO:0019904]; protein-containing complex binding [GO:0044877]; SNARE binding [GO:0000149]; spectrin binding [GO:0030507]; syntaxin binding [GO:0019905]; syntaxin-1 binding [GO:0017075]; zinc ion binding [GO:0008270] g8511.t2 Q4KUS2 56.842 190 1.92e-54 206.0 sp|Q4KUS2|UN13A_MOUSE Protein unc-13 homolog A OS=Mus musculus OX=10090 GN=Unc13a PE=1 SV=3 UN13A_MOUSE reviewed Protein unc-13 homolog A (Munc13-1) Mus musculus (Mouse) GO:0000149; GO:0001956; GO:0005509; GO:0005516; GO:0005543; GO:0005798; GO:0005886; GO:0007269; GO:0007528; GO:0008270; GO:0010807; GO:0016079; GO:0016081; GO:0016082; GO:0016188; GO:0017075; GO:0019904; GO:0019905; GO:0019992; GO:0030154; GO:0030424; GO:0030507; GO:0030672; GO:0031340; GO:0031594; GO:0031915; GO:0032991; GO:0035249; GO:0035493; GO:0042734; GO:0042802; GO:0043005; GO:0043195; GO:0044305; GO:0044877; GO:0045202; GO:0048172; GO:0048786; GO:0050435; GO:0060076; GO:0060291; GO:0060384; GO:0061789; GO:0097060; GO:0098793; GO:0098978; GO:0099011; GO:0150037; GO:1900451; GO:1902991; GO:1903861 amyloid-beta metabolic process [GO:0050435]; cell differentiation [GO:0030154]; dense core granule priming [GO:0061789]; innervation [GO:0060384]; long-term synaptic potentiation [GO:0060291]; neuromuscular junction development [GO:0007528]; neuronal dense core vesicle exocytosis [GO:0099011]; neurotransmitter secretion [GO:0007269]; positive regulation of dendrite extension [GO:1903861]; positive regulation of glutamate receptor signaling pathway [GO:1900451]; positive regulation of neurotransmitter secretion [GO:0001956]; positive regulation of synaptic plasticity [GO:0031915]; positive regulation of vesicle fusion [GO:0031340]; regulation of amyloid precursor protein catabolic process [GO:1902991]; regulation of calcium-dependent activation of synaptic vesicle fusion [GO:0150037]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; regulation of synaptic vesicle priming [GO:0010807]; SNARE complex assembly [GO:0035493]; synaptic transmission, glutamatergic [GO:0035249]; synaptic vesicle docking [GO:0016081]; synaptic vesicle exocytosis [GO:0016079]; synaptic vesicle maturation [GO:0016188]; synaptic vesicle priming [GO:0016082] axon [GO:0030424]; calyx of Held [GO:0044305]; excitatory synapse [GO:0060076]; glutamatergic synapse [GO:0098978]; Golgi-associated vesicle [GO:0005798]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; presynaptic active zone [GO:0048786]; presynaptic membrane [GO:0042734]; protein-containing complex [GO:0032991]; synapse [GO:0045202]; synaptic membrane [GO:0097060]; synaptic vesicle membrane [GO:0030672]; terminal bouton [GO:0043195] calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; diacylglycerol binding [GO:0019992]; identical protein binding [GO:0042802]; phospholipid binding [GO:0005543]; protein domain specific binding [GO:0019904]; protein-containing complex binding [GO:0044877]; SNARE binding [GO:0000149]; spectrin binding [GO:0030507]; syntaxin binding [GO:0019905]; syntaxin-1 binding [GO:0017075]; zinc ion binding [GO:0008270] g8511.t3 Q4KUS2 77.519 129 3.12e-58 211.0 sp|Q4KUS2|UN13A_MOUSE Protein unc-13 homolog A OS=Mus musculus OX=10090 GN=Unc13a PE=1 SV=3 UN13A_MOUSE reviewed Protein unc-13 homolog A (Munc13-1) Mus musculus (Mouse) GO:0000149; GO:0001956; GO:0005509; GO:0005516; GO:0005543; GO:0005798; GO:0005886; GO:0007269; GO:0007528; GO:0008270; GO:0010807; GO:0016079; GO:0016081; GO:0016082; GO:0016188; GO:0017075; GO:0019904; GO:0019905; GO:0019992; GO:0030154; GO:0030424; GO:0030507; GO:0030672; GO:0031340; GO:0031594; GO:0031915; GO:0032991; GO:0035249; GO:0035493; GO:0042734; GO:0042802; GO:0043005; GO:0043195; GO:0044305; GO:0044877; GO:0045202; GO:0048172; GO:0048786; GO:0050435; GO:0060076; GO:0060291; GO:0060384; GO:0061789; GO:0097060; GO:0098793; GO:0098978; GO:0099011; GO:0150037; GO:1900451; GO:1902991; GO:1903861 amyloid-beta metabolic process [GO:0050435]; cell differentiation [GO:0030154]; dense core granule priming [GO:0061789]; innervation [GO:0060384]; long-term synaptic potentiation [GO:0060291]; neuromuscular junction development [GO:0007528]; neuronal dense core vesicle exocytosis [GO:0099011]; neurotransmitter secretion [GO:0007269]; positive regulation of dendrite extension [GO:1903861]; positive regulation of glutamate receptor signaling pathway [GO:1900451]; positive regulation of neurotransmitter secretion [GO:0001956]; positive regulation of synaptic plasticity [GO:0031915]; positive regulation of vesicle fusion [GO:0031340]; regulation of amyloid precursor protein catabolic process [GO:1902991]; regulation of calcium-dependent activation of synaptic vesicle fusion [GO:0150037]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; regulation of synaptic vesicle priming [GO:0010807]; SNARE complex assembly [GO:0035493]; synaptic transmission, glutamatergic [GO:0035249]; synaptic vesicle docking [GO:0016081]; synaptic vesicle exocytosis [GO:0016079]; synaptic vesicle maturation [GO:0016188]; synaptic vesicle priming [GO:0016082] axon [GO:0030424]; calyx of Held [GO:0044305]; excitatory synapse [GO:0060076]; glutamatergic synapse [GO:0098978]; Golgi-associated vesicle [GO:0005798]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; presynaptic active zone [GO:0048786]; presynaptic membrane [GO:0042734]; protein-containing complex [GO:0032991]; synapse [GO:0045202]; synaptic membrane [GO:0097060]; synaptic vesicle membrane [GO:0030672]; terminal bouton [GO:0043195] calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; diacylglycerol binding [GO:0019992]; identical protein binding [GO:0042802]; phospholipid binding [GO:0005543]; protein domain specific binding [GO:0019904]; protein-containing complex binding [GO:0044877]; SNARE binding [GO:0000149]; spectrin binding [GO:0030507]; syntaxin binding [GO:0019905]; syntaxin-1 binding [GO:0017075]; zinc ion binding [GO:0008270] g8511.t3 Q4KUS2 83.333 18 3.12e-58 38.1 sp|Q4KUS2|UN13A_MOUSE Protein unc-13 homolog A OS=Mus musculus OX=10090 GN=Unc13a PE=1 SV=3 UN13A_MOUSE reviewed Protein unc-13 homolog A (Munc13-1) Mus musculus (Mouse) GO:0000149; GO:0001956; GO:0005509; GO:0005516; GO:0005543; GO:0005798; GO:0005886; GO:0007269; GO:0007528; GO:0008270; GO:0010807; GO:0016079; GO:0016081; GO:0016082; GO:0016188; GO:0017075; GO:0019904; GO:0019905; GO:0019992; GO:0030154; GO:0030424; GO:0030507; GO:0030672; GO:0031340; GO:0031594; GO:0031915; GO:0032991; GO:0035249; GO:0035493; GO:0042734; GO:0042802; GO:0043005; GO:0043195; GO:0044305; GO:0044877; GO:0045202; GO:0048172; GO:0048786; GO:0050435; GO:0060076; GO:0060291; GO:0060384; GO:0061789; GO:0097060; GO:0098793; GO:0098978; GO:0099011; GO:0150037; GO:1900451; GO:1902991; GO:1903861 amyloid-beta metabolic process [GO:0050435]; cell differentiation [GO:0030154]; dense core granule priming [GO:0061789]; innervation [GO:0060384]; long-term synaptic potentiation [GO:0060291]; neuromuscular junction development [GO:0007528]; neuronal dense core vesicle exocytosis [GO:0099011]; neurotransmitter secretion [GO:0007269]; positive regulation of dendrite extension [GO:1903861]; positive regulation of glutamate receptor signaling pathway [GO:1900451]; positive regulation of neurotransmitter secretion [GO:0001956]; positive regulation of synaptic plasticity [GO:0031915]; positive regulation of vesicle fusion [GO:0031340]; regulation of amyloid precursor protein catabolic process [GO:1902991]; regulation of calcium-dependent activation of synaptic vesicle fusion [GO:0150037]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; regulation of synaptic vesicle priming [GO:0010807]; SNARE complex assembly [GO:0035493]; synaptic transmission, glutamatergic [GO:0035249]; synaptic vesicle docking [GO:0016081]; synaptic vesicle exocytosis [GO:0016079]; synaptic vesicle maturation [GO:0016188]; synaptic vesicle priming [GO:0016082] axon [GO:0030424]; calyx of Held [GO:0044305]; excitatory synapse [GO:0060076]; glutamatergic synapse [GO:0098978]; Golgi-associated vesicle [GO:0005798]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; presynaptic active zone [GO:0048786]; presynaptic membrane [GO:0042734]; protein-containing complex [GO:0032991]; synapse [GO:0045202]; synaptic membrane [GO:0097060]; synaptic vesicle membrane [GO:0030672]; terminal bouton [GO:0043195] calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; diacylglycerol binding [GO:0019992]; identical protein binding [GO:0042802]; phospholipid binding [GO:0005543]; protein domain specific binding [GO:0019904]; protein-containing complex binding [GO:0044877]; SNARE binding [GO:0000149]; spectrin binding [GO:0030507]; syntaxin binding [GO:0019905]; syntaxin-1 binding [GO:0017075]; zinc ion binding [GO:0008270] g8511.t3 Q4KUS2 57.216 194 1.7299999999999998e-54 206.0 sp|Q4KUS2|UN13A_MOUSE Protein unc-13 homolog A OS=Mus musculus OX=10090 GN=Unc13a PE=1 SV=3 UN13A_MOUSE reviewed Protein unc-13 homolog A (Munc13-1) Mus musculus (Mouse) GO:0000149; GO:0001956; GO:0005509; GO:0005516; GO:0005543; GO:0005798; GO:0005886; GO:0007269; GO:0007528; GO:0008270; GO:0010807; GO:0016079; GO:0016081; GO:0016082; GO:0016188; GO:0017075; GO:0019904; GO:0019905; GO:0019992; GO:0030154; GO:0030424; GO:0030507; GO:0030672; GO:0031340; GO:0031594; GO:0031915; GO:0032991; GO:0035249; GO:0035493; GO:0042734; GO:0042802; GO:0043005; GO:0043195; GO:0044305; GO:0044877; GO:0045202; GO:0048172; GO:0048786; GO:0050435; GO:0060076; GO:0060291; GO:0060384; GO:0061789; GO:0097060; GO:0098793; GO:0098978; GO:0099011; GO:0150037; GO:1900451; GO:1902991; GO:1903861 amyloid-beta metabolic process [GO:0050435]; cell differentiation [GO:0030154]; dense core granule priming [GO:0061789]; innervation [GO:0060384]; long-term synaptic potentiation [GO:0060291]; neuromuscular junction development [GO:0007528]; neuronal dense core vesicle exocytosis [GO:0099011]; neurotransmitter secretion [GO:0007269]; positive regulation of dendrite extension [GO:1903861]; positive regulation of glutamate receptor signaling pathway [GO:1900451]; positive regulation of neurotransmitter secretion [GO:0001956]; positive regulation of synaptic plasticity [GO:0031915]; positive regulation of vesicle fusion [GO:0031340]; regulation of amyloid precursor protein catabolic process [GO:1902991]; regulation of calcium-dependent activation of synaptic vesicle fusion [GO:0150037]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; regulation of synaptic vesicle priming [GO:0010807]; SNARE complex assembly [GO:0035493]; synaptic transmission, glutamatergic [GO:0035249]; synaptic vesicle docking [GO:0016081]; synaptic vesicle exocytosis [GO:0016079]; synaptic vesicle maturation [GO:0016188]; synaptic vesicle priming [GO:0016082] axon [GO:0030424]; calyx of Held [GO:0044305]; excitatory synapse [GO:0060076]; glutamatergic synapse [GO:0098978]; Golgi-associated vesicle [GO:0005798]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; presynaptic active zone [GO:0048786]; presynaptic membrane [GO:0042734]; protein-containing complex [GO:0032991]; synapse [GO:0045202]; synaptic membrane [GO:0097060]; synaptic vesicle membrane [GO:0030672]; terminal bouton [GO:0043195] calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; diacylglycerol binding [GO:0019992]; identical protein binding [GO:0042802]; phospholipid binding [GO:0005543]; protein domain specific binding [GO:0019904]; protein-containing complex binding [GO:0044877]; SNARE binding [GO:0000149]; spectrin binding [GO:0030507]; syntaxin binding [GO:0019905]; syntaxin-1 binding [GO:0017075]; zinc ion binding [GO:0008270] g8512.t1 O14795 67.188 896 0.0 1200.0 sp|O14795|UN13B_HUMAN Protein unc-13 homolog B OS=Homo sapiens OX=9606 GN=UNC13B PE=1 SV=2 UN13B_HUMAN reviewed Protein unc-13 homolog B (Munc13-2) (munc13) Homo sapiens (Human) GO:0005509; GO:0005516; GO:0005543; GO:0005794; GO:0005829; GO:0005886; GO:0007268; GO:0008270; GO:0010808; GO:0016020; GO:0016081; GO:0016082; GO:0017075; GO:0019992; GO:0030672; GO:0030742; GO:0031267; GO:0031594; GO:0035249; GO:0042734; GO:0043065; GO:0043195; GO:0048786; GO:0050714; GO:0060478; GO:0061789; GO:0071333; GO:0097151; GO:0099011 acrosomal vesicle exocytosis [GO:0060478]; cellular response to glucose stimulus [GO:0071333]; chemical synaptic transmission [GO:0007268]; dense core granule priming [GO:0061789]; neuronal dense core vesicle exocytosis [GO:0099011]; positive regulation of apoptotic process [GO:0043065]; positive regulation of inhibitory postsynaptic potential [GO:0097151]; positive regulation of protein secretion [GO:0050714]; positive regulation of synaptic vesicle priming [GO:0010808]; synaptic transmission, glutamatergic [GO:0035249]; synaptic vesicle docking [GO:0016081]; synaptic vesicle priming [GO:0016082] cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; neuromuscular junction [GO:0031594]; plasma membrane [GO:0005886]; presynaptic active zone [GO:0048786]; presynaptic membrane [GO:0042734]; synaptic vesicle membrane [GO:0030672]; terminal bouton [GO:0043195] calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; diacylglycerol binding [GO:0019992]; GTP-dependent protein binding [GO:0030742]; phospholipid binding [GO:0005543]; small GTPase binding [GO:0031267]; syntaxin-1 binding [GO:0017075]; zinc ion binding [GO:0008270] g8512.t2 Q9Z1N9 67.481 901 0.0 1209.0 sp|Q9Z1N9|UN13B_MOUSE Protein unc-13 homolog B OS=Mus musculus OX=10090 GN=Unc13b PE=1 SV=2 g8513.t1 Q5U550 57.143 98 1.73e-37 124.0 sp|Q5U550|DDA1_XENLA DET1- and DDB1-associated protein 1 OS=Xenopus laevis OX=8355 GN=dda1 PE=3 SV=1 g8515.t1 Q8R0P8 47.561 164 1.09e-47 169.0 sp|Q8R0P8|ABHD8_MOUSE Protein ABHD8 OS=Mus musculus OX=10090 GN=Abhd8 PE=2 SV=1 g8516.t1 Q40784 41.199 267 5.04e-66 212.0 sp|Q40784|AAPC_CENCI Putative glucose-6-phosphate 1-epimerase OS=Cenchrus ciliaris OX=35872 PE=2 SV=1 g8517.t1 Q9BX70 80.324 432 0.0 744.0 sp|Q9BX70|BTBD2_HUMAN BTB/POZ domain-containing protein 2 OS=Homo sapiens OX=9606 GN=BTBD2 PE=1 SV=1 BTBD2_HUMAN reviewed BTB/POZ domain-containing protein 2 Homo sapiens (Human) GO:0000932; GO:0005829; GO:0022008 neurogenesis [GO:0022008] cytosol [GO:0005829]; P-body [GO:0000932] g8518.t1 Q9BX70 80.328 122 1.41e-63 213.0 sp|Q9BX70|BTBD2_HUMAN BTB/POZ domain-containing protein 2 OS=Homo sapiens OX=9606 GN=BTBD2 PE=1 SV=1 BTBD2_HUMAN reviewed BTB/POZ domain-containing protein 2 Homo sapiens (Human) GO:0000932; GO:0005829; GO:0022008 neurogenesis [GO:0022008] cytosol [GO:0005829]; P-body [GO:0000932] g8519.t1 E9Q9W4 41.776 608 7.85e-148 443.0 sp|E9Q9W4|S27A6_MOUSE Long-chain fatty acid transport protein 6 OS=Mus musculus OX=10090 GN=Slc27a6 PE=1 SV=1 S27A6_MOUSE reviewed Long-chain fatty acid transport protein 6 (FATP-6) (Fatty acid transport protein 6) (Arachidonate--CoA ligase) (EC 6.2.1.15) (Fatty-acid-coenzyme A ligase, very long-chain 2) (Long-chain-fatty-acid--CoA ligase) (EC 6.2.1.3) (Solute carrier family 27 member 6) (Very long-chain acyl-CoA synthetase homolog 1) (VLACS2) (VLCSH1) (mVLCS-H1) (EC 6.2.1.-) Mus musculus (Mouse) GO:0000166; GO:0001676; GO:0004467; GO:0005324; GO:0005783; GO:0005789; GO:0005886; GO:0031957; GO:0042383; GO:0044539; GO:0047676 long-chain fatty acid import into cell [GO:0044539]; long-chain fatty acid metabolic process [GO:0001676] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383] arachidonate-CoA ligase activity [GO:0047676]; long-chain fatty acid transmembrane transporter activity [GO:0005324]; long-chain fatty acid-CoA ligase activity [GO:0004467]; nucleotide binding [GO:0000166]; very long-chain fatty acid-CoA ligase activity [GO:0031957] g8520.t1 O35465 44.964 278 6.01e-78 252.0 sp|O35465|FKBP8_MOUSE Peptidyl-prolyl cis-trans isomerase FKBP8 OS=Mus musculus OX=10090 GN=Fkbp8 PE=1 SV=2 g8522.t1 G1TU13 90.517 116 1.01e-73 218.0 sp|G1TU13|RS17_RABIT Small ribosomal subunit protein eS17 OS=Oryctolagus cuniculus OX=9986 GN=RPS17 PE=1 SV=1 g8524.t1 Q2KHZ8 39.548 177 1.8099999999999998e-34 131.0 sp|Q2KHZ8|GBA1_BOVIN Lysosomal acid glucosylceramidase OS=Bos taurus OX=9913 GN=GBA1 PE=2 SV=1 GBA1_BOVIN reviewed Lysosomal acid glucosylceramidase (EC 3.2.1.45) (Acid beta-glucosidase) (Beta-glucocerebrosidase) (Cholesterol glucosyltransferase) (SGTase) (EC 2.4.1.-) (Cholesteryl-beta-glucosidase) (EC 3.2.1.-) (D-glucosyl-N-acylsphingosine glucohydrolase) (Lysosomal cholesterol glycosyltransferase) (Lysosomal galactosylceramidase) (EC 3.2.1.46) (Lysosomal glycosylceramidase) Bos taurus (Bovine) GO:0004336; GO:0004348; GO:0005102; GO:0005764; GO:0005765; GO:0005783; GO:0005794; GO:0005802; GO:0006680; GO:0006914; GO:0007040; GO:0008203; GO:0009247; GO:0010605; GO:0016241; GO:0030163; GO:0032006; GO:0042176; GO:0042391; GO:0046527; GO:0050295 autophagy [GO:0006914]; cholesterol metabolic process [GO:0008203]; glucosylceramide catabolic process [GO:0006680]; glycolipid biosynthetic process [GO:0009247]; lysosome organization [GO:0007040]; negative regulation of macromolecule metabolic process [GO:0010605]; protein catabolic process [GO:0030163]; regulation of macroautophagy [GO:0016241]; regulation of membrane potential [GO:0042391]; regulation of protein catabolic process [GO:0042176]; regulation of TOR signaling [GO:0032006] endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; trans-Golgi network [GO:0005802] galactosylceramidase activity [GO:0004336]; glucosylceramidase activity [GO:0004348]; glucosyltransferase activity [GO:0046527]; signaling receptor binding [GO:0005102]; steryl-beta-glucosidase activity [GO:0050295] g8525.t1 P17439 53.871 310 1.5999999999999999e-114 343.0 sp|P17439|GBA1_MOUSE Lysosomal acid glucosylceramidase OS=Mus musculus OX=10090 GN=Gba1 PE=1 SV=1 GBA1_MOUSE reviewed Lysosomal acid glucosylceramidase (Lysosomal acid GCase) (EC 3.2.1.45) (Acid beta-glucosidase) (Beta-glucocerebrosidase) (Cholesterol glucosyltransferase) (SGTase) (EC 2.4.1.-) (Cholesteryl-beta-glucosidase) (EC 3.2.1.-) (D-glucosyl-N-acylsphingosine glucohydrolase) (Lysosomal cholesterol glycosyltransferase) (Lysosomal galactosylceramidase) (EC 3.2.1.46) (Lysosomal glycosylceramidase) Mus musculus (Mouse) GO:0000423; GO:0004336; GO:0004348; GO:0005102; GO:0005124; GO:0005615; GO:0005764; GO:0005765; GO:0005783; GO:0005794; GO:0005802; GO:0006678; GO:0006680; GO:0006914; GO:0007005; GO:0007040; GO:0007417; GO:0008203; GO:0008340; GO:0008422; GO:0009247; GO:0009267; GO:0009268; GO:0014004; GO:0016787; GO:0019882; GO:0019915; GO:0021694; GO:0021859; GO:0022904; GO:0023021; GO:0031333; GO:0032006; GO:0032436; GO:0032715; GO:0033077; GO:0033574; GO:0042391; GO:0043161; GO:0043202; GO:0043409; GO:0043524; GO:0043627; GO:0046512; GO:0046513; GO:0046527; GO:0048469; GO:0048854; GO:0048872; GO:0050295; GO:0050728; GO:0050877; GO:0050905; GO:0051246; GO:0051248; GO:0051402; GO:0061436; GO:0061518; GO:0061744; GO:0071356; GO:0071425; GO:0071548; GO:0072676; GO:0097066; GO:0098773; GO:1901805; GO:1903052; GO:1904457; GO:1905037; GO:1905091; GO:1905146 antigen processing and presentation [GO:0019882]; autophagosome organization [GO:1905037]; autophagy [GO:0006914]; beta-glucoside catabolic process [GO:1901805]; brain morphogenesis [GO:0048854]; cell maturation [GO:0048469]; cellular response to starvation [GO:0009267]; cellular response to tumor necrosis factor [GO:0071356]; central nervous system development [GO:0007417]; ceramide biosynthetic process [GO:0046513]; cerebellar Purkinje cell layer formation [GO:0021694]; cholesterol metabolic process [GO:0008203]; determination of adult lifespan [GO:0008340]; establishment of skin barrier [GO:0061436]; glucosylceramide catabolic process [GO:0006680]; glucosylceramide metabolic process [GO:0006678]; glycolipid biosynthetic process [GO:0009247]; hematopoietic stem cell proliferation [GO:0071425]; homeostasis of number of cells [GO:0048872]; lipid storage [GO:0019915]; lymphocyte migration [GO:0072676]; lysosomal protein catabolic process [GO:1905146]; lysosome organization [GO:0007040]; microglia differentiation [GO:0014004]; microglial cell proliferation [GO:0061518]; mitochondrion organization [GO:0007005]; mitophagy [GO:0000423]; motor behavior [GO:0061744]; negative regulation of inflammatory response [GO:0050728]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of protein metabolic process [GO:0051248]; negative regulation of protein-containing complex assembly [GO:0031333]; nervous system process [GO:0050877]; neuromuscular process [GO:0050905]; neuron apoptotic process [GO:0051402]; positive regulation of neuronal action potential [GO:1904457]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of proteolysis involved in protein catabolic process [GO:1903052]; positive regulation of type 2 mitophagy [GO:1905091]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; pyramidal neuron differentiation [GO:0021859]; regulation of membrane potential [GO:0042391]; regulation of protein metabolic process [GO:0051246]; regulation of TOR signaling [GO:0032006]; respiratory electron transport chain [GO:0022904]; response to dexamethasone [GO:0071548]; response to estrogen [GO:0043627]; response to pH [GO:0009268]; response to testosterone [GO:0033574]; response to thyroid hormone [GO:0097066]; skin epidermis development [GO:0098773]; sphingosine biosynthetic process [GO:0046512]; T cell differentiation in thymus [GO:0033077]; termination of signal transduction [GO:0023021] endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; trans-Golgi network [GO:0005802] beta-glucosidase activity [GO:0008422]; galactosylceramidase activity [GO:0004336]; glucosylceramidase activity [GO:0004348]; glucosyltransferase activity [GO:0046527]; hydrolase activity [GO:0016787]; scavenger receptor binding [GO:0005124]; signaling receptor binding [GO:0005102]; steryl-beta-glucosidase activity [GO:0050295] g8526.t1 Q7ZYC4 55.474 685 0.0 795.0 sp|Q7ZYC4|ACBG2_XENLA Long-chain-fatty-acid--CoA ligase ACSBG2 OS=Xenopus laevis OX=8355 GN=acsbg2 PE=2 SV=1 g8526.t2 Q7ZYC4 56.353 669 0.0 800.0 sp|Q7ZYC4|ACBG2_XENLA Long-chain-fatty-acid--CoA ligase ACSBG2 OS=Xenopus laevis OX=8355 GN=acsbg2 PE=2 SV=1 g8529.t1 Q06441 48.687 914 0.0 719.0 sp|Q06441|TSP4_XENLA Thrombospondin-4 OS=Xenopus laevis OX=8355 GN=thbs4 PE=2 SV=1 g8532.t1 Q6TXF1 31.692 325 2.74e-41 153.0 sp|Q6TXF1|ARRD3_RAT Arrestin domain-containing protein 3 OS=Rattus norvegicus OX=10116 GN=Arrdc3 PE=2 SV=1 g8534.t1 Q8TEY5 43.885 278 4.9e-45 164.0 sp|Q8TEY5|CR3L4_HUMAN Cyclic AMP-responsive element-binding protein 3-like protein 4 OS=Homo sapiens OX=9606 GN=CREB3L4 PE=1 SV=1 CR3L4_HUMAN reviewed Cyclic AMP-responsive element-binding protein 3-like protein 4 (cAMP-responsive element-binding protein 3-like protein 4) (Androgen-induced basic leucine zipper protein) (AIbZIP) (Attaching to CRE-like 1) (ATCE1) (Cyclic AMP-responsive element-binding protein 4) (CREB-4) (cAMP-responsive element-binding protein 4) (Transcript induced in spermiogenesis protein 40) (Tisp40) (hJAL) [Cleaved into: Processed cyclic AMP-responsive element-binding protein 3-like protein 4] Homo sapiens (Human) GO:0000139; GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0005634; GO:0005654; GO:0005739; GO:0005783; GO:0005789; GO:0005794; GO:0006357; GO:0006986; GO:0007283; GO:0031965; GO:0045944; GO:1990837 positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; response to unfolded protein [GO:0006986]; spermatogenesis [GO:0007283] chromatin [GO:0000785]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; mitochondrion [GO:0005739]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837] g8535.t1 O95478 81.923 260 3.42e-162 452.0 sp|O95478|NSA2_HUMAN Ribosome biogenesis protein NSA2 homolog OS=Homo sapiens OX=9606 GN=NSA2 PE=1 SV=1 g8536.t1 Q3T8J9 31.722 331 3.68e-40 167.0 sp|Q3T8J9|GON4L_HUMAN GON-4-like protein OS=Homo sapiens OX=9606 GN=GON4L PE=1 SV=1 GON4L_HUMAN reviewed GON-4-like protein (GON-4 homolog) (Yin Yang 1-associated-related protein) Homo sapiens (Human) GO:0003712; GO:0005634; GO:0005654; GO:0006355; GO:0016604 regulation of DNA-templated transcription [GO:0006355] nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] transcription coregulator activity [GO:0003712] g8538.t1 Q28DG6 35.217 230 8.22e-27 109.0 sp|Q28DG6|LYSM3_XENTR LysM and putative peptidoglycan-binding domain-containing protein 3 OS=Xenopus tropicalis OX=8364 GN=lysmd3 PE=2 SV=1 g8540.t1 Q49SH1 40.355 451 1.2600000000000002e-103 324.0 sp|Q49SH1|NCKX5_DANRE Sodium/potassium/calcium exchanger 5 OS=Danio rerio OX=7955 GN=slc24a5 PE=2 SV=1 NCKX5_DANRE reviewed Sodium/potassium/calcium exchanger 5 (Na(+)/K(+)/Ca(2+)-exchange protein 5) (Protein golden) (Solute carrier family 24 member 5) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005262; GO:0005802; GO:0006874; GO:0008273; GO:0015293; GO:0016020; GO:0030318; GO:0042470; GO:0043473; GO:0048066; GO:0048069; GO:0070588; GO:0097324 calcium ion transmembrane transport [GO:0070588]; developmental pigmentation [GO:0048066]; eye pigmentation [GO:0048069]; intracellular calcium ion homeostasis [GO:0006874]; melanocyte differentiation [GO:0030318]; melanocyte migration [GO:0097324]; pigmentation [GO:0043473] melanosome [GO:0042470]; membrane [GO:0016020]; trans-Golgi network [GO:0005802] calcium channel activity [GO:0005262]; calcium, potassium:sodium antiporter activity [GO:0008273]; symporter activity [GO:0015293] g8543.t1 Q7Z6M2 26.622 447 4.6100000000000005e-32 132.0 sp|Q7Z6M2|FBX33_HUMAN F-box only protein 33 OS=Homo sapiens OX=9606 GN=FBXO33 PE=1 SV=1 g8544.t1 Q68ED7 49.049 263 6.66e-55 201.0 sp|Q68ED7|CRTC1_MOUSE CREB-regulated transcription coactivator 1 OS=Mus musculus OX=10090 GN=Crtc1 PE=1 SV=1 CRTC1_MOUSE reviewed CREB-regulated transcription coactivator 1 (Mucoepidermoid carcinoma translocated protein 1 homolog) (Transducer of regulated cAMP response element-binding protein 1) (TORC-1) (Transducer of CREB protein 1) Mus musculus (Mouse) GO:0003713; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0007613; GO:0008140; GO:0014069; GO:0016604; GO:0030425; GO:0032793; GO:0043025; GO:0043153; GO:0045944; GO:0048511; GO:0051289; GO:0071320; GO:0097009; GO:0098978; GO:0099527; GO:1900006; GO:1900273; GO:1902631 cellular response to cAMP [GO:0071320]; energy homeostasis [GO:0097009]; entrainment of circadian clock by photoperiod [GO:0043153]; memory [GO:0007613]; negative regulation of membrane hyperpolarization [GO:1902631]; positive regulation of CREB transcription factor activity [GO:0032793]; positive regulation of dendrite development [GO:1900006]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of transcription by RNA polymerase II [GO:0045944]; postsynapse to nucleus signaling pathway [GO:0099527]; protein homotetramerization [GO:0051289]; rhythmic process [GO:0048511] cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; neuronal cell body [GO:0043025]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069] cAMP response element binding protein binding [GO:0008140]; transcription coactivator activity [GO:0003713] g8546.t1 P46940 55.699 386 8.56e-112 361.0 sp|P46940|IQGA1_HUMAN Ras GTPase-activating-like protein IQGAP1 OS=Homo sapiens OX=9606 GN=IQGAP1 PE=1 SV=1 IQGA1_HUMAN reviewed Ras GTPase-activating-like protein IQGAP1 (p195) Homo sapiens (Human) GO:0001726; GO:0001817; GO:0005078; GO:0005095; GO:0005096; GO:0005509; GO:0005516; GO:0005547; GO:0005634; GO:0005737; GO:0005829; GO:0005874; GO:0005884; GO:0005886; GO:0005925; GO:0005938; GO:0007165; GO:0007173; GO:0007346; GO:0008543; GO:0009898; GO:0010761; GO:0016323; GO:0016324; GO:0016328; GO:0016477; GO:0019901; GO:0019903; GO:0019904; GO:0030424; GO:0030426; GO:0030496; GO:0030667; GO:0030864; GO:0031267; GO:0032956; GO:0035305; GO:0036057; GO:0036120; GO:0036464; GO:0043005; GO:0043410; GO:0043539; GO:0044548; GO:0045296; GO:0048008; GO:0051015; GO:0060090; GO:0070062; GO:0070836; GO:0071277; GO:0071364; GO:0072015; GO:1903479; GO:1990904 caveola assembly [GO:0070836]; cell migration [GO:0016477]; cellular response to calcium ion [GO:0071277]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; epidermal growth factor receptor signaling pathway [GO:0007173]; fibroblast growth factor receptor signaling pathway [GO:0008543]; fibroblast migration [GO:0010761]; mitotic actomyosin contractile ring assembly actin filament organization [GO:1903479]; negative regulation of dephosphorylation [GO:0035305]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; podocyte development [GO:0072015]; positive regulation of MAPK cascade [GO:0043410]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cytokine production [GO:0001817]; regulation of mitotic cell cycle [GO:0007346]; signal transduction [GO:0007165] actin filament [GO:0005884]; apical plasma membrane [GO:0016324]; axon [GO:0030424]; basolateral plasma membrane [GO:0016323]; cell cortex [GO:0005938]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; growth cone [GO:0030426]; lateral plasma membrane [GO:0016328]; microtubule [GO:0005874]; midbody [GO:0030496]; neuron projection [GO:0043005]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ribonucleoprotein complex [GO:1990904]; ruffle [GO:0001726]; secretory granule membrane [GO:0030667]; slit diaphragm [GO:0036057] actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; GTPase activator activity [GO:0005096]; GTPase inhibitor activity [GO:0005095]; MAP-kinase scaffold activity [GO:0005078]; molecular adaptor activity [GO:0060090]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; protein phosphatase binding [GO:0019903]; protein serine/threonine kinase activator activity [GO:0043539]; S100 protein binding [GO:0044548]; small GTPase binding [GO:0031267] g8547.t1 P46940 50.196 1275 0.0 1170.0 sp|P46940|IQGA1_HUMAN Ras GTPase-activating-like protein IQGAP1 OS=Homo sapiens OX=9606 GN=IQGAP1 PE=1 SV=1 IQGA1_HUMAN reviewed Ras GTPase-activating-like protein IQGAP1 (p195) Homo sapiens (Human) GO:0001726; GO:0001817; GO:0005078; GO:0005095; GO:0005096; GO:0005509; GO:0005516; GO:0005547; GO:0005634; GO:0005737; GO:0005829; GO:0005874; GO:0005884; GO:0005886; GO:0005925; GO:0005938; GO:0007165; GO:0007173; GO:0007346; GO:0008543; GO:0009898; GO:0010761; GO:0016323; GO:0016324; GO:0016328; GO:0016477; GO:0019901; GO:0019903; GO:0019904; GO:0030424; GO:0030426; GO:0030496; GO:0030667; GO:0030864; GO:0031267; GO:0032956; GO:0035305; GO:0036057; GO:0036120; GO:0036464; GO:0043005; GO:0043410; GO:0043539; GO:0044548; GO:0045296; GO:0048008; GO:0051015; GO:0060090; GO:0070062; GO:0070836; GO:0071277; GO:0071364; GO:0072015; GO:1903479; GO:1990904 caveola assembly [GO:0070836]; cell migration [GO:0016477]; cellular response to calcium ion [GO:0071277]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; epidermal growth factor receptor signaling pathway [GO:0007173]; fibroblast growth factor receptor signaling pathway [GO:0008543]; fibroblast migration [GO:0010761]; mitotic actomyosin contractile ring assembly actin filament organization [GO:1903479]; negative regulation of dephosphorylation [GO:0035305]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; podocyte development [GO:0072015]; positive regulation of MAPK cascade [GO:0043410]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cytokine production [GO:0001817]; regulation of mitotic cell cycle [GO:0007346]; signal transduction [GO:0007165] actin filament [GO:0005884]; apical plasma membrane [GO:0016324]; axon [GO:0030424]; basolateral plasma membrane [GO:0016323]; cell cortex [GO:0005938]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; growth cone [GO:0030426]; lateral plasma membrane [GO:0016328]; microtubule [GO:0005874]; midbody [GO:0030496]; neuron projection [GO:0043005]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ribonucleoprotein complex [GO:1990904]; ruffle [GO:0001726]; secretory granule membrane [GO:0030667]; slit diaphragm [GO:0036057] actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; GTPase activator activity [GO:0005096]; GTPase inhibitor activity [GO:0005095]; MAP-kinase scaffold activity [GO:0005078]; molecular adaptor activity [GO:0060090]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; protein phosphatase binding [GO:0019903]; protein serine/threonine kinase activator activity [GO:0043539]; S100 protein binding [GO:0044548]; small GTPase binding [GO:0031267] g8549.t1 Q501Z5 51.807 498 4.0899999999999997e-165 483.0 sp|Q501Z5|GTPB3_DANRE 5-taurinomethyluridine-[tRNA] synthase subunit GTPB3, mitochondrial OS=Danio rerio OX=7955 GN=gtpbp3 PE=2 SV=1 GTPB3_DANRE reviewed 5-taurinomethyluridine-[tRNA] synthase subunit GTPB3, mitochondrial (EC 3.6.1.-) (GTP-binding protein 3) (tRNA modification GTPase GTPBP3, mitochondrial) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0002098; GO:0003924; GO:0005525; GO:0005737; GO:0005739; GO:0030488; GO:0036416; GO:0046872; GO:0048568; GO:0070143; GO:0070153; GO:0070154; GO:0070155; GO:0070183; GO:0070184; GO:0070899; GO:0070900 embryonic organ development [GO:0048568]; mitochondrial alanyl-tRNA aminoacylation [GO:0070143]; mitochondrial leucyl-tRNA aminoacylation [GO:0070153]; mitochondrial lysyl-tRNA aminoacylation [GO:0070154]; mitochondrial methionyl-tRNA aminoacylation [GO:0070155]; mitochondrial tRNA modification [GO:0070900]; mitochondrial tRNA wobble uridine modification [GO:0070899]; mitochondrial tryptophanyl-tRNA aminoacylation [GO:0070183]; mitochondrial tyrosyl-tRNA aminoacylation [GO:0070184]; tRNA methylation [GO:0030488]; tRNA stabilization [GO:0036416]; tRNA wobble uridine modification [GO:0002098] cytoplasm [GO:0005737]; mitochondrion [GO:0005739] GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872] g8550.t1 Q61555 44.925 2749 0.0 2142.0 sp|Q61555|FBN2_MOUSE Fibrillin-2 OS=Mus musculus OX=10090 GN=Fbn2 PE=1 SV=2 FBN2_MOUSE reviewed Fibrillin-2 [Cleaved into: Placensin] Mus musculus (Mouse) GO:0001527; GO:0001890; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0005615; GO:0006006; GO:0030326; GO:0030501; GO:0031012; GO:0035108; GO:0035583; GO:0042593; GO:0043010; GO:0045669; GO:0048048; GO:0060346; GO:1901163 bone trabecula formation [GO:0060346]; camera-type eye development [GO:0043010]; embryonic eye morphogenesis [GO:0048048]; embryonic limb morphogenesis [GO:0030326]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; limb morphogenesis [GO:0035108]; placenta development [GO:0001890]; positive regulation of bone mineralization [GO:0030501]; positive regulation of osteoblast differentiation [GO:0045669]; regulation of trophoblast cell migration [GO:1901163]; sequestering of TGFbeta in extracellular matrix [GO:0035583] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; microfibril [GO:0001527] calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; hormone activity [GO:0005179] g8550.t1 Q61555 32.453 1932 0.0 763.0 sp|Q61555|FBN2_MOUSE Fibrillin-2 OS=Mus musculus OX=10090 GN=Fbn2 PE=1 SV=2 FBN2_MOUSE reviewed Fibrillin-2 [Cleaved into: Placensin] Mus musculus (Mouse) GO:0001527; GO:0001890; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0005615; GO:0006006; GO:0030326; GO:0030501; GO:0031012; GO:0035108; GO:0035583; GO:0042593; GO:0043010; GO:0045669; GO:0048048; GO:0060346; GO:1901163 bone trabecula formation [GO:0060346]; camera-type eye development [GO:0043010]; embryonic eye morphogenesis [GO:0048048]; embryonic limb morphogenesis [GO:0030326]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; limb morphogenesis [GO:0035108]; placenta development [GO:0001890]; positive regulation of bone mineralization [GO:0030501]; positive regulation of osteoblast differentiation [GO:0045669]; regulation of trophoblast cell migration [GO:1901163]; sequestering of TGFbeta in extracellular matrix [GO:0035583] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; microfibril [GO:0001527] calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; hormone activity [GO:0005179] g8550.t1 Q61555 29.393 1599 4.64e-118 425.0 sp|Q61555|FBN2_MOUSE Fibrillin-2 OS=Mus musculus OX=10090 GN=Fbn2 PE=1 SV=2 FBN2_MOUSE reviewed Fibrillin-2 [Cleaved into: Placensin] Mus musculus (Mouse) GO:0001527; GO:0001890; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0005615; GO:0006006; GO:0030326; GO:0030501; GO:0031012; GO:0035108; GO:0035583; GO:0042593; GO:0043010; GO:0045669; GO:0048048; GO:0060346; GO:1901163 bone trabecula formation [GO:0060346]; camera-type eye development [GO:0043010]; embryonic eye morphogenesis [GO:0048048]; embryonic limb morphogenesis [GO:0030326]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; limb morphogenesis [GO:0035108]; placenta development [GO:0001890]; positive regulation of bone mineralization [GO:0030501]; positive regulation of osteoblast differentiation [GO:0045669]; regulation of trophoblast cell migration [GO:1901163]; sequestering of TGFbeta in extracellular matrix [GO:0035583] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; microfibril [GO:0001527] calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; hormone activity [GO:0005179] g8551.t1 P62976 99.476 382 0.0 752.0 sp|P62976|UBIQP_CRIGR Polyubiquitin OS=Cricetulus griseus OX=10029 PE=2 SV=2 g8551.t1 P62976 99.476 382 0.0 752.0 sp|P62976|UBIQP_CRIGR Polyubiquitin OS=Cricetulus griseus OX=10029 PE=2 SV=2 g8551.t1 P62976 99.476 382 0.0 752.0 sp|P62976|UBIQP_CRIGR Polyubiquitin OS=Cricetulus griseus OX=10029 PE=2 SV=2 g8551.t1 P62976 99.215 382 0.0 750.0 sp|P62976|UBIQP_CRIGR Polyubiquitin OS=Cricetulus griseus OX=10029 PE=2 SV=2 g8551.t1 P62976 98.187 331 0.0 642.0 sp|P62976|UBIQP_CRIGR Polyubiquitin OS=Cricetulus griseus OX=10029 PE=2 SV=2 g8552.t1 P0CG50 98.653 297 0.0 580.0 sp|P0CG50|UBC_MOUSE Polyubiquitin-C OS=Mus musculus OX=10090 GN=Ubc PE=1 SV=2 UBC_MOUSE reviewed Polyubiquitin-C [Cleaved into: Ubiquitin; Ubiquitin-related 1; Ubiquitin-related 2] Mus musculus (Mouse) GO:0005634; GO:0005654; GO:0005737; GO:0005741; GO:0005829; GO:0016567; GO:0019941; GO:0031386; GO:0031625; GO:0043209 modification-dependent protein catabolic process [GO:0019941]; protein ubiquitination [GO:0016567] cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial outer membrane [GO:0005741]; myelin sheath [GO:0043209]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] protein tag activity [GO:0031386]; ubiquitin protein ligase binding [GO:0031625] g8552.t1 P0CG50 98.653 297 0.0 580.0 sp|P0CG50|UBC_MOUSE Polyubiquitin-C OS=Mus musculus OX=10090 GN=Ubc PE=1 SV=2 UBC_MOUSE reviewed Polyubiquitin-C [Cleaved into: Ubiquitin; Ubiquitin-related 1; Ubiquitin-related 2] Mus musculus (Mouse) GO:0005634; GO:0005654; GO:0005737; GO:0005741; GO:0005829; GO:0016567; GO:0019941; GO:0031386; GO:0031625; GO:0043209 modification-dependent protein catabolic process [GO:0019941]; protein ubiquitination [GO:0016567] cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial outer membrane [GO:0005741]; myelin sheath [GO:0043209]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] protein tag activity [GO:0031386]; ubiquitin protein ligase binding [GO:0031625] g8552.t1 P0CG50 98.653 297 0.0 580.0 sp|P0CG50|UBC_MOUSE Polyubiquitin-C OS=Mus musculus OX=10090 GN=Ubc PE=1 SV=2 UBC_MOUSE reviewed Polyubiquitin-C [Cleaved into: Ubiquitin; Ubiquitin-related 1; Ubiquitin-related 2] Mus musculus (Mouse) GO:0005634; GO:0005654; GO:0005737; GO:0005741; GO:0005829; GO:0016567; GO:0019941; GO:0031386; GO:0031625; GO:0043209 modification-dependent protein catabolic process [GO:0019941]; protein ubiquitination [GO:0016567] cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial outer membrane [GO:0005741]; myelin sheath [GO:0043209]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] protein tag activity [GO:0031386]; ubiquitin protein ligase binding [GO:0031625] g8552.t1 P0CG50 98.653 297 0.0 580.0 sp|P0CG50|UBC_MOUSE Polyubiquitin-C OS=Mus musculus OX=10090 GN=Ubc PE=1 SV=2 UBC_MOUSE reviewed Polyubiquitin-C [Cleaved into: Ubiquitin; Ubiquitin-related 1; Ubiquitin-related 2] Mus musculus (Mouse) GO:0005634; GO:0005654; GO:0005737; GO:0005741; GO:0005829; GO:0016567; GO:0019941; GO:0031386; GO:0031625; GO:0043209 modification-dependent protein catabolic process [GO:0019941]; protein ubiquitination [GO:0016567] cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial outer membrane [GO:0005741]; myelin sheath [GO:0043209]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] protein tag activity [GO:0031386]; ubiquitin protein ligase binding [GO:0031625] g8552.t1 P0CG50 98.653 297 0.0 580.0 sp|P0CG50|UBC_MOUSE Polyubiquitin-C OS=Mus musculus OX=10090 GN=Ubc PE=1 SV=2 UBC_MOUSE reviewed Polyubiquitin-C [Cleaved into: Ubiquitin; Ubiquitin-related 1; Ubiquitin-related 2] Mus musculus (Mouse) GO:0005634; GO:0005654; GO:0005737; GO:0005741; GO:0005829; GO:0016567; GO:0019941; GO:0031386; GO:0031625; GO:0043209 modification-dependent protein catabolic process [GO:0019941]; protein ubiquitination [GO:0016567] cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial outer membrane [GO:0005741]; myelin sheath [GO:0043209]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] protein tag activity [GO:0031386]; ubiquitin protein ligase binding [GO:0031625] g8552.t1 P0CG50 98.653 297 0.0 580.0 sp|P0CG50|UBC_MOUSE Polyubiquitin-C OS=Mus musculus OX=10090 GN=Ubc PE=1 SV=2 UBC_MOUSE reviewed Polyubiquitin-C [Cleaved into: Ubiquitin; Ubiquitin-related 1; Ubiquitin-related 2] Mus musculus (Mouse) GO:0005634; GO:0005654; GO:0005737; GO:0005741; GO:0005829; GO:0016567; GO:0019941; GO:0031386; GO:0031625; GO:0043209 modification-dependent protein catabolic process [GO:0019941]; protein ubiquitination [GO:0016567] cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial outer membrane [GO:0005741]; myelin sheath [GO:0043209]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] protein tag activity [GO:0031386]; ubiquitin protein ligase binding [GO:0031625] g8552.t1 P0CG50 100.0 55 1.22e-25 111.0 sp|P0CG50|UBC_MOUSE Polyubiquitin-C OS=Mus musculus OX=10090 GN=Ubc PE=1 SV=2 UBC_MOUSE reviewed Polyubiquitin-C [Cleaved into: Ubiquitin; Ubiquitin-related 1; Ubiquitin-related 2] Mus musculus (Mouse) GO:0005634; GO:0005654; GO:0005737; GO:0005741; GO:0005829; GO:0016567; GO:0019941; GO:0031386; GO:0031625; GO:0043209 modification-dependent protein catabolic process [GO:0019941]; protein ubiquitination [GO:0016567] cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial outer membrane [GO:0005741]; myelin sheath [GO:0043209]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] protein tag activity [GO:0031386]; ubiquitin protein ligase binding [GO:0031625] g8552.t1 P0CG50 100.0 55 1.22e-25 111.0 sp|P0CG50|UBC_MOUSE Polyubiquitin-C OS=Mus musculus OX=10090 GN=Ubc PE=1 SV=2 UBC_MOUSE reviewed Polyubiquitin-C [Cleaved into: Ubiquitin; Ubiquitin-related 1; Ubiquitin-related 2] Mus musculus (Mouse) GO:0005634; GO:0005654; GO:0005737; GO:0005741; GO:0005829; GO:0016567; GO:0019941; GO:0031386; GO:0031625; GO:0043209 modification-dependent protein catabolic process [GO:0019941]; protein ubiquitination [GO:0016567] cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial outer membrane [GO:0005741]; myelin sheath [GO:0043209]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] protein tag activity [GO:0031386]; ubiquitin protein ligase binding [GO:0031625] g8552.t1 P0CG50 100.0 55 1.22e-25 111.0 sp|P0CG50|UBC_MOUSE Polyubiquitin-C OS=Mus musculus OX=10090 GN=Ubc PE=1 SV=2 UBC_MOUSE reviewed Polyubiquitin-C [Cleaved into: Ubiquitin; Ubiquitin-related 1; Ubiquitin-related 2] Mus musculus (Mouse) GO:0005634; GO:0005654; GO:0005737; GO:0005741; GO:0005829; GO:0016567; GO:0019941; GO:0031386; GO:0031625; GO:0043209 modification-dependent protein catabolic process [GO:0019941]; protein ubiquitination [GO:0016567] cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial outer membrane [GO:0005741]; myelin sheath [GO:0043209]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] protein tag activity [GO:0031386]; ubiquitin protein ligase binding [GO:0031625] g8552.t1 P0CG50 100.0 55 1.22e-25 111.0 sp|P0CG50|UBC_MOUSE Polyubiquitin-C OS=Mus musculus OX=10090 GN=Ubc PE=1 SV=2 UBC_MOUSE reviewed Polyubiquitin-C [Cleaved into: Ubiquitin; Ubiquitin-related 1; Ubiquitin-related 2] Mus musculus (Mouse) GO:0005634; GO:0005654; GO:0005737; GO:0005741; GO:0005829; GO:0016567; GO:0019941; GO:0031386; GO:0031625; GO:0043209 modification-dependent protein catabolic process [GO:0019941]; protein ubiquitination [GO:0016567] cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial outer membrane [GO:0005741]; myelin sheath [GO:0043209]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] protein tag activity [GO:0031386]; ubiquitin protein ligase binding [GO:0031625] g8552.t1 P0CG50 100.0 55 1.22e-25 111.0 sp|P0CG50|UBC_MOUSE Polyubiquitin-C OS=Mus musculus OX=10090 GN=Ubc PE=1 SV=2 UBC_MOUSE reviewed Polyubiquitin-C [Cleaved into: Ubiquitin; Ubiquitin-related 1; Ubiquitin-related 2] Mus musculus (Mouse) GO:0005634; GO:0005654; GO:0005737; GO:0005741; GO:0005829; GO:0016567; GO:0019941; GO:0031386; GO:0031625; GO:0043209 modification-dependent protein catabolic process [GO:0019941]; protein ubiquitination [GO:0016567] cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial outer membrane [GO:0005741]; myelin sheath [GO:0043209]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] protein tag activity [GO:0031386]; ubiquitin protein ligase binding [GO:0031625] g8552.t1 P0CG50 100.0 55 1.22e-25 111.0 sp|P0CG50|UBC_MOUSE Polyubiquitin-C OS=Mus musculus OX=10090 GN=Ubc PE=1 SV=2 UBC_MOUSE reviewed Polyubiquitin-C [Cleaved into: Ubiquitin; Ubiquitin-related 1; Ubiquitin-related 2] Mus musculus (Mouse) GO:0005634; GO:0005654; GO:0005737; GO:0005741; GO:0005829; GO:0016567; GO:0019941; GO:0031386; GO:0031625; GO:0043209 modification-dependent protein catabolic process [GO:0019941]; protein ubiquitination [GO:0016567] cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial outer membrane [GO:0005741]; myelin sheath [GO:0043209]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] protein tag activity [GO:0031386]; ubiquitin protein ligase binding [GO:0031625] g8552.t1 P0CG50 100.0 55 1.22e-25 111.0 sp|P0CG50|UBC_MOUSE Polyubiquitin-C OS=Mus musculus OX=10090 GN=Ubc PE=1 SV=2 UBC_MOUSE reviewed Polyubiquitin-C [Cleaved into: Ubiquitin; Ubiquitin-related 1; Ubiquitin-related 2] Mus musculus (Mouse) GO:0005634; GO:0005654; GO:0005737; GO:0005741; GO:0005829; GO:0016567; GO:0019941; GO:0031386; GO:0031625; GO:0043209 modification-dependent protein catabolic process [GO:0019941]; protein ubiquitination [GO:0016567] cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial outer membrane [GO:0005741]; myelin sheath [GO:0043209]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] protein tag activity [GO:0031386]; ubiquitin protein ligase binding [GO:0031625] g8552.t1 P0CG50 100.0 55 1.22e-25 111.0 sp|P0CG50|UBC_MOUSE Polyubiquitin-C OS=Mus musculus OX=10090 GN=Ubc PE=1 SV=2 UBC_MOUSE reviewed Polyubiquitin-C [Cleaved into: Ubiquitin; Ubiquitin-related 1; Ubiquitin-related 2] Mus musculus (Mouse) GO:0005634; GO:0005654; GO:0005737; GO:0005741; GO:0005829; GO:0016567; GO:0019941; GO:0031386; GO:0031625; GO:0043209 modification-dependent protein catabolic process [GO:0019941]; protein ubiquitination [GO:0016567] cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial outer membrane [GO:0005741]; myelin sheath [GO:0043209]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] protein tag activity [GO:0031386]; ubiquitin protein ligase binding [GO:0031625] g8553.t1 P0CG60 86.243 189 6.69e-112 321.0 sp|P0CG60|UBB_PONPY Polyubiquitin-B OS=Pongo pygmaeus OX=9600 GN=UBB PE=3 SV=1 g8553.t1 P0CG60 99.346 153 2.36e-105 305.0 sp|P0CG60|UBB_PONPY Polyubiquitin-B OS=Pongo pygmaeus OX=9600 GN=UBB PE=3 SV=1 g8554.t1 Q8BGZ3 43.707 437 5.77e-112 340.0 sp|Q8BGZ3|DCA12_MOUSE DDB1- and CUL4-associated factor 12 OS=Mus musculus OX=10090 GN=Dcaf12 PE=2 SV=1 DCA12_MOUSE reviewed DDB1- and CUL4-associated factor 12 (WD repeat-containing protein 40A) Mus musculus (Mouse) GO:0005634; GO:0005737; GO:0005813; GO:0005829; GO:0007283; GO:0010506; GO:0016567; GO:0035279; GO:0042110; GO:0080008; GO:0140627; GO:1990756 miRNA-mediated gene silencing by mRNA destabilization [GO:0035279]; protein ubiquitination [GO:0016567]; regulation of autophagy [GO:0010506]; spermatogenesis [GO:0007283]; T cell activation [GO:0042110]; ubiquitin-dependent protein catabolic process via the C-end degron rule pathway [GO:0140627] centrosome [GO:0005813]; Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634] ubiquitin-like ligase-substrate adaptor activity [GO:1990756] g8557.t1 A3KPW7 42.47 332 1.02e-70 235.0 sp|A3KPW7|PTAR1_DANRE Protein prenyltransferase alpha subunit repeat-containing protein 1 OS=Danio rerio OX=7955 GN=ptar1 PE=2 SV=1 g8559.t1 Q5RBJ7 47.536 345 1.23e-112 337.0 sp|Q5RBJ7|TM6S1_PONAB Transmembrane 6 superfamily member 1 OS=Pongo abelii OX=9601 GN=TM6SF1 PE=2 SV=1 g8560.t1 P97433 34.681 643 2.22e-88 324.0 sp|P97433|ARG28_MOUSE Rho guanine nucleotide exchange factor 28 OS=Mus musculus OX=10090 GN=Arhgef28 PE=1 SV=2 g8560.t1 P97433 30.921 304 3.58e-24 115.0 sp|P97433|ARG28_MOUSE Rho guanine nucleotide exchange factor 28 OS=Mus musculus OX=10090 GN=Arhgef28 PE=1 SV=2 g8560.t2 P97433 34.681 643 2.41e-88 324.0 sp|P97433|ARG28_MOUSE Rho guanine nucleotide exchange factor 28 OS=Mus musculus OX=10090 GN=Arhgef28 PE=1 SV=2 g8560.t2 P97433 30.921 304 3.62e-24 115.0 sp|P97433|ARG28_MOUSE Rho guanine nucleotide exchange factor 28 OS=Mus musculus OX=10090 GN=Arhgef28 PE=1 SV=2 g8560.t3 P97433 34.52 646 5.04e-88 323.0 sp|P97433|ARG28_MOUSE Rho guanine nucleotide exchange factor 28 OS=Mus musculus OX=10090 GN=Arhgef28 PE=1 SV=2 g8560.t3 P97433 30.921 304 3.6699999999999995e-24 115.0 sp|P97433|ARG28_MOUSE Rho guanine nucleotide exchange factor 28 OS=Mus musculus OX=10090 GN=Arhgef28 PE=1 SV=2 g8560.t4 P97433 34.681 643 2.9600000000000004e-88 324.0 sp|P97433|ARG28_MOUSE Rho guanine nucleotide exchange factor 28 OS=Mus musculus OX=10090 GN=Arhgef28 PE=1 SV=2 g8560.t4 P97433 30.921 304 3.68e-24 115.0 sp|P97433|ARG28_MOUSE Rho guanine nucleotide exchange factor 28 OS=Mus musculus OX=10090 GN=Arhgef28 PE=1 SV=2 g8560.t5 P97433 34.681 643 1.91e-88 324.0 sp|P97433|ARG28_MOUSE Rho guanine nucleotide exchange factor 28 OS=Mus musculus OX=10090 GN=Arhgef28 PE=1 SV=2 g8560.t5 P97433 30.921 304 3.6699999999999995e-24 115.0 sp|P97433|ARG28_MOUSE Rho guanine nucleotide exchange factor 28 OS=Mus musculus OX=10090 GN=Arhgef28 PE=1 SV=2 g8560.t6 P97433 34.681 643 1.96e-88 324.0 sp|P97433|ARG28_MOUSE Rho guanine nucleotide exchange factor 28 OS=Mus musculus OX=10090 GN=Arhgef28 PE=1 SV=2 g8560.t6 P97433 30.921 304 3.79e-24 115.0 sp|P97433|ARG28_MOUSE Rho guanine nucleotide exchange factor 28 OS=Mus musculus OX=10090 GN=Arhgef28 PE=1 SV=2 g8568.t1 Q1LXZ9 44.444 486 1.43e-111 357.0 sp|Q1LXZ9|SKR1B_DANRE SKI family transcriptional corepressor 1 homolog-B OS=Danio rerio OX=7955 GN=skor1b PE=2 SV=1 g8569.t1 Q62422 51.765 170 1.1000000000000002e-59 190.0 sp|Q62422|OSTF1_MOUSE Osteoclast-stimulating factor 1 OS=Mus musculus OX=10090 GN=Ostf1 PE=1 SV=2 g8570.t1 O08700 70.201 547 0.0 810.0 sp|O08700|VPS45_RAT Vacuolar protein sorting-associated protein 45 OS=Rattus norvegicus OX=10116 GN=Vps45 PE=1 SV=1 g8571.t1 Q8VDL4 44.098 449 2.31e-127 382.0 sp|Q8VDL4|ADPGK_MOUSE ADP-dependent glucokinase OS=Mus musculus OX=10090 GN=Adpgk PE=1 SV=2 ADPGK_MOUSE reviewed ADP-dependent glucokinase (ADP-GK) (ADPGK) (EC 2.7.1.147) Mus musculus (Mouse) GO:0005576; GO:0005783; GO:0006006; GO:0006096; GO:0043843; GO:0046872 glucose metabolic process [GO:0006006]; glycolytic process [GO:0006096] endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576] ADP-specific glucokinase activity [GO:0043843]; metal ion binding [GO:0046872] g8572.t1 Q4R3I0 42.414 290 1.5100000000000002e-70 224.0 sp|Q4R3I0|MTX1_MACFA Metaxin-1 OS=Macaca fascicularis OX=9541 GN=MTX1 PE=2 SV=1 g8573.t1 Q2KIZ3 56.442 163 1.06e-60 188.0 sp|Q2KIZ3|MCEE_BOVIN Methylmalonyl-CoA epimerase, mitochondrial OS=Bos taurus OX=9913 GN=MCEE PE=2 SV=1 g8573.t2 Q2KIZ3 58.282 163 6.88e-59 192.0 sp|Q2KIZ3|MCEE_BOVIN Methylmalonyl-CoA epimerase, mitochondrial OS=Bos taurus OX=9913 GN=MCEE PE=2 SV=1 g8577.t1 P14733 41.459 562 2.31e-134 406.0 sp|P14733|LMNB1_MOUSE Lamin-B1 OS=Mus musculus OX=10090 GN=Lmnb1 PE=1 SV=3 g8578.t1 Q9UKP4 41.932 973 0.0 726.0 sp|Q9UKP4|ATS7_HUMAN A disintegrin and metalloproteinase with thrombospondin motifs 7 OS=Homo sapiens OX=9606 GN=ADAMTS7 PE=1 SV=2 ATS7_HUMAN reviewed A disintegrin and metalloproteinase with thrombospondin motifs 7 (ADAM-TS 7) (ADAM-TS7) (ADAMTS-7) (EC 3.4.24.-) Homo sapiens (Human) GO:0002062; GO:0004222; GO:0005788; GO:0006029; GO:0006508; GO:0008237; GO:0009986; GO:0030198; GO:0030199; GO:0031012; GO:0032331; GO:0043931; GO:0046872; GO:0051603; GO:0071347; GO:0071356; GO:0071773 cellular response to BMP stimulus [GO:0071773]; cellular response to interleukin-1 [GO:0071347]; cellular response to tumor necrosis factor [GO:0071356]; chondrocyte differentiation [GO:0002062]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]; negative regulation of chondrocyte differentiation [GO:0032331]; ossification involved in bone maturation [GO:0043931]; proteoglycan metabolic process [GO:0006029]; proteolysis [GO:0006508]; proteolysis involved in protein catabolic process [GO:0051603] cell surface [GO:0009986]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012] metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237] g8580.t1 Q0P5A1 36.782 174 2.69e-29 109.0 sp|Q0P5A1|DCTN3_BOVIN Dynactin subunit 3 OS=Bos taurus OX=9913 GN=DCTN3 PE=2 SV=1 g8581.t1 Q9BRS8 38.554 415 1.19e-66 226.0 sp|Q9BRS8|LARP6_HUMAN La-related protein 6 OS=Homo sapiens OX=9606 GN=LARP6 PE=1 SV=1 LARP6_HUMAN reviewed La-related protein 6 (Acheron) (Achn) (La ribonucleoprotein domain family member 6) Homo sapiens (Human) GO:0003729; GO:0005634; GO:0005737; GO:0006396; GO:0006417; GO:0017022; GO:0032967; GO:0035613; GO:0048027; GO:1990825; GO:1990904 positive regulation of collagen biosynthetic process [GO:0032967]; regulation of translation [GO:0006417]; RNA processing [GO:0006396] cytoplasm [GO:0005737]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904] mRNA 5'-UTR binding [GO:0048027]; mRNA binding [GO:0003729]; myosin binding [GO:0017022]; RNA stem-loop binding [GO:0035613]; sequence-specific mRNA binding [GO:1990825] g8583.t1 Q62132 32.245 245 8.59e-38 154.0 sp|Q62132|PTPRR_MOUSE Receptor-type tyrosine-protein phosphatase R OS=Mus musculus OX=10090 GN=Ptprr PE=1 SV=1 PTPRR_MOUSE reviewed Receptor-type tyrosine-protein phosphatase R (R-PTP-R) (EC 3.1.3.48) (Phosphotyrosine phosphatase 13) (Protein-tyrosine-phosphatase SL) Mus musculus (Mouse) GO:0001701; GO:0004725; GO:0005829; GO:0005886; GO:0007165; GO:0010633; GO:0019901; GO:0030054; GO:0038128; GO:0070373 ERBB2 signaling pathway [GO:0038128]; in utero embryonic development [GO:0001701]; negative regulation of epithelial cell migration [GO:0010633]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; signal transduction [GO:0007165] cell junction [GO:0030054]; cytosol [GO:0005829]; plasma membrane [GO:0005886] protein kinase binding [GO:0019901]; protein tyrosine phosphatase activity [GO:0004725] g8584.t1 Q3U481 48.24 483 8.46e-146 430.0 sp|Q3U481|MFS12_MOUSE Major facilitator superfamily domain-containing protein 12 OS=Mus musculus OX=10090 GN=Mfsd12 PE=1 SV=1 MFS12_MOUSE reviewed Major facilitator superfamily domain-containing protein 12 (Protein grizzled) Mus musculus (Mouse) GO:0005764; GO:0005765; GO:0005770; GO:0005886; GO:0008643; GO:0015293; GO:0033162; GO:0033229; GO:0042438; GO:0042470; GO:0043474; GO:0048021; GO:0048022; GO:1903712 carbohydrate transport [GO:0008643]; cysteine transmembrane transport [GO:1903712]; melanin biosynthetic process [GO:0042438]; negative regulation of melanin biosynthetic process [GO:0048022]; pigment metabolic process involved in pigmentation [GO:0043474]; regulation of melanin biosynthetic process [GO:0048021] late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; melanosome [GO:0042470]; melanosome membrane [GO:0033162]; plasma membrane [GO:0005886] cysteine transmembrane transporter activity [GO:0033229]; symporter activity [GO:0015293] g8585.t1 P20742 31.758 1439 0.0 645.0 sp|P20742|PZP_HUMAN Pregnancy zone protein OS=Homo sapiens OX=9606 GN=PZP PE=1 SV=4 PZP_HUMAN reviewed Pregnancy zone protein (C3 and PZP-like alpha-2-macroglobulin domain-containing protein 6) Homo sapiens (Human) GO:0002020; GO:0004866; GO:0004867; GO:0005576; GO:0005615; GO:0007565; GO:0070062; GO:0072562 female pregnancy [GO:0007565] blood microparticle [GO:0072562]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615] endopeptidase inhibitor activity [GO:0004866]; protease binding [GO:0002020]; serine-type endopeptidase inhibitor activity [GO:0004867] g8586.t1 Q15650 43.854 602 6.5900000000000004e-161 475.0 sp|Q15650|TRIP4_HUMAN Activating signal cointegrator 1 OS=Homo sapiens OX=9606 GN=TRIP4 PE=1 SV=4 TRIP4_HUMAN reviewed Activating signal cointegrator 1 (ASC-1) (Thyroid receptor-interacting protein 4) (TR-interacting protein 4) (TRIP-4) Homo sapiens (Human) GO:0002020; GO:0003713; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0006355; GO:0008270; GO:0016604; GO:0016922; GO:0019901; GO:0030331; GO:0030520; GO:0031594; GO:0032790; GO:0032991; GO:0035035; GO:0044389; GO:0045661; GO:0045893; GO:0072344; GO:0180022; GO:1990116 estrogen receptor signaling pathway [GO:0030520]; positive regulation of DNA-templated transcription [GO:0045893]; regulation of DNA-templated transcription [GO:0006355]; regulation of myoblast differentiation [GO:0045661]; rescue of stalled ribosome [GO:0072344]; ribosome disassembly [GO:0032790]; ribosome-associated ubiquitin-dependent protein catabolic process [GO:1990116] centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; neuromuscular junction [GO:0031594]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; RQC-trigger complex [GO:0180022] histone acetyltransferase binding [GO:0035035]; nuclear estrogen receptor binding [GO:0030331]; nuclear receptor binding [GO:0016922]; protease binding [GO:0002020]; protein kinase binding [GO:0019901]; transcription coactivator activity [GO:0003713]; ubiquitin-like protein ligase binding [GO:0044389]; zinc ion binding [GO:0008270] g8588.t1 Q62763 72.911 395 0.0 583.0 sp|Q62763|KC1G3_RAT Casein kinase I isoform gamma-3 OS=Rattus norvegicus OX=10116 GN=Csnk1g3 PE=1 SV=1 KC1G3_RAT reviewed Casein kinase I isoform gamma-3 (CKI-gamma 3) (EC 2.7.11.1) Rattus norvegicus (Rat) GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005886; GO:0006897; GO:0007165; GO:0016055; GO:0090263; GO:0106310 endocytosis [GO:0006897]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; signal transduction [GO:0007165]; Wnt signaling pathway [GO:0016055] cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886] ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g8589.t1 Q8N960 43.313 972 0.0 689.0 sp|Q8N960|CE120_HUMAN Centrosomal protein of 120 kDa OS=Homo sapiens OX=9606 GN=CEP120 PE=1 SV=2 CE120_HUMAN reviewed Centrosomal protein of 120 kDa (Cep120) (Coiled-coil domain-containing protein 100) Homo sapiens (Human) GO:0005813; GO:0005814; GO:0007098; GO:0010825; GO:0021987; GO:0022008; GO:0022027; GO:0030953; GO:0045724; GO:1903724; GO:1904951 astral microtubule organization [GO:0030953]; centrosome cycle [GO:0007098]; cerebral cortex development [GO:0021987]; interkinetic nuclear migration [GO:0022027]; neurogenesis [GO:0022008]; positive regulation of centriole elongation [GO:1903724]; positive regulation of centrosome duplication [GO:0010825]; positive regulation of cilium assembly [GO:0045724]; positive regulation of establishment of protein localization [GO:1904951] centriole [GO:0005814]; centrosome [GO:0005813] g8591.t1 Q56A10 54.15 253 4.24e-65 247.0 sp|Q56A10|ZN608_MOUSE Zinc finger protein 608 OS=Mus musculus OX=10090 GN=Znf608 PE=1 SV=1 ZN608_MOUSE reviewed Zinc finger protein 608 Mus musculus (Mouse) GO:0000122; GO:0005634; GO:0006357; GO:0008270; GO:0033085 negative regulation of T cell differentiation in thymus [GO:0033085]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] zinc ion binding [GO:0008270] g8594.t1 Q3L254 40.12 334 2.1899999999999997e-82 257.0 sp|Q3L254|WNT7B_CHICK Protein Wnt-7b OS=Gallus gallus OX=9031 GN=WNT7B PE=2 SV=1 g8595.t1 Q7ZTY7 47.17 265 2.0799999999999998e-82 251.0 sp|Q7ZTY7|USE1_DANRE Vesicle transport protein USE1 OS=Danio rerio OX=7955 GN=use1 PE=2 SV=1 USE1_DANRE reviewed Vesicle transport protein USE1 (USE1-like protein) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005484; GO:0005783; GO:0005789; GO:0006890; GO:0015031; GO:0031201 protein transport [GO:0015031]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; SNARE complex [GO:0031201] SNAP receptor activity [GO:0005484] g8597.t1 Q16959 76.685 712 0.0 1029.0 sp|Q16959|DYI2_HELCR Dynein intermediate chain 2, ciliary OS=Heliocidaris crassispina OX=1043166 PE=2 SV=1 g8600.t1 P24367 85.385 130 1.57e-65 202.0 sp|P24367|PPIB_CHICK Peptidyl-prolyl cis-trans isomerase B OS=Gallus gallus OX=9031 GN=PPIB PE=2 SV=1 g8601.t1 Q9R172 39.167 240 2.54e-34 147.0 sp|Q9R172|NOTC3_RAT Neurogenic locus notch homolog protein 3 OS=Rattus norvegicus OX=10116 GN=Notch3 PE=2 SV=2 NOTC3_RAT reviewed Neurogenic locus notch homolog protein 3 (Notch 3) [Cleaved into: Notch 3 extracellular truncation; Notch 3 intracellular domain] Rattus norvegicus (Rat) GO:0000122; GO:0005509; GO:0005634; GO:0005654; GO:0005886; GO:0007219; GO:0007411; GO:0009986; GO:0014016; GO:0019899; GO:0030900; GO:0036120; GO:0038023; GO:0042060; GO:0042246; GO:0042802; GO:0043235; GO:0045596; GO:0045665; GO:0045944; GO:0048661; GO:0048663; GO:0048844; GO:0072104; GO:1902895 artery morphogenesis [GO:0048844]; axon guidance [GO:0007411]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; forebrain development [GO:0030900]; glomerular capillary formation [GO:0072104]; negative regulation of cell differentiation [GO:0045596]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuroblast differentiation [GO:0014016]; neuron fate commitment [GO:0048663]; Notch signaling pathway [GO:0007219]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of transcription by RNA polymerase II [GO:0045944]; tissue regeneration [GO:0042246]; wound healing [GO:0042060] cell surface [GO:0009986]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; signaling receptor activity [GO:0038023] g8601.t1 Q9R172 38.934 244 1.55e-28 128.0 sp|Q9R172|NOTC3_RAT Neurogenic locus notch homolog protein 3 OS=Rattus norvegicus OX=10116 GN=Notch3 PE=2 SV=2 NOTC3_RAT reviewed Neurogenic locus notch homolog protein 3 (Notch 3) [Cleaved into: Notch 3 extracellular truncation; Notch 3 intracellular domain] Rattus norvegicus (Rat) GO:0000122; GO:0005509; GO:0005634; GO:0005654; GO:0005886; GO:0007219; GO:0007411; GO:0009986; GO:0014016; GO:0019899; GO:0030900; GO:0036120; GO:0038023; GO:0042060; GO:0042246; GO:0042802; GO:0043235; GO:0045596; GO:0045665; GO:0045944; GO:0048661; GO:0048663; GO:0048844; GO:0072104; GO:1902895 artery morphogenesis [GO:0048844]; axon guidance [GO:0007411]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; forebrain development [GO:0030900]; glomerular capillary formation [GO:0072104]; negative regulation of cell differentiation [GO:0045596]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuroblast differentiation [GO:0014016]; neuron fate commitment [GO:0048663]; Notch signaling pathway [GO:0007219]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of transcription by RNA polymerase II [GO:0045944]; tissue regeneration [GO:0042246]; wound healing [GO:0042060] cell surface [GO:0009986]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; signaling receptor activity [GO:0038023] g8601.t1 Q9R172 36.948 249 3.47e-26 120.0 sp|Q9R172|NOTC3_RAT Neurogenic locus notch homolog protein 3 OS=Rattus norvegicus OX=10116 GN=Notch3 PE=2 SV=2 NOTC3_RAT reviewed Neurogenic locus notch homolog protein 3 (Notch 3) [Cleaved into: Notch 3 extracellular truncation; Notch 3 intracellular domain] Rattus norvegicus (Rat) GO:0000122; GO:0005509; GO:0005634; GO:0005654; GO:0005886; GO:0007219; GO:0007411; GO:0009986; GO:0014016; GO:0019899; GO:0030900; GO:0036120; GO:0038023; GO:0042060; GO:0042246; GO:0042802; GO:0043235; GO:0045596; GO:0045665; GO:0045944; GO:0048661; GO:0048663; GO:0048844; GO:0072104; GO:1902895 artery morphogenesis [GO:0048844]; axon guidance [GO:0007411]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; forebrain development [GO:0030900]; glomerular capillary formation [GO:0072104]; negative regulation of cell differentiation [GO:0045596]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuroblast differentiation [GO:0014016]; neuron fate commitment [GO:0048663]; Notch signaling pathway [GO:0007219]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of transcription by RNA polymerase II [GO:0045944]; tissue regeneration [GO:0042246]; wound healing [GO:0042060] cell surface [GO:0009986]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; signaling receptor activity [GO:0038023] g8601.t1 Q9R172 35.366 246 3.38e-25 117.0 sp|Q9R172|NOTC3_RAT Neurogenic locus notch homolog protein 3 OS=Rattus norvegicus OX=10116 GN=Notch3 PE=2 SV=2 NOTC3_RAT reviewed Neurogenic locus notch homolog protein 3 (Notch 3) [Cleaved into: Notch 3 extracellular truncation; Notch 3 intracellular domain] Rattus norvegicus (Rat) GO:0000122; GO:0005509; GO:0005634; GO:0005654; GO:0005886; GO:0007219; GO:0007411; GO:0009986; GO:0014016; GO:0019899; GO:0030900; GO:0036120; GO:0038023; GO:0042060; GO:0042246; GO:0042802; GO:0043235; GO:0045596; GO:0045665; GO:0045944; GO:0048661; GO:0048663; GO:0048844; GO:0072104; GO:1902895 artery morphogenesis [GO:0048844]; axon guidance [GO:0007411]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; forebrain development [GO:0030900]; glomerular capillary formation [GO:0072104]; negative regulation of cell differentiation [GO:0045596]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuroblast differentiation [GO:0014016]; neuron fate commitment [GO:0048663]; Notch signaling pathway [GO:0007219]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of transcription by RNA polymerase II [GO:0045944]; tissue regeneration [GO:0042246]; wound healing [GO:0042060] cell surface [GO:0009986]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; signaling receptor activity [GO:0038023] g8601.t1 Q9R172 35.827 254 1.12e-24 115.0 sp|Q9R172|NOTC3_RAT Neurogenic locus notch homolog protein 3 OS=Rattus norvegicus OX=10116 GN=Notch3 PE=2 SV=2 NOTC3_RAT reviewed Neurogenic locus notch homolog protein 3 (Notch 3) [Cleaved into: Notch 3 extracellular truncation; Notch 3 intracellular domain] Rattus norvegicus (Rat) GO:0000122; GO:0005509; GO:0005634; GO:0005654; GO:0005886; GO:0007219; GO:0007411; GO:0009986; GO:0014016; GO:0019899; GO:0030900; GO:0036120; GO:0038023; GO:0042060; GO:0042246; GO:0042802; GO:0043235; GO:0045596; GO:0045665; GO:0045944; GO:0048661; GO:0048663; GO:0048844; GO:0072104; GO:1902895 artery morphogenesis [GO:0048844]; axon guidance [GO:0007411]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; forebrain development [GO:0030900]; glomerular capillary formation [GO:0072104]; negative regulation of cell differentiation [GO:0045596]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuroblast differentiation [GO:0014016]; neuron fate commitment [GO:0048663]; Notch signaling pathway [GO:0007219]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of transcription by RNA polymerase II [GO:0045944]; tissue regeneration [GO:0042246]; wound healing [GO:0042060] cell surface [GO:0009986]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; signaling receptor activity [GO:0038023] g8601.t1 Q9R172 32.66 297 1.1399999999999999e-24 115.0 sp|Q9R172|NOTC3_RAT Neurogenic locus notch homolog protein 3 OS=Rattus norvegicus OX=10116 GN=Notch3 PE=2 SV=2 NOTC3_RAT reviewed Neurogenic locus notch homolog protein 3 (Notch 3) [Cleaved into: Notch 3 extracellular truncation; Notch 3 intracellular domain] Rattus norvegicus (Rat) GO:0000122; GO:0005509; GO:0005634; GO:0005654; GO:0005886; GO:0007219; GO:0007411; GO:0009986; GO:0014016; GO:0019899; GO:0030900; GO:0036120; GO:0038023; GO:0042060; GO:0042246; GO:0042802; GO:0043235; GO:0045596; GO:0045665; GO:0045944; GO:0048661; GO:0048663; GO:0048844; GO:0072104; GO:1902895 artery morphogenesis [GO:0048844]; axon guidance [GO:0007411]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; forebrain development [GO:0030900]; glomerular capillary formation [GO:0072104]; negative regulation of cell differentiation [GO:0045596]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuroblast differentiation [GO:0014016]; neuron fate commitment [GO:0048663]; Notch signaling pathway [GO:0007219]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of transcription by RNA polymerase II [GO:0045944]; tissue regeneration [GO:0042246]; wound healing [GO:0042060] cell surface [GO:0009986]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; signaling receptor activity [GO:0038023] g8601.t1 Q9R172 37.398 246 5.86e-23 110.0 sp|Q9R172|NOTC3_RAT Neurogenic locus notch homolog protein 3 OS=Rattus norvegicus OX=10116 GN=Notch3 PE=2 SV=2 NOTC3_RAT reviewed Neurogenic locus notch homolog protein 3 (Notch 3) [Cleaved into: Notch 3 extracellular truncation; Notch 3 intracellular domain] Rattus norvegicus (Rat) GO:0000122; GO:0005509; GO:0005634; GO:0005654; GO:0005886; GO:0007219; GO:0007411; GO:0009986; GO:0014016; GO:0019899; GO:0030900; GO:0036120; GO:0038023; GO:0042060; GO:0042246; GO:0042802; GO:0043235; GO:0045596; GO:0045665; GO:0045944; GO:0048661; GO:0048663; GO:0048844; GO:0072104; GO:1902895 artery morphogenesis [GO:0048844]; axon guidance [GO:0007411]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; forebrain development [GO:0030900]; glomerular capillary formation [GO:0072104]; negative regulation of cell differentiation [GO:0045596]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuroblast differentiation [GO:0014016]; neuron fate commitment [GO:0048663]; Notch signaling pathway [GO:0007219]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of transcription by RNA polymerase II [GO:0045944]; tissue regeneration [GO:0042246]; wound healing [GO:0042060] cell surface [GO:0009986]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; signaling receptor activity [GO:0038023] g8602.t1 P10079 36.961 487 2.81e-71 252.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g8602.t1 P10079 38.28 465 7.370000000000001e-71 251.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g8602.t1 P10079 37.797 463 5.66e-69 246.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g8602.t1 P10079 34.601 526 2.73e-66 238.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g8602.t1 P10079 37.788 434 4.990000000000001e-66 237.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g8602.t1 P10079 37.822 349 4.11e-52 197.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g8602.t1 P10079 41.629 221 1.8100000000000002e-36 150.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g8602.t2 P10079 37.313 469 1.49e-63 231.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g8602.t2 P10079 37.367 471 2.78e-63 230.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g8602.t2 P10079 35.83 494 3.08e-63 230.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g8602.t2 P10079 34.16 524 9.489999999999999e-61 223.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g8602.t2 P10079 36.674 439 6.77e-59 218.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g8602.t2 P10079 33.509 379 4.2800000000000004e-49 189.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g8602.t2 P10079 32.921 404 4.78e-38 155.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g8602.t3 P10079 37.712 472 3.61e-68 244.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g8602.t3 P10079 37.447 470 6.35e-68 244.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g8602.t3 P10079 35.96 495 6.86e-68 243.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g8602.t3 P10079 34.476 525 6.24e-65 235.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g8602.t3 P10079 36.818 440 1.75e-63 231.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g8602.t3 P10079 33.509 379 6.59e-49 188.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g8602.t3 P10079 32.921 404 4.18e-38 155.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g8602.t4 P10079 37.712 472 3.61e-68 244.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g8602.t4 P10079 37.447 470 6.35e-68 244.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g8602.t4 P10079 35.96 495 6.86e-68 243.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g8602.t4 P10079 34.476 525 6.24e-65 235.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g8602.t4 P10079 36.818 440 1.75e-63 231.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g8602.t4 P10079 33.509 379 6.59e-49 188.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g8602.t4 P10079 32.921 404 4.18e-38 155.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g8602.t5 P10079 35.941 473 2.79e-60 222.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g8602.t5 P10079 34.669 499 1.01e-59 220.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g8602.t5 P10079 35.518 473 1.0800000000000001e-57 214.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g8602.t5 P10079 35.44 443 4.48e-56 209.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g8602.t5 P10079 32.765 528 1.06e-55 208.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g8602.t5 P10079 31.25 416 4.39e-42 167.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g8602.t5 P10079 30.254 433 3.8e-33 140.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g8603.t1 P49914 53.807 197 8.2e-72 219.0 sp|P49914|MTHFS_HUMAN 5-formyltetrahydrofolate cyclo-ligase OS=Homo sapiens OX=9606 GN=MTHFS PE=1 SV=2 MTHFS_HUMAN reviewed 5-formyltetrahydrofolate cyclo-ligase (EC 6.3.3.2) (5,10-methenyl-tetrahydrofolate synthetase) (MTHFS) (Methenyl-THF synthetase) Homo sapiens (Human) GO:0005524; GO:0005542; GO:0005737; GO:0005739; GO:0005759; GO:0005829; GO:0006536; GO:0009396; GO:0015942; GO:0030272; GO:0035999; GO:0046653; GO:0046655; GO:0046657; GO:0046872 folic acid catabolic process [GO:0046657]; folic acid metabolic process [GO:0046655]; folic acid-containing compound biosynthetic process [GO:0009396]; formate metabolic process [GO:0015942]; glutamate metabolic process [GO:0006536]; tetrahydrofolate interconversion [GO:0035999]; tetrahydrofolate metabolic process [GO:0046653] cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] 5-formyltetrahydrofolate cyclo-ligase activity [GO:0030272]; ATP binding [GO:0005524]; folic acid binding [GO:0005542]; metal ion binding [GO:0046872] g8608.t1 Q8N6G6 52.83 159 4.9799999999999993e-48 172.0 sp|Q8N6G6|ATL1_HUMAN ADAMTS-like protein 1 OS=Homo sapiens OX=9606 GN=ADAMTSL1 PE=1 SV=4 ATL1_HUMAN reviewed ADAMTS-like protein 1 (ADAMTSL-1) (Punctin-1) Homo sapiens (Human) GO:0005788; GO:0016787; GO:0030198 extracellular matrix organization [GO:0030198] endoplasmic reticulum lumen [GO:0005788] hydrolase activity [GO:0016787] g8610.t1 Q8N6G6 32.675 557 2.1700000000000002e-85 300.0 sp|Q8N6G6|ATL1_HUMAN ADAMTS-like protein 1 OS=Homo sapiens OX=9606 GN=ADAMTSL1 PE=1 SV=4 ATL1_HUMAN reviewed ADAMTS-like protein 1 (ADAMTSL-1) (Punctin-1) Homo sapiens (Human) GO:0005788; GO:0016787; GO:0030198 extracellular matrix organization [GO:0030198] endoplasmic reticulum lumen [GO:0005788] hydrolase activity [GO:0016787] g8610.t1 Q8N6G6 32.78 241 5.7600000000000005e-27 122.0 sp|Q8N6G6|ATL1_HUMAN ADAMTS-like protein 1 OS=Homo sapiens OX=9606 GN=ADAMTSL1 PE=1 SV=4 ATL1_HUMAN reviewed ADAMTS-like protein 1 (ADAMTSL-1) (Punctin-1) Homo sapiens (Human) GO:0005788; GO:0016787; GO:0030198 extracellular matrix organization [GO:0030198] endoplasmic reticulum lumen [GO:0005788] hydrolase activity [GO:0016787] g8614.t1 P50613 72.941 340 5.62e-178 500.0 sp|P50613|CDK7_HUMAN Cyclin-dependent kinase 7 OS=Homo sapiens OX=9606 GN=CDK7 PE=1 SV=1 CDK7_HUMAN reviewed Cyclin-dependent kinase 7 (EC 2.7.11.22) (EC 2.7.11.23) (39 kDa protein kinase) (p39 Mo15) (CDK-activating kinase 1) (Cell division protein kinase 7) (Serine/threonine-protein kinase 1) (TFIIH basal transcription factor complex kinase subunit) Homo sapiens (Human) GO:0000307; GO:0000439; GO:0001650; GO:0001673; GO:0004672; GO:0004674; GO:0004693; GO:0005524; GO:0005634; GO:0005654; GO:0005675; GO:0005737; GO:0005829; GO:0005886; GO:0006281; GO:0006366; GO:0006367; GO:0008094; GO:0008353; GO:0042795; GO:0045944; GO:0048471; GO:0050821; GO:0051301; GO:0051726; GO:0070516; GO:0070985; GO:0106310; GO:0140836; GO:2000045 cell division [GO:0051301]; DNA repair [GO:0006281]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein stabilization [GO:0050821]; regulation of cell cycle [GO:0051726]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; snRNA transcription by RNA polymerase II [GO:0042795]; transcription by RNA polymerase II [GO:0006366]; transcription initiation at RNA polymerase II promoter [GO:0006367] CAK-ERCC2 complex [GO:0070516]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; male germ cell nucleus [GO:0001673]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; transcription factor TFIIH core complex [GO:0000439]; transcription factor TFIIH holo complex [GO:0005675]; transcription factor TFIIK complex [GO:0070985] ATP binding [GO:0005524]; ATP-dependent activity, acting on DNA [GO:0008094]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353]; RNA polymerase II CTD heptapeptide repeat S5 kinase activity [GO:0140836] g8615.t1 Q9QYV8 68.267 479 0.0 671.0 sp|Q9QYV8|DPOG1_RAT DNA polymerase subunit gamma-1 OS=Rattus norvegicus OX=10116 GN=Polg PE=2 SV=1 DPOG1_RAT reviewed DNA polymerase subunit gamma-1 (EC 2.7.7.7) (3'-5' exodeoxyribonuclease) (EC 3.1.11.-) (5'-deoxyribose-phosphate lyase) (EC 4.2.99.-) (Mitochondrial DNA polymerase catalytic subunit) (PolG-alpha) Rattus norvegicus (Rat) GO:0000262; GO:0002020; GO:0003677; GO:0003682; GO:0003887; GO:0004527; GO:0005739; GO:0005759; GO:0005760; GO:0006261; GO:0006264; GO:0006284; GO:0006287; GO:0008310; GO:0008340; GO:0008408; GO:0009416; GO:0010332; GO:0032991; GO:0042645; GO:0043195; GO:0045004; GO:0046872; GO:0051575; GO:0055093; GO:0071333 base-excision repair [GO:0006284]; base-excision repair, gap-filling [GO:0006287]; cellular response to glucose stimulus [GO:0071333]; determination of adult lifespan [GO:0008340]; DNA replication proofreading [GO:0045004]; DNA-templated DNA replication [GO:0006261]; mitochondrial DNA replication [GO:0006264]; response to gamma radiation [GO:0010332]; response to hyperoxia [GO:0055093]; response to light stimulus [GO:0009416] gamma DNA polymerase complex [GO:0005760]; mitochondrial chromosome [GO:0000262]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; protein-containing complex [GO:0032991]; terminal bouton [GO:0043195] 3'-5' exonuclease activity [GO:0008408]; 5'-deoxyribose-5-phosphate lyase activity [GO:0051575]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; exonuclease activity [GO:0004527]; metal ion binding [GO:0046872]; protease binding [GO:0002020]; single-stranded DNA 3'-5' DNA exonuclease activity [GO:0008310] g8617.t1 P54099 43.906 722 1.3e-173 533.0 sp|P54099|DPOG1_MOUSE DNA polymerase subunit gamma-1 OS=Mus musculus OX=10090 GN=Polg PE=1 SV=3 DPOG1_MOUSE reviewed DNA polymerase subunit gamma-1 (EC 2.7.7.7) (3'-5' exodeoxyribonuclease) (EC 3.1.11.-) (5'-deoxyribose-phosphate lyase) (EC 4.2.99.-) (Mitochondrial DNA polymerase catalytic subunit) (PolG-alpha) (PolgA) Mus musculus (Mouse) GO:0000262; GO:0002020; GO:0003677; GO:0003682; GO:0003887; GO:0004527; GO:0005739; GO:0005743; GO:0005759; GO:0005760; GO:0006261; GO:0006264; GO:0006284; GO:0008310; GO:0008340; GO:0008408; GO:0032991; GO:0042645; GO:0043195; GO:0045004; GO:0046872; GO:0051575 base-excision repair [GO:0006284]; determination of adult lifespan [GO:0008340]; DNA replication proofreading [GO:0045004]; DNA-templated DNA replication [GO:0006261]; mitochondrial DNA replication [GO:0006264] gamma DNA polymerase complex [GO:0005760]; mitochondrial chromosome [GO:0000262]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; protein-containing complex [GO:0032991]; terminal bouton [GO:0043195] 3'-5' exonuclease activity [GO:0008408]; 5'-deoxyribose-5-phosphate lyase activity [GO:0051575]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; exonuclease activity [GO:0004527]; metal ion binding [GO:0046872]; protease binding [GO:0002020]; single-stranded DNA 3'-5' DNA exonuclease activity [GO:0008310] g8619.t1 Q9VVE5 43.182 176 1.4799999999999999e-40 153.0 sp|Q9VVE5|MSIR6_DROME RNA-binding protein Musashi homolog Rbp6 OS=Drosophila melanogaster OX=7227 GN=Rbp6 PE=2 SV=3 g8619.t2 Q9VVE5 43.182 176 3.24e-41 154.0 sp|Q9VVE5|MSIR6_DROME RNA-binding protein Musashi homolog Rbp6 OS=Drosophila melanogaster OX=7227 GN=Rbp6 PE=2 SV=3 g8621.t1 Q3TNH5 41.737 357 6.37e-76 246.0 sp|Q3TNH5|ARB2A_MOUSE Cotranscriptional regulator ARB2A OS=Mus musculus OX=10090 GN=Arb2a PE=1 SV=2 ARB2A_MOUSE reviewed Cotranscriptional regulator ARB2A (Cotranscriptional regulator FAM172A) (Protein FAM172A) Mus musculus (Mouse) GO:0000381; GO:0005634; GO:0005737; GO:0005783; GO:0006397; GO:0008380; GO:0014032; GO:0031048 mRNA processing [GO:0006397]; neural crest cell development [GO:0014032]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulatory ncRNA-mediated heterochromatin formation [GO:0031048]; RNA splicing [GO:0008380] cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634] g8623.t1 O02466 43.333 1170 0.0 885.0 sp|O02466|ILPR_BRALA Insulin-like peptide receptor OS=Branchiostoma lanceolatum OX=7740 PE=2 SV=1 g8623.t2 O02466 43.051 1180 0.0 884.0 sp|O02466|ILPR_BRALA Insulin-like peptide receptor OS=Branchiostoma lanceolatum OX=7740 PE=2 SV=1 g8624.t1 Q05688 59.821 112 1.08e-41 150.0 sp|Q05688|IGF1R_BOVIN Insulin-like growth factor 1 receptor (Fragment) OS=Bos taurus OX=9913 GN=IGF1R PE=2 SV=1 IGF1R_BOVIN reviewed Insulin-like growth factor 1 receptor (EC 2.7.10.1) (Insulin-like growth factor I receptor) (IGF-I receptor) (CD antigen CD221) [Cleaved into: Insulin-like growth factor 1 receptor alpha chain; Insulin-like growth factor 1 receptor beta chain] Bos taurus (Bovine) GO:0004713; GO:0005009; GO:0005010; GO:0005198; GO:0005520; GO:0005524; GO:0005737; GO:0005886; GO:0005899; GO:0008286; GO:0030424; GO:0043066; GO:0043409; GO:0043410; GO:0043548; GO:0043560; GO:0046328; GO:0046777; GO:0048009; GO:0051897; GO:0071333 cellular response to glucose stimulus [GO:0071333]; insulin receptor signaling pathway [GO:0008286]; insulin-like growth factor receptor signaling pathway [GO:0048009]; negative regulation of apoptotic process [GO:0043066]; negative regulation of MAPK cascade [GO:0043409]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; protein autophosphorylation [GO:0046777]; regulation of JNK cascade [GO:0046328] axon [GO:0030424]; cytoplasm [GO:0005737]; insulin receptor complex [GO:0005899]; plasma membrane [GO:0005886] ATP binding [GO:0005524]; insulin receptor activity [GO:0005009]; insulin receptor substrate binding [GO:0043560]; insulin-like growth factor binding [GO:0005520]; insulin-like growth factor receptor activity [GO:0005010]; phosphatidylinositol 3-kinase binding [GO:0043548]; protein tyrosine kinase activity [GO:0004713]; structural molecule activity [GO:0005198] g8625.t1 Q4R708 58.215 706 0.0 849.0 sp|Q4R708|NAA35_MACFA N-alpha-acetyltransferase 35, NatC auxiliary subunit OS=Macaca fascicularis OX=9541 GN=NAA35 PE=2 SV=1 g8628.t1 Q7Z4H7 27.111 450 2.38e-39 162.0 sp|Q7Z4H7|HAUS6_HUMAN HAUS augmin-like complex subunit 6 OS=Homo sapiens OX=9606 GN=HAUS6 PE=1 SV=2 HAUS6_HUMAN reviewed HAUS augmin-like complex subunit 6 Homo sapiens (Human) GO:0000226; GO:0005813; GO:0005829; GO:0007098; GO:0008017; GO:0010968; GO:0051225; GO:0051301; GO:0070652; GO:1990498 cell division [GO:0051301]; centrosome cycle [GO:0007098]; microtubule cytoskeleton organization [GO:0000226]; regulation of microtubule nucleation [GO:0010968]; spindle assembly [GO:0051225] centrosome [GO:0005813]; cytosol [GO:0005829]; HAUS complex [GO:0070652]; mitotic spindle microtubule [GO:1990498] microtubule binding [GO:0008017] g8630.t1 Q5VUM1 69.697 66 5.43e-25 94.7 sp|Q5VUM1|SDHF4_HUMAN Succinate dehydrogenase assembly factor 4, mitochondrial OS=Homo sapiens OX=9606 GN=SDHAF4 PE=1 SV=1 SDHF4_HUMAN reviewed Succinate dehydrogenase assembly factor 4, mitochondrial (SDH assembly factor 4) (SDHAF4) Homo sapiens (Human) GO:0005739; GO:0005759; GO:0006099; GO:0008047; GO:0034553; GO:0044183; GO:0045087; GO:0045333 cellular respiration [GO:0045333]; innate immune response [GO:0045087]; mitochondrial respiratory chain complex II assembly [GO:0034553]; tricarboxylic acid cycle [GO:0006099] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] enzyme activator activity [GO:0008047]; protein folding chaperone [GO:0044183] g8631.t1 Q26473 30.426 516 1e-38 156.0 sp|Q26473|SEM1A_SCHAM Semaphorin-1A OS=Schistocerca americana OX=7009 GN=SEMA-1A PE=1 SV=1 g8633.t1 Q6DH02 50.442 226 1.14e-74 228.0 sp|Q6DH02|RM24_DANRE Large ribosomal subunit protein uL24m OS=Danio rerio OX=7955 GN=mrpl24 PE=2 SV=1 RM24_DANRE reviewed Large ribosomal subunit protein uL24m (39S ribosomal protein L24, mitochondrial) (L24mt) (MRP-L24) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0003723; GO:0003735; GO:0005739; GO:0005762; GO:0006412; GO:0006754; GO:0045333 ATP biosynthetic process [GO:0006754]; cellular respiration [GO:0045333]; translation [GO:0006412] mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739] RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735] g8635.t1 Q9DBN1 27.21 577 1.97e-51 192.0 sp|Q9DBN1|STR6L_MOUSE Stimulated by retinoic acid gene 6 protein-like OS=Mus musculus OX=10090 GN=Stra6l PE=1 SV=1 g8636.t1 Q9DBN1 26.817 578 2.26e-44 172.0 sp|Q9DBN1|STR6L_MOUSE Stimulated by retinoic acid gene 6 protein-like OS=Mus musculus OX=10090 GN=Stra6l PE=1 SV=1 g8637.t1 Q5RD03 46.089 473 2.35e-136 405.0 sp|Q5RD03|ARMC6_PONAB Armadillo repeat-containing protein 6 OS=Pongo abelii OX=9601 GN=ARMC6 PE=2 SV=1 g8640.t1 B3EWZ6 33.711 353 1.02e-30 130.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g8640.t1 B3EWZ6 30.387 362 3.9000000000000003e-29 125.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g8640.t1 B3EWZ6 30.986 355 1.9699999999999999e-28 123.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g8640.t1 B3EWZ6 28.533 368 8.230000000000001e-26 115.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g8640.t1 B3EWZ6 30.671 313 3.3399999999999997e-25 113.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g8640.t1 B3EWZ6 29.63 351 3.46e-25 113.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g8640.t1 B3EWZ6 30.328 366 3e-24 110.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g8640.t1 B3EWZ6 30.105 382 1.1999999999999998e-23 108.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g8640.t1 B3EWZ6 28.684 380 1.3799999999999998e-23 108.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g8640.t1 B3EWZ6 29.539 369 2.25e-23 108.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g8640.t1 B3EWZ6 28.453 362 9.31e-22 103.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g8640.t1 B3EWZ6 28.809 361 1.46e-21 102.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g8641.t1 Q642M9 41.026 351 1.84e-90 277.0 sp|Q642M9|DHDH_DANRE Trans-1,2-dihydrobenzene-1,2-diol dehydrogenase OS=Danio rerio OX=7955 GN=dhdh PE=2 SV=2 g8642.t1 Q642M9 45.143 350 6.16e-102 306.0 sp|Q642M9|DHDH_DANRE Trans-1,2-dihydrobenzene-1,2-diol dehydrogenase OS=Danio rerio OX=7955 GN=dhdh PE=2 SV=2 g8643.t1 Q3B8G7 71.951 82 6.69e-40 129.0 sp|Q3B8G7|IR3IP_XENLA Immediate early response 3-interacting protein 1 OS=Xenopus laevis OX=8355 GN=ier3ip1 PE=3 SV=1 g8644.t1 Q9XZC8 29.814 483 3.5999999999999995e-48 184.0 sp|Q9XZC8|SEM2A_SCHGR Semaphorin-2A OS=Schistocerca gregaria OX=7010 GN=SEMA-2A PE=2 SV=1 g8645.t1 B5G1C4 52.885 104 1.88e-22 90.1 sp|B5G1C4|ARP19_TAEGU cAMP-regulated phosphoprotein 19 OS=Taeniopygia guttata OX=59729 GN=ARPP19 PE=3 SV=2 ARP19_TAEGU reviewed cAMP-regulated phosphoprotein 19 (ARPP-19) Taeniopygia guttata (Zebra finch) (Poephila guttata) GO:0000086; GO:0000278; GO:0004864; GO:0005737; GO:0019212; GO:0019888; GO:0051301; GO:0051721 cell division [GO:0051301]; G2/M transition of mitotic cell cycle [GO:0000086]; mitotic cell cycle [GO:0000278] cytoplasm [GO:0005737] phosphatase inhibitor activity [GO:0019212]; protein phosphatase 2A binding [GO:0051721]; protein phosphatase inhibitor activity [GO:0004864]; protein phosphatase regulator activity [GO:0019888] g8646.t1 O54701 40.554 397 9.14e-84 273.0 sp|O54701|NCKX2_RAT Sodium/potassium/calcium exchanger 2 OS=Rattus norvegicus OX=10116 GN=Slc24a2 PE=1 SV=1 NCKX2_RAT reviewed Sodium/potassium/calcium exchanger 2 (Na(+)/K(+)/Ca(2+)-exchange protein 2) (Retinal cone Na-Ca+K exchanger) (Solute carrier family 24 member 2) Rattus norvegicus (Rat) GO:0005262; GO:0005886; GO:0006816; GO:0006874; GO:0007602; GO:0007612; GO:0007613; GO:0008273; GO:0015293; GO:0016020; GO:0034220; GO:0035725; GO:0036368; GO:0051649; GO:0060291; GO:0060292; GO:0065003; GO:0070050; GO:0070509; GO:0070588; GO:0071486; GO:0071805; GO:0098703; GO:0098793; GO:0098794 calcium ion import [GO:0070509]; calcium ion import across plasma membrane [GO:0098703]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; cellular response to high light intensity [GO:0071486]; cone photoresponse recovery [GO:0036368]; establishment of localization in cell [GO:0051649]; intracellular calcium ion homeostasis [GO:0006874]; learning [GO:0007612]; long-term synaptic depression [GO:0060292]; long-term synaptic potentiation [GO:0060291]; memory [GO:0007613]; monoatomic ion transmembrane transport [GO:0034220]; neuron cellular homeostasis [GO:0070050]; phototransduction [GO:0007602]; potassium ion transmembrane transport [GO:0071805]; protein-containing complex assembly [GO:0065003]; sodium ion transmembrane transport [GO:0035725] membrane [GO:0016020]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; presynapse [GO:0098793] calcium channel activity [GO:0005262]; calcium, potassium:sodium antiporter activity [GO:0008273]; symporter activity [GO:0015293] g8647.t1 Q66H58 52.39 523 0.0 535.0 sp|Q66H58|INT14_RAT Integrator complex subunit 14 OS=Rattus norvegicus OX=10116 GN=Ints14 PE=2 SV=1 g8649.t1 Q7Z7E8 41.758 273 3.6599999999999998e-62 204.0 sp|Q7Z7E8|UB2Q1_HUMAN Ubiquitin-conjugating enzyme E2 Q1 OS=Homo sapiens OX=9606 GN=UBE2Q1 PE=1 SV=1 UB2Q1_HUMAN reviewed Ubiquitin-conjugating enzyme E2 Q1 (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme Q1) (Protein NICE-5) (Ubiquitin carrier protein Q1) (Ubiquitin-protein ligase Q1) Homo sapiens (Human) GO:0000209; GO:0001967; GO:0005524; GO:0005634; GO:0005829; GO:0007566; GO:0007617; GO:0009566; GO:0030175; GO:0061458; GO:0061631; GO:0070459 embryo implantation [GO:0007566]; fertilization [GO:0009566]; mating behavior [GO:0007617]; prolactin secretion [GO:0070459]; protein polyubiquitination [GO:0000209]; reproductive system development [GO:0061458]; suckling behavior [GO:0001967] cytosol [GO:0005829]; filopodium [GO:0030175]; nucleus [GO:0005634] ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631] g8649.t2 Q7TSS2 38.776 294 4.91e-57 192.0 sp|Q7TSS2|UB2Q1_MOUSE Ubiquitin-conjugating enzyme E2 Q1 OS=Mus musculus OX=10090 GN=Ube2q1 PE=1 SV=2 g8650.t1 Q7TSS2 84.466 103 4.77e-64 202.0 sp|Q7TSS2|UB2Q1_MOUSE Ubiquitin-conjugating enzyme E2 Q1 OS=Mus musculus OX=10090 GN=Ube2q1 PE=1 SV=2 g8650.t2 Q7Z7E8 83.654 104 2.43e-62 198.0 sp|Q7Z7E8|UB2Q1_HUMAN Ubiquitin-conjugating enzyme E2 Q1 OS=Homo sapiens OX=9606 GN=UBE2Q1 PE=1 SV=1 UB2Q1_HUMAN reviewed Ubiquitin-conjugating enzyme E2 Q1 (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme Q1) (Protein NICE-5) (Ubiquitin carrier protein Q1) (Ubiquitin-protein ligase Q1) Homo sapiens (Human) GO:0000209; GO:0001967; GO:0005524; GO:0005634; GO:0005829; GO:0007566; GO:0007617; GO:0009566; GO:0030175; GO:0061458; GO:0061631; GO:0070459 embryo implantation [GO:0007566]; fertilization [GO:0009566]; mating behavior [GO:0007617]; prolactin secretion [GO:0070459]; protein polyubiquitination [GO:0000209]; reproductive system development [GO:0061458]; suckling behavior [GO:0001967] cytosol [GO:0005829]; filopodium [GO:0030175]; nucleus [GO:0005634] ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631] g8651.t1 Q71RS6 40.393 458 1.01e-108 337.0 sp|Q71RS6|NCKX5_HUMAN Sodium/potassium/calcium exchanger 5 OS=Homo sapiens OX=9606 GN=SLC24A5 PE=1 SV=1 NCKX5_HUMAN reviewed Sodium/potassium/calcium exchanger 5 (Na(+)/K(+)/Ca(2+)-exchange protein 5) (Solute carrier family 24 member 5) Homo sapiens (Human) GO:0005262; GO:0005802; GO:0006811; GO:0006874; GO:0008273; GO:0015293; GO:0032588; GO:0034220; GO:0042438; GO:0042470; GO:0048022; GO:0070509; GO:0070588 calcium ion import [GO:0070509]; calcium ion transmembrane transport [GO:0070588]; intracellular calcium ion homeostasis [GO:0006874]; melanin biosynthetic process [GO:0042438]; monoatomic ion transmembrane transport [GO:0034220]; monoatomic ion transport [GO:0006811]; negative regulation of melanin biosynthetic process [GO:0048022] melanosome [GO:0042470]; trans-Golgi network [GO:0005802]; trans-Golgi network membrane [GO:0032588] calcium channel activity [GO:0005262]; calcium, potassium:sodium antiporter activity [GO:0008273]; symporter activity [GO:0015293] g8652.t1 Q8BK72 33.898 236 1.98e-26 113.0 sp|Q8BK72|RT27_MOUSE Small ribosomal subunit protein mS27 OS=Mus musculus OX=10090 GN=Mrps27 PE=1 SV=2 g8654.t1 A4FUY7 63.194 144 3.3800000000000004e-66 202.0 sp|A4FUY7|MOC2B_BOVIN Molybdopterin synthase catalytic subunit OS=Bos taurus OX=9913 GN=MOCS2 PE=2 SV=2 g8656.t1 Q66JT5 43.243 296 2.35e-77 241.0 sp|Q66JT5|TPGS2_MOUSE Tubulin polyglutamylase complex subunit 2 OS=Mus musculus OX=10090 GN=Tpgs2 PE=1 SV=2 TPGS2_MOUSE reviewed Tubulin polyglutamylase complex subunit 2 (PGs2) Mus musculus (Mouse) GO:0000226; GO:0005829; GO:0005874; GO:0034451; GO:0046785; GO:0061523 cilium disassembly [GO:0061523]; microtubule cytoskeleton organization [GO:0000226]; microtubule polymerization [GO:0046785] centriolar satellite [GO:0034451]; cytosol [GO:0005829]; microtubule [GO:0005874] g8657.t1 Q60928 37.843 547 1.16e-105 332.0 sp|Q60928|GGT1_MOUSE Glutathione hydrolase 1 proenzyme OS=Mus musculus OX=10090 GN=Ggt1 PE=1 SV=1 GGT1_MOUSE reviewed Glutathione hydrolase 1 proenzyme (EC 3.4.19.13) (Gamma-glutamyltransferase 1) (Gamma-glutamyltranspeptidase 1) (GGT 1) (EC 2.3.2.2) (Leukotriene-C4 hydrolase) (EC 3.4.19.14) (CD antigen CD224) [Cleaved into: Glutathione hydrolase 1 heavy chain; Glutathione hydrolase 1 light chain] Mus musculus (Mouse) GO:0000048; GO:0002682; GO:0002951; GO:0005615; GO:0005783; GO:0005886; GO:0006536; GO:0006749; GO:0006750; GO:0006751; GO:0007283; GO:0016755; GO:0019344; GO:0031179; GO:0031638; GO:0031982; GO:0032355; GO:0032496; GO:0034599; GO:0034612; GO:0036374; GO:0048471; GO:0050727; GO:0061017; GO:0070365; GO:0097305; GO:0097421; GO:0103068 cellular response to oxidative stress [GO:0034599]; cysteine biosynthetic process [GO:0019344]; glutamate metabolic process [GO:0006536]; glutathione biosynthetic process [GO:0006750]; glutathione catabolic process [GO:0006751]; glutathione metabolic process [GO:0006749]; hepatoblast differentiation [GO:0061017]; hepatocyte differentiation [GO:0070365]; liver regeneration [GO:0097421]; peptide modification [GO:0031179]; regulation of immune system process [GO:0002682]; regulation of inflammatory response [GO:0050727]; response to alcohol [GO:0097305]; response to estradiol [GO:0032355]; response to lipopolysaccharide [GO:0032496]; response to tumor necrosis factor [GO:0034612]; spermatogenesis [GO:0007283]; zymogen activation [GO:0031638] endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; vesicle [GO:0031982] aminoacyltransferase activity [GO:0016755]; glutathione hydrolase activity [GO:0036374]; leukotriene C4 gamma-glutamyl transferase activity [GO:0103068]; leukotriene-C(4) hydrolase [GO:0002951]; peptidyltransferase activity [GO:0000048] g8658.t1 P0DPU3 37.389 337 7.41e-65 220.0 sp|P0DPU3|TX14A_SCODE Scoloptoxin SSD14 OS=Scolopendra dehaani OX=2609776 PE=1 SV=1 g8659.t1 P20735 41.176 204 2.57e-41 150.0 sp|P20735|GGT1_PIG Glutathione hydrolase 1 proenzyme OS=Sus scrofa OX=9823 GN=GGT1 PE=2 SV=1 g8660.t1 Q9DBT9 60.727 853 0.0 1101.0 sp|Q9DBT9|M2GD_MOUSE Dimethylglycine dehydrogenase, mitochondrial OS=Mus musculus OX=10090 GN=Dmgdh PE=1 SV=1 g8661.t1 Q95332 70.482 166 2.35e-85 255.0 sp|Q95332|BHMT1_PIG Betaine--homocysteine S-methyltransferase 1 (Fragment) OS=Sus scrofa OX=9823 GN=BHMT PE=1 SV=3 BHMT1_PIG reviewed Betaine--homocysteine S-methyltransferase 1 (EC 2.1.1.5) Sus scrofa (Pig) GO:0005634; GO:0005829; GO:0006579; GO:0008270; GO:0032259; GO:0047150; GO:0071267 amino-acid betaine catabolic process [GO:0006579]; L-methionine salvage [GO:0071267]; methylation [GO:0032259] cytosol [GO:0005829]; nucleus [GO:0005634] betaine-homocysteine S-methyltransferase activity [GO:0047150]; zinc ion binding [GO:0008270] g8662.t1 Q5I597 66.667 210 9.76e-99 295.0 sp|Q5I597|BHMT1_BOVIN Betaine--homocysteine S-methyltransferase 1 OS=Bos taurus OX=9913 GN=BHMT PE=2 SV=1 g8663.t1 Q9WVS7 50.481 208 2.98e-60 197.0 sp|Q9WVS7|MP2K5_MOUSE Dual specificity mitogen-activated protein kinase kinase 5 OS=Mus musculus OX=10090 GN=Map2k5 PE=1 SV=1 g8665.t1 Q62862 68.304 224 5.72e-114 337.0 sp|Q62862|MP2K5_RAT Dual specificity mitogen-activated protein kinase kinase 5 OS=Rattus norvegicus OX=10116 GN=Map2k5 PE=1 SV=1 MP2K5_RAT reviewed Dual specificity mitogen-activated protein kinase kinase 5 (MAP kinase kinase 5) (MAPKK 5) (EC 2.7.12.2) (MAPK/ERK kinase 5) (MEK 5) Rattus norvegicus (Rat) GO:0000122; GO:0000165; GO:0004672; GO:0004707; GO:0004708; GO:0004713; GO:0005524; GO:0005819; GO:0005829; GO:0007507; GO:0016020; GO:0030307; GO:0032717; GO:0034115; GO:0034392; GO:0043124; GO:0045944; GO:0046872; GO:0048009; GO:0050679; GO:0051247; GO:0060761; GO:0070375; GO:0071363; GO:0090051; GO:0106310; GO:2000342; GO:2001240 cellular response to growth factor stimulus [GO:0071363]; ERK5 cascade [GO:0070375]; heart development [GO:0007507]; insulin-like growth factor receptor signaling pathway [GO:0048009]; MAPK cascade [GO:0000165]; negative regulation of canonical NF-kappaB signal transduction [GO:0043124]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of chemokine (C-X-C motif) ligand 2 production [GO:2000342]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; negative regulation of heterotypic cell-cell adhesion [GO:0034115]; negative regulation of interleukin-8 production [GO:0032717]; negative regulation of response to cytokine stimulus [GO:0060761]; negative regulation of smooth muscle cell apoptotic process [GO:0034392]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell growth [GO:0030307]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of protein metabolic process [GO:0051247]; positive regulation of transcription by RNA polymerase II [GO:0045944] cytosol [GO:0005829]; membrane [GO:0016020]; spindle [GO:0005819] ATP binding [GO:0005524]; MAP kinase activity [GO:0004707]; MAP kinase kinase activity [GO:0004708]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein tyrosine kinase activity [GO:0004713] g8667.t1 Q5XGC9 40.0 135 2.35e-21 95.9 sp|Q5XGC9|SRFB1_XENTR Serum response factor-binding protein 1 OS=Xenopus tropicalis OX=8364 GN=srfbp1 PE=2 SV=1 g8668.t1 P20936 49.392 905 0.0 833.0 sp|P20936|RASA1_HUMAN Ras GTPase-activating protein 1 OS=Homo sapiens OX=9606 GN=RASA1 PE=1 SV=1 RASA1_HUMAN reviewed Ras GTPase-activating protein 1 (GAP) (GTPase-activating protein) (RasGAP) (Ras p21 protein activator) (p120GAP) Homo sapiens (Human) GO:0000281; GO:0001525; GO:0001570; GO:0001726; GO:0001784; GO:0001953; GO:0003924; GO:0005096; GO:0005102; GO:0005737; GO:0005829; GO:0005886; GO:0007162; GO:0007165; GO:0008360; GO:0019870; GO:0030833; GO:0035556; GO:0043066; GO:0043524; GO:0048013; GO:0048514; GO:0051020; GO:0051252; GO:1902531 angiogenesis [GO:0001525]; blood vessel morphogenesis [GO:0048514]; ephrin receptor signaling pathway [GO:0048013]; intracellular signal transduction [GO:0035556]; mitotic cytokinesis [GO:0000281]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell adhesion [GO:0007162]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of neuron apoptotic process [GO:0043524]; regulation of actin filament polymerization [GO:0030833]; regulation of cell shape [GO:0008360]; regulation of intracellular signal transduction [GO:1902531]; regulation of RNA metabolic process [GO:0051252]; signal transduction [GO:0007165]; vasculogenesis [GO:0001570] cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; ruffle [GO:0001726] GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; GTPase binding [GO:0051020]; phosphotyrosine residue binding [GO:0001784]; potassium channel inhibitor activity [GO:0019870]; signaling receptor binding [GO:0005102] g8673.t1 P51049 31.884 207 5.860000000000001e-21 96.3 sp|P51049|MR1BB_DANRE Melatonin receptor type 1B-B OS=Danio rerio OX=7955 GN=mtnr1bb PE=2 SV=2 g8677.t1 Q91175 28.931 318 3.2799999999999995e-23 103.0 sp|Q91175|ADA1A_ORYLA Alpha-1A adrenergic receptor OS=Oryzias latipes OX=8090 GN=adra1a PE=3 SV=1 ADA1A_ORYLA reviewed Alpha-1A adrenergic receptor (Alpha-1A adrenoreceptor) (Alpha-1A adrenoceptor) (MAR1) Oryzias latipes (Japanese rice fish) (Japanese killifish) GO:0004937; GO:0005886; GO:0007200; GO:0007204; GO:0007267; GO:0010613; GO:0043410; GO:0071880 adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; cell-cell signaling [GO:0007267]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of MAPK cascade [GO:0043410] plasma membrane [GO:0005886] alpha1-adrenergic receptor activity [GO:0004937] g8682.t1 Q9CPX9 82.143 84 2.64e-41 132.0 sp|Q9CPX9|APC11_MOUSE Anaphase-promoting complex subunit 11 OS=Mus musculus OX=10090 GN=Anapc11 PE=3 SV=1 g8683.t1 P12027 22.196 428 2.4200000000000003e-37 151.0 sp|P12027|PSGP_ONCMY Polysialoglycoprotein OS=Oncorhynchus mykiss OX=8022 PE=1 SV=2 g8683.t1 P12027 22.196 428 2.4200000000000003e-37 151.0 sp|P12027|PSGP_ONCMY Polysialoglycoprotein OS=Oncorhynchus mykiss OX=8022 PE=1 SV=2 g8683.t1 P12027 22.222 414 3.28e-36 148.0 sp|P12027|PSGP_ONCMY Polysialoglycoprotein OS=Oncorhynchus mykiss OX=8022 PE=1 SV=2 g8683.t1 P12027 22.222 423 4.93e-36 147.0 sp|P12027|PSGP_ONCMY Polysialoglycoprotein OS=Oncorhynchus mykiss OX=8022 PE=1 SV=2 g8683.t1 P12027 21.957 419 5.9300000000000004e-36 147.0 sp|P12027|PSGP_ONCMY Polysialoglycoprotein OS=Oncorhynchus mykiss OX=8022 PE=1 SV=2 g8683.t1 P12027 21.963 428 1.07e-35 146.0 sp|P12027|PSGP_ONCMY Polysialoglycoprotein OS=Oncorhynchus mykiss OX=8022 PE=1 SV=2 g8683.t1 P12027 21.729 428 2.01e-35 145.0 sp|P12027|PSGP_ONCMY Polysialoglycoprotein OS=Oncorhynchus mykiss OX=8022 PE=1 SV=2 g8683.t1 P12027 21.749 423 3.76e-34 141.0 sp|P12027|PSGP_ONCMY Polysialoglycoprotein OS=Oncorhynchus mykiss OX=8022 PE=1 SV=2 g8683.t1 P12027 21.905 420 3.79e-34 141.0 sp|P12027|PSGP_ONCMY Polysialoglycoprotein OS=Oncorhynchus mykiss OX=8022 PE=1 SV=2 g8683.t1 P12027 21.48 419 4.52e-34 141.0 sp|P12027|PSGP_ONCMY Polysialoglycoprotein OS=Oncorhynchus mykiss OX=8022 PE=1 SV=2 g8683.t1 P12027 21.48 419 4.8199999999999994e-34 141.0 sp|P12027|PSGP_ONCMY Polysialoglycoprotein OS=Oncorhynchus mykiss OX=8022 PE=1 SV=2 g8683.t1 P12027 21.495 428 7.22e-34 140.0 sp|P12027|PSGP_ONCMY Polysialoglycoprotein OS=Oncorhynchus mykiss OX=8022 PE=1 SV=2 g8683.t1 P12027 20.548 438 4.0999999999999996e-30 129.0 sp|P12027|PSGP_ONCMY Polysialoglycoprotein OS=Oncorhynchus mykiss OX=8022 PE=1 SV=2 g8683.t1 P12027 20.657 426 6.4e-29 125.0 sp|P12027|PSGP_ONCMY Polysialoglycoprotein OS=Oncorhynchus mykiss OX=8022 PE=1 SV=2 g8685.t1 P14400 37.526 477 1.96e-90 315.0 sp|P14400|ENP1_TETCF Electromotor neuron-associated protein 1 (Fragment) OS=Tetronarce californica OX=7787 PE=2 SV=1 g8686.t1 Q4PLW0 29.602 402 9.03e-44 163.0 sp|Q4PLW0|PLIN2_PIG Perilipin-2 OS=Sus scrofa OX=9823 GN=PLIN2 PE=2 SV=1 g8686.t2 Q4PLW0 29.34 409 2.32e-44 165.0 sp|Q4PLW0|PLIN2_PIG Perilipin-2 OS=Sus scrofa OX=9823 GN=PLIN2 PE=2 SV=1 g8688.t1 Q21565 50.238 420 2.2e-94 307.0 sp|Q21565|AMT3_CAEEL Putative ammonium transporter 3 OS=Caenorhabditis elegans OX=6239 GN=amt-3 PE=3 SV=2 g8690.t1 Q21565 45.526 380 1.13e-106 333.0 sp|Q21565|AMT3_CAEEL Putative ammonium transporter 3 OS=Caenorhabditis elegans OX=6239 GN=amt-3 PE=3 SV=2 g8691.t1 P51167 30.878 353 2.7599999999999996e-48 180.0 sp|P51167|SCNNA_XENLA Epithelial sodium channel subunit alpha OS=Xenopus laevis OX=8355 GN=scnn1a PE=1 SV=1 g8694.t1 Q5R5L7 43.204 206 3.01e-51 177.0 sp|Q5R5L7|ARRD3_PONAB Arrestin domain-containing protein 3 OS=Pongo abelii OX=9601 GN=ARRDC3 PE=2 SV=1 g8698.t1 Q803I4 57.471 348 4.3100000000000005e-129 375.0 sp|Q803I4|RING2_DANRE E3 ubiquitin-protein ligase RING2 OS=Danio rerio OX=7955 GN=rnf2 PE=2 SV=1 RING2_DANRE reviewed E3 ubiquitin-protein ligase RING2 (EC 2.3.2.27) (RING finger protein 1B) (RING1b) (RING finger protein 2) (RING-type E3 ubiquitin transferase RING2) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000122; GO:0000151; GO:0003161; GO:0003682; GO:0005634; GO:0005694; GO:0005737; GO:0007417; GO:0008270; GO:0016567; GO:0031519; GO:0032330; GO:0033339; GO:0035102; GO:0040029; GO:0048484; GO:0048701; GO:0060042; GO:0061630; GO:0071339; GO:0140862; GO:1902254; GO:1905292; GO:1905295; GO:1905304 cardiac conduction system development [GO:0003161]; central nervous system development [GO:0007417]; embryonic cranial skeleton morphogenesis [GO:0048701]; enteric nervous system development [GO:0048484]; epigenetic regulation of gene expression [GO:0040029]; negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator [GO:1902254]; negative regulation of transcription by RNA polymerase II [GO:0000122]; pectoral fin development [GO:0033339]; protein ubiquitination [GO:0016567]; regulation of cardiac myofibril assembly [GO:1905304]; regulation of chondrocyte differentiation [GO:0032330]; regulation of neural crest cell differentiation [GO:1905292]; regulation of neural crest cell fate specification [GO:1905295]; retina morphogenesis in camera-type eye [GO:0060042] chromosome [GO:0005694]; cytoplasm [GO:0005737]; MLL1 complex [GO:0071339]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; PRC1 complex [GO:0035102]; ubiquitin ligase complex [GO:0000151] chromatin binding [GO:0003682]; histone H2AK119 ubiquitin ligase activity [GO:0140862]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] g8700.t1 B3EWZ5 33.049 1056 7.18e-152 504.0 sp|B3EWZ5|MLRP1_ACRMI MAM and LDL-receptor class A domain-containing protein 1 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g8700.t1 B3EWZ5 34.198 1041 6.91e-150 498.0 sp|B3EWZ5|MLRP1_ACRMI MAM and LDL-receptor class A domain-containing protein 1 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g8700.t1 B3EWZ5 34.079 983 6.27e-148 493.0 sp|B3EWZ5|MLRP1_ACRMI MAM and LDL-receptor class A domain-containing protein 1 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g8700.t1 B3EWZ5 31.903 1072 5.66e-145 484.0 sp|B3EWZ5|MLRP1_ACRMI MAM and LDL-receptor class A domain-containing protein 1 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g8700.t1 B3EWZ5 32.523 1070 7.45e-145 484.0 sp|B3EWZ5|MLRP1_ACRMI MAM and LDL-receptor class A domain-containing protein 1 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g8700.t1 B3EWZ5 31.946 1033 4.7699999999999997e-138 464.0 sp|B3EWZ5|MLRP1_ACRMI MAM and LDL-receptor class A domain-containing protein 1 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g8700.t1 B3EWZ5 31.835 1068 1.48e-136 459.0 sp|B3EWZ5|MLRP1_ACRMI MAM and LDL-receptor class A domain-containing protein 1 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g8700.t1 B3EWZ5 34.04 896 3.91e-119 408.0 sp|B3EWZ5|MLRP1_ACRMI MAM and LDL-receptor class A domain-containing protein 1 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g8700.t1 B3EWZ5 32.248 952 1.1200000000000001e-116 400.0 sp|B3EWZ5|MLRP1_ACRMI MAM and LDL-receptor class A domain-containing protein 1 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g8700.t1 B3EWZ5 29.679 1122 1.78e-113 391.0 sp|B3EWZ5|MLRP1_ACRMI MAM and LDL-receptor class A domain-containing protein 1 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g8700.t1 B3EWZ5 29.803 1067 8.78e-112 386.0 sp|B3EWZ5|MLRP1_ACRMI MAM and LDL-receptor class A domain-containing protein 1 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g8700.t1 B3EWZ5 25.972 1209 4.48e-92 327.0 sp|B3EWZ5|MLRP1_ACRMI MAM and LDL-receptor class A domain-containing protein 1 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g8700.t1 B3EWZ5 27.892 1072 7.93e-78 284.0 sp|B3EWZ5|MLRP1_ACRMI MAM and LDL-receptor class A domain-containing protein 1 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g8700.t1 B3EWZ5 33.591 518 1.1299999999999999e-68 256.0 sp|B3EWZ5|MLRP1_ACRMI MAM and LDL-receptor class A domain-containing protein 1 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g8700.t1 B3EWZ5 33.818 550 4.14e-62 236.0 sp|B3EWZ5|MLRP1_ACRMI MAM and LDL-receptor class A domain-containing protein 1 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g8700.t1 B3EWZ5 34.474 409 5.43e-53 207.0 sp|B3EWZ5|MLRP1_ACRMI MAM and LDL-receptor class A domain-containing protein 1 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g8700.t1 B3EWZ5 28.018 439 9.73e-34 145.0 sp|B3EWZ5|MLRP1_ACRMI MAM and LDL-receptor class A domain-containing protein 1 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g8700.t1 B3EWZ5 35.859 198 1.1200000000000001e-22 109.0 sp|B3EWZ5|MLRP1_ACRMI MAM and LDL-receptor class A domain-containing protein 1 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g8702.t1 B5DGI7 56.863 153 3.84e-54 172.0 sp|B5DGI7|RBM8A_SALSA RNA-binding protein 8A OS=Salmo salar OX=8030 GN=rbm8a PE=2 SV=1 g8704.t1 O53532 43.662 355 3.7699999999999995e-95 290.0 sp|O53532|Y2258_MYCTU S-adenosylmethionine-dependent methyltransferase Rv2258c OS=Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv) OX=83332 GN=Rv2258c PE=1 SV=1 g8706.t1 O60749 58.47 366 7.67e-146 424.0 sp|O60749|SNX2_HUMAN Sorting nexin-2 OS=Homo sapiens OX=9606 GN=SNX2 PE=1 SV=2 SNX2_HUMAN reviewed Sorting nexin-2 (Transformation-related gene 9 protein) (TRG-9) Homo sapiens (Human) GO:0005154; GO:0005158; GO:0005737; GO:0005764; GO:0005768; GO:0005829; GO:0006886; GO:0010008; GO:0016020; GO:0030027; GO:0030904; GO:0030905; GO:0031901; GO:0032991; GO:0034498; GO:0035091; GO:0042147; GO:0042802; GO:0042803; GO:0045296; GO:0046982; GO:0072673; GO:1990459; GO:1990460 early endosome to Golgi transport [GO:0034498]; intracellular protein transport [GO:0006886]; lamellipodium morphogenesis [GO:0072673]; retrograde transport, endosome to Golgi [GO:0042147] cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; endosome membrane [GO:0010008]; lamellipodium [GO:0030027]; lysosome [GO:0005764]; membrane [GO:0016020]; protein-containing complex [GO:0032991]; retromer complex [GO:0030904]; retromer, tubulation complex [GO:0030905] cadherin binding [GO:0045296]; epidermal growth factor receptor binding [GO:0005154]; identical protein binding [GO:0042802]; insulin receptor binding [GO:0005158]; leptin receptor binding [GO:1990460]; phosphatidylinositol binding [GO:0035091]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; transferrin receptor binding [GO:1990459] g8707.t1 Q5EAD5 62.81 363 6.84e-150 431.0 sp|Q5EAD5|PGTB1_BOVIN Geranylgeranyl transferase type-1 subunit beta OS=Bos taurus OX=9913 GN=PGGT1B PE=2 SV=1 PGTB1_BOVIN reviewed Geranylgeranyl transferase type-1 subunit beta (EC 2.5.1.59) (Geranylgeranyl transferase type I subunit beta) (GGTase-I-beta) (Type I protein geranyl-geranyltransferase subunit beta) Bos taurus (Bovine) GO:0004661; GO:0004662; GO:0005953; GO:0008270; GO:0018344 protein geranylgeranylation [GO:0018344] CAAX-protein geranylgeranyltransferase complex [GO:0005953] CAAX-protein geranylgeranyltransferase activity [GO:0004662]; protein geranylgeranyltransferase activity [GO:0004661]; zinc ion binding [GO:0008270] g8708.t1 Q8TEQ8 52.161 347 3.39e-119 375.0 sp|Q8TEQ8|PIGO_HUMAN GPI ethanolamine phosphate transferase 3, catalytic subunit OS=Homo sapiens OX=9606 GN=PIGO PE=1 SV=3 g8709.t1 Q8TEQ8 29.663 563 7.289999999999999e-40 160.0 sp|Q8TEQ8|PIGO_HUMAN GPI ethanolamine phosphate transferase 3, catalytic subunit OS=Homo sapiens OX=9606 GN=PIGO PE=1 SV=3 g8710.t1 Q24323 32.464 345 2.41e-37 152.0 sp|Q24323|SEM2A_DROME Semaphorin-2A OS=Drosophila melanogaster OX=7227 GN=Sema2a PE=1 SV=2 SEM2A_DROME reviewed Semaphorin-2A (Semaphorin-II) (Sema II) Drosophila melanogaster (Fruit fly) GO:0001755; GO:0005576; GO:0005829; GO:0005886; GO:0007411; GO:0007629; GO:0007632; GO:0012505; GO:0016201; GO:0030215; GO:0030335; GO:0030534; GO:0042756; GO:0045499; GO:0050919; GO:0070983; GO:0071526; GO:0071678; GO:0097374 adult behavior [GO:0030534]; axon guidance [GO:0007411]; dendrite guidance [GO:0070983]; drinking behavior [GO:0042756]; flight behavior [GO:0007629]; negative chemotaxis [GO:0050919]; neural crest cell migration [GO:0001755]; olfactory bulb axon guidance [GO:0071678]; positive regulation of cell migration [GO:0030335]; semaphorin-plexin signaling pathway [GO:0071526]; sensory neuron axon guidance [GO:0097374]; synaptic target inhibition [GO:0016201]; visual behavior [GO:0007632] cytosol [GO:0005829]; endomembrane system [GO:0012505]; extracellular region [GO:0005576]; plasma membrane [GO:0005886] chemorepellent activity [GO:0045499]; semaphorin receptor binding [GO:0030215] g8711.t1 Q8IYS0 38.931 131 7.360000000000001e-29 122.0 sp|Q8IYS0|ASTRC_HUMAN Protein Aster-C OS=Homo sapiens OX=9606 GN=GRAMD1C PE=1 SV=2 g8715.t1 Q9LJN4 32.794 741 2.8300000000000003e-103 337.0 sp|Q9LJN4|BXL5_ARATH Probable beta-D-xylosidase 5 OS=Arabidopsis thaliana OX=3702 GN=BXL5 PE=2 SV=2 g8716.t1 Q94KD8 33.657 722 2.46e-107 348.0 sp|Q94KD8|BXL2_ARATH Probable beta-D-xylosidase 2 OS=Arabidopsis thaliana OX=3702 GN=BXL2 PE=2 SV=1 g8718.t1 P11031 53.03 66 1.49e-23 91.3 sp|P11031|TCP4_MOUSE Activated RNA polymerase II transcriptional coactivator p15 OS=Mus musculus OX=10090 GN=Sub1 PE=1 SV=3 TCP4_MOUSE reviewed Activated RNA polymerase II transcriptional coactivator p15 (Positive cofactor 4) (PC4) (SUB1 homolog) (Single-stranded DNA-binding protein p9) (p14) Mus musculus (Mouse) GO:0000978; GO:0001111; GO:0003678; GO:0003697; GO:0003713; GO:0005634; GO:0005654; GO:0005667; GO:0005730; GO:0006357; GO:0042802; GO:0051053; GO:0051260; GO:0060261; GO:0140297 negative regulation of DNA metabolic process [GO:0051053]; positive regulation of transcription initiation by RNA polymerase II [GO:0060261]; protein homooligomerization [GO:0051260]; regulation of transcription by RNA polymerase II [GO:0006357]; RNA polymerase II promoter clearance [GO:0001111] nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667] DNA helicase activity [GO:0003678]; DNA-binding transcription factor binding [GO:0140297]; identical protein binding [GO:0042802]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; single-stranded DNA binding [GO:0003697]; transcription coactivator activity [GO:0003713] g8722.t1 Q2V2K5 39.583 144 2.33e-30 117.0 sp|Q2V2K5|GNRHR_OCTVU Gonadotropin-releasing hormone receptor OS=Octopus vulgaris OX=6645 GN=GNRHR PE=2 SV=1 g8725.t1 Q6P5H6 44.418 421 5.27e-96 305.0 sp|Q6P5H6|FRMD5_MOUSE FERM domain-containing protein 5 OS=Mus musculus OX=10090 GN=Frmd5 PE=1 SV=1 g8725.t2 Q6P5H6 46.078 408 1.8599999999999998e-101 319.0 sp|Q6P5H6|FRMD5_MOUSE FERM domain-containing protein 5 OS=Mus musculus OX=10090 GN=Frmd5 PE=1 SV=1 g8726.t1 B0BML1 48.276 174 1.85e-48 159.0 sp|B0BML1|GNTK_XENTR Probable gluconokinase OS=Xenopus tropicalis OX=8364 GN=idnk PE=2 SV=1 g8727.t1 Q9UNA4 50.498 402 3.01e-121 385.0 sp|Q9UNA4|POLI_HUMAN DNA polymerase iota OS=Homo sapiens OX=9606 GN=POLI PE=1 SV=3 g8728.t1 Q9DBN9 51.056 521 0.0 542.0 sp|Q9DBN9|DDX59_MOUSE Probable ATP-dependent RNA helicase DDX59 OS=Mus musculus OX=10090 GN=Ddx59 PE=1 SV=1 g8729.t1 P08428 55.263 76 4.29e-22 91.3 sp|P08428|ATPA_XENLA ATP synthase F(1) complex subunit alpha, mitochondrial OS=Xenopus laevis OX=8355 GN=atp5f1a PE=2 SV=1 g8730.t1 Q5R546 91.549 355 0.0 668.0 sp|Q5R546|ATPA_PONAB ATP synthase F(1) complex subunit alpha, mitochondrial OS=Pongo abelii OX=9601 GN=ATP5F1A PE=2 SV=1 ATPA_PONAB reviewed ATP synthase F(1) complex subunit alpha, mitochondrial (ATP synthase F1 subunit alpha) Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0001937; GO:0005524; GO:0005743; GO:0005886; GO:0006629; GO:0015986; GO:0042288; GO:0042776; GO:0043531; GO:0043532; GO:0043536; GO:0045259; GO:0046872; GO:0046933 lipid metabolic process [GO:0006629]; negative regulation of endothelial cell proliferation [GO:0001937]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; proton motive force-driven ATP synthesis [GO:0015986]; proton motive force-driven mitochondrial ATP synthesis [GO:0042776] mitochondrial inner membrane [GO:0005743]; plasma membrane [GO:0005886]; proton-transporting ATP synthase complex [GO:0045259] ADP binding [GO:0043531]; angiostatin binding [GO:0043532]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; MHC class I protein binding [GO:0042288]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933] g8732.t1 Q8N8R7 43.511 131 8.74e-26 102.0 sp|Q8N8R7|AL14E_HUMAN ARL14 effector protein OS=Homo sapiens OX=9606 GN=ARL14EP PE=1 SV=1 AL14E_HUMAN reviewed ARL14 effector protein (ARF7 effector protein) Homo sapiens (Human) GO:0005654; GO:0005730; GO:0005829; GO:0005886; GO:0005925 cytosol [GO:0005829]; focal adhesion [GO:0005925]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] g8734.t1 Q5XIG5 38.462 260 1.86e-32 124.0 sp|Q5XIG5|GKAP1_RAT G kinase-anchoring protein 1 OS=Rattus norvegicus OX=10116 GN=Gkap1 PE=1 SV=1 GKAP1_RAT reviewed G kinase-anchoring protein 1 Rattus norvegicus (Rat) GO:0005794; GO:0007165; GO:0019934; GO:0042802; GO:0046628 cGMP-mediated signaling [GO:0019934]; positive regulation of insulin receptor signaling pathway [GO:0046628]; signal transduction [GO:0007165] Golgi apparatus [GO:0005794] identical protein binding [GO:0042802] g8737.t1 Q66H33 39.175 291 5.74e-57 190.0 sp|Q66H33|CC038_RAT Uncharacterized protein C3orf38 homolog OS=Rattus norvegicus OX=10116 PE=2 SV=1 g8738.t1 Q54RF3 51.429 175 8.51e-56 189.0 sp|Q54RF3|EI2BE_DICDI Translation initiation factor eIF2B subunit epsilon OS=Dictyostelium discoideum OX=44689 GN=eif2b5 PE=3 SV=1 g8739.t1 Q64350 39.825 457 8.84e-96 306.0 sp|Q64350|EI2BE_RAT Translation initiation factor eIF2B subunit epsilon OS=Rattus norvegicus OX=10116 GN=Eif2b5 PE=1 SV=2 EI2BE_RAT reviewed Translation initiation factor eIF2B subunit epsilon (eIF2B GDP-GTP exchange factor subunit epsilon) Rattus norvegicus (Rat) GO:0001541; GO:0002183; GO:0003743; GO:0005085; GO:0005634; GO:0005737; GO:0005829; GO:0005851; GO:0006413; GO:0009408; GO:0009749; GO:0014002; GO:0014003; GO:0021766; GO:0031369; GO:0034976; GO:0042552; GO:0043065; GO:0043434; GO:0045727; GO:0045948; GO:0048708; GO:0050852 astrocyte development [GO:0014002]; astrocyte differentiation [GO:0048708]; cytoplasmic translational initiation [GO:0002183]; hippocampus development [GO:0021766]; myelination [GO:0042552]; oligodendrocyte development [GO:0014003]; ovarian follicle development [GO:0001541]; positive regulation of apoptotic process [GO:0043065]; positive regulation of translation [GO:0045727]; positive regulation of translational initiation [GO:0045948]; response to endoplasmic reticulum stress [GO:0034976]; response to glucose [GO:0009749]; response to heat [GO:0009408]; response to peptide hormone [GO:0043434]; T cell receptor signaling pathway [GO:0050852]; translational initiation [GO:0006413] cytoplasm [GO:0005737]; cytosol [GO:0005829]; eukaryotic translation initiation factor 2B complex [GO:0005851]; nucleus [GO:0005634] guanyl-nucleotide exchange factor activity [GO:0005085]; translation initiation factor activity [GO:0003743]; translation initiation factor binding [GO:0031369] g8740.t1 O02373 70.236 467 0.0 712.0 sp|O02373|UGDH_DROME UDP-glucose 6-dehydrogenase OS=Drosophila melanogaster OX=7227 GN=sgl PE=1 SV=1 g8742.t1 Q9CYC6 38.889 450 8.29e-96 297.0 sp|Q9CYC6|DCP2_MOUSE m7GpppN-mRNA hydrolase OS=Mus musculus OX=10090 GN=Dcp2 PE=1 SV=2 DCP2_MOUSE reviewed m7GpppN-mRNA hydrolase (EC 3.6.1.62) (mRNA-decapping enzyme 2) Mus musculus (Mouse) GO:0000184; GO:0000290; GO:0000932; GO:0004534; GO:0005654; GO:0005737; GO:0006402; GO:0016442; GO:0030054; GO:0030145; GO:0032211; GO:0036464; GO:0043488; GO:0070034; GO:0071044; GO:0140933; GO:1904872 deadenylation-dependent decapping of nuclear-transcribed mRNA [GO:0000290]; histone mRNA catabolic process [GO:0071044]; mRNA catabolic process [GO:0006402]; negative regulation of telomere maintenance via telomerase [GO:0032211]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; regulation of mRNA stability [GO:0043488]; regulation of telomerase RNA localization to Cajal body [GO:1904872] cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; nucleoplasm [GO:0005654]; P-body [GO:0000932]; RISC complex [GO:0016442] 5'-(N(7)-methylguanosine 5'-triphospho)-[mRNA] hydrolase activity [GO:0140933]; 5'-3' RNA exonuclease activity [GO:0004534]; manganese ion binding [GO:0030145]; telomerase RNA binding [GO:0070034] g8745.t1 Q9NPF2 38.589 241 1.31e-49 179.0 sp|Q9NPF2|CHSTB_HUMAN Carbohydrate sulfotransferase 11 OS=Homo sapiens OX=9606 GN=CHST11 PE=1 SV=1 CHSTB_HUMAN reviewed Carbohydrate sulfotransferase 11 (EC 2.8.2.5) (Chondroitin 4-O-sulfotransferase 1) (Chondroitin 4-sulfotransferase 1) (C4S-1) (C4ST-1) (C4ST1) Homo sapiens (Human) GO:0000139; GO:0001537; GO:0001701; GO:0002063; GO:0006915; GO:0007179; GO:0007585; GO:0008146; GO:0009791; GO:0016020; GO:0016051; GO:0030166; GO:0030512; GO:0033037; GO:0036342; GO:0042127; GO:0042733; GO:0043066; GO:0047756; GO:0048589; GO:0048703; GO:0050650; GO:0050659 apoptotic process [GO:0006915]; carbohydrate biosynthetic process [GO:0016051]; chondrocyte development [GO:0002063]; chondroitin sulfate proteoglycan biosynthetic process [GO:0050650]; developmental growth [GO:0048589]; embryonic digit morphogenesis [GO:0042733]; embryonic viscerocranium morphogenesis [GO:0048703]; in utero embryonic development [GO:0001701]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; polysaccharide localization [GO:0033037]; post-anal tail morphogenesis [GO:0036342]; post-embryonic development [GO:0009791]; proteoglycan biosynthetic process [GO:0030166]; regulation of cell population proliferation [GO:0042127]; respiratory gaseous exchange by respiratory system [GO:0007585]; transforming growth factor beta receptor signaling pathway [GO:0007179] Golgi membrane [GO:0000139]; membrane [GO:0016020] chondroitin 4-sulfotransferase activity [GO:0047756]; dermatan 4-sulfotransferase activity [GO:0001537]; N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity [GO:0050659]; sulfotransferase activity [GO:0008146] g8746.t1 Q9NRB3 37.209 129 2.89e-22 94.0 sp|Q9NRB3|CHSTC_HUMAN Carbohydrate sulfotransferase 12 OS=Homo sapiens OX=9606 GN=CHST12 PE=1 SV=2 CHSTC_HUMAN reviewed Carbohydrate sulfotransferase 12 (EC 2.8.2.5) (Chondroitin 4-O-sulfotransferase 2) (Chondroitin 4-sulfotransferase 2) (C4ST-2) (C4ST2) (Sulfotransferase Hlo) Homo sapiens (Human) GO:0000139; GO:0008146; GO:0016020; GO:0016051; GO:0030166; GO:0047756; GO:0050650; GO:0050651; GO:0050656 carbohydrate biosynthetic process [GO:0016051]; chondroitin sulfate proteoglycan biosynthetic process [GO:0050650]; dermatan sulfate proteoglycan biosynthetic process [GO:0050651]; proteoglycan biosynthetic process [GO:0030166] Golgi membrane [GO:0000139]; membrane [GO:0016020] 3'-phosphoadenosine 5'-phosphosulfate binding [GO:0050656]; chondroitin 4-sulfotransferase activity [GO:0047756]; sulfotransferase activity [GO:0008146] g8750.t1 Q0V8R6 51.569 510 1.27e-179 520.0 sp|Q0V8R6|HEXA_BOVIN Beta-hexosaminidase subunit alpha OS=Bos taurus OX=9913 GN=HEXA PE=2 SV=1 HEXA_BOVIN reviewed Beta-hexosaminidase subunit alpha (EC 3.2.1.52) (Beta-N-acetylhexosaminidase subunit alpha) (Hexosaminidase subunit A) (N-acetyl-beta-glucosaminidase subunit alpha) Bos taurus (Bovine) GO:0001501; GO:0004563; GO:0005764; GO:0005829; GO:0005975; GO:0006024; GO:0006491; GO:0006689; GO:0007040; GO:0007605; GO:0007628; GO:0008375; GO:0016020; GO:0019915; GO:0030203; GO:0030209; GO:0030214; GO:0042552; GO:0042582; GO:0046982; GO:0048667; GO:0050884; GO:0050885; GO:1905379 adult walking behavior [GO:0007628]; carbohydrate metabolic process [GO:0005975]; cell morphogenesis involved in neuron differentiation [GO:0048667]; dermatan sulfate proteoglycan catabolic process [GO:0030209]; ganglioside catabolic process [GO:0006689]; glycosaminoglycan biosynthetic process [GO:0006024]; glycosaminoglycan metabolic process [GO:0030203]; hyaluronan catabolic process [GO:0030214]; lipid storage [GO:0019915]; lysosome organization [GO:0007040]; myelination [GO:0042552]; N-glycan processing [GO:0006491]; neuromuscular process controlling balance [GO:0050885]; neuromuscular process controlling posture [GO:0050884]; sensory perception of sound [GO:0007605]; skeletal system development [GO:0001501] azurophil granule [GO:0042582]; beta-N-acetylhexosaminidase complex [GO:1905379]; cytosol [GO:0005829]; lysosome [GO:0005764]; membrane [GO:0016020] acetylglucosaminyltransferase activity [GO:0008375]; beta-N-acetylhexosaminidase activity [GO:0004563]; protein heterodimerization activity [GO:0046982] g8750.t2 Q641X3 46.441 562 2.1199999999999997e-170 498.0 sp|Q641X3|HEXA_RAT Beta-hexosaminidase subunit alpha OS=Rattus norvegicus OX=10116 GN=Hexa PE=2 SV=1 HEXA_RAT reviewed Beta-hexosaminidase subunit alpha (EC 3.2.1.52) (Beta-N-acetylhexosaminidase subunit alpha) (Hexosaminidase subunit A) (N-acetyl-beta-glucosaminidase subunit alpha) Rattus norvegicus (Rat) GO:0001501; GO:0004563; GO:0005764; GO:0005829; GO:0005975; GO:0006024; GO:0006491; GO:0006689; GO:0007040; GO:0007605; GO:0007626; GO:0007628; GO:0008375; GO:0016020; GO:0019915; GO:0030203; GO:0030209; GO:0030214; GO:0042552; GO:0042582; GO:0046982; GO:0048667; GO:0050884; GO:0050885; GO:1905379 adult walking behavior [GO:0007628]; carbohydrate metabolic process [GO:0005975]; cell morphogenesis involved in neuron differentiation [GO:0048667]; dermatan sulfate proteoglycan catabolic process [GO:0030209]; ganglioside catabolic process [GO:0006689]; glycosaminoglycan biosynthetic process [GO:0006024]; glycosaminoglycan metabolic process [GO:0030203]; hyaluronan catabolic process [GO:0030214]; lipid storage [GO:0019915]; locomotory behavior [GO:0007626]; lysosome organization [GO:0007040]; myelination [GO:0042552]; N-glycan processing [GO:0006491]; neuromuscular process controlling balance [GO:0050885]; neuromuscular process controlling posture [GO:0050884]; sensory perception of sound [GO:0007605]; skeletal system development [GO:0001501] azurophil granule [GO:0042582]; beta-N-acetylhexosaminidase complex [GO:1905379]; cytosol [GO:0005829]; lysosome [GO:0005764]; membrane [GO:0016020] acetylglucosaminyltransferase activity [GO:0008375]; beta-N-acetylhexosaminidase activity [GO:0004563]; protein heterodimerization activity [GO:0046982] g8750.t3 Q0V8R6 46.643 566 1.46e-167 491.0 sp|Q0V8R6|HEXA_BOVIN Beta-hexosaminidase subunit alpha OS=Bos taurus OX=9913 GN=HEXA PE=2 SV=1 HEXA_BOVIN reviewed Beta-hexosaminidase subunit alpha (EC 3.2.1.52) (Beta-N-acetylhexosaminidase subunit alpha) (Hexosaminidase subunit A) (N-acetyl-beta-glucosaminidase subunit alpha) Bos taurus (Bovine) GO:0001501; GO:0004563; GO:0005764; GO:0005829; GO:0005975; GO:0006024; GO:0006491; GO:0006689; GO:0007040; GO:0007605; GO:0007628; GO:0008375; GO:0016020; GO:0019915; GO:0030203; GO:0030209; GO:0030214; GO:0042552; GO:0042582; GO:0046982; GO:0048667; GO:0050884; GO:0050885; GO:1905379 adult walking behavior [GO:0007628]; carbohydrate metabolic process [GO:0005975]; cell morphogenesis involved in neuron differentiation [GO:0048667]; dermatan sulfate proteoglycan catabolic process [GO:0030209]; ganglioside catabolic process [GO:0006689]; glycosaminoglycan biosynthetic process [GO:0006024]; glycosaminoglycan metabolic process [GO:0030203]; hyaluronan catabolic process [GO:0030214]; lipid storage [GO:0019915]; lysosome organization [GO:0007040]; myelination [GO:0042552]; N-glycan processing [GO:0006491]; neuromuscular process controlling balance [GO:0050885]; neuromuscular process controlling posture [GO:0050884]; sensory perception of sound [GO:0007605]; skeletal system development [GO:0001501] azurophil granule [GO:0042582]; beta-N-acetylhexosaminidase complex [GO:1905379]; cytosol [GO:0005829]; lysosome [GO:0005764]; membrane [GO:0016020] acetylglucosaminyltransferase activity [GO:0008375]; beta-N-acetylhexosaminidase activity [GO:0004563]; protein heterodimerization activity [GO:0046982] g8750.t4 Q641X3 46.797 562 2.75e-171 500.0 sp|Q641X3|HEXA_RAT Beta-hexosaminidase subunit alpha OS=Rattus norvegicus OX=10116 GN=Hexa PE=2 SV=1 HEXA_RAT reviewed Beta-hexosaminidase subunit alpha (EC 3.2.1.52) (Beta-N-acetylhexosaminidase subunit alpha) (Hexosaminidase subunit A) (N-acetyl-beta-glucosaminidase subunit alpha) Rattus norvegicus (Rat) GO:0001501; GO:0004563; GO:0005764; GO:0005829; GO:0005975; GO:0006024; GO:0006491; GO:0006689; GO:0007040; GO:0007605; GO:0007626; GO:0007628; GO:0008375; GO:0016020; GO:0019915; GO:0030203; GO:0030209; GO:0030214; GO:0042552; GO:0042582; GO:0046982; GO:0048667; GO:0050884; GO:0050885; GO:1905379 adult walking behavior [GO:0007628]; carbohydrate metabolic process [GO:0005975]; cell morphogenesis involved in neuron differentiation [GO:0048667]; dermatan sulfate proteoglycan catabolic process [GO:0030209]; ganglioside catabolic process [GO:0006689]; glycosaminoglycan biosynthetic process [GO:0006024]; glycosaminoglycan metabolic process [GO:0030203]; hyaluronan catabolic process [GO:0030214]; lipid storage [GO:0019915]; locomotory behavior [GO:0007626]; lysosome organization [GO:0007040]; myelination [GO:0042552]; N-glycan processing [GO:0006491]; neuromuscular process controlling balance [GO:0050885]; neuromuscular process controlling posture [GO:0050884]; sensory perception of sound [GO:0007605]; skeletal system development [GO:0001501] azurophil granule [GO:0042582]; beta-N-acetylhexosaminidase complex [GO:1905379]; cytosol [GO:0005829]; lysosome [GO:0005764]; membrane [GO:0016020] acetylglucosaminyltransferase activity [GO:0008375]; beta-N-acetylhexosaminidase activity [GO:0004563]; protein heterodimerization activity [GO:0046982] g8751.t1 Q2TBK8 52.564 312 4.45e-105 315.0 sp|Q2TBK8|SPN1_BOVIN Snurportin-1 OS=Bos taurus OX=9913 GN=SNUPN PE=2 SV=1 SPN1_BOVIN reviewed Snurportin-1 (RNA U transporter 1) Bos taurus (Bovine) GO:0000339; GO:0005634; GO:0005643; GO:0005654; GO:0005829; GO:0005886; GO:0006404; GO:0006606; GO:0007010; GO:0042564; GO:0051259; GO:0051262; GO:0061015; GO:0061608 cytoskeleton organization [GO:0007010]; protein complex oligomerization [GO:0051259]; protein import into nucleus [GO:0006606]; protein tetramerization [GO:0051262]; RNA import into nucleus [GO:0006404]; snRNA import into nucleus [GO:0061015] cytosol [GO:0005829]; NLS-dependent protein nuclear import complex [GO:0042564]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886] nuclear import signal receptor activity [GO:0061608]; RNA cap binding [GO:0000339] g8753.t1 Q8BG93 55.469 128 7.75e-41 138.0 sp|Q8BG93|NUD15_MOUSE Nucleotide triphosphate diphosphatase NUDT15 OS=Mus musculus OX=10090 GN=Nudt15 PE=1 SV=1 NUD15_MOUSE reviewed Nucleotide triphosphate diphosphatase NUDT15 (EC 3.6.1.68) (EC 3.6.1.76) (EC 3.6.1.9) (MutT homolog 2) (mMTH2) (Nucleoside diphosphate-linked moiety X motif 15) (Nudix motif 15) (Nucleoside diphosphate-linked to another moiety X hydrolase 15) (Nudix hydrolase 15) Mus musculus (Mouse) GO:0000278; GO:0000302; GO:0005829; GO:0006195; GO:0006203; GO:0008413; GO:0009217; GO:0035539; GO:0042178; GO:0042262; GO:0044715; GO:0046872; GO:0047429; GO:0061136; GO:0106405; GO:1901292 dGTP catabolic process [GO:0006203]; DNA protection [GO:0042262]; mitotic cell cycle [GO:0000278]; nucleoside phosphate catabolic process [GO:1901292]; purine deoxyribonucleoside triphosphate catabolic process [GO:0009217]; purine nucleotide catabolic process [GO:0006195]; regulation of proteasomal protein catabolic process [GO:0061136]; response to reactive oxygen species [GO:0000302]; xenobiotic catabolic process [GO:0042178] cytosol [GO:0005829] 8-oxo-7,8-dihydrodeoxyguanosine triphosphate pyrophosphatase activity [GO:0035539]; 8-oxo-7,8-dihydroguanosine triphosphate pyrophosphatase activity [GO:0008413]; 8-oxo-dGDP phosphatase activity [GO:0044715]; isoprenoid diphosphate phosphatase activity [GO:0106405]; metal ion binding [GO:0046872]; nucleoside triphosphate diphosphatase activity [GO:0047429] g8754.t1 Q16595 62.195 82 4.01e-32 118.0 sp|Q16595|FRDA_HUMAN Frataxin, mitochondrial OS=Homo sapiens OX=9606 GN=FXN PE=1 SV=2 g8755.t1 Q92889 73.103 145 6.19e-69 229.0 sp|Q92889|XPF_HUMAN DNA repair endonuclease XPF OS=Homo sapiens OX=9606 GN=ERCC4 PE=1 SV=3 g8759.t1 Q96PS8 36.77 291 6.61e-66 212.0 sp|Q96PS8|AQP10_HUMAN Aquaporin-10 OS=Homo sapiens OX=9606 GN=AQP10 PE=1 SV=2 g8759.t2 Q96PS8 36.77 291 8.39e-66 211.0 sp|Q96PS8|AQP10_HUMAN Aquaporin-10 OS=Homo sapiens OX=9606 GN=AQP10 PE=1 SV=2 g8760.t1 P27089 51.339 224 1.96e-52 173.0 sp|P27089|XPA_CHICK DNA repair protein complementing XP-A cells homolog OS=Gallus gallus OX=9031 GN=XPA PE=2 SV=1 g8761.t1 Q6GLE8 37.673 361 1.5200000000000001e-65 216.0 sp|Q6GLE8|LRC28_XENTR Leucine-rich repeat-containing protein 28 OS=Xenopus tropicalis OX=8364 GN=lrrc28 PE=2 SV=1 g8762.t1 P00491 38.281 256 1.25e-48 166.0 sp|P00491|PNPH_HUMAN Purine nucleoside phosphorylase OS=Homo sapiens OX=9606 GN=PNP PE=1 SV=2 PNPH_HUMAN reviewed Purine nucleoside phosphorylase (PNP) (EC 2.4.2.1) (Inosine phosphorylase) (Inosine-guanosine phosphorylase) Homo sapiens (Human) GO:0000255; GO:0001882; GO:0002060; GO:0004731; GO:0005576; GO:0005737; GO:0005829; GO:0006139; GO:0006148; GO:0006149; GO:0006157; GO:0006166; GO:0006204; GO:0006738; GO:0006955; GO:0009165; GO:0009410; GO:0032743; GO:0034418; GO:0034774; GO:0042102; GO:0042301; GO:0042802; GO:0043101; GO:0046059; GO:0046638; GO:0047975; GO:0070062; GO:1904813 allantoin metabolic process [GO:0000255]; dAMP catabolic process [GO:0046059]; deoxyadenosine catabolic process [GO:0006157]; deoxyinosine catabolic process [GO:0006149]; immune response [GO:0006955]; IMP catabolic process [GO:0006204]; inosine catabolic process [GO:0006148]; nicotinamide riboside catabolic process [GO:0006738]; nucleobase-containing compound metabolic process [GO:0006139]; nucleotide biosynthetic process [GO:0009165]; positive regulation of alpha-beta T cell differentiation [GO:0046638]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of T cell proliferation [GO:0042102]; purine ribonucleoside salvage [GO:0006166]; purine-containing compound salvage [GO:0043101]; response to xenobiotic stimulus [GO:0009410]; urate biosynthetic process [GO:0034418] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; secretory granule lumen [GO:0034774] guanosine phosphorylase activity [GO:0047975]; identical protein binding [GO:0042802]; nucleoside binding [GO:0001882]; phosphate ion binding [GO:0042301]; purine nucleobase binding [GO:0002060]; purine-nucleoside phosphorylase activity [GO:0004731] g8766.t1 Q402B2 24.61 577 4.6599999999999997e-38 154.0 sp|Q402B2|WDR93_MOUSE WD repeat-containing protein 93 OS=Mus musculus OX=10090 GN=Wdr93 PE=2 SV=1 g8768.t1 O43315 46.909 275 3.41e-89 270.0 sp|O43315|AQP9_HUMAN Aquaporin-9 OS=Homo sapiens OX=9606 GN=AQP9 PE=1 SV=2 AQP9_HUMAN reviewed Aquaporin-9 (AQP-9) (Aquaglyceroporin-9) (Small solute channel 1) Homo sapiens (Human) GO:0005345; GO:0005350; GO:0005886; GO:0006833; GO:0006863; GO:0015204; GO:0015250; GO:0015254; GO:0015265; GO:0015267; GO:0015793; GO:0015837; GO:0015855; GO:0016323; GO:0043231; GO:0071320; GO:0071722; GO:0071918; GO:0140070 amine transport [GO:0015837]; cellular response to cAMP [GO:0071320]; detoxification of arsenic-containing substance [GO:0071722]; glycerol transmembrane transport [GO:0015793]; purine nucleobase transport [GO:0006863]; pyrimidine nucleobase transport [GO:0015855]; urea transmembrane transport [GO:0071918]; water transport [GO:0006833] basolateral plasma membrane [GO:0016323]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886] channel activity [GO:0015267]; glycerol channel activity [GO:0015254]; hydrogen peroxide channel activity [GO:0140070]; purine nucleobase transmembrane transporter activity [GO:0005345]; pyrimidine nucleobase transmembrane transporter activity [GO:0005350]; urea channel activity [GO:0015265]; urea transmembrane transporter activity [GO:0015204]; water channel activity [GO:0015250] g8769.t1 Q96PS8 38.889 288 1.4599999999999999e-67 216.0 sp|Q96PS8|AQP10_HUMAN Aquaporin-10 OS=Homo sapiens OX=9606 GN=AQP10 PE=1 SV=2 g8770.t1 Q6BD04 30.455 220 2.4e-25 106.0 sp|Q6BD04|GPR54_ORENI G-protein coupled receptor 54 OS=Oreochromis niloticus OX=8128 GN=gpr54 PE=2 SV=1 g8773.t1 Q6BD04 52.381 84 4.91e-23 96.7 sp|Q6BD04|GPR54_ORENI G-protein coupled receptor 54 OS=Oreochromis niloticus OX=8128 GN=gpr54 PE=2 SV=1 g8774.t1 Q6BD04 29.5 200 3.06e-23 100.0 sp|Q6BD04|GPR54_ORENI G-protein coupled receptor 54 OS=Oreochromis niloticus OX=8128 GN=gpr54 PE=2 SV=1 g8775.t1 Q8MQH7 65.052 289 1.1e-105 319.0 sp|Q8MQH7|DRI_STRPU Protein dead ringer homolog OS=Strongylocentrotus purpuratus OX=7668 GN=dri PE=2 SV=1 g8778.t1 P06276 35.4 613 4.84e-107 338.0 sp|P06276|CHLE_HUMAN Cholinesterase OS=Homo sapiens OX=9606 GN=BCHE PE=1 SV=1 CHLE_HUMAN reviewed Cholinesterase (EC 3.1.1.8) (Acylcholine acylhydrolase) (Butyrylcholine esterase) (Choline esterase II) (Pseudocholinesterase) Homo sapiens (Human) GO:0001540; GO:0003824; GO:0003990; GO:0004104; GO:0005576; GO:0005615; GO:0005641; GO:0005788; GO:0005886; GO:0006581; GO:0006805; GO:0007612; GO:0008285; GO:0014016; GO:0016486; GO:0016788; GO:0019695; GO:0019899; GO:0033265; GO:0042802; GO:0043279; GO:0050784; GO:0050805; GO:0051384; GO:0051593; GO:0072562 acetylcholine catabolic process [GO:0006581]; choline metabolic process [GO:0019695]; cocaine catabolic process [GO:0050784]; learning [GO:0007612]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of synaptic transmission [GO:0050805]; neuroblast differentiation [GO:0014016]; peptide hormone processing [GO:0016486]; response to alkaloid [GO:0043279]; response to folic acid [GO:0051593]; response to glucocorticoid [GO:0051384]; xenobiotic metabolic process [GO:0006805] blood microparticle [GO:0072562]; endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; nuclear envelope lumen [GO:0005641]; plasma membrane [GO:0005886] acetylcholinesterase activity [GO:0003990]; amyloid-beta binding [GO:0001540]; catalytic activity [GO:0003824]; choline binding [GO:0033265]; cholinesterase activity [GO:0004104]; enzyme binding [GO:0019899]; hydrolase activity, acting on ester bonds [GO:0016788]; identical protein binding [GO:0042802] g8779.t1 O62760 37.173 573 1.69e-107 339.0 sp|O62760|CHLE_FELCA Cholinesterase OS=Felis catus OX=9685 GN=BCHE PE=2 SV=1 g8780.t1 Q9NVE4 45.631 103 1.84e-24 85.5 sp|Q9NVE4|CCD87_HUMAN Coiled-coil domain-containing protein 87 OS=Homo sapiens OX=9606 GN=CCDC87 PE=1 SV=2 g8780.t1 Q9NVE4 68.75 32 1.84e-24 50.8 sp|Q9NVE4|CCD87_HUMAN Coiled-coil domain-containing protein 87 OS=Homo sapiens OX=9606 GN=CCDC87 PE=1 SV=2 g8780.t1 Q9NVE4 25.688 436 4.1700000000000006e-21 103.0 sp|Q9NVE4|CCD87_HUMAN Coiled-coil domain-containing protein 87 OS=Homo sapiens OX=9606 GN=CCDC87 PE=1 SV=2 g8782.t1 Q9BU70 42.823 418 1.61e-96 301.0 sp|Q9BU70|TRMO_HUMAN tRNA (adenine(37)-N6)-methyltransferase OS=Homo sapiens OX=9606 GN=TRMO PE=1 SV=2 g8784.t1 C0HL13 34.51 255 1.38e-25 115.0 sp|C0HL13|LRP2_PIG Low-density lipoprotein receptor-related protein 2 OS=Sus scrofa OX=9823 GN=LRP2 PE=1 SV=1 LRP2_PIG reviewed Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin) Sus scrofa (Pig) GO:0001843; GO:0003139; GO:0003148; GO:0003223; GO:0005509; GO:0005905; GO:0006898; GO:0007605; GO:0008584; GO:0009897; GO:0016324; GO:0017124; GO:0030001; GO:0030424; GO:0030425; GO:0030514; GO:0031526; GO:0031904; GO:0043235; GO:0050769; GO:0051087; GO:0060068; GO:0060982; GO:0061156; GO:0070447; GO:0140058; GO:1904447; GO:1905167 coronary artery morphogenesis [GO:0060982]; folate import across plasma membrane [GO:1904447]; male gonad development [GO:0008584]; metal ion transport [GO:0030001]; negative regulation of BMP signaling pathway [GO:0030514]; neural tube closure [GO:0001843]; neuron projection arborization [GO:0140058]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of lysosomal protein catabolic process [GO:1905167]; positive regulation of neurogenesis [GO:0050769]; positive regulation of oligodendrocyte progenitor proliferation [GO:0070447]; pulmonary artery morphogenesis [GO:0061156]; receptor-mediated endocytosis [GO:0006898]; secondary heart field specification [GO:0003139]; sensory perception of sound [GO:0007605]; vagina development [GO:0060068]; ventricular compact myocardium morphogenesis [GO:0003223] apical plasma membrane [GO:0016324]; axon [GO:0030424]; brush border membrane [GO:0031526]; clathrin-coated pit [GO:0005905]; dendrite [GO:0030425]; endosome lumen [GO:0031904]; external side of plasma membrane [GO:0009897]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; protein-folding chaperone binding [GO:0051087]; SH3 domain binding [GO:0017124] g8784.t1 C0HL13 36.444 225 1.9000000000000003e-21 102.0 sp|C0HL13|LRP2_PIG Low-density lipoprotein receptor-related protein 2 OS=Sus scrofa OX=9823 GN=LRP2 PE=1 SV=1 LRP2_PIG reviewed Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin) Sus scrofa (Pig) GO:0001843; GO:0003139; GO:0003148; GO:0003223; GO:0005509; GO:0005905; GO:0006898; GO:0007605; GO:0008584; GO:0009897; GO:0016324; GO:0017124; GO:0030001; GO:0030424; GO:0030425; GO:0030514; GO:0031526; GO:0031904; GO:0043235; GO:0050769; GO:0051087; GO:0060068; GO:0060982; GO:0061156; GO:0070447; GO:0140058; GO:1904447; GO:1905167 coronary artery morphogenesis [GO:0060982]; folate import across plasma membrane [GO:1904447]; male gonad development [GO:0008584]; metal ion transport [GO:0030001]; negative regulation of BMP signaling pathway [GO:0030514]; neural tube closure [GO:0001843]; neuron projection arborization [GO:0140058]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of lysosomal protein catabolic process [GO:1905167]; positive regulation of neurogenesis [GO:0050769]; positive regulation of oligodendrocyte progenitor proliferation [GO:0070447]; pulmonary artery morphogenesis [GO:0061156]; receptor-mediated endocytosis [GO:0006898]; secondary heart field specification [GO:0003139]; sensory perception of sound [GO:0007605]; vagina development [GO:0060068]; ventricular compact myocardium morphogenesis [GO:0003223] apical plasma membrane [GO:0016324]; axon [GO:0030424]; brush border membrane [GO:0031526]; clathrin-coated pit [GO:0005905]; dendrite [GO:0030425]; endosome lumen [GO:0031904]; external side of plasma membrane [GO:0009897]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; protein-folding chaperone binding [GO:0051087]; SH3 domain binding [GO:0017124] g8784.t1 C0HL13 33.48 227 4.91e-21 101.0 sp|C0HL13|LRP2_PIG Low-density lipoprotein receptor-related protein 2 OS=Sus scrofa OX=9823 GN=LRP2 PE=1 SV=1 LRP2_PIG reviewed Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin) Sus scrofa (Pig) GO:0001843; GO:0003139; GO:0003148; GO:0003223; GO:0005509; GO:0005905; GO:0006898; GO:0007605; GO:0008584; GO:0009897; GO:0016324; GO:0017124; GO:0030001; GO:0030424; GO:0030425; GO:0030514; GO:0031526; GO:0031904; GO:0043235; GO:0050769; GO:0051087; GO:0060068; GO:0060982; GO:0061156; GO:0070447; GO:0140058; GO:1904447; GO:1905167 coronary artery morphogenesis [GO:0060982]; folate import across plasma membrane [GO:1904447]; male gonad development [GO:0008584]; metal ion transport [GO:0030001]; negative regulation of BMP signaling pathway [GO:0030514]; neural tube closure [GO:0001843]; neuron projection arborization [GO:0140058]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of lysosomal protein catabolic process [GO:1905167]; positive regulation of neurogenesis [GO:0050769]; positive regulation of oligodendrocyte progenitor proliferation [GO:0070447]; pulmonary artery morphogenesis [GO:0061156]; receptor-mediated endocytosis [GO:0006898]; secondary heart field specification [GO:0003139]; sensory perception of sound [GO:0007605]; vagina development [GO:0060068]; ventricular compact myocardium morphogenesis [GO:0003223] apical plasma membrane [GO:0016324]; axon [GO:0030424]; brush border membrane [GO:0031526]; clathrin-coated pit [GO:0005905]; dendrite [GO:0030425]; endosome lumen [GO:0031904]; external side of plasma membrane [GO:0009897]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; protein-folding chaperone binding [GO:0051087]; SH3 domain binding [GO:0017124] g8785.t1 Q71RS6 38.174 482 9.95e-102 319.0 sp|Q71RS6|NCKX5_HUMAN Sodium/potassium/calcium exchanger 5 OS=Homo sapiens OX=9606 GN=SLC24A5 PE=1 SV=1 NCKX5_HUMAN reviewed Sodium/potassium/calcium exchanger 5 (Na(+)/K(+)/Ca(2+)-exchange protein 5) (Solute carrier family 24 member 5) Homo sapiens (Human) GO:0005262; GO:0005802; GO:0006811; GO:0006874; GO:0008273; GO:0015293; GO:0032588; GO:0034220; GO:0042438; GO:0042470; GO:0048022; GO:0070509; GO:0070588 calcium ion import [GO:0070509]; calcium ion transmembrane transport [GO:0070588]; intracellular calcium ion homeostasis [GO:0006874]; melanin biosynthetic process [GO:0042438]; monoatomic ion transmembrane transport [GO:0034220]; monoatomic ion transport [GO:0006811]; negative regulation of melanin biosynthetic process [GO:0048022] melanosome [GO:0042470]; trans-Golgi network [GO:0005802]; trans-Golgi network membrane [GO:0032588] calcium channel activity [GO:0005262]; calcium, potassium:sodium antiporter activity [GO:0008273]; symporter activity [GO:0015293] g8786.t1 O94788 62.781 489 0.0 654.0 sp|O94788|AL1A2_HUMAN Retinal dehydrogenase 2 OS=Homo sapiens OX=9606 GN=ALDH1A2 PE=1 SV=3 g8787.t1 O94788 60.0 485 0.0 635.0 sp|O94788|AL1A2_HUMAN Retinal dehydrogenase 2 OS=Homo sapiens OX=9606 GN=ALDH1A2 PE=1 SV=3 g8790.t1 Q9ERS2 51.773 141 1.24e-41 138.0 sp|Q9ERS2|NDUAD_MOUSE NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 13 OS=Mus musculus OX=10090 GN=Ndufa13 PE=1 SV=3 NDUAD_MOUSE reviewed NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 13 (Cell death regulatory protein GRIM-19) (Complex I-B16.6) (CI-B16.6) (Gene associated with retinoic and interferon-induced mortality 19 protein) (GRIM-19) (Gene associated with retinoic and IFN-induced mortality 19 protein) (NADH-ubiquinone oxidoreductase B16.6 subunit) Mus musculus (Mouse) GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005743; GO:0009060; GO:0031966; GO:0032981; GO:0035458; GO:0042776; GO:0045039; GO:0045202; GO:0045271; GO:0045732; GO:0045892; GO:0071300; GO:0097191; GO:0098803; GO:1900119 aerobic respiration [GO:0009060]; cellular response to interferon-beta [GO:0035458]; cellular response to retinoic acid [GO:0071300]; extrinsic apoptotic signaling pathway [GO:0097191]; mitochondrial respiratory chain complex I assembly [GO:0032981]; negative regulation of DNA-templated transcription [GO:0045892]; positive regulation of execution phase of apoptosis [GO:1900119]; positive regulation of protein catabolic process [GO:0045732]; protein insertion into mitochondrial inner membrane [GO:0045039]; proton motive force-driven mitochondrial ATP synthesis [GO:0042776] cytoplasm [GO:0005737]; mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; respiratory chain complex [GO:0098803]; respiratory chain complex I [GO:0045271]; synapse [GO:0045202] ATP binding [GO:0005524] g8791.t1 A5IGK7 26.124 356 7.320000000000001e-21 95.5 sp|A5IGK7|TDH_LEGPC L-threonine 3-dehydrogenase OS=Legionella pneumophila (strain Corby) OX=400673 GN=tdh PE=3 SV=1 g8792.t1 Q7ZVZ7 80.351 285 1.59e-156 441.0 sp|Q7ZVZ7|AB17C_DANRE Alpha/beta hydrolase domain-containing protein 17C OS=Danio rerio OX=7955 GN=abhd17c PE=2 SV=1 AB17C_DANRE reviewed Alpha/beta hydrolase domain-containing protein 17C (Abhydrolase domain-containing protein 17C) (EC 3.1.2.22) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005886; GO:0008474; GO:0010008; GO:0043197; GO:0055038; GO:0098839; GO:0099175 regulation of postsynapse organization [GO:0099175] dendritic spine [GO:0043197]; endosome membrane [GO:0010008]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; recycling endosome membrane [GO:0055038] palmitoyl-(protein) hydrolase activity [GO:0008474] g8794.t1 Q24488 42.02 307 1.39e-62 225.0 sp|Q24488|ROR1_DROME Tyrosine-protein kinase transmembrane receptor Ror OS=Drosophila melanogaster OX=7227 GN=Ror PE=1 SV=1 ROR1_DROME reviewed Tyrosine-protein kinase transmembrane receptor Ror (dRor) (EC 2.7.10.1) Drosophila melanogaster (Fruit fly) GO:0004713; GO:0004714; GO:0005524; GO:0005886; GO:0006468; GO:0007169; GO:0007417; GO:0016020; GO:0017147; GO:0030424; GO:0043235 cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; central nervous system development [GO:0007417]; protein phosphorylation [GO:0006468] axon [GO:0030424]; membrane [GO:0016020]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] ATP binding [GO:0005524]; protein tyrosine kinase activity [GO:0004713]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; Wnt-protein binding [GO:0017147] g8795.t1 G3V9H8 35.523 411 5.17e-63 232.0 sp|G3V9H8|RET_RAT Proto-oncogene tyrosine-protein kinase receptor Ret OS=Rattus norvegicus OX=10116 GN=Ret PE=1 SV=1 RET_RAT reviewed Proto-oncogene tyrosine-protein kinase receptor Ret (EC 2.7.10.1) [Cleaved into: Soluble RET kinase fragment; Extracellular cell-membrane anchored RET cadherin 120 kDa fragment] Rattus norvegicus (Rat) GO:0000165; GO:0001657; GO:0001755; GO:0001838; GO:0004714; GO:0005509; GO:0005524; GO:0005769; GO:0005886; GO:0007156; GO:0007158; GO:0007169; GO:0007399; GO:0009410; GO:0010008; GO:0010628; GO:0010976; GO:0014042; GO:0030155; GO:0030182; GO:0030335; GO:0030424; GO:0030425; GO:0033619; GO:0033630; GO:0035799; GO:0035860; GO:0042551; GO:0043025; GO:0043235; GO:0043410; GO:0045793; GO:0045893; GO:0048265; GO:0048484; GO:0050770; GO:0051897; GO:0060041; GO:0060384; GO:0061146; GO:0071300; GO:0072300; GO:0098797; GO:0160144; GO:1904894; GO:2001241 cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; cellular response to retinoic acid [GO:0071300]; embryonic epithelial tube formation [GO:0001838]; enteric nervous system development [GO:0048484]; GDF15-GFRAL signaling pathway [GO:0160144]; glial cell-derived neurotrophic factor receptor signaling pathway [GO:0035860]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; innervation [GO:0060384]; MAPK cascade [GO:0000165]; membrane protein proteolysis [GO:0033619]; nervous system development [GO:0007399]; neural crest cell migration [GO:0001755]; neuron cell-cell adhesion [GO:0007158]; neuron differentiation [GO:0030182]; neuron maturation [GO:0042551]; Peyer's patch morphogenesis [GO:0061146]; positive regulation of cell adhesion mediated by integrin [GO:0033630]; positive regulation of cell migration [GO:0030335]; positive regulation of cell size [GO:0045793]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001241]; positive regulation of gene expression [GO:0010628]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of metanephric glomerulus development [GO:0072300]; positive regulation of neuron maturation [GO:0014042]; positive regulation of neuron projection development [GO:0010976]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of receptor signaling pathway via STAT [GO:1904894]; regulation of axonogenesis [GO:0050770]; regulation of cell adhesion [GO:0030155]; response to pain [GO:0048265]; response to xenobiotic stimulus [GO:0009410]; retina development in camera-type eye [GO:0060041]; ureter maturation [GO:0035799]; ureteric bud development [GO:0001657] axon [GO:0030424]; dendrite [GO:0030425]; early endosome [GO:0005769]; endosome membrane [GO:0010008]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; plasma membrane protein complex [GO:0098797]; receptor complex [GO:0043235] ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; transmembrane receptor protein tyrosine kinase activity [GO:0004714] g8796.t1 Q8R4G9 54.244 483 4.6e-151 444.0 sp|Q8R4G9|ACHA3_MOUSE Neuronal acetylcholine receptor subunit alpha-3 OS=Mus musculus OX=10090 GN=Chrna3 PE=1 SV=1 ACHA3_MOUSE reviewed Neuronal acetylcholine receptor subunit alpha-3 Mus musculus (Mouse) GO:0005730; GO:0005783; GO:0005794; GO:0005829; GO:0005886; GO:0005892; GO:0006937; GO:0006940; GO:0007165; GO:0007271; GO:0007274; GO:0007399; GO:0007626; GO:0009410; GO:0014056; GO:0015464; GO:0016607; GO:0022848; GO:0030425; GO:0032991; GO:0034220; GO:0034703; GO:0035094; GO:0035095; GO:0036064; GO:0042166; GO:0042391; GO:0043005; GO:0043025; GO:0044853; GO:0044877; GO:0045202; GO:0045211; GO:0046872; GO:0048814; GO:0051899; GO:0060079; GO:0060084; GO:0095500; GO:0098691; GO:0098793; GO:0098878; GO:0098981; GO:0099171; GO:0099634; GO:1901363; GO:1904315; GO:1905144 acetylcholine receptor signaling pathway [GO:0095500]; behavioral response to nicotine [GO:0035095]; excitatory postsynaptic potential [GO:0060079]; locomotory behavior [GO:0007626]; membrane depolarization [GO:0051899]; monoatomic ion transmembrane transport [GO:0034220]; nervous system development [GO:0007399]; neuromuscular synaptic transmission [GO:0007274]; presynaptic modulation of chemical synaptic transmission [GO:0099171]; regulation of acetylcholine secretion, neurotransmission [GO:0014056]; regulation of dendrite morphogenesis [GO:0048814]; regulation of membrane potential [GO:0042391]; regulation of muscle contraction [GO:0006937]; regulation of smooth muscle contraction [GO:0006940]; response to acetylcholine [GO:1905144]; response to nicotine [GO:0035094]; response to xenobiotic stimulus [GO:0009410]; signal transduction [GO:0007165]; synaptic transmission involved in micturition [GO:0060084]; synaptic transmission, cholinergic [GO:0007271] acetylcholine-gated channel complex [GO:0005892]; cation channel complex [GO:0034703]; cholinergic synapse [GO:0098981]; ciliary basal body [GO:0036064]; cytosol [GO:0005829]; dendrite [GO:0030425]; dopaminergic synapse [GO:0098691]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; neurotransmitter receptor complex [GO:0098878]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic membrane [GO:0045211]; postsynaptic specialization membrane [GO:0099634]; presynapse [GO:0098793]; protein-containing complex [GO:0032991]; synapse [GO:0045202] acetylcholine binding [GO:0042166]; acetylcholine receptor activity [GO:0015464]; acetylcholine-gated monoatomic cation-selective channel activity [GO:0022848]; heterocyclic compound binding [GO:1901363]; metal ion binding [GO:0046872]; protein-containing complex binding [GO:0044877]; transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315] g8797.t1 P22770 43.154 482 2.21e-118 360.0 sp|P22770|ACHA7_CHICK Neuronal acetylcholine receptor subunit alpha-7 OS=Gallus gallus OX=9031 GN=CHRNA7 PE=1 SV=1 g8799.t1 Q9Z2E1 60.619 226 3.83e-93 284.0 sp|Q9Z2E1|MBD2_MOUSE Methyl-CpG-binding domain protein 2 OS=Mus musculus OX=10090 GN=Mbd2 PE=1 SV=2 g8800.t1 A1L3F4 49.446 542 3.01e-120 366.0 sp|A1L3F4|MEX3B_XENLA RNA-binding protein MEX3B OS=Xenopus laevis OX=8355 GN=mex3b PE=2 SV=1 g8806.t1 Q9Z160 39.428 804 2.02e-175 534.0 sp|Q9Z160|COG1_MOUSE Conserved oligomeric Golgi complex subunit 1 OS=Mus musculus OX=10090 GN=Cog1 PE=1 SV=3 g8807.t1 Q9Z160 55.435 92 1.24e-22 95.1 sp|Q9Z160|COG1_MOUSE Conserved oligomeric Golgi complex subunit 1 OS=Mus musculus OX=10090 GN=Cog1 PE=1 SV=3 g8812.t1 P00637 68.389 329 2.43e-158 449.0 sp|P00637|F16P1_RABIT Fructose-1,6-bisphosphatase 1 OS=Oryctolagus cuniculus OX=9986 GN=FBP1 PE=1 SV=4 g8813.t1 O53532 35.933 359 4.29e-77 246.0 sp|O53532|Y2258_MYCTU S-adenosylmethionine-dependent methyltransferase Rv2258c OS=Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv) OX=83332 GN=Rv2258c PE=1 SV=1 g8819.t1 Q3UTY6 40.513 390 1.86e-83 300.0 sp|Q3UTY6|THSD4_MOUSE Thrombospondin type-1 domain-containing protein 4 OS=Mus musculus OX=10090 GN=Thsd4 PE=1 SV=2 THSD4_MOUSE reviewed Thrombospondin type-1 domain-containing protein 4 (A disintegrin and metalloproteinase with thrombospondin motifs-like protein 6) (ADAMTS-like protein 6) (ADAMTSL-6) (ADAMTS-like protein 4) (ADAMTSL-4) Mus musculus (Mouse) GO:0001527; GO:0005576; GO:0016787; GO:0031012; GO:0048251; GO:0160054 elastic fiber assembly [GO:0048251]; microfibril assembly [GO:0160054] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; microfibril [GO:0001527] hydrolase activity [GO:0016787] g8819.t1 Q3UTY6 41.438 292 6.75e-56 216.0 sp|Q3UTY6|THSD4_MOUSE Thrombospondin type-1 domain-containing protein 4 OS=Mus musculus OX=10090 GN=Thsd4 PE=1 SV=2 THSD4_MOUSE reviewed Thrombospondin type-1 domain-containing protein 4 (A disintegrin and metalloproteinase with thrombospondin motifs-like protein 6) (ADAMTS-like protein 6) (ADAMTSL-6) (ADAMTS-like protein 4) (ADAMTSL-4) Mus musculus (Mouse) GO:0001527; GO:0005576; GO:0016787; GO:0031012; GO:0048251; GO:0160054 elastic fiber assembly [GO:0048251]; microfibril assembly [GO:0160054] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; microfibril [GO:0001527] hydrolase activity [GO:0016787] g8821.t1 Q8R2R5 42.913 254 2.52e-53 176.0 sp|Q8R2R5|LRC61_MOUSE Leucine-rich repeat-containing protein 61 OS=Mus musculus OX=10090 GN=Lrrc61 PE=2 SV=1 g8824.t1 Q6TXF1 27.945 433 1.5599999999999999e-30 124.0 sp|Q6TXF1|ARRD3_RAT Arrestin domain-containing protein 3 OS=Rattus norvegicus OX=10116 GN=Arrdc3 PE=2 SV=1 g8825.t1 Q0VCA2 28.571 448 4.62e-34 134.0 sp|Q0VCA2|ARRD3_BOVIN Arrestin domain-containing protein 3 OS=Bos taurus OX=9913 GN=ARRDC3 PE=2 SV=1 ARRD3_BOVIN reviewed Arrestin domain-containing protein 3 Bos taurus (Bovine) GO:0005737; GO:0005764; GO:0005768; GO:0005769; GO:0005886; GO:0015031; GO:0031649; GO:0031651; GO:0031699; GO:0035332; GO:0043588; GO:0060613; GO:0071878; GO:0090327; GO:0120163 fat pad development [GO:0060613]; heat generation [GO:0031649]; negative regulation of adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071878]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of heat generation [GO:0031651]; negative regulation of locomotion involved in locomotory behavior [GO:0090327]; positive regulation of hippo signaling [GO:0035332]; protein transport [GO:0015031]; skin development [GO:0043588] cytoplasm [GO:0005737]; early endosome [GO:0005769]; endosome [GO:0005768]; lysosome [GO:0005764]; plasma membrane [GO:0005886] beta-3 adrenergic receptor binding [GO:0031699] g8826.t1 O45782 26.425 386 1.1399999999999999e-23 105.0 sp|O45782|ARD17_CAEEL Arrestin domain-containing protein 17 OS=Caenorhabditis elegans OX=6239 GN=arrd-17 PE=1 SV=2 g8828.t1 Q6ZMM2 36.691 278 2.43e-62 215.0 sp|Q6ZMM2|ATL5_HUMAN ADAMTS-like protein 5 OS=Homo sapiens OX=9606 GN=ADAMTSL5 PE=1 SV=3 ATL5_HUMAN reviewed ADAMTS-like protein 5 (ADAMTSL-5) (Thrombospondin type-1 domain-containing protein 6) Homo sapiens (Human) GO:0001527; GO:0005576; GO:0008201; GO:0030198; GO:0031012; GO:0050436 extracellular matrix organization [GO:0030198] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; microfibril [GO:0001527] heparin binding [GO:0008201]; microfibril binding [GO:0050436] g8829.t1 Q8BHJ6 35.565 478 2.8900000000000004e-88 281.0 sp|Q8BHJ6|SERC5_MOUSE Serine incorporator 5 OS=Mus musculus OX=10090 GN=Serinc5 PE=2 SV=1 g8830.t1 A0A974E306 45.988 511 1.82e-68 231.0 sp|A0A974E306|CFA53_XENLA Cilia- and flagella-associated protein 53 OS=Xenopus laevis OX=8355 GN=cfap53.L PE=2 SV=1 g8830.t2 A0A974E306 46.967 511 1.13e-78 258.0 sp|A0A974E306|CFA53_XENLA Cilia- and flagella-associated protein 53 OS=Xenopus laevis OX=8355 GN=cfap53.L PE=2 SV=1 g8831.t1 Q8TF62 58.389 298 4.69e-120 375.0 sp|Q8TF62|AT8B4_HUMAN Probable phospholipid-transporting ATPase IM OS=Homo sapiens OX=9606 GN=ATP8B4 PE=1 SV=3 AT8B4_HUMAN reviewed Probable phospholipid-transporting ATPase IM (EC 7.6.2.1) (ATPase class I type 8B member 4) (P4-ATPase flippase complex alpha subunit ATP8B4) Homo sapiens (Human) GO:0000287; GO:0005524; GO:0005794; GO:0005802; GO:0005886; GO:0007030; GO:0016887; GO:0035579; GO:0045332; GO:0070821; GO:0140326; GO:1990531 Golgi organization [GO:0007030]; phospholipid translocation [GO:0045332] Golgi apparatus [GO:0005794]; phospholipid-translocating ATPase complex [GO:1990531]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821]; trans-Golgi network [GO:0005802] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; magnesium ion binding [GO:0000287] g8832.t1 P98198 53.218 404 1.2200000000000002e-129 406.0 sp|P98198|AT8B2_HUMAN Phospholipid-transporting ATPase ID OS=Homo sapiens OX=9606 GN=ATP8B2 PE=1 SV=2 AT8B2_HUMAN reviewed Phospholipid-transporting ATPase ID (EC 7.6.2.1) (ATPase class I type 8B member 2) (P4-ATPase flippase complex alpha subunit ATP8B2) Homo sapiens (Human) GO:0000287; GO:0005524; GO:0005730; GO:0005789; GO:0005794; GO:0005802; GO:0005829; GO:0005886; GO:0007030; GO:0016887; GO:0034220; GO:0045332; GO:0090554; GO:0140326; GO:0140345; GO:1990531 Golgi organization [GO:0007030]; monoatomic ion transmembrane transport [GO:0034220]; phospholipid translocation [GO:0045332] cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; nucleolus [GO:0005730]; phospholipid-translocating ATPase complex [GO:1990531]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; magnesium ion binding [GO:0000287]; phosphatidylcholine flippase activity [GO:0140345]; phosphatidylcholine floppase activity [GO:0090554] g8833.t1 P98198 39.935 308 3.8100000000000005e-70 240.0 sp|P98198|AT8B2_HUMAN Phospholipid-transporting ATPase ID OS=Homo sapiens OX=9606 GN=ATP8B2 PE=1 SV=2 AT8B2_HUMAN reviewed Phospholipid-transporting ATPase ID (EC 7.6.2.1) (ATPase class I type 8B member 2) (P4-ATPase flippase complex alpha subunit ATP8B2) Homo sapiens (Human) GO:0000287; GO:0005524; GO:0005730; GO:0005789; GO:0005794; GO:0005802; GO:0005829; GO:0005886; GO:0007030; GO:0016887; GO:0034220; GO:0045332; GO:0090554; GO:0140326; GO:0140345; GO:1990531 Golgi organization [GO:0007030]; monoatomic ion transmembrane transport [GO:0034220]; phospholipid translocation [GO:0045332] cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; nucleolus [GO:0005730]; phospholipid-translocating ATPase complex [GO:1990531]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; magnesium ion binding [GO:0000287]; phosphatidylcholine flippase activity [GO:0140345]; phosphatidylcholine floppase activity [GO:0090554] g8834.t1 Q9NXJ5 52.105 190 7.859999999999999e-67 207.0 sp|Q9NXJ5|PGPI_HUMAN Pyroglutamyl-peptidase 1 OS=Homo sapiens OX=9606 GN=PGPEP1 PE=1 SV=1 PGPI_HUMAN reviewed Pyroglutamyl-peptidase 1 (EC 3.4.19.3) (5-oxoprolyl-peptidase) (Pyroglutamyl aminopeptidase I) (PAP-I) (Pyroglutamyl-peptidase I) (PGP-I) (Pyrrolidone-carboxylate peptidase) Homo sapiens (Human) GO:0005829; GO:0006508; GO:0016920; GO:0030163 protein catabolic process [GO:0030163]; proteolysis [GO:0006508] cytosol [GO:0005829] pyroglutamyl-peptidase activity [GO:0016920] g8836.t1 Q4R681 37.778 585 1.69e-118 365.0 sp|Q4R681|MSTO1_MACFA Protein misato homolog 1 OS=Macaca fascicularis OX=9541 GN=MSTO1 PE=2 SV=2 g8839.t1 O75899 33.568 709 1.36e-116 384.0 sp|O75899|GABR2_HUMAN Gamma-aminobutyric acid type B receptor subunit 2 OS=Homo sapiens OX=9606 GN=GABBR2 PE=1 SV=1 GABR2_HUMAN reviewed Gamma-aminobutyric acid type B receptor subunit 2 (GABA-B receptor 2) (GABA-B-R2) (GABA-BR2) (GABABR2) (Gb2) (G-protein coupled receptor 51) (HG20) Homo sapiens (Human) GO:0004888; GO:0004965; GO:0005737; GO:0005886; GO:0007186; GO:0007193; GO:0007194; GO:0007214; GO:0007268; GO:0038039; GO:0043005; GO:0045211; GO:0046982; GO:0051932; GO:0150099; GO:1902710; GO:1902712 adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; chemical synaptic transmission [GO:0007268]; G protein-coupled receptor signaling pathway [GO:0007186]; gamma-aminobutyric acid signaling pathway [GO:0007214]; negative regulation of adenylate cyclase activity [GO:0007194]; neuron-glial cell signaling [GO:0150099]; synaptic transmission, GABAergic [GO:0051932] cytoplasm [GO:0005737]; G protein-coupled GABA receptor complex [GO:1902712]; G protein-coupled receptor heterodimeric complex [GO:0038039]; GABA receptor complex [GO:1902710]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211] G protein-coupled GABA receptor activity [GO:0004965]; protein heterodimerization activity [GO:0046982]; transmembrane signaling receptor activity [GO:0004888] g8840.t1 O75899 31.025 722 1.46e-104 345.0 sp|O75899|GABR2_HUMAN Gamma-aminobutyric acid type B receptor subunit 2 OS=Homo sapiens OX=9606 GN=GABBR2 PE=1 SV=1 GABR2_HUMAN reviewed Gamma-aminobutyric acid type B receptor subunit 2 (GABA-B receptor 2) (GABA-B-R2) (GABA-BR2) (GABABR2) (Gb2) (G-protein coupled receptor 51) (HG20) Homo sapiens (Human) GO:0004888; GO:0004965; GO:0005737; GO:0005886; GO:0007186; GO:0007193; GO:0007194; GO:0007214; GO:0007268; GO:0038039; GO:0043005; GO:0045211; GO:0046982; GO:0051932; GO:0150099; GO:1902710; GO:1902712 adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; chemical synaptic transmission [GO:0007268]; G protein-coupled receptor signaling pathway [GO:0007186]; gamma-aminobutyric acid signaling pathway [GO:0007214]; negative regulation of adenylate cyclase activity [GO:0007194]; neuron-glial cell signaling [GO:0150099]; synaptic transmission, GABAergic [GO:0051932] cytoplasm [GO:0005737]; G protein-coupled GABA receptor complex [GO:1902712]; G protein-coupled receptor heterodimeric complex [GO:0038039]; GABA receptor complex [GO:1902710]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211] G protein-coupled GABA receptor activity [GO:0004965]; protein heterodimerization activity [GO:0046982]; transmembrane signaling receptor activity [GO:0004888] g8841.t1 Q26551 52.083 192 1.2900000000000001e-66 207.0 sp|Q26551|PPIB_SCHMA Peptidyl-prolyl cis-trans isomerase B OS=Schistosoma mansoni OX=6183 GN=CYP PE=2 SV=1 g8845.t1 A4IIC5 44.8 125 3.45e-27 113.0 sp|A4IIC5|S39A3_XENTR Zinc transporter ZIP3 OS=Xenopus tropicalis OX=8364 GN=slc39a3 PE=2 SV=1 S39A3_XENTR reviewed Zinc transporter ZIP3 (Solute carrier family 39 member 3) (Zrt- and Irt-like protein 3) (ZIP-3) Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0005385; GO:0005886; GO:0016324; GO:0071577 zinc ion transmembrane transport [GO:0071577] apical plasma membrane [GO:0016324]; plasma membrane [GO:0005886] zinc ion transmembrane transporter activity [GO:0005385] g8847.t1 P82915 63.218 87 3.91e-34 118.0 sp|P82915|RT16_BOVIN Small ribosomal subunit protein bS16m OS=Bos taurus OX=9913 GN=MRPS16 PE=1 SV=2 g8848.t1 Q5TYW4 43.336 2446 0.0 1761.0 sp|Q5TYW4|NBAS_DANRE NBAS subunit of NRZ tethering complex OS=Danio rerio OX=7955 GN=nbas PE=2 SV=1 NBAS_DANRE reviewed NBAS subunit of NRZ tethering complex (Neuroblastoma-amplified gene protein homolog) (Neuroblastoma-amplified sequence) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000149; GO:0000184; GO:0000956; GO:0006890; GO:0015031; GO:0043009; GO:0048703; GO:0070939; GO:2000623 chordate embryonic development [GO:0043009]; embryonic viscerocranium morphogenesis [GO:0048703]; negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:2000623]; nuclear-transcribed mRNA catabolic process [GO:0000956]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; protein transport [GO:0015031]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890] Dsl1/NZR complex [GO:0070939] SNARE binding [GO:0000149] g8848.t2 Q5TYW4 43.318 2447 0.0 1759.0 sp|Q5TYW4|NBAS_DANRE NBAS subunit of NRZ tethering complex OS=Danio rerio OX=7955 GN=nbas PE=2 SV=1 NBAS_DANRE reviewed NBAS subunit of NRZ tethering complex (Neuroblastoma-amplified gene protein homolog) (Neuroblastoma-amplified sequence) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000149; GO:0000184; GO:0000956; GO:0006890; GO:0015031; GO:0043009; GO:0048703; GO:0070939; GO:2000623 chordate embryonic development [GO:0043009]; embryonic viscerocranium morphogenesis [GO:0048703]; negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:2000623]; nuclear-transcribed mRNA catabolic process [GO:0000956]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; protein transport [GO:0015031]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890] Dsl1/NZR complex [GO:0070939] SNARE binding [GO:0000149] g8849.t1 Q38PU8 26.667 765 2.18e-81 285.0 sp|Q38PU8|GRIA1_MACFA Glutamate receptor 1 OS=Macaca fascicularis OX=9541 GN=GRIA1 PE=2 SV=1 GRIA1_MACFA reviewed Glutamate receptor 1 (GluR-1) (AMPA-selective glutamate receptor 1) (GluR-A) (GluR-K1) (Glutamate receptor ionotropic, AMPA 1) (GluA1) Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey) GO:0004970; GO:0004971; GO:0005789; GO:0014069; GO:0022849; GO:0030425; GO:0030666; GO:0031901; GO:0032281; GO:0043197; GO:0045202; GO:0045211; GO:0055038; GO:0098793; GO:0098794; GO:0098839 AMPA glutamate receptor complex [GO:0032281]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; early endosome membrane [GO:0031901]; endocytic vesicle membrane [GO:0030666]; endoplasmic reticulum membrane [GO:0005789]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; postsynaptic density membrane [GO:0098839]; postsynaptic membrane [GO:0045211]; presynapse [GO:0098793]; recycling endosome membrane [GO:0055038]; synapse [GO:0045202] AMPA glutamate receptor activity [GO:0004971]; glutamate-gated calcium ion channel activity [GO:0022849]; glutamate-gated receptor activity [GO:0004970] g8850.t1 P23818 26.133 750 7.18e-70 253.0 sp|P23818|GRIA1_MOUSE Glutamate receptor 1 OS=Mus musculus OX=10090 GN=Gria1 PE=1 SV=1 GRIA1_MOUSE reviewed Glutamate receptor 1 (GluR-1) (AMPA-selective glutamate receptor 1) (GluR-A) (GluR-K1) (Glutamate receptor ionotropic, AMPA 1) (GluA1) Mus musculus (Mouse) GO:0001540; GO:0001919; GO:0001965; GO:0004970; GO:0004971; GO:0005769; GO:0005783; GO:0005789; GO:0005829; GO:0005886; GO:0005911; GO:0007268; GO:0007416; GO:0007616; GO:0008021; GO:0008179; GO:0008328; GO:0009410; GO:0009636; GO:0009744; GO:0009897; GO:0009986; GO:0010226; GO:0010628; GO:0014069; GO:0016020; GO:0019228; GO:0019865; GO:0019901; GO:0019904; GO:0021510; GO:0021987; GO:0022849; GO:0030165; GO:0030425; GO:0030672; GO:0031267; GO:0031489; GO:0031594; GO:0031623; GO:0031667; GO:0031681; GO:0031698; GO:0031901; GO:0032279; GO:0032281; GO:0032355; GO:0032590; GO:0032591; GO:0032809; GO:0032991; GO:0034765; GO:0035249; GO:0035254; GO:0035255; GO:0036477; GO:0042220; GO:0042734; GO:0042802; GO:0043005; GO:0043025; GO:0043197; GO:0043198; GO:0043278; GO:0044297; GO:0044308; GO:0044309; GO:0045202; GO:0045211; GO:0045471; GO:0045838; GO:0046685; GO:0048167; GO:0048266; GO:0048787; GO:0050804; GO:0050806; GO:0051018; GO:0051428; GO:0051602; GO:0055037; GO:0055038; GO:0060076; GO:0060291; GO:0060292; GO:0060992; GO:0071242; GO:0071359; GO:0071375; GO:0071418; GO:0090326; GO:0097060; GO:0097110; GO:0098793; GO:0098794; GO:0098839; GO:0098978; GO:0099092; GO:0099507; GO:0099544; GO:0099604; GO:1904315; GO:1905232; GO:1990416; GO:1990635; GO:1990708; GO:1990911; GO:2000463 behavioral response to pain [GO:0048266]; cellular response to amine stimulus [GO:0071418]; cellular response to ammonium ion [GO:0071242]; cellular response to brain-derived neurotrophic factor stimulus [GO:1990416]; cellular response to dsRNA [GO:0071359]; cellular response to L-glutamate [GO:1905232]; cellular response to peptide hormone stimulus [GO:0071375]; cerebral cortex development [GO:0021987]; chemical synaptic transmission [GO:0007268]; conditioned place preference [GO:1990708]; long-term memory [GO:0007616]; long-term synaptic depression [GO:0060292]; long-term synaptic potentiation [GO:0060291]; modulation of chemical synaptic transmission [GO:0050804]; neuronal action potential [GO:0019228]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of gene expression [GO:0010628]; positive regulation of locomotion involved in locomotory behavior [GO:0090326]; positive regulation of membrane potential [GO:0045838]; positive regulation of synaptic transmission [GO:0050806]; receptor internalization [GO:0031623]; regulation of monoatomic ion transmembrane transport [GO:0034765]; regulation of receptor recycling [GO:0001919]; regulation of synaptic plasticity [GO:0048167]; response to arsenic-containing substance [GO:0046685]; response to cocaine [GO:0042220]; response to electrical stimulus [GO:0051602]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to fungicide [GO:0060992]; response to lithium ion [GO:0010226]; response to morphine [GO:0043278]; response to nutrient levels [GO:0031667]; response to psychosocial stress [GO:1990911]; response to sucrose [GO:0009744]; response to toxic substance [GO:0009636]; response to xenobiotic stimulus [GO:0009410]; spinal cord development [GO:0021510]; synapse assembly [GO:0007416]; synaptic transmission, glutamatergic [GO:0035249] AMPA glutamate receptor complex [GO:0032281]; asymmetric synapse [GO:0032279]; axonal spine [GO:0044308]; cell body [GO:0044297]; cell surface [GO:0009986]; cell-cell junction [GO:0005911]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendrite membrane [GO:0032590]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; dendritic spine membrane [GO:0032591]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; excitatory synapse [GO:0060076]; external side of plasma membrane [GO:0009897]; glutamatergic synapse [GO:0098978]; ionotropic glutamate receptor complex [GO:0008328]; membrane [GO:0016020]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; neuron spine [GO:0044309]; neuronal cell body [GO:0043025]; neuronal cell body membrane [GO:0032809]; perisynaptic space [GO:0099544]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; postsynaptic density membrane [GO:0098839]; postsynaptic density, intracellular component [GO:0099092]; postsynaptic membrane [GO:0045211]; presynapse [GO:0098793]; presynaptic active zone membrane [GO:0048787]; presynaptic membrane [GO:0042734]; protein-containing complex [GO:0032991]; proximal dendrite [GO:1990635]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; somatodendritic compartment [GO:0036477]; synapse [GO:0045202]; synaptic membrane [GO:0097060]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672] adenylate cyclase binding [GO:0008179]; AMPA glutamate receptor activity [GO:0004971]; amyloid-beta binding [GO:0001540]; beta-2 adrenergic receptor binding [GO:0031698]; G-protein alpha-subunit binding [GO:0001965]; G-protein beta-subunit binding [GO:0031681]; glutamate receptor binding [GO:0035254]; glutamate-gated calcium ion channel activity [GO:0022849]; glutamate-gated receptor activity [GO:0004970]; identical protein binding [GO:0042802]; immunoglobulin binding [GO:0019865]; ionotropic glutamate receptor binding [GO:0035255]; ligand-gated calcium channel activity [GO:0099604]; ligand-gated monoatomic ion channel activity involved in regulation of presynaptic membrane potential [GO:0099507]; myosin V binding [GO:0031489]; PDZ domain binding [GO:0030165]; peptide hormone receptor binding [GO:0051428]; protein domain specific binding [GO:0019904]; protein kinase A binding [GO:0051018]; protein kinase binding [GO:0019901]; scaffold protein binding [GO:0097110]; small GTPase binding [GO:0031267]; transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315] g8853.t1 P23818 29.669 755 3.07e-106 353.0 sp|P23818|GRIA1_MOUSE Glutamate receptor 1 OS=Mus musculus OX=10090 GN=Gria1 PE=1 SV=1 GRIA1_MOUSE reviewed Glutamate receptor 1 (GluR-1) (AMPA-selective glutamate receptor 1) (GluR-A) (GluR-K1) (Glutamate receptor ionotropic, AMPA 1) (GluA1) Mus musculus (Mouse) GO:0001540; GO:0001919; GO:0001965; GO:0004970; GO:0004971; GO:0005769; GO:0005783; GO:0005789; GO:0005829; GO:0005886; GO:0005911; GO:0007268; GO:0007416; GO:0007616; GO:0008021; GO:0008179; GO:0008328; GO:0009410; GO:0009636; GO:0009744; GO:0009897; GO:0009986; GO:0010226; GO:0010628; GO:0014069; GO:0016020; GO:0019228; GO:0019865; GO:0019901; GO:0019904; GO:0021510; GO:0021987; GO:0022849; GO:0030165; GO:0030425; GO:0030672; GO:0031267; GO:0031489; GO:0031594; GO:0031623; GO:0031667; GO:0031681; GO:0031698; GO:0031901; GO:0032279; GO:0032281; GO:0032355; GO:0032590; GO:0032591; GO:0032809; GO:0032991; GO:0034765; GO:0035249; GO:0035254; GO:0035255; GO:0036477; GO:0042220; GO:0042734; GO:0042802; GO:0043005; GO:0043025; GO:0043197; GO:0043198; GO:0043278; GO:0044297; GO:0044308; GO:0044309; GO:0045202; GO:0045211; GO:0045471; GO:0045838; GO:0046685; GO:0048167; GO:0048266; GO:0048787; GO:0050804; GO:0050806; GO:0051018; GO:0051428; GO:0051602; GO:0055037; GO:0055038; GO:0060076; GO:0060291; GO:0060292; GO:0060992; GO:0071242; GO:0071359; GO:0071375; GO:0071418; GO:0090326; GO:0097060; GO:0097110; GO:0098793; GO:0098794; GO:0098839; GO:0098978; GO:0099092; GO:0099507; GO:0099544; GO:0099604; GO:1904315; GO:1905232; GO:1990416; GO:1990635; GO:1990708; GO:1990911; GO:2000463 behavioral response to pain [GO:0048266]; cellular response to amine stimulus [GO:0071418]; cellular response to ammonium ion [GO:0071242]; cellular response to brain-derived neurotrophic factor stimulus [GO:1990416]; cellular response to dsRNA [GO:0071359]; cellular response to L-glutamate [GO:1905232]; cellular response to peptide hormone stimulus [GO:0071375]; cerebral cortex development [GO:0021987]; chemical synaptic transmission [GO:0007268]; conditioned place preference [GO:1990708]; long-term memory [GO:0007616]; long-term synaptic depression [GO:0060292]; long-term synaptic potentiation [GO:0060291]; modulation of chemical synaptic transmission [GO:0050804]; neuronal action potential [GO:0019228]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of gene expression [GO:0010628]; positive regulation of locomotion involved in locomotory behavior [GO:0090326]; positive regulation of membrane potential [GO:0045838]; positive regulation of synaptic transmission [GO:0050806]; receptor internalization [GO:0031623]; regulation of monoatomic ion transmembrane transport [GO:0034765]; regulation of receptor recycling [GO:0001919]; regulation of synaptic plasticity [GO:0048167]; response to arsenic-containing substance [GO:0046685]; response to cocaine [GO:0042220]; response to electrical stimulus [GO:0051602]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to fungicide [GO:0060992]; response to lithium ion [GO:0010226]; response to morphine [GO:0043278]; response to nutrient levels [GO:0031667]; response to psychosocial stress [GO:1990911]; response to sucrose [GO:0009744]; response to toxic substance [GO:0009636]; response to xenobiotic stimulus [GO:0009410]; spinal cord development [GO:0021510]; synapse assembly [GO:0007416]; synaptic transmission, glutamatergic [GO:0035249] AMPA glutamate receptor complex [GO:0032281]; asymmetric synapse [GO:0032279]; axonal spine [GO:0044308]; cell body [GO:0044297]; cell surface [GO:0009986]; cell-cell junction [GO:0005911]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendrite membrane [GO:0032590]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; dendritic spine membrane [GO:0032591]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; excitatory synapse [GO:0060076]; external side of plasma membrane [GO:0009897]; glutamatergic synapse [GO:0098978]; ionotropic glutamate receptor complex [GO:0008328]; membrane [GO:0016020]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; neuron spine [GO:0044309]; neuronal cell body [GO:0043025]; neuronal cell body membrane [GO:0032809]; perisynaptic space [GO:0099544]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; postsynaptic density membrane [GO:0098839]; postsynaptic density, intracellular component [GO:0099092]; postsynaptic membrane [GO:0045211]; presynapse [GO:0098793]; presynaptic active zone membrane [GO:0048787]; presynaptic membrane [GO:0042734]; protein-containing complex [GO:0032991]; proximal dendrite [GO:1990635]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; somatodendritic compartment [GO:0036477]; synapse [GO:0045202]; synaptic membrane [GO:0097060]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672] adenylate cyclase binding [GO:0008179]; AMPA glutamate receptor activity [GO:0004971]; amyloid-beta binding [GO:0001540]; beta-2 adrenergic receptor binding [GO:0031698]; G-protein alpha-subunit binding [GO:0001965]; G-protein beta-subunit binding [GO:0031681]; glutamate receptor binding [GO:0035254]; glutamate-gated calcium ion channel activity [GO:0022849]; glutamate-gated receptor activity [GO:0004970]; identical protein binding [GO:0042802]; immunoglobulin binding [GO:0019865]; ionotropic glutamate receptor binding [GO:0035255]; ligand-gated calcium channel activity [GO:0099604]; ligand-gated monoatomic ion channel activity involved in regulation of presynaptic membrane potential [GO:0099507]; myosin V binding [GO:0031489]; PDZ domain binding [GO:0030165]; peptide hormone receptor binding [GO:0051428]; protein domain specific binding [GO:0019904]; protein kinase A binding [GO:0051018]; protein kinase binding [GO:0019901]; scaffold protein binding [GO:0097110]; small GTPase binding [GO:0031267]; transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315] g8856.t1 Q9H2B2 56.569 274 4.37e-105 321.0 sp|Q9H2B2|SYT4_HUMAN Synaptotagmin-4 OS=Homo sapiens OX=9606 GN=SYT4 PE=1 SV=1 SYT4_HUMAN reviewed Synaptotagmin-4 (Synaptotagmin IV) (SytIV) Homo sapiens (Human) GO:0000139; GO:0000149; GO:0005509; GO:0005544; GO:0005886; GO:0006906; GO:0007613; GO:0014049; GO:0014059; GO:0016192; GO:0017158; GO:0030100; GO:0030154; GO:0030424; GO:0030425; GO:0030672; GO:0032127; GO:0033604; GO:0043025; GO:0045202; GO:0045955; GO:0045956; GO:0048174; GO:0048471; GO:0050709; GO:0061891; GO:0070382; GO:0097449; GO:0098978; GO:0098992; GO:0099012; GO:0099502; GO:0099519; GO:0150035; GO:0150044; GO:1903861; GO:1905415; GO:1905433; GO:1990742; GO:2000301 calcium-dependent activation of synaptic vesicle fusion [GO:0099502]; cell differentiation [GO:0030154]; dense core granule cytoskeletal transport [GO:0099519]; memory [GO:0007613]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of catecholamine secretion [GO:0033604]; negative regulation of protein secretion [GO:0050709]; negative regulation of retrograde trans-synaptic signaling by neuropeptide [GO:1905433]; negative regulation of short-term neuronal synaptic plasticity [GO:0048174]; negative regulation of synaptic vesicle exocytosis [GO:2000301]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; positive regulation of dendrite extension [GO:1903861]; positive regulation of dense core granule exocytosis [GO:1905415]; positive regulation of glutamate secretion [GO:0014049]; regulation of calcium ion-dependent exocytosis [GO:0017158]; regulation of dopamine secretion [GO:0014059]; regulation of endocytosis [GO:0030100]; regulation of postsynaptic dense core vesicle exocytosis [GO:0150044]; regulation of trans-synaptic signaling by BDNF, modulating synaptic transmission [GO:0150035]; vesicle fusion [GO:0006906]; vesicle-mediated transport [GO:0016192] astrocyte projection [GO:0097449]; axon [GO:0030424]; dendrite [GO:0030425]; dense core granule membrane [GO:0032127]; exocytic vesicle [GO:0070382]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; microvesicle [GO:1990742]; neuronal cell body [GO:0043025]; neuronal dense core vesicle [GO:0098992]; neuronal dense core vesicle membrane [GO:0099012]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; synapse [GO:0045202]; synaptic vesicle membrane [GO:0030672] calcium ion binding [GO:0005509]; calcium ion sensor activity [GO:0061891]; calcium-dependent phospholipid binding [GO:0005544]; SNARE binding [GO:0000149] g8859.t1 P70426 67.662 201 1.76e-92 274.0 sp|P70426|RIT1_MOUSE GTP-binding protein Rit1 OS=Mus musculus OX=10090 GN=Rit1 PE=1 SV=1 g8861.t1 Q5RE70 53.895 937 0.0 962.0 sp|Q5RE70|INT3_PONAB Integrator complex subunit 3 OS=Pongo abelii OX=9601 GN=INTS3 PE=2 SV=1 g8862.t1 E9Q1U1 34.839 1306 2.83e-169 543.0 sp|E9Q1U1|CC171_MOUSE Coiled-coil domain-containing protein 171 OS=Mus musculus OX=10090 GN=Ccdc171 PE=2 SV=1 g8862.t2 E9Q1U1 34.763 1306 1.93e-175 560.0 sp|E9Q1U1|CC171_MOUSE Coiled-coil domain-containing protein 171 OS=Mus musculus OX=10090 GN=Ccdc171 PE=2 SV=1 g8863.t1 Q96JP0 58.046 522 0.0 635.0 sp|Q96JP0|FEM1C_HUMAN Protein fem-1 homolog C OS=Homo sapiens OX=9606 GN=FEM1C PE=1 SV=1 FEM1C_HUMAN reviewed Protein fem-1 homolog C (FEM1c) (FEM1-gamma) Homo sapiens (Human) GO:0000151; GO:0005654; GO:0005829; GO:0016567; GO:0031462; GO:0043161; GO:0140627; GO:1990756 proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process via the C-end degron rule pathway [GO:0140627] Cul2-RING ubiquitin ligase complex [GO:0031462]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; ubiquitin ligase complex [GO:0000151] ubiquitin-like ligase-substrate adaptor activity [GO:1990756] g8865.t1 Q69ZQ1 52.0 175 1.29e-48 171.0 sp|Q69ZQ1|MYORG_MOUSE Myogenesis-regulating glycosidase OS=Mus musculus OX=10090 GN=Myorg PE=1 SV=2 MYORG_MOUSE reviewed Alpha-galactosidase MYORG (EC 3.2.1.22) (Myogenesis regulating glycosidase) (Nuclear envelope transmembrane protein 37) Mus musculus (Mouse) GO:0004557; GO:0005789; GO:0005975; GO:0031965; GO:0043568; GO:0048741; GO:0051897 carbohydrate metabolic process [GO:0005975]; positive regulation of insulin-like growth factor receptor signaling pathway [GO:0043568]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; skeletal muscle fiber development [GO:0048741] endoplasmic reticulum membrane [GO:0005789]; nuclear membrane [GO:0031965] alpha-galactosidase activity [GO:0004557] g8866.t1 Q6NSJ0 37.822 349 2.66e-83 274.0 sp|Q6NSJ0|MYORG_HUMAN Myogenesis-regulating glycosidase OS=Homo sapiens OX=9606 GN=MYORG PE=1 SV=2 MYORG_HUMAN reviewed Alpha-galactosidase MYORG (EC 3.2.1.22) (Myogenesis regulating glycosidase) (Nuclear envelope transmembrane protein 37) Homo sapiens (Human) GO:0004557; GO:0005789; GO:0005975; GO:0031965; GO:0043568; GO:0048741; GO:0051897 carbohydrate metabolic process [GO:0005975]; positive regulation of insulin-like growth factor receptor signaling pathway [GO:0043568]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; skeletal muscle fiber development [GO:0048741] endoplasmic reticulum membrane [GO:0005789]; nuclear membrane [GO:0031965] alpha-galactosidase activity [GO:0004557] g8867.t1 Q9UPR6 44.737 684 1.39e-145 453.0 sp|Q9UPR6|ZFR2_HUMAN Zinc finger RNA-binding protein 2 OS=Homo sapiens OX=9606 GN=ZFR2 PE=1 SV=3 g8867.t2 Q9UPR6 45.081 681 6.29e-147 457.0 sp|Q9UPR6|ZFR2_HUMAN Zinc finger RNA-binding protein 2 OS=Homo sapiens OX=9606 GN=ZFR2 PE=1 SV=3 g8870.t1 Q6NSJ0 36.484 529 5.66e-119 376.0 sp|Q6NSJ0|MYORG_HUMAN Myogenesis-regulating glycosidase OS=Homo sapiens OX=9606 GN=MYORG PE=1 SV=2 MYORG_HUMAN reviewed Alpha-galactosidase MYORG (EC 3.2.1.22) (Myogenesis regulating glycosidase) (Nuclear envelope transmembrane protein 37) Homo sapiens (Human) GO:0004557; GO:0005789; GO:0005975; GO:0031965; GO:0043568; GO:0048741; GO:0051897 carbohydrate metabolic process [GO:0005975]; positive regulation of insulin-like growth factor receptor signaling pathway [GO:0043568]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; skeletal muscle fiber development [GO:0048741] endoplasmic reticulum membrane [GO:0005789]; nuclear membrane [GO:0031965] alpha-galactosidase activity [GO:0004557] g8871.t1 Q69ZQ1 33.133 332 1.3899999999999999e-46 172.0 sp|Q69ZQ1|MYORG_MOUSE Myogenesis-regulating glycosidase OS=Mus musculus OX=10090 GN=Myorg PE=1 SV=2 MYORG_MOUSE reviewed Alpha-galactosidase MYORG (EC 3.2.1.22) (Myogenesis regulating glycosidase) (Nuclear envelope transmembrane protein 37) Mus musculus (Mouse) GO:0004557; GO:0005789; GO:0005975; GO:0031965; GO:0043568; GO:0048741; GO:0051897 carbohydrate metabolic process [GO:0005975]; positive regulation of insulin-like growth factor receptor signaling pathway [GO:0043568]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; skeletal muscle fiber development [GO:0048741] endoplasmic reticulum membrane [GO:0005789]; nuclear membrane [GO:0031965] alpha-galactosidase activity [GO:0004557] g8872.t1 Q69ZQ1 47.08 274 3.34e-75 246.0 sp|Q69ZQ1|MYORG_MOUSE Myogenesis-regulating glycosidase OS=Mus musculus OX=10090 GN=Myorg PE=1 SV=2 MYORG_MOUSE reviewed Alpha-galactosidase MYORG (EC 3.2.1.22) (Myogenesis regulating glycosidase) (Nuclear envelope transmembrane protein 37) Mus musculus (Mouse) GO:0004557; GO:0005789; GO:0005975; GO:0031965; GO:0043568; GO:0048741; GO:0051897 carbohydrate metabolic process [GO:0005975]; positive regulation of insulin-like growth factor receptor signaling pathway [GO:0043568]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; skeletal muscle fiber development [GO:0048741] endoplasmic reticulum membrane [GO:0005789]; nuclear membrane [GO:0031965] alpha-galactosidase activity [GO:0004557] g8873.t1 O44119 40.845 284 1.98e-40 144.0 sp|O44119|TPM_HOMAM Tropomyosin OS=Homarus americanus OX=6706 GN=TM1 PE=1 SV=1 g8876.t1 A8CVX7 64.637 427 0.0 584.0 sp|A8CVX7|TTLL6_DANRE Tubulin polyglutamylase ttll6 OS=Danio rerio OX=7955 GN=ttll6 PE=2 SV=1 TTLL6_DANRE reviewed Tubulin polyglutamylase ttll6 (EC 6.3.2.-) (Protein polyglutamylase TTLL6) (Tubulin tyrosine ligase-like family member 6) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001578; GO:0003341; GO:0005524; GO:0005874; GO:0005929; GO:0005930; GO:0015631; GO:0018095; GO:0035082; GO:0036064; GO:0046872; GO:0060296; GO:0070739; GO:0070740; GO:0106437; GO:0106438 axoneme assembly [GO:0035082]; cilium movement [GO:0003341]; microtubule bundle formation [GO:0001578]; protein polyglutamylation [GO:0018095]; regulation of cilium beat frequency involved in ciliary motility [GO:0060296] axoneme [GO:0005930]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; microtubule [GO:0005874] ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein-glutamic acid ligase activity [GO:0070739]; protein-glutamic acid ligase activity, elongating [GO:0106438]; protein-glutamic acid ligase activity, initiating [GO:0106437]; tubulin binding [GO:0015631]; tubulin-glutamic acid ligase activity [GO:0070740] g8877.t1 Q28104 63.087 298 8.97e-144 410.0 sp|Q28104|COPE_BOVIN Coatomer subunit epsilon OS=Bos taurus OX=9913 GN=COPE PE=1 SV=3 COPE_BOVIN reviewed Coatomer subunit epsilon (Epsilon-coat protein) (Epsilon-COP) Bos taurus (Bovine) GO:0000139; GO:0005198; GO:0005654; GO:0006888; GO:0006890; GO:0006891; GO:0015031; GO:0030126; GO:0099612 endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intra-Golgi vesicle-mediated transport [GO:0006891]; protein localization to axon [GO:0099612]; protein transport [GO:0015031]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890] COPI vesicle coat [GO:0030126]; Golgi membrane [GO:0000139]; nucleoplasm [GO:0005654] structural molecule activity [GO:0005198] g8878.t1 P97292 31.818 308 3.04e-31 127.0 sp|P97292|HRH2_MOUSE Histamine H2 receptor OS=Mus musculus OX=10090 GN=Hrh2 PE=2 SV=2 HRH2_MOUSE reviewed Histamine H2 receptor (H2R) (HH2R) (Gastric receptor I) Mus musculus (Mouse) GO:0001696; GO:0001697; GO:0001698; GO:0003382; GO:0004969; GO:0005886; GO:0007187; GO:0007268; GO:0007613; GO:0008542; GO:0030425; GO:0030594; GO:0045202; GO:0045907; GO:0048167; GO:0048565; GO:0048732; GO:1900139; GO:1901363 chemical synaptic transmission [GO:0007268]; digestive tract development [GO:0048565]; epithelial cell morphogenesis [GO:0003382]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; gastric acid secretion [GO:0001696]; gastrin-induced gastric acid secretion [GO:0001698]; gland development [GO:0048732]; histamine-induced gastric acid secretion [GO:0001697]; memory [GO:0007613]; negative regulation of arachidonate secretion [GO:1900139]; positive regulation of vasoconstriction [GO:0045907]; regulation of synaptic plasticity [GO:0048167]; visual learning [GO:0008542] dendrite [GO:0030425]; plasma membrane [GO:0005886]; synapse [GO:0045202] heterocyclic compound binding [GO:1901363]; histamine receptor activity [GO:0004969]; neurotransmitter receptor activity [GO:0030594] g8881.t1 P63240 49.571 583 2.78e-166 496.0 sp|P63240|NEC1_MUSCO Neuroendocrine convertase 1 OS=Mus cookii OX=10098 GN=Pcsk1 PE=2 SV=1 NEC1_MUSCO reviewed Neuroendocrine convertase 1 (NEC 1) (EC 3.4.21.93) (Furin homolog) (PC3) (Prohormone convertase 1) (Propeptide-processing protease) (Proprotein convertase 1) (PC1) Mus cookii (Cook's mouse) GO:0004252; GO:0005615; GO:0005788; GO:0016020; GO:0016486; GO:0030133; GO:0034774; GO:0043005 peptide hormone processing [GO:0016486] endoplasmic reticulum lumen [GO:0005788]; extracellular space [GO:0005615]; membrane [GO:0016020]; neuron projection [GO:0043005]; secretory granule lumen [GO:0034774]; transport vesicle [GO:0030133] serine-type endopeptidase activity [GO:0004252] g8882.t1 Q495B1 32.299 548 3.31e-83 276.0 sp|Q495B1|AKD1A_HUMAN Ankyrin repeat and death domain-containing protein 1A OS=Homo sapiens OX=9606 GN=ANKDD1A PE=1 SV=2 g8882.t2 Q495B1 32.664 548 8.77e-86 279.0 sp|Q495B1|AKD1A_HUMAN Ankyrin repeat and death domain-containing protein 1A OS=Homo sapiens OX=9606 GN=ANKDD1A PE=1 SV=2 g8884.t1 Q9DAG6 33.908 174 8.71e-22 97.8 sp|Q9DAG6|GPRL1_MOUSE GLIPR1-like protein 1 OS=Mus musculus OX=10090 GN=Glipr1l1 PE=1 SV=1 GPRL1_MOUSE reviewed GLIPR1-like protein 1 Mus musculus (Mouse) GO:0001669; GO:0002081; GO:0005615; GO:0005886; GO:0007339; GO:0007342; GO:0045121; GO:0060090; GO:0060476; GO:0098635; GO:0120212 binding of sperm to zona pellucida [GO:0007339]; fusion of sperm to egg plasma membrane involved in single fertilization [GO:0007342]; protein localization involved in acrosome reaction [GO:0060476] acrosomal vesicle [GO:0001669]; extracellular space [GO:0005615]; membrane raft [GO:0045121]; outer acrosomal membrane [GO:0002081]; plasma membrane [GO:0005886]; protein complex involved in cell-cell adhesion [GO:0098635]; sperm head-tail coupling apparatus [GO:0120212] molecular adaptor activity [GO:0060090] g8885.t1 O42329 37.333 300 5.35e-58 197.0 sp|O42329|GNRR2_CLAGA Gonadotropin-releasing hormone II receptor OS=Clarias gariepinus OX=13013 PE=2 SV=2 g8888.t1 Q9JJ09 51.743 545 9.57e-149 448.0 sp|Q9JJ09|NPT2B_RAT Sodium-dependent phosphate transport protein 2B OS=Rattus norvegicus OX=10116 GN=Slc34a2 PE=1 SV=1 NPT2B_RAT reviewed Sodium-dependent phosphate transport protein 2B (Sodium-phosphate transport protein 2B) (Na(+)-dependent phosphate cotransporter 2B) (Sodium/phosphate cotransporter 2B) (Na(+)/Pi cotransporter 2B) (NaPi-2b) (Solute carrier family 34 member 2) (rNaPi IIb) Rattus norvegicus (Rat) GO:0001701; GO:0005436; GO:0005903; GO:0006817; GO:0009750; GO:0016020; GO:0016324; GO:0019904; GO:0030643; GO:0031402; GO:0031526; GO:0031528; GO:0031982; GO:0032355; GO:0042301; GO:0043627; GO:0044341 in utero embryonic development [GO:0001701]; intracellular phosphate ion homeostasis [GO:0030643]; phosphate ion transport [GO:0006817]; response to estradiol [GO:0032355]; response to estrogen [GO:0043627]; response to fructose [GO:0009750]; sodium-dependent phosphate transport [GO:0044341] apical plasma membrane [GO:0016324]; brush border [GO:0005903]; brush border membrane [GO:0031526]; membrane [GO:0016020]; microvillus membrane [GO:0031528]; vesicle [GO:0031982] phosphate ion binding [GO:0042301]; protein domain specific binding [GO:0019904]; sodium ion binding [GO:0031402]; sodium:phosphate symporter activity [GO:0005436] g8889.t1 Q96B77 42.405 158 9.31e-41 143.0 sp|Q96B77|TM186_HUMAN Transmembrane protein 186 OS=Homo sapiens OX=9606 GN=TMEM186 PE=1 SV=1 g8890.t1 Q6PD21 38.71 217 1.6599999999999999e-40 155.0 sp|Q6PD21|SHB_MOUSE SH2 domain-containing adapter protein B OS=Mus musculus OX=10090 GN=Shb PE=1 SV=2 SHB_MOUSE reviewed SH2 domain-containing adapter protein B Mus musculus (Mouse) GO:0001525; GO:0001568; GO:0001784; GO:0005654; GO:0005829; GO:0005886; GO:0006915; GO:0030097; GO:0030159; GO:0036464; GO:0042100; GO:0045624; GO:0045931; GO:0048514; GO:0050852; GO:0071425; GO:1900194 angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; B cell proliferation [GO:0042100]; blood vessel development [GO:0001568]; blood vessel morphogenesis [GO:0048514]; hematopoietic stem cell proliferation [GO:0071425]; hemopoiesis [GO:0030097]; negative regulation of oocyte maturation [GO:1900194]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of T-helper cell differentiation [GO:0045624]; T cell receptor signaling pathway [GO:0050852] cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] phosphotyrosine residue binding [GO:0001784]; signaling receptor complex adaptor activity [GO:0030159] g8890.t2 Q6PD21 32.177 317 3.5499999999999997e-40 155.0 sp|Q6PD21|SHB_MOUSE SH2 domain-containing adapter protein B OS=Mus musculus OX=10090 GN=Shb PE=1 SV=2 SHB_MOUSE reviewed SH2 domain-containing adapter protein B Mus musculus (Mouse) GO:0001525; GO:0001568; GO:0001784; GO:0005654; GO:0005829; GO:0005886; GO:0006915; GO:0030097; GO:0030159; GO:0036464; GO:0042100; GO:0045624; GO:0045931; GO:0048514; GO:0050852; GO:0071425; GO:1900194 angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; B cell proliferation [GO:0042100]; blood vessel development [GO:0001568]; blood vessel morphogenesis [GO:0048514]; hematopoietic stem cell proliferation [GO:0071425]; hemopoiesis [GO:0030097]; negative regulation of oocyte maturation [GO:1900194]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of T-helper cell differentiation [GO:0045624]; T cell receptor signaling pathway [GO:0050852] cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] phosphotyrosine residue binding [GO:0001784]; signaling receptor complex adaptor activity [GO:0030159] g8894.t1 Q5UQ13 34.507 426 2.9599999999999997e-24 111.0 sp|Q5UQ13|COLL2_MIMIV Collagen-like protein 2 OS=Acanthamoeba polyphaga mimivirus OX=212035 GN=MIMI_R196 PE=4 SV=1 g8894.t1 Q5UQ13 37.275 389 3.88e-21 101.0 sp|Q5UQ13|COLL2_MIMIV Collagen-like protein 2 OS=Acanthamoeba polyphaga mimivirus OX=212035 GN=MIMI_R196 PE=4 SV=1 g8899.t1 A2AM05 30.968 310 6.190000000000001e-31 130.0 sp|A2AM05|CNTLN_MOUSE Centlein OS=Mus musculus OX=10090 GN=Cntln PE=1 SV=1 CNTLN_MOUSE reviewed Centlein (Centrosomal protein) Mus musculus (Mouse) GO:0005654; GO:0005737; GO:0005813; GO:0005814; GO:0005829; GO:0007283; GO:0007338; GO:0008104; GO:0010457; GO:0019901; GO:0019904; GO:0030674; GO:0032880; GO:0065003; GO:0120212 centriole-centriole cohesion [GO:0010457]; intracellular protein localization [GO:0008104]; protein-containing complex assembly [GO:0065003]; regulation of protein localization [GO:0032880]; single fertilization [GO:0007338]; spermatogenesis [GO:0007283] centriole [GO:0005814]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; sperm head-tail coupling apparatus [GO:0120212] protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; protein-macromolecule adaptor activity [GO:0030674] g8900.t1 Q9NXG0 39.297 313 3.39e-34 144.0 sp|Q9NXG0|CNTLN_HUMAN Centlein OS=Homo sapiens OX=9606 GN=CNTLN PE=1 SV=6 CNTLN_HUMAN reviewed Centlein (Centrosomal protein) Homo sapiens (Human) GO:0005654; GO:0005737; GO:0005813; GO:0005814; GO:0005829; GO:0007283; GO:0007338; GO:0008104; GO:0010457; GO:0019901; GO:0019904; GO:0030674; GO:0032880; GO:0065003; GO:0070062; GO:0120212 centriole-centriole cohesion [GO:0010457]; intracellular protein localization [GO:0008104]; protein-containing complex assembly [GO:0065003]; regulation of protein localization [GO:0032880]; single fertilization [GO:0007338]; spermatogenesis [GO:0007283] centriole [GO:0005814]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; sperm head-tail coupling apparatus [GO:0120212] protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; protein-macromolecule adaptor activity [GO:0030674] g8901.t3 Q6ZN30 64.246 179 2.2500000000000001e-66 243.0 sp|Q6ZN30|BNC2_HUMAN Zinc finger protein basonuclin-2 OS=Homo sapiens OX=9606 GN=BNC2 PE=1 SV=1 BNC2_HUMAN reviewed Zinc finger protein basonuclin-2 Homo sapiens (Human) GO:0000182; GO:0000785; GO:0001650; GO:0003416; GO:0005634; GO:0006355; GO:0008270; GO:0016604; GO:0043586; GO:0060021; GO:0060485 endochondral bone growth [GO:0003416]; mesenchyme development [GO:0060485]; regulation of DNA-templated transcription [GO:0006355]; roof of mouth development [GO:0060021]; tongue development [GO:0043586] chromatin [GO:0000785]; fibrillar center [GO:0001650]; nuclear body [GO:0016604]; nucleus [GO:0005634] rDNA binding [GO:0000182]; zinc ion binding [GO:0008270] g8901.t3 Q6ZN30 71.642 67 4.32e-25 116.0 sp|Q6ZN30|BNC2_HUMAN Zinc finger protein basonuclin-2 OS=Homo sapiens OX=9606 GN=BNC2 PE=1 SV=1 BNC2_HUMAN reviewed Zinc finger protein basonuclin-2 Homo sapiens (Human) GO:0000182; GO:0000785; GO:0001650; GO:0003416; GO:0005634; GO:0006355; GO:0008270; GO:0016604; GO:0043586; GO:0060021; GO:0060485 endochondral bone growth [GO:0003416]; mesenchyme development [GO:0060485]; regulation of DNA-templated transcription [GO:0006355]; roof of mouth development [GO:0060021]; tongue development [GO:0043586] chromatin [GO:0000785]; fibrillar center [GO:0001650]; nuclear body [GO:0016604]; nucleus [GO:0005634] rDNA binding [GO:0000182]; zinc ion binding [GO:0008270] g8902.t1 Q6ZN30 74.576 59 1.6699999999999999e-25 103.0 sp|Q6ZN30|BNC2_HUMAN Zinc finger protein basonuclin-2 OS=Homo sapiens OX=9606 GN=BNC2 PE=1 SV=1 BNC2_HUMAN reviewed Zinc finger protein basonuclin-2 Homo sapiens (Human) GO:0000182; GO:0000785; GO:0001650; GO:0003416; GO:0005634; GO:0006355; GO:0008270; GO:0016604; GO:0043586; GO:0060021; GO:0060485 endochondral bone growth [GO:0003416]; mesenchyme development [GO:0060485]; regulation of DNA-templated transcription [GO:0006355]; roof of mouth development [GO:0060021]; tongue development [GO:0043586] chromatin [GO:0000785]; fibrillar center [GO:0001650]; nuclear body [GO:0016604]; nucleus [GO:0005634] rDNA binding [GO:0000182]; zinc ion binding [GO:0008270] g8904.t1 Q8C8V1 47.386 306 4.49e-86 300.0 sp|Q8C8V1|ZXDC_MOUSE Zinc finger protein ZXDC OS=Mus musculus OX=10090 GN=Zxdc PE=2 SV=1 g8904.t1 Q8C8V1 31.939 263 2.79e-25 117.0 sp|Q8C8V1|ZXDC_MOUSE Zinc finger protein ZXDC OS=Mus musculus OX=10090 GN=Zxdc PE=2 SV=1 g8905.t1 Q5RDU9 33.613 476 2.3499999999999997e-67 226.0 sp|Q5RDU9|EDC3_PONAB Enhancer of mRNA-decapping protein 3 OS=Pongo abelii OX=9601 GN=EDC3 PE=2 SV=1 g8906.t1 Q90W95 65.714 105 4.63e-47 152.0 sp|Q90W95|PTPS_POERE 6-pyruvoyl tetrahydrobiopterin synthase OS=Poecilia reticulata OX=8081 GN=pts PE=2 SV=1 g8907.t1 Q4R7D3 30.33 455 5.55e-66 223.0 sp|Q4R7D3|SAXO1_MACFA Stabilizer of axonemal microtubules 1 OS=Macaca fascicularis OX=9541 GN=SAXO1 PE=2 SV=2 g8908.t1 P25789 83.772 228 1.97e-145 410.0 sp|P25789|PSA4_HUMAN Proteasome subunit alpha type-4 OS=Homo sapiens OX=9606 GN=PSMA4 PE=1 SV=1 PSA4_HUMAN reviewed Proteasome subunit alpha type-4 (Macropain subunit C9) (Multicatalytic endopeptidase complex subunit C9) (Proteasome component C9) (Proteasome subunit L) (Proteasome subunit alpha-3) (alpha-3) Homo sapiens (Human) GO:0000502; GO:0000932; GO:0005634; GO:0005654; GO:0005737; GO:0005814; GO:0005829; GO:0005839; GO:0019773; GO:0043161; GO:0070062; GO:0097225; GO:0120212 proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161] centriole [GO:0005814]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; proteasome complex [GO:0000502]; proteasome core complex [GO:0005839]; proteasome core complex, alpha-subunit complex [GO:0019773]; sperm head-tail coupling apparatus [GO:0120212]; sperm midpiece [GO:0097225] g8909.t1 Q5ZIG3 51.543 324 5.23e-112 336.0 sp|Q5ZIG3|S2546_CHICK Mitochondrial outer membrane protein SLC25A46 OS=Gallus gallus OX=9031 GN=SLC25A46 PE=2 SV=1 g8910.t1 Q3UHD6 54.635 507 0.0 585.0 sp|Q3UHD6|SNX27_MOUSE Sorting nexin-27 OS=Mus musculus OX=10090 GN=Snx27 PE=1 SV=2 g8910.t2 Q3UHD6 55.533 497 0.0 589.0 sp|Q3UHD6|SNX27_MOUSE Sorting nexin-27 OS=Mus musculus OX=10090 GN=Snx27 PE=1 SV=2 g8911.t1 Q568B7 51.477 474 8.930000000000001e-160 464.0 sp|Q568B7|QTMAN_DANRE tRNA-queuosine alpha-mannosyltransferase OS=Danio rerio OX=7955 GN=gtdc1 PE=2 SV=2 g8912.t1 Q8VHR5 45.528 246 8.42e-35 142.0 sp|Q8VHR5|P66B_MOUSE Transcriptional repressor p66-beta OS=Mus musculus OX=10090 GN=Gatad2b PE=1 SV=1 P66B_MOUSE reviewed Transcriptional repressor p66-beta (GATA zinc finger domain-containing protein 2B) (p66/p68) Mus musculus (Mouse) GO:0000122; GO:0000781; GO:0005634; GO:0005654; GO:0006338; GO:0008270; GO:0016581; GO:0016607; GO:0042659; GO:0043565; GO:0045892; GO:0045893; GO:2000736 chromatin remodeling [GO:0006338]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of DNA-templated transcription [GO:0045893]; regulation of cell fate specification [GO:0042659]; regulation of stem cell differentiation [GO:2000736] chromosome, telomeric region [GO:0000781]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; NuRD complex [GO:0016581] sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270] g8914.t1 B1H1Z8 62.037 216 1.8700000000000002e-86 270.0 sp|B1H1Z8|SCC4_XENTR MAU2 chromatid cohesion factor homolog OS=Xenopus tropicalis OX=8364 GN=mau2 PE=2 SV=1 g8915.t1 B4ZIX8 70.126 318 1.79e-162 469.0 sp|B4ZIX8|SCC4_XENLA MAU2 chromatid cohesion factor homolog OS=Xenopus laevis OX=8355 GN=mau2 PE=1 SV=1 SCC4_XENLA reviewed MAU2 chromatid cohesion factor homolog (MAU-2) (Cohesin loading complex subunit SCC4 homolog) Xenopus laevis (African clawed frog) GO:0000785; GO:0005634; GO:0005654; GO:0007059; GO:0007064; GO:0032116; GO:0034088; GO:0051301; GO:0090694 cell division [GO:0051301]; chromosome segregation [GO:0007059]; maintenance of mitotic sister chromatid cohesion [GO:0034088]; mitotic sister chromatid cohesion [GO:0007064] chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Scc2-Scc4 cohesin loading complex [GO:0090694]; SMC loading complex [GO:0032116] g8916.t1 Q8CFI0 59.165 671 0.0 780.0 sp|Q8CFI0|NED4L_MOUSE E3 ubiquitin-protein ligase NEDD4-like OS=Mus musculus OX=10090 GN=Nedd4l PE=1 SV=2 NED4L_MOUSE reviewed E3 ubiquitin-protein ligase NEDD4-like (EC 2.3.2.26) (EC 2.3.2.36) (HECT-type E3 ubiquitin transferase NED4L) (NEDD4.2) (Nedd4-2) Mus musculus (Mouse) GO:0002028; GO:0003085; GO:0003254; GO:0004842; GO:0005737; GO:0005771; GO:0005794; GO:0006511; GO:0006513; GO:0007528; GO:0009651; GO:0010765; GO:0010766; GO:0016324; GO:0016567; GO:0017080; GO:0019870; GO:0019871; GO:0031175; GO:0031623; GO:0031647; GO:0032801; GO:0042391; GO:0043161; GO:0044325; GO:0045732; GO:0048814; GO:0050807; GO:0060306; GO:0061630; GO:0070936; GO:0086005; GO:0098719; GO:0098794; GO:0098978; GO:0099149; GO:0140252; GO:1901380; GO:1902305; GO:1902306; GO:1903765; GO:1903783; GO:1903861; GO:2000009; GO:2000810; GO:2001288 negative regulation of potassium ion export across plasma membrane [GO:1903765]; negative regulation of potassium ion transmembrane transport [GO:1901380]; negative regulation of protein localization to cell surface [GO:2000009]; negative regulation of sodium ion import across plasma membrane [GO:1903783]; negative regulation of sodium ion transmembrane transport [GO:1902306]; negative regulation of sodium ion transport [GO:0010766]; negative regulation of systemic arterial blood pressure [GO:0003085]; neuromuscular junction development [GO:0007528]; neuron projection development [GO:0031175]; positive regulation of caveolin-mediated endocytosis [GO:2001288]; positive regulation of dendrite extension [GO:1903861]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of sodium ion transport [GO:0010765]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K48-linked ubiquitination [GO:0070936]; protein monoubiquitination [GO:0006513]; protein ubiquitination [GO:0016567]; receptor catabolic process [GO:0032801]; receptor internalization [GO:0031623]; regulation of bicellular tight junction assembly [GO:2000810]; regulation of dendrite morphogenesis [GO:0048814]; regulation of membrane depolarization [GO:0003254]; regulation of membrane potential [GO:0042391]; regulation of membrane repolarization [GO:0060306]; regulation of postsynaptic neurotransmitter receptor internalization [GO:0099149]; regulation of protein stability [GO:0031647]; regulation of sodium ion transmembrane transport [GO:1902305]; regulation of sodium ion transport [GO:0002028]; regulation of synapse organization [GO:0050807]; regulation protein catabolic process at postsynapse [GO:0140252]; response to salt stress [GO:0009651]; sodium ion import across plasma membrane [GO:0098719]; ubiquitin-dependent protein catabolic process [GO:0006511]; ventricular cardiac muscle cell action potential [GO:0086005] apical plasma membrane [GO:0016324]; cytoplasm [GO:0005737]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; multivesicular body [GO:0005771]; postsynapse [GO:0098794] potassium channel inhibitor activity [GO:0019870]; sodium channel inhibitor activity [GO:0019871]; sodium channel regulator activity [GO:0017080]; transmembrane transporter binding [GO:0044325]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842] g8916.t1 Q8CFI0 48.148 270 2.53e-57 215.0 sp|Q8CFI0|NED4L_MOUSE E3 ubiquitin-protein ligase NEDD4-like OS=Mus musculus OX=10090 GN=Nedd4l PE=1 SV=2 NED4L_MOUSE reviewed E3 ubiquitin-protein ligase NEDD4-like (EC 2.3.2.26) (EC 2.3.2.36) (HECT-type E3 ubiquitin transferase NED4L) (NEDD4.2) (Nedd4-2) Mus musculus (Mouse) GO:0002028; GO:0003085; GO:0003254; GO:0004842; GO:0005737; GO:0005771; GO:0005794; GO:0006511; GO:0006513; GO:0007528; GO:0009651; GO:0010765; GO:0010766; GO:0016324; GO:0016567; GO:0017080; GO:0019870; GO:0019871; GO:0031175; GO:0031623; GO:0031647; GO:0032801; GO:0042391; GO:0043161; GO:0044325; GO:0045732; GO:0048814; GO:0050807; GO:0060306; GO:0061630; GO:0070936; GO:0086005; GO:0098719; GO:0098794; GO:0098978; GO:0099149; GO:0140252; GO:1901380; GO:1902305; GO:1902306; GO:1903765; GO:1903783; GO:1903861; GO:2000009; GO:2000810; GO:2001288 negative regulation of potassium ion export across plasma membrane [GO:1903765]; negative regulation of potassium ion transmembrane transport [GO:1901380]; negative regulation of protein localization to cell surface [GO:2000009]; negative regulation of sodium ion import across plasma membrane [GO:1903783]; negative regulation of sodium ion transmembrane transport [GO:1902306]; negative regulation of sodium ion transport [GO:0010766]; negative regulation of systemic arterial blood pressure [GO:0003085]; neuromuscular junction development [GO:0007528]; neuron projection development [GO:0031175]; positive regulation of caveolin-mediated endocytosis [GO:2001288]; positive regulation of dendrite extension [GO:1903861]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of sodium ion transport [GO:0010765]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K48-linked ubiquitination [GO:0070936]; protein monoubiquitination [GO:0006513]; protein ubiquitination [GO:0016567]; receptor catabolic process [GO:0032801]; receptor internalization [GO:0031623]; regulation of bicellular tight junction assembly [GO:2000810]; regulation of dendrite morphogenesis [GO:0048814]; regulation of membrane depolarization [GO:0003254]; regulation of membrane potential [GO:0042391]; regulation of membrane repolarization [GO:0060306]; regulation of postsynaptic neurotransmitter receptor internalization [GO:0099149]; regulation of protein stability [GO:0031647]; regulation of sodium ion transmembrane transport [GO:1902305]; regulation of sodium ion transport [GO:0002028]; regulation of synapse organization [GO:0050807]; regulation protein catabolic process at postsynapse [GO:0140252]; response to salt stress [GO:0009651]; sodium ion import across plasma membrane [GO:0098719]; ubiquitin-dependent protein catabolic process [GO:0006511]; ventricular cardiac muscle cell action potential [GO:0086005] apical plasma membrane [GO:0016324]; cytoplasm [GO:0005737]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; multivesicular body [GO:0005771]; postsynapse [GO:0098794] potassium channel inhibitor activity [GO:0019870]; sodium channel inhibitor activity [GO:0019871]; sodium channel regulator activity [GO:0017080]; transmembrane transporter binding [GO:0044325]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842] g8917.t1 Q9Y6I4 53.831 522 0.0 553.0 sp|Q9Y6I4|UBP3_HUMAN Ubiquitin carboxyl-terminal hydrolase 3 OS=Homo sapiens OX=9606 GN=USP3 PE=1 SV=2 UBP3_HUMAN reviewed Ubiquitin carboxyl-terminal hydrolase 3 (EC 3.4.19.12) (Deubiquitinating enzyme 3) (Ubiquitin thioesterase 3) (Ubiquitin-specific-processing protease 3) Homo sapiens (Human) GO:0000785; GO:0004843; GO:0005634; GO:0005654; GO:0005737; GO:0006281; GO:0006508; GO:0008270; GO:0016579; GO:0036464; GO:0042393; GO:0090543; GO:0140861; GO:0140936; GO:0140950 DNA repair [GO:0006281]; DNA repair-dependent chromatin remodeling [GO:0140861]; protein deubiquitination [GO:0016579]; proteolysis [GO:0006508] chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; Flemming body [GO:0090543]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cysteine-type deubiquitinase activity [GO:0004843]; histone binding [GO:0042393]; histone H2A deubiquitinase activity [GO:0140950]; histone H2B deubiquitinase activity [GO:0140936]; zinc ion binding [GO:0008270] g8917.t2 Q9Y6I4 53.728 523 0.0 555.0 sp|Q9Y6I4|UBP3_HUMAN Ubiquitin carboxyl-terminal hydrolase 3 OS=Homo sapiens OX=9606 GN=USP3 PE=1 SV=2 UBP3_HUMAN reviewed Ubiquitin carboxyl-terminal hydrolase 3 (EC 3.4.19.12) (Deubiquitinating enzyme 3) (Ubiquitin thioesterase 3) (Ubiquitin-specific-processing protease 3) Homo sapiens (Human) GO:0000785; GO:0004843; GO:0005634; GO:0005654; GO:0005737; GO:0006281; GO:0006508; GO:0008270; GO:0016579; GO:0036464; GO:0042393; GO:0090543; GO:0140861; GO:0140936; GO:0140950 DNA repair [GO:0006281]; DNA repair-dependent chromatin remodeling [GO:0140861]; protein deubiquitination [GO:0016579]; proteolysis [GO:0006508] chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; Flemming body [GO:0090543]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cysteine-type deubiquitinase activity [GO:0004843]; histone binding [GO:0042393]; histone H2A deubiquitinase activity [GO:0140950]; histone H2B deubiquitinase activity [GO:0140936]; zinc ion binding [GO:0008270] g8918.t1 Q8C854 32.847 274 3.59e-30 127.0 sp|Q8C854|MYEF2_MOUSE Myelin expression factor 2 OS=Mus musculus OX=10090 GN=Myef2 PE=1 SV=1 MYEF2_MOUSE reviewed Myelin expression factor 2 (MEF-2) (MyEF-2) Mus musculus (Mouse) GO:0000122; GO:0000978; GO:0001227; GO:0003729; GO:0005634; GO:0005737; GO:1990904 negative regulation of transcription by RNA polymerase II [GO:0000122] cytoplasm [GO:0005737]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904] DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; mRNA binding [GO:0003729]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978] g8923.t1 Q8C854 43.231 229 2.29e-50 187.0 sp|Q8C854|MYEF2_MOUSE Myelin expression factor 2 OS=Mus musculus OX=10090 GN=Myef2 PE=1 SV=1 MYEF2_MOUSE reviewed Myelin expression factor 2 (MEF-2) (MyEF-2) Mus musculus (Mouse) GO:0000122; GO:0000978; GO:0001227; GO:0003729; GO:0005634; GO:0005737; GO:1990904 negative regulation of transcription by RNA polymerase II [GO:0000122] cytoplasm [GO:0005737]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904] DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; mRNA binding [GO:0003729]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978] g8923.t2 Q9P2K5 43.231 229 6.05e-49 188.0 sp|Q9P2K5|MYEF2_HUMAN Myelin expression factor 2 OS=Homo sapiens OX=9606 GN=MYEF2 PE=1 SV=3 g8924.t1 Q9QWW1 44.972 358 3.22e-94 288.0 sp|Q9QWW1|HOME2_MOUSE Homer protein homolog 2 OS=Mus musculus OX=10090 GN=Homer2 PE=1 SV=1 HOME2_MOUSE reviewed Homer protein homolog 2 (Homer-2) (Cupidin) (VASP/Ena-related gene up-regulated during seizure and LTP 2) (Vesl-2) Mus musculus (Mouse) GO:0003779; GO:0005737; GO:0005829; GO:0005886; GO:0007216; GO:0007605; GO:0008277; GO:0014048; GO:0014069; GO:0019722; GO:0019904; GO:0030160; GO:0030425; GO:0032426; GO:0032703; GO:0035254; GO:0035256; GO:0042220; GO:0042802; GO:0043025; GO:0043229; GO:0044877; GO:0045177; GO:0048148; GO:0051966; GO:0070885; GO:0098978; GO:2001256 behavioral response to cocaine [GO:0048148]; calcium-mediated signaling [GO:0019722]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; negative regulation of calcineurin-NFAT signaling cascade [GO:0070885]; negative regulation of interleukin-2 production [GO:0032703]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; regulation of glutamate secretion [GO:0014048]; regulation of store-operated calcium entry [GO:2001256]; regulation of synaptic transmission, glutamatergic [GO:0051966]; response to cocaine [GO:0042220]; sensory perception of sound [GO:0007605] apical part of cell [GO:0045177]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; intracellular organelle [GO:0043229]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; stereocilium tip [GO:0032426] actin binding [GO:0003779]; G protein-coupled glutamate receptor binding [GO:0035256]; glutamate receptor binding [GO:0035254]; identical protein binding [GO:0042802]; protein domain specific binding [GO:0019904]; protein-containing complex binding [GO:0044877]; synaptic receptor adaptor activity [GO:0030160] g8925.t1 P53762 46.871 751 0.0 608.0 sp|P53762|ARNT_MOUSE Aryl hydrocarbon receptor nuclear translocator OS=Mus musculus OX=10090 GN=Arnt PE=1 SV=3 g8926.t2 Q5XIS7 25.281 534 2.62e-26 115.0 sp|Q5XIS7|UBAP1_RAT Ubiquitin-associated protein 1 OS=Rattus norvegicus OX=10116 GN=Ubap1 PE=2 SV=1 UBAP1_RAT reviewed Ubiquitin-associated protein 1 (UBAP-1) Rattus norvegicus (Rat) GO:0000813; GO:0005737; GO:0005829; GO:0005886; GO:0015031; GO:0043130; GO:0043162 protein transport [GO:0015031]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162] cytoplasm [GO:0005737]; cytosol [GO:0005829]; ESCRT I complex [GO:0000813]; plasma membrane [GO:0005886] ubiquitin binding [GO:0043130] g8927.t1 Q09161 59.74 770 0.0 935.0 sp|Q09161|NCBP1_HUMAN Nuclear cap-binding protein subunit 1 OS=Homo sapiens OX=9606 GN=NCBP1 PE=1 SV=1 NCBP1_HUMAN reviewed Nuclear cap-binding protein subunit 1 (80 kDa nuclear cap-binding protein) (CBP80) (NCBP 80 kDa subunit) Homo sapiens (Human) GO:0000184; GO:0000245; GO:0000339; GO:0000340; GO:0000380; GO:0000398; GO:0002191; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0005846; GO:0006370; GO:0006401; GO:0006406; GO:0006408; GO:0006446; GO:0008334; GO:0008380; GO:0016071; GO:0030307; GO:0031053; GO:0031124; GO:0031442; GO:0032968; GO:0034518; GO:0035194; GO:0035195; GO:0042789; GO:0048026; GO:0050684; GO:0051607; GO:0060090; GO:1990904 7-methylguanosine mRNA capping [GO:0006370]; alternative mRNA splicing, via spliceosome [GO:0000380]; cap-dependent translational initiation [GO:0002191]; defense response to virus [GO:0051607]; histone mRNA metabolic process [GO:0008334]; miRNA-mediated post-transcriptional gene silencing [GO:0035195]; mRNA 3'-end processing [GO:0031124]; mRNA export from nucleus [GO:0006406]; mRNA metabolic process [GO:0016071]; mRNA splicing, via spliceosome [GO:0000398]; mRNA transcription by RNA polymerase II [GO:0042789]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; positive regulation of cell growth [GO:0030307]; positive regulation of mRNA 3'-end processing [GO:0031442]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; positive regulation of transcription elongation by RNA polymerase II [GO:0032968]; primary miRNA processing [GO:0031053]; regulation of mRNA processing [GO:0050684]; regulation of translational initiation [GO:0006446]; regulatory ncRNA-mediated post-transcriptional gene silencing [GO:0035194]; RNA catabolic process [GO:0006401]; RNA splicing [GO:0008380]; snRNA export from nucleus [GO:0006408]; spliceosomal complex assembly [GO:0000245] cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nuclear cap binding complex [GO:0005846]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; RNA cap binding complex [GO:0034518] molecular adaptor activity [GO:0060090]; mRNA binding [GO:0003729]; RNA 7-methylguanosine cap binding [GO:0000340]; RNA binding [GO:0003723]; RNA cap binding [GO:0000339] g8928.t1 Q00657 30.841 214 6.22e-28 117.0 sp|Q00657|CSPG4_RAT Chondroitin sulfate proteoglycan 4 OS=Rattus norvegicus OX=10116 GN=Cspg4 PE=1 SV=2 g8930.t1 Q00657 27.348 1203 1.43e-114 406.0 sp|Q00657|CSPG4_RAT Chondroitin sulfate proteoglycan 4 OS=Rattus norvegicus OX=10116 GN=Cspg4 PE=1 SV=2 g8930.t1 Q00657 25.226 884 3.1e-30 135.0 sp|Q00657|CSPG4_RAT Chondroitin sulfate proteoglycan 4 OS=Rattus norvegicus OX=10116 GN=Cspg4 PE=1 SV=2 g8930.t1 Q00657 23.396 748 5.66e-28 127.0 sp|Q00657|CSPG4_RAT Chondroitin sulfate proteoglycan 4 OS=Rattus norvegicus OX=10116 GN=Cspg4 PE=1 SV=2 g8931.t1 Q1EG27 43.085 752 3.51e-175 550.0 sp|Q1EG27|MYO3B_MOUSE Myosin-IIIb OS=Mus musculus OX=10090 GN=Myo3b PE=1 SV=2 MYO3B_MOUSE reviewed Myosin-IIIb (EC 2.7.11.1) Mus musculus (Mouse) GO:0000146; GO:0001750; GO:0001917; GO:0003779; GO:0004674; GO:0005524; GO:0005829; GO:0007601; GO:0007605; GO:0016459; GO:0030832; GO:0032426; GO:0032433; GO:0051491; GO:0060088; GO:0090103; GO:0106310 auditory receptor cell stereocilium organization [GO:0060088]; cochlea morphogenesis [GO:0090103]; positive regulation of filopodium assembly [GO:0051491]; regulation of actin filament length [GO:0030832]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601] cytosol [GO:0005829]; filopodium tip [GO:0032433]; myosin complex [GO:0016459]; photoreceptor inner segment [GO:0001917]; photoreceptor outer segment [GO:0001750]; stereocilium tip [GO:0032426] actin binding [GO:0003779]; ATP binding [GO:0005524]; microfilament motor activity [GO:0000146]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g8931.t2 Q1EG27 43.085 752 6.13e-175 550.0 sp|Q1EG27|MYO3B_MOUSE Myosin-IIIb OS=Mus musculus OX=10090 GN=Myo3b PE=1 SV=2 MYO3B_MOUSE reviewed Myosin-IIIb (EC 2.7.11.1) Mus musculus (Mouse) GO:0000146; GO:0001750; GO:0001917; GO:0003779; GO:0004674; GO:0005524; GO:0005829; GO:0007601; GO:0007605; GO:0016459; GO:0030832; GO:0032426; GO:0032433; GO:0051491; GO:0060088; GO:0090103; GO:0106310 auditory receptor cell stereocilium organization [GO:0060088]; cochlea morphogenesis [GO:0090103]; positive regulation of filopodium assembly [GO:0051491]; regulation of actin filament length [GO:0030832]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601] cytosol [GO:0005829]; filopodium tip [GO:0032433]; myosin complex [GO:0016459]; photoreceptor inner segment [GO:0001917]; photoreceptor outer segment [GO:0001750]; stereocilium tip [GO:0032426] actin binding [GO:0003779]; ATP binding [GO:0005524]; microfilament motor activity [GO:0000146]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g8932.t1 P41239 56.18 445 1.18e-166 481.0 sp|P41239|CSK_CHICK Tyrosine-protein kinase CSK OS=Gallus gallus OX=9031 GN=CSK PE=2 SV=1 g8935.t1 O01404 43.272 379 8.15e-89 275.0 sp|O01404|PHM_DROME Peptidylglycine alpha-hydroxylating monooxygenase OS=Drosophila melanogaster OX=7227 GN=Phm PE=1 SV=2 PHM_DROME reviewed Peptidylglycine alpha-hydroxylating monooxygenase (dPHM) (EC 1.14.17.3) Drosophila melanogaster (Fruit fly) GO:0004504; GO:0005507; GO:0005576; GO:0005615; GO:0006518; GO:0007320; GO:0007613; GO:0009620; GO:0016020; GO:0044719 insemination [GO:0007320]; memory [GO:0007613]; peptide metabolic process [GO:0006518]; regulation of imaginal disc-derived wing size [GO:0044719]; response to fungus [GO:0009620] extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020] copper ion binding [GO:0005507]; peptidylglycine monooxygenase activity [GO:0004504] g8936.t1 Q6AZN0 50.708 424 8.65e-136 398.0 sp|Q6AZN0|DAAF4_XENLA Dynein axonemal assembly factor 4 OS=Xenopus laevis OX=8355 GN=dnaaf4 PE=2 SV=1 g8937.t1 Q9UJZ1 62.323 353 1.43e-143 414.0 sp|Q9UJZ1|STML2_HUMAN Stomatin-like protein 2, mitochondrial OS=Homo sapiens OX=9606 GN=STOML2 PE=1 SV=1 g8938.t1 Q923Y6 28.523 298 9.74e-26 109.0 sp|Q923Y6|TAAR9_RAT Trace amine-associated receptor 9 OS=Rattus norvegicus OX=10116 GN=Taar9 PE=2 SV=1 g8939.t1 P0C872 54.967 302 2.75e-129 374.0 sp|P0C872|JMJD7_MOUSE Bifunctional peptidase and (3S)-lysyl hydroxylase Jmjd7 OS=Mus musculus OX=10090 GN=Jmjd7 PE=1 SV=1 g8943.t1 Q9UGM3 28.879 464 1.13e-38 153.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g8943.t1 Q9UGM3 27.16 486 8.14e-34 139.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g8943.t1 Q9UGM3 26.446 484 4.84e-32 134.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g8943.t1 Q9UGM3 27.16 486 5.120000000000001e-32 134.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g8943.t1 Q9UGM3 26.971 482 2.8600000000000003e-31 131.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g8943.t1 Q9UGM3 26.349 482 6.8100000000000005e-31 130.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g8944.t1 Q92184 42.071 309 1.22e-79 254.0 sp|Q92184|SIA7B_CHICK Alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 2 OS=Gallus gallus OX=9031 GN=ST6GALNAC2 PE=1 SV=1 g8947.t1 Q92184 38.043 368 6.38e-71 233.0 sp|Q92184|SIA7B_CHICK Alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 2 OS=Gallus gallus OX=9031 GN=ST6GALNAC2 PE=1 SV=1 g8950.t1 Q5R746 50.0 130 6.26e-25 110.0 sp|Q5R746|YTDC2_PONAB 3'-5' RNA helicase YTHDC2 OS=Pongo abelii OX=9601 GN=YTHDC2 PE=2 SV=2 YTDC2_PONAB reviewed 3'-5' RNA helicase YTHDC2 (EC 3.6.4.13) (YTH domain-containing protein C2) Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0003723; GO:0005524; GO:0005737; GO:0007286; GO:0016887; GO:0034458; GO:0035770; GO:0048471; GO:0048599; GO:0051321; GO:0051729; GO:0070063; GO:1990247 germline cell cycle switching, mitotic to meiotic cell cycle [GO:0051729]; meiotic cell cycle [GO:0051321]; oocyte development [GO:0048599]; spermatid development [GO:0007286] cytoplasm [GO:0005737]; perinuclear region of cytoplasm [GO:0048471]; ribonucleoprotein granule [GO:0035770] 3'-5' RNA helicase activity [GO:0034458]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; N6-methyladenosine-containing RNA reader activity [GO:1990247]; RNA binding [GO:0003723]; RNA polymerase binding [GO:0070063] g8952.t1 O93529 64.078 103 3.96e-46 160.0 sp|O93529|FOXB1_XENLA Forkhead box protein B1 OS=Xenopus laevis OX=8355 GN=foxb1 PE=2 SV=1 g8953.t1 Q9I8C7 40.363 441 4.37e-111 339.0 sp|Q9I8C7|ACH10_CHICK Neuronal acetylcholine receptor subunit alpha-10 OS=Gallus gallus OX=9031 GN=CHRNA10 PE=3 SV=1 ACH10_CHICK reviewed Neuronal acetylcholine receptor subunit alpha-10 (Alpha 10 nAChR) (Nicotinic acetylcholine receptor subunit alpha-10) (NACHR alpha-10) Gallus gallus (Chicken) GO:0005231; GO:0005262; GO:0005886; GO:0005892; GO:0007268; GO:0022848; GO:0022850; GO:0034220; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0050910; GO:1902495; GO:1904315 chemical synaptic transmission [GO:0007268]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; monoatomic ion transmembrane transport [GO:0034220]; regulation of membrane potential [GO:0042391] acetylcholine-gated channel complex [GO:0005892]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; transmembrane transporter complex [GO:1902495] acetylcholine-gated monoatomic cation-selective channel activity [GO:0022848]; calcium channel activity [GO:0005262]; excitatory extracellular ligand-gated monoatomic ion channel activity [GO:0005231]; serotonin-gated monoatomic cation channel activity [GO:0022850]; transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315] g8955.t1 Q9I8C7 43.125 320 3.19e-83 262.0 sp|Q9I8C7|ACH10_CHICK Neuronal acetylcholine receptor subunit alpha-10 OS=Gallus gallus OX=9031 GN=CHRNA10 PE=3 SV=1 ACH10_CHICK reviewed Neuronal acetylcholine receptor subunit alpha-10 (Alpha 10 nAChR) (Nicotinic acetylcholine receptor subunit alpha-10) (NACHR alpha-10) Gallus gallus (Chicken) GO:0005231; GO:0005262; GO:0005886; GO:0005892; GO:0007268; GO:0022848; GO:0022850; GO:0034220; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0050910; GO:1902495; GO:1904315 chemical synaptic transmission [GO:0007268]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; monoatomic ion transmembrane transport [GO:0034220]; regulation of membrane potential [GO:0042391] acetylcholine-gated channel complex [GO:0005892]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; transmembrane transporter complex [GO:1902495] acetylcholine-gated monoatomic cation-selective channel activity [GO:0022848]; calcium channel activity [GO:0005262]; excitatory extracellular ligand-gated monoatomic ion channel activity [GO:0005231]; serotonin-gated monoatomic cation channel activity [GO:0022850]; transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315] g8956.t1 Q9I8C7 39.551 445 1.11e-91 288.0 sp|Q9I8C7|ACH10_CHICK Neuronal acetylcholine receptor subunit alpha-10 OS=Gallus gallus OX=9031 GN=CHRNA10 PE=3 SV=1 ACH10_CHICK reviewed Neuronal acetylcholine receptor subunit alpha-10 (Alpha 10 nAChR) (Nicotinic acetylcholine receptor subunit alpha-10) (NACHR alpha-10) Gallus gallus (Chicken) GO:0005231; GO:0005262; GO:0005886; GO:0005892; GO:0007268; GO:0022848; GO:0022850; GO:0034220; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0050910; GO:1902495; GO:1904315 chemical synaptic transmission [GO:0007268]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; monoatomic ion transmembrane transport [GO:0034220]; regulation of membrane potential [GO:0042391] acetylcholine-gated channel complex [GO:0005892]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; transmembrane transporter complex [GO:1902495] acetylcholine-gated monoatomic cation-selective channel activity [GO:0022848]; calcium channel activity [GO:0005262]; excitatory extracellular ligand-gated monoatomic ion channel activity [GO:0005231]; serotonin-gated monoatomic cation channel activity [GO:0022850]; transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315] g8958.t1 Q9I8C7 41.298 339 2.57e-83 268.0 sp|Q9I8C7|ACH10_CHICK Neuronal acetylcholine receptor subunit alpha-10 OS=Gallus gallus OX=9031 GN=CHRNA10 PE=3 SV=1 ACH10_CHICK reviewed Neuronal acetylcholine receptor subunit alpha-10 (Alpha 10 nAChR) (Nicotinic acetylcholine receptor subunit alpha-10) (NACHR alpha-10) Gallus gallus (Chicken) GO:0005231; GO:0005262; GO:0005886; GO:0005892; GO:0007268; GO:0022848; GO:0022850; GO:0034220; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0050910; GO:1902495; GO:1904315 chemical synaptic transmission [GO:0007268]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; monoatomic ion transmembrane transport [GO:0034220]; regulation of membrane potential [GO:0042391] acetylcholine-gated channel complex [GO:0005892]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; transmembrane transporter complex [GO:1902495] acetylcholine-gated monoatomic cation-selective channel activity [GO:0022848]; calcium channel activity [GO:0005262]; excitatory extracellular ligand-gated monoatomic ion channel activity [GO:0005231]; serotonin-gated monoatomic cation channel activity [GO:0022850]; transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315] g8959.t1 O76387 44.915 118 4.8e-22 95.9 sp|O76387|PTH2_CAEEL Probable peptidyl-tRNA hydrolase 2 OS=Caenorhabditis elegans OX=6239 GN=C24G6.8 PE=3 SV=1 g8960.t1 P30875 36.644 292 1.54e-49 173.0 sp|P30875|SSR2_MOUSE Somatostatin receptor type 2 OS=Mus musculus OX=10090 GN=Sstr2 PE=2 SV=1 SSR2_MOUSE reviewed Somatostatin receptor type 2 (SS-2-R) (SS2-R) (SS2R) (SRIF-1) Mus musculus (Mouse) GO:0004994; GO:0005654; GO:0005829; GO:0005886; GO:0007186; GO:0007193; GO:0007218; GO:0016020; GO:0030165; GO:0030432; GO:0042923; GO:0043005; GO:0071385; GO:0071392 adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; cellular response to estradiol stimulus [GO:0071392]; cellular response to glucocorticoid stimulus [GO:0071385]; G protein-coupled receptor signaling pathway [GO:0007186]; neuropeptide signaling pathway [GO:0007218]; peristalsis [GO:0030432] cytosol [GO:0005829]; membrane [GO:0016020]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] neuropeptide binding [GO:0042923]; PDZ domain binding [GO:0030165]; somatostatin receptor activity [GO:0004994] g8975.t1 Q3UKU1 31.757 296 1.9400000000000003e-27 120.0 sp|Q3UKU1|ELL2_MOUSE RNA polymerase II elongation factor ELL2 OS=Mus musculus OX=10090 GN=Ell2 PE=1 SV=2 g8978.t1 P00636 67.674 331 3.9999999999999997e-168 474.0 sp|P00636|F16P1_PIG Fructose-1,6-bisphosphatase 1 OS=Sus scrofa OX=9823 GN=FBP1 PE=1 SV=4 g8980.t1 Q9CPT4 38.931 131 1.14e-22 91.7 sp|Q9CPT4|MYDGF_MOUSE Myeloid-derived growth factor OS=Mus musculus OX=10090 GN=Mydgf PE=1 SV=1 g8981.t1 Q1LWH4 49.922 645 0.0 621.0 sp|Q1LWH4|FAN1_DANRE Fanconi-associated nuclease 1 OS=Danio rerio OX=7955 GN=fan1 PE=2 SV=2 FAN1_DANRE reviewed Fanconi-associated nuclease 1 (EC 3.1.21.-) (EC 3.1.4.1) (FANCD2/FANCI-associated nuclease 1) (Myotubularin-related protein 15) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000724; GO:0004528; GO:0005634; GO:0006281; GO:0006289; GO:0008270; GO:0008409; GO:0017108; GO:0036297; GO:0070336; GO:0140036 DNA repair [GO:0006281]; double-strand break repair via homologous recombination [GO:0000724]; interstrand cross-link repair [GO:0036297]; nucleotide-excision repair [GO:0006289] nucleus [GO:0005634] 5'-3' exonuclease activity [GO:0008409]; 5'-flap endonuclease activity [GO:0017108]; flap-structured DNA binding [GO:0070336]; phosphodiesterase I activity [GO:0004528]; ubiquitin-modified protein reader activity [GO:0140036]; zinc ion binding [GO:0008270] g8982.t1 Q8WXG9 34.77 1044 5.949999999999999e-172 568.0 sp|Q8WXG9|AGRV1_HUMAN Adhesion G-protein coupled receptor V1 OS=Homo sapiens OX=9606 GN=ADGRV1 PE=1 SV=2 AGRV1_HUMAN reviewed Adhesion G-protein coupled receptor V1 (ADGRV1) (EC 3.4.-.-) (G-protein coupled receptor 98) (Monogenic audiogenic seizure susceptibility protein 1 homolog) (Usher syndrome type-2C protein) (Very large G-protein coupled receptor 1) [Cleaved into: ADGRV1 subunit alpha; ADGRV1 subunit beta] Homo sapiens (Human) GO:0001917; GO:0001965; GO:0002141; GO:0002142; GO:0004930; GO:0005509; GO:0005737; GO:0005886; GO:0007166; GO:0007186; GO:0007399; GO:0007601; GO:0007605; GO:0009986; GO:0010855; GO:0016020; GO:0016787; GO:0030501; GO:0031647; GO:0032420; GO:0043235; GO:0045184; GO:0045494; GO:0048496; GO:0048839; GO:0050877; GO:0050910; GO:0050953; GO:0060113; GO:0060122; GO:0060171; GO:0070062; GO:0071277; GO:0097264; GO:0098609; GO:1990075; GO:1990696 cell surface receptor signaling pathway [GO:0007166]; cell-cell adhesion [GO:0098609]; cellular response to calcium ion [GO:0071277]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; establishment of protein localization [GO:0045184]; G protein-coupled receptor signaling pathway [GO:0007186]; inner ear development [GO:0048839]; inner ear receptor cell differentiation [GO:0060113]; inner ear receptor cell stereocilium organization [GO:0060122]; maintenance of animal organ identity [GO:0048496]; nervous system development [GO:0007399]; nervous system process [GO:0050877]; photoreceptor cell maintenance [GO:0045494]; positive regulation of bone mineralization [GO:0030501]; regulation of protein stability [GO:0031647]; self proteolysis [GO:0097264]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601] cell surface [GO:0009986]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; periciliary membrane compartment [GO:1990075]; photoreceptor inner segment [GO:0001917]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; stereocilia ankle link [GO:0002141]; stereocilia ankle link complex [GO:0002142]; stereocilium [GO:0032420]; stereocilium membrane [GO:0060171]; USH2 complex [GO:1990696] adenylate cyclase inhibitor activity [GO:0010855]; calcium ion binding [GO:0005509]; G protein-coupled receptor activity [GO:0004930]; G-protein alpha-subunit binding [GO:0001965]; hydrolase activity [GO:0016787] g8983.t1 Q8WXG9 34.083 2001 0.0 1051.0 sp|Q8WXG9|AGRV1_HUMAN Adhesion G-protein coupled receptor V1 OS=Homo sapiens OX=9606 GN=ADGRV1 PE=1 SV=2 AGRV1_HUMAN reviewed Adhesion G-protein coupled receptor V1 (ADGRV1) (EC 3.4.-.-) (G-protein coupled receptor 98) (Monogenic audiogenic seizure susceptibility protein 1 homolog) (Usher syndrome type-2C protein) (Very large G-protein coupled receptor 1) [Cleaved into: ADGRV1 subunit alpha; ADGRV1 subunit beta] Homo sapiens (Human) GO:0001917; GO:0001965; GO:0002141; GO:0002142; GO:0004930; GO:0005509; GO:0005737; GO:0005886; GO:0007166; GO:0007186; GO:0007399; GO:0007601; GO:0007605; GO:0009986; GO:0010855; GO:0016020; GO:0016787; GO:0030501; GO:0031647; GO:0032420; GO:0043235; GO:0045184; GO:0045494; GO:0048496; GO:0048839; GO:0050877; GO:0050910; GO:0050953; GO:0060113; GO:0060122; GO:0060171; GO:0070062; GO:0071277; GO:0097264; GO:0098609; GO:1990075; GO:1990696 cell surface receptor signaling pathway [GO:0007166]; cell-cell adhesion [GO:0098609]; cellular response to calcium ion [GO:0071277]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; establishment of protein localization [GO:0045184]; G protein-coupled receptor signaling pathway [GO:0007186]; inner ear development [GO:0048839]; inner ear receptor cell differentiation [GO:0060113]; inner ear receptor cell stereocilium organization [GO:0060122]; maintenance of animal organ identity [GO:0048496]; nervous system development [GO:0007399]; nervous system process [GO:0050877]; photoreceptor cell maintenance [GO:0045494]; positive regulation of bone mineralization [GO:0030501]; regulation of protein stability [GO:0031647]; self proteolysis [GO:0097264]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601] cell surface [GO:0009986]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; periciliary membrane compartment [GO:1990075]; photoreceptor inner segment [GO:0001917]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; stereocilia ankle link [GO:0002141]; stereocilia ankle link complex [GO:0002142]; stereocilium [GO:0032420]; stereocilium membrane [GO:0060171]; USH2 complex [GO:1990696] adenylate cyclase inhibitor activity [GO:0010855]; calcium ion binding [GO:0005509]; G protein-coupled receptor activity [GO:0004930]; G-protein alpha-subunit binding [GO:0001965]; hydrolase activity [GO:0016787] g8983.t1 Q8WXG9 25.886 1298 1.74e-62 242.0 sp|Q8WXG9|AGRV1_HUMAN Adhesion G-protein coupled receptor V1 OS=Homo sapiens OX=9606 GN=ADGRV1 PE=1 SV=2 AGRV1_HUMAN reviewed Adhesion G-protein coupled receptor V1 (ADGRV1) (EC 3.4.-.-) (G-protein coupled receptor 98) (Monogenic audiogenic seizure susceptibility protein 1 homolog) (Usher syndrome type-2C protein) (Very large G-protein coupled receptor 1) [Cleaved into: ADGRV1 subunit alpha; ADGRV1 subunit beta] Homo sapiens (Human) GO:0001917; GO:0001965; GO:0002141; GO:0002142; GO:0004930; GO:0005509; GO:0005737; GO:0005886; GO:0007166; GO:0007186; GO:0007399; GO:0007601; GO:0007605; GO:0009986; GO:0010855; GO:0016020; GO:0016787; GO:0030501; GO:0031647; GO:0032420; GO:0043235; GO:0045184; GO:0045494; GO:0048496; GO:0048839; GO:0050877; GO:0050910; GO:0050953; GO:0060113; GO:0060122; GO:0060171; GO:0070062; GO:0071277; GO:0097264; GO:0098609; GO:1990075; GO:1990696 cell surface receptor signaling pathway [GO:0007166]; cell-cell adhesion [GO:0098609]; cellular response to calcium ion [GO:0071277]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; establishment of protein localization [GO:0045184]; G protein-coupled receptor signaling pathway [GO:0007186]; inner ear development [GO:0048839]; inner ear receptor cell differentiation [GO:0060113]; inner ear receptor cell stereocilium organization [GO:0060122]; maintenance of animal organ identity [GO:0048496]; nervous system development [GO:0007399]; nervous system process [GO:0050877]; photoreceptor cell maintenance [GO:0045494]; positive regulation of bone mineralization [GO:0030501]; regulation of protein stability [GO:0031647]; self proteolysis [GO:0097264]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601] cell surface [GO:0009986]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; periciliary membrane compartment [GO:1990075]; photoreceptor inner segment [GO:0001917]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; stereocilia ankle link [GO:0002141]; stereocilia ankle link complex [GO:0002142]; stereocilium [GO:0032420]; stereocilium membrane [GO:0060171]; USH2 complex [GO:1990696] adenylate cyclase inhibitor activity [GO:0010855]; calcium ion binding [GO:0005509]; G protein-coupled receptor activity [GO:0004930]; G-protein alpha-subunit binding [GO:0001965]; hydrolase activity [GO:0016787] g8983.t1 Q8WXG9 25.406 1232 9.440000000000001e-59 229.0 sp|Q8WXG9|AGRV1_HUMAN Adhesion G-protein coupled receptor V1 OS=Homo sapiens OX=9606 GN=ADGRV1 PE=1 SV=2 AGRV1_HUMAN reviewed Adhesion G-protein coupled receptor V1 (ADGRV1) (EC 3.4.-.-) (G-protein coupled receptor 98) (Monogenic audiogenic seizure susceptibility protein 1 homolog) (Usher syndrome type-2C protein) (Very large G-protein coupled receptor 1) [Cleaved into: ADGRV1 subunit alpha; ADGRV1 subunit beta] Homo sapiens (Human) GO:0001917; GO:0001965; GO:0002141; GO:0002142; GO:0004930; GO:0005509; GO:0005737; GO:0005886; GO:0007166; GO:0007186; GO:0007399; GO:0007601; GO:0007605; GO:0009986; GO:0010855; GO:0016020; GO:0016787; GO:0030501; GO:0031647; GO:0032420; GO:0043235; GO:0045184; GO:0045494; GO:0048496; GO:0048839; GO:0050877; GO:0050910; GO:0050953; GO:0060113; GO:0060122; GO:0060171; GO:0070062; GO:0071277; GO:0097264; GO:0098609; GO:1990075; GO:1990696 cell surface receptor signaling pathway [GO:0007166]; cell-cell adhesion [GO:0098609]; cellular response to calcium ion [GO:0071277]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; establishment of protein localization [GO:0045184]; G protein-coupled receptor signaling pathway [GO:0007186]; inner ear development [GO:0048839]; inner ear receptor cell differentiation [GO:0060113]; inner ear receptor cell stereocilium organization [GO:0060122]; maintenance of animal organ identity [GO:0048496]; nervous system development [GO:0007399]; nervous system process [GO:0050877]; photoreceptor cell maintenance [GO:0045494]; positive regulation of bone mineralization [GO:0030501]; regulation of protein stability [GO:0031647]; self proteolysis [GO:0097264]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601] cell surface [GO:0009986]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; periciliary membrane compartment [GO:1990075]; photoreceptor inner segment [GO:0001917]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; stereocilia ankle link [GO:0002141]; stereocilia ankle link complex [GO:0002142]; stereocilium [GO:0032420]; stereocilium membrane [GO:0060171]; USH2 complex [GO:1990696] adenylate cyclase inhibitor activity [GO:0010855]; calcium ion binding [GO:0005509]; G protein-coupled receptor activity [GO:0004930]; G-protein alpha-subunit binding [GO:0001965]; hydrolase activity [GO:0016787] g8983.t1 Q8WXG9 25.894 1147 8.08e-58 226.0 sp|Q8WXG9|AGRV1_HUMAN Adhesion G-protein coupled receptor V1 OS=Homo sapiens OX=9606 GN=ADGRV1 PE=1 SV=2 AGRV1_HUMAN reviewed Adhesion G-protein coupled receptor V1 (ADGRV1) (EC 3.4.-.-) (G-protein coupled receptor 98) (Monogenic audiogenic seizure susceptibility protein 1 homolog) (Usher syndrome type-2C protein) (Very large G-protein coupled receptor 1) [Cleaved into: ADGRV1 subunit alpha; ADGRV1 subunit beta] Homo sapiens (Human) GO:0001917; GO:0001965; GO:0002141; GO:0002142; GO:0004930; GO:0005509; GO:0005737; GO:0005886; GO:0007166; GO:0007186; GO:0007399; GO:0007601; GO:0007605; GO:0009986; GO:0010855; GO:0016020; GO:0016787; GO:0030501; GO:0031647; GO:0032420; GO:0043235; GO:0045184; GO:0045494; GO:0048496; GO:0048839; GO:0050877; GO:0050910; GO:0050953; GO:0060113; GO:0060122; GO:0060171; GO:0070062; GO:0071277; GO:0097264; GO:0098609; GO:1990075; GO:1990696 cell surface receptor signaling pathway [GO:0007166]; cell-cell adhesion [GO:0098609]; cellular response to calcium ion [GO:0071277]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; establishment of protein localization [GO:0045184]; G protein-coupled receptor signaling pathway [GO:0007186]; inner ear development [GO:0048839]; inner ear receptor cell differentiation [GO:0060113]; inner ear receptor cell stereocilium organization [GO:0060122]; maintenance of animal organ identity [GO:0048496]; nervous system development [GO:0007399]; nervous system process [GO:0050877]; photoreceptor cell maintenance [GO:0045494]; positive regulation of bone mineralization [GO:0030501]; regulation of protein stability [GO:0031647]; self proteolysis [GO:0097264]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601] cell surface [GO:0009986]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; periciliary membrane compartment [GO:1990075]; photoreceptor inner segment [GO:0001917]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; stereocilia ankle link [GO:0002141]; stereocilia ankle link complex [GO:0002142]; stereocilium [GO:0032420]; stereocilium membrane [GO:0060171]; USH2 complex [GO:1990696] adenylate cyclase inhibitor activity [GO:0010855]; calcium ion binding [GO:0005509]; G protein-coupled receptor activity [GO:0004930]; G-protein alpha-subunit binding [GO:0001965]; hydrolase activity [GO:0016787] g8983.t1 Q8WXG9 24.973 917 6.869999999999999e-48 194.0 sp|Q8WXG9|AGRV1_HUMAN Adhesion G-protein coupled receptor V1 OS=Homo sapiens OX=9606 GN=ADGRV1 PE=1 SV=2 AGRV1_HUMAN reviewed Adhesion G-protein coupled receptor V1 (ADGRV1) (EC 3.4.-.-) (G-protein coupled receptor 98) (Monogenic audiogenic seizure susceptibility protein 1 homolog) (Usher syndrome type-2C protein) (Very large G-protein coupled receptor 1) [Cleaved into: ADGRV1 subunit alpha; ADGRV1 subunit beta] Homo sapiens (Human) GO:0001917; GO:0001965; GO:0002141; GO:0002142; GO:0004930; GO:0005509; GO:0005737; GO:0005886; GO:0007166; GO:0007186; GO:0007399; GO:0007601; GO:0007605; GO:0009986; GO:0010855; GO:0016020; GO:0016787; GO:0030501; GO:0031647; GO:0032420; GO:0043235; GO:0045184; GO:0045494; GO:0048496; GO:0048839; GO:0050877; GO:0050910; GO:0050953; GO:0060113; GO:0060122; GO:0060171; GO:0070062; GO:0071277; GO:0097264; GO:0098609; GO:1990075; GO:1990696 cell surface receptor signaling pathway [GO:0007166]; cell-cell adhesion [GO:0098609]; cellular response to calcium ion [GO:0071277]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; establishment of protein localization [GO:0045184]; G protein-coupled receptor signaling pathway [GO:0007186]; inner ear development [GO:0048839]; inner ear receptor cell differentiation [GO:0060113]; inner ear receptor cell stereocilium organization [GO:0060122]; maintenance of animal organ identity [GO:0048496]; nervous system development [GO:0007399]; nervous system process [GO:0050877]; photoreceptor cell maintenance [GO:0045494]; positive regulation of bone mineralization [GO:0030501]; regulation of protein stability [GO:0031647]; self proteolysis [GO:0097264]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601] cell surface [GO:0009986]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; periciliary membrane compartment [GO:1990075]; photoreceptor inner segment [GO:0001917]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; stereocilia ankle link [GO:0002141]; stereocilia ankle link complex [GO:0002142]; stereocilium [GO:0032420]; stereocilium membrane [GO:0060171]; USH2 complex [GO:1990696] adenylate cyclase inhibitor activity [GO:0010855]; calcium ion binding [GO:0005509]; G protein-coupled receptor activity [GO:0004930]; G-protein alpha-subunit binding [GO:0001965]; hydrolase activity [GO:0016787] g8983.t1 Q8WXG9 26.321 1003 6.4899999999999996e-46 187.0 sp|Q8WXG9|AGRV1_HUMAN Adhesion G-protein coupled receptor V1 OS=Homo sapiens OX=9606 GN=ADGRV1 PE=1 SV=2 AGRV1_HUMAN reviewed Adhesion G-protein coupled receptor V1 (ADGRV1) (EC 3.4.-.-) (G-protein coupled receptor 98) (Monogenic audiogenic seizure susceptibility protein 1 homolog) (Usher syndrome type-2C protein) (Very large G-protein coupled receptor 1) [Cleaved into: ADGRV1 subunit alpha; ADGRV1 subunit beta] Homo sapiens (Human) GO:0001917; GO:0001965; GO:0002141; GO:0002142; GO:0004930; GO:0005509; GO:0005737; GO:0005886; GO:0007166; GO:0007186; GO:0007399; GO:0007601; GO:0007605; GO:0009986; GO:0010855; GO:0016020; GO:0016787; GO:0030501; GO:0031647; GO:0032420; GO:0043235; GO:0045184; GO:0045494; GO:0048496; GO:0048839; GO:0050877; GO:0050910; GO:0050953; GO:0060113; GO:0060122; GO:0060171; GO:0070062; GO:0071277; GO:0097264; GO:0098609; GO:1990075; GO:1990696 cell surface receptor signaling pathway [GO:0007166]; cell-cell adhesion [GO:0098609]; cellular response to calcium ion [GO:0071277]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; establishment of protein localization [GO:0045184]; G protein-coupled receptor signaling pathway [GO:0007186]; inner ear development [GO:0048839]; inner ear receptor cell differentiation [GO:0060113]; inner ear receptor cell stereocilium organization [GO:0060122]; maintenance of animal organ identity [GO:0048496]; nervous system development [GO:0007399]; nervous system process [GO:0050877]; photoreceptor cell maintenance [GO:0045494]; positive regulation of bone mineralization [GO:0030501]; regulation of protein stability [GO:0031647]; self proteolysis [GO:0097264]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601] cell surface [GO:0009986]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; periciliary membrane compartment [GO:1990075]; photoreceptor inner segment [GO:0001917]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; stereocilia ankle link [GO:0002141]; stereocilia ankle link complex [GO:0002142]; stereocilium [GO:0032420]; stereocilium membrane [GO:0060171]; USH2 complex [GO:1990696] adenylate cyclase inhibitor activity [GO:0010855]; calcium ion binding [GO:0005509]; G protein-coupled receptor activity [GO:0004930]; G-protein alpha-subunit binding [GO:0001965]; hydrolase activity [GO:0016787] g8983.t1 Q8WXG9 24.424 1171 8.22e-46 187.0 sp|Q8WXG9|AGRV1_HUMAN Adhesion G-protein coupled receptor V1 OS=Homo sapiens OX=9606 GN=ADGRV1 PE=1 SV=2 AGRV1_HUMAN reviewed Adhesion G-protein coupled receptor V1 (ADGRV1) (EC 3.4.-.-) (G-protein coupled receptor 98) (Monogenic audiogenic seizure susceptibility protein 1 homolog) (Usher syndrome type-2C protein) (Very large G-protein coupled receptor 1) [Cleaved into: ADGRV1 subunit alpha; ADGRV1 subunit beta] Homo sapiens (Human) GO:0001917; GO:0001965; GO:0002141; GO:0002142; GO:0004930; GO:0005509; GO:0005737; GO:0005886; GO:0007166; GO:0007186; GO:0007399; GO:0007601; GO:0007605; GO:0009986; GO:0010855; GO:0016020; GO:0016787; GO:0030501; GO:0031647; GO:0032420; GO:0043235; GO:0045184; GO:0045494; GO:0048496; GO:0048839; GO:0050877; GO:0050910; GO:0050953; GO:0060113; GO:0060122; GO:0060171; GO:0070062; GO:0071277; GO:0097264; GO:0098609; GO:1990075; GO:1990696 cell surface receptor signaling pathway [GO:0007166]; cell-cell adhesion [GO:0098609]; cellular response to calcium ion [GO:0071277]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; establishment of protein localization [GO:0045184]; G protein-coupled receptor signaling pathway [GO:0007186]; inner ear development [GO:0048839]; inner ear receptor cell differentiation [GO:0060113]; inner ear receptor cell stereocilium organization [GO:0060122]; maintenance of animal organ identity [GO:0048496]; nervous system development [GO:0007399]; nervous system process [GO:0050877]; photoreceptor cell maintenance [GO:0045494]; positive regulation of bone mineralization [GO:0030501]; regulation of protein stability [GO:0031647]; self proteolysis [GO:0097264]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601] cell surface [GO:0009986]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; periciliary membrane compartment [GO:1990075]; photoreceptor inner segment [GO:0001917]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; stereocilia ankle link [GO:0002141]; stereocilia ankle link complex [GO:0002142]; stereocilium [GO:0032420]; stereocilium membrane [GO:0060171]; USH2 complex [GO:1990696] adenylate cyclase inhibitor activity [GO:0010855]; calcium ion binding [GO:0005509]; G protein-coupled receptor activity [GO:0004930]; G-protein alpha-subunit binding [GO:0001965]; hydrolase activity [GO:0016787] g8983.t1 Q8WXG9 27.33 633 2.91e-42 175.0 sp|Q8WXG9|AGRV1_HUMAN Adhesion G-protein coupled receptor V1 OS=Homo sapiens OX=9606 GN=ADGRV1 PE=1 SV=2 AGRV1_HUMAN reviewed Adhesion G-protein coupled receptor V1 (ADGRV1) (EC 3.4.-.-) (G-protein coupled receptor 98) (Monogenic audiogenic seizure susceptibility protein 1 homolog) (Usher syndrome type-2C protein) (Very large G-protein coupled receptor 1) [Cleaved into: ADGRV1 subunit alpha; ADGRV1 subunit beta] Homo sapiens (Human) GO:0001917; GO:0001965; GO:0002141; GO:0002142; GO:0004930; GO:0005509; GO:0005737; GO:0005886; GO:0007166; GO:0007186; GO:0007399; GO:0007601; GO:0007605; GO:0009986; GO:0010855; GO:0016020; GO:0016787; GO:0030501; GO:0031647; GO:0032420; GO:0043235; GO:0045184; GO:0045494; GO:0048496; GO:0048839; GO:0050877; GO:0050910; GO:0050953; GO:0060113; GO:0060122; GO:0060171; GO:0070062; GO:0071277; GO:0097264; GO:0098609; GO:1990075; GO:1990696 cell surface receptor signaling pathway [GO:0007166]; cell-cell adhesion [GO:0098609]; cellular response to calcium ion [GO:0071277]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; establishment of protein localization [GO:0045184]; G protein-coupled receptor signaling pathway [GO:0007186]; inner ear development [GO:0048839]; inner ear receptor cell differentiation [GO:0060113]; inner ear receptor cell stereocilium organization [GO:0060122]; maintenance of animal organ identity [GO:0048496]; nervous system development [GO:0007399]; nervous system process [GO:0050877]; photoreceptor cell maintenance [GO:0045494]; positive regulation of bone mineralization [GO:0030501]; regulation of protein stability [GO:0031647]; self proteolysis [GO:0097264]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601] cell surface [GO:0009986]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; periciliary membrane compartment [GO:1990075]; photoreceptor inner segment [GO:0001917]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; stereocilia ankle link [GO:0002141]; stereocilia ankle link complex [GO:0002142]; stereocilium [GO:0032420]; stereocilium membrane [GO:0060171]; USH2 complex [GO:1990696] adenylate cyclase inhibitor activity [GO:0010855]; calcium ion binding [GO:0005509]; G protein-coupled receptor activity [GO:0004930]; G-protein alpha-subunit binding [GO:0001965]; hydrolase activity [GO:0016787] g8983.t1 Q8WXG9 23.733 1302 5.84e-37 158.0 sp|Q8WXG9|AGRV1_HUMAN Adhesion G-protein coupled receptor V1 OS=Homo sapiens OX=9606 GN=ADGRV1 PE=1 SV=2 AGRV1_HUMAN reviewed Adhesion G-protein coupled receptor V1 (ADGRV1) (EC 3.4.-.-) (G-protein coupled receptor 98) (Monogenic audiogenic seizure susceptibility protein 1 homolog) (Usher syndrome type-2C protein) (Very large G-protein coupled receptor 1) [Cleaved into: ADGRV1 subunit alpha; ADGRV1 subunit beta] Homo sapiens (Human) GO:0001917; GO:0001965; GO:0002141; GO:0002142; GO:0004930; GO:0005509; GO:0005737; GO:0005886; GO:0007166; GO:0007186; GO:0007399; GO:0007601; GO:0007605; GO:0009986; GO:0010855; GO:0016020; GO:0016787; GO:0030501; GO:0031647; GO:0032420; GO:0043235; GO:0045184; GO:0045494; GO:0048496; GO:0048839; GO:0050877; GO:0050910; GO:0050953; GO:0060113; GO:0060122; GO:0060171; GO:0070062; GO:0071277; GO:0097264; GO:0098609; GO:1990075; GO:1990696 cell surface receptor signaling pathway [GO:0007166]; cell-cell adhesion [GO:0098609]; cellular response to calcium ion [GO:0071277]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; establishment of protein localization [GO:0045184]; G protein-coupled receptor signaling pathway [GO:0007186]; inner ear development [GO:0048839]; inner ear receptor cell differentiation [GO:0060113]; inner ear receptor cell stereocilium organization [GO:0060122]; maintenance of animal organ identity [GO:0048496]; nervous system development [GO:0007399]; nervous system process [GO:0050877]; photoreceptor cell maintenance [GO:0045494]; positive regulation of bone mineralization [GO:0030501]; regulation of protein stability [GO:0031647]; self proteolysis [GO:0097264]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601] cell surface [GO:0009986]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; periciliary membrane compartment [GO:1990075]; photoreceptor inner segment [GO:0001917]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; stereocilia ankle link [GO:0002141]; stereocilia ankle link complex [GO:0002142]; stereocilium [GO:0032420]; stereocilium membrane [GO:0060171]; USH2 complex [GO:1990696] adenylate cyclase inhibitor activity [GO:0010855]; calcium ion binding [GO:0005509]; G protein-coupled receptor activity [GO:0004930]; G-protein alpha-subunit binding [GO:0001965]; hydrolase activity [GO:0016787] g8983.t1 Q8WXG9 24.537 1349 8.11e-37 157.0 sp|Q8WXG9|AGRV1_HUMAN Adhesion G-protein coupled receptor V1 OS=Homo sapiens OX=9606 GN=ADGRV1 PE=1 SV=2 AGRV1_HUMAN reviewed Adhesion G-protein coupled receptor V1 (ADGRV1) (EC 3.4.-.-) (G-protein coupled receptor 98) (Monogenic audiogenic seizure susceptibility protein 1 homolog) (Usher syndrome type-2C protein) (Very large G-protein coupled receptor 1) [Cleaved into: ADGRV1 subunit alpha; ADGRV1 subunit beta] Homo sapiens (Human) GO:0001917; GO:0001965; GO:0002141; GO:0002142; GO:0004930; GO:0005509; GO:0005737; GO:0005886; GO:0007166; GO:0007186; GO:0007399; GO:0007601; GO:0007605; GO:0009986; GO:0010855; GO:0016020; GO:0016787; GO:0030501; GO:0031647; GO:0032420; GO:0043235; GO:0045184; GO:0045494; GO:0048496; GO:0048839; GO:0050877; GO:0050910; GO:0050953; GO:0060113; GO:0060122; GO:0060171; GO:0070062; GO:0071277; GO:0097264; GO:0098609; GO:1990075; GO:1990696 cell surface receptor signaling pathway [GO:0007166]; cell-cell adhesion [GO:0098609]; cellular response to calcium ion [GO:0071277]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; establishment of protein localization [GO:0045184]; G protein-coupled receptor signaling pathway [GO:0007186]; inner ear development [GO:0048839]; inner ear receptor cell differentiation [GO:0060113]; inner ear receptor cell stereocilium organization [GO:0060122]; maintenance of animal organ identity [GO:0048496]; nervous system development [GO:0007399]; nervous system process [GO:0050877]; photoreceptor cell maintenance [GO:0045494]; positive regulation of bone mineralization [GO:0030501]; regulation of protein stability [GO:0031647]; self proteolysis [GO:0097264]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601] cell surface [GO:0009986]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; periciliary membrane compartment [GO:1990075]; photoreceptor inner segment [GO:0001917]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; stereocilia ankle link [GO:0002141]; stereocilia ankle link complex [GO:0002142]; stereocilium [GO:0032420]; stereocilium membrane [GO:0060171]; USH2 complex [GO:1990696] adenylate cyclase inhibitor activity [GO:0010855]; calcium ion binding [GO:0005509]; G protein-coupled receptor activity [GO:0004930]; G-protein alpha-subunit binding [GO:0001965]; hydrolase activity [GO:0016787] g8983.t1 Q8WXG9 23.455 955 3.79e-33 145.0 sp|Q8WXG9|AGRV1_HUMAN Adhesion G-protein coupled receptor V1 OS=Homo sapiens OX=9606 GN=ADGRV1 PE=1 SV=2 AGRV1_HUMAN reviewed Adhesion G-protein coupled receptor V1 (ADGRV1) (EC 3.4.-.-) (G-protein coupled receptor 98) (Monogenic audiogenic seizure susceptibility protein 1 homolog) (Usher syndrome type-2C protein) (Very large G-protein coupled receptor 1) [Cleaved into: ADGRV1 subunit alpha; ADGRV1 subunit beta] Homo sapiens (Human) GO:0001917; GO:0001965; GO:0002141; GO:0002142; GO:0004930; GO:0005509; GO:0005737; GO:0005886; GO:0007166; GO:0007186; GO:0007399; GO:0007601; GO:0007605; GO:0009986; GO:0010855; GO:0016020; GO:0016787; GO:0030501; GO:0031647; GO:0032420; GO:0043235; GO:0045184; GO:0045494; GO:0048496; GO:0048839; GO:0050877; GO:0050910; GO:0050953; GO:0060113; GO:0060122; GO:0060171; GO:0070062; GO:0071277; GO:0097264; GO:0098609; GO:1990075; GO:1990696 cell surface receptor signaling pathway [GO:0007166]; cell-cell adhesion [GO:0098609]; cellular response to calcium ion [GO:0071277]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; establishment of protein localization [GO:0045184]; G protein-coupled receptor signaling pathway [GO:0007186]; inner ear development [GO:0048839]; inner ear receptor cell differentiation [GO:0060113]; inner ear receptor cell stereocilium organization [GO:0060122]; maintenance of animal organ identity [GO:0048496]; nervous system development [GO:0007399]; nervous system process [GO:0050877]; photoreceptor cell maintenance [GO:0045494]; positive regulation of bone mineralization [GO:0030501]; regulation of protein stability [GO:0031647]; self proteolysis [GO:0097264]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601] cell surface [GO:0009986]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; periciliary membrane compartment [GO:1990075]; photoreceptor inner segment [GO:0001917]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; stereocilia ankle link [GO:0002141]; stereocilia ankle link complex [GO:0002142]; stereocilium [GO:0032420]; stereocilium membrane [GO:0060171]; USH2 complex [GO:1990696] adenylate cyclase inhibitor activity [GO:0010855]; calcium ion binding [GO:0005509]; G protein-coupled receptor activity [GO:0004930]; G-protein alpha-subunit binding [GO:0001965]; hydrolase activity [GO:0016787] g8983.t1 Q8WXG9 27.68 513 3.87e-29 132.0 sp|Q8WXG9|AGRV1_HUMAN Adhesion G-protein coupled receptor V1 OS=Homo sapiens OX=9606 GN=ADGRV1 PE=1 SV=2 AGRV1_HUMAN reviewed Adhesion G-protein coupled receptor V1 (ADGRV1) (EC 3.4.-.-) (G-protein coupled receptor 98) (Monogenic audiogenic seizure susceptibility protein 1 homolog) (Usher syndrome type-2C protein) (Very large G-protein coupled receptor 1) [Cleaved into: ADGRV1 subunit alpha; ADGRV1 subunit beta] Homo sapiens (Human) GO:0001917; GO:0001965; GO:0002141; GO:0002142; GO:0004930; GO:0005509; GO:0005737; GO:0005886; GO:0007166; GO:0007186; GO:0007399; GO:0007601; GO:0007605; GO:0009986; GO:0010855; GO:0016020; GO:0016787; GO:0030501; GO:0031647; GO:0032420; GO:0043235; GO:0045184; GO:0045494; GO:0048496; GO:0048839; GO:0050877; GO:0050910; GO:0050953; GO:0060113; GO:0060122; GO:0060171; GO:0070062; GO:0071277; GO:0097264; GO:0098609; GO:1990075; GO:1990696 cell surface receptor signaling pathway [GO:0007166]; cell-cell adhesion [GO:0098609]; cellular response to calcium ion [GO:0071277]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; establishment of protein localization [GO:0045184]; G protein-coupled receptor signaling pathway [GO:0007186]; inner ear development [GO:0048839]; inner ear receptor cell differentiation [GO:0060113]; inner ear receptor cell stereocilium organization [GO:0060122]; maintenance of animal organ identity [GO:0048496]; nervous system development [GO:0007399]; nervous system process [GO:0050877]; photoreceptor cell maintenance [GO:0045494]; positive regulation of bone mineralization [GO:0030501]; regulation of protein stability [GO:0031647]; self proteolysis [GO:0097264]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601] cell surface [GO:0009986]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; periciliary membrane compartment [GO:1990075]; photoreceptor inner segment [GO:0001917]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; stereocilia ankle link [GO:0002141]; stereocilia ankle link complex [GO:0002142]; stereocilium [GO:0032420]; stereocilium membrane [GO:0060171]; USH2 complex [GO:1990696] adenylate cyclase inhibitor activity [GO:0010855]; calcium ion binding [GO:0005509]; G protein-coupled receptor activity [GO:0004930]; G-protein alpha-subunit binding [GO:0001965]; hydrolase activity [GO:0016787] g8983.t1 Q8WXG9 23.588 903 2.82e-27 126.0 sp|Q8WXG9|AGRV1_HUMAN Adhesion G-protein coupled receptor V1 OS=Homo sapiens OX=9606 GN=ADGRV1 PE=1 SV=2 AGRV1_HUMAN reviewed Adhesion G-protein coupled receptor V1 (ADGRV1) (EC 3.4.-.-) (G-protein coupled receptor 98) (Monogenic audiogenic seizure susceptibility protein 1 homolog) (Usher syndrome type-2C protein) (Very large G-protein coupled receptor 1) [Cleaved into: ADGRV1 subunit alpha; ADGRV1 subunit beta] Homo sapiens (Human) GO:0001917; GO:0001965; GO:0002141; GO:0002142; GO:0004930; GO:0005509; GO:0005737; GO:0005886; GO:0007166; GO:0007186; GO:0007399; GO:0007601; GO:0007605; GO:0009986; GO:0010855; GO:0016020; GO:0016787; GO:0030501; GO:0031647; GO:0032420; GO:0043235; GO:0045184; GO:0045494; GO:0048496; GO:0048839; GO:0050877; GO:0050910; GO:0050953; GO:0060113; GO:0060122; GO:0060171; GO:0070062; GO:0071277; GO:0097264; GO:0098609; GO:1990075; GO:1990696 cell surface receptor signaling pathway [GO:0007166]; cell-cell adhesion [GO:0098609]; cellular response to calcium ion [GO:0071277]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; establishment of protein localization [GO:0045184]; G protein-coupled receptor signaling pathway [GO:0007186]; inner ear development [GO:0048839]; inner ear receptor cell differentiation [GO:0060113]; inner ear receptor cell stereocilium organization [GO:0060122]; maintenance of animal organ identity [GO:0048496]; nervous system development [GO:0007399]; nervous system process [GO:0050877]; photoreceptor cell maintenance [GO:0045494]; positive regulation of bone mineralization [GO:0030501]; regulation of protein stability [GO:0031647]; self proteolysis [GO:0097264]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601] cell surface [GO:0009986]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; periciliary membrane compartment [GO:1990075]; photoreceptor inner segment [GO:0001917]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; stereocilia ankle link [GO:0002141]; stereocilia ankle link complex [GO:0002142]; stereocilium [GO:0032420]; stereocilium membrane [GO:0060171]; USH2 complex [GO:1990696] adenylate cyclase inhibitor activity [GO:0010855]; calcium ion binding [GO:0005509]; G protein-coupled receptor activity [GO:0004930]; G-protein alpha-subunit binding [GO:0001965]; hydrolase activity [GO:0016787] g8983.t1 Q8WXG9 25.623 843 9.38e-27 124.0 sp|Q8WXG9|AGRV1_HUMAN Adhesion G-protein coupled receptor V1 OS=Homo sapiens OX=9606 GN=ADGRV1 PE=1 SV=2 AGRV1_HUMAN reviewed Adhesion G-protein coupled receptor V1 (ADGRV1) (EC 3.4.-.-) (G-protein coupled receptor 98) (Monogenic audiogenic seizure susceptibility protein 1 homolog) (Usher syndrome type-2C protein) (Very large G-protein coupled receptor 1) [Cleaved into: ADGRV1 subunit alpha; ADGRV1 subunit beta] Homo sapiens (Human) GO:0001917; GO:0001965; GO:0002141; GO:0002142; GO:0004930; GO:0005509; GO:0005737; GO:0005886; GO:0007166; GO:0007186; GO:0007399; GO:0007601; GO:0007605; GO:0009986; GO:0010855; GO:0016020; GO:0016787; GO:0030501; GO:0031647; GO:0032420; GO:0043235; GO:0045184; GO:0045494; GO:0048496; GO:0048839; GO:0050877; GO:0050910; GO:0050953; GO:0060113; GO:0060122; GO:0060171; GO:0070062; GO:0071277; GO:0097264; GO:0098609; GO:1990075; GO:1990696 cell surface receptor signaling pathway [GO:0007166]; cell-cell adhesion [GO:0098609]; cellular response to calcium ion [GO:0071277]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; establishment of protein localization [GO:0045184]; G protein-coupled receptor signaling pathway [GO:0007186]; inner ear development [GO:0048839]; inner ear receptor cell differentiation [GO:0060113]; inner ear receptor cell stereocilium organization [GO:0060122]; maintenance of animal organ identity [GO:0048496]; nervous system development [GO:0007399]; nervous system process [GO:0050877]; photoreceptor cell maintenance [GO:0045494]; positive regulation of bone mineralization [GO:0030501]; regulation of protein stability [GO:0031647]; self proteolysis [GO:0097264]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601] cell surface [GO:0009986]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; periciliary membrane compartment [GO:1990075]; photoreceptor inner segment [GO:0001917]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; stereocilia ankle link [GO:0002141]; stereocilia ankle link complex [GO:0002142]; stereocilium [GO:0032420]; stereocilium membrane [GO:0060171]; USH2 complex [GO:1990696] adenylate cyclase inhibitor activity [GO:0010855]; calcium ion binding [GO:0005509]; G protein-coupled receptor activity [GO:0004930]; G-protein alpha-subunit binding [GO:0001965]; hydrolase activity [GO:0016787] g8984.t1 Q8WXG9 40.722 609 2.0200000000000003e-110 369.0 sp|Q8WXG9|AGRV1_HUMAN Adhesion G-protein coupled receptor V1 OS=Homo sapiens OX=9606 GN=ADGRV1 PE=1 SV=2 AGRV1_HUMAN reviewed Adhesion G-protein coupled receptor V1 (ADGRV1) (EC 3.4.-.-) (G-protein coupled receptor 98) (Monogenic audiogenic seizure susceptibility protein 1 homolog) (Usher syndrome type-2C protein) (Very large G-protein coupled receptor 1) [Cleaved into: ADGRV1 subunit alpha; ADGRV1 subunit beta] Homo sapiens (Human) GO:0001917; GO:0001965; GO:0002141; GO:0002142; GO:0004930; GO:0005509; GO:0005737; GO:0005886; GO:0007166; GO:0007186; GO:0007399; GO:0007601; GO:0007605; GO:0009986; GO:0010855; GO:0016020; GO:0016787; GO:0030501; GO:0031647; GO:0032420; GO:0043235; GO:0045184; GO:0045494; GO:0048496; GO:0048839; GO:0050877; GO:0050910; GO:0050953; GO:0060113; GO:0060122; GO:0060171; GO:0070062; GO:0071277; GO:0097264; GO:0098609; GO:1990075; GO:1990696 cell surface receptor signaling pathway [GO:0007166]; cell-cell adhesion [GO:0098609]; cellular response to calcium ion [GO:0071277]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; establishment of protein localization [GO:0045184]; G protein-coupled receptor signaling pathway [GO:0007186]; inner ear development [GO:0048839]; inner ear receptor cell differentiation [GO:0060113]; inner ear receptor cell stereocilium organization [GO:0060122]; maintenance of animal organ identity [GO:0048496]; nervous system development [GO:0007399]; nervous system process [GO:0050877]; photoreceptor cell maintenance [GO:0045494]; positive regulation of bone mineralization [GO:0030501]; regulation of protein stability [GO:0031647]; self proteolysis [GO:0097264]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601] cell surface [GO:0009986]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; periciliary membrane compartment [GO:1990075]; photoreceptor inner segment [GO:0001917]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; stereocilia ankle link [GO:0002141]; stereocilia ankle link complex [GO:0002142]; stereocilium [GO:0032420]; stereocilium membrane [GO:0060171]; USH2 complex [GO:1990696] adenylate cyclase inhibitor activity [GO:0010855]; calcium ion binding [GO:0005509]; G protein-coupled receptor activity [GO:0004930]; G-protein alpha-subunit binding [GO:0001965]; hydrolase activity [GO:0016787] g8984.t1 Q8WXG9 30.197 457 7.81e-39 157.0 sp|Q8WXG9|AGRV1_HUMAN Adhesion G-protein coupled receptor V1 OS=Homo sapiens OX=9606 GN=ADGRV1 PE=1 SV=2 AGRV1_HUMAN reviewed Adhesion G-protein coupled receptor V1 (ADGRV1) (EC 3.4.-.-) (G-protein coupled receptor 98) (Monogenic audiogenic seizure susceptibility protein 1 homolog) (Usher syndrome type-2C protein) (Very large G-protein coupled receptor 1) [Cleaved into: ADGRV1 subunit alpha; ADGRV1 subunit beta] Homo sapiens (Human) GO:0001917; GO:0001965; GO:0002141; GO:0002142; GO:0004930; GO:0005509; GO:0005737; GO:0005886; GO:0007166; GO:0007186; GO:0007399; GO:0007601; GO:0007605; GO:0009986; GO:0010855; GO:0016020; GO:0016787; GO:0030501; GO:0031647; GO:0032420; GO:0043235; GO:0045184; GO:0045494; GO:0048496; GO:0048839; GO:0050877; GO:0050910; GO:0050953; GO:0060113; GO:0060122; GO:0060171; GO:0070062; GO:0071277; GO:0097264; GO:0098609; GO:1990075; GO:1990696 cell surface receptor signaling pathway [GO:0007166]; cell-cell adhesion [GO:0098609]; cellular response to calcium ion [GO:0071277]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; establishment of protein localization [GO:0045184]; G protein-coupled receptor signaling pathway [GO:0007186]; inner ear development [GO:0048839]; inner ear receptor cell differentiation [GO:0060113]; inner ear receptor cell stereocilium organization [GO:0060122]; maintenance of animal organ identity [GO:0048496]; nervous system development [GO:0007399]; nervous system process [GO:0050877]; photoreceptor cell maintenance [GO:0045494]; positive regulation of bone mineralization [GO:0030501]; regulation of protein stability [GO:0031647]; self proteolysis [GO:0097264]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601] cell surface [GO:0009986]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; periciliary membrane compartment [GO:1990075]; photoreceptor inner segment [GO:0001917]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; stereocilia ankle link [GO:0002141]; stereocilia ankle link complex [GO:0002142]; stereocilium [GO:0032420]; stereocilium membrane [GO:0060171]; USH2 complex [GO:1990696] adenylate cyclase inhibitor activity [GO:0010855]; calcium ion binding [GO:0005509]; G protein-coupled receptor activity [GO:0004930]; G-protein alpha-subunit binding [GO:0001965]; hydrolase activity [GO:0016787] g8984.t1 Q8WXG9 26.341 615 6.3e-37 152.0 sp|Q8WXG9|AGRV1_HUMAN Adhesion G-protein coupled receptor V1 OS=Homo sapiens OX=9606 GN=ADGRV1 PE=1 SV=2 AGRV1_HUMAN reviewed Adhesion G-protein coupled receptor V1 (ADGRV1) (EC 3.4.-.-) (G-protein coupled receptor 98) (Monogenic audiogenic seizure susceptibility protein 1 homolog) (Usher syndrome type-2C protein) (Very large G-protein coupled receptor 1) [Cleaved into: ADGRV1 subunit alpha; ADGRV1 subunit beta] Homo sapiens (Human) GO:0001917; GO:0001965; GO:0002141; GO:0002142; GO:0004930; GO:0005509; GO:0005737; GO:0005886; GO:0007166; GO:0007186; GO:0007399; GO:0007601; GO:0007605; GO:0009986; GO:0010855; GO:0016020; GO:0016787; GO:0030501; GO:0031647; GO:0032420; GO:0043235; GO:0045184; GO:0045494; GO:0048496; GO:0048839; GO:0050877; GO:0050910; GO:0050953; GO:0060113; GO:0060122; GO:0060171; GO:0070062; GO:0071277; GO:0097264; GO:0098609; GO:1990075; GO:1990696 cell surface receptor signaling pathway [GO:0007166]; cell-cell adhesion [GO:0098609]; cellular response to calcium ion [GO:0071277]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; establishment of protein localization [GO:0045184]; G protein-coupled receptor signaling pathway [GO:0007186]; inner ear development [GO:0048839]; inner ear receptor cell differentiation [GO:0060113]; inner ear receptor cell stereocilium organization [GO:0060122]; maintenance of animal organ identity [GO:0048496]; nervous system development [GO:0007399]; nervous system process [GO:0050877]; photoreceptor cell maintenance [GO:0045494]; positive regulation of bone mineralization [GO:0030501]; regulation of protein stability [GO:0031647]; self proteolysis [GO:0097264]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601] cell surface [GO:0009986]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; periciliary membrane compartment [GO:1990075]; photoreceptor inner segment [GO:0001917]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; stereocilia ankle link [GO:0002141]; stereocilia ankle link complex [GO:0002142]; stereocilium [GO:0032420]; stereocilium membrane [GO:0060171]; USH2 complex [GO:1990696] adenylate cyclase inhibitor activity [GO:0010855]; calcium ion binding [GO:0005509]; G protein-coupled receptor activity [GO:0004930]; G-protein alpha-subunit binding [GO:0001965]; hydrolase activity [GO:0016787] g8984.t1 Q8WXG9 29.756 410 5.91e-32 136.0 sp|Q8WXG9|AGRV1_HUMAN Adhesion G-protein coupled receptor V1 OS=Homo sapiens OX=9606 GN=ADGRV1 PE=1 SV=2 AGRV1_HUMAN reviewed Adhesion G-protein coupled receptor V1 (ADGRV1) (EC 3.4.-.-) (G-protein coupled receptor 98) (Monogenic audiogenic seizure susceptibility protein 1 homolog) (Usher syndrome type-2C protein) (Very large G-protein coupled receptor 1) [Cleaved into: ADGRV1 subunit alpha; ADGRV1 subunit beta] Homo sapiens (Human) GO:0001917; GO:0001965; GO:0002141; GO:0002142; GO:0004930; GO:0005509; GO:0005737; GO:0005886; GO:0007166; GO:0007186; GO:0007399; GO:0007601; GO:0007605; GO:0009986; GO:0010855; GO:0016020; GO:0016787; GO:0030501; GO:0031647; GO:0032420; GO:0043235; GO:0045184; GO:0045494; GO:0048496; GO:0048839; GO:0050877; GO:0050910; GO:0050953; GO:0060113; GO:0060122; GO:0060171; GO:0070062; GO:0071277; GO:0097264; GO:0098609; GO:1990075; GO:1990696 cell surface receptor signaling pathway [GO:0007166]; cell-cell adhesion [GO:0098609]; cellular response to calcium ion [GO:0071277]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; establishment of protein localization [GO:0045184]; G protein-coupled receptor signaling pathway [GO:0007186]; inner ear development [GO:0048839]; inner ear receptor cell differentiation [GO:0060113]; inner ear receptor cell stereocilium organization [GO:0060122]; maintenance of animal organ identity [GO:0048496]; nervous system development [GO:0007399]; nervous system process [GO:0050877]; photoreceptor cell maintenance [GO:0045494]; positive regulation of bone mineralization [GO:0030501]; regulation of protein stability [GO:0031647]; self proteolysis [GO:0097264]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601] cell surface [GO:0009986]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; periciliary membrane compartment [GO:1990075]; photoreceptor inner segment [GO:0001917]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; stereocilia ankle link [GO:0002141]; stereocilia ankle link complex [GO:0002142]; stereocilium [GO:0032420]; stereocilium membrane [GO:0060171]; USH2 complex [GO:1990696] adenylate cyclase inhibitor activity [GO:0010855]; calcium ion binding [GO:0005509]; G protein-coupled receptor activity [GO:0004930]; G-protein alpha-subunit binding [GO:0001965]; hydrolase activity [GO:0016787] g8984.t1 Q8WXG9 27.529 603 2.1e-24 113.0 sp|Q8WXG9|AGRV1_HUMAN Adhesion G-protein coupled receptor V1 OS=Homo sapiens OX=9606 GN=ADGRV1 PE=1 SV=2 AGRV1_HUMAN reviewed Adhesion G-protein coupled receptor V1 (ADGRV1) (EC 3.4.-.-) (G-protein coupled receptor 98) (Monogenic audiogenic seizure susceptibility protein 1 homolog) (Usher syndrome type-2C protein) (Very large G-protein coupled receptor 1) [Cleaved into: ADGRV1 subunit alpha; ADGRV1 subunit beta] Homo sapiens (Human) GO:0001917; GO:0001965; GO:0002141; GO:0002142; GO:0004930; GO:0005509; GO:0005737; GO:0005886; GO:0007166; GO:0007186; GO:0007399; GO:0007601; GO:0007605; GO:0009986; GO:0010855; GO:0016020; GO:0016787; GO:0030501; GO:0031647; GO:0032420; GO:0043235; GO:0045184; GO:0045494; GO:0048496; GO:0048839; GO:0050877; GO:0050910; GO:0050953; GO:0060113; GO:0060122; GO:0060171; GO:0070062; GO:0071277; GO:0097264; GO:0098609; GO:1990075; GO:1990696 cell surface receptor signaling pathway [GO:0007166]; cell-cell adhesion [GO:0098609]; cellular response to calcium ion [GO:0071277]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; establishment of protein localization [GO:0045184]; G protein-coupled receptor signaling pathway [GO:0007186]; inner ear development [GO:0048839]; inner ear receptor cell differentiation [GO:0060113]; inner ear receptor cell stereocilium organization [GO:0060122]; maintenance of animal organ identity [GO:0048496]; nervous system development [GO:0007399]; nervous system process [GO:0050877]; photoreceptor cell maintenance [GO:0045494]; positive regulation of bone mineralization [GO:0030501]; regulation of protein stability [GO:0031647]; self proteolysis [GO:0097264]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601] cell surface [GO:0009986]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; periciliary membrane compartment [GO:1990075]; photoreceptor inner segment [GO:0001917]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; stereocilia ankle link [GO:0002141]; stereocilia ankle link complex [GO:0002142]; stereocilium [GO:0032420]; stereocilium membrane [GO:0060171]; USH2 complex [GO:1990696] adenylate cyclase inhibitor activity [GO:0010855]; calcium ion binding [GO:0005509]; G protein-coupled receptor activity [GO:0004930]; G-protein alpha-subunit binding [GO:0001965]; hydrolase activity [GO:0016787] g8984.t1 Q8WXG9 26.238 606 1.39e-22 107.0 sp|Q8WXG9|AGRV1_HUMAN Adhesion G-protein coupled receptor V1 OS=Homo sapiens OX=9606 GN=ADGRV1 PE=1 SV=2 AGRV1_HUMAN reviewed Adhesion G-protein coupled receptor V1 (ADGRV1) (EC 3.4.-.-) (G-protein coupled receptor 98) (Monogenic audiogenic seizure susceptibility protein 1 homolog) (Usher syndrome type-2C protein) (Very large G-protein coupled receptor 1) [Cleaved into: ADGRV1 subunit alpha; ADGRV1 subunit beta] Homo sapiens (Human) GO:0001917; GO:0001965; GO:0002141; GO:0002142; GO:0004930; GO:0005509; GO:0005737; GO:0005886; GO:0007166; GO:0007186; GO:0007399; GO:0007601; GO:0007605; GO:0009986; GO:0010855; GO:0016020; GO:0016787; GO:0030501; GO:0031647; GO:0032420; GO:0043235; GO:0045184; GO:0045494; GO:0048496; GO:0048839; GO:0050877; GO:0050910; GO:0050953; GO:0060113; GO:0060122; GO:0060171; GO:0070062; GO:0071277; GO:0097264; GO:0098609; GO:1990075; GO:1990696 cell surface receptor signaling pathway [GO:0007166]; cell-cell adhesion [GO:0098609]; cellular response to calcium ion [GO:0071277]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; establishment of protein localization [GO:0045184]; G protein-coupled receptor signaling pathway [GO:0007186]; inner ear development [GO:0048839]; inner ear receptor cell differentiation [GO:0060113]; inner ear receptor cell stereocilium organization [GO:0060122]; maintenance of animal organ identity [GO:0048496]; nervous system development [GO:0007399]; nervous system process [GO:0050877]; photoreceptor cell maintenance [GO:0045494]; positive regulation of bone mineralization [GO:0030501]; regulation of protein stability [GO:0031647]; self proteolysis [GO:0097264]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601] cell surface [GO:0009986]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; periciliary membrane compartment [GO:1990075]; photoreceptor inner segment [GO:0001917]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; stereocilia ankle link [GO:0002141]; stereocilia ankle link complex [GO:0002142]; stereocilium [GO:0032420]; stereocilium membrane [GO:0060171]; USH2 complex [GO:1990696] adenylate cyclase inhibitor activity [GO:0010855]; calcium ion binding [GO:0005509]; G protein-coupled receptor activity [GO:0004930]; G-protein alpha-subunit binding [GO:0001965]; hydrolase activity [GO:0016787] g8985.t1 Q8WXG9 40.129 1550 0.0 952.0 sp|Q8WXG9|AGRV1_HUMAN Adhesion G-protein coupled receptor V1 OS=Homo sapiens OX=9606 GN=ADGRV1 PE=1 SV=2 AGRV1_HUMAN reviewed Adhesion G-protein coupled receptor V1 (ADGRV1) (EC 3.4.-.-) (G-protein coupled receptor 98) (Monogenic audiogenic seizure susceptibility protein 1 homolog) (Usher syndrome type-2C protein) (Very large G-protein coupled receptor 1) [Cleaved into: ADGRV1 subunit alpha; ADGRV1 subunit beta] Homo sapiens (Human) GO:0001917; GO:0001965; GO:0002141; GO:0002142; GO:0004930; GO:0005509; GO:0005737; GO:0005886; GO:0007166; GO:0007186; GO:0007399; GO:0007601; GO:0007605; GO:0009986; GO:0010855; GO:0016020; GO:0016787; GO:0030501; GO:0031647; GO:0032420; GO:0043235; GO:0045184; GO:0045494; GO:0048496; GO:0048839; GO:0050877; GO:0050910; GO:0050953; GO:0060113; GO:0060122; GO:0060171; GO:0070062; GO:0071277; GO:0097264; GO:0098609; GO:1990075; GO:1990696 cell surface receptor signaling pathway [GO:0007166]; cell-cell adhesion [GO:0098609]; cellular response to calcium ion [GO:0071277]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; establishment of protein localization [GO:0045184]; G protein-coupled receptor signaling pathway [GO:0007186]; inner ear development [GO:0048839]; inner ear receptor cell differentiation [GO:0060113]; inner ear receptor cell stereocilium organization [GO:0060122]; maintenance of animal organ identity [GO:0048496]; nervous system development [GO:0007399]; nervous system process [GO:0050877]; photoreceptor cell maintenance [GO:0045494]; positive regulation of bone mineralization [GO:0030501]; regulation of protein stability [GO:0031647]; self proteolysis [GO:0097264]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601] cell surface [GO:0009986]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; periciliary membrane compartment [GO:1990075]; photoreceptor inner segment [GO:0001917]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; stereocilia ankle link [GO:0002141]; stereocilia ankle link complex [GO:0002142]; stereocilium [GO:0032420]; stereocilium membrane [GO:0060171]; USH2 complex [GO:1990696] adenylate cyclase inhibitor activity [GO:0010855]; calcium ion binding [GO:0005509]; G protein-coupled receptor activity [GO:0004930]; G-protein alpha-subunit binding [GO:0001965]; hydrolase activity [GO:0016787] g8985.t1 Q8WXG9 26.446 847 1.9299999999999997e-54 214.0 sp|Q8WXG9|AGRV1_HUMAN Adhesion G-protein coupled receptor V1 OS=Homo sapiens OX=9606 GN=ADGRV1 PE=1 SV=2 AGRV1_HUMAN reviewed Adhesion G-protein coupled receptor V1 (ADGRV1) (EC 3.4.-.-) (G-protein coupled receptor 98) (Monogenic audiogenic seizure susceptibility protein 1 homolog) (Usher syndrome type-2C protein) (Very large G-protein coupled receptor 1) [Cleaved into: ADGRV1 subunit alpha; ADGRV1 subunit beta] Homo sapiens (Human) GO:0001917; GO:0001965; GO:0002141; GO:0002142; GO:0004930; GO:0005509; GO:0005737; GO:0005886; GO:0007166; GO:0007186; GO:0007399; GO:0007601; GO:0007605; GO:0009986; GO:0010855; GO:0016020; GO:0016787; GO:0030501; GO:0031647; GO:0032420; GO:0043235; GO:0045184; GO:0045494; GO:0048496; GO:0048839; GO:0050877; GO:0050910; GO:0050953; GO:0060113; GO:0060122; GO:0060171; GO:0070062; GO:0071277; GO:0097264; GO:0098609; GO:1990075; GO:1990696 cell surface receptor signaling pathway [GO:0007166]; cell-cell adhesion [GO:0098609]; cellular response to calcium ion [GO:0071277]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; establishment of protein localization [GO:0045184]; G protein-coupled receptor signaling pathway [GO:0007186]; inner ear development [GO:0048839]; inner ear receptor cell differentiation [GO:0060113]; inner ear receptor cell stereocilium organization [GO:0060122]; maintenance of animal organ identity [GO:0048496]; nervous system development [GO:0007399]; nervous system process [GO:0050877]; photoreceptor cell maintenance [GO:0045494]; positive regulation of bone mineralization [GO:0030501]; regulation of protein stability [GO:0031647]; self proteolysis [GO:0097264]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601] cell surface [GO:0009986]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; periciliary membrane compartment [GO:1990075]; photoreceptor inner segment [GO:0001917]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; stereocilia ankle link [GO:0002141]; stereocilia ankle link complex [GO:0002142]; stereocilium [GO:0032420]; stereocilium membrane [GO:0060171]; USH2 complex [GO:1990696] adenylate cyclase inhibitor activity [GO:0010855]; calcium ion binding [GO:0005509]; G protein-coupled receptor activity [GO:0004930]; G-protein alpha-subunit binding [GO:0001965]; hydrolase activity [GO:0016787] g8985.t1 Q8WXG9 26.103 839 8.13e-46 186.0 sp|Q8WXG9|AGRV1_HUMAN Adhesion G-protein coupled receptor V1 OS=Homo sapiens OX=9606 GN=ADGRV1 PE=1 SV=2 AGRV1_HUMAN reviewed Adhesion G-protein coupled receptor V1 (ADGRV1) (EC 3.4.-.-) (G-protein coupled receptor 98) (Monogenic audiogenic seizure susceptibility protein 1 homolog) (Usher syndrome type-2C protein) (Very large G-protein coupled receptor 1) [Cleaved into: ADGRV1 subunit alpha; ADGRV1 subunit beta] Homo sapiens (Human) GO:0001917; GO:0001965; GO:0002141; GO:0002142; GO:0004930; GO:0005509; GO:0005737; GO:0005886; GO:0007166; GO:0007186; GO:0007399; GO:0007601; GO:0007605; GO:0009986; GO:0010855; GO:0016020; GO:0016787; GO:0030501; GO:0031647; GO:0032420; GO:0043235; GO:0045184; GO:0045494; GO:0048496; GO:0048839; GO:0050877; GO:0050910; GO:0050953; GO:0060113; GO:0060122; GO:0060171; GO:0070062; GO:0071277; GO:0097264; GO:0098609; GO:1990075; GO:1990696 cell surface receptor signaling pathway [GO:0007166]; cell-cell adhesion [GO:0098609]; cellular response to calcium ion [GO:0071277]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; establishment of protein localization [GO:0045184]; G protein-coupled receptor signaling pathway [GO:0007186]; inner ear development [GO:0048839]; inner ear receptor cell differentiation [GO:0060113]; inner ear receptor cell stereocilium organization [GO:0060122]; maintenance of animal organ identity [GO:0048496]; nervous system development [GO:0007399]; nervous system process [GO:0050877]; photoreceptor cell maintenance [GO:0045494]; positive regulation of bone mineralization [GO:0030501]; regulation of protein stability [GO:0031647]; self proteolysis [GO:0097264]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601] cell surface [GO:0009986]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; periciliary membrane compartment [GO:1990075]; photoreceptor inner segment [GO:0001917]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; stereocilia ankle link [GO:0002141]; stereocilia ankle link complex [GO:0002142]; stereocilium [GO:0032420]; stereocilium membrane [GO:0060171]; USH2 complex [GO:1990696] adenylate cyclase inhibitor activity [GO:0010855]; calcium ion binding [GO:0005509]; G protein-coupled receptor activity [GO:0004930]; G-protein alpha-subunit binding [GO:0001965]; hydrolase activity [GO:0016787] g8985.t1 Q8WXG9 27.852 675 4.13e-44 181.0 sp|Q8WXG9|AGRV1_HUMAN Adhesion G-protein coupled receptor V1 OS=Homo sapiens OX=9606 GN=ADGRV1 PE=1 SV=2 AGRV1_HUMAN reviewed Adhesion G-protein coupled receptor V1 (ADGRV1) (EC 3.4.-.-) (G-protein coupled receptor 98) (Monogenic audiogenic seizure susceptibility protein 1 homolog) (Usher syndrome type-2C protein) (Very large G-protein coupled receptor 1) [Cleaved into: ADGRV1 subunit alpha; ADGRV1 subunit beta] Homo sapiens (Human) GO:0001917; GO:0001965; GO:0002141; GO:0002142; GO:0004930; GO:0005509; GO:0005737; GO:0005886; GO:0007166; GO:0007186; GO:0007399; GO:0007601; GO:0007605; GO:0009986; GO:0010855; GO:0016020; GO:0016787; GO:0030501; GO:0031647; GO:0032420; GO:0043235; GO:0045184; GO:0045494; GO:0048496; GO:0048839; GO:0050877; GO:0050910; GO:0050953; GO:0060113; GO:0060122; GO:0060171; GO:0070062; GO:0071277; GO:0097264; GO:0098609; GO:1990075; GO:1990696 cell surface receptor signaling pathway [GO:0007166]; cell-cell adhesion [GO:0098609]; cellular response to calcium ion [GO:0071277]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; establishment of protein localization [GO:0045184]; G protein-coupled receptor signaling pathway [GO:0007186]; inner ear development [GO:0048839]; inner ear receptor cell differentiation [GO:0060113]; inner ear receptor cell stereocilium organization [GO:0060122]; maintenance of animal organ identity [GO:0048496]; nervous system development [GO:0007399]; nervous system process [GO:0050877]; photoreceptor cell maintenance [GO:0045494]; positive regulation of bone mineralization [GO:0030501]; regulation of protein stability [GO:0031647]; self proteolysis [GO:0097264]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601] cell surface [GO:0009986]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; periciliary membrane compartment [GO:1990075]; photoreceptor inner segment [GO:0001917]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; stereocilia ankle link [GO:0002141]; stereocilia ankle link complex [GO:0002142]; stereocilium [GO:0032420]; stereocilium membrane [GO:0060171]; USH2 complex [GO:1990696] adenylate cyclase inhibitor activity [GO:0010855]; calcium ion binding [GO:0005509]; G protein-coupled receptor activity [GO:0004930]; G-protein alpha-subunit binding [GO:0001965]; hydrolase activity [GO:0016787] g8985.t1 Q8WXG9 27.339 823 6.13e-41 170.0 sp|Q8WXG9|AGRV1_HUMAN Adhesion G-protein coupled receptor V1 OS=Homo sapiens OX=9606 GN=ADGRV1 PE=1 SV=2 AGRV1_HUMAN reviewed Adhesion G-protein coupled receptor V1 (ADGRV1) (EC 3.4.-.-) (G-protein coupled receptor 98) (Monogenic audiogenic seizure susceptibility protein 1 homolog) (Usher syndrome type-2C protein) (Very large G-protein coupled receptor 1) [Cleaved into: ADGRV1 subunit alpha; ADGRV1 subunit beta] Homo sapiens (Human) GO:0001917; GO:0001965; GO:0002141; GO:0002142; GO:0004930; GO:0005509; GO:0005737; GO:0005886; GO:0007166; GO:0007186; GO:0007399; GO:0007601; GO:0007605; GO:0009986; GO:0010855; GO:0016020; GO:0016787; GO:0030501; GO:0031647; GO:0032420; GO:0043235; GO:0045184; GO:0045494; GO:0048496; GO:0048839; GO:0050877; GO:0050910; GO:0050953; GO:0060113; GO:0060122; GO:0060171; GO:0070062; GO:0071277; GO:0097264; GO:0098609; GO:1990075; GO:1990696 cell surface receptor signaling pathway [GO:0007166]; cell-cell adhesion [GO:0098609]; cellular response to calcium ion [GO:0071277]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; establishment of protein localization [GO:0045184]; G protein-coupled receptor signaling pathway [GO:0007186]; inner ear development [GO:0048839]; inner ear receptor cell differentiation [GO:0060113]; inner ear receptor cell stereocilium organization [GO:0060122]; maintenance of animal organ identity [GO:0048496]; nervous system development [GO:0007399]; nervous system process [GO:0050877]; photoreceptor cell maintenance [GO:0045494]; positive regulation of bone mineralization [GO:0030501]; regulation of protein stability [GO:0031647]; self proteolysis [GO:0097264]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601] cell surface [GO:0009986]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; periciliary membrane compartment [GO:1990075]; photoreceptor inner segment [GO:0001917]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; stereocilia ankle link [GO:0002141]; stereocilia ankle link complex [GO:0002142]; stereocilium [GO:0032420]; stereocilium membrane [GO:0060171]; USH2 complex [GO:1990696] adenylate cyclase inhibitor activity [GO:0010855]; calcium ion binding [GO:0005509]; G protein-coupled receptor activity [GO:0004930]; G-protein alpha-subunit binding [GO:0001965]; hydrolase activity [GO:0016787] g8985.t1 Q8WXG9 24.697 826 6.51e-39 164.0 sp|Q8WXG9|AGRV1_HUMAN Adhesion G-protein coupled receptor V1 OS=Homo sapiens OX=9606 GN=ADGRV1 PE=1 SV=2 AGRV1_HUMAN reviewed Adhesion G-protein coupled receptor V1 (ADGRV1) (EC 3.4.-.-) (G-protein coupled receptor 98) (Monogenic audiogenic seizure susceptibility protein 1 homolog) (Usher syndrome type-2C protein) (Very large G-protein coupled receptor 1) [Cleaved into: ADGRV1 subunit alpha; ADGRV1 subunit beta] Homo sapiens (Human) GO:0001917; GO:0001965; GO:0002141; GO:0002142; GO:0004930; GO:0005509; GO:0005737; GO:0005886; GO:0007166; GO:0007186; GO:0007399; GO:0007601; GO:0007605; GO:0009986; GO:0010855; GO:0016020; GO:0016787; GO:0030501; GO:0031647; GO:0032420; GO:0043235; GO:0045184; GO:0045494; GO:0048496; GO:0048839; GO:0050877; GO:0050910; GO:0050953; GO:0060113; GO:0060122; GO:0060171; GO:0070062; GO:0071277; GO:0097264; GO:0098609; GO:1990075; GO:1990696 cell surface receptor signaling pathway [GO:0007166]; cell-cell adhesion [GO:0098609]; cellular response to calcium ion [GO:0071277]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; establishment of protein localization [GO:0045184]; G protein-coupled receptor signaling pathway [GO:0007186]; inner ear development [GO:0048839]; inner ear receptor cell differentiation [GO:0060113]; inner ear receptor cell stereocilium organization [GO:0060122]; maintenance of animal organ identity [GO:0048496]; nervous system development [GO:0007399]; nervous system process [GO:0050877]; photoreceptor cell maintenance [GO:0045494]; positive regulation of bone mineralization [GO:0030501]; regulation of protein stability [GO:0031647]; self proteolysis [GO:0097264]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601] cell surface [GO:0009986]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; periciliary membrane compartment [GO:1990075]; photoreceptor inner segment [GO:0001917]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; stereocilia ankle link [GO:0002141]; stereocilia ankle link complex [GO:0002142]; stereocilium [GO:0032420]; stereocilium membrane [GO:0060171]; USH2 complex [GO:1990696] adenylate cyclase inhibitor activity [GO:0010855]; calcium ion binding [GO:0005509]; G protein-coupled receptor activity [GO:0004930]; G-protein alpha-subunit binding [GO:0001965]; hydrolase activity [GO:0016787] g8985.t1 Q8WXG9 26.074 675 4.62e-34 147.0 sp|Q8WXG9|AGRV1_HUMAN Adhesion G-protein coupled receptor V1 OS=Homo sapiens OX=9606 GN=ADGRV1 PE=1 SV=2 AGRV1_HUMAN reviewed Adhesion G-protein coupled receptor V1 (ADGRV1) (EC 3.4.-.-) (G-protein coupled receptor 98) (Monogenic audiogenic seizure susceptibility protein 1 homolog) (Usher syndrome type-2C protein) (Very large G-protein coupled receptor 1) [Cleaved into: ADGRV1 subunit alpha; ADGRV1 subunit beta] Homo sapiens (Human) GO:0001917; GO:0001965; GO:0002141; GO:0002142; GO:0004930; GO:0005509; GO:0005737; GO:0005886; GO:0007166; GO:0007186; GO:0007399; GO:0007601; GO:0007605; GO:0009986; GO:0010855; GO:0016020; GO:0016787; GO:0030501; GO:0031647; GO:0032420; GO:0043235; GO:0045184; GO:0045494; GO:0048496; GO:0048839; GO:0050877; GO:0050910; GO:0050953; GO:0060113; GO:0060122; GO:0060171; GO:0070062; GO:0071277; GO:0097264; GO:0098609; GO:1990075; GO:1990696 cell surface receptor signaling pathway [GO:0007166]; cell-cell adhesion [GO:0098609]; cellular response to calcium ion [GO:0071277]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; establishment of protein localization [GO:0045184]; G protein-coupled receptor signaling pathway [GO:0007186]; inner ear development [GO:0048839]; inner ear receptor cell differentiation [GO:0060113]; inner ear receptor cell stereocilium organization [GO:0060122]; maintenance of animal organ identity [GO:0048496]; nervous system development [GO:0007399]; nervous system process [GO:0050877]; photoreceptor cell maintenance [GO:0045494]; positive regulation of bone mineralization [GO:0030501]; regulation of protein stability [GO:0031647]; self proteolysis [GO:0097264]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601] cell surface [GO:0009986]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; periciliary membrane compartment [GO:1990075]; photoreceptor inner segment [GO:0001917]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; stereocilia ankle link [GO:0002141]; stereocilia ankle link complex [GO:0002142]; stereocilium [GO:0032420]; stereocilium membrane [GO:0060171]; USH2 complex [GO:1990696] adenylate cyclase inhibitor activity [GO:0010855]; calcium ion binding [GO:0005509]; G protein-coupled receptor activity [GO:0004930]; G-protein alpha-subunit binding [GO:0001965]; hydrolase activity [GO:0016787] g8985.t1 Q8WXG9 23.193 858 2.74e-31 139.0 sp|Q8WXG9|AGRV1_HUMAN Adhesion G-protein coupled receptor V1 OS=Homo sapiens OX=9606 GN=ADGRV1 PE=1 SV=2 AGRV1_HUMAN reviewed Adhesion G-protein coupled receptor V1 (ADGRV1) (EC 3.4.-.-) (G-protein coupled receptor 98) (Monogenic audiogenic seizure susceptibility protein 1 homolog) (Usher syndrome type-2C protein) (Very large G-protein coupled receptor 1) [Cleaved into: ADGRV1 subunit alpha; ADGRV1 subunit beta] Homo sapiens (Human) GO:0001917; GO:0001965; GO:0002141; GO:0002142; GO:0004930; GO:0005509; GO:0005737; GO:0005886; GO:0007166; GO:0007186; GO:0007399; GO:0007601; GO:0007605; GO:0009986; GO:0010855; GO:0016020; GO:0016787; GO:0030501; GO:0031647; GO:0032420; GO:0043235; GO:0045184; GO:0045494; GO:0048496; GO:0048839; GO:0050877; GO:0050910; GO:0050953; GO:0060113; GO:0060122; GO:0060171; GO:0070062; GO:0071277; GO:0097264; GO:0098609; GO:1990075; GO:1990696 cell surface receptor signaling pathway [GO:0007166]; cell-cell adhesion [GO:0098609]; cellular response to calcium ion [GO:0071277]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; establishment of protein localization [GO:0045184]; G protein-coupled receptor signaling pathway [GO:0007186]; inner ear development [GO:0048839]; inner ear receptor cell differentiation [GO:0060113]; inner ear receptor cell stereocilium organization [GO:0060122]; maintenance of animal organ identity [GO:0048496]; nervous system development [GO:0007399]; nervous system process [GO:0050877]; photoreceptor cell maintenance [GO:0045494]; positive regulation of bone mineralization [GO:0030501]; regulation of protein stability [GO:0031647]; self proteolysis [GO:0097264]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601] cell surface [GO:0009986]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; periciliary membrane compartment [GO:1990075]; photoreceptor inner segment [GO:0001917]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; stereocilia ankle link [GO:0002141]; stereocilia ankle link complex [GO:0002142]; stereocilium [GO:0032420]; stereocilium membrane [GO:0060171]; USH2 complex [GO:1990696] adenylate cyclase inhibitor activity [GO:0010855]; calcium ion binding [GO:0005509]; G protein-coupled receptor activity [GO:0004930]; G-protein alpha-subunit binding [GO:0001965]; hydrolase activity [GO:0016787] g8985.t1 Q8WXG9 27.208 702 6.93e-31 137.0 sp|Q8WXG9|AGRV1_HUMAN Adhesion G-protein coupled receptor V1 OS=Homo sapiens OX=9606 GN=ADGRV1 PE=1 SV=2 AGRV1_HUMAN reviewed Adhesion G-protein coupled receptor V1 (ADGRV1) (EC 3.4.-.-) (G-protein coupled receptor 98) (Monogenic audiogenic seizure susceptibility protein 1 homolog) (Usher syndrome type-2C protein) (Very large G-protein coupled receptor 1) [Cleaved into: ADGRV1 subunit alpha; ADGRV1 subunit beta] Homo sapiens (Human) GO:0001917; GO:0001965; GO:0002141; GO:0002142; GO:0004930; GO:0005509; GO:0005737; GO:0005886; GO:0007166; GO:0007186; GO:0007399; GO:0007601; GO:0007605; GO:0009986; GO:0010855; GO:0016020; GO:0016787; GO:0030501; GO:0031647; GO:0032420; GO:0043235; GO:0045184; GO:0045494; GO:0048496; GO:0048839; GO:0050877; GO:0050910; GO:0050953; GO:0060113; GO:0060122; GO:0060171; GO:0070062; GO:0071277; GO:0097264; GO:0098609; GO:1990075; GO:1990696 cell surface receptor signaling pathway [GO:0007166]; cell-cell adhesion [GO:0098609]; cellular response to calcium ion [GO:0071277]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; establishment of protein localization [GO:0045184]; G protein-coupled receptor signaling pathway [GO:0007186]; inner ear development [GO:0048839]; inner ear receptor cell differentiation [GO:0060113]; inner ear receptor cell stereocilium organization [GO:0060122]; maintenance of animal organ identity [GO:0048496]; nervous system development [GO:0007399]; nervous system process [GO:0050877]; photoreceptor cell maintenance [GO:0045494]; positive regulation of bone mineralization [GO:0030501]; regulation of protein stability [GO:0031647]; self proteolysis [GO:0097264]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601] cell surface [GO:0009986]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; periciliary membrane compartment [GO:1990075]; photoreceptor inner segment [GO:0001917]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; stereocilia ankle link [GO:0002141]; stereocilia ankle link complex [GO:0002142]; stereocilium [GO:0032420]; stereocilium membrane [GO:0060171]; USH2 complex [GO:1990696] adenylate cyclase inhibitor activity [GO:0010855]; calcium ion binding [GO:0005509]; G protein-coupled receptor activity [GO:0004930]; G-protein alpha-subunit binding [GO:0001965]; hydrolase activity [GO:0016787] g8985.t1 Q8WXG9 25.138 724 1.09e-30 137.0 sp|Q8WXG9|AGRV1_HUMAN Adhesion G-protein coupled receptor V1 OS=Homo sapiens OX=9606 GN=ADGRV1 PE=1 SV=2 AGRV1_HUMAN reviewed Adhesion G-protein coupled receptor V1 (ADGRV1) (EC 3.4.-.-) (G-protein coupled receptor 98) (Monogenic audiogenic seizure susceptibility protein 1 homolog) (Usher syndrome type-2C protein) (Very large G-protein coupled receptor 1) [Cleaved into: ADGRV1 subunit alpha; ADGRV1 subunit beta] Homo sapiens (Human) GO:0001917; GO:0001965; GO:0002141; GO:0002142; GO:0004930; GO:0005509; GO:0005737; GO:0005886; GO:0007166; GO:0007186; GO:0007399; GO:0007601; GO:0007605; GO:0009986; GO:0010855; GO:0016020; GO:0016787; GO:0030501; GO:0031647; GO:0032420; GO:0043235; GO:0045184; GO:0045494; GO:0048496; GO:0048839; GO:0050877; GO:0050910; GO:0050953; GO:0060113; GO:0060122; GO:0060171; GO:0070062; GO:0071277; GO:0097264; GO:0098609; GO:1990075; GO:1990696 cell surface receptor signaling pathway [GO:0007166]; cell-cell adhesion [GO:0098609]; cellular response to calcium ion [GO:0071277]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; establishment of protein localization [GO:0045184]; G protein-coupled receptor signaling pathway [GO:0007186]; inner ear development [GO:0048839]; inner ear receptor cell differentiation [GO:0060113]; inner ear receptor cell stereocilium organization [GO:0060122]; maintenance of animal organ identity [GO:0048496]; nervous system development [GO:0007399]; nervous system process [GO:0050877]; photoreceptor cell maintenance [GO:0045494]; positive regulation of bone mineralization [GO:0030501]; regulation of protein stability [GO:0031647]; self proteolysis [GO:0097264]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601] cell surface [GO:0009986]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; periciliary membrane compartment [GO:1990075]; photoreceptor inner segment [GO:0001917]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; stereocilia ankle link [GO:0002141]; stereocilia ankle link complex [GO:0002142]; stereocilium [GO:0032420]; stereocilium membrane [GO:0060171]; USH2 complex [GO:1990696] adenylate cyclase inhibitor activity [GO:0010855]; calcium ion binding [GO:0005509]; G protein-coupled receptor activity [GO:0004930]; G-protein alpha-subunit binding [GO:0001965]; hydrolase activity [GO:0016787] g8985.t1 Q8WXG9 24.408 844 3.29e-28 128.0 sp|Q8WXG9|AGRV1_HUMAN Adhesion G-protein coupled receptor V1 OS=Homo sapiens OX=9606 GN=ADGRV1 PE=1 SV=2 AGRV1_HUMAN reviewed Adhesion G-protein coupled receptor V1 (ADGRV1) (EC 3.4.-.-) (G-protein coupled receptor 98) (Monogenic audiogenic seizure susceptibility protein 1 homolog) (Usher syndrome type-2C protein) (Very large G-protein coupled receptor 1) [Cleaved into: ADGRV1 subunit alpha; ADGRV1 subunit beta] Homo sapiens (Human) GO:0001917; GO:0001965; GO:0002141; GO:0002142; GO:0004930; GO:0005509; GO:0005737; GO:0005886; GO:0007166; GO:0007186; GO:0007399; GO:0007601; GO:0007605; GO:0009986; GO:0010855; GO:0016020; GO:0016787; GO:0030501; GO:0031647; GO:0032420; GO:0043235; GO:0045184; GO:0045494; GO:0048496; GO:0048839; GO:0050877; GO:0050910; GO:0050953; GO:0060113; GO:0060122; GO:0060171; GO:0070062; GO:0071277; GO:0097264; GO:0098609; GO:1990075; GO:1990696 cell surface receptor signaling pathway [GO:0007166]; cell-cell adhesion [GO:0098609]; cellular response to calcium ion [GO:0071277]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; establishment of protein localization [GO:0045184]; G protein-coupled receptor signaling pathway [GO:0007186]; inner ear development [GO:0048839]; inner ear receptor cell differentiation [GO:0060113]; inner ear receptor cell stereocilium organization [GO:0060122]; maintenance of animal organ identity [GO:0048496]; nervous system development [GO:0007399]; nervous system process [GO:0050877]; photoreceptor cell maintenance [GO:0045494]; positive regulation of bone mineralization [GO:0030501]; regulation of protein stability [GO:0031647]; self proteolysis [GO:0097264]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601] cell surface [GO:0009986]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; periciliary membrane compartment [GO:1990075]; photoreceptor inner segment [GO:0001917]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; stereocilia ankle link [GO:0002141]; stereocilia ankle link complex [GO:0002142]; stereocilium [GO:0032420]; stereocilium membrane [GO:0060171]; USH2 complex [GO:1990696] adenylate cyclase inhibitor activity [GO:0010855]; calcium ion binding [GO:0005509]; G protein-coupled receptor activity [GO:0004930]; G-protein alpha-subunit binding [GO:0001965]; hydrolase activity [GO:0016787] g8985.t1 Q8WXG9 27.586 580 4.46e-28 128.0 sp|Q8WXG9|AGRV1_HUMAN Adhesion G-protein coupled receptor V1 OS=Homo sapiens OX=9606 GN=ADGRV1 PE=1 SV=2 AGRV1_HUMAN reviewed Adhesion G-protein coupled receptor V1 (ADGRV1) (EC 3.4.-.-) (G-protein coupled receptor 98) (Monogenic audiogenic seizure susceptibility protein 1 homolog) (Usher syndrome type-2C protein) (Very large G-protein coupled receptor 1) [Cleaved into: ADGRV1 subunit alpha; ADGRV1 subunit beta] Homo sapiens (Human) GO:0001917; GO:0001965; GO:0002141; GO:0002142; GO:0004930; GO:0005509; GO:0005737; GO:0005886; GO:0007166; GO:0007186; GO:0007399; GO:0007601; GO:0007605; GO:0009986; GO:0010855; GO:0016020; GO:0016787; GO:0030501; GO:0031647; GO:0032420; GO:0043235; GO:0045184; GO:0045494; GO:0048496; GO:0048839; GO:0050877; GO:0050910; GO:0050953; GO:0060113; GO:0060122; GO:0060171; GO:0070062; GO:0071277; GO:0097264; GO:0098609; GO:1990075; GO:1990696 cell surface receptor signaling pathway [GO:0007166]; cell-cell adhesion [GO:0098609]; cellular response to calcium ion [GO:0071277]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; establishment of protein localization [GO:0045184]; G protein-coupled receptor signaling pathway [GO:0007186]; inner ear development [GO:0048839]; inner ear receptor cell differentiation [GO:0060113]; inner ear receptor cell stereocilium organization [GO:0060122]; maintenance of animal organ identity [GO:0048496]; nervous system development [GO:0007399]; nervous system process [GO:0050877]; photoreceptor cell maintenance [GO:0045494]; positive regulation of bone mineralization [GO:0030501]; regulation of protein stability [GO:0031647]; self proteolysis [GO:0097264]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601] cell surface [GO:0009986]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; periciliary membrane compartment [GO:1990075]; photoreceptor inner segment [GO:0001917]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; stereocilia ankle link [GO:0002141]; stereocilia ankle link complex [GO:0002142]; stereocilium [GO:0032420]; stereocilium membrane [GO:0060171]; USH2 complex [GO:1990696] adenylate cyclase inhibitor activity [GO:0010855]; calcium ion binding [GO:0005509]; G protein-coupled receptor activity [GO:0004930]; G-protein alpha-subunit binding [GO:0001965]; hydrolase activity [GO:0016787] g8985.t1 Q8WXG9 27.918 437 3.31e-27 125.0 sp|Q8WXG9|AGRV1_HUMAN Adhesion G-protein coupled receptor V1 OS=Homo sapiens OX=9606 GN=ADGRV1 PE=1 SV=2 AGRV1_HUMAN reviewed Adhesion G-protein coupled receptor V1 (ADGRV1) (EC 3.4.-.-) (G-protein coupled receptor 98) (Monogenic audiogenic seizure susceptibility protein 1 homolog) (Usher syndrome type-2C protein) (Very large G-protein coupled receptor 1) [Cleaved into: ADGRV1 subunit alpha; ADGRV1 subunit beta] Homo sapiens (Human) GO:0001917; GO:0001965; GO:0002141; GO:0002142; GO:0004930; GO:0005509; GO:0005737; GO:0005886; GO:0007166; GO:0007186; GO:0007399; GO:0007601; GO:0007605; GO:0009986; GO:0010855; GO:0016020; GO:0016787; GO:0030501; GO:0031647; GO:0032420; GO:0043235; GO:0045184; GO:0045494; GO:0048496; GO:0048839; GO:0050877; GO:0050910; GO:0050953; GO:0060113; GO:0060122; GO:0060171; GO:0070062; GO:0071277; GO:0097264; GO:0098609; GO:1990075; GO:1990696 cell surface receptor signaling pathway [GO:0007166]; cell-cell adhesion [GO:0098609]; cellular response to calcium ion [GO:0071277]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; establishment of protein localization [GO:0045184]; G protein-coupled receptor signaling pathway [GO:0007186]; inner ear development [GO:0048839]; inner ear receptor cell differentiation [GO:0060113]; inner ear receptor cell stereocilium organization [GO:0060122]; maintenance of animal organ identity [GO:0048496]; nervous system development [GO:0007399]; nervous system process [GO:0050877]; photoreceptor cell maintenance [GO:0045494]; positive regulation of bone mineralization [GO:0030501]; regulation of protein stability [GO:0031647]; self proteolysis [GO:0097264]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601] cell surface [GO:0009986]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; periciliary membrane compartment [GO:1990075]; photoreceptor inner segment [GO:0001917]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; stereocilia ankle link [GO:0002141]; stereocilia ankle link complex [GO:0002142]; stereocilium [GO:0032420]; stereocilium membrane [GO:0060171]; USH2 complex [GO:1990696] adenylate cyclase inhibitor activity [GO:0010855]; calcium ion binding [GO:0005509]; G protein-coupled receptor activity [GO:0004930]; G-protein alpha-subunit binding [GO:0001965]; hydrolase activity [GO:0016787] g8985.t1 Q8WXG9 25.96 547 2.78e-24 115.0 sp|Q8WXG9|AGRV1_HUMAN Adhesion G-protein coupled receptor V1 OS=Homo sapiens OX=9606 GN=ADGRV1 PE=1 SV=2 AGRV1_HUMAN reviewed Adhesion G-protein coupled receptor V1 (ADGRV1) (EC 3.4.-.-) (G-protein coupled receptor 98) (Monogenic audiogenic seizure susceptibility protein 1 homolog) (Usher syndrome type-2C protein) (Very large G-protein coupled receptor 1) [Cleaved into: ADGRV1 subunit alpha; ADGRV1 subunit beta] Homo sapiens (Human) GO:0001917; GO:0001965; GO:0002141; GO:0002142; GO:0004930; GO:0005509; GO:0005737; GO:0005886; GO:0007166; GO:0007186; GO:0007399; GO:0007601; GO:0007605; GO:0009986; GO:0010855; GO:0016020; GO:0016787; GO:0030501; GO:0031647; GO:0032420; GO:0043235; GO:0045184; GO:0045494; GO:0048496; GO:0048839; GO:0050877; GO:0050910; GO:0050953; GO:0060113; GO:0060122; GO:0060171; GO:0070062; GO:0071277; GO:0097264; GO:0098609; GO:1990075; GO:1990696 cell surface receptor signaling pathway [GO:0007166]; cell-cell adhesion [GO:0098609]; cellular response to calcium ion [GO:0071277]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; establishment of protein localization [GO:0045184]; G protein-coupled receptor signaling pathway [GO:0007186]; inner ear development [GO:0048839]; inner ear receptor cell differentiation [GO:0060113]; inner ear receptor cell stereocilium organization [GO:0060122]; maintenance of animal organ identity [GO:0048496]; nervous system development [GO:0007399]; nervous system process [GO:0050877]; photoreceptor cell maintenance [GO:0045494]; positive regulation of bone mineralization [GO:0030501]; regulation of protein stability [GO:0031647]; self proteolysis [GO:0097264]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601] cell surface [GO:0009986]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; periciliary membrane compartment [GO:1990075]; photoreceptor inner segment [GO:0001917]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; stereocilia ankle link [GO:0002141]; stereocilia ankle link complex [GO:0002142]; stereocilium [GO:0032420]; stereocilium membrane [GO:0060171]; USH2 complex [GO:1990696] adenylate cyclase inhibitor activity [GO:0010855]; calcium ion binding [GO:0005509]; G protein-coupled receptor activity [GO:0004930]; G-protein alpha-subunit binding [GO:0001965]; hydrolase activity [GO:0016787] g8985.t1 Q8WXG9 24.299 749 1.0399999999999998e-23 114.0 sp|Q8WXG9|AGRV1_HUMAN Adhesion G-protein coupled receptor V1 OS=Homo sapiens OX=9606 GN=ADGRV1 PE=1 SV=2 AGRV1_HUMAN reviewed Adhesion G-protein coupled receptor V1 (ADGRV1) (EC 3.4.-.-) (G-protein coupled receptor 98) (Monogenic audiogenic seizure susceptibility protein 1 homolog) (Usher syndrome type-2C protein) (Very large G-protein coupled receptor 1) [Cleaved into: ADGRV1 subunit alpha; ADGRV1 subunit beta] Homo sapiens (Human) GO:0001917; GO:0001965; GO:0002141; GO:0002142; GO:0004930; GO:0005509; GO:0005737; GO:0005886; GO:0007166; GO:0007186; GO:0007399; GO:0007601; GO:0007605; GO:0009986; GO:0010855; GO:0016020; GO:0016787; GO:0030501; GO:0031647; GO:0032420; GO:0043235; GO:0045184; GO:0045494; GO:0048496; GO:0048839; GO:0050877; GO:0050910; GO:0050953; GO:0060113; GO:0060122; GO:0060171; GO:0070062; GO:0071277; GO:0097264; GO:0098609; GO:1990075; GO:1990696 cell surface receptor signaling pathway [GO:0007166]; cell-cell adhesion [GO:0098609]; cellular response to calcium ion [GO:0071277]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; establishment of protein localization [GO:0045184]; G protein-coupled receptor signaling pathway [GO:0007186]; inner ear development [GO:0048839]; inner ear receptor cell differentiation [GO:0060113]; inner ear receptor cell stereocilium organization [GO:0060122]; maintenance of animal organ identity [GO:0048496]; nervous system development [GO:0007399]; nervous system process [GO:0050877]; photoreceptor cell maintenance [GO:0045494]; positive regulation of bone mineralization [GO:0030501]; regulation of protein stability [GO:0031647]; self proteolysis [GO:0097264]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601] cell surface [GO:0009986]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; periciliary membrane compartment [GO:1990075]; photoreceptor inner segment [GO:0001917]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; stereocilia ankle link [GO:0002141]; stereocilia ankle link complex [GO:0002142]; stereocilium [GO:0032420]; stereocilium membrane [GO:0060171]; USH2 complex [GO:1990696] adenylate cyclase inhibitor activity [GO:0010855]; calcium ion binding [GO:0005509]; G protein-coupled receptor activity [GO:0004930]; G-protein alpha-subunit binding [GO:0001965]; hydrolase activity [GO:0016787] g8985.t1 Q8WXG9 25.118 844 1.0699999999999998e-23 114.0 sp|Q8WXG9|AGRV1_HUMAN Adhesion G-protein coupled receptor V1 OS=Homo sapiens OX=9606 GN=ADGRV1 PE=1 SV=2 AGRV1_HUMAN reviewed Adhesion G-protein coupled receptor V1 (ADGRV1) (EC 3.4.-.-) (G-protein coupled receptor 98) (Monogenic audiogenic seizure susceptibility protein 1 homolog) (Usher syndrome type-2C protein) (Very large G-protein coupled receptor 1) [Cleaved into: ADGRV1 subunit alpha; ADGRV1 subunit beta] Homo sapiens (Human) GO:0001917; GO:0001965; GO:0002141; GO:0002142; GO:0004930; GO:0005509; GO:0005737; GO:0005886; GO:0007166; GO:0007186; GO:0007399; GO:0007601; GO:0007605; GO:0009986; GO:0010855; GO:0016020; GO:0016787; GO:0030501; GO:0031647; GO:0032420; GO:0043235; GO:0045184; GO:0045494; GO:0048496; GO:0048839; GO:0050877; GO:0050910; GO:0050953; GO:0060113; GO:0060122; GO:0060171; GO:0070062; GO:0071277; GO:0097264; GO:0098609; GO:1990075; GO:1990696 cell surface receptor signaling pathway [GO:0007166]; cell-cell adhesion [GO:0098609]; cellular response to calcium ion [GO:0071277]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; establishment of protein localization [GO:0045184]; G protein-coupled receptor signaling pathway [GO:0007186]; inner ear development [GO:0048839]; inner ear receptor cell differentiation [GO:0060113]; inner ear receptor cell stereocilium organization [GO:0060122]; maintenance of animal organ identity [GO:0048496]; nervous system development [GO:0007399]; nervous system process [GO:0050877]; photoreceptor cell maintenance [GO:0045494]; positive regulation of bone mineralization [GO:0030501]; regulation of protein stability [GO:0031647]; self proteolysis [GO:0097264]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601] cell surface [GO:0009986]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; periciliary membrane compartment [GO:1990075]; photoreceptor inner segment [GO:0001917]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; stereocilia ankle link [GO:0002141]; stereocilia ankle link complex [GO:0002142]; stereocilium [GO:0032420]; stereocilium membrane [GO:0060171]; USH2 complex [GO:1990696] adenylate cyclase inhibitor activity [GO:0010855]; calcium ion binding [GO:0005509]; G protein-coupled receptor activity [GO:0004930]; G-protein alpha-subunit binding [GO:0001965]; hydrolase activity [GO:0016787] g8985.t1 Q8WXG9 26.806 526 8.11e-23 110.0 sp|Q8WXG9|AGRV1_HUMAN Adhesion G-protein coupled receptor V1 OS=Homo sapiens OX=9606 GN=ADGRV1 PE=1 SV=2 AGRV1_HUMAN reviewed Adhesion G-protein coupled receptor V1 (ADGRV1) (EC 3.4.-.-) (G-protein coupled receptor 98) (Monogenic audiogenic seizure susceptibility protein 1 homolog) (Usher syndrome type-2C protein) (Very large G-protein coupled receptor 1) [Cleaved into: ADGRV1 subunit alpha; ADGRV1 subunit beta] Homo sapiens (Human) GO:0001917; GO:0001965; GO:0002141; GO:0002142; GO:0004930; GO:0005509; GO:0005737; GO:0005886; GO:0007166; GO:0007186; GO:0007399; GO:0007601; GO:0007605; GO:0009986; GO:0010855; GO:0016020; GO:0016787; GO:0030501; GO:0031647; GO:0032420; GO:0043235; GO:0045184; GO:0045494; GO:0048496; GO:0048839; GO:0050877; GO:0050910; GO:0050953; GO:0060113; GO:0060122; GO:0060171; GO:0070062; GO:0071277; GO:0097264; GO:0098609; GO:1990075; GO:1990696 cell surface receptor signaling pathway [GO:0007166]; cell-cell adhesion [GO:0098609]; cellular response to calcium ion [GO:0071277]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; establishment of protein localization [GO:0045184]; G protein-coupled receptor signaling pathway [GO:0007186]; inner ear development [GO:0048839]; inner ear receptor cell differentiation [GO:0060113]; inner ear receptor cell stereocilium organization [GO:0060122]; maintenance of animal organ identity [GO:0048496]; nervous system development [GO:0007399]; nervous system process [GO:0050877]; photoreceptor cell maintenance [GO:0045494]; positive regulation of bone mineralization [GO:0030501]; regulation of protein stability [GO:0031647]; self proteolysis [GO:0097264]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601] cell surface [GO:0009986]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; periciliary membrane compartment [GO:1990075]; photoreceptor inner segment [GO:0001917]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; stereocilia ankle link [GO:0002141]; stereocilia ankle link complex [GO:0002142]; stereocilium [GO:0032420]; stereocilium membrane [GO:0060171]; USH2 complex [GO:1990696] adenylate cyclase inhibitor activity [GO:0010855]; calcium ion binding [GO:0005509]; G protein-coupled receptor activity [GO:0004930]; G-protein alpha-subunit binding [GO:0001965]; hydrolase activity [GO:0016787] g8986.t1 Q6JAN0 39.531 640 3.1e-116 389.0 sp|Q6JAN0|AGRV1_DANRE Adhesion G-protein coupled receptor V1 OS=Danio rerio OX=7955 GN=adgrv1 PE=2 SV=1 AGRV1_DANRE reviewed Adhesion G-protein coupled receptor V1 (EC 3.4.-.-) (G-protein coupled receptor 98) (Monogenic audiogenic seizure susceptibility protein 1 homolog) (Very large G-protein coupled receptor 1) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001917; GO:0001965; GO:0004930; GO:0005737; GO:0007166; GO:0007186; GO:0007601; GO:0007605; GO:0010739; GO:0010855; GO:0016787; GO:0031647; GO:0032420; GO:0042462; GO:0060171; GO:0071277; GO:0097264 cell surface receptor signaling pathway [GO:0007166]; cellular response to calcium ion [GO:0071277]; eye photoreceptor cell development [GO:0042462]; G protein-coupled receptor signaling pathway [GO:0007186]; positive regulation of protein kinase A signaling [GO:0010739]; regulation of protein stability [GO:0031647]; self proteolysis [GO:0097264]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601] cytoplasm [GO:0005737]; photoreceptor inner segment [GO:0001917]; stereocilium [GO:0032420]; stereocilium membrane [GO:0060171] adenylate cyclase inhibitor activity [GO:0010855]; G protein-coupled receptor activity [GO:0004930]; G-protein alpha-subunit binding [GO:0001965]; hydrolase activity [GO:0016787] g8986.t1 Q6JAN0 29.663 445 4.59e-36 150.0 sp|Q6JAN0|AGRV1_DANRE Adhesion G-protein coupled receptor V1 OS=Danio rerio OX=7955 GN=adgrv1 PE=2 SV=1 AGRV1_DANRE reviewed Adhesion G-protein coupled receptor V1 (EC 3.4.-.-) (G-protein coupled receptor 98) (Monogenic audiogenic seizure susceptibility protein 1 homolog) (Very large G-protein coupled receptor 1) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001917; GO:0001965; GO:0004930; GO:0005737; GO:0007166; GO:0007186; GO:0007601; GO:0007605; GO:0010739; GO:0010855; GO:0016787; GO:0031647; GO:0032420; GO:0042462; GO:0060171; GO:0071277; GO:0097264 cell surface receptor signaling pathway [GO:0007166]; cellular response to calcium ion [GO:0071277]; eye photoreceptor cell development [GO:0042462]; G protein-coupled receptor signaling pathway [GO:0007186]; positive regulation of protein kinase A signaling [GO:0010739]; regulation of protein stability [GO:0031647]; self proteolysis [GO:0097264]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601] cytoplasm [GO:0005737]; photoreceptor inner segment [GO:0001917]; stereocilium [GO:0032420]; stereocilium membrane [GO:0060171] adenylate cyclase inhibitor activity [GO:0010855]; G protein-coupled receptor activity [GO:0004930]; G-protein alpha-subunit binding [GO:0001965]; hydrolase activity [GO:0016787] g8986.t1 Q6JAN0 29.35 477 8.430000000000001e-27 121.0 sp|Q6JAN0|AGRV1_DANRE Adhesion G-protein coupled receptor V1 OS=Danio rerio OX=7955 GN=adgrv1 PE=2 SV=1 AGRV1_DANRE reviewed Adhesion G-protein coupled receptor V1 (EC 3.4.-.-) (G-protein coupled receptor 98) (Monogenic audiogenic seizure susceptibility protein 1 homolog) (Very large G-protein coupled receptor 1) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001917; GO:0001965; GO:0004930; GO:0005737; GO:0007166; GO:0007186; GO:0007601; GO:0007605; GO:0010739; GO:0010855; GO:0016787; GO:0031647; GO:0032420; GO:0042462; GO:0060171; GO:0071277; GO:0097264 cell surface receptor signaling pathway [GO:0007166]; cellular response to calcium ion [GO:0071277]; eye photoreceptor cell development [GO:0042462]; G protein-coupled receptor signaling pathway [GO:0007186]; positive regulation of protein kinase A signaling [GO:0010739]; regulation of protein stability [GO:0031647]; self proteolysis [GO:0097264]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601] cytoplasm [GO:0005737]; photoreceptor inner segment [GO:0001917]; stereocilium [GO:0032420]; stereocilium membrane [GO:0060171] adenylate cyclase inhibitor activity [GO:0010855]; G protein-coupled receptor activity [GO:0004930]; G-protein alpha-subunit binding [GO:0001965]; hydrolase activity [GO:0016787] g8986.t1 Q6JAN0 27.938 451 9.12e-27 121.0 sp|Q6JAN0|AGRV1_DANRE Adhesion G-protein coupled receptor V1 OS=Danio rerio OX=7955 GN=adgrv1 PE=2 SV=1 AGRV1_DANRE reviewed Adhesion G-protein coupled receptor V1 (EC 3.4.-.-) (G-protein coupled receptor 98) (Monogenic audiogenic seizure susceptibility protein 1 homolog) (Very large G-protein coupled receptor 1) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001917; GO:0001965; GO:0004930; GO:0005737; GO:0007166; GO:0007186; GO:0007601; GO:0007605; GO:0010739; GO:0010855; GO:0016787; GO:0031647; GO:0032420; GO:0042462; GO:0060171; GO:0071277; GO:0097264 cell surface receptor signaling pathway [GO:0007166]; cellular response to calcium ion [GO:0071277]; eye photoreceptor cell development [GO:0042462]; G protein-coupled receptor signaling pathway [GO:0007186]; positive regulation of protein kinase A signaling [GO:0010739]; regulation of protein stability [GO:0031647]; self proteolysis [GO:0097264]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601] cytoplasm [GO:0005737]; photoreceptor inner segment [GO:0001917]; stereocilium [GO:0032420]; stereocilium membrane [GO:0060171] adenylate cyclase inhibitor activity [GO:0010855]; G protein-coupled receptor activity [GO:0004930]; G-protein alpha-subunit binding [GO:0001965]; hydrolase activity [GO:0016787] g8986.t1 Q6JAN0 24.785 698 7.090000000000001e-26 118.0 sp|Q6JAN0|AGRV1_DANRE Adhesion G-protein coupled receptor V1 OS=Danio rerio OX=7955 GN=adgrv1 PE=2 SV=1 AGRV1_DANRE reviewed Adhesion G-protein coupled receptor V1 (EC 3.4.-.-) (G-protein coupled receptor 98) (Monogenic audiogenic seizure susceptibility protein 1 homolog) (Very large G-protein coupled receptor 1) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001917; GO:0001965; GO:0004930; GO:0005737; GO:0007166; GO:0007186; GO:0007601; GO:0007605; GO:0010739; GO:0010855; GO:0016787; GO:0031647; GO:0032420; GO:0042462; GO:0060171; GO:0071277; GO:0097264 cell surface receptor signaling pathway [GO:0007166]; cellular response to calcium ion [GO:0071277]; eye photoreceptor cell development [GO:0042462]; G protein-coupled receptor signaling pathway [GO:0007186]; positive regulation of protein kinase A signaling [GO:0010739]; regulation of protein stability [GO:0031647]; self proteolysis [GO:0097264]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601] cytoplasm [GO:0005737]; photoreceptor inner segment [GO:0001917]; stereocilium [GO:0032420]; stereocilium membrane [GO:0060171] adenylate cyclase inhibitor activity [GO:0010855]; G protein-coupled receptor activity [GO:0004930]; G-protein alpha-subunit binding [GO:0001965]; hydrolase activity [GO:0016787] g8986.t1 Q6JAN0 26.977 645 9.65e-23 108.0 sp|Q6JAN0|AGRV1_DANRE Adhesion G-protein coupled receptor V1 OS=Danio rerio OX=7955 GN=adgrv1 PE=2 SV=1 AGRV1_DANRE reviewed Adhesion G-protein coupled receptor V1 (EC 3.4.-.-) (G-protein coupled receptor 98) (Monogenic audiogenic seizure susceptibility protein 1 homolog) (Very large G-protein coupled receptor 1) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001917; GO:0001965; GO:0004930; GO:0005737; GO:0007166; GO:0007186; GO:0007601; GO:0007605; GO:0010739; GO:0010855; GO:0016787; GO:0031647; GO:0032420; GO:0042462; GO:0060171; GO:0071277; GO:0097264 cell surface receptor signaling pathway [GO:0007166]; cellular response to calcium ion [GO:0071277]; eye photoreceptor cell development [GO:0042462]; G protein-coupled receptor signaling pathway [GO:0007186]; positive regulation of protein kinase A signaling [GO:0010739]; regulation of protein stability [GO:0031647]; self proteolysis [GO:0097264]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601] cytoplasm [GO:0005737]; photoreceptor inner segment [GO:0001917]; stereocilium [GO:0032420]; stereocilium membrane [GO:0060171] adenylate cyclase inhibitor activity [GO:0010855]; G protein-coupled receptor activity [GO:0004930]; G-protein alpha-subunit binding [GO:0001965]; hydrolase activity [GO:0016787] g8986.t1 Q6JAN0 28.051 549 4.45e-22 106.0 sp|Q6JAN0|AGRV1_DANRE Adhesion G-protein coupled receptor V1 OS=Danio rerio OX=7955 GN=adgrv1 PE=2 SV=1 AGRV1_DANRE reviewed Adhesion G-protein coupled receptor V1 (EC 3.4.-.-) (G-protein coupled receptor 98) (Monogenic audiogenic seizure susceptibility protein 1 homolog) (Very large G-protein coupled receptor 1) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001917; GO:0001965; GO:0004930; GO:0005737; GO:0007166; GO:0007186; GO:0007601; GO:0007605; GO:0010739; GO:0010855; GO:0016787; GO:0031647; GO:0032420; GO:0042462; GO:0060171; GO:0071277; GO:0097264 cell surface receptor signaling pathway [GO:0007166]; cellular response to calcium ion [GO:0071277]; eye photoreceptor cell development [GO:0042462]; G protein-coupled receptor signaling pathway [GO:0007186]; positive regulation of protein kinase A signaling [GO:0010739]; regulation of protein stability [GO:0031647]; self proteolysis [GO:0097264]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601] cytoplasm [GO:0005737]; photoreceptor inner segment [GO:0001917]; stereocilium [GO:0032420]; stereocilium membrane [GO:0060171] adenylate cyclase inhibitor activity [GO:0010855]; G protein-coupled receptor activity [GO:0004930]; G-protein alpha-subunit binding [GO:0001965]; hydrolase activity [GO:0016787] g8986.t1 Q6JAN0 27.897 466 9.4e-22 105.0 sp|Q6JAN0|AGRV1_DANRE Adhesion G-protein coupled receptor V1 OS=Danio rerio OX=7955 GN=adgrv1 PE=2 SV=1 AGRV1_DANRE reviewed Adhesion G-protein coupled receptor V1 (EC 3.4.-.-) (G-protein coupled receptor 98) (Monogenic audiogenic seizure susceptibility protein 1 homolog) (Very large G-protein coupled receptor 1) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001917; GO:0001965; GO:0004930; GO:0005737; GO:0007166; GO:0007186; GO:0007601; GO:0007605; GO:0010739; GO:0010855; GO:0016787; GO:0031647; GO:0032420; GO:0042462; GO:0060171; GO:0071277; GO:0097264 cell surface receptor signaling pathway [GO:0007166]; cellular response to calcium ion [GO:0071277]; eye photoreceptor cell development [GO:0042462]; G protein-coupled receptor signaling pathway [GO:0007186]; positive regulation of protein kinase A signaling [GO:0010739]; regulation of protein stability [GO:0031647]; self proteolysis [GO:0097264]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601] cytoplasm [GO:0005737]; photoreceptor inner segment [GO:0001917]; stereocilium [GO:0032420]; stereocilium membrane [GO:0060171] adenylate cyclase inhibitor activity [GO:0010855]; G protein-coupled receptor activity [GO:0004930]; G-protein alpha-subunit binding [GO:0001965]; hydrolase activity [GO:0016787] g8987.t1 Q9ERE4 77.093 227 8.200000000000001e-129 371.0 sp|Q9ERE4|GOLP3_RAT Golgi phosphoprotein 3 OS=Rattus norvegicus OX=10116 GN=Golph3 PE=1 SV=1 GOLP3_RAT reviewed Golgi phosphoprotein 3 (Coat protein GPP34) (Trans-Golgi protein GMx33) Rattus norvegicus (Rat) GO:0000139; GO:0005739; GO:0005758; GO:0005768; GO:0005794; GO:0005802; GO:0005829; GO:0005886; GO:0006890; GO:0007030; GO:0009101; GO:0009306; GO:0010467; GO:0010821; GO:0016477; GO:0019899; GO:0030032; GO:0031985; GO:0032008; GO:0032580; GO:0043001; GO:0043066; GO:0045053; GO:0048194; GO:0050714; GO:0050901; GO:0060352; GO:0070273; GO:0072752; GO:0090161; GO:0090164; GO:0140312; GO:0140450 asymmetric Golgi ribbon formation [GO:0090164]; cell adhesion molecule production [GO:0060352]; cell migration [GO:0016477]; cellular response to rapamycin [GO:0072752]; gene expression [GO:0010467]; glycoprotein biosynthetic process [GO:0009101]; Golgi organization [GO:0007030]; Golgi ribbon formation [GO:0090161]; Golgi to plasma membrane protein transport [GO:0043001]; Golgi vesicle budding [GO:0048194]; lamellipodium assembly [GO:0030032]; leukocyte tethering or rolling [GO:0050901]; negative regulation of apoptotic process [GO:0043066]; positive regulation of protein secretion [GO:0050714]; positive regulation of TOR signaling [GO:0032008]; protein retention in Golgi apparatus [GO:0045053]; protein secretion [GO:0009306]; protein targeting to Golgi apparatus [GO:0140450]; regulation of mitochondrion organization [GO:0010821]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890] cytosol [GO:0005829]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; Golgi cisterna [GO:0031985]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802] cargo adaptor activity [GO:0140312]; enzyme binding [GO:0019899]; phosphatidylinositol-4-phosphate binding [GO:0070273] g8988.t1 O62666 41.772 237 5.35e-45 163.0 sp|O62666|IL16_PANTR Pro-interleukin-16 OS=Pan troglodytes OX=9598 GN=IL16 PE=2 SV=1 g8994.t1 O15018 41.935 248 1.44e-39 165.0 sp|O15018|PDZD2_HUMAN PDZ domain-containing protein 2 OS=Homo sapiens OX=9606 GN=PDZD2 PE=1 SV=4 PDZD2_HUMAN reviewed PDZ domain-containing protein 2 (Activated in prostate cancer protein) (PDZ domain-containing protein 3) [Cleaved into: Processed PDZ domain-containing protein 2] Homo sapiens (Human) GO:0005576; GO:0005634; GO:0005737; GO:0005783; GO:0005829; GO:0005886; GO:0005911; GO:0007155; GO:0034451 cell adhesion [GO:0007155] cell-cell junction [GO:0005911]; centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; nucleus [GO:0005634]; plasma membrane [GO:0005886] g8995.t1 Q568D2 46.863 271 3.18e-84 258.0 sp|Q568D2|CF161_DANRE Cilia- and flagella-associated protein 161 OS=Danio rerio OX=7955 GN=cfap161 PE=2 SV=1 g8996.t1 Q7TMV3 36.453 203 1.86e-28 117.0 sp|Q7TMV3|FAKD5_MOUSE FAST kinase domain-containing protein 5, mitochondrial OS=Mus musculus OX=10090 GN=Fastkd5 PE=2 SV=1 g9005.t1 Q4V7Q6 54.025 472 1.4600000000000002e-161 468.0 sp|Q4V7Q6|ULK3_XENLA Serine/threonine-protein kinase ULK3 OS=Xenopus laevis OX=8355 GN=ulk3 PE=2 SV=1 ULK3_XENLA reviewed Serine/threonine-protein kinase ULK3 (EC 2.7.11.1) (Unc-51-like kinase 3) Xenopus laevis (African clawed frog) GO:0000045; GO:0000407; GO:0000423; GO:0004674; GO:0005524; GO:0005737; GO:0005776; GO:0005829; GO:0010506; GO:0034045; GO:0034727; GO:0042594; GO:0045879; GO:0045880; GO:0046777; GO:0061709; GO:0106310 autophagosome assembly [GO:0000045]; mitophagy [GO:0000423]; negative regulation of smoothened signaling pathway [GO:0045879]; piecemeal microautophagy of the nucleus [GO:0034727]; positive regulation of smoothened signaling pathway [GO:0045880]; protein autophosphorylation [GO:0046777]; regulation of autophagy [GO:0010506]; response to starvation [GO:0042594]; reticulophagy [GO:0061709] autophagosome [GO:0005776]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; phagophore assembly site [GO:0000407]; phagophore assembly site membrane [GO:0034045] ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g9006.t1 Q8BGC3 28.125 288 5.02e-25 108.0 sp|Q8BGC3|MOT12_MOUSE Monocarboxylate transporter 12 OS=Mus musculus OX=10090 GN=Slc16a12 PE=1 SV=1 g9008.t1 Q8BGC3 25.116 430 6.23e-25 110.0 sp|Q8BGC3|MOT12_MOUSE Monocarboxylate transporter 12 OS=Mus musculus OX=10090 GN=Slc16a12 PE=1 SV=1 g9009.t1 Q8BGC3 24.884 430 1.57e-25 111.0 sp|Q8BGC3|MOT12_MOUSE Monocarboxylate transporter 12 OS=Mus musculus OX=10090 GN=Slc16a12 PE=1 SV=1 g9011.t1 Q8BGC3 25.553 407 3.06e-26 114.0 sp|Q8BGC3|MOT12_MOUSE Monocarboxylate transporter 12 OS=Mus musculus OX=10090 GN=Slc16a12 PE=1 SV=1 g9015.t1 Q8BGC3 25.307 407 2.14e-26 114.0 sp|Q8BGC3|MOT12_MOUSE Monocarboxylate transporter 12 OS=Mus musculus OX=10090 GN=Slc16a12 PE=1 SV=1 g9016.t1 Q9DCN1 47.619 441 6.91e-136 402.0 sp|Q9DCN1|NUD12_MOUSE NAD-capped RNA hydrolase NUDT12 OS=Mus musculus OX=10090 GN=Nudt12 PE=1 SV=1 NUD12_MOUSE reviewed NAD-capped RNA hydrolase NUDT12 (DeNADding enzyme NUDT12) (EC 3.6.1.-) (NADH pyrophosphatase NUDT12) (EC 3.6.1.22) (Nucleoside diphosphate-linked moiety X motif 12) (Nudix motif 12) Mus musculus (Mouse) GO:0000210; GO:0000287; GO:0005634; GO:0005737; GO:0005777; GO:0006402; GO:0006742; GO:0008270; GO:0010943; GO:0019677; GO:0032922; GO:0035529; GO:0110153; GO:0110155; GO:0110156; GO:1990174 circadian regulation of gene expression [GO:0032922]; mRNA catabolic process [GO:0006402]; mRNA methylguanosine-cap decapping [GO:0110156]; NAD+ catabolic process [GO:0019677]; NAD-cap decapping [GO:0110155]; NADP+ catabolic process [GO:0006742] cytoplasm [GO:0005737]; nucleus [GO:0005634]; peroxisome [GO:0005777] magnesium ion binding [GO:0000287]; NAD+ diphosphatase activity [GO:0000210]; NADH pyrophosphatase activity [GO:0035529]; NADPH pyrophosphatase activity [GO:0010943]; phosphodiesterase decapping endonuclease activity [GO:1990174]; RNA NAD-cap (NMN-forming) hydrolase activity [GO:0110153]; zinc ion binding [GO:0008270] g9017.t1 Q8N6L1 63.158 114 7.1200000000000005e-43 140.0 sp|Q8N6L1|KTAP2_HUMAN Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit KCP2 OS=Homo sapiens OX=9606 GN=KRTCAP2 PE=1 SV=2 KTAP2_HUMAN reviewed Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit KCP2 (Oligosaccharyl transferase subunit KCP2) (Keratinocyte-associated protein 2) (KCP-2) Homo sapiens (Human) GO:0005789; GO:0006487; GO:0008047; GO:0008250; GO:0018279; GO:0030674; GO:0160226 protein N-linked glycosylation [GO:0006487]; protein N-linked glycosylation via asparagine [GO:0018279] endoplasmic reticulum membrane [GO:0005789]; oligosaccharyltransferase complex [GO:0008250]; oligosaccharyltransferase complex A [GO:0160226] enzyme activator activity [GO:0008047]; protein-macromolecule adaptor activity [GO:0030674] g9019.t1 Q8BPN8 39.766 2648 0.0 1553.0 sp|Q8BPN8|DMXL2_MOUSE DmX-like protein 2 OS=Mus musculus OX=10090 GN=Dmxl2 PE=1 SV=3 DMXL2_MOUSE reviewed DmX-like protein 2 (Rabconnectin-3) Mus musculus (Mouse) GO:0007035; GO:0007268; GO:0007283; GO:0007420; GO:0007608; GO:0008021; GO:0022038; GO:0030672; GO:0031267; GO:0042593; GO:0043291; GO:0098992 brain development [GO:0007420]; chemical synaptic transmission [GO:0007268]; corpus callosum development [GO:0022038]; glucose homeostasis [GO:0042593]; sensory perception of smell [GO:0007608]; spermatogenesis [GO:0007283]; vacuolar acidification [GO:0007035] neuronal dense core vesicle [GO:0098992]; RAVE complex [GO:0043291]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672] small GTPase binding [GO:0031267] g9019.t1 Q8BPN8 39.583 720 2.01e-124 447.0 sp|Q8BPN8|DMXL2_MOUSE DmX-like protein 2 OS=Mus musculus OX=10090 GN=Dmxl2 PE=1 SV=3 DMXL2_MOUSE reviewed DmX-like protein 2 (Rabconnectin-3) Mus musculus (Mouse) GO:0007035; GO:0007268; GO:0007283; GO:0007420; GO:0007608; GO:0008021; GO:0022038; GO:0030672; GO:0031267; GO:0042593; GO:0043291; GO:0098992 brain development [GO:0007420]; chemical synaptic transmission [GO:0007268]; corpus callosum development [GO:0022038]; glucose homeostasis [GO:0042593]; sensory perception of smell [GO:0007608]; spermatogenesis [GO:0007283]; vacuolar acidification [GO:0007035] neuronal dense core vesicle [GO:0098992]; RAVE complex [GO:0043291]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672] small GTPase binding [GO:0031267] g9019.t2 Q8BPN8 39.887 2650 0.0 1554.0 sp|Q8BPN8|DMXL2_MOUSE DmX-like protein 2 OS=Mus musculus OX=10090 GN=Dmxl2 PE=1 SV=3 DMXL2_MOUSE reviewed DmX-like protein 2 (Rabconnectin-3) Mus musculus (Mouse) GO:0007035; GO:0007268; GO:0007283; GO:0007420; GO:0007608; GO:0008021; GO:0022038; GO:0030672; GO:0031267; GO:0042593; GO:0043291; GO:0098992 brain development [GO:0007420]; chemical synaptic transmission [GO:0007268]; corpus callosum development [GO:0022038]; glucose homeostasis [GO:0042593]; sensory perception of smell [GO:0007608]; spermatogenesis [GO:0007283]; vacuolar acidification [GO:0007035] neuronal dense core vesicle [GO:0098992]; RAVE complex [GO:0043291]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672] small GTPase binding [GO:0031267] g9019.t2 Q8BPN8 39.583 720 1.9e-124 447.0 sp|Q8BPN8|DMXL2_MOUSE DmX-like protein 2 OS=Mus musculus OX=10090 GN=Dmxl2 PE=1 SV=3 DMXL2_MOUSE reviewed DmX-like protein 2 (Rabconnectin-3) Mus musculus (Mouse) GO:0007035; GO:0007268; GO:0007283; GO:0007420; GO:0007608; GO:0008021; GO:0022038; GO:0030672; GO:0031267; GO:0042593; GO:0043291; GO:0098992 brain development [GO:0007420]; chemical synaptic transmission [GO:0007268]; corpus callosum development [GO:0022038]; glucose homeostasis [GO:0042593]; sensory perception of smell [GO:0007608]; spermatogenesis [GO:0007283]; vacuolar acidification [GO:0007035] neuronal dense core vesicle [GO:0098992]; RAVE complex [GO:0043291]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672] small GTPase binding [GO:0031267] g9020.t1 Q91447 71.858 366 0.0 536.0 sp|Q91447|MP2K1_SERCA Dual specificity mitogen-activated protein kinase kinase 1 (Fragment) OS=Serinus canaria OX=9135 GN=MAP2K1 PE=2 SV=1 MP2K1_SERCA reviewed Dual specificity mitogen-activated protein kinase kinase 1 (MAP kinase kinase 1) (MAPKK 1) (EC 2.7.12.2) (ERK activator kinase 1) (MAPK/ERK kinase 1) (MEK1) Serinus canaria (Island canary) (Fringilla canaria) GO:0004674; GO:0004708; GO:0004713; GO:0005524; GO:0005634; GO:0005739; GO:0005769; GO:0005770; GO:0005813; GO:0005829; GO:0005925; GO:0032872; GO:0090170; GO:0106310; GO:2000641 regulation of early endosome to late endosome transport [GO:2000641]; regulation of Golgi inheritance [GO:0090170]; regulation of stress-activated MAPK cascade [GO:0032872] centrosome [GO:0005813]; cytosol [GO:0005829]; early endosome [GO:0005769]; focal adhesion [GO:0005925]; late endosome [GO:0005770]; mitochondrion [GO:0005739]; nucleus [GO:0005634] ATP binding [GO:0005524]; MAP kinase kinase activity [GO:0004708]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713] g9022.t1 A0AVT1 54.388 752 0.0 855.0 sp|A0AVT1|UBA6_HUMAN Ubiquitin-like modifier-activating enzyme 6 OS=Homo sapiens OX=9606 GN=UBA6 PE=1 SV=1 UBA6_HUMAN reviewed Ubiquitin-like modifier-activating enzyme 6 (Ubiquitin-activating enzyme 6) (EC 6.2.1.45) (Monocyte protein 4) (MOP-4) (Ubiquitin-activating enzyme E1-like protein 2) (E1-L2) Homo sapiens (Human) GO:0004839; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006511; GO:0006974; GO:0016567; GO:0019780; GO:0046872 DNA damage response [GO:0006974]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634] ATP binding [GO:0005524]; FAT10 activating enzyme activity [GO:0019780]; metal ion binding [GO:0046872]; ubiquitin activating enzyme activity [GO:0004839] g9023.t1 Q8C7R4 58.537 205 1.65e-71 237.0 sp|Q8C7R4|UBA6_MOUSE Ubiquitin-like modifier-activating enzyme 6 OS=Mus musculus OX=10090 GN=Uba6 PE=1 SV=1 UBA6_MOUSE reviewed Ubiquitin-like modifier-activating enzyme 6 (Ubiquitin-activating enzyme 6) (EC 6.2.1.45) (Ubiquitin-activating enzyme E1-like protein 2) (E1-L2) Mus musculus (Mouse) GO:0004839; GO:0005524; GO:0005634; GO:0005737; GO:0006511; GO:0006974; GO:0007612; GO:0007626; GO:0016567; GO:0019780; GO:0021764; GO:0021766; GO:0046872; GO:0060996 amygdala development [GO:0021764]; dendritic spine development [GO:0060996]; DNA damage response [GO:0006974]; hippocampus development [GO:0021766]; learning [GO:0007612]; locomotory behavior [GO:0007626]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511] cytoplasm [GO:0005737]; nucleus [GO:0005634] ATP binding [GO:0005524]; FAT10 activating enzyme activity [GO:0019780]; metal ion binding [GO:0046872]; ubiquitin activating enzyme activity [GO:0004839] g9026.t1 A2ICN5 93.671 79 8.6000000000000005e-47 158.0 sp|A2ICN5|MEF2A_PIG Myocyte-specific enhancer factor 2A OS=Sus scrofa OX=9823 GN=MEF2A PE=2 SV=2 MEF2A_PIG reviewed Myocyte-specific enhancer factor 2A Sus scrofa (Pig) GO:0000122; GO:0000977; GO:0000978; GO:0000981; GO:0001228; GO:0003682; GO:0005634; GO:0006915; GO:0035035; GO:0042826; GO:0045944; GO:0046332; GO:0046983; GO:0048813; GO:0055001; GO:0071277; GO:0140297 apoptotic process [GO:0006915]; cellular response to calcium ion [GO:0071277]; dendrite morphogenesis [GO:0048813]; muscle cell development [GO:0055001]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944] nucleus [GO:0005634] chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription factor binding [GO:0140297]; histone acetyltransferase binding [GO:0035035]; histone deacetylase binding [GO:0042826]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; SMAD binding [GO:0046332] g9028.t1 Q5R5L7 30.548 347 1.38e-43 161.0 sp|Q5R5L7|ARRD3_PONAB Arrestin domain-containing protein 3 OS=Pongo abelii OX=9601 GN=ARRDC3 PE=2 SV=1 g9029.t1 P0DMQ6 58.841 345 2.1e-141 407.0 sp|P0DMQ6|DHSO_CHICK Sorbitol dehydrogenase OS=Gallus gallus OX=9031 GN=SORD PE=1 SV=1 DHSO_CHICK reviewed Sorbitol dehydrogenase (SDH) (EC 1.1.1.-) (Polyol dehydrogenase) Gallus gallus (Chicken) GO:0003939; GO:0006000; GO:0006061; GO:0006062; GO:0008270; GO:0031514; GO:0031966; GO:0032991; GO:0046370; GO:0051287 fructose biosynthetic process [GO:0046370]; fructose metabolic process [GO:0006000]; sorbitol biosynthetic process [GO:0006061]; sorbitol catabolic process [GO:0006062] mitochondrial membrane [GO:0031966]; motile cilium [GO:0031514]; protein-containing complex [GO:0032991] L-iditol 2-dehydrogenase (NAD+) activity [GO:0003939]; NAD binding [GO:0051287]; zinc ion binding [GO:0008270] g9032.t1 Q7SZE8 48.193 166 3.31e-55 175.0 sp|Q7SZE8|TP8L1_DANRE Tumor necrosis factor alpha-induced protein 8-like protein 1 OS=Danio rerio OX=7955 GN=tnfaip8l1 PE=1 SV=1 g9034.t1 F4JTS8 29.209 1390 9.880000000000001e-123 440.0 sp|F4JTS8|NOV_ARATH Protein NO VEIN OS=Arabidopsis thaliana OX=3702 GN=NOV PE=1 SV=1 NOV_ARATH reviewed Protein NO VEIN (Protein EMBRYO DEFECTIVE 2597) Arabidopsis thaliana (Mouse-ear cress) GO:0001708; GO:0005634; GO:0009793; GO:0009926; GO:0010305; GO:0019827; GO:0048364 auxin polar transport [GO:0009926]; cell fate specification [GO:0001708]; embryo development ending in seed dormancy [GO:0009793]; leaf vascular tissue pattern formation [GO:0010305]; root development [GO:0048364]; stem cell population maintenance [GO:0019827] nucleus [GO:0005634] g9035.t1 F4JTS8 35.428 748 1.69e-105 379.0 sp|F4JTS8|NOV_ARATH Protein NO VEIN OS=Arabidopsis thaliana OX=3702 GN=NOV PE=1 SV=1 NOV_ARATH reviewed Protein NO VEIN (Protein EMBRYO DEFECTIVE 2597) Arabidopsis thaliana (Mouse-ear cress) GO:0001708; GO:0005634; GO:0009793; GO:0009926; GO:0010305; GO:0019827; GO:0048364 auxin polar transport [GO:0009926]; cell fate specification [GO:0001708]; embryo development ending in seed dormancy [GO:0009793]; leaf vascular tissue pattern formation [GO:0010305]; root development [GO:0048364]; stem cell population maintenance [GO:0019827] nucleus [GO:0005634] g9038.t1 Q32PY6 36.438 365 9.640000000000001e-73 235.0 sp|Q32PY6|HENMT_RAT Small RNA 2'-O-methyltransferase OS=Rattus norvegicus OX=10116 GN=Henmt1 PE=2 SV=1 HENMT_RAT reviewed Small RNA 2'-O-methyltransferase (EC 2.1.1.386) (HEN1 methyltransferase homolog 1) Rattus norvegicus (Rat) GO:0001510; GO:0003723; GO:0005634; GO:0005737; GO:0008171; GO:0008173; GO:0030422; GO:0034587; GO:0043186; GO:0046872; GO:0090486 piRNA processing [GO:0034587]; RNA methylation [GO:0001510]; siRNA processing [GO:0030422] cytoplasm [GO:0005737]; nucleus [GO:0005634]; P granule [GO:0043186] metal ion binding [GO:0046872]; O-methyltransferase activity [GO:0008171]; RNA binding [GO:0003723]; RNA methyltransferase activity [GO:0008173]; small RNA 2'-O-methyltransferase activity [GO:0090486] g9039.t1 Q9HCG7 54.508 488 0.0 559.0 sp|Q9HCG7|GBA2_HUMAN Non-lysosomal glucosylceramidase OS=Homo sapiens OX=9606 GN=GBA2 PE=1 SV=2 GBA2_HUMAN reviewed Non-lysosomal glucosylceramidase (NLGase) (EC 3.2.1.45) (Beta-glucocerebrosidase 2) (Beta-glucosidase 2) (Bile acid beta-glucosidase GBA2) (Bile acid glucosyl transferase GBA2) (Cholesterol glucosyltransferase GBA2) (EC 2.4.1.-) (Cholesteryl-beta-glucosidase GBA2) (EC 3.2.1.-) (Glucosylceramidase 2) (Non-lysosomal cholesterol glycosyltransferase) (Non-lysosomal galactosylceramidase) (EC 3.2.1.46) (Non-lysosomal glycosylceramidase) Homo sapiens (Human) GO:0000139; GO:0004336; GO:0004348; GO:0005789; GO:0005790; GO:0005829; GO:0005886; GO:0005975; GO:0006680; GO:0007417; GO:0008203; GO:0008206; GO:0008422; GO:0009247; GO:0016020; GO:0016139; GO:0021954; GO:0030833; GO:0031113; GO:0046479; GO:0046527; GO:0050295; GO:0097035 bile acid metabolic process [GO:0008206]; carbohydrate metabolic process [GO:0005975]; central nervous system development [GO:0007417]; central nervous system neuron development [GO:0021954]; cholesterol metabolic process [GO:0008203]; glucosylceramide catabolic process [GO:0006680]; glycolipid biosynthetic process [GO:0009247]; glycoside catabolic process [GO:0016139]; glycosphingolipid catabolic process [GO:0046479]; regulation of actin filament polymerization [GO:0030833]; regulation of membrane lipid distribution [GO:0097035]; regulation of microtubule polymerization [GO:0031113] cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; plasma membrane [GO:0005886]; smooth endoplasmic reticulum [GO:0005790] beta-glucosidase activity [GO:0008422]; galactosylceramidase activity [GO:0004336]; glucosylceramidase activity [GO:0004348]; glucosyltransferase activity [GO:0046527]; steryl-beta-glucosidase activity [GO:0050295] g9040.t1 Q9HCG7 46.909 275 5.45e-65 224.0 sp|Q9HCG7|GBA2_HUMAN Non-lysosomal glucosylceramidase OS=Homo sapiens OX=9606 GN=GBA2 PE=1 SV=2 GBA2_HUMAN reviewed Non-lysosomal glucosylceramidase (NLGase) (EC 3.2.1.45) (Beta-glucocerebrosidase 2) (Beta-glucosidase 2) (Bile acid beta-glucosidase GBA2) (Bile acid glucosyl transferase GBA2) (Cholesterol glucosyltransferase GBA2) (EC 2.4.1.-) (Cholesteryl-beta-glucosidase GBA2) (EC 3.2.1.-) (Glucosylceramidase 2) (Non-lysosomal cholesterol glycosyltransferase) (Non-lysosomal galactosylceramidase) (EC 3.2.1.46) (Non-lysosomal glycosylceramidase) Homo sapiens (Human) GO:0000139; GO:0004336; GO:0004348; GO:0005789; GO:0005790; GO:0005829; GO:0005886; GO:0005975; GO:0006680; GO:0007417; GO:0008203; GO:0008206; GO:0008422; GO:0009247; GO:0016020; GO:0016139; GO:0021954; GO:0030833; GO:0031113; GO:0046479; GO:0046527; GO:0050295; GO:0097035 bile acid metabolic process [GO:0008206]; carbohydrate metabolic process [GO:0005975]; central nervous system development [GO:0007417]; central nervous system neuron development [GO:0021954]; cholesterol metabolic process [GO:0008203]; glucosylceramide catabolic process [GO:0006680]; glycolipid biosynthetic process [GO:0009247]; glycoside catabolic process [GO:0016139]; glycosphingolipid catabolic process [GO:0046479]; regulation of actin filament polymerization [GO:0030833]; regulation of membrane lipid distribution [GO:0097035]; regulation of microtubule polymerization [GO:0031113] cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; plasma membrane [GO:0005886]; smooth endoplasmic reticulum [GO:0005790] beta-glucosidase activity [GO:0008422]; galactosylceramidase activity [GO:0004336]; glucosylceramidase activity [GO:0004348]; glucosyltransferase activity [GO:0046527]; steryl-beta-glucosidase activity [GO:0050295] g9042.t1 Q8R092 40.0 180 4.540000000000001e-31 121.0 sp|Q8R092|CA043_MOUSE Protein C1orf43 homolog OS=Mus musculus OX=10090 PE=2 SV=1 g9043.t1 A5PJA1 61.644 146 1.1600000000000001e-64 199.0 sp|A5PJA1|KAD6_BOVIN Adenylate kinase isoenzyme 6 OS=Bos taurus OX=9913 GN=AK6 PE=2 SV=1 KAD6_BOVIN reviewed Adenylate kinase isoenzyme 6 (AK6) (EC 2.7.4.3) (Coilin-interacting nuclear ATPase protein) (Dual activity adenylate kinase/ATPase) (AK/ATPase) Bos taurus (Bovine) GO:0004017; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0006364; GO:0015030; GO:0016887; GO:0042274 ribosomal small subunit biogenesis [GO:0042274]; rRNA processing [GO:0006364] Cajal body [GO:0015030]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] AMP kinase activity [GO:0004017]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887] g9046.t1 Q6IR75 87.075 441 0.0 731.0 sp|Q6IR75|CSN2_XENLA COP9 signalosome complex subunit 2 (Fragment) OS=Xenopus laevis OX=8355 GN=csn2 PE=2 SV=1 g9047.t1 Q8AVY1 50.622 241 2.13e-76 235.0 sp|Q8AVY1|CMA1A_XENLA Ciliary microtubule associated protein 1A OS=Xenopus laevis OX=8355 GN=cimap1a PE=2 SV=1 g9048.t1 P61025 79.245 53 3.96e-25 92.0 sp|P61025|CKS1_MOUSE Cyclin-dependent kinases regulatory subunit 1 OS=Mus musculus OX=10090 GN=Cks1b PE=3 SV=1 g9049.t1 P62313 100.0 75 2.37e-50 155.0 sp|P62313|LSM6_MOUSE U6 snRNA-associated Sm-like protein LSm6 OS=Mus musculus OX=10090 GN=Lsm6 PE=1 SV=1 g9052.t1 P20742 30.517 1527 0.0 671.0 sp|P20742|PZP_HUMAN Pregnancy zone protein OS=Homo sapiens OX=9606 GN=PZP PE=1 SV=4 PZP_HUMAN reviewed Pregnancy zone protein (C3 and PZP-like alpha-2-macroglobulin domain-containing protein 6) Homo sapiens (Human) GO:0002020; GO:0004866; GO:0004867; GO:0005576; GO:0005615; GO:0007565; GO:0070062; GO:0072562 female pregnancy [GO:0007565] blood microparticle [GO:0072562]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615] endopeptidase inhibitor activity [GO:0004866]; protease binding [GO:0002020]; serine-type endopeptidase inhibitor activity [GO:0004867] g9053.t1 Q03626 37.313 737 1.74e-122 429.0 sp|Q03626|MUG1_RAT Murinoglobulin-1 OS=Rattus norvegicus OX=10116 GN=Mug1 PE=2 SV=1 g9053.t2 Q03626 37.313 737 1.74e-122 429.0 sp|Q03626|MUG1_RAT Murinoglobulin-1 OS=Rattus norvegicus OX=10116 GN=Mug1 PE=2 SV=1 g9053.t3 Q03626 37.313 737 1.93e-122 429.0 sp|Q03626|MUG1_RAT Murinoglobulin-1 OS=Rattus norvegicus OX=10116 GN=Mug1 PE=2 SV=1 g9054.t1 Q8IZJ3 25.982 662 4.46e-49 191.0 sp|Q8IZJ3|CPMD8_HUMAN C3 and PZP-like alpha-2-macroglobulin domain-containing protein 8 OS=Homo sapiens OX=9606 GN=CPAMD8 PE=1 SV=2 CPMD8_HUMAN reviewed C3 and PZP-like alpha-2-macroglobulin domain-containing protein 8 Homo sapiens (Human) GO:0001654; GO:0004867; GO:0005615; GO:0005886 eye development [GO:0001654] extracellular space [GO:0005615]; plasma membrane [GO:0005886] serine-type endopeptidase inhibitor activity [GO:0004867] g9055.t1 A0A250YGJ5 67.73 282 2.67e-140 411.0 sp|A0A250YGJ5|SIR6_CASCN NAD-dependent protein deacylase sirtuin-6 OS=Castor canadensis OX=51338 GN=SIRT6 PE=1 SV=1 SIR6_CASCN reviewed NAD-dependent protein deacylase sirtuin-6 (EC 2.3.1.-) (NAD-dependent protein deacetylase sirtuin-6) (EC 2.3.1.286) (Protein mono-ADP-ribosyltransferase sirtuin-6) (EC 2.4.2.-) Castor canadensis (American beaver) GO:0000122; GO:0000781; GO:0000785; GO:0003684; GO:0003714; GO:0003723; GO:0005634; GO:0005783; GO:0006302; GO:0008340; GO:0010526; GO:0010569; GO:0016779; GO:0016787; GO:0019216; GO:0031490; GO:0031491; GO:0031508; GO:0031648; GO:0032024; GO:0032922; GO:0034244; GO:0034979; GO:0042181; GO:0042308; GO:0042752; GO:0042803; GO:0045600; GO:0045721; GO:0045820; GO:0046827; GO:0046872; GO:0046969; GO:0050994; GO:0051697; GO:0055007; GO:0070403; GO:0097372; GO:0106274; GO:0120162; GO:0120187; GO:0140612; GO:0140765; GO:0140773; GO:0140774; GO:1904841; GO:2000738; GO:2000781 cardiac muscle cell differentiation [GO:0055007]; circadian regulation of gene expression [GO:0032922]; determination of adult lifespan [GO:0008340]; double-strand break repair [GO:0006302]; ketone biosynthetic process [GO:0042181]; negative regulation of gluconeogenesis [GO:0045721]; negative regulation of glycolytic process [GO:0045820]; negative regulation of protein import into nucleus [GO:0042308]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription elongation by RNA polymerase II [GO:0034244]; pericentric heterochromatin formation [GO:0031508]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of insulin secretion [GO:0032024]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of protein localization to chromatin [GO:0120187]; positive regulation of stem cell differentiation [GO:2000738]; protein delipidation [GO:0051697]; protein destabilization [GO:0031648]; regulation of circadian rhythm [GO:0042752]; regulation of double-strand break repair via homologous recombination [GO:0010569]; regulation of lipid catabolic process [GO:0050994]; regulation of lipid metabolic process [GO:0019216]; transposable element silencing [GO:0010526] chromatin [GO:0000785]; chromosome, telomeric region [GO:0000781]; endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634] chromatin DNA binding [GO:0031490]; damaged DNA binding [GO:0003684]; DNA damage sensor activity [GO:0140612]; histone H3K18 deacetylase activity, NAD-dependent [GO:0097372]; histone H3K56 deacetylase activity, NAD-dependent [GO:0140765]; histone H3K9 deacetylase activity, NAD-dependent [GO:0046969]; hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]; NAD+ binding [GO:0070403]; NAD+-protein-arginine ADP-ribosyltransferase activity [GO:0106274]; NAD-dependent protein demyristoylase activity [GO:0140773]; NAD-dependent protein depalmitoylase activity [GO:0140774]; NAD-dependent protein lysine deacetylase activity [GO:0034979]; nucleosome binding [GO:0031491]; nucleotidyltransferase activity [GO:0016779]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; TORC2 complex binding [GO:1904841]; transcription corepressor activity [GO:0003714] g9056.t1 Q68FU5 57.547 106 2e-22 91.3 sp|Q68FU5|CI085_RAT Uncharacterized protein C9orf85 homolog OS=Rattus norvegicus OX=10116 PE=1 SV=1 g9057.t1 O35857 60.377 318 3.8799999999999996e-138 402.0 sp|O35857|TIM44_MOUSE Mitochondrial import inner membrane translocase subunit TIM44 OS=Mus musculus OX=10090 GN=Timm44 PE=1 SV=2 g9058.t1 O35857 56.962 79 6.59e-21 90.1 sp|O35857|TIM44_MOUSE Mitochondrial import inner membrane translocase subunit TIM44 OS=Mus musculus OX=10090 GN=Timm44 PE=1 SV=2 g9059.t1 E9PZM4 62.776 1131 0.0 1329.0 sp|E9PZM4|CHD2_MOUSE Chromodomain-helicase-DNA-binding protein 2 OS=Mus musculus OX=10090 GN=Chd2 PE=1 SV=1 CHD2_MOUSE reviewed ATP-dependent chromatin remodeler CHD2 (EC 3.6.4.-) (Chromo domain-containing protein 2) (CHD-2) Mus musculus (Mouse) GO:0000785; GO:0000978; GO:0003677; GO:0003682; GO:0005524; GO:0005634; GO:0006974; GO:0007517; GO:0010467; GO:0016887; GO:0034728; GO:0042393; GO:0060218; GO:0140658 DNA damage response [GO:0006974]; gene expression [GO:0010467]; hematopoietic stem cell differentiation [GO:0060218]; muscle organ development [GO:0007517]; nucleosome organization [GO:0034728] chromatin [GO:0000785]; nucleus [GO:0005634] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent chromatin remodeler activity [GO:0140658]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; histone binding [GO:0042393]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978] g9059.t2 E9PZM4 62.776 1131 0.0 1332.0 sp|E9PZM4|CHD2_MOUSE Chromodomain-helicase-DNA-binding protein 2 OS=Mus musculus OX=10090 GN=Chd2 PE=1 SV=1 CHD2_MOUSE reviewed ATP-dependent chromatin remodeler CHD2 (EC 3.6.4.-) (Chromo domain-containing protein 2) (CHD-2) Mus musculus (Mouse) GO:0000785; GO:0000978; GO:0003677; GO:0003682; GO:0005524; GO:0005634; GO:0006974; GO:0007517; GO:0010467; GO:0016887; GO:0034728; GO:0042393; GO:0060218; GO:0140658 DNA damage response [GO:0006974]; gene expression [GO:0010467]; hematopoietic stem cell differentiation [GO:0060218]; muscle organ development [GO:0007517]; nucleosome organization [GO:0034728] chromatin [GO:0000785]; nucleus [GO:0005634] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent chromatin remodeler activity [GO:0140658]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; histone binding [GO:0042393]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978] g9059.t2 E9PZM4 38.462 247 1.72e-28 129.0 sp|E9PZM4|CHD2_MOUSE Chromodomain-helicase-DNA-binding protein 2 OS=Mus musculus OX=10090 GN=Chd2 PE=1 SV=1 CHD2_MOUSE reviewed ATP-dependent chromatin remodeler CHD2 (EC 3.6.4.-) (Chromo domain-containing protein 2) (CHD-2) Mus musculus (Mouse) GO:0000785; GO:0000978; GO:0003677; GO:0003682; GO:0005524; GO:0005634; GO:0006974; GO:0007517; GO:0010467; GO:0016887; GO:0034728; GO:0042393; GO:0060218; GO:0140658 DNA damage response [GO:0006974]; gene expression [GO:0010467]; hematopoietic stem cell differentiation [GO:0060218]; muscle organ development [GO:0007517]; nucleosome organization [GO:0034728] chromatin [GO:0000785]; nucleus [GO:0005634] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent chromatin remodeler activity [GO:0140658]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; histone binding [GO:0042393]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978] g9059.t3 E9PZM4 61.618 1162 0.0 1331.0 sp|E9PZM4|CHD2_MOUSE Chromodomain-helicase-DNA-binding protein 2 OS=Mus musculus OX=10090 GN=Chd2 PE=1 SV=1 CHD2_MOUSE reviewed ATP-dependent chromatin remodeler CHD2 (EC 3.6.4.-) (Chromo domain-containing protein 2) (CHD-2) Mus musculus (Mouse) GO:0000785; GO:0000978; GO:0003677; GO:0003682; GO:0005524; GO:0005634; GO:0006974; GO:0007517; GO:0010467; GO:0016887; GO:0034728; GO:0042393; GO:0060218; GO:0140658 DNA damage response [GO:0006974]; gene expression [GO:0010467]; hematopoietic stem cell differentiation [GO:0060218]; muscle organ development [GO:0007517]; nucleosome organization [GO:0034728] chromatin [GO:0000785]; nucleus [GO:0005634] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent chromatin remodeler activity [GO:0140658]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; histone binding [GO:0042393]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978] g9059.t3 E9PZM4 38.376 271 5.6699999999999996e-30 134.0 sp|E9PZM4|CHD2_MOUSE Chromodomain-helicase-DNA-binding protein 2 OS=Mus musculus OX=10090 GN=Chd2 PE=1 SV=1 CHD2_MOUSE reviewed ATP-dependent chromatin remodeler CHD2 (EC 3.6.4.-) (Chromo domain-containing protein 2) (CHD-2) Mus musculus (Mouse) GO:0000785; GO:0000978; GO:0003677; GO:0003682; GO:0005524; GO:0005634; GO:0006974; GO:0007517; GO:0010467; GO:0016887; GO:0034728; GO:0042393; GO:0060218; GO:0140658 DNA damage response [GO:0006974]; gene expression [GO:0010467]; hematopoietic stem cell differentiation [GO:0060218]; muscle organ development [GO:0007517]; nucleosome organization [GO:0034728] chromatin [GO:0000785]; nucleus [GO:0005634] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent chromatin remodeler activity [GO:0140658]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; histone binding [GO:0042393]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978] g9060.t1 Q2KJG3 61.637 391 3.49e-173 499.0 sp|Q2KJG3|SYNC_BOVIN Asparagine--tRNA ligase, cytoplasmic OS=Bos taurus OX=9913 GN=NARS PE=2 SV=3 g9061.t1 O43776 80.208 96 4.59e-53 177.0 sp|O43776|SYNC_HUMAN Asparagine--tRNA ligase, cytoplasmic OS=Homo sapiens OX=9606 GN=NARS1 PE=1 SV=1 SYNC_HUMAN reviewed Asparagine--tRNA ligase, cytoplasmic (EC 6.1.1.22) (Asparaginyl-tRNA synthetase) (AsnRS) (Asparaginyl-tRNA synthetase 1) Homo sapiens (Human) GO:0003676; GO:0004816; GO:0005524; GO:0005737; GO:0005829; GO:0006418; GO:0006421; GO:0016477; GO:0021987; GO:0031728; GO:0046983; GO:0070062 asparaginyl-tRNA aminoacylation [GO:0006421]; cell migration [GO:0016477]; cerebral cortex development [GO:0021987]; tRNA aminoacylation for protein translation [GO:0006418] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062] asparagine-tRNA ligase activity [GO:0004816]; ATP binding [GO:0005524]; CCR3 chemokine receptor binding [GO:0031728]; nucleic acid binding [GO:0003676]; protein dimerization activity [GO:0046983] g9063.t1 Q9DEY9 48.158 760 0.0 696.0 sp|Q9DEY9|BLM_XENLA RecQ-like DNA helicase BLM OS=Xenopus laevis OX=8355 GN=blm PE=2 SV=1 BLM_XENLA reviewed RecQ-like DNA helicase BLM (EC 5.6.2.4) (Bloom syndrome protein homolog) (xBLM) (DNA 3'-5' helicase BLM) (RecQ helicase homolog) Xenopus laevis (African clawed frog) GO:0000400; GO:0000723; GO:0000724; GO:0000729; GO:0003677; GO:0003678; GO:0003697; GO:0005524; GO:0005634; GO:0005694; GO:0005737; GO:0006260; GO:0008094; GO:0008270; GO:0009378; GO:0016887; GO:0042803; GO:0043138; GO:0051259; GO:0051260; GO:0061749 DNA double-strand break processing [GO:0000729]; DNA replication [GO:0006260]; double-strand break repair via homologous recombination [GO:0000724]; protein complex oligomerization [GO:0051259]; protein homooligomerization [GO:0051260]; telomere maintenance [GO:0000723] chromosome [GO:0005694]; cytoplasm [GO:0005737]; nucleus [GO:0005634] 3'-5' DNA helicase activity [GO:0043138]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent activity, acting on DNA [GO:0008094]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; forked DNA-dependent helicase activity [GO:0061749]; four-way junction DNA binding [GO:0000400]; four-way junction helicase activity [GO:0009378]; protein homodimerization activity [GO:0042803]; single-stranded DNA binding [GO:0003697]; zinc ion binding [GO:0008270] g9068.t1 E9PV86 48.918 693 0.0 574.0 sp|E9PV86|MCTP1_MOUSE Multiple C2 and transmembrane domain-containing protein 1 OS=Mus musculus OX=10090 GN=Mctp1 PE=1 SV=1 g9070.t1 Q3T0K2 73.713 544 0.0 849.0 sp|Q3T0K2|TCPG_BOVIN T-complex protein 1 subunit gamma OS=Bos taurus OX=9913 GN=CCT3 PE=1 SV=1 TCPG_BOVIN reviewed T-complex protein 1 subunit gamma (TCP-1-gamma) (EC 3.6.1.-) (CCT-gamma) Bos taurus (Bovine) GO:0002199; GO:0005524; GO:0005832; GO:0005874; GO:0006457; GO:0007339; GO:0016887; GO:0032212; GO:0044297; GO:0046872; GO:0050821; GO:0051082; GO:0140662 binding of sperm to zona pellucida [GO:0007339]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein folding [GO:0006457]; protein stabilization [GO:0050821] cell body [GO:0044297]; chaperonin-containing T-complex [GO:0005832]; microtubule [GO:0005874]; zona pellucida receptor complex [GO:0002199] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent protein folding chaperone [GO:0140662]; metal ion binding [GO:0046872]; unfolded protein binding [GO:0051082] g9071.t1 Q6VAB6 33.654 312 2.3899999999999998e-45 177.0 sp|Q6VAB6|KSR2_HUMAN Kinase suppressor of Ras 2 OS=Homo sapiens OX=9606 GN=KSR2 PE=1 SV=2 KSR2_HUMAN reviewed Kinase suppressor of Ras 2 (hKSR2) (EC 2.7.11.1) Homo sapiens (Human) GO:0004672; GO:0004674; GO:0005078; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0007265; GO:0008270; GO:0019722; GO:0031434; GO:0043410; GO:0106310; GO:0120162 calcium-mediated signaling [GO:0019722]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of MAPK cascade [GO:0043410]; Ras protein signal transduction [GO:0007265] cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886] ATP binding [GO:0005524]; MAP-kinase scaffold activity [GO:0005078]; mitogen-activated protein kinase kinase binding [GO:0031434]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; zinc ion binding [GO:0008270] g9073.t1 Q8AXV1 55.307 358 2.7200000000000002e-124 364.0 sp|Q8AXV1|SH3G2_CHICK Endophilin-A1 OS=Gallus gallus OX=9031 GN=SH3GL2 PE=1 SV=1 g9074.t1 Q5R1T0 33.918 342 2.49e-26 120.0 sp|Q5R1T0|CAF1A_CHICK Chromatin assembly factor 1 subunit A OS=Gallus gallus OX=9031 GN=CHAF1A PE=1 SV=1 CAF1A_CHICK reviewed Chromatin assembly factor 1 subunit A (CAF-1 subunit A) (Chromatin assembly factor I p150 subunit) (CAF-I 150 kDa subunit) (CAF-I p150) Gallus gallus (Chicken) GO:0005634; GO:0006260; GO:0006281; GO:0006334; GO:0006335; GO:0033186 DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA replication-dependent chromatin assembly [GO:0006335]; nucleosome assembly [GO:0006334] CAF-1 complex [GO:0033186]; nucleus [GO:0005634] g9076.t1 Q7SZ59 53.514 185 7.98e-65 205.0 sp|Q7SZ59|RASLC_DANRE Ras-like protein family member 12 OS=Danio rerio OX=7955 GN=RASL12 PE=2 SV=1 g9081.t1 Q96FI4 48.364 275 2.98e-87 268.0 sp|Q96FI4|NEIL1_HUMAN Endonuclease 8-like 1 OS=Homo sapiens OX=9606 GN=NEIL1 PE=1 SV=3 g9082.t1 Q96CS2 37.363 273 3.7400000000000004e-49 167.0 sp|Q96CS2|HAUS1_HUMAN HAUS augmin-like complex subunit 1 OS=Homo sapiens OX=9606 GN=HAUS1 PE=1 SV=1 HAUS1_HUMAN reviewed HAUS augmin-like complex subunit 1 (Coiled-coil domain-containing protein 5) (Enhancer of invasion-cluster) (HEI-C) Homo sapiens (Human) GO:0000922; GO:0005813; GO:0005829; GO:0007098; GO:0010968; GO:0051225; GO:0051301; GO:0070652; GO:1990498 cell division [GO:0051301]; centrosome cycle [GO:0007098]; regulation of microtubule nucleation [GO:0010968]; spindle assembly [GO:0051225] centrosome [GO:0005813]; cytosol [GO:0005829]; HAUS complex [GO:0070652]; mitotic spindle microtubule [GO:1990498]; spindle pole [GO:0000922] g9084.t1 O02833 26.499 517 3.36e-30 129.0 sp|O02833|ALS_PAPHA Insulin-like growth factor-binding protein complex acid labile subunit OS=Papio hamadryas OX=9557 GN=IGFALS PE=2 SV=1 g9085.t1 O02833 29.352 494 1.96e-24 112.0 sp|O02833|ALS_PAPHA Insulin-like growth factor-binding protein complex acid labile subunit OS=Papio hamadryas OX=9557 GN=IGFALS PE=2 SV=1 g9086.t1 Q9VPF0 28.873 426 2.64e-30 131.0 sp|Q9VPF0|ATK_DROME Protein artichoke OS=Drosophila melanogaster OX=7227 GN=atk PE=1 SV=2 ATK_DROME reviewed Protein artichoke Drosophila melanogaster (Fruit fly) GO:0005737; GO:0007423; GO:0031012; GO:0040011; GO:0060271 cilium assembly [GO:0060271]; locomotion [GO:0040011]; sensory organ development [GO:0007423] cytoplasm [GO:0005737]; extracellular matrix [GO:0031012] g9086.t1 Q9VPF0 27.778 414 1.97e-21 103.0 sp|Q9VPF0|ATK_DROME Protein artichoke OS=Drosophila melanogaster OX=7227 GN=atk PE=1 SV=2 ATK_DROME reviewed Protein artichoke Drosophila melanogaster (Fruit fly) GO:0005737; GO:0007423; GO:0031012; GO:0040011; GO:0060271 cilium assembly [GO:0060271]; locomotion [GO:0040011]; sensory organ development [GO:0007423] cytoplasm [GO:0005737]; extracellular matrix [GO:0031012] g9087.t1 P35858 26.932 427 4.17e-28 122.0 sp|P35858|ALS_HUMAN Insulin-like growth factor-binding protein complex acid labile subunit OS=Homo sapiens OX=9606 GN=IGFALS PE=1 SV=1 ALS_HUMAN reviewed Insulin-like growth factor-binding protein complex acid labile subunit (ALS) Homo sapiens (Human) GO:0005520; GO:0005576; GO:0005615; GO:0007155; GO:0007165; GO:0038023; GO:0042567; GO:0070062 cell adhesion [GO:0007155]; signal transduction [GO:0007165] extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; insulin-like growth factor ternary complex [GO:0042567] insulin-like growth factor binding [GO:0005520]; signaling receptor activity [GO:0038023] g9088.t1 Q96CD2 65.027 183 4.55e-84 251.0 sp|Q96CD2|COAC_HUMAN Phosphopantothenoylcysteine decarboxylase OS=Homo sapiens OX=9606 GN=PPCDC PE=1 SV=2 COAC_HUMAN reviewed Phosphopantothenoylcysteine decarboxylase (PPC-DC) (EC 4.1.1.36) (CoaC) Homo sapiens (Human) GO:0004633; GO:0005829; GO:0010181; GO:0015937; GO:0042802; GO:0071513 coenzyme A biosynthetic process [GO:0015937] cytosol [GO:0005829]; phosphopantothenoylcysteine decarboxylase complex [GO:0071513] FMN binding [GO:0010181]; identical protein binding [GO:0042802]; phosphopantothenoylcysteine decarboxylase activity [GO:0004633] g9089.t1 Q5ZM55 49.44 625 0.0 625.0 sp|Q5ZM55|FEM1B_CHICK Protein fem-1 homolog B OS=Gallus gallus OX=9031 GN=FEM1B PE=2 SV=1 g9090.t1 Q6DG36 56.484 455 4.87e-158 478.0 sp|Q6DG36|ZNT5_DANRE Proton-coupled zinc antiporter SLC30A5 OS=Danio rerio OX=7955 GN=slc30a5 PE=2 SV=1 ZNT5_DANRE reviewed Proton-coupled zinc antiporter SLC30A5 (Solute carrier family 30 member 5) (Zinc transporter 5) (ZnT-5) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000139; GO:0005385; GO:0005789; GO:0005794; GO:0006506; GO:0006829; GO:0006882; GO:0010043; GO:0012507; GO:0030667; GO:0031410; GO:0032588; GO:0046872; GO:0062111; GO:0140826; GO:1904257; GO:1990674 GPI anchor biosynthetic process [GO:0006506]; intracellular zinc ion homeostasis [GO:0006882]; response to zinc ion [GO:0010043]; zinc ion import into Golgi lumen [GO:1904257]; zinc ion import into organelle [GO:0062111]; zinc ion transport [GO:0006829] cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum membrane [GO:0005789]; ER to Golgi transport vesicle membrane [GO:0012507]; Golgi apparatus [GO:0005794]; Golgi cis cisterna membrane [GO:1990674]; Golgi membrane [GO:0000139]; secretory granule membrane [GO:0030667]; trans-Golgi network membrane [GO:0032588] metal ion binding [GO:0046872]; zinc ion transmembrane transporter activity [GO:0005385]; zinc:proton antiporter activity [GO:0140826] g9090.t1 Q6DG36 55.682 176 3.67e-52 196.0 sp|Q6DG36|ZNT5_DANRE Proton-coupled zinc antiporter SLC30A5 OS=Danio rerio OX=7955 GN=slc30a5 PE=2 SV=1 ZNT5_DANRE reviewed Proton-coupled zinc antiporter SLC30A5 (Solute carrier family 30 member 5) (Zinc transporter 5) (ZnT-5) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000139; GO:0005385; GO:0005789; GO:0005794; GO:0006506; GO:0006829; GO:0006882; GO:0010043; GO:0012507; GO:0030667; GO:0031410; GO:0032588; GO:0046872; GO:0062111; GO:0140826; GO:1904257; GO:1990674 GPI anchor biosynthetic process [GO:0006506]; intracellular zinc ion homeostasis [GO:0006882]; response to zinc ion [GO:0010043]; zinc ion import into Golgi lumen [GO:1904257]; zinc ion import into organelle [GO:0062111]; zinc ion transport [GO:0006829] cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum membrane [GO:0005789]; ER to Golgi transport vesicle membrane [GO:0012507]; Golgi apparatus [GO:0005794]; Golgi cis cisterna membrane [GO:1990674]; Golgi membrane [GO:0000139]; secretory granule membrane [GO:0030667]; trans-Golgi network membrane [GO:0032588] metal ion binding [GO:0046872]; zinc ion transmembrane transporter activity [GO:0005385]; zinc:proton antiporter activity [GO:0140826] g9096.t1 Q6NWW5 50.418 478 8.899999999999999e-140 466.0 sp|Q6NWW5|KIF24_MOUSE Kinesin-like protein KIF24 OS=Mus musculus OX=10090 GN=Kif24 PE=1 SV=2 KIF24_MOUSE reviewed Kinesin-like protein KIF24 Mus musculus (Mouse) GO:0003777; GO:0005524; GO:0005813; GO:0005814; GO:0005874; GO:0007018; GO:0007019; GO:0008017; GO:0032991; GO:0042802; GO:0060271; GO:1902018 cilium assembly [GO:0060271]; microtubule depolymerization [GO:0007019]; microtubule-based movement [GO:0007018]; negative regulation of cilium assembly [GO:1902018] centriole [GO:0005814]; centrosome [GO:0005813]; microtubule [GO:0005874]; protein-containing complex [GO:0032991] ATP binding [GO:0005524]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777] g9097.t1 Q9U2M7 44.03 134 5.55e-30 109.0 sp|Q9U2M7|AP4A_CAEEL Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical] OS=Caenorhabditis elegans OX=6239 GN=ndx-4 PE=1 SV=1 g9099.t1 O43181 62.5 144 1.98e-63 195.0 sp|O43181|NDUS4_HUMAN NADH dehydrogenase [ubiquinone] iron-sulfur protein 4, mitochondrial OS=Homo sapiens OX=9606 GN=NDUFS4 PE=1 SV=1 NDUS4_HUMAN reviewed NADH dehydrogenase [ubiquinone] iron-sulfur protein 4, mitochondrial (Complex I-18 kDa) (CI-18 kDa) (Complex I-AQDQ) (CI-AQDQ) (NADH-ubiquinone oxidoreductase 18 kDa subunit) Homo sapiens (Human) GO:0001932; GO:0005739; GO:0005743; GO:0006120; GO:0007420; GO:0008137; GO:0009060; GO:0032981; GO:0033011; GO:0042776; GO:0045271; GO:0051591; GO:0072593; GO:0120238 aerobic respiration [GO:0009060]; brain development [GO:0007420]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; mitochondrial respiratory chain complex I assembly [GO:0032981]; proton motive force-driven mitochondrial ATP synthesis [GO:0042776]; reactive oxygen species metabolic process [GO:0072593]; regulation of protein phosphorylation [GO:0001932]; response to cAMP [GO:0051591] mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; perinuclear theca [GO:0033011]; respiratory chain complex I [GO:0045271]; sperm glycocalyx [GO:0120238] NADH dehydrogenase (ubiquinone) activity [GO:0008137] g9100.t1 Q5RFN0 46.591 176 4.51e-52 169.0 sp|Q5RFN0|ARL15_PONAB ADP-ribosylation factor-like protein 15 OS=Pongo abelii OX=9601 GN=ARL15 PE=2 SV=1 g9101.t1 Q9Y4L5 36.455 299 3.28e-53 179.0 sp|Q9Y4L5|RN115_HUMAN E3 ubiquitin-protein ligase RNF115 OS=Homo sapiens OX=9606 GN=RNF115 PE=1 SV=2 RN115_HUMAN reviewed E3 ubiquitin-protein ligase RNF115 (EC 2.3.2.27) (RING finger protein 115) (RING-type E3 ubiquitin transferase RNF115) (Rab7-interacting RING finger protein) (Rabring 7) (Zinc finger protein 364) Homo sapiens (Human) GO:0004842; GO:0005634; GO:0005737; GO:0005783; GO:0005794; GO:0005829; GO:0008270; GO:0016567; GO:0034122; GO:0042059; GO:0043162; GO:0051865; GO:0061630; GO:0070534; GO:0070936; GO:0070979 negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of toll-like receptor signaling pathway [GO:0034122]; protein autoubiquitination [GO:0051865]; protein K11-linked ubiquitination [GO:0070979]; protein K48-linked ubiquitination [GO:0070936]; protein K63-linked ubiquitination [GO:0070534]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; nucleus [GO:0005634] ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] g9103.t1 B3EWZ6 35.514 321 1.1e-46 181.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g9103.t1 B3EWZ6 33.437 323 3.6499999999999997e-45 177.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g9103.t1 B3EWZ6 34.278 353 1.82e-44 174.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g9103.t1 B3EWZ6 27.586 435 9e-44 172.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g9103.t1 B3EWZ6 32.399 321 6.79e-42 167.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g9103.t1 B3EWZ6 35.775 355 6.79e-42 167.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g9103.t1 B3EWZ6 32.051 312 1.24e-40 163.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g9103.t1 B3EWZ6 32.219 329 1.36e-40 163.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g9103.t1 B3EWZ6 33.724 341 2.7399999999999997e-40 162.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g9103.t1 B3EWZ6 33.636 330 1.19e-39 160.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g9103.t1 B3EWZ6 32.153 339 8.96e-39 157.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g9103.t1 B3EWZ6 32.743 339 1.1999999999999998e-38 157.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g9103.t1 B3EWZ6 33.333 321 4.09e-38 155.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g9103.t1 B3EWZ6 32.092 349 8.47e-36 148.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g9103.t1 B3EWZ6 29.661 354 1.5900000000000002e-35 147.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g9103.t1 B3EWZ6 28.035 346 3.53e-35 146.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g9103.t1 B3EWZ6 34.743 331 6.8299999999999995e-34 142.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g9103.t1 B3EWZ6 28.49 351 1.8900000000000002e-32 138.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g9103.t1 B3EWZ6 29.73 370 1.44e-31 135.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g9103.t1 B3EWZ6 30.408 319 6.45e-29 127.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g9103.t1 B3EWZ6 30.0 310 1.57e-27 123.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g9103.t1 B3EWZ6 35.664 143 8.01e-22 105.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g9104.t1 P10079 43.226 465 8.14e-106 349.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g9104.t1 P10079 42.463 471 3.01e-102 340.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g9104.t1 P10079 43.348 466 3.37e-102 340.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g9104.t1 P10079 41.649 461 8.31e-97 325.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g9104.t1 P10079 40.909 440 7.41e-89 303.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g9121.t1 Q63068 36.53 219 6.850000000000001e-33 130.0 sp|Q63068|PHAX_RAT Phosphorylated adapter RNA export protein OS=Rattus norvegicus OX=10116 GN=Phax PE=1 SV=2 PHAX_RAT reviewed Phosphorylated adapter RNA export protein (26 kDa resiniferatoxin-binding protein) (RBP-26) (RNA U small nuclear RNA export adapter protein) (RTX-42) (Resiniferatoxin-binding protein 2) (RBP-2) Rattus norvegicus (Rat) GO:0003723; GO:0005634; GO:0005654; GO:0005737; GO:0006408; GO:0015030; GO:0015031; GO:0015643; GO:0043025; GO:0043489; GO:0140262; GO:1990904 protein transport [GO:0015031]; RNA stabilization [GO:0043489]; snRNA export from nucleus [GO:0006408] Cajal body [GO:0015030]; cytoplasm [GO:0005737]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904] mRNA cap binding complex binding [GO:0140262]; RNA binding [GO:0003723]; toxic substance binding [GO:0015643] g9124.t1 O42115 72.603 73 5.630000000000001e-27 115.0 sp|O42115|ARX_DANRE Aristaless-related homeobox protein OS=Danio rerio OX=7955 GN=arx PE=2 SV=1 g9125.t1 Q9PVY0 51.724 203 3.1800000000000002e-58 187.0 sp|Q9PVY0|RX1_CHICK Retinal homeobox protein Rx1 OS=Gallus gallus OX=9031 GN=RX1 PE=2 SV=1 g9128.t1 P12890 47.923 313 1.57e-85 288.0 sp|P12890|AMDB_XENLA Peptidyl-glycine alpha-amidating monooxygenase B OS=Xenopus laevis OX=8355 GN=pam-b PE=2 SV=1 g9129.t1 A5PK71 70.673 208 4.22e-108 317.0 sp|A5PK71|PACRG_BOVIN Parkin coregulated gene protein OS=Bos taurus OX=9913 GN=PACRG PE=1 SV=1 PACRG_BOVIN reviewed Parkin coregulated gene protein Bos taurus (Bovine) GO:0001664; GO:0002177; GO:0003779; GO:0005829; GO:0005879; GO:0007286; GO:0008104; GO:0030317; GO:0030544; GO:0031625; GO:0031982; GO:0043005; GO:0043014; GO:0044297; GO:0048487; GO:0051879; GO:0097225; GO:0097386; GO:0160112 flagellated sperm motility [GO:0030317]; intracellular protein localization [GO:0008104]; spermatid development [GO:0007286] axonemal B tubule inner sheath [GO:0160112]; axonemal microtubule [GO:0005879]; cell body [GO:0044297]; cytosol [GO:0005829]; glial cell projection [GO:0097386]; manchette [GO:0002177]; neuron projection [GO:0043005]; sperm midpiece [GO:0097225]; vesicle [GO:0031982] actin binding [GO:0003779]; alpha-tubulin binding [GO:0043014]; beta-tubulin binding [GO:0048487]; G protein-coupled receptor binding [GO:0001664]; Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]; ubiquitin protein ligase binding [GO:0031625] g9130.t1 P10731 40.436 779 7.29e-172 528.0 sp|P10731|AMD_BOVIN Peptidyl-glycine alpha-amidating monooxygenase OS=Bos taurus OX=9913 GN=PAM PE=1 SV=2 AMD_BOVIN reviewed Peptidyl-glycine alpha-amidating monooxygenase (PAM) [Includes: Peptidylglycine alpha-hydroxylating monooxygenase (PHM) (EC 1.14.17.3); Peptidyl-alpha-hydroxyglycine alpha-amidating lyase (EC 4.3.2.5) (Peptidylamidoglycolate lyase) (PAL)] Bos taurus (Bovine) GO:0001519; GO:0004504; GO:0004598; GO:0005507; GO:0005509; GO:0005576; GO:0008270; GO:0030658; GO:0030667; GO:0031418; GO:0062112 fatty acid primary amide biosynthetic process [GO:0062112]; peptide amidation [GO:0001519] extracellular region [GO:0005576]; secretory granule membrane [GO:0030667]; transport vesicle membrane [GO:0030658] calcium ion binding [GO:0005509]; copper ion binding [GO:0005507]; L-ascorbic acid binding [GO:0031418]; peptidylamidoglycolate lyase activity [GO:0004598]; peptidylglycine monooxygenase activity [GO:0004504]; zinc ion binding [GO:0008270] g9131.t1 Q9CZV5 38.839 224 5.92e-34 134.0 sp|Q9CZV5|ST65G_MOUSE STAGA complex 65 subunit gamma OS=Mus musculus OX=10090 GN=Supt7l PE=1 SV=1 g9132.t1 Q9VWH4 76.894 264 6.1e-143 410.0 sp|Q9VWH4|IDH3A_DROME Probable isocitrate dehydrogenase [NAD] subunit alpha, mitochondrial OS=Drosophila melanogaster OX=7227 GN=Idh3a PE=2 SV=1 g9133.t1 Q04592 35.651 1798 0.0 852.0 sp|Q04592|PCSK5_MOUSE Proprotein convertase subtilisin/kexin type 5 OS=Mus musculus OX=10090 GN=Pcsk5 PE=1 SV=3 PCSK5_MOUSE reviewed Proprotein convertase subtilisin/kexin type 5 (EC 3.4.21.-) (Proprotein convertase 5) (PC5) (Proprotein convertase 6) (PC6) (Subtilisin-like proprotein convertase 6) (SPC6) (Subtilisin/kexin-like protease PC5) Mus musculus (Mouse) GO:0000139; GO:0001822; GO:0003279; GO:0004175; GO:0004252; GO:0005615; GO:0005788; GO:0005794; GO:0005797; GO:0005802; GO:0006465; GO:0007368; GO:0007507; GO:0007566; GO:0008233; GO:0009952; GO:0016485; GO:0016486; GO:0019058; GO:0030141; GO:0030323; GO:0031410; GO:0033625; GO:0035108; GO:0042277; GO:0043043; GO:0043204; GO:0048566; GO:0048706; GO:0060976; GO:0140447; GO:1904754; GO:1905609; GO:1990635; GO:2001046 anterior/posterior pattern specification [GO:0009952]; cardiac septum development [GO:0003279]; coronary vasculature development [GO:0060976]; cytokine precursor processing [GO:0140447]; determination of left/right symmetry [GO:0007368]; embryo implantation [GO:0007566]; embryonic digestive tract development [GO:0048566]; embryonic skeletal system development [GO:0048706]; heart development [GO:0007507]; kidney development [GO:0001822]; limb morphogenesis [GO:0035108]; peptide biosynthetic process [GO:0043043]; peptide hormone processing [GO:0016486]; positive regulation of integrin activation [GO:0033625]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of smooth muscle cell-matrix adhesion [GO:1905609]; positive regulation of vascular associated smooth muscle cell migration [GO:1904754]; protein processing [GO:0016485]; respiratory tube development [GO:0030323]; signal peptide processing [GO:0006465]; viral life cycle [GO:0019058] cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum lumen [GO:0005788]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; Golgi medial cisterna [GO:0005797]; Golgi membrane [GO:0000139]; perikaryon [GO:0043204]; proximal dendrite [GO:1990635]; secretory granule [GO:0030141]; trans-Golgi network [GO:0005802] endopeptidase activity [GO:0004175]; peptidase activity [GO:0008233]; peptide binding [GO:0042277]; serine-type endopeptidase activity [GO:0004252] g9133.t1 Q04592 26.385 1444 1.9299999999999998e-89 328.0 sp|Q04592|PCSK5_MOUSE Proprotein convertase subtilisin/kexin type 5 OS=Mus musculus OX=10090 GN=Pcsk5 PE=1 SV=3 PCSK5_MOUSE reviewed Proprotein convertase subtilisin/kexin type 5 (EC 3.4.21.-) (Proprotein convertase 5) (PC5) (Proprotein convertase 6) (PC6) (Subtilisin-like proprotein convertase 6) (SPC6) (Subtilisin/kexin-like protease PC5) Mus musculus (Mouse) GO:0000139; GO:0001822; GO:0003279; GO:0004175; GO:0004252; GO:0005615; GO:0005788; GO:0005794; GO:0005797; GO:0005802; GO:0006465; GO:0007368; GO:0007507; GO:0007566; GO:0008233; GO:0009952; GO:0016485; GO:0016486; GO:0019058; GO:0030141; GO:0030323; GO:0031410; GO:0033625; GO:0035108; GO:0042277; GO:0043043; GO:0043204; GO:0048566; GO:0048706; GO:0060976; GO:0140447; GO:1904754; GO:1905609; GO:1990635; GO:2001046 anterior/posterior pattern specification [GO:0009952]; cardiac septum development [GO:0003279]; coronary vasculature development [GO:0060976]; cytokine precursor processing [GO:0140447]; determination of left/right symmetry [GO:0007368]; embryo implantation [GO:0007566]; embryonic digestive tract development [GO:0048566]; embryonic skeletal system development [GO:0048706]; heart development [GO:0007507]; kidney development [GO:0001822]; limb morphogenesis [GO:0035108]; peptide biosynthetic process [GO:0043043]; peptide hormone processing [GO:0016486]; positive regulation of integrin activation [GO:0033625]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of smooth muscle cell-matrix adhesion [GO:1905609]; positive regulation of vascular associated smooth muscle cell migration [GO:1904754]; protein processing [GO:0016485]; respiratory tube development [GO:0030323]; signal peptide processing [GO:0006465]; viral life cycle [GO:0019058] cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum lumen [GO:0005788]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; Golgi medial cisterna [GO:0005797]; Golgi membrane [GO:0000139]; perikaryon [GO:0043204]; proximal dendrite [GO:1990635]; secretory granule [GO:0030141]; trans-Golgi network [GO:0005802] endopeptidase activity [GO:0004175]; peptidase activity [GO:0008233]; peptide binding [GO:0042277]; serine-type endopeptidase activity [GO:0004252] g9134.t1 Q5F3W3 56.433 342 9.14e-126 395.0 sp|Q5F3W3|MK06_CHICK Mitogen-activated protein kinase 6 OS=Gallus gallus OX=9031 GN=MAPK6 PE=2 SV=1 MK06_CHICK reviewed Mitogen-activated protein kinase 6 (MAP kinase 6) (MAPK 6) (EC 2.7.11.24) Gallus gallus (Chicken) GO:0004674; GO:0004707; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0019901; GO:0032156; GO:0032991; GO:0035556; GO:0046982; GO:0060999; GO:0106310 intracellular signal transduction [GO:0035556]; positive regulation of dendritic spine development [GO:0060999] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; septin cytoskeleton [GO:0032156] ATP binding [GO:0005524]; MAP kinase activity [GO:0004707]; protein heterodimerization activity [GO:0046982]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g9135.t1 Q91YK0 46.037 656 1.1600000000000001e-179 535.0 sp|Q91YK0|LRC49_MOUSE Leucine-rich repeat-containing protein 49 OS=Mus musculus OX=10090 GN=Lrrc49 PE=1 SV=1 g9137.t1 Q00765 57.055 163 6.1799999999999996e-68 209.0 sp|Q00765|REEP5_HUMAN Receptor expression-enhancing protein 5 OS=Homo sapiens OX=9606 GN=REEP5 PE=1 SV=3 REEP5_HUMAN reviewed Receptor expression-enhancing protein 5 (Polyposis locus protein 1) (Protein TB2) Homo sapiens (Human) GO:0005783; GO:0007029; GO:0033017; GO:0071782; GO:0090158 endoplasmic reticulum membrane organization [GO:0090158]; endoplasmic reticulum organization [GO:0007029] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum tubular network [GO:0071782]; sarcoplasmic reticulum membrane [GO:0033017] g9138.t1 Q9Y6V7 63.744 422 0.0 550.0 sp|Q9Y6V7|DDX49_HUMAN Probable ATP-dependent RNA helicase DDX49 OS=Homo sapiens OX=9606 GN=DDX49 PE=1 SV=1 DDX49_HUMAN reviewed Probable ATP-dependent RNA helicase DDX49 (EC 3.6.4.13) (DEAD box protein 49) Homo sapiens (Human) GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0006364; GO:0016887; GO:0030307; GO:0044357 positive regulation of cell growth [GO:0030307]; regulation of rRNA stability [GO:0044357]; rRNA processing [GO:0006364] nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724] g9139.t1 Q9U4H5 51.351 185 1.3099999999999999e-52 175.0 sp|Q9U4H5|TM2D3_DROME TM2 domain-containing protein almondex OS=Drosophila melanogaster OX=7227 GN=amx PE=1 SV=1 g9140.t1 A6QNM2 59.646 508 0.0 601.0 sp|A6QNM2|RRF2M_BOVIN Ribosome-releasing factor 2, mitochondrial OS=Bos taurus OX=9913 GN=GFM2 PE=2 SV=1 g9141.t1 A0JMI9 45.946 222 5.73e-63 212.0 sp|A0JMI9|RRF2M_DANRE Ribosome-releasing factor 2, mitochondrial OS=Danio rerio OX=7955 GN=gfm2 PE=2 SV=2 g9142.t1 Q9UI26 52.923 975 0.0 966.0 sp|Q9UI26|IPO11_HUMAN Importin-11 OS=Homo sapiens OX=9606 GN=IPO11 PE=1 SV=1 g9143.t1 Q6SR68 49.067 375 6.18e-75 238.0 sp|Q6SR68|OTP_HELTB Homeobox protein orthopedia OS=Heliocidaris tuberculata OX=7635 GN=Otp PE=2 SV=1 g9145.t1 Q6PEC1 55.882 102 3.52e-34 117.0 sp|Q6PEC1|TBCA_RAT Tubulin-specific chaperone A OS=Rattus norvegicus OX=10116 GN=Tbca PE=1 SV=1 g9146.t1 E9Q4S1 50.0 168 1.4e-38 141.0 sp|E9Q4S1|PDE8B_MOUSE High affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8B OS=Mus musculus OX=10090 GN=Pde8b PE=1 SV=1 PDE8B_MOUSE reviewed High affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8B (PDE8B) (EC 3.1.4.53) (Cell proliferation-inducing gene 22 protein) Mus musculus (Mouse) GO:0001662; GO:0004115; GO:0006198; GO:0007165; GO:0008542; GO:0035106; GO:0046676; GO:0046872; GO:0047555; GO:0050885; GO:0061179; GO:0070374; GO:0090032; GO:0141162 behavioral fear response [GO:0001662]; cAMP catabolic process [GO:0006198]; negative regulation of cAMP/PKA signal transduction [GO:0141162]; negative regulation of insulin secretion [GO:0046676]; negative regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061179]; negative regulation of steroid hormone biosynthetic process [GO:0090032]; neuromuscular process controlling balance [GO:0050885]; operant conditioning [GO:0035106]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; signal transduction [GO:0007165]; visual learning [GO:0008542] 3',5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; 3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; metal ion binding [GO:0046872] g9146.t2 O95263 46.498 514 1.4e-156 469.0 sp|O95263|PDE8B_HUMAN High affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8B OS=Homo sapiens OX=9606 GN=PDE8B PE=1 SV=2 g9153.t1 O60658 60.129 311 1.56e-127 385.0 sp|O60658|PDE8A_HUMAN High affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8A OS=Homo sapiens OX=9606 GN=PDE8A PE=1 SV=2 PDE8A_HUMAN reviewed High affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8A (EC 3.1.4.53) Homo sapiens (Human) GO:0004115; GO:0005829; GO:0006198; GO:0006355; GO:0007165; GO:0019900; GO:0030295; GO:0046872; GO:0047555; GO:0070062; GO:0070374; GO:0071364; GO:0141162 cAMP catabolic process [GO:0006198]; cellular response to epidermal growth factor stimulus [GO:0071364]; negative regulation of cAMP/PKA signal transduction [GO:0141162]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; regulation of DNA-templated transcription [GO:0006355]; signal transduction [GO:0007165] cytosol [GO:0005829]; extracellular exosome [GO:0070062] 3',5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; 3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; kinase binding [GO:0019900]; metal ion binding [GO:0046872]; protein kinase activator activity [GO:0030295] g9162.t1 P10394 31.65 515 4.36e-78 269.0 sp|P10394|POL4_DROME Retrovirus-related Pol polyprotein from transposon 412 OS=Drosophila melanogaster OX=7227 GN=POL PE=4 SV=1 g9163.t1 Q99315 24.654 434 7.73e-27 117.0 sp|Q99315|YG31B_YEAST Transposon Ty3-G Gag-Pol polyprotein OS=Saccharomyces cerevisiae (strain ATCC 204508 / S288c) OX=559292 GN=TY3B-G PE=1 SV=3 g9167.t1 Q6AZN6 65.81 895 0.0 1138.0 sp|Q6AZN6|PK3C3_XENLA Phosphatidylinositol 3-kinase catalytic subunit type 3 OS=Xenopus laevis OX=8355 GN=pik3c3 PE=2 SV=1 PK3C3_XENLA reviewed Phosphatidylinositol 3-kinase catalytic subunit type 3 (PI3-kinase type 3) (PI3K type 3) (PtdIns-3-kinase type 3) (EC 2.7.1.137) (Phosphoinositide-3-kinase class 3) Xenopus laevis (African clawed frog) GO:0000045; GO:0000407; GO:0000425; GO:0005524; GO:0005737; GO:0005768; GO:0005777; GO:0006897; GO:0016020; GO:0016303; GO:0030496; GO:0032465; GO:0034271; GO:0034272; GO:0036092; GO:0048015; GO:0051301 autophagosome assembly [GO:0000045]; cell division [GO:0051301]; endocytosis [GO:0006897]; pexophagy [GO:0000425]; phosphatidylinositol-3-phosphate biosynthetic process [GO:0036092]; phosphatidylinositol-mediated signaling [GO:0048015]; regulation of cytokinesis [GO:0032465] cytoplasm [GO:0005737]; endosome [GO:0005768]; membrane [GO:0016020]; midbody [GO:0030496]; peroxisome [GO:0005777]; phagophore assembly site [GO:0000407]; phosphatidylinositol 3-kinase complex, class III, type I [GO:0034271]; phosphatidylinositol 3-kinase complex, class III, type II [GO:0034272] 1-phosphatidylinositol-3-kinase activity [GO:0016303]; ATP binding [GO:0005524] g9167.t2 Q8NEB9 62.406 133 1.47e-55 198.0 sp|Q8NEB9|PK3C3_HUMAN Phosphatidylinositol 3-kinase catalytic subunit type 3 OS=Homo sapiens OX=9606 GN=PIK3C3 PE=1 SV=1 PK3C3_HUMAN reviewed Phosphatidylinositol 3-kinase catalytic subunit type 3 (PI3-kinase type 3) (PI3K type 3) (PtdIns-3-kinase type 3) (EC 2.7.1.137) (Phosphatidylinositol 3-kinase p100 subunit) (Phosphoinositide-3-kinase class 3) (hVps34) Homo sapiens (Human) GO:0000045; GO:0000407; GO:0000425; GO:0004672; GO:0005524; GO:0005737; GO:0005768; GO:0005770; GO:0005776; GO:0005777; GO:0005829; GO:0005886; GO:0005930; GO:0006622; GO:0006897; GO:0006914; GO:0007032; GO:0010506; GO:0016020; GO:0016236; GO:0016241; GO:0016303; GO:0016485; GO:0030496; GO:0030670; GO:0032465; GO:0034271; GO:0034272; GO:0034497; GO:0035032; GO:0036092; GO:0042149; GO:0043201; GO:0043491; GO:0044754; GO:0044829; GO:0045022; GO:0045954; GO:0046854; GO:0048015; GO:0048488; GO:0051301; GO:0052742; GO:0097352; GO:0098830; GO:0098845; GO:0098978; GO:0098982; GO:1903061 autophagosome assembly [GO:0000045]; autophagosome maturation [GO:0097352]; autophagy [GO:0006914]; cell division [GO:0051301]; cellular response to glucose starvation [GO:0042149]; early endosome to late endosome transport [GO:0045022]; endocytosis [GO:0006897]; endosome organization [GO:0007032]; host-mediated activation of viral genome replication [GO:0044829]; macroautophagy [GO:0016236]; pexophagy [GO:0000425]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; phosphatidylinositol-3-phosphate biosynthetic process [GO:0036092]; phosphatidylinositol-mediated signaling [GO:0048015]; positive regulation of natural killer cell mediated cytotoxicity [GO:0045954]; positive regulation of protein lipidation [GO:1903061]; protein localization to phagophore assembly site [GO:0034497]; protein processing [GO:0016485]; protein targeting to lysosome [GO:0006622]; regulation of autophagy [GO:0010506]; regulation of cytokinesis [GO:0032465]; regulation of macroautophagy [GO:0016241]; response to L-leucine [GO:0043201]; synaptic vesicle endocytosis [GO:0048488] autolysosome [GO:0044754]; autophagosome [GO:0005776]; axoneme [GO:0005930]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome [GO:0005768]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; late endosome [GO:0005770]; membrane [GO:0016020]; midbody [GO:0030496]; peroxisome [GO:0005777]; phagocytic vesicle membrane [GO:0030670]; phagophore assembly site [GO:0000407]; phosphatidylinositol 3-kinase complex, class III [GO:0035032]; phosphatidylinositol 3-kinase complex, class III, type I [GO:0034271]; phosphatidylinositol 3-kinase complex, class III, type II [GO:0034272]; plasma membrane [GO:0005886]; postsynaptic endosome [GO:0098845]; presynaptic endosome [GO:0098830] 1-phosphatidylinositol-3-kinase activity [GO:0016303]; ATP binding [GO:0005524]; phosphatidylinositol kinase activity [GO:0052742]; protein kinase activity [GO:0004672] g9171.t1 Q3UXZ6 29.93 284 2.05e-22 100.0 sp|Q3UXZ6|FA81A_MOUSE Protein FAM81A OS=Mus musculus OX=10090 GN=Fam81a PE=1 SV=2 g9172.t1 Q6NWG0 36.41 195 1.93e-40 142.0 sp|Q6NWG0|TSN36_DANRE Tetraspanin-36 OS=Danio rerio OX=7955 GN=tspan36 PE=1 SV=2 TSN36_DANRE reviewed Tetraspanin-36 (Tetraspanin-3c) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000139; GO:0005789; GO:0005886; GO:0043473 pigmentation [GO:0043473] endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886] g9174.t1 Q5MCW4 25.732 478 2.78e-33 141.0 sp|Q5MCW4|ZN569_HUMAN Zinc finger protein 569 OS=Homo sapiens OX=9606 GN=ZNF569 PE=1 SV=1 ZN569_HUMAN reviewed Zinc finger protein 569 Homo sapiens (Human) GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0008270 regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270] g9174.t1 Q5MCW4 27.752 436 1.06e-28 127.0 sp|Q5MCW4|ZN569_HUMAN Zinc finger protein 569 OS=Homo sapiens OX=9606 GN=ZNF569 PE=1 SV=1 ZN569_HUMAN reviewed Zinc finger protein 569 Homo sapiens (Human) GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0008270 regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270] g9174.t1 Q5MCW4 24.711 433 1.8700000000000003e-27 123.0 sp|Q5MCW4|ZN569_HUMAN Zinc finger protein 569 OS=Homo sapiens OX=9606 GN=ZNF569 PE=1 SV=1 ZN569_HUMAN reviewed Zinc finger protein 569 Homo sapiens (Human) GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0008270 regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270] g9176.t1 Q7Z7F0 50.853 293 8.05e-78 273.0 sp|Q7Z7F0|KHDC4_HUMAN KH homology domain-containing protein 4 OS=Homo sapiens OX=9606 GN=KHDC4 PE=1 SV=1 g9177.t1 A8E4X8 28.393 560 1.39e-64 234.0 sp|A8E4X8|JMY_XENTR Junction-mediating and -regulatory protein OS=Xenopus tropicalis OX=8364 GN=jmy PE=2 SV=1 JMY_XENTR reviewed Junction-mediating and -regulatory protein Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0000421; GO:0003779; GO:0005634; GO:0005856; GO:0006281; GO:0008017; GO:0009267; GO:0012505; GO:0031252; GO:0031410; GO:0034314; GO:0070060; GO:0070358 'de novo' actin filament nucleation [GO:0070060]; actin polymerization-dependent cell motility [GO:0070358]; Arp2/3 complex-mediated actin nucleation [GO:0034314]; cellular response to starvation [GO:0009267]; DNA repair [GO:0006281] autophagosome membrane [GO:0000421]; cell leading edge [GO:0031252]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; endomembrane system [GO:0012505]; nucleus [GO:0005634] actin binding [GO:0003779]; microtubule binding [GO:0008017] g9178.t1 Q9BVS4 72.168 309 1.1300000000000001e-169 494.0 sp|Q9BVS4|RIOK2_HUMAN Serine/threonine-protein kinase RIO2 OS=Homo sapiens OX=9606 GN=RIOK2 PE=1 SV=2 RIOK2_HUMAN reviewed Serine/threonine-protein kinase RIO2 (EC 2.7.11.1) (RIO kinase 2) Homo sapiens (Human) GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0030071; GO:0030490; GO:0030688; GO:0042274; GO:0046777; GO:0046872; GO:0106310; GO:2000208; GO:2000234 maturation of SSU-rRNA [GO:0030490]; positive regulation of ribosomal small subunit export from nucleus [GO:2000208]; positive regulation of rRNA processing [GO:2000234]; protein autophosphorylation [GO:0046777]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; ribosomal small subunit biogenesis [GO:0042274] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; preribosome, small subunit precursor [GO:0030688] ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g9179.t1 Q9UBT6 69.828 232 3.7899999999999994e-95 322.0 sp|Q9UBT6|POLK_HUMAN DNA polymerase kappa OS=Homo sapiens OX=9606 GN=POLK PE=1 SV=1 POLK_HUMAN reviewed DNA polymerase kappa (EC 2.7.7.7) (DINB protein) (DINP) Homo sapiens (Human) GO:0003684; GO:0003887; GO:0005634; GO:0005654; GO:0006260; GO:0006281; GO:0006297; GO:0006974; GO:0008270; GO:0016604; GO:0019985; GO:0034644; GO:0042276; GO:0071897; GO:0090734 cellular response to UV [GO:0034644]; DNA biosynthetic process [GO:0071897]; DNA damage response [GO:0006974]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; error-prone translesion synthesis [GO:0042276]; nucleotide-excision repair, DNA gap filling [GO:0006297]; translesion synthesis [GO:0019985] nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of DNA damage [GO:0090734] damaged DNA binding [GO:0003684]; DNA-directed DNA polymerase activity [GO:0003887]; zinc ion binding [GO:0008270] g9179.t1 Q9UBT6 58.454 207 6.95e-67 244.0 sp|Q9UBT6|POLK_HUMAN DNA polymerase kappa OS=Homo sapiens OX=9606 GN=POLK PE=1 SV=1 POLK_HUMAN reviewed DNA polymerase kappa (EC 2.7.7.7) (DINB protein) (DINP) Homo sapiens (Human) GO:0003684; GO:0003887; GO:0005634; GO:0005654; GO:0006260; GO:0006281; GO:0006297; GO:0006974; GO:0008270; GO:0016604; GO:0019985; GO:0034644; GO:0042276; GO:0071897; GO:0090734 cellular response to UV [GO:0034644]; DNA biosynthetic process [GO:0071897]; DNA damage response [GO:0006974]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; error-prone translesion synthesis [GO:0042276]; nucleotide-excision repair, DNA gap filling [GO:0006297]; translesion synthesis [GO:0019985] nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of DNA damage [GO:0090734] damaged DNA binding [GO:0003684]; DNA-directed DNA polymerase activity [GO:0003887]; zinc ion binding [GO:0008270] g9180.t1 Q6VVX2 50.756 595 0.0 543.0 sp|Q6VVX2|CERT_CRIGR Ceramide transfer protein OS=Cricetulus griseus OX=10029 GN=CERT1 PE=1 SV=1 g9181.t1 Q1HG43 34.653 303 8.98e-36 137.0 sp|Q1HG43|DOXA1_HUMAN Dual oxidase maturation factor 1 OS=Homo sapiens OX=9606 GN=DUOXA1 PE=1 SV=1 DOXA1_HUMAN reviewed Dual oxidase maturation factor 1 (Dual oxidase activator 1) (Numb-interacting protein) Homo sapiens (Human) GO:0005783; GO:0005789; GO:0005886; GO:0008104; GO:0010729; GO:0015031; GO:0016020; GO:0019899; GO:0031252; GO:0042743; GO:0045666; GO:0050727; GO:2000609 hydrogen peroxide metabolic process [GO:0042743]; intracellular protein localization [GO:0008104]; positive regulation of hydrogen peroxide biosynthetic process [GO:0010729]; positive regulation of neuron differentiation [GO:0045666]; protein transport [GO:0015031]; regulation of inflammatory response [GO:0050727]; regulation of thyroid hormone generation [GO:2000609] cell leading edge [GO:0031252]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; plasma membrane [GO:0005886] enzyme binding [GO:0019899] g9181.t2 Q1HG43 34.653 303 9.99e-36 137.0 sp|Q1HG43|DOXA1_HUMAN Dual oxidase maturation factor 1 OS=Homo sapiens OX=9606 GN=DUOXA1 PE=1 SV=1 DOXA1_HUMAN reviewed Dual oxidase maturation factor 1 (Dual oxidase activator 1) (Numb-interacting protein) Homo sapiens (Human) GO:0005783; GO:0005789; GO:0005886; GO:0008104; GO:0010729; GO:0015031; GO:0016020; GO:0019899; GO:0031252; GO:0042743; GO:0045666; GO:0050727; GO:2000609 hydrogen peroxide metabolic process [GO:0042743]; intracellular protein localization [GO:0008104]; positive regulation of hydrogen peroxide biosynthetic process [GO:0010729]; positive regulation of neuron differentiation [GO:0045666]; protein transport [GO:0015031]; regulation of inflammatory response [GO:0050727]; regulation of thyroid hormone generation [GO:2000609] cell leading edge [GO:0031252]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; plasma membrane [GO:0005886] enzyme binding [GO:0019899] g9182.t1 Q8HZK2 44.55 1578 0.0 1301.0 sp|Q8HZK2|DUOX2_PIG Dual oxidase 2 OS=Sus scrofa OX=9823 GN=DUOX2 PE=1 SV=2 g9183.t1 Q1HG43 33.66 306 1.33e-38 147.0 sp|Q1HG43|DOXA1_HUMAN Dual oxidase maturation factor 1 OS=Homo sapiens OX=9606 GN=DUOXA1 PE=1 SV=1 DOXA1_HUMAN reviewed Dual oxidase maturation factor 1 (Dual oxidase activator 1) (Numb-interacting protein) Homo sapiens (Human) GO:0005783; GO:0005789; GO:0005886; GO:0008104; GO:0010729; GO:0015031; GO:0016020; GO:0019899; GO:0031252; GO:0042743; GO:0045666; GO:0050727; GO:2000609 hydrogen peroxide metabolic process [GO:0042743]; intracellular protein localization [GO:0008104]; positive regulation of hydrogen peroxide biosynthetic process [GO:0010729]; positive regulation of neuron differentiation [GO:0045666]; protein transport [GO:0015031]; regulation of inflammatory response [GO:0050727]; regulation of thyroid hormone generation [GO:2000609] cell leading edge [GO:0031252]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; plasma membrane [GO:0005886] enzyme binding [GO:0019899] g9184.t1 Q6DF30 55.2 125 3.740000000000001e-43 148.0 sp|Q6DF30|DHDH_XENTR Trans-1,2-dihydrobenzene-1,2-diol dehydrogenase OS=Xenopus tropicalis OX=8364 GN=dhdh PE=2 SV=1 DHDH_XENTR reviewed Trans-1,2-dihydrobenzene-1,2-diol dehydrogenase (EC 1.3.1.20) (D-xylose 1-dehydrogenase) (D-xylose-NADP dehydrogenase) (EC 1.1.1.179) (Dimeric dihydrodiol dehydrogenase) Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0000166; GO:0042843; GO:0047115; GO:0047837 D-xylose catabolic process [GO:0042843] D-xylose 1-dehydrogenase (NADP+) activity [GO:0047837]; nucleotide binding [GO:0000166]; trans-1,2-dihydrobenzene-1,2-diol dehydrogenase activity [GO:0047115] g9185.t1 Q9UQ10 36.774 155 1.2400000000000001e-27 109.0 sp|Q9UQ10|DHDH_HUMAN Trans-1,2-dihydrobenzene-1,2-diol dehydrogenase OS=Homo sapiens OX=9606 GN=DHDH PE=1 SV=1 g9186.t1 Q8CG46 41.784 1065 0.0 829.0 sp|Q8CG46|SMC5_MOUSE Structural maintenance of chromosomes protein 5 OS=Mus musculus OX=10090 GN=Smc5 PE=1 SV=1 SMC5_MOUSE reviewed Structural maintenance of chromosomes protein 5 (SMC protein 5) (SMC-5) (mSMC5) (Protein expressed in male leptotene and zygotene spermatocytes 453) (MLZ-453) Mus musculus (Mouse) GO:0000217; GO:0000722; GO:0000724; GO:0000775; GO:0000781; GO:0000803; GO:0003697; GO:0005524; GO:0005634; GO:0005737; GO:0006974; GO:0007059; GO:0016605; GO:0016607; GO:0019827; GO:0030054; GO:0030261; GO:0030915; GO:0034184; GO:0035061; GO:0035861; GO:0044772; GO:0044828; GO:0051301; GO:0051984; GO:0071459; GO:0090398 cell division [GO:0051301]; cellular senescence [GO:0090398]; chromosome condensation [GO:0030261]; chromosome segregation [GO:0007059]; DNA damage response [GO:0006974]; double-strand break repair via homologous recombination [GO:0000724]; host-mediated suppression of viral genome replication [GO:0044828]; mitotic cell cycle phase transition [GO:0044772]; positive regulation of chromosome segregation [GO:0051984]; positive regulation of maintenance of mitotic sister chromatid cohesion [GO:0034184]; protein localization to chromosome, centromeric region [GO:0071459]; stem cell population maintenance [GO:0019827]; telomere maintenance via recombination [GO:0000722] cell junction [GO:0030054]; chromosome, centromeric region [GO:0000775]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; interchromatin granule [GO:0035061]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; PML body [GO:0016605]; sex chromosome [GO:0000803]; site of double-strand break [GO:0035861]; Smc5-Smc6 complex [GO:0030915] ATP binding [GO:0005524]; DNA secondary structure binding [GO:0000217]; single-stranded DNA binding [GO:0003697] g9187.t1 Q0ZDF7 36.25 160 1.73e-30 119.0 sp|Q0ZDF7|URAD_AMICA 2-oxo-4-hydroxy-4-carboxy-5-ureidoimidazoline decarboxylase OS=Amia calva OX=7924 GN=urad PE=3 SV=1 g9188.t1 Q0ZDF7 47.788 113 1.0400000000000001e-32 116.0 sp|Q0ZDF7|URAD_AMICA 2-oxo-4-hydroxy-4-carboxy-5-ureidoimidazoline decarboxylase OS=Amia calva OX=7924 GN=urad PE=3 SV=1 g9189.t1 Q0ZDF7 41.954 174 1.36e-43 145.0 sp|Q0ZDF7|URAD_AMICA 2-oxo-4-hydroxy-4-carboxy-5-ureidoimidazoline decarboxylase OS=Amia calva OX=7924 GN=urad PE=3 SV=1 g9197.t1 Q0ZDF7 41.379 174 8.100000000000001e-43 144.0 sp|Q0ZDF7|URAD_AMICA 2-oxo-4-hydroxy-4-carboxy-5-ureidoimidazoline decarboxylase OS=Amia calva OX=7924 GN=urad PE=3 SV=1 g9199.t1 Q9MYM7 42.254 213 1.37e-51 174.0 sp|Q9MYM7|B3GT1_PONPY Beta-1,3-galactosyltransferase 1 OS=Pongo pygmaeus OX=9600 GN=B3GALT1 PE=3 SV=1 g9200.t1 O15146 38.176 296 8.370000000000001e-57 211.0 sp|O15146|MUSK_HUMAN Muscle, skeletal receptor tyrosine-protein kinase OS=Homo sapiens OX=9606 GN=MUSK PE=1 SV=1 g9204.t1 Q9TTF0 57.835 351 2.63e-116 346.0 sp|Q9TTF0|NR2E3_BOVIN Photoreceptor-specific nuclear receptor OS=Bos taurus OX=9913 GN=NR2E3 PE=1 SV=2 g9204.t2 Q9TTF0 57.493 367 5.3400000000000004e-117 353.0 sp|Q9TTF0|NR2E3_BOVIN Photoreceptor-specific nuclear receptor OS=Bos taurus OX=9913 GN=NR2E3 PE=1 SV=2 g9204.t3 Q9TTF0 57.65 366 9.51e-119 358.0 sp|Q9TTF0|NR2E3_BOVIN Photoreceptor-specific nuclear receptor OS=Bos taurus OX=9913 GN=NR2E3 PE=1 SV=2 g9205.t1 Q6DHG8 30.714 280 1.7e-37 136.0 sp|Q6DHG8|SKA1_DANRE SKA complex subunit 1 OS=Danio rerio OX=7955 GN=ska1 PE=2 SV=1 SKA1_DANRE reviewed SKA complex subunit 1 (Spindle and kinetochore-associated protein 1) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000070; GO:0000278; GO:0000940; GO:0005876; GO:0007059; GO:0007080; GO:0008017; GO:0031110; GO:0051301; GO:0051315; GO:0072686; GO:0072687 attachment of mitotic spindle microtubules to kinetochore [GO:0051315]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; mitotic cell cycle [GO:0000278]; mitotic metaphase chromosome alignment [GO:0007080]; mitotic sister chromatid segregation [GO:0000070]; regulation of microtubule polymerization or depolymerization [GO:0031110] meiotic spindle [GO:0072687]; mitotic spindle [GO:0072686]; outer kinetochore [GO:0000940]; spindle microtubule [GO:0005876] microtubule binding [GO:0008017] g9207.t1 Q24323 28.283 495 2.45e-37 152.0 sp|Q24323|SEM2A_DROME Semaphorin-2A OS=Drosophila melanogaster OX=7227 GN=Sema2a PE=1 SV=2 SEM2A_DROME reviewed Semaphorin-2A (Semaphorin-II) (Sema II) Drosophila melanogaster (Fruit fly) GO:0001755; GO:0005576; GO:0005829; GO:0005886; GO:0007411; GO:0007629; GO:0007632; GO:0012505; GO:0016201; GO:0030215; GO:0030335; GO:0030534; GO:0042756; GO:0045499; GO:0050919; GO:0070983; GO:0071526; GO:0071678; GO:0097374 adult behavior [GO:0030534]; axon guidance [GO:0007411]; dendrite guidance [GO:0070983]; drinking behavior [GO:0042756]; flight behavior [GO:0007629]; negative chemotaxis [GO:0050919]; neural crest cell migration [GO:0001755]; olfactory bulb axon guidance [GO:0071678]; positive regulation of cell migration [GO:0030335]; semaphorin-plexin signaling pathway [GO:0071526]; sensory neuron axon guidance [GO:0097374]; synaptic target inhibition [GO:0016201]; visual behavior [GO:0007632] cytosol [GO:0005829]; endomembrane system [GO:0012505]; extracellular region [GO:0005576]; plasma membrane [GO:0005886] chemorepellent activity [GO:0045499]; semaphorin receptor binding [GO:0030215] g9208.t1 Q96M27 57.143 217 8.070000000000001e-72 231.0 sp|Q96M27|PRRC1_HUMAN Protein PRRC1 OS=Homo sapiens OX=9606 GN=PRRC1 PE=1 SV=1 g9208.t2 Q96M27 57.143 217 6.430000000000001e-72 231.0 sp|Q96M27|PRRC1_HUMAN Protein PRRC1 OS=Homo sapiens OX=9606 GN=PRRC1 PE=1 SV=1 g9209.t1 Q9D2K4 33.2 500 8.15e-65 230.0 sp|Q9D2K4|IQCH_MOUSE IQ domain-containing protein H OS=Mus musculus OX=10090 GN=Iqch PE=2 SV=3 g9210.t1 Q86VS3 53.864 440 6.18e-162 486.0 sp|Q86VS3|IQCH_HUMAN IQ domain-containing protein H OS=Homo sapiens OX=9606 GN=IQCH PE=1 SV=2 g9211.t1 Q1LXZ7 67.213 61 4.65e-21 87.8 sp|Q1LXZ7|IQCH_DANRE IQ motif-containing protein H OS=Danio rerio OX=7955 GN=iqch PE=4 SV=1 g9212.t1 O60140 33.591 259 1.25e-41 162.0 sp|O60140|YNS9_SCHPO Uncharacterized protein C18H10.09 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) OX=284812 GN=SPBC18H10.09 PE=4 SV=2 g9214.t1 O43451 50.35 856 0.0 842.0 sp|O43451|MGA_HUMAN Maltase-glucoamylase OS=Homo sapiens OX=9606 GN=MGAM PE=1 SV=6 MGA_HUMAN reviewed Maltase-glucoamylase (Alpha-1,4-glucosidase) (EC 3.2.1.20) Homo sapiens (Human) GO:0000025; GO:0003824; GO:0004558; GO:0004574; GO:0005886; GO:0005983; GO:0016160; GO:0016324; GO:0030246; GO:0070062; GO:0070821; GO:0101003; GO:1901027 dextrin catabolic process [GO:1901027]; maltose catabolic process [GO:0000025]; starch catabolic process [GO:0005983] apical plasma membrane [GO:0016324]; extracellular exosome [GO:0070062]; ficolin-1-rich granule membrane [GO:0101003]; plasma membrane [GO:0005886]; tertiary granule membrane [GO:0070821] alpha-1,4-glucosidase activity [GO:0004558]; amylase activity [GO:0016160]; carbohydrate binding [GO:0030246]; catalytic activity [GO:0003824]; oligo-1,6-glucosidase activity [GO:0004574] g9214.t1 O43451 50.525 857 0.0 832.0 sp|O43451|MGA_HUMAN Maltase-glucoamylase OS=Homo sapiens OX=9606 GN=MGAM PE=1 SV=6 MGA_HUMAN reviewed Maltase-glucoamylase (Alpha-1,4-glucosidase) (EC 3.2.1.20) Homo sapiens (Human) GO:0000025; GO:0003824; GO:0004558; GO:0004574; GO:0005886; GO:0005983; GO:0016160; GO:0016324; GO:0030246; GO:0070062; GO:0070821; GO:0101003; GO:1901027 dextrin catabolic process [GO:1901027]; maltose catabolic process [GO:0000025]; starch catabolic process [GO:0005983] apical plasma membrane [GO:0016324]; extracellular exosome [GO:0070062]; ficolin-1-rich granule membrane [GO:0101003]; plasma membrane [GO:0005886]; tertiary granule membrane [GO:0070821] alpha-1,4-glucosidase activity [GO:0004558]; amylase activity [GO:0016160]; carbohydrate binding [GO:0030246]; catalytic activity [GO:0003824]; oligo-1,6-glucosidase activity [GO:0004574] g9214.t1 O43451 45.645 861 0.0 746.0 sp|O43451|MGA_HUMAN Maltase-glucoamylase OS=Homo sapiens OX=9606 GN=MGAM PE=1 SV=6 MGA_HUMAN reviewed Maltase-glucoamylase (Alpha-1,4-glucosidase) (EC 3.2.1.20) Homo sapiens (Human) GO:0000025; GO:0003824; GO:0004558; GO:0004574; GO:0005886; GO:0005983; GO:0016160; GO:0016324; GO:0030246; GO:0070062; GO:0070821; GO:0101003; GO:1901027 dextrin catabolic process [GO:1901027]; maltose catabolic process [GO:0000025]; starch catabolic process [GO:0005983] apical plasma membrane [GO:0016324]; extracellular exosome [GO:0070062]; ficolin-1-rich granule membrane [GO:0101003]; plasma membrane [GO:0005886]; tertiary granule membrane [GO:0070821] alpha-1,4-glucosidase activity [GO:0004558]; amylase activity [GO:0016160]; carbohydrate binding [GO:0030246]; catalytic activity [GO:0003824]; oligo-1,6-glucosidase activity [GO:0004574] g9215.t1 Q9UJ37 43.189 301 1.52e-66 226.0 sp|Q9UJ37|SIA7B_HUMAN Alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 2 OS=Homo sapiens OX=9606 GN=ST6GALNAC2 PE=1 SV=1 SIA7B_HUMAN reviewed Alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 2 (EC 2.4.3.3) (GalNAc alpha-2,6-sialyltransferase II) (ST6GalNAc II) (ST6GalNAcII) (SThM) (Sialyltransferase 7B) (SIAT7-B) Homo sapiens (Human) GO:0000139; GO:0001665; GO:0006493; GO:0008373; GO:0009101; GO:0016266; GO:0019082; GO:1990743 glycoprotein biosynthetic process [GO:0009101]; protein O-linked glycosylation [GO:0006493]; protein O-linked glycosylation via N-acetyl-galactosamine [GO:0016266]; protein sialylation [GO:1990743]; viral protein processing [GO:0019082] Golgi membrane [GO:0000139] alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity [GO:0001665]; sialyltransferase activity [GO:0008373] g9221.t1 Q9DBN1 28.152 341 7.33e-29 123.0 sp|Q9DBN1|STR6L_MOUSE Stimulated by retinoic acid gene 6 protein-like OS=Mus musculus OX=10090 GN=Stra6l PE=1 SV=1 g9222.t1 Q9DBN1 32.301 226 5.96e-24 103.0 sp|Q9DBN1|STR6L_MOUSE Stimulated by retinoic acid gene 6 protein-like OS=Mus musculus OX=10090 GN=Stra6l PE=1 SV=1 g9223.t1 Q6PHE8 52.466 223 1.82e-35 128.0 sp|Q6PHE8|CC124_DANRE Coiled-coil domain-containing protein 124 OS=Danio rerio OX=7955 GN=ccdc124 PE=2 SV=1 g9224.t1 Q5VW36 30.4 1727 0.0 680.0 sp|Q5VW36|FOCAD_HUMAN Focadhesin OS=Homo sapiens OX=9606 GN=FOCAD PE=1 SV=2 FOCAD_HUMAN reviewed Focadhesin Homo sapiens (Human) GO:0005829; GO:0005925; GO:0060147 regulation of post-transcriptional gene silencing [GO:0060147] cytosol [GO:0005829]; focal adhesion [GO:0005925] g9224.t2 Q5VW36 30.571 1858 0.0 743.0 sp|Q5VW36|FOCAD_HUMAN Focadhesin OS=Homo sapiens OX=9606 GN=FOCAD PE=1 SV=2 FOCAD_HUMAN reviewed Focadhesin Homo sapiens (Human) GO:0005829; GO:0005925; GO:0060147 regulation of post-transcriptional gene silencing [GO:0060147] cytosol [GO:0005829]; focal adhesion [GO:0005925] g9225.t1 P82922 39.946 368 2.1e-84 265.0 sp|P82922|RT29_BOVIN Small ribosomal subunit protein mS29 OS=Bos taurus OX=9913 GN=DAP3 PE=1 SV=3 RT29_BOVIN reviewed Small ribosomal subunit protein mS29 (EC 3.6.5.-) (28S ribosomal protein S29, mitochondrial) (MRP-S29) (S29mt) (Death-associated protein 3) (DAP-3) Bos taurus (Bovine) GO:0003735; GO:0003924; GO:0005739; GO:0005743; GO:0005763; GO:0006915; GO:0032543 apoptotic process [GO:0006915]; mitochondrial translation [GO:0032543] mitochondrial inner membrane [GO:0005743]; mitochondrial small ribosomal subunit [GO:0005763]; mitochondrion [GO:0005739] GTPase activity [GO:0003924]; structural constituent of ribosome [GO:0003735] g9227.t1 Q99MY8 49.008 504 4.48e-128 457.0 sp|Q99MY8|ASH1L_MOUSE Histone-lysine N-methyltransferase ASH1L OS=Mus musculus OX=10090 GN=Ash1l PE=1 SV=3 ASH1L_MOUSE reviewed Histone-lysine N-methyltransferase ASH1L (EC 2.1.1.359) (EC 2.1.1.367) (ASH1-like protein) (Absent small and homeotic disks protein 1 homolog) Mus musculus (Mouse) GO:0001501; GO:0002674; GO:0003677; GO:0003682; GO:0005634; GO:0005654; GO:0005694; GO:0005794; GO:0005923; GO:0006355; GO:0007338; GO:0008270; GO:0009791; GO:0010468; GO:0030317; GO:0032259; GO:0042800; GO:0043409; GO:0045944; GO:0046697; GO:0046974; GO:0046975; GO:0048733; GO:0050728; GO:0061038; GO:0140948; GO:0140955; GO:1903699; GO:1903709 decidualization [GO:0046697]; flagellated sperm motility [GO:0030317]; methylation [GO:0032259]; negative regulation of acute inflammatory response [GO:0002674]; negative regulation of inflammatory response [GO:0050728]; negative regulation of MAPK cascade [GO:0043409]; positive regulation of transcription by RNA polymerase II [GO:0045944]; post-embryonic development [GO:0009791]; regulation of DNA-templated transcription [GO:0006355]; regulation of gene expression [GO:0010468]; sebaceous gland development [GO:0048733]; single fertilization [GO:0007338]; skeletal system development [GO:0001501]; tarsal gland development [GO:1903699]; uterine gland development [GO:1903709]; uterus morphogenesis [GO:0061038] bicellular tight junction [GO:0005923]; chromosome [GO:0005694]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] chromatin binding [GO:0003682]; DNA binding [GO:0003677]; histone H3K36 methyltransferase activity [GO:0046975]; histone H3K36 trimethyltransferase activity [GO:0140955]; histone H3K4 methyltransferase activity [GO:0042800]; histone H3K9 methyltransferase activity [GO:0046974]; histone H3K9 monomethyltransferase activity [GO:0140948]; zinc ion binding [GO:0008270] g9227.t1 Q99MY8 53.086 324 3.5300000000000003e-97 357.0 sp|Q99MY8|ASH1L_MOUSE Histone-lysine N-methyltransferase ASH1L OS=Mus musculus OX=10090 GN=Ash1l PE=1 SV=3 ASH1L_MOUSE reviewed Histone-lysine N-methyltransferase ASH1L (EC 2.1.1.359) (EC 2.1.1.367) (ASH1-like protein) (Absent small and homeotic disks protein 1 homolog) Mus musculus (Mouse) GO:0001501; GO:0002674; GO:0003677; GO:0003682; GO:0005634; GO:0005654; GO:0005694; GO:0005794; GO:0005923; GO:0006355; GO:0007338; GO:0008270; GO:0009791; GO:0010468; GO:0030317; GO:0032259; GO:0042800; GO:0043409; GO:0045944; GO:0046697; GO:0046974; GO:0046975; GO:0048733; GO:0050728; GO:0061038; GO:0140948; GO:0140955; GO:1903699; GO:1903709 decidualization [GO:0046697]; flagellated sperm motility [GO:0030317]; methylation [GO:0032259]; negative regulation of acute inflammatory response [GO:0002674]; negative regulation of inflammatory response [GO:0050728]; negative regulation of MAPK cascade [GO:0043409]; positive regulation of transcription by RNA polymerase II [GO:0045944]; post-embryonic development [GO:0009791]; regulation of DNA-templated transcription [GO:0006355]; regulation of gene expression [GO:0010468]; sebaceous gland development [GO:0048733]; single fertilization [GO:0007338]; skeletal system development [GO:0001501]; tarsal gland development [GO:1903699]; uterine gland development [GO:1903709]; uterus morphogenesis [GO:0061038] bicellular tight junction [GO:0005923]; chromosome [GO:0005694]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] chromatin binding [GO:0003682]; DNA binding [GO:0003677]; histone H3K36 methyltransferase activity [GO:0046975]; histone H3K36 trimethyltransferase activity [GO:0140955]; histone H3K4 methyltransferase activity [GO:0042800]; histone H3K9 methyltransferase activity [GO:0046974]; histone H3K9 monomethyltransferase activity [GO:0140948]; zinc ion binding [GO:0008270] g9229.t1 Q5RDU4 49.74 577 8.66e-178 524.0 sp|Q5RDU4|PARP6_PONAB Protein mono-ADP-ribosyltransferase PARP6 OS=Pongo abelii OX=9601 GN=PARP6 PE=2 SV=1 PARP6_PONAB reviewed Protein mono-ADP-ribosyltransferase PARP6 (EC 2.4.2.-) (ADP-ribosyltransferase diphtheria toxin-like 17) (ARTD17) (Poly [ADP-ribose] polymerase 6) (PARP-6) Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0003950; GO:0016779; GO:0070213; GO:0140803; GO:0140806 protein auto-ADP-ribosylation [GO:0070213] NAD+ poly-ADP-ribosyltransferase activity [GO:0003950]; NAD+-protein-aspartate ADP-ribosyltransferase activity [GO:0140806]; NAD+-protein-cysteine ADP-ribosyltransferase activity [GO:0140803]; nucleotidyltransferase activity [GO:0016779] g9229.t2 Q5RDU4 49.562 571 3.11e-178 524.0 sp|Q5RDU4|PARP6_PONAB Protein mono-ADP-ribosyltransferase PARP6 OS=Pongo abelii OX=9601 GN=PARP6 PE=2 SV=1 PARP6_PONAB reviewed Protein mono-ADP-ribosyltransferase PARP6 (EC 2.4.2.-) (ADP-ribosyltransferase diphtheria toxin-like 17) (ARTD17) (Poly [ADP-ribose] polymerase 6) (PARP-6) Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0003950; GO:0016779; GO:0070213; GO:0140803; GO:0140806 protein auto-ADP-ribosylation [GO:0070213] NAD+ poly-ADP-ribosyltransferase activity [GO:0003950]; NAD+-protein-aspartate ADP-ribosyltransferase activity [GO:0140806]; NAD+-protein-cysteine ADP-ribosyltransferase activity [GO:0140803]; nucleotidyltransferase activity [GO:0016779] g9230.t1 O00566 54.848 330 4.02e-86 287.0 sp|O00566|MPP10_HUMAN U3 small nucleolar ribonucleoprotein protein MPP10 OS=Homo sapiens OX=9606 GN=MPHOSPH10 PE=1 SV=2 MPP10_HUMAN reviewed U3 small nucleolar ribonucleoprotein protein MPP10 (M phase phosphoprotein 10) Homo sapiens (Human) GO:0000375; GO:0003723; GO:0005654; GO:0005694; GO:0005730; GO:0005732; GO:0006396; GO:0008380; GO:0030490; GO:0032040; GO:0034457; GO:0042274 maturation of SSU-rRNA [GO:0030490]; ribosomal small subunit biogenesis [GO:0042274]; RNA processing [GO:0006396]; RNA splicing [GO:0008380]; RNA splicing, via transesterification reactions [GO:0000375] chromosome [GO:0005694]; Mpp10 complex [GO:0034457]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; small-subunit processome [GO:0032040]; sno(s)RNA-containing ribonucleoprotein complex [GO:0005732] RNA binding [GO:0003723] g9231.t1 Q6P3J5 78.205 858 0.0 1337.0 sp|Q6P3J5|EF2_DANRE Elongation factor 2b OS=Danio rerio OX=7955 GN=eef2b PE=1 SV=1 EF2_DANRE reviewed Elongation factor 2b (EF-2) (EC 3.6.5.-) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0003746; GO:0003924; GO:0005525; GO:0005634; GO:0005829; GO:0006414; GO:0043009; GO:0043022; GO:0071466; GO:1990904 cellular response to xenobiotic stimulus [GO:0071466]; chordate embryonic development [GO:0043009]; translational elongation [GO:0006414] cytosol [GO:0005829]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904] GTP binding [GO:0005525]; GTPase activity [GO:0003924]; ribosome binding [GO:0043022]; translation elongation factor activity [GO:0003746] g9232.t1 Q0VCA2 27.586 348 2.7900000000000003e-22 101.0 sp|Q0VCA2|ARRD3_BOVIN Arrestin domain-containing protein 3 OS=Bos taurus OX=9913 GN=ARRDC3 PE=2 SV=1 ARRD3_BOVIN reviewed Arrestin domain-containing protein 3 Bos taurus (Bovine) GO:0005737; GO:0005764; GO:0005768; GO:0005769; GO:0005886; GO:0015031; GO:0031649; GO:0031651; GO:0031699; GO:0035332; GO:0043588; GO:0060613; GO:0071878; GO:0090327; GO:0120163 fat pad development [GO:0060613]; heat generation [GO:0031649]; negative regulation of adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071878]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of heat generation [GO:0031651]; negative regulation of locomotion involved in locomotory behavior [GO:0090327]; positive regulation of hippo signaling [GO:0035332]; protein transport [GO:0015031]; skin development [GO:0043588] cytoplasm [GO:0005737]; early endosome [GO:0005769]; endosome [GO:0005768]; lysosome [GO:0005764]; plasma membrane [GO:0005886] beta-3 adrenergic receptor binding [GO:0031699] g9234.t1 Q8K2C9 36.053 380 7.57e-75 239.0 sp|Q8K2C9|HACD3_MOUSE Very-long-chain (3R)-3-hydroxyacyl-CoA dehydratase 3 OS=Mus musculus OX=10090 GN=Hacd3 PE=1 SV=2 HACD3_MOUSE reviewed Very-long-chain (3R)-3-hydroxyacyl-CoA dehydratase 3 (EC 4.2.1.134) (3-hydroxyacyl-CoA dehydratase 3) (HACD3) (Butyrate-induced protein 1) (B-ind1) (Protein-tyrosine phosphatase-like A domain-containing protein 1) Mus musculus (Mouse) GO:0005783; GO:0005789; GO:0007254; GO:0007266; GO:0018812; GO:0019899; GO:0030148; GO:0030497; GO:0031965; GO:0042761; GO:0045070; GO:0046726; GO:0102158; GO:1902532 fatty acid elongation [GO:0030497]; JNK cascade [GO:0007254]; negative regulation of intracellular signal transduction [GO:1902532]; positive regulation by virus of viral protein levels in host cell [GO:0046726]; positive regulation of viral genome replication [GO:0045070]; Rho protein signal transduction [GO:0007266]; sphingolipid biosynthetic process [GO:0030148]; very long-chain fatty acid biosynthetic process [GO:0042761] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; nuclear membrane [GO:0031965] 3-hydroxyacyl-CoA dehydratase activity [GO:0018812]; enzyme binding [GO:0019899]; very-long-chain (3R)-3-hydroxyacyl-CoA dehydratase activity [GO:0102158] g9235.t1 P30937 27.758 281 1.6200000000000002e-21 98.6 sp|P30937|SSR4_RAT Somatostatin receptor type 4 OS=Rattus norvegicus OX=10116 GN=Sstr4 PE=1 SV=1 SSR4_RAT reviewed Somatostatin receptor type 4 (SS-4-R) (SS4-R) (SS4R) Rattus norvegicus (Rat) GO:0004994; GO:0005886; GO:0007218; GO:0016477; GO:0030900; GO:0042923; GO:0043005; GO:0070374; GO:0071385; GO:0090238; GO:0106072 cell migration [GO:0016477]; cellular response to glucocorticoid stimulus [GO:0071385]; forebrain development [GO:0030900]; negative regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0106072]; neuropeptide signaling pathway [GO:0007218]; positive regulation of arachidonate secretion [GO:0090238]; positive regulation of ERK1 and ERK2 cascade [GO:0070374] neuron projection [GO:0043005]; plasma membrane [GO:0005886] neuropeptide binding [GO:0042923]; somatostatin receptor activity [GO:0004994] g9239.t1 Q8VDF3 52.318 151 3.47e-44 152.0 sp|Q8VDF3|DAPK2_MOUSE Death-associated protein kinase 2 OS=Mus musculus OX=10090 GN=Dapk2 PE=1 SV=1 DAPK2_MOUSE reviewed Death-associated protein kinase 2 (DAP kinase 2) (EC 2.7.11.1) (DAP-kinase-related protein 1) (DRP-1) Mus musculus (Mouse) GO:0004674; GO:0005516; GO:0005524; GO:0005634; GO:0005737; GO:0005794; GO:0006468; GO:0031410; GO:0034423; GO:0035556; GO:0042802; GO:0043065; GO:0043276; GO:0090023; GO:0106310; GO:1990266; GO:2000424; GO:2001242 anoikis [GO:0043276]; intracellular signal transduction [GO:0035556]; neutrophil migration [GO:1990266]; positive regulation of apoptotic process [GO:0043065]; positive regulation of eosinophil chemotaxis [GO:2000424]; positive regulation of neutrophil chemotaxis [GO:0090023]; protein phosphorylation [GO:0006468]; regulation of intrinsic apoptotic signaling pathway [GO:2001242] autophagosome lumen [GO:0034423]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; Golgi apparatus [GO:0005794]; nucleus [GO:0005634] ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; identical protein binding [GO:0042802]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g9240.t1 Q9UIK4 56.818 176 2.53e-67 214.0 sp|Q9UIK4|DAPK2_HUMAN Death-associated protein kinase 2 OS=Homo sapiens OX=9606 GN=DAPK2 PE=1 SV=1 g9243.t1 P53355 44.974 378 5.51e-107 347.0 sp|P53355|DAPK1_HUMAN Death-associated protein kinase 1 OS=Homo sapiens OX=9606 GN=DAPK1 PE=1 SV=6 DAPK1_HUMAN reviewed Death-associated protein kinase 1 (DAP kinase 1) (EC 2.7.11.1) Homo sapiens (Human) GO:0002357; GO:0002834; GO:0004672; GO:0004674; GO:0004683; GO:0005516; GO:0005524; GO:0005525; GO:0005634; GO:0005737; GO:0005886; GO:0006468; GO:0006915; GO:0008625; GO:0010506; GO:0010508; GO:0014069; GO:0015629; GO:0017075; GO:0017148; GO:0035556; GO:0042802; GO:0042981; GO:0043065; GO:0043066; GO:0046777; GO:0071346; GO:0071447; GO:0097190; GO:0098978; GO:0106310; GO:1904094; GO:1990722; GO:2000310 apoptotic process [GO:0006915]; apoptotic signaling pathway [GO:0097190]; cellular response to hydroperoxide [GO:0071447]; cellular response to type II interferon [GO:0071346]; defense response to tumor cell [GO:0002357]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of translation [GO:0017148]; positive regulation of apoptotic process [GO:0043065]; positive regulation of autophagic cell death [GO:1904094]; positive regulation of autophagy [GO:0010508]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of apoptotic process [GO:0042981]; regulation of autophagy [GO:0010506]; regulation of NMDA receptor activity [GO:2000310]; regulation of response to tumor cell [GO:0002834] actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; DAPK1-calmodulin complex [GO:1990722]; glutamatergic synapse [GO:0098978]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069] ATP binding [GO:0005524]; calcium/calmodulin-dependent protein kinase activity [GO:0004683]; calmodulin binding [GO:0005516]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; syntaxin-1 binding [GO:0017075] g9244.t1 Q80YE7 35.859 594 4.8e-110 362.0 sp|Q80YE7|DAPK1_MOUSE Death-associated protein kinase 1 OS=Mus musculus OX=10090 GN=Dapk1 PE=1 SV=3 DAPK1_MOUSE reviewed Death-associated protein kinase 1 (DAP kinase 1) (EC 2.7.11.1) Mus musculus (Mouse) GO:0002357; GO:0002834; GO:0004672; GO:0004674; GO:0004683; GO:0005516; GO:0005524; GO:0005525; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0006468; GO:0006915; GO:0008625; GO:0010508; GO:0014069; GO:0015629; GO:0017075; GO:0017148; GO:0035556; GO:0042802; GO:0043065; GO:0043066; GO:0071346; GO:0071447; GO:0097190; GO:0098978; GO:0106310; GO:1902042; GO:1904094; GO:1990722; GO:2000310 apoptotic process [GO:0006915]; apoptotic signaling pathway [GO:0097190]; cellular response to hydroperoxide [GO:0071447]; cellular response to type II interferon [GO:0071346]; defense response to tumor cell [GO:0002357]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; negative regulation of translation [GO:0017148]; positive regulation of apoptotic process [GO:0043065]; positive regulation of autophagic cell death [GO:1904094]; positive regulation of autophagy [GO:0010508]; protein phosphorylation [GO:0006468]; regulation of NMDA receptor activity [GO:2000310]; regulation of response to tumor cell [GO:0002834] actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; DAPK1-calmodulin complex [GO:1990722]; glutamatergic synapse [GO:0098978]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069] ATP binding [GO:0005524]; calcium/calmodulin-dependent protein kinase activity [GO:0004683]; calmodulin binding [GO:0005516]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; syntaxin-1 binding [GO:0017075] g9246.t1 Q5U2P0 54.175 1054 0.0 1087.0 sp|Q5U2P0|DI3L1_RAT DIS3-like exonuclease 1 OS=Rattus norvegicus OX=10116 GN=Dis3l PE=2 SV=2 DI3L1_RAT reviewed DIS3-like exonuclease 1 (EC 3.1.13.1) Rattus norvegicus (Rat) GO:0000175; GO:0000177; GO:0003723; GO:0005813; GO:0005829; GO:0005886; GO:0006396; GO:0006401; GO:0006402; GO:0008859; GO:0016075; GO:0019899; GO:0036064 mRNA catabolic process [GO:0006402]; RNA catabolic process [GO:0006401]; RNA processing [GO:0006396]; rRNA catabolic process [GO:0016075] centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasmic exosome (RNase complex) [GO:0000177]; cytosol [GO:0005829]; plasma membrane [GO:0005886] 3'-5'-RNA exonuclease activity [GO:0000175]; enzyme binding [GO:0019899]; exoribonuclease II activity [GO:0008859]; RNA binding [GO:0003723] g9247.t1 Q5QJU3 47.71 262 6.1e-91 273.0 sp|Q5QJU3|ACER2_HUMAN Alkaline ceramidase 2 OS=Homo sapiens OX=9606 GN=ACER2 PE=1 SV=2 ACER2_HUMAN reviewed Alkaline ceramidase 2 (AlkCDase 2) (Alkaline CDase 2) (haCER2) (EC 3.5.1.-) (EC 3.5.1.23) (Acylsphingosine deacylase 3-like) (N-acylsphingosine amidohydrolase 3-like) Homo sapiens (Human) GO:0000139; GO:0001953; GO:0005794; GO:0006974; GO:0008284; GO:0010506; GO:0010559; GO:0017040; GO:0030149; GO:0030330; GO:0032526; GO:0033629; GO:0042981; GO:0046512; GO:0046514; GO:0046872; GO:0071466 cellular response to xenobiotic stimulus [GO:0071466]; ceramide catabolic process [GO:0046514]; DNA damage response [GO:0006974]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; negative regulation of cell adhesion mediated by integrin [GO:0033629]; negative regulation of cell-matrix adhesion [GO:0001953]; positive regulation of cell population proliferation [GO:0008284]; regulation of apoptotic process [GO:0042981]; regulation of autophagy [GO:0010506]; regulation of glycoprotein biosynthetic process [GO:0010559]; response to retinoic acid [GO:0032526]; sphingolipid catabolic process [GO:0030149]; sphingosine biosynthetic process [GO:0046512] Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139] metal ion binding [GO:0046872]; N-acylsphingosine amidohydrolase activity [GO:0017040] g9248.t1 Q9UGJ1 55.835 677 0.0 712.0 sp|Q9UGJ1|GCP4_HUMAN Gamma-tubulin complex component 4 OS=Homo sapiens OX=9606 GN=TUBGCP4 PE=1 SV=1 GCP4_HUMAN reviewed Gamma-tubulin complex component 4 (GCP-4) (hGCP4) (Gamma-ring complex protein 76 kDa) (h76p) (hGrip76) Homo sapiens (Human) GO:0000278; GO:0000922; GO:0000930; GO:0000931; GO:0005200; GO:0005813; GO:0005829; GO:0005874; GO:0007020; GO:0015630; GO:0016020; GO:0031122; GO:0043015; GO:0051225; GO:0051321; GO:0055037; GO:0065003 cytoplasmic microtubule organization [GO:0031122]; meiotic cell cycle [GO:0051321]; microtubule nucleation [GO:0007020]; mitotic cell cycle [GO:0000278]; protein-containing complex assembly [GO:0065003]; spindle assembly [GO:0051225] centrosome [GO:0005813]; cytosol [GO:0005829]; gamma-tubulin complex [GO:0000930]; gamma-tubulin ring complex [GO:0000931]; membrane [GO:0016020]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; recycling endosome [GO:0055037]; spindle pole [GO:0000922] gamma-tubulin binding [GO:0043015]; structural constituent of cytoskeleton [GO:0005200] g9249.t1 P70399 34.286 525 7.64e-58 226.0 sp|P70399|TP53B_MOUSE TP53-binding protein 1 OS=Mus musculus OX=10090 GN=Tp53bp1 PE=1 SV=3 TP53B_MOUSE reviewed TP53-binding protein 1 (53BP1) (p53-binding protein 1) (p53BP1) Mus musculus (Mouse) GO:0000077; GO:0000776; GO:0000781; GO:0002039; GO:0003684; GO:0003712; GO:0003713; GO:0005634; GO:0005654; GO:0005657; GO:0005737; GO:0006281; GO:0006302; GO:0006303; GO:0006355; GO:0006974; GO:0016604; GO:0035861; GO:0042162; GO:0042393; GO:0043565; GO:0045830; GO:0045944; GO:0051260; GO:0061629; GO:0061649; GO:0071481; GO:0097680; GO:0110025; GO:0110027; GO:0140005; GO:0140566; GO:0140941; GO:1902255; GO:1990166; GO:1990391; GO:2000042 cellular response to X-ray [GO:0071481]; DNA damage checkpoint signaling [GO:0000077]; DNA damage response [GO:0006974]; DNA repair [GO:0006281]; DNA strand resection involved in replication fork processing [GO:0110025]; double-strand break repair [GO:0006302]; double-strand break repair via classical nonhomologous end joining [GO:0097680]; double-strand break repair via nonhomologous end joining [GO:0006303]; negative regulation of DNA strand resection involved in replication fork processing [GO:0110027]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator [GO:1902255]; positive regulation of isotype switching [GO:0045830]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein homooligomerization [GO:0051260]; protein localization to site of double-strand break [GO:1990166]; regulation of DNA-templated transcription [GO:0006355] chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; DNA repair complex [GO:1990391]; kinetochore [GO:0000776]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; replication fork [GO:0005657]; site of double-strand break [GO:0035861] damaged DNA binding [GO:0003684]; histone binding [GO:0042393]; histone H4K20me methyltransferase activity [GO:0140941]; histone H4K20me2 reader activity [GO:0140005]; histone reader activity [GO:0140566]; p53 binding [GO:0002039]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific DNA binding [GO:0043565]; telomeric DNA binding [GO:0042162]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; ubiquitin-modified histone reader activity [GO:0061649] g9249.t2 P70399 34.286 525 3.14e-58 228.0 sp|P70399|TP53B_MOUSE TP53-binding protein 1 OS=Mus musculus OX=10090 GN=Tp53bp1 PE=1 SV=3 TP53B_MOUSE reviewed TP53-binding protein 1 (53BP1) (p53-binding protein 1) (p53BP1) Mus musculus (Mouse) GO:0000077; GO:0000776; GO:0000781; GO:0002039; GO:0003684; GO:0003712; GO:0003713; GO:0005634; GO:0005654; GO:0005657; GO:0005737; GO:0006281; GO:0006302; GO:0006303; GO:0006355; GO:0006974; GO:0016604; GO:0035861; GO:0042162; GO:0042393; GO:0043565; GO:0045830; GO:0045944; GO:0051260; GO:0061629; GO:0061649; GO:0071481; GO:0097680; GO:0110025; GO:0110027; GO:0140005; GO:0140566; GO:0140941; GO:1902255; GO:1990166; GO:1990391; GO:2000042 cellular response to X-ray [GO:0071481]; DNA damage checkpoint signaling [GO:0000077]; DNA damage response [GO:0006974]; DNA repair [GO:0006281]; DNA strand resection involved in replication fork processing [GO:0110025]; double-strand break repair [GO:0006302]; double-strand break repair via classical nonhomologous end joining [GO:0097680]; double-strand break repair via nonhomologous end joining [GO:0006303]; negative regulation of DNA strand resection involved in replication fork processing [GO:0110027]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator [GO:1902255]; positive regulation of isotype switching [GO:0045830]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein homooligomerization [GO:0051260]; protein localization to site of double-strand break [GO:1990166]; regulation of DNA-templated transcription [GO:0006355] chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; DNA repair complex [GO:1990391]; kinetochore [GO:0000776]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; replication fork [GO:0005657]; site of double-strand break [GO:0035861] damaged DNA binding [GO:0003684]; histone binding [GO:0042393]; histone H4K20me methyltransferase activity [GO:0140941]; histone H4K20me2 reader activity [GO:0140005]; histone reader activity [GO:0140566]; p53 binding [GO:0002039]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific DNA binding [GO:0043565]; telomeric DNA binding [GO:0042162]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; ubiquitin-modified histone reader activity [GO:0061649] g9249.t3 Q12888 40.711 253 2.0299999999999998e-48 195.0 sp|Q12888|TP53B_HUMAN TP53-binding protein 1 OS=Homo sapiens OX=9606 GN=TP53BP1 PE=1 SV=2 TP53B_HUMAN reviewed TP53-binding protein 1 (53BP1) (p53-binding protein 1) (p53BP1) Homo sapiens (Human) GO:0000077; GO:0000776; GO:0000781; GO:0002039; GO:0003684; GO:0003712; GO:0003713; GO:0005634; GO:0005654; GO:0005657; GO:0005737; GO:0006303; GO:0006974; GO:0016604; GO:0035861; GO:0042162; GO:0042393; GO:0045830; GO:0045893; GO:0045944; GO:0051260; GO:0061629; GO:0061649; GO:0071481; GO:0097680; GO:0140005; GO:0140566; GO:0140941; GO:1902255; GO:1990166; GO:1990391; GO:2000042 cellular response to X-ray [GO:0071481]; DNA damage checkpoint signaling [GO:0000077]; DNA damage response [GO:0006974]; double-strand break repair via classical nonhomologous end joining [GO:0097680]; double-strand break repair via nonhomologous end joining [GO:0006303]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator [GO:1902255]; positive regulation of isotype switching [GO:0045830]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein homooligomerization [GO:0051260]; protein localization to site of double-strand break [GO:1990166] chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; DNA repair complex [GO:1990391]; kinetochore [GO:0000776]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; replication fork [GO:0005657]; site of double-strand break [GO:0035861] damaged DNA binding [GO:0003684]; histone binding [GO:0042393]; histone H4K20me methyltransferase activity [GO:0140941]; histone H4K20me2 reader activity [GO:0140005]; histone reader activity [GO:0140566]; p53 binding [GO:0002039]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; telomeric DNA binding [GO:0042162]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; ubiquitin-modified histone reader activity [GO:0061649] g9250.t1 Q96B86 39.173 411 1.2799999999999999e-82 265.0 sp|Q96B86|RGMA_HUMAN Repulsive guidance molecule A OS=Homo sapiens OX=9606 GN=RGMA PE=1 SV=4 g9252.t1 Q91YI6 43.902 328 2.46e-72 244.0 sp|Q91YI6|GLD2_MOUSE Poly(A) RNA polymerase GLD2 OS=Mus musculus OX=10090 GN=Tent2 PE=1 SV=1 GLD2_MOUSE reviewed Poly(A) RNA polymerase GLD2 (mGLD-2) (EC 2.7.7.19) (PAP-associated domain-containing protein 4) (Terminal nucleotidyltransferase 2) Mus musculus (Mouse) GO:0002244; GO:0005524; GO:0005634; GO:0005737; GO:0031123; GO:0031124; GO:0046872; GO:0071044; GO:0090314; GO:0098794; GO:0098978; GO:0099170; GO:0140235; GO:0140240; GO:0140245; GO:0140958; GO:1990817; GO:2000626 hematopoietic progenitor cell differentiation [GO:0002244]; histone mRNA catabolic process [GO:0071044]; mRNA 3'-end processing [GO:0031124]; negative regulation of miRNA catabolic process [GO:2000626]; positive regulation of protein targeting to membrane [GO:0090314]; postsynaptic modulation of chemical synaptic transmission [GO:0099170]; regulation of translation at postsynapse [GO:0140245]; RNA 3'-end processing [GO:0031123]; RNA polyadenylation at postsynapse [GO:0140235]; target-directed miRNA degradation [GO:0140958] cytoplasm [GO:0005737]; glutamatergic synapse [GO:0098978]; nucleus [GO:0005634]; perforant pathway to dendrate granule cell synapse [GO:0140240]; postsynapse [GO:0098794] ATP binding [GO:0005524]; metal ion binding [GO:0046872]; poly(A) RNA polymerase activity [GO:1990817] g9253.t1 Q92900 73.684 1007 0.0 1508.0 sp|Q92900|RENT1_HUMAN Regulator of nonsense transcripts 1 OS=Homo sapiens OX=9606 GN=UPF1 PE=1 SV=2 RENT1_HUMAN reviewed Regulator of nonsense transcripts 1 (EC 3.6.4.12) (EC 3.6.4.13) (ATP-dependent helicase RENT1) (Nonsense mRNA reducing factor 1) (NORF1) (Up-frameshift suppressor 1 homolog) (hUpf1) Homo sapiens (Human) GO:0000184; GO:0000781; GO:0000785; GO:0000932; GO:0000956; GO:0003682; GO:0003723; GO:0003724; GO:0004386; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006260; GO:0006281; GO:0006406; GO:0006449; GO:0008270; GO:0016887; GO:0032201; GO:0032204; GO:0035145; GO:0036121; GO:0042162; GO:0044530; GO:0044770; GO:0044877; GO:0048471; GO:0060816; GO:0061014; GO:0061158; GO:0071044; GO:0071222; GO:0071347; GO:1905746 3'-UTR-mediated mRNA destabilization [GO:0061158]; cell cycle phase transition [GO:0044770]; cellular response to interleukin-1 [GO:0071347]; cellular response to lipopolysaccharide [GO:0071222]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; histone mRNA catabolic process [GO:0071044]; mRNA export from nucleus [GO:0006406]; nuclear-transcribed mRNA catabolic process [GO:0000956]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; positive regulation of mRNA catabolic process [GO:0061014]; positive regulation of mRNA cis splicing, via spliceosome [GO:1905746]; random inactivation of X chromosome [GO:0060816]; regulation of telomere maintenance [GO:0032204]; regulation of translational termination [GO:0006449]; telomere maintenance via semi-conservative replication [GO:0032201] chromatin [GO:0000785]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; exon-exon junction complex [GO:0035145]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; perinuclear region of cytoplasm [GO:0048471]; supraspliceosomal complex [GO:0044530] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; chromatin binding [GO:0003682]; double-stranded DNA helicase activity [GO:0036121]; helicase activity [GO:0004386]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; telomeric DNA binding [GO:0042162]; zinc ion binding [GO:0008270] g9254.t1 O01727 81.967 244 2.06e-146 411.0 sp|O01727|RS6_BRAFL Small ribosomal subunit protein eS6 OS=Branchiostoma floridae OX=7739 GN=RPS6 PE=3 SV=1 g9257.t1 Q16566 61.922 281 1.44e-128 379.0 sp|Q16566|KCC4_HUMAN Calcium/calmodulin-dependent protein kinase type IV OS=Homo sapiens OX=9606 GN=CAMK4 PE=1 SV=1 KCC4_HUMAN reviewed Calcium/calmodulin-dependent protein kinase type IV (CaMK IV) (EC 2.7.11.17) (CaM kinase-GR) Homo sapiens (Human) GO:0001650; GO:0002250; GO:0004683; GO:0005516; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005783; GO:0006468; GO:0006954; GO:0007165; GO:0007616; GO:0009931; GO:0033081; GO:0035556; GO:0043011; GO:0045670; GO:0045893; GO:0070062; GO:0106310 adaptive immune response [GO:0002250]; inflammatory response [GO:0006954]; intracellular signal transduction [GO:0035556]; long-term memory [GO:0007616]; myeloid dendritic cell differentiation [GO:0043011]; positive regulation of DNA-templated transcription [GO:0045893]; protein phosphorylation [GO:0006468]; regulation of osteoclast differentiation [GO:0045670]; regulation of T cell differentiation in thymus [GO:0033081]; signal transduction [GO:0007165] cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] ATP binding [GO:0005524]; calcium-dependent protein serine/threonine kinase activity [GO:0009931]; calcium/calmodulin-dependent protein kinase activity [GO:0004683]; calmodulin binding [GO:0005516]; protein serine kinase activity [GO:0106310] g9263.t1 Q92733 51.304 115 6.23e-30 124.0 sp|Q92733|PRCC_HUMAN Proline-rich protein PRCC OS=Homo sapiens OX=9606 GN=PRCC PE=1 SV=1 PRCC_HUMAN reviewed Proline-rich protein PRCC (Papillary renal cell carcinoma translocation-associated gene protein) Homo sapiens (Human) GO:0005634; GO:0005654; GO:0016607; GO:0051726 regulation of cell cycle [GO:0051726] nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] g9268.t1 P10669 38.851 296 3.73e-58 197.0 sp|P10669|FST_PIG Follistatin OS=Sus scrofa OX=9823 GN=FST PE=1 SV=1 g9270.t1 Q95R48 37.818 550 5.1e-116 358.0 sp|Q95R48|OCTL_DROME Organic cation transporter-like protein OS=Drosophila melanogaster OX=7227 GN=Orct2 PE=2 SV=2 g9272.t1 A5D7U4 34.076 314 2.7e-41 164.0 sp|A5D7U4|SCNNB_BOVIN Epithelial sodium channel subunit beta OS=Bos taurus OX=9913 GN=SCNN1B PE=2 SV=1 SCNNB_BOVIN reviewed Epithelial sodium channel subunit beta (Amiloride-sensitive sodium channel subunit beta) (Beta-NaCH) (Epithelial Na(+) channel subunit beta) (Beta-ENaC) (Nonvoltage-gated sodium channel 1 subunit beta) (SCNEB) Bos taurus (Bovine) GO:0005886; GO:0006883; GO:0015280; GO:0016324; GO:0030659; GO:0034706; GO:0035725; GO:0050699; GO:0098719 intracellular sodium ion homeostasis [GO:0006883]; sodium ion import across plasma membrane [GO:0098719]; sodium ion transmembrane transport [GO:0035725] apical plasma membrane [GO:0016324]; cytoplasmic vesicle membrane [GO:0030659]; plasma membrane [GO:0005886]; sodium channel complex [GO:0034706] ligand-gated sodium channel activity [GO:0015280]; WW domain binding [GO:0050699] g9273.t1 O97742 32.986 288 2.86e-33 140.0 sp|O97742|SCNNB_RABIT Epithelial sodium channel subunit beta OS=Oryctolagus cuniculus OX=9986 GN=SCNN1B PE=2 SV=1 g9274.t1 O13262 35.694 353 1.1699999999999999e-52 193.0 sp|O13262|SCNNC_XENLA Epithelial sodium channel subunit beta-2 OS=Xenopus laevis OX=8355 GN=scnn1b-b PE=1 SV=1 g9276.t1 Q13972 51.342 857 0.0 767.0 sp|Q13972|RGRF1_HUMAN Ras-specific guanine nucleotide-releasing factor 1 OS=Homo sapiens OX=9606 GN=RASGRF1 PE=1 SV=2 RGRF1_HUMAN reviewed Ras-specific guanine nucleotide-releasing factor 1 (Ras-GRF1) (Guanine nucleotide-releasing protein) (GNRP) (Ras-specific nucleotide exchange factor CDC25) Homo sapiens (Human) GO:0005085; GO:0005829; GO:0005886; GO:0007165; GO:0007265; GO:0007616; GO:0030426; GO:0031175; GO:0034976; GO:0035022; GO:0035254; GO:0043005; GO:0043409; GO:0043410; GO:0044342; GO:0046578; GO:0046579; GO:0048167; GO:0048168 long-term memory [GO:0007616]; negative regulation of MAPK cascade [GO:0043409]; neuron projection development [GO:0031175]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of Rac protein signal transduction [GO:0035022]; positive regulation of Ras protein signal transduction [GO:0046579]; Ras protein signal transduction [GO:0007265]; regulation of neuronal synaptic plasticity [GO:0048168]; regulation of Ras protein signal transduction [GO:0046578]; regulation of synaptic plasticity [GO:0048167]; response to endoplasmic reticulum stress [GO:0034976]; signal transduction [GO:0007165]; type B pancreatic cell proliferation [GO:0044342] cytosol [GO:0005829]; growth cone [GO:0030426]; neuron projection [GO:0043005]; plasma membrane [GO:0005886] glutamate receptor binding [GO:0035254]; guanyl-nucleotide exchange factor activity [GO:0005085] g9276.t1 Q13972 57.53 332 1.99e-111 383.0 sp|Q13972|RGRF1_HUMAN Ras-specific guanine nucleotide-releasing factor 1 OS=Homo sapiens OX=9606 GN=RASGRF1 PE=1 SV=2 RGRF1_HUMAN reviewed Ras-specific guanine nucleotide-releasing factor 1 (Ras-GRF1) (Guanine nucleotide-releasing protein) (GNRP) (Ras-specific nucleotide exchange factor CDC25) Homo sapiens (Human) GO:0005085; GO:0005829; GO:0005886; GO:0007165; GO:0007265; GO:0007616; GO:0030426; GO:0031175; GO:0034976; GO:0035022; GO:0035254; GO:0043005; GO:0043409; GO:0043410; GO:0044342; GO:0046578; GO:0046579; GO:0048167; GO:0048168 long-term memory [GO:0007616]; negative regulation of MAPK cascade [GO:0043409]; neuron projection development [GO:0031175]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of Rac protein signal transduction [GO:0035022]; positive regulation of Ras protein signal transduction [GO:0046579]; Ras protein signal transduction [GO:0007265]; regulation of neuronal synaptic plasticity [GO:0048168]; regulation of Ras protein signal transduction [GO:0046578]; regulation of synaptic plasticity [GO:0048167]; response to endoplasmic reticulum stress [GO:0034976]; signal transduction [GO:0007165]; type B pancreatic cell proliferation [GO:0044342] cytosol [GO:0005829]; growth cone [GO:0030426]; neuron projection [GO:0043005]; plasma membrane [GO:0005886] glutamate receptor binding [GO:0035254]; guanyl-nucleotide exchange factor activity [GO:0005085] g9282.t1 P29119 66.845 374 6.219999999999999e-176 513.0 sp|P29119|FURI1_XENLA Furin-1 OS=Xenopus laevis OX=8355 GN=furin PE=2 SV=1 g9283.t1 P16519 44.586 157 1.2299999999999999e-40 147.0 sp|P16519|NEC2_HUMAN Neuroendocrine convertase 2 OS=Homo sapiens OX=9606 GN=PCSK2 PE=1 SV=2 NEC2_HUMAN reviewed Neuroendocrine convertase 2 (NEC 2) (EC 3.4.21.94) (KEX2-like endoprotease 2) (Prohormone convertase 2) (Proprotein convertase 2) (PC2) Homo sapiens (Human) GO:0004252; GO:0005615; GO:0005654; GO:0006508; GO:0007399; GO:0016020; GO:0016486; GO:0016540; GO:0030070; GO:0030133; GO:0030141; GO:0034230; GO:0034231; GO:0043005 enkephalin processing [GO:0034230]; insulin processing [GO:0030070]; islet amyloid polypeptide processing [GO:0034231]; nervous system development [GO:0007399]; peptide hormone processing [GO:0016486]; protein autoprocessing [GO:0016540]; proteolysis [GO:0006508] extracellular space [GO:0005615]; membrane [GO:0016020]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; secretory granule [GO:0030141]; transport vesicle [GO:0030133] serine-type endopeptidase activity [GO:0004252] g9284.t1 Q4QR88 47.853 163 1.2899999999999999e-45 164.0 sp|Q4QR88|TIPIN_RAT TIMELESS-interacting protein OS=Rattus norvegicus OX=10116 GN=Tipin PE=2 SV=1 TIPIN_RAT reviewed TIMELESS-interacting protein Rattus norvegicus (Rat) GO:0000076; GO:0000077; GO:0000785; GO:0003677; GO:0005634; GO:0005737; GO:0008284; GO:0009411; GO:0031297; GO:0031298; GO:0031573; GO:0043111; GO:0044770; GO:0051301 cell cycle phase transition [GO:0044770]; cell division [GO:0051301]; DNA damage checkpoint signaling [GO:0000077]; DNA replication checkpoint signaling [GO:0000076]; mitotic intra-S DNA damage checkpoint signaling [GO:0031573]; positive regulation of cell population proliferation [GO:0008284]; replication fork arrest [GO:0043111]; replication fork processing [GO:0031297]; response to UV [GO:0009411] chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; replication fork protection complex [GO:0031298] DNA binding [GO:0003677] g9285.t1 Q8IV33 26.513 909 9.39e-62 236.0 sp|Q8IV33|K0825_HUMAN Uncharacterized protein KIAA0825 OS=Homo sapiens OX=9606 GN=KIAA0825 PE=1 SV=3 g9286.t1 Q9Y6G5 56.566 198 4.23e-67 207.0 sp|Q9Y6G5|COMDA_HUMAN COMM domain-containing protein 10 OS=Homo sapiens OX=9606 GN=COMMD10 PE=1 SV=1 g9288.t1 Q5R7F5 40.803 473 1.6499999999999998e-94 313.0 sp|Q5R7F5|SEM6D_PONAB Semaphorin-6D OS=Pongo abelii OX=9601 GN=SEMA6D PE=2 SV=1 SEM6D_PONAB reviewed Semaphorin-6D Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0001755; GO:0002291; GO:0005886; GO:0007411; GO:0030215; GO:0030335; GO:0045499; GO:0048018; GO:0071526 axon guidance [GO:0007411]; neural crest cell migration [GO:0001755]; positive regulation of cell migration [GO:0030335]; semaphorin-plexin signaling pathway [GO:0071526]; T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell [GO:0002291] plasma membrane [GO:0005886] chemorepellent activity [GO:0045499]; receptor ligand activity [GO:0048018]; semaphorin receptor binding [GO:0030215] g9290.t1 Q96DM1 22.509 542 7.42e-33 138.0 sp|Q96DM1|PGBD4_HUMAN PiggyBac transposable element-derived protein 4 OS=Homo sapiens OX=9606 GN=PGBD4 PE=1 SV=3 g9297.t1 Q91ZU0 56.721 305 3.65e-123 359.0 sp|Q91ZU0|ASB7_MOUSE Ankyrin repeat and SOCS box protein 7 OS=Mus musculus OX=10090 GN=Asb7 PE=2 SV=2 ASB7_MOUSE reviewed Ankyrin repeat and SOCS box protein 7 (ASB-7) Mus musculus (Mouse) GO:0000212; GO:0000792; GO:0001556; GO:0005634; GO:0005737; GO:0007010; GO:0008608; GO:0016567; GO:0030866; GO:0031466; GO:0035556; GO:0043161; GO:0051276; GO:0051310; GO:0051321; GO:0090306; GO:0120261; GO:1990756 attachment of spindle microtubules to kinetochore [GO:0008608]; chromosome organization [GO:0051276]; cortical actin cytoskeleton organization [GO:0030866]; cytoskeleton organization [GO:0007010]; intracellular signal transduction [GO:0035556]; meiotic cell cycle [GO:0051321]; meiotic spindle assembly [GO:0090306]; meiotic spindle organization [GO:0000212]; metaphase chromosome alignment [GO:0051310]; oocyte maturation [GO:0001556]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of heterochromatin organization [GO:0120261] Cul5-RING ubiquitin ligase complex [GO:0031466]; cytoplasm [GO:0005737]; heterochromatin [GO:0000792]; nucleus [GO:0005634] ubiquitin-like ligase-substrate adaptor activity [GO:1990756] g9298.t1 Q29041 46.46 226 3.5e-53 181.0 sp|Q29041|FCN2_PIG Ficolin-2 OS=Sus scrofa OX=9823 GN=FCN2 PE=1 SV=1 FCN2_PIG reviewed Ficolin-2 (Collagen/fibrinogen domain-containing protein 2) (Ficolin-B) (Ficolin-beta) (L-ficolin) Sus scrofa (Pig) GO:0001867; GO:0003823; GO:0005102; GO:0005581; GO:0005615; GO:0030246; GO:0038187; GO:0046872; GO:0070892; GO:0097367; GO:0106139 complement activation, lectin pathway [GO:0001867] collagen trimer [GO:0005581]; extracellular space [GO:0005615]; symbiont cell surface [GO:0106139] antigen binding [GO:0003823]; carbohydrate binding [GO:0030246]; carbohydrate derivative binding [GO:0097367]; lipoteichoic acid immune receptor activity [GO:0070892]; metal ion binding [GO:0046872]; pattern recognition receptor activity [GO:0038187]; signaling receptor binding [GO:0005102] g9299.t1 Q29042 46.977 215 3.3199999999999995e-54 183.0 sp|Q29042|FCN1_PIG Ficolin-1 OS=Sus scrofa OX=9823 GN=FCN1 PE=1 SV=1 FCN1_PIG reviewed Ficolin-1 (Ficolin-A) (Ficolin-alpha) Sus scrofa (Pig) GO:0001867; GO:0003823; GO:0005102; GO:0005581; GO:0005615; GO:0005886; GO:0030246; GO:0033691; GO:0038187; GO:0046872; GO:0097367; GO:0106139 complement activation, lectin pathway [GO:0001867] collagen trimer [GO:0005581]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; symbiont cell surface [GO:0106139] antigen binding [GO:0003823]; carbohydrate binding [GO:0030246]; carbohydrate derivative binding [GO:0097367]; metal ion binding [GO:0046872]; pattern recognition receptor activity [GO:0038187]; sialic acid binding [GO:0033691]; signaling receptor binding [GO:0005102] g9300.t1 A8DYE2 43.265 1225 0.0 942.0 sp|A8DYE2|TRPCG_DROME Transient receptor potential cation channel trpm OS=Drosophila melanogaster OX=7227 GN=Trpm PE=1 SV=1 TRPCG_DROME reviewed Transient receptor potential cation channel trpm (Transient receptor potential cation channel, subfamily M ortholog) Drosophila melanogaster (Fruit fly) GO:0005261; GO:0005385; GO:0005886; GO:0006882; GO:0010960; GO:0022890; GO:0030001; GO:0034703; GO:0051262; GO:0097682; GO:0098655 intracellular zinc ion homeostasis [GO:0006882]; magnesium ion homeostasis [GO:0010960]; metal ion transport [GO:0030001]; monoatomic cation transmembrane transport [GO:0098655]; protein tetramerization [GO:0051262] cation channel complex [GO:0034703]; plasma membrane [GO:0005886] inorganic cation transmembrane transporter activity [GO:0022890]; intracellularly phosphatidylinositol-3,5-bisphosphate-gated monatomic cation channel activity [GO:0097682]; monoatomic cation channel activity [GO:0005261]; zinc ion transmembrane transporter activity [GO:0005385] g9301.t1 Q6ZS82 41.875 160 2.4900000000000002e-29 112.0 sp|Q6ZS82|R9BP_HUMAN Regulator of G-protein signaling 9-binding protein OS=Homo sapiens OX=9606 GN=RGS9BP PE=1 SV=1 g9303.t1 Q9UMX0 58.609 302 6.7e-102 323.0 sp|Q9UMX0|UBQL1_HUMAN Ubiquilin-1 OS=Homo sapiens OX=9606 GN=UBQLN1 PE=1 SV=2 UBQL1_HUMAN reviewed Ubiquilin-1 (Protein linking IAP with cytoskeleton 1) (PLIC-1) (hPLIC-1) Homo sapiens (Human) GO:0000045; GO:0000502; GO:0005654; GO:0005737; GO:0005776; GO:0005783; GO:0005829; GO:0005886; GO:0006511; GO:0016235; GO:0016236; GO:0016241; GO:0019900; GO:0031396; GO:0031398; GO:0031410; GO:0031593; GO:0032991; GO:0034140; GO:0034976; GO:0035973; GO:0036503; GO:0042802; GO:0048471; GO:0071456; GO:0097352; GO:1901340; GO:1902175; GO:1904294 aggrephagy [GO:0035973]; autophagosome assembly [GO:0000045]; autophagosome maturation [GO:0097352]; cellular response to hypoxia [GO:0071456]; ERAD pathway [GO:0036503]; macroautophagy [GO:0016236]; negative regulation of store-operated calcium channel activity [GO:1901340]; negative regulation of toll-like receptor 3 signaling pathway [GO:0034140]; positive regulation of ERAD pathway [GO:1904294]; positive regulation of protein ubiquitination [GO:0031398]; regulation of macroautophagy [GO:0016241]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; regulation of protein ubiquitination [GO:0031396]; response to endoplasmic reticulum stress [GO:0034976]; ubiquitin-dependent protein catabolic process [GO:0006511] aggresome [GO:0016235]; autophagosome [GO:0005776]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; proteasome complex [GO:0000502]; protein-containing complex [GO:0032991] identical protein binding [GO:0042802]; kinase binding [GO:0019900]; polyubiquitin modification-dependent protein binding [GO:0031593] g9304.t1 Q6PB70 52.743 474 2.18e-148 465.0 sp|Q6PB70|ANO8_MOUSE Anoctamin-8 OS=Mus musculus OX=10090 GN=Ano8 PE=1 SV=3 ANO8_MOUSE reviewed Anoctamin-8 (Transmembrane protein 16H) Mus musculus (Mouse) GO:0005229; GO:0005254; GO:0005886; GO:1902476 chloride transmembrane transport [GO:1902476] plasma membrane [GO:0005886] chloride channel activity [GO:0005254]; intracellularly calcium-gated chloride channel activity [GO:0005229] g9306.t1 P24524 47.115 312 9.2e-86 275.0 sp|P24524|GLRA3_RAT Glycine receptor subunit alpha-3 OS=Rattus norvegicus OX=10116 GN=Glra3 PE=1 SV=1 GLRA3_RAT reviewed Glycine receptor subunit alpha-3 Rattus norvegicus (Rat) GO:0004888; GO:0005231; GO:0005886; GO:0016594; GO:0016934; GO:0016935; GO:0022852; GO:0030425; GO:0042734; GO:0043204; GO:0046872; GO:0051260; GO:0071230; GO:0071294; GO:0071361; GO:0097688; GO:0098690; GO:0098978; GO:0098982; GO:0099171; GO:0099634; GO:1902476 cellular response to amino acid stimulus [GO:0071230]; cellular response to ethanol [GO:0071361]; cellular response to zinc ion [GO:0071294]; chloride transmembrane transport [GO:1902476]; glutamate receptor clustering [GO:0097688]; presynaptic modulation of chemical synaptic transmission [GO:0099171]; protein homooligomerization [GO:0051260] dendrite [GO:0030425]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; glycine-gated chloride channel complex [GO:0016935]; glycinergic synapse [GO:0098690]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic specialization membrane [GO:0099634]; presynaptic membrane [GO:0042734] excitatory extracellular ligand-gated monoatomic ion channel activity [GO:0005231]; extracellularly glycine-gated chloride channel activity [GO:0016934]; glycine binding [GO:0016594]; glycine-gated chloride ion channel activity [GO:0022852]; metal ion binding [GO:0046872]; transmembrane signaling receptor activity [GO:0004888] g9307.t1 P97772 31.99 397 7.07e-41 160.0 sp|P97772|GRM1_MOUSE Metabotropic glutamate receptor 1 OS=Mus musculus OX=10090 GN=Grm1 PE=1 SV=2 g9308.t1 Q14831 25.877 827 1.13e-76 276.0 sp|Q14831|GRM7_HUMAN Metabotropic glutamate receptor 7 OS=Homo sapiens OX=9606 GN=GRM7 PE=1 SV=1 g9308.t1 Q14831 26.708 322 2e-26 121.0 sp|Q14831|GRM7_HUMAN Metabotropic glutamate receptor 7 OS=Homo sapiens OX=9606 GN=GRM7 PE=1 SV=1 g9309.t1 P24049 80.247 162 2.76e-97 282.0 sp|P24049|RL17_RAT Large ribosomal subunit protein uL22 OS=Rattus norvegicus OX=10116 GN=Rpl17 PE=2 SV=3 g9310.t1 Q4R7M4 50.644 233 5.0499999999999994e-74 232.0 sp|Q4R7M4|DTWD2_MACFA tRNA-uridine aminocarboxypropyltransferase 2 OS=Macaca fascicularis OX=9541 GN=DTWD2 PE=2 SV=1 DTWD2_MACFA reviewed tRNA-uridine aminocarboxypropyltransferase 2 (EC 2.5.1.25) (DTW domain-containing protein 2) Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey) GO:0005634; GO:0005737; GO:0006400; GO:0016432; GO:0141217 glycoRNA biosynthetic process [GO:0141217]; tRNA modification [GO:0006400] cytoplasm [GO:0005737]; nucleus [GO:0005634] tRNA-uridine aminocarboxypropyltransferase activity [GO:0016432] g9311.t1 Q866N2 37.069 232 1.3500000000000002e-32 136.0 sp|Q866N2|MYOC_RABIT Myocilin OS=Oryctolagus cuniculus OX=9986 GN=MYOC PE=1 SV=1 g9311.t2 Q866N2 37.069 232 1.36e-32 136.0 sp|Q866N2|MYOC_RABIT Myocilin OS=Oryctolagus cuniculus OX=9986 GN=MYOC PE=1 SV=1 g9319.t1 A2RU49 29.455 404 1.43e-55 190.0 sp|A2RU49|HYKK_HUMAN Hydroxylysine kinase OS=Homo sapiens OX=9606 GN=HYKK PE=1 SV=2 HYKK_HUMAN reviewed Hydroxylysine kinase (5-hydroxy-L-lysine kinase) (EC 2.7.1.81) (Aminoglycoside phosphotransferase domain-containing protein 1) Homo sapiens (Human) GO:0005759; GO:0006554; GO:0019202; GO:0047992 lysine catabolic process [GO:0006554] mitochondrial matrix [GO:0005759] amino acid kinase activity [GO:0019202]; hydroxylysine kinase activity [GO:0047992] g9320.t1 Q6PB06 34.01 394 1.43e-58 199.0 sp|Q6PB06|HYKK_XENLA Hydroxylysine kinase OS=Xenopus laevis OX=8355 GN=hykk PE=2 SV=1 g9321.t1 Q4V9P6 53.276 351 7.68e-125 365.0 sp|Q4V9P6|ADAL_DANRE N6-Methyl-AMP deaminase OS=Danio rerio OX=7955 GN=mapda PE=2 SV=1 ADAL_DANRE reviewed N6-Methyl-AMP deaminase (EC 3.5.4.-) (Adenosine deaminase-like protein) (N6,N6-dimethyl-AMP deaminase) (EC 3.5.4.-) (N6-isopentenyl-AMP deaminase) (EC 3.5.4.-) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0004000; GO:0006154; GO:0009117; GO:0043010; GO:0046103; GO:0046872; GO:0062154 adenosine catabolic process [GO:0006154]; camera-type eye development [GO:0043010]; inosine biosynthetic process [GO:0046103]; nucleotide metabolic process [GO:0009117] adenosine deaminase activity [GO:0004000]; metal ion binding [GO:0046872]; N6-methyl-AMP deaminase activity [GO:0062154] g9322.t1 Q9D0A0 73.937 541 0.0 776.0 sp|Q9D0A0|DET1_MOUSE DET1 homolog OS=Mus musculus OX=10090 GN=Det1 PE=2 SV=2 g9324.t1 Q5ZIQ3 48.352 182 2.33e-41 155.0 sp|Q5ZIQ3|HNRPK_CHICK Heterogeneous nuclear ribonucleoprotein K OS=Gallus gallus OX=9031 GN=HNRNPK PE=2 SV=1 HNRPK_CHICK reviewed Heterogeneous nuclear ribonucleoprotein K (hnRNP K) Gallus gallus (Chicken) GO:0000785; GO:0003677; GO:0003723; GO:0005634; GO:0005654; GO:0005681; GO:0005737; GO:0006397; GO:0008380; GO:0010629; GO:0042981; GO:0045892; GO:1990904 mRNA processing [GO:0006397]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of gene expression [GO:0010629]; regulation of apoptotic process [GO:0042981]; RNA splicing [GO:0008380] chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; spliceosomal complex [GO:0005681] DNA binding [GO:0003677]; RNA binding [GO:0003723] g9325.t1 P70473 55.319 376 1.19e-139 404.0 sp|P70473|AMACR_RAT Alpha-methylacyl-CoA racemase OS=Rattus norvegicus OX=10116 GN=Amacr PE=1 SV=3 AMACR_RAT reviewed Alpha-methylacyl-CoA racemase (EC 5.1.99.4) (2-arylpropionyl-CoA epimerase) (2-methylacyl-CoA racemase) Rattus norvegicus (Rat) GO:0005102; GO:0005737; GO:0005739; GO:0005777; GO:0005886; GO:0006631; GO:0006699; GO:0008111; GO:0008206 bile acid biosynthetic process [GO:0006699]; bile acid metabolic process [GO:0008206]; fatty acid metabolic process [GO:0006631] cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; peroxisome [GO:0005777]; plasma membrane [GO:0005886] alpha-methylacyl-CoA racemase activity [GO:0008111]; signaling receptor binding [GO:0005102] g9326.t1 Q6AYU1 60.882 340 8e-140 401.0 sp|Q6AYU1|MO4L1_RAT Mortality factor 4-like protein 1 OS=Rattus norvegicus OX=10116 GN=Morf4l1 PE=2 SV=1 g9327.t1 Q5BK68 40.828 338 3.23e-76 244.0 sp|Q5BK68|SNPC3_RAT snRNA-activating protein complex subunit 3 OS=Rattus norvegicus OX=10116 GN=Snapc3 PE=2 SV=1 g9328.t1 Q3UHA3 28.439 1076 5.51e-71 263.0 sp|Q3UHA3|SPTCS_MOUSE Spatacsin OS=Mus musculus OX=10090 GN=Spg11 PE=1 SV=3 SPTCS_MOUSE reviewed Spatacsin (Spastic paraplegia 11 protein homolog) Mus musculus (Mouse) GO:0005730; GO:0005737; GO:0005783; GO:0005829; GO:0005886; GO:0006606; GO:0006886; GO:0007040; GO:0007268; GO:0007409; GO:0007528; GO:0007613; GO:0008088; GO:0008104; GO:0019901; GO:0021957; GO:0030163; GO:0030424; GO:0030425; GO:0031410; GO:0033344; GO:0045202; GO:0047496; GO:0048167; GO:0048489; GO:0048675; GO:0048741; GO:0051402; GO:0061744; GO:0090389; GO:0090659; GO:0097049; GO:1905037; GO:2001256 autophagosome organization [GO:1905037]; axo-dendritic transport [GO:0008088]; axon extension [GO:0048675]; axonogenesis [GO:0007409]; chemical synaptic transmission [GO:0007268]; cholesterol efflux [GO:0033344]; corticospinal tract morphogenesis [GO:0021957]; intracellular protein localization [GO:0008104]; intracellular protein transport [GO:0006886]; lysosome organization [GO:0007040]; memory [GO:0007613]; motor behavior [GO:0061744]; motor neuron apoptotic process [GO:0097049]; neuromuscular junction development [GO:0007528]; neuron apoptotic process [GO:0051402]; phagosome-lysosome fusion involved in apoptotic cell clearance [GO:0090389]; protein catabolic process [GO:0030163]; protein import into nucleus [GO:0006606]; regulation of store-operated calcium entry [GO:2001256]; regulation of synaptic plasticity [GO:0048167]; skeletal muscle fiber development [GO:0048741]; synaptic vesicle transport [GO:0048489]; vesicle transport along microtubule [GO:0047496]; walking behavior [GO:0090659] axon [GO:0030424]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; synapse [GO:0045202] protein kinase binding [GO:0019901] g9329.t1 Q3UHA3 28.833 1474 7.74e-155 524.0 sp|Q3UHA3|SPTCS_MOUSE Spatacsin OS=Mus musculus OX=10090 GN=Spg11 PE=1 SV=3 SPTCS_MOUSE reviewed Spatacsin (Spastic paraplegia 11 protein homolog) Mus musculus (Mouse) GO:0005730; GO:0005737; GO:0005783; GO:0005829; GO:0005886; GO:0006606; GO:0006886; GO:0007040; GO:0007268; GO:0007409; GO:0007528; GO:0007613; GO:0008088; GO:0008104; GO:0019901; GO:0021957; GO:0030163; GO:0030424; GO:0030425; GO:0031410; GO:0033344; GO:0045202; GO:0047496; GO:0048167; GO:0048489; GO:0048675; GO:0048741; GO:0051402; GO:0061744; GO:0090389; GO:0090659; GO:0097049; GO:1905037; GO:2001256 autophagosome organization [GO:1905037]; axo-dendritic transport [GO:0008088]; axon extension [GO:0048675]; axonogenesis [GO:0007409]; chemical synaptic transmission [GO:0007268]; cholesterol efflux [GO:0033344]; corticospinal tract morphogenesis [GO:0021957]; intracellular protein localization [GO:0008104]; intracellular protein transport [GO:0006886]; lysosome organization [GO:0007040]; memory [GO:0007613]; motor behavior [GO:0061744]; motor neuron apoptotic process [GO:0097049]; neuromuscular junction development [GO:0007528]; neuron apoptotic process [GO:0051402]; phagosome-lysosome fusion involved in apoptotic cell clearance [GO:0090389]; protein catabolic process [GO:0030163]; protein import into nucleus [GO:0006606]; regulation of store-operated calcium entry [GO:2001256]; regulation of synaptic plasticity [GO:0048167]; skeletal muscle fiber development [GO:0048741]; synaptic vesicle transport [GO:0048489]; vesicle transport along microtubule [GO:0047496]; walking behavior [GO:0090659] axon [GO:0030424]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; synapse [GO:0045202] protein kinase binding [GO:0019901] g9331.t1 E7EZG2 60.0 385 5.0700000000000006e-144 459.0 sp|E7EZG2|MY9AA_DANRE Unconventional myosin-IXAa OS=Danio rerio OX=7955 GN=myo9aa PE=3 SV=1 MY9AA_DANRE reviewed Unconventional myosin-IXAa (Myosin IXAa) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000146; GO:0005096; GO:0005524; GO:0005737; GO:0005884; GO:0007626; GO:0008270; GO:0016020; GO:0016459; GO:0035556; GO:0036269; GO:0044295; GO:0045198; GO:0045202; GO:0048675; GO:0051015; GO:0061564; GO:0098529 axon development [GO:0061564]; axon extension [GO:0048675]; establishment of epithelial cell apical/basal polarity [GO:0045198]; intracellular signal transduction [GO:0035556]; locomotory behavior [GO:0007626]; neuromuscular junction development, skeletal muscle fiber [GO:0098529]; swimming behavior [GO:0036269] actin filament [GO:0005884]; axonal growth cone [GO:0044295]; cytoplasm [GO:0005737]; membrane [GO:0016020]; myosin complex [GO:0016459]; synapse [GO:0045202] actin filament binding [GO:0051015]; ATP binding [GO:0005524]; GTPase activator activity [GO:0005096]; microfilament motor activity [GO:0000146]; zinc ion binding [GO:0008270] g9335.t1 P42026 69.302 215 5.900000000000001e-107 310.0 sp|P42026|NDUS7_BOVIN NADH dehydrogenase [ubiquinone] iron-sulfur protein 7, mitochondrial OS=Bos taurus OX=9913 GN=NDUFS7 PE=1 SV=1 NDUS7_BOVIN reviewed NADH dehydrogenase [ubiquinone] iron-sulfur protein 7, mitochondrial (EC 7.1.1.2) (Complex I-20kD) (CI-20kD) (NADH-ubiquinone oxidoreductase 20 kDa subunit) (PSST subunit) Bos taurus (Bovine) GO:0005743; GO:0006120; GO:0008137; GO:0009060; GO:0015990; GO:0016491; GO:0032981; GO:0045271; GO:0046872; GO:0048038; GO:0051539 aerobic respiration [GO:0009060]; electron transport coupled proton transport [GO:0015990]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; mitochondrial respiratory chain complex I assembly [GO:0032981] mitochondrial inner membrane [GO:0005743]; respiratory chain complex I [GO:0045271] 4 iron, 4 sulfur cluster binding [GO:0051539]; metal ion binding [GO:0046872]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; oxidoreductase activity [GO:0016491]; quinone binding [GO:0048038] g9336.t1 P31674 82.677 127 1.7599999999999998e-74 222.0 sp|P31674|RS15_ORYSJ Small ribosomal subunit protein uS19 OS=Oryza sativa subsp. japonica OX=39947 GN=RPS15 PE=2 SV=2 g9337.t1 Q7Z401 42.045 264 4.9499999999999996e-54 192.0 sp|Q7Z401|MYCPP_HUMAN C-myc promoter-binding protein OS=Homo sapiens OX=9606 GN=DENND4A PE=1 SV=2 MYCPP_HUMAN reviewed C-myc promoter-binding protein (DENN domain-containing protein 4A) Homo sapiens (Human) GO:0003677; GO:0005085; GO:0005634; GO:0005829; GO:0006355; GO:0031410; GO:0032483 regulation of DNA-templated transcription [GO:0006355]; regulation of Rab protein signal transduction [GO:0032483] cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; nucleus [GO:0005634] DNA binding [GO:0003677]; guanyl-nucleotide exchange factor activity [GO:0005085] g9338.t1 Q7Z401 53.795 896 0.0 960.0 sp|Q7Z401|MYCPP_HUMAN C-myc promoter-binding protein OS=Homo sapiens OX=9606 GN=DENND4A PE=1 SV=2 MYCPP_HUMAN reviewed C-myc promoter-binding protein (DENN domain-containing protein 4A) Homo sapiens (Human) GO:0003677; GO:0005085; GO:0005634; GO:0005829; GO:0006355; GO:0031410; GO:0032483 regulation of DNA-templated transcription [GO:0006355]; regulation of Rab protein signal transduction [GO:0032483] cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; nucleus [GO:0005634] DNA binding [GO:0003677]; guanyl-nucleotide exchange factor activity [GO:0005085] g9338.t2 Q7Z401 53.37 905 0.0 952.0 sp|Q7Z401|MYCPP_HUMAN C-myc promoter-binding protein OS=Homo sapiens OX=9606 GN=DENND4A PE=1 SV=2 MYCPP_HUMAN reviewed C-myc promoter-binding protein (DENN domain-containing protein 4A) Homo sapiens (Human) GO:0003677; GO:0005085; GO:0005634; GO:0005829; GO:0006355; GO:0031410; GO:0032483 regulation of DNA-templated transcription [GO:0006355]; regulation of Rab protein signal transduction [GO:0032483] cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; nucleus [GO:0005634] DNA binding [GO:0003677]; guanyl-nucleotide exchange factor activity [GO:0005085] g9339.t1 Q6NRY2 47.911 1125 0.0 1026.0 sp|Q6NRY2|NOL6_XENLA Nucleolar protein 6 OS=Xenopus laevis OX=8355 GN=nol6 PE=2 SV=2 NOL6_XENLA reviewed Nucleolar protein 6 Xenopus laevis (African clawed frog) GO:0003723; GO:0005694; GO:0006364; GO:0006409; GO:0032040; GO:0032545; GO:0034456; GO:0042274 ribosomal small subunit biogenesis [GO:0042274]; rRNA processing [GO:0006364]; tRNA export from nucleus [GO:0006409] chromosome [GO:0005694]; CURI complex [GO:0032545]; small-subunit processome [GO:0032040]; UTP-C complex [GO:0034456] RNA binding [GO:0003723] g9341.t1 P16393 58.635 938 0.0 987.0 sp|P16393|HMDH_STRPU 3-hydroxy-3-methylglutaryl-coenzyme A reductase OS=Strongylocentrotus purpuratus OX=7668 GN=HMGCR PE=2 SV=2 g9342.t1 P0DMQ6 59.544 351 1.7299999999999998e-146 421.0 sp|P0DMQ6|DHSO_CHICK Sorbitol dehydrogenase OS=Gallus gallus OX=9031 GN=SORD PE=1 SV=1 DHSO_CHICK reviewed Sorbitol dehydrogenase (SDH) (EC 1.1.1.-) (Polyol dehydrogenase) Gallus gallus (Chicken) GO:0003939; GO:0006000; GO:0006061; GO:0006062; GO:0008270; GO:0031514; GO:0031966; GO:0032991; GO:0046370; GO:0051287 fructose biosynthetic process [GO:0046370]; fructose metabolic process [GO:0006000]; sorbitol biosynthetic process [GO:0006061]; sorbitol catabolic process [GO:0006062] mitochondrial membrane [GO:0031966]; motile cilium [GO:0031514]; protein-containing complex [GO:0032991] L-iditol 2-dehydrogenase (NAD+) activity [GO:0003939]; NAD binding [GO:0051287]; zinc ion binding [GO:0008270] g9345.t1 O88871 32.578 706 1.05e-120 388.0 sp|O88871|GABR2_RAT Gamma-aminobutyric acid type B receptor subunit 2 OS=Rattus norvegicus OX=10116 GN=Gabbr2 PE=1 SV=2 GABR2_RAT reviewed Gamma-aminobutyric acid type B receptor subunit 2 (GABA-B receptor 2) (GABA-B-R2) (GABA-BR2) (GABABR2) (Gb2) (G-protein coupled receptor 51) Rattus norvegicus (Rat) GO:0004965; GO:0005737; GO:0005886; GO:0007193; GO:0007214; GO:0030425; GO:0038039; GO:0042734; GO:0043005; GO:0043204; GO:0045211; GO:0046982; GO:0051932; GO:0098978; GO:0098982; GO:0150099; GO:1902710; GO:1902712 adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; gamma-aminobutyric acid signaling pathway [GO:0007214]; neuron-glial cell signaling [GO:0150099]; synaptic transmission, GABAergic [GO:0051932] cytoplasm [GO:0005737]; dendrite [GO:0030425]; G protein-coupled GABA receptor complex [GO:1902712]; G protein-coupled receptor heterodimeric complex [GO:0038039]; GABA receptor complex [GO:1902710]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; neuron projection [GO:0043005]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734] G protein-coupled GABA receptor activity [GO:0004965]; protein heterodimerization activity [GO:0046982] g9346.t1 Q17QS1 43.636 165 4.4000000000000004e-35 123.0 sp|Q17QS1|SNX24_BOVIN Sorting nexin-24 OS=Bos taurus OX=9913 GN=SNX24 PE=2 SV=1 g9347.t1 P20585 50.469 747 0.0 781.0 sp|P20585|MSH3_HUMAN DNA mismatch repair protein Msh3 OS=Homo sapiens OX=9606 GN=MSH3 PE=1 SV=4 MSH3_HUMAN reviewed DNA mismatch repair protein Msh3 (hMSH3) (Divergent upstream protein) (DUP) (Mismatch repair protein 1) (MRP1) Homo sapiens (Human) GO:0003690; GO:0005524; GO:0005634; GO:0005654; GO:0006281; GO:0006298; GO:0006312; GO:0016020; GO:0016447; GO:0019899; GO:0030983; GO:0032302; GO:0043570; GO:0045910; GO:0140664 DNA repair [GO:0006281]; maintenance of DNA repeat elements [GO:0043570]; mismatch repair [GO:0006298]; mitotic recombination [GO:0006312]; negative regulation of DNA recombination [GO:0045910]; somatic recombination of immunoglobulin gene segments [GO:0016447] membrane [GO:0016020]; MutSbeta complex [GO:0032302]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] ATP binding [GO:0005524]; ATP-dependent DNA damage sensor activity [GO:0140664]; double-stranded DNA binding [GO:0003690]; enzyme binding [GO:0019899]; mismatched DNA binding [GO:0030983] g9348.t1 P20585 78.448 116 4.24e-49 182.0 sp|P20585|MSH3_HUMAN DNA mismatch repair protein Msh3 OS=Homo sapiens OX=9606 GN=MSH3 PE=1 SV=4 MSH3_HUMAN reviewed DNA mismatch repair protein Msh3 (hMSH3) (Divergent upstream protein) (DUP) (Mismatch repair protein 1) (MRP1) Homo sapiens (Human) GO:0003690; GO:0005524; GO:0005634; GO:0005654; GO:0006281; GO:0006298; GO:0006312; GO:0016020; GO:0016447; GO:0019899; GO:0030983; GO:0032302; GO:0043570; GO:0045910; GO:0140664 DNA repair [GO:0006281]; maintenance of DNA repeat elements [GO:0043570]; mismatch repair [GO:0006298]; mitotic recombination [GO:0006312]; negative regulation of DNA recombination [GO:0045910]; somatic recombination of immunoglobulin gene segments [GO:0016447] membrane [GO:0016020]; MutSbeta complex [GO:0032302]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] ATP binding [GO:0005524]; ATP-dependent DNA damage sensor activity [GO:0140664]; double-stranded DNA binding [GO:0003690]; enzyme binding [GO:0019899]; mismatched DNA binding [GO:0030983] g9349.t1 Q9H5X1 59.375 128 3.27e-45 148.0 sp|Q9H5X1|CIA2A_HUMAN Cytosolic iron-sulfur assembly component 2A OS=Homo sapiens OX=9606 GN=CIAO2A PE=1 SV=1 CIA2A_HUMAN reviewed Cytosolic iron-sulfur assembly component 2A (MIP18 family protein FAM96A) Homo sapiens (Human) GO:0005654; GO:0005829; GO:0007059; GO:0046872; GO:0051604; GO:0097361 chromosome segregation [GO:0007059]; protein maturation [GO:0051604] cytosol [GO:0005829]; cytosolic [4Fe-4S] assembly targeting complex [GO:0097361]; nucleoplasm [GO:0005654] metal ion binding [GO:0046872] g9350.t1 B0VYY3 67.669 133 9.96e-49 157.0 sp|B0VYY3|COX5A_OTOCR Cytochrome c oxidase subunit 5A, mitochondrial OS=Otolemur crassicaudatus OX=9463 GN=COX5A PE=2 SV=1 g9351.t1 Q32NS4 76.11 473 0.0 734.0 sp|Q32NS4|ARI1_XENLA E3 ubiquitin-protein ligase arih1 OS=Xenopus laevis OX=8355 GN=arih1 PE=2 SV=1 ARI1_XENLA reviewed E3 ubiquitin-protein ligase arih1 (EC 2.3.2.31) (Protein ariadne-1 homolog) (ARI-1) Xenopus laevis (African clawed frog) GO:0000151; GO:0004842; GO:0005634; GO:0005737; GO:0006511; GO:0008270; GO:0016567; GO:0016604; GO:0031624; GO:0061630; GO:0097413 protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511] cytoplasm [GO:0005737]; Lewy body [GO:0097413]; nuclear body [GO:0016604]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151] ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] g9358.t1 O53532 34.626 361 2.04e-61 204.0 sp|O53532|Y2258_MYCTU S-adenosylmethionine-dependent methyltransferase Rv2258c OS=Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv) OX=83332 GN=Rv2258c PE=1 SV=1 g9359.t1 O53532 33.564 289 1.79e-43 155.0 sp|O53532|Y2258_MYCTU S-adenosylmethionine-dependent methyltransferase Rv2258c OS=Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv) OX=83332 GN=Rv2258c PE=1 SV=1 g9360.t1 O53532 33.983 359 1.4199999999999998e-61 204.0 sp|O53532|Y2258_MYCTU S-adenosylmethionine-dependent methyltransferase Rv2258c OS=Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv) OX=83332 GN=Rv2258c PE=1 SV=1 g9361.t1 O53532 35.227 352 1.04e-55 189.0 sp|O53532|Y2258_MYCTU S-adenosylmethionine-dependent methyltransferase Rv2258c OS=Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv) OX=83332 GN=Rv2258c PE=1 SV=1 g9362.t1 Q54G14 38.614 202 4.350000000000001e-21 94.4 sp|Q54G14|Y0266_DICDI Uncharacterized protein DDB_G0290685 OS=Dictyostelium discoideum OX=44689 GN=DDB_G0290685 PE=2 SV=2 g9363.t1 O53532 34.392 189 2.17e-21 94.7 sp|O53532|Y2258_MYCTU S-adenosylmethionine-dependent methyltransferase Rv2258c OS=Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv) OX=83332 GN=Rv2258c PE=1 SV=1 g9365.t1 Q63616 48.387 620 0.0 553.0 sp|Q63616|VP33B_RAT Vacuolar protein sorting-associated protein 33B OS=Rattus norvegicus OX=10116 GN=Vps33b PE=2 SV=1 g9366.t1 Q008S8 48.507 134 4.14e-33 127.0 sp|Q008S8|ECT2L_HUMAN Epithelial cell-transforming sequence 2 oncogene-like OS=Homo sapiens OX=9606 GN=ECT2L PE=1 SV=2 g9367.t1 Q008S8 33.047 466 1.14e-71 255.0 sp|Q008S8|ECT2L_HUMAN Epithelial cell-transforming sequence 2 oncogene-like OS=Homo sapiens OX=9606 GN=ECT2L PE=1 SV=2 g9367.t1 Q008S8 54.878 164 2.1999999999999997e-54 206.0 sp|Q008S8|ECT2L_HUMAN Epithelial cell-transforming sequence 2 oncogene-like OS=Homo sapiens OX=9606 GN=ECT2L PE=1 SV=2 g9369.t1 P58390 67.874 414 0.0 608.0 sp|P58390|KCNN2_MOUSE Small conductance calcium-activated potassium channel protein 2 OS=Mus musculus OX=10090 GN=Kcnn2 PE=1 SV=2 KCNN2_MOUSE reviewed Small conductance calcium-activated potassium channel protein 2 (SK2) (SKCa 2) (SKCa2) (KCa2.2) Mus musculus (Mouse) GO:0005216; GO:0005242; GO:0005516; GO:0005790; GO:0005886; GO:0006811; GO:0006813; GO:0009986; GO:0015269; GO:0016020; GO:0016286; GO:0019904; GO:0030018; GO:0030315; GO:0042383; GO:0042803; GO:0043025; GO:0043197; GO:0043268; GO:0045211; GO:0048168; GO:0050804; GO:0051393; GO:0071805; GO:0098914; GO:0098978; GO:1901379 membrane repolarization during atrial cardiac muscle cell action potential [GO:0098914]; modulation of chemical synaptic transmission [GO:0050804]; monoatomic ion transport [GO:0006811]; positive regulation of potassium ion transport [GO:0043268]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; regulation of neuronal synaptic plasticity [GO:0048168]; regulation of potassium ion transmembrane transport [GO:1901379] cell surface [GO:0009986]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; smooth endoplasmic reticulum [GO:0005790]; T-tubule [GO:0030315]; Z disc [GO:0030018] alpha-actinin binding [GO:0051393]; calcium-activated potassium channel activity [GO:0015269]; calmodulin binding [GO:0005516]; inward rectifier potassium channel activity [GO:0005242]; monoatomic ion channel activity [GO:0005216]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]; small conductance calcium-activated potassium channel activity [GO:0016286] g9371.t1 Q61789 31.595 652 6.77e-88 319.0 sp|Q61789|LAMA3_MOUSE Laminin subunit alpha-3 OS=Mus musculus OX=10090 GN=Lama3 PE=1 SV=4 g9371.t1 Q61789 28.185 518 2.65e-38 161.0 sp|Q61789|LAMA3_MOUSE Laminin subunit alpha-3 OS=Mus musculus OX=10090 GN=Lama3 PE=1 SV=4 g9377.t1 Q13367 77.583 629 0.0 1025.0 sp|Q13367|AP3B2_HUMAN AP-3 complex subunit beta-2 OS=Homo sapiens OX=9606 GN=AP3B2 PE=1 SV=2 g9377.t1 Q13367 37.667 300 1.18e-55 214.0 sp|Q13367|AP3B2_HUMAN AP-3 complex subunit beta-2 OS=Homo sapiens OX=9606 GN=AP3B2 PE=1 SV=2 g9377.t2 Q9JME5 77.583 629 0.0 1025.0 sp|Q9JME5|AP3B2_MOUSE AP-3 complex subunit beta-2 OS=Mus musculus OX=10090 GN=Ap3b2 PE=1 SV=2 AP3B2_MOUSE reviewed AP-3 complex subunit beta-2 (Adaptor protein complex AP-3 subunit beta-2) (Adaptor-related protein complex 3 subunit beta-2) (Beta-3B-adaptin) (Clathrin assembly protein complex 3 beta-2 large chain) Mus musculus (Mouse) GO:0005769; GO:0005802; GO:0006882; GO:0006886; GO:0008089; GO:0008344; GO:0016183; GO:0016192; GO:0030123; GO:0030665; GO:0035654; GO:0036465; GO:0048488; GO:0048490; GO:0048499; GO:0065003; GO:0098793; GO:0099180; GO:1904115 adult locomotory behavior [GO:0008344]; anterograde axonal transport [GO:0008089]; anterograde synaptic vesicle transport [GO:0048490]; clathrin-coated vesicle cargo loading, AP-3-mediated [GO:0035654]; intracellular protein transport [GO:0006886]; intracellular zinc ion homeostasis [GO:0006882]; protein-containing complex assembly [GO:0065003]; synaptic vesicle coating [GO:0016183]; synaptic vesicle endocytosis [GO:0048488]; synaptic vesicle membrane organization [GO:0048499]; synaptic vesicle recycling [GO:0036465]; vesicle-mediated transport [GO:0016192]; zinc ion import into synaptic vesicle [GO:0099180] AP-3 adaptor complex [GO:0030123]; axon cytoplasm [GO:1904115]; clathrin-coated vesicle membrane [GO:0030665]; early endosome [GO:0005769]; presynapse [GO:0098793]; trans-Golgi network [GO:0005802] g9377.t2 Q9JME5 36.333 300 5.46e-53 206.0 sp|Q9JME5|AP3B2_MOUSE AP-3 complex subunit beta-2 OS=Mus musculus OX=10090 GN=Ap3b2 PE=1 SV=2 AP3B2_MOUSE reviewed AP-3 complex subunit beta-2 (Adaptor protein complex AP-3 subunit beta-2) (Adaptor-related protein complex 3 subunit beta-2) (Beta-3B-adaptin) (Clathrin assembly protein complex 3 beta-2 large chain) Mus musculus (Mouse) GO:0005769; GO:0005802; GO:0006882; GO:0006886; GO:0008089; GO:0008344; GO:0016183; GO:0016192; GO:0030123; GO:0030665; GO:0035654; GO:0036465; GO:0048488; GO:0048490; GO:0048499; GO:0065003; GO:0098793; GO:0099180; GO:1904115 adult locomotory behavior [GO:0008344]; anterograde axonal transport [GO:0008089]; anterograde synaptic vesicle transport [GO:0048490]; clathrin-coated vesicle cargo loading, AP-3-mediated [GO:0035654]; intracellular protein transport [GO:0006886]; intracellular zinc ion homeostasis [GO:0006882]; protein-containing complex assembly [GO:0065003]; synaptic vesicle coating [GO:0016183]; synaptic vesicle endocytosis [GO:0048488]; synaptic vesicle membrane organization [GO:0048499]; synaptic vesicle recycling [GO:0036465]; vesicle-mediated transport [GO:0016192]; zinc ion import into synaptic vesicle [GO:0099180] AP-3 adaptor complex [GO:0030123]; axon cytoplasm [GO:1904115]; clathrin-coated vesicle membrane [GO:0030665]; early endosome [GO:0005769]; presynapse [GO:0098793]; trans-Golgi network [GO:0005802] g9378.t1 O77735 49.074 324 1.4299999999999999e-90 278.0 sp|O77735|SCAM1_PIG Secretory carrier-associated membrane protein 1 OS=Sus scrofa OX=9823 GN=SCAMP1 PE=2 SV=1 g9378.t2 O15126 44.134 358 2.1299999999999998e-82 258.0 sp|O15126|SCAM1_HUMAN Secretory carrier-associated membrane protein 1 OS=Homo sapiens OX=9606 GN=SCAMP1 PE=1 SV=2 SCAM1_HUMAN reviewed Secretory carrier-associated membrane protein 1 (Secretory carrier membrane protein 1) Homo sapiens (Human) GO:0005802; GO:0005886; GO:0006887; GO:0006892; GO:0006897; GO:0015031; GO:0016020; GO:0019904; GO:0030136; GO:0030672; GO:0032588; GO:0035579; GO:0042589; GO:0051649; GO:0055038 endocytosis [GO:0006897]; establishment of localization in cell [GO:0051649]; exocytosis [GO:0006887]; post-Golgi vesicle-mediated transport [GO:0006892]; protein transport [GO:0015031] clathrin-coated vesicle [GO:0030136]; membrane [GO:0016020]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038]; specific granule membrane [GO:0035579]; synaptic vesicle membrane [GO:0030672]; trans-Golgi network [GO:0005802]; trans-Golgi network membrane [GO:0032588]; zymogen granule membrane [GO:0042589] protein domain specific binding [GO:0019904] g9379.t1 Q6P2X9 25.231 432 1.66e-23 106.0 sp|Q6P2X9|MOT12_XENTR Monocarboxylate transporter 12 OS=Xenopus tropicalis OX=8364 GN=slc16a12 PE=2 SV=1 g9381.t1 Q59HJ6 55.392 204 2.1100000000000003e-59 202.0 sp|Q59HJ6|LONM_BOVIN Lon protease homolog, mitochondrial OS=Bos taurus OX=9913 GN=LONP1 PE=1 SV=1 LONM_BOVIN reviewed Lon protease homolog, mitochondrial (EC 3.4.21.53) (Lon protease-like protein) (LONP) (Mitochondrial ATP-dependent protease Lon) (Serine protease 15) Bos taurus (Bovine) GO:0003697; GO:0004176; GO:0004252; GO:0005524; GO:0005759; GO:0006515; GO:0007005; GO:0016887; GO:0019941; GO:0034599; GO:0043565; GO:0051131; GO:0070407 cellular response to oxidative stress [GO:0034599]; chaperone-mediated protein complex assembly [GO:0051131]; mitochondrion organization [GO:0007005]; modification-dependent protein catabolic process [GO:0019941]; oxidation-dependent protein catabolic process [GO:0070407]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515] mitochondrial matrix [GO:0005759] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent peptidase activity [GO:0004176]; sequence-specific DNA binding [GO:0043565]; serine-type endopeptidase activity [GO:0004252]; single-stranded DNA binding [GO:0003697] g9382.t1 P36776 74.408 633 0.0 933.0 sp|P36776|LONM_HUMAN Lon protease homolog, mitochondrial OS=Homo sapiens OX=9606 GN=LONP1 PE=1 SV=2 LONM_HUMAN reviewed Lon protease homolog, mitochondrial (EC 3.4.21.53) (LONHs) (Lon protease-like protein) (LONP) (Mitochondrial ATP-dependent protease Lon) (Serine protease 15) Homo sapiens (Human) GO:0001666; GO:0003697; GO:0003727; GO:0004176; GO:0004252; GO:0005524; GO:0005654; GO:0005739; GO:0005759; GO:0005829; GO:0006515; GO:0007005; GO:0009725; GO:0010044; GO:0016020; GO:0016887; GO:0034599; GO:0035694; GO:0042645; GO:0042731; GO:0042802; GO:0043531; GO:0043560; GO:0043565; GO:0046627; GO:0051131; GO:0051603; GO:0051880; GO:0070182; GO:0070407 cellular response to oxidative stress [GO:0034599]; chaperone-mediated protein complex assembly [GO:0051131]; mitochondrial protein catabolic process [GO:0035694]; mitochondrion organization [GO:0007005]; negative regulation of insulin receptor signaling pathway [GO:0046627]; oxidation-dependent protein catabolic process [GO:0070407]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; proteolysis involved in protein catabolic process [GO:0051603]; response to aluminum ion [GO:0010044]; response to hormone [GO:0009725]; response to hypoxia [GO:0001666] cytosol [GO:0005829]; membrane [GO:0016020]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654] ADP binding [GO:0043531]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent peptidase activity [GO:0004176]; DNA polymerase binding [GO:0070182]; G-quadruplex DNA binding [GO:0051880]; identical protein binding [GO:0042802]; insulin receptor substrate binding [GO:0043560]; PH domain binding [GO:0042731]; sequence-specific DNA binding [GO:0043565]; serine-type endopeptidase activity [GO:0004252]; single-stranded DNA binding [GO:0003697]; single-stranded RNA binding [GO:0003727] g9384.t1 Q5U2Q4 45.963 322 2.3999999999999998e-89 273.0 sp|Q5U2Q4|PAR16_RAT Protein mono-ADP-ribosyltransferase PARP16 OS=Rattus norvegicus OX=10116 GN=Parp16 PE=2 SV=1 PAR16_RAT reviewed Protein mono-ADP-ribosyltransferase PARP16 (EC 2.4.2.-) (ADP-ribosyltransferase diphtheria toxin-like 15) (Poly [ADP-ribose] polymerase 16) (PARP-16) Rattus norvegicus (Rat) GO:0002181; GO:0003950; GO:0005635; GO:0005783; GO:0005789; GO:0016020; GO:0016779; GO:0019900; GO:0030968; GO:0036498; GO:0043539; GO:0070213; GO:0071782; GO:0140804; GO:0140806; GO:0140807; GO:1990404; GO:1990830; GO:2000766 cellular response to leukemia inhibitory factor [GO:1990830]; cytoplasmic translation [GO:0002181]; endoplasmic reticulum unfolded protein response [GO:0030968]; IRE1-mediated unfolded protein response [GO:0036498]; negative regulation of cytoplasmic translation [GO:2000766]; protein auto-ADP-ribosylation [GO:0070213] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum tubular network [GO:0071782]; membrane [GO:0016020]; nuclear envelope [GO:0005635] kinase binding [GO:0019900]; NAD+ poly-ADP-ribosyltransferase activity [GO:0003950]; NAD+-protein mono-ADP-ribosyltransferase activity [GO:1990404]; NAD+-protein-aspartate ADP-ribosyltransferase activity [GO:0140806]; NAD+-protein-glutamate ADP-ribosyltransferase activity [GO:0140807]; NAD+-protein-lysine ADP-ribosyltransferase activity [GO:0140804]; nucleotidyltransferase activity [GO:0016779]; protein serine/threonine kinase activator activity [GO:0043539] g9385.t1 Q96A54 55.276 199 7.540000000000001e-64 204.0 sp|Q96A54|PAQR1_HUMAN Adiponectin receptor protein 1 OS=Homo sapiens OX=9606 GN=ADIPOR1 PE=1 SV=1 g9386.t1 Q9VCY8 54.369 103 3.55e-28 113.0 sp|Q9VCY8|ADRL_DROME Adiponectin receptor protein OS=Drosophila melanogaster OX=7227 GN=AdipoR PE=1 SV=2 g9387.t1 P15389 43.189 1248 0.0 863.0 sp|P15389|SCN5A_RAT Sodium channel protein type 5 subunit alpha OS=Rattus norvegicus OX=10116 GN=Scn5a PE=1 SV=1 g9388.t1 Q9W0Y8 49.721 358 1.91e-95 319.0 sp|Q9W0Y8|SCN60_DROME Sodium channel protein 60E OS=Drosophila melanogaster OX=7227 GN=NaCP60E PE=2 SV=6 SCN60_DROME reviewed Sodium channel protein 60E (Drosophila ion channel 60) (Drosophila sodium channel 1) (Protein smell-impaired 60E) (Sodium channel 2) (DmNav2) Drosophila melanogaster (Fruit fly) GO:0001518; GO:0005248; GO:0005886; GO:0006814; GO:0007608; GO:0019228; GO:0022843; GO:0035725; GO:0042048; GO:0086010 membrane depolarization during action potential [GO:0086010]; neuronal action potential [GO:0019228]; olfactory behavior [GO:0042048]; sensory perception of smell [GO:0007608]; sodium ion transmembrane transport [GO:0035725]; sodium ion transport [GO:0006814] plasma membrane [GO:0005886]; voltage-gated sodium channel complex [GO:0001518] voltage-gated monoatomic cation channel activity [GO:0022843]; voltage-gated sodium channel activity [GO:0005248] g9390.t1 Q8NAG6 46.038 265 2.53e-62 227.0 sp|Q8NAG6|ANKL1_HUMAN Ankyrin repeat and LEM domain-containing protein 1 OS=Homo sapiens OX=9606 GN=ANKLE1 PE=1 SV=2 ANKL1_HUMAN reviewed Structure-specific endonuclease ANKLE1 (Ankyrin repeat and LEM domain-containing protein 1) (EC 3.1.-.-) (Ankyrin repeat domain-containing protein 41) (LEM-domain containing protein 3) Homo sapiens (Human) GO:0000287; GO:0000712; GO:0000724; GO:0004519; GO:0004520; GO:0005654; GO:0005737; GO:0005829; GO:0006611; GO:0006974; GO:0016787; GO:0030145; GO:0030496; GO:0045950; GO:0050897; GO:0090304; GO:1905453; GO:1905456 DNA damage response [GO:0006974]; double-strand break repair via homologous recombination [GO:0000724]; negative regulation of mitotic recombination [GO:0045950]; nucleic acid metabolic process [GO:0090304]; protein export from nucleus [GO:0006611]; regulation of lymphoid progenitor cell differentiation [GO:1905456]; regulation of myeloid progenitor cell differentiation [GO:1905453]; resolution of meiotic recombination intermediates [GO:0000712] cytoplasm [GO:0005737]; cytosol [GO:0005829]; midbody [GO:0030496]; nucleoplasm [GO:0005654] cobalt ion binding [GO:0050897]; DNA endonuclease activity [GO:0004520]; endonuclease activity [GO:0004519]; hydrolase activity [GO:0016787]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145] g9391.t1 Q2KHZ8 44.6 500 5.71e-153 451.0 sp|Q2KHZ8|GBA1_BOVIN Lysosomal acid glucosylceramidase OS=Bos taurus OX=9913 GN=GBA1 PE=2 SV=1 GBA1_BOVIN reviewed Lysosomal acid glucosylceramidase (EC 3.2.1.45) (Acid beta-glucosidase) (Beta-glucocerebrosidase) (Cholesterol glucosyltransferase) (SGTase) (EC 2.4.1.-) (Cholesteryl-beta-glucosidase) (EC 3.2.1.-) (D-glucosyl-N-acylsphingosine glucohydrolase) (Lysosomal cholesterol glycosyltransferase) (Lysosomal galactosylceramidase) (EC 3.2.1.46) (Lysosomal glycosylceramidase) Bos taurus (Bovine) GO:0004336; GO:0004348; GO:0005102; GO:0005764; GO:0005765; GO:0005783; GO:0005794; GO:0005802; GO:0006680; GO:0006914; GO:0007040; GO:0008203; GO:0009247; GO:0010605; GO:0016241; GO:0030163; GO:0032006; GO:0042176; GO:0042391; GO:0046527; GO:0050295 autophagy [GO:0006914]; cholesterol metabolic process [GO:0008203]; glucosylceramide catabolic process [GO:0006680]; glycolipid biosynthetic process [GO:0009247]; lysosome organization [GO:0007040]; negative regulation of macromolecule metabolic process [GO:0010605]; protein catabolic process [GO:0030163]; regulation of macroautophagy [GO:0016241]; regulation of membrane potential [GO:0042391]; regulation of protein catabolic process [GO:0042176]; regulation of TOR signaling [GO:0032006] endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; trans-Golgi network [GO:0005802] galactosylceramidase activity [GO:0004336]; glucosylceramidase activity [GO:0004348]; glucosyltransferase activity [GO:0046527]; signaling receptor binding [GO:0005102]; steryl-beta-glucosidase activity [GO:0050295] g9392.t1 O35488 43.455 573 3.55e-157 469.0 sp|O35488|S27A2_MOUSE Long-chain fatty acid transport protein 2 OS=Mus musculus OX=10090 GN=Slc27a2 PE=1 SV=2 g9393.t1 E9Q9W4 31.694 183 6.23e-22 95.5 sp|E9Q9W4|S27A6_MOUSE Long-chain fatty acid transport protein 6 OS=Mus musculus OX=10090 GN=Slc27a6 PE=1 SV=1 S27A6_MOUSE reviewed Long-chain fatty acid transport protein 6 (FATP-6) (Fatty acid transport protein 6) (Arachidonate--CoA ligase) (EC 6.2.1.15) (Fatty-acid-coenzyme A ligase, very long-chain 2) (Long-chain-fatty-acid--CoA ligase) (EC 6.2.1.3) (Solute carrier family 27 member 6) (Very long-chain acyl-CoA synthetase homolog 1) (VLACS2) (VLCSH1) (mVLCS-H1) (EC 6.2.1.-) Mus musculus (Mouse) GO:0000166; GO:0001676; GO:0004467; GO:0005324; GO:0005783; GO:0005789; GO:0005886; GO:0031957; GO:0042383; GO:0044539; GO:0047676 long-chain fatty acid import into cell [GO:0044539]; long-chain fatty acid metabolic process [GO:0001676] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383] arachidonate-CoA ligase activity [GO:0047676]; long-chain fatty acid transmembrane transporter activity [GO:0005324]; long-chain fatty acid-CoA ligase activity [GO:0004467]; nucleotide binding [GO:0000166]; very long-chain fatty acid-CoA ligase activity [GO:0031957] g9394.t1 P97524 48.571 350 1.07e-110 338.0 sp|P97524|S27A2_RAT Long-chain fatty acid transport protein 2 OS=Rattus norvegicus OX=10116 GN=Slc27a2 PE=1 SV=1 S27A2_RAT reviewed Long-chain fatty acid transport protein 2 (Arachidonate--CoA ligase) (EC 6.2.1.15) (Fatty acid transport protein 2) (FATP-2) (Fatty-acid-coenzyme A ligase, very long-chain 1) (Long-chain-fatty-acid--CoA ligase) (EC 6.2.1.3) (Phytanate--CoA ligase) (EC 6.2.1.24) (Solute carrier family 27 member 2) (THCA-CoA ligase) (EC 6.2.1.7) (Very long-chain acyl-CoA synthetase) (VLACS) (VLCS) (EC 6.2.1.-) (Very long-chain-fatty-acid-CoA ligase) Rattus norvegicus (Rat) GO:0000038; GO:0001561; GO:0001676; GO:0004467; GO:0005324; GO:0005524; GO:0005777; GO:0005778; GO:0005783; GO:0005788; GO:0005789; GO:0005886; GO:0006635; GO:0006699; GO:0008206; GO:0015245; GO:0015908; GO:0019899; GO:0031957; GO:0042760; GO:0044539; GO:0047676; GO:0047747; GO:0050197; GO:0070251; GO:0097089 bile acid biosynthetic process [GO:0006699]; bile acid metabolic process [GO:0008206]; fatty acid alpha-oxidation [GO:0001561]; fatty acid beta-oxidation [GO:0006635]; fatty acid transport [GO:0015908]; long-chain fatty acid import into cell [GO:0044539]; long-chain fatty acid metabolic process [GO:0001676]; methyl-branched fatty acid metabolic process [GO:0097089]; very long-chain fatty acid catabolic process [GO:0042760]; very long-chain fatty acid metabolic process [GO:0000038] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; plasma membrane [GO:0005886] arachidonate-CoA ligase activity [GO:0047676]; ATP binding [GO:0005524]; cholate-CoA ligase activity [GO:0047747]; enzyme binding [GO:0019899]; fatty acid transmembrane transporter activity [GO:0015245]; long-chain fatty acid transmembrane transporter activity [GO:0005324]; long-chain fatty acid-CoA ligase activity [GO:0004467]; phytanate-CoA ligase activity [GO:0050197]; pristanate-CoA ligase activity [GO:0070251]; very long-chain fatty acid-CoA ligase activity [GO:0031957] g9399.t1 Q9BT43 58.716 109 3.2e-21 92.0 sp|Q9BT43|RPC7L_HUMAN DNA-directed RNA polymerase III subunit RPC7-like OS=Homo sapiens OX=9606 GN=POLR3GL PE=1 SV=1 RPC7L_HUMAN reviewed DNA-directed RNA polymerase III subunit RPC7-like (RNA polymerase III subunit C7-like) (DNA-directed RNA polymerase III subunit G-like) (RNA polymerase III 32 kDa beta subunit) (RPC32-beta) Homo sapiens (Human) GO:0005634; GO:0005654; GO:0005666; GO:0005829; GO:0006383 transcription by RNA polymerase III [GO:0006383] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase III complex [GO:0005666] g9400.t1 O76031 67.093 313 6.9e-118 347.0 sp|O76031|CLPX_HUMAN ATP-dependent clpX-like chaperone, mitochondrial OS=Homo sapiens OX=9606 GN=CLPX PE=1 SV=2 g9400.t1 O76031 75.0 68 6.9e-118 99.8 sp|O76031|CLPX_HUMAN ATP-dependent clpX-like chaperone, mitochondrial OS=Homo sapiens OX=9606 GN=CLPX PE=1 SV=2 g9401.t1 O76031 64.062 128 1.48e-45 159.0 sp|O76031|CLPX_HUMAN ATP-dependent clpX-like chaperone, mitochondrial OS=Homo sapiens OX=9606 GN=CLPX PE=1 SV=2 g9402.t1 Q80VM7 29.352 494 2.45e-49 193.0 sp|Q80VM7|ANR24_MOUSE Ankyrin repeat domain-containing protein 24 OS=Mus musculus OX=10090 GN=Ankrd24 PE=1 SV=4 ANR24_MOUSE reviewed Ankyrin repeat domain-containing protein 24 Mus musculus (Mouse) GO:0003779; GO:0005886; GO:0007605; GO:0032420; GO:0060088 auditory receptor cell stereocilium organization [GO:0060088]; sensory perception of sound [GO:0007605] plasma membrane [GO:0005886]; stereocilium [GO:0032420] actin binding [GO:0003779] g9403.t1 Q8R1E7 48.624 109 1.25e-36 125.0 sp|Q8R1E7|TM234_MOUSE Transmembrane protein 234 OS=Mus musculus OX=10090 GN=Tmem234 PE=1 SV=1 g9404.t1 Q2KJC9 64.729 516 0.0 673.0 sp|Q2KJC9|AL7A1_BOVIN Alpha-aminoadipic semialdehyde dehydrogenase OS=Bos taurus OX=9913 GN=ALDH7A1 PE=2 SV=4 AL7A1_BOVIN reviewed Alpha-aminoadipic semialdehyde dehydrogenase (Alpha-AASA dehydrogenase) (EC 1.2.1.31) (Aldehyde dehydrogenase family 7 member A1) (EC 1.2.1.3) (Antiquitin-1) (Betaine aldehyde dehydrogenase) (EC 1.2.1.8) (Delta1-piperideine-6-carboxylate dehydrogenase) (P6c dehydrogenase) Bos taurus (Bovine) GO:0000139; GO:0004029; GO:0004043; GO:0005634; GO:0005739; GO:0005829; GO:0005886; GO:0006554; GO:0008802; GO:0019285; GO:0042802; GO:0042997; GO:0097009; GO:0110076; GO:1905750 energy homeostasis [GO:0097009]; glycine betaine biosynthetic process from choline [GO:0019285]; lysine catabolic process [GO:0006554]; negative regulation of endosome to plasma membrane protein transport [GO:1905750]; negative regulation of ferroptosis [GO:0110076]; negative regulation of Golgi to plasma membrane protein transport [GO:0042997] cytosol [GO:0005829]; Golgi membrane [GO:0000139]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886] aldehyde dehydrogenase (NAD+) activity [GO:0004029]; betaine-aldehyde dehydrogenase (NAD+) activity [GO:0008802]; identical protein binding [GO:0042802]; L-aminoadipate-semialdehyde dehydrogenase [NAD(P)+] activity [GO:0004043] g9405.t1 Q924U1 46.154 156 5.2700000000000004e-33 129.0 sp|Q924U1|KISSR_RAT KiSS-1 receptor OS=Rattus norvegicus OX=10116 GN=Kiss1r PE=2 SV=2 g9407.t1 Q969F8 36.257 171 1.2400000000000001e-27 110.0 sp|Q969F8|KISSR_HUMAN KiSS-1 receptor OS=Homo sapiens OX=9606 GN=KISS1R PE=1 SV=2 KISSR_HUMAN reviewed KiSS-1 receptor (KiSS-1R) (G-protein coupled receptor 54) (G-protein coupled receptor OT7T175) (hOT7T175) (Hypogonadotropin-1) (Kisspeptins receptor) (Metastin receptor) Homo sapiens (Human) GO:0005886; GO:0005929; GO:0007186; GO:0007218; GO:0008188; GO:0009986; GO:0016020; GO:0046887 G protein-coupled receptor signaling pathway [GO:0007186]; neuropeptide signaling pathway [GO:0007218]; positive regulation of hormone secretion [GO:0046887] cell surface [GO:0009986]; cilium [GO:0005929]; membrane [GO:0016020]; plasma membrane [GO:0005886] neuropeptide receptor activity [GO:0008188] g9413.t1 Q2TBL4 47.736 530 7.260000000000001e-164 478.0 sp|Q2TBL4|RPC3_BOVIN DNA-directed RNA polymerase III subunit RPC3 OS=Bos taurus OX=9913 GN=POLR3C PE=2 SV=1 g9414.t1 Q9V9W8 53.165 79 2.2600000000000002e-26 110.0 sp|Q9V9W8|PYGO_DROME Protein pygopus OS=Drosophila melanogaster OX=7227 GN=pygo PE=1 SV=1 PYGO_DROME reviewed Protein pygopus (Protein gammy legs) Drosophila melanogaster (Fruit fly) GO:0003713; GO:0005634; GO:0005654; GO:0006357; GO:0007367; GO:0007472; GO:0008270; GO:0009880; GO:0035214; GO:0035293; GO:0045944; GO:0048526; GO:0060070; GO:0060232; GO:0140002; GO:1990907 canonical Wnt signaling pathway [GO:0060070]; chitin-based larval cuticle pattern formation [GO:0035293]; delamination [GO:0060232]; embryonic pattern specification [GO:0009880]; eye-antennal disc development [GO:0035214]; imaginal disc-derived wing expansion [GO:0048526]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; segment polarity determination [GO:0007367]; wing disc morphogenesis [GO:0007472] beta-catenin-TCF complex [GO:1990907]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] histone H3K4me3 reader activity [GO:0140002]; transcription coactivator activity [GO:0003713]; zinc ion binding [GO:0008270] g9414.t2 Q9V9W8 53.165 79 2.3500000000000002e-26 110.0 sp|Q9V9W8|PYGO_DROME Protein pygopus OS=Drosophila melanogaster OX=7227 GN=pygo PE=1 SV=1 PYGO_DROME reviewed Protein pygopus (Protein gammy legs) Drosophila melanogaster (Fruit fly) GO:0003713; GO:0005634; GO:0005654; GO:0006357; GO:0007367; GO:0007472; GO:0008270; GO:0009880; GO:0035214; GO:0035293; GO:0045944; GO:0048526; GO:0060070; GO:0060232; GO:0140002; GO:1990907 canonical Wnt signaling pathway [GO:0060070]; chitin-based larval cuticle pattern formation [GO:0035293]; delamination [GO:0060232]; embryonic pattern specification [GO:0009880]; eye-antennal disc development [GO:0035214]; imaginal disc-derived wing expansion [GO:0048526]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; segment polarity determination [GO:0007367]; wing disc morphogenesis [GO:0007472] beta-catenin-TCF complex [GO:1990907]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] histone H3K4me3 reader activity [GO:0140002]; transcription coactivator activity [GO:0003713]; zinc ion binding [GO:0008270] g9417.t1 P51659 57.297 740 0.0 857.0 sp|P51659|DHB4_HUMAN Peroxisomal multifunctional enzyme type 2 OS=Homo sapiens OX=9606 GN=HSD17B4 PE=1 SV=3 DHB4_HUMAN reviewed Peroxisomal multifunctional enzyme type 2 (MFE-2) (17-beta-hydroxysteroid dehydrogenase 4) (17-beta-HSD 4) (D-bifunctional protein) (DBP) (Multifunctional protein 2) (MFP-2) (Short chain dehydrogenase/reductase family 8C member 1) [Cleaved into: (3R)-hydroxyacyl-CoA dehydrogenase (EC 1.1.1.n12); Enoyl-CoA hydratase 2 (EC 4.2.1.107) (EC 4.2.1.119) (3-alpha,7-alpha,12-alpha-trihydroxy-5-beta-cholest-24-enoyl-CoA hydratase)] Homo sapiens (Human) GO:0000038; GO:0001649; GO:0003857; GO:0004300; GO:0004303; GO:0005777; GO:0005778; GO:0005782; GO:0005829; GO:0006635; GO:0006636; GO:0008209; GO:0008210; GO:0016020; GO:0016853; GO:0018812; GO:0033540; GO:0033989; GO:0036109; GO:0036111; GO:0036112; GO:0042759; GO:0042803; GO:0044594; GO:0060009; GO:0106386; GO:1901570 alpha-linolenic acid metabolic process [GO:0036109]; androgen metabolic process [GO:0008209]; estrogen metabolic process [GO:0008210]; fatty acid beta-oxidation [GO:0006635]; fatty acid beta-oxidation using acyl-CoA oxidase [GO:0033540]; fatty acid derivative biosynthetic process [GO:1901570]; long-chain fatty acid biosynthetic process [GO:0042759]; medium-chain fatty-acyl-CoA metabolic process [GO:0036112]; osteoblast differentiation [GO:0001649]; Sertoli cell development [GO:0060009]; unsaturated fatty acid biosynthetic process [GO:0006636]; very long-chain fatty acid metabolic process [GO:0000038]; very long-chain fatty-acyl-CoA metabolic process [GO:0036111] cytosol [GO:0005829]; membrane [GO:0016020]; peroxisomal matrix [GO:0005782]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777] (3R)-3-hydroxyacyl-CoA dehydrogenase (NAD+) activity [GO:0106386]; (3S)-3-hydroxyacyl-CoA dehydrogenase (NAD+) activity [GO:0003857]; 17-beta-hydroxysteroid dehydrogenase (NAD+) activity [GO:0044594]; 3-hydroxyacyl-CoA dehydratase activity [GO:0018812]; 3alpha,7alpha,12alpha-trihydroxy-5beta-cholest-24-enoyl-CoA hydratase activity [GO:0033989]; enoyl-CoA hydratase activity [GO:0004300]; estradiol 17-beta-dehydrogenase [NAD(P)+] activity [GO:0004303]; isomerase activity [GO:0016853]; protein homodimerization activity [GO:0042803] g9419.t1 A6QQM4 46.174 379 4.77e-95 300.0 sp|A6QQM4|ZN474_BOVIN Zinc finger protein 474 OS=Bos taurus OX=9913 GN=ZNF474 PE=2 SV=1 g9419.t1 A6QQM4 36.842 380 2.76e-55 196.0 sp|A6QQM4|ZN474_BOVIN Zinc finger protein 474 OS=Bos taurus OX=9913 GN=ZNF474 PE=2 SV=1 g9419.t1 A6QQM4 59.459 111 5.7599999999999994e-34 137.0 sp|A6QQM4|ZN474_BOVIN Zinc finger protein 474 OS=Bos taurus OX=9913 GN=ZNF474 PE=2 SV=1 g9419.t1 A6QQM4 36.704 267 2.92e-28 121.0 sp|A6QQM4|ZN474_BOVIN Zinc finger protein 474 OS=Bos taurus OX=9913 GN=ZNF474 PE=2 SV=1 g9419.t1 A6QQM4 52.941 102 6.020000000000001e-27 117.0 sp|A6QQM4|ZN474_BOVIN Zinc finger protein 474 OS=Bos taurus OX=9913 GN=ZNF474 PE=2 SV=1 g9420.t1 A0A2I4HXH5 40.596 537 1.27e-107 334.0 sp|A0A2I4HXH5|V5NTD_NAJAT Snake venom 5'-nucleotidase (Fragment) OS=Naja atra OX=8656 PE=1 SV=1 V5NTD_NAJAT reviewed Snake venom 5'-nucleotidase (5'-NT) (EC 3.1.3.5) (Ecto-5'-nucleotidase) Naja atra (Chinese cobra) GO:0000166; GO:0005886; GO:0006196; GO:0008253; GO:0046872; GO:0098552 AMP catabolic process [GO:0006196] plasma membrane [GO:0005886]; side of membrane [GO:0098552] 5'-nucleotidase activity [GO:0008253]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166] g9422.t1 Q06725 87.179 273 2.6500000000000002e-173 487.0 sp|Q06725|N2F1A_DANRE Nuclear receptor subfamily 2 group F member 1-A OS=Danio rerio OX=7955 GN=nr2f1a PE=2 SV=1 g9422.t2 Q06725 87.546 273 8.16e-176 493.0 sp|Q06725|N2F1A_DANRE Nuclear receptor subfamily 2 group F member 1-A OS=Danio rerio OX=7955 GN=nr2f1a PE=2 SV=1 g9425.t1 Q9FN03 31.755 359 2.31e-38 152.0 sp|Q9FN03|UVR8_ARATH Ultraviolet-B receptor UVR8 OS=Arabidopsis thaliana OX=3702 GN=UVR8 PE=1 SV=1 UVR8_ARATH reviewed Ultraviolet-B receptor UVR8 (Protein UV-B RESISTANCE 8) (RCC1 domain-containing protein UVR8) Arabidopsis thaliana (Mouse-ear cress) GO:0000785; GO:0003682; GO:0005085; GO:0005634; GO:0005829; GO:0009411; GO:0009536; GO:0009649; GO:0009881; GO:0010224; GO:0042802; GO:0042803 entrainment of circadian clock [GO:0009649]; response to UV [GO:0009411]; response to UV-B [GO:0010224] chromatin [GO:0000785]; cytosol [GO:0005829]; nucleus [GO:0005634]; plastid [GO:0009536] chromatin binding [GO:0003682]; guanyl-nucleotide exchange factor activity [GO:0005085]; identical protein binding [GO:0042802]; photoreceptor activity [GO:0009881]; protein homodimerization activity [GO:0042803] g9425.t1 Q9FN03 30.24 334 6.52e-33 136.0 sp|Q9FN03|UVR8_ARATH Ultraviolet-B receptor UVR8 OS=Arabidopsis thaliana OX=3702 GN=UVR8 PE=1 SV=1 UVR8_ARATH reviewed Ultraviolet-B receptor UVR8 (Protein UV-B RESISTANCE 8) (RCC1 domain-containing protein UVR8) Arabidopsis thaliana (Mouse-ear cress) GO:0000785; GO:0003682; GO:0005085; GO:0005634; GO:0005829; GO:0009411; GO:0009536; GO:0009649; GO:0009881; GO:0010224; GO:0042802; GO:0042803 entrainment of circadian clock [GO:0009649]; response to UV [GO:0009411]; response to UV-B [GO:0010224] chromatin [GO:0000785]; cytosol [GO:0005829]; nucleus [GO:0005634]; plastid [GO:0009536] chromatin binding [GO:0003682]; guanyl-nucleotide exchange factor activity [GO:0005085]; identical protein binding [GO:0042802]; photoreceptor activity [GO:0009881]; protein homodimerization activity [GO:0042803] g9425.t1 Q9FN03 33.482 224 1.0300000000000001e-21 102.0 sp|Q9FN03|UVR8_ARATH Ultraviolet-B receptor UVR8 OS=Arabidopsis thaliana OX=3702 GN=UVR8 PE=1 SV=1 UVR8_ARATH reviewed Ultraviolet-B receptor UVR8 (Protein UV-B RESISTANCE 8) (RCC1 domain-containing protein UVR8) Arabidopsis thaliana (Mouse-ear cress) GO:0000785; GO:0003682; GO:0005085; GO:0005634; GO:0005829; GO:0009411; GO:0009536; GO:0009649; GO:0009881; GO:0010224; GO:0042802; GO:0042803 entrainment of circadian clock [GO:0009649]; response to UV [GO:0009411]; response to UV-B [GO:0010224] chromatin [GO:0000785]; cytosol [GO:0005829]; nucleus [GO:0005634]; plastid [GO:0009536] chromatin binding [GO:0003682]; guanyl-nucleotide exchange factor activity [GO:0005085]; identical protein binding [GO:0042802]; photoreceptor activity [GO:0009881]; protein homodimerization activity [GO:0042803] g9425.t2 Q9FN03 32.845 341 1.36e-39 155.0 sp|Q9FN03|UVR8_ARATH Ultraviolet-B receptor UVR8 OS=Arabidopsis thaliana OX=3702 GN=UVR8 PE=1 SV=1 UVR8_ARATH reviewed Ultraviolet-B receptor UVR8 (Protein UV-B RESISTANCE 8) (RCC1 domain-containing protein UVR8) Arabidopsis thaliana (Mouse-ear cress) GO:0000785; GO:0003682; GO:0005085; GO:0005634; GO:0005829; GO:0009411; GO:0009536; GO:0009649; GO:0009881; GO:0010224; GO:0042802; GO:0042803 entrainment of circadian clock [GO:0009649]; response to UV [GO:0009411]; response to UV-B [GO:0010224] chromatin [GO:0000785]; cytosol [GO:0005829]; nucleus [GO:0005634]; plastid [GO:0009536] chromatin binding [GO:0003682]; guanyl-nucleotide exchange factor activity [GO:0005085]; identical protein binding [GO:0042802]; photoreceptor activity [GO:0009881]; protein homodimerization activity [GO:0042803] g9425.t2 Q9FN03 31.646 316 9.33e-35 141.0 sp|Q9FN03|UVR8_ARATH Ultraviolet-B receptor UVR8 OS=Arabidopsis thaliana OX=3702 GN=UVR8 PE=1 SV=1 UVR8_ARATH reviewed Ultraviolet-B receptor UVR8 (Protein UV-B RESISTANCE 8) (RCC1 domain-containing protein UVR8) Arabidopsis thaliana (Mouse-ear cress) GO:0000785; GO:0003682; GO:0005085; GO:0005634; GO:0005829; GO:0009411; GO:0009536; GO:0009649; GO:0009881; GO:0010224; GO:0042802; GO:0042803 entrainment of circadian clock [GO:0009649]; response to UV [GO:0009411]; response to UV-B [GO:0010224] chromatin [GO:0000785]; cytosol [GO:0005829]; nucleus [GO:0005634]; plastid [GO:0009536] chromatin binding [GO:0003682]; guanyl-nucleotide exchange factor activity [GO:0005085]; identical protein binding [GO:0042802]; photoreceptor activity [GO:0009881]; protein homodimerization activity [GO:0042803] g9425.t2 Q9FN03 33.482 224 1.0600000000000001e-21 102.0 sp|Q9FN03|UVR8_ARATH Ultraviolet-B receptor UVR8 OS=Arabidopsis thaliana OX=3702 GN=UVR8 PE=1 SV=1 UVR8_ARATH reviewed Ultraviolet-B receptor UVR8 (Protein UV-B RESISTANCE 8) (RCC1 domain-containing protein UVR8) Arabidopsis thaliana (Mouse-ear cress) GO:0000785; GO:0003682; GO:0005085; GO:0005634; GO:0005829; GO:0009411; GO:0009536; GO:0009649; GO:0009881; GO:0010224; GO:0042802; GO:0042803 entrainment of circadian clock [GO:0009649]; response to UV [GO:0009411]; response to UV-B [GO:0010224] chromatin [GO:0000785]; cytosol [GO:0005829]; nucleus [GO:0005634]; plastid [GO:0009536] chromatin binding [GO:0003682]; guanyl-nucleotide exchange factor activity [GO:0005085]; identical protein binding [GO:0042802]; photoreceptor activity [GO:0009881]; protein homodimerization activity [GO:0042803] g9427.t1 Q7TN31 42.173 313 1.72e-56 213.0 sp|Q7TN31|AGGF1_MOUSE Angiogenic factor with G patch and FHA domains 1 OS=Mus musculus OX=10090 GN=Aggf1 PE=2 SV=1 AGGF1_MOUSE reviewed Angiogenic factor with G patch and FHA domains 1 (Angiogenic factor VG5Q) (mVG5Q) Mus musculus (Mouse) GO:0001525; GO:0001938; GO:0003676; GO:0005576; GO:0005737; GO:0007155; GO:0030154; GO:0042802; GO:0045766; GO:0048471 angiogenesis [GO:0001525]; cell adhesion [GO:0007155]; cell differentiation [GO:0030154]; positive regulation of angiogenesis [GO:0045766]; positive regulation of endothelial cell proliferation [GO:0001938] cytoplasm [GO:0005737]; extracellular region [GO:0005576]; perinuclear region of cytoplasm [GO:0048471] identical protein binding [GO:0042802]; nucleic acid binding [GO:0003676] g9427.t2 Q7TN31 40.12 334 2.72e-53 203.0 sp|Q7TN31|AGGF1_MOUSE Angiogenic factor with G patch and FHA domains 1 OS=Mus musculus OX=10090 GN=Aggf1 PE=2 SV=1 AGGF1_MOUSE reviewed Angiogenic factor with G patch and FHA domains 1 (Angiogenic factor VG5Q) (mVG5Q) Mus musculus (Mouse) GO:0001525; GO:0001938; GO:0003676; GO:0005576; GO:0005737; GO:0007155; GO:0030154; GO:0042802; GO:0045766; GO:0048471 angiogenesis [GO:0001525]; cell adhesion [GO:0007155]; cell differentiation [GO:0030154]; positive regulation of angiogenesis [GO:0045766]; positive regulation of endothelial cell proliferation [GO:0001938] cytoplasm [GO:0005737]; extracellular region [GO:0005576]; perinuclear region of cytoplasm [GO:0048471] identical protein binding [GO:0042802]; nucleic acid binding [GO:0003676] g9427.t3 Q7TN31 40.12 334 2.9e-53 203.0 sp|Q7TN31|AGGF1_MOUSE Angiogenic factor with G patch and FHA domains 1 OS=Mus musculus OX=10090 GN=Aggf1 PE=2 SV=1 AGGF1_MOUSE reviewed Angiogenic factor with G patch and FHA domains 1 (Angiogenic factor VG5Q) (mVG5Q) Mus musculus (Mouse) GO:0001525; GO:0001938; GO:0003676; GO:0005576; GO:0005737; GO:0007155; GO:0030154; GO:0042802; GO:0045766; GO:0048471 angiogenesis [GO:0001525]; cell adhesion [GO:0007155]; cell differentiation [GO:0030154]; positive regulation of angiogenesis [GO:0045766]; positive regulation of endothelial cell proliferation [GO:0001938] cytoplasm [GO:0005737]; extracellular region [GO:0005576]; perinuclear region of cytoplasm [GO:0048471] identical protein binding [GO:0042802]; nucleic acid binding [GO:0003676] g9428.t1 O88907 55.128 468 6.29e-148 445.0 sp|O88907|PIAS1_MOUSE E3 SUMO-protein ligase PIAS1 OS=Mus musculus OX=10090 GN=Pias1 PE=1 SV=2 PIAS1_MOUSE reviewed E3 SUMO-protein ligase PIAS1 (EC 2.3.2.27) (DEAD/H box-binding protein 1) (Protein inhibitor of activated STAT protein 1) (RING-type E3 ubiquitin transferase PIAS1) Mus musculus (Mouse) GO:0000082; GO:0000122; GO:0000724; GO:0000729; GO:0000785; GO:0000976; GO:0003712; GO:0003714; GO:0005634; GO:0005654; GO:0005856; GO:0006357; GO:0006974; GO:0007259; GO:0007283; GO:0008270; GO:0008542; GO:0016605; GO:0016607; GO:0016925; GO:0019789; GO:0019899; GO:0019904; GO:0031625; GO:0032436; GO:0033235; GO:0034399; GO:0042127; GO:0043066; GO:0045444; GO:0045893; GO:0051152; GO:0061630; GO:0061665; GO:0065004; GO:0098978; GO:0099523; GO:0099524; GO:0140297; GO:1904377 cell surface receptor signaling pathway via JAK-STAT [GO:0007259]; DNA damage response [GO:0006974]; DNA double-strand break processing [GO:0000729]; double-strand break repair via homologous recombination [GO:0000724]; fat cell differentiation [GO:0045444]; G1/S transition of mitotic cell cycle [GO:0000082]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein localization to cell periphery [GO:1904377]; positive regulation of protein sumoylation [GO:0033235]; positive regulation of smooth muscle cell differentiation [GO:0051152]; protein sumoylation [GO:0016925]; protein-DNA complex assembly [GO:0065004]; regulation of cell population proliferation [GO:0042127]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]; visual learning [GO:0008542] chromatin [GO:0000785]; cytoskeleton [GO:0005856]; glutamatergic synapse [GO:0098978]; nuclear periphery [GO:0034399]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; postsynaptic cytosol [GO:0099524]; presynaptic cytosol [GO:0099523] DNA-binding transcription factor binding [GO:0140297]; enzyme binding [GO:0019899]; protein domain specific binding [GO:0019904]; SUMO ligase activity [GO:0061665]; SUMO transferase activity [GO:0019789]; transcription cis-regulatory region binding [GO:0000976]; transcription coregulator activity [GO:0003712]; transcription corepressor activity [GO:0003714]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270] g9429.t1 A0JMA9 60.457 569 0.0 662.0 sp|A0JMA9|KATL2_XENTR Katanin p60 ATPase-containing subunit A-like 2 OS=Xenopus tropicalis OX=8364 GN=katnal2 PE=2 SV=1 g9430.t1 Q96P56 34.879 539 1.14e-81 267.0 sp|Q96P56|CTSR2_HUMAN Cation channel sperm-associated protein 2 OS=Homo sapiens OX=9606 GN=CATSPER2 PE=1 SV=2 g9438.t1 Q9UDY8 32.536 627 1e-67 244.0 sp|Q9UDY8|MALT1_HUMAN Mucosa-associated lymphoid tissue lymphoma translocation protein 1 OS=Homo sapiens OX=9606 GN=MALT1 PE=1 SV=1 MALT1_HUMAN reviewed Mucosa-associated lymphoid tissue lymphoma translocation protein 1 (EC 3.4.22.-) (MALT lymphoma-associated translocation) (Paracaspase) Homo sapiens (Human) GO:0001650; GO:0001923; GO:0002020; GO:0002096; GO:0002726; GO:0004175; GO:0004197; GO:0004842; GO:0005634; GO:0005737; GO:0005829; GO:0006508; GO:0006952; GO:0008233; GO:0009620; GO:0031398; GO:0031663; GO:0032449; GO:0032731; GO:0032743; GO:0032991; GO:0036094; GO:0042098; GO:0042113; GO:0042802; GO:0042981; GO:0043066; GO:0043123; GO:0045087; GO:0048471; GO:0050852; GO:0050856; GO:0051168; GO:0051603; GO:0061133; GO:2000321 B cell activation [GO:0042113]; B-1 B cell differentiation [GO:0001923]; defense response [GO:0006952]; innate immune response [GO:0045087]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; negative regulation of apoptotic process [GO:0043066]; nuclear export [GO:0051168]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of T cell cytokine production [GO:0002726]; positive regulation of T-helper 17 cell differentiation [GO:2000321]; proteolysis [GO:0006508]; proteolysis involved in protein catabolic process [GO:0051603]; regulation of apoptotic process [GO:0042981]; regulation of T cell receptor signaling pathway [GO:0050856]; response to fungus [GO:0009620]; T cell proliferation [GO:0042098]; T cell receptor signaling pathway [GO:0050852] CBM complex [GO:0032449]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; polkadots [GO:0002096]; protein-containing complex [GO:0032991] cysteine-type endopeptidase activity [GO:0004197]; endopeptidase activator activity [GO:0061133]; endopeptidase activity [GO:0004175]; identical protein binding [GO:0042802]; peptidase activity [GO:0008233]; protease binding [GO:0002020]; small molecule binding [GO:0036094]; ubiquitin-protein transferase activity [GO:0004842] g9440.t1 F6NSX9 28.495 372 4.02e-37 155.0 sp|F6NSX9|Z687B_DANRE Zinc finger protein 687b OS=Danio rerio OX=7955 GN=znf687b PE=2 SV=1 g9441.t1 Q9HCS5 49.083 436 7.76e-133 418.0 sp|Q9HCS5|E41LA_HUMAN Band 4.1-like protein 4A OS=Homo sapiens OX=9606 GN=EPB41L4A PE=1 SV=2 g9442.t1 Q9BY12 47.732 926 0.0 686.0 sp|Q9BY12|SCAPE_HUMAN S phase cyclin A-associated protein in the endoplasmic reticulum OS=Homo sapiens OX=9606 GN=SCAPER PE=1 SV=2 SCAPE_HUMAN reviewed S phase cyclin A-associated protein in the endoplasmic reticulum (S phase cyclin A-associated protein in the ER) (Zinc finger protein 291) Homo sapiens (Human) GO:0001547; GO:0003676; GO:0005654; GO:0005783; GO:0005829; GO:0007283; GO:0008270; GO:0016607; GO:0060041; GO:0061827; GO:0072520; GO:1990917 antral ovarian follicle growth [GO:0001547]; retina development in camera-type eye [GO:0060041]; seminiferous tubule development [GO:0072520]; spermatogenesis [GO:0007283] cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; ooplasm [GO:1990917]; sperm head [GO:0061827] nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270] g9442.t1 Q9BY12 41.077 297 6.6e-43 176.0 sp|Q9BY12|SCAPE_HUMAN S phase cyclin A-associated protein in the endoplasmic reticulum OS=Homo sapiens OX=9606 GN=SCAPER PE=1 SV=2 SCAPE_HUMAN reviewed S phase cyclin A-associated protein in the endoplasmic reticulum (S phase cyclin A-associated protein in the ER) (Zinc finger protein 291) Homo sapiens (Human) GO:0001547; GO:0003676; GO:0005654; GO:0005783; GO:0005829; GO:0007283; GO:0008270; GO:0016607; GO:0060041; GO:0061827; GO:0072520; GO:1990917 antral ovarian follicle growth [GO:0001547]; retina development in camera-type eye [GO:0060041]; seminiferous tubule development [GO:0072520]; spermatogenesis [GO:0007283] cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; ooplasm [GO:1990917]; sperm head [GO:0061827] nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270] g9442.t2 Q9BY12 41.227 1499 0.0 809.0 sp|Q9BY12|SCAPE_HUMAN S phase cyclin A-associated protein in the endoplasmic reticulum OS=Homo sapiens OX=9606 GN=SCAPER PE=1 SV=2 SCAPE_HUMAN reviewed S phase cyclin A-associated protein in the endoplasmic reticulum (S phase cyclin A-associated protein in the ER) (Zinc finger protein 291) Homo sapiens (Human) GO:0001547; GO:0003676; GO:0005654; GO:0005783; GO:0005829; GO:0007283; GO:0008270; GO:0016607; GO:0060041; GO:0061827; GO:0072520; GO:1990917 antral ovarian follicle growth [GO:0001547]; retina development in camera-type eye [GO:0060041]; seminiferous tubule development [GO:0072520]; spermatogenesis [GO:0007283] cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; ooplasm [GO:1990917]; sperm head [GO:0061827] nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270] g9444.t1 P53405 63.043 276 9.47e-111 327.0 sp|P53405|ISL1_DANRE Insulin gene enhancer protein isl-1 OS=Danio rerio OX=7955 GN=isl1 PE=2 SV=1 ISL1_DANRE reviewed Insulin gene enhancer protein isl-1 (Islet-1) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000981; GO:0000987; GO:0003322; GO:0003323; GO:0003324; GO:0005634; GO:0007409; GO:0007507; GO:0008016; GO:0021522; GO:0021527; GO:0031017; GO:0031018; GO:0045944; GO:0046872; GO:0048665; GO:0048666; GO:0048675; GO:0048936; GO:0055011; GO:0060931; GO:0097154 atrial cardiac muscle cell differentiation [GO:0055011]; axon extension [GO:0048675]; axonogenesis [GO:0007409]; endocrine pancreas development [GO:0031018]; exocrine pancreas development [GO:0031017]; GABAergic neuron differentiation [GO:0097154]; heart development [GO:0007507]; neuron development [GO:0048666]; neuron fate specification [GO:0048665]; pancreatic A cell development [GO:0003322]; pancreatic D cell development [GO:0003324]; peripheral nervous system neuron axonogenesis [GO:0048936]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of heart contraction [GO:0008016]; sinoatrial node cell development [GO:0060931]; spinal cord association neuron differentiation [GO:0021527]; spinal cord motor neuron differentiation [GO:0021522]; type B pancreatic cell development [GO:0003323] nucleus [GO:0005634] cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872] g9453.t1 P61643 31.855 248 5.19e-34 130.0 sp|P61643|SIA8B_PANTR Alpha-2,8-sialyltransferase 8B OS=Pan troglodytes OX=9598 GN=ST8SIA2 PE=2 SV=1 g17694.t1 Q61687 45.089 672 7.170000000000001e-163 518.0 sp|Q61687|ATRX_MOUSE Transcriptional regulator ATRX OS=Mus musculus OX=10090 GN=Atrx PE=1 SV=3 g17714.t1 Q9UGM3 42.57 249 3.06e-46 173.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g17714.t1 Q9UGM3 42.169 249 1.3399999999999999e-45 171.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g17714.t1 Q9UGM3 44.541 229 1.5599999999999998e-45 171.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g17714.t1 Q9UGM3 42.4 250 3.01e-45 170.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g17714.t1 Q9UGM3 41.767 249 1.05e-44 168.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g17714.t1 Q9UGM3 39.63 270 4.2400000000000003e-44 166.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g17714.t1 Q9UGM3 41.036 251 4.070000000000001e-43 164.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g17714.t1 Q9UGM3 39.921 253 4.930000000000001e-43 163.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g17714.t1 Q9UGM3 40.637 251 2.0699999999999998e-42 162.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g17714.t1 Q9UGM3 41.393 244 2.7499999999999997e-42 161.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g17714.t1 Q9UGM3 40.164 244 2.4e-41 159.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g17714.t1 Q9UGM3 40.081 247 3.28e-41 158.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g17714.t1 Q9UGM3 45.038 131 1.32e-23 106.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g17715.t1 Q3LXA3 46.087 575 1.54e-154 459.0 sp|Q3LXA3|TKFC_HUMAN Triokinase/FMN cyclase OS=Homo sapiens OX=9606 GN=TKFC PE=1 SV=2 TKFC_HUMAN reviewed Triokinase/FMN cyclase (Bifunctional ATP-dependent dihydroxyacetone kinase/FAD-AMP lyase (cyclizing)) [Includes: ATP-dependent dihydroxyacetone kinase (DHA kinase) (EC 2.7.1.28) (EC 2.7.1.29) (Glycerone kinase) (Triokinase) (Triose kinase); FAD-AMP lyase (cyclizing) (EC 4.6.1.15) (FAD-AMP lyase (cyclic FMN forming)) (FMN cyclase)] Homo sapiens (Human) GO:0004371; GO:0005524; GO:0005634; GO:0005829; GO:0005975; GO:0019563; GO:0034012; GO:0039534; GO:0045088; GO:0046835; GO:0046872; GO:0050354; GO:0061624; GO:0070062 carbohydrate metabolic process [GO:0005975]; carbohydrate phosphorylation [GO:0046835]; fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate [GO:0061624]; glycerol catabolic process [GO:0019563]; negative regulation of MDA-5 signaling pathway [GO:0039534]; regulation of innate immune response [GO:0045088] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634] ATP binding [GO:0005524]; FAD-AMP lyase (cyclizing) activity [GO:0034012]; glycerone kinase activity [GO:0004371]; metal ion binding [GO:0046872]; triokinase activity [GO:0050354] g17718.t1 P79100 54.044 779 0.0 744.0 sp|P79100|TRPC4_BOVIN Short transient receptor potential channel 4 OS=Bos taurus OX=9913 GN=TRPC4 PE=2 SV=2 TRPC4_BOVIN reviewed Short transient receptor potential channel 4 (TrpC4) (Capacitative calcium entry channel 1) (CCE1) Bos taurus (Bovine) GO:0005886; GO:0015279; GO:0034703; GO:0046872; GO:0051480; GO:0070588; GO:0070679 calcium ion transmembrane transport [GO:0070588]; regulation of cytosolic calcium ion concentration [GO:0051480] cation channel complex [GO:0034703]; plasma membrane [GO:0005886] inositol 1,4,5 trisphosphate binding [GO:0070679]; metal ion binding [GO:0046872]; store-operated calcium channel activity [GO:0015279] g17719.t1 Q8AVH7 47.177 248 1.7399999999999998e-61 219.0 sp|Q8AVH7|EGFL6_XENLA Epidermal growth factor-like protein 6 OS=Xenopus laevis OX=8355 GN=egfl6 PE=2 SV=1 g17724.t1 Q8AVH7 40.0 205 2.32e-33 139.0 sp|Q8AVH7|EGFL6_XENLA Epidermal growth factor-like protein 6 OS=Xenopus laevis OX=8355 GN=egfl6 PE=2 SV=1 g17725.t1 Q6R6I7 40.228 701 4.53e-174 523.0 sp|Q6R6I7|RXFP1_MOUSE Relaxin receptor 1 OS=Mus musculus OX=10090 GN=Rxfp1 PE=2 SV=1 RXFP1_MOUSE reviewed Relaxin receptor 1 (Leucine-rich repeat-containing G-protein coupled receptor 7) (Relaxin family peptide receptor 1) Mus musculus (Mouse) GO:0004930; GO:0005886; GO:0007188; GO:0007189; GO:0007567; GO:0008528; GO:0009755; GO:0030154; GO:0030198; GO:0042562; GO:0046872; GO:0060427; GO:0060658 adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; cell differentiation [GO:0030154]; extracellular matrix organization [GO:0030198]; hormone-mediated signaling pathway [GO:0009755]; lung connective tissue development [GO:0060427]; nipple morphogenesis [GO:0060658]; parturition [GO:0007567] plasma membrane [GO:0005886] G protein-coupled peptide receptor activity [GO:0008528]; G protein-coupled receptor activity [GO:0004930]; hormone binding [GO:0042562]; metal ion binding [GO:0046872] g17726.t1 Q5M9N0 25.833 840 1.1999999999999999e-39 165.0 sp|Q5M9N0|CD158_HUMAN Coiled-coil domain-containing protein 158 OS=Homo sapiens OX=9606 GN=CCDC158 PE=1 SV=2 CD158_HUMAN reviewed Coiled-coil domain-containing protein 158 Homo sapiens (Human) GO:0005769; GO:0006898; GO:0030136; GO:0030276 receptor-mediated endocytosis [GO:0006898] clathrin-coated vesicle [GO:0030136]; early endosome [GO:0005769] clathrin binding [GO:0030276] g17728.t1 Q8BSL4 31.532 222 1.9100000000000002e-29 115.0 sp|Q8BSL4|HS3S5_MOUSE Heparan sulfate glucosamine 3-O-sulfotransferase 5 OS=Mus musculus OX=10090 GN=Hs3st5 PE=2 SV=1 g17730.t1 O18894 59.621 738 0.0 840.0 sp|O18894|CLCN3_RABIT H(+)/Cl(-) exchange transporter 3 OS=Oryctolagus cuniculus OX=9986 GN=CLCN3 PE=2 SV=3 g17730.t2 O18894 59.54 739 0.0 839.0 sp|O18894|CLCN3_RABIT H(+)/Cl(-) exchange transporter 3 OS=Oryctolagus cuniculus OX=9986 GN=CLCN3 PE=2 SV=3 g17732.t1 Q6P2T7 44.103 195 2.5099999999999998e-54 174.0 sp|Q6P2T7|CD033_DANRE UPF0462 protein C4orf33 homolog OS=Danio rerio OX=7955 GN=zgc:77739 PE=2 SV=1 g17738.t1 Q9W4S1 42.0 250 2.21e-53 189.0 sp|Q9W4S1|GRCR2_DROME Glutaredoxin domain-containing cysteine-rich protein CG12206 OS=Drosophila melanogaster OX=7227 GN=CG12206 PE=2 SV=2 g17740.t1 Q3ZBE9 67.365 334 1.4999999999999999e-174 491.0 sp|Q3ZBE9|NSDHL_BOVIN Sterol-4-alpha-carboxylate 3-dehydrogenase, decarboxylating OS=Bos taurus OX=9913 GN=NSDHL PE=2 SV=1 NSDHL_BOVIN reviewed Sterol-4-alpha-carboxylate 3-dehydrogenase, decarboxylating (EC 1.1.1.170) Bos taurus (Bovine) GO:0005783; GO:0005789; GO:0005811; GO:0006695; GO:0008203; GO:0016616; GO:0102175 cholesterol biosynthetic process [GO:0006695]; cholesterol metabolic process [GO:0008203] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; lipid droplet [GO:0005811] 3-beta-hydroxysteroid dehydrogenase (NAD+)/C4-decarboxylase activity [GO:0102175]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616] g17750.t1 Q53H12 37.241 435 2.2e-86 273.0 sp|Q53H12|AGK_HUMAN Acylglycerol kinase, mitochondrial OS=Homo sapiens OX=9606 GN=AGK PE=1 SV=2 AGK_HUMAN reviewed Acylglycerol kinase, mitochondrial (hAGK) (EC 2.7.1.107) (EC 2.7.1.138) (EC 2.7.1.94) (Multiple substrate lipid kinase) (HsMuLK) (MuLK) (Multi-substrate lipid kinase) Homo sapiens (Human) GO:0001729; GO:0004143; GO:0005524; GO:0005737; GO:0005739; GO:0005741; GO:0005743; GO:0005758; GO:0005829; GO:0016020; GO:0031966; GO:0042721; GO:0045039; GO:0046486; GO:0046512; GO:0046513; GO:0046834; GO:0047620 ceramide biosynthetic process [GO:0046513]; glycerolipid metabolic process [GO:0046486]; lipid phosphorylation [GO:0046834]; protein insertion into mitochondrial inner membrane [GO:0045039]; sphingosine biosynthetic process [GO:0046512] cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrial membrane [GO:0031966]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; TIM22 mitochondrial import inner membrane insertion complex [GO:0042721] acylglycerol kinase activity [GO:0047620]; ATP binding [GO:0005524]; ATP-dependent diacylglycerol kinase activity [GO:0004143]; ceramide kinase activity [GO:0001729] g17751.t1 Q28F39 37.013 154 2.66e-28 109.0 sp|Q28F39|CC134_XENTR Coiled-coil domain-containing protein 134 OS=Xenopus tropicalis OX=8364 GN=ccdc134 PE=2 SV=1 g17754.t1 Q4R5V2 55.114 176 9.62e-57 183.0 sp|Q4R5V2|EMC7_MACFA Endoplasmic reticulum membrane protein complex subunit 7 OS=Macaca fascicularis OX=9541 GN=EMC7 PE=2 SV=1 EMC7_MACFA reviewed Endoplasmic reticulum membrane protein complex subunit 7 (ER membrane protein complex subunit 7) Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey) GO:0005789; GO:0016020; GO:0030246; GO:0045050; GO:0071816; GO:0072546 protein insertion into ER membrane by stop-transfer membrane-anchor sequence [GO:0045050]; tail-anchored membrane protein insertion into ER membrane [GO:0071816] EMC complex [GO:0072546]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020] carbohydrate binding [GO:0030246] g17755.t1 Q61687 51.515 858 0.0 808.0 sp|Q61687|ATRX_MOUSE Transcriptional regulator ATRX OS=Mus musculus OX=10090 GN=Atrx PE=1 SV=3 g17756.t1 Q61687 55.645 124 5.05e-41 168.0 sp|Q61687|ATRX_MOUSE Transcriptional regulator ATRX OS=Mus musculus OX=10090 GN=Atrx PE=1 SV=3 g17760.t1 O95831 54.237 649 0.0 630.0 sp|O95831|AIFM1_HUMAN Apoptosis-inducing factor 1, mitochondrial OS=Homo sapiens OX=9606 GN=AIFM1 PE=1 SV=1 AIFM1_HUMAN reviewed Apoptosis-inducing factor 1, mitochondrial (EC 1.6.99.-) (Programmed cell death protein 8) Homo sapiens (Human) GO:0002931; GO:0003677; GO:0003954; GO:0005634; GO:0005739; GO:0005743; GO:0005758; GO:0005829; GO:0006915; GO:0009636; GO:0016174; GO:0016651; GO:0030182; GO:0033108; GO:0043065; GO:0043525; GO:0045041; GO:0046983; GO:0048471; GO:0060545; GO:0070059; GO:0070301; GO:0071392; GO:0071456; GO:0071732; GO:0071949; GO:0072572; GO:0120212; GO:0160203; GO:1902065; GO:1904045 apoptotic process [GO:0006915]; cellular response to aldosterone [GO:1904045]; cellular response to estradiol stimulus [GO:0071392]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to hypoxia [GO:0071456]; cellular response to nitric oxide [GO:0071732]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; mitochondrial disulfide relay system [GO:0160203]; mitochondrial respiratory chain complex assembly [GO:0033108]; neuron differentiation [GO:0030182]; positive regulation of apoptotic process [GO:0043065]; positive regulation of necroptotic process [GO:0060545]; positive regulation of neuron apoptotic process [GO:0043525]; protein import into mitochondrial intermembrane space [GO:0045041]; response to ischemia [GO:0002931]; response to L-glutamate [GO:1902065]; response to toxic substance [GO:0009636] cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; sperm head-tail coupling apparatus [GO:0120212] DNA binding [GO:0003677]; FAD binding [GO:0071949]; NAD(P)H oxidase H2O2-forming activity [GO:0016174]; NADH dehydrogenase activity [GO:0003954]; oxidoreductase activity, acting on NAD(P)H [GO:0016651]; poly-ADP-D-ribose binding [GO:0072572]; protein dimerization activity [GO:0046983] g17762.t1 Q8BVQ5 54.082 392 2.06e-134 392.0 sp|Q8BVQ5|PPME1_MOUSE Protein phosphatase methylesterase 1 OS=Mus musculus OX=10090 GN=Ppme1 PE=1 SV=5 g17763.t1 O95831 58.248 491 0.0 559.0 sp|O95831|AIFM1_HUMAN Apoptosis-inducing factor 1, mitochondrial OS=Homo sapiens OX=9606 GN=AIFM1 PE=1 SV=1 AIFM1_HUMAN reviewed Apoptosis-inducing factor 1, mitochondrial (EC 1.6.99.-) (Programmed cell death protein 8) Homo sapiens (Human) GO:0002931; GO:0003677; GO:0003954; GO:0005634; GO:0005739; GO:0005743; GO:0005758; GO:0005829; GO:0006915; GO:0009636; GO:0016174; GO:0016651; GO:0030182; GO:0033108; GO:0043065; GO:0043525; GO:0045041; GO:0046983; GO:0048471; GO:0060545; GO:0070059; GO:0070301; GO:0071392; GO:0071456; GO:0071732; GO:0071949; GO:0072572; GO:0120212; GO:0160203; GO:1902065; GO:1904045 apoptotic process [GO:0006915]; cellular response to aldosterone [GO:1904045]; cellular response to estradiol stimulus [GO:0071392]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to hypoxia [GO:0071456]; cellular response to nitric oxide [GO:0071732]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; mitochondrial disulfide relay system [GO:0160203]; mitochondrial respiratory chain complex assembly [GO:0033108]; neuron differentiation [GO:0030182]; positive regulation of apoptotic process [GO:0043065]; positive regulation of necroptotic process [GO:0060545]; positive regulation of neuron apoptotic process [GO:0043525]; protein import into mitochondrial intermembrane space [GO:0045041]; response to ischemia [GO:0002931]; response to L-glutamate [GO:1902065]; response to toxic substance [GO:0009636] cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; sperm head-tail coupling apparatus [GO:0120212] DNA binding [GO:0003677]; FAD binding [GO:0071949]; NAD(P)H oxidase H2O2-forming activity [GO:0016174]; NADH dehydrogenase activity [GO:0003954]; oxidoreductase activity, acting on NAD(P)H [GO:0016651]; poly-ADP-D-ribose binding [GO:0072572]; protein dimerization activity [GO:0046983] g17770.t1 Q969H0 89.048 210 9.56e-126 374.0 sp|Q969H0|FBXW7_HUMAN F-box/WD repeat-containing protein 7 OS=Homo sapiens OX=9606 GN=FBXW7 PE=1 SV=1 FBXW7_HUMAN reviewed F-box/WD repeat-containing protein 7 (Archipelago homolog) (hAgo) (F-box and WD-40 domain-containing protein 7) (F-box protein FBX30) (SEL-10) (hCdc4) Homo sapiens (Human) GO:0001944; GO:0005634; GO:0005654; GO:0005694; GO:0005730; GO:0005737; GO:0005829; GO:0006281; GO:0006974; GO:0007062; GO:0010629; GO:0010868; GO:0010883; GO:0010992; GO:0016567; GO:0019005; GO:0030332; GO:0030674; GO:0031146; GO:0031398; GO:0031625; GO:0032880; GO:0032991; GO:0034644; GO:0042752; GO:0042802; GO:0043130; GO:0043161; GO:0045742; GO:0045746; GO:0048511; GO:0050816; GO:0050821; GO:0055088; GO:0070374; GO:0097027; GO:1901524; GO:1901800; GO:1902806; GO:1903378; GO:1903955; GO:1990452; GO:1990756; GO:2000060; GO:2000346; GO:2000639; GO:2001205 cellular response to UV [GO:0034644]; DNA damage response [GO:0006974]; DNA repair [GO:0006281]; lipid homeostasis [GO:0055088]; negative regulation of gene expression [GO:0010629]; negative regulation of hepatocyte proliferation [GO:2000346]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of osteoclast development [GO:2001205]; negative regulation of SREBP signaling pathway [GO:2000639]; negative regulation of triglyceride biosynthetic process [GO:0010868]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway [GO:1903378]; positive regulation of proteasomal protein catabolic process [GO:1901800]; positive regulation of protein targeting to mitochondrion [GO:1903955]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein stabilization [GO:0050821]; protein ubiquitination [GO:0016567]; regulation of cell cycle G1/S phase transition [GO:1902806]; regulation of circadian rhythm [GO:0042752]; regulation of lipid storage [GO:0010883]; regulation of mitophagy [GO:1901524]; regulation of protein localization [GO:0032880]; rhythmic process [GO:0048511]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; sister chromatid cohesion [GO:0007062]; ubiquitin recycling [GO:0010992]; vasculature development [GO:0001944] chromosome [GO:0005694]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Parkin-FBXW7-Cul1 ubiquitin ligase complex [GO:1990452]; protein-containing complex [GO:0032991]; SCF ubiquitin ligase complex [GO:0019005] cyclin binding [GO:0030332]; identical protein binding [GO:0042802]; phosphothreonine residue binding [GO:0050816]; protein-macromolecule adaptor activity [GO:0030674]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-like ligase-substrate adaptor activity [GO:1990756]; ubiquitin-protein transferase activator activity [GO:0097027] g17770.t1 Q969H0 46.0 150 4.29e-36 137.0 sp|Q969H0|FBXW7_HUMAN F-box/WD repeat-containing protein 7 OS=Homo sapiens OX=9606 GN=FBXW7 PE=1 SV=1 FBXW7_HUMAN reviewed F-box/WD repeat-containing protein 7 (Archipelago homolog) (hAgo) (F-box and WD-40 domain-containing protein 7) (F-box protein FBX30) (SEL-10) (hCdc4) Homo sapiens (Human) GO:0001944; GO:0005634; GO:0005654; GO:0005694; GO:0005730; GO:0005737; GO:0005829; GO:0006281; GO:0006974; GO:0007062; GO:0010629; GO:0010868; GO:0010883; GO:0010992; GO:0016567; GO:0019005; GO:0030332; GO:0030674; GO:0031146; GO:0031398; GO:0031625; GO:0032880; GO:0032991; GO:0034644; GO:0042752; GO:0042802; GO:0043130; GO:0043161; GO:0045742; GO:0045746; GO:0048511; GO:0050816; GO:0050821; GO:0055088; GO:0070374; GO:0097027; GO:1901524; GO:1901800; GO:1902806; GO:1903378; GO:1903955; GO:1990452; GO:1990756; GO:2000060; GO:2000346; GO:2000639; GO:2001205 cellular response to UV [GO:0034644]; DNA damage response [GO:0006974]; DNA repair [GO:0006281]; lipid homeostasis [GO:0055088]; negative regulation of gene expression [GO:0010629]; negative regulation of hepatocyte proliferation [GO:2000346]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of osteoclast development [GO:2001205]; negative regulation of SREBP signaling pathway [GO:2000639]; negative regulation of triglyceride biosynthetic process [GO:0010868]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway [GO:1903378]; positive regulation of proteasomal protein catabolic process [GO:1901800]; positive regulation of protein targeting to mitochondrion [GO:1903955]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein stabilization [GO:0050821]; protein ubiquitination [GO:0016567]; regulation of cell cycle G1/S phase transition [GO:1902806]; regulation of circadian rhythm [GO:0042752]; regulation of lipid storage [GO:0010883]; regulation of mitophagy [GO:1901524]; regulation of protein localization [GO:0032880]; rhythmic process [GO:0048511]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; sister chromatid cohesion [GO:0007062]; ubiquitin recycling [GO:0010992]; vasculature development [GO:0001944] chromosome [GO:0005694]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Parkin-FBXW7-Cul1 ubiquitin ligase complex [GO:1990452]; protein-containing complex [GO:0032991]; SCF ubiquitin ligase complex [GO:0019005] cyclin binding [GO:0030332]; identical protein binding [GO:0042802]; phosphothreonine residue binding [GO:0050816]; protein-macromolecule adaptor activity [GO:0030674]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-like ligase-substrate adaptor activity [GO:1990756]; ubiquitin-protein transferase activator activity [GO:0097027] g17770.t1 Q969H0 41.104 163 9.21e-33 127.0 sp|Q969H0|FBXW7_HUMAN F-box/WD repeat-containing protein 7 OS=Homo sapiens OX=9606 GN=FBXW7 PE=1 SV=1 FBXW7_HUMAN reviewed F-box/WD repeat-containing protein 7 (Archipelago homolog) (hAgo) (F-box and WD-40 domain-containing protein 7) (F-box protein FBX30) (SEL-10) (hCdc4) Homo sapiens (Human) GO:0001944; GO:0005634; GO:0005654; GO:0005694; GO:0005730; GO:0005737; GO:0005829; GO:0006281; GO:0006974; GO:0007062; GO:0010629; GO:0010868; GO:0010883; GO:0010992; GO:0016567; GO:0019005; GO:0030332; GO:0030674; GO:0031146; GO:0031398; GO:0031625; GO:0032880; GO:0032991; GO:0034644; GO:0042752; GO:0042802; GO:0043130; GO:0043161; GO:0045742; GO:0045746; GO:0048511; GO:0050816; GO:0050821; GO:0055088; GO:0070374; GO:0097027; GO:1901524; GO:1901800; GO:1902806; GO:1903378; GO:1903955; GO:1990452; GO:1990756; GO:2000060; GO:2000346; GO:2000639; GO:2001205 cellular response to UV [GO:0034644]; DNA damage response [GO:0006974]; DNA repair [GO:0006281]; lipid homeostasis [GO:0055088]; negative regulation of gene expression [GO:0010629]; negative regulation of hepatocyte proliferation [GO:2000346]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of osteoclast development [GO:2001205]; negative regulation of SREBP signaling pathway [GO:2000639]; negative regulation of triglyceride biosynthetic process [GO:0010868]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway [GO:1903378]; positive regulation of proteasomal protein catabolic process [GO:1901800]; positive regulation of protein targeting to mitochondrion [GO:1903955]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein stabilization [GO:0050821]; protein ubiquitination [GO:0016567]; regulation of cell cycle G1/S phase transition [GO:1902806]; regulation of circadian rhythm [GO:0042752]; regulation of lipid storage [GO:0010883]; regulation of mitophagy [GO:1901524]; regulation of protein localization [GO:0032880]; rhythmic process [GO:0048511]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; sister chromatid cohesion [GO:0007062]; ubiquitin recycling [GO:0010992]; vasculature development [GO:0001944] chromosome [GO:0005694]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Parkin-FBXW7-Cul1 ubiquitin ligase complex [GO:1990452]; protein-containing complex [GO:0032991]; SCF ubiquitin ligase complex [GO:0019005] cyclin binding [GO:0030332]; identical protein binding [GO:0042802]; phosphothreonine residue binding [GO:0050816]; protein-macromolecule adaptor activity [GO:0030674]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-like ligase-substrate adaptor activity [GO:1990756]; ubiquitin-protein transferase activator activity [GO:0097027] g17770.t1 Q969H0 41.27 126 8.94e-25 104.0 sp|Q969H0|FBXW7_HUMAN F-box/WD repeat-containing protein 7 OS=Homo sapiens OX=9606 GN=FBXW7 PE=1 SV=1 FBXW7_HUMAN reviewed F-box/WD repeat-containing protein 7 (Archipelago homolog) (hAgo) (F-box and WD-40 domain-containing protein 7) (F-box protein FBX30) (SEL-10) (hCdc4) Homo sapiens (Human) GO:0001944; GO:0005634; GO:0005654; GO:0005694; GO:0005730; GO:0005737; GO:0005829; GO:0006281; GO:0006974; GO:0007062; GO:0010629; GO:0010868; GO:0010883; GO:0010992; GO:0016567; GO:0019005; GO:0030332; GO:0030674; GO:0031146; GO:0031398; GO:0031625; GO:0032880; GO:0032991; GO:0034644; GO:0042752; GO:0042802; GO:0043130; GO:0043161; GO:0045742; GO:0045746; GO:0048511; GO:0050816; GO:0050821; GO:0055088; GO:0070374; GO:0097027; GO:1901524; GO:1901800; GO:1902806; GO:1903378; GO:1903955; GO:1990452; GO:1990756; GO:2000060; GO:2000346; GO:2000639; GO:2001205 cellular response to UV [GO:0034644]; DNA damage response [GO:0006974]; DNA repair [GO:0006281]; lipid homeostasis [GO:0055088]; negative regulation of gene expression [GO:0010629]; negative regulation of hepatocyte proliferation [GO:2000346]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of osteoclast development [GO:2001205]; negative regulation of SREBP signaling pathway [GO:2000639]; negative regulation of triglyceride biosynthetic process [GO:0010868]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway [GO:1903378]; positive regulation of proteasomal protein catabolic process [GO:1901800]; positive regulation of protein targeting to mitochondrion [GO:1903955]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein stabilization [GO:0050821]; protein ubiquitination [GO:0016567]; regulation of cell cycle G1/S phase transition [GO:1902806]; regulation of circadian rhythm [GO:0042752]; regulation of lipid storage [GO:0010883]; regulation of mitophagy [GO:1901524]; regulation of protein localization [GO:0032880]; rhythmic process [GO:0048511]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; sister chromatid cohesion [GO:0007062]; ubiquitin recycling [GO:0010992]; vasculature development [GO:0001944] chromosome [GO:0005694]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Parkin-FBXW7-Cul1 ubiquitin ligase complex [GO:1990452]; protein-containing complex [GO:0032991]; SCF ubiquitin ligase complex [GO:0019005] cyclin binding [GO:0030332]; identical protein binding [GO:0042802]; phosphothreonine residue binding [GO:0050816]; protein-macromolecule adaptor activity [GO:0030674]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-like ligase-substrate adaptor activity [GO:1990756]; ubiquitin-protein transferase activator activity [GO:0097027] g17771.t1 Q969H0 64.236 288 9.93e-119 370.0 sp|Q969H0|FBXW7_HUMAN F-box/WD repeat-containing protein 7 OS=Homo sapiens OX=9606 GN=FBXW7 PE=1 SV=1 FBXW7_HUMAN reviewed F-box/WD repeat-containing protein 7 (Archipelago homolog) (hAgo) (F-box and WD-40 domain-containing protein 7) (F-box protein FBX30) (SEL-10) (hCdc4) Homo sapiens (Human) GO:0001944; GO:0005634; GO:0005654; GO:0005694; GO:0005730; GO:0005737; GO:0005829; GO:0006281; GO:0006974; GO:0007062; GO:0010629; GO:0010868; GO:0010883; GO:0010992; GO:0016567; GO:0019005; GO:0030332; GO:0030674; GO:0031146; GO:0031398; GO:0031625; GO:0032880; GO:0032991; GO:0034644; GO:0042752; GO:0042802; GO:0043130; GO:0043161; GO:0045742; GO:0045746; GO:0048511; GO:0050816; GO:0050821; GO:0055088; GO:0070374; GO:0097027; GO:1901524; GO:1901800; GO:1902806; GO:1903378; GO:1903955; GO:1990452; GO:1990756; GO:2000060; GO:2000346; GO:2000639; GO:2001205 cellular response to UV [GO:0034644]; DNA damage response [GO:0006974]; DNA repair [GO:0006281]; lipid homeostasis [GO:0055088]; negative regulation of gene expression [GO:0010629]; negative regulation of hepatocyte proliferation [GO:2000346]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of osteoclast development [GO:2001205]; negative regulation of SREBP signaling pathway [GO:2000639]; negative regulation of triglyceride biosynthetic process [GO:0010868]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway [GO:1903378]; positive regulation of proteasomal protein catabolic process [GO:1901800]; positive regulation of protein targeting to mitochondrion [GO:1903955]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein stabilization [GO:0050821]; protein ubiquitination [GO:0016567]; regulation of cell cycle G1/S phase transition [GO:1902806]; regulation of circadian rhythm [GO:0042752]; regulation of lipid storage [GO:0010883]; regulation of mitophagy [GO:1901524]; regulation of protein localization [GO:0032880]; rhythmic process [GO:0048511]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; sister chromatid cohesion [GO:0007062]; ubiquitin recycling [GO:0010992]; vasculature development [GO:0001944] chromosome [GO:0005694]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Parkin-FBXW7-Cul1 ubiquitin ligase complex [GO:1990452]; protein-containing complex [GO:0032991]; SCF ubiquitin ligase complex [GO:0019005] cyclin binding [GO:0030332]; identical protein binding [GO:0042802]; phosphothreonine residue binding [GO:0050816]; protein-macromolecule adaptor activity [GO:0030674]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-like ligase-substrate adaptor activity [GO:1990756]; ubiquitin-protein transferase activator activity [GO:0097027] g17774.t1 Q5F361 59.027 781 0.0 907.0 sp|Q5F361|TBCK_CHICK TBC domain-containing protein kinase-like protein OS=Gallus gallus OX=9031 GN=TBCK PE=2 SV=2 g17775.t1 E7FDB3 70.175 57 6.39e-22 92.0 sp|E7FDB3|NANO1_DANRE Nanos homolog 1 OS=Danio rerio OX=7955 GN=nanos1 PE=3 SV=1 g17779.t1 Q9Z1M7 71.012 652 0.0 1019.0 sp|Q9Z1M7|LARG1_MOUSE Xylosyl- and glucuronyltransferase LARGE1 OS=Mus musculus OX=10090 GN=Large1 PE=1 SV=1 LARG1_MOUSE reviewed Xylosyl- and glucuronyltransferase LARGE1 (EC 2.4.-.-) (Acetylglucosaminyltransferase-like 1A) (Glycosyltransferase-like protein) (LARGE xylosyl- and glucuronyltransferase 1) [Includes: Alpha-1,3-xylosyltransferase LARGE1 (EC 2.4.2.-); Beta-1,3-glucuronyltransferase LARGE1 (EC 2.4.1.-)] Mus musculus (Mouse) GO:0000139; GO:0001568; GO:0001662; GO:0001764; GO:0005794; GO:0005886; GO:0006493; GO:0006612; GO:0006833; GO:0006886; GO:0006941; GO:0007009; GO:0007010; GO:0007268; GO:0007274; GO:0007420; GO:0007507; GO:0007517; GO:0007528; GO:0007605; GO:0007613; GO:0008104; GO:0008340; GO:0009100; GO:0009101; GO:0009416; GO:0009612; GO:0010467; GO:0010842; GO:0014902; GO:0015020; GO:0016757; GO:0016758; GO:0021542; GO:0021675; GO:0021740; GO:0030145; GO:0030225; GO:0031594; GO:0032991; GO:0035129; GO:0035264; GO:0035269; GO:0042285; GO:0042552; GO:0043403; GO:0043687; GO:0046716; GO:0048167; GO:0048708; GO:0048738; GO:0048741; GO:0050808; GO:0050884; GO:0050905; GO:0051124; GO:0051674; GO:0055002; GO:0055013; GO:0055085; GO:0060041; GO:0060173; GO:0060291; GO:0060348; GO:0060538; GO:0061298; GO:0061448; GO:0065003; GO:0071711; GO:0071805; GO:0072657; GO:0072659; GO:0090659; GO:0095500; GO:0098528; GO:0150103 acetylcholine receptor signaling pathway [GO:0095500]; astrocyte differentiation [GO:0048708]; basement membrane organization [GO:0071711]; behavioral fear response [GO:0001662]; blood vessel development [GO:0001568]; bone development [GO:0060348]; brain development [GO:0007420]; cardiac muscle cell development [GO:0055013]; cardiac muscle tissue development [GO:0048738]; chemical synaptic transmission [GO:0007268]; connective tissue development [GO:0061448]; cytoskeleton organization [GO:0007010]; dentate gyrus development [GO:0021542]; determination of adult lifespan [GO:0008340]; gene expression [GO:0010467]; glycoprotein biosynthetic process [GO:0009101]; glycoprotein metabolic process [GO:0009100]; heart development [GO:0007507]; intracellular protein localization [GO:0008104]; intracellular protein transport [GO:0006886]; limb development [GO:0060173]; localization of cell [GO:0051674]; long-term synaptic potentiation [GO:0060291]; macrophage differentiation [GO:0030225]; memory [GO:0007613]; multicellular organism growth [GO:0035264]; muscle cell cellular homeostasis [GO:0046716]; muscle organ development [GO:0007517]; myelination [GO:0042552]; myotube differentiation [GO:0014902]; nerve development [GO:0021675]; neuromuscular junction development [GO:0007528]; neuromuscular process [GO:0050905]; neuromuscular process controlling posture [GO:0050884]; neuromuscular synaptic transmission [GO:0007274]; neuron migration [GO:0001764]; plasma membrane organization [GO:0007009]; post-embryonic hindlimb morphogenesis [GO:0035129]; post-translational protein modification [GO:0043687]; potassium ion transmembrane transport [GO:0071805]; principal sensory nucleus of trigeminal nerve development [GO:0021740]; protein localization to membrane [GO:0072657]; protein localization to plasma membrane [GO:0072659]; protein O-linked glycosylation [GO:0006493]; protein O-linked glycosylation via mannose [GO:0035269]; protein targeting to membrane [GO:0006612]; protein-containing complex assembly [GO:0065003]; reactive gliosis [GO:0150103]; regulation of synaptic plasticity [GO:0048167]; response to light stimulus [GO:0009416]; response to mechanical stimulus [GO:0009612]; retina development in camera-type eye [GO:0060041]; retina layer formation [GO:0010842]; retina vasculature development in camera-type eye [GO:0061298]; sensory perception of sound [GO:0007605]; skeletal muscle fiber development [GO:0048741]; skeletal muscle fiber differentiation [GO:0098528]; skeletal muscle organ development [GO:0060538]; skeletal muscle tissue regeneration [GO:0043403]; striated muscle cell development [GO:0055002]; striated muscle contraction [GO:0006941]; synapse organization [GO:0050808]; synaptic assembly at neuromuscular junction [GO:0051124]; transmembrane transport [GO:0055085]; walking behavior [GO:0090659]; water transport [GO:0006833] Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; neuromuscular junction [GO:0031594]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] glucuronosyltransferase activity [GO:0015020]; glycosyltransferase activity [GO:0016757]; hexosyltransferase activity [GO:0016758]; manganese ion binding [GO:0030145]; xylosyltransferase activity [GO:0042285] g17780.t1 Q55GU0 44.094 254 3.1199999999999998e-52 203.0 sp|Q55GU0|Y9955_DICDI Probable serine/threonine-protein kinase DDB_G0267514 OS=Dictyostelium discoideum OX=44689 GN=DDB_G0267514 PE=3 SV=1 g17781.t1 P31754 55.136 477 0.0 533.0 sp|P31754|UMPS_BOVIN Uridine 5'-monophosphate synthase OS=Bos taurus OX=9913 GN=UMPS PE=2 SV=1 g17782.t1 Q9CZV8 32.677 254 4.9799999999999996e-23 105.0 sp|Q9CZV8|FXL20_MOUSE F-box/LRR-repeat protein 20 OS=Mus musculus OX=10090 GN=Fbxl20 PE=1 SV=3 FXL20_MOUSE reviewed F-box/LRR-repeat protein 20 (F-box and leucine-rich repeat protein 20) (F-box/LRR-repeat protein 2-like) Mus musculus (Mouse) GO:0001662; GO:0005737; GO:0019005; GO:0031146; GO:0045202; GO:0098685; GO:0098793; GO:0098978; GO:0099575; GO:2000300 behavioral fear response [GO:0001662]; regulation of protein catabolic process at presynapse, modulating synaptic transmission [GO:0099575]; regulation of synaptic vesicle exocytosis [GO:2000300]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146] cytoplasm [GO:0005737]; glutamatergic synapse [GO:0098978]; presynapse [GO:0098793]; SCF ubiquitin ligase complex [GO:0019005]; Schaffer collateral - CA1 synapse [GO:0098685]; synapse [GO:0045202] g17783.t1 Q6ZQ82 51.032 533 6.12e-170 504.0 sp|Q6ZQ82|RHG26_MOUSE Rho GTPase-activating protein 26 OS=Mus musculus OX=10090 GN=Arhgap26 PE=1 SV=3 g17783.t2 Q6ZQ82 51.124 534 1.3199999999999999e-168 501.0 sp|Q6ZQ82|RHG26_MOUSE Rho GTPase-activating protein 26 OS=Mus musculus OX=10090 GN=Arhgap26 PE=1 SV=3 g17783.t3 Q6ZQ82 50.654 535 1.3200000000000001e-166 495.0 sp|Q6ZQ82|RHG26_MOUSE Rho GTPase-activating protein 26 OS=Mus musculus OX=10090 GN=Arhgap26 PE=1 SV=3 g17789.t1 D2I3C6 57.102 697 0.0 739.0 sp|D2I3C6|DCLK2_AILME Serine/threonine-protein kinase DCLK2 OS=Ailuropoda melanoleuca OX=9646 GN=DCLK2 PE=3 SV=1 g17790.t1 Q5ZLF0 55.762 269 1.7e-80 256.0 sp|Q5ZLF0|F10A1_CHICK Hsc70-interacting protein OS=Gallus gallus OX=9031 GN=ST13 PE=2 SV=1 F10A1_CHICK reviewed Hsc70-interacting protein (Hip) (Protein FAM10A1) (Protein ST13 homolog) Gallus gallus (Chicken) GO:0005737; GO:0030544; GO:0046983 cytoplasm [GO:0005737] Hsp70 protein binding [GO:0030544]; protein dimerization activity [GO:0046983] g17791.t1 Q90577 56.209 459 0.0 527.0 sp|Q90577|SRCA_CHICK Sarcalumenin OS=Gallus gallus OX=9031 GN=SRL PE=2 SV=2 g17792.t1 O95714 64.0 275 6.299999999999999e-106 339.0 sp|O95714|HERC2_HUMAN E3 ubiquitin-protein ligase HERC2 OS=Homo sapiens OX=9606 GN=HERC2 PE=1 SV=2 HERC2_HUMAN reviewed E3 ubiquitin-protein ligase HERC2 (EC 2.3.2.26) (HECT domain and RCC1-like domain-containing protein 2) (HECT-type E3 ubiquitin transferase HERC2) Homo sapiens (Human) GO:0005085; GO:0005634; GO:0005654; GO:0005737; GO:0005814; GO:0005829; GO:0005886; GO:0006281; GO:0006886; GO:0006974; GO:0007283; GO:0008270; GO:0016020; GO:0016567; GO:0030182; GO:0031625; GO:0032183; GO:0043161; GO:0045746; GO:0050821; GO:0061630 DNA damage response [GO:0006974]; DNA repair [GO:0006281]; intracellular protein transport [GO:0006886]; negative regulation of Notch signaling pathway [GO:0045746]; neuron differentiation [GO:0030182]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein stabilization [GO:0050821]; protein ubiquitination [GO:0016567]; spermatogenesis [GO:0007283] centriole [GO:0005814]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886] guanyl-nucleotide exchange factor activity [GO:0005085]; SUMO binding [GO:0032183]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270] g17793.t1 Q4U2R1 43.97 2156 0.0 1483.0 sp|Q4U2R1|HERC2_MOUSE E3 ubiquitin-protein ligase HERC2 OS=Mus musculus OX=10090 GN=Herc2 PE=1 SV=3 HERC2_MOUSE reviewed E3 ubiquitin-protein ligase HERC2 (EC 2.3.2.26) (HECT domain and RCC1-like domain-containing protein 2) (HECT-type E3 ubiquitin transferase HERC2) Mus musculus (Mouse) GO:0005634; GO:0005737; GO:0005743; GO:0005814; GO:0005829; GO:0005886; GO:0006281; GO:0006974; GO:0007283; GO:0008270; GO:0016020; GO:0016567; GO:0030182; GO:0031625; GO:0032183; GO:0043161; GO:0045746; GO:0061630 DNA damage response [GO:0006974]; DNA repair [GO:0006281]; negative regulation of Notch signaling pathway [GO:0045746]; neuron differentiation [GO:0030182]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; spermatogenesis [GO:0007283] centriole [GO:0005814]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; nucleus [GO:0005634]; plasma membrane [GO:0005886] SUMO binding [GO:0032183]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270] g17793.t1 Q4U2R1 38.92 352 1.43e-60 236.0 sp|Q4U2R1|HERC2_MOUSE E3 ubiquitin-protein ligase HERC2 OS=Mus musculus OX=10090 GN=Herc2 PE=1 SV=3 HERC2_MOUSE reviewed E3 ubiquitin-protein ligase HERC2 (EC 2.3.2.26) (HECT domain and RCC1-like domain-containing protein 2) (HECT-type E3 ubiquitin transferase HERC2) Mus musculus (Mouse) GO:0005634; GO:0005737; GO:0005743; GO:0005814; GO:0005829; GO:0005886; GO:0006281; GO:0006974; GO:0007283; GO:0008270; GO:0016020; GO:0016567; GO:0030182; GO:0031625; GO:0032183; GO:0043161; GO:0045746; GO:0061630 DNA damage response [GO:0006974]; DNA repair [GO:0006281]; negative regulation of Notch signaling pathway [GO:0045746]; neuron differentiation [GO:0030182]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; spermatogenesis [GO:0007283] centriole [GO:0005814]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; nucleus [GO:0005634]; plasma membrane [GO:0005886] SUMO binding [GO:0032183]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270] g17793.t1 Q4U2R1 36.388 371 9.48e-59 229.0 sp|Q4U2R1|HERC2_MOUSE E3 ubiquitin-protein ligase HERC2 OS=Mus musculus OX=10090 GN=Herc2 PE=1 SV=3 HERC2_MOUSE reviewed E3 ubiquitin-protein ligase HERC2 (EC 2.3.2.26) (HECT domain and RCC1-like domain-containing protein 2) (HECT-type E3 ubiquitin transferase HERC2) Mus musculus (Mouse) GO:0005634; GO:0005737; GO:0005743; GO:0005814; GO:0005829; GO:0005886; GO:0006281; GO:0006974; GO:0007283; GO:0008270; GO:0016020; GO:0016567; GO:0030182; GO:0031625; GO:0032183; GO:0043161; GO:0045746; GO:0061630 DNA damage response [GO:0006974]; DNA repair [GO:0006281]; negative regulation of Notch signaling pathway [GO:0045746]; neuron differentiation [GO:0030182]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; spermatogenesis [GO:0007283] centriole [GO:0005814]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; nucleus [GO:0005634]; plasma membrane [GO:0005886] SUMO binding [GO:0032183]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270] g17793.t2 O95714 56.278 3966 0.0 3969.0 sp|O95714|HERC2_HUMAN E3 ubiquitin-protein ligase HERC2 OS=Homo sapiens OX=9606 GN=HERC2 PE=1 SV=2 HERC2_HUMAN reviewed E3 ubiquitin-protein ligase HERC2 (EC 2.3.2.26) (HECT domain and RCC1-like domain-containing protein 2) (HECT-type E3 ubiquitin transferase HERC2) Homo sapiens (Human) GO:0005085; GO:0005634; GO:0005654; GO:0005737; GO:0005814; GO:0005829; GO:0005886; GO:0006281; GO:0006886; GO:0006974; GO:0007283; GO:0008270; GO:0016020; GO:0016567; GO:0030182; GO:0031625; GO:0032183; GO:0043161; GO:0045746; GO:0050821; GO:0061630 DNA damage response [GO:0006974]; DNA repair [GO:0006281]; intracellular protein transport [GO:0006886]; negative regulation of Notch signaling pathway [GO:0045746]; neuron differentiation [GO:0030182]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein stabilization [GO:0050821]; protein ubiquitination [GO:0016567]; spermatogenesis [GO:0007283] centriole [GO:0005814]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886] guanyl-nucleotide exchange factor activity [GO:0005085]; SUMO binding [GO:0032183]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270] g17793.t2 O95714 49.051 369 3.26e-81 305.0 sp|O95714|HERC2_HUMAN E3 ubiquitin-protein ligase HERC2 OS=Homo sapiens OX=9606 GN=HERC2 PE=1 SV=2 HERC2_HUMAN reviewed E3 ubiquitin-protein ligase HERC2 (EC 2.3.2.26) (HECT domain and RCC1-like domain-containing protein 2) (HECT-type E3 ubiquitin transferase HERC2) Homo sapiens (Human) GO:0005085; GO:0005634; GO:0005654; GO:0005737; GO:0005814; GO:0005829; GO:0005886; GO:0006281; GO:0006886; GO:0006974; GO:0007283; GO:0008270; GO:0016020; GO:0016567; GO:0030182; GO:0031625; GO:0032183; GO:0043161; GO:0045746; GO:0050821; GO:0061630 DNA damage response [GO:0006974]; DNA repair [GO:0006281]; intracellular protein transport [GO:0006886]; negative regulation of Notch signaling pathway [GO:0045746]; neuron differentiation [GO:0030182]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein stabilization [GO:0050821]; protein ubiquitination [GO:0016567]; spermatogenesis [GO:0007283] centriole [GO:0005814]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886] guanyl-nucleotide exchange factor activity [GO:0005085]; SUMO binding [GO:0032183]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270] g17793.t2 O95714 44.865 370 3.29e-81 305.0 sp|O95714|HERC2_HUMAN E3 ubiquitin-protein ligase HERC2 OS=Homo sapiens OX=9606 GN=HERC2 PE=1 SV=2 HERC2_HUMAN reviewed E3 ubiquitin-protein ligase HERC2 (EC 2.3.2.26) (HECT domain and RCC1-like domain-containing protein 2) (HECT-type E3 ubiquitin transferase HERC2) Homo sapiens (Human) GO:0005085; GO:0005634; GO:0005654; GO:0005737; GO:0005814; GO:0005829; GO:0005886; GO:0006281; GO:0006886; GO:0006974; GO:0007283; GO:0008270; GO:0016020; GO:0016567; GO:0030182; GO:0031625; GO:0032183; GO:0043161; GO:0045746; GO:0050821; GO:0061630 DNA damage response [GO:0006974]; DNA repair [GO:0006281]; intracellular protein transport [GO:0006886]; negative regulation of Notch signaling pathway [GO:0045746]; neuron differentiation [GO:0030182]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein stabilization [GO:0050821]; protein ubiquitination [GO:0016567]; spermatogenesis [GO:0007283] centriole [GO:0005814]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886] guanyl-nucleotide exchange factor activity [GO:0005085]; SUMO binding [GO:0032183]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270] g17793.t3 O95714 56.01 3985 0.0 3955.0 sp|O95714|HERC2_HUMAN E3 ubiquitin-protein ligase HERC2 OS=Homo sapiens OX=9606 GN=HERC2 PE=1 SV=2 HERC2_HUMAN reviewed E3 ubiquitin-protein ligase HERC2 (EC 2.3.2.26) (HECT domain and RCC1-like domain-containing protein 2) (HECT-type E3 ubiquitin transferase HERC2) Homo sapiens (Human) GO:0005085; GO:0005634; GO:0005654; GO:0005737; GO:0005814; GO:0005829; GO:0005886; GO:0006281; GO:0006886; GO:0006974; GO:0007283; GO:0008270; GO:0016020; GO:0016567; GO:0030182; GO:0031625; GO:0032183; GO:0043161; GO:0045746; GO:0050821; GO:0061630 DNA damage response [GO:0006974]; DNA repair [GO:0006281]; intracellular protein transport [GO:0006886]; negative regulation of Notch signaling pathway [GO:0045746]; neuron differentiation [GO:0030182]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein stabilization [GO:0050821]; protein ubiquitination [GO:0016567]; spermatogenesis [GO:0007283] centriole [GO:0005814]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886] guanyl-nucleotide exchange factor activity [GO:0005085]; SUMO binding [GO:0032183]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270] g17793.t3 O95714 44.865 370 3.4299999999999997e-81 305.0 sp|O95714|HERC2_HUMAN E3 ubiquitin-protein ligase HERC2 OS=Homo sapiens OX=9606 GN=HERC2 PE=1 SV=2 HERC2_HUMAN reviewed E3 ubiquitin-protein ligase HERC2 (EC 2.3.2.26) (HECT domain and RCC1-like domain-containing protein 2) (HECT-type E3 ubiquitin transferase HERC2) Homo sapiens (Human) GO:0005085; GO:0005634; GO:0005654; GO:0005737; GO:0005814; GO:0005829; GO:0005886; GO:0006281; GO:0006886; GO:0006974; GO:0007283; GO:0008270; GO:0016020; GO:0016567; GO:0030182; GO:0031625; GO:0032183; GO:0043161; GO:0045746; GO:0050821; GO:0061630 DNA damage response [GO:0006974]; DNA repair [GO:0006281]; intracellular protein transport [GO:0006886]; negative regulation of Notch signaling pathway [GO:0045746]; neuron differentiation [GO:0030182]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein stabilization [GO:0050821]; protein ubiquitination [GO:0016567]; spermatogenesis [GO:0007283] centriole [GO:0005814]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886] guanyl-nucleotide exchange factor activity [GO:0005085]; SUMO binding [GO:0032183]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270] g17793.t3 O95714 49.051 369 3.51e-81 305.0 sp|O95714|HERC2_HUMAN E3 ubiquitin-protein ligase HERC2 OS=Homo sapiens OX=9606 GN=HERC2 PE=1 SV=2 HERC2_HUMAN reviewed E3 ubiquitin-protein ligase HERC2 (EC 2.3.2.26) (HECT domain and RCC1-like domain-containing protein 2) (HECT-type E3 ubiquitin transferase HERC2) Homo sapiens (Human) GO:0005085; GO:0005634; GO:0005654; GO:0005737; GO:0005814; GO:0005829; GO:0005886; GO:0006281; GO:0006886; GO:0006974; GO:0007283; GO:0008270; GO:0016020; GO:0016567; GO:0030182; GO:0031625; GO:0032183; GO:0043161; GO:0045746; GO:0050821; GO:0061630 DNA damage response [GO:0006974]; DNA repair [GO:0006281]; intracellular protein transport [GO:0006886]; negative regulation of Notch signaling pathway [GO:0045746]; neuron differentiation [GO:0030182]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein stabilization [GO:0050821]; protein ubiquitination [GO:0016567]; spermatogenesis [GO:0007283] centriole [GO:0005814]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886] guanyl-nucleotide exchange factor activity [GO:0005085]; SUMO binding [GO:0032183]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270] g17793.t4 O95714 45.957 235 2.25e-55 194.0 sp|O95714|HERC2_HUMAN E3 ubiquitin-protein ligase HERC2 OS=Homo sapiens OX=9606 GN=HERC2 PE=1 SV=2 HERC2_HUMAN reviewed E3 ubiquitin-protein ligase HERC2 (EC 2.3.2.26) (HECT domain and RCC1-like domain-containing protein 2) (HECT-type E3 ubiquitin transferase HERC2) Homo sapiens (Human) GO:0005085; GO:0005634; GO:0005654; GO:0005737; GO:0005814; GO:0005829; GO:0005886; GO:0006281; GO:0006886; GO:0006974; GO:0007283; GO:0008270; GO:0016020; GO:0016567; GO:0030182; GO:0031625; GO:0032183; GO:0043161; GO:0045746; GO:0050821; GO:0061630 DNA damage response [GO:0006974]; DNA repair [GO:0006281]; intracellular protein transport [GO:0006886]; negative regulation of Notch signaling pathway [GO:0045746]; neuron differentiation [GO:0030182]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein stabilization [GO:0050821]; protein ubiquitination [GO:0016567]; spermatogenesis [GO:0007283] centriole [GO:0005814]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886] guanyl-nucleotide exchange factor activity [GO:0005085]; SUMO binding [GO:0032183]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270] g17793.t4 O95714 39.07 215 1.18e-39 149.0 sp|O95714|HERC2_HUMAN E3 ubiquitin-protein ligase HERC2 OS=Homo sapiens OX=9606 GN=HERC2 PE=1 SV=2 HERC2_HUMAN reviewed E3 ubiquitin-protein ligase HERC2 (EC 2.3.2.26) (HECT domain and RCC1-like domain-containing protein 2) (HECT-type E3 ubiquitin transferase HERC2) Homo sapiens (Human) GO:0005085; GO:0005634; GO:0005654; GO:0005737; GO:0005814; GO:0005829; GO:0005886; GO:0006281; GO:0006886; GO:0006974; GO:0007283; GO:0008270; GO:0016020; GO:0016567; GO:0030182; GO:0031625; GO:0032183; GO:0043161; GO:0045746; GO:0050821; GO:0061630 DNA damage response [GO:0006974]; DNA repair [GO:0006281]; intracellular protein transport [GO:0006886]; negative regulation of Notch signaling pathway [GO:0045746]; neuron differentiation [GO:0030182]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein stabilization [GO:0050821]; protein ubiquitination [GO:0016567]; spermatogenesis [GO:0007283] centriole [GO:0005814]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886] guanyl-nucleotide exchange factor activity [GO:0005085]; SUMO binding [GO:0032183]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270] g17793.t4 O95714 42.347 196 2.2899999999999998e-38 145.0 sp|O95714|HERC2_HUMAN E3 ubiquitin-protein ligase HERC2 OS=Homo sapiens OX=9606 GN=HERC2 PE=1 SV=2 HERC2_HUMAN reviewed E3 ubiquitin-protein ligase HERC2 (EC 2.3.2.26) (HECT domain and RCC1-like domain-containing protein 2) (HECT-type E3 ubiquitin transferase HERC2) Homo sapiens (Human) GO:0005085; GO:0005634; GO:0005654; GO:0005737; GO:0005814; GO:0005829; GO:0005886; GO:0006281; GO:0006886; GO:0006974; GO:0007283; GO:0008270; GO:0016020; GO:0016567; GO:0030182; GO:0031625; GO:0032183; GO:0043161; GO:0045746; GO:0050821; GO:0061630 DNA damage response [GO:0006974]; DNA repair [GO:0006281]; intracellular protein transport [GO:0006886]; negative regulation of Notch signaling pathway [GO:0045746]; neuron differentiation [GO:0030182]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein stabilization [GO:0050821]; protein ubiquitination [GO:0016567]; spermatogenesis [GO:0007283] centriole [GO:0005814]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886] guanyl-nucleotide exchange factor activity [GO:0005085]; SUMO binding [GO:0032183]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270] g17793.t4 O95714 34.211 190 1.42e-22 100.0 sp|O95714|HERC2_HUMAN E3 ubiquitin-protein ligase HERC2 OS=Homo sapiens OX=9606 GN=HERC2 PE=1 SV=2 HERC2_HUMAN reviewed E3 ubiquitin-protein ligase HERC2 (EC 2.3.2.26) (HECT domain and RCC1-like domain-containing protein 2) (HECT-type E3 ubiquitin transferase HERC2) Homo sapiens (Human) GO:0005085; GO:0005634; GO:0005654; GO:0005737; GO:0005814; GO:0005829; GO:0005886; GO:0006281; GO:0006886; GO:0006974; GO:0007283; GO:0008270; GO:0016020; GO:0016567; GO:0030182; GO:0031625; GO:0032183; GO:0043161; GO:0045746; GO:0050821; GO:0061630 DNA damage response [GO:0006974]; DNA repair [GO:0006281]; intracellular protein transport [GO:0006886]; negative regulation of Notch signaling pathway [GO:0045746]; neuron differentiation [GO:0030182]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein stabilization [GO:0050821]; protein ubiquitination [GO:0016567]; spermatogenesis [GO:0007283] centriole [GO:0005814]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886] guanyl-nucleotide exchange factor activity [GO:0005085]; SUMO binding [GO:0032183]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270] g17793.t4 O95714 39.394 132 5.94e-22 98.2 sp|O95714|HERC2_HUMAN E3 ubiquitin-protein ligase HERC2 OS=Homo sapiens OX=9606 GN=HERC2 PE=1 SV=2 HERC2_HUMAN reviewed E3 ubiquitin-protein ligase HERC2 (EC 2.3.2.26) (HECT domain and RCC1-like domain-containing protein 2) (HECT-type E3 ubiquitin transferase HERC2) Homo sapiens (Human) GO:0005085; GO:0005634; GO:0005654; GO:0005737; GO:0005814; GO:0005829; GO:0005886; GO:0006281; GO:0006886; GO:0006974; GO:0007283; GO:0008270; GO:0016020; GO:0016567; GO:0030182; GO:0031625; GO:0032183; GO:0043161; GO:0045746; GO:0050821; GO:0061630 DNA damage response [GO:0006974]; DNA repair [GO:0006281]; intracellular protein transport [GO:0006886]; negative regulation of Notch signaling pathway [GO:0045746]; neuron differentiation [GO:0030182]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein stabilization [GO:0050821]; protein ubiquitination [GO:0016567]; spermatogenesis [GO:0007283] centriole [GO:0005814]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886] guanyl-nucleotide exchange factor activity [GO:0005085]; SUMO binding [GO:0032183]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270] g17793.t4 O95714 31.731 208 8.050000000000001e-21 95.1 sp|O95714|HERC2_HUMAN E3 ubiquitin-protein ligase HERC2 OS=Homo sapiens OX=9606 GN=HERC2 PE=1 SV=2 HERC2_HUMAN reviewed E3 ubiquitin-protein ligase HERC2 (EC 2.3.2.26) (HECT domain and RCC1-like domain-containing protein 2) (HECT-type E3 ubiquitin transferase HERC2) Homo sapiens (Human) GO:0005085; GO:0005634; GO:0005654; GO:0005737; GO:0005814; GO:0005829; GO:0005886; GO:0006281; GO:0006886; GO:0006974; GO:0007283; GO:0008270; GO:0016020; GO:0016567; GO:0030182; GO:0031625; GO:0032183; GO:0043161; GO:0045746; GO:0050821; GO:0061630 DNA damage response [GO:0006974]; DNA repair [GO:0006281]; intracellular protein transport [GO:0006886]; negative regulation of Notch signaling pathway [GO:0045746]; neuron differentiation [GO:0030182]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein stabilization [GO:0050821]; protein ubiquitination [GO:0016567]; spermatogenesis [GO:0007283] centriole [GO:0005814]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886] guanyl-nucleotide exchange factor activity [GO:0005085]; SUMO binding [GO:0032183]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270] g17795.t1 Q17P71 56.083 337 5.19e-133 390.0 sp|Q17P71|T23O_AEDAE Tryptophan 2,3-dioxygenase OS=Aedes aegypti OX=7159 GN=AAEL000428 PE=1 SV=1 T23O_AEDAE reviewed Tryptophan 2,3-dioxygenase (TDO) (EC 1.13.11.11) (Tryptamin 2,3-dioxygenase) (Tryptophan oxygenase) (TO) (TRPO) (Tryptophan pyrrolase) (Tryptophanase) Aedes aegypti (Yellowfever mosquito) (Culex aegypti) GO:0004833; GO:0006727; GO:0019441; GO:0019442; GO:0020037; GO:0046872 L-tryptophan catabolic process to acetyl-CoA [GO:0019442]; L-tryptophan catabolic process to kynurenine [GO:0019441]; ommochrome biosynthetic process [GO:0006727] heme binding [GO:0020037]; L-tryptophan 2,3-dioxygenase activity [GO:0004833]; metal ion binding [GO:0046872] g17796.t1 Q8BM88 39.073 302 2.86e-72 230.0 sp|Q8BM88|CATO_MOUSE Cathepsin O OS=Mus musculus OX=10090 GN=Ctso PE=2 SV=1 g17798.t1 Q3UGF1 61.93 570 0.0 768.0 sp|Q3UGF1|WDR19_MOUSE WD repeat-containing protein 19 OS=Mus musculus OX=10090 GN=Wdr19 PE=1 SV=1 WDR19_MOUSE reviewed WD repeat-containing protein 19 (Intraflagellar transport 144 homolog) Mus musculus (Mouse) GO:0000902; GO:0001701; GO:0001750; GO:0005886; GO:0005929; GO:0007224; GO:0008406; GO:0030326; GO:0030991; GO:0031076; GO:0031514; GO:0032391; GO:0035721; GO:0042471; GO:0043113; GO:0048701; GO:0050877; GO:0055123; GO:0060271; GO:0061055; GO:0061512; GO:0065003; GO:0097730; GO:1903441 cell morphogenesis [GO:0000902]; cilium assembly [GO:0060271]; digestive system development [GO:0055123]; ear morphogenesis [GO:0042471]; embryonic camera-type eye development [GO:0031076]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic limb morphogenesis [GO:0030326]; gonad development [GO:0008406]; in utero embryonic development [GO:0001701]; intraciliary retrograde transport [GO:0035721]; myotome development [GO:0061055]; nervous system process [GO:0050877]; protein localization to ciliary membrane [GO:1903441]; protein localization to cilium [GO:0061512]; protein-containing complex assembly [GO:0065003]; receptor clustering [GO:0043113]; smoothened signaling pathway [GO:0007224] cilium [GO:0005929]; intraciliary transport particle A [GO:0030991]; motile cilium [GO:0031514]; non-motile cilium [GO:0097730]; photoreceptor connecting cilium [GO:0032391]; photoreceptor outer segment [GO:0001750]; plasma membrane [GO:0005886] g17799.t1 Q3UGF1 67.374 754 0.0 1030.0 sp|Q3UGF1|WDR19_MOUSE WD repeat-containing protein 19 OS=Mus musculus OX=10090 GN=Wdr19 PE=1 SV=1 WDR19_MOUSE reviewed WD repeat-containing protein 19 (Intraflagellar transport 144 homolog) Mus musculus (Mouse) GO:0000902; GO:0001701; GO:0001750; GO:0005886; GO:0005929; GO:0007224; GO:0008406; GO:0030326; GO:0030991; GO:0031076; GO:0031514; GO:0032391; GO:0035721; GO:0042471; GO:0043113; GO:0048701; GO:0050877; GO:0055123; GO:0060271; GO:0061055; GO:0061512; GO:0065003; GO:0097730; GO:1903441 cell morphogenesis [GO:0000902]; cilium assembly [GO:0060271]; digestive system development [GO:0055123]; ear morphogenesis [GO:0042471]; embryonic camera-type eye development [GO:0031076]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic limb morphogenesis [GO:0030326]; gonad development [GO:0008406]; in utero embryonic development [GO:0001701]; intraciliary retrograde transport [GO:0035721]; myotome development [GO:0061055]; nervous system process [GO:0050877]; protein localization to ciliary membrane [GO:1903441]; protein localization to cilium [GO:0061512]; protein-containing complex assembly [GO:0065003]; receptor clustering [GO:0043113]; smoothened signaling pathway [GO:0007224] cilium [GO:0005929]; intraciliary transport particle A [GO:0030991]; motile cilium [GO:0031514]; non-motile cilium [GO:0097730]; photoreceptor connecting cilium [GO:0032391]; photoreceptor outer segment [GO:0001750]; plasma membrane [GO:0005886] g17801.t1 Q86YT5 47.755 490 2.58e-119 366.0 sp|Q86YT5|S13A5_HUMAN Na(+)/citrate cotransporter OS=Homo sapiens OX=9606 GN=SLC13A5 PE=1 SV=1 S13A5_HUMAN reviewed Na(+)/citrate cotransporter (NaCT) (Sodium-coupled citrate transporter) (Sodium-dependent citrate transporter) (Solute carrier family 13 member 5) Homo sapiens (Human) GO:0005343; GO:0005654; GO:0005829; GO:0005886; GO:0015137; GO:0015141; GO:0015729; GO:0015741; GO:0015742; GO:0015744; GO:0015746; GO:0017153; GO:0042802; GO:0055085; GO:0071285 alpha-ketoglutarate transport [GO:0015742]; cellular response to lithium ion [GO:0071285]; citrate transport [GO:0015746]; fumarate transport [GO:0015741]; oxaloacetate transport [GO:0015729]; succinate transport [GO:0015744]; transmembrane transport [GO:0055085] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] citrate transmembrane transporter activity [GO:0015137]; identical protein binding [GO:0042802]; organic acid:sodium symporter activity [GO:0005343]; sodium:dicarboxylate symporter activity [GO:0017153]; succinate transmembrane transporter activity [GO:0015141] g17802.t1 O88871 31.209 910 4.91e-116 385.0 sp|O88871|GABR2_RAT Gamma-aminobutyric acid type B receptor subunit 2 OS=Rattus norvegicus OX=10116 GN=Gabbr2 PE=1 SV=2 GABR2_RAT reviewed Gamma-aminobutyric acid type B receptor subunit 2 (GABA-B receptor 2) (GABA-B-R2) (GABA-BR2) (GABABR2) (Gb2) (G-protein coupled receptor 51) Rattus norvegicus (Rat) GO:0004965; GO:0005737; GO:0005886; GO:0007193; GO:0007214; GO:0030425; GO:0038039; GO:0042734; GO:0043005; GO:0043204; GO:0045211; GO:0046982; GO:0051932; GO:0098978; GO:0098982; GO:0150099; GO:1902710; GO:1902712 adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; gamma-aminobutyric acid signaling pathway [GO:0007214]; neuron-glial cell signaling [GO:0150099]; synaptic transmission, GABAergic [GO:0051932] cytoplasm [GO:0005737]; dendrite [GO:0030425]; G protein-coupled GABA receptor complex [GO:1902712]; G protein-coupled receptor heterodimeric complex [GO:0038039]; GABA receptor complex [GO:1902710]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; neuron projection [GO:0043005]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734] G protein-coupled GABA receptor activity [GO:0004965]; protein heterodimerization activity [GO:0046982] g17803.t1 P48058 42.407 889 0.0 618.0 sp|P48058|GRIA4_HUMAN Glutamate receptor 4 OS=Homo sapiens OX=9606 GN=GRIA4 PE=1 SV=2 GRIA4_HUMAN reviewed Glutamate receptor 4 (GluR-4) (GluR4) (AMPA-selective glutamate receptor 4) (GluR-D) (Glutamate receptor ionotropic, AMPA 4) Homo sapiens (Human) GO:0001540; GO:0004970; GO:0004971; GO:0005886; GO:0007215; GO:0030425; GO:0030666; GO:0032281; GO:0034392; GO:0035249; GO:0043025; GO:0043197; GO:0050804; GO:0098839; GO:0099507; GO:1903561; GO:1904315 glutamate receptor signaling pathway [GO:0007215]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of smooth muscle cell apoptotic process [GO:0034392]; synaptic transmission, glutamatergic [GO:0035249] AMPA glutamate receptor complex [GO:0032281]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; endocytic vesicle membrane [GO:0030666]; extracellular vesicle [GO:1903561]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839] AMPA glutamate receptor activity [GO:0004971]; amyloid-beta binding [GO:0001540]; glutamate-gated receptor activity [GO:0004970]; ligand-gated monoatomic ion channel activity involved in regulation of presynaptic membrane potential [GO:0099507]; transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315] g17804.t1 D1LYT2 32.686 566 1.63e-75 251.0 sp|D1LYT2|GBRB2_MACMU Gamma-aminobutyric acid receptor subunit beta-2 OS=Macaca mulatta OX=9544 GN=GABRB2 PE=2 SV=1 GBRB2_MACMU reviewed Gamma-aminobutyric acid receptor subunit beta-2 (GABA(A) receptor subunit beta-2) (GABAAR subunit beta-2) Macaca mulatta (Rhesus macaque) GO:0004890; GO:0005254; GO:0005886; GO:0007214; GO:0022851; GO:0030659; GO:0034707; GO:0043197; GO:0051932; GO:0060119; GO:0060384; GO:0071420; GO:0090102; GO:0098982; GO:0099634; GO:1902476; GO:1902711; GO:1904315; GO:1904862 cellular response to histamine [GO:0071420]; chloride transmembrane transport [GO:1902476]; cochlea development [GO:0090102]; gamma-aminobutyric acid signaling pathway [GO:0007214]; inhibitory synapse assembly [GO:1904862]; inner ear receptor cell development [GO:0060119]; innervation [GO:0060384]; synaptic transmission, GABAergic [GO:0051932] chloride channel complex [GO:0034707]; cytoplasmic vesicle membrane [GO:0030659]; dendritic spine [GO:0043197]; GABA-A receptor complex [GO:1902711]; GABA-ergic synapse [GO:0098982]; plasma membrane [GO:0005886]; postsynaptic specialization membrane [GO:0099634] chloride channel activity [GO:0005254]; GABA-A receptor activity [GO:0004890]; GABA-gated chloride ion channel activity [GO:0022851]; transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315] g17805.t1 P42262 40.186 861 0.0 573.0 sp|P42262|GRIA2_HUMAN Glutamate receptor 2 OS=Homo sapiens OX=9606 GN=GRIA2 PE=1 SV=3 GRIA2_HUMAN reviewed Glutamate receptor 2 (GluR-2) (AMPA-selective glutamate receptor 2) (GluR-B) (GluR-K2) (Glutamate receptor ionotropic, AMPA 2) Homo sapiens (Human) GO:0001540; GO:0004970; GO:0004971; GO:0005886; GO:0009897; GO:0014069; GO:0030425; GO:0030666; GO:0032279; GO:0032281; GO:0035235; GO:0035249; GO:0043025; GO:0043197; GO:0050804; GO:0060076; GO:0098794; GO:0098839; GO:0098843; GO:0099094; GO:1904315 ionotropic glutamate receptor signaling pathway [GO:0035235]; modulation of chemical synaptic transmission [GO:0050804]; synaptic transmission, glutamatergic [GO:0035249] AMPA glutamate receptor complex [GO:0032281]; asymmetric synapse [GO:0032279]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; endocytic vesicle membrane [GO:0030666]; excitatory synapse [GO:0060076]; external side of plasma membrane [GO:0009897]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; postsynaptic density membrane [GO:0098839]; postsynaptic endocytic zone [GO:0098843] AMPA glutamate receptor activity [GO:0004971]; amyloid-beta binding [GO:0001540]; glutamate-gated receptor activity [GO:0004970]; ligand-gated monoatomic cation channel activity [GO:0099094]; transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315] g17806.t1 P08220 45.833 504 7.770000000000001e-125 377.0 sp|P08220|GBRB1_BOVIN Gamma-aminobutyric acid receptor subunit beta-1 OS=Bos taurus OX=9913 GN=GABRB1 PE=2 SV=1 GBRB1_BOVIN reviewed Gamma-aminobutyric acid receptor subunit beta-1 (GABA(A) receptor subunit beta-1) (GABAAR subunit beta-1) Bos taurus (Bovine) GO:0004890; GO:0005886; GO:0006811; GO:0007214; GO:0015276; GO:0022851; GO:0034707; GO:0045211; GO:0051932; GO:0071420; GO:0098685; GO:0098982; GO:0099507; GO:0150047; GO:1902476; GO:1902711 cellular response to histamine [GO:0071420]; chloride transmembrane transport [GO:1902476]; gamma-aminobutyric acid signaling pathway [GO:0007214]; monoatomic ion transport [GO:0006811]; synaptic transmission, GABAergic [GO:0051932] chloride channel complex [GO:0034707]; GABA-A receptor complex [GO:1902711]; GABA-ergic synapse [GO:0098982]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; Schaffer collateral - CA1 synapse [GO:0098685] G protein-coupled neurotransmitter receptor activity involved in regulation of presynaptic membrane potential [GO:0150047]; GABA-A receptor activity [GO:0004890]; GABA-gated chloride ion channel activity [GO:0022851]; ligand-gated monoatomic ion channel activity [GO:0015276]; ligand-gated monoatomic ion channel activity involved in regulation of presynaptic membrane potential [GO:0099507] g17806.t2 P08220 46.573 496 8.22e-128 384.0 sp|P08220|GBRB1_BOVIN Gamma-aminobutyric acid receptor subunit beta-1 OS=Bos taurus OX=9913 GN=GABRB1 PE=2 SV=1 GBRB1_BOVIN reviewed Gamma-aminobutyric acid receptor subunit beta-1 (GABA(A) receptor subunit beta-1) (GABAAR subunit beta-1) Bos taurus (Bovine) GO:0004890; GO:0005886; GO:0006811; GO:0007214; GO:0015276; GO:0022851; GO:0034707; GO:0045211; GO:0051932; GO:0071420; GO:0098685; GO:0098982; GO:0099507; GO:0150047; GO:1902476; GO:1902711 cellular response to histamine [GO:0071420]; chloride transmembrane transport [GO:1902476]; gamma-aminobutyric acid signaling pathway [GO:0007214]; monoatomic ion transport [GO:0006811]; synaptic transmission, GABAergic [GO:0051932] chloride channel complex [GO:0034707]; GABA-A receptor complex [GO:1902711]; GABA-ergic synapse [GO:0098982]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; Schaffer collateral - CA1 synapse [GO:0098685] G protein-coupled neurotransmitter receptor activity involved in regulation of presynaptic membrane potential [GO:0150047]; GABA-A receptor activity [GO:0004890]; GABA-gated chloride ion channel activity [GO:0022851]; ligand-gated monoatomic ion channel activity [GO:0015276]; ligand-gated monoatomic ion channel activity involved in regulation of presynaptic membrane potential [GO:0099507] g17808.t1 P19150 47.087 206 1.2600000000000001e-59 197.0 sp|P19150|GBRA1_CHICK Gamma-aminobutyric acid receptor subunit alpha-1 OS=Gallus gallus OX=9031 GN=GABRA1 PE=2 SV=1 g17809.t1 Q16445 35.028 177 5.28e-23 97.8 sp|Q16445|GBRA6_HUMAN Gamma-aminobutyric acid receptor subunit alpha-6 OS=Homo sapiens OX=9606 GN=GABRA6 PE=1 SV=2 GBRA6_HUMAN reviewed Gamma-aminobutyric acid receptor subunit alpha-6 (GABA(A) receptor subunit alpha-6) (GABAAR subunit alpha-6) Homo sapiens (Human) GO:0004890; GO:0005886; GO:0007165; GO:0007214; GO:0008503; GO:0022851; GO:0032590; GO:0034707; GO:0051932; GO:0098794; GO:0099192; GO:0099634; GO:1902476; GO:1902711; GO:1904315; GO:1904862 chloride transmembrane transport [GO:1902476]; gamma-aminobutyric acid signaling pathway [GO:0007214]; inhibitory synapse assembly [GO:1904862]; signal transduction [GO:0007165]; synaptic transmission, GABAergic [GO:0051932] cerebellar Golgi cell to granule cell synapse [GO:0099192]; chloride channel complex [GO:0034707]; dendrite membrane [GO:0032590]; GABA-A receptor complex [GO:1902711]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic specialization membrane [GO:0099634] benzodiazepine receptor activity [GO:0008503]; GABA-A receptor activity [GO:0004890]; GABA-gated chloride ion channel activity [GO:0022851]; transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315] g17810.t1 Q8VCK5 44.92 561 3.63e-165 486.0 sp|Q8VCK5|KLH20_MOUSE Kelch-like protein 20 OS=Mus musculus OX=10090 GN=Klhl20 PE=2 SV=2 g17811.t1 P34586 50.98 816 0.0 753.0 sp|P34586|TRPL_CAEEL Transient-receptor-potential-like protein OS=Caenorhabditis elegans OX=6239 GN=trp-1 PE=2 SV=3 g17812.t1 Q9ESN9 42.099 829 5.1100000000000006e-157 508.0 sp|Q9ESN9|JIP3_MOUSE C-Jun-amino-terminal kinase-interacting protein 3 OS=Mus musculus OX=10090 GN=Mapk8ip3 PE=1 SV=1 JIP3_MOUSE reviewed C-Jun-amino-terminal kinase-interacting protein 3 (JIP-3) (JNK-interacting protein 3) (JNK MAP kinase scaffold protein 3) (JNK/SAPK-associated protein 1) (JSAP1) (Mitogen-activated protein kinase 8-interacting protein 3) (Sunday driver 2) Mus musculus (Mouse) GO:0000139; GO:0001701; GO:0005078; GO:0005737; GO:0005790; GO:0005886; GO:0007254; GO:0007411; GO:0007585; GO:0008104; GO:0008432; GO:0009791; GO:0010468; GO:0016192; GO:0019894; GO:0030159; GO:0030424; GO:0030425; GO:0030426; GO:0030673; GO:0030900; GO:0031103; GO:0031410; GO:0031434; GO:0031435; GO:0043066; GO:0044297; GO:0045666; GO:0046328; GO:0046330; GO:0048286; GO:0048471; GO:0050821; GO:0060425; GO:0061564; GO:0099641; GO:1904115; GO:2001224 anterograde axonal protein transport [GO:0099641]; axon development [GO:0061564]; axon guidance [GO:0007411]; axon regeneration [GO:0031103]; forebrain development [GO:0030900]; in utero embryonic development [GO:0001701]; intracellular protein localization [GO:0008104]; JNK cascade [GO:0007254]; lung alveolus development [GO:0048286]; lung morphogenesis [GO:0060425]; negative regulation of apoptotic process [GO:0043066]; positive regulation of JNK cascade [GO:0046330]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of neuron migration [GO:2001224]; post-embryonic development [GO:0009791]; protein stabilization [GO:0050821]; regulation of gene expression [GO:0010468]; regulation of JNK cascade [GO:0046328]; respiratory gaseous exchange by respiratory system [GO:0007585]; vesicle-mediated transport [GO:0016192] axolemma [GO:0030673]; axon [GO:0030424]; axon cytoplasm [GO:1904115]; cell body [GO:0044297]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; dendrite [GO:0030425]; Golgi membrane [GO:0000139]; growth cone [GO:0030426]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; smooth endoplasmic reticulum [GO:0005790] JUN kinase binding [GO:0008432]; kinesin binding [GO:0019894]; MAP-kinase scaffold activity [GO:0005078]; mitogen-activated protein kinase kinase binding [GO:0031434]; mitogen-activated protein kinase kinase kinase binding [GO:0031435]; signaling receptor complex adaptor activity [GO:0030159] g17812.t1 Q9ESN9 54.762 378 2.82e-115 394.0 sp|Q9ESN9|JIP3_MOUSE C-Jun-amino-terminal kinase-interacting protein 3 OS=Mus musculus OX=10090 GN=Mapk8ip3 PE=1 SV=1 JIP3_MOUSE reviewed C-Jun-amino-terminal kinase-interacting protein 3 (JIP-3) (JNK-interacting protein 3) (JNK MAP kinase scaffold protein 3) (JNK/SAPK-associated protein 1) (JSAP1) (Mitogen-activated protein kinase 8-interacting protein 3) (Sunday driver 2) Mus musculus (Mouse) GO:0000139; GO:0001701; GO:0005078; GO:0005737; GO:0005790; GO:0005886; GO:0007254; GO:0007411; GO:0007585; GO:0008104; GO:0008432; GO:0009791; GO:0010468; GO:0016192; GO:0019894; GO:0030159; GO:0030424; GO:0030425; GO:0030426; GO:0030673; GO:0030900; GO:0031103; GO:0031410; GO:0031434; GO:0031435; GO:0043066; GO:0044297; GO:0045666; GO:0046328; GO:0046330; GO:0048286; GO:0048471; GO:0050821; GO:0060425; GO:0061564; GO:0099641; GO:1904115; GO:2001224 anterograde axonal protein transport [GO:0099641]; axon development [GO:0061564]; axon guidance [GO:0007411]; axon regeneration [GO:0031103]; forebrain development [GO:0030900]; in utero embryonic development [GO:0001701]; intracellular protein localization [GO:0008104]; JNK cascade [GO:0007254]; lung alveolus development [GO:0048286]; lung morphogenesis [GO:0060425]; negative regulation of apoptotic process [GO:0043066]; positive regulation of JNK cascade [GO:0046330]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of neuron migration [GO:2001224]; post-embryonic development [GO:0009791]; protein stabilization [GO:0050821]; regulation of gene expression [GO:0010468]; regulation of JNK cascade [GO:0046328]; respiratory gaseous exchange by respiratory system [GO:0007585]; vesicle-mediated transport [GO:0016192] axolemma [GO:0030673]; axon [GO:0030424]; axon cytoplasm [GO:1904115]; cell body [GO:0044297]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; dendrite [GO:0030425]; Golgi membrane [GO:0000139]; growth cone [GO:0030426]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; smooth endoplasmic reticulum [GO:0005790] JUN kinase binding [GO:0008432]; kinesin binding [GO:0019894]; MAP-kinase scaffold activity [GO:0005078]; mitogen-activated protein kinase kinase binding [GO:0031434]; mitogen-activated protein kinase kinase kinase binding [GO:0031435]; signaling receptor complex adaptor activity [GO:0030159] g17812.t2 O60271 45.69 812 3.73e-176 558.0 sp|O60271|JIP4_HUMAN C-Jun-amino-terminal kinase-interacting protein 4 OS=Homo sapiens OX=9606 GN=SPAG9 PE=1 SV=4 JIP4_HUMAN reviewed C-Jun-amino-terminal kinase-interacting protein 4 (JIP-4) (JNK-interacting protein 4) (Cancer/testis antigen 89) (CT89) (Human lung cancer oncogene 6 protein) (HLC-6) (JNK-associated leucine-zipper protein) (JLP) (Mitogen-activated protein kinase 8-interacting protein 4) (Proliferation-inducing protein 6) (Protein highly expressed in testis) (PHET) (Sperm surface protein) (Sperm-associated antigen 9) (Sperm-specific protein) (Sunday driver 1) Homo sapiens (Human) GO:0001669; GO:0005078; GO:0005737; GO:0005765; GO:0005829; GO:0008432; GO:0016192; GO:0019894; GO:0030159; GO:0030335; GO:0032418; GO:0034451; GO:0042147; GO:0042802; GO:0043410; GO:0045665; GO:0045666; GO:0048471; GO:0051146; GO:0070062; GO:1903860 lysosome localization [GO:0032418]; negative regulation of dendrite extension [GO:1903860]; negative regulation of neuron differentiation [GO:0045665]; positive regulation of cell migration [GO:0030335]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of neuron differentiation [GO:0045666]; retrograde transport, endosome to Golgi [GO:0042147]; striated muscle cell differentiation [GO:0051146]; vesicle-mediated transport [GO:0016192] acrosomal vesicle [GO:0001669]; centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; lysosomal membrane [GO:0005765]; perinuclear region of cytoplasm [GO:0048471] identical protein binding [GO:0042802]; JUN kinase binding [GO:0008432]; kinesin binding [GO:0019894]; MAP-kinase scaffold activity [GO:0005078]; signaling receptor complex adaptor activity [GO:0030159] g17812.t2 O60271 56.79 405 9.48e-135 447.0 sp|O60271|JIP4_HUMAN C-Jun-amino-terminal kinase-interacting protein 4 OS=Homo sapiens OX=9606 GN=SPAG9 PE=1 SV=4 JIP4_HUMAN reviewed C-Jun-amino-terminal kinase-interacting protein 4 (JIP-4) (JNK-interacting protein 4) (Cancer/testis antigen 89) (CT89) (Human lung cancer oncogene 6 protein) (HLC-6) (JNK-associated leucine-zipper protein) (JLP) (Mitogen-activated protein kinase 8-interacting protein 4) (Proliferation-inducing protein 6) (Protein highly expressed in testis) (PHET) (Sperm surface protein) (Sperm-associated antigen 9) (Sperm-specific protein) (Sunday driver 1) Homo sapiens (Human) GO:0001669; GO:0005078; GO:0005737; GO:0005765; GO:0005829; GO:0008432; GO:0016192; GO:0019894; GO:0030159; GO:0030335; GO:0032418; GO:0034451; GO:0042147; GO:0042802; GO:0043410; GO:0045665; GO:0045666; GO:0048471; GO:0051146; GO:0070062; GO:1903860 lysosome localization [GO:0032418]; negative regulation of dendrite extension [GO:1903860]; negative regulation of neuron differentiation [GO:0045665]; positive regulation of cell migration [GO:0030335]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of neuron differentiation [GO:0045666]; retrograde transport, endosome to Golgi [GO:0042147]; striated muscle cell differentiation [GO:0051146]; vesicle-mediated transport [GO:0016192] acrosomal vesicle [GO:0001669]; centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; lysosomal membrane [GO:0005765]; perinuclear region of cytoplasm [GO:0048471] identical protein binding [GO:0042802]; JUN kinase binding [GO:0008432]; kinesin binding [GO:0019894]; MAP-kinase scaffold activity [GO:0005078]; signaling receptor complex adaptor activity [GO:0030159] g17812.t3 O60271 43.494 853 8.85e-168 537.0 sp|O60271|JIP4_HUMAN C-Jun-amino-terminal kinase-interacting protein 4 OS=Homo sapiens OX=9606 GN=SPAG9 PE=1 SV=4 JIP4_HUMAN reviewed C-Jun-amino-terminal kinase-interacting protein 4 (JIP-4) (JNK-interacting protein 4) (Cancer/testis antigen 89) (CT89) (Human lung cancer oncogene 6 protein) (HLC-6) (JNK-associated leucine-zipper protein) (JLP) (Mitogen-activated protein kinase 8-interacting protein 4) (Proliferation-inducing protein 6) (Protein highly expressed in testis) (PHET) (Sperm surface protein) (Sperm-associated antigen 9) (Sperm-specific protein) (Sunday driver 1) Homo sapiens (Human) GO:0001669; GO:0005078; GO:0005737; GO:0005765; GO:0005829; GO:0008432; GO:0016192; GO:0019894; GO:0030159; GO:0030335; GO:0032418; GO:0034451; GO:0042147; GO:0042802; GO:0043410; GO:0045665; GO:0045666; GO:0048471; GO:0051146; GO:0070062; GO:1903860 lysosome localization [GO:0032418]; negative regulation of dendrite extension [GO:1903860]; negative regulation of neuron differentiation [GO:0045665]; positive regulation of cell migration [GO:0030335]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of neuron differentiation [GO:0045666]; retrograde transport, endosome to Golgi [GO:0042147]; striated muscle cell differentiation [GO:0051146]; vesicle-mediated transport [GO:0016192] acrosomal vesicle [GO:0001669]; centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; lysosomal membrane [GO:0005765]; perinuclear region of cytoplasm [GO:0048471] identical protein binding [GO:0042802]; JUN kinase binding [GO:0008432]; kinesin binding [GO:0019894]; MAP-kinase scaffold activity [GO:0005078]; signaling receptor complex adaptor activity [GO:0030159] g17812.t3 O60271 56.79 405 3.2199999999999997e-134 447.0 sp|O60271|JIP4_HUMAN C-Jun-amino-terminal kinase-interacting protein 4 OS=Homo sapiens OX=9606 GN=SPAG9 PE=1 SV=4 JIP4_HUMAN reviewed C-Jun-amino-terminal kinase-interacting protein 4 (JIP-4) (JNK-interacting protein 4) (Cancer/testis antigen 89) (CT89) (Human lung cancer oncogene 6 protein) (HLC-6) (JNK-associated leucine-zipper protein) (JLP) (Mitogen-activated protein kinase 8-interacting protein 4) (Proliferation-inducing protein 6) (Protein highly expressed in testis) (PHET) (Sperm surface protein) (Sperm-associated antigen 9) (Sperm-specific protein) (Sunday driver 1) Homo sapiens (Human) GO:0001669; GO:0005078; GO:0005737; GO:0005765; GO:0005829; GO:0008432; GO:0016192; GO:0019894; GO:0030159; GO:0030335; GO:0032418; GO:0034451; GO:0042147; GO:0042802; GO:0043410; GO:0045665; GO:0045666; GO:0048471; GO:0051146; GO:0070062; GO:1903860 lysosome localization [GO:0032418]; negative regulation of dendrite extension [GO:1903860]; negative regulation of neuron differentiation [GO:0045665]; positive regulation of cell migration [GO:0030335]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of neuron differentiation [GO:0045666]; retrograde transport, endosome to Golgi [GO:0042147]; striated muscle cell differentiation [GO:0051146]; vesicle-mediated transport [GO:0016192] acrosomal vesicle [GO:0001669]; centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; lysosomal membrane [GO:0005765]; perinuclear region of cytoplasm [GO:0048471] identical protein binding [GO:0042802]; JUN kinase binding [GO:0008432]; kinesin binding [GO:0019894]; MAP-kinase scaffold activity [GO:0005078]; signaling receptor complex adaptor activity [GO:0030159] g17814.t1 Q9DGG6 39.069 1203 0.0 740.0 sp|Q9DGG6|ADCY9_CHICK Adenylate cyclase type 9 OS=Gallus gallus OX=9031 GN=ADCY9 PE=1 SV=1 ADCY9_CHICK reviewed Adenylate cyclase type 9 (EC 4.6.1.1) (ATP pyrophosphate-lyase 9) (Adenylate cyclase type IX) (Adenylyl cyclase 9) Gallus gallus (Chicken) GO:0004016; GO:0005524; GO:0005886; GO:0006171; GO:0007189; GO:0016020; GO:0035556; GO:0046872; GO:0071880 adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cAMP biosynthetic process [GO:0006171]; intracellular signal transduction [GO:0035556] membrane [GO:0016020]; plasma membrane [GO:0005886] adenylate cyclase activity [GO:0004016]; ATP binding [GO:0005524]; metal ion binding [GO:0046872] g17815.t1 Q09472 61.803 843 0.0 972.0 sp|Q09472|EP300_HUMAN Histone acetyltransferase p300 OS=Homo sapiens OX=9606 GN=EP300 PE=1 SV=2 EP300_HUMAN reviewed Histone acetyltransferase p300 (p300 HAT) (EC 2.3.1.48) (E1A-associated protein p300) (Histone butyryltransferase p300) (EC 2.3.1.-) (Histone crotonyltransferase p300) (EC 2.3.1.-) (Protein 2-hydroxyisobutyryltransferase p300) (EC 2.3.1.-) (Protein isonicotinyltransferase p300) (EC 2.3.1.-) (Protein lactyltransferas p300) (EC 2.3.1.-) (Protein propionyltransferase p300) (EC 2.3.1.-) Homo sapiens (Human) GO:0000122; GO:0000123; GO:0000785; GO:0001221; GO:0001223; GO:0001666; GO:0001756; GO:0001966; GO:0002039; GO:0002209; GO:0002223; GO:0003677; GO:0003682; GO:0003684; GO:0003713; GO:0004402; GO:0004468; GO:0005634; GO:0005654; GO:0005667; GO:0005737; GO:0005829; GO:0006110; GO:0006473; GO:0006475; GO:0006915; GO:0007249; GO:0007399; GO:0007507; GO:0007519; GO:0007611; GO:0007623; GO:0008013; GO:0008270; GO:0009887; GO:0010484; GO:0010485; GO:0010506; GO:0010507; GO:0010821; GO:0010976; GO:0016407; GO:0016746; GO:0016922; GO:0018076; GO:0018393; GO:0030183; GO:0030220; GO:0030324; GO:0030511; GO:0031333; GO:0031490; GO:0031648; GO:0031669; GO:0032460; GO:0032993; GO:0034644; GO:0035264; GO:0035855; GO:0036268; GO:0042307; GO:0042771; GO:0043627; GO:0043923; GO:0043993; GO:0044013; GO:0044017; GO:0045444; GO:0045721; GO:0045815; GO:0045893; GO:0045944; GO:0046427; GO:0048156; GO:0050681; GO:0050821; GO:0051059; GO:0051091; GO:0060070; GO:0060325; GO:0060765; GO:0061629; GO:0061733; GO:0061920; GO:0061921; GO:0071233; GO:0090043; GO:0097157; GO:0097677; GO:0106226; GO:0120301; GO:0140033; GO:0140065; GO:0140066; GO:0140067; GO:0140068; GO:0140069; GO:0140230; GO:0140297; GO:0140861; GO:0140908; GO:0160263; GO:1900034; GO:1901796; GO:1902340; GO:1903444; GO:1904263; GO:1904515; GO:2000330 animal organ morphogenesis [GO:0009887]; apoptotic process [GO:0006915]; B cell differentiation [GO:0030183]; behavioral defense response [GO:0002209]; canonical NF-kappaB signal transduction [GO:0007249]; canonical Wnt signaling pathway [GO:0060070]; cellular response to L-leucine [GO:0071233]; cellular response to nutrient levels [GO:0031669]; cellular response to UV [GO:0034644]; circadian rhythm [GO:0007623]; DNA repair-dependent chromatin remodeling [GO:0140861]; face morphogenesis [GO:0060325]; fat cell differentiation [GO:0045444]; heart development [GO:0007507]; host-mediated activation of viral transcription [GO:0043923]; internal peptidyl-lysine acetylation [GO:0018393]; internal protein amino acid acetylation [GO:0006475]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; learning or memory [GO:0007611]; lung development [GO:0030324]; megakaryocyte development [GO:0035855]; multicellular organism growth [GO:0035264]; N-terminal peptidyl-lysine acetylation [GO:0018076]; negative regulation of autophagy [GO:0010507]; negative regulation of brown fat cell differentiation [GO:1903444]; negative regulation of chromosome condensation [GO:1902340]; negative regulation of gluconeogenesis [GO:0045721]; negative regulation of protein oligomerization [GO:0032460]; negative regulation of protein-containing complex assembly [GO:0031333]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]; peptidyl-lysine butyrylation [GO:0140067]; peptidyl-lysine crotonylation [GO:0140066]; peptidyl-lysine propionylation [GO:0061921]; platelet formation [GO:0030220]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of neuron projection development [GO:0010976]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of T-helper 17 cell lineage commitment [GO:2000330]; positive regulation of TORC1 signaling [GO:1904263]; positive regulation of TORC2 signaling [GO:1904515]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; protein acetylation [GO:0006473]; protein destabilization [GO:0031648]; protein stabilization [GO:0050821]; regulation of androgen receptor signaling pathway [GO:0060765]; regulation of autophagy [GO:0010506]; regulation of cellular response to heat [GO:1900034]; regulation of glycolytic process [GO:0006110]; regulation of mitochondrion organization [GO:0010821]; regulation of signal transduction by p53 class mediator [GO:1901796]; regulation of tubulin deacetylation [GO:0090043]; response to estrogen [GO:0043627]; response to hypoxia [GO:0001666]; skeletal muscle tissue development [GO:0007519]; somitogenesis [GO:0001756]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; swimming [GO:0036268]; thigmotaxis [GO:0001966]; transcription initiation-coupled chromatin remodeling [GO:0045815] chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; histone acetyltransferase complex [GO:0000123]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-DNA complex [GO:0032993]; transcription regulator complex [GO:0005667] acetylation-dependent protein binding [GO:0140033]; acetyltransferase activity [GO:0016407]; acyltransferase activity [GO:0016746]; beta-catenin binding [GO:0008013]; chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; damaged DNA binding [GO:0003684]; DNA binding [GO:0003677]; DNA-binding transcription factor binding [GO:0140297]; histone acetyltransferase activity [GO:0004402]; histone butyryltransferase activity [GO:0140069]; histone crotonyltransferase activity [GO:0140068]; histone H1K75 acetyltransferase activity [GO:0160263]; histone H2B acetyltransferase activity [GO:0044013]; histone H3 acetyltransferase activity [GO:0010484]; histone H3K122 acetyltransferase activity [GO:0140908]; histone H3K18 acetyltransferase activity [GO:0043993]; histone H3K27 acetyltransferase activity [GO:0044017]; histone H4 acetyltransferase activity [GO:0010485]; histone isonicotinyltransferase activity [GO:0140230]; histone lactyltransferase (CoA-dependent) activity [GO:0120301]; L-lysine N-acetyltransferase activity, acting on acetyl phosphate as donor [GO:0004468]; NF-kappaB binding [GO:0051059]; nuclear androgen receptor binding [GO:0050681]; nuclear receptor binding [GO:0016922]; p53 binding [GO:0002039]; peptide 2-hydroxyisobutyryltransferase activity [GO:0106226]; peptide butyryltransferase activity [GO:0140065]; pre-mRNA intronic binding [GO:0097157]; protein propionyltransferase activity [GO:0061920]; protein-lysine-acetyltransferase activity [GO:0061733]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; STAT family protein binding [GO:0097677]; tau protein binding [GO:0048156]; transcription coactivator activity [GO:0003713]; transcription coactivator binding [GO:0001223]; transcription coregulator binding [GO:0001221]; zinc ion binding [GO:0008270] g17815.t1 Q09472 52.841 352 2.15e-80 301.0 sp|Q09472|EP300_HUMAN Histone acetyltransferase p300 OS=Homo sapiens OX=9606 GN=EP300 PE=1 SV=2 EP300_HUMAN reviewed Histone acetyltransferase p300 (p300 HAT) (EC 2.3.1.48) (E1A-associated protein p300) (Histone butyryltransferase p300) (EC 2.3.1.-) (Histone crotonyltransferase p300) (EC 2.3.1.-) (Protein 2-hydroxyisobutyryltransferase p300) (EC 2.3.1.-) (Protein isonicotinyltransferase p300) (EC 2.3.1.-) (Protein lactyltransferas p300) (EC 2.3.1.-) (Protein propionyltransferase p300) (EC 2.3.1.-) Homo sapiens (Human) GO:0000122; GO:0000123; GO:0000785; GO:0001221; GO:0001223; GO:0001666; GO:0001756; GO:0001966; GO:0002039; GO:0002209; GO:0002223; GO:0003677; GO:0003682; GO:0003684; GO:0003713; GO:0004402; GO:0004468; GO:0005634; GO:0005654; GO:0005667; GO:0005737; GO:0005829; GO:0006110; GO:0006473; GO:0006475; GO:0006915; GO:0007249; GO:0007399; GO:0007507; GO:0007519; GO:0007611; GO:0007623; GO:0008013; GO:0008270; GO:0009887; GO:0010484; GO:0010485; GO:0010506; GO:0010507; GO:0010821; GO:0010976; GO:0016407; GO:0016746; GO:0016922; GO:0018076; GO:0018393; GO:0030183; GO:0030220; GO:0030324; GO:0030511; GO:0031333; GO:0031490; GO:0031648; GO:0031669; GO:0032460; GO:0032993; GO:0034644; GO:0035264; GO:0035855; GO:0036268; GO:0042307; GO:0042771; GO:0043627; GO:0043923; GO:0043993; GO:0044013; GO:0044017; GO:0045444; GO:0045721; GO:0045815; GO:0045893; GO:0045944; GO:0046427; GO:0048156; GO:0050681; GO:0050821; GO:0051059; GO:0051091; GO:0060070; GO:0060325; GO:0060765; GO:0061629; GO:0061733; GO:0061920; GO:0061921; GO:0071233; GO:0090043; GO:0097157; GO:0097677; GO:0106226; GO:0120301; GO:0140033; GO:0140065; GO:0140066; GO:0140067; GO:0140068; GO:0140069; GO:0140230; GO:0140297; GO:0140861; GO:0140908; GO:0160263; GO:1900034; GO:1901796; GO:1902340; GO:1903444; GO:1904263; GO:1904515; GO:2000330 animal organ morphogenesis [GO:0009887]; apoptotic process [GO:0006915]; B cell differentiation [GO:0030183]; behavioral defense response [GO:0002209]; canonical NF-kappaB signal transduction [GO:0007249]; canonical Wnt signaling pathway [GO:0060070]; cellular response to L-leucine [GO:0071233]; cellular response to nutrient levels [GO:0031669]; cellular response to UV [GO:0034644]; circadian rhythm [GO:0007623]; DNA repair-dependent chromatin remodeling [GO:0140861]; face morphogenesis [GO:0060325]; fat cell differentiation [GO:0045444]; heart development [GO:0007507]; host-mediated activation of viral transcription [GO:0043923]; internal peptidyl-lysine acetylation [GO:0018393]; internal protein amino acid acetylation [GO:0006475]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; learning or memory [GO:0007611]; lung development [GO:0030324]; megakaryocyte development [GO:0035855]; multicellular organism growth [GO:0035264]; N-terminal peptidyl-lysine acetylation [GO:0018076]; negative regulation of autophagy [GO:0010507]; negative regulation of brown fat cell differentiation [GO:1903444]; negative regulation of chromosome condensation [GO:1902340]; negative regulation of gluconeogenesis [GO:0045721]; negative regulation of protein oligomerization [GO:0032460]; negative regulation of protein-containing complex assembly [GO:0031333]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]; peptidyl-lysine butyrylation [GO:0140067]; peptidyl-lysine crotonylation [GO:0140066]; peptidyl-lysine propionylation [GO:0061921]; platelet formation [GO:0030220]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of neuron projection development [GO:0010976]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of T-helper 17 cell lineage commitment [GO:2000330]; positive regulation of TORC1 signaling [GO:1904263]; positive regulation of TORC2 signaling [GO:1904515]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; protein acetylation [GO:0006473]; protein destabilization [GO:0031648]; protein stabilization [GO:0050821]; regulation of androgen receptor signaling pathway [GO:0060765]; regulation of autophagy [GO:0010506]; regulation of cellular response to heat [GO:1900034]; regulation of glycolytic process [GO:0006110]; regulation of mitochondrion organization [GO:0010821]; regulation of signal transduction by p53 class mediator [GO:1901796]; regulation of tubulin deacetylation [GO:0090043]; response to estrogen [GO:0043627]; response to hypoxia [GO:0001666]; skeletal muscle tissue development [GO:0007519]; somitogenesis [GO:0001756]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; swimming [GO:0036268]; thigmotaxis [GO:0001966]; transcription initiation-coupled chromatin remodeling [GO:0045815] chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; histone acetyltransferase complex [GO:0000123]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-DNA complex [GO:0032993]; transcription regulator complex [GO:0005667] acetylation-dependent protein binding [GO:0140033]; acetyltransferase activity [GO:0016407]; acyltransferase activity [GO:0016746]; beta-catenin binding [GO:0008013]; chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; damaged DNA binding [GO:0003684]; DNA binding [GO:0003677]; DNA-binding transcription factor binding [GO:0140297]; histone acetyltransferase activity [GO:0004402]; histone butyryltransferase activity [GO:0140069]; histone crotonyltransferase activity [GO:0140068]; histone H1K75 acetyltransferase activity [GO:0160263]; histone H2B acetyltransferase activity [GO:0044013]; histone H3 acetyltransferase activity [GO:0010484]; histone H3K122 acetyltransferase activity [GO:0140908]; histone H3K18 acetyltransferase activity [GO:0043993]; histone H3K27 acetyltransferase activity [GO:0044017]; histone H4 acetyltransferase activity [GO:0010485]; histone isonicotinyltransferase activity [GO:0140230]; histone lactyltransferase (CoA-dependent) activity [GO:0120301]; L-lysine N-acetyltransferase activity, acting on acetyl phosphate as donor [GO:0004468]; NF-kappaB binding [GO:0051059]; nuclear androgen receptor binding [GO:0050681]; nuclear receptor binding [GO:0016922]; p53 binding [GO:0002039]; peptide 2-hydroxyisobutyryltransferase activity [GO:0106226]; peptide butyryltransferase activity [GO:0140065]; pre-mRNA intronic binding [GO:0097157]; protein propionyltransferase activity [GO:0061920]; protein-lysine-acetyltransferase activity [GO:0061733]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; STAT family protein binding [GO:0097677]; tau protein binding [GO:0048156]; transcription coactivator activity [GO:0003713]; transcription coactivator binding [GO:0001223]; transcription coregulator binding [GO:0001221]; zinc ion binding [GO:0008270] g17815.t2 Q09472 61.803 843 0.0 972.0 sp|Q09472|EP300_HUMAN Histone acetyltransferase p300 OS=Homo sapiens OX=9606 GN=EP300 PE=1 SV=2 EP300_HUMAN reviewed Histone acetyltransferase p300 (p300 HAT) (EC 2.3.1.48) (E1A-associated protein p300) (Histone butyryltransferase p300) (EC 2.3.1.-) (Histone crotonyltransferase p300) (EC 2.3.1.-) (Protein 2-hydroxyisobutyryltransferase p300) (EC 2.3.1.-) (Protein isonicotinyltransferase p300) (EC 2.3.1.-) (Protein lactyltransferas p300) (EC 2.3.1.-) (Protein propionyltransferase p300) (EC 2.3.1.-) Homo sapiens (Human) GO:0000122; GO:0000123; GO:0000785; GO:0001221; GO:0001223; GO:0001666; GO:0001756; GO:0001966; GO:0002039; GO:0002209; GO:0002223; GO:0003677; GO:0003682; GO:0003684; GO:0003713; GO:0004402; GO:0004468; GO:0005634; GO:0005654; GO:0005667; GO:0005737; GO:0005829; GO:0006110; GO:0006473; GO:0006475; GO:0006915; GO:0007249; GO:0007399; GO:0007507; GO:0007519; GO:0007611; GO:0007623; GO:0008013; GO:0008270; GO:0009887; GO:0010484; GO:0010485; GO:0010506; GO:0010507; GO:0010821; GO:0010976; GO:0016407; GO:0016746; GO:0016922; GO:0018076; GO:0018393; GO:0030183; GO:0030220; GO:0030324; GO:0030511; GO:0031333; GO:0031490; GO:0031648; GO:0031669; GO:0032460; GO:0032993; GO:0034644; GO:0035264; GO:0035855; GO:0036268; GO:0042307; GO:0042771; GO:0043627; GO:0043923; GO:0043993; GO:0044013; GO:0044017; GO:0045444; GO:0045721; GO:0045815; GO:0045893; GO:0045944; GO:0046427; GO:0048156; GO:0050681; GO:0050821; GO:0051059; GO:0051091; GO:0060070; GO:0060325; GO:0060765; GO:0061629; GO:0061733; GO:0061920; GO:0061921; GO:0071233; GO:0090043; GO:0097157; GO:0097677; GO:0106226; GO:0120301; GO:0140033; GO:0140065; GO:0140066; GO:0140067; GO:0140068; GO:0140069; GO:0140230; GO:0140297; GO:0140861; GO:0140908; GO:0160263; GO:1900034; GO:1901796; GO:1902340; GO:1903444; GO:1904263; GO:1904515; GO:2000330 animal organ morphogenesis [GO:0009887]; apoptotic process [GO:0006915]; B cell differentiation [GO:0030183]; behavioral defense response [GO:0002209]; canonical NF-kappaB signal transduction [GO:0007249]; canonical Wnt signaling pathway [GO:0060070]; cellular response to L-leucine [GO:0071233]; cellular response to nutrient levels [GO:0031669]; cellular response to UV [GO:0034644]; circadian rhythm [GO:0007623]; DNA repair-dependent chromatin remodeling [GO:0140861]; face morphogenesis [GO:0060325]; fat cell differentiation [GO:0045444]; heart development [GO:0007507]; host-mediated activation of viral transcription [GO:0043923]; internal peptidyl-lysine acetylation [GO:0018393]; internal protein amino acid acetylation [GO:0006475]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; learning or memory [GO:0007611]; lung development [GO:0030324]; megakaryocyte development [GO:0035855]; multicellular organism growth [GO:0035264]; N-terminal peptidyl-lysine acetylation [GO:0018076]; negative regulation of autophagy [GO:0010507]; negative regulation of brown fat cell differentiation [GO:1903444]; negative regulation of chromosome condensation [GO:1902340]; negative regulation of gluconeogenesis [GO:0045721]; negative regulation of protein oligomerization [GO:0032460]; negative regulation of protein-containing complex assembly [GO:0031333]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]; peptidyl-lysine butyrylation [GO:0140067]; peptidyl-lysine crotonylation [GO:0140066]; peptidyl-lysine propionylation [GO:0061921]; platelet formation [GO:0030220]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of neuron projection development [GO:0010976]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of T-helper 17 cell lineage commitment [GO:2000330]; positive regulation of TORC1 signaling [GO:1904263]; positive regulation of TORC2 signaling [GO:1904515]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; protein acetylation [GO:0006473]; protein destabilization [GO:0031648]; protein stabilization [GO:0050821]; regulation of androgen receptor signaling pathway [GO:0060765]; regulation of autophagy [GO:0010506]; regulation of cellular response to heat [GO:1900034]; regulation of glycolytic process [GO:0006110]; regulation of mitochondrion organization [GO:0010821]; regulation of signal transduction by p53 class mediator [GO:1901796]; regulation of tubulin deacetylation [GO:0090043]; response to estrogen [GO:0043627]; response to hypoxia [GO:0001666]; skeletal muscle tissue development [GO:0007519]; somitogenesis [GO:0001756]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; swimming [GO:0036268]; thigmotaxis [GO:0001966]; transcription initiation-coupled chromatin remodeling [GO:0045815] chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; histone acetyltransferase complex [GO:0000123]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-DNA complex [GO:0032993]; transcription regulator complex [GO:0005667] acetylation-dependent protein binding [GO:0140033]; acetyltransferase activity [GO:0016407]; acyltransferase activity [GO:0016746]; beta-catenin binding [GO:0008013]; chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; damaged DNA binding [GO:0003684]; DNA binding [GO:0003677]; DNA-binding transcription factor binding [GO:0140297]; histone acetyltransferase activity [GO:0004402]; histone butyryltransferase activity [GO:0140069]; histone crotonyltransferase activity [GO:0140068]; histone H1K75 acetyltransferase activity [GO:0160263]; histone H2B acetyltransferase activity [GO:0044013]; histone H3 acetyltransferase activity [GO:0010484]; histone H3K122 acetyltransferase activity [GO:0140908]; histone H3K18 acetyltransferase activity [GO:0043993]; histone H3K27 acetyltransferase activity [GO:0044017]; histone H4 acetyltransferase activity [GO:0010485]; histone isonicotinyltransferase activity [GO:0140230]; histone lactyltransferase (CoA-dependent) activity [GO:0120301]; L-lysine N-acetyltransferase activity, acting on acetyl phosphate as donor [GO:0004468]; NF-kappaB binding [GO:0051059]; nuclear androgen receptor binding [GO:0050681]; nuclear receptor binding [GO:0016922]; p53 binding [GO:0002039]; peptide 2-hydroxyisobutyryltransferase activity [GO:0106226]; peptide butyryltransferase activity [GO:0140065]; pre-mRNA intronic binding [GO:0097157]; protein propionyltransferase activity [GO:0061920]; protein-lysine-acetyltransferase activity [GO:0061733]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; STAT family protein binding [GO:0097677]; tau protein binding [GO:0048156]; transcription coactivator activity [GO:0003713]; transcription coactivator binding [GO:0001223]; transcription coregulator binding [GO:0001221]; zinc ion binding [GO:0008270] g17815.t2 Q09472 52.991 351 2.17e-80 301.0 sp|Q09472|EP300_HUMAN Histone acetyltransferase p300 OS=Homo sapiens OX=9606 GN=EP300 PE=1 SV=2 EP300_HUMAN reviewed Histone acetyltransferase p300 (p300 HAT) (EC 2.3.1.48) (E1A-associated protein p300) (Histone butyryltransferase p300) (EC 2.3.1.-) (Histone crotonyltransferase p300) (EC 2.3.1.-) (Protein 2-hydroxyisobutyryltransferase p300) (EC 2.3.1.-) (Protein isonicotinyltransferase p300) (EC 2.3.1.-) (Protein lactyltransferas p300) (EC 2.3.1.-) (Protein propionyltransferase p300) (EC 2.3.1.-) Homo sapiens (Human) GO:0000122; GO:0000123; GO:0000785; GO:0001221; GO:0001223; GO:0001666; GO:0001756; GO:0001966; GO:0002039; GO:0002209; GO:0002223; GO:0003677; GO:0003682; GO:0003684; GO:0003713; GO:0004402; GO:0004468; GO:0005634; GO:0005654; GO:0005667; GO:0005737; GO:0005829; GO:0006110; GO:0006473; GO:0006475; GO:0006915; GO:0007249; GO:0007399; GO:0007507; GO:0007519; GO:0007611; GO:0007623; GO:0008013; GO:0008270; GO:0009887; GO:0010484; GO:0010485; GO:0010506; GO:0010507; GO:0010821; GO:0010976; GO:0016407; GO:0016746; GO:0016922; GO:0018076; GO:0018393; GO:0030183; GO:0030220; GO:0030324; GO:0030511; GO:0031333; GO:0031490; GO:0031648; GO:0031669; GO:0032460; GO:0032993; GO:0034644; GO:0035264; GO:0035855; GO:0036268; GO:0042307; GO:0042771; GO:0043627; GO:0043923; GO:0043993; GO:0044013; GO:0044017; GO:0045444; GO:0045721; GO:0045815; GO:0045893; GO:0045944; GO:0046427; GO:0048156; GO:0050681; GO:0050821; GO:0051059; GO:0051091; GO:0060070; GO:0060325; GO:0060765; GO:0061629; GO:0061733; GO:0061920; GO:0061921; GO:0071233; GO:0090043; GO:0097157; GO:0097677; GO:0106226; GO:0120301; GO:0140033; GO:0140065; GO:0140066; GO:0140067; GO:0140068; GO:0140069; GO:0140230; GO:0140297; GO:0140861; GO:0140908; GO:0160263; GO:1900034; GO:1901796; GO:1902340; GO:1903444; GO:1904263; GO:1904515; GO:2000330 animal organ morphogenesis [GO:0009887]; apoptotic process [GO:0006915]; B cell differentiation [GO:0030183]; behavioral defense response [GO:0002209]; canonical NF-kappaB signal transduction [GO:0007249]; canonical Wnt signaling pathway [GO:0060070]; cellular response to L-leucine [GO:0071233]; cellular response to nutrient levels [GO:0031669]; cellular response to UV [GO:0034644]; circadian rhythm [GO:0007623]; DNA repair-dependent chromatin remodeling [GO:0140861]; face morphogenesis [GO:0060325]; fat cell differentiation [GO:0045444]; heart development [GO:0007507]; host-mediated activation of viral transcription [GO:0043923]; internal peptidyl-lysine acetylation [GO:0018393]; internal protein amino acid acetylation [GO:0006475]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; learning or memory [GO:0007611]; lung development [GO:0030324]; megakaryocyte development [GO:0035855]; multicellular organism growth [GO:0035264]; N-terminal peptidyl-lysine acetylation [GO:0018076]; negative regulation of autophagy [GO:0010507]; negative regulation of brown fat cell differentiation [GO:1903444]; negative regulation of chromosome condensation [GO:1902340]; negative regulation of gluconeogenesis [GO:0045721]; negative regulation of protein oligomerization [GO:0032460]; negative regulation of protein-containing complex assembly [GO:0031333]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]; peptidyl-lysine butyrylation [GO:0140067]; peptidyl-lysine crotonylation [GO:0140066]; peptidyl-lysine propionylation [GO:0061921]; platelet formation [GO:0030220]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of neuron projection development [GO:0010976]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of T-helper 17 cell lineage commitment [GO:2000330]; positive regulation of TORC1 signaling [GO:1904263]; positive regulation of TORC2 signaling [GO:1904515]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; protein acetylation [GO:0006473]; protein destabilization [GO:0031648]; protein stabilization [GO:0050821]; regulation of androgen receptor signaling pathway [GO:0060765]; regulation of autophagy [GO:0010506]; regulation of cellular response to heat [GO:1900034]; regulation of glycolytic process [GO:0006110]; regulation of mitochondrion organization [GO:0010821]; regulation of signal transduction by p53 class mediator [GO:1901796]; regulation of tubulin deacetylation [GO:0090043]; response to estrogen [GO:0043627]; response to hypoxia [GO:0001666]; skeletal muscle tissue development [GO:0007519]; somitogenesis [GO:0001756]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; swimming [GO:0036268]; thigmotaxis [GO:0001966]; transcription initiation-coupled chromatin remodeling [GO:0045815] chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; histone acetyltransferase complex [GO:0000123]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-DNA complex [GO:0032993]; transcription regulator complex [GO:0005667] acetylation-dependent protein binding [GO:0140033]; acetyltransferase activity [GO:0016407]; acyltransferase activity [GO:0016746]; beta-catenin binding [GO:0008013]; chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; damaged DNA binding [GO:0003684]; DNA binding [GO:0003677]; DNA-binding transcription factor binding [GO:0140297]; histone acetyltransferase activity [GO:0004402]; histone butyryltransferase activity [GO:0140069]; histone crotonyltransferase activity [GO:0140068]; histone H1K75 acetyltransferase activity [GO:0160263]; histone H2B acetyltransferase activity [GO:0044013]; histone H3 acetyltransferase activity [GO:0010484]; histone H3K122 acetyltransferase activity [GO:0140908]; histone H3K18 acetyltransferase activity [GO:0043993]; histone H3K27 acetyltransferase activity [GO:0044017]; histone H4 acetyltransferase activity [GO:0010485]; histone isonicotinyltransferase activity [GO:0140230]; histone lactyltransferase (CoA-dependent) activity [GO:0120301]; L-lysine N-acetyltransferase activity, acting on acetyl phosphate as donor [GO:0004468]; NF-kappaB binding [GO:0051059]; nuclear androgen receptor binding [GO:0050681]; nuclear receptor binding [GO:0016922]; p53 binding [GO:0002039]; peptide 2-hydroxyisobutyryltransferase activity [GO:0106226]; peptide butyryltransferase activity [GO:0140065]; pre-mRNA intronic binding [GO:0097157]; protein propionyltransferase activity [GO:0061920]; protein-lysine-acetyltransferase activity [GO:0061733]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; STAT family protein binding [GO:0097677]; tau protein binding [GO:0048156]; transcription coactivator activity [GO:0003713]; transcription coactivator binding [GO:0001223]; transcription coregulator binding [GO:0001221]; zinc ion binding [GO:0008270] g17816.t1 A7RNG8 56.832 644 0.0 721.0 sp|A7RNG8|CCD22_NEMVE Coiled-coil domain-containing protein 22 homolog OS=Nematostella vectensis OX=45351 GN=v1g180167 PE=3 SV=1 g17817.t1 A0JNJ3 40.0 220 4.7400000000000005e-43 166.0 sp|A0JNJ3|SPART_BOVIN Spartin OS=Bos taurus OX=9913 GN=SPART PE=2 SV=1 g17817.t1 A0JNJ3 46.774 124 1.3e-29 127.0 sp|A0JNJ3|SPART_BOVIN Spartin OS=Bos taurus OX=9913 GN=SPART PE=2 SV=1 g17818.t1 Q6GQE1 32.456 342 1.2300000000000001e-37 144.0 sp|Q6GQE1|T184C_XENLA Transmembrane protein 184C OS=Xenopus laevis OX=8355 GN=tmem184c PE=2 SV=1 g17819.t1 Q6GQE1 36.641 262 2.7799999999999996e-42 153.0 sp|Q6GQE1|T184C_XENLA Transmembrane protein 184C OS=Xenopus laevis OX=8355 GN=tmem184c PE=2 SV=1 g17821.t1 Q9NVA4 34.896 384 3.34e-62 210.0 sp|Q9NVA4|T184C_HUMAN Transmembrane protein 184C OS=Homo sapiens OX=9606 GN=TMEM184C PE=1 SV=2 g17822.t1 Q5ZMP3 36.695 357 2.8499999999999997e-61 214.0 sp|Q5ZMP3|T184C_CHICK Transmembrane protein 184C OS=Gallus gallus OX=9031 GN=TMEM184C PE=2 SV=1 g17823.t1 Q3U3W5 34.055 878 5.3599999999999996e-142 445.0 sp|Q3U3W5|ANM9_MOUSE Protein arginine N-methyltransferase 9 OS=Mus musculus OX=10090 GN=Prmt9 PE=2 SV=2 g17825.t1 Q3KPT0 40.476 168 6.8e-28 108.0 sp|Q3KPT0|CC169_XENLA Coiled-coil domain-containing protein 169 OS=Xenopus laevis OX=8355 GN=ccdc169 PE=2 SV=2 g17829.t1 G3X9Z4 40.244 246 8.259999999999999e-42 170.0 sp|G3X9Z4|PCF11_MOUSE Pre-mRNA cleavage complex 2 protein Pcf11 OS=Mus musculus OX=10090 GN=Pcf11 PE=2 SV=1 PCF11_MOUSE reviewed Pre-mRNA cleavage complex 2 protein Pcf11 (Pre-mRNA cleavage complex II protein Pcf11) Mus musculus (Mouse) GO:0000993; GO:0003729; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005849; GO:0006369; GO:0031124 mRNA 3'-end processing [GO:0031124]; termination of RNA polymerase II transcription [GO:0006369] cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; mRNA cleavage factor complex [GO:0005849]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] mRNA binding [GO:0003729]; RNA polymerase II complex binding [GO:0000993] g17832.t1 O94913 58.788 165 1.1e-51 201.0 sp|O94913|PCF11_HUMAN Pre-mRNA cleavage complex 2 protein Pcf11 OS=Homo sapiens OX=9606 GN=PCF11 PE=1 SV=3 PCF11_HUMAN reviewed Pre-mRNA cleavage complex 2 protein Pcf11 (Pre-mRNA cleavage complex II protein Pcf11) Homo sapiens (Human) GO:0000993; GO:0003729; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005849; GO:0006369; GO:0180010 co-transcriptional mRNA 3'-end processing, cleavage and polyadenylation pathway [GO:0180010]; termination of RNA polymerase II transcription [GO:0006369] cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; mRNA cleavage factor complex [GO:0005849]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] mRNA binding [GO:0003729]; RNA polymerase II complex binding [GO:0000993] g17833.t1 Q923S9 68.182 198 7.52e-98 285.0 sp|Q923S9|RAB30_MOUSE Ras-related protein Rab-30 OS=Mus musculus OX=10090 GN=Rab30 PE=1 SV=1 g17834.t1 Q8C7H1 58.631 336 3.38e-123 366.0 sp|Q8C7H1|MMAA_MOUSE Methylmalonic aciduria type A homolog, mitochondrial OS=Mus musculus OX=10090 GN=Mmaa PE=1 SV=1 g17835.t1 A4IG53 43.396 212 3.88e-61 196.0 sp|A4IG53|COMTB_DANRE Catechol O-methyltransferase B OS=Danio rerio OX=7955 GN=comtb PE=2 SV=1 g17837.t1 P79942 50.15 333 3.2899999999999995e-104 315.0 sp|P79942|NOCT_XENLA Nocturnin OS=Xenopus laevis OX=8355 GN=noct PE=2 SV=1 g17838.t1 B0BN85 54.271 199 5.1499999999999995e-67 212.0 sp|B0BN85|SGT1_RAT Protein SGT1 homolog OS=Rattus norvegicus OX=10116 GN=Sugt1 PE=2 SV=1 SGT1_RAT reviewed Protein SGT1 homolog (Suppressor of G2 allele of SKP1 homolog) Rattus norvegicus (Rat) GO:0000776; GO:0005737; GO:0005829; GO:0007051; GO:0014841; GO:0016604; GO:0031647; GO:0032991; GO:0051087; GO:0051382; GO:0106222 kinetochore assembly [GO:0051382]; regulation of protein stability [GO:0031647]; skeletal muscle satellite cell proliferation [GO:0014841]; spindle organization [GO:0007051] cytoplasm [GO:0005737]; cytosol [GO:0005829]; kinetochore [GO:0000776]; nuclear body [GO:0016604]; protein-containing complex [GO:0032991] lncRNA binding [GO:0106222]; protein-folding chaperone binding [GO:0051087] g17839.t1 Q9NPJ8 49.275 138 5.01e-45 146.0 sp|Q9NPJ8|NXT2_HUMAN NTF2-related export protein 2 OS=Homo sapiens OX=9606 GN=NXT2 PE=1 SV=1 NXT2_HUMAN reviewed NTF2-related export protein 2 (Protein p15-2) Homo sapiens (Human) GO:0005634; GO:0005654; GO:0005829; GO:0006406; GO:0015031; GO:0016973; GO:0042272; GO:0044613; GO:0048471 mRNA export from nucleus [GO:0006406]; poly(A)+ mRNA export from nucleus [GO:0016973]; protein transport [GO:0015031] cytosol [GO:0005829]; nuclear pore central transport channel [GO:0044613]; nuclear RNA export factor complex [GO:0042272]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471] g17842.t1 Q14517 37.948 1199 0.0 721.0 sp|Q14517|FAT1_HUMAN Protocadherin Fat 1 OS=Homo sapiens OX=9606 GN=FAT1 PE=1 SV=2 g17842.t1 Q14517 30.031 646 1.95e-53 211.0 sp|Q14517|FAT1_HUMAN Protocadherin Fat 1 OS=Homo sapiens OX=9606 GN=FAT1 PE=1 SV=2 g17842.t1 Q14517 31.569 548 2.05e-45 185.0 sp|Q14517|FAT1_HUMAN Protocadherin Fat 1 OS=Homo sapiens OX=9606 GN=FAT1 PE=1 SV=2 g17842.t1 Q14517 28.748 647 3.25e-41 171.0 sp|Q14517|FAT1_HUMAN Protocadherin Fat 1 OS=Homo sapiens OX=9606 GN=FAT1 PE=1 SV=2 g17842.t1 Q14517 28.036 667 2.59e-39 165.0 sp|Q14517|FAT1_HUMAN Protocadherin Fat 1 OS=Homo sapiens OX=9606 GN=FAT1 PE=1 SV=2 g17842.t1 Q14517 27.993 543 1.7899999999999998e-38 162.0 sp|Q14517|FAT1_HUMAN Protocadherin Fat 1 OS=Homo sapiens OX=9606 GN=FAT1 PE=1 SV=2 g17842.t1 Q14517 27.855 578 1.93e-38 162.0 sp|Q14517|FAT1_HUMAN Protocadherin Fat 1 OS=Homo sapiens OX=9606 GN=FAT1 PE=1 SV=2 g17842.t1 Q14517 26.711 599 6.58e-38 160.0 sp|Q14517|FAT1_HUMAN Protocadherin Fat 1 OS=Homo sapiens OX=9606 GN=FAT1 PE=1 SV=2 g17842.t1 Q14517 31.592 402 1.41e-35 152.0 sp|Q14517|FAT1_HUMAN Protocadherin Fat 1 OS=Homo sapiens OX=9606 GN=FAT1 PE=1 SV=2 g17842.t1 Q14517 27.519 665 1.98e-34 149.0 sp|Q14517|FAT1_HUMAN Protocadherin Fat 1 OS=Homo sapiens OX=9606 GN=FAT1 PE=1 SV=2 g17842.t1 Q14517 26.43 507 2.57e-29 132.0 sp|Q14517|FAT1_HUMAN Protocadherin Fat 1 OS=Homo sapiens OX=9606 GN=FAT1 PE=1 SV=2 g17842.t1 Q14517 27.112 509 1.34e-27 126.0 sp|Q14517|FAT1_HUMAN Protocadherin Fat 1 OS=Homo sapiens OX=9606 GN=FAT1 PE=1 SV=2 g17843.t1 Q14517 41.987 2989 0.0 2081.0 sp|Q14517|FAT1_HUMAN Protocadherin Fat 1 OS=Homo sapiens OX=9606 GN=FAT1 PE=1 SV=2 g17843.t1 Q14517 27.733 2881 0.0 717.0 sp|Q14517|FAT1_HUMAN Protocadherin Fat 1 OS=Homo sapiens OX=9606 GN=FAT1 PE=1 SV=2 g17843.t1 Q14517 28.377 2354 0.0 653.0 sp|Q14517|FAT1_HUMAN Protocadherin Fat 1 OS=Homo sapiens OX=9606 GN=FAT1 PE=1 SV=2 g17843.t1 Q14517 26.917 2935 0.0 647.0 sp|Q14517|FAT1_HUMAN Protocadherin Fat 1 OS=Homo sapiens OX=9606 GN=FAT1 PE=1 SV=2 g17843.t1 Q14517 26.032 2374 1.54e-131 470.0 sp|Q14517|FAT1_HUMAN Protocadherin Fat 1 OS=Homo sapiens OX=9606 GN=FAT1 PE=1 SV=2 g17843.t1 Q14517 28.089 947 1.3e-68 263.0 sp|Q14517|FAT1_HUMAN Protocadherin Fat 1 OS=Homo sapiens OX=9606 GN=FAT1 PE=1 SV=2 g17844.t1 Q94738 58.286 887 0.0 941.0 sp|Q94738|HSP97_MESFR 97 kDa heat shock protein OS=Mesocentrotus franciscanus OX=1328066 GN=HSP110 PE=2 SV=1 g17845.t1 P52486 60.5 200 3.33e-76 230.0 sp|P52486|UBCD4_DROME Ubiquitin-conjugating enzyme E2-22 kDa OS=Drosophila melanogaster OX=7227 GN=Ubc4 PE=1 SV=2 UBCD4_DROME reviewed Ubiquitin-conjugating enzyme E2-22 kDa (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme 4) (Ubiquitin carrier protein) (Ubiquitin-protein ligase) Drosophila melanogaster (Fruit fly) GO:0000209; GO:0004842; GO:0005524; GO:0005634; GO:0031625; GO:0061059; GO:0061631; GO:0070628 positive regulation of peptidoglycan recognition protein signaling pathway [GO:0061059]; protein polyubiquitination [GO:0000209] nucleus [GO:0005634] ATP binding [GO:0005524]; proteasome binding [GO:0070628]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842] g17846.t1 P60892 75.61 205 1.1900000000000001e-105 308.0 sp|P60892|PRPS1_RAT Ribose-phosphate pyrophosphokinase 1 OS=Rattus norvegicus OX=10116 GN=Prps1 PE=1 SV=2 PRPS1_RAT reviewed Ribose-phosphate pyrophosphokinase 1 (EC 2.7.6.1) (Phosphoribosyl pyrophosphate synthase I) (PRS-I) Rattus norvegicus (Rat) GO:0000287; GO:0002189; GO:0004749; GO:0005524; GO:0005737; GO:0005829; GO:0006015; GO:0006098; GO:0006144; GO:0006164; GO:0006167; GO:0007399; GO:0016208; GO:0016301; GO:0019003; GO:0030246; GO:0031100; GO:0032991; GO:0034418; GO:0042802; GO:0042803; GO:0043531; GO:0046101 5-phosphoribose 1-diphosphate biosynthetic process [GO:0006015]; AMP biosynthetic process [GO:0006167]; animal organ regeneration [GO:0031100]; hypoxanthine biosynthetic process [GO:0046101]; nervous system development [GO:0007399]; pentose-phosphate shunt [GO:0006098]; purine nucleobase metabolic process [GO:0006144]; purine nucleotide biosynthetic process [GO:0006164]; urate biosynthetic process [GO:0034418] cytoplasm [GO:0005737]; cytosol [GO:0005829]; protein-containing complex [GO:0032991]; ribose phosphate diphosphokinase complex [GO:0002189] ADP binding [GO:0043531]; AMP binding [GO:0016208]; ATP binding [GO:0005524]; carbohydrate binding [GO:0030246]; GDP binding [GO:0019003]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; magnesium ion binding [GO:0000287]; protein homodimerization activity [GO:0042803]; ribose phosphate diphosphokinase activity [GO:0004749] g17847.t1 Q7ZXC9 85.417 96 4.23e-53 171.0 sp|Q7ZXC9|PRPS2_XENLA Ribose-phosphate pyrophosphokinase 2 OS=Xenopus laevis OX=8355 GN=prps2 PE=2 SV=1 PRPS2_XENLA reviewed Ribose-phosphate pyrophosphokinase 2 (EC 2.7.6.1) (Phosphoribosyl pyrophosphate synthase II) (PRS-II) Xenopus laevis (African clawed frog) GO:0000287; GO:0002189; GO:0004749; GO:0005524; GO:0005737; GO:0006015; GO:0006164; GO:0009156; GO:0016301; GO:0042803 5-phosphoribose 1-diphosphate biosynthetic process [GO:0006015]; purine nucleotide biosynthetic process [GO:0006164]; ribonucleoside monophosphate biosynthetic process [GO:0009156] cytoplasm [GO:0005737]; ribose phosphate diphosphokinase complex [GO:0002189] ATP binding [GO:0005524]; kinase activity [GO:0016301]; magnesium ion binding [GO:0000287]; protein homodimerization activity [GO:0042803]; ribose phosphate diphosphokinase activity [GO:0004749] g17849.t1 Q96PE3 49.128 344 9.28e-103 345.0 sp|Q96PE3|INP4A_HUMAN Inositol polyphosphate-4-phosphatase type I A OS=Homo sapiens OX=9606 GN=INPP4A PE=1 SV=1 INP4A_HUMAN reviewed Inositol polyphosphate-4-phosphatase type I A (Inositol polyphosphate 4-phosphatase type I) (Type I inositol 3,4-bisphosphate 4-phosphatase) (EC 3.1.3.66) Homo sapiens (Human) GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0006661; GO:0007165; GO:0014069; GO:0016316; GO:0017161; GO:0031901; GO:0031965; GO:0043647; GO:0052828; GO:0055038 inositol phosphate metabolic process [GO:0043647]; phosphatidylinositol biosynthetic process [GO:0006661]; signal transduction [GO:0007165] cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; recycling endosome membrane [GO:0055038] inositol-1,3,4-trisphosphate 4-phosphatase activity [GO:0017161]; inositol-3,4-bisphosphate 4-phosphatase activity [GO:0052828]; phosphatidylinositol-3,4-bisphosphate 4-phosphatase activity [GO:0016316] g17849.t1 Q96PE3 30.536 429 3.5899999999999994e-54 207.0 sp|Q96PE3|INP4A_HUMAN Inositol polyphosphate-4-phosphatase type I A OS=Homo sapiens OX=9606 GN=INPP4A PE=1 SV=1 INP4A_HUMAN reviewed Inositol polyphosphate-4-phosphatase type I A (Inositol polyphosphate 4-phosphatase type I) (Type I inositol 3,4-bisphosphate 4-phosphatase) (EC 3.1.3.66) Homo sapiens (Human) GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0006661; GO:0007165; GO:0014069; GO:0016316; GO:0017161; GO:0031901; GO:0031965; GO:0043647; GO:0052828; GO:0055038 inositol phosphate metabolic process [GO:0043647]; phosphatidylinositol biosynthetic process [GO:0006661]; signal transduction [GO:0007165] cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; recycling endosome membrane [GO:0055038] inositol-1,3,4-trisphosphate 4-phosphatase activity [GO:0017161]; inositol-3,4-bisphosphate 4-phosphatase activity [GO:0052828]; phosphatidylinositol-3,4-bisphosphate 4-phosphatase activity [GO:0016316] g17849.t2 Q96PE3 49.128 344 1.16e-102 345.0 sp|Q96PE3|INP4A_HUMAN Inositol polyphosphate-4-phosphatase type I A OS=Homo sapiens OX=9606 GN=INPP4A PE=1 SV=1 INP4A_HUMAN reviewed Inositol polyphosphate-4-phosphatase type I A (Inositol polyphosphate 4-phosphatase type I) (Type I inositol 3,4-bisphosphate 4-phosphatase) (EC 3.1.3.66) Homo sapiens (Human) GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0006661; GO:0007165; GO:0014069; GO:0016316; GO:0017161; GO:0031901; GO:0031965; GO:0043647; GO:0052828; GO:0055038 inositol phosphate metabolic process [GO:0043647]; phosphatidylinositol biosynthetic process [GO:0006661]; signal transduction [GO:0007165] cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; recycling endosome membrane [GO:0055038] inositol-1,3,4-trisphosphate 4-phosphatase activity [GO:0017161]; inositol-3,4-bisphosphate 4-phosphatase activity [GO:0052828]; phosphatidylinositol-3,4-bisphosphate 4-phosphatase activity [GO:0016316] g17849.t2 Q96PE3 29.909 438 9.93e-52 200.0 sp|Q96PE3|INP4A_HUMAN Inositol polyphosphate-4-phosphatase type I A OS=Homo sapiens OX=9606 GN=INPP4A PE=1 SV=1 INP4A_HUMAN reviewed Inositol polyphosphate-4-phosphatase type I A (Inositol polyphosphate 4-phosphatase type I) (Type I inositol 3,4-bisphosphate 4-phosphatase) (EC 3.1.3.66) Homo sapiens (Human) GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0006661; GO:0007165; GO:0014069; GO:0016316; GO:0017161; GO:0031901; GO:0031965; GO:0043647; GO:0052828; GO:0055038 inositol phosphate metabolic process [GO:0043647]; phosphatidylinositol biosynthetic process [GO:0006661]; signal transduction [GO:0007165] cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; recycling endosome membrane [GO:0055038] inositol-1,3,4-trisphosphate 4-phosphatase activity [GO:0017161]; inositol-3,4-bisphosphate 4-phosphatase activity [GO:0052828]; phosphatidylinositol-3,4-bisphosphate 4-phosphatase activity [GO:0016316] g17852.t1 Q7ZVK4 59.162 382 4.71e-156 447.0 sp|Q7ZVK4|VPS36_DANRE Vacuolar protein-sorting-associated protein 36 OS=Danio rerio OX=7955 GN=vps36 PE=2 SV=1 g17857.t1 Q5RD64 32.0 200 4.63e-24 106.0 sp|Q5RD64|CNTP2_PONAB Contactin-associated protein-like 2 OS=Pongo abelii OX=9601 GN=CNTNAP2 PE=2 SV=1 CNTP2_PONAB reviewed Contactin-associated protein-like 2 Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0007155; GO:0007417; GO:0016020; GO:0033010; GO:0044224; GO:0048812; GO:0071205 cell adhesion [GO:0007155]; central nervous system development [GO:0007417]; neuron projection morphogenesis [GO:0048812]; protein localization to juxtaparanode region of axon [GO:0071205] juxtaparanode region of axon [GO:0044224]; membrane [GO:0016020]; paranodal junction [GO:0033010] g17858.t1 Q9C0A0 36.634 202 4e-25 110.0 sp|Q9C0A0|CNTP4_HUMAN Contactin-associated protein-like 4 OS=Homo sapiens OX=9606 GN=CNTNAP4 PE=1 SV=3 CNTP4_HUMAN reviewed Contactin-associated protein-like 4 (Cell recognition molecule Caspr4) Homo sapiens (Human) GO:0007155; GO:0007399; GO:0032225; GO:0032228; GO:0042734; GO:2000821 cell adhesion [GO:0007155]; nervous system development [GO:0007399]; regulation of grooming behavior [GO:2000821]; regulation of synaptic transmission, dopaminergic [GO:0032225]; regulation of synaptic transmission, GABAergic [GO:0032228] presynaptic membrane [GO:0042734] g17861.t1 Q8SPN2 28.226 248 1.7700000000000003e-21 97.1 sp|Q8SPN2|PKR1_BOVIN Prokineticin receptor 1 OS=Bos taurus OX=9913 GN=PROKR1 PE=2 SV=1 g17863.t1 Q8K458 41.221 131 4.86e-22 93.2 sp|Q8K458|PKR2_MOUSE Prokineticin receptor 2 OS=Mus musculus OX=10090 GN=Prokr2 PE=2 SV=1 g17864.t1 Q60544 62.636 827 0.0 903.0 sp|Q60544|TAF1_MESAU Transcription initiation factor TFIID subunit 1 OS=Mesocricetus auratus OX=10036 GN=TAF1 PE=2 SV=1 g17865.t1 Q80UV9 51.618 618 0.0 613.0 sp|Q80UV9|TAF1_MOUSE Transcription initiation factor TFIID subunit 1 OS=Mus musculus OX=10090 GN=Taf1 PE=1 SV=2 TAF1_MOUSE reviewed Transcription initiation factor TFIID subunit 1 (EC 2.3.1.48) (EC 2.7.11.1) (Cell cycle gene 1 protein) (TBP-associated factor 250 kDa) (p250) (Transcription initiation factor TFIID 250 kDa subunit) (TAF(II)250) (TAFII-250) (TAFII250) Mus musculus (Mouse) GO:0000785; GO:0000979; GO:0001091; GO:0001181; GO:0002039; GO:0003677; GO:0004402; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005667; GO:0005669; GO:0016251; GO:0016301; GO:0016922; GO:0017025; GO:0042789; GO:0045120; GO:0046982; GO:0051123; GO:0060261; GO:0061629; GO:0061631; GO:0071339; GO:0106310; GO:0140046; GO:0140416; GO:0140566; GO:1990841 mRNA transcription by RNA polymerase II [GO:0042789]; positive regulation of transcription initiation by RNA polymerase II [GO:0060261]; RNA polymerase II preinitiation complex assembly [GO:0051123] chromatin [GO:0000785]; MLL1 complex [GO:0071339]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pronucleus [GO:0045120]; transcription factor TFIID complex [GO:0005669]; transcription regulator complex [GO:0005667] ATP binding [GO:0005524]; DNA binding [GO:0003677]; histone acetyltransferase activity [GO:0004402]; histone H4K16ac reader activity [GO:0140046]; histone reader activity [GO:0140566]; kinase activity [GO:0016301]; nuclear receptor binding [GO:0016922]; p53 binding [GO:0002039]; promoter-specific chromatin binding [GO:1990841]; protein heterodimerization activity [GO:0046982]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; RNA polymerase I general transcription initiation factor activity [GO:0001181]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; RNA polymerase II general transcription initiation factor binding [GO:0001091]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; TBP-class protein binding [GO:0017025]; transcription regulator inhibitor activity [GO:0140416]; ubiquitin conjugating enzyme activity [GO:0061631] g17867.t1 Q5U4V2 31.126 302 7.490000000000001e-32 123.0 sp|Q5U4V2|HNMTA_XENLA Histamine N-methyltransferase A OS=Xenopus laevis OX=8355 GN=hnmt-a PE=2 SV=1 g17868.t1 Q8K2G4 68.671 715 0.0 1039.0 sp|Q8K2G4|BBS7_MOUSE BBSome complex member BBS7 OS=Mus musculus OX=10090 GN=Bbs7 PE=1 SV=1 BBS7_MOUSE reviewed BBSome complex member BBS7 (BBS2-like protein 1) (Bardet-Biedl syndrome 7 protein homolog) Mus musculus (Mouse) GO:0001654; GO:0001750; GO:0005634; GO:0005813; GO:0005930; GO:0006357; GO:0007224; GO:0007420; GO:0007507; GO:0008104; GO:0015031; GO:0016020; GO:0032436; GO:0034451; GO:0034464; GO:0036064; GO:0043005; GO:0045444; GO:0060170; GO:0060173; GO:0060271; GO:0061629; GO:1903929; GO:1905515 brain development [GO:0007420]; cilium assembly [GO:0060271]; eye development [GO:0001654]; fat cell differentiation [GO:0045444]; heart development [GO:0007507]; intracellular protein localization [GO:0008104]; limb development [GO:0060173]; non-motile cilium assembly [GO:1905515]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; primary palate development [GO:1903929]; protein transport [GO:0015031]; regulation of transcription by RNA polymerase II [GO:0006357]; smoothened signaling pathway [GO:0007224] axoneme [GO:0005930]; BBSome [GO:0034464]; centriolar satellite [GO:0034451]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary membrane [GO:0060170]; membrane [GO:0016020]; neuron projection [GO:0043005]; nucleus [GO:0005634]; photoreceptor outer segment [GO:0001750] RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629] g17869.t1 Q32LC9 66.135 251 1.1000000000000001e-110 327.0 sp|Q32LC9|ZN330_BOVIN Zinc finger protein 330 OS=Bos taurus OX=9913 GN=ZNF330 PE=2 SV=1 g17872.t1 Q80VI1 32.039 206 1.9e-22 105.0 sp|Q80VI1|TRI56_MOUSE E3 ubiquitin-protein ligase TRIM56 OS=Mus musculus OX=10090 GN=Trim56 PE=1 SV=1 TRI56_MOUSE reviewed E3 ubiquitin-protein ligase TRIM56 (EC 2.3.2.27) (Tripartite motif-containing protein 56) Mus musculus (Mouse) GO:0005654; GO:0005737; GO:0006513; GO:0008270; GO:0032728; GO:0034340; GO:0044790; GO:0045087; GO:0045089; GO:0046597; GO:0051607; GO:0060340; GO:0061630; GO:0070534; GO:0140896; GO:1901224 cGAS/STING signaling pathway [GO:0140896]; defense response to virus [GO:0051607]; host-mediated suppression of symbiont invasion [GO:0046597]; innate immune response [GO:0045087]; positive regulation of innate immune response [GO:0045089]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of non-canonical NF-kappaB signal transduction [GO:1901224]; positive regulation of type I interferon-mediated signaling pathway [GO:0060340]; protein K63-linked ubiquitination [GO:0070534]; protein monoubiquitination [GO:0006513]; response to type I interferon [GO:0034340]; suppression of viral release by host [GO:0044790] cytoplasm [GO:0005737]; nucleoplasm [GO:0005654] ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] g17873.t1 Q80VI1 27.389 314 1.54e-25 112.0 sp|Q80VI1|TRI56_MOUSE E3 ubiquitin-protein ligase TRIM56 OS=Mus musculus OX=10090 GN=Trim56 PE=1 SV=1 TRI56_MOUSE reviewed E3 ubiquitin-protein ligase TRIM56 (EC 2.3.2.27) (Tripartite motif-containing protein 56) Mus musculus (Mouse) GO:0005654; GO:0005737; GO:0006513; GO:0008270; GO:0032728; GO:0034340; GO:0044790; GO:0045087; GO:0045089; GO:0046597; GO:0051607; GO:0060340; GO:0061630; GO:0070534; GO:0140896; GO:1901224 cGAS/STING signaling pathway [GO:0140896]; defense response to virus [GO:0051607]; host-mediated suppression of symbiont invasion [GO:0046597]; innate immune response [GO:0045087]; positive regulation of innate immune response [GO:0045089]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of non-canonical NF-kappaB signal transduction [GO:1901224]; positive regulation of type I interferon-mediated signaling pathway [GO:0060340]; protein K63-linked ubiquitination [GO:0070534]; protein monoubiquitination [GO:0006513]; response to type I interferon [GO:0034340]; suppression of viral release by host [GO:0044790] cytoplasm [GO:0005737]; nucleoplasm [GO:0005654] ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] g17882.t1 E1BD59 28.0 225 6.0700000000000005e-21 94.4 sp|E1BD59|TRI56_BOVIN E3 ubiquitin-protein ligase TRIM56 OS=Bos taurus OX=9913 GN=TRIM56 PE=2 SV=1 TRI56_BOVIN reviewed E3 ubiquitin-protein ligase TRIM56 (EC 2.3.2.27) (Tripartite motif-containing protein 56) Bos taurus (Bovine) GO:0005654; GO:0005737; GO:0006513; GO:0008270; GO:0032728; GO:0034340; GO:0045087; GO:0051607; GO:0060340; GO:0061630; GO:0070534 defense response to virus [GO:0051607]; innate immune response [GO:0045087]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of type I interferon-mediated signaling pathway [GO:0060340]; protein K63-linked ubiquitination [GO:0070534]; protein monoubiquitination [GO:0006513]; response to type I interferon [GO:0034340] cytoplasm [GO:0005737]; nucleoplasm [GO:0005654] ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] g17883.t1 B6ELU0 37.917 240 2.9e-40 154.0 sp|B6ELU0|TTCA_ALISL tRNA-cytidine(32) 2-sulfurtransferase OS=Aliivibrio salmonicida (strain LFI1238) OX=316275 GN=ttcA PE=3 SV=1 TTCA_ALISL reviewed tRNA-cytidine(32) 2-sulfurtransferase (EC 2.8.1.-) (Two-thiocytidine biosynthesis protein A) (tRNA 2-thiocytidine biosynthesis protein TtcA) Aliivibrio salmonicida (strain LFI1238) (Vibrio salmonicida (strain LFI1238)) GO:0000049; GO:0000287; GO:0005524; GO:0005737; GO:0016783; GO:0034227; GO:0051539 tRNA thio-modification [GO:0034227] cytoplasm [GO:0005737] 4 iron, 4 sulfur cluster binding [GO:0051539]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; sulfurtransferase activity [GO:0016783]; tRNA binding [GO:0000049] g17885.t1 P46060 49.497 596 2.42e-167 492.0 sp|P46060|RAGP1_HUMAN Ran GTPase-activating protein 1 OS=Homo sapiens OX=9606 GN=RANGAP1 PE=1 SV=1 RAGP1_HUMAN reviewed Ran GTPase-activating protein 1 (RanGAP1) Homo sapiens (Human) GO:0000776; GO:0003723; GO:0005096; GO:0005634; GO:0005635; GO:0005643; GO:0005654; GO:0005737; GO:0005814; GO:0005829; GO:0007165; GO:0016235; GO:0016925; GO:0030425; GO:0031267; GO:0031625; GO:0031965; GO:0044614; GO:0045296; GO:0046826; GO:0048471; GO:0048678; GO:0051168; GO:0072686; GO:0090630; GO:0106068; GO:1904115; GO:1904117; GO:1990723 activation of GTPase activity [GO:0090630]; cellular response to vasopressin [GO:1904117]; negative regulation of protein export from nucleus [GO:0046826]; nuclear export [GO:0051168]; protein sumoylation [GO:0016925]; response to axon injury [GO:0048678]; signal transduction [GO:0007165] aggresome [GO:0016235]; axon cytoplasm [GO:1904115]; centriole [GO:0005814]; cytoplasm [GO:0005737]; cytoplasmic periphery of the nuclear pore complex [GO:1990723]; cytosol [GO:0005829]; dendrite [GO:0030425]; kinetochore [GO:0000776]; mitotic spindle [GO:0072686]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nuclear pore cytoplasmic filaments [GO:0044614]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; SUMO ligase complex [GO:0106068] cadherin binding [GO:0045296]; GTPase activator activity [GO:0005096]; RNA binding [GO:0003723]; small GTPase binding [GO:0031267]; ubiquitin protein ligase binding [GO:0031625] g17886.t1 Q9QZD5 36.934 685 7.9e-133 409.0 sp|Q9QZD5|RAE2_MOUSE Rab proteins geranylgeranyltransferase component A 2 OS=Mus musculus OX=10090 GN=Chml PE=2 SV=2 g17887.t1 Q9H720 43.266 594 2.77e-155 465.0 sp|Q9H720|PG2IP_HUMAN PGAP2-interacting protein OS=Homo sapiens OX=9606 GN=CWH43 PE=1 SV=2 g17889.t1 Q58DV5 49.533 107 2.01e-24 96.3 sp|Q58DV5|RM30_BOVIN Large ribosomal subunit protein uL30m OS=Bos taurus OX=9913 GN=MRPL30 PE=1 SV=1 g17890.t1 D3YY23 46.825 252 2.6999999999999998e-74 253.0 sp|D3YY23|LONF1_MOUSE LON peptidase N-terminal domain and RING finger protein 1 OS=Mus musculus OX=10090 GN=Lonrf1 PE=1 SV=2 g17890.t1 D3YY23 48.78 41 2.6999999999999998e-74 49.3 sp|D3YY23|LONF1_MOUSE LON peptidase N-terminal domain and RING finger protein 1 OS=Mus musculus OX=10090 GN=Lonrf1 PE=1 SV=2 g17890.t1 D3YY23 31.461 267 3.28e-22 105.0 sp|D3YY23|LONF1_MOUSE LON peptidase N-terminal domain and RING finger protein 1 OS=Mus musculus OX=10090 GN=Lonrf1 PE=1 SV=2 g17891.t1 Q9ERR2 46.829 205 1.08e-59 189.0 sp|Q9ERR2|COMD5_RAT COMM domain-containing protein 5 OS=Rattus norvegicus OX=10116 GN=Commd5 PE=2 SV=1 g17893.t1 Q3ZT31 35.649 547 1.0300000000000001e-103 347.0 sp|Q3ZT31|SNX25_MOUSE Sorting nexin-25 OS=Mus musculus OX=10090 GN=Snx25 PE=1 SV=3 g17893.t1 Q3ZT31 44.206 233 1.07e-44 178.0 sp|Q3ZT31|SNX25_MOUSE Sorting nexin-25 OS=Mus musculus OX=10090 GN=Snx25 PE=1 SV=3 g17894.t1 P70010 69.935 153 9.89e-78 230.0 sp|P70010|NDKA1_XENLA Nucleoside diphosphate kinase A1 OS=Xenopus laevis OX=8355 PE=2 SV=1 g17895.t1 Q5SSI6 43.307 381 7.49e-107 332.0 sp|Q5SSI6|UTP18_MOUSE U3 small nucleolar RNA-associated protein 18 homolog OS=Mus musculus OX=10090 GN=Utp18 PE=1 SV=1 g17896.t1 Q60809 70.545 275 5.4e-147 416.0 sp|Q60809|CNOT7_MOUSE CCR4-NOT transcription complex subunit 7 OS=Mus musculus OX=10090 GN=Cnot7 PE=1 SV=1 CNOT7_MOUSE reviewed CCR4-NOT transcription complex subunit 7 (EC 3.1.13.4) (CCR4-associated factor 1) (CAF-1) Mus musculus (Mouse) GO:0000175; GO:0000288; GO:0000289; GO:0000290; GO:0000932; GO:0003714; GO:0004532; GO:0004535; GO:0005634; GO:0005737; GO:0005829; GO:0006417; GO:0007283; GO:0008284; GO:0008285; GO:0010629; GO:0016604; GO:0016607; GO:0030014; GO:0030015; GO:0031047; GO:0033962; GO:0034584; GO:0035279; GO:0045070; GO:0045892; GO:0045944; GO:0046872; GO:0051607; GO:0060213; GO:0060339; GO:0061014; GO:0140297; GO:0140991; GO:1900153 deadenylation-dependent decapping of nuclear-transcribed mRNA [GO:0000290]; defense response to virus [GO:0051607]; miRNA-mediated gene silencing by mRNA destabilization [GO:0035279]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of gene expression [GO:0010629]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:0000288]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; P-body assembly [GO:0033962]; piRNA-mediated gene silencing by mRNA destabilization [GO:0140991]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of mRNA catabolic process [GO:0061014]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of viral genome replication [GO:0045070]; regulation of translation [GO:0006417]; regulatory ncRNA-mediated gene silencing [GO:0031047]; spermatogenesis [GO:0007283] CCR4-NOT complex [GO:0030014]; CCR4-NOT core complex [GO:0030015]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; P-body [GO:0000932] 3'-5'-RNA exonuclease activity [GO:0000175]; DNA-binding transcription factor binding [GO:0140297]; metal ion binding [GO:0046872]; piRNA binding [GO:0034584]; poly(A)-specific ribonuclease activity [GO:0004535]; RNA exonuclease activity [GO:0004532]; transcription corepressor activity [GO:0003714] g17897.t1 Q8NEZ2 34.129 419 1.28e-50 178.0 sp|Q8NEZ2|VP37A_HUMAN Vacuolar protein sorting-associated protein 37A OS=Homo sapiens OX=9606 GN=VPS37A PE=1 SV=1 VP37A_HUMAN reviewed Vacuolar protein sorting-associated protein 37A (hVps37A) (ESCRT-I complex subunit VPS37A) (Hepatocellular carcinoma-related protein 1) Homo sapiens (Human) GO:0000813; GO:0001669; GO:0005654; GO:0005813; GO:0005814; GO:0005829; GO:0006612; GO:0006623; GO:0010008; GO:0016236; GO:0031902; GO:0033011; GO:0036258; GO:0039702; GO:0043162; GO:0043328; GO:0090148; GO:0097225; GO:0097228; GO:0097229 macroautophagy [GO:0016236]; membrane fission [GO:0090148]; multivesicular body assembly [GO:0036258]; protein targeting to membrane [GO:0006612]; protein targeting to vacuole [GO:0006623]; protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043328]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]; viral budding via host ESCRT complex [GO:0039702] acrosomal vesicle [GO:0001669]; centriole [GO:0005814]; centrosome [GO:0005813]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; ESCRT I complex [GO:0000813]; late endosome membrane [GO:0031902]; nucleoplasm [GO:0005654]; perinuclear theca [GO:0033011]; sperm end piece [GO:0097229]; sperm midpiece [GO:0097225]; sperm principal piece [GO:0097228] g17901.t1 P23921 78.446 798 0.0 1215.0 sp|P23921|RIR1_HUMAN Ribonucleoside-diphosphate reductase large subunit OS=Homo sapiens OX=9606 GN=RRM1 PE=1 SV=1 RIR1_HUMAN reviewed Ribonucleoside-diphosphate reductase large subunit (EC 1.17.4.1) (Ribonucleoside-diphosphate reductase subunit M1) (Ribonucleotide reductase large subunit) Homo sapiens (Human) GO:0000731; GO:0004748; GO:0005524; GO:0005635; GO:0005739; GO:0005829; GO:0005971; GO:0006206; GO:0006264; GO:0006281; GO:0008584; GO:0009185; GO:0009263; GO:0009265; GO:0010212; GO:0010971; GO:0021846; GO:0034451; GO:0036064; GO:0042802; GO:0043025; GO:0051290; GO:0060041; GO:0061731; GO:0070318; GO:0097718; GO:1900087 2'-deoxyribonucleotide biosynthetic process [GO:0009265]; cell proliferation in forebrain [GO:0021846]; deoxyribonucleotide biosynthetic process [GO:0009263]; DNA repair [GO:0006281]; DNA synthesis involved in DNA repair [GO:0000731]; male gonad development [GO:0008584]; mitochondrial DNA replication [GO:0006264]; positive regulation of G0 to G1 transition [GO:0070318]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; protein heterotetramerization [GO:0051290]; pyrimidine nucleobase metabolic process [GO:0006206]; response to ionizing radiation [GO:0010212]; retina development in camera-type eye [GO:0060041]; ribonucleoside diphosphate metabolic process [GO:0009185] centriolar satellite [GO:0034451]; ciliary basal body [GO:0036064]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; nuclear envelope [GO:0005635]; ribonucleoside-diphosphate reductase complex [GO:0005971] ATP binding [GO:0005524]; disordered domain specific binding [GO:0097718]; identical protein binding [GO:0042802]; ribonucleoside-diphosphate reductase activity [GO:0061731]; ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor [GO:0004748] g17906.t1 Q9MYM7 44.569 267 1.13e-74 237.0 sp|Q9MYM7|B3GT1_PONPY Beta-1,3-galactosyltransferase 1 OS=Pongo pygmaeus OX=9600 GN=B3GALT1 PE=3 SV=1 g17907.t1 Q9MYM7 42.754 276 2.39e-75 238.0 sp|Q9MYM7|B3GT1_PONPY Beta-1,3-galactosyltransferase 1 OS=Pongo pygmaeus OX=9600 GN=B3GALT1 PE=3 SV=1 g17910.t1 Q8BY02 36.683 199 5.88e-28 113.0 sp|Q8BY02|NKRF_MOUSE NF-kappa-B-repressing factor OS=Mus musculus OX=10090 GN=Nkrf PE=2 SV=3 g17912.t1 Q9Y345 51.13 354 3.25e-116 360.0 sp|Q9Y345|SC6A5_HUMAN Sodium- and chloride-dependent glycine transporter 2 OS=Homo sapiens OX=9606 GN=SLC6A5 PE=1 SV=3 SC6A5_HUMAN reviewed Sodium- and chloride-dependent glycine transporter 2 (GlyT-2) (GlyT2) (Solute carrier family 6 member 5) Homo sapiens (Human) GO:0005768; GO:0005886; GO:0006836; GO:0007268; GO:0015375; GO:0016020; GO:0031045; GO:0035725; GO:0045202; GO:0046872; GO:0060012; GO:1903804 chemical synaptic transmission [GO:0007268]; glycine import across plasma membrane [GO:1903804]; neurotransmitter transport [GO:0006836]; sodium ion transmembrane transport [GO:0035725]; synaptic transmission, glycinergic [GO:0060012] dense core granule [GO:0031045]; endosome [GO:0005768]; membrane [GO:0016020]; plasma membrane [GO:0005886]; synapse [GO:0045202] glycine:sodium symporter activity [GO:0015375]; metal ion binding [GO:0046872] g17919.t1 Q8WPA2 27.273 319 2.2e-23 102.0 sp|Q8WPA2|AR_BOMMO Allatostatin-A receptor OS=Bombyx mori OX=7091 GN=AR PE=2 SV=1 g17927.t1 Q9IA76 81.356 118 1.94e-66 199.0 sp|Q9IA76|RL31_PAROL Large ribosomal subunit protein eL31 OS=Paralichthys olivaceus OX=8255 GN=rpl31 PE=2 SV=1 g17928.t1 Q16534 44.398 241 3.6e-62 202.0 sp|Q16534|HLF_HUMAN Hepatic leukemia factor OS=Homo sapiens OX=9606 GN=HLF PE=1 SV=1 HLF_HUMAN reviewed Hepatic leukemia factor Homo sapiens (Human) GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0003677; GO:0003690; GO:0005634; GO:0005654; GO:0006357; GO:0035914; GO:0043565; GO:0045944; GO:0048511; GO:0090575; GO:1990837 positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; rhythmic process [GO:0048511]; skeletal muscle cell differentiation [GO:0035914] chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575] DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; double-stranded DNA binding [GO:0003690]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837] g17930.t1 O95164 72.072 111 1.2099999999999999e-55 172.0 sp|O95164|UBL3_HUMAN Ubiquitin-like protein 3 OS=Homo sapiens OX=9606 GN=UBL3 PE=1 SV=1 g17931.t1 Q6ZWJ1 41.061 358 3.38e-80 263.0 sp|Q6ZWJ1|STXB4_HUMAN Syntaxin-binding protein 4 OS=Homo sapiens OX=9606 GN=STXBP4 PE=1 SV=2 STXB4_HUMAN reviewed Syntaxin-binding protein 4 (Syntaxin 4-interacting protein) (STX4-interacting protein) (Synip) Homo sapiens (Human) GO:0006605; GO:0006974; GO:0008286; GO:0010827; GO:0010838; GO:0019905; GO:0031410; GO:0045335; GO:0050821; GO:0061178; GO:0070062; GO:0071346; GO:1902808 cellular response to type II interferon [GO:0071346]; DNA damage response [GO:0006974]; insulin receptor signaling pathway [GO:0008286]; positive regulation of cell cycle G1/S phase transition [GO:1902808]; positive regulation of keratinocyte proliferation [GO:0010838]; protein stabilization [GO:0050821]; protein targeting [GO:0006605]; regulation of D-glucose transmembrane transport [GO:0010827]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178] cytoplasmic vesicle [GO:0031410]; extracellular exosome [GO:0070062]; phagocytic vesicle [GO:0045335] syntaxin binding [GO:0019905] g17933.t1 B2RPY5 31.143 350 6.46e-22 100.0 sp|B2RPY5|GP161_MOUSE G-protein coupled receptor 161 OS=Mus musculus OX=10090 GN=Gpr161 PE=1 SV=1 GP161_MOUSE reviewed G-protein coupled receptor 161 Mus musculus (Mouse) GO:0004930; GO:0005929; GO:0007186; GO:0007189; GO:0055037; GO:0060170; GO:1901621 adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning [GO:1901621] ciliary membrane [GO:0060170]; cilium [GO:0005929]; recycling endosome [GO:0055037] G protein-coupled receptor activity [GO:0004930] g17936.t1 Q708S6 40.708 113 9.570000000000001e-21 89.4 sp|Q708S6|ASI1C_DANRE Acid-sensing ion channel 1C OS=Danio rerio OX=7955 GN=asic1c PE=1 SV=1 ASI1C_DANRE reviewed Acid-sensing ion channel 1C (ASIC1-C) (Acid-sensing ion channel 1.3-C) (Amiloride-sensitive cation channel 2-C, neuronal-C) (ZASIC1.3) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005261; GO:0005886; GO:0007269; GO:0015280; GO:0030425; GO:0035725; GO:0045211; GO:0071467; GO:0098793; GO:0098978; GO:0160128 cellular response to pH [GO:0071467]; neurotransmitter secretion [GO:0007269]; sodium ion transmembrane transport [GO:0035725] dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynapse [GO:0098793] ligand-gated sodium channel activity [GO:0015280]; monoatomic cation channel activity [GO:0005261]; pH-gated monoatomic ion channel activity [GO:0160128] g17938.t1 Q9UHC3 31.013 316 5.1899999999999997e-45 163.0 sp|Q9UHC3|ASIC3_HUMAN Acid-sensing ion channel 3 OS=Homo sapiens OX=9606 GN=ASIC3 PE=1 SV=2 g17940.t1 Q16515 32.199 382 1.4600000000000002e-43 160.0 sp|Q16515|ASIC2_HUMAN Acid-sensing ion channel 2 OS=Homo sapiens OX=9606 GN=ASIC2 PE=1 SV=1 ASIC2_HUMAN reviewed Acid-sensing ion channel 2 (ASIC2) (Amiloride-sensitive cation channel 1, neuronal) (Amiloride-sensitive cation channel neuronal 1) (Brain sodium channel 1) (BNC1) (BNaC1) (Mammalian degenerin homolog) (MDEG) Homo sapiens (Human) GO:0003026; GO:0005886; GO:0007416; GO:0007602; GO:0007605; GO:0015280; GO:0019229; GO:0022839; GO:0034765; GO:0035418; GO:0035725; GO:0042391; GO:0043025; GO:0043066; GO:0043197; GO:0050915; GO:0050974; GO:0051649; GO:0051965; GO:0071466; GO:0071468; GO:0098839; GO:0150052; GO:0160125 cellular response to acidic pH [GO:0071468]; cellular response to xenobiotic stimulus [GO:0071466]; detection of mechanical stimulus involved in sensory perception [GO:0050974]; establishment of localization in cell [GO:0051649]; negative regulation of apoptotic process [GO:0043066]; phototransduction [GO:0007602]; positive regulation of synapse assembly [GO:0051965]; protein localization to synapse [GO:0035418]; regulation of membrane potential [GO:0042391]; regulation of monoatomic ion transmembrane transport [GO:0034765]; regulation of postsynapse assembly [GO:0150052]; regulation of systemic arterial blood pressure by aortic arch baroreceptor feedback [GO:0003026]; regulation of vasoconstriction [GO:0019229]; sensory perception of sound [GO:0007605]; sensory perception of sour taste [GO:0050915]; sodium ion transmembrane transport [GO:0035725]; synapse assembly [GO:0007416] dendritic spine [GO:0043197]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839] ligand-gated sodium channel activity [GO:0015280]; monoatomic ion-gated channel activity [GO:0022839]; pH-gated sodium channel activity [GO:0160125] g17942.t1 Q62962 31.278 454 1.48e-69 234.0 sp|Q62962|ASIC2_RAT Acid-sensing ion channel 2 OS=Rattus norvegicus OX=10116 GN=Asic2 PE=1 SV=1 ASIC2_RAT reviewed Acid-sensing ion channel 2 (ASIC2) (Amiloride-sensitive brain sodium channel) (Amiloride-sensitive brain sodium channel 2) (Amiloride-sensitive cation channel 1, neuronal) (Amiloride-sensitive cation channel neuronal 1) (Brain sodium channel 1) (BNC1) (BNaC1) (Mammalian degenerin homolog) (MDEG) Rattus norvegicus (Rat) GO:0003026; GO:0005216; GO:0005261; GO:0005886; GO:0006812; GO:0006814; GO:0007602; GO:0007605; GO:0009612; GO:0010447; GO:0015280; GO:0016020; GO:0019229; GO:0022839; GO:0034220; GO:0034765; GO:0035418; GO:0035725; GO:0042391; GO:0043005; GO:0043025; GO:0043066; GO:0043197; GO:0045202; GO:0050915; GO:0050974; GO:0051649; GO:0051965; GO:0071466; GO:0071468; GO:0098839; GO:0150052; GO:0160125 cellular response to acidic pH [GO:0071468]; cellular response to xenobiotic stimulus [GO:0071466]; detection of mechanical stimulus involved in sensory perception [GO:0050974]; establishment of localization in cell [GO:0051649]; monoatomic cation transport [GO:0006812]; monoatomic ion transmembrane transport [GO:0034220]; negative regulation of apoptotic process [GO:0043066]; phototransduction [GO:0007602]; positive regulation of synapse assembly [GO:0051965]; protein localization to synapse [GO:0035418]; regulation of membrane potential [GO:0042391]; regulation of monoatomic ion transmembrane transport [GO:0034765]; regulation of postsynapse assembly [GO:0150052]; regulation of systemic arterial blood pressure by aortic arch baroreceptor feedback [GO:0003026]; regulation of vasoconstriction [GO:0019229]; response to acidic pH [GO:0010447]; response to mechanical stimulus [GO:0009612]; sensory perception of sound [GO:0007605]; sensory perception of sour taste [GO:0050915]; sodium ion transmembrane transport [GO:0035725]; sodium ion transport [GO:0006814] dendritic spine [GO:0043197]; membrane [GO:0016020]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; synapse [GO:0045202] ligand-gated sodium channel activity [GO:0015280]; monoatomic cation channel activity [GO:0005261]; monoatomic ion channel activity [GO:0005216]; monoatomic ion-gated channel activity [GO:0022839]; pH-gated sodium channel activity [GO:0160125] g17943.t1 A7Y2W8 51.795 585 0.0 595.0 sp|A7Y2W8|SC6A9_XENLA Sodium- and chloride-dependent glycine transporter 1 OS=Xenopus laevis OX=8355 GN=slc6a9 PE=2 SV=1 g17944.t1 A7Y2W8 52.432 555 0.0 551.0 sp|A7Y2W8|SC6A9_XENLA Sodium- and chloride-dependent glycine transporter 1 OS=Xenopus laevis OX=8355 GN=slc6a9 PE=2 SV=1 g17945.t1 A0A1U8QWA2 38.2 1322 0.0 784.0 sp|A0A1U8QWA2|ATR12_EMENI Glycine betaine reductase ATRR OS=Emericella nidulans (strain FGSC A4 / ATCC 38163 / CBS 112.46 / NRRL 194 / M139) OX=227321 GN=ATRR PE=1 SV=1 ATR12_EMENI reviewed Glycine betaine reductase ATRR (Nonribosomal peptide synthetase-like protein ATRR) [Includes: Carboxylic acid reductase (EC 1.2.1.-); Aldehyde reductase (EC 1.1.1.-)] Emericella nidulans (strain FGSC A4 / ATCC 38163 / CBS 112.46 / NRRL 194 / M139) (Aspergillus nidulans) GO:0016616; GO:0031177 oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]; phosphopantetheine binding [GO:0031177] g17946.t1 Q9Y619 53.633 289 1.79e-96 291.0 sp|Q9Y619|ORNT1_HUMAN Mitochondrial ornithine transporter 1 OS=Homo sapiens OX=9606 GN=SLC25A15 PE=1 SV=1 ORNT1_HUMAN reviewed Mitochondrial ornithine transporter 1 (Solute carrier family 25 member 15) Homo sapiens (Human) GO:0000050; GO:0000064; GO:0005739; GO:0005743; GO:0015189; GO:0015297; GO:0016020; GO:0061459; GO:1903401; GO:1903826; GO:1990575 L-arginine transmembrane transport [GO:1903826]; L-lysine transmembrane transport [GO:1903401]; mitochondrial L-ornithine transmembrane transport [GO:1990575]; urea cycle [GO:0000050] membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739] antiporter activity [GO:0015297]; L-arginine transmembrane transporter activity [GO:0061459]; L-lysine transmembrane transporter activity [GO:0015189]; L-ornithine transmembrane transporter activity [GO:0000064] g17947.t1 P11536 81.188 101 5.21e-54 194.0 sp|P11536|E74EB_DROME Ecdysone-induced protein 74EF isoform B OS=Drosophila melanogaster OX=7227 GN=Eip74EF PE=2 SV=2 E74EB_DROME reviewed Ecdysone-induced protein 74EF isoform B (ETS-related protein E74B) Drosophila melanogaster (Fruit fly) GO:0000981; GO:0001228; GO:0005634; GO:0006357; GO:0006914; GO:0007283; GO:0030154; GO:0040034; GO:0043565; GO:0045944; GO:0048477 autophagy [GO:0006914]; cell differentiation [GO:0030154]; oogenesis [GO:0048477]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of development, heterochronic [GO:0040034]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283] nucleus [GO:0005634] DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific DNA binding [GO:0043565] g17947.t2 P11536 81.188 101 3.45e-55 194.0 sp|P11536|E74EB_DROME Ecdysone-induced protein 74EF isoform B OS=Drosophila melanogaster OX=7227 GN=Eip74EF PE=2 SV=2 E74EB_DROME reviewed Ecdysone-induced protein 74EF isoform B (ETS-related protein E74B) Drosophila melanogaster (Fruit fly) GO:0000981; GO:0001228; GO:0005634; GO:0006357; GO:0006914; GO:0007283; GO:0030154; GO:0040034; GO:0043565; GO:0045944; GO:0048477 autophagy [GO:0006914]; cell differentiation [GO:0030154]; oogenesis [GO:0048477]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of development, heterochronic [GO:0040034]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283] nucleus [GO:0005634] DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific DNA binding [GO:0043565] g17948.t1 Q6ZNB6 50.569 791 0.0 718.0 sp|Q6ZNB6|NFXL1_HUMAN NF-X1-type zinc finger protein NFXL1 OS=Homo sapiens OX=9606 GN=NFXL1 PE=1 SV=2 g17949.t1 Q80Z25 35.019 514 9.059999999999999e-61 219.0 sp|Q80Z25|OFD1_MOUSE Centriole and centriolar satellite protein OFD1 OS=Mus musculus OX=10090 GN=Ofd1 PE=1 SV=1 OFD1_MOUSE reviewed Centriole and centriolar satellite protein OFD1 (Oral-facial-digital syndrome 1 protein homolog) Mus musculus (Mouse) GO:0005576; GO:0005634; GO:0005813; GO:0005814; GO:0005929; GO:0010172; GO:0031514; GO:0034451; GO:0035082; GO:0036064; GO:0042802; GO:0043014; GO:0043015; GO:0060090; GO:0060271; GO:0060287; GO:2000314 axoneme assembly [GO:0035082]; cilium assembly [GO:0060271]; embryonic body morphogenesis [GO:0010172]; epithelial cilium movement involved in determination of left/right asymmetry [GO:0060287]; negative regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation [GO:2000314] centriolar satellite [GO:0034451]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; extracellular region [GO:0005576]; motile cilium [GO:0031514]; nucleus [GO:0005634] alpha-tubulin binding [GO:0043014]; gamma-tubulin binding [GO:0043015]; identical protein binding [GO:0042802]; molecular adaptor activity [GO:0060090] g17952.t1 Q9NP73 37.523 533 2.02e-92 319.0 sp|Q9NP73|ALG13_HUMAN UDP-N-acetylglucosamine transferase subunit ALG13 OS=Homo sapiens OX=9606 GN=ALG13 PE=1 SV=2 ALG13_HUMAN reviewed UDP-N-acetylglucosamine transferase subunit ALG13 (EC 2.4.1.141) (Asparagine-linked glycosylation 13 homolog) (Glycosyltransferase 28 domain-containing protein 1) Homo sapiens (Human) GO:0004577; GO:0005789; GO:0006487; GO:0006488; GO:0006508; GO:0008234; GO:0043541; GO:0098554 dolichol-linked oligosaccharide biosynthetic process [GO:0006488]; protein N-linked glycosylation [GO:0006487]; proteolysis [GO:0006508] cytoplasmic side of endoplasmic reticulum membrane [GO:0098554]; endoplasmic reticulum membrane [GO:0005789]; UDP-N-acetylglucosamine transferase complex [GO:0043541] cysteine-type peptidase activity [GO:0008234]; N-acetylglucosaminyldiphosphodolichol N-acetylglucosaminyltransferase activity [GO:0004577] g17953.t1 P61222 81.0 600 0.0 1028.0 sp|P61222|ABCE1_MOUSE ATP-binding cassette sub-family E member 1 OS=Mus musculus OX=10090 GN=Abce1 PE=1 SV=1 ABCE1_MOUSE reviewed ATP-binding cassette sub-family E member 1 (RNase L inhibitor) (EC 3.6.5.-) (Ribonuclease 4 inhibitor) (RNS4I) Mus musculus (Mouse) GO:0003924; GO:0005506; GO:0005524; GO:0005737; GO:0005739; GO:0005829; GO:0006413; GO:0006415; GO:0006417; GO:0016887; GO:0017111; GO:0022626; GO:0032790; GO:0043024; GO:0043273; GO:0051539; GO:0060698; GO:0071569; GO:0072344; GO:0140708; GO:1990116 CAT tailing [GO:0140708]; protein ufmylation [GO:0071569]; regulation of translation [GO:0006417]; rescue of stalled ribosome [GO:0072344]; ribosome disassembly [GO:0032790]; ribosome-associated ubiquitin-dependent protein catabolic process [GO:1990116]; translational initiation [GO:0006413]; translational termination [GO:0006415] cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; mitochondrion [GO:0005739] 4 iron, 4 sulfur cluster binding [GO:0051539]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; CTPase activity [GO:0043273]; endoribonuclease inhibitor activity [GO:0060698]; GTPase activity [GO:0003924]; iron ion binding [GO:0005506]; ribonucleoside triphosphate phosphatase activity [GO:0017111]; ribosomal small subunit binding [GO:0043024] g17954.t1 Q7ZV34 66.298 181 1.13e-83 248.0 sp|Q7ZV34|MCTS1_DANRE Malignant T-cell-amplified sequence 1 OS=Danio rerio OX=7955 GN=mcts1 PE=2 SV=1 g17957.t1 Q3LSS0 52.844 422 6.08e-159 481.0 sp|Q3LSS0|C19L2_DANRE CWF19-like protein 2 OS=Danio rerio OX=7955 GN=cwf19l2 PE=2 SV=1 g17959.t1 Q9QZN3 48.029 279 2.5699999999999998e-74 234.0 sp|Q9QZN3|FBX8_MOUSE F-box only protein 8 OS=Mus musculus OX=10090 GN=Fbxo8 PE=2 SV=2 g17961.t1 P57101 62.069 116 3.37e-38 135.0 sp|P57101|HAND2_XENLA Heart- and neural crest derivatives-expressed protein 2 OS=Xenopus laevis OX=8355 GN=hand2 PE=2 SV=1 g17962.t1 Q8C5H1 28.034 585 1.21e-49 189.0 sp|Q8C5H1|ANO4_MOUSE Anoctamin-4 OS=Mus musculus OX=10090 GN=Ano4 PE=1 SV=2 ANO4_MOUSE reviewed Anoctamin-4 (Transmembrane protein 16D) Mus musculus (Mouse) GO:0005229; GO:0005254; GO:0005886; GO:0017128; GO:0046983; GO:0061589; GO:0061590; GO:0061591; GO:1902476 calcium activated galactosylceramide scrambling [GO:0061591]; calcium activated phosphatidylcholine scrambling [GO:0061590]; calcium activated phosphatidylserine scrambling [GO:0061589]; chloride transmembrane transport [GO:1902476] plasma membrane [GO:0005886] chloride channel activity [GO:0005254]; intracellularly calcium-gated chloride channel activity [GO:0005229]; phospholipid scramblase activity [GO:0017128]; protein dimerization activity [GO:0046983] g17962.t2 Q8C5H1 28.497 572 1.28e-51 195.0 sp|Q8C5H1|ANO4_MOUSE Anoctamin-4 OS=Mus musculus OX=10090 GN=Ano4 PE=1 SV=2 ANO4_MOUSE reviewed Anoctamin-4 (Transmembrane protein 16D) Mus musculus (Mouse) GO:0005229; GO:0005254; GO:0005886; GO:0017128; GO:0046983; GO:0061589; GO:0061590; GO:0061591; GO:1902476 calcium activated galactosylceramide scrambling [GO:0061591]; calcium activated phosphatidylcholine scrambling [GO:0061590]; calcium activated phosphatidylserine scrambling [GO:0061589]; chloride transmembrane transport [GO:1902476] plasma membrane [GO:0005886] chloride channel activity [GO:0005254]; intracellularly calcium-gated chloride channel activity [GO:0005229]; phospholipid scramblase activity [GO:0017128]; protein dimerization activity [GO:0046983] g17964.t1 Q90744 55.959 386 3.29e-166 474.0 sp|Q90744|NAGAB_CHICK Alpha-N-acetylgalactosaminidase OS=Gallus gallus OX=9031 GN=NAGA PE=1 SV=1 NAGAB_CHICK reviewed Alpha-N-acetylgalactosaminidase (EC 3.2.1.49) (Alpha-galactosidase B) Gallus gallus (Chicken) GO:0004557; GO:0005737; GO:0005764; GO:0008456; GO:0009311; GO:0016020; GO:0016139; GO:0019377 glycolipid catabolic process [GO:0019377]; glycoside catabolic process [GO:0016139]; oligosaccharide metabolic process [GO:0009311] cytoplasm [GO:0005737]; lysosome [GO:0005764]; membrane [GO:0016020] alpha-galactosidase activity [GO:0004557]; alpha-N-acetylgalactosaminidase activity [GO:0008456] g17965.t1 Q90744 70.0 100 7.329999999999999e-52 169.0 sp|Q90744|NAGAB_CHICK Alpha-N-acetylgalactosaminidase OS=Gallus gallus OX=9031 GN=NAGA PE=1 SV=1 NAGAB_CHICK reviewed Alpha-N-acetylgalactosaminidase (EC 3.2.1.49) (Alpha-galactosidase B) Gallus gallus (Chicken) GO:0004557; GO:0005737; GO:0005764; GO:0008456; GO:0009311; GO:0016020; GO:0016139; GO:0019377 glycolipid catabolic process [GO:0019377]; glycoside catabolic process [GO:0016139]; oligosaccharide metabolic process [GO:0009311] cytoplasm [GO:0005737]; lysosome [GO:0005764]; membrane [GO:0016020] alpha-galactosidase activity [GO:0004557]; alpha-N-acetylgalactosaminidase activity [GO:0008456] g17965.t1 Q90744 72.222 36 7.329999999999999e-52 55.1 sp|Q90744|NAGAB_CHICK Alpha-N-acetylgalactosaminidase OS=Gallus gallus OX=9031 GN=NAGA PE=1 SV=1 NAGAB_CHICK reviewed Alpha-N-acetylgalactosaminidase (EC 3.2.1.49) (Alpha-galactosidase B) Gallus gallus (Chicken) GO:0004557; GO:0005737; GO:0005764; GO:0008456; GO:0009311; GO:0016020; GO:0016139; GO:0019377 glycolipid catabolic process [GO:0019377]; glycoside catabolic process [GO:0016139]; oligosaccharide metabolic process [GO:0009311] cytoplasm [GO:0005737]; lysosome [GO:0005764]; membrane [GO:0016020] alpha-galactosidase activity [GO:0004557]; alpha-N-acetylgalactosaminidase activity [GO:0008456] g17966.t1 Q90744 56.098 328 2.87e-128 378.0 sp|Q90744|NAGAB_CHICK Alpha-N-acetylgalactosaminidase OS=Gallus gallus OX=9031 GN=NAGA PE=1 SV=1 NAGAB_CHICK reviewed Alpha-N-acetylgalactosaminidase (EC 3.2.1.49) (Alpha-galactosidase B) Gallus gallus (Chicken) GO:0004557; GO:0005737; GO:0005764; GO:0008456; GO:0009311; GO:0016020; GO:0016139; GO:0019377 glycolipid catabolic process [GO:0019377]; glycoside catabolic process [GO:0016139]; oligosaccharide metabolic process [GO:0009311] cytoplasm [GO:0005737]; lysosome [GO:0005764]; membrane [GO:0016020] alpha-galactosidase activity [GO:0004557]; alpha-N-acetylgalactosaminidase activity [GO:0008456] g17967.t1 Q502W6 41.523 696 7.08e-170 560.0 sp|Q502W6|VWA3B_HUMAN von Willebrand factor A domain-containing protein 3B OS=Homo sapiens OX=9606 GN=VWA3B PE=1 SV=3 VWA3B_HUMAN reviewed von Willebrand factor A domain-containing protein 3B (VWA domain-containing protein 3B) Homo sapiens (Human) GO:0005654; GO:0005829 cytosol [GO:0005829]; nucleoplasm [GO:0005654] g17967.t1 Q502W6 35.714 210 2.1e-36 155.0 sp|Q502W6|VWA3B_HUMAN von Willebrand factor A domain-containing protein 3B OS=Homo sapiens OX=9606 GN=VWA3B PE=1 SV=3 VWA3B_HUMAN reviewed von Willebrand factor A domain-containing protein 3B (VWA domain-containing protein 3B) Homo sapiens (Human) GO:0005654; GO:0005829 cytosol [GO:0005829]; nucleoplasm [GO:0005654] g17967.t1 Q502W6 27.298 359 5.6200000000000004e-33 144.0 sp|Q502W6|VWA3B_HUMAN von Willebrand factor A domain-containing protein 3B OS=Homo sapiens OX=9606 GN=VWA3B PE=1 SV=3 VWA3B_HUMAN reviewed von Willebrand factor A domain-containing protein 3B (VWA domain-containing protein 3B) Homo sapiens (Human) GO:0005654; GO:0005829 cytosol [GO:0005829]; nucleoplasm [GO:0005654] g17967.t2 Q502W6 41.523 696 6.07e-170 560.0 sp|Q502W6|VWA3B_HUMAN von Willebrand factor A domain-containing protein 3B OS=Homo sapiens OX=9606 GN=VWA3B PE=1 SV=3 VWA3B_HUMAN reviewed von Willebrand factor A domain-containing protein 3B (VWA domain-containing protein 3B) Homo sapiens (Human) GO:0005654; GO:0005829 cytosol [GO:0005829]; nucleoplasm [GO:0005654] g17967.t2 Q502W6 36.765 204 3.9300000000000005e-37 157.0 sp|Q502W6|VWA3B_HUMAN von Willebrand factor A domain-containing protein 3B OS=Homo sapiens OX=9606 GN=VWA3B PE=1 SV=3 VWA3B_HUMAN reviewed von Willebrand factor A domain-containing protein 3B (VWA domain-containing protein 3B) Homo sapiens (Human) GO:0005654; GO:0005829 cytosol [GO:0005829]; nucleoplasm [GO:0005654] g17967.t2 Q502W6 27.298 359 5.6500000000000004e-33 144.0 sp|Q502W6|VWA3B_HUMAN von Willebrand factor A domain-containing protein 3B OS=Homo sapiens OX=9606 GN=VWA3B PE=1 SV=3 VWA3B_HUMAN reviewed von Willebrand factor A domain-containing protein 3B (VWA domain-containing protein 3B) Homo sapiens (Human) GO:0005654; GO:0005829 cytosol [GO:0005829]; nucleoplasm [GO:0005654] g17969.t1 Q9WVI4 48.381 556 2.9600000000000004e-160 480.0 sp|Q9WVI4|GCYA2_RAT Guanylate cyclase soluble subunit alpha-2 OS=Rattus norvegicus OX=10116 GN=Gucy1a2 PE=1 SV=2 g17970.t1 P20595 62.258 620 0.0 805.0 sp|P20595|GCYB1_RAT Guanylate cyclase soluble subunit beta-1 OS=Rattus norvegicus OX=10116 GN=Gucy1b1 PE=1 SV=2 GCYB1_RAT reviewed Guanylate cyclase soluble subunit beta-1 (GCS-beta-1) (EC 4.6.1.2) (Guanylate cyclase soluble subunit beta-3) (GCS-beta-3) (Soluble guanylate cyclase small subunit) Rattus norvegicus (Rat) GO:0004383; GO:0005525; GO:0005829; GO:0006182; GO:0008074; GO:0019934; GO:0020037; GO:0032991; GO:0038060; GO:0044877; GO:0046872; GO:0051879; GO:0070026; GO:0070482; GO:0071732; GO:0098831; GO:0098978 cellular response to nitric oxide [GO:0071732]; cGMP biosynthetic process [GO:0006182]; cGMP-mediated signaling [GO:0019934]; nitric oxide-cGMP-mediated signaling [GO:0038060]; response to oxygen levels [GO:0070482] cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; guanylate cyclase complex, soluble [GO:0008074]; presynaptic active zone cytoplasmic component [GO:0098831]; protein-containing complex [GO:0032991] GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; heme binding [GO:0020037]; Hsp90 protein binding [GO:0051879]; metal ion binding [GO:0046872]; nitric oxide binding [GO:0070026]; protein-containing complex binding [GO:0044877] g17971.t1 Q6DJH2 48.789 289 3.4e-96 288.0 sp|Q6DJH2|ADPPT_XENLA L-aminoadipate-semialdehyde dehydrogenase-phosphopantetheinyl transferase OS=Xenopus laevis OX=8355 GN=aasdhppt PE=2 SV=1 g17972.t1 A7Y2W8 46.404 584 8.01e-174 518.0 sp|A7Y2W8|SC6A9_XENLA Sodium- and chloride-dependent glycine transporter 1 OS=Xenopus laevis OX=8355 GN=slc6a9 PE=2 SV=1 g17973.t1 Q9NXR5 44.7 217 1.4e-48 172.0 sp|Q9NXR5|ANR10_HUMAN Ankyrin repeat domain-containing protein 10 OS=Homo sapiens OX=9606 GN=ANKRD10 PE=1 SV=2 g17973.t2 Q5ZLC6 43.6 250 5.68e-49 173.0 sp|Q5ZLC6|ANR10_CHICK Ankyrin repeat domain-containing protein 10 OS=Gallus gallus OX=9031 GN=ANKRD10 PE=2 SV=1 g17974.t1 Q08890 43.617 564 3.92e-145 433.0 sp|Q08890|IDS_MOUSE Iduronate 2-sulfatase OS=Mus musculus OX=10090 GN=Ids PE=2 SV=3 IDS_MOUSE reviewed Iduronate 2-sulfatase (EC 3.1.6.13) (Alpha-L-iduronate sulfate sulfatase) Mus musculus (Mouse) GO:0004423; GO:0005509; GO:0005764; GO:0006027; GO:0008484; GO:0030200; GO:0030209; GO:0043202 dermatan sulfate proteoglycan catabolic process [GO:0030209]; glycosaminoglycan catabolic process [GO:0006027]; heparan sulfate proteoglycan catabolic process [GO:0030200] lysosomal lumen [GO:0043202]; lysosome [GO:0005764] calcium ion binding [GO:0005509]; iduronate-2-sulfatase activity [GO:0004423]; sulfuric ester hydrolase activity [GO:0008484] g17975.t1 A2A3V2 46.769 325 3.68e-98 296.0 sp|A2A3V2|S2543_MOUSE Solute carrier family 25 member 43 OS=Mus musculus OX=10090 GN=Slc25a43 PE=2 SV=1 g17976.t1 Q99K23 46.253 467 1.83e-142 425.0 sp|Q99K23|UFSP2_MOUSE Ufm1-specific protease 2 OS=Mus musculus OX=10090 GN=Ufsp2 PE=1 SV=1 g17977.t1 Q9Z255 92.617 149 2.81e-102 292.0 sp|Q9Z255|UBE2A_MOUSE Ubiquitin-conjugating enzyme E2 A OS=Mus musculus OX=10090 GN=Ube2a PE=1 SV=1 UBE2A_MOUSE reviewed Ubiquitin-conjugating enzyme E2 A (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme A) (RAD6 homolog A) (HR6A) (mHR6A) (Ubiquitin carrier protein A) (Ubiquitin-protein ligase A) Mus musculus (Mouse) GO:0000086; GO:0000209; GO:0000785; GO:0001701; GO:0001741; GO:0001835; GO:0004842; GO:0005524; GO:0005764; GO:0005770; GO:0006281; GO:0006338; GO:0009411; GO:0016567; GO:0031625; GO:0033503; GO:0043161; GO:0060135; GO:0061631; GO:0070936; GO:0070979; GO:1901526 blastocyst hatching [GO:0001835]; chromatin remodeling [GO:0006338]; DNA repair [GO:0006281]; G2/M transition of mitotic cell cycle [GO:0000086]; in utero embryonic development [GO:0001701]; maternal process involved in female pregnancy [GO:0060135]; positive regulation of mitophagy [GO:1901526]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K11-linked ubiquitination [GO:0070979]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; response to UV [GO:0009411] chromatin [GO:0000785]; HULC complex [GO:0033503]; late endosome [GO:0005770]; lysosome [GO:0005764]; XY body [GO:0001741] ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842] g17979.t1 Q8BW70 53.205 312 1.66e-110 367.0 sp|Q8BW70|UBP38_MOUSE Ubiquitin carboxyl-terminal hydrolase 38 OS=Mus musculus OX=10090 GN=Usp38 PE=1 SV=2 UBP38_MOUSE reviewed Ubiquitin carboxyl-terminal hydrolase 38 (EC 3.4.19.12) (Deubiquitinating enzyme 38) (Ubiquitin thioesterase 38) (Ubiquitin-specific-processing protease 38) Mus musculus (Mouse) GO:0000082; GO:0004843; GO:0005634; GO:0005737; GO:0005829; GO:0031647; GO:0032435; GO:0043161; GO:0045824; GO:0070936; GO:0140374; GO:1990168 antiviral innate immune response [GO:0140374]; G1/S transition of mitotic cell cycle [GO:0000082]; negative regulation of innate immune response [GO:0045824]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K33-linked deubiquitination [GO:1990168]; protein K48-linked ubiquitination [GO:0070936]; regulation of protein stability [GO:0031647] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634] cysteine-type deubiquitinase activity [GO:0004843] g17979.t1 Q8BW70 36.795 337 1.2099999999999999e-42 172.0 sp|Q8BW70|UBP38_MOUSE Ubiquitin carboxyl-terminal hydrolase 38 OS=Mus musculus OX=10090 GN=Usp38 PE=1 SV=2 UBP38_MOUSE reviewed Ubiquitin carboxyl-terminal hydrolase 38 (EC 3.4.19.12) (Deubiquitinating enzyme 38) (Ubiquitin thioesterase 38) (Ubiquitin-specific-processing protease 38) Mus musculus (Mouse) GO:0000082; GO:0004843; GO:0005634; GO:0005737; GO:0005829; GO:0031647; GO:0032435; GO:0043161; GO:0045824; GO:0070936; GO:0140374; GO:1990168 antiviral innate immune response [GO:0140374]; G1/S transition of mitotic cell cycle [GO:0000082]; negative regulation of innate immune response [GO:0045824]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K33-linked deubiquitination [GO:1990168]; protein K48-linked ubiquitination [GO:0070936]; regulation of protein stability [GO:0031647] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634] cysteine-type deubiquitinase activity [GO:0004843] g17980.t1 Q03442 38.535 314 1.29e-69 221.0 sp|Q03442|CRJ1A_TRICY Crystallin J1A OS=Tripedalia cystophora OX=6141 PE=1 SV=1 g17981.t1 Q9ULJ7 52.632 285 3.73e-87 286.0 sp|Q9ULJ7|ANR50_HUMAN Ankyrin repeat domain-containing protein 50 OS=Homo sapiens OX=9606 GN=ANKRD50 PE=1 SV=4 g17982.t1 Q9ULJ7 61.013 395 1.2500000000000001e-144 448.0 sp|Q9ULJ7|ANR50_HUMAN Ankyrin repeat domain-containing protein 50 OS=Homo sapiens OX=9606 GN=ANKRD50 PE=1 SV=4 g17982.t1 Q9ULJ7 38.356 292 7.819999999999999e-41 157.0 sp|Q9ULJ7|ANR50_HUMAN Ankyrin repeat domain-containing protein 50 OS=Homo sapiens OX=9606 GN=ANKRD50 PE=1 SV=4 g17982.t1 Q9ULJ7 38.408 289 1.99e-38 150.0 sp|Q9ULJ7|ANR50_HUMAN Ankyrin repeat domain-containing protein 50 OS=Homo sapiens OX=9606 GN=ANKRD50 PE=1 SV=4 g17982.t1 Q9ULJ7 36.402 239 1.72e-32 133.0 sp|Q9ULJ7|ANR50_HUMAN Ankyrin repeat domain-containing protein 50 OS=Homo sapiens OX=9606 GN=ANKRD50 PE=1 SV=4 g17982.t1 Q9ULJ7 35.193 233 2.3800000000000001e-26 115.0 sp|Q9ULJ7|ANR50_HUMAN Ankyrin repeat domain-containing protein 50 OS=Homo sapiens OX=9606 GN=ANKRD50 PE=1 SV=4 g17983.t1 Q9ULJ7 59.22 282 6.95e-99 338.0 sp|Q9ULJ7|ANR50_HUMAN Ankyrin repeat domain-containing protein 50 OS=Homo sapiens OX=9606 GN=ANKRD50 PE=1 SV=4 g17983.t1 Q9ULJ7 32.249 338 7.84e-39 159.0 sp|Q9ULJ7|ANR50_HUMAN Ankyrin repeat domain-containing protein 50 OS=Homo sapiens OX=9606 GN=ANKRD50 PE=1 SV=4 g17983.t1 Q9ULJ7 36.194 268 9.25e-38 156.0 sp|Q9ULJ7|ANR50_HUMAN Ankyrin repeat domain-containing protein 50 OS=Homo sapiens OX=9606 GN=ANKRD50 PE=1 SV=4 g17983.t1 Q9ULJ7 35.907 259 2.58e-34 145.0 sp|Q9ULJ7|ANR50_HUMAN Ankyrin repeat domain-containing protein 50 OS=Homo sapiens OX=9606 GN=ANKRD50 PE=1 SV=4 g17983.t1 Q9ULJ7 34.821 224 6.34e-31 134.0 sp|Q9ULJ7|ANR50_HUMAN Ankyrin repeat domain-containing protein 50 OS=Homo sapiens OX=9606 GN=ANKRD50 PE=1 SV=4 g17983.t1 Q9ULJ7 33.696 276 1.36e-29 130.0 sp|Q9ULJ7|ANR50_HUMAN Ankyrin repeat domain-containing protein 50 OS=Homo sapiens OX=9606 GN=ANKRD50 PE=1 SV=4 g17983.t1 Q9ULJ7 36.073 219 2.31e-24 113.0 sp|Q9ULJ7|ANR50_HUMAN Ankyrin repeat domain-containing protein 50 OS=Homo sapiens OX=9606 GN=ANKRD50 PE=1 SV=4 g17984.t1 Q6PG95 45.249 221 4.41e-51 201.0 sp|Q6PG95|CRML_MOUSE Protein cramped-like OS=Mus musculus OX=10090 GN=Cramp1 PE=1 SV=3 CRML_MOUSE reviewed Protein cramped-like (Cramped chromatin regulator homolog 1) (Hematological and neurological expressed 1-like protein) Mus musculus (Mouse) GO:0003677; GO:0003682; GO:0003700; GO:0005634; GO:0007389; GO:0045893 pattern specification process [GO:0007389]; positive regulation of DNA-templated transcription [GO:0045893] nucleus [GO:0005634] chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700] g17984.t2 Q6PG95 45.249 221 8.58e-51 200.0 sp|Q6PG95|CRML_MOUSE Protein cramped-like OS=Mus musculus OX=10090 GN=Cramp1 PE=1 SV=3 CRML_MOUSE reviewed Protein cramped-like (Cramped chromatin regulator homolog 1) (Hematological and neurological expressed 1-like protein) Mus musculus (Mouse) GO:0003677; GO:0003682; GO:0003700; GO:0005634; GO:0007389; GO:0045893 pattern specification process [GO:0007389]; positive regulation of DNA-templated transcription [GO:0045893] nucleus [GO:0005634] chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700] g17986.t1 Q9ESE1 63.772 1071 0.0 1429.0 sp|Q9ESE1|LRBA_MOUSE Lipopolysaccharide-responsive and beige-like anchor protein OS=Mus musculus OX=10090 GN=Lrba PE=1 SV=1 LRBA_MOUSE reviewed Lipopolysaccharide-responsive and beige-like anchor protein (Beige-like protein) Mus musculus (Mouse) GO:0000423; GO:0005764; GO:0005765; GO:0005783; GO:0005789; GO:0005794; GO:0005802; GO:0005829; GO:0005886; GO:0007165; GO:0008104; GO:0016020; GO:0016197; GO:0019901; GO:0031410; GO:0034497; GO:0051018; GO:1990830 cellular response to leukemia inhibitory factor [GO:1990830]; endosomal transport [GO:0016197]; intracellular protein localization [GO:0008104]; mitophagy [GO:0000423]; protein localization to phagophore assembly site [GO:0034497]; signal transduction [GO:0007165] cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802] protein kinase A binding [GO:0051018]; protein kinase binding [GO:0019901] g17986.t2 Q9ESE1 63.628 1075 0.0 1429.0 sp|Q9ESE1|LRBA_MOUSE Lipopolysaccharide-responsive and beige-like anchor protein OS=Mus musculus OX=10090 GN=Lrba PE=1 SV=1 LRBA_MOUSE reviewed Lipopolysaccharide-responsive and beige-like anchor protein (Beige-like protein) Mus musculus (Mouse) GO:0000423; GO:0005764; GO:0005765; GO:0005783; GO:0005789; GO:0005794; GO:0005802; GO:0005829; GO:0005886; GO:0007165; GO:0008104; GO:0016020; GO:0016197; GO:0019901; GO:0031410; GO:0034497; GO:0051018; GO:1990830 cellular response to leukemia inhibitory factor [GO:1990830]; endosomal transport [GO:0016197]; intracellular protein localization [GO:0008104]; mitophagy [GO:0000423]; protein localization to phagophore assembly site [GO:0034497]; signal transduction [GO:0007165] cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802] protein kinase A binding [GO:0051018]; protein kinase binding [GO:0019901] g17988.t1 O70299 80.973 226 3.2799999999999996e-134 385.0 sp|O70299|MB211_MOUSE Putative nucleotidyltransferase MAB21L1 OS=Mus musculus OX=10090 GN=Mab21l1 PE=2 SV=1 MB211_MOUSE reviewed Putative nucleotidyltransferase MAB21L1 (EC 2.7.7.-) (Protein mab-21-like 1) Mus musculus (Mouse) GO:0000166; GO:0001654; GO:0005634; GO:0008283; GO:0008284; GO:0016779; GO:0043010; GO:0046872 camera-type eye development [GO:0043010]; cell population proliferation [GO:0008283]; eye development [GO:0001654]; positive regulation of cell population proliferation [GO:0008284] nucleus [GO:0005634] metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]; nucleotidyltransferase activity [GO:0016779] g17989.t1 O70299 80.0 65 1.58e-30 112.0 sp|O70299|MB211_MOUSE Putative nucleotidyltransferase MAB21L1 OS=Mus musculus OX=10090 GN=Mab21l1 PE=2 SV=1 MB211_MOUSE reviewed Putative nucleotidyltransferase MAB21L1 (EC 2.7.7.-) (Protein mab-21-like 1) Mus musculus (Mouse) GO:0000166; GO:0001654; GO:0005634; GO:0008283; GO:0008284; GO:0016779; GO:0043010; GO:0046872 camera-type eye development [GO:0043010]; cell population proliferation [GO:0008283]; eye development [GO:0001654]; positive regulation of cell population proliferation [GO:0008284] nucleus [GO:0005634] metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]; nucleotidyltransferase activity [GO:0016779] g17990.t1 Q9W4E2 53.147 143 6.820000000000001e-37 144.0 sp|Q9W4E2|NBEA_DROME Neurobeachin OS=Drosophila melanogaster OX=7227 GN=rg PE=1 SV=4 NBEA_DROME reviewed Neurobeachin (A-kinase anchor protein 550) (AKAP 550) (Protein rugose) (dAKAP550) Drosophila melanogaster (Fruit fly) GO:0005737; GO:0005829; GO:0007528; GO:0007614; GO:0008104; GO:0008355; GO:0016020; GO:0016319; GO:0019901; GO:0042462; GO:0042675; GO:0043025; GO:0043204; GO:0051018 compound eye cone cell differentiation [GO:0042675]; eye photoreceptor cell development [GO:0042462]; intracellular protein localization [GO:0008104]; mushroom body development [GO:0016319]; neuromuscular junction development [GO:0007528]; olfactory learning [GO:0008355]; short-term memory [GO:0007614] cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204] protein kinase A binding [GO:0051018]; protein kinase binding [GO:0019901] g17990.t2 Q9W4E2 51.37 146 4.01e-36 142.0 sp|Q9W4E2|NBEA_DROME Neurobeachin OS=Drosophila melanogaster OX=7227 GN=rg PE=1 SV=4 NBEA_DROME reviewed Neurobeachin (A-kinase anchor protein 550) (AKAP 550) (Protein rugose) (dAKAP550) Drosophila melanogaster (Fruit fly) GO:0005737; GO:0005829; GO:0007528; GO:0007614; GO:0008104; GO:0008355; GO:0016020; GO:0016319; GO:0019901; GO:0042462; GO:0042675; GO:0043025; GO:0043204; GO:0051018 compound eye cone cell differentiation [GO:0042675]; eye photoreceptor cell development [GO:0042462]; intracellular protein localization [GO:0008104]; mushroom body development [GO:0016319]; neuromuscular junction development [GO:0007528]; olfactory learning [GO:0008355]; short-term memory [GO:0007614] cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204] protein kinase A binding [GO:0051018]; protein kinase binding [GO:0019901] g17991.t1 Q8NFP9 68.582 261 2.04e-130 422.0 sp|Q8NFP9|NBEA_HUMAN Neurobeachin OS=Homo sapiens OX=9606 GN=NBEA PE=1 SV=3 NBEA_HUMAN reviewed Neurobeachin (Lysosomal-trafficking regulator 2) (Protein BCL8B) Homo sapiens (Human) GO:0005802; GO:0005829; GO:0005886; GO:0008104; GO:0012505; GO:0016020; GO:0019901 intracellular protein localization [GO:0008104] cytosol [GO:0005829]; endomembrane system [GO:0012505]; membrane [GO:0016020]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802] protein kinase binding [GO:0019901] g17991.t1 Q8NFP9 61.364 44 2.04e-130 64.3 sp|Q8NFP9|NBEA_HUMAN Neurobeachin OS=Homo sapiens OX=9606 GN=NBEA PE=1 SV=3 NBEA_HUMAN reviewed Neurobeachin (Lysosomal-trafficking regulator 2) (Protein BCL8B) Homo sapiens (Human) GO:0005802; GO:0005829; GO:0005886; GO:0008104; GO:0012505; GO:0016020; GO:0019901 intracellular protein localization [GO:0008104] cytosol [GO:0005829]; endomembrane system [GO:0012505]; membrane [GO:0016020]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802] protein kinase binding [GO:0019901] g17991.t1 Q8NFP9 50.0 18 2.04e-130 26.2 sp|Q8NFP9|NBEA_HUMAN Neurobeachin OS=Homo sapiens OX=9606 GN=NBEA PE=1 SV=3 NBEA_HUMAN reviewed Neurobeachin (Lysosomal-trafficking regulator 2) (Protein BCL8B) Homo sapiens (Human) GO:0005802; GO:0005829; GO:0005886; GO:0008104; GO:0012505; GO:0016020; GO:0019901 intracellular protein localization [GO:0008104] cytosol [GO:0005829]; endomembrane system [GO:0012505]; membrane [GO:0016020]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802] protein kinase binding [GO:0019901] g17991.t1 Q8NFP9 59.736 303 8.37e-105 371.0 sp|Q8NFP9|NBEA_HUMAN Neurobeachin OS=Homo sapiens OX=9606 GN=NBEA PE=1 SV=3 NBEA_HUMAN reviewed Neurobeachin (Lysosomal-trafficking regulator 2) (Protein BCL8B) Homo sapiens (Human) GO:0005802; GO:0005829; GO:0005886; GO:0008104; GO:0012505; GO:0016020; GO:0019901 intracellular protein localization [GO:0008104] cytosol [GO:0005829]; endomembrane system [GO:0012505]; membrane [GO:0016020]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802] protein kinase binding [GO:0019901] g17991.t1 Q8NFP9 60.819 171 5.86e-58 224.0 sp|Q8NFP9|NBEA_HUMAN Neurobeachin OS=Homo sapiens OX=9606 GN=NBEA PE=1 SV=3 NBEA_HUMAN reviewed Neurobeachin (Lysosomal-trafficking regulator 2) (Protein BCL8B) Homo sapiens (Human) GO:0005802; GO:0005829; GO:0005886; GO:0008104; GO:0012505; GO:0016020; GO:0019901 intracellular protein localization [GO:0008104] cytosol [GO:0005829]; endomembrane system [GO:0012505]; membrane [GO:0016020]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802] protein kinase binding [GO:0019901] g17991.t1 Q8NFP9 50.382 131 3.0299999999999997e-30 134.0 sp|Q8NFP9|NBEA_HUMAN Neurobeachin OS=Homo sapiens OX=9606 GN=NBEA PE=1 SV=3 NBEA_HUMAN reviewed Neurobeachin (Lysosomal-trafficking regulator 2) (Protein BCL8B) Homo sapiens (Human) GO:0005802; GO:0005829; GO:0005886; GO:0008104; GO:0012505; GO:0016020; GO:0019901 intracellular protein localization [GO:0008104] cytosol [GO:0005829]; endomembrane system [GO:0012505]; membrane [GO:0016020]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802] protein kinase binding [GO:0019901] g17992.t1 Q9R1K9 71.512 172 5.0400000000000003e-79 234.0 sp|Q9R1K9|CETN2_MOUSE Centrin-2 OS=Mus musculus OX=10090 GN=Cetn2 PE=1 SV=1 g17996.t1 Q92870 61.111 162 1.84e-60 204.0 sp|Q92870|APBB2_HUMAN Amyloid beta precursor protein binding family B member 2 OS=Homo sapiens OX=9606 GN=APBB2 PE=1 SV=3 APBB2_HUMAN reviewed Amyloid beta precursor protein binding family B member 2 (Amyloid-beta (A4) precursor protein-binding family B member 2) (Protein Fe65-like 1) Homo sapiens (Human) GO:0000122; GO:0001540; GO:0001764; GO:0005634; GO:0005737; GO:0005769; GO:0005783; GO:0005794; GO:0006355; GO:0006939; GO:0007411; GO:0016020; GO:0030027; GO:0030198; GO:0030426; GO:0035556; GO:0036438; GO:0043065; GO:0043066; GO:0045202; GO:0045944; GO:0050808; GO:0060090; GO:1901988 axon guidance [GO:0007411]; extracellular matrix organization [GO:0030198]; intracellular signal transduction [GO:0035556]; maintenance of lens transparency [GO:0036438]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell cycle phase transition [GO:1901988]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron migration [GO:0001764]; positive regulation of apoptotic process [GO:0043065]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA-templated transcription [GO:0006355]; smooth muscle contraction [GO:0006939]; synapse organization [GO:0050808] cytoplasm [GO:0005737]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; membrane [GO:0016020]; nucleus [GO:0005634]; synapse [GO:0045202] amyloid-beta binding [GO:0001540]; molecular adaptor activity [GO:0060090] g17997.t1 O00213 38.71 186 1.83e-37 141.0 sp|O00213|APBB1_HUMAN Amyloid beta precursor protein binding family B member 1 OS=Homo sapiens OX=9606 GN=APBB1 PE=1 SV=2 APBB1_HUMAN reviewed Amyloid beta precursor protein binding family B member 1 (Amyloid-beta A4 precursor protein-binding family B member 1) (Protein Fe65) Homo sapiens (Human) GO:0000122; GO:0001540; GO:0003682; GO:0003713; GO:0005634; GO:0005654; GO:0005737; GO:0005783; GO:0005886; GO:0006325; GO:0006355; GO:0006915; GO:0006939; GO:0006974; GO:0007165; GO:0007409; GO:0010976; GO:0016607; GO:0030027; GO:0030426; GO:0031625; GO:0042393; GO:0043065; GO:0045202; GO:0045893; GO:0045944; GO:0050714; GO:0050750; GO:0060090; GO:0070064; GO:1902807 apoptotic process [GO:0006915]; axonogenesis [GO:0007409]; chromatin organization [GO:0006325]; DNA damage response [GO:0006974]; negative regulation of cell cycle G1/S phase transition [GO:1902807]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of apoptotic process [GO:0043065]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of neuron projection development [GO:0010976]; positive regulation of protein secretion [GO:0050714]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA-templated transcription [GO:0006355]; signal transduction [GO:0007165]; smooth muscle contraction [GO:0006939] cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; synapse [GO:0045202] amyloid-beta binding [GO:0001540]; chromatin binding [GO:0003682]; histone binding [GO:0042393]; low-density lipoprotein particle receptor binding [GO:0050750]; molecular adaptor activity [GO:0060090]; proline-rich region binding [GO:0070064]; transcription coactivator activity [GO:0003713]; ubiquitin protein ligase binding [GO:0031625] g18000.t1 Q60648 38.095 168 2.51e-31 116.0 sp|Q60648|SAP3_MOUSE Ganglioside GM2 activator OS=Mus musculus OX=10090 GN=Gm2a PE=1 SV=2 SAP3_MOUSE reviewed Ganglioside GM2 activator (Cerebroside sulfate activator protein) (GM2-AP) (Sphingolipid activator protein 3) (SAP-3) Mus musculus (Mouse) GO:0001573; GO:0004563; GO:0005319; GO:0005739; GO:0005764; GO:0005829; GO:0006689; GO:0006869; GO:0007611; GO:0008047; GO:0009313; GO:0009898; GO:0016004; GO:0016323; GO:0016324; GO:0019915; GO:0050877; GO:0050885 ganglioside catabolic process [GO:0006689]; ganglioside metabolic process [GO:0001573]; learning or memory [GO:0007611]; lipid storage [GO:0019915]; lipid transport [GO:0006869]; nervous system process [GO:0050877]; neuromuscular process controlling balance [GO:0050885]; oligosaccharide catabolic process [GO:0009313] apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; lysosome [GO:0005764]; mitochondrion [GO:0005739] beta-N-acetylhexosaminidase activity [GO:0004563]; enzyme activator activity [GO:0008047]; lipid transporter activity [GO:0005319]; phospholipase activator activity [GO:0016004] g18002.t1 Q6NSR3 41.954 348 3.6e-79 261.0 sp|Q6NSR3|ADCK2_MOUSE Uncharacterized aarF domain-containing protein kinase 2 OS=Mus musculus OX=10090 GN=Adck2 PE=2 SV=1 ADCK2_MOUSE reviewed Uncharacterized aarF domain-containing protein kinase 2 (EC 2.7.11.-) Mus musculus (Mouse) GO:0004674; GO:0005524; GO:0005739; GO:0010795; GO:0016020 regulation of ubiquinone biosynthetic process [GO:0010795] membrane [GO:0016020]; mitochondrion [GO:0005739] ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674] g18003.t1 Q6NSR3 58.779 131 4.3899999999999995e-40 144.0 sp|Q6NSR3|ADCK2_MOUSE Uncharacterized aarF domain-containing protein kinase 2 OS=Mus musculus OX=10090 GN=Adck2 PE=2 SV=1 ADCK2_MOUSE reviewed Uncharacterized aarF domain-containing protein kinase 2 (EC 2.7.11.-) Mus musculus (Mouse) GO:0004674; GO:0005524; GO:0005739; GO:0010795; GO:0016020 regulation of ubiquinone biosynthetic process [GO:0010795] membrane [GO:0016020]; mitochondrion [GO:0005739] ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674] g18004.t1 Q5R4W9 67.797 118 4.82e-58 181.0 sp|Q5R4W9|RAB9B_PONAB Ras-related protein Rab-9B OS=Pongo abelii OX=9601 GN=RAB9B PE=2 SV=1 RAB9B_PONAB reviewed Ras-related protein Rab-9B (EC 3.6.5.2) Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0003925; GO:0005525; GO:0005764; GO:0005770; GO:0005829; GO:0005886; GO:0006898; GO:0015031; GO:0019003; GO:0030670; GO:0032482; GO:0042147; GO:0042802; GO:0045335; GO:0046872 protein transport [GO:0015031]; Rab protein signal transduction [GO:0032482]; receptor-mediated endocytosis [GO:0006898]; retrograde transport, endosome to Golgi [GO:0042147] cytosol [GO:0005829]; late endosome [GO:0005770]; lysosome [GO:0005764]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886] G protein activity [GO:0003925]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872] g18005.t1 Q566M8 39.169 337 1.59e-63 214.0 sp|Q566M8|RN150_DANRE RING finger protein 150 OS=Danio rerio OX=7955 GN=rnf150 PE=2 SV=1 g18007.t1 Q8IV35 26.316 779 4.9600000000000005e-75 269.0 sp|Q8IV35|CF337_HUMAN Cilia- and flagella-associated protein 337 OS=Homo sapiens OX=9606 GN=CFAP337 PE=1 SV=2 g18010.t1 Q49A17 50.783 575 0.0 564.0 sp|Q49A17|GLTL6_HUMAN Polypeptide N-acetylgalactosaminyltransferase-like 6 OS=Homo sapiens OX=9606 GN=GALNTL6 PE=2 SV=2 GLTL6_HUMAN reviewed Polypeptide N-acetylgalactosaminyltransferase-like 6 (EC 2.4.1.41) (Polypeptide GalNAc transferase 17) (GalNAc-T17) (pp-GaNTase 17) (Protein-UDP acetylgalactosaminyltransferase 17) (Putative polypeptide N-acetylgalactosaminyltransferase 17) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 17) Homo sapiens (Human) GO:0000139; GO:0004653; GO:0005794; GO:0006493; GO:0016266; GO:0030246; GO:0046872 protein O-linked glycosylation [GO:0006493]; protein O-linked glycosylation via N-acetyl-galactosamine [GO:0016266] Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139] carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653] g18010.t2 Q49A17 50.78 577 0.0 566.0 sp|Q49A17|GLTL6_HUMAN Polypeptide N-acetylgalactosaminyltransferase-like 6 OS=Homo sapiens OX=9606 GN=GALNTL6 PE=2 SV=2 GLTL6_HUMAN reviewed Polypeptide N-acetylgalactosaminyltransferase-like 6 (EC 2.4.1.41) (Polypeptide GalNAc transferase 17) (GalNAc-T17) (pp-GaNTase 17) (Protein-UDP acetylgalactosaminyltransferase 17) (Putative polypeptide N-acetylgalactosaminyltransferase 17) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 17) Homo sapiens (Human) GO:0000139; GO:0004653; GO:0005794; GO:0006493; GO:0016266; GO:0030246; GO:0046872 protein O-linked glycosylation [GO:0006493]; protein O-linked glycosylation via N-acetyl-galactosamine [GO:0016266] Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139] carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653] g18012.t1 Q3V2Q8 48.276 145 1.2199999999999999e-42 160.0 sp|Q3V2Q8|N42L1_MOUSE NEDD4-binding protein 2-like 1 OS=Mus musculus OX=10090 GN=N4bp2l1 PE=1 SV=1 g18013.t1 Q3UMC0 61.473 584 0.0 738.0 sp|Q3UMC0|AFG2A_MOUSE ATPase family gene 2 protein homolog A OS=Mus musculus OX=10090 GN=Afg2a PE=1 SV=2 AFG2A_MOUSE reviewed ATPase family gene 2 protein homolog A (EC 3.6.4.10) (AFG2 AAA ATPase homolog A) (Ribosome biogenesis protein SPATA5) (Spermatogenesis-associated factor protein) (Spermatogenesis-associated protein 5) Mus musculus (Mouse) GO:0005524; GO:0005737; GO:0005739; GO:0005819; GO:0005829; GO:0007283; GO:0007420; GO:0016887; GO:0030154; GO:0042273; GO:1990275 brain development [GO:0007420]; cell differentiation [GO:0030154]; ribosomal large subunit biogenesis [GO:0042273]; spermatogenesis [GO:0007283] cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; spindle [GO:0005819] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; preribosome binding [GO:1990275] g18015.t1 Q9PTL2 52.885 104 1.6e-29 116.0 sp|Q9PTL2|SPY2_CHICK Protein sprouty homolog 2 OS=Gallus gallus OX=9031 GN=SPRY2 PE=2 SV=1 g18018.t1 Q5U2S1 31.98 197 1.71e-24 99.4 sp|Q5U2S1|NFIP1_RAT NEDD4 family-interacting protein 1 OS=Rattus norvegicus OX=10116 GN=Ndfip1 PE=2 SV=1 NFIP1_RAT reviewed NEDD4 family-interacting protein 1 Rattus norvegicus (Rat) GO:0000139; GO:0002761; GO:0002829; GO:0005576; GO:0005783; GO:0005794; GO:0005938; GO:0006511; GO:0006879; GO:0007034; GO:0010008; GO:0010629; GO:0030001; GO:0030425; GO:0031398; GO:0032713; GO:0035739; GO:0045202; GO:0045619; GO:0045732; GO:0048294; GO:0048302; GO:0048471; GO:0050699; GO:0050728; GO:0051224; GO:2000562 CD4-positive, alpha-beta T cell proliferation [GO:0035739]; intracellular iron ion homeostasis [GO:0006879]; metal ion transport [GO:0030001]; negative regulation of CD4-positive, alpha-beta T cell proliferation [GO:2000562]; negative regulation of gene expression [GO:0010629]; negative regulation of inflammatory response [GO:0050728]; negative regulation of interleukin-4 production [GO:0032713]; negative regulation of isotype switching to IgE isotypes [GO:0048294]; negative regulation of protein transport [GO:0051224]; negative regulation of type 2 immune response [GO:0002829]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein ubiquitination [GO:0031398]; regulation of isotype switching to IgG isotypes [GO:0048302]; regulation of lymphocyte differentiation [GO:0045619]; regulation of myeloid leukocyte differentiation [GO:0002761]; ubiquitin-dependent protein catabolic process [GO:0006511]; vacuolar transport [GO:0007034] cell cortex [GO:0005938]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; endosome membrane [GO:0010008]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; perinuclear region of cytoplasm [GO:0048471]; synapse [GO:0045202] WW domain binding [GO:0050699] g18019.t1 P53370 48.551 276 6.02e-91 276.0 sp|P53370|NUDT6_HUMAN Nucleoside diphosphate-linked moiety X motif 6 OS=Homo sapiens OX=9606 GN=NUDT6 PE=1 SV=2 NUDT6_HUMAN reviewed Nudix hydrolase 6 (Antisense basic fibroblast growth factor) (FAD diphosphatase NUDT6) (EC 3.6.1.18) (NADH pyrophosphatase NUDT6) (EC 3.6.1.22) (Nucleoside diphosphate-linked moiety X motif 6) (Nudix motif 6) (Protein GFG) Homo sapiens (Human) GO:0005634; GO:0005737; GO:0005739; GO:0008285; GO:0035529; GO:0045786; GO:0047631; GO:0047884; GO:0051287 negative regulation of cell cycle [GO:0045786]; negative regulation of cell population proliferation [GO:0008285] cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleus [GO:0005634] ADP-ribose diphosphatase activity [GO:0047631]; FAD diphosphatase activity [GO:0047884]; NAD binding [GO:0051287]; NADH pyrophosphatase activity [GO:0035529] g18020.t1 Q9GV77 65.782 1093 0.0 1467.0 sp|Q9GV77|FREM2_LYTVA Extracellular matrix protein 3 OS=Lytechinus variegatus OX=7654 GN=ECM3 PE=1 SV=1 g18020.t1 Q9GV77 74.242 66 9.19e-22 106.0 sp|Q9GV77|FREM2_LYTVA Extracellular matrix protein 3 OS=Lytechinus variegatus OX=7654 GN=ECM3 PE=1 SV=1 g18021.t1 Q9GV77 63.387 1860 0.0 2327.0 sp|Q9GV77|FREM2_LYTVA Extracellular matrix protein 3 OS=Lytechinus variegatus OX=7654 GN=ECM3 PE=1 SV=1 g18024.t1 P33174 44.56 1149 0.0 895.0 sp|P33174|KIF4_MOUSE Chromosome-associated kinesin KIF4 OS=Mus musculus OX=10090 GN=Kif4 PE=1 SV=3 KIF4_MOUSE reviewed Chromosome-associated kinesin KIF4 (Chromokinesin) Mus musculus (Mouse) GO:0000281; GO:0003677; GO:0003777; GO:0005524; GO:0005634; GO:0005694; GO:0005829; GO:0005874; GO:0005875; GO:0007018; GO:0007052; GO:0008017; GO:0030496; GO:0046872; GO:0051231; GO:0051256; GO:0051536 microtubule-based movement [GO:0007018]; mitotic cytokinesis [GO:0000281]; mitotic spindle midzone assembly [GO:0051256]; mitotic spindle organization [GO:0007052]; spindle elongation [GO:0051231] chromosome [GO:0005694]; cytosol [GO:0005829]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; midbody [GO:0030496]; nucleus [GO:0005634] ATP binding [GO:0005524]; DNA binding [GO:0003677]; iron-sulfur cluster binding [GO:0051536]; metal ion binding [GO:0046872]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777] g18026.t1 B3DL84 72.131 305 1.18e-138 446.0 sp|B3DL84|PLK4_XENTR Serine/threonine-protein kinase PLK4 OS=Xenopus tropicalis OX=8364 GN=plk4 PE=2 SV=1 g18026.t1 B3DL84 45.641 390 2.7499999999999997e-90 315.0 sp|B3DL84|PLK4_XENTR Serine/threonine-protein kinase PLK4 OS=Xenopus tropicalis OX=8364 GN=plk4 PE=2 SV=1 g18027.t1 Q9QYJ1 40.551 254 2.15e-60 202.0 sp|Q9QYJ1|SIA7E_MOUSE Alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 5 OS=Mus musculus OX=10090 GN=St6galnac5 PE=1 SV=1 SIA7E_MOUSE reviewed Alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 5 (EC 2.4.99.-) (GD1 alpha synthase) (GalNAc alpha-2,6-sialyltransferase V) (ST6GalNAc V) (ST6GalNAcV) (Sialyltransferase 7E) (SIAT7-E) Mus musculus (Mouse) GO:0000139; GO:0001574; GO:0001665; GO:0006688; GO:0008373; GO:0009311; GO:0009312 ganglioside biosynthetic process [GO:0001574]; glycosphingolipid biosynthetic process [GO:0006688]; oligosaccharide biosynthetic process [GO:0009312]; oligosaccharide metabolic process [GO:0009311] Golgi membrane [GO:0000139] alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity [GO:0001665]; sialyltransferase activity [GO:0008373] g18028.t1 Q9Z2V9 37.157 401 1.6099999999999998e-67 220.0 sp|Q9Z2V9|CCNI_MOUSE Cyclin-I OS=Mus musculus OX=10090 GN=Ccni PE=2 SV=4 g18029.t1 Q16589 36.054 294 1.7799999999999998e-48 170.0 sp|Q16589|CCNG2_HUMAN Cyclin-G2 OS=Homo sapiens OX=9606 GN=CCNG2 PE=1 SV=1 g18033.t1 Q5R4U0 41.772 237 4.35e-53 177.0 sp|Q5R4U0|CAH10_PONAB Carbonic anhydrase-related protein 10 OS=Pongo abelii OX=9601 GN=CA10 PE=2 SV=1 g18034.t1 D4A666 48.305 236 1.9e-51 201.0 sp|D4A666|UBN2_RAT Ubinuclein-2 OS=Rattus norvegicus OX=10116 GN=Ubn2 PE=1 SV=1 g18034.t2 D4A666 48.305 236 1.39e-51 201.0 sp|D4A666|UBN2_RAT Ubinuclein-2 OS=Rattus norvegicus OX=10116 GN=Ubn2 PE=1 SV=1 g18035.t1 Q9NPG3 39.241 158 8.700000000000001e-21 90.5 sp|Q9NPG3|UBN1_HUMAN Ubinuclein-1 OS=Homo sapiens OX=9606 GN=UBN1 PE=1 SV=2 UBN1_HUMAN reviewed Ubinuclein-1 (HIRA-binding protein) (Protein VT4) (Ubiquitously expressed nuclear protein) Homo sapiens (Human) GO:0003677; GO:0005634; GO:0005654; GO:0005923; GO:0006325; GO:0006334; GO:0016604; GO:0016605; GO:0034451 chromatin organization [GO:0006325]; nucleosome assembly [GO:0006334] bicellular tight junction [GO:0005923]; centriolar satellite [GO:0034451]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605] DNA binding [GO:0003677] g18036.t1 A0A0R4IWG9 58.571 70 2.05e-25 100.0 sp|A0A0R4IWG9|GCNA_DANRE Germ cell nuclear acidic protein OS=Danio rerio OX=7955 GN=gcna PE=3 SV=1 GCNA_DANRE reviewed Germ cell nuclear acidic protein (Acidic repeat-containing protein) (Germ cell nuclear acidic peptidase) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005634; GO:0005694; GO:0016605; GO:0051983; GO:0106300; GO:0140014 mitotic nuclear division [GO:0140014]; protein-DNA covalent cross-linking repair [GO:0106300]; regulation of chromosome segregation [GO:0051983] chromosome [GO:0005694]; nucleus [GO:0005634]; PML body [GO:0016605] g18037.t1 A0A0R4IWG9 56.25 96 5.949999999999999e-23 107.0 sp|A0A0R4IWG9|GCNA_DANRE Germ cell nuclear acidic protein OS=Danio rerio OX=7955 GN=gcna PE=3 SV=1 GCNA_DANRE reviewed Germ cell nuclear acidic protein (Acidic repeat-containing protein) (Germ cell nuclear acidic peptidase) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005634; GO:0005694; GO:0016605; GO:0051983; GO:0106300; GO:0140014 mitotic nuclear division [GO:0140014]; protein-DNA covalent cross-linking repair [GO:0106300]; regulation of chromosome segregation [GO:0051983] chromosome [GO:0005694]; nucleus [GO:0005634]; PML body [GO:0016605] g18038.t1 A1L1C7 58.988 573 0.0 640.0 sp|A1L1C7|PAN3_XENTR PAN2-PAN3 deadenylation complex subunit pan3 OS=Xenopus tropicalis OX=8364 GN=pan3 PE=2 SV=1 PAN3_XENTR reviewed PAN2-PAN3 deadenylation complex subunit pan3 (PAB1P-dependent poly(A)-specific ribonuclease) (Poly(A)-nuclease deadenylation complex subunit 3) (PAN deadenylation complex subunit 3) Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0000289; GO:0000932; GO:0004672; GO:0005524; GO:0006397; GO:0008143; GO:0008270; GO:0010606; GO:0031251 mRNA processing [GO:0006397]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; positive regulation of cytoplasmic mRNA processing body assembly [GO:0010606] P-body [GO:0000932]; PAN complex [GO:0031251] ATP binding [GO:0005524]; poly(A) binding [GO:0008143]; protein kinase activity [GO:0004672]; zinc ion binding [GO:0008270] g18042.t1 O75899 37.023 524 1.46e-96 318.0 sp|O75899|GABR2_HUMAN Gamma-aminobutyric acid type B receptor subunit 2 OS=Homo sapiens OX=9606 GN=GABBR2 PE=1 SV=1 GABR2_HUMAN reviewed Gamma-aminobutyric acid type B receptor subunit 2 (GABA-B receptor 2) (GABA-B-R2) (GABA-BR2) (GABABR2) (Gb2) (G-protein coupled receptor 51) (HG20) Homo sapiens (Human) GO:0004888; GO:0004965; GO:0005737; GO:0005886; GO:0007186; GO:0007193; GO:0007194; GO:0007214; GO:0007268; GO:0038039; GO:0043005; GO:0045211; GO:0046982; GO:0051932; GO:0150099; GO:1902710; GO:1902712 adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; chemical synaptic transmission [GO:0007268]; G protein-coupled receptor signaling pathway [GO:0007186]; gamma-aminobutyric acid signaling pathway [GO:0007214]; negative regulation of adenylate cyclase activity [GO:0007194]; neuron-glial cell signaling [GO:0150099]; synaptic transmission, GABAergic [GO:0051932] cytoplasm [GO:0005737]; G protein-coupled GABA receptor complex [GO:1902712]; G protein-coupled receptor heterodimeric complex [GO:0038039]; GABA receptor complex [GO:1902710]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211] G protein-coupled GABA receptor activity [GO:0004965]; protein heterodimerization activity [GO:0046982]; transmembrane signaling receptor activity [GO:0004888] g18045.t1 Q9BVK2 58.915 516 0.0 562.0 sp|Q9BVK2|ALG8_HUMAN Dolichyl pyrophosphate Glc1Man9GlcNAc2 alpha-1,3-glucosyltransferase OS=Homo sapiens OX=9606 GN=ALG8 PE=1 SV=2 ALG8_HUMAN reviewed Dolichyl pyrophosphate Glc1Man9GlcNAc2 alpha-1,3-glucosyltransferase (EC 2.4.1.265) (Asparagine-linked glycosylation protein 8 homolog) (Dol-P-Glc:Glc(1)Man(9)GlcNAc(2)-PP-dolichyl alpha-1,3-glucosyltransferase) (Dolichyl-P-Glc:Glc1Man9GlcNAc2-PP-dolichyl glucosyltransferase) Homo sapiens (Human) GO:0004583; GO:0005789; GO:0006487; GO:0006488; GO:0018279; GO:0042283; GO:0098553 dolichol-linked oligosaccharide biosynthetic process [GO:0006488]; protein N-linked glycosylation [GO:0006487]; protein N-linked glycosylation via asparagine [GO:0018279] endoplasmic reticulum membrane [GO:0005789]; lumenal side of endoplasmic reticulum membrane [GO:0098553] dolichyl pyrophosphate Glc1Man9GlcNAc2 alpha-1,3-glucosyltransferase activity [GO:0042283]; dolichyl-phosphate-glucose-glycolipid alpha-glucosyltransferase activity [GO:0004583] g18047.t1 Q8NHS3 36.605 377 1.94e-62 216.0 sp|Q8NHS3|MFSD8_HUMAN Major facilitator superfamily domain-containing protein 8 OS=Homo sapiens OX=9606 GN=MFSD8 PE=1 SV=1 g18049.t1 P10041 41.722 151 7.17e-25 113.0 sp|P10041|DL_DROME Neurogenic locus protein delta OS=Drosophila melanogaster OX=7227 GN=Delta PE=1 SV=2 DL_DROME reviewed Neurogenic locus protein delta Drosophila melanogaster (Fruit fly) GO:0001708; GO:0005112; GO:0005509; GO:0005768; GO:0005769; GO:0005886; GO:0007015; GO:0007219; GO:0007298; GO:0007400; GO:0007422; GO:0007423; GO:0007475; GO:0007476; GO:0007480; GO:0007498; GO:0008284; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009986; GO:0016020; GO:0016330; GO:0030139; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0031410; GO:0036011; GO:0042051; GO:0043208; GO:0045179; GO:0045466; GO:0045746; GO:0045931; GO:0046331; GO:0046667; GO:0048018; GO:0048056; GO:0048100; GO:0048190; GO:0048477; GO:0048665; GO:0048800; GO:0048863; GO:0090175 actin filament organization [GO:0007015]; antennal morphogenesis [GO:0048800]; apposition of dorsal and ventral imaginal disc-derived wing surfaces [GO:0007475]; asymmetric cell division [GO:0008356]; border follicle cell migration [GO:0007298]; cell fate specification [GO:0001708]; chaeta morphogenesis [GO:0008407]; compound eye photoreceptor development [GO:0042051]; compound eye retinal cell programmed cell death [GO:0046667]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber stalk formation [GO:0030713]; germ-line stem cell population maintenance [GO:0030718]; glial cell migration [GO:0008347]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; lateral inhibition [GO:0046331]; mesoderm development [GO:0007498]; negative regulation of Notch signaling pathway [GO:0045746]; neuroblast fate determination [GO:0007400]; neuron fate specification [GO:0048665]; Notch signaling pathway [GO:0007219]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of mitotic cell cycle [GO:0045931]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of establishment of planar polarity [GO:0090175]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; stem cell differentiation [GO:0048863]; wing disc anterior/posterior pattern formation [GO:0048100]; wing disc dorsal/ventral pattern formation [GO:0048190] apical cortex [GO:0045179]; cell surface [GO:0009986]; cytoplasmic vesicle [GO:0031410]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; membrane [GO:0016020]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; glycosphingolipid binding [GO:0043208]; Notch binding [GO:0005112]; receptor ligand activity [GO:0048018] g18049.t2 P10041 41.722 151 6.36e-25 113.0 sp|P10041|DL_DROME Neurogenic locus protein delta OS=Drosophila melanogaster OX=7227 GN=Delta PE=1 SV=2 DL_DROME reviewed Neurogenic locus protein delta Drosophila melanogaster (Fruit fly) GO:0001708; GO:0005112; GO:0005509; GO:0005768; GO:0005769; GO:0005886; GO:0007015; GO:0007219; GO:0007298; GO:0007400; GO:0007422; GO:0007423; GO:0007475; GO:0007476; GO:0007480; GO:0007498; GO:0008284; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009986; GO:0016020; GO:0016330; GO:0030139; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0031410; GO:0036011; GO:0042051; GO:0043208; GO:0045179; GO:0045466; GO:0045746; GO:0045931; GO:0046331; GO:0046667; GO:0048018; GO:0048056; GO:0048100; GO:0048190; GO:0048477; GO:0048665; GO:0048800; GO:0048863; GO:0090175 actin filament organization [GO:0007015]; antennal morphogenesis [GO:0048800]; apposition of dorsal and ventral imaginal disc-derived wing surfaces [GO:0007475]; asymmetric cell division [GO:0008356]; border follicle cell migration [GO:0007298]; cell fate specification [GO:0001708]; chaeta morphogenesis [GO:0008407]; compound eye photoreceptor development [GO:0042051]; compound eye retinal cell programmed cell death [GO:0046667]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber stalk formation [GO:0030713]; germ-line stem cell population maintenance [GO:0030718]; glial cell migration [GO:0008347]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; lateral inhibition [GO:0046331]; mesoderm development [GO:0007498]; negative regulation of Notch signaling pathway [GO:0045746]; neuroblast fate determination [GO:0007400]; neuron fate specification [GO:0048665]; Notch signaling pathway [GO:0007219]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of mitotic cell cycle [GO:0045931]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of establishment of planar polarity [GO:0090175]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; stem cell differentiation [GO:0048863]; wing disc anterior/posterior pattern formation [GO:0048100]; wing disc dorsal/ventral pattern formation [GO:0048190] apical cortex [GO:0045179]; cell surface [GO:0009986]; cytoplasmic vesicle [GO:0031410]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; membrane [GO:0016020]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; glycosphingolipid binding [GO:0043208]; Notch binding [GO:0005112]; receptor ligand activity [GO:0048018] g18050.t1 Q6F6U3 38.0 200 9.18e-30 116.0 sp|Q6F6U3|PNCA_ACIAD Nicotinamidase OS=Acinetobacter baylyi (strain ATCC 33305 / BD413 / ADP1) OX=62977 GN=pncA PE=1 SV=1 g18052.t1 Q6F6U3 38.889 198 4.73e-33 126.0 sp|Q6F6U3|PNCA_ACIAD Nicotinamidase OS=Acinetobacter baylyi (strain ATCC 33305 / BD413 / ADP1) OX=62977 GN=pncA PE=1 SV=1 g18053.t1 P79761 35.469 437 5.54e-80 262.0 sp|P79761|CP1A5_CHICK Cytochrome P450 1A5 OS=Gallus gallus OX=9031 GN=CYP1A5 PE=2 SV=1 CP1A5_CHICK reviewed Cytochrome P450 1A5 (EC 1.14.14.1) (CYPIA5) (Cytochrome P450 TCDDAA) Gallus gallus (Chicken) GO:0005506; GO:0005739; GO:0005789; GO:0006706; GO:0006805; GO:0008210; GO:0008392; GO:0008395; GO:0009404; GO:0016712; GO:0019825; GO:0020037; GO:0036146; GO:0042178; GO:0043231; GO:0046677; GO:1990748 cellular detoxification [GO:1990748]; cellular response to mycotoxin [GO:0036146]; estrogen metabolic process [GO:0008210]; response to antibiotic [GO:0046677]; steroid catabolic process [GO:0006706]; toxin metabolic process [GO:0009404]; xenobiotic catabolic process [GO:0042178]; xenobiotic metabolic process [GO:0006805] endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739] arachidonate epoxygenase activity [GO:0008392]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; oxygen binding [GO:0019825]; steroid hydroxylase activity [GO:0008395] g18054.t1 P79761 36.842 437 5.3700000000000004e-86 278.0 sp|P79761|CP1A5_CHICK Cytochrome P450 1A5 OS=Gallus gallus OX=9031 GN=CYP1A5 PE=2 SV=1 CP1A5_CHICK reviewed Cytochrome P450 1A5 (EC 1.14.14.1) (CYPIA5) (Cytochrome P450 TCDDAA) Gallus gallus (Chicken) GO:0005506; GO:0005739; GO:0005789; GO:0006706; GO:0006805; GO:0008210; GO:0008392; GO:0008395; GO:0009404; GO:0016712; GO:0019825; GO:0020037; GO:0036146; GO:0042178; GO:0043231; GO:0046677; GO:1990748 cellular detoxification [GO:1990748]; cellular response to mycotoxin [GO:0036146]; estrogen metabolic process [GO:0008210]; response to antibiotic [GO:0046677]; steroid catabolic process [GO:0006706]; toxin metabolic process [GO:0009404]; xenobiotic catabolic process [GO:0042178]; xenobiotic metabolic process [GO:0006805] endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739] arachidonate epoxygenase activity [GO:0008392]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; oxygen binding [GO:0019825]; steroid hydroxylase activity [GO:0008395] g18056.t1 Q9GKT2 52.234 291 3.3100000000000005e-117 345.0 sp|Q9GKT2|FXDC2_MACFA Fatty acid hydroxylase domain-containing protein 2 OS=Macaca fascicularis OX=9541 GN=FAXDC2 PE=2 SV=1 g18058.t1 Q9P273 34.283 1896 0.0 1073.0 sp|Q9P273|TEN3_HUMAN Teneurin-3 OS=Homo sapiens OX=9606 GN=TENM3 PE=1 SV=3 TEN3_HUMAN reviewed Teneurin-3 (Ten-3) (Protein Odd Oz/ten-m homolog 3) (Tenascin-M3) (Ten-m3) (Teneurin transmembrane protein 3) Homo sapiens (Human) GO:0005886; GO:0007156; GO:0007165; GO:0010976; GO:0016020; GO:0030424; GO:0042803; GO:0043005; GO:0046982; GO:0048593; GO:0048666; GO:0050839; GO:1903385 camera-type eye morphogenesis [GO:0048593]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; neuron development [GO:0048666]; positive regulation of neuron projection development [GO:0010976]; regulation of homophilic cell adhesion [GO:1903385]; signal transduction [GO:0007165] axon [GO:0030424]; membrane [GO:0016020]; neuron projection [GO:0043005]; plasma membrane [GO:0005886] cell adhesion molecule binding [GO:0050839]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803] g18059.t1 Q9P273 35.751 386 7.92e-58 218.0 sp|Q9P273|TEN3_HUMAN Teneurin-3 OS=Homo sapiens OX=9606 GN=TENM3 PE=1 SV=3 TEN3_HUMAN reviewed Teneurin-3 (Ten-3) (Protein Odd Oz/ten-m homolog 3) (Tenascin-M3) (Ten-m3) (Teneurin transmembrane protein 3) Homo sapiens (Human) GO:0005886; GO:0007156; GO:0007165; GO:0010976; GO:0016020; GO:0030424; GO:0042803; GO:0043005; GO:0046982; GO:0048593; GO:0048666; GO:0050839; GO:1903385 camera-type eye morphogenesis [GO:0048593]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; neuron development [GO:0048666]; positive regulation of neuron projection development [GO:0010976]; regulation of homophilic cell adhesion [GO:1903385]; signal transduction [GO:0007165] axon [GO:0030424]; membrane [GO:0016020]; neuron projection [GO:0043005]; plasma membrane [GO:0005886] cell adhesion molecule binding [GO:0050839]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803] g18061.t1 P08630 55.079 443 3.4100000000000004e-157 476.0 sp|P08630|BTKL_DROME Tyrosine-protein kinase Btk OS=Drosophila melanogaster OX=7227 GN=Btk PE=2 SV=2 g18062.t1 Q7ZV35 64.234 137 4.4799999999999995e-62 194.0 sp|Q7ZV35|MED7_DANRE Mediator of RNA polymerase II transcription subunit 7 OS=Danio rerio OX=7955 GN=med7 PE=2 SV=1 g18063.t1 Q8BX17 40.413 678 7.18e-160 501.0 sp|Q8BX17|GEMI5_MOUSE Gem-associated protein 5 OS=Mus musculus OX=10090 GN=Gemin5 PE=1 SV=2 GEMI5_MOUSE reviewed Gem-associated protein 5 (Gemin5) Mus musculus (Mouse) GO:0000340; GO:0000387; GO:0003730; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006412; GO:0006417; GO:0016604; GO:0017069; GO:0030619; GO:0030621; GO:0030622; GO:0032797; GO:0034718; GO:0034719; GO:0043022; GO:0097504 regulation of translation [GO:0006417]; spliceosomal snRNP assembly [GO:0000387]; translation [GO:0006412] cytoplasm [GO:0005737]; cytosol [GO:0005829]; Gemini of Cajal bodies [GO:0097504]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SMN complex [GO:0032797]; SMN-Gemin2 complex [GO:0034718]; SMN-Sm protein complex [GO:0034719] mRNA 3'-UTR binding [GO:0003730]; ribosome binding [GO:0043022]; RNA 7-methylguanosine cap binding [GO:0000340]; snRNA binding [GO:0017069]; U1 snRNA binding [GO:0030619]; U4 snRNA binding [GO:0030621]; U4atac snRNA binding [GO:0030622] g18064.t1 Q8TEQ6 28.341 621 9.86e-62 234.0 sp|Q8TEQ6|GEMI5_HUMAN Gem-associated protein 5 OS=Homo sapiens OX=9606 GN=GEMIN5 PE=1 SV=3 GEMI5_HUMAN reviewed Gem-associated protein 5 (Gemin5) Homo sapiens (Human) GO:0000340; GO:0000387; GO:0000398; GO:0003723; GO:0003730; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006412; GO:0006417; GO:0016020; GO:0016604; GO:0017069; GO:0030619; GO:0030621; GO:0030622; GO:0032797; GO:0034718; GO:0034719; GO:0043022; GO:0065003; GO:0097504 mRNA splicing, via spliceosome [GO:0000398]; protein-containing complex assembly [GO:0065003]; regulation of translation [GO:0006417]; spliceosomal snRNP assembly [GO:0000387]; translation [GO:0006412] cytoplasm [GO:0005737]; cytosol [GO:0005829]; Gemini of Cajal bodies [GO:0097504]; membrane [GO:0016020]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SMN complex [GO:0032797]; SMN-Gemin2 complex [GO:0034718]; SMN-Sm protein complex [GO:0034719] mRNA 3'-UTR binding [GO:0003730]; ribosome binding [GO:0043022]; RNA 7-methylguanosine cap binding [GO:0000340]; RNA binding [GO:0003723]; snRNA binding [GO:0017069]; U1 snRNA binding [GO:0030619]; U4 snRNA binding [GO:0030621]; U4atac snRNA binding [GO:0030622] g18064.t1 Q8TEQ6 57.303 89 2e-27 120.0 sp|Q8TEQ6|GEMI5_HUMAN Gem-associated protein 5 OS=Homo sapiens OX=9606 GN=GEMIN5 PE=1 SV=3 GEMI5_HUMAN reviewed Gem-associated protein 5 (Gemin5) Homo sapiens (Human) GO:0000340; GO:0000387; GO:0000398; GO:0003723; GO:0003730; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006412; GO:0006417; GO:0016020; GO:0016604; GO:0017069; GO:0030619; GO:0030621; GO:0030622; GO:0032797; GO:0034718; GO:0034719; GO:0043022; GO:0065003; GO:0097504 mRNA splicing, via spliceosome [GO:0000398]; protein-containing complex assembly [GO:0065003]; regulation of translation [GO:0006417]; spliceosomal snRNP assembly [GO:0000387]; translation [GO:0006412] cytoplasm [GO:0005737]; cytosol [GO:0005829]; Gemini of Cajal bodies [GO:0097504]; membrane [GO:0016020]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SMN complex [GO:0032797]; SMN-Gemin2 complex [GO:0034718]; SMN-Sm protein complex [GO:0034719] mRNA 3'-UTR binding [GO:0003730]; ribosome binding [GO:0043022]; RNA 7-methylguanosine cap binding [GO:0000340]; RNA binding [GO:0003723]; snRNA binding [GO:0017069]; U1 snRNA binding [GO:0030619]; U4 snRNA binding [GO:0030621]; U4atac snRNA binding [GO:0030622] g18064.t1 Q8TEQ6 45.455 22 2e-27 26.2 sp|Q8TEQ6|GEMI5_HUMAN Gem-associated protein 5 OS=Homo sapiens OX=9606 GN=GEMIN5 PE=1 SV=3 GEMI5_HUMAN reviewed Gem-associated protein 5 (Gemin5) Homo sapiens (Human) GO:0000340; GO:0000387; GO:0000398; GO:0003723; GO:0003730; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006412; GO:0006417; GO:0016020; GO:0016604; GO:0017069; GO:0030619; GO:0030621; GO:0030622; GO:0032797; GO:0034718; GO:0034719; GO:0043022; GO:0065003; GO:0097504 mRNA splicing, via spliceosome [GO:0000398]; protein-containing complex assembly [GO:0065003]; regulation of translation [GO:0006417]; spliceosomal snRNP assembly [GO:0000387]; translation [GO:0006412] cytoplasm [GO:0005737]; cytosol [GO:0005829]; Gemini of Cajal bodies [GO:0097504]; membrane [GO:0016020]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SMN complex [GO:0032797]; SMN-Gemin2 complex [GO:0034718]; SMN-Sm protein complex [GO:0034719] mRNA 3'-UTR binding [GO:0003730]; ribosome binding [GO:0043022]; RNA 7-methylguanosine cap binding [GO:0000340]; RNA binding [GO:0003723]; snRNA binding [GO:0017069]; U1 snRNA binding [GO:0030619]; U4 snRNA binding [GO:0030621]; U4atac snRNA binding [GO:0030622] g18065.t1 Q5M823 46.809 94 2.2799999999999997e-23 90.1 sp|Q5M823|NUDC2_RAT NudC domain-containing protein 2 OS=Rattus norvegicus OX=10116 GN=Nudcd2 PE=2 SV=1 g18066.t1 Q6DHL4 50.575 87 3.6999999999999997e-28 101.0 sp|Q6DHL4|SUMO2_DANRE Small ubiquitin-related modifier 2 OS=Danio rerio OX=7955 GN=sumo2 PE=3 SV=1 SUMO2_DANRE reviewed Small ubiquitin-related modifier 2 (SUMO-2) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005634; GO:0016925; GO:0031386; GO:0043009; GO:0044389; GO:0060216 chordate embryonic development [GO:0043009]; definitive hemopoiesis [GO:0060216]; protein sumoylation [GO:0016925] nucleus [GO:0005634] protein tag activity [GO:0031386]; ubiquitin-like protein ligase binding [GO:0044389] g18068.t1 Q6P5M2 76.744 301 3.15e-178 497.0 sp|Q6P5M2|SKI8_DANRE Superkiller complex protein 8 OS=Danio rerio OX=7955 GN=skic8 PE=2 SV=1 SKI8_DANRE reviewed Superkiller complex protein 8 (Ski8) (WD repeat-containing protein 61) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000791; GO:0005634; GO:0005737; GO:0006368; GO:0016593; GO:0055087; GO:0070478; GO:0072344 nuclear-transcribed mRNA catabolic process, 3'-5' exonucleolytic nonsense-mediated decay [GO:0070478]; rescue of stalled ribosome [GO:0072344]; transcription elongation by RNA polymerase II [GO:0006368] Cdc73/Paf1 complex [GO:0016593]; cytoplasm [GO:0005737]; euchromatin [GO:0000791]; nucleus [GO:0005634]; Ski complex [GO:0055087] g18069.t1 Q5ZME8 77.583 513 0.0 814.0 sp|Q5ZME8|SMU1_CHICK WD40 repeat-containing protein SMU1 OS=Gallus gallus OX=9031 GN=SMU1 PE=2 SV=1 SMU1_CHICK reviewed WD40 repeat-containing protein SMU1 (Smu-1 suppressor of mec-8 and unc-52 protein homolog) Gallus gallus (Chicken) GO:0000381; GO:0000398; GO:0005634; GO:0005737; GO:0008380; GO:0016607; GO:0071005; GO:0071011 mRNA splicing, via spliceosome [GO:0000398]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA splicing [GO:0008380] cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; U2-type precatalytic spliceosome [GO:0071005] g18071.t1 A7Y2X0 46.037 593 4.52e-164 493.0 sp|A7Y2X0|SC6A5_XENLA Sodium- and chloride-dependent glycine transporter 2 OS=Xenopus laevis OX=8355 GN=slc6a5 PE=2 SV=1 g18075.t1 Q95218 38.605 215 1.1400000000000001e-29 124.0 sp|Q95218|DMBT1_RABIT Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Oryctolagus cuniculus OX=9986 GN=Dmbt1 PE=1 SV=2 g18075.t1 Q95218 33.333 252 1.58e-25 112.0 sp|Q95218|DMBT1_RABIT Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Oryctolagus cuniculus OX=9986 GN=Dmbt1 PE=1 SV=2 g18075.t1 Q95218 32.549 255 5.68e-24 107.0 sp|Q95218|DMBT1_RABIT Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Oryctolagus cuniculus OX=9986 GN=Dmbt1 PE=1 SV=2 g18075.t1 Q95218 32.653 245 2.9199999999999997e-23 105.0 sp|Q95218|DMBT1_RABIT Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Oryctolagus cuniculus OX=9986 GN=Dmbt1 PE=1 SV=2 g18075.t1 Q95218 31.373 255 4.22e-21 99.4 sp|Q95218|DMBT1_RABIT Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Oryctolagus cuniculus OX=9986 GN=Dmbt1 PE=1 SV=2 g18081.t1 Q9MYM7 38.496 226 2.72e-50 174.0 sp|Q9MYM7|B3GT1_PONPY Beta-1,3-galactosyltransferase 1 OS=Pongo pygmaeus OX=9600 GN=B3GALT1 PE=3 SV=1 g18082.t1 Q9MYM7 37.308 260 7.1e-53 181.0 sp|Q9MYM7|B3GT1_PONPY Beta-1,3-galactosyltransferase 1 OS=Pongo pygmaeus OX=9600 GN=B3GALT1 PE=3 SV=1 g18084.t1 Q15645 66.824 425 0.0 551.0 sp|Q15645|PCH2_HUMAN Pachytene checkpoint protein 2 homolog OS=Homo sapiens OX=9606 GN=TRIP13 PE=1 SV=2 PCH2_HUMAN reviewed Pachytene checkpoint protein 2 homolog (Human papillomavirus type 16 E1 protein-binding protein) (16E1-BP) (HPV16 E1 protein-binding protein) (Thyroid hormone receptor interactor 13) (Thyroid receptor-interacting protein 13) (TR-interacting protein 13) (TRIP-13) Homo sapiens (Human) GO:0001556; GO:0001673; GO:0003712; GO:0005524; GO:0005634; GO:0005694; GO:0006302; GO:0006366; GO:0007094; GO:0007130; GO:0007131; GO:0007141; GO:0007144; GO:0007283; GO:0007286; GO:0016887; GO:0042802; GO:0048477; GO:0051598 double-strand break repair [GO:0006302]; female meiosis I [GO:0007144]; male meiosis I [GO:0007141]; meiotic recombination checkpoint signaling [GO:0051598]; mitotic spindle assembly checkpoint signaling [GO:0007094]; oocyte maturation [GO:0001556]; oogenesis [GO:0048477]; reciprocal meiotic recombination [GO:0007131]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; synaptonemal complex assembly [GO:0007130]; transcription by RNA polymerase II [GO:0006366] chromosome [GO:0005694]; male germ cell nucleus [GO:0001673]; nucleus [GO:0005634] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; identical protein binding [GO:0042802]; transcription coregulator activity [GO:0003712] g18086.t1 P15374 50.442 226 8.140000000000001e-73 224.0 sp|P15374|UCHL3_HUMAN Ubiquitin carboxyl-terminal hydrolase isozyme L3 OS=Homo sapiens OX=9606 GN=UCHL3 PE=1 SV=1 UCHL3_HUMAN reviewed Ubiquitin carboxyl-terminal hydrolase isozyme L3 (UCH-L3) (EC 3.4.19.12) (Ubiquitin thioesterase L3) Homo sapiens (Human) GO:0004843; GO:0005654; GO:0005737; GO:0005794; GO:0005829; GO:0006511; GO:0008233; GO:0016567; GO:0016579; GO:0019784; GO:0030163; GO:0043130; GO:0043687 post-translational protein modification [GO:0043687]; protein catabolic process [GO:0030163]; protein deubiquitination [GO:0016579]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511] cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654] cysteine-type deubiquitinase activity [GO:0004843]; deNEDDylase activity [GO:0019784]; peptidase activity [GO:0008233]; ubiquitin binding [GO:0043130] g18086.t2 P15374 48.673 226 5.25e-72 222.0 sp|P15374|UCHL3_HUMAN Ubiquitin carboxyl-terminal hydrolase isozyme L3 OS=Homo sapiens OX=9606 GN=UCHL3 PE=1 SV=1 UCHL3_HUMAN reviewed Ubiquitin carboxyl-terminal hydrolase isozyme L3 (UCH-L3) (EC 3.4.19.12) (Ubiquitin thioesterase L3) Homo sapiens (Human) GO:0004843; GO:0005654; GO:0005737; GO:0005794; GO:0005829; GO:0006511; GO:0008233; GO:0016567; GO:0016579; GO:0019784; GO:0030163; GO:0043130; GO:0043687 post-translational protein modification [GO:0043687]; protein catabolic process [GO:0030163]; protein deubiquitination [GO:0016579]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511] cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654] cysteine-type deubiquitinase activity [GO:0004843]; deNEDDylase activity [GO:0019784]; peptidase activity [GO:0008233]; ubiquitin binding [GO:0043130] g18086.t3 P15374 43.182 264 1.88e-65 207.0 sp|P15374|UCHL3_HUMAN Ubiquitin carboxyl-terminal hydrolase isozyme L3 OS=Homo sapiens OX=9606 GN=UCHL3 PE=1 SV=1 UCHL3_HUMAN reviewed Ubiquitin carboxyl-terminal hydrolase isozyme L3 (UCH-L3) (EC 3.4.19.12) (Ubiquitin thioesterase L3) Homo sapiens (Human) GO:0004843; GO:0005654; GO:0005737; GO:0005794; GO:0005829; GO:0006511; GO:0008233; GO:0016567; GO:0016579; GO:0019784; GO:0030163; GO:0043130; GO:0043687 post-translational protein modification [GO:0043687]; protein catabolic process [GO:0030163]; protein deubiquitination [GO:0016579]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511] cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654] cysteine-type deubiquitinase activity [GO:0004843]; deNEDDylase activity [GO:0019784]; peptidase activity [GO:0008233]; ubiquitin binding [GO:0043130] g18087.t1 Q5ZHV1 69.143 175 2.51e-92 274.0 sp|Q5ZHV1|RB33B_CHICK Ras-related protein Rab-33B OS=Gallus gallus OX=9031 GN=RAB33B PE=2 SV=1 RB33B_CHICK reviewed Ras-related protein Rab-33B (EC 3.6.5.2) Gallus gallus (Chicken) GO:0000045; GO:0000139; GO:0003924; GO:0003925; GO:0005525; GO:0005768; GO:0005794; GO:0005796; GO:0006891; GO:0015031; GO:0017157; GO:0032482; GO:0034045; GO:0034067; GO:0034497; GO:0046872; GO:0048705; GO:1903358; GO:1903434; GO:2000156 autophagosome assembly [GO:0000045]; intra-Golgi vesicle-mediated transport [GO:0006891]; negative regulation of constitutive secretory pathway [GO:1903434]; protein localization to Golgi apparatus [GO:0034067]; protein localization to phagophore assembly site [GO:0034497]; protein transport [GO:0015031]; Rab protein signal transduction [GO:0032482]; regulation of exocytosis [GO:0017157]; regulation of Golgi organization [GO:1903358]; regulation of retrograde vesicle-mediated transport, Golgi to ER [GO:2000156]; skeletal system morphogenesis [GO:0048705] endosome [GO:0005768]; Golgi apparatus [GO:0005794]; Golgi lumen [GO:0005796]; Golgi membrane [GO:0000139]; phagophore assembly site membrane [GO:0034045] G protein activity [GO:0003925]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872] g18089.t1 P28344 40.97 371 3.28e-87 277.0 sp|P28344|MASY_EMENI Malate synthase, glyoxysomal OS=Emericella nidulans (strain FGSC A4 / ATCC 38163 / CBS 112.46 / NRRL 194 / M139) OX=227321 GN=acuE PE=3 SV=3 g18091.t1 Q96EQ9 30.548 347 2.79e-39 154.0 sp|Q96EQ9|PRDM9_MOUSE Histone-lysine N-methyltransferase PRDM9 OS=Mus musculus OX=10090 GN=Prdm9 PE=1 SV=2 g18091.t1 Q96EQ9 38.506 174 9.27e-37 147.0 sp|Q96EQ9|PRDM9_MOUSE Histone-lysine N-methyltransferase PRDM9 OS=Mus musculus OX=10090 GN=Prdm9 PE=1 SV=2 g18091.t1 Q96EQ9 37.427 171 8.999999999999999e-34 138.0 sp|Q96EQ9|PRDM9_MOUSE Histone-lysine N-methyltransferase PRDM9 OS=Mus musculus OX=10090 GN=Prdm9 PE=1 SV=2 g18092.t1 Q9BXJ9 60.142 843 0.0 998.0 sp|Q9BXJ9|NAA15_HUMAN N-alpha-acetyltransferase 15, NatA auxiliary subunit OS=Homo sapiens OX=9606 GN=NAA15 PE=1 SV=1 NAA15_HUMAN reviewed N-alpha-acetyltransferase 15, NatA auxiliary subunit (Gastric cancer antigen Ga19) (N-terminal acetyltransferase) (NMDA receptor-regulated protein 1) (Protein tubedown-1) (Tbdn100) Homo sapiens (Human) GO:0001525; GO:0003723; GO:0005634; GO:0005667; GO:0005737; GO:0005829; GO:0010698; GO:0016020; GO:0016604; GO:0030154; GO:0031415; GO:0043022; GO:0045893; GO:0050821; GO:0051604 angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; positive regulation of DNA-templated transcription [GO:0045893]; protein maturation [GO:0051604]; protein stabilization [GO:0050821] cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; NatA complex [GO:0031415]; nuclear body [GO:0016604]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667] acetyltransferase activator activity [GO:0010698]; ribosome binding [GO:0043022]; RNA binding [GO:0003723] g18093.t1 A5D8S5 35.862 580 1.27e-75 271.0 sp|A5D8S5|SH3R1_DANRE E3 ubiquitin-protein ligase SH3RF1 OS=Danio rerio OX=7955 GN=sh3rf1 PE=2 SV=2 SH3R1_DANRE reviewed E3 ubiquitin-protein ligase SH3RF1 (EC 2.3.2.27) (Plenty of SH3s) (Protein POSH) (RING-type E3 ubiquitin transferase SH3RF1) (SH3 domain-containing RING finger protein 1) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001764; GO:0005078; GO:0005794; GO:0008270; GO:0016567; GO:0030027; GO:0032436; GO:0043066; GO:0043370; GO:0046330; GO:0048471; GO:0051865; GO:0061630; GO:2000564 negative regulation of apoptotic process [GO:0043066]; neuron migration [GO:0001764]; positive regulation of JNK cascade [GO:0046330]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein autoubiquitination [GO:0051865]; protein ubiquitination [GO:0016567]; regulation of CD4-positive, alpha-beta T cell differentiation [GO:0043370]; regulation of CD8-positive, alpha-beta T cell proliferation [GO:2000564] Golgi apparatus [GO:0005794]; lamellipodium [GO:0030027]; perinuclear region of cytoplasm [GO:0048471] MAP-kinase scaffold activity [GO:0005078]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] g18120.t1 A7Y2W8 49.275 552 9.750000000000001e-173 507.0 sp|A7Y2W8|SC6A9_XENLA Sodium- and chloride-dependent glycine transporter 1 OS=Xenopus laevis OX=8355 GN=slc6a9 PE=2 SV=1 g18121.t1 K0DZA0 31.699 306 5.46e-33 128.0 sp|K0DZA0|HTYE_ASPRU 2-oxoglutarate-dependent dioxygenase htyE OS=Aspergillus rugulosus OX=41736 GN=htyE PE=1 SV=1 g18122.t1 A0A411L030 32.237 304 1.4800000000000001e-33 128.0 sp|A0A411L030|BUAE_PETAA Proline hydroxylase buaE OS=Petromyces alliaceus OX=209559 GN=buaE PE=3 SV=1 g18123.t1 A0A166YZY4 28.152 341 1.02e-30 122.0 sp|A0A166YZY4|PPZD_METRR 2-oxoglutarate-Fe(II) type oxidoreductase ppzD OS=Metarhizium rileyi (strain RCEF 4871) OX=1649241 GN=ppzD PE=3 SV=1 g18126.t1 Q4L235 58.282 163 3.7600000000000004e-59 202.0 sp|Q4L235|ACSF4_HUMAN Beta-alanine-activating enzyme OS=Homo sapiens OX=9606 GN=AASDH PE=1 SV=3 ACSF4_HUMAN reviewed Beta-alanine-activating enzyme (EC 6.2.1.-) (Acyl-CoA synthetase family member 4) (Protein NRPS998) Homo sapiens (Human) GO:0005524; GO:0006631; GO:0016874; GO:0019482; GO:0043041 amino acid activation for nonribosomal peptide biosynthetic process [GO:0043041]; beta-alanine metabolic process [GO:0019482]; fatty acid metabolic process [GO:0006631] ATP binding [GO:0005524]; ligase activity [GO:0016874] g18127.t1 Q4L235 45.26 327 2.38e-75 272.0 sp|Q4L235|ACSF4_HUMAN Beta-alanine-activating enzyme OS=Homo sapiens OX=9606 GN=AASDH PE=1 SV=3 ACSF4_HUMAN reviewed Beta-alanine-activating enzyme (EC 6.2.1.-) (Acyl-CoA synthetase family member 4) (Protein NRPS998) Homo sapiens (Human) GO:0005524; GO:0006631; GO:0016874; GO:0019482; GO:0043041 amino acid activation for nonribosomal peptide biosynthetic process [GO:0043041]; beta-alanine metabolic process [GO:0019482]; fatty acid metabolic process [GO:0006631] ATP binding [GO:0005524]; ligase activity [GO:0016874] g18127.t1 Q4L235 36.475 244 2.55e-33 143.0 sp|Q4L235|ACSF4_HUMAN Beta-alanine-activating enzyme OS=Homo sapiens OX=9606 GN=AASDH PE=1 SV=3 ACSF4_HUMAN reviewed Beta-alanine-activating enzyme (EC 6.2.1.-) (Acyl-CoA synthetase family member 4) (Protein NRPS998) Homo sapiens (Human) GO:0005524; GO:0006631; GO:0016874; GO:0019482; GO:0043041 amino acid activation for nonribosomal peptide biosynthetic process [GO:0043041]; beta-alanine metabolic process [GO:0019482]; fatty acid metabolic process [GO:0006631] ATP binding [GO:0005524]; ligase activity [GO:0016874] g18130.t1 Q96DM1 39.695 131 1.4599999999999999e-24 101.0 sp|Q96DM1|PGBD4_HUMAN PiggyBac transposable element-derived protein 4 OS=Homo sapiens OX=9606 GN=PGBD4 PE=1 SV=3 g18134.t1 P58369 38.837 430 1.69e-97 305.0 sp|P58369|ANKH_TETNG Progressive ankylosis protein homolog OS=Tetraodon nigroviridis OX=99883 GN=ankh PE=2 SV=2 g18135.t1 Q9NQM4 40.314 191 1.18e-41 142.0 sp|Q9NQM4|DAAF6_HUMAN Dynein axonemal assembly factor 6 OS=Homo sapiens OX=9606 GN=DNAAF6 PE=1 SV=1 DAAF6_HUMAN reviewed Dynein axonemal assembly factor 6 (PIH1 domain-containing protein 3) (Sarcoma antigen NY-SAR-97) Homo sapiens (Human) GO:0003341; GO:0005737; GO:0005802; GO:0030317; GO:0036158; GO:0036159; GO:0045505; GO:0051087; GO:0070286 axonemal dynein complex assembly [GO:0070286]; cilium movement [GO:0003341]; flagellated sperm motility [GO:0030317]; inner dynein arm assembly [GO:0036159]; outer dynein arm assembly [GO:0036158] cytoplasm [GO:0005737]; trans-Golgi network [GO:0005802] dynein intermediate chain binding [GO:0045505]; protein-folding chaperone binding [GO:0051087] g18137.t1 Q9UK53 40.377 265 8.98e-45 160.0 sp|Q9UK53|ING1_HUMAN Inhibitor of growth protein 1 OS=Homo sapiens OX=9606 GN=ING1 PE=1 SV=2 ING1_HUMAN reviewed Inhibitor of growth protein 1 Homo sapiens (Human) GO:0000122; GO:0005634; GO:0006606; GO:0008270; GO:0008285; GO:0030308; GO:0030336; GO:0030512; GO:0043067; GO:0045893; GO:0070822; GO:0140002; GO:1902455; GO:1902459 negative regulation of cell growth [GO:0030308]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of stem cell population maintenance [GO:1902455]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of stem cell population maintenance [GO:1902459]; protein import into nucleus [GO:0006606]; regulation of programmed cell death [GO:0043067] nucleus [GO:0005634]; Sin3-type complex [GO:0070822] histone H3K4me3 reader activity [GO:0140002]; zinc ion binding [GO:0008270] g18138.t1 Q2KIF8 44.306 562 3.2100000000000003e-161 480.0 sp|Q2KIF8|SYCM_BOVIN Cysteine--tRNA ligase, mitochondrial OS=Bos taurus OX=9913 GN=CARS2 PE=2 SV=1 SYCM_BOVIN reviewed Cysteine--tRNA ligase, mitochondrial (EC 6.1.1.16) (Cysteinyl-tRNA synthetase) (CysRS) Bos taurus (Bovine) GO:0004817; GO:0005524; GO:0005737; GO:0005739; GO:0006423; GO:0046872 cysteinyl-tRNA aminoacylation [GO:0006423] cytoplasm [GO:0005737]; mitochondrion [GO:0005739] ATP binding [GO:0005524]; cysteine-tRNA ligase activity [GO:0004817]; metal ion binding [GO:0046872] g18142.t1 P35072 39.85 133 5.34e-31 115.0 sp|P35072|TCB1_CAEBR Transposable element Tcb1 transposase OS=Caenorhabditis briggsae OX=6238 PE=3 SV=1 g18175.t1 P10079 52.442 471 3.93e-143 466.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g18175.t1 P10079 52.079 457 1.8899999999999998e-140 459.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g18175.t1 P10079 47.438 527 1.9199999999999998e-138 453.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g18175.t1 P10079 47.879 495 1.75e-137 451.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g18175.t1 P10079 48.904 456 5.46e-130 431.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g18175.t1 P10079 50.777 386 8.63e-117 394.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g18175.t1 P10079 53.459 159 7.5e-42 171.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g18175.t1 P10079 43.455 191 8.499999999999999e-38 158.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g18175.t1 P10079 42.038 157 1.4599999999999998e-23 112.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g18179.t1 Q9P2G9 53.082 584 0.0 655.0 sp|Q9P2G9|KLHL8_HUMAN Kelch-like protein 8 OS=Homo sapiens OX=9606 GN=KLHL8 PE=1 SV=4 KLHL8_HUMAN reviewed Kelch-like protein 8 Homo sapiens (Human) GO:0005654; GO:0005737; GO:0006511; GO:0016567; GO:0031463; GO:0043161; GO:1990756 proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511] Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654] ubiquitin-like ligase-substrate adaptor activity [GO:1990756] g18179.t2 Q9P2G9 53.082 584 0.0 655.0 sp|Q9P2G9|KLHL8_HUMAN Kelch-like protein 8 OS=Homo sapiens OX=9606 GN=KLHL8 PE=1 SV=4 KLHL8_HUMAN reviewed Kelch-like protein 8 Homo sapiens (Human) GO:0005654; GO:0005737; GO:0006511; GO:0016567; GO:0031463; GO:0043161; GO:1990756 proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511] Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654] ubiquitin-like ligase-substrate adaptor activity [GO:1990756] g18180.t1 P55083 41.441 222 2.57e-40 145.0 sp|P55083|MFAP4_HUMAN Microfibril-associated glycoprotein 4 OS=Homo sapiens OX=9606 GN=MFAP4 PE=1 SV=2 MFAP4_HUMAN reviewed Microfibril-associated glycoprotein 4 Homo sapiens (Human) GO:0001527; GO:0005576; GO:0005615; GO:0007155; GO:0009650; GO:0010712; GO:0031012; GO:0048251; GO:0071493; GO:0071953; GO:0097435 cell adhesion [GO:0007155]; cellular response to UV-B [GO:0071493]; elastic fiber assembly [GO:0048251]; regulation of collagen metabolic process [GO:0010712]; supramolecular fiber organization [GO:0097435]; UV protection [GO:0009650] elastic fiber [GO:0071953]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; microfibril [GO:0001527] g18181.t1 Q6ZWQ7 58.046 174 5.78e-68 207.0 sp|Q6ZWQ7|SPCS3_MOUSE Signal peptidase complex subunit 3 OS=Mus musculus OX=10090 GN=Spcs3 PE=1 SV=1 g18182.t1 A5D9H7 78.237 363 0.0 601.0 sp|A5D9H7|UBP12_BOVIN Ubiquitin carboxyl-terminal hydrolase 12 OS=Bos taurus OX=9913 GN=USP12 PE=2 SV=1 UBP12_BOVIN reviewed Ubiquitin carboxyl-terminal hydrolase 12 (EC 3.4.19.12) (Deubiquitinating enzyme 12) (Ubiquitin specific peptidase 12) (Ubiquitin thioesterase 12) (Ubiquitin-specific-processing protease 12) Bos taurus (Bovine) GO:0004197; GO:0004843; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0006508; GO:0016579; GO:0031647; GO:0046872 protein deubiquitination [GO:0016579]; proteolysis [GO:0006508]; regulation of protein stability [GO:0031647] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886] cysteine-type deubiquitinase activity [GO:0004843]; cysteine-type endopeptidase activity [GO:0004197]; metal ion binding [GO:0046872] g18183.t1 O09167 66.667 162 8.38e-67 203.0 sp|O09167|RL21_MOUSE Large ribosomal subunit protein eL21 OS=Mus musculus OX=10090 GN=Rpl21 PE=1 SV=4 g18184.t1 Q6UPE1 74.399 582 0.0 939.0 sp|Q6UPE1|ETFD_RAT Electron transfer flavoprotein-ubiquinone oxidoreductase, mitochondrial OS=Rattus norvegicus OX=10116 GN=Etfdh PE=1 SV=1 ETFD_RAT reviewed Electron transfer flavoprotein-ubiquinone oxidoreductase, mitochondrial (ETF-QO) (ETF-ubiquinone oxidoreductase) (EC 1.5.5.1) (Electron-transferring-flavoprotein dehydrogenase) (ETF dehydrogenase) Rattus norvegicus (Rat) GO:0004174; GO:0005654; GO:0005739; GO:0005743; GO:0005829; GO:0006979; GO:0009055; GO:0016020; GO:0016491; GO:0022900; GO:0031966; GO:0033539; GO:0046872; GO:0048038; GO:0048039; GO:0050660; GO:0051536; GO:0051539 electron transport chain [GO:0022900]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; response to oxidative stress [GO:0006979] cytosol [GO:0005829]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654] 4 iron, 4 sulfur cluster binding [GO:0051539]; electron transfer activity [GO:0009055]; electron-transferring-flavoprotein dehydrogenase activity [GO:0004174]; flavin adenine dinucleotide binding [GO:0050660]; iron-sulfur cluster binding [GO:0051536]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; quinone binding [GO:0048038]; ubiquinone binding [GO:0048039] g18186.t1 E7F587 50.0 332 1.05e-108 324.0 sp|E7F587|ZD20B_DANRE Palmitoyltransferase ZDHHC20-B OS=Danio rerio OX=7955 GN=zdhhc20b PE=3 SV=3 ZD20B_DANRE reviewed Palmitoyltransferase ZDHHC20-B (EC 2.3.1.225) (Acyltransferase ZDHHC20-B) (EC 2.3.1.-) (Zinc finger DHHC domain-containing protein 20-B) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000139; GO:0005783; GO:0005789; GO:0005794; GO:0005886; GO:0006612; GO:0016188; GO:0018345; GO:0019705; GO:0019706; GO:0033116; GO:0046872; GO:0048471; GO:0140439 protein palmitoylation [GO:0018345]; protein targeting to membrane [GO:0006612]; synaptic vesicle maturation [GO:0016188] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886] metal ion binding [GO:0046872]; protein-cysteine S-myristoyltransferase activity [GO:0019705]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]; protein-cysteine S-stearoyltransferase activity [GO:0140439] g18188.t1 P70582 59.162 382 3.58e-161 470.0 sp|P70582|NUP54_RAT Nuclear pore complex protein Nup54 OS=Rattus norvegicus OX=10116 GN=Nup54 PE=1 SV=1 g18189.t1 D4ACE5 34.388 948 8.02e-160 498.0 sp|D4ACE5|INTU_RAT Protein inturned OS=Rattus norvegicus OX=10116 GN=Intu PE=1 SV=1 INTU_RAT reviewed Protein inturned (Inturned planar cell polarity effector homolog) (PDZ domain-containing protein 6) Rattus norvegicus (Rat) GO:0001736; GO:0005737; GO:0005814; GO:0005829; GO:0005929; GO:0007399; GO:0008589; GO:0009986; GO:0010839; GO:0016192; GO:0021513; GO:0021915; GO:0030216; GO:0030278; GO:0031069; GO:0031514; GO:0035091; GO:0035869; GO:0036064; GO:0042733; GO:0043587; GO:0044458; GO:0045880; GO:0051782; GO:0060021; GO:0060173; GO:0060271; GO:1905515 cilium assembly [GO:0060271]; embryonic digit morphogenesis [GO:0042733]; establishment of planar polarity [GO:0001736]; hair follicle morphogenesis [GO:0031069]; keratinocyte differentiation [GO:0030216]; limb development [GO:0060173]; motile cilium assembly [GO:0044458]; negative regulation of cell division [GO:0051782]; negative regulation of keratinocyte proliferation [GO:0010839]; nervous system development [GO:0007399]; neural tube development [GO:0021915]; non-motile cilium assembly [GO:1905515]; positive regulation of smoothened signaling pathway [GO:0045880]; regulation of ossification [GO:0030278]; regulation of smoothened signaling pathway [GO:0008589]; roof of mouth development [GO:0060021]; spinal cord dorsal/ventral patterning [GO:0021513]; tongue morphogenesis [GO:0043587]; vesicle-mediated transport [GO:0016192] cell surface [GO:0009986]; centriole [GO:0005814]; ciliary basal body [GO:0036064]; ciliary transition zone [GO:0035869]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; motile cilium [GO:0031514] phosphatidylinositol binding [GO:0035091] g18191.t1 Q5DTY9 49.416 257 1.14e-66 215.0 sp|Q5DTY9|KCD16_MOUSE BTB/POZ domain-containing protein KCTD16 OS=Mus musculus OX=10090 GN=Kctd16 PE=1 SV=2 KCD16_MOUSE reviewed BTB/POZ domain-containing protein KCTD16 Mus musculus (Mouse) GO:0001662; GO:0007613; GO:0008277; GO:0042734; GO:0043235; GO:0045211; GO:0051260; GO:0099579; GO:0150047 behavioral fear response [GO:0001662]; memory [GO:0007613]; protein homooligomerization [GO:0051260]; regulation of G protein-coupled receptor signaling pathway [GO:0008277] postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; receptor complex [GO:0043235] G protein-coupled neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential [GO:0099579]; G protein-coupled neurotransmitter receptor activity involved in regulation of presynaptic membrane potential [GO:0150047] g18194.t1 Q6ZSM3 25.325 308 7.960000000000001e-21 98.2 sp|Q6ZSM3|MOT12_HUMAN Monocarboxylate transporter 12 OS=Homo sapiens OX=9606 GN=SLC16A12 PE=1 SV=3 MOT12_HUMAN reviewed Monocarboxylate transporter 12 (MCT 12) (Creatine transporter 2) (CRT2) (Solute carrier family 16 member 12) Homo sapiens (Human) GO:0005308; GO:0005886; GO:0015292; GO:0015881; GO:0016323; GO:0022857; GO:0046449; GO:0150104 creatine transmembrane transport [GO:0015881]; creatinine metabolic process [GO:0046449]; transport across blood-brain barrier [GO:0150104] basolateral plasma membrane [GO:0016323]; plasma membrane [GO:0005886] creatine transmembrane transporter activity [GO:0005308]; transmembrane transporter activity [GO:0022857]; uniporter activity [GO:0015292] g18197.t1 Q6ZSM3 25.974 308 1.17e-22 103.0 sp|Q6ZSM3|MOT12_HUMAN Monocarboxylate transporter 12 OS=Homo sapiens OX=9606 GN=SLC16A12 PE=1 SV=3 MOT12_HUMAN reviewed Monocarboxylate transporter 12 (MCT 12) (Creatine transporter 2) (CRT2) (Solute carrier family 16 member 12) Homo sapiens (Human) GO:0005308; GO:0005886; GO:0015292; GO:0015881; GO:0016323; GO:0022857; GO:0046449; GO:0150104 creatine transmembrane transport [GO:0015881]; creatinine metabolic process [GO:0046449]; transport across blood-brain barrier [GO:0150104] basolateral plasma membrane [GO:0016323]; plasma membrane [GO:0005886] creatine transmembrane transporter activity [GO:0005308]; transmembrane transporter activity [GO:0022857]; uniporter activity [GO:0015292] g18199.t1 Q6ZSM3 24.157 356 1.7099999999999998e-23 107.0 sp|Q6ZSM3|MOT12_HUMAN Monocarboxylate transporter 12 OS=Homo sapiens OX=9606 GN=SLC16A12 PE=1 SV=3 MOT12_HUMAN reviewed Monocarboxylate transporter 12 (MCT 12) (Creatine transporter 2) (CRT2) (Solute carrier family 16 member 12) Homo sapiens (Human) GO:0005308; GO:0005886; GO:0015292; GO:0015881; GO:0016323; GO:0022857; GO:0046449; GO:0150104 creatine transmembrane transport [GO:0015881]; creatinine metabolic process [GO:0046449]; transport across blood-brain barrier [GO:0150104] basolateral plasma membrane [GO:0016323]; plasma membrane [GO:0005886] creatine transmembrane transporter activity [GO:0005308]; transmembrane transporter activity [GO:0022857]; uniporter activity [GO:0015292] g18203.t1 Q6ZSM3 26.266 316 3.9200000000000006e-21 99.0 sp|Q6ZSM3|MOT12_HUMAN Monocarboxylate transporter 12 OS=Homo sapiens OX=9606 GN=SLC16A12 PE=1 SV=3 MOT12_HUMAN reviewed Monocarboxylate transporter 12 (MCT 12) (Creatine transporter 2) (CRT2) (Solute carrier family 16 member 12) Homo sapiens (Human) GO:0005308; GO:0005886; GO:0015292; GO:0015881; GO:0016323; GO:0022857; GO:0046449; GO:0150104 creatine transmembrane transport [GO:0015881]; creatinine metabolic process [GO:0046449]; transport across blood-brain barrier [GO:0150104] basolateral plasma membrane [GO:0016323]; plasma membrane [GO:0005886] creatine transmembrane transporter activity [GO:0005308]; transmembrane transporter activity [GO:0022857]; uniporter activity [GO:0015292] g18204.t1 A0JM13 36.416 1222 0.0 686.0 sp|A0JM13|C2CD3_XENTR C2 domain-containing protein 3 OS=Xenopus tropicalis OX=8364 GN=c2cd3 PE=2 SV=2 g18204.t1 A0JM13 47.977 173 5.75e-41 171.0 sp|A0JM13|C2CD3_XENTR C2 domain-containing protein 3 OS=Xenopus tropicalis OX=8364 GN=c2cd3 PE=2 SV=2 g18205.t1 F4ILY9 32.819 454 3.35e-59 203.0 sp|F4ILY9|AVT3B_ARATH Amino acid transporter AVT3B OS=Arabidopsis thaliana OX=3702 GN=AVT3B PE=2 SV=1 g18206.t1 Q9NVU7 58.084 668 0.0 721.0 sp|Q9NVU7|SDA1_HUMAN Protein SDA1 homolog OS=Homo sapiens OX=9606 GN=SDAD1 PE=1 SV=3 g18208.t1 A5D7K7 68.657 67 4.02e-25 96.3 sp|A5D7K7|YIPF7_BOVIN Protein YIPF7 OS=Bos taurus OX=9913 GN=YIPF7 PE=2 SV=1 g18209.t1 Q4R5M4 55.556 117 2.19e-22 93.6 sp|Q4R5M4|YIPF5_MACFA Protein YIPF5 OS=Macaca fascicularis OX=9541 GN=YIPF5 PE=2 SV=1 YIPF5_MACFA reviewed Protein YIPF5 (YIP1 family member 5) Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey) GO:0005654; GO:0005789; GO:0005802; GO:0006888; GO:0015031; GO:0030070; GO:0030134; GO:0048280; GO:0060628; GO:0070971 endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; insulin processing [GO:0030070]; protein transport [GO:0015031]; regulation of ER to Golgi vesicle-mediated transport [GO:0060628]; vesicle fusion with Golgi apparatus [GO:0048280] COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; nucleoplasm [GO:0005654]; trans-Golgi network [GO:0005802] g18210.t1 P51410 67.188 192 2.54e-96 280.0 sp|P51410|RL9_MOUSE Large ribosomal subunit protein uL6 OS=Mus musculus OX=10090 GN=Rpl9 PE=1 SV=2 RL9_MOUSE reviewed Large ribosomal subunit protein uL6 (60S ribosomal protein L9) Mus musculus (Mouse) GO:0002181; GO:0003735; GO:0005737; GO:0005829; GO:0005840; GO:0006412; GO:0019843; GO:0022625; GO:0022626; GO:0045202; GO:0098793; GO:0098794; GO:0140236; GO:0140242 cytoplasmic translation [GO:0002181]; translation [GO:0006412]; translation at postsynapse [GO:0140242]; translation at presynapse [GO:0140236] cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; postsynapse [GO:0098794]; presynapse [GO:0098793]; ribosome [GO:0005840]; synapse [GO:0045202] rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735] g18211.t1 Q6IQ85 56.19 210 4.6199999999999995e-84 253.0 sp|Q6IQ85|YIPF6_DANRE Protein YIPF6 OS=Danio rerio OX=7955 GN=yipf6 PE=2 SV=1 g18212.t1 Q8VHT7 43.609 266 5.07e-75 237.0 sp|Q8VHT7|TF3A_MOUSE Transcription factor IIIA OS=Mus musculus OX=10090 GN=Gtf3a PE=2 SV=2 g18223.t1 Q01664 43.431 274 8.710000000000001e-47 164.0 sp|Q01664|TFAP4_HUMAN Transcription factor AP-4 OS=Homo sapiens OX=9606 GN=TFAP4 PE=1 SV=2 TFAP4_HUMAN reviewed Transcription factor AP-4 (Activating enhancer-binding protein 4) (Class C basic helix-loop-helix protein 41) (bHLHc41) Homo sapiens (Human) GO:0000785; GO:0000976; GO:0000978; GO:0000981; GO:0001228; GO:0003677; GO:0005634; GO:0005654; GO:0005739; GO:0006357; GO:0008285; GO:0010629; GO:0017053; GO:0030330; GO:0042803; GO:0042826; GO:0043065; GO:0043392; GO:0043565; GO:0043922; GO:0043923; GO:0045736; GO:0045892; GO:0045893; GO:0065003; GO:0070888; GO:0071549; GO:1901990; GO:1990837 cellular response to dexamethasone stimulus [GO:0071549]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; host-mediated activation of viral transcription [GO:0043923]; host-mediated suppression of viral transcription [GO:0043922]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; negative regulation of DNA binding [GO:0043392]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of gene expression [GO:0010629]; positive regulation of apoptotic process [GO:0043065]; positive regulation of DNA-templated transcription [GO:0045893]; protein-containing complex assembly [GO:0065003]; regulation of mitotic cell cycle phase transition [GO:1901990]; regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053] DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; E-box binding [GO:0070888]; histone deacetylase binding [GO:0042826]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976] g18223.t2 Q01664 42.657 286 8.449999999999999e-48 166.0 sp|Q01664|TFAP4_HUMAN Transcription factor AP-4 OS=Homo sapiens OX=9606 GN=TFAP4 PE=1 SV=2 TFAP4_HUMAN reviewed Transcription factor AP-4 (Activating enhancer-binding protein 4) (Class C basic helix-loop-helix protein 41) (bHLHc41) Homo sapiens (Human) GO:0000785; GO:0000976; GO:0000978; GO:0000981; GO:0001228; GO:0003677; GO:0005634; GO:0005654; GO:0005739; GO:0006357; GO:0008285; GO:0010629; GO:0017053; GO:0030330; GO:0042803; GO:0042826; GO:0043065; GO:0043392; GO:0043565; GO:0043922; GO:0043923; GO:0045736; GO:0045892; GO:0045893; GO:0065003; GO:0070888; GO:0071549; GO:1901990; GO:1990837 cellular response to dexamethasone stimulus [GO:0071549]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; host-mediated activation of viral transcription [GO:0043923]; host-mediated suppression of viral transcription [GO:0043922]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; negative regulation of DNA binding [GO:0043392]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of gene expression [GO:0010629]; positive regulation of apoptotic process [GO:0043065]; positive regulation of DNA-templated transcription [GO:0045893]; protein-containing complex assembly [GO:0065003]; regulation of mitotic cell cycle phase transition [GO:1901990]; regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053] DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; E-box binding [GO:0070888]; histone deacetylase binding [GO:0042826]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976] g18224.t1 Q5XJQ5 59.654 347 3.41e-151 438.0 sp|Q5XJQ5|EXOS9_DANRE Exosome complex component RRP45 OS=Danio rerio OX=7955 GN=exosc9 PE=2 SV=1 EXOS9_DANRE reviewed Exosome complex component RRP45 (Exosome component 9) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000176; GO:0000177; GO:0000467; GO:0005654; GO:0005730; GO:0016075; GO:0034473; GO:0034475; GO:0034476; GO:0035925; GO:0071028; GO:0071035; GO:0071038 exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000467]; nuclear mRNA surveillance [GO:0071028]; nuclear polyadenylation-dependent rRNA catabolic process [GO:0071035]; rRNA catabolic process [GO:0016075]; TRAMP-dependent tRNA surveillance pathway [GO:0071038]; U1 snRNA 3'-end processing [GO:0034473]; U4 snRNA 3'-end processing [GO:0034475]; U5 snRNA 3'-end processing [GO:0034476] cytoplasmic exosome (RNase complex) [GO:0000177]; nuclear exosome (RNase complex) [GO:0000176]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654] mRNA 3'-UTR AU-rich region binding [GO:0035925] g18225.t1 Q24537 55.556 153 3.86e-49 167.0 sp|Q24537|HMG2_DROME High mobility group protein DSP1 OS=Drosophila melanogaster OX=7227 GN=Dsp1 PE=2 SV=1 HMG2_DROME reviewed High mobility group protein DSP1 (Protein dorsal switch 1) Drosophila melanogaster (Fruit fly) GO:0000122; GO:0003677; GO:0003697; GO:0005634; GO:0005654; GO:0005700; GO:0006338; GO:0007379; GO:0008301; GO:0008348; GO:0017025; GO:0017055; GO:0032502; GO:0035218; GO:0045892; GO:0140297 chromatin remodeling [GO:0006338]; developmental process [GO:0032502]; leg disc development [GO:0035218]; negative regulation of antimicrobial humoral response [GO:0008348]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of RNA polymerase II transcription preinitiation complex assembly [GO:0017055]; negative regulation of transcription by RNA polymerase II [GO:0000122]; segment specification [GO:0007379] nucleoplasm [GO:0005654]; nucleus [GO:0005634]; polytene chromosome [GO:0005700] DNA binding [GO:0003677]; DNA binding, bending [GO:0008301]; DNA-binding transcription factor binding [GO:0140297]; single-stranded DNA binding [GO:0003697]; TBP-class protein binding [GO:0017025] g18226.t1 Q24537 54.651 172 8.46e-49 166.0 sp|Q24537|HMG2_DROME High mobility group protein DSP1 OS=Drosophila melanogaster OX=7227 GN=Dsp1 PE=2 SV=1 HMG2_DROME reviewed High mobility group protein DSP1 (Protein dorsal switch 1) Drosophila melanogaster (Fruit fly) GO:0000122; GO:0003677; GO:0003697; GO:0005634; GO:0005654; GO:0005700; GO:0006338; GO:0007379; GO:0008301; GO:0008348; GO:0017025; GO:0017055; GO:0032502; GO:0035218; GO:0045892; GO:0140297 chromatin remodeling [GO:0006338]; developmental process [GO:0032502]; leg disc development [GO:0035218]; negative regulation of antimicrobial humoral response [GO:0008348]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of RNA polymerase II transcription preinitiation complex assembly [GO:0017055]; negative regulation of transcription by RNA polymerase II [GO:0000122]; segment specification [GO:0007379] nucleoplasm [GO:0005654]; nucleus [GO:0005634]; polytene chromosome [GO:0005700] DNA binding [GO:0003677]; DNA binding, bending [GO:0008301]; DNA-binding transcription factor binding [GO:0140297]; single-stranded DNA binding [GO:0003697]; TBP-class protein binding [GO:0017025] g18227.t1 Q6NYV5 68.333 180 1.3800000000000002e-85 252.0 sp|Q6NYV5|SP30L_DANRE Histone deacetylase complex subunit SAP30L OS=Danio rerio OX=7955 GN=sap30l PE=1 SV=1 SP30L_DANRE reviewed Histone deacetylase complex subunit SAP30L (Sin3 corepressor complex subunit SAP30L) (Sin3-associated protein p30-like) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000118; GO:0000122; GO:0001947; GO:0003677; GO:0003712; GO:0005730; GO:0006355; GO:0008270; GO:0010314; GO:0031491; GO:0032266; GO:0042393; GO:0044378; GO:0070273 heart looping [GO:0001947]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of DNA-templated transcription [GO:0006355] histone deacetylase complex [GO:0000118]; nucleolus [GO:0005730] DNA binding [GO:0003677]; histone binding [GO:0042393]; non-sequence-specific DNA binding, bending [GO:0044378]; nucleosome binding [GO:0031491]; phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol-4-phosphate binding [GO:0070273]; phosphatidylinositol-5-phosphate binding [GO:0010314]; transcription coregulator activity [GO:0003712]; zinc ion binding [GO:0008270] g18227.t2 Q6NYV5 71.098 173 3.51e-88 258.0 sp|Q6NYV5|SP30L_DANRE Histone deacetylase complex subunit SAP30L OS=Danio rerio OX=7955 GN=sap30l PE=1 SV=1 SP30L_DANRE reviewed Histone deacetylase complex subunit SAP30L (Sin3 corepressor complex subunit SAP30L) (Sin3-associated protein p30-like) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000118; GO:0000122; GO:0001947; GO:0003677; GO:0003712; GO:0005730; GO:0006355; GO:0008270; GO:0010314; GO:0031491; GO:0032266; GO:0042393; GO:0044378; GO:0070273 heart looping [GO:0001947]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of DNA-templated transcription [GO:0006355] histone deacetylase complex [GO:0000118]; nucleolus [GO:0005730] DNA binding [GO:0003677]; histone binding [GO:0042393]; non-sequence-specific DNA binding, bending [GO:0044378]; nucleosome binding [GO:0031491]; phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol-4-phosphate binding [GO:0070273]; phosphatidylinositol-5-phosphate binding [GO:0010314]; transcription coregulator activity [GO:0003712]; zinc ion binding [GO:0008270] g18229.t1 Q9BZE0 64.773 176 2.96e-78 253.0 sp|Q9BZE0|GLIS2_HUMAN Zinc finger protein GLIS2 OS=Homo sapiens OX=9606 GN=GLIS2 PE=1 SV=2 GLIS2_HUMAN reviewed Zinc finger protein GLIS2 (GLI-similar 2) (Neuronal Krueppel-like protein) Homo sapiens (Human) GO:0000122; GO:0000976; GO:0000978; GO:0000981; GO:0001227; GO:0001228; GO:0005634; GO:0005654; GO:0005737; GO:0007417; GO:0008270; GO:0016607; GO:0045879; GO:0045892; GO:0045893; GO:0045944; GO:0061005; GO:0061484; GO:0097730; GO:1900182; GO:1990837 cell differentiation involved in kidney development [GO:0061005]; central nervous system development [GO:0007417]; hematopoietic stem cell homeostasis [GO:0061484]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of smoothened signaling pathway [GO:0045879]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of transcription by RNA polymerase II [GO:0045944] cytoplasm [GO:0005737]; non-motile cilium [GO:0097730]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]; zinc ion binding [GO:0008270] g18230.t1 Q6NTU3 65.455 110 1.64e-39 132.0 sp|Q6NTU3|TI16A_XENLA Mitochondrial import inner membrane translocase subunit tim16-A OS=Xenopus laevis OX=8355 GN=pam16-a PE=2 SV=1 g18231.t1 Q8AVS8 66.443 149 1.75e-62 202.0 sp|Q8AVS8|LRC59_XENLA Leucine-rich repeat-containing protein 59 OS=Xenopus laevis OX=8355 GN=lrrc59 PE=2 SV=1 g18232.t1 Q9JLG8 43.556 838 0.0 687.0 sp|Q9JLG8|CAN15_MOUSE Calpain-15 OS=Mus musculus OX=10090 GN=Capn15 PE=1 SV=1 g18233.t1 Q9EQH1 47.826 115 4.03e-28 124.0 sp|Q9EQH1|GAB2_RAT GRB2-associated-binding protein 2 OS=Rattus norvegicus OX=10116 GN=Gab2 PE=1 SV=2 GAB2_RAT reviewed GRB2-associated-binding protein 2 (GRB2-associated binder 2) (Growth factor receptor bound protein 2-associated protein 2) Rattus norvegicus (Rat) GO:0005068; GO:0005547; GO:0005737; GO:0005886; GO:0007165; GO:0007229; GO:0008284; GO:0010634; GO:0016477; GO:0019903; GO:0019904; GO:0030316; GO:0032991; GO:0035556; GO:0043306; GO:0043325; GO:0043491; GO:0045121 cell migration [GO:0016477]; integrin-mediated signaling pathway [GO:0007229]; intracellular signal transduction [GO:0035556]; osteoclast differentiation [GO:0030316]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of mast cell degranulation [GO:0043306]; signal transduction [GO:0007165] cytoplasm [GO:0005737]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; protein domain specific binding [GO:0019904]; protein phosphatase binding [GO:0019903]; transmembrane receptor protein tyrosine kinase adaptor activity [GO:0005068] g18235.t1 Q8LFQ6 43.689 103 5.25e-22 87.0 sp|Q8LFQ6|GRXC4_ARATH Glutaredoxin-C4 OS=Arabidopsis thaliana OX=3702 GN=GRXC4 PE=2 SV=2 g18236.t1 Q96H96 59.866 299 3.48e-128 382.0 sp|Q96H96|COQ2_HUMAN 4-hydroxybenzoate polyprenyltransferase, mitochondrial OS=Homo sapiens OX=9606 GN=COQ2 PE=1 SV=2 COQ2_HUMAN reviewed 4-hydroxybenzoate polyprenyltransferase, mitochondrial (4-HB polyprenyltransferase) (EC 2.5.1.39) (4-hydroxybenzoate decaprenyltransferase) (COQ2 homolog) (hCOQ2) (Para-hydroxybenzoate--polyprenyltransferase) (PHB:PPT) (PHB:polyprenyltransferase) Homo sapiens (Human) GO:0004659; GO:0005739; GO:0005743; GO:0006071; GO:0006744; GO:0008299; GO:0008412; GO:0031314 glycerol metabolic process [GO:0006071]; isoprenoid biosynthetic process [GO:0008299]; ubiquinone biosynthetic process [GO:0006744] extrinsic component of mitochondrial inner membrane [GO:0031314]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739] 4-hydroxybenzoate polyprenyltransferase activity [GO:0008412]; prenyltransferase activity [GO:0004659] g18237.t1 Q6P1H6 38.64 559 4.65e-100 338.0 sp|Q6P1H6|ANKL2_MOUSE Ankyrin repeat and LEM domain-containing protein 2 OS=Mus musculus OX=10090 GN=Ankle2 PE=1 SV=2 ANKL2_MOUSE reviewed Ankyrin repeat and LEM domain-containing protein 2 (LEM domain-containing protein 4) Mus musculus (Mouse) GO:0004860; GO:0005783; GO:0005789; GO:0007084; GO:0007417; GO:0042326; GO:0043066; GO:0051301; GO:0051721 cell division [GO:0051301]; central nervous system development [GO:0007417]; mitotic nuclear membrane reassembly [GO:0007084]; negative regulation of apoptotic process [GO:0043066]; negative regulation of phosphorylation [GO:0042326] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789] protein kinase inhibitor activity [GO:0004860]; protein phosphatase 2A binding [GO:0051721] g18247.t1 Q9C0D6 39.348 399 3.3e-76 276.0 sp|Q9C0D6|FHDC1_HUMAN FH2 domain-containing protein 1 OS=Homo sapiens OX=9606 GN=FHDC1 PE=1 SV=2 FHDC1_HUMAN reviewed FH2 domain-containing protein 1 (Inverted formin-1) Homo sapiens (Human) GO:0003779; GO:0005794; GO:0005874; GO:0005881; GO:0005884; GO:0005929; GO:0008017; GO:0030041; GO:0043149; GO:0060271; GO:0090161 actin filament polymerization [GO:0030041]; cilium assembly [GO:0060271]; Golgi ribbon formation [GO:0090161]; stress fiber assembly [GO:0043149] actin filament [GO:0005884]; cilium [GO:0005929]; cytoplasmic microtubule [GO:0005881]; Golgi apparatus [GO:0005794]; microtubule [GO:0005874] actin binding [GO:0003779]; microtubule binding [GO:0008017] g18247.t2 Q9C0D6 39.109 404 1.4000000000000001e-80 288.0 sp|Q9C0D6|FHDC1_HUMAN FH2 domain-containing protein 1 OS=Homo sapiens OX=9606 GN=FHDC1 PE=1 SV=2 FHDC1_HUMAN reviewed FH2 domain-containing protein 1 (Inverted formin-1) Homo sapiens (Human) GO:0003779; GO:0005794; GO:0005874; GO:0005881; GO:0005884; GO:0005929; GO:0008017; GO:0030041; GO:0043149; GO:0060271; GO:0090161 actin filament polymerization [GO:0030041]; cilium assembly [GO:0060271]; Golgi ribbon formation [GO:0090161]; stress fiber assembly [GO:0043149] actin filament [GO:0005884]; cilium [GO:0005929]; cytoplasmic microtubule [GO:0005881]; Golgi apparatus [GO:0005794]; microtubule [GO:0005874] actin binding [GO:0003779]; microtubule binding [GO:0008017] g18248.t1 Q0GNC1 47.183 142 1.6100000000000002e-33 131.0 sp|Q0GNC1|INF2_MOUSE Inverted formin-2 OS=Mus musculus OX=10090 GN=Inf2 PE=1 SV=1 INF2_MOUSE reviewed Inverted formin-2 Mus musculus (Mouse) GO:0003779; GO:0010467; GO:0031267; GO:0032535; GO:0045010; GO:0048471; GO:0090140 actin nucleation [GO:0045010]; gene expression [GO:0010467]; regulation of cellular component size [GO:0032535]; regulation of mitochondrial fission [GO:0090140] perinuclear region of cytoplasm [GO:0048471] actin binding [GO:0003779]; small GTPase binding [GO:0031267] g18256.t1 Q6XPS3 44.286 420 4.52e-108 337.0 sp|Q6XPS3|TPTE2_HUMAN Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase TPTE2 OS=Homo sapiens OX=9606 GN=TPTE2 PE=1 SV=2 TPTE2_HUMAN reviewed Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase TPTE2 (EC 3.1.3.67) (Lipid phosphatase TPIP) (TPTE and PTEN homologous inositol lipid phosphatase) Homo sapiens (Human) GO:0000139; GO:0005216; GO:0005737; GO:0005789; GO:0005829; GO:0006661; GO:0016314; GO:0051800 phosphatidylinositol biosynthetic process [GO:0006661] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139] monoatomic ion channel activity [GO:0005216]; phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity [GO:0016314]; phosphatidylinositol-3,4-bisphosphate 3-phosphatase activity [GO:0051800] g18259.t1 Q8WWI1 52.941 136 6.37e-34 147.0 sp|Q8WWI1|LMO7_HUMAN LIM domain only protein 7 OS=Homo sapiens OX=9606 GN=LMO7 PE=1 SV=3 LMO7_HUMAN reviewed LIM domain only protein 7 (LMO-7) (F-box only protein 20) (LOMP) Homo sapiens (Human) GO:0000151; GO:0004842; GO:0005634; GO:0005635; GO:0005737; GO:0005739; GO:0005829; GO:0005925; GO:0009986; GO:0016324; GO:0016567; GO:0023051; GO:0030155; GO:0045944; GO:0046872 positive regulation of transcription by RNA polymerase II [GO:0045944]; protein ubiquitination [GO:0016567]; regulation of cell adhesion [GO:0030155]; regulation of signaling [GO:0023051] apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; mitochondrion [GO:0005739]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151] metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842] g18259.t2 Q8WWI1 52.941 136 6.37e-34 147.0 sp|Q8WWI1|LMO7_HUMAN LIM domain only protein 7 OS=Homo sapiens OX=9606 GN=LMO7 PE=1 SV=3 LMO7_HUMAN reviewed LIM domain only protein 7 (LMO-7) (F-box only protein 20) (LOMP) Homo sapiens (Human) GO:0000151; GO:0004842; GO:0005634; GO:0005635; GO:0005737; GO:0005739; GO:0005829; GO:0005925; GO:0009986; GO:0016324; GO:0016567; GO:0023051; GO:0030155; GO:0045944; GO:0046872 positive regulation of transcription by RNA polymerase II [GO:0045944]; protein ubiquitination [GO:0016567]; regulation of cell adhesion [GO:0030155]; regulation of signaling [GO:0023051] apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; mitochondrion [GO:0005739]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151] metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842] g18259.t3 Q8WWI1 52.941 136 6.02e-34 147.0 sp|Q8WWI1|LMO7_HUMAN LIM domain only protein 7 OS=Homo sapiens OX=9606 GN=LMO7 PE=1 SV=3 LMO7_HUMAN reviewed LIM domain only protein 7 (LMO-7) (F-box only protein 20) (LOMP) Homo sapiens (Human) GO:0000151; GO:0004842; GO:0005634; GO:0005635; GO:0005737; GO:0005739; GO:0005829; GO:0005925; GO:0009986; GO:0016324; GO:0016567; GO:0023051; GO:0030155; GO:0045944; GO:0046872 positive regulation of transcription by RNA polymerase II [GO:0045944]; protein ubiquitination [GO:0016567]; regulation of cell adhesion [GO:0030155]; regulation of signaling [GO:0023051] apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; mitochondrion [GO:0005739]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151] metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842] g18259.t4 Q8WWI1 52.941 136 8.19e-34 147.0 sp|Q8WWI1|LMO7_HUMAN LIM domain only protein 7 OS=Homo sapiens OX=9606 GN=LMO7 PE=1 SV=3 LMO7_HUMAN reviewed LIM domain only protein 7 (LMO-7) (F-box only protein 20) (LOMP) Homo sapiens (Human) GO:0000151; GO:0004842; GO:0005634; GO:0005635; GO:0005737; GO:0005739; GO:0005829; GO:0005925; GO:0009986; GO:0016324; GO:0016567; GO:0023051; GO:0030155; GO:0045944; GO:0046872 positive regulation of transcription by RNA polymerase II [GO:0045944]; protein ubiquitination [GO:0016567]; regulation of cell adhesion [GO:0030155]; regulation of signaling [GO:0023051] apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; mitochondrion [GO:0005739]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151] metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842] g18264.t1 Q8N442 64.219 640 0.0 857.0 sp|Q8N442|GUF1_HUMAN Translation factor GUF1, mitochondrial OS=Homo sapiens OX=9606 GN=GUF1 PE=1 SV=1 g18265.t1 E2QUI9 55.39 269 4.73e-106 316.0 sp|E2QUI9|NNRD_CANLF ATP-dependent (S)-NAD(P)H-hydrate dehydratase OS=Canis lupus familiaris OX=9615 GN=NAXD PE=3 SV=1 g18268.t1 Q9WVA1 58.904 73 1.8800000000000002e-27 99.0 sp|Q9WVA1|TIM8A_RAT Mitochondrial import inner membrane translocase subunit Tim8 A OS=Rattus norvegicus OX=10116 GN=Timm8a PE=1 SV=1 g18269.t1 P53367 61.355 251 1.3999999999999999e-114 336.0 sp|P53367|ARFP1_HUMAN Arfaptin-1 OS=Homo sapiens OX=9606 GN=ARFIP1 PE=1 SV=2 ARFP1_HUMAN reviewed Arfaptin-1 (ADP-ribosylation factor-interacting protein 1) Homo sapiens (Human) GO:0000139; GO:0005543; GO:0005829; GO:0006886; GO:0019904; GO:0032588; GO:0034315; GO:0050708; GO:0070273; GO:1905280 intracellular protein transport [GO:0006886]; negative regulation of retrograde transport, endosome to Golgi [GO:1905280]; regulation of Arp2/3 complex-mediated actin nucleation [GO:0034315]; regulation of protein secretion [GO:0050708] cytosol [GO:0005829]; Golgi membrane [GO:0000139]; trans-Golgi network membrane [GO:0032588] phosphatidylinositol-4-phosphate binding [GO:0070273]; phospholipid binding [GO:0005543]; protein domain specific binding [GO:0019904] g18276.t1 G5EBX9 47.393 633 0.0 618.0 sp|G5EBX9|PPE_CAEEL Serine/threonine-protein phosphatase with EF-hands pef-1 OS=Caenorhabditis elegans OX=6239 GN=pef-1 PE=1 SV=1 PPE_CAEEL reviewed Serine/threonine-protein phosphatase with EF-hands pef-1 (CePPEF) (EC 3.1.3.16) (Phosphatase with EF hands 1) Caenorhabditis elegans GO:0004722; GO:0005506; GO:0005509; GO:0005634; GO:0005829; GO:0005886; GO:0005929; GO:0030145; GO:0030424; GO:0030425; GO:0043025; GO:0043204; GO:0050906 detection of stimulus involved in sensory perception [GO:0050906] axon [GO:0030424]; cilium [GO:0005929]; cytosol [GO:0005829]; dendrite [GO:0030425]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; perikaryon [GO:0043204]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; iron ion binding [GO:0005506]; manganese ion binding [GO:0030145]; protein serine/threonine phosphatase activity [GO:0004722] g18277.t1 Q9P2J5 63.413 1178 0.0 1501.0 sp|Q9P2J5|SYLC_HUMAN Leucine--tRNA ligase, cytoplasmic OS=Homo sapiens OX=9606 GN=LARS1 PE=1 SV=2 SYLC_HUMAN reviewed Leucine--tRNA ligase, cytoplasmic (EC 6.1.1.4) (Leucyl-tRNA synthetase) (LeuRS) (cLRS) Homo sapiens (Human) GO:0002161; GO:0004819; GO:0004823; GO:0005096; GO:0005524; GO:0005737; GO:0005764; GO:0005783; GO:0005829; GO:0006418; GO:0006425; GO:0006429; GO:0012505; GO:0016604; GO:0017101; GO:0034198; GO:0071230; GO:0071233; GO:1904263; GO:1990253 cellular response to amino acid starvation [GO:0034198]; cellular response to amino acid stimulus [GO:0071230]; cellular response to L-leucine [GO:0071233]; cellular response to leucine starvation [GO:1990253]; glutaminyl-tRNA aminoacylation [GO:0006425]; leucyl-tRNA aminoacylation [GO:0006429]; positive regulation of TORC1 signaling [GO:1904263]; tRNA aminoacylation for protein translation [GO:0006418] aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; lysosome [GO:0005764]; nuclear body [GO:0016604] aminoacyl-tRNA deacylase activity [GO:0002161]; ATP binding [GO:0005524]; glutamine-tRNA ligase activity [GO:0004819]; GTPase activator activity [GO:0005096]; leucine-tRNA ligase activity [GO:0004823] g18278.t1 P96202 26.722 2309 7.42e-170 584.0 sp|P96202|PPSC_MYCTU Phenolphthiocerol/phthiocerol polyketide synthase subunit C OS=Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv) OX=83332 GN=ppsC PE=1 SV=2 g18279.t1 A5PKL6 36.591 440 6.68e-90 297.0 sp|A5PKL6|GSTCD_BOVIN Glutathione S-transferase C-terminal domain-containing protein OS=Bos taurus OX=9913 GN=GSTCD PE=2 SV=1 g18280.t1 O54873 42.953 298 1.85e-67 224.0 sp|O54873|AIMP1_CRIGR Aminoacyl tRNA synthase complex-interacting multifunctional protein 1 OS=Cricetulus griseus OX=10029 GN=AIMP1 PE=2 SV=1 g18287.t1 O54799 37.7 313 8.299999999999999e-45 162.0 sp|O54799|NMBR_MOUSE Neuromedin-B receptor OS=Mus musculus OX=10090 GN=Nmbr PE=1 SV=1 g18291.t1 Q96IG2 29.0 300 4.05e-25 107.0 sp|Q96IG2|FXL20_HUMAN F-box/LRR-repeat protein 20 OS=Homo sapiens OX=9606 GN=FBXL20 PE=1 SV=2 g18293.t1 Q13586 50.0 426 6.969999999999999e-147 446.0 sp|Q13586|STIM1_HUMAN Stromal interaction molecule 1 OS=Homo sapiens OX=9606 GN=STIM1 PE=1 SV=3 g18294.t1 Q80VJ2 35.407 209 1.1800000000000001e-26 108.0 sp|Q80VJ2|SRA1_MOUSE Steroid receptor RNA activator 1 OS=Mus musculus OX=10090 GN=Sra1 PE=1 SV=4 SRA1_MOUSE reviewed Steroid receptor RNA activator 1 (Steroid receptor RNA activator protein) (SRAP) Mus musculus (Mouse) GO:0002153; GO:0003713; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0005929; GO:0006357; GO:0006915; GO:0015630; GO:0045171; GO:0045662; GO:0045944; GO:1990904 apoptotic process [GO:0006915]; negative regulation of myoblast differentiation [GO:0045662]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357] cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intercellular bridge [GO:0045171]; microtubule cytoskeleton [GO:0015630]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ribonucleoprotein complex [GO:1990904] steroid receptor RNA activator RNA binding [GO:0002153]; transcription coactivator activity [GO:0003713] g18295.t1 P27615 36.968 376 3.79e-83 267.0 sp|P27615|SCRB2_RAT Lysosome membrane protein 2 OS=Rattus norvegicus OX=10116 GN=Scarb2 PE=1 SV=2 SCRB2_RAT reviewed Lysosome membrane protein 2 (85 kDa lysosomal membrane sialoglycoprotein) (LGP85) (CD36 antigen-like 2) (Lysosome membrane protein II) (LIMP II) (Scavenger receptor class B member 2) (CD antigen CD36) Rattus norvegicus (Rat) GO:0001786; GO:0005044; GO:0005765; GO:0005886; GO:0006622; GO:0006898; GO:0006914; GO:0007605; GO:0010976; GO:0015485; GO:0015917; GO:0019899; GO:0030666; GO:0031210; GO:0038024; GO:0042803; GO:0043202; GO:0043470; GO:0051087; GO:0099638 aminophospholipid transport [GO:0015917]; autophagy [GO:0006914]; endosome to plasma membrane protein transport [GO:0099638]; positive regulation of neuron projection development [GO:0010976]; protein targeting to lysosome [GO:0006622]; receptor-mediated endocytosis [GO:0006898]; regulation of carbohydrate catabolic process [GO:0043470]; sensory perception of sound [GO:0007605] endocytic vesicle membrane [GO:0030666]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886] cargo receptor activity [GO:0038024]; cholesterol binding [GO:0015485]; enzyme binding [GO:0019899]; phosphatidylcholine binding [GO:0031210]; phosphatidylserine binding [GO:0001786]; protein homodimerization activity [GO:0042803]; protein-folding chaperone binding [GO:0051087]; scavenger receptor activity [GO:0005044] g18295.t2 P27615 36.968 376 3.79e-83 266.0 sp|P27615|SCRB2_RAT Lysosome membrane protein 2 OS=Rattus norvegicus OX=10116 GN=Scarb2 PE=1 SV=2 SCRB2_RAT reviewed Lysosome membrane protein 2 (85 kDa lysosomal membrane sialoglycoprotein) (LGP85) (CD36 antigen-like 2) (Lysosome membrane protein II) (LIMP II) (Scavenger receptor class B member 2) (CD antigen CD36) Rattus norvegicus (Rat) GO:0001786; GO:0005044; GO:0005765; GO:0005886; GO:0006622; GO:0006898; GO:0006914; GO:0007605; GO:0010976; GO:0015485; GO:0015917; GO:0019899; GO:0030666; GO:0031210; GO:0038024; GO:0042803; GO:0043202; GO:0043470; GO:0051087; GO:0099638 aminophospholipid transport [GO:0015917]; autophagy [GO:0006914]; endosome to plasma membrane protein transport [GO:0099638]; positive regulation of neuron projection development [GO:0010976]; protein targeting to lysosome [GO:0006622]; receptor-mediated endocytosis [GO:0006898]; regulation of carbohydrate catabolic process [GO:0043470]; sensory perception of sound [GO:0007605] endocytic vesicle membrane [GO:0030666]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886] cargo receptor activity [GO:0038024]; cholesterol binding [GO:0015485]; enzyme binding [GO:0019899]; phosphatidylcholine binding [GO:0031210]; phosphatidylserine binding [GO:0001786]; protein homodimerization activity [GO:0042803]; protein-folding chaperone binding [GO:0051087]; scavenger receptor activity [GO:0005044] g18296.t1 Q03041 59.174 605 0.0 620.0 sp|Q03041|CNGA2_BOVIN Cyclic nucleotide-gated channel alpha-2 OS=Bos taurus OX=9913 GN=CNGA2 PE=1 SV=1 CNGA2_BOVIN reviewed Cyclic nucleotide-gated channel alpha-2 (CNG channel alpha-2) (CNG-2) (CNG2) (Cyclic nucleotide-gated channel alpha 3) (CNCalpha3) (CNGa3) (Olfactory cyclic nucleotide-gated channel subunit 1) (OCNC1) Bos taurus (Bovine) GO:0005216; GO:0005222; GO:0005223; GO:0005262; GO:0005516; GO:0005886; GO:0006813; GO:0006814; GO:0006816; GO:0007606; GO:0007608; GO:0017071; GO:0030552; GO:0030553; GO:0098655; GO:0098804 calcium ion transport [GO:0006816]; monoatomic cation transmembrane transport [GO:0098655]; potassium ion transport [GO:0006813]; sensory perception of chemical stimulus [GO:0007606]; sensory perception of smell [GO:0007608]; sodium ion transport [GO:0006814] intracellular cyclic nucleotide activated cation channel complex [GO:0017071]; non-motile cilium membrane [GO:0098804]; plasma membrane [GO:0005886] calcium channel activity [GO:0005262]; calmodulin binding [GO:0005516]; cAMP binding [GO:0030552]; cGMP binding [GO:0030553]; intracellularly cAMP-activated cation channel activity [GO:0005222]; intracellularly cGMP-activated cation channel activity [GO:0005223]; monoatomic ion channel activity [GO:0005216] g18297.t1 G5E8F4 35.774 601 6.439999999999999e-104 328.0 sp|G5E8F4|FPGT_MOUSE Fucose-1-phosphate guanylyltransferase OS=Mus musculus OX=10090 GN=Fpgt PE=1 SV=1 g18298.t1 Q13887 81.818 99 6.13e-55 191.0 sp|Q13887|KLF5_HUMAN Krueppel-like factor 5 OS=Homo sapiens OX=9606 GN=KLF5 PE=1 SV=2 KLF5_HUMAN reviewed Krueppel-like factor 5 (Basic transcription element-binding protein 2) (BTE-binding protein 2) (Colon krueppel-like factor) (GC-box-binding protein 2) (Intestinal-enriched krueppel-like factor) (Transcription factor BTEB2) Homo sapiens (Human) GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0001525; GO:0005654; GO:0005667; GO:0005794; GO:0006357; GO:0008270; GO:0008284; GO:0014816; GO:0014901; GO:0014908; GO:0030033; GO:0032534; GO:0043426; GO:0045600; GO:0045944; GO:0060576; GO:0061586; GO:1990830; GO:1990837; GO:1990859 angiogenesis [GO:0001525]; cellular response to endothelin [GO:1990859]; cellular response to leukemia inhibitory factor [GO:1990830]; intestinal epithelial cell development [GO:0060576]; microvillus assembly [GO:0030033]; myotube differentiation involved in skeletal muscle regeneration [GO:0014908]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription by transcription factor localization [GO:0061586]; regulation of microvillus assembly [GO:0032534]; regulation of transcription by RNA polymerase II [GO:0006357]; satellite cell activation involved in skeletal muscle regeneration [GO:0014901]; skeletal muscle satellite cell differentiation [GO:0014816] chromatin [GO:0000785]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; transcription regulator complex [GO:0005667] DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; MRF binding [GO:0043426]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; zinc ion binding [GO:0008270] g18300.t1 B1H120 74.568 405 0.0 638.0 sp|B1H120|SEPT8_XENTR Septin-8 OS=Xenopus tropicalis OX=8364 GN=septin8 PE=2 SV=1 g18301.t1 Q5U317 37.273 220 4.4099999999999993e-23 107.0 sp|Q5U317|FIP1_RAT Pre-mRNA 3'-end-processing factor FIP1 OS=Rattus norvegicus OX=10116 GN=Fip1l1 PE=1 SV=1 g18303.t1 A4IHW6 80.899 267 6.44e-171 476.0 sp|A4IHW6|GNPI2_XENTR Glucosamine-6-phosphate deaminase 2 OS=Xenopus tropicalis OX=8364 GN=gnpda2 PE=2 SV=1 g18304.t1 Q62066 89.855 69 1.26e-36 133.0 sp|Q62066|PHX2A_MOUSE Paired mesoderm homeobox protein 2A OS=Mus musculus OX=10090 GN=Phox2a PE=2 SV=1 PHX2A_MOUSE reviewed Paired mesoderm homeobox protein 2A (Aristaless homeobox protein homolog) (PHOX2A homeodomain protein) (Paired-like homeobox 2A) Mus musculus (Mouse) GO:0000785; GO:0000977; GO:0000978; GO:0000981; GO:0001228; GO:0003357; GO:0005634; GO:0006357; GO:0021523; GO:0021623; GO:0021642; GO:0021703; GO:0030901; GO:0043576; GO:0045944; GO:0048485; GO:0048486; GO:0048666; GO:1990837 locus ceruleus development [GO:0021703]; midbrain development [GO:0030901]; neuron development [GO:0048666]; noradrenergic neuron differentiation [GO:0003357]; oculomotor nerve formation [GO:0021623]; parasympathetic nervous system development [GO:0048486]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of respiratory gaseous exchange [GO:0043576]; regulation of transcription by RNA polymerase II [GO:0006357]; somatic motor neuron differentiation [GO:0021523]; sympathetic nervous system development [GO:0048485]; trochlear nerve formation [GO:0021642] chromatin [GO:0000785]; nucleus [GO:0005634] DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837] g18306.t1 Q5E9N5 64.499 569 0.0 706.0 sp|Q5E9N5|CLPB_BOVIN Mitochondrial disaggregase OS=Bos taurus OX=9913 GN=CLPB PE=2 SV=1 CLPB_BOVIN reviewed Mitochondrial disaggregase (EC 3.6.1.-) (Suppressor of potassium transport defect 3) [Cleaved into: Mitochondrial disaggregase, cleaved form] Bos taurus (Bovine) GO:0005524; GO:0005737; GO:0005739; GO:0005758; GO:0016887; GO:0034605 cellular response to heat [GO:0034605] cytoplasm [GO:0005737]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887] g18316.t1 Q9NWY4 53.722 309 4.88e-122 361.0 sp|Q9NWY4|HPF1_HUMAN Histone PARylation factor 1 OS=Homo sapiens OX=9606 GN=HPF1 PE=1 SV=2 HPF1_HUMAN reviewed Histone PARylation factor 1 Homo sapiens (Human) GO:0000785; GO:0003682; GO:0005634; GO:0006281; GO:0006302; GO:0006974; GO:0010835; GO:0042393; GO:0072572; GO:0090734; GO:0140768; GO:0140861 DNA damage response [GO:0006974]; DNA repair [GO:0006281]; DNA repair-dependent chromatin remodeling [GO:0140861]; double-strand break repair [GO:0006302]; regulation of protein ADP-ribosylation [GO:0010835] chromatin [GO:0000785]; nucleus [GO:0005634]; site of DNA damage [GO:0090734] chromatin binding [GO:0003682]; histone binding [GO:0042393]; poly-ADP-D-ribose binding [GO:0072572]; protein ADP-ribosyltransferase-substrate adaptor activity [GO:0140768] g18317.t1 Q0VFH6 56.742 178 1.1099999999999999e-67 211.0 sp|Q0VFH6|RM22_XENTR Large ribosomal subunit protein uL22m OS=Xenopus tropicalis OX=8364 GN=mrpl22 PE=2 SV=1 g18320.t1 Q6DIN3 41.648 437 3.05e-98 333.0 sp|Q6DIN3|MBTD1_XENTR MBT domain-containing protein 1 OS=Xenopus tropicalis OX=8364 GN=mbtd1 PE=2 SV=1 g18321.t1 Q5F457 57.5 80 3.89e-23 101.0 sp|Q5F457|WBP4_CHICK WW domain-binding protein 4 OS=Gallus gallus OX=9031 GN=WBP4 PE=2 SV=1 WBP4_CHICK reviewed WW domain-binding protein 4 (WBP-4) Gallus gallus (Chicken) GO:0000398; GO:0003676; GO:0005634; GO:0008270; GO:0016607; GO:0071005 mRNA splicing, via spliceosome [GO:0000398] nuclear speck [GO:0016607]; nucleus [GO:0005634]; U2-type precatalytic spliceosome [GO:0071005] nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270] g18322.t1 Q7TMR0 57.282 206 3e-82 255.0 sp|Q7TMR0|PCP_MOUSE Lysosomal Pro-X carboxypeptidase OS=Mus musculus OX=10090 GN=Prcp PE=1 SV=2 PCP_MOUSE reviewed Lysosomal Pro-X carboxypeptidase (EC 3.4.16.2) (Proline carboxypeptidase) (Prolylcarboxypeptidase) (PRCP) Mus musculus (Mouse) GO:0002003; GO:0002155; GO:0002353; GO:0003085; GO:0004181; GO:0004185; GO:0005576; GO:0005764; GO:0008239; GO:0042593; GO:0043535; GO:0045178; GO:0060055; GO:0097009; GO:2000377 angiogenesis involved in wound healing [GO:0060055]; angiotensin maturation [GO:0002003]; energy homeostasis [GO:0097009]; glucose homeostasis [GO:0042593]; negative regulation of systemic arterial blood pressure [GO:0003085]; plasma kallikrein-kinin cascade [GO:0002353]; regulation of blood vessel endothelial cell migration [GO:0043535]; regulation of reactive oxygen species metabolic process [GO:2000377]; regulation of thyroid hormone receptor signaling pathway [GO:0002155] basal part of cell [GO:0045178]; extracellular region [GO:0005576]; lysosome [GO:0005764] dipeptidyl-peptidase activity [GO:0008239]; metallocarboxypeptidase activity [GO:0004181]; serine-type carboxypeptidase activity [GO:0004185] g18323.t1 Q5RBU7 63.736 182 3.05e-83 258.0 sp|Q5RBU7|PCP_PONAB Lysosomal Pro-X carboxypeptidase OS=Pongo abelii OX=9601 GN=PRCP PE=2 SV=1 PCP_PONAB reviewed Lysosomal Pro-X carboxypeptidase (EC 3.4.16.2) (Proline carboxypeptidase) (Prolylcarboxypeptidase) (PRCP) Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0003085; GO:0004185; GO:0005764; GO:0006508; GO:0008239; GO:0043535; GO:0060055 angiogenesis involved in wound healing [GO:0060055]; negative regulation of systemic arterial blood pressure [GO:0003085]; proteolysis [GO:0006508]; regulation of blood vessel endothelial cell migration [GO:0043535] lysosome [GO:0005764] dipeptidyl-peptidase activity [GO:0008239]; serine-type carboxypeptidase activity [GO:0004185] g18324.t1 Q8N6F8 31.818 198 3.3700000000000003e-22 94.4 sp|Q8N6F8|MET27_HUMAN Methyltransferase-like protein 27 OS=Homo sapiens OX=9606 GN=METTL27 PE=1 SV=2 MET27_HUMAN reviewed Methyltransferase-like protein 27 (Williams-Beuren syndrome chromosomal region 27 protein) Homo sapiens (Human) g18326.t1 O15973 26.48 321 2.25e-22 101.0 sp|O15973|OPSD1_MIZYE Rhodopsin, GQ-coupled OS=Mizuhopecten yessoensis OX=6573 GN=SCOP1 PE=1 SV=1 g18329.t1 Q14CM0 46.182 550 3.34e-123 419.0 sp|Q14CM0|FRPD4_HUMAN FERM and PDZ domain-containing protein 4 OS=Homo sapiens OX=9606 GN=FRMPD4 PE=1 SV=1 FRPD4_HUMAN reviewed FERM and PDZ domain-containing protein 4 (PDZ domain-containing protein 10) (PSD-95-interacting regulator of spine morphogenesis) (Preso) Homo sapiens (Human) GO:0005546; GO:0032991; GO:0043197; GO:0051835 positive regulation of synapse structural plasticity [GO:0051835] dendritic spine [GO:0043197]; protein-containing complex [GO:0032991] phosphatidylinositol-4,5-bisphosphate binding [GO:0005546] g18331.t1 Q9PVV4 41.459 521 3.72e-86 318.0 sp|Q9PVV4|PCM1_XENLA Pericentriolar material 1 protein OS=Xenopus laevis OX=8355 GN=pcm1 PE=1 SV=1 g18332.t1 Q5RES6 73.881 134 6.43e-71 212.0 sp|Q5RES6|TPPC2_PONAB Trafficking protein particle complex subunit 2 OS=Pongo abelii OX=9601 GN=TRAPPC2 PE=2 SV=1 TPPC2_PONAB reviewed Trafficking protein particle complex subunit 2 Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0001222; GO:0005634; GO:0005640; GO:0005654; GO:0005783; GO:0005793; GO:0006888; GO:0010628; GO:0048471; GO:0140416 endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; positive regulation of gene expression [GO:0010628] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; nuclear outer membrane [GO:0005640]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471] transcription corepressor binding [GO:0001222]; transcription regulator inhibitor activity [GO:0140416] g18334.t1 Q66L32 65.753 73 1.15e-32 112.0 sp|Q66L32|TIM8A_XENLA Mitochondrial import inner membrane translocase subunit Tim8 A OS=Xenopus laevis OX=8355 GN=timm8a PE=3 SV=1 g18335.t1 A7Y2W8 44.521 584 5.55e-166 491.0 sp|A7Y2W8|SC6A9_XENLA Sodium- and chloride-dependent glycine transporter 1 OS=Xenopus laevis OX=8355 GN=slc6a9 PE=2 SV=1 g18337.t1 Q9Y345 47.379 515 3.04e-161 487.0 sp|Q9Y345|SC6A5_HUMAN Sodium- and chloride-dependent glycine transporter 2 OS=Homo sapiens OX=9606 GN=SLC6A5 PE=1 SV=3 SC6A5_HUMAN reviewed Sodium- and chloride-dependent glycine transporter 2 (GlyT-2) (GlyT2) (Solute carrier family 6 member 5) Homo sapiens (Human) GO:0005768; GO:0005886; GO:0006836; GO:0007268; GO:0015375; GO:0016020; GO:0031045; GO:0035725; GO:0045202; GO:0046872; GO:0060012; GO:1903804 chemical synaptic transmission [GO:0007268]; glycine import across plasma membrane [GO:1903804]; neurotransmitter transport [GO:0006836]; sodium ion transmembrane transport [GO:0035725]; synaptic transmission, glycinergic [GO:0060012] dense core granule [GO:0031045]; endosome [GO:0005768]; membrane [GO:0016020]; plasma membrane [GO:0005886]; synapse [GO:0045202] glycine:sodium symporter activity [GO:0015375]; metal ion binding [GO:0046872] g18338.t1 A7Y2W8 46.787 607 0.0 548.0 sp|A7Y2W8|SC6A9_XENLA Sodium- and chloride-dependent glycine transporter 1 OS=Xenopus laevis OX=8355 GN=slc6a9 PE=2 SV=1 g18339.t1 Q13614 70.825 473 0.0 744.0 sp|Q13614|MTMR2_HUMAN Phosphatidylinositol-3,5-bisphosphate 3-phosphatase MTMR2 OS=Homo sapiens OX=9606 GN=MTMR2 PE=1 SV=4 MTMR2_HUMAN reviewed Phosphatidylinositol-3,5-bisphosphate 3-phosphatase MTMR2 (EC 3.1.3.95) (Myotubularin-related protein 2) (Phosphatidylinositol-3-phosphate phosphatase) Homo sapiens (Human) GO:0002091; GO:0004438; GO:0005634; GO:0005737; GO:0005774; GO:0005829; GO:0006661; GO:0008021; GO:0014069; GO:0016020; GO:0030424; GO:0030425; GO:0031642; GO:0031901; GO:0032288; GO:0042802; GO:0043197; GO:0045806; GO:0046856; GO:0048471; GO:0048666; GO:0052629; GO:0060304; GO:0070062; GO:0090394; GO:0097060; GO:0097062; GO:2000643; GO:2000645 dendritic spine maintenance [GO:0097062]; myelin assembly [GO:0032288]; negative regulation of endocytosis [GO:0045806]; negative regulation of excitatory postsynaptic potential [GO:0090394]; negative regulation of myelination [GO:0031642]; negative regulation of receptor catabolic process [GO:2000645]; negative regulation of receptor internalization [GO:0002091]; neuron development [GO:0048666]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol dephosphorylation [GO:0046856]; positive regulation of early endosome to late endosome transport [GO:2000643]; regulation of phosphatidylinositol dephosphorylation [GO:0060304] axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; early endosome membrane [GO:0031901]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic density [GO:0014069]; synaptic membrane [GO:0097060]; synaptic vesicle [GO:0008021]; vacuolar membrane [GO:0005774] identical protein binding [GO:0042802]; phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity [GO:0052629]; phosphatidylinositol-3-phosphate phosphatase activity [GO:0004438] g18340.t1 A2RST1 42.857 133 5.32e-25 97.1 sp|A2RST1|MGST2_MOUSE Microsomal glutathione S-transferase 2 OS=Mus musculus OX=10090 GN=Mgst2 PE=2 SV=1 MGST2_MOUSE reviewed Microsomal glutathione S-transferase 2 (Microsomal GST-2) (EC 2.5.1.18) (Glutathione peroxidase MGST2) (EC 1.11.1.-) (Leukotriene C4 synthase MGST2) (EC 4.4.1.20) (Microsomal glutathione S-transferase II) (Microsomal GST-II) Mus musculus (Mouse) GO:0004364; GO:0004464; GO:0004602; GO:0005635; GO:0005783; GO:0005789; GO:0005886; GO:0006629; GO:0006750; GO:0008047; GO:0016020; GO:0019370; GO:0032496; GO:0042802; GO:0043295; GO:0046466 glutathione biosynthetic process [GO:0006750]; leukotriene biosynthetic process [GO:0019370]; lipid metabolic process [GO:0006629]; membrane lipid catabolic process [GO:0046466]; response to lipopolysaccharide [GO:0032496] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; plasma membrane [GO:0005886] enzyme activator activity [GO:0008047]; glutathione binding [GO:0043295]; glutathione peroxidase activity [GO:0004602]; glutathione transferase activity [GO:0004364]; identical protein binding [GO:0042802]; leukotriene-C4 synthase activity [GO:0004464] g18341.t1 Q10138 32.474 194 2.67e-21 94.7 sp|Q10138|YAS2_SCHPO CRAL-TRIO domain-containing protein C3H8.02 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) OX=284812 GN=SPAC3H8.02 PE=1 SV=1 g18342.t1 Q6P1U3 27.206 816 2.1399999999999997e-48 186.0 sp|Q6P1U3|TDRD3_XENTR Tudor domain-containing protein 3 OS=Xenopus tropicalis OX=8364 GN=tdrd3 PE=2 SV=2 g18343.t1 Q9HC07 58.921 241 1.12e-80 250.0 sp|Q9HC07|TM165_HUMAN Putative divalent cation/proton antiporter TMEM165 OS=Homo sapiens OX=9606 GN=TMEM165 PE=1 SV=1 TM165_HUMAN reviewed Putative divalent cation/proton antiporter TMEM165 (Transmembrane protein 165) (Transmembrane protein PT27) (Transmembrane protein TPARL) Homo sapiens (Human) GO:0000139; GO:0005384; GO:0005765; GO:0005794; GO:0006487; GO:0006816; GO:0006828; GO:0006874; GO:0010008; GO:0015085; GO:0015297; GO:0032468; GO:0032472; GO:0032588; GO:0033106; GO:0035751; GO:0070588; GO:0071421 calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; Golgi calcium ion homeostasis [GO:0032468]; Golgi calcium ion transport [GO:0032472]; intracellular calcium ion homeostasis [GO:0006874]; manganese ion transmembrane transport [GO:0071421]; manganese ion transport [GO:0006828]; protein N-linked glycosylation [GO:0006487]; regulation of lysosomal lumen pH [GO:0035751] cis-Golgi network membrane [GO:0033106]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; lysosomal membrane [GO:0005765]; trans-Golgi network membrane [GO:0032588] antiporter activity [GO:0015297]; calcium ion transmembrane transporter activity [GO:0015085]; manganese ion transmembrane transporter activity [GO:0005384] g18344.t1 Q0VF22 41.042 480 3.71e-100 323.0 sp|Q0VF22|CC138_MOUSE Coiled-coil domain-containing protein 138 OS=Mus musculus OX=10090 GN=Ccdc138 PE=1 SV=1 g18345.t1 Q9Z142 49.378 241 6.96e-72 224.0 sp|Q9Z142|TMM33_RAT Transmembrane protein 33 OS=Rattus norvegicus OX=10116 GN=Tmem33 PE=2 SV=1 g18347.t1 Q9UI36 76.106 113 2.5e-56 190.0 sp|Q9UI36|DACH1_HUMAN Dachshund homolog 1 OS=Homo sapiens OX=9606 GN=DACH1 PE=1 SV=4 DACH1_HUMAN reviewed Dachshund homolog 1 (Dach1) Homo sapiens (Human) GO:0000122; GO:0000977; GO:0000978; GO:0000981; GO:0001227; GO:0001967; GO:0005634; GO:0005654; GO:0005667; GO:0005794; GO:0005829; GO:0006357; GO:0007585; GO:0010944; GO:0016607; GO:0030336; GO:0033262; GO:0044342; GO:0045892; GO:0046545; GO:0048147; GO:0060244; GO:2000279 development of primary female sexual characteristics [GO:0046545]; negative regulation of cell migration [GO:0030336]; negative regulation of cell proliferation involved in contact inhibition [GO:0060244]; negative regulation of DNA biosynthetic process [GO:2000279]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of transcription by competitive promoter binding [GO:0010944]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of nuclear cell cycle DNA replication [GO:0033262]; regulation of transcription by RNA polymerase II [GO:0006357]; respiratory gaseous exchange by respiratory system [GO:0007585]; suckling behavior [GO:0001967]; type B pancreatic cell proliferation [GO:0044342] cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667] DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977] g18349.t1 Q9HC56 32.13 831 3.83e-124 417.0 sp|Q9HC56|PCDH9_HUMAN Protocadherin-9 OS=Homo sapiens OX=9606 GN=PCDH9 PE=1 SV=2 g18350.t1 Q99M87 55.039 387 2.58e-136 405.0 sp|Q99M87|DNJA3_MOUSE DnaJ homolog subfamily A member 3, mitochondrial OS=Mus musculus OX=10090 GN=Dnaja3 PE=1 SV=1 g18350.t2 Q99M87 55.556 378 2.83e-135 401.0 sp|Q99M87|DNJA3_MOUSE DnaJ homolog subfamily A member 3, mitochondrial OS=Mus musculus OX=10090 GN=Dnaja3 PE=1 SV=1 g18351.t1 Q0V8F1 42.348 954 0.0 777.0 sp|Q0V8F1|CORO7_BOVIN Coronin-7 OS=Bos taurus OX=9913 GN=CORO7 PE=2 SV=1 g18352.t1 Q2KJG2 87.059 85 4.29e-51 159.0 sp|Q2KJG2|UFM1_BOVIN Ubiquitin-fold modifier 1 OS=Bos taurus OX=9913 GN=UFM1 PE=3 SV=1 g18353.t1 O02467 58.805 318 6.8e-108 321.0 sp|O02467|ASPG_SPOFR N(4)-(Beta-N-acetylglucosaminyl)-L-asparaginase (Fragment) OS=Spodoptera frugiperda OX=7108 PE=1 SV=1 g18354.t1 P46872 78.571 700 0.0 1015.0 sp|P46872|KRP85_STRPU Kinesin-II 85 kDa subunit OS=Strongylocentrotus purpuratus OX=7668 GN=KRP85 PE=1 SV=1 g18356.t1 Q6GMK0 57.666 437 9.49e-174 506.0 sp|Q6GMK0|MGT4B_DANRE Alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase B OS=Danio rerio OX=7955 GN=mgat4bQ9UQ53 PE=2 SV=1 MGT4B_DANRE reviewed Alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase B (EC 2.4.1.145) (N-glycosyl-oligosaccharide-glycoprotein N-acetylglucosaminyltransferase IVb) (GlcNAc-T IVb) (GnT-IVb) (N-acetylglucosaminyltransferase IVb) (UDP-N-acetylglucosamine: alpha-1,3-D-mannoside beta-1,4-N-acetylglucosaminyltransferase IVb) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000139; GO:0005783; GO:0005793; GO:0005795; GO:0006487; GO:0008375; GO:0008454; GO:0009101; GO:0046872 glycoprotein biosynthetic process [GO:0009101]; protein N-linked glycosylation [GO:0006487] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795] acetylglucosaminyltransferase activity [GO:0008375]; alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity [GO:0008454]; metal ion binding [GO:0046872] g18357.t1 Q05187 41.772 553 4.08e-139 424.0 sp|Q05187|TGMH_TACTR Hemocyte protein-glutamine gamma-glutamyltransferase OS=Tachypleus tridentatus OX=6853 PE=1 SV=1 g18359.t1 Q8WV99 48.263 259 3.2600000000000005e-73 228.0 sp|Q8WV99|ZFN2B_HUMAN AN1-type zinc finger protein 2B OS=Homo sapiens OX=9606 GN=ZFAND2B PE=1 SV=1 ZFN2B_HUMAN reviewed AN1-type zinc finger protein 2B (Arsenite-inducible RNA-associated protein-like protein) (AIRAP-like protein) Homo sapiens (Human) GO:0000502; GO:0005737; GO:0005783; GO:0005789; GO:0006616; GO:0008270; GO:0016020; GO:0036435; GO:0043130; GO:0043161; GO:0043567; GO:0045047 proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein targeting to ER [GO:0045047]; regulation of insulin-like growth factor receptor signaling pathway [GO:0043567]; SRP-dependent cotranslational protein targeting to membrane, translocation [GO:0006616] cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; proteasome complex [GO:0000502] K48-linked polyubiquitin modification-dependent protein binding [GO:0036435]; ubiquitin binding [GO:0043130]; zinc ion binding [GO:0008270] g18359.t2 Q8WV99 47.104 259 6.3799999999999994e-68 214.0 sp|Q8WV99|ZFN2B_HUMAN AN1-type zinc finger protein 2B OS=Homo sapiens OX=9606 GN=ZFAND2B PE=1 SV=1 ZFN2B_HUMAN reviewed AN1-type zinc finger protein 2B (Arsenite-inducible RNA-associated protein-like protein) (AIRAP-like protein) Homo sapiens (Human) GO:0000502; GO:0005737; GO:0005783; GO:0005789; GO:0006616; GO:0008270; GO:0016020; GO:0036435; GO:0043130; GO:0043161; GO:0043567; GO:0045047 proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein targeting to ER [GO:0045047]; regulation of insulin-like growth factor receptor signaling pathway [GO:0043567]; SRP-dependent cotranslational protein targeting to membrane, translocation [GO:0006616] cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; proteasome complex [GO:0000502] K48-linked polyubiquitin modification-dependent protein binding [GO:0036435]; ubiquitin binding [GO:0043130]; zinc ion binding [GO:0008270] g18366.t1 P35565 59.911 449 1.05e-165 488.0 sp|P35565|CALX_RAT Calnexin OS=Rattus norvegicus OX=10116 GN=Canx PE=1 SV=1 CALX_RAT reviewed Calnexin Rattus norvegicus (Rat) GO:0005509; GO:0005783; GO:0005789; GO:0005790; GO:0005840; GO:0006457; GO:0016020; GO:0030246; GO:0030424; GO:0031965; GO:0031966; GO:0032839; GO:0032991; GO:0033162; GO:0034185; GO:0035255; GO:0036503; GO:0043025; GO:0043197; GO:0044233; GO:0044322; GO:0045211; GO:0048488; GO:0048787; GO:0051082; GO:0072583; GO:0098978 clathrin-dependent endocytosis [GO:0072583]; ERAD pathway [GO:0036503]; protein folding [GO:0006457]; synaptic vesicle endocytosis [GO:0048488] axon [GO:0030424]; dendrite cytoplasm [GO:0032839]; dendritic spine [GO:0043197]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum quality control compartment [GO:0044322]; glutamatergic synapse [GO:0098978]; melanosome membrane [GO:0033162]; membrane [GO:0016020]; mitochondria-associated endoplasmic reticulum membrane contact site [GO:0044233]; mitochondrial membrane [GO:0031966]; neuronal cell body [GO:0043025]; nuclear membrane [GO:0031965]; postsynaptic membrane [GO:0045211]; presynaptic active zone membrane [GO:0048787]; protein-containing complex [GO:0032991]; ribosome [GO:0005840]; smooth endoplasmic reticulum [GO:0005790] apolipoprotein binding [GO:0034185]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; ionotropic glutamate receptor binding [GO:0035255]; unfolded protein binding [GO:0051082] g18368.t1 P38024 60.68 412 0.0 548.0 sp|P38024|PUR6_CHICK Multifunctional protein ADE2 OS=Gallus gallus OX=9031 GN=AIRC PE=2 SV=1 g18369.t1 P28173 69.278 485 0.0 692.0 sp|P28173|PUR1_CHICK Amidophosphoribosyltransferase OS=Gallus gallus OX=9031 GN=PPAT PE=1 SV=1 g18370.t1 B5DEQ3 55.23 239 3.45e-99 301.0 sp|B5DEQ3|XPP3_RAT Xaa-Pro aminopeptidase 3 OS=Rattus norvegicus OX=10116 GN=Xpnpep3 PE=1 SV=1 XPP3_RAT reviewed Xaa-Pro aminopeptidase 3 (X-Pro aminopeptidase 3) (EC 3.4.11.9) (Aminopeptidase P3) (APP3) Rattus norvegicus (Rat) GO:0003094; GO:0004177; GO:0005737; GO:0005739; GO:0005829; GO:0006508; GO:0016485; GO:0030145; GO:0042803; GO:0070006 glomerular filtration [GO:0003094]; protein processing [GO:0016485]; proteolysis [GO:0006508] cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739] aminopeptidase activity [GO:0004177]; manganese ion binding [GO:0030145]; metalloaminopeptidase activity [GO:0070006]; protein homodimerization activity [GO:0042803] g18371.t1 Q9NQH7 54.225 142 5.28e-49 171.0 sp|Q9NQH7|XPP3_HUMAN Xaa-Pro aminopeptidase 3 OS=Homo sapiens OX=9606 GN=XPNPEP3 PE=1 SV=1 XPP3_HUMAN reviewed Xaa-Pro aminopeptidase 3 (X-Pro aminopeptidase 3) (EC 3.4.11.9) (Aminopeptidase P3) (APP3) Homo sapiens (Human) GO:0003094; GO:0004177; GO:0005737; GO:0005739; GO:0005829; GO:0006508; GO:0016485; GO:0030145; GO:0042803; GO:0070006 glomerular filtration [GO:0003094]; protein processing [GO:0016485]; proteolysis [GO:0006508] cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739] aminopeptidase activity [GO:0004177]; manganese ion binding [GO:0030145]; metalloaminopeptidase activity [GO:0070006]; protein homodimerization activity [GO:0042803] g18372.t1 B3FL73 34.336 399 1.79e-73 239.0 sp|B3FL73|FXL21_SHEEP F-box/LRR-repeat protein 21 OS=Ovis aries OX=9940 GN=Fbxl21 PE=1 SV=1 FXL21_SHEEP reviewed F-box/LRR-repeat protein 21 (F-box and leucine-rich repeat protein 21) Ovis aries (Sheep) GO:0005634; GO:0005829; GO:0016567; GO:0019005; GO:0043153; GO:0048511 entrainment of circadian clock by photoperiod [GO:0043153]; protein ubiquitination [GO:0016567]; rhythmic process [GO:0048511] cytosol [GO:0005829]; nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005] g18373.t1 Q12931 60.451 665 0.0 834.0 sp|Q12931|TRAP1_HUMAN Heat shock protein 75 kDa, mitochondrial OS=Homo sapiens OX=9606 GN=TRAP1 PE=1 SV=3 TRAP1_HUMAN reviewed Heat shock protein 75 kDa, mitochondrial (HSP 75) (Heat shock protein family C member 5) (TNFR-associated protein 1) (Tumor necrosis factor type 1 receptor-associated protein) (TRAP-1) Homo sapiens (Human) GO:0003723; GO:0005164; GO:0005524; GO:0005654; GO:0005739; GO:0005743; GO:0005758; GO:0005759; GO:0006457; GO:0009386; GO:0016020; GO:0016887; GO:0019901; GO:0051082; GO:0140662; GO:1901856; GO:1903427; GO:1903751 negative regulation of cellular respiration [GO:1901856]; negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:1903751]; negative regulation of reactive oxygen species biosynthetic process [GO:1903427]; protein folding [GO:0006457]; translational attenuation [GO:0009386] membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent protein folding chaperone [GO:0140662]; protein kinase binding [GO:0019901]; RNA binding [GO:0003723]; tumor necrosis factor receptor binding [GO:0005164]; unfolded protein binding [GO:0051082] g18375.t1 Q9H920 67.32 306 3.1399999999999996e-140 403.0 sp|Q9H920|RN121_HUMAN E3 ubiquitin ligase RNF121 OS=Homo sapiens OX=9606 GN=RNF121 PE=1 SV=1 g18376.t1 Q32NR4 36.446 439 1.93e-81 263.0 sp|Q32NR4|TTC29_XENLA Tetratricopeptide repeat protein 29 OS=Xenopus laevis OX=8355 GN=ttc29 PE=2 SV=1 g18379.t1 O08623 32.927 492 5.29e-57 198.0 sp|O08623|SQSTM_RAT Sequestosome-1 OS=Rattus norvegicus OX=10116 GN=Sqstm1 PE=1 SV=1 g18380.t1 P56720 51.903 289 3.83e-106 251.0 sp|P56720|SRBP1_RAT Sterol regulatory element-binding protein 1 OS=Rattus norvegicus OX=10116 GN=Srebf1 PE=1 SV=3 g18380.t1 P56720 47.273 165 3.83e-106 157.0 sp|P56720|SRBP1_RAT Sterol regulatory element-binding protein 1 OS=Rattus norvegicus OX=10116 GN=Srebf1 PE=1 SV=3 g18380.t1 P56720 51.282 117 1.52e-26 121.0 sp|P56720|SRBP1_RAT Sterol regulatory element-binding protein 1 OS=Rattus norvegicus OX=10116 GN=Srebf1 PE=1 SV=3 g18381.t1 Q3U1N2 47.668 193 2.77e-46 166.0 sp|Q3U1N2|SRBP2_MOUSE Sterol regulatory element-binding protein 2 OS=Mus musculus OX=10090 GN=Srebf2 PE=1 SV=2 SRBP2_MOUSE reviewed Sterol regulatory element-binding protein 2 (SREBP-2) (Sterol regulatory element-binding transcription factor 2) [Cleaved into: Processed sterol regulatory element-binding protein 2 (Transcription factor SREBF2)] Mus musculus (Mouse) GO:0000122; GO:0000139; GO:0000976; GO:0000978; GO:0000981; GO:0001227; GO:0003677; GO:0003682; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0005783; GO:0006355; GO:0006357; GO:0008203; GO:0008593; GO:0009267; GO:0009725; GO:0010886; GO:0012507; GO:0016020; GO:0030425; GO:0032933; GO:0032937; GO:0042632; GO:0043565; GO:0045542; GO:0045893; GO:0045944; GO:0046983; GO:0070888; GO:0071404; GO:0090370; GO:1900222; GO:1902895; GO:1990837 cellular response to low-density lipoprotein particle stimulus [GO:0071404]; cellular response to starvation [GO:0009267]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; negative regulation of amyloid-beta clearance [GO:1900222]; negative regulation of cholesterol efflux [GO:0090370]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cholesterol biosynthetic process [GO:0045542]; positive regulation of cholesterol storage [GO:0010886]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA-templated transcription [GO:0006355]; regulation of Notch signaling pathway [GO:0008593]; regulation of transcription by RNA polymerase II [GO:0006357]; response to hormone [GO:0009725]; SREBP signaling pathway [GO:0032933] cytoplasm [GO:0005737]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; ER to Golgi transport vesicle membrane [GO:0012507]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SREBP-SCAP-Insig complex [GO:0032937] chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; E-box binding [GO:0070888]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976] g18383.t1 Q9CZG3 42.442 172 1.96e-41 140.0 sp|Q9CZG3|COMD8_MOUSE COMM domain-containing protein 8 OS=Mus musculus OX=10090 GN=Commd8 PE=1 SV=1 g18386.t1 Q8MIQ9 48.718 702 0.0 600.0 sp|Q8MIQ9|P_PIG P protein OS=Sus scrofa OX=9823 GN=Oca2 PE=2 SV=3 g18391.t1 P52948 40.73 1397 0.0 881.0 sp|P52948|NUP98_HUMAN Nuclear pore complex protein Nup98-Nup96 OS=Homo sapiens OX=9606 GN=NUP98 PE=1 SV=4 NUP98_HUMAN reviewed Nuclear pore complex protein Nup98-Nup96 (EC 3.4.21.-) [Cleaved into: Nuclear pore complex protein Nup98 (98 kDa nucleoporin) (Nucleoporin Nup98) (Nup98); Nuclear pore complex protein Nup96 (96 kDa nucleoporin) (Nucleoporin Nup96) (Nup96)] Homo sapiens (Human) GO:0000973; GO:0003713; GO:0003723; GO:0003729; GO:0005635; GO:0005643; GO:0005654; GO:0005829; GO:0006405; GO:0006508; GO:0006606; GO:0006913; GO:0006999; GO:0008139; GO:0008236; GO:0016604; GO:0017056; GO:0031080; GO:0031965; GO:0034398; GO:0034399; GO:0042405; GO:0044614; GO:0044615; GO:0048026; GO:0051028; GO:0051292; GO:0140693; GO:1990841; GO:1990904 mRNA transport [GO:0051028]; nuclear pore complex assembly [GO:0051292]; nuclear pore organization [GO:0006999]; nucleocytoplasmic transport [GO:0006913]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; post-transcriptional tethering of RNA polymerase II gene DNA at nuclear periphery [GO:0000973]; protein import into nucleus [GO:0006606]; proteolysis [GO:0006508]; RNA export from nucleus [GO:0006405]; telomere tethering at nuclear periphery [GO:0034398] cytosol [GO:0005829]; nuclear body [GO:0016604]; nuclear envelope [GO:0005635]; nuclear inclusion body [GO:0042405]; nuclear membrane [GO:0031965]; nuclear periphery [GO:0034399]; nuclear pore [GO:0005643]; nuclear pore cytoplasmic filaments [GO:0044614]; nuclear pore nuclear basket [GO:0044615]; nuclear pore outer ring [GO:0031080]; nucleoplasm [GO:0005654]; ribonucleoprotein complex [GO:1990904] molecular condensate scaffold activity [GO:0140693]; mRNA binding [GO:0003729]; nuclear localization sequence binding [GO:0008139]; promoter-specific chromatin binding [GO:1990841]; RNA binding [GO:0003723]; serine-type peptidase activity [GO:0008236]; structural constituent of nuclear pore [GO:0017056]; transcription coactivator activity [GO:0003713] g18391.t1 P52948 43.103 232 7.449999999999999e-23 111.0 sp|P52948|NUP98_HUMAN Nuclear pore complex protein Nup98-Nup96 OS=Homo sapiens OX=9606 GN=NUP98 PE=1 SV=4 NUP98_HUMAN reviewed Nuclear pore complex protein Nup98-Nup96 (EC 3.4.21.-) [Cleaved into: Nuclear pore complex protein Nup98 (98 kDa nucleoporin) (Nucleoporin Nup98) (Nup98); Nuclear pore complex protein Nup96 (96 kDa nucleoporin) (Nucleoporin Nup96) (Nup96)] Homo sapiens (Human) GO:0000973; GO:0003713; GO:0003723; GO:0003729; GO:0005635; GO:0005643; GO:0005654; GO:0005829; GO:0006405; GO:0006508; GO:0006606; GO:0006913; GO:0006999; GO:0008139; GO:0008236; GO:0016604; GO:0017056; GO:0031080; GO:0031965; GO:0034398; GO:0034399; GO:0042405; GO:0044614; GO:0044615; GO:0048026; GO:0051028; GO:0051292; GO:0140693; GO:1990841; GO:1990904 mRNA transport [GO:0051028]; nuclear pore complex assembly [GO:0051292]; nuclear pore organization [GO:0006999]; nucleocytoplasmic transport [GO:0006913]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; post-transcriptional tethering of RNA polymerase II gene DNA at nuclear periphery [GO:0000973]; protein import into nucleus [GO:0006606]; proteolysis [GO:0006508]; RNA export from nucleus [GO:0006405]; telomere tethering at nuclear periphery [GO:0034398] cytosol [GO:0005829]; nuclear body [GO:0016604]; nuclear envelope [GO:0005635]; nuclear inclusion body [GO:0042405]; nuclear membrane [GO:0031965]; nuclear periphery [GO:0034399]; nuclear pore [GO:0005643]; nuclear pore cytoplasmic filaments [GO:0044614]; nuclear pore nuclear basket [GO:0044615]; nuclear pore outer ring [GO:0031080]; nucleoplasm [GO:0005654]; ribonucleoprotein complex [GO:1990904] molecular condensate scaffold activity [GO:0140693]; mRNA binding [GO:0003729]; nuclear localization sequence binding [GO:0008139]; promoter-specific chromatin binding [GO:1990841]; RNA binding [GO:0003723]; serine-type peptidase activity [GO:0008236]; structural constituent of nuclear pore [GO:0017056]; transcription coactivator activity [GO:0003713] g18392.t1 Q7Z2H8 45.178 394 2.15e-93 294.0 sp|Q7Z2H8|S36A1_HUMAN Proton-coupled amino acid transporter 1 OS=Homo sapiens OX=9606 GN=SLC36A1 PE=1 SV=1 S36A1_HUMAN reviewed Proton-coupled amino acid transporter 1 (Proton/amino acid transporter 1) (hPAT1) (Solute carrier family 36 member 1) Homo sapiens (Human) GO:0005280; GO:0005297; GO:0005765; GO:0005774; GO:0005783; GO:0005886; GO:0006811; GO:0006865; GO:0015171; GO:0015180; GO:0015187; GO:0015193; GO:0015411; GO:0015734; GO:0015808; GO:0015816; GO:0015824; GO:0016324; GO:0022858; GO:0032328; GO:0035524; GO:0089718; GO:1902600 alanine transport [GO:0032328]; amino acid import across plasma membrane [GO:0089718]; amino acid transport [GO:0006865]; glycine transport [GO:0015816]; L-alanine transport [GO:0015808]; monoatomic ion transport [GO:0006811]; proline transmembrane transport [GO:0035524]; proline transport [GO:0015824]; proton transmembrane transport [GO:1902600]; taurine transmembrane transport [GO:0015734] apical plasma membrane [GO:0016324]; endoplasmic reticulum [GO:0005783]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; vacuolar membrane [GO:0005774] ABC-type taurine transporter transporter activity [GO:0015411]; alanine transmembrane transporter activity [GO:0022858]; amino acid transmembrane transporter activity [GO:0015171]; amino acid:proton symporter activity [GO:0005280]; glycine transmembrane transporter activity [GO:0015187]; L-alanine transmembrane transporter activity [GO:0015180]; L-proline transmembrane transporter activity [GO:0015193]; proline:proton symporter activity [GO:0005297] g18394.t1 Q7Z2H8 46.384 401 1.2999999999999999e-82 266.0 sp|Q7Z2H8|S36A1_HUMAN Proton-coupled amino acid transporter 1 OS=Homo sapiens OX=9606 GN=SLC36A1 PE=1 SV=1 S36A1_HUMAN reviewed Proton-coupled amino acid transporter 1 (Proton/amino acid transporter 1) (hPAT1) (Solute carrier family 36 member 1) Homo sapiens (Human) GO:0005280; GO:0005297; GO:0005765; GO:0005774; GO:0005783; GO:0005886; GO:0006811; GO:0006865; GO:0015171; GO:0015180; GO:0015187; GO:0015193; GO:0015411; GO:0015734; GO:0015808; GO:0015816; GO:0015824; GO:0016324; GO:0022858; GO:0032328; GO:0035524; GO:0089718; GO:1902600 alanine transport [GO:0032328]; amino acid import across plasma membrane [GO:0089718]; amino acid transport [GO:0006865]; glycine transport [GO:0015816]; L-alanine transport [GO:0015808]; monoatomic ion transport [GO:0006811]; proline transmembrane transport [GO:0035524]; proline transport [GO:0015824]; proton transmembrane transport [GO:1902600]; taurine transmembrane transport [GO:0015734] apical plasma membrane [GO:0016324]; endoplasmic reticulum [GO:0005783]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; vacuolar membrane [GO:0005774] ABC-type taurine transporter transporter activity [GO:0015411]; alanine transmembrane transporter activity [GO:0022858]; amino acid transmembrane transporter activity [GO:0015171]; amino acid:proton symporter activity [GO:0005280]; glycine transmembrane transporter activity [GO:0015187]; L-alanine transmembrane transporter activity [GO:0015180]; L-proline transmembrane transporter activity [GO:0015193]; proline:proton symporter activity [GO:0005297] g18397.t1 O60264 76.266 1007 0.0 1435.0 sp|O60264|SMCA5_HUMAN SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A member 5 OS=Homo sapiens OX=9606 GN=SMARCA5 PE=1 SV=1 SMCA5_HUMAN reviewed SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A member 5 (SMARCA5) (SWI/SNF-related matrix-associated actin-dependent regulator of chromatin A5) (EC 3.6.4.-) (Sucrose nonfermenting protein 2 homolog) (hSNF2H) Homo sapiens (Human) GO:0000183; GO:0000785; GO:0000793; GO:0001650; GO:0003677; GO:0003682; GO:0004386; GO:0005524; GO:0005634; GO:0005654; GO:0005677; GO:0005721; GO:0005730; GO:0006275; GO:0006281; GO:0006325; GO:0006334; GO:0006338; GO:0006346; GO:0006352; GO:0006355; GO:0006357; GO:0006974; GO:0008623; GO:0016479; GO:0016589; GO:0016590; GO:0016887; GO:0031213; GO:0031491; GO:0031507; GO:0035861; GO:0045740; GO:0045943; GO:0045944; GO:0045945; GO:0090535; GO:0090536; GO:0090537; GO:0110016; GO:0140374; GO:0140658; GO:0140750; GO:0140751; GO:1905213; GO:1990830 antiviral innate immune response [GO:0140374]; cellular response to leukemia inhibitory factor [GO:1990830]; chromatin organization [GO:0006325]; chromatin remodeling [GO:0006338]; DNA damage response [GO:0006974]; DNA methylation-dependent constitutive heterochromatin formation [GO:0006346]; DNA repair [GO:0006281]; DNA-templated transcription initiation [GO:0006352]; heterochromatin formation [GO:0031507]; negative regulation of mitotic chromosome condensation [GO:1905213]; negative regulation of transcription by RNA polymerase I [GO:0016479]; nucleosome assembly [GO:0006334]; positive regulation of DNA replication [GO:0045740]; positive regulation of transcription by RNA polymerase I [GO:0045943]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription by RNA polymerase III [GO:0045945]; rDNA heterochromatin formation [GO:0000183]; regulation of DNA replication [GO:0006275]; regulation of DNA-templated transcription [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357] ACF complex [GO:0016590]; B-WICH complex [GO:0110016]; CERF complex [GO:0090537]; CHRAC [GO:0008623]; chromatin [GO:0000785]; chromatin silencing complex [GO:0005677]; condensed chromosome [GO:0000793]; fibrillar center [GO:0001650]; NoRC complex [GO:0090536]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; NURF complex [GO:0016589]; pericentric heterochromatin [GO:0005721]; RSF complex [GO:0031213]; site of double-strand break [GO:0035861]; WICH complex [GO:0090535] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent chromatin remodeler activity [GO:0140658]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; helicase activity [GO:0004386]; histone octamer slider activity [GO:0140751]; nucleosome array spacer activity [GO:0140750]; nucleosome binding [GO:0031491] g18397.t2 O60264 77.598 991 0.0 1446.0 sp|O60264|SMCA5_HUMAN SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A member 5 OS=Homo sapiens OX=9606 GN=SMARCA5 PE=1 SV=1 SMCA5_HUMAN reviewed SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A member 5 (SMARCA5) (SWI/SNF-related matrix-associated actin-dependent regulator of chromatin A5) (EC 3.6.4.-) (Sucrose nonfermenting protein 2 homolog) (hSNF2H) Homo sapiens (Human) GO:0000183; GO:0000785; GO:0000793; GO:0001650; GO:0003677; GO:0003682; GO:0004386; GO:0005524; GO:0005634; GO:0005654; GO:0005677; GO:0005721; GO:0005730; GO:0006275; GO:0006281; GO:0006325; GO:0006334; GO:0006338; GO:0006346; GO:0006352; GO:0006355; GO:0006357; GO:0006974; GO:0008623; GO:0016479; GO:0016589; GO:0016590; GO:0016887; GO:0031213; GO:0031491; GO:0031507; GO:0035861; GO:0045740; GO:0045943; GO:0045944; GO:0045945; GO:0090535; GO:0090536; GO:0090537; GO:0110016; GO:0140374; GO:0140658; GO:0140750; GO:0140751; GO:1905213; GO:1990830 antiviral innate immune response [GO:0140374]; cellular response to leukemia inhibitory factor [GO:1990830]; chromatin organization [GO:0006325]; chromatin remodeling [GO:0006338]; DNA damage response [GO:0006974]; DNA methylation-dependent constitutive heterochromatin formation [GO:0006346]; DNA repair [GO:0006281]; DNA-templated transcription initiation [GO:0006352]; heterochromatin formation [GO:0031507]; negative regulation of mitotic chromosome condensation [GO:1905213]; negative regulation of transcription by RNA polymerase I [GO:0016479]; nucleosome assembly [GO:0006334]; positive regulation of DNA replication [GO:0045740]; positive regulation of transcription by RNA polymerase I [GO:0045943]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription by RNA polymerase III [GO:0045945]; rDNA heterochromatin formation [GO:0000183]; regulation of DNA replication [GO:0006275]; regulation of DNA-templated transcription [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357] ACF complex [GO:0016590]; B-WICH complex [GO:0110016]; CERF complex [GO:0090537]; CHRAC [GO:0008623]; chromatin [GO:0000785]; chromatin silencing complex [GO:0005677]; condensed chromosome [GO:0000793]; fibrillar center [GO:0001650]; NoRC complex [GO:0090536]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; NURF complex [GO:0016589]; pericentric heterochromatin [GO:0005721]; RSF complex [GO:0031213]; site of double-strand break [GO:0035861]; WICH complex [GO:0090535] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent chromatin remodeler activity [GO:0140658]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; helicase activity [GO:0004386]; histone octamer slider activity [GO:0140751]; nucleosome array spacer activity [GO:0140750]; nucleosome binding [GO:0031491] g18398.t1 Q5RHX6 60.905 243 3.11e-101 298.0 sp|Q5RHX6|DCNL4_DANRE DCN1-like protein 4 OS=Danio rerio OX=7955 GN=dcun1d4 PE=3 SV=2 g18399.t1 Q27802 76.263 4335 0.0 6773.0 sp|Q27802|DYHC2_TRIGR Cytoplasmic dynein 2 heavy chain 1 OS=Tripneustes gratilla OX=7673 GN=DYH1B PE=2 SV=2 g18400.t1 Q9UHJ9 43.379 219 3.4099999999999998e-53 175.0 sp|Q9UHJ9|PGAP2_HUMAN Acyltransferase PGAP2 OS=Homo sapiens OX=9606 GN=PGAP2 PE=1 SV=2 g18401.t1 Q05086 53.875 800 0.0 847.0 sp|Q05086|UBE3A_HUMAN Ubiquitin-protein ligase E3A OS=Homo sapiens OX=9606 GN=UBE3A PE=1 SV=4 UBE3A_HUMAN reviewed Ubiquitin-protein ligase E3A (EC 2.3.2.26) (E6AP ubiquitin-protein ligase) (HECT-type ubiquitin transferase E3A) (Human papillomavirus E6-associated protein) (Oncogenic protein-associated protein E6-AP) (Renal carcinoma antigen NY-REN-54) Homo sapiens (Human) GO:0000209; GO:0000502; GO:0001541; GO:0003713; GO:0004842; GO:0005634; GO:0005829; GO:0006508; GO:0006511; GO:0007420; GO:0008021; GO:0008270; GO:0030521; GO:0031398; GO:0032570; GO:0035037; GO:0042752; GO:0043161; GO:0045944; GO:0048167; GO:0048511; GO:0050847; GO:0051865; GO:0051897; GO:0060736; GO:0061630; GO:0070936; GO:0098978; GO:0099524; GO:1904262; GO:1905528; GO:2000058 androgen receptor signaling pathway [GO:0030521]; brain development [GO:0007420]; negative regulation of TORC1 signaling [GO:1904262]; ovarian follicle development [GO:0001541]; positive regulation of Golgi lumen acidification [GO:1905528]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of transcription by RNA polymerase II [GO:0045944]; progesterone receptor signaling pathway [GO:0050847]; prostate gland growth [GO:0060736]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; proteolysis [GO:0006508]; regulation of circadian rhythm [GO:0042752]; regulation of synaptic plasticity [GO:0048167]; regulation of ubiquitin-dependent protein catabolic process [GO:2000058]; response to progesterone [GO:0032570]; rhythmic process [GO:0048511]; sperm entry [GO:0035037]; ubiquitin-dependent protein catabolic process [GO:0006511] cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; nucleus [GO:0005634]; postsynaptic cytosol [GO:0099524]; proteasome complex [GO:0000502]; synaptic vesicle [GO:0008021] transcription coactivator activity [GO:0003713]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] g18402.t1 Q3TZM9 61.124 427 0.0 551.0 sp|Q3TZM9|ALG11_MOUSE GDP-Man:Man(3)GlcNAc(2)-PP-Dol alpha-1,2-mannosyltransferase OS=Mus musculus OX=10090 GN=Alg11 PE=2 SV=1 g18403.t1 O94868 37.534 738 1.85e-127 400.0 sp|O94868|FCSD2_HUMAN F-BAR and double SH3 domains protein 2 OS=Homo sapiens OX=9606 GN=FCHSD2 PE=1 SV=3 g18403.t2 O94868 38.277 708 4.14e-127 400.0 sp|O94868|FCSD2_HUMAN F-BAR and double SH3 domains protein 2 OS=Homo sapiens OX=9606 GN=FCHSD2 PE=1 SV=3 g18403.t3 O94868 37.827 727 4.1e-128 402.0 sp|O94868|FCSD2_HUMAN F-BAR and double SH3 domains protein 2 OS=Homo sapiens OX=9606 GN=FCHSD2 PE=1 SV=3 g18406.t1 O43159 44.144 222 1.3500000000000002e-59 207.0 sp|O43159|RRP8_HUMAN Ribosomal RNA-processing protein 8 OS=Homo sapiens OX=9606 GN=RRP8 PE=1 SV=2 RRP8_HUMAN reviewed Ribosomal RNA-processing protein 8 (EC 2.1.1.-) (Cerebral protein 1) (Nucleomethylin) Homo sapiens (Human) GO:0000183; GO:0003723; GO:0005654; GO:0005677; GO:0005730; GO:0005829; GO:0005886; GO:0006364; GO:0008168; GO:0032259; GO:0033553; GO:0042149; GO:0045786; GO:0045892; GO:0046015; GO:0061773; GO:0062072; GO:0072332; GO:0097009; GO:1903450 cellular response to glucose starvation [GO:0042149]; energy homeostasis [GO:0097009]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; methylation [GO:0032259]; negative regulation of cell cycle [GO:0045786]; negative regulation of DNA-templated transcription [GO:0045892]; rDNA heterochromatin formation [GO:0000183]; regulation of G1 to G0 transition [GO:1903450]; regulation of transcription by glucose [GO:0046015]; rRNA processing [GO:0006364] chromatin silencing complex [GO:0005677]; cytosol [GO:0005829]; eNoSc complex [GO:0061773]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; rDNA heterochromatin [GO:0033553] histone H3K9me2/3 reader activity [GO:0062072]; methyltransferase activity [GO:0008168]; RNA binding [GO:0003723] g18407.t1 Q9DF58 63.333 450 0.0 625.0 sp|Q9DF58|ILK_CHICK Scaffold protein ILK OS=Gallus gallus OX=9031 GN=ILK PE=1 SV=1 ILK_CHICK reviewed Scaffold protein ILK (ILK-1) (ILK-2) (Inactive integrin-linked kinase) (p59ILK) Gallus gallus (Chicken) GO:0000287; GO:0000785; GO:0000902; GO:0001658; GO:0003151; GO:0004672; GO:0005178; GO:0005524; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005886; GO:0005925; GO:0005938; GO:0007052; GO:0007165; GO:0007229; GO:0008284; GO:0010761; GO:0015629; GO:0019901; GO:0021675; GO:0022011; GO:0030017; GO:0030027; GO:0030030; GO:0030513; GO:0033209; GO:0034446; GO:0043123; GO:0043491; GO:0045197; GO:0045669; GO:0045893; GO:0061351; GO:0070836; GO:0072697; GO:0090263; GO:1900026; GO:2000178 branching involved in ureteric bud morphogenesis [GO:0001658]; caveola assembly [GO:0070836]; cell morphogenesis [GO:0000902]; cell projection organization [GO:0030030]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; fibroblast migration [GO:0010761]; integrin-mediated signaling pathway [GO:0007229]; mitotic spindle organization [GO:0007052]; myelination in peripheral nervous system [GO:0022011]; negative regulation of neural precursor cell proliferation [GO:2000178]; nerve development [GO:0021675]; neural precursor cell proliferation [GO:0061351]; outflow tract morphogenesis [GO:0003151]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; protein localization to cell cortex [GO:0072697]; signal transduction [GO:0007165]; substrate adhesion-dependent cell spreading [GO:0034446]; tumor necrosis factor-mediated signaling pathway [GO:0033209] actin cytoskeleton [GO:0015629]; cell cortex [GO:0005938]; centrosome [GO:0005813]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; sarcomere [GO:0030017] ATP binding [GO:0005524]; integrin binding [GO:0005178]; magnesium ion binding [GO:0000287]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901] g18408.t1 Q9JHW5 61.927 218 4.48e-94 277.0 sp|Q9JHW5|VAMP7_RAT Vesicle-associated membrane protein 7 OS=Rattus norvegicus OX=10116 GN=Vamp7 PE=1 SV=1 VAMP7_RAT reviewed Vesicle-associated membrane protein 7 (VAMP-7) (Synaptobrevin-like protein 1) Rattus norvegicus (Rat) GO:0000149; GO:0005484; GO:0005737; GO:0005765; GO:0005789; GO:0005794; GO:0005802; GO:0005886; GO:0006887; GO:0006888; GO:0006906; GO:0006911; GO:0008333; GO:0009986; GO:0016020; GO:0016079; GO:0016192; GO:0017156; GO:0019905; GO:0030027; GO:0030133; GO:0030141; GO:0030175; GO:0030667; GO:0030670; GO:0030672; GO:0031091; GO:0031143; GO:0031201; GO:0031902; GO:0034197; GO:0035493; GO:0035577; GO:0043001; GO:0043005; GO:0043308; GO:0043312; GO:0043320; GO:0045177; GO:0045335; GO:0047496; GO:0048280; GO:0048471; GO:0050775; GO:0098686; GO:1900483; GO:1903595 calcium-ion regulated exocytosis [GO:0017156]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; endosome to lysosome transport [GO:0008333]; eosinophil degranulation [GO:0043308]; exocytosis [GO:0006887]; Golgi to plasma membrane protein transport [GO:0043001]; natural killer cell degranulation [GO:0043320]; neutrophil degranulation [GO:0043312]; phagocytosis, engulfment [GO:0006911]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of histamine secretion by mast cell [GO:1903595]; regulation of protein targeting to vacuolar membrane [GO:1900483]; SNARE complex assembly [GO:0035493]; synaptic vesicle exocytosis [GO:0016079]; triglyceride transport [GO:0034197]; vesicle fusion [GO:0006906]; vesicle fusion with Golgi apparatus [GO:0048280]; vesicle transport along microtubule [GO:0047496]; vesicle-mediated transport [GO:0016192] apical part of cell [GO:0045177]; azurophil granule membrane [GO:0035577]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; filopodium [GO:0030175]; Golgi apparatus [GO:0005794]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; lamellipodium [GO:0030027]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; neuron projection [GO:0043005]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; platelet alpha granule [GO:0031091]; pseudopodium [GO:0031143]; secretory granule [GO:0030141]; secretory granule membrane [GO:0030667]; SNARE complex [GO:0031201]; synaptic vesicle membrane [GO:0030672]; trans-Golgi network [GO:0005802]; transport vesicle [GO:0030133] SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905] g18409.t1 O95671 50.952 210 5.9999999999999995e-61 203.0 sp|O95671|ASML_HUMAN Probable bifunctional dTTP/UTP pyrophosphatase/methyltransferase protein OS=Homo sapiens OX=9606 GN=ASMTL PE=1 SV=3 ASML_HUMAN reviewed Probable bifunctional dTTP/UTP pyrophosphatase/methyltransferase protein [Includes: dTTP/UTP pyrophosphatase (dTTPase/UTPase) (EC 3.6.1.9) (Nucleoside triphosphate pyrophosphatase) (Nucleotide pyrophosphatase) (Nucleotide PPase); N-acetylserotonin O-methyltransferase-like protein (ASMTL) (EC 2.1.1.-)] Homo sapiens (Human) GO:0005829; GO:0008171; GO:0009117; GO:0032259; GO:0036218; GO:0036221; GO:0046983; GO:0047429 methylation [GO:0032259]; nucleotide metabolic process [GO:0009117] cytosol [GO:0005829] dTTP diphosphatase activity [GO:0036218]; nucleoside triphosphate diphosphatase activity [GO:0047429]; O-methyltransferase activity [GO:0008171]; protein dimerization activity [GO:0046983]; UTP diphosphatase activity [GO:0036221] g18414.t1 Q0KHY3 30.628 924 9.71e-89 323.0 sp|Q0KHY3|MESH_DROME Protein mesh OS=Drosophila melanogaster OX=7227 GN=mesh PE=1 SV=2 MESH_DROME reviewed Protein mesh Drosophila melanogaster (Fruit fly) GO:0005615; GO:0005920; GO:0007160; GO:0016327; GO:0090528 cell-matrix adhesion [GO:0007160]; smooth septate junction assembly [GO:0090528] apicolateral plasma membrane [GO:0016327]; extracellular space [GO:0005615]; smooth septate junction [GO:0005920] g18416.t1 Q9D9G3 58.434 166 3.95e-60 187.0 sp|Q9D9G3|CHIC2_MOUSE Cysteine-rich hydrophobic domain-containing protein 2 OS=Mus musculus OX=10090 GN=Chic2 PE=2 SV=1 g18423.t1 Q96PE2 46.011 539 6.78e-137 461.0 sp|Q96PE2|ARHGH_HUMAN Rho guanine nucleotide exchange factor 17 OS=Homo sapiens OX=9606 GN=ARHGEF17 PE=1 SV=1 ARHGH_HUMAN reviewed Rho guanine nucleotide exchange factor 17 (164 kDa Rho-specific guanine-nucleotide exchange factor) (p164-RhoGEF) (p164RhoGEF) (Tumor endothelial marker 4) Homo sapiens (Human) GO:0005085; GO:0005737; GO:0005829; GO:0030036; GO:0051056 actin cytoskeleton organization [GO:0030036]; regulation of small GTPase mediated signal transduction [GO:0051056] cytoplasm [GO:0005737]; cytosol [GO:0005829] guanyl-nucleotide exchange factor activity [GO:0005085] g18423.t1 Q96PE2 55.786 337 4.96e-108 376.0 sp|Q96PE2|ARHGH_HUMAN Rho guanine nucleotide exchange factor 17 OS=Homo sapiens OX=9606 GN=ARHGEF17 PE=1 SV=1 ARHGH_HUMAN reviewed Rho guanine nucleotide exchange factor 17 (164 kDa Rho-specific guanine-nucleotide exchange factor) (p164-RhoGEF) (p164RhoGEF) (Tumor endothelial marker 4) Homo sapiens (Human) GO:0005085; GO:0005737; GO:0005829; GO:0030036; GO:0051056 actin cytoskeleton organization [GO:0030036]; regulation of small GTPase mediated signal transduction [GO:0051056] cytoplasm [GO:0005737]; cytosol [GO:0005829] guanyl-nucleotide exchange factor activity [GO:0005085] g18426.t1 O60841 68.167 622 0.0 922.0 sp|O60841|IF2P_HUMAN Eukaryotic translation initiation factor 5B OS=Homo sapiens OX=9606 GN=EIF5B PE=1 SV=4 IF2P_HUMAN reviewed Eukaryotic translation initiation factor 5B (eIF-5B) (EC 3.6.5.3) (Translation initiation factor IF-2) Homo sapiens (Human) GO:0000049; GO:0003723; GO:0003743; GO:0003924; GO:0005525; GO:0005737; GO:0005829; GO:0006413; GO:0006446; GO:0042255; GO:0045202; GO:0046872 regulation of translational initiation [GO:0006446]; ribosome assembly [GO:0042255]; translational initiation [GO:0006413] cytoplasm [GO:0005737]; cytosol [GO:0005829]; synapse [GO:0045202] GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; translation initiation factor activity [GO:0003743]; tRNA binding [GO:0000049] g18428.t1 Q8VEH0 52.96 321 1.91e-94 288.0 sp|Q8VEH0|TM144_MOUSE Transmembrane protein 144 OS=Mus musculus OX=10090 GN=Tmem144 PE=2 SV=1 g18429.t1 P62909 90.476 231 1.54e-152 428.0 sp|P62909|RS3_RAT Small ribosomal subunit protein uS3 OS=Rattus norvegicus OX=10116 GN=Rps3 PE=1 SV=1 RS3_RAT reviewed Small ribosomal subunit protein uS3 (EC 4.2.99.18) (40S ribosomal protein S3) Rattus norvegicus (Rat) GO:0003677; GO:0003684; GO:0003723; GO:0003729; GO:0003735; GO:0003906; GO:0004520; GO:0005634; GO:0005730; GO:0005737; GO:0005743; GO:0005759; GO:0005783; GO:0005829; GO:0005840; GO:0005886; GO:0006281; GO:0006284; GO:0006412; GO:0006915; GO:0006974; GO:0007059; GO:0008017; GO:0010628; GO:0014069; GO:0015631; GO:0017148; GO:0019899; GO:0019900; GO:0019901; GO:0022626; GO:0022627; GO:0030425; GO:0030544; GO:0031116; GO:0031334; GO:0031397; GO:0032357; GO:0032358; GO:0032587; GO:0032743; GO:0034614; GO:0042104; GO:0042981; GO:0044390; GO:0044877; GO:0045202; GO:0045738; GO:0045739; GO:0050862; GO:0051018; GO:0051225; GO:0051301; GO:0051879; GO:0061481; GO:0070181; GO:0070301; GO:0071159; GO:0071356; GO:0072686; GO:0097100; GO:0098556; GO:0140078; GO:0140297; GO:1901224; GO:1902231; GO:1905053; GO:1990090; GO:1990904; GO:2001235 apoptotic process [GO:0006915]; base-excision repair [GO:0006284]; cell division [GO:0051301]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to nerve growth factor stimulus [GO:1990090]; cellular response to reactive oxygen species [GO:0034614]; cellular response to tumor necrosis factor [GO:0071356]; chromosome segregation [GO:0007059]; DNA damage response [GO:0006974]; DNA repair [GO:0006281]; negative regulation of DNA repair [GO:0045738]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of translation [GO:0017148]; positive regulation of activated T cell proliferation [GO:0042104]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of base-excision repair [GO:1905053]; positive regulation of DNA repair [GO:0045739]; positive regulation of gene expression [GO:0010628]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage [GO:1902231]; positive regulation of microtubule polymerization [GO:0031116]; positive regulation of non-canonical NF-kappaB signal transduction [GO:1901224]; positive regulation of protein-containing complex assembly [GO:0031334]; positive regulation of T cell receptor signaling pathway [GO:0050862]; regulation of apoptotic process [GO:0042981]; response to TNF agonist [GO:0061481]; spindle assembly [GO:0051225]; translation [GO:0006412] cytoplasm [GO:0005737]; cytoplasmic side of rough endoplasmic reticulum membrane [GO:0098556]; cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitotic spindle [GO:0072686]; NF-kappaB complex [GO:0071159]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; ribonucleoprotein complex [GO:1990904]; ribosome [GO:0005840]; ruffle membrane [GO:0032587]; synapse [GO:0045202] class I DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0140078]; damaged DNA binding [GO:0003684]; DNA binding [GO:0003677]; DNA endonuclease activity [GO:0004520]; DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0003906]; DNA-binding transcription factor binding [GO:0140297]; enzyme binding [GO:0019899]; Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]; kinase binding [GO:0019900]; microtubule binding [GO:0008017]; mRNA binding [GO:0003729]; oxidized purine DNA binding [GO:0032357]; oxidized pyrimidine DNA binding [GO:0032358]; protein kinase A binding [GO:0051018]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; small ribosomal subunit rRNA binding [GO:0070181]; structural constituent of ribosome [GO:0003735]; supercoiled DNA binding [GO:0097100]; tubulin binding [GO:0015631]; ubiquitin-like protein conjugating enzyme binding [GO:0044390] g18431.t1 P46692 88.889 72 4.51e-39 136.0 sp|P46692|HMD1_CHICK Homeobox protein CHOX-CAD OS=Gallus gallus OX=9031 GN=CHOX-CAD1 PE=2 SV=1 g18433.t1 P70118 59.559 136 6.6500000000000005e-43 154.0 sp|P70118|PDX1_MESAU Pancreas/duodenum homeobox protein 1 OS=Mesocricetus auratus OX=10036 GN=PDX1 PE=1 SV=1 g18435.t1 P31316 63.478 115 2.34e-36 134.0 sp|P31316|GSX2_MOUSE GS homeobox 2 OS=Mus musculus OX=10090 GN=Gsx2 PE=1 SV=2 g18438.t1 Q864S8 39.251 721 8.3e-144 503.0 sp|Q864S8|BRCA2_FELCA Breast cancer type 2 susceptibility protein homolog OS=Felis catus OX=9685 GN=BRCA2 PE=2 SV=2 g18441.t1 Q7T1N4 35.959 292 1.7e-64 216.0 sp|Q7T1N4|ASIC1_OPSTA Acid-sensing ion channel 1 OS=Opsanus tau OX=8068 GN=asic1 PE=1 SV=1 ASIC1_OPSTA reviewed Acid-sensing ion channel 1 (ASIC1) Opsanus tau (Oyster toadfish) (Gadus tau) GO:0005886; GO:0015280; GO:0030425; GO:0035725; GO:0045211; GO:0071467; GO:0160128 cellular response to pH [GO:0071467]; sodium ion transmembrane transport [GO:0035725] dendrite [GO:0030425]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211] ligand-gated sodium channel activity [GO:0015280]; pH-gated monoatomic ion channel activity [GO:0160128] g18446.t1 P78348 33.696 460 3.25e-86 277.0 sp|P78348|ASIC1_HUMAN Acid-sensing ion channel 1 OS=Homo sapiens OX=9606 GN=ASIC1 PE=1 SV=3 ASIC1_HUMAN reviewed Acid-sensing ion channel 1 (ASIC1) (Amiloride-sensitive cation channel 2, neuronal) (Brain sodium channel 2) Homo sapiens (Human) GO:0001662; GO:0001975; GO:0005794; GO:0005886; GO:0006814; GO:0007269; GO:0007613; GO:0008306; GO:0009986; GO:0010447; GO:0015280; GO:0022839; GO:0030425; GO:0035725; GO:0042391; GO:0046929; GO:0050915; GO:0070588; GO:0071467; GO:0098793; GO:0098839; GO:0098978; GO:0150052; GO:0160128 associative learning [GO:0008306]; behavioral fear response [GO:0001662]; calcium ion transmembrane transport [GO:0070588]; cellular response to pH [GO:0071467]; memory [GO:0007613]; negative regulation of neurotransmitter secretion [GO:0046929]; neurotransmitter secretion [GO:0007269]; regulation of membrane potential [GO:0042391]; regulation of postsynapse assembly [GO:0150052]; response to acidic pH [GO:0010447]; response to amphetamine [GO:0001975]; sensory perception of sour taste [GO:0050915]; sodium ion transmembrane transport [GO:0035725]; sodium ion transport [GO:0006814] cell surface [GO:0009986]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; presynapse [GO:0098793] ligand-gated sodium channel activity [GO:0015280]; monoatomic ion-gated channel activity [GO:0022839]; pH-gated monoatomic ion channel activity [GO:0160128] g18447.t1 P55926 35.106 470 3.7e-87 280.0 sp|P55926|ASIC1_RAT Acid-sensing ion channel 1 OS=Rattus norvegicus OX=10116 GN=Asic1 PE=1 SV=1 g18448.t1 Q6ZV65 31.202 391 3.38e-36 140.0 sp|Q6ZV65|FA47E_HUMAN Protein FAM47E OS=Homo sapiens OX=9606 GN=FAM47E PE=1 SV=3 FA47E_HUMAN reviewed Protein FAM47E Homo sapiens (Human) GO:0000785; GO:0005634; GO:0005737; GO:0008047; GO:0045815; GO:0071168 protein localization to chromatin [GO:0071168]; transcription initiation-coupled chromatin remodeling [GO:0045815] chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleus [GO:0005634] enzyme activator activity [GO:0008047] g18451.t1 O54834 38.934 488 1.22e-67 250.0 sp|O54834|RHG06_MOUSE Rho GTPase-activating protein 6 OS=Mus musculus OX=10090 GN=Arhgap6 PE=1 SV=3 g18455.t1 O75592 47.454 2514 0.0 2041.0 sp|O75592|MYCB2_HUMAN E3 ubiquitin-protein ligase MYCBP2 OS=Homo sapiens OX=9606 GN=MYCBP2 PE=1 SV=4 MYCB2_HUMAN reviewed E3 ubiquitin-protein ligase MYCBP2 (EC 2.3.2.33) (Myc-binding protein 2) (Protein associated with Myc) Homo sapiens (Human) GO:0005085; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0007411; GO:0008270; GO:0008582; GO:0015630; GO:0016020; GO:0016567; GO:0021785; GO:0021952; GO:0030424; GO:0031267; GO:0031398; GO:0032880; GO:0032922; GO:0042177; GO:0042802; GO:0050905; GO:0051493; GO:0061630; GO:0070936; GO:1902667 axon guidance [GO:0007411]; branchiomotor neuron axon guidance [GO:0021785]; central nervous system projection neuron axonogenesis [GO:0021952]; circadian regulation of gene expression [GO:0032922]; negative regulation of protein catabolic process [GO:0042177]; neuromuscular process [GO:0050905]; positive regulation of protein ubiquitination [GO:0031398]; protein K48-linked ubiquitination [GO:0070936]; protein ubiquitination [GO:0016567]; regulation of axon guidance [GO:1902667]; regulation of cytoskeleton organization [GO:0051493]; regulation of protein localization [GO:0032880]; regulation of synaptic assembly at neuromuscular junction [GO:0008582] axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886] guanyl-nucleotide exchange factor activity [GO:0005085]; identical protein binding [GO:0042802]; small GTPase binding [GO:0031267]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] g18455.t1 O75592 61.054 1176 0.0 1436.0 sp|O75592|MYCB2_HUMAN E3 ubiquitin-protein ligase MYCBP2 OS=Homo sapiens OX=9606 GN=MYCBP2 PE=1 SV=4 MYCB2_HUMAN reviewed E3 ubiquitin-protein ligase MYCBP2 (EC 2.3.2.33) (Myc-binding protein 2) (Protein associated with Myc) Homo sapiens (Human) GO:0005085; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0007411; GO:0008270; GO:0008582; GO:0015630; GO:0016020; GO:0016567; GO:0021785; GO:0021952; GO:0030424; GO:0031267; GO:0031398; GO:0032880; GO:0032922; GO:0042177; GO:0042802; GO:0050905; GO:0051493; GO:0061630; GO:0070936; GO:1902667 axon guidance [GO:0007411]; branchiomotor neuron axon guidance [GO:0021785]; central nervous system projection neuron axonogenesis [GO:0021952]; circadian regulation of gene expression [GO:0032922]; negative regulation of protein catabolic process [GO:0042177]; neuromuscular process [GO:0050905]; positive regulation of protein ubiquitination [GO:0031398]; protein K48-linked ubiquitination [GO:0070936]; protein ubiquitination [GO:0016567]; regulation of axon guidance [GO:1902667]; regulation of cytoskeleton organization [GO:0051493]; regulation of protein localization [GO:0032880]; regulation of synaptic assembly at neuromuscular junction [GO:0008582] axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886] guanyl-nucleotide exchange factor activity [GO:0005085]; identical protein binding [GO:0042802]; small GTPase binding [GO:0031267]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] g18455.t1 O75592 49.049 263 5.84e-44 182.0 sp|O75592|MYCB2_HUMAN E3 ubiquitin-protein ligase MYCBP2 OS=Homo sapiens OX=9606 GN=MYCBP2 PE=1 SV=4 MYCB2_HUMAN reviewed E3 ubiquitin-protein ligase MYCBP2 (EC 2.3.2.33) (Myc-binding protein 2) (Protein associated with Myc) Homo sapiens (Human) GO:0005085; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0007411; GO:0008270; GO:0008582; GO:0015630; GO:0016020; GO:0016567; GO:0021785; GO:0021952; GO:0030424; GO:0031267; GO:0031398; GO:0032880; GO:0032922; GO:0042177; GO:0042802; GO:0050905; GO:0051493; GO:0061630; GO:0070936; GO:1902667 axon guidance [GO:0007411]; branchiomotor neuron axon guidance [GO:0021785]; central nervous system projection neuron axonogenesis [GO:0021952]; circadian regulation of gene expression [GO:0032922]; negative regulation of protein catabolic process [GO:0042177]; neuromuscular process [GO:0050905]; positive regulation of protein ubiquitination [GO:0031398]; protein K48-linked ubiquitination [GO:0070936]; protein ubiquitination [GO:0016567]; regulation of axon guidance [GO:1902667]; regulation of cytoskeleton organization [GO:0051493]; regulation of protein localization [GO:0032880]; regulation of synaptic assembly at neuromuscular junction [GO:0008582] axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886] guanyl-nucleotide exchange factor activity [GO:0005085]; identical protein binding [GO:0042802]; small GTPase binding [GO:0031267]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] g18455.t2 O75592 47.542 2522 0.0 2046.0 sp|O75592|MYCB2_HUMAN E3 ubiquitin-protein ligase MYCBP2 OS=Homo sapiens OX=9606 GN=MYCBP2 PE=1 SV=4 MYCB2_HUMAN reviewed E3 ubiquitin-protein ligase MYCBP2 (EC 2.3.2.33) (Myc-binding protein 2) (Protein associated with Myc) Homo sapiens (Human) GO:0005085; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0007411; GO:0008270; GO:0008582; GO:0015630; GO:0016020; GO:0016567; GO:0021785; GO:0021952; GO:0030424; GO:0031267; GO:0031398; GO:0032880; GO:0032922; GO:0042177; GO:0042802; GO:0050905; GO:0051493; GO:0061630; GO:0070936; GO:1902667 axon guidance [GO:0007411]; branchiomotor neuron axon guidance [GO:0021785]; central nervous system projection neuron axonogenesis [GO:0021952]; circadian regulation of gene expression [GO:0032922]; negative regulation of protein catabolic process [GO:0042177]; neuromuscular process [GO:0050905]; positive regulation of protein ubiquitination [GO:0031398]; protein K48-linked ubiquitination [GO:0070936]; protein ubiquitination [GO:0016567]; regulation of axon guidance [GO:1902667]; regulation of cytoskeleton organization [GO:0051493]; regulation of protein localization [GO:0032880]; regulation of synaptic assembly at neuromuscular junction [GO:0008582] axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886] guanyl-nucleotide exchange factor activity [GO:0005085]; identical protein binding [GO:0042802]; small GTPase binding [GO:0031267]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] g18455.t2 O75592 61.054 1176 0.0 1436.0 sp|O75592|MYCB2_HUMAN E3 ubiquitin-protein ligase MYCBP2 OS=Homo sapiens OX=9606 GN=MYCBP2 PE=1 SV=4 MYCB2_HUMAN reviewed E3 ubiquitin-protein ligase MYCBP2 (EC 2.3.2.33) (Myc-binding protein 2) (Protein associated with Myc) Homo sapiens (Human) GO:0005085; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0007411; GO:0008270; GO:0008582; GO:0015630; GO:0016020; GO:0016567; GO:0021785; GO:0021952; GO:0030424; GO:0031267; GO:0031398; GO:0032880; GO:0032922; GO:0042177; GO:0042802; GO:0050905; GO:0051493; GO:0061630; GO:0070936; GO:1902667 axon guidance [GO:0007411]; branchiomotor neuron axon guidance [GO:0021785]; central nervous system projection neuron axonogenesis [GO:0021952]; circadian regulation of gene expression [GO:0032922]; negative regulation of protein catabolic process [GO:0042177]; neuromuscular process [GO:0050905]; positive regulation of protein ubiquitination [GO:0031398]; protein K48-linked ubiquitination [GO:0070936]; protein ubiquitination [GO:0016567]; regulation of axon guidance [GO:1902667]; regulation of cytoskeleton organization [GO:0051493]; regulation of protein localization [GO:0032880]; regulation of synaptic assembly at neuromuscular junction [GO:0008582] axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886] guanyl-nucleotide exchange factor activity [GO:0005085]; identical protein binding [GO:0042802]; small GTPase binding [GO:0031267]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] g18455.t2 O75592 49.049 263 5.63e-44 182.0 sp|O75592|MYCB2_HUMAN E3 ubiquitin-protein ligase MYCBP2 OS=Homo sapiens OX=9606 GN=MYCBP2 PE=1 SV=4 MYCB2_HUMAN reviewed E3 ubiquitin-protein ligase MYCBP2 (EC 2.3.2.33) (Myc-binding protein 2) (Protein associated with Myc) Homo sapiens (Human) GO:0005085; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0007411; GO:0008270; GO:0008582; GO:0015630; GO:0016020; GO:0016567; GO:0021785; GO:0021952; GO:0030424; GO:0031267; GO:0031398; GO:0032880; GO:0032922; GO:0042177; GO:0042802; GO:0050905; GO:0051493; GO:0061630; GO:0070936; GO:1902667 axon guidance [GO:0007411]; branchiomotor neuron axon guidance [GO:0021785]; central nervous system projection neuron axonogenesis [GO:0021952]; circadian regulation of gene expression [GO:0032922]; negative regulation of protein catabolic process [GO:0042177]; neuromuscular process [GO:0050905]; positive regulation of protein ubiquitination [GO:0031398]; protein K48-linked ubiquitination [GO:0070936]; protein ubiquitination [GO:0016567]; regulation of axon guidance [GO:1902667]; regulation of cytoskeleton organization [GO:0051493]; regulation of protein localization [GO:0032880]; regulation of synaptic assembly at neuromuscular junction [GO:0008582] axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886] guanyl-nucleotide exchange factor activity [GO:0005085]; identical protein binding [GO:0042802]; small GTPase binding [GO:0031267]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] g18455.t3 O75592 47.354 2532 0.0 2042.0 sp|O75592|MYCB2_HUMAN E3 ubiquitin-protein ligase MYCBP2 OS=Homo sapiens OX=9606 GN=MYCBP2 PE=1 SV=4 MYCB2_HUMAN reviewed E3 ubiquitin-protein ligase MYCBP2 (EC 2.3.2.33) (Myc-binding protein 2) (Protein associated with Myc) Homo sapiens (Human) GO:0005085; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0007411; GO:0008270; GO:0008582; GO:0015630; GO:0016020; GO:0016567; GO:0021785; GO:0021952; GO:0030424; GO:0031267; GO:0031398; GO:0032880; GO:0032922; GO:0042177; GO:0042802; GO:0050905; GO:0051493; GO:0061630; GO:0070936; GO:1902667 axon guidance [GO:0007411]; branchiomotor neuron axon guidance [GO:0021785]; central nervous system projection neuron axonogenesis [GO:0021952]; circadian regulation of gene expression [GO:0032922]; negative regulation of protein catabolic process [GO:0042177]; neuromuscular process [GO:0050905]; positive regulation of protein ubiquitination [GO:0031398]; protein K48-linked ubiquitination [GO:0070936]; protein ubiquitination [GO:0016567]; regulation of axon guidance [GO:1902667]; regulation of cytoskeleton organization [GO:0051493]; regulation of protein localization [GO:0032880]; regulation of synaptic assembly at neuromuscular junction [GO:0008582] axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886] guanyl-nucleotide exchange factor activity [GO:0005085]; identical protein binding [GO:0042802]; small GTPase binding [GO:0031267]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] g18455.t3 O75592 61.054 1176 0.0 1436.0 sp|O75592|MYCB2_HUMAN E3 ubiquitin-protein ligase MYCBP2 OS=Homo sapiens OX=9606 GN=MYCBP2 PE=1 SV=4 MYCB2_HUMAN reviewed E3 ubiquitin-protein ligase MYCBP2 (EC 2.3.2.33) (Myc-binding protein 2) (Protein associated with Myc) Homo sapiens (Human) GO:0005085; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0007411; GO:0008270; GO:0008582; GO:0015630; GO:0016020; GO:0016567; GO:0021785; GO:0021952; GO:0030424; GO:0031267; GO:0031398; GO:0032880; GO:0032922; GO:0042177; GO:0042802; GO:0050905; GO:0051493; GO:0061630; GO:0070936; GO:1902667 axon guidance [GO:0007411]; branchiomotor neuron axon guidance [GO:0021785]; central nervous system projection neuron axonogenesis [GO:0021952]; circadian regulation of gene expression [GO:0032922]; negative regulation of protein catabolic process [GO:0042177]; neuromuscular process [GO:0050905]; positive regulation of protein ubiquitination [GO:0031398]; protein K48-linked ubiquitination [GO:0070936]; protein ubiquitination [GO:0016567]; regulation of axon guidance [GO:1902667]; regulation of cytoskeleton organization [GO:0051493]; regulation of protein localization [GO:0032880]; regulation of synaptic assembly at neuromuscular junction [GO:0008582] axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886] guanyl-nucleotide exchange factor activity [GO:0005085]; identical protein binding [GO:0042802]; small GTPase binding [GO:0031267]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] g18455.t3 O75592 49.049 263 5.84e-44 182.0 sp|O75592|MYCB2_HUMAN E3 ubiquitin-protein ligase MYCBP2 OS=Homo sapiens OX=9606 GN=MYCBP2 PE=1 SV=4 MYCB2_HUMAN reviewed E3 ubiquitin-protein ligase MYCBP2 (EC 2.3.2.33) (Myc-binding protein 2) (Protein associated with Myc) Homo sapiens (Human) GO:0005085; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0007411; GO:0008270; GO:0008582; GO:0015630; GO:0016020; GO:0016567; GO:0021785; GO:0021952; GO:0030424; GO:0031267; GO:0031398; GO:0032880; GO:0032922; GO:0042177; GO:0042802; GO:0050905; GO:0051493; GO:0061630; GO:0070936; GO:1902667 axon guidance [GO:0007411]; branchiomotor neuron axon guidance [GO:0021785]; central nervous system projection neuron axonogenesis [GO:0021952]; circadian regulation of gene expression [GO:0032922]; negative regulation of protein catabolic process [GO:0042177]; neuromuscular process [GO:0050905]; positive regulation of protein ubiquitination [GO:0031398]; protein K48-linked ubiquitination [GO:0070936]; protein ubiquitination [GO:0016567]; regulation of axon guidance [GO:1902667]; regulation of cytoskeleton organization [GO:0051493]; regulation of protein localization [GO:0032880]; regulation of synaptic assembly at neuromuscular junction [GO:0008582] axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886] guanyl-nucleotide exchange factor activity [GO:0005085]; identical protein binding [GO:0042802]; small GTPase binding [GO:0031267]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] g18456.t1 O43451 45.612 866 0.0 744.0 sp|O43451|MGA_HUMAN Maltase-glucoamylase OS=Homo sapiens OX=9606 GN=MGAM PE=1 SV=6 MGA_HUMAN reviewed Maltase-glucoamylase (Alpha-1,4-glucosidase) (EC 3.2.1.20) Homo sapiens (Human) GO:0000025; GO:0003824; GO:0004558; GO:0004574; GO:0005886; GO:0005983; GO:0016160; GO:0016324; GO:0030246; GO:0070062; GO:0070821; GO:0101003; GO:1901027 dextrin catabolic process [GO:1901027]; maltose catabolic process [GO:0000025]; starch catabolic process [GO:0005983] apical plasma membrane [GO:0016324]; extracellular exosome [GO:0070062]; ficolin-1-rich granule membrane [GO:0101003]; plasma membrane [GO:0005886]; tertiary granule membrane [GO:0070821] alpha-1,4-glucosidase activity [GO:0004558]; amylase activity [GO:0016160]; carbohydrate binding [GO:0030246]; catalytic activity [GO:0003824]; oligo-1,6-glucosidase activity [GO:0004574] g18456.t1 O43451 44.222 900 0.0 704.0 sp|O43451|MGA_HUMAN Maltase-glucoamylase OS=Homo sapiens OX=9606 GN=MGAM PE=1 SV=6 MGA_HUMAN reviewed Maltase-glucoamylase (Alpha-1,4-glucosidase) (EC 3.2.1.20) Homo sapiens (Human) GO:0000025; GO:0003824; GO:0004558; GO:0004574; GO:0005886; GO:0005983; GO:0016160; GO:0016324; GO:0030246; GO:0070062; GO:0070821; GO:0101003; GO:1901027 dextrin catabolic process [GO:1901027]; maltose catabolic process [GO:0000025]; starch catabolic process [GO:0005983] apical plasma membrane [GO:0016324]; extracellular exosome [GO:0070062]; ficolin-1-rich granule membrane [GO:0101003]; plasma membrane [GO:0005886]; tertiary granule membrane [GO:0070821] alpha-1,4-glucosidase activity [GO:0004558]; amylase activity [GO:0016160]; carbohydrate binding [GO:0030246]; catalytic activity [GO:0003824]; oligo-1,6-glucosidase activity [GO:0004574] g18456.t1 O43451 44.793 893 0.0 690.0 sp|O43451|MGA_HUMAN Maltase-glucoamylase OS=Homo sapiens OX=9606 GN=MGAM PE=1 SV=6 MGA_HUMAN reviewed Maltase-glucoamylase (Alpha-1,4-glucosidase) (EC 3.2.1.20) Homo sapiens (Human) GO:0000025; GO:0003824; GO:0004558; GO:0004574; GO:0005886; GO:0005983; GO:0016160; GO:0016324; GO:0030246; GO:0070062; GO:0070821; GO:0101003; GO:1901027 dextrin catabolic process [GO:1901027]; maltose catabolic process [GO:0000025]; starch catabolic process [GO:0005983] apical plasma membrane [GO:0016324]; extracellular exosome [GO:0070062]; ficolin-1-rich granule membrane [GO:0101003]; plasma membrane [GO:0005886]; tertiary granule membrane [GO:0070821] alpha-1,4-glucosidase activity [GO:0004558]; amylase activity [GO:0016160]; carbohydrate binding [GO:0030246]; catalytic activity [GO:0003824]; oligo-1,6-glucosidase activity [GO:0004574] g18457.t1 P17948 44.196 672 1.48e-144 493.0 sp|P17948|VGFR1_HUMAN Vascular endothelial growth factor receptor 1 OS=Homo sapiens OX=9606 GN=FLT1 PE=1 SV=2 VGFR1_HUMAN reviewed Vascular endothelial growth factor receptor 1 (VEGFR-1) (EC 2.7.10.1) (Fms-like tyrosine kinase 1) (FLT-1) (Tyrosine-protein kinase FRT) (Tyrosine-protein kinase receptor FLT) (FLT) (Vascular permeability factor receptor) Homo sapiens (Human) GO:0002040; GO:0002548; GO:0004714; GO:0005021; GO:0005524; GO:0005615; GO:0005768; GO:0005829; GO:0005886; GO:0005925; GO:0007169; GO:0008284; GO:0015629; GO:0016477; GO:0018108; GO:0019838; GO:0030154; GO:0030335; GO:0035924; GO:0036323; GO:0036332; GO:0043235; GO:0043406; GO:0043410; GO:0045766; GO:0046777; GO:0048010; GO:0048514; GO:0048598; GO:0051897; GO:1905563; GO:1990384 blood vessel morphogenesis [GO:0048514]; cell differentiation [GO:0030154]; cell migration [GO:0016477]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; embryonic morphogenesis [GO:0048598]; hyaloid vascular plexus regression [GO:1990384]; monocyte chemotaxis [GO:0002548]; negative regulation of vascular endothelial cell proliferation [GO:1905563]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; protein autophosphorylation [GO:0046777]; sprouting angiogenesis [GO:0002040]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]; vascular endothelial growth factor receptor-1 signaling pathway [GO:0036323] actin cytoskeleton [GO:0015629]; cytosol [GO:0005829]; endosome [GO:0005768]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] ATP binding [GO:0005524]; growth factor binding [GO:0019838]; placental growth factor receptor activity [GO:0036332]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; vascular endothelial growth factor receptor activity [GO:0005021] g18457.t1 P17948 23.778 757 1.1900000000000002e-43 180.0 sp|P17948|VGFR1_HUMAN Vascular endothelial growth factor receptor 1 OS=Homo sapiens OX=9606 GN=FLT1 PE=1 SV=2 VGFR1_HUMAN reviewed Vascular endothelial growth factor receptor 1 (VEGFR-1) (EC 2.7.10.1) (Fms-like tyrosine kinase 1) (FLT-1) (Tyrosine-protein kinase FRT) (Tyrosine-protein kinase receptor FLT) (FLT) (Vascular permeability factor receptor) Homo sapiens (Human) GO:0002040; GO:0002548; GO:0004714; GO:0005021; GO:0005524; GO:0005615; GO:0005768; GO:0005829; GO:0005886; GO:0005925; GO:0007169; GO:0008284; GO:0015629; GO:0016477; GO:0018108; GO:0019838; GO:0030154; GO:0030335; GO:0035924; GO:0036323; GO:0036332; GO:0043235; GO:0043406; GO:0043410; GO:0045766; GO:0046777; GO:0048010; GO:0048514; GO:0048598; GO:0051897; GO:1905563; GO:1990384 blood vessel morphogenesis [GO:0048514]; cell differentiation [GO:0030154]; cell migration [GO:0016477]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; embryonic morphogenesis [GO:0048598]; hyaloid vascular plexus regression [GO:1990384]; monocyte chemotaxis [GO:0002548]; negative regulation of vascular endothelial cell proliferation [GO:1905563]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; protein autophosphorylation [GO:0046777]; sprouting angiogenesis [GO:0002040]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]; vascular endothelial growth factor receptor-1 signaling pathway [GO:0036323] actin cytoskeleton [GO:0015629]; cytosol [GO:0005829]; endosome [GO:0005768]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] ATP binding [GO:0005524]; growth factor binding [GO:0019838]; placental growth factor receptor activity [GO:0036332]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; vascular endothelial growth factor receptor activity [GO:0005021] g18458.t1 Q5R9L9 55.752 113 3.42e-35 122.0 sp|Q5R9L9|POMP_PONAB Proteasome maturation protein OS=Pongo abelii OX=9601 GN=POMP PE=2 SV=1 g18459.t1 Q64446 55.932 295 1.96e-82 273.0 sp|Q64446|ATP7B_MOUSE Copper-transporting ATPase 2 OS=Mus musculus OX=10090 GN=Atp7b PE=1 SV=2 ATP7B_MOUSE reviewed Copper-transporting ATPase 2 (EC 7.2.2.8) (Copper pump 2) (Wilson disease-associated protein homolog) Mus musculus (Mouse) GO:0005375; GO:0005507; GO:0005524; GO:0005770; GO:0005794; GO:0005802; GO:0005886; GO:0005923; GO:0006825; GO:0006878; GO:0006882; GO:0007595; GO:0008270; GO:0015677; GO:0016020; GO:0016323; GO:0016887; GO:0032588; GO:0043682; GO:0045177; GO:0046688; GO:0048471; GO:0051208; GO:0051604; GO:0060003; GO:0070160; GO:0071280; GO:0140581 cellular response to copper ion [GO:0071280]; copper ion export [GO:0060003]; copper ion import [GO:0015677]; copper ion transport [GO:0006825]; intracellular copper ion homeostasis [GO:0006878]; intracellular zinc ion homeostasis [GO:0006882]; lactation [GO:0007595]; protein maturation [GO:0051604]; response to copper ion [GO:0046688]; sequestering of calcium ion [GO:0051208] apical part of cell [GO:0045177]; basolateral plasma membrane [GO:0016323]; bicellular tight junction [GO:0005923]; Golgi apparatus [GO:0005794]; late endosome [GO:0005770]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; tight junction [GO:0070160]; trans-Golgi network [GO:0005802]; trans-Golgi network membrane [GO:0032588] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; copper ion binding [GO:0005507]; copper ion transmembrane transporter activity [GO:0005375]; P-type divalent copper transporter activity [GO:0043682]; P-type monovalent copper transporter activity [GO:0140581]; zinc ion binding [GO:0008270] g18460.t1 P35670 45.608 592 2.21e-148 466.0 sp|P35670|ATP7B_HUMAN Copper-transporting ATPase 2 OS=Homo sapiens OX=9606 GN=ATP7B PE=1 SV=4 ATP7B_HUMAN reviewed Copper-transporting ATPase 2 (EC 7.2.2.8) (Copper pump 2) (Wilson disease-associated protein) [Cleaved into: WND/140 kDa] Homo sapiens (Human) GO:0000139; GO:0005375; GO:0005507; GO:0005524; GO:0005739; GO:0005770; GO:0005794; GO:0005886; GO:0006825; GO:0006878; GO:0006882; GO:0007595; GO:0015677; GO:0016020; GO:0016887; GO:0032588; GO:0034220; GO:0043682; GO:0046688; GO:0051208; GO:0051604; GO:0051649; GO:0060003; GO:0075523; GO:0140581; GO:1990961 copper ion export [GO:0060003]; copper ion import [GO:0015677]; copper ion transport [GO:0006825]; establishment of localization in cell [GO:0051649]; intracellular copper ion homeostasis [GO:0006878]; intracellular zinc ion homeostasis [GO:0006882]; lactation [GO:0007595]; monoatomic ion transmembrane transport [GO:0034220]; protein maturation [GO:0051604]; response to copper ion [GO:0046688]; sequestering of calcium ion [GO:0051208]; viral translational frameshifting [GO:0075523]; xenobiotic detoxification by transmembrane export across the plasma membrane [GO:1990961] Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; late endosome [GO:0005770]; membrane [GO:0016020]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; trans-Golgi network membrane [GO:0032588] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; copper ion binding [GO:0005507]; copper ion transmembrane transporter activity [GO:0005375]; P-type divalent copper transporter activity [GO:0043682]; P-type monovalent copper transporter activity [GO:0140581] g18461.t1 Q9XT50 46.018 113 1.85e-21 92.0 sp|Q9XT50|ATP7B_SHEEP Copper-transporting ATPase 2 OS=Ovis aries OX=9940 GN=ATP7B PE=2 SV=1 g18461.t1 Q9XT50 36.364 44 1.85e-21 30.4 sp|Q9XT50|ATP7B_SHEEP Copper-transporting ATPase 2 OS=Ovis aries OX=9940 GN=ATP7B PE=2 SV=1 g18465.t1 P34913 46.558 552 1.64e-178 518.0 sp|P34913|HYES_HUMAN Bifunctional epoxide hydrolase 2 OS=Homo sapiens OX=9606 GN=EPHX2 PE=1 SV=2 HYES_HUMAN reviewed Bifunctional epoxide hydrolase 2 [Includes: Cytosolic epoxide hydrolase 2 (CEH) (EC 3.3.2.10) (Epoxide hydratase) (Soluble epoxide hydrolase) (SEH); Lipid-phosphate phosphatase (EC 3.1.3.76)] Homo sapiens (Human) GO:0000287; GO:0001558; GO:0004301; GO:0005777; GO:0005782; GO:0005829; GO:0009636; GO:0010628; GO:0015643; GO:0016311; GO:0016791; GO:0033885; GO:0042577; GO:0042632; GO:0042803; GO:0046272; GO:0046839; GO:0052642; GO:0070062; GO:0090181; GO:0097176 cholesterol homeostasis [GO:0042632]; dephosphorylation [GO:0016311]; epoxide metabolic process [GO:0097176]; phospholipid dephosphorylation [GO:0046839]; positive regulation of gene expression [GO:0010628]; regulation of cell growth [GO:0001558]; regulation of cholesterol metabolic process [GO:0090181]; response to toxic substance [GO:0009636]; stilbene catabolic process [GO:0046272] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777] 10-hydroxy-9-(phosphonooxy)octadecanoate phosphatase activity [GO:0033885]; epoxide hydrolase activity [GO:0004301]; lipid phosphatase activity [GO:0042577]; lysophosphatidic acid phosphatase activity [GO:0052642]; magnesium ion binding [GO:0000287]; phosphatase activity [GO:0016791]; protein homodimerization activity [GO:0042803]; toxic substance binding [GO:0015643] g18466.t1 Q96DM1 24.894 470 3.7600000000000004e-37 149.0 sp|Q96DM1|PGBD4_HUMAN PiggyBac transposable element-derived protein 4 OS=Homo sapiens OX=9606 GN=PGBD4 PE=1 SV=3 g18467.t1 E9QI36 67.123 511 0.0 640.0 sp|E9QI36|HARS1_DANRE Histidine--tRNA ligase OS=Danio rerio OX=7955 GN=hars PE=3 SV=2 g18469.t1 O61735 45.07 142 1.03e-32 126.0 sp|O61735|CLOCK_DROME Circadian locomoter output cycles protein kaput OS=Drosophila melanogaster OX=7227 GN=Clk PE=1 SV=3 g18470.t1 Q5RAK8 67.133 143 2.28e-58 214.0 sp|Q5RAK8|CLOCK_PONAB Circadian locomoter output cycles protein kaput OS=Pongo abelii OX=9601 GN=CLOCK PE=2 SV=1 CLOCK_PONAB reviewed Circadian locomoter output cycles protein kaput (EC 2.3.1.48) Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0000978; GO:0000981; GO:0003677; GO:0003700; GO:0004402; GO:0005634; GO:0005667; GO:0005829; GO:0006355; GO:0006473; GO:0006974; GO:0007283; GO:0031490; GO:0032922; GO:0033391; GO:0042634; GO:0042752; GO:0043161; GO:0043565; GO:0045892; GO:0045893; GO:0046983; GO:0050796; GO:0051092; GO:0051775; GO:0070888; GO:1990513; GO:2000074; GO:2000323 circadian regulation of gene expression [GO:0032922]; DNA damage response [GO:0006974]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of nuclear receptor-mediated glucocorticoid signaling pathway [GO:2000323]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein acetylation [GO:0006473]; regulation of circadian rhythm [GO:0042752]; regulation of DNA-templated transcription [GO:0006355]; regulation of hair cycle [GO:0042634]; regulation of insulin secretion [GO:0050796]; regulation of type B pancreatic cell development [GO:2000074]; response to redox state [GO:0051775]; spermatogenesis [GO:0007283] chromatoid body [GO:0033391]; CLOCK-BMAL transcription complex [GO:1990513]; cytosol [GO:0005829]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667] chromatin DNA binding [GO:0031490]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; E-box binding [GO:0070888]; histone acetyltransferase activity [GO:0004402]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565] g18471.t1 P40938 73.632 201 2.18e-115 335.0 sp|P40938|RFC3_HUMAN Replication factor C subunit 3 OS=Homo sapiens OX=9606 GN=RFC3 PE=1 SV=2 RFC3_HUMAN reviewed Replication factor C subunit 3 (Activator 1 38 kDa subunit) (A1 38 kDa subunit) (Activator 1 subunit 3) (Replication factor C 38 kDa subunit) (RF-C 38 kDa subunit) (RFC38) Homo sapiens (Human) GO:0000731; GO:0003677; GO:0003689; GO:0005634; GO:0005654; GO:0005663; GO:0006260; GO:0006261; GO:0006271; GO:0006281; GO:0008094; GO:0031390; GO:1900264 DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA strand elongation involved in DNA replication [GO:0006271]; DNA synthesis involved in DNA repair [GO:0000731]; DNA-templated DNA replication [GO:0006261]; positive regulation of DNA-directed DNA polymerase activity [GO:1900264] Ctf18 RFC-like complex [GO:0031390]; DNA replication factor C complex [GO:0005663]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] ATP-dependent activity, acting on DNA [GO:0008094]; DNA binding [GO:0003677]; DNA clamp loader activity [GO:0003689] g18472.t1 Q8R323 82.313 147 1.09e-88 265.0 sp|Q8R323|RFC3_MOUSE Replication factor C subunit 3 OS=Mus musculus OX=10090 GN=Rfc3 PE=1 SV=1 g18474.t1 A0A1B0GV85 41.772 158 2.7899999999999997e-23 99.8 sp|A0A1B0GV85|RELD1_HUMAN Reelin domain-containing protein 1 OS=Homo sapiens OX=9606 GN=REELD1 PE=2 SV=2 g18475.t1 Q0Q028 37.791 172 7.94e-26 101.0 sp|Q0Q028|DFP3_ANTMY Putative defense protein 3 OS=Antheraea mylitta OX=34739 PE=2 SV=1 g18476.t1 Q8QG64 100.0 87 3.4799999999999997e-61 185.0 sp|Q8QG64|RBX1_SALSA E3 ubiquitin-protein ligase RBX1 OS=Salmo salar OX=8030 GN=rbx1 PE=2 SV=2 g18477.t1 Q3V1U8 46.535 303 1.4e-90 275.0 sp|Q3V1U8|ELMD1_MOUSE ELMO domain-containing protein 1 OS=Mus musculus OX=10090 GN=Elmod1 PE=1 SV=2 g18478.t1 O70472 44.071 565 3.48e-136 437.0 sp|O70472|TM131_MOUSE Transmembrane protein 131 OS=Mus musculus OX=10090 GN=Tmem131 PE=2 SV=2 g18479.t1 Q92545 35.45 567 3.35e-95 342.0 sp|Q92545|TM131_HUMAN Transmembrane protein 131 OS=Homo sapiens OX=9606 GN=TMEM131 PE=1 SV=3 TM131_HUMAN reviewed Transmembrane protein 131 (Protein RW1) Homo sapiens (Human) GO:0005518; GO:0016020; GO:0032964 collagen biosynthetic process [GO:0032964] membrane [GO:0016020] collagen binding [GO:0005518] g18481.t1 Q9VCZ3 30.539 334 3.41e-39 148.0 sp|Q9VCZ3|OCTB1_DROME Octopamine receptor beta-1R OS=Drosophila melanogaster OX=7227 GN=Octbeta1R PE=2 SV=1 g18482.t1 Q9UBS8 45.38 487 3.82e-144 425.0 sp|Q9UBS8|RNF14_HUMAN E3 ubiquitin-protein ligase RNF14 OS=Homo sapiens OX=9606 GN=RNF14 PE=1 SV=1 RNF14_HUMAN reviewed E3 ubiquitin-protein ligase RNF14 (EC 2.3.2.31) (Androgen receptor-associated protein 54) (HFB30) (RING finger protein 14) Homo sapiens (Human) GO:0000151; GO:0003713; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006355; GO:0006357; GO:0006511; GO:0007165; GO:0008270; GO:0016567; GO:0019787; GO:0022626; GO:0030521; GO:0031624; GO:0045893; GO:0050681; GO:0060765; GO:0060828; GO:0061630; GO:0072344; GO:0085020; GO:0160127 androgen receptor signaling pathway [GO:0030521]; positive regulation of DNA-templated transcription [GO:0045893]; protein K6-linked ubiquitination [GO:0085020]; protein ubiquitination [GO:0016567]; protein-RNA covalent cross-linking repair [GO:0160127]; regulation of androgen receptor signaling pathway [GO:0060765]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of DNA-templated transcription [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; rescue of stalled ribosome [GO:0072344]; signal transduction [GO:0007165]; ubiquitin-dependent protein catabolic process [GO:0006511] cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151] nuclear androgen receptor binding [GO:0050681]; transcription coactivator activity [GO:0003713]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-like protein transferase activity [GO:0019787]; zinc ion binding [GO:0008270] g18491.t1 Q9WUC8 65.116 516 0.0 719.0 sp|Q9WUC8|PLRG1_RAT Pleiotropic regulator 1 OS=Rattus norvegicus OX=10116 GN=Plrg1 PE=2 SV=1 g18492.t1 P46869 37.931 377 2.9300000000000003e-66 236.0 sp|P46869|FLA10_CHLRE Kinesin-like protein FLA10 OS=Chlamydomonas reinhardtii OX=3055 GN=FLA10 PE=1 SV=1 g18493.t1 Q6PBY1 71.613 155 4.95e-75 228.0 sp|Q6PBY1|RS3A_DANRE Small ribosomal subunit protein eS1 OS=Danio rerio OX=7955 GN=rps3a PE=1 SV=3 g18494.t1 Q4R4Z6 81.633 98 1.76e-43 145.0 sp|Q4R4Z6|RS3A_MACFA Small ribosomal subunit protein eS1 OS=Macaca fascicularis OX=9541 GN=RPS3A PE=2 SV=3 RS3A_MACFA reviewed Small ribosomal subunit protein eS1 (40S ribosomal protein S3a) Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey) GO:0003735; GO:0006412; GO:0022627; GO:0030154; GO:0032040; GO:0042274; GO:1990904 cell differentiation [GO:0030154]; ribosomal small subunit biogenesis [GO:0042274]; translation [GO:0006412] cytosolic small ribosomal subunit [GO:0022627]; ribonucleoprotein complex [GO:1990904]; small-subunit processome [GO:0032040] structural constituent of ribosome [GO:0003735] g18495.t1 Q6NXB2 51.181 127 9.27e-41 136.0 sp|Q6NXB2|PDZ11_DANRE PDZ domain-containing protein 11 OS=Danio rerio OX=7955 GN=pdzd11 PE=2 SV=1 g18496.t1 Q9JMD3 47.826 138 2.35e-40 140.0 sp|Q9JMD3|STA10_MOUSE START domain-containing protein 10 OS=Mus musculus OX=10090 GN=Stard10 PE=1 SV=1 STA10_MOUSE reviewed START domain-containing protein 10 (StARD10) (PCTP-like protein) (PCTP-L) (Serologically defined colon cancer antigen 28 homolog) (StAR-related lipid transfer protein 10) Mus musculus (Mouse) GO:0005829; GO:0005902; GO:0006869; GO:0008289; GO:0016020; GO:0031514; GO:0032782; GO:0035360; GO:0046581 bile acid secretion [GO:0032782]; lipid transport [GO:0006869]; positive regulation of peroxisome proliferator activated receptor signaling pathway [GO:0035360] cytosol [GO:0005829]; intercellular canaliculus [GO:0046581]; membrane [GO:0016020]; microvillus [GO:0005902]; motile cilium [GO:0031514] lipid binding [GO:0008289] g18505.t1 Q27J81 47.839 347 6.09e-79 290.0 sp|Q27J81|INF2_HUMAN Inverted formin-2 OS=Homo sapiens OX=9606 GN=INF2 PE=1 SV=2 INF2_HUMAN reviewed Inverted formin-2 (HBEBP2-binding protein C) Homo sapiens (Human) GO:0003779; GO:0005884; GO:0030041; GO:0031267; GO:0048471; GO:0090140 actin filament polymerization [GO:0030041]; regulation of mitochondrial fission [GO:0090140] actin filament [GO:0005884]; perinuclear region of cytoplasm [GO:0048471] actin binding [GO:0003779]; small GTPase binding [GO:0031267] g18505.t1 Q27J81 35.862 435 1.08e-52 207.0 sp|Q27J81|INF2_HUMAN Inverted formin-2 OS=Homo sapiens OX=9606 GN=INF2 PE=1 SV=2 INF2_HUMAN reviewed Inverted formin-2 (HBEBP2-binding protein C) Homo sapiens (Human) GO:0003779; GO:0005884; GO:0030041; GO:0031267; GO:0048471; GO:0090140 actin filament polymerization [GO:0030041]; regulation of mitochondrial fission [GO:0090140] actin filament [GO:0005884]; perinuclear region of cytoplasm [GO:0048471] actin binding [GO:0003779]; small GTPase binding [GO:0031267] g18505.t2 Q27J81 48.538 342 1.4700000000000002e-79 292.0 sp|Q27J81|INF2_HUMAN Inverted formin-2 OS=Homo sapiens OX=9606 GN=INF2 PE=1 SV=2 INF2_HUMAN reviewed Inverted formin-2 (HBEBP2-binding protein C) Homo sapiens (Human) GO:0003779; GO:0005884; GO:0030041; GO:0031267; GO:0048471; GO:0090140 actin filament polymerization [GO:0030041]; regulation of mitochondrial fission [GO:0090140] actin filament [GO:0005884]; perinuclear region of cytoplasm [GO:0048471] actin binding [GO:0003779]; small GTPase binding [GO:0031267] g18505.t2 Q27J81 35.862 435 1.2399999999999999e-52 207.0 sp|Q27J81|INF2_HUMAN Inverted formin-2 OS=Homo sapiens OX=9606 GN=INF2 PE=1 SV=2 INF2_HUMAN reviewed Inverted formin-2 (HBEBP2-binding protein C) Homo sapiens (Human) GO:0003779; GO:0005884; GO:0030041; GO:0031267; GO:0048471; GO:0090140 actin filament polymerization [GO:0030041]; regulation of mitochondrial fission [GO:0090140] actin filament [GO:0005884]; perinuclear region of cytoplasm [GO:0048471] actin binding [GO:0003779]; small GTPase binding [GO:0031267] g18506.t1 Q5RFI8 53.589 599 0.0 671.0 sp|Q5RFI8|PGM2_PONAB Phosphopentomutase OS=Pongo abelii OX=9601 GN=PGM2 PE=2 SV=3 PGM2_PONAB reviewed Phosphopentomutase (EC 5.4.2.7) (Glucose phosphomutase 2) (Phosphodeoxyribomutase) (Phosphoglucomutase-2) (PGM 2) (EC 5.4.2.2) Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0000287; GO:0004614; GO:0005634; GO:0005829; GO:0006006; GO:0006166; GO:0008973 glucose metabolic process [GO:0006006]; purine ribonucleoside salvage [GO:0006166] cytosol [GO:0005829]; nucleus [GO:0005634] magnesium ion binding [GO:0000287]; phosphoglucomutase activity [GO:0004614]; phosphopentomutase activity [GO:0008973] g18510.t1 Q9GZS1 30.549 419 5.54e-50 177.0 sp|Q9GZS1|RPA49_HUMAN DNA-directed RNA polymerase I subunit RPA49 OS=Homo sapiens OX=9606 GN=POLR1E PE=1 SV=3 RPA49_HUMAN reviewed DNA-directed RNA polymerase I subunit RPA49 (RNA polymerase I subunit A49) (DNA-directed RNA polymerase I subunit E) (RNA polymerase I-associated factor 1) (RNA polymerase I-associated factor 53) Homo sapiens (Human) GO:0001179; GO:0001188; GO:0001650; GO:0003677; GO:0005654; GO:0005730; GO:0005736; GO:0006361; GO:0006362; GO:0042790 nucleolar large rRNA transcription by RNA polymerase I [GO:0042790]; RNA polymerase I preinitiation complex assembly [GO:0001188]; transcription elongation by RNA polymerase I [GO:0006362]; transcription initiation at RNA polymerase I promoter [GO:0006361] fibrillar center [GO:0001650]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; RNA polymerase I complex [GO:0005736] DNA binding [GO:0003677]; RNA polymerase I general transcription initiation factor binding [GO:0001179] g18512.t1 Q9BVH7 40.0 105 2.6e-22 84.3 sp|Q9BVH7|SIA7E_HUMAN Alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 5 OS=Homo sapiens OX=9606 GN=ST6GALNAC5 PE=1 SV=1 SIA7E_HUMAN reviewed Alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 5 (EC 2.4.99.-) (GD1 alpha synthase) (GalNAc alpha-2,6-sialyltransferase V) (ST6GalNAc V) (ST6GalNAcV) (Sialyltransferase 7E) (SIAT7-E) Homo sapiens (Human) GO:0000139; GO:0001574; GO:0001665; GO:0006688; GO:0008373; GO:0009311; GO:0009312 ganglioside biosynthetic process [GO:0001574]; glycosphingolipid biosynthetic process [GO:0006688]; oligosaccharide biosynthetic process [GO:0009312]; oligosaccharide metabolic process [GO:0009311] Golgi membrane [GO:0000139] alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity [GO:0001665]; sialyltransferase activity [GO:0008373] g18512.t1 Q9BVH7 68.0 25 2.6e-22 42.7 sp|Q9BVH7|SIA7E_HUMAN Alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 5 OS=Homo sapiens OX=9606 GN=ST6GALNAC5 PE=1 SV=1 SIA7E_HUMAN reviewed Alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 5 (EC 2.4.99.-) (GD1 alpha synthase) (GalNAc alpha-2,6-sialyltransferase V) (ST6GalNAc V) (ST6GalNAcV) (Sialyltransferase 7E) (SIAT7-E) Homo sapiens (Human) GO:0000139; GO:0001574; GO:0001665; GO:0006688; GO:0008373; GO:0009311; GO:0009312 ganglioside biosynthetic process [GO:0001574]; glycosphingolipid biosynthetic process [GO:0006688]; oligosaccharide biosynthetic process [GO:0009312]; oligosaccharide metabolic process [GO:0009311] Golgi membrane [GO:0000139] alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity [GO:0001665]; sialyltransferase activity [GO:0008373] g18513.t1 P81436 75.67 1044 0.0 1648.0 sp|P81436|OGT1_RABIT UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit OS=Oryctolagus cuniculus OX=9986 GN=OGT PE=1 SV=2 g18516.t1 Q9Y2L1 61.398 329 2.87e-141 426.0 sp|Q9Y2L1|RRP44_HUMAN Exosome complex exonuclease RRP44 OS=Homo sapiens OX=9606 GN=DIS3 PE=1 SV=2 RRP44_HUMAN reviewed Exosome complex exonuclease RRP44 (EC 3.1.13.-) (EC 3.1.26.-) (Protein DIS3 homolog) (Ribosomal RNA-processing protein 44) Homo sapiens (Human) GO:0000175; GO:0000176; GO:0000177; GO:0000178; GO:0000288; GO:0003723; GO:0004519; GO:0005085; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0006364; GO:0006396; GO:0006401; GO:0016020; GO:0016075; GO:0071031; GO:0071034 CUT catabolic process [GO:0071034]; nuclear mRNA surveillance of mRNA 3'-end processing [GO:0071031]; nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:0000288]; RNA catabolic process [GO:0006401]; RNA processing [GO:0006396]; rRNA catabolic process [GO:0016075]; rRNA processing [GO:0006364] cytoplasmic exosome (RNase complex) [GO:0000177]; cytosol [GO:0005829]; exosome (RNase complex) [GO:0000178]; membrane [GO:0016020]; nuclear exosome (RNase complex) [GO:0000176]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] 3'-5'-RNA exonuclease activity [GO:0000175]; endonuclease activity [GO:0004519]; guanyl-nucleotide exchange factor activity [GO:0005085]; RNA binding [GO:0003723] g18517.t1 Q9Y2L1 54.475 514 0.0 536.0 sp|Q9Y2L1|RRP44_HUMAN Exosome complex exonuclease RRP44 OS=Homo sapiens OX=9606 GN=DIS3 PE=1 SV=2 RRP44_HUMAN reviewed Exosome complex exonuclease RRP44 (EC 3.1.13.-) (EC 3.1.26.-) (Protein DIS3 homolog) (Ribosomal RNA-processing protein 44) Homo sapiens (Human) GO:0000175; GO:0000176; GO:0000177; GO:0000178; GO:0000288; GO:0003723; GO:0004519; GO:0005085; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0006364; GO:0006396; GO:0006401; GO:0016020; GO:0016075; GO:0071031; GO:0071034 CUT catabolic process [GO:0071034]; nuclear mRNA surveillance of mRNA 3'-end processing [GO:0071031]; nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:0000288]; RNA catabolic process [GO:0006401]; RNA processing [GO:0006396]; rRNA catabolic process [GO:0016075]; rRNA processing [GO:0006364] cytoplasmic exosome (RNase complex) [GO:0000177]; cytosol [GO:0005829]; exosome (RNase complex) [GO:0000178]; membrane [GO:0016020]; nuclear exosome (RNase complex) [GO:0000176]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] 3'-5'-RNA exonuclease activity [GO:0000175]; endonuclease activity [GO:0004519]; guanyl-nucleotide exchange factor activity [GO:0005085]; RNA binding [GO:0003723] g18519.t1 Q6UWW8 29.487 390 3.94e-41 162.0 sp|Q6UWW8|EST3_HUMAN Carboxylesterase 3 OS=Homo sapiens OX=9606 GN=CES3 PE=1 SV=1 EST3_HUMAN reviewed Carboxylesterase 3 (EC 3.1.1.1) (Liver carboxylesterase 31 homolog) Homo sapiens (Human) GO:0005788; GO:0005829; GO:0006805; GO:0034383; GO:0052689; GO:0070062; GO:0106435 low-density lipoprotein particle clearance [GO:0034383]; xenobiotic metabolic process [GO:0006805] cytosol [GO:0005829]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062] carboxylesterase activity [GO:0106435]; carboxylic ester hydrolase activity [GO:0052689] g18520.t1 Q8IZP9 31.373 459 1.51e-41 169.0 sp|Q8IZP9|AGRG2_HUMAN Adhesion G-protein coupled receptor G2 OS=Homo sapiens OX=9606 GN=ADGRG2 PE=1 SV=2 AGRG2_HUMAN reviewed Adhesion G-protein coupled receptor G2 (G-protein coupled receptor 64) (Human epididymis-specific protein 6) (He6) [Cleaved into: Adhesion G-protein coupled receptor G2, N-terminal fragment (ADGRG2 N-terminal fragment); Adhesion G-protein coupled receptor G2, C-terminal fragment (ADGRG2 C-terminal fragment)] Homo sapiens (Human) GO:0004930; GO:0005829; GO:0005886; GO:0007166; GO:0007186; GO:0007189; GO:0007200; GO:0007283; GO:0007286; GO:0009986; GO:0016020; GO:0016324; GO:0070062 adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283] apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; plasma membrane [GO:0005886] G protein-coupled receptor activity [GO:0004930] g18522.t1 P81908 32.222 540 1.34e-67 239.0 sp|P81908|CHLE_HORSE Cholinesterase OS=Equus caballus OX=9796 GN=BCHE PE=1 SV=1 g18523.t1 Q8R0W5 31.743 545 8.149999999999999e-68 239.0 sp|Q8R0W5|EST4A_MOUSE Carboxylesterase 4A OS=Mus musculus OX=10090 GN=Ces4a PE=2 SV=2 g18524.t1 P16303 32.995 591 5.04e-78 271.0 sp|P16303|EST1D_RAT Carboxylesterase 1D OS=Rattus norvegicus OX=10116 GN=Ces1d PE=1 SV=2 EST1D_RAT reviewed Carboxylesterase 1D (Carboxyesterase ES-10) (Carboxylesterase 3) (EC 3.1.1.1, EC 3.1.1.67) (ES-HVEL) (Fatty acid ethyl ester synthase) (FAEE synthase) (Liver carboxylesterase 10) (pI 6.1 esterase) Rattus norvegicus (Rat) GO:0001523; GO:0004771; GO:0004806; GO:0005737; GO:0005783; GO:0005788; GO:0005811; GO:0005829; GO:0006695; GO:0008203; GO:0009409; GO:0010875; GO:0010887; GO:0016042; GO:0019626; GO:0030339; GO:0030855; GO:0034379; GO:0042632; GO:0043231; GO:0043691; GO:0045471; GO:0045944; GO:0046464; GO:0047376; GO:0050253; GO:0051791; GO:0052689; GO:0060086; GO:0061725; GO:0070417; GO:0070857; GO:0071397; GO:0071404; GO:0090205; GO:0106106; GO:0106435; GO:0120188 acylglycerol catabolic process [GO:0046464]; cellular response to cholesterol [GO:0071397]; cellular response to cold [GO:0070417]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; cholesterol biosynthetic process [GO:0006695]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; circadian temperature homeostasis [GO:0060086]; cold-induced thermogenesis [GO:0106106]; cytosolic lipolysis [GO:0061725]; epithelial cell differentiation [GO:0030855]; lipid catabolic process [GO:0016042]; medium-chain fatty acid metabolic process [GO:0051791]; negative regulation of cholesterol storage [GO:0010887]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of cholesterol metabolic process [GO:0090205]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of bile acid biosynthetic process [GO:0070857]; regulation of bile acid secretion [GO:0120188]; response to cold [GO:0009409]; response to ethanol [GO:0045471]; retinoid metabolic process [GO:0001523]; reverse cholesterol transport [GO:0043691]; short-chain fatty acid catabolic process [GO:0019626]; very-low-density lipoprotein particle assembly [GO:0034379] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; intracellular membrane-bounded organelle [GO:0043231]; lipid droplet [GO:0005811] all-trans-retinyl-palmitate hydrolase, all-trans-retinol forming activity [GO:0047376]; carboxylesterase activity [GO:0106435]; carboxylic ester hydrolase activity [GO:0052689]; fatty-acyl-ethyl-ester synthase activity [GO:0030339]; retinyl-palmitate esterase activity [GO:0050253]; sterol ester esterase activity [GO:0004771]; triacylglycerol lipase activity [GO:0004806] g18524.t1 P16303 29.443 557 9.4e-61 222.0 sp|P16303|EST1D_RAT Carboxylesterase 1D OS=Rattus norvegicus OX=10116 GN=Ces1d PE=1 SV=2 EST1D_RAT reviewed Carboxylesterase 1D (Carboxyesterase ES-10) (Carboxylesterase 3) (EC 3.1.1.1, EC 3.1.1.67) (ES-HVEL) (Fatty acid ethyl ester synthase) (FAEE synthase) (Liver carboxylesterase 10) (pI 6.1 esterase) Rattus norvegicus (Rat) GO:0001523; GO:0004771; GO:0004806; GO:0005737; GO:0005783; GO:0005788; GO:0005811; GO:0005829; GO:0006695; GO:0008203; GO:0009409; GO:0010875; GO:0010887; GO:0016042; GO:0019626; GO:0030339; GO:0030855; GO:0034379; GO:0042632; GO:0043231; GO:0043691; GO:0045471; GO:0045944; GO:0046464; GO:0047376; GO:0050253; GO:0051791; GO:0052689; GO:0060086; GO:0061725; GO:0070417; GO:0070857; GO:0071397; GO:0071404; GO:0090205; GO:0106106; GO:0106435; GO:0120188 acylglycerol catabolic process [GO:0046464]; cellular response to cholesterol [GO:0071397]; cellular response to cold [GO:0070417]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; cholesterol biosynthetic process [GO:0006695]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; circadian temperature homeostasis [GO:0060086]; cold-induced thermogenesis [GO:0106106]; cytosolic lipolysis [GO:0061725]; epithelial cell differentiation [GO:0030855]; lipid catabolic process [GO:0016042]; medium-chain fatty acid metabolic process [GO:0051791]; negative regulation of cholesterol storage [GO:0010887]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of cholesterol metabolic process [GO:0090205]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of bile acid biosynthetic process [GO:0070857]; regulation of bile acid secretion [GO:0120188]; response to cold [GO:0009409]; response to ethanol [GO:0045471]; retinoid metabolic process [GO:0001523]; reverse cholesterol transport [GO:0043691]; short-chain fatty acid catabolic process [GO:0019626]; very-low-density lipoprotein particle assembly [GO:0034379] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; intracellular membrane-bounded organelle [GO:0043231]; lipid droplet [GO:0005811] all-trans-retinyl-palmitate hydrolase, all-trans-retinol forming activity [GO:0047376]; carboxylesterase activity [GO:0106435]; carboxylic ester hydrolase activity [GO:0052689]; fatty-acyl-ethyl-ester synthase activity [GO:0030339]; retinyl-palmitate esterase activity [GO:0050253]; sterol ester esterase activity [GO:0004771]; triacylglycerol lipase activity [GO:0004806] g18525.t1 P23795 29.942 344 9.390000000000001e-26 116.0 sp|P23795|ACES_BOVIN Acetylcholinesterase OS=Bos taurus OX=9913 GN=ACHE PE=1 SV=2 ACES_BOVIN reviewed Acetylcholinesterase (AChE) (EC 3.1.1.7) Bos taurus (Bovine) GO:0001540; GO:0003990; GO:0005615; GO:0005886; GO:0006581; GO:0019695; GO:0045202; GO:0098552 acetylcholine catabolic process [GO:0006581]; choline metabolic process [GO:0019695] extracellular space [GO:0005615]; plasma membrane [GO:0005886]; side of membrane [GO:0098552]; synapse [GO:0045202] acetylcholinesterase activity [GO:0003990]; amyloid-beta binding [GO:0001540] g18528.t1 O62761 42.951 305 2.1199999999999998e-53 192.0 sp|O62761|CHLE_PANTT Cholinesterase OS=Panthera tigris tigris OX=74535 GN=BCHE PE=2 SV=1 g18529.t1 Q9NV70 48.373 922 0.0 832.0 sp|Q9NV70|EXOC1_HUMAN Exocyst complex component 1 OS=Homo sapiens OX=9606 GN=EXOC1 PE=1 SV=4 EXOC1_HUMAN reviewed Exocyst complex component 1 (Exocyst complex component Sec3) Homo sapiens (Human) GO:0000145; GO:0000281; GO:0005546; GO:0005737; GO:0005829; GO:0005886; GO:0006887; GO:0006893; GO:0006904; GO:0015031; GO:0016020; GO:0016241; GO:0048471; GO:0051607; GO:0090148; GO:0090522; GO:0090543 defense response to virus [GO:0051607]; exocytosis [GO:0006887]; Golgi to plasma membrane transport [GO:0006893]; membrane fission [GO:0090148]; mitotic cytokinesis [GO:0000281]; protein transport [GO:0015031]; regulation of macroautophagy [GO:0016241]; vesicle docking involved in exocytosis [GO:0006904]; vesicle tethering involved in exocytosis [GO:0090522] cytoplasm [GO:0005737]; cytosol [GO:0005829]; exocyst [GO:0000145]; Flemming body [GO:0090543]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886] phosphatidylinositol-4,5-bisphosphate binding [GO:0005546] g18532.t1 Q8WZ64 29.66 1089 2.9900000000000003e-122 431.0 sp|Q8WZ64|ARAP2_HUMAN Arf-GAP with Rho-GAP domain, ANK repeat and PH domain-containing protein 2 OS=Homo sapiens OX=9606 GN=ARAP2 PE=1 SV=3 g18533.t1 Q9QZ03 32.026 306 1.2300000000000001e-37 140.0 sp|Q9QZ03|S39A1_MOUSE Zinc transporter ZIP1 OS=Mus musculus OX=10090 GN=Slc39a1 PE=1 SV=3 S39A1_MOUSE reviewed Zinc transporter ZIP1 (Solute carrier family 39 member 1) (Zinc-iron-regulated transporter-like) (Zrt- and Irt-like protein 1) (ZIP-1) (mZIP1) Mus musculus (Mouse) GO:0001701; GO:0005102; GO:0005385; GO:0005789; GO:0005886; GO:0006829; GO:0048701; GO:0060173; GO:0071577 embryonic cranial skeleton morphogenesis [GO:0048701]; in utero embryonic development [GO:0001701]; limb development [GO:0060173]; zinc ion transmembrane transport [GO:0071577]; zinc ion transport [GO:0006829] endoplasmic reticulum membrane [GO:0005789]; plasma membrane [GO:0005886] signaling receptor binding [GO:0005102]; zinc ion transmembrane transporter activity [GO:0005385] g18534.t1 Q7T1N4 29.333 450 8.370000000000001e-63 215.0 sp|Q7T1N4|ASIC1_OPSTA Acid-sensing ion channel 1 OS=Opsanus tau OX=8068 GN=asic1 PE=1 SV=1 ASIC1_OPSTA reviewed Acid-sensing ion channel 1 (ASIC1) Opsanus tau (Oyster toadfish) (Gadus tau) GO:0005886; GO:0015280; GO:0030425; GO:0035725; GO:0045211; GO:0071467; GO:0160128 cellular response to pH [GO:0071467]; sodium ion transmembrane transport [GO:0035725] dendrite [GO:0030425]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211] ligand-gated sodium channel activity [GO:0015280]; pH-gated monoatomic ion channel activity [GO:0160128] g18536.t1 P51954 78.182 275 5.9299999999999995e-149 454.0 sp|P51954|NEK1_MOUSE Serine/threonine-protein kinase Nek1 OS=Mus musculus OX=10090 GN=Nek1 PE=1 SV=2 NEK1_MOUSE reviewed Serine/threonine-protein kinase Nek1 (EC 2.7.11.1) (Never in mitosis A-related kinase 1) (NimA-related protein kinase 1) Mus musculus (Mouse) GO:0000242; GO:0001822; GO:0004672; GO:0004674; GO:0004713; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005929; GO:0006974; GO:0007283; GO:0010212; GO:0016301; GO:0034451; GO:0035264; GO:0046872; GO:0051301; GO:0060271; GO:0071889; GO:0106310; GO:2000001 cell division [GO:0051301]; cilium assembly [GO:0060271]; DNA damage response [GO:0006974]; kidney development [GO:0001822]; multicellular organism growth [GO:0035264]; regulation of DNA damage checkpoint [GO:2000001]; response to ionizing radiation [GO:0010212]; spermatogenesis [GO:0007283] centriolar satellite [GO:0034451]; centrosome [GO:0005813]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pericentriolar material [GO:0000242] 14-3-3 protein binding [GO:0071889]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713] g18537.t1 O43678 59.341 91 4.23e-34 115.0 sp|O43678|NDUA2_HUMAN NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 2 OS=Homo sapiens OX=9606 GN=NDUFA2 PE=1 SV=3 NDUA2_HUMAN reviewed NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 2 (Complex I-B8) (CI-B8) (NADH-ubiquinone oxidoreductase B8 subunit) Homo sapiens (Human) GO:0001835; GO:0005739; GO:0005743; GO:0006120; GO:0008137; GO:0009060; GO:0031966; GO:0042776; GO:0045271 aerobic respiration [GO:0009060]; blastocyst hatching [GO:0001835]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; proton motive force-driven mitochondrial ATP synthesis [GO:0042776] mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; respiratory chain complex I [GO:0045271] NADH dehydrogenase (ubiquinone) activity [GO:0008137] g18538.t1 P35846 43.056 216 5.76e-62 198.0 sp|P35846|FOLR1_MOUSE Folate receptor alpha OS=Mus musculus OX=10090 GN=Folr1 PE=1 SV=2 FOLR1_MOUSE reviewed Folate receptor alpha (FR-alpha) (Folate receptor 1) (Folate-binding protein 1) Mus musculus (Mouse) GO:0001947; GO:0003147; GO:0003253; GO:0005542; GO:0005576; GO:0005634; GO:0005768; GO:0005886; GO:0006620; GO:0007155; GO:0007342; GO:0009897; GO:0015884; GO:0016020; GO:0016323; GO:0016324; GO:0017015; GO:0030136; GO:0031103; GO:0031526; GO:0035036; GO:0038023; GO:0046654; GO:0046655; GO:0048678; GO:0060828; GO:0061626; GO:0061713; GO:0061714; GO:0071231 anterior neural tube closure [GO:0061713]; axon regeneration [GO:0031103]; cardiac neural crest cell migration involved in outflow tract morphogenesis [GO:0003253]; cell adhesion [GO:0007155]; cellular response to folic acid [GO:0071231]; folic acid metabolic process [GO:0046655]; folic acid transport [GO:0015884]; fusion of sperm to egg plasma membrane involved in single fertilization [GO:0007342]; heart looping [GO:0001947]; neural crest cell migration involved in heart formation [GO:0003147]; pharyngeal arch artery morphogenesis [GO:0061626]; post-translational protein targeting to endoplasmic reticulum membrane [GO:0006620]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of transforming growth factor beta receptor signaling pathway [GO:0017015]; response to axon injury [GO:0048678]; sperm-egg recognition [GO:0035036]; tetrahydrofolate biosynthetic process [GO:0046654] apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; brush border membrane [GO:0031526]; clathrin-coated vesicle [GO:0030136]; endosome [GO:0005768]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886] folic acid binding [GO:0005542]; folic acid receptor activity [GO:0061714]; signaling receptor activity [GO:0038023] g18539.t1 Q3EC11 28.519 540 8.680000000000001e-65 223.0 sp|Q3EC11|ZDHC2_ARATH Probable protein S-acyltransferase 23 OS=Arabidopsis thaliana OX=3702 GN=PAT23 PE=2 SV=2 ZDHC2_ARATH reviewed Probable protein S-acyltransferase 23 (EC 2.3.1.225) (Probable palmitoyltransferase At2g14255) (Zinc finger DHHC domain-containing protein At2g14255) Arabidopsis thaliana (Mouse-ear cress) GO:0000139; GO:0005794; GO:0019706 Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139] protein-cysteine S-palmitoyltransferase activity [GO:0019706] g18544.t1 Q0GE19 65.559 331 3.4199999999999996e-146 419.0 sp|Q0GE19|NTCP7_HUMAN Sodium/bile acid cotransporter 7 OS=Homo sapiens OX=9606 GN=SLC10A7 PE=1 SV=2 NTCP7_HUMAN reviewed Sodium/bile acid cotransporter 7 (Na(+)/bile acid cotransporter 7) (Solute carrier family 10 member 7) Homo sapiens (Human) GO:0000139; GO:0005783; GO:0005789; GO:0005794; GO:0005886; GO:0006814; GO:0006874; GO:0015293; GO:0030210; GO:0060348 bone development [GO:0060348]; heparin proteoglycan biosynthetic process [GO:0030210]; intracellular calcium ion homeostasis [GO:0006874]; sodium ion transport [GO:0006814] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886] symporter activity [GO:0015293] g18545.t1 Q8K2Y0 52.991 117 1.8e-35 143.0 sp|Q8K2Y0|OBI1_MOUSE ORC ubiquitin ligase 1 OS=Mus musculus OX=10090 GN=Obi1 PE=1 SV=2 g18549.t1 Q63934 68.889 225 1.7399999999999998e-94 285.0 sp|Q63934|PO4F2_MOUSE POU domain, class 4, transcription factor 2 OS=Mus musculus OX=10090 GN=Pou4f2 PE=1 SV=1 PO4F2_MOUSE reviewed POU domain, class 4, transcription factor 2 (Brain-specific homeobox/POU domain protein 3B) (Brain-3B) (Brn-3B) (Brn-3.2) Mus musculus (Mouse) GO:0000122; GO:0000165; GO:0000791; GO:0000977; GO:0000978; GO:0000981; GO:0001227; GO:0001228; GO:0002039; GO:0003682; GO:0003700; GO:0005634; GO:0005667; GO:0005737; GO:0006357; GO:0006915; GO:0007283; GO:0007409; GO:0007411; GO:0007507; GO:0007605; GO:0010468; GO:0010666; GO:0016607; GO:0030182; GO:0030520; GO:0031290; GO:0032869; GO:0043068; GO:0043433; GO:0043565; GO:0045596; GO:0045597; GO:0045672; GO:0045773; GO:0045944; GO:0046326; GO:0048675; GO:0050885; GO:0051090; GO:0060041; GO:0071345; GO:0071392; GO:0071453; GO:0072332; GO:0090259; GO:1902870; GO:1904178; GO:1990791; GO:1990841; GO:2000679 apoptotic process [GO:0006915]; axon extension [GO:0048675]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; cellular response to cytokine stimulus [GO:0071345]; cellular response to estradiol stimulus [GO:0071392]; cellular response to insulin stimulus [GO:0032869]; cellular response to oxygen levels [GO:0071453]; dorsal root ganglion development [GO:1990791]; estrogen receptor signaling pathway [GO:0030520]; heart development [GO:0007507]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; MAPK cascade [GO:0000165]; negative regulation of adipose tissue development [GO:1904178]; negative regulation of amacrine cell differentiation [GO:1902870]; negative regulation of cell differentiation [GO:0045596]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuromuscular process controlling balance [GO:0050885]; neuron differentiation [GO:0030182]; positive regulation of axon extension [GO:0045773]; positive regulation of cardiac muscle cell apoptotic process [GO:0010666]; positive regulation of cell differentiation [GO:0045597]; positive regulation of D-glucose import [GO:0046326]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of programmed cell death [GO:0043068]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription regulatory region DNA binding [GO:2000679]; regulation of DNA-binding transcription factor activity [GO:0051090]; regulation of gene expression [GO:0010468]; regulation of retinal ganglion cell axon guidance [GO:0090259]; regulation of transcription by RNA polymerase II [GO:0006357]; retina development in camera-type eye [GO:0060041]; retinal ganglion cell axon guidance [GO:0031290]; sensory perception of sound [GO:0007605]; spermatogenesis [GO:0007283] cytoplasm [GO:0005737]; euchromatin [GO:0000791]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667] chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; p53 binding [GO:0002039]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565] g18550.t1 Q3MII6 39.106 179 3.16e-29 125.0 sp|Q3MII6|TBC25_HUMAN TBC1 domain family member 25 OS=Homo sapiens OX=9606 GN=TBC1D25 PE=1 SV=2 TBC25_HUMAN reviewed TBC1 domain family member 25 Homo sapiens (Human) GO:0005096; GO:0005776; GO:0006914; GO:0031410; GO:1901096 autophagy [GO:0006914]; regulation of autophagosome maturation [GO:1901096] autophagosome [GO:0005776]; cytoplasmic vesicle [GO:0031410] GTPase activator activity [GO:0005096] g18551.t1 Q9UHC3 28.541 473 2.7200000000000003e-31 130.0 sp|Q9UHC3|ASIC3_HUMAN Acid-sensing ion channel 3 OS=Homo sapiens OX=9606 GN=ASIC3 PE=1 SV=2 g18552.t1 Q10751 46.78 590 0.0 584.0 sp|Q10751|ACE_CHICK Angiotensin-converting enzyme OS=Gallus gallus OX=9031 GN=ACE PE=2 SV=2 ACE_CHICK reviewed Angiotensin-converting enzyme (ACE) (EC 3.4.15.1) (Dipeptidyl carboxypeptidase I) (Kininase II) Gallus gallus (Chicken) GO:0001822; GO:0002003; GO:0003084; GO:0004180; GO:0004222; GO:0005615; GO:0005737; GO:0005886; GO:0008217; GO:0008237; GO:0008241; GO:0008270; GO:0008283; GO:0010814; GO:0010815; GO:0016020; GO:0031404; GO:0042445; GO:0042447; GO:0048167; GO:0060319; GO:0070573 angiotensin maturation [GO:0002003]; bradykinin catabolic process [GO:0010815]; cell population proliferation [GO:0008283]; hormone catabolic process [GO:0042447]; hormone metabolic process [GO:0042445]; kidney development [GO:0001822]; positive regulation of systemic arterial blood pressure [GO:0003084]; primitive erythrocyte differentiation [GO:0060319]; regulation of blood pressure [GO:0008217]; regulation of synaptic plasticity [GO:0048167]; substance P catabolic process [GO:0010814] cytoplasm [GO:0005737]; extracellular space [GO:0005615]; membrane [GO:0016020]; plasma membrane [GO:0005886] carboxypeptidase activity [GO:0004180]; chloride ion binding [GO:0031404]; metallodipeptidase activity [GO:0070573]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; peptidyl-dipeptidase activity [GO:0008241]; zinc ion binding [GO:0008270] g18552.t1 Q10751 43.426 578 2.1899999999999998e-176 539.0 sp|Q10751|ACE_CHICK Angiotensin-converting enzyme OS=Gallus gallus OX=9031 GN=ACE PE=2 SV=2 ACE_CHICK reviewed Angiotensin-converting enzyme (ACE) (EC 3.4.15.1) (Dipeptidyl carboxypeptidase I) (Kininase II) Gallus gallus (Chicken) GO:0001822; GO:0002003; GO:0003084; GO:0004180; GO:0004222; GO:0005615; GO:0005737; GO:0005886; GO:0008217; GO:0008237; GO:0008241; GO:0008270; GO:0008283; GO:0010814; GO:0010815; GO:0016020; GO:0031404; GO:0042445; GO:0042447; GO:0048167; GO:0060319; GO:0070573 angiotensin maturation [GO:0002003]; bradykinin catabolic process [GO:0010815]; cell population proliferation [GO:0008283]; hormone catabolic process [GO:0042447]; hormone metabolic process [GO:0042445]; kidney development [GO:0001822]; positive regulation of systemic arterial blood pressure [GO:0003084]; primitive erythrocyte differentiation [GO:0060319]; regulation of blood pressure [GO:0008217]; regulation of synaptic plasticity [GO:0048167]; substance P catabolic process [GO:0010814] cytoplasm [GO:0005737]; extracellular space [GO:0005615]; membrane [GO:0016020]; plasma membrane [GO:0005886] carboxypeptidase activity [GO:0004180]; chloride ion binding [GO:0031404]; metallodipeptidase activity [GO:0070573]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; peptidyl-dipeptidase activity [GO:0008241]; zinc ion binding [GO:0008270] g18553.t1 P61647 35.616 219 2.17e-38 145.0 sp|P61647|SIA8F_HUMAN Alpha-2,8-sialyltransferase 8F OS=Homo sapiens OX=9606 GN=ST8SIA6 PE=1 SV=1 SIA8F_HUMAN reviewed Alpha-2,8-sialyltransferase 8F (EC 2.4.99.-) (Sialyltransferase 8F) (SIAT8-F) (Sialyltransferase St8Sia VI) (ST8SiaVI) Homo sapiens (Human) GO:0000139; GO:0001574; GO:0001835; GO:0003828; GO:0006491; GO:0006493; GO:0008373; GO:0009100; GO:0009247; GO:0009311; GO:0016051 blastocyst hatching [GO:0001835]; carbohydrate biosynthetic process [GO:0016051]; ganglioside biosynthetic process [GO:0001574]; glycolipid biosynthetic process [GO:0009247]; glycoprotein metabolic process [GO:0009100]; N-glycan processing [GO:0006491]; oligosaccharide metabolic process [GO:0009311]; protein O-linked glycosylation [GO:0006493] Golgi membrane [GO:0000139] alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity [GO:0003828]; sialyltransferase activity [GO:0008373] g18557.t1 Q8NFD2 31.661 319 2.9099999999999998e-30 128.0 sp|Q8NFD2|ANKK1_HUMAN Ankyrin repeat and protein kinase domain-containing protein 1 OS=Homo sapiens OX=9606 GN=ANKK1 PE=1 SV=1 ANKK1_HUMAN reviewed Ankyrin repeat and protein kinase domain-containing protein 1 (EC 2.7.11.1) (Protein kinase PKK2) (Sugen kinase 288) (SgK288) (X-kinase) Homo sapiens (Human) GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0010564; GO:0042995; GO:0071300; GO:0106310 cellular response to retinoic acid [GO:0071300]; regulation of cell cycle process [GO:0010564] cell projection [GO:0042995]; cytoplasm [GO:0005737]; nucleus [GO:0005634] ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g18557.t1 Q8NFD2 28.71 310 5.0599999999999996e-24 109.0 sp|Q8NFD2|ANKK1_HUMAN Ankyrin repeat and protein kinase domain-containing protein 1 OS=Homo sapiens OX=9606 GN=ANKK1 PE=1 SV=1 ANKK1_HUMAN reviewed Ankyrin repeat and protein kinase domain-containing protein 1 (EC 2.7.11.1) (Protein kinase PKK2) (Sugen kinase 288) (SgK288) (X-kinase) Homo sapiens (Human) GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0010564; GO:0042995; GO:0071300; GO:0106310 cellular response to retinoic acid [GO:0071300]; regulation of cell cycle process [GO:0010564] cell projection [GO:0042995]; cytoplasm [GO:0005737]; nucleus [GO:0005634] ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g18558.t1 P23606 37.951 693 8.01e-152 464.0 sp|P23606|TGM1_RAT Protein-glutamine gamma-glutamyltransferase K OS=Rattus norvegicus OX=10116 GN=Tgm1 PE=1 SV=1 g18559.t1 O18927 36.345 476 3.4e-76 250.0 sp|O18927|MMP13_HORSE Collagenase 3 OS=Equus caballus OX=9796 GN=MMP13 PE=2 SV=1 g18563.t1 Q4G0Z9 32.206 680 2.86e-98 320.0 sp|Q4G0Z9|MCMD2_HUMAN Minichromosome maintenance domain-containing protein 2 OS=Homo sapiens OX=9606 GN=MCMDC2 PE=1 SV=3 MCMD2_HUMAN reviewed Minichromosome maintenance domain-containing protein 2 (MCM domain-containing protein 2) Homo sapiens (Human) GO:0000727; GO:0003677; GO:0005524; GO:0005634; GO:0007130; GO:0007283; GO:0042140; GO:0048477; GO:1990918 double-strand break repair involved in meiotic recombination [GO:1990918]; double-strand break repair via break-induced replication [GO:0000727]; late meiotic recombination nodule assembly [GO:0042140]; oogenesis [GO:0048477]; spermatogenesis [GO:0007283]; synaptonemal complex assembly [GO:0007130] nucleus [GO:0005634] ATP binding [GO:0005524]; DNA binding [GO:0003677] g18563.t2 Q4G0Z9 32.206 680 7.88e-99 321.0 sp|Q4G0Z9|MCMD2_HUMAN Minichromosome maintenance domain-containing protein 2 OS=Homo sapiens OX=9606 GN=MCMDC2 PE=1 SV=3 MCMD2_HUMAN reviewed Minichromosome maintenance domain-containing protein 2 (MCM domain-containing protein 2) Homo sapiens (Human) GO:0000727; GO:0003677; GO:0005524; GO:0005634; GO:0007130; GO:0007283; GO:0042140; GO:0048477; GO:1990918 double-strand break repair involved in meiotic recombination [GO:1990918]; double-strand break repair via break-induced replication [GO:0000727]; late meiotic recombination nodule assembly [GO:0042140]; oogenesis [GO:0048477]; spermatogenesis [GO:0007283]; synaptonemal complex assembly [GO:0007130] nucleus [GO:0005634] ATP binding [GO:0005524]; DNA binding [GO:0003677] g18564.t1 Q6P0U0 59.901 404 0.0 518.0 sp|Q6P0U0|NAGA_DANRE N-acetylglucosamine-6-phosphate deacetylase OS=Danio rerio OX=7955 GN=amdhd2 PE=2 SV=1 g18566.t1 A2AF53 62.379 311 1.4900000000000001e-133 386.0 sp|A2AF53|T185A_MOUSE Transmembrane protein 185A OS=Mus musculus OX=10090 GN=Tmem185a PE=1 SV=1 g18570.t1 Q6VUC1 71.622 74 2.3399999999999997e-23 87.8 sp|Q6VUC1|DPH3_CRIGR Diphthamide biosynthesis protein 3 OS=Cricetulus griseus OX=10029 GN=DPH3 PE=3 SV=1 g18571.t1 Q96B26 56.044 273 6.64e-102 300.0 sp|Q96B26|EXOS8_HUMAN Exosome complex component RRP43 OS=Homo sapiens OX=9606 GN=EXOSC8 PE=1 SV=1 EXOS8_HUMAN reviewed Exosome complex component RRP43 (Exosome component 8) (Opa-interacting protein 2) (OIP-2) (Ribosomal RNA-processing protein 43) (p9) Homo sapiens (Human) GO:0000176; GO:0000177; GO:0000178; GO:0000467; GO:0001650; GO:0005634; GO:0005654; GO:0005694; GO:0005730; GO:0005737; GO:0005829; GO:0006396; GO:0006401; GO:0016075; GO:0034473; GO:0034475; GO:0034476; GO:0035925; GO:0042802; GO:0071028; GO:0071035; GO:0071038; GO:0101019 exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000467]; nuclear mRNA surveillance [GO:0071028]; nuclear polyadenylation-dependent rRNA catabolic process [GO:0071035]; RNA catabolic process [GO:0006401]; RNA processing [GO:0006396]; rRNA catabolic process [GO:0016075]; TRAMP-dependent tRNA surveillance pathway [GO:0071038]; U1 snRNA 3'-end processing [GO:0034473]; U4 snRNA 3'-end processing [GO:0034475]; U5 snRNA 3'-end processing [GO:0034476] chromosome [GO:0005694]; cytoplasm [GO:0005737]; cytoplasmic exosome (RNase complex) [GO:0000177]; cytosol [GO:0005829]; exosome (RNase complex) [GO:0000178]; fibrillar center [GO:0001650]; nuclear exosome (RNase complex) [GO:0000176]; nucleolar exosome (RNase complex) [GO:0101019]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] identical protein binding [GO:0042802]; mRNA 3'-UTR AU-rich region binding [GO:0035925] g18576.t1 Q66HC7 53.521 284 5.28e-75 241.0 sp|Q66HC7|SP20H_RAT Transcription factor SPT20 homolog OS=Rattus norvegicus OX=10116 GN=Supt20h PE=2 SV=1 SP20H_RAT reviewed Transcription factor SPT20 homolog Rattus norvegicus (Rat) GO:0000124; GO:0003712; GO:0006357; GO:0007369; GO:0045722; GO:0045944; GO:0070461 gastrulation [GO:0007369]; positive regulation of gluconeogenesis [GO:0045722]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357] SAGA complex [GO:0000124]; SAGA-type complex [GO:0070461] transcription coregulator activity [GO:0003712] g18579.t1 Q9JME2 36.218 312 1.71e-51 181.0 sp|Q9JME2|CHSTB_MOUSE Carbohydrate sulfotransferase 11 OS=Mus musculus OX=10090 GN=Chst11 PE=2 SV=1 CHSTB_MOUSE reviewed Carbohydrate sulfotransferase 11 (EC 2.8.2.5) (Chondroitin 4-O-sulfotransferase 1) (Chondroitin 4-sulfotransferase 1) (C4S-1) (C4ST-1) (C4ST1) Mus musculus (Mouse) GO:0000139; GO:0001537; GO:0001701; GO:0002063; GO:0007585; GO:0008146; GO:0009791; GO:0016051; GO:0030166; GO:0030326; GO:0030512; GO:0033037; GO:0036342; GO:0042127; GO:0042733; GO:0043066; GO:0047756; GO:0048589; GO:0048703; GO:0048704; GO:0050650; GO:0050654; GO:0050659; GO:0051216 carbohydrate biosynthetic process [GO:0016051]; cartilage development [GO:0051216]; chondrocyte development [GO:0002063]; chondroitin sulfate proteoglycan biosynthetic process [GO:0050650]; chondroitin sulfate proteoglycan metabolic process [GO:0050654]; developmental growth [GO:0048589]; embryonic digit morphogenesis [GO:0042733]; embryonic limb morphogenesis [GO:0030326]; embryonic skeletal system morphogenesis [GO:0048704]; embryonic viscerocranium morphogenesis [GO:0048703]; in utero embryonic development [GO:0001701]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; polysaccharide localization [GO:0033037]; post-anal tail morphogenesis [GO:0036342]; post-embryonic development [GO:0009791]; proteoglycan biosynthetic process [GO:0030166]; regulation of cell population proliferation [GO:0042127]; respiratory gaseous exchange by respiratory system [GO:0007585] Golgi membrane [GO:0000139] chondroitin 4-sulfotransferase activity [GO:0047756]; dermatan 4-sulfotransferase activity [GO:0001537]; N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity [GO:0050659]; sulfotransferase activity [GO:0008146] g18580.t1 P28573 34.752 282 4.12e-36 141.0 sp|P28573|SC6A7_RAT Sodium-dependent proline transporter OS=Rattus norvegicus OX=10116 GN=Slc6a7 PE=1 SV=2 SC6A7_RAT reviewed Sodium-dependent proline transporter (Solute carrier family 6 member 7) Rattus norvegicus (Rat) GO:0005298; GO:0005886; GO:0006836; GO:0015193; GO:0015824; GO:0030163; GO:0030672; GO:0035524; GO:0035725; GO:0042734; GO:0045202; GO:0098685; GO:0098978; GO:1903804 glycine import across plasma membrane [GO:1903804]; neurotransmitter transport [GO:0006836]; proline transmembrane transport [GO:0035524]; proline transport [GO:0015824]; protein catabolic process [GO:0030163]; sodium ion transmembrane transport [GO:0035725] glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; Schaffer collateral - CA1 synapse [GO:0098685]; synapse [GO:0045202]; synaptic vesicle membrane [GO:0030672] L-proline transmembrane transporter activity [GO:0015193]; proline:sodium symporter activity [GO:0005298] g18582.t1 Q9Y345 51.672 598 0.0 586.0 sp|Q9Y345|SC6A5_HUMAN Sodium- and chloride-dependent glycine transporter 2 OS=Homo sapiens OX=9606 GN=SLC6A5 PE=1 SV=3 SC6A5_HUMAN reviewed Sodium- and chloride-dependent glycine transporter 2 (GlyT-2) (GlyT2) (Solute carrier family 6 member 5) Homo sapiens (Human) GO:0005768; GO:0005886; GO:0006836; GO:0007268; GO:0015375; GO:0016020; GO:0031045; GO:0035725; GO:0045202; GO:0046872; GO:0060012; GO:1903804 chemical synaptic transmission [GO:0007268]; glycine import across plasma membrane [GO:1903804]; neurotransmitter transport [GO:0006836]; sodium ion transmembrane transport [GO:0035725]; synaptic transmission, glycinergic [GO:0060012] dense core granule [GO:0031045]; endosome [GO:0005768]; membrane [GO:0016020]; plasma membrane [GO:0005886]; synapse [GO:0045202] glycine:sodium symporter activity [GO:0015375]; metal ion binding [GO:0046872] g18586.t1 Q08BG7 58.716 109 1e-28 104.0 sp|Q08BG7|SCOCA_DANRE Short coiled-coil protein A OS=Danio rerio OX=7955 GN=scoca PE=3 SV=1 g18587.t1 Q7ZUU1 62.371 194 1.6399999999999998e-67 210.0 sp|Q7ZUU1|UNC50_DANRE Protein unc-50 homolog OS=Danio rerio OX=7955 GN=unc50 PE=2 SV=1 g18588.t1 Q28CA1 68.75 80 1.48e-34 115.0 sp|Q28CA1|COA5_XENTR Cytochrome c oxidase assembly factor 5 OS=Xenopus tropicalis OX=8364 GN=coa5 PE=3 SV=1 g18591.t1 Q9CQ69 51.282 78 2.92e-25 94.0 sp|Q9CQ69|QCR8_MOUSE Cytochrome b-c1 complex subunit 8 OS=Mus musculus OX=10090 GN=Uqcrq PE=1 SV=3 g18592.t1 Q9W391 50.722 1246 0.0 1186.0 sp|Q9W391|KPBA_DROME Probable phosphorylase b kinase regulatory subunit alpha OS=Drosophila melanogaster OX=7227 GN=CG7766 PE=1 SV=2 g18592.t2 Q9W391 49.687 1278 0.0 1176.0 sp|Q9W391|KPBA_DROME Probable phosphorylase b kinase regulatory subunit alpha OS=Drosophila melanogaster OX=7227 GN=CG7766 PE=1 SV=2 g18593.t1 P43141 29.394 330 8.04e-25 107.0 sp|P43141|ADB4C_MELGA Beta-4C adrenergic receptor OS=Meleagris gallopavo OX=9103 GN=ADRB4C PE=2 SV=1 g18594.t1 Q9JI35 27.807 374 4.7699999999999996e-30 124.0 sp|Q9JI35|HRH3_CAVPO Histamine H3 receptor OS=Cavia porcellus OX=10141 GN=HRH3 PE=2 SV=2 g18595.t1 A0A1D5NSM8 32.821 390 2.38e-49 199.0 sp|A0A1D5NSM8|SVEP1_DANRE Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 OS=Danio rerio OX=7955 GN=svep1 PE=1 SV=1 SVEP1_DANRE reviewed Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 (Polydom) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001945; GO:0005509; GO:0005576; GO:0005634; GO:0005737; GO:0008544; GO:0009913; GO:0016020; GO:0016477; GO:0036303; GO:0090136 cell migration [GO:0016477]; epidermal cell differentiation [GO:0009913]; epidermis development [GO:0008544]; epithelial cell-cell adhesion [GO:0090136]; lymph vessel development [GO:0001945]; lymph vessel morphogenesis [GO:0036303] cytoplasm [GO:0005737]; extracellular region [GO:0005576]; membrane [GO:0016020]; nucleus [GO:0005634] calcium ion binding [GO:0005509] g18595.t1 A0A1D5NSM8 32.609 322 2.1e-37 159.0 sp|A0A1D5NSM8|SVEP1_DANRE Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 OS=Danio rerio OX=7955 GN=svep1 PE=1 SV=1 SVEP1_DANRE reviewed Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 (Polydom) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001945; GO:0005509; GO:0005576; GO:0005634; GO:0005737; GO:0008544; GO:0009913; GO:0016020; GO:0016477; GO:0036303; GO:0090136 cell migration [GO:0016477]; epidermal cell differentiation [GO:0009913]; epidermis development [GO:0008544]; epithelial cell-cell adhesion [GO:0090136]; lymph vessel development [GO:0001945]; lymph vessel morphogenesis [GO:0036303] cytoplasm [GO:0005737]; extracellular region [GO:0005576]; membrane [GO:0016020]; nucleus [GO:0005634] calcium ion binding [GO:0005509] g18595.t1 A0A1D5NSM8 34.361 227 3.17e-31 139.0 sp|A0A1D5NSM8|SVEP1_DANRE Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 OS=Danio rerio OX=7955 GN=svep1 PE=1 SV=1 SVEP1_DANRE reviewed Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 (Polydom) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001945; GO:0005509; GO:0005576; GO:0005634; GO:0005737; GO:0008544; GO:0009913; GO:0016020; GO:0016477; GO:0036303; GO:0090136 cell migration [GO:0016477]; epidermal cell differentiation [GO:0009913]; epidermis development [GO:0008544]; epithelial cell-cell adhesion [GO:0090136]; lymph vessel development [GO:0001945]; lymph vessel morphogenesis [GO:0036303] cytoplasm [GO:0005737]; extracellular region [GO:0005576]; membrane [GO:0016020]; nucleus [GO:0005634] calcium ion binding [GO:0005509] g18595.t1 A0A1D5NSM8 27.425 536 1.0700000000000001e-29 134.0 sp|A0A1D5NSM8|SVEP1_DANRE Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 OS=Danio rerio OX=7955 GN=svep1 PE=1 SV=1 SVEP1_DANRE reviewed Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 (Polydom) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001945; GO:0005509; GO:0005576; GO:0005634; GO:0005737; GO:0008544; GO:0009913; GO:0016020; GO:0016477; GO:0036303; GO:0090136 cell migration [GO:0016477]; epidermal cell differentiation [GO:0009913]; epidermis development [GO:0008544]; epithelial cell-cell adhesion [GO:0090136]; lymph vessel development [GO:0001945]; lymph vessel morphogenesis [GO:0036303] cytoplasm [GO:0005737]; extracellular region [GO:0005576]; membrane [GO:0016020]; nucleus [GO:0005634] calcium ion binding [GO:0005509] g18595.t1 A0A1D5NSM8 28.571 406 2.07e-25 120.0 sp|A0A1D5NSM8|SVEP1_DANRE Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 OS=Danio rerio OX=7955 GN=svep1 PE=1 SV=1 SVEP1_DANRE reviewed Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 (Polydom) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001945; GO:0005509; GO:0005576; GO:0005634; GO:0005737; GO:0008544; GO:0009913; GO:0016020; GO:0016477; GO:0036303; GO:0090136 cell migration [GO:0016477]; epidermal cell differentiation [GO:0009913]; epidermis development [GO:0008544]; epithelial cell-cell adhesion [GO:0090136]; lymph vessel development [GO:0001945]; lymph vessel morphogenesis [GO:0036303] cytoplasm [GO:0005737]; extracellular region [GO:0005576]; membrane [GO:0016020]; nucleus [GO:0005634] calcium ion binding [GO:0005509] g18596.t1 A0A1D5NSM8 29.252 1470 2.49e-177 593.0 sp|A0A1D5NSM8|SVEP1_DANRE Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 OS=Danio rerio OX=7955 GN=svep1 PE=1 SV=1 SVEP1_DANRE reviewed Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 (Polydom) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001945; GO:0005509; GO:0005576; GO:0005634; GO:0005737; GO:0008544; GO:0009913; GO:0016020; GO:0016477; GO:0036303; GO:0090136 cell migration [GO:0016477]; epidermal cell differentiation [GO:0009913]; epidermis development [GO:0008544]; epithelial cell-cell adhesion [GO:0090136]; lymph vessel development [GO:0001945]; lymph vessel morphogenesis [GO:0036303] cytoplasm [GO:0005737]; extracellular region [GO:0005576]; membrane [GO:0016020]; nucleus [GO:0005634] calcium ion binding [GO:0005509] g18596.t2 A0A1D5NSM8 29.252 1470 2.66e-177 593.0 sp|A0A1D5NSM8|SVEP1_DANRE Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 OS=Danio rerio OX=7955 GN=svep1 PE=1 SV=1 SVEP1_DANRE reviewed Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 (Polydom) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001945; GO:0005509; GO:0005576; GO:0005634; GO:0005737; GO:0008544; GO:0009913; GO:0016020; GO:0016477; GO:0036303; GO:0090136 cell migration [GO:0016477]; epidermal cell differentiation [GO:0009913]; epidermis development [GO:0008544]; epithelial cell-cell adhesion [GO:0090136]; lymph vessel development [GO:0001945]; lymph vessel morphogenesis [GO:0036303] cytoplasm [GO:0005737]; extracellular region [GO:0005576]; membrane [GO:0016020]; nucleus [GO:0005634] calcium ion binding [GO:0005509] g18597.t1 Q75N90 33.588 524 2.89e-47 190.0 sp|Q75N90|FBN3_HUMAN Fibrillin-3 OS=Homo sapiens OX=9606 GN=FBN3 PE=1 SV=3 FBN3_HUMAN reviewed Fibrillin-3 [Cleaved into: Fibrillin-3 C-terminal peptide] Homo sapiens (Human) GO:0001527; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0006006; GO:0030023; GO:0042593; GO:0043010; GO:0048048 camera-type eye development [GO:0043010]; embryonic eye morphogenesis [GO:0048048]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006] extracellular region [GO:0005576]; microfibril [GO:0001527] calcium ion binding [GO:0005509]; extracellular matrix constituent conferring elasticity [GO:0030023]; extracellular matrix structural constituent [GO:0005201]; hormone activity [GO:0005179] g18597.t1 Q75N90 27.932 648 1.1e-36 155.0 sp|Q75N90|FBN3_HUMAN Fibrillin-3 OS=Homo sapiens OX=9606 GN=FBN3 PE=1 SV=3 FBN3_HUMAN reviewed Fibrillin-3 [Cleaved into: Fibrillin-3 C-terminal peptide] Homo sapiens (Human) GO:0001527; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0006006; GO:0030023; GO:0042593; GO:0043010; GO:0048048 camera-type eye development [GO:0043010]; embryonic eye morphogenesis [GO:0048048]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006] extracellular region [GO:0005576]; microfibril [GO:0001527] calcium ion binding [GO:0005509]; extracellular matrix constituent conferring elasticity [GO:0030023]; extracellular matrix structural constituent [GO:0005201]; hormone activity [GO:0005179] g18597.t1 Q75N90 31.202 516 3.34e-36 154.0 sp|Q75N90|FBN3_HUMAN Fibrillin-3 OS=Homo sapiens OX=9606 GN=FBN3 PE=1 SV=3 FBN3_HUMAN reviewed Fibrillin-3 [Cleaved into: Fibrillin-3 C-terminal peptide] Homo sapiens (Human) GO:0001527; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0006006; GO:0030023; GO:0042593; GO:0043010; GO:0048048 camera-type eye development [GO:0043010]; embryonic eye morphogenesis [GO:0048048]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006] extracellular region [GO:0005576]; microfibril [GO:0001527] calcium ion binding [GO:0005509]; extracellular matrix constituent conferring elasticity [GO:0030023]; extracellular matrix structural constituent [GO:0005201]; hormone activity [GO:0005179] g18597.t1 Q75N90 30.224 536 4.64e-36 154.0 sp|Q75N90|FBN3_HUMAN Fibrillin-3 OS=Homo sapiens OX=9606 GN=FBN3 PE=1 SV=3 FBN3_HUMAN reviewed Fibrillin-3 [Cleaved into: Fibrillin-3 C-terminal peptide] Homo sapiens (Human) GO:0001527; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0006006; GO:0030023; GO:0042593; GO:0043010; GO:0048048 camera-type eye development [GO:0043010]; embryonic eye morphogenesis [GO:0048048]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006] extracellular region [GO:0005576]; microfibril [GO:0001527] calcium ion binding [GO:0005509]; extracellular matrix constituent conferring elasticity [GO:0030023]; extracellular matrix structural constituent [GO:0005201]; hormone activity [GO:0005179] g18597.t1 Q75N90 31.225 506 7.95e-33 143.0 sp|Q75N90|FBN3_HUMAN Fibrillin-3 OS=Homo sapiens OX=9606 GN=FBN3 PE=1 SV=3 FBN3_HUMAN reviewed Fibrillin-3 [Cleaved into: Fibrillin-3 C-terminal peptide] Homo sapiens (Human) GO:0001527; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0006006; GO:0030023; GO:0042593; GO:0043010; GO:0048048 camera-type eye development [GO:0043010]; embryonic eye morphogenesis [GO:0048048]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006] extracellular region [GO:0005576]; microfibril [GO:0001527] calcium ion binding [GO:0005509]; extracellular matrix constituent conferring elasticity [GO:0030023]; extracellular matrix structural constituent [GO:0005201]; hormone activity [GO:0005179] g18597.t1 Q75N90 29.735 491 9.820000000000001e-33 143.0 sp|Q75N90|FBN3_HUMAN Fibrillin-3 OS=Homo sapiens OX=9606 GN=FBN3 PE=1 SV=3 FBN3_HUMAN reviewed Fibrillin-3 [Cleaved into: Fibrillin-3 C-terminal peptide] Homo sapiens (Human) GO:0001527; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0006006; GO:0030023; GO:0042593; GO:0043010; GO:0048048 camera-type eye development [GO:0043010]; embryonic eye morphogenesis [GO:0048048]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006] extracellular region [GO:0005576]; microfibril [GO:0001527] calcium ion binding [GO:0005509]; extracellular matrix constituent conferring elasticity [GO:0030023]; extracellular matrix structural constituent [GO:0005201]; hormone activity [GO:0005179] g18597.t1 Q75N90 28.97 573 7.64e-31 137.0 sp|Q75N90|FBN3_HUMAN Fibrillin-3 OS=Homo sapiens OX=9606 GN=FBN3 PE=1 SV=3 FBN3_HUMAN reviewed Fibrillin-3 [Cleaved into: Fibrillin-3 C-terminal peptide] Homo sapiens (Human) GO:0001527; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0006006; GO:0030023; GO:0042593; GO:0043010; GO:0048048 camera-type eye development [GO:0043010]; embryonic eye morphogenesis [GO:0048048]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006] extracellular region [GO:0005576]; microfibril [GO:0001527] calcium ion binding [GO:0005509]; extracellular matrix constituent conferring elasticity [GO:0030023]; extracellular matrix structural constituent [GO:0005201]; hormone activity [GO:0005179] g18597.t1 Q75N90 27.665 741 7.23e-30 133.0 sp|Q75N90|FBN3_HUMAN Fibrillin-3 OS=Homo sapiens OX=9606 GN=FBN3 PE=1 SV=3 FBN3_HUMAN reviewed Fibrillin-3 [Cleaved into: Fibrillin-3 C-terminal peptide] Homo sapiens (Human) GO:0001527; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0006006; GO:0030023; GO:0042593; GO:0043010; GO:0048048 camera-type eye development [GO:0043010]; embryonic eye morphogenesis [GO:0048048]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006] extracellular region [GO:0005576]; microfibril [GO:0001527] calcium ion binding [GO:0005509]; extracellular matrix constituent conferring elasticity [GO:0030023]; extracellular matrix structural constituent [GO:0005201]; hormone activity [GO:0005179] g18597.t1 Q75N90 28.81 538 2.2700000000000004e-21 105.0 sp|Q75N90|FBN3_HUMAN Fibrillin-3 OS=Homo sapiens OX=9606 GN=FBN3 PE=1 SV=3 FBN3_HUMAN reviewed Fibrillin-3 [Cleaved into: Fibrillin-3 C-terminal peptide] Homo sapiens (Human) GO:0001527; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0006006; GO:0030023; GO:0042593; GO:0043010; GO:0048048 camera-type eye development [GO:0043010]; embryonic eye morphogenesis [GO:0048048]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006] extracellular region [GO:0005576]; microfibril [GO:0001527] calcium ion binding [GO:0005509]; extracellular matrix constituent conferring elasticity [GO:0030023]; extracellular matrix structural constituent [GO:0005201]; hormone activity [GO:0005179] g18598.t1 P0C6B8 32.282 824 1.94e-112 384.0 sp|P0C6B8|SVEP1_RAT Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 OS=Rattus norvegicus OX=10116 GN=Svep1 PE=1 SV=1 SVEP1_RAT reviewed Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 Rattus norvegicus (Rat) GO:0001945; GO:0003017; GO:0003682; GO:0005178; GO:0005509; GO:0005576; GO:0005615; GO:0005634; GO:0005737; GO:0008544; GO:0010467; GO:0010572; GO:0016020; GO:0031012; GO:0031099; GO:0036303; GO:0045906; GO:0048014; GO:0098640; GO:0120193 epidermis development [GO:0008544]; gene expression [GO:0010467]; lymph circulation [GO:0003017]; lymph vessel development [GO:0001945]; lymph vessel morphogenesis [GO:0036303]; negative regulation of vasoconstriction [GO:0045906]; positive regulation of platelet activation [GO:0010572]; regeneration [GO:0031099]; Tie signaling pathway [GO:0048014]; tight junction organization [GO:0120193] cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; nucleus [GO:0005634] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; integrin binding [GO:0005178]; integrin binding involved in cell-matrix adhesion [GO:0098640] g18599.t1 Q4LDE5 36.048 663 3.5000000000000004e-129 388.0 sp|Q4LDE5|SVEP1_HUMAN Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 OS=Homo sapiens OX=9606 GN=SVEP1 PE=1 SV=3 SVEP1_HUMAN reviewed Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 (CCP module-containing protein 22) (Polydom) (Selectin-like osteoblast-derived protein) (SEL-OB) (Serologically defined breast cancer antigen NY-BR-38) Homo sapiens (Human) GO:0003017; GO:0003682; GO:0005178; GO:0005509; GO:0005576; GO:0005615; GO:0005634; GO:0005737; GO:0008544; GO:0010467; GO:0010572; GO:0016020; GO:0036303; GO:0045906; GO:0048014; GO:0098640; GO:0120193 epidermis development [GO:0008544]; gene expression [GO:0010467]; lymph circulation [GO:0003017]; lymph vessel morphogenesis [GO:0036303]; negative regulation of vasoconstriction [GO:0045906]; positive regulation of platelet activation [GO:0010572]; Tie signaling pathway [GO:0048014]; tight junction organization [GO:0120193] cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; nucleus [GO:0005634] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; integrin binding [GO:0005178]; integrin binding involved in cell-matrix adhesion [GO:0098640] g18599.t1 Q4LDE5 47.368 95 3.5000000000000004e-129 97.8 sp|Q4LDE5|SVEP1_HUMAN Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 OS=Homo sapiens OX=9606 GN=SVEP1 PE=1 SV=3 SVEP1_HUMAN reviewed Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 (CCP module-containing protein 22) (Polydom) (Selectin-like osteoblast-derived protein) (SEL-OB) (Serologically defined breast cancer antigen NY-BR-38) Homo sapiens (Human) GO:0003017; GO:0003682; GO:0005178; GO:0005509; GO:0005576; GO:0005615; GO:0005634; GO:0005737; GO:0008544; GO:0010467; GO:0010572; GO:0016020; GO:0036303; GO:0045906; GO:0048014; GO:0098640; GO:0120193 epidermis development [GO:0008544]; gene expression [GO:0010467]; lymph circulation [GO:0003017]; lymph vessel morphogenesis [GO:0036303]; negative regulation of vasoconstriction [GO:0045906]; positive regulation of platelet activation [GO:0010572]; Tie signaling pathway [GO:0048014]; tight junction organization [GO:0120193] cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; nucleus [GO:0005634] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; integrin binding [GO:0005178]; integrin binding involved in cell-matrix adhesion [GO:0098640] g18610.t1 A0A1B0GVH7 29.825 228 1.31e-26 118.0 sp|A0A1B0GVH7|IQCM_HUMAN IQ domain-containing protein M OS=Homo sapiens OX=9606 GN=IQCM PE=4 SV=1 g18620.t1 Q503Q1 44.568 451 3.6200000000000004e-122 369.0 sp|Q503Q1|MIEAP_DANRE Mitochondria-eating protein OS=Danio rerio OX=7955 GN=spata18 PE=2 SV=2 g18621.t1 P17200 35.371 458 8.51e-89 281.0 sp|P17200|ACM4_CHICK Muscarinic acetylcholine receptor M4 OS=Gallus gallus OX=9031 GN=CHRM4 PE=2 SV=1 g18622.t1 Q5RFQ3 57.805 884 0.0 1088.0 sp|Q5RFQ3|PWP2_PONAB Periodic tryptophan protein 2 homolog OS=Pongo abelii OX=9601 GN=PWP2 PE=2 SV=1 g18626.t1 Q2T9I5 31.973 588 1.7e-61 232.0 sp|Q2T9I5|RBM26_XENLA RNA-binding protein 26 OS=Xenopus laevis OX=8355 GN=rbm26 PE=2 SV=2 g18626.t1 Q2T9I5 58.14 86 2.16e-22 108.0 sp|Q2T9I5|RBM26_XENLA RNA-binding protein 26 OS=Xenopus laevis OX=8355 GN=rbm26 PE=2 SV=2 g18628.t1 P14099 52.614 899 0.0 838.0 sp|P14099|PDE2A_BOVIN cGMP-dependent 3',5'-cyclic phosphodiesterase OS=Bos taurus OX=9913 GN=PDE2A PE=1 SV=2 PDE2A_BOVIN reviewed cGMP-dependent 3',5'-cyclic phosphodiesterase (EC 3.1.4.17) (Cyclic GMP-stimulated phosphodiesterase) (CGS-PDE) (cGSPDE) Bos taurus (Bovine) GO:0000122; GO:0004115; GO:0004118; GO:0005634; GO:0005737; GO:0005741; GO:0005743; GO:0005759; GO:0005783; GO:0005794; GO:0005829; GO:0005886; GO:0007165; GO:0010628; GO:0010754; GO:0010821; GO:0019934; GO:0030553; GO:0036006; GO:0042734; GO:0042803; GO:0043116; GO:0043117; GO:0046038; GO:0046069; GO:0046872; GO:0047555; GO:0048471; GO:0050729; GO:0061028; GO:0071260; GO:0071321; GO:0097011; GO:0097060; GO:0106072; GO:0141162 cellular response to cGMP [GO:0071321]; cellular response to granulocyte macrophage colony-stimulating factor stimulus [GO:0097011]; cellular response to macrophage colony-stimulating factor stimulus [GO:0036006]; cellular response to mechanical stimulus [GO:0071260]; cGMP catabolic process [GO:0046069]; cGMP-mediated signaling [GO:0019934]; establishment of endothelial barrier [GO:0061028]; GMP catabolic process [GO:0046038]; negative regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0106072]; negative regulation of cAMP/PKA signal transduction [GO:0141162]; negative regulation of cGMP-mediated signaling [GO:0010754]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of vascular permeability [GO:0043116]; positive regulation of gene expression [GO:0010628]; positive regulation of inflammatory response [GO:0050729]; positive regulation of vascular permeability [GO:0043117]; regulation of mitochondrion organization [GO:0010821]; signal transduction [GO:0007165] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial outer membrane [GO:0005741]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; synaptic membrane [GO:0097060] 3',5'-cGMP-stimulated cyclic-nucleotide phosphodiesterase activity [GO:0004118]; 3',5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; 3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; cGMP binding [GO:0030553]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803] g18628.t2 P14099 53.281 899 0.0 859.0 sp|P14099|PDE2A_BOVIN cGMP-dependent 3',5'-cyclic phosphodiesterase OS=Bos taurus OX=9913 GN=PDE2A PE=1 SV=2 PDE2A_BOVIN reviewed cGMP-dependent 3',5'-cyclic phosphodiesterase (EC 3.1.4.17) (Cyclic GMP-stimulated phosphodiesterase) (CGS-PDE) (cGSPDE) Bos taurus (Bovine) GO:0000122; GO:0004115; GO:0004118; GO:0005634; GO:0005737; GO:0005741; GO:0005743; GO:0005759; GO:0005783; GO:0005794; GO:0005829; GO:0005886; GO:0007165; GO:0010628; GO:0010754; GO:0010821; GO:0019934; GO:0030553; GO:0036006; GO:0042734; GO:0042803; GO:0043116; GO:0043117; GO:0046038; GO:0046069; GO:0046872; GO:0047555; GO:0048471; GO:0050729; GO:0061028; GO:0071260; GO:0071321; GO:0097011; GO:0097060; GO:0106072; GO:0141162 cellular response to cGMP [GO:0071321]; cellular response to granulocyte macrophage colony-stimulating factor stimulus [GO:0097011]; cellular response to macrophage colony-stimulating factor stimulus [GO:0036006]; cellular response to mechanical stimulus [GO:0071260]; cGMP catabolic process [GO:0046069]; cGMP-mediated signaling [GO:0019934]; establishment of endothelial barrier [GO:0061028]; GMP catabolic process [GO:0046038]; negative regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0106072]; negative regulation of cAMP/PKA signal transduction [GO:0141162]; negative regulation of cGMP-mediated signaling [GO:0010754]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of vascular permeability [GO:0043116]; positive regulation of gene expression [GO:0010628]; positive regulation of inflammatory response [GO:0050729]; positive regulation of vascular permeability [GO:0043117]; regulation of mitochondrion organization [GO:0010821]; signal transduction [GO:0007165] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial outer membrane [GO:0005741]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; synaptic membrane [GO:0097060] 3',5'-cGMP-stimulated cyclic-nucleotide phosphodiesterase activity [GO:0004118]; 3',5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; 3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; cGMP binding [GO:0030553]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803] g18628.t3 P14099 53.961 871 0.0 855.0 sp|P14099|PDE2A_BOVIN cGMP-dependent 3',5'-cyclic phosphodiesterase OS=Bos taurus OX=9913 GN=PDE2A PE=1 SV=2 PDE2A_BOVIN reviewed cGMP-dependent 3',5'-cyclic phosphodiesterase (EC 3.1.4.17) (Cyclic GMP-stimulated phosphodiesterase) (CGS-PDE) (cGSPDE) Bos taurus (Bovine) GO:0000122; GO:0004115; GO:0004118; GO:0005634; GO:0005737; GO:0005741; GO:0005743; GO:0005759; GO:0005783; GO:0005794; GO:0005829; GO:0005886; GO:0007165; GO:0010628; GO:0010754; GO:0010821; GO:0019934; GO:0030553; GO:0036006; GO:0042734; GO:0042803; GO:0043116; GO:0043117; GO:0046038; GO:0046069; GO:0046872; GO:0047555; GO:0048471; GO:0050729; GO:0061028; GO:0071260; GO:0071321; GO:0097011; GO:0097060; GO:0106072; GO:0141162 cellular response to cGMP [GO:0071321]; cellular response to granulocyte macrophage colony-stimulating factor stimulus [GO:0097011]; cellular response to macrophage colony-stimulating factor stimulus [GO:0036006]; cellular response to mechanical stimulus [GO:0071260]; cGMP catabolic process [GO:0046069]; cGMP-mediated signaling [GO:0019934]; establishment of endothelial barrier [GO:0061028]; GMP catabolic process [GO:0046038]; negative regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0106072]; negative regulation of cAMP/PKA signal transduction [GO:0141162]; negative regulation of cGMP-mediated signaling [GO:0010754]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of vascular permeability [GO:0043116]; positive regulation of gene expression [GO:0010628]; positive regulation of inflammatory response [GO:0050729]; positive regulation of vascular permeability [GO:0043117]; regulation of mitochondrion organization [GO:0010821]; signal transduction [GO:0007165] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial outer membrane [GO:0005741]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; synaptic membrane [GO:0097060] 3',5'-cGMP-stimulated cyclic-nucleotide phosphodiesterase activity [GO:0004118]; 3',5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; 3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; cGMP binding [GO:0030553]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803] g18628.t4 P14099 51.836 926 0.0 851.0 sp|P14099|PDE2A_BOVIN cGMP-dependent 3',5'-cyclic phosphodiesterase OS=Bos taurus OX=9913 GN=PDE2A PE=1 SV=2 PDE2A_BOVIN reviewed cGMP-dependent 3',5'-cyclic phosphodiesterase (EC 3.1.4.17) (Cyclic GMP-stimulated phosphodiesterase) (CGS-PDE) (cGSPDE) Bos taurus (Bovine) GO:0000122; GO:0004115; GO:0004118; GO:0005634; GO:0005737; GO:0005741; GO:0005743; GO:0005759; GO:0005783; GO:0005794; GO:0005829; GO:0005886; GO:0007165; GO:0010628; GO:0010754; GO:0010821; GO:0019934; GO:0030553; GO:0036006; GO:0042734; GO:0042803; GO:0043116; GO:0043117; GO:0046038; GO:0046069; GO:0046872; GO:0047555; GO:0048471; GO:0050729; GO:0061028; GO:0071260; GO:0071321; GO:0097011; GO:0097060; GO:0106072; GO:0141162 cellular response to cGMP [GO:0071321]; cellular response to granulocyte macrophage colony-stimulating factor stimulus [GO:0097011]; cellular response to macrophage colony-stimulating factor stimulus [GO:0036006]; cellular response to mechanical stimulus [GO:0071260]; cGMP catabolic process [GO:0046069]; cGMP-mediated signaling [GO:0019934]; establishment of endothelial barrier [GO:0061028]; GMP catabolic process [GO:0046038]; negative regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0106072]; negative regulation of cAMP/PKA signal transduction [GO:0141162]; negative regulation of cGMP-mediated signaling [GO:0010754]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of vascular permeability [GO:0043116]; positive regulation of gene expression [GO:0010628]; positive regulation of inflammatory response [GO:0050729]; positive regulation of vascular permeability [GO:0043117]; regulation of mitochondrion organization [GO:0010821]; signal transduction [GO:0007165] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial outer membrane [GO:0005741]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; synaptic membrane [GO:0097060] 3',5'-cGMP-stimulated cyclic-nucleotide phosphodiesterase activity [GO:0004118]; 3',5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; 3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; cGMP binding [GO:0030553]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803] g18628.t5 Q01062 64.423 520 0.0 642.0 sp|Q01062|PDE2A_RAT cGMP-dependent 3',5'-cyclic phosphodiesterase OS=Rattus norvegicus OX=10116 GN=Pde2a PE=1 SV=2 PDE2A_RAT reviewed cGMP-dependent 3',5'-cyclic phosphodiesterase (EC 3.1.4.17) (Cyclic GMP-stimulated phosphodiesterase) (CGS-PDE) (cGSPDE) Rattus norvegicus (Rat) GO:0000122; GO:0000287; GO:0003170; GO:0003279; GO:0003281; GO:0004115; GO:0004118; GO:0005634; GO:0005737; GO:0005739; GO:0005741; GO:0005743; GO:0005759; GO:0005783; GO:0005794; GO:0005829; GO:0005886; GO:0007193; GO:0007507; GO:0008270; GO:0010628; GO:0010749; GO:0010752; GO:0010754; GO:0010821; GO:0019934; GO:0030224; GO:0030424; GO:0030425; GO:0030552; GO:0030553; GO:0030911; GO:0035556; GO:0035904; GO:0036004; GO:0036006; GO:0042301; GO:0042734; GO:0042802; GO:0042803; GO:0043116; GO:0043117; GO:0046069; GO:0047555; GO:0048471; GO:0050729; GO:0060976; GO:0061028; GO:0071222; GO:0071260; GO:0071320; GO:0071321; GO:0071466; GO:0071560; GO:0090324; GO:0097011; GO:0097060; GO:0097457; GO:0106072; GO:0141162; GO:1904613; GO:1904880 adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; aorta development [GO:0035904]; cardiac septum development [GO:0003279]; cellular response to 2,3,7,8-tetrachlorodibenzodioxine [GO:1904613]; cellular response to cAMP [GO:0071320]; cellular response to cGMP [GO:0071321]; cellular response to granulocyte macrophage colony-stimulating factor stimulus [GO:0097011]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to macrophage colony-stimulating factor stimulus [GO:0036006]; cellular response to mechanical stimulus [GO:0071260]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cellular response to xenobiotic stimulus [GO:0071466]; cGMP catabolic process [GO:0046069]; cGMP-mediated signaling [GO:0019934]; coronary vasculature development [GO:0060976]; establishment of endothelial barrier [GO:0061028]; heart development [GO:0007507]; heart valve development [GO:0003170]; intracellular signal transduction [GO:0035556]; monocyte differentiation [GO:0030224]; negative regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0106072]; negative regulation of cAMP/PKA signal transduction [GO:0141162]; negative regulation of cGMP-mediated signaling [GO:0010754]; negative regulation of oxidative phosphorylation [GO:0090324]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of vascular permeability [GO:0043116]; positive regulation of gene expression [GO:0010628]; positive regulation of inflammatory response [GO:0050729]; positive regulation of vascular permeability [GO:0043117]; regulation of cGMP-mediated signaling [GO:0010752]; regulation of mitochondrion organization [GO:0010821]; regulation of nitric oxide mediated signal transduction [GO:0010749]; response to hydrogen sulfide [GO:1904880]; ventricular septum development [GO:0003281] axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; hippocampal mossy fiber [GO:0097457]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; synaptic membrane [GO:0097060] 3',5'-cGMP-stimulated cyclic-nucleotide phosphodiesterase activity [GO:0004118]; 3',5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; 3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; cAMP binding [GO:0030552]; cGMP binding [GO:0030553]; GAF domain binding [GO:0036004]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; phosphate ion binding [GO:0042301]; protein homodimerization activity [GO:0042803]; TPR domain binding [GO:0030911]; zinc ion binding [GO:0008270] g18630.t1 P24861 50.58 431 9.73e-134 395.0 sp|P24861|CCNA_PATVU G2/mitotic-specific cyclin-A OS=Patella vulgata OX=6465 PE=2 SV=1 g18631.t1 Q29449 60.563 710 0.0 842.0 sp|Q29449|AT8A1_BOVIN Probable phospholipid-transporting ATPase IA OS=Bos taurus OX=9913 GN=ATP8A1 PE=1 SV=2 AT8A1_BOVIN reviewed Probable phospholipid-transporting ATPase IA (EC 7.6.2.1) (ATPase class I type 8A member 1) (Chromaffin granule ATPase II) Bos taurus (Bovine) GO:0000287; GO:0005524; GO:0005783; GO:0005802; GO:0005886; GO:0016887; GO:0031090; GO:0031410; GO:0042584; GO:0045332; GO:0090556; GO:0140326; GO:0140331; GO:0140346; GO:1990531 aminophospholipid translocation [GO:0140331]; phospholipid translocation [GO:0045332] chromaffin granule membrane [GO:0042584]; cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum [GO:0005783]; organelle membrane [GO:0031090]; phospholipid-translocating ATPase complex [GO:1990531]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; magnesium ion binding [GO:0000287]; phosphatidylserine flippase activity [GO:0140346]; phosphatidylserine floppase activity [GO:0090556] g18632.t1 Q9Y2Q0 48.438 320 4.28e-92 303.0 sp|Q9Y2Q0|AT8A1_HUMAN Phospholipid-transporting ATPase IA OS=Homo sapiens OX=9606 GN=ATP8A1 PE=1 SV=1 AT8A1_HUMAN reviewed Phospholipid-transporting ATPase IA (EC 7.6.2.1) (ATPase class I type 8A member 1) (Chromaffin granule ATPase II) (P4-ATPase flippase complex alpha subunit ATP8A1) Homo sapiens (Human) GO:0000287; GO:0005524; GO:0005783; GO:0005794; GO:0005802; GO:0005829; GO:0005886; GO:0007612; GO:0016020; GO:0016887; GO:0019829; GO:0030335; GO:0030672; GO:0031090; GO:0031410; GO:0034220; GO:0035577; GO:0035579; GO:0042584; GO:0045332; GO:0048488; GO:0061092; GO:0070062; GO:0090556; GO:0098978; GO:0140326; GO:0140331; GO:0140346; GO:0150104; GO:1990531 aminophospholipid translocation [GO:0140331]; learning [GO:0007612]; monoatomic ion transmembrane transport [GO:0034220]; phospholipid translocation [GO:0045332]; positive regulation of cell migration [GO:0030335]; positive regulation of phospholipid translocation [GO:0061092]; synaptic vesicle endocytosis [GO:0048488]; transport across blood-brain barrier [GO:0150104] azurophil granule membrane [GO:0035577]; chromaffin granule membrane [GO:0042584]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; organelle membrane [GO:0031090]; phospholipid-translocating ATPase complex [GO:1990531]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; synaptic vesicle membrane [GO:0030672]; trans-Golgi network [GO:0005802] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; ATPase-coupled monoatomic cation transmembrane transporter activity [GO:0019829]; magnesium ion binding [GO:0000287]; phosphatidylserine flippase activity [GO:0140346]; phosphatidylserine floppase activity [GO:0090556] g18632.t2 Q9Y2Q0 49.838 309 3.43e-94 308.0 sp|Q9Y2Q0|AT8A1_HUMAN Phospholipid-transporting ATPase IA OS=Homo sapiens OX=9606 GN=ATP8A1 PE=1 SV=1 AT8A1_HUMAN reviewed Phospholipid-transporting ATPase IA (EC 7.6.2.1) (ATPase class I type 8A member 1) (Chromaffin granule ATPase II) (P4-ATPase flippase complex alpha subunit ATP8A1) Homo sapiens (Human) GO:0000287; GO:0005524; GO:0005783; GO:0005794; GO:0005802; GO:0005829; GO:0005886; GO:0007612; GO:0016020; GO:0016887; GO:0019829; GO:0030335; GO:0030672; GO:0031090; GO:0031410; GO:0034220; GO:0035577; GO:0035579; GO:0042584; GO:0045332; GO:0048488; GO:0061092; GO:0070062; GO:0090556; GO:0098978; GO:0140326; GO:0140331; GO:0140346; GO:0150104; GO:1990531 aminophospholipid translocation [GO:0140331]; learning [GO:0007612]; monoatomic ion transmembrane transport [GO:0034220]; phospholipid translocation [GO:0045332]; positive regulation of cell migration [GO:0030335]; positive regulation of phospholipid translocation [GO:0061092]; synaptic vesicle endocytosis [GO:0048488]; transport across blood-brain barrier [GO:0150104] azurophil granule membrane [GO:0035577]; chromaffin granule membrane [GO:0042584]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; organelle membrane [GO:0031090]; phospholipid-translocating ATPase complex [GO:1990531]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; synaptic vesicle membrane [GO:0030672]; trans-Golgi network [GO:0005802] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; ATPase-coupled monoatomic cation transmembrane transporter activity [GO:0019829]; magnesium ion binding [GO:0000287]; phosphatidylserine flippase activity [GO:0140346]; phosphatidylserine floppase activity [GO:0090556] g18635.t1 Q6ZQ58 49.599 623 0.0 548.0 sp|Q6ZQ58|LARP1_MOUSE La-related protein 1 OS=Mus musculus OX=10090 GN=Larp1 PE=1 SV=3 g18637.t1 Q02040 59.643 280 7.66e-104 328.0 sp|Q02040|AK17A_HUMAN A-kinase anchor protein 17A OS=Homo sapiens OX=9606 GN=AKAP17A PE=1 SV=2 AK17A_HUMAN reviewed A-kinase anchor protein 17A (AKAP-17A) (721P) (B-lymphocyte antigen) (Protein XE7) (Protein kinase A-anchoring protein 17A) (PRKA17A) (Splicing factor, arginine/serine-rich 17A) Homo sapiens (Human) GO:0003723; GO:0005634; GO:0005681; GO:0005829; GO:0006355; GO:0006397; GO:0007165; GO:0008380; GO:0016607; GO:0042113; GO:0043484; GO:0051018 B cell activation [GO:0042113]; mRNA processing [GO:0006397]; regulation of DNA-templated transcription [GO:0006355]; regulation of RNA splicing [GO:0043484]; RNA splicing [GO:0008380]; signal transduction [GO:0007165] cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681] protein kinase A binding [GO:0051018]; RNA binding [GO:0003723] g18638.t1 Q6P1S4 58.147 626 0.0 702.0 sp|Q6P1S4|SYRC_XENTR Arginine--tRNA ligase, cytoplasmic OS=Xenopus tropicalis OX=8364 GN=rars1 PE=2 SV=1 g18639.t1 Q8C1A9 57.483 294 1.3600000000000001e-124 378.0 sp|Q8C1A9|ABD18_MOUSE Protein ABHD18 OS=Mus musculus OX=10090 GN=Abhd18 PE=2 SV=1 g18639.t1 Q8C1A9 50.549 91 1.11e-22 105.0 sp|Q8C1A9|ABD18_MOUSE Protein ABHD18 OS=Mus musculus OX=10090 GN=Abhd18 PE=2 SV=1 g18640.t1 Q1RMG8 58.333 108 2.3299999999999997e-40 134.0 sp|Q1RMG8|RPAC2_BOVIN DNA-directed RNA polymerases I and III subunit RPAC2 OS=Bos taurus OX=9913 GN=POLR1D PE=2 SV=1 g18641.t1 Q805E5 46.043 278 1.76e-87 274.0 sp|Q805E5|CHSTE_DANRE Carbohydrate sulfotransferase 14 OS=Danio rerio OX=7955 GN=chst14 PE=2 SV=1 CHSTE_DANRE reviewed Carbohydrate sulfotransferase 14 (EC 2.8.2.-) (Dermatan 4-sulfotransferase 1) (D4ST-1) (zD4ST-1) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000139; GO:0001537; GO:0008146; GO:0016051; GO:0050655 carbohydrate biosynthetic process [GO:0016051]; dermatan sulfate proteoglycan metabolic process [GO:0050655] Golgi membrane [GO:0000139] dermatan 4-sulfotransferase activity [GO:0001537]; sulfotransferase activity [GO:0008146] g18643.t1 A4IF63 33.696 276 2.93e-31 129.0 sp|A4IF63|TRIM2_BOVIN Tripartite motif-containing protein 2 OS=Bos taurus OX=9913 GN=TRIM2 PE=2 SV=1 TRIM2_BOVIN reviewed Tripartite motif-containing protein 2 (EC 2.3.2.27) (E3 ubiquitin-protein ligase TRIM2) (RING-type E3 ubiquitin transferase TRIM2) Bos taurus (Bovine) GO:0000209; GO:0004842; GO:0005737; GO:0008270; GO:0043161; GO:0043523; GO:0061630 proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; regulation of neuron apoptotic process [GO:0043523] cytoplasm [GO:0005737] ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] g18647.t1 O15067 58.148 1350 0.0 1490.0 sp|O15067|PUR4_HUMAN Phosphoribosylformylglycinamidine synthase OS=Homo sapiens OX=9606 GN=PFAS PE=1 SV=4 PUR4_HUMAN reviewed Phosphoribosylformylglycinamidine synthase (FGAM synthase) (FGAMS) (EC 6.3.5.3) (Formylglycinamide ribonucleotide amidotransferase) (FGAR amidotransferase) (FGAR-AT) (Formylglycinamide ribotide amidotransferase) (Phosphoribosylformylglycineamide amidotransferase) Homo sapiens (Human) GO:0004642; GO:0005524; GO:0005737; GO:0005829; GO:0006164; GO:0006177; GO:0006189; GO:0006541; GO:0009168; GO:0009410; GO:0044208; GO:0046872; GO:0070062; GO:0097065; GO:0097294 'de novo' AMP biosynthetic process [GO:0044208]; 'de novo' IMP biosynthetic process [GO:0006189]; 'de novo' XMP biosynthetic process [GO:0097294]; anterior head development [GO:0097065]; glutamine metabolic process [GO:0006541]; GMP biosynthetic process [GO:0006177]; purine nucleotide biosynthetic process [GO:0006164]; purine ribonucleoside monophosphate biosynthetic process [GO:0009168]; response to xenobiotic stimulus [GO:0009410] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062] ATP binding [GO:0005524]; metal ion binding [GO:0046872]; phosphoribosylformylglycinamidine synthase activity [GO:0004642] g18648.t1 Q8NB91 22.344 640 1.7199999999999998e-23 110.0 sp|Q8NB91|FANCB_HUMAN Fanconi anemia group B protein OS=Homo sapiens OX=9606 GN=FANCB PE=1 SV=1 FANCB_HUMAN reviewed Fanconi anemia group B protein (Protein FACB) (Fanconi anemia-associated polypeptide of 95 kDa) (FAAP95) Homo sapiens (Human) GO:0000785; GO:0005654; GO:0005829; GO:0036297; GO:0043240; GO:1905168; GO:1990414; GO:2000042 interstrand cross-link repair [GO:0036297]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; replication-born double-strand break repair via sister chromatid exchange [GO:1990414] chromatin [GO:0000785]; cytosol [GO:0005829]; Fanconi anaemia nuclear complex [GO:0043240]; nucleoplasm [GO:0005654] g18649.t1 Q7T163 53.791 277 4.6e-91 299.0 sp|Q7T163|KDISB_DANRE Kinase D-interacting substrate of 220 kDa B OS=Danio rerio OX=7955 GN=kidins220b PE=1 SV=3 g18649.t1 Q7T163 37.6 250 1.82e-38 147.0 sp|Q7T163|KDISB_DANRE Kinase D-interacting substrate of 220 kDa B OS=Danio rerio OX=7955 GN=kidins220b PE=1 SV=3 g18649.t1 Q7T163 33.476 233 1.9999999999999998e-30 124.0 sp|Q7T163|KDISB_DANRE Kinase D-interacting substrate of 220 kDa B OS=Danio rerio OX=7955 GN=kidins220b PE=1 SV=3 g18649.t1 Q7T163 37.5 184 2.4599999999999996e-23 103.0 sp|Q7T163|KDISB_DANRE Kinase D-interacting substrate of 220 kDa B OS=Danio rerio OX=7955 GN=kidins220b PE=1 SV=3 g18649.t1 Q7T163 30.144 209 1.8000000000000003e-21 98.6 sp|Q7T163|KDISB_DANRE Kinase D-interacting substrate of 220 kDa B OS=Danio rerio OX=7955 GN=kidins220b PE=1 SV=3 g18650.t1 Q7T163 43.293 917 0.0 704.0 sp|Q7T163|KDISB_DANRE Kinase D-interacting substrate of 220 kDa B OS=Danio rerio OX=7955 GN=kidins220b PE=1 SV=3 g18653.t1 Q9CWP6 31.692 467 2.1300000000000002e-72 243.0 sp|Q9CWP6|MSPD2_MOUSE Motile sperm domain-containing protein 2 OS=Mus musculus OX=10090 GN=Mospd2 PE=1 SV=2 MSPD2_MOUSE reviewed Motile sperm domain-containing protein 2 Mus musculus (Mouse) GO:0005783; GO:0005789; GO:0005886; GO:0006935; GO:0012505; GO:0033149; GO:0044232; GO:0051260; GO:0090023; GO:0090026; GO:0140042; GO:0140284 chemotaxis [GO:0006935]; lipid droplet formation [GO:0140042]; positive regulation of monocyte chemotaxis [GO:0090026]; positive regulation of neutrophil chemotaxis [GO:0090023]; protein homooligomerization [GO:0051260] endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-endosome membrane contact site [GO:0140284]; organelle membrane contact site [GO:0044232]; plasma membrane [GO:0005886] FFAT motif binding [GO:0033149] g18658.t1 Q5SQX6 64.7 932 0.0 1256.0 sp|Q5SQX6|CYFP2_MOUSE Cytoplasmic FMR1-interacting protein 2 OS=Mus musculus OX=10090 GN=Cyfip2 PE=1 SV=2 CYFP2_MOUSE reviewed Cytoplasmic FMR1-interacting protein 2 (p53-inducible protein 121) Mus musculus (Mouse) GO:0000902; GO:0005634; GO:0005737; GO:0006915; GO:0007411; GO:0030031; GO:0030833; GO:0031175; GO:0031209; GO:0031267; GO:0043005; GO:0045202; GO:0045862; GO:0048471; GO:0051388; GO:0097484; GO:0098609; GO:0150052 apoptotic process [GO:0006915]; axon guidance [GO:0007411]; cell morphogenesis [GO:0000902]; cell projection assembly [GO:0030031]; cell-cell adhesion [GO:0098609]; dendrite extension [GO:0097484]; neuron projection development [GO:0031175]; positive regulation of neurotrophin TRK receptor signaling pathway [GO:0051388]; positive regulation of proteolysis [GO:0045862]; regulation of actin filament polymerization [GO:0030833]; regulation of postsynapse assembly [GO:0150052] cytoplasm [GO:0005737]; neuron projection [GO:0043005]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; SCAR complex [GO:0031209]; synapse [GO:0045202] small GTPase binding [GO:0031267] g18659.t1 Q6GQD1 71.711 152 9.199999999999999e-60 202.0 sp|Q6GQD1|CYFP2_XENLA Cytoplasmic FMR1-interacting protein 2 OS=Xenopus laevis OX=8355 GN=cyfip2 PE=2 SV=1 g18659.t1 Q6GQD1 71.429 28 9.199999999999999e-60 48.9 sp|Q6GQD1|CYFP2_XENLA Cytoplasmic FMR1-interacting protein 2 OS=Xenopus laevis OX=8355 GN=cyfip2 PE=2 SV=1 g18659.t2 Q6GQD1 71.711 152 5.06e-60 204.0 sp|Q6GQD1|CYFP2_XENLA Cytoplasmic FMR1-interacting protein 2 OS=Xenopus laevis OX=8355 GN=cyfip2 PE=2 SV=1 g18659.t2 Q6GQD1 71.429 28 5.06e-60 48.9 sp|Q6GQD1|CYFP2_XENLA Cytoplasmic FMR1-interacting protein 2 OS=Xenopus laevis OX=8355 GN=cyfip2 PE=2 SV=1 g18660.t1 Q8BYJ6 41.317 881 0.0 596.0 sp|Q8BYJ6|TBCD4_MOUSE TBC1 domain family member 4 OS=Mus musculus OX=10090 GN=Tbc1d4 PE=1 SV=2 g18661.t1 O60343 57.895 76 3.8700000000000004e-21 93.2 sp|O60343|TBCD4_HUMAN TBC1 domain family member 4 OS=Homo sapiens OX=9606 GN=TBC1D4 PE=1 SV=2 TBCD4_HUMAN reviewed TBC1 domain family member 4 (Akt substrate of 160 kDa) (AS160) Homo sapiens (Human) GO:0005096; GO:0005794; GO:0005829; GO:0016192; GO:0031339; GO:0031982; GO:0032869 cellular response to insulin stimulus [GO:0032869]; negative regulation of vesicle fusion [GO:0031339]; vesicle-mediated transport [GO:0016192] cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; vesicle [GO:0031982] GTPase activator activity [GO:0005096] g18662.t1 Q8BYJ6 34.359 195 6.55e-22 101.0 sp|Q8BYJ6|TBCD4_MOUSE TBC1 domain family member 4 OS=Mus musculus OX=10090 GN=Tbc1d4 PE=1 SV=2 g18664.t1 B2ZZS9 43.807 331 1.3499999999999999e-95 294.0 sp|B2ZZS9|WDR55_ORYLA WD repeat-containing protein 55 OS=Oryzias latipes OX=8090 GN=wdr55 PE=1 SV=1 WDR55_ORYLA reviewed WD repeat-containing protein 55 (Protein hokecha) Oryzias latipes (Japanese rice fish) (Japanese killifish) GO:0001654; GO:0001889; GO:0005730; GO:0006364; GO:0048536; GO:0048538; GO:0060322; GO:0160093 chordate pharynx development [GO:0160093]; eye development [GO:0001654]; head development [GO:0060322]; liver development [GO:0001889]; rRNA processing [GO:0006364]; spleen development [GO:0048536]; thymus development [GO:0048538] nucleolus [GO:0005730] g18665.t1 Q9H8H3 39.916 238 1.42e-53 177.0 sp|Q9H8H3|TMT1A_HUMAN Thiol S-methyltransferase TMT1A OS=Homo sapiens OX=9606 GN=TMT1A PE=1 SV=1 TMT1A_HUMAN reviewed Thiol S-methyltransferase TMT1A (EC 2.1.1.9) (Methyltransferase-like protein 7A) (N6-adenosine-methyltransferase TMT1A) (EC 2.1.1.348) (Protein AAM-B) (Thiol methyltransferase 1A) Homo sapiens (Human) GO:0001649; GO:0001734; GO:0005576; GO:0005783; GO:0005811; GO:0005829; GO:0008168; GO:0008173; GO:0016020; GO:0018708; GO:0032259; GO:0042476; GO:0180035; GO:1904724 lncRNA processing [GO:0180035]; methylation [GO:0032259]; odontogenesis [GO:0042476]; osteoblast differentiation [GO:0001649] cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; lipid droplet [GO:0005811]; membrane [GO:0016020]; tertiary granule lumen [GO:1904724] methyltransferase activity [GO:0008168]; mRNA m(6)A methyltransferase activity [GO:0001734]; RNA methyltransferase activity [GO:0008173]; thiol S-methyltransferase activity [GO:0018708] g18666.t1 B0V207 42.672 232 3.77e-45 179.0 sp|B0V207|FHI1B_DANRE FHF complex subunit HOOK-interacting protein 1B OS=Danio rerio OX=7955 GN=fhip1b PE=3 SV=1 FHI1B_DANRE reviewed FHF complex subunit HOOK-interacting protein 1B (FHIP1B) (FTS- and Hook-interacting protein homolog) (FHIP) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0007032; GO:0007040; GO:0008333; GO:0015031; GO:0045022; GO:0070695; GO:1905719 early endosome to late endosome transport [GO:0045022]; endosome organization [GO:0007032]; endosome to lysosome transport [GO:0008333]; lysosome organization [GO:0007040]; protein localization to perinuclear region of cytoplasm [GO:1905719]; protein transport [GO:0015031] FHF complex [GO:0070695] g18666.t1 B0V207 37.727 220 1.6800000000000001e-31 136.0 sp|B0V207|FHI1B_DANRE FHF complex subunit HOOK-interacting protein 1B OS=Danio rerio OX=7955 GN=fhip1b PE=3 SV=1 FHI1B_DANRE reviewed FHF complex subunit HOOK-interacting protein 1B (FHIP1B) (FTS- and Hook-interacting protein homolog) (FHIP) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0007032; GO:0007040; GO:0008333; GO:0015031; GO:0045022; GO:0070695; GO:1905719 early endosome to late endosome transport [GO:0045022]; endosome organization [GO:0007032]; endosome to lysosome transport [GO:0008333]; lysosome organization [GO:0007040]; protein localization to perinuclear region of cytoplasm [GO:1905719]; protein transport [GO:0015031] FHF complex [GO:0070695] g18667.t1 Q05DH4 55.376 186 1.57e-60 207.0 sp|Q05DH4|FHI1A_HUMAN FHF complex subunit HOOK-interacting protein 1A OS=Homo sapiens OX=9606 GN=FHIP1A PE=1 SV=2 g18667.t2 Q05DH4 55.738 183 4.37e-60 206.0 sp|Q05DH4|FHI1A_HUMAN FHF complex subunit HOOK-interacting protein 1A OS=Homo sapiens OX=9606 GN=FHIP1A PE=1 SV=2 g18672.t1 P97376 61.215 214 1.34e-97 289.0 sp|P97376|FRG1_MOUSE Protein FRG1 OS=Mus musculus OX=10090 GN=Frg1 PE=1 SV=2 g18673.t1 Q6R1L1 42.262 336 1.72e-49 174.0 sp|Q6R1L1|TAF7_CRIGR Transcription initiation factor TFIID subunit 7 OS=Cricetulus griseus OX=10029 GN=TAF7 PE=1 SV=1 g18674.t1 Q3SWX0 60.472 339 2.42e-102 311.0 sp|Q3SWX0|NIPA2_BOVIN Magnesium transporter NIPA2 OS=Bos taurus OX=9913 GN=NIPA2 PE=2 SV=1 g18674.t2 Q3SWX0 58.991 317 7.239999999999999e-104 313.0 sp|Q3SWX0|NIPA2_BOVIN Magnesium transporter NIPA2 OS=Bos taurus OX=9913 GN=NIPA2 PE=2 SV=1 g18675.t1 Q8VDT1 46.386 664 0.0 552.0 sp|Q8VDT1|SC5A9_MOUSE Sodium/glucose cotransporter 4 OS=Mus musculus OX=10090 GN=Slc5a9 PE=1 SV=3 g18676.t1 Q96PQ7 59.93 569 0.0 689.0 sp|Q96PQ7|KLHL5_HUMAN Kelch-like protein 5 OS=Homo sapiens OX=9606 GN=KLHL5 PE=1 SV=3 g18677.t1 Q96NL6 32.166 628 2.32e-90 301.0 sp|Q96NL6|SCLT1_HUMAN Sodium channel and clathrin linker 1 OS=Homo sapiens OX=9606 GN=SCLT1 PE=1 SV=2 SCLT1_HUMAN reviewed Sodium channel and clathrin linker 1 (Sodium channel-associated protein 1) Homo sapiens (Human) GO:0005813; GO:0005814; GO:0005829; GO:0015630; GO:0017080; GO:0030276; GO:0036064; GO:0045162; GO:0060271; GO:0071439; GO:0097539 cilium assembly [GO:0060271]; clustering of voltage-gated sodium channels [GO:0045162] centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary transition fiber [GO:0097539]; clathrin complex [GO:0071439]; cytosol [GO:0005829]; microtubule cytoskeleton [GO:0015630] clathrin binding [GO:0030276]; sodium channel regulator activity [GO:0017080] g18678.t1 A4IF63 54.668 739 0.0 780.0 sp|A4IF63|TRIM2_BOVIN Tripartite motif-containing protein 2 OS=Bos taurus OX=9913 GN=TRIM2 PE=2 SV=1 TRIM2_BOVIN reviewed Tripartite motif-containing protein 2 (EC 2.3.2.27) (E3 ubiquitin-protein ligase TRIM2) (RING-type E3 ubiquitin transferase TRIM2) Bos taurus (Bovine) GO:0000209; GO:0004842; GO:0005737; GO:0008270; GO:0043161; GO:0043523; GO:0061630 proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; regulation of neuron apoptotic process [GO:0043523] cytoplasm [GO:0005737] ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] g18679.t1 Q7L576 55.618 178 1.13e-60 214.0 sp|Q7L576|CYFP1_HUMAN Cytoplasmic FMR1-interacting protein 1 OS=Homo sapiens OX=9606 GN=CYFIP1 PE=1 SV=1 CYFP1_HUMAN reviewed Cytoplasmic FMR1-interacting protein 1 (Specifically Rac1-associated protein 1) (Sra-1) (p140sra-1) Homo sapiens (Human) GO:0000340; GO:0000902; GO:0001726; GO:0005576; GO:0005829; GO:0005925; GO:0006417; GO:0007411; GO:0008360; GO:0010592; GO:0016601; GO:0030027; GO:0030032; GO:0030371; GO:0030833; GO:0031209; GO:0031267; GO:0031529; GO:0034774; GO:0035580; GO:0043005; GO:0045202; GO:0048471; GO:0048675; GO:0050890; GO:0051015; GO:0051388; GO:0070062; GO:0097484; GO:0098794; GO:0099578; GO:1904724; GO:1905274; GO:2000601 axon extension [GO:0048675]; axon guidance [GO:0007411]; cell morphogenesis [GO:0000902]; cognition [GO:0050890]; dendrite extension [GO:0097484]; lamellipodium assembly [GO:0030032]; positive regulation of Arp2/3 complex-mediated actin nucleation [GO:2000601]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of neurotrophin TRK receptor signaling pathway [GO:0051388]; Rac protein signal transduction [GO:0016601]; regulation of actin filament polymerization [GO:0030833]; regulation of cell shape [GO:0008360]; regulation of modification of postsynaptic actin cytoskeleton [GO:1905274]; regulation of translation [GO:0006417]; regulation of translation at postsynapse, modulating synaptic transmission [GO:0099578]; ruffle organization [GO:0031529] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; neuron projection [GO:0043005]; perinuclear region of cytoplasm [GO:0048471]; postsynapse [GO:0098794]; ruffle [GO:0001726]; SCAR complex [GO:0031209]; secretory granule lumen [GO:0034774]; specific granule lumen [GO:0035580]; synapse [GO:0045202]; tertiary granule lumen [GO:1904724] actin filament binding [GO:0051015]; RNA 7-methylguanosine cap binding [GO:0000340]; small GTPase binding [GO:0031267]; translation repressor activity [GO:0030371] g18679.t1 Q7L576 55.102 98 1.31e-31 130.0 sp|Q7L576|CYFP1_HUMAN Cytoplasmic FMR1-interacting protein 1 OS=Homo sapiens OX=9606 GN=CYFIP1 PE=1 SV=1 CYFP1_HUMAN reviewed Cytoplasmic FMR1-interacting protein 1 (Specifically Rac1-associated protein 1) (Sra-1) (p140sra-1) Homo sapiens (Human) GO:0000340; GO:0000902; GO:0001726; GO:0005576; GO:0005829; GO:0005925; GO:0006417; GO:0007411; GO:0008360; GO:0010592; GO:0016601; GO:0030027; GO:0030032; GO:0030371; GO:0030833; GO:0031209; GO:0031267; GO:0031529; GO:0034774; GO:0035580; GO:0043005; GO:0045202; GO:0048471; GO:0048675; GO:0050890; GO:0051015; GO:0051388; GO:0070062; GO:0097484; GO:0098794; GO:0099578; GO:1904724; GO:1905274; GO:2000601 axon extension [GO:0048675]; axon guidance [GO:0007411]; cell morphogenesis [GO:0000902]; cognition [GO:0050890]; dendrite extension [GO:0097484]; lamellipodium assembly [GO:0030032]; positive regulation of Arp2/3 complex-mediated actin nucleation [GO:2000601]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of neurotrophin TRK receptor signaling pathway [GO:0051388]; Rac protein signal transduction [GO:0016601]; regulation of actin filament polymerization [GO:0030833]; regulation of cell shape [GO:0008360]; regulation of modification of postsynaptic actin cytoskeleton [GO:1905274]; regulation of translation [GO:0006417]; regulation of translation at postsynapse, modulating synaptic transmission [GO:0099578]; ruffle organization [GO:0031529] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; neuron projection [GO:0043005]; perinuclear region of cytoplasm [GO:0048471]; postsynapse [GO:0098794]; ruffle [GO:0001726]; SCAR complex [GO:0031209]; secretory granule lumen [GO:0034774]; specific granule lumen [GO:0035580]; synapse [GO:0045202]; tertiary granule lumen [GO:1904724] actin filament binding [GO:0051015]; RNA 7-methylguanosine cap binding [GO:0000340]; small GTPase binding [GO:0031267]; translation repressor activity [GO:0030371] g18683.t1 Q5HYK7 34.19 389 1.87e-66 244.0 sp|Q5HYK7|SH319_HUMAN SH3 domain-containing protein 19 OS=Homo sapiens OX=9606 GN=SH3D19 PE=1 SV=2 SH319_HUMAN reviewed SH3 domain-containing protein 19 (ADAM-binding protein Eve-1) (EEN-binding protein) (EBP) Homo sapiens (Human) GO:0005654; GO:0005829; GO:0005886; GO:0007010; GO:0022604; GO:0051044; GO:0070064 cytoskeleton organization [GO:0007010]; positive regulation of membrane protein ectodomain proteolysis [GO:0051044]; regulation of cell morphogenesis [GO:0022604] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] proline-rich region binding [GO:0070064] g18683.t1 Q5HYK7 30.053 376 1.38e-43 175.0 sp|Q5HYK7|SH319_HUMAN SH3 domain-containing protein 19 OS=Homo sapiens OX=9606 GN=SH3D19 PE=1 SV=2 SH319_HUMAN reviewed SH3 domain-containing protein 19 (ADAM-binding protein Eve-1) (EEN-binding protein) (EBP) Homo sapiens (Human) GO:0005654; GO:0005829; GO:0005886; GO:0007010; GO:0022604; GO:0051044; GO:0070064 cytoskeleton organization [GO:0007010]; positive regulation of membrane protein ectodomain proteolysis [GO:0051044]; regulation of cell morphogenesis [GO:0022604] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] proline-rich region binding [GO:0070064] g18683.t1 Q5HYK7 28.837 215 6.56e-22 106.0 sp|Q5HYK7|SH319_HUMAN SH3 domain-containing protein 19 OS=Homo sapiens OX=9606 GN=SH3D19 PE=1 SV=2 SH319_HUMAN reviewed SH3 domain-containing protein 19 (ADAM-binding protein Eve-1) (EEN-binding protein) (EBP) Homo sapiens (Human) GO:0005654; GO:0005829; GO:0005886; GO:0007010; GO:0022604; GO:0051044; GO:0070064 cytoskeleton organization [GO:0007010]; positive regulation of membrane protein ectodomain proteolysis [GO:0051044]; regulation of cell morphogenesis [GO:0022604] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] proline-rich region binding [GO:0070064] g18684.t1 Q7ZVP1 54.175 515 0.0 559.0 sp|Q7ZVP1|JADE3_DANRE Protein Jade-3 OS=Danio rerio OX=7955 GN=jade3 PE=2 SV=1 g18685.t1 Q5E9N4 48.0 425 2.1e-159 459.0 sp|Q5E9N4|AADAT_BOVIN Kynurenine/alpha-aminoadipate aminotransferase, mitochondrial OS=Bos taurus OX=9913 GN=AADAT PE=2 SV=1 AADAT_BOVIN reviewed Kynurenine/alpha-aminoadipate aminotransferase, mitochondrial (KAT/AadAT) (2-aminoadipate aminotransferase) (2-aminoadipate transaminase) (EC 2.6.1.39) (Alpha-aminoadipate aminotransferase) (AadAT) (Glycine transaminase AADAT) (EC 2.6.1.4) (Kynurenine aminotransferase II) (Kynurenine--glyoxylate transaminase AADAT) (EC 2.6.1.63) (Kynurenine--oxoglutarate aminotransferase II) (Kynurenine--oxoglutarate transaminase 2) (EC 2.6.1.7) (Kynurenine--oxoglutarate transaminase II) (Methionine--glyoxylate transaminase AADAT) (EC 2.6.1.73) Bos taurus (Bovine) GO:0005759; GO:0006103; GO:0006536; GO:0016212; GO:0030170; GO:0033512; GO:0047315; GO:0047536; GO:0047958; GO:0050094; GO:0070189; GO:1901605 2-oxoglutarate metabolic process [GO:0006103]; alpha-amino acid metabolic process [GO:1901605]; glutamate metabolic process [GO:0006536]; kynurenine metabolic process [GO:0070189]; L-lysine catabolic process to acetyl-CoA via saccharopine [GO:0033512] mitochondrial matrix [GO:0005759] 2-aminoadipate transaminase activity [GO:0047536]; glycine:2-oxoglutarate aminotransferase activity [GO:0047958]; kynurenine-glyoxylate transaminase activity [GO:0047315]; kynurenine-oxoglutarate transaminase activity [GO:0016212]; methionine-glyoxylate transaminase activity [GO:0050094]; pyridoxal phosphate binding [GO:0030170] g18687.t1 Q6UY18 29.845 516 7.540000000000001e-43 168.0 sp|Q6UY18|LIGO4_HUMAN Leucine-rich repeat and immunoglobulin-like domain-containing nogo receptor-interacting protein 4 OS=Homo sapiens OX=9606 GN=LINGO4 PE=2 SV=1 g18688.t1 Q6P1D7 43.846 130 2.68e-22 106.0 sp|Q6P1D7|SLX4_MOUSE Structure-specific endonuclease subunit SLX4 OS=Mus musculus OX=10090 GN=Slx4 PE=1 SV=1 SLX4_MOUSE reviewed Structure-specific endonuclease subunit SLX4 (BTB/POZ domain-containing protein 12) Mus musculus (Mouse) GO:0000712; GO:0000724; GO:0000781; GO:0000785; GO:0003677; GO:0005654; GO:0006260; GO:0006281; GO:0006289; GO:0008047; GO:0008270; GO:0010792; GO:0032206; GO:0033557; GO:0048476; GO:0061820; GO:0070522; GO:0072429; GO:0090656; GO:1904357; GO:1904431 DNA double-strand break processing involved in repair via single-strand annealing [GO:0010792]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; double-strand break repair via homologous recombination [GO:0000724]; negative regulation of telomere maintenance via telomere lengthening [GO:1904357]; nucleotide-excision repair [GO:0006289]; positive regulation of t-circle formation [GO:1904431]; positive regulation of telomere maintenance [GO:0032206]; resolution of meiotic recombination intermediates [GO:0000712]; response to intra-S DNA damage checkpoint signaling [GO:0072429]; t-circle formation [GO:0090656]; telomeric D-loop disassembly [GO:0061820] chromatin [GO:0000785]; chromosome, telomeric region [GO:0000781]; ERCC4-ERCC1 complex [GO:0070522]; Holliday junction resolvase complex [GO:0048476]; nucleoplasm [GO:0005654]; Slx1-Slx4 complex [GO:0033557] DNA binding [GO:0003677]; enzyme activator activity [GO:0008047]; zinc ion binding [GO:0008270] g18697.t1 P70031 40.171 351 2.6400000000000003e-79 255.0 sp|P70031|CCKAR_XENLA Cholecystokinin receptor OS=Xenopus laevis OX=8355 GN=cckar PE=2 SV=1 g18698.t1 Q8N5T2 50.189 265 1.14e-90 281.0 sp|Q8N5T2|TBC19_HUMAN TBC1 domain family member 19 OS=Homo sapiens OX=9606 GN=TBC1D19 PE=1 SV=2 g18702.t1 Q8N5T2 75.194 258 6.869999999999999e-128 376.0 sp|Q8N5T2|TBC19_HUMAN TBC1 domain family member 19 OS=Homo sapiens OX=9606 GN=TBC1D19 PE=1 SV=2 g18709.t1 Q7LHG5 53.043 115 8.08e-34 133.0 sp|Q7LHG5|YI31B_YEAST Transposon Ty3-I Gag-Pol polyprotein OS=Saccharomyces cerevisiae (strain ATCC 204508 / S288c) OX=559292 GN=TY3B-I PE=1 SV=2 YI31B_YEAST reviewed Transposon Ty3-I Gag-Pol polyprotein (Gag3-Pol3) (Transposon Ty3-2 TYA-TYB polyprotein) [Cleaved into: Capsid protein (CA) (p24); Spacer peptide p3; Nucleocapsid protein p11 (NC); Ty3 protease (PR) (EC 3.4.23.-) (p16); Spacer peptide J; Reverse transcriptase/ribonuclease H (RT) (RT-RH) (EC 2.7.7.49) (EC 2.7.7.7) (EC 3.1.26.4) (p55); Integrase p52 (IN); Integrase p49 (IN)] Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast) GO:0003677; GO:0003723; GO:0003887; GO:0003964; GO:0004190; GO:0004523; GO:0005524; GO:0005634; GO:0005737; GO:0006310; GO:0006508; GO:0008270; GO:0015074; GO:0075523 DNA integration [GO:0015074]; DNA recombination [GO:0006310]; proteolysis [GO:0006508]; viral translational frameshifting [GO:0075523] cytoplasm [GO:0005737]; nucleus [GO:0005634] aspartic-type endopeptidase activity [GO:0004190]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; RNA binding [GO:0003723]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; zinc ion binding [GO:0008270] g18720.t1 Q28HC7 43.046 151 2.66e-38 132.0 sp|Q28HC7|COMD6_XENTR COMM domain-containing protein 6 OS=Xenopus tropicalis OX=8364 GN=commd6 PE=2 SV=1 g18721.t1 Q8CD10 39.788 377 7.970000000000001e-70 230.0 sp|Q8CD10|MICU2_MOUSE Calcium uptake protein 2, mitochondrial OS=Mus musculus OX=10090 GN=Micu2 PE=1 SV=2 MICU2_MOUSE reviewed Calcium uptake protein 2, mitochondrial (EF-hand domain-containing family member A1) Mus musculus (Mouse) GO:0005246; GO:0005509; GO:0005739; GO:0005743; GO:0005758; GO:0006851; GO:0034704; GO:0036444; GO:0046982; GO:0051560; GO:0051561; GO:0051562; GO:0061891; GO:0071277; GO:1990246 calcium import into the mitochondrion [GO:0036444]; cellular response to calcium ion [GO:0071277]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrial calcium ion transmembrane transport [GO:0006851]; negative regulation of mitochondrial calcium ion concentration [GO:0051562]; positive regulation of mitochondrial calcium ion concentration [GO:0051561] calcium channel complex [GO:0034704]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; uniplex complex [GO:1990246] calcium channel regulator activity [GO:0005246]; calcium ion binding [GO:0005509]; calcium ion sensor activity [GO:0061891]; protein heterodimerization activity [GO:0046982] g18721.t2 Q8CD10 39.683 378 1.97e-66 221.0 sp|Q8CD10|MICU2_MOUSE Calcium uptake protein 2, mitochondrial OS=Mus musculus OX=10090 GN=Micu2 PE=1 SV=2 MICU2_MOUSE reviewed Calcium uptake protein 2, mitochondrial (EF-hand domain-containing family member A1) Mus musculus (Mouse) GO:0005246; GO:0005509; GO:0005739; GO:0005743; GO:0005758; GO:0006851; GO:0034704; GO:0036444; GO:0046982; GO:0051560; GO:0051561; GO:0051562; GO:0061891; GO:0071277; GO:1990246 calcium import into the mitochondrion [GO:0036444]; cellular response to calcium ion [GO:0071277]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrial calcium ion transmembrane transport [GO:0006851]; negative regulation of mitochondrial calcium ion concentration [GO:0051562]; positive regulation of mitochondrial calcium ion concentration [GO:0051561] calcium channel complex [GO:0034704]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; uniplex complex [GO:1990246] calcium channel regulator activity [GO:0005246]; calcium ion binding [GO:0005509]; calcium ion sensor activity [GO:0061891]; protein heterodimerization activity [GO:0046982] g18721.t3 A0A8I6A2H6 44.186 430 3.2799999999999995e-95 299.0 sp|A0A8I6A2H6|MICU3_RAT Calcium uptake protein 3, mitochondrial OS=Rattus norvegicus OX=10116 GN=Micu3 PE=3 SV=1 MICU3_RAT reviewed Calcium uptake protein 3, mitochondrial Rattus norvegicus (Rat) GO:0001956; GO:0005246; GO:0005509; GO:0005739; GO:0005758; GO:0036444; GO:0046982; GO:0051560; GO:0061891; GO:0071277; GO:1990246 calcium import into the mitochondrion [GO:0036444]; cellular response to calcium ion [GO:0071277]; mitochondrial calcium ion homeostasis [GO:0051560]; positive regulation of neurotransmitter secretion [GO:0001956] mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; uniplex complex [GO:1990246] calcium channel regulator activity [GO:0005246]; calcium ion binding [GO:0005509]; calcium ion sensor activity [GO:0061891]; protein heterodimerization activity [GO:0046982] g18722.t1 Q91875 38.583 127 4.28e-21 91.3 sp|Q91875|FGF9_XENLA Fibroblast growth factor 9 OS=Xenopus laevis OX=8355 GN=fgf9 PE=2 SV=1 FGF9_XENLA reviewed Fibroblast growth factor 9 (FGF-9) (Glia-activating factor) (GAF) (HBGF-9) (Heparin-binding growth factor 9) (XFGF-9) Xenopus laevis (African clawed frog) GO:0000122; GO:0001525; GO:0001649; GO:0001654; GO:0002053; GO:0002062; GO:0005104; GO:0005615; GO:0005737; GO:0006606; GO:0007267; GO:0008083; GO:0008201; GO:0008284; GO:0008543; GO:0008584; GO:0010628; GO:0021762; GO:0022008; GO:0030178; GO:0030238; GO:0030324; GO:0030326; GO:0030334; GO:0030949; GO:0032927; GO:0042472; GO:0043410; GO:0045880; GO:0048505; GO:0048566; GO:0048706; GO:0050679; GO:0051781; GO:0060045; GO:0060484; GO:0070062; GO:0090263 angiogenesis [GO:0001525]; cell-cell signaling [GO:0007267]; chondrocyte differentiation [GO:0002062]; embryonic digestive tract development [GO:0048566]; embryonic limb morphogenesis [GO:0030326]; embryonic skeletal system development [GO:0048706]; eye development [GO:0001654]; fibroblast growth factor receptor signaling pathway [GO:0008543]; inner ear morphogenesis [GO:0042472]; lung development [GO:0030324]; lung-associated mesenchyme development [GO:0060484]; male gonad development [GO:0008584]; male sex determination [GO:0030238]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of Wnt signaling pathway [GO:0030178]; neurogenesis [GO:0022008]; osteoblast differentiation [GO:0001649]; positive regulation of activin receptor signaling pathway [GO:0032927]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell division [GO:0051781]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of gene expression [GO:0010628]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of smoothened signaling pathway [GO:0045880]; positive regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030949]; protein import into nucleus [GO:0006606]; regulation of cell migration [GO:0030334]; regulation of timing of cell differentiation [GO:0048505]; substantia nigra development [GO:0021762] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615] fibroblast growth factor receptor binding [GO:0005104]; growth factor activity [GO:0008083]; heparin binding [GO:0008201] g18724.t1 O76039 77.333 300 2.91e-175 522.0 sp|O76039|CDKL5_HUMAN Cyclin-dependent kinase-like 5 OS=Homo sapiens OX=9606 GN=CDKL5 PE=1 SV=2 CDKL5_HUMAN reviewed Cyclin-dependent kinase-like 5 (EC 2.7.11.22) (Serine/threonine-protein kinase 9) Homo sapiens (Human) GO:0001764; GO:0004672; GO:0004674; GO:0004693; GO:0005524; GO:0005634; GO:0005654; GO:0005813; GO:0016301; GO:0031267; GO:0032839; GO:0035022; GO:0036064; GO:0044294; GO:0045773; GO:0050773; GO:0050775; GO:0050804; GO:0097542; GO:0098978; GO:0099175; GO:0106310; GO:1902017 modulation of chemical synaptic transmission [GO:0050804]; neuron migration [GO:0001764]; positive regulation of axon extension [GO:0045773]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of Rac protein signal transduction [GO:0035022]; regulation of cilium assembly [GO:1902017]; regulation of dendrite development [GO:0050773]; regulation of postsynapse organization [GO:0099175] centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary tip [GO:0097542]; dendrite cytoplasm [GO:0032839]; dendritic growth cone [GO:0044294]; glutamatergic synapse [GO:0098978]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; kinase activity [GO:0016301]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; small GTPase binding [GO:0031267] g18725.t1 Q923Q2 50.242 619 0.0 606.0 sp|Q923Q2|STA13_MOUSE StAR-related lipid transfer protein 13 OS=Mus musculus OX=10090 GN=Stard13 PE=1 SV=5 g18725.t1 Q923Q2 36.207 290 9.47e-31 135.0 sp|Q923Q2|STA13_MOUSE StAR-related lipid transfer protein 13 OS=Mus musculus OX=10090 GN=Stard13 PE=1 SV=5 g18725.t2 Q923Q2 50.242 619 0.0 606.0 sp|Q923Q2|STA13_MOUSE StAR-related lipid transfer protein 13 OS=Mus musculus OX=10090 GN=Stard13 PE=1 SV=5 g18725.t2 Q923Q2 35.526 304 7.98e-30 132.0 sp|Q923Q2|STA13_MOUSE StAR-related lipid transfer protein 13 OS=Mus musculus OX=10090 GN=Stard13 PE=1 SV=5 g18725.t3 Q923Q2 50.242 619 0.0 605.0 sp|Q923Q2|STA13_MOUSE StAR-related lipid transfer protein 13 OS=Mus musculus OX=10090 GN=Stard13 PE=1 SV=5 g18725.t3 Q923Q2 35.39 308 2.0099999999999997e-30 134.0 sp|Q923Q2|STA13_MOUSE StAR-related lipid transfer protein 13 OS=Mus musculus OX=10090 GN=Stard13 PE=1 SV=5 g18727.t1 O00625 66.187 278 1.0400000000000001e-121 358.0 sp|O00625|PIR_HUMAN Pirin OS=Homo sapiens OX=9606 GN=PIR PE=1 SV=1 PIR_HUMAN reviewed Pirin (EC 1.13.11.24) (Probable quercetin 2,3-dioxygenase PIR) (Probable quercetinase) Homo sapiens (Human) GO:0003712; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006366; GO:0007586; GO:0008127; GO:0016604; GO:0030224; GO:0046872 digestion [GO:0007586]; monocyte differentiation [GO:0030224]; transcription by RNA polymerase II [GO:0006366] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] metal ion binding [GO:0046872]; quercetin 2,3-dioxygenase activity [GO:0008127]; transcription coregulator activity [GO:0003712] g18730.t1 O35114 34.091 440 3.38e-78 254.0 sp|O35114|SCRB2_MOUSE Lysosome membrane protein 2 OS=Mus musculus OX=10090 GN=Scarb2 PE=1 SV=3 SCRB2_MOUSE reviewed Lysosome membrane protein 2 (85 kDa lysosomal membrane sialoglycoprotein) (LGP85) (Lysosome membrane protein II) (LIMP II) (Scavenger receptor class B member 2) Mus musculus (Mouse) GO:0001786; GO:0005044; GO:0005765; GO:0005886; GO:0006622; GO:0006898; GO:0006914; GO:0010976; GO:0015485; GO:0015917; GO:0019899; GO:0030666; GO:0031210; GO:0038024; GO:0042803; GO:0043202; GO:0043470; GO:0051087; GO:0099638 aminophospholipid transport [GO:0015917]; autophagy [GO:0006914]; endosome to plasma membrane protein transport [GO:0099638]; positive regulation of neuron projection development [GO:0010976]; protein targeting to lysosome [GO:0006622]; receptor-mediated endocytosis [GO:0006898]; regulation of carbohydrate catabolic process [GO:0043470] endocytic vesicle membrane [GO:0030666]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886] cargo receptor activity [GO:0038024]; cholesterol binding [GO:0015485]; enzyme binding [GO:0019899]; phosphatidylcholine binding [GO:0031210]; phosphatidylserine binding [GO:0001786]; protein homodimerization activity [GO:0042803]; protein-folding chaperone binding [GO:0051087]; scavenger receptor activity [GO:0005044] g18731.t1 Q5F3U9 51.529 1112 0.0 1154.0 sp|Q5F3U9|PDS5B_CHICK Sister chromatid cohesion protein PDS5 homolog B OS=Gallus gallus OX=9031 GN=PDS5B PE=2 SV=3 g18734.t1 B6CZ61 40.462 173 3.29e-39 135.0 sp|B6CZ61|LRC51_RAT Leucine-rich repeat-containing protein 51 OS=Rattus norvegicus OX=10116 GN=Lrrc51 PE=2 SV=1 g18735.t1 Q6P2W7 41.104 163 7.55e-29 107.0 sp|Q6P2W7|LTOR1_XENTR Ragulator complex protein LAMTOR1 OS=Xenopus tropicalis OX=8364 GN=lamtor1 PE=2 SV=1 LTOR1_XENTR reviewed Ragulator complex protein LAMTOR1 (Late endosomal/lysosomal adaptor and MAPK and MTOR activator 1) Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0001558; GO:0001919; GO:0005764; GO:0005765; GO:0007032; GO:0007040; GO:0008104; GO:0010874; GO:0016197; GO:0031902; GO:0032008; GO:0032418; GO:0042632; GO:0043410; GO:0043495; GO:0045121; GO:0060620; GO:0071230; GO:0071986; GO:0072657; GO:1904263 cellular response to amino acid stimulus [GO:0071230]; cholesterol homeostasis [GO:0042632]; endosomal transport [GO:0016197]; endosome organization [GO:0007032]; intracellular protein localization [GO:0008104]; lysosome localization [GO:0032418]; lysosome organization [GO:0007040]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of TOR signaling [GO:0032008]; positive regulation of TORC1 signaling [GO:1904263]; protein localization to membrane [GO:0072657]; regulation of cell growth [GO:0001558]; regulation of cholesterol efflux [GO:0010874]; regulation of cholesterol import [GO:0060620]; regulation of receptor recycling [GO:0001919] late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane raft [GO:0045121]; Ragulator complex [GO:0071986] protein-membrane adaptor activity [GO:0043495] g18736.t1 Q9CPW7 62.821 156 1.0399999999999999e-46 155.0 sp|Q9CPW7|ZMAT2_MOUSE Zinc finger matrin-type protein 2 OS=Mus musculus OX=10090 GN=Zmat2 PE=2 SV=1 g18738.t1 Q17QB3 46.384 401 1.0599999999999999e-131 387.0 sp|Q17QB3|ASAH1_BOVIN Acid ceramidase OS=Bos taurus OX=9913 GN=ASAH1 PE=2 SV=3 ASAH1_BOVIN reviewed Acid ceramidase (AC) (ACDase) (Acid CDase) (EC 3.5.1.23) (Acylsphingosine deacylase) (N-acylethanolamine hydrolase ASAH1) (EC 3.5.1.-) (N-acylsphingosine amidohydrolase) [Cleaved into: Acid ceramidase subunit alpha; Acid ceramidase subunit beta] Bos taurus (Bovine) GO:0005615; GO:0005634; GO:0005764; GO:0006631; GO:0016020; GO:0017040; GO:0017064; GO:0030216; GO:0046512; GO:0046513; GO:0046514; GO:0050810; GO:0062098; GO:0071356 cellular response to tumor necrosis factor [GO:0071356]; ceramide biosynthetic process [GO:0046513]; ceramide catabolic process [GO:0046514]; fatty acid metabolic process [GO:0006631]; keratinocyte differentiation [GO:0030216]; regulation of programmed necrotic cell death [GO:0062098]; regulation of steroid biosynthetic process [GO:0050810]; sphingosine biosynthetic process [GO:0046512] extracellular space [GO:0005615]; lysosome [GO:0005764]; membrane [GO:0016020]; nucleus [GO:0005634] fatty acid amide hydrolase activity [GO:0017064]; N-acylsphingosine amidohydrolase activity [GO:0017040] g18739.t1 Q5QT17 33.898 354 2.09e-59 200.0 sp|Q5QT17|LEG1H_ONCMY Protein LEG1 homolog OS=Oncorhynchus mykiss OX=8022 GN=leg1 PE=2 SV=1 g18740.t1 Q96M20 33.023 215 4.15e-24 110.0 sp|Q96M20|CNBD2_HUMAN Cyclic nucleotide-binding domain-containing protein 2 OS=Homo sapiens OX=9606 GN=CNBD2 PE=1 SV=2 g18741.t1 Q761V0 42.572 451 1.5099999999999999e-112 355.0 sp|Q761V0|SC6A5_MOUSE Sodium- and chloride-dependent glycine transporter 2 OS=Mus musculus OX=10090 GN=Slc6a5 PE=1 SV=1 SC6A5_MOUSE reviewed Sodium- and chloride-dependent glycine transporter 2 (GlyT-2) (GlyT2) (Solute carrier family 6 member 5) Mus musculus (Mouse) GO:0001504; GO:0005768; GO:0005886; GO:0015187; GO:0015375; GO:0015816; GO:0031045; GO:0035725; GO:0042734; GO:0046872; GO:0060012; GO:0098690; GO:0098810; GO:1903804 glycine import across plasma membrane [GO:1903804]; glycine transport [GO:0015816]; neurotransmitter reuptake [GO:0098810]; neurotransmitter uptake [GO:0001504]; sodium ion transmembrane transport [GO:0035725]; synaptic transmission, glycinergic [GO:0060012] dense core granule [GO:0031045]; endosome [GO:0005768]; glycinergic synapse [GO:0098690]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734] glycine transmembrane transporter activity [GO:0015187]; glycine:sodium symporter activity [GO:0015375]; metal ion binding [GO:0046872] g18743.t1 Q80WQ4 59.184 147 7.17e-62 199.0 sp|Q80WQ4|TRM9B_MOUSE Probable tRNA methyltransferase 9B OS=Mus musculus OX=10090 GN=Trmt9b PE=1 SV=1 g18744.t1 C3Y3G4 58.396 399 1.93e-148 429.0 sp|C3Y3G4|LIAS_BRAFL Lipoyl synthase, mitochondrial OS=Branchiostoma floridae OX=7739 GN=BRAFLDRAFT_125969 PE=3 SV=1 g18746.t1 Q90744 54.182 275 4.0400000000000004e-103 309.0 sp|Q90744|NAGAB_CHICK Alpha-N-acetylgalactosaminidase OS=Gallus gallus OX=9031 GN=NAGA PE=1 SV=1 NAGAB_CHICK reviewed Alpha-N-acetylgalactosaminidase (EC 3.2.1.49) (Alpha-galactosidase B) Gallus gallus (Chicken) GO:0004557; GO:0005737; GO:0005764; GO:0008456; GO:0009311; GO:0016020; GO:0016139; GO:0019377 glycolipid catabolic process [GO:0019377]; glycoside catabolic process [GO:0016139]; oligosaccharide metabolic process [GO:0009311] cytoplasm [GO:0005737]; lysosome [GO:0005764]; membrane [GO:0016020] alpha-galactosidase activity [GO:0004557]; alpha-N-acetylgalactosaminidase activity [GO:0008456] g18747.t1 A7Y2W8 42.857 658 2.0599999999999997e-170 505.0 sp|A7Y2W8|SC6A9_XENLA Sodium- and chloride-dependent glycine transporter 1 OS=Xenopus laevis OX=8355 GN=slc6a9 PE=2 SV=1 g18748.t1 Q9H8P0 37.943 282 6.5e-53 179.0 sp|Q9H8P0|SR5A3_HUMAN Polyprenal reductase OS=Homo sapiens OX=9606 GN=SRD5A3 PE=1 SV=1 SR5A3_HUMAN reviewed Polyprenal reductase (EC 1.3.1.94) (3-oxo-5-alpha-steroid 4-dehydrogenase 3) (EC 1.3.1.22) (Steroid 5-alpha-reductase 2-like) (Steroid 5-alpha-reductase 3) (S5AR 3) (SR type 3) Homo sapiens (Human) GO:0003865; GO:0005783; GO:0005789; GO:0006488; GO:0006702; GO:0016095; GO:0016628; GO:0043048; GO:0047751; GO:0102389; GO:0160198 androgen biosynthetic process [GO:0006702]; dolichol-linked oligosaccharide biosynthetic process [GO:0006488]; dolichyl monophosphate biosynthetic process [GO:0043048]; polyprenol catabolic process [GO:0016095] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789] 3-oxo-5-alpha-steroid 4-dehydrogenase (NADP+) activity [GO:0047751]; 3-oxo-5-alpha-steroid 4-dehydrogenase activity [GO:0003865]; oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor [GO:0016628]; polyprenal reductase activity [GO:0160198]; polyprenol reductase activity [GO:0102389] g18749.t1 Q8BTV1 68.942 293 6.69e-151 431.0 sp|Q8BTV1|TUSC3_MOUSE Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit TUSC3 OS=Mus musculus OX=10090 GN=Tusc3 PE=1 SV=1 g18750.t1 Q13326 40.265 226 3.4e-47 161.0 sp|Q13326|SGCG_HUMAN Gamma-sarcoglycan OS=Homo sapiens OX=9606 GN=SGCG PE=1 SV=4 g18750.t2 Q0VCU7 42.308 286 3.98e-67 214.0 sp|Q0VCU7|SGCG_BOVIN Gamma-sarcoglycan OS=Bos taurus OX=9913 GN=SGCG PE=2 SV=1 g18751.t1 Q8IZU2 55.352 1308 0.0 1431.0 sp|Q8IZU2|WDR17_HUMAN WD repeat-containing protein 17 OS=Homo sapiens OX=9606 GN=WDR17 PE=1 SV=2 g18752.t1 Q6DMN8 43.434 198 7.57e-60 195.0 sp|Q6DMN8|SPAT4_PANTR Spermatogenesis-associated protein 4 OS=Pan troglodytes OX=9598 GN=SPATA4 PE=2 SV=1 g18753.t1 Q5I0J5 57.627 236 1.72e-92 275.0 sp|Q5I0J5|MITD1_RAT MIT domain-containing protein 1 OS=Rattus norvegicus OX=10116 GN=Mitd1 PE=2 SV=1 g18754.t1 P49596 64.901 302 4.9e-141 405.0 sp|P49596|PP2C2_CAEEL Probable protein phosphatase 2C T23F11.1 OS=Caenorhabditis elegans OX=6239 GN=ppm-2 PE=3 SV=2 g18756.t1 Q6DC37 27.946 297 5.04e-26 107.0 sp|Q6DC37|HNMT_DANRE Histamine N-methyltransferase OS=Danio rerio OX=7955 GN=hnmt PE=2 SV=1 g18757.t1 O60879 46.862 478 3.65e-111 376.0 sp|O60879|DIAP2_HUMAN Protein diaphanous homolog 2 OS=Homo sapiens OX=9606 GN=DIAPH2 PE=1 SV=1 DIAP2_HUMAN reviewed Protein diaphanous homolog 2 (Diaphanous-related formin-2) (DRF2) Homo sapiens (Human) GO:0003779; GO:0005102; GO:0005730; GO:0005769; GO:0005783; GO:0005829; GO:0005884; GO:0007292; GO:0030041; GO:0031267; GO:0048477 actin filament polymerization [GO:0030041]; female gamete generation [GO:0007292]; oogenesis [GO:0048477] actin filament [GO:0005884]; cytosol [GO:0005829]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; nucleolus [GO:0005730] actin binding [GO:0003779]; signaling receptor binding [GO:0005102]; small GTPase binding [GO:0031267] g18757.t1 O60879 43.556 450 2.37e-87 309.0 sp|O60879|DIAP2_HUMAN Protein diaphanous homolog 2 OS=Homo sapiens OX=9606 GN=DIAPH2 PE=1 SV=1 DIAP2_HUMAN reviewed Protein diaphanous homolog 2 (Diaphanous-related formin-2) (DRF2) Homo sapiens (Human) GO:0003779; GO:0005102; GO:0005730; GO:0005769; GO:0005783; GO:0005829; GO:0005884; GO:0007292; GO:0030041; GO:0031267; GO:0048477 actin filament polymerization [GO:0030041]; female gamete generation [GO:0007292]; oogenesis [GO:0048477] actin filament [GO:0005884]; cytosol [GO:0005829]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; nucleolus [GO:0005730] actin binding [GO:0003779]; signaling receptor binding [GO:0005102]; small GTPase binding [GO:0031267] g18760.t1 Q9CTY5 49.107 112 2.35e-27 112.0 sp|Q9CTY5|MICU3_MOUSE Calcium uptake protein 3, mitochondrial OS=Mus musculus OX=10090 GN=Micu3 PE=1 SV=2 MICU3_MOUSE reviewed Calcium uptake protein 3, mitochondrial (EF-hand domain-containing family member A2) Mus musculus (Mouse) GO:0001956; GO:0005246; GO:0005509; GO:0005739; GO:0005758; GO:0036444; GO:0046982; GO:0051560; GO:0061891; GO:0071277; GO:1990246 calcium import into the mitochondrion [GO:0036444]; cellular response to calcium ion [GO:0071277]; mitochondrial calcium ion homeostasis [GO:0051560]; positive regulation of neurotransmitter secretion [GO:0001956] mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; uniplex complex [GO:1990246] calcium channel regulator activity [GO:0005246]; calcium ion binding [GO:0005509]; calcium ion sensor activity [GO:0061891]; protein heterodimerization activity [GO:0046982] g18761.t1 P34981 27.164 335 3.2400000000000004e-21 97.4 sp|P34981|TRFR_HUMAN Thyrotropin-releasing hormone receptor OS=Homo sapiens OX=9606 GN=TRHR PE=1 SV=1 TRFR_HUMAN reviewed Thyrotropin-releasing hormone receptor (TRH-R) (Thyroliberin receptor) Homo sapiens (Human) GO:0004997; GO:0005886; GO:0007186; GO:0007200 G protein-coupled receptor signaling pathway [GO:0007186]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200] plasma membrane [GO:0005886] thyrotropin-releasing hormone receptor activity [GO:0004997] g18763.t1 Q08890 45.221 544 6.87e-155 459.0 sp|Q08890|IDS_MOUSE Iduronate 2-sulfatase OS=Mus musculus OX=10090 GN=Ids PE=2 SV=3 IDS_MOUSE reviewed Iduronate 2-sulfatase (EC 3.1.6.13) (Alpha-L-iduronate sulfate sulfatase) Mus musculus (Mouse) GO:0004423; GO:0005509; GO:0005764; GO:0006027; GO:0008484; GO:0030200; GO:0030209; GO:0043202 dermatan sulfate proteoglycan catabolic process [GO:0030209]; glycosaminoglycan catabolic process [GO:0006027]; heparan sulfate proteoglycan catabolic process [GO:0030200] lysosomal lumen [GO:0043202]; lysosome [GO:0005764] calcium ion binding [GO:0005509]; iduronate-2-sulfatase activity [GO:0004423]; sulfuric ester hydrolase activity [GO:0008484] g18765.t1 O15973 26.667 315 6.15e-22 99.4 sp|O15973|OPSD1_MIZYE Rhodopsin, GQ-coupled OS=Mizuhopecten yessoensis OX=6573 GN=SCOP1 PE=1 SV=1 g18766.t1 B0UYT5 26.087 391 3.4099999999999995e-24 112.0 sp|B0UYT5|MFD6B_DANRE Major facilitator superfamily domain-containing protein 6-B OS=Danio rerio OX=7955 GN=mfsd6b PE=3 SV=1 g18767.t1 Q66GS9 40.345 1217 0.0 794.0 sp|Q66GS9|CP135_HUMAN Centrosomal protein of 135 kDa OS=Homo sapiens OX=9606 GN=CEP135 PE=1 SV=2 CP135_HUMAN reviewed Centrosomal protein of 135 kDa (Cep135) (Centrosomal protein 4) Homo sapiens (Human) GO:0005813; GO:0005814; GO:0005829; GO:0007099; GO:0008017; GO:0010457; GO:0015631; GO:0042802; GO:0042803; GO:1902857; GO:1904951 centriole replication [GO:0007099]; centriole-centriole cohesion [GO:0010457]; positive regulation of establishment of protein localization [GO:1904951]; positive regulation of non-motile cilium assembly [GO:1902857] centriole [GO:0005814]; centrosome [GO:0005813]; cytosol [GO:0005829] identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; protein homodimerization activity [GO:0042803]; tubulin binding [GO:0015631] g18769.t1 Q0GA40 35.308 422 1.49e-76 251.0 sp|Q0GA40|LGSN_RABIT Lengsin OS=Oryctolagus cuniculus OX=9986 GN=LGSN PE=2 SV=1 g18770.t1 P98106 37.805 164 1.1500000000000002e-21 95.5 sp|P98106|LYAM3_RAT P-selectin OS=Rattus norvegicus OX=10116 GN=Selp PE=2 SV=1 g18771.t1 Q5F452 60.741 540 0.0 706.0 sp|Q5F452|MTMR8_CHICK Phosphatidylinositol-3,5-bisphosphate 3-phosphatase MTMR8 OS=Gallus gallus OX=9031 GN=MTMR8 PE=2 SV=1 MTMR8_CHICK reviewed Phosphatidylinositol-3,5-bisphosphate 3-phosphatase MTMR8 (EC 3.1.3.95) (Myotubularin-related protein 8) (Phosphatidylinositol-3-phosphate phosphatase) Gallus gallus (Chicken) GO:0004438; GO:0005635; GO:0005737; GO:0046856; GO:0052629; GO:0106018 phosphatidylinositol dephosphorylation [GO:0046856] cytoplasm [GO:0005737]; nuclear envelope [GO:0005635] phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity [GO:0052629]; phosphatidylinositol-3,5-bisphosphate phosphatase activity [GO:0106018]; phosphatidylinositol-3-phosphate phosphatase activity [GO:0004438] g18772.t1 P70581 47.085 223 1.62e-61 218.0 sp|P70581|NUP58_RAT Nucleoporin p58/p45 OS=Rattus norvegicus OX=10116 GN=Nup58 PE=1 SV=1 g18773.t1 O18883 56.311 206 1.48e-87 261.0 sp|O18883|TXND9_BOVIN Thioredoxin domain-containing protein 9 OS=Bos taurus OX=9913 GN=TXNDC9 PE=2 SV=2 g18774.t1 P31403 82.581 155 6.85e-55 172.0 sp|P31403|VATL_MANSE V-type proton ATPase 16 kDa proteolipid subunit c OS=Manduca sexta OX=7130 GN=VHA16 PE=2 SV=1 g18775.t1 A4FUF0 41.758 546 3.45e-132 398.0 sp|A4FUF0|GLYR1_BOVIN Cytokine-like nuclear factor N-PAC OS=Bos taurus OX=9913 GN=GLYR1 PE=2 SV=1 GLYR1_BOVIN reviewed Cytokine-like nuclear factor N-PAC (NPAC) (Glyoxylate reductase 1 homolog) (Nuclear protein NP60) (Putative oxidoreductase GLYR1) Bos taurus (Bovine) GO:0000785; GO:0000786; GO:0003677; GO:0005654; GO:0005829; GO:0031491; GO:0042393; GO:0045815; GO:0050661; GO:0051287; GO:0140463; GO:0140673 transcription elongation-coupled chromatin remodeling [GO:0140673]; transcription initiation-coupled chromatin remodeling [GO:0045815] chromatin [GO:0000785]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786] chromatin-protein adaptor activity [GO:0140463]; DNA binding [GO:0003677]; histone binding [GO:0042393]; NAD binding [GO:0051287]; NADP binding [GO:0050661]; nucleosome binding [GO:0031491] g18778.t1 P51826 37.324 284 3.2399999999999997e-40 167.0 sp|P51826|AFF3_HUMAN AF4/FMR2 family member 3 OS=Homo sapiens OX=9606 GN=AFF3 PE=1 SV=3 AFF3_HUMAN reviewed AF4/FMR2 family member 3 (Lymphoid nuclear protein related to AF4) (Protein LAF-4) Homo sapiens (Human) GO:0003690; GO:0003700; GO:0005634; GO:0005654; GO:0005829; GO:0010468; GO:0016604; GO:0032783; GO:0034612; GO:0035116 embryonic hindlimb morphogenesis [GO:0035116]; regulation of gene expression [GO:0010468]; response to tumor necrosis factor [GO:0034612] cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; super elongation complex [GO:0032783] DNA-binding transcription factor activity [GO:0003700]; double-stranded DNA binding [GO:0003690] g18778.t2 Q9UHB7 44.231 156 1.8700000000000002e-29 132.0 sp|Q9UHB7|AFF4_HUMAN AF4/FMR2 family member 4 OS=Homo sapiens OX=9606 GN=AFF4 PE=1 SV=1 g18779.t1 Q9Y6R7 29.205 2390 0.0 885.0 sp|Q9Y6R7|FCGBP_HUMAN IgGFc-binding protein OS=Homo sapiens OX=9606 GN=FCGBP PE=1 SV=3 FCGBP_HUMAN reviewed IgGFc-binding protein (Fcgamma-binding protein antigen) (FcgammaBP) Homo sapiens (Human) GO:0005201; GO:0005615; GO:0005796; GO:0031012; GO:0070062 extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796] extracellular matrix structural constituent [GO:0005201] g18779.t1 Q9Y6R7 28.512 2406 0.0 845.0 sp|Q9Y6R7|FCGBP_HUMAN IgGFc-binding protein OS=Homo sapiens OX=9606 GN=FCGBP PE=1 SV=3 FCGBP_HUMAN reviewed IgGFc-binding protein (Fcgamma-binding protein antigen) (FcgammaBP) Homo sapiens (Human) GO:0005201; GO:0005615; GO:0005796; GO:0031012; GO:0070062 extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796] extracellular matrix structural constituent [GO:0005201] g18779.t1 Q9Y6R7 28.369 2404 0.0 825.0 sp|Q9Y6R7|FCGBP_HUMAN IgGFc-binding protein OS=Homo sapiens OX=9606 GN=FCGBP PE=1 SV=3 FCGBP_HUMAN reviewed IgGFc-binding protein (Fcgamma-binding protein antigen) (FcgammaBP) Homo sapiens (Human) GO:0005201; GO:0005615; GO:0005796; GO:0031012; GO:0070062 extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796] extracellular matrix structural constituent [GO:0005201] g18779.t1 Q9Y6R7 28.395 2423 0.0 812.0 sp|Q9Y6R7|FCGBP_HUMAN IgGFc-binding protein OS=Homo sapiens OX=9606 GN=FCGBP PE=1 SV=3 FCGBP_HUMAN reviewed IgGFc-binding protein (Fcgamma-binding protein antigen) (FcgammaBP) Homo sapiens (Human) GO:0005201; GO:0005615; GO:0005796; GO:0031012; GO:0070062 extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796] extracellular matrix structural constituent [GO:0005201] g18779.t1 Q9Y6R7 28.318 2426 0.0 802.0 sp|Q9Y6R7|FCGBP_HUMAN IgGFc-binding protein OS=Homo sapiens OX=9606 GN=FCGBP PE=1 SV=3 FCGBP_HUMAN reviewed IgGFc-binding protein (Fcgamma-binding protein antigen) (FcgammaBP) Homo sapiens (Human) GO:0005201; GO:0005615; GO:0005796; GO:0031012; GO:0070062 extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796] extracellular matrix structural constituent [GO:0005201] g18779.t1 Q9Y6R7 28.292 2400 0.0 801.0 sp|Q9Y6R7|FCGBP_HUMAN IgGFc-binding protein OS=Homo sapiens OX=9606 GN=FCGBP PE=1 SV=3 FCGBP_HUMAN reviewed IgGFc-binding protein (Fcgamma-binding protein antigen) (FcgammaBP) Homo sapiens (Human) GO:0005201; GO:0005615; GO:0005796; GO:0031012; GO:0070062 extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796] extracellular matrix structural constituent [GO:0005201] g18779.t1 Q9Y6R7 27.956 2368 0.0 795.0 sp|Q9Y6R7|FCGBP_HUMAN IgGFc-binding protein OS=Homo sapiens OX=9606 GN=FCGBP PE=1 SV=3 FCGBP_HUMAN reviewed IgGFc-binding protein (Fcgamma-binding protein antigen) (FcgammaBP) Homo sapiens (Human) GO:0005201; GO:0005615; GO:0005796; GO:0031012; GO:0070062 extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796] extracellular matrix structural constituent [GO:0005201] g18779.t1 Q9Y6R7 28.262 2399 0.0 790.0 sp|Q9Y6R7|FCGBP_HUMAN IgGFc-binding protein OS=Homo sapiens OX=9606 GN=FCGBP PE=1 SV=3 FCGBP_HUMAN reviewed IgGFc-binding protein (Fcgamma-binding protein antigen) (FcgammaBP) Homo sapiens (Human) GO:0005201; GO:0005615; GO:0005796; GO:0031012; GO:0070062 extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796] extracellular matrix structural constituent [GO:0005201] g18779.t1 Q9Y6R7 25.706 673 2.18e-43 180.0 sp|Q9Y6R7|FCGBP_HUMAN IgGFc-binding protein OS=Homo sapiens OX=9606 GN=FCGBP PE=1 SV=3 FCGBP_HUMAN reviewed IgGFc-binding protein (Fcgamma-binding protein antigen) (FcgammaBP) Homo sapiens (Human) GO:0005201; GO:0005615; GO:0005796; GO:0031012; GO:0070062 extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796] extracellular matrix structural constituent [GO:0005201] g18783.t1 P57999 24.247 1893 4.6e-121 429.0 sp|P57999|ZAN_RABIT Zonadhesin (Fragment) OS=Oryctolagus cuniculus OX=9986 GN=ZAN PE=2 SV=2 g18783.t1 P57999 25.154 1463 6.9200000000000005e-109 390.0 sp|P57999|ZAN_RABIT Zonadhesin (Fragment) OS=Oryctolagus cuniculus OX=9986 GN=ZAN PE=2 SV=2 g18783.t1 P57999 23.935 1479 1.94e-83 309.0 sp|P57999|ZAN_RABIT Zonadhesin (Fragment) OS=Oryctolagus cuniculus OX=9986 GN=ZAN PE=2 SV=2 g18783.t1 P57999 26.21 992 3.34e-77 289.0 sp|P57999|ZAN_RABIT Zonadhesin (Fragment) OS=Oryctolagus cuniculus OX=9986 GN=ZAN PE=2 SV=2 g18783.t1 P57999 25.303 577 7.39e-31 137.0 sp|P57999|ZAN_RABIT Zonadhesin (Fragment) OS=Oryctolagus cuniculus OX=9986 GN=ZAN PE=2 SV=2 g18785.t1 O94915 49.539 1520 0.0 1347.0 sp|O94915|FRYL_HUMAN Protein furry homolog-like OS=Homo sapiens OX=9606 GN=FRYL PE=1 SV=2 FRYL_HUMAN reviewed Protein furry homolog-like (ALL1-fused gene from chromosome 4p12 protein) Homo sapiens (Human) GO:0000902; GO:0005938; GO:0030427; GO:0031175 cell morphogenesis [GO:0000902]; neuron projection development [GO:0031175] cell cortex [GO:0005938]; site of polarized growth [GO:0030427] g18785.t1 O94915 39.729 886 2.5599999999999996e-150 531.0 sp|O94915|FRYL_HUMAN Protein furry homolog-like OS=Homo sapiens OX=9606 GN=FRYL PE=1 SV=2 FRYL_HUMAN reviewed Protein furry homolog-like (ALL1-fused gene from chromosome 4p12 protein) Homo sapiens (Human) GO:0000902; GO:0005938; GO:0030427; GO:0031175 cell morphogenesis [GO:0000902]; neuron projection development [GO:0031175] cell cortex [GO:0005938]; site of polarized growth [GO:0030427] g18785.t1 O94915 36.036 333 2.04e-50 203.0 sp|O94915|FRYL_HUMAN Protein furry homolog-like OS=Homo sapiens OX=9606 GN=FRYL PE=1 SV=2 FRYL_HUMAN reviewed Protein furry homolog-like (ALL1-fused gene from chromosome 4p12 protein) Homo sapiens (Human) GO:0000902; GO:0005938; GO:0030427; GO:0031175 cell morphogenesis [GO:0000902]; neuron projection development [GO:0031175] cell cortex [GO:0005938]; site of polarized growth [GO:0030427] g18785.t2 O94915 49.474 1520 0.0 1348.0 sp|O94915|FRYL_HUMAN Protein furry homolog-like OS=Homo sapiens OX=9606 GN=FRYL PE=1 SV=2 FRYL_HUMAN reviewed Protein furry homolog-like (ALL1-fused gene from chromosome 4p12 protein) Homo sapiens (Human) GO:0000902; GO:0005938; GO:0030427; GO:0031175 cell morphogenesis [GO:0000902]; neuron projection development [GO:0031175] cell cortex [GO:0005938]; site of polarized growth [GO:0030427] g18785.t2 O94915 39.729 886 1.7e-150 531.0 sp|O94915|FRYL_HUMAN Protein furry homolog-like OS=Homo sapiens OX=9606 GN=FRYL PE=1 SV=2 FRYL_HUMAN reviewed Protein furry homolog-like (ALL1-fused gene from chromosome 4p12 protein) Homo sapiens (Human) GO:0000902; GO:0005938; GO:0030427; GO:0031175 cell morphogenesis [GO:0000902]; neuron projection development [GO:0031175] cell cortex [GO:0005938]; site of polarized growth [GO:0030427] g18785.t2 O94915 36.145 332 2.49e-50 202.0 sp|O94915|FRYL_HUMAN Protein furry homolog-like OS=Homo sapiens OX=9606 GN=FRYL PE=1 SV=2 FRYL_HUMAN reviewed Protein furry homolog-like (ALL1-fused gene from chromosome 4p12 protein) Homo sapiens (Human) GO:0000902; GO:0005938; GO:0030427; GO:0031175 cell morphogenesis [GO:0000902]; neuron projection development [GO:0031175] cell cortex [GO:0005938]; site of polarized growth [GO:0030427] g18785.t3 O94915 49.539 1520 0.0 1347.0 sp|O94915|FRYL_HUMAN Protein furry homolog-like OS=Homo sapiens OX=9606 GN=FRYL PE=1 SV=2 FRYL_HUMAN reviewed Protein furry homolog-like (ALL1-fused gene from chromosome 4p12 protein) Homo sapiens (Human) GO:0000902; GO:0005938; GO:0030427; GO:0031175 cell morphogenesis [GO:0000902]; neuron projection development [GO:0031175] cell cortex [GO:0005938]; site of polarized growth [GO:0030427] g18785.t3 O94915 39.729 886 2e-150 531.0 sp|O94915|FRYL_HUMAN Protein furry homolog-like OS=Homo sapiens OX=9606 GN=FRYL PE=1 SV=2 FRYL_HUMAN reviewed Protein furry homolog-like (ALL1-fused gene from chromosome 4p12 protein) Homo sapiens (Human) GO:0000902; GO:0005938; GO:0030427; GO:0031175 cell morphogenesis [GO:0000902]; neuron projection development [GO:0031175] cell cortex [GO:0005938]; site of polarized growth [GO:0030427] g18785.t3 O94915 36.55 342 1.9e-50 203.0 sp|O94915|FRYL_HUMAN Protein furry homolog-like OS=Homo sapiens OX=9606 GN=FRYL PE=1 SV=2 FRYL_HUMAN reviewed Protein furry homolog-like (ALL1-fused gene from chromosome 4p12 protein) Homo sapiens (Human) GO:0000902; GO:0005938; GO:0030427; GO:0031175 cell morphogenesis [GO:0000902]; neuron projection development [GO:0031175] cell cortex [GO:0005938]; site of polarized growth [GO:0030427] g18785.t4 O94915 49.539 1520 0.0 1347.0 sp|O94915|FRYL_HUMAN Protein furry homolog-like OS=Homo sapiens OX=9606 GN=FRYL PE=1 SV=2 FRYL_HUMAN reviewed Protein furry homolog-like (ALL1-fused gene from chromosome 4p12 protein) Homo sapiens (Human) GO:0000902; GO:0005938; GO:0030427; GO:0031175 cell morphogenesis [GO:0000902]; neuron projection development [GO:0031175] cell cortex [GO:0005938]; site of polarized growth [GO:0030427] g18785.t4 O94915 40.091 878 1.12e-152 539.0 sp|O94915|FRYL_HUMAN Protein furry homolog-like OS=Homo sapiens OX=9606 GN=FRYL PE=1 SV=2 FRYL_HUMAN reviewed Protein furry homolog-like (ALL1-fused gene from chromosome 4p12 protein) Homo sapiens (Human) GO:0000902; GO:0005938; GO:0030427; GO:0031175 cell morphogenesis [GO:0000902]; neuron projection development [GO:0031175] cell cortex [GO:0005938]; site of polarized growth [GO:0030427] g18785.t4 O94915 36.145 332 2.53e-50 202.0 sp|O94915|FRYL_HUMAN Protein furry homolog-like OS=Homo sapiens OX=9606 GN=FRYL PE=1 SV=2 FRYL_HUMAN reviewed Protein furry homolog-like (ALL1-fused gene from chromosome 4p12 protein) Homo sapiens (Human) GO:0000902; GO:0005938; GO:0030427; GO:0031175 cell morphogenesis [GO:0000902]; neuron projection development [GO:0031175] cell cortex [GO:0005938]; site of polarized growth [GO:0030427] g18786.t1 Q9Z286 27.955 973 1.0600000000000001e-99 349.0 sp|Q9Z286|ADCYA_RAT Adenylate cyclase type 10 OS=Rattus norvegicus OX=10116 GN=Adcy10 PE=1 SV=1 ADCYA_RAT reviewed Adenylate cyclase type 10 (EC 4.6.1.1) (Germ cell soluble adenylyl cyclase) (sAC) (Testicular soluble adenylyl cyclase) Rattus norvegicus (Rat) GO:0000287; GO:0003351; GO:0004016; GO:0005524; GO:0005576; GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0006007; GO:0006171; GO:0007286; GO:0010613; GO:0010666; GO:0010917; GO:0015630; GO:0016020; GO:0016324; GO:0030145; GO:0030424; GO:0030425; GO:0030426; GO:0031514; GO:0035556; GO:0043025; GO:0043065; GO:0045177; GO:0045178; GO:0045773; GO:0045778; GO:0045819; GO:0048471; GO:0051117; GO:0051901; GO:0060306; GO:0071890; GO:0090724; GO:0097450; GO:0106028; GO:0106135; GO:1901524; GO:1903378; GO:1903427; GO:1903428; GO:1903955; GO:1905461; GO:1990138; GO:1990535; GO:1990544; GO:2001171; GO:2001244 cAMP biosynthetic process [GO:0006171]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; glucose catabolic process [GO:0006007]; intracellular signal transduction [GO:0035556]; mitochondrial ATP transmembrane transport [GO:1990544]; negative regulation of cardiac muscle cell contraction [GO:0106135]; negative regulation of mitochondrial membrane potential [GO:0010917]; negative regulation of reactive oxygen species biosynthetic process [GO:1903427]; neuron projection extension [GO:1990138]; neuron projection maintenance [GO:1990535]; neuron projection retraction [GO:0106028]; positive regulation of apoptotic process [GO:0043065]; positive regulation of ATP biosynthetic process [GO:2001171]; positive regulation of axon extension [GO:0045773]; positive regulation of cardiac muscle cell apoptotic process [GO:0010666]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of glycogen catabolic process [GO:0045819]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; positive regulation of mitochondrial depolarization [GO:0051901]; positive regulation of ossification [GO:0045778]; positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway [GO:1903378]; positive regulation of protein targeting to mitochondrion [GO:1903955]; positive regulation of reactive oxygen species biosynthetic process [GO:1903428]; positive regulation of vascular associated smooth muscle cell apoptotic process [GO:1905461]; regulation of membrane repolarization [GO:0060306]; regulation of mitophagy [GO:1901524]; spermatid development [GO:0007286] apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; astrocyte end-foot [GO:0097450]; axon [GO:0030424]; basal part of cell [GO:0045178]; central region of growth cone [GO:0090724]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; extracellular region [GO:0005576]; growth cone [GO:0030426]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; mitochondrion [GO:0005739]; motile cilium [GO:0031514]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471] adenylate cyclase activity [GO:0004016]; ATP binding [GO:0005524]; ATPase binding [GO:0051117]; bicarbonate binding [GO:0071890]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145] g18787.t1 Q96DM1 31.054 351 3.56e-51 185.0 sp|Q96DM1|PGBD4_HUMAN PiggyBac transposable element-derived protein 4 OS=Homo sapiens OX=9606 GN=PGBD4 PE=1 SV=3 g18792.t1 Q5JR59 28.322 459 2.15e-28 129.0 sp|Q5JR59|MTUS2_HUMAN Microtubule-associated tumor suppressor candidate 2 OS=Homo sapiens OX=9606 GN=MTUS2 PE=1 SV=3 MTUS2_HUMAN reviewed Microtubule-associated tumor suppressor candidate 2 (Cardiac zipper protein) (Microtubule plus-end tracking protein TIP150) (Tracking protein of 150 kDa) Homo sapiens (Human) GO:0005634; GO:0005874; GO:0008017; GO:0015630; GO:0042803; GO:0045171 intercellular bridge [GO:0045171]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; nucleus [GO:0005634] microtubule binding [GO:0008017]; protein homodimerization activity [GO:0042803] g18792.t2 Q5JR59 28.322 459 2.96e-28 128.0 sp|Q5JR59|MTUS2_HUMAN Microtubule-associated tumor suppressor candidate 2 OS=Homo sapiens OX=9606 GN=MTUS2 PE=1 SV=3 MTUS2_HUMAN reviewed Microtubule-associated tumor suppressor candidate 2 (Cardiac zipper protein) (Microtubule plus-end tracking protein TIP150) (Tracking protein of 150 kDa) Homo sapiens (Human) GO:0005634; GO:0005874; GO:0008017; GO:0015630; GO:0042803; GO:0045171 intercellular bridge [GO:0045171]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; nucleus [GO:0005634] microtubule binding [GO:0008017]; protein homodimerization activity [GO:0042803] g18793.t1 Q56I99 79.266 463 0.0 672.0 sp|Q56I99|SMAD5_CHICK Mothers against decapentaplegic homolog 5 OS=Gallus gallus OX=9031 GN=SMAD5 PE=1 SV=1 SMAD5_CHICK reviewed SMAD family member 5 (SMAD 5) (Mothers against decapentaplegic homolog 5) (MAD homolog 5) (Mothers against DPP homolog 5) Gallus gallus (Chicken) GO:0000978; GO:0000981; GO:0005634; GO:0005737; GO:0006357; GO:0007179; GO:0009653; GO:0030154; GO:0030509; GO:0046872; GO:0060395; GO:0070411; GO:0071144 anatomical structure morphogenesis [GO:0009653]; BMP signaling pathway [GO:0030509]; cell differentiation [GO:0030154]; regulation of transcription by RNA polymerase II [GO:0006357]; SMAD protein signal transduction [GO:0060395]; transforming growth factor beta receptor signaling pathway [GO:0007179] cytoplasm [GO:0005737]; heteromeric SMAD protein complex [GO:0071144]; nucleus [GO:0005634] DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; I-SMAD binding [GO:0070411]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978] g18801.t1 Q86TZ1 45.7 407 3.87e-107 357.0 sp|Q86TZ1|TTC6_HUMAN Tetratricopeptide repeat protein 6 OS=Homo sapiens OX=9606 GN=TTC6 PE=1 SV=1 g18801.t1 Q86TZ1 23.769 589 7.039999999999999e-23 108.0 sp|Q86TZ1|TTC6_HUMAN Tetratricopeptide repeat protein 6 OS=Homo sapiens OX=9606 GN=TTC6 PE=1 SV=1 g18801.t2 Q86TZ1 45.7 407 3.85e-107 357.0 sp|Q86TZ1|TTC6_HUMAN Tetratricopeptide repeat protein 6 OS=Homo sapiens OX=9606 GN=TTC6 PE=1 SV=1 g18801.t2 Q86TZ1 23.769 589 7.009999999999999e-23 108.0 sp|Q86TZ1|TTC6_HUMAN Tetratricopeptide repeat protein 6 OS=Homo sapiens OX=9606 GN=TTC6 PE=1 SV=1 g18801.t3 Q86TZ1 45.7 407 3.85e-107 357.0 sp|Q86TZ1|TTC6_HUMAN Tetratricopeptide repeat protein 6 OS=Homo sapiens OX=9606 GN=TTC6 PE=1 SV=1 g18801.t3 Q86TZ1 23.769 589 7.019999999999999e-23 108.0 sp|Q86TZ1|TTC6_HUMAN Tetratricopeptide repeat protein 6 OS=Homo sapiens OX=9606 GN=TTC6 PE=1 SV=1 g18802.t1 Q2HJJ1 51.304 230 5.4599999999999996e-67 213.0 sp|Q2HJJ1|RM28_BOVIN Large ribosomal subunit protein bL28m OS=Bos taurus OX=9913 GN=MRPL28 PE=1 SV=1 g18806.t1 Q14AW5 42.245 490 6.63e-105 338.0 sp|Q14AW5|NSUN7_MOUSE Putative methyltransferase NSUN7 OS=Mus musculus OX=10090 GN=Nsun7 PE=2 SV=2 g18807.t1 Q9Y673 58.804 301 2.03e-139 400.0 sp|Q9Y673|ALG5_HUMAN Dolichyl-phosphate beta-glucosyltransferase OS=Homo sapiens OX=9606 GN=ALG5 PE=1 SV=1 g18808.t1 Q2PZL6 39.37 4506 0.0 2958.0 sp|Q2PZL6|FAT4_MOUSE Protocadherin Fat 4 OS=Mus musculus OX=10090 GN=Fat4 PE=1 SV=2 FAT4_MOUSE reviewed Protocadherin Fat 4 (FAT tumor suppressor homolog 4) (Fat-like cadherin protein FAT-J) Mus musculus (Mouse) GO:0001658; GO:0001736; GO:0001822; GO:0003007; GO:0005509; GO:0005886; GO:0005912; GO:0007009; GO:0007156; GO:0007157; GO:0007219; GO:0007409; GO:0008543; GO:0021987; GO:0022008; GO:0030855; GO:0035329; GO:0043931; GO:0044331; GO:0045177; GO:0048565; GO:0060122; GO:0072006; GO:0072137; GO:0072307 axonogenesis [GO:0007409]; branching involved in ureteric bud morphogenesis [GO:0001658]; cell-cell adhesion mediated by cadherin [GO:0044331]; cerebral cortex development [GO:0021987]; condensed mesenchymal cell proliferation [GO:0072137]; digestive tract development [GO:0048565]; epithelial cell differentiation [GO:0030855]; establishment of planar polarity [GO:0001736]; fibroblast growth factor receptor signaling pathway [GO:0008543]; heart morphogenesis [GO:0003007]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; hippo signaling [GO:0035329]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; inner ear receptor cell stereocilium organization [GO:0060122]; kidney development [GO:0001822]; nephron development [GO:0072006]; neurogenesis [GO:0022008]; Notch signaling pathway [GO:0007219]; ossification involved in bone maturation [GO:0043931]; plasma membrane organization [GO:0007009]; regulation of metanephric nephron tubule epithelial cell differentiation [GO:0072307] adherens junction [GO:0005912]; apical part of cell [GO:0045177]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509] g18809.t1 Q8WXW3 46.789 763 0.0 630.0 sp|Q8WXW3|PIBF1_HUMAN Progesterone-induced-blocking factor 1 OS=Homo sapiens OX=9606 GN=PIBF1 PE=1 SV=2 PIBF1_HUMAN reviewed Progesterone-induced-blocking factor 1 (PIBF) (Centrosomal protein of 90 kDa) (CEP90) Homo sapiens (Human) GO:0002376; GO:0005136; GO:0005615; GO:0005634; GO:0005737; GO:0005813; GO:0005815; GO:0007080; GO:0031393; GO:0032695; GO:0032733; GO:0032815; GO:0034451; GO:0036064; GO:0042531; GO:0042532; GO:0042976; GO:0060271; GO:0071539; GO:0090307; GO:1905515 activation of Janus kinase activity [GO:0042976]; cilium assembly [GO:0060271]; immune system process [GO:0002376]; mitotic metaphase chromosome alignment [GO:0007080]; mitotic spindle assembly [GO:0090307]; negative regulation of interleukin-12 production [GO:0032695]; negative regulation of natural killer cell activation [GO:0032815]; negative regulation of prostaglandin biosynthetic process [GO:0031393]; negative regulation of tyrosine phosphorylation of STAT protein [GO:0042532]; non-motile cilium assembly [GO:1905515]; positive regulation of interleukin-10 production [GO:0032733]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; protein localization to centrosome [GO:0071539] centriolar satellite [GO:0034451]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; extracellular space [GO:0005615]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634] interleukin-4 receptor binding [GO:0005136] g18810.t1 Q9NRY5 40.29 345 1.28e-63 223.0 sp|Q9NRY5|F1142_HUMAN Protein FAM114A2 OS=Homo sapiens OX=9606 GN=FAM114A2 PE=1 SV=4 g18814.t1 Q4R4Z9 46.321 598 0.0 560.0 sp|Q4R4Z9|ACSF2_MACFA Medium-chain acyl-CoA ligase ACSF2, mitochondrial OS=Macaca fascicularis OX=9541 GN=ACSF2 PE=2 SV=1 g18817.t1 Q0P4F7 51.537 553 0.0 608.0 sp|Q0P4F7|ACSF2_DANRE Medium-chain acyl-CoA ligase ACSF2, mitochondrial OS=Danio rerio OX=7955 GN=acsf2 PE=2 SV=1 ACSF2_DANRE reviewed Medium-chain acyl-CoA ligase ACSF2, mitochondrial (EC 6.2.1.2) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005524; GO:0005739; GO:0006631; GO:0031956 fatty acid metabolic process [GO:0006631] mitochondrion [GO:0005739] ATP binding [GO:0005524]; medium-chain fatty acid-CoA ligase activity [GO:0031956] g18824.t1 Q5XIU9 54.438 169 1.72e-61 192.0 sp|Q5XIU9|PGRC2_RAT Membrane-associated progesterone receptor component 2 OS=Rattus norvegicus OX=10116 GN=Pgrmc2 PE=1 SV=1 PGRC2_RAT reviewed Membrane-associated progesterone receptor component 2 Rattus norvegicus (Rat) GO:0005496; GO:0005576; GO:0005635; GO:0005783; GO:0012505; GO:0015232; GO:0015886; GO:0016020; GO:0020037; GO:0045202; GO:0060612; GO:0098978 adipose tissue development [GO:0060612]; heme transport [GO:0015886] endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; synapse [GO:0045202] heme binding [GO:0020037]; heme transmembrane transporter activity [GO:0015232]; steroid binding [GO:0005496] g18825.t1 Q66HG8 62.315 337 5.25e-118 370.0 sp|Q66HG8|RED_RAT Protein Red OS=Rattus norvegicus OX=10116 GN=Ik PE=1 SV=1 RED_RAT reviewed Protein Red (Cytokine IK) (IK factor) Rattus norvegicus (Rat) GO:0000228; GO:0000278; GO:0000398; GO:0005634; GO:0005654; GO:0007094; GO:0016607; GO:0034501; GO:0042802; GO:0071005; GO:0097431 mitotic cell cycle [GO:0000278]; mitotic spindle assembly checkpoint signaling [GO:0007094]; mRNA splicing, via spliceosome [GO:0000398]; protein localization to kinetochore [GO:0034501] mitotic spindle pole [GO:0097431]; nuclear chromosome [GO:0000228]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U2-type precatalytic spliceosome [GO:0071005] identical protein binding [GO:0042802] g18825.t1 Q66HG8 55.435 184 1.66e-39 157.0 sp|Q66HG8|RED_RAT Protein Red OS=Rattus norvegicus OX=10116 GN=Ik PE=1 SV=1 RED_RAT reviewed Protein Red (Cytokine IK) (IK factor) Rattus norvegicus (Rat) GO:0000228; GO:0000278; GO:0000398; GO:0005634; GO:0005654; GO:0007094; GO:0016607; GO:0034501; GO:0042802; GO:0071005; GO:0097431 mitotic cell cycle [GO:0000278]; mitotic spindle assembly checkpoint signaling [GO:0007094]; mRNA splicing, via spliceosome [GO:0000398]; protein localization to kinetochore [GO:0034501] mitotic spindle pole [GO:0097431]; nuclear chromosome [GO:0000228]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U2-type precatalytic spliceosome [GO:0071005] identical protein binding [GO:0042802] g18826.t1 O94762 50.472 636 0.0 622.0 sp|O94762|RECQ5_HUMAN ATP-dependent DNA helicase Q5 OS=Homo sapiens OX=9606 GN=RECQL5 PE=1 SV=2 RECQ5_HUMAN reviewed ATP-dependent DNA helicase Q5 (EC 5.6.2.4) (DNA 3'-5' helicase RecQ5) (DNA helicase, RecQ-like type 5) (RecQ5) (RecQ protein-like 5) Homo sapiens (Human) GO:0000278; GO:0000724; GO:0000993; GO:0003677; GO:0003678; GO:0004386; GO:0005524; GO:0005634; GO:0005654; GO:0005657; GO:0005694; GO:0005737; GO:0005829; GO:0006259; GO:0006260; GO:0006281; GO:0009378; GO:0016887; GO:0034244; GO:0042802; GO:0043138; GO:0046872; GO:0051301; GO:0051304; GO:0071466; GO:0072757; GO:0097550; GO:1990414; GO:1990506; GO:2000042 cell division [GO:0051301]; cellular response to camptothecin [GO:0072757]; cellular response to xenobiotic stimulus [GO:0071466]; chromosome separation [GO:0051304]; DNA metabolic process [GO:0006259]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; double-strand break repair via homologous recombination [GO:0000724]; mitotic cell cycle [GO:0000278]; mitotic DNA-templated DNA replication [GO:1990506]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; negative regulation of transcription elongation by RNA polymerase II [GO:0034244]; replication-born double-strand break repair via sister chromatid exchange [GO:1990414] chromosome [GO:0005694]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; replication fork [GO:0005657]; transcription preinitiation complex [GO:0097550] 3'-5' DNA helicase activity [GO:0043138]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; four-way junction helicase activity [GO:0009378]; helicase activity [GO:0004386]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; RNA polymerase II complex binding [GO:0000993] g18827.t1 O94762 49.137 637 0.0 600.0 sp|O94762|RECQ5_HUMAN ATP-dependent DNA helicase Q5 OS=Homo sapiens OX=9606 GN=RECQL5 PE=1 SV=2 RECQ5_HUMAN reviewed ATP-dependent DNA helicase Q5 (EC 5.6.2.4) (DNA 3'-5' helicase RecQ5) (DNA helicase, RecQ-like type 5) (RecQ5) (RecQ protein-like 5) Homo sapiens (Human) GO:0000278; GO:0000724; GO:0000993; GO:0003677; GO:0003678; GO:0004386; GO:0005524; GO:0005634; GO:0005654; GO:0005657; GO:0005694; GO:0005737; GO:0005829; GO:0006259; GO:0006260; GO:0006281; GO:0009378; GO:0016887; GO:0034244; GO:0042802; GO:0043138; GO:0046872; GO:0051301; GO:0051304; GO:0071466; GO:0072757; GO:0097550; GO:1990414; GO:1990506; GO:2000042 cell division [GO:0051301]; cellular response to camptothecin [GO:0072757]; cellular response to xenobiotic stimulus [GO:0071466]; chromosome separation [GO:0051304]; DNA metabolic process [GO:0006259]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; double-strand break repair via homologous recombination [GO:0000724]; mitotic cell cycle [GO:0000278]; mitotic DNA-templated DNA replication [GO:1990506]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; negative regulation of transcription elongation by RNA polymerase II [GO:0034244]; replication-born double-strand break repair via sister chromatid exchange [GO:1990414] chromosome [GO:0005694]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; replication fork [GO:0005657]; transcription preinitiation complex [GO:0097550] 3'-5' DNA helicase activity [GO:0043138]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; four-way junction helicase activity [GO:0009378]; helicase activity [GO:0004386]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; RNA polymerase II complex binding [GO:0000993] g18828.t1 Q3T0P6 74.696 411 0.0 592.0 sp|Q3T0P6|PGK1_BOVIN Phosphoglycerate kinase 1 OS=Bos taurus OX=9913 GN=PGK1 PE=2 SV=3 PGK1_BOVIN reviewed Phosphoglycerate kinase 1 (EC 2.7.11.1) (EC 2.7.2.3) Bos taurus (Bovine) GO:0004618; GO:0004674; GO:0005524; GO:0005615; GO:0005759; GO:0005829; GO:0006094; GO:0006096; GO:0016525; GO:0030855; GO:0031639; GO:0043531; GO:0044325; GO:0045121; GO:0046872; GO:0047134; GO:0061621; GO:0071456; GO:0106310; GO:0160218 canonical glycolysis [GO:0061621]; cellular response to hypoxia [GO:0071456]; epithelial cell differentiation [GO:0030855]; gluconeogenesis [GO:0006094]; glycolytic process [GO:0006096]; negative regulation of angiogenesis [GO:0016525]; negative regulation of pyruvate decarboxylation to acetyl-CoA [GO:0160218]; plasminogen activation [GO:0031639] cytosol [GO:0005829]; extracellular space [GO:0005615]; membrane raft [GO:0045121]; mitochondrial matrix [GO:0005759] ADP binding [GO:0043531]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; phosphoglycerate kinase activity [GO:0004618]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein-disulfide reductase [NAD(P)H] activity [GO:0047134]; transmembrane transporter binding [GO:0044325] g18829.t1 Q99JT1 67.879 165 7.12e-78 244.0 sp|Q99JT1|GATB_MOUSE Glutamyl-tRNA(Gln) amidotransferase subunit B, mitochondrial OS=Mus musculus OX=10090 GN=Gatb PE=1 SV=1 g18830.t1 Q99JT1 47.213 305 3.2000000000000003e-97 300.0 sp|Q99JT1|GATB_MOUSE Glutamyl-tRNA(Gln) amidotransferase subunit B, mitochondrial OS=Mus musculus OX=10090 GN=Gatb PE=1 SV=1 g18831.t1 Q24292 37.772 2989 0.0 1692.0 sp|Q24292|DS_DROME Protein dachsous OS=Drosophila melanogaster OX=7227 GN=ds PE=1 SV=3 DS_DROME reviewed Protein dachsous (Adherin) Drosophila melanogaster (Fruit fly) GO:0001736; GO:0005509; GO:0005886; GO:0005912; GO:0007156; GO:0007409; GO:0007560; GO:0016327; GO:0030855; GO:0035331; GO:0035332; GO:0042067; GO:0044331; GO:0090251 axonogenesis [GO:0007409]; cell-cell adhesion mediated by cadherin [GO:0044331]; epithelial cell differentiation [GO:0030855]; establishment of ommatidial planar polarity [GO:0042067]; establishment of planar polarity [GO:0001736]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; imaginal disc morphogenesis [GO:0007560]; negative regulation of hippo signaling [GO:0035331]; positive regulation of hippo signaling [GO:0035332]; protein localization involved in establishment of planar polarity [GO:0090251] adherens junction [GO:0005912]; apicolateral plasma membrane [GO:0016327]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509] g18831.t1 Q24292 29.514 2077 3.899999999999999e-180 629.0 sp|Q24292|DS_DROME Protein dachsous OS=Drosophila melanogaster OX=7227 GN=ds PE=1 SV=3 DS_DROME reviewed Protein dachsous (Adherin) Drosophila melanogaster (Fruit fly) GO:0001736; GO:0005509; GO:0005886; GO:0005912; GO:0007156; GO:0007409; GO:0007560; GO:0016327; GO:0030855; GO:0035331; GO:0035332; GO:0042067; GO:0044331; GO:0090251 axonogenesis [GO:0007409]; cell-cell adhesion mediated by cadherin [GO:0044331]; epithelial cell differentiation [GO:0030855]; establishment of ommatidial planar polarity [GO:0042067]; establishment of planar polarity [GO:0001736]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; imaginal disc morphogenesis [GO:0007560]; negative regulation of hippo signaling [GO:0035331]; positive regulation of hippo signaling [GO:0035332]; protein localization involved in establishment of planar polarity [GO:0090251] adherens junction [GO:0005912]; apicolateral plasma membrane [GO:0016327]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509] g18831.t1 Q24292 30.286 1258 1.1600000000000001e-117 425.0 sp|Q24292|DS_DROME Protein dachsous OS=Drosophila melanogaster OX=7227 GN=ds PE=1 SV=3 DS_DROME reviewed Protein dachsous (Adherin) Drosophila melanogaster (Fruit fly) GO:0001736; GO:0005509; GO:0005886; GO:0005912; GO:0007156; GO:0007409; GO:0007560; GO:0016327; GO:0030855; GO:0035331; GO:0035332; GO:0042067; GO:0044331; GO:0090251 axonogenesis [GO:0007409]; cell-cell adhesion mediated by cadherin [GO:0044331]; epithelial cell differentiation [GO:0030855]; establishment of ommatidial planar polarity [GO:0042067]; establishment of planar polarity [GO:0001736]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; imaginal disc morphogenesis [GO:0007560]; negative regulation of hippo signaling [GO:0035331]; positive regulation of hippo signaling [GO:0035332]; protein localization involved in establishment of planar polarity [GO:0090251] adherens junction [GO:0005912]; apicolateral plasma membrane [GO:0016327]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509] g18831.t1 Q24292 24.866 1122 1.41e-48 197.0 sp|Q24292|DS_DROME Protein dachsous OS=Drosophila melanogaster OX=7227 GN=ds PE=1 SV=3 DS_DROME reviewed Protein dachsous (Adherin) Drosophila melanogaster (Fruit fly) GO:0001736; GO:0005509; GO:0005886; GO:0005912; GO:0007156; GO:0007409; GO:0007560; GO:0016327; GO:0030855; GO:0035331; GO:0035332; GO:0042067; GO:0044331; GO:0090251 axonogenesis [GO:0007409]; cell-cell adhesion mediated by cadherin [GO:0044331]; epithelial cell differentiation [GO:0030855]; establishment of ommatidial planar polarity [GO:0042067]; establishment of planar polarity [GO:0001736]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; imaginal disc morphogenesis [GO:0007560]; negative regulation of hippo signaling [GO:0035331]; positive regulation of hippo signaling [GO:0035332]; protein localization involved in establishment of planar polarity [GO:0090251] adherens junction [GO:0005912]; apicolateral plasma membrane [GO:0016327]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509] g18833.t1 P82349 30.743 296 4.29e-34 129.0 sp|P82349|SGCB_MOUSE Beta-sarcoglycan OS=Mus musculus OX=10090 GN=Sgcb PE=1 SV=1 SGCB_MOUSE reviewed Beta-sarcoglycan (Beta-SG) (43 kDa dystrophin-associated glycoprotein) (43DAG) Mus musculus (Mouse) GO:0005856; GO:0005886; GO:0007517; GO:0009749; GO:0010467; GO:0016010; GO:0016011; GO:0016012; GO:0042383; GO:0042593; GO:0044381; GO:0055001; GO:0055013; GO:0061024; GO:0097084 cardiac muscle cell development [GO:0055013]; gene expression [GO:0010467]; glucose homeostasis [GO:0042593]; glucose import in response to insulin stimulus [GO:0044381]; membrane organization [GO:0061024]; muscle cell development [GO:0055001]; muscle organ development [GO:0007517]; response to glucose [GO:0009749]; vascular associated smooth muscle cell development [GO:0097084] cytoskeleton [GO:0005856]; dystroglycan complex [GO:0016011]; dystrophin-associated glycoprotein complex [GO:0016010]; plasma membrane [GO:0005886]; sarcoglycan complex [GO:0016012]; sarcolemma [GO:0042383] g18833.t2 P82349 34.007 297 7.68e-39 142.0 sp|P82349|SGCB_MOUSE Beta-sarcoglycan OS=Mus musculus OX=10090 GN=Sgcb PE=1 SV=1 SGCB_MOUSE reviewed Beta-sarcoglycan (Beta-SG) (43 kDa dystrophin-associated glycoprotein) (43DAG) Mus musculus (Mouse) GO:0005856; GO:0005886; GO:0007517; GO:0009749; GO:0010467; GO:0016010; GO:0016011; GO:0016012; GO:0042383; GO:0042593; GO:0044381; GO:0055001; GO:0055013; GO:0061024; GO:0097084 cardiac muscle cell development [GO:0055013]; gene expression [GO:0010467]; glucose homeostasis [GO:0042593]; glucose import in response to insulin stimulus [GO:0044381]; membrane organization [GO:0061024]; muscle cell development [GO:0055001]; muscle organ development [GO:0007517]; response to glucose [GO:0009749]; vascular associated smooth muscle cell development [GO:0097084] cytoskeleton [GO:0005856]; dystroglycan complex [GO:0016011]; dystrophin-associated glycoprotein complex [GO:0016010]; plasma membrane [GO:0005886]; sarcoglycan complex [GO:0016012]; sarcolemma [GO:0042383] g18834.t1 M0R8U1 57.246 138 3.01e-48 169.0 sp|M0R8U1|DYH5_RAT Dynein axonemal heavy chain 5 (Fragment) OS=Rattus norvegicus OX=10116 GN=Dnah5 PE=1 SV=1 DYH5_RAT reviewed Dynein axonemal heavy chain 5 (Axonemal beta dynein heavy chain 5) (Ciliary dynein heavy chain 5) Rattus norvegicus (Rat) GO:0003341; GO:0003351; GO:0003777; GO:0005524; GO:0005576; GO:0005737; GO:0005858; GO:0005874; GO:0005930; GO:0007368; GO:0007507; GO:0008569; GO:0021670; GO:0030317; GO:0031514; GO:0036157; GO:0036158; GO:0045505; GO:0051649; GO:0051959; GO:0060271; GO:0060294; GO:0097386; GO:0097728; GO:0097729 cilium assembly [GO:0060271]; cilium movement [GO:0003341]; cilium movement involved in cell motility [GO:0060294]; determination of left/right symmetry [GO:0007368]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; establishment of localization in cell [GO:0051649]; flagellated sperm motility [GO:0030317]; heart development [GO:0007507]; lateral ventricle development [GO:0021670]; outer dynein arm assembly [GO:0036158] 9+0 motile cilium [GO:0097728]; 9+2 motile cilium [GO:0097729]; axonemal dynein complex [GO:0005858]; axoneme [GO:0005930]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; glial cell projection [GO:0097386]; microtubule [GO:0005874]; motile cilium [GO:0031514]; outer dynein arm [GO:0036157] ATP binding [GO:0005524]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]; minus-end-directed microtubule motor activity [GO:0008569] g18835.t1 Q8TE73 58.764 1489 0.0 1740.0 sp|Q8TE73|DYH5_HUMAN Dynein axonemal heavy chain 5 OS=Homo sapiens OX=9606 GN=DNAH5 PE=1 SV=3 DYH5_HUMAN reviewed Dynein axonemal heavy chain 5 (Axonemal beta dynein heavy chain 5) (Ciliary dynein heavy chain 5) Homo sapiens (Human) GO:0003341; GO:0003351; GO:0005524; GO:0005576; GO:0005737; GO:0005874; GO:0005930; GO:0007368; GO:0007507; GO:0008569; GO:0021670; GO:0030317; GO:0031514; GO:0036157; GO:0036158; GO:0045505; GO:0051649; GO:0051959; GO:0060271; GO:0060294; GO:0097386; GO:0097728; GO:0097729 cilium assembly [GO:0060271]; cilium movement [GO:0003341]; cilium movement involved in cell motility [GO:0060294]; determination of left/right symmetry [GO:0007368]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; establishment of localization in cell [GO:0051649]; flagellated sperm motility [GO:0030317]; heart development [GO:0007507]; lateral ventricle development [GO:0021670]; outer dynein arm assembly [GO:0036158] 9+0 motile cilium [GO:0097728]; 9+2 motile cilium [GO:0097729]; axoneme [GO:0005930]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; glial cell projection [GO:0097386]; microtubule [GO:0005874]; motile cilium [GO:0031514]; outer dynein arm [GO:0036157] ATP binding [GO:0005524]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; minus-end-directed microtubule motor activity [GO:0008569] g18835.t1 Q8TE73 63.183 823 0.0 1036.0 sp|Q8TE73|DYH5_HUMAN Dynein axonemal heavy chain 5 OS=Homo sapiens OX=9606 GN=DNAH5 PE=1 SV=3 DYH5_HUMAN reviewed Dynein axonemal heavy chain 5 (Axonemal beta dynein heavy chain 5) (Ciliary dynein heavy chain 5) Homo sapiens (Human) GO:0003341; GO:0003351; GO:0005524; GO:0005576; GO:0005737; GO:0005874; GO:0005930; GO:0007368; GO:0007507; GO:0008569; GO:0021670; GO:0030317; GO:0031514; GO:0036157; GO:0036158; GO:0045505; GO:0051649; GO:0051959; GO:0060271; GO:0060294; GO:0097386; GO:0097728; GO:0097729 cilium assembly [GO:0060271]; cilium movement [GO:0003341]; cilium movement involved in cell motility [GO:0060294]; determination of left/right symmetry [GO:0007368]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; establishment of localization in cell [GO:0051649]; flagellated sperm motility [GO:0030317]; heart development [GO:0007507]; lateral ventricle development [GO:0021670]; outer dynein arm assembly [GO:0036158] 9+0 motile cilium [GO:0097728]; 9+2 motile cilium [GO:0097729]; axoneme [GO:0005930]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; glial cell projection [GO:0097386]; microtubule [GO:0005874]; motile cilium [GO:0031514]; outer dynein arm [GO:0036157] ATP binding [GO:0005524]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; minus-end-directed microtubule motor activity [GO:0008569] g18836.t1 Q8TE73 75.074 1693 0.0 2519.0 sp|Q8TE73|DYH5_HUMAN Dynein axonemal heavy chain 5 OS=Homo sapiens OX=9606 GN=DNAH5 PE=1 SV=3 DYH5_HUMAN reviewed Dynein axonemal heavy chain 5 (Axonemal beta dynein heavy chain 5) (Ciliary dynein heavy chain 5) Homo sapiens (Human) GO:0003341; GO:0003351; GO:0005524; GO:0005576; GO:0005737; GO:0005874; GO:0005930; GO:0007368; GO:0007507; GO:0008569; GO:0021670; GO:0030317; GO:0031514; GO:0036157; GO:0036158; GO:0045505; GO:0051649; GO:0051959; GO:0060271; GO:0060294; GO:0097386; GO:0097728; GO:0097729 cilium assembly [GO:0060271]; cilium movement [GO:0003341]; cilium movement involved in cell motility [GO:0060294]; determination of left/right symmetry [GO:0007368]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; establishment of localization in cell [GO:0051649]; flagellated sperm motility [GO:0030317]; heart development [GO:0007507]; lateral ventricle development [GO:0021670]; outer dynein arm assembly [GO:0036158] 9+0 motile cilium [GO:0097728]; 9+2 motile cilium [GO:0097729]; axoneme [GO:0005930]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; glial cell projection [GO:0097386]; microtubule [GO:0005874]; motile cilium [GO:0031514]; outer dynein arm [GO:0036157] ATP binding [GO:0005524]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; minus-end-directed microtubule motor activity [GO:0008569] g18837.t1 Q8TE73 73.643 516 0.0 780.0 sp|Q8TE73|DYH5_HUMAN Dynein axonemal heavy chain 5 OS=Homo sapiens OX=9606 GN=DNAH5 PE=1 SV=3 DYH5_HUMAN reviewed Dynein axonemal heavy chain 5 (Axonemal beta dynein heavy chain 5) (Ciliary dynein heavy chain 5) Homo sapiens (Human) GO:0003341; GO:0003351; GO:0005524; GO:0005576; GO:0005737; GO:0005874; GO:0005930; GO:0007368; GO:0007507; GO:0008569; GO:0021670; GO:0030317; GO:0031514; GO:0036157; GO:0036158; GO:0045505; GO:0051649; GO:0051959; GO:0060271; GO:0060294; GO:0097386; GO:0097728; GO:0097729 cilium assembly [GO:0060271]; cilium movement [GO:0003341]; cilium movement involved in cell motility [GO:0060294]; determination of left/right symmetry [GO:0007368]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; establishment of localization in cell [GO:0051649]; flagellated sperm motility [GO:0030317]; heart development [GO:0007507]; lateral ventricle development [GO:0021670]; outer dynein arm assembly [GO:0036158] 9+0 motile cilium [GO:0097728]; 9+2 motile cilium [GO:0097729]; axoneme [GO:0005930]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; glial cell projection [GO:0097386]; microtubule [GO:0005874]; motile cilium [GO:0031514]; outer dynein arm [GO:0036157] ATP binding [GO:0005524]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; minus-end-directed microtubule motor activity [GO:0008569] g18855.t1 Q8VD76 59.14 279 1.3e-116 341.0 sp|Q8VD76|TF2H3_MOUSE General transcription factor IIH subunit 3 OS=Mus musculus OX=10090 GN=Gtf2h3 PE=1 SV=1 g18856.t1 Q3ZBV9 51.181 254 6.54e-96 285.0 sp|Q3ZBV9|DHR11_BOVIN Dehydrogenase/reductase SDR family member 11 OS=Bos taurus OX=9913 GN=DHRS11 PE=2 SV=1 DHR11_BOVIN reviewed Dehydrogenase/reductase SDR family member 11 (17-beta-hydroxysteroid dehydrogenase) (3-beta-hydroxysteroid 3-dehydrogenase) (EC 1.1.1.270) (Estradiol 17-beta-dehydrogenase) (EC 1.1.1.62) (Short-chain dehydrogenase/reductase family 24C member 1) Bos taurus (Bovine) GO:0000166; GO:0000253; GO:0004303; GO:0005576; GO:0006703 estrogen biosynthetic process [GO:0006703] extracellular region [GO:0005576] 3-beta-hydroxysteroid 3-dehydrogenase (NADP+) activity [GO:0000253]; estradiol 17-beta-dehydrogenase [NAD(P)+] activity [GO:0004303]; nucleotide binding [GO:0000166] g18856.t2 Q3ZBV9 51.181 254 3.37e-89 283.0 sp|Q3ZBV9|DHR11_BOVIN Dehydrogenase/reductase SDR family member 11 OS=Bos taurus OX=9913 GN=DHRS11 PE=2 SV=1 DHR11_BOVIN reviewed Dehydrogenase/reductase SDR family member 11 (17-beta-hydroxysteroid dehydrogenase) (3-beta-hydroxysteroid 3-dehydrogenase) (EC 1.1.1.270) (Estradiol 17-beta-dehydrogenase) (EC 1.1.1.62) (Short-chain dehydrogenase/reductase family 24C member 1) Bos taurus (Bovine) GO:0000166; GO:0000253; GO:0004303; GO:0005576; GO:0006703 estrogen biosynthetic process [GO:0006703] extracellular region [GO:0005576] 3-beta-hydroxysteroid 3-dehydrogenase (NADP+) activity [GO:0000253]; estradiol 17-beta-dehydrogenase [NAD(P)+] activity [GO:0004303]; nucleotide binding [GO:0000166] g18857.t1 Q71R50 56.79 81 5.2499999999999995e-24 95.1 sp|Q71R50|DHR11_CHICK Dehydrogenase/reductase SDR family member 11 OS=Gallus gallus OX=9031 GN=DHRS11 PE=2 SV=1 g18858.t1 Q3ZBV9 52.055 146 4.9e-47 155.0 sp|Q3ZBV9|DHR11_BOVIN Dehydrogenase/reductase SDR family member 11 OS=Bos taurus OX=9913 GN=DHRS11 PE=2 SV=1 DHR11_BOVIN reviewed Dehydrogenase/reductase SDR family member 11 (17-beta-hydroxysteroid dehydrogenase) (3-beta-hydroxysteroid 3-dehydrogenase) (EC 1.1.1.270) (Estradiol 17-beta-dehydrogenase) (EC 1.1.1.62) (Short-chain dehydrogenase/reductase family 24C member 1) Bos taurus (Bovine) GO:0000166; GO:0000253; GO:0004303; GO:0005576; GO:0006703 estrogen biosynthetic process [GO:0006703] extracellular region [GO:0005576] 3-beta-hydroxysteroid 3-dehydrogenase (NADP+) activity [GO:0000253]; estradiol 17-beta-dehydrogenase [NAD(P)+] activity [GO:0004303]; nucleotide binding [GO:0000166] g18860.t1 P21328 28.488 344 5.79e-25 115.0 sp|P21328|RTJK_DROME RNA-directed DNA polymerase from mobile element jockey OS=Drosophila melanogaster OX=7227 GN=pol PE=1 SV=1 g18861.t1 Q3ZBV9 47.059 204 1.53e-63 201.0 sp|Q3ZBV9|DHR11_BOVIN Dehydrogenase/reductase SDR family member 11 OS=Bos taurus OX=9913 GN=DHRS11 PE=2 SV=1 DHR11_BOVIN reviewed Dehydrogenase/reductase SDR family member 11 (17-beta-hydroxysteroid dehydrogenase) (3-beta-hydroxysteroid 3-dehydrogenase) (EC 1.1.1.270) (Estradiol 17-beta-dehydrogenase) (EC 1.1.1.62) (Short-chain dehydrogenase/reductase family 24C member 1) Bos taurus (Bovine) GO:0000166; GO:0000253; GO:0004303; GO:0005576; GO:0006703 estrogen biosynthetic process [GO:0006703] extracellular region [GO:0005576] 3-beta-hydroxysteroid 3-dehydrogenase (NADP+) activity [GO:0000253]; estradiol 17-beta-dehydrogenase [NAD(P)+] activity [GO:0004303]; nucleotide binding [GO:0000166] g18863.t1 A8WHP3 56.625 634 0.0 628.0 sp|A8WHP3|SC5A9_DANRE Sodium/glucose cotransporter 4 OS=Danio rerio OX=7955 GN=slc5a9 PE=2 SV=1 g18864.t1 Q9XWN7 36.513 304 2.95e-40 147.0 sp|Q9XWN7|NSH1_CAEEL Nucleoside hydrolase OS=Caenorhabditis elegans OX=6239 GN=Y43F8C.13 PE=1 SV=1 NSH1_CAEEL reviewed Nucleoside hydrolase (EC 3.2.2.-) (EC 3.2.2.1) (EC 3.2.2.2) (EC 3.2.2.3) (EC 3.2.2.7) (EC 3.2.2.8) Caenorhabditis elegans GO:0005509; GO:0006152; GO:0008477; GO:0045437; GO:0047622; GO:0047724 purine nucleoside catabolic process [GO:0006152] adenosine nucleosidase activity [GO:0047622]; calcium ion binding [GO:0005509]; inosine nucleosidase activity [GO:0047724]; purine nucleosidase activity [GO:0008477]; uridine nucleosidase activity [GO:0045437] g18864.t2 Q9XWN7 36.513 304 2.72e-40 147.0 sp|Q9XWN7|NSH1_CAEEL Nucleoside hydrolase OS=Caenorhabditis elegans OX=6239 GN=Y43F8C.13 PE=1 SV=1 NSH1_CAEEL reviewed Nucleoside hydrolase (EC 3.2.2.-) (EC 3.2.2.1) (EC 3.2.2.2) (EC 3.2.2.3) (EC 3.2.2.7) (EC 3.2.2.8) Caenorhabditis elegans GO:0005509; GO:0006152; GO:0008477; GO:0045437; GO:0047622; GO:0047724 purine nucleoside catabolic process [GO:0006152] adenosine nucleosidase activity [GO:0047622]; calcium ion binding [GO:0005509]; inosine nucleosidase activity [GO:0047724]; purine nucleosidase activity [GO:0008477]; uridine nucleosidase activity [GO:0045437] g18865.t1 Q92626 35.909 660 1.8500000000000002e-103 350.0 sp|Q92626|PXDN_HUMAN Peroxidasin homolog OS=Homo sapiens OX=9606 GN=PXDN PE=1 SV=2 PXDN_HUMAN reviewed Peroxidasin homolog (EC 1.11.2.-) (Melanoma-associated antigen MG50) (Peroxidasin 1) (hsPxd01) (Vascular peroxidase 1) (p53-responsive gene 2 protein) [Cleaved into: PXDN active fragment] Homo sapiens (Human) GO:0001525; GO:0001654; GO:0004601; GO:0005152; GO:0005201; GO:0005576; GO:0005604; GO:0005615; GO:0005783; GO:0006955; GO:0006979; GO:0007155; GO:0009986; GO:0016684; GO:0020037; GO:0030198; GO:0030199; GO:0031012; GO:0042744; GO:0043237; GO:0046872; GO:0051260; GO:0070062; GO:0070207; GO:0070831; GO:0071711 angiogenesis [GO:0001525]; basement membrane assembly [GO:0070831]; basement membrane organization [GO:0071711]; cell adhesion [GO:0007155]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]; eye development [GO:0001654]; hydrogen peroxide catabolic process [GO:0042744]; immune response [GO:0006955]; protein homooligomerization [GO:0051260]; protein homotrimerization [GO:0070207]; response to oxidative stress [GO:0006979] basement membrane [GO:0005604]; cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615] extracellular matrix structural constituent [GO:0005201]; heme binding [GO:0020037]; interleukin-1 receptor antagonist activity [GO:0005152]; laminin-1 binding [GO:0043237]; metal ion binding [GO:0046872]; oxidoreductase activity, acting on peroxide as acceptor [GO:0016684]; peroxidase activity [GO:0004601] g18866.t1 O14874 64.021 378 0.0 521.0 sp|O14874|BCKD_HUMAN Branched-chain alpha-ketoacid dehydrogenase kinase OS=Homo sapiens OX=9606 GN=BCKDK PE=1 SV=2 g18867.t1 Q6DDL7 28.312 385 1.42e-39 152.0 sp|Q6DDL7|UN93A_XENLA Protein unc-93 homolog A OS=Xenopus laevis OX=8355 GN=unc93a PE=2 SV=1 g18869.t1 Q99L20 41.791 201 9.05e-56 181.0 sp|Q99L20|GSTT3_MOUSE Glutathione S-transferase theta-3 OS=Mus musculus OX=10090 GN=Gstt3 PE=1 SV=1 g18870.t1 Q2NL00 39.171 217 6.69e-48 160.0 sp|Q2NL00|GSTT1_BOVIN Glutathione S-transferase theta-1 OS=Bos taurus OX=9913 GN=GSTT1 PE=2 SV=3 g18871.t1 P0CG30 39.462 223 8.81e-49 175.0 sp|P0CG30|GSTT2_HUMAN Glutathione S-transferase theta-2B OS=Homo sapiens OX=9606 GN=GSTT2B PE=1 SV=1 GSTT2_HUMAN reviewed Glutathione S-transferase theta-2B (EC 2.5.1.18) (Glutathione S-transferase theta-2) (GST class-theta-2) Homo sapiens (Human) GO:0004364; GO:0005737; GO:0005829; GO:0006749; GO:0070062 glutathione metabolic process [GO:0006749] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062] glutathione transferase activity [GO:0004364] g18871.t1 P0CG30 38.785 214 8.22e-44 161.0 sp|P0CG30|GSTT2_HUMAN Glutathione S-transferase theta-2B OS=Homo sapiens OX=9606 GN=GSTT2B PE=1 SV=1 GSTT2_HUMAN reviewed Glutathione S-transferase theta-2B (EC 2.5.1.18) (Glutathione S-transferase theta-2) (GST class-theta-2) Homo sapiens (Human) GO:0004364; GO:0005737; GO:0005829; GO:0006749; GO:0070062 glutathione metabolic process [GO:0006749] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062] glutathione transferase activity [GO:0004364] g18871.t1 P0CG30 37.327 217 3.83e-37 142.0 sp|P0CG30|GSTT2_HUMAN Glutathione S-transferase theta-2B OS=Homo sapiens OX=9606 GN=GSTT2B PE=1 SV=1 GSTT2_HUMAN reviewed Glutathione S-transferase theta-2B (EC 2.5.1.18) (Glutathione S-transferase theta-2) (GST class-theta-2) Homo sapiens (Human) GO:0004364; GO:0005737; GO:0005829; GO:0006749; GO:0070062 glutathione metabolic process [GO:0006749] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062] glutathione transferase activity [GO:0004364] g18872.t1 Q17QU7 49.502 301 3.07e-73 234.0 sp|Q17QU7|DHR13_BOVIN Dehydrogenase/reductase SDR family member 13 OS=Bos taurus OX=9913 GN=DHRS13 PE=2 SV=1 g18873.t1 P46023 32.5 520 5.27e-65 244.0 sp|P46023|GR101_LYMST G-protein coupled receptor GRL101 OS=Lymnaea stagnalis OX=6523 PE=2 SV=1 g18875.t1 A6NHX0 46.828 331 2e-86 266.0 sp|A6NHX0|CAST2_HUMAN Cytosolic arginine sensor for mTORC1 subunit 2 OS=Homo sapiens OX=9606 GN=CASTOR2 PE=1 SV=3 CAST2_HUMAN reviewed Cytosolic arginine sensor for mTORC1 subunit 2 (Cellular arginine sensor for mTORC1 protein 2) (GATS-like protein 2) Homo sapiens (Human) GO:0005829; GO:0042802; GO:1903577; GO:1904262 cellular response to L-arginine [GO:1903577]; negative regulation of TORC1 signaling [GO:1904262] cytosol [GO:0005829] identical protein binding [GO:0042802] g18875.t2 A6NHX0 46.687 332 2.41e-86 266.0 sp|A6NHX0|CAST2_HUMAN Cytosolic arginine sensor for mTORC1 subunit 2 OS=Homo sapiens OX=9606 GN=CASTOR2 PE=1 SV=3 CAST2_HUMAN reviewed Cytosolic arginine sensor for mTORC1 subunit 2 (Cellular arginine sensor for mTORC1 protein 2) (GATS-like protein 2) Homo sapiens (Human) GO:0005829; GO:0042802; GO:1903577; GO:1904262 cellular response to L-arginine [GO:1903577]; negative regulation of TORC1 signaling [GO:1904262] cytosol [GO:0005829] identical protein binding [GO:0042802] g18875.t3 A6NHX0 46.547 333 1.13e-84 262.0 sp|A6NHX0|CAST2_HUMAN Cytosolic arginine sensor for mTORC1 subunit 2 OS=Homo sapiens OX=9606 GN=CASTOR2 PE=1 SV=3 CAST2_HUMAN reviewed Cytosolic arginine sensor for mTORC1 subunit 2 (Cellular arginine sensor for mTORC1 protein 2) (GATS-like protein 2) Homo sapiens (Human) GO:0005829; GO:0042802; GO:1903577; GO:1904262 cellular response to L-arginine [GO:1903577]; negative regulation of TORC1 signaling [GO:1904262] cytosol [GO:0005829] identical protein binding [GO:0042802] g18879.t1 Q92614 47.746 599 4.1099999999999995e-147 479.0 sp|Q92614|MY18A_HUMAN Unconventional myosin-XVIIIa OS=Homo sapiens OX=9606 GN=MYO18A PE=1 SV=3 g18879.t2 Q9JMH9 43.639 1187 0.0 854.0 sp|Q9JMH9|MY18A_MOUSE Unconventional myosin-XVIIIa OS=Mus musculus OX=10090 GN=Myo18a PE=1 SV=2 g18879.t3 Q9JMH9 43.639 1187 0.0 854.0 sp|Q9JMH9|MY18A_MOUSE Unconventional myosin-XVIIIa OS=Mus musculus OX=10090 GN=Myo18a PE=1 SV=2 g18879.t4 Q92614 44.304 1817 0.0 1313.0 sp|Q92614|MY18A_HUMAN Unconventional myosin-XVIIIa OS=Homo sapiens OX=9606 GN=MYO18A PE=1 SV=3 g18883.t1 O13076 48.675 302 2.5e-61 203.0 sp|O13076|AA2BR_CHICK Adenosine receptor A2b OS=Gallus gallus OX=9031 GN=ADORA2B PE=2 SV=1 g18884.t1 Q5RBM6 68.146 383 0.0 565.0 sp|Q5RBM6|BUP1_PONAB Beta-ureidopropionase OS=Pongo abelii OX=9601 GN=UPB1 PE=2 SV=1 BUP1_PONAB reviewed Beta-ureidopropionase (EC 3.5.1.6) (Beta-alanine synthase) (N-carbamoyl-beta-alanine amidohydrolase) Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0003837; GO:0005737; GO:0033396; GO:0046135; GO:0051260 beta-alanine biosynthetic process via 3-ureidopropionate [GO:0033396]; protein homooligomerization [GO:0051260]; pyrimidine nucleoside catabolic process [GO:0046135] cytoplasm [GO:0005737] beta-ureidopropionase activity [GO:0003837] g18885.t1 Q6JQN1 56.195 1025 0.0 1201.0 sp|Q6JQN1|ACD10_HUMAN Acyl-CoA dehydrogenase family member 10 OS=Homo sapiens OX=9606 GN=ACAD10 PE=1 SV=1 ACD10_HUMAN reviewed Acyl-CoA dehydrogenase family member 10 (ACAD-10) (EC 1.3.99.-) Homo sapiens (Human) GO:0003995; GO:0005737; GO:0005739; GO:0005759; GO:0006635; GO:0033539; GO:0050660 fatty acid beta-oxidation [GO:0006635]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539] cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] acyl-CoA dehydrogenase activity [GO:0003995]; flavin adenine dinucleotide binding [GO:0050660] g18887.t1 A8WGF7 50.0 432 5.05e-141 419.0 sp|A8WGF7|SPNS1_XENTR Protein spinster homolog 1 OS=Xenopus tropicalis OX=8364 GN=spns1 PE=2 SV=2 g18888.t1 Q5PPV3 45.378 238 4.02e-68 211.0 sp|Q5PPV3|MORN3_XENLA MORN repeat-containing protein 3 OS=Xenopus laevis OX=8355 GN=morn3 PE=2 SV=1 g18889.t1 Q5M7X9 34.018 341 2.2700000000000002e-63 207.0 sp|Q5M7X9|MUL1A_DANRE Mitochondrial ubiquitin ligase activator of nfkb 1-A OS=Danio rerio OX=7955 GN=mul1a PE=2 SV=1 MUL1A_DANRE reviewed Mitochondrial ubiquitin ligase activator of nfkb 1-A (EC 2.3.2.27) (E3 ubiquitin-protein ligase mul1-A) (RING-type E3 ubiquitin transferase nfkb 1-A) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000266; GO:0004842; GO:0005741; GO:0005777; GO:0008270; GO:0009893; GO:0016567; GO:0022603; GO:0031647; GO:0042802; GO:0043123; GO:0051094; GO:0051646; GO:0061630 mitochondrial fission [GO:0000266]; mitochondrion localization [GO:0051646]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of developmental process [GO:0051094]; positive regulation of metabolic process [GO:0009893]; protein ubiquitination [GO:0016567]; regulation of anatomical structure morphogenesis [GO:0022603]; regulation of protein stability [GO:0031647] mitochondrial outer membrane [GO:0005741]; peroxisome [GO:0005777] identical protein binding [GO:0042802]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] g18891.t1 C3XVM1 63.78 127 5.68e-51 163.0 sp|C3XVM1|GATC_BRAFL Glutamyl-tRNA(Gln) amidotransferase subunit C, mitochondrial OS=Branchiostoma floridae OX=7739 GN=BRAFLDRAFT_270748 PE=3 SV=1 g18892.t1 Q7SXP4 72.396 192 1.22e-72 226.0 sp|Q7SXP4|SRS1A_DANRE Serine/arginine-rich splicing factor 1A OS=Danio rerio OX=7955 GN=srsf1a PE=2 SV=2 g18893.t1 O02414 89.888 89 3.8300000000000003e-59 178.0 sp|O02414|DYL1_HELCR Dynein light chain LC6, flagellar outer arm OS=Heliocidaris crassispina OX=1043166 PE=3 SV=1 g18905.t1 P59015 49.58 833 0.0 798.0 sp|P59015|VPS18_DANRE Vacuolar protein sorting-associated protein 18 homolog OS=Danio rerio OX=7955 GN=vps18 PE=2 SV=2 VPS18_DANRE reviewed Vacuolar protein sorting-associated protein 18 homolog Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005765; GO:0005768; GO:0006886; GO:0006904; GO:0007032; GO:0007040; GO:0007634; GO:0008270; GO:0008333; GO:0015721; GO:0030674; GO:0030897; GO:0031902; GO:0043485; GO:0045176; GO:0048069; GO:0048284; GO:0048757; GO:0060036 apical protein localization [GO:0045176]; bile acid and bile salt transport [GO:0015721]; endosome organization [GO:0007032]; endosome to lysosome transport [GO:0008333]; endosome to pigment granule transport [GO:0043485]; eye pigmentation [GO:0048069]; intracellular protein transport [GO:0006886]; lysosome organization [GO:0007040]; notochord cell vacuolation [GO:0060036]; optokinetic behavior [GO:0007634]; organelle fusion [GO:0048284]; pigment granule maturation [GO:0048757]; vesicle docking involved in exocytosis [GO:0006904] endosome [GO:0005768]; HOPS complex [GO:0030897]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765] protein-macromolecule adaptor activity [GO:0030674]; zinc ion binding [GO:0008270] g18907.t1 Q9DAN9 35.811 148 1.1799999999999999e-25 100.0 sp|Q9DAN9|CF97D_MOUSE Sperm axonemal maintenance protein CFAP97D1 OS=Mus musculus OX=10090 GN=Cfap97d1 PE=2 SV=1 g18908.t1 Q8BVN3 36.08 352 1.72e-40 155.0 sp|Q8BVN3|CTSR4_MOUSE Cation channel sperm-associated protein 4 OS=Mus musculus OX=10090 GN=Catsper4 PE=1 SV=1 g18909.t1 H2L0H3 45.352 355 2.62e-102 310.0 sp|H2L0H3|CHAT1_CAEEL CDC50 family protein chat-1 OS=Caenorhabditis elegans OX=6239 GN=chat-1 PE=2 SV=1 g18909.t2 H2L0H3 45.198 354 1.49e-101 308.0 sp|H2L0H3|CHAT1_CAEEL CDC50 family protein chat-1 OS=Caenorhabditis elegans OX=6239 GN=chat-1 PE=2 SV=1 g18909.t3 H2L0H3 45.232 367 7.579999999999999e-104 313.0 sp|H2L0H3|CHAT1_CAEEL CDC50 family protein chat-1 OS=Caenorhabditis elegans OX=6239 GN=chat-1 PE=2 SV=1 g18910.t1 Q8N4B1 51.562 128 8.32e-44 155.0 sp|Q8N4B1|SESQ1_HUMAN Sesquipedalian-1 OS=Homo sapiens OX=9606 GN=PHETA1 PE=1 SV=1 SESQ1_HUMAN reviewed Sesquipedalian-1 (Ses1) (27 kDa inositol polyphosphate phosphatase-interacting protein A) (IPIP27A) (PH domain-containing endocytic trafficking adaptor 1) Homo sapiens (Human) GO:0001881; GO:0005769; GO:0005802; GO:0005829; GO:0007032; GO:0030136; GO:0042147; GO:0042803; GO:0055037 endosome organization [GO:0007032]; receptor recycling [GO:0001881]; retrograde transport, endosome to Golgi [GO:0042147] clathrin-coated vesicle [GO:0030136]; cytosol [GO:0005829]; early endosome [GO:0005769]; recycling endosome [GO:0055037]; trans-Golgi network [GO:0005802] protein homodimerization activity [GO:0042803] g18911.t1 Q8NHP8 50.766 522 0.0 541.0 sp|Q8NHP8|PLBL2_HUMAN Putative phospholipase B-like 2 OS=Homo sapiens OX=9606 GN=PLBD2 PE=1 SV=2 PLBL2_HUMAN reviewed Putative aminopeptidase PLBD2 (EC 3.4.11.-) (76 kDa protein) (p76) (LAMA-like protein 2) (Lamina ancestor homolog 2) (Phospholipase B domain-containing protein 2) [Cleaved into: Putative aminopeptidase PLBD2 32 kDa form; Putative aminopeptidase PLBD2 45 kDa form] Homo sapiens (Human) GO:0004620; GO:0005576; GO:0009395; GO:0043202; GO:0070062 phospholipid catabolic process [GO:0009395] extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; lysosomal lumen [GO:0043202] phospholipase activity [GO:0004620] g18912.t1 Q5M819 51.542 227 2.43e-84 253.0 sp|Q5M819|SERB_RAT Phosphoserine phosphatase OS=Rattus norvegicus OX=10116 GN=Psph PE=2 SV=1 SERB_RAT reviewed Phosphoserine phosphatase (PSP) (PSPase) (EC 3.1.3.3) (O-phosphoserine phosphohydrolase) Rattus norvegicus (Rat) GO:0000287; GO:0001701; GO:0005737; GO:0005829; GO:0006563; GO:0006564; GO:0009612; GO:0031667; GO:0033574; GO:0036424; GO:0042802; GO:0042803 in utero embryonic development [GO:0001701]; L-serine biosynthetic process [GO:0006564]; L-serine metabolic process [GO:0006563]; response to mechanical stimulus [GO:0009612]; response to nutrient levels [GO:0031667]; response to testosterone [GO:0033574] cytoplasm [GO:0005737]; cytosol [GO:0005829] identical protein binding [GO:0042802]; L-phosphoserine phosphatase activity [GO:0036424]; magnesium ion binding [GO:0000287]; protein homodimerization activity [GO:0042803] g18918.t1 Q7ZVN7 41.912 272 3.1e-62 225.0 sp|Q7ZVN7|MED15_DANRE Mediator of RNA polymerase II transcription subunit 15 OS=Danio rerio OX=7955 GN=med15 PE=2 SV=1 g18918.t2 Q7ZVN7 41.912 272 3.52e-62 225.0 sp|Q7ZVN7|MED15_DANRE Mediator of RNA polymerase II transcription subunit 15 OS=Danio rerio OX=7955 GN=med15 PE=2 SV=1 g18918.t3 Q7ZVN7 41.912 272 7.05e-62 224.0 sp|Q7ZVN7|MED15_DANRE Mediator of RNA polymerase II transcription subunit 15 OS=Danio rerio OX=7955 GN=med15 PE=2 SV=1 g18918.t4 Q7ZVN7 41.912 272 4.08e-62 225.0 sp|Q7ZVN7|MED15_DANRE Mediator of RNA polymerase II transcription subunit 15 OS=Danio rerio OX=7955 GN=med15 PE=2 SV=1 g18919.t1 Q9GZT4 44.582 323 7.05e-82 254.0 sp|Q9GZT4|SRR_HUMAN Serine racemase OS=Homo sapiens OX=9606 GN=SRR PE=1 SV=1 SRR_HUMAN reviewed Serine racemase (EC 5.1.1.18) (D-serine ammonia-lyase) (D-serine dehydratase) (EC 4.3.1.18) (L-serine ammonia-lyase) (L-serine dehydratase) (EC 4.3.1.17) Homo sapiens (Human) GO:0000287; GO:0003941; GO:0005509; GO:0005524; GO:0005737; GO:0005829; GO:0006563; GO:0008721; GO:0009069; GO:0009410; GO:0016594; GO:0018114; GO:0030165; GO:0030170; GO:0030378; GO:0032496; GO:0042802; GO:0042803; GO:0042866; GO:0043025; GO:0045177; GO:0070178; GO:0070179; GO:1901986 D-serine biosynthetic process [GO:0070179]; D-serine metabolic process [GO:0070178]; L-serine metabolic process [GO:0006563]; pyruvate biosynthetic process [GO:0042866]; response to ketamine [GO:1901986]; response to lipopolysaccharide [GO:0032496]; response to xenobiotic stimulus [GO:0009410]; serine family amino acid metabolic process [GO:0009069] apical part of cell [GO:0045177]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; neuronal cell body [GO:0043025] ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; D-serine ammonia-lyase activity [GO:0008721]; glycine binding [GO:0016594]; identical protein binding [GO:0042802]; L-serine ammonia-lyase activity [GO:0003941]; magnesium ion binding [GO:0000287]; PDZ domain binding [GO:0030165]; protein homodimerization activity [GO:0042803]; pyridoxal phosphate binding [GO:0030170]; serine racemase activity [GO:0030378]; threonine racemase activity [GO:0018114] g18920.t1 P62323 77.692 130 8.08e-61 186.0 sp|P62323|SMD3_XENLA Small nuclear ribonucleoprotein Sm D3 OS=Xenopus laevis OX=8355 GN=snrpd3 PE=2 SV=1 g18921.t1 A7SLX5 66.497 394 0.0 568.0 sp|A7SLX5|DPH1_NEMVE 2-(3-amino-3-carboxypropyl)histidine synthase subunit 1 OS=Nematostella vectensis OX=45351 GN=dph1 PE=3 SV=1 g18922.t1 Q9BYB4 43.75 320 2.31e-83 258.0 sp|Q9BYB4|GNB1L_HUMAN Guanine nucleotide-binding protein subunit beta-like protein 1 OS=Homo sapiens OX=9606 GN=GNB1L PE=1 SV=2 GNB1L_HUMAN reviewed Guanine nucleotide-binding protein subunit beta-like protein 1 (G protein subunit beta-like protein 1) (DGCRK3) (WD repeat-containing protein 14) (WD40 repeat-containing protein deleted in VCFS) (WDVCF) Homo sapiens (Human) GO:0000077; GO:0005634; GO:0005737; GO:0006974; GO:0035176 DNA damage checkpoint signaling [GO:0000077]; DNA damage response [GO:0006974]; social behavior [GO:0035176] cytoplasm [GO:0005737]; nucleus [GO:0005634] g18924.t1 Q08AX9 43.156 716 2.2500000000000002e-163 491.0 sp|Q08AX9|SANBR_XENLA SANT and BTB domain regulator of class switch recombination OS=Xenopus laevis OX=8355 GN=sanbr PE=2 SV=1 g18925.t1 Q6P9F0 47.249 309 4.36e-72 245.0 sp|Q6P9F0|CCD62_HUMAN Coiled-coil domain-containing protein 62 OS=Homo sapiens OX=9606 GN=CCDC62 PE=1 SV=2 CCD62_HUMAN reviewed Coiled-coil domain-containing protein 62 (Protein TSP-NY) (Protein aaa) Homo sapiens (Human) GO:0001669; GO:0001835; GO:0003713; GO:0005634; GO:0005815; GO:0007286; GO:0030331; GO:0030520; GO:0045944; GO:0071392 blastocyst hatching [GO:0001835]; cellular response to estradiol stimulus [GO:0071392]; estrogen receptor signaling pathway [GO:0030520]; positive regulation of transcription by RNA polymerase II [GO:0045944]; spermatid development [GO:0007286] acrosomal vesicle [GO:0001669]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634] nuclear estrogen receptor binding [GO:0030331]; transcription coactivator activity [GO:0003713] g18926.t1 Q2HJ47 48.37 184 6.78e-46 152.0 sp|Q2HJ47|DENR_BOVIN Density-regulated protein OS=Bos taurus OX=9913 GN=DENR PE=2 SV=1 g18932.t1 Q5RAR0 53.595 306 7.73e-112 328.0 sp|Q5RAR0|EI2BA_PONAB Translation initiation factor eIF2B subunit alpha OS=Pongo abelii OX=9601 GN=EIF2B1 PE=2 SV=2 g18933.t1 Q96FN5 46.292 391 2.11e-99 330.0 sp|Q96FN5|KIF12_HUMAN Kinesin-like protein KIF12 OS=Homo sapiens OX=9606 GN=KIF12 PE=1 SV=3 g18934.t1 Q05940 35.359 181 9.710000000000001e-37 137.0 sp|Q05940|VMAT2_HUMAN Synaptic vesicular amine transporter OS=Homo sapiens OX=9606 GN=SLC18A2 PE=1 SV=2 VMAT2_HUMAN reviewed Synaptic vesicular amine transporter (Solute carrier family 18 member 2) (Vesicular amine transporter 2) (VAT2) (Vesicular monoamine transporter 2) Homo sapiens (Human) GO:0001975; GO:0002552; GO:0002553; GO:0005335; GO:0005813; GO:0005886; GO:0006836; GO:0007268; GO:0007626; GO:0008021; GO:0008504; GO:0009636; GO:0009791; GO:0015311; GO:0015842; GO:0015844; GO:0015872; GO:0016020; GO:0030424; GO:0030425; GO:0030667; GO:0030672; GO:0043195; GO:0051610; GO:0051615; GO:0070083; GO:0098691; GO:0098700; GO:0099123; GO:1903427 aminergic neurotransmitter loading into synaptic vesicle [GO:0015842]; chemical synaptic transmission [GO:0007268]; dopamine transport [GO:0015872]; histamine secretion by mast cell [GO:0002553]; histamine uptake [GO:0051615]; locomotory behavior [GO:0007626]; monoamine transport [GO:0015844]; negative regulation of reactive oxygen species biosynthetic process [GO:1903427]; neurotransmitter loading into synaptic vesicle [GO:0098700]; neurotransmitter transport [GO:0006836]; post-embryonic development [GO:0009791]; response to amphetamine [GO:0001975]; response to toxic substance [GO:0009636]; serotonin secretion by mast cell [GO:0002552]; serotonin uptake [GO:0051610]; somato-dendritic dopamine secretion [GO:0099123] axon [GO:0030424]; centrosome [GO:0005813]; clathrin-sculpted monoamine transport vesicle membrane [GO:0070083]; dendrite [GO:0030425]; dopaminergic synapse [GO:0098691]; membrane [GO:0016020]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672]; terminal bouton [GO:0043195] monoamine transmembrane transporter activity [GO:0008504]; monoamine:proton antiporter activity [GO:0015311]; serotonin:sodium:chloride symporter activity [GO:0005335] g18936.t1 Q9GZT4 45.758 330 1.42e-94 287.0 sp|Q9GZT4|SRR_HUMAN Serine racemase OS=Homo sapiens OX=9606 GN=SRR PE=1 SV=1 SRR_HUMAN reviewed Serine racemase (EC 5.1.1.18) (D-serine ammonia-lyase) (D-serine dehydratase) (EC 4.3.1.18) (L-serine ammonia-lyase) (L-serine dehydratase) (EC 4.3.1.17) Homo sapiens (Human) GO:0000287; GO:0003941; GO:0005509; GO:0005524; GO:0005737; GO:0005829; GO:0006563; GO:0008721; GO:0009069; GO:0009410; GO:0016594; GO:0018114; GO:0030165; GO:0030170; GO:0030378; GO:0032496; GO:0042802; GO:0042803; GO:0042866; GO:0043025; GO:0045177; GO:0070178; GO:0070179; GO:1901986 D-serine biosynthetic process [GO:0070179]; D-serine metabolic process [GO:0070178]; L-serine metabolic process [GO:0006563]; pyruvate biosynthetic process [GO:0042866]; response to ketamine [GO:1901986]; response to lipopolysaccharide [GO:0032496]; response to xenobiotic stimulus [GO:0009410]; serine family amino acid metabolic process [GO:0009069] apical part of cell [GO:0045177]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; neuronal cell body [GO:0043025] ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; D-serine ammonia-lyase activity [GO:0008721]; glycine binding [GO:0016594]; identical protein binding [GO:0042802]; L-serine ammonia-lyase activity [GO:0003941]; magnesium ion binding [GO:0000287]; PDZ domain binding [GO:0030165]; protein homodimerization activity [GO:0042803]; pyridoxal phosphate binding [GO:0030170]; serine racemase activity [GO:0030378]; threonine racemase activity [GO:0018114] g18936.t2 Q9GZT4 45.758 330 1.57e-94 287.0 sp|Q9GZT4|SRR_HUMAN Serine racemase OS=Homo sapiens OX=9606 GN=SRR PE=1 SV=1 SRR_HUMAN reviewed Serine racemase (EC 5.1.1.18) (D-serine ammonia-lyase) (D-serine dehydratase) (EC 4.3.1.18) (L-serine ammonia-lyase) (L-serine dehydratase) (EC 4.3.1.17) Homo sapiens (Human) GO:0000287; GO:0003941; GO:0005509; GO:0005524; GO:0005737; GO:0005829; GO:0006563; GO:0008721; GO:0009069; GO:0009410; GO:0016594; GO:0018114; GO:0030165; GO:0030170; GO:0030378; GO:0032496; GO:0042802; GO:0042803; GO:0042866; GO:0043025; GO:0045177; GO:0070178; GO:0070179; GO:1901986 D-serine biosynthetic process [GO:0070179]; D-serine metabolic process [GO:0070178]; L-serine metabolic process [GO:0006563]; pyruvate biosynthetic process [GO:0042866]; response to ketamine [GO:1901986]; response to lipopolysaccharide [GO:0032496]; response to xenobiotic stimulus [GO:0009410]; serine family amino acid metabolic process [GO:0009069] apical part of cell [GO:0045177]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; neuronal cell body [GO:0043025] ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; D-serine ammonia-lyase activity [GO:0008721]; glycine binding [GO:0016594]; identical protein binding [GO:0042802]; L-serine ammonia-lyase activity [GO:0003941]; magnesium ion binding [GO:0000287]; PDZ domain binding [GO:0030165]; protein homodimerization activity [GO:0042803]; pyridoxal phosphate binding [GO:0030170]; serine racemase activity [GO:0030378]; threonine racemase activity [GO:0018114] g18939.t1 P10394 28.221 326 3.05e-37 146.0 sp|P10394|POL4_DROME Retrovirus-related Pol polyprotein from transposon 412 OS=Drosophila melanogaster OX=7227 GN=POL PE=4 SV=1 g18940.t1 P04323 37.755 294 5.65e-59 209.0 sp|P04323|POL3_DROME Retrovirus-related Pol polyprotein from transposon 17.6 OS=Drosophila melanogaster OX=7227 GN=pol PE=4 SV=1 g18943.t1 Q9GZT4 48.148 324 3.8200000000000005e-105 314.0 sp|Q9GZT4|SRR_HUMAN Serine racemase OS=Homo sapiens OX=9606 GN=SRR PE=1 SV=1 SRR_HUMAN reviewed Serine racemase (EC 5.1.1.18) (D-serine ammonia-lyase) (D-serine dehydratase) (EC 4.3.1.18) (L-serine ammonia-lyase) (L-serine dehydratase) (EC 4.3.1.17) Homo sapiens (Human) GO:0000287; GO:0003941; GO:0005509; GO:0005524; GO:0005737; GO:0005829; GO:0006563; GO:0008721; GO:0009069; GO:0009410; GO:0016594; GO:0018114; GO:0030165; GO:0030170; GO:0030378; GO:0032496; GO:0042802; GO:0042803; GO:0042866; GO:0043025; GO:0045177; GO:0070178; GO:0070179; GO:1901986 D-serine biosynthetic process [GO:0070179]; D-serine metabolic process [GO:0070178]; L-serine metabolic process [GO:0006563]; pyruvate biosynthetic process [GO:0042866]; response to ketamine [GO:1901986]; response to lipopolysaccharide [GO:0032496]; response to xenobiotic stimulus [GO:0009410]; serine family amino acid metabolic process [GO:0009069] apical part of cell [GO:0045177]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; neuronal cell body [GO:0043025] ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; D-serine ammonia-lyase activity [GO:0008721]; glycine binding [GO:0016594]; identical protein binding [GO:0042802]; L-serine ammonia-lyase activity [GO:0003941]; magnesium ion binding [GO:0000287]; PDZ domain binding [GO:0030165]; protein homodimerization activity [GO:0042803]; pyridoxal phosphate binding [GO:0030170]; serine racemase activity [GO:0030378]; threonine racemase activity [GO:0018114] g18944.t1 A2CES0 50.685 219 6.230000000000001e-79 243.0 sp|A2CES0|NEUFC_DANRE Neuferricin OS=Danio rerio OX=7955 GN=cyb5d2 PE=3 SV=1 g18945.t1 Q8CG08 34.343 198 2.29e-27 107.0 sp|Q8CG08|CTHR1_RAT Collagen triple helix repeat-containing protein 1 OS=Rattus norvegicus OX=10116 GN=Cthrc1 PE=1 SV=1 CTHR1_RAT reviewed Collagen triple helix repeat-containing protein 1 Rattus norvegicus (Rat) GO:0004666; GO:0005109; GO:0005581; GO:0005615; GO:0005737; GO:0016477; GO:0016528; GO:0017147; GO:0019371; GO:0031012; GO:0033690; GO:0043005; GO:0043932; GO:0045669; GO:0060071; GO:0060122; GO:0090090; GO:0090103; GO:0090177 cell migration [GO:0016477]; cochlea morphogenesis [GO:0090103]; cyclooxygenase pathway [GO:0019371]; establishment of planar polarity involved in neural tube closure [GO:0090177]; inner ear receptor cell stereocilium organization [GO:0060122]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; ossification involved in bone remodeling [GO:0043932]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of osteoblast proliferation [GO:0033690]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071] collagen trimer [GO:0005581]; cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; neuron projection [GO:0043005]; sarcoplasm [GO:0016528] frizzled binding [GO:0005109]; prostaglandin-endoperoxide synthase activity [GO:0004666]; Wnt-protein binding [GO:0017147] g18946.t1 Q5ZJI0 60.308 325 7.86e-148 428.0 sp|Q5ZJI0|TPST2_CHICK Protein-tyrosine sulfotransferase 2 OS=Gallus gallus OX=9031 GN=TPST2 PE=2 SV=1 g18946.t2 Q4R863 60.736 326 8.46e-148 428.0 sp|Q4R863|TPST2_MACFA Protein-tyrosine sulfotransferase 2 OS=Macaca fascicularis OX=9541 GN=TPST2 PE=2 SV=1 TPST2_MACFA reviewed Protein-tyrosine sulfotransferase 2 (EC 2.8.2.20) (Tyrosylprotein sulfotransferase 2) (TPST-2) Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey) GO:0000139; GO:0006478; GO:0008476; GO:0050427 3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; peptidyl-tyrosine sulfation [GO:0006478] Golgi membrane [GO:0000139] protein-tyrosine sulfotransferase activity [GO:0008476] g18950.t1 Q96AY4 54.424 1865 0.0 1941.0 sp|Q96AY4|TTC28_HUMAN Tetratricopeptide repeat protein 28 OS=Homo sapiens OX=9606 GN=TTC28 PE=1 SV=4 TTC28_HUMAN reviewed Tetratricopeptide repeat protein 28 (TPR repeat protein 28) (TPR repeat-containing big gene cloned at Keio) Homo sapiens (Human) GO:0000922; GO:0005813; GO:0007346; GO:0019900; GO:0030496; GO:0051301 cell division [GO:0051301]; regulation of mitotic cell cycle [GO:0007346] centrosome [GO:0005813]; midbody [GO:0030496]; spindle pole [GO:0000922] kinase binding [GO:0019900] g18951.t1 Q96AY4 65.714 70 3.36e-23 97.8 sp|Q96AY4|TTC28_HUMAN Tetratricopeptide repeat protein 28 OS=Homo sapiens OX=9606 GN=TTC28 PE=1 SV=4 TTC28_HUMAN reviewed Tetratricopeptide repeat protein 28 (TPR repeat protein 28) (TPR repeat-containing big gene cloned at Keio) Homo sapiens (Human) GO:0000922; GO:0005813; GO:0007346; GO:0019900; GO:0030496; GO:0051301 cell division [GO:0051301]; regulation of mitotic cell cycle [GO:0007346] centrosome [GO:0005813]; midbody [GO:0030496]; spindle pole [GO:0000922] kinase binding [GO:0019900] g18952.t1 Q8BTK5 38.264 311 2.95e-61 213.0 sp|Q8BTK5|SMYD4_MOUSE Protein-lysine N-methyltransferase SMYD4 OS=Mus musculus OX=10090 GN=Smyd4 PE=2 SV=2 SMYD4_MOUSE reviewed Protein-lysine N-methyltransferase SMYD4 (EC 2.1.1.-) (SET and MYND domain-containing protein 4) Mus musculus (Mouse) GO:0005634; GO:0005737; GO:0007507; GO:0008270; GO:0016279; GO:0032259; GO:0042826 heart development [GO:0007507]; methylation [GO:0032259] cytoplasm [GO:0005737]; nucleus [GO:0005634] histone deacetylase binding [GO:0042826]; protein-lysine N-methyltransferase activity [GO:0016279]; zinc ion binding [GO:0008270] g18954.t1 Q71RH2 32.967 273 1.19e-47 163.0 sp|Q71RH2|TLC3B_HUMAN Ceramide synthase OS=Homo sapiens OX=9606 GN=TLCD3B PE=1 SV=1 g18955.t1 Q96ES7 71.269 268 8.07e-143 407.0 sp|Q96ES7|SGF29_HUMAN SAGA-associated factor 29 OS=Homo sapiens OX=9606 GN=SGF29 PE=1 SV=1 g18956.t1 Q5R7X9 68.613 274 1.2500000000000001e-132 380.0 sp|Q5R7X9|RAD1_PONAB Cell cycle checkpoint protein RAD1 OS=Pongo abelii OX=9601 GN=RAD1 PE=2 SV=1 g18958.t1 Q8N434 25.752 532 2.29e-44 167.0 sp|Q8N434|SVOPL_HUMAN Putative transporter SVOPL OS=Homo sapiens OX=9606 GN=SVOPL PE=1 SV=2 g18960.t1 Q1JP63 53.556 450 1.03e-136 408.0 sp|Q1JP63|SVOP_BOVIN Synaptic vesicle 2-related protein OS=Bos taurus OX=9913 GN=SVOP PE=2 SV=1 g18961.t1 P20735 53.346 523 0.0 543.0 sp|P20735|GGT1_PIG Glutathione hydrolase 1 proenzyme OS=Sus scrofa OX=9823 GN=GGT1 PE=2 SV=1 g18966.t1 Q60928 43.405 417 1.18e-95 307.0 sp|Q60928|GGT1_MOUSE Glutathione hydrolase 1 proenzyme OS=Mus musculus OX=10090 GN=Ggt1 PE=1 SV=1 GGT1_MOUSE reviewed Glutathione hydrolase 1 proenzyme (EC 3.4.19.13) (Gamma-glutamyltransferase 1) (Gamma-glutamyltranspeptidase 1) (GGT 1) (EC 2.3.2.2) (Leukotriene-C4 hydrolase) (EC 3.4.19.14) (CD antigen CD224) [Cleaved into: Glutathione hydrolase 1 heavy chain; Glutathione hydrolase 1 light chain] Mus musculus (Mouse) GO:0000048; GO:0002682; GO:0002951; GO:0005615; GO:0005783; GO:0005886; GO:0006536; GO:0006749; GO:0006750; GO:0006751; GO:0007283; GO:0016755; GO:0019344; GO:0031179; GO:0031638; GO:0031982; GO:0032355; GO:0032496; GO:0034599; GO:0034612; GO:0036374; GO:0048471; GO:0050727; GO:0061017; GO:0070365; GO:0097305; GO:0097421; GO:0103068 cellular response to oxidative stress [GO:0034599]; cysteine biosynthetic process [GO:0019344]; glutamate metabolic process [GO:0006536]; glutathione biosynthetic process [GO:0006750]; glutathione catabolic process [GO:0006751]; glutathione metabolic process [GO:0006749]; hepatoblast differentiation [GO:0061017]; hepatocyte differentiation [GO:0070365]; liver regeneration [GO:0097421]; peptide modification [GO:0031179]; regulation of immune system process [GO:0002682]; regulation of inflammatory response [GO:0050727]; response to alcohol [GO:0097305]; response to estradiol [GO:0032355]; response to lipopolysaccharide [GO:0032496]; response to tumor necrosis factor [GO:0034612]; spermatogenesis [GO:0007283]; zymogen activation [GO:0031638] endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; vesicle [GO:0031982] aminoacyltransferase activity [GO:0016755]; glutathione hydrolase activity [GO:0036374]; leukotriene C4 gamma-glutamyl transferase activity [GO:0103068]; leukotriene-C(4) hydrolase [GO:0002951]; peptidyltransferase activity [GO:0000048] g18969.t1 Q5RAU0 60.0 100 1.72e-35 130.0 sp|Q5RAU0|ACOX3_PONAB Peroxisomal acyl-coenzyme A oxidase 3 OS=Pongo abelii OX=9601 GN=ACOX3 PE=2 SV=1 ACOX3_PONAB reviewed Peroxisomal acyl-coenzyme A oxidase 3 (EC 1.3.3.6) (Branched-chain acyl-CoA oxidase) (BRCACox) (Pristanoyl-CoA oxidase) Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0005504; GO:0005782; GO:0016402; GO:0033540; GO:0055088; GO:0071949 fatty acid beta-oxidation using acyl-CoA oxidase [GO:0033540]; lipid homeostasis [GO:0055088] peroxisomal matrix [GO:0005782] FAD binding [GO:0071949]; fatty acid binding [GO:0005504]; pristanoyl-CoA oxidase activity [GO:0016402] g18970.t1 O15254 50.0 572 0.0 590.0 sp|O15254|ACOX3_HUMAN Peroxisomal acyl-coenzyme A oxidase 3 OS=Homo sapiens OX=9606 GN=ACOX3 PE=1 SV=2 ACOX3_HUMAN reviewed Peroxisomal acyl-coenzyme A oxidase 3 (EC 1.3.3.6) (Branched-chain acyl-CoA oxidase) (BRCACox) (Pristanoyl-CoA oxidase) Homo sapiens (Human) GO:0005504; GO:0005777; GO:0005782; GO:0005829; GO:0016020; GO:0016402; GO:0033540; GO:0050660; GO:0071949 fatty acid beta-oxidation using acyl-CoA oxidase [GO:0033540] cytosol [GO:0005829]; membrane [GO:0016020]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777] FAD binding [GO:0071949]; fatty acid binding [GO:0005504]; flavin adenine dinucleotide binding [GO:0050660]; pristanoyl-CoA oxidase activity [GO:0016402] g18972.t1 Q2KNA0 28.447 573 7.76e-41 162.0 sp|Q2KNA0|CYTSA_CANLF Cytospin-A OS=Canis lupus familiaris OX=9615 GN=SPECC1L PE=2 SV=1 CYTSA_CANLF reviewed Cytospin-A (SPECC1-like protein) (Sperm antigen with calponin homology and coiled-coil domains 1-like) Canis lupus familiaris (Dog) (Canis familiaris) GO:0005737; GO:0005815; GO:0005819; GO:0005921; GO:0007026; GO:0008013; GO:0016477; GO:0030036; GO:0030835; GO:0031941; GO:0034332; GO:0036032; GO:0051301; GO:0051897; GO:0061713 actin cytoskeleton organization [GO:0030036]; adherens junction organization [GO:0034332]; anterior neural tube closure [GO:0061713]; cell division [GO:0051301]; cell migration [GO:0016477]; negative regulation of actin filament depolymerization [GO:0030835]; negative regulation of microtubule depolymerization [GO:0007026]; neural crest cell delamination [GO:0036032]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897] cytoplasm [GO:0005737]; filamentous actin [GO:0031941]; gap junction [GO:0005921]; microtubule organizing center [GO:0005815]; spindle [GO:0005819] beta-catenin binding [GO:0008013] g18973.t1 Q2KN93 74.038 104 2.6e-52 184.0 sp|Q2KN93|CYTSA_DANRE Cytospin-A OS=Danio rerio OX=7955 GN=specc1la PE=2 SV=2 CYTSA_DANRE reviewed Cytospin-A (SPECC1-like protein) (Sperm antigen with calponin homology and coiled-coil domains 1-like) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005815; GO:0005819; GO:0005921; GO:0030036; GO:0031941; GO:0051301; GO:0060325 actin cytoskeleton organization [GO:0030036]; cell division [GO:0051301]; face morphogenesis [GO:0060325] filamentous actin [GO:0031941]; gap junction [GO:0005921]; microtubule organizing center [GO:0005815]; spindle [GO:0005819] g18974.t1 O02414 97.753 89 7.33e-62 185.0 sp|O02414|DYL1_HELCR Dynein light chain LC6, flagellar outer arm OS=Heliocidaris crassispina OX=1043166 PE=3 SV=1 g18975.t1 Q4V7R3 56.352 307 2.3500000000000002e-122 357.0 sp|Q4V7R3|COQ5_XENLA 2-methoxy-6-polyprenyl-1,4-benzoquinol methylase, mitochondrial OS=Xenopus laevis OX=8355 GN=coq5 PE=2 SV=1 g18976.t1 Q7ZY56 44.526 548 3.71e-131 436.0 sp|Q7ZY56|HEAT6_XENLA HEAT repeat-containing protein 6 OS=Xenopus laevis OX=8355 GN=heatr6 PE=2 SV=1 g18976.t1 Q7ZY56 53.182 220 5.57e-57 220.0 sp|Q7ZY56|HEAT6_XENLA HEAT repeat-containing protein 6 OS=Xenopus laevis OX=8355 GN=heatr6 PE=2 SV=1 g18976.t1 Q7ZY56 38.333 240 4.56e-39 162.0 sp|Q7ZY56|HEAT6_XENLA HEAT repeat-containing protein 6 OS=Xenopus laevis OX=8355 GN=heatr6 PE=2 SV=1 g18978.t1 Q99571 47.98 396 6.55e-116 348.0 sp|Q99571|P2RX4_HUMAN P2X purinoceptor 4 OS=Homo sapiens OX=9606 GN=P2RX4 PE=1 SV=2 P2RX4_HUMAN reviewed P2X purinoceptor 4 (P2X4) (ATP receptor) (Purinergic receptor) Homo sapiens (Human) GO:0001614; GO:0001894; GO:0002028; GO:0002931; GO:0004931; GO:0005102; GO:0005507; GO:0005524; GO:0005765; GO:0005886; GO:0007165; GO:0008217; GO:0008270; GO:0010524; GO:0010614; GO:0016020; GO:0019233; GO:0019722; GO:0030054; GO:0032308; GO:0033198; GO:0034220; GO:0034405; GO:0035590; GO:0042118; GO:0042802; GO:0043536; GO:0044297; GO:0045296; GO:0045429; GO:0048266; GO:0048471; GO:0048678; GO:0050850; GO:0050920; GO:0050975; GO:0051897; GO:0051899; GO:0051928; GO:0055117; GO:0055119; GO:0070062; GO:0070588; GO:0071294; GO:0071318; GO:0097190; GO:0098794; GO:0099604; GO:1904141; GO:2001028 apoptotic signaling pathway [GO:0097190]; behavioral response to pain [GO:0048266]; calcium ion transmembrane transport [GO:0070588]; calcium-mediated signaling [GO:0019722]; cellular response to ATP [GO:0071318]; cellular response to zinc ion [GO:0071294]; endothelial cell activation [GO:0042118]; membrane depolarization [GO:0051899]; monoatomic ion transmembrane transport [GO:0034220]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of calcium ion transport into cytosol [GO:0010524]; positive regulation of calcium-mediated signaling [GO:0050850]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of microglial cell migration [GO:1904141]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of prostaglandin secretion [GO:0032308]; purinergic nucleotide receptor signaling pathway [GO:0035590]; regulation of blood pressure [GO:0008217]; regulation of cardiac muscle contraction [GO:0055117]; regulation of chemotaxis [GO:0050920]; regulation of sodium ion transport [GO:0002028]; relaxation of cardiac muscle [GO:0055119]; response to ATP [GO:0033198]; response to axon injury [GO:0048678]; response to fluid shear stress [GO:0034405]; response to ischemia [GO:0002931]; sensory perception of pain [GO:0019233]; sensory perception of touch [GO:0050975]; signal transduction [GO:0007165]; tissue homeostasis [GO:0001894] cell body [GO:0044297]; cell junction [GO:0030054]; extracellular exosome [GO:0070062]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynapse [GO:0098794] ATP binding [GO:0005524]; cadherin binding [GO:0045296]; copper ion binding [GO:0005507]; extracellularly ATP-gated monoatomic cation channel activity [GO:0004931]; identical protein binding [GO:0042802]; ligand-gated calcium channel activity [GO:0099604]; purinergic nucleotide receptor activity [GO:0001614]; signaling receptor binding [GO:0005102]; zinc ion binding [GO:0008270] g18978.t2 Q99571 49.606 381 1.72e-116 350.0 sp|Q99571|P2RX4_HUMAN P2X purinoceptor 4 OS=Homo sapiens OX=9606 GN=P2RX4 PE=1 SV=2 P2RX4_HUMAN reviewed P2X purinoceptor 4 (P2X4) (ATP receptor) (Purinergic receptor) Homo sapiens (Human) GO:0001614; GO:0001894; GO:0002028; GO:0002931; GO:0004931; GO:0005102; GO:0005507; GO:0005524; GO:0005765; GO:0005886; GO:0007165; GO:0008217; GO:0008270; GO:0010524; GO:0010614; GO:0016020; GO:0019233; GO:0019722; GO:0030054; GO:0032308; GO:0033198; GO:0034220; GO:0034405; GO:0035590; GO:0042118; GO:0042802; GO:0043536; GO:0044297; GO:0045296; GO:0045429; GO:0048266; GO:0048471; GO:0048678; GO:0050850; GO:0050920; GO:0050975; GO:0051897; GO:0051899; GO:0051928; GO:0055117; GO:0055119; GO:0070062; GO:0070588; GO:0071294; GO:0071318; GO:0097190; GO:0098794; GO:0099604; GO:1904141; GO:2001028 apoptotic signaling pathway [GO:0097190]; behavioral response to pain [GO:0048266]; calcium ion transmembrane transport [GO:0070588]; calcium-mediated signaling [GO:0019722]; cellular response to ATP [GO:0071318]; cellular response to zinc ion [GO:0071294]; endothelial cell activation [GO:0042118]; membrane depolarization [GO:0051899]; monoatomic ion transmembrane transport [GO:0034220]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of calcium ion transport into cytosol [GO:0010524]; positive regulation of calcium-mediated signaling [GO:0050850]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of microglial cell migration [GO:1904141]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of prostaglandin secretion [GO:0032308]; purinergic nucleotide receptor signaling pathway [GO:0035590]; regulation of blood pressure [GO:0008217]; regulation of cardiac muscle contraction [GO:0055117]; regulation of chemotaxis [GO:0050920]; regulation of sodium ion transport [GO:0002028]; relaxation of cardiac muscle [GO:0055119]; response to ATP [GO:0033198]; response to axon injury [GO:0048678]; response to fluid shear stress [GO:0034405]; response to ischemia [GO:0002931]; sensory perception of pain [GO:0019233]; sensory perception of touch [GO:0050975]; signal transduction [GO:0007165]; tissue homeostasis [GO:0001894] cell body [GO:0044297]; cell junction [GO:0030054]; extracellular exosome [GO:0070062]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynapse [GO:0098794] ATP binding [GO:0005524]; cadherin binding [GO:0045296]; copper ion binding [GO:0005507]; extracellularly ATP-gated monoatomic cation channel activity [GO:0004931]; identical protein binding [GO:0042802]; ligand-gated calcium channel activity [GO:0099604]; purinergic nucleotide receptor activity [GO:0001614]; signaling receptor binding [GO:0005102]; zinc ion binding [GO:0008270] g18978.t3 Q99571 49.869 381 3.79e-119 356.0 sp|Q99571|P2RX4_HUMAN P2X purinoceptor 4 OS=Homo sapiens OX=9606 GN=P2RX4 PE=1 SV=2 P2RX4_HUMAN reviewed P2X purinoceptor 4 (P2X4) (ATP receptor) (Purinergic receptor) Homo sapiens (Human) GO:0001614; GO:0001894; GO:0002028; GO:0002931; GO:0004931; GO:0005102; GO:0005507; GO:0005524; GO:0005765; GO:0005886; GO:0007165; GO:0008217; GO:0008270; GO:0010524; GO:0010614; GO:0016020; GO:0019233; GO:0019722; GO:0030054; GO:0032308; GO:0033198; GO:0034220; GO:0034405; GO:0035590; GO:0042118; GO:0042802; GO:0043536; GO:0044297; GO:0045296; GO:0045429; GO:0048266; GO:0048471; GO:0048678; GO:0050850; GO:0050920; GO:0050975; GO:0051897; GO:0051899; GO:0051928; GO:0055117; GO:0055119; GO:0070062; GO:0070588; GO:0071294; GO:0071318; GO:0097190; GO:0098794; GO:0099604; GO:1904141; GO:2001028 apoptotic signaling pathway [GO:0097190]; behavioral response to pain [GO:0048266]; calcium ion transmembrane transport [GO:0070588]; calcium-mediated signaling [GO:0019722]; cellular response to ATP [GO:0071318]; cellular response to zinc ion [GO:0071294]; endothelial cell activation [GO:0042118]; membrane depolarization [GO:0051899]; monoatomic ion transmembrane transport [GO:0034220]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of calcium ion transport into cytosol [GO:0010524]; positive regulation of calcium-mediated signaling [GO:0050850]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of microglial cell migration [GO:1904141]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of prostaglandin secretion [GO:0032308]; purinergic nucleotide receptor signaling pathway [GO:0035590]; regulation of blood pressure [GO:0008217]; regulation of cardiac muscle contraction [GO:0055117]; regulation of chemotaxis [GO:0050920]; regulation of sodium ion transport [GO:0002028]; relaxation of cardiac muscle [GO:0055119]; response to ATP [GO:0033198]; response to axon injury [GO:0048678]; response to fluid shear stress [GO:0034405]; response to ischemia [GO:0002931]; sensory perception of pain [GO:0019233]; sensory perception of touch [GO:0050975]; signal transduction [GO:0007165]; tissue homeostasis [GO:0001894] cell body [GO:0044297]; cell junction [GO:0030054]; extracellular exosome [GO:0070062]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynapse [GO:0098794] ATP binding [GO:0005524]; cadherin binding [GO:0045296]; copper ion binding [GO:0005507]; extracellularly ATP-gated monoatomic cation channel activity [GO:0004931]; identical protein binding [GO:0042802]; ligand-gated calcium channel activity [GO:0099604]; purinergic nucleotide receptor activity [GO:0001614]; signaling receptor binding [GO:0005102]; zinc ion binding [GO:0008270] g18979.t1 Q99571 54.709 223 8.02e-78 244.0 sp|Q99571|P2RX4_HUMAN P2X purinoceptor 4 OS=Homo sapiens OX=9606 GN=P2RX4 PE=1 SV=2 P2RX4_HUMAN reviewed P2X purinoceptor 4 (P2X4) (ATP receptor) (Purinergic receptor) Homo sapiens (Human) GO:0001614; GO:0001894; GO:0002028; GO:0002931; GO:0004931; GO:0005102; GO:0005507; GO:0005524; GO:0005765; GO:0005886; GO:0007165; GO:0008217; GO:0008270; GO:0010524; GO:0010614; GO:0016020; GO:0019233; GO:0019722; GO:0030054; GO:0032308; GO:0033198; GO:0034220; GO:0034405; GO:0035590; GO:0042118; GO:0042802; GO:0043536; GO:0044297; GO:0045296; GO:0045429; GO:0048266; GO:0048471; GO:0048678; GO:0050850; GO:0050920; GO:0050975; GO:0051897; GO:0051899; GO:0051928; GO:0055117; GO:0055119; GO:0070062; GO:0070588; GO:0071294; GO:0071318; GO:0097190; GO:0098794; GO:0099604; GO:1904141; GO:2001028 apoptotic signaling pathway [GO:0097190]; behavioral response to pain [GO:0048266]; calcium ion transmembrane transport [GO:0070588]; calcium-mediated signaling [GO:0019722]; cellular response to ATP [GO:0071318]; cellular response to zinc ion [GO:0071294]; endothelial cell activation [GO:0042118]; membrane depolarization [GO:0051899]; monoatomic ion transmembrane transport [GO:0034220]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of calcium ion transport into cytosol [GO:0010524]; positive regulation of calcium-mediated signaling [GO:0050850]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of microglial cell migration [GO:1904141]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of prostaglandin secretion [GO:0032308]; purinergic nucleotide receptor signaling pathway [GO:0035590]; regulation of blood pressure [GO:0008217]; regulation of cardiac muscle contraction [GO:0055117]; regulation of chemotaxis [GO:0050920]; regulation of sodium ion transport [GO:0002028]; relaxation of cardiac muscle [GO:0055119]; response to ATP [GO:0033198]; response to axon injury [GO:0048678]; response to fluid shear stress [GO:0034405]; response to ischemia [GO:0002931]; sensory perception of pain [GO:0019233]; sensory perception of touch [GO:0050975]; signal transduction [GO:0007165]; tissue homeostasis [GO:0001894] cell body [GO:0044297]; cell junction [GO:0030054]; extracellular exosome [GO:0070062]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynapse [GO:0098794] ATP binding [GO:0005524]; cadherin binding [GO:0045296]; copper ion binding [GO:0005507]; extracellularly ATP-gated monoatomic cation channel activity [GO:0004931]; identical protein binding [GO:0042802]; ligand-gated calcium channel activity [GO:0099604]; purinergic nucleotide receptor activity [GO:0001614]; signaling receptor binding [GO:0005102]; zinc ion binding [GO:0008270] g18980.t1 Q9JJX6 48.872 133 4.0399999999999996e-24 99.8 sp|Q9JJX6|P2RX4_MOUSE P2X purinoceptor 4 OS=Mus musculus OX=10090 GN=P2rx4 PE=1 SV=1 g18981.t1 P81623 39.912 228 1.3699999999999999e-42 148.0 sp|P81623|ERP29_BOVIN Endoplasmic reticulum resident protein 29 OS=Bos taurus OX=9913 GN=ERP29 PE=1 SV=2 g18983.t1 O75140 60.127 158 6.15e-56 194.0 sp|O75140|DEPD5_HUMAN GATOR1 complex protein DEPDC5 OS=Homo sapiens OX=9606 GN=DEPDC5 PE=1 SV=2 DEPD5_HUMAN reviewed GATOR1 complex protein DEPDC5 (DEP domain-containing protein 5) Homo sapiens (Human) GO:0005096; GO:0005764; GO:0005765; GO:0005829; GO:0010508; GO:0031267; GO:0034198; GO:0035556; GO:0044877; GO:0048471; GO:1904262; GO:1990130 cellular response to amino acid starvation [GO:0034198]; intracellular signal transduction [GO:0035556]; negative regulation of TORC1 signaling [GO:1904262]; positive regulation of autophagy [GO:0010508] cytosol [GO:0005829]; GATOR1 complex [GO:1990130]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; perinuclear region of cytoplasm [GO:0048471] GTPase activator activity [GO:0005096]; protein-containing complex binding [GO:0044877]; small GTPase binding [GO:0031267] g18990.t1 Q9W0E3 50.893 112 1.5299999999999999e-34 129.0 sp|Q9W0E3|IML1_DROME GATOR complex protein Iml1 OS=Drosophila melanogaster OX=7227 GN=Iml1 PE=1 SV=2 IML1_DROME reviewed GATOR complex protein Iml1 (Increased minichromosome loss 1) Drosophila melanogaster (Fruit fly) GO:0005096; GO:0005764; GO:0005765; GO:0010508; GO:0032007; GO:0034198; GO:0035859; GO:0045792; GO:0048142; GO:0051321; GO:0051729; GO:1904262; GO:1990130 cellular response to amino acid starvation [GO:0034198]; germarium-derived cystoblast division [GO:0048142]; germline cell cycle switching, mitotic to meiotic cell cycle [GO:0051729]; meiotic cell cycle [GO:0051321]; negative regulation of cell size [GO:0045792]; negative regulation of TOR signaling [GO:0032007]; negative regulation of TORC1 signaling [GO:1904262]; positive regulation of autophagy [GO:0010508] GATOR1 complex [GO:1990130]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; Seh1-associated complex [GO:0035859] GTPase activator activity [GO:0005096] g18991.t1 Q9W0E3 26.184 718 8.999999999999999e-42 171.0 sp|Q9W0E3|IML1_DROME GATOR complex protein Iml1 OS=Drosophila melanogaster OX=7227 GN=Iml1 PE=1 SV=2 IML1_DROME reviewed GATOR complex protein Iml1 (Increased minichromosome loss 1) Drosophila melanogaster (Fruit fly) GO:0005096; GO:0005764; GO:0005765; GO:0010508; GO:0032007; GO:0034198; GO:0035859; GO:0045792; GO:0048142; GO:0051321; GO:0051729; GO:1904262; GO:1990130 cellular response to amino acid starvation [GO:0034198]; germarium-derived cystoblast division [GO:0048142]; germline cell cycle switching, mitotic to meiotic cell cycle [GO:0051729]; meiotic cell cycle [GO:0051321]; negative regulation of cell size [GO:0045792]; negative regulation of TOR signaling [GO:0032007]; negative regulation of TORC1 signaling [GO:1904262]; positive regulation of autophagy [GO:0010508] GATOR1 complex [GO:1990130]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; Seh1-associated complex [GO:0035859] GTPase activator activity [GO:0005096] g18992.t1 P46531 36.412 379 3.25e-39 158.0 sp|P46531|NOTC1_HUMAN Neurogenic locus notch homolog protein 1 OS=Homo sapiens OX=9606 GN=NOTCH1 PE=1 SV=4 NOTC1_HUMAN reviewed Neurogenic locus notch homolog protein 1 (Notch 1) (hN1) (Translocation-associated notch protein TAN-1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Homo sapiens (Human) GO:0000122; GO:0000139; GO:0001554; GO:0001669; GO:0001701; GO:0001837; GO:0001889; GO:0001947; GO:0002040; GO:0002052; GO:0002085; GO:0002193; GO:0002437; GO:0003151; GO:0003157; GO:0003160; GO:0003162; GO:0003169; GO:0003180; GO:0003181; GO:0003182; GO:0003184; GO:0003192; GO:0003198; GO:0003203; GO:0003207; GO:0003208; GO:0003209; GO:0003213; GO:0003214; GO:0003219; GO:0003222; GO:0003241; GO:0003252; GO:0003270; GO:0003273; GO:0003332; GO:0003344; GO:0003713; GO:0004857; GO:0004888; GO:0005112; GO:0005509; GO:0005576; GO:0005634; GO:0005654; GO:0005789; GO:0005829; GO:0005886; GO:0005912; GO:0006355; GO:0006357; GO:0006366; GO:0006606; GO:0006955; GO:0006959; GO:0007219; GO:0007221; GO:0007283; GO:0007368; GO:0007386; GO:0007411; GO:0007440; GO:0007492; GO:0007507; GO:0008284; GO:0008285; GO:0009912; GO:0009957; GO:0009986; GO:0010008; GO:0010614; GO:0010628; GO:0010629; GO:0010667; GO:0010812; GO:0010832; GO:0014031; GO:0014807; GO:0016324; GO:0017156; GO:0019899; GO:0021515; GO:0021915; GO:0021953; GO:0030163; GO:0030216; GO:0030279; GO:0030324; GO:0030335; GO:0030513; GO:0030514; GO:0030900; GO:0031069; GO:0031100; GO:0031490; GO:0031902; GO:0032495; GO:0032496; GO:0032966; GO:0035116; GO:0035148; GO:0035914; GO:0035924; GO:0042246; GO:0042670; GO:0042802; GO:0043086; GO:0043235; GO:0045070; GO:0045603; GO:0045608; GO:0045618; GO:0045662; GO:0045668; GO:0045747; GO:0045892; GO:0045893; GO:0045944; GO:0045955; GO:0046427; GO:0046533; GO:0046579; GO:0048103; GO:0048708; GO:0048709; GO:0048711; GO:0048715; GO:0048754; GO:0048873; GO:0050673; GO:0050679; GO:0050680; GO:0050768; GO:0051152; GO:0055008; GO:0060038; GO:0060045; GO:0060253; GO:0060271; GO:0060317; GO:0060354; GO:0060379; GO:0060411; GO:0060412; GO:0060528; GO:0060740; GO:0060768; GO:0060842; GO:0060843; GO:0060948; GO:0060956; GO:0060979; GO:0060982; GO:0061101; GO:0061344; GO:0061384; GO:0062043; GO:0070168; GO:0070374; GO:0070986; GO:0071228; GO:0071372; GO:0071456; GO:0072017; GO:0072044; GO:0072091; GO:0072144; GO:0072148; GO:0072538; GO:0090051; GO:0090090; GO:0097150; GO:0097400; GO:0098685; GO:0098839; GO:0098978; GO:0099565; GO:0120163; GO:0140537; GO:1901201; GO:1902263; GO:1902339; GO:1903849; GO:2000048; GO:2000737; GO:2000811; GO:2000974; GO:2001027 animal organ regeneration [GO:0031100]; aortic valve morphogenesis [GO:0003180]; apoptotic process involved in embryonic digit morphogenesis [GO:1902263]; arterial endothelial cell differentiation [GO:0060842]; astrocyte differentiation [GO:0048708]; atrioventricular node development [GO:0003162]; atrioventricular valve morphogenesis [GO:0003181]; auditory receptor cell fate commitment [GO:0009912]; axon guidance [GO:0007411]; branching morphogenesis of an epithelial tube [GO:0048754]; calcium-ion regulated exocytosis [GO:0017156]; cardiac atrium morphogenesis [GO:0003209]; cardiac chamber formation [GO:0003207]; cardiac epithelial to mesenchymal transition [GO:0060317]; cardiac left ventricle morphogenesis [GO:0003214]; cardiac muscle cell myoblast differentiation [GO:0060379]; cardiac muscle cell proliferation [GO:0060038]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac right atrium morphogenesis [GO:0003213]; cardiac right ventricle formation [GO:0003219]; cardiac septum morphogenesis [GO:0060411]; cardiac vascular smooth muscle cell development [GO:0060948]; cardiac ventricle morphogenesis [GO:0003208]; cell differentiation in spinal cord [GO:0021515]; cell migration involved in endocardial cushion formation [GO:0003273]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to hypoxia [GO:0071456]; cellular response to tumor cell [GO:0071228]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; central nervous system neuron differentiation [GO:0021953]; chemical synaptic transmission, postsynaptic [GO:0099565]; cilium assembly [GO:0060271]; collecting duct development [GO:0072044]; compartment pattern specification [GO:0007386]; coronary artery morphogenesis [GO:0060982]; coronary sinus valve morphogenesis [GO:0003182]; coronary vein morphogenesis [GO:0003169]; determination of left/right symmetry [GO:0007368]; distal tubule development [GO:0072017]; embryonic hindlimb morphogenesis [GO:0035116]; endocardial cell differentiation [GO:0060956]; endocardial cushion morphogenesis [GO:0003203]; endocardium development [GO:0003157]; endocardium morphogenesis [GO:0003160]; endoderm development [GO:0007492]; epidermal cell fate specification [GO:0009957]; epithelial cell fate commitment [GO:0072148]; epithelial cell proliferation [GO:0050673]; epithelial to mesenchymal transition [GO:0001837]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; forebrain development [GO:0030900]; foregut morphogenesis [GO:0007440]; glomerular mesangial cell development [GO:0072144]; growth involved in heart morphogenesis [GO:0003241]; hair follicle morphogenesis [GO:0031069]; heart development [GO:0007507]; heart looping [GO:0001947]; heart trabecula morphogenesis [GO:0061384]; homeostasis of number of cells within a tissue [GO:0048873]; humoral immune response [GO:0006959]; immune response [GO:0006955]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; inhibition of neuroepithelial cell differentiation [GO:0002085]; interleukin-17-mediated signaling pathway [GO:0097400]; keratinocyte differentiation [GO:0030216]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; lung development [GO:0030324]; luteolysis [GO:0001554]; mesenchymal cell development [GO:0014031]; mitral valve formation [GO:0003192]; negative regulation of anoikis [GO:2000811]; negative regulation of biomineral tissue development [GO:0070168]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of catalytic activity [GO:0043086]; negative regulation of cell adhesion molecule production [GO:0060354]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell proliferation involved in heart valve morphogenesis [GO:0003252]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of collagen biosynthetic process [GO:0032966]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of endothelial cell chemotaxis [GO:2001027]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of extracellular matrix constituent secretion [GO:0003332]; negative regulation of gene expression [GO:0010629]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of inner ear auditory receptor cell differentiation [GO:0045608]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of neurogenesis [GO:0050768]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of ossification [GO:0030279]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of photoreceptor cell differentiation [GO:0046533]; negative regulation of pro-B cell differentiation [GO:2000974]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural tube development [GO:0021915]; neuroendocrine cell differentiation [GO:0061101]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; Notch signaling pathway involved in regulation of secondary heart field cardioblast proliferation [GO:0003270]; oligodendrocyte differentiation [GO:0048709]; outflow tract morphogenesis [GO:0003151]; pericardium morphogenesis [GO:0003344]; positive regulation of aorta morphogenesis [GO:1903849]; positive regulation of apoptotic process involved in morphogenesis [GO:1902339]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cardiac epithelial to mesenchymal transition [GO:0062043]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of smooth muscle cell differentiation [GO:0051152]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription of Notch receptor target [GO:0007221]; positive regulation of viral genome replication [GO:0045070]; prostate gland epithelium morphogenesis [GO:0060740]; protein catabolic process [GO:0030163]; protein import into nucleus [GO:0006606]; pulmonary valve morphogenesis [GO:0003184]; regulation of cell adhesion involved in heart morphogenesis [GO:0061344]; regulation of DNA-templated transcription [GO:0006355]; regulation of epithelial cell proliferation involved in prostate gland development [GO:0060768]; regulation of extracellular matrix assembly [GO:1901201]; regulation of somitogenesis [GO:0014807]; regulation of stem cell proliferation [GO:0072091]; regulation of transcription by RNA polymerase II [GO:0006357]; response to lipopolysaccharide [GO:0032496]; response to muramyl dipeptide [GO:0032495]; retinal cone cell differentiation [GO:0042670]; secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development [GO:0060528]; skeletal muscle cell differentiation [GO:0035914]; somatic stem cell division [GO:0048103]; spermatogenesis [GO:0007283]; sprouting angiogenesis [GO:0002040]; T-helper 17 type immune response [GO:0072538]; tissue regeneration [GO:0042246]; transcription by RNA polymerase II [GO:0006366]; tube formation [GO:0035148]; vasculogenesis involved in coronary vascular morphogenesis [GO:0060979]; venous endothelial cell differentiation [GO:0060843]; ventricular septum morphogenesis [GO:0060412]; ventricular trabecula myocardium morphogenesis [GO:0003222] acrosomal vesicle [GO:0001669]; adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; late endosome membrane [GO:0031902]; MAML1-RBP-Jkappa- ICN1 complex [GO:0002193]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; receptor complex [GO:0043235]; Schaffer collateral - CA1 synapse [GO:0098685] calcium ion binding [GO:0005509]; chromatin DNA binding [GO:0031490]; enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; identical protein binding [GO:0042802]; Notch binding [GO:0005112]; transcription coactivator activity [GO:0003713]; transcription regulator activator activity [GO:0140537]; transmembrane signaling receptor activity [GO:0004888] g18992.t1 P46531 34.606 393 4.56e-32 136.0 sp|P46531|NOTC1_HUMAN Neurogenic locus notch homolog protein 1 OS=Homo sapiens OX=9606 GN=NOTCH1 PE=1 SV=4 NOTC1_HUMAN reviewed Neurogenic locus notch homolog protein 1 (Notch 1) (hN1) (Translocation-associated notch protein TAN-1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Homo sapiens (Human) GO:0000122; GO:0000139; GO:0001554; GO:0001669; GO:0001701; GO:0001837; GO:0001889; GO:0001947; GO:0002040; GO:0002052; GO:0002085; GO:0002193; GO:0002437; GO:0003151; GO:0003157; GO:0003160; GO:0003162; GO:0003169; GO:0003180; GO:0003181; GO:0003182; GO:0003184; GO:0003192; GO:0003198; GO:0003203; GO:0003207; GO:0003208; GO:0003209; GO:0003213; GO:0003214; GO:0003219; GO:0003222; GO:0003241; GO:0003252; GO:0003270; GO:0003273; GO:0003332; GO:0003344; GO:0003713; GO:0004857; GO:0004888; GO:0005112; GO:0005509; GO:0005576; GO:0005634; GO:0005654; GO:0005789; GO:0005829; GO:0005886; GO:0005912; GO:0006355; GO:0006357; GO:0006366; GO:0006606; GO:0006955; GO:0006959; GO:0007219; GO:0007221; GO:0007283; GO:0007368; GO:0007386; GO:0007411; GO:0007440; GO:0007492; GO:0007507; GO:0008284; GO:0008285; GO:0009912; GO:0009957; GO:0009986; GO:0010008; GO:0010614; GO:0010628; GO:0010629; GO:0010667; GO:0010812; GO:0010832; GO:0014031; GO:0014807; GO:0016324; GO:0017156; GO:0019899; GO:0021515; GO:0021915; GO:0021953; GO:0030163; GO:0030216; GO:0030279; GO:0030324; GO:0030335; GO:0030513; GO:0030514; GO:0030900; GO:0031069; GO:0031100; GO:0031490; GO:0031902; GO:0032495; GO:0032496; GO:0032966; GO:0035116; GO:0035148; GO:0035914; GO:0035924; GO:0042246; GO:0042670; GO:0042802; GO:0043086; GO:0043235; GO:0045070; GO:0045603; GO:0045608; GO:0045618; GO:0045662; GO:0045668; GO:0045747; GO:0045892; GO:0045893; GO:0045944; GO:0045955; GO:0046427; GO:0046533; GO:0046579; GO:0048103; GO:0048708; GO:0048709; GO:0048711; GO:0048715; GO:0048754; GO:0048873; GO:0050673; GO:0050679; GO:0050680; GO:0050768; GO:0051152; GO:0055008; GO:0060038; GO:0060045; GO:0060253; GO:0060271; GO:0060317; GO:0060354; GO:0060379; GO:0060411; GO:0060412; GO:0060528; GO:0060740; GO:0060768; GO:0060842; GO:0060843; GO:0060948; GO:0060956; GO:0060979; GO:0060982; GO:0061101; GO:0061344; GO:0061384; GO:0062043; GO:0070168; GO:0070374; GO:0070986; GO:0071228; GO:0071372; GO:0071456; GO:0072017; GO:0072044; GO:0072091; GO:0072144; GO:0072148; GO:0072538; GO:0090051; GO:0090090; GO:0097150; GO:0097400; GO:0098685; GO:0098839; GO:0098978; GO:0099565; GO:0120163; GO:0140537; GO:1901201; GO:1902263; GO:1902339; GO:1903849; GO:2000048; GO:2000737; GO:2000811; GO:2000974; GO:2001027 animal organ regeneration [GO:0031100]; aortic valve morphogenesis [GO:0003180]; apoptotic process involved in embryonic digit morphogenesis [GO:1902263]; arterial endothelial cell differentiation [GO:0060842]; astrocyte differentiation [GO:0048708]; atrioventricular node development [GO:0003162]; atrioventricular valve morphogenesis [GO:0003181]; auditory receptor cell fate commitment [GO:0009912]; axon guidance [GO:0007411]; branching morphogenesis of an epithelial tube [GO:0048754]; calcium-ion regulated exocytosis [GO:0017156]; cardiac atrium morphogenesis [GO:0003209]; cardiac chamber formation [GO:0003207]; cardiac epithelial to mesenchymal transition [GO:0060317]; cardiac left ventricle morphogenesis [GO:0003214]; cardiac muscle cell myoblast differentiation [GO:0060379]; cardiac muscle cell proliferation [GO:0060038]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac right atrium morphogenesis [GO:0003213]; cardiac right ventricle formation [GO:0003219]; cardiac septum morphogenesis [GO:0060411]; cardiac vascular smooth muscle cell development [GO:0060948]; cardiac ventricle morphogenesis [GO:0003208]; cell differentiation in spinal cord [GO:0021515]; cell migration involved in endocardial cushion formation [GO:0003273]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to hypoxia [GO:0071456]; cellular response to tumor cell [GO:0071228]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; central nervous system neuron differentiation [GO:0021953]; chemical synaptic transmission, postsynaptic [GO:0099565]; cilium assembly [GO:0060271]; collecting duct development [GO:0072044]; compartment pattern specification [GO:0007386]; coronary artery morphogenesis [GO:0060982]; coronary sinus valve morphogenesis [GO:0003182]; coronary vein morphogenesis [GO:0003169]; determination of left/right symmetry [GO:0007368]; distal tubule development [GO:0072017]; embryonic hindlimb morphogenesis [GO:0035116]; endocardial cell differentiation [GO:0060956]; endocardial cushion morphogenesis [GO:0003203]; endocardium development [GO:0003157]; endocardium morphogenesis [GO:0003160]; endoderm development [GO:0007492]; epidermal cell fate specification [GO:0009957]; epithelial cell fate commitment [GO:0072148]; epithelial cell proliferation [GO:0050673]; epithelial to mesenchymal transition [GO:0001837]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; forebrain development [GO:0030900]; foregut morphogenesis [GO:0007440]; glomerular mesangial cell development [GO:0072144]; growth involved in heart morphogenesis [GO:0003241]; hair follicle morphogenesis [GO:0031069]; heart development [GO:0007507]; heart looping [GO:0001947]; heart trabecula morphogenesis [GO:0061384]; homeostasis of number of cells within a tissue [GO:0048873]; humoral immune response [GO:0006959]; immune response [GO:0006955]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; inhibition of neuroepithelial cell differentiation [GO:0002085]; interleukin-17-mediated signaling pathway [GO:0097400]; keratinocyte differentiation [GO:0030216]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; lung development [GO:0030324]; luteolysis [GO:0001554]; mesenchymal cell development [GO:0014031]; mitral valve formation [GO:0003192]; negative regulation of anoikis [GO:2000811]; negative regulation of biomineral tissue development [GO:0070168]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of catalytic activity [GO:0043086]; negative regulation of cell adhesion molecule production [GO:0060354]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell proliferation involved in heart valve morphogenesis [GO:0003252]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of collagen biosynthetic process [GO:0032966]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of endothelial cell chemotaxis [GO:2001027]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of extracellular matrix constituent secretion [GO:0003332]; negative regulation of gene expression [GO:0010629]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of inner ear auditory receptor cell differentiation [GO:0045608]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of neurogenesis [GO:0050768]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of ossification [GO:0030279]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of photoreceptor cell differentiation [GO:0046533]; negative regulation of pro-B cell differentiation [GO:2000974]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural tube development [GO:0021915]; neuroendocrine cell differentiation [GO:0061101]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; Notch signaling pathway involved in regulation of secondary heart field cardioblast proliferation [GO:0003270]; oligodendrocyte differentiation [GO:0048709]; outflow tract morphogenesis [GO:0003151]; pericardium morphogenesis [GO:0003344]; positive regulation of aorta morphogenesis [GO:1903849]; positive regulation of apoptotic process involved in morphogenesis [GO:1902339]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cardiac epithelial to mesenchymal transition [GO:0062043]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of smooth muscle cell differentiation [GO:0051152]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription of Notch receptor target [GO:0007221]; positive regulation of viral genome replication [GO:0045070]; prostate gland epithelium morphogenesis [GO:0060740]; protein catabolic process [GO:0030163]; protein import into nucleus [GO:0006606]; pulmonary valve morphogenesis [GO:0003184]; regulation of cell adhesion involved in heart morphogenesis [GO:0061344]; regulation of DNA-templated transcription [GO:0006355]; regulation of epithelial cell proliferation involved in prostate gland development [GO:0060768]; regulation of extracellular matrix assembly [GO:1901201]; regulation of somitogenesis [GO:0014807]; regulation of stem cell proliferation [GO:0072091]; regulation of transcription by RNA polymerase II [GO:0006357]; response to lipopolysaccharide [GO:0032496]; response to muramyl dipeptide [GO:0032495]; retinal cone cell differentiation [GO:0042670]; secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development [GO:0060528]; skeletal muscle cell differentiation [GO:0035914]; somatic stem cell division [GO:0048103]; spermatogenesis [GO:0007283]; sprouting angiogenesis [GO:0002040]; T-helper 17 type immune response [GO:0072538]; tissue regeneration [GO:0042246]; transcription by RNA polymerase II [GO:0006366]; tube formation [GO:0035148]; vasculogenesis involved in coronary vascular morphogenesis [GO:0060979]; venous endothelial cell differentiation [GO:0060843]; ventricular septum morphogenesis [GO:0060412]; ventricular trabecula myocardium morphogenesis [GO:0003222] acrosomal vesicle [GO:0001669]; adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; late endosome membrane [GO:0031902]; MAML1-RBP-Jkappa- ICN1 complex [GO:0002193]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; receptor complex [GO:0043235]; Schaffer collateral - CA1 synapse [GO:0098685] calcium ion binding [GO:0005509]; chromatin DNA binding [GO:0031490]; enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; identical protein binding [GO:0042802]; Notch binding [GO:0005112]; transcription coactivator activity [GO:0003713]; transcription regulator activator activity [GO:0140537]; transmembrane signaling receptor activity [GO:0004888] g18992.t1 P46531 32.09 402 8.98e-31 132.0 sp|P46531|NOTC1_HUMAN Neurogenic locus notch homolog protein 1 OS=Homo sapiens OX=9606 GN=NOTCH1 PE=1 SV=4 NOTC1_HUMAN reviewed Neurogenic locus notch homolog protein 1 (Notch 1) (hN1) (Translocation-associated notch protein TAN-1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Homo sapiens (Human) GO:0000122; GO:0000139; GO:0001554; GO:0001669; GO:0001701; GO:0001837; GO:0001889; GO:0001947; GO:0002040; GO:0002052; GO:0002085; GO:0002193; GO:0002437; GO:0003151; GO:0003157; GO:0003160; GO:0003162; GO:0003169; GO:0003180; GO:0003181; GO:0003182; GO:0003184; GO:0003192; GO:0003198; GO:0003203; GO:0003207; GO:0003208; GO:0003209; GO:0003213; GO:0003214; GO:0003219; GO:0003222; GO:0003241; GO:0003252; GO:0003270; GO:0003273; GO:0003332; GO:0003344; GO:0003713; GO:0004857; GO:0004888; GO:0005112; GO:0005509; GO:0005576; GO:0005634; GO:0005654; GO:0005789; GO:0005829; GO:0005886; GO:0005912; GO:0006355; GO:0006357; GO:0006366; GO:0006606; GO:0006955; GO:0006959; GO:0007219; GO:0007221; GO:0007283; GO:0007368; GO:0007386; GO:0007411; GO:0007440; GO:0007492; GO:0007507; GO:0008284; GO:0008285; GO:0009912; GO:0009957; GO:0009986; GO:0010008; GO:0010614; GO:0010628; GO:0010629; GO:0010667; GO:0010812; GO:0010832; GO:0014031; GO:0014807; GO:0016324; GO:0017156; GO:0019899; GO:0021515; GO:0021915; GO:0021953; GO:0030163; GO:0030216; GO:0030279; GO:0030324; GO:0030335; GO:0030513; GO:0030514; GO:0030900; GO:0031069; GO:0031100; GO:0031490; GO:0031902; GO:0032495; GO:0032496; GO:0032966; GO:0035116; GO:0035148; GO:0035914; GO:0035924; GO:0042246; GO:0042670; GO:0042802; GO:0043086; GO:0043235; GO:0045070; GO:0045603; GO:0045608; GO:0045618; GO:0045662; GO:0045668; GO:0045747; GO:0045892; GO:0045893; GO:0045944; GO:0045955; GO:0046427; GO:0046533; GO:0046579; GO:0048103; GO:0048708; GO:0048709; GO:0048711; GO:0048715; GO:0048754; GO:0048873; GO:0050673; GO:0050679; GO:0050680; GO:0050768; GO:0051152; GO:0055008; GO:0060038; GO:0060045; GO:0060253; GO:0060271; GO:0060317; GO:0060354; GO:0060379; GO:0060411; GO:0060412; GO:0060528; GO:0060740; GO:0060768; GO:0060842; GO:0060843; GO:0060948; GO:0060956; GO:0060979; GO:0060982; GO:0061101; GO:0061344; GO:0061384; GO:0062043; GO:0070168; GO:0070374; GO:0070986; GO:0071228; GO:0071372; GO:0071456; GO:0072017; GO:0072044; GO:0072091; GO:0072144; GO:0072148; GO:0072538; GO:0090051; GO:0090090; GO:0097150; GO:0097400; GO:0098685; GO:0098839; GO:0098978; GO:0099565; GO:0120163; GO:0140537; GO:1901201; GO:1902263; GO:1902339; GO:1903849; GO:2000048; GO:2000737; GO:2000811; GO:2000974; GO:2001027 animal organ regeneration [GO:0031100]; aortic valve morphogenesis [GO:0003180]; apoptotic process involved in embryonic digit morphogenesis [GO:1902263]; arterial endothelial cell differentiation [GO:0060842]; astrocyte differentiation [GO:0048708]; atrioventricular node development [GO:0003162]; atrioventricular valve morphogenesis [GO:0003181]; auditory receptor cell fate commitment [GO:0009912]; axon guidance [GO:0007411]; branching morphogenesis of an epithelial tube [GO:0048754]; calcium-ion regulated exocytosis [GO:0017156]; cardiac atrium morphogenesis [GO:0003209]; cardiac chamber formation [GO:0003207]; cardiac epithelial to mesenchymal transition [GO:0060317]; cardiac left ventricle morphogenesis [GO:0003214]; cardiac muscle cell myoblast differentiation [GO:0060379]; cardiac muscle cell proliferation [GO:0060038]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac right atrium morphogenesis [GO:0003213]; cardiac right ventricle formation [GO:0003219]; cardiac septum morphogenesis [GO:0060411]; cardiac vascular smooth muscle cell development [GO:0060948]; cardiac ventricle morphogenesis [GO:0003208]; cell differentiation in spinal cord [GO:0021515]; cell migration involved in endocardial cushion formation [GO:0003273]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to hypoxia [GO:0071456]; cellular response to tumor cell [GO:0071228]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; central nervous system neuron differentiation [GO:0021953]; chemical synaptic transmission, postsynaptic [GO:0099565]; cilium assembly [GO:0060271]; collecting duct development [GO:0072044]; compartment pattern specification [GO:0007386]; coronary artery morphogenesis [GO:0060982]; coronary sinus valve morphogenesis [GO:0003182]; coronary vein morphogenesis [GO:0003169]; determination of left/right symmetry [GO:0007368]; distal tubule development [GO:0072017]; embryonic hindlimb morphogenesis [GO:0035116]; endocardial cell differentiation [GO:0060956]; endocardial cushion morphogenesis [GO:0003203]; endocardium development [GO:0003157]; endocardium morphogenesis [GO:0003160]; endoderm development [GO:0007492]; epidermal cell fate specification [GO:0009957]; epithelial cell fate commitment [GO:0072148]; epithelial cell proliferation [GO:0050673]; epithelial to mesenchymal transition [GO:0001837]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; forebrain development [GO:0030900]; foregut morphogenesis [GO:0007440]; glomerular mesangial cell development [GO:0072144]; growth involved in heart morphogenesis [GO:0003241]; hair follicle morphogenesis [GO:0031069]; heart development [GO:0007507]; heart looping [GO:0001947]; heart trabecula morphogenesis [GO:0061384]; homeostasis of number of cells within a tissue [GO:0048873]; humoral immune response [GO:0006959]; immune response [GO:0006955]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; inhibition of neuroepithelial cell differentiation [GO:0002085]; interleukin-17-mediated signaling pathway [GO:0097400]; keratinocyte differentiation [GO:0030216]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; lung development [GO:0030324]; luteolysis [GO:0001554]; mesenchymal cell development [GO:0014031]; mitral valve formation [GO:0003192]; negative regulation of anoikis [GO:2000811]; negative regulation of biomineral tissue development [GO:0070168]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of catalytic activity [GO:0043086]; negative regulation of cell adhesion molecule production [GO:0060354]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell proliferation involved in heart valve morphogenesis [GO:0003252]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of collagen biosynthetic process [GO:0032966]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of endothelial cell chemotaxis [GO:2001027]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of extracellular matrix constituent secretion [GO:0003332]; negative regulation of gene expression [GO:0010629]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of inner ear auditory receptor cell differentiation [GO:0045608]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of neurogenesis [GO:0050768]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of ossification [GO:0030279]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of photoreceptor cell differentiation [GO:0046533]; negative regulation of pro-B cell differentiation [GO:2000974]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural tube development [GO:0021915]; neuroendocrine cell differentiation [GO:0061101]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; Notch signaling pathway involved in regulation of secondary heart field cardioblast proliferation [GO:0003270]; oligodendrocyte differentiation [GO:0048709]; outflow tract morphogenesis [GO:0003151]; pericardium morphogenesis [GO:0003344]; positive regulation of aorta morphogenesis [GO:1903849]; positive regulation of apoptotic process involved in morphogenesis [GO:1902339]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cardiac epithelial to mesenchymal transition [GO:0062043]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of smooth muscle cell differentiation [GO:0051152]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription of Notch receptor target [GO:0007221]; positive regulation of viral genome replication [GO:0045070]; prostate gland epithelium morphogenesis [GO:0060740]; protein catabolic process [GO:0030163]; protein import into nucleus [GO:0006606]; pulmonary valve morphogenesis [GO:0003184]; regulation of cell adhesion involved in heart morphogenesis [GO:0061344]; regulation of DNA-templated transcription [GO:0006355]; regulation of epithelial cell proliferation involved in prostate gland development [GO:0060768]; regulation of extracellular matrix assembly [GO:1901201]; regulation of somitogenesis [GO:0014807]; regulation of stem cell proliferation [GO:0072091]; regulation of transcription by RNA polymerase II [GO:0006357]; response to lipopolysaccharide [GO:0032496]; response to muramyl dipeptide [GO:0032495]; retinal cone cell differentiation [GO:0042670]; secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development [GO:0060528]; skeletal muscle cell differentiation [GO:0035914]; somatic stem cell division [GO:0048103]; spermatogenesis [GO:0007283]; sprouting angiogenesis [GO:0002040]; T-helper 17 type immune response [GO:0072538]; tissue regeneration [GO:0042246]; transcription by RNA polymerase II [GO:0006366]; tube formation [GO:0035148]; vasculogenesis involved in coronary vascular morphogenesis [GO:0060979]; venous endothelial cell differentiation [GO:0060843]; ventricular septum morphogenesis [GO:0060412]; ventricular trabecula myocardium morphogenesis [GO:0003222] acrosomal vesicle [GO:0001669]; adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; late endosome membrane [GO:0031902]; MAML1-RBP-Jkappa- ICN1 complex [GO:0002193]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; receptor complex [GO:0043235]; Schaffer collateral - CA1 synapse [GO:0098685] calcium ion binding [GO:0005509]; chromatin DNA binding [GO:0031490]; enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; identical protein binding [GO:0042802]; Notch binding [GO:0005112]; transcription coactivator activity [GO:0003713]; transcription regulator activator activity [GO:0140537]; transmembrane signaling receptor activity [GO:0004888] g18992.t1 P46531 33.78 373 1.3299999999999999e-30 132.0 sp|P46531|NOTC1_HUMAN Neurogenic locus notch homolog protein 1 OS=Homo sapiens OX=9606 GN=NOTCH1 PE=1 SV=4 NOTC1_HUMAN reviewed Neurogenic locus notch homolog protein 1 (Notch 1) (hN1) (Translocation-associated notch protein TAN-1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Homo sapiens (Human) GO:0000122; GO:0000139; GO:0001554; GO:0001669; GO:0001701; GO:0001837; GO:0001889; GO:0001947; GO:0002040; GO:0002052; GO:0002085; GO:0002193; GO:0002437; GO:0003151; GO:0003157; GO:0003160; GO:0003162; GO:0003169; GO:0003180; GO:0003181; GO:0003182; GO:0003184; GO:0003192; GO:0003198; GO:0003203; GO:0003207; GO:0003208; GO:0003209; GO:0003213; GO:0003214; GO:0003219; GO:0003222; GO:0003241; GO:0003252; GO:0003270; GO:0003273; GO:0003332; GO:0003344; GO:0003713; GO:0004857; GO:0004888; GO:0005112; GO:0005509; GO:0005576; GO:0005634; GO:0005654; GO:0005789; GO:0005829; GO:0005886; GO:0005912; GO:0006355; GO:0006357; GO:0006366; GO:0006606; GO:0006955; GO:0006959; GO:0007219; GO:0007221; GO:0007283; GO:0007368; GO:0007386; GO:0007411; GO:0007440; GO:0007492; GO:0007507; GO:0008284; GO:0008285; GO:0009912; GO:0009957; GO:0009986; GO:0010008; GO:0010614; GO:0010628; GO:0010629; GO:0010667; GO:0010812; GO:0010832; GO:0014031; GO:0014807; GO:0016324; GO:0017156; GO:0019899; GO:0021515; GO:0021915; GO:0021953; GO:0030163; GO:0030216; GO:0030279; GO:0030324; GO:0030335; GO:0030513; GO:0030514; GO:0030900; GO:0031069; GO:0031100; GO:0031490; GO:0031902; GO:0032495; GO:0032496; GO:0032966; GO:0035116; GO:0035148; GO:0035914; GO:0035924; GO:0042246; GO:0042670; GO:0042802; GO:0043086; GO:0043235; GO:0045070; GO:0045603; GO:0045608; GO:0045618; GO:0045662; GO:0045668; GO:0045747; GO:0045892; GO:0045893; GO:0045944; GO:0045955; GO:0046427; GO:0046533; GO:0046579; GO:0048103; GO:0048708; GO:0048709; GO:0048711; GO:0048715; GO:0048754; GO:0048873; GO:0050673; GO:0050679; GO:0050680; GO:0050768; GO:0051152; GO:0055008; GO:0060038; GO:0060045; GO:0060253; GO:0060271; GO:0060317; GO:0060354; GO:0060379; GO:0060411; GO:0060412; GO:0060528; GO:0060740; GO:0060768; GO:0060842; GO:0060843; GO:0060948; GO:0060956; GO:0060979; GO:0060982; GO:0061101; GO:0061344; GO:0061384; GO:0062043; GO:0070168; GO:0070374; GO:0070986; GO:0071228; GO:0071372; GO:0071456; GO:0072017; GO:0072044; GO:0072091; GO:0072144; GO:0072148; GO:0072538; GO:0090051; GO:0090090; GO:0097150; GO:0097400; GO:0098685; GO:0098839; GO:0098978; GO:0099565; GO:0120163; GO:0140537; GO:1901201; GO:1902263; GO:1902339; GO:1903849; GO:2000048; GO:2000737; GO:2000811; GO:2000974; GO:2001027 animal organ regeneration [GO:0031100]; aortic valve morphogenesis [GO:0003180]; apoptotic process involved in embryonic digit morphogenesis [GO:1902263]; arterial endothelial cell differentiation [GO:0060842]; astrocyte differentiation [GO:0048708]; atrioventricular node development [GO:0003162]; atrioventricular valve morphogenesis [GO:0003181]; auditory receptor cell fate commitment [GO:0009912]; axon guidance [GO:0007411]; branching morphogenesis of an epithelial tube [GO:0048754]; calcium-ion regulated exocytosis [GO:0017156]; cardiac atrium morphogenesis [GO:0003209]; cardiac chamber formation [GO:0003207]; cardiac epithelial to mesenchymal transition [GO:0060317]; cardiac left ventricle morphogenesis [GO:0003214]; cardiac muscle cell myoblast differentiation [GO:0060379]; cardiac muscle cell proliferation [GO:0060038]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac right atrium morphogenesis [GO:0003213]; cardiac right ventricle formation [GO:0003219]; cardiac septum morphogenesis [GO:0060411]; cardiac vascular smooth muscle cell development [GO:0060948]; cardiac ventricle morphogenesis [GO:0003208]; cell differentiation in spinal cord [GO:0021515]; cell migration involved in endocardial cushion formation [GO:0003273]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to hypoxia [GO:0071456]; cellular response to tumor cell [GO:0071228]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; central nervous system neuron differentiation [GO:0021953]; chemical synaptic transmission, postsynaptic [GO:0099565]; cilium assembly [GO:0060271]; collecting duct development [GO:0072044]; compartment pattern specification [GO:0007386]; coronary artery morphogenesis [GO:0060982]; coronary sinus valve morphogenesis [GO:0003182]; coronary vein morphogenesis [GO:0003169]; determination of left/right symmetry [GO:0007368]; distal tubule development [GO:0072017]; embryonic hindlimb morphogenesis [GO:0035116]; endocardial cell differentiation [GO:0060956]; endocardial cushion morphogenesis [GO:0003203]; endocardium development [GO:0003157]; endocardium morphogenesis [GO:0003160]; endoderm development [GO:0007492]; epidermal cell fate specification [GO:0009957]; epithelial cell fate commitment [GO:0072148]; epithelial cell proliferation [GO:0050673]; epithelial to mesenchymal transition [GO:0001837]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; forebrain development [GO:0030900]; foregut morphogenesis [GO:0007440]; glomerular mesangial cell development [GO:0072144]; growth involved in heart morphogenesis [GO:0003241]; hair follicle morphogenesis [GO:0031069]; heart development [GO:0007507]; heart looping [GO:0001947]; heart trabecula morphogenesis [GO:0061384]; homeostasis of number of cells within a tissue [GO:0048873]; humoral immune response [GO:0006959]; immune response [GO:0006955]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; inhibition of neuroepithelial cell differentiation [GO:0002085]; interleukin-17-mediated signaling pathway [GO:0097400]; keratinocyte differentiation [GO:0030216]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; lung development [GO:0030324]; luteolysis [GO:0001554]; mesenchymal cell development [GO:0014031]; mitral valve formation [GO:0003192]; negative regulation of anoikis [GO:2000811]; negative regulation of biomineral tissue development [GO:0070168]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of catalytic activity [GO:0043086]; negative regulation of cell adhesion molecule production [GO:0060354]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell proliferation involved in heart valve morphogenesis [GO:0003252]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of collagen biosynthetic process [GO:0032966]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of endothelial cell chemotaxis [GO:2001027]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of extracellular matrix constituent secretion [GO:0003332]; negative regulation of gene expression [GO:0010629]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of inner ear auditory receptor cell differentiation [GO:0045608]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of neurogenesis [GO:0050768]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of ossification [GO:0030279]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of photoreceptor cell differentiation [GO:0046533]; negative regulation of pro-B cell differentiation [GO:2000974]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural tube development [GO:0021915]; neuroendocrine cell differentiation [GO:0061101]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; Notch signaling pathway involved in regulation of secondary heart field cardioblast proliferation [GO:0003270]; oligodendrocyte differentiation [GO:0048709]; outflow tract morphogenesis [GO:0003151]; pericardium morphogenesis [GO:0003344]; positive regulation of aorta morphogenesis [GO:1903849]; positive regulation of apoptotic process involved in morphogenesis [GO:1902339]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cardiac epithelial to mesenchymal transition [GO:0062043]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of smooth muscle cell differentiation [GO:0051152]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription of Notch receptor target [GO:0007221]; positive regulation of viral genome replication [GO:0045070]; prostate gland epithelium morphogenesis [GO:0060740]; protein catabolic process [GO:0030163]; protein import into nucleus [GO:0006606]; pulmonary valve morphogenesis [GO:0003184]; regulation of cell adhesion involved in heart morphogenesis [GO:0061344]; regulation of DNA-templated transcription [GO:0006355]; regulation of epithelial cell proliferation involved in prostate gland development [GO:0060768]; regulation of extracellular matrix assembly [GO:1901201]; regulation of somitogenesis [GO:0014807]; regulation of stem cell proliferation [GO:0072091]; regulation of transcription by RNA polymerase II [GO:0006357]; response to lipopolysaccharide [GO:0032496]; response to muramyl dipeptide [GO:0032495]; retinal cone cell differentiation [GO:0042670]; secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development [GO:0060528]; skeletal muscle cell differentiation [GO:0035914]; somatic stem cell division [GO:0048103]; spermatogenesis [GO:0007283]; sprouting angiogenesis [GO:0002040]; T-helper 17 type immune response [GO:0072538]; tissue regeneration [GO:0042246]; transcription by RNA polymerase II [GO:0006366]; tube formation [GO:0035148]; vasculogenesis involved in coronary vascular morphogenesis [GO:0060979]; venous endothelial cell differentiation [GO:0060843]; ventricular septum morphogenesis [GO:0060412]; ventricular trabecula myocardium morphogenesis [GO:0003222] acrosomal vesicle [GO:0001669]; adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; late endosome membrane [GO:0031902]; MAML1-RBP-Jkappa- ICN1 complex [GO:0002193]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; receptor complex [GO:0043235]; Schaffer collateral - CA1 synapse [GO:0098685] calcium ion binding [GO:0005509]; chromatin DNA binding [GO:0031490]; enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; identical protein binding [GO:0042802]; Notch binding [GO:0005112]; transcription coactivator activity [GO:0003713]; transcription regulator activator activity [GO:0140537]; transmembrane signaling receptor activity [GO:0004888] g18992.t1 P46531 34.828 379 5.2699999999999996e-30 130.0 sp|P46531|NOTC1_HUMAN Neurogenic locus notch homolog protein 1 OS=Homo sapiens OX=9606 GN=NOTCH1 PE=1 SV=4 NOTC1_HUMAN reviewed Neurogenic locus notch homolog protein 1 (Notch 1) (hN1) (Translocation-associated notch protein TAN-1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Homo sapiens (Human) GO:0000122; GO:0000139; GO:0001554; GO:0001669; GO:0001701; GO:0001837; GO:0001889; GO:0001947; GO:0002040; GO:0002052; GO:0002085; GO:0002193; GO:0002437; GO:0003151; GO:0003157; GO:0003160; GO:0003162; GO:0003169; GO:0003180; GO:0003181; GO:0003182; GO:0003184; GO:0003192; GO:0003198; GO:0003203; GO:0003207; GO:0003208; GO:0003209; GO:0003213; GO:0003214; GO:0003219; GO:0003222; GO:0003241; GO:0003252; GO:0003270; GO:0003273; GO:0003332; GO:0003344; GO:0003713; GO:0004857; GO:0004888; GO:0005112; GO:0005509; GO:0005576; GO:0005634; GO:0005654; GO:0005789; GO:0005829; GO:0005886; GO:0005912; GO:0006355; GO:0006357; GO:0006366; GO:0006606; GO:0006955; GO:0006959; GO:0007219; GO:0007221; GO:0007283; GO:0007368; GO:0007386; GO:0007411; GO:0007440; GO:0007492; GO:0007507; GO:0008284; GO:0008285; GO:0009912; GO:0009957; GO:0009986; GO:0010008; GO:0010614; GO:0010628; GO:0010629; GO:0010667; GO:0010812; GO:0010832; GO:0014031; GO:0014807; GO:0016324; GO:0017156; GO:0019899; GO:0021515; GO:0021915; GO:0021953; GO:0030163; GO:0030216; GO:0030279; GO:0030324; GO:0030335; GO:0030513; GO:0030514; GO:0030900; GO:0031069; GO:0031100; GO:0031490; GO:0031902; GO:0032495; GO:0032496; GO:0032966; GO:0035116; GO:0035148; GO:0035914; GO:0035924; GO:0042246; GO:0042670; GO:0042802; GO:0043086; GO:0043235; GO:0045070; GO:0045603; GO:0045608; GO:0045618; GO:0045662; GO:0045668; GO:0045747; GO:0045892; GO:0045893; GO:0045944; GO:0045955; GO:0046427; GO:0046533; GO:0046579; GO:0048103; GO:0048708; GO:0048709; GO:0048711; GO:0048715; GO:0048754; GO:0048873; GO:0050673; GO:0050679; GO:0050680; GO:0050768; GO:0051152; GO:0055008; GO:0060038; GO:0060045; GO:0060253; GO:0060271; GO:0060317; GO:0060354; GO:0060379; GO:0060411; GO:0060412; GO:0060528; GO:0060740; GO:0060768; GO:0060842; GO:0060843; GO:0060948; GO:0060956; GO:0060979; GO:0060982; GO:0061101; GO:0061344; GO:0061384; GO:0062043; GO:0070168; GO:0070374; GO:0070986; GO:0071228; GO:0071372; GO:0071456; GO:0072017; GO:0072044; GO:0072091; GO:0072144; GO:0072148; GO:0072538; GO:0090051; GO:0090090; GO:0097150; GO:0097400; GO:0098685; GO:0098839; GO:0098978; GO:0099565; GO:0120163; GO:0140537; GO:1901201; GO:1902263; GO:1902339; GO:1903849; GO:2000048; GO:2000737; GO:2000811; GO:2000974; GO:2001027 animal organ regeneration [GO:0031100]; aortic valve morphogenesis [GO:0003180]; apoptotic process involved in embryonic digit morphogenesis [GO:1902263]; arterial endothelial cell differentiation [GO:0060842]; astrocyte differentiation [GO:0048708]; atrioventricular node development [GO:0003162]; atrioventricular valve morphogenesis [GO:0003181]; auditory receptor cell fate commitment [GO:0009912]; axon guidance [GO:0007411]; branching morphogenesis of an epithelial tube [GO:0048754]; calcium-ion regulated exocytosis [GO:0017156]; cardiac atrium morphogenesis [GO:0003209]; cardiac chamber formation [GO:0003207]; cardiac epithelial to mesenchymal transition [GO:0060317]; cardiac left ventricle morphogenesis [GO:0003214]; cardiac muscle cell myoblast differentiation [GO:0060379]; cardiac muscle cell proliferation [GO:0060038]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac right atrium morphogenesis [GO:0003213]; cardiac right ventricle formation [GO:0003219]; cardiac septum morphogenesis [GO:0060411]; cardiac vascular smooth muscle cell development [GO:0060948]; cardiac ventricle morphogenesis [GO:0003208]; cell differentiation in spinal cord [GO:0021515]; cell migration involved in endocardial cushion formation [GO:0003273]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to hypoxia [GO:0071456]; cellular response to tumor cell [GO:0071228]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; central nervous system neuron differentiation [GO:0021953]; chemical synaptic transmission, postsynaptic [GO:0099565]; cilium assembly [GO:0060271]; collecting duct development [GO:0072044]; compartment pattern specification [GO:0007386]; coronary artery morphogenesis [GO:0060982]; coronary sinus valve morphogenesis [GO:0003182]; coronary vein morphogenesis [GO:0003169]; determination of left/right symmetry [GO:0007368]; distal tubule development [GO:0072017]; embryonic hindlimb morphogenesis [GO:0035116]; endocardial cell differentiation [GO:0060956]; endocardial cushion morphogenesis [GO:0003203]; endocardium development [GO:0003157]; endocardium morphogenesis [GO:0003160]; endoderm development [GO:0007492]; epidermal cell fate specification [GO:0009957]; epithelial cell fate commitment [GO:0072148]; epithelial cell proliferation [GO:0050673]; epithelial to mesenchymal transition [GO:0001837]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; forebrain development [GO:0030900]; foregut morphogenesis [GO:0007440]; glomerular mesangial cell development [GO:0072144]; growth involved in heart morphogenesis [GO:0003241]; hair follicle morphogenesis [GO:0031069]; heart development [GO:0007507]; heart looping [GO:0001947]; heart trabecula morphogenesis [GO:0061384]; homeostasis of number of cells within a tissue [GO:0048873]; humoral immune response [GO:0006959]; immune response [GO:0006955]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; inhibition of neuroepithelial cell differentiation [GO:0002085]; interleukin-17-mediated signaling pathway [GO:0097400]; keratinocyte differentiation [GO:0030216]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; lung development [GO:0030324]; luteolysis [GO:0001554]; mesenchymal cell development [GO:0014031]; mitral valve formation [GO:0003192]; negative regulation of anoikis [GO:2000811]; negative regulation of biomineral tissue development [GO:0070168]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of catalytic activity [GO:0043086]; negative regulation of cell adhesion molecule production [GO:0060354]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell proliferation involved in heart valve morphogenesis [GO:0003252]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of collagen biosynthetic process [GO:0032966]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of endothelial cell chemotaxis [GO:2001027]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of extracellular matrix constituent secretion [GO:0003332]; negative regulation of gene expression [GO:0010629]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of inner ear auditory receptor cell differentiation [GO:0045608]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of neurogenesis [GO:0050768]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of ossification [GO:0030279]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of photoreceptor cell differentiation [GO:0046533]; negative regulation of pro-B cell differentiation [GO:2000974]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural tube development [GO:0021915]; neuroendocrine cell differentiation [GO:0061101]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; Notch signaling pathway involved in regulation of secondary heart field cardioblast proliferation [GO:0003270]; oligodendrocyte differentiation [GO:0048709]; outflow tract morphogenesis [GO:0003151]; pericardium morphogenesis [GO:0003344]; positive regulation of aorta morphogenesis [GO:1903849]; positive regulation of apoptotic process involved in morphogenesis [GO:1902339]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cardiac epithelial to mesenchymal transition [GO:0062043]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of smooth muscle cell differentiation [GO:0051152]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription of Notch receptor target [GO:0007221]; positive regulation of viral genome replication [GO:0045070]; prostate gland epithelium morphogenesis [GO:0060740]; protein catabolic process [GO:0030163]; protein import into nucleus [GO:0006606]; pulmonary valve morphogenesis [GO:0003184]; regulation of cell adhesion involved in heart morphogenesis [GO:0061344]; regulation of DNA-templated transcription [GO:0006355]; regulation of epithelial cell proliferation involved in prostate gland development [GO:0060768]; regulation of extracellular matrix assembly [GO:1901201]; regulation of somitogenesis [GO:0014807]; regulation of stem cell proliferation [GO:0072091]; regulation of transcription by RNA polymerase II [GO:0006357]; response to lipopolysaccharide [GO:0032496]; response to muramyl dipeptide [GO:0032495]; retinal cone cell differentiation [GO:0042670]; secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development [GO:0060528]; skeletal muscle cell differentiation [GO:0035914]; somatic stem cell division [GO:0048103]; spermatogenesis [GO:0007283]; sprouting angiogenesis [GO:0002040]; T-helper 17 type immune response [GO:0072538]; tissue regeneration [GO:0042246]; transcription by RNA polymerase II [GO:0006366]; tube formation [GO:0035148]; vasculogenesis involved in coronary vascular morphogenesis [GO:0060979]; venous endothelial cell differentiation [GO:0060843]; ventricular septum morphogenesis [GO:0060412]; ventricular trabecula myocardium morphogenesis [GO:0003222] acrosomal vesicle [GO:0001669]; adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; late endosome membrane [GO:0031902]; MAML1-RBP-Jkappa- ICN1 complex [GO:0002193]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; receptor complex [GO:0043235]; Schaffer collateral - CA1 synapse [GO:0098685] calcium ion binding [GO:0005509]; chromatin DNA binding [GO:0031490]; enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; identical protein binding [GO:0042802]; Notch binding [GO:0005112]; transcription coactivator activity [GO:0003713]; transcription regulator activator activity [GO:0140537]; transmembrane signaling receptor activity [GO:0004888] g18992.t1 P46531 31.593 364 3.0400000000000004e-27 121.0 sp|P46531|NOTC1_HUMAN Neurogenic locus notch homolog protein 1 OS=Homo sapiens OX=9606 GN=NOTCH1 PE=1 SV=4 NOTC1_HUMAN reviewed Neurogenic locus notch homolog protein 1 (Notch 1) (hN1) (Translocation-associated notch protein TAN-1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Homo sapiens (Human) GO:0000122; GO:0000139; GO:0001554; GO:0001669; GO:0001701; GO:0001837; GO:0001889; GO:0001947; GO:0002040; GO:0002052; GO:0002085; GO:0002193; GO:0002437; GO:0003151; GO:0003157; GO:0003160; GO:0003162; GO:0003169; GO:0003180; GO:0003181; GO:0003182; GO:0003184; GO:0003192; GO:0003198; GO:0003203; GO:0003207; GO:0003208; GO:0003209; GO:0003213; GO:0003214; GO:0003219; GO:0003222; GO:0003241; GO:0003252; GO:0003270; GO:0003273; GO:0003332; GO:0003344; GO:0003713; GO:0004857; GO:0004888; GO:0005112; GO:0005509; GO:0005576; GO:0005634; GO:0005654; GO:0005789; GO:0005829; GO:0005886; GO:0005912; GO:0006355; GO:0006357; GO:0006366; GO:0006606; GO:0006955; GO:0006959; GO:0007219; GO:0007221; GO:0007283; GO:0007368; GO:0007386; GO:0007411; GO:0007440; GO:0007492; GO:0007507; GO:0008284; GO:0008285; GO:0009912; GO:0009957; GO:0009986; GO:0010008; GO:0010614; GO:0010628; GO:0010629; GO:0010667; GO:0010812; GO:0010832; GO:0014031; GO:0014807; GO:0016324; GO:0017156; GO:0019899; GO:0021515; GO:0021915; GO:0021953; GO:0030163; GO:0030216; GO:0030279; GO:0030324; GO:0030335; GO:0030513; GO:0030514; GO:0030900; GO:0031069; GO:0031100; GO:0031490; GO:0031902; GO:0032495; GO:0032496; GO:0032966; GO:0035116; GO:0035148; GO:0035914; GO:0035924; GO:0042246; GO:0042670; GO:0042802; GO:0043086; GO:0043235; GO:0045070; GO:0045603; GO:0045608; GO:0045618; GO:0045662; GO:0045668; GO:0045747; GO:0045892; GO:0045893; GO:0045944; GO:0045955; GO:0046427; GO:0046533; GO:0046579; GO:0048103; GO:0048708; GO:0048709; GO:0048711; GO:0048715; GO:0048754; GO:0048873; GO:0050673; GO:0050679; GO:0050680; GO:0050768; GO:0051152; GO:0055008; GO:0060038; GO:0060045; GO:0060253; GO:0060271; GO:0060317; GO:0060354; GO:0060379; GO:0060411; GO:0060412; GO:0060528; GO:0060740; GO:0060768; GO:0060842; GO:0060843; GO:0060948; GO:0060956; GO:0060979; GO:0060982; GO:0061101; GO:0061344; GO:0061384; GO:0062043; GO:0070168; GO:0070374; GO:0070986; GO:0071228; GO:0071372; GO:0071456; GO:0072017; GO:0072044; GO:0072091; GO:0072144; GO:0072148; GO:0072538; GO:0090051; GO:0090090; GO:0097150; GO:0097400; GO:0098685; GO:0098839; GO:0098978; GO:0099565; GO:0120163; GO:0140537; GO:1901201; GO:1902263; GO:1902339; GO:1903849; GO:2000048; GO:2000737; GO:2000811; GO:2000974; GO:2001027 animal organ regeneration [GO:0031100]; aortic valve morphogenesis [GO:0003180]; apoptotic process involved in embryonic digit morphogenesis [GO:1902263]; arterial endothelial cell differentiation [GO:0060842]; astrocyte differentiation [GO:0048708]; atrioventricular node development [GO:0003162]; atrioventricular valve morphogenesis [GO:0003181]; auditory receptor cell fate commitment [GO:0009912]; axon guidance [GO:0007411]; branching morphogenesis of an epithelial tube [GO:0048754]; calcium-ion regulated exocytosis [GO:0017156]; cardiac atrium morphogenesis [GO:0003209]; cardiac chamber formation [GO:0003207]; cardiac epithelial to mesenchymal transition [GO:0060317]; cardiac left ventricle morphogenesis [GO:0003214]; cardiac muscle cell myoblast differentiation [GO:0060379]; cardiac muscle cell proliferation [GO:0060038]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac right atrium morphogenesis [GO:0003213]; cardiac right ventricle formation [GO:0003219]; cardiac septum morphogenesis [GO:0060411]; cardiac vascular smooth muscle cell development [GO:0060948]; cardiac ventricle morphogenesis [GO:0003208]; cell differentiation in spinal cord [GO:0021515]; cell migration involved in endocardial cushion formation [GO:0003273]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to hypoxia [GO:0071456]; cellular response to tumor cell [GO:0071228]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; central nervous system neuron differentiation [GO:0021953]; chemical synaptic transmission, postsynaptic [GO:0099565]; cilium assembly [GO:0060271]; collecting duct development [GO:0072044]; compartment pattern specification [GO:0007386]; coronary artery morphogenesis [GO:0060982]; coronary sinus valve morphogenesis [GO:0003182]; coronary vein morphogenesis [GO:0003169]; determination of left/right symmetry [GO:0007368]; distal tubule development [GO:0072017]; embryonic hindlimb morphogenesis [GO:0035116]; endocardial cell differentiation [GO:0060956]; endocardial cushion morphogenesis [GO:0003203]; endocardium development [GO:0003157]; endocardium morphogenesis [GO:0003160]; endoderm development [GO:0007492]; epidermal cell fate specification [GO:0009957]; epithelial cell fate commitment [GO:0072148]; epithelial cell proliferation [GO:0050673]; epithelial to mesenchymal transition [GO:0001837]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; forebrain development [GO:0030900]; foregut morphogenesis [GO:0007440]; glomerular mesangial cell development [GO:0072144]; growth involved in heart morphogenesis [GO:0003241]; hair follicle morphogenesis [GO:0031069]; heart development [GO:0007507]; heart looping [GO:0001947]; heart trabecula morphogenesis [GO:0061384]; homeostasis of number of cells within a tissue [GO:0048873]; humoral immune response [GO:0006959]; immune response [GO:0006955]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; inhibition of neuroepithelial cell differentiation [GO:0002085]; interleukin-17-mediated signaling pathway [GO:0097400]; keratinocyte differentiation [GO:0030216]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; lung development [GO:0030324]; luteolysis [GO:0001554]; mesenchymal cell development [GO:0014031]; mitral valve formation [GO:0003192]; negative regulation of anoikis [GO:2000811]; negative regulation of biomineral tissue development [GO:0070168]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of catalytic activity [GO:0043086]; negative regulation of cell adhesion molecule production [GO:0060354]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell proliferation involved in heart valve morphogenesis [GO:0003252]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of collagen biosynthetic process [GO:0032966]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of endothelial cell chemotaxis [GO:2001027]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of extracellular matrix constituent secretion [GO:0003332]; negative regulation of gene expression [GO:0010629]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of inner ear auditory receptor cell differentiation [GO:0045608]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of neurogenesis [GO:0050768]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of ossification [GO:0030279]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of photoreceptor cell differentiation [GO:0046533]; negative regulation of pro-B cell differentiation [GO:2000974]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural tube development [GO:0021915]; neuroendocrine cell differentiation [GO:0061101]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; Notch signaling pathway involved in regulation of secondary heart field cardioblast proliferation [GO:0003270]; oligodendrocyte differentiation [GO:0048709]; outflow tract morphogenesis [GO:0003151]; pericardium morphogenesis [GO:0003344]; positive regulation of aorta morphogenesis [GO:1903849]; positive regulation of apoptotic process involved in morphogenesis [GO:1902339]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cardiac epithelial to mesenchymal transition [GO:0062043]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of smooth muscle cell differentiation [GO:0051152]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription of Notch receptor target [GO:0007221]; positive regulation of viral genome replication [GO:0045070]; prostate gland epithelium morphogenesis [GO:0060740]; protein catabolic process [GO:0030163]; protein import into nucleus [GO:0006606]; pulmonary valve morphogenesis [GO:0003184]; regulation of cell adhesion involved in heart morphogenesis [GO:0061344]; regulation of DNA-templated transcription [GO:0006355]; regulation of epithelial cell proliferation involved in prostate gland development [GO:0060768]; regulation of extracellular matrix assembly [GO:1901201]; regulation of somitogenesis [GO:0014807]; regulation of stem cell proliferation [GO:0072091]; regulation of transcription by RNA polymerase II [GO:0006357]; response to lipopolysaccharide [GO:0032496]; response to muramyl dipeptide [GO:0032495]; retinal cone cell differentiation [GO:0042670]; secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development [GO:0060528]; skeletal muscle cell differentiation [GO:0035914]; somatic stem cell division [GO:0048103]; spermatogenesis [GO:0007283]; sprouting angiogenesis [GO:0002040]; T-helper 17 type immune response [GO:0072538]; tissue regeneration [GO:0042246]; transcription by RNA polymerase II [GO:0006366]; tube formation [GO:0035148]; vasculogenesis involved in coronary vascular morphogenesis [GO:0060979]; venous endothelial cell differentiation [GO:0060843]; ventricular septum morphogenesis [GO:0060412]; ventricular trabecula myocardium morphogenesis [GO:0003222] acrosomal vesicle [GO:0001669]; adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; late endosome membrane [GO:0031902]; MAML1-RBP-Jkappa- ICN1 complex [GO:0002193]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; receptor complex [GO:0043235]; Schaffer collateral - CA1 synapse [GO:0098685] calcium ion binding [GO:0005509]; chromatin DNA binding [GO:0031490]; enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; identical protein binding [GO:0042802]; Notch binding [GO:0005112]; transcription coactivator activity [GO:0003713]; transcription regulator activator activity [GO:0140537]; transmembrane signaling receptor activity [GO:0004888] g18992.t1 P46531 31.389 360 7.52e-26 117.0 sp|P46531|NOTC1_HUMAN Neurogenic locus notch homolog protein 1 OS=Homo sapiens OX=9606 GN=NOTCH1 PE=1 SV=4 NOTC1_HUMAN reviewed Neurogenic locus notch homolog protein 1 (Notch 1) (hN1) (Translocation-associated notch protein TAN-1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Homo sapiens (Human) GO:0000122; GO:0000139; GO:0001554; GO:0001669; GO:0001701; GO:0001837; GO:0001889; GO:0001947; GO:0002040; GO:0002052; GO:0002085; GO:0002193; GO:0002437; GO:0003151; GO:0003157; GO:0003160; GO:0003162; GO:0003169; GO:0003180; GO:0003181; GO:0003182; GO:0003184; GO:0003192; GO:0003198; GO:0003203; GO:0003207; GO:0003208; GO:0003209; GO:0003213; GO:0003214; GO:0003219; GO:0003222; GO:0003241; GO:0003252; GO:0003270; GO:0003273; GO:0003332; GO:0003344; GO:0003713; GO:0004857; GO:0004888; GO:0005112; GO:0005509; GO:0005576; GO:0005634; GO:0005654; GO:0005789; GO:0005829; GO:0005886; GO:0005912; GO:0006355; GO:0006357; GO:0006366; GO:0006606; GO:0006955; GO:0006959; GO:0007219; GO:0007221; GO:0007283; GO:0007368; GO:0007386; GO:0007411; GO:0007440; GO:0007492; GO:0007507; GO:0008284; GO:0008285; GO:0009912; GO:0009957; GO:0009986; GO:0010008; GO:0010614; GO:0010628; GO:0010629; GO:0010667; GO:0010812; GO:0010832; GO:0014031; GO:0014807; GO:0016324; GO:0017156; GO:0019899; GO:0021515; GO:0021915; GO:0021953; GO:0030163; GO:0030216; GO:0030279; GO:0030324; GO:0030335; GO:0030513; GO:0030514; GO:0030900; GO:0031069; GO:0031100; GO:0031490; GO:0031902; GO:0032495; GO:0032496; GO:0032966; GO:0035116; GO:0035148; GO:0035914; GO:0035924; GO:0042246; GO:0042670; GO:0042802; GO:0043086; GO:0043235; GO:0045070; GO:0045603; GO:0045608; GO:0045618; GO:0045662; GO:0045668; GO:0045747; GO:0045892; GO:0045893; GO:0045944; GO:0045955; GO:0046427; GO:0046533; GO:0046579; GO:0048103; GO:0048708; GO:0048709; GO:0048711; GO:0048715; GO:0048754; GO:0048873; GO:0050673; GO:0050679; GO:0050680; GO:0050768; GO:0051152; GO:0055008; GO:0060038; GO:0060045; GO:0060253; GO:0060271; GO:0060317; GO:0060354; GO:0060379; GO:0060411; GO:0060412; GO:0060528; GO:0060740; GO:0060768; GO:0060842; GO:0060843; GO:0060948; GO:0060956; GO:0060979; GO:0060982; GO:0061101; GO:0061344; GO:0061384; GO:0062043; GO:0070168; GO:0070374; GO:0070986; GO:0071228; GO:0071372; GO:0071456; GO:0072017; GO:0072044; GO:0072091; GO:0072144; GO:0072148; GO:0072538; GO:0090051; GO:0090090; GO:0097150; GO:0097400; GO:0098685; GO:0098839; GO:0098978; GO:0099565; GO:0120163; GO:0140537; GO:1901201; GO:1902263; GO:1902339; GO:1903849; GO:2000048; GO:2000737; GO:2000811; GO:2000974; GO:2001027 animal organ regeneration [GO:0031100]; aortic valve morphogenesis [GO:0003180]; apoptotic process involved in embryonic digit morphogenesis [GO:1902263]; arterial endothelial cell differentiation [GO:0060842]; astrocyte differentiation [GO:0048708]; atrioventricular node development [GO:0003162]; atrioventricular valve morphogenesis [GO:0003181]; auditory receptor cell fate commitment [GO:0009912]; axon guidance [GO:0007411]; branching morphogenesis of an epithelial tube [GO:0048754]; calcium-ion regulated exocytosis [GO:0017156]; cardiac atrium morphogenesis [GO:0003209]; cardiac chamber formation [GO:0003207]; cardiac epithelial to mesenchymal transition [GO:0060317]; cardiac left ventricle morphogenesis [GO:0003214]; cardiac muscle cell myoblast differentiation [GO:0060379]; cardiac muscle cell proliferation [GO:0060038]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac right atrium morphogenesis [GO:0003213]; cardiac right ventricle formation [GO:0003219]; cardiac septum morphogenesis [GO:0060411]; cardiac vascular smooth muscle cell development [GO:0060948]; cardiac ventricle morphogenesis [GO:0003208]; cell differentiation in spinal cord [GO:0021515]; cell migration involved in endocardial cushion formation [GO:0003273]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to hypoxia [GO:0071456]; cellular response to tumor cell [GO:0071228]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; central nervous system neuron differentiation [GO:0021953]; chemical synaptic transmission, postsynaptic [GO:0099565]; cilium assembly [GO:0060271]; collecting duct development [GO:0072044]; compartment pattern specification [GO:0007386]; coronary artery morphogenesis [GO:0060982]; coronary sinus valve morphogenesis [GO:0003182]; coronary vein morphogenesis [GO:0003169]; determination of left/right symmetry [GO:0007368]; distal tubule development [GO:0072017]; embryonic hindlimb morphogenesis [GO:0035116]; endocardial cell differentiation [GO:0060956]; endocardial cushion morphogenesis [GO:0003203]; endocardium development [GO:0003157]; endocardium morphogenesis [GO:0003160]; endoderm development [GO:0007492]; epidermal cell fate specification [GO:0009957]; epithelial cell fate commitment [GO:0072148]; epithelial cell proliferation [GO:0050673]; epithelial to mesenchymal transition [GO:0001837]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; forebrain development [GO:0030900]; foregut morphogenesis [GO:0007440]; glomerular mesangial cell development [GO:0072144]; growth involved in heart morphogenesis [GO:0003241]; hair follicle morphogenesis [GO:0031069]; heart development [GO:0007507]; heart looping [GO:0001947]; heart trabecula morphogenesis [GO:0061384]; homeostasis of number of cells within a tissue [GO:0048873]; humoral immune response [GO:0006959]; immune response [GO:0006955]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; inhibition of neuroepithelial cell differentiation [GO:0002085]; interleukin-17-mediated signaling pathway [GO:0097400]; keratinocyte differentiation [GO:0030216]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; lung development [GO:0030324]; luteolysis [GO:0001554]; mesenchymal cell development [GO:0014031]; mitral valve formation [GO:0003192]; negative regulation of anoikis [GO:2000811]; negative regulation of biomineral tissue development [GO:0070168]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of catalytic activity [GO:0043086]; negative regulation of cell adhesion molecule production [GO:0060354]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell proliferation involved in heart valve morphogenesis [GO:0003252]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of collagen biosynthetic process [GO:0032966]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of endothelial cell chemotaxis [GO:2001027]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of extracellular matrix constituent secretion [GO:0003332]; negative regulation of gene expression [GO:0010629]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of inner ear auditory receptor cell differentiation [GO:0045608]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of neurogenesis [GO:0050768]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of ossification [GO:0030279]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of photoreceptor cell differentiation [GO:0046533]; negative regulation of pro-B cell differentiation [GO:2000974]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural tube development [GO:0021915]; neuroendocrine cell differentiation [GO:0061101]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; Notch signaling pathway involved in regulation of secondary heart field cardioblast proliferation [GO:0003270]; oligodendrocyte differentiation [GO:0048709]; outflow tract morphogenesis [GO:0003151]; pericardium morphogenesis [GO:0003344]; positive regulation of aorta morphogenesis [GO:1903849]; positive regulation of apoptotic process involved in morphogenesis [GO:1902339]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cardiac epithelial to mesenchymal transition [GO:0062043]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of smooth muscle cell differentiation [GO:0051152]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription of Notch receptor target [GO:0007221]; positive regulation of viral genome replication [GO:0045070]; prostate gland epithelium morphogenesis [GO:0060740]; protein catabolic process [GO:0030163]; protein import into nucleus [GO:0006606]; pulmonary valve morphogenesis [GO:0003184]; regulation of cell adhesion involved in heart morphogenesis [GO:0061344]; regulation of DNA-templated transcription [GO:0006355]; regulation of epithelial cell proliferation involved in prostate gland development [GO:0060768]; regulation of extracellular matrix assembly [GO:1901201]; regulation of somitogenesis [GO:0014807]; regulation of stem cell proliferation [GO:0072091]; regulation of transcription by RNA polymerase II [GO:0006357]; response to lipopolysaccharide [GO:0032496]; response to muramyl dipeptide [GO:0032495]; retinal cone cell differentiation [GO:0042670]; secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development [GO:0060528]; skeletal muscle cell differentiation [GO:0035914]; somatic stem cell division [GO:0048103]; spermatogenesis [GO:0007283]; sprouting angiogenesis [GO:0002040]; T-helper 17 type immune response [GO:0072538]; tissue regeneration [GO:0042246]; transcription by RNA polymerase II [GO:0006366]; tube formation [GO:0035148]; vasculogenesis involved in coronary vascular morphogenesis [GO:0060979]; venous endothelial cell differentiation [GO:0060843]; ventricular septum morphogenesis [GO:0060412]; ventricular trabecula myocardium morphogenesis [GO:0003222] acrosomal vesicle [GO:0001669]; adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; late endosome membrane [GO:0031902]; MAML1-RBP-Jkappa- ICN1 complex [GO:0002193]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; receptor complex [GO:0043235]; Schaffer collateral - CA1 synapse [GO:0098685] calcium ion binding [GO:0005509]; chromatin DNA binding [GO:0031490]; enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; identical protein binding [GO:0042802]; Notch binding [GO:0005112]; transcription coactivator activity [GO:0003713]; transcription regulator activator activity [GO:0140537]; transmembrane signaling receptor activity [GO:0004888] g18992.t1 P46531 32.133 361 8.1e-24 110.0 sp|P46531|NOTC1_HUMAN Neurogenic locus notch homolog protein 1 OS=Homo sapiens OX=9606 GN=NOTCH1 PE=1 SV=4 NOTC1_HUMAN reviewed Neurogenic locus notch homolog protein 1 (Notch 1) (hN1) (Translocation-associated notch protein TAN-1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Homo sapiens (Human) GO:0000122; GO:0000139; GO:0001554; GO:0001669; GO:0001701; GO:0001837; GO:0001889; GO:0001947; GO:0002040; GO:0002052; GO:0002085; GO:0002193; GO:0002437; GO:0003151; GO:0003157; GO:0003160; GO:0003162; GO:0003169; GO:0003180; GO:0003181; GO:0003182; GO:0003184; GO:0003192; GO:0003198; GO:0003203; GO:0003207; GO:0003208; GO:0003209; GO:0003213; GO:0003214; GO:0003219; GO:0003222; GO:0003241; GO:0003252; GO:0003270; GO:0003273; GO:0003332; GO:0003344; GO:0003713; GO:0004857; GO:0004888; GO:0005112; GO:0005509; GO:0005576; GO:0005634; GO:0005654; GO:0005789; GO:0005829; GO:0005886; GO:0005912; GO:0006355; GO:0006357; GO:0006366; GO:0006606; GO:0006955; GO:0006959; GO:0007219; GO:0007221; GO:0007283; GO:0007368; GO:0007386; GO:0007411; GO:0007440; GO:0007492; GO:0007507; GO:0008284; GO:0008285; GO:0009912; GO:0009957; GO:0009986; GO:0010008; GO:0010614; GO:0010628; GO:0010629; GO:0010667; GO:0010812; GO:0010832; GO:0014031; GO:0014807; GO:0016324; GO:0017156; GO:0019899; GO:0021515; GO:0021915; GO:0021953; GO:0030163; GO:0030216; GO:0030279; GO:0030324; GO:0030335; GO:0030513; GO:0030514; GO:0030900; GO:0031069; GO:0031100; GO:0031490; GO:0031902; GO:0032495; GO:0032496; GO:0032966; GO:0035116; GO:0035148; GO:0035914; GO:0035924; GO:0042246; GO:0042670; GO:0042802; GO:0043086; GO:0043235; GO:0045070; GO:0045603; GO:0045608; GO:0045618; GO:0045662; GO:0045668; GO:0045747; GO:0045892; GO:0045893; GO:0045944; GO:0045955; GO:0046427; GO:0046533; GO:0046579; GO:0048103; GO:0048708; GO:0048709; GO:0048711; GO:0048715; GO:0048754; GO:0048873; GO:0050673; GO:0050679; GO:0050680; GO:0050768; GO:0051152; GO:0055008; GO:0060038; GO:0060045; GO:0060253; GO:0060271; GO:0060317; GO:0060354; GO:0060379; GO:0060411; GO:0060412; GO:0060528; GO:0060740; GO:0060768; GO:0060842; GO:0060843; GO:0060948; GO:0060956; GO:0060979; GO:0060982; GO:0061101; GO:0061344; GO:0061384; GO:0062043; GO:0070168; GO:0070374; GO:0070986; GO:0071228; GO:0071372; GO:0071456; GO:0072017; GO:0072044; GO:0072091; GO:0072144; GO:0072148; GO:0072538; GO:0090051; GO:0090090; GO:0097150; GO:0097400; GO:0098685; GO:0098839; GO:0098978; GO:0099565; GO:0120163; GO:0140537; GO:1901201; GO:1902263; GO:1902339; GO:1903849; GO:2000048; GO:2000737; GO:2000811; GO:2000974; GO:2001027 animal organ regeneration [GO:0031100]; aortic valve morphogenesis [GO:0003180]; apoptotic process involved in embryonic digit morphogenesis [GO:1902263]; arterial endothelial cell differentiation [GO:0060842]; astrocyte differentiation [GO:0048708]; atrioventricular node development [GO:0003162]; atrioventricular valve morphogenesis [GO:0003181]; auditory receptor cell fate commitment [GO:0009912]; axon guidance [GO:0007411]; branching morphogenesis of an epithelial tube [GO:0048754]; calcium-ion regulated exocytosis [GO:0017156]; cardiac atrium morphogenesis [GO:0003209]; cardiac chamber formation [GO:0003207]; cardiac epithelial to mesenchymal transition [GO:0060317]; cardiac left ventricle morphogenesis [GO:0003214]; cardiac muscle cell myoblast differentiation [GO:0060379]; cardiac muscle cell proliferation [GO:0060038]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac right atrium morphogenesis [GO:0003213]; cardiac right ventricle formation [GO:0003219]; cardiac septum morphogenesis [GO:0060411]; cardiac vascular smooth muscle cell development [GO:0060948]; cardiac ventricle morphogenesis [GO:0003208]; cell differentiation in spinal cord [GO:0021515]; cell migration involved in endocardial cushion formation [GO:0003273]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to hypoxia [GO:0071456]; cellular response to tumor cell [GO:0071228]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; central nervous system neuron differentiation [GO:0021953]; chemical synaptic transmission, postsynaptic [GO:0099565]; cilium assembly [GO:0060271]; collecting duct development [GO:0072044]; compartment pattern specification [GO:0007386]; coronary artery morphogenesis [GO:0060982]; coronary sinus valve morphogenesis [GO:0003182]; coronary vein morphogenesis [GO:0003169]; determination of left/right symmetry [GO:0007368]; distal tubule development [GO:0072017]; embryonic hindlimb morphogenesis [GO:0035116]; endocardial cell differentiation [GO:0060956]; endocardial cushion morphogenesis [GO:0003203]; endocardium development [GO:0003157]; endocardium morphogenesis [GO:0003160]; endoderm development [GO:0007492]; epidermal cell fate specification [GO:0009957]; epithelial cell fate commitment [GO:0072148]; epithelial cell proliferation [GO:0050673]; epithelial to mesenchymal transition [GO:0001837]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; forebrain development [GO:0030900]; foregut morphogenesis [GO:0007440]; glomerular mesangial cell development [GO:0072144]; growth involved in heart morphogenesis [GO:0003241]; hair follicle morphogenesis [GO:0031069]; heart development [GO:0007507]; heart looping [GO:0001947]; heart trabecula morphogenesis [GO:0061384]; homeostasis of number of cells within a tissue [GO:0048873]; humoral immune response [GO:0006959]; immune response [GO:0006955]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; inhibition of neuroepithelial cell differentiation [GO:0002085]; interleukin-17-mediated signaling pathway [GO:0097400]; keratinocyte differentiation [GO:0030216]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; lung development [GO:0030324]; luteolysis [GO:0001554]; mesenchymal cell development [GO:0014031]; mitral valve formation [GO:0003192]; negative regulation of anoikis [GO:2000811]; negative regulation of biomineral tissue development [GO:0070168]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of catalytic activity [GO:0043086]; negative regulation of cell adhesion molecule production [GO:0060354]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell proliferation involved in heart valve morphogenesis [GO:0003252]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of collagen biosynthetic process [GO:0032966]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of endothelial cell chemotaxis [GO:2001027]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of extracellular matrix constituent secretion [GO:0003332]; negative regulation of gene expression [GO:0010629]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of inner ear auditory receptor cell differentiation [GO:0045608]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of neurogenesis [GO:0050768]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of ossification [GO:0030279]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of photoreceptor cell differentiation [GO:0046533]; negative regulation of pro-B cell differentiation [GO:2000974]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural tube development [GO:0021915]; neuroendocrine cell differentiation [GO:0061101]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; Notch signaling pathway involved in regulation of secondary heart field cardioblast proliferation [GO:0003270]; oligodendrocyte differentiation [GO:0048709]; outflow tract morphogenesis [GO:0003151]; pericardium morphogenesis [GO:0003344]; positive regulation of aorta morphogenesis [GO:1903849]; positive regulation of apoptotic process involved in morphogenesis [GO:1902339]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cardiac epithelial to mesenchymal transition [GO:0062043]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of smooth muscle cell differentiation [GO:0051152]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription of Notch receptor target [GO:0007221]; positive regulation of viral genome replication [GO:0045070]; prostate gland epithelium morphogenesis [GO:0060740]; protein catabolic process [GO:0030163]; protein import into nucleus [GO:0006606]; pulmonary valve morphogenesis [GO:0003184]; regulation of cell adhesion involved in heart morphogenesis [GO:0061344]; regulation of DNA-templated transcription [GO:0006355]; regulation of epithelial cell proliferation involved in prostate gland development [GO:0060768]; regulation of extracellular matrix assembly [GO:1901201]; regulation of somitogenesis [GO:0014807]; regulation of stem cell proliferation [GO:0072091]; regulation of transcription by RNA polymerase II [GO:0006357]; response to lipopolysaccharide [GO:0032496]; response to muramyl dipeptide [GO:0032495]; retinal cone cell differentiation [GO:0042670]; secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development [GO:0060528]; skeletal muscle cell differentiation [GO:0035914]; somatic stem cell division [GO:0048103]; spermatogenesis [GO:0007283]; sprouting angiogenesis [GO:0002040]; T-helper 17 type immune response [GO:0072538]; tissue regeneration [GO:0042246]; transcription by RNA polymerase II [GO:0006366]; tube formation [GO:0035148]; vasculogenesis involved in coronary vascular morphogenesis [GO:0060979]; venous endothelial cell differentiation [GO:0060843]; ventricular septum morphogenesis [GO:0060412]; ventricular trabecula myocardium morphogenesis [GO:0003222] acrosomal vesicle [GO:0001669]; adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; late endosome membrane [GO:0031902]; MAML1-RBP-Jkappa- ICN1 complex [GO:0002193]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; receptor complex [GO:0043235]; Schaffer collateral - CA1 synapse [GO:0098685] calcium ion binding [GO:0005509]; chromatin DNA binding [GO:0031490]; enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; identical protein binding [GO:0042802]; Notch binding [GO:0005112]; transcription coactivator activity [GO:0003713]; transcription regulator activator activity [GO:0140537]; transmembrane signaling receptor activity [GO:0004888] g18992.t2 P10079 37.33 367 8.79e-38 153.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g18992.t2 P10079 34.435 363 4.65e-37 150.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g18992.t2 P10079 34.511 368 2.4800000000000002e-33 139.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g18992.t2 P10079 32.5 400 7.38e-33 138.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g18992.t2 P10079 32.668 401 7.510000000000001e-33 138.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g18992.t2 P10079 34.53 362 1.83e-32 137.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g18992.t2 P10079 32.178 404 1.1600000000000001e-29 128.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g18992.t2 P10079 36.254 331 3.75e-28 123.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g18993.t1 P07207 38.396 1284 0.0 648.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g18993.t1 P07207 34.958 1313 0.0 622.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g18993.t1 P07207 36.953 1142 3.12e-170 570.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g18993.t1 P07207 37.027 1110 3.1100000000000004e-154 523.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g18993.t1 P07207 36.897 870 1.41e-131 456.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g18993.t1 P07207 34.831 801 2.36e-93 338.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g18993.t1 P07207 34.856 591 5.21e-63 242.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g18993.t2 P07207 37.743 1338 0.0 667.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g18993.t2 P07207 36.282 1334 0.0 652.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g18993.t2 P07207 38.372 1118 0.0 605.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g18993.t2 P07207 37.443 1103 4.55e-154 525.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g18993.t2 P07207 34.831 801 4.04e-93 338.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g18993.t2 P07207 34.856 591 6.7e-63 242.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g18993.t3 P07207 38.048 1301 0.0 665.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g18993.t3 P07207 37.313 1139 6.29e-177 590.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g18993.t3 P07207 36.82 1176 1.8000000000000002e-160 543.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g18993.t3 P07207 37.054 869 2.28e-139 480.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g18993.t3 P07207 34.418 799 1.05e-91 334.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g18993.t3 P07207 34.856 591 7.57e-63 241.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g18993.t4 P07207 38.048 1301 0.0 664.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g18993.t4 P07207 37.401 1139 1.5e-177 592.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g18993.t4 P07207 36.82 1176 7.5e-161 544.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g18993.t4 P07207 37.054 869 1.68e-139 480.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g18993.t4 P07207 34.418 799 4.46e-91 332.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g18993.t4 P07207 34.856 591 5.96e-63 242.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g18993.t5 P07207 38.048 1301 0.0 665.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g18993.t5 P07207 37.313 1139 6.29e-177 590.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g18993.t5 P07207 36.82 1176 1.8000000000000002e-160 543.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g18993.t5 P07207 37.054 869 2.28e-139 480.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g18993.t5 P07207 34.418 799 1.05e-91 334.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g18993.t5 P07207 34.856 591 7.57e-63 241.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g18993.t6 P07207 38.077 1300 0.0 659.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g18993.t6 P07207 35.542 1328 0.0 634.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g18993.t6 P07207 35.91 1242 0.0 613.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g18993.t6 P07207 37.128 1142 7.54e-173 579.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g18993.t6 P07207 34.776 1294 3.97e-159 539.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g18993.t6 P07207 37.443 1103 3.58e-154 524.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g18993.t6 P07207 37.159 880 5.8600000000000006e-133 461.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g18993.t6 P07207 34.831 801 4.19e-93 338.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g18993.t6 P07207 37.739 522 2.61e-85 313.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g19001.t1 Q5TAA0 26.095 525 4.73e-30 129.0 sp|Q5TAA0|TTC22_HUMAN Tetratricopeptide repeat protein 22 OS=Homo sapiens OX=9606 GN=TTC22 PE=1 SV=1 g19004.t1 Q9Y5R2 39.602 553 1.67e-108 343.0 sp|Q9Y5R2|MMP24_HUMAN Matrix metalloproteinase-24 OS=Homo sapiens OX=9606 GN=MMP24 PE=1 SV=1 MMP24_HUMAN reviewed Matrix metalloproteinase-24 (MMP-24) (EC 3.4.24.-) (Membrane-type matrix metalloproteinase 5) (MT-MMP 5) (MTMMP5) (Membrane-type-5 matrix metalloproteinase) (MT5-MMP) (MT5MMP) [Cleaved into: Processed matrix metalloproteinase-24] Homo sapiens (Human) GO:0004222; GO:0005615; GO:0005886; GO:0006508; GO:0008047; GO:0008270; GO:0010001; GO:0030198; GO:0030574; GO:0031012; GO:0032588; GO:0044331; GO:0045296; GO:0050965; GO:0070062; GO:0097150; GO:0098742 cell-cell adhesion mediated by cadherin [GO:0044331]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; collagen catabolic process [GO:0030574]; detection of temperature stimulus involved in sensory perception of pain [GO:0050965]; extracellular matrix organization [GO:0030198]; glial cell differentiation [GO:0010001]; neuronal stem cell population maintenance [GO:0097150]; proteolysis [GO:0006508] extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; trans-Golgi network membrane [GO:0032588] cadherin binding [GO:0045296]; enzyme activator activity [GO:0008047]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270] g19005.t1 Q8N653 57.683 820 0.0 939.0 sp|Q8N653|LZTR1_HUMAN Leucine-zipper-like transcriptional regulator 1 OS=Homo sapiens OX=9606 GN=LZTR1 PE=1 SV=2 LZTR1_HUMAN reviewed Leucine-zipper-like transcriptional regulator 1 (LZTR-1) Homo sapiens (Human) GO:0005794; GO:0012505; GO:0016567; GO:0031267; GO:0031463; GO:0046580; GO:0055038 negative regulation of Ras protein signal transduction [GO:0046580]; protein ubiquitination [GO:0016567] Cul3-RING ubiquitin ligase complex [GO:0031463]; endomembrane system [GO:0012505]; Golgi apparatus [GO:0005794]; recycling endosome membrane [GO:0055038] small GTPase binding [GO:0031267] g19006.t1 Q5EBP3 35.759 316 1.16e-27 125.0 sp|Q5EBP3|ARMC5_MOUSE Armadillo repeat-containing protein 5 OS=Mus musculus OX=10090 GN=Armc5 PE=2 SV=1 ARMC5_MOUSE reviewed Armadillo repeat-containing protein 5 Mus musculus (Mouse) GO:0000785; GO:0001701; GO:0001707; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005925; GO:0006366; GO:0006368; GO:0006633; GO:0006636; GO:0007369; GO:0009653; GO:0010467; GO:0016020; GO:0030163; GO:0031463; GO:0032933; GO:0035801; GO:0042098; GO:0043161; GO:0043367; GO:0050810; GO:0051607; GO:0061630; GO:0160240; GO:1990756 adrenal cortex development [GO:0035801]; anatomical structure morphogenesis [GO:0009653]; CD4-positive, alpha-beta T cell differentiation [GO:0043367]; defense response to virus [GO:0051607]; fatty acid biosynthetic process [GO:0006633]; gastrulation [GO:0007369]; gene expression [GO:0010467]; in utero embryonic development [GO:0001701]; mesoderm formation [GO:0001707]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein catabolic process [GO:0030163]; regulation of steroid biosynthetic process [GO:0050810]; RNA polymerase II transcription initiation surveillance [GO:0160240]; SREBP signaling pathway [GO:0032933]; T cell proliferation [GO:0042098]; transcription by RNA polymerase II [GO:0006366]; transcription elongation by RNA polymerase II [GO:0006368]; unsaturated fatty acid biosynthetic process [GO:0006636] chromatin [GO:0000785]; Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] ubiquitin protein ligase activity [GO:0061630]; ubiquitin-like ligase-substrate adaptor activity [GO:1990756] g19008.t1 O35130 70.936 203 9.76e-109 316.0 sp|O35130|NEP1_MOUSE Ribosomal RNA small subunit methyltransferase NEP1 OS=Mus musculus OX=10090 GN=Emg1 PE=1 SV=1 NEP1_MOUSE reviewed Ribosomal RNA small subunit methyltransferase NEP1 (EC 2.1.1.-) (18S rRNA (pseudouridine(1248)-N1)-methyltransferase) (18S rRNA Psi1248 methyltransferase) (Nucleolar protein EMG1 homolog) (Protein C2f) (Ribosome biogenesis protein NEP1) Mus musculus (Mouse) GO:0001824; GO:0005634; GO:0005654; GO:0005694; GO:0005730; GO:0017126; GO:0019843; GO:0032040; GO:0042274; GO:0042802; GO:0070037; GO:0070475 blastocyst development [GO:0001824]; nucleologenesis [GO:0017126]; ribosomal small subunit biogenesis [GO:0042274]; rRNA base methylation [GO:0070475] chromosome [GO:0005694]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; small-subunit processome [GO:0032040] identical protein binding [GO:0042802]; rRNA (pseudouridine) methyltransferase activity [GO:0070037]; rRNA binding [GO:0019843] g19009.t1 Q9NP71 54.825 228 8.93e-69 251.0 sp|Q9NP71|MLXPL_HUMAN Carbohydrate-responsive element-binding protein OS=Homo sapiens OX=9606 GN=MLXIPL PE=1 SV=1 MLXPL_HUMAN reviewed Carbohydrate-responsive element-binding protein (ChREBP) (Class D basic helix-loop-helix protein 14) (bHLHd14) (MLX interactor) (MLX-interacting protein-like) (WS basic-helix-loop-helix leucine zipper protein) (WS-bHLH) (Williams-Beuren syndrome chromosomal region 14 protein) Homo sapiens (Human) GO:0000432; GO:0000785; GO:0000978; GO:0000981; GO:0001216; GO:0001227; GO:0001228; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0005667; GO:0005737; GO:0005829; GO:0006355; GO:0006357; GO:0008284; GO:0008610; GO:0009653; GO:0010255; GO:0035538; GO:0035774; GO:0042593; GO:0045723; GO:0045821; GO:0045892; GO:0045893; GO:0045944; GO:0046889; GO:0046982; GO:0055089; GO:0061629; GO:0070328; GO:0090324; GO:0097009; GO:0140297; GO:1901797 anatomical structure morphogenesis [GO:0009653]; energy homeostasis [GO:0097009]; fatty acid homeostasis [GO:0055089]; glucose homeostasis [GO:0042593]; glucose mediated signaling pathway [GO:0010255]; lipid biosynthetic process [GO:0008610]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of oxidative phosphorylation [GO:0090324]; negative regulation of signal transduction by p53 class mediator [GO:1901797]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of fatty acid biosynthetic process [GO:0045723]; positive regulation of glycolytic process [GO:0045821]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of lipid biosynthetic process [GO:0046889]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter by glucose [GO:0000432]; regulation of DNA-templated transcription [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; triglyceride homeostasis [GO:0070328] chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667] carbohydrate response element binding [GO:0035538]; DNA binding [GO:0003677]; DNA-binding transcription activator activity [GO:0001216]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription factor binding [GO:0140297]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; protein heterodimerization activity [GO:0046982]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629] g19009.t1 Q9NP71 40.892 269 7.44e-46 182.0 sp|Q9NP71|MLXPL_HUMAN Carbohydrate-responsive element-binding protein OS=Homo sapiens OX=9606 GN=MLXIPL PE=1 SV=1 MLXPL_HUMAN reviewed Carbohydrate-responsive element-binding protein (ChREBP) (Class D basic helix-loop-helix protein 14) (bHLHd14) (MLX interactor) (MLX-interacting protein-like) (WS basic-helix-loop-helix leucine zipper protein) (WS-bHLH) (Williams-Beuren syndrome chromosomal region 14 protein) Homo sapiens (Human) GO:0000432; GO:0000785; GO:0000978; GO:0000981; GO:0001216; GO:0001227; GO:0001228; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0005667; GO:0005737; GO:0005829; GO:0006355; GO:0006357; GO:0008284; GO:0008610; GO:0009653; GO:0010255; GO:0035538; GO:0035774; GO:0042593; GO:0045723; GO:0045821; GO:0045892; GO:0045893; GO:0045944; GO:0046889; GO:0046982; GO:0055089; GO:0061629; GO:0070328; GO:0090324; GO:0097009; GO:0140297; GO:1901797 anatomical structure morphogenesis [GO:0009653]; energy homeostasis [GO:0097009]; fatty acid homeostasis [GO:0055089]; glucose homeostasis [GO:0042593]; glucose mediated signaling pathway [GO:0010255]; lipid biosynthetic process [GO:0008610]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of oxidative phosphorylation [GO:0090324]; negative regulation of signal transduction by p53 class mediator [GO:1901797]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of fatty acid biosynthetic process [GO:0045723]; positive regulation of glycolytic process [GO:0045821]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of lipid biosynthetic process [GO:0046889]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter by glucose [GO:0000432]; regulation of DNA-templated transcription [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; triglyceride homeostasis [GO:0070328] chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667] carbohydrate response element binding [GO:0035538]; DNA binding [GO:0003677]; DNA-binding transcription activator activity [GO:0001216]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription factor binding [GO:0140297]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; protein heterodimerization activity [GO:0046982]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629] g19009.t2 Q9NP71 54.825 228 8.859999999999999e-69 251.0 sp|Q9NP71|MLXPL_HUMAN Carbohydrate-responsive element-binding protein OS=Homo sapiens OX=9606 GN=MLXIPL PE=1 SV=1 MLXPL_HUMAN reviewed Carbohydrate-responsive element-binding protein (ChREBP) (Class D basic helix-loop-helix protein 14) (bHLHd14) (MLX interactor) (MLX-interacting protein-like) (WS basic-helix-loop-helix leucine zipper protein) (WS-bHLH) (Williams-Beuren syndrome chromosomal region 14 protein) Homo sapiens (Human) GO:0000432; GO:0000785; GO:0000978; GO:0000981; GO:0001216; GO:0001227; GO:0001228; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0005667; GO:0005737; GO:0005829; GO:0006355; GO:0006357; GO:0008284; GO:0008610; GO:0009653; GO:0010255; GO:0035538; GO:0035774; GO:0042593; GO:0045723; GO:0045821; GO:0045892; GO:0045893; GO:0045944; GO:0046889; GO:0046982; GO:0055089; GO:0061629; GO:0070328; GO:0090324; GO:0097009; GO:0140297; GO:1901797 anatomical structure morphogenesis [GO:0009653]; energy homeostasis [GO:0097009]; fatty acid homeostasis [GO:0055089]; glucose homeostasis [GO:0042593]; glucose mediated signaling pathway [GO:0010255]; lipid biosynthetic process [GO:0008610]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of oxidative phosphorylation [GO:0090324]; negative regulation of signal transduction by p53 class mediator [GO:1901797]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of fatty acid biosynthetic process [GO:0045723]; positive regulation of glycolytic process [GO:0045821]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of lipid biosynthetic process [GO:0046889]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter by glucose [GO:0000432]; regulation of DNA-templated transcription [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; triglyceride homeostasis [GO:0070328] chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667] carbohydrate response element binding [GO:0035538]; DNA binding [GO:0003677]; DNA-binding transcription activator activity [GO:0001216]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription factor binding [GO:0140297]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; protein heterodimerization activity [GO:0046982]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629] g19009.t2 Q9NP71 40.149 269 9.96e-46 182.0 sp|Q9NP71|MLXPL_HUMAN Carbohydrate-responsive element-binding protein OS=Homo sapiens OX=9606 GN=MLXIPL PE=1 SV=1 MLXPL_HUMAN reviewed Carbohydrate-responsive element-binding protein (ChREBP) (Class D basic helix-loop-helix protein 14) (bHLHd14) (MLX interactor) (MLX-interacting protein-like) (WS basic-helix-loop-helix leucine zipper protein) (WS-bHLH) (Williams-Beuren syndrome chromosomal region 14 protein) Homo sapiens (Human) GO:0000432; GO:0000785; GO:0000978; GO:0000981; GO:0001216; GO:0001227; GO:0001228; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0005667; GO:0005737; GO:0005829; GO:0006355; GO:0006357; GO:0008284; GO:0008610; GO:0009653; GO:0010255; GO:0035538; GO:0035774; GO:0042593; GO:0045723; GO:0045821; GO:0045892; GO:0045893; GO:0045944; GO:0046889; GO:0046982; GO:0055089; GO:0061629; GO:0070328; GO:0090324; GO:0097009; GO:0140297; GO:1901797 anatomical structure morphogenesis [GO:0009653]; energy homeostasis [GO:0097009]; fatty acid homeostasis [GO:0055089]; glucose homeostasis [GO:0042593]; glucose mediated signaling pathway [GO:0010255]; lipid biosynthetic process [GO:0008610]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of oxidative phosphorylation [GO:0090324]; negative regulation of signal transduction by p53 class mediator [GO:1901797]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of fatty acid biosynthetic process [GO:0045723]; positive regulation of glycolytic process [GO:0045821]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of lipid biosynthetic process [GO:0046889]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter by glucose [GO:0000432]; regulation of DNA-templated transcription [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; triglyceride homeostasis [GO:0070328] chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667] carbohydrate response element binding [GO:0035538]; DNA binding [GO:0003677]; DNA-binding transcription activator activity [GO:0001216]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription factor binding [GO:0140297]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; protein heterodimerization activity [GO:0046982]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629] g19012.t1 G1SKF7 59.375 256 1.6e-78 241.0 sp|G1SKF7|RL6_RABIT Large ribosomal subunit protein eL6 OS=Oryctolagus cuniculus OX=9986 GN=RPL6 PE=1 SV=1 g19013.t1 Q6GVH4 53.316 377 1.3900000000000001e-129 404.0 sp|Q6GVH4|GGNB2_CHICK Gametogenetin-binding protein 2 OS=Gallus gallus OX=9031 GN=GGNBP2 PE=2 SV=1 g19014.t1 P62262 57.915 259 3.17e-92 275.0 sp|P62262|1433E_SHEEP 14-3-3 protein epsilon OS=Ovis aries OX=9940 GN=YWHAE PE=1 SV=1 1433E_SHEEP reviewed 14-3-3 protein epsilon (14-3-3E) (Protein kinase C inhibitor protein 1) (KCIP-1) Ovis aries (Sheep) GO:0000165; GO:0001764; GO:0002753; GO:0004864; GO:0005634; GO:0005737; GO:0005783; GO:0005829; GO:0005886; GO:0006605; GO:0006888; GO:0006893; GO:0015459; GO:0019855; GO:0019903; GO:0019904; GO:0021766; GO:0021987; GO:0030007; GO:0031625; GO:0034122; GO:0034123; GO:0034142; GO:0034504; GO:0034605; GO:0035329; GO:0035332; GO:0035591; GO:0042470; GO:0042802; GO:0042826; GO:0044325; GO:0046827; GO:0046982; GO:0050815; GO:0051480; GO:0060306; GO:0070972; GO:0070979; GO:0097110; GO:0140311; GO:1901379; GO:1905913 cellular response to heat [GO:0034605]; cerebral cortex development [GO:0021987]; cytoplasmic pattern recognition receptor signaling pathway [GO:0002753]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi to plasma membrane transport [GO:0006893]; hippo signaling [GO:0035329]; hippocampus development [GO:0021766]; intracellular potassium ion homeostasis [GO:0030007]; MAPK cascade [GO:0000165]; negative regulation of calcium ion export across plasma membrane [GO:1905913]; negative regulation of toll-like receptor signaling pathway [GO:0034122]; neuron migration [GO:0001764]; positive regulation of hippo signaling [GO:0035332]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of toll-like receptor signaling pathway [GO:0034123]; protein K11-linked ubiquitination [GO:0070979]; protein localization to endoplasmic reticulum [GO:0070972]; protein localization to nucleus [GO:0034504]; protein targeting [GO:0006605]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of membrane repolarization [GO:0060306]; regulation of potassium ion transmembrane transport [GO:1901379]; toll-like receptor 4 signaling pathway [GO:0034142] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; melanosome [GO:0042470]; nucleus [GO:0005634]; plasma membrane [GO:0005886] calcium channel inhibitor activity [GO:0019855]; histone deacetylase binding [GO:0042826]; identical protein binding [GO:0042802]; phosphoserine residue binding [GO:0050815]; potassium channel regulator activity [GO:0015459]; protein domain specific binding [GO:0019904]; protein heterodimerization activity [GO:0046982]; protein phosphatase binding [GO:0019903]; protein phosphatase inhibitor activity [GO:0004864]; protein sequestering activity [GO:0140311]; scaffold protein binding [GO:0097110]; signaling adaptor activity [GO:0035591]; transmembrane transporter binding [GO:0044325]; ubiquitin protein ligase binding [GO:0031625] g19014.t2 P62262 58.301 259 1.99e-93 278.0 sp|P62262|1433E_SHEEP 14-3-3 protein epsilon OS=Ovis aries OX=9940 GN=YWHAE PE=1 SV=1 1433E_SHEEP reviewed 14-3-3 protein epsilon (14-3-3E) (Protein kinase C inhibitor protein 1) (KCIP-1) Ovis aries (Sheep) GO:0000165; GO:0001764; GO:0002753; GO:0004864; GO:0005634; GO:0005737; GO:0005783; GO:0005829; GO:0005886; GO:0006605; GO:0006888; GO:0006893; GO:0015459; GO:0019855; GO:0019903; GO:0019904; GO:0021766; GO:0021987; GO:0030007; GO:0031625; GO:0034122; GO:0034123; GO:0034142; GO:0034504; GO:0034605; GO:0035329; GO:0035332; GO:0035591; GO:0042470; GO:0042802; GO:0042826; GO:0044325; GO:0046827; GO:0046982; GO:0050815; GO:0051480; GO:0060306; GO:0070972; GO:0070979; GO:0097110; GO:0140311; GO:1901379; GO:1905913 cellular response to heat [GO:0034605]; cerebral cortex development [GO:0021987]; cytoplasmic pattern recognition receptor signaling pathway [GO:0002753]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi to plasma membrane transport [GO:0006893]; hippo signaling [GO:0035329]; hippocampus development [GO:0021766]; intracellular potassium ion homeostasis [GO:0030007]; MAPK cascade [GO:0000165]; negative regulation of calcium ion export across plasma membrane [GO:1905913]; negative regulation of toll-like receptor signaling pathway [GO:0034122]; neuron migration [GO:0001764]; positive regulation of hippo signaling [GO:0035332]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of toll-like receptor signaling pathway [GO:0034123]; protein K11-linked ubiquitination [GO:0070979]; protein localization to endoplasmic reticulum [GO:0070972]; protein localization to nucleus [GO:0034504]; protein targeting [GO:0006605]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of membrane repolarization [GO:0060306]; regulation of potassium ion transmembrane transport [GO:1901379]; toll-like receptor 4 signaling pathway [GO:0034142] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; melanosome [GO:0042470]; nucleus [GO:0005634]; plasma membrane [GO:0005886] calcium channel inhibitor activity [GO:0019855]; histone deacetylase binding [GO:0042826]; identical protein binding [GO:0042802]; phosphoserine residue binding [GO:0050815]; potassium channel regulator activity [GO:0015459]; protein domain specific binding [GO:0019904]; protein heterodimerization activity [GO:0046982]; protein phosphatase binding [GO:0019903]; protein phosphatase inhibitor activity [GO:0004864]; protein sequestering activity [GO:0140311]; scaffold protein binding [GO:0097110]; signaling adaptor activity [GO:0035591]; transmembrane transporter binding [GO:0044325]; ubiquitin protein ligase binding [GO:0031625] g19015.t1 Q20655 54.545 253 1.6000000000000001e-87 271.0 sp|Q20655|14332_CAEEL 14-3-3-like protein 2 OS=Caenorhabditis elegans OX=6239 GN=ftt-2 PE=1 SV=1 14332_CAEEL reviewed 14-3-3-like protein 2 Caenorhabditis elegans GO:0005634; GO:0005737; GO:0007165; GO:0008104; GO:0010468; GO:0010629; GO:0040024; GO:0042308; GO:0051457; GO:0140297; GO:0140311 dauer larval development [GO:0040024]; intracellular protein localization [GO:0008104]; maintenance of protein location in nucleus [GO:0051457]; negative regulation of gene expression [GO:0010629]; negative regulation of protein import into nucleus [GO:0042308]; regulation of gene expression [GO:0010468]; signal transduction [GO:0007165] cytoplasm [GO:0005737]; nucleus [GO:0005634] DNA-binding transcription factor binding [GO:0140297]; protein sequestering activity [GO:0140311] g19015.t1 Q20655 62.019 208 7.68e-84 262.0 sp|Q20655|14332_CAEEL 14-3-3-like protein 2 OS=Caenorhabditis elegans OX=6239 GN=ftt-2 PE=1 SV=1 14332_CAEEL reviewed 14-3-3-like protein 2 Caenorhabditis elegans GO:0005634; GO:0005737; GO:0007165; GO:0008104; GO:0010468; GO:0010629; GO:0040024; GO:0042308; GO:0051457; GO:0140297; GO:0140311 dauer larval development [GO:0040024]; intracellular protein localization [GO:0008104]; maintenance of protein location in nucleus [GO:0051457]; negative regulation of gene expression [GO:0010629]; negative regulation of protein import into nucleus [GO:0042308]; regulation of gene expression [GO:0010468]; signal transduction [GO:0007165] cytoplasm [GO:0005737]; nucleus [GO:0005634] DNA-binding transcription factor binding [GO:0140297]; protein sequestering activity [GO:0140311] g19016.t1 P62262 73.016 252 5.3000000000000004e-129 369.0 sp|P62262|1433E_SHEEP 14-3-3 protein epsilon OS=Ovis aries OX=9940 GN=YWHAE PE=1 SV=1 1433E_SHEEP reviewed 14-3-3 protein epsilon (14-3-3E) (Protein kinase C inhibitor protein 1) (KCIP-1) Ovis aries (Sheep) GO:0000165; GO:0001764; GO:0002753; GO:0004864; GO:0005634; GO:0005737; GO:0005783; GO:0005829; GO:0005886; GO:0006605; GO:0006888; GO:0006893; GO:0015459; GO:0019855; GO:0019903; GO:0019904; GO:0021766; GO:0021987; GO:0030007; GO:0031625; GO:0034122; GO:0034123; GO:0034142; GO:0034504; GO:0034605; GO:0035329; GO:0035332; GO:0035591; GO:0042470; GO:0042802; GO:0042826; GO:0044325; GO:0046827; GO:0046982; GO:0050815; GO:0051480; GO:0060306; GO:0070972; GO:0070979; GO:0097110; GO:0140311; GO:1901379; GO:1905913 cellular response to heat [GO:0034605]; cerebral cortex development [GO:0021987]; cytoplasmic pattern recognition receptor signaling pathway [GO:0002753]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi to plasma membrane transport [GO:0006893]; hippo signaling [GO:0035329]; hippocampus development [GO:0021766]; intracellular potassium ion homeostasis [GO:0030007]; MAPK cascade [GO:0000165]; negative regulation of calcium ion export across plasma membrane [GO:1905913]; negative regulation of toll-like receptor signaling pathway [GO:0034122]; neuron migration [GO:0001764]; positive regulation of hippo signaling [GO:0035332]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of toll-like receptor signaling pathway [GO:0034123]; protein K11-linked ubiquitination [GO:0070979]; protein localization to endoplasmic reticulum [GO:0070972]; protein localization to nucleus [GO:0034504]; protein targeting [GO:0006605]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of membrane repolarization [GO:0060306]; regulation of potassium ion transmembrane transport [GO:1901379]; toll-like receptor 4 signaling pathway [GO:0034142] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; melanosome [GO:0042470]; nucleus [GO:0005634]; plasma membrane [GO:0005886] calcium channel inhibitor activity [GO:0019855]; histone deacetylase binding [GO:0042826]; identical protein binding [GO:0042802]; phosphoserine residue binding [GO:0050815]; potassium channel regulator activity [GO:0015459]; protein domain specific binding [GO:0019904]; protein heterodimerization activity [GO:0046982]; protein phosphatase binding [GO:0019903]; protein phosphatase inhibitor activity [GO:0004864]; protein sequestering activity [GO:0140311]; scaffold protein binding [GO:0097110]; signaling adaptor activity [GO:0035591]; transmembrane transporter binding [GO:0044325]; ubiquitin protein ligase binding [GO:0031625] g19017.t1 Q9H6U6 43.969 257 3.78e-37 144.0 sp|Q9H6U6|BCAS3_HUMAN BCAS3 microtubule associated cell migration factor OS=Homo sapiens OX=9606 GN=BCAS3 PE=1 SV=3 BCAS3_HUMAN reviewed BCAS3 microtubule associated cell migration factor (Breast carcinoma-amplified sequence 3) (GAOB1) Homo sapiens (Human) GO:0000407; GO:0000791; GO:0001525; GO:0003682; GO:0005634; GO:0005737; GO:0005881; GO:0006914; GO:0007267; GO:0010595; GO:0010698; GO:0016922; GO:0031252; GO:0032956; GO:0035035; GO:0035091; GO:0042393; GO:0042594; GO:0043085; GO:0043627; GO:0045111; GO:0045944; GO:0048487; GO:0071391 angiogenesis [GO:0001525]; autophagy [GO:0006914]; cell-cell signaling [GO:0007267]; cellular response to estrogen stimulus [GO:0071391]; positive regulation of catalytic activity [GO:0043085]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of actin cytoskeleton organization [GO:0032956]; response to estrogen [GO:0043627]; response to starvation [GO:0042594] cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; cytoplasmic microtubule [GO:0005881]; euchromatin [GO:0000791]; intermediate filament cytoskeleton [GO:0045111]; nucleus [GO:0005634]; phagophore assembly site [GO:0000407] acetyltransferase activator activity [GO:0010698]; beta-tubulin binding [GO:0048487]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; histone binding [GO:0042393]; nuclear receptor binding [GO:0016922]; phosphatidylinositol binding [GO:0035091] g19017.t2 Q9H6U6 43.969 257 4.24e-37 144.0 sp|Q9H6U6|BCAS3_HUMAN BCAS3 microtubule associated cell migration factor OS=Homo sapiens OX=9606 GN=BCAS3 PE=1 SV=3 BCAS3_HUMAN reviewed BCAS3 microtubule associated cell migration factor (Breast carcinoma-amplified sequence 3) (GAOB1) Homo sapiens (Human) GO:0000407; GO:0000791; GO:0001525; GO:0003682; GO:0005634; GO:0005737; GO:0005881; GO:0006914; GO:0007267; GO:0010595; GO:0010698; GO:0016922; GO:0031252; GO:0032956; GO:0035035; GO:0035091; GO:0042393; GO:0042594; GO:0043085; GO:0043627; GO:0045111; GO:0045944; GO:0048487; GO:0071391 angiogenesis [GO:0001525]; autophagy [GO:0006914]; cell-cell signaling [GO:0007267]; cellular response to estrogen stimulus [GO:0071391]; positive regulation of catalytic activity [GO:0043085]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of actin cytoskeleton organization [GO:0032956]; response to estrogen [GO:0043627]; response to starvation [GO:0042594] cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; cytoplasmic microtubule [GO:0005881]; euchromatin [GO:0000791]; intermediate filament cytoskeleton [GO:0045111]; nucleus [GO:0005634]; phagophore assembly site [GO:0000407] acetyltransferase activator activity [GO:0010698]; beta-tubulin binding [GO:0048487]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; histone binding [GO:0042393]; nuclear receptor binding [GO:0016922]; phosphatidylinositol binding [GO:0035091] g19018.t1 Q9H6U6 45.593 590 6.69e-135 419.0 sp|Q9H6U6|BCAS3_HUMAN BCAS3 microtubule associated cell migration factor OS=Homo sapiens OX=9606 GN=BCAS3 PE=1 SV=3 BCAS3_HUMAN reviewed BCAS3 microtubule associated cell migration factor (Breast carcinoma-amplified sequence 3) (GAOB1) Homo sapiens (Human) GO:0000407; GO:0000791; GO:0001525; GO:0003682; GO:0005634; GO:0005737; GO:0005881; GO:0006914; GO:0007267; GO:0010595; GO:0010698; GO:0016922; GO:0031252; GO:0032956; GO:0035035; GO:0035091; GO:0042393; GO:0042594; GO:0043085; GO:0043627; GO:0045111; GO:0045944; GO:0048487; GO:0071391 angiogenesis [GO:0001525]; autophagy [GO:0006914]; cell-cell signaling [GO:0007267]; cellular response to estrogen stimulus [GO:0071391]; positive regulation of catalytic activity [GO:0043085]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of actin cytoskeleton organization [GO:0032956]; response to estrogen [GO:0043627]; response to starvation [GO:0042594] cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; cytoplasmic microtubule [GO:0005881]; euchromatin [GO:0000791]; intermediate filament cytoskeleton [GO:0045111]; nucleus [GO:0005634]; phagophore assembly site [GO:0000407] acetyltransferase activator activity [GO:0010698]; beta-tubulin binding [GO:0048487]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; histone binding [GO:0042393]; nuclear receptor binding [GO:0016922]; phosphatidylinositol binding [GO:0035091] g19022.t1 Q14254 68.483 422 1.39e-176 503.0 sp|Q14254|FLOT2_HUMAN Flotillin-2 OS=Homo sapiens OX=9606 GN=FLOT2 PE=1 SV=2 g19024.t1 Q810B6 58.764 1181 0.0 1368.0 sp|Q810B6|ANFY1_MOUSE Rabankyrin-5 OS=Mus musculus OX=10090 GN=Ankfy1 PE=1 SV=2 ANFY1_MOUSE reviewed Ankyrin repeat and FYVE domain-containing protein 1 (Ankyrin repeats hooked to a zinc finger motif) (Rab5-binding and ankyrin repeats-containing protein) (Rabankyrin-5) (Rank-5) Mus musculus (Mouse) GO:0005768; GO:0005769; GO:0005829; GO:0006897; GO:0008270; GO:0010008; GO:0016020; GO:0016197; GO:0030904; GO:0031267; GO:0034058; GO:0042147; GO:0044354; GO:0048549; GO:0090160; GO:1901981 endocytosis [GO:0006897]; endosomal transport [GO:0016197]; endosomal vesicle fusion [GO:0034058]; Golgi to lysosome transport [GO:0090160]; positive regulation of pinocytosis [GO:0048549]; retrograde transport, endosome to Golgi [GO:0042147] cytosol [GO:0005829]; early endosome [GO:0005769]; endosome [GO:0005768]; endosome membrane [GO:0010008]; macropinosome [GO:0044354]; membrane [GO:0016020]; retromer complex [GO:0030904] phosphatidylinositol phosphate binding [GO:1901981]; small GTPase binding [GO:0031267]; zinc ion binding [GO:0008270] g19024.t2 Q810B6 57.45 1208 0.0 1355.0 sp|Q810B6|ANFY1_MOUSE Rabankyrin-5 OS=Mus musculus OX=10090 GN=Ankfy1 PE=1 SV=2 ANFY1_MOUSE reviewed Ankyrin repeat and FYVE domain-containing protein 1 (Ankyrin repeats hooked to a zinc finger motif) (Rab5-binding and ankyrin repeats-containing protein) (Rabankyrin-5) (Rank-5) Mus musculus (Mouse) GO:0005768; GO:0005769; GO:0005829; GO:0006897; GO:0008270; GO:0010008; GO:0016020; GO:0016197; GO:0030904; GO:0031267; GO:0034058; GO:0042147; GO:0044354; GO:0048549; GO:0090160; GO:1901981 endocytosis [GO:0006897]; endosomal transport [GO:0016197]; endosomal vesicle fusion [GO:0034058]; Golgi to lysosome transport [GO:0090160]; positive regulation of pinocytosis [GO:0048549]; retrograde transport, endosome to Golgi [GO:0042147] cytosol [GO:0005829]; early endosome [GO:0005769]; endosome [GO:0005768]; endosome membrane [GO:0010008]; macropinosome [GO:0044354]; membrane [GO:0016020]; retromer complex [GO:0030904] phosphatidylinositol phosphate binding [GO:1901981]; small GTPase binding [GO:0031267]; zinc ion binding [GO:0008270] g19026.t1 Q4KMP7 59.882 339 6.03e-151 463.0 sp|Q4KMP7|TB10B_HUMAN TBC1 domain family member 10B OS=Homo sapiens OX=9606 GN=TBC1D10B PE=1 SV=3 TB10B_HUMAN reviewed TBC1 domain family member 10B (Rab27A-GAP-beta) Homo sapiens (Human) GO:0005096; GO:0005829; GO:0005886; GO:0042147; GO:0043087 regulation of GTPase activity [GO:0043087]; retrograde transport, endosome to Golgi [GO:0042147] cytosol [GO:0005829]; plasma membrane [GO:0005886] GTPase activator activity [GO:0005096] g19027.t1 O70305 35.897 234 2.68e-31 137.0 sp|O70305|ATX2_MOUSE Ataxin-2 OS=Mus musculus OX=10090 GN=Atxn2 PE=1 SV=1 ATX2_MOUSE reviewed Ataxin-2 (Spinocerebellar ataxia type 2 protein homolog) Mus musculus (Mouse) GO:0002091; GO:0003729; GO:0005154; GO:0005737; GO:0005794; GO:0005802; GO:0005829; GO:0010494; GO:0021702; GO:0033962; GO:0034063; GO:0040015; GO:0048471; GO:0048812; GO:0048872; GO:0050905; GO:1990904 cerebellar Purkinje cell differentiation [GO:0021702]; homeostasis of number of cells [GO:0048872]; negative regulation of multicellular organism growth [GO:0040015]; negative regulation of receptor internalization [GO:0002091]; neuromuscular process [GO:0050905]; neuron projection morphogenesis [GO:0048812]; P-body assembly [GO:0033962]; stress granule assembly [GO:0034063] cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; perinuclear region of cytoplasm [GO:0048471]; ribonucleoprotein complex [GO:1990904]; trans-Golgi network [GO:0005802] epidermal growth factor receptor binding [GO:0005154]; mRNA binding [GO:0003729] g19027.t2 O70305 35.897 234 2.79e-31 137.0 sp|O70305|ATX2_MOUSE Ataxin-2 OS=Mus musculus OX=10090 GN=Atxn2 PE=1 SV=1 ATX2_MOUSE reviewed Ataxin-2 (Spinocerebellar ataxia type 2 protein homolog) Mus musculus (Mouse) GO:0002091; GO:0003729; GO:0005154; GO:0005737; GO:0005794; GO:0005802; GO:0005829; GO:0010494; GO:0021702; GO:0033962; GO:0034063; GO:0040015; GO:0048471; GO:0048812; GO:0048872; GO:0050905; GO:1990904 cerebellar Purkinje cell differentiation [GO:0021702]; homeostasis of number of cells [GO:0048872]; negative regulation of multicellular organism growth [GO:0040015]; negative regulation of receptor internalization [GO:0002091]; neuromuscular process [GO:0050905]; neuron projection morphogenesis [GO:0048812]; P-body assembly [GO:0033962]; stress granule assembly [GO:0034063] cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; perinuclear region of cytoplasm [GO:0048471]; ribonucleoprotein complex [GO:1990904]; trans-Golgi network [GO:0005802] epidermal growth factor receptor binding [GO:0005154]; mRNA binding [GO:0003729] g19030.t1 Q04678 57.075 212 2.24e-83 264.0 sp|Q04678|SSRP1_CHICK FACT complex subunit SSRP1 OS=Gallus gallus OX=9031 GN=SSRP1 PE=2 SV=2 g19031.t1 Q04678 52.381 378 1.1e-118 367.0 sp|Q04678|SSRP1_CHICK FACT complex subunit SSRP1 OS=Gallus gallus OX=9031 GN=SSRP1 PE=2 SV=2 g19033.t1 A4IHK6 45.455 385 2.18e-84 270.0 sp|A4IHK6|LAT4_XENTR Large neutral amino acids transporter small subunit 4 OS=Xenopus tropicalis OX=8364 GN=slc43a2 PE=2 SV=1 LAT4_XENTR reviewed Large neutral amino acids transporter small subunit 4 (L-type amino acid transporter 4) (Solute carrier family 43 member 2) Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0015188; GO:0015190; GO:0015191; GO:0015192; GO:0015818; GO:0015820; GO:0015821; GO:0015823; GO:0016323 isoleucine transport [GO:0015818]; L-leucine transport [GO:0015820]; methionine transport [GO:0015821]; phenylalanine transport [GO:0015823] basolateral plasma membrane [GO:0016323] L-isoleucine transmembrane transporter activity [GO:0015188]; L-leucine transmembrane transporter activity [GO:0015190]; L-methionine transmembrane transporter activity [GO:0015191]; L-phenylalanine transmembrane transporter activity [GO:0015192] g19034.t1 Q0VCM6 51.875 160 2.38e-38 144.0 sp|Q0VCM6|LAT4_BOVIN Large neutral amino acids transporter small subunit 4 OS=Bos taurus OX=9913 GN=SLC43A2 PE=2 SV=1 LAT4_BOVIN reviewed Large neutral amino acids transporter small subunit 4 (L-type amino acid transporter 4) (Solute carrier family 43 member 2) Bos taurus (Bovine) GO:0015175; GO:0015179; GO:0015188; GO:0015190; GO:0015191; GO:0015192; GO:0015804; GO:0015818; GO:0015820; GO:0015821; GO:0015823; GO:0016323 isoleucine transport [GO:0015818]; L-leucine transport [GO:0015820]; methionine transport [GO:0015821]; neutral amino acid transport [GO:0015804]; phenylalanine transport [GO:0015823] basolateral plasma membrane [GO:0016323] L-amino acid transmembrane transporter activity [GO:0015179]; L-isoleucine transmembrane transporter activity [GO:0015188]; L-leucine transmembrane transporter activity [GO:0015190]; L-methionine transmembrane transporter activity [GO:0015191]; L-phenylalanine transmembrane transporter activity [GO:0015192]; neutral L-amino acid transmembrane transporter activity [GO:0015175] g19035.t1 Q8NBI5 40.223 179 1.63e-30 120.0 sp|Q8NBI5|S43A3_HUMAN Equilibrative nucleobase transporter 1 OS=Homo sapiens OX=9606 GN=SLC43A3 PE=1 SV=2 S43A3_HUMAN reviewed Equilibrative nucleobase transporter 1 (Protein FOAP-13) (Solute carrier family 43 member 3) Homo sapiens (Human) GO:0015207; GO:0015208; GO:0015245; GO:0016323; GO:0035344; GO:0042910 hypoxanthine transport [GO:0035344] basolateral plasma membrane [GO:0016323] adenine transmembrane transporter activity [GO:0015207]; fatty acid transmembrane transporter activity [GO:0015245]; guanine transmembrane transporter activity [GO:0015208]; xenobiotic transmembrane transporter activity [GO:0042910] g19036.t1 Q1JPD8 36.327 245 1.1900000000000002e-37 149.0 sp|Q1JPD8|S43A3_BOVIN Equilibrative nucleobase transporter 1 OS=Bos taurus OX=9913 GN=SLC43A3 PE=2 SV=1 g19040.t2 P86854 32.432 148 7.38e-21 88.2 sp|P86854|PLCL_MYTGA Perlucin-like protein OS=Mytilus galloprovincialis OX=29158 PE=1 SV=1 g19041.t2 Q5SSG5 47.368 95 7.56e-27 102.0 sp|Q5SSG5|RSLAB_MOUSE Ras-like protein family member 10B OS=Mus musculus OX=10090 GN=Rasl10b PE=1 SV=1 RSLAB_MOUSE reviewed Ras-like protein family member 10B (EC 3.6.5.2) Mus musculus (Mouse) GO:0003050; GO:0003925; GO:0005525; GO:0005886; GO:0090277 positive regulation of peptide hormone secretion [GO:0090277]; regulation of systemic arterial blood pressure by atrial natriuretic peptide [GO:0003050] plasma membrane [GO:0005886] G protein activity [GO:0003925]; GTP binding [GO:0005525] g19041.t3 Q5SSG5 36.875 160 7.890000000000001e-31 115.0 sp|Q5SSG5|RSLAB_MOUSE Ras-like protein family member 10B OS=Mus musculus OX=10090 GN=Rasl10b PE=1 SV=1 RSLAB_MOUSE reviewed Ras-like protein family member 10B (EC 3.6.5.2) Mus musculus (Mouse) GO:0003050; GO:0003925; GO:0005525; GO:0005886; GO:0090277 positive regulation of peptide hormone secretion [GO:0090277]; regulation of systemic arterial blood pressure by atrial natriuretic peptide [GO:0003050] plasma membrane [GO:0005886] G protein activity [GO:0003925]; GTP binding [GO:0005525] g19045.t1 P06027 43.056 144 1.21e-34 121.0 sp|P06027|LECE_HELCR Echinoidin OS=Heliocidaris crassispina OX=1043166 PE=1 SV=1 g19046.t1 Q8WPD0 35.673 171 1.1100000000000001e-29 109.0 sp|Q8WPD0|LECG_PATPE Alpha-N-acetylgalactosamine-specific lectin OS=Patiria pectinifera OX=7594 PE=1 SV=1 g19047.t1 Q8WPD0 39.655 174 1.9e-32 116.0 sp|Q8WPD0|LECG_PATPE Alpha-N-acetylgalactosamine-specific lectin OS=Patiria pectinifera OX=7594 PE=1 SV=1 g19050.t1 Q8WYQ5 44.009 459 4.79e-106 339.0 sp|Q8WYQ5|DGCR8_HUMAN Microprocessor complex subunit DGCR8 OS=Homo sapiens OX=9606 GN=DGCR8 PE=1 SV=1 DGCR8_HUMAN reviewed Microprocessor complex subunit DGCR8 (DiGeorge syndrome critical region 8) Homo sapiens (Human) GO:0003725; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0006974; GO:0014069; GO:0016604; GO:0020037; GO:0030674; GO:0031053; GO:0035861; GO:0042802; GO:0042803; GO:0046872; GO:0070877; GO:0070878; GO:0072091; GO:0098978; GO:0140517; GO:2000633 DNA damage response [GO:0006974]; positive regulation of pre-miRNA processing [GO:2000633]; primary miRNA processing [GO:0031053]; regulation of stem cell proliferation [GO:0072091] cytoplasm [GO:0005737]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; microprocessor complex [GO:0070877]; nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]; site of double-strand break [GO:0035861] double-stranded RNA binding [GO:0003725]; heme binding [GO:0020037]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; primary miRNA binding [GO:0070878]; protein homodimerization activity [GO:0042803]; protein-macromolecule adaptor activity [GO:0030674]; protein-RNA adaptor activity [GO:0140517] g19053.t1 Q9HA64 60.645 310 7.91e-137 392.0 sp|Q9HA64|KT3K_HUMAN Ketosamine-3-kinase OS=Homo sapiens OX=9606 GN=FN3KRP PE=1 SV=2 g19055.t1 Q14CX7 37.854 988 0.0 649.0 sp|Q14CX7|NAA25_HUMAN N-alpha-acetyltransferase 25, NatB auxiliary subunit OS=Homo sapiens OX=9606 GN=NAA25 PE=1 SV=1 NAA25_HUMAN reviewed N-alpha-acetyltransferase 25, NatB auxiliary subunit (Mitochondrial distribution and morphology protein 20) (N-terminal acetyltransferase B complex subunit MDM20) (NatB complex subunit MDM20) (N-terminal acetyltransferase B complex subunit NAA25) (p120) Homo sapiens (Human) GO:0005737; GO:0005794; GO:0005829; GO:0007010; GO:0010698; GO:0031416 cytoskeleton organization [GO:0007010] cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; NatB complex [GO:0031416] acetyltransferase activator activity [GO:0010698] g19056.t1 Q3ZBL5 61.628 172 1.8400000000000002e-73 221.0 sp|Q3ZBL5|PTH2_BOVIN Peptidyl-tRNA hydrolase 2, mitochondrial OS=Bos taurus OX=9913 GN=PTRH2 PE=2 SV=1 g19057.t1 O97524 53.191 611 0.0 612.0 sp|O97524|BGLR_FELCA Beta-glucuronidase OS=Felis catus OX=9685 GN=GUSB PE=1 SV=1 g19058.t1 Q8NHM5 43.902 205 1.01e-49 176.0 sp|Q8NHM5|KDM2B_HUMAN Lysine-specific demethylase 2B OS=Homo sapiens OX=9606 GN=KDM2B PE=1 SV=1 KDM2B_HUMAN reviewed Lysine-specific demethylase 2B (EC 1.14.11.27) (CXXC-type zinc finger protein 2) (F-box and leucine-rich repeat protein 10) (F-box protein FBL10) (F-box/LRR-repeat protein 10) (JmjC domain-containing histone demethylation protein 1B) (Jumonji domain-containing EMSY-interactor methyltransferase motif protein) (Protein JEMMA) (Protein-containing CXXC domain 2) ([Histone-H3]-lysine-36 demethylase 1B) Homo sapiens (Human) GO:0000122; GO:0000978; GO:0003677; GO:0003712; GO:0005634; GO:0005654; GO:0005694; GO:0005730; GO:0006338; GO:0006357; GO:0007283; GO:0008270; GO:0019843; GO:0021555; GO:0021592; GO:0021670; GO:0021678; GO:0021993; GO:0030307; GO:0030900; GO:0030901; GO:0030902; GO:0031519; GO:0032452; GO:0043524; GO:0045322; GO:0048596; GO:0051864; GO:0140680; GO:1902459; GO:2000178 chromatin remodeling [GO:0006338]; embryonic camera-type eye morphogenesis [GO:0048596]; forebrain development [GO:0030900]; fourth ventricle development [GO:0021592]; hindbrain development [GO:0030902]; initiation of neural tube closure [GO:0021993]; lateral ventricle development [GO:0021670]; midbrain development [GO:0030901]; midbrain-hindbrain boundary morphogenesis [GO:0021555]; negative regulation of neural precursor cell proliferation [GO:2000178]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell growth [GO:0030307]; positive regulation of stem cell population maintenance [GO:1902459]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]; third ventricle development [GO:0021678] chromosome [GO:0005694]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PcG protein complex [GO:0031519] DNA binding [GO:0003677]; histone demethylase activity [GO:0032452]; histone H3K36 demethylase activity [GO:0051864]; histone H3K36me/H3K36me2 demethylase activity [GO:0140680]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; rRNA binding [GO:0019843]; transcription coregulator activity [GO:0003712]; unmethylated CpG binding [GO:0045322]; zinc ion binding [GO:0008270] g19060.t1 Q5U263 65.988 344 9.93e-159 492.0 sp|Q5U263|KDM2A_XENTR Lysine-specific demethylase 2A OS=Xenopus tropicalis OX=8364 GN=kdm2a PE=2 SV=1 g19061.t1 Q8BH10 58.654 208 2.1e-71 220.0 sp|Q8BH10|ORAI2_MOUSE Protein orai-2 OS=Mus musculus OX=10090 GN=Orai2 PE=2 SV=1 g19066.t1 Q9MYM7 38.053 226 1.3799999999999999e-52 179.0 sp|Q9MYM7|B3GT1_PONPY Beta-1,3-galactosyltransferase 1 OS=Pongo pygmaeus OX=9600 GN=B3GALT1 PE=3 SV=1 g19068.t1 Q9VBW3 46.154 325 4.44e-89 298.0 sp|Q9VBW3|CAD96_DROME Tyrosine kinase receptor Cad96Ca OS=Drosophila melanogaster OX=7227 GN=Cad96Ca PE=2 SV=2 CAD96_DROME reviewed Tyrosine kinase receptor Cad96Ca (EC 2.7.10.1) (Cadherin-96Ca) (Tyrosine kinase receptor HD-14) Drosophila melanogaster (Fruit fly) GO:0004713; GO:0004714; GO:0005509; GO:0005524; GO:0005886; GO:0006468; GO:0007030; GO:0007156; GO:0007169; GO:0016339; GO:0042060; GO:0043235; GO:0045177; GO:0045792; GO:0051897; GO:0090303 calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; Golgi organization [GO:0007030]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell size [GO:0045792]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of wound healing [GO:0090303]; protein phosphorylation [GO:0006468]; wound healing [GO:0042060] apical part of cell [GO:0045177]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; protein tyrosine kinase activity [GO:0004713]; transmembrane receptor protein tyrosine kinase activity [GO:0004714] g19070.t1 Q2PC93 29.924 1310 6.38e-141 504.0 sp|Q2PC93|SSPO_CHICK SCO-spondin OS=Gallus gallus OX=9031 GN=SSPO PE=2 SV=1 g19072.t1 Q9MYM7 35.526 228 1.12e-48 170.0 sp|Q9MYM7|B3GT1_PONPY Beta-1,3-galactosyltransferase 1 OS=Pongo pygmaeus OX=9600 GN=B3GALT1 PE=3 SV=1 g19073.t1 Q9MYM7 33.197 244 4.67e-48 168.0 sp|Q9MYM7|B3GT1_PONPY Beta-1,3-galactosyltransferase 1 OS=Pongo pygmaeus OX=9600 GN=B3GALT1 PE=3 SV=1 g19074.t1 Q9UJX3 46.986 564 2.52e-158 467.0 sp|Q9UJX3|APC7_HUMAN Anaphase-promoting complex subunit 7 OS=Homo sapiens OX=9606 GN=ANAPC7 PE=1 SV=5 APC7_HUMAN reviewed Anaphase-promoting complex subunit 7 (APC7) (Cyclosome subunit 7) Homo sapiens (Human) GO:0000792; GO:0005634; GO:0005654; GO:0005680; GO:0005819; GO:0005829; GO:0007346; GO:0007420; GO:0015630; GO:0016567; GO:0019903; GO:0031145; GO:0045171; GO:0045842; GO:0051301; GO:0051445; GO:0070936; GO:0070979; GO:0072686; GO:0140767; GO:0141198 anaphase-promoting complex-dependent catabolic process [GO:0031145]; brain development [GO:0007420]; cell division [GO:0051301]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; protein branched polyubiquitination [GO:0141198]; protein K11-linked ubiquitination [GO:0070979]; protein K48-linked ubiquitination [GO:0070936]; protein ubiquitination [GO:0016567]; regulation of meiotic cell cycle [GO:0051445]; regulation of mitotic cell cycle [GO:0007346] anaphase-promoting complex [GO:0005680]; cytosol [GO:0005829]; heterochromatin [GO:0000792]; intercellular bridge [GO:0045171]; microtubule cytoskeleton [GO:0015630]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819] enzyme-substrate adaptor activity [GO:0140767]; protein phosphatase binding [GO:0019903] g19076.t1 A3KGZ2 52.347 277 1.43e-106 317.0 sp|A3KGZ2|OGFD2_DANRE 2-oxoglutarate and iron-dependent oxygenase domain-containing protein 2 OS=Danio rerio OX=7955 GN=ogfod2 PE=2 SV=1 g19077.t1 Q8WPD0 42.254 142 5.2e-31 112.0 sp|Q8WPD0|LECG_PATPE Alpha-N-acetylgalactosamine-specific lectin OS=Patiria pectinifera OX=7594 PE=1 SV=1 g19080.t1 Q8WPD0 39.08 174 5.5800000000000005e-33 118.0 sp|Q8WPD0|LECG_PATPE Alpha-N-acetylgalactosamine-specific lectin OS=Patiria pectinifera OX=7594 PE=1 SV=1 g19081.t1 Q8WPD0 40.351 171 6.38e-35 123.0 sp|Q8WPD0|LECG_PATPE Alpha-N-acetylgalactosamine-specific lectin OS=Patiria pectinifera OX=7594 PE=1 SV=1 g19083.t1 Q8WPD0 36.932 176 3.33e-29 108.0 sp|Q8WPD0|LECG_PATPE Alpha-N-acetylgalactosamine-specific lectin OS=Patiria pectinifera OX=7594 PE=1 SV=1 g19084.t1 Q8WPD0 37.931 174 7.55e-31 112.0 sp|Q8WPD0|LECG_PATPE Alpha-N-acetylgalactosamine-specific lectin OS=Patiria pectinifera OX=7594 PE=1 SV=1 g19086.t1 P06027 37.5 144 7.1e-28 104.0 sp|P06027|LECE_HELCR Echinoidin OS=Heliocidaris crassispina OX=1043166 PE=1 SV=1 g19087.t1 P06027 37.5 144 1.4000000000000002e-27 103.0 sp|P06027|LECE_HELCR Echinoidin OS=Heliocidaris crassispina OX=1043166 PE=1 SV=1 g19089.t1 P98073 58.824 68 2.9199999999999997e-23 94.4 sp|P98073|ENTK_HUMAN Enteropeptidase OS=Homo sapiens OX=9606 GN=TMPRSS15 PE=1 SV=3 ENTK_HUMAN reviewed Enteropeptidase (EC 3.4.21.9) (Enterokinase) (Serine protease 7) (Transmembrane protease serine 15) [Cleaved into: Enteropeptidase non-catalytic heavy chain; Enteropeptidase catalytic light chain] Homo sapiens (Human) GO:0004252; GO:0005903; GO:0006508; GO:0008236; GO:0016020 proteolysis [GO:0006508] brush border [GO:0005903]; membrane [GO:0016020] serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236] g19090.t1 Q8BIK6 32.646 291 1.14e-27 119.0 sp|Q8BIK6|TMPS7_MOUSE Transmembrane protease serine 7 OS=Mus musculus OX=10090 GN=Tmprss7 PE=1 SV=3 TMPS7_MOUSE reviewed Transmembrane protease serine 7 (EC 3.4.21.-) (Matriptase-3) Mus musculus (Mouse) GO:0004252; GO:0005886; GO:0006508; GO:0008236 proteolysis [GO:0006508] plasma membrane [GO:0005886] serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236] g19091.t1 Q64264 34.595 370 2.75e-63 219.0 sp|Q64264|5HT1A_MOUSE 5-hydroxytryptamine receptor 1A OS=Mus musculus OX=10090 GN=Htr1a PE=2 SV=2 5HT1A_MOUSE reviewed 5-hydroxytryptamine receptor 1A (5-HT-1A) (5-HT1A) (Serotonin receptor 1A) Mus musculus (Mouse) GO:0001586; GO:0001662; GO:0001965; GO:0004993; GO:0005102; GO:0005886; GO:0007186; GO:0007187; GO:0007198; GO:0007210; GO:0007214; GO:0007268; GO:0014053; GO:0014062; GO:0019229; GO:0030425; GO:0030594; GO:0031117; GO:0035640; GO:0042053; GO:0042428; GO:0042734; GO:0043025; GO:0043203; GO:0046883; GO:0051378; GO:0060259; GO:0071625; GO:0090722; GO:0097114; GO:0098982; GO:0099171; GO:0099589 adenylate cyclase-inhibiting serotonin receptor signaling pathway [GO:0007198]; behavioral fear response [GO:0001662]; chemical synaptic transmission [GO:0007268]; exploration behavior [GO:0035640]; G protein-coupled receptor signaling pathway [GO:0007186]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; gamma-aminobutyric acid signaling pathway [GO:0007214]; negative regulation of gamma-aminobutyric acid secretion [GO:0014053]; NMDA glutamate receptor clustering [GO:0097114]; positive regulation of microtubule depolymerization [GO:0031117]; presynaptic modulation of chemical synaptic transmission [GO:0099171]; regulation of dopamine metabolic process [GO:0042053]; regulation of feeding behavior [GO:0060259]; regulation of hormone secretion [GO:0046883]; regulation of serotonin secretion [GO:0014062]; regulation of vasoconstriction [GO:0019229]; serotonin metabolic process [GO:0042428]; serotonin receptor signaling pathway [GO:0007210]; vocalization behavior [GO:0071625] axon hillock [GO:0043203]; dendrite [GO:0030425]; GABA-ergic synapse [GO:0098982]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734] G protein-coupled serotonin receptor activity [GO:0004993]; G-protein alpha-subunit binding [GO:0001965]; Gi/o-coupled serotonin receptor activity [GO:0001586]; neurotransmitter receptor activity [GO:0030594]; receptor-receptor interaction [GO:0090722]; serotonin binding [GO:0051378]; serotonin receptor activity [GO:0099589]; signaling receptor binding [GO:0005102] g19092.t1 Q3T0J3 53.333 225 1.3899999999999999e-68 215.0 sp|Q3T0J3|RM16_BOVIN Large ribosomal subunit protein uL16m OS=Bos taurus OX=9913 GN=MRPL16 PE=1 SV=1 g19093.t1 Q9W0E3 29.942 521 1.86e-48 189.0 sp|Q9W0E3|IML1_DROME GATOR complex protein Iml1 OS=Drosophila melanogaster OX=7227 GN=Iml1 PE=1 SV=2 IML1_DROME reviewed GATOR complex protein Iml1 (Increased minichromosome loss 1) Drosophila melanogaster (Fruit fly) GO:0005096; GO:0005764; GO:0005765; GO:0010508; GO:0032007; GO:0034198; GO:0035859; GO:0045792; GO:0048142; GO:0051321; GO:0051729; GO:1904262; GO:1990130 cellular response to amino acid starvation [GO:0034198]; germarium-derived cystoblast division [GO:0048142]; germline cell cycle switching, mitotic to meiotic cell cycle [GO:0051729]; meiotic cell cycle [GO:0051321]; negative regulation of cell size [GO:0045792]; negative regulation of TOR signaling [GO:0032007]; negative regulation of TORC1 signaling [GO:1904262]; positive regulation of autophagy [GO:0010508] GATOR1 complex [GO:1990130]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; Seh1-associated complex [GO:0035859] GTPase activator activity [GO:0005096] g19093.t2 O75140 41.699 259 8.66e-45 177.0 sp|O75140|DEPD5_HUMAN GATOR1 complex protein DEPDC5 OS=Homo sapiens OX=9606 GN=DEPDC5 PE=1 SV=2 DEPD5_HUMAN reviewed GATOR1 complex protein DEPDC5 (DEP domain-containing protein 5) Homo sapiens (Human) GO:0005096; GO:0005764; GO:0005765; GO:0005829; GO:0010508; GO:0031267; GO:0034198; GO:0035556; GO:0044877; GO:0048471; GO:1904262; GO:1990130 cellular response to amino acid starvation [GO:0034198]; intracellular signal transduction [GO:0035556]; negative regulation of TORC1 signaling [GO:1904262]; positive regulation of autophagy [GO:0010508] cytosol [GO:0005829]; GATOR1 complex [GO:1990130]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; perinuclear region of cytoplasm [GO:0048471] GTPase activator activity [GO:0005096]; protein-containing complex binding [GO:0044877]; small GTPase binding [GO:0031267] g19094.t1 P61460 38.182 220 8.94e-36 137.0 sp|P61460|DEPD5_MOUSE GATOR1 complex protein DEPDC5 OS=Mus musculus OX=10090 GN=Depdc5 PE=1 SV=2 DEPD5_MOUSE reviewed GATOR1 complex protein DEPDC5 (DEP domain-containing protein 5) Mus musculus (Mouse) GO:0002181; GO:0005096; GO:0005764; GO:0005765; GO:0005829; GO:0010508; GO:0031267; GO:0031463; GO:0031669; GO:0034198; GO:0038202; GO:0044877; GO:0045947; GO:0045948; GO:0048471; GO:0061462; GO:1904262; GO:1904263; GO:1990130 cellular response to amino acid starvation [GO:0034198]; cellular response to nutrient levels [GO:0031669]; cytoplasmic translation [GO:0002181]; negative regulation of TORC1 signaling [GO:1904262]; negative regulation of translational initiation [GO:0045947]; positive regulation of autophagy [GO:0010508]; positive regulation of TORC1 signaling [GO:1904263]; positive regulation of translational initiation [GO:0045948]; protein localization to lysosome [GO:0061462]; TORC1 signaling [GO:0038202] Cul3-RING ubiquitin ligase complex [GO:0031463]; cytosol [GO:0005829]; GATOR1 complex [GO:1990130]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; perinuclear region of cytoplasm [GO:0048471] GTPase activator activity [GO:0005096]; protein-containing complex binding [GO:0044877]; small GTPase binding [GO:0031267] g19095.t1 Q5T1A1 27.797 590 3.98e-57 216.0 sp|Q5T1A1|DCST2_HUMAN DC-STAMP domain-containing protein 2 OS=Homo sapiens OX=9606 GN=DCST2 PE=1 SV=2 g19097.t1 Q96I76 34.271 391 4.18e-49 176.0 sp|Q96I76|GPTC3_HUMAN G patch domain-containing protein 3 OS=Homo sapiens OX=9606 GN=GPATCH3 PE=1 SV=1 g19098.t1 Q96I76 47.468 158 5.8e-38 139.0 sp|Q96I76|GPTC3_HUMAN G patch domain-containing protein 3 OS=Homo sapiens OX=9606 GN=GPATCH3 PE=1 SV=1 g19105.t1 Q8N0U8 44.318 176 7.419999999999999e-52 166.0 sp|Q8N0U8|VKORL_HUMAN Vitamin K epoxide reductase complex subunit 1-like protein 1 OS=Homo sapiens OX=9606 GN=VKORC1L1 PE=1 SV=2 VKORL_HUMAN reviewed Vitamin K epoxide reductase complex subunit 1-like protein 1 (VKORC1-like protein 1) (EC 1.17.4.4) Homo sapiens (Human) GO:0005783; GO:0005789; GO:0017187; GO:0034599; GO:0042373; GO:0047057; GO:0048038 cellular response to oxidative stress [GO:0034599]; peptidyl-glutamic acid carboxylation [GO:0017187]; vitamin K metabolic process [GO:0042373] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789] quinone binding [GO:0048038]; vitamin-K-epoxide reductase (warfarin-sensitive) activity [GO:0047057] g19107.t1 Q13164 56.818 352 4.69e-132 425.0 sp|Q13164|MK07_HUMAN Mitogen-activated protein kinase 7 OS=Homo sapiens OX=9606 GN=MAPK7 PE=1 SV=2 MK07_HUMAN reviewed Mitogen-activated protein kinase 7 (MAP kinase 7) (MAPK 7) (EC 2.7.11.24) (Big MAP kinase 1) (BMK-1) (Extracellular signal-regulated kinase 5) (ERK-5) Homo sapiens (Human) GO:0000165; GO:0004674; GO:0004707; GO:0004857; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007165; GO:0007189; GO:0016605; GO:0030154; GO:0033173; GO:0034115; GO:0034392; GO:0035556; GO:0045765; GO:0045944; GO:0050728; GO:0051019; GO:0051247; GO:0060761; GO:0070301; GO:0070885; GO:0071363; GO:0071499; GO:0071560; GO:0106310; GO:1902176; GO:2000352; GO:2001240 adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; calcineurin-NFAT signaling cascade [GO:0033173]; cell differentiation [GO:0030154]; cellular response to growth factor stimulus [GO:0071363]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to laminar fluid shear stress [GO:0071499]; cellular response to transforming growth factor beta stimulus [GO:0071560]; intracellular signal transduction [GO:0035556]; MAPK cascade [GO:0000165]; negative regulation of calcineurin-NFAT signaling cascade [GO:0070885]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; negative regulation of heterotypic cell-cell adhesion [GO:0034115]; negative regulation of inflammatory response [GO:0050728]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of response to cytokine stimulus [GO:0060761]; negative regulation of smooth muscle cell apoptotic process [GO:0034392]; positive regulation of protein metabolic process [GO:0051247]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of angiogenesis [GO:0045765]; signal transduction [GO:0007165] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605] ATP binding [GO:0005524]; enzyme inhibitor activity [GO:0004857]; MAP kinase activity [GO:0004707]; mitogen-activated protein kinase binding [GO:0051019]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g19110.t1 Q8BZ39 27.576 330 1.4100000000000001e-22 102.0 sp|Q8BZ39|NMUR2_MOUSE Neuromedin-U receptor 2 OS=Mus musculus OX=10090 GN=Nmur2 PE=2 SV=1 g19119.t1 Q6DRL5 30.014 713 4.550000000000001e-72 261.0 sp|Q6DRL5|MBB1A_DANRE Myb-binding protein 1A-like protein OS=Danio rerio OX=7955 GN=mybbp1a PE=1 SV=1 MBB1A_DANRE reviewed Myb-binding protein 1A-like protein Danio rerio (Zebrafish) (Brachydanio rerio) GO:0003714; GO:0005730; GO:0043565; GO:0048511 rhythmic process [GO:0048511] nucleolus [GO:0005730] sequence-specific DNA binding [GO:0043565]; transcription corepressor activity [GO:0003714] g19120.t1 Q5RBR8 67.416 89 1.57e-34 124.0 sp|Q5RBR8|IF4H_PONAB Eukaryotic translation initiation factor 4H OS=Pongo abelii OX=9601 GN=EIF4H PE=2 SV=1 g19125.t1 Q6ZM63 64.103 273 3.51e-133 381.0 sp|Q6ZM63|GPN3_DANRE GPN-loop GTPase 3 OS=Danio rerio OX=7955 GN=gpn3 PE=2 SV=2 g19126.t1 Q9JM76 65.169 178 9.15e-83 245.0 sp|Q9JM76|ARPC3_MOUSE Actin-related protein 2/3 complex subunit 3 OS=Mus musculus OX=10090 GN=Arpc3 PE=1 SV=3 g19127.t1 Q0EEE2 43.219 553 3.73e-144 444.0 sp|Q0EEE2|PTHD3_MOUSE Patched domain-containing protein 3 OS=Mus musculus OX=10090 GN=Ptchd3 PE=1 SV=1 PTHD3_MOUSE reviewed Patched domain-containing protein 3 (RND-type protein RNDEu-3) Mus musculus (Mouse) GO:0005783; GO:0005789; GO:0016020; GO:0097225 endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; sperm midpiece [GO:0097225] g19129.t1 Q0EEE2 38.308 851 0.0 554.0 sp|Q0EEE2|PTHD3_MOUSE Patched domain-containing protein 3 OS=Mus musculus OX=10090 GN=Ptchd3 PE=1 SV=1 PTHD3_MOUSE reviewed Patched domain-containing protein 3 (RND-type protein RNDEu-3) Mus musculus (Mouse) GO:0005783; GO:0005789; GO:0016020; GO:0097225 endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; sperm midpiece [GO:0097225] g19130.t1 M0R3Q7 60.952 105 1.14e-31 122.0 sp|M0R3Q7|PTHD3_RAT Patched domain-containing protein 3 OS=Rattus norvegicus OX=10116 GN=Ptchd3 PE=1 SV=1 g19131.t1 Q0EEE2 33.631 672 2.01e-102 337.0 sp|Q0EEE2|PTHD3_MOUSE Patched domain-containing protein 3 OS=Mus musculus OX=10090 GN=Ptchd3 PE=1 SV=1 PTHD3_MOUSE reviewed Patched domain-containing protein 3 (RND-type protein RNDEu-3) Mus musculus (Mouse) GO:0005783; GO:0005789; GO:0016020; GO:0097225 endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; sperm midpiece [GO:0097225] g19132.t1 C8VJR7 32.508 1212 3.82e-149 523.0 sp|C8VJR7|ALNA_EMENI Highly reducing polyketide synthase alnA OS=Emericella nidulans (strain FGSC A4 / ATCC 38163 / CBS 112.46 / NRRL 194 / M139) OX=227321 GN=alnA PE=1 SV=1 ALNA_EMENI reviewed Highly reducing polyketide synthase alnA (EC 2.3.1.-) (Asperlin biosynthesis cluster protein A) Emericella nidulans (strain FGSC A4 / ATCC 38163 / CBS 112.46 / NRRL 194 / M139) (Aspergillus nidulans) GO:0004312; GO:0004315; GO:0006633; GO:0016491; GO:0019748; GO:0030639; GO:0031177; GO:0044550 fatty acid biosynthetic process [GO:0006633]; polyketide biosynthetic process [GO:0030639]; secondary metabolic process [GO:0019748]; secondary metabolite biosynthetic process [GO:0044550] 3-oxoacyl-[acyl-carrier-protein] synthase activity [GO:0004315]; fatty acid synthase activity [GO:0004312]; oxidoreductase activity [GO:0016491]; phosphopantetheine binding [GO:0031177] g19133.t1 Q0EEE2 28.77 504 1.1899999999999999e-55 202.0 sp|Q0EEE2|PTHD3_MOUSE Patched domain-containing protein 3 OS=Mus musculus OX=10090 GN=Ptchd3 PE=1 SV=1 PTHD3_MOUSE reviewed Patched domain-containing protein 3 (RND-type protein RNDEu-3) Mus musculus (Mouse) GO:0005783; GO:0005789; GO:0016020; GO:0097225 endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; sperm midpiece [GO:0097225] g19134.t1 Q0EEE2 33.4 503 8.46e-77 262.0 sp|Q0EEE2|PTHD3_MOUSE Patched domain-containing protein 3 OS=Mus musculus OX=10090 GN=Ptchd3 PE=1 SV=1 PTHD3_MOUSE reviewed Patched domain-containing protein 3 (RND-type protein RNDEu-3) Mus musculus (Mouse) GO:0005783; GO:0005789; GO:0016020; GO:0097225 endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; sperm midpiece [GO:0097225] g19135.t1 M0R3Q7 45.756 271 1.4300000000000002e-73 248.0 sp|M0R3Q7|PTHD3_RAT Patched domain-containing protein 3 OS=Rattus norvegicus OX=10116 GN=Ptchd3 PE=1 SV=1 g19136.t1 Q0EEE2 42.545 503 3.64e-137 424.0 sp|Q0EEE2|PTHD3_MOUSE Patched domain-containing protein 3 OS=Mus musculus OX=10090 GN=Ptchd3 PE=1 SV=1 PTHD3_MOUSE reviewed Patched domain-containing protein 3 (RND-type protein RNDEu-3) Mus musculus (Mouse) GO:0005783; GO:0005789; GO:0016020; GO:0097225 endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; sperm midpiece [GO:0097225] g19137.t1 Q0EEE2 42.744 503 2.05e-138 434.0 sp|Q0EEE2|PTHD3_MOUSE Patched domain-containing protein 3 OS=Mus musculus OX=10090 GN=Ptchd3 PE=1 SV=1 PTHD3_MOUSE reviewed Patched domain-containing protein 3 (RND-type protein RNDEu-3) Mus musculus (Mouse) GO:0005783; GO:0005789; GO:0016020; GO:0097225 endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; sperm midpiece [GO:0097225] g19138.t1 Q0EEE2 35.581 801 5.4e-158 486.0 sp|Q0EEE2|PTHD3_MOUSE Patched domain-containing protein 3 OS=Mus musculus OX=10090 GN=Ptchd3 PE=1 SV=1 PTHD3_MOUSE reviewed Patched domain-containing protein 3 (RND-type protein RNDEu-3) Mus musculus (Mouse) GO:0005783; GO:0005789; GO:0016020; GO:0097225 endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; sperm midpiece [GO:0097225] g19139.t1 Q0EEE2 36.235 850 4.49e-178 543.0 sp|Q0EEE2|PTHD3_MOUSE Patched domain-containing protein 3 OS=Mus musculus OX=10090 GN=Ptchd3 PE=1 SV=1 PTHD3_MOUSE reviewed Patched domain-containing protein 3 (RND-type protein RNDEu-3) Mus musculus (Mouse) GO:0005783; GO:0005789; GO:0016020; GO:0097225 endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; sperm midpiece [GO:0097225] g19142.t1 Q03132 31.109 1154 4.21e-143 506.0 sp|Q03132|ERYA2_SACER Erythronolide synthase EryA2 OS=Saccharopolyspora erythraea OX=1836 GN=eryA PE=1 SV=3 g19142.t1 Q03132 34.365 905 2.2400000000000002e-132 471.0 sp|Q03132|ERYA2_SACER Erythronolide synthase EryA2 OS=Saccharopolyspora erythraea OX=1836 GN=eryA PE=1 SV=3 g19143.t1 P46196 81.686 344 0.0 563.0 sp|P46196|MK01_BOVIN Mitogen-activated protein kinase 1 OS=Bos taurus OX=9913 GN=MAPK1 PE=2 SV=3 g19144.t1 Q0VGK4 41.935 310 7.22e-74 233.0 sp|Q0VGK4|GDPD1_RAT Lysophospholipase D GDPD1 OS=Rattus norvegicus OX=10116 GN=Gdpd1 PE=2 SV=1 GDPD1_RAT reviewed Lysophospholipase D GDPD1 (EC 3.1.4.-) (Glycerophosphodiester phosphodiesterase 4) (Glycerophosphodiester phosphodiesterase domain-containing protein 1) Rattus norvegicus (Rat) GO:0004622; GO:0005783; GO:0005789; GO:0006644; GO:0008081; GO:0016020; GO:0046475; GO:0046872; GO:0048471; GO:0070291 glycerophospholipid catabolic process [GO:0046475]; N-acylethanolamine metabolic process [GO:0070291]; phospholipid metabolic process [GO:0006644] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471] metal ion binding [GO:0046872]; phosphatidylcholine lysophospholipase activity [GO:0004622]; phosphoric diester hydrolase activity [GO:0008081] g19145.t1 Q5XI31 42.366 524 1.97e-119 366.0 sp|Q5XI31|PIGS_RAT GPI-anchor transamidase component PIGS OS=Rattus norvegicus OX=10116 GN=Pigs PE=2 SV=3 g19146.t1 Q9QZ67 53.71 283 3.39e-96 311.0 sp|Q9QZ67|PPM1D_MOUSE Protein phosphatase 1D OS=Mus musculus OX=10090 GN=Ppm1d PE=2 SV=2 PPM1D_MOUSE reviewed Protein phosphatase 1D (EC 3.1.3.16) (Protein phosphatase 2C isoform delta) (PP2C-delta) (Protein phosphatase magnesium-dependent 1 delta) (p53-induced protein phosphatase 1) Mus musculus (Mouse) GO:0000086; GO:0004722; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0006346; GO:0009267; GO:0009617; GO:0030330; GO:0045814; GO:0046872; GO:0051019; GO:1902531 cellular response to starvation [GO:0009267]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; DNA methylation-dependent constitutive heterochromatin formation [GO:0006346]; G2/M transition of mitotic cell cycle [GO:0000086]; negative regulation of gene expression, epigenetic [GO:0045814]; regulation of intracellular signal transduction [GO:1902531]; response to bacterium [GO:0009617] cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] metal ion binding [GO:0046872]; mitogen-activated protein kinase binding [GO:0051019]; protein serine/threonine phosphatase activity [GO:0004722] g19147.t1 P40937 78.882 322 0.0 553.0 sp|P40937|RFC5_HUMAN Replication factor C subunit 5 OS=Homo sapiens OX=9606 GN=RFC5 PE=1 SV=1 RFC5_HUMAN reviewed Replication factor C subunit 5 (Activator 1 36 kDa subunit) (A1 36 kDa subunit) (Activator 1 subunit 5) (Replication factor C 36 kDa subunit) (RF-C 36 kDa subunit) (RFC36) Homo sapiens (Human) GO:0003677; GO:0005524; GO:0005634; GO:0005654; GO:0005663; GO:0006260; GO:0006261; GO:0006281; GO:0016887; GO:0019899; GO:0031390; GO:1900264 DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA-templated DNA replication [GO:0006261]; positive regulation of DNA-directed DNA polymerase activity [GO:1900264] Ctf18 RFC-like complex [GO:0031390]; DNA replication factor C complex [GO:0005663]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA binding [GO:0003677]; enzyme binding [GO:0019899] g19148.t1 Q6VAB6 45.013 391 1.1200000000000001e-100 340.0 sp|Q6VAB6|KSR2_HUMAN Kinase suppressor of Ras 2 OS=Homo sapiens OX=9606 GN=KSR2 PE=1 SV=2 KSR2_HUMAN reviewed Kinase suppressor of Ras 2 (hKSR2) (EC 2.7.11.1) Homo sapiens (Human) GO:0004672; GO:0004674; GO:0005078; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0007265; GO:0008270; GO:0019722; GO:0031434; GO:0043410; GO:0106310; GO:0120162 calcium-mediated signaling [GO:0019722]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of MAPK cascade [GO:0043410]; Ras protein signal transduction [GO:0007265] cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886] ATP binding [GO:0005524]; MAP-kinase scaffold activity [GO:0005078]; mitogen-activated protein kinase kinase binding [GO:0031434]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; zinc ion binding [GO:0008270] g19148.t2 Q6VAB6 45.57 395 7.61e-101 339.0 sp|Q6VAB6|KSR2_HUMAN Kinase suppressor of Ras 2 OS=Homo sapiens OX=9606 GN=KSR2 PE=1 SV=2 KSR2_HUMAN reviewed Kinase suppressor of Ras 2 (hKSR2) (EC 2.7.11.1) Homo sapiens (Human) GO:0004672; GO:0004674; GO:0005078; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0007265; GO:0008270; GO:0019722; GO:0031434; GO:0043410; GO:0106310; GO:0120162 calcium-mediated signaling [GO:0019722]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of MAPK cascade [GO:0043410]; Ras protein signal transduction [GO:0007265] cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886] ATP binding [GO:0005524]; MAP-kinase scaffold activity [GO:0005078]; mitogen-activated protein kinase kinase binding [GO:0031434]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; zinc ion binding [GO:0008270] g19149.t1 Q9W4K2 25.431 464 2.05e-22 103.0 sp|Q9W4K2|Y3556_DROME Uncharacterized protein CG3556 OS=Drosophila melanogaster OX=7227 GN=CG3556 PE=2 SV=1 g19152.t1 P61406 43.114 1002 0.0 682.0 sp|P61406|EST1A_MOUSE Telomerase-binding protein EST1A OS=Mus musculus OX=10090 GN=Smg6 PE=1 SV=1 EST1A_MOUSE reviewed Telomerase-binding protein EST1A (EC 3.1.-.-) (Ever shorter telomeres 1A) (Nonsense mediated mRNA decay factor SMG6) (Smg-6 homolog) Mus musculus (Mouse) GO:0000184; GO:0000781; GO:0003723; GO:0004521; GO:0005634; GO:0005697; GO:0005730; GO:0005737; GO:0005829; GO:0005886; GO:0016787; GO:0032204; GO:0035145; GO:0036064; GO:0042162; GO:0043021; GO:0046872; GO:0070034; GO:0070182; GO:1904354 negative regulation of telomere capping [GO:1904354]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; regulation of telomere maintenance [GO:0032204] chromosome, telomeric region [GO:0000781]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; exon-exon junction complex [GO:0035145]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; telomerase holoenzyme complex [GO:0005697] DNA polymerase binding [GO:0070182]; hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]; ribonucleoprotein complex binding [GO:0043021]; RNA binding [GO:0003723]; RNA endonuclease activity [GO:0004521]; telomerase RNA binding [GO:0070034]; telomeric DNA binding [GO:0042162] g19152.t2 P61406 43.214 1002 0.0 692.0 sp|P61406|EST1A_MOUSE Telomerase-binding protein EST1A OS=Mus musculus OX=10090 GN=Smg6 PE=1 SV=1 EST1A_MOUSE reviewed Telomerase-binding protein EST1A (EC 3.1.-.-) (Ever shorter telomeres 1A) (Nonsense mediated mRNA decay factor SMG6) (Smg-6 homolog) Mus musculus (Mouse) GO:0000184; GO:0000781; GO:0003723; GO:0004521; GO:0005634; GO:0005697; GO:0005730; GO:0005737; GO:0005829; GO:0005886; GO:0016787; GO:0032204; GO:0035145; GO:0036064; GO:0042162; GO:0043021; GO:0046872; GO:0070034; GO:0070182; GO:1904354 negative regulation of telomere capping [GO:1904354]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; regulation of telomere maintenance [GO:0032204] chromosome, telomeric region [GO:0000781]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; exon-exon junction complex [GO:0035145]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; telomerase holoenzyme complex [GO:0005697] DNA polymerase binding [GO:0070182]; hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]; ribonucleoprotein complex binding [GO:0043021]; RNA binding [GO:0003723]; RNA endonuclease activity [GO:0004521]; telomerase RNA binding [GO:0070034]; telomeric DNA binding [GO:0042162] g19153.t1 P69079 100.0 136 1.54e-95 274.0 sp|P69079|H3_STRDR Histone H3, embryonic OS=Strongylocentrotus droebachiensis OX=7671 PE=2 SV=2 g19155.t1 Q9H0G5 58.794 199 1.59e-34 137.0 sp|Q9H0G5|NSRP1_HUMAN Nuclear speckle splicing regulatory protein 1 OS=Homo sapiens OX=9606 GN=NSRP1 PE=1 SV=1 g19156.t1 Q54PZ6 25.952 289 3.12e-23 107.0 sp|Q54PZ6|Y5897_DICDI Putative uncharacterized protein DDB_G0284213 OS=Dictyostelium discoideum OX=44689 GN=DDB_G0284213 PE=4 SV=2 g19157.t1 Q8CJB9 65.13 347 1.1999999999999999e-139 446.0 sp|Q8CJB9|BRE1B_RAT E3 ubiquitin-protein ligase BRE1B OS=Rattus norvegicus OX=10116 GN=Rnf40 PE=1 SV=1 BRE1B_RAT reviewed E3 ubiquitin-protein ligase BRE1B (BRE1-B) (EC 2.3.2.27) (RING finger protein 40) (RING-type E3 ubiquitin transferase BRE1B) (Syntaxin-1-interacting RING finger protein) (Protein staring) Rattus norvegicus (Rat) GO:0000151; GO:0003730; GO:0004842; GO:0005634; GO:0005654; GO:0006325; GO:0006511; GO:0008270; GO:0016567; GO:0017075; GO:0031624; GO:0031625; GO:0032991; GO:0033503; GO:0042803; GO:0043434; GO:0045944; GO:0061630; GO:1901800; GO:1902916 chromatin organization [GO:0006325]; positive regulation of proteasomal protein catabolic process [GO:1901800]; positive regulation of protein polyubiquitination [GO:1902916]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein ubiquitination [GO:0016567]; response to peptide hormone [GO:0043434]; ubiquitin-dependent protein catabolic process [GO:0006511] HULC complex [GO:0033503]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; ubiquitin ligase complex [GO:0000151] mRNA 3'-UTR binding [GO:0003730]; protein homodimerization activity [GO:0042803]; syntaxin-1 binding [GO:0017075]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] g19157.t1 Q8CJB9 47.619 357 2.91e-85 299.0 sp|Q8CJB9|BRE1B_RAT E3 ubiquitin-protein ligase BRE1B OS=Rattus norvegicus OX=10116 GN=Rnf40 PE=1 SV=1 BRE1B_RAT reviewed E3 ubiquitin-protein ligase BRE1B (BRE1-B) (EC 2.3.2.27) (RING finger protein 40) (RING-type E3 ubiquitin transferase BRE1B) (Syntaxin-1-interacting RING finger protein) (Protein staring) Rattus norvegicus (Rat) GO:0000151; GO:0003730; GO:0004842; GO:0005634; GO:0005654; GO:0006325; GO:0006511; GO:0008270; GO:0016567; GO:0017075; GO:0031624; GO:0031625; GO:0032991; GO:0033503; GO:0042803; GO:0043434; GO:0045944; GO:0061630; GO:1901800; GO:1902916 chromatin organization [GO:0006325]; positive regulation of proteasomal protein catabolic process [GO:1901800]; positive regulation of protein polyubiquitination [GO:1902916]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein ubiquitination [GO:0016567]; response to peptide hormone [GO:0043434]; ubiquitin-dependent protein catabolic process [GO:0006511] HULC complex [GO:0033503]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; ubiquitin ligase complex [GO:0000151] mRNA 3'-UTR binding [GO:0003730]; protein homodimerization activity [GO:0042803]; syntaxin-1 binding [GO:0017075]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] g19157.t1 Q8CJB9 49.02 102 2.9100000000000002e-21 103.0 sp|Q8CJB9|BRE1B_RAT E3 ubiquitin-protein ligase BRE1B OS=Rattus norvegicus OX=10116 GN=Rnf40 PE=1 SV=1 BRE1B_RAT reviewed E3 ubiquitin-protein ligase BRE1B (BRE1-B) (EC 2.3.2.27) (RING finger protein 40) (RING-type E3 ubiquitin transferase BRE1B) (Syntaxin-1-interacting RING finger protein) (Protein staring) Rattus norvegicus (Rat) GO:0000151; GO:0003730; GO:0004842; GO:0005634; GO:0005654; GO:0006325; GO:0006511; GO:0008270; GO:0016567; GO:0017075; GO:0031624; GO:0031625; GO:0032991; GO:0033503; GO:0042803; GO:0043434; GO:0045944; GO:0061630; GO:1901800; GO:1902916 chromatin organization [GO:0006325]; positive regulation of proteasomal protein catabolic process [GO:1901800]; positive regulation of protein polyubiquitination [GO:1902916]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein ubiquitination [GO:0016567]; response to peptide hormone [GO:0043434]; ubiquitin-dependent protein catabolic process [GO:0006511] HULC complex [GO:0033503]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; ubiquitin ligase complex [GO:0000151] mRNA 3'-UTR binding [GO:0003730]; protein homodimerization activity [GO:0042803]; syntaxin-1 binding [GO:0017075]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] g19158.t1 Q6NS38 54.113 231 2.21e-88 267.0 sp|Q6NS38|ALKB2_HUMAN DNA oxidative demethylase ALKBH2 OS=Homo sapiens OX=9606 GN=ALKBH2 PE=1 SV=1 ALKB2_HUMAN reviewed DNA oxidative demethylase ALKBH2 (EC 1.14.11.33) (Alkylated DNA repair protein alkB homolog 2) (Alpha-ketoglutarate-dependent dioxygenase alkB homolog 2) (Oxy DC1) Homo sapiens (Human) GO:0000182; GO:0005634; GO:0005654; GO:0005730; GO:0006307; GO:0008198; GO:0035516; GO:0051747 DNA alkylation repair [GO:0006307] nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] broad specificity oxidative DNA demethylase activity [GO:0035516]; cytosine C-5 DNA demethylase activity [GO:0051747]; ferrous iron binding [GO:0008198]; rDNA binding [GO:0000182] g19159.t1 P23443 65.302 464 0.0 555.0 sp|P23443|KS6B1_HUMAN Ribosomal protein S6 kinase beta-1 OS=Homo sapiens OX=9606 GN=RPS6KB1 PE=1 SV=2 KS6B1_HUMAN reviewed Ribosomal protein S6 kinase beta-1 (S6K-beta-1) (S6K1) (EC 2.7.11.1) (70 kDa ribosomal protein S6 kinase 1) (P70S6K1) (p70-S6K 1) (Ribosomal protein S6 kinase I) (Serine/threonine-protein kinase 14A) (p70 ribosomal S6 kinase alpha) (p70 S6 kinase alpha) (p70 S6K-alpha) (p70 S6KA) Homo sapiens (Human) GO:0000082; GO:0001662; GO:0004672; GO:0004674; GO:0004712; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005741; GO:0005829; GO:0006915; GO:0007165; GO:0007281; GO:0018105; GO:0031667; GO:0031670; GO:0031929; GO:0032869; GO:0038202; GO:0043005; GO:0043066; GO:0044539; GO:0045727; GO:0045931; GO:0045948; GO:0046627; GO:0048015; GO:0050804; GO:0071346; GO:0071363; GO:0071549; GO:0098978; GO:0106310; GO:1903940; GO:1904263; GO:2001237 apoptotic process [GO:0006915]; behavioral fear response [GO:0001662]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to growth factor stimulus [GO:0071363]; cellular response to insulin stimulus [GO:0032869]; cellular response to nutrient [GO:0031670]; cellular response to type II interferon [GO:0071346]; G1/S transition of mitotic cell cycle [GO:0000082]; germ cell development [GO:0007281]; long-chain fatty acid import into cell [GO:0044539]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of apoptotic process [GO:0043066]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of TORC2 signaling [GO:1903940]; peptidyl-serine phosphorylation [GO:0018105]; phosphatidylinositol-mediated signaling [GO:0048015]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of TORC1 signaling [GO:1904263]; positive regulation of translation [GO:0045727]; positive regulation of translational initiation [GO:0045948]; response to nutrient levels [GO:0031667]; signal transduction [GO:0007165]; TOR signaling [GO:0031929]; TORC1 signaling [GO:0038202] cytoplasm [GO:0005737]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712] g19160.t1 Q32L19 61.463 205 3.37e-87 258.0 sp|Q32L19|MND1_BOVIN Meiotic nuclear division protein 1 homolog OS=Bos taurus OX=9913 GN=MND1 PE=2 SV=1 g19164.t1 Q9FJ09 30.241 291 3.8200000000000005e-27 113.0 sp|Q9FJ09|IMPA5_ARATH Importin subunit alpha-5 OS=Arabidopsis thaliana OX=3702 GN=IMPA5 PE=2 SV=1 g19167.t1 Q76I76 51.805 471 6.44e-149 491.0 sp|Q76I76|SSH2_HUMAN Protein phosphatase Slingshot homolog 2 OS=Homo sapiens OX=9606 GN=SSH2 PE=1 SV=1 SSH2_HUMAN reviewed Protein phosphatase Slingshot homolog 2 (EC 3.1.3.16) (EC 3.1.3.48) (SSH-like protein 2) (SSH-2L) (hSSH-2L) Homo sapiens (Human) GO:0001669; GO:0003779; GO:0004721; GO:0004722; GO:0004725; GO:0005615; GO:0005737; GO:0005856; GO:0005925; GO:0006470; GO:0007283; GO:0030036; GO:0030154; GO:0030837 actin cytoskeleton organization [GO:0030036]; cell differentiation [GO:0030154]; negative regulation of actin filament polymerization [GO:0030837]; protein dephosphorylation [GO:0006470]; spermatogenesis [GO:0007283] acrosomal vesicle [GO:0001669]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; extracellular space [GO:0005615]; focal adhesion [GO:0005925] actin binding [GO:0003779]; phosphoprotein phosphatase activity [GO:0004721]; protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine phosphatase activity [GO:0004725] g19168.t1 A4FU69 40.48 709 3.57e-152 506.0 sp|A4FU69|EFCB5_HUMAN EF-hand calcium-binding domain-containing protein 5 OS=Homo sapiens OX=9606 GN=EFCAB5 PE=1 SV=3 EFCB5_HUMAN reviewed EF-hand calcium-binding domain-containing protein 5 Homo sapiens (Human) GO:0005509 calcium ion binding [GO:0005509] g19168.t1 A4FU69 35.739 291 1.43e-38 162.0 sp|A4FU69|EFCB5_HUMAN EF-hand calcium-binding domain-containing protein 5 OS=Homo sapiens OX=9606 GN=EFCAB5 PE=1 SV=3 EFCB5_HUMAN reviewed EF-hand calcium-binding domain-containing protein 5 Homo sapiens (Human) GO:0005509 calcium ion binding [GO:0005509] g19168.t2 A4FU69 41.935 682 8.190000000000001e-156 515.0 sp|A4FU69|EFCB5_HUMAN EF-hand calcium-binding domain-containing protein 5 OS=Homo sapiens OX=9606 GN=EFCAB5 PE=1 SV=3 EFCB5_HUMAN reviewed EF-hand calcium-binding domain-containing protein 5 Homo sapiens (Human) GO:0005509 calcium ion binding [GO:0005509] g19168.t2 A4FU69 35.739 291 1.66e-38 161.0 sp|A4FU69|EFCB5_HUMAN EF-hand calcium-binding domain-containing protein 5 OS=Homo sapiens OX=9606 GN=EFCAB5 PE=1 SV=3 EFCB5_HUMAN reviewed EF-hand calcium-binding domain-containing protein 5 Homo sapiens (Human) GO:0005509 calcium ion binding [GO:0005509] g19168.t3 A4FU69 41.935 682 3.43e-160 504.0 sp|A4FU69|EFCB5_HUMAN EF-hand calcium-binding domain-containing protein 5 OS=Homo sapiens OX=9606 GN=EFCAB5 PE=1 SV=3 EFCB5_HUMAN reviewed EF-hand calcium-binding domain-containing protein 5 Homo sapiens (Human) GO:0005509 calcium ion binding [GO:0005509] g19168.t4 A4FU69 35.739 291 5.34e-40 162.0 sp|A4FU69|EFCB5_HUMAN EF-hand calcium-binding domain-containing protein 5 OS=Homo sapiens OX=9606 GN=EFCAB5 PE=1 SV=3 EFCB5_HUMAN reviewed EF-hand calcium-binding domain-containing protein 5 Homo sapiens (Human) GO:0005509 calcium ion binding [GO:0005509] g19171.t1 Q8K1T0 40.4 250 8.09e-50 183.0 sp|Q8K1T0|TMPS3_MOUSE Transmembrane protease serine 3 OS=Mus musculus OX=10090 GN=Tmprss3 PE=1 SV=2 TMPS3_MOUSE reviewed Transmembrane protease serine 3 (EC 3.4.21.-) Mus musculus (Mouse) GO:0004252; GO:0005783; GO:0005789; GO:0006508; GO:0006883; GO:0007605; GO:0008236; GO:0017080; GO:0043025 intracellular sodium ion homeostasis [GO:0006883]; proteolysis [GO:0006508]; sensory perception of sound [GO:0007605] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; neuronal cell body [GO:0043025] serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]; sodium channel regulator activity [GO:0017080] g19172.t1 P70277 34.694 245 6.29e-36 138.0 sp|P70277|SIA7B_MOUSE Alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 2 OS=Mus musculus OX=10090 GN=St6galnac2 PE=1 SV=2 SIA7B_MOUSE reviewed Alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 2 (EC 2.4.3.3) (Gal-beta-1,3-GalNAc alpha-2,6-sialyltransferase) (GalNAc alpha-2,6-sialyltransferase II) (ST6GalNAc II) (ST6GalNAcII) (Sialyltransferase 7B) (SIAT7-B) Mus musculus (Mouse) GO:0000139; GO:0001665; GO:0006493; GO:1990743 protein O-linked glycosylation [GO:0006493]; protein sialylation [GO:1990743] Golgi membrane [GO:0000139] alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity [GO:0001665] g19174.t1 Q4V8F7 31.347 453 1.84e-43 165.0 sp|Q4V8F7|CCD63_RAT Coiled-coil domain-containing protein 63 OS=Rattus norvegicus OX=10116 GN=Ccdc63 PE=2 SV=1 g19176.t1 P00730 35.865 237 3.52e-42 152.0 sp|P00730|CBPA1_BOVIN Carboxypeptidase A1 OS=Bos taurus OX=9913 GN=CPA1 PE=1 SV=3 CBPA1_BOVIN reviewed Carboxypeptidase A1 (EC 3.4.17.1) Bos taurus (Bovine) GO:0004181; GO:0005615; GO:0006508; GO:0006691; GO:0008270 leukotriene metabolic process [GO:0006691]; proteolysis [GO:0006508] extracellular space [GO:0005615] metallocarboxypeptidase activity [GO:0004181]; zinc ion binding [GO:0008270] g19177.t1 P48052 37.688 398 6.72e-92 286.0 sp|P48052|CBPA2_HUMAN Carboxypeptidase A2 OS=Homo sapiens OX=9606 GN=CPA2 PE=1 SV=3 CBPA2_HUMAN reviewed Carboxypeptidase A2 (EC 3.4.17.15) Homo sapiens (Human) GO:0004180; GO:0004181; GO:0005576; GO:0005615; GO:0005773; GO:0006508; GO:0007039; GO:0008270 protein catabolic process in the vacuole [GO:0007039]; proteolysis [GO:0006508] extracellular region [GO:0005576]; extracellular space [GO:0005615]; vacuole [GO:0005773] carboxypeptidase activity [GO:0004180]; metallocarboxypeptidase activity [GO:0004181]; zinc ion binding [GO:0008270] g19178.t1 P00731 41.855 399 6.15e-107 325.0 sp|P00731|CBPA1_RAT Carboxypeptidase A1 OS=Rattus norvegicus OX=10116 GN=Cpa1 PE=2 SV=2 g19179.t1 A2BGL3 41.595 464 3.63e-113 353.0 sp|A2BGL3|WSCD2_DANRE Sialate:O-sulfotransferase 2 OS=Danio rerio OX=7955 GN=wscd2 PE=3 SV=1 g19180.t1 Q9Y4C8 54.079 662 0.0 649.0 sp|Q9Y4C8|RBM19_HUMAN Probable RNA-binding protein 19 OS=Homo sapiens OX=9606 GN=RBM19 PE=1 SV=3 RBM19_HUMAN reviewed Probable RNA-binding protein 19 (RNA-binding motif protein 19) Homo sapiens (Human) GO:0000381; GO:0003723; GO:0003729; GO:0005654; GO:0005694; GO:0005730; GO:0005737; GO:0016020; GO:0016607; GO:0040019 positive regulation of embryonic development [GO:0040019]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381] chromosome [GO:0005694]; cytoplasm [GO:0005737]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654] mRNA binding [GO:0003729]; RNA binding [GO:0003723] g19180.t1 Q9Y4C8 38.956 249 1.08e-32 140.0 sp|Q9Y4C8|RBM19_HUMAN Probable RNA-binding protein 19 OS=Homo sapiens OX=9606 GN=RBM19 PE=1 SV=3 RBM19_HUMAN reviewed Probable RNA-binding protein 19 (RNA-binding motif protein 19) Homo sapiens (Human) GO:0000381; GO:0003723; GO:0003729; GO:0005654; GO:0005694; GO:0005730; GO:0005737; GO:0016020; GO:0016607; GO:0040019 positive regulation of embryonic development [GO:0040019]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381] chromosome [GO:0005694]; cytoplasm [GO:0005737]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654] mRNA binding [GO:0003729]; RNA binding [GO:0003723] g19182.t1 Q9H2C1 60.526 266 1.48e-100 303.0 sp|Q9H2C1|LHX5_HUMAN LIM/homeobox protein Lhx5 OS=Homo sapiens OX=9606 GN=LHX5 PE=1 SV=1 g19186.t1 A2BIR6 40.256 313 6.23e-75 235.0 sp|A2BIR6|YDJC_DANRE Carbohydrate deacetylase OS=Danio rerio OX=7955 GN=ydjc PE=3 SV=1 g19187.t1 P52435 80.0 70 2.31e-37 123.0 sp|P52435|RPB11_HUMAN DNA-directed RNA polymerase II subunit RPB11-a OS=Homo sapiens OX=9606 GN=POLR2J PE=1 SV=1 RPB11_HUMAN reviewed DNA-directed RNA polymerase II subunit RPB11-a (RNA polymerase II subunit B11-a) (RPB11a) (DNA-directed RNA polymerase II subunit J-1) (RNA polymerase II 13.3 kDa subunit) Homo sapiens (Human) GO:0003677; GO:0003899; GO:0005634; GO:0005654; GO:0005665; GO:0006366; GO:0030275; GO:0046983 transcription by RNA polymerase II [GO:0006366] nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II, core complex [GO:0005665] DNA binding [GO:0003677]; DNA-directed RNA polymerase activity [GO:0003899]; LRR domain binding [GO:0030275]; protein dimerization activity [GO:0046983] g19188.t1 Q5RJI4 28.889 270 1.41e-34 136.0 sp|Q5RJI4|PKDCC_MOUSE Extracellular tyrosine-protein kinase PKDCC OS=Mus musculus OX=10090 GN=Pkdcc PE=1 SV=2 PKDCC_MOUSE reviewed Extracellular tyrosine-protein kinase PKDCC (EC 2.7.10.2) (Protein kinase domain-containing protein, cytoplasmic) (Protein kinase-like protein SgK493) (Sugen kinase 493) (Vertebrate lonesome kinase) Mus musculus (Mouse) GO:0001501; GO:0004672; GO:0004715; GO:0005524; GO:0005576; GO:0005794; GO:0015031; GO:0018108; GO:0030154; GO:0030282; GO:0030501; GO:0032332; GO:0035108; GO:0035264; GO:0042997; GO:0048286; GO:0048566; GO:0060021 bone mineralization [GO:0030282]; cell differentiation [GO:0030154]; embryonic digestive tract development [GO:0048566]; limb morphogenesis [GO:0035108]; lung alveolus development [GO:0048286]; multicellular organism growth [GO:0035264]; negative regulation of Golgi to plasma membrane protein transport [GO:0042997]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of bone mineralization [GO:0030501]; positive regulation of chondrocyte differentiation [GO:0032332]; protein transport [GO:0015031]; roof of mouth development [GO:0060021]; skeletal system development [GO:0001501] extracellular region [GO:0005576]; Golgi apparatus [GO:0005794] ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein kinase activity [GO:0004672] g19189.t1 Q9BW91 56.25 288 8.08e-107 319.0 sp|Q9BW91|NUDT9_HUMAN ADP-ribose pyrophosphatase, mitochondrial OS=Homo sapiens OX=9606 GN=NUDT9 PE=1 SV=1 NUDT9_HUMAN reviewed ADP-ribose pyrophosphatase (EC 3.6.1.13) (ADP-ribose diphosphatase) (ADP-ribose phosphohydrolase) (Adenosine diphosphoribose pyrophosphatase) (ADPR-PPase) (Nucleoside diphosphate-linked moiety X motif 9) (Nudix motif 9) Homo sapiens (Human) GO:0005737; GO:0005739; GO:0005759; GO:0005829; GO:0016604; GO:0019144; GO:0030054; GO:0031965; GO:0046032; GO:0047631; GO:0055086; GO:0070062 ADP catabolic process [GO:0046032]; nucleobase-containing small molecule metabolic process [GO:0055086] cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nuclear body [GO:0016604]; nuclear membrane [GO:0031965] ADP-ribose diphosphatase activity [GO:0047631]; ADP-sugar diphosphatase activity [GO:0019144] g19190.t1 Q9X248 41.767 249 1.58e-48 164.0 sp|Q9X248|FABG_THEMA 3-oxoacyl-[acyl-carrier-protein] reductase FabG OS=Thermotoga maritima (strain ATCC 43589 / DSM 3109 / JCM 10099 / NBRC 100826 / MSB8) OX=243274 GN=fabG PE=3 SV=1 g19191.t1 Q7K556 68.333 60 9.34e-24 95.5 sp|Q7K556|TTD14_DROME TRPL translocation defect protein 14 OS=Drosophila melanogaster OX=7227 GN=Ttd14 PE=1 SV=1 g19192.t1 Q7K556 48.525 305 3.46e-95 291.0 sp|Q7K556|TTD14_DROME TRPL translocation defect protein 14 OS=Drosophila melanogaster OX=7227 GN=Ttd14 PE=1 SV=1 g19193.t1 Q9CUS9 65.079 378 4.3e-127 372.0 sp|Q9CUS9|SPPL3_MOUSE Signal peptide peptidase-like 3 OS=Mus musculus OX=10090 GN=Sppl3 PE=1 SV=3 SPPL3_MOUSE reviewed Signal peptide peptidase-like 3 (SPP-like 3) (EC 3.4.23.-) (Intramembrane protease 2) (IMP-2) (Presenilin-like protein 4) Mus musculus (Mouse) GO:0005791; GO:0005794; GO:0005886; GO:0006465; GO:0007204; GO:0016020; GO:0030660; GO:0033116; GO:0033619; GO:0042500; GO:0042803; GO:0050852; GO:0070886; GO:0098553; GO:0098554 membrane protein proteolysis [GO:0033619]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; signal peptide processing [GO:0006465]; T cell receptor signaling pathway [GO:0050852] cytoplasmic side of endoplasmic reticulum membrane [GO:0098554]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi apparatus [GO:0005794]; Golgi-associated vesicle membrane [GO:0030660]; lumenal side of endoplasmic reticulum membrane [GO:0098553]; membrane [GO:0016020]; plasma membrane [GO:0005886]; rough endoplasmic reticulum [GO:0005791] aspartic endopeptidase activity, intramembrane cleaving [GO:0042500]; protein homodimerization activity [GO:0042803] g19193.t2 Q9CUS9 64.908 379 1e-127 374.0 sp|Q9CUS9|SPPL3_MOUSE Signal peptide peptidase-like 3 OS=Mus musculus OX=10090 GN=Sppl3 PE=1 SV=3 SPPL3_MOUSE reviewed Signal peptide peptidase-like 3 (SPP-like 3) (EC 3.4.23.-) (Intramembrane protease 2) (IMP-2) (Presenilin-like protein 4) Mus musculus (Mouse) GO:0005791; GO:0005794; GO:0005886; GO:0006465; GO:0007204; GO:0016020; GO:0030660; GO:0033116; GO:0033619; GO:0042500; GO:0042803; GO:0050852; GO:0070886; GO:0098553; GO:0098554 membrane protein proteolysis [GO:0033619]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; signal peptide processing [GO:0006465]; T cell receptor signaling pathway [GO:0050852] cytoplasmic side of endoplasmic reticulum membrane [GO:0098554]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi apparatus [GO:0005794]; Golgi-associated vesicle membrane [GO:0030660]; lumenal side of endoplasmic reticulum membrane [GO:0098553]; membrane [GO:0016020]; plasma membrane [GO:0005886]; rough endoplasmic reticulum [GO:0005791] aspartic endopeptidase activity, intramembrane cleaving [GO:0042500]; protein homodimerization activity [GO:0042803] g19194.t1 Q02290 34.884 430 6.14e-33 136.0 sp|Q02290|XYNB_NEOPA Endo-1,4-beta-xylanase B OS=Neocallimastix patriciarum OX=4758 GN=xynB PE=2 SV=1 g19194.t1 Q02290 30.704 469 1.2800000000000001e-21 102.0 sp|Q02290|XYNB_NEOPA Endo-1,4-beta-xylanase B OS=Neocallimastix patriciarum OX=4758 GN=xynB PE=2 SV=1 g19196.t1 Q91739 59.813 107 2.98e-36 133.0 sp|Q91739|HNFAB_XENLA Hepatocyte nuclear factor 1-alpha-B OS=Xenopus laevis OX=8355 GN=hnf1a-b PE=2 SV=2 g19200.t1 Q6ICL7 34.629 283 3.35e-40 147.0 sp|Q6ICL7|S35E4_HUMAN Solute carrier family 35 member E4 OS=Homo sapiens OX=9606 GN=SLC35E4 PE=1 SV=1 S35E4_HUMAN reviewed Solute carrier family 35 member E4 Homo sapiens (Human) GO:0005794; GO:0015297; GO:0016020; GO:0055085 transmembrane transport [GO:0055085] Golgi apparatus [GO:0005794]; membrane [GO:0016020] antiporter activity [GO:0015297] g19202.t1 Q12872 65.934 91 7.840000000000001e-32 132.0 sp|Q12872|SFSWA_HUMAN Splicing factor, suppressor of white-apricot homolog OS=Homo sapiens OX=9606 GN=SFSWAP PE=1 SV=3 SFSWA_HUMAN reviewed Splicing factor, suppressor of white-apricot homolog (Splicing factor, arginine/serine-rich 8) (Suppressor of white apricot protein homolog) Homo sapiens (Human) GO:0000380; GO:0000395; GO:0003723; GO:0005634; GO:0048025 alternative mRNA splicing, via spliceosome [GO:0000380]; mRNA 5'-splice site recognition [GO:0000395]; negative regulation of mRNA splicing, via spliceosome [GO:0048025] nucleus [GO:0005634] RNA binding [GO:0003723] g19203.t1 Q28IL7 79.195 149 1.24e-87 255.0 sp|Q28IL7|OSTC_XENTR Oligosaccharyltransferase complex subunit ostc OS=Xenopus tropicalis OX=8364 GN=ostc PE=2 SV=1 g19204.t1 Q5BK13 34.158 202 1.27e-25 101.0 sp|Q5BK13|VMA12_RAT Vacuolar ATPase assembly protein VMA12 OS=Rattus norvegicus OX=10116 GN=Vma12 PE=2 SV=1 g19205.t1 Q9Y2S7 62.366 372 2.31e-162 461.0 sp|Q9Y2S7|PDIP2_HUMAN Polymerase delta-interacting protein 2 OS=Homo sapiens OX=9606 GN=POLDIP2 PE=1 SV=1 g19205.t2 Q9Y2S7 62.903 372 1.2000000000000001e-164 467.0 sp|Q9Y2S7|PDIP2_HUMAN Polymerase delta-interacting protein 2 OS=Homo sapiens OX=9606 GN=POLDIP2 PE=1 SV=1 g19207.t1 Q5R8V1 62.558 430 3.97e-161 503.0 sp|Q5R8V1|CASP_PONAB Protein CASP OS=Pongo abelii OX=9601 GN=CUTL1 PE=2 SV=1 g19208.t1 Q13948 51.965 229 2.48e-67 222.0 sp|Q13948|CASP_HUMAN Protein CASP OS=Homo sapiens OX=9606 GN=CUX1 PE=1 SV=2 g19213.t1 Q53F19 45.588 136 2.66e-28 125.0 sp|Q53F19|NCBP3_HUMAN Nuclear cap-binding protein subunit 3 OS=Homo sapiens OX=9606 GN=NCBP3 PE=1 SV=2 NCBP3_HUMAN reviewed Nuclear cap-binding protein subunit 3 (Protein ELG) Homo sapiens (Human) GO:0000339; GO:0000340; GO:0003723; GO:0003729; GO:0005634; GO:0005737; GO:0005846; GO:0006370; GO:0006406; GO:0006408; GO:0016607; GO:0034518; GO:0035194; GO:0042789; GO:0051607 7-methylguanosine mRNA capping [GO:0006370]; defense response to virus [GO:0051607]; mRNA export from nucleus [GO:0006406]; mRNA transcription by RNA polymerase II [GO:0042789]; regulatory ncRNA-mediated post-transcriptional gene silencing [GO:0035194]; snRNA export from nucleus [GO:0006408] cytoplasm [GO:0005737]; nuclear cap binding complex [GO:0005846]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; RNA cap binding complex [GO:0034518] mRNA binding [GO:0003729]; RNA 7-methylguanosine cap binding [GO:0000340]; RNA binding [GO:0003723]; RNA cap binding [GO:0000339] g19214.t1 D3ZPG5 34.177 237 1.1e-28 122.0 sp|D3ZPG5|UBP30_RAT Ubiquitin carboxyl-terminal hydrolase 30 OS=Rattus norvegicus OX=10116 GN=Usp30 PE=3 SV=1 UBP30_RAT reviewed Ubiquitin carboxyl-terminal hydrolase 30 (EC 3.4.19.12) (Deubiquitinating enzyme 30) (Ubiquitin thioesterase 30) (Ubiquitin-specific-processing protease 30) (Ub-specific protease 30) Rattus norvegicus (Rat) GO:0000422; GO:0004197; GO:0004843; GO:0005634; GO:0005739; GO:0005741; GO:0005829; GO:0006508; GO:0008053; GO:0016579; GO:0031647; GO:0035871; GO:0044313; GO:1901525 autophagy of mitochondrion [GO:0000422]; mitochondrial fusion [GO:0008053]; negative regulation of mitophagy [GO:1901525]; protein deubiquitination [GO:0016579]; protein K11-linked deubiquitination [GO:0035871]; protein K6-linked deubiquitination [GO:0044313]; proteolysis [GO:0006508]; regulation of protein stability [GO:0031647] cytosol [GO:0005829]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nucleus [GO:0005634] cysteine-type deubiquitinase activity [GO:0004843]; cysteine-type endopeptidase activity [GO:0004197] g19215.t1 A2BGT0 32.576 264 8.33e-30 122.0 sp|A2BGT0|UBP30_DANRE Ubiquitin carboxyl-terminal hydrolase 30 OS=Danio rerio OX=7955 GN=usp30 PE=3 SV=1 UBP30_DANRE reviewed Ubiquitin carboxyl-terminal hydrolase 30 (EC 3.4.19.12) (Deubiquitinating enzyme 30) (Ubiquitin thioesterase 30) (Ubiquitin-specific-processing protease 30) (Ub-specific protease 30) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000422; GO:0004197; GO:0004843; GO:0005634; GO:0005739; GO:0005741; GO:0005829; GO:0006508; GO:0008053; GO:0016579; GO:0031647; GO:0035871; GO:0044313 autophagy of mitochondrion [GO:0000422]; mitochondrial fusion [GO:0008053]; protein deubiquitination [GO:0016579]; protein K11-linked deubiquitination [GO:0035871]; protein K6-linked deubiquitination [GO:0044313]; proteolysis [GO:0006508]; regulation of protein stability [GO:0031647] cytosol [GO:0005829]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nucleus [GO:0005634] cysteine-type deubiquitinase activity [GO:0004843]; cysteine-type endopeptidase activity [GO:0004197] g19216.t1 Q8IW41 53.564 463 1.09e-176 507.0 sp|Q8IW41|MAPK5_HUMAN MAP kinase-activated protein kinase 5 OS=Homo sapiens OX=9606 GN=MAPKAPK5 PE=1 SV=2 MAPK5_HUMAN reviewed MAP kinase-activated protein kinase 5 (MAPK-activated protein kinase 5) (MAPKAP kinase 5) (MAPKAP-K5) (MAPKAPK-5) (MK-5) (MK5) (EC 2.7.11.1) (p38-regulated/activated protein kinase) (PRAK) Homo sapiens (Human) GO:0002039; GO:0004674; GO:0004683; GO:0004708; GO:0005516; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006417; GO:0007165; GO:0007265; GO:0009931; GO:0032007; GO:0032156; GO:0032206; GO:0032991; GO:0045944; GO:0046777; GO:0051019; GO:0060999; GO:0090398; GO:0090400; GO:0106310; GO:1901796 cellular senescence [GO:0090398]; negative regulation of TOR signaling [GO:0032007]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of telomere maintenance [GO:0032206]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein autophosphorylation [GO:0046777]; Ras protein signal transduction [GO:0007265]; regulation of signal transduction by p53 class mediator [GO:1901796]; regulation of translation [GO:0006417]; signal transduction [GO:0007165]; stress-induced premature senescence [GO:0090400] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; septin cytoskeleton [GO:0032156] ATP binding [GO:0005524]; calcium-dependent protein serine/threonine kinase activity [GO:0009931]; calcium/calmodulin-dependent protein kinase activity [GO:0004683]; calmodulin binding [GO:0005516]; MAP kinase kinase activity [GO:0004708]; mitogen-activated protein kinase binding [GO:0051019]; p53 binding [GO:0002039]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g19221.t1 Q9VKV5 29.605 304 1.42e-28 116.0 sp|Q9VKV5|CD2B2_DROME CD2 antigen cytoplasmic tail-binding protein 2 homolog OS=Drosophila melanogaster OX=7227 GN=holn1 PE=1 SV=1 CD2B2_DROME reviewed CD2 antigen cytoplasmic tail-binding protein 2 homolog (Protein hole-in-one) Drosophila melanogaster (Fruit fly) GO:0005634; GO:0005682; GO:0022416; GO:0035220; GO:0042060; GO:0048749; GO:0090303 chaeta development [GO:0022416]; compound eye development [GO:0048749]; positive regulation of wound healing [GO:0090303]; wing disc development [GO:0035220]; wound healing [GO:0042060] nucleus [GO:0005634]; U5 snRNP [GO:0005682] g19222.t1 Q2TBR7 58.427 89 2.96e-31 111.0 sp|Q2TBR7|CENPS_BOVIN Centromere protein S OS=Bos taurus OX=9913 GN=CENPS PE=2 SV=1 g19223.t1 Q6ZNB5 43.429 175 1.22e-39 149.0 sp|Q6ZNB5|XNDC1_HUMAN Protein XNDC1N OS=Homo sapiens OX=9606 GN=XNDC1N PE=2 SV=2 g19225.t1 Q8BIQ3 35.897 156 4.67e-22 103.0 sp|Q8BIQ3|ZNF2_MOUSE Zinc finger protein 2 OS=Mus musculus OX=10090 GN=Znf2 PE=2 SV=1 g19227.t1 Q9BPW8 52.756 254 1.9e-93 280.0 sp|Q9BPW8|NIPS1_HUMAN Protein NipSnap homolog 1 OS=Homo sapiens OX=9606 GN=NIPSNAP1 PE=1 SV=1 NIPS1_HUMAN reviewed Protein NipSnap homolog 1 (NipSnap1) Homo sapiens (Human) GO:0000423; GO:0005739; GO:0005759; GO:0019233; GO:0030674; GO:0097060 mitophagy [GO:0000423]; sensory perception of pain [GO:0019233] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; synaptic membrane [GO:0097060] protein-macromolecule adaptor activity [GO:0030674] g19228.t1 A7S8T5 72.347 311 1.03e-157 446.0 sp|A7S8T5|CCD42_NEMVE Coiled-coil domain-containing protein 42 homolog OS=Nematostella vectensis OX=45351 GN=v1g187067 PE=3 SV=1 g19230.t1 A0A0P0XM10 31.183 465 1.01e-56 202.0 sp|A0A0P0XM10|PAO6_ORYSJ Polyamine oxidase 6 OS=Oryza sativa subsp. japonica OX=39947 GN=PAO6 PE=2 SV=1 g19231.t1 P29274 38.291 316 1.25e-60 203.0 sp|P29274|AA2AR_HUMAN Adenosine receptor A2a OS=Homo sapiens OX=9606 GN=ADORA2A PE=1 SV=2 AA2AR_HUMAN reviewed Adenosine receptor A2a Homo sapiens (Human) GO:0001609; GO:0001963; GO:0001973; GO:0001975; GO:0005516; GO:0005882; GO:0005886; GO:0006355; GO:0006909; GO:0006915; GO:0006954; GO:0006968; GO:0007188; GO:0007189; GO:0007200; GO:0007267; GO:0007271; GO:0007417; GO:0007596; GO:0007600; GO:0007626; GO:0008015; GO:0008285; GO:0008289; GO:0009410; GO:0014049; GO:0014057; GO:0014061; GO:0014074; GO:0016020; GO:0019899; GO:0030425; GO:0030673; GO:0031000; GO:0031802; GO:0032230; GO:0032279; GO:0035249; GO:0035810; GO:0042311; GO:0042734; GO:0042755; GO:0042802; GO:0043025; GO:0043116; GO:0043524; GO:0044877; GO:0045211; GO:0045938; GO:0046636; GO:0048143; GO:0048786; GO:0048812; GO:0050714; GO:0050728; GO:0051393; GO:0051881; GO:0051899; GO:0051924; GO:0051968; GO:0060079; GO:0060080; GO:0060134; GO:0070374; GO:0097190; GO:0098978; GO:0099171; GO:1900273; GO:2001235 adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; apoptotic process [GO:0006915]; apoptotic signaling pathway [GO:0097190]; astrocyte activation [GO:0048143]; blood circulation [GO:0008015]; blood coagulation [GO:0007596]; cell-cell signaling [GO:0007267]; cellular defense response [GO:0006968]; central nervous system development [GO:0007417]; eating behavior [GO:0042755]; excitatory postsynaptic potential [GO:0060079]; G protein-coupled adenosine receptor signaling pathway [GO:0001973]; inflammatory response [GO:0006954]; inhibitory postsynaptic potential [GO:0060080]; locomotory behavior [GO:0007626]; membrane depolarization [GO:0051899]; negative regulation of alpha-beta T cell activation [GO:0046636]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of inflammatory response [GO:0050728]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of vascular permeability [GO:0043116]; neuron projection morphogenesis [GO:0048812]; phagocytosis [GO:0006909]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of acetylcholine secretion, neurotransmission [GO:0014057]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of circadian sleep/wake cycle, sleep [GO:0045938]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of glutamate secretion [GO:0014049]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of protein secretion [GO:0050714]; positive regulation of synaptic transmission, GABAergic [GO:0032230]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; positive regulation of urine volume [GO:0035810]; prepulse inhibition [GO:0060134]; presynaptic modulation of chemical synaptic transmission [GO:0099171]; regulation of calcium ion transport [GO:0051924]; regulation of DNA-templated transcription [GO:0006355]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of norepinephrine secretion [GO:0014061]; response to amphetamine [GO:0001975]; response to caffeine [GO:0031000]; response to purine-containing compound [GO:0014074]; response to xenobiotic stimulus [GO:0009410]; sensory perception [GO:0007600]; synaptic transmission, cholinergic [GO:0007271]; synaptic transmission, dopaminergic [GO:0001963]; synaptic transmission, glutamatergic [GO:0035249]; vasodilation [GO:0042311] asymmetric synapse [GO:0032279]; axolemma [GO:0030673]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; intermediate filament [GO:0005882]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic active zone [GO:0048786]; presynaptic membrane [GO:0042734] alpha-actinin binding [GO:0051393]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; G protein-coupled adenosine receptor activity [GO:0001609]; identical protein binding [GO:0042802]; lipid binding [GO:0008289]; protein-containing complex binding [GO:0044877]; type 5 metabotropic glutamate receptor binding [GO:0031802] g19233.t1 Q17232 30.097 412 4.9499999999999996e-54 191.0 sp|Q17232|OAR_BOMMO Octopamine receptor OS=Bombyx mori OX=7091 PE=2 SV=1 g19234.t1 E0D206 33.165 1185 4.53e-153 536.0 sp|E0D206|GFSE_STRHA Polyketide synthase GfsE OS=Streptomyces halstedii OX=1944 GN=gfsE PE=1 SV=1 g19234.t1 E0D206 31.193 1215 8.079999999999999e-138 488.0 sp|E0D206|GFSE_STRHA Polyketide synthase GfsE OS=Streptomyces halstedii OX=1944 GN=gfsE PE=1 SV=1 g19236.t1 Q0EEE2 43.806 557 2.44e-160 487.0 sp|Q0EEE2|PTHD3_MOUSE Patched domain-containing protein 3 OS=Mus musculus OX=10090 GN=Ptchd3 PE=1 SV=1 PTHD3_MOUSE reviewed Patched domain-containing protein 3 (RND-type protein RNDEu-3) Mus musculus (Mouse) GO:0005783; GO:0005789; GO:0016020; GO:0097225 endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; sperm midpiece [GO:0097225] g19238.t1 P70545 43.75 624 2.73e-131 400.0 sp|P70545|S13A2_RAT Solute carrier family 13 member 2 OS=Rattus norvegicus OX=10116 GN=Slc13a2 PE=1 SV=3 S13A2_RAT reviewed Solute carrier family 13 member 2 (Intestinal sodium/dicarboxylate cotransporter) (Na(+)/dicarboxylate cotransporter 1) (NaDC-1) Rattus norvegicus (Rat) GO:0005886; GO:0015138; GO:0015139; GO:0015141; GO:0015741; GO:0015742; GO:0016324; GO:0017153; GO:0071285; GO:0071422 alpha-ketoglutarate transport [GO:0015742]; cellular response to lithium ion [GO:0071285]; fumarate transport [GO:0015741]; succinate transmembrane transport [GO:0071422] apical plasma membrane [GO:0016324]; plasma membrane [GO:0005886] alpha-ketoglutarate transmembrane transporter activity [GO:0015139]; fumarate transmembrane transporter activity [GO:0015138]; sodium:dicarboxylate symporter activity [GO:0017153]; succinate transmembrane transporter activity [GO:0015141] g19240.t1 A0PJN4 50.625 160 8.399999999999999e-54 176.0 sp|A0PJN4|U2QL1_MOUSE Ubiquitin-conjugating enzyme E2Q-like protein 1 OS=Mus musculus OX=10090 GN=Ube2ql1 PE=2 SV=2 U2QL1_MOUSE reviewed Ubiquitin-conjugating enzyme E2Q-like protein 1 (EC 2.3.2.23) (E2Q-like ubiquitin-conjugating enzyme 1) Mus musculus (Mouse) GO:0000209; GO:0005524; GO:0005634; GO:0005654; GO:0005886; GO:0061631 protein polyubiquitination [GO:0000209] nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886] ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631] g19240.t2 A0PJN4 57.143 126 6.93e-49 164.0 sp|A0PJN4|U2QL1_MOUSE Ubiquitin-conjugating enzyme E2Q-like protein 1 OS=Mus musculus OX=10090 GN=Ube2ql1 PE=2 SV=2 U2QL1_MOUSE reviewed Ubiquitin-conjugating enzyme E2Q-like protein 1 (EC 2.3.2.23) (E2Q-like ubiquitin-conjugating enzyme 1) Mus musculus (Mouse) GO:0000209; GO:0005524; GO:0005634; GO:0005654; GO:0005886; GO:0061631 protein polyubiquitination [GO:0000209] nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886] ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631] g19241.t1 E0D205 31.279 1314 3.3e-152 535.0 sp|E0D205|GFSD_STRHA Polyketide synthase GfsD OS=Streptomyces halstedii OX=1944 GN=gfsD PE=1 SV=1 g19241.t1 E0D205 31.154 1178 1.26e-138 491.0 sp|E0D205|GFSD_STRHA Polyketide synthase GfsD OS=Streptomyces halstedii OX=1944 GN=gfsD PE=1 SV=1 g19245.t1 Q91ZQ0 64.752 383 4.94e-165 474.0 sp|Q91ZQ0|VMP1_RAT Vacuole membrane protein 1 OS=Rattus norvegicus OX=10116 GN=Vmp1 PE=1 SV=1 VMP1_RAT reviewed Vacuole membrane protein 1 Rattus norvegicus (Rat) GO:0000045; GO:0000407; GO:0000421; GO:0005730; GO:0005783; GO:0005789; GO:0005886; GO:0006914; GO:0007030; GO:0007566; GO:0012505; GO:0016020; GO:0016240; GO:0017128; GO:0033116; GO:0034329; GO:0042953; GO:0098609; GO:0140056; GO:1901896; GO:1990456 autophagosome assembly [GO:0000045]; autophagosome membrane docking [GO:0016240]; autophagy [GO:0006914]; cell junction assembly [GO:0034329]; cell-cell adhesion [GO:0098609]; embryo implantation [GO:0007566]; Golgi organization [GO:0007030]; lipoprotein transport [GO:0042953]; mitochondrion-endoplasmic reticulum membrane tethering [GO:1990456]; organelle localization by membrane tethering [GO:0140056]; positive regulation of ATPase-coupled calcium transmembrane transporter activity [GO:1901896] autophagosome membrane [GO:0000421]; endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; membrane [GO:0016020]; nucleolus [GO:0005730]; phagophore assembly site [GO:0000407]; plasma membrane [GO:0005886] phospholipid scramblase activity [GO:0017128] g19247.t1 Q503L9 43.494 269 1.2e-75 239.0 sp|Q503L9|NXN_DANRE Nucleoredoxin OS=Danio rerio OX=7955 GN=nxn PE=2 SV=1 g19247.t1 Q503L9 37.58 157 9.929999999999999e-30 119.0 sp|Q503L9|NXN_DANRE Nucleoredoxin OS=Danio rerio OX=7955 GN=nxn PE=2 SV=1 g19248.t1 Q13615 34.545 165 1.62e-26 110.0 sp|Q13615|MTMR3_HUMAN Phosphatidylinositol-3,5-bisphosphate 3-phosphatase MTMR3 OS=Homo sapiens OX=9606 GN=MTMR3 PE=1 SV=3 MTMR3_HUMAN reviewed Phosphatidylinositol-3,5-bisphosphate 3-phosphatase MTMR3 (EC 3.1.3.95) (FYVE domain-containing dual specificity protein phosphatase 1) (FYVE-DSP1) (Myotubularin-related protein 3) (Phosphatidylinositol-3,5-bisphosphate 3-phosphatase) (Phosphatidylinositol-3-phosphate phosphatase) (Zinc finger FYVE domain-containing protein 10) Homo sapiens (Human) GO:0004438; GO:0004722; GO:0004725; GO:0005737; GO:0005829; GO:0006470; GO:0006661; GO:0008138; GO:0008270; GO:0016020; GO:0016236; GO:0019903; GO:0042149; GO:0046856; GO:0052629; GO:0060090; GO:0060304; GO:0061952; GO:1904562; GO:2000785 cellular response to glucose starvation [GO:0042149]; macroautophagy [GO:0016236]; midbody abscission [GO:0061952]; phosphatidylinositol 5-phosphate metabolic process [GO:1904562]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol dephosphorylation [GO:0046856]; protein dephosphorylation [GO:0006470]; regulation of autophagosome assembly [GO:2000785]; regulation of phosphatidylinositol dephosphorylation [GO:0060304] cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020] molecular adaptor activity [GO:0060090]; phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity [GO:0052629]; phosphatidylinositol-3-phosphate phosphatase activity [GO:0004438]; protein phosphatase binding [GO:0019903]; protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; zinc ion binding [GO:0008270] g19250.t1 Q13615 56.217 571 0.0 639.0 sp|Q13615|MTMR3_HUMAN Phosphatidylinositol-3,5-bisphosphate 3-phosphatase MTMR3 OS=Homo sapiens OX=9606 GN=MTMR3 PE=1 SV=3 MTMR3_HUMAN reviewed Phosphatidylinositol-3,5-bisphosphate 3-phosphatase MTMR3 (EC 3.1.3.95) (FYVE domain-containing dual specificity protein phosphatase 1) (FYVE-DSP1) (Myotubularin-related protein 3) (Phosphatidylinositol-3,5-bisphosphate 3-phosphatase) (Phosphatidylinositol-3-phosphate phosphatase) (Zinc finger FYVE domain-containing protein 10) Homo sapiens (Human) GO:0004438; GO:0004722; GO:0004725; GO:0005737; GO:0005829; GO:0006470; GO:0006661; GO:0008138; GO:0008270; GO:0016020; GO:0016236; GO:0019903; GO:0042149; GO:0046856; GO:0052629; GO:0060090; GO:0060304; GO:0061952; GO:1904562; GO:2000785 cellular response to glucose starvation [GO:0042149]; macroautophagy [GO:0016236]; midbody abscission [GO:0061952]; phosphatidylinositol 5-phosphate metabolic process [GO:1904562]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol dephosphorylation [GO:0046856]; protein dephosphorylation [GO:0006470]; regulation of autophagosome assembly [GO:2000785]; regulation of phosphatidylinositol dephosphorylation [GO:0060304] cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020] molecular adaptor activity [GO:0060090]; phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity [GO:0052629]; phosphatidylinositol-3-phosphate phosphatase activity [GO:0004438]; protein phosphatase binding [GO:0019903]; protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; zinc ion binding [GO:0008270] g19251.t1 Q9H2K8 71.019 314 1.05e-158 490.0 sp|Q9H2K8|TAOK3_HUMAN Serine/threonine-protein kinase TAO3 OS=Homo sapiens OX=9606 GN=TAOK3 PE=1 SV=2 TAOK3_HUMAN reviewed Serine/threonine-protein kinase TAO3 (EC 2.7.11.1) (Cutaneous T-cell lymphoma-associated antigen HD-CL-09) (CTCL-associated antigen HD-CL-09) (Dendritic cell-derived protein kinase) (JNK/SAPK-inhibitory kinase) (Jun kinase-inhibitory kinase) (Kinase from chicken homolog A) (hKFC-A) (Thousand and one amino acid protein 3) Homo sapiens (Human) GO:0000165; GO:0004674; GO:0004860; GO:0005524; GO:0005737; GO:0005811; GO:0005886; GO:0006281; GO:0006468; GO:0006974; GO:0007095; GO:0016740; GO:0032874; GO:0043408; GO:0043507; GO:0045121; GO:0046329; GO:0046330; GO:0048812; GO:0106310 DNA damage response [GO:0006974]; DNA repair [GO:0006281]; MAPK cascade [GO:0000165]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; negative regulation of JNK cascade [GO:0046329]; neuron projection morphogenesis [GO:0048812]; positive regulation of JNK cascade [GO:0046330]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein phosphorylation [GO:0006468]; regulation of MAPK cascade [GO:0043408] cytoplasm [GO:0005737]; lipid droplet [GO:0005811]; membrane raft [GO:0045121]; plasma membrane [GO:0005886] ATP binding [GO:0005524]; protein kinase inhibitor activity [GO:0004860]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; transferase activity [GO:0016740] g19251.t1 Q9H2K8 45.374 454 1.81e-92 315.0 sp|Q9H2K8|TAOK3_HUMAN Serine/threonine-protein kinase TAO3 OS=Homo sapiens OX=9606 GN=TAOK3 PE=1 SV=2 TAOK3_HUMAN reviewed Serine/threonine-protein kinase TAO3 (EC 2.7.11.1) (Cutaneous T-cell lymphoma-associated antigen HD-CL-09) (CTCL-associated antigen HD-CL-09) (Dendritic cell-derived protein kinase) (JNK/SAPK-inhibitory kinase) (Jun kinase-inhibitory kinase) (Kinase from chicken homolog A) (hKFC-A) (Thousand and one amino acid protein 3) Homo sapiens (Human) GO:0000165; GO:0004674; GO:0004860; GO:0005524; GO:0005737; GO:0005811; GO:0005886; GO:0006281; GO:0006468; GO:0006974; GO:0007095; GO:0016740; GO:0032874; GO:0043408; GO:0043507; GO:0045121; GO:0046329; GO:0046330; GO:0048812; GO:0106310 DNA damage response [GO:0006974]; DNA repair [GO:0006281]; MAPK cascade [GO:0000165]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; negative regulation of JNK cascade [GO:0046329]; neuron projection morphogenesis [GO:0048812]; positive regulation of JNK cascade [GO:0046330]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein phosphorylation [GO:0006468]; regulation of MAPK cascade [GO:0043408] cytoplasm [GO:0005737]; lipid droplet [GO:0005811]; membrane raft [GO:0045121]; plasma membrane [GO:0005886] ATP binding [GO:0005524]; protein kinase inhibitor activity [GO:0004860]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; transferase activity [GO:0016740] g19251.t2 Q9H2K8 71.019 314 4.5600000000000005e-157 488.0 sp|Q9H2K8|TAOK3_HUMAN Serine/threonine-protein kinase TAO3 OS=Homo sapiens OX=9606 GN=TAOK3 PE=1 SV=2 TAOK3_HUMAN reviewed Serine/threonine-protein kinase TAO3 (EC 2.7.11.1) (Cutaneous T-cell lymphoma-associated antigen HD-CL-09) (CTCL-associated antigen HD-CL-09) (Dendritic cell-derived protein kinase) (JNK/SAPK-inhibitory kinase) (Jun kinase-inhibitory kinase) (Kinase from chicken homolog A) (hKFC-A) (Thousand and one amino acid protein 3) Homo sapiens (Human) GO:0000165; GO:0004674; GO:0004860; GO:0005524; GO:0005737; GO:0005811; GO:0005886; GO:0006281; GO:0006468; GO:0006974; GO:0007095; GO:0016740; GO:0032874; GO:0043408; GO:0043507; GO:0045121; GO:0046329; GO:0046330; GO:0048812; GO:0106310 DNA damage response [GO:0006974]; DNA repair [GO:0006281]; MAPK cascade [GO:0000165]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; negative regulation of JNK cascade [GO:0046329]; neuron projection morphogenesis [GO:0048812]; positive regulation of JNK cascade [GO:0046330]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein phosphorylation [GO:0006468]; regulation of MAPK cascade [GO:0043408] cytoplasm [GO:0005737]; lipid droplet [GO:0005811]; membrane raft [GO:0045121]; plasma membrane [GO:0005886] ATP binding [GO:0005524]; protein kinase inhibitor activity [GO:0004860]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; transferase activity [GO:0016740] g19251.t2 Q9H2K8 46.018 452 2.6e-92 315.0 sp|Q9H2K8|TAOK3_HUMAN Serine/threonine-protein kinase TAO3 OS=Homo sapiens OX=9606 GN=TAOK3 PE=1 SV=2 TAOK3_HUMAN reviewed Serine/threonine-protein kinase TAO3 (EC 2.7.11.1) (Cutaneous T-cell lymphoma-associated antigen HD-CL-09) (CTCL-associated antigen HD-CL-09) (Dendritic cell-derived protein kinase) (JNK/SAPK-inhibitory kinase) (Jun kinase-inhibitory kinase) (Kinase from chicken homolog A) (hKFC-A) (Thousand and one amino acid protein 3) Homo sapiens (Human) GO:0000165; GO:0004674; GO:0004860; GO:0005524; GO:0005737; GO:0005811; GO:0005886; GO:0006281; GO:0006468; GO:0006974; GO:0007095; GO:0016740; GO:0032874; GO:0043408; GO:0043507; GO:0045121; GO:0046329; GO:0046330; GO:0048812; GO:0106310 DNA damage response [GO:0006974]; DNA repair [GO:0006281]; MAPK cascade [GO:0000165]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; negative regulation of JNK cascade [GO:0046329]; neuron projection morphogenesis [GO:0048812]; positive regulation of JNK cascade [GO:0046330]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein phosphorylation [GO:0006468]; regulation of MAPK cascade [GO:0043408] cytoplasm [GO:0005737]; lipid droplet [GO:0005811]; membrane raft [GO:0045121]; plasma membrane [GO:0005886] ATP binding [GO:0005524]; protein kinase inhibitor activity [GO:0004860]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; transferase activity [GO:0016740] g19252.t1 B6NK32 61.765 68 4.69e-29 101.0 sp|B6NK32|LYRM9_BRAFL LYR motif-containing protein 9 OS=Branchiostoma floridae OX=7739 GN=LYRM9 PE=3 SV=1 g19253.t1 A2VE54 41.52 171 1.6999999999999998e-38 139.0 sp|A2VE54|UN93A_BOVIN Protein unc-93 homolog A OS=Bos taurus OX=9913 GN=UNC93A PE=2 SV=1 g19254.t1 Q6DDL7 39.464 261 2.17e-40 149.0 sp|Q6DDL7|UN93A_XENLA Protein unc-93 homolog A OS=Xenopus laevis OX=8355 GN=unc93a PE=2 SV=1 g19255.t1 Q9Y115 35.792 461 3.23e-67 229.0 sp|Q9Y115|UN93L_DROME UNC93-like protein OS=Drosophila melanogaster OX=7227 GN=CG4928 PE=2 SV=1 g19256.t1 Q6DDL7 34.382 477 6.09e-64 218.0 sp|Q6DDL7|UN93A_XENLA Protein unc-93 homolog A OS=Xenopus laevis OX=8355 GN=unc93a PE=2 SV=1 g19257.t1 Q5SPL2 48.658 298 1.62e-61 232.0 sp|Q5SPL2|PHF12_MOUSE PHD finger protein 12 OS=Mus musculus OX=10090 GN=Phf12 PE=1 SV=1 PHF12_MOUSE reviewed PHD finger protein 12 (PHD factor 1) (Pf1) Mus musculus (Mouse) GO:0000122; GO:0001222; GO:0003714; GO:0005634; GO:0005654; GO:0008270; GO:0017053; GO:0035091; GO:0045892; GO:0070822 negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122] nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Sin3-type complex [GO:0070822]; transcription repressor complex [GO:0017053] phosphatidylinositol binding [GO:0035091]; transcription corepressor activity [GO:0003714]; transcription corepressor binding [GO:0001222]; zinc ion binding [GO:0008270] g19257.t1 Q5SPL2 42.105 285 4.15e-58 221.0 sp|Q5SPL2|PHF12_MOUSE PHD finger protein 12 OS=Mus musculus OX=10090 GN=Phf12 PE=1 SV=1 PHF12_MOUSE reviewed PHD finger protein 12 (PHD factor 1) (Pf1) Mus musculus (Mouse) GO:0000122; GO:0001222; GO:0003714; GO:0005634; GO:0005654; GO:0008270; GO:0017053; GO:0035091; GO:0045892; GO:0070822 negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122] nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Sin3-type complex [GO:0070822]; transcription repressor complex [GO:0017053] phosphatidylinositol binding [GO:0035091]; transcription corepressor activity [GO:0003714]; transcription corepressor binding [GO:0001222]; zinc ion binding [GO:0008270] g19257.t1 Q5SPL2 71.875 96 8.7e-34 144.0 sp|Q5SPL2|PHF12_MOUSE PHD finger protein 12 OS=Mus musculus OX=10090 GN=Phf12 PE=1 SV=1 PHF12_MOUSE reviewed PHD finger protein 12 (PHD factor 1) (Pf1) Mus musculus (Mouse) GO:0000122; GO:0001222; GO:0003714; GO:0005634; GO:0005654; GO:0008270; GO:0017053; GO:0035091; GO:0045892; GO:0070822 negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122] nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Sin3-type complex [GO:0070822]; transcription repressor complex [GO:0017053] phosphatidylinositol binding [GO:0035091]; transcription corepressor activity [GO:0003714]; transcription corepressor binding [GO:0001222]; zinc ion binding [GO:0008270] g19257.t2 Q5SPL2 48.667 300 6.12e-62 233.0 sp|Q5SPL2|PHF12_MOUSE PHD finger protein 12 OS=Mus musculus OX=10090 GN=Phf12 PE=1 SV=1 PHF12_MOUSE reviewed PHD finger protein 12 (PHD factor 1) (Pf1) Mus musculus (Mouse) GO:0000122; GO:0001222; GO:0003714; GO:0005634; GO:0005654; GO:0008270; GO:0017053; GO:0035091; GO:0045892; GO:0070822 negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122] nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Sin3-type complex [GO:0070822]; transcription repressor complex [GO:0017053] phosphatidylinositol binding [GO:0035091]; transcription corepressor activity [GO:0003714]; transcription corepressor binding [GO:0001222]; zinc ion binding [GO:0008270] g19257.t2 Q5SPL2 42.105 285 3.3900000000000005e-58 221.0 sp|Q5SPL2|PHF12_MOUSE PHD finger protein 12 OS=Mus musculus OX=10090 GN=Phf12 PE=1 SV=1 PHF12_MOUSE reviewed PHD finger protein 12 (PHD factor 1) (Pf1) Mus musculus (Mouse) GO:0000122; GO:0001222; GO:0003714; GO:0005634; GO:0005654; GO:0008270; GO:0017053; GO:0035091; GO:0045892; GO:0070822 negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122] nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Sin3-type complex [GO:0070822]; transcription repressor complex [GO:0017053] phosphatidylinositol binding [GO:0035091]; transcription corepressor activity [GO:0003714]; transcription corepressor binding [GO:0001222]; zinc ion binding [GO:0008270] g19257.t2 Q5SPL2 71.875 96 7.73e-34 145.0 sp|Q5SPL2|PHF12_MOUSE PHD finger protein 12 OS=Mus musculus OX=10090 GN=Phf12 PE=1 SV=1 PHF12_MOUSE reviewed PHD finger protein 12 (PHD factor 1) (Pf1) Mus musculus (Mouse) GO:0000122; GO:0001222; GO:0003714; GO:0005634; GO:0005654; GO:0008270; GO:0017053; GO:0035091; GO:0045892; GO:0070822 negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122] nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Sin3-type complex [GO:0070822]; transcription repressor complex [GO:0017053] phosphatidylinositol binding [GO:0035091]; transcription corepressor activity [GO:0003714]; transcription corepressor binding [GO:0001222]; zinc ion binding [GO:0008270] g19262.t1 A0JPI9 38.369 417 2.14e-95 302.0 sp|A0JPI9|LR74A_RAT Leucine-rich repeat-containing protein 74A OS=Rattus norvegicus OX=10116 GN=Lrrc74a PE=2 SV=1 g19262.t2 A0JPI9 38.369 417 1.16e-95 302.0 sp|A0JPI9|LR74A_RAT Leucine-rich repeat-containing protein 74A OS=Rattus norvegicus OX=10116 GN=Lrrc74a PE=2 SV=1 g19263.t1 E9PVA8 64.314 1530 0.0 1906.0 sp|E9PVA8|GCN1_MOUSE Stalled ribosome sensor GCN1 OS=Mus musculus OX=10090 GN=Gcn1 PE=1 SV=1 GCN1_MOUSE reviewed Stalled ribosome sensor GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1) Mus musculus (Mouse) GO:0005737; GO:0005829; GO:0006414; GO:0006417; GO:0006511; GO:0019887; GO:0022626; GO:0034198; GO:0043539; GO:0055106; GO:0060090; GO:0072344; GO:0085020; GO:0140469; GO:0160127; GO:0170011 cellular response to amino acid starvation [GO:0034198]; GCN2-mediated signaling [GO:0140469]; protein K6-linked ubiquitination [GO:0085020]; protein-RNA covalent cross-linking repair [GO:0160127]; regulation of translation [GO:0006417]; rescue of stalled ribosome [GO:0072344]; translational elongation [GO:0006414]; ubiquitin-dependent protein catabolic process [GO:0006511] cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic ribosome [GO:0022626] molecular adaptor activity [GO:0060090]; protein kinase regulator activity [GO:0019887]; protein serine/threonine kinase activator activity [GO:0043539]; stalled ribosome sensor activity [GO:0170011]; ubiquitin-protein transferase regulator activity [GO:0055106] g19264.t1 E9PVA8 41.513 1137 0.0 753.0 sp|E9PVA8|GCN1_MOUSE Stalled ribosome sensor GCN1 OS=Mus musculus OX=10090 GN=Gcn1 PE=1 SV=1 GCN1_MOUSE reviewed Stalled ribosome sensor GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1) Mus musculus (Mouse) GO:0005737; GO:0005829; GO:0006414; GO:0006417; GO:0006511; GO:0019887; GO:0022626; GO:0034198; GO:0043539; GO:0055106; GO:0060090; GO:0072344; GO:0085020; GO:0140469; GO:0160127; GO:0170011 cellular response to amino acid starvation [GO:0034198]; GCN2-mediated signaling [GO:0140469]; protein K6-linked ubiquitination [GO:0085020]; protein-RNA covalent cross-linking repair [GO:0160127]; regulation of translation [GO:0006417]; rescue of stalled ribosome [GO:0072344]; translational elongation [GO:0006414]; ubiquitin-dependent protein catabolic process [GO:0006511] cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic ribosome [GO:0022626] molecular adaptor activity [GO:0060090]; protein kinase regulator activity [GO:0019887]; protein serine/threonine kinase activator activity [GO:0043539]; stalled ribosome sensor activity [GO:0170011]; ubiquitin-protein transferase regulator activity [GO:0055106] g19265.t1 Q5FW48 55.16 281 9.2e-98 291.0 sp|Q5FW48|ASPDH_XENTR Aspartate dehydrogenase domain-containing protein OS=Xenopus tropicalis OX=8364 GN=aspdh PE=2 SV=1 g19266.t1 Q2TA16 59.347 337 7.470000000000001e-129 382.0 sp|Q2TA16|DRC2_BOVIN Dynein regulatory complex subunit 2 OS=Bos taurus OX=9913 GN=CCDC65 PE=2 SV=1 g19267.t1 Q2TA16 49.074 108 1.2099999999999999e-30 116.0 sp|Q2TA16|DRC2_BOVIN Dynein regulatory complex subunit 2 OS=Bos taurus OX=9913 GN=CCDC65 PE=2 SV=1 g19268.t1 Q8NI37 58.361 305 2.12e-116 340.0 sp|Q8NI37|PPTC7_HUMAN Protein phosphatase PTC7 homolog OS=Homo sapiens OX=9606 GN=PPTC7 PE=1 SV=1 PPTC7_HUMAN reviewed Protein phosphatase PTC7 homolog (EC 3.1.3.16) (T-cell activation protein phosphatase 2C) (TA-PP2C) (T-cell activation protein phosphatase 2C-like) Homo sapiens (Human) GO:0004722; GO:0005739; GO:0005741; GO:0005759; GO:0010795; GO:0030674; GO:0046872; GO:1901525; GO:1904775 negative regulation of mitophagy [GO:1901525]; positive regulation of ubiquinone biosynthetic process [GO:1904775]; regulation of ubiquinone biosynthetic process [GO:0010795] mitochondrial matrix [GO:0005759]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739] metal ion binding [GO:0046872]; protein serine/threonine phosphatase activity [GO:0004722]; protein-macromolecule adaptor activity [GO:0030674] g19270.t1 Q08378 26.585 489 8.7e-33 135.0 sp|Q08378|GOGA3_HUMAN Golgin subfamily A member 3 OS=Homo sapiens OX=9606 GN=GOLGA3 PE=1 SV=2 GOGA3_HUMAN reviewed Golgin subfamily A member 3 (Golgi complex-associated protein of 170 kDa) (GCP170) (Golgin-160) Homo sapiens (Human) GO:0000139; GO:0005654; GO:0005730; GO:0005794; GO:0005829; GO:0016020; GO:0032580; GO:0045296 cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654] cadherin binding [GO:0045296] g19272.t1 Q5FVR8 49.002 551 3.18e-162 477.0 sp|Q5FVR8|TBCC1_RAT TBCC domain-containing protein 1 OS=Rattus norvegicus OX=10116 GN=Tbccd1 PE=2 SV=1 g19273.t1 Q9TR36 61.029 272 2.09e-112 327.0 sp|Q9TR36|PIPNB_BOVIN Phosphatidylinositol transfer protein beta isoform OS=Bos taurus OX=9913 GN=PITPNB PE=1 SV=3 PIPNB_BOVIN reviewed Phosphatidylinositol transfer protein beta isoform (PI-TP-beta) (PtdIns transfer protein beta) (PtdInsTP beta) (Phosphatidylinositol-transfer protein 36 kDa isoform) (PI-TP 36 kda isoform) Bos taurus (Bovine) GO:0000139; GO:0005737; GO:0005789; GO:0005794; GO:0006890; GO:0008525; GO:0008526; GO:0031210; GO:0035091; GO:0120019; GO:0140338 retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890] cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139] phosphatidylcholine binding [GO:0031210]; phosphatidylcholine transfer activity [GO:0120019]; phosphatidylcholine transporter activity [GO:0008525]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol transfer activity [GO:0008526]; sphingomyelin transfer activity [GO:0140338] g19275.t1 P00730 39.953 423 2.08e-99 305.0 sp|P00730|CBPA1_BOVIN Carboxypeptidase A1 OS=Bos taurus OX=9913 GN=CPA1 PE=1 SV=3 CBPA1_BOVIN reviewed Carboxypeptidase A1 (EC 3.4.17.1) Bos taurus (Bovine) GO:0004181; GO:0005615; GO:0006508; GO:0006691; GO:0008270 leukotriene metabolic process [GO:0006691]; proteolysis [GO:0006508] extracellular space [GO:0005615] metallocarboxypeptidase activity [GO:0004181]; zinc ion binding [GO:0008270] g19276.t1 Q68FB2 34.202 307 9.76e-50 170.0 sp|Q68FB2|TM248_XENTR Transmembrane protein 248 OS=Xenopus tropicalis OX=8364 GN=tmem248 PE=2 SV=1 g19277.t1 Q9Y6X9 57.07 587 0.0 664.0 sp|Q9Y6X9|MORC2_HUMAN ATPase MORC2 OS=Homo sapiens OX=9606 GN=MORC2 PE=1 SV=2 MORC2_HUMAN reviewed ATPase MORC2 (EC 3.6.1.-) (MORC family CW-type zinc finger protein 2) (Zinc finger CW-type coiled-coil domain protein 1) Homo sapiens (Human) GO:0000287; GO:0000792; GO:0003682; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006338; GO:0006631; GO:0006974; GO:0008270; GO:0016363; GO:0016887; GO:0042802; GO:0042803; GO:0140658; GO:0140719; GO:0141005 chromatin remodeling [GO:0006338]; constitutive heterochromatin formation [GO:0140719]; DNA damage response [GO:0006974]; fatty acid metabolic process [GO:0006631]; transposable element silencing by heterochromatin formation [GO:0141005] cytoplasm [GO:0005737]; cytosol [GO:0005829]; heterochromatin [GO:0000792]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent chromatin remodeler activity [GO:0140658]; chromatin binding [GO:0003682]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; protein homodimerization activity [GO:0042803]; zinc ion binding [GO:0008270] g19277.t2 Q9Y6X9 57.192 584 0.0 660.0 sp|Q9Y6X9|MORC2_HUMAN ATPase MORC2 OS=Homo sapiens OX=9606 GN=MORC2 PE=1 SV=2 MORC2_HUMAN reviewed ATPase MORC2 (EC 3.6.1.-) (MORC family CW-type zinc finger protein 2) (Zinc finger CW-type coiled-coil domain protein 1) Homo sapiens (Human) GO:0000287; GO:0000792; GO:0003682; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006338; GO:0006631; GO:0006974; GO:0008270; GO:0016363; GO:0016887; GO:0042802; GO:0042803; GO:0140658; GO:0140719; GO:0141005 chromatin remodeling [GO:0006338]; constitutive heterochromatin formation [GO:0140719]; DNA damage response [GO:0006974]; fatty acid metabolic process [GO:0006631]; transposable element silencing by heterochromatin formation [GO:0141005] cytoplasm [GO:0005737]; cytosol [GO:0005829]; heterochromatin [GO:0000792]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent chromatin remodeler activity [GO:0140658]; chromatin binding [GO:0003682]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; protein homodimerization activity [GO:0042803]; zinc ion binding [GO:0008270] g19281.t1 Q5SPX3 33.208 265 3.83e-38 142.0 sp|Q5SPX3|RN215_MOUSE RING finger protein 215 OS=Mus musculus OX=10090 GN=Rnf215 PE=2 SV=1 g19286.t1 Q32NQ8 36.927 807 7.15e-144 446.0 sp|Q32NQ8|RNF10_XENLA E3 ubiquitin-protein ligase RNF10 OS=Xenopus laevis OX=8355 GN=rnf10 PE=2 SV=1 g19287.t1 Q4R941 71.698 106 8.85e-57 174.0 sp|Q4R941|SPT4H_MACFA Transcription elongation factor SPT4 OS=Macaca fascicularis OX=9541 GN=SUPT4H1 PE=1 SV=1 g19288.t1 Q5M782 35.088 228 2.82e-31 117.0 sp|Q5M782|RIPB_XENLA RPA-interacting protein B OS=Xenopus laevis OX=8355 GN=rpain-b PE=2 SV=2 g19289.t1 Q9C086 43.386 189 4.66e-26 110.0 sp|Q9C086|IN80B_HUMAN INO80 complex subunit B OS=Homo sapiens OX=9606 GN=INO80B PE=1 SV=2 g19290.t1 O35551 40.633 411 1.0200000000000001e-66 244.0 sp|O35551|RABE1_MOUSE Rab GTPase-binding effector protein 1 OS=Mus musculus OX=10090 GN=Rabep1 PE=1 SV=2 RABE1_MOUSE reviewed Rab GTPase-binding effector protein 1 (Rabaptin-5) (Rabaptin-5alpha) Mus musculus (Mouse) GO:0005096; GO:0005768; GO:0005769; GO:0005829; GO:0006893; GO:0006897; GO:0006915; GO:0008083; GO:0015031; GO:0016192; GO:0019904; GO:0030139; GO:0032991; GO:0042803; GO:0055037; GO:0098978; GO:0099149; GO:0099523; GO:1903441 apoptotic process [GO:0006915]; endocytosis [GO:0006897]; Golgi to plasma membrane transport [GO:0006893]; protein localization to ciliary membrane [GO:1903441]; protein transport [GO:0015031]; regulation of postsynaptic neurotransmitter receptor internalization [GO:0099149]; vesicle-mediated transport [GO:0016192] cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; glutamatergic synapse [GO:0098978]; presynaptic cytosol [GO:0099523]; protein-containing complex [GO:0032991]; recycling endosome [GO:0055037] growth factor activity [GO:0008083]; GTPase activator activity [GO:0005096]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803] g19290.t1 O35551 49.479 192 6.48e-32 138.0 sp|O35551|RABE1_MOUSE Rab GTPase-binding effector protein 1 OS=Mus musculus OX=10090 GN=Rabep1 PE=1 SV=2 RABE1_MOUSE reviewed Rab GTPase-binding effector protein 1 (Rabaptin-5) (Rabaptin-5alpha) Mus musculus (Mouse) GO:0005096; GO:0005768; GO:0005769; GO:0005829; GO:0006893; GO:0006897; GO:0006915; GO:0008083; GO:0015031; GO:0016192; GO:0019904; GO:0030139; GO:0032991; GO:0042803; GO:0055037; GO:0098978; GO:0099149; GO:0099523; GO:1903441 apoptotic process [GO:0006915]; endocytosis [GO:0006897]; Golgi to plasma membrane transport [GO:0006893]; protein localization to ciliary membrane [GO:1903441]; protein transport [GO:0015031]; regulation of postsynaptic neurotransmitter receptor internalization [GO:0099149]; vesicle-mediated transport [GO:0016192] cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; glutamatergic synapse [GO:0098978]; presynaptic cytosol [GO:0099523]; protein-containing complex [GO:0032991]; recycling endosome [GO:0055037] growth factor activity [GO:0008083]; GTPase activator activity [GO:0005096]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803] g19290.t2 Q15276 38.71 465 4.9899999999999996e-67 245.0 sp|Q15276|RABE1_HUMAN Rab GTPase-binding effector protein 1 OS=Homo sapiens OX=9606 GN=RABEP1 PE=1 SV=2 RABE1_HUMAN reviewed Rab GTPase-binding effector protein 1 (Rabaptin-4) (Rabaptin-5) (Rabaptin-5alpha) (Renal carcinoma antigen NY-REN-17) Homo sapiens (Human) GO:0005096; GO:0005768; GO:0005769; GO:0005829; GO:0006893; GO:0006897; GO:0006915; GO:0008083; GO:0015031; GO:0016192; GO:0019904; GO:0030139; GO:0031901; GO:0032991; GO:0042803; GO:0055037; GO:0061025; GO:0098978; GO:0099149; GO:1903441 apoptotic process [GO:0006915]; endocytosis [GO:0006897]; Golgi to plasma membrane transport [GO:0006893]; membrane fusion [GO:0061025]; protein localization to ciliary membrane [GO:1903441]; protein transport [GO:0015031]; regulation of postsynaptic neurotransmitter receptor internalization [GO:0099149]; vesicle-mediated transport [GO:0016192] cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; glutamatergic synapse [GO:0098978]; protein-containing complex [GO:0032991]; recycling endosome [GO:0055037] growth factor activity [GO:0008083]; GTPase activator activity [GO:0005096]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803] g19290.t2 Q15276 49.479 192 5.63e-32 138.0 sp|Q15276|RABE1_HUMAN Rab GTPase-binding effector protein 1 OS=Homo sapiens OX=9606 GN=RABEP1 PE=1 SV=2 RABE1_HUMAN reviewed Rab GTPase-binding effector protein 1 (Rabaptin-4) (Rabaptin-5) (Rabaptin-5alpha) (Renal carcinoma antigen NY-REN-17) Homo sapiens (Human) GO:0005096; GO:0005768; GO:0005769; GO:0005829; GO:0006893; GO:0006897; GO:0006915; GO:0008083; GO:0015031; GO:0016192; GO:0019904; GO:0030139; GO:0031901; GO:0032991; GO:0042803; GO:0055037; GO:0061025; GO:0098978; GO:0099149; GO:1903441 apoptotic process [GO:0006915]; endocytosis [GO:0006897]; Golgi to plasma membrane transport [GO:0006893]; membrane fusion [GO:0061025]; protein localization to ciliary membrane [GO:1903441]; protein transport [GO:0015031]; regulation of postsynaptic neurotransmitter receptor internalization [GO:0099149]; vesicle-mediated transport [GO:0016192] cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; glutamatergic synapse [GO:0098978]; protein-containing complex [GO:0032991]; recycling endosome [GO:0055037] growth factor activity [GO:0008083]; GTPase activator activity [GO:0005096]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803] g19294.t1 Q96AB6 40.78 282 7.33e-75 235.0 sp|Q96AB6|NTAN1_HUMAN Protein N-terminal asparagine amidohydrolase OS=Homo sapiens OX=9606 GN=NTAN1 PE=1 SV=3 NTAN1_HUMAN reviewed Protein N-terminal asparagine amidohydrolase (EC 3.5.1.121) (Protein NH2-terminal asparagine amidohydrolase) (PNAA) (Protein NH2-terminal asparagine deamidase) (PNAD) (Protein N-terminal Asn amidase) (Protein N-terminal asparagine amidase) (Protein NTN-amidase) Homo sapiens (Human) GO:0005634; GO:0005737; GO:0006511; GO:0007613; GO:0008344; GO:0008418 adult locomotory behavior [GO:0008344]; memory [GO:0007613]; ubiquitin-dependent protein catabolic process [GO:0006511] cytoplasm [GO:0005737]; nucleus [GO:0005634] protein-N-terminal asparagine amidohydrolase activity [GO:0008418] g19295.t1 Q91618 44.819 386 2.8e-93 299.0 sp|Q91618|PMYT1_XENLA Membrane-associated tyrosine- and threonine-specific cdc2-inhibitory kinase OS=Xenopus laevis OX=8355 GN=pkmyt1 PE=1 SV=1 PMYT1_XENLA reviewed Membrane-associated tyrosine- and threonine-specific cdc2-inhibitory kinase (EC 2.7.11.1) (Myt1 kinase) Xenopus laevis (African clawed frog) GO:0000139; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005789; GO:0007088; GO:0010972; GO:0046872; GO:0051321; GO:0106310; GO:0110031 meiotic cell cycle [GO:0051321]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; negative regulation of G2/MI transition of meiotic cell cycle [GO:0110031]; regulation of mitotic nuclear division [GO:0007088] cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; nucleus [GO:0005634] ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g19297.t1 Q7Z449 35.412 449 3.1e-85 277.0 sp|Q7Z449|CP2U1_HUMAN Cytochrome P450 2U1 OS=Homo sapiens OX=9606 GN=CYP2U1 PE=1 SV=1 CP2U1_HUMAN reviewed Cytochrome P450 2U1 (Long-chain fatty acid omega-monooxygenase) (EC 1.14.14.80) Homo sapiens (Human) GO:0004497; GO:0005506; GO:0005737; GO:0005743; GO:0005789; GO:0006082; GO:0006805; GO:0008202; GO:0008395; GO:0016712; GO:0020037; GO:0052869; GO:0097267; GO:0102033; GO:1903604 cytochrome metabolic process [GO:1903604]; omega-hydroxylase P450 pathway [GO:0097267]; organic acid metabolic process [GO:0006082]; steroid metabolic process [GO:0008202]; xenobiotic metabolic process [GO:0006805] cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; mitochondrial inner membrane [GO:0005743] arachidonate omega-hydroxylase activity [GO:0052869]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; long-chain fatty acid omega-hydroxylase activity [GO:0102033]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; steroid hydroxylase activity [GO:0008395] g19298.t1 O54750 40.181 331 1.14e-76 249.0 sp|O54750|CP2J6_MOUSE Cytochrome P450 2J6 OS=Mus musculus OX=10090 GN=Cyp2j6 PE=2 SV=2 g19300.t1 Q9X248 37.698 252 1.59e-43 150.0 sp|Q9X248|FABG_THEMA 3-oxoacyl-[acyl-carrier-protein] reductase FabG OS=Thermotoga maritima (strain ATCC 43589 / DSM 3109 / JCM 10099 / NBRC 100826 / MSB8) OX=243274 GN=fabG PE=3 SV=1 g19301.t1 Q9X248 36.111 252 3.6300000000000004e-35 128.0 sp|Q9X248|FABG_THEMA 3-oxoacyl-[acyl-carrier-protein] reductase FabG OS=Thermotoga maritima (strain ATCC 43589 / DSM 3109 / JCM 10099 / NBRC 100826 / MSB8) OX=243274 GN=fabG PE=3 SV=1 g19302.t1 Q5SV80 42.788 832 0.0 625.0 sp|Q5SV80|MYO19_MOUSE Unconventional myosin-XIX OS=Mus musculus OX=10090 GN=Myo19 PE=1 SV=1 MYO19_MOUSE reviewed Unconventional myosin-XIX (Myosin head domain-containing protein 1) Mus musculus (Mouse) GO:0000146; GO:0003779; GO:0005524; GO:0005737; GO:0005739; GO:0005741; GO:0005829; GO:0006897; GO:0007015; GO:0015629; GO:0016020; GO:0016459; GO:0016887; GO:0032027; GO:0032465; GO:0034642; GO:0051015; GO:0060002; GO:0090140; GO:0160040 actin filament organization [GO:0007015]; endocytosis [GO:0006897]; mitochondrion migration along actin filament [GO:0034642]; mitocytosis [GO:0160040]; regulation of cytokinesis [GO:0032465]; regulation of mitochondrial fission [GO:0090140] actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; myosin complex [GO:0016459] actin binding [GO:0003779]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microfilament motor activity [GO:0000146]; myosin light chain binding [GO:0032027]; plus-end directed microfilament motor activity [GO:0060002] g19304.t1 P49020 80.769 182 4.32e-114 326.0 sp|P49020|TMED2_CRIGR Transmembrane emp24 domain-containing protein 2 (Fragment) OS=Cricetulus griseus OX=10029 GN=TMED2 PE=1 SV=1 g19305.t1 A3KN83 59.025 1313 0.0 1419.0 sp|A3KN83|SBNO1_HUMAN Protein strawberry notch homolog 1 OS=Homo sapiens OX=9606 GN=SBNO1 PE=1 SV=1 SBNO1_HUMAN reviewed Protein strawberry notch homolog 1 (Monocyte protein 3) (MOP-3) Homo sapiens (Human) GO:0005634; GO:0006355; GO:0006954; GO:0016055; GO:0031490; GO:0042393; GO:0043124; GO:0043409; GO:0090263; GO:0150079; GO:2000179 inflammatory response [GO:0006954]; negative regulation of canonical NF-kappaB signal transduction [GO:0043124]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of neuroinflammatory response [GO:0150079]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of neural precursor cell proliferation [GO:2000179]; regulation of DNA-templated transcription [GO:0006355]; Wnt signaling pathway [GO:0016055] nucleus [GO:0005634] chromatin DNA binding [GO:0031490]; histone binding [GO:0042393] g19305.t2 A3KN83 59.025 1313 0.0 1419.0 sp|A3KN83|SBNO1_HUMAN Protein strawberry notch homolog 1 OS=Homo sapiens OX=9606 GN=SBNO1 PE=1 SV=1 SBNO1_HUMAN reviewed Protein strawberry notch homolog 1 (Monocyte protein 3) (MOP-3) Homo sapiens (Human) GO:0005634; GO:0006355; GO:0006954; GO:0016055; GO:0031490; GO:0042393; GO:0043124; GO:0043409; GO:0090263; GO:0150079; GO:2000179 inflammatory response [GO:0006954]; negative regulation of canonical NF-kappaB signal transduction [GO:0043124]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of neuroinflammatory response [GO:0150079]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of neural precursor cell proliferation [GO:2000179]; regulation of DNA-templated transcription [GO:0006355]; Wnt signaling pathway [GO:0016055] nucleus [GO:0005634] chromatin DNA binding [GO:0031490]; histone binding [GO:0042393] g19306.t1 Q8L7W2 38.039 255 1.9900000000000002e-56 188.0 sp|Q8L7W2|NUDT8_ARATH Nudix hydrolase 8 OS=Arabidopsis thaliana OX=3702 GN=NUDT8 PE=2 SV=2 g19307.t1 Q0V9E9 57.143 182 8.73e-63 207.0 sp|Q0V9E9|KMT5A_XENTR N-lysine methyltransferase KMT5A OS=Xenopus tropicalis OX=8364 GN=kmt5a PE=2 SV=1 KMT5A_XENTR reviewed N-lysine methyltransferase KMT5A (EC 2.1.1.-) (Histone-lysine N-methyltransferase KMT5A) (EC 2.1.1.361) (Lysine-specific methylase 5A) (SET domain-containing protein 8) Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0005634; GO:0005700; GO:0006357; GO:0032259; GO:0042054; GO:0042799; GO:0043516; GO:0051301; GO:0140944 cell division [GO:0051301]; methylation [GO:0032259]; regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043516]; regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634]; polytene chromosome [GO:0005700] histone H4K20 methyltransferase activity [GO:0042799]; histone H4K20 monomethyltransferase activity [GO:0140944]; histone methyltransferase activity [GO:0042054] g19310.t1 Q8UVK2 59.223 1133 0.0 1348.0 sp|Q8UVK2|SPT6H_DANRE Transcription elongation factor SPT6 OS=Danio rerio OX=7955 GN=supt6h PE=1 SV=1 g19310.t1 Q8UVK2 58.571 280 6.74e-69 262.0 sp|Q8UVK2|SPT6H_DANRE Transcription elongation factor SPT6 OS=Danio rerio OX=7955 GN=supt6h PE=1 SV=1 g19311.t1 Q6AY87 47.059 340 2.31e-106 317.0 sp|Q6AY87|THOC6_RAT THO complex subunit 6 homolog OS=Rattus norvegicus OX=10116 GN=Thoc6 PE=2 SV=1 THOC6_RAT reviewed THO complex subunit 6 homolog (WD repeat-containing protein 58) Rattus norvegicus (Rat) GO:0000346; GO:0000347; GO:0000445; GO:0000781; GO:0003723; GO:0005634; GO:0005654; GO:0006397; GO:0006406; GO:0006915; GO:0007417; GO:0008380; GO:0016604; GO:0016607 apoptotic process [GO:0006915]; central nervous system development [GO:0007417]; mRNA export from nucleus [GO:0006406]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380] chromosome, telomeric region [GO:0000781]; nuclear body [GO:0016604]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; THO complex [GO:0000347]; THO complex part of transcription export complex [GO:0000445]; transcription export complex [GO:0000346] RNA binding [GO:0003723] g19312.t1 Q869C3 35.949 548 1.15e-81 277.0 sp|Q869C3|ACES_ANOGA Acetylcholinesterase OS=Anopheles gambiae OX=7165 GN=Ace PE=1 SV=3 g19313.t1 P21783 35.738 915 4.9499999999999996e-102 355.0 sp|P21783|NOTC1_XENLA Neurogenic locus notch homolog protein 1 OS=Xenopus laevis OX=8355 GN=notch1 PE=1 SV=3 g19313.t1 P21783 34.582 934 5.04e-100 349.0 sp|P21783|NOTC1_XENLA Neurogenic locus notch homolog protein 1 OS=Xenopus laevis OX=8355 GN=notch1 PE=1 SV=3 g19313.t1 P21783 33.507 958 4.65e-96 337.0 sp|P21783|NOTC1_XENLA Neurogenic locus notch homolog protein 1 OS=Xenopus laevis OX=8355 GN=notch1 PE=1 SV=3 g19313.t1 P21783 33.692 929 5.01e-92 325.0 sp|P21783|NOTC1_XENLA Neurogenic locus notch homolog protein 1 OS=Xenopus laevis OX=8355 GN=notch1 PE=1 SV=3 g19313.t1 P21783 31.828 886 4.8e-81 292.0 sp|P21783|NOTC1_XENLA Neurogenic locus notch homolog protein 1 OS=Xenopus laevis OX=8355 GN=notch1 PE=1 SV=3 g19313.t1 P21783 31.91 890 2.04e-75 275.0 sp|P21783|NOTC1_XENLA Neurogenic locus notch homolog protein 1 OS=Xenopus laevis OX=8355 GN=notch1 PE=1 SV=3 g19313.t1 P21783 34.051 790 7.5e-74 270.0 sp|P21783|NOTC1_XENLA Neurogenic locus notch homolog protein 1 OS=Xenopus laevis OX=8355 GN=notch1 PE=1 SV=3 g19313.t1 P21783 33.333 624 6.47e-58 221.0 sp|P21783|NOTC1_XENLA Neurogenic locus notch homolog protein 1 OS=Xenopus laevis OX=8355 GN=notch1 PE=1 SV=3 g19313.t1 P21783 35.417 528 1.23e-57 221.0 sp|P21783|NOTC1_XENLA Neurogenic locus notch homolog protein 1 OS=Xenopus laevis OX=8355 GN=notch1 PE=1 SV=3 g19313.t1 P21783 32.119 604 4.309999999999999e-52 203.0 sp|P21783|NOTC1_XENLA Neurogenic locus notch homolog protein 1 OS=Xenopus laevis OX=8355 GN=notch1 PE=1 SV=3 g19314.t1 P58355 27.068 266 2.1899999999999998e-25 114.0 sp|P58355|S45A2_MOUSE Membrane-associated transporter protein OS=Mus musculus OX=10090 GN=Slc45a2 PE=1 SV=1 S45A2_MOUSE reviewed Membrane-associated transporter protein (Melanoma antigen AIM1) (Protein AIM-1) (Protein underwhite) (Solute carrier family 45 member 2) Mus musculus (Mouse) GO:0005356; GO:0006583; GO:0007601; GO:0008506; GO:0015770; GO:0016020; GO:0033162; GO:0035752; GO:0048066 developmental pigmentation [GO:0048066]; lysosomal lumen pH elevation [GO:0035752]; melanin biosynthetic process from tyrosine [GO:0006583]; sucrose transport [GO:0015770]; visual perception [GO:0007601] melanosome membrane [GO:0033162]; membrane [GO:0016020] D-glucose:proton symporter activity [GO:0005356]; sucrose:proton symporter activity [GO:0008506] g19315.t1 Q29042 46.288 229 3.98e-53 181.0 sp|Q29042|FCN1_PIG Ficolin-1 OS=Sus scrofa OX=9823 GN=FCN1 PE=1 SV=1 FCN1_PIG reviewed Ficolin-1 (Ficolin-A) (Ficolin-alpha) Sus scrofa (Pig) GO:0001867; GO:0003823; GO:0005102; GO:0005581; GO:0005615; GO:0005886; GO:0030246; GO:0033691; GO:0038187; GO:0046872; GO:0097367; GO:0106139 complement activation, lectin pathway [GO:0001867] collagen trimer [GO:0005581]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; symbiont cell surface [GO:0106139] antigen binding [GO:0003823]; carbohydrate binding [GO:0030246]; carbohydrate derivative binding [GO:0097367]; metal ion binding [GO:0046872]; pattern recognition receptor activity [GO:0038187]; sialic acid binding [GO:0033691]; signaling receptor binding [GO:0005102] g19316.t1 P61315 36.771 223 1.2599999999999999e-30 122.0 sp|P61315|G3ST3_MOUSE Galactose-3-O-sulfotransferase 3 OS=Mus musculus OX=10090 GN=Gal3st3 PE=2 SV=1 g19317.t1 Q90Y54 31.604 424 8.150000000000001e-37 149.0 sp|Q90Y54|JAG1B_DANRE Protein jagged-1b OS=Danio rerio OX=7955 GN=jag1b PE=2 SV=1 JAG1B_DANRE reviewed Protein jagged-1b (Jagged1b) (Jagged3) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001889; GO:0005112; GO:0005509; GO:0005886; GO:0007219; GO:0009913; GO:0009953; GO:0016020; GO:0030878; GO:0031016; GO:0031017; GO:0031101; GO:0032474; GO:0035622; GO:0042472; GO:0048752; GO:0060117; GO:0060325; GO:0060351; GO:0060872; GO:0061008; GO:1904888 auditory receptor cell development [GO:0060117]; cartilage development involved in endochondral bone morphogenesis [GO:0060351]; cranial skeletal system development [GO:1904888]; dorsal/ventral pattern formation [GO:0009953]; epidermal cell differentiation [GO:0009913]; exocrine pancreas development [GO:0031017]; face morphogenesis [GO:0060325]; fin regeneration [GO:0031101]; hepaticobiliary system development [GO:0061008]; inner ear morphogenesis [GO:0042472]; intrahepatic bile duct development [GO:0035622]; liver development [GO:0001889]; Notch signaling pathway [GO:0007219]; otolith morphogenesis [GO:0032474]; pancreas development [GO:0031016]; semicircular canal development [GO:0060872]; semicircular canal morphogenesis [GO:0048752]; thyroid gland development [GO:0030878] membrane [GO:0016020]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; Notch binding [GO:0005112] g19317.t1 Q90Y54 29.954 434 2.62e-24 111.0 sp|Q90Y54|JAG1B_DANRE Protein jagged-1b OS=Danio rerio OX=7955 GN=jag1b PE=2 SV=1 JAG1B_DANRE reviewed Protein jagged-1b (Jagged1b) (Jagged3) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001889; GO:0005112; GO:0005509; GO:0005886; GO:0007219; GO:0009913; GO:0009953; GO:0016020; GO:0030878; GO:0031016; GO:0031017; GO:0031101; GO:0032474; GO:0035622; GO:0042472; GO:0048752; GO:0060117; GO:0060325; GO:0060351; GO:0060872; GO:0061008; GO:1904888 auditory receptor cell development [GO:0060117]; cartilage development involved in endochondral bone morphogenesis [GO:0060351]; cranial skeletal system development [GO:1904888]; dorsal/ventral pattern formation [GO:0009953]; epidermal cell differentiation [GO:0009913]; exocrine pancreas development [GO:0031017]; face morphogenesis [GO:0060325]; fin regeneration [GO:0031101]; hepaticobiliary system development [GO:0061008]; inner ear morphogenesis [GO:0042472]; intrahepatic bile duct development [GO:0035622]; liver development [GO:0001889]; Notch signaling pathway [GO:0007219]; otolith morphogenesis [GO:0032474]; pancreas development [GO:0031016]; semicircular canal development [GO:0060872]; semicircular canal morphogenesis [GO:0048752]; thyroid gland development [GO:0030878] membrane [GO:0016020]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; Notch binding [GO:0005112] g19317.t1 Q90Y54 30.168 358 2.18e-22 105.0 sp|Q90Y54|JAG1B_DANRE Protein jagged-1b OS=Danio rerio OX=7955 GN=jag1b PE=2 SV=1 JAG1B_DANRE reviewed Protein jagged-1b (Jagged1b) (Jagged3) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001889; GO:0005112; GO:0005509; GO:0005886; GO:0007219; GO:0009913; GO:0009953; GO:0016020; GO:0030878; GO:0031016; GO:0031017; GO:0031101; GO:0032474; GO:0035622; GO:0042472; GO:0048752; GO:0060117; GO:0060325; GO:0060351; GO:0060872; GO:0061008; GO:1904888 auditory receptor cell development [GO:0060117]; cartilage development involved in endochondral bone morphogenesis [GO:0060351]; cranial skeletal system development [GO:1904888]; dorsal/ventral pattern formation [GO:0009953]; epidermal cell differentiation [GO:0009913]; exocrine pancreas development [GO:0031017]; face morphogenesis [GO:0060325]; fin regeneration [GO:0031101]; hepaticobiliary system development [GO:0061008]; inner ear morphogenesis [GO:0042472]; intrahepatic bile duct development [GO:0035622]; liver development [GO:0001889]; Notch signaling pathway [GO:0007219]; otolith morphogenesis [GO:0032474]; pancreas development [GO:0031016]; semicircular canal development [GO:0060872]; semicircular canal morphogenesis [GO:0048752]; thyroid gland development [GO:0030878] membrane [GO:0016020]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; Notch binding [GO:0005112] g19317.t1 Q90Y54 28.736 435 2.6600000000000002e-21 101.0 sp|Q90Y54|JAG1B_DANRE Protein jagged-1b OS=Danio rerio OX=7955 GN=jag1b PE=2 SV=1 JAG1B_DANRE reviewed Protein jagged-1b (Jagged1b) (Jagged3) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001889; GO:0005112; GO:0005509; GO:0005886; GO:0007219; GO:0009913; GO:0009953; GO:0016020; GO:0030878; GO:0031016; GO:0031017; GO:0031101; GO:0032474; GO:0035622; GO:0042472; GO:0048752; GO:0060117; GO:0060325; GO:0060351; GO:0060872; GO:0061008; GO:1904888 auditory receptor cell development [GO:0060117]; cartilage development involved in endochondral bone morphogenesis [GO:0060351]; cranial skeletal system development [GO:1904888]; dorsal/ventral pattern formation [GO:0009953]; epidermal cell differentiation [GO:0009913]; exocrine pancreas development [GO:0031017]; face morphogenesis [GO:0060325]; fin regeneration [GO:0031101]; hepaticobiliary system development [GO:0061008]; inner ear morphogenesis [GO:0042472]; intrahepatic bile duct development [GO:0035622]; liver development [GO:0001889]; Notch signaling pathway [GO:0007219]; otolith morphogenesis [GO:0032474]; pancreas development [GO:0031016]; semicircular canal development [GO:0060872]; semicircular canal morphogenesis [GO:0048752]; thyroid gland development [GO:0030878] membrane [GO:0016020]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; Notch binding [GO:0005112] g19317.t2 Q04721 33.956 321 1.3e-34 141.0 sp|Q04721|NOTC2_HUMAN Neurogenic locus notch homolog protein 2 OS=Homo sapiens OX=9606 GN=NOTCH2 PE=1 SV=3 NOTC2_HUMAN reviewed Neurogenic locus notch homolog protein 2 (Notch 2) (hN2) [Cleaved into: Notch 2 extracellular truncation (N2ECD); Notch 2 intracellular domain (N2ICD)] Homo sapiens (Human) GO:0000122; GO:0000139; GO:0001701; GO:0001709; GO:0001947; GO:0002011; GO:0002315; GO:0002437; GO:0003162; GO:0003184; GO:0003713; GO:0005509; GO:0005576; GO:0005634; GO:0005654; GO:0005789; GO:0005794; GO:0005886; GO:0005929; GO:0006915; GO:0006959; GO:0007219; GO:0007399; GO:0007411; GO:0009887; GO:0009986; GO:0010629; GO:0010838; GO:0016020; GO:0019899; GO:0030097; GO:0030326; GO:0030509; GO:0030513; GO:0035264; GO:0035556; GO:0035622; GO:0038023; GO:0042060; GO:0042742; GO:0043011; GO:0043065; GO:0043066; GO:0043235; GO:0045672; GO:0045944; GO:0046579; GO:0046849; GO:0051059; GO:0051152; GO:0060413; GO:0060674; GO:0061073; GO:0070374; GO:0070986; GO:0071228; GO:0072014; GO:0072015; GO:0072104; GO:0072574; GO:1902895; GO:1990705; GO:2001204 animal organ morphogenesis [GO:0009887]; apoptotic process [GO:0006915]; atrial septum morphogenesis [GO:0060413]; atrioventricular node development [GO:0003162]; axon guidance [GO:0007411]; BMP signaling pathway [GO:0030509]; bone remodeling [GO:0046849]; cell fate determination [GO:0001709]; cellular response to tumor cell [GO:0071228]; cholangiocyte proliferation [GO:1990705]; ciliary body morphogenesis [GO:0061073]; defense response to bacterium [GO:0042742]; embryonic limb morphogenesis [GO:0030326]; glomerular capillary formation [GO:0072104]; heart looping [GO:0001947]; hemopoiesis [GO:0030097]; hepatocyte proliferation [GO:0072574]; humoral immune response [GO:0006959]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; intracellular signal transduction [GO:0035556]; intrahepatic bile duct development [GO:0035622]; left/right axis specification [GO:0070986]; marginal zone B cell differentiation [GO:0002315]; morphogenesis of an epithelial sheet [GO:0002011]; multicellular organism growth [GO:0035264]; myeloid dendritic cell differentiation [GO:0043011]; negative regulation of apoptotic process [GO:0043066]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]; Notch signaling pathway [GO:0007219]; placenta blood vessel development [GO:0060674]; podocyte development [GO:0072015]; positive regulation of apoptotic process [GO:0043065]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of keratinocyte proliferation [GO:0010838]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of smooth muscle cell differentiation [GO:0051152]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proximal tubule development [GO:0072014]; pulmonary valve morphogenesis [GO:0003184]; regulation of osteoclast development [GO:2001204]; wound healing [GO:0042060] cell surface [GO:0009986]; cilium [GO:0005929]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; enzyme binding [GO:0019899]; NF-kappaB binding [GO:0051059]; signaling receptor activity [GO:0038023]; transcription coactivator activity [GO:0003713] g19317.t2 Q04721 29.863 365 3.03e-27 119.0 sp|Q04721|NOTC2_HUMAN Neurogenic locus notch homolog protein 2 OS=Homo sapiens OX=9606 GN=NOTCH2 PE=1 SV=3 NOTC2_HUMAN reviewed Neurogenic locus notch homolog protein 2 (Notch 2) (hN2) [Cleaved into: Notch 2 extracellular truncation (N2ECD); Notch 2 intracellular domain (N2ICD)] Homo sapiens (Human) GO:0000122; GO:0000139; GO:0001701; GO:0001709; GO:0001947; GO:0002011; GO:0002315; GO:0002437; GO:0003162; GO:0003184; GO:0003713; GO:0005509; GO:0005576; GO:0005634; GO:0005654; GO:0005789; GO:0005794; GO:0005886; GO:0005929; GO:0006915; GO:0006959; GO:0007219; GO:0007399; GO:0007411; GO:0009887; GO:0009986; GO:0010629; GO:0010838; GO:0016020; GO:0019899; GO:0030097; GO:0030326; GO:0030509; GO:0030513; GO:0035264; GO:0035556; GO:0035622; GO:0038023; GO:0042060; GO:0042742; GO:0043011; GO:0043065; GO:0043066; GO:0043235; GO:0045672; GO:0045944; GO:0046579; GO:0046849; GO:0051059; GO:0051152; GO:0060413; GO:0060674; GO:0061073; GO:0070374; GO:0070986; GO:0071228; GO:0072014; GO:0072015; GO:0072104; GO:0072574; GO:1902895; GO:1990705; GO:2001204 animal organ morphogenesis [GO:0009887]; apoptotic process [GO:0006915]; atrial septum morphogenesis [GO:0060413]; atrioventricular node development [GO:0003162]; axon guidance [GO:0007411]; BMP signaling pathway [GO:0030509]; bone remodeling [GO:0046849]; cell fate determination [GO:0001709]; cellular response to tumor cell [GO:0071228]; cholangiocyte proliferation [GO:1990705]; ciliary body morphogenesis [GO:0061073]; defense response to bacterium [GO:0042742]; embryonic limb morphogenesis [GO:0030326]; glomerular capillary formation [GO:0072104]; heart looping [GO:0001947]; hemopoiesis [GO:0030097]; hepatocyte proliferation [GO:0072574]; humoral immune response [GO:0006959]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; intracellular signal transduction [GO:0035556]; intrahepatic bile duct development [GO:0035622]; left/right axis specification [GO:0070986]; marginal zone B cell differentiation [GO:0002315]; morphogenesis of an epithelial sheet [GO:0002011]; multicellular organism growth [GO:0035264]; myeloid dendritic cell differentiation [GO:0043011]; negative regulation of apoptotic process [GO:0043066]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]; Notch signaling pathway [GO:0007219]; placenta blood vessel development [GO:0060674]; podocyte development [GO:0072015]; positive regulation of apoptotic process [GO:0043065]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of keratinocyte proliferation [GO:0010838]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of smooth muscle cell differentiation [GO:0051152]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proximal tubule development [GO:0072014]; pulmonary valve morphogenesis [GO:0003184]; regulation of osteoclast development [GO:2001204]; wound healing [GO:0042060] cell surface [GO:0009986]; cilium [GO:0005929]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; enzyme binding [GO:0019899]; NF-kappaB binding [GO:0051059]; signaling receptor activity [GO:0038023]; transcription coactivator activity [GO:0003713] g19317.t2 Q04721 31.056 322 8.26e-22 103.0 sp|Q04721|NOTC2_HUMAN Neurogenic locus notch homolog protein 2 OS=Homo sapiens OX=9606 GN=NOTCH2 PE=1 SV=3 NOTC2_HUMAN reviewed Neurogenic locus notch homolog protein 2 (Notch 2) (hN2) [Cleaved into: Notch 2 extracellular truncation (N2ECD); Notch 2 intracellular domain (N2ICD)] Homo sapiens (Human) GO:0000122; GO:0000139; GO:0001701; GO:0001709; GO:0001947; GO:0002011; GO:0002315; GO:0002437; GO:0003162; GO:0003184; GO:0003713; GO:0005509; GO:0005576; GO:0005634; GO:0005654; GO:0005789; GO:0005794; GO:0005886; GO:0005929; GO:0006915; GO:0006959; GO:0007219; GO:0007399; GO:0007411; GO:0009887; GO:0009986; GO:0010629; GO:0010838; GO:0016020; GO:0019899; GO:0030097; GO:0030326; GO:0030509; GO:0030513; GO:0035264; GO:0035556; GO:0035622; GO:0038023; GO:0042060; GO:0042742; GO:0043011; GO:0043065; GO:0043066; GO:0043235; GO:0045672; GO:0045944; GO:0046579; GO:0046849; GO:0051059; GO:0051152; GO:0060413; GO:0060674; GO:0061073; GO:0070374; GO:0070986; GO:0071228; GO:0072014; GO:0072015; GO:0072104; GO:0072574; GO:1902895; GO:1990705; GO:2001204 animal organ morphogenesis [GO:0009887]; apoptotic process [GO:0006915]; atrial septum morphogenesis [GO:0060413]; atrioventricular node development [GO:0003162]; axon guidance [GO:0007411]; BMP signaling pathway [GO:0030509]; bone remodeling [GO:0046849]; cell fate determination [GO:0001709]; cellular response to tumor cell [GO:0071228]; cholangiocyte proliferation [GO:1990705]; ciliary body morphogenesis [GO:0061073]; defense response to bacterium [GO:0042742]; embryonic limb morphogenesis [GO:0030326]; glomerular capillary formation [GO:0072104]; heart looping [GO:0001947]; hemopoiesis [GO:0030097]; hepatocyte proliferation [GO:0072574]; humoral immune response [GO:0006959]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; intracellular signal transduction [GO:0035556]; intrahepatic bile duct development [GO:0035622]; left/right axis specification [GO:0070986]; marginal zone B cell differentiation [GO:0002315]; morphogenesis of an epithelial sheet [GO:0002011]; multicellular organism growth [GO:0035264]; myeloid dendritic cell differentiation [GO:0043011]; negative regulation of apoptotic process [GO:0043066]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]; Notch signaling pathway [GO:0007219]; placenta blood vessel development [GO:0060674]; podocyte development [GO:0072015]; positive regulation of apoptotic process [GO:0043065]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of keratinocyte proliferation [GO:0010838]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of smooth muscle cell differentiation [GO:0051152]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proximal tubule development [GO:0072014]; pulmonary valve morphogenesis [GO:0003184]; regulation of osteoclast development [GO:2001204]; wound healing [GO:0042060] cell surface [GO:0009986]; cilium [GO:0005929]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; enzyme binding [GO:0019899]; NF-kappaB binding [GO:0051059]; signaling receptor activity [GO:0038023]; transcription coactivator activity [GO:0003713] g19317.t2 Q04721 28.954 373 2.0300000000000002e-21 102.0 sp|Q04721|NOTC2_HUMAN Neurogenic locus notch homolog protein 2 OS=Homo sapiens OX=9606 GN=NOTCH2 PE=1 SV=3 NOTC2_HUMAN reviewed Neurogenic locus notch homolog protein 2 (Notch 2) (hN2) [Cleaved into: Notch 2 extracellular truncation (N2ECD); Notch 2 intracellular domain (N2ICD)] Homo sapiens (Human) GO:0000122; GO:0000139; GO:0001701; GO:0001709; GO:0001947; GO:0002011; GO:0002315; GO:0002437; GO:0003162; GO:0003184; GO:0003713; GO:0005509; GO:0005576; GO:0005634; GO:0005654; GO:0005789; GO:0005794; GO:0005886; GO:0005929; GO:0006915; GO:0006959; GO:0007219; GO:0007399; GO:0007411; GO:0009887; GO:0009986; GO:0010629; GO:0010838; GO:0016020; GO:0019899; GO:0030097; GO:0030326; GO:0030509; GO:0030513; GO:0035264; GO:0035556; GO:0035622; GO:0038023; GO:0042060; GO:0042742; GO:0043011; GO:0043065; GO:0043066; GO:0043235; GO:0045672; GO:0045944; GO:0046579; GO:0046849; GO:0051059; GO:0051152; GO:0060413; GO:0060674; GO:0061073; GO:0070374; GO:0070986; GO:0071228; GO:0072014; GO:0072015; GO:0072104; GO:0072574; GO:1902895; GO:1990705; GO:2001204 animal organ morphogenesis [GO:0009887]; apoptotic process [GO:0006915]; atrial septum morphogenesis [GO:0060413]; atrioventricular node development [GO:0003162]; axon guidance [GO:0007411]; BMP signaling pathway [GO:0030509]; bone remodeling [GO:0046849]; cell fate determination [GO:0001709]; cellular response to tumor cell [GO:0071228]; cholangiocyte proliferation [GO:1990705]; ciliary body morphogenesis [GO:0061073]; defense response to bacterium [GO:0042742]; embryonic limb morphogenesis [GO:0030326]; glomerular capillary formation [GO:0072104]; heart looping [GO:0001947]; hemopoiesis [GO:0030097]; hepatocyte proliferation [GO:0072574]; humoral immune response [GO:0006959]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; intracellular signal transduction [GO:0035556]; intrahepatic bile duct development [GO:0035622]; left/right axis specification [GO:0070986]; marginal zone B cell differentiation [GO:0002315]; morphogenesis of an epithelial sheet [GO:0002011]; multicellular organism growth [GO:0035264]; myeloid dendritic cell differentiation [GO:0043011]; negative regulation of apoptotic process [GO:0043066]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]; Notch signaling pathway [GO:0007219]; placenta blood vessel development [GO:0060674]; podocyte development [GO:0072015]; positive regulation of apoptotic process [GO:0043065]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of keratinocyte proliferation [GO:0010838]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of smooth muscle cell differentiation [GO:0051152]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proximal tubule development [GO:0072014]; pulmonary valve morphogenesis [GO:0003184]; regulation of osteoclast development [GO:2001204]; wound healing [GO:0042060] cell surface [GO:0009986]; cilium [GO:0005929]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; enzyme binding [GO:0019899]; NF-kappaB binding [GO:0051059]; signaling receptor activity [GO:0038023]; transcription coactivator activity [GO:0003713] g19317.t3 Q90Y54 31.678 423 5.9400000000000004e-37 149.0 sp|Q90Y54|JAG1B_DANRE Protein jagged-1b OS=Danio rerio OX=7955 GN=jag1b PE=2 SV=1 JAG1B_DANRE reviewed Protein jagged-1b (Jagged1b) (Jagged3) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001889; GO:0005112; GO:0005509; GO:0005886; GO:0007219; GO:0009913; GO:0009953; GO:0016020; GO:0030878; GO:0031016; GO:0031017; GO:0031101; GO:0032474; GO:0035622; GO:0042472; GO:0048752; GO:0060117; GO:0060325; GO:0060351; GO:0060872; GO:0061008; GO:1904888 auditory receptor cell development [GO:0060117]; cartilage development involved in endochondral bone morphogenesis [GO:0060351]; cranial skeletal system development [GO:1904888]; dorsal/ventral pattern formation [GO:0009953]; epidermal cell differentiation [GO:0009913]; exocrine pancreas development [GO:0031017]; face morphogenesis [GO:0060325]; fin regeneration [GO:0031101]; hepaticobiliary system development [GO:0061008]; inner ear morphogenesis [GO:0042472]; intrahepatic bile duct development [GO:0035622]; liver development [GO:0001889]; Notch signaling pathway [GO:0007219]; otolith morphogenesis [GO:0032474]; pancreas development [GO:0031016]; semicircular canal development [GO:0060872]; semicircular canal morphogenesis [GO:0048752]; thyroid gland development [GO:0030878] membrane [GO:0016020]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; Notch binding [GO:0005112] g19317.t3 Q90Y54 30.168 358 2.01e-22 105.0 sp|Q90Y54|JAG1B_DANRE Protein jagged-1b OS=Danio rerio OX=7955 GN=jag1b PE=2 SV=1 JAG1B_DANRE reviewed Protein jagged-1b (Jagged1b) (Jagged3) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001889; GO:0005112; GO:0005509; GO:0005886; GO:0007219; GO:0009913; GO:0009953; GO:0016020; GO:0030878; GO:0031016; GO:0031017; GO:0031101; GO:0032474; GO:0035622; GO:0042472; GO:0048752; GO:0060117; GO:0060325; GO:0060351; GO:0060872; GO:0061008; GO:1904888 auditory receptor cell development [GO:0060117]; cartilage development involved in endochondral bone morphogenesis [GO:0060351]; cranial skeletal system development [GO:1904888]; dorsal/ventral pattern formation [GO:0009953]; epidermal cell differentiation [GO:0009913]; exocrine pancreas development [GO:0031017]; face morphogenesis [GO:0060325]; fin regeneration [GO:0031101]; hepaticobiliary system development [GO:0061008]; inner ear morphogenesis [GO:0042472]; intrahepatic bile duct development [GO:0035622]; liver development [GO:0001889]; Notch signaling pathway [GO:0007219]; otolith morphogenesis [GO:0032474]; pancreas development [GO:0031016]; semicircular canal development [GO:0060872]; semicircular canal morphogenesis [GO:0048752]; thyroid gland development [GO:0030878] membrane [GO:0016020]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; Notch binding [GO:0005112] g19317.t3 Q90Y54 28.736 435 2.32e-21 102.0 sp|Q90Y54|JAG1B_DANRE Protein jagged-1b OS=Danio rerio OX=7955 GN=jag1b PE=2 SV=1 JAG1B_DANRE reviewed Protein jagged-1b (Jagged1b) (Jagged3) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001889; GO:0005112; GO:0005509; GO:0005886; GO:0007219; GO:0009913; GO:0009953; GO:0016020; GO:0030878; GO:0031016; GO:0031017; GO:0031101; GO:0032474; GO:0035622; GO:0042472; GO:0048752; GO:0060117; GO:0060325; GO:0060351; GO:0060872; GO:0061008; GO:1904888 auditory receptor cell development [GO:0060117]; cartilage development involved in endochondral bone morphogenesis [GO:0060351]; cranial skeletal system development [GO:1904888]; dorsal/ventral pattern formation [GO:0009953]; epidermal cell differentiation [GO:0009913]; exocrine pancreas development [GO:0031017]; face morphogenesis [GO:0060325]; fin regeneration [GO:0031101]; hepaticobiliary system development [GO:0061008]; inner ear morphogenesis [GO:0042472]; intrahepatic bile duct development [GO:0035622]; liver development [GO:0001889]; Notch signaling pathway [GO:0007219]; otolith morphogenesis [GO:0032474]; pancreas development [GO:0031016]; semicircular canal development [GO:0060872]; semicircular canal morphogenesis [GO:0048752]; thyroid gland development [GO:0030878] membrane [GO:0016020]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; Notch binding [GO:0005112] g19317.t4 Q04721 32.394 355 4.920000000000001e-37 148.0 sp|Q04721|NOTC2_HUMAN Neurogenic locus notch homolog protein 2 OS=Homo sapiens OX=9606 GN=NOTCH2 PE=1 SV=3 NOTC2_HUMAN reviewed Neurogenic locus notch homolog protein 2 (Notch 2) (hN2) [Cleaved into: Notch 2 extracellular truncation (N2ECD); Notch 2 intracellular domain (N2ICD)] Homo sapiens (Human) GO:0000122; GO:0000139; GO:0001701; GO:0001709; GO:0001947; GO:0002011; GO:0002315; GO:0002437; GO:0003162; GO:0003184; GO:0003713; GO:0005509; GO:0005576; GO:0005634; GO:0005654; GO:0005789; GO:0005794; GO:0005886; GO:0005929; GO:0006915; GO:0006959; GO:0007219; GO:0007399; GO:0007411; GO:0009887; GO:0009986; GO:0010629; GO:0010838; GO:0016020; GO:0019899; GO:0030097; GO:0030326; GO:0030509; GO:0030513; GO:0035264; GO:0035556; GO:0035622; GO:0038023; GO:0042060; GO:0042742; GO:0043011; GO:0043065; GO:0043066; GO:0043235; GO:0045672; GO:0045944; GO:0046579; GO:0046849; GO:0051059; GO:0051152; GO:0060413; GO:0060674; GO:0061073; GO:0070374; GO:0070986; GO:0071228; GO:0072014; GO:0072015; GO:0072104; GO:0072574; GO:1902895; GO:1990705; GO:2001204 animal organ morphogenesis [GO:0009887]; apoptotic process [GO:0006915]; atrial septum morphogenesis [GO:0060413]; atrioventricular node development [GO:0003162]; axon guidance [GO:0007411]; BMP signaling pathway [GO:0030509]; bone remodeling [GO:0046849]; cell fate determination [GO:0001709]; cellular response to tumor cell [GO:0071228]; cholangiocyte proliferation [GO:1990705]; ciliary body morphogenesis [GO:0061073]; defense response to bacterium [GO:0042742]; embryonic limb morphogenesis [GO:0030326]; glomerular capillary formation [GO:0072104]; heart looping [GO:0001947]; hemopoiesis [GO:0030097]; hepatocyte proliferation [GO:0072574]; humoral immune response [GO:0006959]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; intracellular signal transduction [GO:0035556]; intrahepatic bile duct development [GO:0035622]; left/right axis specification [GO:0070986]; marginal zone B cell differentiation [GO:0002315]; morphogenesis of an epithelial sheet [GO:0002011]; multicellular organism growth [GO:0035264]; myeloid dendritic cell differentiation [GO:0043011]; negative regulation of apoptotic process [GO:0043066]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]; Notch signaling pathway [GO:0007219]; placenta blood vessel development [GO:0060674]; podocyte development [GO:0072015]; positive regulation of apoptotic process [GO:0043065]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of keratinocyte proliferation [GO:0010838]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of smooth muscle cell differentiation [GO:0051152]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proximal tubule development [GO:0072014]; pulmonary valve morphogenesis [GO:0003184]; regulation of osteoclast development [GO:2001204]; wound healing [GO:0042060] cell surface [GO:0009986]; cilium [GO:0005929]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; enzyme binding [GO:0019899]; NF-kappaB binding [GO:0051059]; signaling receptor activity [GO:0038023]; transcription coactivator activity [GO:0003713] g19317.t4 Q04721 29.282 362 7.48e-28 121.0 sp|Q04721|NOTC2_HUMAN Neurogenic locus notch homolog protein 2 OS=Homo sapiens OX=9606 GN=NOTCH2 PE=1 SV=3 NOTC2_HUMAN reviewed Neurogenic locus notch homolog protein 2 (Notch 2) (hN2) [Cleaved into: Notch 2 extracellular truncation (N2ECD); Notch 2 intracellular domain (N2ICD)] Homo sapiens (Human) GO:0000122; GO:0000139; GO:0001701; GO:0001709; GO:0001947; GO:0002011; GO:0002315; GO:0002437; GO:0003162; GO:0003184; GO:0003713; GO:0005509; GO:0005576; GO:0005634; GO:0005654; GO:0005789; GO:0005794; GO:0005886; GO:0005929; GO:0006915; GO:0006959; GO:0007219; GO:0007399; GO:0007411; GO:0009887; GO:0009986; GO:0010629; GO:0010838; GO:0016020; GO:0019899; GO:0030097; GO:0030326; GO:0030509; GO:0030513; GO:0035264; GO:0035556; GO:0035622; GO:0038023; GO:0042060; GO:0042742; GO:0043011; GO:0043065; GO:0043066; GO:0043235; GO:0045672; GO:0045944; GO:0046579; GO:0046849; GO:0051059; GO:0051152; GO:0060413; GO:0060674; GO:0061073; GO:0070374; GO:0070986; GO:0071228; GO:0072014; GO:0072015; GO:0072104; GO:0072574; GO:1902895; GO:1990705; GO:2001204 animal organ morphogenesis [GO:0009887]; apoptotic process [GO:0006915]; atrial septum morphogenesis [GO:0060413]; atrioventricular node development [GO:0003162]; axon guidance [GO:0007411]; BMP signaling pathway [GO:0030509]; bone remodeling [GO:0046849]; cell fate determination [GO:0001709]; cellular response to tumor cell [GO:0071228]; cholangiocyte proliferation [GO:1990705]; ciliary body morphogenesis [GO:0061073]; defense response to bacterium [GO:0042742]; embryonic limb morphogenesis [GO:0030326]; glomerular capillary formation [GO:0072104]; heart looping [GO:0001947]; hemopoiesis [GO:0030097]; hepatocyte proliferation [GO:0072574]; humoral immune response [GO:0006959]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; intracellular signal transduction [GO:0035556]; intrahepatic bile duct development [GO:0035622]; left/right axis specification [GO:0070986]; marginal zone B cell differentiation [GO:0002315]; morphogenesis of an epithelial sheet [GO:0002011]; multicellular organism growth [GO:0035264]; myeloid dendritic cell differentiation [GO:0043011]; negative regulation of apoptotic process [GO:0043066]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]; Notch signaling pathway [GO:0007219]; placenta blood vessel development [GO:0060674]; podocyte development [GO:0072015]; positive regulation of apoptotic process [GO:0043065]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of keratinocyte proliferation [GO:0010838]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of smooth muscle cell differentiation [GO:0051152]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proximal tubule development [GO:0072014]; pulmonary valve morphogenesis [GO:0003184]; regulation of osteoclast development [GO:2001204]; wound healing [GO:0042060] cell surface [GO:0009986]; cilium [GO:0005929]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; enzyme binding [GO:0019899]; NF-kappaB binding [GO:0051059]; signaling receptor activity [GO:0038023]; transcription coactivator activity [GO:0003713] g19317.t4 Q04721 30.532 357 4.5400000000000003e-26 115.0 sp|Q04721|NOTC2_HUMAN Neurogenic locus notch homolog protein 2 OS=Homo sapiens OX=9606 GN=NOTCH2 PE=1 SV=3 NOTC2_HUMAN reviewed Neurogenic locus notch homolog protein 2 (Notch 2) (hN2) [Cleaved into: Notch 2 extracellular truncation (N2ECD); Notch 2 intracellular domain (N2ICD)] Homo sapiens (Human) GO:0000122; GO:0000139; GO:0001701; GO:0001709; GO:0001947; GO:0002011; GO:0002315; GO:0002437; GO:0003162; GO:0003184; GO:0003713; GO:0005509; GO:0005576; GO:0005634; GO:0005654; GO:0005789; GO:0005794; GO:0005886; GO:0005929; GO:0006915; GO:0006959; GO:0007219; GO:0007399; GO:0007411; GO:0009887; GO:0009986; GO:0010629; GO:0010838; GO:0016020; GO:0019899; GO:0030097; GO:0030326; GO:0030509; GO:0030513; GO:0035264; GO:0035556; GO:0035622; GO:0038023; GO:0042060; GO:0042742; GO:0043011; GO:0043065; GO:0043066; GO:0043235; GO:0045672; GO:0045944; GO:0046579; GO:0046849; GO:0051059; GO:0051152; GO:0060413; GO:0060674; GO:0061073; GO:0070374; GO:0070986; GO:0071228; GO:0072014; GO:0072015; GO:0072104; GO:0072574; GO:1902895; GO:1990705; GO:2001204 animal organ morphogenesis [GO:0009887]; apoptotic process [GO:0006915]; atrial septum morphogenesis [GO:0060413]; atrioventricular node development [GO:0003162]; axon guidance [GO:0007411]; BMP signaling pathway [GO:0030509]; bone remodeling [GO:0046849]; cell fate determination [GO:0001709]; cellular response to tumor cell [GO:0071228]; cholangiocyte proliferation [GO:1990705]; ciliary body morphogenesis [GO:0061073]; defense response to bacterium [GO:0042742]; embryonic limb morphogenesis [GO:0030326]; glomerular capillary formation [GO:0072104]; heart looping [GO:0001947]; hemopoiesis [GO:0030097]; hepatocyte proliferation [GO:0072574]; humoral immune response [GO:0006959]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; intracellular signal transduction [GO:0035556]; intrahepatic bile duct development [GO:0035622]; left/right axis specification [GO:0070986]; marginal zone B cell differentiation [GO:0002315]; morphogenesis of an epithelial sheet [GO:0002011]; multicellular organism growth [GO:0035264]; myeloid dendritic cell differentiation [GO:0043011]; negative regulation of apoptotic process [GO:0043066]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]; Notch signaling pathway [GO:0007219]; placenta blood vessel development [GO:0060674]; podocyte development [GO:0072015]; positive regulation of apoptotic process [GO:0043065]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of keratinocyte proliferation [GO:0010838]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of smooth muscle cell differentiation [GO:0051152]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proximal tubule development [GO:0072014]; pulmonary valve morphogenesis [GO:0003184]; regulation of osteoclast development [GO:2001204]; wound healing [GO:0042060] cell surface [GO:0009986]; cilium [GO:0005929]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; enzyme binding [GO:0019899]; NF-kappaB binding [GO:0051059]; signaling receptor activity [GO:0038023]; transcription coactivator activity [GO:0003713] g19317.t4 Q04721 30.556 360 1.48e-23 108.0 sp|Q04721|NOTC2_HUMAN Neurogenic locus notch homolog protein 2 OS=Homo sapiens OX=9606 GN=NOTCH2 PE=1 SV=3 NOTC2_HUMAN reviewed Neurogenic locus notch homolog protein 2 (Notch 2) (hN2) [Cleaved into: Notch 2 extracellular truncation (N2ECD); Notch 2 intracellular domain (N2ICD)] Homo sapiens (Human) GO:0000122; GO:0000139; GO:0001701; GO:0001709; GO:0001947; GO:0002011; GO:0002315; GO:0002437; GO:0003162; GO:0003184; GO:0003713; GO:0005509; GO:0005576; GO:0005634; GO:0005654; GO:0005789; GO:0005794; GO:0005886; GO:0005929; GO:0006915; GO:0006959; GO:0007219; GO:0007399; GO:0007411; GO:0009887; GO:0009986; GO:0010629; GO:0010838; GO:0016020; GO:0019899; GO:0030097; GO:0030326; GO:0030509; GO:0030513; GO:0035264; GO:0035556; GO:0035622; GO:0038023; GO:0042060; GO:0042742; GO:0043011; GO:0043065; GO:0043066; GO:0043235; GO:0045672; GO:0045944; GO:0046579; GO:0046849; GO:0051059; GO:0051152; GO:0060413; GO:0060674; GO:0061073; GO:0070374; GO:0070986; GO:0071228; GO:0072014; GO:0072015; GO:0072104; GO:0072574; GO:1902895; GO:1990705; GO:2001204 animal organ morphogenesis [GO:0009887]; apoptotic process [GO:0006915]; atrial septum morphogenesis [GO:0060413]; atrioventricular node development [GO:0003162]; axon guidance [GO:0007411]; BMP signaling pathway [GO:0030509]; bone remodeling [GO:0046849]; cell fate determination [GO:0001709]; cellular response to tumor cell [GO:0071228]; cholangiocyte proliferation [GO:1990705]; ciliary body morphogenesis [GO:0061073]; defense response to bacterium [GO:0042742]; embryonic limb morphogenesis [GO:0030326]; glomerular capillary formation [GO:0072104]; heart looping [GO:0001947]; hemopoiesis [GO:0030097]; hepatocyte proliferation [GO:0072574]; humoral immune response [GO:0006959]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; intracellular signal transduction [GO:0035556]; intrahepatic bile duct development [GO:0035622]; left/right axis specification [GO:0070986]; marginal zone B cell differentiation [GO:0002315]; morphogenesis of an epithelial sheet [GO:0002011]; multicellular organism growth [GO:0035264]; myeloid dendritic cell differentiation [GO:0043011]; negative regulation of apoptotic process [GO:0043066]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]; Notch signaling pathway [GO:0007219]; placenta blood vessel development [GO:0060674]; podocyte development [GO:0072015]; positive regulation of apoptotic process [GO:0043065]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of keratinocyte proliferation [GO:0010838]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of smooth muscle cell differentiation [GO:0051152]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proximal tubule development [GO:0072014]; pulmonary valve morphogenesis [GO:0003184]; regulation of osteoclast development [GO:2001204]; wound healing [GO:0042060] cell surface [GO:0009986]; cilium [GO:0005929]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; enzyme binding [GO:0019899]; NF-kappaB binding [GO:0051059]; signaling receptor activity [GO:0038023]; transcription coactivator activity [GO:0003713] g19317.t4 Q04721 29.692 357 3.3899999999999994e-23 107.0 sp|Q04721|NOTC2_HUMAN Neurogenic locus notch homolog protein 2 OS=Homo sapiens OX=9606 GN=NOTCH2 PE=1 SV=3 NOTC2_HUMAN reviewed Neurogenic locus notch homolog protein 2 (Notch 2) (hN2) [Cleaved into: Notch 2 extracellular truncation (N2ECD); Notch 2 intracellular domain (N2ICD)] Homo sapiens (Human) GO:0000122; GO:0000139; GO:0001701; GO:0001709; GO:0001947; GO:0002011; GO:0002315; GO:0002437; GO:0003162; GO:0003184; GO:0003713; GO:0005509; GO:0005576; GO:0005634; GO:0005654; GO:0005789; GO:0005794; GO:0005886; GO:0005929; GO:0006915; GO:0006959; GO:0007219; GO:0007399; GO:0007411; GO:0009887; GO:0009986; GO:0010629; GO:0010838; GO:0016020; GO:0019899; GO:0030097; GO:0030326; GO:0030509; GO:0030513; GO:0035264; GO:0035556; GO:0035622; GO:0038023; GO:0042060; GO:0042742; GO:0043011; GO:0043065; GO:0043066; GO:0043235; GO:0045672; GO:0045944; GO:0046579; GO:0046849; GO:0051059; GO:0051152; GO:0060413; GO:0060674; GO:0061073; GO:0070374; GO:0070986; GO:0071228; GO:0072014; GO:0072015; GO:0072104; GO:0072574; GO:1902895; GO:1990705; GO:2001204 animal organ morphogenesis [GO:0009887]; apoptotic process [GO:0006915]; atrial septum morphogenesis [GO:0060413]; atrioventricular node development [GO:0003162]; axon guidance [GO:0007411]; BMP signaling pathway [GO:0030509]; bone remodeling [GO:0046849]; cell fate determination [GO:0001709]; cellular response to tumor cell [GO:0071228]; cholangiocyte proliferation [GO:1990705]; ciliary body morphogenesis [GO:0061073]; defense response to bacterium [GO:0042742]; embryonic limb morphogenesis [GO:0030326]; glomerular capillary formation [GO:0072104]; heart looping [GO:0001947]; hemopoiesis [GO:0030097]; hepatocyte proliferation [GO:0072574]; humoral immune response [GO:0006959]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; intracellular signal transduction [GO:0035556]; intrahepatic bile duct development [GO:0035622]; left/right axis specification [GO:0070986]; marginal zone B cell differentiation [GO:0002315]; morphogenesis of an epithelial sheet [GO:0002011]; multicellular organism growth [GO:0035264]; myeloid dendritic cell differentiation [GO:0043011]; negative regulation of apoptotic process [GO:0043066]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]; Notch signaling pathway [GO:0007219]; placenta blood vessel development [GO:0060674]; podocyte development [GO:0072015]; positive regulation of apoptotic process [GO:0043065]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of keratinocyte proliferation [GO:0010838]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of smooth muscle cell differentiation [GO:0051152]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proximal tubule development [GO:0072014]; pulmonary valve morphogenesis [GO:0003184]; regulation of osteoclast development [GO:2001204]; wound healing [GO:0042060] cell surface [GO:0009986]; cilium [GO:0005929]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; enzyme binding [GO:0019899]; NF-kappaB binding [GO:0051059]; signaling receptor activity [GO:0038023]; transcription coactivator activity [GO:0003713] g19317.t4 Q04721 28.788 396 3.61e-23 107.0 sp|Q04721|NOTC2_HUMAN Neurogenic locus notch homolog protein 2 OS=Homo sapiens OX=9606 GN=NOTCH2 PE=1 SV=3 NOTC2_HUMAN reviewed Neurogenic locus notch homolog protein 2 (Notch 2) (hN2) [Cleaved into: Notch 2 extracellular truncation (N2ECD); Notch 2 intracellular domain (N2ICD)] Homo sapiens (Human) GO:0000122; GO:0000139; GO:0001701; GO:0001709; GO:0001947; GO:0002011; GO:0002315; GO:0002437; GO:0003162; GO:0003184; GO:0003713; GO:0005509; GO:0005576; GO:0005634; GO:0005654; GO:0005789; GO:0005794; GO:0005886; GO:0005929; GO:0006915; GO:0006959; GO:0007219; GO:0007399; GO:0007411; GO:0009887; GO:0009986; GO:0010629; GO:0010838; GO:0016020; GO:0019899; GO:0030097; GO:0030326; GO:0030509; GO:0030513; GO:0035264; GO:0035556; GO:0035622; GO:0038023; GO:0042060; GO:0042742; GO:0043011; GO:0043065; GO:0043066; GO:0043235; GO:0045672; GO:0045944; GO:0046579; GO:0046849; GO:0051059; GO:0051152; GO:0060413; GO:0060674; GO:0061073; GO:0070374; GO:0070986; GO:0071228; GO:0072014; GO:0072015; GO:0072104; GO:0072574; GO:1902895; GO:1990705; GO:2001204 animal organ morphogenesis [GO:0009887]; apoptotic process [GO:0006915]; atrial septum morphogenesis [GO:0060413]; atrioventricular node development [GO:0003162]; axon guidance [GO:0007411]; BMP signaling pathway [GO:0030509]; bone remodeling [GO:0046849]; cell fate determination [GO:0001709]; cellular response to tumor cell [GO:0071228]; cholangiocyte proliferation [GO:1990705]; ciliary body morphogenesis [GO:0061073]; defense response to bacterium [GO:0042742]; embryonic limb morphogenesis [GO:0030326]; glomerular capillary formation [GO:0072104]; heart looping [GO:0001947]; hemopoiesis [GO:0030097]; hepatocyte proliferation [GO:0072574]; humoral immune response [GO:0006959]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; intracellular signal transduction [GO:0035556]; intrahepatic bile duct development [GO:0035622]; left/right axis specification [GO:0070986]; marginal zone B cell differentiation [GO:0002315]; morphogenesis of an epithelial sheet [GO:0002011]; multicellular organism growth [GO:0035264]; myeloid dendritic cell differentiation [GO:0043011]; negative regulation of apoptotic process [GO:0043066]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]; Notch signaling pathway [GO:0007219]; placenta blood vessel development [GO:0060674]; podocyte development [GO:0072015]; positive regulation of apoptotic process [GO:0043065]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of keratinocyte proliferation [GO:0010838]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of smooth muscle cell differentiation [GO:0051152]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proximal tubule development [GO:0072014]; pulmonary valve morphogenesis [GO:0003184]; regulation of osteoclast development [GO:2001204]; wound healing [GO:0042060] cell surface [GO:0009986]; cilium [GO:0005929]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; enzyme binding [GO:0019899]; NF-kappaB binding [GO:0051059]; signaling receptor activity [GO:0038023]; transcription coactivator activity [GO:0003713] g19319.t1 P10079 35.513 994 7.689999999999999e-128 421.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g19319.t1 P10079 38.179 626 1.1699999999999999e-94 329.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g19319.t2 P10079 34.831 979 5.45e-120 398.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g19319.t2 P10079 37.069 812 9.75e-114 381.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g19319.t2 P10079 36.927 807 7.860000000000001e-109 368.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g19319.t2 P10079 37.023 524 1.1299999999999999e-67 251.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g19319.t2 P10079 33.466 502 3.5899999999999994e-52 203.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g19322.t1 O35462 36.649 191 3.59e-22 100.0 sp|O35462|ANGP2_RAT Angiopoietin-2 OS=Rattus norvegicus OX=10116 GN=Angpt2 PE=2 SV=2 ANGP2_RAT reviewed Angiopoietin-2 (ANG-2) Rattus norvegicus (Rat) GO:0001525; GO:0001666; GO:0005615; GO:0007281; GO:0007596; GO:0009612; GO:0009749; GO:0010467; GO:0010812; GO:0014823; GO:0016525; GO:0030195; GO:0030971; GO:0031100; GO:0042995; GO:0043537; GO:0045766; GO:0046872; GO:0048014; GO:0048018; GO:0048514; GO:0050820; GO:0050928; GO:0060135; GO:0071363; GO:0072012 angiogenesis [GO:0001525]; animal organ regeneration [GO:0031100]; blood coagulation [GO:0007596]; blood vessel morphogenesis [GO:0048514]; cellular response to growth factor stimulus [GO:0071363]; gene expression [GO:0010467]; germ cell development [GO:0007281]; glomerulus vasculature development [GO:0072012]; maternal process involved in female pregnancy [GO:0060135]; negative regulation of angiogenesis [GO:0016525]; negative regulation of blood coagulation [GO:0030195]; negative regulation of blood vessel endothelial cell migration [GO:0043537]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of positive chemotaxis [GO:0050928]; positive regulation of angiogenesis [GO:0045766]; positive regulation of coagulation [GO:0050820]; response to activity [GO:0014823]; response to glucose [GO:0009749]; response to hypoxia [GO:0001666]; response to mechanical stimulus [GO:0009612]; Tie signaling pathway [GO:0048014] cell projection [GO:0042995]; extracellular space [GO:0005615] metal ion binding [GO:0046872]; receptor ligand activity [GO:0048018]; receptor tyrosine kinase binding [GO:0030971] g19326.t1 Q9JKW1 51.149 174 1.9e-49 162.0 sp|Q9JKW1|TIM22_RAT Mitochondrial import inner membrane translocase subunit Tim22 OS=Rattus norvegicus OX=10116 GN=Timm22 PE=2 SV=2 g19327.t1 Q3T0X9 37.391 115 2.2e-22 87.4 sp|Q3T0X9|DPOD4_BOVIN DNA polymerase delta subunit 4 OS=Bos taurus OX=9913 GN=POLD4 PE=1 SV=1 g19328.t1 Q9Y4P3 54.913 346 4.23e-141 415.0 sp|Q9Y4P3|TBL2_HUMAN Transducin beta-like protein 2 OS=Homo sapiens OX=9606 GN=TBL2 PE=1 SV=1 TBL2_HUMAN reviewed Transducin beta-like protein 2 (WS beta-transducin repeats protein) (WS-betaTRP) (Williams-Beuren syndrome chromosomal region 13 protein) Homo sapiens (Human) GO:0003723; GO:0005783; GO:0005789; GO:0019901; GO:0030968; GO:0031369; GO:0042149; GO:0051219; GO:0071456 cellular response to glucose starvation [GO:0042149]; cellular response to hypoxia [GO:0071456]; endoplasmic reticulum unfolded protein response [GO:0030968] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789] phosphoprotein binding [GO:0051219]; protein kinase binding [GO:0019901]; RNA binding [GO:0003723]; translation initiation factor binding [GO:0031369] g19335.t1 Q9UMZ2 47.805 205 1.45e-44 181.0 sp|Q9UMZ2|SYNRG_HUMAN Synergin gamma OS=Homo sapiens OX=9606 GN=SYNRG PE=1 SV=2 SYNRG_HUMAN reviewed Synergin gamma (AP1 subunit gamma-binding protein 1) (Gamma-synergin) Homo sapiens (Human) GO:0005737; GO:0005794; GO:0006886; GO:0006897; GO:0030121; GO:0030130; GO:0048471 endocytosis [GO:0006897]; intracellular protein transport [GO:0006886] AP-1 adaptor complex [GO:0030121]; clathrin coat of trans-Golgi network vesicle [GO:0030130]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; perinuclear region of cytoplasm [GO:0048471] g19335.t2 Q9UMZ2 47.805 205 1.45e-44 181.0 sp|Q9UMZ2|SYNRG_HUMAN Synergin gamma OS=Homo sapiens OX=9606 GN=SYNRG PE=1 SV=2 SYNRG_HUMAN reviewed Synergin gamma (AP1 subunit gamma-binding protein 1) (Gamma-synergin) Homo sapiens (Human) GO:0005737; GO:0005794; GO:0006886; GO:0006897; GO:0030121; GO:0030130; GO:0048471 endocytosis [GO:0006897]; intracellular protein transport [GO:0006886] AP-1 adaptor complex [GO:0030121]; clathrin coat of trans-Golgi network vesicle [GO:0030130]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; perinuclear region of cytoplasm [GO:0048471] g19335.t3 Q9UMZ2 47.805 205 1.59e-44 181.0 sp|Q9UMZ2|SYNRG_HUMAN Synergin gamma OS=Homo sapiens OX=9606 GN=SYNRG PE=1 SV=2 SYNRG_HUMAN reviewed Synergin gamma (AP1 subunit gamma-binding protein 1) (Gamma-synergin) Homo sapiens (Human) GO:0005737; GO:0005794; GO:0006886; GO:0006897; GO:0030121; GO:0030130; GO:0048471 endocytosis [GO:0006897]; intracellular protein transport [GO:0006886] AP-1 adaptor complex [GO:0030121]; clathrin coat of trans-Golgi network vesicle [GO:0030130]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; perinuclear region of cytoplasm [GO:0048471] g19336.t1 B5DE73 38.125 320 2.3699999999999998e-60 201.0 sp|B5DE73|ASPH2_XENTR Aspartate beta-hydroxylase domain-containing protein 2 OS=Xenopus tropicalis OX=8364 GN=asphd2 PE=2 SV=1 g19340.t1 Q68F72 39.196 597 2.43e-134 407.0 sp|Q68F72|S15A4_XENLA Solute carrier family 15 member 4 OS=Xenopus laevis OX=8355 GN=slc15a4 PE=2 SV=1 S15A4_XENLA reviewed Solute carrier family 15 member 4 Xenopus laevis (African clawed frog) GO:0005290; GO:0005765; GO:0015031; GO:0015333; GO:0015647; GO:0015835; GO:0016020; GO:0031901; GO:0033023; GO:0034157; GO:0034161; GO:0034165; GO:0036020; GO:0045087; GO:0045089; GO:0048302; GO:0070424; GO:0070430; GO:0070434; GO:0071916; GO:0140206 dipeptide import across plasma membrane [GO:0140206]; innate immune response [GO:0045087]; mast cell homeostasis [GO:0033023]; peptidoglycan transport [GO:0015835]; positive regulation of innate immune response [GO:0045089]; positive regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway [GO:0070430]; positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway [GO:0070434]; positive regulation of toll-like receptor 7 signaling pathway [GO:0034157]; positive regulation of toll-like receptor 8 signaling pathway [GO:0034161]; positive regulation of toll-like receptor 9 signaling pathway [GO:0034165]; protein transport [GO:0015031]; regulation of isotype switching to IgG isotypes [GO:0048302]; regulation of nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway [GO:0070424] early endosome membrane [GO:0031901]; endolysosome membrane [GO:0036020]; lysosomal membrane [GO:0005765]; membrane [GO:0016020] dipeptide transmembrane transporter activity [GO:0071916]; L-histidine transmembrane transporter activity [GO:0005290]; peptide:proton symporter activity [GO:0015333]; peptidoglycan transmembrane transporter activity [GO:0015647] g19343.t1 Q28279 44.898 196 3.9799999999999994e-54 186.0 sp|Q28279|CNGA1_CANLF Cyclic nucleotide-gated channel alpha-1 OS=Canis lupus familiaris OX=9615 GN=CNGA1 PE=2 SV=1 CNGA1_CANLF reviewed Cyclic nucleotide-gated channel alpha-1 (CNG channel alpha-1) (CNG-1) (CNG1) (Cyclic nucleotide-gated cation channel 1) (Cyclic nucleotide-gated channel, photoreceptor) (Rod photoreceptor cGMP-gated cation channel subunit alpha) (cGMP-gated cation channel alpha-1) Canis lupus familiaris (Dog) (Canis familiaris) GO:0005222; GO:0005223; GO:0005262; GO:0005272; GO:0005886; GO:0006814; GO:0006816; GO:0007601; GO:0007606; GO:0017071; GO:0030552; GO:0030553; GO:0098655; GO:0120200 calcium ion transport [GO:0006816]; monoatomic cation transmembrane transport [GO:0098655]; sensory perception of chemical stimulus [GO:0007606]; sodium ion transport [GO:0006814]; visual perception [GO:0007601] intracellular cyclic nucleotide activated cation channel complex [GO:0017071]; plasma membrane [GO:0005886]; rod photoreceptor outer segment [GO:0120200] calcium channel activity [GO:0005262]; cAMP binding [GO:0030552]; cGMP binding [GO:0030553]; intracellularly cAMP-activated cation channel activity [GO:0005222]; intracellularly cGMP-activated cation channel activity [GO:0005223]; sodium channel activity [GO:0005272] g19345.t1 Q9CY73 44.488 254 1.5e-70 226.0 sp|Q9CY73|RM44_MOUSE Large ribosomal subunit protein mL44 OS=Mus musculus OX=10090 GN=Mrpl44 PE=1 SV=3 RM44_MOUSE reviewed Large ribosomal subunit protein mL44 (39S ribosomal protein L44, mitochondrial) (L44mt) (MRP-L44) Mus musculus (Mouse) GO:0003725; GO:0004525; GO:0005634; GO:0005654; GO:0005739; GO:0005743; GO:0005759; GO:0005762; GO:0005886; GO:0006396; GO:0016604; GO:0032543; GO:0070125 mitochondrial translation [GO:0032543]; mitochondrial translational elongation [GO:0070125]; RNA processing [GO:0006396] mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886] double-stranded RNA binding [GO:0003725]; ribonuclease III activity [GO:0004525] g19346.t1 Q3ZCX4 34.884 387 1.34e-59 218.0 sp|Q3ZCX4|ZN568_HUMAN Zinc finger protein 568 OS=Homo sapiens OX=9606 GN=ZNF568 PE=1 SV=2 ZN568_HUMAN reviewed Zinc finger protein 568 Homo sapiens (Human) GO:0000122; GO:0000976; GO:0000978; GO:0000981; GO:0001701; GO:0005634; GO:0006357; GO:0008270; GO:0045892; GO:0060669 embryonic placenta morphogenesis [GO:0060669]; in utero embryonic development [GO:0001701]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription cis-regulatory region binding [GO:0000976]; zinc ion binding [GO:0008270] g19346.t1 Q3ZCX4 34.367 387 5.28e-57 211.0 sp|Q3ZCX4|ZN568_HUMAN Zinc finger protein 568 OS=Homo sapiens OX=9606 GN=ZNF568 PE=1 SV=2 ZN568_HUMAN reviewed Zinc finger protein 568 Homo sapiens (Human) GO:0000122; GO:0000976; GO:0000978; GO:0000981; GO:0001701; GO:0005634; GO:0006357; GO:0008270; GO:0045892; GO:0060669 embryonic placenta morphogenesis [GO:0060669]; in utero embryonic development [GO:0001701]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription cis-regulatory region binding [GO:0000976]; zinc ion binding [GO:0008270] g19346.t1 Q3ZCX4 32.361 377 1.11e-43 172.0 sp|Q3ZCX4|ZN568_HUMAN Zinc finger protein 568 OS=Homo sapiens OX=9606 GN=ZNF568 PE=1 SV=2 ZN568_HUMAN reviewed Zinc finger protein 568 Homo sapiens (Human) GO:0000122; GO:0000976; GO:0000978; GO:0000981; GO:0001701; GO:0005634; GO:0006357; GO:0008270; GO:0045892; GO:0060669 embryonic placenta morphogenesis [GO:0060669]; in utero embryonic development [GO:0001701]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription cis-regulatory region binding [GO:0000976]; zinc ion binding [GO:0008270] g19347.t1 P51522 37.799 209 2.21e-27 121.0 sp|P51522|ZNF83_HUMAN Zinc finger protein 83 OS=Homo sapiens OX=9606 GN=ZNF83 PE=1 SV=3 g19347.t1 P51522 40.113 177 1.33e-25 115.0 sp|P51522|ZNF83_HUMAN Zinc finger protein 83 OS=Homo sapiens OX=9606 GN=ZNF83 PE=1 SV=3 g19349.t1 Q5RC74 77.021 235 1.32e-128 367.0 sp|Q5RC74|DERL2_PONAB Derlin-2 OS=Pongo abelii OX=9601 GN=DERL2 PE=2 SV=1 g19350.t1 A6H6W9 51.399 286 3.9200000000000005e-86 266.0 sp|A6H6W9|SDS3_BOVIN Sin3 histone deacetylase corepressor complex component SDS3 OS=Bos taurus OX=9913 GN=SUDS3 PE=2 SV=1 SDS3_BOVIN reviewed Sin3 histone deacetylase corepressor complex component SDS3 (Suppressor of defective silencing 3 protein homolog) Bos taurus (Bovine) GO:0000122; GO:0004407; GO:0005634; GO:0005829; GO:0006338; GO:0006915; GO:0016604; GO:0042826; GO:0070822 apoptotic process [GO:0006915]; chromatin remodeling [GO:0006338]; negative regulation of transcription by RNA polymerase II [GO:0000122] cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleus [GO:0005634]; Sin3-type complex [GO:0070822] histone deacetylase activity [GO:0004407]; histone deacetylase binding [GO:0042826] g19351.t1 Q13769 45.44 647 9.15e-174 514.0 sp|Q13769|THOC5_HUMAN THO complex subunit 5 OS=Homo sapiens OX=9606 GN=THOC5 PE=1 SV=2 THOC5_HUMAN reviewed THO complex subunit 5 (Functional spliceosome-associated protein 79) (fSAP79) (NF2/meningioma region protein pK1.3) (Placental protein 39.2) (PP39.2) (hTREX90) Homo sapiens (Human) GO:0000346; GO:0000347; GO:0000445; GO:0003729; GO:0005634; GO:0005654; GO:0005737; GO:0006397; GO:0006406; GO:0008380; GO:0030224; GO:0060215 monocyte differentiation [GO:0030224]; mRNA export from nucleus [GO:0006406]; mRNA processing [GO:0006397]; primitive hemopoiesis [GO:0060215]; RNA splicing [GO:0008380] cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; THO complex [GO:0000347]; THO complex part of transcription export complex [GO:0000445]; transcription export complex [GO:0000346] mRNA binding [GO:0003729] g19353.t1 Q969J3 44.503 191 1.41e-37 133.0 sp|Q969J3|BORC5_HUMAN BLOC-1-related complex subunit 5 OS=Homo sapiens OX=9606 GN=BORCS5 PE=1 SV=1 BORC5_HUMAN reviewed BLOC-1-related complex subunit 5 (Loss of heterozygosity 12 chromosomal region 1) (Myristoylated lysosomal protein) (Myrlysin) Homo sapiens (Human) GO:0005886; GO:0007399; GO:0016020; GO:0030424; GO:0030672; GO:0032418; GO:0051036; GO:0062196; GO:0072384; GO:0098574; GO:0099078; GO:1903744 lysosome localization [GO:0032418]; nervous system development [GO:0007399]; organelle transport along microtubule [GO:0072384]; positive regulation of anterograde synaptic vesicle transport [GO:1903744]; regulation of endosome size [GO:0051036]; regulation of lysosome size [GO:0062196] axon [GO:0030424]; BORC complex [GO:0099078]; cytoplasmic side of lysosomal membrane [GO:0098574]; membrane [GO:0016020]; plasma membrane [GO:0005886]; synaptic vesicle membrane [GO:0030672] g19354.t1 Q6IRE4 56.18 178 7.93e-58 197.0 sp|Q6IRE4|TS101_RAT Tumor susceptibility gene 101 protein OS=Rattus norvegicus OX=10116 GN=Tsg101 PE=1 SV=1 TS101_RAT reviewed Tumor susceptibility gene 101 protein (ESCRT-I complex subunit TSG101) Rattus norvegicus (Rat) GO:0000122; GO:0000813; GO:0001558; GO:0003714; GO:0005634; GO:0005730; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005813; GO:0005829; GO:0005886; GO:0006858; GO:0008285; GO:0008333; GO:0010008; GO:0015031; GO:0030154; GO:0030216; GO:0031625; GO:0031901; GO:0031902; GO:0042059; GO:0042803; GO:0043130; GO:0043162; GO:0044877; GO:0045893; GO:0046755; GO:0046790; GO:0048306; GO:0051301; GO:0051726; GO:0070062; GO:0090543; GO:1902527; GO:1903543; GO:1903551; GO:1903774; GO:1990182; GO:2000397 cell differentiation [GO:0030154]; cell division [GO:0051301]; endosome to lysosome transport [GO:0008333]; exosomal secretion [GO:1990182]; extracellular transport [GO:0006858]; keratinocyte differentiation [GO:0030216]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of protein monoubiquitination [GO:1902527]; positive regulation of ubiquitin-dependent endocytosis [GO:2000397]; positive regulation of viral budding via host ESCRT complex [GO:1903774]; protein transport [GO:0015031]; regulation of cell cycle [GO:0051726]; regulation of cell growth [GO:0001558]; regulation of extracellular exosome assembly [GO:1903551]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]; viral budding [GO:0046755] centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; endosome membrane [GO:0010008]; ESCRT I complex [GO:0000813]; extracellular exosome [GO:0070062]; Flemming body [GO:0090543]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886] calcium-dependent protein binding [GO:0048306]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; transcription corepressor activity [GO:0003714]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]; virion binding [GO:0046790] g19354.t1 Q6IRE4 50.857 175 4.73e-56 193.0 sp|Q6IRE4|TS101_RAT Tumor susceptibility gene 101 protein OS=Rattus norvegicus OX=10116 GN=Tsg101 PE=1 SV=1 TS101_RAT reviewed Tumor susceptibility gene 101 protein (ESCRT-I complex subunit TSG101) Rattus norvegicus (Rat) GO:0000122; GO:0000813; GO:0001558; GO:0003714; GO:0005634; GO:0005730; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005813; GO:0005829; GO:0005886; GO:0006858; GO:0008285; GO:0008333; GO:0010008; GO:0015031; GO:0030154; GO:0030216; GO:0031625; GO:0031901; GO:0031902; GO:0042059; GO:0042803; GO:0043130; GO:0043162; GO:0044877; GO:0045893; GO:0046755; GO:0046790; GO:0048306; GO:0051301; GO:0051726; GO:0070062; GO:0090543; GO:1902527; GO:1903543; GO:1903551; GO:1903774; GO:1990182; GO:2000397 cell differentiation [GO:0030154]; cell division [GO:0051301]; endosome to lysosome transport [GO:0008333]; exosomal secretion [GO:1990182]; extracellular transport [GO:0006858]; keratinocyte differentiation [GO:0030216]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of protein monoubiquitination [GO:1902527]; positive regulation of ubiquitin-dependent endocytosis [GO:2000397]; positive regulation of viral budding via host ESCRT complex [GO:1903774]; protein transport [GO:0015031]; regulation of cell cycle [GO:0051726]; regulation of cell growth [GO:0001558]; regulation of extracellular exosome assembly [GO:1903551]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]; viral budding [GO:0046755] centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; endosome membrane [GO:0010008]; ESCRT I complex [GO:0000813]; extracellular exosome [GO:0070062]; Flemming body [GO:0090543]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886] calcium-dependent protein binding [GO:0048306]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; transcription corepressor activity [GO:0003714]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]; virion binding [GO:0046790] g19355.t1 Q91755 33.019 848 1.6399999999999998e-135 431.0 sp|Q91755|GRIK2_XENLA Glutamate receptor ionotropic, kainate 2 OS=Xenopus laevis OX=8355 GN=grik2 PE=2 SV=2 GRIK2_XENLA reviewed Glutamate receptor ionotropic, kainate 2 (GluK2) (Glutamate receptor 6) (GluR-6) (GluR6) Xenopus laevis (African clawed frog) GO:0004970; GO:0005234; GO:0005886; GO:0015277; GO:0022849; GO:0032983; GO:0035249; GO:0042734; GO:0050804; GO:0098839; GO:0120169; GO:1904315 detection of cold stimulus involved in thermoception [GO:0120169]; modulation of chemical synaptic transmission [GO:0050804]; synaptic transmission, glutamatergic [GO:0035249] kainate selective glutamate receptor complex [GO:0032983]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; presynaptic membrane [GO:0042734] extracellularly glutamate-gated ion channel activity [GO:0005234]; glutamate-gated calcium ion channel activity [GO:0022849]; glutamate-gated receptor activity [GO:0004970]; kainate selective glutamate receptor activity [GO:0015277]; transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315] g19356.t1 Q8BGS2 52.381 84 1.1199999999999999e-28 101.0 sp|Q8BGS2|BOLA2_MOUSE BolA-like protein 2 OS=Mus musculus OX=10090 GN=Bola2 PE=1 SV=1 g19357.t1 Q91Y81 74.78 341 1.2399999999999999e-180 508.0 sp|Q91Y81|SEPT2_RAT Septin-2 OS=Rattus norvegicus OX=10116 GN=Septin2 PE=1 SV=1 SEPT2_RAT reviewed Septin-2 (Vascular endothelial cell specific protein 11) Rattus norvegicus (Rat) GO:0000145; GO:0002036; GO:0003924; GO:0005525; GO:0005634; GO:0005654; GO:0005737; GO:0005819; GO:0005886; GO:0005929; GO:0005930; GO:0005940; GO:0007224; GO:0007283; GO:0008104; GO:0009986; GO:0015629; GO:0015630; GO:0030234; GO:0030496; GO:0031105; GO:0031175; GO:0032153; GO:0032154; GO:0032391; GO:0032880; GO:0035869; GO:0042802; GO:0042995; GO:0045171; GO:0045202; GO:0048471; GO:0060090; GO:0060170; GO:0060271; GO:0061640; GO:0097227; GO:0097730; GO:0098793 cilium assembly [GO:0060271]; cytoskeleton-dependent cytokinesis [GO:0061640]; intracellular protein localization [GO:0008104]; neuron projection development [GO:0031175]; regulation of L-glutamate import across plasma membrane [GO:0002036]; regulation of protein localization [GO:0032880]; smoothened signaling pathway [GO:0007224]; spermatogenesis [GO:0007283] actin cytoskeleton [GO:0015629]; axoneme [GO:0005930]; cell division site [GO:0032153]; cell projection [GO:0042995]; cell surface [GO:0009986]; ciliary membrane [GO:0060170]; ciliary transition zone [GO:0035869]; cilium [GO:0005929]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; exocyst [GO:0000145]; intercellular bridge [GO:0045171]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; non-motile cilium [GO:0097730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; photoreceptor connecting cilium [GO:0032391]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; septin complex [GO:0031105]; septin ring [GO:0005940]; sperm annulus [GO:0097227]; spindle [GO:0005819]; synapse [GO:0045202] enzyme regulator activity [GO:0030234]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; molecular adaptor activity [GO:0060090] g19358.t1 A4IFI1 32.659 692 3.85e-85 289.0 sp|A4IFI1|CC157_BOVIN Coiled-coil domain-containing protein 157 OS=Bos taurus OX=9913 GN=CCDC157 PE=2 SV=2 g19359.t1 Q6DFS0 43.846 260 6.06e-84 256.0 sp|Q6DFS0|TMX2_XENTR Thioredoxin-related transmembrane protein 2 OS=Xenopus tropicalis OX=8364 GN=tmx2 PE=2 SV=1 TMX2_XENTR reviewed Thioredoxin-related transmembrane protein 2 (Thioredoxin domain-containing protein 14) Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0005739; GO:0005789; GO:0007420; GO:0015036; GO:0031966; GO:0044233 brain development [GO:0007420] endoplasmic reticulum membrane [GO:0005789]; mitochondria-associated endoplasmic reticulum membrane contact site [GO:0044233]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739] disulfide oxidoreductase activity [GO:0015036] g19366.t1 O55230 43.789 322 1.19e-90 276.0 sp|O55230|RA51D_MOUSE DNA repair protein RAD51 homolog 4 OS=Mus musculus OX=10090 GN=Rad51d PE=1 SV=1 g19367.t1 Q5U2Q3 53.821 301 6.72e-116 340.0 sp|Q5U2Q3|CK054_RAT Ester hydrolase C11orf54 homolog OS=Rattus norvegicus OX=10116 PE=1 SV=1 g19368.t1 Q1RM03 49.109 393 1.63e-98 309.0 sp|Q1RM03|TCHP_DANRE Trichoplein keratin filament-binding protein OS=Danio rerio OX=7955 GN=tchp PE=2 SV=1 g19369.t1 P62752 80.87 115 9.61e-61 188.0 sp|P62752|RL23A_RAT Large ribosomal subunit protein uL23 OS=Rattus norvegicus OX=10116 GN=Rpl23a PE=1 SV=1 g19370.t1 Q920Q6 67.358 193 2.23e-93 289.0 sp|Q920Q6|MSI2H_MOUSE RNA-binding protein Musashi homolog 2 OS=Mus musculus OX=10090 GN=Msi2 PE=1 SV=1 g19370.t2 Q920Q6 57.613 243 1.07e-95 294.0 sp|Q920Q6|MSI2H_MOUSE RNA-binding protein Musashi homolog 2 OS=Mus musculus OX=10090 GN=Msi2 PE=1 SV=1 g19372.t1 Q9D2Q2 40.595 739 9.82e-165 495.0 sp|Q9D2Q2|TRM44_MOUSE Probable tRNA (uracil-O(2)-)-methyltransferase OS=Mus musculus OX=10090 GN=Trmt44 PE=2 SV=2 g19376.t1 Q7TNF8 41.497 294 8.81e-62 238.0 sp|Q7TNF8|RIMB1_MOUSE Peripheral-type benzodiazepine receptor-associated protein 1 OS=Mus musculus OX=10090 GN=Tspoap1 PE=2 SV=2 RIMB1_MOUSE reviewed Peripheral-type benzodiazepine receptor-associated protein 1 (PRAX-1) (Peripheral benzodiazepine receptor-interacting protein) (PBR-IP) (RIMS-binding protein 1) (RIM-BP1) (TSPO-associated protein 1) Mus musculus (Mouse) GO:0005737; GO:0005739; GO:0030156; GO:0044305; GO:0046928; GO:0098978; GO:0099626 regulation of neurotransmitter secretion [GO:0046928] calyx of Held [GO:0044305]; cytoplasm [GO:0005737]; glutamatergic synapse [GO:0098978]; mitochondrion [GO:0005739] benzodiazepine receptor binding [GO:0030156]; voltage-gated calcium channel activity involved in regulation of presynaptic cytosolic calcium levels [GO:0099626] g19376.t1 Q7TNF8 33.411 428 3.71e-50 200.0 sp|Q7TNF8|RIMB1_MOUSE Peripheral-type benzodiazepine receptor-associated protein 1 OS=Mus musculus OX=10090 GN=Tspoap1 PE=2 SV=2 RIMB1_MOUSE reviewed Peripheral-type benzodiazepine receptor-associated protein 1 (PRAX-1) (Peripheral benzodiazepine receptor-interacting protein) (PBR-IP) (RIMS-binding protein 1) (RIM-BP1) (TSPO-associated protein 1) Mus musculus (Mouse) GO:0005737; GO:0005739; GO:0030156; GO:0044305; GO:0046928; GO:0098978; GO:0099626 regulation of neurotransmitter secretion [GO:0046928] calyx of Held [GO:0044305]; cytoplasm [GO:0005737]; glutamatergic synapse [GO:0098978]; mitochondrion [GO:0005739] benzodiazepine receptor binding [GO:0030156]; voltage-gated calcium channel activity involved in regulation of presynaptic cytosolic calcium levels [GO:0099626] g19376.t1 Q7TNF8 48.095 210 3.21e-42 174.0 sp|Q7TNF8|RIMB1_MOUSE Peripheral-type benzodiazepine receptor-associated protein 1 OS=Mus musculus OX=10090 GN=Tspoap1 PE=2 SV=2 RIMB1_MOUSE reviewed Peripheral-type benzodiazepine receptor-associated protein 1 (PRAX-1) (Peripheral benzodiazepine receptor-interacting protein) (PBR-IP) (RIMS-binding protein 1) (RIM-BP1) (TSPO-associated protein 1) Mus musculus (Mouse) GO:0005737; GO:0005739; GO:0030156; GO:0044305; GO:0046928; GO:0098978; GO:0099626 regulation of neurotransmitter secretion [GO:0046928] calyx of Held [GO:0044305]; cytoplasm [GO:0005737]; glutamatergic synapse [GO:0098978]; mitochondrion [GO:0005739] benzodiazepine receptor binding [GO:0030156]; voltage-gated calcium channel activity involved in regulation of presynaptic cytosolic calcium levels [GO:0099626] g19376.t2 O95153 34.282 808 5.87e-115 404.0 sp|O95153|RIMB1_HUMAN Peripheral-type benzodiazepine receptor-associated protein 1 OS=Homo sapiens OX=9606 GN=TSPOAP1 PE=1 SV=2 RIMB1_HUMAN reviewed Peripheral-type benzodiazepine receptor-associated protein 1 (PRAX-1) (Peripheral benzodiazepine receptor-interacting protein) (PBR-IP) (RIMS-binding protein 1) (RIM-BP1) (TSPO-associated protein 1) Homo sapiens (Human) GO:0005737; GO:0005739; GO:0005829; GO:0030156; GO:0044305; GO:0046928; GO:0098978; GO:0099626 regulation of neurotransmitter secretion [GO:0046928] calyx of Held [GO:0044305]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; mitochondrion [GO:0005739] benzodiazepine receptor binding [GO:0030156]; voltage-gated calcium channel activity involved in regulation of presynaptic cytosolic calcium levels [GO:0099626] g19379.t1 P20918 40.206 291 1.69e-55 203.0 sp|P20918|PLMN_MOUSE Plasminogen OS=Mus musculus OX=10090 GN=Plg PE=1 SV=3 PLMN_MOUSE reviewed Plasminogen (EC 3.4.21.7) [Cleaved into: Plasmin heavy chain A; Activation peptide; Angiostatin; Plasmin heavy chain A, short form; Plasmin light chain B] Mus musculus (Mouse) GO:0002020; GO:0004175; GO:0004252; GO:0005102; GO:0005576; GO:0005615; GO:0006508; GO:0007596; GO:0009897; GO:0009986; GO:0010812; GO:0016485; GO:0016525; GO:0019899; GO:0019900; GO:0019904; GO:0022617; GO:0031012; GO:0034185; GO:0042246; GO:0042730; GO:0043536; GO:0045445; GO:0046716; GO:0048771; GO:0051087; GO:0051603; GO:0051702; GO:0051918; GO:0051919; GO:0060707; GO:0060716; GO:0071674; GO:0098685; GO:0098978; GO:0099183; GO:1990405 biological process involved in interaction with symbiont [GO:0051702]; blood coagulation [GO:0007596]; extracellular matrix disassembly [GO:0022617]; fibrinolysis [GO:0042730]; labyrinthine layer blood vessel development [GO:0060716]; mononuclear cell migration [GO:0071674]; muscle cell cellular homeostasis [GO:0046716]; myoblast differentiation [GO:0045445]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of fibrinolysis [GO:0051918]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of fibrinolysis [GO:0051919]; protein processing [GO:0016485]; proteolysis [GO:0006508]; proteolysis involved in protein catabolic process [GO:0051603]; tissue regeneration [GO:0042246]; tissue remodeling [GO:0048771]; trans-synaptic signaling by BDNF, modulating synaptic transmission [GO:0099183]; trophoblast giant cell differentiation [GO:0060707] cell surface [GO:0009986]; external side of plasma membrane [GO:0009897]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; glutamatergic synapse [GO:0098978]; Schaffer collateral - CA1 synapse [GO:0098685] apolipoprotein binding [GO:0034185]; endopeptidase activity [GO:0004175]; enzyme binding [GO:0019899]; kinase binding [GO:0019900]; protease binding [GO:0002020]; protein antigen binding [GO:1990405]; protein domain specific binding [GO:0019904]; protein-folding chaperone binding [GO:0051087]; serine-type endopeptidase activity [GO:0004252]; signaling receptor binding [GO:0005102] g19380.t1 O46658 38.411 453 4.3e-101 316.0 sp|O46658|CP2DP_PIG Vitamin D(3) 25-hydroxylase OS=Sus scrofa OX=9823 GN=CYP2D25 PE=1 SV=3 g19381.t1 Q0IIF9 36.914 512 2.99e-105 328.0 sp|Q0IIF9|CP2U1_BOVIN Cytochrome P450 2U1 OS=Bos taurus OX=9913 GN=CYP2U1 PE=2 SV=1 CP2U1_BOVIN reviewed Cytochrome P450 2U1 (Long-chain fatty acid omega-monooxygenase) (EC 1.14.14.80) Bos taurus (Bovine) GO:0005506; GO:0005737; GO:0005743; GO:0005789; GO:0006082; GO:0006805; GO:0008202; GO:0008395; GO:0016712; GO:0020037; GO:0052869; GO:0102033 organic acid metabolic process [GO:0006082]; steroid metabolic process [GO:0008202]; xenobiotic metabolic process [GO:0006805] cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; mitochondrial inner membrane [GO:0005743] arachidonate omega-hydroxylase activity [GO:0052869]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; long-chain fatty acid omega-hydroxylase activity [GO:0102033]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; steroid hydroxylase activity [GO:0008395] g19382.t1 Q0IIF9 37.5 512 1.0400000000000001e-110 342.0 sp|Q0IIF9|CP2U1_BOVIN Cytochrome P450 2U1 OS=Bos taurus OX=9913 GN=CYP2U1 PE=2 SV=1 CP2U1_BOVIN reviewed Cytochrome P450 2U1 (Long-chain fatty acid omega-monooxygenase) (EC 1.14.14.80) Bos taurus (Bovine) GO:0005506; GO:0005737; GO:0005743; GO:0005789; GO:0006082; GO:0006805; GO:0008202; GO:0008395; GO:0016712; GO:0020037; GO:0052869; GO:0102033 organic acid metabolic process [GO:0006082]; steroid metabolic process [GO:0008202]; xenobiotic metabolic process [GO:0006805] cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; mitochondrial inner membrane [GO:0005743] arachidonate omega-hydroxylase activity [GO:0052869]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; long-chain fatty acid omega-hydroxylase activity [GO:0102033]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; steroid hydroxylase activity [GO:0008395] g19383.t1 Q0IIF9 37.622 513 1.52e-99 313.0 sp|Q0IIF9|CP2U1_BOVIN Cytochrome P450 2U1 OS=Bos taurus OX=9913 GN=CYP2U1 PE=2 SV=1 CP2U1_BOVIN reviewed Cytochrome P450 2U1 (Long-chain fatty acid omega-monooxygenase) (EC 1.14.14.80) Bos taurus (Bovine) GO:0005506; GO:0005737; GO:0005743; GO:0005789; GO:0006082; GO:0006805; GO:0008202; GO:0008395; GO:0016712; GO:0020037; GO:0052869; GO:0102033 organic acid metabolic process [GO:0006082]; steroid metabolic process [GO:0008202]; xenobiotic metabolic process [GO:0006805] cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; mitochondrial inner membrane [GO:0005743] arachidonate omega-hydroxylase activity [GO:0052869]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; long-chain fatty acid omega-hydroxylase activity [GO:0102033]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; steroid hydroxylase activity [GO:0008395] g19384.t1 Q3UF64 41.724 290 1.79e-72 236.0 sp|Q3UF64|RNFT2_MOUSE RING finger and transmembrane domain-containing protein 2 OS=Mus musculus OX=10090 GN=Rnft2 PE=2 SV=2 g19385.t1 Q6INX3 54.887 266 3.2699999999999995e-89 270.0 sp|Q6INX3|MLECA_XENLA Malectin-A OS=Xenopus laevis OX=8355 GN=mlec-a PE=1 SV=1 g19386.t1 Q08C92 71.127 426 0.0 639.0 sp|Q08C92|TYW1_DANRE S-adenosyl-L-methionine-dependent tRNA 4-demethylwyosine synthase TYW1 OS=Danio rerio OX=7955 GN=tyw1 PE=2 SV=1 g19386.t1 Q08C92 55.556 162 1.53e-53 201.0 sp|Q08C92|TYW1_DANRE S-adenosyl-L-methionine-dependent tRNA 4-demethylwyosine synthase TYW1 OS=Danio rerio OX=7955 GN=tyw1 PE=2 SV=1 g19387.t1 Q1JQ92 38.554 166 9.47e-32 114.0 sp|Q1JQ92|POP5_BOVIN Ribonuclease P/MRP protein subunit POP5 OS=Bos taurus OX=9913 GN=POP5 PE=2 SV=1 g19391.t1 Q6GNT2 50.246 203 3.05e-60 190.0 sp|Q6GNT2|SPRNG_XENLA SREBP regulating gene protein OS=Xenopus laevis OX=8355 GN=spring1 PE=2 SV=1 g19394.t1 Q2XWK0 52.738 493 5.48e-161 471.0 sp|Q2XWK0|SVOP_XENLA Synaptic vesicle 2-related protein OS=Xenopus laevis OX=8355 GN=svop PE=2 SV=1 g19395.t1 Q8N539 37.037 243 1.09e-39 149.0 sp|Q8N539|FBCD1_HUMAN Fibrinogen C domain-containing protein 1 OS=Homo sapiens OX=9606 GN=FIBCD1 PE=1 SV=2 FBCD1_HUMAN reviewed Fibrinogen C domain-containing protein 1 Homo sapiens (Human) GO:0005615; GO:0008061; GO:0016020; GO:0046872 extracellular space [GO:0005615]; membrane [GO:0016020] chitin binding [GO:0008061]; metal ion binding [GO:0046872] g19396.t1 Q29041 45.378 238 9.82e-47 164.0 sp|Q29041|FCN2_PIG Ficolin-2 OS=Sus scrofa OX=9823 GN=FCN2 PE=1 SV=1 FCN2_PIG reviewed Ficolin-2 (Collagen/fibrinogen domain-containing protein 2) (Ficolin-B) (Ficolin-beta) (L-ficolin) Sus scrofa (Pig) GO:0001867; GO:0003823; GO:0005102; GO:0005581; GO:0005615; GO:0030246; GO:0038187; GO:0046872; GO:0070892; GO:0097367; GO:0106139 complement activation, lectin pathway [GO:0001867] collagen trimer [GO:0005581]; extracellular space [GO:0005615]; symbiont cell surface [GO:0106139] antigen binding [GO:0003823]; carbohydrate binding [GO:0030246]; carbohydrate derivative binding [GO:0097367]; lipoteichoic acid immune receptor activity [GO:0070892]; metal ion binding [GO:0046872]; pattern recognition receptor activity [GO:0038187]; signaling receptor binding [GO:0005102] g19397.t1 Q8N539 37.037 243 1.09e-39 149.0 sp|Q8N539|FBCD1_HUMAN Fibrinogen C domain-containing protein 1 OS=Homo sapiens OX=9606 GN=FIBCD1 PE=1 SV=2 FBCD1_HUMAN reviewed Fibrinogen C domain-containing protein 1 Homo sapiens (Human) GO:0005615; GO:0008061; GO:0016020; GO:0046872 extracellular space [GO:0005615]; membrane [GO:0016020] chitin binding [GO:0008061]; metal ion binding [GO:0046872] g19412.t1 Q5F2F2 38.72 328 1.9e-60 207.0 sp|Q5F2F2|ABH15_MOUSE Protein ABHD15 OS=Mus musculus OX=10090 GN=Abhd15 PE=1 SV=1 ABH15_MOUSE reviewed Protein ABHD15 (Alpha/beta hydrolase domain-containing protein 15) (Abhydrolase domain-containing protein 15) Mus musculus (Mouse) GO:0005576; GO:0006629; GO:0016042; GO:0034338; GO:0047372; GO:0060612 adipose tissue development [GO:0060612]; lipid catabolic process [GO:0016042]; lipid metabolic process [GO:0006629] extracellular region [GO:0005576] monoacylglycerol lipase activity [GO:0047372]; short-chain carboxylesterase activity [GO:0034338] g19417.t1 Q58DH2 57.006 314 1.14e-111 337.0 sp|Q58DH2|PISD_BOVIN Phosphatidylserine decarboxylase proenzyme, mitochondrial OS=Bos taurus OX=9913 GN=PISD PE=2 SV=1 PISD_BOVIN reviewed Phosphatidylserine decarboxylase proenzyme, mitochondrial (EC 4.1.1.65) [Cleaved into: Phosphatidylserine decarboxylase beta chain; Phosphatidylserine decarboxylase alpha chain] Bos taurus (Bovine) GO:0004609; GO:0005739; GO:0005743; GO:0005811; GO:0006646; GO:0010821; GO:0016540; GO:0035694; GO:0140042 lipid droplet formation [GO:0140042]; mitochondrial protein catabolic process [GO:0035694]; phosphatidylethanolamine biosynthetic process [GO:0006646]; protein autoprocessing [GO:0016540]; regulation of mitochondrion organization [GO:0010821] lipid droplet [GO:0005811]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739] phosphatidylserine decarboxylase activity [GO:0004609] g19420.t1 P53445 70.028 357 0.0 514.0 sp|P53445|ALF1_LETCA Fructose-bisphosphate aldolase, muscle type OS=Lethenteron camtschaticum OX=980415 PE=2 SV=1 g19421.t1 Q9HC36 54.118 170 6.619999999999999e-61 199.0 sp|Q9HC36|MRM3_HUMAN rRNA methyltransferase 3, mitochondrial OS=Homo sapiens OX=9606 GN=MRM3 PE=1 SV=2 MRM3_HUMAN reviewed rRNA methyltransferase 3, mitochondrial (EC 2.1.1.-) (16S rRNA (guanosine(1370)-2'-O)-methyltransferase) (16S rRNA [Gm1370] 2'-O-methyltransferase) (RNA methyltransferase-like protein 1) Homo sapiens (Human) GO:0000451; GO:0003723; GO:0005739; GO:0005759; GO:0006364; GO:0042802; GO:0070039; GO:1902775 mitochondrial large ribosomal subunit assembly [GO:1902775]; rRNA 2'-O-methylation [GO:0000451]; rRNA processing [GO:0006364] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] identical protein binding [GO:0042802]; RNA binding [GO:0003723]; rRNA (guanosine-2'-O-)-methyltransferase activity [GO:0070039] g19426.t1 Q1JQC1 32.174 460 1.47e-60 209.0 sp|Q1JQC1|MFSD1_BOVIN Lysosomal dipeptide transporter MFSD1 OS=Bos taurus OX=9913 GN=MFSD1 PE=2 SV=1 MFSD1_BOVIN reviewed Lysosomal dipeptide transporter MFSD1 (Major facilitator superfamily domain-containing protein 1) Bos taurus (Bovine) GO:0005764; GO:0005765; GO:0042803; GO:0050821; GO:0061462; GO:0141204; GO:0160178 dipeptide transmembrane transport from lysosomal lumen to cytosol [GO:0141204]; protein localization to lysosome [GO:0061462]; protein stabilization [GO:0050821] lysosomal membrane [GO:0005765]; lysosome [GO:0005764] dipeptide uniporter activity [GO:0160178]; protein homodimerization activity [GO:0042803] g19429.t1 P53675 33.518 361 4.56e-65 228.0 sp|P53675|CLH2_HUMAN Clathrin heavy chain 2 OS=Homo sapiens OX=9606 GN=CLTCL1 PE=1 SV=2 CLH2_HUMAN reviewed Clathrin heavy chain 2 (Clathrin heavy chain on chromosome 22) (CLH-22) Homo sapiens (Human) GO:0000278; GO:0005198; GO:0005770; GO:0005802; GO:0005819; GO:0005829; GO:0005905; GO:0006886; GO:0006898; GO:0009653; GO:0016020; GO:0030130; GO:0030135; GO:0030136; GO:0032051; GO:0042147; GO:0045334; GO:0046326; GO:0070062; GO:0071439; GO:0097443 anatomical structure morphogenesis [GO:0009653]; intracellular protein transport [GO:0006886]; mitotic cell cycle [GO:0000278]; positive regulation of D-glucose import [GO:0046326]; receptor-mediated endocytosis [GO:0006898]; retrograde transport, endosome to Golgi [GO:0042147] clathrin coat of trans-Golgi network vesicle [GO:0030130]; clathrin complex [GO:0071439]; clathrin-coated endocytic vesicle [GO:0045334]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; coated vesicle [GO:0030135]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; late endosome [GO:0005770]; membrane [GO:0016020]; sorting endosome [GO:0097443]; spindle [GO:0005819]; trans-Golgi network [GO:0005802] clathrin light chain binding [GO:0032051]; structural molecule activity [GO:0005198] g19430.t1 A5D8M6 66.534 251 7.920000000000001e-109 316.0 sp|A5D8M6|SBDS_XENLA Ribosome maturation protein SBDS OS=Xenopus laevis OX=8355 GN=sbds PE=2 SV=1 g19431.t1 Q8C1R0 45.695 302 3.3399999999999996e-82 268.0 sp|Q8C1R0|TSSK5_MOUSE Testis-specific serine/threonine-protein kinase 5 OS=Mus musculus OX=10090 GN=Tssk5 PE=2 SV=2 g19434.t1 Q96NN9 46.743 522 1.35e-171 501.0 sp|Q96NN9|AIFM3_HUMAN Apoptosis-inducing factor 3 OS=Homo sapiens OX=9606 GN=AIFM3 PE=1 SV=1 g19436.t1 P26153 45.895 475 3.13e-119 361.0 sp|P26153|ACHB4_CHICK Neuronal acetylcholine receptor subunit beta-4 (Fragment) OS=Gallus gallus OX=9031 GN=CHRNB4 PE=1 SV=1 g19437.t1 Q8R4G9 39.641 502 1.18e-120 369.0 sp|Q8R4G9|ACHA3_MOUSE Neuronal acetylcholine receptor subunit alpha-3 OS=Mus musculus OX=10090 GN=Chrna3 PE=1 SV=1 ACHA3_MOUSE reviewed Neuronal acetylcholine receptor subunit alpha-3 Mus musculus (Mouse) GO:0005730; GO:0005783; GO:0005794; GO:0005829; GO:0005886; GO:0005892; GO:0006937; GO:0006940; GO:0007165; GO:0007271; GO:0007274; GO:0007399; GO:0007626; GO:0009410; GO:0014056; GO:0015464; GO:0016607; GO:0022848; GO:0030425; GO:0032991; GO:0034220; GO:0034703; GO:0035094; GO:0035095; GO:0036064; GO:0042166; GO:0042391; GO:0043005; GO:0043025; GO:0044853; GO:0044877; GO:0045202; GO:0045211; GO:0046872; GO:0048814; GO:0051899; GO:0060079; GO:0060084; GO:0095500; GO:0098691; GO:0098793; GO:0098878; GO:0098981; GO:0099171; GO:0099634; GO:1901363; GO:1904315; GO:1905144 acetylcholine receptor signaling pathway [GO:0095500]; behavioral response to nicotine [GO:0035095]; excitatory postsynaptic potential [GO:0060079]; locomotory behavior [GO:0007626]; membrane depolarization [GO:0051899]; monoatomic ion transmembrane transport [GO:0034220]; nervous system development [GO:0007399]; neuromuscular synaptic transmission [GO:0007274]; presynaptic modulation of chemical synaptic transmission [GO:0099171]; regulation of acetylcholine secretion, neurotransmission [GO:0014056]; regulation of dendrite morphogenesis [GO:0048814]; regulation of membrane potential [GO:0042391]; regulation of muscle contraction [GO:0006937]; regulation of smooth muscle contraction [GO:0006940]; response to acetylcholine [GO:1905144]; response to nicotine [GO:0035094]; response to xenobiotic stimulus [GO:0009410]; signal transduction [GO:0007165]; synaptic transmission involved in micturition [GO:0060084]; synaptic transmission, cholinergic [GO:0007271] acetylcholine-gated channel complex [GO:0005892]; cation channel complex [GO:0034703]; cholinergic synapse [GO:0098981]; ciliary basal body [GO:0036064]; cytosol [GO:0005829]; dendrite [GO:0030425]; dopaminergic synapse [GO:0098691]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; neurotransmitter receptor complex [GO:0098878]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic membrane [GO:0045211]; postsynaptic specialization membrane [GO:0099634]; presynapse [GO:0098793]; protein-containing complex [GO:0032991]; synapse [GO:0045202] acetylcholine binding [GO:0042166]; acetylcholine receptor activity [GO:0015464]; acetylcholine-gated monoatomic cation-selective channel activity [GO:0022848]; heterocyclic compound binding [GO:1901363]; metal ion binding [GO:0046872]; protein-containing complex binding [GO:0044877]; transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315] g19438.t1 P09481 44.764 487 3.7e-140 417.0 sp|P09481|ACHA3_CHICK Neuronal acetylcholine receptor subunit alpha-3 OS=Gallus gallus OX=9031 GN=CHRNA3 PE=1 SV=2 g19439.t1 O77404 41.844 141 3.24e-31 112.0 sp|O77404|TYPX_TRYBB Tryparedoxin OS=Trypanosoma brucei brucei OX=5702 PE=1 SV=1 g19440.t1 Q503L9 41.282 390 3.98e-99 305.0 sp|Q503L9|NXN_DANRE Nucleoredoxin OS=Danio rerio OX=7955 GN=nxn PE=2 SV=1 g19440.t1 Q503L9 40.602 133 1.39e-28 119.0 sp|Q503L9|NXN_DANRE Nucleoredoxin OS=Danio rerio OX=7955 GN=nxn PE=2 SV=1 g19441.t1 Q04336 49.731 929 0.0 890.0 sp|Q04336|YM54_YEAST Uncharacterized protein YMR196W OS=Saccharomyces cerevisiae (strain ATCC 204508 / S288c) OX=559292 GN=YMR196W PE=1 SV=1 g19444.t1 A8WGS4 33.333 231 1.49e-25 103.0 sp|A8WGS4|TLCD2_DANRE TLC domain-containing protein 2 OS=Danio rerio OX=7955 GN=tlcd2 PE=2 SV=1 g19445.t1 Q4V7W8 48.214 224 4.939999999999999e-54 181.0 sp|Q4V7W8|ETKMT_XENLA Electron transfer flavoprotein beta subunit lysine methyltransferase OS=Xenopus laevis OX=8355 GN=etfbkmt PE=2 SV=1 g19446.t1 Q9UH65 34.304 309 1.6800000000000002e-43 169.0 sp|Q9UH65|SWP70_HUMAN Switch-associated protein 70 OS=Homo sapiens OX=9606 GN=SWAP70 PE=1 SV=1 g19447.t1 P00919 39.313 262 1.98e-51 174.0 sp|P00919|CAH2_RABIT Carbonic anhydrase 2 OS=Oryctolagus cuniculus OX=9986 GN=CA2 PE=1 SV=3 g19450.t1 Q9QZR0 45.693 267 4.7100000000000005e-73 237.0 sp|Q9QZR0|RNF25_MOUSE E3 ubiquitin-protein ligase RNF25 OS=Mus musculus OX=10090 GN=Rnf25 PE=1 SV=2 RNF25_MOUSE reviewed E3 ubiquitin-protein ligase RNF25 (EC 2.3.2.27) (RING finger protein 25) (RING finger protein AO7) Mus musculus (Mouse) GO:0004842; GO:0005634; GO:0005829; GO:0006414; GO:0006415; GO:0006511; GO:0008270; GO:0016567; GO:0022626; GO:0051059; GO:0051092; GO:0061630; GO:0072344; GO:0085020; GO:0160127 positive regulation of NF-kappaB transcription factor activity [GO:0051092]; protein K6-linked ubiquitination [GO:0085020]; protein ubiquitination [GO:0016567]; protein-RNA covalent cross-linking repair [GO:0160127]; rescue of stalled ribosome [GO:0072344]; translational elongation [GO:0006414]; translational termination [GO:0006415]; ubiquitin-dependent protein catabolic process [GO:0006511] cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; nucleus [GO:0005634] NF-kappaB binding [GO:0051059]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] g19451.t1 Q2NL00 41.553 219 1.1e-58 188.0 sp|Q2NL00|GSTT1_BOVIN Glutathione S-transferase theta-1 OS=Bos taurus OX=9913 GN=GSTT1 PE=2 SV=3 g19451.t2 P30711 40.851 235 4.36e-59 191.0 sp|P30711|GSTT1_HUMAN Glutathione S-transferase theta-1 OS=Homo sapiens OX=9606 GN=GSTT1 PE=1 SV=4 GSTT1_HUMAN reviewed Glutathione S-transferase theta-1 (EC 2.5.1.18) (GST class-theta-1) (Glutathione transferase T1-1) Homo sapiens (Human) GO:0004364; GO:0004602; GO:0005737; GO:0005829; GO:0006749; GO:0070062 glutathione metabolic process [GO:0006749] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062] glutathione peroxidase activity [GO:0004602]; glutathione transferase activity [GO:0004364] g19452.t1 Q64471 47.0 200 1.7600000000000001e-59 190.0 sp|Q64471|GSTT1_MOUSE Glutathione S-transferase theta-1 OS=Mus musculus OX=10090 GN=Gstt1 PE=1 SV=4 GSTT1_MOUSE reviewed Glutathione S-transferase theta-1 (EC 2.5.1.18) (GST class-theta-1) Mus musculus (Mouse) GO:0004364; GO:0004602; GO:0005634; GO:0005737; GO:0005829; GO:0006304; GO:0006749; GO:0009751; GO:0010269; GO:0018900; GO:0033197; GO:0047651 dichloromethane metabolic process [GO:0018900]; DNA modification [GO:0006304]; glutathione metabolic process [GO:0006749]; response to salicylic acid [GO:0009751]; response to selenium ion [GO:0010269]; response to vitamin E [GO:0033197] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634] alkylhalidase activity [GO:0047651]; glutathione peroxidase activity [GO:0004602]; glutathione transferase activity [GO:0004364] g19452.t2 Q64471 45.631 206 1.99e-57 185.0 sp|Q64471|GSTT1_MOUSE Glutathione S-transferase theta-1 OS=Mus musculus OX=10090 GN=Gstt1 PE=1 SV=4 GSTT1_MOUSE reviewed Glutathione S-transferase theta-1 (EC 2.5.1.18) (GST class-theta-1) Mus musculus (Mouse) GO:0004364; GO:0004602; GO:0005634; GO:0005737; GO:0005829; GO:0006304; GO:0006749; GO:0009751; GO:0010269; GO:0018900; GO:0033197; GO:0047651 dichloromethane metabolic process [GO:0018900]; DNA modification [GO:0006304]; glutathione metabolic process [GO:0006749]; response to salicylic acid [GO:0009751]; response to selenium ion [GO:0010269]; response to vitamin E [GO:0033197] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634] alkylhalidase activity [GO:0047651]; glutathione peroxidase activity [GO:0004602]; glutathione transferase activity [GO:0004364] g19453.t1 Q9Z265 50.108 465 5.13e-155 456.0 sp|Q9Z265|CHK2_MOUSE Serine/threonine-protein kinase Chk2 OS=Mus musculus OX=10090 GN=Chek2 PE=1 SV=1 CHK2_MOUSE reviewed Serine/threonine-protein kinase Chk2 (EC 2.7.11.1) (CHK2 checkpoint homolog) (Checkpoint kinase 2) Mus musculus (Mouse) GO:0000045; GO:0000077; GO:0000086; GO:0000781; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005794; GO:0006302; GO:0006355; GO:0006915; GO:0006974; GO:0006979; GO:0008630; GO:0010332; GO:0016301; GO:0016605; GO:0019901; GO:0030163; GO:0030330; GO:0031573; GO:0031625; GO:0033554; GO:0042176; GO:0042594; GO:0042770; GO:0042771; GO:0042802; GO:0042803; GO:0044773; GO:0045893; GO:0046777; GO:0046872; GO:0050821; GO:0051301; GO:0070534; GO:0071466; GO:0071480; GO:0090307; GO:0106310; GO:1903416; GO:1903926; GO:2000002; GO:2000210; GO:2000785; GO:2000786 apoptotic process [GO:0006915]; autophagosome assembly [GO:0000045]; cell division [GO:0051301]; cellular response to bisphenol A [GO:1903926]; cellular response to gamma radiation [GO:0071480]; cellular response to stress [GO:0033554]; cellular response to xenobiotic stimulus [GO:0071466]; DNA damage checkpoint signaling [GO:0000077]; DNA damage response [GO:0006974]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; double-strand break repair [GO:0006302]; G2/M transition of mitotic cell cycle [GO:0000086]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; mitotic DNA damage checkpoint signaling [GO:0044773]; mitotic intra-S DNA damage checkpoint signaling [GO:0031573]; mitotic spindle assembly [GO:0090307]; negative regulation of DNA damage checkpoint [GO:2000002]; positive regulation of anoikis [GO:2000210]; positive regulation of autophagosome assembly [GO:2000786]; positive regulation of DNA-templated transcription [GO:0045893]; protein autophosphorylation [GO:0046777]; protein catabolic process [GO:0030163]; protein K63-linked ubiquitination [GO:0070534]; protein stabilization [GO:0050821]; regulation of autophagosome assembly [GO:2000785]; regulation of DNA-templated transcription [GO:0006355]; regulation of protein catabolic process [GO:0042176]; response to gamma radiation [GO:0010332]; response to glycoside [GO:1903416]; response to oxidative stress [GO:0006979]; response to starvation [GO:0042594]; signal transduction in response to DNA damage [GO:0042770] chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605] ATP binding [GO:0005524]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; ubiquitin protein ligase binding [GO:0031625] g19454.t1 A0JN61 53.425 146 1.84e-28 105.0 sp|A0JN61|RPC9_BOVIN DNA-directed RNA polymerase III subunit RPC9 OS=Bos taurus OX=9913 GN=CRCP PE=2 SV=1 g19455.t1 Q9Y6H1 52.778 108 1.48e-22 90.9 sp|Q9Y6H1|CHCH2_HUMAN Coiled-coil-helix-coiled-coil-helix domain-containing protein 2 OS=Homo sapiens OX=9606 GN=CHCHD2 PE=1 SV=1 CHCH2_HUMAN reviewed Coiled-coil-helix-coiled-coil-helix domain-containing protein 2 (Aging-associated gene 10 protein) (HCV NS2 trans-regulated protein) (NS2TP) Homo sapiens (Human) GO:0005634; GO:0005739; GO:0005758; GO:0007005; GO:0034599; GO:0043467; GO:0043565; GO:0045944; GO:0140297; GO:1900037; GO:1905448 cellular response to oxidative stress [GO:0034599]; mitochondrion organization [GO:0007005]; positive regulation of mitochondrial ATP synthesis coupled electron transport [GO:1905448]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cellular response to hypoxia [GO:1900037]; regulation of generation of precursor metabolites and energy [GO:0043467] mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; nucleus [GO:0005634] DNA-binding transcription factor binding [GO:0140297]; sequence-specific DNA binding [GO:0043565] g19456.t1 O77245 34.819 359 3.63e-59 206.0 sp|O77245|E75_METEN Nuclear hormone receptor E75 OS=Metapenaeus ensis OX=32278 GN=E75 PE=2 SV=1 g19457.t1 Q9NQG7 29.338 317 8.349999999999999e-30 130.0 sp|Q9NQG7|HPS4_HUMAN BLOC-3 complex member HPS4 OS=Homo sapiens OX=9606 GN=HPS4 PE=1 SV=2 HPS4_HUMAN reviewed BLOC-3 complex member HPS4 (Hermansky-Pudlak syndrome 4 protein) (Light-ear protein homolog) Homo sapiens (Human) GO:0005085; GO:0005737; GO:0005764; GO:0005765; GO:0005829; GO:0006605; GO:0007040; GO:0007596; GO:0007599; GO:0016020; GO:0016192; GO:0030318; GO:0031085; GO:0031267; GO:0031410; GO:0042470; GO:0042803; GO:0042827; GO:0046983; GO:0048075; GO:0050821; GO:0060155; GO:1903232; GO:1903955 blood coagulation [GO:0007596]; hemostasis [GO:0007599]; lysosome organization [GO:0007040]; melanocyte differentiation [GO:0030318]; melanosome assembly [GO:1903232]; platelet dense granule organization [GO:0060155]; positive regulation of eye pigmentation [GO:0048075]; positive regulation of protein targeting to mitochondrion [GO:1903955]; protein stabilization [GO:0050821]; protein targeting [GO:0006605]; vesicle-mediated transport [GO:0016192] BLOC-3 complex [GO:0031085]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; melanosome [GO:0042470]; membrane [GO:0016020]; platelet dense granule [GO:0042827] guanyl-nucleotide exchange factor activity [GO:0005085]; protein dimerization activity [GO:0046983]; protein homodimerization activity [GO:0042803]; small GTPase binding [GO:0031267] g19461.t1 Q9D826 45.288 382 7.970000000000001e-103 312.0 sp|Q9D826|SOX_MOUSE Peroxisomal sarcosine oxidase OS=Mus musculus OX=10090 GN=Pipox PE=1 SV=1 SOX_MOUSE reviewed Peroxisomal sarcosine oxidase (PSO) (EC 1.5.3.1) (EC 1.5.3.7) (L-pipecolate oxidase) (L-pipecolic acid oxidase) Mus musculus (Mouse) GO:0005777; GO:0008115; GO:0033514; GO:0050031; GO:0050660 L-lysine catabolic process to acetyl-CoA via L-pipecolate [GO:0033514] peroxisome [GO:0005777] flavin adenine dinucleotide binding [GO:0050660]; L-pipecolate oxidase activity [GO:0050031]; sarcosine oxidase activity [GO:0008115] g19462.t1 P11023 40.437 183 4.1999999999999995e-40 140.0 sp|P11023|RAB3A_BOVIN Ras-related protein Rab-3A OS=Bos taurus OX=9913 GN=RAB3A PE=1 SV=3 RAB3A_BOVIN reviewed Ras-related protein Rab-3A (EC 3.6.5.2) (SMG P25A) Bos taurus (Bovine) GO:0003016; GO:0003924; GO:0003925; GO:0005525; GO:0005764; GO:0005768; GO:0005829; GO:0005886; GO:0007005; GO:0007274; GO:0007409; GO:0008021; GO:0009791; GO:0015031; GO:0016020; GO:0016079; GO:0016188; GO:0017157; GO:0030324; GO:0030424; GO:0030672; GO:0031489; GO:0031630; GO:0046872; GO:0048786; GO:0048790; GO:0050975; GO:0051602; GO:0060478; GO:0098793; GO:0098794 acrosomal vesicle exocytosis [GO:0060478]; axonogenesis [GO:0007409]; lung development [GO:0030324]; maintenance of presynaptic active zone structure [GO:0048790]; mitochondrion organization [GO:0007005]; neuromuscular synaptic transmission [GO:0007274]; post-embryonic development [GO:0009791]; protein transport [GO:0015031]; regulation of exocytosis [GO:0017157]; regulation of synaptic vesicle fusion to presynaptic active zone membrane [GO:0031630]; respiratory system process [GO:0003016]; response to electrical stimulus [GO:0051602]; sensory perception of touch [GO:0050975]; synaptic vesicle exocytosis [GO:0016079]; synaptic vesicle maturation [GO:0016188] axon [GO:0030424]; cytosol [GO:0005829]; endosome [GO:0005768]; lysosome [GO:0005764]; membrane [GO:0016020]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; presynapse [GO:0098793]; presynaptic active zone [GO:0048786]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672] G protein activity [GO:0003925]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; myosin V binding [GO:0031489] g19463.t1 A0A6N3IN21 54.717 106 2.99e-31 117.0 sp|A0A6N3IN21|SDSL_RAT Serine dehydratase-like OS=Rattus norvegicus OX=10116 GN=Sdsl PE=1 SV=1 SDSL_RAT reviewed Serine dehydratase-like (Glutamate racemase) (EC 5.1.1.3) (L-serine deaminase) (EC 4.3.1.17) (L-serine dehydratase/L-threonine deaminase) (L-threonine dehydratase) (TDH) (EC 4.3.1.19) Rattus norvegicus (Rat) GO:0003941; GO:0004794; GO:0006629; GO:0008881; GO:0030170; GO:0042802 lipid metabolic process [GO:0006629] glutamate racemase activity [GO:0008881]; identical protein binding [GO:0042802]; L-serine ammonia-lyase activity [GO:0003941]; pyridoxal phosphate binding [GO:0030170]; threonine deaminase activity [GO:0004794] g19464.t1 Q96GA7 56.25 144 3.21e-31 117.0 sp|Q96GA7|SDSL_HUMAN Serine dehydratase-like OS=Homo sapiens OX=9606 GN=SDSL PE=1 SV=1 SDSL_HUMAN reviewed Serine dehydratase-like (Cancerous serine dehydratase) (cSDH) (Glutamate racemase) (EC 5.1.1.3) (L-serine deaminase) (EC 4.3.1.17) (L-serine dehydratase/L-threonine deaminase) (SDHL) (L-threonine dehydratase) (TDH) (EC 4.3.1.19) (Serine dehydratase 2) (SDH 2) Homo sapiens (Human) GO:0003941; GO:0004794; GO:0005829; GO:0006565; GO:0006629; GO:0008881; GO:0030170; GO:0042802 L-serine catabolic process [GO:0006565]; lipid metabolic process [GO:0006629] cytosol [GO:0005829] glutamate racemase activity [GO:0008881]; identical protein binding [GO:0042802]; L-serine ammonia-lyase activity [GO:0003941]; pyridoxal phosphate binding [GO:0030170]; threonine deaminase activity [GO:0004794] g19466.t1 Q92890 62.662 308 5.35e-130 375.0 sp|Q92890|UFD1_HUMAN Ubiquitin recognition factor in ER-associated degradation protein 1 OS=Homo sapiens OX=9606 GN=UFD1 PE=1 SV=3 UFD1_HUMAN reviewed Ubiquitin recognition factor in ER-associated degradation protein 1 (Ubiquitin fusion degradation protein 1) (UB fusion protein 1) Homo sapiens (Human) GO:0001501; GO:0004843; GO:0005634; GO:0005654; GO:0005829; GO:0006511; GO:0030970; GO:0031593; GO:0032480; GO:0034098; GO:0036435; GO:0036501; GO:0036503; GO:0039536; GO:0043161; GO:0071218 cellular response to misfolded protein [GO:0071218]; ERAD pathway [GO:0036503]; negative regulation of RIG-I signaling pathway [GO:0039536]; negative regulation of type I interferon production [GO:0032480]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; retrograde protein transport, ER to cytosol [GO:0030970]; skeletal system development [GO:0001501]; ubiquitin-dependent protein catabolic process [GO:0006511] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; UFD1-NPL4 complex [GO:0036501]; VCP-NPL4-UFD1 AAA ATPase complex [GO:0034098] cysteine-type deubiquitinase activity [GO:0004843]; K48-linked polyubiquitin modification-dependent protein binding [GO:0036435]; polyubiquitin modification-dependent protein binding [GO:0031593] g19466.t2 Q92890 63.946 294 2.6e-128 370.0 sp|Q92890|UFD1_HUMAN Ubiquitin recognition factor in ER-associated degradation protein 1 OS=Homo sapiens OX=9606 GN=UFD1 PE=1 SV=3 UFD1_HUMAN reviewed Ubiquitin recognition factor in ER-associated degradation protein 1 (Ubiquitin fusion degradation protein 1) (UB fusion protein 1) Homo sapiens (Human) GO:0001501; GO:0004843; GO:0005634; GO:0005654; GO:0005829; GO:0006511; GO:0030970; GO:0031593; GO:0032480; GO:0034098; GO:0036435; GO:0036501; GO:0036503; GO:0039536; GO:0043161; GO:0071218 cellular response to misfolded protein [GO:0071218]; ERAD pathway [GO:0036503]; negative regulation of RIG-I signaling pathway [GO:0039536]; negative regulation of type I interferon production [GO:0032480]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; retrograde protein transport, ER to cytosol [GO:0030970]; skeletal system development [GO:0001501]; ubiquitin-dependent protein catabolic process [GO:0006511] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; UFD1-NPL4 complex [GO:0036501]; VCP-NPL4-UFD1 AAA ATPase complex [GO:0034098] cysteine-type deubiquitinase activity [GO:0004843]; K48-linked polyubiquitin modification-dependent protein binding [GO:0036435]; polyubiquitin modification-dependent protein binding [GO:0031593] g19467.t1 O75419 52.9 569 0.0 565.0 sp|O75419|CDC45_HUMAN Cell division control protein 45 homolog OS=Homo sapiens OX=9606 GN=CDC45 PE=1 SV=1 CDC45_HUMAN reviewed Cell division control protein 45 homolog (PORC-PI-1) Homo sapiens (Human) GO:0000076; GO:0000727; GO:0003682; GO:0003688; GO:0003697; GO:0005634; GO:0005654; GO:0005813; GO:0006260; GO:0006270; GO:0031261; GO:0036064; GO:0071162; GO:1902977 DNA replication [GO:0006260]; DNA replication checkpoint signaling [GO:0000076]; DNA replication initiation [GO:0006270]; double-strand break repair via break-induced replication [GO:0000727]; mitotic DNA replication preinitiation complex assembly [GO:1902977] centrosome [GO:0005813]; ciliary basal body [GO:0036064]; CMG complex [GO:0071162]; DNA replication preinitiation complex [GO:0031261]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] chromatin binding [GO:0003682]; DNA replication origin binding [GO:0003688]; single-stranded DNA binding [GO:0003697] g19468.t1 D3Z4R1 41.304 276 4.37e-46 184.0 sp|D3Z4R1|HFM1_MOUSE Probable ATP-dependent DNA helicase HFM1 OS=Mus musculus OX=10090 GN=Hfm1 PE=3 SV=2 HFM1_MOUSE reviewed Probable ATP-dependent DNA helicase HFM1 (EC 5.6.2.4) (DNA 3'-5' helicase HFM1) Mus musculus (Mouse) GO:0000712; GO:0003676; GO:0003678; GO:0005524; GO:0005634; GO:0007283; GO:0008270; GO:0016887; GO:0043138; GO:0048477 oogenesis [GO:0048477]; resolution of meiotic recombination intermediates [GO:0000712]; spermatogenesis [GO:0007283] nucleus [GO:0005634] 3'-5' DNA helicase activity [GO:0043138]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA helicase activity [GO:0003678]; nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270] g19469.t1 A2RUV5 62.821 702 0.0 944.0 sp|A2RUV5|HFM1_XENTR Probable ATP-dependent DNA helicase HFM1 OS=Xenopus tropicalis OX=8364 GN=hfm1 PE=2 SV=1 g19470.t1 Q15485 45.175 228 6.82e-52 174.0 sp|Q15485|FCN2_HUMAN Ficolin-2 OS=Homo sapiens OX=9606 GN=FCN2 PE=1 SV=2 FCN2_HUMAN reviewed Ficolin-2 (37 kDa elastin-binding protein) (EBP-37) (Collagen/fibrinogen domain-containing protein 2) (Ficolin-B) (Ficolin-beta) (Hucolin) (L-ficolin) (Serum lectin p35) Homo sapiens (Human) GO:0001867; GO:0002752; GO:0003823; GO:0005102; GO:0005576; GO:0005581; GO:0005615; GO:0006508; GO:0008228; GO:0009897; GO:0038187; GO:0043394; GO:0043654; GO:0046872; GO:0048306; GO:0050829; GO:0050830; GO:0070062; GO:0070892; GO:0072562; GO:0097367; GO:0106139; GO:1903028; GO:1905370; GO:2001065 cell surface pattern recognition receptor signaling pathway [GO:0002752]; complement activation, lectin pathway [GO:0001867]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; opsonization [GO:0008228]; positive regulation of opsonization [GO:1903028]; proteolysis [GO:0006508]; recognition of apoptotic cell [GO:0043654] blood microparticle [GO:0072562]; collagen trimer [GO:0005581]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; serine-type endopeptidase complex [GO:1905370]; symbiont cell surface [GO:0106139] antigen binding [GO:0003823]; calcium-dependent protein binding [GO:0048306]; carbohydrate derivative binding [GO:0097367]; lipoteichoic acid immune receptor activity [GO:0070892]; mannan binding [GO:2001065]; metal ion binding [GO:0046872]; pattern recognition receptor activity [GO:0038187]; proteoglycan binding [GO:0043394]; signaling receptor binding [GO:0005102] g19471.t1 Q9DG67 55.611 802 0.0 859.0 sp|Q9DG67|RA54B_CHICK DNA repair and recombination protein RAD54B OS=Gallus gallus OX=9031 GN=RAD54B PE=2 SV=1 g19473.t1 Q7ZYL5 58.63 365 6.06e-143 427.0 sp|Q7ZYL5|KF22B_XENLA Kinesin-like protein KIF22-B OS=Xenopus laevis OX=8355 GN=kif22-b PE=2 SV=2 KF22B_XENLA reviewed Kinesin-like protein KIF22-B (Chromokinesin kid-B) (Xkid-B) Xenopus laevis (African clawed frog) GO:0003677; GO:0003777; GO:0005524; GO:0005634; GO:0005737; GO:0005871; GO:0005874; GO:0007018; GO:0007052; GO:0008017; GO:0016887; GO:0051231 microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; spindle elongation [GO:0051231] cytoplasm [GO:0005737]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; nucleus [GO:0005634] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA binding [GO:0003677]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777] g19475.t1 Q9H3F6 71.483 263 2.8e-134 386.0 sp|Q9H3F6|BACD3_HUMAN BTB/POZ domain-containing adapter for CUL3-mediated RhoA degradation protein 3 OS=Homo sapiens OX=9606 GN=KCTD10 PE=1 SV=1 BACD3_HUMAN reviewed BTB/POZ domain-containing adapter for CUL3-mediated RhoA degradation protein 3 (hBACURD3) (BTB/POZ domain-containing protein KCTD10) (Potassium channel tetramerization domain-containing protein 10) Homo sapiens (Human) GO:0005112; GO:0005654; GO:0005829; GO:0005886; GO:0006511; GO:0016567; GO:0031463; GO:0035024; GO:0042802; GO:0043161; GO:0051260 negative regulation of Rho protein signal transduction [GO:0035024]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein homooligomerization [GO:0051260]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511] Cul3-RING ubiquitin ligase complex [GO:0031463]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] identical protein binding [GO:0042802]; Notch binding [GO:0005112] g19483.t1 Q3V0L5 35.119 504 4.7299999999999996e-54 200.0 sp|Q3V0L5|LRC43_MOUSE Leucine-rich repeat-containing protein 43 OS=Mus musculus OX=10090 GN=Lrrc43 PE=2 SV=1 g19487.t1 Q6GQ82 75.335 373 0.0 563.0 sp|Q6GQ82|SNF5_XENLA SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily B member 1 OS=Xenopus laevis OX=8355 GN=smarcb1 PE=2 SV=1 SNF5_XENLA reviewed SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily B member 1 Xenopus laevis (African clawed frog) GO:0000228; GO:0003677; GO:0003713; GO:0005634; GO:0006338; GO:0006357; GO:0007399; GO:0035060; GO:0071564; GO:0071565 chromatin remodeling [GO:0006338]; nervous system development [GO:0007399]; regulation of transcription by RNA polymerase II [GO:0006357] brahma complex [GO:0035060]; nBAF complex [GO:0071565]; npBAF complex [GO:0071564]; nuclear chromosome [GO:0000228]; nucleus [GO:0005634] DNA binding [GO:0003677]; transcription coactivator activity [GO:0003713] g19488.t1 O42467 57.0 100 5.78e-30 115.0 sp|O42467|SNF5_DICFU SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily B member 1 OS=Dichotomyctere fluviatilis OX=2593188 GN=smarcb1 PE=3 SV=1 g19491.t1 Q5RJT2 64.557 316 2.7e-145 453.0 sp|Q5RJT2|SPB1_RAT pre-rRNA 2'-O-ribose RNA methyltransferase FTSJ3 OS=Rattus norvegicus OX=10116 GN=Ftsj3 PE=1 SV=1 g19491.t1 Q5RJT2 52.151 186 2.8400000000000004e-32 139.0 sp|Q5RJT2|SPB1_RAT pre-rRNA 2'-O-ribose RNA methyltransferase FTSJ3 OS=Rattus norvegicus OX=10116 GN=Ftsj3 PE=1 SV=1 g19492.t1 Q08890 45.018 562 1.74e-163 480.0 sp|Q08890|IDS_MOUSE Iduronate 2-sulfatase OS=Mus musculus OX=10090 GN=Ids PE=2 SV=3 IDS_MOUSE reviewed Iduronate 2-sulfatase (EC 3.1.6.13) (Alpha-L-iduronate sulfate sulfatase) Mus musculus (Mouse) GO:0004423; GO:0005509; GO:0005764; GO:0006027; GO:0008484; GO:0030200; GO:0030209; GO:0043202 dermatan sulfate proteoglycan catabolic process [GO:0030209]; glycosaminoglycan catabolic process [GO:0006027]; heparan sulfate proteoglycan catabolic process [GO:0030200] lysosomal lumen [GO:0043202]; lysosome [GO:0005764] calcium ion binding [GO:0005509]; iduronate-2-sulfatase activity [GO:0004423]; sulfuric ester hydrolase activity [GO:0008484] g19493.t1 Q5RDN9 92.857 112 5.4500000000000004e-77 226.0 sp|Q5RDN9|YPEL2_PONAB Protein yippee-like 2 OS=Pongo abelii OX=9601 GN=YPEL2 PE=3 SV=1 g19496.t1 Q8SWR2 41.87 246 2.74e-37 151.0 sp|Q8SWR2|BICDR_DROME Bicaudal D-related protein homolog OS=Drosophila melanogaster OX=7227 GN=BicDR PE=1 SV=1 g19496.t2 Q8SWR2 41.87 246 2.5000000000000003e-37 151.0 sp|Q8SWR2|BICDR_DROME Bicaudal D-related protein homolog OS=Drosophila melanogaster OX=7227 GN=BicDR PE=1 SV=1 g19497.t1 E9PSL7 42.188 1984 0.0 1444.0 sp|E9PSL7|CTRO_RAT Citron rho-interacting kinase OS=Rattus norvegicus OX=10116 GN=Cit PE=1 SV=1 CTRO_RAT reviewed Citron rho-interacting kinase (CRIK) (EC 2.7.11.1) (Rho-interacting, serine/threonine-protein kinase 21) Rattus norvegicus (Rat) GO:0000070; GO:0000086; GO:0000278; GO:0000281; GO:0001223; GO:0001726; GO:0001889; GO:0004674; GO:0005524; GO:0005737; GO:0005773; GO:0005829; GO:0007030; GO:0007091; GO:0007214; GO:0007283; GO:0008064; GO:0008270; GO:0015629; GO:0016358; GO:0019901; GO:0030165; GO:0030291; GO:0030496; GO:0030517; GO:0031985; GO:0032154; GO:0032467; GO:0032956; GO:0035331; GO:0043025; GO:0045665; GO:0048699; GO:0050774; GO:0051402; GO:0097110; GO:0097119; GO:0098982; GO:0099092; GO:0099188; GO:0099573; GO:0106310 dendrite development [GO:0016358]; G2/M transition of mitotic cell cycle [GO:0000086]; gamma-aminobutyric acid signaling pathway [GO:0007214]; generation of neurons [GO:0048699]; Golgi organization [GO:0007030]; liver development [GO:0001889]; metaphase/anaphase transition of mitotic cell cycle [GO:0007091]; mitotic cell cycle [GO:0000278]; mitotic cytokinesis [GO:0000281]; mitotic sister chromatid segregation [GO:0000070]; negative regulation of axon extension [GO:0030517]; negative regulation of dendrite morphogenesis [GO:0050774]; negative regulation of hippo signaling [GO:0035331]; negative regulation of neuron differentiation [GO:0045665]; neuron apoptotic process [GO:0051402]; positive regulation of cytokinesis [GO:0032467]; postsynaptic cytoskeleton organization [GO:0099188]; postsynaptic density protein 95 clustering [GO:0097119]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of actin polymerization or depolymerization [GO:0008064]; spermatogenesis [GO:0007283] actin cytoskeleton [GO:0015629]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; GABA-ergic synapse [GO:0098982]; glutamatergic postsynaptic density [GO:0099573]; Golgi cisterna [GO:0031985]; midbody [GO:0030496]; neuronal cell body [GO:0043025]; postsynaptic density, intracellular component [GO:0099092]; ruffle [GO:0001726]; vacuole [GO:0005773] ATP binding [GO:0005524]; PDZ domain binding [GO:0030165]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine kinase inhibitor activity [GO:0030291]; scaffold protein binding [GO:0097110]; transcription coactivator binding [GO:0001223]; zinc ion binding [GO:0008270] g19498.t1 Q6NY74 49.918 607 0.0 598.0 sp|Q6NY74|RFA1_DANRE Replication protein A 70 kDa DNA-binding subunit OS=Danio rerio OX=7955 GN=rpa1 PE=1 SV=1 RFA1_DANRE reviewed Replication protein A 70 kDa DNA-binding subunit (RP-A p70) (Replication factor A protein 1) (RF-A protein 1) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000724; GO:0003684; GO:0003697; GO:0005634; GO:0005662; GO:0006260; GO:0006289; GO:0007004; GO:0007507; GO:0008270; GO:0016605; GO:0034502; GO:0043047; GO:0051321 DNA replication [GO:0006260]; double-strand break repair via homologous recombination [GO:0000724]; heart development [GO:0007507]; meiotic cell cycle [GO:0051321]; nucleotide-excision repair [GO:0006289]; protein localization to chromosome [GO:0034502]; telomere maintenance via telomerase [GO:0007004] DNA replication factor A complex [GO:0005662]; nucleus [GO:0005634]; PML body [GO:0016605] damaged DNA binding [GO:0003684]; single-stranded DNA binding [GO:0003697]; single-stranded telomeric DNA binding [GO:0043047]; zinc ion binding [GO:0008270] g19500.t1 Q504N0 37.232 419 2.51e-87 276.0 sp|Q504N0|CBPA2_MOUSE Carboxypeptidase A2 OS=Mus musculus OX=10090 GN=Cpa2 PE=1 SV=1 g19501.t1 Q8IZ69 43.967 605 3.14e-173 511.0 sp|Q8IZ69|TRM2A_HUMAN tRNA (uracil-5-)-methyltransferase homolog A OS=Homo sapiens OX=9606 GN=TRMT2A PE=1 SV=2 TRM2A_HUMAN reviewed tRNA (uracil-5-)-methyltransferase homolog A (EC 2.1.1.35) (mRNA (uracil-5-)-methyltransferase TRMT2A) (EC 2.1.1.-) Homo sapiens (Human) GO:0003723; GO:0005829; GO:0006397; GO:0008033; GO:0008169; GO:0030697; GO:0032259 methylation [GO:0032259]; mRNA processing [GO:0006397]; tRNA processing [GO:0008033] cytosol [GO:0005829] C-methyltransferase activity [GO:0008169]; RNA binding [GO:0003723]; tRNA (uracil(54)-C5)-methyltransferase activity, S-adenosyl methionine-dependent [GO:0030697] g19502.t1 Q9QY93 55.372 121 1.24e-44 157.0 sp|Q9QY93|DCTP1_MOUSE dCTP pyrophosphatase 1 OS=Mus musculus OX=10090 GN=Dctpp1 PE=1 SV=1 DCTP1_MOUSE reviewed dCTP pyrophosphatase 1 (EC 3.6.1.12) (Deoxycytidine-triphosphatase 1) (dCTPase 1) (RS21-C6) Mus musculus (Mouse) GO:0000287; GO:0005634; GO:0005654; GO:0005739; GO:0005829; GO:0006253; GO:0009143; GO:0016462; GO:0032556; GO:0042262; GO:0042802; GO:0047429; GO:0047840 dCTP catabolic process [GO:0006253]; DNA protection [GO:0042262]; nucleoside triphosphate catabolic process [GO:0009143] cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] dCTP diphosphatase activity [GO:0047840]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; nucleoside triphosphate diphosphatase activity [GO:0047429]; pyrimidine deoxyribonucleotide binding [GO:0032556]; pyrophosphatase activity [GO:0016462] g19503.t1 Q80U63 53.958 758 0.0 825.0 sp|Q80U63|MFN2_MOUSE Mitofusin-2 OS=Mus musculus OX=10090 GN=Mfn2 PE=1 SV=3 MFN2_MOUSE reviewed Mitofusin-2 (EC 3.6.5.-) (Hypertension-related protein 1) (Mitochondrial assembly regulatory factor) (HSG protein) (Transmembrane GTPase MFN2) Mus musculus (Mouse) GO:0001825; GO:0003924; GO:0005525; GO:0005739; GO:0005741; GO:0005829; GO:0006626; GO:0006915; GO:0006986; GO:0007005; GO:0007006; GO:0008053; GO:0008285; GO:0009060; GO:0010628; GO:0010667; GO:0010729; GO:0010918; GO:0015630; GO:0031267; GO:0031625; GO:0034497; GO:0042802; GO:0043394; GO:0045786; GO:0045792; GO:0046326; GO:0046580; GO:0046628; GO:0048312; GO:0048593; GO:0048662; GO:0051020; GO:0051560; GO:0051646; GO:0060253; GO:0060299; GO:0061003; GO:0061734; GO:0090201; GO:0090258; GO:0120162; GO:1901857; GO:1903427; GO:1903428; GO:1904706; GO:1904707; GO:1905461; GO:2000386; GO:2000866; GO:2000872 aerobic respiration [GO:0009060]; apoptotic process [GO:0006915]; blastocyst formation [GO:0001825]; camera-type eye morphogenesis [GO:0048593]; intracellular distribution of mitochondria [GO:0048312]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrial fusion [GO:0008053]; mitochondrial membrane organization [GO:0007006]; mitochondrion localization [GO:0051646]; mitochondrion organization [GO:0007005]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell size [GO:0045792]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of mitochondrial fission [GO:0090258]; negative regulation of Ras protein signal transduction [GO:0046580]; negative regulation of reactive oxygen species biosynthetic process [GO:1903427]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; negative regulation of sarcomere organization [GO:0060299]; negative regulation of smooth muscle cell proliferation [GO:0048662]; negative regulation of vascular associated smooth muscle cell proliferation [GO:1904706]; positive regulation of cellular respiration [GO:1901857]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of D-glucose import [GO:0046326]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of estradiol secretion [GO:2000866]; positive regulation of gene expression [GO:0010628]; positive regulation of hydrogen peroxide biosynthetic process [GO:0010729]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of mitochondrial membrane potential [GO:0010918]; positive regulation of ovarian follicle development [GO:2000386]; positive regulation of progesterone secretion [GO:2000872]; positive regulation of reactive oxygen species biosynthetic process [GO:1903428]; positive regulation of vascular associated smooth muscle cell apoptotic process [GO:1905461]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; protein localization to phagophore assembly site [GO:0034497]; protein targeting to mitochondrion [GO:0006626]; response to unfolded protein [GO:0006986]; type 2 mitophagy [GO:0061734] cytosol [GO:0005829]; microtubule cytoskeleton [GO:0015630]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739] GTP binding [GO:0005525]; GTPase activity [GO:0003924]; GTPase binding [GO:0051020]; identical protein binding [GO:0042802]; proteoglycan binding [GO:0043394]; small GTPase binding [GO:0031267]; ubiquitin protein ligase binding [GO:0031625] g19510.t1 P42028 86.74 181 2.16e-105 305.0 sp|P42028|NDUS8_BOVIN NADH dehydrogenase [ubiquinone] iron-sulfur protein 8, mitochondrial OS=Bos taurus OX=9913 GN=NDUFS8 PE=1 SV=1 g19511.t1 E9Q9W4 49.727 366 1.83e-123 372.0 sp|E9Q9W4|S27A6_MOUSE Long-chain fatty acid transport protein 6 OS=Mus musculus OX=10090 GN=Slc27a6 PE=1 SV=1 S27A6_MOUSE reviewed Long-chain fatty acid transport protein 6 (FATP-6) (Fatty acid transport protein 6) (Arachidonate--CoA ligase) (EC 6.2.1.15) (Fatty-acid-coenzyme A ligase, very long-chain 2) (Long-chain-fatty-acid--CoA ligase) (EC 6.2.1.3) (Solute carrier family 27 member 6) (Very long-chain acyl-CoA synthetase homolog 1) (VLACS2) (VLCSH1) (mVLCS-H1) (EC 6.2.1.-) Mus musculus (Mouse) GO:0000166; GO:0001676; GO:0004467; GO:0005324; GO:0005783; GO:0005789; GO:0005886; GO:0031957; GO:0042383; GO:0044539; GO:0047676 long-chain fatty acid import into cell [GO:0044539]; long-chain fatty acid metabolic process [GO:0001676] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383] arachidonate-CoA ligase activity [GO:0047676]; long-chain fatty acid transmembrane transporter activity [GO:0005324]; long-chain fatty acid-CoA ligase activity [GO:0004467]; nucleotide binding [GO:0000166]; very long-chain fatty acid-CoA ligase activity [GO:0031957] g19512.t1 O14975 39.326 178 1.13e-33 127.0 sp|O14975|S27A2_HUMAN Long-chain fatty acid transport protein 2 OS=Homo sapiens OX=9606 GN=SLC27A2 PE=1 SV=2 S27A2_HUMAN reviewed Long-chain fatty acid transport protein 2 (Arachidonate--CoA ligase) (EC 6.2.1.15) (Fatty acid transport protein 2) (FATP-2) (Fatty-acid-coenzyme A ligase, very long-chain 1) (Long-chain-fatty-acid--CoA ligase) (EC 6.2.1.3) (Phytanate--CoA ligase) (EC 6.2.1.24) (Solute carrier family 27 member 2) (THCA-CoA ligase) (EC 6.2.1.7) (Very long-chain acyl-CoA synthetase) (VLACS) (VLCS) (EC 6.2.1.-) (Very long-chain-fatty-acid-CoA ligase) Homo sapiens (Human) GO:0001561; GO:0001676; GO:0004467; GO:0005324; GO:0005524; GO:0005778; GO:0005788; GO:0005789; GO:0005829; GO:0005886; GO:0006635; GO:0006699; GO:0008206; GO:0019899; GO:0031957; GO:0033540; GO:0035579; GO:0042760; GO:0044539; GO:0046949; GO:0047676; GO:0047747; GO:0050197; GO:0070062; GO:0070251; GO:0097089 bile acid biosynthetic process [GO:0006699]; bile acid metabolic process [GO:0008206]; fatty acid alpha-oxidation [GO:0001561]; fatty acid beta-oxidation [GO:0006635]; fatty acid beta-oxidation using acyl-CoA oxidase [GO:0033540]; fatty-acyl-CoA biosynthetic process [GO:0046949]; long-chain fatty acid import into cell [GO:0044539]; long-chain fatty acid metabolic process [GO:0001676]; methyl-branched fatty acid metabolic process [GO:0097089]; very long-chain fatty acid catabolic process [GO:0042760] cytosol [GO:0005829]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; peroxisomal membrane [GO:0005778]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579] arachidonate-CoA ligase activity [GO:0047676]; ATP binding [GO:0005524]; cholate-CoA ligase activity [GO:0047747]; enzyme binding [GO:0019899]; long-chain fatty acid transmembrane transporter activity [GO:0005324]; long-chain fatty acid-CoA ligase activity [GO:0004467]; phytanate-CoA ligase activity [GO:0050197]; pristanate-CoA ligase activity [GO:0070251]; very long-chain fatty acid-CoA ligase activity [GO:0031957] g19512.t1 O14975 55.172 29 1.13e-33 37.7 sp|O14975|S27A2_HUMAN Long-chain fatty acid transport protein 2 OS=Homo sapiens OX=9606 GN=SLC27A2 PE=1 SV=2 S27A2_HUMAN reviewed Long-chain fatty acid transport protein 2 (Arachidonate--CoA ligase) (EC 6.2.1.15) (Fatty acid transport protein 2) (FATP-2) (Fatty-acid-coenzyme A ligase, very long-chain 1) (Long-chain-fatty-acid--CoA ligase) (EC 6.2.1.3) (Phytanate--CoA ligase) (EC 6.2.1.24) (Solute carrier family 27 member 2) (THCA-CoA ligase) (EC 6.2.1.7) (Very long-chain acyl-CoA synthetase) (VLACS) (VLCS) (EC 6.2.1.-) (Very long-chain-fatty-acid-CoA ligase) Homo sapiens (Human) GO:0001561; GO:0001676; GO:0004467; GO:0005324; GO:0005524; GO:0005778; GO:0005788; GO:0005789; GO:0005829; GO:0005886; GO:0006635; GO:0006699; GO:0008206; GO:0019899; GO:0031957; GO:0033540; GO:0035579; GO:0042760; GO:0044539; GO:0046949; GO:0047676; GO:0047747; GO:0050197; GO:0070062; GO:0070251; GO:0097089 bile acid biosynthetic process [GO:0006699]; bile acid metabolic process [GO:0008206]; fatty acid alpha-oxidation [GO:0001561]; fatty acid beta-oxidation [GO:0006635]; fatty acid beta-oxidation using acyl-CoA oxidase [GO:0033540]; fatty-acyl-CoA biosynthetic process [GO:0046949]; long-chain fatty acid import into cell [GO:0044539]; long-chain fatty acid metabolic process [GO:0001676]; methyl-branched fatty acid metabolic process [GO:0097089]; very long-chain fatty acid catabolic process [GO:0042760] cytosol [GO:0005829]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; peroxisomal membrane [GO:0005778]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579] arachidonate-CoA ligase activity [GO:0047676]; ATP binding [GO:0005524]; cholate-CoA ligase activity [GO:0047747]; enzyme binding [GO:0019899]; long-chain fatty acid transmembrane transporter activity [GO:0005324]; long-chain fatty acid-CoA ligase activity [GO:0004467]; phytanate-CoA ligase activity [GO:0050197]; pristanate-CoA ligase activity [GO:0070251]; very long-chain fatty acid-CoA ligase activity [GO:0031957] g19513.t1 P62783 100.0 82 2.27e-53 165.0 sp|P62783|H4_STRPU Histone H4 OS=Strongylocentrotus purpuratus OX=7668 PE=3 SV=2 g19514.t1 P04735 83.607 122 9.02e-71 211.0 sp|P04735|H2A1_PSAMI Late histone H2A.1 OS=Psammechinus miliaris OX=7660 PE=2 SV=2 g19515.t2 O01814 39.552 134 3.75e-23 90.9 sp|O01814|FABP5_CAEEL Fatty acid-binding protein homolog 5 OS=Caenorhabditis elegans OX=6239 GN=lbp-5 PE=3 SV=1 g19517.t1 Q05423 45.455 132 2.4400000000000002e-29 106.0 sp|Q05423|FABP7_CHICK Fatty acid-binding protein, brain OS=Gallus gallus OX=9031 GN=FABP7 PE=2 SV=2 g19518.t1 B0R0D7 42.71 487 7.4e-120 362.0 sp|B0R0D7|COR1C_DANRE Coronin-1C-A OS=Danio rerio OX=7955 GN=coro1ca PE=2 SV=1 COR1C_DANRE reviewed Coronin-1C-A Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001755; GO:0005856; GO:0005938; GO:0007015; GO:0010008; GO:0016197; GO:0030027; GO:0032587; GO:0051015; GO:0090148; GO:0097750; GO:0140285 actin filament organization [GO:0007015]; endosomal transport [GO:0016197]; endosome fission [GO:0140285]; endosome membrane tubulation [GO:0097750]; membrane fission [GO:0090148]; neural crest cell migration [GO:0001755] cell cortex [GO:0005938]; cytoskeleton [GO:0005856]; endosome membrane [GO:0010008]; lamellipodium [GO:0030027]; ruffle membrane [GO:0032587] actin filament binding [GO:0051015] g19520.t1 Q803K4 40.657 396 5.17e-82 261.0 sp|Q803K4|SETD6_DANRE N-lysine methyltransferase setd6 OS=Danio rerio OX=7955 GN=setd6 PE=2 SV=1 g19521.t1 Q8NFA0 58.333 96 2.68e-36 132.0 sp|Q8NFA0|UBP32_HUMAN Ubiquitin carboxyl-terminal hydrolase 32 OS=Homo sapiens OX=9606 GN=USP32 PE=1 SV=1 UBP32_HUMAN reviewed Ubiquitin carboxyl-terminal hydrolase 32 (EC 3.4.19.12) (Deubiquitinating enzyme 32) (Renal carcinoma antigen NY-REN-60) (Ubiquitin thioesterase 32) (Ubiquitin-specific-processing protease 32) Homo sapiens (Human) GO:0000139; GO:0004843; GO:0005509; GO:0005794; GO:0005829; GO:0006508; GO:0016579; GO:1904263 positive regulation of TORC1 signaling [GO:1904263]; protein deubiquitination [GO:0016579]; proteolysis [GO:0006508] cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139] calcium ion binding [GO:0005509]; cysteine-type deubiquitinase activity [GO:0004843] g19522.t1 Q8NFA0 55.593 885 0.0 967.0 sp|Q8NFA0|UBP32_HUMAN Ubiquitin carboxyl-terminal hydrolase 32 OS=Homo sapiens OX=9606 GN=USP32 PE=1 SV=1 UBP32_HUMAN reviewed Ubiquitin carboxyl-terminal hydrolase 32 (EC 3.4.19.12) (Deubiquitinating enzyme 32) (Renal carcinoma antigen NY-REN-60) (Ubiquitin thioesterase 32) (Ubiquitin-specific-processing protease 32) Homo sapiens (Human) GO:0000139; GO:0004843; GO:0005509; GO:0005794; GO:0005829; GO:0006508; GO:0016579; GO:1904263 positive regulation of TORC1 signaling [GO:1904263]; protein deubiquitination [GO:0016579]; proteolysis [GO:0006508] cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139] calcium ion binding [GO:0005509]; cysteine-type deubiquitinase activity [GO:0004843] g19522.t2 Q8NFA0 55.919 887 0.0 969.0 sp|Q8NFA0|UBP32_HUMAN Ubiquitin carboxyl-terminal hydrolase 32 OS=Homo sapiens OX=9606 GN=USP32 PE=1 SV=1 UBP32_HUMAN reviewed Ubiquitin carboxyl-terminal hydrolase 32 (EC 3.4.19.12) (Deubiquitinating enzyme 32) (Renal carcinoma antigen NY-REN-60) (Ubiquitin thioesterase 32) (Ubiquitin-specific-processing protease 32) Homo sapiens (Human) GO:0000139; GO:0004843; GO:0005509; GO:0005794; GO:0005829; GO:0006508; GO:0016579; GO:1904263 positive regulation of TORC1 signaling [GO:1904263]; protein deubiquitination [GO:0016579]; proteolysis [GO:0006508] cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139] calcium ion binding [GO:0005509]; cysteine-type deubiquitinase activity [GO:0004843] g19523.t1 F8VPZ3 50.737 339 2e-104 340.0 sp|F8VPZ3|UBP32_MOUSE Ubiquitin carboxyl-terminal hydrolase 32 OS=Mus musculus OX=10090 GN=Usp32 PE=2 SV=1 UBP32_MOUSE reviewed Ubiquitin carboxyl-terminal hydrolase 32 (EC 3.4.19.12) (Deubiquitinating enzyme 32) (Ubiquitin thioesterase 32) (Ubiquitin-specific-processing protease 32) Mus musculus (Mouse) GO:0000139; GO:0004843; GO:0005509; GO:0005737; GO:0005794; GO:0005829; GO:0005886; GO:0006508; GO:0016579; GO:0055037; GO:0098978; GO:0099092; GO:1904263 positive regulation of TORC1 signaling [GO:1904263]; protein deubiquitination [GO:0016579]; proteolysis [GO:0006508] cytoplasm [GO:0005737]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886]; postsynaptic density, intracellular component [GO:0099092]; recycling endosome [GO:0055037] calcium ion binding [GO:0005509]; cysteine-type deubiquitinase activity [GO:0004843] g19524.t1 D3ZUQ0 33.903 351 9.779999999999999e-39 149.0 sp|D3ZUQ0|RIPL1_RAT RILP-like protein 1 OS=Rattus norvegicus OX=10116 GN=Rilpl1 PE=1 SV=1 RIPL1_RAT reviewed RILP-like protein 1 (GAPDH's competitor of SIAH1 protein enhances life) (GOSPEL) (Rab-interacting lysosomal-like protein 1) Rattus norvegicus (Rat) GO:0003382; GO:0005654; GO:0005737; GO:0005813; GO:0005814; GO:0005829; GO:0005886; GO:0005929; GO:0007263; GO:0031267; GO:0036064; GO:0046983; GO:0051959; GO:0060271; GO:1903445 cilium assembly [GO:0060271]; epithelial cell morphogenesis [GO:0003382]; nitric oxide mediated signal transduction [GO:0007263]; protein transport from ciliary membrane to plasma membrane [GO:1903445] centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] dynein light intermediate chain binding [GO:0051959]; protein dimerization activity [GO:0046983]; small GTPase binding [GO:0031267] g19525.t1 Q29RU9 46.579 380 6.8e-112 335.0 sp|Q29RU9|SOX_BOVIN Peroxisomal sarcosine oxidase OS=Bos taurus OX=9913 GN=PIPOX PE=2 SV=2 g19526.t1 Q9D273 56.853 197 1.4500000000000001e-77 242.0 sp|Q9D273|MMAB_MOUSE Corrinoid adenosyltransferase MMAB OS=Mus musculus OX=10090 GN=Mmab PE=1 SV=1 MMAB_MOUSE reviewed Corrinoid adenosyltransferase MMAB (EC 2.5.1.-) (ATP:co(I)rrinoid adenosyltransferase MMAB) (Methylmalonic aciduria type B homolog) Mus musculus (Mouse) GO:0005524; GO:0005739; GO:0008817; GO:0009235; GO:0016765; GO:0031419 cobalamin metabolic process [GO:0009235] mitochondrion [GO:0005739] ATP binding [GO:0005524]; cobalamin binding [GO:0031419]; corrinoid adenosyltransferase activity [GO:0008817]; transferase activity, transferring alkyl or aryl (other than methyl) groups [GO:0016765] g19527.t1 Q8BHT6 45.773 485 1.41e-136 407.0 sp|Q8BHT6|B3GLT_MOUSE Beta-1,3-glucosyltransferase OS=Mus musculus OX=10090 GN=B3glct PE=1 SV=3 B3GLT_MOUSE reviewed Beta-1,3-glucosyltransferase (Beta3Glc-T) (EC 2.4.1.-) (Beta 3-glucosyltransferase) (Beta-3-glycosyltransferase-like) Mus musculus (Mouse) GO:0001501; GO:0005789; GO:0006004; GO:0007420; GO:0008375; GO:0009306; GO:0010467; GO:0016757; GO:0036066; GO:0043010; GO:0044782; GO:0060021; GO:0060173; GO:0060271; GO:0160265; GO:1904888 brain development [GO:0007420]; camera-type eye development [GO:0043010]; cilium assembly [GO:0060271]; cilium organization [GO:0044782]; cranial skeletal system development [GO:1904888]; fucose metabolic process [GO:0006004]; gene expression [GO:0010467]; limb development [GO:0060173]; protein O-linked glycosylation via fucose [GO:0036066]; protein secretion [GO:0009306]; roof of mouth development [GO:0060021]; skeletal system development [GO:0001501] endoplasmic reticulum membrane [GO:0005789] acetylglucosaminyltransferase activity [GO:0008375]; glycosyltransferase activity [GO:0016757]; O-fucosylpeptide 3-beta-glucosyltransferase activity [GO:0160265] g19530.t1 Q6PAY6 34.921 315 9.18e-56 194.0 sp|Q6PAY6|HYPDH_XENLA Hydroxyproline dehydrogenase OS=Xenopus laevis OX=8355 GN=prodh2 PE=2 SV=1 g19531.t1 P09237 37.449 243 1.37e-31 121.0 sp|P09237|MMP7_HUMAN Matrilysin OS=Homo sapiens OX=9606 GN=MMP7 PE=1 SV=1 MMP7_HUMAN reviewed Matrilysin (EC 3.4.24.23) (Matrin) (Matrix metalloproteinase-7) (MMP-7) (Pump-1 protease) (Uterine metalloproteinase) Homo sapiens (Human) GO:0002779; GO:0002780; GO:0004175; GO:0004222; GO:0004252; GO:0005576; GO:0005615; GO:0006508; GO:0006509; GO:0008237; GO:0008270; GO:0009410; GO:0022617; GO:0030198; GO:0030335; GO:0030574; GO:0031012; GO:0031293; GO:0042127; GO:0050829; GO:0050830; GO:0070062 antibacterial peptide biosynthetic process [GO:0002780]; antibacterial peptide secretion [GO:0002779]; collagen catabolic process [GO:0030574]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; extracellular matrix disassembly [GO:0022617]; extracellular matrix organization [GO:0030198]; membrane protein ectodomain proteolysis [GO:0006509]; membrane protein intracellular domain proteolysis [GO:0031293]; positive regulation of cell migration [GO:0030335]; proteolysis [GO:0006508]; regulation of cell population proliferation [GO:0042127]; response to xenobiotic stimulus [GO:0009410] extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615] endopeptidase activity [GO:0004175]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; serine-type endopeptidase activity [GO:0004252]; zinc ion binding [GO:0008270] g19533.t1 Q5RES1 34.747 495 1.39e-64 224.0 sp|Q5RES1|MMP14_PONAB Matrix metalloproteinase-14 OS=Pongo abelii OX=9601 GN=MMP14 PE=2 SV=1 MMP14_PONAB reviewed Matrix metalloproteinase-14 (MMP-14) (EC 3.4.24.80) Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0001501; GO:0004222; GO:0005615; GO:0005886; GO:0008270; GO:0009653; GO:0010831; GO:0030198; GO:0030574; GO:0031012; GO:0031638; GO:0042470; GO:0045579; GO:0045746; GO:0048870 anatomical structure morphogenesis [GO:0009653]; cell motility [GO:0048870]; collagen catabolic process [GO:0030574]; extracellular matrix organization [GO:0030198]; negative regulation of Notch signaling pathway [GO:0045746]; positive regulation of B cell differentiation [GO:0045579]; positive regulation of myotube differentiation [GO:0010831]; skeletal system development [GO:0001501]; zymogen activation [GO:0031638] extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; melanosome [GO:0042470]; plasma membrane [GO:0005886] metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270] g19534.t1 Q9WTR0 41.093 494 1.6e-108 340.0 sp|Q9WTR0|MMP16_MOUSE Matrix metalloproteinase-16 OS=Mus musculus OX=10090 GN=Mmp16 PE=2 SV=3 MMP16_MOUSE reviewed Matrix metalloproteinase-16 (MMP-16) (EC 3.4.24.-) (Membrane-type matrix metalloproteinase 3) (MT-MMP 3) (MTMMP3) (Membrane-type-3 matrix metalloproteinase) (MT3-MMP) (MT3MMP) Mus musculus (Mouse) GO:0001501; GO:0001503; GO:0001958; GO:0004222; GO:0005615; GO:0005886; GO:0006508; GO:0008270; GO:0016485; GO:0030198; GO:0030574; GO:0031012; GO:0035988; GO:0048701; GO:0060348; GO:0070006; GO:0097094 bone development [GO:0060348]; chondrocyte proliferation [GO:0035988]; collagen catabolic process [GO:0030574]; craniofacial suture morphogenesis [GO:0097094]; embryonic cranial skeleton morphogenesis [GO:0048701]; endochondral ossification [GO:0001958]; extracellular matrix organization [GO:0030198]; ossification [GO:0001503]; protein processing [GO:0016485]; proteolysis [GO:0006508]; skeletal system development [GO:0001501] extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; plasma membrane [GO:0005886] metalloaminopeptidase activity [GO:0070006]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270] g19537.t1 Q9MYM7 40.0 275 2.98e-65 211.0 sp|Q9MYM7|B3GT1_PONPY Beta-1,3-galactosyltransferase 1 OS=Pongo pygmaeus OX=9600 GN=B3GALT1 PE=3 SV=1 g19540.t1 Q9MYM7 43.75 112 3.31e-27 105.0 sp|Q9MYM7|B3GT1_PONPY Beta-1,3-galactosyltransferase 1 OS=Pongo pygmaeus OX=9600 GN=B3GALT1 PE=3 SV=1 g19541.t1 Q9ULZ9 37.037 486 1.08e-92 298.0 sp|Q9ULZ9|MMP17_HUMAN Matrix metalloproteinase-17 OS=Homo sapiens OX=9606 GN=MMP17 PE=1 SV=4 MMP17_HUMAN reviewed Matrix metalloproteinase-17 (MMP-17) (EC 3.4.24.-) (Membrane-type matrix metalloproteinase 4) (MT-MMP 4) (MTMMP4) (Membrane-type-4 matrix metalloproteinase) (MT4-MMP) (MT4MMP) Homo sapiens (Human) GO:0001822; GO:0004222; GO:0005615; GO:0005886; GO:0006508; GO:0008047; GO:0008270; GO:0030198; GO:0030574; GO:0031012; GO:0042756; GO:0070006; GO:0098552 collagen catabolic process [GO:0030574]; drinking behavior [GO:0042756]; extracellular matrix organization [GO:0030198]; kidney development [GO:0001822]; proteolysis [GO:0006508] extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; side of membrane [GO:0098552] enzyme activator activity [GO:0008047]; metalloaminopeptidase activity [GO:0070006]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270] g19542.t1 Q9WTR0 36.885 244 6e-33 128.0 sp|Q9WTR0|MMP16_MOUSE Matrix metalloproteinase-16 OS=Mus musculus OX=10090 GN=Mmp16 PE=2 SV=3 MMP16_MOUSE reviewed Matrix metalloproteinase-16 (MMP-16) (EC 3.4.24.-) (Membrane-type matrix metalloproteinase 3) (MT-MMP 3) (MTMMP3) (Membrane-type-3 matrix metalloproteinase) (MT3-MMP) (MT3MMP) Mus musculus (Mouse) GO:0001501; GO:0001503; GO:0001958; GO:0004222; GO:0005615; GO:0005886; GO:0006508; GO:0008270; GO:0016485; GO:0030198; GO:0030574; GO:0031012; GO:0035988; GO:0048701; GO:0060348; GO:0070006; GO:0097094 bone development [GO:0060348]; chondrocyte proliferation [GO:0035988]; collagen catabolic process [GO:0030574]; craniofacial suture morphogenesis [GO:0097094]; embryonic cranial skeleton morphogenesis [GO:0048701]; endochondral ossification [GO:0001958]; extracellular matrix organization [GO:0030198]; ossification [GO:0001503]; protein processing [GO:0016485]; proteolysis [GO:0006508]; skeletal system development [GO:0001501] extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; plasma membrane [GO:0005886] metalloaminopeptidase activity [GO:0070006]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270] g19543.t1 Q99542 36.0 250 2.08e-40 149.0 sp|Q99542|MMP19_HUMAN Matrix metalloproteinase-19 OS=Homo sapiens OX=9606 GN=MMP19 PE=1 SV=1 MMP19_HUMAN reviewed Matrix metalloproteinase-19 (MMP-19) (EC 3.4.24.-) (Matrix metalloproteinase RASI) (Matrix metalloproteinase-18) (MMP-18) Homo sapiens (Human) GO:0001525; GO:0001541; GO:0001542; GO:0001554; GO:0004222; GO:0004252; GO:0005576; GO:0005615; GO:0006508; GO:0008270; GO:0009725; GO:0022617; GO:0030154; GO:0030198; GO:0030574; GO:0031012; GO:0051591 angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; collagen catabolic process [GO:0030574]; extracellular matrix disassembly [GO:0022617]; extracellular matrix organization [GO:0030198]; luteolysis [GO:0001554]; ovarian follicle development [GO:0001541]; ovulation from ovarian follicle [GO:0001542]; proteolysis [GO:0006508]; response to cAMP [GO:0051591]; response to hormone [GO:0009725] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615] metalloendopeptidase activity [GO:0004222]; serine-type endopeptidase activity [GO:0004252]; zinc ion binding [GO:0008270] g19544.t1 Q61382 50.647 464 3.87e-180 515.0 sp|Q61382|TRAF4_MOUSE TNF receptor-associated factor 4 OS=Mus musculus OX=10090 GN=Traf4 PE=1 SV=2 TRAF4_MOUSE reviewed TNF receptor-associated factor 4 (EC 2.3.2.27) (Cysteine-rich motif associated to RING and Traf domains protein 1) Mus musculus (Mouse) GO:0001650; GO:0005164; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0005923; GO:0006915; GO:0007166; GO:0007585; GO:0008270; GO:0019901; GO:0030323; GO:0031625; GO:0031996; GO:0035591; GO:0042802; GO:0042981; GO:0043122; GO:0043161; GO:0045087; GO:0045860; GO:0046330; GO:0048471; GO:0050699; GO:0061630 apoptotic process [GO:0006915]; cell surface receptor signaling pathway [GO:0007166]; innate immune response [GO:0045087]; positive regulation of JNK cascade [GO:0046330]; positive regulation of protein kinase activity [GO:0045860]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of apoptotic process [GO:0042981]; regulation of canonical NF-kappaB signal transduction [GO:0043122]; respiratory gaseous exchange by respiratory system [GO:0007585]; respiratory tube development [GO:0030323] bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886] identical protein binding [GO:0042802]; protein kinase binding [GO:0019901]; signaling adaptor activity [GO:0035591]; thioesterase binding [GO:0031996]; tumor necrosis factor receptor binding [GO:0005164]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; WW domain binding [GO:0050699]; zinc ion binding [GO:0008270] g19545.t1 Q66H76 78.528 163 1.94e-93 285.0 sp|Q66H76|PAXI_RAT Paxillin OS=Rattus norvegicus OX=10116 GN=Pxn PE=1 SV=1 PAXI_RAT reviewed Paxillin Rattus norvegicus (Rat) GO:0001725; GO:0005078; GO:0005178; GO:0005829; GO:0005886; GO:0005911; GO:0005925; GO:0005938; GO:0007010; GO:0007179; GO:0007229; GO:0008013; GO:0008360; GO:0016477; GO:0017166; GO:0019901; GO:0019903; GO:0030027; GO:0030032; GO:0031252; GO:0031663; GO:0034446; GO:0034614; GO:0038191; GO:0043542; GO:0044877; GO:0045766; GO:0046872; GO:0048041; GO:0048754; GO:0051435; GO:0051496; GO:0060396; GO:1900026; GO:1901652 branching morphogenesis of an epithelial tube [GO:0048754]; cell migration [GO:0016477]; cellular response to reactive oxygen species [GO:0034614]; cytoskeleton organization [GO:0007010]; endothelial cell migration [GO:0043542]; focal adhesion assembly [GO:0048041]; growth hormone receptor signaling pathway [GO:0060396]; integrin-mediated signaling pathway [GO:0007229]; lamellipodium assembly [GO:0030032]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; positive regulation of angiogenesis [GO:0045766]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; regulation of cell shape [GO:0008360]; response to peptide [GO:1901652]; substrate adhesion-dependent cell spreading [GO:0034446]; transforming growth factor beta receptor signaling pathway [GO:0007179] cell cortex [GO:0005938]; cell leading edge [GO:0031252]; cell-cell junction [GO:0005911]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; plasma membrane [GO:0005886]; stress fiber [GO:0001725] beta-catenin binding [GO:0008013]; BH4 domain binding [GO:0051435]; integrin binding [GO:0005178]; MAP-kinase scaffold activity [GO:0005078]; metal ion binding [GO:0046872]; neuropilin binding [GO:0038191]; protein kinase binding [GO:0019901]; protein phosphatase binding [GO:0019903]; protein-containing complex binding [GO:0044877]; vinculin binding [GO:0017166] g19546.t1 Q8VI36 53.977 176 3.2599999999999998e-52 187.0 sp|Q8VI36|PAXI_MOUSE Paxillin OS=Mus musculus OX=10090 GN=Pxn PE=1 SV=1 PAXI_MOUSE reviewed Paxillin Mus musculus (Mouse) GO:0001725; GO:0005078; GO:0005178; GO:0005829; GO:0005886; GO:0005911; GO:0005925; GO:0005938; GO:0007010; GO:0007179; GO:0007229; GO:0008013; GO:0008360; GO:0016477; GO:0017166; GO:0019901; GO:0019903; GO:0030027; GO:0030032; GO:0030159; GO:0031252; GO:0031663; GO:0034446; GO:0038191; GO:0043542; GO:0044877; GO:0045766; GO:0046872; GO:0048041; GO:0048754; GO:0051435; GO:0051496; GO:0060396; GO:1900026; GO:1901652 branching morphogenesis of an epithelial tube [GO:0048754]; cell migration [GO:0016477]; cytoskeleton organization [GO:0007010]; endothelial cell migration [GO:0043542]; focal adhesion assembly [GO:0048041]; growth hormone receptor signaling pathway [GO:0060396]; integrin-mediated signaling pathway [GO:0007229]; lamellipodium assembly [GO:0030032]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; positive regulation of angiogenesis [GO:0045766]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; regulation of cell shape [GO:0008360]; response to peptide [GO:1901652]; substrate adhesion-dependent cell spreading [GO:0034446]; transforming growth factor beta receptor signaling pathway [GO:0007179] cell cortex [GO:0005938]; cell leading edge [GO:0031252]; cell-cell junction [GO:0005911]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; plasma membrane [GO:0005886]; stress fiber [GO:0001725] beta-catenin binding [GO:0008013]; BH4 domain binding [GO:0051435]; integrin binding [GO:0005178]; MAP-kinase scaffold activity [GO:0005078]; metal ion binding [GO:0046872]; neuropilin binding [GO:0038191]; protein kinase binding [GO:0019901]; protein phosphatase binding [GO:0019903]; protein-containing complex binding [GO:0044877]; signaling receptor complex adaptor activity [GO:0030159]; vinculin binding [GO:0017166] g19546.t2 Q8VI36 53.977 176 1.23e-51 187.0 sp|Q8VI36|PAXI_MOUSE Paxillin OS=Mus musculus OX=10090 GN=Pxn PE=1 SV=1 PAXI_MOUSE reviewed Paxillin Mus musculus (Mouse) GO:0001725; GO:0005078; GO:0005178; GO:0005829; GO:0005886; GO:0005911; GO:0005925; GO:0005938; GO:0007010; GO:0007179; GO:0007229; GO:0008013; GO:0008360; GO:0016477; GO:0017166; GO:0019901; GO:0019903; GO:0030027; GO:0030032; GO:0030159; GO:0031252; GO:0031663; GO:0034446; GO:0038191; GO:0043542; GO:0044877; GO:0045766; GO:0046872; GO:0048041; GO:0048754; GO:0051435; GO:0051496; GO:0060396; GO:1900026; GO:1901652 branching morphogenesis of an epithelial tube [GO:0048754]; cell migration [GO:0016477]; cytoskeleton organization [GO:0007010]; endothelial cell migration [GO:0043542]; focal adhesion assembly [GO:0048041]; growth hormone receptor signaling pathway [GO:0060396]; integrin-mediated signaling pathway [GO:0007229]; lamellipodium assembly [GO:0030032]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; positive regulation of angiogenesis [GO:0045766]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; regulation of cell shape [GO:0008360]; response to peptide [GO:1901652]; substrate adhesion-dependent cell spreading [GO:0034446]; transforming growth factor beta receptor signaling pathway [GO:0007179] cell cortex [GO:0005938]; cell leading edge [GO:0031252]; cell-cell junction [GO:0005911]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; plasma membrane [GO:0005886]; stress fiber [GO:0001725] beta-catenin binding [GO:0008013]; BH4 domain binding [GO:0051435]; integrin binding [GO:0005178]; MAP-kinase scaffold activity [GO:0005078]; metal ion binding [GO:0046872]; neuropilin binding [GO:0038191]; protein kinase binding [GO:0019901]; protein phosphatase binding [GO:0019903]; protein-containing complex binding [GO:0044877]; signaling receptor complex adaptor activity [GO:0030159]; vinculin binding [GO:0017166] g19547.t1 Q9EQ80 48.148 351 2.66e-112 334.0 sp|Q9EQ80|NIF3L_MOUSE NIF3-like protein 1 OS=Mus musculus OX=10090 GN=Nif3l1 PE=1 SV=4 NIF3L_MOUSE reviewed NIF3-like protein 1 Mus musculus (Mouse) GO:0000122; GO:0005634; GO:0005737; GO:0005739; GO:0030182; GO:0042802; GO:0045893; GO:0061629 negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron differentiation [GO:0030182]; positive regulation of DNA-templated transcription [GO:0045893] cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleus [GO:0005634] identical protein binding [GO:0042802]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629] g19548.t1 Q8R216 61.786 280 8.079999999999999e-131 380.0 sp|Q8R216|SIR4_MOUSE NAD-dependent protein lipoamidase sirtuin-4, mitochondrial OS=Mus musculus OX=10090 GN=Sirt4 PE=1 SV=3 SIR4_MOUSE reviewed NAD-dependent protein lipoamidase sirtuin-4, mitochondrial (EC 2.3.1.-) (NAD-dependent ADP-ribosyltransferase sirtuin-4) (EC 2.4.2.-) (NAD-dependent protein biotinylase sirtuin-4) (EC 2.3.1.-) (NAD-dependent protein deacetylase sirtuin-4) (EC 2.3.1.286) (Regulatory protein SIR2 homolog 4) (SIR2-like protein 4) Mus musculus (Mouse) GO:0000820; GO:0003950; GO:0004407; GO:0005739; GO:0005743; GO:0005759; GO:0006541; GO:0006974; GO:0008270; GO:0010667; GO:0016779; GO:0034979; GO:0034983; GO:0046322; GO:0046676; GO:0046889; GO:0061690; GO:0070403; GO:0071456; GO:0072350; GO:0106419; GO:0106420; GO:0140803; GO:0160218; GO:1903217 cellular response to hypoxia [GO:0071456]; DNA damage response [GO:0006974]; glutamine metabolic process [GO:0006541]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of fatty acid oxidation [GO:0046322]; negative regulation of insulin secretion [GO:0046676]; negative regulation of protein processing involved in protein targeting to mitochondrion [GO:1903217]; negative regulation of pyruvate decarboxylation to acetyl-CoA [GO:0160218]; peptidyl-lysine deacetylation [GO:0034983]; positive regulation of lipid biosynthetic process [GO:0046889]; regulation of glutamine family amino acid metabolic process [GO:0000820]; tricarboxylic acid metabolic process [GO:0072350] mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] histone deacetylase activity [GO:0004407]; lipoamidase activity [GO:0061690]; NAD+ binding [GO:0070403]; NAD+ poly-ADP-ribosyltransferase activity [GO:0003950]; NAD+-protein-cysteine ADP-ribosyltransferase activity [GO:0140803]; NAD-dependent protein biotinidase activity [GO:0106420]; NAD-dependent protein lipoamidase activity [GO:0106419]; NAD-dependent protein lysine deacetylase activity [GO:0034979]; nucleotidyltransferase activity [GO:0016779]; zinc ion binding [GO:0008270] g19549.t1 Q80Z30 48.087 366 1.08e-107 346.0 sp|Q80Z30|PPM1E_RAT Protein phosphatase 1E OS=Rattus norvegicus OX=10116 GN=Ppm1e PE=1 SV=1 PPM1E_RAT reviewed Protein phosphatase 1E (EC 3.1.3.16) (Ca(2+)/calmodulin-dependent protein kinase phosphatase N) (CaMKP-N) (CaMKP-nucleus) (CaMKN) (Partner of PIX 1) (Partner of PIX-alpha) (Partner of PIXA) Rattus norvegicus (Rat) GO:0004722; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0007165; GO:0032991; GO:0046872; GO:0051496; GO:0071222; GO:0071466 cellular response to lipopolysaccharide [GO:0071222]; cellular response to xenobiotic stimulus [GO:0071466]; positive regulation of stress fiber assembly [GO:0051496]; signal transduction [GO:0007165] cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991] metal ion binding [GO:0046872]; protein serine/threonine phosphatase activity [GO:0004722] g19550.t1 Q96DF8 44.505 182 1.57e-30 119.0 sp|Q96DF8|ESS2_HUMAN Splicing factor ESS-2 homolog OS=Homo sapiens OX=9606 GN=ESS2 PE=1 SV=1 ESS2_HUMAN reviewed Splicing factor ESS-2 homolog (DiGeorge syndrome critical region 13) (DiGeorge syndrome critical region 14) (DiGeorge syndrome protein H) (DGS-H) (Protein ES2) Homo sapiens (Human) GO:0000398; GO:0005634; GO:0007399; GO:0071013 mRNA splicing, via spliceosome [GO:0000398]; nervous system development [GO:0007399] catalytic step 2 spliceosome [GO:0071013]; nucleus [GO:0005634] g19551.t1 Q96DF8 44.483 290 8.78e-57 194.0 sp|Q96DF8|ESS2_HUMAN Splicing factor ESS-2 homolog OS=Homo sapiens OX=9606 GN=ESS2 PE=1 SV=1 ESS2_HUMAN reviewed Splicing factor ESS-2 homolog (DiGeorge syndrome critical region 13) (DiGeorge syndrome critical region 14) (DiGeorge syndrome protein H) (DGS-H) (Protein ES2) Homo sapiens (Human) GO:0000398; GO:0005634; GO:0007399; GO:0071013 mRNA splicing, via spliceosome [GO:0000398]; nervous system development [GO:0007399] catalytic step 2 spliceosome [GO:0071013]; nucleus [GO:0005634] g19552.t1 Q5I0D1 66.554 296 2.8799999999999997e-150 426.0 sp|Q5I0D1|GLOD4_RAT Glyoxalase domain-containing protein 4 OS=Rattus norvegicus OX=10116 GN=Glod4 PE=1 SV=1 g19553.t1 Q92959 29.038 613 1.8200000000000002e-66 234.0 sp|Q92959|SO2A1_HUMAN Solute carrier organic anion transporter family member 2A1 OS=Homo sapiens OX=9606 GN=SLCO2A1 PE=1 SV=2 SO2A1_HUMAN reviewed Solute carrier organic anion transporter family member 2A1 (SLCO2A1) (OATP2A1) (PHOAR2) (Prostaglandin transporter) (PGT) (Solute carrier family 21 member 2) (SLC21A2) Homo sapiens (Human) GO:0005319; GO:0005764; GO:0005886; GO:0006869; GO:0009925; GO:0015132; GO:0015347; GO:0015732; GO:0016020; GO:0016323; GO:0043252 lipid transport [GO:0006869]; prostaglandin transport [GO:0015732]; sodium-independent organic anion transport [GO:0043252] basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; lysosome [GO:0005764]; membrane [GO:0016020]; plasma membrane [GO:0005886] lipid transporter activity [GO:0005319]; prostaglandin transmembrane transporter activity [GO:0015132]; sodium-independent organic anion transmembrane transporter activity [GO:0015347] g19554.t1 P70610 68.493 292 4.91e-135 404.0 sp|P70610|DOC2B_RAT Double C2-like domain-containing protein beta OS=Rattus norvegicus OX=10116 GN=Doc2b PE=1 SV=2 DOC2B_RAT reviewed Double C2-like domain-containing protein beta (Doc2-beta) Rattus norvegicus (Rat) GO:0005509; GO:0005544; GO:0005737; GO:0005886; GO:0006887; GO:0008104; GO:0019905; GO:0031340; GO:0032024; GO:0045202; GO:0045956; GO:0048791; GO:0061669; GO:0098850; GO:0098978; GO:0099502 calcium ion-regulated exocytosis of neurotransmitter [GO:0048791]; calcium-dependent activation of synaptic vesicle fusion [GO:0099502]; exocytosis [GO:0006887]; intracellular protein localization [GO:0008104]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; positive regulation of insulin secretion [GO:0032024]; positive regulation of vesicle fusion [GO:0031340]; spontaneous neurotransmitter secretion [GO:0061669] cytoplasm [GO:0005737]; extrinsic component of synaptic vesicle membrane [GO:0098850]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; synapse [GO:0045202] calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; syntaxin binding [GO:0019905] g19556.t1 P72449 24.291 494 2.7999999999999998e-24 110.0 sp|P72449|CRTU_STRGR Carotenoid phi-ring synthase OS=Streptomyces griseus OX=1911 GN=crtU PE=1 SV=1 g19559.t1 Q499P8 44.368 435 3.4e-92 290.0 sp|Q499P8|RUSF1_RAT RUS family member 1 OS=Rattus norvegicus OX=10116 GN=Rusf1 PE=2 SV=1 g19559.t2 Q499P8 43.722 446 1.08e-90 287.0 sp|Q499P8|RUSF1_RAT RUS family member 1 OS=Rattus norvegicus OX=10116 GN=Rusf1 PE=2 SV=1 g19560.t2 Q9NWS8 54.545 297 3.09e-113 343.0 sp|Q9NWS8|RMND1_HUMAN Required for meiotic nuclear division protein 1 homolog OS=Homo sapiens OX=9606 GN=RMND1 PE=1 SV=2 RMND1_HUMAN reviewed Required for meiotic nuclear division protein 1 homolog Homo sapiens (Human) GO:0005739; GO:0006412; GO:0070131 positive regulation of mitochondrial translation [GO:0070131]; translation [GO:0006412] mitochondrion [GO:0005739] g19561.t1 Q969V4 49.25 400 1.06e-124 369.0 sp|Q969V4|TEKT1_HUMAN Tektin-1 OS=Homo sapiens OX=9606 GN=TEKT1 PE=1 SV=1 TEKT1_HUMAN reviewed Tektin-1 Homo sapiens (Human) GO:0005634; GO:0005879; GO:0015630; GO:0030317; GO:0036126; GO:0060271; GO:0060294; GO:0160111 cilium assembly [GO:0060271]; cilium movement involved in cell motility [GO:0060294]; flagellated sperm motility [GO:0030317] axonemal A tubule inner sheath [GO:0160111]; axonemal microtubule [GO:0005879]; microtubule cytoskeleton [GO:0015630]; nucleus [GO:0005634]; sperm flagellum [GO:0036126] g19562.t1 P79110 71.233 292 1.5099999999999999e-146 419.0 sp|P79110|TXTP_BOVIN Tricarboxylate transport protein, mitochondrial OS=Bos taurus OX=9913 GN=SLC25A1 PE=1 SV=1 TXTP_BOVIN reviewed Tricarboxylate transport protein, mitochondrial (Citrate transport protein) (CTP) (Solute carrier family 25 member 1) (Tricarboxylate carrier protein) Bos taurus (Bovine) GO:0005739; GO:0005743; GO:0006843; GO:0015297; GO:0071913 mitochondrial citrate transmembrane transport [GO:0006843] mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739] antiporter activity [GO:0015297]; citrate secondary active transmembrane transporter activity [GO:0071913] g19563.t1 Q9SAL0 46.947 262 5.93e-78 247.0 sp|Q9SAL0|RGLG4_ARATH E3 ubiquitin-protein ligase RGLG4 OS=Arabidopsis thaliana OX=3702 GN=RGLG4 PE=1 SV=1 g19567.t1 Q9JMB7 52.625 762 0.0 840.0 sp|Q9JMB7|PIWL1_MOUSE Piwi-like protein 1 OS=Mus musculus OX=10090 GN=Piwil1 PE=1 SV=1 PIWL1_MOUSE reviewed Piwi-like protein 1 (EC 3.1.26.-) Mus musculus (Mouse) GO:0003727; GO:0003729; GO:0004521; GO:0005634; GO:0005737; GO:0005829; GO:0007283; GO:0007286; GO:0016787; GO:0019901; GO:0031047; GO:0033391; GO:0034584; GO:0034587; GO:0035092; GO:0043186; GO:0046872; GO:0051321; GO:0097433; GO:0140262; GO:0140990; GO:0140991; GO:0141006; GO:2000765 meiotic cell cycle [GO:0051321]; piRNA processing [GO:0034587]; piRNA-mediated gene silencing by mRNA destabilization [GO:0140991]; primary piRNA processing [GO:0140990]; regulation of cytoplasmic translation [GO:2000765]; regulatory ncRNA-mediated gene silencing [GO:0031047]; sperm DNA condensation [GO:0035092]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; transposable element silencing by piRNA-mediated heterochromatin formation [GO:0141006] chromatoid body [GO:0033391]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dense body [GO:0097433]; nucleus [GO:0005634]; P granule [GO:0043186] hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]; mRNA binding [GO:0003729]; mRNA cap binding complex binding [GO:0140262]; piRNA binding [GO:0034584]; protein kinase binding [GO:0019901]; RNA endonuclease activity [GO:0004521]; single-stranded RNA binding [GO:0003727] g19569.t1 B2RXZ1 34.893 513 7.05e-99 312.0 sp|B2RXZ1|PNDC1_MOUSE Poly(A)-specific ribonuclease PNLDC1 OS=Mus musculus OX=10090 GN=Pnldc1 PE=1 SV=1 PNDC1_MOUSE reviewed Poly(A)-specific ribonuclease PNLDC1 (EC 3.1.13.4) (PARN-like domain-containing protein 1) (Poly(A)-specific ribonuclease domain-containing protein 1) Mus musculus (Mouse) GO:0000175; GO:0000184; GO:0000289; GO:0001825; GO:0003723; GO:0004535; GO:0005634; GO:0005783; GO:0005789; GO:0007283; GO:0034587; GO:0046872; GO:1990431; GO:1990432 blastocyst formation [GO:0001825]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; piRNA processing [GO:0034587]; priRNA 3'-end processing [GO:1990431]; siRNA 3'-end processing [GO:1990432]; spermatogenesis [GO:0007283] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; nucleus [GO:0005634] 3'-5'-RNA exonuclease activity [GO:0000175]; metal ion binding [GO:0046872]; poly(A)-specific ribonuclease activity [GO:0004535]; RNA binding [GO:0003723] g19570.t1 A6QPF8 51.212 330 3.1700000000000003e-110 327.0 sp|A6QPF8|T120B_BOVIN Transmembrane protein 120B OS=Bos taurus OX=9913 GN=TMEM120B PE=2 SV=1 g19571.t1 Q3T0B6 33.641 217 7.46e-30 117.0 sp|Q3T0B6|C1QBP_BOVIN Complement component 1 Q subcomponent-binding protein, mitochondrial OS=Bos taurus OX=9913 GN=C1QBP PE=2 SV=1 C1QBP_BOVIN reviewed Complement component 1 Q subcomponent-binding protein, mitochondrial Bos taurus (Bovine) GO:0000122; GO:0000724; GO:0000957; GO:0001849; GO:0003714; GO:0003729; GO:0004857; GO:0005540; GO:0005576; GO:0005634; GO:0005730; GO:0005737; GO:0005759; GO:0005829; GO:0005886; GO:0006397; GO:0006915; GO:0006958; GO:0008380; GO:0009986; GO:0030449; GO:0030984; GO:0031690; GO:0032689; GO:0032695; GO:0032991; GO:0039534; GO:0039536; GO:0042256; GO:0043065; GO:0043491; GO:0045087; GO:0045785; GO:0048025; GO:0050687; GO:0051897; GO:0060703; GO:0062153; GO:0070131; GO:0090023; GO:0097177; GO:1900026; GO:1901165; GO:2000042; GO:2000510 apoptotic process [GO:0006915]; complement activation, classical pathway [GO:0006958]; cytosolic ribosome assembly [GO:0042256]; double-strand break repair via homologous recombination [GO:0000724]; innate immune response [GO:0045087]; mitochondrial RNA catabolic process [GO:0000957]; mRNA processing [GO:0006397]; negative regulation of defense response to virus [GO:0050687]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; negative regulation of interleukin-12 production [GO:0032695]; negative regulation of MDA-5 signaling pathway [GO:0039534]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; negative regulation of RIG-I signaling pathway [GO:0039536]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of type II interferon production [GO:0032689]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell adhesion [GO:0045785]; positive regulation of dendritic cell chemotaxis [GO:2000510]; positive regulation of mitochondrial translation [GO:0070131]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; positive regulation of trophoblast cell migration [GO:1901165]; regulation of complement activation [GO:0030449]; RNA splicing [GO:0008380] cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; mitochondrial matrix [GO:0005759]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] adrenergic receptor binding [GO:0031690]; C5-methylcytidine-containing RNA reader activity [GO:0062153]; complement component C1q complex binding [GO:0001849]; deoxyribonuclease inhibitor activity [GO:0060703]; enzyme inhibitor activity [GO:0004857]; hyaluronic acid binding [GO:0005540]; kininogen binding [GO:0030984]; mitochondrial ribosome binding [GO:0097177]; mRNA binding [GO:0003729]; transcription corepressor activity [GO:0003714] g19573.t1 P02286 100.0 91 7.17e-62 188.0 sp|P02286|H2B_ASTRU Histone H2B, gonadal OS=Asterias rubens OX=7604 PE=1 SV=2 g19574.t1 P02269 100.0 95 8.930000000000001e-64 193.0 sp|P02269|H2A_ASTRU Histone H2A OS=Asterias rubens OX=7604 PE=1 SV=2 g19577.t1 P62255 59.813 107 8.839999999999999e-46 148.0 sp|P62255|UB2G1_RAT Ubiquitin-conjugating enzyme E2 G1 OS=Rattus norvegicus OX=10116 GN=Ube2g1 PE=2 SV=3 UB2G1_RAT reviewed Ubiquitin-conjugating enzyme E2 G1 (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme G1) (E217K) (UBC7) (Ubiquitin carrier protein G1) (Ubiquitin-protein ligase G1) [Cleaved into: Ubiquitin-conjugating enzyme E2 G1, N-terminally processed] Rattus norvegicus (Rat) GO:0000209; GO:0004842; GO:0005524; GO:0006511; GO:0016567; GO:0031625; GO:0043161; GO:0061631; GO:0070534; GO:0070936 proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K48-linked ubiquitination [GO:0070936]; protein K63-linked ubiquitination [GO:0070534]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511] ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842] g19583.t1 P59644 37.473 467 2.39e-91 302.0 sp|P59644|PI5PA_MOUSE Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A OS=Mus musculus OX=10090 GN=Inpp5j PE=1 SV=2 PI5PA_MOUSE reviewed Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A (EC 3.1.3.36) (Inositol polyphosphate 5-phosphatase J) (Phosphatidylinositol 1,3,4,5-tetrakisphosphate 5-phosphatase) (EC 3.1.3.56) (Phosphatidylinositol 1,4,5-trisphosphate 5-phosphatase) (EC 3.1.3.56) Mus musculus (Mouse) GO:0001726; GO:0004439; GO:0004445; GO:0005737; GO:0005886; GO:0010977; GO:0017124; GO:0030426; GO:0031115; GO:0032587; GO:0034485; GO:0043005; GO:0043198; GO:0046030; GO:0046856; GO:0052658; GO:0052659 negative regulation of microtubule polymerization [GO:0031115]; negative regulation of neuron projection development [GO:0010977]; phosphatidylinositol dephosphorylation [GO:0046856] cytoplasm [GO:0005737]; dendritic shaft [GO:0043198]; growth cone [GO:0030426]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; ruffle membrane [GO:0032587] inositol trisphosphate phosphatase activity [GO:0046030]; inositol-1,3,4,5-tetrakisphosphate 5-phosphatase activity [GO:0052659]; inositol-1,4,5-trisphosphate 5-phosphatase activity [GO:0052658]; inositol-polyphosphate 5-phosphatase activity [GO:0004445]; phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity [GO:0034485]; phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity [GO:0004439]; SH3 domain binding [GO:0017124] g19584.t1 O75146 54.651 86 1.72e-25 102.0 sp|O75146|HIP1R_HUMAN Huntingtin-interacting protein 1-related protein OS=Homo sapiens OX=9606 GN=HIP1R PE=1 SV=2 HIP1R_HUMAN reviewed Huntingtin-interacting protein 1-related protein (HIP1-related protein) (Huntingtin-interacting protein 12) (HIP-12) Homo sapiens (Human) GO:0005546; GO:0005547; GO:0005739; GO:0005829; GO:0005886; GO:0005905; GO:0006897; GO:0006898; GO:0007015; GO:0014069; GO:0016324; GO:0017124; GO:0030100; GO:0030136; GO:0030276; GO:0030665; GO:0030837; GO:0030864; GO:0032051; GO:0032587; GO:0032839; GO:0032956; GO:0034316; GO:0035091; GO:0035615; GO:0042802; GO:0042803; GO:0042981; GO:0043025; GO:0043066; GO:0043197; GO:0043325; GO:0045742; GO:0046982; GO:0048268; GO:0048471; GO:0050821; GO:0051015; GO:0055123; GO:0060453; GO:0080025; GO:0097060; GO:0097193; GO:0098843; GO:0098978; GO:0099173; GO:1901030; GO:1905445; GO:2000369; GO:2000588 actin filament organization [GO:0007015]; clathrin coat assembly [GO:0048268]; digestive system development [GO:0055123]; endocytosis [GO:0006897]; intrinsic apoptotic signaling pathway [GO:0097193]; negative regulation of actin filament polymerization [GO:0030837]; negative regulation of apoptotic process [GO:0043066]; negative regulation of Arp2/3 complex-mediated actin nucleation [GO:0034316]; positive regulation of clathrin coat assembly [GO:1905445]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901030]; positive regulation of platelet-derived growth factor receptor-beta signaling pathway [GO:2000588]; postsynapse organization [GO:0099173]; protein stabilization [GO:0050821]; receptor-mediated endocytosis [GO:0006898]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of apoptotic process [GO:0042981]; regulation of clathrin-dependent endocytosis [GO:2000369]; regulation of endocytosis [GO:0030100]; regulation of gastric acid secretion [GO:0060453] apical plasma membrane [GO:0016324]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; clathrin-coated vesicle membrane [GO:0030665]; cortical actin cytoskeleton [GO:0030864]; cytosol [GO:0005829]; dendrite cytoplasm [GO:0032839]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic endocytic zone [GO:0098843]; ruffle membrane [GO:0032587]; synaptic membrane [GO:0097060] actin filament binding [GO:0051015]; clathrin adaptor activity [GO:0035615]; clathrin binding [GO:0030276]; clathrin light chain binding [GO:0032051]; identical protein binding [GO:0042802]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; SH3 domain binding [GO:0017124] g19585.t1 Q8VD75 39.548 885 1.82e-168 517.0 sp|Q8VD75|HIP1_MOUSE Huntingtin-interacting protein 1 OS=Mus musculus OX=10090 GN=Hip1 PE=1 SV=2 HIP1_MOUSE reviewed Huntingtin-interacting protein 1 (HIP-1) (Huntingtin-interacting protein I) (HIP-I) Mus musculus (Mouse) GO:0005634; GO:0005737; GO:0005794; GO:0005886; GO:0006897; GO:0006915; GO:0007015; GO:0030136; GO:0030154; GO:0030276; GO:0030665; GO:0030864; GO:0032051; GO:0032266; GO:0035091; GO:0035612; GO:0035615; GO:0042734; GO:0042803; GO:0042981; GO:0043325; GO:0045211; GO:0045742; GO:0046982; GO:0048260; GO:0048268; GO:0050821; GO:0051015; GO:0080025; GO:0097190; GO:0098685; GO:0098793; GO:0098978; GO:0099149; GO:0099171; GO:2000588 actin filament organization [GO:0007015]; apoptotic process [GO:0006915]; apoptotic signaling pathway [GO:0097190]; cell differentiation [GO:0030154]; clathrin coat assembly [GO:0048268]; endocytosis [GO:0006897]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of platelet-derived growth factor receptor-beta signaling pathway [GO:2000588]; positive regulation of receptor-mediated endocytosis [GO:0048260]; presynaptic modulation of chemical synaptic transmission [GO:0099171]; protein stabilization [GO:0050821]; regulation of apoptotic process [GO:0042981]; regulation of postsynaptic neurotransmitter receptor internalization [GO:0099149] clathrin-coated vesicle [GO:0030136]; clathrin-coated vesicle membrane [GO:0030665]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynapse [GO:0098793]; presynaptic membrane [GO:0042734]; Schaffer collateral - CA1 synapse [GO:0098685] actin filament binding [GO:0051015]; AP-2 adaptor complex binding [GO:0035612]; clathrin adaptor activity [GO:0035615]; clathrin binding [GO:0030276]; clathrin light chain binding [GO:0032051]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-3-phosphate binding [GO:0032266]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803] g19586.t1 Q14667 38.677 1603 0.0 1046.0 sp|Q14667|BLTP2_HUMAN Bridge-like lipid transfer protein family member 2 OS=Homo sapiens OX=9606 GN=BLTP2 PE=1 SV=3 g19586.t1 Q14667 50.365 137 1.71e-25 120.0 sp|Q14667|BLTP2_HUMAN Bridge-like lipid transfer protein family member 2 OS=Homo sapiens OX=9606 GN=BLTP2 PE=1 SV=3 g19587.t1 Q174D3 54.412 136 3.52e-41 143.0 sp|Q174D3|MED19_AEDAE Mediator of RNA polymerase II transcription subunit 19 OS=Aedes aegypti OX=7159 GN=MED19 PE=3 SV=1 g19588.t1 Q502L2 60.965 228 7.930000000000001e-103 304.0 sp|Q502L2|PGAM5_DANRE Serine/threonine-protein phosphatase PGAM5, mitochondrial OS=Danio rerio OX=7955 GN=pgam5 PE=2 SV=2 g19588.t2 Q502L2 61.404 228 2.7899999999999998e-104 308.0 sp|Q502L2|PGAM5_DANRE Serine/threonine-protein phosphatase PGAM5, mitochondrial OS=Danio rerio OX=7955 GN=pgam5 PE=2 SV=2 g19589.t1 Q6DGR4 50.144 347 2.77e-90 278.0 sp|Q6DGR4|HGH1_DANRE Protein HGH1 homolog OS=Danio rerio OX=7955 GN=hgh1 PE=2 SV=1 g19591.t1 Q9VR07 45.338 547 2.1100000000000002e-179 536.0 sp|Q9VR07|INE_DROME Sodium- and chloride-dependent GABA transporter ine OS=Drosophila melanogaster OX=7227 GN=ine PE=1 SV=1 g19593.t1 Q96LW2 45.333 300 8.69e-82 259.0 sp|Q96LW2|KS6R_HUMAN Ribosomal protein S6 kinase-related protein OS=Homo sapiens OX=9606 GN=RSKR PE=1 SV=3 g19595.t1 E7F7V7 26.814 317 9.68e-22 98.6 sp|E7F7V7|GAL2B_DANRE Galanin receptor 2b OS=Danio rerio OX=7955 GN=galr2b PE=2 SV=1 g19598.t1 E7F7V7 26.625 323 3.4199999999999996e-23 102.0 sp|E7F7V7|GAL2B_DANRE Galanin receptor 2b OS=Danio rerio OX=7955 GN=galr2b PE=2 SV=1 g19601.t1 Q6DDG2 28.883 412 2.04e-42 163.0 sp|Q6DDG2|K2013_XENLA Uncharacterized protein KIAA2013 homolog OS=Xenopus laevis OX=8355 PE=2 SV=1 g19603.t1 O88956 39.051 274 8.170000000000001e-56 186.0 sp|O88956|PLPP1_CAVPO Phospholipid phosphatase 1 OS=Cavia porcellus OX=10141 GN=PLPP1 PE=1 SV=1 g19606.t1 A6QR20 26.667 600 2.49e-36 153.0 sp|A6QR20|SLF1_BOVIN SMC5-SMC6 complex localization factor protein 1 OS=Bos taurus OX=9913 GN=SLF1 PE=2 SV=2 SLF1_BOVIN reviewed SMC5-SMC6 complex localization factor protein 1 (Ankyrin repeat domain-containing protein 32) (BRCT domain-containing protein 1) Bos taurus (Bovine) GO:0005634; GO:0005737; GO:0005813; GO:0006281; GO:0006974; GO:0031334; GO:0031625; GO:0034184; GO:0035861; GO:1990166; GO:2000781 DNA damage response [GO:0006974]; DNA repair [GO:0006281]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of maintenance of mitotic sister chromatid cohesion [GO:0034184]; positive regulation of protein-containing complex assembly [GO:0031334]; protein localization to site of double-strand break [GO:1990166] centrosome [GO:0005813]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; site of double-strand break [GO:0035861] ubiquitin protein ligase binding [GO:0031625] g19608.t1 A6QR20 32.83 265 4.1e-25 116.0 sp|A6QR20|SLF1_BOVIN SMC5-SMC6 complex localization factor protein 1 OS=Bos taurus OX=9913 GN=SLF1 PE=2 SV=2 SLF1_BOVIN reviewed SMC5-SMC6 complex localization factor protein 1 (Ankyrin repeat domain-containing protein 32) (BRCT domain-containing protein 1) Bos taurus (Bovine) GO:0005634; GO:0005737; GO:0005813; GO:0006281; GO:0006974; GO:0031334; GO:0031625; GO:0034184; GO:0035861; GO:1990166; GO:2000781 DNA damage response [GO:0006974]; DNA repair [GO:0006281]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of maintenance of mitotic sister chromatid cohesion [GO:0034184]; positive regulation of protein-containing complex assembly [GO:0031334]; protein localization to site of double-strand break [GO:1990166] centrosome [GO:0005813]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; site of double-strand break [GO:0035861] ubiquitin protein ligase binding [GO:0031625] g19609.t1 A6QR20 40.252 159 3.3200000000000004e-26 117.0 sp|A6QR20|SLF1_BOVIN SMC5-SMC6 complex localization factor protein 1 OS=Bos taurus OX=9913 GN=SLF1 PE=2 SV=2 SLF1_BOVIN reviewed SMC5-SMC6 complex localization factor protein 1 (Ankyrin repeat domain-containing protein 32) (BRCT domain-containing protein 1) Bos taurus (Bovine) GO:0005634; GO:0005737; GO:0005813; GO:0006281; GO:0006974; GO:0031334; GO:0031625; GO:0034184; GO:0035861; GO:1990166; GO:2000781 DNA damage response [GO:0006974]; DNA repair [GO:0006281]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of maintenance of mitotic sister chromatid cohesion [GO:0034184]; positive regulation of protein-containing complex assembly [GO:0031334]; protein localization to site of double-strand break [GO:1990166] centrosome [GO:0005813]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; site of double-strand break [GO:0035861] ubiquitin protein ligase binding [GO:0031625] g19609.t1 A6QR20 39.241 158 1.29e-25 115.0 sp|A6QR20|SLF1_BOVIN SMC5-SMC6 complex localization factor protein 1 OS=Bos taurus OX=9913 GN=SLF1 PE=2 SV=2 SLF1_BOVIN reviewed SMC5-SMC6 complex localization factor protein 1 (Ankyrin repeat domain-containing protein 32) (BRCT domain-containing protein 1) Bos taurus (Bovine) GO:0005634; GO:0005737; GO:0005813; GO:0006281; GO:0006974; GO:0031334; GO:0031625; GO:0034184; GO:0035861; GO:1990166; GO:2000781 DNA damage response [GO:0006974]; DNA repair [GO:0006281]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of maintenance of mitotic sister chromatid cohesion [GO:0034184]; positive regulation of protein-containing complex assembly [GO:0031334]; protein localization to site of double-strand break [GO:1990166] centrosome [GO:0005813]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; site of double-strand break [GO:0035861] ubiquitin protein ligase binding [GO:0031625] g19610.t1 Q6NU91 46.507 501 1.11e-153 452.0 sp|Q6NU91|NOC4B_XENLA Nucleolar complex protein 4 homolog B OS=Xenopus laevis OX=8355 GN=noc4l-b PE=2 SV=1 g19611.t1 T1SH39 55.085 118 1.1299999999999999e-41 137.0 sp|T1SH39|TXD17_EPICO Thioredoxin domain-containing protein 17 OS=Epinephelus coioides OX=94232 PE=2 SV=1 g19612.t1 P35670 54.223 1042 0.0 995.0 sp|P35670|ATP7B_HUMAN Copper-transporting ATPase 2 OS=Homo sapiens OX=9606 GN=ATP7B PE=1 SV=4 ATP7B_HUMAN reviewed Copper-transporting ATPase 2 (EC 7.2.2.8) (Copper pump 2) (Wilson disease-associated protein) [Cleaved into: WND/140 kDa] Homo sapiens (Human) GO:0000139; GO:0005375; GO:0005507; GO:0005524; GO:0005739; GO:0005770; GO:0005794; GO:0005886; GO:0006825; GO:0006878; GO:0006882; GO:0007595; GO:0015677; GO:0016020; GO:0016887; GO:0032588; GO:0034220; GO:0043682; GO:0046688; GO:0051208; GO:0051604; GO:0051649; GO:0060003; GO:0075523; GO:0140581; GO:1990961 copper ion export [GO:0060003]; copper ion import [GO:0015677]; copper ion transport [GO:0006825]; establishment of localization in cell [GO:0051649]; intracellular copper ion homeostasis [GO:0006878]; intracellular zinc ion homeostasis [GO:0006882]; lactation [GO:0007595]; monoatomic ion transmembrane transport [GO:0034220]; protein maturation [GO:0051604]; response to copper ion [GO:0046688]; sequestering of calcium ion [GO:0051208]; viral translational frameshifting [GO:0075523]; xenobiotic detoxification by transmembrane export across the plasma membrane [GO:1990961] Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; late endosome [GO:0005770]; membrane [GO:0016020]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; trans-Golgi network membrane [GO:0032588] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; copper ion binding [GO:0005507]; copper ion transmembrane transporter activity [GO:0005375]; P-type divalent copper transporter activity [GO:0043682]; P-type monovalent copper transporter activity [GO:0140581] g19612.t1 P35670 28.094 299 8.25e-28 125.0 sp|P35670|ATP7B_HUMAN Copper-transporting ATPase 2 OS=Homo sapiens OX=9606 GN=ATP7B PE=1 SV=4 ATP7B_HUMAN reviewed Copper-transporting ATPase 2 (EC 7.2.2.8) (Copper pump 2) (Wilson disease-associated protein) [Cleaved into: WND/140 kDa] Homo sapiens (Human) GO:0000139; GO:0005375; GO:0005507; GO:0005524; GO:0005739; GO:0005770; GO:0005794; GO:0005886; GO:0006825; GO:0006878; GO:0006882; GO:0007595; GO:0015677; GO:0016020; GO:0016887; GO:0032588; GO:0034220; GO:0043682; GO:0046688; GO:0051208; GO:0051604; GO:0051649; GO:0060003; GO:0075523; GO:0140581; GO:1990961 copper ion export [GO:0060003]; copper ion import [GO:0015677]; copper ion transport [GO:0006825]; establishment of localization in cell [GO:0051649]; intracellular copper ion homeostasis [GO:0006878]; intracellular zinc ion homeostasis [GO:0006882]; lactation [GO:0007595]; monoatomic ion transmembrane transport [GO:0034220]; protein maturation [GO:0051604]; response to copper ion [GO:0046688]; sequestering of calcium ion [GO:0051208]; viral translational frameshifting [GO:0075523]; xenobiotic detoxification by transmembrane export across the plasma membrane [GO:1990961] Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; late endosome [GO:0005770]; membrane [GO:0016020]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; trans-Golgi network membrane [GO:0032588] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; copper ion binding [GO:0005507]; copper ion transmembrane transporter activity [GO:0005375]; P-type divalent copper transporter activity [GO:0043682]; P-type monovalent copper transporter activity [GO:0140581] g19612.t2 P35670 52.509 1076 0.0 984.0 sp|P35670|ATP7B_HUMAN Copper-transporting ATPase 2 OS=Homo sapiens OX=9606 GN=ATP7B PE=1 SV=4 ATP7B_HUMAN reviewed Copper-transporting ATPase 2 (EC 7.2.2.8) (Copper pump 2) (Wilson disease-associated protein) [Cleaved into: WND/140 kDa] Homo sapiens (Human) GO:0000139; GO:0005375; GO:0005507; GO:0005524; GO:0005739; GO:0005770; GO:0005794; GO:0005886; GO:0006825; GO:0006878; GO:0006882; GO:0007595; GO:0015677; GO:0016020; GO:0016887; GO:0032588; GO:0034220; GO:0043682; GO:0046688; GO:0051208; GO:0051604; GO:0051649; GO:0060003; GO:0075523; GO:0140581; GO:1990961 copper ion export [GO:0060003]; copper ion import [GO:0015677]; copper ion transport [GO:0006825]; establishment of localization in cell [GO:0051649]; intracellular copper ion homeostasis [GO:0006878]; intracellular zinc ion homeostasis [GO:0006882]; lactation [GO:0007595]; monoatomic ion transmembrane transport [GO:0034220]; protein maturation [GO:0051604]; response to copper ion [GO:0046688]; sequestering of calcium ion [GO:0051208]; viral translational frameshifting [GO:0075523]; xenobiotic detoxification by transmembrane export across the plasma membrane [GO:1990961] Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; late endosome [GO:0005770]; membrane [GO:0016020]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; trans-Golgi network membrane [GO:0032588] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; copper ion binding [GO:0005507]; copper ion transmembrane transporter activity [GO:0005375]; P-type divalent copper transporter activity [GO:0043682]; P-type monovalent copper transporter activity [GO:0140581] g19613.t1 Q13356 62.898 283 2.5700000000000003e-129 380.0 sp|Q13356|PPIL2_HUMAN RING-type E3 ubiquitin-protein ligase PPIL2 OS=Homo sapiens OX=9606 GN=PPIL2 PE=1 SV=1 PPIL2_HUMAN reviewed RING-type E3 ubiquitin-protein ligase PPIL2 (EC 2.3.2.27) (CYC4) (Cyclophilin-60) (Cyclophilin-like protein Cyp-60) (Cyp60) (hCyP-60) (Probable inactive peptidyl-prolyl cis-trans isomerase-like 2) (PPIase) (Rotamase PPIL2) Homo sapiens (Human) GO:0000209; GO:0005634; GO:0005654; GO:0005737; GO:0005796; GO:0005886; GO:0006397; GO:0006457; GO:0008380; GO:0034450; GO:0061630; GO:0071013; GO:0072659 mRNA processing [GO:0006397]; protein folding [GO:0006457]; protein localization to plasma membrane [GO:0072659]; protein polyubiquitination [GO:0000209]; RNA splicing [GO:0008380] catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; Golgi lumen [GO:0005796]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886] ubiquitin protein ligase activity [GO:0061630]; ubiquitin-ubiquitin ligase activity [GO:0034450] g19614.t1 Q9D787 55.357 168 6.94e-53 180.0 sp|Q9D787|PPIL2_MOUSE RING-type E3 ubiquitin-protein ligase PPIL2 OS=Mus musculus OX=10090 GN=Ppil2 PE=1 SV=2 PPIL2_MOUSE reviewed RING-type E3 ubiquitin-protein ligase PPIL2 (EC 2.3.2.27) (CYC4) (Probable inactive peptidyl-prolyl cis-trans isomerase-like 2) (PPIase) Mus musculus (Mouse) GO:0000209; GO:0003755; GO:0004842; GO:0005634; GO:0005654; GO:0005737; GO:0005886; GO:0006397; GO:0006457; GO:0008380; GO:0034450; GO:0061630; GO:0071013; GO:0072659 mRNA processing [GO:0006397]; protein folding [GO:0006457]; protein localization to plasma membrane [GO:0072659]; protein polyubiquitination [GO:0000209]; RNA splicing [GO:0008380] catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886] peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; ubiquitin-ubiquitin ligase activity [GO:0034450] g19615.t1 P79385 32.911 158 1.9000000000000003e-21 95.5 sp|P79385|MFGM_PIG Lactadherin OS=Sus scrofa OX=9823 GN=MFGE8 PE=1 SV=2 g19617.t1 P70490 36.31 168 4.63e-22 100.0 sp|P70490|MFGM_RAT Lactadherin OS=Rattus norvegicus OX=10116 GN=Mfge8 PE=2 SV=1 MFGM_RAT reviewed Lactadherin (MFGM) (Milk fat globule-EGF factor 8) (MFG-E8) (O-acetyl GD3 ganglioside synthase) (AGS) (SED1) Rattus norvegicus (Rat) GO:0001525; GO:0001786; GO:0002080; GO:0005178; GO:0005615; GO:0006910; GO:0006911; GO:0007155; GO:0007338; GO:0008284; GO:0008429; GO:0009897; GO:0043277; GO:0043627; GO:0050766 angiogenesis [GO:0001525]; apoptotic cell clearance [GO:0043277]; cell adhesion [GO:0007155]; phagocytosis, engulfment [GO:0006911]; phagocytosis, recognition [GO:0006910]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of phagocytosis [GO:0050766]; response to estrogen [GO:0043627]; single fertilization [GO:0007338] acrosomal membrane [GO:0002080]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615] integrin binding [GO:0005178]; phosphatidylethanolamine binding [GO:0008429]; phosphatidylserine binding [GO:0001786] g19621.t1 Q7ZT75 48.062 129 3.3100000000000004e-26 107.0 sp|Q7ZT75|FCN1A_XENLA Ficolin-1-A OS=Xenopus laevis OX=8355 GN=fcn1-a PE=1 SV=2 FCN1A_XENLA reviewed Ficolin-1-A Xenopus laevis (African clawed frog) GO:0001867; GO:0003823; GO:0005102; GO:0005581; GO:0005615; GO:0030246; GO:0033691; GO:0038187; GO:0097367; GO:0106139 complement activation, lectin pathway [GO:0001867] collagen trimer [GO:0005581]; extracellular space [GO:0005615]; symbiont cell surface [GO:0106139] antigen binding [GO:0003823]; carbohydrate binding [GO:0030246]; carbohydrate derivative binding [GO:0097367]; pattern recognition receptor activity [GO:0038187]; sialic acid binding [GO:0033691]; signaling receptor binding [GO:0005102] g19622.t1 P70490 36.709 158 1.52e-21 96.3 sp|P70490|MFGM_RAT Lactadherin OS=Rattus norvegicus OX=10116 GN=Mfge8 PE=2 SV=1 MFGM_RAT reviewed Lactadherin (MFGM) (Milk fat globule-EGF factor 8) (MFG-E8) (O-acetyl GD3 ganglioside synthase) (AGS) (SED1) Rattus norvegicus (Rat) GO:0001525; GO:0001786; GO:0002080; GO:0005178; GO:0005615; GO:0006910; GO:0006911; GO:0007155; GO:0007338; GO:0008284; GO:0008429; GO:0009897; GO:0043277; GO:0043627; GO:0050766 angiogenesis [GO:0001525]; apoptotic cell clearance [GO:0043277]; cell adhesion [GO:0007155]; phagocytosis, engulfment [GO:0006911]; phagocytosis, recognition [GO:0006910]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of phagocytosis [GO:0050766]; response to estrogen [GO:0043627]; single fertilization [GO:0007338] acrosomal membrane [GO:0002080]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615] integrin binding [GO:0005178]; phosphatidylethanolamine binding [GO:0008429]; phosphatidylserine binding [GO:0001786] g19623.t1 Q7ZT75 47.015 134 1.51e-24 102.0 sp|Q7ZT75|FCN1A_XENLA Ficolin-1-A OS=Xenopus laevis OX=8355 GN=fcn1-a PE=1 SV=2 FCN1A_XENLA reviewed Ficolin-1-A Xenopus laevis (African clawed frog) GO:0001867; GO:0003823; GO:0005102; GO:0005581; GO:0005615; GO:0030246; GO:0033691; GO:0038187; GO:0097367; GO:0106139 complement activation, lectin pathway [GO:0001867] collagen trimer [GO:0005581]; extracellular space [GO:0005615]; symbiont cell surface [GO:0106139] antigen binding [GO:0003823]; carbohydrate binding [GO:0030246]; carbohydrate derivative binding [GO:0097367]; pattern recognition receptor activity [GO:0038187]; sialic acid binding [GO:0033691]; signaling receptor binding [GO:0005102] g19627.t1 P30622 44.444 315 1.14e-73 275.0 sp|P30622|CLIP1_HUMAN CAP-Gly domain-containing linker protein 1 OS=Homo sapiens OX=9606 GN=CLIP1 PE=1 SV=2 CLIP1_HUMAN reviewed CAP-Gly domain-containing linker protein 1 (Cytoplasmic linker protein 1) (Cytoplasmic linker protein 170 alpha-2) (CLIP-170) (Reed-Sternberg intermediate filament-associated protein) (Restin) Homo sapiens (Human) GO:0000278; GO:0000776; GO:0001578; GO:0001726; GO:0005634; GO:0005813; GO:0005829; GO:0005874; GO:0005882; GO:0005886; GO:0005938; GO:0008017; GO:0008270; GO:0015630; GO:0015631; GO:0030659; GO:0031116; GO:0031122; GO:0042802; GO:0051010 cytoplasmic microtubule organization [GO:0031122]; microtubule bundle formation [GO:0001578]; mitotic cell cycle [GO:0000278]; positive regulation of microtubule polymerization [GO:0031116] cell cortex [GO:0005938]; centrosome [GO:0005813]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; intermediate filament [GO:0005882]; kinetochore [GO:0000776]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ruffle [GO:0001726] identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; microtubule plus-end binding [GO:0051010]; tubulin binding [GO:0015631]; zinc ion binding [GO:0008270] g19627.t1 P30622 31.224 474 1.1399999999999999e-48 194.0 sp|P30622|CLIP1_HUMAN CAP-Gly domain-containing linker protein 1 OS=Homo sapiens OX=9606 GN=CLIP1 PE=1 SV=2 CLIP1_HUMAN reviewed CAP-Gly domain-containing linker protein 1 (Cytoplasmic linker protein 1) (Cytoplasmic linker protein 170 alpha-2) (CLIP-170) (Reed-Sternberg intermediate filament-associated protein) (Restin) Homo sapiens (Human) GO:0000278; GO:0000776; GO:0001578; GO:0001726; GO:0005634; GO:0005813; GO:0005829; GO:0005874; GO:0005882; GO:0005886; GO:0005938; GO:0008017; GO:0008270; GO:0015630; GO:0015631; GO:0030659; GO:0031116; GO:0031122; GO:0042802; GO:0051010 cytoplasmic microtubule organization [GO:0031122]; microtubule bundle formation [GO:0001578]; mitotic cell cycle [GO:0000278]; positive regulation of microtubule polymerization [GO:0031116] cell cortex [GO:0005938]; centrosome [GO:0005813]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; intermediate filament [GO:0005882]; kinetochore [GO:0000776]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ruffle [GO:0001726] identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; microtubule plus-end binding [GO:0051010]; tubulin binding [GO:0015631]; zinc ion binding [GO:0008270] g19627.t2 Q922J3 53.219 233 4.960000000000001e-72 269.0 sp|Q922J3|CLIP1_MOUSE CAP-Gly domain-containing linker protein 1 OS=Mus musculus OX=10090 GN=Clip1 PE=1 SV=1 CLIP1_MOUSE reviewed CAP-Gly domain-containing linker protein 1 (Cytoplasmic linker protein 170) (CLIP-170) (Restin) Mus musculus (Mouse) GO:0001578; GO:0001726; GO:0005634; GO:0005635; GO:0005813; GO:0005874; GO:0005881; GO:0005938; GO:0008017; GO:0008270; GO:0015630; GO:0015631; GO:0030659; GO:0031116; GO:0031122; GO:0035371; GO:0042802; GO:0044861; GO:0051010; GO:1900006 cytoplasmic microtubule organization [GO:0031122]; microtubule bundle formation [GO:0001578]; positive regulation of dendrite development [GO:1900006]; positive regulation of microtubule polymerization [GO:0031116]; protein transport into plasma membrane raft [GO:0044861] cell cortex [GO:0005938]; centrosome [GO:0005813]; cytoplasmic microtubule [GO:0005881]; cytoplasmic vesicle membrane [GO:0030659]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; microtubule plus-end [GO:0035371]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; ruffle [GO:0001726] identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; microtubule plus-end binding [GO:0051010]; tubulin binding [GO:0015631]; zinc ion binding [GO:0008270] g19627.t2 Q922J3 41.704 223 6.09e-48 192.0 sp|Q922J3|CLIP1_MOUSE CAP-Gly domain-containing linker protein 1 OS=Mus musculus OX=10090 GN=Clip1 PE=1 SV=1 CLIP1_MOUSE reviewed CAP-Gly domain-containing linker protein 1 (Cytoplasmic linker protein 170) (CLIP-170) (Restin) Mus musculus (Mouse) GO:0001578; GO:0001726; GO:0005634; GO:0005635; GO:0005813; GO:0005874; GO:0005881; GO:0005938; GO:0008017; GO:0008270; GO:0015630; GO:0015631; GO:0030659; GO:0031116; GO:0031122; GO:0035371; GO:0042802; GO:0044861; GO:0051010; GO:1900006 cytoplasmic microtubule organization [GO:0031122]; microtubule bundle formation [GO:0001578]; positive regulation of dendrite development [GO:1900006]; positive regulation of microtubule polymerization [GO:0031116]; protein transport into plasma membrane raft [GO:0044861] cell cortex [GO:0005938]; centrosome [GO:0005813]; cytoplasmic microtubule [GO:0005881]; cytoplasmic vesicle membrane [GO:0030659]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; microtubule plus-end [GO:0035371]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; ruffle [GO:0001726] identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; microtubule plus-end binding [GO:0051010]; tubulin binding [GO:0015631]; zinc ion binding [GO:0008270] g19627.t3 P30622 44.444 315 1.47e-73 274.0 sp|P30622|CLIP1_HUMAN CAP-Gly domain-containing linker protein 1 OS=Homo sapiens OX=9606 GN=CLIP1 PE=1 SV=2 CLIP1_HUMAN reviewed CAP-Gly domain-containing linker protein 1 (Cytoplasmic linker protein 1) (Cytoplasmic linker protein 170 alpha-2) (CLIP-170) (Reed-Sternberg intermediate filament-associated protein) (Restin) Homo sapiens (Human) GO:0000278; GO:0000776; GO:0001578; GO:0001726; GO:0005634; GO:0005813; GO:0005829; GO:0005874; GO:0005882; GO:0005886; GO:0005938; GO:0008017; GO:0008270; GO:0015630; GO:0015631; GO:0030659; GO:0031116; GO:0031122; GO:0042802; GO:0051010 cytoplasmic microtubule organization [GO:0031122]; microtubule bundle formation [GO:0001578]; mitotic cell cycle [GO:0000278]; positive regulation of microtubule polymerization [GO:0031116] cell cortex [GO:0005938]; centrosome [GO:0005813]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; intermediate filament [GO:0005882]; kinetochore [GO:0000776]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ruffle [GO:0001726] identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; microtubule plus-end binding [GO:0051010]; tubulin binding [GO:0015631]; zinc ion binding [GO:0008270] g19627.t3 P30622 31.224 474 1.01e-48 194.0 sp|P30622|CLIP1_HUMAN CAP-Gly domain-containing linker protein 1 OS=Homo sapiens OX=9606 GN=CLIP1 PE=1 SV=2 CLIP1_HUMAN reviewed CAP-Gly domain-containing linker protein 1 (Cytoplasmic linker protein 1) (Cytoplasmic linker protein 170 alpha-2) (CLIP-170) (Reed-Sternberg intermediate filament-associated protein) (Restin) Homo sapiens (Human) GO:0000278; GO:0000776; GO:0001578; GO:0001726; GO:0005634; GO:0005813; GO:0005829; GO:0005874; GO:0005882; GO:0005886; GO:0005938; GO:0008017; GO:0008270; GO:0015630; GO:0015631; GO:0030659; GO:0031116; GO:0031122; GO:0042802; GO:0051010 cytoplasmic microtubule organization [GO:0031122]; microtubule bundle formation [GO:0001578]; mitotic cell cycle [GO:0000278]; positive regulation of microtubule polymerization [GO:0031116] cell cortex [GO:0005938]; centrosome [GO:0005813]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; intermediate filament [GO:0005882]; kinetochore [GO:0000776]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ruffle [GO:0001726] identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; microtubule plus-end binding [GO:0051010]; tubulin binding [GO:0015631]; zinc ion binding [GO:0008270] g19627.t4 P30622 44.444 315 4.3799999999999995e-74 276.0 sp|P30622|CLIP1_HUMAN CAP-Gly domain-containing linker protein 1 OS=Homo sapiens OX=9606 GN=CLIP1 PE=1 SV=2 CLIP1_HUMAN reviewed CAP-Gly domain-containing linker protein 1 (Cytoplasmic linker protein 1) (Cytoplasmic linker protein 170 alpha-2) (CLIP-170) (Reed-Sternberg intermediate filament-associated protein) (Restin) Homo sapiens (Human) GO:0000278; GO:0000776; GO:0001578; GO:0001726; GO:0005634; GO:0005813; GO:0005829; GO:0005874; GO:0005882; GO:0005886; GO:0005938; GO:0008017; GO:0008270; GO:0015630; GO:0015631; GO:0030659; GO:0031116; GO:0031122; GO:0042802; GO:0051010 cytoplasmic microtubule organization [GO:0031122]; microtubule bundle formation [GO:0001578]; mitotic cell cycle [GO:0000278]; positive regulation of microtubule polymerization [GO:0031116] cell cortex [GO:0005938]; centrosome [GO:0005813]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; intermediate filament [GO:0005882]; kinetochore [GO:0000776]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ruffle [GO:0001726] identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; microtubule plus-end binding [GO:0051010]; tubulin binding [GO:0015631]; zinc ion binding [GO:0008270] g19627.t4 P30622 31.224 474 8.2e-49 195.0 sp|P30622|CLIP1_HUMAN CAP-Gly domain-containing linker protein 1 OS=Homo sapiens OX=9606 GN=CLIP1 PE=1 SV=2 CLIP1_HUMAN reviewed CAP-Gly domain-containing linker protein 1 (Cytoplasmic linker protein 1) (Cytoplasmic linker protein 170 alpha-2) (CLIP-170) (Reed-Sternberg intermediate filament-associated protein) (Restin) Homo sapiens (Human) GO:0000278; GO:0000776; GO:0001578; GO:0001726; GO:0005634; GO:0005813; GO:0005829; GO:0005874; GO:0005882; GO:0005886; GO:0005938; GO:0008017; GO:0008270; GO:0015630; GO:0015631; GO:0030659; GO:0031116; GO:0031122; GO:0042802; GO:0051010 cytoplasmic microtubule organization [GO:0031122]; microtubule bundle formation [GO:0001578]; mitotic cell cycle [GO:0000278]; positive regulation of microtubule polymerization [GO:0031116] cell cortex [GO:0005938]; centrosome [GO:0005813]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; intermediate filament [GO:0005882]; kinetochore [GO:0000776]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ruffle [GO:0001726] identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; microtubule plus-end binding [GO:0051010]; tubulin binding [GO:0015631]; zinc ion binding [GO:0008270] g19629.t1 O64411 33.333 492 9.13e-70 235.0 sp|O64411|PAO1_MAIZE Polyamine oxidase 1 OS=Zea mays OX=4577 GN=MPAO1 PE=1 SV=1 g19630.t1 Q92804 59.551 89 4.25e-24 110.0 sp|Q92804|RBP56_HUMAN TATA-binding protein-associated factor 2N OS=Homo sapiens OX=9606 GN=TAF15 PE=1 SV=1 RBP56_HUMAN reviewed TATA-binding protein-associated factor 2N (68 kDa TATA-binding protein-associated factor) (TAF(II)68) (TAFII68) (RNA-binding protein 56) Homo sapiens (Human) GO:0003677; GO:0003712; GO:0003723; GO:0003730; GO:0005634; GO:0005654; GO:0005737; GO:0008270; GO:0008380; GO:0045893; GO:0048255 mRNA stabilization [GO:0048255]; positive regulation of DNA-templated transcription [GO:0045893]; RNA splicing [GO:0008380] cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] DNA binding [GO:0003677]; mRNA 3'-UTR binding [GO:0003730]; RNA binding [GO:0003723]; transcription coregulator activity [GO:0003712]; zinc ion binding [GO:0008270] g19631.t1 B0S6U7 50.279 179 5.230000000000001e-43 162.0 sp|B0S6U7|ERAL1_DANRE GTPase Era, mitochondrial OS=Danio rerio OX=7955 GN=eral1 PE=2 SV=1 ERAL1_DANRE reviewed GTPase Era, mitochondrial (ERA-like protein 1) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000028; GO:0005525; GO:0005743; GO:0005759; GO:0019843; GO:0043024 ribosomal small subunit assembly [GO:0000028] mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759] GTP binding [GO:0005525]; ribosomal small subunit binding [GO:0043024]; rRNA binding [GO:0019843] g19631.t1 B0S6U7 37.333 150 1.0199999999999999e-24 110.0 sp|B0S6U7|ERAL1_DANRE GTPase Era, mitochondrial OS=Danio rerio OX=7955 GN=eral1 PE=2 SV=1 ERAL1_DANRE reviewed GTPase Era, mitochondrial (ERA-like protein 1) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000028; GO:0005525; GO:0005743; GO:0005759; GO:0019843; GO:0043024 ribosomal small subunit assembly [GO:0000028] mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759] GTP binding [GO:0005525]; ribosomal small subunit binding [GO:0043024]; rRNA binding [GO:0019843] g19633.t1 O73718 62.376 202 1.51e-76 251.0 sp|O73718|TBX3_CHICK T-box transcription factor TBX3 (Fragment) OS=Gallus gallus OX=9031 GN=TBX3 PE=2 SV=1 g19636.t1 O75594 45.113 133 2.3100000000000002e-33 120.0 sp|O75594|PGRP1_HUMAN Peptidoglycan recognition protein 1 OS=Homo sapiens OX=9606 GN=PGLYRP1 PE=1 SV=1 PGRP1_HUMAN reviewed Peptidoglycan recognition protein 1 (Peptidoglycan recognition protein short) (PGRP-S) Homo sapiens (Human) GO:0005576; GO:0005615; GO:0006955; GO:0008270; GO:0008745; GO:0009253; GO:0016019; GO:0016045; GO:0030544; GO:0031640; GO:0032689; GO:0032827; GO:0035580; GO:0042742; GO:0042834; GO:0045087; GO:0048018; GO:0050728; GO:0050830; GO:0051701; GO:0060090; GO:0061844; GO:0070062; GO:0097013; GO:1904724 antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; biological process involved in interaction with host [GO:0051701]; defense response to bacterium [GO:0042742]; defense response to Gram-positive bacterium [GO:0050830]; detection of bacterium [GO:0016045]; immune response [GO:0006955]; innate immune response [GO:0045087]; killing of cells of another organism [GO:0031640]; negative regulation of inflammatory response [GO:0050728]; negative regulation of natural killer cell differentiation involved in immune response [GO:0032827]; negative regulation of type II interferon production [GO:0032689]; peptidoglycan catabolic process [GO:0009253] extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle lumen [GO:0097013]; specific granule lumen [GO:0035580]; tertiary granule lumen [GO:1904724] Hsp70 protein binding [GO:0030544]; molecular adaptor activity [GO:0060090]; N-acetylmuramoyl-L-alanine amidase activity [GO:0008745]; peptidoglycan binding [GO:0042834]; peptidoglycan immune receptor activity [GO:0016019]; receptor ligand activity [GO:0048018]; zinc ion binding [GO:0008270] g19637.t1 Q70PU1 46.154 91 1.5200000000000002e-27 103.0 sp|Q70PU1|PGSC2_DROSI Peptidoglycan-recognition protein SC2 OS=Drosophila simulans OX=7240 GN=PGRP-SC2 PE=3 SV=1 g19638.t1 O76537 43.636 165 4.16e-38 136.0 sp|O76537|PGRP_TRINI Peptidoglycan recognition protein OS=Trichoplusia ni OX=7111 GN=PGRP PE=1 SV=1 g19640.t1 Q70PU2 45.0 140 1.6999999999999998e-38 134.0 sp|Q70PU2|PGSC1_DROSI Peptidoglycan-recognition protein SC1a/b OS=Drosophila simulans OX=7240 GN=PGRP-SC1a PE=3 SV=1 g19641.t1 Q641W4 75.723 346 0.0 566.0 sp|Q641W4|RFC2_RAT Replication factor C subunit 2 OS=Rattus norvegicus OX=10116 GN=Rfc2 PE=2 SV=1 g19644.t1 O88831 64.033 367 6.81e-148 444.0 sp|O88831|KKCC2_RAT Calcium/calmodulin-dependent protein kinase kinase 2 OS=Rattus norvegicus OX=10116 GN=Camkk2 PE=1 SV=1 KKCC2_RAT reviewed Calcium/calmodulin-dependent protein kinase kinase 2 (CaM-KK 2) (CaM-kinase kinase 2) (CaMKK 2) (EC 2.7.11.17) (Calcium/calmodulin-dependent protein kinase kinase beta) (CaM-KK beta) (CaM-kinase kinase beta) (CaMKK beta) Rattus norvegicus (Rat) GO:0004672; GO:0004674; GO:0004683; GO:0005509; GO:0005516; GO:0005524; GO:0005654; GO:0005829; GO:0006468; GO:0030295; GO:0043005; GO:0046777; GO:0061762; GO:0106310; GO:1903599 CAMKK-AMPK signaling cascade [GO:0061762]; positive regulation of autophagy of mitochondrion [GO:1903599]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468] cytosol [GO:0005829]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654] ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calcium/calmodulin-dependent protein kinase activity [GO:0004683]; calmodulin binding [GO:0005516]; protein kinase activator activity [GO:0030295]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g19645.t1 Q28HL3 55.897 195 1.7e-73 227.0 sp|Q28HL3|CDIN1_XENTR CDAN1-interacting nuclease 1 OS=Xenopus tropicalis OX=8364 GN=cdin1 PE=2 SV=1 g19646.t1 Q16RX1 66.165 133 3.95e-57 178.0 sp|Q16RX1|MED21_AEDAE Mediator of RNA polymerase II transcription subunit 21 OS=Aedes aegypti OX=7159 GN=MED21 PE=3 SV=1 g19652.t1 Q55CD9 42.895 373 4.23e-90 282.0 sp|Q55CD9|NDH_DICDI Probable NADH dehydrogenase OS=Dictyostelium discoideum OX=44689 GN=DDB_G0270104 PE=3 SV=2 g19653.t1 Q6NWI1 42.073 164 3.3700000000000003e-22 102.0 sp|Q6NWI1|RSRC2_DANRE Arginine/serine-rich coiled-coil protein 2 OS=Danio rerio OX=7955 GN=rsrc2 PE=2 SV=1 g19656.t1 Q08CZ0 55.273 1100 0.0 1221.0 sp|Q08CZ0|UBE3B_XENTR Ubiquitin-protein ligase E3B OS=Xenopus tropicalis OX=8364 GN=ube3b PE=2 SV=1 g19657.t1 O88845 39.667 600 3.82e-135 415.0 sp|O88845|AKA10_MOUSE A-kinase anchor protein 10, mitochondrial OS=Mus musculus OX=10090 GN=Akap10 PE=1 SV=3 AKA10_MOUSE reviewed A-kinase anchor protein 10, mitochondrial (AKAP-10) (Dual specificity A kinase-anchoring protein 2) (D-AKAP-2) (Protein kinase A-anchoring protein 10) (PRKA10) Mus musculus (Mouse) GO:0005739; GO:0005829; GO:0005886; GO:0008104; GO:0032991; GO:0051018 intracellular protein localization [GO:0008104] cytosol [GO:0005829]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] protein kinase A binding [GO:0051018] g19658.t1 Q6DIM3 48.387 465 2.2599999999999998e-136 402.0 sp|Q6DIM3|TBD_XENTR Tubulin delta chain OS=Xenopus tropicalis OX=8364 GN=tubd1 PE=2 SV=1 g19667.t1 Q95SX7 27.989 368 2.8200000000000003e-22 105.0 sp|Q95SX7|RTBS_DROME Probable RNA-directed DNA polymerase from transposon BS OS=Drosophila melanogaster OX=7227 GN=RTase PE=2 SV=1 g19668.t1 Q802G7 46.154 117 4.65e-28 104.0 sp|Q802G7|SELM_DANRE Selenoprotein M OS=Danio rerio OX=7955 GN=Selenom PE=2 SV=2 SELM_DANRE reviewed Selenoprotein M (SePM) (SelM) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005788; GO:0016491 endoplasmic reticulum lumen [GO:0005788] oxidoreductase activity [GO:0016491] g19669.t1 Q9WU19 44.595 296 4.21e-84 261.0 sp|Q9WU19|HAOX1_MOUSE 2-Hydroxyacid oxidase 1 OS=Mus musculus OX=10090 GN=Hao1 PE=1 SV=1 HAOX1_MOUSE reviewed 2-Hydroxyacid oxidase 1 (HAOX1) (EC 1.1.3.15) (Glycolate oxidase) (GOX) (Glyoxylate oxidase) (EC 1.2.3.5) Mus musculus (Mouse) GO:0001561; GO:0003973; GO:0005777; GO:0005782; GO:0006545; GO:0006979; GO:0010181; GO:0046296; GO:0047969 fatty acid alpha-oxidation [GO:0001561]; glycine biosynthetic process [GO:0006545]; glycolate catabolic process [GO:0046296]; response to oxidative stress [GO:0006979] peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777] (S)-2-hydroxy-acid oxidase activity [GO:0003973]; FMN binding [GO:0010181]; glyoxylate oxidase activity [GO:0047969] g19670.t1 Q23023 40.152 132 4.6799999999999994e-23 97.1 sp|Q23023|UNC51_CAEEL Serine/threonine-protein kinase unc-51 OS=Caenorhabditis elegans OX=6239 GN=unc-51 PE=1 SV=1 UNC51_CAEEL reviewed Serine/threonine-protein kinase unc-51 (EC 2.7.11.1) (Uncoordinated protein 51) Caenorhabditis elegans GO:0000045; GO:0000407; GO:0000423; GO:0004674; GO:0005524; GO:0005737; GO:0005776; GO:0005829; GO:0006914; GO:0007409; GO:0007411; GO:0008340; GO:0008361; GO:0009792; GO:0010506; GO:0012501; GO:0016236; GO:0016477; GO:0030424; GO:0030516; GO:0032880; GO:0034045; GO:0034727; GO:0040014; GO:0040024; GO:0042594; GO:0043005; GO:0043025; GO:0043277; GO:0045138; GO:0046872; GO:0048675; GO:0061709; GO:0106310; GO:1902554 apoptotic cell clearance [GO:0043277]; autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; axon extension [GO:0048675]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; cell migration [GO:0016477]; dauer larval development [GO:0040024]; determination of adult lifespan [GO:0008340]; embryo development ending in birth or egg hatching [GO:0009792]; macroautophagy [GO:0016236]; mitophagy [GO:0000423]; nematode male tail tip morphogenesis [GO:0045138]; piecemeal microautophagy of the nucleus [GO:0034727]; programmed cell death [GO:0012501]; regulation of autophagy [GO:0010506]; regulation of axon extension [GO:0030516]; regulation of cell size [GO:0008361]; regulation of multicellular organism growth [GO:0040014]; regulation of protein localization [GO:0032880]; response to starvation [GO:0042594]; reticulophagy [GO:0061709] autophagosome [GO:0005776]; axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; phagophore assembly site [GO:0000407]; phagophore assembly site membrane [GO:0034045]; serine/threonine protein kinase complex [GO:1902554] ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g19671.t1 O70405 66.421 271 9.72e-115 377.0 sp|O70405|ULK1_MOUSE Serine/threonine-protein kinase ULK1 OS=Mus musculus OX=10090 GN=Ulk1 PE=1 SV=1 ULK1_MOUSE reviewed Serine/threonine-protein kinase ULK1 (EC 2.7.11.1) (Serine/threonine-protein kinase Unc51.1) (Unc-51-like kinase 1) Mus musculus (Mouse) GO:0000045; GO:0000407; GO:0000421; GO:0000423; GO:0004672; GO:0004674; GO:0005524; GO:0005737; GO:0005776; GO:0005829; GO:0006511; GO:0006914; GO:0007265; GO:0007409; GO:0007411; GO:0008104; GO:0008285; GO:0010468; GO:0010506; GO:0010508; GO:0016020; GO:0016236; GO:0016241; GO:0018105; GO:0019901; GO:0021707; GO:0021933; GO:0030424; GO:0030659; GO:0031102; GO:0031175; GO:0031267; GO:0031333; GO:0031623; GO:0031669; GO:0033554; GO:0034045; GO:0034198; GO:0034727; GO:0042594; GO:0042802; GO:0043005; GO:0043025; GO:0044877; GO:0048668; GO:0048671; GO:0048675; GO:0051020; GO:0051386; GO:0051879; GO:0061709; GO:0065003; GO:0098780; GO:0106310; GO:0160038; GO:1903349; GO:1990316; GO:2000786 autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; axon extension [GO:0048675]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; cellular response to amino acid starvation [GO:0034198]; cellular response to nutrient levels [GO:0031669]; cellular response to stress [GO:0033554]; cerebellar granule cell differentiation [GO:0021707]; collateral sprouting [GO:0048668]; intracellular protein localization [GO:0008104]; macroautophagy [GO:0016236]; mitophagy [GO:0000423]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of collateral sprouting [GO:0048671]; negative regulation of protein-containing complex assembly [GO:0031333]; neuron projection development [GO:0031175]; neuron projection regeneration [GO:0031102]; peptidyl-serine phosphorylation [GO:0018105]; piecemeal microautophagy of the nucleus [GO:0034727]; positive regulation of autophagosome assembly [GO:2000786]; positive regulation of autophagy [GO:0010508]; protein-containing complex assembly [GO:0065003]; radial glia guided migration of cerebellar granule cell [GO:0021933]; Ras protein signal transduction [GO:0007265]; receptor internalization [GO:0031623]; regulation of autophagy [GO:0010506]; regulation of gene expression [GO:0010468]; regulation of macroautophagy [GO:0016241]; regulation of neurotrophin TRK receptor signaling pathway [GO:0051386]; response to mitochondrial depolarisation [GO:0098780]; response to starvation [GO:0042594]; reticulophagy [GO:0061709]; somatic sensory system development [GO:0160038]; ubiquitin-dependent protein catabolic process [GO:0006511] Atg1/ULK1 kinase complex [GO:1990316]; autophagosome [GO:0005776]; autophagosome membrane [GO:0000421]; axon [GO:0030424]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; membrane [GO:0016020]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; omegasome membrane [GO:1903349]; phagophore assembly site [GO:0000407]; phagophore assembly site membrane [GO:0034045] ATP binding [GO:0005524]; GTPase binding [GO:0051020]; Hsp90 protein binding [GO:0051879]; identical protein binding [GO:0042802]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein-containing complex binding [GO:0044877]; small GTPase binding [GO:0031267] g19672.t1 O08715 40.411 292 1.8099999999999999e-62 223.0 sp|O08715|AKAP1_MOUSE A-kinase anchor protein 1, mitochondrial OS=Mus musculus OX=10090 GN=Akap1 PE=1 SV=4 g19677.t1 Q6R653 40.726 248 1.42e-49 180.0 sp|Q6R653|UN5CL_MOUSE UNC5C-like protein OS=Mus musculus OX=10090 GN=Unc5cl PE=2 SV=2 g19678.t1 Q9R189 24.515 722 6.47e-39 162.0 sp|Q9R189|UN13D_RAT Protein unc-13 homolog D OS=Rattus norvegicus OX=10116 GN=Unc13d PE=1 SV=1 g19680.t1 Q5M8K8 50.0 186 2.01e-67 207.0 sp|Q5M8K8|IFT22_XENTR Intraflagellar transport protein 22 homolog OS=Xenopus tropicalis OX=8364 GN=ift22 PE=2 SV=1 g19681.t1 O95294 48.395 841 0.0 759.0 sp|O95294|RASL1_HUMAN RasGAP-activating-like protein 1 OS=Homo sapiens OX=9606 GN=RASAL1 PE=1 SV=3 RASL1_HUMAN reviewed RasGAP-activating-like protein 1 (RAS protein activator like 1) (Ras GTPase-activating-like protein) Homo sapiens (Human) GO:0005096; GO:0005543; GO:0005829; GO:0007165; GO:0008270; GO:0030154; GO:0035556; GO:0046580; GO:0071277; GO:1902531; GO:1903861 cell differentiation [GO:0030154]; cellular response to calcium ion [GO:0071277]; intracellular signal transduction [GO:0035556]; negative regulation of Ras protein signal transduction [GO:0046580]; positive regulation of dendrite extension [GO:1903861]; regulation of intracellular signal transduction [GO:1902531]; signal transduction [GO:0007165] cytosol [GO:0005829] GTPase activator activity [GO:0005096]; phospholipid binding [GO:0005543]; zinc ion binding [GO:0008270] g19681.t2 O95294 48.113 848 0.0 758.0 sp|O95294|RASL1_HUMAN RasGAP-activating-like protein 1 OS=Homo sapiens OX=9606 GN=RASAL1 PE=1 SV=3 RASL1_HUMAN reviewed RasGAP-activating-like protein 1 (RAS protein activator like 1) (Ras GTPase-activating-like protein) Homo sapiens (Human) GO:0005096; GO:0005543; GO:0005829; GO:0007165; GO:0008270; GO:0030154; GO:0035556; GO:0046580; GO:0071277; GO:1902531; GO:1903861 cell differentiation [GO:0030154]; cellular response to calcium ion [GO:0071277]; intracellular signal transduction [GO:0035556]; negative regulation of Ras protein signal transduction [GO:0046580]; positive regulation of dendrite extension [GO:1903861]; regulation of intracellular signal transduction [GO:1902531]; signal transduction [GO:0007165] cytosol [GO:0005829] GTPase activator activity [GO:0005096]; phospholipid binding [GO:0005543]; zinc ion binding [GO:0008270] g19682.t1 Q08E38 68.35 515 0.0 735.0 sp|Q08E38|PRP19_BOVIN Pre-mRNA-processing factor 19 OS=Bos taurus OX=9913 GN=PRPF19 PE=2 SV=1 PRP19_BOVIN reviewed Pre-mRNA-processing factor 19 (EC 2.3.2.27) (PRP19/PSO4 homolog) (RING-type E3 ubiquitin transferase PRP19) Bos taurus (Bovine) GO:0000077; GO:0000244; GO:0000245; GO:0000398; GO:0000974; GO:0001833; GO:0004842; GO:0005634; GO:0005662; GO:0005737; GO:0005811; GO:0005819; GO:0006303; GO:0008104; GO:0008610; GO:0010498; GO:0016607; GO:0034450; GO:0035861; GO:0042802; GO:0048026; GO:0061630; GO:0070534; GO:0071006; GO:0071007 DNA damage checkpoint signaling [GO:0000077]; double-strand break repair via nonhomologous end joining [GO:0006303]; inner cell mass cell proliferation [GO:0001833]; intracellular protein localization [GO:0008104]; lipid biosynthetic process [GO:0008610]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; proteasomal protein catabolic process [GO:0010498]; protein K63-linked ubiquitination [GO:0070534]; spliceosomal complex assembly [GO:0000245]; spliceosomal tri-snRNP complex assembly [GO:0000244] cytoplasm [GO:0005737]; DNA replication factor A complex [GO:0005662]; lipid droplet [GO:0005811]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; Prp19 complex [GO:0000974]; site of double-strand break [GO:0035861]; spindle [GO:0005819]; U2-type catalytic step 1 spliceosome [GO:0071006]; U2-type catalytic step 2 spliceosome [GO:0071007] identical protein binding [GO:0042802]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; ubiquitin-ubiquitin ligase activity [GO:0034450] g19683.t1 A6QNS3 39.642 782 0.0 566.0 sp|A6QNS3|ABR_BOVIN Active breakpoint cluster region-related protein OS=Bos taurus OX=9913 GN=ABR PE=2 SV=1 g19684.t1 O35899 56.124 547 0.0 629.0 sp|O35899|SC6A4_CAVPO Sodium-dependent serotonin transporter OS=Cavia porcellus OX=10141 GN=SLC6A4 PE=1 SV=1 g19685.t1 Q99542 32.636 478 6.13e-67 227.0 sp|Q99542|MMP19_HUMAN Matrix metalloproteinase-19 OS=Homo sapiens OX=9606 GN=MMP19 PE=1 SV=1 MMP19_HUMAN reviewed Matrix metalloproteinase-19 (MMP-19) (EC 3.4.24.-) (Matrix metalloproteinase RASI) (Matrix metalloproteinase-18) (MMP-18) Homo sapiens (Human) GO:0001525; GO:0001541; GO:0001542; GO:0001554; GO:0004222; GO:0004252; GO:0005576; GO:0005615; GO:0006508; GO:0008270; GO:0009725; GO:0022617; GO:0030154; GO:0030198; GO:0030574; GO:0031012; GO:0051591 angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; collagen catabolic process [GO:0030574]; extracellular matrix disassembly [GO:0022617]; extracellular matrix organization [GO:0030198]; luteolysis [GO:0001554]; ovarian follicle development [GO:0001541]; ovulation from ovarian follicle [GO:0001542]; proteolysis [GO:0006508]; response to cAMP [GO:0051591]; response to hormone [GO:0009725] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615] metalloendopeptidase activity [GO:0004222]; serine-type endopeptidase activity [GO:0004252]; zinc ion binding [GO:0008270] g19690.t1 Q8R4G9 42.324 482 2.46e-116 355.0 sp|Q8R4G9|ACHA3_MOUSE Neuronal acetylcholine receptor subunit alpha-3 OS=Mus musculus OX=10090 GN=Chrna3 PE=1 SV=1 ACHA3_MOUSE reviewed Neuronal acetylcholine receptor subunit alpha-3 Mus musculus (Mouse) GO:0005730; GO:0005783; GO:0005794; GO:0005829; GO:0005886; GO:0005892; GO:0006937; GO:0006940; GO:0007165; GO:0007271; GO:0007274; GO:0007399; GO:0007626; GO:0009410; GO:0014056; GO:0015464; GO:0016607; GO:0022848; GO:0030425; GO:0032991; GO:0034220; GO:0034703; GO:0035094; GO:0035095; GO:0036064; GO:0042166; GO:0042391; GO:0043005; GO:0043025; GO:0044853; GO:0044877; GO:0045202; GO:0045211; GO:0046872; GO:0048814; GO:0051899; GO:0060079; GO:0060084; GO:0095500; GO:0098691; GO:0098793; GO:0098878; GO:0098981; GO:0099171; GO:0099634; GO:1901363; GO:1904315; GO:1905144 acetylcholine receptor signaling pathway [GO:0095500]; behavioral response to nicotine [GO:0035095]; excitatory postsynaptic potential [GO:0060079]; locomotory behavior [GO:0007626]; membrane depolarization [GO:0051899]; monoatomic ion transmembrane transport [GO:0034220]; nervous system development [GO:0007399]; neuromuscular synaptic transmission [GO:0007274]; presynaptic modulation of chemical synaptic transmission [GO:0099171]; regulation of acetylcholine secretion, neurotransmission [GO:0014056]; regulation of dendrite morphogenesis [GO:0048814]; regulation of membrane potential [GO:0042391]; regulation of muscle contraction [GO:0006937]; regulation of smooth muscle contraction [GO:0006940]; response to acetylcholine [GO:1905144]; response to nicotine [GO:0035094]; response to xenobiotic stimulus [GO:0009410]; signal transduction [GO:0007165]; synaptic transmission involved in micturition [GO:0060084]; synaptic transmission, cholinergic [GO:0007271] acetylcholine-gated channel complex [GO:0005892]; cation channel complex [GO:0034703]; cholinergic synapse [GO:0098981]; ciliary basal body [GO:0036064]; cytosol [GO:0005829]; dendrite [GO:0030425]; dopaminergic synapse [GO:0098691]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; neurotransmitter receptor complex [GO:0098878]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic membrane [GO:0045211]; postsynaptic specialization membrane [GO:0099634]; presynapse [GO:0098793]; protein-containing complex [GO:0032991]; synapse [GO:0045202] acetylcholine binding [GO:0042166]; acetylcholine receptor activity [GO:0015464]; acetylcholine-gated monoatomic cation-selective channel activity [GO:0022848]; heterocyclic compound binding [GO:1901363]; metal ion binding [GO:0046872]; protein-containing complex binding [GO:0044877]; transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315] g19691.t1 Q07263 42.214 533 3.09e-137 411.0 sp|Q07263|ACHA3_BOVIN Neuronal acetylcholine receptor subunit alpha-3 OS=Bos taurus OX=9913 GN=CHRNA3 PE=2 SV=1 g19691.t2 Q07263 43.532 487 5.28e-140 416.0 sp|Q07263|ACHA3_BOVIN Neuronal acetylcholine receptor subunit alpha-3 OS=Bos taurus OX=9913 GN=CHRNA3 PE=2 SV=1 g19692.t1 Q6DIQ1 55.172 87 3.14e-25 99.4 sp|Q6DIQ1|GL1D1_XENTR Glycosyltransferase 1 domain-containing protein 1 OS=Xenopus tropicalis OX=8364 GN=glt1d1 PE=2 SV=1 g19693.t1 Q5RAF1 39.754 244 2.38e-59 194.0 sp|Q5RAF1|GL1D1_PONAB Glycosyltransferase 1 domain-containing protein 1 OS=Pongo abelii OX=9601 GN=GLT1D1 PE=2 SV=1 g19694.t1 Q62985 51.316 152 3.94e-39 157.0 sp|Q62985|SH2B1_RAT SH2B adapter protein 1 OS=Rattus norvegicus OX=10116 GN=Sh2b1 PE=1 SV=1 g19700.t1 Q54BU4 53.608 582 0.0 629.0 sp|Q54BU4|ABCB1_DICDI ABC transporter B family member 1 OS=Dictyostelium discoideum OX=44689 GN=abcB1 PE=3 SV=1 g19705.t1 Q810L3 50.515 97 1.81e-22 98.2 sp|Q810L3|CHFR_MOUSE E3 ubiquitin-protein ligase CHFR OS=Mus musculus OX=10090 GN=Chfr PE=1 SV=1 CHFR_MOUSE reviewed E3 ubiquitin-protein ligase CHFR (EC 2.3.2.27) (Checkpoint with forkhead and RING finger domains protein) (RING-type E3 ubiquitin transferase CHFR) Mus musculus (Mouse) GO:0000166; GO:0000209; GO:0000278; GO:0004842; GO:0005634; GO:0006511; GO:0008270; GO:0016605; GO:0031398; GO:0031648; GO:0032436; GO:0044779; GO:0044818; GO:0051301; GO:0061630 cell division [GO:0051301]; meiotic spindle checkpoint signaling [GO:0044779]; mitotic cell cycle [GO:0000278]; mitotic G2/M transition checkpoint [GO:0044818]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein ubiquitination [GO:0031398]; protein destabilization [GO:0031648]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511] nucleus [GO:0005634]; PML body [GO:0016605] nucleotide binding [GO:0000166]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] g19706.t1 Q810L3 48.223 197 4.21e-54 199.0 sp|Q810L3|CHFR_MOUSE E3 ubiquitin-protein ligase CHFR OS=Mus musculus OX=10090 GN=Chfr PE=1 SV=1 CHFR_MOUSE reviewed E3 ubiquitin-protein ligase CHFR (EC 2.3.2.27) (Checkpoint with forkhead and RING finger domains protein) (RING-type E3 ubiquitin transferase CHFR) Mus musculus (Mouse) GO:0000166; GO:0000209; GO:0000278; GO:0004842; GO:0005634; GO:0006511; GO:0008270; GO:0016605; GO:0031398; GO:0031648; GO:0032436; GO:0044779; GO:0044818; GO:0051301; GO:0061630 cell division [GO:0051301]; meiotic spindle checkpoint signaling [GO:0044779]; mitotic cell cycle [GO:0000278]; mitotic G2/M transition checkpoint [GO:0044818]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein ubiquitination [GO:0031398]; protein destabilization [GO:0031648]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511] nucleus [GO:0005634]; PML body [GO:0016605] nucleotide binding [GO:0000166]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] g19706.t1 Q810L3 64.516 93 9.97e-33 137.0 sp|Q810L3|CHFR_MOUSE E3 ubiquitin-protein ligase CHFR OS=Mus musculus OX=10090 GN=Chfr PE=1 SV=1 CHFR_MOUSE reviewed E3 ubiquitin-protein ligase CHFR (EC 2.3.2.27) (Checkpoint with forkhead and RING finger domains protein) (RING-type E3 ubiquitin transferase CHFR) Mus musculus (Mouse) GO:0000166; GO:0000209; GO:0000278; GO:0004842; GO:0005634; GO:0006511; GO:0008270; GO:0016605; GO:0031398; GO:0031648; GO:0032436; GO:0044779; GO:0044818; GO:0051301; GO:0061630 cell division [GO:0051301]; meiotic spindle checkpoint signaling [GO:0044779]; mitotic cell cycle [GO:0000278]; mitotic G2/M transition checkpoint [GO:0044818]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein ubiquitination [GO:0031398]; protein destabilization [GO:0031648]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511] nucleus [GO:0005634]; PML body [GO:0016605] nucleotide binding [GO:0000166]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] g19707.t1 B2RPY5 27.976 336 3.4299999999999995e-24 107.0 sp|B2RPY5|GP161_MOUSE G-protein coupled receptor 161 OS=Mus musculus OX=10090 GN=Gpr161 PE=1 SV=1 GP161_MOUSE reviewed G-protein coupled receptor 161 Mus musculus (Mouse) GO:0004930; GO:0005929; GO:0007186; GO:0007189; GO:0055037; GO:0060170; GO:1901621 adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning [GO:1901621] ciliary membrane [GO:0060170]; cilium [GO:0005929]; recycling endosome [GO:0055037] G protein-coupled receptor activity [GO:0004930] g19712.t1 Q4V8D1 37.702 496 1.14e-120 367.0 sp|Q4V8D1|CP2U1_RAT Cytochrome P450 2U1 OS=Rattus norvegicus OX=10116 GN=Cyp2u1 PE=1 SV=1 CP2U1_RAT reviewed Cytochrome P450 2U1 (Long-chain fatty acid omega-monooxygenase) (EC 1.14.14.80) Rattus norvegicus (Rat) GO:0005506; GO:0005737; GO:0005743; GO:0005789; GO:0006082; GO:0006805; GO:0008202; GO:0008395; GO:0016712; GO:0020037; GO:0052869; GO:0097267; GO:0102033 omega-hydroxylase P450 pathway [GO:0097267]; organic acid metabolic process [GO:0006082]; steroid metabolic process [GO:0008202]; xenobiotic metabolic process [GO:0006805] cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; mitochondrial inner membrane [GO:0005743] arachidonate omega-hydroxylase activity [GO:0052869]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; long-chain fatty acid omega-hydroxylase activity [GO:0102033]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; steroid hydroxylase activity [GO:0008395] g19713.t1 P97526 55.167 2487 0.0 2623.0 sp|P97526|NF1_RAT Neurofibromin OS=Rattus norvegicus OX=10116 GN=Nf1 PE=1 SV=1 NF1_RAT reviewed Neurofibromin (Neurofibromatosis-related protein NF-1) Rattus norvegicus (Rat) GO:0000165; GO:0001649; GO:0001656; GO:0001666; GO:0001889; GO:0001937; GO:0001938; GO:0001952; GO:0001953; GO:0002686; GO:0005096; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005886; GO:0007154; GO:0007265; GO:0007406; GO:0007420; GO:0007422; GO:0007507; GO:0007519; GO:0008017; GO:0008285; GO:0008429; GO:0008542; GO:0008625; GO:0010468; GO:0010626; GO:0010976; GO:0014037; GO:0014044; GO:0016525; GO:0021510; GO:0021764; GO:0021897; GO:0021915; GO:0021987; GO:0022011; GO:0030036; GO:0030198; GO:0030199; GO:0030325; GO:0030336; GO:0030424; GO:0030425; GO:0031210; GO:0032228; GO:0032991; GO:0033027; GO:0033034; GO:0034605; GO:0035021; GO:0042060; GO:0042127; GO:0042308; GO:0043065; GO:0043408; GO:0043409; GO:0043473; GO:0043491; GO:0043525; GO:0043535; GO:0043547; GO:0045124; GO:0045545; GO:0045664; GO:0045671; GO:0045685; GO:0045765; GO:0046580; GO:0046929; GO:0048147; GO:0048169; GO:0048485; GO:0048593; GO:0048712; GO:0048715; GO:0048745; GO:0048820; GO:0048844; GO:0048853; GO:0050890; GO:0060253; GO:0060291; GO:0061534; GO:0061535; GO:0070372; GO:0070667; GO:0071549; GO:0097529; GO:0098597; GO:0098793; GO:0098926; GO:0098978; GO:0099159; GO:0099175; GO:1900148; GO:1900271; GO:1902531; GO:1904707; GO:1904753; GO:1990090; GO:2000108; GO:2000647; GO:2001241 actin cytoskeleton organization [GO:0030036]; adrenal gland development [GO:0030325]; amygdala development [GO:0021764]; artery morphogenesis [GO:0048844]; brain development [GO:0007420]; camera-type eye morphogenesis [GO:0048593]; cell communication [GO:0007154]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to heat [GO:0034605]; cellular response to nerve growth factor stimulus [GO:1990090]; cerebral cortex development [GO:0021987]; cognition [GO:0050890]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; forebrain astrocyte development [GO:0021897]; forebrain morphogenesis [GO:0048853]; gamma-aminobutyric acid secretion, neurotransmission [GO:0061534]; glutamate secretion, neurotransmission [GO:0061535]; hair follicle maturation [GO:0048820]; heart development [GO:0007507]; liver development [GO:0001889]; long-term synaptic potentiation [GO:0060291]; MAPK cascade [GO:0000165]; metanephros development [GO:0001656]; myelination in peripheral nervous system [GO:0022011]; myeloid leukocyte migration [GO:0097529]; negative regulation of angiogenesis [GO:0016525]; negative regulation of astrocyte differentiation [GO:0048712]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of leukocyte migration [GO:0002686]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of mast cell proliferation [GO:0070667]; negative regulation of neuroblast proliferation [GO:0007406]; negative regulation of neurotransmitter secretion [GO:0046929]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of osteoclast differentiation [GO:0045671]; negative regulation of protein import into nucleus [GO:0042308]; negative regulation of Rac protein signal transduction [GO:0035021]; negative regulation of Ras protein signal transduction [GO:0046580]; negative regulation of Schwann cell migration [GO:1900148]; negative regulation of Schwann cell proliferation [GO:0010626]; negative regulation of stem cell proliferation [GO:2000647]; negative regulation of vascular associated smooth muscle cell migration [GO:1904753]; neural tube development [GO:0021915]; observational learning [GO:0098597]; osteoblast differentiation [GO:0001649]; peripheral nervous system development [GO:0007422]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; pigmentation [GO:0043473]; positive regulation of apoptotic process [GO:0043065]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001241]; positive regulation of GTPase activity [GO:0043547]; positive regulation of leukocyte apoptotic process [GO:2000108]; positive regulation of mast cell apoptotic process [GO:0033027]; positive regulation of myeloid cell apoptotic process [GO:0033034]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of neuron projection development [GO:0010976]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; postsynaptic signal transduction [GO:0098926]; Ras protein signal transduction [GO:0007265]; regulation of angiogenesis [GO:0045765]; regulation of blood vessel endothelial cell migration [GO:0043535]; regulation of bone resorption [GO:0045124]; regulation of cell population proliferation [GO:0042127]; regulation of cell-matrix adhesion [GO:0001952]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of gene expression [GO:0010468]; regulation of glial cell differentiation [GO:0045685]; regulation of intracellular signal transduction [GO:1902531]; regulation of long-term neuronal synaptic plasticity [GO:0048169]; regulation of long-term synaptic potentiation [GO:1900271]; regulation of MAPK cascade [GO:0043408]; regulation of modification of postsynaptic structure [GO:0099159]; regulation of neuron differentiation [GO:0045664]; regulation of postsynapse organization [GO:0099175]; regulation of synaptic transmission, GABAergic [GO:0032228]; response to hypoxia [GO:0001666]; Schwann cell development [GO:0014044]; Schwann cell differentiation [GO:0014037]; skeletal muscle tissue development [GO:0007519]; smooth muscle tissue development [GO:0048745]; spinal cord development [GO:0021510]; sympathetic nervous system development [GO:0048485]; visual learning [GO:0008542]; wound healing [GO:0042060] axon [GO:0030424]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; protein-containing complex [GO:0032991] GTPase activator activity [GO:0005096]; microtubule binding [GO:0008017]; phosphatidylcholine binding [GO:0031210]; phosphatidylethanolamine binding [GO:0008429]; syndecan binding [GO:0045545] g19713.t1 P97526 49.794 243 9.49e-36 154.0 sp|P97526|NF1_RAT Neurofibromin OS=Rattus norvegicus OX=10116 GN=Nf1 PE=1 SV=1 NF1_RAT reviewed Neurofibromin (Neurofibromatosis-related protein NF-1) Rattus norvegicus (Rat) GO:0000165; GO:0001649; GO:0001656; GO:0001666; GO:0001889; GO:0001937; GO:0001938; GO:0001952; GO:0001953; GO:0002686; GO:0005096; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005886; GO:0007154; GO:0007265; GO:0007406; GO:0007420; GO:0007422; GO:0007507; GO:0007519; GO:0008017; GO:0008285; GO:0008429; GO:0008542; GO:0008625; GO:0010468; GO:0010626; GO:0010976; GO:0014037; GO:0014044; GO:0016525; GO:0021510; GO:0021764; GO:0021897; GO:0021915; GO:0021987; GO:0022011; GO:0030036; GO:0030198; GO:0030199; GO:0030325; GO:0030336; GO:0030424; GO:0030425; GO:0031210; GO:0032228; GO:0032991; GO:0033027; GO:0033034; GO:0034605; GO:0035021; GO:0042060; GO:0042127; GO:0042308; GO:0043065; GO:0043408; GO:0043409; GO:0043473; GO:0043491; GO:0043525; GO:0043535; GO:0043547; GO:0045124; GO:0045545; GO:0045664; GO:0045671; GO:0045685; GO:0045765; GO:0046580; GO:0046929; GO:0048147; GO:0048169; GO:0048485; GO:0048593; GO:0048712; GO:0048715; GO:0048745; GO:0048820; GO:0048844; GO:0048853; GO:0050890; GO:0060253; GO:0060291; GO:0061534; GO:0061535; GO:0070372; GO:0070667; GO:0071549; GO:0097529; GO:0098597; GO:0098793; GO:0098926; GO:0098978; GO:0099159; GO:0099175; GO:1900148; GO:1900271; GO:1902531; GO:1904707; GO:1904753; GO:1990090; GO:2000108; GO:2000647; GO:2001241 actin cytoskeleton organization [GO:0030036]; adrenal gland development [GO:0030325]; amygdala development [GO:0021764]; artery morphogenesis [GO:0048844]; brain development [GO:0007420]; camera-type eye morphogenesis [GO:0048593]; cell communication [GO:0007154]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to heat [GO:0034605]; cellular response to nerve growth factor stimulus [GO:1990090]; cerebral cortex development [GO:0021987]; cognition [GO:0050890]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; forebrain astrocyte development [GO:0021897]; forebrain morphogenesis [GO:0048853]; gamma-aminobutyric acid secretion, neurotransmission [GO:0061534]; glutamate secretion, neurotransmission [GO:0061535]; hair follicle maturation [GO:0048820]; heart development [GO:0007507]; liver development [GO:0001889]; long-term synaptic potentiation [GO:0060291]; MAPK cascade [GO:0000165]; metanephros development [GO:0001656]; myelination in peripheral nervous system [GO:0022011]; myeloid leukocyte migration [GO:0097529]; negative regulation of angiogenesis [GO:0016525]; negative regulation of astrocyte differentiation [GO:0048712]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of leukocyte migration [GO:0002686]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of mast cell proliferation [GO:0070667]; negative regulation of neuroblast proliferation [GO:0007406]; negative regulation of neurotransmitter secretion [GO:0046929]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of osteoclast differentiation [GO:0045671]; negative regulation of protein import into nucleus [GO:0042308]; negative regulation of Rac protein signal transduction [GO:0035021]; negative regulation of Ras protein signal transduction [GO:0046580]; negative regulation of Schwann cell migration [GO:1900148]; negative regulation of Schwann cell proliferation [GO:0010626]; negative regulation of stem cell proliferation [GO:2000647]; negative regulation of vascular associated smooth muscle cell migration [GO:1904753]; neural tube development [GO:0021915]; observational learning [GO:0098597]; osteoblast differentiation [GO:0001649]; peripheral nervous system development [GO:0007422]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; pigmentation [GO:0043473]; positive regulation of apoptotic process [GO:0043065]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001241]; positive regulation of GTPase activity [GO:0043547]; positive regulation of leukocyte apoptotic process [GO:2000108]; positive regulation of mast cell apoptotic process [GO:0033027]; positive regulation of myeloid cell apoptotic process [GO:0033034]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of neuron projection development [GO:0010976]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; postsynaptic signal transduction [GO:0098926]; Ras protein signal transduction [GO:0007265]; regulation of angiogenesis [GO:0045765]; regulation of blood vessel endothelial cell migration [GO:0043535]; regulation of bone resorption [GO:0045124]; regulation of cell population proliferation [GO:0042127]; regulation of cell-matrix adhesion [GO:0001952]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of gene expression [GO:0010468]; regulation of glial cell differentiation [GO:0045685]; regulation of intracellular signal transduction [GO:1902531]; regulation of long-term neuronal synaptic plasticity [GO:0048169]; regulation of long-term synaptic potentiation [GO:1900271]; regulation of MAPK cascade [GO:0043408]; regulation of modification of postsynaptic structure [GO:0099159]; regulation of neuron differentiation [GO:0045664]; regulation of postsynapse organization [GO:0099175]; regulation of synaptic transmission, GABAergic [GO:0032228]; response to hypoxia [GO:0001666]; Schwann cell development [GO:0014044]; Schwann cell differentiation [GO:0014037]; skeletal muscle tissue development [GO:0007519]; smooth muscle tissue development [GO:0048745]; spinal cord development [GO:0021510]; sympathetic nervous system development [GO:0048485]; visual learning [GO:0008542]; wound healing [GO:0042060] axon [GO:0030424]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; protein-containing complex [GO:0032991] GTPase activator activity [GO:0005096]; microtubule binding [GO:0008017]; phosphatidylcholine binding [GO:0031210]; phosphatidylethanolamine binding [GO:0008429]; syndecan binding [GO:0045545] g19713.t2 P97526 54.948 2506 0.0 2618.0 sp|P97526|NF1_RAT Neurofibromin OS=Rattus norvegicus OX=10116 GN=Nf1 PE=1 SV=1 NF1_RAT reviewed Neurofibromin (Neurofibromatosis-related protein NF-1) Rattus norvegicus (Rat) GO:0000165; GO:0001649; GO:0001656; GO:0001666; GO:0001889; GO:0001937; GO:0001938; GO:0001952; GO:0001953; GO:0002686; GO:0005096; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005886; GO:0007154; GO:0007265; GO:0007406; GO:0007420; GO:0007422; GO:0007507; GO:0007519; GO:0008017; GO:0008285; GO:0008429; GO:0008542; GO:0008625; GO:0010468; GO:0010626; GO:0010976; GO:0014037; GO:0014044; GO:0016525; GO:0021510; GO:0021764; GO:0021897; GO:0021915; GO:0021987; GO:0022011; GO:0030036; GO:0030198; GO:0030199; GO:0030325; GO:0030336; GO:0030424; GO:0030425; GO:0031210; GO:0032228; GO:0032991; GO:0033027; GO:0033034; GO:0034605; GO:0035021; GO:0042060; GO:0042127; GO:0042308; GO:0043065; GO:0043408; GO:0043409; GO:0043473; GO:0043491; GO:0043525; GO:0043535; GO:0043547; GO:0045124; GO:0045545; GO:0045664; GO:0045671; GO:0045685; GO:0045765; GO:0046580; GO:0046929; GO:0048147; GO:0048169; GO:0048485; GO:0048593; GO:0048712; GO:0048715; GO:0048745; GO:0048820; GO:0048844; GO:0048853; GO:0050890; GO:0060253; GO:0060291; GO:0061534; GO:0061535; GO:0070372; GO:0070667; GO:0071549; GO:0097529; GO:0098597; GO:0098793; GO:0098926; GO:0098978; GO:0099159; GO:0099175; GO:1900148; GO:1900271; GO:1902531; GO:1904707; GO:1904753; GO:1990090; GO:2000108; GO:2000647; GO:2001241 actin cytoskeleton organization [GO:0030036]; adrenal gland development [GO:0030325]; amygdala development [GO:0021764]; artery morphogenesis [GO:0048844]; brain development [GO:0007420]; camera-type eye morphogenesis [GO:0048593]; cell communication [GO:0007154]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to heat [GO:0034605]; cellular response to nerve growth factor stimulus [GO:1990090]; cerebral cortex development [GO:0021987]; cognition [GO:0050890]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; forebrain astrocyte development [GO:0021897]; forebrain morphogenesis [GO:0048853]; gamma-aminobutyric acid secretion, neurotransmission [GO:0061534]; glutamate secretion, neurotransmission [GO:0061535]; hair follicle maturation [GO:0048820]; heart development [GO:0007507]; liver development [GO:0001889]; long-term synaptic potentiation [GO:0060291]; MAPK cascade [GO:0000165]; metanephros development [GO:0001656]; myelination in peripheral nervous system [GO:0022011]; myeloid leukocyte migration [GO:0097529]; negative regulation of angiogenesis [GO:0016525]; negative regulation of astrocyte differentiation [GO:0048712]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of leukocyte migration [GO:0002686]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of mast cell proliferation [GO:0070667]; negative regulation of neuroblast proliferation [GO:0007406]; negative regulation of neurotransmitter secretion [GO:0046929]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of osteoclast differentiation [GO:0045671]; negative regulation of protein import into nucleus [GO:0042308]; negative regulation of Rac protein signal transduction [GO:0035021]; negative regulation of Ras protein signal transduction [GO:0046580]; negative regulation of Schwann cell migration [GO:1900148]; negative regulation of Schwann cell proliferation [GO:0010626]; negative regulation of stem cell proliferation [GO:2000647]; negative regulation of vascular associated smooth muscle cell migration [GO:1904753]; neural tube development [GO:0021915]; observational learning [GO:0098597]; osteoblast differentiation [GO:0001649]; peripheral nervous system development [GO:0007422]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; pigmentation [GO:0043473]; positive regulation of apoptotic process [GO:0043065]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001241]; positive regulation of GTPase activity [GO:0043547]; positive regulation of leukocyte apoptotic process [GO:2000108]; positive regulation of mast cell apoptotic process [GO:0033027]; positive regulation of myeloid cell apoptotic process [GO:0033034]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of neuron projection development [GO:0010976]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; postsynaptic signal transduction [GO:0098926]; Ras protein signal transduction [GO:0007265]; regulation of angiogenesis [GO:0045765]; regulation of blood vessel endothelial cell migration [GO:0043535]; regulation of bone resorption [GO:0045124]; regulation of cell population proliferation [GO:0042127]; regulation of cell-matrix adhesion [GO:0001952]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of gene expression [GO:0010468]; regulation of glial cell differentiation [GO:0045685]; regulation of intracellular signal transduction [GO:1902531]; regulation of long-term neuronal synaptic plasticity [GO:0048169]; regulation of long-term synaptic potentiation [GO:1900271]; regulation of MAPK cascade [GO:0043408]; regulation of modification of postsynaptic structure [GO:0099159]; regulation of neuron differentiation [GO:0045664]; regulation of postsynapse organization [GO:0099175]; regulation of synaptic transmission, GABAergic [GO:0032228]; response to hypoxia [GO:0001666]; Schwann cell development [GO:0014044]; Schwann cell differentiation [GO:0014037]; skeletal muscle tissue development [GO:0007519]; smooth muscle tissue development [GO:0048745]; spinal cord development [GO:0021510]; sympathetic nervous system development [GO:0048485]; visual learning [GO:0008542]; wound healing [GO:0042060] axon [GO:0030424]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; protein-containing complex [GO:0032991] GTPase activator activity [GO:0005096]; microtubule binding [GO:0008017]; phosphatidylcholine binding [GO:0031210]; phosphatidylethanolamine binding [GO:0008429]; syndecan binding [GO:0045545] g19713.t2 P97526 49.794 243 9.530000000000001e-36 154.0 sp|P97526|NF1_RAT Neurofibromin OS=Rattus norvegicus OX=10116 GN=Nf1 PE=1 SV=1 NF1_RAT reviewed Neurofibromin (Neurofibromatosis-related protein NF-1) Rattus norvegicus (Rat) GO:0000165; GO:0001649; GO:0001656; GO:0001666; GO:0001889; GO:0001937; GO:0001938; GO:0001952; GO:0001953; GO:0002686; GO:0005096; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005886; GO:0007154; GO:0007265; GO:0007406; GO:0007420; GO:0007422; GO:0007507; GO:0007519; GO:0008017; GO:0008285; GO:0008429; GO:0008542; GO:0008625; GO:0010468; GO:0010626; GO:0010976; GO:0014037; GO:0014044; GO:0016525; GO:0021510; GO:0021764; GO:0021897; GO:0021915; GO:0021987; GO:0022011; GO:0030036; GO:0030198; GO:0030199; GO:0030325; GO:0030336; GO:0030424; GO:0030425; GO:0031210; GO:0032228; GO:0032991; GO:0033027; GO:0033034; GO:0034605; GO:0035021; GO:0042060; GO:0042127; GO:0042308; GO:0043065; GO:0043408; GO:0043409; GO:0043473; GO:0043491; GO:0043525; GO:0043535; GO:0043547; GO:0045124; GO:0045545; GO:0045664; GO:0045671; GO:0045685; GO:0045765; GO:0046580; GO:0046929; GO:0048147; GO:0048169; GO:0048485; GO:0048593; GO:0048712; GO:0048715; GO:0048745; GO:0048820; GO:0048844; GO:0048853; GO:0050890; GO:0060253; GO:0060291; GO:0061534; GO:0061535; GO:0070372; GO:0070667; GO:0071549; GO:0097529; GO:0098597; GO:0098793; GO:0098926; GO:0098978; GO:0099159; GO:0099175; GO:1900148; GO:1900271; GO:1902531; GO:1904707; GO:1904753; GO:1990090; GO:2000108; GO:2000647; GO:2001241 actin cytoskeleton organization [GO:0030036]; adrenal gland development [GO:0030325]; amygdala development [GO:0021764]; artery morphogenesis [GO:0048844]; brain development [GO:0007420]; camera-type eye morphogenesis [GO:0048593]; cell communication [GO:0007154]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to heat [GO:0034605]; cellular response to nerve growth factor stimulus [GO:1990090]; cerebral cortex development [GO:0021987]; cognition [GO:0050890]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; forebrain astrocyte development [GO:0021897]; forebrain morphogenesis [GO:0048853]; gamma-aminobutyric acid secretion, neurotransmission [GO:0061534]; glutamate secretion, neurotransmission [GO:0061535]; hair follicle maturation [GO:0048820]; heart development [GO:0007507]; liver development [GO:0001889]; long-term synaptic potentiation [GO:0060291]; MAPK cascade [GO:0000165]; metanephros development [GO:0001656]; myelination in peripheral nervous system [GO:0022011]; myeloid leukocyte migration [GO:0097529]; negative regulation of angiogenesis [GO:0016525]; negative regulation of astrocyte differentiation [GO:0048712]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of leukocyte migration [GO:0002686]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of mast cell proliferation [GO:0070667]; negative regulation of neuroblast proliferation [GO:0007406]; negative regulation of neurotransmitter secretion [GO:0046929]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of osteoclast differentiation [GO:0045671]; negative regulation of protein import into nucleus [GO:0042308]; negative regulation of Rac protein signal transduction [GO:0035021]; negative regulation of Ras protein signal transduction [GO:0046580]; negative regulation of Schwann cell migration [GO:1900148]; negative regulation of Schwann cell proliferation [GO:0010626]; negative regulation of stem cell proliferation [GO:2000647]; negative regulation of vascular associated smooth muscle cell migration [GO:1904753]; neural tube development [GO:0021915]; observational learning [GO:0098597]; osteoblast differentiation [GO:0001649]; peripheral nervous system development [GO:0007422]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; pigmentation [GO:0043473]; positive regulation of apoptotic process [GO:0043065]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001241]; positive regulation of GTPase activity [GO:0043547]; positive regulation of leukocyte apoptotic process [GO:2000108]; positive regulation of mast cell apoptotic process [GO:0033027]; positive regulation of myeloid cell apoptotic process [GO:0033034]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of neuron projection development [GO:0010976]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; postsynaptic signal transduction [GO:0098926]; Ras protein signal transduction [GO:0007265]; regulation of angiogenesis [GO:0045765]; regulation of blood vessel endothelial cell migration [GO:0043535]; regulation of bone resorption [GO:0045124]; regulation of cell population proliferation [GO:0042127]; regulation of cell-matrix adhesion [GO:0001952]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of gene expression [GO:0010468]; regulation of glial cell differentiation [GO:0045685]; regulation of intracellular signal transduction [GO:1902531]; regulation of long-term neuronal synaptic plasticity [GO:0048169]; regulation of long-term synaptic potentiation [GO:1900271]; regulation of MAPK cascade [GO:0043408]; regulation of modification of postsynaptic structure [GO:0099159]; regulation of neuron differentiation [GO:0045664]; regulation of postsynapse organization [GO:0099175]; regulation of synaptic transmission, GABAergic [GO:0032228]; response to hypoxia [GO:0001666]; Schwann cell development [GO:0014044]; Schwann cell differentiation [GO:0014037]; skeletal muscle tissue development [GO:0007519]; smooth muscle tissue development [GO:0048745]; spinal cord development [GO:0021510]; sympathetic nervous system development [GO:0048485]; visual learning [GO:0008542]; wound healing [GO:0042060] axon [GO:0030424]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; protein-containing complex [GO:0032991] GTPase activator activity [GO:0005096]; microtubule binding [GO:0008017]; phosphatidylcholine binding [GO:0031210]; phosphatidylethanolamine binding [GO:0008429]; syndecan binding [GO:0045545] g19715.t1 Q70E20 34.911 338 8.19e-31 130.0 sp|Q70E20|SNED1_MOUSE Sushi, nidogen and EGF-like domain-containing protein 1 OS=Mus musculus OX=10090 GN=Sned1 PE=2 SV=2 g19715.t1 Q70E20 29.769 346 4.2e-25 113.0 sp|Q70E20|SNED1_MOUSE Sushi, nidogen and EGF-like domain-containing protein 1 OS=Mus musculus OX=10090 GN=Sned1 PE=2 SV=2 g19715.t1 Q70E20 32.448 339 1.3e-21 102.0 sp|Q70E20|SNED1_MOUSE Sushi, nidogen and EGF-like domain-containing protein 1 OS=Mus musculus OX=10090 GN=Sned1 PE=2 SV=2 g19715.t1 Q70E20 32.095 296 6.180000000000001e-21 100.0 sp|Q70E20|SNED1_MOUSE Sushi, nidogen and EGF-like domain-containing protein 1 OS=Mus musculus OX=10090 GN=Sned1 PE=2 SV=2 g19716.t1 Q925Q3 41.924 291 6.17e-58 209.0 sp|Q925Q3|NCLX_MOUSE Mitochondrial sodium/calcium exchanger protein OS=Mus musculus OX=10090 GN=Slc8b1 PE=2 SV=2 g19716.t1 Q925Q3 47.826 253 1.0100000000000001e-35 146.0 sp|Q925Q3|NCLX_MOUSE Mitochondrial sodium/calcium exchanger protein OS=Mus musculus OX=10090 GN=Slc8b1 PE=2 SV=2 g19718.t1 Q9UQ35 57.895 152 1.45e-36 146.0 sp|Q9UQ35|SRRM2_HUMAN Serine/arginine repetitive matrix protein 2 OS=Homo sapiens OX=9606 GN=SRRM2 PE=1 SV=2 SRRM2_HUMAN reviewed Serine/arginine repetitive matrix protein 2 (300 kDa nuclear matrix antigen) (Serine/arginine-rich splicing factor-related nuclear matrix protein of 300 kDa) (SR-related nuclear matrix protein of 300 kDa) (Ser/Arg-related nuclear matrix protein of 300 kDa) (Splicing coactivator subunit SRm300) (Tax-responsive enhancer element-binding protein 803) (TaxREB803) Homo sapiens (Human) GO:0000398; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0015030; GO:0016607; GO:0070742; GO:0071005; GO:0071007; GO:0071013 mRNA splicing, via spliceosome [GO:0000398] Cajal body [GO:0015030]; catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U2-type catalytic step 2 spliceosome [GO:0071007]; U2-type precatalytic spliceosome [GO:0071005] C2H2 zinc finger domain binding [GO:0070742]; mRNA binding [GO:0003729]; RNA binding [GO:0003723] g19718.t2 Q9UQ35 57.895 152 1.55e-38 152.0 sp|Q9UQ35|SRRM2_HUMAN Serine/arginine repetitive matrix protein 2 OS=Homo sapiens OX=9606 GN=SRRM2 PE=1 SV=2 SRRM2_HUMAN reviewed Serine/arginine repetitive matrix protein 2 (300 kDa nuclear matrix antigen) (Serine/arginine-rich splicing factor-related nuclear matrix protein of 300 kDa) (SR-related nuclear matrix protein of 300 kDa) (Ser/Arg-related nuclear matrix protein of 300 kDa) (Splicing coactivator subunit SRm300) (Tax-responsive enhancer element-binding protein 803) (TaxREB803) Homo sapiens (Human) GO:0000398; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0015030; GO:0016607; GO:0070742; GO:0071005; GO:0071007; GO:0071013 mRNA splicing, via spliceosome [GO:0000398] Cajal body [GO:0015030]; catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U2-type catalytic step 2 spliceosome [GO:0071007]; U2-type precatalytic spliceosome [GO:0071005] C2H2 zinc finger domain binding [GO:0070742]; mRNA binding [GO:0003729]; RNA binding [GO:0003723] g19719.t1 Q2KIY1 39.548 177 6.93e-45 150.0 sp|Q2KIY1|PXMP2_BOVIN Peroxisomal membrane protein 2 OS=Bos taurus OX=9913 GN=PXMP2 PE=2 SV=3 g19720.t1 P98154 31.231 333 1.1400000000000001e-33 136.0 sp|P98154|IDD_MOUSE Integral membrane protein DGCR2/IDD OS=Mus musculus OX=10090 GN=Dgcr2 PE=2 SV=1 g19721.t1 Q4V8T0 58.824 289 1.08e-127 368.0 sp|Q4V8T0|MIOX_DANRE Inositol oxygenase OS=Danio rerio OX=7955 GN=miox PE=2 SV=1 g19722.t1 Q5ZI89 52.905 1136 0.0 1208.0 sp|Q5ZI89|TPC11_CHICK Trafficking protein particle complex subunit 11 OS=Gallus gallus OX=9031 GN=TRAPPC11 PE=2 SV=1 g19725.t1 Q9Y6I7 47.727 440 3.41e-137 403.0 sp|Q9Y6I7|WSB1_HUMAN WD repeat and SOCS box-containing protein 1 OS=Homo sapiens OX=9606 GN=WSB1 PE=1 SV=1 WSB1_HUMAN reviewed WD repeat and SOCS box-containing protein 1 (WSB-1) (SOCS box-containing WD protein SWiP-1) Homo sapiens (Human) GO:0000209; GO:0005829; GO:0035556; GO:0044314; GO:0061630; GO:0097413; GO:0140454 intracellular signal transduction [GO:0035556]; protein aggregate center assembly [GO:0140454]; protein K27-linked ubiquitination [GO:0044314]; protein polyubiquitination [GO:0000209] cytosol [GO:0005829]; Lewy body [GO:0097413] ubiquitin protein ligase activity [GO:0061630] g19726.t1 Q9Z2Q6 67.059 340 1.3e-147 427.0 sp|Q9Z2Q6|SEPT5_MOUSE Septin-5 OS=Mus musculus OX=10090 GN=Septin5 PE=1 SV=2 SEPT5_MOUSE reviewed Septin-5 (Cell division control-related protein 1) (CDCrel-1) (Peanut-like protein 1) Mus musculus (Mouse) GO:0001725; GO:0003924; GO:0005525; GO:0005886; GO:0005938; GO:0005940; GO:0008021; GO:0008104; GO:0015630; GO:0017075; GO:0017157; GO:0019003; GO:0019905; GO:0030534; GO:0031105; GO:0031201; GO:0032153; GO:0032154; GO:0032991; GO:0035091; GO:0035176; GO:0042802; GO:0042803; GO:0043195; GO:0043679; GO:0044305; GO:0045202; GO:0060090; GO:0061640; GO:0098793; GO:0099148; GO:1903306 adult behavior [GO:0030534]; cytoskeleton-dependent cytokinesis [GO:0061640]; intracellular protein localization [GO:0008104]; negative regulation of regulated secretory pathway [GO:1903306]; regulation of exocytosis [GO:0017157]; regulation of synaptic vesicle docking [GO:0099148]; social behavior [GO:0035176] axon terminus [GO:0043679]; calyx of Held [GO:0044305]; cell cortex [GO:0005938]; cell division site [GO:0032153]; cleavage furrow [GO:0032154]; microtubule cytoskeleton [GO:0015630]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; protein-containing complex [GO:0032991]; septin complex [GO:0031105]; septin ring [GO:0005940]; SNARE complex [GO:0031201]; stress fiber [GO:0001725]; synapse [GO:0045202]; synaptic vesicle [GO:0008021]; terminal bouton [GO:0043195] GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; molecular adaptor activity [GO:0060090]; phosphatidylinositol binding [GO:0035091]; protein homodimerization activity [GO:0042803]; syntaxin binding [GO:0019905]; syntaxin-1 binding [GO:0017075] g19727.t1 A0A1L8HFX9 54.362 149 1.43e-48 189.0 sp|A0A1L8HFX9|G2L2L_XENLA GAS2-like protein 2A OS=Xenopus laevis OX=8355 GN=gas2l2.L PE=3 SV=1 g19727.t1 A0A1L8HFX9 75.362 69 4.1000000000000003e-29 128.0 sp|A0A1L8HFX9|G2L2L_XENLA GAS2-like protein 2A OS=Xenopus laevis OX=8355 GN=gas2l2.L PE=3 SV=1 g19741.t1 Q9Y4D8 41.379 609 9.38e-128 421.0 sp|Q9Y4D8|HECD4_HUMAN Probable E3 ubiquitin-protein ligase HECTD4 OS=Homo sapiens OX=9606 GN=HECTD4 PE=1 SV=5 g19741.t2 Q9Y4D8 41.519 619 2.1199999999999998e-126 426.0 sp|Q9Y4D8|HECD4_HUMAN Probable E3 ubiquitin-protein ligase HECTD4 OS=Homo sapiens OX=9606 GN=HECTD4 PE=1 SV=5 g19742.t1 Q9Y4D8 58.234 1087 0.0 1146.0 sp|Q9Y4D8|HECD4_HUMAN Probable E3 ubiquitin-protein ligase HECTD4 OS=Homo sapiens OX=9606 GN=HECTD4 PE=1 SV=5 g19742.t2 Q9Y4D8 58.326 1087 0.0 1152.0 sp|Q9Y4D8|HECD4_HUMAN Probable E3 ubiquitin-protein ligase HECTD4 OS=Homo sapiens OX=9606 GN=HECTD4 PE=1 SV=5 g19743.t1 Q9Y4D8 50.113 1325 0.0 1166.0 sp|Q9Y4D8|HECD4_HUMAN Probable E3 ubiquitin-protein ligase HECTD4 OS=Homo sapiens OX=9606 GN=HECTD4 PE=1 SV=5 g19743.t1 Q9Y4D8 50.748 869 0.0 815.0 sp|Q9Y4D8|HECD4_HUMAN Probable E3 ubiquitin-protein ligase HECTD4 OS=Homo sapiens OX=9606 GN=HECTD4 PE=1 SV=5 g19745.t1 Q2NKQ1 49.646 707 0.0 669.0 sp|Q2NKQ1|SGSM1_HUMAN Small G protein signaling modulator 1 OS=Homo sapiens OX=9606 GN=SGSM1 PE=1 SV=2 SGSM1_HUMAN reviewed Small G protein signaling modulator 1 (RUN and TBC1 domain-containing protein 2) Homo sapiens (Human) GO:0005096; GO:0005737; GO:0005794; GO:0005829; GO:0030659; GO:0031267 cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794] GTPase activator activity [GO:0005096]; small GTPase binding [GO:0031267] g19746.t1 Q2NKQ1 81.702 235 6.95e-141 429.0 sp|Q2NKQ1|SGSM1_HUMAN Small G protein signaling modulator 1 OS=Homo sapiens OX=9606 GN=SGSM1 PE=1 SV=2 SGSM1_HUMAN reviewed Small G protein signaling modulator 1 (RUN and TBC1 domain-containing protein 2) Homo sapiens (Human) GO:0005096; GO:0005737; GO:0005794; GO:0005829; GO:0030659; GO:0031267 cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794] GTPase activator activity [GO:0005096]; small GTPase binding [GO:0031267] g19748.t1 Q0VH32 64.444 90 4.3800000000000005e-31 125.0 sp|Q0VH32|MNT_XENLA Max-binding protein MNT OS=Xenopus laevis OX=8355 GN=mnt PE=2 SV=1 g19749.t1 A6QQ71 36.688 308 8.58e-61 204.0 sp|A6QQ71|FKBP6_BOVIN Inactive peptidyl-prolyl cis-trans isomerase FKBP6 OS=Bos taurus OX=9913 GN=FKBP6 PE=2 SV=1 FKBP6_BOVIN reviewed Inactive peptidyl-prolyl cis-trans isomerase FKBP6 (Inactive PPIase FKBP6) (36 kDa FK506-binding protein) (FK506-binding protein 6) (FKBP-6) (Immunophilin FKBP36) Bos taurus (Bovine) GO:0000795; GO:0005737; GO:0005829; GO:0006457; GO:0007283; GO:0030154; GO:0031047; GO:0034587; GO:0051321; GO:0051879; GO:0141196 cell differentiation [GO:0030154]; meiotic cell cycle [GO:0051321]; piRNA processing [GO:0034587]; protein folding [GO:0006457]; regulatory ncRNA-mediated gene silencing [GO:0031047]; spermatogenesis [GO:0007283]; transposable element silencing by piRNA-mediated DNA methylation [GO:0141196] cytoplasm [GO:0005737]; cytosol [GO:0005829]; synaptonemal complex [GO:0000795] Hsp90 protein binding [GO:0051879] g19750.t1 P43487 57.436 195 3.84e-62 196.0 sp|P43487|RANG_HUMAN Ran-specific GTPase-activating protein OS=Homo sapiens OX=9606 GN=RANBP1 PE=1 SV=1 RANG_HUMAN reviewed Ran-specific GTPase-activating protein (Ran-binding protein 1) (RanBP1) Homo sapiens (Human) GO:0005092; GO:0005096; GO:0005634; GO:0005635; GO:0005643; GO:0005737; GO:0005813; GO:0005829; GO:0006913; GO:0007165; GO:0031267; GO:0045296; GO:0046604 nucleocytoplasmic transport [GO:0006913]; positive regulation of mitotic centrosome separation [GO:0046604]; signal transduction [GO:0007165] centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear envelope [GO:0005635]; nuclear pore [GO:0005643]; nucleus [GO:0005634] cadherin binding [GO:0045296]; GDP-dissociation inhibitor activity [GO:0005092]; GTPase activator activity [GO:0005096]; small GTPase binding [GO:0031267] g19751.t1 Q91YT2 68.235 170 3.36e-48 160.0 sp|Q91YT2|RN185_MOUSE E3 ubiquitin-protein ligase RNF185 OS=Mus musculus OX=10090 GN=Rnf185 PE=2 SV=1 RN185_MOUSE reviewed E3 ubiquitin-protein ligase RNF185 (EC 2.3.2.27) (RING finger protein 185) Mus musculus (Mouse) GO:0005741; GO:0005783; GO:0005789; GO:0006511; GO:0006914; GO:0008270; GO:0036503; GO:0043130; GO:0044314; GO:0044390; GO:0044877; GO:0045087; GO:0045089; GO:0051607; GO:0051865; GO:0060340; GO:0061630; GO:0140896; GO:1904294 autophagy [GO:0006914]; cGAS/STING signaling pathway [GO:0140896]; defense response to virus [GO:0051607]; ERAD pathway [GO:0036503]; innate immune response [GO:0045087]; positive regulation of ERAD pathway [GO:1904294]; positive regulation of innate immune response [GO:0045089]; positive regulation of type I interferon-mediated signaling pathway [GO:0060340]; protein autoubiquitination [GO:0051865]; protein K27-linked ubiquitination [GO:0044314]; ubiquitin-dependent protein catabolic process [GO:0006511] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; mitochondrial outer membrane [GO:0005741] protein-containing complex binding [GO:0044877]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-like protein conjugating enzyme binding [GO:0044390]; zinc ion binding [GO:0008270] g19753.t1 Q9Z0U4 38.532 218 2.01e-39 147.0 sp|Q9Z0U4|GABR1_RAT Gamma-aminobutyric acid type B receptor subunit 1 OS=Rattus norvegicus OX=10116 GN=Gabbr1 PE=1 SV=2 GABR1_RAT reviewed Gamma-aminobutyric acid type B receptor subunit 1 (GABA-B receptor 1) (GABA-B-R1) (GABA-BR1) (GABABR1) (Gb1) Rattus norvegicus (Rat) GO:0001649; GO:0004965; GO:0005615; GO:0005737; GO:0005789; GO:0005886; GO:0007193; GO:0007214; GO:0008021; GO:0008285; GO:0014048; GO:0014049; GO:0014053; GO:0016020; GO:0030673; GO:0031966; GO:0032811; GO:0033602; GO:0035094; GO:0038037; GO:0038039; GO:0042734; GO:0043025; GO:0043197; GO:0043198; GO:0043204; GO:0045211; GO:0045471; GO:0046982; GO:0050805; GO:0051932; GO:0060124; GO:0097060; GO:0098685; GO:0098793; GO:0098978; GO:0098982; GO:0099579; GO:0150047; GO:0150099; GO:1902710; GO:1902712; GO:1990430 adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; gamma-aminobutyric acid signaling pathway [GO:0007214]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of dopamine secretion [GO:0033602]; negative regulation of epinephrine secretion [GO:0032811]; negative regulation of gamma-aminobutyric acid secretion [GO:0014053]; negative regulation of synaptic transmission [GO:0050805]; neuron-glial cell signaling [GO:0150099]; osteoblast differentiation [GO:0001649]; positive regulation of glutamate secretion [GO:0014049]; positive regulation of growth hormone secretion [GO:0060124]; regulation of glutamate secretion [GO:0014048]; response to ethanol [GO:0045471]; response to nicotine [GO:0035094]; synaptic transmission, GABAergic [GO:0051932] axolemma [GO:0030673]; cytoplasm [GO:0005737]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; endoplasmic reticulum membrane [GO:0005789]; extracellular space [GO:0005615]; G protein-coupled GABA receptor complex [GO:1902712]; G protein-coupled receptor dimeric complex [GO:0038037]; G protein-coupled receptor heterodimeric complex [GO:0038039]; GABA receptor complex [GO:1902710]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; mitochondrial membrane [GO:0031966]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynapse [GO:0098793]; presynaptic membrane [GO:0042734]; Schaffer collateral - CA1 synapse [GO:0098685]; synaptic membrane [GO:0097060]; synaptic vesicle [GO:0008021] extracellular matrix protein binding [GO:1990430]; G protein-coupled GABA receptor activity [GO:0004965]; G protein-coupled neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential [GO:0099579]; G protein-coupled neurotransmitter receptor activity involved in regulation of presynaptic membrane potential [GO:0150047]; protein heterodimerization activity [GO:0046982] g19756.t1 Q5EAJ7 77.922 154 3.02e-73 238.0 sp|Q5EAJ7|MVP_STRPU Major vault protein OS=Strongylocentrotus purpuratus OX=7668 GN=MVP PE=1 SV=1 g19757.t1 Q9CQL5 47.518 141 3.86e-44 148.0 sp|Q9CQL5|RM18_MOUSE Large ribosomal subunit protein uL18m OS=Mus musculus OX=10090 GN=Mrpl18 PE=1 SV=1 g19761.t1 Q8IVN8 32.624 282 5.74e-38 137.0 sp|Q8IVN8|SBSPO_HUMAN Somatomedin-B and thrombospondin type-1 domain-containing protein OS=Homo sapiens OX=9606 GN=SBSPON PE=1 SV=2 g19762.t1 Q68FD5 85.371 1039 0.0 1814.0 sp|Q68FD5|CLH1_MOUSE Clathrin heavy chain 1 OS=Mus musculus OX=10090 GN=Cltc PE=1 SV=3 CLH1_MOUSE reviewed Clathrin heavy chain 1 Mus musculus (Mouse) GO:0000278; GO:0003725; GO:0005198; GO:0005739; GO:0005764; GO:0005768; GO:0005819; GO:0005829; GO:0005905; GO:0006886; GO:0006898; GO:0006914; GO:0007030; GO:0016020; GO:0019901; GO:0030117; GO:0030118; GO:0030130; GO:0030132; GO:0030136; GO:0030315; GO:0030506; GO:0031072; GO:0031523; GO:0031623; GO:0032051; GO:0032991; GO:0033572; GO:0034451; GO:0042147; GO:0042277; GO:0042383; GO:0042470; GO:0043209; GO:0045334; GO:0048268; GO:0048488; GO:0050750; GO:0051301; GO:0060236; GO:0071439; GO:0072318; GO:0072583; GO:0072686; GO:0090307; GO:0097718; GO:0098684; GO:0098835; GO:0098843; GO:0098850; GO:0098978; GO:0120283; GO:0150093; GO:1900126; GO:1903077; GO:1990381; GO:1990498 amyloid-beta clearance by transcytosis [GO:0150093]; autophagy [GO:0006914]; cell division [GO:0051301]; clathrin coat assembly [GO:0048268]; clathrin coat disassembly [GO:0072318]; clathrin-dependent endocytosis [GO:0072583]; Golgi organization [GO:0007030]; intracellular protein transport [GO:0006886]; mitotic cell cycle [GO:0000278]; mitotic spindle assembly [GO:0090307]; negative regulation of hyaluronan biosynthetic process [GO:1900126]; negative regulation of protein localization to plasma membrane [GO:1903077]; receptor internalization [GO:0031623]; receptor-mediated endocytosis [GO:0006898]; regulation of mitotic spindle organization [GO:0060236]; retrograde transport, endosome to Golgi [GO:0042147]; synaptic vesicle endocytosis [GO:0048488]; transferrin transport [GO:0033572] centriolar satellite [GO:0034451]; clathrin coat [GO:0030118]; clathrin coat of coated pit [GO:0030132]; clathrin coat of trans-Golgi network vesicle [GO:0030130]; clathrin complex [GO:0071439]; clathrin-coated endocytic vesicle [GO:0045334]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; cytosol [GO:0005829]; endosome [GO:0005768]; extrinsic component of synaptic vesicle membrane [GO:0098850]; glutamatergic synapse [GO:0098978]; lysosome [GO:0005764]; melanosome [GO:0042470]; membrane [GO:0016020]; membrane coat [GO:0030117]; mitochondrion [GO:0005739]; mitotic spindle [GO:0072686]; mitotic spindle microtubule [GO:1990498]; Myb complex [GO:0031523]; myelin sheath [GO:0043209]; photoreceptor ribbon synapse [GO:0098684]; postsynaptic endocytic zone [GO:0098843]; presynaptic endocytic zone membrane [GO:0098835]; protein-containing complex [GO:0032991]; sarcolemma [GO:0042383]; spindle [GO:0005819]; T-tubule [GO:0030315] ankyrin binding [GO:0030506]; clathrin light chain binding [GO:0032051]; disordered domain specific binding [GO:0097718]; double-stranded RNA binding [GO:0003725]; heat shock protein binding [GO:0031072]; low-density lipoprotein particle receptor binding [GO:0050750]; peptide binding [GO:0042277]; protein kinase binding [GO:0019901]; protein serine/threonine kinase binding [GO:0120283]; structural molecule activity [GO:0005198]; ubiquitin-specific protease binding [GO:1990381] g19763.t1 P49951 86.165 571 0.0 1015.0 sp|P49951|CLH1_BOVIN Clathrin heavy chain 1 OS=Bos taurus OX=9913 GN=CLTC PE=1 SV=1 CLH1_BOVIN reviewed Clathrin heavy chain 1 Bos taurus (Bovine) GO:0000278; GO:0005198; GO:0005739; GO:0005819; GO:0006886; GO:0006898; GO:0006914; GO:0019904; GO:0030117; GO:0030130; GO:0030132; GO:0032051; GO:0042470; GO:0042802; GO:0045334; GO:0048268; GO:0051301; GO:0071439; GO:0072318; GO:0097718; GO:1900126; GO:1990763 autophagy [GO:0006914]; cell division [GO:0051301]; clathrin coat assembly [GO:0048268]; clathrin coat disassembly [GO:0072318]; intracellular protein transport [GO:0006886]; mitotic cell cycle [GO:0000278]; negative regulation of hyaluronan biosynthetic process [GO:1900126]; receptor-mediated endocytosis [GO:0006898] clathrin coat of coated pit [GO:0030132]; clathrin coat of trans-Golgi network vesicle [GO:0030130]; clathrin complex [GO:0071439]; clathrin-coated endocytic vesicle [GO:0045334]; melanosome [GO:0042470]; membrane coat [GO:0030117]; mitochondrion [GO:0005739]; spindle [GO:0005819] arrestin family protein binding [GO:1990763]; clathrin light chain binding [GO:0032051]; disordered domain specific binding [GO:0097718]; identical protein binding [GO:0042802]; protein domain specific binding [GO:0019904]; structural molecule activity [GO:0005198] g19764.t1 Q8BZI6 39.574 235 4.65e-48 162.0 sp|Q8BZI6|GUCD1_MOUSE Protein GUCD1 OS=Mus musculus OX=10090 GN=Gucd1 PE=2 SV=2 g19765.t1 Q5RFM4 38.667 150 1.87e-24 102.0 sp|Q5RFM4|ZW10_PONAB Centromere/kinetochore protein zw10 homolog OS=Pongo abelii OX=9601 GN=ZW10 PE=2 SV=3 g19766.t1 O43264 40.033 602 4.5600000000000004e-154 464.0 sp|O43264|ZW10_HUMAN Centromere/kinetochore protein zw10 homolog OS=Homo sapiens OX=9606 GN=ZW10 PE=1 SV=3 ZW10_HUMAN reviewed Centromere/kinetochore protein zw10 homolog Homo sapiens (Human) GO:0000070; GO:0000132; GO:0000776; GO:0000922; GO:0005634; GO:0005783; GO:0005789; GO:0005811; GO:0005828; GO:0005829; GO:0006888; GO:0006890; GO:0007030; GO:0007080; GO:0007094; GO:0007096; GO:0015031; GO:0016020; GO:0019237; GO:0034501; GO:0051301; GO:0051321; GO:0051988; GO:0065003; GO:0070939; GO:1990423 cell division [GO:0051301]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; establishment of mitotic spindle orientation [GO:0000132]; Golgi organization [GO:0007030]; meiotic cell cycle [GO:0051321]; mitotic metaphase chromosome alignment [GO:0007080]; mitotic sister chromatid segregation [GO:0000070]; mitotic spindle assembly checkpoint signaling [GO:0007094]; protein localization to kinetochore [GO:0034501]; protein transport [GO:0015031]; protein-containing complex assembly [GO:0065003]; regulation of attachment of spindle microtubules to kinetochore [GO:0051988]; regulation of exit from mitosis [GO:0007096]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890] cytosol [GO:0005829]; Dsl1/NZR complex [GO:0070939]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; kinetochore [GO:0000776]; kinetochore microtubule [GO:0005828]; lipid droplet [GO:0005811]; membrane [GO:0016020]; nucleus [GO:0005634]; RZZ complex [GO:1990423]; spindle pole [GO:0000922] centromeric DNA binding [GO:0019237] g19767.t1 Q2KHM9 56.303 119 1.16e-27 124.0 sp|Q2KHM9|MOONR_HUMAN Protein moonraker OS=Homo sapiens OX=9606 GN=KIAA0753 PE=1 SV=3 MOONR_HUMAN reviewed Protein moonraker (MNR) (OFD1- and FOPNL-interacting protein) Homo sapiens (Human) GO:0005783; GO:0005813; GO:0005814; GO:0005815; GO:0005829; GO:0005929; GO:0007099; GO:0034451; GO:0036064; GO:0046872; GO:0051537; GO:0060271; GO:0061824; GO:0071539 centriole replication [GO:0007099]; cilium assembly [GO:0060271]; cytosolic ciliogenesis [GO:0061824]; protein localization to centrosome [GO:0071539] centriolar satellite [GO:0034451]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; microtubule organizing center [GO:0005815] 2 iron, 2 sulfur cluster binding [GO:0051537]; metal ion binding [GO:0046872] g19768.t1 P87362 54.725 455 3.14e-178 508.0 sp|P87362|BLMH_CHICK Bleomycin hydrolase OS=Gallus gallus OX=9031 GN=BLMH PE=1 SV=1 g19769.t1 Q63615 62.007 608 0.0 782.0 sp|Q63615|VP33A_RAT Vacuolar protein sorting-associated protein 33A OS=Rattus norvegicus OX=10116 GN=Vps33a PE=1 SV=1 VP33A_RAT reviewed Vacuolar protein sorting-associated protein 33A (r-vps33a) Rattus norvegicus (Rat) GO:0005764; GO:0005765; GO:0005769; GO:0005770; GO:0005776; GO:0006886; GO:0008333; GO:0016192; GO:0030123; GO:0030136; GO:0030220; GO:0030897; GO:0031902; GO:0032400; GO:0032418; GO:0033263; GO:0035751; GO:0043473; GO:0044877; GO:0048070; GO:0048471; GO:0071439; GO:0097352 autophagosome maturation [GO:0097352]; endosome to lysosome transport [GO:0008333]; intracellular protein transport [GO:0006886]; lysosome localization [GO:0032418]; melanosome localization [GO:0032400]; pigmentation [GO:0043473]; platelet formation [GO:0030220]; regulation of developmental pigmentation [GO:0048070]; regulation of lysosomal lumen pH [GO:0035751]; vesicle-mediated transport [GO:0016192] AP-3 adaptor complex [GO:0030123]; autophagosome [GO:0005776]; clathrin complex [GO:0071439]; clathrin-coated vesicle [GO:0030136]; CORVET complex [GO:0033263]; early endosome [GO:0005769]; HOPS complex [GO:0030897]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; perinuclear region of cytoplasm [GO:0048471] protein-containing complex binding [GO:0044877] g19770.t1 Q566L8 51.864 295 4.81e-100 300.0 sp|Q566L8|MAT2B_XENTR Methionine adenosyltransferase 2 subunit beta OS=Xenopus tropicalis OX=8364 GN=mat2b PE=2 SV=1 g19771.t1 Q07954 31.845 336 1.07e-37 147.0 sp|Q07954|LRP1_HUMAN Prolow-density lipoprotein receptor-related protein 1 OS=Homo sapiens OX=9606 GN=LRP1 PE=1 SV=2 LRP1_HUMAN reviewed Prolow-density lipoprotein receptor-related protein 1 (LRP-1) (Alpha-2-macroglobulin receptor) (A2MR) (Apolipoprotein E receptor) (APOER) (CD antigen CD91) [Cleaved into: Low-density lipoprotein receptor-related protein 1 85 kDa subunit (LRP-85); Low-density lipoprotein receptor-related protein 1 515 kDa subunit (LRP-515); Low-density lipoprotein receptor-related protein 1 intracellular domain (LRPICD)] Homo sapiens (Human) GO:0001523; GO:0001540; GO:0002265; GO:0003723; GO:0005041; GO:0005044; GO:0005509; GO:0005730; GO:0005765; GO:0005769; GO:0005815; GO:0005829; GO:0005886; GO:0005905; GO:0005925; GO:0006629; GO:0006898; GO:0006909; GO:0007041; GO:0007167; GO:0010629; GO:0010715; GO:0010875; GO:0014912; GO:0016020; GO:0016323; GO:0016964; GO:0030178; GO:0030226; GO:0030666; GO:0031623; GO:0032050; GO:0032370; GO:0032956; GO:0034185; GO:0035909; GO:0038023; GO:0038024; GO:0042953; GO:0043235; GO:0043277; GO:0043395; GO:0044877; GO:0045056; GO:0045807; GO:0060392; GO:0070325; GO:0097242; GO:0098797; GO:0150093; GO:0150094; GO:0150104; GO:1900223; GO:1903053; GO:1903064; GO:1903078; GO:1904300; GO:1904646; GO:1905167; GO:2000587 amyloid-beta clearance [GO:0097242]; amyloid-beta clearance by cellular catabolic process [GO:0150094]; amyloid-beta clearance by transcytosis [GO:0150093]; aorta morphogenesis [GO:0035909]; apoptotic cell clearance [GO:0043277]; astrocyte activation involved in immune response [GO:0002265]; cellular response to amyloid-beta [GO:1904646]; enzyme-linked receptor protein signaling pathway [GO:0007167]; lipid metabolic process [GO:0006629]; lipoprotein transport [GO:0042953]; lysosomal transport [GO:0007041]; negative regulation of gene expression [GO:0010629]; negative regulation of platelet-derived growth factor receptor-beta signaling pathway [GO:2000587]; negative regulation of SMAD protein signal transduction [GO:0060392]; negative regulation of smooth muscle cell migration [GO:0014912]; negative regulation of Wnt signaling pathway [GO:0030178]; phagocytosis [GO:0006909]; positive regulation of amyloid-beta clearance [GO:1900223]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of endocytosis [GO:0045807]; positive regulation of lipid transport [GO:0032370]; positive regulation of lysosomal protein catabolic process [GO:1905167]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of reverse cholesterol transport [GO:1903064]; positive regulation of transcytosis [GO:1904300]; receptor internalization [GO:0031623]; receptor-mediated endocytosis [GO:0006898]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of extracellular matrix disassembly [GO:0010715]; regulation of extracellular matrix organization [GO:1903053]; retinoid metabolic process [GO:0001523]; transcytosis [GO:0045056]; transport across blood-brain barrier [GO:0150104] basolateral plasma membrane [GO:0016323]; clathrin-coated pit [GO:0005905]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle membrane [GO:0030666]; focal adhesion [GO:0005925]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; plasma membrane protein complex [GO:0098797]; receptor complex [GO:0043235] alpha-2 macroglobulin receptor activity [GO:0016964]; amyloid-beta binding [GO:0001540]; apolipoprotein binding [GO:0034185]; apolipoprotein receptor activity [GO:0030226]; calcium ion binding [GO:0005509]; cargo receptor activity [GO:0038024]; clathrin heavy chain binding [GO:0032050]; heparan sulfate proteoglycan binding [GO:0043395]; lipoprotein particle receptor binding [GO:0070325]; low-density lipoprotein particle receptor activity [GO:0005041]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; scavenger receptor activity [GO:0005044]; signaling receptor activity [GO:0038023] g19771.t1 Q07954 29.697 330 3.85e-31 128.0 sp|Q07954|LRP1_HUMAN Prolow-density lipoprotein receptor-related protein 1 OS=Homo sapiens OX=9606 GN=LRP1 PE=1 SV=2 LRP1_HUMAN reviewed Prolow-density lipoprotein receptor-related protein 1 (LRP-1) (Alpha-2-macroglobulin receptor) (A2MR) (Apolipoprotein E receptor) (APOER) (CD antigen CD91) [Cleaved into: Low-density lipoprotein receptor-related protein 1 85 kDa subunit (LRP-85); Low-density lipoprotein receptor-related protein 1 515 kDa subunit (LRP-515); Low-density lipoprotein receptor-related protein 1 intracellular domain (LRPICD)] Homo sapiens (Human) GO:0001523; GO:0001540; GO:0002265; GO:0003723; GO:0005041; GO:0005044; GO:0005509; GO:0005730; GO:0005765; GO:0005769; GO:0005815; GO:0005829; GO:0005886; GO:0005905; GO:0005925; GO:0006629; GO:0006898; GO:0006909; GO:0007041; GO:0007167; GO:0010629; GO:0010715; GO:0010875; GO:0014912; GO:0016020; GO:0016323; GO:0016964; GO:0030178; GO:0030226; GO:0030666; GO:0031623; GO:0032050; GO:0032370; GO:0032956; GO:0034185; GO:0035909; GO:0038023; GO:0038024; GO:0042953; GO:0043235; GO:0043277; GO:0043395; GO:0044877; GO:0045056; GO:0045807; GO:0060392; GO:0070325; GO:0097242; GO:0098797; GO:0150093; GO:0150094; GO:0150104; GO:1900223; GO:1903053; GO:1903064; GO:1903078; GO:1904300; GO:1904646; GO:1905167; GO:2000587 amyloid-beta clearance [GO:0097242]; amyloid-beta clearance by cellular catabolic process [GO:0150094]; amyloid-beta clearance by transcytosis [GO:0150093]; aorta morphogenesis [GO:0035909]; apoptotic cell clearance [GO:0043277]; astrocyte activation involved in immune response [GO:0002265]; cellular response to amyloid-beta [GO:1904646]; enzyme-linked receptor protein signaling pathway [GO:0007167]; lipid metabolic process [GO:0006629]; lipoprotein transport [GO:0042953]; lysosomal transport [GO:0007041]; negative regulation of gene expression [GO:0010629]; negative regulation of platelet-derived growth factor receptor-beta signaling pathway [GO:2000587]; negative regulation of SMAD protein signal transduction [GO:0060392]; negative regulation of smooth muscle cell migration [GO:0014912]; negative regulation of Wnt signaling pathway [GO:0030178]; phagocytosis [GO:0006909]; positive regulation of amyloid-beta clearance [GO:1900223]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of endocytosis [GO:0045807]; positive regulation of lipid transport [GO:0032370]; positive regulation of lysosomal protein catabolic process [GO:1905167]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of reverse cholesterol transport [GO:1903064]; positive regulation of transcytosis [GO:1904300]; receptor internalization [GO:0031623]; receptor-mediated endocytosis [GO:0006898]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of extracellular matrix disassembly [GO:0010715]; regulation of extracellular matrix organization [GO:1903053]; retinoid metabolic process [GO:0001523]; transcytosis [GO:0045056]; transport across blood-brain barrier [GO:0150104] basolateral plasma membrane [GO:0016323]; clathrin-coated pit [GO:0005905]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle membrane [GO:0030666]; focal adhesion [GO:0005925]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; plasma membrane protein complex [GO:0098797]; receptor complex [GO:0043235] alpha-2 macroglobulin receptor activity [GO:0016964]; amyloid-beta binding [GO:0001540]; apolipoprotein binding [GO:0034185]; apolipoprotein receptor activity [GO:0030226]; calcium ion binding [GO:0005509]; cargo receptor activity [GO:0038024]; clathrin heavy chain binding [GO:0032050]; heparan sulfate proteoglycan binding [GO:0043395]; lipoprotein particle receptor binding [GO:0070325]; low-density lipoprotein particle receptor activity [GO:0005041]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; scavenger receptor activity [GO:0005044]; signaling receptor activity [GO:0038023] g19771.t1 Q07954 29.653 317 1.37e-24 108.0 sp|Q07954|LRP1_HUMAN Prolow-density lipoprotein receptor-related protein 1 OS=Homo sapiens OX=9606 GN=LRP1 PE=1 SV=2 LRP1_HUMAN reviewed Prolow-density lipoprotein receptor-related protein 1 (LRP-1) (Alpha-2-macroglobulin receptor) (A2MR) (Apolipoprotein E receptor) (APOER) (CD antigen CD91) [Cleaved into: Low-density lipoprotein receptor-related protein 1 85 kDa subunit (LRP-85); Low-density lipoprotein receptor-related protein 1 515 kDa subunit (LRP-515); Low-density lipoprotein receptor-related protein 1 intracellular domain (LRPICD)] Homo sapiens (Human) GO:0001523; GO:0001540; GO:0002265; GO:0003723; GO:0005041; GO:0005044; GO:0005509; GO:0005730; GO:0005765; GO:0005769; GO:0005815; GO:0005829; GO:0005886; GO:0005905; GO:0005925; GO:0006629; GO:0006898; GO:0006909; GO:0007041; GO:0007167; GO:0010629; GO:0010715; GO:0010875; GO:0014912; GO:0016020; GO:0016323; GO:0016964; GO:0030178; GO:0030226; GO:0030666; GO:0031623; GO:0032050; GO:0032370; GO:0032956; GO:0034185; GO:0035909; GO:0038023; GO:0038024; GO:0042953; GO:0043235; GO:0043277; GO:0043395; GO:0044877; GO:0045056; GO:0045807; GO:0060392; GO:0070325; GO:0097242; GO:0098797; GO:0150093; GO:0150094; GO:0150104; GO:1900223; GO:1903053; GO:1903064; GO:1903078; GO:1904300; GO:1904646; GO:1905167; GO:2000587 amyloid-beta clearance [GO:0097242]; amyloid-beta clearance by cellular catabolic process [GO:0150094]; amyloid-beta clearance by transcytosis [GO:0150093]; aorta morphogenesis [GO:0035909]; apoptotic cell clearance [GO:0043277]; astrocyte activation involved in immune response [GO:0002265]; cellular response to amyloid-beta [GO:1904646]; enzyme-linked receptor protein signaling pathway [GO:0007167]; lipid metabolic process [GO:0006629]; lipoprotein transport [GO:0042953]; lysosomal transport [GO:0007041]; negative regulation of gene expression [GO:0010629]; negative regulation of platelet-derived growth factor receptor-beta signaling pathway [GO:2000587]; negative regulation of SMAD protein signal transduction [GO:0060392]; negative regulation of smooth muscle cell migration [GO:0014912]; negative regulation of Wnt signaling pathway [GO:0030178]; phagocytosis [GO:0006909]; positive regulation of amyloid-beta clearance [GO:1900223]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of endocytosis [GO:0045807]; positive regulation of lipid transport [GO:0032370]; positive regulation of lysosomal protein catabolic process [GO:1905167]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of reverse cholesterol transport [GO:1903064]; positive regulation of transcytosis [GO:1904300]; receptor internalization [GO:0031623]; receptor-mediated endocytosis [GO:0006898]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of extracellular matrix disassembly [GO:0010715]; regulation of extracellular matrix organization [GO:1903053]; retinoid metabolic process [GO:0001523]; transcytosis [GO:0045056]; transport across blood-brain barrier [GO:0150104] basolateral plasma membrane [GO:0016323]; clathrin-coated pit [GO:0005905]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle membrane [GO:0030666]; focal adhesion [GO:0005925]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; plasma membrane protein complex [GO:0098797]; receptor complex [GO:0043235] alpha-2 macroglobulin receptor activity [GO:0016964]; amyloid-beta binding [GO:0001540]; apolipoprotein binding [GO:0034185]; apolipoprotein receptor activity [GO:0030226]; calcium ion binding [GO:0005509]; cargo receptor activity [GO:0038024]; clathrin heavy chain binding [GO:0032050]; heparan sulfate proteoglycan binding [GO:0043395]; lipoprotein particle receptor binding [GO:0070325]; low-density lipoprotein particle receptor activity [GO:0005041]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; scavenger receptor activity [GO:0005044]; signaling receptor activity [GO:0038023] g19772.t1 P21783 33.333 276 6.04e-26 122.0 sp|P21783|NOTC1_XENLA Neurogenic locus notch homolog protein 1 OS=Xenopus laevis OX=8355 GN=notch1 PE=1 SV=3 g19772.t1 P21783 34.783 230 2.08e-22 110.0 sp|P21783|NOTC1_XENLA Neurogenic locus notch homolog protein 1 OS=Xenopus laevis OX=8355 GN=notch1 PE=1 SV=3 g19772.t1 P21783 29.252 294 4.55e-22 109.0 sp|P21783|NOTC1_XENLA Neurogenic locus notch homolog protein 1 OS=Xenopus laevis OX=8355 GN=notch1 PE=1 SV=3 g19772.t1 P21783 29.831 295 7.34e-22 108.0 sp|P21783|NOTC1_XENLA Neurogenic locus notch homolog protein 1 OS=Xenopus laevis OX=8355 GN=notch1 PE=1 SV=3 g19772.t1 P21783 31.111 270 1.54e-21 107.0 sp|P21783|NOTC1_XENLA Neurogenic locus notch homolog protein 1 OS=Xenopus laevis OX=8355 GN=notch1 PE=1 SV=3 g19772.t1 P21783 31.494 308 4.040000000000001e-21 106.0 sp|P21783|NOTC1_XENLA Neurogenic locus notch homolog protein 1 OS=Xenopus laevis OX=8355 GN=notch1 PE=1 SV=3 g19775.t1 Q6PCL0 65.0 320 2.2799999999999998e-128 397.0 sp|Q6PCL0|TBX2B_XENLA T-box transcription factor TBX2-B OS=Xenopus laevis OX=8355 GN=tbx2-b PE=2 SV=2 g19775.t2 Q13207 60.345 348 4.34e-130 402.0 sp|Q13207|TBX2_HUMAN T-box transcription factor TBX2 OS=Homo sapiens OX=9606 GN=TBX2 PE=1 SV=3 TBX2_HUMAN reviewed T-box transcription factor TBX2 (T-box protein 2) Homo sapiens (Human) GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0001227; GO:0001708; GO:0001947; GO:0003148; GO:0003151; GO:0003203; GO:0003272; GO:0003677; GO:0005634; GO:0005654; GO:0005667; GO:0005737; GO:0006357; GO:0006915; GO:0007219; GO:0007521; GO:0008016; GO:0008543; GO:0022008; GO:0032526; GO:0035050; GO:0035909; GO:0036302; GO:0042733; GO:0042826; GO:0043474; GO:0043565; GO:0045892; GO:0045944; GO:0048596; GO:0048738; GO:0051145; GO:0060021; GO:0060037; GO:0060045; GO:0060379; GO:0060441; GO:0060560; GO:0060596; GO:0060916; GO:0071549; GO:0072105; GO:0090103; GO:0090398; GO:0097325; GO:0140297; GO:1901208; GO:1901211; GO:1902808; GO:1905072; GO:1905222; GO:1990837; GO:2000773 aorta morphogenesis [GO:0035909]; apoptotic process [GO:0006915]; atrioventricular canal development [GO:0036302]; atrioventricular canal morphogenesis [GO:1905222]; cardiac jelly development [GO:1905072]; cardiac muscle cell myoblast differentiation [GO:0060379]; cardiac muscle tissue development [GO:0048738]; cell fate specification [GO:0001708]; cellular response to dexamethasone stimulus [GO:0071549]; cellular senescence [GO:0090398]; cochlea morphogenesis [GO:0090103]; developmental growth involved in morphogenesis [GO:0060560]; embryonic camera-type eye morphogenesis [GO:0048596]; embryonic digit morphogenesis [GO:0042733]; embryonic heart tube development [GO:0035050]; endocardial cushion formation [GO:0003272]; endocardial cushion morphogenesis [GO:0003203]; epithelial tube branching involved in lung morphogenesis [GO:0060441]; fibroblast growth factor receptor signaling pathway [GO:0008543]; heart looping [GO:0001947]; mammary placode formation [GO:0060596]; melanocyte proliferation [GO:0097325]; mesenchymal cell proliferation involved in lung development [GO:0060916]; muscle cell fate determination [GO:0007521]; negative regulation of cardiac chamber formation [GO:1901211]; negative regulation of cellular senescence [GO:2000773]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of heart looping [GO:1901208]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neurogenesis [GO:0022008]; Notch signaling pathway [GO:0007219]; outflow tract morphogenesis [GO:0003151]; outflow tract septum morphogenesis [GO:0003148]; pharyngeal system development [GO:0060037]; pigment metabolic process involved in pigmentation [GO:0043474]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell cycle G1/S phase transition [GO:1902808]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of heart contraction [GO:0008016]; regulation of transcription by RNA polymerase II [GO:0006357]; response to retinoic acid [GO:0032526]; roof of mouth development [GO:0060021]; smooth muscle cell differentiation [GO:0051145]; ureteric peristalsis [GO:0072105] chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667] DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription factor binding [GO:0140297]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; histone deacetylase binding [GO:0042826]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837] g19779.t1 A0A8J1M587 62.857 140 1.13e-48 174.0 sp|A0A8J1M587|FANCJ_XENLA Fanconi anemia group J protein homolog OS=Xenopus laevis OX=8355 GN=brip1.L PE=3 SV=2 FANCJ_XENLA reviewed Fanconi anemia group J protein homolog (EC 5.6.2.3) (BRCA1-interacting protein C-terminal helicase homolog 1.L) (BRCA1-interacting protein homolog 1.L) (DNA 5'-3' helicase FANCJ) Xenopus laevis (African clawed frog) GO:0003677; GO:0005524; GO:0005634; GO:0006289; GO:0016818; GO:0043139; GO:0046872; GO:0051539; GO:0106300; GO:1990918 double-strand break repair involved in meiotic recombination [GO:1990918]; nucleotide-excision repair [GO:0006289]; protein-DNA covalent cross-linking repair [GO:0106300] nucleus [GO:0005634] 4 iron, 4 sulfur cluster binding [GO:0051539]; 5'-3' DNA helicase activity [GO:0043139]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides [GO:0016818]; metal ion binding [GO:0046872] g19780.t1 A0A8J1M587 47.327 505 4.62e-152 477.0 sp|A0A8J1M587|FANCJ_XENLA Fanconi anemia group J protein homolog OS=Xenopus laevis OX=8355 GN=brip1.L PE=3 SV=2 FANCJ_XENLA reviewed Fanconi anemia group J protein homolog (EC 5.6.2.3) (BRCA1-interacting protein C-terminal helicase homolog 1.L) (BRCA1-interacting protein homolog 1.L) (DNA 5'-3' helicase FANCJ) Xenopus laevis (African clawed frog) GO:0003677; GO:0005524; GO:0005634; GO:0006289; GO:0016818; GO:0043139; GO:0046872; GO:0051539; GO:0106300; GO:1990918 double-strand break repair involved in meiotic recombination [GO:1990918]; nucleotide-excision repair [GO:0006289]; protein-DNA covalent cross-linking repair [GO:0106300] nucleus [GO:0005634] 4 iron, 4 sulfur cluster binding [GO:0051539]; 5'-3' DNA helicase activity [GO:0043139]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides [GO:0016818]; metal ion binding [GO:0046872] g19781.t1 Q9VUL9 42.771 166 4.23e-30 125.0 sp|Q9VUL9|FUCTA_DROME Glycoprotein 3-alpha-L-fucosyltransferase A OS=Drosophila melanogaster OX=7227 GN=FucTA PE=1 SV=2 FUCTA_DROME reviewed Glycoprotein 3-alpha-L-fucosyltransferase A (EC 2.4.1.214) (Core alpha-(1,3)-fucosyltransferase) Drosophila melanogaster (Fruit fly) GO:0005797; GO:0006491; GO:0007399; GO:0018279; GO:0018392; GO:0032580; GO:0046920 N-glycan processing [GO:0006491]; nervous system development [GO:0007399]; protein N-linked glycosylation via asparagine [GO:0018279] Golgi cisterna membrane [GO:0032580]; Golgi medial cisterna [GO:0005797] alpha-(1->3)-fucosyltransferase activity [GO:0046920]; glycoprotein 3-alpha-L-fucosyltransferase activity [GO:0018392] g19782.t1 Q4QQT0 43.793 290 1.43e-76 247.0 sp|Q4QQT0|RUSD4_RAT Pseudouridylate synthase RPUSD4, mitochondrial OS=Rattus norvegicus OX=10116 GN=Rpusd4 PE=2 SV=1 RUSD4_RAT reviewed Pseudouridylate synthase RPUSD4, mitochondrial (EC 5.4.99.-) (RNA pseudouridylate synthase domain-containing protein 4) Rattus norvegicus (Rat) GO:0000049; GO:0005654; GO:0005739; GO:0005759; GO:0006397; GO:0008380; GO:0009982; GO:0031118; GO:0035770; GO:0070131; GO:0070902; GO:0106029; GO:1990400; GO:1990481 mitochondrial tRNA pseudouridine synthesis [GO:0070902]; mRNA processing [GO:0006397]; mRNA pseudouridine synthesis [GO:1990481]; positive regulation of mitochondrial translation [GO:0070131]; RNA splicing [GO:0008380]; rRNA pseudouridine synthesis [GO:0031118] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; ribonucleoprotein granule [GO:0035770] mitochondrial ribosomal large subunit rRNA binding [GO:1990400]; pseudouridine synthase activity [GO:0009982]; tRNA binding [GO:0000049]; tRNA pseudouridine synthase activity [GO:0106029] g19783.t1 P53667 49.139 639 0.0 590.0 sp|P53667|LIMK1_HUMAN LIM domain kinase 1 OS=Homo sapiens OX=9606 GN=LIMK1 PE=1 SV=3 LIMK1_HUMAN reviewed LIM domain kinase 1 (LIMK-1) (EC 2.7.11.1) Homo sapiens (Human) GO:0001673; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005856; GO:0005925; GO:0006468; GO:0007165; GO:0007266; GO:0007399; GO:0016020; GO:0016607; GO:0030027; GO:0030036; GO:0031072; GO:0031625; GO:0032233; GO:0038096; GO:0043005; GO:0043149; GO:0045773; GO:0046872; GO:0048675; GO:0051496; GO:0098794; GO:0098978; GO:0106310; GO:1990948 actin cytoskeleton organization [GO:0030036]; axon extension [GO:0048675]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; nervous system development [GO:0007399]; positive regulation of actin filament bundle assembly [GO:0032233]; positive regulation of axon extension [GO:0045773]; positive regulation of stress fiber assembly [GO:0051496]; protein phosphorylation [GO:0006468]; Rho protein signal transduction [GO:0007266]; signal transduction [GO:0007165]; stress fiber assembly [GO:0043149] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; lamellipodium [GO:0030027]; male germ cell nucleus [GO:0001673]; membrane [GO:0016020]; neuron projection [GO:0043005]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; postsynapse [GO:0098794] ATP binding [GO:0005524]; heat shock protein binding [GO:0031072]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; ubiquitin ligase inhibitor activity [GO:1990948]; ubiquitin protein ligase binding [GO:0031625] g19784.t1 Q9NZ52 74.074 54 6.03e-23 93.6 sp|Q9NZ52|GGA3_HUMAN ADP-ribosylation factor-binding protein GGA3 OS=Homo sapiens OX=9606 GN=GGA3 PE=1 SV=1 g19788.t1 Q96DM1 30.751 426 2.43e-51 187.0 sp|Q96DM1|PGBD4_HUMAN PiggyBac transposable element-derived protein 4 OS=Homo sapiens OX=9606 GN=PGBD4 PE=1 SV=3 g19790.t1 P43690 82.74 365 0.0 562.0 sp|P43690|DRG1_XENLA Developmentally-regulated GTP-binding protein 1 OS=Xenopus laevis OX=8355 GN=drg1 PE=1 SV=1 g19793.t1 Q9JLT4 60.75 507 0.0 650.0 sp|Q9JLT4|TRXR2_MOUSE Thioredoxin reductase 2, mitochondrial OS=Mus musculus OX=10090 GN=Txnrd2 PE=1 SV=4 g19794.t1 Q6ZQM0 41.899 358 8.300000000000001e-72 234.0 sp|Q6ZQM0|RFFL_MOUSE E3 ubiquitin-protein ligase rififylin OS=Mus musculus OX=10090 GN=Rffl PE=1 SV=1 g19795.t1 Q28FE2 74.775 111 5.7699999999999996e-61 188.0 sp|Q28FE2|MED31_XENTR Mediator of RNA polymerase II transcription subunit 31 OS=Xenopus tropicalis OX=8364 GN=med31 PE=2 SV=2 g19796.t1 Q5ZKU4 50.746 1206 0.0 1092.0 sp|Q5ZKU4|INT2_CHICK Integrator complex subunit 2 OS=Gallus gallus OX=9031 GN=INTS2 PE=2 SV=1 g19798.t1 Q95LU3 36.957 230 2.0800000000000002e-31 130.0 sp|Q95LU3|FBCD1_MACFA Fibrinogen C domain-containing protein 1 OS=Macaca fascicularis OX=9541 GN=FIBCD1 PE=2 SV=1 g19800.t1 Q8IY37 59.572 935 0.0 1108.0 sp|Q8IY37|DHX37_HUMAN Probable ATP-dependent RNA helicase DHX37 OS=Homo sapiens OX=9606 GN=DHX37 PE=1 SV=1 DHX37_HUMAN reviewed Probable ATP-dependent RNA helicase DHX37 (EC 3.6.4.13) (DEAH box protein 37) Homo sapiens (Human) GO:0000462; GO:0003723; GO:0003724; GO:0004386; GO:0005524; GO:0005654; GO:0005730; GO:0005737; GO:0007420; GO:0016887; GO:0031965; GO:0032040; GO:0034511; GO:0042254; GO:0042255; GO:0042274; GO:2000020 brain development [GO:0007420]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; positive regulation of male gonad development [GO:2000020]; ribosomal small subunit biogenesis [GO:0042274]; ribosome assembly [GO:0042255]; ribosome biogenesis [GO:0042254] cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; small-subunit processome [GO:0032040] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; helicase activity [GO:0004386]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; U3 snoRNA binding [GO:0034511] g19801.t1 Q5R5J4 65.043 821 0.0 1054.0 sp|Q5R5J4|VPS53_PONAB Vacuolar protein sorting-associated protein 53 homolog OS=Pongo abelii OX=9601 GN=VPS53 PE=2 SV=2 g19801.t2 Q5R5J4 66.135 815 0.0 1071.0 sp|Q5R5J4|VPS53_PONAB Vacuolar protein sorting-associated protein 53 homolog OS=Pongo abelii OX=9601 GN=VPS53 PE=2 SV=2 g19802.t1 Q9Y2E6 57.561 205 2.05e-76 258.0 sp|Q9Y2E6|DTX4_HUMAN E3 ubiquitin-protein ligase DTX4 OS=Homo sapiens OX=9606 GN=DTX4 PE=1 SV=2 DTX4_HUMAN reviewed E3 ubiquitin-protein ligase DTX4 (EC 2.3.2.27) (Protein deltex-4) (Deltex4) (RING finger protein 155) (RING-type E3 ubiquitin transferase DTX4) Homo sapiens (Human) GO:0004842; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0007219; GO:0008270; GO:0010498; GO:0016567; GO:0032479; GO:0043161; GO:0045824; GO:0061630; GO:0070936 negative regulation of innate immune response [GO:0045824]; Notch signaling pathway [GO:0007219]; proteasomal protein catabolic process [GO:0010498]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K48-linked ubiquitination [GO:0070936]; protein ubiquitination [GO:0016567]; regulation of type I interferon production [GO:0032479] centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654] ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] g19802.t1 Q9Y2E6 37.241 145 7.28e-24 109.0 sp|Q9Y2E6|DTX4_HUMAN E3 ubiquitin-protein ligase DTX4 OS=Homo sapiens OX=9606 GN=DTX4 PE=1 SV=2 DTX4_HUMAN reviewed E3 ubiquitin-protein ligase DTX4 (EC 2.3.2.27) (Protein deltex-4) (Deltex4) (RING finger protein 155) (RING-type E3 ubiquitin transferase DTX4) Homo sapiens (Human) GO:0004842; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0007219; GO:0008270; GO:0010498; GO:0016567; GO:0032479; GO:0043161; GO:0045824; GO:0061630; GO:0070936 negative regulation of innate immune response [GO:0045824]; Notch signaling pathway [GO:0007219]; proteasomal protein catabolic process [GO:0010498]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K48-linked ubiquitination [GO:0070936]; protein ubiquitination [GO:0016567]; regulation of type I interferon production [GO:0032479] centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654] ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] g19802.t2 Q9Y2E6 54.772 241 3.86e-80 268.0 sp|Q9Y2E6|DTX4_HUMAN E3 ubiquitin-protein ligase DTX4 OS=Homo sapiens OX=9606 GN=DTX4 PE=1 SV=2 DTX4_HUMAN reviewed E3 ubiquitin-protein ligase DTX4 (EC 2.3.2.27) (Protein deltex-4) (Deltex4) (RING finger protein 155) (RING-type E3 ubiquitin transferase DTX4) Homo sapiens (Human) GO:0004842; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0007219; GO:0008270; GO:0010498; GO:0016567; GO:0032479; GO:0043161; GO:0045824; GO:0061630; GO:0070936 negative regulation of innate immune response [GO:0045824]; Notch signaling pathway [GO:0007219]; proteasomal protein catabolic process [GO:0010498]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K48-linked ubiquitination [GO:0070936]; protein ubiquitination [GO:0016567]; regulation of type I interferon production [GO:0032479] centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654] ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] g19802.t2 Q9Y2E6 37.241 145 5.95e-24 110.0 sp|Q9Y2E6|DTX4_HUMAN E3 ubiquitin-protein ligase DTX4 OS=Homo sapiens OX=9606 GN=DTX4 PE=1 SV=2 DTX4_HUMAN reviewed E3 ubiquitin-protein ligase DTX4 (EC 2.3.2.27) (Protein deltex-4) (Deltex4) (RING finger protein 155) (RING-type E3 ubiquitin transferase DTX4) Homo sapiens (Human) GO:0004842; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0007219; GO:0008270; GO:0010498; GO:0016567; GO:0032479; GO:0043161; GO:0045824; GO:0061630; GO:0070936 negative regulation of innate immune response [GO:0045824]; Notch signaling pathway [GO:0007219]; proteasomal protein catabolic process [GO:0010498]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K48-linked ubiquitination [GO:0070936]; protein ubiquitination [GO:0016567]; regulation of type I interferon production [GO:0032479] centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654] ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] g19803.t1 Q8IVF4 67.029 4325 0.0 5732.0 sp|Q8IVF4|DYH10_HUMAN Dynein axonemal heavy chain 10 OS=Homo sapiens OX=9606 GN=DNAH10 PE=1 SV=4 DYH10_HUMAN reviewed Dynein axonemal heavy chain 10 (Axonemal beta dynein heavy chain 10) (Ciliary dynein heavy chain 10) Homo sapiens (Human) GO:0005524; GO:0005858; GO:0005874; GO:0008017; GO:0008569; GO:0030286; GO:0045505; GO:0051959; GO:0060294; GO:0097729 cilium movement involved in cell motility [GO:0060294] 9+2 motile cilium [GO:0097729]; axonemal dynein complex [GO:0005858]; dynein complex [GO:0030286]; microtubule [GO:0005874] ATP binding [GO:0005524]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; microtubule binding [GO:0008017]; minus-end-directed microtubule motor activity [GO:0008569] g19804.t1 Q8IVF4 59.434 106 5.52e-34 125.0 sp|Q8IVF4|DYH10_HUMAN Dynein axonemal heavy chain 10 OS=Homo sapiens OX=9606 GN=DNAH10 PE=1 SV=4 DYH10_HUMAN reviewed Dynein axonemal heavy chain 10 (Axonemal beta dynein heavy chain 10) (Ciliary dynein heavy chain 10) Homo sapiens (Human) GO:0005524; GO:0005858; GO:0005874; GO:0008017; GO:0008569; GO:0030286; GO:0045505; GO:0051959; GO:0060294; GO:0097729 cilium movement involved in cell motility [GO:0060294] 9+2 motile cilium [GO:0097729]; axonemal dynein complex [GO:0005858]; dynein complex [GO:0030286]; microtubule [GO:0005874] ATP binding [GO:0005524]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; microtubule binding [GO:0008017]; minus-end-directed microtubule motor activity [GO:0008569] g19805.t1 O88854 25.157 318 1.96e-24 106.0 sp|O88854|GALR2_MOUSE Galanin receptor type 2 OS=Mus musculus OX=10090 GN=Galr2 PE=2 SV=2 g19806.t1 Q32LM4 26.562 448 1.0299999999999999e-30 127.0 sp|Q32LM4|FBX39_BOVIN F-box only protein 39 OS=Bos taurus OX=9913 GN=FBXO39 PE=2 SV=1 g19807.t1 Q9VUL9 45.763 118 1.25e-30 118.0 sp|Q9VUL9|FUCTA_DROME Glycoprotein 3-alpha-L-fucosyltransferase A OS=Drosophila melanogaster OX=7227 GN=FucTA PE=1 SV=2 FUCTA_DROME reviewed Glycoprotein 3-alpha-L-fucosyltransferase A (EC 2.4.1.214) (Core alpha-(1,3)-fucosyltransferase) Drosophila melanogaster (Fruit fly) GO:0005797; GO:0006491; GO:0007399; GO:0018279; GO:0018392; GO:0032580; GO:0046920 N-glycan processing [GO:0006491]; nervous system development [GO:0007399]; protein N-linked glycosylation via asparagine [GO:0018279] Golgi cisterna membrane [GO:0032580]; Golgi medial cisterna [GO:0005797] alpha-(1->3)-fucosyltransferase activity [GO:0046920]; glycoprotein 3-alpha-L-fucosyltransferase activity [GO:0018392] g19809.t1 P50135 26.452 310 5.56e-22 98.6 sp|P50135|HNMT_HUMAN Histamine N-methyltransferase OS=Homo sapiens OX=9606 GN=HNMT PE=1 SV=1 HNMT_HUMAN reviewed Histamine N-methyltransferase (HMT) (EC 2.1.1.8) Homo sapiens (Human) GO:0001692; GO:0001695; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0006548; GO:0007268; GO:0007585; GO:0032259; GO:0045202; GO:0046539; GO:0070062 chemical synaptic transmission [GO:0007268]; histamine catabolic process [GO:0001695]; histamine metabolic process [GO:0001692]; L-histidine catabolic process [GO:0006548]; methylation [GO:0032259]; respiratory gaseous exchange by respiratory system [GO:0007585] centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; synapse [GO:0045202] histamine N-methyltransferase activity [GO:0046539] g19812.t1 Q9DB30 49.66 294 1.07e-96 293.0 sp|Q9DB30|PHKG2_MOUSE Phosphorylase b kinase gamma catalytic chain, liver/testis isoform OS=Mus musculus OX=10090 GN=Phkg2 PE=2 SV=2 PHKG2_MOUSE reviewed Phosphorylase b kinase gamma catalytic chain, liver/testis isoform (PHK-gamma-LT) (PHK-gamma-T) (EC 2.7.11.19) (Phosphorylase kinase subunit gamma-2) Mus musculus (Mouse) GO:0004689; GO:0005516; GO:0005524; GO:0005737; GO:0005829; GO:0005964; GO:0005977; GO:0005980; GO:0007165; GO:0019899; GO:0045819 glycogen catabolic process [GO:0005980]; glycogen metabolic process [GO:0005977]; positive regulation of glycogen catabolic process [GO:0045819]; signal transduction [GO:0007165] cytoplasm [GO:0005737]; cytosol [GO:0005829]; phosphorylase kinase complex [GO:0005964] ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; phosphorylase kinase activity [GO:0004689] g19813.t1 Q9UH36 47.594 187 1.1e-50 177.0 sp|Q9UH36|SRR1L_HUMAN SRR1-like protein OS=Homo sapiens OX=9606 GN=SRRD PE=1 SV=1 g19814.t1 P80928 45.217 115 6.05e-33 114.0 sp|P80928|MIF_PIG Macrophage migration inhibitory factor OS=Sus scrofa OX=9823 GN=MIF PE=1 SV=3 g19817.t1 Q7ZT72 40.86 186 2.58e-29 112.0 sp|Q7ZT72|FCN1B_XENLA Ficolin-1-B OS=Xenopus laevis OX=8355 GN=fcn1-b PE=2 SV=1 FCN1B_XENLA reviewed Ficolin-1-B Xenopus laevis (African clawed frog) GO:0001867; GO:0003823; GO:0005102; GO:0005581; GO:0005615; GO:0030246; GO:0033691; GO:0038187; GO:0046872; GO:0097367; GO:0106139 complement activation, lectin pathway [GO:0001867] collagen trimer [GO:0005581]; extracellular space [GO:0005615]; symbiont cell surface [GO:0106139] antigen binding [GO:0003823]; carbohydrate binding [GO:0030246]; carbohydrate derivative binding [GO:0097367]; metal ion binding [GO:0046872]; pattern recognition receptor activity [GO:0038187]; sialic acid binding [GO:0033691]; signaling receptor binding [GO:0005102] g19819.t1 O75636 42.784 194 4.2200000000000006e-37 133.0 sp|O75636|FCN3_HUMAN Ficolin-3 OS=Homo sapiens OX=9606 GN=FCN3 PE=1 SV=2 FCN3_HUMAN reviewed Ficolin-3 (Collagen/fibrinogen domain-containing lectin 3 p35) (Collagen/fibrinogen domain-containing protein 3) (H-ficolin) (Hakata antigen) Homo sapiens (Human) GO:0001867; GO:0002752; GO:0003823; GO:0005102; GO:0005576; GO:0005581; GO:0005615; GO:0006508; GO:0006956; GO:0009897; GO:0030246; GO:0038187; GO:0043654; GO:0046597; GO:0046872; GO:0051607; GO:0072562; GO:0097367; GO:0106139; GO:1902679; GO:1903028; GO:1905370 cell surface pattern recognition receptor signaling pathway [GO:0002752]; complement activation [GO:0006956]; complement activation, lectin pathway [GO:0001867]; defense response to virus [GO:0051607]; host-mediated suppression of symbiont invasion [GO:0046597]; negative regulation of RNA biosynthetic process [GO:1902679]; positive regulation of opsonization [GO:1903028]; proteolysis [GO:0006508]; recognition of apoptotic cell [GO:0043654] blood microparticle [GO:0072562]; collagen trimer [GO:0005581]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; serine-type endopeptidase complex [GO:1905370]; symbiont cell surface [GO:0106139] antigen binding [GO:0003823]; carbohydrate binding [GO:0030246]; carbohydrate derivative binding [GO:0097367]; metal ion binding [GO:0046872]; pattern recognition receptor activity [GO:0038187]; signaling receptor binding [GO:0005102] g19820.t1 O75636 42.174 230 1.28e-41 152.0 sp|O75636|FCN3_HUMAN Ficolin-3 OS=Homo sapiens OX=9606 GN=FCN3 PE=1 SV=2 FCN3_HUMAN reviewed Ficolin-3 (Collagen/fibrinogen domain-containing lectin 3 p35) (Collagen/fibrinogen domain-containing protein 3) (H-ficolin) (Hakata antigen) Homo sapiens (Human) GO:0001867; GO:0002752; GO:0003823; GO:0005102; GO:0005576; GO:0005581; GO:0005615; GO:0006508; GO:0006956; GO:0009897; GO:0030246; GO:0038187; GO:0043654; GO:0046597; GO:0046872; GO:0051607; GO:0072562; GO:0097367; GO:0106139; GO:1902679; GO:1903028; GO:1905370 cell surface pattern recognition receptor signaling pathway [GO:0002752]; complement activation [GO:0006956]; complement activation, lectin pathway [GO:0001867]; defense response to virus [GO:0051607]; host-mediated suppression of symbiont invasion [GO:0046597]; negative regulation of RNA biosynthetic process [GO:1902679]; positive regulation of opsonization [GO:1903028]; proteolysis [GO:0006508]; recognition of apoptotic cell [GO:0043654] blood microparticle [GO:0072562]; collagen trimer [GO:0005581]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; serine-type endopeptidase complex [GO:1905370]; symbiont cell surface [GO:0106139] antigen binding [GO:0003823]; carbohydrate binding [GO:0030246]; carbohydrate derivative binding [GO:0097367]; metal ion binding [GO:0046872]; pattern recognition receptor activity [GO:0038187]; signaling receptor binding [GO:0005102] g19821.t1 O75636 41.41 227 6.21e-39 143.0 sp|O75636|FCN3_HUMAN Ficolin-3 OS=Homo sapiens OX=9606 GN=FCN3 PE=1 SV=2 FCN3_HUMAN reviewed Ficolin-3 (Collagen/fibrinogen domain-containing lectin 3 p35) (Collagen/fibrinogen domain-containing protein 3) (H-ficolin) (Hakata antigen) Homo sapiens (Human) GO:0001867; GO:0002752; GO:0003823; GO:0005102; GO:0005576; GO:0005581; GO:0005615; GO:0006508; GO:0006956; GO:0009897; GO:0030246; GO:0038187; GO:0043654; GO:0046597; GO:0046872; GO:0051607; GO:0072562; GO:0097367; GO:0106139; GO:1902679; GO:1903028; GO:1905370 cell surface pattern recognition receptor signaling pathway [GO:0002752]; complement activation [GO:0006956]; complement activation, lectin pathway [GO:0001867]; defense response to virus [GO:0051607]; host-mediated suppression of symbiont invasion [GO:0046597]; negative regulation of RNA biosynthetic process [GO:1902679]; positive regulation of opsonization [GO:1903028]; proteolysis [GO:0006508]; recognition of apoptotic cell [GO:0043654] blood microparticle [GO:0072562]; collagen trimer [GO:0005581]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; serine-type endopeptidase complex [GO:1905370]; symbiont cell surface [GO:0106139] antigen binding [GO:0003823]; carbohydrate binding [GO:0030246]; carbohydrate derivative binding [GO:0097367]; metal ion binding [GO:0046872]; pattern recognition receptor activity [GO:0038187]; signaling receptor binding [GO:0005102] g19822.t1 Q9H790 33.036 336 1.38e-50 178.0 sp|Q9H790|EXO5_HUMAN Exonuclease V OS=Homo sapiens OX=9606 GN=EXO5 PE=1 SV=1 EXO5_HUMAN reviewed Exonuclease V (Exo V) (hExo5) (EC 3.1.-.-) (Defects in morphology protein 1 homolog) Homo sapiens (Human) GO:0003677; GO:0005634; GO:0005654; GO:0005829; GO:0008310; GO:0036297; GO:0045145; GO:0046872; GO:0051539 interstrand cross-link repair [GO:0036297] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] 4 iron, 4 sulfur cluster binding [GO:0051539]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; single-stranded DNA 3'-5' DNA exonuclease activity [GO:0008310]; single-stranded DNA 5'-3' DNA exonuclease activity [GO:0045145] g19825.t1 Q5ZLG0 67.958 671 0.0 966.0 sp|Q5ZLG0|AACS_CHICK Acetoacetyl-CoA synthetase OS=Gallus gallus OX=9031 GN=AACS PE=2 SV=1 g19826.t1 Q14C87 24.898 735 1.6e-51 198.0 sp|Q14C87|T132D_HUMAN Transmembrane protein 132D OS=Homo sapiens OX=9606 GN=TMEM132D PE=1 SV=1 g19829.t1 Q8R0J7 39.773 176 7.55e-26 105.0 sp|Q8R0J7|VP37B_MOUSE Vacuolar protein sorting-associated protein 37B OS=Mus musculus OX=10090 GN=Vps37b PE=1 SV=1 VP37B_MOUSE reviewed Vacuolar protein sorting-associated protein 37B (Vps37B) (ESCRT-I complex subunit VPS37B) Mus musculus (Mouse) GO:0000813; GO:0005737; GO:0005768; GO:0005886; GO:0006612; GO:0006623; GO:0010008; GO:0016236; GO:0019076; GO:0030496; GO:0031902; GO:0036258; GO:0039702; GO:0043162; GO:0048306; GO:1903774 macroautophagy [GO:0016236]; multivesicular body assembly [GO:0036258]; positive regulation of viral budding via host ESCRT complex [GO:1903774]; protein targeting to membrane [GO:0006612]; protein targeting to vacuole [GO:0006623]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]; viral budding via host ESCRT complex [GO:0039702]; viral release from host cell [GO:0019076] cytoplasm [GO:0005737]; endosome [GO:0005768]; endosome membrane [GO:0010008]; ESCRT I complex [GO:0000813]; late endosome membrane [GO:0031902]; midbody [GO:0030496]; plasma membrane [GO:0005886] calcium-dependent protein binding [GO:0048306] g19830.t1 P59041 35.165 182 9.23e-27 105.0 sp|P59041|DJC30_MOUSE DnaJ homolog subfamily C member 30, mitochondrial OS=Mus musculus OX=10090 GN=Dnajc30 PE=1 SV=1 g19831.t1 Q9CY21 60.211 284 9.61e-118 342.0 sp|Q9CY21|BUD23_MOUSE 18S rRNA (guanine-N(7))-methyltransferase OS=Mus musculus OX=10090 GN=Bud23 PE=1 SV=1 g19832.t1 P52301 83.412 211 2.8499999999999997e-134 379.0 sp|P52301|RAN_XENLA GTP-binding nuclear protein Ran OS=Xenopus laevis OX=8355 GN=ran PE=1 SV=2 g19833.t1 Q16932 74.359 273 2.26e-142 405.0 sp|Q16932|STX_APLCA Syntaxin OS=Aplysia californica OX=6500 PE=2 SV=1 g19833.t2 Q16932 75.472 265 4.839999999999999e-140 399.0 sp|Q16932|STX_APLCA Syntaxin OS=Aplysia californica OX=6500 PE=2 SV=1 g19834.t1 Q7PPA5 74.02 1020 0.0 1495.0 sp|Q7PPA5|ATC1_ANOGA Calcium-transporting ATPase sarcoplasmic/endoplasmic reticulum type OS=Anopheles gambiae OX=7165 GN=SERCA PE=3 SV=5 g19835.t1 Q53HC0 35.829 187 6.44e-29 117.0 sp|Q53HC0|CCD92_HUMAN Coiled-coil domain-containing protein 92 OS=Homo sapiens OX=9606 GN=CCDC92 PE=1 SV=2 CCD92_HUMAN reviewed Coiled-coil domain-containing protein 92 (Limkain beta-2) Homo sapiens (Human) GO:0005654; GO:0005737; GO:0005813; GO:0005814; GO:0042802; GO:0045087; GO:0050688 innate immune response [GO:0045087]; regulation of defense response to virus [GO:0050688] centriole [GO:0005814]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654] identical protein binding [GO:0042802] g19836.t1 Q99PV0 92.657 2315 0.0 4375.0 sp|Q99PV0|PRP8_MOUSE Pre-mRNA-processing-splicing factor 8 OS=Mus musculus OX=10090 GN=Prpf8 PE=1 SV=2 PRP8_MOUSE reviewed Pre-mRNA-processing-splicing factor 8 (Splicing factor Prp8) Mus musculus (Mouse) GO:0000244; GO:0000398; GO:0005634; GO:0005681; GO:0005682; GO:0008237; GO:0016607; GO:0017070; GO:0030532; GO:0030619; GO:0030620; GO:0030623; GO:0046540; GO:0070530; GO:0071005; GO:0071006; GO:0071007; GO:0071013; GO:0071222; GO:0071356; GO:0097157 cellular response to lipopolysaccharide [GO:0071222]; cellular response to tumor necrosis factor [GO:0071356]; mRNA splicing, via spliceosome [GO:0000398]; spliceosomal tri-snRNP complex assembly [GO:0000244] catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; small nuclear ribonucleoprotein complex [GO:0030532]; spliceosomal complex [GO:0005681]; U2-type catalytic step 1 spliceosome [GO:0071006]; U2-type catalytic step 2 spliceosome [GO:0071007]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682] K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; metallopeptidase activity [GO:0008237]; pre-mRNA intronic binding [GO:0097157]; U1 snRNA binding [GO:0030619]; U2 snRNA binding [GO:0030620]; U5 snRNA binding [GO:0030623]; U6 snRNA binding [GO:0017070] g19837.t1 Q3MHL7 79.661 531 0.0 878.0 sp|Q3MHL7|TCPZ_BOVIN T-complex protein 1 subunit zeta OS=Bos taurus OX=9913 GN=CCT6A PE=1 SV=3 g19839.t1 O35954 67.729 251 2.33e-122 388.0 sp|O35954|PITM1_MOUSE Membrane-associated phosphatidylinositol transfer protein 1 OS=Mus musculus OX=10090 GN=Pitpnm1 PE=1 SV=1 PITM1_MOUSE reviewed Membrane-associated phosphatidylinositol transfer protein 1 (Drosophila retinal degeneration B homolog 1) (RdgB1) (Mpt-1) (Phosphatidylinositol transfer protein, membrane-associated 1) (PITPnm 1) (Pyk2 N-terminal domain-interacting receptor 2) (NIR-2) Mus musculus (Mouse) GO:0005509; GO:0005543; GO:0005737; GO:0005789; GO:0005811; GO:0005829; GO:0008525; GO:0008526; GO:0015031; GO:0015914; GO:0030496; GO:0030971; GO:0031210; GO:0032154; GO:0032580; GO:0035091; GO:0044297; GO:0070300 phospholipid transport [GO:0015914]; protein transport [GO:0015031] cell body [GO:0044297]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi cisterna membrane [GO:0032580]; lipid droplet [GO:0005811]; midbody [GO:0030496] calcium ion binding [GO:0005509]; phosphatidic acid binding [GO:0070300]; phosphatidylcholine binding [GO:0031210]; phosphatidylcholine transporter activity [GO:0008525]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol transfer activity [GO:0008526]; phospholipid binding [GO:0005543]; receptor tyrosine kinase binding [GO:0030971] g19840.t1 Q9BZ72 52.195 615 0.0 607.0 sp|Q9BZ72|PITM2_HUMAN Membrane-associated phosphatidylinositol transfer protein 2 OS=Homo sapiens OX=9606 GN=PITPNM2 PE=1 SV=1 PITM2_HUMAN reviewed Membrane-associated phosphatidylinositol transfer protein 2 (Phosphatidylinositol transfer protein, membrane-associated 2) (PITPnm 2) (Pyk2 N-terminal domain-interacting receptor 3) (NIR-3) Homo sapiens (Human) GO:0005509; GO:0005737; GO:0005829; GO:0006661; GO:0008525; GO:0008526; GO:0012505; GO:0030971; GO:0031210; GO:0035091 phosphatidylinositol biosynthetic process [GO:0006661] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endomembrane system [GO:0012505] calcium ion binding [GO:0005509]; phosphatidylcholine binding [GO:0031210]; phosphatidylcholine transporter activity [GO:0008525]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol transfer activity [GO:0008526]; receptor tyrosine kinase binding [GO:0030971] g19840.t2 Q9BZ72 50.551 635 0.0 597.0 sp|Q9BZ72|PITM2_HUMAN Membrane-associated phosphatidylinositol transfer protein 2 OS=Homo sapiens OX=9606 GN=PITPNM2 PE=1 SV=1 PITM2_HUMAN reviewed Membrane-associated phosphatidylinositol transfer protein 2 (Phosphatidylinositol transfer protein, membrane-associated 2) (PITPnm 2) (Pyk2 N-terminal domain-interacting receptor 3) (NIR-3) Homo sapiens (Human) GO:0005509; GO:0005737; GO:0005829; GO:0006661; GO:0008525; GO:0008526; GO:0012505; GO:0030971; GO:0031210; GO:0035091 phosphatidylinositol biosynthetic process [GO:0006661] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endomembrane system [GO:0012505] calcium ion binding [GO:0005509]; phosphatidylcholine binding [GO:0031210]; phosphatidylcholine transporter activity [GO:0008525]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol transfer activity [GO:0008526]; receptor tyrosine kinase binding [GO:0030971] g19841.t1 P00389 59.172 676 0.0 860.0 sp|P00389|NCPR_RABIT NADPH--cytochrome P450 reductase OS=Oryctolagus cuniculus OX=9986 GN=POR PE=1 SV=1 g19844.t1 Q08D57 48.223 197 8.039999999999999e-54 201.0 sp|Q08D57|SET1B_XENTR Histone-lysine N-methyltransferase SETD1B OS=Xenopus tropicalis OX=8364 GN=setd1b PE=2 SV=1 g19847.t1 O77656 42.586 263 9.71e-50 184.0 sp|O77656|MMP13_BOVIN Collagenase 3 OS=Bos taurus OX=9913 GN=MMP13 PE=2 SV=1 g19848.t1 O08658 34.519 759 2.83e-127 397.0 sp|O08658|NUP88_RAT Nuclear pore complex protein Nup88 OS=Rattus norvegicus OX=10116 GN=Nup88 PE=1 SV=1 g19856.t1 Q14588 43.087 311 7.590000000000001e-70 245.0 sp|Q14588|ZN234_HUMAN Zinc finger protein 234 OS=Homo sapiens OX=9606 GN=ZNF234 PE=1 SV=3 g19856.t1 Q14588 37.778 360 1.1399999999999999e-62 225.0 sp|Q14588|ZN234_HUMAN Zinc finger protein 234 OS=Homo sapiens OX=9606 GN=ZNF234 PE=1 SV=3 g19856.t1 Q14588 38.253 332 1.71e-58 214.0 sp|Q14588|ZN234_HUMAN Zinc finger protein 234 OS=Homo sapiens OX=9606 GN=ZNF234 PE=1 SV=3 g19856.t1 Q14588 39.667 300 6.76e-57 209.0 sp|Q14588|ZN234_HUMAN Zinc finger protein 234 OS=Homo sapiens OX=9606 GN=ZNF234 PE=1 SV=3 g19856.t1 Q14588 40.559 286 1.1299999999999999e-55 206.0 sp|Q14588|ZN234_HUMAN Zinc finger protein 234 OS=Homo sapiens OX=9606 GN=ZNF234 PE=1 SV=3 g19856.t1 Q14588 37.942 311 4.4499999999999994e-55 204.0 sp|Q14588|ZN234_HUMAN Zinc finger protein 234 OS=Homo sapiens OX=9606 GN=ZNF234 PE=1 SV=3 g19857.t1 Q6TGZ5 69.351 385 0.0 570.0 sp|Q6TGZ5|HPPD_DANRE 4-hydroxyphenylpyruvate dioxygenase OS=Danio rerio OX=7955 GN=hpd PE=2 SV=1 g19858.t1 E1BY51 49.189 185 1.09e-44 150.0 sp|E1BY51|TMM17_CHICK Transmembrane protein 17 OS=Gallus gallus OX=9031 GN=TMEM17 PE=3 SV=1 g19860.t1 Q08D68 48.418 316 1.51e-72 259.0 sp|Q08D68|ZNRF3_XENTR E3 ubiquitin-protein ligase ZNRF3 OS=Xenopus tropicalis OX=8364 GN=znrf3 PE=1 SV=1 ZNRF3_XENTR reviewed E3 ubiquitin-protein ligase ZNRF3 (EC 2.3.2.27) (RING-type E3 ubiquitin transferase ZNRF3) (Zinc/RING finger protein 3) Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0004842; GO:0005109; GO:0005886; GO:0006511; GO:0008270; GO:0009952; GO:0016055; GO:0016567; GO:0030178; GO:0038018; GO:0060173; GO:0061630; GO:0072089; GO:0090090; GO:2000051 anterior/posterior pattern specification [GO:0009952]; limb development [GO:0060173]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of non-canonical Wnt signaling pathway [GO:2000051]; negative regulation of Wnt signaling pathway [GO:0030178]; protein ubiquitination [GO:0016567]; stem cell proliferation [GO:0072089]; ubiquitin-dependent protein catabolic process [GO:0006511]; Wnt receptor catabolic process [GO:0038018]; Wnt signaling pathway [GO:0016055] plasma membrane [GO:0005886] frizzled binding [GO:0005109]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] g19862.t1 A2BGR3 51.8 639 0.0 637.0 sp|A2BGR3|ERC6L_DANRE DNA excision repair protein ERCC-6-like OS=Danio rerio OX=7955 GN=ercc6l PE=1 SV=1 ERC6L_DANRE reviewed DNA excision repair protein ERCC-6-like (EC 3.6.4.12) (ATP-dependent helicase ERCC6-like) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000776; GO:0003677; GO:0003678; GO:0005524; GO:0006281; GO:0015616; GO:0016539; GO:0016887; GO:0051301 cell division [GO:0051301]; DNA repair [GO:0006281]; intein-mediated protein splicing [GO:0016539] kinetochore [GO:0000776] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; DNA translocase activity [GO:0015616] g19864.t1 Q924H5 53.67 218 4.24e-76 236.0 sp|Q924H5|RA51C_MOUSE DNA repair protein RAD51 homolog 3 OS=Mus musculus OX=10090 GN=Rad51c PE=1 SV=1 g19865.t1 B0BMZ6 42.604 169 4.41e-44 155.0 sp|B0BMZ6|CF119_RAT Cilia- and flagella-associated protein 119 OS=Rattus norvegicus OX=10116 GN=Cfap119 PE=1 SV=1 CF119_RAT reviewed Cilia- and flagella-associated protein 119 (Coiled-coil domain-containing protein 189) (Spergen-4) Rattus norvegicus (Rat) GO:0001534; GO:0001669; GO:0005737; GO:0005930; GO:0007338; GO:0010467; GO:0097228; GO:0120316 gene expression [GO:0010467]; single fertilization [GO:0007338]; sperm flagellum assembly [GO:0120316] acrosomal vesicle [GO:0001669]; axoneme [GO:0005930]; cytoplasm [GO:0005737]; radial spoke [GO:0001534]; sperm principal piece [GO:0097228] g19866.t1 Q9Z0J4 58.777 1128 0.0 1345.0 sp|Q9Z0J4|NOS1_MOUSE Nitric oxide synthase 1 OS=Mus musculus OX=10090 GN=Nos1 PE=1 SV=1 g19866.t1 Q9Z0J4 50.735 136 1.5099999999999999e-30 135.0 sp|Q9Z0J4|NOS1_MOUSE Nitric oxide synthase 1 OS=Mus musculus OX=10090 GN=Nos1 PE=1 SV=1 g19866.t2 Q9Z0J4 58.777 1128 0.0 1345.0 sp|Q9Z0J4|NOS1_MOUSE Nitric oxide synthase 1 OS=Mus musculus OX=10090 GN=Nos1 PE=1 SV=1 g19866.t2 Q9Z0J4 50.735 136 1.47e-30 136.0 sp|Q9Z0J4|NOS1_MOUSE Nitric oxide synthase 1 OS=Mus musculus OX=10090 GN=Nos1 PE=1 SV=1 g19868.t1 Q8TBY9 47.55 898 0.0 853.0 sp|Q8TBY9|CF251_HUMAN Cilia- and flagella-associated protein 251 OS=Homo sapiens OX=9606 GN=CFAP251 PE=1 SV=2 CF251_HUMAN reviewed Cilia- and flagella-associated protein 251 (WD repeat-containing protein 66) Homo sapiens (Human) GO:0003341; GO:0005930; GO:0030317; GO:0031514; GO:0036126 cilium movement [GO:0003341]; flagellated sperm motility [GO:0030317] axoneme [GO:0005930]; motile cilium [GO:0031514]; sperm flagellum [GO:0036126] g19869.t1 P29476 47.187 1191 0.0 1087.0 sp|P29476|NOS1_RAT Nitric oxide synthase 1 OS=Rattus norvegicus OX=10116 GN=Nos1 PE=1 SV=1 g19871.t1 Q66I67 75.758 132 3.06e-51 162.0 sp|Q66I67|IFT20_DANRE Intraflagellar transport protein 20 homolog OS=Danio rerio OX=7955 GN=ift20 PE=2 SV=1 IFT20_DANRE reviewed Intraflagellar transport protein 20 homolog Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001669; GO:0005737; GO:0005794; GO:0005813; GO:0005814; GO:0005930; GO:0007283; GO:0030154; GO:0030990; GO:0030992; GO:0036064; GO:0042073; GO:0043005; GO:0060271; GO:0061512; GO:0097546; GO:0097730; GO:2000583 cell differentiation [GO:0030154]; cilium assembly [GO:0060271]; intraciliary transport [GO:0042073]; protein localization to cilium [GO:0061512]; regulation of platelet-derived growth factor receptor-alpha signaling pathway [GO:2000583]; spermatogenesis [GO:0007283] acrosomal vesicle [GO:0001669]; axoneme [GO:0005930]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary base [GO:0097546]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; intraciliary transport particle [GO:0030990]; intraciliary transport particle B [GO:0030992]; neuron projection [GO:0043005]; non-motile cilium [GO:0097730] g19872.t1 Q6R5J2 32.799 1061 0.0 578.0 sp|Q6R5J2|DISP1_DANRE Protein dispatched homolog 1 OS=Danio rerio OX=7955 GN=disp1 PE=2 SV=1 DISP1_DANRE reviewed Protein dispatched homolog 1 (Protein chameleon) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0007224; GO:0007519; GO:0008015; GO:0009887; GO:0009952; GO:0016020; GO:0021984; GO:0031290; GO:0042694; GO:0048701; GO:0048839 adenohypophysis development [GO:0021984]; animal organ morphogenesis [GO:0009887]; anterior/posterior pattern specification [GO:0009952]; blood circulation [GO:0008015]; embryonic cranial skeleton morphogenesis [GO:0048701]; inner ear development [GO:0048839]; muscle cell fate specification [GO:0042694]; retinal ganglion cell axon guidance [GO:0031290]; skeletal muscle tissue development [GO:0007519]; smoothened signaling pathway [GO:0007224] membrane [GO:0016020] g19873.t1 Q6DFQ5 51.095 137 4.29e-30 110.0 sp|Q6DFQ5|SGMR2_XENTR Sigma intracellular receptor 2 OS=Xenopus tropicalis OX=8364 GN=tmem97 PE=2 SV=1 SGMR2_XENTR reviewed Sigma intracellular receptor 2 (Sigma-2 receptor) (Sigma2 receptor) (Transmembrane protein 97) Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0005764; GO:0005783; GO:0005791; GO:0005886; GO:0008142; GO:0015485; GO:0030867; GO:0031965; GO:0032377; GO:0032383; GO:0042632; GO:0140077 cholesterol homeostasis [GO:0042632]; positive regulation of lipoprotein transport [GO:0140077]; regulation of intracellular cholesterol transport [GO:0032383]; regulation of intracellular lipid transport [GO:0032377] endoplasmic reticulum [GO:0005783]; lysosome [GO:0005764]; nuclear membrane [GO:0031965]; plasma membrane [GO:0005886]; rough endoplasmic reticulum [GO:0005791]; rough endoplasmic reticulum membrane [GO:0030867] cholesterol binding [GO:0015485]; oxysterol binding [GO:0008142] g19874.t1 Q9D5J6 44.14 401 9.82e-125 372.0 sp|Q9D5J6|SHPK_MOUSE Sedoheptulokinase OS=Mus musculus OX=10090 GN=Shpk PE=1 SV=1 SHPK_MOUSE reviewed Sedoheptulokinase (SHK) (EC 2.7.1.14) (Carbohydrate kinase-like protein) Mus musculus (Mouse) GO:0005524; GO:0005737; GO:0005829; GO:0005975; GO:0009052; GO:0016310; GO:0035963; GO:0043030; GO:0050277; GO:0050727; GO:0071222; GO:0071353 carbohydrate metabolic process [GO:0005975]; cellular response to interleukin-13 [GO:0035963]; cellular response to interleukin-4 [GO:0071353]; cellular response to lipopolysaccharide [GO:0071222]; pentose-phosphate shunt, non-oxidative branch [GO:0009052]; phosphorylation [GO:0016310]; regulation of inflammatory response [GO:0050727]; regulation of macrophage activation [GO:0043030] cytoplasm [GO:0005737]; cytosol [GO:0005829] ATP binding [GO:0005524]; sedoheptulokinase activity [GO:0050277] g19875.t1 Q6NW29 47.283 184 2.35e-55 176.0 sp|Q6NW29|RWDD4_HUMAN RWD domain-containing protein 4 OS=Homo sapiens OX=9606 GN=RWDD4 PE=1 SV=3 RWDD4_HUMAN reviewed RWD domain-containing protein 4 (Protein FAM28A) Homo sapiens (Human) g19876.t1 Q810K9 51.792 307 2.17e-101 318.0 sp|Q810K9|GXLT2_MOUSE Glucoside xylosyltransferase 2 OS=Mus musculus OX=10090 GN=Gxylt2 PE=2 SV=1 g19877.t1 Q24K15 41.549 142 2.49e-25 114.0 sp|Q24K15|ANGP4_BOVIN Angiopoietin-4 OS=Bos taurus OX=9913 GN=ANGPT4 PE=2 SV=1 g19877.t2 P70490 31.073 354 2.16e-35 143.0 sp|P70490|MFGM_RAT Lactadherin OS=Rattus norvegicus OX=10116 GN=Mfge8 PE=2 SV=1 MFGM_RAT reviewed Lactadherin (MFGM) (Milk fat globule-EGF factor 8) (MFG-E8) (O-acetyl GD3 ganglioside synthase) (AGS) (SED1) Rattus norvegicus (Rat) GO:0001525; GO:0001786; GO:0002080; GO:0005178; GO:0005615; GO:0006910; GO:0006911; GO:0007155; GO:0007338; GO:0008284; GO:0008429; GO:0009897; GO:0043277; GO:0043627; GO:0050766 angiogenesis [GO:0001525]; apoptotic cell clearance [GO:0043277]; cell adhesion [GO:0007155]; phagocytosis, engulfment [GO:0006911]; phagocytosis, recognition [GO:0006910]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of phagocytosis [GO:0050766]; response to estrogen [GO:0043627]; single fertilization [GO:0007338] acrosomal membrane [GO:0002080]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615] integrin binding [GO:0005178]; phosphatidylethanolamine binding [GO:0008429]; phosphatidylserine binding [GO:0001786] g19878.t1 A4FVI0 48.571 140 1.73e-37 127.0 sp|A4FVI0|ZSWM7_DANRE Zinc finger SWIM domain-containing protein 7 OS=Danio rerio OX=7955 GN=zswim7 PE=2 SV=2 g19879.t1 G3I6Z6 33.44 1564 1.9699999999999998e-172 588.0 sp|G3I6Z6|NOTC1_CRIGR Neurogenic locus notch homolog protein 1 OS=Cricetulus griseus OX=10029 GN=NOTCH1 PE=1 SV=2 NOTC1_CRIGR reviewed Neurogenic locus notch homolog protein 1 (Notch 1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Cricetulus griseus (Chinese hamster) (Cricetulus barabensis griseus) GO:0000139; GO:0001525; GO:0005509; GO:0005634; GO:0005796; GO:0005912; GO:0006355; GO:0007411; GO:0009986; GO:0016324; GO:0031902; GO:0038023; GO:0043235; GO:0050793; GO:0060271; GO:0061314 angiogenesis [GO:0001525]; axon guidance [GO:0007411]; cilium assembly [GO:0060271]; Notch signaling involved in heart development [GO:0061314]; regulation of developmental process [GO:0050793]; regulation of DNA-templated transcription [GO:0006355] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; Golgi lumen [GO:0005796]; Golgi membrane [GO:0000139]; late endosome membrane [GO:0031902]; nucleus [GO:0005634]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; signaling receptor activity [GO:0038023] g19879.t1 G3I6Z6 35.901 1337 5.9e-161 554.0 sp|G3I6Z6|NOTC1_CRIGR Neurogenic locus notch homolog protein 1 OS=Cricetulus griseus OX=10029 GN=NOTCH1 PE=1 SV=2 NOTC1_CRIGR reviewed Neurogenic locus notch homolog protein 1 (Notch 1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Cricetulus griseus (Chinese hamster) (Cricetulus barabensis griseus) GO:0000139; GO:0001525; GO:0005509; GO:0005634; GO:0005796; GO:0005912; GO:0006355; GO:0007411; GO:0009986; GO:0016324; GO:0031902; GO:0038023; GO:0043235; GO:0050793; GO:0060271; GO:0061314 angiogenesis [GO:0001525]; axon guidance [GO:0007411]; cilium assembly [GO:0060271]; Notch signaling involved in heart development [GO:0061314]; regulation of developmental process [GO:0050793]; regulation of DNA-templated transcription [GO:0006355] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; Golgi lumen [GO:0005796]; Golgi membrane [GO:0000139]; late endosome membrane [GO:0031902]; nucleus [GO:0005634]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; signaling receptor activity [GO:0038023] g19879.t1 G3I6Z6 36.237 1217 2.82e-154 534.0 sp|G3I6Z6|NOTC1_CRIGR Neurogenic locus notch homolog protein 1 OS=Cricetulus griseus OX=10029 GN=NOTCH1 PE=1 SV=2 NOTC1_CRIGR reviewed Neurogenic locus notch homolog protein 1 (Notch 1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Cricetulus griseus (Chinese hamster) (Cricetulus barabensis griseus) GO:0000139; GO:0001525; GO:0005509; GO:0005634; GO:0005796; GO:0005912; GO:0006355; GO:0007411; GO:0009986; GO:0016324; GO:0031902; GO:0038023; GO:0043235; GO:0050793; GO:0060271; GO:0061314 angiogenesis [GO:0001525]; axon guidance [GO:0007411]; cilium assembly [GO:0060271]; Notch signaling involved in heart development [GO:0061314]; regulation of developmental process [GO:0050793]; regulation of DNA-templated transcription [GO:0006355] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; Golgi lumen [GO:0005796]; Golgi membrane [GO:0000139]; late endosome membrane [GO:0031902]; nucleus [GO:0005634]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; signaling receptor activity [GO:0038023] g19879.t1 G3I6Z6 33.125 1277 1.3100000000000001e-133 470.0 sp|G3I6Z6|NOTC1_CRIGR Neurogenic locus notch homolog protein 1 OS=Cricetulus griseus OX=10029 GN=NOTCH1 PE=1 SV=2 NOTC1_CRIGR reviewed Neurogenic locus notch homolog protein 1 (Notch 1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Cricetulus griseus (Chinese hamster) (Cricetulus barabensis griseus) GO:0000139; GO:0001525; GO:0005509; GO:0005634; GO:0005796; GO:0005912; GO:0006355; GO:0007411; GO:0009986; GO:0016324; GO:0031902; GO:0038023; GO:0043235; GO:0050793; GO:0060271; GO:0061314 angiogenesis [GO:0001525]; axon guidance [GO:0007411]; cilium assembly [GO:0060271]; Notch signaling involved in heart development [GO:0061314]; regulation of developmental process [GO:0050793]; regulation of DNA-templated transcription [GO:0006355] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; Golgi lumen [GO:0005796]; Golgi membrane [GO:0000139]; late endosome membrane [GO:0031902]; nucleus [GO:0005634]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; signaling receptor activity [GO:0038023] g19879.t1 G3I6Z6 35.671 998 2.4000000000000003e-124 441.0 sp|G3I6Z6|NOTC1_CRIGR Neurogenic locus notch homolog protein 1 OS=Cricetulus griseus OX=10029 GN=NOTCH1 PE=1 SV=2 NOTC1_CRIGR reviewed Neurogenic locus notch homolog protein 1 (Notch 1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Cricetulus griseus (Chinese hamster) (Cricetulus barabensis griseus) GO:0000139; GO:0001525; GO:0005509; GO:0005634; GO:0005796; GO:0005912; GO:0006355; GO:0007411; GO:0009986; GO:0016324; GO:0031902; GO:0038023; GO:0043235; GO:0050793; GO:0060271; GO:0061314 angiogenesis [GO:0001525]; axon guidance [GO:0007411]; cilium assembly [GO:0060271]; Notch signaling involved in heart development [GO:0061314]; regulation of developmental process [GO:0050793]; regulation of DNA-templated transcription [GO:0006355] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; Golgi lumen [GO:0005796]; Golgi membrane [GO:0000139]; late endosome membrane [GO:0031902]; nucleus [GO:0005634]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; signaling receptor activity [GO:0038023] g19879.t1 G3I6Z6 33.53 847 1.35e-90 333.0 sp|G3I6Z6|NOTC1_CRIGR Neurogenic locus notch homolog protein 1 OS=Cricetulus griseus OX=10029 GN=NOTCH1 PE=1 SV=2 NOTC1_CRIGR reviewed Neurogenic locus notch homolog protein 1 (Notch 1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Cricetulus griseus (Chinese hamster) (Cricetulus barabensis griseus) GO:0000139; GO:0001525; GO:0005509; GO:0005634; GO:0005796; GO:0005912; GO:0006355; GO:0007411; GO:0009986; GO:0016324; GO:0031902; GO:0038023; GO:0043235; GO:0050793; GO:0060271; GO:0061314 angiogenesis [GO:0001525]; axon guidance [GO:0007411]; cilium assembly [GO:0060271]; Notch signaling involved in heart development [GO:0061314]; regulation of developmental process [GO:0050793]; regulation of DNA-templated transcription [GO:0006355] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; Golgi lumen [GO:0005796]; Golgi membrane [GO:0000139]; late endosome membrane [GO:0031902]; nucleus [GO:0005634]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; signaling receptor activity [GO:0038023] g19879.t1 G3I6Z6 37.148 568 4.1199999999999996e-82 306.0 sp|G3I6Z6|NOTC1_CRIGR Neurogenic locus notch homolog protein 1 OS=Cricetulus griseus OX=10029 GN=NOTCH1 PE=1 SV=2 NOTC1_CRIGR reviewed Neurogenic locus notch homolog protein 1 (Notch 1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Cricetulus griseus (Chinese hamster) (Cricetulus barabensis griseus) GO:0000139; GO:0001525; GO:0005509; GO:0005634; GO:0005796; GO:0005912; GO:0006355; GO:0007411; GO:0009986; GO:0016324; GO:0031902; GO:0038023; GO:0043235; GO:0050793; GO:0060271; GO:0061314 angiogenesis [GO:0001525]; axon guidance [GO:0007411]; cilium assembly [GO:0060271]; Notch signaling involved in heart development [GO:0061314]; regulation of developmental process [GO:0050793]; regulation of DNA-templated transcription [GO:0006355] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; Golgi lumen [GO:0005796]; Golgi membrane [GO:0000139]; late endosome membrane [GO:0031902]; nucleus [GO:0005634]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; signaling receptor activity [GO:0038023] g19879.t1 G3I6Z6 33.824 408 1.87e-40 169.0 sp|G3I6Z6|NOTC1_CRIGR Neurogenic locus notch homolog protein 1 OS=Cricetulus griseus OX=10029 GN=NOTCH1 PE=1 SV=2 NOTC1_CRIGR reviewed Neurogenic locus notch homolog protein 1 (Notch 1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Cricetulus griseus (Chinese hamster) (Cricetulus barabensis griseus) GO:0000139; GO:0001525; GO:0005509; GO:0005634; GO:0005796; GO:0005912; GO:0006355; GO:0007411; GO:0009986; GO:0016324; GO:0031902; GO:0038023; GO:0043235; GO:0050793; GO:0060271; GO:0061314 angiogenesis [GO:0001525]; axon guidance [GO:0007411]; cilium assembly [GO:0060271]; Notch signaling involved in heart development [GO:0061314]; regulation of developmental process [GO:0050793]; regulation of DNA-templated transcription [GO:0006355] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; Golgi lumen [GO:0005796]; Golgi membrane [GO:0000139]; late endosome membrane [GO:0031902]; nucleus [GO:0005634]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; signaling receptor activity [GO:0038023] g19879.t1 G3I6Z6 34.75 400 1.89e-40 169.0 sp|G3I6Z6|NOTC1_CRIGR Neurogenic locus notch homolog protein 1 OS=Cricetulus griseus OX=10029 GN=NOTCH1 PE=1 SV=2 NOTC1_CRIGR reviewed Neurogenic locus notch homolog protein 1 (Notch 1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Cricetulus griseus (Chinese hamster) (Cricetulus barabensis griseus) GO:0000139; GO:0001525; GO:0005509; GO:0005634; GO:0005796; GO:0005912; GO:0006355; GO:0007411; GO:0009986; GO:0016324; GO:0031902; GO:0038023; GO:0043235; GO:0050793; GO:0060271; GO:0061314 angiogenesis [GO:0001525]; axon guidance [GO:0007411]; cilium assembly [GO:0060271]; Notch signaling involved in heart development [GO:0061314]; regulation of developmental process [GO:0050793]; regulation of DNA-templated transcription [GO:0006355] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; Golgi lumen [GO:0005796]; Golgi membrane [GO:0000139]; late endosome membrane [GO:0031902]; nucleus [GO:0005634]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; signaling receptor activity [GO:0038023] g19879.t1 G3I6Z6 33.081 396 4.07e-40 168.0 sp|G3I6Z6|NOTC1_CRIGR Neurogenic locus notch homolog protein 1 OS=Cricetulus griseus OX=10029 GN=NOTCH1 PE=1 SV=2 NOTC1_CRIGR reviewed Neurogenic locus notch homolog protein 1 (Notch 1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Cricetulus griseus (Chinese hamster) (Cricetulus barabensis griseus) GO:0000139; GO:0001525; GO:0005509; GO:0005634; GO:0005796; GO:0005912; GO:0006355; GO:0007411; GO:0009986; GO:0016324; GO:0031902; GO:0038023; GO:0043235; GO:0050793; GO:0060271; GO:0061314 angiogenesis [GO:0001525]; axon guidance [GO:0007411]; cilium assembly [GO:0060271]; Notch signaling involved in heart development [GO:0061314]; regulation of developmental process [GO:0050793]; regulation of DNA-templated transcription [GO:0006355] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; Golgi lumen [GO:0005796]; Golgi membrane [GO:0000139]; late endosome membrane [GO:0031902]; nucleus [GO:0005634]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; signaling receptor activity [GO:0038023] g19879.t1 G3I6Z6 31.477 413 2.6400000000000002e-36 155.0 sp|G3I6Z6|NOTC1_CRIGR Neurogenic locus notch homolog protein 1 OS=Cricetulus griseus OX=10029 GN=NOTCH1 PE=1 SV=2 NOTC1_CRIGR reviewed Neurogenic locus notch homolog protein 1 (Notch 1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Cricetulus griseus (Chinese hamster) (Cricetulus barabensis griseus) GO:0000139; GO:0001525; GO:0005509; GO:0005634; GO:0005796; GO:0005912; GO:0006355; GO:0007411; GO:0009986; GO:0016324; GO:0031902; GO:0038023; GO:0043235; GO:0050793; GO:0060271; GO:0061314 angiogenesis [GO:0001525]; axon guidance [GO:0007411]; cilium assembly [GO:0060271]; Notch signaling involved in heart development [GO:0061314]; regulation of developmental process [GO:0050793]; regulation of DNA-templated transcription [GO:0006355] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; Golgi lumen [GO:0005796]; Golgi membrane [GO:0000139]; late endosome membrane [GO:0031902]; nucleus [GO:0005634]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; signaling receptor activity [GO:0038023] g19879.t1 G3I6Z6 33.411 431 6.34e-36 154.0 sp|G3I6Z6|NOTC1_CRIGR Neurogenic locus notch homolog protein 1 OS=Cricetulus griseus OX=10029 GN=NOTCH1 PE=1 SV=2 NOTC1_CRIGR reviewed Neurogenic locus notch homolog protein 1 (Notch 1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Cricetulus griseus (Chinese hamster) (Cricetulus barabensis griseus) GO:0000139; GO:0001525; GO:0005509; GO:0005634; GO:0005796; GO:0005912; GO:0006355; GO:0007411; GO:0009986; GO:0016324; GO:0031902; GO:0038023; GO:0043235; GO:0050793; GO:0060271; GO:0061314 angiogenesis [GO:0001525]; axon guidance [GO:0007411]; cilium assembly [GO:0060271]; Notch signaling involved in heart development [GO:0061314]; regulation of developmental process [GO:0050793]; regulation of DNA-templated transcription [GO:0006355] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; Golgi lumen [GO:0005796]; Golgi membrane [GO:0000139]; late endosome membrane [GO:0031902]; nucleus [GO:0005634]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; signaling receptor activity [GO:0038023] g19879.t1 G3I6Z6 31.519 441 1.91e-35 152.0 sp|G3I6Z6|NOTC1_CRIGR Neurogenic locus notch homolog protein 1 OS=Cricetulus griseus OX=10029 GN=NOTCH1 PE=1 SV=2 NOTC1_CRIGR reviewed Neurogenic locus notch homolog protein 1 (Notch 1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Cricetulus griseus (Chinese hamster) (Cricetulus barabensis griseus) GO:0000139; GO:0001525; GO:0005509; GO:0005634; GO:0005796; GO:0005912; GO:0006355; GO:0007411; GO:0009986; GO:0016324; GO:0031902; GO:0038023; GO:0043235; GO:0050793; GO:0060271; GO:0061314 angiogenesis [GO:0001525]; axon guidance [GO:0007411]; cilium assembly [GO:0060271]; Notch signaling involved in heart development [GO:0061314]; regulation of developmental process [GO:0050793]; regulation of DNA-templated transcription [GO:0006355] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; Golgi lumen [GO:0005796]; Golgi membrane [GO:0000139]; late endosome membrane [GO:0031902]; nucleus [GO:0005634]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; signaling receptor activity [GO:0038023] g19879.t1 G3I6Z6 33.962 371 2.1300000000000002e-35 152.0 sp|G3I6Z6|NOTC1_CRIGR Neurogenic locus notch homolog protein 1 OS=Cricetulus griseus OX=10029 GN=NOTCH1 PE=1 SV=2 NOTC1_CRIGR reviewed Neurogenic locus notch homolog protein 1 (Notch 1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Cricetulus griseus (Chinese hamster) (Cricetulus barabensis griseus) GO:0000139; GO:0001525; GO:0005509; GO:0005634; GO:0005796; GO:0005912; GO:0006355; GO:0007411; GO:0009986; GO:0016324; GO:0031902; GO:0038023; GO:0043235; GO:0050793; GO:0060271; GO:0061314 angiogenesis [GO:0001525]; axon guidance [GO:0007411]; cilium assembly [GO:0060271]; Notch signaling involved in heart development [GO:0061314]; regulation of developmental process [GO:0050793]; regulation of DNA-templated transcription [GO:0006355] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; Golgi lumen [GO:0005796]; Golgi membrane [GO:0000139]; late endosome membrane [GO:0031902]; nucleus [GO:0005634]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; signaling receptor activity [GO:0038023] g19879.t1 G3I6Z6 33.875 369 5.12e-35 151.0 sp|G3I6Z6|NOTC1_CRIGR Neurogenic locus notch homolog protein 1 OS=Cricetulus griseus OX=10029 GN=NOTCH1 PE=1 SV=2 NOTC1_CRIGR reviewed Neurogenic locus notch homolog protein 1 (Notch 1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Cricetulus griseus (Chinese hamster) (Cricetulus barabensis griseus) GO:0000139; GO:0001525; GO:0005509; GO:0005634; GO:0005796; GO:0005912; GO:0006355; GO:0007411; GO:0009986; GO:0016324; GO:0031902; GO:0038023; GO:0043235; GO:0050793; GO:0060271; GO:0061314 angiogenesis [GO:0001525]; axon guidance [GO:0007411]; cilium assembly [GO:0060271]; Notch signaling involved in heart development [GO:0061314]; regulation of developmental process [GO:0050793]; regulation of DNA-templated transcription [GO:0006355] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; Golgi lumen [GO:0005796]; Golgi membrane [GO:0000139]; late endosome membrane [GO:0031902]; nucleus [GO:0005634]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; signaling receptor activity [GO:0038023] g19879.t1 G3I6Z6 32.927 410 6.05e-35 151.0 sp|G3I6Z6|NOTC1_CRIGR Neurogenic locus notch homolog protein 1 OS=Cricetulus griseus OX=10029 GN=NOTCH1 PE=1 SV=2 NOTC1_CRIGR reviewed Neurogenic locus notch homolog protein 1 (Notch 1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Cricetulus griseus (Chinese hamster) (Cricetulus barabensis griseus) GO:0000139; GO:0001525; GO:0005509; GO:0005634; GO:0005796; GO:0005912; GO:0006355; GO:0007411; GO:0009986; GO:0016324; GO:0031902; GO:0038023; GO:0043235; GO:0050793; GO:0060271; GO:0061314 angiogenesis [GO:0001525]; axon guidance [GO:0007411]; cilium assembly [GO:0060271]; Notch signaling involved in heart development [GO:0061314]; regulation of developmental process [GO:0050793]; regulation of DNA-templated transcription [GO:0006355] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; Golgi lumen [GO:0005796]; Golgi membrane [GO:0000139]; late endosome membrane [GO:0031902]; nucleus [GO:0005634]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; signaling receptor activity [GO:0038023] g19879.t1 G3I6Z6 32.653 392 2.89e-33 145.0 sp|G3I6Z6|NOTC1_CRIGR Neurogenic locus notch homolog protein 1 OS=Cricetulus griseus OX=10029 GN=NOTCH1 PE=1 SV=2 NOTC1_CRIGR reviewed Neurogenic locus notch homolog protein 1 (Notch 1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Cricetulus griseus (Chinese hamster) (Cricetulus barabensis griseus) GO:0000139; GO:0001525; GO:0005509; GO:0005634; GO:0005796; GO:0005912; GO:0006355; GO:0007411; GO:0009986; GO:0016324; GO:0031902; GO:0038023; GO:0043235; GO:0050793; GO:0060271; GO:0061314 angiogenesis [GO:0001525]; axon guidance [GO:0007411]; cilium assembly [GO:0060271]; Notch signaling involved in heart development [GO:0061314]; regulation of developmental process [GO:0050793]; regulation of DNA-templated transcription [GO:0006355] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; Golgi lumen [GO:0005796]; Golgi membrane [GO:0000139]; late endosome membrane [GO:0031902]; nucleus [GO:0005634]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; signaling receptor activity [GO:0038023] g19879.t1 G3I6Z6 33.099 284 4.84e-28 128.0 sp|G3I6Z6|NOTC1_CRIGR Neurogenic locus notch homolog protein 1 OS=Cricetulus griseus OX=10029 GN=NOTCH1 PE=1 SV=2 NOTC1_CRIGR reviewed Neurogenic locus notch homolog protein 1 (Notch 1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Cricetulus griseus (Chinese hamster) (Cricetulus barabensis griseus) GO:0000139; GO:0001525; GO:0005509; GO:0005634; GO:0005796; GO:0005912; GO:0006355; GO:0007411; GO:0009986; GO:0016324; GO:0031902; GO:0038023; GO:0043235; GO:0050793; GO:0060271; GO:0061314 angiogenesis [GO:0001525]; axon guidance [GO:0007411]; cilium assembly [GO:0060271]; Notch signaling involved in heart development [GO:0061314]; regulation of developmental process [GO:0050793]; regulation of DNA-templated transcription [GO:0006355] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; Golgi lumen [GO:0005796]; Golgi membrane [GO:0000139]; late endosome membrane [GO:0031902]; nucleus [GO:0005634]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; signaling receptor activity [GO:0038023] g19879.t2 P46531 36.775 1414 1.47e-175 598.0 sp|P46531|NOTC1_HUMAN Neurogenic locus notch homolog protein 1 OS=Homo sapiens OX=9606 GN=NOTCH1 PE=1 SV=4 NOTC1_HUMAN reviewed Neurogenic locus notch homolog protein 1 (Notch 1) (hN1) (Translocation-associated notch protein TAN-1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Homo sapiens (Human) GO:0000122; GO:0000139; GO:0001554; GO:0001669; GO:0001701; GO:0001837; GO:0001889; GO:0001947; GO:0002040; GO:0002052; GO:0002085; GO:0002193; GO:0002437; GO:0003151; GO:0003157; GO:0003160; GO:0003162; GO:0003169; GO:0003180; GO:0003181; GO:0003182; GO:0003184; GO:0003192; GO:0003198; GO:0003203; GO:0003207; GO:0003208; GO:0003209; GO:0003213; GO:0003214; GO:0003219; GO:0003222; GO:0003241; GO:0003252; GO:0003270; GO:0003273; GO:0003332; GO:0003344; GO:0003713; GO:0004857; GO:0004888; GO:0005112; GO:0005509; GO:0005576; GO:0005634; GO:0005654; GO:0005789; GO:0005829; GO:0005886; GO:0005912; GO:0006355; GO:0006357; GO:0006366; GO:0006606; GO:0006955; GO:0006959; GO:0007219; GO:0007221; GO:0007283; GO:0007368; GO:0007386; GO:0007411; GO:0007440; GO:0007492; GO:0007507; GO:0008284; GO:0008285; GO:0009912; GO:0009957; GO:0009986; GO:0010008; GO:0010614; GO:0010628; GO:0010629; GO:0010667; GO:0010812; GO:0010832; GO:0014031; GO:0014807; GO:0016324; GO:0017156; GO:0019899; GO:0021515; GO:0021915; GO:0021953; GO:0030163; GO:0030216; GO:0030279; GO:0030324; GO:0030335; GO:0030513; GO:0030514; GO:0030900; GO:0031069; GO:0031100; GO:0031490; GO:0031902; GO:0032495; GO:0032496; GO:0032966; GO:0035116; GO:0035148; GO:0035914; GO:0035924; GO:0042246; GO:0042670; GO:0042802; GO:0043086; GO:0043235; GO:0045070; GO:0045603; GO:0045608; GO:0045618; GO:0045662; GO:0045668; GO:0045747; GO:0045892; GO:0045893; GO:0045944; GO:0045955; GO:0046427; GO:0046533; GO:0046579; GO:0048103; GO:0048708; GO:0048709; GO:0048711; GO:0048715; GO:0048754; GO:0048873; GO:0050673; GO:0050679; GO:0050680; GO:0050768; GO:0051152; GO:0055008; GO:0060038; GO:0060045; GO:0060253; GO:0060271; GO:0060317; GO:0060354; GO:0060379; GO:0060411; GO:0060412; GO:0060528; GO:0060740; GO:0060768; GO:0060842; GO:0060843; GO:0060948; GO:0060956; GO:0060979; GO:0060982; GO:0061101; GO:0061344; GO:0061384; GO:0062043; GO:0070168; GO:0070374; GO:0070986; GO:0071228; GO:0071372; GO:0071456; GO:0072017; GO:0072044; GO:0072091; GO:0072144; GO:0072148; GO:0072538; GO:0090051; GO:0090090; GO:0097150; GO:0097400; GO:0098685; GO:0098839; GO:0098978; GO:0099565; GO:0120163; GO:0140537; GO:1901201; GO:1902263; GO:1902339; GO:1903849; GO:2000048; GO:2000737; GO:2000811; GO:2000974; GO:2001027 animal organ regeneration [GO:0031100]; aortic valve morphogenesis [GO:0003180]; apoptotic process involved in embryonic digit morphogenesis [GO:1902263]; arterial endothelial cell differentiation [GO:0060842]; astrocyte differentiation [GO:0048708]; atrioventricular node development [GO:0003162]; atrioventricular valve morphogenesis [GO:0003181]; auditory receptor cell fate commitment [GO:0009912]; axon guidance [GO:0007411]; branching morphogenesis of an epithelial tube [GO:0048754]; calcium-ion regulated exocytosis [GO:0017156]; cardiac atrium morphogenesis [GO:0003209]; cardiac chamber formation [GO:0003207]; cardiac epithelial to mesenchymal transition [GO:0060317]; cardiac left ventricle morphogenesis [GO:0003214]; cardiac muscle cell myoblast differentiation [GO:0060379]; cardiac muscle cell proliferation [GO:0060038]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac right atrium morphogenesis [GO:0003213]; cardiac right ventricle formation [GO:0003219]; cardiac septum morphogenesis [GO:0060411]; cardiac vascular smooth muscle cell development [GO:0060948]; cardiac ventricle morphogenesis [GO:0003208]; cell differentiation in spinal cord [GO:0021515]; cell migration involved in endocardial cushion formation [GO:0003273]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to hypoxia [GO:0071456]; cellular response to tumor cell [GO:0071228]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; central nervous system neuron differentiation [GO:0021953]; chemical synaptic transmission, postsynaptic [GO:0099565]; cilium assembly [GO:0060271]; collecting duct development [GO:0072044]; compartment pattern specification [GO:0007386]; coronary artery morphogenesis [GO:0060982]; coronary sinus valve morphogenesis [GO:0003182]; coronary vein morphogenesis [GO:0003169]; determination of left/right symmetry [GO:0007368]; distal tubule development [GO:0072017]; embryonic hindlimb morphogenesis [GO:0035116]; endocardial cell differentiation [GO:0060956]; endocardial cushion morphogenesis [GO:0003203]; endocardium development [GO:0003157]; endocardium morphogenesis [GO:0003160]; endoderm development [GO:0007492]; epidermal cell fate specification [GO:0009957]; epithelial cell fate commitment [GO:0072148]; epithelial cell proliferation [GO:0050673]; epithelial to mesenchymal transition [GO:0001837]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; forebrain development [GO:0030900]; foregut morphogenesis [GO:0007440]; glomerular mesangial cell development [GO:0072144]; growth involved in heart morphogenesis [GO:0003241]; hair follicle morphogenesis [GO:0031069]; heart development [GO:0007507]; heart looping [GO:0001947]; heart trabecula morphogenesis [GO:0061384]; homeostasis of number of cells within a tissue [GO:0048873]; humoral immune response [GO:0006959]; immune response [GO:0006955]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; inhibition of neuroepithelial cell differentiation [GO:0002085]; interleukin-17-mediated signaling pathway [GO:0097400]; keratinocyte differentiation [GO:0030216]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; lung development [GO:0030324]; luteolysis [GO:0001554]; mesenchymal cell development [GO:0014031]; mitral valve formation [GO:0003192]; negative regulation of anoikis [GO:2000811]; negative regulation of biomineral tissue development [GO:0070168]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of catalytic activity [GO:0043086]; negative regulation of cell adhesion molecule production [GO:0060354]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell proliferation involved in heart valve morphogenesis [GO:0003252]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of collagen biosynthetic process [GO:0032966]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of endothelial cell chemotaxis [GO:2001027]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of extracellular matrix constituent secretion [GO:0003332]; negative regulation of gene expression [GO:0010629]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of inner ear auditory receptor cell differentiation [GO:0045608]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of neurogenesis [GO:0050768]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of ossification [GO:0030279]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of photoreceptor cell differentiation [GO:0046533]; negative regulation of pro-B cell differentiation [GO:2000974]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural tube development [GO:0021915]; neuroendocrine cell differentiation [GO:0061101]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; Notch signaling pathway involved in regulation of secondary heart field cardioblast proliferation [GO:0003270]; oligodendrocyte differentiation [GO:0048709]; outflow tract morphogenesis [GO:0003151]; pericardium morphogenesis [GO:0003344]; positive regulation of aorta morphogenesis [GO:1903849]; positive regulation of apoptotic process involved in morphogenesis [GO:1902339]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cardiac epithelial to mesenchymal transition [GO:0062043]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of smooth muscle cell differentiation [GO:0051152]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription of Notch receptor target [GO:0007221]; positive regulation of viral genome replication [GO:0045070]; prostate gland epithelium morphogenesis [GO:0060740]; protein catabolic process [GO:0030163]; protein import into nucleus [GO:0006606]; pulmonary valve morphogenesis [GO:0003184]; regulation of cell adhesion involved in heart morphogenesis [GO:0061344]; regulation of DNA-templated transcription [GO:0006355]; regulation of epithelial cell proliferation involved in prostate gland development [GO:0060768]; regulation of extracellular matrix assembly [GO:1901201]; regulation of somitogenesis [GO:0014807]; regulation of stem cell proliferation [GO:0072091]; regulation of transcription by RNA polymerase II [GO:0006357]; response to lipopolysaccharide [GO:0032496]; response to muramyl dipeptide [GO:0032495]; retinal cone cell differentiation [GO:0042670]; secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development [GO:0060528]; skeletal muscle cell differentiation [GO:0035914]; somatic stem cell division [GO:0048103]; spermatogenesis [GO:0007283]; sprouting angiogenesis [GO:0002040]; T-helper 17 type immune response [GO:0072538]; tissue regeneration [GO:0042246]; transcription by RNA polymerase II [GO:0006366]; tube formation [GO:0035148]; vasculogenesis involved in coronary vascular morphogenesis [GO:0060979]; venous endothelial cell differentiation [GO:0060843]; ventricular septum morphogenesis [GO:0060412]; ventricular trabecula myocardium morphogenesis [GO:0003222] acrosomal vesicle [GO:0001669]; adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; late endosome membrane [GO:0031902]; MAML1-RBP-Jkappa- ICN1 complex [GO:0002193]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; receptor complex [GO:0043235]; Schaffer collateral - CA1 synapse [GO:0098685] calcium ion binding [GO:0005509]; chromatin DNA binding [GO:0031490]; enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; identical protein binding [GO:0042802]; Notch binding [GO:0005112]; transcription coactivator activity [GO:0003713]; transcription regulator activator activity [GO:0140537]; transmembrane signaling receptor activity [GO:0004888] g19879.t2 P46531 35.757 1348 3.16e-160 553.0 sp|P46531|NOTC1_HUMAN Neurogenic locus notch homolog protein 1 OS=Homo sapiens OX=9606 GN=NOTCH1 PE=1 SV=4 NOTC1_HUMAN reviewed Neurogenic locus notch homolog protein 1 (Notch 1) (hN1) (Translocation-associated notch protein TAN-1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Homo sapiens (Human) GO:0000122; GO:0000139; GO:0001554; GO:0001669; GO:0001701; GO:0001837; GO:0001889; GO:0001947; GO:0002040; GO:0002052; GO:0002085; GO:0002193; GO:0002437; GO:0003151; GO:0003157; GO:0003160; GO:0003162; GO:0003169; GO:0003180; GO:0003181; GO:0003182; GO:0003184; GO:0003192; GO:0003198; GO:0003203; GO:0003207; GO:0003208; GO:0003209; GO:0003213; GO:0003214; GO:0003219; GO:0003222; GO:0003241; GO:0003252; GO:0003270; GO:0003273; GO:0003332; GO:0003344; GO:0003713; GO:0004857; GO:0004888; GO:0005112; GO:0005509; GO:0005576; GO:0005634; GO:0005654; GO:0005789; GO:0005829; GO:0005886; GO:0005912; GO:0006355; GO:0006357; GO:0006366; GO:0006606; GO:0006955; GO:0006959; GO:0007219; GO:0007221; GO:0007283; GO:0007368; GO:0007386; GO:0007411; GO:0007440; GO:0007492; GO:0007507; GO:0008284; GO:0008285; GO:0009912; GO:0009957; GO:0009986; GO:0010008; GO:0010614; GO:0010628; GO:0010629; GO:0010667; GO:0010812; GO:0010832; GO:0014031; GO:0014807; GO:0016324; GO:0017156; GO:0019899; GO:0021515; GO:0021915; GO:0021953; GO:0030163; GO:0030216; GO:0030279; GO:0030324; GO:0030335; GO:0030513; GO:0030514; GO:0030900; GO:0031069; GO:0031100; GO:0031490; GO:0031902; GO:0032495; GO:0032496; GO:0032966; GO:0035116; GO:0035148; GO:0035914; GO:0035924; GO:0042246; GO:0042670; GO:0042802; GO:0043086; GO:0043235; GO:0045070; GO:0045603; GO:0045608; GO:0045618; GO:0045662; GO:0045668; GO:0045747; GO:0045892; GO:0045893; GO:0045944; GO:0045955; GO:0046427; GO:0046533; GO:0046579; GO:0048103; GO:0048708; GO:0048709; GO:0048711; GO:0048715; GO:0048754; GO:0048873; GO:0050673; GO:0050679; GO:0050680; GO:0050768; GO:0051152; GO:0055008; GO:0060038; GO:0060045; GO:0060253; GO:0060271; GO:0060317; GO:0060354; GO:0060379; GO:0060411; GO:0060412; GO:0060528; GO:0060740; GO:0060768; GO:0060842; GO:0060843; GO:0060948; GO:0060956; GO:0060979; GO:0060982; GO:0061101; GO:0061344; GO:0061384; GO:0062043; GO:0070168; GO:0070374; GO:0070986; GO:0071228; GO:0071372; GO:0071456; GO:0072017; GO:0072044; GO:0072091; GO:0072144; GO:0072148; GO:0072538; GO:0090051; GO:0090090; GO:0097150; GO:0097400; GO:0098685; GO:0098839; GO:0098978; GO:0099565; GO:0120163; GO:0140537; GO:1901201; GO:1902263; GO:1902339; GO:1903849; GO:2000048; GO:2000737; GO:2000811; GO:2000974; GO:2001027 animal organ regeneration [GO:0031100]; aortic valve morphogenesis [GO:0003180]; apoptotic process involved in embryonic digit morphogenesis [GO:1902263]; arterial endothelial cell differentiation [GO:0060842]; astrocyte differentiation [GO:0048708]; atrioventricular node development [GO:0003162]; atrioventricular valve morphogenesis [GO:0003181]; auditory receptor cell fate commitment [GO:0009912]; axon guidance [GO:0007411]; branching morphogenesis of an epithelial tube [GO:0048754]; calcium-ion regulated exocytosis [GO:0017156]; cardiac atrium morphogenesis [GO:0003209]; cardiac chamber formation [GO:0003207]; cardiac epithelial to mesenchymal transition [GO:0060317]; cardiac left ventricle morphogenesis [GO:0003214]; cardiac muscle cell myoblast differentiation [GO:0060379]; cardiac muscle cell proliferation [GO:0060038]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac right atrium morphogenesis [GO:0003213]; cardiac right ventricle formation [GO:0003219]; cardiac septum morphogenesis [GO:0060411]; cardiac vascular smooth muscle cell development [GO:0060948]; cardiac ventricle morphogenesis [GO:0003208]; cell differentiation in spinal cord [GO:0021515]; cell migration involved in endocardial cushion formation [GO:0003273]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to hypoxia [GO:0071456]; cellular response to tumor cell [GO:0071228]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; central nervous system neuron differentiation [GO:0021953]; chemical synaptic transmission, postsynaptic [GO:0099565]; cilium assembly [GO:0060271]; collecting duct development [GO:0072044]; compartment pattern specification [GO:0007386]; coronary artery morphogenesis [GO:0060982]; coronary sinus valve morphogenesis [GO:0003182]; coronary vein morphogenesis [GO:0003169]; determination of left/right symmetry [GO:0007368]; distal tubule development [GO:0072017]; embryonic hindlimb morphogenesis [GO:0035116]; endocardial cell differentiation [GO:0060956]; endocardial cushion morphogenesis [GO:0003203]; endocardium development [GO:0003157]; endocardium morphogenesis [GO:0003160]; endoderm development [GO:0007492]; epidermal cell fate specification [GO:0009957]; epithelial cell fate commitment [GO:0072148]; epithelial cell proliferation [GO:0050673]; epithelial to mesenchymal transition [GO:0001837]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; forebrain development [GO:0030900]; foregut morphogenesis [GO:0007440]; glomerular mesangial cell development [GO:0072144]; growth involved in heart morphogenesis [GO:0003241]; hair follicle morphogenesis [GO:0031069]; heart development [GO:0007507]; heart looping [GO:0001947]; heart trabecula morphogenesis [GO:0061384]; homeostasis of number of cells within a tissue [GO:0048873]; humoral immune response [GO:0006959]; immune response [GO:0006955]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; inhibition of neuroepithelial cell differentiation [GO:0002085]; interleukin-17-mediated signaling pathway [GO:0097400]; keratinocyte differentiation [GO:0030216]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; lung development [GO:0030324]; luteolysis [GO:0001554]; mesenchymal cell development [GO:0014031]; mitral valve formation [GO:0003192]; negative regulation of anoikis [GO:2000811]; negative regulation of biomineral tissue development [GO:0070168]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of catalytic activity [GO:0043086]; negative regulation of cell adhesion molecule production [GO:0060354]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell proliferation involved in heart valve morphogenesis [GO:0003252]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of collagen biosynthetic process [GO:0032966]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of endothelial cell chemotaxis [GO:2001027]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of extracellular matrix constituent secretion [GO:0003332]; negative regulation of gene expression [GO:0010629]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of inner ear auditory receptor cell differentiation [GO:0045608]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of neurogenesis [GO:0050768]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of ossification [GO:0030279]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of photoreceptor cell differentiation [GO:0046533]; negative regulation of pro-B cell differentiation [GO:2000974]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural tube development [GO:0021915]; neuroendocrine cell differentiation [GO:0061101]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; Notch signaling pathway involved in regulation of secondary heart field cardioblast proliferation [GO:0003270]; oligodendrocyte differentiation [GO:0048709]; outflow tract morphogenesis [GO:0003151]; pericardium morphogenesis [GO:0003344]; positive regulation of aorta morphogenesis [GO:1903849]; positive regulation of apoptotic process involved in morphogenesis [GO:1902339]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cardiac epithelial to mesenchymal transition [GO:0062043]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of smooth muscle cell differentiation [GO:0051152]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription of Notch receptor target [GO:0007221]; positive regulation of viral genome replication [GO:0045070]; prostate gland epithelium morphogenesis [GO:0060740]; protein catabolic process [GO:0030163]; protein import into nucleus [GO:0006606]; pulmonary valve morphogenesis [GO:0003184]; regulation of cell adhesion involved in heart morphogenesis [GO:0061344]; regulation of DNA-templated transcription [GO:0006355]; regulation of epithelial cell proliferation involved in prostate gland development [GO:0060768]; regulation of extracellular matrix assembly [GO:1901201]; regulation of somitogenesis [GO:0014807]; regulation of stem cell proliferation [GO:0072091]; regulation of transcription by RNA polymerase II [GO:0006357]; response to lipopolysaccharide [GO:0032496]; response to muramyl dipeptide [GO:0032495]; retinal cone cell differentiation [GO:0042670]; secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development [GO:0060528]; skeletal muscle cell differentiation [GO:0035914]; somatic stem cell division [GO:0048103]; spermatogenesis [GO:0007283]; sprouting angiogenesis [GO:0002040]; T-helper 17 type immune response [GO:0072538]; tissue regeneration [GO:0042246]; transcription by RNA polymerase II [GO:0006366]; tube formation [GO:0035148]; vasculogenesis involved in coronary vascular morphogenesis [GO:0060979]; venous endothelial cell differentiation [GO:0060843]; ventricular septum morphogenesis [GO:0060412]; ventricular trabecula myocardium morphogenesis [GO:0003222] acrosomal vesicle [GO:0001669]; adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; late endosome membrane [GO:0031902]; MAML1-RBP-Jkappa- ICN1 complex [GO:0002193]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; receptor complex [GO:0043235]; Schaffer collateral - CA1 synapse [GO:0098685] calcium ion binding [GO:0005509]; chromatin DNA binding [GO:0031490]; enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; identical protein binding [GO:0042802]; Notch binding [GO:0005112]; transcription coactivator activity [GO:0003713]; transcription regulator activator activity [GO:0140537]; transmembrane signaling receptor activity [GO:0004888] g19879.t2 P46531 35.697 1227 1.98e-147 514.0 sp|P46531|NOTC1_HUMAN Neurogenic locus notch homolog protein 1 OS=Homo sapiens OX=9606 GN=NOTCH1 PE=1 SV=4 NOTC1_HUMAN reviewed Neurogenic locus notch homolog protein 1 (Notch 1) (hN1) (Translocation-associated notch protein TAN-1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Homo sapiens (Human) GO:0000122; GO:0000139; GO:0001554; GO:0001669; GO:0001701; GO:0001837; GO:0001889; GO:0001947; GO:0002040; GO:0002052; GO:0002085; GO:0002193; GO:0002437; GO:0003151; GO:0003157; GO:0003160; GO:0003162; GO:0003169; GO:0003180; GO:0003181; GO:0003182; GO:0003184; GO:0003192; GO:0003198; GO:0003203; GO:0003207; GO:0003208; GO:0003209; GO:0003213; GO:0003214; GO:0003219; GO:0003222; GO:0003241; GO:0003252; GO:0003270; GO:0003273; GO:0003332; GO:0003344; GO:0003713; GO:0004857; GO:0004888; GO:0005112; GO:0005509; GO:0005576; GO:0005634; GO:0005654; GO:0005789; GO:0005829; GO:0005886; GO:0005912; GO:0006355; GO:0006357; GO:0006366; GO:0006606; GO:0006955; GO:0006959; GO:0007219; GO:0007221; GO:0007283; GO:0007368; GO:0007386; GO:0007411; GO:0007440; GO:0007492; GO:0007507; GO:0008284; GO:0008285; GO:0009912; GO:0009957; GO:0009986; GO:0010008; GO:0010614; GO:0010628; GO:0010629; GO:0010667; GO:0010812; GO:0010832; GO:0014031; GO:0014807; GO:0016324; GO:0017156; GO:0019899; GO:0021515; GO:0021915; GO:0021953; GO:0030163; GO:0030216; GO:0030279; GO:0030324; GO:0030335; GO:0030513; GO:0030514; GO:0030900; GO:0031069; GO:0031100; GO:0031490; GO:0031902; GO:0032495; GO:0032496; GO:0032966; GO:0035116; GO:0035148; GO:0035914; GO:0035924; GO:0042246; GO:0042670; GO:0042802; GO:0043086; GO:0043235; GO:0045070; GO:0045603; GO:0045608; GO:0045618; GO:0045662; GO:0045668; GO:0045747; GO:0045892; GO:0045893; GO:0045944; GO:0045955; GO:0046427; GO:0046533; GO:0046579; GO:0048103; GO:0048708; GO:0048709; GO:0048711; GO:0048715; GO:0048754; GO:0048873; GO:0050673; GO:0050679; GO:0050680; GO:0050768; GO:0051152; GO:0055008; GO:0060038; GO:0060045; GO:0060253; GO:0060271; GO:0060317; GO:0060354; GO:0060379; GO:0060411; GO:0060412; GO:0060528; GO:0060740; GO:0060768; GO:0060842; GO:0060843; GO:0060948; GO:0060956; GO:0060979; GO:0060982; GO:0061101; GO:0061344; GO:0061384; GO:0062043; GO:0070168; GO:0070374; GO:0070986; GO:0071228; GO:0071372; GO:0071456; GO:0072017; GO:0072044; GO:0072091; GO:0072144; GO:0072148; GO:0072538; GO:0090051; GO:0090090; GO:0097150; GO:0097400; GO:0098685; GO:0098839; GO:0098978; GO:0099565; GO:0120163; GO:0140537; GO:1901201; GO:1902263; GO:1902339; GO:1903849; GO:2000048; GO:2000737; GO:2000811; GO:2000974; GO:2001027 animal organ regeneration [GO:0031100]; aortic valve morphogenesis [GO:0003180]; apoptotic process involved in embryonic digit morphogenesis [GO:1902263]; arterial endothelial cell differentiation [GO:0060842]; astrocyte differentiation [GO:0048708]; atrioventricular node development [GO:0003162]; atrioventricular valve morphogenesis [GO:0003181]; auditory receptor cell fate commitment [GO:0009912]; axon guidance [GO:0007411]; branching morphogenesis of an epithelial tube [GO:0048754]; calcium-ion regulated exocytosis [GO:0017156]; cardiac atrium morphogenesis [GO:0003209]; cardiac chamber formation [GO:0003207]; cardiac epithelial to mesenchymal transition [GO:0060317]; cardiac left ventricle morphogenesis [GO:0003214]; cardiac muscle cell myoblast differentiation [GO:0060379]; cardiac muscle cell proliferation [GO:0060038]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac right atrium morphogenesis [GO:0003213]; cardiac right ventricle formation [GO:0003219]; cardiac septum morphogenesis [GO:0060411]; cardiac vascular smooth muscle cell development [GO:0060948]; cardiac ventricle morphogenesis [GO:0003208]; cell differentiation in spinal cord [GO:0021515]; cell migration involved in endocardial cushion formation [GO:0003273]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to hypoxia [GO:0071456]; cellular response to tumor cell [GO:0071228]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; central nervous system neuron differentiation [GO:0021953]; chemical synaptic transmission, postsynaptic [GO:0099565]; cilium assembly [GO:0060271]; collecting duct development [GO:0072044]; compartment pattern specification [GO:0007386]; coronary artery morphogenesis [GO:0060982]; coronary sinus valve morphogenesis [GO:0003182]; coronary vein morphogenesis [GO:0003169]; determination of left/right symmetry [GO:0007368]; distal tubule development [GO:0072017]; embryonic hindlimb morphogenesis [GO:0035116]; endocardial cell differentiation [GO:0060956]; endocardial cushion morphogenesis [GO:0003203]; endocardium development [GO:0003157]; endocardium morphogenesis [GO:0003160]; endoderm development [GO:0007492]; epidermal cell fate specification [GO:0009957]; epithelial cell fate commitment [GO:0072148]; epithelial cell proliferation [GO:0050673]; epithelial to mesenchymal transition [GO:0001837]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; forebrain development [GO:0030900]; foregut morphogenesis [GO:0007440]; glomerular mesangial cell development [GO:0072144]; growth involved in heart morphogenesis [GO:0003241]; hair follicle morphogenesis [GO:0031069]; heart development [GO:0007507]; heart looping [GO:0001947]; heart trabecula morphogenesis [GO:0061384]; homeostasis of number of cells within a tissue [GO:0048873]; humoral immune response [GO:0006959]; immune response [GO:0006955]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; inhibition of neuroepithelial cell differentiation [GO:0002085]; interleukin-17-mediated signaling pathway [GO:0097400]; keratinocyte differentiation [GO:0030216]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; lung development [GO:0030324]; luteolysis [GO:0001554]; mesenchymal cell development [GO:0014031]; mitral valve formation [GO:0003192]; negative regulation of anoikis [GO:2000811]; negative regulation of biomineral tissue development [GO:0070168]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of catalytic activity [GO:0043086]; negative regulation of cell adhesion molecule production [GO:0060354]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell proliferation involved in heart valve morphogenesis [GO:0003252]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of collagen biosynthetic process [GO:0032966]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of endothelial cell chemotaxis [GO:2001027]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of extracellular matrix constituent secretion [GO:0003332]; negative regulation of gene expression [GO:0010629]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of inner ear auditory receptor cell differentiation [GO:0045608]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of neurogenesis [GO:0050768]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of ossification [GO:0030279]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of photoreceptor cell differentiation [GO:0046533]; negative regulation of pro-B cell differentiation [GO:2000974]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural tube development [GO:0021915]; neuroendocrine cell differentiation [GO:0061101]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; Notch signaling pathway involved in regulation of secondary heart field cardioblast proliferation [GO:0003270]; oligodendrocyte differentiation [GO:0048709]; outflow tract morphogenesis [GO:0003151]; pericardium morphogenesis [GO:0003344]; positive regulation of aorta morphogenesis [GO:1903849]; positive regulation of apoptotic process involved in morphogenesis [GO:1902339]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cardiac epithelial to mesenchymal transition [GO:0062043]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of smooth muscle cell differentiation [GO:0051152]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription of Notch receptor target [GO:0007221]; positive regulation of viral genome replication [GO:0045070]; prostate gland epithelium morphogenesis [GO:0060740]; protein catabolic process [GO:0030163]; protein import into nucleus [GO:0006606]; pulmonary valve morphogenesis [GO:0003184]; regulation of cell adhesion involved in heart morphogenesis [GO:0061344]; regulation of DNA-templated transcription [GO:0006355]; regulation of epithelial cell proliferation involved in prostate gland development [GO:0060768]; regulation of extracellular matrix assembly [GO:1901201]; regulation of somitogenesis [GO:0014807]; regulation of stem cell proliferation [GO:0072091]; regulation of transcription by RNA polymerase II [GO:0006357]; response to lipopolysaccharide [GO:0032496]; response to muramyl dipeptide [GO:0032495]; retinal cone cell differentiation [GO:0042670]; secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development [GO:0060528]; skeletal muscle cell differentiation [GO:0035914]; somatic stem cell division [GO:0048103]; spermatogenesis [GO:0007283]; sprouting angiogenesis [GO:0002040]; T-helper 17 type immune response [GO:0072538]; tissue regeneration [GO:0042246]; transcription by RNA polymerase II [GO:0006366]; tube formation [GO:0035148]; vasculogenesis involved in coronary vascular morphogenesis [GO:0060979]; venous endothelial cell differentiation [GO:0060843]; ventricular septum morphogenesis [GO:0060412]; ventricular trabecula myocardium morphogenesis [GO:0003222] acrosomal vesicle [GO:0001669]; adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; late endosome membrane [GO:0031902]; MAML1-RBP-Jkappa- ICN1 complex [GO:0002193]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; receptor complex [GO:0043235]; Schaffer collateral - CA1 synapse [GO:0098685] calcium ion binding [GO:0005509]; chromatin DNA binding [GO:0031490]; enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; identical protein binding [GO:0042802]; Notch binding [GO:0005112]; transcription coactivator activity [GO:0003713]; transcription regulator activator activity [GO:0140537]; transmembrane signaling receptor activity [GO:0004888] g19879.t2 P46531 35.498 1124 1.62e-145 508.0 sp|P46531|NOTC1_HUMAN Neurogenic locus notch homolog protein 1 OS=Homo sapiens OX=9606 GN=NOTCH1 PE=1 SV=4 NOTC1_HUMAN reviewed Neurogenic locus notch homolog protein 1 (Notch 1) (hN1) (Translocation-associated notch protein TAN-1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Homo sapiens (Human) GO:0000122; GO:0000139; GO:0001554; GO:0001669; GO:0001701; GO:0001837; GO:0001889; GO:0001947; GO:0002040; GO:0002052; GO:0002085; GO:0002193; GO:0002437; GO:0003151; GO:0003157; GO:0003160; GO:0003162; GO:0003169; GO:0003180; GO:0003181; GO:0003182; GO:0003184; GO:0003192; GO:0003198; GO:0003203; GO:0003207; GO:0003208; GO:0003209; GO:0003213; GO:0003214; GO:0003219; GO:0003222; GO:0003241; GO:0003252; GO:0003270; GO:0003273; GO:0003332; GO:0003344; GO:0003713; GO:0004857; GO:0004888; GO:0005112; GO:0005509; GO:0005576; GO:0005634; GO:0005654; GO:0005789; GO:0005829; GO:0005886; GO:0005912; GO:0006355; GO:0006357; GO:0006366; GO:0006606; GO:0006955; GO:0006959; GO:0007219; GO:0007221; GO:0007283; GO:0007368; GO:0007386; GO:0007411; GO:0007440; GO:0007492; GO:0007507; GO:0008284; GO:0008285; GO:0009912; GO:0009957; GO:0009986; GO:0010008; GO:0010614; GO:0010628; GO:0010629; GO:0010667; GO:0010812; GO:0010832; GO:0014031; GO:0014807; GO:0016324; GO:0017156; GO:0019899; GO:0021515; GO:0021915; GO:0021953; GO:0030163; GO:0030216; GO:0030279; GO:0030324; GO:0030335; GO:0030513; GO:0030514; GO:0030900; GO:0031069; GO:0031100; GO:0031490; GO:0031902; GO:0032495; GO:0032496; GO:0032966; GO:0035116; GO:0035148; GO:0035914; GO:0035924; GO:0042246; GO:0042670; GO:0042802; GO:0043086; GO:0043235; GO:0045070; GO:0045603; GO:0045608; GO:0045618; GO:0045662; GO:0045668; GO:0045747; GO:0045892; GO:0045893; GO:0045944; GO:0045955; GO:0046427; GO:0046533; GO:0046579; GO:0048103; GO:0048708; GO:0048709; GO:0048711; GO:0048715; GO:0048754; GO:0048873; GO:0050673; GO:0050679; GO:0050680; GO:0050768; GO:0051152; GO:0055008; GO:0060038; GO:0060045; GO:0060253; GO:0060271; GO:0060317; GO:0060354; GO:0060379; GO:0060411; GO:0060412; GO:0060528; GO:0060740; GO:0060768; GO:0060842; GO:0060843; GO:0060948; GO:0060956; GO:0060979; GO:0060982; GO:0061101; GO:0061344; GO:0061384; GO:0062043; GO:0070168; GO:0070374; GO:0070986; GO:0071228; GO:0071372; GO:0071456; GO:0072017; GO:0072044; GO:0072091; GO:0072144; GO:0072148; GO:0072538; GO:0090051; GO:0090090; GO:0097150; GO:0097400; GO:0098685; GO:0098839; GO:0098978; GO:0099565; GO:0120163; GO:0140537; GO:1901201; GO:1902263; GO:1902339; GO:1903849; GO:2000048; GO:2000737; GO:2000811; GO:2000974; GO:2001027 animal organ regeneration [GO:0031100]; aortic valve morphogenesis [GO:0003180]; apoptotic process involved in embryonic digit morphogenesis [GO:1902263]; arterial endothelial cell differentiation [GO:0060842]; astrocyte differentiation [GO:0048708]; atrioventricular node development [GO:0003162]; atrioventricular valve morphogenesis [GO:0003181]; auditory receptor cell fate commitment [GO:0009912]; axon guidance [GO:0007411]; branching morphogenesis of an epithelial tube [GO:0048754]; calcium-ion regulated exocytosis [GO:0017156]; cardiac atrium morphogenesis [GO:0003209]; cardiac chamber formation [GO:0003207]; cardiac epithelial to mesenchymal transition [GO:0060317]; cardiac left ventricle morphogenesis [GO:0003214]; cardiac muscle cell myoblast differentiation [GO:0060379]; cardiac muscle cell proliferation [GO:0060038]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac right atrium morphogenesis [GO:0003213]; cardiac right ventricle formation [GO:0003219]; cardiac septum morphogenesis [GO:0060411]; cardiac vascular smooth muscle cell development [GO:0060948]; cardiac ventricle morphogenesis [GO:0003208]; cell differentiation in spinal cord [GO:0021515]; cell migration involved in endocardial cushion formation [GO:0003273]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to hypoxia [GO:0071456]; cellular response to tumor cell [GO:0071228]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; central nervous system neuron differentiation [GO:0021953]; chemical synaptic transmission, postsynaptic [GO:0099565]; cilium assembly [GO:0060271]; collecting duct development [GO:0072044]; compartment pattern specification [GO:0007386]; coronary artery morphogenesis [GO:0060982]; coronary sinus valve morphogenesis [GO:0003182]; coronary vein morphogenesis [GO:0003169]; determination of left/right symmetry [GO:0007368]; distal tubule development [GO:0072017]; embryonic hindlimb morphogenesis [GO:0035116]; endocardial cell differentiation [GO:0060956]; endocardial cushion morphogenesis [GO:0003203]; endocardium development [GO:0003157]; endocardium morphogenesis [GO:0003160]; endoderm development [GO:0007492]; epidermal cell fate specification [GO:0009957]; epithelial cell fate commitment [GO:0072148]; epithelial cell proliferation [GO:0050673]; epithelial to mesenchymal transition [GO:0001837]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; forebrain development [GO:0030900]; foregut morphogenesis [GO:0007440]; glomerular mesangial cell development [GO:0072144]; growth involved in heart morphogenesis [GO:0003241]; hair follicle morphogenesis [GO:0031069]; heart development [GO:0007507]; heart looping [GO:0001947]; heart trabecula morphogenesis [GO:0061384]; homeostasis of number of cells within a tissue [GO:0048873]; humoral immune response [GO:0006959]; immune response [GO:0006955]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; inhibition of neuroepithelial cell differentiation [GO:0002085]; interleukin-17-mediated signaling pathway [GO:0097400]; keratinocyte differentiation [GO:0030216]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; lung development [GO:0030324]; luteolysis [GO:0001554]; mesenchymal cell development [GO:0014031]; mitral valve formation [GO:0003192]; negative regulation of anoikis [GO:2000811]; negative regulation of biomineral tissue development [GO:0070168]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of catalytic activity [GO:0043086]; negative regulation of cell adhesion molecule production [GO:0060354]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell proliferation involved in heart valve morphogenesis [GO:0003252]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of collagen biosynthetic process [GO:0032966]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of endothelial cell chemotaxis [GO:2001027]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of extracellular matrix constituent secretion [GO:0003332]; negative regulation of gene expression [GO:0010629]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of inner ear auditory receptor cell differentiation [GO:0045608]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of neurogenesis [GO:0050768]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of ossification [GO:0030279]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of photoreceptor cell differentiation [GO:0046533]; negative regulation of pro-B cell differentiation [GO:2000974]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural tube development [GO:0021915]; neuroendocrine cell differentiation [GO:0061101]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; Notch signaling pathway involved in regulation of secondary heart field cardioblast proliferation [GO:0003270]; oligodendrocyte differentiation [GO:0048709]; outflow tract morphogenesis [GO:0003151]; pericardium morphogenesis [GO:0003344]; positive regulation of aorta morphogenesis [GO:1903849]; positive regulation of apoptotic process involved in morphogenesis [GO:1902339]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cardiac epithelial to mesenchymal transition [GO:0062043]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of smooth muscle cell differentiation [GO:0051152]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription of Notch receptor target [GO:0007221]; positive regulation of viral genome replication [GO:0045070]; prostate gland epithelium morphogenesis [GO:0060740]; protein catabolic process [GO:0030163]; protein import into nucleus [GO:0006606]; pulmonary valve morphogenesis [GO:0003184]; regulation of cell adhesion involved in heart morphogenesis [GO:0061344]; regulation of DNA-templated transcription [GO:0006355]; regulation of epithelial cell proliferation involved in prostate gland development [GO:0060768]; regulation of extracellular matrix assembly [GO:1901201]; regulation of somitogenesis [GO:0014807]; regulation of stem cell proliferation [GO:0072091]; regulation of transcription by RNA polymerase II [GO:0006357]; response to lipopolysaccharide [GO:0032496]; response to muramyl dipeptide [GO:0032495]; retinal cone cell differentiation [GO:0042670]; secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development [GO:0060528]; skeletal muscle cell differentiation [GO:0035914]; somatic stem cell division [GO:0048103]; spermatogenesis [GO:0007283]; sprouting angiogenesis [GO:0002040]; T-helper 17 type immune response [GO:0072538]; tissue regeneration [GO:0042246]; transcription by RNA polymerase II [GO:0006366]; tube formation [GO:0035148]; vasculogenesis involved in coronary vascular morphogenesis [GO:0060979]; venous endothelial cell differentiation [GO:0060843]; ventricular septum morphogenesis [GO:0060412]; ventricular trabecula myocardium morphogenesis [GO:0003222] acrosomal vesicle [GO:0001669]; adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; late endosome membrane [GO:0031902]; MAML1-RBP-Jkappa- ICN1 complex [GO:0002193]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; receptor complex [GO:0043235]; Schaffer collateral - CA1 synapse [GO:0098685] calcium ion binding [GO:0005509]; chromatin DNA binding [GO:0031490]; enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; identical protein binding [GO:0042802]; Notch binding [GO:0005112]; transcription coactivator activity [GO:0003713]; transcription regulator activator activity [GO:0140537]; transmembrane signaling receptor activity [GO:0004888] g19879.t2 P46531 36.457 1067 4.47e-139 488.0 sp|P46531|NOTC1_HUMAN Neurogenic locus notch homolog protein 1 OS=Homo sapiens OX=9606 GN=NOTCH1 PE=1 SV=4 NOTC1_HUMAN reviewed Neurogenic locus notch homolog protein 1 (Notch 1) (hN1) (Translocation-associated notch protein TAN-1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Homo sapiens (Human) GO:0000122; GO:0000139; GO:0001554; GO:0001669; GO:0001701; GO:0001837; GO:0001889; GO:0001947; GO:0002040; GO:0002052; GO:0002085; GO:0002193; GO:0002437; GO:0003151; GO:0003157; GO:0003160; GO:0003162; GO:0003169; GO:0003180; GO:0003181; GO:0003182; GO:0003184; GO:0003192; GO:0003198; GO:0003203; GO:0003207; GO:0003208; GO:0003209; GO:0003213; GO:0003214; GO:0003219; GO:0003222; GO:0003241; GO:0003252; GO:0003270; GO:0003273; GO:0003332; GO:0003344; GO:0003713; GO:0004857; GO:0004888; GO:0005112; GO:0005509; GO:0005576; GO:0005634; GO:0005654; GO:0005789; GO:0005829; GO:0005886; GO:0005912; GO:0006355; GO:0006357; GO:0006366; GO:0006606; GO:0006955; GO:0006959; GO:0007219; GO:0007221; GO:0007283; GO:0007368; GO:0007386; GO:0007411; GO:0007440; GO:0007492; GO:0007507; GO:0008284; GO:0008285; GO:0009912; GO:0009957; GO:0009986; GO:0010008; GO:0010614; GO:0010628; GO:0010629; GO:0010667; GO:0010812; GO:0010832; GO:0014031; GO:0014807; GO:0016324; GO:0017156; GO:0019899; GO:0021515; GO:0021915; GO:0021953; GO:0030163; GO:0030216; GO:0030279; GO:0030324; GO:0030335; GO:0030513; GO:0030514; GO:0030900; GO:0031069; GO:0031100; GO:0031490; GO:0031902; GO:0032495; GO:0032496; GO:0032966; GO:0035116; GO:0035148; GO:0035914; GO:0035924; GO:0042246; GO:0042670; GO:0042802; GO:0043086; GO:0043235; GO:0045070; GO:0045603; GO:0045608; GO:0045618; GO:0045662; GO:0045668; GO:0045747; GO:0045892; GO:0045893; GO:0045944; GO:0045955; GO:0046427; GO:0046533; GO:0046579; GO:0048103; GO:0048708; GO:0048709; GO:0048711; GO:0048715; GO:0048754; GO:0048873; GO:0050673; GO:0050679; GO:0050680; GO:0050768; GO:0051152; GO:0055008; GO:0060038; GO:0060045; GO:0060253; GO:0060271; GO:0060317; GO:0060354; GO:0060379; GO:0060411; GO:0060412; GO:0060528; GO:0060740; GO:0060768; GO:0060842; GO:0060843; GO:0060948; GO:0060956; GO:0060979; GO:0060982; GO:0061101; GO:0061344; GO:0061384; GO:0062043; GO:0070168; GO:0070374; GO:0070986; GO:0071228; GO:0071372; GO:0071456; GO:0072017; GO:0072044; GO:0072091; GO:0072144; GO:0072148; GO:0072538; GO:0090051; GO:0090090; GO:0097150; GO:0097400; GO:0098685; GO:0098839; GO:0098978; GO:0099565; GO:0120163; GO:0140537; GO:1901201; GO:1902263; GO:1902339; GO:1903849; GO:2000048; GO:2000737; GO:2000811; GO:2000974; GO:2001027 animal organ regeneration [GO:0031100]; aortic valve morphogenesis [GO:0003180]; apoptotic process involved in embryonic digit morphogenesis [GO:1902263]; arterial endothelial cell differentiation [GO:0060842]; astrocyte differentiation [GO:0048708]; atrioventricular node development [GO:0003162]; atrioventricular valve morphogenesis [GO:0003181]; auditory receptor cell fate commitment [GO:0009912]; axon guidance [GO:0007411]; branching morphogenesis of an epithelial tube [GO:0048754]; calcium-ion regulated exocytosis [GO:0017156]; cardiac atrium morphogenesis [GO:0003209]; cardiac chamber formation [GO:0003207]; cardiac epithelial to mesenchymal transition [GO:0060317]; cardiac left ventricle morphogenesis [GO:0003214]; cardiac muscle cell myoblast differentiation [GO:0060379]; cardiac muscle cell proliferation [GO:0060038]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac right atrium morphogenesis [GO:0003213]; cardiac right ventricle formation [GO:0003219]; cardiac septum morphogenesis [GO:0060411]; cardiac vascular smooth muscle cell development [GO:0060948]; cardiac ventricle morphogenesis [GO:0003208]; cell differentiation in spinal cord [GO:0021515]; cell migration involved in endocardial cushion formation [GO:0003273]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to hypoxia [GO:0071456]; cellular response to tumor cell [GO:0071228]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; central nervous system neuron differentiation [GO:0021953]; chemical synaptic transmission, postsynaptic [GO:0099565]; cilium assembly [GO:0060271]; collecting duct development [GO:0072044]; compartment pattern specification [GO:0007386]; coronary artery morphogenesis [GO:0060982]; coronary sinus valve morphogenesis [GO:0003182]; coronary vein morphogenesis [GO:0003169]; determination of left/right symmetry [GO:0007368]; distal tubule development [GO:0072017]; embryonic hindlimb morphogenesis [GO:0035116]; endocardial cell differentiation [GO:0060956]; endocardial cushion morphogenesis [GO:0003203]; endocardium development [GO:0003157]; endocardium morphogenesis [GO:0003160]; endoderm development [GO:0007492]; epidermal cell fate specification [GO:0009957]; epithelial cell fate commitment [GO:0072148]; epithelial cell proliferation [GO:0050673]; epithelial to mesenchymal transition [GO:0001837]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; forebrain development [GO:0030900]; foregut morphogenesis [GO:0007440]; glomerular mesangial cell development [GO:0072144]; growth involved in heart morphogenesis [GO:0003241]; hair follicle morphogenesis [GO:0031069]; heart development [GO:0007507]; heart looping [GO:0001947]; heart trabecula morphogenesis [GO:0061384]; homeostasis of number of cells within a tissue [GO:0048873]; humoral immune response [GO:0006959]; immune response [GO:0006955]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; inhibition of neuroepithelial cell differentiation [GO:0002085]; interleukin-17-mediated signaling pathway [GO:0097400]; keratinocyte differentiation [GO:0030216]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; lung development [GO:0030324]; luteolysis [GO:0001554]; mesenchymal cell development [GO:0014031]; mitral valve formation [GO:0003192]; negative regulation of anoikis [GO:2000811]; negative regulation of biomineral tissue development [GO:0070168]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of catalytic activity [GO:0043086]; negative regulation of cell adhesion molecule production [GO:0060354]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell proliferation involved in heart valve morphogenesis [GO:0003252]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of collagen biosynthetic process [GO:0032966]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of endothelial cell chemotaxis [GO:2001027]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of extracellular matrix constituent secretion [GO:0003332]; negative regulation of gene expression [GO:0010629]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of inner ear auditory receptor cell differentiation [GO:0045608]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of neurogenesis [GO:0050768]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of ossification [GO:0030279]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of photoreceptor cell differentiation [GO:0046533]; negative regulation of pro-B cell differentiation [GO:2000974]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural tube development [GO:0021915]; neuroendocrine cell differentiation [GO:0061101]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; Notch signaling pathway involved in regulation of secondary heart field cardioblast proliferation [GO:0003270]; oligodendrocyte differentiation [GO:0048709]; outflow tract morphogenesis [GO:0003151]; pericardium morphogenesis [GO:0003344]; positive regulation of aorta morphogenesis [GO:1903849]; positive regulation of apoptotic process involved in morphogenesis [GO:1902339]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cardiac epithelial to mesenchymal transition [GO:0062043]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of smooth muscle cell differentiation [GO:0051152]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription of Notch receptor target [GO:0007221]; positive regulation of viral genome replication [GO:0045070]; prostate gland epithelium morphogenesis [GO:0060740]; protein catabolic process [GO:0030163]; protein import into nucleus [GO:0006606]; pulmonary valve morphogenesis [GO:0003184]; regulation of cell adhesion involved in heart morphogenesis [GO:0061344]; regulation of DNA-templated transcription [GO:0006355]; regulation of epithelial cell proliferation involved in prostate gland development [GO:0060768]; regulation of extracellular matrix assembly [GO:1901201]; regulation of somitogenesis [GO:0014807]; regulation of stem cell proliferation [GO:0072091]; regulation of transcription by RNA polymerase II [GO:0006357]; response to lipopolysaccharide [GO:0032496]; response to muramyl dipeptide [GO:0032495]; retinal cone cell differentiation [GO:0042670]; secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development [GO:0060528]; skeletal muscle cell differentiation [GO:0035914]; somatic stem cell division [GO:0048103]; spermatogenesis [GO:0007283]; sprouting angiogenesis [GO:0002040]; T-helper 17 type immune response [GO:0072538]; tissue regeneration [GO:0042246]; transcription by RNA polymerase II [GO:0006366]; tube formation [GO:0035148]; vasculogenesis involved in coronary vascular morphogenesis [GO:0060979]; venous endothelial cell differentiation [GO:0060843]; ventricular septum morphogenesis [GO:0060412]; ventricular trabecula myocardium morphogenesis [GO:0003222] acrosomal vesicle [GO:0001669]; adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; late endosome membrane [GO:0031902]; MAML1-RBP-Jkappa- ICN1 complex [GO:0002193]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; receptor complex [GO:0043235]; Schaffer collateral - CA1 synapse [GO:0098685] calcium ion binding [GO:0005509]; chromatin DNA binding [GO:0031490]; enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; identical protein binding [GO:0042802]; Notch binding [GO:0005112]; transcription coactivator activity [GO:0003713]; transcription regulator activator activity [GO:0140537]; transmembrane signaling receptor activity [GO:0004888] g19879.t2 P46531 32.542 1432 7.73e-138 484.0 sp|P46531|NOTC1_HUMAN Neurogenic locus notch homolog protein 1 OS=Homo sapiens OX=9606 GN=NOTCH1 PE=1 SV=4 NOTC1_HUMAN reviewed Neurogenic locus notch homolog protein 1 (Notch 1) (hN1) (Translocation-associated notch protein TAN-1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Homo sapiens (Human) GO:0000122; GO:0000139; GO:0001554; GO:0001669; GO:0001701; GO:0001837; GO:0001889; GO:0001947; GO:0002040; GO:0002052; GO:0002085; GO:0002193; GO:0002437; GO:0003151; GO:0003157; GO:0003160; GO:0003162; GO:0003169; GO:0003180; GO:0003181; GO:0003182; GO:0003184; GO:0003192; GO:0003198; GO:0003203; GO:0003207; GO:0003208; GO:0003209; GO:0003213; GO:0003214; GO:0003219; GO:0003222; GO:0003241; GO:0003252; GO:0003270; GO:0003273; GO:0003332; GO:0003344; GO:0003713; GO:0004857; GO:0004888; GO:0005112; GO:0005509; GO:0005576; GO:0005634; GO:0005654; GO:0005789; GO:0005829; GO:0005886; GO:0005912; GO:0006355; GO:0006357; GO:0006366; GO:0006606; GO:0006955; GO:0006959; GO:0007219; GO:0007221; GO:0007283; GO:0007368; GO:0007386; GO:0007411; GO:0007440; GO:0007492; GO:0007507; GO:0008284; GO:0008285; GO:0009912; GO:0009957; GO:0009986; GO:0010008; GO:0010614; GO:0010628; GO:0010629; GO:0010667; GO:0010812; GO:0010832; GO:0014031; GO:0014807; GO:0016324; GO:0017156; GO:0019899; GO:0021515; GO:0021915; GO:0021953; GO:0030163; GO:0030216; GO:0030279; GO:0030324; GO:0030335; GO:0030513; GO:0030514; GO:0030900; GO:0031069; GO:0031100; GO:0031490; GO:0031902; GO:0032495; GO:0032496; GO:0032966; GO:0035116; GO:0035148; GO:0035914; GO:0035924; GO:0042246; GO:0042670; GO:0042802; GO:0043086; GO:0043235; GO:0045070; GO:0045603; GO:0045608; GO:0045618; GO:0045662; GO:0045668; GO:0045747; GO:0045892; GO:0045893; GO:0045944; GO:0045955; GO:0046427; GO:0046533; GO:0046579; GO:0048103; GO:0048708; GO:0048709; GO:0048711; GO:0048715; GO:0048754; GO:0048873; GO:0050673; GO:0050679; GO:0050680; GO:0050768; GO:0051152; GO:0055008; GO:0060038; GO:0060045; GO:0060253; GO:0060271; GO:0060317; GO:0060354; GO:0060379; GO:0060411; GO:0060412; GO:0060528; GO:0060740; GO:0060768; GO:0060842; GO:0060843; GO:0060948; GO:0060956; GO:0060979; GO:0060982; GO:0061101; GO:0061344; GO:0061384; GO:0062043; GO:0070168; GO:0070374; GO:0070986; GO:0071228; GO:0071372; GO:0071456; GO:0072017; GO:0072044; GO:0072091; GO:0072144; GO:0072148; GO:0072538; GO:0090051; GO:0090090; GO:0097150; GO:0097400; GO:0098685; GO:0098839; GO:0098978; GO:0099565; GO:0120163; GO:0140537; GO:1901201; GO:1902263; GO:1902339; GO:1903849; GO:2000048; GO:2000737; GO:2000811; GO:2000974; GO:2001027 animal organ regeneration [GO:0031100]; aortic valve morphogenesis [GO:0003180]; apoptotic process involved in embryonic digit morphogenesis [GO:1902263]; arterial endothelial cell differentiation [GO:0060842]; astrocyte differentiation [GO:0048708]; atrioventricular node development [GO:0003162]; atrioventricular valve morphogenesis [GO:0003181]; auditory receptor cell fate commitment [GO:0009912]; axon guidance [GO:0007411]; branching morphogenesis of an epithelial tube [GO:0048754]; calcium-ion regulated exocytosis [GO:0017156]; cardiac atrium morphogenesis [GO:0003209]; cardiac chamber formation [GO:0003207]; cardiac epithelial to mesenchymal transition [GO:0060317]; cardiac left ventricle morphogenesis [GO:0003214]; cardiac muscle cell myoblast differentiation [GO:0060379]; cardiac muscle cell proliferation [GO:0060038]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac right atrium morphogenesis [GO:0003213]; cardiac right ventricle formation [GO:0003219]; cardiac septum morphogenesis [GO:0060411]; cardiac vascular smooth muscle cell development [GO:0060948]; cardiac ventricle morphogenesis [GO:0003208]; cell differentiation in spinal cord [GO:0021515]; cell migration involved in endocardial cushion formation [GO:0003273]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to hypoxia [GO:0071456]; cellular response to tumor cell [GO:0071228]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; central nervous system neuron differentiation [GO:0021953]; chemical synaptic transmission, postsynaptic [GO:0099565]; cilium assembly [GO:0060271]; collecting duct development [GO:0072044]; compartment pattern specification [GO:0007386]; coronary artery morphogenesis [GO:0060982]; coronary sinus valve morphogenesis [GO:0003182]; coronary vein morphogenesis [GO:0003169]; determination of left/right symmetry [GO:0007368]; distal tubule development [GO:0072017]; embryonic hindlimb morphogenesis [GO:0035116]; endocardial cell differentiation [GO:0060956]; endocardial cushion morphogenesis [GO:0003203]; endocardium development [GO:0003157]; endocardium morphogenesis [GO:0003160]; endoderm development [GO:0007492]; epidermal cell fate specification [GO:0009957]; epithelial cell fate commitment [GO:0072148]; epithelial cell proliferation [GO:0050673]; epithelial to mesenchymal transition [GO:0001837]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; forebrain development [GO:0030900]; foregut morphogenesis [GO:0007440]; glomerular mesangial cell development [GO:0072144]; growth involved in heart morphogenesis [GO:0003241]; hair follicle morphogenesis [GO:0031069]; heart development [GO:0007507]; heart looping [GO:0001947]; heart trabecula morphogenesis [GO:0061384]; homeostasis of number of cells within a tissue [GO:0048873]; humoral immune response [GO:0006959]; immune response [GO:0006955]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; inhibition of neuroepithelial cell differentiation [GO:0002085]; interleukin-17-mediated signaling pathway [GO:0097400]; keratinocyte differentiation [GO:0030216]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; lung development [GO:0030324]; luteolysis [GO:0001554]; mesenchymal cell development [GO:0014031]; mitral valve formation [GO:0003192]; negative regulation of anoikis [GO:2000811]; negative regulation of biomineral tissue development [GO:0070168]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of catalytic activity [GO:0043086]; negative regulation of cell adhesion molecule production [GO:0060354]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell proliferation involved in heart valve morphogenesis [GO:0003252]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of collagen biosynthetic process [GO:0032966]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of endothelial cell chemotaxis [GO:2001027]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of extracellular matrix constituent secretion [GO:0003332]; negative regulation of gene expression [GO:0010629]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of inner ear auditory receptor cell differentiation [GO:0045608]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of neurogenesis [GO:0050768]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of ossification [GO:0030279]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of photoreceptor cell differentiation [GO:0046533]; negative regulation of pro-B cell differentiation [GO:2000974]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural tube development [GO:0021915]; neuroendocrine cell differentiation [GO:0061101]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; Notch signaling pathway involved in regulation of secondary heart field cardioblast proliferation [GO:0003270]; oligodendrocyte differentiation [GO:0048709]; outflow tract morphogenesis [GO:0003151]; pericardium morphogenesis [GO:0003344]; positive regulation of aorta morphogenesis [GO:1903849]; positive regulation of apoptotic process involved in morphogenesis [GO:1902339]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cardiac epithelial to mesenchymal transition [GO:0062043]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of smooth muscle cell differentiation [GO:0051152]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription of Notch receptor target [GO:0007221]; positive regulation of viral genome replication [GO:0045070]; prostate gland epithelium morphogenesis [GO:0060740]; protein catabolic process [GO:0030163]; protein import into nucleus [GO:0006606]; pulmonary valve morphogenesis [GO:0003184]; regulation of cell adhesion involved in heart morphogenesis [GO:0061344]; regulation of DNA-templated transcription [GO:0006355]; regulation of epithelial cell proliferation involved in prostate gland development [GO:0060768]; regulation of extracellular matrix assembly [GO:1901201]; regulation of somitogenesis [GO:0014807]; regulation of stem cell proliferation [GO:0072091]; regulation of transcription by RNA polymerase II [GO:0006357]; response to lipopolysaccharide [GO:0032496]; response to muramyl dipeptide [GO:0032495]; retinal cone cell differentiation [GO:0042670]; secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development [GO:0060528]; skeletal muscle cell differentiation [GO:0035914]; somatic stem cell division [GO:0048103]; spermatogenesis [GO:0007283]; sprouting angiogenesis [GO:0002040]; T-helper 17 type immune response [GO:0072538]; tissue regeneration [GO:0042246]; transcription by RNA polymerase II [GO:0006366]; tube formation [GO:0035148]; vasculogenesis involved in coronary vascular morphogenesis [GO:0060979]; venous endothelial cell differentiation [GO:0060843]; ventricular septum morphogenesis [GO:0060412]; ventricular trabecula myocardium morphogenesis [GO:0003222] acrosomal vesicle [GO:0001669]; adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; late endosome membrane [GO:0031902]; MAML1-RBP-Jkappa- ICN1 complex [GO:0002193]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; receptor complex [GO:0043235]; Schaffer collateral - CA1 synapse [GO:0098685] calcium ion binding [GO:0005509]; chromatin DNA binding [GO:0031490]; enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; identical protein binding [GO:0042802]; Notch binding [GO:0005112]; transcription coactivator activity [GO:0003713]; transcription regulator activator activity [GO:0140537]; transmembrane signaling receptor activity [GO:0004888] g19879.t2 P46531 31.793 1450 4.860000000000001e-122 435.0 sp|P46531|NOTC1_HUMAN Neurogenic locus notch homolog protein 1 OS=Homo sapiens OX=9606 GN=NOTCH1 PE=1 SV=4 NOTC1_HUMAN reviewed Neurogenic locus notch homolog protein 1 (Notch 1) (hN1) (Translocation-associated notch protein TAN-1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Homo sapiens (Human) GO:0000122; GO:0000139; GO:0001554; GO:0001669; GO:0001701; GO:0001837; GO:0001889; GO:0001947; GO:0002040; GO:0002052; GO:0002085; GO:0002193; GO:0002437; GO:0003151; GO:0003157; GO:0003160; GO:0003162; GO:0003169; GO:0003180; GO:0003181; GO:0003182; GO:0003184; GO:0003192; GO:0003198; GO:0003203; GO:0003207; GO:0003208; GO:0003209; GO:0003213; GO:0003214; GO:0003219; GO:0003222; GO:0003241; GO:0003252; GO:0003270; GO:0003273; GO:0003332; GO:0003344; GO:0003713; GO:0004857; GO:0004888; GO:0005112; GO:0005509; GO:0005576; GO:0005634; GO:0005654; GO:0005789; GO:0005829; GO:0005886; GO:0005912; GO:0006355; GO:0006357; GO:0006366; GO:0006606; GO:0006955; GO:0006959; GO:0007219; GO:0007221; GO:0007283; GO:0007368; GO:0007386; GO:0007411; GO:0007440; GO:0007492; GO:0007507; GO:0008284; GO:0008285; GO:0009912; GO:0009957; GO:0009986; GO:0010008; GO:0010614; GO:0010628; GO:0010629; GO:0010667; GO:0010812; GO:0010832; GO:0014031; GO:0014807; GO:0016324; GO:0017156; GO:0019899; GO:0021515; GO:0021915; GO:0021953; GO:0030163; GO:0030216; GO:0030279; GO:0030324; GO:0030335; GO:0030513; GO:0030514; GO:0030900; GO:0031069; GO:0031100; GO:0031490; GO:0031902; GO:0032495; GO:0032496; GO:0032966; GO:0035116; GO:0035148; GO:0035914; GO:0035924; GO:0042246; GO:0042670; GO:0042802; GO:0043086; GO:0043235; GO:0045070; GO:0045603; GO:0045608; GO:0045618; GO:0045662; GO:0045668; GO:0045747; GO:0045892; GO:0045893; GO:0045944; GO:0045955; GO:0046427; GO:0046533; GO:0046579; GO:0048103; GO:0048708; GO:0048709; GO:0048711; GO:0048715; GO:0048754; GO:0048873; GO:0050673; GO:0050679; GO:0050680; GO:0050768; GO:0051152; GO:0055008; GO:0060038; GO:0060045; GO:0060253; GO:0060271; GO:0060317; GO:0060354; GO:0060379; GO:0060411; GO:0060412; GO:0060528; GO:0060740; GO:0060768; GO:0060842; GO:0060843; GO:0060948; GO:0060956; GO:0060979; GO:0060982; GO:0061101; GO:0061344; GO:0061384; GO:0062043; GO:0070168; GO:0070374; GO:0070986; GO:0071228; GO:0071372; GO:0071456; GO:0072017; GO:0072044; GO:0072091; GO:0072144; GO:0072148; GO:0072538; GO:0090051; GO:0090090; GO:0097150; GO:0097400; GO:0098685; GO:0098839; GO:0098978; GO:0099565; GO:0120163; GO:0140537; GO:1901201; GO:1902263; GO:1902339; GO:1903849; GO:2000048; GO:2000737; GO:2000811; GO:2000974; GO:2001027 animal organ regeneration [GO:0031100]; aortic valve morphogenesis [GO:0003180]; apoptotic process involved in embryonic digit morphogenesis [GO:1902263]; arterial endothelial cell differentiation [GO:0060842]; astrocyte differentiation [GO:0048708]; atrioventricular node development [GO:0003162]; atrioventricular valve morphogenesis [GO:0003181]; auditory receptor cell fate commitment [GO:0009912]; axon guidance [GO:0007411]; branching morphogenesis of an epithelial tube [GO:0048754]; calcium-ion regulated exocytosis [GO:0017156]; cardiac atrium morphogenesis [GO:0003209]; cardiac chamber formation [GO:0003207]; cardiac epithelial to mesenchymal transition [GO:0060317]; cardiac left ventricle morphogenesis [GO:0003214]; cardiac muscle cell myoblast differentiation [GO:0060379]; cardiac muscle cell proliferation [GO:0060038]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac right atrium morphogenesis [GO:0003213]; cardiac right ventricle formation [GO:0003219]; cardiac septum morphogenesis [GO:0060411]; cardiac vascular smooth muscle cell development [GO:0060948]; cardiac ventricle morphogenesis [GO:0003208]; cell differentiation in spinal cord [GO:0021515]; cell migration involved in endocardial cushion formation [GO:0003273]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to hypoxia [GO:0071456]; cellular response to tumor cell [GO:0071228]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; central nervous system neuron differentiation [GO:0021953]; chemical synaptic transmission, postsynaptic [GO:0099565]; cilium assembly [GO:0060271]; collecting duct development [GO:0072044]; compartment pattern specification [GO:0007386]; coronary artery morphogenesis [GO:0060982]; coronary sinus valve morphogenesis [GO:0003182]; coronary vein morphogenesis [GO:0003169]; determination of left/right symmetry [GO:0007368]; distal tubule development [GO:0072017]; embryonic hindlimb morphogenesis [GO:0035116]; endocardial cell differentiation [GO:0060956]; endocardial cushion morphogenesis [GO:0003203]; endocardium development [GO:0003157]; endocardium morphogenesis [GO:0003160]; endoderm development [GO:0007492]; epidermal cell fate specification [GO:0009957]; epithelial cell fate commitment [GO:0072148]; epithelial cell proliferation [GO:0050673]; epithelial to mesenchymal transition [GO:0001837]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; forebrain development [GO:0030900]; foregut morphogenesis [GO:0007440]; glomerular mesangial cell development [GO:0072144]; growth involved in heart morphogenesis [GO:0003241]; hair follicle morphogenesis [GO:0031069]; heart development [GO:0007507]; heart looping [GO:0001947]; heart trabecula morphogenesis [GO:0061384]; homeostasis of number of cells within a tissue [GO:0048873]; humoral immune response [GO:0006959]; immune response [GO:0006955]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; inhibition of neuroepithelial cell differentiation [GO:0002085]; interleukin-17-mediated signaling pathway [GO:0097400]; keratinocyte differentiation [GO:0030216]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; lung development [GO:0030324]; luteolysis [GO:0001554]; mesenchymal cell development [GO:0014031]; mitral valve formation [GO:0003192]; negative regulation of anoikis [GO:2000811]; negative regulation of biomineral tissue development [GO:0070168]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of catalytic activity [GO:0043086]; negative regulation of cell adhesion molecule production [GO:0060354]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell proliferation involved in heart valve morphogenesis [GO:0003252]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of collagen biosynthetic process [GO:0032966]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of endothelial cell chemotaxis [GO:2001027]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of extracellular matrix constituent secretion [GO:0003332]; negative regulation of gene expression [GO:0010629]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of inner ear auditory receptor cell differentiation [GO:0045608]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of neurogenesis [GO:0050768]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of ossification [GO:0030279]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of photoreceptor cell differentiation [GO:0046533]; negative regulation of pro-B cell differentiation [GO:2000974]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural tube development [GO:0021915]; neuroendocrine cell differentiation [GO:0061101]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; Notch signaling pathway involved in regulation of secondary heart field cardioblast proliferation [GO:0003270]; oligodendrocyte differentiation [GO:0048709]; outflow tract morphogenesis [GO:0003151]; pericardium morphogenesis [GO:0003344]; positive regulation of aorta morphogenesis [GO:1903849]; positive regulation of apoptotic process involved in morphogenesis [GO:1902339]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cardiac epithelial to mesenchymal transition [GO:0062043]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of smooth muscle cell differentiation [GO:0051152]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription of Notch receptor target [GO:0007221]; positive regulation of viral genome replication [GO:0045070]; prostate gland epithelium morphogenesis [GO:0060740]; protein catabolic process [GO:0030163]; protein import into nucleus [GO:0006606]; pulmonary valve morphogenesis [GO:0003184]; regulation of cell adhesion involved in heart morphogenesis [GO:0061344]; regulation of DNA-templated transcription [GO:0006355]; regulation of epithelial cell proliferation involved in prostate gland development [GO:0060768]; regulation of extracellular matrix assembly [GO:1901201]; regulation of somitogenesis [GO:0014807]; regulation of stem cell proliferation [GO:0072091]; regulation of transcription by RNA polymerase II [GO:0006357]; response to lipopolysaccharide [GO:0032496]; response to muramyl dipeptide [GO:0032495]; retinal cone cell differentiation [GO:0042670]; secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development [GO:0060528]; skeletal muscle cell differentiation [GO:0035914]; somatic stem cell division [GO:0048103]; spermatogenesis [GO:0007283]; sprouting angiogenesis [GO:0002040]; T-helper 17 type immune response [GO:0072538]; tissue regeneration [GO:0042246]; transcription by RNA polymerase II [GO:0006366]; tube formation [GO:0035148]; vasculogenesis involved in coronary vascular morphogenesis [GO:0060979]; venous endothelial cell differentiation [GO:0060843]; ventricular septum morphogenesis [GO:0060412]; ventricular trabecula myocardium morphogenesis [GO:0003222] acrosomal vesicle [GO:0001669]; adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; late endosome membrane [GO:0031902]; MAML1-RBP-Jkappa- ICN1 complex [GO:0002193]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; receptor complex [GO:0043235]; Schaffer collateral - CA1 synapse [GO:0098685] calcium ion binding [GO:0005509]; chromatin DNA binding [GO:0031490]; enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; identical protein binding [GO:0042802]; Notch binding [GO:0005112]; transcription coactivator activity [GO:0003713]; transcription regulator activator activity [GO:0140537]; transmembrane signaling receptor activity [GO:0004888] g19879.t2 P46531 33.605 1104 1.92e-115 414.0 sp|P46531|NOTC1_HUMAN Neurogenic locus notch homolog protein 1 OS=Homo sapiens OX=9606 GN=NOTCH1 PE=1 SV=4 NOTC1_HUMAN reviewed Neurogenic locus notch homolog protein 1 (Notch 1) (hN1) (Translocation-associated notch protein TAN-1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Homo sapiens (Human) GO:0000122; GO:0000139; GO:0001554; GO:0001669; GO:0001701; GO:0001837; GO:0001889; GO:0001947; GO:0002040; GO:0002052; GO:0002085; GO:0002193; GO:0002437; GO:0003151; GO:0003157; GO:0003160; GO:0003162; GO:0003169; GO:0003180; GO:0003181; GO:0003182; GO:0003184; GO:0003192; GO:0003198; GO:0003203; GO:0003207; GO:0003208; GO:0003209; GO:0003213; GO:0003214; GO:0003219; GO:0003222; GO:0003241; GO:0003252; GO:0003270; GO:0003273; GO:0003332; GO:0003344; GO:0003713; GO:0004857; GO:0004888; GO:0005112; GO:0005509; GO:0005576; GO:0005634; GO:0005654; GO:0005789; GO:0005829; GO:0005886; GO:0005912; GO:0006355; GO:0006357; GO:0006366; GO:0006606; GO:0006955; GO:0006959; GO:0007219; GO:0007221; GO:0007283; GO:0007368; GO:0007386; GO:0007411; GO:0007440; GO:0007492; GO:0007507; GO:0008284; GO:0008285; GO:0009912; GO:0009957; GO:0009986; GO:0010008; GO:0010614; GO:0010628; GO:0010629; GO:0010667; GO:0010812; GO:0010832; GO:0014031; GO:0014807; GO:0016324; GO:0017156; GO:0019899; GO:0021515; GO:0021915; GO:0021953; GO:0030163; GO:0030216; GO:0030279; GO:0030324; GO:0030335; GO:0030513; GO:0030514; GO:0030900; GO:0031069; GO:0031100; GO:0031490; GO:0031902; GO:0032495; GO:0032496; GO:0032966; GO:0035116; GO:0035148; GO:0035914; GO:0035924; GO:0042246; GO:0042670; GO:0042802; GO:0043086; GO:0043235; GO:0045070; GO:0045603; GO:0045608; GO:0045618; GO:0045662; GO:0045668; GO:0045747; GO:0045892; GO:0045893; GO:0045944; GO:0045955; GO:0046427; GO:0046533; GO:0046579; GO:0048103; GO:0048708; GO:0048709; GO:0048711; GO:0048715; GO:0048754; GO:0048873; GO:0050673; GO:0050679; GO:0050680; GO:0050768; GO:0051152; GO:0055008; GO:0060038; GO:0060045; GO:0060253; GO:0060271; GO:0060317; GO:0060354; GO:0060379; GO:0060411; GO:0060412; GO:0060528; GO:0060740; GO:0060768; GO:0060842; GO:0060843; GO:0060948; GO:0060956; GO:0060979; GO:0060982; GO:0061101; GO:0061344; GO:0061384; GO:0062043; GO:0070168; GO:0070374; GO:0070986; GO:0071228; GO:0071372; GO:0071456; GO:0072017; GO:0072044; GO:0072091; GO:0072144; GO:0072148; GO:0072538; GO:0090051; GO:0090090; GO:0097150; GO:0097400; GO:0098685; GO:0098839; GO:0098978; GO:0099565; GO:0120163; GO:0140537; GO:1901201; GO:1902263; GO:1902339; GO:1903849; GO:2000048; GO:2000737; GO:2000811; GO:2000974; GO:2001027 animal organ regeneration [GO:0031100]; aortic valve morphogenesis [GO:0003180]; apoptotic process involved in embryonic digit morphogenesis [GO:1902263]; arterial endothelial cell differentiation [GO:0060842]; astrocyte differentiation [GO:0048708]; atrioventricular node development [GO:0003162]; atrioventricular valve morphogenesis [GO:0003181]; auditory receptor cell fate commitment [GO:0009912]; axon guidance [GO:0007411]; branching morphogenesis of an epithelial tube [GO:0048754]; calcium-ion regulated exocytosis [GO:0017156]; cardiac atrium morphogenesis [GO:0003209]; cardiac chamber formation [GO:0003207]; cardiac epithelial to mesenchymal transition [GO:0060317]; cardiac left ventricle morphogenesis [GO:0003214]; cardiac muscle cell myoblast differentiation [GO:0060379]; cardiac muscle cell proliferation [GO:0060038]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac right atrium morphogenesis [GO:0003213]; cardiac right ventricle formation [GO:0003219]; cardiac septum morphogenesis [GO:0060411]; cardiac vascular smooth muscle cell development [GO:0060948]; cardiac ventricle morphogenesis [GO:0003208]; cell differentiation in spinal cord [GO:0021515]; cell migration involved in endocardial cushion formation [GO:0003273]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to hypoxia [GO:0071456]; cellular response to tumor cell [GO:0071228]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; central nervous system neuron differentiation [GO:0021953]; chemical synaptic transmission, postsynaptic [GO:0099565]; cilium assembly [GO:0060271]; collecting duct development [GO:0072044]; compartment pattern specification [GO:0007386]; coronary artery morphogenesis [GO:0060982]; coronary sinus valve morphogenesis [GO:0003182]; coronary vein morphogenesis [GO:0003169]; determination of left/right symmetry [GO:0007368]; distal tubule development [GO:0072017]; embryonic hindlimb morphogenesis [GO:0035116]; endocardial cell differentiation [GO:0060956]; endocardial cushion morphogenesis [GO:0003203]; endocardium development [GO:0003157]; endocardium morphogenesis [GO:0003160]; endoderm development [GO:0007492]; epidermal cell fate specification [GO:0009957]; epithelial cell fate commitment [GO:0072148]; epithelial cell proliferation [GO:0050673]; epithelial to mesenchymal transition [GO:0001837]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; forebrain development [GO:0030900]; foregut morphogenesis [GO:0007440]; glomerular mesangial cell development [GO:0072144]; growth involved in heart morphogenesis [GO:0003241]; hair follicle morphogenesis [GO:0031069]; heart development [GO:0007507]; heart looping [GO:0001947]; heart trabecula morphogenesis [GO:0061384]; homeostasis of number of cells within a tissue [GO:0048873]; humoral immune response [GO:0006959]; immune response [GO:0006955]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; inhibition of neuroepithelial cell differentiation [GO:0002085]; interleukin-17-mediated signaling pathway [GO:0097400]; keratinocyte differentiation [GO:0030216]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; lung development [GO:0030324]; luteolysis [GO:0001554]; mesenchymal cell development [GO:0014031]; mitral valve formation [GO:0003192]; negative regulation of anoikis [GO:2000811]; negative regulation of biomineral tissue development [GO:0070168]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of catalytic activity [GO:0043086]; negative regulation of cell adhesion molecule production [GO:0060354]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell proliferation involved in heart valve morphogenesis [GO:0003252]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of collagen biosynthetic process [GO:0032966]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of endothelial cell chemotaxis [GO:2001027]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of extracellular matrix constituent secretion [GO:0003332]; negative regulation of gene expression [GO:0010629]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of inner ear auditory receptor cell differentiation [GO:0045608]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of neurogenesis [GO:0050768]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of ossification [GO:0030279]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of photoreceptor cell differentiation [GO:0046533]; negative regulation of pro-B cell differentiation [GO:2000974]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural tube development [GO:0021915]; neuroendocrine cell differentiation [GO:0061101]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; Notch signaling pathway involved in regulation of secondary heart field cardioblast proliferation [GO:0003270]; oligodendrocyte differentiation [GO:0048709]; outflow tract morphogenesis [GO:0003151]; pericardium morphogenesis [GO:0003344]; positive regulation of aorta morphogenesis [GO:1903849]; positive regulation of apoptotic process involved in morphogenesis [GO:1902339]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cardiac epithelial to mesenchymal transition [GO:0062043]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of smooth muscle cell differentiation [GO:0051152]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription of Notch receptor target [GO:0007221]; positive regulation of viral genome replication [GO:0045070]; prostate gland epithelium morphogenesis [GO:0060740]; protein catabolic process [GO:0030163]; protein import into nucleus [GO:0006606]; pulmonary valve morphogenesis [GO:0003184]; regulation of cell adhesion involved in heart morphogenesis [GO:0061344]; regulation of DNA-templated transcription [GO:0006355]; regulation of epithelial cell proliferation involved in prostate gland development [GO:0060768]; regulation of extracellular matrix assembly [GO:1901201]; regulation of somitogenesis [GO:0014807]; regulation of stem cell proliferation [GO:0072091]; regulation of transcription by RNA polymerase II [GO:0006357]; response to lipopolysaccharide [GO:0032496]; response to muramyl dipeptide [GO:0032495]; retinal cone cell differentiation [GO:0042670]; secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development [GO:0060528]; skeletal muscle cell differentiation [GO:0035914]; somatic stem cell division [GO:0048103]; spermatogenesis [GO:0007283]; sprouting angiogenesis [GO:0002040]; T-helper 17 type immune response [GO:0072538]; tissue regeneration [GO:0042246]; transcription by RNA polymerase II [GO:0006366]; tube formation [GO:0035148]; vasculogenesis involved in coronary vascular morphogenesis [GO:0060979]; venous endothelial cell differentiation [GO:0060843]; ventricular septum morphogenesis [GO:0060412]; ventricular trabecula myocardium morphogenesis [GO:0003222] acrosomal vesicle [GO:0001669]; adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; late endosome membrane [GO:0031902]; MAML1-RBP-Jkappa- ICN1 complex [GO:0002193]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; receptor complex [GO:0043235]; Schaffer collateral - CA1 synapse [GO:0098685] calcium ion binding [GO:0005509]; chromatin DNA binding [GO:0031490]; enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; identical protein binding [GO:0042802]; Notch binding [GO:0005112]; transcription coactivator activity [GO:0003713]; transcription regulator activator activity [GO:0140537]; transmembrane signaling receptor activity [GO:0004888] g19879.t2 P46531 35.25 400 1.2199999999999999e-42 176.0 sp|P46531|NOTC1_HUMAN Neurogenic locus notch homolog protein 1 OS=Homo sapiens OX=9606 GN=NOTCH1 PE=1 SV=4 NOTC1_HUMAN reviewed Neurogenic locus notch homolog protein 1 (Notch 1) (hN1) (Translocation-associated notch protein TAN-1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Homo sapiens (Human) GO:0000122; GO:0000139; GO:0001554; GO:0001669; GO:0001701; GO:0001837; GO:0001889; GO:0001947; GO:0002040; GO:0002052; GO:0002085; GO:0002193; GO:0002437; GO:0003151; GO:0003157; GO:0003160; GO:0003162; GO:0003169; GO:0003180; GO:0003181; GO:0003182; GO:0003184; GO:0003192; GO:0003198; GO:0003203; GO:0003207; GO:0003208; GO:0003209; GO:0003213; GO:0003214; GO:0003219; GO:0003222; GO:0003241; GO:0003252; GO:0003270; GO:0003273; GO:0003332; GO:0003344; GO:0003713; GO:0004857; GO:0004888; GO:0005112; GO:0005509; GO:0005576; GO:0005634; GO:0005654; GO:0005789; GO:0005829; GO:0005886; GO:0005912; GO:0006355; GO:0006357; GO:0006366; GO:0006606; GO:0006955; GO:0006959; GO:0007219; GO:0007221; GO:0007283; GO:0007368; GO:0007386; GO:0007411; GO:0007440; GO:0007492; GO:0007507; GO:0008284; GO:0008285; GO:0009912; GO:0009957; GO:0009986; GO:0010008; GO:0010614; GO:0010628; GO:0010629; GO:0010667; GO:0010812; GO:0010832; GO:0014031; GO:0014807; GO:0016324; GO:0017156; GO:0019899; GO:0021515; GO:0021915; GO:0021953; GO:0030163; GO:0030216; GO:0030279; GO:0030324; GO:0030335; GO:0030513; GO:0030514; GO:0030900; GO:0031069; GO:0031100; GO:0031490; GO:0031902; GO:0032495; GO:0032496; GO:0032966; GO:0035116; GO:0035148; GO:0035914; GO:0035924; GO:0042246; GO:0042670; GO:0042802; GO:0043086; GO:0043235; GO:0045070; GO:0045603; GO:0045608; GO:0045618; GO:0045662; GO:0045668; GO:0045747; GO:0045892; GO:0045893; GO:0045944; GO:0045955; GO:0046427; GO:0046533; GO:0046579; GO:0048103; GO:0048708; GO:0048709; GO:0048711; GO:0048715; GO:0048754; GO:0048873; GO:0050673; GO:0050679; GO:0050680; GO:0050768; GO:0051152; GO:0055008; GO:0060038; GO:0060045; GO:0060253; GO:0060271; GO:0060317; GO:0060354; GO:0060379; GO:0060411; GO:0060412; GO:0060528; GO:0060740; GO:0060768; GO:0060842; GO:0060843; GO:0060948; GO:0060956; GO:0060979; GO:0060982; GO:0061101; GO:0061344; GO:0061384; GO:0062043; GO:0070168; GO:0070374; GO:0070986; GO:0071228; GO:0071372; GO:0071456; GO:0072017; GO:0072044; GO:0072091; GO:0072144; GO:0072148; GO:0072538; GO:0090051; GO:0090090; GO:0097150; GO:0097400; GO:0098685; GO:0098839; GO:0098978; GO:0099565; GO:0120163; GO:0140537; GO:1901201; GO:1902263; GO:1902339; GO:1903849; GO:2000048; GO:2000737; GO:2000811; GO:2000974; GO:2001027 animal organ regeneration [GO:0031100]; aortic valve morphogenesis [GO:0003180]; apoptotic process involved in embryonic digit morphogenesis [GO:1902263]; arterial endothelial cell differentiation [GO:0060842]; astrocyte differentiation [GO:0048708]; atrioventricular node development [GO:0003162]; atrioventricular valve morphogenesis [GO:0003181]; auditory receptor cell fate commitment [GO:0009912]; axon guidance [GO:0007411]; branching morphogenesis of an epithelial tube [GO:0048754]; calcium-ion regulated exocytosis [GO:0017156]; cardiac atrium morphogenesis [GO:0003209]; cardiac chamber formation [GO:0003207]; cardiac epithelial to mesenchymal transition [GO:0060317]; cardiac left ventricle morphogenesis [GO:0003214]; cardiac muscle cell myoblast differentiation [GO:0060379]; cardiac muscle cell proliferation [GO:0060038]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac right atrium morphogenesis [GO:0003213]; cardiac right ventricle formation [GO:0003219]; cardiac septum morphogenesis [GO:0060411]; cardiac vascular smooth muscle cell development [GO:0060948]; cardiac ventricle morphogenesis [GO:0003208]; cell differentiation in spinal cord [GO:0021515]; cell migration involved in endocardial cushion formation [GO:0003273]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to hypoxia [GO:0071456]; cellular response to tumor cell [GO:0071228]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; central nervous system neuron differentiation [GO:0021953]; chemical synaptic transmission, postsynaptic [GO:0099565]; cilium assembly [GO:0060271]; collecting duct development [GO:0072044]; compartment pattern specification [GO:0007386]; coronary artery morphogenesis [GO:0060982]; coronary sinus valve morphogenesis [GO:0003182]; coronary vein morphogenesis [GO:0003169]; determination of left/right symmetry [GO:0007368]; distal tubule development [GO:0072017]; embryonic hindlimb morphogenesis [GO:0035116]; endocardial cell differentiation [GO:0060956]; endocardial cushion morphogenesis [GO:0003203]; endocardium development [GO:0003157]; endocardium morphogenesis [GO:0003160]; endoderm development [GO:0007492]; epidermal cell fate specification [GO:0009957]; epithelial cell fate commitment [GO:0072148]; epithelial cell proliferation [GO:0050673]; epithelial to mesenchymal transition [GO:0001837]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; forebrain development [GO:0030900]; foregut morphogenesis [GO:0007440]; glomerular mesangial cell development [GO:0072144]; growth involved in heart morphogenesis [GO:0003241]; hair follicle morphogenesis [GO:0031069]; heart development [GO:0007507]; heart looping [GO:0001947]; heart trabecula morphogenesis [GO:0061384]; homeostasis of number of cells within a tissue [GO:0048873]; humoral immune response [GO:0006959]; immune response [GO:0006955]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; inhibition of neuroepithelial cell differentiation [GO:0002085]; interleukin-17-mediated signaling pathway [GO:0097400]; keratinocyte differentiation [GO:0030216]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; lung development [GO:0030324]; luteolysis [GO:0001554]; mesenchymal cell development [GO:0014031]; mitral valve formation [GO:0003192]; negative regulation of anoikis [GO:2000811]; negative regulation of biomineral tissue development [GO:0070168]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of catalytic activity [GO:0043086]; negative regulation of cell adhesion molecule production [GO:0060354]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell proliferation involved in heart valve morphogenesis [GO:0003252]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of collagen biosynthetic process [GO:0032966]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of endothelial cell chemotaxis [GO:2001027]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of extracellular matrix constituent secretion [GO:0003332]; negative regulation of gene expression [GO:0010629]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of inner ear auditory receptor cell differentiation [GO:0045608]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of neurogenesis [GO:0050768]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of ossification [GO:0030279]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of photoreceptor cell differentiation [GO:0046533]; negative regulation of pro-B cell differentiation [GO:2000974]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural tube development [GO:0021915]; neuroendocrine cell differentiation [GO:0061101]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; Notch signaling pathway involved in regulation of secondary heart field cardioblast proliferation [GO:0003270]; oligodendrocyte differentiation [GO:0048709]; outflow tract morphogenesis [GO:0003151]; pericardium morphogenesis [GO:0003344]; positive regulation of aorta morphogenesis [GO:1903849]; positive regulation of apoptotic process involved in morphogenesis [GO:1902339]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cardiac epithelial to mesenchymal transition [GO:0062043]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of smooth muscle cell differentiation [GO:0051152]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription of Notch receptor target [GO:0007221]; positive regulation of viral genome replication [GO:0045070]; prostate gland epithelium morphogenesis [GO:0060740]; protein catabolic process [GO:0030163]; protein import into nucleus [GO:0006606]; pulmonary valve morphogenesis [GO:0003184]; regulation of cell adhesion involved in heart morphogenesis [GO:0061344]; regulation of DNA-templated transcription [GO:0006355]; regulation of epithelial cell proliferation involved in prostate gland development [GO:0060768]; regulation of extracellular matrix assembly [GO:1901201]; regulation of somitogenesis [GO:0014807]; regulation of stem cell proliferation [GO:0072091]; regulation of transcription by RNA polymerase II [GO:0006357]; response to lipopolysaccharide [GO:0032496]; response to muramyl dipeptide [GO:0032495]; retinal cone cell differentiation [GO:0042670]; secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development [GO:0060528]; skeletal muscle cell differentiation [GO:0035914]; somatic stem cell division [GO:0048103]; spermatogenesis [GO:0007283]; sprouting angiogenesis [GO:0002040]; T-helper 17 type immune response [GO:0072538]; tissue regeneration [GO:0042246]; transcription by RNA polymerase II [GO:0006366]; tube formation [GO:0035148]; vasculogenesis involved in coronary vascular morphogenesis [GO:0060979]; venous endothelial cell differentiation [GO:0060843]; ventricular septum morphogenesis [GO:0060412]; ventricular trabecula myocardium morphogenesis [GO:0003222] acrosomal vesicle [GO:0001669]; adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; late endosome membrane [GO:0031902]; MAML1-RBP-Jkappa- ICN1 complex [GO:0002193]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; receptor complex [GO:0043235]; Schaffer collateral - CA1 synapse [GO:0098685] calcium ion binding [GO:0005509]; chromatin DNA binding [GO:0031490]; enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; identical protein binding [GO:0042802]; Notch binding [GO:0005112]; transcription coactivator activity [GO:0003713]; transcription regulator activator activity [GO:0140537]; transmembrane signaling receptor activity [GO:0004888] g19879.t2 P46531 36.082 388 1.8999999999999998e-42 176.0 sp|P46531|NOTC1_HUMAN Neurogenic locus notch homolog protein 1 OS=Homo sapiens OX=9606 GN=NOTCH1 PE=1 SV=4 NOTC1_HUMAN reviewed Neurogenic locus notch homolog protein 1 (Notch 1) (hN1) (Translocation-associated notch protein TAN-1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Homo sapiens (Human) GO:0000122; GO:0000139; GO:0001554; GO:0001669; GO:0001701; GO:0001837; GO:0001889; GO:0001947; GO:0002040; GO:0002052; GO:0002085; GO:0002193; GO:0002437; GO:0003151; GO:0003157; GO:0003160; GO:0003162; GO:0003169; GO:0003180; GO:0003181; GO:0003182; GO:0003184; GO:0003192; GO:0003198; GO:0003203; GO:0003207; GO:0003208; GO:0003209; GO:0003213; GO:0003214; GO:0003219; GO:0003222; GO:0003241; GO:0003252; GO:0003270; GO:0003273; GO:0003332; GO:0003344; GO:0003713; GO:0004857; GO:0004888; GO:0005112; GO:0005509; GO:0005576; GO:0005634; GO:0005654; GO:0005789; GO:0005829; GO:0005886; GO:0005912; GO:0006355; GO:0006357; GO:0006366; GO:0006606; GO:0006955; GO:0006959; GO:0007219; GO:0007221; GO:0007283; GO:0007368; GO:0007386; GO:0007411; GO:0007440; GO:0007492; GO:0007507; GO:0008284; GO:0008285; GO:0009912; GO:0009957; GO:0009986; GO:0010008; GO:0010614; GO:0010628; GO:0010629; GO:0010667; GO:0010812; GO:0010832; GO:0014031; GO:0014807; GO:0016324; GO:0017156; GO:0019899; GO:0021515; GO:0021915; GO:0021953; GO:0030163; GO:0030216; GO:0030279; GO:0030324; GO:0030335; GO:0030513; GO:0030514; GO:0030900; GO:0031069; GO:0031100; GO:0031490; GO:0031902; GO:0032495; GO:0032496; GO:0032966; GO:0035116; GO:0035148; GO:0035914; GO:0035924; GO:0042246; GO:0042670; GO:0042802; GO:0043086; GO:0043235; GO:0045070; GO:0045603; GO:0045608; GO:0045618; GO:0045662; GO:0045668; GO:0045747; GO:0045892; GO:0045893; GO:0045944; GO:0045955; GO:0046427; GO:0046533; GO:0046579; GO:0048103; GO:0048708; GO:0048709; GO:0048711; GO:0048715; GO:0048754; GO:0048873; GO:0050673; GO:0050679; GO:0050680; GO:0050768; GO:0051152; GO:0055008; GO:0060038; GO:0060045; GO:0060253; GO:0060271; GO:0060317; GO:0060354; GO:0060379; GO:0060411; GO:0060412; GO:0060528; GO:0060740; GO:0060768; GO:0060842; GO:0060843; GO:0060948; GO:0060956; GO:0060979; GO:0060982; GO:0061101; GO:0061344; GO:0061384; GO:0062043; GO:0070168; GO:0070374; GO:0070986; GO:0071228; GO:0071372; GO:0071456; GO:0072017; GO:0072044; GO:0072091; GO:0072144; GO:0072148; GO:0072538; GO:0090051; GO:0090090; GO:0097150; GO:0097400; GO:0098685; GO:0098839; GO:0098978; GO:0099565; GO:0120163; GO:0140537; GO:1901201; GO:1902263; GO:1902339; GO:1903849; GO:2000048; GO:2000737; GO:2000811; GO:2000974; GO:2001027 animal organ regeneration [GO:0031100]; aortic valve morphogenesis [GO:0003180]; apoptotic process involved in embryonic digit morphogenesis [GO:1902263]; arterial endothelial cell differentiation [GO:0060842]; astrocyte differentiation [GO:0048708]; atrioventricular node development [GO:0003162]; atrioventricular valve morphogenesis [GO:0003181]; auditory receptor cell fate commitment [GO:0009912]; axon guidance [GO:0007411]; branching morphogenesis of an epithelial tube [GO:0048754]; calcium-ion regulated exocytosis [GO:0017156]; cardiac atrium morphogenesis [GO:0003209]; cardiac chamber formation [GO:0003207]; cardiac epithelial to mesenchymal transition [GO:0060317]; cardiac left ventricle morphogenesis [GO:0003214]; cardiac muscle cell myoblast differentiation [GO:0060379]; cardiac muscle cell proliferation [GO:0060038]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac right atrium morphogenesis [GO:0003213]; cardiac right ventricle formation [GO:0003219]; cardiac septum morphogenesis [GO:0060411]; cardiac vascular smooth muscle cell development [GO:0060948]; cardiac ventricle morphogenesis [GO:0003208]; cell differentiation in spinal cord [GO:0021515]; cell migration involved in endocardial cushion formation [GO:0003273]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to hypoxia [GO:0071456]; cellular response to tumor cell [GO:0071228]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; central nervous system neuron differentiation [GO:0021953]; chemical synaptic transmission, postsynaptic [GO:0099565]; cilium assembly [GO:0060271]; collecting duct development [GO:0072044]; compartment pattern specification [GO:0007386]; coronary artery morphogenesis [GO:0060982]; coronary sinus valve morphogenesis [GO:0003182]; coronary vein morphogenesis [GO:0003169]; determination of left/right symmetry [GO:0007368]; distal tubule development [GO:0072017]; embryonic hindlimb morphogenesis [GO:0035116]; endocardial cell differentiation [GO:0060956]; endocardial cushion morphogenesis [GO:0003203]; endocardium development [GO:0003157]; endocardium morphogenesis [GO:0003160]; endoderm development [GO:0007492]; epidermal cell fate specification [GO:0009957]; epithelial cell fate commitment [GO:0072148]; epithelial cell proliferation [GO:0050673]; epithelial to mesenchymal transition [GO:0001837]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; forebrain development [GO:0030900]; foregut morphogenesis [GO:0007440]; glomerular mesangial cell development [GO:0072144]; growth involved in heart morphogenesis [GO:0003241]; hair follicle morphogenesis [GO:0031069]; heart development [GO:0007507]; heart looping [GO:0001947]; heart trabecula morphogenesis [GO:0061384]; homeostasis of number of cells within a tissue [GO:0048873]; humoral immune response [GO:0006959]; immune response [GO:0006955]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; inhibition of neuroepithelial cell differentiation [GO:0002085]; interleukin-17-mediated signaling pathway [GO:0097400]; keratinocyte differentiation [GO:0030216]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; lung development [GO:0030324]; luteolysis [GO:0001554]; mesenchymal cell development [GO:0014031]; mitral valve formation [GO:0003192]; negative regulation of anoikis [GO:2000811]; negative regulation of biomineral tissue development [GO:0070168]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of catalytic activity [GO:0043086]; negative regulation of cell adhesion molecule production [GO:0060354]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell proliferation involved in heart valve morphogenesis [GO:0003252]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of collagen biosynthetic process [GO:0032966]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of endothelial cell chemotaxis [GO:2001027]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of extracellular matrix constituent secretion [GO:0003332]; negative regulation of gene expression [GO:0010629]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of inner ear auditory receptor cell differentiation [GO:0045608]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of neurogenesis [GO:0050768]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of ossification [GO:0030279]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of photoreceptor cell differentiation [GO:0046533]; negative regulation of pro-B cell differentiation [GO:2000974]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural tube development [GO:0021915]; neuroendocrine cell differentiation [GO:0061101]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; Notch signaling pathway involved in regulation of secondary heart field cardioblast proliferation [GO:0003270]; oligodendrocyte differentiation [GO:0048709]; outflow tract morphogenesis [GO:0003151]; pericardium morphogenesis [GO:0003344]; positive regulation of aorta morphogenesis [GO:1903849]; positive regulation of apoptotic process involved in morphogenesis [GO:1902339]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cardiac epithelial to mesenchymal transition [GO:0062043]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of smooth muscle cell differentiation [GO:0051152]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription of Notch receptor target [GO:0007221]; positive regulation of viral genome replication [GO:0045070]; prostate gland epithelium morphogenesis [GO:0060740]; protein catabolic process [GO:0030163]; protein import into nucleus [GO:0006606]; pulmonary valve morphogenesis [GO:0003184]; regulation of cell adhesion involved in heart morphogenesis [GO:0061344]; regulation of DNA-templated transcription [GO:0006355]; regulation of epithelial cell proliferation involved in prostate gland development [GO:0060768]; regulation of extracellular matrix assembly [GO:1901201]; regulation of somitogenesis [GO:0014807]; regulation of stem cell proliferation [GO:0072091]; regulation of transcription by RNA polymerase II [GO:0006357]; response to lipopolysaccharide [GO:0032496]; response to muramyl dipeptide [GO:0032495]; retinal cone cell differentiation [GO:0042670]; secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development [GO:0060528]; skeletal muscle cell differentiation [GO:0035914]; somatic stem cell division [GO:0048103]; spermatogenesis [GO:0007283]; sprouting angiogenesis [GO:0002040]; T-helper 17 type immune response [GO:0072538]; tissue regeneration [GO:0042246]; transcription by RNA polymerase II [GO:0006366]; tube formation [GO:0035148]; vasculogenesis involved in coronary vascular morphogenesis [GO:0060979]; venous endothelial cell differentiation [GO:0060843]; ventricular septum morphogenesis [GO:0060412]; ventricular trabecula myocardium morphogenesis [GO:0003222] acrosomal vesicle [GO:0001669]; adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; late endosome membrane [GO:0031902]; MAML1-RBP-Jkappa- ICN1 complex [GO:0002193]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; receptor complex [GO:0043235]; Schaffer collateral - CA1 synapse [GO:0098685] calcium ion binding [GO:0005509]; chromatin DNA binding [GO:0031490]; enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; identical protein binding [GO:0042802]; Notch binding [GO:0005112]; transcription coactivator activity [GO:0003713]; transcription regulator activator activity [GO:0140537]; transmembrane signaling receptor activity [GO:0004888] g19879.t2 P46531 35.77 383 8.74e-40 167.0 sp|P46531|NOTC1_HUMAN Neurogenic locus notch homolog protein 1 OS=Homo sapiens OX=9606 GN=NOTCH1 PE=1 SV=4 NOTC1_HUMAN reviewed Neurogenic locus notch homolog protein 1 (Notch 1) (hN1) (Translocation-associated notch protein TAN-1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Homo sapiens (Human) GO:0000122; GO:0000139; GO:0001554; GO:0001669; GO:0001701; GO:0001837; GO:0001889; GO:0001947; GO:0002040; GO:0002052; GO:0002085; GO:0002193; GO:0002437; GO:0003151; GO:0003157; GO:0003160; GO:0003162; GO:0003169; GO:0003180; GO:0003181; GO:0003182; GO:0003184; GO:0003192; GO:0003198; GO:0003203; GO:0003207; GO:0003208; GO:0003209; GO:0003213; GO:0003214; GO:0003219; GO:0003222; GO:0003241; GO:0003252; GO:0003270; GO:0003273; GO:0003332; GO:0003344; GO:0003713; GO:0004857; GO:0004888; GO:0005112; GO:0005509; GO:0005576; GO:0005634; GO:0005654; GO:0005789; GO:0005829; GO:0005886; GO:0005912; GO:0006355; GO:0006357; GO:0006366; GO:0006606; GO:0006955; GO:0006959; GO:0007219; GO:0007221; GO:0007283; GO:0007368; GO:0007386; GO:0007411; GO:0007440; GO:0007492; GO:0007507; GO:0008284; GO:0008285; GO:0009912; GO:0009957; GO:0009986; GO:0010008; GO:0010614; GO:0010628; GO:0010629; GO:0010667; GO:0010812; GO:0010832; GO:0014031; GO:0014807; GO:0016324; GO:0017156; GO:0019899; GO:0021515; GO:0021915; GO:0021953; GO:0030163; GO:0030216; GO:0030279; GO:0030324; GO:0030335; GO:0030513; GO:0030514; GO:0030900; GO:0031069; GO:0031100; GO:0031490; GO:0031902; GO:0032495; GO:0032496; GO:0032966; GO:0035116; GO:0035148; GO:0035914; GO:0035924; GO:0042246; GO:0042670; GO:0042802; GO:0043086; GO:0043235; GO:0045070; GO:0045603; GO:0045608; GO:0045618; GO:0045662; GO:0045668; GO:0045747; GO:0045892; GO:0045893; GO:0045944; GO:0045955; GO:0046427; GO:0046533; GO:0046579; GO:0048103; GO:0048708; GO:0048709; GO:0048711; GO:0048715; GO:0048754; GO:0048873; GO:0050673; GO:0050679; GO:0050680; GO:0050768; GO:0051152; GO:0055008; GO:0060038; GO:0060045; GO:0060253; GO:0060271; GO:0060317; GO:0060354; GO:0060379; GO:0060411; GO:0060412; GO:0060528; GO:0060740; GO:0060768; GO:0060842; GO:0060843; GO:0060948; GO:0060956; GO:0060979; GO:0060982; GO:0061101; GO:0061344; GO:0061384; GO:0062043; GO:0070168; GO:0070374; GO:0070986; GO:0071228; GO:0071372; GO:0071456; GO:0072017; GO:0072044; GO:0072091; GO:0072144; GO:0072148; GO:0072538; GO:0090051; GO:0090090; GO:0097150; GO:0097400; GO:0098685; GO:0098839; GO:0098978; GO:0099565; GO:0120163; GO:0140537; GO:1901201; GO:1902263; GO:1902339; GO:1903849; GO:2000048; GO:2000737; GO:2000811; GO:2000974; GO:2001027 animal organ regeneration [GO:0031100]; aortic valve morphogenesis [GO:0003180]; apoptotic process involved in embryonic digit morphogenesis [GO:1902263]; arterial endothelial cell differentiation [GO:0060842]; astrocyte differentiation [GO:0048708]; atrioventricular node development [GO:0003162]; atrioventricular valve morphogenesis [GO:0003181]; auditory receptor cell fate commitment [GO:0009912]; axon guidance [GO:0007411]; branching morphogenesis of an epithelial tube [GO:0048754]; calcium-ion regulated exocytosis [GO:0017156]; cardiac atrium morphogenesis [GO:0003209]; cardiac chamber formation [GO:0003207]; cardiac epithelial to mesenchymal transition [GO:0060317]; cardiac left ventricle morphogenesis [GO:0003214]; cardiac muscle cell myoblast differentiation [GO:0060379]; cardiac muscle cell proliferation [GO:0060038]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac right atrium morphogenesis [GO:0003213]; cardiac right ventricle formation [GO:0003219]; cardiac septum morphogenesis [GO:0060411]; cardiac vascular smooth muscle cell development [GO:0060948]; cardiac ventricle morphogenesis [GO:0003208]; cell differentiation in spinal cord [GO:0021515]; cell migration involved in endocardial cushion formation [GO:0003273]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to hypoxia [GO:0071456]; cellular response to tumor cell [GO:0071228]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; central nervous system neuron differentiation [GO:0021953]; chemical synaptic transmission, postsynaptic [GO:0099565]; cilium assembly [GO:0060271]; collecting duct development [GO:0072044]; compartment pattern specification [GO:0007386]; coronary artery morphogenesis [GO:0060982]; coronary sinus valve morphogenesis [GO:0003182]; coronary vein morphogenesis [GO:0003169]; determination of left/right symmetry [GO:0007368]; distal tubule development [GO:0072017]; embryonic hindlimb morphogenesis [GO:0035116]; endocardial cell differentiation [GO:0060956]; endocardial cushion morphogenesis [GO:0003203]; endocardium development [GO:0003157]; endocardium morphogenesis [GO:0003160]; endoderm development [GO:0007492]; epidermal cell fate specification [GO:0009957]; epithelial cell fate commitment [GO:0072148]; epithelial cell proliferation [GO:0050673]; epithelial to mesenchymal transition [GO:0001837]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; forebrain development [GO:0030900]; foregut morphogenesis [GO:0007440]; glomerular mesangial cell development [GO:0072144]; growth involved in heart morphogenesis [GO:0003241]; hair follicle morphogenesis [GO:0031069]; heart development [GO:0007507]; heart looping [GO:0001947]; heart trabecula morphogenesis [GO:0061384]; homeostasis of number of cells within a tissue [GO:0048873]; humoral immune response [GO:0006959]; immune response [GO:0006955]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; inhibition of neuroepithelial cell differentiation [GO:0002085]; interleukin-17-mediated signaling pathway [GO:0097400]; keratinocyte differentiation [GO:0030216]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; lung development [GO:0030324]; luteolysis [GO:0001554]; mesenchymal cell development [GO:0014031]; mitral valve formation [GO:0003192]; negative regulation of anoikis [GO:2000811]; negative regulation of biomineral tissue development [GO:0070168]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of catalytic activity [GO:0043086]; negative regulation of cell adhesion molecule production [GO:0060354]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell proliferation involved in heart valve morphogenesis [GO:0003252]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of collagen biosynthetic process [GO:0032966]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of endothelial cell chemotaxis [GO:2001027]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of extracellular matrix constituent secretion [GO:0003332]; negative regulation of gene expression [GO:0010629]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of inner ear auditory receptor cell differentiation [GO:0045608]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of neurogenesis [GO:0050768]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of ossification [GO:0030279]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of photoreceptor cell differentiation [GO:0046533]; negative regulation of pro-B cell differentiation [GO:2000974]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural tube development [GO:0021915]; neuroendocrine cell differentiation [GO:0061101]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; Notch signaling pathway involved in regulation of secondary heart field cardioblast proliferation [GO:0003270]; oligodendrocyte differentiation [GO:0048709]; outflow tract morphogenesis [GO:0003151]; pericardium morphogenesis [GO:0003344]; positive regulation of aorta morphogenesis [GO:1903849]; positive regulation of apoptotic process involved in morphogenesis [GO:1902339]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cardiac epithelial to mesenchymal transition [GO:0062043]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of smooth muscle cell differentiation [GO:0051152]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription of Notch receptor target [GO:0007221]; positive regulation of viral genome replication [GO:0045070]; prostate gland epithelium morphogenesis [GO:0060740]; protein catabolic process [GO:0030163]; protein import into nucleus [GO:0006606]; pulmonary valve morphogenesis [GO:0003184]; regulation of cell adhesion involved in heart morphogenesis [GO:0061344]; regulation of DNA-templated transcription [GO:0006355]; regulation of epithelial cell proliferation involved in prostate gland development [GO:0060768]; regulation of extracellular matrix assembly [GO:1901201]; regulation of somitogenesis [GO:0014807]; regulation of stem cell proliferation [GO:0072091]; regulation of transcription by RNA polymerase II [GO:0006357]; response to lipopolysaccharide [GO:0032496]; response to muramyl dipeptide [GO:0032495]; retinal cone cell differentiation [GO:0042670]; secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development [GO:0060528]; skeletal muscle cell differentiation [GO:0035914]; somatic stem cell division [GO:0048103]; spermatogenesis [GO:0007283]; sprouting angiogenesis [GO:0002040]; T-helper 17 type immune response [GO:0072538]; tissue regeneration [GO:0042246]; transcription by RNA polymerase II [GO:0006366]; tube formation [GO:0035148]; vasculogenesis involved in coronary vascular morphogenesis [GO:0060979]; venous endothelial cell differentiation [GO:0060843]; ventricular septum morphogenesis [GO:0060412]; ventricular trabecula myocardium morphogenesis [GO:0003222] acrosomal vesicle [GO:0001669]; adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; late endosome membrane [GO:0031902]; MAML1-RBP-Jkappa- ICN1 complex [GO:0002193]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; receptor complex [GO:0043235]; Schaffer collateral - CA1 synapse [GO:0098685] calcium ion binding [GO:0005509]; chromatin DNA binding [GO:0031490]; enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; identical protein binding [GO:0042802]; Notch binding [GO:0005112]; transcription coactivator activity [GO:0003713]; transcription regulator activator activity [GO:0140537]; transmembrane signaling receptor activity [GO:0004888] g19879.t2 P46531 34.783 368 2.7400000000000002e-36 155.0 sp|P46531|NOTC1_HUMAN Neurogenic locus notch homolog protein 1 OS=Homo sapiens OX=9606 GN=NOTCH1 PE=1 SV=4 NOTC1_HUMAN reviewed Neurogenic locus notch homolog protein 1 (Notch 1) (hN1) (Translocation-associated notch protein TAN-1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Homo sapiens (Human) GO:0000122; GO:0000139; GO:0001554; GO:0001669; GO:0001701; GO:0001837; GO:0001889; GO:0001947; GO:0002040; GO:0002052; GO:0002085; GO:0002193; GO:0002437; GO:0003151; GO:0003157; GO:0003160; GO:0003162; GO:0003169; GO:0003180; GO:0003181; GO:0003182; GO:0003184; GO:0003192; GO:0003198; GO:0003203; GO:0003207; GO:0003208; GO:0003209; GO:0003213; GO:0003214; GO:0003219; GO:0003222; GO:0003241; GO:0003252; GO:0003270; GO:0003273; GO:0003332; GO:0003344; GO:0003713; GO:0004857; GO:0004888; GO:0005112; GO:0005509; GO:0005576; GO:0005634; GO:0005654; GO:0005789; GO:0005829; GO:0005886; GO:0005912; GO:0006355; GO:0006357; GO:0006366; GO:0006606; GO:0006955; GO:0006959; GO:0007219; GO:0007221; GO:0007283; GO:0007368; GO:0007386; GO:0007411; GO:0007440; GO:0007492; GO:0007507; GO:0008284; GO:0008285; GO:0009912; GO:0009957; GO:0009986; GO:0010008; GO:0010614; GO:0010628; GO:0010629; GO:0010667; GO:0010812; GO:0010832; GO:0014031; GO:0014807; GO:0016324; GO:0017156; GO:0019899; GO:0021515; GO:0021915; GO:0021953; GO:0030163; GO:0030216; GO:0030279; GO:0030324; GO:0030335; GO:0030513; GO:0030514; GO:0030900; GO:0031069; GO:0031100; GO:0031490; GO:0031902; GO:0032495; GO:0032496; GO:0032966; GO:0035116; GO:0035148; GO:0035914; GO:0035924; GO:0042246; GO:0042670; GO:0042802; GO:0043086; GO:0043235; GO:0045070; GO:0045603; GO:0045608; GO:0045618; GO:0045662; GO:0045668; GO:0045747; GO:0045892; GO:0045893; GO:0045944; GO:0045955; GO:0046427; GO:0046533; GO:0046579; GO:0048103; GO:0048708; GO:0048709; GO:0048711; GO:0048715; GO:0048754; GO:0048873; GO:0050673; GO:0050679; GO:0050680; GO:0050768; GO:0051152; GO:0055008; GO:0060038; GO:0060045; GO:0060253; GO:0060271; GO:0060317; GO:0060354; GO:0060379; GO:0060411; GO:0060412; GO:0060528; GO:0060740; GO:0060768; GO:0060842; GO:0060843; GO:0060948; GO:0060956; GO:0060979; GO:0060982; GO:0061101; GO:0061344; GO:0061384; GO:0062043; GO:0070168; GO:0070374; GO:0070986; GO:0071228; GO:0071372; GO:0071456; GO:0072017; GO:0072044; GO:0072091; GO:0072144; GO:0072148; GO:0072538; GO:0090051; GO:0090090; GO:0097150; GO:0097400; GO:0098685; GO:0098839; GO:0098978; GO:0099565; GO:0120163; GO:0140537; GO:1901201; GO:1902263; GO:1902339; GO:1903849; GO:2000048; GO:2000737; GO:2000811; GO:2000974; GO:2001027 animal organ regeneration [GO:0031100]; aortic valve morphogenesis [GO:0003180]; apoptotic process involved in embryonic digit morphogenesis [GO:1902263]; arterial endothelial cell differentiation [GO:0060842]; astrocyte differentiation [GO:0048708]; atrioventricular node development [GO:0003162]; atrioventricular valve morphogenesis [GO:0003181]; auditory receptor cell fate commitment [GO:0009912]; axon guidance [GO:0007411]; branching morphogenesis of an epithelial tube [GO:0048754]; calcium-ion regulated exocytosis [GO:0017156]; cardiac atrium morphogenesis [GO:0003209]; cardiac chamber formation [GO:0003207]; cardiac epithelial to mesenchymal transition [GO:0060317]; cardiac left ventricle morphogenesis [GO:0003214]; cardiac muscle cell myoblast differentiation [GO:0060379]; cardiac muscle cell proliferation [GO:0060038]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac right atrium morphogenesis [GO:0003213]; cardiac right ventricle formation [GO:0003219]; cardiac septum morphogenesis [GO:0060411]; cardiac vascular smooth muscle cell development [GO:0060948]; cardiac ventricle morphogenesis [GO:0003208]; cell differentiation in spinal cord [GO:0021515]; cell migration involved in endocardial cushion formation [GO:0003273]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to hypoxia [GO:0071456]; cellular response to tumor cell [GO:0071228]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; central nervous system neuron differentiation [GO:0021953]; chemical synaptic transmission, postsynaptic [GO:0099565]; cilium assembly [GO:0060271]; collecting duct development [GO:0072044]; compartment pattern specification [GO:0007386]; coronary artery morphogenesis [GO:0060982]; coronary sinus valve morphogenesis [GO:0003182]; coronary vein morphogenesis [GO:0003169]; determination of left/right symmetry [GO:0007368]; distal tubule development [GO:0072017]; embryonic hindlimb morphogenesis [GO:0035116]; endocardial cell differentiation [GO:0060956]; endocardial cushion morphogenesis [GO:0003203]; endocardium development [GO:0003157]; endocardium morphogenesis [GO:0003160]; endoderm development [GO:0007492]; epidermal cell fate specification [GO:0009957]; epithelial cell fate commitment [GO:0072148]; epithelial cell proliferation [GO:0050673]; epithelial to mesenchymal transition [GO:0001837]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; forebrain development [GO:0030900]; foregut morphogenesis [GO:0007440]; glomerular mesangial cell development [GO:0072144]; growth involved in heart morphogenesis [GO:0003241]; hair follicle morphogenesis [GO:0031069]; heart development [GO:0007507]; heart looping [GO:0001947]; heart trabecula morphogenesis [GO:0061384]; homeostasis of number of cells within a tissue [GO:0048873]; humoral immune response [GO:0006959]; immune response [GO:0006955]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; inhibition of neuroepithelial cell differentiation [GO:0002085]; interleukin-17-mediated signaling pathway [GO:0097400]; keratinocyte differentiation [GO:0030216]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; lung development [GO:0030324]; luteolysis [GO:0001554]; mesenchymal cell development [GO:0014031]; mitral valve formation [GO:0003192]; negative regulation of anoikis [GO:2000811]; negative regulation of biomineral tissue development [GO:0070168]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of catalytic activity [GO:0043086]; negative regulation of cell adhesion molecule production [GO:0060354]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell proliferation involved in heart valve morphogenesis [GO:0003252]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of collagen biosynthetic process [GO:0032966]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of endothelial cell chemotaxis [GO:2001027]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of extracellular matrix constituent secretion [GO:0003332]; negative regulation of gene expression [GO:0010629]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of inner ear auditory receptor cell differentiation [GO:0045608]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of neurogenesis [GO:0050768]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of ossification [GO:0030279]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of photoreceptor cell differentiation [GO:0046533]; negative regulation of pro-B cell differentiation [GO:2000974]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural tube development [GO:0021915]; neuroendocrine cell differentiation [GO:0061101]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; Notch signaling pathway involved in regulation of secondary heart field cardioblast proliferation [GO:0003270]; oligodendrocyte differentiation [GO:0048709]; outflow tract morphogenesis [GO:0003151]; pericardium morphogenesis [GO:0003344]; positive regulation of aorta morphogenesis [GO:1903849]; positive regulation of apoptotic process involved in morphogenesis [GO:1902339]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cardiac epithelial to mesenchymal transition [GO:0062043]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of smooth muscle cell differentiation [GO:0051152]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription of Notch receptor target [GO:0007221]; positive regulation of viral genome replication [GO:0045070]; prostate gland epithelium morphogenesis [GO:0060740]; protein catabolic process [GO:0030163]; protein import into nucleus [GO:0006606]; pulmonary valve morphogenesis [GO:0003184]; regulation of cell adhesion involved in heart morphogenesis [GO:0061344]; regulation of DNA-templated transcription [GO:0006355]; regulation of epithelial cell proliferation involved in prostate gland development [GO:0060768]; regulation of extracellular matrix assembly [GO:1901201]; regulation of somitogenesis [GO:0014807]; regulation of stem cell proliferation [GO:0072091]; regulation of transcription by RNA polymerase II [GO:0006357]; response to lipopolysaccharide [GO:0032496]; response to muramyl dipeptide [GO:0032495]; retinal cone cell differentiation [GO:0042670]; secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development [GO:0060528]; skeletal muscle cell differentiation [GO:0035914]; somatic stem cell division [GO:0048103]; spermatogenesis [GO:0007283]; sprouting angiogenesis [GO:0002040]; T-helper 17 type immune response [GO:0072538]; tissue regeneration [GO:0042246]; transcription by RNA polymerase II [GO:0006366]; tube formation [GO:0035148]; vasculogenesis involved in coronary vascular morphogenesis [GO:0060979]; venous endothelial cell differentiation [GO:0060843]; ventricular septum morphogenesis [GO:0060412]; ventricular trabecula myocardium morphogenesis [GO:0003222] acrosomal vesicle [GO:0001669]; adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; late endosome membrane [GO:0031902]; MAML1-RBP-Jkappa- ICN1 complex [GO:0002193]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; receptor complex [GO:0043235]; Schaffer collateral - CA1 synapse [GO:0098685] calcium ion binding [GO:0005509]; chromatin DNA binding [GO:0031490]; enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; identical protein binding [GO:0042802]; Notch binding [GO:0005112]; transcription coactivator activity [GO:0003713]; transcription regulator activator activity [GO:0140537]; transmembrane signaling receptor activity [GO:0004888] g19879.t2 P46531 34.343 396 8.98e-36 154.0 sp|P46531|NOTC1_HUMAN Neurogenic locus notch homolog protein 1 OS=Homo sapiens OX=9606 GN=NOTCH1 PE=1 SV=4 NOTC1_HUMAN reviewed Neurogenic locus notch homolog protein 1 (Notch 1) (hN1) (Translocation-associated notch protein TAN-1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Homo sapiens (Human) GO:0000122; GO:0000139; GO:0001554; GO:0001669; GO:0001701; GO:0001837; GO:0001889; GO:0001947; GO:0002040; GO:0002052; GO:0002085; GO:0002193; GO:0002437; GO:0003151; GO:0003157; GO:0003160; GO:0003162; GO:0003169; GO:0003180; GO:0003181; GO:0003182; GO:0003184; GO:0003192; GO:0003198; GO:0003203; GO:0003207; GO:0003208; GO:0003209; GO:0003213; GO:0003214; GO:0003219; GO:0003222; GO:0003241; GO:0003252; GO:0003270; GO:0003273; GO:0003332; GO:0003344; GO:0003713; GO:0004857; GO:0004888; GO:0005112; GO:0005509; GO:0005576; GO:0005634; GO:0005654; GO:0005789; GO:0005829; GO:0005886; GO:0005912; GO:0006355; GO:0006357; GO:0006366; GO:0006606; GO:0006955; GO:0006959; GO:0007219; GO:0007221; GO:0007283; GO:0007368; GO:0007386; GO:0007411; GO:0007440; GO:0007492; GO:0007507; GO:0008284; GO:0008285; GO:0009912; GO:0009957; GO:0009986; GO:0010008; GO:0010614; GO:0010628; GO:0010629; GO:0010667; GO:0010812; GO:0010832; GO:0014031; GO:0014807; GO:0016324; GO:0017156; GO:0019899; GO:0021515; GO:0021915; GO:0021953; GO:0030163; GO:0030216; GO:0030279; GO:0030324; GO:0030335; GO:0030513; GO:0030514; GO:0030900; GO:0031069; GO:0031100; GO:0031490; GO:0031902; GO:0032495; GO:0032496; GO:0032966; GO:0035116; GO:0035148; GO:0035914; GO:0035924; GO:0042246; GO:0042670; GO:0042802; GO:0043086; GO:0043235; GO:0045070; GO:0045603; GO:0045608; GO:0045618; GO:0045662; GO:0045668; GO:0045747; GO:0045892; GO:0045893; GO:0045944; GO:0045955; GO:0046427; GO:0046533; GO:0046579; GO:0048103; GO:0048708; GO:0048709; GO:0048711; GO:0048715; GO:0048754; GO:0048873; GO:0050673; GO:0050679; GO:0050680; GO:0050768; GO:0051152; GO:0055008; GO:0060038; GO:0060045; GO:0060253; GO:0060271; GO:0060317; GO:0060354; GO:0060379; GO:0060411; GO:0060412; GO:0060528; GO:0060740; GO:0060768; GO:0060842; GO:0060843; GO:0060948; GO:0060956; GO:0060979; GO:0060982; GO:0061101; GO:0061344; GO:0061384; GO:0062043; GO:0070168; GO:0070374; GO:0070986; GO:0071228; GO:0071372; GO:0071456; GO:0072017; GO:0072044; GO:0072091; GO:0072144; GO:0072148; GO:0072538; GO:0090051; GO:0090090; GO:0097150; GO:0097400; GO:0098685; GO:0098839; GO:0098978; GO:0099565; GO:0120163; GO:0140537; GO:1901201; GO:1902263; GO:1902339; GO:1903849; GO:2000048; GO:2000737; GO:2000811; GO:2000974; GO:2001027 animal organ regeneration [GO:0031100]; aortic valve morphogenesis [GO:0003180]; apoptotic process involved in embryonic digit morphogenesis [GO:1902263]; arterial endothelial cell differentiation [GO:0060842]; astrocyte differentiation [GO:0048708]; atrioventricular node development [GO:0003162]; atrioventricular valve morphogenesis [GO:0003181]; auditory receptor cell fate commitment [GO:0009912]; axon guidance [GO:0007411]; branching morphogenesis of an epithelial tube [GO:0048754]; calcium-ion regulated exocytosis [GO:0017156]; cardiac atrium morphogenesis [GO:0003209]; cardiac chamber formation [GO:0003207]; cardiac epithelial to mesenchymal transition [GO:0060317]; cardiac left ventricle morphogenesis [GO:0003214]; cardiac muscle cell myoblast differentiation [GO:0060379]; cardiac muscle cell proliferation [GO:0060038]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac right atrium morphogenesis [GO:0003213]; cardiac right ventricle formation [GO:0003219]; cardiac septum morphogenesis [GO:0060411]; cardiac vascular smooth muscle cell development [GO:0060948]; cardiac ventricle morphogenesis [GO:0003208]; cell differentiation in spinal cord [GO:0021515]; cell migration involved in endocardial cushion formation [GO:0003273]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to hypoxia [GO:0071456]; cellular response to tumor cell [GO:0071228]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; central nervous system neuron differentiation [GO:0021953]; chemical synaptic transmission, postsynaptic [GO:0099565]; cilium assembly [GO:0060271]; collecting duct development [GO:0072044]; compartment pattern specification [GO:0007386]; coronary artery morphogenesis [GO:0060982]; coronary sinus valve morphogenesis [GO:0003182]; coronary vein morphogenesis [GO:0003169]; determination of left/right symmetry [GO:0007368]; distal tubule development [GO:0072017]; embryonic hindlimb morphogenesis [GO:0035116]; endocardial cell differentiation [GO:0060956]; endocardial cushion morphogenesis [GO:0003203]; endocardium development [GO:0003157]; endocardium morphogenesis [GO:0003160]; endoderm development [GO:0007492]; epidermal cell fate specification [GO:0009957]; epithelial cell fate commitment [GO:0072148]; epithelial cell proliferation [GO:0050673]; epithelial to mesenchymal transition [GO:0001837]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; forebrain development [GO:0030900]; foregut morphogenesis [GO:0007440]; glomerular mesangial cell development [GO:0072144]; growth involved in heart morphogenesis [GO:0003241]; hair follicle morphogenesis [GO:0031069]; heart development [GO:0007507]; heart looping [GO:0001947]; heart trabecula morphogenesis [GO:0061384]; homeostasis of number of cells within a tissue [GO:0048873]; humoral immune response [GO:0006959]; immune response [GO:0006955]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; inhibition of neuroepithelial cell differentiation [GO:0002085]; interleukin-17-mediated signaling pathway [GO:0097400]; keratinocyte differentiation [GO:0030216]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; lung development [GO:0030324]; luteolysis [GO:0001554]; mesenchymal cell development [GO:0014031]; mitral valve formation [GO:0003192]; negative regulation of anoikis [GO:2000811]; negative regulation of biomineral tissue development [GO:0070168]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of catalytic activity [GO:0043086]; negative regulation of cell adhesion molecule production [GO:0060354]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell proliferation involved in heart valve morphogenesis [GO:0003252]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of collagen biosynthetic process [GO:0032966]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of endothelial cell chemotaxis [GO:2001027]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of extracellular matrix constituent secretion [GO:0003332]; negative regulation of gene expression [GO:0010629]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of inner ear auditory receptor cell differentiation [GO:0045608]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of neurogenesis [GO:0050768]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of ossification [GO:0030279]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of photoreceptor cell differentiation [GO:0046533]; negative regulation of pro-B cell differentiation [GO:2000974]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural tube development [GO:0021915]; neuroendocrine cell differentiation [GO:0061101]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; Notch signaling pathway involved in regulation of secondary heart field cardioblast proliferation [GO:0003270]; oligodendrocyte differentiation [GO:0048709]; outflow tract morphogenesis [GO:0003151]; pericardium morphogenesis [GO:0003344]; positive regulation of aorta morphogenesis [GO:1903849]; positive regulation of apoptotic process involved in morphogenesis [GO:1902339]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cardiac epithelial to mesenchymal transition [GO:0062043]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of smooth muscle cell differentiation [GO:0051152]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription of Notch receptor target [GO:0007221]; positive regulation of viral genome replication [GO:0045070]; prostate gland epithelium morphogenesis [GO:0060740]; protein catabolic process [GO:0030163]; protein import into nucleus [GO:0006606]; pulmonary valve morphogenesis [GO:0003184]; regulation of cell adhesion involved in heart morphogenesis [GO:0061344]; regulation of DNA-templated transcription [GO:0006355]; regulation of epithelial cell proliferation involved in prostate gland development [GO:0060768]; regulation of extracellular matrix assembly [GO:1901201]; regulation of somitogenesis [GO:0014807]; regulation of stem cell proliferation [GO:0072091]; regulation of transcription by RNA polymerase II [GO:0006357]; response to lipopolysaccharide [GO:0032496]; response to muramyl dipeptide [GO:0032495]; retinal cone cell differentiation [GO:0042670]; secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development [GO:0060528]; skeletal muscle cell differentiation [GO:0035914]; somatic stem cell division [GO:0048103]; spermatogenesis [GO:0007283]; sprouting angiogenesis [GO:0002040]; T-helper 17 type immune response [GO:0072538]; tissue regeneration [GO:0042246]; transcription by RNA polymerase II [GO:0006366]; tube formation [GO:0035148]; vasculogenesis involved in coronary vascular morphogenesis [GO:0060979]; venous endothelial cell differentiation [GO:0060843]; ventricular septum morphogenesis [GO:0060412]; ventricular trabecula myocardium morphogenesis [GO:0003222] acrosomal vesicle [GO:0001669]; adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; late endosome membrane [GO:0031902]; MAML1-RBP-Jkappa- ICN1 complex [GO:0002193]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; receptor complex [GO:0043235]; Schaffer collateral - CA1 synapse [GO:0098685] calcium ion binding [GO:0005509]; chromatin DNA binding [GO:0031490]; enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; identical protein binding [GO:0042802]; Notch binding [GO:0005112]; transcription coactivator activity [GO:0003713]; transcription regulator activator activity [GO:0140537]; transmembrane signaling receptor activity [GO:0004888] g19879.t2 P46531 29.773 440 2e-35 152.0 sp|P46531|NOTC1_HUMAN Neurogenic locus notch homolog protein 1 OS=Homo sapiens OX=9606 GN=NOTCH1 PE=1 SV=4 NOTC1_HUMAN reviewed Neurogenic locus notch homolog protein 1 (Notch 1) (hN1) (Translocation-associated notch protein TAN-1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Homo sapiens (Human) GO:0000122; GO:0000139; GO:0001554; GO:0001669; GO:0001701; GO:0001837; GO:0001889; GO:0001947; GO:0002040; GO:0002052; GO:0002085; GO:0002193; GO:0002437; GO:0003151; GO:0003157; GO:0003160; GO:0003162; GO:0003169; GO:0003180; GO:0003181; GO:0003182; GO:0003184; GO:0003192; GO:0003198; GO:0003203; GO:0003207; GO:0003208; GO:0003209; GO:0003213; GO:0003214; GO:0003219; GO:0003222; GO:0003241; GO:0003252; GO:0003270; GO:0003273; GO:0003332; GO:0003344; GO:0003713; GO:0004857; GO:0004888; GO:0005112; GO:0005509; GO:0005576; GO:0005634; GO:0005654; GO:0005789; GO:0005829; GO:0005886; GO:0005912; GO:0006355; GO:0006357; GO:0006366; GO:0006606; GO:0006955; GO:0006959; GO:0007219; GO:0007221; GO:0007283; GO:0007368; GO:0007386; GO:0007411; GO:0007440; GO:0007492; GO:0007507; GO:0008284; GO:0008285; GO:0009912; GO:0009957; GO:0009986; GO:0010008; GO:0010614; GO:0010628; GO:0010629; GO:0010667; GO:0010812; GO:0010832; GO:0014031; GO:0014807; GO:0016324; GO:0017156; GO:0019899; GO:0021515; GO:0021915; GO:0021953; GO:0030163; GO:0030216; GO:0030279; GO:0030324; GO:0030335; GO:0030513; GO:0030514; GO:0030900; GO:0031069; GO:0031100; GO:0031490; GO:0031902; GO:0032495; GO:0032496; GO:0032966; GO:0035116; GO:0035148; GO:0035914; GO:0035924; GO:0042246; GO:0042670; GO:0042802; GO:0043086; GO:0043235; GO:0045070; GO:0045603; GO:0045608; GO:0045618; GO:0045662; GO:0045668; GO:0045747; GO:0045892; GO:0045893; GO:0045944; GO:0045955; GO:0046427; GO:0046533; GO:0046579; GO:0048103; GO:0048708; GO:0048709; GO:0048711; GO:0048715; GO:0048754; GO:0048873; GO:0050673; GO:0050679; GO:0050680; GO:0050768; GO:0051152; GO:0055008; GO:0060038; GO:0060045; GO:0060253; GO:0060271; GO:0060317; GO:0060354; GO:0060379; GO:0060411; GO:0060412; GO:0060528; GO:0060740; GO:0060768; GO:0060842; GO:0060843; GO:0060948; GO:0060956; GO:0060979; GO:0060982; GO:0061101; GO:0061344; GO:0061384; GO:0062043; GO:0070168; GO:0070374; GO:0070986; GO:0071228; GO:0071372; GO:0071456; GO:0072017; GO:0072044; GO:0072091; GO:0072144; GO:0072148; GO:0072538; GO:0090051; GO:0090090; GO:0097150; GO:0097400; GO:0098685; GO:0098839; GO:0098978; GO:0099565; GO:0120163; GO:0140537; GO:1901201; GO:1902263; GO:1902339; GO:1903849; GO:2000048; GO:2000737; GO:2000811; GO:2000974; GO:2001027 animal organ regeneration [GO:0031100]; aortic valve morphogenesis [GO:0003180]; apoptotic process involved in embryonic digit morphogenesis [GO:1902263]; arterial endothelial cell differentiation [GO:0060842]; astrocyte differentiation [GO:0048708]; atrioventricular node development [GO:0003162]; atrioventricular valve morphogenesis [GO:0003181]; auditory receptor cell fate commitment [GO:0009912]; axon guidance [GO:0007411]; branching morphogenesis of an epithelial tube [GO:0048754]; calcium-ion regulated exocytosis [GO:0017156]; cardiac atrium morphogenesis [GO:0003209]; cardiac chamber formation [GO:0003207]; cardiac epithelial to mesenchymal transition [GO:0060317]; cardiac left ventricle morphogenesis [GO:0003214]; cardiac muscle cell myoblast differentiation [GO:0060379]; cardiac muscle cell proliferation [GO:0060038]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac right atrium morphogenesis [GO:0003213]; cardiac right ventricle formation [GO:0003219]; cardiac septum morphogenesis [GO:0060411]; cardiac vascular smooth muscle cell development [GO:0060948]; cardiac ventricle morphogenesis [GO:0003208]; cell differentiation in spinal cord [GO:0021515]; cell migration involved in endocardial cushion formation [GO:0003273]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to hypoxia [GO:0071456]; cellular response to tumor cell [GO:0071228]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; central nervous system neuron differentiation [GO:0021953]; chemical synaptic transmission, postsynaptic [GO:0099565]; cilium assembly [GO:0060271]; collecting duct development [GO:0072044]; compartment pattern specification [GO:0007386]; coronary artery morphogenesis [GO:0060982]; coronary sinus valve morphogenesis [GO:0003182]; coronary vein morphogenesis [GO:0003169]; determination of left/right symmetry [GO:0007368]; distal tubule development [GO:0072017]; embryonic hindlimb morphogenesis [GO:0035116]; endocardial cell differentiation [GO:0060956]; endocardial cushion morphogenesis [GO:0003203]; endocardium development [GO:0003157]; endocardium morphogenesis [GO:0003160]; endoderm development [GO:0007492]; epidermal cell fate specification [GO:0009957]; epithelial cell fate commitment [GO:0072148]; epithelial cell proliferation [GO:0050673]; epithelial to mesenchymal transition [GO:0001837]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; forebrain development [GO:0030900]; foregut morphogenesis [GO:0007440]; glomerular mesangial cell development [GO:0072144]; growth involved in heart morphogenesis [GO:0003241]; hair follicle morphogenesis [GO:0031069]; heart development [GO:0007507]; heart looping [GO:0001947]; heart trabecula morphogenesis [GO:0061384]; homeostasis of number of cells within a tissue [GO:0048873]; humoral immune response [GO:0006959]; immune response [GO:0006955]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; inhibition of neuroepithelial cell differentiation [GO:0002085]; interleukin-17-mediated signaling pathway [GO:0097400]; keratinocyte differentiation [GO:0030216]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; lung development [GO:0030324]; luteolysis [GO:0001554]; mesenchymal cell development [GO:0014031]; mitral valve formation [GO:0003192]; negative regulation of anoikis [GO:2000811]; negative regulation of biomineral tissue development [GO:0070168]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of catalytic activity [GO:0043086]; negative regulation of cell adhesion molecule production [GO:0060354]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell proliferation involved in heart valve morphogenesis [GO:0003252]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of collagen biosynthetic process [GO:0032966]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of endothelial cell chemotaxis [GO:2001027]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of extracellular matrix constituent secretion [GO:0003332]; negative regulation of gene expression [GO:0010629]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of inner ear auditory receptor cell differentiation [GO:0045608]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of neurogenesis [GO:0050768]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of ossification [GO:0030279]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of photoreceptor cell differentiation [GO:0046533]; negative regulation of pro-B cell differentiation [GO:2000974]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural tube development [GO:0021915]; neuroendocrine cell differentiation [GO:0061101]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; Notch signaling pathway involved in regulation of secondary heart field cardioblast proliferation [GO:0003270]; oligodendrocyte differentiation [GO:0048709]; outflow tract morphogenesis [GO:0003151]; pericardium morphogenesis [GO:0003344]; positive regulation of aorta morphogenesis [GO:1903849]; positive regulation of apoptotic process involved in morphogenesis [GO:1902339]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cardiac epithelial to mesenchymal transition [GO:0062043]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of smooth muscle cell differentiation [GO:0051152]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription of Notch receptor target [GO:0007221]; positive regulation of viral genome replication [GO:0045070]; prostate gland epithelium morphogenesis [GO:0060740]; protein catabolic process [GO:0030163]; protein import into nucleus [GO:0006606]; pulmonary valve morphogenesis [GO:0003184]; regulation of cell adhesion involved in heart morphogenesis [GO:0061344]; regulation of DNA-templated transcription [GO:0006355]; regulation of epithelial cell proliferation involved in prostate gland development [GO:0060768]; regulation of extracellular matrix assembly [GO:1901201]; regulation of somitogenesis [GO:0014807]; regulation of stem cell proliferation [GO:0072091]; regulation of transcription by RNA polymerase II [GO:0006357]; response to lipopolysaccharide [GO:0032496]; response to muramyl dipeptide [GO:0032495]; retinal cone cell differentiation [GO:0042670]; secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development [GO:0060528]; skeletal muscle cell differentiation [GO:0035914]; somatic stem cell division [GO:0048103]; spermatogenesis [GO:0007283]; sprouting angiogenesis [GO:0002040]; T-helper 17 type immune response [GO:0072538]; tissue regeneration [GO:0042246]; transcription by RNA polymerase II [GO:0006366]; tube formation [GO:0035148]; vasculogenesis involved in coronary vascular morphogenesis [GO:0060979]; venous endothelial cell differentiation [GO:0060843]; ventricular septum morphogenesis [GO:0060412]; ventricular trabecula myocardium morphogenesis [GO:0003222] acrosomal vesicle [GO:0001669]; adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; late endosome membrane [GO:0031902]; MAML1-RBP-Jkappa- ICN1 complex [GO:0002193]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; receptor complex [GO:0043235]; Schaffer collateral - CA1 synapse [GO:0098685] calcium ion binding [GO:0005509]; chromatin DNA binding [GO:0031490]; enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; identical protein binding [GO:0042802]; Notch binding [GO:0005112]; transcription coactivator activity [GO:0003713]; transcription regulator activator activity [GO:0140537]; transmembrane signaling receptor activity [GO:0004888] g19879.t2 P46531 32.398 392 3.98e-33 145.0 sp|P46531|NOTC1_HUMAN Neurogenic locus notch homolog protein 1 OS=Homo sapiens OX=9606 GN=NOTCH1 PE=1 SV=4 NOTC1_HUMAN reviewed Neurogenic locus notch homolog protein 1 (Notch 1) (hN1) (Translocation-associated notch protein TAN-1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Homo sapiens (Human) GO:0000122; GO:0000139; GO:0001554; GO:0001669; GO:0001701; GO:0001837; GO:0001889; GO:0001947; GO:0002040; GO:0002052; GO:0002085; GO:0002193; GO:0002437; GO:0003151; GO:0003157; GO:0003160; GO:0003162; GO:0003169; GO:0003180; GO:0003181; GO:0003182; GO:0003184; GO:0003192; GO:0003198; GO:0003203; GO:0003207; GO:0003208; GO:0003209; GO:0003213; GO:0003214; GO:0003219; GO:0003222; GO:0003241; GO:0003252; GO:0003270; GO:0003273; GO:0003332; GO:0003344; GO:0003713; GO:0004857; GO:0004888; GO:0005112; GO:0005509; GO:0005576; GO:0005634; GO:0005654; GO:0005789; GO:0005829; GO:0005886; GO:0005912; GO:0006355; GO:0006357; GO:0006366; GO:0006606; GO:0006955; GO:0006959; GO:0007219; GO:0007221; GO:0007283; GO:0007368; GO:0007386; GO:0007411; GO:0007440; GO:0007492; GO:0007507; GO:0008284; GO:0008285; GO:0009912; GO:0009957; GO:0009986; GO:0010008; GO:0010614; GO:0010628; GO:0010629; GO:0010667; GO:0010812; GO:0010832; GO:0014031; GO:0014807; GO:0016324; GO:0017156; GO:0019899; GO:0021515; GO:0021915; GO:0021953; GO:0030163; GO:0030216; GO:0030279; GO:0030324; GO:0030335; GO:0030513; GO:0030514; GO:0030900; GO:0031069; GO:0031100; GO:0031490; GO:0031902; GO:0032495; GO:0032496; GO:0032966; GO:0035116; GO:0035148; GO:0035914; GO:0035924; GO:0042246; GO:0042670; GO:0042802; GO:0043086; GO:0043235; GO:0045070; GO:0045603; GO:0045608; GO:0045618; GO:0045662; GO:0045668; GO:0045747; GO:0045892; GO:0045893; GO:0045944; GO:0045955; GO:0046427; GO:0046533; GO:0046579; GO:0048103; GO:0048708; GO:0048709; GO:0048711; GO:0048715; GO:0048754; GO:0048873; GO:0050673; GO:0050679; GO:0050680; GO:0050768; GO:0051152; GO:0055008; GO:0060038; GO:0060045; GO:0060253; GO:0060271; GO:0060317; GO:0060354; GO:0060379; GO:0060411; GO:0060412; GO:0060528; GO:0060740; GO:0060768; GO:0060842; GO:0060843; GO:0060948; GO:0060956; GO:0060979; GO:0060982; GO:0061101; GO:0061344; GO:0061384; GO:0062043; GO:0070168; GO:0070374; GO:0070986; GO:0071228; GO:0071372; GO:0071456; GO:0072017; GO:0072044; GO:0072091; GO:0072144; GO:0072148; GO:0072538; GO:0090051; GO:0090090; GO:0097150; GO:0097400; GO:0098685; GO:0098839; GO:0098978; GO:0099565; GO:0120163; GO:0140537; GO:1901201; GO:1902263; GO:1902339; GO:1903849; GO:2000048; GO:2000737; GO:2000811; GO:2000974; GO:2001027 animal organ regeneration [GO:0031100]; aortic valve morphogenesis [GO:0003180]; apoptotic process involved in embryonic digit morphogenesis [GO:1902263]; arterial endothelial cell differentiation [GO:0060842]; astrocyte differentiation [GO:0048708]; atrioventricular node development [GO:0003162]; atrioventricular valve morphogenesis [GO:0003181]; auditory receptor cell fate commitment [GO:0009912]; axon guidance [GO:0007411]; branching morphogenesis of an epithelial tube [GO:0048754]; calcium-ion regulated exocytosis [GO:0017156]; cardiac atrium morphogenesis [GO:0003209]; cardiac chamber formation [GO:0003207]; cardiac epithelial to mesenchymal transition [GO:0060317]; cardiac left ventricle morphogenesis [GO:0003214]; cardiac muscle cell myoblast differentiation [GO:0060379]; cardiac muscle cell proliferation [GO:0060038]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac right atrium morphogenesis [GO:0003213]; cardiac right ventricle formation [GO:0003219]; cardiac septum morphogenesis [GO:0060411]; cardiac vascular smooth muscle cell development [GO:0060948]; cardiac ventricle morphogenesis [GO:0003208]; cell differentiation in spinal cord [GO:0021515]; cell migration involved in endocardial cushion formation [GO:0003273]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to hypoxia [GO:0071456]; cellular response to tumor cell [GO:0071228]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; central nervous system neuron differentiation [GO:0021953]; chemical synaptic transmission, postsynaptic [GO:0099565]; cilium assembly [GO:0060271]; collecting duct development [GO:0072044]; compartment pattern specification [GO:0007386]; coronary artery morphogenesis [GO:0060982]; coronary sinus valve morphogenesis [GO:0003182]; coronary vein morphogenesis [GO:0003169]; determination of left/right symmetry [GO:0007368]; distal tubule development [GO:0072017]; embryonic hindlimb morphogenesis [GO:0035116]; endocardial cell differentiation [GO:0060956]; endocardial cushion morphogenesis [GO:0003203]; endocardium development [GO:0003157]; endocardium morphogenesis [GO:0003160]; endoderm development [GO:0007492]; epidermal cell fate specification [GO:0009957]; epithelial cell fate commitment [GO:0072148]; epithelial cell proliferation [GO:0050673]; epithelial to mesenchymal transition [GO:0001837]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; forebrain development [GO:0030900]; foregut morphogenesis [GO:0007440]; glomerular mesangial cell development [GO:0072144]; growth involved in heart morphogenesis [GO:0003241]; hair follicle morphogenesis [GO:0031069]; heart development [GO:0007507]; heart looping [GO:0001947]; heart trabecula morphogenesis [GO:0061384]; homeostasis of number of cells within a tissue [GO:0048873]; humoral immune response [GO:0006959]; immune response [GO:0006955]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; inhibition of neuroepithelial cell differentiation [GO:0002085]; interleukin-17-mediated signaling pathway [GO:0097400]; keratinocyte differentiation [GO:0030216]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; lung development [GO:0030324]; luteolysis [GO:0001554]; mesenchymal cell development [GO:0014031]; mitral valve formation [GO:0003192]; negative regulation of anoikis [GO:2000811]; negative regulation of biomineral tissue development [GO:0070168]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of catalytic activity [GO:0043086]; negative regulation of cell adhesion molecule production [GO:0060354]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell proliferation involved in heart valve morphogenesis [GO:0003252]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of collagen biosynthetic process [GO:0032966]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of endothelial cell chemotaxis [GO:2001027]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of extracellular matrix constituent secretion [GO:0003332]; negative regulation of gene expression [GO:0010629]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of inner ear auditory receptor cell differentiation [GO:0045608]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of neurogenesis [GO:0050768]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of ossification [GO:0030279]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of photoreceptor cell differentiation [GO:0046533]; negative regulation of pro-B cell differentiation [GO:2000974]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural tube development [GO:0021915]; neuroendocrine cell differentiation [GO:0061101]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; Notch signaling pathway involved in regulation of secondary heart field cardioblast proliferation [GO:0003270]; oligodendrocyte differentiation [GO:0048709]; outflow tract morphogenesis [GO:0003151]; pericardium morphogenesis [GO:0003344]; positive regulation of aorta morphogenesis [GO:1903849]; positive regulation of apoptotic process involved in morphogenesis [GO:1902339]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cardiac epithelial to mesenchymal transition [GO:0062043]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of smooth muscle cell differentiation [GO:0051152]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription of Notch receptor target [GO:0007221]; positive regulation of viral genome replication [GO:0045070]; prostate gland epithelium morphogenesis [GO:0060740]; protein catabolic process [GO:0030163]; protein import into nucleus [GO:0006606]; pulmonary valve morphogenesis [GO:0003184]; regulation of cell adhesion involved in heart morphogenesis [GO:0061344]; regulation of DNA-templated transcription [GO:0006355]; regulation of epithelial cell proliferation involved in prostate gland development [GO:0060768]; regulation of extracellular matrix assembly [GO:1901201]; regulation of somitogenesis [GO:0014807]; regulation of stem cell proliferation [GO:0072091]; regulation of transcription by RNA polymerase II [GO:0006357]; response to lipopolysaccharide [GO:0032496]; response to muramyl dipeptide [GO:0032495]; retinal cone cell differentiation [GO:0042670]; secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development [GO:0060528]; skeletal muscle cell differentiation [GO:0035914]; somatic stem cell division [GO:0048103]; spermatogenesis [GO:0007283]; sprouting angiogenesis [GO:0002040]; T-helper 17 type immune response [GO:0072538]; tissue regeneration [GO:0042246]; transcription by RNA polymerase II [GO:0006366]; tube formation [GO:0035148]; vasculogenesis involved in coronary vascular morphogenesis [GO:0060979]; venous endothelial cell differentiation [GO:0060843]; ventricular septum morphogenesis [GO:0060412]; ventricular trabecula myocardium morphogenesis [GO:0003222] acrosomal vesicle [GO:0001669]; adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; late endosome membrane [GO:0031902]; MAML1-RBP-Jkappa- ICN1 complex [GO:0002193]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; receptor complex [GO:0043235]; Schaffer collateral - CA1 synapse [GO:0098685] calcium ion binding [GO:0005509]; chromatin DNA binding [GO:0031490]; enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; identical protein binding [GO:0042802]; Notch binding [GO:0005112]; transcription coactivator activity [GO:0003713]; transcription regulator activator activity [GO:0140537]; transmembrane signaling receptor activity [GO:0004888] g19879.t2 P46531 32.66 297 3.43e-26 122.0 sp|P46531|NOTC1_HUMAN Neurogenic locus notch homolog protein 1 OS=Homo sapiens OX=9606 GN=NOTCH1 PE=1 SV=4 NOTC1_HUMAN reviewed Neurogenic locus notch homolog protein 1 (Notch 1) (hN1) (Translocation-associated notch protein TAN-1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Homo sapiens (Human) GO:0000122; GO:0000139; GO:0001554; GO:0001669; GO:0001701; GO:0001837; GO:0001889; GO:0001947; GO:0002040; GO:0002052; GO:0002085; GO:0002193; GO:0002437; GO:0003151; GO:0003157; GO:0003160; GO:0003162; GO:0003169; GO:0003180; GO:0003181; GO:0003182; GO:0003184; GO:0003192; GO:0003198; GO:0003203; GO:0003207; GO:0003208; GO:0003209; GO:0003213; GO:0003214; GO:0003219; GO:0003222; GO:0003241; GO:0003252; GO:0003270; GO:0003273; GO:0003332; GO:0003344; GO:0003713; GO:0004857; GO:0004888; GO:0005112; GO:0005509; GO:0005576; GO:0005634; GO:0005654; GO:0005789; GO:0005829; GO:0005886; GO:0005912; GO:0006355; GO:0006357; GO:0006366; GO:0006606; GO:0006955; GO:0006959; GO:0007219; GO:0007221; GO:0007283; GO:0007368; GO:0007386; GO:0007411; GO:0007440; GO:0007492; GO:0007507; GO:0008284; GO:0008285; GO:0009912; GO:0009957; GO:0009986; GO:0010008; GO:0010614; GO:0010628; GO:0010629; GO:0010667; GO:0010812; GO:0010832; GO:0014031; GO:0014807; GO:0016324; GO:0017156; GO:0019899; GO:0021515; GO:0021915; GO:0021953; GO:0030163; GO:0030216; GO:0030279; GO:0030324; GO:0030335; GO:0030513; GO:0030514; GO:0030900; GO:0031069; GO:0031100; GO:0031490; GO:0031902; GO:0032495; GO:0032496; GO:0032966; GO:0035116; GO:0035148; GO:0035914; GO:0035924; GO:0042246; GO:0042670; GO:0042802; GO:0043086; GO:0043235; GO:0045070; GO:0045603; GO:0045608; GO:0045618; GO:0045662; GO:0045668; GO:0045747; GO:0045892; GO:0045893; GO:0045944; GO:0045955; GO:0046427; GO:0046533; GO:0046579; GO:0048103; GO:0048708; GO:0048709; GO:0048711; GO:0048715; GO:0048754; GO:0048873; GO:0050673; GO:0050679; GO:0050680; GO:0050768; GO:0051152; GO:0055008; GO:0060038; GO:0060045; GO:0060253; GO:0060271; GO:0060317; GO:0060354; GO:0060379; GO:0060411; GO:0060412; GO:0060528; GO:0060740; GO:0060768; GO:0060842; GO:0060843; GO:0060948; GO:0060956; GO:0060979; GO:0060982; GO:0061101; GO:0061344; GO:0061384; GO:0062043; GO:0070168; GO:0070374; GO:0070986; GO:0071228; GO:0071372; GO:0071456; GO:0072017; GO:0072044; GO:0072091; GO:0072144; GO:0072148; GO:0072538; GO:0090051; GO:0090090; GO:0097150; GO:0097400; GO:0098685; GO:0098839; GO:0098978; GO:0099565; GO:0120163; GO:0140537; GO:1901201; GO:1902263; GO:1902339; GO:1903849; GO:2000048; GO:2000737; GO:2000811; GO:2000974; GO:2001027 animal organ regeneration [GO:0031100]; aortic valve morphogenesis [GO:0003180]; apoptotic process involved in embryonic digit morphogenesis [GO:1902263]; arterial endothelial cell differentiation [GO:0060842]; astrocyte differentiation [GO:0048708]; atrioventricular node development [GO:0003162]; atrioventricular valve morphogenesis [GO:0003181]; auditory receptor cell fate commitment [GO:0009912]; axon guidance [GO:0007411]; branching morphogenesis of an epithelial tube [GO:0048754]; calcium-ion regulated exocytosis [GO:0017156]; cardiac atrium morphogenesis [GO:0003209]; cardiac chamber formation [GO:0003207]; cardiac epithelial to mesenchymal transition [GO:0060317]; cardiac left ventricle morphogenesis [GO:0003214]; cardiac muscle cell myoblast differentiation [GO:0060379]; cardiac muscle cell proliferation [GO:0060038]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac right atrium morphogenesis [GO:0003213]; cardiac right ventricle formation [GO:0003219]; cardiac septum morphogenesis [GO:0060411]; cardiac vascular smooth muscle cell development [GO:0060948]; cardiac ventricle morphogenesis [GO:0003208]; cell differentiation in spinal cord [GO:0021515]; cell migration involved in endocardial cushion formation [GO:0003273]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to hypoxia [GO:0071456]; cellular response to tumor cell [GO:0071228]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; central nervous system neuron differentiation [GO:0021953]; chemical synaptic transmission, postsynaptic [GO:0099565]; cilium assembly [GO:0060271]; collecting duct development [GO:0072044]; compartment pattern specification [GO:0007386]; coronary artery morphogenesis [GO:0060982]; coronary sinus valve morphogenesis [GO:0003182]; coronary vein morphogenesis [GO:0003169]; determination of left/right symmetry [GO:0007368]; distal tubule development [GO:0072017]; embryonic hindlimb morphogenesis [GO:0035116]; endocardial cell differentiation [GO:0060956]; endocardial cushion morphogenesis [GO:0003203]; endocardium development [GO:0003157]; endocardium morphogenesis [GO:0003160]; endoderm development [GO:0007492]; epidermal cell fate specification [GO:0009957]; epithelial cell fate commitment [GO:0072148]; epithelial cell proliferation [GO:0050673]; epithelial to mesenchymal transition [GO:0001837]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; forebrain development [GO:0030900]; foregut morphogenesis [GO:0007440]; glomerular mesangial cell development [GO:0072144]; growth involved in heart morphogenesis [GO:0003241]; hair follicle morphogenesis [GO:0031069]; heart development [GO:0007507]; heart looping [GO:0001947]; heart trabecula morphogenesis [GO:0061384]; homeostasis of number of cells within a tissue [GO:0048873]; humoral immune response [GO:0006959]; immune response [GO:0006955]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; inhibition of neuroepithelial cell differentiation [GO:0002085]; interleukin-17-mediated signaling pathway [GO:0097400]; keratinocyte differentiation [GO:0030216]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; lung development [GO:0030324]; luteolysis [GO:0001554]; mesenchymal cell development [GO:0014031]; mitral valve formation [GO:0003192]; negative regulation of anoikis [GO:2000811]; negative regulation of biomineral tissue development [GO:0070168]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of catalytic activity [GO:0043086]; negative regulation of cell adhesion molecule production [GO:0060354]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell proliferation involved in heart valve morphogenesis [GO:0003252]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of collagen biosynthetic process [GO:0032966]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of endothelial cell chemotaxis [GO:2001027]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of extracellular matrix constituent secretion [GO:0003332]; negative regulation of gene expression [GO:0010629]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of inner ear auditory receptor cell differentiation [GO:0045608]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of neurogenesis [GO:0050768]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of ossification [GO:0030279]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of photoreceptor cell differentiation [GO:0046533]; negative regulation of pro-B cell differentiation [GO:2000974]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural tube development [GO:0021915]; neuroendocrine cell differentiation [GO:0061101]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; Notch signaling pathway involved in regulation of secondary heart field cardioblast proliferation [GO:0003270]; oligodendrocyte differentiation [GO:0048709]; outflow tract morphogenesis [GO:0003151]; pericardium morphogenesis [GO:0003344]; positive regulation of aorta morphogenesis [GO:1903849]; positive regulation of apoptotic process involved in morphogenesis [GO:1902339]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cardiac epithelial to mesenchymal transition [GO:0062043]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of smooth muscle cell differentiation [GO:0051152]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription of Notch receptor target [GO:0007221]; positive regulation of viral genome replication [GO:0045070]; prostate gland epithelium morphogenesis [GO:0060740]; protein catabolic process [GO:0030163]; protein import into nucleus [GO:0006606]; pulmonary valve morphogenesis [GO:0003184]; regulation of cell adhesion involved in heart morphogenesis [GO:0061344]; regulation of DNA-templated transcription [GO:0006355]; regulation of epithelial cell proliferation involved in prostate gland development [GO:0060768]; regulation of extracellular matrix assembly [GO:1901201]; regulation of somitogenesis [GO:0014807]; regulation of stem cell proliferation [GO:0072091]; regulation of transcription by RNA polymerase II [GO:0006357]; response to lipopolysaccharide [GO:0032496]; response to muramyl dipeptide [GO:0032495]; retinal cone cell differentiation [GO:0042670]; secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development [GO:0060528]; skeletal muscle cell differentiation [GO:0035914]; somatic stem cell division [GO:0048103]; spermatogenesis [GO:0007283]; sprouting angiogenesis [GO:0002040]; T-helper 17 type immune response [GO:0072538]; tissue regeneration [GO:0042246]; transcription by RNA polymerase II [GO:0006366]; tube formation [GO:0035148]; vasculogenesis involved in coronary vascular morphogenesis [GO:0060979]; venous endothelial cell differentiation [GO:0060843]; ventricular septum morphogenesis [GO:0060412]; ventricular trabecula myocardium morphogenesis [GO:0003222] acrosomal vesicle [GO:0001669]; adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; late endosome membrane [GO:0031902]; MAML1-RBP-Jkappa- ICN1 complex [GO:0002193]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; receptor complex [GO:0043235]; Schaffer collateral - CA1 synapse [GO:0098685] calcium ion binding [GO:0005509]; chromatin DNA binding [GO:0031490]; enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; identical protein binding [GO:0042802]; Notch binding [GO:0005112]; transcription coactivator activity [GO:0003713]; transcription regulator activator activity [GO:0140537]; transmembrane signaling receptor activity [GO:0004888] g19879.t3 A2RUV0 36.697 1417 1.76e-177 604.0 sp|A2RUV0|NOTC1_XENTR Neurogenic locus notch homolog protein 1 OS=Xenopus tropicalis OX=8364 GN=notch1 PE=1 SV=2 NOTC1_XENTR reviewed Neurogenic locus notch homolog protein 1 (Notch 1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0001525; GO:0005509; GO:0005634; GO:0005886; GO:0006355; GO:0007219; GO:0007411; GO:0009986; GO:0038023; GO:0043235; GO:0050793; GO:0060271; GO:0061314 angiogenesis [GO:0001525]; axon guidance [GO:0007411]; cilium assembly [GO:0060271]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; regulation of developmental process [GO:0050793]; regulation of DNA-templated transcription [GO:0006355] cell surface [GO:0009986]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; signaling receptor activity [GO:0038023] g19879.t3 A2RUV0 34.78 1475 3.8e-169 579.0 sp|A2RUV0|NOTC1_XENTR Neurogenic locus notch homolog protein 1 OS=Xenopus tropicalis OX=8364 GN=notch1 PE=1 SV=2 NOTC1_XENTR reviewed Neurogenic locus notch homolog protein 1 (Notch 1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0001525; GO:0005509; GO:0005634; GO:0005886; GO:0006355; GO:0007219; GO:0007411; GO:0009986; GO:0038023; GO:0043235; GO:0050793; GO:0060271; GO:0061314 angiogenesis [GO:0001525]; axon guidance [GO:0007411]; cilium assembly [GO:0060271]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; regulation of developmental process [GO:0050793]; regulation of DNA-templated transcription [GO:0006355] cell surface [GO:0009986]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; signaling receptor activity [GO:0038023] g19879.t3 A2RUV0 36.074 1350 1.71e-165 568.0 sp|A2RUV0|NOTC1_XENTR Neurogenic locus notch homolog protein 1 OS=Xenopus tropicalis OX=8364 GN=notch1 PE=1 SV=2 NOTC1_XENTR reviewed Neurogenic locus notch homolog protein 1 (Notch 1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0001525; GO:0005509; GO:0005634; GO:0005886; GO:0006355; GO:0007219; GO:0007411; GO:0009986; GO:0038023; GO:0043235; GO:0050793; GO:0060271; GO:0061314 angiogenesis [GO:0001525]; axon guidance [GO:0007411]; cilium assembly [GO:0060271]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; regulation of developmental process [GO:0050793]; regulation of DNA-templated transcription [GO:0006355] cell surface [GO:0009986]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; signaling receptor activity [GO:0038023] g19879.t3 A2RUV0 32.291 1279 3.25e-134 473.0 sp|A2RUV0|NOTC1_XENTR Neurogenic locus notch homolog protein 1 OS=Xenopus tropicalis OX=8364 GN=notch1 PE=1 SV=2 NOTC1_XENTR reviewed Neurogenic locus notch homolog protein 1 (Notch 1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0001525; GO:0005509; GO:0005634; GO:0005886; GO:0006355; GO:0007219; GO:0007411; GO:0009986; GO:0038023; GO:0043235; GO:0050793; GO:0060271; GO:0061314 angiogenesis [GO:0001525]; axon guidance [GO:0007411]; cilium assembly [GO:0060271]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; regulation of developmental process [GO:0050793]; regulation of DNA-templated transcription [GO:0006355] cell surface [GO:0009986]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; signaling receptor activity [GO:0038023] g19879.t3 A2RUV0 35.24 979 2.43e-118 423.0 sp|A2RUV0|NOTC1_XENTR Neurogenic locus notch homolog protein 1 OS=Xenopus tropicalis OX=8364 GN=notch1 PE=1 SV=2 NOTC1_XENTR reviewed Neurogenic locus notch homolog protein 1 (Notch 1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0001525; GO:0005509; GO:0005634; GO:0005886; GO:0006355; GO:0007219; GO:0007411; GO:0009986; GO:0038023; GO:0043235; GO:0050793; GO:0060271; GO:0061314 angiogenesis [GO:0001525]; axon guidance [GO:0007411]; cilium assembly [GO:0060271]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; regulation of developmental process [GO:0050793]; regulation of DNA-templated transcription [GO:0006355] cell surface [GO:0009986]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; signaling receptor activity [GO:0038023] g19879.t3 A2RUV0 35.426 892 1.18e-104 379.0 sp|A2RUV0|NOTC1_XENTR Neurogenic locus notch homolog protein 1 OS=Xenopus tropicalis OX=8364 GN=notch1 PE=1 SV=2 NOTC1_XENTR reviewed Neurogenic locus notch homolog protein 1 (Notch 1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0001525; GO:0005509; GO:0005634; GO:0005886; GO:0006355; GO:0007219; GO:0007411; GO:0009986; GO:0038023; GO:0043235; GO:0050793; GO:0060271; GO:0061314 angiogenesis [GO:0001525]; axon guidance [GO:0007411]; cilium assembly [GO:0060271]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; regulation of developmental process [GO:0050793]; regulation of DNA-templated transcription [GO:0006355] cell surface [GO:0009986]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; signaling receptor activity [GO:0038023] g19879.t3 A2RUV0 31.885 1151 7.15e-97 354.0 sp|A2RUV0|NOTC1_XENTR Neurogenic locus notch homolog protein 1 OS=Xenopus tropicalis OX=8364 GN=notch1 PE=1 SV=2 NOTC1_XENTR reviewed Neurogenic locus notch homolog protein 1 (Notch 1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0001525; GO:0005509; GO:0005634; GO:0005886; GO:0006355; GO:0007219; GO:0007411; GO:0009986; GO:0038023; GO:0043235; GO:0050793; GO:0060271; GO:0061314 angiogenesis [GO:0001525]; axon guidance [GO:0007411]; cilium assembly [GO:0060271]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; regulation of developmental process [GO:0050793]; regulation of DNA-templated transcription [GO:0006355] cell surface [GO:0009986]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; signaling receptor activity [GO:0038023] g19879.t3 A2RUV0 34.515 423 1.19e-40 170.0 sp|A2RUV0|NOTC1_XENTR Neurogenic locus notch homolog protein 1 OS=Xenopus tropicalis OX=8364 GN=notch1 PE=1 SV=2 NOTC1_XENTR reviewed Neurogenic locus notch homolog protein 1 (Notch 1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0001525; GO:0005509; GO:0005634; GO:0005886; GO:0006355; GO:0007219; GO:0007411; GO:0009986; GO:0038023; GO:0043235; GO:0050793; GO:0060271; GO:0061314 angiogenesis [GO:0001525]; axon guidance [GO:0007411]; cilium assembly [GO:0060271]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; regulation of developmental process [GO:0050793]; regulation of DNA-templated transcription [GO:0006355] cell surface [GO:0009986]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; signaling receptor activity [GO:0038023] g19879.t3 A2RUV0 32.653 392 1.8600000000000002e-35 153.0 sp|A2RUV0|NOTC1_XENTR Neurogenic locus notch homolog protein 1 OS=Xenopus tropicalis OX=8364 GN=notch1 PE=1 SV=2 NOTC1_XENTR reviewed Neurogenic locus notch homolog protein 1 (Notch 1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0001525; GO:0005509; GO:0005634; GO:0005886; GO:0006355; GO:0007219; GO:0007411; GO:0009986; GO:0038023; GO:0043235; GO:0050793; GO:0060271; GO:0061314 angiogenesis [GO:0001525]; axon guidance [GO:0007411]; cilium assembly [GO:0060271]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; regulation of developmental process [GO:0050793]; regulation of DNA-templated transcription [GO:0006355] cell surface [GO:0009986]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; signaling receptor activity [GO:0038023] g19879.t3 A2RUV0 30.769 429 7.210000000000001e-35 150.0 sp|A2RUV0|NOTC1_XENTR Neurogenic locus notch homolog protein 1 OS=Xenopus tropicalis OX=8364 GN=notch1 PE=1 SV=2 NOTC1_XENTR reviewed Neurogenic locus notch homolog protein 1 (Notch 1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0001525; GO:0005509; GO:0005634; GO:0005886; GO:0006355; GO:0007219; GO:0007411; GO:0009986; GO:0038023; GO:0043235; GO:0050793; GO:0060271; GO:0061314 angiogenesis [GO:0001525]; axon guidance [GO:0007411]; cilium assembly [GO:0060271]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; regulation of developmental process [GO:0050793]; regulation of DNA-templated transcription [GO:0006355] cell surface [GO:0009986]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; signaling receptor activity [GO:0038023] g19879.t3 A2RUV0 34.161 322 1.6400000000000001e-31 140.0 sp|A2RUV0|NOTC1_XENTR Neurogenic locus notch homolog protein 1 OS=Xenopus tropicalis OX=8364 GN=notch1 PE=1 SV=2 NOTC1_XENTR reviewed Neurogenic locus notch homolog protein 1 (Notch 1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0001525; GO:0005509; GO:0005634; GO:0005886; GO:0006355; GO:0007219; GO:0007411; GO:0009986; GO:0038023; GO:0043235; GO:0050793; GO:0060271; GO:0061314 angiogenesis [GO:0001525]; axon guidance [GO:0007411]; cilium assembly [GO:0060271]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; regulation of developmental process [GO:0050793]; regulation of DNA-templated transcription [GO:0006355] cell surface [GO:0009986]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; signaling receptor activity [GO:0038023] g19879.t3 A2RUV0 31.845 336 2.49e-22 109.0 sp|A2RUV0|NOTC1_XENTR Neurogenic locus notch homolog protein 1 OS=Xenopus tropicalis OX=8364 GN=notch1 PE=1 SV=2 NOTC1_XENTR reviewed Neurogenic locus notch homolog protein 1 (Notch 1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0001525; GO:0005509; GO:0005634; GO:0005886; GO:0006355; GO:0007219; GO:0007411; GO:0009986; GO:0038023; GO:0043235; GO:0050793; GO:0060271; GO:0061314 angiogenesis [GO:0001525]; axon guidance [GO:0007411]; cilium assembly [GO:0060271]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; regulation of developmental process [GO:0050793]; regulation of DNA-templated transcription [GO:0006355] cell surface [GO:0009986]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; signaling receptor activity [GO:0038023] g19879.t4 A2RUV0 36.517 1424 3.81e-176 600.0 sp|A2RUV0|NOTC1_XENTR Neurogenic locus notch homolog protein 1 OS=Xenopus tropicalis OX=8364 GN=notch1 PE=1 SV=2 NOTC1_XENTR reviewed Neurogenic locus notch homolog protein 1 (Notch 1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0001525; GO:0005509; GO:0005634; GO:0005886; GO:0006355; GO:0007219; GO:0007411; GO:0009986; GO:0038023; GO:0043235; GO:0050793; GO:0060271; GO:0061314 angiogenesis [GO:0001525]; axon guidance [GO:0007411]; cilium assembly [GO:0060271]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; regulation of developmental process [GO:0050793]; regulation of DNA-templated transcription [GO:0006355] cell surface [GO:0009986]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; signaling receptor activity [GO:0038023] g19879.t4 A2RUV0 33.155 1493 3.28e-165 568.0 sp|A2RUV0|NOTC1_XENTR Neurogenic locus notch homolog protein 1 OS=Xenopus tropicalis OX=8364 GN=notch1 PE=1 SV=2 NOTC1_XENTR reviewed Neurogenic locus notch homolog protein 1 (Notch 1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0001525; GO:0005509; GO:0005634; GO:0005886; GO:0006355; GO:0007219; GO:0007411; GO:0009986; GO:0038023; GO:0043235; GO:0050793; GO:0060271; GO:0061314 angiogenesis [GO:0001525]; axon guidance [GO:0007411]; cilium assembly [GO:0060271]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; regulation of developmental process [GO:0050793]; regulation of DNA-templated transcription [GO:0006355] cell surface [GO:0009986]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; signaling receptor activity [GO:0038023] g19879.t4 A2RUV0 35.508 1349 3.04e-161 556.0 sp|A2RUV0|NOTC1_XENTR Neurogenic locus notch homolog protein 1 OS=Xenopus tropicalis OX=8364 GN=notch1 PE=1 SV=2 NOTC1_XENTR reviewed Neurogenic locus notch homolog protein 1 (Notch 1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0001525; GO:0005509; GO:0005634; GO:0005886; GO:0006355; GO:0007219; GO:0007411; GO:0009986; GO:0038023; GO:0043235; GO:0050793; GO:0060271; GO:0061314 angiogenesis [GO:0001525]; axon guidance [GO:0007411]; cilium assembly [GO:0060271]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; regulation of developmental process [GO:0050793]; regulation of DNA-templated transcription [GO:0006355] cell surface [GO:0009986]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; signaling receptor activity [GO:0038023] g19879.t4 A2RUV0 34.527 1396 7.23e-151 525.0 sp|A2RUV0|NOTC1_XENTR Neurogenic locus notch homolog protein 1 OS=Xenopus tropicalis OX=8364 GN=notch1 PE=1 SV=2 NOTC1_XENTR reviewed Neurogenic locus notch homolog protein 1 (Notch 1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0001525; GO:0005509; GO:0005634; GO:0005886; GO:0006355; GO:0007219; GO:0007411; GO:0009986; GO:0038023; GO:0043235; GO:0050793; GO:0060271; GO:0061314 angiogenesis [GO:0001525]; axon guidance [GO:0007411]; cilium assembly [GO:0060271]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; regulation of developmental process [GO:0050793]; regulation of DNA-templated transcription [GO:0006355] cell surface [GO:0009986]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; signaling receptor activity [GO:0038023] g19879.t4 A2RUV0 32.291 1279 1.42e-133 471.0 sp|A2RUV0|NOTC1_XENTR Neurogenic locus notch homolog protein 1 OS=Xenopus tropicalis OX=8364 GN=notch1 PE=1 SV=2 NOTC1_XENTR reviewed Neurogenic locus notch homolog protein 1 (Notch 1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0001525; GO:0005509; GO:0005634; GO:0005886; GO:0006355; GO:0007219; GO:0007411; GO:0009986; GO:0038023; GO:0043235; GO:0050793; GO:0060271; GO:0061314 angiogenesis [GO:0001525]; axon guidance [GO:0007411]; cilium assembly [GO:0060271]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; regulation of developmental process [GO:0050793]; regulation of DNA-templated transcription [GO:0006355] cell surface [GO:0009986]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; signaling receptor activity [GO:0038023] g19879.t4 A2RUV0 35.199 929 4.58e-109 393.0 sp|A2RUV0|NOTC1_XENTR Neurogenic locus notch homolog protein 1 OS=Xenopus tropicalis OX=8364 GN=notch1 PE=1 SV=2 NOTC1_XENTR reviewed Neurogenic locus notch homolog protein 1 (Notch 1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0001525; GO:0005509; GO:0005634; GO:0005886; GO:0006355; GO:0007219; GO:0007411; GO:0009986; GO:0038023; GO:0043235; GO:0050793; GO:0060271; GO:0061314 angiogenesis [GO:0001525]; axon guidance [GO:0007411]; cilium assembly [GO:0060271]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; regulation of developmental process [GO:0050793]; regulation of DNA-templated transcription [GO:0006355] cell surface [GO:0009986]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; signaling receptor activity [GO:0038023] g19879.t4 A2RUV0 33.246 1149 2.25e-99 362.0 sp|A2RUV0|NOTC1_XENTR Neurogenic locus notch homolog protein 1 OS=Xenopus tropicalis OX=8364 GN=notch1 PE=1 SV=2 NOTC1_XENTR reviewed Neurogenic locus notch homolog protein 1 (Notch 1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0001525; GO:0005509; GO:0005634; GO:0005886; GO:0006355; GO:0007219; GO:0007411; GO:0009986; GO:0038023; GO:0043235; GO:0050793; GO:0060271; GO:0061314 angiogenesis [GO:0001525]; axon guidance [GO:0007411]; cilium assembly [GO:0060271]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; regulation of developmental process [GO:0050793]; regulation of DNA-templated transcription [GO:0006355] cell surface [GO:0009986]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; signaling receptor activity [GO:0038023] g19879.t4 A2RUV0 34.515 423 2.02e-40 169.0 sp|A2RUV0|NOTC1_XENTR Neurogenic locus notch homolog protein 1 OS=Xenopus tropicalis OX=8364 GN=notch1 PE=1 SV=2 NOTC1_XENTR reviewed Neurogenic locus notch homolog protein 1 (Notch 1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0001525; GO:0005509; GO:0005634; GO:0005886; GO:0006355; GO:0007219; GO:0007411; GO:0009986; GO:0038023; GO:0043235; GO:0050793; GO:0060271; GO:0061314 angiogenesis [GO:0001525]; axon guidance [GO:0007411]; cilium assembly [GO:0060271]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; regulation of developmental process [GO:0050793]; regulation of DNA-templated transcription [GO:0006355] cell surface [GO:0009986]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; signaling receptor activity [GO:0038023] g19879.t4 A2RUV0 32.653 392 3.25e-35 152.0 sp|A2RUV0|NOTC1_XENTR Neurogenic locus notch homolog protein 1 OS=Xenopus tropicalis OX=8364 GN=notch1 PE=1 SV=2 NOTC1_XENTR reviewed Neurogenic locus notch homolog protein 1 (Notch 1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0001525; GO:0005509; GO:0005634; GO:0005886; GO:0006355; GO:0007219; GO:0007411; GO:0009986; GO:0038023; GO:0043235; GO:0050793; GO:0060271; GO:0061314 angiogenesis [GO:0001525]; axon guidance [GO:0007411]; cilium assembly [GO:0060271]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; regulation of developmental process [GO:0050793]; regulation of DNA-templated transcription [GO:0006355] cell surface [GO:0009986]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; signaling receptor activity [GO:0038023] g19879.t4 A2RUV0 30.769 429 1.2e-34 150.0 sp|A2RUV0|NOTC1_XENTR Neurogenic locus notch homolog protein 1 OS=Xenopus tropicalis OX=8364 GN=notch1 PE=1 SV=2 NOTC1_XENTR reviewed Neurogenic locus notch homolog protein 1 (Notch 1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0001525; GO:0005509; GO:0005634; GO:0005886; GO:0006355; GO:0007219; GO:0007411; GO:0009986; GO:0038023; GO:0043235; GO:0050793; GO:0060271; GO:0061314 angiogenesis [GO:0001525]; axon guidance [GO:0007411]; cilium assembly [GO:0060271]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; regulation of developmental process [GO:0050793]; regulation of DNA-templated transcription [GO:0006355] cell surface [GO:0009986]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; signaling receptor activity [GO:0038023] g19879.t4 A2RUV0 31.845 336 3.6300000000000003e-22 109.0 sp|A2RUV0|NOTC1_XENTR Neurogenic locus notch homolog protein 1 OS=Xenopus tropicalis OX=8364 GN=notch1 PE=1 SV=2 NOTC1_XENTR reviewed Neurogenic locus notch homolog protein 1 (Notch 1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0001525; GO:0005509; GO:0005634; GO:0005886; GO:0006355; GO:0007219; GO:0007411; GO:0009986; GO:0038023; GO:0043235; GO:0050793; GO:0060271; GO:0061314 angiogenesis [GO:0001525]; axon guidance [GO:0007411]; cilium assembly [GO:0060271]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; regulation of developmental process [GO:0050793]; regulation of DNA-templated transcription [GO:0006355] cell surface [GO:0009986]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; signaling receptor activity [GO:0038023] g19879.t5 A2RUV0 36.517 1424 3.81e-176 600.0 sp|A2RUV0|NOTC1_XENTR Neurogenic locus notch homolog protein 1 OS=Xenopus tropicalis OX=8364 GN=notch1 PE=1 SV=2 NOTC1_XENTR reviewed Neurogenic locus notch homolog protein 1 (Notch 1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0001525; GO:0005509; GO:0005634; GO:0005886; GO:0006355; GO:0007219; GO:0007411; GO:0009986; GO:0038023; GO:0043235; GO:0050793; GO:0060271; GO:0061314 angiogenesis [GO:0001525]; axon guidance [GO:0007411]; cilium assembly [GO:0060271]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; regulation of developmental process [GO:0050793]; regulation of DNA-templated transcription [GO:0006355] cell surface [GO:0009986]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; signaling receptor activity [GO:0038023] g19879.t5 A2RUV0 33.155 1493 3.28e-165 568.0 sp|A2RUV0|NOTC1_XENTR Neurogenic locus notch homolog protein 1 OS=Xenopus tropicalis OX=8364 GN=notch1 PE=1 SV=2 NOTC1_XENTR reviewed Neurogenic locus notch homolog protein 1 (Notch 1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0001525; GO:0005509; GO:0005634; GO:0005886; GO:0006355; GO:0007219; GO:0007411; GO:0009986; GO:0038023; GO:0043235; GO:0050793; GO:0060271; GO:0061314 angiogenesis [GO:0001525]; axon guidance [GO:0007411]; cilium assembly [GO:0060271]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; regulation of developmental process [GO:0050793]; regulation of DNA-templated transcription [GO:0006355] cell surface [GO:0009986]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; signaling receptor activity [GO:0038023] g19879.t5 A2RUV0 35.508 1349 3.04e-161 556.0 sp|A2RUV0|NOTC1_XENTR Neurogenic locus notch homolog protein 1 OS=Xenopus tropicalis OX=8364 GN=notch1 PE=1 SV=2 NOTC1_XENTR reviewed Neurogenic locus notch homolog protein 1 (Notch 1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0001525; GO:0005509; GO:0005634; GO:0005886; GO:0006355; GO:0007219; GO:0007411; GO:0009986; GO:0038023; GO:0043235; GO:0050793; GO:0060271; GO:0061314 angiogenesis [GO:0001525]; axon guidance [GO:0007411]; cilium assembly [GO:0060271]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; regulation of developmental process [GO:0050793]; regulation of DNA-templated transcription [GO:0006355] cell surface [GO:0009986]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; signaling receptor activity [GO:0038023] g19879.t5 A2RUV0 34.527 1396 7.23e-151 525.0 sp|A2RUV0|NOTC1_XENTR Neurogenic locus notch homolog protein 1 OS=Xenopus tropicalis OX=8364 GN=notch1 PE=1 SV=2 NOTC1_XENTR reviewed Neurogenic locus notch homolog protein 1 (Notch 1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0001525; GO:0005509; GO:0005634; GO:0005886; GO:0006355; GO:0007219; GO:0007411; GO:0009986; GO:0038023; GO:0043235; GO:0050793; GO:0060271; GO:0061314 angiogenesis [GO:0001525]; axon guidance [GO:0007411]; cilium assembly [GO:0060271]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; regulation of developmental process [GO:0050793]; regulation of DNA-templated transcription [GO:0006355] cell surface [GO:0009986]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; signaling receptor activity [GO:0038023] g19879.t5 A2RUV0 32.291 1279 1.42e-133 471.0 sp|A2RUV0|NOTC1_XENTR Neurogenic locus notch homolog protein 1 OS=Xenopus tropicalis OX=8364 GN=notch1 PE=1 SV=2 NOTC1_XENTR reviewed Neurogenic locus notch homolog protein 1 (Notch 1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0001525; GO:0005509; GO:0005634; GO:0005886; GO:0006355; GO:0007219; GO:0007411; GO:0009986; GO:0038023; GO:0043235; GO:0050793; GO:0060271; GO:0061314 angiogenesis [GO:0001525]; axon guidance [GO:0007411]; cilium assembly [GO:0060271]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; regulation of developmental process [GO:0050793]; regulation of DNA-templated transcription [GO:0006355] cell surface [GO:0009986]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; signaling receptor activity [GO:0038023] g19879.t5 A2RUV0 35.199 929 4.58e-109 393.0 sp|A2RUV0|NOTC1_XENTR Neurogenic locus notch homolog protein 1 OS=Xenopus tropicalis OX=8364 GN=notch1 PE=1 SV=2 NOTC1_XENTR reviewed Neurogenic locus notch homolog protein 1 (Notch 1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0001525; GO:0005509; GO:0005634; GO:0005886; GO:0006355; GO:0007219; GO:0007411; GO:0009986; GO:0038023; GO:0043235; GO:0050793; GO:0060271; GO:0061314 angiogenesis [GO:0001525]; axon guidance [GO:0007411]; cilium assembly [GO:0060271]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; regulation of developmental process [GO:0050793]; regulation of DNA-templated transcription [GO:0006355] cell surface [GO:0009986]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; signaling receptor activity [GO:0038023] g19879.t5 A2RUV0 33.246 1149 2.25e-99 362.0 sp|A2RUV0|NOTC1_XENTR Neurogenic locus notch homolog protein 1 OS=Xenopus tropicalis OX=8364 GN=notch1 PE=1 SV=2 NOTC1_XENTR reviewed Neurogenic locus notch homolog protein 1 (Notch 1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0001525; GO:0005509; GO:0005634; GO:0005886; GO:0006355; GO:0007219; GO:0007411; GO:0009986; GO:0038023; GO:0043235; GO:0050793; GO:0060271; GO:0061314 angiogenesis [GO:0001525]; axon guidance [GO:0007411]; cilium assembly [GO:0060271]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; regulation of developmental process [GO:0050793]; regulation of DNA-templated transcription [GO:0006355] cell surface [GO:0009986]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; signaling receptor activity [GO:0038023] g19879.t5 A2RUV0 34.515 423 2.02e-40 169.0 sp|A2RUV0|NOTC1_XENTR Neurogenic locus notch homolog protein 1 OS=Xenopus tropicalis OX=8364 GN=notch1 PE=1 SV=2 NOTC1_XENTR reviewed Neurogenic locus notch homolog protein 1 (Notch 1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0001525; GO:0005509; GO:0005634; GO:0005886; GO:0006355; GO:0007219; GO:0007411; GO:0009986; GO:0038023; GO:0043235; GO:0050793; GO:0060271; GO:0061314 angiogenesis [GO:0001525]; axon guidance [GO:0007411]; cilium assembly [GO:0060271]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; regulation of developmental process [GO:0050793]; regulation of DNA-templated transcription [GO:0006355] cell surface [GO:0009986]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; signaling receptor activity [GO:0038023] g19879.t5 A2RUV0 32.653 392 3.25e-35 152.0 sp|A2RUV0|NOTC1_XENTR Neurogenic locus notch homolog protein 1 OS=Xenopus tropicalis OX=8364 GN=notch1 PE=1 SV=2 NOTC1_XENTR reviewed Neurogenic locus notch homolog protein 1 (Notch 1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0001525; GO:0005509; GO:0005634; GO:0005886; GO:0006355; GO:0007219; GO:0007411; GO:0009986; GO:0038023; GO:0043235; GO:0050793; GO:0060271; GO:0061314 angiogenesis [GO:0001525]; axon guidance [GO:0007411]; cilium assembly [GO:0060271]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; regulation of developmental process [GO:0050793]; regulation of DNA-templated transcription [GO:0006355] cell surface [GO:0009986]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; signaling receptor activity [GO:0038023] g19879.t5 A2RUV0 30.769 429 1.2e-34 150.0 sp|A2RUV0|NOTC1_XENTR Neurogenic locus notch homolog protein 1 OS=Xenopus tropicalis OX=8364 GN=notch1 PE=1 SV=2 NOTC1_XENTR reviewed Neurogenic locus notch homolog protein 1 (Notch 1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0001525; GO:0005509; GO:0005634; GO:0005886; GO:0006355; GO:0007219; GO:0007411; GO:0009986; GO:0038023; GO:0043235; GO:0050793; GO:0060271; GO:0061314 angiogenesis [GO:0001525]; axon guidance [GO:0007411]; cilium assembly [GO:0060271]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; regulation of developmental process [GO:0050793]; regulation of DNA-templated transcription [GO:0006355] cell surface [GO:0009986]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; signaling receptor activity [GO:0038023] g19879.t5 A2RUV0 31.845 336 3.6300000000000003e-22 109.0 sp|A2RUV0|NOTC1_XENTR Neurogenic locus notch homolog protein 1 OS=Xenopus tropicalis OX=8364 GN=notch1 PE=1 SV=2 NOTC1_XENTR reviewed Neurogenic locus notch homolog protein 1 (Notch 1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0001525; GO:0005509; GO:0005634; GO:0005886; GO:0006355; GO:0007219; GO:0007411; GO:0009986; GO:0038023; GO:0043235; GO:0050793; GO:0060271; GO:0061314 angiogenesis [GO:0001525]; axon guidance [GO:0007411]; cilium assembly [GO:0060271]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; regulation of developmental process [GO:0050793]; regulation of DNA-templated transcription [GO:0006355] cell surface [GO:0009986]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; signaling receptor activity [GO:0038023] g19881.t1 A6NFN9 35.054 368 5.5200000000000005e-73 246.0 sp|A6NFN9|ANKUB_HUMAN Protein ANKUB1 OS=Homo sapiens OX=9606 GN=ANKUB1 PE=2 SV=3 g19882.t1 Q9GZN7 41.852 270 1.72e-61 199.0 sp|Q9GZN7|ROGDI_HUMAN Protein rogdi homolog OS=Homo sapiens OX=9606 GN=ROGDI PE=1 SV=1 ROGDI_HUMAN reviewed Protein rogdi homolog Homo sapiens (Human) GO:0005635; GO:0007420; GO:0007613; GO:0008021; GO:0008284; GO:0009410; GO:0010467; GO:0022008; GO:0030097; GO:0030282; GO:0030424; GO:0030425; GO:0040011; GO:0042475; GO:0043204; GO:0043291; GO:0045475; GO:0045851; GO:0050905; GO:0070166; GO:0098686 bone mineralization [GO:0030282]; brain development [GO:0007420]; enamel mineralization [GO:0070166]; gene expression [GO:0010467]; hemopoiesis [GO:0030097]; locomotion [GO:0040011]; locomotor rhythm [GO:0045475]; memory [GO:0007613]; neurogenesis [GO:0022008]; neuromuscular process [GO:0050905]; odontogenesis of dentin-containing tooth [GO:0042475]; pH reduction [GO:0045851]; positive regulation of cell population proliferation [GO:0008284]; response to xenobiotic stimulus [GO:0009410] axon [GO:0030424]; dendrite [GO:0030425]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; nuclear envelope [GO:0005635]; perikaryon [GO:0043204]; RAVE complex [GO:0043291]; synaptic vesicle [GO:0008021] g19882.t2 Q9GZN7 43.066 274 1.09e-65 210.0 sp|Q9GZN7|ROGDI_HUMAN Protein rogdi homolog OS=Homo sapiens OX=9606 GN=ROGDI PE=1 SV=1 ROGDI_HUMAN reviewed Protein rogdi homolog Homo sapiens (Human) GO:0005635; GO:0007420; GO:0007613; GO:0008021; GO:0008284; GO:0009410; GO:0010467; GO:0022008; GO:0030097; GO:0030282; GO:0030424; GO:0030425; GO:0040011; GO:0042475; GO:0043204; GO:0043291; GO:0045475; GO:0045851; GO:0050905; GO:0070166; GO:0098686 bone mineralization [GO:0030282]; brain development [GO:0007420]; enamel mineralization [GO:0070166]; gene expression [GO:0010467]; hemopoiesis [GO:0030097]; locomotion [GO:0040011]; locomotor rhythm [GO:0045475]; memory [GO:0007613]; neurogenesis [GO:0022008]; neuromuscular process [GO:0050905]; odontogenesis of dentin-containing tooth [GO:0042475]; pH reduction [GO:0045851]; positive regulation of cell population proliferation [GO:0008284]; response to xenobiotic stimulus [GO:0009410] axon [GO:0030424]; dendrite [GO:0030425]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; nuclear envelope [GO:0005635]; perikaryon [GO:0043204]; RAVE complex [GO:0043291]; synaptic vesicle [GO:0008021] g19883.t1 P15651 73.81 378 0.0 570.0 sp|P15651|ACADS_RAT Short-chain specific acyl-CoA dehydrogenase, mitochondrial OS=Rattus norvegicus OX=10116 GN=Acads PE=1 SV=2 g19884.t1 Q9D826 39.018 387 4.66e-84 264.0 sp|Q9D826|SOX_MOUSE Peroxisomal sarcosine oxidase OS=Mus musculus OX=10090 GN=Pipox PE=1 SV=1 SOX_MOUSE reviewed Peroxisomal sarcosine oxidase (PSO) (EC 1.5.3.1) (EC 1.5.3.7) (L-pipecolate oxidase) (L-pipecolic acid oxidase) Mus musculus (Mouse) GO:0005777; GO:0008115; GO:0033514; GO:0050031; GO:0050660 L-lysine catabolic process to acetyl-CoA via L-pipecolate [GO:0033514] peroxisome [GO:0005777] flavin adenine dinucleotide binding [GO:0050660]; L-pipecolate oxidase activity [GO:0050031]; sarcosine oxidase activity [GO:0008115] g19885.t1 O75636 45.385 130 1.35e-21 97.8 sp|O75636|FCN3_HUMAN Ficolin-3 OS=Homo sapiens OX=9606 GN=FCN3 PE=1 SV=2 FCN3_HUMAN reviewed Ficolin-3 (Collagen/fibrinogen domain-containing lectin 3 p35) (Collagen/fibrinogen domain-containing protein 3) (H-ficolin) (Hakata antigen) Homo sapiens (Human) GO:0001867; GO:0002752; GO:0003823; GO:0005102; GO:0005576; GO:0005581; GO:0005615; GO:0006508; GO:0006956; GO:0009897; GO:0030246; GO:0038187; GO:0043654; GO:0046597; GO:0046872; GO:0051607; GO:0072562; GO:0097367; GO:0106139; GO:1902679; GO:1903028; GO:1905370 cell surface pattern recognition receptor signaling pathway [GO:0002752]; complement activation [GO:0006956]; complement activation, lectin pathway [GO:0001867]; defense response to virus [GO:0051607]; host-mediated suppression of symbiont invasion [GO:0046597]; negative regulation of RNA biosynthetic process [GO:1902679]; positive regulation of opsonization [GO:1903028]; proteolysis [GO:0006508]; recognition of apoptotic cell [GO:0043654] blood microparticle [GO:0072562]; collagen trimer [GO:0005581]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; serine-type endopeptidase complex [GO:1905370]; symbiont cell surface [GO:0106139] antigen binding [GO:0003823]; carbohydrate binding [GO:0030246]; carbohydrate derivative binding [GO:0097367]; metal ion binding [GO:0046872]; pattern recognition receptor activity [GO:0038187]; signaling receptor binding [GO:0005102] g19887.t1 Q7ZT75 50.0 128 4.78e-25 103.0 sp|Q7ZT75|FCN1A_XENLA Ficolin-1-A OS=Xenopus laevis OX=8355 GN=fcn1-a PE=1 SV=2 FCN1A_XENLA reviewed Ficolin-1-A Xenopus laevis (African clawed frog) GO:0001867; GO:0003823; GO:0005102; GO:0005581; GO:0005615; GO:0030246; GO:0033691; GO:0038187; GO:0097367; GO:0106139 complement activation, lectin pathway [GO:0001867] collagen trimer [GO:0005581]; extracellular space [GO:0005615]; symbiont cell surface [GO:0106139] antigen binding [GO:0003823]; carbohydrate binding [GO:0030246]; carbohydrate derivative binding [GO:0097367]; pattern recognition receptor activity [GO:0038187]; sialic acid binding [GO:0033691]; signaling receptor binding [GO:0005102] g19889.t1 A5HK05 67.826 575 0.0 808.0 sp|A5HK05|APBP2_RAT Amyloid protein-binding protein 2 OS=Rattus norvegicus OX=10116 GN=Appbp2 PE=2 SV=1 APBP2_RAT reviewed Amyloid protein-binding protein 2 (Amyloid beta precursor protein-binding protein 2) (APP-BP2) Rattus norvegicus (Rat) GO:0005654; GO:0005874; GO:0006886; GO:0016567; GO:0030659; GO:0031462; GO:0043161; GO:0140627; GO:0160276; GO:1990756 intracellular protein transport [GO:0006886]; negative regulation of beige fat cell differentiation [GO:0160276]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process via the C-end degron rule pathway [GO:0140627] Cul2-RING ubiquitin ligase complex [GO:0031462]; cytoplasmic vesicle membrane [GO:0030659]; microtubule [GO:0005874]; nucleoplasm [GO:0005654] ubiquitin-like ligase-substrate adaptor activity [GO:1990756] g19890.t1 Q8VDH1 53.846 130 3.34e-42 150.0 sp|Q8VDH1|FBX21_MOUSE F-box only protein 21 OS=Mus musculus OX=10090 GN=Fbxo21 PE=1 SV=1 g19894.t1 Q7YRC1 48.178 247 9.66e-71 223.0 sp|Q7YRC1|AIP_BOVIN AH receptor-interacting protein OS=Bos taurus OX=9913 GN=AIP PE=2 SV=1 g19895.t1 Q8BZT7 40.323 124 2.05e-25 110.0 sp|Q8BZT7|PA2G3_MOUSE Group 3 secretory phospholipase A2 OS=Mus musculus OX=10090 GN=Pla2g3 PE=1 SV=1 PA2G3_MOUSE reviewed Group 3 secretory phospholipase A2 (EC 3.1.1.4) (Group III secretory phospholipase A2) (GIII sPLA2) (sPLA2-III) (Phosphatidylcholine 2-acylhydrolase 3) Mus musculus (Mouse) GO:0001675; GO:0002532; GO:0004620; GO:0005576; GO:0005814; GO:0005886; GO:0006644; GO:0006658; GO:0007288; GO:0010629; GO:0010744; GO:0010976; GO:0019372; GO:0031394; GO:0032308; GO:0034374; GO:0034375; GO:0042116; GO:0043303; GO:0043524; GO:0046337; GO:0046470; GO:0046471; GO:0046473; GO:0046488; GO:0046872; GO:0047498; GO:0048468; GO:0048469; GO:0050482; GO:0055037; GO:0060271; GO:0060376; GO:1900017; GO:1900222; GO:1903595; GO:2001135 acrosome assembly [GO:0001675]; arachidonate secretion [GO:0050482]; cell development [GO:0048468]; cell maturation [GO:0048469]; cilium assembly [GO:0060271]; high-density lipoprotein particle remodeling [GO:0034375]; lipoxygenase pathway [GO:0019372]; low-density lipoprotein particle remodeling [GO:0034374]; macrophage activation [GO:0042116]; mast cell degranulation [GO:0043303]; negative regulation of amyloid-beta clearance [GO:1900222]; negative regulation of gene expression [GO:0010629]; negative regulation of neuron apoptotic process [GO:0043524]; phosphatidic acid metabolic process [GO:0046473]; phosphatidylcholine metabolic process [GO:0046470]; phosphatidylethanolamine metabolic process [GO:0046337]; phosphatidylglycerol metabolic process [GO:0046471]; phosphatidylinositol metabolic process [GO:0046488]; phosphatidylserine metabolic process [GO:0006658]; phospholipid metabolic process [GO:0006644]; positive regulation of cytokine production involved in inflammatory response [GO:1900017]; positive regulation of histamine secretion by mast cell [GO:1903595]; positive regulation of macrophage derived foam cell differentiation [GO:0010744]; positive regulation of mast cell differentiation [GO:0060376]; positive regulation of neuron projection development [GO:0010976]; positive regulation of prostaglandin biosynthetic process [GO:0031394]; positive regulation of prostaglandin secretion [GO:0032308]; production of molecular mediator involved in inflammatory response [GO:0002532]; regulation of endocytic recycling [GO:2001135]; sperm axoneme assembly [GO:0007288] centriole [GO:0005814]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037] calcium-dependent phospholipase A2 activity [GO:0047498]; metal ion binding [GO:0046872]; phospholipase activity [GO:0004620] g19896.t1 P16354 40.441 136 9.580000000000001e-32 115.0 sp|P16354|PA23_HELSU Phospholipase A2 isozymes PA3A/PA3B/PA5 OS=Heloderma suspectum OX=8554 PE=1 SV=3 g19897.t1 Q5BJ92 78.176 307 4.66e-174 484.0 sp|Q5BJ92|PP4C_RAT Serine/threonine-protein phosphatase 4 catalytic subunit OS=Rattus norvegicus OX=10116 GN=Ppp4c PE=2 SV=1 PP4C_RAT reviewed Serine/threonine-protein phosphatase 4 catalytic subunit (PP4C) (Pp4) (EC 3.1.3.16) Rattus norvegicus (Rat) GO:0000724; GO:0000785; GO:0004722; GO:0005521; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005886; GO:0010569; GO:0016791; GO:0030289; GO:0044877; GO:0046872; GO:0071347; GO:2000779 cellular response to interleukin-1 [GO:0071347]; double-strand break repair via homologous recombination [GO:0000724]; regulation of double-strand break repair [GO:2000779]; regulation of double-strand break repair via homologous recombination [GO:0010569] centrosome [GO:0005813]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein phosphatase 4 complex [GO:0030289] lamin binding [GO:0005521]; metal ion binding [GO:0046872]; phosphatase activity [GO:0016791]; protein serine/threonine phosphatase activity [GO:0004722]; protein-containing complex binding [GO:0044877] g19898.t1 O75976 33.582 1343 0.0 644.0 sp|O75976|CBPD_HUMAN Carboxypeptidase D OS=Homo sapiens OX=9606 GN=CPD PE=1 SV=2 g19898.t1 O75976 42.164 804 0.0 595.0 sp|O75976|CBPD_HUMAN Carboxypeptidase D OS=Homo sapiens OX=9606 GN=CPD PE=1 SV=2 g19898.t2 O75976 34.028 1343 0.0 668.0 sp|O75976|CBPD_HUMAN Carboxypeptidase D OS=Homo sapiens OX=9606 GN=CPD PE=1 SV=2 g19898.t2 O75976 42.164 804 0.0 595.0 sp|O75976|CBPD_HUMAN Carboxypeptidase D OS=Homo sapiens OX=9606 GN=CPD PE=1 SV=2 g19899.t1 P83852 54.867 339 5.7e-123 364.0 sp|P83852|CBPD_LOPSP Carboxypeptidase D (Fragment) OS=Lophonetta specularioides OX=75873 GN=CPD PE=1 SV=1 CBPD_LOPSP reviewed Carboxypeptidase D (EC 3.4.17.22) (CPD-2) (Metallocarboxypeptidase D) Lophonetta specularioides (Crested duck) (Anas specularioides) GO:0004181; GO:0005615; GO:0006508; GO:0006518; GO:0008270; GO:0016020; GO:0016485 peptide metabolic process [GO:0006518]; protein processing [GO:0016485]; proteolysis [GO:0006508] extracellular space [GO:0005615]; membrane [GO:0016020] metallocarboxypeptidase activity [GO:0004181]; zinc ion binding [GO:0008270] g19901.t1 P49410 60.86 442 0.0 553.0 sp|P49410|EFTU_BOVIN Elongation factor Tu, mitochondrial OS=Bos taurus OX=9913 GN=TUFM PE=1 SV=1 EFTU_BOVIN reviewed Elongation factor Tu, mitochondrial (EF-Tu) (EC 3.6.5.3) Bos taurus (Bovine) GO:0000287; GO:0003746; GO:0003924; GO:0005525; GO:0005739; GO:0005743; GO:0005759; GO:0006414; GO:0032543; GO:0070125 mitochondrial translation [GO:0032543]; mitochondrial translational elongation [GO:0070125]; translational elongation [GO:0006414] mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] GTP binding [GO:0005525]; GTPase activity [GO:0003924]; magnesium ion binding [GO:0000287]; translation elongation factor activity [GO:0003746] g19903.t1 Q06AU4 56.522 207 4.1200000000000004e-79 241.0 sp|Q06AU4|RAB34_PIG Ras-related protein Rab-34 OS=Sus scrofa OX=9823 GN=RAB34 PE=2 SV=1 g19904.t1 A2BG43 33.333 201 1.6299999999999999e-34 124.0 sp|A2BG43|GLTP_DANRE Glycolipid transfer protein OS=Danio rerio OX=7955 GN=gltp PE=3 SV=1 g19905.t1 Q15370 61.983 121 2.1399999999999997e-46 149.0 sp|Q15370|ELOB_HUMAN Elongin-B OS=Homo sapiens OX=9606 GN=ELOB PE=1 SV=1 ELOB_HUMAN reviewed Elongin-B (EloB) (Elongin 18 kDa subunit) (RNA polymerase II transcription factor SIII subunit B) (SIII p18) (Transcription elongation factor B polypeptide 2) Homo sapiens (Human) GO:0001222; GO:0005654; GO:0005829; GO:0006367; GO:0006368; GO:0016567; GO:0030891; GO:0031462; GO:0031466; GO:0031625; GO:0032436; GO:0065003; GO:0070449; GO:0140627; GO:0140958 positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein ubiquitination [GO:0016567]; protein-containing complex assembly [GO:0065003]; target-directed miRNA degradation [GO:0140958]; transcription elongation by RNA polymerase II [GO:0006368]; transcription initiation at RNA polymerase II promoter [GO:0006367]; ubiquitin-dependent protein catabolic process via the C-end degron rule pathway [GO:0140627] Cul2-RING ubiquitin ligase complex [GO:0031462]; Cul5-RING ubiquitin ligase complex [GO:0031466]; cytosol [GO:0005829]; elongin complex [GO:0070449]; nucleoplasm [GO:0005654]; VCB complex [GO:0030891] transcription corepressor binding [GO:0001222]; ubiquitin protein ligase binding [GO:0031625] g19906.t1 Q6PFQ2 72.5 360 0.0 557.0 sp|Q6PFQ2|EIF3C_DANRE Eukaryotic translation initiation factor 3 subunit C OS=Danio rerio OX=7955 GN=eif3c PE=1 SV=1 g19906.t1 Q6PFQ2 52.756 254 1.43e-69 254.0 sp|Q6PFQ2|EIF3C_DANRE Eukaryotic translation initiation factor 3 subunit C OS=Danio rerio OX=7955 GN=eif3c PE=1 SV=1 g19906.t1 Q6PFQ2 50.909 165 9.189999999999999e-30 131.0 sp|Q6PFQ2|EIF3C_DANRE Eukaryotic translation initiation factor 3 subunit C OS=Danio rerio OX=7955 GN=eif3c PE=1 SV=1 g19907.t1 Q6GR37 49.487 390 5.4e-126 386.0 sp|Q6GR37|MET16_XENLA RNA N(6)-adenosine-methyltransferase mettl16 OS=Xenopus laevis OX=8355 GN=mettl16 PE=2 SV=1 MET16_XENLA reviewed RNA N(6)-adenosine-methyltransferase mettl16 (EC 2.1.1.348) (Methyltransferase 10 domain-containing protein) (Methyltransferase-like protein 16) (U6 small nuclear RNA (adenine-(43)-N(6))-methyltransferase) (EC 2.1.1.346) Xenopus laevis (African clawed frog) GO:0001734; GO:0003723; GO:0005634; GO:0005737; GO:0006397; GO:0006402; GO:0006556; GO:0010608; GO:0030629; GO:0035613; GO:0048024; GO:0052907; GO:0061157; GO:0070475; GO:0120048; GO:0120049 mRNA catabolic process [GO:0006402]; mRNA destabilization [GO:0061157]; mRNA processing [GO:0006397]; post-transcriptional regulation of gene expression [GO:0010608]; regulation of mRNA splicing, via spliceosome [GO:0048024]; rRNA base methylation [GO:0070475]; S-adenosylmethionine biosynthetic process [GO:0006556]; snRNA (adenine-N6)-methylation [GO:0120049] cytoplasm [GO:0005737]; nucleus [GO:0005634] 23S rRNA (adenine(1618)-N(6))-methyltransferase activity [GO:0052907]; mRNA m(6)A methyltransferase activity [GO:0001734]; RNA binding [GO:0003723]; RNA stem-loop binding [GO:0035613]; U6 snRNA (adenine-(43)-N(6))-methyltransferase activity [GO:0120048]; U6 snRNA 3'-end binding [GO:0030629] g19908.t1 C3XVT5 71.096 429 0.0 635.0 sp|C3XVT5|LIS1_BRAFL Lissencephaly-1 homolog OS=Branchiostoma floridae OX=7739 GN=BRAFLDRAFT_59218 PE=3 SV=1 LIS1_BRAFL reviewed Lissencephaly-1 homolog Branchiostoma floridae (Florida lancelet) (Amphioxus) GO:0000132; GO:0000776; GO:0005635; GO:0005813; GO:0005875; GO:0005881; GO:0007097; GO:0007281; GO:0008090; GO:0031023; GO:0043005; GO:0043025; GO:0047496; GO:0048854; GO:0051010; GO:0051012; GO:0051301; GO:0070840; GO:1904115 brain morphogenesis [GO:0048854]; cell division [GO:0051301]; establishment of mitotic spindle orientation [GO:0000132]; germ cell development [GO:0007281]; microtubule organizing center organization [GO:0031023]; microtubule sliding [GO:0051012]; nuclear migration [GO:0007097]; retrograde axonal transport [GO:0008090]; vesicle transport along microtubule [GO:0047496] axon cytoplasm [GO:1904115]; centrosome [GO:0005813]; cytoplasmic microtubule [GO:0005881]; kinetochore [GO:0000776]; microtubule associated complex [GO:0005875]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nuclear envelope [GO:0005635] dynein complex binding [GO:0070840]; microtubule plus-end binding [GO:0051010] g19908.t2 C3XVT5 74.104 251 5.22e-134 387.0 sp|C3XVT5|LIS1_BRAFL Lissencephaly-1 homolog OS=Branchiostoma floridae OX=7739 GN=BRAFLDRAFT_59218 PE=3 SV=1 LIS1_BRAFL reviewed Lissencephaly-1 homolog Branchiostoma floridae (Florida lancelet) (Amphioxus) GO:0000132; GO:0000776; GO:0005635; GO:0005813; GO:0005875; GO:0005881; GO:0007097; GO:0007281; GO:0008090; GO:0031023; GO:0043005; GO:0043025; GO:0047496; GO:0048854; GO:0051010; GO:0051012; GO:0051301; GO:0070840; GO:1904115 brain morphogenesis [GO:0048854]; cell division [GO:0051301]; establishment of mitotic spindle orientation [GO:0000132]; germ cell development [GO:0007281]; microtubule organizing center organization [GO:0031023]; microtubule sliding [GO:0051012]; nuclear migration [GO:0007097]; retrograde axonal transport [GO:0008090]; vesicle transport along microtubule [GO:0047496] axon cytoplasm [GO:1904115]; centrosome [GO:0005813]; cytoplasmic microtubule [GO:0005881]; kinetochore [GO:0000776]; microtubule associated complex [GO:0005875]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nuclear envelope [GO:0005635] dynein complex binding [GO:0070840]; microtubule plus-end binding [GO:0051010] g19908.t2 C3XVT5 33.108 148 4.3499999999999997e-23 100.0 sp|C3XVT5|LIS1_BRAFL Lissencephaly-1 homolog OS=Branchiostoma floridae OX=7739 GN=BRAFLDRAFT_59218 PE=3 SV=1 LIS1_BRAFL reviewed Lissencephaly-1 homolog Branchiostoma floridae (Florida lancelet) (Amphioxus) GO:0000132; GO:0000776; GO:0005635; GO:0005813; GO:0005875; GO:0005881; GO:0007097; GO:0007281; GO:0008090; GO:0031023; GO:0043005; GO:0043025; GO:0047496; GO:0048854; GO:0051010; GO:0051012; GO:0051301; GO:0070840; GO:1904115 brain morphogenesis [GO:0048854]; cell division [GO:0051301]; establishment of mitotic spindle orientation [GO:0000132]; germ cell development [GO:0007281]; microtubule organizing center organization [GO:0031023]; microtubule sliding [GO:0051012]; nuclear migration [GO:0007097]; retrograde axonal transport [GO:0008090]; vesicle transport along microtubule [GO:0047496] axon cytoplasm [GO:1904115]; centrosome [GO:0005813]; cytoplasmic microtubule [GO:0005881]; kinetochore [GO:0000776]; microtubule associated complex [GO:0005875]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nuclear envelope [GO:0005635] dynein complex binding [GO:0070840]; microtubule plus-end binding [GO:0051010] g19908.t3 Q7T394 76.129 155 5.98e-88 265.0 sp|Q7T394|LIS1A_DANRE Lissencephaly-1 homolog A OS=Danio rerio OX=7955 GN=pafah1b1a PE=2 SV=3 LIS1A_DANRE reviewed Lissencephaly-1 homolog A (Platelet-activating factor acetylhydrolase IB subunit alpha a) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000132; GO:0000776; GO:0005635; GO:0005737; GO:0005813; GO:0005875; GO:0005881; GO:0007097; GO:0007281; GO:0008090; GO:0008247; GO:0031023; GO:0038026; GO:0043005; GO:0043025; GO:0046982; GO:0047496; GO:0048854; GO:0051010; GO:0051012; GO:0051301; GO:0070840; GO:1904115 brain morphogenesis [GO:0048854]; cell division [GO:0051301]; establishment of mitotic spindle orientation [GO:0000132]; germ cell development [GO:0007281]; microtubule organizing center organization [GO:0031023]; microtubule sliding [GO:0051012]; nuclear migration [GO:0007097]; reelin-mediated signaling pathway [GO:0038026]; retrograde axonal transport [GO:0008090]; vesicle transport along microtubule [GO:0047496] 1-alkyl-2-acetylglycerophosphocholine esterase complex [GO:0008247]; axon cytoplasm [GO:1904115]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoplasmic microtubule [GO:0005881]; kinetochore [GO:0000776]; microtubule associated complex [GO:0005875]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nuclear envelope [GO:0005635] dynein complex binding [GO:0070840]; microtubule plus-end binding [GO:0051010]; protein heterodimerization activity [GO:0046982] g19908.t3 Q7T394 31.395 172 3.6200000000000004e-21 91.7 sp|Q7T394|LIS1A_DANRE Lissencephaly-1 homolog A OS=Danio rerio OX=7955 GN=pafah1b1a PE=2 SV=3 LIS1A_DANRE reviewed Lissencephaly-1 homolog A (Platelet-activating factor acetylhydrolase IB subunit alpha a) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000132; GO:0000776; GO:0005635; GO:0005737; GO:0005813; GO:0005875; GO:0005881; GO:0007097; GO:0007281; GO:0008090; GO:0008247; GO:0031023; GO:0038026; GO:0043005; GO:0043025; GO:0046982; GO:0047496; GO:0048854; GO:0051010; GO:0051012; GO:0051301; GO:0070840; GO:1904115 brain morphogenesis [GO:0048854]; cell division [GO:0051301]; establishment of mitotic spindle orientation [GO:0000132]; germ cell development [GO:0007281]; microtubule organizing center organization [GO:0031023]; microtubule sliding [GO:0051012]; nuclear migration [GO:0007097]; reelin-mediated signaling pathway [GO:0038026]; retrograde axonal transport [GO:0008090]; vesicle transport along microtubule [GO:0047496] 1-alkyl-2-acetylglycerophosphocholine esterase complex [GO:0008247]; axon cytoplasm [GO:1904115]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoplasmic microtubule [GO:0005881]; kinetochore [GO:0000776]; microtubule associated complex [GO:0005875]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nuclear envelope [GO:0005635] dynein complex binding [GO:0070840]; microtubule plus-end binding [GO:0051010]; protein heterodimerization activity [GO:0046982] g19909.t1 A0JMD0 60.572 1329 0.0 1639.0 sp|A0JMD0|CLU_DANRE Clustered mitochondria protein homolog OS=Danio rerio OX=7955 GN=cluh PE=2 SV=1 g19910.t1 Q4KKX4 45.928 442 3.7500000000000004e-79 297.0 sp|Q4KKX4|NCOR1_XENTR Nuclear receptor corepressor 1 OS=Xenopus tropicalis OX=8364 GN=ncor1 PE=2 SV=1 g19910.t2 Q4KKX4 45.928 442 3.7600000000000004e-79 297.0 sp|Q4KKX4|NCOR1_XENTR Nuclear receptor corepressor 1 OS=Xenopus tropicalis OX=8364 GN=ncor1 PE=2 SV=1 g19911.t1 Q9NXB0 45.324 556 1.9800000000000003e-157 464.0 sp|Q9NXB0|MKS1_HUMAN Tectonic-like complex member MKS1 OS=Homo sapiens OX=9606 GN=MKS1 PE=1 SV=2 MKS1_HUMAN reviewed Tectonic-like complex member MKS1 (Meckel syndrome type 1 protein) Homo sapiens (Human) GO:0001843; GO:0003271; GO:0005654; GO:0005730; GO:0005737; GO:0005813; GO:0005814; GO:0005829; GO:0007368; GO:0008589; GO:0010669; GO:0016020; GO:0021904; GO:0036038; GO:0036064; GO:0042733; GO:0044458; GO:0048706; GO:0048754; GO:0060122; GO:0060271; GO:0060322; GO:0060411; GO:0060828; GO:0061009; GO:1905515; GO:1990403; GO:2000095 branching morphogenesis of an epithelial tube [GO:0048754]; cardiac septum morphogenesis [GO:0060411]; cilium assembly [GO:0060271]; common bile duct development [GO:0061009]; determination of left/right symmetry [GO:0007368]; dorsal/ventral neural tube patterning [GO:0021904]; embryonic brain development [GO:1990403]; embryonic digit morphogenesis [GO:0042733]; embryonic skeletal system development [GO:0048706]; epithelial structure maintenance [GO:0010669]; head development [GO:0060322]; inner ear receptor cell stereocilium organization [GO:0060122]; motile cilium assembly [GO:0044458]; neural tube closure [GO:0001843]; non-motile cilium assembly [GO:1905515]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of smoothened signaling pathway [GO:0008589]; regulation of Wnt signaling pathway, planar cell polarity pathway [GO:2000095]; smoothened signaling pathway involved in regulation of secondary heart field cardioblast proliferation [GO:0003271] centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; MKS complex [GO:0036038]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654] g19916.t1 Q96DM1 24.319 477 8.15e-25 111.0 sp|Q96DM1|PGBD4_HUMAN PiggyBac transposable element-derived protein 4 OS=Homo sapiens OX=9606 GN=PGBD4 PE=1 SV=3 g19926.t1 Q3SZ73 42.105 266 3.52e-62 203.0 sp|Q3SZ73|ABHDB_BOVIN sn-1-specific diacylglycerol lipase ABHD11 OS=Bos taurus OX=9913 GN=ABHD11 PE=1 SV=1 ABHDB_BOVIN reviewed sn-1-specific diacylglycerol lipase ABHD11 (EC 3.1.1.116) (Alpha/beta hydrolase domain-containing protein 11) (Abhydrolase domain-containing protein 11) Bos taurus (Bovine) GO:0005739; GO:0005759; GO:0006629; GO:0016298; GO:0045252; GO:0052689 lipid metabolic process [GO:0006629] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; oxoglutarate dehydrogenase complex [GO:0045252] carboxylic ester hydrolase activity [GO:0052689]; lipase activity [GO:0016298] g19927.t1 Q5U316 85.263 190 4.65e-116 331.0 sp|Q5U316|RAB35_RAT Ras-related protein Rab-35 OS=Rattus norvegicus OX=10116 GN=Rab35 PE=1 SV=1 RAB35_RAT reviewed Ras-related protein Rab-35 (EC 3.6.5.2) Rattus norvegicus (Rat) GO:0000281; GO:0003924; GO:0003925; GO:0005525; GO:0005546; GO:0005886; GO:0005905; GO:0008104; GO:0010008; GO:0015031; GO:0016197; GO:0019003; GO:0019882; GO:0030672; GO:0031175; GO:0031253; GO:0032456; GO:0032482; GO:0036010; GO:0042470; GO:0045171; GO:0045334; GO:0046872; GO:0048227; GO:1990090 antigen processing and presentation [GO:0019882]; cellular response to nerve growth factor stimulus [GO:1990090]; endocytic recycling [GO:0032456]; endosomal transport [GO:0016197]; intracellular protein localization [GO:0008104]; mitotic cytokinesis [GO:0000281]; neuron projection development [GO:0031175]; plasma membrane to endosome transport [GO:0048227]; protein localization to endosome [GO:0036010]; protein transport [GO:0015031]; Rab protein signal transduction [GO:0032482] cell projection membrane [GO:0031253]; clathrin-coated endocytic vesicle [GO:0045334]; clathrin-coated pit [GO:0005905]; endosome membrane [GO:0010008]; intercellular bridge [GO:0045171]; melanosome [GO:0042470]; plasma membrane [GO:0005886]; synaptic vesicle membrane [GO:0030672] G protein activity [GO:0003925]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546] g19932.t1 Q6IDD9 50.806 372 1.93e-117 387.0 sp|Q6IDD9|SARM1_DROME NAD(+) hydrolase sarm1 OS=Drosophila melanogaster OX=7227 GN=Sarm PE=1 SV=1 SARM1_DROME reviewed NAD(+) hydrolase sarm1 (NADase sarm1) (EC 3.2.2.6) (Sterile alpha and TIR motif-containing protein 1) (Tir-1 homolog) Drosophila melanogaster (Fruit fly) GO:0003953; GO:0005739; GO:0005829; GO:0007165; GO:0019677; GO:0030424; GO:0030425; GO:0035591; GO:0043005; GO:0043025; GO:0048678; GO:0051607; GO:0061809; GO:0097677; GO:0140374; GO:1904894 antiviral innate immune response [GO:0140374]; defense response to virus [GO:0051607]; NAD+ catabolic process [GO:0019677]; positive regulation of receptor signaling pathway via STAT [GO:1904894]; response to axon injury [GO:0048678]; signal transduction [GO:0007165] axon [GO:0030424]; cytosol [GO:0005829]; dendrite [GO:0030425]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025] NAD+ nucleosidase activity [GO:0003953]; NAD+ nucleosidase activity, cyclic ADP-ribose generating [GO:0061809]; signaling adaptor activity [GO:0035591]; STAT family protein binding [GO:0097677] g19935.t1 P16258 55.108 744 0.0 736.0 sp|P16258|OSBP1_RABIT Oxysterol-binding protein 1 OS=Oryctolagus cuniculus OX=9986 GN=OSBP PE=1 SV=1 g19936.t1 P55266 38.919 370 3.42e-60 228.0 sp|P55266|DSRAD_RAT Double-stranded RNA-specific adenosine deaminase OS=Rattus norvegicus OX=10116 GN=Adar PE=1 SV=1 DSRAD_RAT reviewed Double-stranded RNA-specific adenosine deaminase (DRADA) (EC 3.5.4.37) Rattus norvegicus (Rat) GO:0001649; GO:0001701; GO:0002244; GO:0002566; GO:0003677; GO:0003725; GO:0003726; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006382; GO:0006396; GO:0006397; GO:0006606; GO:0006611; GO:0008251; GO:0009615; GO:0016553; GO:0016607; GO:0030218; GO:0031054; GO:0035196; GO:0035455; GO:0044387; GO:0044530; GO:0045070; GO:0045071; GO:0045087; GO:0046872; GO:0051607; GO:0060216; GO:0060339; GO:0061484; GO:0070922; GO:0098586; GO:1900369; GO:1903944 adenosine to inosine editing [GO:0006382]; base conversion or substitution editing [GO:0016553]; cellular response to virus [GO:0098586]; defense response to virus [GO:0051607]; definitive hemopoiesis [GO:0060216]; erythrocyte differentiation [GO:0030218]; hematopoietic progenitor cell differentiation [GO:0002244]; hematopoietic stem cell homeostasis [GO:0061484]; in utero embryonic development [GO:0001701]; innate immune response [GO:0045087]; miRNA processing [GO:0035196]; mRNA processing [GO:0006397]; negative regulation of hepatocyte apoptotic process [GO:1903944]; negative regulation of post-transcriptional gene silencing by regulatory ncRNA [GO:1900369]; negative regulation of protein kinase activity by regulation of protein phosphorylation [GO:0044387]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; negative regulation of viral genome replication [GO:0045071]; osteoblast differentiation [GO:0001649]; positive regulation of viral genome replication [GO:0045070]; pre-miRNA processing [GO:0031054]; protein export from nucleus [GO:0006611]; protein import into nucleus [GO:0006606]; response to interferon-alpha [GO:0035455]; response to virus [GO:0009615]; RISC complex assembly [GO:0070922]; RNA processing [GO:0006396]; somatic diversification of immune receptors via somatic mutation [GO:0002566] cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; supraspliceosomal complex [GO:0044530] DNA binding [GO:0003677]; double-stranded RNA adenosine deaminase activity [GO:0003726]; double-stranded RNA binding [GO:0003725]; metal ion binding [GO:0046872]; tRNA-specific adenosine deaminase activity [GO:0008251] g19937.t1 Q6PCX9 63.567 656 0.0 771.0 sp|Q6PCX9|TRI37_MOUSE E3 ubiquitin-protein ligase TRIM37 OS=Mus musculus OX=10090 GN=Trim37 PE=1 SV=1 TRI37_MOUSE reviewed E3 ubiquitin-protein ligase TRIM37 (EC 2.3.2.27) (RING-type E3 ubiquitin transferase TRIM37) (Tripartite motif-containing protein 37) Mus musculus (Mouse) GO:0000122; GO:0003682; GO:0003713; GO:0004842; GO:0005164; GO:0005694; GO:0005737; GO:0005777; GO:0005778; GO:0005829; GO:0006513; GO:0008270; GO:0016235; GO:0016558; GO:0031625; GO:0035098; GO:0042803; GO:0045814; GO:0046600; GO:0048471; GO:0050821; GO:0051865; GO:0061630; GO:0070842; GO:0140862 aggresome assembly [GO:0070842]; negative regulation of centriole replication [GO:0046600]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of transcription by RNA polymerase II [GO:0000122]; protein autoubiquitination [GO:0051865]; protein import into peroxisome matrix [GO:0016558]; protein monoubiquitination [GO:0006513]; protein stabilization [GO:0050821] aggresome [GO:0016235]; chromosome [GO:0005694]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; ESC/E(Z) complex [GO:0035098]; perinuclear region of cytoplasm [GO:0048471]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777] chromatin binding [GO:0003682]; histone H2AK119 ubiquitin ligase activity [GO:0140862]; protein homodimerization activity [GO:0042803]; transcription coactivator activity [GO:0003713]; tumor necrosis factor receptor binding [GO:0005164]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] g19937.t2 Q6PCX9 63.664 655 0.0 771.0 sp|Q6PCX9|TRI37_MOUSE E3 ubiquitin-protein ligase TRIM37 OS=Mus musculus OX=10090 GN=Trim37 PE=1 SV=1 TRI37_MOUSE reviewed E3 ubiquitin-protein ligase TRIM37 (EC 2.3.2.27) (RING-type E3 ubiquitin transferase TRIM37) (Tripartite motif-containing protein 37) Mus musculus (Mouse) GO:0000122; GO:0003682; GO:0003713; GO:0004842; GO:0005164; GO:0005694; GO:0005737; GO:0005777; GO:0005778; GO:0005829; GO:0006513; GO:0008270; GO:0016235; GO:0016558; GO:0031625; GO:0035098; GO:0042803; GO:0045814; GO:0046600; GO:0048471; GO:0050821; GO:0051865; GO:0061630; GO:0070842; GO:0140862 aggresome assembly [GO:0070842]; negative regulation of centriole replication [GO:0046600]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of transcription by RNA polymerase II [GO:0000122]; protein autoubiquitination [GO:0051865]; protein import into peroxisome matrix [GO:0016558]; protein monoubiquitination [GO:0006513]; protein stabilization [GO:0050821] aggresome [GO:0016235]; chromosome [GO:0005694]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; ESC/E(Z) complex [GO:0035098]; perinuclear region of cytoplasm [GO:0048471]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777] chromatin binding [GO:0003682]; histone H2AK119 ubiquitin ligase activity [GO:0140862]; protein homodimerization activity [GO:0042803]; transcription coactivator activity [GO:0003713]; tumor necrosis factor receptor binding [GO:0005164]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] g19937.t3 Q6PCX9 63.664 655 0.0 775.0 sp|Q6PCX9|TRI37_MOUSE E3 ubiquitin-protein ligase TRIM37 OS=Mus musculus OX=10090 GN=Trim37 PE=1 SV=1 TRI37_MOUSE reviewed E3 ubiquitin-protein ligase TRIM37 (EC 2.3.2.27) (RING-type E3 ubiquitin transferase TRIM37) (Tripartite motif-containing protein 37) Mus musculus (Mouse) GO:0000122; GO:0003682; GO:0003713; GO:0004842; GO:0005164; GO:0005694; GO:0005737; GO:0005777; GO:0005778; GO:0005829; GO:0006513; GO:0008270; GO:0016235; GO:0016558; GO:0031625; GO:0035098; GO:0042803; GO:0045814; GO:0046600; GO:0048471; GO:0050821; GO:0051865; GO:0061630; GO:0070842; GO:0140862 aggresome assembly [GO:0070842]; negative regulation of centriole replication [GO:0046600]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of transcription by RNA polymerase II [GO:0000122]; protein autoubiquitination [GO:0051865]; protein import into peroxisome matrix [GO:0016558]; protein monoubiquitination [GO:0006513]; protein stabilization [GO:0050821] aggresome [GO:0016235]; chromosome [GO:0005694]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; ESC/E(Z) complex [GO:0035098]; perinuclear region of cytoplasm [GO:0048471]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777] chromatin binding [GO:0003682]; histone H2AK119 ubiquitin ligase activity [GO:0140862]; protein homodimerization activity [GO:0042803]; transcription coactivator activity [GO:0003713]; tumor necrosis factor receptor binding [GO:0005164]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] g19937.t4 Q6PCX9 63.567 656 0.0 771.0 sp|Q6PCX9|TRI37_MOUSE E3 ubiquitin-protein ligase TRIM37 OS=Mus musculus OX=10090 GN=Trim37 PE=1 SV=1 TRI37_MOUSE reviewed E3 ubiquitin-protein ligase TRIM37 (EC 2.3.2.27) (RING-type E3 ubiquitin transferase TRIM37) (Tripartite motif-containing protein 37) Mus musculus (Mouse) GO:0000122; GO:0003682; GO:0003713; GO:0004842; GO:0005164; GO:0005694; GO:0005737; GO:0005777; GO:0005778; GO:0005829; GO:0006513; GO:0008270; GO:0016235; GO:0016558; GO:0031625; GO:0035098; GO:0042803; GO:0045814; GO:0046600; GO:0048471; GO:0050821; GO:0051865; GO:0061630; GO:0070842; GO:0140862 aggresome assembly [GO:0070842]; negative regulation of centriole replication [GO:0046600]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of transcription by RNA polymerase II [GO:0000122]; protein autoubiquitination [GO:0051865]; protein import into peroxisome matrix [GO:0016558]; protein monoubiquitination [GO:0006513]; protein stabilization [GO:0050821] aggresome [GO:0016235]; chromosome [GO:0005694]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; ESC/E(Z) complex [GO:0035098]; perinuclear region of cytoplasm [GO:0048471]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777] chromatin binding [GO:0003682]; histone H2AK119 ubiquitin ligase activity [GO:0140862]; protein homodimerization activity [GO:0042803]; transcription coactivator activity [GO:0003713]; tumor necrosis factor receptor binding [GO:0005164]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] g19938.t1 A6NIH7 66.986 209 6.96e-97 286.0 sp|A6NIH7|U119B_HUMAN Protein unc-119 homolog B OS=Homo sapiens OX=9606 GN=UNC119B PE=1 SV=1 U119B_HUMAN reviewed Protein unc-119 homolog B Homo sapiens (Human) GO:0005829; GO:0005929; GO:0007399; GO:0008289; GO:0035869; GO:0042953; GO:0060271 cilium assembly [GO:0060271]; lipoprotein transport [GO:0042953]; nervous system development [GO:0007399] ciliary transition zone [GO:0035869]; cilium [GO:0005929]; cytosol [GO:0005829] lipid binding [GO:0008289] g19942.t1 O89019 32.895 304 9.5e-29 127.0 sp|O89019|INVS_MOUSE Inversin OS=Mus musculus OX=10090 GN=Invs PE=1 SV=2 g19943.t1 E1BLT8 59.2 250 8.62e-87 285.0 sp|E1BLT8|ZDHC5_BOVIN Palmitoyltransferase ZDHHC5 OS=Bos taurus OX=9913 GN=ZDHHC5 PE=3 SV=1 ZDHC5_BOVIN reviewed Palmitoyltransferase ZDHHC5 (EC 2.3.1.225) (Zinc finger DHHC domain-containing protein 5) (DHHC-5) Bos taurus (Bovine) GO:0005654; GO:0005886; GO:0015908; GO:0016409; GO:0019706; GO:0030163; GO:0030425; GO:0032495; GO:0042742; GO:0044546; GO:0045087; GO:0045335; GO:0051604; GO:0062208; GO:0070427; GO:0070431; GO:0070534; GO:0072659; GO:0098794; GO:0098978; GO:0140639; GO:0141201; GO:0160075; GO:1900227; GO:1903078; GO:1905171 defense response to bacterium [GO:0042742]; fatty acid transport [GO:0015908]; innate immune response [GO:0045087]; NLRP3 inflammasome complex assembly [GO:0044546]; non-canonical inflammasome complex assembly [GO:0160075]; nucleotide-binding oligomerization domain containing 1 signaling pathway [GO:0070427]; nucleotide-binding oligomerization domain containing 2 signaling pathway [GO:0070431]; positive regulation of NLRP3 inflammasome complex assembly [GO:1900227]; positive regulation of pattern recognition receptor signaling pathway [GO:0062208]; positive regulation of protein localization to phagocytic vesicle [GO:1905171]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of pyroptotic inflammatory response [GO:0140639]; protein catabolic process [GO:0030163]; protein K63-linked ubiquitination [GO:0070534]; protein localization to plasma membrane [GO:0072659]; protein maturation [GO:0051604]; pyroptotic cell death [GO:0141201]; response to muramyl dipeptide [GO:0032495] dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; nucleoplasm [GO:0005654]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; postsynapse [GO:0098794] palmitoyltransferase activity [GO:0016409]; protein-cysteine S-palmitoyltransferase activity [GO:0019706] g19944.t1 Q4KLN4 53.846 78 1.2199999999999999e-23 95.9 sp|Q4KLN4|GLE1_RAT mRNA export factor GLE1 OS=Rattus norvegicus OX=10116 GN=Gle1 PE=2 SV=1 GLE1_RAT reviewed mRNA export factor GLE1 (GLE1 RNA export mediator) (GLE1-like protein) (Nucleoporin GLE1) Rattus norvegicus (Rat) GO:0000822; GO:0005543; GO:0005635; GO:0005730; GO:0005737; GO:0005813; GO:0005814; GO:0005829; GO:0015031; GO:0016973; GO:0031369; GO:0031965; GO:0036064; GO:0042802; GO:0044614 poly(A)+ mRNA export from nucleus [GO:0016973]; protein transport [GO:0015031] centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear pore cytoplasmic filaments [GO:0044614]; nucleolus [GO:0005730] identical protein binding [GO:0042802]; inositol hexakisphosphate binding [GO:0000822]; phospholipid binding [GO:0005543]; translation initiation factor binding [GO:0031369] g19946.t1 Q6DRB1 47.826 115 5.300000000000001e-27 112.0 sp|Q6DRB1|GLE1_DANRE mRNA export factor GLE1 OS=Danio rerio OX=7955 GN=gle1 PE=2 SV=2 GLE1_DANRE reviewed mRNA export factor GLE1 (GLE1 RNA export mediator) (GLE1-like protein) (Nucleoporin GLE1) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000822; GO:0005543; GO:0005576; GO:0005737; GO:0010842; GO:0014010; GO:0014037; GO:0014044; GO:0015031; GO:0016973; GO:0031369; GO:0044614; GO:0048666; GO:0060287; GO:0060296 epithelial cilium movement involved in determination of left/right asymmetry [GO:0060287]; neuron development [GO:0048666]; poly(A)+ mRNA export from nucleus [GO:0016973]; protein transport [GO:0015031]; regulation of cilium beat frequency involved in ciliary motility [GO:0060296]; retina layer formation [GO:0010842]; Schwann cell development [GO:0014044]; Schwann cell differentiation [GO:0014037]; Schwann cell proliferation [GO:0014010] cytoplasm [GO:0005737]; extracellular region [GO:0005576]; nuclear pore cytoplasmic filaments [GO:0044614] inositol hexakisphosphate binding [GO:0000822]; phospholipid binding [GO:0005543]; translation initiation factor binding [GO:0031369] g19949.t1 Q6GNG8 54.701 117 2.21e-38 132.0 sp|Q6GNG8|PKRI1_XENLA PRKR-interacting protein 1 homolog OS=Xenopus laevis OX=8355 GN=prkrip1 PE=2 SV=1 g19950.t1 Q6NVU2 90.214 327 0.0 617.0 sp|Q6NVU2|PPIG_XENTR Serine/threonine-protein phosphatase PP1-gamma catalytic subunit OS=Xenopus tropicalis OX=8364 GN=ppp1cc PE=2 SV=1 PPIG_XENTR reviewed Serine/threonine-protein phosphatase PP1-gamma catalytic subunit (PP-1G) (EC 3.1.3.16) Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0000776; GO:0004722; GO:0005634; GO:0005730; GO:0005737; GO:0005739; GO:0005815; GO:0005977; GO:0006470; GO:0007084; GO:0016607; GO:0030496; GO:0032154; GO:0042752; GO:0046872; GO:0051301 cell division [GO:0051301]; glycogen metabolic process [GO:0005977]; mitotic nuclear membrane reassembly [GO:0007084]; protein dephosphorylation [GO:0006470]; regulation of circadian rhythm [GO:0042752] cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; kinetochore [GO:0000776]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]; mitochondrion [GO:0005739]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleus [GO:0005634] metal ion binding [GO:0046872]; protein serine/threonine phosphatase activity [GO:0004722] g19954.t1 Q6UL01 59.74 77 2.87e-23 90.1 sp|Q6UL01|MORN2_MOUSE MORN repeat-containing protein 2 OS=Mus musculus OX=10090 GN=Morn2 PE=1 SV=1 g19955.t1 Q9H867 48.372 215 9.28e-53 172.0 sp|Q9H867|MT21D_HUMAN Protein N-lysine methyltransferase METTL21D OS=Homo sapiens OX=9606 GN=VCPKMT PE=1 SV=2 g19956.t1 Q99MS0 44.416 394 3.1500000000000002e-117 350.0 sp|Q99MS0|S14L2_RAT SEC14-like protein 2 OS=Rattus norvegicus OX=10116 GN=Sec14l2 PE=1 SV=1 g19958.t1 Q24UI6 32.287 223 2.94e-28 119.0 sp|Q24UI6|IF2_DESHY Translation initiation factor IF-2 OS=Desulfitobacterium hafniense (strain Y51) OX=138119 GN=infB PE=3 SV=1 g19958.t1 Q24UI6 31.174 247 5.38e-28 118.0 sp|Q24UI6|IF2_DESHY Translation initiation factor IF-2 OS=Desulfitobacterium hafniense (strain Y51) OX=138119 GN=infB PE=3 SV=1 g19958.t1 Q24UI6 32.719 217 5.48e-28 118.0 sp|Q24UI6|IF2_DESHY Translation initiation factor IF-2 OS=Desulfitobacterium hafniense (strain Y51) OX=138119 GN=infB PE=3 SV=1 g19958.t1 Q24UI6 32.407 216 2.89e-27 115.0 sp|Q24UI6|IF2_DESHY Translation initiation factor IF-2 OS=Desulfitobacterium hafniense (strain Y51) OX=138119 GN=infB PE=3 SV=1 g19958.t1 Q24UI6 32.589 224 6.0099999999999995e-25 109.0 sp|Q24UI6|IF2_DESHY Translation initiation factor IF-2 OS=Desulfitobacterium hafniense (strain Y51) OX=138119 GN=infB PE=3 SV=1 g19959.t1 P35626 75.217 690 0.0 1096.0 sp|P35626|ARBK2_HUMAN G protein-coupled receptor kinase 3 OS=Homo sapiens OX=9606 GN=GRK3 PE=1 SV=2 ARBK2_HUMAN reviewed G protein-coupled receptor kinase 3 (EC 2.7.11.15) (Beta-adrenergic receptor kinase 2) (Beta-ARK-2) Homo sapiens (Human) GO:0001664; GO:0002029; GO:0004672; GO:0004703; GO:0005524; GO:0005829; GO:0005886; GO:0007165; GO:0007186; GO:0031623; GO:0047696; GO:0098793; GO:0098794 desensitization of G protein-coupled receptor signaling pathway [GO:0002029]; G protein-coupled receptor signaling pathway [GO:0007186]; receptor internalization [GO:0031623]; signal transduction [GO:0007165] cytosol [GO:0005829]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; presynapse [GO:0098793] ATP binding [GO:0005524]; beta-adrenergic receptor kinase activity [GO:0047696]; G protein-coupled receptor binding [GO:0001664]; G protein-coupled receptor kinase activity [GO:0004703]; protein kinase activity [GO:0004672] g19963.t1 Q99LB0 39.275 331 2.67e-65 213.0 sp|Q99LB0|TDIF1_MOUSE Deoxynucleotidyltransferase terminal-interacting protein 1 OS=Mus musculus OX=10090 GN=Dnttip1 PE=1 SV=1 g19964.t1 Q6IN84 40.755 265 6.28e-58 194.0 sp|Q6IN84|MRM1_HUMAN rRNA methyltransferase 1, mitochondrial OS=Homo sapiens OX=9606 GN=MRM1 PE=1 SV=1 MRM1_HUMAN reviewed rRNA methyltransferase 1, mitochondrial (EC 2.1.1.-) (16S rRNA (guanosine(1145)-2'-O)-methyltransferase) (16S rRNA [Gm1145] 2'-O-methyltransferase) Homo sapiens (Human) GO:0000154; GO:0000451; GO:0003723; GO:0005739; GO:0005759; GO:0006364; GO:0016435; GO:0070039 rRNA 2'-O-methylation [GO:0000451]; rRNA modification [GO:0000154]; rRNA processing [GO:0006364] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] RNA binding [GO:0003723]; rRNA (guanine) methyltransferase activity [GO:0016435]; rRNA (guanosine-2'-O-)-methyltransferase activity [GO:0070039] g19967.t1 Q9UJ41 46.076 497 1.12e-156 457.0 sp|Q9UJ41|RABX5_HUMAN Rab5 GDP/GTP exchange factor OS=Homo sapiens OX=9606 GN=RABGEF1 PE=1 SV=3 RABX5_HUMAN reviewed Rab5 GDP/GTP exchange factor (RAP1) (Rabaptin-5-associated exchange factor for Rab5) (Rabex-5) Homo sapiens (Human) GO:0002686; GO:0003677; GO:0005085; GO:0005730; GO:0005769; GO:0005829; GO:0006612; GO:0006898; GO:0007265; GO:0008270; GO:0015031; GO:0016197; GO:0030139; GO:0030425; GO:0031267; GO:0031901; GO:0032715; GO:0032764; GO:0033004; GO:0038109; GO:0043303; GO:0043305; GO:0046580; GO:0048261; GO:0050728; GO:0055037; GO:0060368; GO:0061630; GO:0097531; GO:0098830; GO:0098935; GO:1900235 dendritic transport [GO:0098935]; endosomal transport [GO:0016197]; Kit signaling pathway [GO:0038109]; mast cell degranulation [GO:0043303]; mast cell migration [GO:0097531]; negative regulation of inflammatory response [GO:0050728]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of Kit signaling pathway [GO:1900235]; negative regulation of leukocyte migration [GO:0002686]; negative regulation of mast cell activation [GO:0033004]; negative regulation of mast cell cytokine production [GO:0032764]; negative regulation of mast cell degranulation [GO:0043305]; negative regulation of Ras protein signal transduction [GO:0046580]; negative regulation of receptor-mediated endocytosis [GO:0048261]; protein targeting to membrane [GO:0006612]; protein transport [GO:0015031]; Ras protein signal transduction [GO:0007265]; receptor-mediated endocytosis [GO:0006898]; regulation of Fc receptor mediated stimulatory signaling pathway [GO:0060368] cytosol [GO:0005829]; dendrite [GO:0030425]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endocytic vesicle [GO:0030139]; nucleolus [GO:0005730]; presynaptic endosome [GO:0098830]; recycling endosome [GO:0055037] DNA binding [GO:0003677]; guanyl-nucleotide exchange factor activity [GO:0005085]; small GTPase binding [GO:0031267]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] g19971.t1 Q8CJ11 31.421 401 9.97e-53 197.0 sp|Q8CJ11|AGRG2_RAT Adhesion G-protein coupled receptor G2 OS=Rattus norvegicus OX=10116 GN=Adgrg2 PE=1 SV=1 AGRG2_RAT reviewed Adhesion G-protein coupled receptor G2 (G-protein coupled receptor 64) (Rat epididymis-specific protein 6) (Re6) [Cleaved into: Adhesion G-protein coupled receptor G2, N-terminal fragment (ADGRG2 N-terminal fragment); Adhesion G-protein coupled receptor G2, C-terminal fragment (ADGRG2 C-terminal fragment)] Rattus norvegicus (Rat) GO:0004930; GO:0005829; GO:0005886; GO:0007166; GO:0007186; GO:0007189; GO:0007200; GO:0007286; GO:0016324 adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; spermatid development [GO:0007286] apical plasma membrane [GO:0016324]; cytosol [GO:0005829]; plasma membrane [GO:0005886] G protein-coupled receptor activity [GO:0004930] g19974.t1 Q9Y6R7 31.05 3314 0.0 1494.0 sp|Q9Y6R7|FCGBP_HUMAN IgGFc-binding protein OS=Homo sapiens OX=9606 GN=FCGBP PE=1 SV=3 FCGBP_HUMAN reviewed IgGFc-binding protein (Fcgamma-binding protein antigen) (FcgammaBP) Homo sapiens (Human) GO:0005201; GO:0005615; GO:0005796; GO:0031012; GO:0070062 extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796] extracellular matrix structural constituent [GO:0005201] g19974.t1 Q9Y6R7 29.435 3343 0.0 1358.0 sp|Q9Y6R7|FCGBP_HUMAN IgGFc-binding protein OS=Homo sapiens OX=9606 GN=FCGBP PE=1 SV=3 FCGBP_HUMAN reviewed IgGFc-binding protein (Fcgamma-binding protein antigen) (FcgammaBP) Homo sapiens (Human) GO:0005201; GO:0005615; GO:0005796; GO:0031012; GO:0070062 extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796] extracellular matrix structural constituent [GO:0005201] g19974.t1 Q9Y6R7 30.49 2919 0.0 1272.0 sp|Q9Y6R7|FCGBP_HUMAN IgGFc-binding protein OS=Homo sapiens OX=9606 GN=FCGBP PE=1 SV=3 FCGBP_HUMAN reviewed IgGFc-binding protein (Fcgamma-binding protein antigen) (FcgammaBP) Homo sapiens (Human) GO:0005201; GO:0005615; GO:0005796; GO:0031012; GO:0070062 extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796] extracellular matrix structural constituent [GO:0005201] g19974.t1 Q9Y6R7 29.446 3070 0.0 1246.0 sp|Q9Y6R7|FCGBP_HUMAN IgGFc-binding protein OS=Homo sapiens OX=9606 GN=FCGBP PE=1 SV=3 FCGBP_HUMAN reviewed IgGFc-binding protein (Fcgamma-binding protein antigen) (FcgammaBP) Homo sapiens (Human) GO:0005201; GO:0005615; GO:0005796; GO:0031012; GO:0070062 extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796] extracellular matrix structural constituent [GO:0005201] g19974.t1 Q9Y6R7 33.71 442 1.0200000000000001e-58 231.0 sp|Q9Y6R7|FCGBP_HUMAN IgGFc-binding protein OS=Homo sapiens OX=9606 GN=FCGBP PE=1 SV=3 FCGBP_HUMAN reviewed IgGFc-binding protein (Fcgamma-binding protein antigen) (FcgammaBP) Homo sapiens (Human) GO:0005201; GO:0005615; GO:0005796; GO:0031012; GO:0070062 extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796] extracellular matrix structural constituent [GO:0005201] g19975.t1 Q9Y6R7 33.763 930 9.800000000000001e-132 441.0 sp|Q9Y6R7|FCGBP_HUMAN IgGFc-binding protein OS=Homo sapiens OX=9606 GN=FCGBP PE=1 SV=3 FCGBP_HUMAN reviewed IgGFc-binding protein (Fcgamma-binding protein antigen) (FcgammaBP) Homo sapiens (Human) GO:0005201; GO:0005615; GO:0005796; GO:0031012; GO:0070062 extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796] extracellular matrix structural constituent [GO:0005201] g19975.t1 Q9Y6R7 32.839 944 2.07e-130 437.0 sp|Q9Y6R7|FCGBP_HUMAN IgGFc-binding protein OS=Homo sapiens OX=9606 GN=FCGBP PE=1 SV=3 FCGBP_HUMAN reviewed IgGFc-binding protein (Fcgamma-binding protein antigen) (FcgammaBP) Homo sapiens (Human) GO:0005201; GO:0005615; GO:0005796; GO:0031012; GO:0070062 extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796] extracellular matrix structural constituent [GO:0005201] g19975.t1 Q9Y6R7 33.051 944 5.49e-128 430.0 sp|Q9Y6R7|FCGBP_HUMAN IgGFc-binding protein OS=Homo sapiens OX=9606 GN=FCGBP PE=1 SV=3 FCGBP_HUMAN reviewed IgGFc-binding protein (Fcgamma-binding protein antigen) (FcgammaBP) Homo sapiens (Human) GO:0005201; GO:0005615; GO:0005796; GO:0031012; GO:0070062 extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796] extracellular matrix structural constituent [GO:0005201] g19975.t1 Q9Y6R7 32.839 944 3.38e-127 428.0 sp|Q9Y6R7|FCGBP_HUMAN IgGFc-binding protein OS=Homo sapiens OX=9606 GN=FCGBP PE=1 SV=3 FCGBP_HUMAN reviewed IgGFc-binding protein (Fcgamma-binding protein antigen) (FcgammaBP) Homo sapiens (Human) GO:0005201; GO:0005615; GO:0005796; GO:0031012; GO:0070062 extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796] extracellular matrix structural constituent [GO:0005201] g19975.t1 Q9Y6R7 31.59 956 1.47e-121 411.0 sp|Q9Y6R7|FCGBP_HUMAN IgGFc-binding protein OS=Homo sapiens OX=9606 GN=FCGBP PE=1 SV=3 FCGBP_HUMAN reviewed IgGFc-binding protein (Fcgamma-binding protein antigen) (FcgammaBP) Homo sapiens (Human) GO:0005201; GO:0005615; GO:0005796; GO:0031012; GO:0070062 extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796] extracellular matrix structural constituent [GO:0005201] g19975.t1 Q9Y6R7 31.901 931 2.4600000000000002e-121 410.0 sp|Q9Y6R7|FCGBP_HUMAN IgGFc-binding protein OS=Homo sapiens OX=9606 GN=FCGBP PE=1 SV=3 FCGBP_HUMAN reviewed IgGFc-binding protein (Fcgamma-binding protein antigen) (FcgammaBP) Homo sapiens (Human) GO:0005201; GO:0005615; GO:0005796; GO:0031012; GO:0070062 extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796] extracellular matrix structural constituent [GO:0005201] g19975.t1 Q9Y6R7 31.794 931 1.6699999999999999e-119 405.0 sp|Q9Y6R7|FCGBP_HUMAN IgGFc-binding protein OS=Homo sapiens OX=9606 GN=FCGBP PE=1 SV=3 FCGBP_HUMAN reviewed IgGFc-binding protein (Fcgamma-binding protein antigen) (FcgammaBP) Homo sapiens (Human) GO:0005201; GO:0005615; GO:0005796; GO:0031012; GO:0070062 extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796] extracellular matrix structural constituent [GO:0005201] g19975.t1 Q9Y6R7 30.208 960 5.93e-119 404.0 sp|Q9Y6R7|FCGBP_HUMAN IgGFc-binding protein OS=Homo sapiens OX=9606 GN=FCGBP PE=1 SV=3 FCGBP_HUMAN reviewed IgGFc-binding protein (Fcgamma-binding protein antigen) (FcgammaBP) Homo sapiens (Human) GO:0005201; GO:0005615; GO:0005796; GO:0031012; GO:0070062 extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796] extracellular matrix structural constituent [GO:0005201] g19975.t1 Q9Y6R7 30.208 960 5.4e-118 401.0 sp|Q9Y6R7|FCGBP_HUMAN IgGFc-binding protein OS=Homo sapiens OX=9606 GN=FCGBP PE=1 SV=3 FCGBP_HUMAN reviewed IgGFc-binding protein (Fcgamma-binding protein antigen) (FcgammaBP) Homo sapiens (Human) GO:0005201; GO:0005615; GO:0005796; GO:0031012; GO:0070062 extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796] extracellular matrix structural constituent [GO:0005201] g19975.t1 Q9Y6R7 34.4 750 1.94e-111 382.0 sp|Q9Y6R7|FCGBP_HUMAN IgGFc-binding protein OS=Homo sapiens OX=9606 GN=FCGBP PE=1 SV=3 FCGBP_HUMAN reviewed IgGFc-binding protein (Fcgamma-binding protein antigen) (FcgammaBP) Homo sapiens (Human) GO:0005201; GO:0005615; GO:0005796; GO:0031012; GO:0070062 extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796] extracellular matrix structural constituent [GO:0005201] g19975.t1 Q9Y6R7 30.703 925 8.36e-106 365.0 sp|Q9Y6R7|FCGBP_HUMAN IgGFc-binding protein OS=Homo sapiens OX=9606 GN=FCGBP PE=1 SV=3 FCGBP_HUMAN reviewed IgGFc-binding protein (Fcgamma-binding protein antigen) (FcgammaBP) Homo sapiens (Human) GO:0005201; GO:0005615; GO:0005796; GO:0031012; GO:0070062 extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796] extracellular matrix structural constituent [GO:0005201] g19975.t1 Q9Y6R7 30.148 743 1.11e-69 257.0 sp|Q9Y6R7|FCGBP_HUMAN IgGFc-binding protein OS=Homo sapiens OX=9606 GN=FCGBP PE=1 SV=3 FCGBP_HUMAN reviewed IgGFc-binding protein (Fcgamma-binding protein antigen) (FcgammaBP) Homo sapiens (Human) GO:0005201; GO:0005615; GO:0005796; GO:0031012; GO:0070062 extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796] extracellular matrix structural constituent [GO:0005201] g19976.t1 Q2PC93 29.683 758 9.509999999999999e-68 256.0 sp|Q2PC93|SSPO_CHICK SCO-spondin OS=Gallus gallus OX=9031 GN=SSPO PE=2 SV=1 g19976.t1 Q2PC93 31.078 399 9.64e-41 169.0 sp|Q2PC93|SSPO_CHICK SCO-spondin OS=Gallus gallus OX=9031 GN=SSPO PE=2 SV=1 g19976.t1 Q2PC93 30.27 370 1.4200000000000002e-32 142.0 sp|Q2PC93|SSPO_CHICK SCO-spondin OS=Gallus gallus OX=9031 GN=SSPO PE=2 SV=1 g19977.t1 P10079 45.833 120 5.29e-22 100.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g19978.t1 Q2TBU3 65.182 247 1.63e-115 333.0 sp|Q2TBU3|GOSR1_BOVIN Golgi SNAP receptor complex member 1 OS=Bos taurus OX=9913 GN=GOSR1 PE=2 SV=1 GOSR1_BOVIN reviewed Golgi SNAP receptor complex member 1 (28 kDa Golgi SNARE protein) (28 kDa cis-Golgi SNARE p28) Bos taurus (Bovine) GO:0000139; GO:0005484; GO:0005797; GO:0005801; GO:0006888; GO:0006906; GO:0015031; GO:0031201; GO:0048219 endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; inter-Golgi cisterna vesicle-mediated transport [GO:0048219]; protein transport [GO:0015031]; vesicle fusion [GO:0006906] cis-Golgi network [GO:0005801]; Golgi medial cisterna [GO:0005797]; Golgi membrane [GO:0000139]; SNARE complex [GO:0031201] SNAP receptor activity [GO:0005484] g19979.t1 Q69ZM6 39.771 1310 0.0 780.0 sp|Q69ZM6|STK36_MOUSE Serine/threonine-protein kinase 36 OS=Mus musculus OX=10090 GN=Stk36 PE=1 SV=3 STK36_MOUSE reviewed Serine/threonine-protein kinase 36 (EC 2.7.11.1) (Fused homolog) Mus musculus (Mouse) GO:0001222; GO:0003351; GO:0004674; GO:0005524; GO:0005576; GO:0005634; GO:0005737; GO:0005829; GO:0005930; GO:0007224; GO:0007420; GO:0009791; GO:0035082; GO:0045880; GO:0046872; GO:0051090; GO:0060271; GO:0106310 axoneme assembly [GO:0035082]; brain development [GO:0007420]; cilium assembly [GO:0060271]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; positive regulation of smoothened signaling pathway [GO:0045880]; post-embryonic development [GO:0009791]; regulation of DNA-binding transcription factor activity [GO:0051090]; smoothened signaling pathway [GO:0007224] axoneme [GO:0005930]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; nucleus [GO:0005634] ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; transcription corepressor binding [GO:0001222] g19980.t1 Q6DJ48 32.796 372 7.67e-65 213.0 sp|Q6DJ48|STN1_XENTR CST complex subunit STN1 OS=Xenopus tropicalis OX=8364 GN=stn1 PE=2 SV=1 g19982.t1 Q6R5J2 38.676 1042 0.0 604.0 sp|Q6R5J2|DISP1_DANRE Protein dispatched homolog 1 OS=Danio rerio OX=7955 GN=disp1 PE=2 SV=1 DISP1_DANRE reviewed Protein dispatched homolog 1 (Protein chameleon) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0007224; GO:0007519; GO:0008015; GO:0009887; GO:0009952; GO:0016020; GO:0021984; GO:0031290; GO:0042694; GO:0048701; GO:0048839 adenohypophysis development [GO:0021984]; animal organ morphogenesis [GO:0009887]; anterior/posterior pattern specification [GO:0009952]; blood circulation [GO:0008015]; embryonic cranial skeleton morphogenesis [GO:0048701]; inner ear development [GO:0048839]; muscle cell fate specification [GO:0042694]; retinal ganglion cell axon guidance [GO:0031290]; skeletal muscle tissue development [GO:0007519]; smoothened signaling pathway [GO:0007224] membrane [GO:0016020] g19982.t2 Q6R5J2 38.676 1042 0.0 604.0 sp|Q6R5J2|DISP1_DANRE Protein dispatched homolog 1 OS=Danio rerio OX=7955 GN=disp1 PE=2 SV=1 DISP1_DANRE reviewed Protein dispatched homolog 1 (Protein chameleon) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0007224; GO:0007519; GO:0008015; GO:0009887; GO:0009952; GO:0016020; GO:0021984; GO:0031290; GO:0042694; GO:0048701; GO:0048839 adenohypophysis development [GO:0021984]; animal organ morphogenesis [GO:0009887]; anterior/posterior pattern specification [GO:0009952]; blood circulation [GO:0008015]; embryonic cranial skeleton morphogenesis [GO:0048701]; inner ear development [GO:0048839]; muscle cell fate specification [GO:0042694]; retinal ganglion cell axon guidance [GO:0031290]; skeletal muscle tissue development [GO:0007519]; smoothened signaling pathway [GO:0007224] membrane [GO:0016020] g19984.t1 Q9QZ88 89.56 182 7.370000000000001e-122 344.0 sp|Q9QZ88|VPS29_MOUSE Vacuolar protein sorting-associated protein 29 OS=Mus musculus OX=10090 GN=Vps29 PE=1 SV=1 VPS29_MOUSE reviewed Vacuolar protein sorting-associated protein 29 (Vesicle protein sorting 29) Mus musculus (Mouse) GO:0005768; GO:0005829; GO:0006886; GO:0006896; GO:0010008; GO:0030904; GO:0030906; GO:0032456; GO:0042147; GO:0046872 endocytic recycling [GO:0032456]; Golgi to vacuole transport [GO:0006896]; intracellular protein transport [GO:0006886]; retrograde transport, endosome to Golgi [GO:0042147] cytosol [GO:0005829]; endosome [GO:0005768]; endosome membrane [GO:0010008]; retromer complex [GO:0030904]; retromer, cargo-selective complex [GO:0030906] metal ion binding [GO:0046872] g19985.t1 Q6WBX8 40.85 306 4.8600000000000003e-79 256.0 sp|Q6WBX8|RAD9B_HUMAN Cell cycle checkpoint control protein RAD9B OS=Homo sapiens OX=9606 GN=RAD9B PE=1 SV=2 g19987.t1 P22781 60.127 474 0.0 628.0 sp|P22781|DDC_CAVPO Aromatic-L-amino-acid decarboxylase OS=Cavia porcellus OX=10141 GN=DDC PE=2 SV=1 g19993.t1 Q9HC77 68.306 183 6.38e-87 295.0 sp|Q9HC77|CPAP_HUMAN Centrosomal P4.1-associated protein OS=Homo sapiens OX=9606 GN=CPAP PE=1 SV=2 g19993.t1 Q9HC77 52.809 89 7.13e-22 103.0 sp|Q9HC77|CPAP_HUMAN Centrosomal P4.1-associated protein OS=Homo sapiens OX=9606 GN=CPAP PE=1 SV=2 g20000.t1 Q9I8C7 33.994 353 1.02e-70 235.0 sp|Q9I8C7|ACH10_CHICK Neuronal acetylcholine receptor subunit alpha-10 OS=Gallus gallus OX=9031 GN=CHRNA10 PE=3 SV=1 ACH10_CHICK reviewed Neuronal acetylcholine receptor subunit alpha-10 (Alpha 10 nAChR) (Nicotinic acetylcholine receptor subunit alpha-10) (NACHR alpha-10) Gallus gallus (Chicken) GO:0005231; GO:0005262; GO:0005886; GO:0005892; GO:0007268; GO:0022848; GO:0022850; GO:0034220; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0050910; GO:1902495; GO:1904315 chemical synaptic transmission [GO:0007268]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; monoatomic ion transmembrane transport [GO:0034220]; regulation of membrane potential [GO:0042391] acetylcholine-gated channel complex [GO:0005892]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; transmembrane transporter complex [GO:1902495] acetylcholine-gated monoatomic cation-selective channel activity [GO:0022848]; calcium channel activity [GO:0005262]; excitatory extracellular ligand-gated monoatomic ion channel activity [GO:0005231]; serotonin-gated monoatomic cation channel activity [GO:0022850]; transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315] g20002.t1 Q9PTS8 31.663 439 1.62e-72 239.0 sp|Q9PTS8|ACHA9_CHICK Neuronal acetylcholine receptor subunit alpha-9 OS=Gallus gallus OX=9031 GN=CHRNA9 PE=1 SV=1 g20003.t1 Q9I8C7 33.807 352 1.71e-58 202.0 sp|Q9I8C7|ACH10_CHICK Neuronal acetylcholine receptor subunit alpha-10 OS=Gallus gallus OX=9031 GN=CHRNA10 PE=3 SV=1 ACH10_CHICK reviewed Neuronal acetylcholine receptor subunit alpha-10 (Alpha 10 nAChR) (Nicotinic acetylcholine receptor subunit alpha-10) (NACHR alpha-10) Gallus gallus (Chicken) GO:0005231; GO:0005262; GO:0005886; GO:0005892; GO:0007268; GO:0022848; GO:0022850; GO:0034220; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0050910; GO:1902495; GO:1904315 chemical synaptic transmission [GO:0007268]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; monoatomic ion transmembrane transport [GO:0034220]; regulation of membrane potential [GO:0042391] acetylcholine-gated channel complex [GO:0005892]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; transmembrane transporter complex [GO:1902495] acetylcholine-gated monoatomic cation-selective channel activity [GO:0022848]; calcium channel activity [GO:0005262]; excitatory extracellular ligand-gated monoatomic ion channel activity [GO:0005231]; serotonin-gated monoatomic cation channel activity [GO:0022850]; transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315] g20004.t1 P17644 36.86 293 2.41e-58 204.0 sp|P17644|ACH2_DROME Acetylcholine receptor subunit alpha-like 2 OS=Drosophila melanogaster OX=7227 GN=nAChRalpha2 PE=2 SV=1 ACH2_DROME reviewed Acetylcholine receptor subunit alpha-like 2 (Nicotinic acetylcholine receptor alpha 2) Drosophila melanogaster (Fruit fly) GO:0004888; GO:0005231; GO:0005886; GO:0005892; GO:0007268; GO:0007271; GO:0022848; GO:0034220; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0098655; GO:0098662; GO:1904315 chemical synaptic transmission [GO:0007268]; inorganic cation transmembrane transport [GO:0098662]; monoatomic cation transmembrane transport [GO:0098655]; monoatomic ion transmembrane transport [GO:0034220]; regulation of membrane potential [GO:0042391]; synaptic transmission, cholinergic [GO:0007271] acetylcholine-gated channel complex [GO:0005892]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202] acetylcholine-gated monoatomic cation-selective channel activity [GO:0022848]; excitatory extracellular ligand-gated monoatomic ion channel activity [GO:0005231]; transmembrane signaling receptor activity [GO:0004888]; transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315] g20006.t1 Q9I8C7 34.877 367 4.19e-68 228.0 sp|Q9I8C7|ACH10_CHICK Neuronal acetylcholine receptor subunit alpha-10 OS=Gallus gallus OX=9031 GN=CHRNA10 PE=3 SV=1 ACH10_CHICK reviewed Neuronal acetylcholine receptor subunit alpha-10 (Alpha 10 nAChR) (Nicotinic acetylcholine receptor subunit alpha-10) (NACHR alpha-10) Gallus gallus (Chicken) GO:0005231; GO:0005262; GO:0005886; GO:0005892; GO:0007268; GO:0022848; GO:0022850; GO:0034220; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0050910; GO:1902495; GO:1904315 chemical synaptic transmission [GO:0007268]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; monoatomic ion transmembrane transport [GO:0034220]; regulation of membrane potential [GO:0042391] acetylcholine-gated channel complex [GO:0005892]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; transmembrane transporter complex [GO:1902495] acetylcholine-gated monoatomic cation-selective channel activity [GO:0022848]; calcium channel activity [GO:0005262]; excitatory extracellular ligand-gated monoatomic ion channel activity [GO:0005231]; serotonin-gated monoatomic cation channel activity [GO:0022850]; transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315] g20007.t1 Q9UGM1 31.294 425 1.98e-62 212.0 sp|Q9UGM1|ACHA9_HUMAN Neuronal acetylcholine receptor subunit alpha-9 OS=Homo sapiens OX=9606 GN=CHRNA9 PE=1 SV=2 ACHA9_HUMAN reviewed Neuronal acetylcholine receptor subunit alpha-9 (Nicotinic acetylcholine receptor subunit alpha-9) (NACHR alpha-9) Homo sapiens (Human) GO:0005231; GO:0005262; GO:0005886; GO:0005892; GO:0007204; GO:0007268; GO:0010996; GO:0022848; GO:0022850; GO:0034220; GO:0042391; GO:0042472; GO:0043005; GO:0045202; GO:0050910; GO:0051899; GO:0070373; GO:0095500; GO:0098981; GO:0099634; GO:1902495; GO:1904315 acetylcholine receptor signaling pathway [GO:0095500]; chemical synaptic transmission [GO:0007268]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; inner ear morphogenesis [GO:0042472]; membrane depolarization [GO:0051899]; monoatomic ion transmembrane transport [GO:0034220]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; regulation of membrane potential [GO:0042391]; response to auditory stimulus [GO:0010996] acetylcholine-gated channel complex [GO:0005892]; cholinergic synapse [GO:0098981]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic specialization membrane [GO:0099634]; synapse [GO:0045202]; transmembrane transporter complex [GO:1902495] acetylcholine-gated monoatomic cation-selective channel activity [GO:0022848]; calcium channel activity [GO:0005262]; excitatory extracellular ligand-gated monoatomic ion channel activity [GO:0005231]; serotonin-gated monoatomic cation channel activity [GO:0022850]; transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315] g20008.t1 Q8BMN3 34.878 410 1.6600000000000001e-65 221.0 sp|Q8BMN3|ACHB3_MOUSE Neuronal acetylcholine receptor subunit beta-3 OS=Mus musculus OX=10090 GN=Chrnb3 PE=2 SV=1 ACHB3_MOUSE reviewed Neuronal acetylcholine receptor subunit beta-3 Mus musculus (Mouse) GO:0004888; GO:0005886; GO:0005892; GO:0007271; GO:0007274; GO:0022848; GO:0032991; GO:0034220; GO:0034703; GO:0035094; GO:0042166; GO:0043005; GO:0045202; GO:0045211; GO:0051899; GO:0095500; GO:0098691; GO:0098793; GO:0098878; GO:0099171; GO:1901363 acetylcholine receptor signaling pathway [GO:0095500]; membrane depolarization [GO:0051899]; monoatomic ion transmembrane transport [GO:0034220]; neuromuscular synaptic transmission [GO:0007274]; presynaptic modulation of chemical synaptic transmission [GO:0099171]; response to nicotine [GO:0035094]; synaptic transmission, cholinergic [GO:0007271] acetylcholine-gated channel complex [GO:0005892]; cation channel complex [GO:0034703]; dopaminergic synapse [GO:0098691]; neuron projection [GO:0043005]; neurotransmitter receptor complex [GO:0098878]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynapse [GO:0098793]; protein-containing complex [GO:0032991]; synapse [GO:0045202] acetylcholine binding [GO:0042166]; acetylcholine-gated monoatomic cation-selective channel activity [GO:0022848]; heterocyclic compound binding [GO:1901363]; transmembrane signaling receptor activity [GO:0004888] g20009.t1 P17644 39.194 273 1.93e-52 187.0 sp|P17644|ACH2_DROME Acetylcholine receptor subunit alpha-like 2 OS=Drosophila melanogaster OX=7227 GN=nAChRalpha2 PE=2 SV=1 ACH2_DROME reviewed Acetylcholine receptor subunit alpha-like 2 (Nicotinic acetylcholine receptor alpha 2) Drosophila melanogaster (Fruit fly) GO:0004888; GO:0005231; GO:0005886; GO:0005892; GO:0007268; GO:0007271; GO:0022848; GO:0034220; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0098655; GO:0098662; GO:1904315 chemical synaptic transmission [GO:0007268]; inorganic cation transmembrane transport [GO:0098662]; monoatomic cation transmembrane transport [GO:0098655]; monoatomic ion transmembrane transport [GO:0034220]; regulation of membrane potential [GO:0042391]; synaptic transmission, cholinergic [GO:0007271] acetylcholine-gated channel complex [GO:0005892]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202] acetylcholine-gated monoatomic cation-selective channel activity [GO:0022848]; excitatory extracellular ligand-gated monoatomic ion channel activity [GO:0005231]; transmembrane signaling receptor activity [GO:0004888]; transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315] g20010.t1 Q9WVT6 40.0 260 3.68e-51 174.0 sp|Q9WVT6|CAH14_MOUSE Carbonic anhydrase 14 OS=Mus musculus OX=10090 GN=Ca14 PE=1 SV=1 g20012.t1 O43272 52.131 610 0.0 585.0 sp|O43272|PROD_HUMAN Proline dehydrogenase 1, mitochondrial OS=Homo sapiens OX=9606 GN=PRODH PE=1 SV=4 PROD_HUMAN reviewed Proline dehydrogenase 1, mitochondrial (EC 1.5.5.2) (Proline oxidase) (Proline oxidase 2) (p53-induced gene 6 protein) Homo sapiens (Human) GO:0004657; GO:0005654; GO:0005739; GO:0005743; GO:0005759; GO:0006560; GO:0006562; GO:0008631; GO:0010133; GO:0016649; GO:0019470; GO:0071949; GO:1903376 intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; L-proline catabolic process [GO:0006562]; L-proline catabolic process to L-glutamate [GO:0010133]; proline metabolic process [GO:0006560]; regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway [GO:1903376]; trans-4-hydroxy-L-proline catabolic process [GO:0019470] mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654] FAD binding [GO:0071949]; oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor [GO:0016649]; proline dehydrogenase activity [GO:0004657] g20014.t1 Q96DM1 24.55 444 7.44e-27 120.0 sp|Q96DM1|PGBD4_HUMAN PiggyBac transposable element-derived protein 4 OS=Homo sapiens OX=9606 GN=PGBD4 PE=1 SV=3 g20015.t1 P97292 29.07 344 8.720000000000001e-29 118.0 sp|P97292|HRH2_MOUSE Histamine H2 receptor OS=Mus musculus OX=10090 GN=Hrh2 PE=2 SV=2 HRH2_MOUSE reviewed Histamine H2 receptor (H2R) (HH2R) (Gastric receptor I) Mus musculus (Mouse) GO:0001696; GO:0001697; GO:0001698; GO:0003382; GO:0004969; GO:0005886; GO:0007187; GO:0007268; GO:0007613; GO:0008542; GO:0030425; GO:0030594; GO:0045202; GO:0045907; GO:0048167; GO:0048565; GO:0048732; GO:1900139; GO:1901363 chemical synaptic transmission [GO:0007268]; digestive tract development [GO:0048565]; epithelial cell morphogenesis [GO:0003382]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; gastric acid secretion [GO:0001696]; gastrin-induced gastric acid secretion [GO:0001698]; gland development [GO:0048732]; histamine-induced gastric acid secretion [GO:0001697]; memory [GO:0007613]; negative regulation of arachidonate secretion [GO:1900139]; positive regulation of vasoconstriction [GO:0045907]; regulation of synaptic plasticity [GO:0048167]; visual learning [GO:0008542] dendrite [GO:0030425]; plasma membrane [GO:0005886]; synapse [GO:0045202] heterocyclic compound binding [GO:1901363]; histamine receptor activity [GO:0004969]; neurotransmitter receptor activity [GO:0030594] g20017.t1 Q99JY8 44.8 125 5.0699999999999996e-30 113.0 sp|Q99JY8|PLPP3_MOUSE Phospholipid phosphatase 3 OS=Mus musculus OX=10090 GN=Plpp3 PE=1 SV=1 PLPP3_MOUSE reviewed Phospholipid phosphatase 3 (EC 3.1.3.-) (EC 3.1.3.4) (Lipid phosphate phosphohydrolase 3) (PAP2-beta) (Phosphatidate phosphohydrolase type 2b) (Phosphatidic acid phosphatase 2b) (PAP-2b) (PAP2b) Mus musculus (Mouse) GO:0000139; GO:0001568; GO:0001702; GO:0005178; GO:0005789; GO:0005794; GO:0005802; GO:0005886; GO:0005912; GO:0006644; GO:0006670; GO:0006672; GO:0006890; GO:0007155; GO:0007165; GO:0007229; GO:0008195; GO:0010595; GO:0016020; GO:0016323; GO:0030111; GO:0033116; GO:0033631; GO:0034112; GO:0042392; GO:0042577; GO:0045121; GO:0045944; GO:0046839; GO:0050821; GO:0060020; GO:0070097; GO:0070971; GO:0098609; GO:0106235; GO:1902068; GO:1902533; GO:1904906 Bergmann glial cell differentiation [GO:0060020]; blood vessel development [GO:0001568]; cell adhesion [GO:0007155]; cell-cell adhesion [GO:0098609]; cell-cell adhesion mediated by integrin [GO:0033631]; ceramide metabolic process [GO:0006672]; gastrulation with mouth forming second [GO:0001702]; integrin-mediated signaling pathway [GO:0007229]; phospholipid dephosphorylation [GO:0046839]; phospholipid metabolic process [GO:0006644]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell-matrix adhesion via fibronectin [GO:1904906]; positive regulation of homotypic cell-cell adhesion [GO:0034112]; positive regulation of intracellular signal transduction [GO:1902533]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein stabilization [GO:0050821]; regulation of sphingolipid mediated signaling pathway [GO:1902068]; regulation of Wnt signaling pathway [GO:0030111]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; signal transduction [GO:0007165]; sphingosine metabolic process [GO:0006670] adherens junction [GO:0005912]; basolateral plasma membrane [GO:0016323]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802] ceramide-1-phosphate phosphatase activity [GO:0106235]; delta-catenin binding [GO:0070097]; integrin binding [GO:0005178]; lipid phosphatase activity [GO:0042577]; phosphatidate phosphatase activity [GO:0008195]; sphingosine-1-phosphate phosphatase activity [GO:0042392] g20019.t1 O35643 86.542 587 0.0 1038.0 sp|O35643|AP1B1_MOUSE AP-1 complex subunit beta-1 OS=Mus musculus OX=10090 GN=Ap1b1 PE=1 SV=2 AP1B1_MOUSE reviewed AP-1 complex subunit beta-1 (Adaptor protein complex AP-1 subunit beta-1) (Adaptor-related protein complex 1 subunit beta-1) (Beta-1-adaptin) (Beta-adaptin 1) (Clathrin assembly protein complex 1 beta large chain) (Golgi adaptor HA1/AP1 adaptin beta subunit) Mus musculus (Mouse) GO:0001822; GO:0005765; GO:0005769; GO:0005794; GO:0005802; GO:0005829; GO:0006886; GO:0007368; GO:0007507; GO:0008021; GO:0016192; GO:0019901; GO:0030121; GO:0030276; GO:0032588; GO:0048268; GO:0060155; GO:0110010; GO:0120283; GO:1903232 basolateral protein secretion [GO:0110010]; clathrin coat assembly [GO:0048268]; determination of left/right symmetry [GO:0007368]; heart development [GO:0007507]; intracellular protein transport [GO:0006886]; kidney development [GO:0001822]; melanosome assembly [GO:1903232]; platelet dense granule organization [GO:0060155]; vesicle-mediated transport [GO:0016192] AP-1 adaptor complex [GO:0030121]; cytosol [GO:0005829]; early endosome [GO:0005769]; Golgi apparatus [GO:0005794]; lysosomal membrane [GO:0005765]; synaptic vesicle [GO:0008021]; trans-Golgi network [GO:0005802]; trans-Golgi network membrane [GO:0032588] clathrin binding [GO:0030276]; protein kinase binding [GO:0019901]; protein serine/threonine kinase binding [GO:0120283] g20019.t1 O35643 53.012 249 7.39e-78 276.0 sp|O35643|AP1B1_MOUSE AP-1 complex subunit beta-1 OS=Mus musculus OX=10090 GN=Ap1b1 PE=1 SV=2 AP1B1_MOUSE reviewed AP-1 complex subunit beta-1 (Adaptor protein complex AP-1 subunit beta-1) (Adaptor-related protein complex 1 subunit beta-1) (Beta-1-adaptin) (Beta-adaptin 1) (Clathrin assembly protein complex 1 beta large chain) (Golgi adaptor HA1/AP1 adaptin beta subunit) Mus musculus (Mouse) GO:0001822; GO:0005765; GO:0005769; GO:0005794; GO:0005802; GO:0005829; GO:0006886; GO:0007368; GO:0007507; GO:0008021; GO:0016192; GO:0019901; GO:0030121; GO:0030276; GO:0032588; GO:0048268; GO:0060155; GO:0110010; GO:0120283; GO:1903232 basolateral protein secretion [GO:0110010]; clathrin coat assembly [GO:0048268]; determination of left/right symmetry [GO:0007368]; heart development [GO:0007507]; intracellular protein transport [GO:0006886]; kidney development [GO:0001822]; melanosome assembly [GO:1903232]; platelet dense granule organization [GO:0060155]; vesicle-mediated transport [GO:0016192] AP-1 adaptor complex [GO:0030121]; cytosol [GO:0005829]; early endosome [GO:0005769]; Golgi apparatus [GO:0005794]; lysosomal membrane [GO:0005765]; synaptic vesicle [GO:0008021]; trans-Golgi network [GO:0005802]; trans-Golgi network membrane [GO:0032588] clathrin binding [GO:0030276]; protein kinase binding [GO:0019901]; protein serine/threonine kinase binding [GO:0120283] g20020.t1 A4FUD4 44.875 361 1.72e-94 288.0 sp|A4FUD4|PEX12_BOVIN Peroxisome assembly protein 12 OS=Bos taurus OX=9913 GN=PEX12 PE=2 SV=1 PEX12_BOVIN reviewed Peroxisome assembly protein 12 (Peroxin-12) Bos taurus (Bovine) GO:0000209; GO:0000425; GO:0004842; GO:0005778; GO:0006513; GO:0007031; GO:0008270; GO:0016558; GO:0016562; GO:0034614; GO:0043335; GO:0044721; GO:1990429; GO:1990757 cellular response to reactive oxygen species [GO:0034614]; peroxisome organization [GO:0007031]; pexophagy [GO:0000425]; protein import into peroxisome matrix [GO:0016558]; protein import into peroxisome matrix, receptor recycling [GO:0016562]; protein import into peroxisome matrix, substrate release [GO:0044721]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; protein unfolding [GO:0043335] peroxisomal importomer complex [GO:1990429]; peroxisomal membrane [GO:0005778] ubiquitin ligase activator activity [GO:1990757]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] g20029.t1 Q7K4Y6 57.947 604 0.0 697.0 sp|Q7K4Y6|DAT_DROME Sodium-dependent dopamine transporter OS=Drosophila melanogaster OX=7227 GN=DAT PE=1 SV=1 DAT_DROME reviewed Sodium-dependent dopamine transporter (Protein fumin) Drosophila melanogaster (Fruit fly) GO:0005330; GO:0005886; GO:0006865; GO:0008344; GO:0015872; GO:0015874; GO:0019811; GO:0030424; GO:0030431; GO:0032809; GO:0035725; GO:0042734; GO:0042745; GO:0046872; GO:0051583; GO:0099509; GO:1990834 adult locomotory behavior [GO:0008344]; amino acid transport [GO:0006865]; circadian sleep/wake cycle [GO:0042745]; dopamine transport [GO:0015872]; dopamine uptake involved in synaptic transmission [GO:0051583]; norepinephrine transport [GO:0015874]; regulation of presynaptic cytosolic calcium ion concentration [GO:0099509]; response to odorant [GO:1990834]; sleep [GO:0030431]; sodium ion transmembrane transport [GO:0035725] axon [GO:0030424]; neuronal cell body membrane [GO:0032809]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734] cocaine binding [GO:0019811]; dopamine:sodium symporter activity [GO:0005330]; metal ion binding [GO:0046872] g20031.t1 Q7Z569 59.333 450 0.0 579.0 sp|Q7Z569|BRAP_HUMAN BRCA1-associated protein OS=Homo sapiens OX=9606 GN=BRAP PE=1 SV=2 BRAP_HUMAN reviewed BRCA1-associated protein (EC 2.3.2.27) (BRAP2) (Impedes mitogenic signal propagation) (IMP) (RING finger protein 52) (RING-type E3 ubiquitin transferase BRAP2) (Renal carcinoma antigen NY-REN-63) Homo sapiens (Human) GO:0000151; GO:0000165; GO:0003676; GO:0004842; GO:0005654; GO:0005737; GO:0005829; GO:0007265; GO:0008139; GO:0008270; GO:0009968; GO:0016567; GO:0031965; GO:0042802; GO:0061630 MAPK cascade [GO:0000165]; negative regulation of signal transduction [GO:0009968]; protein ubiquitination [GO:0016567]; Ras protein signal transduction [GO:0007265] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; ubiquitin ligase complex [GO:0000151] identical protein binding [GO:0042802]; nuclear localization sequence binding [GO:0008139]; nucleic acid binding [GO:0003676]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] g20032.t1 A7SG73 60.14 286 2.29e-116 346.0 sp|A7SG73|NADC_NEMVE Nicotinate-nucleotide pyrophosphorylase [carboxylating] (Fragment) OS=Nematostella vectensis OX=45351 GN=qprt PE=3 SV=1 g20033.t1 Q6ZTN6 53.94 571 0.0 595.0 sp|Q6ZTN6|AN13D_HUMAN Ankyrin repeat domain-containing protein 13D OS=Homo sapiens OX=9606 GN=ANKRD13D PE=1 SV=3 AN13D_HUMAN reviewed Ankyrin repeat domain-containing protein 13D Homo sapiens (Human) GO:0002091; GO:0005737; GO:0005770; GO:0005886; GO:0048471; GO:0140036 negative regulation of receptor internalization [GO:0002091] cytoplasm [GO:0005737]; late endosome [GO:0005770]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886] ubiquitin-modified protein reader activity [GO:0140036] g20037.t1 P53814 60.526 114 8.17e-45 169.0 sp|P53814|SMTN_HUMAN Smoothelin OS=Homo sapiens OX=9606 GN=SMTN PE=1 SV=7 SMTN_HUMAN reviewed Smoothelin Homo sapiens (Human) GO:0003779; GO:0005856; GO:0006939; GO:0007517; GO:0008307; GO:0015629 muscle organ development [GO:0007517]; smooth muscle contraction [GO:0006939] actin cytoskeleton [GO:0015629]; cytoskeleton [GO:0005856] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g20038.t1 Q3SZP8 52.448 429 2.3300000000000002e-148 432.0 sp|Q3SZP8|TAD2A_BOVIN Transcriptional adapter 2-alpha OS=Bos taurus OX=9913 GN=TADA2A PE=2 SV=1 TAD2A_BOVIN reviewed Transcriptional adapter 2-alpha (Transcriptional adapter 2-like) (ADA2-like protein) Bos taurus (Bovine) GO:0000278; GO:0003677; GO:0003682; GO:0003713; GO:0005634; GO:0006338; GO:0006357; GO:0008270; GO:0031647; GO:0045995; GO:0051302; GO:0051726; GO:0070461; GO:0072686; GO:0140672 chromatin remodeling [GO:0006338]; mitotic cell cycle [GO:0000278]; regulation of cell cycle [GO:0051726]; regulation of cell division [GO:0051302]; regulation of embryonic development [GO:0045995]; regulation of protein stability [GO:0031647]; regulation of transcription by RNA polymerase II [GO:0006357] ATAC complex [GO:0140672]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]; SAGA-type complex [GO:0070461] chromatin binding [GO:0003682]; DNA binding [GO:0003677]; transcription coactivator activity [GO:0003713]; zinc ion binding [GO:0008270] g20040.t1 Q17RP2 31.119 286 1.83e-35 136.0 sp|Q17RP2|TIGD6_HUMAN Tigger transposable element-derived protein 6 OS=Homo sapiens OX=9606 GN=TIGD6 PE=1 SV=2 g20041.t1 Q8BUZ3 43.697 119 5.59e-28 110.0 sp|Q8BUZ3|TIGD4_MOUSE Tigger transposable element-derived protein 4 OS=Mus musculus OX=10090 GN=Tigd4 PE=2 SV=1 g20043.t1 Q8QFR2 41.739 345 5.76e-91 300.0 sp|Q8QFR2|HIRA_XENLA Protein HIRA OS=Xenopus laevis OX=8355 GN=hira PE=1 SV=2 g20044.t1 Q61666 55.148 573 0.0 647.0 sp|Q61666|HIRA_MOUSE Protein HIRA OS=Mus musculus OX=10090 GN=Hira PE=1 SV=3 g20044.t2 Q8QFR2 54.561 592 0.0 635.0 sp|Q8QFR2|HIRA_XENLA Protein HIRA OS=Xenopus laevis OX=8355 GN=hira PE=1 SV=2 g20045.t1 Q6AXL8 35.0 180 3.2500000000000003e-31 114.0 sp|Q6AXL8|ZMAT5_DANRE Zinc finger matrin-type protein 5 OS=Danio rerio OX=7955 GN=zmat5 PE=2 SV=1 g20046.t1 Q66H91 49.089 768 0.0 672.0 sp|Q66H91|GIT2_RAT ARF GTPase-activating protein GIT2 OS=Rattus norvegicus OX=10116 GN=Git2 PE=1 SV=1 g20048.t1 O08662 47.868 1876 0.0 1565.0 sp|O08662|PI4KA_RAT Phosphatidylinositol 4-kinase alpha OS=Rattus norvegicus OX=10116 GN=Pi4ka PE=1 SV=2 PI4KA_RAT reviewed Phosphatidylinositol 4-kinase alpha (PI4-kinase alpha) (PI4K-alpha) (PtdIns-4-kinase alpha) (EC 2.7.1.67) Rattus norvegicus (Rat) GO:0004430; GO:0005524; GO:0005737; GO:0005886; GO:0022011; GO:0030036; GO:0030660; GO:0036135; GO:0044788; GO:0046854; GO:0048015; GO:0140754 actin cytoskeleton organization [GO:0030036]; host-mediated perturbation of viral process [GO:0044788]; myelination in peripheral nervous system [GO:0022011]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; phosphatidylinositol-mediated signaling [GO:0048015]; reorganization of cellular membranes to establish viral sites of replication [GO:0140754]; Schwann cell migration [GO:0036135] cytoplasm [GO:0005737]; Golgi-associated vesicle membrane [GO:0030660]; plasma membrane [GO:0005886] 1-phosphatidylinositol 4-kinase activity [GO:0004430]; ATP binding [GO:0005524] g20048.t2 O08662 51.301 2113 0.0 1982.0 sp|O08662|PI4KA_RAT Phosphatidylinositol 4-kinase alpha OS=Rattus norvegicus OX=10116 GN=Pi4ka PE=1 SV=2 PI4KA_RAT reviewed Phosphatidylinositol 4-kinase alpha (PI4-kinase alpha) (PI4K-alpha) (PtdIns-4-kinase alpha) (EC 2.7.1.67) Rattus norvegicus (Rat) GO:0004430; GO:0005524; GO:0005737; GO:0005886; GO:0022011; GO:0030036; GO:0030660; GO:0036135; GO:0044788; GO:0046854; GO:0048015; GO:0140754 actin cytoskeleton organization [GO:0030036]; host-mediated perturbation of viral process [GO:0044788]; myelination in peripheral nervous system [GO:0022011]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; phosphatidylinositol-mediated signaling [GO:0048015]; reorganization of cellular membranes to establish viral sites of replication [GO:0140754]; Schwann cell migration [GO:0036135] cytoplasm [GO:0005737]; Golgi-associated vesicle membrane [GO:0030660]; plasma membrane [GO:0005886] 1-phosphatidylinositol 4-kinase activity [GO:0004430]; ATP binding [GO:0005524] g20048.t3 A4QPH2 73.684 247 3.71e-134 393.0 sp|A4QPH2|PI4P2_HUMAN Putative phosphatidylinositol 4-kinase alpha-like protein P2 OS=Homo sapiens OX=9606 GN=PI4KAP2 PE=5 SV=3 PI4P2_HUMAN reviewed Putative phosphatidylinositol 4-kinase alpha-like protein P2 Homo sapiens (Human) GO:0016301; GO:0046854 phosphatidylinositol phosphate biosynthetic process [GO:0046854] kinase activity [GO:0016301] g20051.t1 A8WQK3 31.352 488 1.26e-60 210.0 sp|A8WQK3|ACH1_CAEBR Acetylcholine receptor subunit alpha-type acr-16 OS=Caenorhabditis briggsae OX=6238 GN=acr-16 PE=3 SV=2 g20052.t1 Q0IH86 46.865 303 1.25e-86 264.0 sp|Q0IH86|SLX1_XENLA Structure-specific endonuclease subunit slx1 OS=Xenopus laevis OX=8355 GN=slx1a PE=2 SV=1 g20054.t1 Q8VDP6 68.246 211 3.82e-103 300.0 sp|Q8VDP6|CDIPT_MOUSE CDP-diacylglycerol--inositol 3-phosphatidyltransferase OS=Mus musculus OX=10090 GN=Cdipt PE=1 SV=1 CDIPT_MOUSE reviewed CDP-diacylglycerol--inositol 3-phosphatidyltransferase (EC 2.7.8.11) (Phosphatidylinositol synthase) (PI synthase) (PtdIns synthase) Mus musculus (Mouse) GO:0003881; GO:0005789; GO:0005794; GO:0005886; GO:0006661; GO:0016020; GO:0019992; GO:0030145; GO:0030246; GO:0043178; GO:0046341 CDP-diacylglycerol metabolic process [GO:0046341]; phosphatidylinositol biosynthetic process [GO:0006661] endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; plasma membrane [GO:0005886] alcohol binding [GO:0043178]; carbohydrate binding [GO:0030246]; CDP-diacylglycerol-inositol 3-phosphatidyltransferase activity [GO:0003881]; diacylglycerol binding [GO:0019992]; manganese ion binding [GO:0030145] g20061.t1 B5X171 50.549 455 8.64e-152 451.0 sp|B5X171|PESC_SALSA Pescadillo homolog OS=Salmo salar OX=8030 GN=pes1 PE=2 SV=1 PESC_SALSA reviewed Pescadillo homolog Salmo salar (Atlantic salmon) GO:0000463; GO:0000466; GO:0003723; GO:0005654; GO:0005730; GO:0030687; GO:0043021; GO:0051726; GO:0070545 maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000466]; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]; regulation of cell cycle [GO:0051726] nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; PeBoW complex [GO:0070545]; preribosome, large subunit precursor [GO:0030687] ribonucleoprotein complex binding [GO:0043021]; RNA binding [GO:0003723] g20062.t1 A8WGS4 41.176 221 5.67e-48 162.0 sp|A8WGS4|TLCD2_DANRE TLC domain-containing protein 2 OS=Danio rerio OX=7955 GN=tlcd2 PE=2 SV=1 g20064.t1 Q99J08 40.38 421 1.78e-116 349.0 sp|Q99J08|S14L2_MOUSE SEC14-like protein 2 OS=Mus musculus OX=10090 GN=Sec14l2 PE=1 SV=1 g20070.t1 Q99315 35.071 211 2.48e-38 144.0 sp|Q99315|YG31B_YEAST Transposon Ty3-G Gag-Pol polyprotein OS=Saccharomyces cerevisiae (strain ATCC 204508 / S288c) OX=559292 GN=TY3B-G PE=1 SV=3 g20074.t1 Q9DC11 48.175 274 1.67e-84 275.0 sp|Q9DC11|PXDC2_MOUSE Plexin domain-containing protein 2 OS=Mus musculus OX=10090 GN=Plxdc2 PE=1 SV=1 PXDC2_MOUSE reviewed Plexin domain-containing protein 2 (Tumor endothelial marker 7-related protein) Mus musculus (Mouse) GO:0005886; GO:0031012 extracellular matrix [GO:0031012]; plasma membrane [GO:0005886] g20074.t2 Q9DC11 48.175 274 1.54e-84 275.0 sp|Q9DC11|PXDC2_MOUSE Plexin domain-containing protein 2 OS=Mus musculus OX=10090 GN=Plxdc2 PE=1 SV=1 PXDC2_MOUSE reviewed Plexin domain-containing protein 2 (Tumor endothelial marker 7-related protein) Mus musculus (Mouse) GO:0005886; GO:0031012 extracellular matrix [GO:0031012]; plasma membrane [GO:0005886] g20075.t1 Q9UHV7 48.313 563 6.37e-133 469.0 sp|Q9UHV7|MED13_HUMAN Mediator of RNA polymerase II transcription subunit 13 OS=Homo sapiens OX=9606 GN=MED13 PE=1 SV=3 MED13_HUMAN reviewed Mediator of RNA polymerase II transcription subunit 13 (Activator-recruited cofactor 250 kDa component) (ARC250) (Mediator complex subunit 13) (Thyroid hormone receptor-associated protein 1) (Thyroid hormone receptor-associated protein complex 240 kDa component) (Trap240) (Vitamin D3 receptor-interacting protein complex component DRIP250) (DRIP250) Homo sapiens (Human) GO:0000122; GO:0003712; GO:0003713; GO:0005634; GO:0005654; GO:0016020; GO:0016592; GO:0042632; GO:0042809; GO:0045893; GO:0045944; GO:0046966; GO:0060261; GO:0070328; GO:1990508 cholesterol homeostasis [GO:0042632]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription initiation by RNA polymerase II [GO:0060261]; triglyceride homeostasis [GO:0070328] CKM complex [GO:1990508]; mediator complex [GO:0016592]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] nuclear thyroid hormone receptor binding [GO:0046966]; nuclear vitamin D receptor binding [GO:0042809]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712] g20075.t1 Q9UHV7 41.604 661 1.46e-112 404.0 sp|Q9UHV7|MED13_HUMAN Mediator of RNA polymerase II transcription subunit 13 OS=Homo sapiens OX=9606 GN=MED13 PE=1 SV=3 MED13_HUMAN reviewed Mediator of RNA polymerase II transcription subunit 13 (Activator-recruited cofactor 250 kDa component) (ARC250) (Mediator complex subunit 13) (Thyroid hormone receptor-associated protein 1) (Thyroid hormone receptor-associated protein complex 240 kDa component) (Trap240) (Vitamin D3 receptor-interacting protein complex component DRIP250) (DRIP250) Homo sapiens (Human) GO:0000122; GO:0003712; GO:0003713; GO:0005634; GO:0005654; GO:0016020; GO:0016592; GO:0042632; GO:0042809; GO:0045893; GO:0045944; GO:0046966; GO:0060261; GO:0070328; GO:1990508 cholesterol homeostasis [GO:0042632]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription initiation by RNA polymerase II [GO:0060261]; triglyceride homeostasis [GO:0070328] CKM complex [GO:1990508]; mediator complex [GO:0016592]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] nuclear thyroid hormone receptor binding [GO:0046966]; nuclear vitamin D receptor binding [GO:0042809]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712] g20075.t1 Q9UHV7 36.699 515 8.61e-83 308.0 sp|Q9UHV7|MED13_HUMAN Mediator of RNA polymerase II transcription subunit 13 OS=Homo sapiens OX=9606 GN=MED13 PE=1 SV=3 MED13_HUMAN reviewed Mediator of RNA polymerase II transcription subunit 13 (Activator-recruited cofactor 250 kDa component) (ARC250) (Mediator complex subunit 13) (Thyroid hormone receptor-associated protein 1) (Thyroid hormone receptor-associated protein complex 240 kDa component) (Trap240) (Vitamin D3 receptor-interacting protein complex component DRIP250) (DRIP250) Homo sapiens (Human) GO:0000122; GO:0003712; GO:0003713; GO:0005634; GO:0005654; GO:0016020; GO:0016592; GO:0042632; GO:0042809; GO:0045893; GO:0045944; GO:0046966; GO:0060261; GO:0070328; GO:1990508 cholesterol homeostasis [GO:0042632]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription initiation by RNA polymerase II [GO:0060261]; triglyceride homeostasis [GO:0070328] CKM complex [GO:1990508]; mediator complex [GO:0016592]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] nuclear thyroid hormone receptor binding [GO:0046966]; nuclear vitamin D receptor binding [GO:0042809]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712] g20077.t1 Q8K3A0 39.13 161 1.55e-35 126.0 sp|Q8K3A0|HSC20_MOUSE Iron-sulfur cluster co-chaperone protein HscB OS=Mus musculus OX=10090 GN=Hscb PE=1 SV=2 HSC20_MOUSE reviewed Iron-sulfur cluster co-chaperone protein HscB [Cleaved into: Iron-sulfur cluster co-chaperone protein HscB, mitochondrial (C-HSC20); Iron-sulfur cluster co-chaperone protein HscB, cytoplasmic] Mus musculus (Mouse) GO:0001671; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0016226; GO:0030218; GO:0042802; GO:0044571; GO:0046872; GO:0051087; GO:0051259; GO:0060215; GO:0060319 [2Fe-2S] cluster assembly [GO:0044571]; erythrocyte differentiation [GO:0030218]; iron-sulfur cluster assembly [GO:0016226]; primitive erythrocyte differentiation [GO:0060319]; primitive hemopoiesis [GO:0060215]; protein complex oligomerization [GO:0051259] cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654] ATPase activator activity [GO:0001671]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein-folding chaperone binding [GO:0051087] g20078.t1 E7FAM5 29.195 298 1.36e-22 100.0 sp|E7FAM5|LIN41_DANRE E3 ubiquitin-protein ligase TRIM71 OS=Danio rerio OX=7955 GN=trim71 PE=1 SV=1 LIN41_DANRE reviewed E3 ubiquitin-protein ligase TRIM71 (EC 2.3.2.27) (Protein lin-41 homolog) (RING-type E3 ubiquitin transferase TRIM71) (Tripartite motif-containing protein 71) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000082; GO:0000209; GO:0000932; GO:0004842; GO:0008270; GO:0008543; GO:0021915; GO:0035198; GO:0035278; GO:0043161; GO:0051865; GO:0061630; GO:0072089; GO:2000177 fibroblast growth factor receptor signaling pathway [GO:0008543]; G1/S transition of mitotic cell cycle [GO:0000082]; miRNA-mediated gene silencing by inhibition of translation [GO:0035278]; neural tube development [GO:0021915]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein polyubiquitination [GO:0000209]; regulation of neural precursor cell proliferation [GO:2000177]; stem cell proliferation [GO:0072089] P-body [GO:0000932] miRNA binding [GO:0035198]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] g20080.t1 Q9EQJ0 48.37 767 0.0 549.0 sp|Q9EQJ0|TPC1_MOUSE Two pore calcium channel protein 1 OS=Mus musculus OX=10090 GN=Tpcn1 PE=1 SV=1 TPC1_MOUSE reviewed Two pore calcium channel protein 1 (Voltage-dependent calcium channel protein TPC1) Mus musculus (Mouse) GO:0005248; GO:0005765; GO:0010008; GO:0010508; GO:0015280; GO:0016020; GO:0019905; GO:0022832; GO:0031901; GO:0034702; GO:0035725; GO:0036019; GO:0042802; GO:0042803; GO:0055038; GO:0072345; GO:0075509; GO:0080025; GO:0097682 endocytosis involved in viral entry into host cell [GO:0075509]; positive regulation of autophagy [GO:0010508]; sodium ion transmembrane transport [GO:0035725] early endosome membrane [GO:0031901]; endolysosome [GO:0036019]; endosome membrane [GO:0010008]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; monoatomic ion channel complex [GO:0034702]; recycling endosome membrane [GO:0055038] identical protein binding [GO:0042802]; intracellularly phosphatidylinositol-3,5-bisphosphate-gated monatomic cation channel activity [GO:0097682]; ligand-gated sodium channel activity [GO:0015280]; NAADP-sensitive calcium-release channel activity [GO:0072345]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; protein homodimerization activity [GO:0042803]; syntaxin binding [GO:0019905]; voltage-gated channel activity [GO:0022832]; voltage-gated sodium channel activity [GO:0005248] g20081.t1 Q96DY2 37.143 455 1.8e-79 258.0 sp|Q96DY2|DRC10_HUMAN Dynein regulatory complex protein 10 OS=Homo sapiens OX=9606 GN=IQCD PE=1 SV=2 g20082.t1 Q96DY2 32.731 443 3.23e-61 209.0 sp|Q96DY2|DRC10_HUMAN Dynein regulatory complex protein 10 OS=Homo sapiens OX=9606 GN=IQCD PE=1 SV=2 g20085.t1 Q8AXX2 57.947 302 2.71e-92 286.0 sp|Q8AXX2|TBX1_DANRE T-box transcription factor TBX1 OS=Danio rerio OX=7955 GN=tbx1 PE=2 SV=1 TBX1_DANRE reviewed T-box transcription factor TBX1 (T-box protein 1) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000785; GO:0000978; GO:0000981; GO:0001708; GO:0001755; GO:0001947; GO:0003143; GO:0005634; GO:0006357; GO:0007507; GO:0014032; GO:0042471; GO:0042803; GO:0043282; GO:0043565; GO:0043583; GO:0045893; GO:0048538; GO:0048703; GO:0048752; GO:0055007; GO:0060017; GO:0060023; GO:0060037; GO:0060536; GO:0072513 cardiac muscle cell differentiation [GO:0055007]; cartilage morphogenesis [GO:0060536]; cell fate specification [GO:0001708]; chordate pharyngeal muscle development [GO:0043282]; ear development [GO:0043583]; ear morphogenesis [GO:0042471]; embryonic heart tube morphogenesis [GO:0003143]; embryonic viscerocranium morphogenesis [GO:0048703]; heart development [GO:0007507]; heart looping [GO:0001947]; neural crest cell development [GO:0014032]; neural crest cell migration [GO:0001755]; parathyroid gland development [GO:0060017]; pharyngeal system development [GO:0060037]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of secondary heart field cardioblast proliferation [GO:0072513]; regulation of transcription by RNA polymerase II [GO:0006357]; semicircular canal morphogenesis [GO:0048752]; soft palate development [GO:0060023]; thymus development [GO:0048538] chromatin [GO:0000785]; nucleus [GO:0005634] DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565] g20085.t2 Q8AXX2 54.89 317 1.49e-90 281.0 sp|Q8AXX2|TBX1_DANRE T-box transcription factor TBX1 OS=Danio rerio OX=7955 GN=tbx1 PE=2 SV=1 TBX1_DANRE reviewed T-box transcription factor TBX1 (T-box protein 1) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000785; GO:0000978; GO:0000981; GO:0001708; GO:0001755; GO:0001947; GO:0003143; GO:0005634; GO:0006357; GO:0007507; GO:0014032; GO:0042471; GO:0042803; GO:0043282; GO:0043565; GO:0043583; GO:0045893; GO:0048538; GO:0048703; GO:0048752; GO:0055007; GO:0060017; GO:0060023; GO:0060037; GO:0060536; GO:0072513 cardiac muscle cell differentiation [GO:0055007]; cartilage morphogenesis [GO:0060536]; cell fate specification [GO:0001708]; chordate pharyngeal muscle development [GO:0043282]; ear development [GO:0043583]; ear morphogenesis [GO:0042471]; embryonic heart tube morphogenesis [GO:0003143]; embryonic viscerocranium morphogenesis [GO:0048703]; heart development [GO:0007507]; heart looping [GO:0001947]; neural crest cell development [GO:0014032]; neural crest cell migration [GO:0001755]; parathyroid gland development [GO:0060017]; pharyngeal system development [GO:0060037]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of secondary heart field cardioblast proliferation [GO:0072513]; regulation of transcription by RNA polymerase II [GO:0006357]; semicircular canal morphogenesis [GO:0048752]; soft palate development [GO:0060023]; thymus development [GO:0048538] chromatin [GO:0000785]; nucleus [GO:0005634] DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565] g20087.t1 Q15020 38.616 795 9.15e-177 538.0 sp|Q15020|SART3_HUMAN Spliceosome associated factor 3, U4/U6 recycling protein OS=Homo sapiens OX=9606 GN=SART3 PE=1 SV=1 g20089.t1 Q6ZPR5 34.826 804 2.13e-131 415.0 sp|Q6ZPR5|NSMA3_MOUSE Sphingomyelin phosphodiesterase 4 OS=Mus musculus OX=10090 GN=Smpd4 PE=1 SV=2 g20089.t2 Q6ZPR5 35.183 793 4.86e-133 419.0 sp|Q6ZPR5|NSMA3_MOUSE Sphingomyelin phosphodiesterase 4 OS=Mus musculus OX=10090 GN=Smpd4 PE=1 SV=2 g10392.t1 Q04205 57.84 287 3.59e-107 353.0 sp|Q04205|TENS1_CHICK Tensin-1 OS=Gallus gallus OX=9031 GN=TNS1 PE=1 SV=3 g10394.t1 Q04205 53.298 379 8.3e-124 431.0 sp|Q04205|TENS1_CHICK Tensin-1 OS=Gallus gallus OX=9031 GN=TNS1 PE=1 SV=3 g10396.t1 Q5ZHT1 54.994 791 0.0 877.0 sp|Q5ZHT1|ACD11_CHICK Acyl-CoA dehydrogenase family member 11 OS=Gallus gallus OX=9031 GN=ACAD11 PE=2 SV=1 ACD11_CHICK reviewed Acyl-CoA dehydrogenase family member 11 (ACAD-11) (EC 1.3.8.8) Gallus gallus (Chicken) GO:0003995; GO:0005737; GO:0005739; GO:0005777; GO:0031966; GO:0033539; GO:0050660 fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539] cytoplasm [GO:0005737]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; peroxisome [GO:0005777] acyl-CoA dehydrogenase activity [GO:0003995]; flavin adenine dinucleotide binding [GO:0050660] g10397.t1 O35166 56.604 212 8.35e-86 255.0 sp|O35166|GOSR2_MOUSE Golgi SNAP receptor complex member 2 OS=Mus musculus OX=10090 GN=Gosr2 PE=1 SV=2 GOSR2_MOUSE reviewed Golgi SNAP receptor complex member 2 (27 kDa Golgi SNARE protein) (Membrin) Mus musculus (Mouse) GO:0000139; GO:0000149; GO:0005484; GO:0005654; GO:0005789; GO:0005794; GO:0005829; GO:0006891; GO:0006906; GO:0012507; GO:0015031; GO:0016192; GO:0031201; GO:0031902 intra-Golgi vesicle-mediated transport [GO:0006891]; protein transport [GO:0015031]; vesicle fusion [GO:0006906]; vesicle-mediated transport [GO:0016192] cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; ER to Golgi transport vesicle membrane [GO:0012507]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; late endosome membrane [GO:0031902]; nucleoplasm [GO:0005654]; SNARE complex [GO:0031201] SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149] g10399.t1 O42280 49.057 265 1.45e-78 244.0 sp|O42280|WNT9A_CHICK Protein Wnt-9a OS=Gallus gallus OX=9031 GN=WNT9A PE=2 SV=1 g10400.t1 Q9MYM7 41.176 238 4.0799999999999994e-54 184.0 sp|Q9MYM7|B3GT1_PONPY Beta-1,3-galactosyltransferase 1 OS=Pongo pygmaeus OX=9600 GN=B3GALT1 PE=3 SV=1 g10401.t1 Q9MYM7 39.223 283 1.3e-53 184.0 sp|Q9MYM7|B3GT1_PONPY Beta-1,3-galactosyltransferase 1 OS=Pongo pygmaeus OX=9600 GN=B3GALT1 PE=3 SV=1 g10402.t1 Q7T6Y2 37.313 268 1.9699999999999998e-42 167.0 sp|Q7T6Y2|YR831_MIMIV Putative serine/threonine-protein kinase/receptor R831 OS=Acanthamoeba polyphaga mimivirus OX=212035 GN=MIMI_R831 PE=3 SV=2 g10402.t1 Q7T6Y2 32.746 284 4.86e-37 151.0 sp|Q7T6Y2|YR831_MIMIV Putative serine/threonine-protein kinase/receptor R831 OS=Acanthamoeba polyphaga mimivirus OX=212035 GN=MIMI_R831 PE=3 SV=2 g10410.t1 Q13685 49.442 269 1.1e-93 288.0 sp|Q13685|AAMP_HUMAN Angio-associated migratory cell protein OS=Homo sapiens OX=9606 GN=AAMP PE=1 SV=2 AAMP_HUMAN reviewed Angio-associated migratory cell protein Homo sapiens (Human) GO:0001525; GO:0005829; GO:0005886; GO:0008201; GO:0009986; GO:0010595; GO:0014909; GO:0015630; GO:0030154; GO:0045171 angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; positive regulation of endothelial cell migration [GO:0010595]; smooth muscle cell migration [GO:0014909] cell surface [GO:0009986]; cytosol [GO:0005829]; intercellular bridge [GO:0045171]; microtubule cytoskeleton [GO:0015630]; plasma membrane [GO:0005886] heparin binding [GO:0008201] g10412.t1 E1BMP7 43.83 1013 0.0 786.0 sp|E1BMP7|DNA2_BOVIN DNA replication ATP-dependent helicase/nuclease DNA2 OS=Bos taurus OX=9913 GN=DNA2 PE=3 SV=3 DNA2_BOVIN reviewed DNA replication ATP-dependent helicase/nuclease DNA2 (DNA replication ATP-dependent helicase-like homolog) [Includes: DNA replication nuclease DNA2 (EC 3.1.-.-); DNA replication ATP-dependent helicase DNA2 (EC 3.6.4.12)] Bos taurus (Bovine) GO:0000076; GO:0000729; GO:0003677; GO:0003723; GO:0004518; GO:0005524; GO:0005634; GO:0005737; GO:0005739; GO:0006260; GO:0006284; GO:0016887; GO:0017108; GO:0017116; GO:0033567; GO:0043139; GO:0046872; GO:0051539; GO:0071932 base-excision repair [GO:0006284]; DNA double-strand break processing [GO:0000729]; DNA replication [GO:0006260]; DNA replication checkpoint signaling [GO:0000076]; DNA replication, Okazaki fragment processing [GO:0033567]; replication fork reversal [GO:0071932] cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleus [GO:0005634] 4 iron, 4 sulfur cluster binding [GO:0051539]; 5'-3' DNA helicase activity [GO:0043139]; 5'-flap endonuclease activity [GO:0017108]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; nuclease activity [GO:0004518]; RNA binding [GO:0003723]; single-stranded DNA helicase activity [GO:0017116] g10412.t2 E1BMP7 43.874 1012 0.0 786.0 sp|E1BMP7|DNA2_BOVIN DNA replication ATP-dependent helicase/nuclease DNA2 OS=Bos taurus OX=9913 GN=DNA2 PE=3 SV=3 DNA2_BOVIN reviewed DNA replication ATP-dependent helicase/nuclease DNA2 (DNA replication ATP-dependent helicase-like homolog) [Includes: DNA replication nuclease DNA2 (EC 3.1.-.-); DNA replication ATP-dependent helicase DNA2 (EC 3.6.4.12)] Bos taurus (Bovine) GO:0000076; GO:0000729; GO:0003677; GO:0003723; GO:0004518; GO:0005524; GO:0005634; GO:0005737; GO:0005739; GO:0006260; GO:0006284; GO:0016887; GO:0017108; GO:0017116; GO:0033567; GO:0043139; GO:0046872; GO:0051539; GO:0071932 base-excision repair [GO:0006284]; DNA double-strand break processing [GO:0000729]; DNA replication [GO:0006260]; DNA replication checkpoint signaling [GO:0000076]; DNA replication, Okazaki fragment processing [GO:0033567]; replication fork reversal [GO:0071932] cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleus [GO:0005634] 4 iron, 4 sulfur cluster binding [GO:0051539]; 5'-3' DNA helicase activity [GO:0043139]; 5'-flap endonuclease activity [GO:0017108]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; nuclease activity [GO:0004518]; RNA binding [GO:0003723]; single-stranded DNA helicase activity [GO:0017116] g10413.t1 Q9D995 31.679 262 1.1699999999999999e-34 131.0 sp|Q9D995|CNTD1_MOUSE Cyclin N-terminal domain-containing protein 1 OS=Mus musculus OX=10090 GN=Cntd1 PE=1 SV=1 CNTD1_MOUSE reviewed Cyclin N-terminal domain-containing protein 1 Mus musculus (Mouse) GO:0005634; GO:0005694; GO:0005737; GO:0007131; GO:0007283; GO:0035861; GO:0051445 reciprocal meiotic recombination [GO:0007131]; regulation of meiotic cell cycle [GO:0051445]; spermatogenesis [GO:0007283] chromosome [GO:0005694]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; site of double-strand break [GO:0035861] g10414.t1 Q32NH8 41.558 770 0.0 582.0 sp|Q32NH8|PLCD4_XENLA 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase delta-4 OS=Xenopus laevis OX=8355 GN=plcd4 PE=2 SV=1 PLCD4_XENLA reviewed 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase delta-4 (EC 3.1.4.11) (Phosphoinositide phospholipase C-delta-4) (Phospholipase C-delta-4) (PLC-delta-4) Xenopus laevis (African clawed frog) GO:0004435; GO:0005509; GO:0005634; GO:0005783; GO:0005886; GO:0016042; GO:0035556; GO:0120548 intracellular signal transduction [GO:0035556]; lipid catabolic process [GO:0016042] endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; phosphatidylinositol phospholipase C activity [GO:0120548]; phosphatidylinositol-4,5-bisphosphate phospholipase C activity [GO:0004435] g10414.t2 Q32NH8 41.965 753 0.0 582.0 sp|Q32NH8|PLCD4_XENLA 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase delta-4 OS=Xenopus laevis OX=8355 GN=plcd4 PE=2 SV=1 PLCD4_XENLA reviewed 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase delta-4 (EC 3.1.4.11) (Phosphoinositide phospholipase C-delta-4) (Phospholipase C-delta-4) (PLC-delta-4) Xenopus laevis (African clawed frog) GO:0004435; GO:0005509; GO:0005634; GO:0005783; GO:0005886; GO:0016042; GO:0035556; GO:0120548 intracellular signal transduction [GO:0035556]; lipid catabolic process [GO:0016042] endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; phosphatidylinositol phospholipase C activity [GO:0120548]; phosphatidylinositol-4,5-bisphosphate phospholipase C activity [GO:0004435] g10414.t3 Q32NH8 42.359 746 0.0 583.0 sp|Q32NH8|PLCD4_XENLA 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase delta-4 OS=Xenopus laevis OX=8355 GN=plcd4 PE=2 SV=1 PLCD4_XENLA reviewed 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase delta-4 (EC 3.1.4.11) (Phosphoinositide phospholipase C-delta-4) (Phospholipase C-delta-4) (PLC-delta-4) Xenopus laevis (African clawed frog) GO:0004435; GO:0005509; GO:0005634; GO:0005783; GO:0005886; GO:0016042; GO:0035556; GO:0120548 intracellular signal transduction [GO:0035556]; lipid catabolic process [GO:0016042] endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; phosphatidylinositol phospholipase C activity [GO:0120548]; phosphatidylinositol-4,5-bisphosphate phospholipase C activity [GO:0004435] g10415.t1 P46101 35.806 782 6.31e-164 500.0 sp|P46101|DPP6_RAT A-type potassium channel modulatory protein DPP6 OS=Rattus norvegicus OX=10116 GN=Dpp6 PE=1 SV=1 g10415.t2 Q8N608 35.751 772 1.89e-161 491.0 sp|Q8N608|DPP10_HUMAN Inactive dipeptidyl peptidase 10 OS=Homo sapiens OX=9606 GN=DPP10 PE=1 SV=2 DPP10_HUMAN reviewed Inactive dipeptidyl peptidase 10 (Dipeptidyl peptidase IV-related protein 3) (DPRP-3) (Dipeptidyl peptidase X) (DPP X) (Dipeptidyl peptidase-like protein 2) (DPL2) Homo sapiens (Human) GO:0005886; GO:0006508; GO:0008076; GO:0008236; GO:0015459; GO:0016020; GO:0044325; GO:0072659; GO:1901379; GO:1903078 positive regulation of protein localization to plasma membrane [GO:1903078]; protein localization to plasma membrane [GO:0072659]; proteolysis [GO:0006508]; regulation of potassium ion transmembrane transport [GO:1901379] membrane [GO:0016020]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076] potassium channel regulator activity [GO:0015459]; serine-type peptidase activity [GO:0008236]; transmembrane transporter binding [GO:0044325] g10418.t1 Q5R8R1 86.842 418 0.0 757.0 sp|Q5R8R1|ARP3_PONAB Actin-related protein 3 OS=Pongo abelii OX=9601 GN=ACTR3 PE=2 SV=3 ARP3_PONAB reviewed Actin-related protein 3 (Actin-like protein 3) Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0005200; GO:0005524; GO:0005634; GO:0005737; GO:0005885; GO:0005903; GO:0005911; GO:0007163; GO:0008356; GO:0010592; GO:0016344; GO:0030027; GO:0033206; GO:0034314; GO:0035861; GO:0045944; GO:0051015; GO:0051653; GO:0060271; GO:0071346 Arp2/3 complex-mediated actin nucleation [GO:0034314]; asymmetric cell division [GO:0008356]; cellular response to type II interferon [GO:0071346]; cilium assembly [GO:0060271]; establishment or maintenance of cell polarity [GO:0007163]; meiotic chromosome movement towards spindle pole [GO:0016344]; meiotic cytokinesis [GO:0033206]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of transcription by RNA polymerase II [GO:0045944]; spindle localization [GO:0051653] Arp2/3 protein complex [GO:0005885]; brush border [GO:0005903]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; lamellipodium [GO:0030027]; nucleus [GO:0005634]; site of double-strand break [GO:0035861] actin filament binding [GO:0051015]; ATP binding [GO:0005524]; structural constituent of cytoskeleton [GO:0005200] g10420.t1 Q66K94 62.319 138 2.75e-60 191.0 sp|Q66K94|SOSB1_XENTR SOSS complex subunit B1 OS=Xenopus tropicalis OX=8364 GN=nabp2 PE=2 SV=1 SOSB1_XENTR reviewed SOSS complex subunit B1 (Nucleic acid-binding protein 2) (Oligonucleotide/oligosaccharide-binding fold-containing protein 2B) (Sensor of single-strand DNA complex subunit B1) (Sensor of ssDNA subunit B1) (SOSS-B1) (Single-stranded DNA-binding protein 1) Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0000724; GO:0003677; GO:0003697; GO:0005634; GO:0005694; GO:0006281; GO:0006974; GO:0010212; GO:0044818; GO:0070876 DNA damage response [GO:0006974]; DNA repair [GO:0006281]; double-strand break repair via homologous recombination [GO:0000724]; mitotic G2/M transition checkpoint [GO:0044818]; response to ionizing radiation [GO:0010212] chromosome [GO:0005694]; nucleus [GO:0005634]; SOSS complex [GO:0070876] DNA binding [GO:0003677]; single-stranded DNA binding [GO:0003697] g10421.t1 Q6DD06 50.588 425 3.83e-90 283.0 sp|Q6DD06|ZC3HF_XENLA Zinc finger CCCH domain-containing protein 15 OS=Xenopus laevis OX=8355 GN=zc3h15 PE=2 SV=1 g10423.t1 Q6NRT6 43.617 658 0.0 560.0 sp|Q6NRT6|DJC10_XENLA DnaJ homolog subfamily C member 10 OS=Xenopus laevis OX=8355 GN=dnajc10 PE=2 SV=1 g10423.t1 Q6NRT6 25.61 492 9.35e-35 145.0 sp|Q6NRT6|DJC10_XENLA DnaJ homolog subfamily C member 10 OS=Xenopus laevis OX=8355 GN=dnajc10 PE=2 SV=1 g10424.t1 P18514 53.58 405 1.6e-130 391.0 sp|P18514|RARA_NOTVI Retinoic acid receptor alpha OS=Notophthalmus viridescens OX=8316 GN=RARA PE=2 SV=1 g10424.t2 P18514 57.337 368 1.7399999999999999e-134 400.0 sp|P18514|RARA_NOTVI Retinoic acid receptor alpha OS=Notophthalmus viridescens OX=8316 GN=RARA PE=2 SV=1 g10424.t3 P18514 53.58 405 5.06e-130 390.0 sp|P18514|RARA_NOTVI Retinoic acid receptor alpha OS=Notophthalmus viridescens OX=8316 GN=RARA PE=2 SV=1 g10425.t1 Q8IW40 37.662 231 3.32e-46 157.0 sp|Q8IW40|DAA19_HUMAN Dynein axonemal assembly factor 19 OS=Homo sapiens OX=9606 GN=DNAAF19 PE=1 SV=1 DAA19_HUMAN reviewed Dynein axonemal assembly factor 19 (Coiled-coil domain-containing protein 103) Homo sapiens (Human) GO:0001947; GO:0003341; GO:0003351; GO:0005576; GO:0005737; GO:0005930; GO:0007368; GO:0031514; GO:0036157; GO:0036158; GO:0036159; GO:0042803; GO:0060287; GO:0070286; GO:0071907 axonemal dynein complex assembly [GO:0070286]; cilium movement [GO:0003341]; determination of digestive tract left/right asymmetry [GO:0071907]; determination of left/right symmetry [GO:0007368]; epithelial cilium movement involved in determination of left/right asymmetry [GO:0060287]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; heart looping [GO:0001947]; inner dynein arm assembly [GO:0036159]; outer dynein arm assembly [GO:0036158] axoneme [GO:0005930]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; motile cilium [GO:0031514]; outer dynein arm [GO:0036157] protein homodimerization activity [GO:0042803] g10426.t1 P13055 65.347 101 2.57e-39 159.0 sp|P13055|E75BB_DROME Ecdysone-induced protein 75B, isoform B OS=Drosophila melanogaster OX=7227 GN=Eip75B PE=2 SV=2 E75BB_DROME reviewed Ecdysone-induced protein 75B, isoform B (E75-C) (Nuclear receptor subfamily 1 group D member 3, isoform B) Drosophila melanogaster (Fruit fly) GO:0000122; GO:0000978; GO:0003677; GO:0004879; GO:0005634; GO:0007553; GO:0007591; GO:0008270; GO:0009755; GO:0010468; GO:0018990; GO:0020037; GO:0030154; GO:0030522; GO:0035075; GO:0045944; GO:0048477; GO:0061060 cell differentiation [GO:0030154]; ecdysis, chitin-based cuticle [GO:0018990]; hormone-mediated signaling pathway [GO:0009755]; intracellular receptor signaling pathway [GO:0030522]; molting cycle, chitin-based cuticle [GO:0007591]; negative regulation of peptidoglycan recognition protein signaling pathway [GO:0061060]; negative regulation of transcription by RNA polymerase II [GO:0000122]; oogenesis [GO:0048477]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of ecdysteroid metabolic process [GO:0007553]; regulation of gene expression [GO:0010468]; response to ecdysone [GO:0035075] nucleus [GO:0005634] DNA binding [GO:0003677]; heme binding [GO:0020037]; nuclear receptor activity [GO:0004879]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270] g10427.t1 Q5ZJH7 40.945 254 1e-48 177.0 sp|Q5ZJH7|CNPD1_CHICK Protein CNPPD1 OS=Gallus gallus OX=9031 GN=CNPPD1 PE=2 SV=1 g10428.t1 O77245 38.177 351 3.69e-71 235.0 sp|O77245|E75_METEN Nuclear hormone receptor E75 OS=Metapenaeus ensis OX=32278 GN=E75 PE=2 SV=1 g10429.t1 P20664 47.816 412 2.2600000000000002e-129 380.0 sp|P20664|PRI1_MOUSE DNA primase small subunit OS=Mus musculus OX=10090 GN=Prim1 PE=1 SV=1 g10430.t1 Q02446 69.369 111 3.45e-44 171.0 sp|Q02446|SP4_HUMAN Transcription factor Sp4 OS=Homo sapiens OX=9606 GN=SP4 PE=1 SV=2 SP4_HUMAN reviewed Transcription factor Sp4 (SPR-1) Homo sapiens (Human) GO:0000785; GO:0000978; GO:0000981; GO:0005654; GO:0005829; GO:0006357; GO:0008270; GO:0042802; GO:0043565 regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; cytosol [GO:0005829]; nucleoplasm [GO:0005654] DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270] g10430.t1 Q02446 40.252 159 4.99e-28 122.0 sp|Q02446|SP4_HUMAN Transcription factor Sp4 OS=Homo sapiens OX=9606 GN=SP4 PE=1 SV=2 SP4_HUMAN reviewed Transcription factor Sp4 (SPR-1) Homo sapiens (Human) GO:0000785; GO:0000978; GO:0000981; GO:0005654; GO:0005829; GO:0006357; GO:0008270; GO:0042802; GO:0043565 regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; cytosol [GO:0005829]; nucleoplasm [GO:0005654] DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270] g10430.t2 Q02446 69.369 111 3.94e-44 171.0 sp|Q02446|SP4_HUMAN Transcription factor Sp4 OS=Homo sapiens OX=9606 GN=SP4 PE=1 SV=2 SP4_HUMAN reviewed Transcription factor Sp4 (SPR-1) Homo sapiens (Human) GO:0000785; GO:0000978; GO:0000981; GO:0005654; GO:0005829; GO:0006357; GO:0008270; GO:0042802; GO:0043565 regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; cytosol [GO:0005829]; nucleoplasm [GO:0005654] DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270] g10430.t2 Q02446 40.123 162 4.88e-28 123.0 sp|Q02446|SP4_HUMAN Transcription factor Sp4 OS=Homo sapiens OX=9606 GN=SP4 PE=1 SV=2 SP4_HUMAN reviewed Transcription factor Sp4 (SPR-1) Homo sapiens (Human) GO:0000785; GO:0000978; GO:0000981; GO:0005654; GO:0005829; GO:0006357; GO:0008270; GO:0042802; GO:0043565 regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; cytosol [GO:0005829]; nucleoplasm [GO:0005654] DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270] g10431.t1 Q02446 56.502 223 7.95e-72 253.0 sp|Q02446|SP4_HUMAN Transcription factor Sp4 OS=Homo sapiens OX=9606 GN=SP4 PE=1 SV=2 SP4_HUMAN reviewed Transcription factor Sp4 (SPR-1) Homo sapiens (Human) GO:0000785; GO:0000978; GO:0000981; GO:0005654; GO:0005829; GO:0006357; GO:0008270; GO:0042802; GO:0043565 regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; cytosol [GO:0005829]; nucleoplasm [GO:0005654] DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270] g10432.t1 Q7ZU42 71.722 389 0.0 582.0 sp|Q7ZU42|OLA1_DANRE Obg-like ATPase 1 OS=Danio rerio OX=7955 GN=ola1 PE=2 SV=1 g10434.t1 Q9NXE8 47.093 172 8.199999999999999e-30 125.0 sp|Q9NXE8|CWC25_HUMAN Pre-mRNA-splicing factor CWC25 homolog OS=Homo sapiens OX=9606 GN=CWC25 PE=1 SV=1 CWC25_HUMAN reviewed Pre-mRNA-splicing factor CWC25 homolog (Coiled-coil domain-containing protein 49) (Spliceosome-associated protein homolog CWC25) Homo sapiens (Human) GO:0000398; GO:0005634; GO:0005654; GO:0005684; GO:0016607; GO:0071006 mRNA splicing, via spliceosome [GO:0000398] nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U2-type catalytic step 1 spliceosome [GO:0071006]; U2-type spliceosomal complex [GO:0005684] g10435.t1 Q9H8Y8 60.351 285 5.07e-93 286.0 sp|Q9H8Y8|GORS2_HUMAN Golgi reassembly-stacking protein 2 OS=Homo sapiens OX=9606 GN=GORASP2 PE=1 SV=3 g10440.t1 Q80V42 47.074 376 7.580000000000001e-107 327.0 sp|Q80V42|CBPM_MOUSE Carboxypeptidase M OS=Mus musculus OX=10090 GN=Cpm PE=1 SV=2 g10443.t1 Q9ULJ8 46.78 295 2.01e-63 234.0 sp|Q9ULJ8|NEB1_HUMAN Neurabin-1 OS=Homo sapiens OX=9606 GN=PPP1R9A PE=1 SV=2 g10443.t2 Q9ULJ8 46.78 295 5.36e-63 234.0 sp|Q9ULJ8|NEB1_HUMAN Neurabin-1 OS=Homo sapiens OX=9606 GN=PPP1R9A PE=1 SV=2 g10443.t3 Q9ULJ8 46.78 295 1.38e-62 233.0 sp|Q9ULJ8|NEB1_HUMAN Neurabin-1 OS=Homo sapiens OX=9606 GN=PPP1R9A PE=1 SV=2 g10443.t4 Q9ULJ8 46.78 295 6.04e-63 234.0 sp|Q9ULJ8|NEB1_HUMAN Neurabin-1 OS=Homo sapiens OX=9606 GN=PPP1R9A PE=1 SV=2 g10443.t5 O35867 43.333 390 1.16e-81 290.0 sp|O35867|NEB1_RAT Neurabin-1 OS=Rattus norvegicus OX=10116 GN=Ppp1r9a PE=1 SV=1 NEB1_RAT reviewed Neurabin-1 (Neurabin-I) (Neural tissue-specific F-actin-binding protein I) (PP1bp175) (Protein phosphatase 1 regulatory subunit 9A) (p180) Rattus norvegicus (Rat) GO:0005737; GO:0005856; GO:0007015; GO:0008157; GO:0010976; GO:0014069; GO:0015629; GO:0019722; GO:0019901; GO:0019904; GO:0030027; GO:0030175; GO:0030425; GO:0030426; GO:0030833; GO:0030864; GO:0031175; GO:0031594; GO:0042802; GO:0043025; GO:0043197; GO:0044325; GO:0044326; GO:0044877; GO:0048666; GO:0050804; GO:0051015; GO:0051020; GO:0051489; GO:0051497; GO:0051823; GO:0051963; GO:0060079; GO:0060999; GO:0061001; GO:0097237; GO:0098871; GO:0098974; GO:0098978; GO:1900272; GO:1900454; GO:1904049; GO:1990761 actin filament organization [GO:0007015]; calcium-mediated signaling [GO:0019722]; cellular response to toxic substance [GO:0097237]; excitatory postsynaptic potential [GO:0060079]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of long-term synaptic potentiation [GO:1900272]; negative regulation of spontaneous neurotransmitter secretion [GO:1904049]; negative regulation of stress fiber assembly [GO:0051497]; neuron development [GO:0048666]; neuron projection development [GO:0031175]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of long-term synaptic depression [GO:1900454]; positive regulation of neuron projection development [GO:0010976]; postsynaptic actin cytoskeleton organization [GO:0098974]; regulation of actin filament polymerization [GO:0030833]; regulation of dendritic spine morphogenesis [GO:0061001]; regulation of filopodium assembly [GO:0051489]; regulation of synapse assembly [GO:0051963]; regulation of synapse structural plasticity [GO:0051823] actin cytoskeleton [GO:0015629]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; dendritic spine neck [GO:0044326]; filopodium [GO:0030175]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; growth cone lamellipodium [GO:1990761]; lamellipodium [GO:0030027]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; postsynaptic actin cytoskeleton [GO:0098871]; postsynaptic density [GO:0014069] actin filament binding [GO:0051015]; GTPase binding [GO:0051020]; identical protein binding [GO:0042802]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; protein phosphatase 1 binding [GO:0008157]; protein-containing complex binding [GO:0044877]; transmembrane transporter binding [GO:0044325] g10446.t1 O08858 47.312 93 9.049999999999999e-23 95.1 sp|O08858|SSR5_MOUSE Somatostatin receptor type 5 OS=Mus musculus OX=10090 GN=Sstr5 PE=1 SV=3 g10450.t1 O43556 31.349 252 2.9800000000000003e-27 115.0 sp|O43556|SGCE_HUMAN Epsilon-sarcoglycan OS=Homo sapiens OX=9606 GN=SGCE PE=1 SV=6 SGCE_HUMAN reviewed Epsilon-sarcoglycan (Epsilon-SG) Homo sapiens (Human) GO:0000139; GO:0005789; GO:0005794; GO:0005856; GO:0005886; GO:0007160; GO:0007517; GO:0016010; GO:0016012; GO:0032590; GO:0042383 cell-matrix adhesion [GO:0007160]; muscle organ development [GO:0007517] cytoskeleton [GO:0005856]; dendrite membrane [GO:0032590]; dystrophin-associated glycoprotein complex [GO:0016010]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886]; sarcoglycan complex [GO:0016012]; sarcolemma [GO:0042383] g10451.t1 Q6AYD3 61.453 358 1.48e-159 457.0 sp|Q6AYD3|PA2G4_RAT Proliferation-associated protein 2G4 OS=Rattus norvegicus OX=10116 GN=Pa2g4 PE=1 SV=1 PA2G4_RAT reviewed Proliferation-associated protein 2G4 Rattus norvegicus (Rat) GO:0003676; GO:0003714; GO:0003723; GO:0005634; GO:0005730; GO:0005737; GO:0006364; GO:0006417; GO:0031625; GO:0043066; GO:0045597; GO:0045892; GO:1990904 negative regulation of apoptotic process [GO:0043066]; negative regulation of DNA-templated transcription [GO:0045892]; positive regulation of cell differentiation [GO:0045597]; regulation of translation [GO:0006417]; rRNA processing [GO:0006364] cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904] nucleic acid binding [GO:0003676]; RNA binding [GO:0003723]; transcription corepressor activity [GO:0003714]; ubiquitin protein ligase binding [GO:0031625] g10452.t1 D3ZAA9 47.527 566 5.08e-173 503.0 sp|D3ZAA9|MPP2_RAT MAGUK p55 subfamily member 2 OS=Rattus norvegicus OX=10116 GN=Mpp2 PE=1 SV=2 MPP2_RAT reviewed MAGUK p55 subfamily member 2 (Protein MPP2) Rattus norvegicus (Rat) GO:0005856; GO:0005886; GO:0005911; GO:0014069; GO:0030165; GO:0032590; GO:0043197; GO:0043198; GO:0044325; GO:0051260; GO:0060079; GO:0060291; GO:0098685; GO:0098839; GO:0098919; GO:0098978 excitatory postsynaptic potential [GO:0060079]; long-term synaptic potentiation [GO:0060291]; protein homooligomerization [GO:0051260] cell-cell junction [GO:0005911]; cytoskeleton [GO:0005856]; dendrite membrane [GO:0032590]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic density membrane [GO:0098839]; Schaffer collateral - CA1 synapse [GO:0098685] PDZ domain binding [GO:0030165]; structural constituent of postsynaptic density [GO:0098919]; transmembrane transporter binding [GO:0044325] g10452.t2 D3ZAA9 47.461 571 4.43e-172 501.0 sp|D3ZAA9|MPP2_RAT MAGUK p55 subfamily member 2 OS=Rattus norvegicus OX=10116 GN=Mpp2 PE=1 SV=2 MPP2_RAT reviewed MAGUK p55 subfamily member 2 (Protein MPP2) Rattus norvegicus (Rat) GO:0005856; GO:0005886; GO:0005911; GO:0014069; GO:0030165; GO:0032590; GO:0043197; GO:0043198; GO:0044325; GO:0051260; GO:0060079; GO:0060291; GO:0098685; GO:0098839; GO:0098919; GO:0098978 excitatory postsynaptic potential [GO:0060079]; long-term synaptic potentiation [GO:0060291]; protein homooligomerization [GO:0051260] cell-cell junction [GO:0005911]; cytoskeleton [GO:0005856]; dendrite membrane [GO:0032590]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic density membrane [GO:0098839]; Schaffer collateral - CA1 synapse [GO:0098685] PDZ domain binding [GO:0030165]; structural constituent of postsynaptic density [GO:0098919]; transmembrane transporter binding [GO:0044325] g10453.t1 Q6XDT4 40.58 138 1.86e-28 122.0 sp|Q6XDT4|IKZF_OIKDI Ikaros family zinc finger protein OS=Oikopleura dioica OX=34765 PE=2 SV=1 g10454.t1 O75962 51.204 789 0.0 806.0 sp|O75962|TRIO_HUMAN Triple functional domain protein OS=Homo sapiens OX=9606 GN=TRIO PE=1 SV=2 g10456.t1 Q1LUA6 57.681 690 0.0 797.0 sp|Q1LUA6|TRIO_DANRE Triple functional domain protein OS=Danio rerio OX=7955 GN=trio PE=3 SV=1 TRIO_DANRE reviewed Triple functional domain protein (EC 2.7.11.1) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0004674; GO:0005085; GO:0005524; GO:0005737; GO:0007411; GO:0019898; GO:0106310 axon guidance [GO:0007411] cytoplasm [GO:0005737]; extrinsic component of membrane [GO:0019898] ATP binding [GO:0005524]; guanyl-nucleotide exchange factor activity [GO:0005085]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g10456.t1 Q1LUA6 39.362 282 4.39e-57 214.0 sp|Q1LUA6|TRIO_DANRE Triple functional domain protein OS=Danio rerio OX=7955 GN=trio PE=3 SV=1 TRIO_DANRE reviewed Triple functional domain protein (EC 2.7.11.1) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0004674; GO:0005085; GO:0005524; GO:0005737; GO:0007411; GO:0019898; GO:0106310 axon guidance [GO:0007411] cytoplasm [GO:0005737]; extrinsic component of membrane [GO:0019898] ATP binding [GO:0005524]; guanyl-nucleotide exchange factor activity [GO:0005085]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g10456.t1 Q1LUA6 24.297 391 5.1800000000000005e-27 122.0 sp|Q1LUA6|TRIO_DANRE Triple functional domain protein OS=Danio rerio OX=7955 GN=trio PE=3 SV=1 TRIO_DANRE reviewed Triple functional domain protein (EC 2.7.11.1) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0004674; GO:0005085; GO:0005524; GO:0005737; GO:0007411; GO:0019898; GO:0106310 axon guidance [GO:0007411] cytoplasm [GO:0005737]; extrinsic component of membrane [GO:0019898] ATP binding [GO:0005524]; guanyl-nucleotide exchange factor activity [GO:0005085]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g10457.t1 P97924 41.481 675 8.57e-143 495.0 sp|P97924|KALRN_RAT Kalirin OS=Rattus norvegicus OX=10116 GN=Kalrn PE=1 SV=3 g10457.t1 P97924 51.327 339 8.29e-97 352.0 sp|P97924|KALRN_RAT Kalirin OS=Rattus norvegicus OX=10116 GN=Kalrn PE=1 SV=3 g10457.t1 P97924 34.268 321 3.3199999999999996e-45 184.0 sp|P97924|KALRN_RAT Kalirin OS=Rattus norvegicus OX=10116 GN=Kalrn PE=1 SV=3 g10457.t2 P97924 41.481 675 1.5899999999999999e-142 494.0 sp|P97924|KALRN_RAT Kalirin OS=Rattus norvegicus OX=10116 GN=Kalrn PE=1 SV=3 g10457.t2 P97924 51.327 339 1.2e-96 352.0 sp|P97924|KALRN_RAT Kalirin OS=Rattus norvegicus OX=10116 GN=Kalrn PE=1 SV=3 g10457.t2 P97924 34.268 321 4.0599999999999997e-45 184.0 sp|P97924|KALRN_RAT Kalirin OS=Rattus norvegicus OX=10116 GN=Kalrn PE=1 SV=3 g10457.t3 P97924 41.481 675 1.67e-142 495.0 sp|P97924|KALRN_RAT Kalirin OS=Rattus norvegicus OX=10116 GN=Kalrn PE=1 SV=3 g10457.t3 P97924 51.327 339 9.29e-97 352.0 sp|P97924|KALRN_RAT Kalirin OS=Rattus norvegicus OX=10116 GN=Kalrn PE=1 SV=3 g10457.t3 P97924 34.268 321 3.61e-45 184.0 sp|P97924|KALRN_RAT Kalirin OS=Rattus norvegicus OX=10116 GN=Kalrn PE=1 SV=3 g10457.t4 P97924 41.481 675 1.36e-142 495.0 sp|P97924|KALRN_RAT Kalirin OS=Rattus norvegicus OX=10116 GN=Kalrn PE=1 SV=3 g10457.t4 P97924 51.327 339 9.92e-97 352.0 sp|P97924|KALRN_RAT Kalirin OS=Rattus norvegicus OX=10116 GN=Kalrn PE=1 SV=3 g10457.t4 P97924 34.268 321 3.7e-45 184.0 sp|P97924|KALRN_RAT Kalirin OS=Rattus norvegicus OX=10116 GN=Kalrn PE=1 SV=3 g10458.t1 Q8BUG5 36.015 522 9.99e-96 308.0 sp|Q8BUG5|CAYP2_MOUSE Calcyphosin-2 OS=Mus musculus OX=10090 GN=Caps2 PE=2 SV=2 g10459.t1 Q5T440 45.246 305 1.06e-70 228.0 sp|Q5T440|CAF17_HUMAN Iron-sulfur cluster assembly factor IBA57, mitochondrial OS=Homo sapiens OX=9606 GN=IBA57 PE=1 SV=1 CAF17_HUMAN reviewed Iron-sulfur cluster assembly factor IBA57, mitochondrial (Iron-sulfur cluster assembly factor homolog) Homo sapiens (Human) GO:0003723; GO:0005739; GO:0005759; GO:0006783; GO:0016226 heme biosynthetic process [GO:0006783]; iron-sulfur cluster assembly [GO:0016226] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] RNA binding [GO:0003723] g10465.t1 Q8N184 44.242 165 2.49e-31 134.0 sp|Q8N184|ZN567_HUMAN Zinc finger protein 567 OS=Homo sapiens OX=9606 GN=ZNF567 PE=1 SV=3 g10465.t1 Q8N184 41.935 155 1.03e-25 116.0 sp|Q8N184|ZN567_HUMAN Zinc finger protein 567 OS=Homo sapiens OX=9606 GN=ZNF567 PE=1 SV=3 g10465.t1 Q8N184 36.788 193 1.94e-25 115.0 sp|Q8N184|ZN567_HUMAN Zinc finger protein 567 OS=Homo sapiens OX=9606 GN=ZNF567 PE=1 SV=3 g10465.t1 Q8N184 40.136 147 1.93e-23 109.0 sp|Q8N184|ZN567_HUMAN Zinc finger protein 567 OS=Homo sapiens OX=9606 GN=ZNF567 PE=1 SV=3 g10465.t1 Q8N184 39.333 150 2.9700000000000003e-21 102.0 sp|Q8N184|ZN567_HUMAN Zinc finger protein 567 OS=Homo sapiens OX=9606 GN=ZNF567 PE=1 SV=3 g10466.t1 Q9BYK8 41.652 557 8.18e-118 390.0 sp|Q9BYK8|HELZ2_HUMAN 3'-5' exoribonuclease HELZ2 OS=Homo sapiens OX=9606 GN=HELZ2 PE=1 SV=7 HELZ2_HUMAN reviewed 3'-5' exoribonuclease HELZ2 (EC 3.1.13.1) (ATP-dependent RNA helicase PRIC285) (EC 3.6.4.13) (Helicase with zinc finger 2, transcriptional coactivator) (Helicase with zinc finger domain 2) (PPAR-alpha-interacting complex protein 285) (PPAR-gamma DNA-binding domain-interacting protein 1) (PDIP1) (PPAR-gamma DBD-interacting protein 1) (Peroxisomal proliferator-activated receptor A-interacting complex 285 kDa protein) Homo sapiens (Human) GO:0003677; GO:0003713; GO:0003723; GO:0003724; GO:0005524; GO:0005654; GO:0005737; GO:0005829; GO:0008270; GO:0008859; GO:0016020; GO:0016887; GO:0035194; GO:0043186; GO:0045944 positive regulation of transcription by RNA polymerase II [GO:0045944]; regulatory ncRNA-mediated post-transcriptional gene silencing [GO:0035194] cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; P granule [GO:0043186] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA binding [GO:0003677]; exoribonuclease II activity [GO:0008859]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; transcription coactivator activity [GO:0003713]; zinc ion binding [GO:0008270] g10467.t1 E9QAM5 28.247 2025 2.45e-177 614.0 sp|E9QAM5|HELZ2_MOUSE 3'-5' exoribonuclease HELZ2 OS=Mus musculus OX=10090 GN=Helz2 PE=1 SV=1 g10467.t1 E9QAM5 29.193 322 6.229999999999999e-23 112.0 sp|E9QAM5|HELZ2_MOUSE 3'-5' exoribonuclease HELZ2 OS=Mus musculus OX=10090 GN=Helz2 PE=1 SV=1 g10468.t1 Q6NYU2 38.918 776 2.53e-143 500.0 sp|Q6NYU2|HELZ_DANRE Probable helicase with zinc finger domain OS=Danio rerio OX=7955 GN=helz PE=2 SV=1 HELZ_DANRE reviewed ATP-dependent RNA helicase with zinc finger domain (EC 3.6.4.13) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0003677; GO:0003700; GO:0003723; GO:0004386; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0008270; GO:0008284; GO:0016787; GO:0017148; GO:0035194; GO:0043186; GO:1900153 negative regulation of translation [GO:0017148]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; regulatory ncRNA-mediated post-transcriptional gene silencing [GO:0035194] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; P granule [GO:0043186] ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; helicase activity [GO:0004386]; hydrolase activity [GO:0016787]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270] g10469.t1 Q9BYK8 42.71 487 1.27e-114 375.0 sp|Q9BYK8|HELZ2_HUMAN 3'-5' exoribonuclease HELZ2 OS=Homo sapiens OX=9606 GN=HELZ2 PE=1 SV=7 HELZ2_HUMAN reviewed 3'-5' exoribonuclease HELZ2 (EC 3.1.13.1) (ATP-dependent RNA helicase PRIC285) (EC 3.6.4.13) (Helicase with zinc finger 2, transcriptional coactivator) (Helicase with zinc finger domain 2) (PPAR-alpha-interacting complex protein 285) (PPAR-gamma DNA-binding domain-interacting protein 1) (PDIP1) (PPAR-gamma DBD-interacting protein 1) (Peroxisomal proliferator-activated receptor A-interacting complex 285 kDa protein) Homo sapiens (Human) GO:0003677; GO:0003713; GO:0003723; GO:0003724; GO:0005524; GO:0005654; GO:0005737; GO:0005829; GO:0008270; GO:0008859; GO:0016020; GO:0016887; GO:0035194; GO:0043186; GO:0045944 positive regulation of transcription by RNA polymerase II [GO:0045944]; regulatory ncRNA-mediated post-transcriptional gene silencing [GO:0035194] cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; P granule [GO:0043186] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA binding [GO:0003677]; exoribonuclease II activity [GO:0008859]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; transcription coactivator activity [GO:0003713]; zinc ion binding [GO:0008270] g10471.t1 Q6NYU2 34.334 999 1.87e-140 491.0 sp|Q6NYU2|HELZ_DANRE Probable helicase with zinc finger domain OS=Danio rerio OX=7955 GN=helz PE=2 SV=1 HELZ_DANRE reviewed ATP-dependent RNA helicase with zinc finger domain (EC 3.6.4.13) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0003677; GO:0003700; GO:0003723; GO:0004386; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0008270; GO:0008284; GO:0016787; GO:0017148; GO:0035194; GO:0043186; GO:1900153 negative regulation of translation [GO:0017148]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; regulatory ncRNA-mediated post-transcriptional gene silencing [GO:0035194] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; P granule [GO:0043186] ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; helicase activity [GO:0004386]; hydrolase activity [GO:0016787]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270] g10473.t1 Q9JLB4 27.287 623 1.7600000000000001e-29 133.0 sp|Q9JLB4|CUBN_MOUSE Cubilin OS=Mus musculus OX=10090 GN=Cubn PE=1 SV=3 CUBN_MOUSE reviewed Cubilin (Intrinsic factor-cobalamin receptor) Mus musculus (Mouse) GO:0001701; GO:0005509; GO:0005737; GO:0005765; GO:0005768; GO:0005783; GO:0005794; GO:0005798; GO:0005903; GO:0005905; GO:0006898; GO:0007584; GO:0008203; GO:0009617; GO:0015889; GO:0016020; GO:0016324; GO:0020028; GO:0030135; GO:0030139; GO:0030492; GO:0030666; GO:0031419; GO:0031526; GO:0031528; GO:0032991; GO:0038023; GO:0038024; GO:0042366; GO:0042802; GO:0042803; GO:0042953; GO:0043202; GO:0043235; GO:0045177; GO:0070062 cholesterol metabolic process [GO:0008203]; cobalamin catabolic process [GO:0042366]; cobalamin transport [GO:0015889]; endocytic hemoglobin import into cell [GO:0020028]; in utero embryonic development [GO:0001701]; lipoprotein transport [GO:0042953]; receptor-mediated endocytosis [GO:0006898]; response to bacterium [GO:0009617]; response to nutrient [GO:0007584] apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; brush border [GO:0005903]; brush border membrane [GO:0031526]; clathrin-coated pit [GO:0005905]; coated vesicle [GO:0030135]; cytoplasm [GO:0005737]; endocytic vesicle [GO:0030139]; endocytic vesicle membrane [GO:0030666]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi-associated vesicle [GO:0005798]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; microvillus membrane [GO:0031528]; protein-containing complex [GO:0032991]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; cargo receptor activity [GO:0038024]; cobalamin binding [GO:0031419]; hemoglobin binding [GO:0030492]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023] g10475.t1 Q6ZTW0 34.483 261 6.19e-33 124.0 sp|Q6ZTW0|TPGS1_HUMAN Tubulin polyglutamylase complex subunit 1 OS=Homo sapiens OX=9606 GN=TPGS1 PE=1 SV=2 TPGS1_HUMAN reviewed Tubulin polyglutamylase complex subunit 1 (PGs1) Homo sapiens (Human) GO:0005813; GO:0005815; GO:0005874; GO:0005930; GO:0007268; GO:0007288; GO:0008017; GO:0030424; GO:0030425; GO:0030534; GO:0034451; GO:0045202; GO:0051648; GO:0070740 adult behavior [GO:0030534]; chemical synaptic transmission [GO:0007268]; sperm axoneme assembly [GO:0007288]; vesicle localization [GO:0051648] axon [GO:0030424]; axoneme [GO:0005930]; centriolar satellite [GO:0034451]; centrosome [GO:0005813]; dendrite [GO:0030425]; microtubule [GO:0005874]; microtubule organizing center [GO:0005815]; synapse [GO:0045202] microtubule binding [GO:0008017]; tubulin-glutamic acid ligase activity [GO:0070740] g10476.t1 O18992 31.278 454 1.5200000000000001e-58 204.0 sp|O18992|CP2DJ_CALJA Cytochrome P450 2D19 OS=Callithrix jacchus OX=9483 GN=CYP2D19 PE=2 SV=1 g10477.t1 Q5U3N0 36.612 549 5.43e-99 311.0 sp|Q5U3N0|PKHA8_DANRE Pleckstrin homology domain-containing family A member 8 OS=Danio rerio OX=7955 GN=plekha8 PE=2 SV=1 g10479.t1 Q99615 56.463 441 1.26e-160 468.0 sp|Q99615|DNJC7_HUMAN DnaJ homolog subfamily C member 7 OS=Homo sapiens OX=9606 GN=DNAJC7 PE=1 SV=2 DNJC7_HUMAN reviewed DnaJ homolog subfamily C member 7 (Tetratricopeptide repeat protein 2) (TPR repeat protein 2) Homo sapiens (Human) GO:0001671; GO:0005654; GO:0005737; GO:0005829; GO:0005856; GO:0006457; GO:0016020; GO:0031072; GO:0070062; GO:1900034 protein folding [GO:0006457]; regulation of cellular response to heat [GO:1900034] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleoplasm [GO:0005654] ATPase activator activity [GO:0001671]; heat shock protein binding [GO:0031072] g10480.t1 Q91W82 76.374 182 6.54e-98 286.0 sp|Q91W82|UB2E2_MOUSE Ubiquitin-conjugating enzyme E2 E2 OS=Mus musculus OX=10090 GN=Ube2e2 PE=2 SV=1 g10481.t1 A4FV48 49.051 316 6.5e-84 262.0 sp|A4FV48|FADS2_BOVIN Acyl-CoA 6-desaturase OS=Bos taurus OX=9913 GN=FADS2 PE=2 SV=1 FADS2_BOVIN reviewed Acyl-CoA 6-desaturase (EC 1.14.19.3) (Delta(6) fatty acid desaturase) (D6D) (Delta(6) desaturase) (Delta-6 desaturase) (Fatty acid desaturase 2) Bos taurus (Bovine) GO:0004768; GO:0005789; GO:0006629; GO:0006636; GO:0016020; GO:0016213; GO:0016717; GO:0036109; GO:0042759; GO:0043651; GO:1901570 alpha-linolenic acid metabolic process [GO:0036109]; fatty acid derivative biosynthetic process [GO:1901570]; linoleic acid metabolic process [GO:0043651]; lipid metabolic process [GO:0006629]; long-chain fatty acid biosynthetic process [GO:0042759]; unsaturated fatty acid biosynthetic process [GO:0006636] endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020] acyl-CoA 6-desaturase activity [GO:0016213]; oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water [GO:0016717]; stearoyl-CoA 9-desaturase activity [GO:0004768] g10481.t2 A4FV48 45.994 337 9.700000000000001e-79 250.0 sp|A4FV48|FADS2_BOVIN Acyl-CoA 6-desaturase OS=Bos taurus OX=9913 GN=FADS2 PE=2 SV=1 FADS2_BOVIN reviewed Acyl-CoA 6-desaturase (EC 1.14.19.3) (Delta(6) fatty acid desaturase) (D6D) (Delta(6) desaturase) (Delta-6 desaturase) (Fatty acid desaturase 2) Bos taurus (Bovine) GO:0004768; GO:0005789; GO:0006629; GO:0006636; GO:0016020; GO:0016213; GO:0016717; GO:0036109; GO:0042759; GO:0043651; GO:1901570 alpha-linolenic acid metabolic process [GO:0036109]; fatty acid derivative biosynthetic process [GO:1901570]; linoleic acid metabolic process [GO:0043651]; lipid metabolic process [GO:0006629]; long-chain fatty acid biosynthetic process [GO:0042759]; unsaturated fatty acid biosynthetic process [GO:0006636] endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020] acyl-CoA 6-desaturase activity [GO:0016213]; oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water [GO:0016717]; stearoyl-CoA 9-desaturase activity [GO:0004768] g10482.t1 O60427 72.727 99 2.7799999999999997e-46 156.0 sp|O60427|FADS1_HUMAN Acyl-CoA (8-3)-desaturase OS=Homo sapiens OX=9606 GN=FADS1 PE=1 SV=3 FADS1_HUMAN reviewed Acyl-CoA (8-3)-desaturase (EC 1.14.19.44) (Delta(5) fatty acid desaturase) (D5D) (Delta(5) desaturase) (Delta-5 desaturase) (Fatty acid desaturase 1) Homo sapiens (Human) GO:0000248; GO:0005739; GO:0005789; GO:0006355; GO:0006629; GO:0006636; GO:0007267; GO:0008654; GO:0009267; GO:0016020; GO:0016213; GO:0016491; GO:0016717; GO:0036109; GO:0042759; GO:0043231; GO:0043651; GO:0045485; GO:0045595; GO:0046456; GO:0062076 alpha-linolenic acid metabolic process [GO:0036109]; cell-cell signaling [GO:0007267]; cellular response to starvation [GO:0009267]; icosanoid biosynthetic process [GO:0046456]; linoleic acid metabolic process [GO:0043651]; lipid metabolic process [GO:0006629]; long-chain fatty acid biosynthetic process [GO:0042759]; phospholipid biosynthetic process [GO:0008654]; regulation of cell differentiation [GO:0045595]; regulation of DNA-templated transcription [GO:0006355]; unsaturated fatty acid biosynthetic process [GO:0006636] endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; mitochondrion [GO:0005739] acyl-CoA (8-3)-desaturase activity [GO:0062076]; acyl-CoA 6-desaturase activity [GO:0016213]; C-5 sterol desaturase activity [GO:0000248]; omega-6 fatty acid desaturase activity [GO:0045485]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water [GO:0016717] g10483.t1 B2KKL4 48.459 357 1.3199999999999999e-113 343.0 sp|B2KKL4|FAD1_SIGCA Acyl-CoA Delta-6 desaturase OS=Siganus canaliculatus OX=75042 GN=fad1 PE=1 SV=2 g10484.t1 P13233 27.04 429 1.66e-44 164.0 sp|P13233|CN37_RAT 2',3'-cyclic-nucleotide 3'-phosphodiesterase OS=Rattus norvegicus OX=10116 GN=Cnp PE=1 SV=2 CN37_RAT reviewed 2',3'-cyclic-nucleotide 3'-phosphodiesterase (CNP) (CNPase) (EC 3.1.4.37) Rattus norvegicus (Rat) GO:0003723; GO:0004113; GO:0005615; GO:0005737; GO:0005741; GO:0005743; GO:0005874; GO:0005902; GO:0007409; GO:0008344; GO:0009214; GO:0009636; GO:0016020; GO:0030551; GO:0030900; GO:0031143; GO:0032496; GO:0035748; GO:0035749; GO:0042470; GO:0042995; GO:0043209; GO:0046902; GO:0048471; GO:0048709 adult locomotory behavior [GO:0008344]; axonogenesis [GO:0007409]; cyclic nucleotide catabolic process [GO:0009214]; forebrain development [GO:0030900]; oligodendrocyte differentiation [GO:0048709]; regulation of mitochondrial membrane permeability [GO:0046902]; response to lipopolysaccharide [GO:0032496]; response to toxic substance [GO:0009636] cell projection [GO:0042995]; cytoplasm [GO:0005737]; extracellular space [GO:0005615]; melanosome [GO:0042470]; membrane [GO:0016020]; microtubule [GO:0005874]; microvillus [GO:0005902]; mitochondrial inner membrane [GO:0005743]; mitochondrial outer membrane [GO:0005741]; myelin sheath [GO:0043209]; myelin sheath abaxonal region [GO:0035748]; myelin sheath adaxonal region [GO:0035749]; perinuclear region of cytoplasm [GO:0048471]; pseudopodium [GO:0031143] 2',3'-cyclic-nucleotide 3'-phosphodiesterase activity [GO:0004113]; cyclic nucleotide binding [GO:0030551]; RNA binding [GO:0003723] g10485.t1 Q28EL0 67.541 305 1.82e-139 402.0 sp|Q28EL0|CCYL1_XENTR Cyclin-Y-like protein 1 OS=Xenopus tropicalis OX=8364 GN=ccnyl1 PE=2 SV=1 g10486.t1 A4FV48 50.441 454 9.52e-160 462.0 sp|A4FV48|FADS2_BOVIN Acyl-CoA 6-desaturase OS=Bos taurus OX=9913 GN=FADS2 PE=2 SV=1 FADS2_BOVIN reviewed Acyl-CoA 6-desaturase (EC 1.14.19.3) (Delta(6) fatty acid desaturase) (D6D) (Delta(6) desaturase) (Delta-6 desaturase) (Fatty acid desaturase 2) Bos taurus (Bovine) GO:0004768; GO:0005789; GO:0006629; GO:0006636; GO:0016020; GO:0016213; GO:0016717; GO:0036109; GO:0042759; GO:0043651; GO:1901570 alpha-linolenic acid metabolic process [GO:0036109]; fatty acid derivative biosynthetic process [GO:1901570]; linoleic acid metabolic process [GO:0043651]; lipid metabolic process [GO:0006629]; long-chain fatty acid biosynthetic process [GO:0042759]; unsaturated fatty acid biosynthetic process [GO:0006636] endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020] acyl-CoA 6-desaturase activity [GO:0016213]; oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water [GO:0016717]; stearoyl-CoA 9-desaturase activity [GO:0004768] g10488.t1 Q9EP82 56.618 136 2.83e-39 142.0 sp|Q9EP82|WDR4_MOUSE tRNA (guanine-N(7)-)-methyltransferase non-catalytic subunit WDR4 OS=Mus musculus OX=10090 GN=Wdr4 PE=1 SV=2 WDR4_MOUSE reviewed tRNA (guanine-N(7)-)-methyltransferase non-catalytic subunit WDR4 (Protein Wuho homolog) (mWH) (WD repeat-containing protein 4) Mus musculus (Mouse) GO:0005634; GO:0005654; GO:0005694; GO:0005829; GO:0006400; GO:0006974; GO:0008047; GO:0036416; GO:0043527; GO:0106004; GO:0106143; GO:0141106 DNA damage response [GO:0006974]; tRNA (guanine-N7)-methylation [GO:0106004]; tRNA modification [GO:0006400]; tRNA stabilization [GO:0036416] chromosome [GO:0005694]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; tRNA (m7G46) methyltransferase complex [GO:0106143]; tRNA methyltransferase complex [GO:0043527] enzyme activator activity [GO:0008047]; tRNA methyltransferase activator activity [GO:0141106] g10491.t1 Q8UVC3 58.711 574 0.0 681.0 sp|Q8UVC3|INVS_CHICK Inversin OS=Gallus gallus OX=9031 GN=INVS PE=2 SV=2 g10493.t1 Q66J74 42.117 463 7.74e-102 328.0 sp|Q66J74|TFP11_XENLA Tuftelin-interacting protein 11 OS=Xenopus laevis OX=8355 GN=tfip11 PE=2 SV=1 g10494.t1 Q5ZII9 47.842 278 2.81e-90 288.0 sp|Q5ZII9|TFP11_CHICK Tuftelin-interacting protein 11 OS=Gallus gallus OX=9031 GN=TFIP11 PE=2 SV=1 g10495.t1 Q5XG71 41.824 581 3.7899999999999997e-128 418.0 sp|Q5XG71|UTP20_MOUSE Small subunit processome component 20 homolog OS=Mus musculus OX=10090 GN=Utp20 PE=1 SV=2 UTP20_MOUSE reviewed Small subunit processome component 20 homolog (Down-regulated in metastasis protein) Mus musculus (Mouse) GO:0005730; GO:0005886; GO:0006364; GO:0030686; GO:0032040; GO:0042274 ribosomal small subunit biogenesis [GO:0042274]; rRNA processing [GO:0006364] 90S preribosome [GO:0030686]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; small-subunit processome [GO:0032040] g10496.t1 O75691 37.701 2236 0.0 1303.0 sp|O75691|UTP20_HUMAN Small subunit processome component 20 homolog OS=Homo sapiens OX=9606 GN=UTP20 PE=1 SV=3 UTP20_HUMAN reviewed Small subunit processome component 20 homolog (Down-regulated in metastasis protein) (Novel nucleolar protein 73) (NNP73) (Protein Key-1A6) Homo sapiens (Human) GO:0000447; GO:0000472; GO:0000480; GO:0003723; GO:0005654; GO:0005730; GO:0005737; GO:0005886; GO:0006364; GO:0008285; GO:0030686; GO:0030688; GO:0032040; GO:0042274 endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000480]; endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000447]; endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000472]; negative regulation of cell population proliferation [GO:0008285]; ribosomal small subunit biogenesis [GO:0042274]; rRNA processing [GO:0006364] 90S preribosome [GO:0030686]; cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; preribosome, small subunit precursor [GO:0030688]; small-subunit processome [GO:0032040] RNA binding [GO:0003723] g10497.t1 D4ABH7 38.976 254 5.54e-50 168.0 sp|D4ABH7|BN3D2_RAT RNA 5'-monophosphate methyltransferase OS=Rattus norvegicus OX=10116 GN=Bcdin3d PE=3 SV=1 BN3D2_RAT reviewed RNA 5'-monophosphate methyltransferase (EC 2.1.1.-) (BCDIN3 domain-containing protein) Rattus norvegicus (Rat) GO:0001510; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0008171; GO:0008173; GO:0008175; GO:0030488; GO:0031054; GO:0070883; GO:0090486; GO:2000632 negative regulation of pre-miRNA processing [GO:2000632]; pre-miRNA processing [GO:0031054]; RNA methylation [GO:0001510]; tRNA methylation [GO:0030488] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] O-methyltransferase activity [GO:0008171]; pre-miRNA binding [GO:0070883]; RNA methyltransferase activity [GO:0008173]; small RNA 2'-O-methyltransferase activity [GO:0090486]; tRNA methyltransferase activity [GO:0008175] g10498.t1 Q15042 48.654 1077 0.0 936.0 sp|Q15042|RB3GP_HUMAN Rab3 GTPase-activating protein catalytic subunit OS=Homo sapiens OX=9606 GN=RAB3GAP1 PE=1 SV=3 g10499.t1 Q99KV1 66.949 354 1.68e-168 476.0 sp|Q99KV1|DJB11_MOUSE DnaJ homolog subfamily B member 11 OS=Mus musculus OX=10090 GN=Dnajb11 PE=1 SV=1 g10500.t1 P98157 39.815 648 2.26e-134 440.0 sp|P98157|LRP1_CHICK Low-density lipoprotein receptor-related protein 1 OS=Gallus gallus OX=9031 GN=LRP1 PE=2 SV=1 g10500.t1 P98157 30.133 677 4.13e-75 268.0 sp|P98157|LRP1_CHICK Low-density lipoprotein receptor-related protein 1 OS=Gallus gallus OX=9031 GN=LRP1 PE=2 SV=1 g10500.t1 P98157 29.305 604 1.33e-64 236.0 sp|P98157|LRP1_CHICK Low-density lipoprotein receptor-related protein 1 OS=Gallus gallus OX=9031 GN=LRP1 PE=2 SV=1 g10500.t1 P98157 28.409 616 1.01e-54 207.0 sp|P98157|LRP1_CHICK Low-density lipoprotein receptor-related protein 1 OS=Gallus gallus OX=9031 GN=LRP1 PE=2 SV=1 g10500.t1 P98157 28.226 496 3.53e-41 166.0 sp|P98157|LRP1_CHICK Low-density lipoprotein receptor-related protein 1 OS=Gallus gallus OX=9031 GN=LRP1 PE=2 SV=1 g10500.t1 P98157 27.146 501 3.53e-41 166.0 sp|P98157|LRP1_CHICK Low-density lipoprotein receptor-related protein 1 OS=Gallus gallus OX=9031 GN=LRP1 PE=2 SV=1 g10500.t1 P98157 27.247 356 4.96e-24 112.0 sp|P98157|LRP1_CHICK Low-density lipoprotein receptor-related protein 1 OS=Gallus gallus OX=9031 GN=LRP1 PE=2 SV=1 g10501.t1 O73925 46.269 536 2.13e-136 414.0 sp|O73925|KCNQ1_SQUAC Potassium voltage-gated channel subfamily KQT member 1 OS=Squalus acanthias OX=7797 GN=KCNQ1 PE=2 SV=1 g10504.t1 Q5FWK3 46.883 369 1.56e-115 351.0 sp|Q5FWK3|RHG01_MOUSE Rho GTPase-activating protein 1 OS=Mus musculus OX=10090 GN=Arhgap1 PE=1 SV=1 RHG01_MOUSE reviewed Rho GTPase-activating protein 1 (Rho-type GTPase-activating protein 1) Mus musculus (Mouse) GO:0001726; GO:0005096; GO:0005737; GO:0005829; GO:0005886; GO:0005929; GO:0007264; GO:0010008; GO:0016197; GO:0017124; GO:0031252; GO:0031267; GO:0033572; GO:0048471; GO:0097443; GO:2001136 endosomal transport [GO:0016197]; negative regulation of endocytic recycling [GO:2001136]; small GTPase-mediated signal transduction [GO:0007264]; transferrin transport [GO:0033572] cell leading edge [GO:0031252]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; sorting endosome [GO:0097443] GTPase activator activity [GO:0005096]; SH3 domain binding [GO:0017124]; small GTPase binding [GO:0031267] g10505.t1 Q7ZUG0 87.059 85 7.41e-51 157.0 sp|Q7ZUG0|RUXE_DANRE Small nuclear ribonucleoprotein E OS=Danio rerio OX=7955 GN=snrpe PE=3 SV=1 RUXE_DANRE reviewed Small nuclear ribonucleoprotein E (snRNP-E) (Sm protein E) (Sm-E) (SmE) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000387; GO:0000398; GO:0003723; GO:0005634; GO:0005682; GO:0005684; GO:0005685; GO:0005686; GO:0005687; GO:0005829; GO:0034709; GO:0034715; GO:0034719; GO:0046540; GO:0071005; GO:0071007; GO:0071011 mRNA splicing, via spliceosome [GO:0000398]; spliceosomal snRNP assembly [GO:0000387] cytosol [GO:0005829]; methylosome [GO:0034709]; nucleus [GO:0005634]; pICln-Sm protein complex [GO:0034715]; precatalytic spliceosome [GO:0071011]; SMN-Sm protein complex [GO:0034719]; U1 snRNP [GO:0005685]; U2 snRNP [GO:0005686]; U2-type catalytic step 2 spliceosome [GO:0071007]; U2-type precatalytic spliceosome [GO:0071005]; U2-type spliceosomal complex [GO:0005684]; U4 snRNP [GO:0005687]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682] RNA binding [GO:0003723] g10506.t1 Q6P1E8 26.91 301 1.92e-21 105.0 sp|Q6P1E8|EFCB6_MOUSE EF-hand calcium-binding domain-containing protein 6 OS=Mus musculus OX=10090 GN=Efcab6 PE=1 SV=2 EFCB6_MOUSE reviewed EF-hand calcium-binding domain-containing protein 6 (DJ-1-binding protein) (DJBP) Mus musculus (Mouse) GO:0005509; GO:0005654; GO:0030317; GO:0036126; GO:0160111 flagellated sperm motility [GO:0030317] axonemal A tubule inner sheath [GO:0160111]; nucleoplasm [GO:0005654]; sperm flagellum [GO:0036126] calcium ion binding [GO:0005509] g10507.t1 A6QNK1 36.599 347 5.0499999999999995e-67 229.0 sp|A6QNK1|G3ST1_BOVIN Galactosylceramide sulfotransferase OS=Bos taurus OX=9913 GN=GAL3ST1 PE=2 SV=1 G3ST1_BOVIN reviewed Galactosylceramide sulfotransferase (GalCer sulfotransferase) (EC 2.8.2.11) (3'-phosphoadenosine-5'-phosphosulfate:GalCer sulfotransferase) (3'-phosphoadenylylsulfate:galactosylceramide 3'-sulfotransferase) (Cerebroside sulfotransferase) Bos taurus (Bovine) GO:0000139; GO:0001733; GO:0006665; GO:0006681; GO:0006682; GO:0042552; GO:0046486 galactosylceramide biosynthetic process [GO:0006682]; galactosylceramide metabolic process [GO:0006681]; glycerolipid metabolic process [GO:0046486]; myelination [GO:0042552]; sphingolipid metabolic process [GO:0006665] Golgi membrane [GO:0000139] galactosylceramide sulfotransferase activity [GO:0001733] g10508.t1 A6QNK1 36.228 334 1.12e-66 223.0 sp|A6QNK1|G3ST1_BOVIN Galactosylceramide sulfotransferase OS=Bos taurus OX=9913 GN=GAL3ST1 PE=2 SV=1 G3ST1_BOVIN reviewed Galactosylceramide sulfotransferase (GalCer sulfotransferase) (EC 2.8.2.11) (3'-phosphoadenosine-5'-phosphosulfate:GalCer sulfotransferase) (3'-phosphoadenylylsulfate:galactosylceramide 3'-sulfotransferase) (Cerebroside sulfotransferase) Bos taurus (Bovine) GO:0000139; GO:0001733; GO:0006665; GO:0006681; GO:0006682; GO:0042552; GO:0046486 galactosylceramide biosynthetic process [GO:0006682]; galactosylceramide metabolic process [GO:0006681]; glycerolipid metabolic process [GO:0046486]; myelination [GO:0042552]; sphingolipid metabolic process [GO:0006665] Golgi membrane [GO:0000139] galactosylceramide sulfotransferase activity [GO:0001733] g10509.t1 Q791V5 43.103 232 2.89e-62 199.0 sp|Q791V5|MTCH2_MOUSE Mitochondrial carrier homolog 2 OS=Mus musculus OX=10090 GN=Mtch2 PE=1 SV=1 MTCH2_MOUSE reviewed Mitochondrial carrier homolog 2 (Met-induced mitochondrial protein) Mus musculus (Mouse) GO:0005739; GO:0005741; GO:0005743; GO:0006089; GO:0010635; GO:0010917; GO:0016020; GO:0032977; GO:0035701; GO:0042775; GO:0043065; GO:0045040; GO:0045820; GO:0055088; GO:0061484; GO:0070585; GO:0071478; GO:0090152; GO:0097284; GO:1902108; GO:1902231; GO:2000738 cellular response to radiation [GO:0071478]; establishment of protein localization to mitochondrial membrane involved in mitochondrial fission [GO:0090152]; hematopoietic stem cell homeostasis [GO:0061484]; hematopoietic stem cell migration [GO:0035701]; hepatocyte apoptotic process [GO:0097284]; lactate metabolic process [GO:0006089]; lipid homeostasis [GO:0055088]; mitochondrial ATP synthesis coupled electron transport [GO:0042775]; negative regulation of glycolytic process [GO:0045820]; negative regulation of mitochondrial membrane potential [GO:0010917]; positive regulation of apoptotic process [GO:0043065]; positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage [GO:1902231]; positive regulation of stem cell differentiation [GO:2000738]; protein insertion into mitochondrial outer membrane [GO:0045040]; protein localization to mitochondrion [GO:0070585]; regulation of mitochondrial fusion [GO:0010635]; regulation of mitochondrial membrane permeability involved in apoptotic process [GO:1902108] membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739] membrane insertase activity [GO:0032977] g10511.t1 Q8AVJ1 48.148 189 3.26e-43 157.0 sp|Q8AVJ1|PRR5_XENLA Proline-rich protein 5 OS=Xenopus laevis OX=8355 GN=prr5 PE=2 SV=1 g10512.t1 Q801F8 59.701 67 9.02e-23 100.0 sp|Q801F8|DMRT1_ORYLA Doublesex- and mab-3-related transcription factor 1 OS=Oryzias latipes OX=8090 GN=dmrt1 PE=2 SV=1 g10513.t1 Q96BA8 58.333 156 1.3199999999999999e-48 179.0 sp|Q96BA8|CR3L1_HUMAN Cyclic AMP-responsive element-binding protein 3-like protein 1 OS=Homo sapiens OX=9606 GN=CREB3L1 PE=1 SV=1 g10514.t1 E9Q8T7 62.845 2285 0.0 2819.0 sp|E9Q8T7|DYH1_MOUSE Dynein axonemal heavy chain 1 OS=Mus musculus OX=10090 GN=Dnah1 PE=1 SV=1 DYH1_MOUSE reviewed Dynein axonemal heavy chain 1 (Axonemal beta dynein heavy chain 1) (Ciliary dynein heavy chain 1) (mDHC7) Mus musculus (Mouse) GO:0003351; GO:0003777; GO:0005524; GO:0005576; GO:0005874; GO:0005930; GO:0007288; GO:0008569; GO:0030286; GO:0030317; GO:0036126; GO:0036156; GO:0036159; GO:0045505; GO:0051959; GO:0060294 cilium movement involved in cell motility [GO:0060294]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; flagellated sperm motility [GO:0030317]; inner dynein arm assembly [GO:0036159]; sperm axoneme assembly [GO:0007288] axoneme [GO:0005930]; dynein complex [GO:0030286]; extracellular region [GO:0005576]; inner dynein arm [GO:0036156]; microtubule [GO:0005874]; sperm flagellum [GO:0036126] ATP binding [GO:0005524]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]; minus-end-directed microtubule motor activity [GO:0008569] g10514.t2 E9Q8T7 63.388 2267 0.0 2821.0 sp|E9Q8T7|DYH1_MOUSE Dynein axonemal heavy chain 1 OS=Mus musculus OX=10090 GN=Dnah1 PE=1 SV=1 DYH1_MOUSE reviewed Dynein axonemal heavy chain 1 (Axonemal beta dynein heavy chain 1) (Ciliary dynein heavy chain 1) (mDHC7) Mus musculus (Mouse) GO:0003351; GO:0003777; GO:0005524; GO:0005576; GO:0005874; GO:0005930; GO:0007288; GO:0008569; GO:0030286; GO:0030317; GO:0036126; GO:0036156; GO:0036159; GO:0045505; GO:0051959; GO:0060294 cilium movement involved in cell motility [GO:0060294]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; flagellated sperm motility [GO:0030317]; inner dynein arm assembly [GO:0036159]; sperm axoneme assembly [GO:0007288] axoneme [GO:0005930]; dynein complex [GO:0030286]; extracellular region [GO:0005576]; inner dynein arm [GO:0036156]; microtubule [GO:0005874]; sperm flagellum [GO:0036126] ATP binding [GO:0005524]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]; minus-end-directed microtubule motor activity [GO:0008569] g10515.t1 E9Q8T7 67.358 1253 0.0 1707.0 sp|E9Q8T7|DYH1_MOUSE Dynein axonemal heavy chain 1 OS=Mus musculus OX=10090 GN=Dnah1 PE=1 SV=1 DYH1_MOUSE reviewed Dynein axonemal heavy chain 1 (Axonemal beta dynein heavy chain 1) (Ciliary dynein heavy chain 1) (mDHC7) Mus musculus (Mouse) GO:0003351; GO:0003777; GO:0005524; GO:0005576; GO:0005874; GO:0005930; GO:0007288; GO:0008569; GO:0030286; GO:0030317; GO:0036126; GO:0036156; GO:0036159; GO:0045505; GO:0051959; GO:0060294 cilium movement involved in cell motility [GO:0060294]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; flagellated sperm motility [GO:0030317]; inner dynein arm assembly [GO:0036159]; sperm axoneme assembly [GO:0007288] axoneme [GO:0005930]; dynein complex [GO:0030286]; extracellular region [GO:0005576]; inner dynein arm [GO:0036156]; microtubule [GO:0005874]; sperm flagellum [GO:0036126] ATP binding [GO:0005524]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]; minus-end-directed microtubule motor activity [GO:0008569] g10516.t1 Q9P2D7 72.426 573 0.0 898.0 sp|Q9P2D7|DYH1_HUMAN Dynein axonemal heavy chain 1 OS=Homo sapiens OX=9606 GN=DNAH1 PE=1 SV=6 DYH1_HUMAN reviewed Dynein axonemal heavy chain 1 (Axonemal beta dynein heavy chain 1) (Ciliary dynein heavy chain 1) (Heat shock regulated protein 1) (HSRF-1) (hDHC7) Homo sapiens (Human) GO:0003351; GO:0003777; GO:0005524; GO:0005576; GO:0005858; GO:0005874; GO:0005930; GO:0007288; GO:0008569; GO:0030286; GO:0030317; GO:0036126; GO:0036156; GO:0036159; GO:0045505; GO:0051959; GO:0060285 cilium-dependent cell motility [GO:0060285]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; flagellated sperm motility [GO:0030317]; inner dynein arm assembly [GO:0036159]; sperm axoneme assembly [GO:0007288] axonemal dynein complex [GO:0005858]; axoneme [GO:0005930]; dynein complex [GO:0030286]; extracellular region [GO:0005576]; inner dynein arm [GO:0036156]; microtubule [GO:0005874]; sperm flagellum [GO:0036126] ATP binding [GO:0005524]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]; minus-end-directed microtubule motor activity [GO:0008569] g10517.t1 Q9UQF2 48.81 252 2.2800000000000002e-79 266.0 sp|Q9UQF2|JIP1_HUMAN C-Jun-amino-terminal kinase-interacting protein 1 OS=Homo sapiens OX=9606 GN=MAPK8IP1 PE=1 SV=1 JIP1_HUMAN reviewed C-Jun-amino-terminal kinase-interacting protein 1 (JIP-1) (JNK-interacting protein 1) (Islet-brain 1) (IB-1) (JNK MAP kinase scaffold protein 1) (Mitogen-activated protein kinase 8-interacting protein 1) Homo sapiens (Human) GO:0004860; GO:0005078; GO:0005634; GO:0005737; GO:0005789; GO:0005829; GO:0005886; GO:0006355; GO:0007254; GO:0008432; GO:0016192; GO:0019894; GO:0031434; GO:0031435; GO:0031966; GO:0043025; GO:0043508; GO:0044294; GO:0044295; GO:0044302; GO:0045202; GO:0046328; GO:0046330; GO:0048471; GO:2000564; GO:2001243 JNK cascade [GO:0007254]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of JUN kinase activity [GO:0043508]; positive regulation of JNK cascade [GO:0046330]; regulation of CD8-positive, alpha-beta T cell proliferation [GO:2000564]; regulation of DNA-templated transcription [GO:0006355]; regulation of JNK cascade [GO:0046328]; vesicle-mediated transport [GO:0016192] axonal growth cone [GO:0044295]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic growth cone [GO:0044294]; dentate gyrus mossy fiber [GO:0044302]; endoplasmic reticulum membrane [GO:0005789]; mitochondrial membrane [GO:0031966]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; synapse [GO:0045202] JUN kinase binding [GO:0008432]; kinesin binding [GO:0019894]; MAP-kinase scaffold activity [GO:0005078]; mitogen-activated protein kinase kinase binding [GO:0031434]; mitogen-activated protein kinase kinase kinase binding [GO:0031435]; protein kinase inhibitor activity [GO:0004860] g10518.t1 Q9ULM3 50.286 350 1.9e-93 337.0 sp|Q9ULM3|YETS2_HUMAN YEATS domain-containing protein 2 OS=Homo sapiens OX=9606 GN=YEATS2 PE=1 SV=2 g10518.t1 Q9ULM3 31.667 300 1.01e-37 159.0 sp|Q9ULM3|YETS2_HUMAN YEATS domain-containing protein 2 OS=Homo sapiens OX=9606 GN=YEATS2 PE=1 SV=2 g10524.t1 Q9BY84 55.319 282 2.88e-105 345.0 sp|Q9BY84|DUS16_HUMAN Dual specificity protein phosphatase 16 OS=Homo sapiens OX=9606 GN=DUSP16 PE=1 SV=1 g10525.t1 Q96HH6 46.906 307 8.34e-93 282.0 sp|Q96HH6|TMM19_HUMAN Transmembrane protein 19 OS=Homo sapiens OX=9606 GN=TMEM19 PE=1 SV=1 TMM19_HUMAN reviewed Transmembrane protein 19 Homo sapiens (Human) GO:0016020 membrane [GO:0016020] g10527.t1 Q4R646 50.052 963 0.0 936.0 sp|Q4R646|SYIM_MACFA Isoleucine--tRNA ligase, mitochondrial (Fragment) OS=Macaca fascicularis OX=9541 GN=IARS2 PE=2 SV=2 SYIM_MACFA reviewed Isoleucine--tRNA ligase, mitochondrial (EC 6.1.1.5) (Isoleucyl-tRNA synthetase) (IleRS) Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey) GO:0000049; GO:0002161; GO:0004822; GO:0005524; GO:0005759; GO:0006428; GO:0032543 isoleucyl-tRNA aminoacylation [GO:0006428]; mitochondrial translation [GO:0032543] mitochondrial matrix [GO:0005759] aminoacyl-tRNA deacylase activity [GO:0002161]; ATP binding [GO:0005524]; isoleucine-tRNA ligase activity [GO:0004822]; tRNA binding [GO:0000049] g10528.t1 Q08DK4 56.322 261 7.33e-97 291.0 sp|Q08DK4|GHC1_BOVIN Mitochondrial glutamate carrier 1 OS=Bos taurus OX=9913 GN=SLC25A22 PE=2 SV=1 g10528.t2 Q08DK4 56.202 258 5.34e-95 287.0 sp|Q08DK4|GHC1_BOVIN Mitochondrial glutamate carrier 1 OS=Bos taurus OX=9913 GN=SLC25A22 PE=2 SV=1 g10529.t1 Q4R761 56.195 226 1.82e-69 214.0 sp|Q4R761|VATE1_MACFA V-type proton ATPase subunit E 1 OS=Macaca fascicularis OX=9541 GN=ATP6V1E1 PE=2 SV=1 VATE1_MACFA reviewed V-type proton ATPase subunit E 1 (V-ATPase subunit E 1) (Vacuolar proton pump subunit E 1) Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey) GO:0000221; GO:0005768; GO:0005829; GO:0016324; GO:0030665; GO:0030672; GO:0046961 apical plasma membrane [GO:0016324]; clathrin-coated vesicle membrane [GO:0030665]; cytosol [GO:0005829]; endosome [GO:0005768]; synaptic vesicle membrane [GO:0030672]; vacuolar proton-transporting V-type ATPase, V1 domain [GO:0000221] proton-transporting ATPase activity, rotational mechanism [GO:0046961] g10531.t1 Q8K0H1 34.834 511 3.41e-96 311.0 sp|Q8K0H1|S47A1_MOUSE Multidrug and toxin extrusion protein 1 OS=Mus musculus OX=10090 GN=Slc47a1 PE=1 SV=2 S47A1_MOUSE reviewed Multidrug and toxin extrusion protein 1 (MATE-1) (mMATE-1) (Solute carrier family 47 member 1) Mus musculus (Mouse) GO:0005886; GO:0006812; GO:0006855; GO:0015101; GO:0015179; GO:0015234; GO:0015297; GO:0015489; GO:0015695; GO:0015847; GO:0016020; GO:0016323; GO:0016324; GO:0031982; GO:0042887; GO:0042910; GO:0055085; GO:0061459; GO:0097638; GO:0098655; GO:0140968; GO:1990961 L-arginine import across plasma membrane [GO:0097638]; monoatomic cation transmembrane transport [GO:0098655]; monoatomic cation transport [GO:0006812]; organic cation transport [GO:0015695]; putrescine transport [GO:0015847]; transmembrane transport [GO:0055085]; xenobiotic detoxification by transmembrane export across the plasma membrane [GO:1990961]; xenobiotic transmembrane transport [GO:0006855] apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; membrane [GO:0016020]; plasma membrane [GO:0005886]; vesicle [GO:0031982] amide transmembrane transporter activity [GO:0042887]; antiporter activity [GO:0015297]; L-amino acid transmembrane transporter activity [GO:0015179]; L-arginine transmembrane transporter activity [GO:0061459]; organic cation transmembrane transporter activity [GO:0015101]; polyspecific organic cation:proton antiporter activity [GO:0140968]; putrescine transmembrane transporter activity [GO:0015489]; thiamine transmembrane transporter activity [GO:0015234]; xenobiotic transmembrane transporter activity [GO:0042910] g10532.t1 Q96FL8 36.614 508 4.5e-102 327.0 sp|Q96FL8|S47A1_HUMAN Multidrug and toxin extrusion protein 1 OS=Homo sapiens OX=9606 GN=SLC47A1 PE=1 SV=1 g10533.t1 O15078 40.115 1047 0.0 589.0 sp|O15078|CE290_HUMAN Centrosomal protein of 290 kDa OS=Homo sapiens OX=9606 GN=CEP290 PE=1 SV=2 CE290_HUMAN reviewed Centrosomal protein of 290 kDa (Cep290) (Bardet-Biedl syndrome 14 protein) (Cancer/testis antigen 87) (CT87) (Nephrocystin-6) (Tumor antigen se2-2) Homo sapiens (Human) GO:0001822; GO:0005576; GO:0005634; GO:0005737; GO:0005813; GO:0005814; GO:0005829; GO:0015031; GO:0016020; GO:0030902; GO:0030916; GO:0032391; GO:0032991; GO:0034451; GO:0035580; GO:0035869; GO:0036038; GO:0036064; GO:0042462; GO:0042802; GO:0043010; GO:0045893; GO:0048793; GO:0060271; GO:0070201; GO:0090316; GO:0097711; GO:1905349; GO:1905515 camera-type eye development [GO:0043010]; ciliary basal body-plasma membrane docking [GO:0097711]; ciliary transition zone assembly [GO:1905349]; cilium assembly [GO:0060271]; eye photoreceptor cell development [GO:0042462]; hindbrain development [GO:0030902]; kidney development [GO:0001822]; non-motile cilium assembly [GO:1905515]; otic vesicle formation [GO:0030916]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of intracellular protein transport [GO:0090316]; pronephros development [GO:0048793]; protein transport [GO:0015031]; regulation of establishment of protein localization [GO:0070201] centriolar satellite [GO:0034451]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary transition zone [GO:0035869]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; membrane [GO:0016020]; MKS complex [GO:0036038]; nucleus [GO:0005634]; photoreceptor connecting cilium [GO:0032391]; protein-containing complex [GO:0032991]; specific granule lumen [GO:0035580] identical protein binding [GO:0042802] g10534.t1 O15078 43.416 1458 0.0 977.0 sp|O15078|CE290_HUMAN Centrosomal protein of 290 kDa OS=Homo sapiens OX=9606 GN=CEP290 PE=1 SV=2 CE290_HUMAN reviewed Centrosomal protein of 290 kDa (Cep290) (Bardet-Biedl syndrome 14 protein) (Cancer/testis antigen 87) (CT87) (Nephrocystin-6) (Tumor antigen se2-2) Homo sapiens (Human) GO:0001822; GO:0005576; GO:0005634; GO:0005737; GO:0005813; GO:0005814; GO:0005829; GO:0015031; GO:0016020; GO:0030902; GO:0030916; GO:0032391; GO:0032991; GO:0034451; GO:0035580; GO:0035869; GO:0036038; GO:0036064; GO:0042462; GO:0042802; GO:0043010; GO:0045893; GO:0048793; GO:0060271; GO:0070201; GO:0090316; GO:0097711; GO:1905349; GO:1905515 camera-type eye development [GO:0043010]; ciliary basal body-plasma membrane docking [GO:0097711]; ciliary transition zone assembly [GO:1905349]; cilium assembly [GO:0060271]; eye photoreceptor cell development [GO:0042462]; hindbrain development [GO:0030902]; kidney development [GO:0001822]; non-motile cilium assembly [GO:1905515]; otic vesicle formation [GO:0030916]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of intracellular protein transport [GO:0090316]; pronephros development [GO:0048793]; protein transport [GO:0015031]; regulation of establishment of protein localization [GO:0070201] centriolar satellite [GO:0034451]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary transition zone [GO:0035869]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; membrane [GO:0016020]; MKS complex [GO:0036038]; nucleus [GO:0005634]; photoreceptor connecting cilium [GO:0032391]; protein-containing complex [GO:0032991]; specific granule lumen [GO:0035580] identical protein binding [GO:0042802] g10535.t1 C9K4X8 48.696 115 1.1300000000000001e-32 113.0 sp|C9K4X8|GSS_PATPE Gonad-stimulating substance OS=Patiria pectinifera OX=7594 GN=GSS PE=1 SV=1 GSS_PATPE reviewed Gonad-stimulating substance (Relaxin-like gonad-stimulating peptide) [Cleaved into: Gonad-stimulating substance B chain; Gonad-stimulating substance A chain] Patiria pectinifera (Starfish) (Asterina pectinifera) GO:0005179; GO:0005615; GO:0005886; GO:0007189; GO:0060279; GO:1900195 adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; positive regulation of oocyte maturation [GO:1900195]; positive regulation of ovulation [GO:0060279] extracellular space [GO:0005615]; plasma membrane [GO:0005886] hormone activity [GO:0005179] g10536.t1 O00338 32.653 294 8.99e-55 183.0 sp|O00338|ST1C2_HUMAN Sulfotransferase 1C2 OS=Homo sapiens OX=9606 GN=SULT1C2 PE=1 SV=1 ST1C2_HUMAN reviewed Sulfotransferase 1C2 (ST1C2) (EC 2.8.2.1) (Sulfotransferase 1C1) (SULT1C#1) (humSULTC2) Homo sapiens (Human) GO:0004062; GO:0005737; GO:0005739; GO:0005764; GO:0005829; GO:0008146; GO:0009308; GO:0051922; GO:0051923 amine metabolic process [GO:0009308]; sulfation [GO:0051923] cytoplasm [GO:0005737]; cytosol [GO:0005829]; lysosome [GO:0005764]; mitochondrion [GO:0005739] aryl sulfotransferase activity [GO:0004062]; cholesterol sulfotransferase activity [GO:0051922]; sulfotransferase activity [GO:0008146] g10537.t1 M9PH32 25.507 345 2.4100000000000002e-29 128.0 sp|M9PH32|MEI26_DROME Protein meiotic P26 OS=Drosophila melanogaster OX=7227 GN=mei-P26 PE=1 SV=1 MEI26_DROME reviewed Protein meiotic P26 Drosophila melanogaster (Fruit fly) GO:0004842; GO:0005737; GO:0008270; GO:0016567; GO:0036464 protein ubiquitination [GO:0016567] cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464] ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] g10539.t1 Q9EQS0 67.278 327 1.09e-160 455.0 sp|Q9EQS0|TALDO_RAT Transaldolase OS=Rattus norvegicus OX=10116 GN=Taldo1 PE=1 SV=2 TALDO_RAT reviewed Transaldolase (EC 2.2.1.2) Rattus norvegicus (Rat) GO:0004801; GO:0005634; GO:0005737; GO:0005829; GO:0005975; GO:0006002; GO:0006098; GO:0009052; GO:0019682; GO:0030246; GO:0042802; GO:0048029 carbohydrate metabolic process [GO:0005975]; fructose 6-phosphate metabolic process [GO:0006002]; glyceraldehyde-3-phosphate metabolic process [GO:0019682]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, non-oxidative branch [GO:0009052] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634] carbohydrate binding [GO:0030246]; identical protein binding [GO:0042802]; monosaccharide binding [GO:0048029]; transaldolase activity [GO:0004801] g10541.t1 Q9WUW8 38.235 272 4.03e-55 183.0 sp|Q9WUW8|ST1C2_RAT Sulfotransferase 1C2 OS=Rattus norvegicus OX=10116 GN=Sult1c2 PE=1 SV=2 ST1C2_RAT reviewed Sulfotransferase 1C2 (ST1C2) (rSULT1C2) (EC 2.8.2.1) (Sulfotransferase K1) Rattus norvegicus (Rat) GO:0004062; GO:0005737; GO:0005739; GO:0005764; GO:0051922; GO:0051923 sulfation [GO:0051923] cytoplasm [GO:0005737]; lysosome [GO:0005764]; mitochondrion [GO:0005739] aryl sulfotransferase activity [GO:0004062]; cholesterol sulfotransferase activity [GO:0051922] g10542.t1 Q5ZMA6 65.722 706 0.0 999.0 sp|Q5ZMA6|NADE_CHICK Glutamine-dependent NAD(+) synthetase OS=Gallus gallus OX=9031 GN=NADSYN1 PE=2 SV=1 NADE_CHICK reviewed Glutamine-dependent NAD(+) synthetase (EC 6.3.5.1) (NAD(+) synthase [glutamine-hydrolyzing]) (NAD(+) synthetase) Gallus gallus (Chicken) GO:0003952; GO:0004359; GO:0005524; GO:0005737; GO:0005829; GO:0009435; GO:0034354 'de novo' NAD+ biosynthetic process from L-tryptophan [GO:0034354]; NAD+ biosynthetic process [GO:0009435] cytoplasm [GO:0005737]; cytosol [GO:0005829] ATP binding [GO:0005524]; glutaminase activity [GO:0004359]; NAD+ synthase (glutamine-hydrolyzing) activity [GO:0003952] g10542.t2 Q5ZMA6 64.177 723 0.0 986.0 sp|Q5ZMA6|NADE_CHICK Glutamine-dependent NAD(+) synthetase OS=Gallus gallus OX=9031 GN=NADSYN1 PE=2 SV=1 NADE_CHICK reviewed Glutamine-dependent NAD(+) synthetase (EC 6.3.5.1) (NAD(+) synthase [glutamine-hydrolyzing]) (NAD(+) synthetase) Gallus gallus (Chicken) GO:0003952; GO:0004359; GO:0005524; GO:0005737; GO:0005829; GO:0009435; GO:0034354 'de novo' NAD+ biosynthetic process from L-tryptophan [GO:0034354]; NAD+ biosynthetic process [GO:0009435] cytoplasm [GO:0005737]; cytosol [GO:0005829] ATP binding [GO:0005524]; glutaminase activity [GO:0004359]; NAD+ synthase (glutamine-hydrolyzing) activity [GO:0003952] g10545.t1 Q9HCB6 42.857 189 2.23e-62 147.0 sp|Q9HCB6|SPON1_HUMAN Spondin-1 OS=Homo sapiens OX=9606 GN=SPON1 PE=1 SV=2 SPON1_HUMAN reviewed Spondin-1 (F-spondin) (Vascular smooth muscle cell growth-promoting factor) Homo sapiens (Human) GO:0005201; GO:0005615; GO:0005788; GO:0007155; GO:0010954; GO:0016485; GO:0031012; GO:0046872; GO:0050693; GO:1902430; GO:1902993 cell adhesion [GO:0007155]; negative regulation of amyloid-beta formation [GO:1902430]; positive regulation of amyloid precursor protein catabolic process [GO:1902993]; positive regulation of protein processing [GO:0010954]; protein processing [GO:0016485] endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615] extracellular matrix structural constituent [GO:0005201]; LBD domain binding [GO:0050693]; metal ion binding [GO:0046872] g10545.t1 Q9HCB6 48.673 113 2.23e-62 114.0 sp|Q9HCB6|SPON1_HUMAN Spondin-1 OS=Homo sapiens OX=9606 GN=SPON1 PE=1 SV=2 SPON1_HUMAN reviewed Spondin-1 (F-spondin) (Vascular smooth muscle cell growth-promoting factor) Homo sapiens (Human) GO:0005201; GO:0005615; GO:0005788; GO:0007155; GO:0010954; GO:0016485; GO:0031012; GO:0046872; GO:0050693; GO:1902430; GO:1902993 cell adhesion [GO:0007155]; negative regulation of amyloid-beta formation [GO:1902430]; positive regulation of amyloid precursor protein catabolic process [GO:1902993]; positive regulation of protein processing [GO:0010954]; protein processing [GO:0016485] endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615] extracellular matrix structural constituent [GO:0005201]; LBD domain binding [GO:0050693]; metal ion binding [GO:0046872] g10547.t1 Q99999 32.808 317 2.36e-51 178.0 sp|Q99999|G3ST1_HUMAN Galactosylceramide sulfotransferase OS=Homo sapiens OX=9606 GN=GAL3ST1 PE=1 SV=1 G3ST1_HUMAN reviewed Galactosylceramide sulfotransferase (GalCer sulfotransferase) (EC 2.8.2.11) (3'-phosphoadenosine-5'-phosphosulfate:GalCer sulfotransferase) (3'-phosphoadenylylsulfate:galactosylceramide 3'-sulfotransferase) (Cerebroside sulfotransferase) Homo sapiens (Human) GO:0000139; GO:0001733; GO:0005886; GO:0006487; GO:0006665; GO:0006681; GO:0006682; GO:0006688; GO:0007283; GO:0008146; GO:0016020; GO:0042552; GO:0046486 galactosylceramide biosynthetic process [GO:0006682]; galactosylceramide metabolic process [GO:0006681]; glycerolipid metabolic process [GO:0046486]; glycosphingolipid biosynthetic process [GO:0006688]; myelination [GO:0042552]; protein N-linked glycosylation [GO:0006487]; spermatogenesis [GO:0007283]; sphingolipid metabolic process [GO:0006665] Golgi membrane [GO:0000139]; membrane [GO:0016020]; plasma membrane [GO:0005886] galactosylceramide sulfotransferase activity [GO:0001733]; sulfotransferase activity [GO:0008146] g10549.t1 Q9JHE4 39.252 321 1.1599999999999999e-54 186.0 sp|Q9JHE4|G3ST1_MOUSE Galactosylceramide sulfotransferase OS=Mus musculus OX=10090 GN=Gal3st1 PE=1 SV=2 G3ST1_MOUSE reviewed Galactosylceramide sulfotransferase (GalCer sulfotransferase) (EC 2.8.2.11) (3'-phosphoadenosine-5'-phosphosulfate:GalCer sulfotransferase) (3'-phosphoadenylylsulfate:galactosylceramide 3'-sulfotransferase) (Cerebroside sulfotransferase) Mus musculus (Mouse) GO:0000139; GO:0001733; GO:0006665; GO:0006681; GO:0006682; GO:0007283; GO:0009247; GO:0016020; GO:0042552; GO:0046486 galactosylceramide biosynthetic process [GO:0006682]; galactosylceramide metabolic process [GO:0006681]; glycerolipid metabolic process [GO:0046486]; glycolipid biosynthetic process [GO:0009247]; myelination [GO:0042552]; spermatogenesis [GO:0007283]; sphingolipid metabolic process [GO:0006665] Golgi membrane [GO:0000139]; membrane [GO:0016020] galactosylceramide sulfotransferase activity [GO:0001733] g10550.t1 Q571I9 41.333 375 3.49e-78 259.0 sp|Q571I9|A16A1_MOUSE Aldehyde dehydrogenase family 16 member A1 OS=Mus musculus OX=10090 GN=Aldh16a1 PE=1 SV=2 g10552.t1 Q3T1L0 45.401 337 1.68e-95 304.0 sp|Q3T1L0|A16A1_RAT Aldehyde dehydrogenase family 16 member A1 OS=Rattus norvegicus OX=10116 GN=Aldh16a1 PE=2 SV=1 g10553.t1 P41823 76.508 315 1.16e-168 483.0 sp|P41823|SY65_APLCA Synaptotagmin-1 OS=Aplysia californica OX=6500 GN=SYT1 PE=1 SV=2 g10556.t1 G8HTB6 29.565 230 1.33e-22 105.0 sp|G8HTB6|ZPP_ACRMI ZP domain-containing protein OS=Acropora millepora OX=45264 PE=1 SV=1 g10556.t2 G8HTB6 29.565 230 1.33e-22 105.0 sp|G8HTB6|ZPP_ACRMI ZP domain-containing protein OS=Acropora millepora OX=45264 PE=1 SV=1 g10557.t1 Q5THR3 29.247 1501 0.0 689.0 sp|Q5THR3|EFCB6_HUMAN EF-hand calcium-binding domain-containing protein 6 OS=Homo sapiens OX=9606 GN=EFCAB6 PE=1 SV=1 EFCB6_HUMAN reviewed EF-hand calcium-binding domain-containing protein 6 (CAP-binding protein complex-interacting protein 1) (DJ-1-binding protein) (DJBP) Homo sapiens (Human) GO:0005509; GO:0005654; GO:0030317; GO:0036126; GO:0160111 flagellated sperm motility [GO:0030317] axonemal A tubule inner sheath [GO:0160111]; nucleoplasm [GO:0005654]; sperm flagellum [GO:0036126] calcium ion binding [GO:0005509] g10557.t1 Q5THR3 20.705 681 1.5899999999999998e-23 112.0 sp|Q5THR3|EFCB6_HUMAN EF-hand calcium-binding domain-containing protein 6 OS=Homo sapiens OX=9606 GN=EFCAB6 PE=1 SV=1 EFCB6_HUMAN reviewed EF-hand calcium-binding domain-containing protein 6 (CAP-binding protein complex-interacting protein 1) (DJ-1-binding protein) (DJBP) Homo sapiens (Human) GO:0005509; GO:0005654; GO:0030317; GO:0036126; GO:0160111 flagellated sperm motility [GO:0030317] axonemal A tubule inner sheath [GO:0160111]; nucleoplasm [GO:0005654]; sperm flagellum [GO:0036126] calcium ion binding [GO:0005509] g10558.t1 P63047 48.162 272 1.33e-81 250.0 sp|P63047|ST4A1_RAT Sulfotransferase 4A1 OS=Rattus norvegicus OX=10116 GN=Sult4a1 PE=1 SV=1 g10559.t1 Q64464 32.749 513 1.4e-92 294.0 sp|Q64464|CP3AD_MOUSE Cytochrome P450 3A13 OS=Mus musculus OX=10090 GN=Cyp3a13 PE=1 SV=1 CP3AD_MOUSE reviewed Cytochrome P450 3A13 (EC 1.14.14.1) (CYPIIIA13) Mus musculus (Mouse) GO:0004497; GO:0005496; GO:0005506; GO:0005737; GO:0005789; GO:0008202; GO:0008395; GO:0008401; GO:0010628; GO:0016491; GO:0019899; GO:0020037; GO:0030343; GO:0034875; GO:0042908; GO:0050649; GO:0062181; GO:0070576; GO:0070989; GO:0101020; GO:0101021 oxidative demethylation [GO:0070989]; positive regulation of gene expression [GO:0010628]; steroid metabolic process [GO:0008202]; xenobiotic transport [GO:0042908] cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789] 1-alpha,25-dihydroxyvitamin D3 23-hydroxylase activity [GO:0062181]; caffeine oxidase activity [GO:0034875]; enzyme binding [GO:0019899]; estrogen 16-alpha-hydroxylase activity [GO:0101020]; estrogen 2-hydroxylase activity [GO:0101021]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity [GO:0016491]; retinoic acid 4-hydroxylase activity [GO:0008401]; steroid binding [GO:0005496]; steroid hydroxylase activity [GO:0008395]; testosterone 6-beta-hydroxylase activity [GO:0050649]; vitamin D 24-hydroxylase activity [GO:0070576]; vitamin D3 25-hydroxylase activity [GO:0030343] g10560.t1 K0DZA0 26.979 341 6.949999999999999e-24 102.0 sp|K0DZA0|HTYE_ASPRU 2-oxoglutarate-dependent dioxygenase htyE OS=Aspergillus rugulosus OX=41736 GN=htyE PE=1 SV=1 g10562.t1 P35223 77.075 711 0.0 1089.0 sp|P35223|CTNB_TRIGR Catenin beta OS=Tripneustes gratilla OX=7673 PE=2 SV=1 g10563.t1 Q8JG30 36.594 276 9.799999999999999e-55 183.0 sp|Q8JG30|ST1B1_CHICK Sulfotransferase 1B1 OS=Gallus gallus OX=9031 GN=SULT1B1 PE=1 SV=1 g10564.t1 P56501 67.105 76 1.42e-31 114.0 sp|P56501|UCP3_MOUSE Putative mitochondrial transporter UCP3 OS=Mus musculus OX=10090 GN=Ucp3 PE=1 SV=1 UCP3_MOUSE reviewed Putative mitochondrial transporter UCP3 (Solute carrier family 25 member 9) (Uncoupling protein 3) (UCP 3) Mus musculus (Mouse) GO:0000303; GO:0001666; GO:0005739; GO:0005743; GO:0006631; GO:0007584; GO:0009409; GO:0014823; GO:0015078; GO:0017077; GO:0032868; GO:0032870; GO:0051384; GO:1901373; GO:1901557; GO:1902600; GO:1990542; GO:1990845 adaptive thermogenesis [GO:1990845]; cellular response to hormone stimulus [GO:0032870]; fatty acid metabolic process [GO:0006631]; lipid hydroperoxide transport [GO:1901373]; mitochondrial transmembrane transport [GO:1990542]; proton transmembrane transport [GO:1902600]; response to activity [GO:0014823]; response to cold [GO:0009409]; response to fenofibrate [GO:1901557]; response to glucocorticoid [GO:0051384]; response to hypoxia [GO:0001666]; response to insulin [GO:0032868]; response to nutrient [GO:0007584]; response to superoxide [GO:0000303] mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739] oxidative phosphorylation uncoupler activity [GO:0017077]; proton transmembrane transporter activity [GO:0015078] g10565.t1 P56500 59.292 113 2.47e-28 109.0 sp|P56500|UCP2_RAT Dicarboxylate carrier UCP2 OS=Rattus norvegicus OX=10116 GN=Ucp2 PE=2 SV=1 UCP2_RAT reviewed Dicarboxylate carrier UCP2 (Mitochondrial uncoupling protein 2) (UCP 2) (Solute carrier family 25 member 8) Rattus norvegicus (Rat) GO:0000266; GO:0000303; GO:0001666; GO:0005739; GO:0005743; GO:0006096; GO:0006541; GO:0006839; GO:0008271; GO:0009409; GO:0009749; GO:0015078; GO:0015108; GO:0015131; GO:0015140; GO:0015183; GO:0015297; GO:0015740; GO:0015909; GO:0017077; GO:0019003; GO:0030225; GO:0031966; GO:0032869; GO:0032870; GO:0034198; GO:0042803; GO:0043066; GO:0043524; GO:0051881; GO:0061179; GO:0070542; GO:0071284; GO:0071333; GO:0071548; GO:0072593; GO:0097421; GO:0110099; GO:0120162; GO:0140787; GO:1990542; GO:1990845 adaptive thermogenesis [GO:1990845]; C4-dicarboxylate transport [GO:0015740]; cellular response to amino acid starvation [GO:0034198]; cellular response to glucose stimulus [GO:0071333]; cellular response to hormone stimulus [GO:0032870]; cellular response to insulin stimulus [GO:0032869]; cellular response to lead ion [GO:0071284]; glutamine metabolic process [GO:0006541]; glycolytic process [GO:0006096]; liver regeneration [GO:0097421]; long-chain fatty acid transport [GO:0015909]; macrophage differentiation [GO:0030225]; mitochondrial fission [GO:0000266]; mitochondrial transmembrane transport [GO:1990542]; mitochondrial transport [GO:0006839]; negative regulation of apoptotic process [GO:0043066]; negative regulation of calcium import into the mitochondrion [GO:0110099]; negative regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061179]; negative regulation of neuron apoptotic process [GO:0043524]; positive regulation of cold-induced thermogenesis [GO:0120162]; reactive oxygen species metabolic process [GO:0072593]; regulation of mitochondrial membrane potential [GO:0051881]; response to cold [GO:0009409]; response to dexamethasone [GO:0071548]; response to fatty acid [GO:0070542]; response to glucose [GO:0009749]; response to hypoxia [GO:0001666]; response to superoxide [GO:0000303] mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739] antiporter activity [GO:0015297]; chloride transmembrane transporter activity [GO:0015108]; GDP binding [GO:0019003]; L-aspartate transmembrane transporter activity [GO:0015183]; malate transmembrane transporter activity [GO:0015140]; oxaloacetate transmembrane transporter activity [GO:0015131]; oxidative phosphorylation uncoupler activity [GO:0017077]; phosphate ion uniporter activity [GO:0140787]; protein homodimerization activity [GO:0042803]; proton transmembrane transporter activity [GO:0015078]; secondary active sulfate transmembrane transporter activity [GO:0008271] g10571.t1 Q5R628 88.889 90 1.9099999999999999e-53 164.0 sp|Q5R628|LSM5_PONAB U6 snRNA-associated Sm-like protein LSm5 OS=Pongo abelii OX=9601 GN=LSM5 PE=3 SV=3 g10572.t1 P50416 49.325 667 0.0 663.0 sp|P50416|CPT1A_HUMAN Carnitine O-palmitoyltransferase 1, liver isoform OS=Homo sapiens OX=9606 GN=CPT1A PE=1 SV=2 CPT1A_HUMAN reviewed Carnitine O-palmitoyltransferase 1, liver isoform (CPT1-L) (EC 2.3.1.21) (Carnitine O-palmitoyltransferase I, liver isoform) (CPT I) (CPTI-L) (Carnitine palmitoyltransferase 1A) (Succinyltransferase CPT1A) (EC 2.3.1.-) Homo sapiens (Human) GO:0001666; GO:0001676; GO:0004095; GO:0005739; GO:0005741; GO:0006006; GO:0006631; GO:0006635; GO:0006641; GO:0006853; GO:0007584; GO:0009410; GO:0009437; GO:0016020; GO:0030674; GO:0030855; GO:0032000; GO:0042755; GO:0042802; GO:0043279; GO:0045089; GO:0045471; GO:0046222; GO:0050796; GO:0071398; GO:0097421; GO:1904772 aflatoxin metabolic process [GO:0046222]; carnitine metabolic process [GO:0009437]; carnitine shuttle [GO:0006853]; cellular response to fatty acid [GO:0071398]; eating behavior [GO:0042755]; epithelial cell differentiation [GO:0030855]; fatty acid beta-oxidation [GO:0006635]; fatty acid metabolic process [GO:0006631]; glucose metabolic process [GO:0006006]; liver regeneration [GO:0097421]; long-chain fatty acid metabolic process [GO:0001676]; positive regulation of fatty acid beta-oxidation [GO:0032000]; positive regulation of innate immune response [GO:0045089]; regulation of insulin secretion [GO:0050796]; response to alkaloid [GO:0043279]; response to ethanol [GO:0045471]; response to hypoxia [GO:0001666]; response to nutrient [GO:0007584]; response to tetrachloromethane [GO:1904772]; response to xenobiotic stimulus [GO:0009410]; triglyceride metabolic process [GO:0006641] membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739] carnitine O-palmitoyltransferase activity [GO:0004095]; identical protein binding [GO:0042802]; protein-macromolecule adaptor activity [GO:0030674] g10572.t2 P50416 51.25 640 0.0 672.0 sp|P50416|CPT1A_HUMAN Carnitine O-palmitoyltransferase 1, liver isoform OS=Homo sapiens OX=9606 GN=CPT1A PE=1 SV=2 CPT1A_HUMAN reviewed Carnitine O-palmitoyltransferase 1, liver isoform (CPT1-L) (EC 2.3.1.21) (Carnitine O-palmitoyltransferase I, liver isoform) (CPT I) (CPTI-L) (Carnitine palmitoyltransferase 1A) (Succinyltransferase CPT1A) (EC 2.3.1.-) Homo sapiens (Human) GO:0001666; GO:0001676; GO:0004095; GO:0005739; GO:0005741; GO:0006006; GO:0006631; GO:0006635; GO:0006641; GO:0006853; GO:0007584; GO:0009410; GO:0009437; GO:0016020; GO:0030674; GO:0030855; GO:0032000; GO:0042755; GO:0042802; GO:0043279; GO:0045089; GO:0045471; GO:0046222; GO:0050796; GO:0071398; GO:0097421; GO:1904772 aflatoxin metabolic process [GO:0046222]; carnitine metabolic process [GO:0009437]; carnitine shuttle [GO:0006853]; cellular response to fatty acid [GO:0071398]; eating behavior [GO:0042755]; epithelial cell differentiation [GO:0030855]; fatty acid beta-oxidation [GO:0006635]; fatty acid metabolic process [GO:0006631]; glucose metabolic process [GO:0006006]; liver regeneration [GO:0097421]; long-chain fatty acid metabolic process [GO:0001676]; positive regulation of fatty acid beta-oxidation [GO:0032000]; positive regulation of innate immune response [GO:0045089]; regulation of insulin secretion [GO:0050796]; response to alkaloid [GO:0043279]; response to ethanol [GO:0045471]; response to hypoxia [GO:0001666]; response to nutrient [GO:0007584]; response to tetrachloromethane [GO:1904772]; response to xenobiotic stimulus [GO:0009410]; triglyceride metabolic process [GO:0006641] membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739] carnitine O-palmitoyltransferase activity [GO:0004095]; identical protein binding [GO:0042802]; protein-macromolecule adaptor activity [GO:0030674] g10573.t1 Q68Y62 59.42 69 8.79e-24 95.9 sp|Q68Y62|CPT1A_HORSE Carnitine O-palmitoyltransferase 1, liver isoform OS=Equus caballus OX=9796 GN=CPT1A PE=2 SV=1 g10576.t1 Q5E964 58.245 376 9.309999999999999e-165 469.0 sp|Q5E964|PSD13_BOVIN 26S proteasome non-ATPase regulatory subunit 13 OS=Bos taurus OX=9913 GN=PSMD13 PE=2 SV=1 g10577.t1 E9Q9D5 64.651 215 5.08e-102 298.0 sp|E9Q9D5|RBL2A_MOUSE Rab-like protein 2A OS=Mus musculus OX=10090 GN=Rabl2 PE=1 SV=1 RBL2A_MOUSE reviewed Rab-like protein 2A (EC 3.6.5.2) Mus musculus (Mouse) GO:0000242; GO:0003924; GO:0003925; GO:0005525; GO:0005737; GO:0005814; GO:0006886; GO:0007338; GO:0008594; GO:0012505; GO:0030317; GO:0030992; GO:0036064; GO:0060271; GO:0097225 cilium assembly [GO:0060271]; flagellated sperm motility [GO:0030317]; intracellular protein transport [GO:0006886]; photoreceptor cell morphogenesis [GO:0008594]; single fertilization [GO:0007338] centriole [GO:0005814]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; endomembrane system [GO:0012505]; intraciliary transport particle B [GO:0030992]; pericentriolar material [GO:0000242]; sperm midpiece [GO:0097225] G protein activity [GO:0003925]; GTP binding [GO:0005525]; GTPase activity [GO:0003924] g10578.t1 Q5E9K0 55.446 101 5.740000000000001e-32 113.0 sp|Q5E9K0|PSB2_BOVIN Proteasome subunit beta type-2 OS=Bos taurus OX=9913 GN=PSMB2 PE=1 SV=1 PSB2_BOVIN reviewed Proteasome subunit beta type-2 Bos taurus (Bovine) GO:0005634; GO:0005654; GO:0005829; GO:0005839; GO:0019774; GO:0043161 proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome core complex [GO:0005839]; proteasome core complex, beta-subunit complex [GO:0019774] g10579.t1 P40307 58.442 77 4.24e-23 90.5 sp|P40307|PSB2_RAT Proteasome subunit beta type-2 OS=Rattus norvegicus OX=10116 GN=Psmb2 PE=1 SV=1 g10582.t1 O45870 39.45 327 1.0600000000000001e-66 221.0 sp|O45870|NSMA_CAEEL Putative neutral sphingomyelinase OS=Caenorhabditis elegans OX=6239 GN=T27F6.6 PE=3 SV=2 g10583.t1 Q9CWU9 50.157 319 3.91e-113 333.0 sp|Q9CWU9|NUP37_MOUSE Nucleoporin Nup37 OS=Mus musculus OX=10090 GN=Nup37 PE=1 SV=2 g10584.t1 B5FWC0 40.26 154 1.23e-32 116.0 sp|B5FWC0|RM23_OTOGA Large ribosomal subunit protein uL23m OS=Otolemur garnettii OX=30611 GN=MRPL23 PE=3 SV=1 g10588.t1 P22735 43.51 678 0.0 555.0 sp|P22735|TGM1_HUMAN Protein-glutamine gamma-glutamyltransferase K OS=Homo sapiens OX=9606 GN=TGM1 PE=1 SV=4 TGM1_HUMAN reviewed Protein-glutamine gamma-glutamyltransferase K (EC 2.3.2.13) (Epidermal TGase) (Transglutaminase K) (TG(K)) (TGK) (TGase K) (Transglutaminase-1) (TGase-1) [Cleaved into: Protein-glutamine gamma-glutamyltransferase K 67 kDa chain; Protein-glutamine gamma-glutamyltransferase K 33 kDa chain] Homo sapiens (Human) GO:0001533; GO:0003810; GO:0005829; GO:0005886; GO:0010838; GO:0016020; GO:0030216; GO:0036211; GO:0042802; GO:0043163; GO:0045787; GO:0046872; GO:0070062; GO:0070268 cell envelope organization [GO:0043163]; cornification [GO:0070268]; keratinocyte differentiation [GO:0030216]; positive regulation of cell cycle [GO:0045787]; positive regulation of keratinocyte proliferation [GO:0010838]; protein modification process [GO:0036211] cornified envelope [GO:0001533]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; plasma membrane [GO:0005886] identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein-glutamine gamma-glutamyltransferase activity [GO:0003810] g10589.t1 Q86SS6 57.576 330 2.4600000000000002e-117 356.0 sp|Q86SS6|SYT9_HUMAN Synaptotagmin-9 OS=Homo sapiens OX=9606 GN=SYT9 PE=1 SV=1 SYT9_HUMAN reviewed Synaptotagmin-9 (Synaptotagmin IX) (SytIX) Homo sapiens (Human) GO:0000149; GO:0001786; GO:0005544; GO:0005546; GO:0005886; GO:0007268; GO:0016192; GO:0017158; GO:0030669; GO:0030672; GO:0031045; GO:0031340; GO:0042802; GO:0046872; GO:0061891; GO:0070382; GO:0098686; GO:0099502 calcium-dependent activation of synaptic vesicle fusion [GO:0099502]; chemical synaptic transmission [GO:0007268]; positive regulation of vesicle fusion [GO:0031340]; regulation of calcium ion-dependent exocytosis [GO:0017158]; vesicle-mediated transport [GO:0016192] clathrin-coated endocytic vesicle membrane [GO:0030669]; dense core granule [GO:0031045]; exocytic vesicle [GO:0070382]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; plasma membrane [GO:0005886]; synaptic vesicle membrane [GO:0030672] calcium ion sensor activity [GO:0061891]; calcium-dependent phospholipid binding [GO:0005544]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphatidylserine binding [GO:0001786]; SNARE binding [GO:0000149] g10590.t1 P83509 34.025 241 3.07e-32 131.0 sp|P83509|RHG35_CANLF Rho GTPase-activating protein 35 OS=Canis lupus familiaris OX=9615 GN=ARHGAP35 PE=2 SV=1 RHG35_CANLF reviewed Rho GTPase-activating protein 35 (Glucocorticoid receptor DNA-binding factor 1) (Rho GAP p190A) (p190-A) Canis lupus familiaris (Dog) (Canis familiaris) GO:0001843; GO:0003677; GO:0003924; GO:0005096; GO:0005525; GO:0005543; GO:0005634; GO:0005829; GO:0005886; GO:0007266; GO:0007411; GO:0007413; GO:0008064; GO:0008360; GO:0008361; GO:0010976; GO:0015629; GO:0016477; GO:0021955; GO:0030879; GO:0030900; GO:0030950; GO:0032956; GO:0035024; GO:0036064; GO:0042478; GO:0043010; GO:0043116; GO:0043547; GO:0044319; GO:0045724; GO:0050770; GO:0097485 axon guidance [GO:0007411]; axonal fasciculation [GO:0007413]; camera-type eye development [GO:0043010]; cell migration [GO:0016477]; central nervous system neuron axonogenesis [GO:0021955]; establishment or maintenance of actin cytoskeleton polarity [GO:0030950]; forebrain development [GO:0030900]; mammary gland development [GO:0030879]; negative regulation of Rho protein signal transduction [GO:0035024]; negative regulation of vascular permeability [GO:0043116]; neural tube closure [GO:0001843]; neuron projection guidance [GO:0097485]; positive regulation of cilium assembly [GO:0045724]; positive regulation of GTPase activity [GO:0043547]; positive regulation of neuron projection development [GO:0010976]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of actin polymerization or depolymerization [GO:0008064]; regulation of axonogenesis [GO:0050770]; regulation of cell shape [GO:0008360]; regulation of cell size [GO:0008361]; regulation of eye photoreceptor cell development [GO:0042478]; Rho protein signal transduction [GO:0007266]; wound healing, spreading of cells [GO:0044319] actin cytoskeleton [GO:0015629]; ciliary basal body [GO:0036064]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886] DNA binding [GO:0003677]; GTP binding [GO:0005525]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; phospholipid binding [GO:0005543] g10594.t1 P04176 37.838 333 8.71e-68 221.0 sp|P04176|PH4H_RAT Phenylalanine-4-hydroxylase OS=Rattus norvegicus OX=10116 GN=Pah PE=1 SV=3 PH4H_RAT reviewed Phenylalanine-4-hydroxylase (PAH) (EC 1.14.16.1) (Phe-4-monooxygenase) Rattus norvegicus (Rat) GO:0004505; GO:0005506; GO:0006558; GO:0006559; GO:0006571; GO:0016597; GO:0019293; GO:0042802 L-phenylalanine catabolic process [GO:0006559]; L-phenylalanine metabolic process [GO:0006558]; tyrosine biosynthetic process [GO:0006571]; tyrosine biosynthetic process, by oxidation of phenylalanine [GO:0019293] amino acid binding [GO:0016597]; identical protein binding [GO:0042802]; iron ion binding [GO:0005506]; phenylalanine 4-monooxygenase activity [GO:0004505] g10595.t1 Q2KIH7 64.828 435 0.0 593.0 sp|Q2KIH7|PH4H_BOVIN Phenylalanine-4-hydroxylase OS=Bos taurus OX=9913 GN=PAH PE=2 SV=1 PH4H_BOVIN reviewed Phenylalanine-4-hydroxylase (PAH) (EC 1.14.16.1) (Phe-4-monooxygenase) Bos taurus (Bovine) GO:0004505; GO:0005506; GO:0006559; GO:0006571 L-phenylalanine catabolic process [GO:0006559]; tyrosine biosynthetic process [GO:0006571] iron ion binding [GO:0005506]; phenylalanine 4-monooxygenase activity [GO:0004505] g10595.t2 Q2KIH7 65.581 430 0.0 599.0 sp|Q2KIH7|PH4H_BOVIN Phenylalanine-4-hydroxylase OS=Bos taurus OX=9913 GN=PAH PE=2 SV=1 PH4H_BOVIN reviewed Phenylalanine-4-hydroxylase (PAH) (EC 1.14.16.1) (Phe-4-monooxygenase) Bos taurus (Bovine) GO:0004505; GO:0005506; GO:0006559; GO:0006571 L-phenylalanine catabolic process [GO:0006559]; tyrosine biosynthetic process [GO:0006571] iron ion binding [GO:0005506]; phenylalanine 4-monooxygenase activity [GO:0004505] g10596.t1 Q14596 32.877 438 2.39e-47 188.0 sp|Q14596|NBR1_HUMAN Next to BRCA1 gene 1 protein OS=Homo sapiens OX=9606 GN=NBR1 PE=1 SV=3 NBR1_HUMAN reviewed Next to BRCA1 gene 1 protein (Cell migration-inducing gene 19 protein) (Membrane component chromosome 17 surface marker 2) (Neighbor of BRCA1 gene 1 protein) (Protein 1A1-3B) Homo sapiens (Human) GO:0000407; GO:0005654; GO:0005758; GO:0005764; GO:0005770; GO:0005776; GO:0005778; GO:0005829; GO:0008270; GO:0016020; GO:0016236; GO:0016604; GO:0030500; GO:0031430; GO:0032872; GO:0043130; GO:0043235; GO:0045668; GO:0051019 macroautophagy [GO:0016236]; negative regulation of osteoblast differentiation [GO:0045668]; regulation of bone mineralization [GO:0030500]; regulation of stress-activated MAPK cascade [GO:0032872] autophagosome [GO:0005776]; cytosol [GO:0005829]; late endosome [GO:0005770]; lysosome [GO:0005764]; M band [GO:0031430]; membrane [GO:0016020]; mitochondrial intermembrane space [GO:0005758]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; peroxisomal membrane [GO:0005778]; phagophore assembly site [GO:0000407]; receptor complex [GO:0043235] mitogen-activated protein kinase binding [GO:0051019]; ubiquitin binding [GO:0043130]; zinc ion binding [GO:0008270] g10598.t1 P43446 43.944 355 3.92e-97 299.0 sp|P43446|WN10A_DANRE Protein Wnt-10a OS=Danio rerio OX=7955 GN=wnt10a PE=1 SV=1 g10599.t1 Q14995 34.715 193 8.920000000000001e-29 126.0 sp|Q14995|NR1D2_HUMAN Nuclear receptor subfamily 1 group D member 2 OS=Homo sapiens OX=9606 GN=NR1D2 PE=1 SV=4 NR1D2_HUMAN reviewed Nuclear receptor subfamily 1 group D member 2 (Orphan nuclear hormone receptor BD73) (Rev-erb alpha-related receptor) (RVR) (Rev-erb-beta) (V-erbA-related protein 1-related) (EAR-1R) Homo sapiens (Human) GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0001227; GO:0004879; GO:0005634; GO:0005654; GO:0005737; GO:0006355; GO:0008270; GO:0009755; GO:0019216; GO:0030154; GO:0030522; GO:0042752; GO:0045892; GO:0045893; GO:0045944; GO:0048512; GO:0050727; GO:0050728; GO:0055088; GO:0097009; GO:1990837; GO:2001014 cell differentiation [GO:0030154]; circadian behavior [GO:0048512]; energy homeostasis [GO:0097009]; hormone-mediated signaling pathway [GO:0009755]; intracellular receptor signaling pathway [GO:0030522]; lipid homeostasis [GO:0055088]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of inflammatory response [GO:0050728]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of circadian rhythm [GO:0042752]; regulation of DNA-templated transcription [GO:0006355]; regulation of inflammatory response [GO:0050727]; regulation of lipid metabolic process [GO:0019216]; regulation of skeletal muscle cell differentiation [GO:2001014] chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; nuclear receptor activity [GO:0004879]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; zinc ion binding [GO:0008270] g10599.t1 Q14995 54.545 88 1.3399999999999999e-24 113.0 sp|Q14995|NR1D2_HUMAN Nuclear receptor subfamily 1 group D member 2 OS=Homo sapiens OX=9606 GN=NR1D2 PE=1 SV=4 NR1D2_HUMAN reviewed Nuclear receptor subfamily 1 group D member 2 (Orphan nuclear hormone receptor BD73) (Rev-erb alpha-related receptor) (RVR) (Rev-erb-beta) (V-erbA-related protein 1-related) (EAR-1R) Homo sapiens (Human) GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0001227; GO:0004879; GO:0005634; GO:0005654; GO:0005737; GO:0006355; GO:0008270; GO:0009755; GO:0019216; GO:0030154; GO:0030522; GO:0042752; GO:0045892; GO:0045893; GO:0045944; GO:0048512; GO:0050727; GO:0050728; GO:0055088; GO:0097009; GO:1990837; GO:2001014 cell differentiation [GO:0030154]; circadian behavior [GO:0048512]; energy homeostasis [GO:0097009]; hormone-mediated signaling pathway [GO:0009755]; intracellular receptor signaling pathway [GO:0030522]; lipid homeostasis [GO:0055088]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of inflammatory response [GO:0050728]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of circadian rhythm [GO:0042752]; regulation of DNA-templated transcription [GO:0006355]; regulation of inflammatory response [GO:0050727]; regulation of lipid metabolic process [GO:0019216]; regulation of skeletal muscle cell differentiation [GO:2001014] chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; nuclear receptor activity [GO:0004879]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; zinc ion binding [GO:0008270] g10600.t1 C0HL13 41.612 1687 0.0 1064.0 sp|C0HL13|LRP2_PIG Low-density lipoprotein receptor-related protein 2 OS=Sus scrofa OX=9823 GN=LRP2 PE=1 SV=1 LRP2_PIG reviewed Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin) Sus scrofa (Pig) GO:0001843; GO:0003139; GO:0003148; GO:0003223; GO:0005509; GO:0005905; GO:0006898; GO:0007605; GO:0008584; GO:0009897; GO:0016324; GO:0017124; GO:0030001; GO:0030424; GO:0030425; GO:0030514; GO:0031526; GO:0031904; GO:0043235; GO:0050769; GO:0051087; GO:0060068; GO:0060982; GO:0061156; GO:0070447; GO:0140058; GO:1904447; GO:1905167 coronary artery morphogenesis [GO:0060982]; folate import across plasma membrane [GO:1904447]; male gonad development [GO:0008584]; metal ion transport [GO:0030001]; negative regulation of BMP signaling pathway [GO:0030514]; neural tube closure [GO:0001843]; neuron projection arborization [GO:0140058]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of lysosomal protein catabolic process [GO:1905167]; positive regulation of neurogenesis [GO:0050769]; positive regulation of oligodendrocyte progenitor proliferation [GO:0070447]; pulmonary artery morphogenesis [GO:0061156]; receptor-mediated endocytosis [GO:0006898]; secondary heart field specification [GO:0003139]; sensory perception of sound [GO:0007605]; vagina development [GO:0060068]; ventricular compact myocardium morphogenesis [GO:0003223] apical plasma membrane [GO:0016324]; axon [GO:0030424]; brush border membrane [GO:0031526]; clathrin-coated pit [GO:0005905]; dendrite [GO:0030425]; endosome lumen [GO:0031904]; external side of plasma membrane [GO:0009897]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; protein-folding chaperone binding [GO:0051087]; SH3 domain binding [GO:0017124] g10600.t1 C0HL13 30.68 1294 1.3599999999999998e-128 454.0 sp|C0HL13|LRP2_PIG Low-density lipoprotein receptor-related protein 2 OS=Sus scrofa OX=9823 GN=LRP2 PE=1 SV=1 LRP2_PIG reviewed Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin) Sus scrofa (Pig) GO:0001843; GO:0003139; GO:0003148; GO:0003223; GO:0005509; GO:0005905; GO:0006898; GO:0007605; GO:0008584; GO:0009897; GO:0016324; GO:0017124; GO:0030001; GO:0030424; GO:0030425; GO:0030514; GO:0031526; GO:0031904; GO:0043235; GO:0050769; GO:0051087; GO:0060068; GO:0060982; GO:0061156; GO:0070447; GO:0140058; GO:1904447; GO:1905167 coronary artery morphogenesis [GO:0060982]; folate import across plasma membrane [GO:1904447]; male gonad development [GO:0008584]; metal ion transport [GO:0030001]; negative regulation of BMP signaling pathway [GO:0030514]; neural tube closure [GO:0001843]; neuron projection arborization [GO:0140058]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of lysosomal protein catabolic process [GO:1905167]; positive regulation of neurogenesis [GO:0050769]; positive regulation of oligodendrocyte progenitor proliferation [GO:0070447]; pulmonary artery morphogenesis [GO:0061156]; receptor-mediated endocytosis [GO:0006898]; secondary heart field specification [GO:0003139]; sensory perception of sound [GO:0007605]; vagina development [GO:0060068]; ventricular compact myocardium morphogenesis [GO:0003223] apical plasma membrane [GO:0016324]; axon [GO:0030424]; brush border membrane [GO:0031526]; clathrin-coated pit [GO:0005905]; dendrite [GO:0030425]; endosome lumen [GO:0031904]; external side of plasma membrane [GO:0009897]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; protein-folding chaperone binding [GO:0051087]; SH3 domain binding [GO:0017124] g10600.t1 C0HL13 37.26 730 8.260000000000001e-99 360.0 sp|C0HL13|LRP2_PIG Low-density lipoprotein receptor-related protein 2 OS=Sus scrofa OX=9823 GN=LRP2 PE=1 SV=1 LRP2_PIG reviewed Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin) Sus scrofa (Pig) GO:0001843; GO:0003139; GO:0003148; GO:0003223; GO:0005509; GO:0005905; GO:0006898; GO:0007605; GO:0008584; GO:0009897; GO:0016324; GO:0017124; GO:0030001; GO:0030424; GO:0030425; GO:0030514; GO:0031526; GO:0031904; GO:0043235; GO:0050769; GO:0051087; GO:0060068; GO:0060982; GO:0061156; GO:0070447; GO:0140058; GO:1904447; GO:1905167 coronary artery morphogenesis [GO:0060982]; folate import across plasma membrane [GO:1904447]; male gonad development [GO:0008584]; metal ion transport [GO:0030001]; negative regulation of BMP signaling pathway [GO:0030514]; neural tube closure [GO:0001843]; neuron projection arborization [GO:0140058]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of lysosomal protein catabolic process [GO:1905167]; positive regulation of neurogenesis [GO:0050769]; positive regulation of oligodendrocyte progenitor proliferation [GO:0070447]; pulmonary artery morphogenesis [GO:0061156]; receptor-mediated endocytosis [GO:0006898]; secondary heart field specification [GO:0003139]; sensory perception of sound [GO:0007605]; vagina development [GO:0060068]; ventricular compact myocardium morphogenesis [GO:0003223] apical plasma membrane [GO:0016324]; axon [GO:0030424]; brush border membrane [GO:0031526]; clathrin-coated pit [GO:0005905]; dendrite [GO:0030425]; endosome lumen [GO:0031904]; external side of plasma membrane [GO:0009897]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; protein-folding chaperone binding [GO:0051087]; SH3 domain binding [GO:0017124] g10600.t1 C0HL13 33.288 739 3.97e-97 354.0 sp|C0HL13|LRP2_PIG Low-density lipoprotein receptor-related protein 2 OS=Sus scrofa OX=9823 GN=LRP2 PE=1 SV=1 LRP2_PIG reviewed Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin) Sus scrofa (Pig) GO:0001843; GO:0003139; GO:0003148; GO:0003223; GO:0005509; GO:0005905; GO:0006898; GO:0007605; GO:0008584; GO:0009897; GO:0016324; GO:0017124; GO:0030001; GO:0030424; GO:0030425; GO:0030514; GO:0031526; GO:0031904; GO:0043235; GO:0050769; GO:0051087; GO:0060068; GO:0060982; GO:0061156; GO:0070447; GO:0140058; GO:1904447; GO:1905167 coronary artery morphogenesis [GO:0060982]; folate import across plasma membrane [GO:1904447]; male gonad development [GO:0008584]; metal ion transport [GO:0030001]; negative regulation of BMP signaling pathway [GO:0030514]; neural tube closure [GO:0001843]; neuron projection arborization [GO:0140058]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of lysosomal protein catabolic process [GO:1905167]; positive regulation of neurogenesis [GO:0050769]; positive regulation of oligodendrocyte progenitor proliferation [GO:0070447]; pulmonary artery morphogenesis [GO:0061156]; receptor-mediated endocytosis [GO:0006898]; secondary heart field specification [GO:0003139]; sensory perception of sound [GO:0007605]; vagina development [GO:0060068]; ventricular compact myocardium morphogenesis [GO:0003223] apical plasma membrane [GO:0016324]; axon [GO:0030424]; brush border membrane [GO:0031526]; clathrin-coated pit [GO:0005905]; dendrite [GO:0030425]; endosome lumen [GO:0031904]; external side of plasma membrane [GO:0009897]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; protein-folding chaperone binding [GO:0051087]; SH3 domain binding [GO:0017124] g10600.t1 C0HL13 33.622 693 1.4e-84 314.0 sp|C0HL13|LRP2_PIG Low-density lipoprotein receptor-related protein 2 OS=Sus scrofa OX=9823 GN=LRP2 PE=1 SV=1 LRP2_PIG reviewed Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin) Sus scrofa (Pig) GO:0001843; GO:0003139; GO:0003148; GO:0003223; GO:0005509; GO:0005905; GO:0006898; GO:0007605; GO:0008584; GO:0009897; GO:0016324; GO:0017124; GO:0030001; GO:0030424; GO:0030425; GO:0030514; GO:0031526; GO:0031904; GO:0043235; GO:0050769; GO:0051087; GO:0060068; GO:0060982; GO:0061156; GO:0070447; GO:0140058; GO:1904447; GO:1905167 coronary artery morphogenesis [GO:0060982]; folate import across plasma membrane [GO:1904447]; male gonad development [GO:0008584]; metal ion transport [GO:0030001]; negative regulation of BMP signaling pathway [GO:0030514]; neural tube closure [GO:0001843]; neuron projection arborization [GO:0140058]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of lysosomal protein catabolic process [GO:1905167]; positive regulation of neurogenesis [GO:0050769]; positive regulation of oligodendrocyte progenitor proliferation [GO:0070447]; pulmonary artery morphogenesis [GO:0061156]; receptor-mediated endocytosis [GO:0006898]; secondary heart field specification [GO:0003139]; sensory perception of sound [GO:0007605]; vagina development [GO:0060068]; ventricular compact myocardium morphogenesis [GO:0003223] apical plasma membrane [GO:0016324]; axon [GO:0030424]; brush border membrane [GO:0031526]; clathrin-coated pit [GO:0005905]; dendrite [GO:0030425]; endosome lumen [GO:0031904]; external side of plasma membrane [GO:0009897]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; protein-folding chaperone binding [GO:0051087]; SH3 domain binding [GO:0017124] g10600.t1 C0HL13 29.926 812 9.6e-74 278.0 sp|C0HL13|LRP2_PIG Low-density lipoprotein receptor-related protein 2 OS=Sus scrofa OX=9823 GN=LRP2 PE=1 SV=1 LRP2_PIG reviewed Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin) Sus scrofa (Pig) GO:0001843; GO:0003139; GO:0003148; GO:0003223; GO:0005509; GO:0005905; GO:0006898; GO:0007605; GO:0008584; GO:0009897; GO:0016324; GO:0017124; GO:0030001; GO:0030424; GO:0030425; GO:0030514; GO:0031526; GO:0031904; GO:0043235; GO:0050769; GO:0051087; GO:0060068; GO:0060982; GO:0061156; GO:0070447; GO:0140058; GO:1904447; GO:1905167 coronary artery morphogenesis [GO:0060982]; folate import across plasma membrane [GO:1904447]; male gonad development [GO:0008584]; metal ion transport [GO:0030001]; negative regulation of BMP signaling pathway [GO:0030514]; neural tube closure [GO:0001843]; neuron projection arborization [GO:0140058]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of lysosomal protein catabolic process [GO:1905167]; positive regulation of neurogenesis [GO:0050769]; positive regulation of oligodendrocyte progenitor proliferation [GO:0070447]; pulmonary artery morphogenesis [GO:0061156]; receptor-mediated endocytosis [GO:0006898]; secondary heart field specification [GO:0003139]; sensory perception of sound [GO:0007605]; vagina development [GO:0060068]; ventricular compact myocardium morphogenesis [GO:0003223] apical plasma membrane [GO:0016324]; axon [GO:0030424]; brush border membrane [GO:0031526]; clathrin-coated pit [GO:0005905]; dendrite [GO:0030425]; endosome lumen [GO:0031904]; external side of plasma membrane [GO:0009897]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; protein-folding chaperone binding [GO:0051087]; SH3 domain binding [GO:0017124] g10600.t1 C0HL13 28.273 718 3.0499999999999995e-54 214.0 sp|C0HL13|LRP2_PIG Low-density lipoprotein receptor-related protein 2 OS=Sus scrofa OX=9823 GN=LRP2 PE=1 SV=1 LRP2_PIG reviewed Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin) Sus scrofa (Pig) GO:0001843; GO:0003139; GO:0003148; GO:0003223; GO:0005509; GO:0005905; GO:0006898; GO:0007605; GO:0008584; GO:0009897; GO:0016324; GO:0017124; GO:0030001; GO:0030424; GO:0030425; GO:0030514; GO:0031526; GO:0031904; GO:0043235; GO:0050769; GO:0051087; GO:0060068; GO:0060982; GO:0061156; GO:0070447; GO:0140058; GO:1904447; GO:1905167 coronary artery morphogenesis [GO:0060982]; folate import across plasma membrane [GO:1904447]; male gonad development [GO:0008584]; metal ion transport [GO:0030001]; negative regulation of BMP signaling pathway [GO:0030514]; neural tube closure [GO:0001843]; neuron projection arborization [GO:0140058]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of lysosomal protein catabolic process [GO:1905167]; positive regulation of neurogenesis [GO:0050769]; positive regulation of oligodendrocyte progenitor proliferation [GO:0070447]; pulmonary artery morphogenesis [GO:0061156]; receptor-mediated endocytosis [GO:0006898]; secondary heart field specification [GO:0003139]; sensory perception of sound [GO:0007605]; vagina development [GO:0060068]; ventricular compact myocardium morphogenesis [GO:0003223] apical plasma membrane [GO:0016324]; axon [GO:0030424]; brush border membrane [GO:0031526]; clathrin-coated pit [GO:0005905]; dendrite [GO:0030425]; endosome lumen [GO:0031904]; external side of plasma membrane [GO:0009897]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; protein-folding chaperone binding [GO:0051087]; SH3 domain binding [GO:0017124] g10600.t1 C0HL13 28.628 758 8.44e-49 197.0 sp|C0HL13|LRP2_PIG Low-density lipoprotein receptor-related protein 2 OS=Sus scrofa OX=9823 GN=LRP2 PE=1 SV=1 LRP2_PIG reviewed Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin) Sus scrofa (Pig) GO:0001843; GO:0003139; GO:0003148; GO:0003223; GO:0005509; GO:0005905; GO:0006898; GO:0007605; GO:0008584; GO:0009897; GO:0016324; GO:0017124; GO:0030001; GO:0030424; GO:0030425; GO:0030514; GO:0031526; GO:0031904; GO:0043235; GO:0050769; GO:0051087; GO:0060068; GO:0060982; GO:0061156; GO:0070447; GO:0140058; GO:1904447; GO:1905167 coronary artery morphogenesis [GO:0060982]; folate import across plasma membrane [GO:1904447]; male gonad development [GO:0008584]; metal ion transport [GO:0030001]; negative regulation of BMP signaling pathway [GO:0030514]; neural tube closure [GO:0001843]; neuron projection arborization [GO:0140058]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of lysosomal protein catabolic process [GO:1905167]; positive regulation of neurogenesis [GO:0050769]; positive regulation of oligodendrocyte progenitor proliferation [GO:0070447]; pulmonary artery morphogenesis [GO:0061156]; receptor-mediated endocytosis [GO:0006898]; secondary heart field specification [GO:0003139]; sensory perception of sound [GO:0007605]; vagina development [GO:0060068]; ventricular compact myocardium morphogenesis [GO:0003223] apical plasma membrane [GO:0016324]; axon [GO:0030424]; brush border membrane [GO:0031526]; clathrin-coated pit [GO:0005905]; dendrite [GO:0030425]; endosome lumen [GO:0031904]; external side of plasma membrane [GO:0009897]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; protein-folding chaperone binding [GO:0051087]; SH3 domain binding [GO:0017124] g10600.t1 C0HL13 38.591 298 4.02e-34 148.0 sp|C0HL13|LRP2_PIG Low-density lipoprotein receptor-related protein 2 OS=Sus scrofa OX=9823 GN=LRP2 PE=1 SV=1 LRP2_PIG reviewed Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin) Sus scrofa (Pig) GO:0001843; GO:0003139; GO:0003148; GO:0003223; GO:0005509; GO:0005905; GO:0006898; GO:0007605; GO:0008584; GO:0009897; GO:0016324; GO:0017124; GO:0030001; GO:0030424; GO:0030425; GO:0030514; GO:0031526; GO:0031904; GO:0043235; GO:0050769; GO:0051087; GO:0060068; GO:0060982; GO:0061156; GO:0070447; GO:0140058; GO:1904447; GO:1905167 coronary artery morphogenesis [GO:0060982]; folate import across plasma membrane [GO:1904447]; male gonad development [GO:0008584]; metal ion transport [GO:0030001]; negative regulation of BMP signaling pathway [GO:0030514]; neural tube closure [GO:0001843]; neuron projection arborization [GO:0140058]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of lysosomal protein catabolic process [GO:1905167]; positive regulation of neurogenesis [GO:0050769]; positive regulation of oligodendrocyte progenitor proliferation [GO:0070447]; pulmonary artery morphogenesis [GO:0061156]; receptor-mediated endocytosis [GO:0006898]; secondary heart field specification [GO:0003139]; sensory perception of sound [GO:0007605]; vagina development [GO:0060068]; ventricular compact myocardium morphogenesis [GO:0003223] apical plasma membrane [GO:0016324]; axon [GO:0030424]; brush border membrane [GO:0031526]; clathrin-coated pit [GO:0005905]; dendrite [GO:0030425]; endosome lumen [GO:0031904]; external side of plasma membrane [GO:0009897]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; protein-folding chaperone binding [GO:0051087]; SH3 domain binding [GO:0017124] g10600.t1 C0HL13 29.096 354 9.19e-33 144.0 sp|C0HL13|LRP2_PIG Low-density lipoprotein receptor-related protein 2 OS=Sus scrofa OX=9823 GN=LRP2 PE=1 SV=1 LRP2_PIG reviewed Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin) Sus scrofa (Pig) GO:0001843; GO:0003139; GO:0003148; GO:0003223; GO:0005509; GO:0005905; GO:0006898; GO:0007605; GO:0008584; GO:0009897; GO:0016324; GO:0017124; GO:0030001; GO:0030424; GO:0030425; GO:0030514; GO:0031526; GO:0031904; GO:0043235; GO:0050769; GO:0051087; GO:0060068; GO:0060982; GO:0061156; GO:0070447; GO:0140058; GO:1904447; GO:1905167 coronary artery morphogenesis [GO:0060982]; folate import across plasma membrane [GO:1904447]; male gonad development [GO:0008584]; metal ion transport [GO:0030001]; negative regulation of BMP signaling pathway [GO:0030514]; neural tube closure [GO:0001843]; neuron projection arborization [GO:0140058]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of lysosomal protein catabolic process [GO:1905167]; positive regulation of neurogenesis [GO:0050769]; positive regulation of oligodendrocyte progenitor proliferation [GO:0070447]; pulmonary artery morphogenesis [GO:0061156]; receptor-mediated endocytosis [GO:0006898]; secondary heart field specification [GO:0003139]; sensory perception of sound [GO:0007605]; vagina development [GO:0060068]; ventricular compact myocardium morphogenesis [GO:0003223] apical plasma membrane [GO:0016324]; axon [GO:0030424]; brush border membrane [GO:0031526]; clathrin-coated pit [GO:0005905]; dendrite [GO:0030425]; endosome lumen [GO:0031904]; external side of plasma membrane [GO:0009897]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; protein-folding chaperone binding [GO:0051087]; SH3 domain binding [GO:0017124] g10600.t1 C0HL13 36.137 321 4.6600000000000003e-32 141.0 sp|C0HL13|LRP2_PIG Low-density lipoprotein receptor-related protein 2 OS=Sus scrofa OX=9823 GN=LRP2 PE=1 SV=1 LRP2_PIG reviewed Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin) Sus scrofa (Pig) GO:0001843; GO:0003139; GO:0003148; GO:0003223; GO:0005509; GO:0005905; GO:0006898; GO:0007605; GO:0008584; GO:0009897; GO:0016324; GO:0017124; GO:0030001; GO:0030424; GO:0030425; GO:0030514; GO:0031526; GO:0031904; GO:0043235; GO:0050769; GO:0051087; GO:0060068; GO:0060982; GO:0061156; GO:0070447; GO:0140058; GO:1904447; GO:1905167 coronary artery morphogenesis [GO:0060982]; folate import across plasma membrane [GO:1904447]; male gonad development [GO:0008584]; metal ion transport [GO:0030001]; negative regulation of BMP signaling pathway [GO:0030514]; neural tube closure [GO:0001843]; neuron projection arborization [GO:0140058]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of lysosomal protein catabolic process [GO:1905167]; positive regulation of neurogenesis [GO:0050769]; positive regulation of oligodendrocyte progenitor proliferation [GO:0070447]; pulmonary artery morphogenesis [GO:0061156]; receptor-mediated endocytosis [GO:0006898]; secondary heart field specification [GO:0003139]; sensory perception of sound [GO:0007605]; vagina development [GO:0060068]; ventricular compact myocardium morphogenesis [GO:0003223] apical plasma membrane [GO:0016324]; axon [GO:0030424]; brush border membrane [GO:0031526]; clathrin-coated pit [GO:0005905]; dendrite [GO:0030425]; endosome lumen [GO:0031904]; external side of plasma membrane [GO:0009897]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; protein-folding chaperone binding [GO:0051087]; SH3 domain binding [GO:0017124] g10600.t1 C0HL13 36.17 282 3.4e-25 119.0 sp|C0HL13|LRP2_PIG Low-density lipoprotein receptor-related protein 2 OS=Sus scrofa OX=9823 GN=LRP2 PE=1 SV=1 LRP2_PIG reviewed Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin) Sus scrofa (Pig) GO:0001843; GO:0003139; GO:0003148; GO:0003223; GO:0005509; GO:0005905; GO:0006898; GO:0007605; GO:0008584; GO:0009897; GO:0016324; GO:0017124; GO:0030001; GO:0030424; GO:0030425; GO:0030514; GO:0031526; GO:0031904; GO:0043235; GO:0050769; GO:0051087; GO:0060068; GO:0060982; GO:0061156; GO:0070447; GO:0140058; GO:1904447; GO:1905167 coronary artery morphogenesis [GO:0060982]; folate import across plasma membrane [GO:1904447]; male gonad development [GO:0008584]; metal ion transport [GO:0030001]; negative regulation of BMP signaling pathway [GO:0030514]; neural tube closure [GO:0001843]; neuron projection arborization [GO:0140058]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of lysosomal protein catabolic process [GO:1905167]; positive regulation of neurogenesis [GO:0050769]; positive regulation of oligodendrocyte progenitor proliferation [GO:0070447]; pulmonary artery morphogenesis [GO:0061156]; receptor-mediated endocytosis [GO:0006898]; secondary heart field specification [GO:0003139]; sensory perception of sound [GO:0007605]; vagina development [GO:0060068]; ventricular compact myocardium morphogenesis [GO:0003223] apical plasma membrane [GO:0016324]; axon [GO:0030424]; brush border membrane [GO:0031526]; clathrin-coated pit [GO:0005905]; dendrite [GO:0030425]; endosome lumen [GO:0031904]; external side of plasma membrane [GO:0009897]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; protein-folding chaperone binding [GO:0051087]; SH3 domain binding [GO:0017124] g10600.t1 C0HL13 28.571 357 2.78e-24 116.0 sp|C0HL13|LRP2_PIG Low-density lipoprotein receptor-related protein 2 OS=Sus scrofa OX=9823 GN=LRP2 PE=1 SV=1 LRP2_PIG reviewed Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin) Sus scrofa (Pig) GO:0001843; GO:0003139; GO:0003148; GO:0003223; GO:0005509; GO:0005905; GO:0006898; GO:0007605; GO:0008584; GO:0009897; GO:0016324; GO:0017124; GO:0030001; GO:0030424; GO:0030425; GO:0030514; GO:0031526; GO:0031904; GO:0043235; GO:0050769; GO:0051087; GO:0060068; GO:0060982; GO:0061156; GO:0070447; GO:0140058; GO:1904447; GO:1905167 coronary artery morphogenesis [GO:0060982]; folate import across plasma membrane [GO:1904447]; male gonad development [GO:0008584]; metal ion transport [GO:0030001]; negative regulation of BMP signaling pathway [GO:0030514]; neural tube closure [GO:0001843]; neuron projection arborization [GO:0140058]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of lysosomal protein catabolic process [GO:1905167]; positive regulation of neurogenesis [GO:0050769]; positive regulation of oligodendrocyte progenitor proliferation [GO:0070447]; pulmonary artery morphogenesis [GO:0061156]; receptor-mediated endocytosis [GO:0006898]; secondary heart field specification [GO:0003139]; sensory perception of sound [GO:0007605]; vagina development [GO:0060068]; ventricular compact myocardium morphogenesis [GO:0003223] apical plasma membrane [GO:0016324]; axon [GO:0030424]; brush border membrane [GO:0031526]; clathrin-coated pit [GO:0005905]; dendrite [GO:0030425]; endosome lumen [GO:0031904]; external side of plasma membrane [GO:0009897]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; protein-folding chaperone binding [GO:0051087]; SH3 domain binding [GO:0017124] g10600.t2 C0HL13 41.491 1704 0.0 1067.0 sp|C0HL13|LRP2_PIG Low-density lipoprotein receptor-related protein 2 OS=Sus scrofa OX=9823 GN=LRP2 PE=1 SV=1 LRP2_PIG reviewed Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin) Sus scrofa (Pig) GO:0001843; GO:0003139; GO:0003148; GO:0003223; GO:0005509; GO:0005905; GO:0006898; GO:0007605; GO:0008584; GO:0009897; GO:0016324; GO:0017124; GO:0030001; GO:0030424; GO:0030425; GO:0030514; GO:0031526; GO:0031904; GO:0043235; GO:0050769; GO:0051087; GO:0060068; GO:0060982; GO:0061156; GO:0070447; GO:0140058; GO:1904447; GO:1905167 coronary artery morphogenesis [GO:0060982]; folate import across plasma membrane [GO:1904447]; male gonad development [GO:0008584]; metal ion transport [GO:0030001]; negative regulation of BMP signaling pathway [GO:0030514]; neural tube closure [GO:0001843]; neuron projection arborization [GO:0140058]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of lysosomal protein catabolic process [GO:1905167]; positive regulation of neurogenesis [GO:0050769]; positive regulation of oligodendrocyte progenitor proliferation [GO:0070447]; pulmonary artery morphogenesis [GO:0061156]; receptor-mediated endocytosis [GO:0006898]; secondary heart field specification [GO:0003139]; sensory perception of sound [GO:0007605]; vagina development [GO:0060068]; ventricular compact myocardium morphogenesis [GO:0003223] apical plasma membrane [GO:0016324]; axon [GO:0030424]; brush border membrane [GO:0031526]; clathrin-coated pit [GO:0005905]; dendrite [GO:0030425]; endosome lumen [GO:0031904]; external side of plasma membrane [GO:0009897]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; protein-folding chaperone binding [GO:0051087]; SH3 domain binding [GO:0017124] g10600.t2 C0HL13 30.68 1294 9.96e-129 454.0 sp|C0HL13|LRP2_PIG Low-density lipoprotein receptor-related protein 2 OS=Sus scrofa OX=9823 GN=LRP2 PE=1 SV=1 LRP2_PIG reviewed Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin) Sus scrofa (Pig) GO:0001843; GO:0003139; GO:0003148; GO:0003223; GO:0005509; GO:0005905; GO:0006898; GO:0007605; GO:0008584; GO:0009897; GO:0016324; GO:0017124; GO:0030001; GO:0030424; GO:0030425; GO:0030514; GO:0031526; GO:0031904; GO:0043235; GO:0050769; GO:0051087; GO:0060068; GO:0060982; GO:0061156; GO:0070447; GO:0140058; GO:1904447; GO:1905167 coronary artery morphogenesis [GO:0060982]; folate import across plasma membrane [GO:1904447]; male gonad development [GO:0008584]; metal ion transport [GO:0030001]; negative regulation of BMP signaling pathway [GO:0030514]; neural tube closure [GO:0001843]; neuron projection arborization [GO:0140058]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of lysosomal protein catabolic process [GO:1905167]; positive regulation of neurogenesis [GO:0050769]; positive regulation of oligodendrocyte progenitor proliferation [GO:0070447]; pulmonary artery morphogenesis [GO:0061156]; receptor-mediated endocytosis [GO:0006898]; secondary heart field specification [GO:0003139]; sensory perception of sound [GO:0007605]; vagina development [GO:0060068]; ventricular compact myocardium morphogenesis [GO:0003223] apical plasma membrane [GO:0016324]; axon [GO:0030424]; brush border membrane [GO:0031526]; clathrin-coated pit [GO:0005905]; dendrite [GO:0030425]; endosome lumen [GO:0031904]; external side of plasma membrane [GO:0009897]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; protein-folding chaperone binding [GO:0051087]; SH3 domain binding [GO:0017124] g10600.t2 C0HL13 37.26 730 6.73e-99 360.0 sp|C0HL13|LRP2_PIG Low-density lipoprotein receptor-related protein 2 OS=Sus scrofa OX=9823 GN=LRP2 PE=1 SV=1 LRP2_PIG reviewed Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin) Sus scrofa (Pig) GO:0001843; GO:0003139; GO:0003148; GO:0003223; GO:0005509; GO:0005905; GO:0006898; GO:0007605; GO:0008584; GO:0009897; GO:0016324; GO:0017124; GO:0030001; GO:0030424; GO:0030425; GO:0030514; GO:0031526; GO:0031904; GO:0043235; GO:0050769; GO:0051087; GO:0060068; GO:0060982; GO:0061156; GO:0070447; GO:0140058; GO:1904447; GO:1905167 coronary artery morphogenesis [GO:0060982]; folate import across plasma membrane [GO:1904447]; male gonad development [GO:0008584]; metal ion transport [GO:0030001]; negative regulation of BMP signaling pathway [GO:0030514]; neural tube closure [GO:0001843]; neuron projection arborization [GO:0140058]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of lysosomal protein catabolic process [GO:1905167]; positive regulation of neurogenesis [GO:0050769]; positive regulation of oligodendrocyte progenitor proliferation [GO:0070447]; pulmonary artery morphogenesis [GO:0061156]; receptor-mediated endocytosis [GO:0006898]; secondary heart field specification [GO:0003139]; sensory perception of sound [GO:0007605]; vagina development [GO:0060068]; ventricular compact myocardium morphogenesis [GO:0003223] apical plasma membrane [GO:0016324]; axon [GO:0030424]; brush border membrane [GO:0031526]; clathrin-coated pit [GO:0005905]; dendrite [GO:0030425]; endosome lumen [GO:0031904]; external side of plasma membrane [GO:0009897]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; protein-folding chaperone binding [GO:0051087]; SH3 domain binding [GO:0017124] g10600.t2 C0HL13 33.288 739 3.03e-97 355.0 sp|C0HL13|LRP2_PIG Low-density lipoprotein receptor-related protein 2 OS=Sus scrofa OX=9823 GN=LRP2 PE=1 SV=1 LRP2_PIG reviewed Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin) Sus scrofa (Pig) GO:0001843; GO:0003139; GO:0003148; GO:0003223; GO:0005509; GO:0005905; GO:0006898; GO:0007605; GO:0008584; GO:0009897; GO:0016324; GO:0017124; GO:0030001; GO:0030424; GO:0030425; GO:0030514; GO:0031526; GO:0031904; GO:0043235; GO:0050769; GO:0051087; GO:0060068; GO:0060982; GO:0061156; GO:0070447; GO:0140058; GO:1904447; GO:1905167 coronary artery morphogenesis [GO:0060982]; folate import across plasma membrane [GO:1904447]; male gonad development [GO:0008584]; metal ion transport [GO:0030001]; negative regulation of BMP signaling pathway [GO:0030514]; neural tube closure [GO:0001843]; neuron projection arborization [GO:0140058]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of lysosomal protein catabolic process [GO:1905167]; positive regulation of neurogenesis [GO:0050769]; positive regulation of oligodendrocyte progenitor proliferation [GO:0070447]; pulmonary artery morphogenesis [GO:0061156]; receptor-mediated endocytosis [GO:0006898]; secondary heart field specification [GO:0003139]; sensory perception of sound [GO:0007605]; vagina development [GO:0060068]; ventricular compact myocardium morphogenesis [GO:0003223] apical plasma membrane [GO:0016324]; axon [GO:0030424]; brush border membrane [GO:0031526]; clathrin-coated pit [GO:0005905]; dendrite [GO:0030425]; endosome lumen [GO:0031904]; external side of plasma membrane [GO:0009897]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; protein-folding chaperone binding [GO:0051087]; SH3 domain binding [GO:0017124] g10600.t2 C0HL13 33.622 693 1.32e-84 314.0 sp|C0HL13|LRP2_PIG Low-density lipoprotein receptor-related protein 2 OS=Sus scrofa OX=9823 GN=LRP2 PE=1 SV=1 LRP2_PIG reviewed Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin) Sus scrofa (Pig) GO:0001843; GO:0003139; GO:0003148; GO:0003223; GO:0005509; GO:0005905; GO:0006898; GO:0007605; GO:0008584; GO:0009897; GO:0016324; GO:0017124; GO:0030001; GO:0030424; GO:0030425; GO:0030514; GO:0031526; GO:0031904; GO:0043235; GO:0050769; GO:0051087; GO:0060068; GO:0060982; GO:0061156; GO:0070447; GO:0140058; GO:1904447; GO:1905167 coronary artery morphogenesis [GO:0060982]; folate import across plasma membrane [GO:1904447]; male gonad development [GO:0008584]; metal ion transport [GO:0030001]; negative regulation of BMP signaling pathway [GO:0030514]; neural tube closure [GO:0001843]; neuron projection arborization [GO:0140058]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of lysosomal protein catabolic process [GO:1905167]; positive regulation of neurogenesis [GO:0050769]; positive regulation of oligodendrocyte progenitor proliferation [GO:0070447]; pulmonary artery morphogenesis [GO:0061156]; receptor-mediated endocytosis [GO:0006898]; secondary heart field specification [GO:0003139]; sensory perception of sound [GO:0007605]; vagina development [GO:0060068]; ventricular compact myocardium morphogenesis [GO:0003223] apical plasma membrane [GO:0016324]; axon [GO:0030424]; brush border membrane [GO:0031526]; clathrin-coated pit [GO:0005905]; dendrite [GO:0030425]; endosome lumen [GO:0031904]; external side of plasma membrane [GO:0009897]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; protein-folding chaperone binding [GO:0051087]; SH3 domain binding [GO:0017124] g10600.t2 C0HL13 29.926 812 8.55e-74 278.0 sp|C0HL13|LRP2_PIG Low-density lipoprotein receptor-related protein 2 OS=Sus scrofa OX=9823 GN=LRP2 PE=1 SV=1 LRP2_PIG reviewed Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin) Sus scrofa (Pig) GO:0001843; GO:0003139; GO:0003148; GO:0003223; GO:0005509; GO:0005905; GO:0006898; GO:0007605; GO:0008584; GO:0009897; GO:0016324; GO:0017124; GO:0030001; GO:0030424; GO:0030425; GO:0030514; GO:0031526; GO:0031904; GO:0043235; GO:0050769; GO:0051087; GO:0060068; GO:0060982; GO:0061156; GO:0070447; GO:0140058; GO:1904447; GO:1905167 coronary artery morphogenesis [GO:0060982]; folate import across plasma membrane [GO:1904447]; male gonad development [GO:0008584]; metal ion transport [GO:0030001]; negative regulation of BMP signaling pathway [GO:0030514]; neural tube closure [GO:0001843]; neuron projection arborization [GO:0140058]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of lysosomal protein catabolic process [GO:1905167]; positive regulation of neurogenesis [GO:0050769]; positive regulation of oligodendrocyte progenitor proliferation [GO:0070447]; pulmonary artery morphogenesis [GO:0061156]; receptor-mediated endocytosis [GO:0006898]; secondary heart field specification [GO:0003139]; sensory perception of sound [GO:0007605]; vagina development [GO:0060068]; ventricular compact myocardium morphogenesis [GO:0003223] apical plasma membrane [GO:0016324]; axon [GO:0030424]; brush border membrane [GO:0031526]; clathrin-coated pit [GO:0005905]; dendrite [GO:0030425]; endosome lumen [GO:0031904]; external side of plasma membrane [GO:0009897]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; protein-folding chaperone binding [GO:0051087]; SH3 domain binding [GO:0017124] g10600.t2 C0HL13 28.273 718 2.41e-54 215.0 sp|C0HL13|LRP2_PIG Low-density lipoprotein receptor-related protein 2 OS=Sus scrofa OX=9823 GN=LRP2 PE=1 SV=1 LRP2_PIG reviewed Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin) Sus scrofa (Pig) GO:0001843; GO:0003139; GO:0003148; GO:0003223; GO:0005509; GO:0005905; GO:0006898; GO:0007605; GO:0008584; GO:0009897; GO:0016324; GO:0017124; GO:0030001; GO:0030424; GO:0030425; GO:0030514; GO:0031526; GO:0031904; GO:0043235; GO:0050769; GO:0051087; GO:0060068; GO:0060982; GO:0061156; GO:0070447; GO:0140058; GO:1904447; GO:1905167 coronary artery morphogenesis [GO:0060982]; folate import across plasma membrane [GO:1904447]; male gonad development [GO:0008584]; metal ion transport [GO:0030001]; negative regulation of BMP signaling pathway [GO:0030514]; neural tube closure [GO:0001843]; neuron projection arborization [GO:0140058]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of lysosomal protein catabolic process [GO:1905167]; positive regulation of neurogenesis [GO:0050769]; positive regulation of oligodendrocyte progenitor proliferation [GO:0070447]; pulmonary artery morphogenesis [GO:0061156]; receptor-mediated endocytosis [GO:0006898]; secondary heart field specification [GO:0003139]; sensory perception of sound [GO:0007605]; vagina development [GO:0060068]; ventricular compact myocardium morphogenesis [GO:0003223] apical plasma membrane [GO:0016324]; axon [GO:0030424]; brush border membrane [GO:0031526]; clathrin-coated pit [GO:0005905]; dendrite [GO:0030425]; endosome lumen [GO:0031904]; external side of plasma membrane [GO:0009897]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; protein-folding chaperone binding [GO:0051087]; SH3 domain binding [GO:0017124] g10600.t2 C0HL13 28.628 758 6.15e-49 197.0 sp|C0HL13|LRP2_PIG Low-density lipoprotein receptor-related protein 2 OS=Sus scrofa OX=9823 GN=LRP2 PE=1 SV=1 LRP2_PIG reviewed Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin) Sus scrofa (Pig) GO:0001843; GO:0003139; GO:0003148; GO:0003223; GO:0005509; GO:0005905; GO:0006898; GO:0007605; GO:0008584; GO:0009897; GO:0016324; GO:0017124; GO:0030001; GO:0030424; GO:0030425; GO:0030514; GO:0031526; GO:0031904; GO:0043235; GO:0050769; GO:0051087; GO:0060068; GO:0060982; GO:0061156; GO:0070447; GO:0140058; GO:1904447; GO:1905167 coronary artery morphogenesis [GO:0060982]; folate import across plasma membrane [GO:1904447]; male gonad development [GO:0008584]; metal ion transport [GO:0030001]; negative regulation of BMP signaling pathway [GO:0030514]; neural tube closure [GO:0001843]; neuron projection arborization [GO:0140058]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of lysosomal protein catabolic process [GO:1905167]; positive regulation of neurogenesis [GO:0050769]; positive regulation of oligodendrocyte progenitor proliferation [GO:0070447]; pulmonary artery morphogenesis [GO:0061156]; receptor-mediated endocytosis [GO:0006898]; secondary heart field specification [GO:0003139]; sensory perception of sound [GO:0007605]; vagina development [GO:0060068]; ventricular compact myocardium morphogenesis [GO:0003223] apical plasma membrane [GO:0016324]; axon [GO:0030424]; brush border membrane [GO:0031526]; clathrin-coated pit [GO:0005905]; dendrite [GO:0030425]; endosome lumen [GO:0031904]; external side of plasma membrane [GO:0009897]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; protein-folding chaperone binding [GO:0051087]; SH3 domain binding [GO:0017124] g10600.t2 C0HL13 38.591 298 3.23e-34 149.0 sp|C0HL13|LRP2_PIG Low-density lipoprotein receptor-related protein 2 OS=Sus scrofa OX=9823 GN=LRP2 PE=1 SV=1 LRP2_PIG reviewed Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin) Sus scrofa (Pig) GO:0001843; GO:0003139; GO:0003148; GO:0003223; GO:0005509; GO:0005905; GO:0006898; GO:0007605; GO:0008584; GO:0009897; GO:0016324; GO:0017124; GO:0030001; GO:0030424; GO:0030425; GO:0030514; GO:0031526; GO:0031904; GO:0043235; GO:0050769; GO:0051087; GO:0060068; GO:0060982; GO:0061156; GO:0070447; GO:0140058; GO:1904447; GO:1905167 coronary artery morphogenesis [GO:0060982]; folate import across plasma membrane [GO:1904447]; male gonad development [GO:0008584]; metal ion transport [GO:0030001]; negative regulation of BMP signaling pathway [GO:0030514]; neural tube closure [GO:0001843]; neuron projection arborization [GO:0140058]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of lysosomal protein catabolic process [GO:1905167]; positive regulation of neurogenesis [GO:0050769]; positive regulation of oligodendrocyte progenitor proliferation [GO:0070447]; pulmonary artery morphogenesis [GO:0061156]; receptor-mediated endocytosis [GO:0006898]; secondary heart field specification [GO:0003139]; sensory perception of sound [GO:0007605]; vagina development [GO:0060068]; ventricular compact myocardium morphogenesis [GO:0003223] apical plasma membrane [GO:0016324]; axon [GO:0030424]; brush border membrane [GO:0031526]; clathrin-coated pit [GO:0005905]; dendrite [GO:0030425]; endosome lumen [GO:0031904]; external side of plasma membrane [GO:0009897]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; protein-folding chaperone binding [GO:0051087]; SH3 domain binding [GO:0017124] g10600.t2 C0HL13 29.096 354 9.33e-33 144.0 sp|C0HL13|LRP2_PIG Low-density lipoprotein receptor-related protein 2 OS=Sus scrofa OX=9823 GN=LRP2 PE=1 SV=1 LRP2_PIG reviewed Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin) Sus scrofa (Pig) GO:0001843; GO:0003139; GO:0003148; GO:0003223; GO:0005509; GO:0005905; GO:0006898; GO:0007605; GO:0008584; GO:0009897; GO:0016324; GO:0017124; GO:0030001; GO:0030424; GO:0030425; GO:0030514; GO:0031526; GO:0031904; GO:0043235; GO:0050769; GO:0051087; GO:0060068; GO:0060982; GO:0061156; GO:0070447; GO:0140058; GO:1904447; GO:1905167 coronary artery morphogenesis [GO:0060982]; folate import across plasma membrane [GO:1904447]; male gonad development [GO:0008584]; metal ion transport [GO:0030001]; negative regulation of BMP signaling pathway [GO:0030514]; neural tube closure [GO:0001843]; neuron projection arborization [GO:0140058]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of lysosomal protein catabolic process [GO:1905167]; positive regulation of neurogenesis [GO:0050769]; positive regulation of oligodendrocyte progenitor proliferation [GO:0070447]; pulmonary artery morphogenesis [GO:0061156]; receptor-mediated endocytosis [GO:0006898]; secondary heart field specification [GO:0003139]; sensory perception of sound [GO:0007605]; vagina development [GO:0060068]; ventricular compact myocardium morphogenesis [GO:0003223] apical plasma membrane [GO:0016324]; axon [GO:0030424]; brush border membrane [GO:0031526]; clathrin-coated pit [GO:0005905]; dendrite [GO:0030425]; endosome lumen [GO:0031904]; external side of plasma membrane [GO:0009897]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; protein-folding chaperone binding [GO:0051087]; SH3 domain binding [GO:0017124] g10600.t2 C0HL13 36.137 321 3.9600000000000003e-32 142.0 sp|C0HL13|LRP2_PIG Low-density lipoprotein receptor-related protein 2 OS=Sus scrofa OX=9823 GN=LRP2 PE=1 SV=1 LRP2_PIG reviewed Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin) Sus scrofa (Pig) GO:0001843; GO:0003139; GO:0003148; GO:0003223; GO:0005509; GO:0005905; GO:0006898; GO:0007605; GO:0008584; GO:0009897; GO:0016324; GO:0017124; GO:0030001; GO:0030424; GO:0030425; GO:0030514; GO:0031526; GO:0031904; GO:0043235; GO:0050769; GO:0051087; GO:0060068; GO:0060982; GO:0061156; GO:0070447; GO:0140058; GO:1904447; GO:1905167 coronary artery morphogenesis [GO:0060982]; folate import across plasma membrane [GO:1904447]; male gonad development [GO:0008584]; metal ion transport [GO:0030001]; negative regulation of BMP signaling pathway [GO:0030514]; neural tube closure [GO:0001843]; neuron projection arborization [GO:0140058]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of lysosomal protein catabolic process [GO:1905167]; positive regulation of neurogenesis [GO:0050769]; positive regulation of oligodendrocyte progenitor proliferation [GO:0070447]; pulmonary artery morphogenesis [GO:0061156]; receptor-mediated endocytosis [GO:0006898]; secondary heart field specification [GO:0003139]; sensory perception of sound [GO:0007605]; vagina development [GO:0060068]; ventricular compact myocardium morphogenesis [GO:0003223] apical plasma membrane [GO:0016324]; axon [GO:0030424]; brush border membrane [GO:0031526]; clathrin-coated pit [GO:0005905]; dendrite [GO:0030425]; endosome lumen [GO:0031904]; external side of plasma membrane [GO:0009897]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; protein-folding chaperone binding [GO:0051087]; SH3 domain binding [GO:0017124] g10600.t2 C0HL13 36.17 282 2.82e-25 119.0 sp|C0HL13|LRP2_PIG Low-density lipoprotein receptor-related protein 2 OS=Sus scrofa OX=9823 GN=LRP2 PE=1 SV=1 LRP2_PIG reviewed Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin) Sus scrofa (Pig) GO:0001843; GO:0003139; GO:0003148; GO:0003223; GO:0005509; GO:0005905; GO:0006898; GO:0007605; GO:0008584; GO:0009897; GO:0016324; GO:0017124; GO:0030001; GO:0030424; GO:0030425; GO:0030514; GO:0031526; GO:0031904; GO:0043235; GO:0050769; GO:0051087; GO:0060068; GO:0060982; GO:0061156; GO:0070447; GO:0140058; GO:1904447; GO:1905167 coronary artery morphogenesis [GO:0060982]; folate import across plasma membrane [GO:1904447]; male gonad development [GO:0008584]; metal ion transport [GO:0030001]; negative regulation of BMP signaling pathway [GO:0030514]; neural tube closure [GO:0001843]; neuron projection arborization [GO:0140058]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of lysosomal protein catabolic process [GO:1905167]; positive regulation of neurogenesis [GO:0050769]; positive regulation of oligodendrocyte progenitor proliferation [GO:0070447]; pulmonary artery morphogenesis [GO:0061156]; receptor-mediated endocytosis [GO:0006898]; secondary heart field specification [GO:0003139]; sensory perception of sound [GO:0007605]; vagina development [GO:0060068]; ventricular compact myocardium morphogenesis [GO:0003223] apical plasma membrane [GO:0016324]; axon [GO:0030424]; brush border membrane [GO:0031526]; clathrin-coated pit [GO:0005905]; dendrite [GO:0030425]; endosome lumen [GO:0031904]; external side of plasma membrane [GO:0009897]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; protein-folding chaperone binding [GO:0051087]; SH3 domain binding [GO:0017124] g10600.t2 C0HL13 28.571 357 2.89e-24 116.0 sp|C0HL13|LRP2_PIG Low-density lipoprotein receptor-related protein 2 OS=Sus scrofa OX=9823 GN=LRP2 PE=1 SV=1 LRP2_PIG reviewed Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin) Sus scrofa (Pig) GO:0001843; GO:0003139; GO:0003148; GO:0003223; GO:0005509; GO:0005905; GO:0006898; GO:0007605; GO:0008584; GO:0009897; GO:0016324; GO:0017124; GO:0030001; GO:0030424; GO:0030425; GO:0030514; GO:0031526; GO:0031904; GO:0043235; GO:0050769; GO:0051087; GO:0060068; GO:0060982; GO:0061156; GO:0070447; GO:0140058; GO:1904447; GO:1905167 coronary artery morphogenesis [GO:0060982]; folate import across plasma membrane [GO:1904447]; male gonad development [GO:0008584]; metal ion transport [GO:0030001]; negative regulation of BMP signaling pathway [GO:0030514]; neural tube closure [GO:0001843]; neuron projection arborization [GO:0140058]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of lysosomal protein catabolic process [GO:1905167]; positive regulation of neurogenesis [GO:0050769]; positive regulation of oligodendrocyte progenitor proliferation [GO:0070447]; pulmonary artery morphogenesis [GO:0061156]; receptor-mediated endocytosis [GO:0006898]; secondary heart field specification [GO:0003139]; sensory perception of sound [GO:0007605]; vagina development [GO:0060068]; ventricular compact myocardium morphogenesis [GO:0003223] apical plasma membrane [GO:0016324]; axon [GO:0030424]; brush border membrane [GO:0031526]; clathrin-coated pit [GO:0005905]; dendrite [GO:0030425]; endosome lumen [GO:0031904]; external side of plasma membrane [GO:0009897]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; protein-folding chaperone binding [GO:0051087]; SH3 domain binding [GO:0017124] g10601.t1 Q9Y6R7 26.183 317 2.0600000000000002e-21 103.0 sp|Q9Y6R7|FCGBP_HUMAN IgGFc-binding protein OS=Homo sapiens OX=9606 GN=FCGBP PE=1 SV=3 FCGBP_HUMAN reviewed IgGFc-binding protein (Fcgamma-binding protein antigen) (FcgammaBP) Homo sapiens (Human) GO:0005201; GO:0005615; GO:0005796; GO:0031012; GO:0070062 extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796] extracellular matrix structural constituent [GO:0005201] g10603.t1 Q5RF84 84.242 165 6.96e-102 293.0 sp|Q5RF84|UB2G2_PONAB Ubiquitin-conjugating enzyme E2 G2 OS=Pongo abelii OX=9601 GN=UBE2G2 PE=2 SV=1 UB2G2_PONAB reviewed Ubiquitin-conjugating enzyme E2 G2 (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme G2) (Ubiquitin carrier protein G2) (Ubiquitin-protein ligase G2) Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0004842; GO:0005524; GO:0005783; GO:0005811; GO:0005829; GO:0035458; GO:0036503; GO:0042802; GO:0061631; GO:0070936; GO:1904153 cellular response to interferon-beta [GO:0035458]; ERAD pathway [GO:0036503]; negative regulation of retrograde protein transport, ER to cytosol [GO:1904153]; protein K48-linked ubiquitination [GO:0070936] cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; lipid droplet [GO:0005811] ATP binding [GO:0005524]; identical protein binding [GO:0042802]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842] g10604.t1 O42131 66.592 1341 0.0 1806.0 sp|O42131|TOP2B_CHICK DNA topoisomerase 2-beta OS=Gallus gallus OX=9031 GN=TOP2B PE=2 SV=1 g10606.t1 Q9H4F1 38.115 244 1.72e-53 182.0 sp|Q9H4F1|SIA7D_HUMAN Alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1,3-N-acetyl-galactosaminide alpha-2,6-sialyltransferase OS=Homo sapiens OX=9606 GN=ST6GALNAC4 PE=1 SV=2 g10607.t1 Q9VZF4 29.622 503 4.6599999999999994e-46 181.0 sp|Q9VZF4|FBXW7_DROME F-box/WD repeat-containing protein 7 OS=Drosophila melanogaster OX=7227 GN=ago PE=1 SV=1 FBXW7_DROME reviewed F-box/WD repeat-containing protein 7 (F-box and WD-40 domain-containing protein 7) (Protein archipelago) Drosophila melanogaster (Fruit fly) GO:0005634; GO:0007088; GO:0007096; GO:0007419; GO:0016567; GO:0019005; GO:0030162; GO:0030332; GO:0031146; GO:0035147; GO:0042023; GO:0045571; GO:0045926; GO:0060253; GO:0060438; GO:0071456; GO:1900038; GO:1990381 branch fusion, open tracheal system [GO:0035147]; cellular response to hypoxia [GO:0071456]; DNA endoreduplication [GO:0042023]; negative regulation of cellular response to hypoxia [GO:1900038]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of growth [GO:0045926]; negative regulation of imaginal disc growth [GO:0045571]; protein ubiquitination [GO:0016567]; regulation of exit from mitosis [GO:0007096]; regulation of mitotic nuclear division [GO:0007088]; regulation of proteolysis [GO:0030162]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; trachea development [GO:0060438]; ventral cord development [GO:0007419] nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005] cyclin binding [GO:0030332]; ubiquitin-specific protease binding [GO:1990381] g10608.t1 Q6UXS0 40.625 160 1.7300000000000001e-29 114.0 sp|Q6UXS0|CL19A_HUMAN C-type lectin domain family 19 member A OS=Homo sapiens OX=9606 GN=CLEC19A PE=1 SV=2 g10609.t1 Q91ZT9 52.107 261 9.91e-98 291.0 sp|Q91ZT9|ASB8_MOUSE Ankyrin repeat and SOCS box protein 8 OS=Mus musculus OX=10090 GN=Asb8 PE=2 SV=1 g10610.t1 P80204 74.328 335 5.3499999999999995e-180 520.0 sp|P80204|TGFR1_RAT TGF-beta receptor type-1 OS=Rattus norvegicus OX=10116 GN=Tgfbr1 PE=1 SV=1 TGFR1_RAT reviewed TGF-beta receptor type-1 (TGFR-1) (EC 2.7.11.30) (Serine/threonine-protein kinase receptor R4) (SKR4) (TGF-beta type I receptor) (Transforming growth factor-beta receptor type I) (TGF-beta receptor type I) (TbetaR-I) Rattus norvegicus (Rat) GO:0001501; GO:0001525; GO:0001666; GO:0001701; GO:0001822; GO:0001824; GO:0001837; GO:0001937; GO:0001938; GO:0002088; GO:0003222; GO:0003223; GO:0004672; GO:0004674; GO:0004675; GO:0005024; GO:0005025; GO:0005102; GO:0005114; GO:0005524; GO:0005634; GO:0005654; GO:0005768; GO:0005886; GO:0005901; GO:0005923; GO:0005929; GO:0006355; GO:0006915; GO:0007165; GO:0007179; GO:0007399; GO:0007507; GO:0007566; GO:0008284; GO:0008354; GO:0008584; GO:0009636; GO:0009791; GO:0009952; GO:0009986; GO:0010468; GO:0010628; GO:0010717; GO:0010718; GO:0016323; GO:0016324; GO:0016361; GO:0030199; GO:0030307; GO:0030324; GO:0030335; GO:0030336; GO:0031100; GO:0031396; GO:0031625; GO:0032331; GO:0032924; GO:0032991; GO:0034695; GO:0035556; GO:0036446; GO:0042118; GO:0043065; GO:0043066; GO:0043235; GO:0043542; GO:0043627; GO:0044877; GO:0045121; GO:0045602; GO:0045893; GO:0046332; GO:0046872; GO:0048179; GO:0048185; GO:0048538; GO:0048565; GO:0048663; GO:0048701; GO:0048705; GO:0048762; GO:0048844; GO:0048870; GO:0050431; GO:0051491; GO:0051496; GO:0051602; GO:0051897; GO:0060017; GO:0060021; GO:0060037; GO:0060043; GO:0060317; GO:0060391; GO:0060395; GO:0060412; GO:0060978; GO:0060982; GO:0061450; GO:0070021; GO:0070411; GO:0070723; GO:0071363; GO:0071560; GO:0101023; GO:1901203; GO:1902462; GO:1902894; GO:1902895; GO:1904018; GO:1905007; GO:1905075; GO:1905223; GO:2001235; GO:2001237 activin receptor signaling pathway [GO:0032924]; angiogenesis [GO:0001525]; angiogenesis involved in coronary vascular morphogenesis [GO:0060978]; animal organ regeneration [GO:0031100]; anterior/posterior pattern specification [GO:0009952]; apoptotic process [GO:0006915]; artery morphogenesis [GO:0048844]; blastocyst development [GO:0001824]; cardiac epithelial to mesenchymal transition [GO:0060317]; cell motility [GO:0048870]; cellular response to growth factor stimulus [GO:0071363]; cellular response to transforming growth factor beta stimulus [GO:0071560]; collagen fibril organization [GO:0030199]; coronary artery morphogenesis [GO:0060982]; digestive tract development [GO:0048565]; embryo implantation [GO:0007566]; embryonic cranial skeleton morphogenesis [GO:0048701]; endothelial cell activation [GO:0042118]; endothelial cell migration [GO:0043542]; epicardium morphogenesis [GO:1905223]; epithelial to mesenchymal transition [GO:0001837]; germ cell migration [GO:0008354]; heart development [GO:0007507]; in utero embryonic development [GO:0001701]; intracellular signal transduction [GO:0035556]; kidney development [GO:0001822]; lens development in camera-type eye [GO:0002088]; lung development [GO:0030324]; male gonad development [GO:0008584]; mesenchymal cell differentiation [GO:0048762]; myofibroblast differentiation [GO:0036446]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell migration [GO:0030336]; negative regulation of chondrocyte differentiation [GO:0032331]; negative regulation of endothelial cell differentiation [GO:0045602]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of miRNA transcription [GO:1902894]; nervous system development [GO:0007399]; neuron fate commitment [GO:0048663]; parathyroid gland development [GO:0060017]; pharyngeal system development [GO:0060037]; positive regulation of apoptotic process [GO:0043065]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation [GO:1905007]; positive regulation of extracellular matrix assembly [GO:1901203]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of gene expression [GO:0010628]; positive regulation of mesenchymal stem cell proliferation [GO:1902462]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of SMAD protein signal transduction [GO:0060391]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of tight junction disassembly [GO:1905075]; positive regulation of vasculature development [GO:1904018]; post-embryonic development [GO:0009791]; regulation of cardiac muscle cell proliferation [GO:0060043]; regulation of DNA-templated transcription [GO:0006355]; regulation of epithelial to mesenchymal transition [GO:0010717]; regulation of gene expression [GO:0010468]; regulation of protein ubiquitination [GO:0031396]; response to cholesterol [GO:0070723]; response to electrical stimulus [GO:0051602]; response to estrogen [GO:0043627]; response to hypoxia [GO:0001666]; response to prostaglandin E [GO:0034695]; response to toxic substance [GO:0009636]; roof of mouth development [GO:0060021]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; skeletal system morphogenesis [GO:0048705]; SMAD protein signal transduction [GO:0060395]; thymus development [GO:0048538]; transforming growth factor beta receptor signaling pathway [GO:0007179]; trophoblast cell migration [GO:0061450]; vascular endothelial cell proliferation [GO:0101023]; ventricular compact myocardium morphogenesis [GO:0003223]; ventricular septum morphogenesis [GO:0060412]; ventricular trabecula myocardium morphogenesis [GO:0003222] activin receptor complex [GO:0048179]; apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; bicellular tight junction [GO:0005923]; caveola [GO:0005901]; cell surface [GO:0009986]; cilium [GO:0005929]; endosome [GO:0005768]; membrane raft [GO:0045121]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; receptor complex [GO:0043235]; transforming growth factor beta ligand-receptor complex [GO:0070021] activin binding [GO:0048185]; activin receptor activity, type I [GO:0016361]; ATP binding [GO:0005524]; I-SMAD binding [GO:0070411]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; protein-containing complex binding [GO:0044877]; signaling receptor binding [GO:0005102]; SMAD binding [GO:0046332]; transforming growth factor beta binding [GO:0050431]; transforming growth factor beta receptor activity [GO:0005024]; transforming growth factor beta receptor activity, type I [GO:0005025]; transmembrane receptor protein serine/threonine kinase activity [GO:0004675]; type II transforming growth factor beta receptor binding [GO:0005114]; ubiquitin protein ligase binding [GO:0031625] g10612.t1 Q08BY5 55.59 322 9.110000000000001e-129 384.0 sp|Q08BY5|JMJD4_DANRE 2-oxoglutarate and iron-dependent oxygenase JMJD4 OS=Danio rerio OX=7955 GN=jmjd4 PE=2 SV=1 g10613.t1 Q9QZ86 61.233 454 8.979999999999999e-176 508.0 sp|Q9QZ86|NOP58_RAT Nucleolar protein 58 OS=Rattus norvegicus OX=10116 GN=Nop58 PE=1 SV=1 NOP58_RAT reviewed Nucleolar protein 58 (Nopp140-associated protein of 65 kDa) (Nucleolar protein 5) Rattus norvegicus (Rat) GO:0001094; GO:0001650; GO:0005654; GO:0005730; GO:0005732; GO:0005829; GO:0015030; GO:0030515; GO:0031428; GO:0032040; GO:0042274; GO:0048254; GO:0051117; GO:0070761 ribosomal small subunit biogenesis [GO:0042274]; snoRNA localization [GO:0048254] box C/D methylation guide snoRNP complex [GO:0031428]; Cajal body [GO:0015030]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; pre-snoRNP complex [GO:0070761]; small-subunit processome [GO:0032040]; sno(s)RNA-containing ribonucleoprotein complex [GO:0005732] ATPase binding [GO:0051117]; snoRNA binding [GO:0030515]; TFIID-class transcription factor complex binding [GO:0001094] g10615.t1 Q19AZ8 38.756 209 1.9400000000000002e-32 136.0 sp|Q19AZ8|THRB_PIG Prothrombin OS=Sus scrofa OX=9823 GN=F2 PE=2 SV=1 THRB_PIG reviewed Prothrombin (EC 3.4.21.5) (Coagulation factor II) [Cleaved into: Activation peptide fragment 1; Activation peptide fragment 2; Thrombin light chain; Thrombin heavy chain] Sus scrofa (Pig) GO:0004252; GO:0005509; GO:0005615; GO:0006508; GO:0006953; GO:0030168; GO:0030194 acute-phase response [GO:0006953]; platelet activation [GO:0030168]; positive regulation of blood coagulation [GO:0030194]; proteolysis [GO:0006508] extracellular space [GO:0005615] calcium ion binding [GO:0005509]; serine-type endopeptidase activity [GO:0004252] g10616.t1 A0A8M9Q308 50.0 480 6.08e-154 451.0 sp|A0A8M9Q308|FLC2B_DANRE Choline/ethanolamine transporter flvcr2b OS=Danio rerio OX=7955 GN=flvcr2b PE=3 SV=1 FLC2B_DANRE reviewed Choline/ethanolamine transporter flvcr2b (Feline leukemia virus subgroup C receptor-related protein 2 homolog B) (Heme transporter flvcr2b) (Major facilitator superfamily domain containing 7C-b) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005789; GO:0005886; GO:0015220; GO:0031966; GO:0034228; GO:0150104 transport across blood-brain barrier [GO:0150104] endoplasmic reticulum membrane [GO:0005789]; mitochondrial membrane [GO:0031966]; plasma membrane [GO:0005886] choline transmembrane transporter activity [GO:0015220]; ethanolamine transmembrane transporter activity [GO:0034228] g10617.t1 P43354 63.609 338 5.57e-128 399.0 sp|P43354|NR4A2_HUMAN Nuclear receptor subfamily 4 group A member 2 OS=Homo sapiens OX=9606 GN=NR4A2 PE=1 SV=1 NR4A2_HUMAN reviewed Nuclear receptor subfamily 4 group A member 2 (Immediate-early response protein NOT) (Orphan nuclear receptor NURR1) (Transcriptionally-inducible nuclear receptor) Homo sapiens (Human) GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0001666; GO:0001764; GO:0001975; GO:0003677; GO:0004879; GO:0005634; GO:0005654; GO:0005667; GO:0005737; GO:0006351; GO:0006357; GO:0006366; GO:0008013; GO:0008270; GO:0008344; GO:0009791; GO:0016607; GO:0021952; GO:0021953; GO:0021986; GO:0032991; GO:0034599; GO:0035259; GO:0042053; GO:0042416; GO:0042551; GO:0043524; GO:0043576; GO:0045444; GO:0045944; GO:0046965; GO:0046982; GO:0051402; GO:0051866; GO:0060070; GO:0071376; GO:0071542; GO:1904948; GO:1990837; GO:2001234 adult locomotory behavior [GO:0008344]; canonical Wnt signaling pathway [GO:0060070]; cellular response to corticotropin-releasing hormone stimulus [GO:0071376]; cellular response to oxidative stress [GO:0034599]; central nervous system neuron differentiation [GO:0021953]; central nervous system projection neuron axonogenesis [GO:0021952]; DNA-templated transcription [GO:0006351]; dopamine biosynthetic process [GO:0042416]; dopaminergic neuron differentiation [GO:0071542]; fat cell differentiation [GO:0045444]; general adaptation syndrome [GO:0051866]; habenula development [GO:0021986]; midbrain dopaminergic neuron differentiation [GO:1904948]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron apoptotic process [GO:0051402]; neuron maturation [GO:0042551]; neuron migration [GO:0001764]; positive regulation of transcription by RNA polymerase II [GO:0045944]; post-embryonic development [GO:0009791]; regulation of dopamine metabolic process [GO:0042053]; regulation of respiratory gaseous exchange [GO:0043576]; regulation of transcription by RNA polymerase II [GO:0006357]; response to amphetamine [GO:0001975]; response to hypoxia [GO:0001666]; transcription by RNA polymerase II [GO:0006366] chromatin [GO:0000785]; cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcription regulator complex [GO:0005667] beta-catenin binding [GO:0008013]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; nuclear glucocorticoid receptor binding [GO:0035259]; nuclear receptor activity [GO:0004879]; nuclear retinoid X receptor binding [GO:0046965]; protein heterodimerization activity [GO:0046982]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; zinc ion binding [GO:0008270] g10619.t1 P43304 64.441 689 0.0 925.0 sp|P43304|GPDM_HUMAN Glycerol-3-phosphate dehydrogenase, mitochondrial OS=Homo sapiens OX=9606 GN=GPD2 PE=1 SV=3 GPDM_HUMAN reviewed Glycerol-3-phosphate dehydrogenase, mitochondrial (GPD-M) (GPDH-M) (EC 1.1.5.3) (mitochondrial glycerophosphate dehydrogenase gene) (mGDH) (mtGPD) Homo sapiens (Human) GO:0004368; GO:0005509; GO:0005739; GO:0005743; GO:0006072; GO:0006094; GO:0006127; GO:0019563; GO:0035264; GO:0043010; GO:0047952 camera-type eye development [GO:0043010]; gluconeogenesis [GO:0006094]; glycerol catabolic process [GO:0019563]; glycerol-3-phosphate metabolic process [GO:0006072]; glycerol-3-phosphate shuttle [GO:0006127]; multicellular organism growth [GO:0035264] mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739] calcium ion binding [GO:0005509]; glycerol-3-phosphate dehydrogenase (quinone) activity [GO:0004368]; glycerol-3-phosphate dehydrogenase [NAD(P)+] activity [GO:0047952] g10621.t1 P08594 43.094 362 5.2e-67 223.0 sp|P08594|AQL1_THEAQ Aqualysin-1 OS=Thermus aquaticus OX=271 GN=pstI PE=1 SV=2 g10622.t1 Q8R367 36.735 196 9.46e-38 135.0 sp|Q8R367|RERG_MOUSE Ras-related and estrogen-regulated growth inhibitor OS=Mus musculus OX=10090 GN=Rerg PE=2 SV=1 g10623.t1 Q8JZR6 55.497 755 0.0 721.0 sp|Q8JZR6|S4A8_MOUSE Electroneutral sodium bicarbonate exchanger 1 OS=Mus musculus OX=10090 GN=Slc4a8 PE=1 SV=1 S4A8_MOUSE reviewed Electroneutral sodium bicarbonate exchanger 1 (Electroneutral Na+-driven Cl-HCO3 exchanger) (Solute carrier family 4 member 8) (k-NBC3) Mus musculus (Mouse) GO:0005886; GO:0008021; GO:0008270; GO:0008510; GO:0015081; GO:0015106; GO:0015108; GO:0015701; GO:0016020; GO:0016323; GO:0016324; GO:0030425; GO:0030672; GO:0032279; GO:0032280; GO:0032809; GO:0035725; GO:0042391; GO:0042734; GO:0042802; GO:0043005; GO:0043195; GO:0043679; GO:0050804; GO:0051453; GO:0055085; GO:0097386; GO:0097457; GO:0098793; GO:0098978; GO:0110010; GO:0140892; GO:1902476; GO:2000300; GO:2000302 basolateral protein secretion [GO:0110010]; bicarbonate transport [GO:0015701]; chloride transmembrane transport [GO:1902476]; modulation of chemical synaptic transmission [GO:0050804]; positive regulation of synaptic vesicle exocytosis [GO:2000302]; regulation of intracellular pH [GO:0051453]; regulation of membrane potential [GO:0042391]; regulation of synaptic vesicle exocytosis [GO:2000300]; sodium ion transmembrane transport [GO:0035725]; transmembrane transport [GO:0055085] apical plasma membrane [GO:0016324]; asymmetric synapse [GO:0032279]; axon terminus [GO:0043679]; basolateral plasma membrane [GO:0016323]; dendrite [GO:0030425]; glial cell projection [GO:0097386]; glutamatergic synapse [GO:0098978]; hippocampal mossy fiber [GO:0097457]; membrane [GO:0016020]; neuron projection [GO:0043005]; neuronal cell body membrane [GO:0032809]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; presynaptic membrane [GO:0042734]; symmetric synapse [GO:0032280]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672]; terminal bouton [GO:0043195] bicarbonate transmembrane transporter activity [GO:0015106]; chloride transmembrane transporter activity [GO:0015108]; identical protein binding [GO:0042802]; sodium ion transmembrane transporter activity [GO:0015081]; sodium,bicarbonate:chloride antiporter activity [GO:0140892]; sodium:bicarbonate symporter activity [GO:0008510]; zinc ion binding [GO:0008270] g10624.t1 Q8BTY2 46.957 345 2.09e-65 228.0 sp|Q8BTY2|S4A7_MOUSE Sodium bicarbonate cotransporter 3 OS=Mus musculus OX=10090 GN=Slc4a7 PE=1 SV=2 S4A7_MOUSE reviewed Sodium bicarbonate cotransporter 3 (Solute carrier family 4 member 7) Mus musculus (Mouse) GO:0005452; GO:0005737; GO:0005886; GO:0006164; GO:0006221; GO:0007601; GO:0007605; GO:0008509; GO:0008510; GO:0015701; GO:0016020; GO:0016323; GO:0016324; GO:0021747; GO:0031410; GO:0032420; GO:0035641; GO:0046666; GO:0051453; GO:0055085; GO:0060117; GO:0060219; GO:0061299; GO:0071363; GO:0090383 auditory receptor cell development [GO:0060117]; bicarbonate transport [GO:0015701]; camera-type eye photoreceptor cell differentiation [GO:0060219]; cellular response to growth factor stimulus [GO:0071363]; cochlear nucleus development [GO:0021747]; locomotory exploration behavior [GO:0035641]; phagosome acidification [GO:0090383]; purine nucleotide biosynthetic process [GO:0006164]; pyrimidine nucleotide biosynthetic process [GO:0006221]; regulation of intracellular pH [GO:0051453]; retina vasculature morphogenesis in camera-type eye [GO:0061299]; retinal cell programmed cell death [GO:0046666]; sensory perception of sound [GO:0007605]; transmembrane transport [GO:0055085]; visual perception [GO:0007601] apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; membrane [GO:0016020]; plasma membrane [GO:0005886]; stereocilium [GO:0032420] monoatomic anion transmembrane transporter activity [GO:0008509]; sodium:bicarbonate symporter activity [GO:0008510]; solute:inorganic anion antiporter activity [GO:0005452] g10628.t1 Q9Y2E4 71.014 483 0.0 648.0 sp|Q9Y2E4|DIP2C_HUMAN Disco-interacting protein 2 homolog C OS=Homo sapiens OX=9606 GN=DIP2C PE=1 SV=2 g10629.t1 Q9Y2E4 56.893 1030 0.0 1115.0 sp|Q9Y2E4|DIP2C_HUMAN Disco-interacting protein 2 homolog C OS=Homo sapiens OX=9606 GN=DIP2C PE=1 SV=2 g10629.t1 Q9Y2E4 25.701 428 5.67e-24 113.0 sp|Q9Y2E4|DIP2C_HUMAN Disco-interacting protein 2 homolog C OS=Homo sapiens OX=9606 GN=DIP2C PE=1 SV=2 g10629.t2 Q9W0S9 64.371 842 0.0 1078.0 sp|Q9W0S9|DIP2_DROME Disco-interacting protein 2 OS=Drosophila melanogaster OX=7227 GN=DIP2 PE=1 SV=2 DIP2_DROME reviewed Disco-interacting protein 2 Drosophila melanogaster (Fruit fly) GO:0003987; GO:0005886; GO:0006085; GO:0007411 acetyl-CoA biosynthetic process [GO:0006085]; axon guidance [GO:0007411] plasma membrane [GO:0005886] acetate-CoA ligase activity [GO:0003987] g10630.t1 Q32LP4 53.206 998 0.0 926.0 sp|Q32LP4|S4A10_BOVIN Sodium-driven chloride bicarbonate exchanger OS=Bos taurus OX=9913 GN=SLC4A10 PE=2 SV=1 S4A10_BOVIN reviewed Sodium-driven chloride bicarbonate exchanger (Solute carrier family 4 member 10) Bos taurus (Bovine) GO:0005452; GO:0005886; GO:0007601; GO:0008509; GO:0008510; GO:0015701; GO:0016323; GO:0016324; GO:0030425; GO:0036477; GO:0043025; GO:0043204; GO:0043679; GO:0045202; GO:0048172; GO:0051453; GO:0055085; GO:0098794; GO:0098982 bicarbonate transport [GO:0015701]; regulation of intracellular pH [GO:0051453]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; transmembrane transport [GO:0055085]; visual perception [GO:0007601] apical plasma membrane [GO:0016324]; axon terminus [GO:0043679]; basolateral plasma membrane [GO:0016323]; dendrite [GO:0030425]; GABA-ergic synapse [GO:0098982]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; somatodendritic compartment [GO:0036477]; synapse [GO:0045202] monoatomic anion transmembrane transporter activity [GO:0008509]; sodium:bicarbonate symporter activity [GO:0008510]; solute:inorganic anion antiporter activity [GO:0005452] g10632.t1 P21551 51.705 352 2.4e-136 396.0 sp|P21551|WNT1_AMBME Protein Wnt-1 OS=Ambystoma mexicanum OX=8296 GN=WNT-1 PE=2 SV=1 g10633.t1 P22727 51.143 350 1.6599999999999998e-135 393.0 sp|P22727|WNT6_MOUSE Protein Wnt-6 OS=Mus musculus OX=10090 GN=Wnt6 PE=1 SV=2 WNT6_MOUSE reviewed Protein Wnt-6 Mus musculus (Mouse) GO:0001658; GO:0005102; GO:0005109; GO:0005125; GO:0005615; GO:0005788; GO:0007165; GO:0007267; GO:0009798; GO:0009887; GO:0009986; GO:0010628; GO:0016055; GO:0030182; GO:0031012; GO:0042475; GO:0045165; GO:0045893; GO:0060070; GO:0060684; GO:0070172; GO:0072079; GO:0072080 animal organ morphogenesis [GO:0009887]; axis specification [GO:0009798]; branching involved in ureteric bud morphogenesis [GO:0001658]; canonical Wnt signaling pathway [GO:0060070]; cell fate commitment [GO:0045165]; cell-cell signaling [GO:0007267]; epithelial-mesenchymal cell signaling [GO:0060684]; nephron tubule development [GO:0072080]; nephron tubule formation [GO:0072079]; neuron differentiation [GO:0030182]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of gene expression [GO:0010628]; positive regulation of tooth mineralization [GO:0070172]; signal transduction [GO:0007165]; Wnt signaling pathway [GO:0016055] cell surface [GO:0009986]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615] cytokine activity [GO:0005125]; frizzled binding [GO:0005109]; signaling receptor binding [GO:0005102] g10634.t1 Q8BVD5 40.29 551 7.03e-132 399.0 sp|Q8BVD5|MPP7_MOUSE MAGUK p55 subfamily member 7 OS=Mus musculus OX=10090 GN=Mpp7 PE=1 SV=2 g10636.t1 Q7ZUK7 54.639 97 3.45e-26 117.0 sp|Q7ZUK7|WAC_DANRE WW domain-containing adapter protein with coiled-coil OS=Danio rerio OX=7955 GN=waca PE=2 SV=1 g10636.t1 Q7ZUK7 37.824 193 8.620000000000001e-21 100.0 sp|Q7ZUK7|WAC_DANRE WW domain-containing adapter protein with coiled-coil OS=Danio rerio OX=7955 GN=waca PE=2 SV=1 g10639.t1 Q9UJL9 29.326 341 4.53e-22 104.0 sp|Q9UJL9|ZF69B_HUMAN Zinc finger protein 69 homolog B OS=Homo sapiens OX=9606 GN=ZFP69B PE=1 SV=2 ZF69B_HUMAN reviewed Zinc finger protein 69 homolog B (Zinc finger protein 643) Homo sapiens (Human) GO:0000977; GO:0000981; GO:0005634; GO:0005730; GO:0006357; GO:0007030; GO:0008270 Golgi organization [GO:0007030]; regulation of transcription by RNA polymerase II [GO:0006357] nucleolus [GO:0005730]; nucleus [GO:0005634] DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; zinc ion binding [GO:0008270] g10641.t1 P98158 42.111 862 0.0 638.0 sp|P98158|LRP2_RAT Low-density lipoprotein receptor-related protein 2 OS=Rattus norvegicus OX=10116 GN=Lrp2 PE=1 SV=1 g10641.t1 P98158 35.281 890 4.09e-157 546.0 sp|P98158|LRP2_RAT Low-density lipoprotein receptor-related protein 2 OS=Rattus norvegicus OX=10116 GN=Lrp2 PE=1 SV=1 g10641.t1 P98158 31.567 887 9.999999999999999e-112 403.0 sp|P98158|LRP2_RAT Low-density lipoprotein receptor-related protein 2 OS=Rattus norvegicus OX=10116 GN=Lrp2 PE=1 SV=1 g10641.t1 P98158 31.384 889 1.58e-104 380.0 sp|P98158|LRP2_RAT Low-density lipoprotein receptor-related protein 2 OS=Rattus norvegicus OX=10116 GN=Lrp2 PE=1 SV=1 g10641.t1 P98158 32.677 762 2.82e-97 356.0 sp|P98158|LRP2_RAT Low-density lipoprotein receptor-related protein 2 OS=Rattus norvegicus OX=10116 GN=Lrp2 PE=1 SV=1 g10641.t1 P98158 32.956 707 2.53e-82 307.0 sp|P98158|LRP2_RAT Low-density lipoprotein receptor-related protein 2 OS=Rattus norvegicus OX=10116 GN=Lrp2 PE=1 SV=1 g10641.t1 P98158 30.207 629 9.180000000000001e-73 272.0 sp|P98158|LRP2_RAT Low-density lipoprotein receptor-related protein 2 OS=Rattus norvegicus OX=10116 GN=Lrp2 PE=1 SV=1 g10641.t1 P98158 43.75 32 9.180000000000001e-73 27.3 sp|P98158|LRP2_RAT Low-density lipoprotein receptor-related protein 2 OS=Rattus norvegicus OX=10116 GN=Lrp2 PE=1 SV=1 g10641.t1 P98158 31.873 662 1.24e-70 269.0 sp|P98158|LRP2_RAT Low-density lipoprotein receptor-related protein 2 OS=Rattus norvegicus OX=10116 GN=Lrp2 PE=1 SV=1 g10641.t1 P98158 27.751 418 6.46e-36 154.0 sp|P98158|LRP2_RAT Low-density lipoprotein receptor-related protein 2 OS=Rattus norvegicus OX=10116 GN=Lrp2 PE=1 SV=1 g10641.t1 P98158 22.796 658 1.6e-34 150.0 sp|P98158|LRP2_RAT Low-density lipoprotein receptor-related protein 2 OS=Rattus norvegicus OX=10116 GN=Lrp2 PE=1 SV=1 g10641.t1 P98158 32.407 432 8.16e-34 147.0 sp|P98158|LRP2_RAT Low-density lipoprotein receptor-related protein 2 OS=Rattus norvegicus OX=10116 GN=Lrp2 PE=1 SV=1 g10641.t1 P98158 42.268 194 1.63e-30 132.0 sp|P98158|LRP2_RAT Low-density lipoprotein receptor-related protein 2 OS=Rattus norvegicus OX=10116 GN=Lrp2 PE=1 SV=1 g10641.t1 P98158 46.875 32 1.63e-30 26.2 sp|P98158|LRP2_RAT Low-density lipoprotein receptor-related protein 2 OS=Rattus norvegicus OX=10116 GN=Lrp2 PE=1 SV=1 g10641.t1 P98158 42.132 197 7.28e-30 134.0 sp|P98158|LRP2_RAT Low-density lipoprotein receptor-related protein 2 OS=Rattus norvegicus OX=10116 GN=Lrp2 PE=1 SV=1 g10641.t1 P98158 27.828 442 4.65e-29 132.0 sp|P98158|LRP2_RAT Low-density lipoprotein receptor-related protein 2 OS=Rattus norvegicus OX=10116 GN=Lrp2 PE=1 SV=1 g10641.t1 P98158 37.113 194 5.32e-29 127.0 sp|P98158|LRP2_RAT Low-density lipoprotein receptor-related protein 2 OS=Rattus norvegicus OX=10116 GN=Lrp2 PE=1 SV=1 g10641.t1 P98158 39.286 28 5.32e-29 25.8 sp|P98158|LRP2_RAT Low-density lipoprotein receptor-related protein 2 OS=Rattus norvegicus OX=10116 GN=Lrp2 PE=1 SV=1 g10641.t1 P98158 22.463 601 3.16e-28 129.0 sp|P98158|LRP2_RAT Low-density lipoprotein receptor-related protein 2 OS=Rattus norvegicus OX=10116 GN=Lrp2 PE=1 SV=1 g10641.t1 P98158 27.99 393 6.61e-28 128.0 sp|P98158|LRP2_RAT Low-density lipoprotein receptor-related protein 2 OS=Rattus norvegicus OX=10116 GN=Lrp2 PE=1 SV=1 g10641.t1 P98158 29.651 344 7.44e-28 128.0 sp|P98158|LRP2_RAT Low-density lipoprotein receptor-related protein 2 OS=Rattus norvegicus OX=10116 GN=Lrp2 PE=1 SV=1 g10641.t1 P98158 36.916 214 3.39e-26 122.0 sp|P98158|LRP2_RAT Low-density lipoprotein receptor-related protein 2 OS=Rattus norvegicus OX=10116 GN=Lrp2 PE=1 SV=1 g10641.t1 P98158 36.792 212 6.7e-26 121.0 sp|P98158|LRP2_RAT Low-density lipoprotein receptor-related protein 2 OS=Rattus norvegicus OX=10116 GN=Lrp2 PE=1 SV=1 g10641.t1 P98158 40.449 178 1.32e-22 110.0 sp|P98158|LRP2_RAT Low-density lipoprotein receptor-related protein 2 OS=Rattus norvegicus OX=10116 GN=Lrp2 PE=1 SV=1 g10641.t1 P98158 38.994 159 2.17e-21 107.0 sp|P98158|LRP2_RAT Low-density lipoprotein receptor-related protein 2 OS=Rattus norvegicus OX=10116 GN=Lrp2 PE=1 SV=1 g10642.t1 P98164 44.288 639 1.0900000000000001e-163 524.0 sp|P98164|LRP2_HUMAN Low-density lipoprotein receptor-related protein 2 OS=Homo sapiens OX=9606 GN=LRP2 PE=1 SV=3 LRP2_HUMAN reviewed Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin) Homo sapiens (Human) GO:0001523; GO:0001822; GO:0001843; GO:0003139; GO:0003148; GO:0003223; GO:0003281; GO:0005041; GO:0005509; GO:0005764; GO:0005765; GO:0005783; GO:0005794; GO:0005886; GO:0005905; GO:0006629; GO:0006897; GO:0006898; GO:0007605; GO:0008283; GO:0008584; GO:0009897; GO:0010467; GO:0015031; GO:0015889; GO:0016324; GO:0017124; GO:0030001; GO:0030424; GO:0030425; GO:0030514; GO:0030669; GO:0030900; GO:0031526; GO:0031904; GO:0031994; GO:0034311; GO:0035904; GO:0038024; GO:0042359; GO:0042562; GO:0043066; GO:0043235; GO:0043491; GO:0044321; GO:0045056; GO:0050769; GO:0051087; GO:0060068; GO:0060982; GO:0061156; GO:0070062; GO:0070447; GO:0071363; GO:0097242; GO:0140058; GO:0140318; GO:0150104; GO:1904447; GO:1904888; GO:1905167 amyloid-beta clearance [GO:0097242]; aorta development [GO:0035904]; cell population proliferation [GO:0008283]; cellular response to growth factor stimulus [GO:0071363]; cobalamin transport [GO:0015889]; coronary artery morphogenesis [GO:0060982]; cranial skeletal system development [GO:1904888]; diol metabolic process [GO:0034311]; endocytosis [GO:0006897]; folate import across plasma membrane [GO:1904447]; forebrain development [GO:0030900]; gene expression [GO:0010467]; kidney development [GO:0001822]; lipid metabolic process [GO:0006629]; male gonad development [GO:0008584]; metal ion transport [GO:0030001]; negative regulation of apoptotic process [GO:0043066]; negative regulation of BMP signaling pathway [GO:0030514]; neural tube closure [GO:0001843]; neuron projection arborization [GO:0140058]; outflow tract septum morphogenesis [GO:0003148]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; positive regulation of lysosomal protein catabolic process [GO:1905167]; positive regulation of neurogenesis [GO:0050769]; positive regulation of oligodendrocyte progenitor proliferation [GO:0070447]; protein transport [GO:0015031]; pulmonary artery morphogenesis [GO:0061156]; receptor-mediated endocytosis [GO:0006898]; response to leptin [GO:0044321]; retinoid metabolic process [GO:0001523]; secondary heart field specification [GO:0003139]; sensory perception of sound [GO:0007605]; transcytosis [GO:0045056]; transport across blood-brain barrier [GO:0150104]; vagina development [GO:0060068]; ventricular compact myocardium morphogenesis [GO:0003223]; ventricular septum development [GO:0003281]; vitamin D metabolic process [GO:0042359] apical plasma membrane [GO:0016324]; axon [GO:0030424]; brush border membrane [GO:0031526]; clathrin-coated endocytic vesicle membrane [GO:0030669]; clathrin-coated pit [GO:0005905]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; endosome lumen [GO:0031904]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; cargo receptor activity [GO:0038024]; hormone binding [GO:0042562]; insulin-like growth factor I binding [GO:0031994]; low-density lipoprotein particle receptor activity [GO:0005041]; protein transporter activity [GO:0140318]; protein-folding chaperone binding [GO:0051087]; SH3 domain binding [GO:0017124] g10642.t1 P98164 29.221 616 6.76e-62 228.0 sp|P98164|LRP2_HUMAN Low-density lipoprotein receptor-related protein 2 OS=Homo sapiens OX=9606 GN=LRP2 PE=1 SV=3 LRP2_HUMAN reviewed Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin) Homo sapiens (Human) GO:0001523; GO:0001822; GO:0001843; GO:0003139; GO:0003148; GO:0003223; GO:0003281; GO:0005041; GO:0005509; GO:0005764; GO:0005765; GO:0005783; GO:0005794; GO:0005886; GO:0005905; GO:0006629; GO:0006897; GO:0006898; GO:0007605; GO:0008283; GO:0008584; GO:0009897; GO:0010467; GO:0015031; GO:0015889; GO:0016324; GO:0017124; GO:0030001; GO:0030424; GO:0030425; GO:0030514; GO:0030669; GO:0030900; GO:0031526; GO:0031904; GO:0031994; GO:0034311; GO:0035904; GO:0038024; GO:0042359; GO:0042562; GO:0043066; GO:0043235; GO:0043491; GO:0044321; GO:0045056; GO:0050769; GO:0051087; GO:0060068; GO:0060982; GO:0061156; GO:0070062; GO:0070447; GO:0071363; GO:0097242; GO:0140058; GO:0140318; GO:0150104; GO:1904447; GO:1904888; GO:1905167 amyloid-beta clearance [GO:0097242]; aorta development [GO:0035904]; cell population proliferation [GO:0008283]; cellular response to growth factor stimulus [GO:0071363]; cobalamin transport [GO:0015889]; coronary artery morphogenesis [GO:0060982]; cranial skeletal system development [GO:1904888]; diol metabolic process [GO:0034311]; endocytosis [GO:0006897]; folate import across plasma membrane [GO:1904447]; forebrain development [GO:0030900]; gene expression [GO:0010467]; kidney development [GO:0001822]; lipid metabolic process [GO:0006629]; male gonad development [GO:0008584]; metal ion transport [GO:0030001]; negative regulation of apoptotic process [GO:0043066]; negative regulation of BMP signaling pathway [GO:0030514]; neural tube closure [GO:0001843]; neuron projection arborization [GO:0140058]; outflow tract septum morphogenesis [GO:0003148]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; positive regulation of lysosomal protein catabolic process [GO:1905167]; positive regulation of neurogenesis [GO:0050769]; positive regulation of oligodendrocyte progenitor proliferation [GO:0070447]; protein transport [GO:0015031]; pulmonary artery morphogenesis [GO:0061156]; receptor-mediated endocytosis [GO:0006898]; response to leptin [GO:0044321]; retinoid metabolic process [GO:0001523]; secondary heart field specification [GO:0003139]; sensory perception of sound [GO:0007605]; transcytosis [GO:0045056]; transport across blood-brain barrier [GO:0150104]; vagina development [GO:0060068]; ventricular compact myocardium morphogenesis [GO:0003223]; ventricular septum development [GO:0003281]; vitamin D metabolic process [GO:0042359] apical plasma membrane [GO:0016324]; axon [GO:0030424]; brush border membrane [GO:0031526]; clathrin-coated endocytic vesicle membrane [GO:0030669]; clathrin-coated pit [GO:0005905]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; endosome lumen [GO:0031904]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; cargo receptor activity [GO:0038024]; hormone binding [GO:0042562]; insulin-like growth factor I binding [GO:0031994]; low-density lipoprotein particle receptor activity [GO:0005041]; protein transporter activity [GO:0140318]; protein-folding chaperone binding [GO:0051087]; SH3 domain binding [GO:0017124] g10642.t1 P98164 26.58 617 9.449999999999999e-60 221.0 sp|P98164|LRP2_HUMAN Low-density lipoprotein receptor-related protein 2 OS=Homo sapiens OX=9606 GN=LRP2 PE=1 SV=3 LRP2_HUMAN reviewed Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin) Homo sapiens (Human) GO:0001523; GO:0001822; GO:0001843; GO:0003139; GO:0003148; GO:0003223; GO:0003281; GO:0005041; GO:0005509; GO:0005764; GO:0005765; GO:0005783; GO:0005794; GO:0005886; GO:0005905; GO:0006629; GO:0006897; GO:0006898; GO:0007605; GO:0008283; GO:0008584; GO:0009897; GO:0010467; GO:0015031; GO:0015889; GO:0016324; GO:0017124; GO:0030001; GO:0030424; GO:0030425; GO:0030514; GO:0030669; GO:0030900; GO:0031526; GO:0031904; GO:0031994; GO:0034311; GO:0035904; GO:0038024; GO:0042359; GO:0042562; GO:0043066; GO:0043235; GO:0043491; GO:0044321; GO:0045056; GO:0050769; GO:0051087; GO:0060068; GO:0060982; GO:0061156; GO:0070062; GO:0070447; GO:0071363; GO:0097242; GO:0140058; GO:0140318; GO:0150104; GO:1904447; GO:1904888; GO:1905167 amyloid-beta clearance [GO:0097242]; aorta development [GO:0035904]; cell population proliferation [GO:0008283]; cellular response to growth factor stimulus [GO:0071363]; cobalamin transport [GO:0015889]; coronary artery morphogenesis [GO:0060982]; cranial skeletal system development [GO:1904888]; diol metabolic process [GO:0034311]; endocytosis [GO:0006897]; folate import across plasma membrane [GO:1904447]; forebrain development [GO:0030900]; gene expression [GO:0010467]; kidney development [GO:0001822]; lipid metabolic process [GO:0006629]; male gonad development [GO:0008584]; metal ion transport [GO:0030001]; negative regulation of apoptotic process [GO:0043066]; negative regulation of BMP signaling pathway [GO:0030514]; neural tube closure [GO:0001843]; neuron projection arborization [GO:0140058]; outflow tract septum morphogenesis [GO:0003148]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; positive regulation of lysosomal protein catabolic process [GO:1905167]; positive regulation of neurogenesis [GO:0050769]; positive regulation of oligodendrocyte progenitor proliferation [GO:0070447]; protein transport [GO:0015031]; pulmonary artery morphogenesis [GO:0061156]; receptor-mediated endocytosis [GO:0006898]; response to leptin [GO:0044321]; retinoid metabolic process [GO:0001523]; secondary heart field specification [GO:0003139]; sensory perception of sound [GO:0007605]; transcytosis [GO:0045056]; transport across blood-brain barrier [GO:0150104]; vagina development [GO:0060068]; ventricular compact myocardium morphogenesis [GO:0003223]; ventricular septum development [GO:0003281]; vitamin D metabolic process [GO:0042359] apical plasma membrane [GO:0016324]; axon [GO:0030424]; brush border membrane [GO:0031526]; clathrin-coated endocytic vesicle membrane [GO:0030669]; clathrin-coated pit [GO:0005905]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; endosome lumen [GO:0031904]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; cargo receptor activity [GO:0038024]; hormone binding [GO:0042562]; insulin-like growth factor I binding [GO:0031994]; low-density lipoprotein particle receptor activity [GO:0005041]; protein transporter activity [GO:0140318]; protein-folding chaperone binding [GO:0051087]; SH3 domain binding [GO:0017124] g10642.t1 P98164 27.027 555 2.0099999999999998e-54 205.0 sp|P98164|LRP2_HUMAN Low-density lipoprotein receptor-related protein 2 OS=Homo sapiens OX=9606 GN=LRP2 PE=1 SV=3 LRP2_HUMAN reviewed Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin) Homo sapiens (Human) GO:0001523; GO:0001822; GO:0001843; GO:0003139; GO:0003148; GO:0003223; GO:0003281; GO:0005041; GO:0005509; GO:0005764; GO:0005765; GO:0005783; GO:0005794; GO:0005886; GO:0005905; GO:0006629; GO:0006897; GO:0006898; GO:0007605; GO:0008283; GO:0008584; GO:0009897; GO:0010467; GO:0015031; GO:0015889; GO:0016324; GO:0017124; GO:0030001; GO:0030424; GO:0030425; GO:0030514; GO:0030669; GO:0030900; GO:0031526; GO:0031904; GO:0031994; GO:0034311; GO:0035904; GO:0038024; GO:0042359; GO:0042562; GO:0043066; GO:0043235; GO:0043491; GO:0044321; GO:0045056; GO:0050769; GO:0051087; GO:0060068; GO:0060982; GO:0061156; GO:0070062; GO:0070447; GO:0071363; GO:0097242; GO:0140058; GO:0140318; GO:0150104; GO:1904447; GO:1904888; GO:1905167 amyloid-beta clearance [GO:0097242]; aorta development [GO:0035904]; cell population proliferation [GO:0008283]; cellular response to growth factor stimulus [GO:0071363]; cobalamin transport [GO:0015889]; coronary artery morphogenesis [GO:0060982]; cranial skeletal system development [GO:1904888]; diol metabolic process [GO:0034311]; endocytosis [GO:0006897]; folate import across plasma membrane [GO:1904447]; forebrain development [GO:0030900]; gene expression [GO:0010467]; kidney development [GO:0001822]; lipid metabolic process [GO:0006629]; male gonad development [GO:0008584]; metal ion transport [GO:0030001]; negative regulation of apoptotic process [GO:0043066]; negative regulation of BMP signaling pathway [GO:0030514]; neural tube closure [GO:0001843]; neuron projection arborization [GO:0140058]; outflow tract septum morphogenesis [GO:0003148]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; positive regulation of lysosomal protein catabolic process [GO:1905167]; positive regulation of neurogenesis [GO:0050769]; positive regulation of oligodendrocyte progenitor proliferation [GO:0070447]; protein transport [GO:0015031]; pulmonary artery morphogenesis [GO:0061156]; receptor-mediated endocytosis [GO:0006898]; response to leptin [GO:0044321]; retinoid metabolic process [GO:0001523]; secondary heart field specification [GO:0003139]; sensory perception of sound [GO:0007605]; transcytosis [GO:0045056]; transport across blood-brain barrier [GO:0150104]; vagina development [GO:0060068]; ventricular compact myocardium morphogenesis [GO:0003223]; ventricular septum development [GO:0003281]; vitamin D metabolic process [GO:0042359] apical plasma membrane [GO:0016324]; axon [GO:0030424]; brush border membrane [GO:0031526]; clathrin-coated endocytic vesicle membrane [GO:0030669]; clathrin-coated pit [GO:0005905]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; endosome lumen [GO:0031904]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; cargo receptor activity [GO:0038024]; hormone binding [GO:0042562]; insulin-like growth factor I binding [GO:0031994]; low-density lipoprotein particle receptor activity [GO:0005041]; protein transporter activity [GO:0140318]; protein-folding chaperone binding [GO:0051087]; SH3 domain binding [GO:0017124] g10642.t1 P98164 29.369 412 8.22e-34 143.0 sp|P98164|LRP2_HUMAN Low-density lipoprotein receptor-related protein 2 OS=Homo sapiens OX=9606 GN=LRP2 PE=1 SV=3 LRP2_HUMAN reviewed Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin) Homo sapiens (Human) GO:0001523; GO:0001822; GO:0001843; GO:0003139; GO:0003148; GO:0003223; GO:0003281; GO:0005041; GO:0005509; GO:0005764; GO:0005765; GO:0005783; GO:0005794; GO:0005886; GO:0005905; GO:0006629; GO:0006897; GO:0006898; GO:0007605; GO:0008283; GO:0008584; GO:0009897; GO:0010467; GO:0015031; GO:0015889; GO:0016324; GO:0017124; GO:0030001; GO:0030424; GO:0030425; GO:0030514; GO:0030669; GO:0030900; GO:0031526; GO:0031904; GO:0031994; GO:0034311; GO:0035904; GO:0038024; GO:0042359; GO:0042562; GO:0043066; GO:0043235; GO:0043491; GO:0044321; GO:0045056; GO:0050769; GO:0051087; GO:0060068; GO:0060982; GO:0061156; GO:0070062; GO:0070447; GO:0071363; GO:0097242; GO:0140058; GO:0140318; GO:0150104; GO:1904447; GO:1904888; GO:1905167 amyloid-beta clearance [GO:0097242]; aorta development [GO:0035904]; cell population proliferation [GO:0008283]; cellular response to growth factor stimulus [GO:0071363]; cobalamin transport [GO:0015889]; coronary artery morphogenesis [GO:0060982]; cranial skeletal system development [GO:1904888]; diol metabolic process [GO:0034311]; endocytosis [GO:0006897]; folate import across plasma membrane [GO:1904447]; forebrain development [GO:0030900]; gene expression [GO:0010467]; kidney development [GO:0001822]; lipid metabolic process [GO:0006629]; male gonad development [GO:0008584]; metal ion transport [GO:0030001]; negative regulation of apoptotic process [GO:0043066]; negative regulation of BMP signaling pathway [GO:0030514]; neural tube closure [GO:0001843]; neuron projection arborization [GO:0140058]; outflow tract septum morphogenesis [GO:0003148]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; positive regulation of lysosomal protein catabolic process [GO:1905167]; positive regulation of neurogenesis [GO:0050769]; positive regulation of oligodendrocyte progenitor proliferation [GO:0070447]; protein transport [GO:0015031]; pulmonary artery morphogenesis [GO:0061156]; receptor-mediated endocytosis [GO:0006898]; response to leptin [GO:0044321]; retinoid metabolic process [GO:0001523]; secondary heart field specification [GO:0003139]; sensory perception of sound [GO:0007605]; transcytosis [GO:0045056]; transport across blood-brain barrier [GO:0150104]; vagina development [GO:0060068]; ventricular compact myocardium morphogenesis [GO:0003223]; ventricular septum development [GO:0003281]; vitamin D metabolic process [GO:0042359] apical plasma membrane [GO:0016324]; axon [GO:0030424]; brush border membrane [GO:0031526]; clathrin-coated endocytic vesicle membrane [GO:0030669]; clathrin-coated pit [GO:0005905]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; endosome lumen [GO:0031904]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; cargo receptor activity [GO:0038024]; hormone binding [GO:0042562]; insulin-like growth factor I binding [GO:0031994]; low-density lipoprotein particle receptor activity [GO:0005041]; protein transporter activity [GO:0140318]; protein-folding chaperone binding [GO:0051087]; SH3 domain binding [GO:0017124] g10642.t1 P98164 28.06 335 1.09e-32 139.0 sp|P98164|LRP2_HUMAN Low-density lipoprotein receptor-related protein 2 OS=Homo sapiens OX=9606 GN=LRP2 PE=1 SV=3 LRP2_HUMAN reviewed Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin) Homo sapiens (Human) GO:0001523; GO:0001822; GO:0001843; GO:0003139; GO:0003148; GO:0003223; GO:0003281; GO:0005041; GO:0005509; GO:0005764; GO:0005765; GO:0005783; GO:0005794; GO:0005886; GO:0005905; GO:0006629; GO:0006897; GO:0006898; GO:0007605; GO:0008283; GO:0008584; GO:0009897; GO:0010467; GO:0015031; GO:0015889; GO:0016324; GO:0017124; GO:0030001; GO:0030424; GO:0030425; GO:0030514; GO:0030669; GO:0030900; GO:0031526; GO:0031904; GO:0031994; GO:0034311; GO:0035904; GO:0038024; GO:0042359; GO:0042562; GO:0043066; GO:0043235; GO:0043491; GO:0044321; GO:0045056; GO:0050769; GO:0051087; GO:0060068; GO:0060982; GO:0061156; GO:0070062; GO:0070447; GO:0071363; GO:0097242; GO:0140058; GO:0140318; GO:0150104; GO:1904447; GO:1904888; GO:1905167 amyloid-beta clearance [GO:0097242]; aorta development [GO:0035904]; cell population proliferation [GO:0008283]; cellular response to growth factor stimulus [GO:0071363]; cobalamin transport [GO:0015889]; coronary artery morphogenesis [GO:0060982]; cranial skeletal system development [GO:1904888]; diol metabolic process [GO:0034311]; endocytosis [GO:0006897]; folate import across plasma membrane [GO:1904447]; forebrain development [GO:0030900]; gene expression [GO:0010467]; kidney development [GO:0001822]; lipid metabolic process [GO:0006629]; male gonad development [GO:0008584]; metal ion transport [GO:0030001]; negative regulation of apoptotic process [GO:0043066]; negative regulation of BMP signaling pathway [GO:0030514]; neural tube closure [GO:0001843]; neuron projection arborization [GO:0140058]; outflow tract septum morphogenesis [GO:0003148]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; positive regulation of lysosomal protein catabolic process [GO:1905167]; positive regulation of neurogenesis [GO:0050769]; positive regulation of oligodendrocyte progenitor proliferation [GO:0070447]; protein transport [GO:0015031]; pulmonary artery morphogenesis [GO:0061156]; receptor-mediated endocytosis [GO:0006898]; response to leptin [GO:0044321]; retinoid metabolic process [GO:0001523]; secondary heart field specification [GO:0003139]; sensory perception of sound [GO:0007605]; transcytosis [GO:0045056]; transport across blood-brain barrier [GO:0150104]; vagina development [GO:0060068]; ventricular compact myocardium morphogenesis [GO:0003223]; ventricular septum development [GO:0003281]; vitamin D metabolic process [GO:0042359] apical plasma membrane [GO:0016324]; axon [GO:0030424]; brush border membrane [GO:0031526]; clathrin-coated endocytic vesicle membrane [GO:0030669]; clathrin-coated pit [GO:0005905]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; endosome lumen [GO:0031904]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; cargo receptor activity [GO:0038024]; hormone binding [GO:0042562]; insulin-like growth factor I binding [GO:0031994]; low-density lipoprotein particle receptor activity [GO:0005041]; protein transporter activity [GO:0140318]; protein-folding chaperone binding [GO:0051087]; SH3 domain binding [GO:0017124] g10642.t1 P98164 32.143 224 3.14e-28 125.0 sp|P98164|LRP2_HUMAN Low-density lipoprotein receptor-related protein 2 OS=Homo sapiens OX=9606 GN=LRP2 PE=1 SV=3 LRP2_HUMAN reviewed Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin) Homo sapiens (Human) GO:0001523; GO:0001822; GO:0001843; GO:0003139; GO:0003148; GO:0003223; GO:0003281; GO:0005041; GO:0005509; GO:0005764; GO:0005765; GO:0005783; GO:0005794; GO:0005886; GO:0005905; GO:0006629; GO:0006897; GO:0006898; GO:0007605; GO:0008283; GO:0008584; GO:0009897; GO:0010467; GO:0015031; GO:0015889; GO:0016324; GO:0017124; GO:0030001; GO:0030424; GO:0030425; GO:0030514; GO:0030669; GO:0030900; GO:0031526; GO:0031904; GO:0031994; GO:0034311; GO:0035904; GO:0038024; GO:0042359; GO:0042562; GO:0043066; GO:0043235; GO:0043491; GO:0044321; GO:0045056; GO:0050769; GO:0051087; GO:0060068; GO:0060982; GO:0061156; GO:0070062; GO:0070447; GO:0071363; GO:0097242; GO:0140058; GO:0140318; GO:0150104; GO:1904447; GO:1904888; GO:1905167 amyloid-beta clearance [GO:0097242]; aorta development [GO:0035904]; cell population proliferation [GO:0008283]; cellular response to growth factor stimulus [GO:0071363]; cobalamin transport [GO:0015889]; coronary artery morphogenesis [GO:0060982]; cranial skeletal system development [GO:1904888]; diol metabolic process [GO:0034311]; endocytosis [GO:0006897]; folate import across plasma membrane [GO:1904447]; forebrain development [GO:0030900]; gene expression [GO:0010467]; kidney development [GO:0001822]; lipid metabolic process [GO:0006629]; male gonad development [GO:0008584]; metal ion transport [GO:0030001]; negative regulation of apoptotic process [GO:0043066]; negative regulation of BMP signaling pathway [GO:0030514]; neural tube closure [GO:0001843]; neuron projection arborization [GO:0140058]; outflow tract septum morphogenesis [GO:0003148]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; positive regulation of lysosomal protein catabolic process [GO:1905167]; positive regulation of neurogenesis [GO:0050769]; positive regulation of oligodendrocyte progenitor proliferation [GO:0070447]; protein transport [GO:0015031]; pulmonary artery morphogenesis [GO:0061156]; receptor-mediated endocytosis [GO:0006898]; response to leptin [GO:0044321]; retinoid metabolic process [GO:0001523]; secondary heart field specification [GO:0003139]; sensory perception of sound [GO:0007605]; transcytosis [GO:0045056]; transport across blood-brain barrier [GO:0150104]; vagina development [GO:0060068]; ventricular compact myocardium morphogenesis [GO:0003223]; ventricular septum development [GO:0003281]; vitamin D metabolic process [GO:0042359] apical plasma membrane [GO:0016324]; axon [GO:0030424]; brush border membrane [GO:0031526]; clathrin-coated endocytic vesicle membrane [GO:0030669]; clathrin-coated pit [GO:0005905]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; endosome lumen [GO:0031904]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; cargo receptor activity [GO:0038024]; hormone binding [GO:0042562]; insulin-like growth factor I binding [GO:0031994]; low-density lipoprotein particle receptor activity [GO:0005041]; protein transporter activity [GO:0140318]; protein-folding chaperone binding [GO:0051087]; SH3 domain binding [GO:0017124] g10642.t1 P98164 27.607 326 8.99e-27 120.0 sp|P98164|LRP2_HUMAN Low-density lipoprotein receptor-related protein 2 OS=Homo sapiens OX=9606 GN=LRP2 PE=1 SV=3 LRP2_HUMAN reviewed Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin) Homo sapiens (Human) GO:0001523; GO:0001822; GO:0001843; GO:0003139; GO:0003148; GO:0003223; GO:0003281; GO:0005041; GO:0005509; GO:0005764; GO:0005765; GO:0005783; GO:0005794; GO:0005886; GO:0005905; GO:0006629; GO:0006897; GO:0006898; GO:0007605; GO:0008283; GO:0008584; GO:0009897; GO:0010467; GO:0015031; GO:0015889; GO:0016324; GO:0017124; GO:0030001; GO:0030424; GO:0030425; GO:0030514; GO:0030669; GO:0030900; GO:0031526; GO:0031904; GO:0031994; GO:0034311; GO:0035904; GO:0038024; GO:0042359; GO:0042562; GO:0043066; GO:0043235; GO:0043491; GO:0044321; GO:0045056; GO:0050769; GO:0051087; GO:0060068; GO:0060982; GO:0061156; GO:0070062; GO:0070447; GO:0071363; GO:0097242; GO:0140058; GO:0140318; GO:0150104; GO:1904447; GO:1904888; GO:1905167 amyloid-beta clearance [GO:0097242]; aorta development [GO:0035904]; cell population proliferation [GO:0008283]; cellular response to growth factor stimulus [GO:0071363]; cobalamin transport [GO:0015889]; coronary artery morphogenesis [GO:0060982]; cranial skeletal system development [GO:1904888]; diol metabolic process [GO:0034311]; endocytosis [GO:0006897]; folate import across plasma membrane [GO:1904447]; forebrain development [GO:0030900]; gene expression [GO:0010467]; kidney development [GO:0001822]; lipid metabolic process [GO:0006629]; male gonad development [GO:0008584]; metal ion transport [GO:0030001]; negative regulation of apoptotic process [GO:0043066]; negative regulation of BMP signaling pathway [GO:0030514]; neural tube closure [GO:0001843]; neuron projection arborization [GO:0140058]; outflow tract septum morphogenesis [GO:0003148]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; positive regulation of lysosomal protein catabolic process [GO:1905167]; positive regulation of neurogenesis [GO:0050769]; positive regulation of oligodendrocyte progenitor proliferation [GO:0070447]; protein transport [GO:0015031]; pulmonary artery morphogenesis [GO:0061156]; receptor-mediated endocytosis [GO:0006898]; response to leptin [GO:0044321]; retinoid metabolic process [GO:0001523]; secondary heart field specification [GO:0003139]; sensory perception of sound [GO:0007605]; transcytosis [GO:0045056]; transport across blood-brain barrier [GO:0150104]; vagina development [GO:0060068]; ventricular compact myocardium morphogenesis [GO:0003223]; ventricular septum development [GO:0003281]; vitamin D metabolic process [GO:0042359] apical plasma membrane [GO:0016324]; axon [GO:0030424]; brush border membrane [GO:0031526]; clathrin-coated endocytic vesicle membrane [GO:0030669]; clathrin-coated pit [GO:0005905]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; endosome lumen [GO:0031904]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; cargo receptor activity [GO:0038024]; hormone binding [GO:0042562]; insulin-like growth factor I binding [GO:0031994]; low-density lipoprotein particle receptor activity [GO:0005041]; protein transporter activity [GO:0140318]; protein-folding chaperone binding [GO:0051087]; SH3 domain binding [GO:0017124] g10642.t1 P98164 27.668 253 1.07e-21 104.0 sp|P98164|LRP2_HUMAN Low-density lipoprotein receptor-related protein 2 OS=Homo sapiens OX=9606 GN=LRP2 PE=1 SV=3 LRP2_HUMAN reviewed Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin) Homo sapiens (Human) GO:0001523; GO:0001822; GO:0001843; GO:0003139; GO:0003148; GO:0003223; GO:0003281; GO:0005041; GO:0005509; GO:0005764; GO:0005765; GO:0005783; GO:0005794; GO:0005886; GO:0005905; GO:0006629; GO:0006897; GO:0006898; GO:0007605; GO:0008283; GO:0008584; GO:0009897; GO:0010467; GO:0015031; GO:0015889; GO:0016324; GO:0017124; GO:0030001; GO:0030424; GO:0030425; GO:0030514; GO:0030669; GO:0030900; GO:0031526; GO:0031904; GO:0031994; GO:0034311; GO:0035904; GO:0038024; GO:0042359; GO:0042562; GO:0043066; GO:0043235; GO:0043491; GO:0044321; GO:0045056; GO:0050769; GO:0051087; GO:0060068; GO:0060982; GO:0061156; GO:0070062; GO:0070447; GO:0071363; GO:0097242; GO:0140058; GO:0140318; GO:0150104; GO:1904447; GO:1904888; GO:1905167 amyloid-beta clearance [GO:0097242]; aorta development [GO:0035904]; cell population proliferation [GO:0008283]; cellular response to growth factor stimulus [GO:0071363]; cobalamin transport [GO:0015889]; coronary artery morphogenesis [GO:0060982]; cranial skeletal system development [GO:1904888]; diol metabolic process [GO:0034311]; endocytosis [GO:0006897]; folate import across plasma membrane [GO:1904447]; forebrain development [GO:0030900]; gene expression [GO:0010467]; kidney development [GO:0001822]; lipid metabolic process [GO:0006629]; male gonad development [GO:0008584]; metal ion transport [GO:0030001]; negative regulation of apoptotic process [GO:0043066]; negative regulation of BMP signaling pathway [GO:0030514]; neural tube closure [GO:0001843]; neuron projection arborization [GO:0140058]; outflow tract septum morphogenesis [GO:0003148]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; positive regulation of lysosomal protein catabolic process [GO:1905167]; positive regulation of neurogenesis [GO:0050769]; positive regulation of oligodendrocyte progenitor proliferation [GO:0070447]; protein transport [GO:0015031]; pulmonary artery morphogenesis [GO:0061156]; receptor-mediated endocytosis [GO:0006898]; response to leptin [GO:0044321]; retinoid metabolic process [GO:0001523]; secondary heart field specification [GO:0003139]; sensory perception of sound [GO:0007605]; transcytosis [GO:0045056]; transport across blood-brain barrier [GO:0150104]; vagina development [GO:0060068]; ventricular compact myocardium morphogenesis [GO:0003223]; ventricular septum development [GO:0003281]; vitamin D metabolic process [GO:0042359] apical plasma membrane [GO:0016324]; axon [GO:0030424]; brush border membrane [GO:0031526]; clathrin-coated endocytic vesicle membrane [GO:0030669]; clathrin-coated pit [GO:0005905]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; endosome lumen [GO:0031904]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; cargo receptor activity [GO:0038024]; hormone binding [GO:0042562]; insulin-like growth factor I binding [GO:0031994]; low-density lipoprotein particle receptor activity [GO:0005041]; protein transporter activity [GO:0140318]; protein-folding chaperone binding [GO:0051087]; SH3 domain binding [GO:0017124] g10643.t1 A2ARV4 47.176 1806 0.0 1457.0 sp|A2ARV4|LRP2_MOUSE Low-density lipoprotein receptor-related protein 2 OS=Mus musculus OX=10090 GN=Lrp2 PE=1 SV=1 LRP2_MOUSE reviewed Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin) Mus musculus (Mouse) GO:0001822; GO:0001843; GO:0003139; GO:0003148; GO:0003151; GO:0003223; GO:0003281; GO:0005509; GO:0005615; GO:0005768; GO:0005783; GO:0005794; GO:0005886; GO:0005903; GO:0005905; GO:0006066; GO:0006766; GO:0006897; GO:0006898; GO:0007507; GO:0007605; GO:0008283; GO:0008584; GO:0009897; GO:0009986; GO:0010165; GO:0010467; GO:0015031; GO:0016020; GO:0016197; GO:0016324; GO:0016922; GO:0017038; GO:0017124; GO:0020028; GO:0030001; GO:0030139; GO:0030165; GO:0030424; GO:0030425; GO:0030492; GO:0030514; GO:0030900; GO:0031526; GO:0031904; GO:0031994; GO:0032991; GO:0035904; GO:0038024; GO:0042359; GO:0042562; GO:0043066; GO:0043235; GO:0043491; GO:0044295; GO:0044321; GO:0044877; GO:0045056; GO:0045177; GO:0045807; GO:0050750; GO:0050769; GO:0051087; GO:0060068; GO:0060976; GO:0060982; GO:0061156; GO:0061642; GO:0070447; GO:0071363; GO:0097242; GO:0140058; GO:0140077; GO:0140318; GO:1904447; GO:1904888 alcohol metabolic process [GO:0006066]; amyloid-beta clearance [GO:0097242]; aorta development [GO:0035904]; cell population proliferation [GO:0008283]; cellular response to growth factor stimulus [GO:0071363]; chemoattraction of axon [GO:0061642]; coronary artery morphogenesis [GO:0060982]; coronary vasculature development [GO:0060976]; cranial skeletal system development [GO:1904888]; endocytic hemoglobin import into cell [GO:0020028]; endocytosis [GO:0006897]; endosomal transport [GO:0016197]; folate import across plasma membrane [GO:1904447]; forebrain development [GO:0030900]; gene expression [GO:0010467]; heart development [GO:0007507]; kidney development [GO:0001822]; male gonad development [GO:0008584]; metal ion transport [GO:0030001]; negative regulation of apoptotic process [GO:0043066]; negative regulation of BMP signaling pathway [GO:0030514]; neural tube closure [GO:0001843]; neuron projection arborization [GO:0140058]; outflow tract morphogenesis [GO:0003151]; outflow tract septum morphogenesis [GO:0003148]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; positive regulation of endocytosis [GO:0045807]; positive regulation of lipoprotein transport [GO:0140077]; positive regulation of neurogenesis [GO:0050769]; positive regulation of oligodendrocyte progenitor proliferation [GO:0070447]; protein import [GO:0017038]; protein transport [GO:0015031]; pulmonary artery morphogenesis [GO:0061156]; receptor-mediated endocytosis [GO:0006898]; response to leptin [GO:0044321]; response to X-ray [GO:0010165]; secondary heart field specification [GO:0003139]; sensory perception of sound [GO:0007605]; transcytosis [GO:0045056]; vagina development [GO:0060068]; ventricular compact myocardium morphogenesis [GO:0003223]; ventricular septum development [GO:0003281]; vitamin D metabolic process [GO:0042359]; vitamin metabolic process [GO:0006766] apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; axon [GO:0030424]; axonal growth cone [GO:0044295]; brush border [GO:0005903]; brush border membrane [GO:0031526]; cell surface [GO:0009986]; clathrin-coated pit [GO:0005905]; dendrite [GO:0030425]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; endosome lumen [GO:0031904]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; cargo receptor activity [GO:0038024]; hemoglobin binding [GO:0030492]; hormone binding [GO:0042562]; insulin-like growth factor I binding [GO:0031994]; low-density lipoprotein particle receptor binding [GO:0050750]; nuclear receptor binding [GO:0016922]; PDZ domain binding [GO:0030165]; protein transporter activity [GO:0140318]; protein-containing complex binding [GO:0044877]; protein-folding chaperone binding [GO:0051087]; SH3 domain binding [GO:0017124] g10643.t1 A2ARV4 34.091 1276 1.63e-159 551.0 sp|A2ARV4|LRP2_MOUSE Low-density lipoprotein receptor-related protein 2 OS=Mus musculus OX=10090 GN=Lrp2 PE=1 SV=1 LRP2_MOUSE reviewed Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin) Mus musculus (Mouse) GO:0001822; GO:0001843; GO:0003139; GO:0003148; GO:0003151; GO:0003223; GO:0003281; GO:0005509; GO:0005615; GO:0005768; GO:0005783; GO:0005794; GO:0005886; GO:0005903; GO:0005905; GO:0006066; GO:0006766; GO:0006897; GO:0006898; GO:0007507; GO:0007605; GO:0008283; GO:0008584; GO:0009897; GO:0009986; GO:0010165; GO:0010467; GO:0015031; GO:0016020; GO:0016197; GO:0016324; GO:0016922; GO:0017038; GO:0017124; GO:0020028; GO:0030001; GO:0030139; GO:0030165; GO:0030424; GO:0030425; GO:0030492; GO:0030514; GO:0030900; GO:0031526; GO:0031904; GO:0031994; GO:0032991; GO:0035904; GO:0038024; GO:0042359; GO:0042562; GO:0043066; GO:0043235; GO:0043491; GO:0044295; GO:0044321; GO:0044877; GO:0045056; GO:0045177; GO:0045807; GO:0050750; GO:0050769; GO:0051087; GO:0060068; GO:0060976; GO:0060982; GO:0061156; GO:0061642; GO:0070447; GO:0071363; GO:0097242; GO:0140058; GO:0140077; GO:0140318; GO:1904447; GO:1904888 alcohol metabolic process [GO:0006066]; amyloid-beta clearance [GO:0097242]; aorta development [GO:0035904]; cell population proliferation [GO:0008283]; cellular response to growth factor stimulus [GO:0071363]; chemoattraction of axon [GO:0061642]; coronary artery morphogenesis [GO:0060982]; coronary vasculature development [GO:0060976]; cranial skeletal system development [GO:1904888]; endocytic hemoglobin import into cell [GO:0020028]; endocytosis [GO:0006897]; endosomal transport [GO:0016197]; folate import across plasma membrane [GO:1904447]; forebrain development [GO:0030900]; gene expression [GO:0010467]; heart development [GO:0007507]; kidney development [GO:0001822]; male gonad development [GO:0008584]; metal ion transport [GO:0030001]; negative regulation of apoptotic process [GO:0043066]; negative regulation of BMP signaling pathway [GO:0030514]; neural tube closure [GO:0001843]; neuron projection arborization [GO:0140058]; outflow tract morphogenesis [GO:0003151]; outflow tract septum morphogenesis [GO:0003148]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; positive regulation of endocytosis [GO:0045807]; positive regulation of lipoprotein transport [GO:0140077]; positive regulation of neurogenesis [GO:0050769]; positive regulation of oligodendrocyte progenitor proliferation [GO:0070447]; protein import [GO:0017038]; protein transport [GO:0015031]; pulmonary artery morphogenesis [GO:0061156]; receptor-mediated endocytosis [GO:0006898]; response to leptin [GO:0044321]; response to X-ray [GO:0010165]; secondary heart field specification [GO:0003139]; sensory perception of sound [GO:0007605]; transcytosis [GO:0045056]; vagina development [GO:0060068]; ventricular compact myocardium morphogenesis [GO:0003223]; ventricular septum development [GO:0003281]; vitamin D metabolic process [GO:0042359]; vitamin metabolic process [GO:0006766] apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; axon [GO:0030424]; axonal growth cone [GO:0044295]; brush border [GO:0005903]; brush border membrane [GO:0031526]; cell surface [GO:0009986]; clathrin-coated pit [GO:0005905]; dendrite [GO:0030425]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; endosome lumen [GO:0031904]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; cargo receptor activity [GO:0038024]; hemoglobin binding [GO:0030492]; hormone binding [GO:0042562]; insulin-like growth factor I binding [GO:0031994]; low-density lipoprotein particle receptor binding [GO:0050750]; nuclear receptor binding [GO:0016922]; PDZ domain binding [GO:0030165]; protein transporter activity [GO:0140318]; protein-containing complex binding [GO:0044877]; protein-folding chaperone binding [GO:0051087]; SH3 domain binding [GO:0017124] g10643.t1 A2ARV4 36.971 733 9.459999999999999e-115 412.0 sp|A2ARV4|LRP2_MOUSE Low-density lipoprotein receptor-related protein 2 OS=Mus musculus OX=10090 GN=Lrp2 PE=1 SV=1 LRP2_MOUSE reviewed Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin) Mus musculus (Mouse) GO:0001822; GO:0001843; GO:0003139; GO:0003148; GO:0003151; GO:0003223; GO:0003281; GO:0005509; GO:0005615; GO:0005768; GO:0005783; GO:0005794; GO:0005886; GO:0005903; GO:0005905; GO:0006066; GO:0006766; GO:0006897; GO:0006898; GO:0007507; GO:0007605; GO:0008283; GO:0008584; GO:0009897; GO:0009986; GO:0010165; GO:0010467; GO:0015031; GO:0016020; GO:0016197; GO:0016324; GO:0016922; GO:0017038; GO:0017124; GO:0020028; GO:0030001; GO:0030139; GO:0030165; GO:0030424; GO:0030425; GO:0030492; GO:0030514; GO:0030900; GO:0031526; GO:0031904; GO:0031994; GO:0032991; GO:0035904; GO:0038024; GO:0042359; GO:0042562; GO:0043066; GO:0043235; GO:0043491; GO:0044295; GO:0044321; GO:0044877; GO:0045056; GO:0045177; GO:0045807; GO:0050750; GO:0050769; GO:0051087; GO:0060068; GO:0060976; GO:0060982; GO:0061156; GO:0061642; GO:0070447; GO:0071363; GO:0097242; GO:0140058; GO:0140077; GO:0140318; GO:1904447; GO:1904888 alcohol metabolic process [GO:0006066]; amyloid-beta clearance [GO:0097242]; aorta development [GO:0035904]; cell population proliferation [GO:0008283]; cellular response to growth factor stimulus [GO:0071363]; chemoattraction of axon [GO:0061642]; coronary artery morphogenesis [GO:0060982]; coronary vasculature development [GO:0060976]; cranial skeletal system development [GO:1904888]; endocytic hemoglobin import into cell [GO:0020028]; endocytosis [GO:0006897]; endosomal transport [GO:0016197]; folate import across plasma membrane [GO:1904447]; forebrain development [GO:0030900]; gene expression [GO:0010467]; heart development [GO:0007507]; kidney development [GO:0001822]; male gonad development [GO:0008584]; metal ion transport [GO:0030001]; negative regulation of apoptotic process [GO:0043066]; negative regulation of BMP signaling pathway [GO:0030514]; neural tube closure [GO:0001843]; neuron projection arborization [GO:0140058]; outflow tract morphogenesis [GO:0003151]; outflow tract septum morphogenesis [GO:0003148]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; positive regulation of endocytosis [GO:0045807]; positive regulation of lipoprotein transport [GO:0140077]; positive regulation of neurogenesis [GO:0050769]; positive regulation of oligodendrocyte progenitor proliferation [GO:0070447]; protein import [GO:0017038]; protein transport [GO:0015031]; pulmonary artery morphogenesis [GO:0061156]; receptor-mediated endocytosis [GO:0006898]; response to leptin [GO:0044321]; response to X-ray [GO:0010165]; secondary heart field specification [GO:0003139]; sensory perception of sound [GO:0007605]; transcytosis [GO:0045056]; vagina development [GO:0060068]; ventricular compact myocardium morphogenesis [GO:0003223]; ventricular septum development [GO:0003281]; vitamin D metabolic process [GO:0042359]; vitamin metabolic process [GO:0006766] apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; axon [GO:0030424]; axonal growth cone [GO:0044295]; brush border [GO:0005903]; brush border membrane [GO:0031526]; cell surface [GO:0009986]; clathrin-coated pit [GO:0005905]; dendrite [GO:0030425]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; endosome lumen [GO:0031904]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; cargo receptor activity [GO:0038024]; hemoglobin binding [GO:0030492]; hormone binding [GO:0042562]; insulin-like growth factor I binding [GO:0031994]; low-density lipoprotein particle receptor binding [GO:0050750]; nuclear receptor binding [GO:0016922]; PDZ domain binding [GO:0030165]; protein transporter activity [GO:0140318]; protein-containing complex binding [GO:0044877]; protein-folding chaperone binding [GO:0051087]; SH3 domain binding [GO:0017124] g10643.t1 A2ARV4 33.848 712 1.34e-97 357.0 sp|A2ARV4|LRP2_MOUSE Low-density lipoprotein receptor-related protein 2 OS=Mus musculus OX=10090 GN=Lrp2 PE=1 SV=1 LRP2_MOUSE reviewed Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin) Mus musculus (Mouse) GO:0001822; GO:0001843; GO:0003139; GO:0003148; GO:0003151; GO:0003223; GO:0003281; GO:0005509; GO:0005615; GO:0005768; GO:0005783; GO:0005794; GO:0005886; GO:0005903; GO:0005905; GO:0006066; GO:0006766; GO:0006897; GO:0006898; GO:0007507; GO:0007605; GO:0008283; GO:0008584; GO:0009897; GO:0009986; GO:0010165; GO:0010467; GO:0015031; GO:0016020; GO:0016197; GO:0016324; GO:0016922; GO:0017038; GO:0017124; GO:0020028; GO:0030001; GO:0030139; GO:0030165; GO:0030424; GO:0030425; GO:0030492; GO:0030514; GO:0030900; GO:0031526; GO:0031904; GO:0031994; GO:0032991; GO:0035904; GO:0038024; GO:0042359; GO:0042562; GO:0043066; GO:0043235; GO:0043491; GO:0044295; GO:0044321; GO:0044877; GO:0045056; GO:0045177; GO:0045807; GO:0050750; GO:0050769; GO:0051087; GO:0060068; GO:0060976; GO:0060982; GO:0061156; GO:0061642; GO:0070447; GO:0071363; GO:0097242; GO:0140058; GO:0140077; GO:0140318; GO:1904447; GO:1904888 alcohol metabolic process [GO:0006066]; amyloid-beta clearance [GO:0097242]; aorta development [GO:0035904]; cell population proliferation [GO:0008283]; cellular response to growth factor stimulus [GO:0071363]; chemoattraction of axon [GO:0061642]; coronary artery morphogenesis [GO:0060982]; coronary vasculature development [GO:0060976]; cranial skeletal system development [GO:1904888]; endocytic hemoglobin import into cell [GO:0020028]; endocytosis [GO:0006897]; endosomal transport [GO:0016197]; folate import across plasma membrane [GO:1904447]; forebrain development [GO:0030900]; gene expression [GO:0010467]; heart development [GO:0007507]; kidney development [GO:0001822]; male gonad development [GO:0008584]; metal ion transport [GO:0030001]; negative regulation of apoptotic process [GO:0043066]; negative regulation of BMP signaling pathway [GO:0030514]; neural tube closure [GO:0001843]; neuron projection arborization [GO:0140058]; outflow tract morphogenesis [GO:0003151]; outflow tract septum morphogenesis [GO:0003148]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; positive regulation of endocytosis [GO:0045807]; positive regulation of lipoprotein transport [GO:0140077]; positive regulation of neurogenesis [GO:0050769]; positive regulation of oligodendrocyte progenitor proliferation [GO:0070447]; protein import [GO:0017038]; protein transport [GO:0015031]; pulmonary artery morphogenesis [GO:0061156]; receptor-mediated endocytosis [GO:0006898]; response to leptin [GO:0044321]; response to X-ray [GO:0010165]; secondary heart field specification [GO:0003139]; sensory perception of sound [GO:0007605]; transcytosis [GO:0045056]; vagina development [GO:0060068]; ventricular compact myocardium morphogenesis [GO:0003223]; ventricular septum development [GO:0003281]; vitamin D metabolic process [GO:0042359]; vitamin metabolic process [GO:0006766] apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; axon [GO:0030424]; axonal growth cone [GO:0044295]; brush border [GO:0005903]; brush border membrane [GO:0031526]; cell surface [GO:0009986]; clathrin-coated pit [GO:0005905]; dendrite [GO:0030425]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; endosome lumen [GO:0031904]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; cargo receptor activity [GO:0038024]; hemoglobin binding [GO:0030492]; hormone binding [GO:0042562]; insulin-like growth factor I binding [GO:0031994]; low-density lipoprotein particle receptor binding [GO:0050750]; nuclear receptor binding [GO:0016922]; PDZ domain binding [GO:0030165]; protein transporter activity [GO:0140318]; protein-containing complex binding [GO:0044877]; protein-folding chaperone binding [GO:0051087]; SH3 domain binding [GO:0017124] g10643.t1 A2ARV4 33.903 702 3.54e-83 310.0 sp|A2ARV4|LRP2_MOUSE Low-density lipoprotein receptor-related protein 2 OS=Mus musculus OX=10090 GN=Lrp2 PE=1 SV=1 LRP2_MOUSE reviewed Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin) Mus musculus (Mouse) GO:0001822; GO:0001843; GO:0003139; GO:0003148; GO:0003151; GO:0003223; GO:0003281; GO:0005509; GO:0005615; GO:0005768; GO:0005783; GO:0005794; GO:0005886; GO:0005903; GO:0005905; GO:0006066; GO:0006766; GO:0006897; GO:0006898; GO:0007507; GO:0007605; GO:0008283; GO:0008584; GO:0009897; GO:0009986; GO:0010165; GO:0010467; GO:0015031; GO:0016020; GO:0016197; GO:0016324; GO:0016922; GO:0017038; GO:0017124; GO:0020028; GO:0030001; GO:0030139; GO:0030165; GO:0030424; GO:0030425; GO:0030492; GO:0030514; GO:0030900; GO:0031526; GO:0031904; GO:0031994; GO:0032991; GO:0035904; GO:0038024; GO:0042359; GO:0042562; GO:0043066; GO:0043235; GO:0043491; GO:0044295; GO:0044321; GO:0044877; GO:0045056; GO:0045177; GO:0045807; GO:0050750; GO:0050769; GO:0051087; GO:0060068; GO:0060976; GO:0060982; GO:0061156; GO:0061642; GO:0070447; GO:0071363; GO:0097242; GO:0140058; GO:0140077; GO:0140318; GO:1904447; GO:1904888 alcohol metabolic process [GO:0006066]; amyloid-beta clearance [GO:0097242]; aorta development [GO:0035904]; cell population proliferation [GO:0008283]; cellular response to growth factor stimulus [GO:0071363]; chemoattraction of axon [GO:0061642]; coronary artery morphogenesis [GO:0060982]; coronary vasculature development [GO:0060976]; cranial skeletal system development [GO:1904888]; endocytic hemoglobin import into cell [GO:0020028]; endocytosis [GO:0006897]; endosomal transport [GO:0016197]; folate import across plasma membrane [GO:1904447]; forebrain development [GO:0030900]; gene expression [GO:0010467]; heart development [GO:0007507]; kidney development [GO:0001822]; male gonad development [GO:0008584]; metal ion transport [GO:0030001]; negative regulation of apoptotic process [GO:0043066]; negative regulation of BMP signaling pathway [GO:0030514]; neural tube closure [GO:0001843]; neuron projection arborization [GO:0140058]; outflow tract morphogenesis [GO:0003151]; outflow tract septum morphogenesis [GO:0003148]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; positive regulation of endocytosis [GO:0045807]; positive regulation of lipoprotein transport [GO:0140077]; positive regulation of neurogenesis [GO:0050769]; positive regulation of oligodendrocyte progenitor proliferation [GO:0070447]; protein import [GO:0017038]; protein transport [GO:0015031]; pulmonary artery morphogenesis [GO:0061156]; receptor-mediated endocytosis [GO:0006898]; response to leptin [GO:0044321]; response to X-ray [GO:0010165]; secondary heart field specification [GO:0003139]; sensory perception of sound [GO:0007605]; transcytosis [GO:0045056]; vagina development [GO:0060068]; ventricular compact myocardium morphogenesis [GO:0003223]; ventricular septum development [GO:0003281]; vitamin D metabolic process [GO:0042359]; vitamin metabolic process [GO:0006766] apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; axon [GO:0030424]; axonal growth cone [GO:0044295]; brush border [GO:0005903]; brush border membrane [GO:0031526]; cell surface [GO:0009986]; clathrin-coated pit [GO:0005905]; dendrite [GO:0030425]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; endosome lumen [GO:0031904]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; cargo receptor activity [GO:0038024]; hemoglobin binding [GO:0030492]; hormone binding [GO:0042562]; insulin-like growth factor I binding [GO:0031994]; low-density lipoprotein particle receptor binding [GO:0050750]; nuclear receptor binding [GO:0016922]; PDZ domain binding [GO:0030165]; protein transporter activity [GO:0140318]; protein-containing complex binding [GO:0044877]; protein-folding chaperone binding [GO:0051087]; SH3 domain binding [GO:0017124] g10643.t1 A2ARV4 33.647 743 3.5700000000000004e-79 296.0 sp|A2ARV4|LRP2_MOUSE Low-density lipoprotein receptor-related protein 2 OS=Mus musculus OX=10090 GN=Lrp2 PE=1 SV=1 LRP2_MOUSE reviewed Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin) Mus musculus (Mouse) GO:0001822; GO:0001843; GO:0003139; GO:0003148; GO:0003151; GO:0003223; GO:0003281; GO:0005509; GO:0005615; GO:0005768; GO:0005783; GO:0005794; GO:0005886; GO:0005903; GO:0005905; GO:0006066; GO:0006766; GO:0006897; GO:0006898; GO:0007507; GO:0007605; GO:0008283; GO:0008584; GO:0009897; GO:0009986; GO:0010165; GO:0010467; GO:0015031; GO:0016020; GO:0016197; GO:0016324; GO:0016922; GO:0017038; GO:0017124; GO:0020028; GO:0030001; GO:0030139; GO:0030165; GO:0030424; GO:0030425; GO:0030492; GO:0030514; GO:0030900; GO:0031526; GO:0031904; GO:0031994; GO:0032991; GO:0035904; GO:0038024; GO:0042359; GO:0042562; GO:0043066; GO:0043235; GO:0043491; GO:0044295; GO:0044321; GO:0044877; GO:0045056; GO:0045177; GO:0045807; GO:0050750; GO:0050769; GO:0051087; GO:0060068; GO:0060976; GO:0060982; GO:0061156; GO:0061642; GO:0070447; GO:0071363; GO:0097242; GO:0140058; GO:0140077; GO:0140318; GO:1904447; GO:1904888 alcohol metabolic process [GO:0006066]; amyloid-beta clearance [GO:0097242]; aorta development [GO:0035904]; cell population proliferation [GO:0008283]; cellular response to growth factor stimulus [GO:0071363]; chemoattraction of axon [GO:0061642]; coronary artery morphogenesis [GO:0060982]; coronary vasculature development [GO:0060976]; cranial skeletal system development [GO:1904888]; endocytic hemoglobin import into cell [GO:0020028]; endocytosis [GO:0006897]; endosomal transport [GO:0016197]; folate import across plasma membrane [GO:1904447]; forebrain development [GO:0030900]; gene expression [GO:0010467]; heart development [GO:0007507]; kidney development [GO:0001822]; male gonad development [GO:0008584]; metal ion transport [GO:0030001]; negative regulation of apoptotic process [GO:0043066]; negative regulation of BMP signaling pathway [GO:0030514]; neural tube closure [GO:0001843]; neuron projection arborization [GO:0140058]; outflow tract morphogenesis [GO:0003151]; outflow tract septum morphogenesis [GO:0003148]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; positive regulation of endocytosis [GO:0045807]; positive regulation of lipoprotein transport [GO:0140077]; positive regulation of neurogenesis [GO:0050769]; positive regulation of oligodendrocyte progenitor proliferation [GO:0070447]; protein import [GO:0017038]; protein transport [GO:0015031]; pulmonary artery morphogenesis [GO:0061156]; receptor-mediated endocytosis [GO:0006898]; response to leptin [GO:0044321]; response to X-ray [GO:0010165]; secondary heart field specification [GO:0003139]; sensory perception of sound [GO:0007605]; transcytosis [GO:0045056]; vagina development [GO:0060068]; ventricular compact myocardium morphogenesis [GO:0003223]; ventricular septum development [GO:0003281]; vitamin D metabolic process [GO:0042359]; vitamin metabolic process [GO:0006766] apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; axon [GO:0030424]; axonal growth cone [GO:0044295]; brush border [GO:0005903]; brush border membrane [GO:0031526]; cell surface [GO:0009986]; clathrin-coated pit [GO:0005905]; dendrite [GO:0030425]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; endosome lumen [GO:0031904]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; cargo receptor activity [GO:0038024]; hemoglobin binding [GO:0030492]; hormone binding [GO:0042562]; insulin-like growth factor I binding [GO:0031994]; low-density lipoprotein particle receptor binding [GO:0050750]; nuclear receptor binding [GO:0016922]; PDZ domain binding [GO:0030165]; protein transporter activity [GO:0140318]; protein-containing complex binding [GO:0044877]; protein-folding chaperone binding [GO:0051087]; SH3 domain binding [GO:0017124] g10643.t1 A2ARV4 31.18 712 8.53e-64 246.0 sp|A2ARV4|LRP2_MOUSE Low-density lipoprotein receptor-related protein 2 OS=Mus musculus OX=10090 GN=Lrp2 PE=1 SV=1 LRP2_MOUSE reviewed Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin) Mus musculus (Mouse) GO:0001822; GO:0001843; GO:0003139; GO:0003148; GO:0003151; GO:0003223; GO:0003281; GO:0005509; GO:0005615; GO:0005768; GO:0005783; GO:0005794; GO:0005886; GO:0005903; GO:0005905; GO:0006066; GO:0006766; GO:0006897; GO:0006898; GO:0007507; GO:0007605; GO:0008283; GO:0008584; GO:0009897; GO:0009986; GO:0010165; GO:0010467; GO:0015031; GO:0016020; GO:0016197; GO:0016324; GO:0016922; GO:0017038; GO:0017124; GO:0020028; GO:0030001; GO:0030139; GO:0030165; GO:0030424; GO:0030425; GO:0030492; GO:0030514; GO:0030900; GO:0031526; GO:0031904; GO:0031994; GO:0032991; GO:0035904; GO:0038024; GO:0042359; GO:0042562; GO:0043066; GO:0043235; GO:0043491; GO:0044295; GO:0044321; GO:0044877; GO:0045056; GO:0045177; GO:0045807; GO:0050750; GO:0050769; GO:0051087; GO:0060068; GO:0060976; GO:0060982; GO:0061156; GO:0061642; GO:0070447; GO:0071363; GO:0097242; GO:0140058; GO:0140077; GO:0140318; GO:1904447; GO:1904888 alcohol metabolic process [GO:0006066]; amyloid-beta clearance [GO:0097242]; aorta development [GO:0035904]; cell population proliferation [GO:0008283]; cellular response to growth factor stimulus [GO:0071363]; chemoattraction of axon [GO:0061642]; coronary artery morphogenesis [GO:0060982]; coronary vasculature development [GO:0060976]; cranial skeletal system development [GO:1904888]; endocytic hemoglobin import into cell [GO:0020028]; endocytosis [GO:0006897]; endosomal transport [GO:0016197]; folate import across plasma membrane [GO:1904447]; forebrain development [GO:0030900]; gene expression [GO:0010467]; heart development [GO:0007507]; kidney development [GO:0001822]; male gonad development [GO:0008584]; metal ion transport [GO:0030001]; negative regulation of apoptotic process [GO:0043066]; negative regulation of BMP signaling pathway [GO:0030514]; neural tube closure [GO:0001843]; neuron projection arborization [GO:0140058]; outflow tract morphogenesis [GO:0003151]; outflow tract septum morphogenesis [GO:0003148]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; positive regulation of endocytosis [GO:0045807]; positive regulation of lipoprotein transport [GO:0140077]; positive regulation of neurogenesis [GO:0050769]; positive regulation of oligodendrocyte progenitor proliferation [GO:0070447]; protein import [GO:0017038]; protein transport [GO:0015031]; pulmonary artery morphogenesis [GO:0061156]; receptor-mediated endocytosis [GO:0006898]; response to leptin [GO:0044321]; response to X-ray [GO:0010165]; secondary heart field specification [GO:0003139]; sensory perception of sound [GO:0007605]; transcytosis [GO:0045056]; vagina development [GO:0060068]; ventricular compact myocardium morphogenesis [GO:0003223]; ventricular septum development [GO:0003281]; vitamin D metabolic process [GO:0042359]; vitamin metabolic process [GO:0006766] apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; axon [GO:0030424]; axonal growth cone [GO:0044295]; brush border [GO:0005903]; brush border membrane [GO:0031526]; cell surface [GO:0009986]; clathrin-coated pit [GO:0005905]; dendrite [GO:0030425]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; endosome lumen [GO:0031904]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; cargo receptor activity [GO:0038024]; hemoglobin binding [GO:0030492]; hormone binding [GO:0042562]; insulin-like growth factor I binding [GO:0031994]; low-density lipoprotein particle receptor binding [GO:0050750]; nuclear receptor binding [GO:0016922]; PDZ domain binding [GO:0030165]; protein transporter activity [GO:0140318]; protein-containing complex binding [GO:0044877]; protein-folding chaperone binding [GO:0051087]; SH3 domain binding [GO:0017124] g10643.t1 A2ARV4 28.883 367 6.200000000000001e-37 157.0 sp|A2ARV4|LRP2_MOUSE Low-density lipoprotein receptor-related protein 2 OS=Mus musculus OX=10090 GN=Lrp2 PE=1 SV=1 LRP2_MOUSE reviewed Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin) Mus musculus (Mouse) GO:0001822; GO:0001843; GO:0003139; GO:0003148; GO:0003151; GO:0003223; GO:0003281; GO:0005509; GO:0005615; GO:0005768; GO:0005783; GO:0005794; GO:0005886; GO:0005903; GO:0005905; GO:0006066; GO:0006766; GO:0006897; GO:0006898; GO:0007507; GO:0007605; GO:0008283; GO:0008584; GO:0009897; GO:0009986; GO:0010165; GO:0010467; GO:0015031; GO:0016020; GO:0016197; GO:0016324; GO:0016922; GO:0017038; GO:0017124; GO:0020028; GO:0030001; GO:0030139; GO:0030165; GO:0030424; GO:0030425; GO:0030492; GO:0030514; GO:0030900; GO:0031526; GO:0031904; GO:0031994; GO:0032991; GO:0035904; GO:0038024; GO:0042359; GO:0042562; GO:0043066; GO:0043235; GO:0043491; GO:0044295; GO:0044321; GO:0044877; GO:0045056; GO:0045177; GO:0045807; GO:0050750; GO:0050769; GO:0051087; GO:0060068; GO:0060976; GO:0060982; GO:0061156; GO:0061642; GO:0070447; GO:0071363; GO:0097242; GO:0140058; GO:0140077; GO:0140318; GO:1904447; GO:1904888 alcohol metabolic process [GO:0006066]; amyloid-beta clearance [GO:0097242]; aorta development [GO:0035904]; cell population proliferation [GO:0008283]; cellular response to growth factor stimulus [GO:0071363]; chemoattraction of axon [GO:0061642]; coronary artery morphogenesis [GO:0060982]; coronary vasculature development [GO:0060976]; cranial skeletal system development [GO:1904888]; endocytic hemoglobin import into cell [GO:0020028]; endocytosis [GO:0006897]; endosomal transport [GO:0016197]; folate import across plasma membrane [GO:1904447]; forebrain development [GO:0030900]; gene expression [GO:0010467]; heart development [GO:0007507]; kidney development [GO:0001822]; male gonad development [GO:0008584]; metal ion transport [GO:0030001]; negative regulation of apoptotic process [GO:0043066]; negative regulation of BMP signaling pathway [GO:0030514]; neural tube closure [GO:0001843]; neuron projection arborization [GO:0140058]; outflow tract morphogenesis [GO:0003151]; outflow tract septum morphogenesis [GO:0003148]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; positive regulation of endocytosis [GO:0045807]; positive regulation of lipoprotein transport [GO:0140077]; positive regulation of neurogenesis [GO:0050769]; positive regulation of oligodendrocyte progenitor proliferation [GO:0070447]; protein import [GO:0017038]; protein transport [GO:0015031]; pulmonary artery morphogenesis [GO:0061156]; receptor-mediated endocytosis [GO:0006898]; response to leptin [GO:0044321]; response to X-ray [GO:0010165]; secondary heart field specification [GO:0003139]; sensory perception of sound [GO:0007605]; transcytosis [GO:0045056]; vagina development [GO:0060068]; ventricular compact myocardium morphogenesis [GO:0003223]; ventricular septum development [GO:0003281]; vitamin D metabolic process [GO:0042359]; vitamin metabolic process [GO:0006766] apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; axon [GO:0030424]; axonal growth cone [GO:0044295]; brush border [GO:0005903]; brush border membrane [GO:0031526]; cell surface [GO:0009986]; clathrin-coated pit [GO:0005905]; dendrite [GO:0030425]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; endosome lumen [GO:0031904]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; cargo receptor activity [GO:0038024]; hemoglobin binding [GO:0030492]; hormone binding [GO:0042562]; insulin-like growth factor I binding [GO:0031994]; low-density lipoprotein particle receptor binding [GO:0050750]; nuclear receptor binding [GO:0016922]; PDZ domain binding [GO:0030165]; protein transporter activity [GO:0140318]; protein-containing complex binding [GO:0044877]; protein-folding chaperone binding [GO:0051087]; SH3 domain binding [GO:0017124] g10643.t1 A2ARV4 27.778 342 1.38e-26 124.0 sp|A2ARV4|LRP2_MOUSE Low-density lipoprotein receptor-related protein 2 OS=Mus musculus OX=10090 GN=Lrp2 PE=1 SV=1 LRP2_MOUSE reviewed Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin) Mus musculus (Mouse) GO:0001822; GO:0001843; GO:0003139; GO:0003148; GO:0003151; GO:0003223; GO:0003281; GO:0005509; GO:0005615; GO:0005768; GO:0005783; GO:0005794; GO:0005886; GO:0005903; GO:0005905; GO:0006066; GO:0006766; GO:0006897; GO:0006898; GO:0007507; GO:0007605; GO:0008283; GO:0008584; GO:0009897; GO:0009986; GO:0010165; GO:0010467; GO:0015031; GO:0016020; GO:0016197; GO:0016324; GO:0016922; GO:0017038; GO:0017124; GO:0020028; GO:0030001; GO:0030139; GO:0030165; GO:0030424; GO:0030425; GO:0030492; GO:0030514; GO:0030900; GO:0031526; GO:0031904; GO:0031994; GO:0032991; GO:0035904; GO:0038024; GO:0042359; GO:0042562; GO:0043066; GO:0043235; GO:0043491; GO:0044295; GO:0044321; GO:0044877; GO:0045056; GO:0045177; GO:0045807; GO:0050750; GO:0050769; GO:0051087; GO:0060068; GO:0060976; GO:0060982; GO:0061156; GO:0061642; GO:0070447; GO:0071363; GO:0097242; GO:0140058; GO:0140077; GO:0140318; GO:1904447; GO:1904888 alcohol metabolic process [GO:0006066]; amyloid-beta clearance [GO:0097242]; aorta development [GO:0035904]; cell population proliferation [GO:0008283]; cellular response to growth factor stimulus [GO:0071363]; chemoattraction of axon [GO:0061642]; coronary artery morphogenesis [GO:0060982]; coronary vasculature development [GO:0060976]; cranial skeletal system development [GO:1904888]; endocytic hemoglobin import into cell [GO:0020028]; endocytosis [GO:0006897]; endosomal transport [GO:0016197]; folate import across plasma membrane [GO:1904447]; forebrain development [GO:0030900]; gene expression [GO:0010467]; heart development [GO:0007507]; kidney development [GO:0001822]; male gonad development [GO:0008584]; metal ion transport [GO:0030001]; negative regulation of apoptotic process [GO:0043066]; negative regulation of BMP signaling pathway [GO:0030514]; neural tube closure [GO:0001843]; neuron projection arborization [GO:0140058]; outflow tract morphogenesis [GO:0003151]; outflow tract septum morphogenesis [GO:0003148]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; positive regulation of endocytosis [GO:0045807]; positive regulation of lipoprotein transport [GO:0140077]; positive regulation of neurogenesis [GO:0050769]; positive regulation of oligodendrocyte progenitor proliferation [GO:0070447]; protein import [GO:0017038]; protein transport [GO:0015031]; pulmonary artery morphogenesis [GO:0061156]; receptor-mediated endocytosis [GO:0006898]; response to leptin [GO:0044321]; response to X-ray [GO:0010165]; secondary heart field specification [GO:0003139]; sensory perception of sound [GO:0007605]; transcytosis [GO:0045056]; vagina development [GO:0060068]; ventricular compact myocardium morphogenesis [GO:0003223]; ventricular septum development [GO:0003281]; vitamin D metabolic process [GO:0042359]; vitamin metabolic process [GO:0006766] apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; axon [GO:0030424]; axonal growth cone [GO:0044295]; brush border [GO:0005903]; brush border membrane [GO:0031526]; cell surface [GO:0009986]; clathrin-coated pit [GO:0005905]; dendrite [GO:0030425]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; endosome lumen [GO:0031904]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; cargo receptor activity [GO:0038024]; hemoglobin binding [GO:0030492]; hormone binding [GO:0042562]; insulin-like growth factor I binding [GO:0031994]; low-density lipoprotein particle receptor binding [GO:0050750]; nuclear receptor binding [GO:0016922]; PDZ domain binding [GO:0030165]; protein transporter activity [GO:0140318]; protein-containing complex binding [GO:0044877]; protein-folding chaperone binding [GO:0051087]; SH3 domain binding [GO:0017124] g10643.t1 A2ARV4 36.396 283 1.43e-23 114.0 sp|A2ARV4|LRP2_MOUSE Low-density lipoprotein receptor-related protein 2 OS=Mus musculus OX=10090 GN=Lrp2 PE=1 SV=1 LRP2_MOUSE reviewed Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin) Mus musculus (Mouse) GO:0001822; GO:0001843; GO:0003139; GO:0003148; GO:0003151; GO:0003223; GO:0003281; GO:0005509; GO:0005615; GO:0005768; GO:0005783; GO:0005794; GO:0005886; GO:0005903; GO:0005905; GO:0006066; GO:0006766; GO:0006897; GO:0006898; GO:0007507; GO:0007605; GO:0008283; GO:0008584; GO:0009897; GO:0009986; GO:0010165; GO:0010467; GO:0015031; GO:0016020; GO:0016197; GO:0016324; GO:0016922; GO:0017038; GO:0017124; GO:0020028; GO:0030001; GO:0030139; GO:0030165; GO:0030424; GO:0030425; GO:0030492; GO:0030514; GO:0030900; GO:0031526; GO:0031904; GO:0031994; GO:0032991; GO:0035904; GO:0038024; GO:0042359; GO:0042562; GO:0043066; GO:0043235; GO:0043491; GO:0044295; GO:0044321; GO:0044877; GO:0045056; GO:0045177; GO:0045807; GO:0050750; GO:0050769; GO:0051087; GO:0060068; GO:0060976; GO:0060982; GO:0061156; GO:0061642; GO:0070447; GO:0071363; GO:0097242; GO:0140058; GO:0140077; GO:0140318; GO:1904447; GO:1904888 alcohol metabolic process [GO:0006066]; amyloid-beta clearance [GO:0097242]; aorta development [GO:0035904]; cell population proliferation [GO:0008283]; cellular response to growth factor stimulus [GO:0071363]; chemoattraction of axon [GO:0061642]; coronary artery morphogenesis [GO:0060982]; coronary vasculature development [GO:0060976]; cranial skeletal system development [GO:1904888]; endocytic hemoglobin import into cell [GO:0020028]; endocytosis [GO:0006897]; endosomal transport [GO:0016197]; folate import across plasma membrane [GO:1904447]; forebrain development [GO:0030900]; gene expression [GO:0010467]; heart development [GO:0007507]; kidney development [GO:0001822]; male gonad development [GO:0008584]; metal ion transport [GO:0030001]; negative regulation of apoptotic process [GO:0043066]; negative regulation of BMP signaling pathway [GO:0030514]; neural tube closure [GO:0001843]; neuron projection arborization [GO:0140058]; outflow tract morphogenesis [GO:0003151]; outflow tract septum morphogenesis [GO:0003148]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; positive regulation of endocytosis [GO:0045807]; positive regulation of lipoprotein transport [GO:0140077]; positive regulation of neurogenesis [GO:0050769]; positive regulation of oligodendrocyte progenitor proliferation [GO:0070447]; protein import [GO:0017038]; protein transport [GO:0015031]; pulmonary artery morphogenesis [GO:0061156]; receptor-mediated endocytosis [GO:0006898]; response to leptin [GO:0044321]; response to X-ray [GO:0010165]; secondary heart field specification [GO:0003139]; sensory perception of sound [GO:0007605]; transcytosis [GO:0045056]; vagina development [GO:0060068]; ventricular compact myocardium morphogenesis [GO:0003223]; ventricular septum development [GO:0003281]; vitamin D metabolic process [GO:0042359]; vitamin metabolic process [GO:0006766] apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; axon [GO:0030424]; axonal growth cone [GO:0044295]; brush border [GO:0005903]; brush border membrane [GO:0031526]; cell surface [GO:0009986]; clathrin-coated pit [GO:0005905]; dendrite [GO:0030425]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; endosome lumen [GO:0031904]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; cargo receptor activity [GO:0038024]; hemoglobin binding [GO:0030492]; hormone binding [GO:0042562]; insulin-like growth factor I binding [GO:0031994]; low-density lipoprotein particle receptor binding [GO:0050750]; nuclear receptor binding [GO:0016922]; PDZ domain binding [GO:0030165]; protein transporter activity [GO:0140318]; protein-containing complex binding [GO:0044877]; protein-folding chaperone binding [GO:0051087]; SH3 domain binding [GO:0017124] g10643.t1 A2ARV4 38.132 257 2.2e-23 113.0 sp|A2ARV4|LRP2_MOUSE Low-density lipoprotein receptor-related protein 2 OS=Mus musculus OX=10090 GN=Lrp2 PE=1 SV=1 LRP2_MOUSE reviewed Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin) Mus musculus (Mouse) GO:0001822; GO:0001843; GO:0003139; GO:0003148; GO:0003151; GO:0003223; GO:0003281; GO:0005509; GO:0005615; GO:0005768; GO:0005783; GO:0005794; GO:0005886; GO:0005903; GO:0005905; GO:0006066; GO:0006766; GO:0006897; GO:0006898; GO:0007507; GO:0007605; GO:0008283; GO:0008584; GO:0009897; GO:0009986; GO:0010165; GO:0010467; GO:0015031; GO:0016020; GO:0016197; GO:0016324; GO:0016922; GO:0017038; GO:0017124; GO:0020028; GO:0030001; GO:0030139; GO:0030165; GO:0030424; GO:0030425; GO:0030492; GO:0030514; GO:0030900; GO:0031526; GO:0031904; GO:0031994; GO:0032991; GO:0035904; GO:0038024; GO:0042359; GO:0042562; GO:0043066; GO:0043235; GO:0043491; GO:0044295; GO:0044321; GO:0044877; GO:0045056; GO:0045177; GO:0045807; GO:0050750; GO:0050769; GO:0051087; GO:0060068; GO:0060976; GO:0060982; GO:0061156; GO:0061642; GO:0070447; GO:0071363; GO:0097242; GO:0140058; GO:0140077; GO:0140318; GO:1904447; GO:1904888 alcohol metabolic process [GO:0006066]; amyloid-beta clearance [GO:0097242]; aorta development [GO:0035904]; cell population proliferation [GO:0008283]; cellular response to growth factor stimulus [GO:0071363]; chemoattraction of axon [GO:0061642]; coronary artery morphogenesis [GO:0060982]; coronary vasculature development [GO:0060976]; cranial skeletal system development [GO:1904888]; endocytic hemoglobin import into cell [GO:0020028]; endocytosis [GO:0006897]; endosomal transport [GO:0016197]; folate import across plasma membrane [GO:1904447]; forebrain development [GO:0030900]; gene expression [GO:0010467]; heart development [GO:0007507]; kidney development [GO:0001822]; male gonad development [GO:0008584]; metal ion transport [GO:0030001]; negative regulation of apoptotic process [GO:0043066]; negative regulation of BMP signaling pathway [GO:0030514]; neural tube closure [GO:0001843]; neuron projection arborization [GO:0140058]; outflow tract morphogenesis [GO:0003151]; outflow tract septum morphogenesis [GO:0003148]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; positive regulation of endocytosis [GO:0045807]; positive regulation of lipoprotein transport [GO:0140077]; positive regulation of neurogenesis [GO:0050769]; positive regulation of oligodendrocyte progenitor proliferation [GO:0070447]; protein import [GO:0017038]; protein transport [GO:0015031]; pulmonary artery morphogenesis [GO:0061156]; receptor-mediated endocytosis [GO:0006898]; response to leptin [GO:0044321]; response to X-ray [GO:0010165]; secondary heart field specification [GO:0003139]; sensory perception of sound [GO:0007605]; transcytosis [GO:0045056]; vagina development [GO:0060068]; ventricular compact myocardium morphogenesis [GO:0003223]; ventricular septum development [GO:0003281]; vitamin D metabolic process [GO:0042359]; vitamin metabolic process [GO:0006766] apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; axon [GO:0030424]; axonal growth cone [GO:0044295]; brush border [GO:0005903]; brush border membrane [GO:0031526]; cell surface [GO:0009986]; clathrin-coated pit [GO:0005905]; dendrite [GO:0030425]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; endosome lumen [GO:0031904]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; cargo receptor activity [GO:0038024]; hemoglobin binding [GO:0030492]; hormone binding [GO:0042562]; insulin-like growth factor I binding [GO:0031994]; low-density lipoprotein particle receptor binding [GO:0050750]; nuclear receptor binding [GO:0016922]; PDZ domain binding [GO:0030165]; protein transporter activity [GO:0140318]; protein-containing complex binding [GO:0044877]; protein-folding chaperone binding [GO:0051087]; SH3 domain binding [GO:0017124] g10643.t1 A2ARV4 25.5 400 4.8799999999999997e-23 112.0 sp|A2ARV4|LRP2_MOUSE Low-density lipoprotein receptor-related protein 2 OS=Mus musculus OX=10090 GN=Lrp2 PE=1 SV=1 LRP2_MOUSE reviewed Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin) Mus musculus (Mouse) GO:0001822; GO:0001843; GO:0003139; GO:0003148; GO:0003151; GO:0003223; GO:0003281; GO:0005509; GO:0005615; GO:0005768; GO:0005783; GO:0005794; GO:0005886; GO:0005903; GO:0005905; GO:0006066; GO:0006766; GO:0006897; GO:0006898; GO:0007507; GO:0007605; GO:0008283; GO:0008584; GO:0009897; GO:0009986; GO:0010165; GO:0010467; GO:0015031; GO:0016020; GO:0016197; GO:0016324; GO:0016922; GO:0017038; GO:0017124; GO:0020028; GO:0030001; GO:0030139; GO:0030165; GO:0030424; GO:0030425; GO:0030492; GO:0030514; GO:0030900; GO:0031526; GO:0031904; GO:0031994; GO:0032991; GO:0035904; GO:0038024; GO:0042359; GO:0042562; GO:0043066; GO:0043235; GO:0043491; GO:0044295; GO:0044321; GO:0044877; GO:0045056; GO:0045177; GO:0045807; GO:0050750; GO:0050769; GO:0051087; GO:0060068; GO:0060976; GO:0060982; GO:0061156; GO:0061642; GO:0070447; GO:0071363; GO:0097242; GO:0140058; GO:0140077; GO:0140318; GO:1904447; GO:1904888 alcohol metabolic process [GO:0006066]; amyloid-beta clearance [GO:0097242]; aorta development [GO:0035904]; cell population proliferation [GO:0008283]; cellular response to growth factor stimulus [GO:0071363]; chemoattraction of axon [GO:0061642]; coronary artery morphogenesis [GO:0060982]; coronary vasculature development [GO:0060976]; cranial skeletal system development [GO:1904888]; endocytic hemoglobin import into cell [GO:0020028]; endocytosis [GO:0006897]; endosomal transport [GO:0016197]; folate import across plasma membrane [GO:1904447]; forebrain development [GO:0030900]; gene expression [GO:0010467]; heart development [GO:0007507]; kidney development [GO:0001822]; male gonad development [GO:0008584]; metal ion transport [GO:0030001]; negative regulation of apoptotic process [GO:0043066]; negative regulation of BMP signaling pathway [GO:0030514]; neural tube closure [GO:0001843]; neuron projection arborization [GO:0140058]; outflow tract morphogenesis [GO:0003151]; outflow tract septum morphogenesis [GO:0003148]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; positive regulation of endocytosis [GO:0045807]; positive regulation of lipoprotein transport [GO:0140077]; positive regulation of neurogenesis [GO:0050769]; positive regulation of oligodendrocyte progenitor proliferation [GO:0070447]; protein import [GO:0017038]; protein transport [GO:0015031]; pulmonary artery morphogenesis [GO:0061156]; receptor-mediated endocytosis [GO:0006898]; response to leptin [GO:0044321]; response to X-ray [GO:0010165]; secondary heart field specification [GO:0003139]; sensory perception of sound [GO:0007605]; transcytosis [GO:0045056]; vagina development [GO:0060068]; ventricular compact myocardium morphogenesis [GO:0003223]; ventricular septum development [GO:0003281]; vitamin D metabolic process [GO:0042359]; vitamin metabolic process [GO:0006766] apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; axon [GO:0030424]; axonal growth cone [GO:0044295]; brush border [GO:0005903]; brush border membrane [GO:0031526]; cell surface [GO:0009986]; clathrin-coated pit [GO:0005905]; dendrite [GO:0030425]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; endosome lumen [GO:0031904]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; cargo receptor activity [GO:0038024]; hemoglobin binding [GO:0030492]; hormone binding [GO:0042562]; insulin-like growth factor I binding [GO:0031994]; low-density lipoprotein particle receptor binding [GO:0050750]; nuclear receptor binding [GO:0016922]; PDZ domain binding [GO:0030165]; protein transporter activity [GO:0140318]; protein-containing complex binding [GO:0044877]; protein-folding chaperone binding [GO:0051087]; SH3 domain binding [GO:0017124] g10643.t1 A2ARV4 40.088 227 7.8e-22 108.0 sp|A2ARV4|LRP2_MOUSE Low-density lipoprotein receptor-related protein 2 OS=Mus musculus OX=10090 GN=Lrp2 PE=1 SV=1 LRP2_MOUSE reviewed Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin) Mus musculus (Mouse) GO:0001822; GO:0001843; GO:0003139; GO:0003148; GO:0003151; GO:0003223; GO:0003281; GO:0005509; GO:0005615; GO:0005768; GO:0005783; GO:0005794; GO:0005886; GO:0005903; GO:0005905; GO:0006066; GO:0006766; GO:0006897; GO:0006898; GO:0007507; GO:0007605; GO:0008283; GO:0008584; GO:0009897; GO:0009986; GO:0010165; GO:0010467; GO:0015031; GO:0016020; GO:0016197; GO:0016324; GO:0016922; GO:0017038; GO:0017124; GO:0020028; GO:0030001; GO:0030139; GO:0030165; GO:0030424; GO:0030425; GO:0030492; GO:0030514; GO:0030900; GO:0031526; GO:0031904; GO:0031994; GO:0032991; GO:0035904; GO:0038024; GO:0042359; GO:0042562; GO:0043066; GO:0043235; GO:0043491; GO:0044295; GO:0044321; GO:0044877; GO:0045056; GO:0045177; GO:0045807; GO:0050750; GO:0050769; GO:0051087; GO:0060068; GO:0060976; GO:0060982; GO:0061156; GO:0061642; GO:0070447; GO:0071363; GO:0097242; GO:0140058; GO:0140077; GO:0140318; GO:1904447; GO:1904888 alcohol metabolic process [GO:0006066]; amyloid-beta clearance [GO:0097242]; aorta development [GO:0035904]; cell population proliferation [GO:0008283]; cellular response to growth factor stimulus [GO:0071363]; chemoattraction of axon [GO:0061642]; coronary artery morphogenesis [GO:0060982]; coronary vasculature development [GO:0060976]; cranial skeletal system development [GO:1904888]; endocytic hemoglobin import into cell [GO:0020028]; endocytosis [GO:0006897]; endosomal transport [GO:0016197]; folate import across plasma membrane [GO:1904447]; forebrain development [GO:0030900]; gene expression [GO:0010467]; heart development [GO:0007507]; kidney development [GO:0001822]; male gonad development [GO:0008584]; metal ion transport [GO:0030001]; negative regulation of apoptotic process [GO:0043066]; negative regulation of BMP signaling pathway [GO:0030514]; neural tube closure [GO:0001843]; neuron projection arborization [GO:0140058]; outflow tract morphogenesis [GO:0003151]; outflow tract septum morphogenesis [GO:0003148]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; positive regulation of endocytosis [GO:0045807]; positive regulation of lipoprotein transport [GO:0140077]; positive regulation of neurogenesis [GO:0050769]; positive regulation of oligodendrocyte progenitor proliferation [GO:0070447]; protein import [GO:0017038]; protein transport [GO:0015031]; pulmonary artery morphogenesis [GO:0061156]; receptor-mediated endocytosis [GO:0006898]; response to leptin [GO:0044321]; response to X-ray [GO:0010165]; secondary heart field specification [GO:0003139]; sensory perception of sound [GO:0007605]; transcytosis [GO:0045056]; vagina development [GO:0060068]; ventricular compact myocardium morphogenesis [GO:0003223]; ventricular septum development [GO:0003281]; vitamin D metabolic process [GO:0042359]; vitamin metabolic process [GO:0006766] apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; axon [GO:0030424]; axonal growth cone [GO:0044295]; brush border [GO:0005903]; brush border membrane [GO:0031526]; cell surface [GO:0009986]; clathrin-coated pit [GO:0005905]; dendrite [GO:0030425]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; endosome lumen [GO:0031904]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; cargo receptor activity [GO:0038024]; hemoglobin binding [GO:0030492]; hormone binding [GO:0042562]; insulin-like growth factor I binding [GO:0031994]; low-density lipoprotein particle receptor binding [GO:0050750]; nuclear receptor binding [GO:0016922]; PDZ domain binding [GO:0030165]; protein transporter activity [GO:0140318]; protein-containing complex binding [GO:0044877]; protein-folding chaperone binding [GO:0051087]; SH3 domain binding [GO:0017124] g10643.t2 P98158 46.244 1957 0.0 1527.0 sp|P98158|LRP2_RAT Low-density lipoprotein receptor-related protein 2 OS=Rattus norvegicus OX=10116 GN=Lrp2 PE=1 SV=1 g10643.t2 P98158 34.299 1277 5.53e-164 567.0 sp|P98158|LRP2_RAT Low-density lipoprotein receptor-related protein 2 OS=Rattus norvegicus OX=10116 GN=Lrp2 PE=1 SV=1 g10643.t2 P98158 37.775 728 8.76e-119 426.0 sp|P98158|LRP2_RAT Low-density lipoprotein receptor-related protein 2 OS=Rattus norvegicus OX=10116 GN=Lrp2 PE=1 SV=1 g10643.t2 P98158 33.939 716 5.82e-98 358.0 sp|P98158|LRP2_RAT Low-density lipoprotein receptor-related protein 2 OS=Rattus norvegicus OX=10116 GN=Lrp2 PE=1 SV=1 g10643.t2 P98158 34.15 735 9.64e-87 322.0 sp|P98158|LRP2_RAT Low-density lipoprotein receptor-related protein 2 OS=Rattus norvegicus OX=10116 GN=Lrp2 PE=1 SV=1 g10643.t2 P98158 35.561 748 2e-82 307.0 sp|P98158|LRP2_RAT Low-density lipoprotein receptor-related protein 2 OS=Rattus norvegicus OX=10116 GN=Lrp2 PE=1 SV=1 g10643.t2 P98158 28.834 763 4.25e-65 251.0 sp|P98158|LRP2_RAT Low-density lipoprotein receptor-related protein 2 OS=Rattus norvegicus OX=10116 GN=Lrp2 PE=1 SV=1 g10643.t2 P98158 28.065 367 1.5900000000000002e-35 153.0 sp|P98158|LRP2_RAT Low-density lipoprotein receptor-related protein 2 OS=Rattus norvegicus OX=10116 GN=Lrp2 PE=1 SV=1 g10643.t2 P98158 28.655 342 5.37e-28 128.0 sp|P98158|LRP2_RAT Low-density lipoprotein receptor-related protein 2 OS=Rattus norvegicus OX=10116 GN=Lrp2 PE=1 SV=1 g10643.t2 P98158 36.749 283 1.03e-24 117.0 sp|P98158|LRP2_RAT Low-density lipoprotein receptor-related protein 2 OS=Rattus norvegicus OX=10116 GN=Lrp2 PE=1 SV=1 g10643.t2 P98158 38.462 234 1.5099999999999998e-23 114.0 sp|P98158|LRP2_RAT Low-density lipoprotein receptor-related protein 2 OS=Rattus norvegicus OX=10116 GN=Lrp2 PE=1 SV=1 g10643.t2 P98158 38.272 243 6.559999999999999e-23 112.0 sp|P98158|LRP2_RAT Low-density lipoprotein receptor-related protein 2 OS=Rattus norvegicus OX=10116 GN=Lrp2 PE=1 SV=1 g10643.t2 P98158 24.485 388 1.43e-22 110.0 sp|P98158|LRP2_RAT Low-density lipoprotein receptor-related protein 2 OS=Rattus norvegicus OX=10116 GN=Lrp2 PE=1 SV=1 g10643.t2 P98158 37.276 279 2.0600000000000001e-22 110.0 sp|P98158|LRP2_RAT Low-density lipoprotein receptor-related protein 2 OS=Rattus norvegicus OX=10116 GN=Lrp2 PE=1 SV=1 g10644.t1 Q8AYS8 47.471 1028 0.0 855.0 sp|Q8AYS8|KCMA1_CHICK Calcium-activated potassium channel subunit alpha-1 OS=Gallus gallus OX=9031 GN=KCNMA1 PE=1 SV=2 KCMA1_CHICK reviewed Calcium-activated potassium channel subunit alpha-1 (BK channel) (BKCA alpha) (Calcium-activated potassium channel, subfamily M subunit alpha-1) (K(VCA)alpha) (KCa1.1) (Maxi K channel) (MaxiK) (Slo-alpha) (Slo1) (Slowpoke homolog) (Slo homolog) (cSlo) Gallus gallus (Chicken) GO:0005249; GO:0015269; GO:0034702; GO:0045211; GO:0046872; GO:0060072; GO:0071805 potassium ion transmembrane transport [GO:0071805] monoatomic ion channel complex [GO:0034702]; postsynaptic membrane [GO:0045211] calcium-activated potassium channel activity [GO:0015269]; large conductance calcium-activated potassium channel activity [GO:0060072]; metal ion binding [GO:0046872]; voltage-gated potassium channel activity [GO:0005249] g10646.t1 P50227 35.036 274 1.73e-44 155.0 sp|P50227|ST1A1_BOVIN Sulfotransferase 1A1 OS=Bos taurus OX=9913 GN=SULT1A1 PE=1 SV=2 ST1A1_BOVIN reviewed Sulfotransferase 1A1 (ST1A1) (EC 2.8.2.1) (Aryl sulfotransferase) (Phenol sulfotransferase) (Phenol-sulfating phenol sulfotransferase) (P-PST) Bos taurus (Bovine) GO:0004062; GO:0005737; GO:0008146; GO:0008202; GO:0042403; GO:0042420; GO:0050656; GO:0051923 dopamine catabolic process [GO:0042420]; steroid metabolic process [GO:0008202]; sulfation [GO:0051923]; thyroid hormone metabolic process [GO:0042403] cytoplasm [GO:0005737] 3'-phosphoadenosine 5'-phosphosulfate binding [GO:0050656]; aryl sulfotransferase activity [GO:0004062]; sulfotransferase activity [GO:0008146] g10647.t1 A2VDP6 31.959 485 2.27e-82 272.0 sp|A2VDP6|NXPE3_BOVIN NXPE family member 3 OS=Bos taurus OX=9913 GN=NXPE3 PE=2 SV=1 g10653.t1 O88413 50.83 482 1.49e-150 440.0 sp|O88413|TULP3_MOUSE Tubby-related protein 3 OS=Mus musculus OX=10090 GN=Tulp3 PE=1 SV=1 TULP3_MOUSE reviewed Tubby-related protein 3 (Tubby-like protein 3) Mus musculus (Mouse) GO:0001664; GO:0001841; GO:0001843; GO:0005576; GO:0005634; GO:0005654; GO:0005730; GO:0005886; GO:0005929; GO:0005930; GO:0007224; GO:0007420; GO:0008277; GO:0008589; GO:0009952; GO:0019899; GO:0021904; GO:0021915; GO:0021953; GO:0031076; GO:0035091; GO:0036064; GO:0042733; GO:0044877; GO:0045879; GO:0048702; GO:0060173; GO:0060348; GO:0060434; GO:0061512; GO:0061548; GO:0097546; GO:0097731; GO:0120160 anterior/posterior pattern specification [GO:0009952]; bone development [GO:0060348]; brain development [GO:0007420]; bronchus morphogenesis [GO:0060434]; central nervous system neuron differentiation [GO:0021953]; dorsal/ventral neural tube patterning [GO:0021904]; embryonic camera-type eye development [GO:0031076]; embryonic digit morphogenesis [GO:0042733]; embryonic neurocranium morphogenesis [GO:0048702]; ganglion development [GO:0061548]; limb development [GO:0060173]; negative regulation of smoothened signaling pathway [GO:0045879]; neural tube closure [GO:0001843]; neural tube development [GO:0021915]; neural tube formation [GO:0001841]; protein localization to cilium [GO:0061512]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; regulation of smoothened signaling pathway [GO:0008589]; smoothened signaling pathway [GO:0007224] 9+0 non-motile cilium [GO:0097731]; axoneme [GO:0005930]; ciliary basal body [GO:0036064]; ciliary base [GO:0097546]; cilium [GO:0005929]; extracellular region [GO:0005576]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886] enzyme binding [GO:0019899]; G protein-coupled receptor binding [GO:0001664]; intraciliary transport particle A binding [GO:0120160]; phosphatidylinositol binding [GO:0035091]; protein-containing complex binding [GO:0044877] g10654.t1 Q8K3X2 67.308 312 4.2e-162 457.0 sp|Q8K3X2|FCL_CRIGR GDP-L-fucose synthase OS=Cricetulus griseus OX=10029 GN=GFUS PE=2 SV=1 g10666.t1 Q92900 34.085 355 3.2299999999999996e-45 174.0 sp|Q92900|RENT1_HUMAN Regulator of nonsense transcripts 1 OS=Homo sapiens OX=9606 GN=UPF1 PE=1 SV=2 RENT1_HUMAN reviewed Regulator of nonsense transcripts 1 (EC 3.6.4.12) (EC 3.6.4.13) (ATP-dependent helicase RENT1) (Nonsense mRNA reducing factor 1) (NORF1) (Up-frameshift suppressor 1 homolog) (hUpf1) Homo sapiens (Human) GO:0000184; GO:0000781; GO:0000785; GO:0000932; GO:0000956; GO:0003682; GO:0003723; GO:0003724; GO:0004386; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006260; GO:0006281; GO:0006406; GO:0006449; GO:0008270; GO:0016887; GO:0032201; GO:0032204; GO:0035145; GO:0036121; GO:0042162; GO:0044530; GO:0044770; GO:0044877; GO:0048471; GO:0060816; GO:0061014; GO:0061158; GO:0071044; GO:0071222; GO:0071347; GO:1905746 3'-UTR-mediated mRNA destabilization [GO:0061158]; cell cycle phase transition [GO:0044770]; cellular response to interleukin-1 [GO:0071347]; cellular response to lipopolysaccharide [GO:0071222]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; histone mRNA catabolic process [GO:0071044]; mRNA export from nucleus [GO:0006406]; nuclear-transcribed mRNA catabolic process [GO:0000956]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; positive regulation of mRNA catabolic process [GO:0061014]; positive regulation of mRNA cis splicing, via spliceosome [GO:1905746]; random inactivation of X chromosome [GO:0060816]; regulation of telomere maintenance [GO:0032204]; regulation of translational termination [GO:0006449]; telomere maintenance via semi-conservative replication [GO:0032201] chromatin [GO:0000785]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; exon-exon junction complex [GO:0035145]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; perinuclear region of cytoplasm [GO:0048471]; supraspliceosomal complex [GO:0044530] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; chromatin binding [GO:0003682]; double-stranded DNA helicase activity [GO:0036121]; helicase activity [GO:0004386]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; telomeric DNA binding [GO:0042162]; zinc ion binding [GO:0008270] g10668.t1 Q14247 46.957 115 1.2500000000000001e-21 97.4 sp|Q14247|SRC8_HUMAN Src substrate cortactin OS=Homo sapiens OX=9606 GN=CTTN PE=1 SV=2 g10669.t1 Q66HL2 73.333 75 4.51e-40 113.0 sp|Q66HL2|SRC8_RAT Src substrate cortactin OS=Rattus norvegicus OX=10116 GN=Cttn PE=1 SV=1 SRC8_RAT reviewed Src substrate cortactin Rattus norvegicus (Rat) GO:0001726; GO:0002102; GO:0005522; GO:0005737; GO:0005783; GO:0005794; GO:0005884; GO:0005886; GO:0005905; GO:0005925; GO:0005938; GO:0006886; GO:0006898; GO:0006930; GO:0008076; GO:0016477; GO:0030027; GO:0030036; GO:0030054; GO:0030427; GO:0030516; GO:0030833; GO:0030838; GO:0030863; GO:0030864; GO:0043197; GO:0045987; GO:0048041; GO:0048812; GO:0048870; GO:0050921; GO:0051015; GO:0060491; GO:0070064; GO:0071933; GO:0097062; GO:0097191; GO:0097581; GO:0098794; GO:0098871; GO:0098885; GO:0098978; GO:0099010; GO:1901524; GO:1990023; GO:2001237 actin cytoskeleton organization [GO:0030036]; cell migration [GO:0016477]; cell motility [GO:0048870]; dendritic spine maintenance [GO:0097062]; extrinsic apoptotic signaling pathway [GO:0097191]; focal adhesion assembly [GO:0048041]; intracellular protein transport [GO:0006886]; lamellipodium organization [GO:0097581]; modification of postsynaptic actin cytoskeleton [GO:0098885]; modification of postsynaptic structure [GO:0099010]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; neuron projection morphogenesis [GO:0048812]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of chemotaxis [GO:0050921]; positive regulation of smooth muscle contraction [GO:0045987]; receptor-mediated endocytosis [GO:0006898]; regulation of actin filament polymerization [GO:0030833]; regulation of axon extension [GO:0030516]; regulation of cell projection assembly [GO:0060491]; regulation of mitophagy [GO:1901524]; substrate-dependent cell migration, cell extension [GO:0006930] actin filament [GO:0005884]; cell cortex [GO:0005938]; cell junction [GO:0030054]; clathrin-coated pit [GO:0005905]; cortical actin cytoskeleton [GO:0030864]; cortical cytoskeleton [GO:0030863]; cytoplasm [GO:0005737]; dendritic spine [GO:0043197]; endoplasmic reticulum [GO:0005783]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; lamellipodium [GO:0030027]; mitotic spindle midzone [GO:1990023]; plasma membrane [GO:0005886]; podosome [GO:0002102]; postsynapse [GO:0098794]; postsynaptic actin cytoskeleton [GO:0098871]; ruffle [GO:0001726]; site of polarized growth [GO:0030427]; voltage-gated potassium channel complex [GO:0008076] actin filament binding [GO:0051015]; Arp2/3 complex binding [GO:0071933]; profilin binding [GO:0005522]; proline-rich region binding [GO:0070064] g10669.t1 Q66HL2 69.388 49 4.51e-40 72.4 sp|Q66HL2|SRC8_RAT Src substrate cortactin OS=Rattus norvegicus OX=10116 GN=Cttn PE=1 SV=1 SRC8_RAT reviewed Src substrate cortactin Rattus norvegicus (Rat) GO:0001726; GO:0002102; GO:0005522; GO:0005737; GO:0005783; GO:0005794; GO:0005884; GO:0005886; GO:0005905; GO:0005925; GO:0005938; GO:0006886; GO:0006898; GO:0006930; GO:0008076; GO:0016477; GO:0030027; GO:0030036; GO:0030054; GO:0030427; GO:0030516; GO:0030833; GO:0030838; GO:0030863; GO:0030864; GO:0043197; GO:0045987; GO:0048041; GO:0048812; GO:0048870; GO:0050921; GO:0051015; GO:0060491; GO:0070064; GO:0071933; GO:0097062; GO:0097191; GO:0097581; GO:0098794; GO:0098871; GO:0098885; GO:0098978; GO:0099010; GO:1901524; GO:1990023; GO:2001237 actin cytoskeleton organization [GO:0030036]; cell migration [GO:0016477]; cell motility [GO:0048870]; dendritic spine maintenance [GO:0097062]; extrinsic apoptotic signaling pathway [GO:0097191]; focal adhesion assembly [GO:0048041]; intracellular protein transport [GO:0006886]; lamellipodium organization [GO:0097581]; modification of postsynaptic actin cytoskeleton [GO:0098885]; modification of postsynaptic structure [GO:0099010]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; neuron projection morphogenesis [GO:0048812]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of chemotaxis [GO:0050921]; positive regulation of smooth muscle contraction [GO:0045987]; receptor-mediated endocytosis [GO:0006898]; regulation of actin filament polymerization [GO:0030833]; regulation of axon extension [GO:0030516]; regulation of cell projection assembly [GO:0060491]; regulation of mitophagy [GO:1901524]; substrate-dependent cell migration, cell extension [GO:0006930] actin filament [GO:0005884]; cell cortex [GO:0005938]; cell junction [GO:0030054]; clathrin-coated pit [GO:0005905]; cortical actin cytoskeleton [GO:0030864]; cortical cytoskeleton [GO:0030863]; cytoplasm [GO:0005737]; dendritic spine [GO:0043197]; endoplasmic reticulum [GO:0005783]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; lamellipodium [GO:0030027]; mitotic spindle midzone [GO:1990023]; plasma membrane [GO:0005886]; podosome [GO:0002102]; postsynapse [GO:0098794]; postsynaptic actin cytoskeleton [GO:0098871]; ruffle [GO:0001726]; site of polarized growth [GO:0030427]; voltage-gated potassium channel complex [GO:0008076] actin filament binding [GO:0051015]; Arp2/3 complex binding [GO:0071933]; profilin binding [GO:0005522]; proline-rich region binding [GO:0070064] g10669.t1 Q66HL2 64.773 88 1.21e-28 114.0 sp|Q66HL2|SRC8_RAT Src substrate cortactin OS=Rattus norvegicus OX=10116 GN=Cttn PE=1 SV=1 SRC8_RAT reviewed Src substrate cortactin Rattus norvegicus (Rat) GO:0001726; GO:0002102; GO:0005522; GO:0005737; GO:0005783; GO:0005794; GO:0005884; GO:0005886; GO:0005905; GO:0005925; GO:0005938; GO:0006886; GO:0006898; GO:0006930; GO:0008076; GO:0016477; GO:0030027; GO:0030036; GO:0030054; GO:0030427; GO:0030516; GO:0030833; GO:0030838; GO:0030863; GO:0030864; GO:0043197; GO:0045987; GO:0048041; GO:0048812; GO:0048870; GO:0050921; GO:0051015; GO:0060491; GO:0070064; GO:0071933; GO:0097062; GO:0097191; GO:0097581; GO:0098794; GO:0098871; GO:0098885; GO:0098978; GO:0099010; GO:1901524; GO:1990023; GO:2001237 actin cytoskeleton organization [GO:0030036]; cell migration [GO:0016477]; cell motility [GO:0048870]; dendritic spine maintenance [GO:0097062]; extrinsic apoptotic signaling pathway [GO:0097191]; focal adhesion assembly [GO:0048041]; intracellular protein transport [GO:0006886]; lamellipodium organization [GO:0097581]; modification of postsynaptic actin cytoskeleton [GO:0098885]; modification of postsynaptic structure [GO:0099010]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; neuron projection morphogenesis [GO:0048812]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of chemotaxis [GO:0050921]; positive regulation of smooth muscle contraction [GO:0045987]; receptor-mediated endocytosis [GO:0006898]; regulation of actin filament polymerization [GO:0030833]; regulation of axon extension [GO:0030516]; regulation of cell projection assembly [GO:0060491]; regulation of mitophagy [GO:1901524]; substrate-dependent cell migration, cell extension [GO:0006930] actin filament [GO:0005884]; cell cortex [GO:0005938]; cell junction [GO:0030054]; clathrin-coated pit [GO:0005905]; cortical actin cytoskeleton [GO:0030864]; cortical cytoskeleton [GO:0030863]; cytoplasm [GO:0005737]; dendritic spine [GO:0043197]; endoplasmic reticulum [GO:0005783]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; lamellipodium [GO:0030027]; mitotic spindle midzone [GO:1990023]; plasma membrane [GO:0005886]; podosome [GO:0002102]; postsynapse [GO:0098794]; postsynaptic actin cytoskeleton [GO:0098871]; ruffle [GO:0001726]; site of polarized growth [GO:0030427]; voltage-gated potassium channel complex [GO:0008076] actin filament binding [GO:0051015]; Arp2/3 complex binding [GO:0071933]; profilin binding [GO:0005522]; proline-rich region binding [GO:0070064] g10669.t1 Q66HL2 61.364 88 6.74e-26 106.0 sp|Q66HL2|SRC8_RAT Src substrate cortactin OS=Rattus norvegicus OX=10116 GN=Cttn PE=1 SV=1 SRC8_RAT reviewed Src substrate cortactin Rattus norvegicus (Rat) GO:0001726; GO:0002102; GO:0005522; GO:0005737; GO:0005783; GO:0005794; GO:0005884; GO:0005886; GO:0005905; GO:0005925; GO:0005938; GO:0006886; GO:0006898; GO:0006930; GO:0008076; GO:0016477; GO:0030027; GO:0030036; GO:0030054; GO:0030427; GO:0030516; GO:0030833; GO:0030838; GO:0030863; GO:0030864; GO:0043197; GO:0045987; GO:0048041; GO:0048812; GO:0048870; GO:0050921; GO:0051015; GO:0060491; GO:0070064; GO:0071933; GO:0097062; GO:0097191; GO:0097581; GO:0098794; GO:0098871; GO:0098885; GO:0098978; GO:0099010; GO:1901524; GO:1990023; GO:2001237 actin cytoskeleton organization [GO:0030036]; cell migration [GO:0016477]; cell motility [GO:0048870]; dendritic spine maintenance [GO:0097062]; extrinsic apoptotic signaling pathway [GO:0097191]; focal adhesion assembly [GO:0048041]; intracellular protein transport [GO:0006886]; lamellipodium organization [GO:0097581]; modification of postsynaptic actin cytoskeleton [GO:0098885]; modification of postsynaptic structure [GO:0099010]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; neuron projection morphogenesis [GO:0048812]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of chemotaxis [GO:0050921]; positive regulation of smooth muscle contraction [GO:0045987]; receptor-mediated endocytosis [GO:0006898]; regulation of actin filament polymerization [GO:0030833]; regulation of axon extension [GO:0030516]; regulation of cell projection assembly [GO:0060491]; regulation of mitophagy [GO:1901524]; substrate-dependent cell migration, cell extension [GO:0006930] actin filament [GO:0005884]; cell cortex [GO:0005938]; cell junction [GO:0030054]; clathrin-coated pit [GO:0005905]; cortical actin cytoskeleton [GO:0030864]; cortical cytoskeleton [GO:0030863]; cytoplasm [GO:0005737]; dendritic spine [GO:0043197]; endoplasmic reticulum [GO:0005783]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; lamellipodium [GO:0030027]; mitotic spindle midzone [GO:1990023]; plasma membrane [GO:0005886]; podosome [GO:0002102]; postsynapse [GO:0098794]; postsynaptic actin cytoskeleton [GO:0098871]; ruffle [GO:0001726]; site of polarized growth [GO:0030427]; voltage-gated potassium channel complex [GO:0008076] actin filament binding [GO:0051015]; Arp2/3 complex binding [GO:0071933]; profilin binding [GO:0005522]; proline-rich region binding [GO:0070064] g10670.t1 Q9HB97 56.0 375 5.539999999999999e-134 390.0 sp|Q9HB97|PARVA_RAT Alpha-parvin OS=Rattus norvegicus OX=10116 GN=Parva PE=1 SV=2 g10671.t1 P28347 72.936 436 0.0 612.0 sp|P28347|TEAD1_HUMAN Transcriptional enhancer factor TEF-1 OS=Homo sapiens OX=9606 GN=TEAD1 PE=1 SV=2 TEAD1_HUMAN reviewed Transcriptional enhancer factor TEF-1 (NTEF-1) (Protein GT-IIC) (TEA domain family member 1) (TEAD-1) (Transcription factor 13) (TCF-13) Homo sapiens (Human) GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0005667; GO:0006357; GO:0030307; GO:0035329; GO:0045893; GO:0045944; GO:0048568; GO:0065003; GO:0140552; GO:1902895; GO:1990837 embryonic organ development [GO:0048568]; hippo signaling [GO:0035329]; positive regulation of cell growth [GO:0030307]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein-containing complex assembly [GO:0065003]; regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; TEAD-YAP complex [GO:0140552]; transcription regulator complex [GO:0005667] DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837] g10671.t2 P28347 69.348 460 0.0 597.0 sp|P28347|TEAD1_HUMAN Transcriptional enhancer factor TEF-1 OS=Homo sapiens OX=9606 GN=TEAD1 PE=1 SV=2 TEAD1_HUMAN reviewed Transcriptional enhancer factor TEF-1 (NTEF-1) (Protein GT-IIC) (TEA domain family member 1) (TEAD-1) (Transcription factor 13) (TCF-13) Homo sapiens (Human) GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0005667; GO:0006357; GO:0030307; GO:0035329; GO:0045893; GO:0045944; GO:0048568; GO:0065003; GO:0140552; GO:1902895; GO:1990837 embryonic organ development [GO:0048568]; hippo signaling [GO:0035329]; positive regulation of cell growth [GO:0030307]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein-containing complex assembly [GO:0065003]; regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; TEAD-YAP complex [GO:0140552]; transcription regulator complex [GO:0005667] DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837] g10671.t3 P28347 69.803 457 0.0 602.0 sp|P28347|TEAD1_HUMAN Transcriptional enhancer factor TEF-1 OS=Homo sapiens OX=9606 GN=TEAD1 PE=1 SV=2 TEAD1_HUMAN reviewed Transcriptional enhancer factor TEF-1 (NTEF-1) (Protein GT-IIC) (TEA domain family member 1) (TEAD-1) (Transcription factor 13) (TCF-13) Homo sapiens (Human) GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0005667; GO:0006357; GO:0030307; GO:0035329; GO:0045893; GO:0045944; GO:0048568; GO:0065003; GO:0140552; GO:1902895; GO:1990837 embryonic organ development [GO:0048568]; hippo signaling [GO:0035329]; positive regulation of cell growth [GO:0030307]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein-containing complex assembly [GO:0065003]; regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; TEAD-YAP complex [GO:0140552]; transcription regulator complex [GO:0005667] DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837] g10671.t4 P28347 66.736 478 0.0 588.0 sp|P28347|TEAD1_HUMAN Transcriptional enhancer factor TEF-1 OS=Homo sapiens OX=9606 GN=TEAD1 PE=1 SV=2 TEAD1_HUMAN reviewed Transcriptional enhancer factor TEF-1 (NTEF-1) (Protein GT-IIC) (TEA domain family member 1) (TEAD-1) (Transcription factor 13) (TCF-13) Homo sapiens (Human) GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0005667; GO:0006357; GO:0030307; GO:0035329; GO:0045893; GO:0045944; GO:0048568; GO:0065003; GO:0140552; GO:1902895; GO:1990837 embryonic organ development [GO:0048568]; hippo signaling [GO:0035329]; positive regulation of cell growth [GO:0030307]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein-containing complex assembly [GO:0065003]; regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; TEAD-YAP complex [GO:0140552]; transcription regulator complex [GO:0005667] DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837] g10672.t1 Q9BH04 55.556 198 9.29e-75 226.0 sp|Q9BH04|KBRS1_MACFA NF-kappa-B inhibitor-interacting Ras-like protein 1 OS=Macaca fascicularis OX=9541 GN=NKIRAS1 PE=2 SV=1 g10673.t1 Q8C180 57.303 89 4.55e-25 112.0 sp|Q8C180|FRS2_MOUSE Fibroblast growth factor receptor substrate 2 OS=Mus musculus OX=10090 GN=Frs2 PE=1 SV=3 FRS2_MOUSE reviewed Fibroblast growth factor receptor substrate 2 (FGFR substrate 2) (FGFR-signaling adaptor SNT) (FRS2-alpha) (Suc1-associated neurotrophic factor target 1) (SNT-1) Mus musculus (Mouse) GO:0001702; GO:0001759; GO:0002088; GO:0003281; GO:0005068; GO:0005104; GO:0005168; GO:0005737; GO:0005829; GO:0005886; GO:0005911; GO:0005912; GO:0007169; GO:0007405; GO:0008543; GO:0008595; GO:0030900; GO:0042981; GO:0043410; GO:0044344; GO:0046619; GO:0050678; GO:0060527; GO:0070307; GO:0070372; GO:1904707; GO:2000726 anterior/posterior axis specification, embryo [GO:0008595]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; cellular response to fibroblast growth factor stimulus [GO:0044344]; fibroblast growth factor receptor signaling pathway [GO:0008543]; forebrain development [GO:0030900]; gastrulation with mouth forming second [GO:0001702]; lens development in camera-type eye [GO:0002088]; lens fiber cell development [GO:0070307]; lens placode formation involved in camera-type eye formation [GO:0046619]; negative regulation of cardiac muscle cell differentiation [GO:2000726]; neuroblast proliferation [GO:0007405]; organ induction [GO:0001759]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis [GO:0060527]; regulation of apoptotic process [GO:0042981]; regulation of epithelial cell proliferation [GO:0050678]; regulation of ERK1 and ERK2 cascade [GO:0070372]; ventricular septum development [GO:0003281] adherens junction [GO:0005912]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886] fibroblast growth factor receptor binding [GO:0005104]; neurotrophin TRKA receptor binding [GO:0005168]; transmembrane receptor protein tyrosine kinase adaptor activity [GO:0005068] g10675.t1 Q8WNW2 56.357 291 6.58e-88 268.0 sp|Q8WNW2|CCND2_PIG G1/S-specific cyclin-D2 OS=Sus scrofa OX=9823 GN=CCND2 PE=2 SV=1 g10676.t1 A0JMD4 40.887 812 3.32e-169 511.0 sp|A0JMD4|TPC2_DANRE Two pore channel protein 2 OS=Danio rerio OX=7955 GN=tpcn2 PE=2 SV=1 TPC2_DANRE reviewed Two pore channel protein 2 (Two pore calcium channel protein 2) (Voltage-dependent calcium channel protein TPC2) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005245; GO:0005764; GO:0005765; GO:0006939; GO:0014866; GO:0015280; GO:0019722; GO:0031902; GO:0034702; GO:0035725; GO:0042802; GO:0072345; GO:0075509; GO:0080025; GO:0097682; GO:2000290 calcium-mediated signaling [GO:0019722]; endocytosis involved in viral entry into host cell [GO:0075509]; regulation of myotome development [GO:2000290]; skeletal myofibril assembly [GO:0014866]; smooth muscle contraction [GO:0006939]; sodium ion transmembrane transport [GO:0035725] late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; monoatomic ion channel complex [GO:0034702] identical protein binding [GO:0042802]; intracellularly phosphatidylinositol-3,5-bisphosphate-gated monatomic cation channel activity [GO:0097682]; ligand-gated sodium channel activity [GO:0015280]; NAADP-sensitive calcium-release channel activity [GO:0072345]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; voltage-gated calcium channel activity [GO:0005245] g10678.t1 Q8JG30 39.597 149 7.98e-31 115.0 sp|Q8JG30|ST1B1_CHICK Sulfotransferase 1B1 OS=Gallus gallus OX=9031 GN=SULT1B1 PE=1 SV=1 g10680.t1 Q95JD5 36.594 276 2.96e-52 177.0 sp|Q95JD5|ST1B1_CANLF Sulfotransferase 1B1 OS=Canis lupus familiaris OX=9615 GN=SULT1B1 PE=1 SV=1 g10681.t1 A1L0Z0 37.335 683 6.29e-102 367.0 sp|A1L0Z0|MED1_XENTR Mediator of RNA polymerase II transcription subunit 1 OS=Xenopus tropicalis OX=8364 GN=med1 PE=1 SV=1 g10682.t1 Q6GP52 58.314 439 3.1800000000000003e-160 462.0 sp|Q6GP52|BECN1_XENLA Beclin-1 OS=Xenopus laevis OX=8355 GN=becn1 PE=2 SV=1 BECN1_XENLA reviewed Beclin-1 Xenopus laevis (African clawed frog) GO:0000045; GO:0000407; GO:0000423; GO:0005776; GO:0005789; GO:0005794; GO:0006914; GO:0006995; GO:0010008; GO:0010508; GO:0030674; GO:0031966; GO:0032465; GO:0034271; GO:0034272; GO:0043548; GO:0045022; GO:0045324; GO:0051301; GO:0051607 autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; cell division [GO:0051301]; cellular response to nitrogen starvation [GO:0006995]; defense response to virus [GO:0051607]; early endosome to late endosome transport [GO:0045022]; late endosome to vacuole transport [GO:0045324]; mitophagy [GO:0000423]; positive regulation of autophagy [GO:0010508]; regulation of cytokinesis [GO:0032465] autophagosome [GO:0005776]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; mitochondrial membrane [GO:0031966]; phagophore assembly site [GO:0000407]; phosphatidylinositol 3-kinase complex, class III, type I [GO:0034271]; phosphatidylinositol 3-kinase complex, class III, type II [GO:0034272] phosphatidylinositol 3-kinase binding [GO:0043548]; protein-macromolecule adaptor activity [GO:0030674] g10683.t1 Q64520 56.757 185 1.05e-72 222.0 sp|Q64520|KGUA_MOUSE Guanylate kinase OS=Mus musculus OX=10090 GN=Guk1 PE=1 SV=2 KGUA_MOUSE reviewed Guanylate kinase (EC 2.7.4.8) (GMP kinase) (Guanylate kinase 1) Mus musculus (Mouse) GO:0001917; GO:0004385; GO:0005524; GO:0005739; GO:0005829; GO:0006163; GO:0006185; GO:0006805; GO:0019673; GO:0034436; GO:0046037; GO:0046054; GO:0046060; GO:0046711 dATP metabolic process [GO:0046060]; dGDP biosynthetic process [GO:0006185]; dGMP metabolic process [GO:0046054]; GDP biosynthetic process [GO:0046711]; GDP-mannose metabolic process [GO:0019673]; glycoprotein transport [GO:0034436]; GMP metabolic process [GO:0046037]; purine nucleotide metabolic process [GO:0006163]; xenobiotic metabolic process [GO:0006805] cytosol [GO:0005829]; mitochondrion [GO:0005739]; photoreceptor inner segment [GO:0001917] ATP binding [GO:0005524]; GMP kinase activity [GO:0004385] g10684.t1 C3YEM5 41.509 159 3.34e-39 138.0 sp|C3YEM5|EFTS_BRAFL Elongation factor Ts, mitochondrial OS=Branchiostoma floridae OX=7739 GN=BRAFLDRAFT_84221 PE=3 SV=1 g10685.t1 C3YEM5 70.909 55 2.52e-28 87.0 sp|C3YEM5|EFTS_BRAFL Elongation factor Ts, mitochondrial OS=Branchiostoma floridae OX=7739 GN=BRAFLDRAFT_84221 PE=3 SV=1 g10685.t1 C3YEM5 55.102 49 2.52e-28 58.2 sp|C3YEM5|EFTS_BRAFL Elongation factor Ts, mitochondrial OS=Branchiostoma floridae OX=7739 GN=BRAFLDRAFT_84221 PE=3 SV=1 g10688.t1 P31285 58.915 129 6.22e-50 165.0 sp|P31285|WNT3A_XENLA Protein Wnt-3a OS=Xenopus laevis OX=8355 GN=wnt3a PE=1 SV=1 g10689.t1 P27467 43.523 193 9.28e-50 167.0 sp|P27467|WNT3A_MOUSE Protein Wnt-3a OS=Mus musculus OX=10090 GN=Wnt3a PE=1 SV=1 WNT3A_MOUSE reviewed Protein Wnt-3a Mus musculus (Mouse) GO:0001649; GO:0001701; GO:0001756; GO:0001819; GO:0001947; GO:0002092; GO:0003713; GO:0005102; GO:0005109; GO:0005125; GO:0005576; GO:0005615; GO:0005788; GO:0007165; GO:0007267; GO:0007368; GO:0007409; GO:0007411; GO:0007498; GO:0007507; GO:0008104; GO:0008284; GO:0009887; GO:0009952; GO:0009986; GO:0010387; GO:0010628; GO:0010977; GO:0016055; GO:0019904; GO:0021527; GO:0021766; GO:0021846; GO:0021904; GO:0022008; GO:0030097; GO:0030168; GO:0030182; GO:0030198; GO:0030509; GO:0030879; GO:0030890; GO:0030901; GO:0032212; GO:0033278; GO:0035567; GO:0035914; GO:0036342; GO:0039706; GO:0042472; GO:0042802; GO:0045165; GO:0045202; GO:0045595; GO:0045599; GO:0045893; GO:0045944; GO:0048018; GO:0048103; GO:0048337; GO:0048343; GO:0048643; GO:0048697; GO:0048843; GO:0050768; GO:0050770; GO:0050804; GO:0050807; GO:0060070; GO:0060923; GO:0061184; GO:0062009; GO:0070507; GO:0070527; GO:0071542; GO:0090245; GO:0090263; GO:0090676; GO:0098978; GO:1903078; GO:1904339; GO:1905539; GO:1905606; GO:1990851; GO:1990909; GO:2000049; GO:2000179; GO:2000347; GO:2000727; GO:2001141 animal organ morphogenesis [GO:0009887]; anterior/posterior pattern specification [GO:0009952]; axis elongation involved in somitogenesis [GO:0090245]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; BMP signaling pathway [GO:0030509]; calcium ion transmembrane transport via low voltage-gated calcium channel [GO:0090676]; canonical Wnt signaling pathway [GO:0060070]; cardiac muscle cell fate commitment [GO:0060923]; cell fate commitment [GO:0045165]; cell proliferation in forebrain [GO:0021846]; cell proliferation in midbrain [GO:0033278]; cell-cell signaling [GO:0007267]; COP9 signalosome assembly [GO:0010387]; determination of left/right symmetry [GO:0007368]; dopaminergic neuron differentiation [GO:0071542]; dorsal/ventral neural tube patterning [GO:0021904]; extracellular matrix organization [GO:0030198]; heart development [GO:0007507]; heart looping [GO:0001947]; hemopoiesis [GO:0030097]; hippocampus development [GO:0021766]; in utero embryonic development [GO:0001701]; inner ear morphogenesis [GO:0042472]; intracellular protein localization [GO:0008104]; mammary gland development [GO:0030879]; mesoderm development [GO:0007498]; midbrain development [GO:0030901]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of axon extension involved in axon guidance [GO:0048843]; negative regulation of dopaminergic neuron differentiation [GO:1904339]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron projection development [GO:0010977]; neurogenesis [GO:0022008]; neuron differentiation [GO:0030182]; non-canonical Wnt signaling pathway [GO:0035567]; osteoblast differentiation [GO:0001649]; paraxial mesodermal cell fate commitment [GO:0048343]; platelet activation [GO:0030168]; platelet aggregation [GO:0070527]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cardiac muscle cell differentiation [GO:2000727]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cell-cell adhesion mediated by cadherin [GO:2000049]; positive regulation of collateral sprouting in absence of injury [GO:0048697]; positive regulation of cytokine production [GO:0001819]; positive regulation of dermatome development [GO:0061184]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of gene expression [GO:0010628]; positive regulation of hepatocyte proliferation [GO:2000347]; positive regulation of mesodermal cell fate specification [GO:0048337]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of receptor internalization [GO:0002092]; positive regulation of skeletal muscle tissue development [GO:0048643]; positive regulation of telomere maintenance via telomerase [GO:0032212]; positive regulation of transcription by RNA polymerase II [GO:0045944]; post-anal tail morphogenesis [GO:0036342]; regulation of axonogenesis [GO:0050770]; regulation of cell differentiation [GO:0045595]; regulation of microtubule cytoskeleton organization [GO:0070507]; regulation of postsynapse to nucleus signaling pathway [GO:1905539]; regulation of presynapse assembly [GO:1905606]; regulation of RNA biosynthetic process [GO:2001141]; regulation of synapse organization [GO:0050807]; secondary palate development [GO:0062009]; signal transduction [GO:0007165]; skeletal muscle cell differentiation [GO:0035914]; somatic stem cell division [GO:0048103]; somitogenesis [GO:0001756]; spinal cord association neuron differentiation [GO:0021527]; Wnt signaling pathway [GO:0016055] cell surface [GO:0009986]; endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; glutamatergic synapse [GO:0098978]; synapse [GO:0045202]; Wnt signalosome [GO:1990909]; Wnt-Frizzled-LRP5/6 complex [GO:1990851] co-receptor binding [GO:0039706]; cytokine activity [GO:0005125]; frizzled binding [GO:0005109]; identical protein binding [GO:0042802]; protein domain specific binding [GO:0019904]; receptor ligand activity [GO:0048018]; signaling receptor binding [GO:0005102]; transcription coactivator activity [GO:0003713] g10693.t1 Q53FA7 47.907 215 1.36e-63 203.0 sp|Q53FA7|QORX_HUMAN Quinone oxidoreductase PIG3 OS=Homo sapiens OX=9606 GN=TP53I3 PE=1 SV=2 QORX_HUMAN reviewed Quinone oxidoreductase PIG3 (EC 1.6.5.5) (NADPH:quinone reductase PIG3) (Tumor protein p53-inducible protein 3) (Protein PIG3) (p53-induced gene 3 protein) Homo sapiens (Human) GO:0003960; GO:0005829; GO:0006915; GO:0048038; GO:0070402; GO:1903409 apoptotic process [GO:0006915]; reactive oxygen species biosynthetic process [GO:1903409] cytosol [GO:0005829] NADPH binding [GO:0070402]; quinone binding [GO:0048038]; quinone reductase (NADPH) activity [GO:0003960] g10694.t1 Q91090 40.252 318 8.170000000000001e-66 215.0 sp|Q91090|PON2_MELGA Serum paraoxonase/arylesterase 2 OS=Meleagris gallopavo OX=9103 GN=PON2 PE=2 SV=1 g10695.t1 P55159 35.816 282 9.44e-44 157.0 sp|P55159|PON1_RAT Serum paraoxonase/arylesterase 1 OS=Rattus norvegicus OX=10116 GN=Pon1 PE=1 SV=3 g10696.t1 A2ASS6 26.005 1492 4.56e-118 418.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10696.t1 A2ASS6 35.0 40 4.56e-118 33.1 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10696.t1 A2ASS6 25.832 1502 3.78e-110 402.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10696.t1 A2ASS6 25.488 1487 7.72e-109 397.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10696.t1 A2ASS6 25.641 1482 2.0399999999999998e-108 396.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10696.t1 A2ASS6 25.219 1598 4.24e-106 388.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10696.t1 A2ASS6 23.626 1528 4e-104 382.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10696.t1 A2ASS6 24.521 1566 7.69e-104 381.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10696.t1 A2ASS6 25.184 1493 5.37e-103 378.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10696.t1 A2ASS6 23.794 1492 8.44e-102 374.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10696.t1 A2ASS6 22.868 1513 5.5199999999999996e-98 361.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10696.t1 A2ASS6 23.491 1541 1.9700000000000002e-97 360.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10696.t1 A2ASS6 24.649 1497 4.29e-97 358.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10696.t1 A2ASS6 24.145 1549 1.33e-93 347.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10696.t1 A2ASS6 23.691 1528 2.22e-93 346.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10696.t1 A2ASS6 23.794 1534 2.7300000000000003e-88 329.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10696.t1 A2ASS6 24.187 1414 1.13e-79 301.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10696.t1 A2ASS6 26.249 1021 8.26e-68 261.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10696.t1 A2ASS6 24.043 1123 2.0099999999999997e-61 240.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10696.t1 A2ASS6 21.919 1428 1.29e-44 184.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10696.t1 A2ASS6 23.013 1434 2.2699999999999998e-42 177.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10696.t1 A2ASS6 22.0 850 5.0099999999999996e-40 169.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10696.t1 A2ASS6 25.682 623 1.7e-35 154.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10696.t1 A2ASS6 21.151 1546 7.56e-33 145.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10696.t1 A2ASS6 22.545 896 9.580000000000001e-27 125.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10696.t1 A2ASS6 33.981 206 1.63e-22 111.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10696.t1 A2ASS6 27.083 336 1.8000000000000001e-22 111.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10696.t1 A2ASS6 33.854 192 8.62e-22 109.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10696.t1 A2ASS6 27.451 306 4.71e-21 107.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10696.t2 A2ASS6 26.005 1492 1.38e-117 416.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10696.t2 A2ASS6 35.0 40 1.38e-117 33.1 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10696.t2 A2ASS6 25.832 1502 1.4200000000000002e-109 400.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10696.t2 A2ASS6 25.488 1487 3.36e-108 395.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10696.t2 A2ASS6 25.641 1482 8.97e-108 394.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10696.t2 A2ASS6 25.219 1598 1.21e-105 387.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10696.t2 A2ASS6 24.521 1566 2.32e-103 379.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10696.t2 A2ASS6 23.626 1528 2.56e-103 379.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10696.t2 A2ASS6 25.184 1493 1.91e-102 376.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10696.t2 A2ASS6 23.794 1492 3.68e-101 372.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10696.t2 A2ASS6 22.868 1513 2.84e-97 359.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10696.t2 A2ASS6 23.491 1541 9.99e-97 357.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10696.t2 A2ASS6 24.649 1497 2.57e-96 356.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10696.t2 A2ASS6 24.145 1549 6.31e-93 345.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10696.t2 A2ASS6 23.691 1528 1.0299999999999999e-92 344.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10696.t2 A2ASS6 23.389 1428 1.12e-90 337.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10696.t2 A2ASS6 23.347 1512 2.29e-88 330.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10696.t2 A2ASS6 24.187 1414 4.0000000000000006e-79 299.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10696.t2 A2ASS6 26.249 1021 2.7399999999999998e-67 259.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10696.t2 A2ASS6 21.919 1428 6.9e-44 182.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10696.t2 A2ASS6 23.013 1434 1.41e-41 174.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10696.t2 A2ASS6 22.0 850 1.38e-39 168.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10696.t2 A2ASS6 25.682 623 3.06e-35 154.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10696.t2 A2ASS6 21.151 1546 5.060000000000001e-32 143.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10696.t2 A2ASS6 22.656 896 4.43e-26 123.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10696.t2 A2ASS6 33.981 206 1.89e-22 111.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10696.t2 A2ASS6 33.854 192 1.1200000000000002e-21 108.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10696.t2 A2ASS6 27.451 306 5.170000000000001e-21 106.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10696.t3 A2ASS6 26.005 1492 1.04e-117 417.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10696.t3 A2ASS6 35.0 40 1.04e-117 33.1 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10696.t3 A2ASS6 25.832 1502 9.290000000000001e-110 400.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10696.t3 A2ASS6 25.488 1487 2.46e-108 395.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10696.t3 A2ASS6 25.641 1482 5.82e-108 394.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10696.t3 A2ASS6 25.219 1598 9.319999999999999e-106 387.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10696.t3 A2ASS6 24.521 1566 1.6600000000000002e-103 380.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10696.t3 A2ASS6 23.626 1528 1.76e-103 380.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10696.t3 A2ASS6 25.184 1493 1.33e-102 377.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10696.t3 A2ASS6 23.794 1492 2.37e-101 372.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10696.t3 A2ASS6 22.868 1513 1.72e-97 360.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10696.t3 A2ASS6 23.491 1541 7.400000000000001e-97 358.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10696.t3 A2ASS6 24.649 1497 1.89e-96 356.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10696.t3 A2ASS6 24.145 1549 4.44e-93 345.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10696.t3 A2ASS6 23.691 1528 5.34e-93 345.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10696.t3 A2ASS6 23.389 1428 7.34e-91 338.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10696.t3 A2ASS6 23.347 1512 1.65e-88 330.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10696.t3 A2ASS6 24.257 1414 2.58e-79 300.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10696.t3 A2ASS6 26.249 1021 2.53e-67 260.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10696.t3 A2ASS6 21.919 1428 3.76e-44 183.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10696.t3 A2ASS6 23.013 1434 6.949999999999999e-42 176.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10696.t3 A2ASS6 22.0 850 1.08e-39 168.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10696.t3 A2ASS6 25.682 623 2.36e-35 154.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10696.t3 A2ASS6 21.151 1546 2.37e-32 144.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10696.t3 A2ASS6 22.656 896 2.11e-26 124.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10696.t3 A2ASS6 33.981 206 1.76e-22 111.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10696.t3 A2ASS6 33.854 192 1.1100000000000001e-21 108.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10696.t3 A2ASS6 27.451 306 5.22e-21 106.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10699.t1 Q8WZ42 29.567 416 2.09e-49 188.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10699.t1 Q8WZ42 27.579 475 9.26e-46 177.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10699.t1 Q8WZ42 27.533 454 4.88e-44 172.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10699.t1 Q8WZ42 28.205 429 2.53e-43 170.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10699.t1 Q8WZ42 27.765 425 4.570000000000001e-43 169.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10699.t1 Q8WZ42 28.271 428 5.11e-43 169.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10699.t1 Q8WZ42 28.009 432 1.0399999999999998e-42 168.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10699.t1 Q8WZ42 27.61 431 1.9799999999999997e-42 167.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10699.t1 Q8WZ42 26.353 425 1.06e-41 165.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10699.t1 Q8WZ42 28.009 432 1.07e-39 159.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10699.t1 Q8WZ42 26.45 431 4.73e-39 157.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10699.t1 Q8WZ42 28.211 436 9.95e-39 156.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10699.t1 Q8WZ42 26.45 431 1.69e-38 155.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10699.t1 Q8WZ42 24.942 429 2.34e-38 155.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10699.t1 Q8WZ42 26.761 426 2.9399999999999997e-38 155.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10699.t1 Q8WZ42 26.606 436 2.01e-37 152.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10699.t1 Q8WZ42 25.352 426 2.6000000000000002e-37 152.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10699.t1 Q8WZ42 40.625 192 9.950000000000001e-37 150.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10699.t1 Q8WZ42 27.083 432 2.4600000000000002e-36 149.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10699.t1 Q8WZ42 26.415 424 1.81e-35 146.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10699.t1 Q8WZ42 25.236 424 2.83e-34 143.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10699.t1 Q8WZ42 25.06 419 1e-33 141.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10699.t1 Q8WZ42 24.009 429 1.84e-33 140.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10699.t1 Q8WZ42 26.492 419 2.6200000000000002e-33 140.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10699.t1 Q8WZ42 27.914 326 3.06e-33 140.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10699.t1 Q8WZ42 26.852 432 1.76e-32 137.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10699.t1 Q8WZ42 25.173 433 7.88e-32 135.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10699.t1 Q8WZ42 25.059 423 3.23e-31 134.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10699.t1 Q8WZ42 24.419 430 7.76e-30 129.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10699.t1 Q8WZ42 24.48 433 5.7e-29 127.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10699.t1 Q8WZ42 25.995 427 8.61e-29 126.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10699.t1 Q8WZ42 26.327 452 1.7700000000000002e-27 122.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10699.t1 Q8WZ42 23.419 427 4.910000000000001e-27 120.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10699.t1 Q8WZ42 32.444 225 8.690000000000001e-27 120.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10699.t1 Q8WZ42 22.791 430 2.2800000000000001e-26 119.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10699.t1 Q8WZ42 23.502 434 2.44e-26 118.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10699.t1 Q8WZ42 23.733 434 1.27e-25 116.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10699.t1 Q8WZ42 26.0 450 1.76e-25 115.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10699.t1 Q8WZ42 26.289 388 2.4599999999999996e-23 109.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10700.t1 Q8WZ42 35.094 530 2.9099999999999996e-94 318.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10700.t1 Q8WZ42 23.541 514 1.4e-26 118.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10700.t1 Q8WZ42 23.729 472 9.59e-26 116.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10700.t1 Q8WZ42 23.261 460 1.37e-24 112.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10700.t1 Q8WZ42 25.815 368 1.79e-24 112.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10700.t1 Q8WZ42 22.669 472 5.48e-24 110.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10700.t1 Q8WZ42 23.76 484 1.13e-23 109.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10700.t1 Q8WZ42 22.18 532 1.57e-22 106.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10700.t1 Q8WZ42 25.251 499 4.33e-22 104.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10700.t1 Q8WZ42 27.108 332 1.07e-21 103.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10700.t1 Q8WZ42 21.935 465 1.2600000000000002e-21 103.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10700.t1 Q8WZ42 23.989 371 4.100000000000001e-21 101.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10700.t1 Q8WZ42 25.455 330 9.18e-21 100.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10701.t1 Q9I7U4 31.055 512 3.81e-73 278.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g10701.t1 Q9I7U4 33.789 512 1.31e-72 276.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g10701.t1 Q9I7U4 32.866 499 9.47e-70 267.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g10701.t1 Q9I7U4 33.988 509 2.2499999999999998e-69 266.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g10701.t1 Q9I7U4 31.621 506 3.0500000000000005e-64 249.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g10701.t1 Q9I7U4 31.443 582 4.56e-64 248.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g10701.t1 Q9I7U4 38.66 388 4.92e-64 248.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g10701.t1 Q9I7U4 31.463 499 1.87e-63 246.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g10701.t1 Q9I7U4 30.328 488 3.41e-63 245.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g10701.t1 Q9I7U4 33.068 502 4.65e-63 245.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g10701.t1 Q9I7U4 31.507 511 2.73e-62 242.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g10701.t1 Q9I7U4 33.198 491 5.24e-60 235.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g10701.t1 Q9I7U4 31.429 490 2.69e-59 233.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g10701.t1 Q9I7U4 32.465 499 3.6100000000000003e-59 232.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g10701.t1 Q9I7U4 30.816 490 6.65e-59 231.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g10701.t1 Q9I7U4 32.072 502 3.3e-58 229.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g10701.t1 Q9I7U4 29.249 506 1.06e-55 221.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g10701.t1 Q9I7U4 29.532 491 6.579999999999999e-54 214.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g10701.t1 Q9I7U4 30.545 514 5.39e-53 212.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g10701.t1 Q9I7U4 27.071 495 5.74e-48 195.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g10701.t1 Q9I7U4 29.026 503 2.45e-46 189.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g10701.t1 Q9I7U4 27.356 435 3.75e-35 152.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g10701.t1 Q9I7U4 30.296 406 1.49e-31 140.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g10701.t1 Q9I7U4 28.889 315 6.2899999999999995e-30 135.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g10701.t1 Q9I7U4 29.878 328 1.53e-28 131.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g10701.t1 Q9I7U4 28.01 407 1.87e-28 130.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g10701.t1 Q9I7U4 25.984 381 2.5900000000000003e-27 127.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g10701.t1 Q9I7U4 25.0 428 3.28e-27 126.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g10701.t1 Q9I7U4 26.813 455 7.51e-27 125.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g10701.t1 Q9I7U4 27.796 313 1.6500000000000002e-26 124.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g10701.t1 Q9I7U4 24.499 449 2.03e-26 124.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g10701.t1 Q9I7U4 25.908 413 1.11e-24 118.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g10701.t1 Q9I7U4 25.816 337 1.7799999999999997e-24 117.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g10701.t1 Q9I7U4 24.194 372 5.7e-24 115.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g10701.t1 Q9I7U4 26.486 370 8.249999999999999e-24 115.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g10701.t1 Q9I7U4 26.776 366 1e-23 115.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g10701.t1 Q9I7U4 24.686 478 1.5699999999999997e-23 114.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g10701.t1 Q9I7U4 35.023 217 5.57e-23 112.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g10701.t1 Q9I7U4 26.446 363 7.279999999999999e-23 112.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g10701.t1 Q9I7U4 23.782 513 1.0300000000000001e-22 111.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g10701.t1 Q9I7U4 23.577 492 1.04e-22 111.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g10701.t1 Q9I7U4 27.213 305 1.06e-22 111.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g10701.t1 Q9I7U4 23.664 393 1.33e-22 111.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g10701.t1 Q9I7U4 27.344 384 1.0000000000000001e-21 108.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g10706.t1 Q9I7U4 39.571 326 2.6199999999999997e-55 220.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g10706.t1 Q9I7U4 27.455 448 7.4599999999999995e-34 149.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g10706.t1 Q9I7U4 28.132 423 2.1e-33 147.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g10706.t1 Q9I7U4 30.982 326 4.98e-33 146.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g10706.t1 Q9I7U4 28.745 494 1.8400000000000002e-32 144.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g10706.t1 Q9I7U4 27.8 500 5.590000000000001e-29 133.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g10706.t1 Q9I7U4 22.744 554 3.34e-27 127.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g10706.t1 Q9I7U4 25.251 499 1.43e-24 118.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g10706.t1 Q9I7U4 25.175 429 2.6699999999999998e-24 117.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g10706.t1 Q9I7U4 27.052 329 1.0099999999999999e-23 115.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g10706.t1 Q9I7U4 27.987 318 1.6299999999999997e-23 115.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g10706.t1 Q9I7U4 26.471 374 2.36e-22 111.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g10706.t1 Q9I7U4 26.551 403 1.24e-21 108.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g10706.t1 Q9I7U4 25.102 490 1.8700000000000002e-21 108.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g10706.t2 Q9I7U4 33.942 548 4.18e-71 272.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g10706.t2 Q9I7U4 27.455 448 2.34e-33 147.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g10706.t2 Q9I7U4 28.132 423 6.39e-33 146.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g10706.t2 Q9I7U4 30.982 326 1.53e-32 145.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g10706.t2 Q9I7U4 27.664 488 1.65e-32 144.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g10706.t2 Q9I7U4 27.8 500 6.03e-29 133.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g10706.t2 Q9I7U4 26.875 320 2.64e-26 124.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g10706.t2 Q9I7U4 26.452 310 1.51e-24 118.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g10706.t2 Q9I7U4 25.175 429 4.27e-24 117.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g10706.t2 Q9I7U4 25.251 499 8.679999999999999e-24 115.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g10706.t2 Q9I7U4 27.052 329 1.0699999999999998e-23 115.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g10706.t2 Q9I7U4 24.798 371 2.73e-23 114.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g10706.t2 Q9I7U4 28.483 323 1.89e-22 111.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g10706.t2 Q9I7U4 26.738 374 1.24e-21 108.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g10706.t2 Q9I7U4 26.42 405 2.32e-21 108.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g10706.t2 Q9I7U4 25.051 491 9.690000000000001e-21 105.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g10707.t1 Q8WZ42 29.501 1844 0.0 677.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10707.t1 Q8WZ42 28.657 1839 1.26e-148 530.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10707.t1 Q8WZ42 37.978 732 9.71e-124 447.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10707.t1 Q8WZ42 36.442 815 1.2300000000000001e-123 447.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10707.t1 Q8WZ42 31.55 1103 1.3000000000000001e-123 447.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10707.t1 Q8WZ42 34.684 839 3.22e-118 429.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10707.t1 Q8WZ42 35.103 829 1.23e-116 424.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10707.t1 Q8WZ42 35.094 795 3.4599999999999998e-115 419.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10707.t1 Q8WZ42 33.252 824 2.75e-112 409.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10707.t1 Q8WZ42 34.014 832 2.32e-111 406.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10707.t1 Q8WZ42 35.15 734 4.38e-109 399.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10707.t1 Q8WZ42 34.559 816 7.930000000000001e-109 398.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10707.t1 Q8WZ42 32.394 852 2.87e-108 396.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10707.t1 Q8WZ42 36.589 645 1.98e-105 387.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10707.t1 Q8WZ42 35.61 688 8.33e-99 365.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10707.t1 Q8WZ42 33.333 723 2.02e-98 363.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10707.t1 Q8WZ42 34.548 741 3.25e-97 359.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10707.t1 Q8WZ42 34.459 740 2.36e-96 357.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10707.t1 Q8WZ42 33.062 738 2.7e-96 356.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10707.t1 Q8WZ42 32.44 746 8.63e-96 355.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10707.t1 Q8WZ42 34.393 692 4.0899999999999994e-95 352.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10707.t1 Q8WZ42 33.822 751 3.85e-94 349.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10707.t1 Q8WZ42 34.648 710 1.53e-93 347.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10707.t1 Q8WZ42 34.146 697 1.5899999999999998e-92 344.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10707.t1 Q8WZ42 32.304 842 4.46e-92 342.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10707.t1 Q8WZ42 27.808 1104 2.04e-91 340.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10707.t1 Q8WZ42 32.927 738 5.4999999999999994e-89 332.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10707.t1 Q8WZ42 32.659 692 2.12e-88 330.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10707.t1 Q8WZ42 30.707 863 4.68e-88 329.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10707.t1 Q8WZ42 34.45 746 1.6900000000000002e-86 324.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10707.t1 Q8WZ42 36.334 622 1.55e-84 317.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10707.t1 Q8WZ42 32.547 805 2.9799999999999998e-84 316.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10707.t1 Q8WZ42 33.113 755 6.12e-84 315.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10707.t1 Q8WZ42 30.66 773 3.98e-83 313.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10707.t1 Q8WZ42 30.813 886 4.33e-83 312.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10707.t1 Q8WZ42 33.019 742 1.31e-82 311.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10707.t1 Q8WZ42 31.579 665 8.159999999999999e-82 308.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10707.t1 Q8WZ42 35.714 630 8.87e-82 308.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10707.t1 Q8WZ42 35.494 617 1.43e-81 307.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10707.t1 Q8WZ42 29.098 1031 5.969999999999999e-81 305.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10707.t1 Q8WZ42 32.653 735 7.39e-79 298.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10707.t1 Q8WZ42 31.884 690 7.45e-79 298.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10707.t1 Q8WZ42 33.801 642 1.7e-78 297.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10707.t1 Q8WZ42 35.846 650 4.03e-78 296.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10707.t1 Q8WZ42 30.429 792 8.57e-78 295.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10707.t1 Q8WZ42 25.701 1249 7.05e-77 292.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10707.t1 Q8WZ42 33.008 615 1.39e-76 291.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10707.t1 Q8WZ42 30.036 839 2.49e-75 287.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10707.t1 Q8WZ42 30.788 799 4.17e-75 286.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10707.t1 Q8WZ42 27.874 922 2.11e-74 284.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10707.t1 Q8WZ42 28.856 752 4.33e-73 279.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10707.t1 Q8WZ42 29.103 914 7.95e-72 275.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10707.t1 Q8WZ42 30.063 795 6.420000000000001e-70 269.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10707.t1 Q8WZ42 26.422 1037 2.97e-69 266.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10707.t1 Q8WZ42 30.154 713 1.4499999999999998e-68 265.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10707.t1 Q8WZ42 32.283 635 1.69e-68 264.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10707.t1 Q8WZ42 24.961 1294 5.8699999999999996e-68 262.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10707.t1 Q8WZ42 32.07 633 1.73e-67 261.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10707.t1 Q8WZ42 31.379 631 2.2899999999999997e-67 260.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10707.t1 Q8WZ42 26.424 1018 4.18e-63 246.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10707.t1 Q8WZ42 34.394 503 3.23e-61 240.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10707.t1 Q8WZ42 28.173 717 6.669999999999999e-60 236.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10707.t1 Q8WZ42 22.931 1317 1.45e-59 234.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10707.t1 Q8WZ42 29.404 738 7.99e-59 232.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10707.t1 Q8WZ42 30.596 621 1.88e-58 231.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10707.t1 Q8WZ42 25.817 949 1.61e-57 228.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10707.t1 Q8WZ42 28.478 611 3.41e-57 227.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10707.t1 Q8WZ42 29.746 669 2.6300000000000002e-56 224.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10707.t1 Q8WZ42 28.537 827 8.830000000000001e-56 222.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10707.t1 Q8WZ42 26.294 734 5.21e-53 213.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10707.t1 Q8WZ42 27.391 617 1.4299999999999998e-52 211.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10707.t1 Q8WZ42 31.5 400 1.94e-52 211.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10707.t1 Q8WZ42 26.618 680 6.79e-52 209.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10707.t1 Q8WZ42 23.201 1181 6.9e-52 209.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10707.t1 Q8WZ42 22.488 1085 6.0799999999999995e-46 189.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10707.t1 Q8WZ42 21.964 1334 1.62e-45 188.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10707.t1 Q8WZ42 21.775 1093 8.22e-44 182.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10707.t1 Q8WZ42 23.232 1089 1.06e-41 175.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10707.t1 Q8WZ42 27.031 640 6.23e-41 173.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10707.t1 Q8WZ42 27.666 647 1.03e-39 169.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10707.t1 Q8WZ42 28.487 509 4.6e-38 163.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10707.t1 Q8WZ42 23.07 1101 1.5700000000000002e-37 161.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10707.t1 Q8WZ42 24.855 688 1.92e-37 161.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10707.t1 Q8WZ42 24.269 684 3.73e-35 154.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10707.t1 Q8WZ42 23.95 643 5.11e-32 143.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10707.t1 Q8WZ42 24.669 604 4.1199999999999995e-30 137.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10707.t1 Q8WZ42 26.164 451 3.4200000000000003e-29 134.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10707.t1 Q8WZ42 21.726 962 3.2000000000000003e-27 127.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10707.t1 Q8WZ42 30.667 300 1.27e-25 122.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10707.t1 Q8WZ42 36.126 191 1.09e-24 119.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10707.t1 Q8WZ42 35.079 191 1.85e-24 118.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10707.t1 Q8WZ42 33.871 186 2.48e-24 118.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10707.t1 Q8WZ42 25.984 254 1.13e-22 112.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10707.t1 Q8WZ42 30.932 236 1.42e-22 112.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10707.t1 Q8WZ42 27.848 316 3.06e-22 111.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10707.t1 Q8WZ42 31.915 188 7.56e-22 109.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10707.t1 Q8WZ42 29.07 258 1.1e-21 109.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10707.t1 Q8WZ42 31.905 210 2.4600000000000003e-21 108.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10707.t1 Q8WZ42 31.579 190 2.8800000000000002e-21 107.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10707.t1 Q8WZ42 25.517 435 3.4e-21 107.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10707.t1 Q8WZ42 31.183 186 3.4900000000000005e-21 107.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10707.t1 Q8WZ42 32.258 186 3.8600000000000005e-21 107.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10707.t2 A2ASS6 32.641 1011 3.3799999999999997e-147 525.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10707.t2 A2ASS6 27.677 1550 3.18e-137 492.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10707.t2 A2ASS6 38.108 761 2.64e-133 479.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10707.t2 A2ASS6 32.759 754 1.3099999999999999e-104 384.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10707.t2 A2ASS6 36.219 693 2.23e-102 376.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10707.t2 A2ASS6 34.972 712 1.9e-101 373.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10707.t2 A2ASS6 28.051 1180 2.16e-100 370.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10707.t2 A2ASS6 32.254 741 1.44e-98 364.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10707.t2 A2ASS6 31.556 919 7.15e-95 352.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10707.t2 A2ASS6 30.714 840 1.07e-94 351.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10707.t2 A2ASS6 34.057 737 8.15e-94 348.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10707.t2 A2ASS6 33.472 720 1.79e-93 347.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10707.t2 A2ASS6 31.769 746 4.46e-93 345.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10707.t2 A2ASS6 32.532 707 2.0599999999999998e-92 343.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10707.t2 A2ASS6 32.645 726 1.11e-91 341.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10707.t2 A2ASS6 33.028 763 2.09e-91 340.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10707.t2 A2ASS6 31.704 716 3.78e-91 339.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10707.t2 A2ASS6 31.193 763 5.999999999999999e-91 338.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10707.t2 A2ASS6 27.516 1123 8.379999999999999e-91 338.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10707.t2 A2ASS6 31.674 723 9.42e-91 338.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10707.t2 A2ASS6 31.378 733 1.49e-90 337.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10707.t2 A2ASS6 33.472 720 3.39e-90 336.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10707.t2 A2ASS6 32.74 730 7.75e-90 335.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10707.t2 A2ASS6 33.121 785 4.86e-87 325.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10707.t2 A2ASS6 31.572 795 1.06e-86 325.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10707.t2 A2ASS6 31.25 736 1.33e-86 324.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10707.t2 A2ASS6 32.166 771 1.13e-85 321.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10707.t2 A2ASS6 30.827 798 2.1700000000000002e-85 320.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10707.t2 A2ASS6 33.52 713 4.6e-85 319.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10707.t2 A2ASS6 30.89 764 1.7e-82 310.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10707.t2 A2ASS6 30.882 748 2.1699999999999998e-82 310.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10707.t2 A2ASS6 32.69 725 2.96e-82 310.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10707.t2 A2ASS6 31.224 727 5.679999999999999e-82 309.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10707.t2 A2ASS6 32.128 719 1.01e-80 305.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10707.t2 A2ASS6 33.994 656 1.62e-79 301.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10707.t2 A2ASS6 31.612 794 2.99e-79 300.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10707.t2 A2ASS6 30.296 812 7.29e-78 295.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10707.t2 A2ASS6 30.151 796 1.22e-76 291.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10707.t2 A2ASS6 31.111 675 1.73e-74 284.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10707.t2 A2ASS6 27.06 813 6.66e-72 275.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10707.t2 A2ASS6 31.065 676 8.27e-72 275.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10707.t2 A2ASS6 30.793 643 2.4700000000000002e-70 270.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10707.t2 A2ASS6 28.767 730 3.5700000000000005e-70 270.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10707.t2 A2ASS6 32.562 648 1.45e-69 268.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10707.t2 A2ASS6 35.361 526 1.6599999999999999e-68 264.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10707.t2 A2ASS6 28.412 718 1.7999999999999998e-68 264.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10707.t2 A2ASS6 40.053 377 2.1299999999999997e-68 264.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10707.t2 A2ASS6 35.968 506 6.7499999999999996e-68 262.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10707.t2 A2ASS6 28.022 910 3.3800000000000004e-66 256.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10707.t2 A2ASS6 35.259 502 6.940000000000001e-66 255.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10707.t2 A2ASS6 35.685 496 5.4e-63 246.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10707.t2 A2ASS6 34.717 530 9.78e-63 245.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10707.t2 A2ASS6 34.314 510 2.58e-62 244.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10707.t2 A2ASS6 28.829 666 3.15e-62 243.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10707.t2 A2ASS6 34.171 597 5.9399999999999996e-61 239.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10707.t2 A2ASS6 29.064 609 4.38e-60 236.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10707.t2 A2ASS6 27.66 705 3.7000000000000004e-59 233.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10707.t2 A2ASS6 31.133 697 6.64e-59 232.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10707.t2 A2ASS6 30.744 618 4.18e-58 230.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10707.t2 A2ASS6 33.973 521 1.2700000000000001e-57 228.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10707.t2 A2ASS6 28.148 675 1.8800000000000001e-56 224.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10707.t2 A2ASS6 27.9 681 5.070000000000001e-56 223.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10707.t2 A2ASS6 28.125 672 6.100000000000001e-56 223.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10707.t2 A2ASS6 22.533 1429 1.0499999999999999e-55 222.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10707.t2 A2ASS6 32.617 512 1.23e-54 218.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10707.t2 A2ASS6 34.462 502 2.6499999999999997e-54 217.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10707.t2 A2ASS6 33.463 514 8.829999999999999e-54 215.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10707.t2 A2ASS6 27.143 700 2.64e-53 214.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10707.t2 A2ASS6 29.448 652 6.79e-53 213.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10707.t2 A2ASS6 26.725 681 2.63e-52 211.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10707.t2 A2ASS6 27.854 657 2.83e-51 207.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10707.t2 A2ASS6 31.61 503 1e-50 205.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10707.t2 A2ASS6 29.088 636 2.2e-50 204.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10707.t2 A2ASS6 25.978 920 1.53e-49 201.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10707.t2 A2ASS6 30.303 396 4.31e-49 200.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10707.t2 A2ASS6 21.459 1165 1.0099999999999999e-46 192.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10707.t2 A2ASS6 26.562 576 3.15e-45 187.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10707.t2 A2ASS6 31.237 493 2e-44 184.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10707.t2 A2ASS6 25.802 748 9.27e-43 179.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10707.t2 A2ASS6 25.41 854 1.51e-41 175.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10707.t2 A2ASS6 26.488 672 1.82e-41 174.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10707.t2 A2ASS6 29.055 561 1.82e-41 174.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10707.t2 A2ASS6 27.464 619 2.11e-41 174.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10707.t2 A2ASS6 27.969 522 1.09e-40 172.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10707.t2 A2ASS6 31.078 399 1.95e-40 171.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10707.t2 A2ASS6 28.933 553 3.14e-39 167.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10707.t2 A2ASS6 25.603 746 5.49e-39 166.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10707.t2 A2ASS6 23.803 752 1.59e-38 165.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10707.t2 A2ASS6 24.897 731 1.6400000000000001e-37 161.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10707.t2 A2ASS6 21.804 1142 7.600000000000001e-36 156.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10707.t2 A2ASS6 23.37 736 2.94e-35 154.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10707.t2 A2ASS6 23.228 762 1.0699999999999999e-34 152.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10707.t2 A2ASS6 25.871 746 4.08e-33 147.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10707.t2 A2ASS6 24.396 787 1.53e-31 142.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10707.t2 A2ASS6 22.957 575 1.9000000000000002e-31 141.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10707.t2 A2ASS6 22.654 746 2.8300000000000003e-31 141.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10707.t2 A2ASS6 22.19 1050 2.88e-31 141.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10707.t2 A2ASS6 24.15 588 5.21e-31 140.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10707.t2 A2ASS6 20.406 1181 6.5900000000000004e-31 139.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10707.t2 A2ASS6 23.407 769 4.9200000000000004e-29 133.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10707.t2 A2ASS6 23.181 742 1.37e-28 132.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10707.t2 A2ASS6 23.91 757 1.34e-26 125.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10707.t2 A2ASS6 30.822 292 5.38e-26 123.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10707.t2 A2ASS6 23.311 755 1.27e-25 122.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10707.t2 A2ASS6 35.602 191 2.52e-24 118.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10707.t2 A2ASS6 28.852 357 3.13e-24 117.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10707.t2 A2ASS6 34.409 186 1.29e-23 115.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10707.t2 A2ASS6 35.079 191 1.41e-23 115.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10707.t2 A2ASS6 30.263 228 4.9399999999999994e-23 114.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10707.t2 A2ASS6 29.845 258 1.45e-22 112.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10707.t2 A2ASS6 33.333 186 1.2600000000000002e-21 109.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10707.t2 A2ASS6 32.632 190 2.73e-21 108.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10707.t2 A2ASS6 32.258 186 6.6300000000000006e-21 106.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10707.t3 Q8WZ42 31.672 1525 0.0 684.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10707.t3 Q8WZ42 27.865 1920 8.93e-158 560.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10707.t3 Q8WZ42 31.701 1123 1.87e-139 499.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10707.t3 Q8WZ42 37.978 732 4.74e-124 448.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10707.t3 Q8WZ42 31.55 1103 8.230000000000001e-124 447.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10707.t3 Q8WZ42 36.442 815 9.340000000000001e-124 447.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10707.t3 Q8WZ42 34.684 839 2.14e-118 429.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10707.t3 Q8WZ42 35.103 829 9.4e-117 424.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10707.t3 Q8WZ42 35.094 795 2.2e-115 419.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10707.t3 Q8WZ42 33.252 824 2.14e-112 410.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10707.t3 Q8WZ42 34.014 832 1.16e-111 407.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10707.t3 Q8WZ42 35.15 734 3.18e-109 399.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10707.t3 Q8WZ42 34.559 816 6.980000000000001e-109 398.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10707.t3 Q8WZ42 32.394 852 1.63e-108 397.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10707.t3 Q8WZ42 36.589 645 1.06e-105 387.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10707.t3 Q8WZ42 35.942 690 6.57e-99 365.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10707.t3 Q8WZ42 33.333 723 1.34e-98 364.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10707.t3 Q8WZ42 34.548 741 2.03e-97 360.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10707.t3 Q8WZ42 33.062 738 1.37e-96 357.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10707.t3 Q8WZ42 34.459 740 1.6e-96 357.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10707.t3 Q8WZ42 32.44 746 6.98e-96 355.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10707.t3 Q8WZ42 34.393 692 3.0899999999999996e-95 353.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10707.t3 Q8WZ42 33.464 768 3.59e-94 349.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10707.t3 Q8WZ42 33.028 763 9.87e-94 348.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10707.t3 Q8WZ42 34.146 697 7.54e-93 345.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10707.t3 Q8WZ42 32.304 842 2.39e-92 343.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10707.t3 Q8WZ42 27.808 1104 1.93e-91 340.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10707.t3 Q8WZ42 32.791 738 2.7399999999999997e-89 333.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10707.t3 Q8WZ42 32.659 692 1.69e-88 330.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10707.t3 Q8WZ42 30.707 863 3.1000000000000003e-88 330.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10707.t3 Q8WZ42 34.45 746 1.3700000000000001e-86 324.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10707.t3 Q8WZ42 36.334 622 9.83e-85 318.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10707.t3 Q8WZ42 32.547 805 2.23e-84 317.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10707.t3 Q8WZ42 33.113 755 4.66e-84 316.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10707.t3 Q8WZ42 30.813 886 2.48e-83 313.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10707.t3 Q8WZ42 30.66 773 2.77e-83 313.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10707.t3 Q8WZ42 33.019 742 1.1e-82 311.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10707.t3 Q8WZ42 31.579 665 4.99e-82 309.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10707.t3 Q8WZ42 35.714 630 5.81e-82 309.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10707.t3 Q8WZ42 35.494 617 9.59e-82 308.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10707.t3 Q8WZ42 29.098 1031 3.02e-81 306.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10707.t3 Q8WZ42 32.653 735 4.0200000000000005e-79 299.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10707.t3 Q8WZ42 31.884 690 5.3900000000000004e-79 299.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10707.t3 Q8WZ42 33.801 642 8.540000000000001e-79 298.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10707.t3 Q8WZ42 35.846 650 2.68e-78 296.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10707.t3 Q8WZ42 30.33 788 4.82e-78 296.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10707.t3 Q8WZ42 33.008 615 1.47e-76 291.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10707.t3 Q8WZ42 30.036 839 1.56e-75 288.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10707.t3 Q8WZ42 30.788 799 4.7e-75 286.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10707.t3 Q8WZ42 27.874 922 1.6299999999999998e-74 284.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10707.t3 Q8WZ42 28.856 752 3.5500000000000005e-73 280.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10707.t3 Q8WZ42 29.103 914 6.79e-72 275.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10707.t3 Q8WZ42 31.466 607 6.72e-71 272.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10707.t3 Q8WZ42 30.063 795 5.44e-70 269.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10707.t3 Q8WZ42 28.229 751 2.55e-69 267.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10707.t3 Q8WZ42 26.422 1037 2.5999999999999997e-69 267.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10707.t3 Q8WZ42 30.154 713 7.9e-69 265.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10707.t3 Q8WZ42 32.283 635 1.2199999999999999e-68 265.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10707.t3 Q8WZ42 32.07 633 1.25e-67 261.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10707.t3 Q8WZ42 31.379 631 1.5999999999999998e-67 261.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10707.t3 Q8WZ42 28.017 721 2.1800000000000003e-64 251.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10707.t3 Q8WZ42 26.424 1018 3.33e-63 246.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10707.t3 Q8WZ42 29.557 609 3.55e-62 243.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10707.t3 Q8WZ42 34.394 503 2.6199999999999997e-61 240.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10707.t3 Q8WZ42 28.173 717 6.19e-60 236.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10707.t3 Q8WZ42 27.677 719 1.23e-59 235.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10707.t3 Q8WZ42 29.404 738 6.930000000000001e-59 232.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10707.t3 Q8WZ42 30.596 621 1.8e-58 231.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10707.t3 Q8WZ42 29.746 669 2.3800000000000003e-56 224.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10707.t3 Q8WZ42 28.537 827 5.390000000000001e-56 223.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10707.t3 Q8WZ42 22.792 1483 6.210000000000001e-56 223.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10707.t3 Q8WZ42 28.254 676 1.7099999999999998e-55 221.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10707.t3 Q8WZ42 26.366 732 9.35e-53 212.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10707.t3 Q8WZ42 31.5 400 1.66e-52 211.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10707.t3 Q8WZ42 23.39 1227 3.16e-51 207.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10707.t3 Q8WZ42 26.286 700 1.43e-49 201.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10707.t3 Q8WZ42 22.625 1158 6.69e-48 196.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10707.t3 Q8WZ42 25.487 667 1.8700000000000002e-47 194.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10707.t3 Q8WZ42 24.821 838 1.97e-44 184.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10707.t3 Q8WZ42 25.403 744 3.01e-44 184.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10707.t3 Q8WZ42 27.16 729 1.0800000000000002e-43 182.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10707.t3 Q8WZ42 26.804 679 5.089999999999999e-41 173.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10707.t3 Q8WZ42 27.666 647 9.73e-40 169.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10707.t3 Q8WZ42 24.571 757 1.79e-39 168.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10707.t3 Q8WZ42 23.407 769 8.61e-36 156.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10707.t3 Q8WZ42 21.909 744 1.15e-32 145.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10707.t3 Q8WZ42 21.462 1053 2.23e-30 138.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10707.t3 Q8WZ42 21.928 1058 2.49e-30 138.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10707.t3 Q8WZ42 23.342 754 6.2899999999999995e-30 136.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10707.t3 Q8WZ42 23.385 774 2.0500000000000003e-27 128.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10707.t3 Q8WZ42 23.91 757 5.0900000000000004e-27 127.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10707.t3 Q8WZ42 24.183 612 3.43e-26 124.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10707.t3 Q8WZ42 30.667 300 1.09e-25 122.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10707.t3 Q8WZ42 36.126 191 1.11e-24 119.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10707.t3 Q8WZ42 35.079 191 1.8899999999999998e-24 118.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10707.t3 Q8WZ42 33.871 186 2.5399999999999998e-24 118.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10707.t3 Q8WZ42 25.984 254 1.19e-22 112.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10707.t3 Q8WZ42 30.932 236 1.45e-22 112.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10707.t3 Q8WZ42 25.478 471 1.98e-22 112.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10707.t3 Q8WZ42 27.848 316 3e-22 111.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10707.t3 Q8WZ42 31.915 188 7.720000000000001e-22 109.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10707.t3 Q8WZ42 31.905 210 2.51e-21 108.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10707.t3 Q8WZ42 31.579 190 2.9900000000000004e-21 107.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10707.t3 Q8WZ42 25.517 435 3.36e-21 107.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10707.t3 Q8WZ42 31.183 186 3.56e-21 107.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10707.t3 Q8WZ42 32.258 186 4.2500000000000004e-21 107.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10708.t1 A2ASS6 32.326 7378 0.0 2904.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10708.t1 A2ASS6 31.902 7103 0.0 2786.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10708.t1 A2ASS6 31.041 7184 0.0 2597.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10708.t1 A2ASS6 32.067 5816 0.0 2300.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10708.t1 A2ASS6 31.554 6031 0.0 2263.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10708.t1 A2ASS6 31.378 6119 0.0 2262.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10708.t1 A2ASS6 30.491 6543 0.0 2227.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10708.t1 A2ASS6 30.505 6494 0.0 2211.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10708.t1 A2ASS6 31.022 6215 0.0 2191.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10708.t1 A2ASS6 31.761 5447 0.0 2135.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10708.t1 A2ASS6 31.353 5773 0.0 2132.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10708.t1 A2ASS6 31.401 5347 0.0 1996.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10708.t1 A2ASS6 30.922 5501 0.0 1991.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10708.t1 A2ASS6 31.83 4810 0.0 1897.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10708.t1 A2ASS6 30.824 5447 0.0 1854.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10708.t1 A2ASS6 31.71 4456 0.0 1607.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10708.t1 A2ASS6 30.962 3585 0.0 1343.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10708.t1 A2ASS6 32.084 3469 0.0 1332.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10708.t1 A2ASS6 31.676 3539 0.0 1323.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10708.t1 A2ASS6 32.592 3461 0.0 1307.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10708.t1 A2ASS6 31.069 3341 0.0 1268.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10708.t1 A2ASS6 32.585 3164 0.0 1220.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10708.t1 A2ASS6 31.18 2941 0.0 1154.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10708.t1 A2ASS6 32.297 2895 0.0 1151.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10708.t1 A2ASS6 31.213 3066 0.0 1135.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10708.t1 A2ASS6 31.42 3049 0.0 1120.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10708.t1 A2ASS6 30.179 2684 0.0 935.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10708.t1 A2ASS6 30.425 2281 0.0 818.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10708.t1 A2ASS6 33.107 1622 0.0 734.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10708.t1 A2ASS6 32.406 1438 1.98e-172 610.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10708.t1 A2ASS6 35.027 1122 2.55e-168 596.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10708.t1 A2ASS6 33.983 1180 1.42e-154 550.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10708.t1 A2ASS6 39.13 805 3.4899999999999997e-146 523.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10708.t1 A2ASS6 37.717 806 3.9499999999999996e-146 523.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10708.t1 A2ASS6 38.847 798 1.75e-145 520.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10708.t1 A2ASS6 37.175 807 4.54e-145 519.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10708.t1 A2ASS6 33.004 1112 3.57e-142 509.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10708.t1 A2ASS6 31.434 1158 1.52e-139 501.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10708.t1 A2ASS6 31.993 1144 7e-139 498.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10708.t1 A2ASS6 36.262 808 8.38e-138 495.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10708.t1 A2ASS6 36.042 849 9.62e-135 485.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10708.t1 A2ASS6 36.108 853 2.45e-134 483.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10708.t1 A2ASS6 36.498 811 4.2200000000000003e-132 476.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10708.t1 A2ASS6 30.824 1129 4.01e-130 469.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10708.t1 A2ASS6 36.654 813 2.25e-129 467.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10708.t1 A2ASS6 34.165 802 7.02e-124 449.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10708.t1 A2ASS6 36.887 816 1.02e-122 445.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10708.t1 A2ASS6 30.887 1172 1.3000000000000001e-122 444.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10708.t1 A2ASS6 35.589 857 1.25e-117 428.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10708.t1 A2ASS6 32.121 825 1.74e-107 394.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10708.t1 A2ASS6 29.815 1137 2.2900000000000002e-107 394.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10708.t1 A2ASS6 32.227 844 9.79e-105 385.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10708.t1 A2ASS6 32.083 960 3.39e-103 380.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10708.t1 A2ASS6 32.805 820 3.9e-103 380.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10708.t1 A2ASS6 31.952 917 5.100000000000001e-103 379.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10708.t1 A2ASS6 32.648 827 6.41e-100 369.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10708.t1 A2ASS6 31.728 810 5.94e-98 363.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10708.t1 A2ASS6 32.497 837 4.21e-94 350.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10708.t1 A2ASS6 38.889 522 4.24e-94 350.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10708.t1 A2ASS6 30.51 862 7.18e-94 349.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10708.t1 A2ASS6 36.155 567 3.86e-90 337.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10708.t1 A2ASS6 34.72 625 9.85e-90 335.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10708.t1 A2ASS6 34.684 617 3.36e-89 333.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10708.t1 A2ASS6 34.3 621 9.64e-89 332.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10708.t1 A2ASS6 36.995 619 5.34e-88 330.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10708.t1 A2ASS6 37.41 556 4.89e-87 327.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10708.t1 A2ASS6 34.548 631 4.07e-85 320.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10708.t1 A2ASS6 33.175 633 5.91e-81 306.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10708.t1 A2ASS6 34.262 610 2.23e-80 304.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10708.t1 A2ASS6 33.07 632 1.2600000000000001e-77 295.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10708.t1 A2ASS6 32.318 591 5.35e-76 290.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10708.t1 A2ASS6 31.648 613 1.28e-74 285.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10708.t1 A2ASS6 27.387 1110 2.06e-65 255.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10708.t1 A2ASS6 28.452 840 4.460000000000001e-56 224.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10708.t1 A2ASS6 33.532 504 3.12e-53 214.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10708.t1 A2ASS6 30.078 512 2.78e-50 204.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10708.t1 A2ASS6 37.126 334 3.2799999999999995e-48 197.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10708.t1 A2ASS6 27.97 665 6.65e-44 183.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10708.t1 A2ASS6 29.666 509 7.17e-44 183.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10708.t1 A2ASS6 32.054 443 7.16e-42 177.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10708.t1 A2ASS6 34.444 270 2.52e-39 168.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10708.t1 A2ASS6 25.806 589 1.0099999999999999e-38 166.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10708.t1 A2ASS6 25.625 640 2.38e-36 158.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10708.t1 A2ASS6 29.7 367 1.51e-33 149.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10708.t1 A2ASS6 34.302 344 1.64e-28 132.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10708.t1 A2ASS6 30.994 342 7.25e-28 130.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10708.t1 A2ASS6 27.789 475 1.64e-27 129.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10708.t2 Q8WZ42 32.185 7376 0.0 2899.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10708.t2 Q8WZ42 31.481 7074 0.0 2744.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10708.t2 Q8WZ42 31.446 7349 0.0 2661.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10708.t2 Q8WZ42 31.147 7195 0.0 2607.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10708.t2 Q8WZ42 32.312 6561 0.0 2579.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10708.t2 Q8WZ42 30.573 6715 0.0 2352.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10708.t2 Q8WZ42 31.955 5924 0.0 2319.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10708.t2 Q8WZ42 32.239 5819 0.0 2284.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10708.t2 Q8WZ42 31.981 5816 0.0 2281.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10708.t2 Q8WZ42 31.31 6129 0.0 2254.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10708.t2 Q8WZ42 31.523 5856 0.0 2210.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10708.t2 Q8WZ42 31.778 5315 0.0 2009.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10708.t2 Q8WZ42 30.603 5493 0.0 1943.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10708.t2 Q8WZ42 32.4 3963 0.0 1529.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10708.t2 Q8WZ42 30.729 4006 0.0 1418.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10708.t2 Q8WZ42 30.859 3853 0.0 1389.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10708.t2 Q8WZ42 30.705 3602 0.0 1340.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10708.t2 Q8WZ42 32.518 3149 0.0 1276.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10708.t2 Q8WZ42 31.086 3471 0.0 1251.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10708.t2 Q8WZ42 31.962 3160 0.0 1216.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10708.t2 Q8WZ42 32.465 3148 0.0 1199.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10708.t2 Q8WZ42 32.221 2998 0.0 1196.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10708.t2 Q8WZ42 30.363 3310 0.0 1174.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10708.t2 Q8WZ42 30.917 3063 0.0 1068.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10708.t2 Q8WZ42 30.628 2883 0.0 987.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10708.t2 Q8WZ42 31.247 2173 0.0 904.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10708.t2 Q8WZ42 30.488 2273 0.0 803.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10708.t2 Q8WZ42 31.537 2004 0.0 784.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10708.t2 Q8WZ42 30.089 1798 1.4800000000000002e-167 593.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10708.t2 Q8WZ42 34.467 1117 3.56e-165 585.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10708.t2 Q8WZ42 38.188 817 9.82e-149 531.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10708.t2 Q8WZ42 37.669 815 1.49e-147 527.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10708.t2 Q8WZ42 38.717 842 1.11e-145 521.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10708.t2 Q8WZ42 37.965 806 8.46e-145 518.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10708.t2 Q8WZ42 37.16 810 2.61e-144 516.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10708.t2 Q8WZ42 38.413 794 4.35e-144 516.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10708.t2 Q8WZ42 35.967 848 5.539999999999999e-134 482.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10708.t2 Q8WZ42 36.816 804 1.6e-133 481.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10708.t2 Q8WZ42 31.742 1131 1.2300000000000001e-132 478.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10708.t2 Q8WZ42 37.269 813 1.0099999999999999e-131 474.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10708.t2 Q8WZ42 36.498 811 1.2e-131 474.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10708.t2 Q8WZ42 29.782 1145 3.71e-124 449.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10708.t2 Q8WZ42 34.037 805 1.3e-121 441.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10708.t2 Q8WZ42 36.029 816 8.27e-120 435.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10708.t2 Q8WZ42 35.006 857 1.65e-115 421.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10708.t2 Q8WZ42 32.407 864 7.3e-109 399.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10708.t2 Q8WZ42 29.914 1160 1.21e-106 392.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10708.t2 Q8WZ42 32.371 797 1.1000000000000001e-100 372.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10708.t2 Q8WZ42 32.567 826 1.33e-100 372.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10708.t2 Q8WZ42 31.818 836 7.52e-99 365.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10708.t2 Q8WZ42 29.278 1052 1.58e-96 358.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10708.t2 Q8WZ42 30.983 865 1.88e-96 358.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10708.t2 Q8WZ42 34.253 616 9.68e-94 348.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10708.t2 Q8WZ42 38.432 523 5.46e-93 346.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10708.t2 Q8WZ42 31.205 830 9.16e-91 339.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10708.t2 Q8WZ42 37.476 531 1.11e-90 338.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10708.t2 Q8WZ42 35.144 626 6.47e-90 336.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10708.t2 Q8WZ42 34.194 620 2.22e-86 324.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10708.t2 Q8WZ42 33.764 619 5.65e-86 323.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10708.t2 Q8WZ42 34.548 631 2.61e-85 321.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10708.t2 Q8WZ42 36.511 619 3.13e-85 320.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10708.t2 Q8WZ42 33.595 637 3.9e-82 310.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10708.t2 Q8WZ42 34.007 594 1.9100000000000003e-79 301.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10708.t2 Q8WZ42 33.861 632 8.19e-78 296.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10708.t2 Q8WZ42 31.757 592 1.0899999999999999e-74 285.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10708.t2 Q8WZ42 27.126 1117 1.5399999999999998e-67 262.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10708.t2 Q8WZ42 32.772 534 1.39e-63 249.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10708.t2 Q8WZ42 27.647 850 1.63e-62 245.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10708.t2 Q8WZ42 26.611 838 1.71e-56 225.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10708.t2 Q8WZ42 33.73 504 3.75e-53 214.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10708.t2 Q8WZ42 28.166 845 7.32e-53 213.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10708.t2 Q8WZ42 27.667 806 1.16e-49 202.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10708.t2 Q8WZ42 27.227 797 1.69e-47 195.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10708.t2 Q8WZ42 36.527 334 5.71e-47 194.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10708.t2 Q8WZ42 27.994 668 5.75e-45 187.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10708.t2 Q8WZ42 26.377 690 1.99e-42 179.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10708.t2 Q8WZ42 25.297 589 9.61e-39 166.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10708.t2 Q8WZ42 25.786 636 1.84e-36 159.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10708.t2 Q8WZ42 29.459 370 1.6100000000000002e-33 149.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10711.t1 A2ASS6 35.909 880 2.38e-162 533.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10711.t1 A2ASS6 32.492 911 5.66e-132 444.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10711.t1 A2ASS6 31.438 897 3.46e-107 371.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10711.t1 A2ASS6 29.967 911 3.76e-107 371.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10711.t1 A2ASS6 30.617 908 1.03e-105 367.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10711.t1 A2ASS6 31.823 883 1.0900000000000001e-103 360.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10711.t1 A2ASS6 36.047 688 1.28e-103 360.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10711.t1 A2ASS6 30.373 912 2.08e-101 353.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10711.t1 A2ASS6 29.721 895 5.48e-97 340.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10711.t1 A2ASS6 32.808 698 2.94e-95 335.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10711.t1 A2ASS6 32.946 689 2e-94 333.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10711.t1 A2ASS6 33.052 711 6.74e-94 331.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10711.t1 A2ASS6 33.048 702 1.28e-91 325.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10711.t1 A2ASS6 33.142 697 1.8e-91 324.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10711.t1 A2ASS6 32.749 684 2.69e-91 323.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10711.t1 A2ASS6 33.43 691 1.69e-89 318.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10711.t1 A2ASS6 32.005 728 3.1399999999999998e-89 317.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10711.t1 A2ASS6 30.299 703 7.43e-86 307.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10711.t1 A2ASS6 32.34 705 2.1100000000000002e-85 306.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10711.t1 A2ASS6 32.549 765 8.33e-85 304.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10711.t1 A2ASS6 32.448 715 3.17e-84 302.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10711.t1 A2ASS6 30.737 719 1.0499999999999999e-82 298.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10711.t1 A2ASS6 30.949 727 4.3399999999999995e-82 296.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10711.t1 A2ASS6 31.514 733 5.27e-80 290.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10711.t1 A2ASS6 32.059 680 6.94e-80 289.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10711.t1 A2ASS6 32.072 608 8.26e-80 289.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10711.t1 A2ASS6 31.456 728 4.7700000000000003e-79 287.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10711.t1 A2ASS6 30.508 708 1.36e-78 285.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10711.t1 A2ASS6 35.833 480 8.41e-78 283.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10711.t1 A2ASS6 31.519 698 1.1900000000000001e-77 283.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10711.t1 A2ASS6 30.682 704 3.0900000000000002e-77 281.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10711.t1 A2ASS6 33.386 638 4.8300000000000005e-77 281.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10711.t1 A2ASS6 34.677 496 5.41e-76 278.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10711.t1 A2ASS6 29.625 746 2e-74 273.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10711.t1 A2ASS6 31.044 728 5.02e-74 271.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10711.t1 A2ASS6 29.932 735 1.1e-73 271.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10711.t1 A2ASS6 30.647 695 1.5700000000000002e-72 267.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10711.t1 A2ASS6 30.069 725 1.62e-72 267.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10711.t1 A2ASS6 30.758 712 5.900000000000001e-72 265.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10711.t1 A2ASS6 29.877 733 6.23e-72 265.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10711.t1 A2ASS6 30.59 729 2.95e-71 263.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10711.t1 A2ASS6 30.303 726 3.06e-71 263.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10711.t1 A2ASS6 29.404 738 3.06e-71 263.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10711.t1 A2ASS6 30.685 730 4.73e-71 263.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10711.t1 A2ASS6 30.718 599 7.460000000000001e-71 262.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10711.t1 A2ASS6 29.023 727 8.47e-71 262.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10711.t1 A2ASS6 30.1 701 9.19e-71 261.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10711.t1 A2ASS6 30.014 703 1.58e-70 261.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10711.t1 A2ASS6 30.299 703 9.650000000000001e-70 258.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10711.t1 A2ASS6 33.543 477 3.76e-69 257.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10711.t1 A2ASS6 30.32 719 4.1199999999999996e-69 256.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10711.t1 A2ASS6 27.863 786 4.98e-69 256.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10711.t1 A2ASS6 32.454 758 6.25e-69 256.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10711.t1 A2ASS6 27.409 799 2.86e-68 254.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10711.t1 A2ASS6 32.47 502 1.32e-67 252.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10711.t1 A2ASS6 29.557 609 2.9299999999999997e-67 251.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10711.t1 A2ASS6 30.051 782 8.599999999999999e-67 249.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10711.t1 A2ASS6 30.265 717 8.679999999999999e-67 249.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10711.t1 A2ASS6 29.317 747 9.159999999999999e-67 249.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10711.t1 A2ASS6 31.502 619 1.6900000000000002e-66 249.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10711.t1 A2ASS6 29.888 716 2.5000000000000003e-66 248.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10711.t1 A2ASS6 29.339 726 3.1900000000000003e-66 248.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10711.t1 A2ASS6 29.51 715 2.56e-65 245.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10711.t1 A2ASS6 30.52 711 5.98e-65 244.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10711.t1 A2ASS6 30.122 737 1.43e-64 243.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10711.t1 A2ASS6 31.557 713 1.2e-63 240.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10711.t1 A2ASS6 28.297 728 1.5399999999999999e-62 236.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10711.t1 A2ASS6 33.138 513 4.17e-62 235.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10711.t1 A2ASS6 28.972 749 7.28e-62 234.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10711.t1 A2ASS6 29.032 775 1.44e-60 230.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10711.t1 A2ASS6 30.194 722 3.72e-58 223.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10711.t1 A2ASS6 28.947 722 1.53e-57 221.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10711.t1 A2ASS6 31.75 400 1.91e-47 189.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10711.t1 A2ASS6 39.527 296 2.09e-46 186.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10711.t1 A2ASS6 37.193 285 8.739999999999999e-45 181.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10711.t1 A2ASS6 37.377 305 1.3e-44 180.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10711.t1 A2ASS6 29.167 384 4.29e-44 179.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10711.t1 A2ASS6 37.333 300 5.56e-44 178.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10711.t1 A2ASS6 39.916 238 6.810000000000001e-43 175.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10711.t1 A2ASS6 36.877 301 7.37e-43 174.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10711.t1 A2ASS6 38.246 285 7.889999999999999e-42 171.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10711.t1 A2ASS6 31.525 387 2.71e-41 169.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10711.t1 A2ASS6 35.88 301 4.25e-41 169.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10711.t1 A2ASS6 36.897 290 1.17e-40 167.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10711.t1 A2ASS6 36.207 290 3.29e-40 166.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10711.t1 A2ASS6 35.474 327 5.1e-38 159.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10711.t1 A2ASS6 30.973 339 1.4200000000000002e-35 151.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10711.t1 A2ASS6 34.843 287 2.8600000000000003e-35 150.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10711.t1 A2ASS6 27.29 524 1.4e-29 132.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10711.t1 A2ASS6 30.094 319 1.5e-29 132.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10711.t1 A2ASS6 32.931 331 7.01e-28 126.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10711.t1 A2ASS6 29.102 323 2.06e-24 115.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10711.t1 A2ASS6 24.498 498 5.24e-24 114.0 sp|A2ASS6|TITIN_MOUSE Titin OS=Mus musculus OX=10090 GN=Ttn PE=1 SV=1 TITIN_MOUSE reviewed Titin (EC 2.7.11.1) (Connectin) Mus musculus (Mouse) GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0043056; GO:0045214; GO:0048738; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0060419; GO:0097493; GO:0106310; GO:1901897; GO:1990733 adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591] A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] g10712.t1 Q23551 38.588 609 1.6599999999999998e-135 444.0 sp|Q23551|UNC22_CAEEL Twitchin OS=Caenorhabditis elegans OX=6239 GN=unc-22 PE=1 SV=3 UNC22_CAEEL reviewed Twitchin (EC 2.7.11.1) (Uncoordinated protein 22) Caenorhabditis elegans GO:0004674; GO:0005516; GO:0005524; GO:0008344; GO:0019899; GO:0031430; GO:0031672; GO:0040017; GO:0045214; GO:0045989; GO:0046872; GO:0051782; GO:0060298; GO:0106310 adult locomotory behavior [GO:0008344]; negative regulation of cell division [GO:0051782]; positive regulation of locomotion [GO:0040017]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of striated muscle contraction [GO:0045989]; sarcomere organization [GO:0045214] A band [GO:0031672]; M band [GO:0031430] ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g10713.t1 P56276 43.75 80 1.41e-21 86.3 sp|P56276|MYLK_MELGA Telokin OS=Meleagris gallopavo OX=9103 PE=1 SV=1 g10714.t1 Q8WZ42 26.952 538 7.96e-35 151.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10714.t1 Q8WZ42 25.536 560 1.65e-29 134.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10714.t1 Q8WZ42 22.438 566 6.11e-26 122.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10714.t1 Q8WZ42 22.995 561 2.6599999999999997e-23 113.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10714.t1 Q8WZ42 30.508 236 4.2199999999999997e-23 112.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10714.t1 Q8WZ42 21.685 558 6.81e-23 112.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10714.t1 Q8WZ42 31.193 218 1.1100000000000001e-21 108.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10714.t1 Q8WZ42 21.528 576 3.33e-21 106.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g10715.t1 O75936 36.137 321 1.69e-68 233.0 sp|O75936|BODG_HUMAN Gamma-butyrobetaine dioxygenase OS=Homo sapiens OX=9606 GN=BBOX1 PE=1 SV=1 BODG_HUMAN reviewed Gamma-butyrobetaine dioxygenase (EC 1.14.11.1) (Gamma-butyrobetaine hydroxylase) (Gamma-BBH) (Gamma-butyrobetaine,2-oxoglutarate dioxygenase) Homo sapiens (Human) GO:0005506; GO:0005739; GO:0005829; GO:0008270; GO:0008336; GO:0042802; GO:0045329; GO:0070062 carnitine biosynthetic process [GO:0045329] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; mitochondrion [GO:0005739] gamma-butyrobetaine dioxygenase activity [GO:0008336]; identical protein binding [GO:0042802]; iron ion binding [GO:0005506]; zinc ion binding [GO:0008270] g10715.t1 O75936 36.578 339 1.5799999999999998e-67 230.0 sp|O75936|BODG_HUMAN Gamma-butyrobetaine dioxygenase OS=Homo sapiens OX=9606 GN=BBOX1 PE=1 SV=1 BODG_HUMAN reviewed Gamma-butyrobetaine dioxygenase (EC 1.14.11.1) (Gamma-butyrobetaine hydroxylase) (Gamma-BBH) (Gamma-butyrobetaine,2-oxoglutarate dioxygenase) Homo sapiens (Human) GO:0005506; GO:0005739; GO:0005829; GO:0008270; GO:0008336; GO:0042802; GO:0045329; GO:0070062 carnitine biosynthetic process [GO:0045329] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; mitochondrion [GO:0005739] gamma-butyrobetaine dioxygenase activity [GO:0008336]; identical protein binding [GO:0042802]; iron ion binding [GO:0005506]; zinc ion binding [GO:0008270] g10716.t1 Q15746 59.669 181 6.56e-72 239.0 sp|Q15746|MYLK_HUMAN Myosin light chain kinase, smooth muscle OS=Homo sapiens OX=9606 GN=MYLK PE=1 SV=4 MYLK_HUMAN reviewed Myosin light chain kinase, smooth muscle (MLCK) (smMLCK) (EC 2.7.11.18) (Kinase-related protein) (KRP) (Telokin) [Cleaved into: Myosin light chain kinase, smooth muscle, deglutamylated form] Homo sapiens (Human) GO:0001725; GO:0003779; GO:0004687; GO:0005516; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0006468; GO:0006939; GO:0014820; GO:0015629; GO:0030027; GO:0030335; GO:0032060; GO:0032154; GO:0045202; GO:0046872; GO:0051928; GO:0060414; GO:0071476; GO:0090303; GO:0097110; GO:1900242 aorta smooth muscle tissue morphogenesis [GO:0060414]; bleb assembly [GO:0032060]; cellular hypotonic response [GO:0071476]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of cell migration [GO:0030335]; positive regulation of wound healing [GO:0090303]; protein phosphorylation [GO:0006468]; regulation of synaptic vesicle endocytosis [GO:1900242]; smooth muscle contraction [GO:0006939]; tonic smooth muscle contraction [GO:0014820] actin cytoskeleton [GO:0015629]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; lamellipodium [GO:0030027]; plasma membrane [GO:0005886]; stress fiber [GO:0001725]; synapse [GO:0045202] actin binding [GO:0003779]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; myosin light chain kinase activity [GO:0004687]; scaffold protein binding [GO:0097110] g10717.t1 Q28824 43.706 707 2.73e-158 529.0 sp|Q28824|MYLK_BOVIN Myosin light chain kinase, smooth muscle OS=Bos taurus OX=9913 GN=MYLK PE=1 SV=1 MYLK_BOVIN reviewed Myosin light chain kinase, smooth muscle (MLCK) (smMLCK) (EC 2.7.11.18) (Telokin) [Cleaved into: Myosin light chain kinase, smooth muscle, deglutamylated form] Bos taurus (Bovine) GO:0001725; GO:0003779; GO:0004687; GO:0005516; GO:0005524; GO:0005737; GO:0014820; GO:0030027; GO:0032154; GO:0046872 tonic smooth muscle contraction [GO:0014820] cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; lamellipodium [GO:0030027]; stress fiber [GO:0001725] actin binding [GO:0003779]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; myosin light chain kinase activity [GO:0004687] g10717.t1 Q28824 51.497 167 5.359999999999999e-42 174.0 sp|Q28824|MYLK_BOVIN Myosin light chain kinase, smooth muscle OS=Bos taurus OX=9913 GN=MYLK PE=1 SV=1 MYLK_BOVIN reviewed Myosin light chain kinase, smooth muscle (MLCK) (smMLCK) (EC 2.7.11.18) (Telokin) [Cleaved into: Myosin light chain kinase, smooth muscle, deglutamylated form] Bos taurus (Bovine) GO:0001725; GO:0003779; GO:0004687; GO:0005516; GO:0005524; GO:0005737; GO:0014820; GO:0030027; GO:0032154; GO:0046872 tonic smooth muscle contraction [GO:0014820] cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; lamellipodium [GO:0030027]; stress fiber [GO:0001725] actin binding [GO:0003779]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; myosin light chain kinase activity [GO:0004687] g10717.t1 Q28824 55.914 93 3.6499999999999994e-23 112.0 sp|Q28824|MYLK_BOVIN Myosin light chain kinase, smooth muscle OS=Bos taurus OX=9913 GN=MYLK PE=1 SV=1 MYLK_BOVIN reviewed Myosin light chain kinase, smooth muscle (MLCK) (smMLCK) (EC 2.7.11.18) (Telokin) [Cleaved into: Myosin light chain kinase, smooth muscle, deglutamylated form] Bos taurus (Bovine) GO:0001725; GO:0003779; GO:0004687; GO:0005516; GO:0005524; GO:0005737; GO:0014820; GO:0030027; GO:0032154; GO:0046872 tonic smooth muscle contraction [GO:0014820] cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; lamellipodium [GO:0030027]; stress fiber [GO:0001725] actin binding [GO:0003779]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; myosin light chain kinase activity [GO:0004687] g10717.t1 Q28824 44.144 111 2.66e-22 110.0 sp|Q28824|MYLK_BOVIN Myosin light chain kinase, smooth muscle OS=Bos taurus OX=9913 GN=MYLK PE=1 SV=1 MYLK_BOVIN reviewed Myosin light chain kinase, smooth muscle (MLCK) (smMLCK) (EC 2.7.11.18) (Telokin) [Cleaved into: Myosin light chain kinase, smooth muscle, deglutamylated form] Bos taurus (Bovine) GO:0001725; GO:0003779; GO:0004687; GO:0005516; GO:0005524; GO:0005737; GO:0014820; GO:0030027; GO:0032154; GO:0046872 tonic smooth muscle contraction [GO:0014820] cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; lamellipodium [GO:0030027]; stress fiber [GO:0001725] actin binding [GO:0003779]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; myosin light chain kinase activity [GO:0004687] g10717.t2 Q28824 43.706 707 2.74e-158 529.0 sp|Q28824|MYLK_BOVIN Myosin light chain kinase, smooth muscle OS=Bos taurus OX=9913 GN=MYLK PE=1 SV=1 MYLK_BOVIN reviewed Myosin light chain kinase, smooth muscle (MLCK) (smMLCK) (EC 2.7.11.18) (Telokin) [Cleaved into: Myosin light chain kinase, smooth muscle, deglutamylated form] Bos taurus (Bovine) GO:0001725; GO:0003779; GO:0004687; GO:0005516; GO:0005524; GO:0005737; GO:0014820; GO:0030027; GO:0032154; GO:0046872 tonic smooth muscle contraction [GO:0014820] cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; lamellipodium [GO:0030027]; stress fiber [GO:0001725] actin binding [GO:0003779]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; myosin light chain kinase activity [GO:0004687] g10717.t2 Q28824 51.497 167 5.39e-42 174.0 sp|Q28824|MYLK_BOVIN Myosin light chain kinase, smooth muscle OS=Bos taurus OX=9913 GN=MYLK PE=1 SV=1 MYLK_BOVIN reviewed Myosin light chain kinase, smooth muscle (MLCK) (smMLCK) (EC 2.7.11.18) (Telokin) [Cleaved into: Myosin light chain kinase, smooth muscle, deglutamylated form] Bos taurus (Bovine) GO:0001725; GO:0003779; GO:0004687; GO:0005516; GO:0005524; GO:0005737; GO:0014820; GO:0030027; GO:0032154; GO:0046872 tonic smooth muscle contraction [GO:0014820] cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; lamellipodium [GO:0030027]; stress fiber [GO:0001725] actin binding [GO:0003779]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; myosin light chain kinase activity [GO:0004687] g10717.t2 Q28824 55.914 93 3.6699999999999995e-23 112.0 sp|Q28824|MYLK_BOVIN Myosin light chain kinase, smooth muscle OS=Bos taurus OX=9913 GN=MYLK PE=1 SV=1 MYLK_BOVIN reviewed Myosin light chain kinase, smooth muscle (MLCK) (smMLCK) (EC 2.7.11.18) (Telokin) [Cleaved into: Myosin light chain kinase, smooth muscle, deglutamylated form] Bos taurus (Bovine) GO:0001725; GO:0003779; GO:0004687; GO:0005516; GO:0005524; GO:0005737; GO:0014820; GO:0030027; GO:0032154; GO:0046872 tonic smooth muscle contraction [GO:0014820] cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; lamellipodium [GO:0030027]; stress fiber [GO:0001725] actin binding [GO:0003779]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; myosin light chain kinase activity [GO:0004687] g10717.t2 Q28824 44.144 111 2.68e-22 110.0 sp|Q28824|MYLK_BOVIN Myosin light chain kinase, smooth muscle OS=Bos taurus OX=9913 GN=MYLK PE=1 SV=1 MYLK_BOVIN reviewed Myosin light chain kinase, smooth muscle (MLCK) (smMLCK) (EC 2.7.11.18) (Telokin) [Cleaved into: Myosin light chain kinase, smooth muscle, deglutamylated form] Bos taurus (Bovine) GO:0001725; GO:0003779; GO:0004687; GO:0005516; GO:0005524; GO:0005737; GO:0014820; GO:0030027; GO:0032154; GO:0046872 tonic smooth muscle contraction [GO:0014820] cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; lamellipodium [GO:0030027]; stress fiber [GO:0001725] actin binding [GO:0003779]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; myosin light chain kinase activity [GO:0004687] g10718.t1 A2AAJ9 26.98 871 1.89e-53 213.0 sp|A2AAJ9|OBSCN_MOUSE Obscurin OS=Mus musculus OX=10090 GN=Obscn PE=1 SV=3 OBSCN_MOUSE reviewed Obscurin (EC 2.7.11.1) (Obscurin-RhoGEF) (Obscurin-myosin light chain kinase) (Obscurin-MLCK) Mus musculus (Mouse) GO:0004672; GO:0004674; GO:0005085; GO:0005516; GO:0005524; GO:0005546; GO:0005547; GO:0005615; GO:0005829; GO:0005863; GO:0005886; GO:0006468; GO:0010314; GO:0014704; GO:0016604; GO:0030017; GO:0030018; GO:0030154; GO:0030506; GO:0031430; GO:0031432; GO:0032266; GO:0042383; GO:0043325; GO:0045296; GO:0046777; GO:0046872; GO:0051898; GO:0070273; GO:0106310; GO:1902531; GO:1902936 cell differentiation [GO:0030154]; negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051898]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of intracellular signal transduction [GO:1902531] cytosol [GO:0005829]; extracellular space [GO:0005615]; intercalated disc [GO:0014704]; M band [GO:0031430]; nuclear body [GO:0016604]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; cadherin binding [GO:0045296]; calmodulin binding [GO:0005516]; guanyl-nucleotide exchange factor activity [GO:0005085]; metal ion binding [GO:0046872]; phosphatidylinositol bisphosphate binding [GO:1902936]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphatidylinositol-4-phosphate binding [GO:0070273]; phosphatidylinositol-5-phosphate binding [GO:0010314]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; titin binding [GO:0031432] g10721.t1 P29294 49.885 433 1.42e-131 409.0 sp|P29294|MYLK_RABIT Myosin light chain kinase, smooth muscle OS=Oryctolagus cuniculus OX=9986 GN=MYLK PE=1 SV=2 g10722.t1 Q15772 28.638 1285 7.01e-139 487.0 sp|Q15772|SPEG_HUMAN Striated muscle preferentially expressed protein kinase OS=Homo sapiens OX=9606 GN=SPEG PE=1 SV=4 g10722.t1 Q15772 37.453 267 6.449999999999999e-45 184.0 sp|Q15772|SPEG_HUMAN Striated muscle preferentially expressed protein kinase OS=Homo sapiens OX=9606 GN=SPEG PE=1 SV=4 g10722.t1 Q15772 33.333 282 3.4599999999999997e-41 172.0 sp|Q15772|SPEG_HUMAN Striated muscle preferentially expressed protein kinase OS=Homo sapiens OX=9606 GN=SPEG PE=1 SV=4 g10722.t1 Q15772 31.298 262 1.87e-33 146.0 sp|Q15772|SPEG_HUMAN Striated muscle preferentially expressed protein kinase OS=Homo sapiens OX=9606 GN=SPEG PE=1 SV=4 g10723.t1 Q6L8Q7 45.316 395 5.13e-118 368.0 sp|Q6L8Q7|PDE12_HUMAN 2',5'-phosphodiesterase 12 OS=Homo sapiens OX=9606 GN=PDE12 PE=1 SV=2 PDE12_HUMAN reviewed 2',5'-phosphodiesterase 12 (2'-PDE) (2-PDE) (EC 3.1.4.-) (Mitochondrial deadenylase) (EC 3.1.13.4) Homo sapiens (Human) GO:0000175; GO:0000288; GO:0000958; GO:0004527; GO:0004535; GO:0005739; GO:0005759; GO:0005829; GO:0006397; GO:0035457; GO:0044528; GO:0045070; GO:0046872; GO:0051607; GO:0071346; GO:0071359; GO:0090304; GO:0140374 antiviral innate immune response [GO:0140374]; cellular response to dsRNA [GO:0071359]; cellular response to interferon-alpha [GO:0035457]; cellular response to type II interferon [GO:0071346]; defense response to virus [GO:0051607]; mitochondrial mRNA catabolic process [GO:0000958]; mRNA processing [GO:0006397]; nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:0000288]; nucleic acid metabolic process [GO:0090304]; positive regulation of viral genome replication [GO:0045070]; regulation of mitochondrial mRNA stability [GO:0044528] cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] 3'-5'-RNA exonuclease activity [GO:0000175]; exonuclease activity [GO:0004527]; metal ion binding [GO:0046872]; poly(A)-specific ribonuclease activity [GO:0004535] g10733.t1 P08594 46.104 308 1.32e-69 231.0 sp|P08594|AQL1_THEAQ Aqualysin-1 OS=Thermus aquaticus OX=271 GN=pstI PE=1 SV=2 g10736.t1 Q68CP9 40.107 187 7.180000000000001e-33 135.0 sp|Q68CP9|ARID2_HUMAN AT-rich interactive domain-containing protein 2 OS=Homo sapiens OX=9606 GN=ARID2 PE=1 SV=2 ARID2_HUMAN reviewed AT-rich interactive domain-containing protein 2 (ARID domain-containing protein 2) (BRG1-associated factor 200) (BAF200) (Zinc finger protein with activation potential) (Zipzap/p200) Homo sapiens (Human) GO:0000776; GO:0000785; GO:0003007; GO:0003677; GO:0005634; GO:0005654; GO:0005886; GO:0006337; GO:0006338; GO:0006357; GO:0008270; GO:0008285; GO:0016363; GO:0016514; GO:0016586; GO:0030071; GO:0030336; GO:0042592; GO:0045582; GO:0045597; GO:0045663; GO:0048568; GO:0060038; GO:0060982; GO:0070316; GO:1905168; GO:2000045; GO:2000781; GO:2000819 cardiac muscle cell proliferation [GO:0060038]; chromatin remodeling [GO:0006338]; coronary artery morphogenesis [GO:0060982]; embryonic organ development [GO:0048568]; heart morphogenesis [GO:0003007]; homeostatic process [GO:0042592]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; nucleosome disassembly [GO:0006337]; positive regulation of cell differentiation [GO:0045597]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of T cell differentiation [GO:0045582]; regulation of G0 to G1 transition [GO:0070316]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; regulation of nucleotide-excision repair [GO:2000819]; regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; kinetochore [GO:0000776]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; RSC-type complex [GO:0016586]; SWI/SNF complex [GO:0016514] DNA binding [GO:0003677]; zinc ion binding [GO:0008270] g10738.t1 E9Q7E2 42.338 633 3e-157 515.0 sp|E9Q7E2|ARID2_MOUSE AT-rich interactive domain-containing protein 2 OS=Mus musculus OX=10090 GN=Arid2 PE=1 SV=1 g10739.t1 P04634 51.715 379 1.11e-137 404.0 sp|P04634|LIPF_RAT Gastric triacylglycerol lipase OS=Rattus norvegicus OX=10116 GN=Lipf PE=1 SV=1 LIPF_RAT reviewed Gastric triacylglycerol lipase (GL) (Gastric lipase) (EC 3.1.1.3) (Lingual lipase) Rattus norvegicus (Rat) GO:0004806; GO:0005576; GO:0005739; GO:0006108; GO:0006629; GO:0016042; GO:0016298; GO:0016615 lipid catabolic process [GO:0016042]; lipid metabolic process [GO:0006629]; malate metabolic process [GO:0006108] extracellular region [GO:0005576]; mitochondrion [GO:0005739] lipase activity [GO:0016298]; malate dehydrogenase activity [GO:0016615]; triacylglycerol lipase activity [GO:0004806] g10745.t1 Q5RBZ2 45.741 317 3.08e-94 286.0 sp|Q5RBZ2|MEP50_PONAB Methylosome protein WDR77 OS=Pongo abelii OX=9601 GN=WDR77 PE=2 SV=1 g10746.t1 Q78PY7 58.564 905 0.0 1003.0 sp|Q78PY7|SND1_MOUSE Staphylococcal nuclease domain-containing protein 1 OS=Mus musculus OX=10090 GN=Snd1 PE=1 SV=1 SND1_MOUSE reviewed Staphylococcal nuclease domain-containing protein 1 (EC 3.1.31.1) (100 kDa coactivator) (p100 co-activator) Mus musculus (Mouse) GO:0003723; GO:0004518; GO:0004519; GO:0004521; GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0006402; GO:0010564; GO:0010587; GO:0031047; GO:0031332; GO:0042470; GO:0097433; GO:1905172; GO:1990599 miRNA catabolic process [GO:0010587]; mRNA catabolic process [GO:0006402]; regulation of cell cycle process [GO:0010564]; regulatory ncRNA-mediated gene silencing [GO:0031047] cytoplasm [GO:0005737]; cytosol [GO:0005829]; dense body [GO:0097433]; melanosome [GO:0042470]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; RNAi effector complex [GO:0031332] 3' overhang single-stranded DNA endodeoxyribonuclease activity [GO:1990599]; endonuclease activity [GO:0004519]; nuclease activity [GO:0004518]; RISC complex binding [GO:1905172]; RNA binding [GO:0003723]; RNA endonuclease activity [GO:0004521] g10746.t2 Q5REU4 58.739 904 0.0 1003.0 sp|Q5REU4|SND1_PONAB Staphylococcal nuclease domain-containing protein 1 OS=Pongo abelii OX=9601 GN=SND1 PE=2 SV=1 g10749.t1 Q8BZK4 35.55 391 6.789999999999999e-68 228.0 sp|Q8BZK4|S35F4_MOUSE Solute carrier family 35 member F4 OS=Mus musculus OX=10090 GN=Slc35f4 PE=2 SV=1 g10754.t1 Q8HXG8 42.383 512 3.37e-130 393.0 sp|Q8HXG8|BCDO2_MACFA Carotenoid-cleaving dioxygenase, mitochondrial OS=Macaca fascicularis OX=9541 GN=BCO2 PE=2 SV=2 g10761.t1 O14513 46.759 216 1.18e-33 146.0 sp|O14513|NCKP5_HUMAN Nck-associated protein 5 OS=Homo sapiens OX=9606 GN=NCKAP5 PE=1 SV=2 NCKP5_HUMAN reviewed Nck-associated protein 5 (NAP-5) (Peripheral clock protein) Homo sapiens (Human) GO:0001578; GO:0007019; GO:0035371 microtubule bundle formation [GO:0001578]; microtubule depolymerization [GO:0007019] microtubule plus-end [GO:0035371] g10763.t1 P54360 35.507 138 2.25e-22 100.0 sp|P54360|FOJO_DROME Extracellular serine/threonine protein kinase four-jointed OS=Drosophila melanogaster OX=7227 GN=fj PE=1 SV=2 g10764.t1 P54360 39.231 130 6.96e-24 99.4 sp|P54360|FOJO_DROME Extracellular serine/threonine protein kinase four-jointed OS=Drosophila melanogaster OX=7227 GN=fj PE=1 SV=2 g10769.t1 O97859 29.53 447 4.98e-46 169.0 sp|O97859|NEUR3_BOVIN Sialidase-3 OS=Bos taurus OX=9913 GN=NEU3 PE=1 SV=1 g10769.t2 O97859 29.621 449 2.63e-49 177.0 sp|O97859|NEUR3_BOVIN Sialidase-3 OS=Bos taurus OX=9913 GN=NEU3 PE=1 SV=1 g10769.t3 O97859 29.122 467 1.09e-46 171.0 sp|O97859|NEUR3_BOVIN Sialidase-3 OS=Bos taurus OX=9913 GN=NEU3 PE=1 SV=1 g10770.t1 Q9NTJ4 44.91 167 3.5000000000000004e-43 155.0 sp|Q9NTJ4|MA2C1_HUMAN Alpha-mannosidase 2C1 OS=Homo sapiens OX=9606 GN=MAN2C1 PE=1 SV=1 g10771.t1 Q91W89 52.234 873 0.0 842.0 sp|Q91W89|MA2C1_MOUSE Alpha-mannosidase 2C1 OS=Mus musculus OX=10090 GN=Man2c1 PE=1 SV=1 MA2C1_MOUSE reviewed Alpha-mannosidase 2C1 (EC 3.2.1.24) (Alpha-D-mannoside mannohydrolase) (Mannosidase alpha class 2C member 1) (Neutral/cytosolic alpha-mannosidase) Mus musculus (Mouse) GO:0004559; GO:0005654; GO:0005737; GO:0006013; GO:0009313; GO:0030246; GO:0046872 mannose metabolic process [GO:0006013]; oligosaccharide catabolic process [GO:0009313] cytoplasm [GO:0005737]; nucleoplasm [GO:0005654] alpha-mannosidase activity [GO:0004559]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872] g10773.t1 Q9EQC4 57.229 166 3.4300000000000005e-64 203.0 sp|Q9EQC4|ELOV4_MOUSE Very long chain fatty acid elongase 4 OS=Mus musculus OX=10090 GN=Elovl4 PE=1 SV=2 ELOV4_MOUSE reviewed Very long chain fatty acid elongase 4 (EC 2.3.1.199) (3-keto acyl-CoA synthase Elovl4) (ELOVL fatty acid elongase 4) (ELOVL FA elongase 4) (Elongation of very long chain fatty acids protein 4) (Very long chain 3-ketoacyl-CoA synthase 4) (Very long chain 3-oxoacyl-CoA synthase 4) Mus musculus (Mouse) GO:0005783; GO:0005789; GO:0006636; GO:0009922; GO:0019367; GO:0030148; GO:0034625; GO:0034626; GO:0035338; GO:0042761; GO:0061886; GO:0097151; GO:1990926 fatty acid elongation, monounsaturated fatty acid [GO:0034625]; fatty acid elongation, polyunsaturated fatty acid [GO:0034626]; fatty acid elongation, saturated fatty acid [GO:0019367]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; negative regulation of mini excitatory postsynaptic potential [GO:0061886]; positive regulation of inhibitory postsynaptic potential [GO:0097151]; short-term synaptic potentiation [GO:1990926]; sphingolipid biosynthetic process [GO:0030148]; unsaturated fatty acid biosynthetic process [GO:0006636]; very long-chain fatty acid biosynthetic process [GO:0042761] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789] fatty acid elongase activity [GO:0009922] g10775.t1 Q8N2E2 34.687 1133 0.0 635.0 sp|Q8N2E2|VWDE_HUMAN von Willebrand factor D and EGF domain-containing protein OS=Homo sapiens OX=9606 GN=VWDE PE=1 SV=4 g10775.t1 Q8N2E2 35.484 341 2.98e-63 242.0 sp|Q8N2E2|VWDE_HUMAN von Willebrand factor D and EGF domain-containing protein OS=Homo sapiens OX=9606 GN=VWDE PE=1 SV=4 g10775.t1 Q8N2E2 36.299 281 9.1e-47 188.0 sp|Q8N2E2|VWDE_HUMAN von Willebrand factor D and EGF domain-containing protein OS=Homo sapiens OX=9606 GN=VWDE PE=1 SV=4 g10775.t1 Q8N2E2 39.286 168 5.46e-33 144.0 sp|Q8N2E2|VWDE_HUMAN von Willebrand factor D and EGF domain-containing protein OS=Homo sapiens OX=9606 GN=VWDE PE=1 SV=4 g10778.t1 Q5RC02 47.162 969 0.0 898.0 sp|Q5RC02|SYAC_PONAB Alanine--tRNA ligase, cytoplasmic OS=Pongo abelii OX=9601 GN=AARS1 PE=2 SV=1 SYAC_PONAB reviewed Alanine--tRNA ligase, cytoplasmic (EC 6.1.1.7) (Alanyl-tRNA synthetase) (AlaRS) (Protein lactyltransferase AARS1) (EC 6.-.-.-) Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0000049; GO:0002161; GO:0002196; GO:0004813; GO:0005524; GO:0005634; GO:0005737; GO:0005739; GO:0006400; GO:0006419; GO:0008270; GO:0035332; GO:0141207; GO:1901797 alanyl-tRNA aminoacylation [GO:0006419]; negative regulation of signal transduction by p53 class mediator [GO:1901797]; positive regulation of hippo signaling [GO:0035332]; tRNA modification [GO:0006400] cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleus [GO:0005634] alanine-tRNA ligase activity [GO:0004813]; aminoacyl-tRNA deacylase activity [GO:0002161]; ATP binding [GO:0005524]; peptide lactyltransferase (ATP-dependent) activity [GO:0141207]; Ser-tRNA(Ala) deacylase activity [GO:0002196]; tRNA binding [GO:0000049]; zinc ion binding [GO:0008270] g10778.t2 Q9VLM8 59.508 447 0.0 612.0 sp|Q9VLM8|SYAC_DROME Alanine--tRNA ligase, cytoplasmic OS=Drosophila melanogaster OX=7227 GN=AlaRS PE=2 SV=1 g10778.t2 Q9VLM8 32.381 525 2.6e-73 268.0 sp|Q9VLM8|SYAC_DROME Alanine--tRNA ligase, cytoplasmic OS=Drosophila melanogaster OX=7227 GN=AlaRS PE=2 SV=1 g10781.t1 O75165 60.921 1108 0.0 1358.0 sp|O75165|DJC13_HUMAN DnaJ homolog subfamily C member 13 OS=Homo sapiens OX=9606 GN=DNAJC13 PE=1 SV=5 DJC13_HUMAN reviewed DnaJ homolog subfamily C member 13 (Required for receptor-mediated endocytosis 8) (RME-8) Homo sapiens (Human) GO:0001649; GO:0005765; GO:0005829; GO:0005886; GO:0006898; GO:0007032; GO:0010008; GO:0015031; GO:0016020; GO:0030667; GO:0031901; GO:0035577; GO:0070062; GO:1902954; GO:2000641 endosome organization [GO:0007032]; osteoblast differentiation [GO:0001649]; protein transport [GO:0015031]; receptor-mediated endocytosis [GO:0006898]; regulation of early endosome to late endosome transport [GO:2000641]; regulation of early endosome to recycling endosome transport [GO:1902954] azurophil granule membrane [GO:0035577]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667] g10782.t1 O75165 65.951 1072 0.0 1386.0 sp|O75165|DJC13_HUMAN DnaJ homolog subfamily C member 13 OS=Homo sapiens OX=9606 GN=DNAJC13 PE=1 SV=5 DJC13_HUMAN reviewed DnaJ homolog subfamily C member 13 (Required for receptor-mediated endocytosis 8) (RME-8) Homo sapiens (Human) GO:0001649; GO:0005765; GO:0005829; GO:0005886; GO:0006898; GO:0007032; GO:0010008; GO:0015031; GO:0016020; GO:0030667; GO:0031901; GO:0035577; GO:0070062; GO:1902954; GO:2000641 endosome organization [GO:0007032]; osteoblast differentiation [GO:0001649]; protein transport [GO:0015031]; receptor-mediated endocytosis [GO:0006898]; regulation of early endosome to late endosome transport [GO:2000641]; regulation of early endosome to recycling endosome transport [GO:1902954] azurophil granule membrane [GO:0035577]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667] g10783.t1 P70428 61.158 708 0.0 907.0 sp|P70428|EXT2_MOUSE Exostosin-2 OS=Mus musculus OX=10090 GN=Ext2 PE=1 SV=2 g10784.t1 Q6NXH8 39.931 288 5.32e-57 207.0 sp|Q6NXH8|MET25_MOUSE Probable methyltransferase-like protein 25 OS=Mus musculus OX=10090 GN=Mettl25 PE=2 SV=1 g10786.t1 Q8TCG1 40.936 855 0.0 595.0 sp|Q8TCG1|CIP2A_HUMAN Protein CIP2A OS=Homo sapiens OX=9606 GN=CIP2A PE=1 SV=2 CIP2A_HUMAN reviewed Protein CIP2A (Cancerous inhibitor of PP2A) (p90 autoantigen) Homo sapiens (Human) GO:0004864; GO:0005694; GO:0005737; GO:0005813; GO:0005829; GO:0005886; GO:0006974; GO:0036064; GO:0042803; GO:0045296; GO:0051276; GO:0141112 broken chromosome clustering [GO:0141112]; chromosome organization [GO:0051276]; DNA damage response [GO:0006974] centrosome [GO:0005813]; chromosome [GO:0005694]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886] cadherin binding [GO:0045296]; protein homodimerization activity [GO:0042803]; protein phosphatase inhibitor activity [GO:0004864] g10788.t1 Q9Y5X5 25.676 296 2.19e-23 103.0 sp|Q9Y5X5|NPFF2_HUMAN Neuropeptide FF receptor 2 OS=Homo sapiens OX=9606 GN=NPFFR2 PE=1 SV=2 NPFF2_HUMAN reviewed Neuropeptide FF receptor 2 (G-protein coupled receptor 74) (G-protein coupled receptor HLWAR77) (Neuropeptide G-protein coupled receptor) Homo sapiens (Human) GO:0004930; GO:0005886; GO:0007186; GO:0007218; GO:0008188; GO:0009582; GO:0015629; GO:0031628; GO:0032870; GO:0043408 cellular response to hormone stimulus [GO:0032870]; detection of abiotic stimulus [GO:0009582]; G protein-coupled receptor signaling pathway [GO:0007186]; neuropeptide signaling pathway [GO:0007218]; regulation of MAPK cascade [GO:0043408] actin cytoskeleton [GO:0015629]; plasma membrane [GO:0005886] G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; opioid receptor binding [GO:0031628] g10789.t1 P0CB85 46.951 164 7.66e-38 131.0 sp|P0CB85|NDUB8_PONAB NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 8, mitochondrial OS=Pongo abelii OX=9601 GN=NDUFB8 PE=2 SV=1 g10790.t1 Q6P2X9 23.718 468 1.49e-35 140.0 sp|Q6P2X9|MOT12_XENTR Monocarboxylate transporter 12 OS=Xenopus tropicalis OX=8364 GN=slc16a12 PE=2 SV=1 g10793.t1 Q68EF4 28.14 860 1.14e-105 350.0 sp|Q68EF4|GRM4_MOUSE Metabotropic glutamate receptor 4 OS=Mus musculus OX=10090 GN=Grm4 PE=1 SV=2 GRM4_MOUSE reviewed Metabotropic glutamate receptor 4 (mGluR4) Mus musculus (Mouse) GO:0001640; GO:0001642; GO:0004930; GO:0005516; GO:0005886; GO:0007193; GO:0007196; GO:0007216; GO:0007268; GO:0007612; GO:0008066; GO:0031410; GO:0043005; GO:0043195; GO:0043198; GO:0043410; GO:0048306; GO:0048787; GO:0051966; GO:0098688; GO:0098978; GO:0099171; GO:0150048 adenylate cyclase-inhibiting G protein-coupled glutamate receptor signaling pathway [GO:0007196]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; chemical synaptic transmission [GO:0007268]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; learning [GO:0007612]; positive regulation of MAPK cascade [GO:0043410]; presynaptic modulation of chemical synaptic transmission [GO:0099171]; regulation of synaptic transmission, glutamatergic [GO:0051966] cerebellar granule cell to Purkinje cell synapse [GO:0150048]; cytoplasmic vesicle [GO:0031410]; dendritic shaft [GO:0043198]; glutamatergic synapse [GO:0098978]; neuron projection [GO:0043005]; parallel fiber to Purkinje cell synapse [GO:0098688]; plasma membrane [GO:0005886]; presynaptic active zone membrane [GO:0048787]; terminal bouton [GO:0043195] adenylate cyclase inhibiting G protein-coupled glutamate receptor activity [GO:0001640]; calcium-dependent protein binding [GO:0048306]; calmodulin binding [GO:0005516]; G protein-coupled receptor activity [GO:0004930]; glutamate receptor activity [GO:0008066]; group III metabotropic glutamate receptor activity [GO:0001642] g10803.t1 A7J1T0 61.245 498 0.0 608.0 sp|A7J1T0|M313B_XENLA Mitogen-activated protein kinase kinase kinase 13-B OS=Xenopus laevis OX=8355 GN=map3k13-b PE=2 SV=1 M313B_XENLA reviewed Mitogen-activated protein kinase kinase kinase 13-B (EC 2.7.11.25) Xenopus laevis (African clawed frog) GO:0004674; GO:0004709; GO:0005524; GO:0005737; GO:0007254; GO:0016020; GO:0051403; GO:0106310 JNK cascade [GO:0007254]; stress-activated MAPK cascade [GO:0051403] cytoplasm [GO:0005737]; membrane [GO:0016020] ATP binding [GO:0005524]; MAP kinase kinase kinase activity [GO:0004709]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g10805.t1 Q9UM22 44.886 176 3.9e-50 168.0 sp|Q9UM22|EPDR1_HUMAN Mammalian ependymin-related protein 1 OS=Homo sapiens OX=9606 GN=EPDR1 PE=1 SV=2 g10807.t1 Q9NSI2 41.27 126 1.57e-22 94.7 sp|Q9NSI2|SLX9_HUMAN Ribosome biogenesis protein SLX9 homolog OS=Homo sapiens OX=9606 GN=SLX9 PE=1 SV=2 g10809.t1 P31327 65.475 1454 0.0 1976.0 sp|P31327|CPSM_HUMAN Carbamoyl-phosphate synthase [ammonia], mitochondrial OS=Homo sapiens OX=9606 GN=CPS1 PE=1 SV=2 CPSM_HUMAN reviewed Carbamoyl-phosphate synthase [ammonia], mitochondrial (EC 6.3.4.16) (Carbamoyl-phosphate synthetase I) (CPSase I) Homo sapiens (Human) GO:0000050; GO:0004087; GO:0004088; GO:0004175; GO:0005509; GO:0005524; GO:0005543; GO:0005730; GO:0005737; GO:0005739; GO:0005743; GO:0005759; GO:0005829; GO:0005886; GO:0006207; GO:0006541; GO:0007494; GO:0009410; GO:0009636; GO:0010043; GO:0014075; GO:0016595; GO:0019240; GO:0019433; GO:0030955; GO:0032094; GO:0032496; GO:0032991; GO:0036094; GO:0042311; GO:0042594; GO:0042645; GO:0043200; GO:0044344; GO:0044877; GO:0046209; GO:0046872; GO:0050667; GO:0055081; GO:0060416; GO:0070365; GO:0070409; GO:0071242; GO:0071320; GO:0071377; GO:0071400; GO:0071548; GO:0072341; GO:0097225; GO:0097228; GO:0097305 'de novo' pyrimidine nucleobase biosynthetic process [GO:0006207]; carbamoyl phosphate biosynthetic process [GO:0070409]; cellular response to ammonium ion [GO:0071242]; cellular response to cAMP [GO:0071320]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to glucagon stimulus [GO:0071377]; cellular response to oleic acid [GO:0071400]; citrulline biosynthetic process [GO:0019240]; glutamine metabolic process [GO:0006541]; hepatocyte differentiation [GO:0070365]; homocysteine metabolic process [GO:0050667]; midgut development [GO:0007494]; monoatomic anion homeostasis [GO:0055081]; nitric oxide metabolic process [GO:0046209]; response to alcohol [GO:0097305]; response to amine [GO:0014075]; response to amino acid [GO:0043200]; response to dexamethasone [GO:0071548]; response to food [GO:0032094]; response to growth hormone [GO:0060416]; response to lipopolysaccharide [GO:0032496]; response to starvation [GO:0042594]; response to toxic substance [GO:0009636]; response to xenobiotic stimulus [GO:0009410]; response to zinc ion [GO:0010043]; triglyceride catabolic process [GO:0019433]; urea cycle [GO:0000050]; vasodilation [GO:0042311] cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; sperm midpiece [GO:0097225]; sperm principal piece [GO:0097228] ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; carbamoyl-phosphate synthase (ammonia) activity [GO:0004087]; carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity [GO:0004088]; endopeptidase activity [GO:0004175]; glutamate binding [GO:0016595]; metal ion binding [GO:0046872]; modified amino acid binding [GO:0072341]; phospholipid binding [GO:0005543]; potassium ion binding [GO:0030955]; protein-containing complex binding [GO:0044877]; small molecule binding [GO:0036094] g10810.t1 Q66KG5 62.791 430 0.0 549.0 sp|Q66KG5|GMPAB_XENLA Mannose-1-phosphate guanyltransferase alpha-B OS=Xenopus laevis OX=8355 GN=gmppa-b PE=2 SV=1 g10810.t2 Q0VFM6 61.176 425 0.0 533.0 sp|Q0VFM6|GMPPA_XENTR Mannose-1-phosphate guanylyltransferase regulatory subunit alpha OS=Xenopus tropicalis OX=8364 GN=gmppa PE=2 SV=1 g10811.t1 Q8VHQ2 59.88 167 3.17e-51 194.0 sp|Q8VHQ2|SOCS7_MOUSE Suppressor of cytokine signaling 7 OS=Mus musculus OX=10090 GN=Socs7 PE=1 SV=1 SOCS7_MOUSE reviewed Suppressor of cytokine signaling 7 (SOCS-7) Mus musculus (Mouse) GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0008286; GO:0009968; GO:0016567; GO:0021799; GO:0021819; GO:0021942; GO:0031466; GO:0035556; GO:0035591; GO:0043161; GO:0045444; GO:0140031; GO:1990756 cerebral cortex radially oriented cell migration [GO:0021799]; fat cell differentiation [GO:0045444]; insulin receptor signaling pathway [GO:0008286]; intracellular signal transduction [GO:0035556]; layer formation in cerebral cortex [GO:0021819]; negative regulation of signal transduction [GO:0009968]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; radial glia guided migration of Purkinje cell [GO:0021942] Cul5-RING ubiquitin ligase complex [GO:0031466]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886] phosphorylation-dependent protein binding [GO:0140031]; signaling adaptor activity [GO:0035591]; ubiquitin-like ligase-substrate adaptor activity [GO:1990756] g10812.t1 Q3TBW2 33.478 230 6.07e-33 123.0 sp|Q3TBW2|RM10_MOUSE Large ribosomal subunit protein uL10m OS=Mus musculus OX=10090 GN=Mrpl10 PE=1 SV=2 g10813.t1 Q6WQJ1 43.931 173 4.89e-43 157.0 sp|Q6WQJ1|DGLA_MOUSE Diacylglycerol lipase-alpha OS=Mus musculus OX=10090 GN=Dagla PE=1 SV=2 DGLA_MOUSE reviewed Diacylglycerol lipase-alpha (DAGL-alpha) (DGL-alpha) (EC 3.1.1.116) (Neural stem cell-derived dendrite regulator) (Sn1-specific diacylglycerol lipase alpha) Mus musculus (Mouse) GO:0004465; GO:0005737; GO:0005886; GO:0007405; GO:0016787; GO:0019369; GO:0022008; GO:0031901; GO:0032590; GO:0032591; GO:0043196; GO:0045211; GO:0046340; GO:0046872; GO:0047372; GO:0098839; GO:0098921; GO:0150077; GO:1901696 arachidonate metabolic process [GO:0019369]; cannabinoid biosynthetic process [GO:1901696]; diacylglycerol catabolic process [GO:0046340]; neuroblast proliferation [GO:0007405]; neurogenesis [GO:0022008]; regulation of neuroinflammatory response [GO:0150077]; retrograde trans-synaptic signaling by endocannabinoid [GO:0098921] cytoplasm [GO:0005737]; dendrite membrane [GO:0032590]; dendritic spine membrane [GO:0032591]; early endosome membrane [GO:0031901]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; postsynaptic membrane [GO:0045211]; varicosity [GO:0043196] hydrolase activity [GO:0016787]; lipoprotein lipase activity [GO:0004465]; metal ion binding [GO:0046872]; monoacylglycerol lipase activity [GO:0047372] g10816.t1 Q9Y4D2 49.832 297 7.41e-86 300.0 sp|Q9Y4D2|DGLA_HUMAN Diacylglycerol lipase-alpha OS=Homo sapiens OX=9606 GN=DAGLA PE=1 SV=3 g10816.t2 Q9Y4D2 49.832 297 1.37e-87 299.0 sp|Q9Y4D2|DGLA_HUMAN Diacylglycerol lipase-alpha OS=Homo sapiens OX=9606 GN=DAGLA PE=1 SV=3 g10824.t1 Q7Z5V6 32.967 455 1.1900000000000001e-64 218.0 sp|Q7Z5V6|SAXO4_HUMAN Stabilizer of axonemal microtubules 4 OS=Homo sapiens OX=9606 GN=SAXO4 PE=1 SV=1 SAXO4_HUMAN reviewed Stabilizer of axonemal microtubules 4 (Protein phosphatase 1 regulatory subunit 32) Homo sapiens (Human) GO:0005737; GO:0019902; GO:0030317; GO:0036064; GO:0036126; GO:0160111 flagellated sperm motility [GO:0030317] axonemal A tubule inner sheath [GO:0160111]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; sperm flagellum [GO:0036126] phosphatase binding [GO:0019902] g10825.t1 Q75J93 27.057 547 2e-51 195.0 sp|Q75J93|CPAS1_DICDI Circularly permutated Ras protein 1 OS=Dictyostelium discoideum OX=44689 GN=cpras1 PE=3 SV=1 g10825.t2 Q75J93 27.057 547 2.29e-51 195.0 sp|Q75J93|CPAS1_DICDI Circularly permutated Ras protein 1 OS=Dictyostelium discoideum OX=44689 GN=cpras1 PE=3 SV=1 g10828.t1 Q17DK5 51.828 465 8.350000000000001e-166 481.0 sp|Q17DK5|CRY1_AEDAE Cryptochrome-1 OS=Aedes aegypti OX=7159 GN=cry PE=3 SV=1 g10829.t1 Q12996 68.296 716 0.0 990.0 sp|Q12996|CSTF3_HUMAN Cleavage stimulation factor subunit 3 OS=Homo sapiens OX=9606 GN=CSTF3 PE=1 SV=1 CSTF3_HUMAN reviewed Cleavage stimulation factor subunit 3 (CF-1 77 kDa subunit) (Cleavage stimulation factor 77 kDa subunit) (CSTF 77 kDa subunit) (CstF-77) Homo sapiens (Human) GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0005848; GO:0031123; GO:0180010 co-transcriptional mRNA 3'-end processing, cleavage and polyadenylation pathway [GO:0180010]; RNA 3'-end processing [GO:0031123] mRNA cleavage stimulating factor complex [GO:0005848]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] mRNA binding [GO:0003729]; RNA binding [GO:0003723] g10830.t1 Q5RGJ6 47.895 190 2.9599999999999998e-53 172.0 sp|Q5RGJ6|WASC3_DANRE WASH complex subunit 3 OS=Danio rerio OX=7955 GN=washc3 PE=2 SV=1 g10831.t1 Q8QG61 67.814 494 0.0 719.0 sp|Q8QG61|CRY1_CHICK Cryptochrome-1 OS=Gallus gallus OX=9031 GN=CRY1 PE=2 SV=1 g10833.t1 Q9UPX8 38.599 671 2.31e-125 437.0 sp|Q9UPX8|SHAN2_HUMAN SH3 and multiple ankyrin repeat domains protein 2 OS=Homo sapiens OX=9606 GN=SHANK2 PE=1 SV=4 g10833.t2 Q9UPX8 36.434 774 9.109999999999999e-126 438.0 sp|Q9UPX8|SHAN2_HUMAN SH3 and multiple ankyrin repeat domains protein 2 OS=Homo sapiens OX=9606 GN=SHANK2 PE=1 SV=4 g10833.t3 Q9UPX8 38.599 671 4.83e-125 436.0 sp|Q9UPX8|SHAN2_HUMAN SH3 and multiple ankyrin repeat domains protein 2 OS=Homo sapiens OX=9606 GN=SHANK2 PE=1 SV=4 g10836.t1 Q8BGR8 46.296 108 1.2799999999999999e-28 105.0 sp|Q8BGR8|GSKIP_MOUSE GSK3B-interacting protein OS=Mus musculus OX=10090 GN=Gskip PE=2 SV=1 g10837.t1 Q5BKH5 35.0 160 2.75e-30 110.0 sp|Q5BKH5|PRLD2_XENTR PRELI domain-containing protein 2 OS=Xenopus tropicalis OX=8364 GN=prelid2 PE=2 SV=1 g10838.t1 P26256 52.564 312 1.39e-94 303.0 sp|P26256|ANX12_HYDVU Annexin-B12 OS=Hydra vulgaris OX=6087 GN=ANXB12 PE=1 SV=1 g10840.t1 Q8CGU9 63.768 414 0.0 541.0 sp|Q8CGU9|TPH2_RAT Tryptophan 5-hydroxylase 2 OS=Rattus norvegicus OX=10116 GN=Tph2 PE=1 SV=1 TPH2_RAT reviewed Tryptophan 5-hydroxylase 2 (EC 1.14.16.4) (Neuronal tryptophan hydroxylase) (Tryptophan 5-monooxygenase 2) Rattus norvegicus (Rat) GO:0004510; GO:0005506; GO:0007623; GO:0009072; GO:0014823; GO:0030424; GO:0031667; GO:0042427; GO:0043005; GO:0043025; GO:0043627; GO:0051384; GO:0051592; GO:0071285 aromatic amino acid metabolic process [GO:0009072]; cellular response to lithium ion [GO:0071285]; circadian rhythm [GO:0007623]; response to activity [GO:0014823]; response to calcium ion [GO:0051592]; response to estrogen [GO:0043627]; response to glucocorticoid [GO:0051384]; response to nutrient levels [GO:0031667]; serotonin biosynthetic process [GO:0042427] axon [GO:0030424]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025] iron ion binding [GO:0005506]; tryptophan 5-monooxygenase activity [GO:0004510] g10841.t1 P35992 44.536 485 1.28e-112 401.0 sp|P35992|PTP10_DROME Tyrosine-protein phosphatase 10D OS=Drosophila melanogaster OX=7227 GN=Ptp10D PE=1 SV=4 g10842.t1 P20611 45.576 373 7.04e-108 328.0 sp|P20611|PPAL_RAT Lysosomal acid phosphatase OS=Rattus norvegicus OX=10116 GN=Acp2 PE=1 SV=1 PPAL_RAT reviewed Lysosomal acid phosphatase (LAP) (EC 3.1.3.2) Rattus norvegicus (Rat) GO:0001501; GO:0001784; GO:0003993; GO:0004721; GO:0005764; GO:0005765; GO:0007040; GO:0007268; GO:0043202; GO:0045202; GO:0048102; GO:0070305 autophagic cell death [GO:0048102]; chemical synaptic transmission [GO:0007268]; lysosome organization [GO:0007040]; response to cGMP [GO:0070305]; skeletal system development [GO:0001501] lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; synapse [GO:0045202] acid phosphatase activity [GO:0003993]; phosphoprotein phosphatase activity [GO:0004721]; phosphotyrosine residue binding [GO:0001784] g10843.t1 Q9EQC4 56.327 245 8.779999999999999e-98 292.0 sp|Q9EQC4|ELOV4_MOUSE Very long chain fatty acid elongase 4 OS=Mus musculus OX=10090 GN=Elovl4 PE=1 SV=2 ELOV4_MOUSE reviewed Very long chain fatty acid elongase 4 (EC 2.3.1.199) (3-keto acyl-CoA synthase Elovl4) (ELOVL fatty acid elongase 4) (ELOVL FA elongase 4) (Elongation of very long chain fatty acids protein 4) (Very long chain 3-ketoacyl-CoA synthase 4) (Very long chain 3-oxoacyl-CoA synthase 4) Mus musculus (Mouse) GO:0005783; GO:0005789; GO:0006636; GO:0009922; GO:0019367; GO:0030148; GO:0034625; GO:0034626; GO:0035338; GO:0042761; GO:0061886; GO:0097151; GO:1990926 fatty acid elongation, monounsaturated fatty acid [GO:0034625]; fatty acid elongation, polyunsaturated fatty acid [GO:0034626]; fatty acid elongation, saturated fatty acid [GO:0019367]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; negative regulation of mini excitatory postsynaptic potential [GO:0061886]; positive regulation of inhibitory postsynaptic potential [GO:0097151]; short-term synaptic potentiation [GO:1990926]; sphingolipid biosynthetic process [GO:0030148]; unsaturated fatty acid biosynthetic process [GO:0006636]; very long-chain fatty acid biosynthetic process [GO:0042761] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789] fatty acid elongase activity [GO:0009922] g10845.t1 P97411 62.799 293 1.25e-123 376.0 sp|P97411|ICA69_MOUSE Islet cell autoantigen 1 OS=Mus musculus OX=10090 GN=Ica1 PE=1 SV=3 ICA69_MOUSE reviewed Islet cell autoantigen 1 (69 kDa islet cell autoantigen) (ICA69) (Islet cell autoantigen p69) (ICAp69) (p69) Mus musculus (Mouse) GO:0000139; GO:0005795; GO:0005829; GO:0006836; GO:0019904; GO:0030425; GO:0030667; GO:0030672; GO:0043254; GO:0046928; GO:0048471; GO:0051046; GO:0097753; GO:0140090 membrane bending [GO:0097753]; neurotransmitter transport [GO:0006836]; regulation of neurotransmitter secretion [GO:0046928]; regulation of protein-containing complex assembly [GO:0043254]; regulation of secretion [GO:0051046] cytosol [GO:0005829]; dendrite [GO:0030425]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; perinuclear region of cytoplasm [GO:0048471]; secretory granule membrane [GO:0030667]; synaptic vesicle membrane [GO:0030672] membrane curvature sensor activity [GO:0140090]; protein domain specific binding [GO:0019904] g10845.t2 P97411 62.799 293 1.7500000000000003e-123 376.0 sp|P97411|ICA69_MOUSE Islet cell autoantigen 1 OS=Mus musculus OX=10090 GN=Ica1 PE=1 SV=3 ICA69_MOUSE reviewed Islet cell autoantigen 1 (69 kDa islet cell autoantigen) (ICA69) (Islet cell autoantigen p69) (ICAp69) (p69) Mus musculus (Mouse) GO:0000139; GO:0005795; GO:0005829; GO:0006836; GO:0019904; GO:0030425; GO:0030667; GO:0030672; GO:0043254; GO:0046928; GO:0048471; GO:0051046; GO:0097753; GO:0140090 membrane bending [GO:0097753]; neurotransmitter transport [GO:0006836]; regulation of neurotransmitter secretion [GO:0046928]; regulation of protein-containing complex assembly [GO:0043254]; regulation of secretion [GO:0051046] cytosol [GO:0005829]; dendrite [GO:0030425]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; perinuclear region of cytoplasm [GO:0048471]; secretory granule membrane [GO:0030667]; synaptic vesicle membrane [GO:0030672] membrane curvature sensor activity [GO:0140090]; protein domain specific binding [GO:0019904] g10846.t1 Q9WV76 42.061 592 1.92e-157 479.0 sp|Q9WV76|AP4B1_MOUSE AP-4 complex subunit beta-1 OS=Mus musculus OX=10090 GN=Ap4b1 PE=1 SV=2 AP4B1_MOUSE reviewed AP-4 complex subunit beta-1 (AP-4 adaptor complex subunit beta) (Adaptor-related protein complex 4 subunit beta-1) (Beta subunit of AP-4) (Beta4-adaptin) Mus musculus (Mouse) GO:0005802; GO:0005829; GO:0006605; GO:0006886; GO:0016192; GO:0030124; GO:0030131; GO:0030276; GO:0061938; GO:0098541 intracellular protein transport [GO:0006886]; protein localization to somatodendritic compartment [GO:0061938]; protein targeting [GO:0006605]; vesicle-mediated transport [GO:0016192] AP-4 adaptor complex [GO:0030124]; clathrin adaptor complex [GO:0030131]; cytoplasmic side of trans-Golgi network transport vesicle membrane [GO:0098541]; cytosol [GO:0005829]; trans-Golgi network [GO:0005802] clathrin binding [GO:0030276] g10847.t1 O35348 33.333 369 1.29e-29 125.0 sp|O35348|COLQ_MOUSE Acetylcholinesterase collagenic tail peptide OS=Mus musculus OX=10090 GN=Colq PE=2 SV=2 g10847.t2 Q03637 32.464 345 3.24e-35 142.0 sp|Q03637|COLQ_TORMA Acetylcholinesterase collagenic tail peptide OS=Torpedo marmorata OX=7788 PE=1 SV=1 g10849.t1 Q8BX79 25.688 327 3.3099999999999997e-23 102.0 sp|Q8BX79|GPR21_MOUSE Probable G-protein coupled receptor 21 OS=Mus musculus OX=10090 GN=Gpr21 PE=2 SV=1 g10850.t1 P51954 49.802 253 1.98e-77 273.0 sp|P51954|NEK1_MOUSE Serine/threonine-protein kinase Nek1 OS=Mus musculus OX=10090 GN=Nek1 PE=1 SV=2 NEK1_MOUSE reviewed Serine/threonine-protein kinase Nek1 (EC 2.7.11.1) (Never in mitosis A-related kinase 1) (NimA-related protein kinase 1) Mus musculus (Mouse) GO:0000242; GO:0001822; GO:0004672; GO:0004674; GO:0004713; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005929; GO:0006974; GO:0007283; GO:0010212; GO:0016301; GO:0034451; GO:0035264; GO:0046872; GO:0051301; GO:0060271; GO:0071889; GO:0106310; GO:2000001 cell division [GO:0051301]; cilium assembly [GO:0060271]; DNA damage response [GO:0006974]; kidney development [GO:0001822]; multicellular organism growth [GO:0035264]; regulation of DNA damage checkpoint [GO:2000001]; response to ionizing radiation [GO:0010212]; spermatogenesis [GO:0007283] centriolar satellite [GO:0034451]; centrosome [GO:0005813]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pericentriolar material [GO:0000242] 14-3-3 protein binding [GO:0071889]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713] g10852.t1 P43006 52.072 555 7.740000000000001e-161 473.0 sp|P43006|EAA2_MOUSE Excitatory amino acid transporter 2 OS=Mus musculus OX=10090 GN=Slc1a2 PE=1 SV=1 EAA2_MOUSE reviewed Excitatory amino acid transporter 2 (GLT-1) (Sodium-dependent glutamate/aspartate transporter 2) (Solute carrier family 1 member 2) Mus musculus (Mouse) GO:0005313; GO:0005314; GO:0005886; GO:0006750; GO:0007399; GO:0007632; GO:0008509; GO:0009410; GO:0009416; GO:0009611; GO:0009986; GO:0015175; GO:0015501; GO:0015813; GO:0016020; GO:0021537; GO:0030424; GO:0030534; GO:0030673; GO:0031982; GO:0033229; GO:0035264; GO:0042734; GO:0043197; GO:0043198; GO:0043200; GO:0044297; GO:0044306; GO:0045121; GO:0045202; GO:0046326; GO:0046872; GO:0070207; GO:0070778; GO:0070779; GO:0071314; GO:0097449; GO:0098656; GO:0098712; GO:0098796; GO:0098810; GO:0098978; GO:0140009 adult behavior [GO:0030534]; cellular response to cocaine [GO:0071314]; D-aspartate import across plasma membrane [GO:0070779]; glutathione biosynthetic process [GO:0006750]; L-aspartate import across plasma membrane [GO:0140009]; L-aspartate transmembrane transport [GO:0070778]; L-glutamate import across plasma membrane [GO:0098712]; L-glutamate transmembrane transport [GO:0015813]; monoatomic anion transmembrane transport [GO:0098656]; multicellular organism growth [GO:0035264]; nervous system development [GO:0007399]; neurotransmitter reuptake [GO:0098810]; positive regulation of D-glucose import [GO:0046326]; protein homotrimerization [GO:0070207]; response to amino acid [GO:0043200]; response to light stimulus [GO:0009416]; response to wounding [GO:0009611]; response to xenobiotic stimulus [GO:0009410]; telencephalon development [GO:0021537]; visual behavior [GO:0007632] astrocyte projection [GO:0097449]; axolemma [GO:0030673]; axon [GO:0030424]; cell body [GO:0044297]; cell surface [GO:0009986]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; membrane protein complex [GO:0098796]; membrane raft [GO:0045121]; neuron projection terminus [GO:0044306]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; synapse [GO:0045202]; vesicle [GO:0031982] cysteine transmembrane transporter activity [GO:0033229]; glutamate:sodium symporter activity [GO:0015501]; high-affinity L-glutamate transmembrane transporter activity [GO:0005314]; L-glutamate transmembrane transporter activity [GO:0005313]; metal ion binding [GO:0046872]; monoatomic anion transmembrane transporter activity [GO:0008509]; neutral L-amino acid transmembrane transporter activity [GO:0015175] g10853.t1 Q6QNK2 31.902 489 1.83e-64 228.0 sp|Q6QNK2|AGRD1_HUMAN Adhesion G-protein coupled receptor D1 OS=Homo sapiens OX=9606 GN=ADGRD1 PE=1 SV=1 AGRD1_HUMAN reviewed Adhesion G-protein coupled receptor D1 (G-protein coupled receptor 133) (G-protein coupled receptor PGR25) [Cleaved into: Adhesion G-protein coupled receptor D1, N-terminal fragment (ADGRD1 N-terminal fragment); Adhesion G-protein coupled receptor D1, C-terminal fragment (ADGRD1 C-terminal fragment)] Homo sapiens (Human) GO:0004930; GO:0005654; GO:0005829; GO:0005886; GO:0007166; GO:0007186; GO:0007189; GO:0014819; GO:0016020; GO:0016607 adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186]; regulation of skeletal muscle contraction [GO:0014819] cytosol [GO:0005829]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] G protein-coupled receptor activity [GO:0004930] g10857.t3 Q8IVL1 50.332 904 0.0 737.0 sp|Q8IVL1|NAV2_HUMAN Neuron navigator 2 OS=Homo sapiens OX=9606 GN=NAV2 PE=1 SV=3 g10857.t4 Q8IVL1 53.064 767 0.0 692.0 sp|Q8IVL1|NAV2_HUMAN Neuron navigator 2 OS=Homo sapiens OX=9606 GN=NAV2 PE=1 SV=3 g10858.t1 Q6IQ26 47.132 1360 0.0 1164.0 sp|Q6IQ26|DEN5A_HUMAN DENN domain-containing protein 5A OS=Homo sapiens OX=9606 GN=DENND5A PE=1 SV=2 DEN5A_HUMAN reviewed DENN domain-containing protein 5A (Rab6-interacting protein 1) (Rab6IP1) Homo sapiens (Human) GO:0000139; GO:0005085; GO:0005802; GO:0005829; GO:0010977; GO:0031267; GO:0042147 negative regulation of neuron projection development [GO:0010977]; retrograde transport, endosome to Golgi [GO:0042147] cytosol [GO:0005829]; Golgi membrane [GO:0000139]; trans-Golgi network [GO:0005802] guanyl-nucleotide exchange factor activity [GO:0005085]; small GTPase binding [GO:0031267] g10858.t2 Q6IQ26 46.171 1384 0.0 1145.0 sp|Q6IQ26|DEN5A_HUMAN DENN domain-containing protein 5A OS=Homo sapiens OX=9606 GN=DENND5A PE=1 SV=2 DEN5A_HUMAN reviewed DENN domain-containing protein 5A (Rab6-interacting protein 1) (Rab6IP1) Homo sapiens (Human) GO:0000139; GO:0005085; GO:0005802; GO:0005829; GO:0010977; GO:0031267; GO:0042147 negative regulation of neuron projection development [GO:0010977]; retrograde transport, endosome to Golgi [GO:0042147] cytosol [GO:0005829]; Golgi membrane [GO:0000139]; trans-Golgi network [GO:0005802] guanyl-nucleotide exchange factor activity [GO:0005085]; small GTPase binding [GO:0031267] g10860.t1 Q8CGC6 38.106 454 1.79e-63 229.0 sp|Q8CGC6|RBM28_MOUSE RNA-binding protein 28 OS=Mus musculus OX=10090 GN=Rbm28 PE=1 SV=4 g10861.t1 P30536 40.127 157 5.51e-34 120.0 sp|P30536|TSPO_HUMAN Translocator protein OS=Homo sapiens OX=9606 GN=TSPO PE=1 SV=3 TSPO_HUMAN reviewed Translocator protein (Mitochondrial benzodiazepine receptor) (PKBS) (Peripheral-type benzodiazepine receptor) (PBR) Homo sapiens (Human) GO:0005497; GO:0005739; GO:0005741; GO:0005829; GO:0006626; GO:0006700; GO:0006783; GO:0006820; GO:0006821; GO:0008202; GO:0008347; GO:0008503; GO:0009410; GO:0010042; GO:0010266; GO:0014012; GO:0015485; GO:0016020; GO:0030325; GO:0031397; GO:0032374; GO:0032570; GO:0032720; GO:0033574; GO:0042127; GO:0042632; GO:0043065; GO:0044325; GO:0045019; GO:0048266; GO:0050810; GO:0051901; GO:0051928; GO:0060242; GO:0060252; GO:0060253; GO:0062100; GO:0070062; GO:0071222; GO:0071294; GO:0071476; GO:0072656; GO:0120020; GO:1901525; GO:1903579; GO:1905144; GO:2000379; GO:2000853 adrenal gland development [GO:0030325]; behavioral response to pain [GO:0048266]; C21-steroid hormone biosynthetic process [GO:0006700]; cellular hypotonic response [GO:0071476]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to zinc ion [GO:0071294]; chloride transport [GO:0006821]; cholesterol homeostasis [GO:0042632]; contact inhibition [GO:0060242]; glial cell migration [GO:0008347]; heme biosynthetic process [GO:0006783]; maintenance of protein location in mitochondrion [GO:0072656]; monoatomic anion transport [GO:0006820]; negative regulation of ATP metabolic process [GO:1903579]; negative regulation of corticosterone secretion [GO:2000853]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of mitophagy [GO:1901525]; negative regulation of nitric oxide biosynthetic process [GO:0045019]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of tumor necrosis factor production [GO:0032720]; peripheral nervous system axon regeneration [GO:0014012]; positive regulation of apoptotic process [GO:0043065]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of glial cell proliferation [GO:0060252]; positive regulation of mitochondrial depolarization [GO:0051901]; positive regulation of programmed necrotic cell death [GO:0062100]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; protein targeting to mitochondrion [GO:0006626]; regulation of cell population proliferation [GO:0042127]; regulation of cholesterol transport [GO:0032374]; regulation of steroid biosynthetic process [GO:0050810]; response to acetylcholine [GO:1905144]; response to manganese ion [GO:0010042]; response to progesterone [GO:0032570]; response to testosterone [GO:0033574]; response to vitamin B1 [GO:0010266]; response to xenobiotic stimulus [GO:0009410]; steroid metabolic process [GO:0008202] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739] androgen binding [GO:0005497]; benzodiazepine receptor activity [GO:0008503]; cholesterol binding [GO:0015485]; cholesterol transfer activity [GO:0120020]; transmembrane transporter binding [GO:0044325] g10862.t1 P30536 38.028 142 7.74e-26 99.8 sp|P30536|TSPO_HUMAN Translocator protein OS=Homo sapiens OX=9606 GN=TSPO PE=1 SV=3 TSPO_HUMAN reviewed Translocator protein (Mitochondrial benzodiazepine receptor) (PKBS) (Peripheral-type benzodiazepine receptor) (PBR) Homo sapiens (Human) GO:0005497; GO:0005739; GO:0005741; GO:0005829; GO:0006626; GO:0006700; GO:0006783; GO:0006820; GO:0006821; GO:0008202; GO:0008347; GO:0008503; GO:0009410; GO:0010042; GO:0010266; GO:0014012; GO:0015485; GO:0016020; GO:0030325; GO:0031397; GO:0032374; GO:0032570; GO:0032720; GO:0033574; GO:0042127; GO:0042632; GO:0043065; GO:0044325; GO:0045019; GO:0048266; GO:0050810; GO:0051901; GO:0051928; GO:0060242; GO:0060252; GO:0060253; GO:0062100; GO:0070062; GO:0071222; GO:0071294; GO:0071476; GO:0072656; GO:0120020; GO:1901525; GO:1903579; GO:1905144; GO:2000379; GO:2000853 adrenal gland development [GO:0030325]; behavioral response to pain [GO:0048266]; C21-steroid hormone biosynthetic process [GO:0006700]; cellular hypotonic response [GO:0071476]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to zinc ion [GO:0071294]; chloride transport [GO:0006821]; cholesterol homeostasis [GO:0042632]; contact inhibition [GO:0060242]; glial cell migration [GO:0008347]; heme biosynthetic process [GO:0006783]; maintenance of protein location in mitochondrion [GO:0072656]; monoatomic anion transport [GO:0006820]; negative regulation of ATP metabolic process [GO:1903579]; negative regulation of corticosterone secretion [GO:2000853]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of mitophagy [GO:1901525]; negative regulation of nitric oxide biosynthetic process [GO:0045019]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of tumor necrosis factor production [GO:0032720]; peripheral nervous system axon regeneration [GO:0014012]; positive regulation of apoptotic process [GO:0043065]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of glial cell proliferation [GO:0060252]; positive regulation of mitochondrial depolarization [GO:0051901]; positive regulation of programmed necrotic cell death [GO:0062100]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; protein targeting to mitochondrion [GO:0006626]; regulation of cell population proliferation [GO:0042127]; regulation of cholesterol transport [GO:0032374]; regulation of steroid biosynthetic process [GO:0050810]; response to acetylcholine [GO:1905144]; response to manganese ion [GO:0010042]; response to progesterone [GO:0032570]; response to testosterone [GO:0033574]; response to vitamin B1 [GO:0010266]; response to xenobiotic stimulus [GO:0009410]; steroid metabolic process [GO:0008202] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739] androgen binding [GO:0005497]; benzodiazepine receptor activity [GO:0008503]; cholesterol binding [GO:0015485]; cholesterol transfer activity [GO:0120020]; transmembrane transporter binding [GO:0044325] g10863.t1 Q8C8M1 47.748 222 1.4999999999999998e-60 195.0 sp|Q8C8M1|SHCAF_MOUSE SIN3-HDAC complex-associated factor OS=Mus musculus OX=10090 GN=Sinhcaf PE=1 SV=1 SHCAF_MOUSE reviewed SIN3-HDAC complex-associated factor (Protein FAM60A) (Tera protein) Mus musculus (Mouse) GO:0000122; GO:0005634; GO:0008284; GO:0030336; GO:0030512; GO:0045596; GO:0070822; GO:1902455; GO:1902459 negative regulation of cell differentiation [GO:0045596]; negative regulation of cell migration [GO:0030336]; negative regulation of stem cell population maintenance [GO:1902455]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of stem cell population maintenance [GO:1902459] nucleus [GO:0005634]; Sin3-type complex [GO:0070822] g10864.t1 Q5F471 46.516 531 1.8600000000000002e-144 439.0 sp|Q5F471|PP6R3_CHICK Serine/threonine-protein phosphatase 6 regulatory subunit 3 OS=Gallus gallus OX=9031 GN=PPP6R3 PE=2 SV=1 PP6R3_CHICK reviewed Serine/threonine-protein phosphatase 6 regulatory subunit 3 (SAPS domain family member 3) Gallus gallus (Chicken) GO:0005634; GO:0005829; GO:0009966; GO:0019888; GO:0019903 regulation of signal transduction [GO:0009966] cytosol [GO:0005829]; nucleus [GO:0005634] protein phosphatase binding [GO:0019903]; protein phosphatase regulator activity [GO:0019888] g10864.t2 Q5F471 47.137 524 6.839999999999999e-147 445.0 sp|Q5F471|PP6R3_CHICK Serine/threonine-protein phosphatase 6 regulatory subunit 3 OS=Gallus gallus OX=9031 GN=PPP6R3 PE=2 SV=1 PP6R3_CHICK reviewed Serine/threonine-protein phosphatase 6 regulatory subunit 3 (SAPS domain family member 3) Gallus gallus (Chicken) GO:0005634; GO:0005829; GO:0009966; GO:0019888; GO:0019903 regulation of signal transduction [GO:0009966] cytosol [GO:0005829]; nucleus [GO:0005634] protein phosphatase binding [GO:0019903]; protein phosphatase regulator activity [GO:0019888] g10865.t1 Q922D4 40.4 250 8.86e-25 111.0 sp|Q922D4|PP6R3_MOUSE Serine/threonine-protein phosphatase 6 regulatory subunit 3 OS=Mus musculus OX=10090 GN=Ppp6r3 PE=1 SV=1 g10866.t1 P35282 78.431 204 1.38e-117 336.0 sp|P35282|RAB21_MOUSE Ras-related protein Rab-21 OS=Mus musculus OX=10090 GN=Rab21 PE=1 SV=4 RAB21_MOUSE reviewed Ras-related protein Rab-21 (EC 3.6.5.2) (Rab-12) Mus musculus (Mouse) GO:0000139; GO:0003924; GO:0003925; GO:0005525; GO:0005768; GO:0005769; GO:0005789; GO:0005802; GO:0006886; GO:0008089; GO:0009898; GO:0012505; GO:0012506; GO:0017157; GO:0019003; GO:0030516; GO:0032154; GO:0032482; GO:0032580; GO:0043005; GO:0045202; GO:0046872; GO:0048260; GO:0050775; GO:0050821; GO:0098559; GO:1904115; GO:2000643 anterograde axonal transport [GO:0008089]; intracellular protein transport [GO:0006886]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of early endosome to late endosome transport [GO:2000643]; positive regulation of receptor-mediated endocytosis [GO:0048260]; protein stabilization [GO:0050821]; Rab protein signal transduction [GO:0032482]; regulation of axon extension [GO:0030516]; regulation of exocytosis [GO:0017157] axon cytoplasm [GO:1904115]; cleavage furrow [GO:0032154]; cytoplasmic side of early endosome membrane [GO:0098559]; cytoplasmic side of plasma membrane [GO:0009898]; early endosome [GO:0005769]; endomembrane system [GO:0012505]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; neuron projection [GO:0043005]; synapse [GO:0045202]; trans-Golgi network [GO:0005802]; vesicle membrane [GO:0012506] G protein activity [GO:0003925]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872] g10867.t1 Q9D0S9 57.143 112 5.37e-48 156.0 sp|Q9D0S9|HINT2_MOUSE Adenosine 5'-monophosphoramidase HINT2 OS=Mus musculus OX=10090 GN=Hint2 PE=1 SV=1 g10870.t1 P70579 29.797 688 2.64e-91 311.0 sp|P70579|GRM8_RAT Metabotropic glutamate receptor 8 OS=Rattus norvegicus OX=10116 GN=Grm8 PE=1 SV=1 GRM8_RAT reviewed Metabotropic glutamate receptor 8 (mGluR8) Rattus norvegicus (Rat) GO:0001642; GO:0004930; GO:0005886; GO:0007193; GO:0007196; GO:0007216; GO:0007268; GO:0008066; GO:0019233; GO:0035249; GO:0042734; GO:0043025; GO:0045211; GO:0046928; GO:0048787; GO:0050966; GO:0051966; GO:0098978; GO:0098982; GO:0099171 adenylate cyclase-inhibiting G protein-coupled glutamate receptor signaling pathway [GO:0007196]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; chemical synaptic transmission [GO:0007268]; detection of mechanical stimulus involved in sensory perception of pain [GO:0050966]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; presynaptic modulation of chemical synaptic transmission [GO:0099171]; regulation of neurotransmitter secretion [GO:0046928]; regulation of synaptic transmission, glutamatergic [GO:0051966]; sensory perception of pain [GO:0019233]; synaptic transmission, glutamatergic [GO:0035249] GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic active zone membrane [GO:0048787]; presynaptic membrane [GO:0042734] G protein-coupled receptor activity [GO:0004930]; glutamate receptor activity [GO:0008066]; group III metabotropic glutamate receptor activity [GO:0001642] g10875.t1 B0BN95 30.488 246 9.41e-28 115.0 sp|B0BN95|HARB1_RAT Putative nuclease HARBI1 OS=Rattus norvegicus OX=10116 GN=Harbi1 PE=2 SV=1 HARB1_RAT reviewed Putative nuclease HARBI1 (EC 3.1.-.-) (Harbinger transposase-derived nuclease) Rattus norvegicus (Rat) GO:0004518; GO:0005634; GO:0005829; GO:0005886; GO:0016787; GO:0034451; GO:0046872 centriolar satellite [GO:0034451]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886] hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]; nuclease activity [GO:0004518] g10878.t1 Q62746 46.711 304 1.13e-86 275.0 sp|Q62746|SYT6_RAT Synaptotagmin-6 OS=Rattus norvegicus OX=10116 GN=Syt6 PE=1 SV=1 SYT6_RAT reviewed Synaptotagmin-6 (Synaptotagmin VI) (SytVI) Rattus norvegicus (Rat) GO:0000149; GO:0001786; GO:0005544; GO:0005829; GO:0005886; GO:0007268; GO:0007340; GO:0009898; GO:0016020; GO:0016192; GO:0017158; GO:0019905; GO:0030276; GO:0030672; GO:0042802; GO:0042803; GO:0046872; GO:0046982; GO:0048306; GO:0060478; GO:0061891; GO:0070382; GO:0097038; GO:0097060; GO:0098794; GO:0098978; GO:0150038 acrosomal vesicle exocytosis [GO:0060478]; acrosome reaction [GO:0007340]; chemical synaptic transmission [GO:0007268]; postsynaptic dense core vesicle exocytosis [GO:0150038]; regulation of calcium ion-dependent exocytosis [GO:0017158]; vesicle-mediated transport [GO:0016192] cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; exocytic vesicle [GO:0070382]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; perinuclear endoplasmic reticulum [GO:0097038]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; synaptic membrane [GO:0097060]; synaptic vesicle membrane [GO:0030672] calcium ion sensor activity [GO:0061891]; calcium-dependent phospholipid binding [GO:0005544]; calcium-dependent protein binding [GO:0048306]; clathrin binding [GO:0030276]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; phosphatidylserine binding [GO:0001786]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905] g10878.t2 Q9R0N8 46.689 302 2.11e-86 275.0 sp|Q9R0N8|SYT6_MOUSE Synaptotagmin-6 OS=Mus musculus OX=10090 GN=Syt6 PE=1 SV=2 g10879.t1 Q9Y5L0 54.526 928 0.0 976.0 sp|Q9Y5L0|TNPO3_HUMAN Transportin-3 OS=Homo sapiens OX=9606 GN=TNPO3 PE=1 SV=3 TNPO3_HUMAN reviewed Transportin-3 (Importin-12) (Imp12) (Transportin-SR) (TRN-SR) Homo sapiens (Human) GO:0005635; GO:0005642; GO:0005654; GO:0005737; GO:0005829; GO:0006606; GO:0031267; GO:0042802; GO:0061608 protein import into nucleus [GO:0006606] annulate lamellae [GO:0005642]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654] identical protein binding [GO:0042802]; nuclear import signal receptor activity [GO:0061608]; small GTPase binding [GO:0031267] g10880.t1 Q8R367 38.202 178 3.22e-36 128.0 sp|Q8R367|RERG_MOUSE Ras-related and estrogen-regulated growth inhibitor OS=Mus musculus OX=10090 GN=Rerg PE=2 SV=1 g10882.t1 Q8R367 38.202 178 2.92e-32 119.0 sp|Q8R367|RERG_MOUSE Ras-related and estrogen-regulated growth inhibitor OS=Mus musculus OX=10090 GN=Rerg PE=2 SV=1 g10883.t1 Q8R367 46.746 169 4.49e-42 144.0 sp|Q8R367|RERG_MOUSE Ras-related and estrogen-regulated growth inhibitor OS=Mus musculus OX=10090 GN=Rerg PE=2 SV=1 g10884.t1 Q9NB33 79.808 104 1.64e-55 170.0 sp|Q9NB33|RL44_OCHTR Large ribosomal subunit protein eL42 OS=Ochlerotatus triseriatus OX=7162 GN=RpL44 PE=3 SV=3 g10885.t1 Q5R8Y8 53.788 264 9.3e-77 254.0 sp|Q5R8Y8|CELF2_PONAB CUGBP Elav-like family member 2 OS=Pongo abelii OX=9601 GN=CELF2 PE=2 SV=2 CELF2_PONAB reviewed CUGBP Elav-like family member 2 (CELF-2) (Bruno-like protein 3) (CUG triplet repeat RNA-binding protein 2) (CUG-BP2) (CUG-BP- and ETR-3-like factor 2) (RNA-binding protein BRUNOL-3) Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0005634; GO:0005737; GO:0006376; GO:0036002; GO:1990904 mRNA splice site recognition [GO:0006376] cytoplasm [GO:0005737]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904] pre-mRNA binding [GO:0036002] g10885.t1 Q5R8Y8 72.727 132 9.509999999999999e-52 188.0 sp|Q5R8Y8|CELF2_PONAB CUGBP Elav-like family member 2 OS=Pongo abelii OX=9601 GN=CELF2 PE=2 SV=2 CELF2_PONAB reviewed CUGBP Elav-like family member 2 (CELF-2) (Bruno-like protein 3) (CUG triplet repeat RNA-binding protein 2) (CUG-BP2) (CUG-BP- and ETR-3-like factor 2) (RNA-binding protein BRUNOL-3) Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0005634; GO:0005737; GO:0006376; GO:0036002; GO:1990904 mRNA splice site recognition [GO:0006376] cytoplasm [GO:0005737]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904] pre-mRNA binding [GO:0036002] g10885.t2 Q792H5 53.409 264 7.47e-76 253.0 sp|Q792H5|CELF2_RAT CUGBP Elav-like family member 2 OS=Rattus norvegicus OX=10116 GN=Celf2 PE=2 SV=1 CELF2_RAT reviewed CUGBP Elav-like family member 2 (CELF-2) (Bruno-like protein 3) (CUG triplet repeat RNA-binding protein 2) (CUG-BP2) (CUG-BP- and ETR-3-like factor 2) (ELAV-type RNA-binding protein 3) (ETR-3) (Protein ETR-R3) (Neuroblastoma apoptosis-related RNA-binding protein) (rNapor) (RNA-binding protein BRUNOL-3) Rattus norvegicus (Rat) GO:0000381; GO:0003723; GO:0003730; GO:0005634; GO:0005654; GO:0005737; GO:0006376; GO:0016441; GO:0036002; GO:0090543; GO:0106222; GO:1990904 mRNA splice site recognition [GO:0006376]; post-transcriptional gene silencing [GO:0016441]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381] cytoplasm [GO:0005737]; Flemming body [GO:0090543]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904] lncRNA binding [GO:0106222]; mRNA 3'-UTR binding [GO:0003730]; pre-mRNA binding [GO:0036002]; RNA binding [GO:0003723] g10885.t2 Q792H5 68.571 140 4.91e-49 181.0 sp|Q792H5|CELF2_RAT CUGBP Elav-like family member 2 OS=Rattus norvegicus OX=10116 GN=Celf2 PE=2 SV=1 CELF2_RAT reviewed CUGBP Elav-like family member 2 (CELF-2) (Bruno-like protein 3) (CUG triplet repeat RNA-binding protein 2) (CUG-BP2) (CUG-BP- and ETR-3-like factor 2) (ELAV-type RNA-binding protein 3) (ETR-3) (Protein ETR-R3) (Neuroblastoma apoptosis-related RNA-binding protein) (rNapor) (RNA-binding protein BRUNOL-3) Rattus norvegicus (Rat) GO:0000381; GO:0003723; GO:0003730; GO:0005634; GO:0005654; GO:0005737; GO:0006376; GO:0016441; GO:0036002; GO:0090543; GO:0106222; GO:1990904 mRNA splice site recognition [GO:0006376]; post-transcriptional gene silencing [GO:0016441]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381] cytoplasm [GO:0005737]; Flemming body [GO:0090543]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904] lncRNA binding [GO:0106222]; mRNA 3'-UTR binding [GO:0003730]; pre-mRNA binding [GO:0036002]; RNA binding [GO:0003723] g10885.t3 Q792H5 53.788 264 1e-76 255.0 sp|Q792H5|CELF2_RAT CUGBP Elav-like family member 2 OS=Rattus norvegicus OX=10116 GN=Celf2 PE=2 SV=1 CELF2_RAT reviewed CUGBP Elav-like family member 2 (CELF-2) (Bruno-like protein 3) (CUG triplet repeat RNA-binding protein 2) (CUG-BP2) (CUG-BP- and ETR-3-like factor 2) (ELAV-type RNA-binding protein 3) (ETR-3) (Protein ETR-R3) (Neuroblastoma apoptosis-related RNA-binding protein) (rNapor) (RNA-binding protein BRUNOL-3) Rattus norvegicus (Rat) GO:0000381; GO:0003723; GO:0003730; GO:0005634; GO:0005654; GO:0005737; GO:0006376; GO:0016441; GO:0036002; GO:0090543; GO:0106222; GO:1990904 mRNA splice site recognition [GO:0006376]; post-transcriptional gene silencing [GO:0016441]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381] cytoplasm [GO:0005737]; Flemming body [GO:0090543]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904] lncRNA binding [GO:0106222]; mRNA 3'-UTR binding [GO:0003730]; pre-mRNA binding [GO:0036002]; RNA binding [GO:0003723] g10885.t3 Q792H5 68.571 140 4.75e-49 181.0 sp|Q792H5|CELF2_RAT CUGBP Elav-like family member 2 OS=Rattus norvegicus OX=10116 GN=Celf2 PE=2 SV=1 CELF2_RAT reviewed CUGBP Elav-like family member 2 (CELF-2) (Bruno-like protein 3) (CUG triplet repeat RNA-binding protein 2) (CUG-BP2) (CUG-BP- and ETR-3-like factor 2) (ELAV-type RNA-binding protein 3) (ETR-3) (Protein ETR-R3) (Neuroblastoma apoptosis-related RNA-binding protein) (rNapor) (RNA-binding protein BRUNOL-3) Rattus norvegicus (Rat) GO:0000381; GO:0003723; GO:0003730; GO:0005634; GO:0005654; GO:0005737; GO:0006376; GO:0016441; GO:0036002; GO:0090543; GO:0106222; GO:1990904 mRNA splice site recognition [GO:0006376]; post-transcriptional gene silencing [GO:0016441]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381] cytoplasm [GO:0005737]; Flemming body [GO:0090543]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904] lncRNA binding [GO:0106222]; mRNA 3'-UTR binding [GO:0003730]; pre-mRNA binding [GO:0036002]; RNA binding [GO:0003723] g10885.t4 A4IIM2 53.788 264 2.14e-76 255.0 sp|A4IIM2|CELF2_XENTR CUGBP Elav-like family member 2 OS=Xenopus tropicalis OX=8364 GN=celf2 PE=2 SV=1 g10885.t4 A4IIM2 68.571 140 7.27e-49 181.0 sp|A4IIM2|CELF2_XENTR CUGBP Elav-like family member 2 OS=Xenopus tropicalis OX=8364 GN=celf2 PE=2 SV=1 g10887.t1 Q9BYT3 56.615 325 4.03e-121 366.0 sp|Q9BYT3|STK33_HUMAN Serine/threonine-protein kinase 33 OS=Homo sapiens OX=9606 GN=STK33 PE=1 SV=1 g10889.t1 Q75V66 41.975 648 2.33e-164 501.0 sp|Q75V66|ANO5_HUMAN Anoctamin-5 OS=Homo sapiens OX=9606 GN=ANO5 PE=1 SV=1 ANO5_HUMAN reviewed Anoctamin-5 (Gnathodiaphyseal dysplasia 1 protein) (Transmembrane protein 16E) Homo sapiens (Human) GO:0001778; GO:0005229; GO:0005254; GO:0005789; GO:0005886; GO:0031982; GO:0034220; GO:0046983; GO:1902476 chloride transmembrane transport [GO:1902476]; monoatomic ion transmembrane transport [GO:0034220]; plasma membrane repair [GO:0001778] endoplasmic reticulum membrane [GO:0005789]; plasma membrane [GO:0005886]; vesicle [GO:0031982] chloride channel activity [GO:0005254]; intracellularly calcium-gated chloride channel activity [GO:0005229]; protein dimerization activity [GO:0046983] g10889.t2 Q75V66 41.782 651 6.22e-163 498.0 sp|Q75V66|ANO5_HUMAN Anoctamin-5 OS=Homo sapiens OX=9606 GN=ANO5 PE=1 SV=1 ANO5_HUMAN reviewed Anoctamin-5 (Gnathodiaphyseal dysplasia 1 protein) (Transmembrane protein 16E) Homo sapiens (Human) GO:0001778; GO:0005229; GO:0005254; GO:0005789; GO:0005886; GO:0031982; GO:0034220; GO:0046983; GO:1902476 chloride transmembrane transport [GO:1902476]; monoatomic ion transmembrane transport [GO:0034220]; plasma membrane repair [GO:0001778] endoplasmic reticulum membrane [GO:0005789]; plasma membrane [GO:0005886]; vesicle [GO:0031982] chloride channel activity [GO:0005254]; intracellularly calcium-gated chloride channel activity [GO:0005229]; protein dimerization activity [GO:0046983] g10889.t3 Q75V66 41.782 651 7.32e-163 498.0 sp|Q75V66|ANO5_HUMAN Anoctamin-5 OS=Homo sapiens OX=9606 GN=ANO5 PE=1 SV=1 ANO5_HUMAN reviewed Anoctamin-5 (Gnathodiaphyseal dysplasia 1 protein) (Transmembrane protein 16E) Homo sapiens (Human) GO:0001778; GO:0005229; GO:0005254; GO:0005789; GO:0005886; GO:0031982; GO:0034220; GO:0046983; GO:1902476 chloride transmembrane transport [GO:1902476]; monoatomic ion transmembrane transport [GO:0034220]; plasma membrane repair [GO:0001778] endoplasmic reticulum membrane [GO:0005789]; plasma membrane [GO:0005886]; vesicle [GO:0031982] chloride channel activity [GO:0005254]; intracellularly calcium-gated chloride channel activity [GO:0005229]; protein dimerization activity [GO:0046983] g10889.t4 Q75V66 41.782 651 1.75e-162 498.0 sp|Q75V66|ANO5_HUMAN Anoctamin-5 OS=Homo sapiens OX=9606 GN=ANO5 PE=1 SV=1 ANO5_HUMAN reviewed Anoctamin-5 (Gnathodiaphyseal dysplasia 1 protein) (Transmembrane protein 16E) Homo sapiens (Human) GO:0001778; GO:0005229; GO:0005254; GO:0005789; GO:0005886; GO:0031982; GO:0034220; GO:0046983; GO:1902476 chloride transmembrane transport [GO:1902476]; monoatomic ion transmembrane transport [GO:0034220]; plasma membrane repair [GO:0001778] endoplasmic reticulum membrane [GO:0005789]; plasma membrane [GO:0005886]; vesicle [GO:0031982] chloride channel activity [GO:0005254]; intracellularly calcium-gated chloride channel activity [GO:0005229]; protein dimerization activity [GO:0046983] g10890.t1 Q8C5H1 36.296 135 9.319999999999999e-23 96.3 sp|Q8C5H1|ANO4_MOUSE Anoctamin-4 OS=Mus musculus OX=10090 GN=Ano4 PE=1 SV=2 ANO4_MOUSE reviewed Anoctamin-4 (Transmembrane protein 16D) Mus musculus (Mouse) GO:0005229; GO:0005254; GO:0005886; GO:0017128; GO:0046983; GO:0061589; GO:0061590; GO:0061591; GO:1902476 calcium activated galactosylceramide scrambling [GO:0061591]; calcium activated phosphatidylcholine scrambling [GO:0061590]; calcium activated phosphatidylserine scrambling [GO:0061589]; chloride transmembrane transport [GO:1902476] plasma membrane [GO:0005886] chloride channel activity [GO:0005254]; intracellularly calcium-gated chloride channel activity [GO:0005229]; phospholipid scramblase activity [GO:0017128]; protein dimerization activity [GO:0046983] g10891.t1 Q7ZXL5 32.024 840 2.54e-133 418.0 sp|Q7ZXL5|NELL2_XENLA Protein kinase C-binding protein NELL2 OS=Xenopus laevis OX=8355 GN=nell2.L PE=2 SV=1 g10891.t2 Q7ZXL5 32.485 825 1.61e-135 423.0 sp|Q7ZXL5|NELL2_XENLA Protein kinase C-binding protein NELL2 OS=Xenopus laevis OX=8355 GN=nell2.L PE=2 SV=1 g10893.t1 Q8AVY1 46.774 248 5.8599999999999994e-67 208.0 sp|Q8AVY1|CMA1A_XENLA Ciliary microtubule associated protein 1A OS=Xenopus laevis OX=8355 GN=cimap1a PE=2 SV=1 g10894.t1 Q63802 49.902 511 1.37e-149 450.0 sp|Q63802|WEE1_RAT Wee1-like protein kinase OS=Rattus norvegicus OX=10116 GN=Wee1 PE=1 SV=1 WEE1_RAT reviewed Wee1-like protein kinase (EC 2.7.10.2) (Wee1A kinase) Rattus norvegicus (Rat) GO:0000086; GO:0000226; GO:0000287; GO:0004672; GO:0004713; GO:0004715; GO:0005524; GO:0005634; GO:0005730; GO:0005737; GO:0006998; GO:0007077; GO:0010971; GO:0010972; GO:0030010; GO:0048812; GO:0051301 cell division [GO:0051301]; establishment of cell polarity [GO:0030010]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule cytoskeleton organization [GO:0000226]; mitotic nuclear membrane disassembly [GO:0007077]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; neuron projection morphogenesis [GO:0048812]; nuclear envelope organization [GO:0006998]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971] cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleus [GO:0005634] ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein kinase activity [GO:0004672]; protein tyrosine kinase activity [GO:0004713] g10895.t1 Q9NUJ3 44.924 463 1.07e-133 400.0 sp|Q9NUJ3|T11L1_HUMAN T-complex protein 11-like protein 1 OS=Homo sapiens OX=9606 GN=TCP11L1 PE=1 SV=1 T11L1_HUMAN reviewed T-complex protein 11-like protein 1 Homo sapiens (Human) GO:0005874; GO:0007165 signal transduction [GO:0007165] microtubule [GO:0005874] g10897.t1 Q2HJ56 46.653 478 7.66e-143 423.0 sp|Q2HJ56|PWP1_BOVIN Periodic tryptophan protein 1 homolog OS=Bos taurus OX=9913 GN=PWP1 PE=2 SV=1 g10898.t1 Q6AX60 50.455 549 5.24e-174 523.0 sp|Q6AX60|PTHB1_XENLA Protein PTHB1 OS=Xenopus laevis OX=8355 GN=bbs9 PE=2 SV=1 g10898.t2 Q6AX60 49.553 559 1.19e-170 514.0 sp|Q6AX60|PTHB1_XENLA Protein PTHB1 OS=Xenopus laevis OX=8355 GN=bbs9 PE=2 SV=1 g10899.t1 Q6AX60 62.857 245 1.22e-99 312.0 sp|Q6AX60|PTHB1_XENLA Protein PTHB1 OS=Xenopus laevis OX=8355 GN=bbs9 PE=2 SV=1 g10900.t1 Q28BR5 55.644 1001 0.0 1122.0 sp|Q28BR5|PREP_XENTR Presequence protease, mitochondrial OS=Xenopus tropicalis OX=8364 GN=pitrm1 PE=2 SV=1 g10901.t1 E9Q0N2 50.413 242 3.29e-74 246.0 sp|E9Q0N2|PTPRH_MOUSE Receptor-type tyrosine-protein phosphatase H OS=Mus musculus OX=10090 GN=Ptprh PE=1 SV=1 PTPRH_MOUSE reviewed Receptor-type tyrosine-protein phosphatase H (R-PTP-H) (EC 3.1.3.48) (Stomach cancer-associated protein tyrosine phosphatase 1) (SAP-1) Mus musculus (Mouse) GO:0004725; GO:0005829; GO:0005886; GO:0005902; GO:0007165; GO:0007411; GO:0016324; GO:0016607; GO:0031528; GO:0045296 axon guidance [GO:0007411]; signal transduction [GO:0007165] apical plasma membrane [GO:0016324]; cytosol [GO:0005829]; microvillus [GO:0005902]; microvillus membrane [GO:0031528]; nuclear speck [GO:0016607]; plasma membrane [GO:0005886] cadherin binding [GO:0045296]; protein tyrosine phosphatase activity [GO:0004725] g10902.t1 Q80Z71 25.982 1120 9.54e-49 199.0 sp|Q80Z71|TENN_MOUSE Tenascin-N OS=Mus musculus OX=10090 GN=Tnn PE=1 SV=2 TENN_MOUSE reviewed Tenascin-N (TN-N) (Tenascin-W) (TN-W) Mus musculus (Mouse) GO:0001764; GO:0002076; GO:0005178; GO:0005615; GO:0007160; GO:0007409; GO:0009986; GO:0010976; GO:0030155; GO:0030334; GO:0031012; GO:0042802; GO:0043005; GO:0043025; GO:0070593; GO:0090733; GO:0097442; GO:1903010; GO:1903672; GO:1905899; GO:1990026; GO:1990138; GO:2001223 axonogenesis [GO:0007409]; cell-matrix adhesion [GO:0007160]; dendrite self-avoidance [GO:0070593]; negative regulation of neuron migration [GO:2001223]; neuron migration [GO:0001764]; neuron projection extension [GO:1990138]; osteoblast development [GO:0002076]; positive regulation of neuron projection development [GO:0010976]; positive regulation of sprouting angiogenesis [GO:1903672]; regulation of bone development [GO:1903010]; regulation of cell adhesion [GO:0030155]; regulation of cell migration [GO:0030334]; regulation of smooth muscle tissue development [GO:1905899] CA3 pyramidal cell dendrite [GO:0097442]; cell surface [GO:0009986]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; hippocampal mossy fiber expansion [GO:1990026]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; tenascin complex [GO:0090733] identical protein binding [GO:0042802]; integrin binding [GO:0005178] g10902.t1 Q80Z71 26.772 945 3.01e-47 194.0 sp|Q80Z71|TENN_MOUSE Tenascin-N OS=Mus musculus OX=10090 GN=Tnn PE=1 SV=2 TENN_MOUSE reviewed Tenascin-N (TN-N) (Tenascin-W) (TN-W) Mus musculus (Mouse) GO:0001764; GO:0002076; GO:0005178; GO:0005615; GO:0007160; GO:0007409; GO:0009986; GO:0010976; GO:0030155; GO:0030334; GO:0031012; GO:0042802; GO:0043005; GO:0043025; GO:0070593; GO:0090733; GO:0097442; GO:1903010; GO:1903672; GO:1905899; GO:1990026; GO:1990138; GO:2001223 axonogenesis [GO:0007409]; cell-matrix adhesion [GO:0007160]; dendrite self-avoidance [GO:0070593]; negative regulation of neuron migration [GO:2001223]; neuron migration [GO:0001764]; neuron projection extension [GO:1990138]; osteoblast development [GO:0002076]; positive regulation of neuron projection development [GO:0010976]; positive regulation of sprouting angiogenesis [GO:1903672]; regulation of bone development [GO:1903010]; regulation of cell adhesion [GO:0030155]; regulation of cell migration [GO:0030334]; regulation of smooth muscle tissue development [GO:1905899] CA3 pyramidal cell dendrite [GO:0097442]; cell surface [GO:0009986]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; hippocampal mossy fiber expansion [GO:1990026]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; tenascin complex [GO:0090733] identical protein binding [GO:0042802]; integrin binding [GO:0005178] g10902.t1 Q80Z71 25.66 1060 2.36e-42 177.0 sp|Q80Z71|TENN_MOUSE Tenascin-N OS=Mus musculus OX=10090 GN=Tnn PE=1 SV=2 TENN_MOUSE reviewed Tenascin-N (TN-N) (Tenascin-W) (TN-W) Mus musculus (Mouse) GO:0001764; GO:0002076; GO:0005178; GO:0005615; GO:0007160; GO:0007409; GO:0009986; GO:0010976; GO:0030155; GO:0030334; GO:0031012; GO:0042802; GO:0043005; GO:0043025; GO:0070593; GO:0090733; GO:0097442; GO:1903010; GO:1903672; GO:1905899; GO:1990026; GO:1990138; GO:2001223 axonogenesis [GO:0007409]; cell-matrix adhesion [GO:0007160]; dendrite self-avoidance [GO:0070593]; negative regulation of neuron migration [GO:2001223]; neuron migration [GO:0001764]; neuron projection extension [GO:1990138]; osteoblast development [GO:0002076]; positive regulation of neuron projection development [GO:0010976]; positive regulation of sprouting angiogenesis [GO:1903672]; regulation of bone development [GO:1903010]; regulation of cell adhesion [GO:0030155]; regulation of cell migration [GO:0030334]; regulation of smooth muscle tissue development [GO:1905899] CA3 pyramidal cell dendrite [GO:0097442]; cell surface [GO:0009986]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; hippocampal mossy fiber expansion [GO:1990026]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; tenascin complex [GO:0090733] identical protein binding [GO:0042802]; integrin binding [GO:0005178] g10902.t1 Q80Z71 23.904 1163 2.03e-33 148.0 sp|Q80Z71|TENN_MOUSE Tenascin-N OS=Mus musculus OX=10090 GN=Tnn PE=1 SV=2 TENN_MOUSE reviewed Tenascin-N (TN-N) (Tenascin-W) (TN-W) Mus musculus (Mouse) GO:0001764; GO:0002076; GO:0005178; GO:0005615; GO:0007160; GO:0007409; GO:0009986; GO:0010976; GO:0030155; GO:0030334; GO:0031012; GO:0042802; GO:0043005; GO:0043025; GO:0070593; GO:0090733; GO:0097442; GO:1903010; GO:1903672; GO:1905899; GO:1990026; GO:1990138; GO:2001223 axonogenesis [GO:0007409]; cell-matrix adhesion [GO:0007160]; dendrite self-avoidance [GO:0070593]; negative regulation of neuron migration [GO:2001223]; neuron migration [GO:0001764]; neuron projection extension [GO:1990138]; osteoblast development [GO:0002076]; positive regulation of neuron projection development [GO:0010976]; positive regulation of sprouting angiogenesis [GO:1903672]; regulation of bone development [GO:1903010]; regulation of cell adhesion [GO:0030155]; regulation of cell migration [GO:0030334]; regulation of smooth muscle tissue development [GO:1905899] CA3 pyramidal cell dendrite [GO:0097442]; cell surface [GO:0009986]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; hippocampal mossy fiber expansion [GO:1990026]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; tenascin complex [GO:0090733] identical protein binding [GO:0042802]; integrin binding [GO:0005178] g10902.t1 Q80Z71 23.491 1060 2.1900000000000003e-31 142.0 sp|Q80Z71|TENN_MOUSE Tenascin-N OS=Mus musculus OX=10090 GN=Tnn PE=1 SV=2 TENN_MOUSE reviewed Tenascin-N (TN-N) (Tenascin-W) (TN-W) Mus musculus (Mouse) GO:0001764; GO:0002076; GO:0005178; GO:0005615; GO:0007160; GO:0007409; GO:0009986; GO:0010976; GO:0030155; GO:0030334; GO:0031012; GO:0042802; GO:0043005; GO:0043025; GO:0070593; GO:0090733; GO:0097442; GO:1903010; GO:1903672; GO:1905899; GO:1990026; GO:1990138; GO:2001223 axonogenesis [GO:0007409]; cell-matrix adhesion [GO:0007160]; dendrite self-avoidance [GO:0070593]; negative regulation of neuron migration [GO:2001223]; neuron migration [GO:0001764]; neuron projection extension [GO:1990138]; osteoblast development [GO:0002076]; positive regulation of neuron projection development [GO:0010976]; positive regulation of sprouting angiogenesis [GO:1903672]; regulation of bone development [GO:1903010]; regulation of cell adhesion [GO:0030155]; regulation of cell migration [GO:0030334]; regulation of smooth muscle tissue development [GO:1905899] CA3 pyramidal cell dendrite [GO:0097442]; cell surface [GO:0009986]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; hippocampal mossy fiber expansion [GO:1990026]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; tenascin complex [GO:0090733] identical protein binding [GO:0042802]; integrin binding [GO:0005178] g10902.t1 Q80Z71 23.536 939 7.489999999999999e-30 137.0 sp|Q80Z71|TENN_MOUSE Tenascin-N OS=Mus musculus OX=10090 GN=Tnn PE=1 SV=2 TENN_MOUSE reviewed Tenascin-N (TN-N) (Tenascin-W) (TN-W) Mus musculus (Mouse) GO:0001764; GO:0002076; GO:0005178; GO:0005615; GO:0007160; GO:0007409; GO:0009986; GO:0010976; GO:0030155; GO:0030334; GO:0031012; GO:0042802; GO:0043005; GO:0043025; GO:0070593; GO:0090733; GO:0097442; GO:1903010; GO:1903672; GO:1905899; GO:1990026; GO:1990138; GO:2001223 axonogenesis [GO:0007409]; cell-matrix adhesion [GO:0007160]; dendrite self-avoidance [GO:0070593]; negative regulation of neuron migration [GO:2001223]; neuron migration [GO:0001764]; neuron projection extension [GO:1990138]; osteoblast development [GO:0002076]; positive regulation of neuron projection development [GO:0010976]; positive regulation of sprouting angiogenesis [GO:1903672]; regulation of bone development [GO:1903010]; regulation of cell adhesion [GO:0030155]; regulation of cell migration [GO:0030334]; regulation of smooth muscle tissue development [GO:1905899] CA3 pyramidal cell dendrite [GO:0097442]; cell surface [GO:0009986]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; hippocampal mossy fiber expansion [GO:1990026]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; tenascin complex [GO:0090733] identical protein binding [GO:0042802]; integrin binding [GO:0005178] g10902.t1 Q80Z71 23.042 1111 4.31e-29 134.0 sp|Q80Z71|TENN_MOUSE Tenascin-N OS=Mus musculus OX=10090 GN=Tnn PE=1 SV=2 TENN_MOUSE reviewed Tenascin-N (TN-N) (Tenascin-W) (TN-W) Mus musculus (Mouse) GO:0001764; GO:0002076; GO:0005178; GO:0005615; GO:0007160; GO:0007409; GO:0009986; GO:0010976; GO:0030155; GO:0030334; GO:0031012; GO:0042802; GO:0043005; GO:0043025; GO:0070593; GO:0090733; GO:0097442; GO:1903010; GO:1903672; GO:1905899; GO:1990026; GO:1990138; GO:2001223 axonogenesis [GO:0007409]; cell-matrix adhesion [GO:0007160]; dendrite self-avoidance [GO:0070593]; negative regulation of neuron migration [GO:2001223]; neuron migration [GO:0001764]; neuron projection extension [GO:1990138]; osteoblast development [GO:0002076]; positive regulation of neuron projection development [GO:0010976]; positive regulation of sprouting angiogenesis [GO:1903672]; regulation of bone development [GO:1903010]; regulation of cell adhesion [GO:0030155]; regulation of cell migration [GO:0030334]; regulation of smooth muscle tissue development [GO:1905899] CA3 pyramidal cell dendrite [GO:0097442]; cell surface [GO:0009986]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; hippocampal mossy fiber expansion [GO:1990026]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; tenascin complex [GO:0090733] identical protein binding [GO:0042802]; integrin binding [GO:0005178] g10902.t1 Q80Z71 24.375 960 7.16e-28 130.0 sp|Q80Z71|TENN_MOUSE Tenascin-N OS=Mus musculus OX=10090 GN=Tnn PE=1 SV=2 TENN_MOUSE reviewed Tenascin-N (TN-N) (Tenascin-W) (TN-W) Mus musculus (Mouse) GO:0001764; GO:0002076; GO:0005178; GO:0005615; GO:0007160; GO:0007409; GO:0009986; GO:0010976; GO:0030155; GO:0030334; GO:0031012; GO:0042802; GO:0043005; GO:0043025; GO:0070593; GO:0090733; GO:0097442; GO:1903010; GO:1903672; GO:1905899; GO:1990026; GO:1990138; GO:2001223 axonogenesis [GO:0007409]; cell-matrix adhesion [GO:0007160]; dendrite self-avoidance [GO:0070593]; negative regulation of neuron migration [GO:2001223]; neuron migration [GO:0001764]; neuron projection extension [GO:1990138]; osteoblast development [GO:0002076]; positive regulation of neuron projection development [GO:0010976]; positive regulation of sprouting angiogenesis [GO:1903672]; regulation of bone development [GO:1903010]; regulation of cell adhesion [GO:0030155]; regulation of cell migration [GO:0030334]; regulation of smooth muscle tissue development [GO:1905899] CA3 pyramidal cell dendrite [GO:0097442]; cell surface [GO:0009986]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; hippocampal mossy fiber expansion [GO:1990026]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; tenascin complex [GO:0090733] identical protein binding [GO:0042802]; integrin binding [GO:0005178] g10902.t1 Q80Z71 23.75 960 1.16e-27 129.0 sp|Q80Z71|TENN_MOUSE Tenascin-N OS=Mus musculus OX=10090 GN=Tnn PE=1 SV=2 TENN_MOUSE reviewed Tenascin-N (TN-N) (Tenascin-W) (TN-W) Mus musculus (Mouse) GO:0001764; GO:0002076; GO:0005178; GO:0005615; GO:0007160; GO:0007409; GO:0009986; GO:0010976; GO:0030155; GO:0030334; GO:0031012; GO:0042802; GO:0043005; GO:0043025; GO:0070593; GO:0090733; GO:0097442; GO:1903010; GO:1903672; GO:1905899; GO:1990026; GO:1990138; GO:2001223 axonogenesis [GO:0007409]; cell-matrix adhesion [GO:0007160]; dendrite self-avoidance [GO:0070593]; negative regulation of neuron migration [GO:2001223]; neuron migration [GO:0001764]; neuron projection extension [GO:1990138]; osteoblast development [GO:0002076]; positive regulation of neuron projection development [GO:0010976]; positive regulation of sprouting angiogenesis [GO:1903672]; regulation of bone development [GO:1903010]; regulation of cell adhesion [GO:0030155]; regulation of cell migration [GO:0030334]; regulation of smooth muscle tissue development [GO:1905899] CA3 pyramidal cell dendrite [GO:0097442]; cell surface [GO:0009986]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; hippocampal mossy fiber expansion [GO:1990026]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; tenascin complex [GO:0090733] identical protein binding [GO:0042802]; integrin binding [GO:0005178] g10902.t1 Q80Z71 22.807 1083 3.3100000000000004e-26 124.0 sp|Q80Z71|TENN_MOUSE Tenascin-N OS=Mus musculus OX=10090 GN=Tnn PE=1 SV=2 TENN_MOUSE reviewed Tenascin-N (TN-N) (Tenascin-W) (TN-W) Mus musculus (Mouse) GO:0001764; GO:0002076; GO:0005178; GO:0005615; GO:0007160; GO:0007409; GO:0009986; GO:0010976; GO:0030155; GO:0030334; GO:0031012; GO:0042802; GO:0043005; GO:0043025; GO:0070593; GO:0090733; GO:0097442; GO:1903010; GO:1903672; GO:1905899; GO:1990026; GO:1990138; GO:2001223 axonogenesis [GO:0007409]; cell-matrix adhesion [GO:0007160]; dendrite self-avoidance [GO:0070593]; negative regulation of neuron migration [GO:2001223]; neuron migration [GO:0001764]; neuron projection extension [GO:1990138]; osteoblast development [GO:0002076]; positive regulation of neuron projection development [GO:0010976]; positive regulation of sprouting angiogenesis [GO:1903672]; regulation of bone development [GO:1903010]; regulation of cell adhesion [GO:0030155]; regulation of cell migration [GO:0030334]; regulation of smooth muscle tissue development [GO:1905899] CA3 pyramidal cell dendrite [GO:0097442]; cell surface [GO:0009986]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; hippocampal mossy fiber expansion [GO:1990026]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; tenascin complex [GO:0090733] identical protein binding [GO:0042802]; integrin binding [GO:0005178] g10902.t1 Q80Z71 22.562 1046 8.95e-25 120.0 sp|Q80Z71|TENN_MOUSE Tenascin-N OS=Mus musculus OX=10090 GN=Tnn PE=1 SV=2 TENN_MOUSE reviewed Tenascin-N (TN-N) (Tenascin-W) (TN-W) Mus musculus (Mouse) GO:0001764; GO:0002076; GO:0005178; GO:0005615; GO:0007160; GO:0007409; GO:0009986; GO:0010976; GO:0030155; GO:0030334; GO:0031012; GO:0042802; GO:0043005; GO:0043025; GO:0070593; GO:0090733; GO:0097442; GO:1903010; GO:1903672; GO:1905899; GO:1990026; GO:1990138; GO:2001223 axonogenesis [GO:0007409]; cell-matrix adhesion [GO:0007160]; dendrite self-avoidance [GO:0070593]; negative regulation of neuron migration [GO:2001223]; neuron migration [GO:0001764]; neuron projection extension [GO:1990138]; osteoblast development [GO:0002076]; positive regulation of neuron projection development [GO:0010976]; positive regulation of sprouting angiogenesis [GO:1903672]; regulation of bone development [GO:1903010]; regulation of cell adhesion [GO:0030155]; regulation of cell migration [GO:0030334]; regulation of smooth muscle tissue development [GO:1905899] CA3 pyramidal cell dendrite [GO:0097442]; cell surface [GO:0009986]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; hippocampal mossy fiber expansion [GO:1990026]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; tenascin complex [GO:0090733] identical protein binding [GO:0042802]; integrin binding [GO:0005178] g10902.t1 Q80Z71 23.258 976 9.5e-25 120.0 sp|Q80Z71|TENN_MOUSE Tenascin-N OS=Mus musculus OX=10090 GN=Tnn PE=1 SV=2 TENN_MOUSE reviewed Tenascin-N (TN-N) (Tenascin-W) (TN-W) Mus musculus (Mouse) GO:0001764; GO:0002076; GO:0005178; GO:0005615; GO:0007160; GO:0007409; GO:0009986; GO:0010976; GO:0030155; GO:0030334; GO:0031012; GO:0042802; GO:0043005; GO:0043025; GO:0070593; GO:0090733; GO:0097442; GO:1903010; GO:1903672; GO:1905899; GO:1990026; GO:1990138; GO:2001223 axonogenesis [GO:0007409]; cell-matrix adhesion [GO:0007160]; dendrite self-avoidance [GO:0070593]; negative regulation of neuron migration [GO:2001223]; neuron migration [GO:0001764]; neuron projection extension [GO:1990138]; osteoblast development [GO:0002076]; positive regulation of neuron projection development [GO:0010976]; positive regulation of sprouting angiogenesis [GO:1903672]; regulation of bone development [GO:1903010]; regulation of cell adhesion [GO:0030155]; regulation of cell migration [GO:0030334]; regulation of smooth muscle tissue development [GO:1905899] CA3 pyramidal cell dendrite [GO:0097442]; cell surface [GO:0009986]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; hippocampal mossy fiber expansion [GO:1990026]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; tenascin complex [GO:0090733] identical protein binding [GO:0042802]; integrin binding [GO:0005178] g10902.t1 Q80Z71 24.218 863 1.6400000000000002e-21 109.0 sp|Q80Z71|TENN_MOUSE Tenascin-N OS=Mus musculus OX=10090 GN=Tnn PE=1 SV=2 TENN_MOUSE reviewed Tenascin-N (TN-N) (Tenascin-W) (TN-W) Mus musculus (Mouse) GO:0001764; GO:0002076; GO:0005178; GO:0005615; GO:0007160; GO:0007409; GO:0009986; GO:0010976; GO:0030155; GO:0030334; GO:0031012; GO:0042802; GO:0043005; GO:0043025; GO:0070593; GO:0090733; GO:0097442; GO:1903010; GO:1903672; GO:1905899; GO:1990026; GO:1990138; GO:2001223 axonogenesis [GO:0007409]; cell-matrix adhesion [GO:0007160]; dendrite self-avoidance [GO:0070593]; negative regulation of neuron migration [GO:2001223]; neuron migration [GO:0001764]; neuron projection extension [GO:1990138]; osteoblast development [GO:0002076]; positive regulation of neuron projection development [GO:0010976]; positive regulation of sprouting angiogenesis [GO:1903672]; regulation of bone development [GO:1903010]; regulation of cell adhesion [GO:0030155]; regulation of cell migration [GO:0030334]; regulation of smooth muscle tissue development [GO:1905899] CA3 pyramidal cell dendrite [GO:0097442]; cell surface [GO:0009986]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; hippocampal mossy fiber expansion [GO:1990026]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; tenascin complex [GO:0090733] identical protein binding [GO:0042802]; integrin binding [GO:0005178] g10902.t1 Q80Z71 23.665 824 2.0600000000000002e-21 108.0 sp|Q80Z71|TENN_MOUSE Tenascin-N OS=Mus musculus OX=10090 GN=Tnn PE=1 SV=2 TENN_MOUSE reviewed Tenascin-N (TN-N) (Tenascin-W) (TN-W) Mus musculus (Mouse) GO:0001764; GO:0002076; GO:0005178; GO:0005615; GO:0007160; GO:0007409; GO:0009986; GO:0010976; GO:0030155; GO:0030334; GO:0031012; GO:0042802; GO:0043005; GO:0043025; GO:0070593; GO:0090733; GO:0097442; GO:1903010; GO:1903672; GO:1905899; GO:1990026; GO:1990138; GO:2001223 axonogenesis [GO:0007409]; cell-matrix adhesion [GO:0007160]; dendrite self-avoidance [GO:0070593]; negative regulation of neuron migration [GO:2001223]; neuron migration [GO:0001764]; neuron projection extension [GO:1990138]; osteoblast development [GO:0002076]; positive regulation of neuron projection development [GO:0010976]; positive regulation of sprouting angiogenesis [GO:1903672]; regulation of bone development [GO:1903010]; regulation of cell adhesion [GO:0030155]; regulation of cell migration [GO:0030334]; regulation of smooth muscle tissue development [GO:1905899] CA3 pyramidal cell dendrite [GO:0097442]; cell surface [GO:0009986]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; hippocampal mossy fiber expansion [GO:1990026]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; tenascin complex [GO:0090733] identical protein binding [GO:0042802]; integrin binding [GO:0005178] g10904.t1 Q60821 34.074 270 3.63e-36 146.0 sp|Q60821|ZBT17_MOUSE Zinc finger and BTB domain-containing protein 17 OS=Mus musculus OX=10090 GN=Zbtb17 PE=1 SV=2 ZBT17_MOUSE reviewed Zinc finger and BTB domain-containing protein 17 (LP-1) (Polyomavirus late initiator promoter-binding protein) (Zinc finger protein 100) (Zfp-100) (Zinc finger protein 151) (Zinc finger protein Z13) Mus musculus (Mouse) GO:0000977; GO:0000978; GO:0000981; GO:0001046; GO:0001223; GO:0001228; GO:0001702; GO:0003677; GO:0003700; GO:0005634; GO:0006357; GO:0007398; GO:0008270; GO:0008285; GO:0032991; GO:0032993; GO:0045893; GO:0045944; GO:0070314; GO:0140297 ectoderm development [GO:0007398]; G1 to G0 transition [GO:0070314]; gastrulation with mouth forming second [GO:0001702]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634]; protein-containing complex [GO:0032991]; protein-DNA complex [GO:0032993] core promoter sequence-specific DNA binding [GO:0001046]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription factor binding [GO:0140297]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; transcription coactivator binding [GO:0001223]; zinc ion binding [GO:0008270] g10905.t1 Q6ZMW2 34.711 242 2.3800000000000002e-29 128.0 sp|Q6ZMW2|ZN782_HUMAN Zinc finger protein 782 OS=Homo sapiens OX=9606 GN=ZNF782 PE=1 SV=1 g10905.t1 Q6ZMW2 32.636 239 3.16e-25 115.0 sp|Q6ZMW2|ZN782_HUMAN Zinc finger protein 782 OS=Homo sapiens OX=9606 GN=ZNF782 PE=1 SV=1 g10906.t1 A2VDP4 37.023 262 1.39e-41 164.0 sp|A2VDP4|ZN567_BOVIN Zinc finger protein 567 OS=Bos taurus OX=9913 GN=ZNF567 PE=2 SV=1 g10906.t2 Q90625 31.33 233 3.53e-22 105.0 sp|Q90625|ZBT17_CHICK Zinc finger and BTB domain-containing protein 17 (Fragment) OS=Gallus gallus OX=9031 GN=ZBTB17 PE=2 SV=1 g10907.t1 Q90ZK6 62.791 129 2.55e-56 186.0 sp|Q90ZK6|ACVR1_CHICK Activin receptor type-1 OS=Gallus gallus OX=9031 GN=ACVR1 PE=2 SV=1 ACVR1_CHICK reviewed Activin receptor type-1 (EC 2.7.11.30) (Activin receptor type I) (Type I TGF B receptor) Gallus gallus (Chicken) GO:0000082; GO:0001569; GO:0001702; GO:0001707; GO:0001755; GO:0002526; GO:0003143; GO:0003181; GO:0003183; GO:0003272; GO:0003274; GO:0003289; GO:0004672; GO:0004674; GO:0005025; GO:0005524; GO:0005886; GO:0006468; GO:0007179; GO:0007281; GO:0007368; GO:0007369; GO:0007498; GO:0007507; GO:0009953; GO:0009968; GO:0010694; GO:0010718; GO:0016020; GO:0016361; GO:0016477; GO:0018107; GO:0019838; GO:0030154; GO:0030278; GO:0030335; GO:0030501; GO:0030509; GO:0030513; GO:0032924; GO:0032926; GO:0035556; GO:0042118; GO:0042803; GO:0045177; GO:0045669; GO:0045893; GO:0045944; GO:0046332; GO:0046872; GO:0048179; GO:0048185; GO:0048762; GO:0050431; GO:0051145; GO:0060037; GO:0060317; GO:0060412; GO:0060923; GO:0061445; GO:0062043; GO:0070724; GO:0071363; GO:0071773; GO:2000017; GO:2001237 activin receptor signaling pathway [GO:0032924]; acute inflammatory response [GO:0002526]; atrial septum primum morphogenesis [GO:0003289]; atrioventricular valve morphogenesis [GO:0003181]; BMP signaling pathway [GO:0030509]; branching involved in blood vessel morphogenesis [GO:0001569]; cardiac epithelial to mesenchymal transition [GO:0060317]; cardiac muscle cell fate commitment [GO:0060923]; cell differentiation [GO:0030154]; cell migration [GO:0016477]; cellular response to BMP stimulus [GO:0071773]; cellular response to growth factor stimulus [GO:0071363]; determination of left/right symmetry [GO:0007368]; dorsal/ventral pattern formation [GO:0009953]; embryonic heart tube morphogenesis [GO:0003143]; endocardial cushion cell fate commitment [GO:0061445]; endocardial cushion formation [GO:0003272]; endocardial cushion fusion [GO:0003274]; endothelial cell activation [GO:0042118]; G1/S transition of mitotic cell cycle [GO:0000082]; gastrulation [GO:0007369]; gastrulation with mouth forming second [GO:0001702]; germ cell development [GO:0007281]; heart development [GO:0007507]; intracellular signal transduction [GO:0035556]; mesenchymal cell differentiation [GO:0048762]; mesoderm development [GO:0007498]; mesoderm formation [GO:0001707]; mitral valve morphogenesis [GO:0003183]; negative regulation of activin receptor signaling pathway [GO:0032926]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of signal transduction [GO:0009968]; neural crest cell migration [GO:0001755]; peptidyl-threonine phosphorylation [GO:0018107]; pharyngeal system development [GO:0060037]; positive regulation of alkaline phosphatase activity [GO:0010694]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of bone mineralization [GO:0030501]; positive regulation of cardiac epithelial to mesenchymal transition [GO:0062043]; positive regulation of cell migration [GO:0030335]; positive regulation of determination of dorsal identity [GO:2000017]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein phosphorylation [GO:0006468]; regulation of ossification [GO:0030278]; smooth muscle cell differentiation [GO:0051145]; transforming growth factor beta receptor signaling pathway [GO:0007179]; ventricular septum morphogenesis [GO:0060412] activin receptor complex [GO:0048179]; apical part of cell [GO:0045177]; BMP receptor complex [GO:0070724]; membrane [GO:0016020]; plasma membrane [GO:0005886] activin binding [GO:0048185]; activin receptor activity, type I [GO:0016361]; ATP binding [GO:0005524]; growth factor binding [GO:0019838]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; SMAD binding [GO:0046332]; transforming growth factor beta binding [GO:0050431]; transforming growth factor beta receptor activity, type I [GO:0005025] g10908.t1 Q90ZK6 53.472 288 1.03e-93 292.0 sp|Q90ZK6|ACVR1_CHICK Activin receptor type-1 OS=Gallus gallus OX=9031 GN=ACVR1 PE=2 SV=1 ACVR1_CHICK reviewed Activin receptor type-1 (EC 2.7.11.30) (Activin receptor type I) (Type I TGF B receptor) Gallus gallus (Chicken) GO:0000082; GO:0001569; GO:0001702; GO:0001707; GO:0001755; GO:0002526; GO:0003143; GO:0003181; GO:0003183; GO:0003272; GO:0003274; GO:0003289; GO:0004672; GO:0004674; GO:0005025; GO:0005524; GO:0005886; GO:0006468; GO:0007179; GO:0007281; GO:0007368; GO:0007369; GO:0007498; GO:0007507; GO:0009953; GO:0009968; GO:0010694; GO:0010718; GO:0016020; GO:0016361; GO:0016477; GO:0018107; GO:0019838; GO:0030154; GO:0030278; GO:0030335; GO:0030501; GO:0030509; GO:0030513; GO:0032924; GO:0032926; GO:0035556; GO:0042118; GO:0042803; GO:0045177; GO:0045669; GO:0045893; GO:0045944; GO:0046332; GO:0046872; GO:0048179; GO:0048185; GO:0048762; GO:0050431; GO:0051145; GO:0060037; GO:0060317; GO:0060412; GO:0060923; GO:0061445; GO:0062043; GO:0070724; GO:0071363; GO:0071773; GO:2000017; GO:2001237 activin receptor signaling pathway [GO:0032924]; acute inflammatory response [GO:0002526]; atrial septum primum morphogenesis [GO:0003289]; atrioventricular valve morphogenesis [GO:0003181]; BMP signaling pathway [GO:0030509]; branching involved in blood vessel morphogenesis [GO:0001569]; cardiac epithelial to mesenchymal transition [GO:0060317]; cardiac muscle cell fate commitment [GO:0060923]; cell differentiation [GO:0030154]; cell migration [GO:0016477]; cellular response to BMP stimulus [GO:0071773]; cellular response to growth factor stimulus [GO:0071363]; determination of left/right symmetry [GO:0007368]; dorsal/ventral pattern formation [GO:0009953]; embryonic heart tube morphogenesis [GO:0003143]; endocardial cushion cell fate commitment [GO:0061445]; endocardial cushion formation [GO:0003272]; endocardial cushion fusion [GO:0003274]; endothelial cell activation [GO:0042118]; G1/S transition of mitotic cell cycle [GO:0000082]; gastrulation [GO:0007369]; gastrulation with mouth forming second [GO:0001702]; germ cell development [GO:0007281]; heart development [GO:0007507]; intracellular signal transduction [GO:0035556]; mesenchymal cell differentiation [GO:0048762]; mesoderm development [GO:0007498]; mesoderm formation [GO:0001707]; mitral valve morphogenesis [GO:0003183]; negative regulation of activin receptor signaling pathway [GO:0032926]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of signal transduction [GO:0009968]; neural crest cell migration [GO:0001755]; peptidyl-threonine phosphorylation [GO:0018107]; pharyngeal system development [GO:0060037]; positive regulation of alkaline phosphatase activity [GO:0010694]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of bone mineralization [GO:0030501]; positive regulation of cardiac epithelial to mesenchymal transition [GO:0062043]; positive regulation of cell migration [GO:0030335]; positive regulation of determination of dorsal identity [GO:2000017]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein phosphorylation [GO:0006468]; regulation of ossification [GO:0030278]; smooth muscle cell differentiation [GO:0051145]; transforming growth factor beta receptor signaling pathway [GO:0007179]; ventricular septum morphogenesis [GO:0060412] activin receptor complex [GO:0048179]; apical part of cell [GO:0045177]; BMP receptor complex [GO:0070724]; membrane [GO:0016020]; plasma membrane [GO:0005886] activin binding [GO:0048185]; activin receptor activity, type I [GO:0016361]; ATP binding [GO:0005524]; growth factor binding [GO:0019838]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; SMAD binding [GO:0046332]; transforming growth factor beta binding [GO:0050431]; transforming growth factor beta receptor activity, type I [GO:0005025] g10910.t1 Q149M9 27.491 1626 2e-155 520.0 sp|Q149M9|NWD1_HUMAN NACHT domain- and WD repeat-containing protein 1 OS=Homo sapiens OX=9606 GN=NWD1 PE=1 SV=3 g10911.t1 Q5ZID6 49.007 302 1.1299999999999999e-104 312.0 sp|Q5ZID6|5NT3A_CHICK Cytosolic 5'-nucleotidase 3A OS=Gallus gallus OX=9031 GN=NT5C3A PE=1 SV=3 5NT3A_CHICK reviewed Cytosolic 5'-nucleotidase 3A (EC 3.1.3.5) (7-methylguanosine phosphate-specific 5'-nucleotidase) (7-methylguanosine nucleotidase) (EC 3.1.3.91) (Cytosolic 5'-nucleotidase 3) (Cytosolic 5'-nucleotidase III) (cN-III) (Pyrimidine 5'-nucleotidase 1) (P5'N-1) (P5N-1) (PN-I) Gallus gallus (Chicken) GO:0000166; GO:0000287; GO:0005737; GO:0005783; GO:0005829; GO:0006248; GO:0008253; GO:0016604; GO:0016740 CMP catabolic process [GO:0006248] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nuclear body [GO:0016604] 5'-nucleotidase activity [GO:0008253]; magnesium ion binding [GO:0000287]; nucleotide binding [GO:0000166]; transferase activity [GO:0016740] g10913.t1 Q8WXB1 51.376 218 3.3199999999999995e-54 176.0 sp|Q8WXB1|MT21A_HUMAN Protein N-lysine methyltransferase METTL21A OS=Homo sapiens OX=9606 GN=METTL21A PE=1 SV=2 MT21A_HUMAN reviewed Protein N-lysine methyltransferase METTL21A (EC 2.1.1.-) (HSPA lysine methyltransferase) (HSPA-KMT) (Hepatocellular carcinoma-associated antigen 557b) (Methyltransferase-like protein 21A) Homo sapiens (Human) GO:0005654; GO:0005829; GO:0006479; GO:0008276; GO:0016279; GO:0030544; GO:0031072; GO:0032991; GO:0051117; GO:1903333 negative regulation of protein folding [GO:1903333]; protein methylation [GO:0006479] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991] ATPase binding [GO:0051117]; heat shock protein binding [GO:0031072]; Hsp70 protein binding [GO:0030544]; protein methyltransferase activity [GO:0008276]; protein-lysine N-methyltransferase activity [GO:0016279] g10914.t1 E7F6T8 36.876 621 1.08e-90 315.0 sp|E7F6T8|UBP37_DANRE Ubiquitin carboxyl-terminal hydrolase 37 OS=Danio rerio OX=7955 GN=usp37 PE=2 SV=1 g10916.t1 Q503I8 34.842 221 2.7400000000000002e-27 111.0 sp|Q503I8|NGLY1_DANRE Peptide-N(4)-(N-acetyl-beta-glucosaminyl)asparagine amidase OS=Danio rerio OX=7955 GN=ngly1 PE=2 SV=1 NGLY1_DANRE reviewed Peptide-N(4)-(N-acetyl-beta-glucosaminyl)asparagine amidase (PNGase) (EC 3.5.1.52) (N-glycanase 1) (Peptide:N-glycanase) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000224; GO:0005634; GO:0005737; GO:0005829; GO:0006516; GO:0007519; GO:0030513; GO:0036269; GO:0042176; GO:0046872; GO:0048936; GO:1903332 glycoprotein catabolic process [GO:0006516]; peripheral nervous system neuron axonogenesis [GO:0048936]; positive regulation of BMP signaling pathway [GO:0030513]; regulation of protein catabolic process [GO:0042176]; regulation of protein folding [GO:1903332]; skeletal muscle tissue development [GO:0007519]; swimming behavior [GO:0036269] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634] metal ion binding [GO:0046872]; peptide-N4-(N-acetyl-beta-glucosaminyl)asparagine amidase activity [GO:0000224] g10917.t1 Q5ZJM3 57.071 198 1.3700000000000001e-70 229.0 sp|Q5ZJM3|NGLY1_CHICK Peptide-N(4)-(N-acetyl-beta-glucosaminyl)asparagine amidase OS=Gallus gallus OX=9031 GN=NGLY1 PE=2 SV=1 NGLY1_CHICK reviewed Peptide-N(4)-(N-acetyl-beta-glucosaminyl)asparagine amidase (PNGase) (EC 3.5.1.52) (N-glycanase 1) (Peptide:N-glycanase) Gallus gallus (Chicken) GO:0000224; GO:0005634; GO:0005737; GO:0005829; GO:0006516; GO:0030513; GO:0046872 glycoprotein catabolic process [GO:0006516]; positive regulation of BMP signaling pathway [GO:0030513] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634] metal ion binding [GO:0046872]; peptide-N4-(N-acetyl-beta-glucosaminyl)asparagine amidase activity [GO:0000224] g10917.t2 Q5ZJM3 65.0 160 1.9899999999999998e-69 226.0 sp|Q5ZJM3|NGLY1_CHICK Peptide-N(4)-(N-acetyl-beta-glucosaminyl)asparagine amidase OS=Gallus gallus OX=9031 GN=NGLY1 PE=2 SV=1 NGLY1_CHICK reviewed Peptide-N(4)-(N-acetyl-beta-glucosaminyl)asparagine amidase (PNGase) (EC 3.5.1.52) (N-glycanase 1) (Peptide:N-glycanase) Gallus gallus (Chicken) GO:0000224; GO:0005634; GO:0005737; GO:0005829; GO:0006516; GO:0030513; GO:0046872 glycoprotein catabolic process [GO:0006516]; positive regulation of BMP signaling pathway [GO:0030513] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634] metal ion binding [GO:0046872]; peptide-N4-(N-acetyl-beta-glucosaminyl)asparagine amidase activity [GO:0000224] g10923.t1 Q9IA79 56.25 224 1.84e-78 239.0 sp|Q9IA79|BI1_PAROL Probable Bax inhibitor 1 OS=Paralichthys olivaceus OX=8255 GN=tmbim6 PE=2 SV=1 g10925.t1 Q9NPF2 34.354 294 2.48e-49 172.0 sp|Q9NPF2|CHSTB_HUMAN Carbohydrate sulfotransferase 11 OS=Homo sapiens OX=9606 GN=CHST11 PE=1 SV=1 CHSTB_HUMAN reviewed Carbohydrate sulfotransferase 11 (EC 2.8.2.5) (Chondroitin 4-O-sulfotransferase 1) (Chondroitin 4-sulfotransferase 1) (C4S-1) (C4ST-1) (C4ST1) Homo sapiens (Human) GO:0000139; GO:0001537; GO:0001701; GO:0002063; GO:0006915; GO:0007179; GO:0007585; GO:0008146; GO:0009791; GO:0016020; GO:0016051; GO:0030166; GO:0030512; GO:0033037; GO:0036342; GO:0042127; GO:0042733; GO:0043066; GO:0047756; GO:0048589; GO:0048703; GO:0050650; GO:0050659 apoptotic process [GO:0006915]; carbohydrate biosynthetic process [GO:0016051]; chondrocyte development [GO:0002063]; chondroitin sulfate proteoglycan biosynthetic process [GO:0050650]; developmental growth [GO:0048589]; embryonic digit morphogenesis [GO:0042733]; embryonic viscerocranium morphogenesis [GO:0048703]; in utero embryonic development [GO:0001701]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; polysaccharide localization [GO:0033037]; post-anal tail morphogenesis [GO:0036342]; post-embryonic development [GO:0009791]; proteoglycan biosynthetic process [GO:0030166]; regulation of cell population proliferation [GO:0042127]; respiratory gaseous exchange by respiratory system [GO:0007585]; transforming growth factor beta receptor signaling pathway [GO:0007179] Golgi membrane [GO:0000139]; membrane [GO:0016020] chondroitin 4-sulfotransferase activity [GO:0047756]; dermatan 4-sulfotransferase activity [GO:0001537]; N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity [GO:0050659]; sulfotransferase activity [GO:0008146] g10926.t1 Q9JME2 37.943 282 3.33e-57 193.0 sp|Q9JME2|CHSTB_MOUSE Carbohydrate sulfotransferase 11 OS=Mus musculus OX=10090 GN=Chst11 PE=2 SV=1 CHSTB_MOUSE reviewed Carbohydrate sulfotransferase 11 (EC 2.8.2.5) (Chondroitin 4-O-sulfotransferase 1) (Chondroitin 4-sulfotransferase 1) (C4S-1) (C4ST-1) (C4ST1) Mus musculus (Mouse) GO:0000139; GO:0001537; GO:0001701; GO:0002063; GO:0007585; GO:0008146; GO:0009791; GO:0016051; GO:0030166; GO:0030326; GO:0030512; GO:0033037; GO:0036342; GO:0042127; GO:0042733; GO:0043066; GO:0047756; GO:0048589; GO:0048703; GO:0048704; GO:0050650; GO:0050654; GO:0050659; GO:0051216 carbohydrate biosynthetic process [GO:0016051]; cartilage development [GO:0051216]; chondrocyte development [GO:0002063]; chondroitin sulfate proteoglycan biosynthetic process [GO:0050650]; chondroitin sulfate proteoglycan metabolic process [GO:0050654]; developmental growth [GO:0048589]; embryonic digit morphogenesis [GO:0042733]; embryonic limb morphogenesis [GO:0030326]; embryonic skeletal system morphogenesis [GO:0048704]; embryonic viscerocranium morphogenesis [GO:0048703]; in utero embryonic development [GO:0001701]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; polysaccharide localization [GO:0033037]; post-anal tail morphogenesis [GO:0036342]; post-embryonic development [GO:0009791]; proteoglycan biosynthetic process [GO:0030166]; regulation of cell population proliferation [GO:0042127]; respiratory gaseous exchange by respiratory system [GO:0007585] Golgi membrane [GO:0000139] chondroitin 4-sulfotransferase activity [GO:0047756]; dermatan 4-sulfotransferase activity [GO:0001537]; N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity [GO:0050659]; sulfotransferase activity [GO:0008146] g10927.t1 P33610 30.184 434 7.26e-33 137.0 sp|P33610|PRI2_MOUSE DNA primase large subunit OS=Mus musculus OX=10090 GN=Prim2 PE=1 SV=1 g10928.t1 Q6PD31 38.743 764 7.74e-110 370.0 sp|Q6PD31|TRAK1_MOUSE Trafficking kinesin-binding protein 1 OS=Mus musculus OX=10090 GN=Trak1 PE=1 SV=1 TRAK1_MOUSE reviewed Trafficking kinesin-binding protein 1 (Protein Milton) Mus musculus (Mouse) GO:0005634; GO:0005737; GO:0005739; GO:0005769; GO:0005938; GO:0006605; GO:0008333; GO:0017022; GO:0019896; GO:0022008; GO:0030425; GO:0030911; GO:0031410; GO:0031966; GO:0044295; GO:0047496; GO:0048311; GO:0048471; GO:0048813; GO:0050772; GO:0050811; GO:1904115 axonal transport of mitochondrion [GO:0019896]; dendrite morphogenesis [GO:0048813]; endosome to lysosome transport [GO:0008333]; mitochondrion distribution [GO:0048311]; neurogenesis [GO:0022008]; positive regulation of axonogenesis [GO:0050772]; protein targeting [GO:0006605]; vesicle transport along microtubule [GO:0047496] axon cytoplasm [GO:1904115]; axonal growth cone [GO:0044295]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; dendrite [GO:0030425]; early endosome [GO:0005769]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471] GABA receptor binding [GO:0050811]; myosin binding [GO:0017022]; TPR domain binding [GO:0030911] g10928.t2 Q6PD31 34.487 809 2.84e-88 308.0 sp|Q6PD31|TRAK1_MOUSE Trafficking kinesin-binding protein 1 OS=Mus musculus OX=10090 GN=Trak1 PE=1 SV=1 TRAK1_MOUSE reviewed Trafficking kinesin-binding protein 1 (Protein Milton) Mus musculus (Mouse) GO:0005634; GO:0005737; GO:0005739; GO:0005769; GO:0005938; GO:0006605; GO:0008333; GO:0017022; GO:0019896; GO:0022008; GO:0030425; GO:0030911; GO:0031410; GO:0031966; GO:0044295; GO:0047496; GO:0048311; GO:0048471; GO:0048813; GO:0050772; GO:0050811; GO:1904115 axonal transport of mitochondrion [GO:0019896]; dendrite morphogenesis [GO:0048813]; endosome to lysosome transport [GO:0008333]; mitochondrion distribution [GO:0048311]; neurogenesis [GO:0022008]; positive regulation of axonogenesis [GO:0050772]; protein targeting [GO:0006605]; vesicle transport along microtubule [GO:0047496] axon cytoplasm [GO:1904115]; axonal growth cone [GO:0044295]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; dendrite [GO:0030425]; early endosome [GO:0005769]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471] GABA receptor binding [GO:0050811]; myosin binding [GO:0017022]; TPR domain binding [GO:0030911] g10928.t3 Q6PD31 34.379 797 8.040000000000001e-88 308.0 sp|Q6PD31|TRAK1_MOUSE Trafficking kinesin-binding protein 1 OS=Mus musculus OX=10090 GN=Trak1 PE=1 SV=1 TRAK1_MOUSE reviewed Trafficking kinesin-binding protein 1 (Protein Milton) Mus musculus (Mouse) GO:0005634; GO:0005737; GO:0005739; GO:0005769; GO:0005938; GO:0006605; GO:0008333; GO:0017022; GO:0019896; GO:0022008; GO:0030425; GO:0030911; GO:0031410; GO:0031966; GO:0044295; GO:0047496; GO:0048311; GO:0048471; GO:0048813; GO:0050772; GO:0050811; GO:1904115 axonal transport of mitochondrion [GO:0019896]; dendrite morphogenesis [GO:0048813]; endosome to lysosome transport [GO:0008333]; mitochondrion distribution [GO:0048311]; neurogenesis [GO:0022008]; positive regulation of axonogenesis [GO:0050772]; protein targeting [GO:0006605]; vesicle transport along microtubule [GO:0047496] axon cytoplasm [GO:1904115]; axonal growth cone [GO:0044295]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; dendrite [GO:0030425]; early endosome [GO:0005769]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471] GABA receptor binding [GO:0050811]; myosin binding [GO:0017022]; TPR domain binding [GO:0030911] g10929.t1 B2RY50 76.771 607 0.0 949.0 sp|B2RY50|ODAD2_MOUSE Outer dynein arm-docking complex subunit 2 OS=Mus musculus OX=10090 GN=Odad2 PE=1 SV=1 ODAD2_MOUSE reviewed Outer dynein arm-docking complex subunit 2 (Armadillo repeat-containing protein 4) Mus musculus (Mouse) GO:0003341; GO:0003356; GO:0005930; GO:0007368; GO:0007507; GO:0021591; GO:0036158; GO:0097546 cilium movement [GO:0003341]; determination of left/right symmetry [GO:0007368]; heart development [GO:0007507]; outer dynein arm assembly [GO:0036158]; regulation of cilium beat frequency [GO:0003356]; ventricular system development [GO:0021591] axoneme [GO:0005930]; ciliary base [GO:0097546] g10929.t1 B2RY50 42.484 306 1.22e-60 228.0 sp|B2RY50|ODAD2_MOUSE Outer dynein arm-docking complex subunit 2 OS=Mus musculus OX=10090 GN=Odad2 PE=1 SV=1 ODAD2_MOUSE reviewed Outer dynein arm-docking complex subunit 2 (Armadillo repeat-containing protein 4) Mus musculus (Mouse) GO:0003341; GO:0003356; GO:0005930; GO:0007368; GO:0007507; GO:0021591; GO:0036158; GO:0097546 cilium movement [GO:0003341]; determination of left/right symmetry [GO:0007368]; heart development [GO:0007507]; outer dynein arm assembly [GO:0036158]; regulation of cilium beat frequency [GO:0003356]; ventricular system development [GO:0021591] axoneme [GO:0005930]; ciliary base [GO:0097546] g10931.t1 O08684 41.515 1043 0.0 750.0 sp|O08684|PLD1_CRIGR Phospholipase D1 OS=Cricetulus griseus OX=10029 GN=PLD1 PE=2 SV=1 g10933.t1 Q80XC3 63.953 344 5.95e-152 454.0 sp|Q80XC3|US6NL_MOUSE USP6 N-terminal-like protein OS=Mus musculus OX=10090 GN=Usp6nl PE=1 SV=2 g10934.t1 Q16611 39.881 168 1.34e-36 132.0 sp|Q16611|BAK_HUMAN Bcl-2 homologous antagonist/killer OS=Homo sapiens OX=9606 GN=BAK1 PE=1 SV=1 BAK_HUMAN reviewed Bcl-2 homologous antagonist/killer (Apoptosis regulator BAK) (Bcl-2-like protein 7) (Bcl2-L-7) Homo sapiens (Human) GO:0001782; GO:0001783; GO:0001836; GO:0001974; GO:0002262; GO:0002352; GO:0005739; GO:0005741; GO:0005783; GO:0005829; GO:0006915; GO:0008053; GO:0008285; GO:0008630; GO:0009410; GO:0009620; GO:0010046; GO:0010225; GO:0010248; GO:0010332; GO:0010524; GO:0010629; GO:0015267; GO:0015288; GO:0031018; GO:0031072; GO:0031100; GO:0031334; GO:0032469; GO:0032471; GO:0034620; GO:0034644; GO:0035108; GO:0042542; GO:0042802; GO:0042803; GO:0043065; GO:0044325; GO:0044346; GO:0044877; GO:0045471; GO:0045862; GO:0046872; GO:0046902; GO:0046930; GO:0046982; GO:0048597; GO:0050673; GO:0051087; GO:0051400; GO:0051726; GO:0051881; GO:0060068; GO:0060402; GO:0070059; GO:0070242; GO:0071260; GO:0090200; GO:0090201; GO:0097136; GO:0097145; GO:0097190; GO:0097192; GO:0097193; GO:1901029; GO:1901030; GO:1902262; GO:1903896 animal organ regeneration [GO:0031100]; apoptotic process [GO:0006915]; apoptotic process involved in blood vessel morphogenesis [GO:1902262]; apoptotic signaling pathway [GO:0097190]; B cell apoptotic process [GO:0001783]; B cell homeostasis [GO:0001782]; B cell negative selection [GO:0002352]; blood vessel remodeling [GO:0001974]; calcium ion transport into cytosol [GO:0060402]; cellular response to mechanical stimulus [GO:0071260]; cellular response to unfolded protein [GO:0034620]; cellular response to UV [GO:0034644]; endocrine pancreas development [GO:0031018]; endoplasmic reticulum calcium ion homeostasis [GO:0032469]; epithelial cell proliferation [GO:0050673]; establishment or maintenance of transmembrane electrochemical gradient [GO:0010248]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; fibroblast apoptotic process [GO:0044346]; intrinsic apoptotic signaling pathway [GO:0097193]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; limb morphogenesis [GO:0035108]; mitochondrial fusion [GO:0008053]; myeloid cell homeostasis [GO:0002262]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of endoplasmic reticulum calcium ion concentration [GO:0032471]; negative regulation of gene expression [GO:0010629]; negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901029]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; positive regulation of apoptotic process [GO:0043065]; positive regulation of calcium ion transport into cytosol [GO:0010524]; positive regulation of IRE1-mediated unfolded protein response [GO:1903896]; positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901030]; positive regulation of protein-containing complex assembly [GO:0031334]; positive regulation of proteolysis [GO:0045862]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; post-embryonic camera-type eye morphogenesis [GO:0048597]; regulation of cell cycle [GO:0051726]; regulation of mitochondrial membrane permeability [GO:0046902]; regulation of mitochondrial membrane potential [GO:0051881]; release of cytochrome c from mitochondria [GO:0001836]; response to ethanol [GO:0045471]; response to fungus [GO:0009620]; response to gamma radiation [GO:0010332]; response to hydrogen peroxide [GO:0042542]; response to mycotoxin [GO:0010046]; response to UV-C [GO:0010225]; response to xenobiotic stimulus [GO:0009410]; thymocyte apoptotic process [GO:0070242]; vagina development [GO:0060068] BAK complex [GO:0097145]; Bcl-2 family protein complex [GO:0097136]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; pore complex [GO:0046930] BH domain binding [GO:0051400]; channel activity [GO:0015267]; heat shock protein binding [GO:0031072]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; porin activity [GO:0015288]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; protein-folding chaperone binding [GO:0051087]; transmembrane transporter binding [GO:0044325] g10934.t2 Q16611 38.172 186 1.95e-37 132.0 sp|Q16611|BAK_HUMAN Bcl-2 homologous antagonist/killer OS=Homo sapiens OX=9606 GN=BAK1 PE=1 SV=1 BAK_HUMAN reviewed Bcl-2 homologous antagonist/killer (Apoptosis regulator BAK) (Bcl-2-like protein 7) (Bcl2-L-7) Homo sapiens (Human) GO:0001782; GO:0001783; GO:0001836; GO:0001974; GO:0002262; GO:0002352; GO:0005739; GO:0005741; GO:0005783; GO:0005829; GO:0006915; GO:0008053; GO:0008285; GO:0008630; GO:0009410; GO:0009620; GO:0010046; GO:0010225; GO:0010248; GO:0010332; GO:0010524; GO:0010629; GO:0015267; GO:0015288; GO:0031018; GO:0031072; GO:0031100; GO:0031334; GO:0032469; GO:0032471; GO:0034620; GO:0034644; GO:0035108; GO:0042542; GO:0042802; GO:0042803; GO:0043065; GO:0044325; GO:0044346; GO:0044877; GO:0045471; GO:0045862; GO:0046872; GO:0046902; GO:0046930; GO:0046982; GO:0048597; GO:0050673; GO:0051087; GO:0051400; GO:0051726; GO:0051881; GO:0060068; GO:0060402; GO:0070059; GO:0070242; GO:0071260; GO:0090200; GO:0090201; GO:0097136; GO:0097145; GO:0097190; GO:0097192; GO:0097193; GO:1901029; GO:1901030; GO:1902262; GO:1903896 animal organ regeneration [GO:0031100]; apoptotic process [GO:0006915]; apoptotic process involved in blood vessel morphogenesis [GO:1902262]; apoptotic signaling pathway [GO:0097190]; B cell apoptotic process [GO:0001783]; B cell homeostasis [GO:0001782]; B cell negative selection [GO:0002352]; blood vessel remodeling [GO:0001974]; calcium ion transport into cytosol [GO:0060402]; cellular response to mechanical stimulus [GO:0071260]; cellular response to unfolded protein [GO:0034620]; cellular response to UV [GO:0034644]; endocrine pancreas development [GO:0031018]; endoplasmic reticulum calcium ion homeostasis [GO:0032469]; epithelial cell proliferation [GO:0050673]; establishment or maintenance of transmembrane electrochemical gradient [GO:0010248]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; fibroblast apoptotic process [GO:0044346]; intrinsic apoptotic signaling pathway [GO:0097193]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; limb morphogenesis [GO:0035108]; mitochondrial fusion [GO:0008053]; myeloid cell homeostasis [GO:0002262]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of endoplasmic reticulum calcium ion concentration [GO:0032471]; negative regulation of gene expression [GO:0010629]; negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901029]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; positive regulation of apoptotic process [GO:0043065]; positive regulation of calcium ion transport into cytosol [GO:0010524]; positive regulation of IRE1-mediated unfolded protein response [GO:1903896]; positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901030]; positive regulation of protein-containing complex assembly [GO:0031334]; positive regulation of proteolysis [GO:0045862]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; post-embryonic camera-type eye morphogenesis [GO:0048597]; regulation of cell cycle [GO:0051726]; regulation of mitochondrial membrane permeability [GO:0046902]; regulation of mitochondrial membrane potential [GO:0051881]; release of cytochrome c from mitochondria [GO:0001836]; response to ethanol [GO:0045471]; response to fungus [GO:0009620]; response to gamma radiation [GO:0010332]; response to hydrogen peroxide [GO:0042542]; response to mycotoxin [GO:0010046]; response to UV-C [GO:0010225]; response to xenobiotic stimulus [GO:0009410]; thymocyte apoptotic process [GO:0070242]; vagina development [GO:0060068] BAK complex [GO:0097145]; Bcl-2 family protein complex [GO:0097136]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; pore complex [GO:0046930] BH domain binding [GO:0051400]; channel activity [GO:0015267]; heat shock protein binding [GO:0031072]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; porin activity [GO:0015288]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; protein-folding chaperone binding [GO:0051087]; transmembrane transporter binding [GO:0044325] g10944.t1 Q5RFH9 45.417 240 1.9199999999999998e-74 229.0 sp|Q5RFH9|AT5F1_PONAB ATP synthase peripheral stalk subunit b, mitochondrial OS=Pongo abelii OX=9601 GN=ATP5PB PE=2 SV=1 g10945.t1 D4A7U2 46.526 331 3.4799999999999996e-82 277.0 sp|D4A7U2|CARTF_RAT Calcium-responsive transcription factor OS=Rattus norvegicus OX=10116 GN=Carf PE=1 SV=1 g10949.t1 P62907 79.07 215 4.2e-111 320.0 sp|P62907|RL10A_RAT Large ribosomal subunit protein uL1 OS=Rattus norvegicus OX=10116 GN=Rpl10a PE=1 SV=2 g10950.t1 Q8BY87 52.527 554 2.95e-174 533.0 sp|Q8BY87|UBP47_MOUSE Ubiquitin carboxyl-terminal hydrolase 47 OS=Mus musculus OX=10090 GN=Usp47 PE=1 SV=2 UBP47_MOUSE reviewed Ubiquitin carboxyl-terminal hydrolase 47 (EC 3.4.19.12) (Deubiquitinating enzyme 47) (Ubiquitin thioesterase 47) (Ubiquitin-specific-processing protease 47) Mus musculus (Mouse) GO:0004843; GO:0005634; GO:0005737; GO:0005829; GO:0006284; GO:0006508; GO:0006974; GO:0019005; GO:0031647; GO:0035520; GO:0071987; GO:0090263; GO:0101005; GO:1902230 base-excision repair [GO:0006284]; DNA damage response [GO:0006974]; monoubiquitinated protein deubiquitination [GO:0035520]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage [GO:1902230]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; proteolysis [GO:0006508]; regulation of protein stability [GO:0031647] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005] cysteine-type deubiquitinase activity [GO:0004843]; deubiquitinase activity [GO:0101005]; WD40-repeat domain binding [GO:0071987] g10951.t1 E1C1R4 58.511 188 3.91e-55 204.0 sp|E1C1R4|UBP47_CHICK Ubiquitin carboxyl-terminal hydrolase 47 OS=Gallus gallus OX=9031 GN=USP47 PE=3 SV=1 g10951.t1 E1C1R4 53.642 151 9.12e-41 162.0 sp|E1C1R4|UBP47_CHICK Ubiquitin carboxyl-terminal hydrolase 47 OS=Gallus gallus OX=9031 GN=USP47 PE=3 SV=1 g10952.t1 E1C1R4 60.87 115 3.03e-33 127.0 sp|E1C1R4|UBP47_CHICK Ubiquitin carboxyl-terminal hydrolase 47 OS=Gallus gallus OX=9031 GN=USP47 PE=3 SV=1 g10953.t1 Q16543 57.778 225 8.78e-82 253.0 sp|Q16543|CDC37_HUMAN Hsp90 co-chaperone Cdc37 OS=Homo sapiens OX=9606 GN=CDC37 PE=1 SV=1 g10953.t2 Q16543 46.698 424 3.3e-115 345.0 sp|Q16543|CDC37_HUMAN Hsp90 co-chaperone Cdc37 OS=Homo sapiens OX=9606 GN=CDC37 PE=1 SV=1 g10953.t3 Q9DGQ7 61.176 85 1.36e-29 112.0 sp|Q9DGQ7|CDC37_DICFU Hsp90 co-chaperone Cdc37 OS=Dichotomyctere fluviatilis OX=2593188 GN=cdc37 PE=3 SV=1 g10954.t1 A6H730 36.544 353 4.36e-72 233.0 sp|A6H730|PPAP_BOVIN Prostatic acid phosphatase OS=Bos taurus OX=9913 GN=ACP3 PE=2 SV=1 PPAP_BOVIN reviewed Prostatic acid phosphatase (EC 3.1.3.2) (Protein tyrosine phosphatase ACP3) (EC 3.1.3.48) Bos taurus (Bovine) GO:0003993; GO:0004725; GO:0005615; GO:0005886; GO:0006629; GO:0006772; GO:0008253; GO:0012506; GO:0016791; GO:0042131; GO:0046085; GO:0051930; GO:0052642; GO:0060168 adenosine metabolic process [GO:0046085]; lipid metabolic process [GO:0006629]; positive regulation of adenosine receptor signaling pathway [GO:0060168]; regulation of sensory perception of pain [GO:0051930]; thiamine metabolic process [GO:0006772] extracellular space [GO:0005615]; plasma membrane [GO:0005886]; vesicle membrane [GO:0012506] 5'-nucleotidase activity [GO:0008253]; acid phosphatase activity [GO:0003993]; lysophosphatidic acid phosphatase activity [GO:0052642]; phosphatase activity [GO:0016791]; protein tyrosine phosphatase activity [GO:0004725]; thiamine phosphate phosphatase activity [GO:0042131] g10954.t2 A6H730 56.115 139 8.12e-50 176.0 sp|A6H730|PPAP_BOVIN Prostatic acid phosphatase OS=Bos taurus OX=9913 GN=ACP3 PE=2 SV=1 PPAP_BOVIN reviewed Prostatic acid phosphatase (EC 3.1.3.2) (Protein tyrosine phosphatase ACP3) (EC 3.1.3.48) Bos taurus (Bovine) GO:0003993; GO:0004725; GO:0005615; GO:0005886; GO:0006629; GO:0006772; GO:0008253; GO:0012506; GO:0016791; GO:0042131; GO:0046085; GO:0051930; GO:0052642; GO:0060168 adenosine metabolic process [GO:0046085]; lipid metabolic process [GO:0006629]; positive regulation of adenosine receptor signaling pathway [GO:0060168]; regulation of sensory perception of pain [GO:0051930]; thiamine metabolic process [GO:0006772] extracellular space [GO:0005615]; plasma membrane [GO:0005886]; vesicle membrane [GO:0012506] 5'-nucleotidase activity [GO:0008253]; acid phosphatase activity [GO:0003993]; lysophosphatidic acid phosphatase activity [GO:0052642]; phosphatase activity [GO:0016791]; protein tyrosine phosphatase activity [GO:0004725]; thiamine phosphate phosphatase activity [GO:0042131] g10955.t1 Q00492 75.472 265 2.93e-129 369.0 sp|Q00492|SUM1_LYTVA Transcription factor SUM-1 OS=Lytechinus variegatus OX=7654 GN=SUM-1 PE=2 SV=1 g10963.t1 Q96A58 38.974 195 3.09e-41 142.0 sp|Q96A58|RERG_HUMAN Ras-related and estrogen-regulated growth inhibitor OS=Homo sapiens OX=9606 GN=RERG PE=1 SV=1 RERG_HUMAN reviewed Ras-related and estrogen-regulated growth inhibitor (EC 3.6.5.2) Homo sapiens (Human) GO:0001650; GO:0003924; GO:0003925; GO:0005525; GO:0005634; GO:0005654; GO:0005829; GO:0005886; GO:0007264; GO:0008285; GO:0009725; GO:0019003; GO:0030308; GO:0030331 negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; response to hormone [GO:0009725]; small GTPase-mediated signal transduction [GO:0007264] cytosol [GO:0005829]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886] G protein activity [GO:0003925]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; nuclear estrogen receptor binding [GO:0030331] g10964.t1 Q3TC46 35.038 391 1.7700000000000002e-64 235.0 sp|Q3TC46|PATL1_MOUSE Protein PAT1 homolog 1 OS=Mus musculus OX=10090 GN=Patl1 PE=1 SV=2 PATL1_MOUSE reviewed Protein PAT1 homolog 1 (PAT1-like protein 1) (Protein PAT1 homolog b) (Pat1b) Mus musculus (Mouse) GO:0000290; GO:0000932; GO:0002151; GO:0003723; GO:0005737; GO:0005829; GO:0008266; GO:0016605; GO:0016607; GO:0017148; GO:0030014; GO:0030371; GO:0033962; GO:0034046; GO:0036464 deadenylation-dependent decapping of nuclear-transcribed mRNA [GO:0000290]; negative regulation of translation [GO:0017148]; P-body assembly [GO:0033962] CCR4-NOT complex [GO:0030014]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; P-body [GO:0000932]; PML body [GO:0016605] G-quadruplex RNA binding [GO:0002151]; poly(G) binding [GO:0034046]; poly(U) RNA binding [GO:0008266]; RNA binding [GO:0003723]; translation repressor activity [GO:0030371] g10964.t2 Q3TC46 35.038 391 1.65e-64 236.0 sp|Q3TC46|PATL1_MOUSE Protein PAT1 homolog 1 OS=Mus musculus OX=10090 GN=Patl1 PE=1 SV=2 PATL1_MOUSE reviewed Protein PAT1 homolog 1 (PAT1-like protein 1) (Protein PAT1 homolog b) (Pat1b) Mus musculus (Mouse) GO:0000290; GO:0000932; GO:0002151; GO:0003723; GO:0005737; GO:0005829; GO:0008266; GO:0016605; GO:0016607; GO:0017148; GO:0030014; GO:0030371; GO:0033962; GO:0034046; GO:0036464 deadenylation-dependent decapping of nuclear-transcribed mRNA [GO:0000290]; negative regulation of translation [GO:0017148]; P-body assembly [GO:0033962] CCR4-NOT complex [GO:0030014]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; P-body [GO:0000932]; PML body [GO:0016605] G-quadruplex RNA binding [GO:0002151]; poly(G) binding [GO:0034046]; poly(U) RNA binding [GO:0008266]; RNA binding [GO:0003723]; translation repressor activity [GO:0030371] g10965.t1 Q24180 64.348 115 2.7e-40 156.0 sp|Q24180|DEAF1_DROME Deformed epidermal autoregulatory factor 1 OS=Drosophila melanogaster OX=7227 GN=Deaf1 PE=1 SV=1 DEAF1_DROME reviewed Deformed epidermal autoregulatory factor 1 (Protein DEAF-1) Drosophila melanogaster (Fruit fly) GO:0000981; GO:0003700; GO:0005634; GO:0005700; GO:0006357; GO:0008270; GO:0009792; GO:0043565; GO:0045893; GO:0050776 embryo development ending in birth or egg hatching [GO:0009792]; positive regulation of DNA-templated transcription [GO:0045893]; regulation of immune response [GO:0050776]; regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634]; polytene chromosome [GO:0005700] DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270] g10967.t1 Q8IUR5 44.314 853 0.0 632.0 sp|Q8IUR5|TMTC1_HUMAN Protein O-mannosyl-transferase TMTC1 OS=Homo sapiens OX=9606 GN=TMTC1 PE=1 SV=3 g10968.t1 A0AVK6 39.873 474 8.82e-83 295.0 sp|A0AVK6|E2F8_HUMAN Transcription factor E2F8 OS=Homo sapiens OX=9606 GN=E2F8 PE=1 SV=1 E2F8_HUMAN reviewed Transcription factor E2F8 (E2F-8) Homo sapiens (Human) GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0000987; GO:0001217; GO:0001227; GO:0001890; GO:0002040; GO:0003700; GO:0005654; GO:0005730; GO:0005829; GO:0006357; GO:0032466; GO:0032877; GO:0033301; GO:0042802; GO:0045944; GO:0048144; GO:0060707; GO:0060718; GO:0070365; GO:0090575; GO:1990837 cell cycle comprising mitosis without cytokinesis [GO:0033301]; chorionic trophoblast cell differentiation [GO:0060718]; fibroblast proliferation [GO:0048144]; hepatocyte differentiation [GO:0070365]; negative regulation of cytokinesis [GO:0032466]; negative regulation of transcription by RNA polymerase II [GO:0000122]; placenta development [GO:0001890]; positive regulation of DNA endoreduplication [GO:0032877]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; sprouting angiogenesis [GO:0002040]; trophoblast giant cell differentiation [GO:0060707] chromatin [GO:0000785]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; RNA polymerase II transcription regulator complex [GO:0090575] cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity [GO:0001217]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; identical protein binding [GO:0042802]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837] g10970.t1 P97610 47.015 268 1.24e-78 252.0 sp|P97610|SYT12_RAT Synaptotagmin-12 OS=Rattus norvegicus OX=10116 GN=Syt12 PE=1 SV=1 SYT12_RAT reviewed Synaptotagmin-12 (Synaptotagmin XII) (SytXII) (Synaptotagmin-related gene 1 protein) (Srg1) Rattus norvegicus (Rat) GO:0000149; GO:0005544; GO:0005886; GO:0008021; GO:0016192; GO:0017158; GO:0030672; GO:0046928; GO:0048792; GO:0060291; GO:0061891; GO:0070382; GO:0098686; GO:0098793; GO:0099171 long-term synaptic potentiation [GO:0060291]; presynaptic modulation of chemical synaptic transmission [GO:0099171]; regulation of calcium ion-dependent exocytosis [GO:0017158]; regulation of neurotransmitter secretion [GO:0046928]; spontaneous exocytosis of neurotransmitter [GO:0048792]; vesicle-mediated transport [GO:0016192] exocytic vesicle [GO:0070382]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672] calcium ion sensor activity [GO:0061891]; calcium-dependent phospholipid binding [GO:0005544]; SNARE binding [GO:0000149] g10976.t1 A8T6P4 39.286 168 1.89e-33 139.0 sp|A8T6P4|MYRIP_DANRE Rab effector MyRIP OS=Danio rerio OX=7955 GN=myrip PE=1 SV=1 MYRIP_DANRE reviewed Rab effector MyRIP (Exophilin-8) (Myosin VIIa- and Rab-interacting protein) (Synaptotagmin-like protein lacking C2 domains C) (SlaC2-c) (Slp homolog lacking C2 domains c) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0003779; GO:0006886; GO:0008270; GO:0017022; GO:0030133; GO:0030864; GO:0031267; GO:0048471 intracellular protein transport [GO:0006886] cortical actin cytoskeleton [GO:0030864]; perinuclear region of cytoplasm [GO:0048471]; transport vesicle [GO:0030133] actin binding [GO:0003779]; myosin binding [GO:0017022]; small GTPase binding [GO:0031267]; zinc ion binding [GO:0008270] g10977.t1 Q7ZUZ0 57.219 187 1.39e-76 230.0 sp|Q7ZUZ0|CSN8_DANRE COP9 signalosome complex subunit 8 OS=Danio rerio OX=7955 GN=cops8 PE=2 SV=1 g10978.t1 Q08CH3 44.977 438 7.959999999999999e-128 382.0 sp|Q08CH3|MPND_DANRE MPN domain-containing protein OS=Danio rerio OX=7955 GN=mpnd PE=2 SV=1 g10979.t1 Q9BZF3 52.212 113 1.98e-31 123.0 sp|Q9BZF3|OSBL6_HUMAN Oxysterol-binding protein-related protein 6 OS=Homo sapiens OX=9606 GN=OSBPL6 PE=1 SV=1 g10980.t1 Q8BXR9 49.74 577 8.92e-175 528.0 sp|Q8BXR9|OSBL6_MOUSE Oxysterol-binding protein-related protein 6 OS=Mus musculus OX=10090 GN=Osbpl6 PE=1 SV=1 OSBL6_MOUSE reviewed Oxysterol-binding protein-related protein 6 (ORP-6) (OSBP-related protein 6) Mus musculus (Mouse) GO:0005789; GO:0005829; GO:0005886; GO:0006699; GO:0015485; GO:0031901; GO:0031965; GO:0032374; GO:0097038; GO:0120015 bile acid biosynthetic process [GO:0006699]; regulation of cholesterol transport [GO:0032374] cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endoplasmic reticulum membrane [GO:0005789]; nuclear membrane [GO:0031965]; perinuclear endoplasmic reticulum [GO:0097038]; plasma membrane [GO:0005886] cholesterol binding [GO:0015485]; sterol transfer activity [GO:0120015] g10980.t2 Q8BXR9 50.362 552 1.0900000000000001e-167 511.0 sp|Q8BXR9|OSBL6_MOUSE Oxysterol-binding protein-related protein 6 OS=Mus musculus OX=10090 GN=Osbpl6 PE=1 SV=1 OSBL6_MOUSE reviewed Oxysterol-binding protein-related protein 6 (ORP-6) (OSBP-related protein 6) Mus musculus (Mouse) GO:0005789; GO:0005829; GO:0005886; GO:0006699; GO:0015485; GO:0031901; GO:0031965; GO:0032374; GO:0097038; GO:0120015 bile acid biosynthetic process [GO:0006699]; regulation of cholesterol transport [GO:0032374] cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endoplasmic reticulum membrane [GO:0005789]; nuclear membrane [GO:0031965]; perinuclear endoplasmic reticulum [GO:0097038]; plasma membrane [GO:0005886] cholesterol binding [GO:0015485]; sterol transfer activity [GO:0120015] g10984.t1 Q15542 61.148 610 0.0 746.0 sp|Q15542|TAF5_HUMAN Transcription initiation factor TFIID subunit 5 OS=Homo sapiens OX=9606 GN=TAF5 PE=1 SV=3 TAF5_HUMAN reviewed Transcription initiation factor TFIID subunit 5 (Transcription initiation factor TFIID 100 kDa subunit) (TAF(II)100) (TAFII-100) (TAFII100) Homo sapiens (Human) GO:0000785; GO:0005634; GO:0005654; GO:0005669; GO:0006282; GO:0006352; GO:0006357; GO:0006367; GO:0015629; GO:0016251; GO:0033276; GO:0042789; GO:0042802; GO:0045893; GO:0051123; GO:0060261 DNA-templated transcription initiation [GO:0006352]; mRNA transcription by RNA polymerase II [GO:0042789]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription initiation by RNA polymerase II [GO:0060261]; regulation of DNA repair [GO:0006282]; regulation of transcription by RNA polymerase II [GO:0006357]; RNA polymerase II preinitiation complex assembly [GO:0051123]; transcription initiation at RNA polymerase II promoter [GO:0006367] actin cytoskeleton [GO:0015629]; chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor TFIID complex [GO:0005669]; transcription factor TFTC complex [GO:0033276] identical protein binding [GO:0042802]; RNA polymerase II general transcription initiation factor activity [GO:0016251] g10985.t1 Q5XIC8 46.512 258 1.03e-67 227.0 sp|Q5XIC8|ALKB3_RAT Alpha-ketoglutarate-dependent dioxygenase alkB homolog 3 OS=Rattus norvegicus OX=10116 GN=Alkbh3 PE=2 SV=1 ALKB3_RAT reviewed Alpha-ketoglutarate-dependent dioxygenase alkB homolog 3 (EC 1.14.11.33) (EC 1.14.11.54) (Alkylated DNA repair protein alkB homolog 3) Rattus norvegicus (Rat) GO:0005654; GO:0005739; GO:0005829; GO:0006281; GO:0006307; GO:0008198; GO:0008283; GO:0016706; GO:0035515; GO:0035516; GO:0051747; GO:1990930; GO:2000766 cell population proliferation [GO:0008283]; DNA alkylation repair [GO:0006307]; DNA repair [GO:0006281]; negative regulation of cytoplasmic translation [GO:2000766] cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654] 2-oxoglutarate-dependent dioxygenase activity [GO:0016706]; broad specificity oxidative DNA demethylase activity [GO:0035516]; cytosine C-5 DNA demethylase activity [GO:0051747]; ferrous iron binding [GO:0008198]; mRNA N1-methyladenosine dioxygenase activity [GO:1990930]; oxidative RNA demethylase activity [GO:0035515] g10985.t2 Q5XIC8 46.512 258 1.01e-67 227.0 sp|Q5XIC8|ALKB3_RAT Alpha-ketoglutarate-dependent dioxygenase alkB homolog 3 OS=Rattus norvegicus OX=10116 GN=Alkbh3 PE=2 SV=1 ALKB3_RAT reviewed Alpha-ketoglutarate-dependent dioxygenase alkB homolog 3 (EC 1.14.11.33) (EC 1.14.11.54) (Alkylated DNA repair protein alkB homolog 3) Rattus norvegicus (Rat) GO:0005654; GO:0005739; GO:0005829; GO:0006281; GO:0006307; GO:0008198; GO:0008283; GO:0016706; GO:0035515; GO:0035516; GO:0051747; GO:1990930; GO:2000766 cell population proliferation [GO:0008283]; DNA alkylation repair [GO:0006307]; DNA repair [GO:0006281]; negative regulation of cytoplasmic translation [GO:2000766] cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654] 2-oxoglutarate-dependent dioxygenase activity [GO:0016706]; broad specificity oxidative DNA demethylase activity [GO:0035516]; cytosine C-5 DNA demethylase activity [GO:0051747]; ferrous iron binding [GO:0008198]; mRNA N1-methyladenosine dioxygenase activity [GO:1990930]; oxidative RNA demethylase activity [GO:0035515] g10986.t1 Q6DCX5 31.45 407 1.89e-51 185.0 sp|Q6DCX5|PCFT_XENLA Proton-coupled folate transporter OS=Xenopus laevis OX=8355 GN=slc46a1 PE=2 SV=1 PCFT_XENLA reviewed Proton-coupled folate transporter (Heme carrier protein 1) (Solute carrier family 46 member 1) Xenopus laevis (African clawed frog) GO:0005542; GO:0005768; GO:0005886; GO:0010008; GO:0015293; GO:0015350; GO:0016323; GO:0016324; GO:0022857; GO:0055085 transmembrane transport [GO:0055085] apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; endosome [GO:0005768]; endosome membrane [GO:0010008]; plasma membrane [GO:0005886] folic acid binding [GO:0005542]; methotrexate transmembrane transporter activity [GO:0015350]; symporter activity [GO:0015293]; transmembrane transporter activity [GO:0022857] g10987.t1 Q7ZWG6 32.178 404 2.65e-53 191.0 sp|Q7ZWG6|PCFT_DANRE Proton-coupled folate transporter OS=Danio rerio OX=7955 GN=slc46a1 PE=2 SV=1 PCFT_DANRE reviewed Proton-coupled folate transporter (Solute carrier family 46 member 1) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005542; GO:0005768; GO:0005886; GO:0010008; GO:0015293; GO:0015350; GO:0016323; GO:0016324; GO:0022857; GO:0055085 transmembrane transport [GO:0055085] apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; endosome [GO:0005768]; endosome membrane [GO:0010008]; plasma membrane [GO:0005886] folic acid binding [GO:0005542]; methotrexate transmembrane transporter activity [GO:0015350]; symporter activity [GO:0015293]; transmembrane transporter activity [GO:0022857] g10988.t1 Q07263 24.895 478 4.22e-45 167.0 sp|Q07263|ACHA3_BOVIN Neuronal acetylcholine receptor subunit alpha-3 OS=Bos taurus OX=9913 GN=CHRNA3 PE=2 SV=1 g10990.t1 P05091 55.513 517 0.0 535.0 sp|P05091|ALDH2_HUMAN Aldehyde dehydrogenase, mitochondrial OS=Homo sapiens OX=9606 GN=ALDH2 PE=1 SV=2 ALDH2_HUMAN reviewed Aldehyde dehydrogenase, mitochondrial (EC 1.2.1.3) (ALDH class 2) (ALDH-E2) (ALDHI) Homo sapiens (Human) GO:0004029; GO:0004030; GO:0005739; GO:0005759; GO:0005975; GO:0006066; GO:0006067; GO:0006068; GO:0008957; GO:0009055; GO:0018937; GO:0046185; GO:0051287; GO:0070062; GO:0106435; GO:0110095; GO:1903179; GO:1905627 alcohol metabolic process [GO:0006066]; aldehyde catabolic process [GO:0046185]; carbohydrate metabolic process [GO:0005975]; cellular detoxification of aldehyde [GO:0110095]; ethanol catabolic process [GO:0006068]; ethanol metabolic process [GO:0006067]; nitroglycerin metabolic process [GO:0018937]; regulation of dopamine biosynthetic process [GO:1903179]; regulation of serotonin biosynthetic process [GO:1905627] extracellular exosome [GO:0070062]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] aldehyde dehydrogenase (NAD+) activity [GO:0004029]; aldehyde dehydrogenase [NAD(P)+] activity [GO:0004030]; carboxylesterase activity [GO:0106435]; electron transfer activity [GO:0009055]; NAD binding [GO:0051287]; phenylacetaldehyde dehydrogenase (NAD+) activity [GO:0008957] g10991.t1 A2RUC4 60.396 303 6.84e-139 398.0 sp|A2RUC4|TYW5_HUMAN tRNA wybutosine-synthesizing protein 5 OS=Homo sapiens OX=9606 GN=TYW5 PE=1 SV=1 TYW5_HUMAN reviewed tRNA wybutosine-synthesizing protein 5 (hTYW5) (tRNA yW-synthesizing protein 5) (EC 1.14.11.42) (tRNA(Phe) (7-(3-amino-3-carboxypropyl)wyosine(37)-C(2))-hydroxylase) Homo sapiens (Human) GO:0000049; GO:0005506; GO:0005737; GO:0031591; GO:0042803; GO:0102524 wybutosine biosynthetic process [GO:0031591] cytoplasm [GO:0005737] iron ion binding [GO:0005506]; protein homodimerization activity [GO:0042803]; tRNA binding [GO:0000049]; tRNA(Phe) (7-(3-amino-3-carboxypropyl)wyosine37-C2)-hydroxylase activity [GO:0102524] g10992.t1 Q6AY04 31.527 203 6.07e-36 132.0 sp|Q6AY04|MAIP1_RAT m-AAA protease-interacting protein 1, mitochondrial OS=Rattus norvegicus OX=10116 GN=Maip1 PE=2 SV=1 g11003.t1 X1WER2 74.865 370 0.0 538.0 sp|X1WER2|UBA5_DANRE Ubiquitin-like modifier-activating enzyme 5 OS=Danio rerio OX=7955 GN=uba5 PE=3 SV=2 g11004.t1 A0JM23 44.012 1311 0.0 979.0 sp|A0JM23|NPHP3_XENTR Nephrocystin-3 OS=Xenopus tropicalis OX=8364 GN=nphp3 PE=2 SV=2 g11006.t1 Q8BWW4 47.771 314 9.93e-74 260.0 sp|Q8BWW4|LARP4_MOUSE La-related protein 4 OS=Mus musculus OX=10090 GN=Larp4 PE=1 SV=2 g11007.t1 Q9VZS3 51.376 109 5.13e-30 106.0 sp|Q9VZS3|ETIF1_DROME Eukaryotic translation initiation factor eIF1 OS=Drosophila melanogaster OX=7227 GN=eIF1 PE=1 SV=1 g11008.t1 Q5FWL3 63.95 319 2.55e-160 452.0 sp|Q5FWL3|RNF41_XENLA E3 ubiquitin-protein ligase NRDP1 OS=Xenopus laevis OX=8355 GN=rnf41 PE=2 SV=1 g11010.t1 E9Q5F9 51.319 417 2.59e-116 418.0 sp|E9Q5F9|SETD2_MOUSE Histone-lysine N-methyltransferase SETD2 OS=Mus musculus OX=10090 GN=Setd2 PE=1 SV=1 g11010.t1 E9Q5F9 68.072 166 1.17e-56 223.0 sp|E9Q5F9|SETD2_MOUSE Histone-lysine N-methyltransferase SETD2 OS=Mus musculus OX=10090 GN=Setd2 PE=1 SV=1 g11011.t1 P98158 38.028 213 4.6800000000000005e-21 103.0 sp|P98158|LRP2_RAT Low-density lipoprotein receptor-related protein 2 OS=Rattus norvegicus OX=10116 GN=Lrp2 PE=1 SV=1 g11012.t1 P18519 31.142 289 3.57e-36 137.0 sp|P18519|TNR16_CHICK Tumor necrosis factor receptor superfamily member 16 OS=Gallus gallus OX=9031 GN=NGFR PE=2 SV=1 g11014.t1 Q14790 40.392 255 3.73e-51 185.0 sp|Q14790|CASP8_HUMAN Caspase-8 OS=Homo sapiens OX=9606 GN=CASP8 PE=1 SV=1 g11017.t1 Q8N159 43.287 432 9.09e-114 352.0 sp|Q8N159|NAGS_HUMAN N-acetylglutamate synthase, mitochondrial OS=Homo sapiens OX=9606 GN=NAGS PE=1 SV=1 NAGS_HUMAN reviewed N-acetylglutamate synthase, mitochondrial (EC 2.3.1.1) (Amino-acid acetyltransferase) [Cleaved into: N-acetylglutamate synthase long form; N-acetylglutamate synthase short form; N-acetylglutamate synthase conserved domain form] Homo sapiens (Human) GO:0000050; GO:0004042; GO:0005739; GO:0005759; GO:0006526; GO:0006536 glutamate metabolic process [GO:0006536]; L-arginine biosynthetic process [GO:0006526]; urea cycle [GO:0000050] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] L-glutamate N-acetyltransferase activity [GO:0004042] g11018.t1 F1P4W9 39.253 1740 0.0 1221.0 sp|F1P4W9|CFA65_CHICK Cilia- and flagella-associated protein 65 OS=Gallus gallus OX=9031 GN=CFAP65 PE=2 SV=2 g11020.t1 P20825 31.013 158 9.09e-22 73.6 sp|P20825|POL2_DROME Retrovirus-related Pol polyprotein from transposon 297 OS=Drosophila melanogaster OX=7227 GN=pol PE=4 SV=1 g11020.t1 P20825 70.968 31 9.09e-22 51.6 sp|P20825|POL2_DROME Retrovirus-related Pol polyprotein from transposon 297 OS=Drosophila melanogaster OX=7227 GN=pol PE=4 SV=1 g11022.t1 Q6GLN7 34.0 200 9.229999999999999e-23 96.7 sp|Q6GLN7|TM163_XENLA Transmembrane protein 163 OS=Xenopus laevis OX=8355 GN=tmem163 PE=2 SV=1 g11023.t1 Q5ZM13 41.593 339 3.79e-81 263.0 sp|Q5ZM13|HYCCI_CHICK Hyccin OS=Gallus gallus OX=9031 GN=HYCC1 PE=2 SV=2 HYCCI_CHICK reviewed Hyccin (Down-regulated by CTNNB1 protein A) Gallus gallus (Chicken) GO:0005829; GO:0005886; GO:0042552; GO:0046854; GO:0072659 myelination [GO:0042552]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; protein localization to plasma membrane [GO:0072659] cytosol [GO:0005829]; plasma membrane [GO:0005886] g11037.t1 P46459 79.0 100 2.99e-32 123.0 sp|P46459|NSF_HUMAN Vesicle-fusing ATPase OS=Homo sapiens OX=9606 GN=NSF PE=1 SV=3 NSF_HUMAN reviewed Vesicle-fusing ATPase (EC 3.6.4.6) (N-ethylmaleimide-sensitive fusion protein) (NEM-sensitive fusion protein) (Vesicular-fusion protein NSF) Homo sapiens (Human) GO:0000149; GO:0001669; GO:0001921; GO:0005524; GO:0005765; GO:0005794; GO:0005795; GO:0005829; GO:0005886; GO:0006813; GO:0006886; GO:0006887; GO:0006891; GO:0016192; GO:0016887; GO:0017075; GO:0017157; GO:0019901; GO:0030165; GO:0035255; GO:0035494; GO:0043001; GO:0043198; GO:0044877; GO:0045026; GO:0045732; GO:0046872; GO:0097225; GO:0097228; GO:0097229; GO:0098982; GO:0099091; GO:0140545 exocytosis [GO:0006887]; Golgi to plasma membrane protein transport [GO:0043001]; intra-Golgi vesicle-mediated transport [GO:0006891]; intracellular protein transport [GO:0006886]; plasma membrane fusion [GO:0045026]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of receptor recycling [GO:0001921]; potassium ion transport [GO:0006813]; regulation of exocytosis [GO:0017157]; SNARE complex disassembly [GO:0035494]; vesicle-mediated transport [GO:0016192] acrosomal vesicle [GO:0001669]; cytosol [GO:0005829]; dendritic shaft [GO:0043198]; GABA-ergic synapse [GO:0098982]; Golgi apparatus [GO:0005794]; Golgi stack [GO:0005795]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; postsynaptic specialization, intracellular component [GO:0099091]; sperm end piece [GO:0097229]; sperm midpiece [GO:0097225]; sperm principal piece [GO:0097228] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent protein disaggregase activity [GO:0140545]; ionotropic glutamate receptor binding [GO:0035255]; metal ion binding [GO:0046872]; PDZ domain binding [GO:0030165]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; SNARE binding [GO:0000149]; syntaxin-1 binding [GO:0017075] g11038.t1 P46460 65.844 527 0.0 729.0 sp|P46460|NSF_MOUSE Vesicle-fusing ATPase OS=Mus musculus OX=10090 GN=Nsf PE=1 SV=2 g11039.t1 Q95SX7 29.368 269 1e-25 113.0 sp|Q95SX7|RTBS_DROME Probable RNA-directed DNA polymerase from transposon BS OS=Drosophila melanogaster OX=7227 GN=RTase PE=2 SV=1 g11040.t1 O97859 31.797 434 1.99e-46 171.0 sp|O97859|NEUR3_BOVIN Sialidase-3 OS=Bos taurus OX=9913 GN=NEU3 PE=1 SV=1 g11045.t1 G5E8K5 25.0 484 7.21e-22 106.0 sp|G5E8K5|ANK3_MOUSE Ankyrin-3 OS=Mus musculus OX=10090 GN=Ank3 PE=1 SV=1 ANK3_MOUSE reviewed Ankyrin-3 (ANK-3) (Ankyrin-G) Mus musculus (Mouse) GO:0000281; GO:0005200; GO:0005737; GO:0005764; GO:0005886; GO:0007009; GO:0007165; GO:0007409; GO:0007411; GO:0007528; GO:0008089; GO:0008092; GO:0009925; GO:0009986; GO:0010628; GO:0010650; GO:0010765; GO:0010960; GO:0014069; GO:0014704; GO:0014731; GO:0016020; GO:0016323; GO:0016328; GO:0016529; GO:0017080; GO:0019228; GO:0030018; GO:0030315; GO:0030424; GO:0030425; GO:0030507; GO:0030674; GO:0030951; GO:0031594; GO:0032507; GO:0033268; GO:0033270; GO:0034112; GO:0042383; GO:0043001; GO:0043034; GO:0043194; GO:0043266; GO:0044325; GO:0045162; GO:0045184; GO:0045202; GO:0045211; GO:0045296; GO:0045760; GO:0045806; GO:0045838; GO:0050808; GO:0061564; GO:0071286; GO:0071709; GO:0072659; GO:0072660; GO:0090314; GO:0098794; GO:0098978; GO:0099103; GO:0099159; GO:0099612; GO:0140031; GO:1900827; GO:1901224; GO:1902260; GO:1903533; GO:1903784; GO:1904115 anterograde axonal transport [GO:0008089]; axon development [GO:0061564]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; cellular response to magnesium ion [GO:0071286]; clustering of voltage-gated sodium channels [GO:0045162]; establishment of protein localization [GO:0045184]; establishment or maintenance of microtubule cytoskeleton polarity [GO:0030951]; Golgi to plasma membrane protein transport [GO:0043001]; magnesium ion homeostasis [GO:0010960]; maintenance of protein location in cell [GO:0032507]; maintenance of protein location in plasma membrane [GO:0072660]; membrane assembly [GO:0071709]; mitotic cytokinesis [GO:0000281]; negative regulation of delayed rectifier potassium channel activity [GO:1902260]; negative regulation of endocytosis [GO:0045806]; neuromuscular junction development [GO:0007528]; neuronal action potential [GO:0019228]; plasma membrane organization [GO:0007009]; positive regulation of action potential [GO:0045760]; positive regulation of cell communication by electrical coupling [GO:0010650]; positive regulation of gene expression [GO:0010628]; positive regulation of homotypic cell-cell adhesion [GO:0034112]; positive regulation of membrane depolarization during cardiac muscle cell action potential [GO:1900827]; positive regulation of membrane potential [GO:0045838]; positive regulation of non-canonical NF-kappaB signal transduction [GO:1901224]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of sodium ion import across plasma membrane [GO:1903784]; positive regulation of sodium ion transport [GO:0010765]; protein localization to axon [GO:0099612]; protein localization to plasma membrane [GO:0072659]; regulation of modification of postsynaptic structure [GO:0099159]; regulation of potassium ion transport [GO:0043266]; regulation of protein targeting [GO:1903533]; signal transduction [GO:0007165]; synapse organization [GO:0050808] axon [GO:0030424]; axon cytoplasm [GO:1904115]; axon initial segment [GO:0043194]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; costamere [GO:0043034]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; intercalated disc [GO:0014704]; lateral plasma membrane [GO:0016328]; lysosome [GO:0005764]; membrane [GO:0016020]; neuromuscular junction [GO:0031594]; node of Ranvier [GO:0033268]; paranode region of axon [GO:0033270]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; sarcoplasmic reticulum [GO:0016529]; spectrin-associated cytoskeleton [GO:0014731]; synapse [GO:0045202]; T-tubule [GO:0030315]; Z disc [GO:0030018] cadherin binding [GO:0045296]; channel activator activity [GO:0099103]; cytoskeletal protein binding [GO:0008092]; phosphorylation-dependent protein binding [GO:0140031]; protein-macromolecule adaptor activity [GO:0030674]; sodium channel regulator activity [GO:0017080]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]; transmembrane transporter binding [GO:0044325] g11059.t1 Q571H0 29.808 832 3e-86 318.0 sp|Q571H0|NPA1P_MOUSE Nucleolar pre-ribosomal-associated protein 1 OS=Mus musculus OX=10090 GN=Urb1 PE=1 SV=2 g11059.t1 Q571H0 36.697 436 4.8700000000000006e-73 276.0 sp|Q571H0|NPA1P_MOUSE Nucleolar pre-ribosomal-associated protein 1 OS=Mus musculus OX=10090 GN=Urb1 PE=1 SV=2 g11060.t1 Q99741 42.125 527 5.2900000000000004e-123 377.0 sp|Q99741|CDC6_HUMAN Cell division control protein 6 homolog OS=Homo sapiens OX=9606 GN=CDC6 PE=1 SV=1 CDC6_HUMAN reviewed Cell division control protein 6 homolog (CDC6-related protein) (Cdc18-related protein) (HsCdc18) (p62(cdc6)) (HsCDC6) Homo sapiens (Human) GO:0000076; GO:0000079; GO:0000166; GO:0000922; GO:0003682; GO:0003688; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006270; GO:0007089; GO:0008156; GO:0008285; GO:0030071; GO:0032467; GO:0033314; GO:0045171; GO:0048146; GO:0051233; GO:0051301; GO:0051984; GO:0072686; GO:0120283; GO:1904117; GO:1904385 cell division [GO:0051301]; cellular response to angiotensin [GO:1904385]; cellular response to vasopressin [GO:1904117]; DNA replication checkpoint signaling [GO:0000076]; DNA replication initiation [GO:0006270]; mitotic DNA replication checkpoint signaling [GO:0033314]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of DNA replication [GO:0008156]; positive regulation of chromosome segregation [GO:0051984]; positive regulation of cytokinesis [GO:0032467]; positive regulation of fibroblast proliferation [GO:0048146]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; traversing start control point of mitotic cell cycle [GO:0007089] cytoplasm [GO:0005737]; cytosol [GO:0005829]; intercellular bridge [GO:0045171]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle midzone [GO:0051233]; spindle pole [GO:0000922] ATP binding [GO:0005524]; chromatin binding [GO:0003682]; DNA replication origin binding [GO:0003688]; nucleotide binding [GO:0000166]; protein serine/threonine kinase binding [GO:0120283] g11062.t1 Q86TI4 43.243 333 6.8400000000000005e-105 321.0 sp|Q86TI4|WDR86_HUMAN WD repeat-containing protein 86 OS=Homo sapiens OX=9606 GN=WDR86 PE=2 SV=3 g11067.t1 P62071 65.366 205 2.42e-86 256.0 sp|P62071|RRAS2_MOUSE Ras-related protein R-Ras2 OS=Mus musculus OX=10090 GN=Rras2 PE=1 SV=1 g11068.t1 Q9NQS7 51.2 125 6.1399999999999995e-24 113.0 sp|Q9NQS7|INCE_HUMAN Inner centromere protein OS=Homo sapiens OX=9606 GN=INCENP PE=1 SV=3 INCE_HUMAN reviewed Inner centromere protein Homo sapiens (Human) GO:0000278; GO:0000281; GO:0000775; GO:0000776; GO:0000800; GO:0000801; GO:0005634; GO:0005654; GO:0005721; GO:0005819; GO:0005829; GO:0005874; GO:0007059; GO:0010369; GO:0015630; GO:0016604; GO:0030496; GO:0032133; GO:0032991; GO:0051256; GO:0051257; GO:0051310; GO:0090267; GO:0090307; GO:0140677; GO:1901970; GO:1902425; GO:1903490; GO:1990385 chromosome segregation [GO:0007059]; meiotic spindle midzone assembly [GO:0051257]; metaphase chromosome alignment [GO:0051310]; mitotic cell cycle [GO:0000278]; mitotic cytokinesis [GO:0000281]; mitotic spindle assembly [GO:0090307]; mitotic spindle midzone assembly [GO:0051256]; positive regulation of attachment of mitotic spindle microtubules to kinetochore [GO:1902425]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; positive regulation of mitotic cytokinesis [GO:1903490]; positive regulation of mitotic sister chromatid separation [GO:1901970] central element [GO:0000801]; chromocenter [GO:0010369]; chromosome passenger complex [GO:0032133]; chromosome, centromeric region [GO:0000775]; cytosol [GO:0005829]; kinetochore [GO:0000776]; lateral element [GO:0000800]; meiotic spindle midzone [GO:1990385]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pericentric heterochromatin [GO:0005721]; protein-containing complex [GO:0032991]; spindle [GO:0005819] molecular function activator activity [GO:0140677] g11069.t1 Q5ZIA5 77.182 951 0.0 1494.0 sp|Q5ZIA5|COPB_CHICK Coatomer subunit beta OS=Gallus gallus OX=9031 GN=COPB1 PE=2 SV=1 g11071.t1 Q3T0V9 68.652 319 1.08e-168 474.0 sp|Q3T0V9|DEOC_BOVIN Deoxyribose-phosphate aldolase OS=Bos taurus OX=9913 GN=DERA PE=2 SV=1 g11073.t1 Q9NPI0 60.284 141 3.07e-58 182.0 sp|Q9NPI0|TM138_HUMAN Transmembrane protein 138 OS=Homo sapiens OX=9606 GN=TMEM138 PE=1 SV=1 TM138_HUMAN reviewed Transmembrane protein 138 Homo sapiens (Human) GO:0005774; GO:0005929; GO:0015630; GO:0060271 cilium assembly [GO:0060271] cilium [GO:0005929]; microtubule cytoskeleton [GO:0015630]; vacuolar membrane [GO:0005774] g11076.t1 Q9IBG7 38.676 2040 0.0 1227.0 sp|Q9IBG7|KCP_XENLA Kielin/chordin-like protein OS=Xenopus laevis OX=8355 GN=kcp PE=2 SV=1 g11076.t1 Q9IBG7 35.9 1688 0.0 876.0 sp|Q9IBG7|KCP_XENLA Kielin/chordin-like protein OS=Xenopus laevis OX=8355 GN=kcp PE=2 SV=1 g11076.t1 Q9IBG7 34.8 1727 0.0 802.0 sp|Q9IBG7|KCP_XENLA Kielin/chordin-like protein OS=Xenopus laevis OX=8355 GN=kcp PE=2 SV=1 g11076.t2 Q9IBG7 38.375 2056 0.0 1220.0 sp|Q9IBG7|KCP_XENLA Kielin/chordin-like protein OS=Xenopus laevis OX=8355 GN=kcp PE=2 SV=1 g11076.t2 Q9IBG7 35.563 1704 0.0 869.0 sp|Q9IBG7|KCP_XENLA Kielin/chordin-like protein OS=Xenopus laevis OX=8355 GN=kcp PE=2 SV=1 g11076.t2 Q9IBG7 34.481 1743 0.0 795.0 sp|Q9IBG7|KCP_XENLA Kielin/chordin-like protein OS=Xenopus laevis OX=8355 GN=kcp PE=2 SV=1 g11077.t1 P06845 29.63 270 4.78e-27 113.0 sp|P06845|TYRO_STRGA Tyrosinase OS=Streptomyces glaucescens OX=1907 GN=melC2 PE=1 SV=3 g11081.t1 Q60614 30.201 298 3.47e-28 115.0 sp|Q60614|AA2BR_MOUSE Adenosine receptor A2b OS=Mus musculus OX=10090 GN=Adora2b PE=2 SV=2 AA2BR_MOUSE reviewed Adenosine receptor A2b Mus musculus (Mouse) GO:0001609; GO:0001938; GO:0001973; GO:0002882; GO:0004930; GO:0005886; GO:0007189; GO:0008284; GO:0008285; GO:0009986; GO:0010575; GO:0010595; GO:0010701; GO:0010753; GO:0010893; GO:0010906; GO:0032722; GO:0032755; GO:0032966; GO:0033605; GO:0042311; GO:0043306; GO:0045202; GO:0060087; GO:0098685; GO:0098793; GO:0098978; GO:0099171; GO:0141163; GO:1990776 adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; G protein-coupled adenosine receptor signaling pathway [GO:0001973]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of collagen biosynthetic process [GO:0032966]; positive regulation of cAMP/PKA signal transduction [GO:0141163]; positive regulation of catecholamine secretion [GO:0033605]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cGMP-mediated signaling [GO:0010753]; positive regulation of chemokine production [GO:0032722]; positive regulation of chronic inflammatory response to non-antigenic stimulus [GO:0002882]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of mast cell degranulation [GO:0043306]; positive regulation of norepinephrine secretion [GO:0010701]; positive regulation of steroid biosynthetic process [GO:0010893]; positive regulation of vascular endothelial growth factor production [GO:0010575]; presynaptic modulation of chemical synaptic transmission [GO:0099171]; regulation of glucose metabolic process [GO:0010906]; relaxation of vascular associated smooth muscle [GO:0060087]; response to angiotensin [GO:1990776]; vasodilation [GO:0042311] cell surface [GO:0009986]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; Schaffer collateral - CA1 synapse [GO:0098685]; synapse [GO:0045202] G protein-coupled adenosine receptor activity [GO:0001609]; G protein-coupled receptor activity [GO:0004930] g11082.t1 Q96PB1 41.623 764 0.0 595.0 sp|Q96PB1|CASD1_HUMAN N-acetylneuraminate (7)9-O-acetyltransferase OS=Homo sapiens OX=9606 GN=CASD1 PE=1 SV=1 CASD1_HUMAN reviewed N-acetylneuraminate (7)9-O-acetyltransferase (EC 2.3.1.45) (CAS1 domain-containing protein 1) (CAS1 protein) (Cas1p) (Sialate O-acetyltransferase) (SOAT) Homo sapiens (Human) GO:0000139; GO:0005975; GO:0047186 carbohydrate metabolic process [GO:0005975] Golgi membrane [GO:0000139] N-acetylneuraminate 9-O-acetyltransferase activity [GO:0047186] g11084.t1 A0A096X8J7 49.659 1027 0.0 900.0 sp|A0A096X8J7|B3A3_DANRE Anion exchange protein 3 OS=Danio rerio OX=7955 GN=Slc4a3 PE=2 SV=1 B3A3_DANRE reviewed Anion exchange protein 3 (AE 3) (Solute carrier family 4 member 3) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005452; GO:0005886; GO:0008509; GO:0015701; GO:0022857; GO:0051453; GO:0055085; GO:0086001 bicarbonate transport [GO:0015701]; cardiac muscle cell action potential [GO:0086001]; regulation of intracellular pH [GO:0051453]; transmembrane transport [GO:0055085] plasma membrane [GO:0005886] monoatomic anion transmembrane transporter activity [GO:0008509]; solute:inorganic anion antiporter activity [GO:0005452]; transmembrane transporter activity [GO:0022857] g11084.t2 A0A096X8J7 53.226 744 0.0 721.0 sp|A0A096X8J7|B3A3_DANRE Anion exchange protein 3 OS=Danio rerio OX=7955 GN=Slc4a3 PE=2 SV=1 B3A3_DANRE reviewed Anion exchange protein 3 (AE 3) (Solute carrier family 4 member 3) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005452; GO:0005886; GO:0008509; GO:0015701; GO:0022857; GO:0051453; GO:0055085; GO:0086001 bicarbonate transport [GO:0015701]; cardiac muscle cell action potential [GO:0086001]; regulation of intracellular pH [GO:0051453]; transmembrane transport [GO:0055085] plasma membrane [GO:0005886] monoatomic anion transmembrane transporter activity [GO:0008509]; solute:inorganic anion antiporter activity [GO:0005452]; transmembrane transporter activity [GO:0022857] g11084.t3 Q6SJP2 50.673 223 2.25e-53 197.0 sp|Q6SJP2|B3A2_HORSE Anion exchange protein 2 OS=Equus caballus OX=9796 GN=SLC4A2 PE=2 SV=1 g11085.t1 P48751 41.683 1010 0.0 663.0 sp|P48751|B3A3_HUMAN Anion exchange protein 3 OS=Homo sapiens OX=9606 GN=SLC4A3 PE=1 SV=2 B3A3_HUMAN reviewed Anion exchange protein 3 (AE 3) (Anion exchanger 3) (CAE3/BAE3) (Cardiac/brain band 3-like protein) (Neuronal band 3-like protein) (Solute carrier family 4 member 3) Homo sapiens (Human) GO:0005452; GO:0005886; GO:0009897; GO:0015106; GO:0015701; GO:0016020; GO:0022857; GO:0045851; GO:0051453; GO:0055085; GO:0061337; GO:0086001; GO:0098901; GO:0140900; GO:0150104 bicarbonate transport [GO:0015701]; cardiac conduction [GO:0061337]; cardiac muscle cell action potential [GO:0086001]; pH reduction [GO:0045851]; regulation of cardiac muscle cell action potential [GO:0098901]; regulation of intracellular pH [GO:0051453]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104] external side of plasma membrane [GO:0009897]; membrane [GO:0016020]; plasma membrane [GO:0005886] bicarbonate transmembrane transporter activity [GO:0015106]; chloride:bicarbonate antiporter activity [GO:0140900]; solute:inorganic anion antiporter activity [GO:0005452]; transmembrane transporter activity [GO:0022857] g11087.t1 P27169 35.423 319 2.21e-56 191.0 sp|P27169|PON1_HUMAN Serum paraoxonase/arylesterase 1 OS=Homo sapiens OX=9606 GN=PON1 PE=1 SV=3 PON1_HUMAN reviewed Serum paraoxonase/arylesterase 1 (PON 1) (EC 3.1.1.2) (EC 3.1.1.81) (EC 3.1.8.1) (Aromatic esterase 1) (A-esterase 1) (K-45) (Serum aryldialkylphosphatase 1) Homo sapiens (Human) GO:0004063; GO:0004064; GO:0005509; GO:0005543; GO:0005576; GO:0005615; GO:0005789; GO:0008203; GO:0009636; GO:0010875; GO:0034364; GO:0034366; GO:0042803; GO:0046395; GO:0046434; GO:0046470; GO:0070062; GO:0072562; GO:0102007; GO:1901335 carboxylic acid catabolic process [GO:0046395]; cholesterol metabolic process [GO:0008203]; lactone catabolic process [GO:1901335]; organophosphate catabolic process [GO:0046434]; phosphatidylcholine metabolic process [GO:0046470]; positive regulation of cholesterol efflux [GO:0010875]; response to toxic substance [GO:0009636] blood microparticle [GO:0072562]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; high-density lipoprotein particle [GO:0034364]; spherical high-density lipoprotein particle [GO:0034366] acyl-L-homoserine-lactone lactonohydrolase activity [GO:0102007]; aryldialkylphosphatase activity [GO:0004063]; arylesterase activity [GO:0004064]; calcium ion binding [GO:0005509]; phospholipid binding [GO:0005543]; protein homodimerization activity [GO:0042803] g11088.t1 Q11011 51.914 418 1.81e-138 420.0 sp|Q11011|PSA_MOUSE Puromycin-sensitive aminopeptidase OS=Mus musculus OX=10090 GN=Npepps PE=1 SV=2 PSA_MOUSE reviewed Puromycin-sensitive aminopeptidase (PSA) (EC 3.4.11.14) (Cytosol alanyl aminopeptidase) (AAP-S) Mus musculus (Mouse) GO:0004177; GO:0005576; GO:0005634; GO:0005829; GO:0006508; GO:0008270; GO:0016285; GO:0043171; GO:0070006; GO:0071456 cellular response to hypoxia [GO:0071456]; peptide catabolic process [GO:0043171]; proteolysis [GO:0006508] cytosol [GO:0005829]; extracellular region [GO:0005576]; nucleus [GO:0005634] alanyl aminopeptidase activity [GO:0016285]; aminopeptidase activity [GO:0004177]; metalloaminopeptidase activity [GO:0070006]; zinc ion binding [GO:0008270] g11089.t1 P55786 70.529 397 0.0 601.0 sp|P55786|PSA_HUMAN Puromycin-sensitive aminopeptidase OS=Homo sapiens OX=9606 GN=NPEPPS PE=1 SV=2 PSA_HUMAN reviewed Puromycin-sensitive aminopeptidase (PSA) (EC 3.4.11.14) (Cytosol alanyl aminopeptidase) (AAP-S) Homo sapiens (Human) GO:0000209; GO:0004177; GO:0005576; GO:0005634; GO:0005829; GO:0006508; GO:0008270; GO:0016285; GO:0043171; GO:0070006; GO:0070062; GO:0071456; GO:1903955 cellular response to hypoxia [GO:0071456]; peptide catabolic process [GO:0043171]; positive regulation of protein targeting to mitochondrion [GO:1903955]; protein polyubiquitination [GO:0000209]; proteolysis [GO:0006508] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; nucleus [GO:0005634] alanyl aminopeptidase activity [GO:0016285]; aminopeptidase activity [GO:0004177]; metalloaminopeptidase activity [GO:0070006]; zinc ion binding [GO:0008270] g11090.t1 Q6NT55 47.257 474 3.5100000000000003e-156 460.0 sp|Q6NT55|CP4FN_HUMAN Ultra-long-chain fatty acid omega-hydroxylase OS=Homo sapiens OX=9606 GN=CYP4F22 PE=1 SV=1 CP4FN_HUMAN reviewed Ultra-long-chain fatty acid omega-hydroxylase (EC 1.14.14.177) (Cytochrome P450 4F22) Homo sapiens (Human) GO:0004497; GO:0005506; GO:0005789; GO:0006690; GO:0016705; GO:0020037; GO:0046513 ceramide biosynthetic process [GO:0046513]; icosanoid metabolic process [GO:0006690] endoplasmic reticulum membrane [GO:0005789] heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705] g11091.t1 P97259 46.963 428 6.97e-124 380.0 sp|P97259|MGT5A_CRIGR Alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase A OS=Cricetulus griseus OX=10029 GN=MGAT5 PE=1 SV=1 g11092.t1 Q09328 58.755 257 1.2799999999999999e-95 299.0 sp|Q09328|MGT5A_HUMAN Alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase A OS=Homo sapiens OX=9606 GN=MGAT5 PE=1 SV=1 MGT5A_HUMAN reviewed Alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase A (EC 2.4.1.155) (Alpha-mannoside beta-1,6-N-acetylglucosaminyltransferase V) (GlcNAc-T V) (GNT-V) (Mannoside acetylglucosaminyltransferase 5) (N-acetylglucosaminyl-transferase V) [Cleaved into: Secreted alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase A (Secreted beta-1,6-N-acetylglucosaminyltransferase V) (Secreted GNT-V)] Homo sapiens (Human) GO:0000139; GO:0004864; GO:0005794; GO:0006487; GO:0016020; GO:0018279; GO:0019082; GO:0030144; GO:0030145; GO:0030335; GO:0070062; GO:1904894 positive regulation of cell migration [GO:0030335]; positive regulation of receptor signaling pathway via STAT [GO:1904894]; protein N-linked glycosylation [GO:0006487]; protein N-linked glycosylation via asparagine [GO:0018279]; viral protein processing [GO:0019082] extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; membrane [GO:0016020] alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity [GO:0030144]; manganese ion binding [GO:0030145]; protein phosphatase inhibitor activity [GO:0004864] g11094.t1 P98158 37.452 259 7.0600000000000005e-31 127.0 sp|P98158|LRP2_RAT Low-density lipoprotein receptor-related protein 2 OS=Rattus norvegicus OX=10116 GN=Lrp2 PE=1 SV=1 g11094.t1 P98158 37.647 255 1.02e-26 115.0 sp|P98158|LRP2_RAT Low-density lipoprotein receptor-related protein 2 OS=Rattus norvegicus OX=10116 GN=Lrp2 PE=1 SV=1 g11094.t1 P98158 30.662 287 6.95e-25 110.0 sp|P98158|LRP2_RAT Low-density lipoprotein receptor-related protein 2 OS=Rattus norvegicus OX=10116 GN=Lrp2 PE=1 SV=1 g11094.t1 P98158 36.842 247 2.59e-24 108.0 sp|P98158|LRP2_RAT Low-density lipoprotein receptor-related protein 2 OS=Rattus norvegicus OX=10116 GN=Lrp2 PE=1 SV=1 g11094.t1 P98158 36.047 258 2.08e-22 102.0 sp|P98158|LRP2_RAT Low-density lipoprotein receptor-related protein 2 OS=Rattus norvegicus OX=10116 GN=Lrp2 PE=1 SV=1 g11096.t1 Q5E9Y2 59.0 100 1.1400000000000001e-33 122.0 sp|Q5E9Y2|STX17_BOVIN Syntaxin-17 OS=Bos taurus OX=9913 GN=STX17 PE=2 SV=1 STX17_BOVIN reviewed Syntaxin-17 Bos taurus (Bovine) GO:0000149; GO:0000421; GO:0005484; GO:0005739; GO:0005776; GO:0005789; GO:0005793; GO:0005829; GO:0005886; GO:0006886; GO:0006887; GO:0006888; GO:0006906; GO:0007030; GO:0012505; GO:0012507; GO:0016240; GO:0019903; GO:0030134; GO:0030868; GO:0030897; GO:0031201; GO:0031966; GO:0033116; GO:0034497; GO:0044233; GO:0048278; GO:0061909; GO:0097111; GO:0097352; GO:0120281 autophagosome maturation [GO:0097352]; autophagosome membrane docking [GO:0016240]; autophagosome-lysosome fusion [GO:0061909]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; endoplasmic reticulum-Golgi intermediate compartment organization [GO:0097111]; exocytosis [GO:0006887]; Golgi organization [GO:0007030]; intracellular protein transport [GO:0006886]; protein localization to phagophore assembly site [GO:0034497]; vesicle docking [GO:0048278]; vesicle fusion [GO:0006906] autolysosome membrane [GO:0120281]; autophagosome [GO:0005776]; autophagosome membrane [GO:0000421]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; ER to Golgi transport vesicle membrane [GO:0012507]; HOPS complex [GO:0030897]; mitochondria-associated endoplasmic reticulum membrane contact site [GO:0044233]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; smooth endoplasmic reticulum membrane [GO:0030868]; SNARE complex [GO:0031201] protein phosphatase binding [GO:0019903]; SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149] g11111.t1 P54288 63.801 442 1.59e-176 524.0 sp|P54288|CACB2_RABIT Voltage-dependent L-type calcium channel subunit beta-2 OS=Oryctolagus cuniculus OX=9986 GN=CACNB2 PE=1 SV=1 g11113.t1 Q9CY34 61.497 187 1.18e-84 250.0 sp|Q9CY34|UB2FA_MOUSE NEDD8-conjugating enzyme UBE2F OS=Mus musculus OX=10090 GN=Ube2f PE=1 SV=1 UB2FA_MOUSE reviewed NEDD8-conjugating enzyme UBE2F (EC 2.3.2.34) (NEDD8 carrier protein UBE2F) (NEDD8 protein ligase UBE2F) (NEDD8-conjugating enzyme 2) (RING-type E3 NEDD8 transferase UBE2F) (Ubiquitin-conjugating enzyme E2 F) Mus musculus (Mouse) GO:0005524; GO:0005634; GO:0005829; GO:0019788; GO:0043161; GO:0045087; GO:0045116; GO:0051607; GO:0061654 defense response to virus [GO:0051607]; innate immune response [GO:0045087]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein neddylation [GO:0045116] cytosol [GO:0005829]; nucleus [GO:0005634] ATP binding [GO:0005524]; NEDD8 conjugating enzyme activity [GO:0061654]; NEDD8 transferase activity [GO:0019788] g11114.t1 Q6NWF4 62.791 172 1.06e-82 244.0 sp|Q6NWF4|VPS25_DANRE Vacuolar protein-sorting-associated protein 25 OS=Danio rerio OX=7955 GN=vps25 PE=2 SV=2 g11120.t1 G8JYB2 47.222 720 0.0 612.0 sp|G8JYB2|CTNL1_CAEEL Alpha-catulin OS=Caenorhabditis elegans OX=6239 GN=ctn-1 PE=1 SV=1 CTNL1_CAEEL reviewed Alpha-catulin Caenorhabditis elegans GO:0005886; GO:0007155; GO:0007266; GO:0040012; GO:0045296; GO:0051015; GO:0055120 cell adhesion [GO:0007155]; regulation of locomotion [GO:0040012]; Rho protein signal transduction [GO:0007266] plasma membrane [GO:0005886]; striated muscle dense body [GO:0055120] actin filament binding [GO:0051015]; cadherin binding [GO:0045296] g11120.t2 G8JYB2 46.955 739 0.0 625.0 sp|G8JYB2|CTNL1_CAEEL Alpha-catulin OS=Caenorhabditis elegans OX=6239 GN=ctn-1 PE=1 SV=1 CTNL1_CAEEL reviewed Alpha-catulin Caenorhabditis elegans GO:0005886; GO:0007155; GO:0007266; GO:0040012; GO:0045296; GO:0051015; GO:0055120 cell adhesion [GO:0007155]; regulation of locomotion [GO:0040012]; Rho protein signal transduction [GO:0007266] plasma membrane [GO:0005886]; striated muscle dense body [GO:0055120] actin filament binding [GO:0051015]; cadherin binding [GO:0045296] g11128.t1 Q8WXX0 70.341 3955 0.0 5517.0 sp|Q8WXX0|DYH7_HUMAN Dynein axonemal heavy chain 7 OS=Homo sapiens OX=9606 GN=DNAH7 PE=1 SV=2 DYH7_HUMAN reviewed Dynein axonemal heavy chain 7 (Axonemal beta dynein heavy chain 7) (Ciliary dynein heavy chain 7) (Dynein heavy chain-like protein 2) (hDHC2) Homo sapiens (Human) GO:0003341; GO:0003777; GO:0005509; GO:0005524; GO:0005858; GO:0005874; GO:0005929; GO:0008569; GO:0036156; GO:0036159; GO:0045505; GO:0051959; GO:0060285; GO:0060294; GO:0097729 cilium movement [GO:0003341]; cilium movement involved in cell motility [GO:0060294]; cilium-dependent cell motility [GO:0060285]; inner dynein arm assembly [GO:0036159] 9+2 motile cilium [GO:0097729]; axonemal dynein complex [GO:0005858]; cilium [GO:0005929]; inner dynein arm [GO:0036156]; microtubule [GO:0005874] ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]; minus-end-directed microtubule motor activity [GO:0008569] g11130.t1 D4A6L0 40.0 185 2.92e-38 145.0 sp|D4A6L0|MGLYR_RAT Metabotropic glycine receptor OS=Rattus norvegicus OX=10116 GN=Gpr158 PE=1 SV=1 MGLYR_RAT reviewed Metabotropic glycine receptor (mGlyR) (G-protein coupled receptor 158) Rattus norvegicus (Rat) GO:0001956; GO:0004888; GO:0005634; GO:0005886; GO:0007186; GO:0007420; GO:0008047; GO:0008277; GO:0016020; GO:0042734; GO:0045211; GO:0045744; GO:0050807; GO:0050890; GO:0072659; GO:0098839; GO:0160079 brain development [GO:0007420]; cognition [GO:0050890]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of G protein-coupled receptor signaling pathway [GO:0045744]; positive regulation of neurotransmitter secretion [GO:0001956]; protein localization to plasma membrane [GO:0072659]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; regulation of synapse organization [GO:0050807] membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734] enzyme activator activity [GO:0008047]; G protein-coupled glycine receptor activity [GO:0160079]; transmembrane signaling receptor activity [GO:0004888] g11131.t1 D4A6L0 39.153 189 7.58e-38 141.0 sp|D4A6L0|MGLYR_RAT Metabotropic glycine receptor OS=Rattus norvegicus OX=10116 GN=Gpr158 PE=1 SV=1 MGLYR_RAT reviewed Metabotropic glycine receptor (mGlyR) (G-protein coupled receptor 158) Rattus norvegicus (Rat) GO:0001956; GO:0004888; GO:0005634; GO:0005886; GO:0007186; GO:0007420; GO:0008047; GO:0008277; GO:0016020; GO:0042734; GO:0045211; GO:0045744; GO:0050807; GO:0050890; GO:0072659; GO:0098839; GO:0160079 brain development [GO:0007420]; cognition [GO:0050890]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of G protein-coupled receptor signaling pathway [GO:0045744]; positive regulation of neurotransmitter secretion [GO:0001956]; protein localization to plasma membrane [GO:0072659]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; regulation of synapse organization [GO:0050807] membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734] enzyme activator activity [GO:0008047]; G protein-coupled glycine receptor activity [GO:0160079]; transmembrane signaling receptor activity [GO:0004888] g11134.t1 Q9HAQ2 43.919 148 8.830000000000001e-31 120.0 sp|Q9HAQ2|KIF9_HUMAN Kinesin-like protein KIF9 OS=Homo sapiens OX=9606 GN=KIF9 PE=1 SV=4 g11135.t1 Q9WV04 55.993 609 0.0 631.0 sp|Q9WV04|KIF9_MOUSE Kinesin-like protein KIF9 OS=Mus musculus OX=10090 GN=Kif9 PE=1 SV=2 KIF9_MOUSE reviewed Kinesin-like protein KIF9 Mus musculus (Mouse) GO:0002102; GO:0003777; GO:0005524; GO:0005737; GO:0005829; GO:0005871; GO:0005874; GO:0005879; GO:0007018; GO:0008017; GO:0016887; GO:0022617; GO:0031982; GO:0036126; GO:0042802; GO:0071801; GO:1901317; GO:1903008 extracellular matrix disassembly [GO:0022617]; microtubule-based movement [GO:0007018]; organelle disassembly [GO:1903008]; regulation of flagellated sperm motility [GO:1901317]; regulation of podosome assembly [GO:0071801] axonemal microtubule [GO:0005879]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; podosome [GO:0002102]; sperm flagellum [GO:0036126]; vesicle [GO:0031982] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777] g11138.t1 Q920R0 34.857 525 6.18e-89 304.0 sp|Q920R0|ALS2_MOUSE Alsin OS=Mus musculus OX=10090 GN=Als2 PE=1 SV=3 ALS2_MOUSE reviewed Alsin (Amyotrophic lateral sclerosis 2 protein homolog) Mus musculus (Mouse) GO:0001662; GO:0001726; GO:0001881; GO:0005085; GO:0005096; GO:0005634; GO:0005737; GO:0005769; GO:0005813; GO:0005829; GO:0006979; GO:0007032; GO:0007041; GO:0007409; GO:0007528; GO:0007626; GO:0008104; GO:0014069; GO:0016020; GO:0016050; GO:0016197; GO:0016601; GO:0030027; GO:0030424; GO:0030425; GO:0030426; GO:0031267; GO:0031982; GO:0032991; GO:0035249; GO:0042802; GO:0042803; GO:0043025; GO:0043197; GO:0043539; GO:0043547; GO:0045860; GO:0048812; GO:0051036; GO:0051260; GO:0098978; GO:0099072 axonogenesis [GO:0007409]; behavioral fear response [GO:0001662]; endosomal transport [GO:0016197]; endosome organization [GO:0007032]; intracellular protein localization [GO:0008104]; locomotory behavior [GO:0007626]; lysosomal transport [GO:0007041]; neuromuscular junction development [GO:0007528]; neuron projection morphogenesis [GO:0048812]; positive regulation of GTPase activity [GO:0043547]; positive regulation of protein kinase activity [GO:0045860]; protein homooligomerization [GO:0051260]; Rac protein signal transduction [GO:0016601]; receptor recycling [GO:0001881]; regulation of endosome size [GO:0051036]; regulation of postsynaptic membrane neurotransmitter receptor levels [GO:0099072]; response to oxidative stress [GO:0006979]; synaptic transmission, glutamatergic [GO:0035249]; vesicle organization [GO:0016050] axon [GO:0030424]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; early endosome [GO:0005769]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]; protein-containing complex [GO:0032991]; ruffle [GO:0001726]; vesicle [GO:0031982] GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; protein serine/threonine kinase activator activity [GO:0043539]; small GTPase binding [GO:0031267] g11138.t2 Q920R0 34.142 536 6.1600000000000006e-86 295.0 sp|Q920R0|ALS2_MOUSE Alsin OS=Mus musculus OX=10090 GN=Als2 PE=1 SV=3 ALS2_MOUSE reviewed Alsin (Amyotrophic lateral sclerosis 2 protein homolog) Mus musculus (Mouse) GO:0001662; GO:0001726; GO:0001881; GO:0005085; GO:0005096; GO:0005634; GO:0005737; GO:0005769; GO:0005813; GO:0005829; GO:0006979; GO:0007032; GO:0007041; GO:0007409; GO:0007528; GO:0007626; GO:0008104; GO:0014069; GO:0016020; GO:0016050; GO:0016197; GO:0016601; GO:0030027; GO:0030424; GO:0030425; GO:0030426; GO:0031267; GO:0031982; GO:0032991; GO:0035249; GO:0042802; GO:0042803; GO:0043025; GO:0043197; GO:0043539; GO:0043547; GO:0045860; GO:0048812; GO:0051036; GO:0051260; GO:0098978; GO:0099072 axonogenesis [GO:0007409]; behavioral fear response [GO:0001662]; endosomal transport [GO:0016197]; endosome organization [GO:0007032]; intracellular protein localization [GO:0008104]; locomotory behavior [GO:0007626]; lysosomal transport [GO:0007041]; neuromuscular junction development [GO:0007528]; neuron projection morphogenesis [GO:0048812]; positive regulation of GTPase activity [GO:0043547]; positive regulation of protein kinase activity [GO:0045860]; protein homooligomerization [GO:0051260]; Rac protein signal transduction [GO:0016601]; receptor recycling [GO:0001881]; regulation of endosome size [GO:0051036]; regulation of postsynaptic membrane neurotransmitter receptor levels [GO:0099072]; response to oxidative stress [GO:0006979]; synaptic transmission, glutamatergic [GO:0035249]; vesicle organization [GO:0016050] axon [GO:0030424]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; early endosome [GO:0005769]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]; protein-containing complex [GO:0032991]; ruffle [GO:0001726]; vesicle [GO:0031982] GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; protein serine/threonine kinase activator activity [GO:0043539]; small GTPase binding [GO:0031267] g11139.t1 Q920R0 42.209 661 2.36e-151 481.0 sp|Q920R0|ALS2_MOUSE Alsin OS=Mus musculus OX=10090 GN=Als2 PE=1 SV=3 ALS2_MOUSE reviewed Alsin (Amyotrophic lateral sclerosis 2 protein homolog) Mus musculus (Mouse) GO:0001662; GO:0001726; GO:0001881; GO:0005085; GO:0005096; GO:0005634; GO:0005737; GO:0005769; GO:0005813; GO:0005829; GO:0006979; GO:0007032; GO:0007041; GO:0007409; GO:0007528; GO:0007626; GO:0008104; GO:0014069; GO:0016020; GO:0016050; GO:0016197; GO:0016601; GO:0030027; GO:0030424; GO:0030425; GO:0030426; GO:0031267; GO:0031982; GO:0032991; GO:0035249; GO:0042802; GO:0042803; GO:0043025; GO:0043197; GO:0043539; GO:0043547; GO:0045860; GO:0048812; GO:0051036; GO:0051260; GO:0098978; GO:0099072 axonogenesis [GO:0007409]; behavioral fear response [GO:0001662]; endosomal transport [GO:0016197]; endosome organization [GO:0007032]; intracellular protein localization [GO:0008104]; locomotory behavior [GO:0007626]; lysosomal transport [GO:0007041]; neuromuscular junction development [GO:0007528]; neuron projection morphogenesis [GO:0048812]; positive regulation of GTPase activity [GO:0043547]; positive regulation of protein kinase activity [GO:0045860]; protein homooligomerization [GO:0051260]; Rac protein signal transduction [GO:0016601]; receptor recycling [GO:0001881]; regulation of endosome size [GO:0051036]; regulation of postsynaptic membrane neurotransmitter receptor levels [GO:0099072]; response to oxidative stress [GO:0006979]; synaptic transmission, glutamatergic [GO:0035249]; vesicle organization [GO:0016050] axon [GO:0030424]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; early endosome [GO:0005769]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]; protein-containing complex [GO:0032991]; ruffle [GO:0001726]; vesicle [GO:0031982] GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; protein serine/threonine kinase activator activity [GO:0043539]; small GTPase binding [GO:0031267] g11140.t1 O00522 37.979 574 1.65e-128 397.0 sp|O00522|KRIT1_HUMAN Krev interaction trapped protein 1 OS=Homo sapiens OX=9606 GN=KRIT1 PE=1 SV=2 KRIT1_HUMAN reviewed Krev interaction trapped protein 1 (Krev interaction trapped 1) (Cerebral cavernous malformations 1 protein) Homo sapiens (Human) GO:0001525; GO:0001937; GO:0003158; GO:0005546; GO:0005615; GO:0005737; GO:0005856; GO:0005886; GO:0005911; GO:0007264; GO:0008017; GO:0010596; GO:0016525; GO:0030695; GO:0032991; GO:0033622; GO:0045454; GO:0045765; GO:2000114; GO:2000352 angiogenesis [GO:0001525]; cell redox homeostasis [GO:0045454]; endothelium development [GO:0003158]; integrin activation [GO:0033622]; negative regulation of angiogenesis [GO:0016525]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of endothelial cell proliferation [GO:0001937]; regulation of angiogenesis [GO:0045765]; regulation of establishment of cell polarity [GO:2000114]; small GTPase-mediated signal transduction [GO:0007264] cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] GTPase regulator activity [GO:0030695]; microtubule binding [GO:0008017]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546] g11141.t1 Q6ZS30 32.749 171 2.1500000000000002e-26 109.0 sp|Q6ZS30|NBEL1_HUMAN Neurobeachin-like protein 1 OS=Homo sapiens OX=9606 GN=NBEAL1 PE=1 SV=3 g11143.t1 Q6ZS30 50.797 1254 0.0 1283.0 sp|Q6ZS30|NBEL1_HUMAN Neurobeachin-like protein 1 OS=Homo sapiens OX=9606 GN=NBEAL1 PE=1 SV=3 g11143.t1 Q6ZS30 40.397 807 4.56e-175 600.0 sp|Q6ZS30|NBEL1_HUMAN Neurobeachin-like protein 1 OS=Homo sapiens OX=9606 GN=NBEAL1 PE=1 SV=3 g11145.t1 Q8C5N3 72.283 184 5.27e-94 295.0 sp|Q8C5N3|CWC22_MOUSE Pre-mRNA-splicing factor CWC22 homolog OS=Mus musculus OX=10090 GN=Cwc22 PE=1 SV=1 g11146.t1 Q9HCG8 70.968 155 5.6000000000000005e-70 231.0 sp|Q9HCG8|CWC22_HUMAN Pre-mRNA-splicing factor CWC22 homolog OS=Homo sapiens OX=9606 GN=CWC22 PE=1 SV=3 g11147.t1 Q08C72 78.873 71 1.0200000000000001e-29 127.0 sp|Q08C72|CWC22_DANRE Pre-mRNA-splicing factor CWC22 homolog OS=Danio rerio OX=7955 GN=cwc22 PE=2 SV=1 CWC22_DANRE reviewed Pre-mRNA-splicing factor CWC22 homolog (Nucampholin homolog) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000398; GO:0003723; GO:0005634; GO:0005681; GO:0016607; GO:0071005; GO:0071006; GO:0071007; GO:0071013 mRNA splicing, via spliceosome [GO:0000398] catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U2-type catalytic step 1 spliceosome [GO:0071006]; U2-type catalytic step 2 spliceosome [GO:0071007]; U2-type precatalytic spliceosome [GO:0071005] RNA binding [GO:0003723] g11147.t2 Q08C72 78.873 71 1.0400000000000001e-29 127.0 sp|Q08C72|CWC22_DANRE Pre-mRNA-splicing factor CWC22 homolog OS=Danio rerio OX=7955 GN=cwc22 PE=2 SV=1 CWC22_DANRE reviewed Pre-mRNA-splicing factor CWC22 homolog (Nucampholin homolog) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000398; GO:0003723; GO:0005634; GO:0005681; GO:0016607; GO:0071005; GO:0071006; GO:0071007; GO:0071013 mRNA splicing, via spliceosome [GO:0000398] catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U2-type catalytic step 1 spliceosome [GO:0071006]; U2-type catalytic step 2 spliceosome [GO:0071007]; U2-type precatalytic spliceosome [GO:0071005] RNA binding [GO:0003723] g11148.t1 Q63424 51.928 389 3.0500000000000005e-129 399.0 sp|Q63424|S15A2_RAT Solute carrier family 15 member 2 OS=Rattus norvegicus OX=10116 GN=Slc15a2 PE=1 SV=1 S15A2_RAT reviewed Solute carrier family 15 member 2 (Kidney H(+)/peptide cotransporter) (Oligopeptide transporter, kidney isoform) (Peptide transporter 2) Rattus norvegicus (Rat) GO:0005886; GO:0006857; GO:0015031; GO:0015333; GO:0015334; GO:0015835; GO:0016020; GO:0016324; GO:0030670; GO:0042908; GO:0042937; GO:0042938; GO:0070293; GO:0070424; GO:0071916; GO:0072237; GO:0140206; GO:0140207; GO:0140367 antibacterial innate immune response [GO:0140367]; dipeptide import across plasma membrane [GO:0140206]; dipeptide transport [GO:0042938]; metanephric proximal tubule development [GO:0072237]; oligopeptide transport [GO:0006857]; peptidoglycan transport [GO:0015835]; protein transport [GO:0015031]; regulation of nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway [GO:0070424]; renal absorption [GO:0070293]; tripeptide import across plasma membrane [GO:0140207]; xenobiotic transport [GO:0042908] apical plasma membrane [GO:0016324]; membrane [GO:0016020]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886] dipeptide transmembrane transporter activity [GO:0071916]; high-affinity oligopeptide transmembrane transporter activity [GO:0015334]; peptide:proton symporter activity [GO:0015333]; tripeptide transmembrane transporter activity [GO:0042937] g11148.t2 Q63424 51.928 389 4.45e-129 398.0 sp|Q63424|S15A2_RAT Solute carrier family 15 member 2 OS=Rattus norvegicus OX=10116 GN=Slc15a2 PE=1 SV=1 S15A2_RAT reviewed Solute carrier family 15 member 2 (Kidney H(+)/peptide cotransporter) (Oligopeptide transporter, kidney isoform) (Peptide transporter 2) Rattus norvegicus (Rat) GO:0005886; GO:0006857; GO:0015031; GO:0015333; GO:0015334; GO:0015835; GO:0016020; GO:0016324; GO:0030670; GO:0042908; GO:0042937; GO:0042938; GO:0070293; GO:0070424; GO:0071916; GO:0072237; GO:0140206; GO:0140207; GO:0140367 antibacterial innate immune response [GO:0140367]; dipeptide import across plasma membrane [GO:0140206]; dipeptide transport [GO:0042938]; metanephric proximal tubule development [GO:0072237]; oligopeptide transport [GO:0006857]; peptidoglycan transport [GO:0015835]; protein transport [GO:0015031]; regulation of nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway [GO:0070424]; renal absorption [GO:0070293]; tripeptide import across plasma membrane [GO:0140207]; xenobiotic transport [GO:0042908] apical plasma membrane [GO:0016324]; membrane [GO:0016020]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886] dipeptide transmembrane transporter activity [GO:0071916]; high-affinity oligopeptide transmembrane transporter activity [GO:0015334]; peptide:proton symporter activity [GO:0015333]; tripeptide transmembrane transporter activity [GO:0042937] g11149.t1 B0S6T2 52.899 138 1.74e-36 135.0 sp|B0S6T2|S15A2_DANRE Solute carrier family 15 member 2 OS=Danio rerio OX=7955 GN=slc15a2 PE=1 SV=1 S15A2_DANRE reviewed Solute carrier family 15 member 2 (Peptide transporter 2) (PEPT2) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001878; GO:0005886; GO:0015031; GO:0015333; GO:0015835; GO:0016324; GO:0030670; GO:0042937; GO:0045087; GO:0070424; GO:0071916; GO:0140206; GO:0140207 dipeptide import across plasma membrane [GO:0140206]; innate immune response [GO:0045087]; peptidoglycan transport [GO:0015835]; protein transport [GO:0015031]; regulation of nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway [GO:0070424]; response to yeast [GO:0001878]; tripeptide import across plasma membrane [GO:0140207] apical plasma membrane [GO:0016324]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886] dipeptide transmembrane transporter activity [GO:0071916]; peptide:proton symporter activity [GO:0015333]; tripeptide transmembrane transporter activity [GO:0042937] g11150.t1 Q8N3P4 46.772 759 0.0 657.0 sp|Q8N3P4|VPS8_HUMAN Vacuolar protein sorting-associated protein 8 homolog OS=Homo sapiens OX=9606 GN=VPS8 PE=1 SV=3 VPS8_HUMAN reviewed Vacuolar protein sorting-associated protein 8 homolog Homo sapiens (Human) GO:0005769; GO:0005770; GO:0006623; GO:0008270; GO:0030897; GO:0033263; GO:0034058; GO:0035542 endosomal vesicle fusion [GO:0034058]; protein targeting to vacuole [GO:0006623]; regulation of SNARE complex assembly [GO:0035542] CORVET complex [GO:0033263]; early endosome [GO:0005769]; HOPS complex [GO:0030897]; late endosome [GO:0005770] zinc ion binding [GO:0008270] g11150.t2 Q8N3P4 45.19 790 0.0 643.0 sp|Q8N3P4|VPS8_HUMAN Vacuolar protein sorting-associated protein 8 homolog OS=Homo sapiens OX=9606 GN=VPS8 PE=1 SV=3 VPS8_HUMAN reviewed Vacuolar protein sorting-associated protein 8 homolog Homo sapiens (Human) GO:0005769; GO:0005770; GO:0006623; GO:0008270; GO:0030897; GO:0033263; GO:0034058; GO:0035542 endosomal vesicle fusion [GO:0034058]; protein targeting to vacuole [GO:0006623]; regulation of SNARE complex assembly [GO:0035542] CORVET complex [GO:0033263]; early endosome [GO:0005769]; HOPS complex [GO:0030897]; late endosome [GO:0005770] zinc ion binding [GO:0008270] g11150.t3 Q8N3P4 45.223 785 0.0 644.0 sp|Q8N3P4|VPS8_HUMAN Vacuolar protein sorting-associated protein 8 homolog OS=Homo sapiens OX=9606 GN=VPS8 PE=1 SV=3 VPS8_HUMAN reviewed Vacuolar protein sorting-associated protein 8 homolog Homo sapiens (Human) GO:0005769; GO:0005770; GO:0006623; GO:0008270; GO:0030897; GO:0033263; GO:0034058; GO:0035542 endosomal vesicle fusion [GO:0034058]; protein targeting to vacuole [GO:0006623]; regulation of SNARE complex assembly [GO:0035542] CORVET complex [GO:0033263]; early endosome [GO:0005769]; HOPS complex [GO:0030897]; late endosome [GO:0005770] zinc ion binding [GO:0008270] g11151.t1 Q0P5W1 48.957 623 0.0 587.0 sp|Q0P5W1|VPS8_MOUSE Vacuolar protein sorting-associated protein 8 homolog OS=Mus musculus OX=10090 GN=Vps8 PE=1 SV=1 VPS8_MOUSE reviewed Vacuolar protein sorting-associated protein 8 homolog Mus musculus (Mouse) GO:0005769; GO:0005770; GO:0006623; GO:0008270; GO:0030897; GO:0033263; GO:0034058 endosomal vesicle fusion [GO:0034058]; protein targeting to vacuole [GO:0006623] CORVET complex [GO:0033263]; early endosome [GO:0005769]; HOPS complex [GO:0030897]; late endosome [GO:0005770] zinc ion binding [GO:0008270] g11152.t1 O75366 49.371 318 5.59e-96 305.0 sp|O75366|AVIL_HUMAN Advillin OS=Homo sapiens OX=9606 GN=AVIL PE=1 SV=3 AVIL_HUMAN reviewed Advillin (p92) Homo sapiens (Human) GO:0003779; GO:0005546; GO:0005737; GO:0005884; GO:0005925; GO:0007015; GO:0007399; GO:0008154; GO:0010592; GO:0010976; GO:0015629; GO:0030027; GO:0030424; GO:0042995; GO:0043005; GO:0051014; GO:0051015; GO:0051016; GO:0060271; GO:0071933; GO:1900480 actin filament organization [GO:0007015]; actin filament severing [GO:0051014]; actin polymerization or depolymerization [GO:0008154]; barbed-end actin filament capping [GO:0051016]; cilium assembly [GO:0060271]; nervous system development [GO:0007399]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of neuron projection development [GO:0010976]; regulation of diacylglycerol biosynthetic process [GO:1900480] actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; axon [GO:0030424]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; neuron projection [GO:0043005] actin binding [GO:0003779]; actin filament binding [GO:0051015]; Arp2/3 complex binding [GO:0071933]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546] g11152.t1 O75366 28.481 316 3.9900000000000006e-27 115.0 sp|O75366|AVIL_HUMAN Advillin OS=Homo sapiens OX=9606 GN=AVIL PE=1 SV=3 AVIL_HUMAN reviewed Advillin (p92) Homo sapiens (Human) GO:0003779; GO:0005546; GO:0005737; GO:0005884; GO:0005925; GO:0007015; GO:0007399; GO:0008154; GO:0010592; GO:0010976; GO:0015629; GO:0030027; GO:0030424; GO:0042995; GO:0043005; GO:0051014; GO:0051015; GO:0051016; GO:0060271; GO:0071933; GO:1900480 actin filament organization [GO:0007015]; actin filament severing [GO:0051014]; actin polymerization or depolymerization [GO:0008154]; barbed-end actin filament capping [GO:0051016]; cilium assembly [GO:0060271]; nervous system development [GO:0007399]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of neuron projection development [GO:0010976]; regulation of diacylglycerol biosynthetic process [GO:1900480] actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; axon [GO:0030424]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; neuron projection [GO:0043005] actin binding [GO:0003779]; actin filament binding [GO:0051015]; Arp2/3 complex binding [GO:0071933]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546] g11153.t1 Q29261 46.091 486 1.12e-140 427.0 sp|Q29261|VILI_PIG Villin-1 OS=Sus scrofa OX=9823 GN=VIL1 PE=2 SV=2 VILI_PIG reviewed Villin-1 Sus scrofa (Pig) GO:0001726; GO:0005509; GO:0005546; GO:0005737; GO:0005902; GO:0006915; GO:0007173; GO:0008154; GO:0008360; GO:0009617; GO:0010634; GO:0015629; GO:0030027; GO:0030041; GO:0030042; GO:0030175; GO:0030335; GO:0032233; GO:0032432; GO:0032433; GO:0035727; GO:0035729; GO:0042803; GO:0043027; GO:0051014; GO:0051015; GO:0051016; GO:0051125; GO:0051693; GO:0060327; GO:0061041; GO:0071364; GO:2000392 actin filament capping [GO:0051693]; actin filament depolymerization [GO:0030042]; actin filament polymerization [GO:0030041]; actin filament severing [GO:0051014]; actin polymerization or depolymerization [GO:0008154]; apoptotic process [GO:0006915]; barbed-end actin filament capping [GO:0051016]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cytoplasmic actin-based contraction involved in cell motility [GO:0060327]; epidermal growth factor receptor signaling pathway [GO:0007173]; positive regulation of actin filament bundle assembly [GO:0032233]; positive regulation of cell migration [GO:0030335]; positive regulation of epithelial cell migration [GO:0010634]; regulation of actin nucleation [GO:0051125]; regulation of cell shape [GO:0008360]; regulation of lamellipodium morphogenesis [GO:2000392]; regulation of wound healing [GO:0061041]; response to bacterium [GO:0009617] actin cytoskeleton [GO:0015629]; actin filament bundle [GO:0032432]; cytoplasm [GO:0005737]; filopodium [GO:0030175]; filopodium tip [GO:0032433]; lamellipodium [GO:0030027]; microvillus [GO:0005902]; ruffle [GO:0001726] actin filament binding [GO:0051015]; calcium ion binding [GO:0005509]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; lysophosphatidic acid binding [GO:0035727]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; protein homodimerization activity [GO:0042803] g11153.t1 Q29261 30.4 375 3.48e-34 140.0 sp|Q29261|VILI_PIG Villin-1 OS=Sus scrofa OX=9823 GN=VIL1 PE=2 SV=2 VILI_PIG reviewed Villin-1 Sus scrofa (Pig) GO:0001726; GO:0005509; GO:0005546; GO:0005737; GO:0005902; GO:0006915; GO:0007173; GO:0008154; GO:0008360; GO:0009617; GO:0010634; GO:0015629; GO:0030027; GO:0030041; GO:0030042; GO:0030175; GO:0030335; GO:0032233; GO:0032432; GO:0032433; GO:0035727; GO:0035729; GO:0042803; GO:0043027; GO:0051014; GO:0051015; GO:0051016; GO:0051125; GO:0051693; GO:0060327; GO:0061041; GO:0071364; GO:2000392 actin filament capping [GO:0051693]; actin filament depolymerization [GO:0030042]; actin filament polymerization [GO:0030041]; actin filament severing [GO:0051014]; actin polymerization or depolymerization [GO:0008154]; apoptotic process [GO:0006915]; barbed-end actin filament capping [GO:0051016]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cytoplasmic actin-based contraction involved in cell motility [GO:0060327]; epidermal growth factor receptor signaling pathway [GO:0007173]; positive regulation of actin filament bundle assembly [GO:0032233]; positive regulation of cell migration [GO:0030335]; positive regulation of epithelial cell migration [GO:0010634]; regulation of actin nucleation [GO:0051125]; regulation of cell shape [GO:0008360]; regulation of lamellipodium morphogenesis [GO:2000392]; regulation of wound healing [GO:0061041]; response to bacterium [GO:0009617] actin cytoskeleton [GO:0015629]; actin filament bundle [GO:0032432]; cytoplasm [GO:0005737]; filopodium [GO:0030175]; filopodium tip [GO:0032433]; lamellipodium [GO:0030027]; microvillus [GO:0005902]; ruffle [GO:0001726] actin filament binding [GO:0051015]; calcium ion binding [GO:0005509]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; lysophosphatidic acid binding [GO:0035727]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; protein homodimerization activity [GO:0042803] g11154.t1 Q9PTJ6 64.207 271 2.76e-109 320.0 sp|Q9PTJ6|CTDSL_CHICK CTD small phosphatase-like protein OS=Gallus gallus OX=9031 GN=NFI1 PE=2 SV=2 g11154.t2 Q9PTJ6 64.207 271 9.88e-108 315.0 sp|Q9PTJ6|CTDSL_CHICK CTD small phosphatase-like protein OS=Gallus gallus OX=9031 GN=NFI1 PE=2 SV=2 g11157.t1 Q8BM54 29.36 344 2.2199999999999998e-39 148.0 sp|Q8BM54|MYLIP_MOUSE E3 ubiquitin-protein ligase MYLIP OS=Mus musculus OX=10090 GN=Mylip PE=1 SV=1 MYLIP_MOUSE reviewed E3 ubiquitin-protein ligase MYLIP (EC 2.3.2.27) (Inducible degrader of the LDL-receptor) (Idol) (Myosin regulatory light chain-interacting protein) (MIR) (RING-type E3 ubiquitin transferase MYLIP) Mus musculus (Mouse) GO:0004842; GO:0005737; GO:0005886; GO:0006511; GO:0007399; GO:0008092; GO:0008270; GO:0010977; GO:0010989; GO:0016567; GO:0031648; GO:0032803; GO:0042632; GO:0045732; GO:0061630; GO:0071404 cellular response to low-density lipoprotein particle stimulus [GO:0071404]; cholesterol homeostasis [GO:0042632]; negative regulation of low-density lipoprotein particle clearance [GO:0010989]; negative regulation of neuron projection development [GO:0010977]; nervous system development [GO:0007399]; positive regulation of protein catabolic process [GO:0045732]; protein destabilization [GO:0031648]; protein ubiquitination [GO:0016567]; regulation of low-density lipoprotein particle receptor catabolic process [GO:0032803]; ubiquitin-dependent protein catabolic process [GO:0006511] cytoplasm [GO:0005737]; plasma membrane [GO:0005886] cytoskeletal protein binding [GO:0008092]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] g11158.t1 P70168 69.714 875 0.0 1228.0 sp|P70168|IMB1_MOUSE Importin subunit beta-1 OS=Mus musculus OX=10090 GN=Kpnb1 PE=1 SV=2 IMB1_MOUSE reviewed Importin subunit beta-1 (Karyopherin subunit beta-1) (Nuclear factor p97) (Pore targeting complex 97 kDa subunit) (PTAC97) (SCG) Mus musculus (Mouse) GO:0005634; GO:0005635; GO:0005643; GO:0005654; GO:0005737; GO:0005829; GO:0006404; GO:0006606; GO:0006607; GO:0006610; GO:0007079; GO:0007080; GO:0008139; GO:0010494; GO:0019894; GO:0019899; GO:0019904; GO:0030953; GO:0031267; GO:0031965; GO:0032991; GO:0035332; GO:0040001; GO:0042564; GO:0044877; GO:0045542; GO:0045893; GO:0051879; GO:0061608; GO:0061676; GO:0071782; GO:0090307 astral microtubule organization [GO:0030953]; establishment of mitotic spindle localization [GO:0040001]; mitotic chromosome movement towards spindle pole [GO:0007079]; mitotic metaphase chromosome alignment [GO:0007080]; mitotic spindle assembly [GO:0090307]; NLS-bearing protein import into nucleus [GO:0006607]; positive regulation of cholesterol biosynthetic process [GO:0045542]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of hippo signaling [GO:0035332]; protein import into nucleus [GO:0006606]; ribosomal protein import into nucleus [GO:0006610]; RNA import into nucleus [GO:0006404] cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; endoplasmic reticulum tubular network [GO:0071782]; NLS-dependent protein nuclear import complex [GO:0042564]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991] enzyme binding [GO:0019899]; Hsp90 protein binding [GO:0051879]; importin-alpha family protein binding [GO:0061676]; kinesin binding [GO:0019894]; nuclear import signal receptor activity [GO:0061608]; nuclear localization sequence binding [GO:0008139]; protein domain specific binding [GO:0019904]; protein-containing complex binding [GO:0044877]; small GTPase binding [GO:0031267] g11160.t1 P39060 49.664 149 9.43e-45 160.0 sp|P39060|COIA1_HUMAN Collagen alpha-1(XVIII) chain OS=Homo sapiens OX=9606 GN=COL18A1 PE=1 SV=5 COIA1_HUMAN reviewed Collagen alpha-1(XVIII) chain [Cleaved into: Endostatin; Non-collagenous domain 1 (NC1)] Homo sapiens (Human) GO:0001501; GO:0001525; GO:0001886; GO:0005576; GO:0005581; GO:0005604; GO:0005615; GO:0005788; GO:0007155; GO:0007601; GO:0008285; GO:0009410; GO:0009887; GO:0030020; GO:0031012; GO:0046872; GO:0051599; GO:0070062 angiogenesis [GO:0001525]; animal organ morphogenesis [GO:0009887]; cell adhesion [GO:0007155]; endothelial cell morphogenesis [GO:0001886]; negative regulation of cell population proliferation [GO:0008285]; response to hydrostatic pressure [GO:0051599]; response to xenobiotic stimulus [GO:0009410]; skeletal system development [GO:0001501]; visual perception [GO:0007601] basement membrane [GO:0005604]; collagen trimer [GO:0005581]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615] extracellular matrix structural constituent conferring tensile strength [GO:0030020]; metal ion binding [GO:0046872] g11162.t1 O35206 35.887 248 7.1e-27 117.0 sp|O35206|COFA1_MOUSE Collagen alpha-1(XV) chain OS=Mus musculus OX=10090 GN=Col15a1 PE=1 SV=2 COFA1_MOUSE reviewed Collagen alpha-1(XV) chain [Cleaved into: Restin (Endostatin-XV)] Mus musculus (Mouse) GO:0005581; GO:0005604; GO:0005615; GO:0005783; GO:0007155; GO:0030020; GO:0031012 cell adhesion [GO:0007155] basement membrane [GO:0005604]; collagen trimer [GO:0005581]; endoplasmic reticulum [GO:0005783]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615] extracellular matrix structural constituent conferring tensile strength [GO:0030020] g11165.t1 Q8VIL2 38.462 260 2.18e-43 151.0 sp|Q8VIL2|RWDD3_MOUSE RWD domain-containing protein 3 OS=Mus musculus OX=10090 GN=Rwdd3 PE=2 SV=1 g11165.t2 Q8VIL2 35.22 159 7.8799999999999995e-28 108.0 sp|Q8VIL2|RWDD3_MOUSE RWD domain-containing protein 3 OS=Mus musculus OX=10090 GN=Rwdd3 PE=2 SV=1 g11168.t1 Q49A88 35.751 193 3.24e-24 109.0 sp|Q49A88|CCD14_HUMAN Coiled-coil domain-containing protein 14 OS=Homo sapiens OX=9606 GN=CCDC14 PE=1 SV=3 CCD14_HUMAN reviewed Coiled-coil domain-containing protein 14 Homo sapiens (Human) GO:0005813; GO:0005929; GO:0015630; GO:0021762; GO:0034451; GO:0036064; GO:0071539 protein localization to centrosome [GO:0071539]; substantia nigra development [GO:0021762] centriolar satellite [GO:0034451]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; microtubule cytoskeleton [GO:0015630] g11169.t1 Q76B49 41.35 237 2.77e-47 159.0 sp|Q76B49|CD63_FELCA CD63 antigen OS=Felis catus OX=9685 GN=CD63 PE=2 SV=3 g11170.t1 A9CMA6 36.471 255 7.85e-40 143.0 sp|A9CMA6|TM163_RAT Transmembrane protein 163 OS=Rattus norvegicus OX=10116 GN=Tmem163 PE=1 SV=1 TM163_RAT reviewed Transmembrane protein 163 (Synaptic vesicle membrane protein of 31 kDa) Rattus norvegicus (Rat) GO:0005765; GO:0005886; GO:0008270; GO:0030672; GO:0031901; GO:0031902; GO:0042552; GO:0097708; GO:0099180; GO:0140882 myelination [GO:0042552]; zinc export across plasma membrane [GO:0140882]; zinc ion import into synaptic vesicle [GO:0099180] early endosome membrane [GO:0031901]; intracellular vesicle [GO:0097708]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; synaptic vesicle membrane [GO:0030672] zinc ion binding [GO:0008270] g11171.t1 Q28EM8 29.213 267 3.0199999999999998e-30 122.0 sp|Q28EM8|LTMD1_XENTR LETM1 domain-containing protein 1 OS=Xenopus tropicalis OX=8364 GN=letmd1 PE=2 SV=1 g11173.t1 Q8WYN3 55.204 221 1.5800000000000001e-77 259.0 sp|Q8WYN3|CSRN3_HUMAN Cysteine/serine-rich nuclear protein 3 OS=Homo sapiens OX=9606 GN=CSRNP3 PE=1 SV=1 g11175.t1 F1N2K1 41.015 473 8.550000000000001e-109 336.0 sp|F1N2K1|PCYOX_BOVIN Prenylcysteine oxidase 1 OS=Bos taurus OX=9913 GN=PCYOX1 PE=1 SV=2 PCYOX_BOVIN reviewed Prenylcysteine oxidase 1 (EC 1.8.3.5) (Prenylcysteine lyase) Bos taurus (Bovine) GO:0001735; GO:0005764; GO:0030327; GO:0030328 prenylated protein catabolic process [GO:0030327]; prenylcysteine catabolic process [GO:0030328] lysosome [GO:0005764] prenylcysteine oxidase activity [GO:0001735] g11176.t1 Q96L42 55.781 640 0.0 628.0 sp|Q96L42|KCNH8_HUMAN Voltage-gated delayed rectifier potassium channel KCNH8 OS=Homo sapiens OX=9606 GN=KCNH8 PE=1 SV=2 KCNH8_HUMAN reviewed Voltage-gated delayed rectifier potassium channel KCNH8 (ELK1) (hElk-1) (Ether-a-go-go-like potassium channel 3) (ELK channel 3) (ELK3) (Potassium voltage-gated channel subfamily H member 8) (Voltage-gated potassium channel subunit Kv12.1) Homo sapiens (Human) GO:0005249; GO:0005251; GO:0005886; GO:0006813; GO:0034702; GO:0042391; GO:0071805 potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; regulation of membrane potential [GO:0042391] monoatomic ion channel complex [GO:0034702]; plasma membrane [GO:0005886] delayed rectifier potassium channel activity [GO:0005251]; voltage-gated potassium channel activity [GO:0005249] g11176.t2 Q96L42 55.694 641 0.0 627.0 sp|Q96L42|KCNH8_HUMAN Voltage-gated delayed rectifier potassium channel KCNH8 OS=Homo sapiens OX=9606 GN=KCNH8 PE=1 SV=2 KCNH8_HUMAN reviewed Voltage-gated delayed rectifier potassium channel KCNH8 (ELK1) (hElk-1) (Ether-a-go-go-like potassium channel 3) (ELK channel 3) (ELK3) (Potassium voltage-gated channel subfamily H member 8) (Voltage-gated potassium channel subunit Kv12.1) Homo sapiens (Human) GO:0005249; GO:0005251; GO:0005886; GO:0006813; GO:0034702; GO:0042391; GO:0071805 potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; regulation of membrane potential [GO:0042391] monoatomic ion channel complex [GO:0034702]; plasma membrane [GO:0005886] delayed rectifier potassium channel activity [GO:0005251]; voltage-gated potassium channel activity [GO:0005249] g11178.t1 Q6GPB8 49.55 555 7.06e-174 506.0 sp|Q6GPB8|DBR1A_XENLA Lariat debranching enzyme A OS=Xenopus laevis OX=8355 GN=dbr1-a PE=2 SV=1 DBR1A_XENLA reviewed Lariat debranching enzyme A (EC 3.1.4.-) Xenopus laevis (African clawed frog) GO:0000375; GO:0000398; GO:0005634; GO:0008419; GO:0046872 mRNA splicing, via spliceosome [GO:0000398]; RNA splicing, via transesterification reactions [GO:0000375] nucleus [GO:0005634] metal ion binding [GO:0046872]; RNA lariat debranching enzyme activity [GO:0008419] g11179.t1 Q9R1P4 75.949 237 1.23e-133 382.0 sp|Q9R1P4|PSA1_MOUSE Proteasome subunit alpha type-1 OS=Mus musculus OX=10090 GN=Psma1 PE=1 SV=1 PSA1_MOUSE reviewed Proteasome subunit alpha type-1 (Macropain subunit C2) (Multicatalytic endopeptidase complex subunit C2) (Proteasome component C2) (Proteasome nu chain) (Proteasome subunit alpha-6) (alpha-6) Mus musculus (Mouse) GO:0000502; GO:0001530; GO:0002376; GO:0002862; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005839; GO:0019773; GO:0043161 immune system process [GO:0002376]; negative regulation of inflammatory response to antigenic stimulus [GO:0002862]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161] centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; proteasome core complex [GO:0005839]; proteasome core complex, alpha-subunit complex [GO:0019773] lipopolysaccharide binding [GO:0001530] g11182.t1 Q63085 61.453 358 1.53e-139 445.0 sp|Q63085|PDE3B_RAT cGMP-inhibited 3',5'-cyclic phosphodiesterase 3B OS=Rattus norvegicus OX=10116 GN=Pde3b PE=1 SV=1 PDE3B_RAT reviewed cGMP-inhibited 3',5'-cyclic phosphodiesterase 3B (EC 3.1.4.17) (CGI PDE) (Cyclic GMP-inhibited phosphodiesterase B) (CGI-PDE B) (RcGIPl) Rattus norvegicus (Rat) GO:0001525; GO:0004114; GO:0004115; GO:0005783; GO:0005794; GO:0007162; GO:0008286; GO:0016020; GO:0016525; GO:0031018; GO:0032045; GO:0042593; GO:0043422; GO:0045765; GO:0046872; GO:0047555; GO:0050796; GO:0050995; GO:0051219; GO:0051896; GO:0061179; GO:0141162 angiogenesis [GO:0001525]; endocrine pancreas development [GO:0031018]; glucose homeostasis [GO:0042593]; insulin receptor signaling pathway [GO:0008286]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cAMP/PKA signal transduction [GO:0141162]; negative regulation of cell adhesion [GO:0007162]; negative regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061179]; negative regulation of lipid catabolic process [GO:0050995]; regulation of angiogenesis [GO:0045765]; regulation of insulin secretion [GO:0050796]; regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051896] endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; guanyl-nucleotide exchange factor complex [GO:0032045]; membrane [GO:0016020] 3',5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; 3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; 3',5'-cyclic-nucleotide phosphodiesterase activity [GO:0004114]; metal ion binding [GO:0046872]; phosphoprotein binding [GO:0051219]; protein kinase B binding [GO:0043422] g11183.t1 Q9UA35 60.504 119 2.02e-40 149.0 sp|Q9UA35|S28A3_EPTST Solute carrier family 28 member 3 OS=Eptatretus stoutii OX=7765 GN=SLC28A3 PE=2 SV=1 g11183.t1 Q9UA35 61.039 77 1.9300000000000001e-22 98.2 sp|Q9UA35|S28A3_EPTST Solute carrier family 28 member 3 OS=Eptatretus stoutii OX=7765 GN=SLC28A3 PE=2 SV=1 g11184.t1 Q9UA35 45.708 431 7.449999999999999e-111 346.0 sp|Q9UA35|S28A3_EPTST Solute carrier family 28 member 3 OS=Eptatretus stoutii OX=7765 GN=SLC28A3 PE=2 SV=1 g11188.t1 Q8WPD0 34.32 169 4.1100000000000004e-26 100.0 sp|Q8WPD0|LECG_PATPE Alpha-N-acetylgalactosamine-specific lectin OS=Patiria pectinifera OX=7594 PE=1 SV=1 g11190.t1 Q90368 53.409 88 1.28e-25 102.0 sp|Q90368|SMAP_COTJA Small acidic protein OS=Coturnix japonica OX=93934 GN=SMAP PE=2 SV=1 g11191.t1 A6H7H7 33.506 385 6.43e-46 168.0 sp|A6H7H7|FBX3_BOVIN F-box only protein 3 OS=Bos taurus OX=9913 GN=FBXO3 PE=2 SV=1 g11192.t1 Q56A06 52.847 439 2.17e-145 456.0 sp|Q56A06|TMTC2_MOUSE Protein O-mannosyl-transferase TMTC2 OS=Mus musculus OX=10090 GN=Tmtc2 PE=2 SV=1 TMTC2_MOUSE reviewed Protein O-mannosyl-transferase TMTC2 (EC 2.4.1.109) (Transmembrane O-mannosyltransferase targeting cadherins 2) (Transmembrane and tetratricopeptide repeat-containing 2) Mus musculus (Mouse) GO:0000030; GO:0004169; GO:0005783; GO:0005789; GO:0035269; GO:0055074 calcium ion homeostasis [GO:0055074]; protein O-linked glycosylation via mannose [GO:0035269] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789] dolichyl-phosphate-mannose-protein mannosyltransferase activity [GO:0004169]; mannosyltransferase activity [GO:0000030] g11192.t1 Q56A06 54.03 335 2.8599999999999997e-91 311.0 sp|Q56A06|TMTC2_MOUSE Protein O-mannosyl-transferase TMTC2 OS=Mus musculus OX=10090 GN=Tmtc2 PE=2 SV=1 TMTC2_MOUSE reviewed Protein O-mannosyl-transferase TMTC2 (EC 2.4.1.109) (Transmembrane O-mannosyltransferase targeting cadherins 2) (Transmembrane and tetratricopeptide repeat-containing 2) Mus musculus (Mouse) GO:0000030; GO:0004169; GO:0005783; GO:0005789; GO:0035269; GO:0055074 calcium ion homeostasis [GO:0055074]; protein O-linked glycosylation via mannose [GO:0035269] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789] dolichyl-phosphate-mannose-protein mannosyltransferase activity [GO:0004169]; mannosyltransferase activity [GO:0000030] g11193.t1 P16331 47.098 448 1.12e-141 416.0 sp|P16331|PH4H_MOUSE Phenylalanine-4-hydroxylase OS=Mus musculus OX=10090 GN=Pah PE=1 SV=4 PH4H_MOUSE reviewed Phenylalanine-4-hydroxylase (PAH) (EC 1.14.16.1) (Phe-4-monooxygenase) Mus musculus (Mouse) GO:0004505; GO:0005506; GO:0006558; GO:0006559; GO:0006571; GO:0016597; GO:0019293; GO:0042802 L-phenylalanine catabolic process [GO:0006559]; L-phenylalanine metabolic process [GO:0006558]; tyrosine biosynthetic process [GO:0006571]; tyrosine biosynthetic process, by oxidation of phenylalanine [GO:0019293] amino acid binding [GO:0016597]; identical protein binding [GO:0042802]; iron ion binding [GO:0005506]; phenylalanine 4-monooxygenase activity [GO:0004505] g11198.t1 Q5E959 64.505 293 7.58e-135 389.0 sp|Q5E959|STRAP_BOVIN Serine-threonine kinase receptor-associated protein OS=Bos taurus OX=9913 GN=STRAP PE=2 SV=1 STRAP_BOVIN reviewed Serine-threonine kinase receptor-associated protein Bos taurus (Bovine) GO:0000122; GO:0000380; GO:0000387; GO:0003723; GO:0003729; GO:0005102; GO:0005634; GO:0005829; GO:0030182; GO:0030277; GO:0030512; GO:0032797; GO:0034653; GO:0034719; GO:0048384; GO:1990447 alternative mRNA splicing, via spliceosome [GO:0000380]; maintenance of gastrointestinal epithelium [GO:0030277]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; neuron differentiation [GO:0030182]; retinoic acid catabolic process [GO:0034653]; retinoic acid receptor signaling pathway [GO:0048384]; spliceosomal snRNP assembly [GO:0000387] cytosol [GO:0005829]; nucleus [GO:0005634]; SMN complex [GO:0032797]; SMN-Sm protein complex [GO:0034719] mRNA binding [GO:0003729]; RNA binding [GO:0003723]; signaling receptor binding [GO:0005102]; U2 snRNP binding [GO:1990447] g11199.t1 Q5E9B6 45.05 404 6.01e-107 330.0 sp|Q5E9B6|NR1H3_BOVIN Oxysterols receptor LXR-alpha OS=Bos taurus OX=9913 GN=NR1H3 PE=2 SV=1 NR1H3_BOVIN reviewed Oxysterols receptor LXR-alpha (Liver X receptor alpha) (Nuclear receptor subfamily 1 group H member 3) Bos taurus (Bovine) GO:0000122; GO:0000785; GO:0000978; GO:0001228; GO:0004879; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0008270; GO:0009755; GO:0010867; GO:0010875; GO:0010883; GO:0010887; GO:0030154; GO:0030522; GO:0031490; GO:0032369; GO:0032570; GO:0032810; GO:0034145; GO:0036151; GO:0042632; GO:0042789; GO:0043031; GO:0043235; GO:0043277; GO:0043565; GO:0045723; GO:0045861; GO:0045893; GO:0045944; GO:0046965; GO:0048550; GO:0050728; GO:0070328; GO:0071222; GO:0090188; GO:0090341; GO:0090575; GO:0120163; GO:1903573 apoptotic cell clearance [GO:0043277]; cell differentiation [GO:0030154]; cellular response to lipopolysaccharide [GO:0071222]; cholesterol homeostasis [GO:0042632]; hormone-mediated signaling pathway [GO:0009755]; intracellular receptor signaling pathway [GO:0030522]; mRNA transcription by RNA polymerase II [GO:0042789]; negative regulation of cholesterol storage [GO:0010887]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of inflammatory response [GO:0050728]; negative regulation of lipid transport [GO:0032369]; negative regulation of macrophage activation [GO:0043031]; negative regulation of pancreatic juice secretion [GO:0090188]; negative regulation of pinocytosis [GO:0048550]; negative regulation of proteolysis [GO:0045861]; negative regulation of response to endoplasmic reticulum stress [GO:1903573]; negative regulation of secretion of lysosomal enzymes [GO:0090341]; negative regulation of transcription by RNA polymerase II [GO:0000122]; phosphatidylcholine acyl-chain remodeling [GO:0036151]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of fatty acid biosynthetic process [GO:0045723]; positive regulation of toll-like receptor 4 signaling pathway [GO:0034145]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of triglyceride biosynthetic process [GO:0010867]; regulation of lipid storage [GO:0010883]; response to progesterone [GO:0032570]; triglyceride homeostasis [GO:0070328] chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; receptor complex [GO:0043235]; RNA polymerase II transcription regulator complex [GO:0090575] chromatin DNA binding [GO:0031490]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; nuclear receptor activity [GO:0004879]; nuclear retinoid X receptor binding [GO:0046965]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sterol response element binding [GO:0032810]; zinc ion binding [GO:0008270] g11204.t1 G8HTB6 27.843 255 3.57e-24 110.0 sp|G8HTB6|ZPP_ACRMI ZP domain-containing protein OS=Acropora millepora OX=45264 PE=1 SV=1 g11205.t1 G8HTB6 28.516 256 7.6e-26 115.0 sp|G8HTB6|ZPP_ACRMI ZP domain-containing protein OS=Acropora millepora OX=45264 PE=1 SV=1 g11208.t1 O15442 60.909 220 2.36e-99 295.0 sp|O15442|MPPD1_HUMAN Metallophosphoesterase domain-containing protein 1 OS=Homo sapiens OX=9606 GN=MPPED1 PE=1 SV=3 g11208.t2 O15442 59.055 254 3.44e-109 323.0 sp|O15442|MPPD1_HUMAN Metallophosphoesterase domain-containing protein 1 OS=Homo sapiens OX=9606 GN=MPPED1 PE=1 SV=3 g11209.t1 P27085 84.348 115 1.45e-53 168.0 sp|P27085|RS26_OCTVU Small ribosomal subunit protein eS26 OS=Octopus vulgaris OX=6645 GN=RPS26 PE=2 SV=1 g11210.t1 Q96EH3 51.049 143 7.600000000000001e-43 152.0 sp|Q96EH3|MASU1_HUMAN Mitochondrial assembly of ribosomal large subunit protein 1 OS=Homo sapiens OX=9606 GN=MALSU1 PE=1 SV=1 MASU1_HUMAN reviewed Mitochondrial assembly of ribosomal large subunit protein 1 Homo sapiens (Human) GO:0005739; GO:0005759; GO:0005829; GO:0017148; GO:0042273; GO:0043023; GO:0070130; GO:0090071; GO:0140978; GO:1902775 mitochondrial large ribosomal subunit assembly [GO:1902775]; negative regulation of mitochondrial translation [GO:0070130]; negative regulation of ribosome biogenesis [GO:0090071]; negative regulation of translation [GO:0017148]; ribosomal large subunit biogenesis [GO:0042273] cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] mitochondrial large ribosomal subunit binding [GO:0140978]; ribosomal large subunit binding [GO:0043023] g11211.t1 Q90YB1 52.632 855 0.0 928.0 sp|Q90YB1|DNLI4_CHICK DNA ligase 4 OS=Gallus gallus OX=9031 GN=LIG4 PE=2 SV=2 DNLI4_CHICK reviewed DNA ligase 4 (EC 6.5.1.1) (DNA ligase IV) (Polydeoxyribonucleotide synthase [ATP] 4) Gallus gallus (Chicken) GO:0003677; GO:0003910; GO:0005524; GO:0005654; GO:0005958; GO:0006297; GO:0006303; GO:0032807; GO:0033152; GO:0046872; GO:0051301; GO:0070419; GO:0071897 cell division [GO:0051301]; DNA biosynthetic process [GO:0071897]; double-strand break repair via nonhomologous end joining [GO:0006303]; immunoglobulin V(D)J recombination [GO:0033152]; nucleotide-excision repair, DNA gap filling [GO:0006297] DNA ligase IV complex [GO:0032807]; DNA-dependent protein kinase-DNA ligase 4 complex [GO:0005958]; nonhomologous end joining complex [GO:0070419]; nucleoplasm [GO:0005654] ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA ligase (ATP) activity [GO:0003910]; metal ion binding [GO:0046872] g11212.t1 Q7Z6J2 48.092 131 2.22e-27 112.0 sp|Q7Z6J2|GRASP_HUMAN Protein TAMALIN OS=Homo sapiens OX=9606 GN=TAMALIN PE=1 SV=1 g11214.t1 Q9D534 46.939 147 4.08e-33 127.0 sp|Q9D534|ZC21B_MOUSE Zinc finger C2HC domain-containing protein 1B OS=Mus musculus OX=10090 GN=Zc2hc1b PE=2 SV=1 g11215.t1 Q80W71 32.857 210 4.6000000000000006e-31 126.0 sp|Q80W71|PKHA8_MOUSE Pleckstrin homology domain-containing family A member 8 OS=Mus musculus OX=10090 GN=Plekha8 PE=1 SV=2 g11221.t1 O95425 45.297 925 0.0 790.0 sp|O95425|SVIL_HUMAN Supervillin OS=Homo sapiens OX=9606 GN=SVIL PE=1 SV=2 SVIL_HUMAN reviewed Supervillin (Archvillin) (p205/p250) Homo sapiens (Human) GO:0002102; GO:0005546; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0005925; GO:0007519; GO:0008154; GO:0015629; GO:0030496; GO:0032154; GO:0032467; GO:0036449; GO:0042995; GO:0043034; GO:0051014; GO:0051015; GO:0051016 actin filament severing [GO:0051014]; actin polymerization or depolymerization [GO:0008154]; barbed-end actin filament capping [GO:0051016]; positive regulation of cytokinesis [GO:0032467]; skeletal muscle tissue development [GO:0007519] actin cytoskeleton [GO:0015629]; cell projection [GO:0042995]; cleavage furrow [GO:0032154]; costamere [GO:0043034]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; microtubule minus-end [GO:0036449]; midbody [GO:0030496]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; podosome [GO:0002102] actin filament binding [GO:0051015]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546] g11229.t1 Q62739 42.282 298 1.64e-59 203.0 sp|Q62739|RAB3I_RAT Rab-3A-interacting protein OS=Rattus norvegicus OX=10116 GN=Rab3ip PE=1 SV=2 RAB3I_RAT reviewed Rab-3A-interacting protein (Rab3A-interacting protein) (Rabin-3) (SSX2-interacting protein) Rattus norvegicus (Rat) GO:0005085; GO:0005634; GO:0005654; GO:0005813; GO:0005829; GO:0006612; GO:0015031; GO:0030027; GO:0031267; GO:0042802; GO:0048471; GO:0051020; GO:0051490; GO:0060271; GO:1990635 cilium assembly [GO:0060271]; negative regulation of filopodium assembly [GO:0051490]; protein targeting to membrane [GO:0006612]; protein transport [GO:0015031] centrosome [GO:0005813]; cytosol [GO:0005829]; lamellipodium [GO:0030027]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; proximal dendrite [GO:1990635] GTPase binding [GO:0051020]; guanyl-nucleotide exchange factor activity [GO:0005085]; identical protein binding [GO:0042802]; small GTPase binding [GO:0031267] g11232.t1 Q86YQ8 50.0 86 3.66e-22 92.4 sp|Q86YQ8|CPNE8_HUMAN Copine-8 OS=Homo sapiens OX=9606 GN=CPNE8 PE=1 SV=2 g11234.t1 Q07817 34.351 131 4.96e-21 90.1 sp|Q07817|B2CL1_HUMAN Bcl-2-like protein 1 OS=Homo sapiens OX=9606 GN=BCL2L1 PE=1 SV=1 B2CL1_HUMAN reviewed Bcl-2-like protein 1 (Bcl2-L-1) (Apoptosis regulator Bcl-X) Homo sapiens (Human) GO:0001541; GO:0001701; GO:0001836; GO:0005737; GO:0005739; GO:0005741; GO:0005743; GO:0005759; GO:0005783; GO:0005813; GO:0005829; GO:0006897; GO:0007281; GO:0007283; GO:0008584; GO:0008630; GO:0008637; GO:0009566; GO:0010507; GO:0015267; GO:0019901; GO:0030672; GO:0031965; GO:0032465; GO:0032946; GO:0034097; GO:0035234; GO:0040008; GO:0042802; GO:0043065; GO:0043066; GO:0043524; GO:0044565; GO:0046898; GO:0046902; GO:0050673; GO:0051093; GO:0051402; GO:0051434; GO:0051607; GO:0051881; GO:0071230; GO:0071312; GO:0071480; GO:0071839; GO:0090201; GO:0097048; GO:0097136; GO:0097192; GO:0097284; GO:1900118; GO:1901029; GO:1902042; GO:1902230; GO:1902236; GO:1903077; GO:2000242; GO:2000669; GO:2000811; GO:2001240; GO:2001243 apoptotic mitochondrial changes [GO:0008637]; apoptotic process in bone marrow cell [GO:0071839]; cellular response to alkaloid [GO:0071312]; cellular response to amino acid stimulus [GO:0071230]; cellular response to gamma radiation [GO:0071480]; defense response to virus [GO:0051607]; dendritic cell apoptotic process [GO:0097048]; dendritic cell proliferation [GO:0044565]; ectopic germ cell programmed cell death [GO:0035234]; endocytosis [GO:0006897]; epithelial cell proliferation [GO:0050673]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; fertilization [GO:0009566]; germ cell development [GO:0007281]; hepatocyte apoptotic process [GO:0097284]; in utero embryonic development [GO:0001701]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; male gonad development [GO:0008584]; negative regulation of anoikis [GO:2000811]; negative regulation of apoptotic process [GO:0043066]; negative regulation of autophagy [GO:0010507]; negative regulation of dendritic cell apoptotic process [GO:2000669]; negative regulation of developmental process [GO:0051093]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]; negative regulation of execution phase of apoptosis [GO:1900118]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage [GO:1902230]; negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901029]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of protein localization to plasma membrane [GO:1903077]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; negative regulation of reproductive process [GO:2000242]; neuron apoptotic process [GO:0051402]; ovarian follicle development [GO:0001541]; positive regulation of apoptotic process [GO:0043065]; positive regulation of mononuclear cell proliferation [GO:0032946]; regulation of cytokinesis [GO:0032465]; regulation of growth [GO:0040008]; regulation of mitochondrial membrane permeability [GO:0046902]; regulation of mitochondrial membrane potential [GO:0051881]; release of cytochrome c from mitochondria [GO:0001836]; response to cycloheximide [GO:0046898]; response to cytokine [GO:0034097]; spermatogenesis [GO:0007283] Bcl-2 family protein complex [GO:0097136]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nuclear membrane [GO:0031965]; synaptic vesicle membrane [GO:0030672] BH3 domain binding [GO:0051434]; channel activity [GO:0015267]; identical protein binding [GO:0042802]; protein kinase binding [GO:0019901] g11244.t1 A0A1L8F5J9 56.173 324 1.09e-120 371.0 sp|A0A1L8F5J9|NMDZ1_XENLA Glutamate receptor ionotropic, NMDA 1 OS=Xenopus laevis OX=8355 GN=grin1 PE=1 SV=1 NMDZ1_XENLA reviewed Glutamate receptor ionotropic, NMDA 1 (GluN1) (N-methyl-D-aspartate receptor subunit NR1) (NMD-R1) Xenopus laevis (African clawed frog) GO:0004972; GO:0005886; GO:0007268; GO:0010043; GO:0015276; GO:0015280; GO:0017146; GO:0022849; GO:0035235; GO:0035725; GO:0038023; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0046872; GO:0048167; GO:0070588; GO:0098839 calcium ion transmembrane transport [GO:0070588]; chemical synaptic transmission [GO:0007268]; ionotropic glutamate receptor signaling pathway [GO:0035235]; regulation of membrane potential [GO:0042391]; regulation of synaptic plasticity [GO:0048167]; response to zinc ion [GO:0010043]; sodium ion transmembrane transport [GO:0035725] neuron projection [GO:0043005]; NMDA selective glutamate receptor complex [GO:0017146]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202] glutamate-gated calcium ion channel activity [GO:0022849]; ligand-gated monoatomic ion channel activity [GO:0015276]; ligand-gated sodium channel activity [GO:0015280]; metal ion binding [GO:0046872]; NMDA glutamate receptor activity [GO:0004972]; signaling receptor activity [GO:0038023] g11245.t1 P35439 40.248 323 3.68e-76 256.0 sp|P35439|NMDZ1_RAT Glutamate receptor ionotropic, NMDA 1 OS=Rattus norvegicus OX=10116 GN=Grin1 PE=1 SV=1 NMDZ1_RAT reviewed Glutamate receptor ionotropic, NMDA 1 (GluN1) (Glutamate [NMDA] receptor subunit zeta-1) (N-methyl-D-aspartate receptor subunit NR1) (NMD-R1) Rattus norvegicus (Rat) GO:0001540; GO:0001661; GO:0001666; GO:0001964; GO:0001967; GO:0001975; GO:0004970; GO:0004972; GO:0005102; GO:0005261; GO:0005262; GO:0005509; GO:0005516; GO:0005737; GO:0005783; GO:0005789; GO:0005886; GO:0006812; GO:0006816; GO:0006874; GO:0007268; GO:0007611; GO:0007612; GO:0007613; GO:0007616; GO:0008021; GO:0008306; GO:0008344; GO:0008355; GO:0008542; GO:0009986; GO:0010524; GO:0010646; GO:0014069; GO:0014075; GO:0015276; GO:0015280; GO:0016020; GO:0016323; GO:0016594; GO:0016595; GO:0017146; GO:0018964; GO:0019233; GO:0019899; GO:0019902; GO:0021586; GO:0021987; GO:0022824; GO:0022843; GO:0022849; GO:0030425; GO:0030672; GO:0032590; GO:0034702; GO:0035176; GO:0035235; GO:0035249; GO:0035254; GO:0035725; GO:0038023; GO:0042391; GO:0042734; GO:0043005; GO:0043025; GO:0043065; GO:0043083; GO:0043195; GO:0043197; GO:0043278; GO:0043523; GO:0043524; GO:0043576; GO:0044307; GO:0044877; GO:0045202; GO:0045211; GO:0045471; GO:0045944; GO:0048167; GO:0048168; GO:0048169; GO:0048511; GO:0048787; GO:0048814; GO:0050770; GO:0050905; GO:0051290; GO:0051592; GO:0051963; GO:0051968; GO:0055074; GO:0060076; GO:0060079; GO:0060134; GO:0060179; GO:0060992; GO:0065003; GO:0070050; GO:0070588; GO:0071287; GO:0097060; GO:0097553; GO:0098655; GO:0098686; GO:0098688; GO:0098839; GO:0098878; GO:0098978; GO:0099507; GO:1900149; GO:1902952; GO:1903416; GO:1903428; GO:1903539; GO:1904062; GO:1904315; GO:1905429; GO:1905430; GO:2000463 adult locomotory behavior [GO:0008344]; associative learning [GO:0008306]; calcium ion homeostasis [GO:0055074]; calcium ion transmembrane import into cytosol [GO:0097553]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; cellular response to glycine [GO:1905430]; cellular response to manganese ion [GO:0071287]; cerebral cortex development [GO:0021987]; chemical synaptic transmission [GO:0007268]; conditioned taste aversion [GO:0001661]; excitatory postsynaptic potential [GO:0060079]; intracellular calcium ion homeostasis [GO:0006874]; ionotropic glutamate receptor signaling pathway [GO:0035235]; learning [GO:0007612]; learning or memory [GO:0007611]; long-term memory [GO:0007616]; male mating behavior [GO:0060179]; memory [GO:0007613]; monoatomic cation transmembrane transport [GO:0098655]; monoatomic cation transport [GO:0006812]; negative regulation of neuron apoptotic process [GO:0043524]; neuromuscular process [GO:0050905]; neuron cellular homeostasis [GO:0070050]; olfactory learning [GO:0008355]; pons maturation [GO:0021586]; positive regulation of apoptotic process [GO:0043065]; positive regulation of calcium ion transport into cytosol [GO:0010524]; positive regulation of dendritic spine maintenance [GO:1902952]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of reactive oxygen species biosynthetic process [GO:1903428]; positive regulation of Schwann cell migration [GO:1900149]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; positive regulation of transcription by RNA polymerase II [GO:0045944]; prepulse inhibition [GO:0060134]; propylene metabolic process [GO:0018964]; protein heterotetramerization [GO:0051290]; protein localization to postsynaptic membrane [GO:1903539]; protein-containing complex assembly [GO:0065003]; regulation of axonogenesis [GO:0050770]; regulation of cell communication [GO:0010646]; regulation of dendrite morphogenesis [GO:0048814]; regulation of long-term neuronal synaptic plasticity [GO:0048169]; regulation of membrane potential [GO:0042391]; regulation of monoatomic cation transmembrane transport [GO:1904062]; regulation of neuron apoptotic process [GO:0043523]; regulation of neuronal synaptic plasticity [GO:0048168]; regulation of respiratory gaseous exchange [GO:0043576]; regulation of synapse assembly [GO:0051963]; regulation of synaptic plasticity [GO:0048167]; response to amine [GO:0014075]; response to amphetamine [GO:0001975]; response to calcium ion [GO:0051592]; response to ethanol [GO:0045471]; response to fungicide [GO:0060992]; response to glycine [GO:1905429]; response to glycoside [GO:1903416]; response to hypoxia [GO:0001666]; response to morphine [GO:0043278]; rhythmic process [GO:0048511]; sensory perception of pain [GO:0019233]; social behavior [GO:0035176]; sodium ion transmembrane transport [GO:0035725]; startle response [GO:0001964]; suckling behavior [GO:0001967]; synaptic transmission, glutamatergic [GO:0035249]; visual learning [GO:0008542] basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; dendrite membrane [GO:0032590]; dendritic branch [GO:0044307]; dendritic spine [GO:0043197]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; excitatory synapse [GO:0060076]; glutamatergic synapse [GO:0098978]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; membrane [GO:0016020]; monoatomic ion channel complex [GO:0034702]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; neurotransmitter receptor complex [GO:0098878]; NMDA selective glutamate receptor complex [GO:0017146]; parallel fiber to Purkinje cell synapse [GO:0098688]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic density membrane [GO:0098839]; postsynaptic membrane [GO:0045211]; presynaptic active zone membrane [GO:0048787]; presynaptic membrane [GO:0042734]; synapse [GO:0045202]; synaptic cleft [GO:0043083]; synaptic membrane [GO:0097060]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672]; terminal bouton [GO:0043195] amyloid-beta binding [GO:0001540]; calcium channel activity [GO:0005262]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; glutamate binding [GO:0016595]; glutamate receptor binding [GO:0035254]; glutamate-gated calcium ion channel activity [GO:0022849]; glutamate-gated receptor activity [GO:0004970]; glycine binding [GO:0016594]; ligand-gated monoatomic ion channel activity [GO:0015276]; ligand-gated monoatomic ion channel activity involved in regulation of presynaptic membrane potential [GO:0099507]; ligand-gated sodium channel activity [GO:0015280]; monoatomic cation channel activity [GO:0005261]; NMDA glutamate receptor activity [GO:0004972]; phosphatase binding [GO:0019902]; protein-containing complex binding [GO:0044877]; signaling receptor activity [GO:0038023]; signaling receptor binding [GO:0005102]; transmitter-gated monoatomic ion channel activity [GO:0022824]; transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; voltage-gated monoatomic cation channel activity [GO:0022843] g11246.t1 Q3HNM7 35.955 534 1.57e-84 276.0 sp|Q3HNM7|INSC_MOUSE Protein inscuteable homolog OS=Mus musculus OX=10090 GN=Insc PE=1 SV=2 INSC_MOUSE reviewed Protein inscuteable homolog (Minsc) Mus musculus (Mouse) GO:0005886; GO:0007399; GO:0008093; GO:0008356; GO:0009786; GO:0019904; GO:0030154; GO:0030674; GO:0031647; GO:0032991; GO:0045176; GO:0045179 apical protein localization [GO:0045176]; asymmetric cell division [GO:0008356]; cell differentiation [GO:0030154]; nervous system development [GO:0007399]; regulation of asymmetric cell division [GO:0009786]; regulation of protein stability [GO:0031647] apical cortex [GO:0045179]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] cytoskeletal anchor activity [GO:0008093]; protein domain specific binding [GO:0019904]; protein-macromolecule adaptor activity [GO:0030674] g11247.t1 Q9PWF7 67.959 490 0.0 718.0 sp|Q9PWF7|CATA_GLARU Catalase OS=Glandirana rugosa OX=8410 GN=cat PE=2 SV=3 g11248.t1 P30372 27.848 474 1.94e-44 165.0 sp|P30372|ACM2_CHICK Muscarinic acetylcholine receptor M2 OS=Gallus gallus OX=9031 GN=CHRM2 PE=3 SV=1 g11249.t1 Q9H0E2 47.855 303 7.67e-82 251.0 sp|Q9H0E2|TOLIP_HUMAN Toll-interacting protein OS=Homo sapiens OX=9606 GN=TOLLIP PE=1 SV=1 TOLIP_HUMAN reviewed Toll-interacting protein Homo sapiens (Human) GO:0005150; GO:0005576; GO:0005737; GO:0005769; GO:0005829; GO:0006511; GO:0006914; GO:0006954; GO:0007165; GO:0016310; GO:0016604; GO:0019897; GO:0019900; GO:0030855; GO:0031624; GO:0031625; GO:0032183; GO:0032991; GO:0033235; GO:0035325; GO:0035578; GO:0035580; GO:0036010; GO:0043130; GO:0045087; GO:0045321; GO:0048471; GO:0060090; GO:0070062; GO:0070498 autophagy [GO:0006914]; epithelial cell differentiation [GO:0030855]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; interleukin-1-mediated signaling pathway [GO:0070498]; leukocyte activation [GO:0045321]; phosphorylation [GO:0016310]; positive regulation of protein sumoylation [GO:0033235]; protein localization to endosome [GO:0036010]; signal transduction [GO:0007165]; ubiquitin-dependent protein catabolic process [GO:0006511] azurophil granule lumen [GO:0035578]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extrinsic component of plasma membrane [GO:0019897]; nuclear body [GO:0016604]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; specific granule lumen [GO:0035580] interleukin-1, type I receptor binding [GO:0005150]; kinase binding [GO:0019900]; molecular adaptor activity [GO:0060090]; SUMO binding [GO:0032183]; Toll-like receptor binding [GO:0035325]; ubiquitin binding [GO:0043130]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase binding [GO:0031625] g11257.t1 P42694 28.652 356 9.69e-32 137.0 sp|P42694|HELZ_HUMAN Probable helicase with zinc finger domain OS=Homo sapiens OX=9606 GN=HELZ PE=1 SV=2 HELZ_HUMAN reviewed ATP-dependent RNA helicase with zinc finger domain (EC 3.6.4.13) (Down-regulated in human cancers protein) Homo sapiens (Human) GO:0003723; GO:0004386; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0008270; GO:0008284; GO:0016020; GO:0016787; GO:0017148; GO:0035194; GO:0043186; GO:1900153; GO:1905762 negative regulation of translation [GO:0017148]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; regulatory ncRNA-mediated post-transcriptional gene silencing [GO:0035194] cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; P granule [GO:0043186] ATP binding [GO:0005524]; CCR4-NOT complex binding [GO:1905762]; helicase activity [GO:0004386]; hydrolase activity [GO:0016787]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270] g11258.t1 E9QAM5 31.005 1661 0.0 647.0 sp|E9QAM5|HELZ2_MOUSE 3'-5' exoribonuclease HELZ2 OS=Mus musculus OX=10090 GN=Helz2 PE=1 SV=1 g11258.t1 E9QAM5 32.971 552 2.14e-68 261.0 sp|E9QAM5|HELZ2_MOUSE 3'-5' exoribonuclease HELZ2 OS=Mus musculus OX=10090 GN=Helz2 PE=1 SV=1 g11258.t1 E9QAM5 30.448 335 6.04e-26 122.0 sp|E9QAM5|HELZ2_MOUSE 3'-5' exoribonuclease HELZ2 OS=Mus musculus OX=10090 GN=Helz2 PE=1 SV=1 g11259.t1 P35992 38.086 491 1.88e-93 335.0 sp|P35992|PTP10_DROME Tyrosine-protein phosphatase 10D OS=Drosophila melanogaster OX=7227 GN=Ptp10D PE=1 SV=4 g11259.t2 P35992 38.086 491 5.66e-93 335.0 sp|P35992|PTP10_DROME Tyrosine-protein phosphatase 10D OS=Drosophila melanogaster OX=7227 GN=Ptp10D PE=1 SV=4 g11260.t1 P09380 43.511 131 1.75e-36 126.0 sp|P09380|SSBPA_XENLA Single-stranded DNA-binding protein 1-A, mitochondrial OS=Xenopus laevis OX=8355 GN=ssbp1-a PE=1 SV=2 g11261.t1 Q9Z1T6 40.556 360 7.330000000000001e-72 259.0 sp|Q9Z1T6|FYV1_MOUSE 1-phosphatidylinositol 3-phosphate 5-kinase OS=Mus musculus OX=10090 GN=Pikfyve PE=1 SV=3 FYV1_MOUSE reviewed 1-phosphatidylinositol 3-phosphate 5-kinase (Phosphatidylinositol 3-phosphate 5-kinase) (EC 2.7.1.150) (FYVE finger-containing phosphoinositide kinase) (PIKfyve) (Phosphatidylinositol 3-phosphate 5-kinase type III) (PIPkin-III) (Type III PIP kinase) (Serine-protein kinase PIKFYVE) (EC 2.7.11.1) (p235) Mus musculus (Mouse) GO:0000139; GO:0000285; GO:0004674; GO:0005524; GO:0005829; GO:0005911; GO:0006612; GO:0008270; GO:0010008; GO:0012506; GO:0016301; GO:0016308; GO:0019065; GO:0019886; GO:0030593; GO:0030670; GO:0031410; GO:0031901; GO:0031902; GO:0032288; GO:0032438; GO:0034504; GO:0035556; GO:0036289; GO:0042147; GO:0045121; GO:0048471; GO:0052810; GO:0090382; GO:0090385; GO:0106310; GO:1903100; GO:1903426; GO:1904562; GO:2000785 1-phosphatidyl-1D-myo-inositol 3,5-bisphosphate metabolic process [GO:1903100]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; intracellular signal transduction [GO:0035556]; melanosome organization [GO:0032438]; myelin assembly [GO:0032288]; neutrophil chemotaxis [GO:0030593]; peptidyl-serine autophosphorylation [GO:0036289]; phagosome maturation [GO:0090382]; phagosome-lysosome fusion [GO:0090385]; phosphatidylinositol 5-phosphate metabolic process [GO:1904562]; protein localization to nucleus [GO:0034504]; protein targeting to membrane [GO:0006612]; receptor-mediated endocytosis of virus by host cell [GO:0019065]; regulation of autophagosome assembly [GO:2000785]; regulation of reactive oxygen species biosynthetic process [GO:1903426]; retrograde transport, endosome to Golgi [GO:0042147] cell-cell junction [GO:0005911]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endosome membrane [GO:0010008]; Golgi membrane [GO:0000139]; late endosome membrane [GO:0031902]; membrane raft [GO:0045121]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle membrane [GO:0030670]; vesicle membrane [GO:0012506] 1-phosphatidylinositol-3-phosphate 5-kinase activity [GO:0000285]; 1-phosphatidylinositol-4-phosphate 5-kinase activity [GO:0016308]; 1-phosphatidylinositol-5-kinase activity [GO:0052810]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; zinc ion binding [GO:0008270] g11261.t2 Q9Z1T6 40.556 360 6.6e-72 259.0 sp|Q9Z1T6|FYV1_MOUSE 1-phosphatidylinositol 3-phosphate 5-kinase OS=Mus musculus OX=10090 GN=Pikfyve PE=1 SV=3 FYV1_MOUSE reviewed 1-phosphatidylinositol 3-phosphate 5-kinase (Phosphatidylinositol 3-phosphate 5-kinase) (EC 2.7.1.150) (FYVE finger-containing phosphoinositide kinase) (PIKfyve) (Phosphatidylinositol 3-phosphate 5-kinase type III) (PIPkin-III) (Type III PIP kinase) (Serine-protein kinase PIKFYVE) (EC 2.7.11.1) (p235) Mus musculus (Mouse) GO:0000139; GO:0000285; GO:0004674; GO:0005524; GO:0005829; GO:0005911; GO:0006612; GO:0008270; GO:0010008; GO:0012506; GO:0016301; GO:0016308; GO:0019065; GO:0019886; GO:0030593; GO:0030670; GO:0031410; GO:0031901; GO:0031902; GO:0032288; GO:0032438; GO:0034504; GO:0035556; GO:0036289; GO:0042147; GO:0045121; GO:0048471; GO:0052810; GO:0090382; GO:0090385; GO:0106310; GO:1903100; GO:1903426; GO:1904562; GO:2000785 1-phosphatidyl-1D-myo-inositol 3,5-bisphosphate metabolic process [GO:1903100]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; intracellular signal transduction [GO:0035556]; melanosome organization [GO:0032438]; myelin assembly [GO:0032288]; neutrophil chemotaxis [GO:0030593]; peptidyl-serine autophosphorylation [GO:0036289]; phagosome maturation [GO:0090382]; phagosome-lysosome fusion [GO:0090385]; phosphatidylinositol 5-phosphate metabolic process [GO:1904562]; protein localization to nucleus [GO:0034504]; protein targeting to membrane [GO:0006612]; receptor-mediated endocytosis of virus by host cell [GO:0019065]; regulation of autophagosome assembly [GO:2000785]; regulation of reactive oxygen species biosynthetic process [GO:1903426]; retrograde transport, endosome to Golgi [GO:0042147] cell-cell junction [GO:0005911]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endosome membrane [GO:0010008]; Golgi membrane [GO:0000139]; late endosome membrane [GO:0031902]; membrane raft [GO:0045121]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle membrane [GO:0030670]; vesicle membrane [GO:0012506] 1-phosphatidylinositol-3-phosphate 5-kinase activity [GO:0000285]; 1-phosphatidylinositol-4-phosphate 5-kinase activity [GO:0016308]; 1-phosphatidylinositol-5-kinase activity [GO:0052810]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; zinc ion binding [GO:0008270] g11261.t3 Q9Z1T6 40.556 360 6.79e-72 259.0 sp|Q9Z1T6|FYV1_MOUSE 1-phosphatidylinositol 3-phosphate 5-kinase OS=Mus musculus OX=10090 GN=Pikfyve PE=1 SV=3 FYV1_MOUSE reviewed 1-phosphatidylinositol 3-phosphate 5-kinase (Phosphatidylinositol 3-phosphate 5-kinase) (EC 2.7.1.150) (FYVE finger-containing phosphoinositide kinase) (PIKfyve) (Phosphatidylinositol 3-phosphate 5-kinase type III) (PIPkin-III) (Type III PIP kinase) (Serine-protein kinase PIKFYVE) (EC 2.7.11.1) (p235) Mus musculus (Mouse) GO:0000139; GO:0000285; GO:0004674; GO:0005524; GO:0005829; GO:0005911; GO:0006612; GO:0008270; GO:0010008; GO:0012506; GO:0016301; GO:0016308; GO:0019065; GO:0019886; GO:0030593; GO:0030670; GO:0031410; GO:0031901; GO:0031902; GO:0032288; GO:0032438; GO:0034504; GO:0035556; GO:0036289; GO:0042147; GO:0045121; GO:0048471; GO:0052810; GO:0090382; GO:0090385; GO:0106310; GO:1903100; GO:1903426; GO:1904562; GO:2000785 1-phosphatidyl-1D-myo-inositol 3,5-bisphosphate metabolic process [GO:1903100]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; intracellular signal transduction [GO:0035556]; melanosome organization [GO:0032438]; myelin assembly [GO:0032288]; neutrophil chemotaxis [GO:0030593]; peptidyl-serine autophosphorylation [GO:0036289]; phagosome maturation [GO:0090382]; phagosome-lysosome fusion [GO:0090385]; phosphatidylinositol 5-phosphate metabolic process [GO:1904562]; protein localization to nucleus [GO:0034504]; protein targeting to membrane [GO:0006612]; receptor-mediated endocytosis of virus by host cell [GO:0019065]; regulation of autophagosome assembly [GO:2000785]; regulation of reactive oxygen species biosynthetic process [GO:1903426]; retrograde transport, endosome to Golgi [GO:0042147] cell-cell junction [GO:0005911]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endosome membrane [GO:0010008]; Golgi membrane [GO:0000139]; late endosome membrane [GO:0031902]; membrane raft [GO:0045121]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle membrane [GO:0030670]; vesicle membrane [GO:0012506] 1-phosphatidylinositol-3-phosphate 5-kinase activity [GO:0000285]; 1-phosphatidylinositol-4-phosphate 5-kinase activity [GO:0016308]; 1-phosphatidylinositol-5-kinase activity [GO:0052810]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; zinc ion binding [GO:0008270] g11265.t1 Q9Y2I7 50.0 492 3.22e-135 471.0 sp|Q9Y2I7|FYV1_HUMAN 1-phosphatidylinositol 3-phosphate 5-kinase OS=Homo sapiens OX=9606 GN=PIKFYVE PE=1 SV=3 g11265.t1 Q9Y2I7 36.364 528 1.59e-79 296.0 sp|Q9Y2I7|FYV1_HUMAN 1-phosphatidylinositol 3-phosphate 5-kinase OS=Homo sapiens OX=9606 GN=PIKFYVE PE=1 SV=3 g11265.t1 Q9Y2I7 47.351 302 1.46e-68 261.0 sp|Q9Y2I7|FYV1_HUMAN 1-phosphatidylinositol 3-phosphate 5-kinase OS=Homo sapiens OX=9606 GN=PIKFYVE PE=1 SV=3 g11266.t1 Q8CDU5 46.774 124 3.42e-38 139.0 sp|Q8CDU5|EFHB_MOUSE EF-hand domain-containing family member B OS=Mus musculus OX=10090 GN=Efhb PE=1 SV=2 g11267.t1 F1MMV1 48.93 374 8.85e-115 358.0 sp|F1MMV1|EFHB_BOVIN EF-hand domain-containing family member B OS=Bos taurus OX=9913 GN=EFHB PE=1 SV=3 EFHB_BOVIN reviewed EF-hand domain-containing family member B (Cilia- and flagella-associated protein 21) Bos taurus (Bovine) GO:0005509; GO:0005879; GO:0006816; GO:0030317; GO:0036126; GO:0061891; GO:0070884; GO:0160111; GO:2001256 calcium ion transport [GO:0006816]; flagellated sperm motility [GO:0030317]; regulation of calcineurin-NFAT signaling cascade [GO:0070884]; regulation of store-operated calcium entry [GO:2001256] axonemal A tubule inner sheath [GO:0160111]; axonemal microtubule [GO:0005879]; sperm flagellum [GO:0036126] calcium ion binding [GO:0005509]; calcium ion sensor activity [GO:0061891] g11268.t1 Q98932 79.724 217 6.48e-116 332.0 sp|Q98932|RAB5C_CHICK Ras-related protein Rab-5C OS=Gallus gallus OX=9031 GN=RAB5C PE=1 SV=1 g11269.t1 Q8BVT6 44.538 119 9.810000000000001e-27 115.0 sp|Q8BVT6|PP2D1_MOUSE Protein phosphatase 2C-like domain-containing protein 1 OS=Mus musculus OX=10090 GN=Pp2d1 PE=2 SV=1 g11271.t1 Q8R314 53.43 481 2.81e-135 404.0 sp|Q8R314|S35F5_MOUSE Solute carrier family 35 member F5 OS=Mus musculus OX=10090 GN=Slc35f5 PE=2 SV=1 g11273.t1 Q9Y2U5 57.294 473 1.91e-154 463.0 sp|Q9Y2U5|M3K2_HUMAN Mitogen-activated protein kinase kinase kinase 2 OS=Homo sapiens OX=9606 GN=MAP3K2 PE=1 SV=2 g11273.t2 Q61083 55.533 488 2.94e-152 457.0 sp|Q61083|M3K2_MOUSE Mitogen-activated protein kinase kinase kinase 2 OS=Mus musculus OX=10090 GN=Map3k2 PE=1 SV=2 M3K2_MOUSE reviewed Mitogen-activated protein kinase kinase kinase 2 (EC 2.7.11.25) (MAPK/ERK kinase kinase 2) (MEK kinase 2) (MEKK 2) Mus musculus (Mouse) GO:0004672; GO:0004674; GO:0004709; GO:0005524; GO:0005654; GO:0005737; GO:0005829; GO:0019901; GO:0035556; GO:0046872; GO:0106310 intracellular signal transduction [GO:0035556] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654] ATP binding [GO:0005524]; MAP kinase kinase kinase activity [GO:0004709]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g11274.t1 Q32L09 34.335 233 2.13e-30 118.0 sp|Q32L09|SHFL_BOVIN Shiftless antiviral inhibitor of ribosomal frameshifting protein homolog OS=Bos taurus OX=9913 GN=SHFL PE=2 SV=1 SHFL_BOVIN reviewed Shiftless antiviral inhibitor of ribosomal frameshifting protein homolog (SHFL) (Repressor of yield of DENV protein homolog) (RyDEN) Bos taurus (Bovine) GO:0000932; GO:0003723; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006449; GO:0034340; GO:0034341; GO:0034342; GO:0035456; GO:0043022; GO:0045071; GO:0045087; GO:0051607; GO:0075523; GO:1990825; GO:2001125 defense response to virus [GO:0051607]; innate immune response [GO:0045087]; negative regulation of translational frameshifting [GO:2001125]; negative regulation of viral genome replication [GO:0045071]; regulation of translational termination [GO:0006449]; response to interferon-beta [GO:0035456]; response to type I interferon [GO:0034340]; response to type II interferon [GO:0034341]; response to type III interferon [GO:0034342]; viral translational frameshifting [GO:0075523] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932] ribosome binding [GO:0043022]; RNA binding [GO:0003723]; sequence-specific mRNA binding [GO:1990825] g11276.t1 Q8TE57 31.452 744 1.31e-93 318.0 sp|Q8TE57|ATS16_HUMAN A disintegrin and metalloproteinase with thrombospondin motifs 16 OS=Homo sapiens OX=9606 GN=ADAMTS16 PE=1 SV=3 ATS16_HUMAN reviewed A disintegrin and metalloproteinase with thrombospondin motifs 16 (ADAM-TS 16) (ADAM-TS16) (ADAMTS-16) (EC 3.4.24.-) Homo sapiens (Human) GO:0001658; GO:0003073; GO:0004222; GO:0006508; GO:0030198; GO:0031012; GO:0046872; GO:0048232; GO:1902017 branching involved in ureteric bud morphogenesis [GO:0001658]; extracellular matrix organization [GO:0030198]; male gamete generation [GO:0048232]; proteolysis [GO:0006508]; regulation of cilium assembly [GO:1902017]; regulation of systemic arterial blood pressure [GO:0003073] extracellular matrix [GO:0031012] metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222] g11278.t1 P35992 26.555 1077 9.56e-71 270.0 sp|P35992|PTP10_DROME Tyrosine-protein phosphatase 10D OS=Drosophila melanogaster OX=7227 GN=Ptp10D PE=1 SV=4 g11279.t1 Q9JMH7 31.567 453 2.12e-47 171.0 sp|Q9JMH7|NEUR3_MOUSE Sialidase-3 OS=Mus musculus OX=10090 GN=Neu3 PE=1 SV=1 NEUR3_MOUSE reviewed Sialidase-3 (EC 3.2.1.18) (Ganglioside sialidase) (Membrane sialidase) (N-acetyl-alpha-neuraminidase 3) Mus musculus (Mouse) GO:0004308; GO:0005737; GO:0005764; GO:0005765; GO:0005886; GO:0005901; GO:0005975; GO:0006689; GO:0009313; GO:0009897; GO:0016020; GO:0016997; GO:0031901; GO:0045742; GO:0055038; GO:1900186 carbohydrate metabolic process [GO:0005975]; ganglioside catabolic process [GO:0006689]; negative regulation of clathrin-dependent endocytosis [GO:1900186]; oligosaccharide catabolic process [GO:0009313]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742] caveola [GO:0005901]; cytoplasm [GO:0005737]; early endosome membrane [GO:0031901]; external side of plasma membrane [GO:0009897]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038] alpha-sialidase activity [GO:0016997]; exo-alpha-sialidase activity [GO:0004308] g11286.t1 Q9Y6F6 35.906 298 5.38e-30 133.0 sp|Q9Y6F6|IRAG1_HUMAN Inositol 1,4,5-triphosphate receptor associated 1 OS=Homo sapiens OX=9606 GN=IRAG1 PE=1 SV=4 g11286.t2 Q12912 39.648 227 2.2599999999999998e-30 132.0 sp|Q12912|IRAG2_HUMAN Inositol 1,4,5-triphosphate receptor associated 2 OS=Homo sapiens OX=9606 GN=IRAG2 PE=1 SV=3 IRAG2_HUMAN reviewed Inositol 1,4,5-triphosphate receptor associated 2 (Lymphoid-restricted membrane protein) (Protein Jaw1) [Cleaved into: Processed inositol 1,4,5-triphosphate receptor associated 2] Homo sapiens (Human) GO:0000922; GO:0002376; GO:0005635; GO:0005694; GO:0005789; GO:0005813; GO:0005886; GO:0006903; GO:0006906; GO:0006997; GO:0007338; GO:0008017; GO:0016020; GO:0035577 immune system process [GO:0002376]; nucleus organization [GO:0006997]; single fertilization [GO:0007338]; vesicle fusion [GO:0006906]; vesicle targeting [GO:0006903] azurophil granule membrane [GO:0035577]; centrosome [GO:0005813]; chromosome [GO:0005694]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; plasma membrane [GO:0005886]; spindle pole [GO:0000922] microtubule binding [GO:0008017] g11290.t1 P11862 43.051 295 6.6e-66 211.0 sp|P11862|GAS2_MOUSE Growth arrest-specific protein 2 OS=Mus musculus OX=10090 GN=Gas2 PE=1 SV=1 GAS2_MOUSE reviewed Growth arrest-specific protein 2 (GAS-2) Mus musculus (Mouse) GO:0001544; GO:0001547; GO:0001725; GO:0006915; GO:0008017; GO:0008360; GO:0008593; GO:0016020; GO:0030728; GO:0051015; GO:0051726; GO:0051764; GO:0071711 actin crosslink formation [GO:0051764]; antral ovarian follicle growth [GO:0001547]; apoptotic process [GO:0006915]; basement membrane organization [GO:0071711]; initiation of primordial ovarian follicle growth [GO:0001544]; ovulation [GO:0030728]; regulation of cell cycle [GO:0051726]; regulation of cell shape [GO:0008360]; regulation of Notch signaling pathway [GO:0008593] membrane [GO:0016020]; stress fiber [GO:0001725] actin filament binding [GO:0051015]; microtubule binding [GO:0008017] g11291.t1 Q92621 47.441 801 0.0 725.0 sp|Q92621|NU205_HUMAN Nuclear pore complex protein Nup205 OS=Homo sapiens OX=9606 GN=NUP205 PE=1 SV=3 NU205_HUMAN reviewed Nuclear pore complex protein Nup205 (205 kDa nucleoporin) (Nucleoporin Nup205) Homo sapiens (Human) GO:0005635; GO:0005643; GO:0005829; GO:0006913; GO:0006999; GO:0015031; GO:0016020; GO:0017056; GO:0031965; GO:0034399; GO:0044611; GO:0051028; GO:0051292 mRNA transport [GO:0051028]; nuclear pore complex assembly [GO:0051292]; nuclear pore organization [GO:0006999]; nucleocytoplasmic transport [GO:0006913]; protein transport [GO:0015031] cytosol [GO:0005829]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear periphery [GO:0034399]; nuclear pore [GO:0005643]; nuclear pore inner ring [GO:0044611] structural constituent of nuclear pore [GO:0017056] g11292.t1 Q92621 38.982 1257 0.0 780.0 sp|Q92621|NU205_HUMAN Nuclear pore complex protein Nup205 OS=Homo sapiens OX=9606 GN=NUP205 PE=1 SV=3 NU205_HUMAN reviewed Nuclear pore complex protein Nup205 (205 kDa nucleoporin) (Nucleoporin Nup205) Homo sapiens (Human) GO:0005635; GO:0005643; GO:0005829; GO:0006913; GO:0006999; GO:0015031; GO:0016020; GO:0017056; GO:0031965; GO:0034399; GO:0044611; GO:0051028; GO:0051292 mRNA transport [GO:0051028]; nuclear pore complex assembly [GO:0051292]; nuclear pore organization [GO:0006999]; nucleocytoplasmic transport [GO:0006913]; protein transport [GO:0015031] cytosol [GO:0005829]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear periphery [GO:0034399]; nuclear pore [GO:0005643]; nuclear pore inner ring [GO:0044611] structural constituent of nuclear pore [GO:0017056] g11294.t1 P0CY46 39.513 1192 0.0 762.0 sp|P0CY46|EGFR_APIME Epidermal growth factor receptor OS=Apis mellifera OX=7460 GN=Egfr PE=2 SV=1 EGFR_APIME reviewed Epidermal growth factor receptor (Egfr) (EC 2.7.10.1) Apis mellifera (Honeybee) GO:0004714; GO:0005524; GO:0008284; GO:0009925; GO:0009966; GO:0022008; GO:0038127; GO:0043066; GO:0043235 ERBB signaling pathway [GO:0038127]; negative regulation of apoptotic process [GO:0043066]; neurogenesis [GO:0022008]; positive regulation of cell population proliferation [GO:0008284]; regulation of signal transduction [GO:0009966] basal plasma membrane [GO:0009925]; receptor complex [GO:0043235] ATP binding [GO:0005524]; transmembrane receptor protein tyrosine kinase activity [GO:0004714] g11308.t1 Q505I5 59.756 82 4.95e-29 110.0 sp|Q505I5|F133B_RAT Protein FAM133B OS=Rattus norvegicus OX=10116 GN=Fam133b PE=2 SV=1 g11308.t2 Q505I5 59.756 82 4.8000000000000004e-29 110.0 sp|Q505I5|F133B_RAT Protein FAM133B OS=Rattus norvegicus OX=10116 GN=Fam133b PE=2 SV=1 g11309.t1 Q6IMK3 41.975 162 3.13e-38 135.0 sp|Q6IMK3|DJC27_DANRE DnaJ homolog subfamily C member 27 OS=Danio rerio OX=7955 GN=dnajc27 PE=2 SV=1 g11310.t1 A9ULE9 32.958 355 1.18e-47 167.0 sp|A9ULE9|DJC22_XENTR DnaJ homolog subfamily C member 22 OS=Xenopus tropicalis OX=8364 GN=dnajc22 PE=2 SV=1 g11311.t1 Q6ZQQ6 27.536 621 6.47e-47 190.0 sp|Q6ZQQ6|WDR87_HUMAN WD repeat-containing protein 87 OS=Homo sapiens OX=9606 GN=WDR87 PE=1 SV=4 g11312.t1 Q3ZBH0 71.645 529 0.0 754.0 sp|Q3ZBH0|TCPB_BOVIN T-complex protein 1 subunit beta OS=Bos taurus OX=9913 GN=CCT2 PE=1 SV=3 TCPB_BOVIN reviewed T-complex protein 1 subunit beta (TCP-1-beta) (EC 3.6.1.-) (CCT-beta) Bos taurus (Bovine) GO:0002199; GO:0005524; GO:0005832; GO:0005874; GO:0006457; GO:0007339; GO:0016887; GO:0031625; GO:0032212; GO:0044297; GO:0046872; GO:0050821; GO:0051082; GO:0051131; GO:0090666; GO:0140662; GO:1904874 binding of sperm to zona pellucida [GO:0007339]; chaperone-mediated protein complex assembly [GO:0051131]; positive regulation of telomerase RNA localization to Cajal body [GO:1904874]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; scaRNA localization to Cajal body [GO:0090666] cell body [GO:0044297]; chaperonin-containing T-complex [GO:0005832]; microtubule [GO:0005874]; zona pellucida receptor complex [GO:0002199] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent protein folding chaperone [GO:0140662]; metal ion binding [GO:0046872]; ubiquitin protein ligase binding [GO:0031625]; unfolded protein binding [GO:0051082] g11313.t1 P61166 84.416 77 3.1e-33 112.0 sp|P61166|TM258_MOUSE Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit TMEM258 OS=Mus musculus OX=10090 GN=Tmem258 PE=1 SV=1 TM258_MOUSE reviewed Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit TMEM258 (Oligosaccharyl transferase subunit TMEM258) (Transmembrane protein 258) Mus musculus (Mouse) GO:0005737; GO:0005783; GO:0005789; GO:0006487; GO:0006954; GO:0008250; GO:0009306; GO:0016020; GO:0034976; GO:0062062; GO:0160226; GO:0160227; GO:1904019 epithelial cell apoptotic process [GO:1904019]; inflammatory response [GO:0006954]; protein N-linked glycosylation [GO:0006487]; protein secretion [GO:0009306]; response to endoplasmic reticulum stress [GO:0034976] cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; oligosaccharyltransferase complex [GO:0008250]; oligosaccharyltransferase complex A [GO:0160226]; oligosaccharyltransferase complex B [GO:0160227] oligosaccharyltransferase complex binding [GO:0062062] g11316.t1 Q3C2C2 42.361 144 3.7000000000000003e-29 107.0 sp|Q3C2C2|PA21_ACAPL Phospholipase A2 AP-PLA2-I OS=Acanthaster planci OX=133434 PE=1 SV=1 PA21_ACAPL reviewed Phospholipase A2 AP-PLA2-I (PLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase 2) Acanthaster planci (Crown-of-thorns starfish) GO:0005509; GO:0005543; GO:0005576; GO:0006644; GO:0016042; GO:0031640; GO:0047498; GO:0050482; GO:0090729 arachidonate secretion [GO:0050482]; killing of cells of another organism [GO:0031640]; lipid catabolic process [GO:0016042]; phospholipid metabolic process [GO:0006644] extracellular region [GO:0005576] calcium ion binding [GO:0005509]; calcium-dependent phospholipase A2 activity [GO:0047498]; phospholipid binding [GO:0005543]; toxin activity [GO:0090729] g11319.t1 B0BLT0 57.273 110 7.86e-44 143.0 sp|B0BLT0|ZN593_XENTR Zinc finger protein 593 OS=Xenopus tropicalis OX=8364 GN=znf593 PE=2 SV=1 g11324.t1 Q6DHJ3 40.0 410 7.920000000000001e-103 317.0 sp|Q6DHJ3|NVD_DANRE Cholesterol 7-desaturase nvd OS=Danio rerio OX=7955 GN=nvd PE=1 SV=1 NVD_DANRE reviewed Cholesterol 7-desaturase nvd (EC 1.14.19.21) (Protein neverland) (Nvd protein) (nvd-Dr) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005737; GO:0008203; GO:0016020; GO:0016491; GO:0046872; GO:0051537; GO:0170056 cholesterol metabolic process [GO:0008203] cytoplasm [GO:0005737]; membrane [GO:0016020] 2 iron, 2 sulfur cluster binding [GO:0051537]; cholesterol 7-desaturase [NAD(P)H] activity [GO:0170056]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491] g11328.t1 Q8CH62 41.6 125 6.13e-25 95.9 sp|Q8CH62|LTO1_MOUSE Protein LTO1 homolog OS=Mus musculus OX=10090 GN=Lto1 PE=1 SV=1 g11329.t1 B1WAX6 48.966 145 3.4999999999999997e-25 106.0 sp|B1WAX6|TIGAR_XENTR Fructose-2,6-bisphosphatase TIGAR OS=Xenopus tropicalis OX=8364 GN=tigar PE=2 SV=1 g11330.t1 Q9D864 60.101 396 9.690000000000001e-179 506.0 sp|Q9D864|ARP6_MOUSE Actin-related protein 6 OS=Mus musculus OX=10090 GN=Actr6 PE=1 SV=2 g11334.t1 O43581 53.947 304 1.02e-114 347.0 sp|O43581|SYT7_HUMAN Synaptotagmin-7 OS=Homo sapiens OX=9606 GN=SYT7 PE=1 SV=3 SYT7_HUMAN reviewed Synaptotagmin-7 (IPCA-7) (Prostate cancer-associated protein 7) (Synaptotagmin VII) (SytVII) Homo sapiens (Human) GO:0000149; GO:0001778; GO:0005509; GO:0005516; GO:0005544; GO:0005546; GO:0005764; GO:0005765; GO:0005777; GO:0005778; GO:0005829; GO:0005886; GO:0006906; GO:0006909; GO:0008021; GO:0016192; GO:0017158; GO:0019905; GO:0030276; GO:0030424; GO:0030670; GO:0030672; GO:0031045; GO:0032009; GO:0036465; GO:0042734; GO:0045202; GO:0045956; GO:0046850; GO:0048791; GO:0050764; GO:0050796; GO:0061891; GO:0070062; GO:0070092; GO:0090119; GO:0090385; GO:0098686; GO:0099502; GO:1900242; GO:1990926; GO:1990927 calcium ion regulated lysosome exocytosis [GO:1990927]; calcium ion-regulated exocytosis of neurotransmitter [GO:0048791]; calcium-dependent activation of synaptic vesicle fusion [GO:0099502]; phagocytosis [GO:0006909]; phagosome-lysosome fusion [GO:0090385]; plasma membrane repair [GO:0001778]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; regulation of bone remodeling [GO:0046850]; regulation of calcium ion-dependent exocytosis [GO:0017158]; regulation of glucagon secretion [GO:0070092]; regulation of insulin secretion [GO:0050796]; regulation of phagocytosis [GO:0050764]; regulation of synaptic vesicle endocytosis [GO:1900242]; short-term synaptic potentiation [GO:1990926]; synaptic vesicle recycling [GO:0036465]; vesicle fusion [GO:0006906]; vesicle-mediated cholesterol transport [GO:0090119]; vesicle-mediated transport [GO:0016192] axon [GO:0030424]; cytosol [GO:0005829]; dense core granule [GO:0031045]; early phagosome [GO:0032009]; extracellular exosome [GO:0070062]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; synapse [GO:0045202]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672] calcium ion binding [GO:0005509]; calcium ion sensor activity [GO:0061891]; calcium-dependent phospholipid binding [GO:0005544]; calmodulin binding [GO:0005516]; clathrin binding [GO:0030276]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905] g11334.t2 O43581 57.621 269 3.5699999999999996e-114 345.0 sp|O43581|SYT7_HUMAN Synaptotagmin-7 OS=Homo sapiens OX=9606 GN=SYT7 PE=1 SV=3 SYT7_HUMAN reviewed Synaptotagmin-7 (IPCA-7) (Prostate cancer-associated protein 7) (Synaptotagmin VII) (SytVII) Homo sapiens (Human) GO:0000149; GO:0001778; GO:0005509; GO:0005516; GO:0005544; GO:0005546; GO:0005764; GO:0005765; GO:0005777; GO:0005778; GO:0005829; GO:0005886; GO:0006906; GO:0006909; GO:0008021; GO:0016192; GO:0017158; GO:0019905; GO:0030276; GO:0030424; GO:0030670; GO:0030672; GO:0031045; GO:0032009; GO:0036465; GO:0042734; GO:0045202; GO:0045956; GO:0046850; GO:0048791; GO:0050764; GO:0050796; GO:0061891; GO:0070062; GO:0070092; GO:0090119; GO:0090385; GO:0098686; GO:0099502; GO:1900242; GO:1990926; GO:1990927 calcium ion regulated lysosome exocytosis [GO:1990927]; calcium ion-regulated exocytosis of neurotransmitter [GO:0048791]; calcium-dependent activation of synaptic vesicle fusion [GO:0099502]; phagocytosis [GO:0006909]; phagosome-lysosome fusion [GO:0090385]; plasma membrane repair [GO:0001778]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; regulation of bone remodeling [GO:0046850]; regulation of calcium ion-dependent exocytosis [GO:0017158]; regulation of glucagon secretion [GO:0070092]; regulation of insulin secretion [GO:0050796]; regulation of phagocytosis [GO:0050764]; regulation of synaptic vesicle endocytosis [GO:1900242]; short-term synaptic potentiation [GO:1990926]; synaptic vesicle recycling [GO:0036465]; vesicle fusion [GO:0006906]; vesicle-mediated cholesterol transport [GO:0090119]; vesicle-mediated transport [GO:0016192] axon [GO:0030424]; cytosol [GO:0005829]; dense core granule [GO:0031045]; early phagosome [GO:0032009]; extracellular exosome [GO:0070062]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; synapse [GO:0045202]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672] calcium ion binding [GO:0005509]; calcium ion sensor activity [GO:0061891]; calcium-dependent phospholipid binding [GO:0005544]; calmodulin binding [GO:0005516]; clathrin binding [GO:0030276]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905] g11336.t1 Q99K28 42.446 556 1.07e-111 345.0 sp|Q99K28|ARFG2_MOUSE ADP-ribosylation factor GTPase-activating protein 2 OS=Mus musculus OX=10090 GN=Arfgap2 PE=1 SV=1 g11337.t1 Q02067 57.325 157 2.0500000000000003e-31 116.0 sp|Q02067|ASCL1_MOUSE Achaete-scute homolog 1 OS=Mus musculus OX=10090 GN=Ascl1 PE=1 SV=2 ASCL1_MOUSE reviewed Achaete-scute homolog 1 (ASH-1) (mASH-1) (mASH1) Mus musculus (Mouse) GO:0000122; GO:0000977; GO:0000978; GO:0000981; GO:0001227; GO:0001764; GO:0003358; GO:0003359; GO:0003676; GO:0003682; GO:0003690; GO:0003700; GO:0005634; GO:0006357; GO:0007219; GO:0007346; GO:0007389; GO:0007399; GO:0007400; GO:0007405; GO:0007423; GO:0007507; GO:0008593; GO:0010001; GO:0010468; GO:0014003; GO:0021527; GO:0021529; GO:0021530; GO:0021750; GO:0021779; GO:0021879; GO:0021892; GO:0021902; GO:0021954; GO:0021987; GO:0022008; GO:0030154; GO:0030182; GO:0030856; GO:0032526; GO:0042127; GO:0042802; GO:0043025; GO:0043066; GO:0043425; GO:0043525; GO:0043565; GO:0045665; GO:0045666; GO:0045747; GO:0045787; GO:0045892; GO:0045944; GO:0046983; GO:0048469; GO:0048484; GO:0048485; GO:0048486; GO:0048663; GO:0048665; GO:0048666; GO:0048699; GO:0048709; GO:0050767; GO:0050769; GO:0050883; GO:0051593; GO:0060163; GO:0060165; GO:0060166; GO:0060579; GO:0061100; GO:0061102; GO:0061103; GO:0061104; GO:0061549; GO:0070849; GO:0070888; GO:0071259; GO:0090575; GO:1990837; GO:2000179 adrenal chromaffin cell differentiation [GO:0061104]; carotid body glomus cell differentiation [GO:0061103]; cell differentiation [GO:0030154]; cell maturation [GO:0048469]; cellular response to magnetism [GO:0071259]; central nervous system neuron development [GO:0021954]; cerebral cortex development [GO:0021987]; cerebral cortex GABAergic interneuron differentiation [GO:0021892]; commitment of neuronal cell to specific neuron type in forebrain [GO:0021902]; enteric nervous system development [GO:0048484]; forebrain neuron differentiation [GO:0021879]; generation of neurons [GO:0048699]; glial cell differentiation [GO:0010001]; heart development [GO:0007507]; lung neuroendocrine cell differentiation [GO:0061100]; musculoskeletal movement, spinal reflex action [GO:0050883]; negative regulation of apoptotic process [GO:0043066]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]; neuroblast fate determination [GO:0007400]; neuroblast proliferation [GO:0007405]; neurogenesis [GO:0022008]; neuron development [GO:0048666]; neuron differentiation [GO:0030182]; neuron fate commitment [GO:0048663]; neuron fate specification [GO:0048665]; neuron migration [GO:0001764]; noradrenergic neuron development [GO:0003358]; noradrenergic neuron fate commitment [GO:0003359]; Notch signaling pathway [GO:0007219]; olfactory pit development [GO:0060166]; oligodendrocyte cell fate commitment [GO:0021779]; oligodendrocyte development [GO:0014003]; oligodendrocyte differentiation [GO:0048709]; parasympathetic nervous system development [GO:0048486]; pattern specification process [GO:0007389]; positive regulation of cell cycle [GO:0045787]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of neurogenesis [GO:0050769]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell population proliferation [GO:0042127]; regulation of epithelial cell differentiation [GO:0030856]; regulation of gene expression [GO:0010468]; regulation of mitotic cell cycle [GO:0007346]; regulation of neurogenesis [GO:0050767]; regulation of Notch signaling pathway [GO:0008593]; regulation of timing of subpallium neuron differentiation [GO:0060165]; regulation of transcription by RNA polymerase II [GO:0006357]; response to epidermal growth factor [GO:0070849]; response to folic acid [GO:0051593]; response to retinoic acid [GO:0032526]; sensory organ development [GO:0007423]; spinal cord association neuron differentiation [GO:0021527]; spinal cord oligodendrocyte cell differentiation [GO:0021529]; spinal cord oligodendrocyte cell fate specification [GO:0021530]; stomach neuroendocrine cell differentiation [GO:0061102]; subpallium neuron fate commitment [GO:0060163]; sympathetic ganglion development [GO:0061549]; sympathetic nervous system development [GO:0048485]; ventral spinal cord interneuron fate commitment [GO:0060579]; vestibular nucleus development [GO:0021750] neuronal cell body [GO:0043025]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575] bHLH transcription factor binding [GO:0043425]; chromatin binding [GO:0003682]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; double-stranded DNA binding [GO:0003690]; E-box binding [GO:0070888]; identical protein binding [GO:0042802]; nucleic acid binding [GO:0003676]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837] g11342.t1 G3MWR8 46.003 663 1.18e-150 515.0 sp|G3MWR8|MICA3_BOVIN [F-actin]-monooxygenase MICAL3 OS=Bos taurus OX=9913 GN=MICAL3 PE=3 SV=1 MICA3_BOVIN reviewed [F-actin]-monooxygenase MICAL3 (EC 1.14.13.225) (Molecule interacting with CasL protein 3) (MICAL-3) Bos taurus (Bovine) GO:0003779; GO:0005634; GO:0005819; GO:0005938; GO:0006887; GO:0007010; GO:0016709; GO:0030042; GO:0030496; GO:0046872; GO:0071949; GO:0120501 actin filament depolymerization [GO:0030042]; cytoskeleton organization [GO:0007010]; exocytosis [GO:0006887] cell cortex [GO:0005938]; midbody [GO:0030496]; nucleus [GO:0005634]; spindle [GO:0005819] actin binding [GO:0003779]; F-actin monooxygenase activity [GO:0120501]; FAD binding [GO:0071949]; metal ion binding [GO:0046872]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen [GO:0016709] g11342.t1 G3MWR8 62.5 184 1.05e-28 130.0 sp|G3MWR8|MICA3_BOVIN [F-actin]-monooxygenase MICAL3 OS=Bos taurus OX=9913 GN=MICAL3 PE=3 SV=1 MICA3_BOVIN reviewed [F-actin]-monooxygenase MICAL3 (EC 1.14.13.225) (Molecule interacting with CasL protein 3) (MICAL-3) Bos taurus (Bovine) GO:0003779; GO:0005634; GO:0005819; GO:0005938; GO:0006887; GO:0007010; GO:0016709; GO:0030042; GO:0030496; GO:0046872; GO:0071949; GO:0120501 actin filament depolymerization [GO:0030042]; cytoskeleton organization [GO:0007010]; exocytosis [GO:0006887] cell cortex [GO:0005938]; midbody [GO:0030496]; nucleus [GO:0005634]; spindle [GO:0005819] actin binding [GO:0003779]; F-actin monooxygenase activity [GO:0120501]; FAD binding [GO:0071949]; metal ion binding [GO:0046872]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen [GO:0016709] g11342.t2 G3MWR8 46.003 663 1.54e-150 515.0 sp|G3MWR8|MICA3_BOVIN [F-actin]-monooxygenase MICAL3 OS=Bos taurus OX=9913 GN=MICAL3 PE=3 SV=1 MICA3_BOVIN reviewed [F-actin]-monooxygenase MICAL3 (EC 1.14.13.225) (Molecule interacting with CasL protein 3) (MICAL-3) Bos taurus (Bovine) GO:0003779; GO:0005634; GO:0005819; GO:0005938; GO:0006887; GO:0007010; GO:0016709; GO:0030042; GO:0030496; GO:0046872; GO:0071949; GO:0120501 actin filament depolymerization [GO:0030042]; cytoskeleton organization [GO:0007010]; exocytosis [GO:0006887] cell cortex [GO:0005938]; midbody [GO:0030496]; nucleus [GO:0005634]; spindle [GO:0005819] actin binding [GO:0003779]; F-actin monooxygenase activity [GO:0120501]; FAD binding [GO:0071949]; metal ion binding [GO:0046872]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen [GO:0016709] g11342.t2 G3MWR8 62.941 170 3.9400000000000004e-31 138.0 sp|G3MWR8|MICA3_BOVIN [F-actin]-monooxygenase MICAL3 OS=Bos taurus OX=9913 GN=MICAL3 PE=3 SV=1 MICA3_BOVIN reviewed [F-actin]-monooxygenase MICAL3 (EC 1.14.13.225) (Molecule interacting with CasL protein 3) (MICAL-3) Bos taurus (Bovine) GO:0003779; GO:0005634; GO:0005819; GO:0005938; GO:0006887; GO:0007010; GO:0016709; GO:0030042; GO:0030496; GO:0046872; GO:0071949; GO:0120501 actin filament depolymerization [GO:0030042]; cytoskeleton organization [GO:0007010]; exocytosis [GO:0006887] cell cortex [GO:0005938]; midbody [GO:0030496]; nucleus [GO:0005634]; spindle [GO:0005819] actin binding [GO:0003779]; F-actin monooxygenase activity [GO:0120501]; FAD binding [GO:0071949]; metal ion binding [GO:0046872]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen [GO:0016709] g11343.t1 Q8CJ19 68.075 213 1.6e-91 246.0 sp|Q8CJ19|MICA3_MOUSE [F-actin]-monooxygenase MICAL3 OS=Mus musculus OX=10090 GN=Mical3 PE=1 SV=2 MICA3_MOUSE reviewed [F-actin]-monooxygenase MICAL3 (EC 1.14.13.225) (Molecule interacting with CasL protein 3) (MICAL-3) Mus musculus (Mouse) GO:0003779; GO:0005634; GO:0005654; GO:0005819; GO:0005829; GO:0005886; GO:0005938; GO:0006887; GO:0007010; GO:0016709; GO:0019417; GO:0030042; GO:0045171; GO:0046872; GO:0051301; GO:0060090; GO:0071949; GO:0090543; GO:0120501 actin filament depolymerization [GO:0030042]; cell division [GO:0051301]; cytoskeleton organization [GO:0007010]; exocytosis [GO:0006887]; sulfur oxidation [GO:0019417] cell cortex [GO:0005938]; cytosol [GO:0005829]; Flemming body [GO:0090543]; intercellular bridge [GO:0045171]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; spindle [GO:0005819] actin binding [GO:0003779]; F-actin monooxygenase activity [GO:0120501]; FAD binding [GO:0071949]; metal ion binding [GO:0046872]; molecular adaptor activity [GO:0060090]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen [GO:0016709] g11343.t1 Q8CJ19 83.607 61 1.6e-91 111.0 sp|Q8CJ19|MICA3_MOUSE [F-actin]-monooxygenase MICAL3 OS=Mus musculus OX=10090 GN=Mical3 PE=1 SV=2 MICA3_MOUSE reviewed [F-actin]-monooxygenase MICAL3 (EC 1.14.13.225) (Molecule interacting with CasL protein 3) (MICAL-3) Mus musculus (Mouse) GO:0003779; GO:0005634; GO:0005654; GO:0005819; GO:0005829; GO:0005886; GO:0005938; GO:0006887; GO:0007010; GO:0016709; GO:0019417; GO:0030042; GO:0045171; GO:0046872; GO:0051301; GO:0060090; GO:0071949; GO:0090543; GO:0120501 actin filament depolymerization [GO:0030042]; cell division [GO:0051301]; cytoskeleton organization [GO:0007010]; exocytosis [GO:0006887]; sulfur oxidation [GO:0019417] cell cortex [GO:0005938]; cytosol [GO:0005829]; Flemming body [GO:0090543]; intercellular bridge [GO:0045171]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; spindle [GO:0005819] actin binding [GO:0003779]; F-actin monooxygenase activity [GO:0120501]; FAD binding [GO:0071949]; metal ion binding [GO:0046872]; molecular adaptor activity [GO:0060090]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen [GO:0016709] g11347.t1 Q9DBR7 60.364 275 3.26e-101 345.0 sp|Q9DBR7|MYPT1_MOUSE Protein phosphatase 1 regulatory subunit 12A OS=Mus musculus OX=10090 GN=Ppp1r12a PE=1 SV=2 MYPT1_MOUSE reviewed Protein phosphatase 1 regulatory subunit 12A (Myosin phosphatase-targeting subunit 1) (Myosin phosphatase target subunit 1) Mus musculus (Mouse) GO:0000278; GO:0000776; GO:0001725; GO:0004721; GO:0004857; GO:0005730; GO:0005737; GO:0005813; GO:0005829; GO:0005886; GO:0007098; GO:0007165; GO:0015629; GO:0017020; GO:0019208; GO:0019901; GO:0030018; GO:0030155; GO:0031672; GO:0043086; GO:0043292; GO:0045944; GO:0046822; GO:0048812; GO:0071466; GO:0071889; GO:0072357 cellular response to xenobiotic stimulus [GO:0071466]; centrosome cycle [GO:0007098]; mitotic cell cycle [GO:0000278]; negative regulation of catalytic activity [GO:0043086]; neuron projection morphogenesis [GO:0048812]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell adhesion [GO:0030155]; regulation of nucleocytoplasmic transport [GO:0046822]; signal transduction [GO:0007165] A band [GO:0031672]; actin cytoskeleton [GO:0015629]; centrosome [GO:0005813]; contractile muscle fiber [GO:0043292]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; kinetochore [GO:0000776]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; PTW/PP1 phosphatase complex [GO:0072357]; stress fiber [GO:0001725]; Z disc [GO:0030018] 14-3-3 protein binding [GO:0071889]; enzyme inhibitor activity [GO:0004857]; myosin phosphatase regulator activity [GO:0017020]; phosphatase regulator activity [GO:0019208]; phosphoprotein phosphatase activity [GO:0004721]; protein kinase binding [GO:0019901] g11347.t2 Q10728 60.364 275 2.52e-102 348.0 sp|Q10728|MYPT1_RAT Protein phosphatase 1 regulatory subunit 12A OS=Rattus norvegicus OX=10116 GN=Ppp1r12a PE=1 SV=2 MYPT1_RAT reviewed Protein phosphatase 1 regulatory subunit 12A (MBSP) (Myosin phosphatase-targeting subunit 1) (Myosin phosphatase target subunit 1) (Protein phosphatase myosin-binding subunit) (Protein phosphatase subunit 1M) (PP-1M) (Serine/threonine protein phosphatase PP1 smooth muscle regulatory subunit M110) Rattus norvegicus (Rat) GO:0000278; GO:0000776; GO:0001725; GO:0004721; GO:0004857; GO:0005730; GO:0005737; GO:0005813; GO:0005829; GO:0005886; GO:0006470; GO:0007098; GO:0007165; GO:0015629; GO:0017020; GO:0019208; GO:0019901; GO:0030018; GO:0030155; GO:0031672; GO:0043086; GO:0043292; GO:0045944; GO:0046822; GO:0048812; GO:0071466; GO:0071889; GO:0072357 cellular response to xenobiotic stimulus [GO:0071466]; centrosome cycle [GO:0007098]; mitotic cell cycle [GO:0000278]; negative regulation of catalytic activity [GO:0043086]; neuron projection morphogenesis [GO:0048812]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein dephosphorylation [GO:0006470]; regulation of cell adhesion [GO:0030155]; regulation of nucleocytoplasmic transport [GO:0046822]; signal transduction [GO:0007165] A band [GO:0031672]; actin cytoskeleton [GO:0015629]; centrosome [GO:0005813]; contractile muscle fiber [GO:0043292]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; kinetochore [GO:0000776]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; PTW/PP1 phosphatase complex [GO:0072357]; stress fiber [GO:0001725]; Z disc [GO:0030018] 14-3-3 protein binding [GO:0071889]; enzyme inhibitor activity [GO:0004857]; myosin phosphatase regulator activity [GO:0017020]; phosphatase regulator activity [GO:0019208]; phosphoprotein phosphatase activity [GO:0004721]; protein kinase binding [GO:0019901] g11347.t3 Q10728 60.364 275 9.939999999999999e-104 351.0 sp|Q10728|MYPT1_RAT Protein phosphatase 1 regulatory subunit 12A OS=Rattus norvegicus OX=10116 GN=Ppp1r12a PE=1 SV=2 MYPT1_RAT reviewed Protein phosphatase 1 regulatory subunit 12A (MBSP) (Myosin phosphatase-targeting subunit 1) (Myosin phosphatase target subunit 1) (Protein phosphatase myosin-binding subunit) (Protein phosphatase subunit 1M) (PP-1M) (Serine/threonine protein phosphatase PP1 smooth muscle regulatory subunit M110) Rattus norvegicus (Rat) GO:0000278; GO:0000776; GO:0001725; GO:0004721; GO:0004857; GO:0005730; GO:0005737; GO:0005813; GO:0005829; GO:0005886; GO:0006470; GO:0007098; GO:0007165; GO:0015629; GO:0017020; GO:0019208; GO:0019901; GO:0030018; GO:0030155; GO:0031672; GO:0043086; GO:0043292; GO:0045944; GO:0046822; GO:0048812; GO:0071466; GO:0071889; GO:0072357 cellular response to xenobiotic stimulus [GO:0071466]; centrosome cycle [GO:0007098]; mitotic cell cycle [GO:0000278]; negative regulation of catalytic activity [GO:0043086]; neuron projection morphogenesis [GO:0048812]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein dephosphorylation [GO:0006470]; regulation of cell adhesion [GO:0030155]; regulation of nucleocytoplasmic transport [GO:0046822]; signal transduction [GO:0007165] A band [GO:0031672]; actin cytoskeleton [GO:0015629]; centrosome [GO:0005813]; contractile muscle fiber [GO:0043292]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; kinetochore [GO:0000776]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; PTW/PP1 phosphatase complex [GO:0072357]; stress fiber [GO:0001725]; Z disc [GO:0030018] 14-3-3 protein binding [GO:0071889]; enzyme inhibitor activity [GO:0004857]; myosin phosphatase regulator activity [GO:0017020]; phosphatase regulator activity [GO:0019208]; phosphoprotein phosphatase activity [GO:0004721]; protein kinase binding [GO:0019901] g11347.t4 Q10728 48.352 455 2.84e-106 358.0 sp|Q10728|MYPT1_RAT Protein phosphatase 1 regulatory subunit 12A OS=Rattus norvegicus OX=10116 GN=Ppp1r12a PE=1 SV=2 MYPT1_RAT reviewed Protein phosphatase 1 regulatory subunit 12A (MBSP) (Myosin phosphatase-targeting subunit 1) (Myosin phosphatase target subunit 1) (Protein phosphatase myosin-binding subunit) (Protein phosphatase subunit 1M) (PP-1M) (Serine/threonine protein phosphatase PP1 smooth muscle regulatory subunit M110) Rattus norvegicus (Rat) GO:0000278; GO:0000776; GO:0001725; GO:0004721; GO:0004857; GO:0005730; GO:0005737; GO:0005813; GO:0005829; GO:0005886; GO:0006470; GO:0007098; GO:0007165; GO:0015629; GO:0017020; GO:0019208; GO:0019901; GO:0030018; GO:0030155; GO:0031672; GO:0043086; GO:0043292; GO:0045944; GO:0046822; GO:0048812; GO:0071466; GO:0071889; GO:0072357 cellular response to xenobiotic stimulus [GO:0071466]; centrosome cycle [GO:0007098]; mitotic cell cycle [GO:0000278]; negative regulation of catalytic activity [GO:0043086]; neuron projection morphogenesis [GO:0048812]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein dephosphorylation [GO:0006470]; regulation of cell adhesion [GO:0030155]; regulation of nucleocytoplasmic transport [GO:0046822]; signal transduction [GO:0007165] A band [GO:0031672]; actin cytoskeleton [GO:0015629]; centrosome [GO:0005813]; contractile muscle fiber [GO:0043292]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; kinetochore [GO:0000776]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; PTW/PP1 phosphatase complex [GO:0072357]; stress fiber [GO:0001725]; Z disc [GO:0030018] 14-3-3 protein binding [GO:0071889]; enzyme inhibitor activity [GO:0004857]; myosin phosphatase regulator activity [GO:0017020]; phosphatase regulator activity [GO:0019208]; phosphoprotein phosphatase activity [GO:0004721]; protein kinase binding [GO:0019901] g11349.t1 Q9P2G1 48.886 763 0.0 749.0 sp|Q9P2G1|AKIB1_HUMAN Ankyrin repeat and IBR domain-containing protein 1 OS=Homo sapiens OX=9606 GN=ANKIB1 PE=1 SV=3 AKIB1_HUMAN reviewed Ankyrin repeat and IBR domain-containing protein 1 (EC 2.3.2.31) Homo sapiens (Human) GO:0000151; GO:0005737; GO:0006511; GO:0008270; GO:0016567; GO:0031624; GO:0061630 protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511] cytoplasm [GO:0005737]; ubiquitin ligase complex [GO:0000151] ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] g11351.t1 Q8BIA3 36.308 325 2.63e-44 160.0 sp|Q8BIA3|MKX_MOUSE Homeobox protein Mohawk OS=Mus musculus OX=10090 GN=Mkx PE=2 SV=1 MKX_MOUSE reviewed Homeobox protein Mohawk Mus musculus (Mouse) GO:0000122; GO:0000978; GO:0000981; GO:0001227; GO:0001228; GO:0002932; GO:0005634; GO:0005667; GO:0006357; GO:0007517; GO:0010468; GO:0010628; GO:0030199; GO:0030279; GO:0032331; GO:0032967; GO:0035990; GO:0035992; GO:0036077; GO:0045599; GO:0045662; GO:0045944; GO:0048468; GO:0061629; GO:0071260 cell development [GO:0048468]; cellular response to mechanical stimulus [GO:0071260]; collagen fibril organization [GO:0030199]; intratendonous ossification [GO:0036077]; muscle organ development [GO:0007517]; negative regulation of chondrocyte differentiation [GO:0032331]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of ossification [GO:0030279]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of collagen biosynthetic process [GO:0032967]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; regulation of transcription by RNA polymerase II [GO:0006357]; tendon cell differentiation [GO:0035990]; tendon formation [GO:0035992]; tendon sheath development [GO:0002932] nucleus [GO:0005634]; transcription regulator complex [GO:0005667] DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629] g11352.t1 Q8NEV4 49.025 1128 0.0 1055.0 sp|Q8NEV4|MYO3A_HUMAN Myosin-IIIa OS=Homo sapiens OX=9606 GN=MYO3A PE=1 SV=2 MYO3A_HUMAN reviewed Myosin-IIIa (EC 2.7.11.1) Homo sapiens (Human) GO:0000146; GO:0001917; GO:0003779; GO:0004672; GO:0004674; GO:0005516; GO:0005524; GO:0005737; GO:0007601; GO:0007605; GO:0016459; GO:0016887; GO:0030175; GO:0030832; GO:0031941; GO:0032426; GO:0032433; GO:0043531; GO:0046777; GO:0051491; GO:0060002; GO:0090103; GO:0106310 cochlea morphogenesis [GO:0090103]; positive regulation of filopodium assembly [GO:0051491]; protein autophosphorylation [GO:0046777]; regulation of actin filament length [GO:0030832]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601] cytoplasm [GO:0005737]; filamentous actin [GO:0031941]; filopodium [GO:0030175]; filopodium tip [GO:0032433]; myosin complex [GO:0016459]; photoreceptor inner segment [GO:0001917]; stereocilium tip [GO:0032426] actin binding [GO:0003779]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; plus-end directed microfilament motor activity [GO:0060002]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g11352.t2 Q8NEV4 49.373 1116 0.0 1060.0 sp|Q8NEV4|MYO3A_HUMAN Myosin-IIIa OS=Homo sapiens OX=9606 GN=MYO3A PE=1 SV=2 MYO3A_HUMAN reviewed Myosin-IIIa (EC 2.7.11.1) Homo sapiens (Human) GO:0000146; GO:0001917; GO:0003779; GO:0004672; GO:0004674; GO:0005516; GO:0005524; GO:0005737; GO:0007601; GO:0007605; GO:0016459; GO:0016887; GO:0030175; GO:0030832; GO:0031941; GO:0032426; GO:0032433; GO:0043531; GO:0046777; GO:0051491; GO:0060002; GO:0090103; GO:0106310 cochlea morphogenesis [GO:0090103]; positive regulation of filopodium assembly [GO:0051491]; protein autophosphorylation [GO:0046777]; regulation of actin filament length [GO:0030832]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601] cytoplasm [GO:0005737]; filamentous actin [GO:0031941]; filopodium [GO:0030175]; filopodium tip [GO:0032433]; myosin complex [GO:0016459]; photoreceptor inner segment [GO:0001917]; stereocilium tip [GO:0032426] actin binding [GO:0003779]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; plus-end directed microfilament motor activity [GO:0060002]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g11352.t3 Q8NEV4 48.549 1137 0.0 1056.0 sp|Q8NEV4|MYO3A_HUMAN Myosin-IIIa OS=Homo sapiens OX=9606 GN=MYO3A PE=1 SV=2 MYO3A_HUMAN reviewed Myosin-IIIa (EC 2.7.11.1) Homo sapiens (Human) GO:0000146; GO:0001917; GO:0003779; GO:0004672; GO:0004674; GO:0005516; GO:0005524; GO:0005737; GO:0007601; GO:0007605; GO:0016459; GO:0016887; GO:0030175; GO:0030832; GO:0031941; GO:0032426; GO:0032433; GO:0043531; GO:0046777; GO:0051491; GO:0060002; GO:0090103; GO:0106310 cochlea morphogenesis [GO:0090103]; positive regulation of filopodium assembly [GO:0051491]; protein autophosphorylation [GO:0046777]; regulation of actin filament length [GO:0030832]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601] cytoplasm [GO:0005737]; filamentous actin [GO:0031941]; filopodium [GO:0030175]; filopodium tip [GO:0032433]; myosin complex [GO:0016459]; photoreceptor inner segment [GO:0001917]; stereocilium tip [GO:0032426] actin binding [GO:0003779]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; plus-end directed microfilament motor activity [GO:0060002]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g11352.t4 Q8NEV4 48.549 1137 0.0 1056.0 sp|Q8NEV4|MYO3A_HUMAN Myosin-IIIa OS=Homo sapiens OX=9606 GN=MYO3A PE=1 SV=2 MYO3A_HUMAN reviewed Myosin-IIIa (EC 2.7.11.1) Homo sapiens (Human) GO:0000146; GO:0001917; GO:0003779; GO:0004672; GO:0004674; GO:0005516; GO:0005524; GO:0005737; GO:0007601; GO:0007605; GO:0016459; GO:0016887; GO:0030175; GO:0030832; GO:0031941; GO:0032426; GO:0032433; GO:0043531; GO:0046777; GO:0051491; GO:0060002; GO:0090103; GO:0106310 cochlea morphogenesis [GO:0090103]; positive regulation of filopodium assembly [GO:0051491]; protein autophosphorylation [GO:0046777]; regulation of actin filament length [GO:0030832]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601] cytoplasm [GO:0005737]; filamentous actin [GO:0031941]; filopodium [GO:0030175]; filopodium tip [GO:0032433]; myosin complex [GO:0016459]; photoreceptor inner segment [GO:0001917]; stereocilium tip [GO:0032426] actin binding [GO:0003779]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; plus-end directed microfilament motor activity [GO:0060002]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g11354.t1 Q9JHX2 77.863 131 9.71e-59 199.0 sp|Q9JHX2|SP5_MOUSE Transcription factor Sp5 OS=Mus musculus OX=10090 GN=Sp5 PE=2 SV=1 g11358.t1 F1NVK6 31.933 238 4.22e-24 107.0 sp|F1NVK6|TM237_CHICK Transmembrane protein 237 OS=Gallus gallus OX=9031 GN=TMEM237 PE=3 SV=2 g11361.t1 O08762 45.963 161 5.86e-32 129.0 sp|O08762|NETR_MOUSE Neurotrypsin OS=Mus musculus OX=10090 GN=Prss12 PE=1 SV=1 NETR_MOUSE reviewed Neurotrypsin (EC 3.4.21.-) (Brain-specific serine protease 3) (BSSP-3) (Motopsin) (Serine protease 12) Mus musculus (Mouse) GO:0004252; GO:0005886; GO:0006508; GO:0006887; GO:0008233; GO:0030424; GO:0030425; GO:0031410; GO:0031638; GO:0043083; GO:0043195; GO:0045202; GO:0098685; GO:0098793; GO:0098978 exocytosis [GO:0006887]; proteolysis [GO:0006508]; zymogen activation [GO:0031638] axon [GO:0030424]; cytoplasmic vesicle [GO:0031410]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; Schaffer collateral - CA1 synapse [GO:0098685]; synapse [GO:0045202]; synaptic cleft [GO:0043083]; terminal bouton [GO:0043195] peptidase activity [GO:0008233]; serine-type endopeptidase activity [GO:0004252] g11361.t1 O08762 38.764 178 5.89e-26 112.0 sp|O08762|NETR_MOUSE Neurotrypsin OS=Mus musculus OX=10090 GN=Prss12 PE=1 SV=1 NETR_MOUSE reviewed Neurotrypsin (EC 3.4.21.-) (Brain-specific serine protease 3) (BSSP-3) (Motopsin) (Serine protease 12) Mus musculus (Mouse) GO:0004252; GO:0005886; GO:0006508; GO:0006887; GO:0008233; GO:0030424; GO:0030425; GO:0031410; GO:0031638; GO:0043083; GO:0043195; GO:0045202; GO:0098685; GO:0098793; GO:0098978 exocytosis [GO:0006887]; proteolysis [GO:0006508]; zymogen activation [GO:0031638] axon [GO:0030424]; cytoplasmic vesicle [GO:0031410]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; Schaffer collateral - CA1 synapse [GO:0098685]; synapse [GO:0045202]; synaptic cleft [GO:0043083]; terminal bouton [GO:0043195] peptidase activity [GO:0008233]; serine-type endopeptidase activity [GO:0004252] g11364.t1 P21757 45.631 103 1.2299999999999998e-23 104.0 sp|P21757|MSRE_HUMAN Macrophage scavenger receptor types I and II OS=Homo sapiens OX=9606 GN=MSR1 PE=1 SV=1 MSRE_HUMAN reviewed Macrophage scavenger receptor types I and II (Macrophage acetylated LDL receptor I and II) (Scavenger receptor class A member 1) (CD antigen CD204) Homo sapiens (Human) GO:0001540; GO:0005044; GO:0005581; GO:0005886; GO:0006898; GO:0006911; GO:0010629; GO:0010744; GO:0010886; GO:0016020; GO:0030169; GO:0030301; GO:0030666; GO:0034362; GO:0034381; GO:0038024; GO:0042953; GO:0051649; GO:0097242 amyloid-beta clearance [GO:0097242]; cholesterol transport [GO:0030301]; establishment of localization in cell [GO:0051649]; lipoprotein transport [GO:0042953]; negative regulation of gene expression [GO:0010629]; phagocytosis, engulfment [GO:0006911]; plasma lipoprotein particle clearance [GO:0034381]; positive regulation of cholesterol storage [GO:0010886]; positive regulation of macrophage derived foam cell differentiation [GO:0010744]; receptor-mediated endocytosis [GO:0006898] collagen trimer [GO:0005581]; endocytic vesicle membrane [GO:0030666]; low-density lipoprotein particle [GO:0034362]; membrane [GO:0016020]; plasma membrane [GO:0005886] amyloid-beta binding [GO:0001540]; cargo receptor activity [GO:0038024]; low-density lipoprotein particle binding [GO:0030169]; scavenger receptor activity [GO:0005044] g11365.t1 Q8BV79 38.395 1607 0.0 928.0 sp|Q8BV79|TRNK1_MOUSE TPR and ankyrin repeat-containing protein 1 OS=Mus musculus OX=10090 GN=Trank1 PE=2 SV=3 g11365.t1 Q8BV79 31.276 243 1.75e-22 110.0 sp|Q8BV79|TRNK1_MOUSE TPR and ankyrin repeat-containing protein 1 OS=Mus musculus OX=10090 GN=Trank1 PE=2 SV=3 g11365.t2 Q8BV79 38.395 1607 0.0 927.0 sp|Q8BV79|TRNK1_MOUSE TPR and ankyrin repeat-containing protein 1 OS=Mus musculus OX=10090 GN=Trank1 PE=2 SV=3 g11365.t2 Q8BV79 31.276 243 1.69e-22 110.0 sp|Q8BV79|TRNK1_MOUSE TPR and ankyrin repeat-containing protein 1 OS=Mus musculus OX=10090 GN=Trank1 PE=2 SV=3 g11368.t1 Q8BJZ4 60.851 235 3.39e-102 305.0 sp|Q8BJZ4|RT35_MOUSE Small ribosomal subunit protein mS35 OS=Mus musculus OX=10090 GN=Mrps35 PE=1 SV=2 g11370.t1 Q9D7Z6 38.095 126 3.05e-34 107.0 sp|Q9D7Z6|CLCA1_MOUSE Calcium-activated chloride channel regulator 1 OS=Mus musculus OX=10090 GN=Clca1 PE=1 SV=2 CLCA1_MOUSE reviewed Calcium-activated chloride channel regulator 1 (EC 3.4.-.-) (Calcium-activated chloride channel family member 3) (mCLCA3) (Protein gob-5) Mus musculus (Mouse) GO:0005229; GO:0005254; GO:0005576; GO:0005886; GO:0005902; GO:0006508; GO:0006816; GO:0006821; GO:0008237; GO:0016020; GO:0030141; GO:0042589; GO:0046872; GO:0071456 calcium ion transport [GO:0006816]; cellular response to hypoxia [GO:0071456]; chloride transport [GO:0006821]; proteolysis [GO:0006508] extracellular region [GO:0005576]; membrane [GO:0016020]; microvillus [GO:0005902]; plasma membrane [GO:0005886]; secretory granule [GO:0030141]; zymogen granule membrane [GO:0042589] chloride channel activity [GO:0005254]; intracellularly calcium-gated chloride channel activity [GO:0005229]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237] g11370.t1 Q9D7Z6 52.941 51 3.05e-34 59.3 sp|Q9D7Z6|CLCA1_MOUSE Calcium-activated chloride channel regulator 1 OS=Mus musculus OX=10090 GN=Clca1 PE=1 SV=2 CLCA1_MOUSE reviewed Calcium-activated chloride channel regulator 1 (EC 3.4.-.-) (Calcium-activated chloride channel family member 3) (mCLCA3) (Protein gob-5) Mus musculus (Mouse) GO:0005229; GO:0005254; GO:0005576; GO:0005886; GO:0005902; GO:0006508; GO:0006816; GO:0006821; GO:0008237; GO:0016020; GO:0030141; GO:0042589; GO:0046872; GO:0071456 calcium ion transport [GO:0006816]; cellular response to hypoxia [GO:0071456]; chloride transport [GO:0006821]; proteolysis [GO:0006508] extracellular region [GO:0005576]; membrane [GO:0016020]; microvillus [GO:0005902]; plasma membrane [GO:0005886]; secretory granule [GO:0030141]; zymogen granule membrane [GO:0042589] chloride channel activity [GO:0005254]; intracellularly calcium-gated chloride channel activity [GO:0005229]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237] g11371.t1 Q9QX15 31.737 668 1.02e-75 267.0 sp|Q9QX15|CA3A1_MOUSE Calcium-activated chloride channel regulator 3A-1 OS=Mus musculus OX=10090 GN=Clca3a1 PE=1 SV=1 CA3A1_MOUSE reviewed Calcium-activated chloride channel regulator 3A-1 (EC 3.4.-.-) Mus musculus (Mouse) GO:0005229; GO:0005886; GO:0006508; GO:0006821; GO:0008237; GO:0046872 chloride transport [GO:0006821]; proteolysis [GO:0006508] plasma membrane [GO:0005886] intracellularly calcium-gated chloride channel activity [GO:0005229]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237] g11372.t2 P22105 25.91 467 2.38e-23 111.0 sp|P22105|TENX_HUMAN Tenascin-X OS=Homo sapiens OX=9606 GN=TNXB PE=1 SV=5 TENX_HUMAN reviewed Tenascin-X (TN-X) (Hexabrachion-like protein) Homo sapiens (Human) GO:0005178; GO:0005201; GO:0005518; GO:0005576; GO:0005615; GO:0006631; GO:0006641; GO:0007155; GO:0007160; GO:0008201; GO:0008284; GO:0010718; GO:0030036; GO:0030155; GO:0030199; GO:0030334; GO:0031012; GO:0031175; GO:0032963; GO:0045595; GO:0046328; GO:0048251; GO:0070062; GO:0090733; GO:0098609; GO:0098633; GO:1900748; GO:1904028; GO:1905935 actin cytoskeleton organization [GO:0030036]; cell adhesion [GO:0007155]; cell-cell adhesion [GO:0098609]; cell-matrix adhesion [GO:0007160]; collagen fibril organization [GO:0030199]; collagen metabolic process [GO:0032963]; elastic fiber assembly [GO:0048251]; fatty acid metabolic process [GO:0006631]; neuron projection development [GO:0031175]; positive regulation of cell fate determination [GO:1905935]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of collagen fibril organization [GO:1904028]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of vascular endothelial growth factor signaling pathway [GO:1900748]; regulation of cell adhesion [GO:0030155]; regulation of cell differentiation [GO:0045595]; regulation of cell migration [GO:0030334]; regulation of JNK cascade [GO:0046328]; triglyceride metabolic process [GO:0006641] extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; tenascin complex [GO:0090733] collagen binding [GO:0005518]; collagen fibril binding [GO:0098633]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; integrin binding [GO:0005178] g11372.t3 P22105 26.653 499 2.87e-23 111.0 sp|P22105|TENX_HUMAN Tenascin-X OS=Homo sapiens OX=9606 GN=TNXB PE=1 SV=5 TENX_HUMAN reviewed Tenascin-X (TN-X) (Hexabrachion-like protein) Homo sapiens (Human) GO:0005178; GO:0005201; GO:0005518; GO:0005576; GO:0005615; GO:0006631; GO:0006641; GO:0007155; GO:0007160; GO:0008201; GO:0008284; GO:0010718; GO:0030036; GO:0030155; GO:0030199; GO:0030334; GO:0031012; GO:0031175; GO:0032963; GO:0045595; GO:0046328; GO:0048251; GO:0070062; GO:0090733; GO:0098609; GO:0098633; GO:1900748; GO:1904028; GO:1905935 actin cytoskeleton organization [GO:0030036]; cell adhesion [GO:0007155]; cell-cell adhesion [GO:0098609]; cell-matrix adhesion [GO:0007160]; collagen fibril organization [GO:0030199]; collagen metabolic process [GO:0032963]; elastic fiber assembly [GO:0048251]; fatty acid metabolic process [GO:0006631]; neuron projection development [GO:0031175]; positive regulation of cell fate determination [GO:1905935]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of collagen fibril organization [GO:1904028]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of vascular endothelial growth factor signaling pathway [GO:1900748]; regulation of cell adhesion [GO:0030155]; regulation of cell differentiation [GO:0045595]; regulation of cell migration [GO:0030334]; regulation of JNK cascade [GO:0046328]; triglyceride metabolic process [GO:0006641] extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; tenascin complex [GO:0090733] collagen binding [GO:0005518]; collagen fibril binding [GO:0098633]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; integrin binding [GO:0005178] g11375.t1 A4D1F6 31.906 724 7.1e-107 352.0 sp|A4D1F6|LRRD1_HUMAN Leucine-rich repeat and death domain-containing protein 1 OS=Homo sapiens OX=9606 GN=LRRD1 PE=1 SV=2 g11376.t1 Q502G2 62.944 197 6.85e-72 225.0 sp|Q502G2|T41AA_DANRE Transmembrane protein 41A-A OS=Danio rerio OX=7955 GN=tmem41aa PE=2 SV=1 g11378.t1 P37287 65.47 362 1.15e-175 500.0 sp|P37287|PIGA_HUMAN Phosphatidylinositol N-acetylglucosaminyltransferase subunit A OS=Homo sapiens OX=9606 GN=PIGA PE=1 SV=1 PIGA_HUMAN reviewed Phosphatidylinositol N-acetylglucosaminyltransferase subunit A (EC 2.4.1.198) (GlcNAc-PI synthesis protein) (Phosphatidylinositol-glycan biosynthesis class A protein) (PIG-A) Homo sapiens (Human) GO:0000506; GO:0005789; GO:0006506; GO:0008194; GO:0016020; GO:0017176; GO:1990830 cellular response to leukemia inhibitory factor [GO:1990830]; GPI anchor biosynthetic process [GO:0006506] endoplasmic reticulum membrane [GO:0005789]; glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex [GO:0000506]; membrane [GO:0016020] phosphatidylinositol N-acetylglucosaminyltransferase activity [GO:0017176]; UDP-glycosyltransferase activity [GO:0008194] g11379.t1 Q5RDX1 33.088 272 5.02e-33 130.0 sp|Q5RDX1|Z585A_PONAB Zinc finger protein 585A OS=Pongo abelii OX=9601 GN=ZNF585A PE=2 SV=1 g11379.t1 Q5RDX1 29.151 271 7.3e-26 110.0 sp|Q5RDX1|Z585A_PONAB Zinc finger protein 585A OS=Pongo abelii OX=9601 GN=ZNF585A PE=2 SV=1 g11381.t1 Q9PVW8 34.354 294 1.4399999999999999e-34 136.0 sp|Q9PVW8|SAL_SILAS Rhamnose-binding lectin OS=Silurus asotus OX=30991 PE=1 SV=1 g11383.t1 O76536 30.363 1156 2.5600000000000002e-86 315.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g11383.t1 O76536 32.282 1078 4e-84 308.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g11383.t1 O76536 31.477 1185 2.42e-78 290.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g11383.t1 O76536 29.965 1148 3.5e-78 290.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g11383.t1 O76536 29.956 1145 9.15e-76 282.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g11383.t1 O76536 31.45 1186 1.32e-75 281.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g11383.t1 O76536 29.13 1150 7.55e-75 279.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g11383.t1 O76536 29.174 1162 2.27e-74 278.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g11383.t1 O76536 30.163 1104 4.32e-68 258.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g11383.t1 O76536 30.769 650 6.92e-55 216.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g11383.t1 O76536 30.104 578 6.83e-44 181.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g11385.t1 P58421 64.943 522 0.0 669.0 sp|P58421|FZD5_XENLA Frizzled-5 OS=Xenopus laevis OX=8355 GN=fzd5 PE=2 SV=1 g11390.t1 Q6DJM7 61.944 360 4.43e-154 444.0 sp|Q6DJM7|CDK14_XENLA Cyclin-dependent kinase 14 OS=Xenopus laevis OX=8355 GN=cdk14 PE=2 SV=1 CDK14_XENLA reviewed Cyclin-dependent kinase 14 (EC 2.7.11.22) (Cell division protein kinase 14) Xenopus laevis (African clawed frog) GO:0000086; GO:0000308; GO:0004693; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0016055; GO:0030332; GO:0051301; GO:0060828; GO:0106310; GO:1901987 cell division [GO:0051301]; G2/M transition of mitotic cell cycle [GO:0000086]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of cell cycle phase transition [GO:1901987]; Wnt signaling pathway [GO:0016055] cytoplasm [GO:0005737]; cytoplasmic cyclin-dependent protein kinase holoenzyme complex [GO:0000308]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886] ATP binding [GO:0005524]; cyclin binding [GO:0030332]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; protein serine kinase activity [GO:0106310] g11390.t2 A4IIW7 66.261 329 2.94e-152 439.0 sp|A4IIW7|CDK14_XENTR Cyclin-dependent kinase 14 OS=Xenopus tropicalis OX=8364 GN=cdk14 PE=2 SV=1 CDK14_XENTR reviewed Cyclin-dependent kinase 14 (EC 2.7.11.22) (Cell division protein kinase 14) Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0000086; GO:0000308; GO:0004693; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0016055; GO:0030332; GO:0051301; GO:0060828; GO:0106310; GO:1901987 cell division [GO:0051301]; G2/M transition of mitotic cell cycle [GO:0000086]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of cell cycle phase transition [GO:1901987]; Wnt signaling pathway [GO:0016055] cytoplasm [GO:0005737]; cytoplasmic cyclin-dependent protein kinase holoenzyme complex [GO:0000308]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886] ATP binding [GO:0005524]; cyclin binding [GO:0030332]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; protein serine kinase activity [GO:0106310] g11392.t1 Q9I9M5 58.144 528 0.0 623.0 sp|Q9I9M5|FZD1_XENLA Frizzled-1 OS=Xenopus laevis OX=8355 GN=fzd1 PE=1 SV=1 g11398.t1 Q63421 56.776 428 1.4299999999999999e-168 507.0 sp|Q63421|PDE1C_RAT Dual specificity calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C OS=Rattus norvegicus OX=10116 GN=Pde1c PE=1 SV=1 PDE1C_RAT reviewed Dual specificity calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C (Cam-PDE 1C) (EC 3.1.4.17) Rattus norvegicus (Rat) GO:0004115; GO:0004117; GO:0005516; GO:0005764; GO:0005929; GO:0007165; GO:0007608; GO:0030552; GO:0043025; GO:0046872; GO:0047555; GO:0048101; GO:0051592; GO:0061179; GO:0141162 negative regulation of cAMP/PKA signal transduction [GO:0141162]; negative regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061179]; response to calcium ion [GO:0051592]; sensory perception of smell [GO:0007608]; signal transduction [GO:0007165] cilium [GO:0005929]; lysosome [GO:0005764]; neuronal cell body [GO:0043025] 3',5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; 3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; calmodulin binding [GO:0005516]; calmodulin-activated 3',5'-cyclic-GMP phosphodiesterase activity [GO:0048101]; calmodulin-activated dual specificity 3',5'-cyclic-GMP, 3',5'-cyclic-AMP phosphodiesterase activity [GO:0004117]; cAMP binding [GO:0030552]; metal ion binding [GO:0046872] g11398.t2 Q63421 55.056 445 1.7599999999999998e-168 506.0 sp|Q63421|PDE1C_RAT Dual specificity calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C OS=Rattus norvegicus OX=10116 GN=Pde1c PE=1 SV=1 PDE1C_RAT reviewed Dual specificity calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C (Cam-PDE 1C) (EC 3.1.4.17) Rattus norvegicus (Rat) GO:0004115; GO:0004117; GO:0005516; GO:0005764; GO:0005929; GO:0007165; GO:0007608; GO:0030552; GO:0043025; GO:0046872; GO:0047555; GO:0048101; GO:0051592; GO:0061179; GO:0141162 negative regulation of cAMP/PKA signal transduction [GO:0141162]; negative regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061179]; response to calcium ion [GO:0051592]; sensory perception of smell [GO:0007608]; signal transduction [GO:0007165] cilium [GO:0005929]; lysosome [GO:0005764]; neuronal cell body [GO:0043025] 3',5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; 3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; calmodulin binding [GO:0005516]; calmodulin-activated 3',5'-cyclic-GMP phosphodiesterase activity [GO:0048101]; calmodulin-activated dual specificity 3',5'-cyclic-GMP, 3',5'-cyclic-AMP phosphodiesterase activity [GO:0004117]; cAMP binding [GO:0030552]; metal ion binding [GO:0046872] g11398.t3 Q63421 52.463 467 4.6e-165 498.0 sp|Q63421|PDE1C_RAT Dual specificity calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C OS=Rattus norvegicus OX=10116 GN=Pde1c PE=1 SV=1 PDE1C_RAT reviewed Dual specificity calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C (Cam-PDE 1C) (EC 3.1.4.17) Rattus norvegicus (Rat) GO:0004115; GO:0004117; GO:0005516; GO:0005764; GO:0005929; GO:0007165; GO:0007608; GO:0030552; GO:0043025; GO:0046872; GO:0047555; GO:0048101; GO:0051592; GO:0061179; GO:0141162 negative regulation of cAMP/PKA signal transduction [GO:0141162]; negative regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061179]; response to calcium ion [GO:0051592]; sensory perception of smell [GO:0007608]; signal transduction [GO:0007165] cilium [GO:0005929]; lysosome [GO:0005764]; neuronal cell body [GO:0043025] 3',5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; 3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; calmodulin binding [GO:0005516]; calmodulin-activated 3',5'-cyclic-GMP phosphodiesterase activity [GO:0048101]; calmodulin-activated dual specificity 3',5'-cyclic-GMP, 3',5'-cyclic-AMP phosphodiesterase activity [GO:0004117]; cAMP binding [GO:0030552]; metal ion binding [GO:0046872] g11400.t1 O08584 51.701 294 1.9299999999999998e-89 270.0 sp|O08584|KLF6_MOUSE Krueppel-like factor 6 OS=Mus musculus OX=10090 GN=Klf6 PE=2 SV=3 KLF6_MOUSE reviewed Krueppel-like factor 6 (Core promoter element-binding protein) Mus musculus (Mouse) GO:0000978; GO:0000981; GO:0001228; GO:0001650; GO:0003677; GO:0003690; GO:0003700; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0006357; GO:0008270; GO:0019221; GO:0045944; GO:1905205; GO:1990837 cytokine-mediated signaling pathway [GO:0019221]; positive regulation of connective tissue replacement [GO:1905205]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357] cytoplasm [GO:0005737]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; double-stranded DNA binding [GO:0003690]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; zinc ion binding [GO:0008270] g11404.t1 Q76IQ3 55.911 406 4.2900000000000004e-161 469.0 sp|Q76IQ3|TY3H_CANLF Tyrosine 3-monooxygenase OS=Canis lupus familiaris OX=9615 GN=TH PE=2 SV=1 g11406.t1 P84173 77.016 248 3.0099999999999998e-146 414.0 sp|P84173|PHB1_CHICK Prohibitin 1 OS=Gallus gallus OX=9031 GN=PHB1 PE=1 SV=1 g11407.t1 P10881 49.074 324 1.9899999999999998e-82 262.0 sp|P10881|LA_BOVIN Lupus La protein homolog OS=Bos taurus OX=9913 GN=SSB PE=2 SV=2 g11408.t1 Q9H3S7 45.81 358 1.14e-92 337.0 sp|Q9H3S7|PTN23_HUMAN Tyrosine-protein phosphatase non-receptor type 23 OS=Homo sapiens OX=9606 GN=PTPN23 PE=1 SV=1 PTN23_HUMAN reviewed Tyrosine-protein phosphatase non-receptor type 23 (EC 3.1.3.48) (His domain-containing protein tyrosine phosphatase) (HD-PTP) (Protein tyrosine phosphatase TD14) (PTP-TD14) Homo sapiens (Human) GO:0004725; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005829; GO:0010633; GO:0016604; GO:0019901; GO:0032456; GO:0034451; GO:0036064; GO:0043162; GO:0043328; GO:0045022; GO:0060271; GO:0061357; GO:0070062; GO:0097225; GO:0120238; GO:1903387; GO:1903393; GO:2000643 cilium assembly [GO:0060271]; early endosome to late endosome transport [GO:0045022]; endocytic recycling [GO:0032456]; negative regulation of epithelial cell migration [GO:0010633]; positive regulation of adherens junction organization [GO:1903393]; positive regulation of early endosome to late endosome transport [GO:2000643]; positive regulation of homophilic cell adhesion [GO:1903387]; positive regulation of Wnt protein secretion [GO:0061357]; protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043328]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162] centriolar satellite [GO:0034451]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; sperm glycocalyx [GO:0120238]; sperm midpiece [GO:0097225] protein kinase binding [GO:0019901]; protein tyrosine phosphatase activity [GO:0004725] g11408.t1 Q9H3S7 42.917 240 1.37e-51 205.0 sp|Q9H3S7|PTN23_HUMAN Tyrosine-protein phosphatase non-receptor type 23 OS=Homo sapiens OX=9606 GN=PTPN23 PE=1 SV=1 PTN23_HUMAN reviewed Tyrosine-protein phosphatase non-receptor type 23 (EC 3.1.3.48) (His domain-containing protein tyrosine phosphatase) (HD-PTP) (Protein tyrosine phosphatase TD14) (PTP-TD14) Homo sapiens (Human) GO:0004725; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005829; GO:0010633; GO:0016604; GO:0019901; GO:0032456; GO:0034451; GO:0036064; GO:0043162; GO:0043328; GO:0045022; GO:0060271; GO:0061357; GO:0070062; GO:0097225; GO:0120238; GO:1903387; GO:1903393; GO:2000643 cilium assembly [GO:0060271]; early endosome to late endosome transport [GO:0045022]; endocytic recycling [GO:0032456]; negative regulation of epithelial cell migration [GO:0010633]; positive regulation of adherens junction organization [GO:1903393]; positive regulation of early endosome to late endosome transport [GO:2000643]; positive regulation of homophilic cell adhesion [GO:1903387]; positive regulation of Wnt protein secretion [GO:0061357]; protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043328]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162] centriolar satellite [GO:0034451]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; sperm glycocalyx [GO:0120238]; sperm midpiece [GO:0097225] protein kinase binding [GO:0019901]; protein tyrosine phosphatase activity [GO:0004725] g11409.t1 Q9H3S7 54.926 406 2.46e-147 459.0 sp|Q9H3S7|PTN23_HUMAN Tyrosine-protein phosphatase non-receptor type 23 OS=Homo sapiens OX=9606 GN=PTPN23 PE=1 SV=1 PTN23_HUMAN reviewed Tyrosine-protein phosphatase non-receptor type 23 (EC 3.1.3.48) (His domain-containing protein tyrosine phosphatase) (HD-PTP) (Protein tyrosine phosphatase TD14) (PTP-TD14) Homo sapiens (Human) GO:0004725; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005829; GO:0010633; GO:0016604; GO:0019901; GO:0032456; GO:0034451; GO:0036064; GO:0043162; GO:0043328; GO:0045022; GO:0060271; GO:0061357; GO:0070062; GO:0097225; GO:0120238; GO:1903387; GO:1903393; GO:2000643 cilium assembly [GO:0060271]; early endosome to late endosome transport [GO:0045022]; endocytic recycling [GO:0032456]; negative regulation of epithelial cell migration [GO:0010633]; positive regulation of adherens junction organization [GO:1903393]; positive regulation of early endosome to late endosome transport [GO:2000643]; positive regulation of homophilic cell adhesion [GO:1903387]; positive regulation of Wnt protein secretion [GO:0061357]; protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043328]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162] centriolar satellite [GO:0034451]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; sperm glycocalyx [GO:0120238]; sperm midpiece [GO:0097225] protein kinase binding [GO:0019901]; protein tyrosine phosphatase activity [GO:0004725] g11410.t1 Q9W6N4 50.135 371 2.06e-116 347.0 sp|Q9W6N4|THA_HIPHI Thyroid hormone receptor alpha OS=Hippoglossus hippoglossus OX=8267 GN=thra PE=2 SV=1 g11414.t1 D3YWQ0 51.261 991 0.0 928.0 sp|D3YWQ0|DGKI_MOUSE Diacylglycerol kinase iota OS=Mus musculus OX=10090 GN=Dgki PE=1 SV=2 DGKI_MOUSE reviewed Diacylglycerol kinase iota (DAG kinase iota) (EC 2.7.1.107) Mus musculus (Mouse) GO:0004143; GO:0005095; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0006654; GO:0007200; GO:0007265; GO:0007269; GO:0008021; GO:0014069; GO:0030672; GO:0031267; GO:0032045; GO:0032991; GO:0035556; GO:0043025; GO:0043197; GO:0043679; GO:0045202; GO:0046339; GO:0046579; GO:0046834; GO:0046959; GO:0048471; GO:0048786; GO:0051966; GO:0060076; GO:0060079; GO:0097060; GO:0098685; GO:0098891; GO:0098978; GO:0099147; GO:0099171; GO:1900452 diacylglycerol metabolic process [GO:0046339]; excitatory postsynaptic potential [GO:0060079]; habituation [GO:0046959]; intracellular signal transduction [GO:0035556]; lipid phosphorylation [GO:0046834]; neurotransmitter secretion [GO:0007269]; phosphatidic acid biosynthetic process [GO:0006654]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of Ras protein signal transduction [GO:0046579]; presynaptic modulation of chemical synaptic transmission [GO:0099171]; Ras protein signal transduction [GO:0007265]; regulation of long-term synaptic depression [GO:1900452]; regulation of synaptic transmission, glutamatergic [GO:0051966] axon terminus [GO:0043679]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; excitatory synapse [GO:0060076]; extrinsic component of postsynaptic density membrane [GO:0099147]; extrinsic component of presynaptic active zone membrane [GO:0098891]; glutamatergic synapse [GO:0098978]; guanyl-nucleotide exchange factor complex [GO:0032045]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; presynaptic active zone [GO:0048786]; protein-containing complex [GO:0032991]; Schaffer collateral - CA1 synapse [GO:0098685]; synapse [GO:0045202]; synaptic membrane [GO:0097060]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672] ATP binding [GO:0005524]; ATP-dependent diacylglycerol kinase activity [GO:0004143]; GTPase inhibitor activity [GO:0005095]; small GTPase binding [GO:0031267] g11414.t2 D3YWQ0 51.212 990 0.0 925.0 sp|D3YWQ0|DGKI_MOUSE Diacylglycerol kinase iota OS=Mus musculus OX=10090 GN=Dgki PE=1 SV=2 DGKI_MOUSE reviewed Diacylglycerol kinase iota (DAG kinase iota) (EC 2.7.1.107) Mus musculus (Mouse) GO:0004143; GO:0005095; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0006654; GO:0007200; GO:0007265; GO:0007269; GO:0008021; GO:0014069; GO:0030672; GO:0031267; GO:0032045; GO:0032991; GO:0035556; GO:0043025; GO:0043197; GO:0043679; GO:0045202; GO:0046339; GO:0046579; GO:0046834; GO:0046959; GO:0048471; GO:0048786; GO:0051966; GO:0060076; GO:0060079; GO:0097060; GO:0098685; GO:0098891; GO:0098978; GO:0099147; GO:0099171; GO:1900452 diacylglycerol metabolic process [GO:0046339]; excitatory postsynaptic potential [GO:0060079]; habituation [GO:0046959]; intracellular signal transduction [GO:0035556]; lipid phosphorylation [GO:0046834]; neurotransmitter secretion [GO:0007269]; phosphatidic acid biosynthetic process [GO:0006654]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of Ras protein signal transduction [GO:0046579]; presynaptic modulation of chemical synaptic transmission [GO:0099171]; Ras protein signal transduction [GO:0007265]; regulation of long-term synaptic depression [GO:1900452]; regulation of synaptic transmission, glutamatergic [GO:0051966] axon terminus [GO:0043679]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; excitatory synapse [GO:0060076]; extrinsic component of postsynaptic density membrane [GO:0099147]; extrinsic component of presynaptic active zone membrane [GO:0098891]; glutamatergic synapse [GO:0098978]; guanyl-nucleotide exchange factor complex [GO:0032045]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; presynaptic active zone [GO:0048786]; protein-containing complex [GO:0032991]; Schaffer collateral - CA1 synapse [GO:0098685]; synapse [GO:0045202]; synaptic membrane [GO:0097060]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672] ATP binding [GO:0005524]; ATP-dependent diacylglycerol kinase activity [GO:0004143]; GTPase inhibitor activity [GO:0005095]; small GTPase binding [GO:0031267] g11414.t3 Q13574 56.375 949 0.0 978.0 sp|Q13574|DGKZ_HUMAN Diacylglycerol kinase zeta OS=Homo sapiens OX=9606 GN=DGKZ PE=1 SV=4 g11420.t1 Q13702 43.478 414 2.5200000000000002e-116 348.0 sp|Q13702|RAPSN_HUMAN 43 kDa receptor-associated protein of the synapse OS=Homo sapiens OX=9606 GN=RAPSN PE=1 SV=4 g11422.t1 Q0MQC7 66.129 62 1.03e-23 89.7 sp|Q0MQC7|NDUB2_PONPY NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 2, mitochondrial OS=Pongo pygmaeus OX=9600 GN=NDUFB2 PE=3 SV=1 g11423.t1 Q5R5M1 38.559 472 6.33e-81 287.0 sp|Q5R5M1|PRDM4_PONAB PR domain zinc finger protein 4 OS=Pongo abelii OX=9601 GN=PRDM4 PE=2 SV=1 g11423.t2 Q5R5M1 38.559 472 6.369999999999999e-81 287.0 sp|Q5R5M1|PRDM4_PONAB PR domain zinc finger protein 4 OS=Pongo abelii OX=9601 GN=PRDM4 PE=2 SV=1 g11424.t1 Q9Y5A7 34.307 548 3.52e-78 263.0 sp|Q9Y5A7|NUB1_HUMAN NEDD8 ultimate buster 1 OS=Homo sapiens OX=9606 GN=NUB1 PE=1 SV=2 g11425.t1 A2A6Q5 53.584 851 0.0 892.0 sp|A2A6Q5|CDC27_MOUSE Cell division cycle protein 27 homolog OS=Mus musculus OX=10090 GN=Cdc27 PE=1 SV=1 CDC27_MOUSE reviewed Cell division cycle protein 27 homolog Mus musculus (Mouse) GO:0005634; GO:0005654; GO:0005680; GO:0005737; GO:0005813; GO:0005819; GO:0007091; GO:0016567; GO:0019903; GO:0031145; GO:0031175; GO:0051301; GO:0070936; GO:0070979; GO:0072686; GO:0141198 anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell division [GO:0051301]; metaphase/anaphase transition of mitotic cell cycle [GO:0007091]; neuron projection development [GO:0031175]; protein branched polyubiquitination [GO:0141198]; protein K11-linked ubiquitination [GO:0070979]; protein K48-linked ubiquitination [GO:0070936]; protein ubiquitination [GO:0016567] anaphase-promoting complex [GO:0005680]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819] protein phosphatase binding [GO:0019903] g11426.t1 Q2KI54 56.25 656 0.0 739.0 sp|Q2KI54|ARMC8_BOVIN Armadillo repeat-containing protein 8 OS=Bos taurus OX=9913 GN=ARMC8 PE=2 SV=1 g11427.t1 Q8K1N4 44.898 147 4e-31 132.0 sp|Q8K1N4|SPAS2_MOUSE Spermatogenesis-associated serine-rich protein 2 OS=Mus musculus OX=10090 GN=Spats2 PE=1 SV=1 g11428.t1 Q96EZ8 70.448 335 1.29e-168 487.0 sp|Q96EZ8|MCRS1_HUMAN Microspherule protein 1 OS=Homo sapiens OX=9606 GN=MCRS1 PE=1 SV=1 MCRS1_HUMAN reviewed Microspherule protein 1 (58 kDa microspherule protein) (Cell cycle-regulated factor p78) (INO80 complex subunit J) (MCRS2) Homo sapiens (Human) GO:0000123; GO:0000723; GO:0000776; GO:0000922; GO:0002151; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005764; GO:0006275; GO:0006281; GO:0006282; GO:0006310; GO:0006338; GO:0008266; GO:0010521; GO:0016604; GO:0030425; GO:0031011; GO:0033044; GO:0034046; GO:0034451; GO:0036211; GO:0043204; GO:0044545; GO:0045739; GO:0045893; GO:0045944; GO:0045995; GO:0051726; GO:0060382; GO:0071339; GO:1904357; GO:1904507; GO:1904751 chromatin remodeling [GO:0006338]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; negative regulation of telomere maintenance via telomere lengthening [GO:1904357]; positive regulation of DNA repair [GO:0045739]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of protein localization to nucleolus [GO:1904751]; positive regulation of telomere maintenance in response to DNA damage [GO:1904507]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein modification process [GO:0036211]; regulation of cell cycle [GO:0051726]; regulation of chromosome organization [GO:0033044]; regulation of DNA repair [GO:0006282]; regulation of DNA replication [GO:0006275]; regulation of DNA strand elongation [GO:0060382]; regulation of embryonic development [GO:0045995]; telomere maintenance [GO:0000723] centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; histone acetyltransferase complex [GO:0000123]; Ino80 complex [GO:0031011]; kinetochore [GO:0000776]; lysosome [GO:0005764]; MLL1 complex [GO:0071339]; NSL complex [GO:0044545]; nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; spindle pole [GO:0000922] G-quadruplex RNA binding [GO:0002151]; poly(G) binding [GO:0034046]; poly(U) RNA binding [GO:0008266]; telomerase inhibitor activity [GO:0010521] g11429.t1 Q9D1Q6 50.611 409 4.769999999999999e-146 424.0 sp|Q9D1Q6|ERP44_MOUSE Endoplasmic reticulum resident protein 44 OS=Mus musculus OX=10090 GN=Erp44 PE=1 SV=1 ERP44_MOUSE reviewed Endoplasmic reticulum resident protein 44 (ER protein 44) (ERp44) (Thioredoxin domain-containing protein 4) Mus musculus (Mouse) GO:0003756; GO:0005788; GO:0005789; GO:0005793; GO:0006457; GO:0006986; GO:0009100; GO:0009986; GO:0034976 glycoprotein metabolic process [GO:0009100]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]; response to unfolded protein [GO:0006986] cell surface [GO:0009986]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793] protein disulfide isomerase activity [GO:0003756] g11430.t1 Q7ZU45 53.061 490 1.55e-174 511.0 sp|Q7ZU45|ODAD4_DANRE Outer dynein arm-docking complex subunit 4 OS=Danio rerio OX=7955 GN=odad4 PE=2 SV=2 ODAD4_DANRE reviewed Outer dynein arm-docking complex subunit 4 (Tetratricopeptide repeat protein 25) (TPR repeat protein 25) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0003341; GO:0005737; GO:0005930; GO:0032474; GO:0036158; GO:0060271; GO:0061371 cilium assembly [GO:0060271]; cilium movement [GO:0003341]; determination of heart left/right asymmetry [GO:0061371]; otolith morphogenesis [GO:0032474]; outer dynein arm assembly [GO:0036158] axoneme [GO:0005930]; cytoplasm [GO:0005737] g11431.t1 P55345 48.756 402 1.3099999999999998e-140 412.0 sp|P55345|ANM2_HUMAN Protein arginine N-methyltransferase 2 OS=Homo sapiens OX=9606 GN=PRMT2 PE=1 SV=1 ANM2_HUMAN reviewed Protein arginine N-methyltransferase 2 (EC 2.1.1.319) (Histone-arginine N-methyltransferase PRMT2) Homo sapiens (Human) GO:0003713; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0006338; GO:0006355; GO:0006479; GO:0007165; GO:0016274; GO:0030331; GO:0032088; GO:0033142; GO:0035242; GO:0042054; GO:0042803; GO:0042974; GO:0042975; GO:0043065; GO:0043124; GO:0044877; GO:0045892; GO:0045893; GO:0046966; GO:0048588; GO:0050681; GO:0050728; GO:0060765; GO:0140592; GO:0140938; GO:2000134 chromatin remodeling [GO:0006338]; developmental cell growth [GO:0048588]; negative regulation of canonical NF-kappaB signal transduction [GO:0043124]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of inflammatory response [GO:0050728]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; positive regulation of apoptotic process [GO:0043065]; positive regulation of DNA-templated transcription [GO:0045893]; protein methylation [GO:0006479]; regulation of androgen receptor signaling pathway [GO:0060765]; regulation of DNA-templated transcription [GO:0006355]; signal transduction [GO:0007165] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] histone H3 methyltransferase activity [GO:0140938]; histone H3R8 methyltransferase activity [GO:0140592]; histone methyltransferase activity [GO:0042054]; nuclear androgen receptor binding [GO:0050681]; nuclear estrogen receptor binding [GO:0030331]; nuclear progesterone receptor binding [GO:0033142]; nuclear retinoic acid receptor binding [GO:0042974]; nuclear thyroid hormone receptor binding [GO:0046966]; peroxisome proliferator activated receptor binding [GO:0042975]; protein homodimerization activity [GO:0042803]; protein-arginine N-methyltransferase activity [GO:0016274]; protein-arginine omega-N asymmetric methyltransferase activity [GO:0035242]; protein-containing complex binding [GO:0044877]; transcription coactivator activity [GO:0003713] g11431.t2 P55345 47.904 334 1.3e-112 339.0 sp|P55345|ANM2_HUMAN Protein arginine N-methyltransferase 2 OS=Homo sapiens OX=9606 GN=PRMT2 PE=1 SV=1 ANM2_HUMAN reviewed Protein arginine N-methyltransferase 2 (EC 2.1.1.319) (Histone-arginine N-methyltransferase PRMT2) Homo sapiens (Human) GO:0003713; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0006338; GO:0006355; GO:0006479; GO:0007165; GO:0016274; GO:0030331; GO:0032088; GO:0033142; GO:0035242; GO:0042054; GO:0042803; GO:0042974; GO:0042975; GO:0043065; GO:0043124; GO:0044877; GO:0045892; GO:0045893; GO:0046966; GO:0048588; GO:0050681; GO:0050728; GO:0060765; GO:0140592; GO:0140938; GO:2000134 chromatin remodeling [GO:0006338]; developmental cell growth [GO:0048588]; negative regulation of canonical NF-kappaB signal transduction [GO:0043124]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of inflammatory response [GO:0050728]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; positive regulation of apoptotic process [GO:0043065]; positive regulation of DNA-templated transcription [GO:0045893]; protein methylation [GO:0006479]; regulation of androgen receptor signaling pathway [GO:0060765]; regulation of DNA-templated transcription [GO:0006355]; signal transduction [GO:0007165] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] histone H3 methyltransferase activity [GO:0140938]; histone H3R8 methyltransferase activity [GO:0140592]; histone methyltransferase activity [GO:0042054]; nuclear androgen receptor binding [GO:0050681]; nuclear estrogen receptor binding [GO:0030331]; nuclear progesterone receptor binding [GO:0033142]; nuclear retinoic acid receptor binding [GO:0042974]; nuclear thyroid hormone receptor binding [GO:0046966]; peroxisome proliferator activated receptor binding [GO:0042975]; protein homodimerization activity [GO:0042803]; protein-arginine N-methyltransferase activity [GO:0016274]; protein-arginine omega-N asymmetric methyltransferase activity [GO:0035242]; protein-containing complex binding [GO:0044877]; transcription coactivator activity [GO:0003713] g11440.t1 B8JI71 35.125 279 8.130000000000001e-33 140.0 sp|B8JI71|EYS_DANRE Protein eyes shut homolog OS=Danio rerio OX=7955 GN=eys PE=1 SV=2 EYS_DANRE reviewed Protein eyes shut homolog Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005112; GO:0005509; GO:0005886; GO:0005930; GO:0007417; GO:0007601; GO:0033165; GO:0045597; GO:0048589; GO:0051240; GO:0051241; GO:0060218; GO:1901222 central nervous system development [GO:0007417]; developmental growth [GO:0048589]; hematopoietic stem cell differentiation [GO:0060218]; negative regulation of multicellular organismal process [GO:0051241]; positive regulation of cell differentiation [GO:0045597]; positive regulation of multicellular organismal process [GO:0051240]; regulation of non-canonical NF-kappaB signal transduction [GO:1901222]; visual perception [GO:0007601] axoneme [GO:0005930]; interphotoreceptor matrix [GO:0033165]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; Notch binding [GO:0005112] g11440.t1 B8JI71 32.734 278 8.49e-27 121.0 sp|B8JI71|EYS_DANRE Protein eyes shut homolog OS=Danio rerio OX=7955 GN=eys PE=1 SV=2 EYS_DANRE reviewed Protein eyes shut homolog Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005112; GO:0005509; GO:0005886; GO:0005930; GO:0007417; GO:0007601; GO:0033165; GO:0045597; GO:0048589; GO:0051240; GO:0051241; GO:0060218; GO:1901222 central nervous system development [GO:0007417]; developmental growth [GO:0048589]; hematopoietic stem cell differentiation [GO:0060218]; negative regulation of multicellular organismal process [GO:0051241]; positive regulation of cell differentiation [GO:0045597]; positive regulation of multicellular organismal process [GO:0051240]; regulation of non-canonical NF-kappaB signal transduction [GO:1901222]; visual perception [GO:0007601] axoneme [GO:0005930]; interphotoreceptor matrix [GO:0033165]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; Notch binding [GO:0005112] g11440.t1 B8JI71 31.104 299 2.6899999999999997e-24 113.0 sp|B8JI71|EYS_DANRE Protein eyes shut homolog OS=Danio rerio OX=7955 GN=eys PE=1 SV=2 EYS_DANRE reviewed Protein eyes shut homolog Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005112; GO:0005509; GO:0005886; GO:0005930; GO:0007417; GO:0007601; GO:0033165; GO:0045597; GO:0048589; GO:0051240; GO:0051241; GO:0060218; GO:1901222 central nervous system development [GO:0007417]; developmental growth [GO:0048589]; hematopoietic stem cell differentiation [GO:0060218]; negative regulation of multicellular organismal process [GO:0051241]; positive regulation of cell differentiation [GO:0045597]; positive regulation of multicellular organismal process [GO:0051240]; regulation of non-canonical NF-kappaB signal transduction [GO:1901222]; visual perception [GO:0007601] axoneme [GO:0005930]; interphotoreceptor matrix [GO:0033165]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; Notch binding [GO:0005112] g11440.t1 B8JI71 29.73 259 1.95e-21 104.0 sp|B8JI71|EYS_DANRE Protein eyes shut homolog OS=Danio rerio OX=7955 GN=eys PE=1 SV=2 EYS_DANRE reviewed Protein eyes shut homolog Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005112; GO:0005509; GO:0005886; GO:0005930; GO:0007417; GO:0007601; GO:0033165; GO:0045597; GO:0048589; GO:0051240; GO:0051241; GO:0060218; GO:1901222 central nervous system development [GO:0007417]; developmental growth [GO:0048589]; hematopoietic stem cell differentiation [GO:0060218]; negative regulation of multicellular organismal process [GO:0051241]; positive regulation of cell differentiation [GO:0045597]; positive regulation of multicellular organismal process [GO:0051240]; regulation of non-canonical NF-kappaB signal transduction [GO:1901222]; visual perception [GO:0007601] axoneme [GO:0005930]; interphotoreceptor matrix [GO:0033165]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; Notch binding [GO:0005112] g11441.t1 P10079 37.079 267 1.5400000000000002e-32 141.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g11441.t1 P10079 34.457 267 1.0500000000000001e-29 132.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g11441.t1 P10079 34.8 250 9.82e-28 125.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g11441.t1 P10079 34.47 264 2.13e-26 121.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g11441.t1 P10079 30.392 306 1.09e-25 119.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g11441.t1 P10079 34.274 248 1.9e-25 118.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g11441.t1 P10079 34.649 228 2.22e-22 108.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g11443.t1 Q8N8U9 46.522 647 0.0 558.0 sp|Q8N8U9|BMPER_HUMAN BMP-binding endothelial regulator protein OS=Homo sapiens OX=9606 GN=BMPER PE=1 SV=3 BMPER_HUMAN reviewed BMP-binding endothelial regulator protein (Bone morphogenetic protein-binding endothelial cell precursor-derived regulator) (Protein crossveinless-2) (hCV2) Homo sapiens (Human) GO:0001568; GO:0001657; GO:0002043; GO:0005201; GO:0005615; GO:0010594; GO:0030509; GO:0030514; GO:0031012; GO:0032880; GO:0042118; GO:0045765; GO:0048839; GO:0060391; GO:0060395; GO:0070374; GO:1903672 blood vessel development [GO:0001568]; blood vessel endothelial cell proliferation involved in sprouting angiogenesis [GO:0002043]; BMP signaling pathway [GO:0030509]; endothelial cell activation [GO:0042118]; inner ear development [GO:0048839]; negative regulation of BMP signaling pathway [GO:0030514]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of SMAD protein signal transduction [GO:0060391]; positive regulation of sprouting angiogenesis [GO:1903672]; regulation of angiogenesis [GO:0045765]; regulation of endothelial cell migration [GO:0010594]; regulation of protein localization [GO:0032880]; SMAD protein signal transduction [GO:0060395]; ureteric bud development [GO:0001657] extracellular matrix [GO:0031012]; extracellular space [GO:0005615] extracellular matrix structural constituent [GO:0005201] g11444.t1 Q868T3 34.845 419 1.6e-68 229.0 sp|Q868T3|CCAPR_DROME Cardioacceleratory peptide receptor OS=Drosophila melanogaster OX=7227 GN=CCAP-R PE=2 SV=4 g11445.t1 Q9WTV9 38.303 389 1.5300000000000001e-75 245.0 sp|Q9WTV9|V1AR_MICOH Vasopressin V1a receptor OS=Microtus ochrogaster OX=79684 GN=Avpr1a PE=3 SV=1 g11446.t1 O35507 33.508 382 8.65e-49 176.0 sp|O35507|PPARA_CAVPO Peroxisome proliferator-activated receptor alpha OS=Cavia porcellus OX=10141 GN=PPARA PE=2 SV=1 g11447.t1 Q5ZLS8 34.972 712 5.53e-122 383.0 sp|Q5ZLS8|INT10_CHICK Integrator complex subunit 10 OS=Gallus gallus OX=9031 GN=INTS10 PE=2 SV=1 g11449.t1 Q9NYT6 32.296 257 3.9e-34 145.0 sp|Q9NYT6|ZN226_HUMAN Zinc finger protein 226 OS=Homo sapiens OX=9606 GN=ZNF226 PE=1 SV=2 g11449.t1 Q9NYT6 37.004 227 1.17e-31 137.0 sp|Q9NYT6|ZN226_HUMAN Zinc finger protein 226 OS=Homo sapiens OX=9606 GN=ZNF226 PE=1 SV=2 g11449.t1 Q9NYT6 38.14 215 2.1300000000000002e-29 130.0 sp|Q9NYT6|ZN226_HUMAN Zinc finger protein 226 OS=Homo sapiens OX=9606 GN=ZNF226 PE=1 SV=2 g11449.t1 Q9NYT6 34.211 228 1.17e-28 128.0 sp|Q9NYT6|ZN226_HUMAN Zinc finger protein 226 OS=Homo sapiens OX=9606 GN=ZNF226 PE=1 SV=2 g11449.t1 Q9NYT6 38.65 163 2.04e-26 121.0 sp|Q9NYT6|ZN226_HUMAN Zinc finger protein 226 OS=Homo sapiens OX=9606 GN=ZNF226 PE=1 SV=2 g11449.t2 Q9NYT6 32.296 257 3.87e-34 145.0 sp|Q9NYT6|ZN226_HUMAN Zinc finger protein 226 OS=Homo sapiens OX=9606 GN=ZNF226 PE=1 SV=2 g11449.t2 Q9NYT6 37.004 227 1.16e-31 137.0 sp|Q9NYT6|ZN226_HUMAN Zinc finger protein 226 OS=Homo sapiens OX=9606 GN=ZNF226 PE=1 SV=2 g11449.t2 Q9NYT6 38.14 215 2.1200000000000002e-29 130.0 sp|Q9NYT6|ZN226_HUMAN Zinc finger protein 226 OS=Homo sapiens OX=9606 GN=ZNF226 PE=1 SV=2 g11449.t2 Q9NYT6 34.211 228 1.1599999999999999e-28 128.0 sp|Q9NYT6|ZN226_HUMAN Zinc finger protein 226 OS=Homo sapiens OX=9606 GN=ZNF226 PE=1 SV=2 g11449.t2 Q9NYT6 38.65 163 2.03e-26 121.0 sp|Q9NYT6|ZN226_HUMAN Zinc finger protein 226 OS=Homo sapiens OX=9606 GN=ZNF226 PE=1 SV=2 g11450.t1 Q96N22 38.683 243 3.6900000000000002e-37 152.0 sp|Q96N22|ZN681_HUMAN Zinc finger protein 681 OS=Homo sapiens OX=9606 GN=ZNF681 PE=1 SV=2 g11450.t1 Q96N22 40.964 166 3.63e-29 127.0 sp|Q96N22|ZN681_HUMAN Zinc finger protein 681 OS=Homo sapiens OX=9606 GN=ZNF681 PE=1 SV=2 g11450.t1 Q96N22 43.421 152 1.48e-27 122.0 sp|Q96N22|ZN681_HUMAN Zinc finger protein 681 OS=Homo sapiens OX=9606 GN=ZNF681 PE=1 SV=2 g11450.t1 Q96N22 34.536 194 2.1e-22 106.0 sp|Q96N22|ZN681_HUMAN Zinc finger protein 681 OS=Homo sapiens OX=9606 GN=ZNF681 PE=1 SV=2 g11454.t1 A1L1J6 40.0 165 9.53e-32 135.0 sp|A1L1J6|ZN652_RAT Zinc finger protein 652 OS=Rattus norvegicus OX=10116 GN=Znf652 PE=1 SV=1 g11455.t1 Q9UJL9 37.021 235 1.0300000000000001e-29 125.0 sp|Q9UJL9|ZF69B_HUMAN Zinc finger protein 69 homolog B OS=Homo sapiens OX=9606 GN=ZFP69B PE=1 SV=2 ZF69B_HUMAN reviewed Zinc finger protein 69 homolog B (Zinc finger protein 643) Homo sapiens (Human) GO:0000977; GO:0000981; GO:0005634; GO:0005730; GO:0006357; GO:0007030; GO:0008270 Golgi organization [GO:0007030]; regulation of transcription by RNA polymerase II [GO:0006357] nucleolus [GO:0005730]; nucleus [GO:0005634] DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; zinc ion binding [GO:0008270] g11462.t1 P90666 65.523 641 0.0 861.0 sp|P90666|TXND3_HELCR Thioredoxin domain-containing protein 3 homolog OS=Heliocidaris crassispina OX=1043166 GN=NME8 PE=1 SV=1 g11462.t2 P90666 64.094 635 0.0 830.0 sp|P90666|TXND3_HELCR Thioredoxin domain-containing protein 3 homolog OS=Heliocidaris crassispina OX=1043166 GN=NME8 PE=1 SV=1 g14500.t1 P48319 66.189 488 0.0 683.0 sp|P48319|DCE1_PIG Glutamate decarboxylase 1 OS=Sus scrofa OX=9823 GN=GAD1 PE=2 SV=1 g14501.t1 P18293 38.391 982 0.0 629.0 sp|P18293|ANPRA_MOUSE Atrial natriuretic peptide receptor 1 OS=Mus musculus OX=10090 GN=Npr1 PE=1 SV=2 ANPRA_MOUSE reviewed Atrial natriuretic peptide receptor 1 (EC 4.6.1.2) (Atrial natriuretic peptide receptor type A) (ANP-A) (ANPR-A) (NPR-A) (Guanylate cyclase A) (GC-A) Mus musculus (Mouse) GO:0001653; GO:0004383; GO:0004672; GO:0005524; GO:0005525; GO:0005886; GO:0006182; GO:0007166; GO:0007168; GO:0008217; GO:0010753; GO:0016941; GO:0017046; GO:0019934; GO:0035556; GO:0042417; GO:0042562; GO:0043114; GO:0043235; GO:0048662; GO:0097746; GO:1990620 blood vessel diameter maintenance [GO:0097746]; cell surface receptor signaling pathway [GO:0007166]; cGMP biosynthetic process [GO:0006182]; cGMP-mediated signaling [GO:0019934]; dopamine metabolic process [GO:0042417]; intracellular signal transduction [GO:0035556]; negative regulation of smooth muscle cell proliferation [GO:0048662]; positive regulation of cGMP-mediated signaling [GO:0010753]; receptor guanylyl cyclase signaling pathway [GO:0007168]; regulation of blood pressure [GO:0008217]; regulation of vascular permeability [GO:0043114] ANPR-A receptor complex [GO:1990620]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] ATP binding [GO:0005524]; GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; hormone binding [GO:0042562]; natriuretic peptide receptor activity [GO:0016941]; peptide hormone binding [GO:0017046]; peptide receptor activity [GO:0001653]; protein kinase activity [GO:0004672] g14505.t1 A1ZAX0 28.909 339 2.32e-25 110.0 sp|A1ZAX0|CCH1R_DROME Neuropeptide CCHamide-1 receptor OS=Drosophila melanogaster OX=7227 GN=CCHa1-R PE=2 SV=2 g14506.t1 Q6AXL5 37.581 463 1.24e-96 302.0 sp|Q6AXL5|HBAP1_DANRE HSPB1-associated protein 1 homolog OS=Danio rerio OX=7955 GN=hspbap1 PE=2 SV=2 g14507.t1 Q9JJ22 36.433 914 0.0 592.0 sp|Q9JJ22|ERAP1_RAT Endoplasmic reticulum aminopeptidase 1 OS=Rattus norvegicus OX=10116 GN=Erap1 PE=2 SV=2 ERAP1_RAT reviewed Endoplasmic reticulum aminopeptidase 1 (EC 3.4.11.-) (ARTS-1) (Adipocyte-derived leucine aminopeptidase) (A-LAP) (Aminopeptidase PILS) (Puromycin-insensitive leucyl-specific aminopeptidase) (PILS-AP) Rattus norvegicus (Rat) GO:0002250; GO:0002502; GO:0004175; GO:0004177; GO:0005138; GO:0005164; GO:0005576; GO:0005737; GO:0005788; GO:0005789; GO:0006508; GO:0006509; GO:0008233; GO:0008235; GO:0008270; GO:0019882; GO:0030163; GO:0043171; GO:0045766; GO:0070006 adaptive immune response [GO:0002250]; antigen processing and presentation [GO:0019882]; membrane protein ectodomain proteolysis [GO:0006509]; peptide antigen assembly with MHC class I protein complex [GO:0002502]; peptide catabolic process [GO:0043171]; positive regulation of angiogenesis [GO:0045766]; protein catabolic process [GO:0030163]; proteolysis [GO:0006508] cytoplasm [GO:0005737]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576] aminopeptidase activity [GO:0004177]; endopeptidase activity [GO:0004175]; interleukin-6 receptor binding [GO:0005138]; metalloaminopeptidase activity [GO:0070006]; metalloexopeptidase activity [GO:0008235]; peptidase activity [GO:0008233]; tumor necrosis factor receptor binding [GO:0005164]; zinc ion binding [GO:0008270] g14507.t2 Q9JJ22 36.433 914 0.0 591.0 sp|Q9JJ22|ERAP1_RAT Endoplasmic reticulum aminopeptidase 1 OS=Rattus norvegicus OX=10116 GN=Erap1 PE=2 SV=2 ERAP1_RAT reviewed Endoplasmic reticulum aminopeptidase 1 (EC 3.4.11.-) (ARTS-1) (Adipocyte-derived leucine aminopeptidase) (A-LAP) (Aminopeptidase PILS) (Puromycin-insensitive leucyl-specific aminopeptidase) (PILS-AP) Rattus norvegicus (Rat) GO:0002250; GO:0002502; GO:0004175; GO:0004177; GO:0005138; GO:0005164; GO:0005576; GO:0005737; GO:0005788; GO:0005789; GO:0006508; GO:0006509; GO:0008233; GO:0008235; GO:0008270; GO:0019882; GO:0030163; GO:0043171; GO:0045766; GO:0070006 adaptive immune response [GO:0002250]; antigen processing and presentation [GO:0019882]; membrane protein ectodomain proteolysis [GO:0006509]; peptide antigen assembly with MHC class I protein complex [GO:0002502]; peptide catabolic process [GO:0043171]; positive regulation of angiogenesis [GO:0045766]; protein catabolic process [GO:0030163]; proteolysis [GO:0006508] cytoplasm [GO:0005737]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576] aminopeptidase activity [GO:0004177]; endopeptidase activity [GO:0004175]; interleukin-6 receptor binding [GO:0005138]; metalloaminopeptidase activity [GO:0070006]; metalloexopeptidase activity [GO:0008235]; peptidase activity [GO:0008233]; tumor necrosis factor receptor binding [GO:0005164]; zinc ion binding [GO:0008270] g14510.t1 Q8NDZ4 27.064 436 1.56e-28 121.0 sp|Q8NDZ4|DIK2A_HUMAN Divergent protein kinase domain 2A OS=Homo sapiens OX=9606 GN=DIPK2A PE=1 SV=1 DIK2A_HUMAN reviewed Divergent protein kinase domain 2A (Deleted in autism protein 1) (Golgi Protein of 49 kDa) (GoPro49) (Hypoxia and AKT-induced stem cell factor) (HASF) Homo sapiens (Human) GO:0000139; GO:0005615; GO:0030126; GO:0034392; GO:0051896; GO:0060038; GO:1900020 cardiac muscle cell proliferation [GO:0060038]; negative regulation of smooth muscle cell apoptotic process [GO:0034392]; positive regulation of protein kinase C activity [GO:1900020]; regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051896] COPI vesicle coat [GO:0030126]; extracellular space [GO:0005615]; Golgi membrane [GO:0000139] g14519.t1 Q8TCJ2 78.221 652 0.0 1028.0 sp|Q8TCJ2|STT3B_HUMAN Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit STT3B OS=Homo sapiens OX=9606 GN=STT3B PE=1 SV=1 STT3B_HUMAN reviewed Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit STT3B (Oligosaccharyl transferase subunit STT3B) (STT3-B) (EC 2.4.99.18) (Source of immunodominant MHC-associated peptides homolog) Homo sapiens (Human) GO:0004579; GO:0005783; GO:0005789; GO:0006487; GO:0006516; GO:0006986; GO:0008250; GO:0016020; GO:0018279; GO:0032991; GO:0036503; GO:0043687; GO:0046872; GO:0160227 ERAD pathway [GO:0036503]; glycoprotein catabolic process [GO:0006516]; post-translational protein modification [GO:0043687]; protein N-linked glycosylation [GO:0006487]; protein N-linked glycosylation via asparagine [GO:0018279]; response to unfolded protein [GO:0006986] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; oligosaccharyltransferase complex [GO:0008250]; oligosaccharyltransferase complex B [GO:0160227]; protein-containing complex [GO:0032991] dolichyl-diphosphooligosaccharide-protein glycotransferase activity [GO:0004579]; metal ion binding [GO:0046872] g14521.t1 Q5R4G6 80.829 772 0.0 1297.0 sp|Q5R4G6|CUL1_PONAB Cullin-1 OS=Pongo abelii OX=9601 GN=CUL1 PE=2 SV=1 CUL1_PONAB reviewed Cullin-1 (CUL-1) Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0000045; GO:0000082; GO:0005886; GO:0006513; GO:0007040; GO:0008283; GO:0009887; GO:0010507; GO:0010508; GO:0019005; GO:0031146; GO:0031625; GO:0031669; GO:0034599; GO:0038202; GO:0043123; GO:0043124; GO:0070936; GO:0097193; GO:0140374; GO:0160072; GO:1904037; GO:1904262; GO:1990452 animal organ morphogenesis [GO:0009887]; antiviral innate immune response [GO:0140374]; autophagosome assembly [GO:0000045]; cell population proliferation [GO:0008283]; cellular response to nutrient levels [GO:0031669]; cellular response to oxidative stress [GO:0034599]; G1/S transition of mitotic cell cycle [GO:0000082]; intrinsic apoptotic signaling pathway [GO:0097193]; lysosome organization [GO:0007040]; negative regulation of autophagy [GO:0010507]; negative regulation of canonical NF-kappaB signal transduction [GO:0043124]; negative regulation of TORC1 signaling [GO:1904262]; positive regulation of autophagy [GO:0010508]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of epithelial cell apoptotic process [GO:1904037]; protein K48-linked ubiquitination [GO:0070936]; protein monoubiquitination [GO:0006513]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; TORC1 signaling [GO:0038202] Parkin-FBXW7-Cul1 ubiquitin ligase complex [GO:1990452]; plasma membrane [GO:0005886]; SCF ubiquitin ligase complex [GO:0019005] ubiquitin ligase complex scaffold activity [GO:0160072]; ubiquitin protein ligase binding [GO:0031625] g14527.t1 Q55CB8 39.053 169 9.95e-36 130.0 sp|Q55CB8|RASX_DICDI Ras-like protein rasX OS=Dictyostelium discoideum OX=44689 GN=rasX PE=3 SV=1 g14528.t1 Q66IC8 39.683 126 1.9200000000000002e-29 108.0 sp|Q66IC8|DYLT5_DANRE Dynein light chain Tctex-type 5 OS=Danio rerio OX=7955 GN=dynlt5 PE=2 SV=1 g14529.t1 E2QRY6 65.854 246 2.24e-114 334.0 sp|E2QRY6|NNRE_CANLF NAD(P)H-hydrate epimerase OS=Canis lupus familiaris OX=9615 GN=NAXE PE=3 SV=1 NNRE_CANLF reviewed NAD(P)H-hydrate epimerase (EC 5.1.99.6) (Apolipoprotein A-I-binding protein) (AI-BP) (NAD(P)HX epimerase) Canis lupus familiaris (Dog) (Canis familiaris) GO:0000166; GO:0002040; GO:0005576; GO:0005739; GO:0006869; GO:0010874; GO:0016525; GO:0031580; GO:0046496; GO:0046872; GO:0052856 lipid transport [GO:0006869]; membrane raft distribution [GO:0031580]; negative regulation of angiogenesis [GO:0016525]; nicotinamide nucleotide metabolic process [GO:0046496]; regulation of cholesterol efflux [GO:0010874]; sprouting angiogenesis [GO:0002040] extracellular region [GO:0005576]; mitochondrion [GO:0005739] metal ion binding [GO:0046872]; NAD(P)HX epimerase activity [GO:0052856]; nucleotide binding [GO:0000166] g14530.t1 Q96CT2 29.208 606 3.43e-83 283.0 sp|Q96CT2|KLH29_HUMAN Kelch-like protein 29 OS=Homo sapiens OX=9606 GN=KLHL29 PE=1 SV=3 g14531.t1 Q80U22 42.365 203 1.3899999999999999e-40 164.0 sp|Q80U22|RUSC2_MOUSE AP-4 complex accessory subunit RUSC2 OS=Mus musculus OX=10090 GN=Rusc2 PE=1 SV=2 g14535.t1 Q8N695 47.515 503 2.4799999999999998e-146 440.0 sp|Q8N695|SC5A8_HUMAN Sodium-coupled monocarboxylate transporter 1 OS=Homo sapiens OX=9606 GN=SLC5A8 PE=1 SV=2 SC5A8_HUMAN reviewed Sodium-coupled monocarboxylate transporter 1 (Apical iodide transporter) (Electrogenic sodium monocarboxylate cotransporter) (Sodium iodide-related cotransporter) (Solute carrier family 5 member 8) Homo sapiens (Human) GO:0000811; GO:0005343; GO:0005886; GO:0006811; GO:0006814; GO:0006821; GO:0006846; GO:0006848; GO:0006915; GO:0008028; GO:0015129; GO:0015552; GO:0015705; GO:0015706; GO:0015727; GO:0015730; GO:0016324; GO:0070062; GO:0090416; GO:0140161; GO:0160081; GO:1901847; GO:2001142 acetate transport [GO:0006846]; apoptotic process [GO:0006915]; chloride transport [GO:0006821]; iodide transport [GO:0015705]; lactate transport [GO:0015727]; monoatomic ion transport [GO:0006811]; nicotinate metabolic process [GO:1901847]; nicotinate transport [GO:2001142]; nitrate transmembrane transport [GO:0015706]; propanoate transmembrane transport [GO:0015730]; pyruvate transport [GO:0006848]; sodium ion transport [GO:0006814] apical plasma membrane [GO:0016324]; extracellular exosome [GO:0070062]; GINS complex [GO:0000811]; plasma membrane [GO:0005886] iodide channel activity [GO:0160081]; lactate transmembrane transporter activity [GO:0015129]; monocarboxylate:sodium symporter activity [GO:0140161]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; nicotinate transmembrane transporter activity [GO:0090416]; organic acid:sodium symporter activity [GO:0005343]; propionate transmembrane transporter activity [GO:0015552] g14536.t1 Q9Y2W6 31.928 498 4.08e-57 202.0 sp|Q9Y2W6|TDRKH_HUMAN Tudor and KH domain-containing protein OS=Homo sapiens OX=9606 GN=TDRKH PE=1 SV=2 TDRKH_HUMAN reviewed Tudor and KH domain-containing protein (Tudor domain-containing protein 2) Homo sapiens (Human) GO:0003723; GO:0005739; GO:0007140; GO:0007283; GO:0009566; GO:0030719; GO:0034587; GO:0043186; GO:0071546; GO:0071547 fertilization [GO:0009566]; male meiotic nuclear division [GO:0007140]; P granule organization [GO:0030719]; piRNA processing [GO:0034587]; spermatogenesis [GO:0007283] mitochondrion [GO:0005739]; P granule [GO:0043186]; pi-body [GO:0071546]; piP-body [GO:0071547] RNA binding [GO:0003723] g14537.t1 Q969G6 66.667 144 4.0100000000000005e-73 219.0 sp|Q969G6|RIFK_HUMAN Riboflavin kinase OS=Homo sapiens OX=9606 GN=RFK PE=1 SV=2 RIFK_HUMAN reviewed Riboflavin kinase (EC 2.7.1.26) (ATP:riboflavin 5'-phosphotransferase) (Flavokinase) Homo sapiens (Human) GO:0005524; GO:0005737; GO:0005739; GO:0005829; GO:0006771; GO:0006915; GO:0008531; GO:0009231; GO:0009398; GO:0033864; GO:0046872; GO:0072388; GO:0072593 apoptotic process [GO:0006915]; flavin adenine dinucleotide biosynthetic process [GO:0072388]; FMN biosynthetic process [GO:0009398]; positive regulation of NAD(P)H oxidase activity [GO:0033864]; reactive oxygen species metabolic process [GO:0072593]; riboflavin biosynthetic process [GO:0009231]; riboflavin metabolic process [GO:0006771] cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739] ATP binding [GO:0005524]; metal ion binding [GO:0046872]; riboflavin kinase activity [GO:0008531] g14538.t1 Q99N94 44.33 194 1.71e-41 145.0 sp|Q99N94|RM09_MOUSE Large ribosomal subunit protein bL9m OS=Mus musculus OX=10090 GN=Mrpl9 PE=1 SV=2 g14539.t1 Q9H0A8 61.809 199 2.22e-90 266.0 sp|Q9H0A8|COMD4_HUMAN COMM domain-containing protein 4 OS=Homo sapiens OX=9606 GN=COMMD4 PE=1 SV=1 COMD4_HUMAN reviewed COMM domain-containing protein 4 Homo sapiens (Human) GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0007165 signal transduction [GO:0007165] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886] g14540.t1 Q9CZN7 64.848 495 0.0 676.0 sp|Q9CZN7|GLYM_MOUSE Serine hydroxymethyltransferase, mitochondrial OS=Mus musculus OX=10090 GN=Shmt2 PE=1 SV=1 GLYM_MOUSE reviewed Serine hydroxymethyltransferase, mitochondrial (SHMT) (EC 2.1.2.1) (Glycine hydroxymethyltransferase) (Serine methylase) Mus musculus (Mouse) GO:0002082; GO:0003682; GO:0004372; GO:0005634; GO:0005737; GO:0005739; GO:0005743; GO:0005759; GO:0006544; GO:0006545; GO:0006563; GO:0006564; GO:0006730; GO:0008284; GO:0008732; GO:0015630; GO:0015943; GO:0016597; GO:0019264; GO:0030170; GO:0034340; GO:0035999; GO:0042645; GO:0042802; GO:0046653; GO:0051262; GO:0051289; GO:0070129; GO:0070536; GO:0070552; GO:1903715 formate biosynthetic process [GO:0015943]; glycine biosynthetic process [GO:0006545]; glycine biosynthetic process from serine [GO:0019264]; glycine metabolic process [GO:0006544]; L-serine biosynthetic process [GO:0006564]; L-serine metabolic process [GO:0006563]; one-carbon metabolic process [GO:0006730]; positive regulation of cell population proliferation [GO:0008284]; protein homotetramerization [GO:0051289]; protein K63-linked deubiquitination [GO:0070536]; protein tetramerization [GO:0051262]; regulation of aerobic respiration [GO:1903715]; regulation of mitochondrial translation [GO:0070129]; regulation of oxidative phosphorylation [GO:0002082]; response to type I interferon [GO:0034340]; tetrahydrofolate interconversion [GO:0035999]; tetrahydrofolate metabolic process [GO:0046653] BRISC complex [GO:0070552]; cytoplasm [GO:0005737]; microtubule cytoskeleton [GO:0015630]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nucleus [GO:0005634] amino acid binding [GO:0016597]; chromatin binding [GO:0003682]; glycine hydroxymethyltransferase activity [GO:0004372]; identical protein binding [GO:0042802]; L-allo-threonine aldolase activity [GO:0008732]; pyridoxal phosphate binding [GO:0030170] g14541.t1 Q99K85 59.452 365 4.19e-171 484.0 sp|Q99K85|SERC_MOUSE Phosphoserine aminotransferase OS=Mus musculus OX=10090 GN=Psat1 PE=1 SV=1 g14542.t1 Q28C98 62.983 181 2.0100000000000002e-72 219.0 sp|Q28C98|MESH1_XENTR Guanosine-3',5'-bis(diphosphate) 3'-pyrophosphohydrolase MESH1 OS=Xenopus tropicalis OX=8364 GN=hddc3 PE=2 SV=1 g14543.t1 Q28C98 65.193 181 2.7299999999999997e-74 224.0 sp|Q28C98|MESH1_XENTR Guanosine-3',5'-bis(diphosphate) 3'-pyrophosphohydrolase MESH1 OS=Xenopus tropicalis OX=8364 GN=hddc3 PE=2 SV=1 g14544.t1 Q28C98 63.006 173 2.92e-68 208.0 sp|Q28C98|MESH1_XENTR Guanosine-3',5'-bis(diphosphate) 3'-pyrophosphohydrolase MESH1 OS=Xenopus tropicalis OX=8364 GN=hddc3 PE=2 SV=1 g14545.t1 Q92828 46.993 449 9.07e-148 443.0 sp|Q92828|COR2A_HUMAN Coronin-2A OS=Homo sapiens OX=9606 GN=CORO2A PE=1 SV=2 g14546.t1 Q8HY67 61.842 152 3.58e-50 169.0 sp|Q8HY67|AN32A_CANLF Acidic leucine-rich nuclear phosphoprotein 32 family member A OS=Canis lupus familiaris OX=9615 GN=ANP32A PE=2 SV=1 g14546.t2 Q8HY67 61.486 148 1.7099999999999998e-48 164.0 sp|Q8HY67|AN32A_CANLF Acidic leucine-rich nuclear phosphoprotein 32 family member A OS=Canis lupus familiaris OX=9615 GN=ANP32A PE=2 SV=1 g14547.t1 O60678 53.347 478 5.68e-168 486.0 sp|O60678|ANM3_HUMAN Protein arginine N-methyltransferase 3 OS=Homo sapiens OX=9606 GN=PRMT3 PE=1 SV=4 ANM3_HUMAN reviewed Protein arginine N-methyltransferase 3 (EC 2.1.1.319) (Heterogeneous nuclear ribonucleoprotein methyltransferase-like protein 3) Homo sapiens (Human) GO:0005634; GO:0005737; GO:0005829; GO:0006338; GO:0006355; GO:0008168; GO:0008270; GO:0016274; GO:0031397; GO:0032259; GO:0035241; GO:0035242; GO:0042054; GO:0044020; GO:0045669; GO:0045815; GO:1900053 chromatin remodeling [GO:0006338]; methylation [GO:0032259]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of retinoic acid biosynthetic process [GO:1900053]; positive regulation of osteoblast differentiation [GO:0045669]; regulation of DNA-templated transcription [GO:0006355]; transcription initiation-coupled chromatin remodeling [GO:0045815] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634] histone H4R3 methyltransferase activity [GO:0044020]; histone methyltransferase activity [GO:0042054]; methyltransferase activity [GO:0008168]; protein-arginine N-methyltransferase activity [GO:0016274]; protein-arginine omega-N asymmetric methyltransferase activity [GO:0035242]; protein-arginine omega-N monomethyltransferase activity [GO:0035241]; zinc ion binding [GO:0008270] g14550.t1 P24712 35.393 178 1.5099999999999998e-23 100.0 sp|P24712|INVO_SAGOE Involucrin OS=Saguinus oedipus OX=9490 GN=IVL PE=2 SV=1 g14551.t1 Q9ESQ4 32.484 314 7.78e-28 116.0 sp|Q9ESQ4|NMUR2_RAT Neuromedin-U receptor 2 OS=Rattus norvegicus OX=10116 GN=Nmur2 PE=1 SV=2 NMUR2_RAT reviewed Neuromedin-U receptor 2 (NMU-R2) (G-protein coupled receptor TGR-1) (G-protein-coupled receptor FM-4) Rattus norvegicus (Rat) GO:0001607; GO:0002023; GO:0005229; GO:0005525; GO:0005886; GO:0007200; GO:0007218; GO:0007625; GO:0008188; GO:0016020; GO:0042924; GO:0048265; GO:0050482; GO:0051930 arachidonate secretion [GO:0050482]; grooming behavior [GO:0007625]; neuropeptide signaling pathway [GO:0007218]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; reduction of food intake in response to dietary excess [GO:0002023]; regulation of sensory perception of pain [GO:0051930]; response to pain [GO:0048265] membrane [GO:0016020]; plasma membrane [GO:0005886] GTP binding [GO:0005525]; intracellularly calcium-gated chloride channel activity [GO:0005229]; neuromedin U binding [GO:0042924]; neuromedin U receptor activity [GO:0001607]; neuropeptide receptor activity [GO:0008188] g14554.t1 Q10751 54.815 540 0.0 607.0 sp|Q10751|ACE_CHICK Angiotensin-converting enzyme OS=Gallus gallus OX=9031 GN=ACE PE=2 SV=2 ACE_CHICK reviewed Angiotensin-converting enzyme (ACE) (EC 3.4.15.1) (Dipeptidyl carboxypeptidase I) (Kininase II) Gallus gallus (Chicken) GO:0001822; GO:0002003; GO:0003084; GO:0004180; GO:0004222; GO:0005615; GO:0005737; GO:0005886; GO:0008217; GO:0008237; GO:0008241; GO:0008270; GO:0008283; GO:0010814; GO:0010815; GO:0016020; GO:0031404; GO:0042445; GO:0042447; GO:0048167; GO:0060319; GO:0070573 angiotensin maturation [GO:0002003]; bradykinin catabolic process [GO:0010815]; cell population proliferation [GO:0008283]; hormone catabolic process [GO:0042447]; hormone metabolic process [GO:0042445]; kidney development [GO:0001822]; positive regulation of systemic arterial blood pressure [GO:0003084]; primitive erythrocyte differentiation [GO:0060319]; regulation of blood pressure [GO:0008217]; regulation of synaptic plasticity [GO:0048167]; substance P catabolic process [GO:0010814] cytoplasm [GO:0005737]; extracellular space [GO:0005615]; membrane [GO:0016020]; plasma membrane [GO:0005886] carboxypeptidase activity [GO:0004180]; chloride ion binding [GO:0031404]; metallodipeptidase activity [GO:0070573]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; peptidyl-dipeptidase activity [GO:0008241]; zinc ion binding [GO:0008270] g14554.t1 Q10751 52.816 515 0.0 588.0 sp|Q10751|ACE_CHICK Angiotensin-converting enzyme OS=Gallus gallus OX=9031 GN=ACE PE=2 SV=2 ACE_CHICK reviewed Angiotensin-converting enzyme (ACE) (EC 3.4.15.1) (Dipeptidyl carboxypeptidase I) (Kininase II) Gallus gallus (Chicken) GO:0001822; GO:0002003; GO:0003084; GO:0004180; GO:0004222; GO:0005615; GO:0005737; GO:0005886; GO:0008217; GO:0008237; GO:0008241; GO:0008270; GO:0008283; GO:0010814; GO:0010815; GO:0016020; GO:0031404; GO:0042445; GO:0042447; GO:0048167; GO:0060319; GO:0070573 angiotensin maturation [GO:0002003]; bradykinin catabolic process [GO:0010815]; cell population proliferation [GO:0008283]; hormone catabolic process [GO:0042447]; hormone metabolic process [GO:0042445]; kidney development [GO:0001822]; positive regulation of systemic arterial blood pressure [GO:0003084]; primitive erythrocyte differentiation [GO:0060319]; regulation of blood pressure [GO:0008217]; regulation of synaptic plasticity [GO:0048167]; substance P catabolic process [GO:0010814] cytoplasm [GO:0005737]; extracellular space [GO:0005615]; membrane [GO:0016020]; plasma membrane [GO:0005886] carboxypeptidase activity [GO:0004180]; chloride ion binding [GO:0031404]; metallodipeptidase activity [GO:0070573]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; peptidyl-dipeptidase activity [GO:0008241]; zinc ion binding [GO:0008270] g14555.t1 P12820 46.633 594 0.0 558.0 sp|P12820|ACE_BOVIN Angiotensin-converting enzyme OS=Bos taurus OX=9913 GN=ACE PE=1 SV=3 ACE_BOVIN reviewed Angiotensin-converting enzyme (ACE) (EC 3.4.15.1) (Dipeptidyl carboxypeptidase I) (Kininase II) (CD antigen CD143) [Cleaved into: Angiotensin-converting enzyme, soluble form] Bos taurus (Bovine) GO:0001822; GO:0002003; GO:0002034; GO:0002446; GO:0003084; GO:0004181; GO:0004222; GO:0005516; GO:0005615; GO:0005764; GO:0005768; GO:0005886; GO:0007283; GO:0008217; GO:0008233; GO:0008237; GO:0008240; GO:0008241; GO:0008270; GO:0008584; GO:0009897; GO:0010608; GO:0010629; GO:0010814; GO:0010815; GO:0031404; GO:0031434; GO:0031711; GO:0038166; GO:0042311; GO:0042445; GO:0042447; GO:0048167; GO:0050435; GO:0050482; GO:0051019; GO:0060047; GO:0060177; GO:0070062; GO:0070573; GO:0071838; GO:0086091; GO:1902033; GO:1903597 amyloid-beta metabolic process [GO:0050435]; angiotensin maturation [GO:0002003]; angiotensin-activated signaling pathway [GO:0038166]; arachidonate secretion [GO:0050482]; bradykinin catabolic process [GO:0010815]; cell proliferation in bone marrow [GO:0071838]; heart contraction [GO:0060047]; hormone catabolic process [GO:0042447]; hormone metabolic process [GO:0042445]; kidney development [GO:0001822]; maintenance of blood vessel diameter homeostasis by renin-angiotensin [GO:0002034]; male gonad development [GO:0008584]; negative regulation of gap junction assembly [GO:1903597]; negative regulation of gene expression [GO:0010629]; neutrophil mediated immunity [GO:0002446]; positive regulation of systemic arterial blood pressure [GO:0003084]; post-transcriptional regulation of gene expression [GO:0010608]; regulation of angiotensin metabolic process [GO:0060177]; regulation of blood pressure [GO:0008217]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of hematopoietic stem cell proliferation [GO:1902033]; regulation of synaptic plasticity [GO:0048167]; spermatogenesis [GO:0007283]; substance P catabolic process [GO:0010814]; vasodilation [GO:0042311] endosome [GO:0005768]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; lysosome [GO:0005764]; plasma membrane [GO:0005886] bradykinin receptor binding [GO:0031711]; calmodulin binding [GO:0005516]; chloride ion binding [GO:0031404]; metallocarboxypeptidase activity [GO:0004181]; metallodipeptidase activity [GO:0070573]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; mitogen-activated protein kinase binding [GO:0051019]; mitogen-activated protein kinase kinase binding [GO:0031434]; peptidase activity [GO:0008233]; peptidyl-dipeptidase activity [GO:0008241]; tripeptidyl-peptidase activity [GO:0008240]; zinc ion binding [GO:0008270] g14555.t1 P12820 44.662 562 5.879999999999999e-165 509.0 sp|P12820|ACE_BOVIN Angiotensin-converting enzyme OS=Bos taurus OX=9913 GN=ACE PE=1 SV=3 ACE_BOVIN reviewed Angiotensin-converting enzyme (ACE) (EC 3.4.15.1) (Dipeptidyl carboxypeptidase I) (Kininase II) (CD antigen CD143) [Cleaved into: Angiotensin-converting enzyme, soluble form] Bos taurus (Bovine) GO:0001822; GO:0002003; GO:0002034; GO:0002446; GO:0003084; GO:0004181; GO:0004222; GO:0005516; GO:0005615; GO:0005764; GO:0005768; GO:0005886; GO:0007283; GO:0008217; GO:0008233; GO:0008237; GO:0008240; GO:0008241; GO:0008270; GO:0008584; GO:0009897; GO:0010608; GO:0010629; GO:0010814; GO:0010815; GO:0031404; GO:0031434; GO:0031711; GO:0038166; GO:0042311; GO:0042445; GO:0042447; GO:0048167; GO:0050435; GO:0050482; GO:0051019; GO:0060047; GO:0060177; GO:0070062; GO:0070573; GO:0071838; GO:0086091; GO:1902033; GO:1903597 amyloid-beta metabolic process [GO:0050435]; angiotensin maturation [GO:0002003]; angiotensin-activated signaling pathway [GO:0038166]; arachidonate secretion [GO:0050482]; bradykinin catabolic process [GO:0010815]; cell proliferation in bone marrow [GO:0071838]; heart contraction [GO:0060047]; hormone catabolic process [GO:0042447]; hormone metabolic process [GO:0042445]; kidney development [GO:0001822]; maintenance of blood vessel diameter homeostasis by renin-angiotensin [GO:0002034]; male gonad development [GO:0008584]; negative regulation of gap junction assembly [GO:1903597]; negative regulation of gene expression [GO:0010629]; neutrophil mediated immunity [GO:0002446]; positive regulation of systemic arterial blood pressure [GO:0003084]; post-transcriptional regulation of gene expression [GO:0010608]; regulation of angiotensin metabolic process [GO:0060177]; regulation of blood pressure [GO:0008217]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of hematopoietic stem cell proliferation [GO:1902033]; regulation of synaptic plasticity [GO:0048167]; spermatogenesis [GO:0007283]; substance P catabolic process [GO:0010814]; vasodilation [GO:0042311] endosome [GO:0005768]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; lysosome [GO:0005764]; plasma membrane [GO:0005886] bradykinin receptor binding [GO:0031711]; calmodulin binding [GO:0005516]; chloride ion binding [GO:0031404]; metallocarboxypeptidase activity [GO:0004181]; metallodipeptidase activity [GO:0070573]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; mitogen-activated protein kinase binding [GO:0051019]; mitogen-activated protein kinase kinase binding [GO:0031434]; peptidase activity [GO:0008233]; peptidyl-dipeptidase activity [GO:0008241]; tripeptidyl-peptidase activity [GO:0008240]; zinc ion binding [GO:0008270] g14557.t1 Q5RBZ6 34.914 232 1.45e-29 118.0 sp|Q5RBZ6|CHSTA_PONAB Carbohydrate sulfotransferase 10 OS=Pongo abelii OX=9601 GN=CHST10 PE=2 SV=1 CHSTA_PONAB reviewed Carbohydrate sulfotransferase 10 (EC 2.8.2.-) (HNK-1 sulfotransferase) (HNK-1ST) (HNK1ST) Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0000139; GO:0007612; GO:0007616; GO:0008146; GO:0008209; GO:0008210; GO:0016051; GO:0030166 androgen metabolic process [GO:0008209]; carbohydrate biosynthetic process [GO:0016051]; estrogen metabolic process [GO:0008210]; learning [GO:0007612]; long-term memory [GO:0007616]; proteoglycan biosynthetic process [GO:0030166] Golgi membrane [GO:0000139] sulfotransferase activity [GO:0008146] g14558.t1 P78383 63.576 302 1.81e-116 342.0 sp|P78383|S35B1_HUMAN Solute carrier family 35 member B1 OS=Homo sapiens OX=9606 GN=SLC35B1 PE=1 SV=1 S35B1_HUMAN reviewed Solute carrier family 35 member B1 (ATP/ADP exchanger ER) (AXER) (Endoplasmic reticulum ATP/ADP translocase) (UDP-galactose transporter-related protein 1) (UGTrel1) Homo sapiens (Human) GO:0000139; GO:0005459; GO:0005460; GO:0005471; GO:0005654; GO:0005783; GO:0005789; GO:0043231; GO:0072334 UDP-galactose transmembrane transport [GO:0072334] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654] ATP:ADP antiporter activity [GO:0005471]; UDP-galactose transmembrane transporter activity [GO:0005459]; UDP-glucose transmembrane transporter activity [GO:0005460] g14559.t1 O54702 29.259 270 3.51e-28 117.0 sp|O54702|CHSTA_RAT Carbohydrate sulfotransferase 10 OS=Rattus norvegicus OX=10116 GN=Chst10 PE=1 SV=1 g14560.t1 Q6DIB5 41.304 230 1.8700000000000002e-32 135.0 sp|Q6DIB5|MEG10_MOUSE Multiple epidermal growth factor-like domains protein 10 OS=Mus musculus OX=10090 GN=Megf10 PE=1 SV=1 MEG10_MOUSE reviewed Multiple epidermal growth factor-like domains protein 10 (Multiple EGF-like domains protein 10) Mus musculus (Mouse) GO:0001849; GO:0001891; GO:0005044; GO:0005112; GO:0005886; GO:0014719; GO:0014816; GO:0014841; GO:0022409; GO:0033002; GO:0034109; GO:0043277; GO:0043652; GO:0043654; GO:0048627; GO:0048641; GO:0051147; GO:0051451; GO:0055001; GO:1902742; GO:2000288 apoptotic cell clearance [GO:0043277]; apoptotic process involved in development [GO:1902742]; engulfment of apoptotic cell [GO:0043652]; homotypic cell-cell adhesion [GO:0034109]; muscle cell development [GO:0055001]; muscle cell proliferation [GO:0033002]; myoblast development [GO:0048627]; myoblast migration [GO:0051451]; positive regulation of cell-cell adhesion [GO:0022409]; positive regulation of myoblast proliferation [GO:2000288]; recognition of apoptotic cell [GO:0043654]; regulation of muscle cell differentiation [GO:0051147]; regulation of skeletal muscle tissue development [GO:0048641]; skeletal muscle satellite cell activation [GO:0014719]; skeletal muscle satellite cell differentiation [GO:0014816]; skeletal muscle satellite cell proliferation [GO:0014841] phagocytic cup [GO:0001891]; plasma membrane [GO:0005886] complement component C1q complex binding [GO:0001849]; Notch binding [GO:0005112]; scavenger receptor activity [GO:0005044] g14560.t1 Q6DIB5 35.622 233 3.0799999999999997e-24 110.0 sp|Q6DIB5|MEG10_MOUSE Multiple epidermal growth factor-like domains protein 10 OS=Mus musculus OX=10090 GN=Megf10 PE=1 SV=1 MEG10_MOUSE reviewed Multiple epidermal growth factor-like domains protein 10 (Multiple EGF-like domains protein 10) Mus musculus (Mouse) GO:0001849; GO:0001891; GO:0005044; GO:0005112; GO:0005886; GO:0014719; GO:0014816; GO:0014841; GO:0022409; GO:0033002; GO:0034109; GO:0043277; GO:0043652; GO:0043654; GO:0048627; GO:0048641; GO:0051147; GO:0051451; GO:0055001; GO:1902742; GO:2000288 apoptotic cell clearance [GO:0043277]; apoptotic process involved in development [GO:1902742]; engulfment of apoptotic cell [GO:0043652]; homotypic cell-cell adhesion [GO:0034109]; muscle cell development [GO:0055001]; muscle cell proliferation [GO:0033002]; myoblast development [GO:0048627]; myoblast migration [GO:0051451]; positive regulation of cell-cell adhesion [GO:0022409]; positive regulation of myoblast proliferation [GO:2000288]; recognition of apoptotic cell [GO:0043654]; regulation of muscle cell differentiation [GO:0051147]; regulation of skeletal muscle tissue development [GO:0048641]; skeletal muscle satellite cell activation [GO:0014719]; skeletal muscle satellite cell differentiation [GO:0014816]; skeletal muscle satellite cell proliferation [GO:0014841] phagocytic cup [GO:0001891]; plasma membrane [GO:0005886] complement component C1q complex binding [GO:0001849]; Notch binding [GO:0005112]; scavenger receptor activity [GO:0005044] g14560.t1 Q6DIB5 36.123 227 8.240000000000001e-22 102.0 sp|Q6DIB5|MEG10_MOUSE Multiple epidermal growth factor-like domains protein 10 OS=Mus musculus OX=10090 GN=Megf10 PE=1 SV=1 MEG10_MOUSE reviewed Multiple epidermal growth factor-like domains protein 10 (Multiple EGF-like domains protein 10) Mus musculus (Mouse) GO:0001849; GO:0001891; GO:0005044; GO:0005112; GO:0005886; GO:0014719; GO:0014816; GO:0014841; GO:0022409; GO:0033002; GO:0034109; GO:0043277; GO:0043652; GO:0043654; GO:0048627; GO:0048641; GO:0051147; GO:0051451; GO:0055001; GO:1902742; GO:2000288 apoptotic cell clearance [GO:0043277]; apoptotic process involved in development [GO:1902742]; engulfment of apoptotic cell [GO:0043652]; homotypic cell-cell adhesion [GO:0034109]; muscle cell development [GO:0055001]; muscle cell proliferation [GO:0033002]; myoblast development [GO:0048627]; myoblast migration [GO:0051451]; positive regulation of cell-cell adhesion [GO:0022409]; positive regulation of myoblast proliferation [GO:2000288]; recognition of apoptotic cell [GO:0043654]; regulation of muscle cell differentiation [GO:0051147]; regulation of skeletal muscle tissue development [GO:0048641]; skeletal muscle satellite cell activation [GO:0014719]; skeletal muscle satellite cell differentiation [GO:0014816]; skeletal muscle satellite cell proliferation [GO:0014841] phagocytic cup [GO:0001891]; plasma membrane [GO:0005886] complement component C1q complex binding [GO:0001849]; Notch binding [GO:0005112]; scavenger receptor activity [GO:0005044] g14563.t1 P23588 43.229 192 6.680000000000001e-26 117.0 sp|P23588|IF4B_HUMAN Eukaryotic translation initiation factor 4B OS=Homo sapiens OX=9606 GN=EIF4B PE=1 SV=2 IF4B_HUMAN reviewed Eukaryotic translation initiation factor 4B (eIF-4B) Homo sapiens (Human) GO:0001731; GO:0003723; GO:0003743; GO:0005829; GO:0006446; GO:0016281; GO:0033592; GO:0034057; GO:0043024; GO:0097010 eukaryotic translation initiation factor 4F complex assembly [GO:0097010]; formation of translation preinitiation complex [GO:0001731]; regulation of translational initiation [GO:0006446] cytosol [GO:0005829]; eukaryotic translation initiation factor 4F complex [GO:0016281] ribosomal small subunit binding [GO:0043024]; RNA binding [GO:0003723]; RNA strand annealing activity [GO:0033592]; RNA strand-exchange activity [GO:0034057]; translation initiation factor activity [GO:0003743] g14564.t1 Q3ZBL4 52.313 281 2.9199999999999996e-89 271.0 sp|Q3ZBL4|LZTL1_BOVIN Leucine zipper transcription factor-like protein 1 OS=Bos taurus OX=9913 GN=LZTFL1 PE=2 SV=1 g14566.t1 E9QAU8 49.635 137 9.149999999999999e-34 131.0 sp|E9QAU8|ARK2C_MOUSE E3 ubiquitin-protein ligase ARK2C OS=Mus musculus OX=10090 GN=Ark2c PE=1 SV=1 g14567.t1 Q5BJV9 51.596 188 5.24e-69 212.0 sp|Q5BJV9|NTAQ1_RAT Protein N-terminal glutamine amidohydrolase OS=Rattus norvegicus OX=10116 GN=Ntaq1 PE=2 SV=1 NTAQ1_RAT reviewed Protein N-terminal glutamine amidohydrolase (EC 3.5.1.122) (Protein NH2-terminal glutamine deamidase) (N-terminal Gln amidase) (Nt(Q)-amidase) (WDYHV motif-containing protein 1) Rattus norvegicus (Rat) GO:0005634; GO:0005829; GO:0008418; GO:0036211; GO:0070773 protein modification process [GO:0036211] cytosol [GO:0005829]; nucleus [GO:0005634] protein-N-terminal asparagine amidohydrolase activity [GO:0008418]; protein-N-terminal glutamine amidohydrolase activity [GO:0070773] g14568.t1 Q6P824 67.049 349 8.490000000000001e-173 487.0 sp|Q6P824|GPD1L_XENTR Glycerol-3-phosphate dehydrogenase 1-like protein OS=Xenopus tropicalis OX=8364 GN=gpd1l PE=2 SV=1 g14572.t1 Q0IJ01 31.123 543 2.01e-74 253.0 sp|Q0IJ01|ZWILC_XENTR Protein zwilch homolog OS=Xenopus tropicalis OX=8364 GN=zwilch PE=2 SV=1 g14573.t1 P49165 68.802 359 0.0 522.0 sp|P49165|RL4_URECA Large ribosomal subunit protein uL4 OS=Urechis caupo OX=6431 GN=RPL4 PE=2 SV=1 g14575.t1 P00639 43.956 273 5.43e-74 231.0 sp|P00639|DNAS1_BOVIN Deoxyribonuclease-1 OS=Bos taurus OX=9913 GN=DNASE1 PE=1 SV=3 DNAS1_BOVIN reviewed Deoxyribonuclease-1 (EC 3.1.21.1) (Deoxyribonuclease I) (DNase I) Bos taurus (Bovine) GO:0002283; GO:0002673; GO:0003677; GO:0003779; GO:0004530; GO:0005576; GO:0005634; GO:0005635; GO:0006308; GO:0006915; GO:0042588; GO:0070948 apoptotic process [GO:0006915]; DNA catabolic process [GO:0006308]; neutrophil activation involved in immune response [GO:0002283]; regulation of acute inflammatory response [GO:0002673]; regulation of neutrophil mediated cytotoxicity [GO:0070948] extracellular region [GO:0005576]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; zymogen granule [GO:0042588] actin binding [GO:0003779]; deoxyribonuclease I activity [GO:0004530]; DNA binding [GO:0003677] g14576.t1 Q9D1G0 34.266 286 1.0599999999999999e-48 166.0 sp|Q9D1G0|DNSL2_MOUSE Deoxyribonuclease-1-like 2 OS=Mus musculus OX=10090 GN=Dnase1l2 PE=2 SV=1 g14577.t1 Q6GNV7 34.812 451 8.16e-72 238.0 sp|Q6GNV7|DIRC2_XENLA Solute carrier family 49 member 4 homolog OS=Xenopus laevis OX=8355 GN=slc49a4 PE=2 SV=1 DIRC2_XENLA reviewed Solute carrier family 49 member 4 homolog (Disrupted in renal carcinoma protein 2 homolog) Xenopus laevis (African clawed frog) GO:0005765; GO:0016020; GO:0022857; GO:0031923 pyridoxine transport [GO:0031923] lysosomal membrane [GO:0005765]; membrane [GO:0016020] transmembrane transporter activity [GO:0022857] g14578.t1 Q6GNV7 34.967 449 1.32e-69 233.0 sp|Q6GNV7|DIRC2_XENLA Solute carrier family 49 member 4 homolog OS=Xenopus laevis OX=8355 GN=slc49a4 PE=2 SV=1 DIRC2_XENLA reviewed Solute carrier family 49 member 4 homolog (Disrupted in renal carcinoma protein 2 homolog) Xenopus laevis (African clawed frog) GO:0005765; GO:0016020; GO:0022857; GO:0031923 pyridoxine transport [GO:0031923] lysosomal membrane [GO:0005765]; membrane [GO:0016020] transmembrane transporter activity [GO:0022857] g14581.t1 E9PTA2 42.57 249 9.14e-55 196.0 sp|E9PTA2|TRPM2_RAT Transient receptor potential cation channel subfamily M member 2 OS=Rattus norvegicus OX=10116 GN=Trpm2 PE=1 SV=3 TRPM2_RAT reviewed Transient receptor potential cation channel subfamily M member 2 Rattus norvegicus (Rat) GO:0001659; GO:0002407; GO:0005261; GO:0005272; GO:0005384; GO:0005509; GO:0005764; GO:0005765; GO:0005886; GO:0006828; GO:0009408; GO:0014074; GO:0015278; GO:0030659; GO:0032024; GO:0032956; GO:0033194; GO:0042995; GO:0043025; GO:0043204; GO:0044849; GO:0051209; GO:0051289; GO:0051489; GO:0070301; GO:0070588; GO:0071277; GO:0071502; GO:0071577; GO:0072571; GO:0097028; GO:0097553; GO:0098703; GO:0099604; GO:1900409 calcium ion import across plasma membrane [GO:0098703]; calcium ion transmembrane import into cytosol [GO:0097553]; calcium ion transmembrane transport [GO:0070588]; cellular response to calcium ion [GO:0071277]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to temperature stimulus [GO:0071502]; dendritic cell chemotaxis [GO:0002407]; dendritic cell differentiation [GO:0097028]; estrous cycle [GO:0044849]; manganese ion transport [GO:0006828]; positive regulation of cellular response to oxidative stress [GO:1900409]; positive regulation of insulin secretion [GO:0032024]; protein homotetramerization [GO:0051289]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of filopodium assembly [GO:0051489]; release of sequestered calcium ion into cytosol [GO:0051209]; response to heat [GO:0009408]; response to hydroperoxide [GO:0033194]; response to purine-containing compound [GO:0014074]; temperature homeostasis [GO:0001659]; zinc ion transmembrane transport [GO:0071577] cell projection [GO:0042995]; cytoplasmic vesicle membrane [GO:0030659]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; intracellularly gated calcium channel activity [GO:0015278]; ligand-gated calcium channel activity [GO:0099604]; manganese ion transmembrane transporter activity [GO:0005384]; mono-ADP-D-ribose binding [GO:0072571]; monoatomic cation channel activity [GO:0005261]; sodium channel activity [GO:0005272] g14582.t1 A7T1N0 33.364 1073 1.79e-157 509.0 sp|A7T1N0|TMP2L_NEMVE Transient receptor potential cation channel subfamily M member-like 2 OS=Nematostella vectensis OX=45351 GN=TRPM2 PE=1 SV=1 TMP2L_NEMVE reviewed Transient receptor potential cation channel subfamily M member-like 2 (nvTRPM2) Nematostella vectensis (Starlet sea anemone) GO:0005886; GO:0015280; GO:0035725; GO:0046872; GO:0047631; GO:0070588; GO:0099604 calcium ion transmembrane transport [GO:0070588]; sodium ion transmembrane transport [GO:0035725] plasma membrane [GO:0005886] ADP-ribose diphosphatase activity [GO:0047631]; ligand-gated calcium channel activity [GO:0099604]; ligand-gated sodium channel activity [GO:0015280]; metal ion binding [GO:0046872] g14583.t1 A7T1N0 66.839 193 3.55e-76 251.0 sp|A7T1N0|TMP2L_NEMVE Transient receptor potential cation channel subfamily M member-like 2 OS=Nematostella vectensis OX=45351 GN=TRPM2 PE=1 SV=1 TMP2L_NEMVE reviewed Transient receptor potential cation channel subfamily M member-like 2 (nvTRPM2) Nematostella vectensis (Starlet sea anemone) GO:0005886; GO:0015280; GO:0035725; GO:0046872; GO:0047631; GO:0070588; GO:0099604 calcium ion transmembrane transport [GO:0070588]; sodium ion transmembrane transport [GO:0035725] plasma membrane [GO:0005886] ADP-ribose diphosphatase activity [GO:0047631]; ligand-gated calcium channel activity [GO:0099604]; ligand-gated sodium channel activity [GO:0015280]; metal ion binding [GO:0046872] g14584.t1 A7T1N0 40.203 1577 0.0 1013.0 sp|A7T1N0|TMP2L_NEMVE Transient receptor potential cation channel subfamily M member-like 2 OS=Nematostella vectensis OX=45351 GN=TRPM2 PE=1 SV=1 TMP2L_NEMVE reviewed Transient receptor potential cation channel subfamily M member-like 2 (nvTRPM2) Nematostella vectensis (Starlet sea anemone) GO:0005886; GO:0015280; GO:0035725; GO:0046872; GO:0047631; GO:0070588; GO:0099604 calcium ion transmembrane transport [GO:0070588]; sodium ion transmembrane transport [GO:0035725] plasma membrane [GO:0005886] ADP-ribose diphosphatase activity [GO:0047631]; ligand-gated calcium channel activity [GO:0099604]; ligand-gated sodium channel activity [GO:0015280]; metal ion binding [GO:0046872] g14584.t2 A7T1N0 40.126 1590 0.0 1014.0 sp|A7T1N0|TMP2L_NEMVE Transient receptor potential cation channel subfamily M member-like 2 OS=Nematostella vectensis OX=45351 GN=TRPM2 PE=1 SV=1 TMP2L_NEMVE reviewed Transient receptor potential cation channel subfamily M member-like 2 (nvTRPM2) Nematostella vectensis (Starlet sea anemone) GO:0005886; GO:0015280; GO:0035725; GO:0046872; GO:0047631; GO:0070588; GO:0099604 calcium ion transmembrane transport [GO:0070588]; sodium ion transmembrane transport [GO:0035725] plasma membrane [GO:0005886] ADP-ribose diphosphatase activity [GO:0047631]; ligand-gated calcium channel activity [GO:0099604]; ligand-gated sodium channel activity [GO:0015280]; metal ion binding [GO:0046872] g14586.t1 P31937 72.961 233 1.7900000000000002e-124 359.0 sp|P31937|3HIDH_HUMAN 3-hydroxyisobutyrate dehydrogenase, mitochondrial OS=Homo sapiens OX=9606 GN=HIBADH PE=1 SV=2 3HIDH_HUMAN reviewed 3-hydroxyisobutyrate dehydrogenase, mitochondrial (HIBADH) (EC 1.1.1.31) Homo sapiens (Human) GO:0005739; GO:0005759; GO:0006574; GO:0008442; GO:0050661; GO:0051287 L-valine catabolic process [GO:0006574] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] 3-hydroxyisobutyrate dehydrogenase activity [GO:0008442]; NAD binding [GO:0051287]; NADP binding [GO:0050661] g14587.t1 Q9C0E8 42.994 314 8.21e-68 222.0 sp|Q9C0E8|LNP_HUMAN Endoplasmic reticulum junction formation protein lunapark OS=Homo sapiens OX=9606 GN=LNPK PE=1 SV=2 LNP_HUMAN reviewed Endoplasmic reticulum junction formation protein lunapark (ER junction formation factor lunapark) Homo sapiens (Human) GO:0005654; GO:0005783; GO:0005789; GO:0007029; GO:0007596; GO:0008270; GO:0016020; GO:0032330; GO:0035115; GO:0042733; GO:0042802; GO:0060173; GO:0071782; GO:0071786; GO:0071788; GO:0097225; GO:0097228; GO:0097229; GO:0098826; GO:0120212; GO:1903373 blood coagulation [GO:0007596]; embryonic digit morphogenesis [GO:0042733]; embryonic forelimb morphogenesis [GO:0035115]; endoplasmic reticulum organization [GO:0007029]; endoplasmic reticulum tubular network maintenance [GO:0071788]; endoplasmic reticulum tubular network organization [GO:0071786]; limb development [GO:0060173]; positive regulation of endoplasmic reticulum tubular network organization [GO:1903373]; regulation of chondrocyte differentiation [GO:0032330] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum tubular network [GO:0071782]; endoplasmic reticulum tubular network membrane [GO:0098826]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; sperm end piece [GO:0097229]; sperm head-tail coupling apparatus [GO:0120212]; sperm midpiece [GO:0097225]; sperm principal piece [GO:0097228] identical protein binding [GO:0042802]; zinc ion binding [GO:0008270] g14588.t1 Q14696 59.441 143 8.39e-42 143.0 sp|Q14696|MESD_HUMAN LRP chaperone MESD OS=Homo sapiens OX=9606 GN=MESD PE=1 SV=2 MESD_HUMAN reviewed LRP chaperone MESD (LDLR chaperone MESD) (Mesoderm development LRP chaperone MESD) (Mesoderm development candidate 2) (Mesoderm development protein) (Renal carcinoma antigen NY-REN-61) Homo sapiens (Human) GO:0001503; GO:0005783; GO:0005886; GO:0006457; GO:0006909; GO:0007498; GO:0016055; GO:0030177; GO:0034394; GO:0042802; GO:0044183; GO:0050750; GO:0072659; GO:1904395 mesoderm development [GO:0007498]; ossification [GO:0001503]; phagocytosis [GO:0006909]; positive regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904395]; positive regulation of Wnt signaling pathway [GO:0030177]; protein folding [GO:0006457]; protein localization to cell surface [GO:0034394]; protein localization to plasma membrane [GO:0072659]; Wnt signaling pathway [GO:0016055] endoplasmic reticulum [GO:0005783]; plasma membrane [GO:0005886] identical protein binding [GO:0042802]; low-density lipoprotein particle receptor binding [GO:0050750]; protein folding chaperone [GO:0044183] g14589.t1 Q60520 55.959 193 8.22e-62 219.0 sp|Q60520|SIN3A_MOUSE Paired amphipathic helix protein Sin3a OS=Mus musculus OX=10090 GN=Sin3a PE=1 SV=3 SIN3A_MOUSE reviewed Paired amphipathic helix protein Sin3a (Histone deacetylase complex subunit Sin3a) (Transcriptional corepressor Sin3a) Mus musculus (Mouse) GO:0000118; GO:0000122; GO:0000776; GO:0000785; GO:0001701; GO:0002218; GO:0002230; GO:0002244; GO:0003677; GO:0003682; GO:0003714; GO:0003723; GO:0005634; GO:0005654; GO:0005667; GO:0005730; GO:0006260; GO:0006355; GO:0008104; GO:0010817; GO:0010971; GO:0017053; GO:0021895; GO:0030336; GO:0030512; GO:0030516; GO:0031507; GO:0032991; GO:0042754; GO:0043066; GO:0044877; GO:0045666; GO:0045892; GO:0048511; GO:0051595; GO:0060337; GO:0061629; GO:0070822; GO:0071333; GO:0072736; GO:0140416; GO:1900181; GO:1902455; GO:1902459; GO:1903351 activation of innate immune response [GO:0002218]; cellular response to dopamine [GO:1903351]; cellular response to glucose stimulus [GO:0071333]; cellular response to tert-butyl hydroperoxide [GO:0072736]; cerebral cortex neuron differentiation [GO:0021895]; DNA replication [GO:0006260]; hematopoietic progenitor cell differentiation [GO:0002244]; heterochromatin formation [GO:0031507]; in utero embryonic development [GO:0001701]; intracellular protein localization [GO:0008104]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell migration [GO:0030336]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of protein localization to nucleus [GO:1900181]; negative regulation of stem cell population maintenance [GO:1902455]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of stem cell population maintenance [GO:1902459]; regulation of axon extension [GO:0030516]; regulation of DNA-templated transcription [GO:0006355]; regulation of hormone levels [GO:0010817]; response to methylglyoxal [GO:0051595]; rhythmic process [GO:0048511]; type I interferon-mediated signaling pathway [GO:0060337] chromatin [GO:0000785]; histone deacetylase complex [GO:0000118]; kinetochore [GO:0000776]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; Sin3-type complex [GO:0070822]; transcription regulator complex [GO:0005667]; transcription repressor complex [GO:0017053] chromatin binding [GO:0003682]; DNA binding [GO:0003677]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription corepressor activity [GO:0003714]; transcription regulator inhibitor activity [GO:0140416] g14589.t1 Q60520 51.613 93 1.96e-25 112.0 sp|Q60520|SIN3A_MOUSE Paired amphipathic helix protein Sin3a OS=Mus musculus OX=10090 GN=Sin3a PE=1 SV=3 SIN3A_MOUSE reviewed Paired amphipathic helix protein Sin3a (Histone deacetylase complex subunit Sin3a) (Transcriptional corepressor Sin3a) Mus musculus (Mouse) GO:0000118; GO:0000122; GO:0000776; GO:0000785; GO:0001701; GO:0002218; GO:0002230; GO:0002244; GO:0003677; GO:0003682; GO:0003714; GO:0003723; GO:0005634; GO:0005654; GO:0005667; GO:0005730; GO:0006260; GO:0006355; GO:0008104; GO:0010817; GO:0010971; GO:0017053; GO:0021895; GO:0030336; GO:0030512; GO:0030516; GO:0031507; GO:0032991; GO:0042754; GO:0043066; GO:0044877; GO:0045666; GO:0045892; GO:0048511; GO:0051595; GO:0060337; GO:0061629; GO:0070822; GO:0071333; GO:0072736; GO:0140416; GO:1900181; GO:1902455; GO:1902459; GO:1903351 activation of innate immune response [GO:0002218]; cellular response to dopamine [GO:1903351]; cellular response to glucose stimulus [GO:0071333]; cellular response to tert-butyl hydroperoxide [GO:0072736]; cerebral cortex neuron differentiation [GO:0021895]; DNA replication [GO:0006260]; hematopoietic progenitor cell differentiation [GO:0002244]; heterochromatin formation [GO:0031507]; in utero embryonic development [GO:0001701]; intracellular protein localization [GO:0008104]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell migration [GO:0030336]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of protein localization to nucleus [GO:1900181]; negative regulation of stem cell population maintenance [GO:1902455]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of stem cell population maintenance [GO:1902459]; regulation of axon extension [GO:0030516]; regulation of DNA-templated transcription [GO:0006355]; regulation of hormone levels [GO:0010817]; response to methylglyoxal [GO:0051595]; rhythmic process [GO:0048511]; type I interferon-mediated signaling pathway [GO:0060337] chromatin [GO:0000785]; histone deacetylase complex [GO:0000118]; kinetochore [GO:0000776]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; Sin3-type complex [GO:0070822]; transcription regulator complex [GO:0005667]; transcription repressor complex [GO:0017053] chromatin binding [GO:0003682]; DNA binding [GO:0003677]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription corepressor activity [GO:0003714]; transcription regulator inhibitor activity [GO:0140416] g14590.t1 Q60520 65.084 358 1.0200000000000001e-161 488.0 sp|Q60520|SIN3A_MOUSE Paired amphipathic helix protein Sin3a OS=Mus musculus OX=10090 GN=Sin3a PE=1 SV=3 SIN3A_MOUSE reviewed Paired amphipathic helix protein Sin3a (Histone deacetylase complex subunit Sin3a) (Transcriptional corepressor Sin3a) Mus musculus (Mouse) GO:0000118; GO:0000122; GO:0000776; GO:0000785; GO:0001701; GO:0002218; GO:0002230; GO:0002244; GO:0003677; GO:0003682; GO:0003714; GO:0003723; GO:0005634; GO:0005654; GO:0005667; GO:0005730; GO:0006260; GO:0006355; GO:0008104; GO:0010817; GO:0010971; GO:0017053; GO:0021895; GO:0030336; GO:0030512; GO:0030516; GO:0031507; GO:0032991; GO:0042754; GO:0043066; GO:0044877; GO:0045666; GO:0045892; GO:0048511; GO:0051595; GO:0060337; GO:0061629; GO:0070822; GO:0071333; GO:0072736; GO:0140416; GO:1900181; GO:1902455; GO:1902459; GO:1903351 activation of innate immune response [GO:0002218]; cellular response to dopamine [GO:1903351]; cellular response to glucose stimulus [GO:0071333]; cellular response to tert-butyl hydroperoxide [GO:0072736]; cerebral cortex neuron differentiation [GO:0021895]; DNA replication [GO:0006260]; hematopoietic progenitor cell differentiation [GO:0002244]; heterochromatin formation [GO:0031507]; in utero embryonic development [GO:0001701]; intracellular protein localization [GO:0008104]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell migration [GO:0030336]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of protein localization to nucleus [GO:1900181]; negative regulation of stem cell population maintenance [GO:1902455]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of stem cell population maintenance [GO:1902459]; regulation of axon extension [GO:0030516]; regulation of DNA-templated transcription [GO:0006355]; regulation of hormone levels [GO:0010817]; response to methylglyoxal [GO:0051595]; rhythmic process [GO:0048511]; type I interferon-mediated signaling pathway [GO:0060337] chromatin [GO:0000785]; histone deacetylase complex [GO:0000118]; kinetochore [GO:0000776]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; Sin3-type complex [GO:0070822]; transcription regulator complex [GO:0005667]; transcription repressor complex [GO:0017053] chromatin binding [GO:0003682]; DNA binding [GO:0003677]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription corepressor activity [GO:0003714]; transcription regulator inhibitor activity [GO:0140416] g14591.t1 Q60520 57.692 182 2.29e-64 195.0 sp|Q60520|SIN3A_MOUSE Paired amphipathic helix protein Sin3a OS=Mus musculus OX=10090 GN=Sin3a PE=1 SV=3 SIN3A_MOUSE reviewed Paired amphipathic helix protein Sin3a (Histone deacetylase complex subunit Sin3a) (Transcriptional corepressor Sin3a) Mus musculus (Mouse) GO:0000118; GO:0000122; GO:0000776; GO:0000785; GO:0001701; GO:0002218; GO:0002230; GO:0002244; GO:0003677; GO:0003682; GO:0003714; GO:0003723; GO:0005634; GO:0005654; GO:0005667; GO:0005730; GO:0006260; GO:0006355; GO:0008104; GO:0010817; GO:0010971; GO:0017053; GO:0021895; GO:0030336; GO:0030512; GO:0030516; GO:0031507; GO:0032991; GO:0042754; GO:0043066; GO:0044877; GO:0045666; GO:0045892; GO:0048511; GO:0051595; GO:0060337; GO:0061629; GO:0070822; GO:0071333; GO:0072736; GO:0140416; GO:1900181; GO:1902455; GO:1902459; GO:1903351 activation of innate immune response [GO:0002218]; cellular response to dopamine [GO:1903351]; cellular response to glucose stimulus [GO:0071333]; cellular response to tert-butyl hydroperoxide [GO:0072736]; cerebral cortex neuron differentiation [GO:0021895]; DNA replication [GO:0006260]; hematopoietic progenitor cell differentiation [GO:0002244]; heterochromatin formation [GO:0031507]; in utero embryonic development [GO:0001701]; intracellular protein localization [GO:0008104]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell migration [GO:0030336]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of protein localization to nucleus [GO:1900181]; negative regulation of stem cell population maintenance [GO:1902455]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of stem cell population maintenance [GO:1902459]; regulation of axon extension [GO:0030516]; regulation of DNA-templated transcription [GO:0006355]; regulation of hormone levels [GO:0010817]; response to methylglyoxal [GO:0051595]; rhythmic process [GO:0048511]; type I interferon-mediated signaling pathway [GO:0060337] chromatin [GO:0000785]; histone deacetylase complex [GO:0000118]; kinetochore [GO:0000776]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; Sin3-type complex [GO:0070822]; transcription regulator complex [GO:0005667]; transcription repressor complex [GO:0017053] chromatin binding [GO:0003682]; DNA binding [GO:0003677]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription corepressor activity [GO:0003714]; transcription regulator inhibitor activity [GO:0140416] g14591.t1 Q60520 81.579 38 2.29e-64 74.3 sp|Q60520|SIN3A_MOUSE Paired amphipathic helix protein Sin3a OS=Mus musculus OX=10090 GN=Sin3a PE=1 SV=3 SIN3A_MOUSE reviewed Paired amphipathic helix protein Sin3a (Histone deacetylase complex subunit Sin3a) (Transcriptional corepressor Sin3a) Mus musculus (Mouse) GO:0000118; GO:0000122; GO:0000776; GO:0000785; GO:0001701; GO:0002218; GO:0002230; GO:0002244; GO:0003677; GO:0003682; GO:0003714; GO:0003723; GO:0005634; GO:0005654; GO:0005667; GO:0005730; GO:0006260; GO:0006355; GO:0008104; GO:0010817; GO:0010971; GO:0017053; GO:0021895; GO:0030336; GO:0030512; GO:0030516; GO:0031507; GO:0032991; GO:0042754; GO:0043066; GO:0044877; GO:0045666; GO:0045892; GO:0048511; GO:0051595; GO:0060337; GO:0061629; GO:0070822; GO:0071333; GO:0072736; GO:0140416; GO:1900181; GO:1902455; GO:1902459; GO:1903351 activation of innate immune response [GO:0002218]; cellular response to dopamine [GO:1903351]; cellular response to glucose stimulus [GO:0071333]; cellular response to tert-butyl hydroperoxide [GO:0072736]; cerebral cortex neuron differentiation [GO:0021895]; DNA replication [GO:0006260]; hematopoietic progenitor cell differentiation [GO:0002244]; heterochromatin formation [GO:0031507]; in utero embryonic development [GO:0001701]; intracellular protein localization [GO:0008104]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell migration [GO:0030336]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of protein localization to nucleus [GO:1900181]; negative regulation of stem cell population maintenance [GO:1902455]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of stem cell population maintenance [GO:1902459]; regulation of axon extension [GO:0030516]; regulation of DNA-templated transcription [GO:0006355]; regulation of hormone levels [GO:0010817]; response to methylglyoxal [GO:0051595]; rhythmic process [GO:0048511]; type I interferon-mediated signaling pathway [GO:0060337] chromatin [GO:0000785]; histone deacetylase complex [GO:0000118]; kinetochore [GO:0000776]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; Sin3-type complex [GO:0070822]; transcription regulator complex [GO:0005667]; transcription repressor complex [GO:0017053] chromatin binding [GO:0003682]; DNA binding [GO:0003677]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription corepressor activity [GO:0003714]; transcription regulator inhibitor activity [GO:0140416] g14591.t1 Q60520 88.636 88 1.82e-41 164.0 sp|Q60520|SIN3A_MOUSE Paired amphipathic helix protein Sin3a OS=Mus musculus OX=10090 GN=Sin3a PE=1 SV=3 SIN3A_MOUSE reviewed Paired amphipathic helix protein Sin3a (Histone deacetylase complex subunit Sin3a) (Transcriptional corepressor Sin3a) Mus musculus (Mouse) GO:0000118; GO:0000122; GO:0000776; GO:0000785; GO:0001701; GO:0002218; GO:0002230; GO:0002244; GO:0003677; GO:0003682; GO:0003714; GO:0003723; GO:0005634; GO:0005654; GO:0005667; GO:0005730; GO:0006260; GO:0006355; GO:0008104; GO:0010817; GO:0010971; GO:0017053; GO:0021895; GO:0030336; GO:0030512; GO:0030516; GO:0031507; GO:0032991; GO:0042754; GO:0043066; GO:0044877; GO:0045666; GO:0045892; GO:0048511; GO:0051595; GO:0060337; GO:0061629; GO:0070822; GO:0071333; GO:0072736; GO:0140416; GO:1900181; GO:1902455; GO:1902459; GO:1903351 activation of innate immune response [GO:0002218]; cellular response to dopamine [GO:1903351]; cellular response to glucose stimulus [GO:0071333]; cellular response to tert-butyl hydroperoxide [GO:0072736]; cerebral cortex neuron differentiation [GO:0021895]; DNA replication [GO:0006260]; hematopoietic progenitor cell differentiation [GO:0002244]; heterochromatin formation [GO:0031507]; in utero embryonic development [GO:0001701]; intracellular protein localization [GO:0008104]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell migration [GO:0030336]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of protein localization to nucleus [GO:1900181]; negative regulation of stem cell population maintenance [GO:1902455]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of stem cell population maintenance [GO:1902459]; regulation of axon extension [GO:0030516]; regulation of DNA-templated transcription [GO:0006355]; regulation of hormone levels [GO:0010817]; response to methylglyoxal [GO:0051595]; rhythmic process [GO:0048511]; type I interferon-mediated signaling pathway [GO:0060337] chromatin [GO:0000785]; histone deacetylase complex [GO:0000118]; kinetochore [GO:0000776]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; Sin3-type complex [GO:0070822]; transcription regulator complex [GO:0005667]; transcription repressor complex [GO:0017053] chromatin binding [GO:0003682]; DNA binding [GO:0003677]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription corepressor activity [GO:0003714]; transcription regulator inhibitor activity [GO:0140416] g14592.t1 Q6DCH7 70.913 471 0.0 707.0 sp|Q6DCH7|SBP1B_XENLA Methanethiol oxidase OS=Xenopus laevis OX=8355 GN=selenbp1-b PE=2 SV=1 SBP1B_XENLA reviewed Methanethiol oxidase (MTO) (EC 1.8.3.4) (Selenium-binding protein 1-B) Xenopus laevis (African clawed frog) GO:0005634; GO:0005829; GO:0008430; GO:0015031; GO:0016020; GO:0018549 protein transport [GO:0015031] cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634] methanethiol oxidase activity [GO:0018549]; selenium binding [GO:0008430] g14593.t1 P04058 37.121 528 1.8499999999999998e-98 315.0 sp|P04058|ACES_TETCF Acetylcholinesterase OS=Tetronarce californica OX=7787 GN=ache PE=1 SV=2 g14594.t1 P81908 31.897 580 3.0399999999999997e-89 291.0 sp|P81908|CHLE_HORSE Cholinesterase OS=Equus caballus OX=9796 GN=BCHE PE=1 SV=1 g14595.t1 Q92035 34.69 565 7.77e-103 326.0 sp|Q92035|ACES_BUNFA Acetylcholinesterase OS=Bungarus fasciatus OX=8613 GN=ACHE PE=1 SV=2 g14596.t1 P81908 31.882 574 2.1e-96 309.0 sp|P81908|CHLE_HORSE Cholinesterase OS=Equus caballus OX=9796 GN=BCHE PE=1 SV=1 g14598.t1 P81908 34.722 576 4.94e-109 342.0 sp|P81908|CHLE_HORSE Cholinesterase OS=Equus caballus OX=9796 GN=BCHE PE=1 SV=1 g14600.t1 Q869C3 37.44 414 6.82e-81 268.0 sp|Q869C3|ACES_ANOGA Acetylcholinesterase OS=Anopheles gambiae OX=7165 GN=Ace PE=1 SV=3 g14601.t1 P21836 36.348 575 2.81e-108 342.0 sp|P21836|ACES_MOUSE Acetylcholinesterase OS=Mus musculus OX=10090 GN=Ache PE=1 SV=1 ACES_MOUSE reviewed Acetylcholinesterase (AChE) (EC 3.1.1.7) Mus musculus (Mouse) GO:0001919; GO:0002076; GO:0003990; GO:0004104; GO:0005518; GO:0005576; GO:0005604; GO:0005615; GO:0005635; GO:0005788; GO:0005794; GO:0005886; GO:0006581; GO:0007155; GO:0007416; GO:0008291; GO:0009986; GO:0016020; GO:0016787; GO:0017171; GO:0019695; GO:0030424; GO:0030425; GO:0031594; GO:0031623; GO:0032868; GO:0042166; GO:0042734; GO:0042802; GO:0042803; GO:0043025; GO:0043083; GO:0043236; GO:0045121; GO:0045202; GO:0045211; GO:0048471; GO:0050772; GO:0050775; GO:0060041; GO:0095500; GO:0098552; GO:0120162 acetylcholine catabolic process [GO:0006581]; acetylcholine metabolic process [GO:0008291]; acetylcholine receptor signaling pathway [GO:0095500]; cell adhesion [GO:0007155]; choline metabolic process [GO:0019695]; osteoblast development [GO:0002076]; positive regulation of axonogenesis [GO:0050772]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of dendrite morphogenesis [GO:0050775]; receptor internalization [GO:0031623]; regulation of receptor recycling [GO:0001919]; response to insulin [GO:0032868]; retina development in camera-type eye [GO:0060041]; synapse assembly [GO:0007416] axon [GO:0030424]; basement membrane [GO:0005604]; cell surface [GO:0009986]; dendrite [GO:0030425]; endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; membrane raft [GO:0045121]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; nuclear envelope [GO:0005635]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; side of membrane [GO:0098552]; synapse [GO:0045202]; synaptic cleft [GO:0043083] acetylcholine binding [GO:0042166]; acetylcholinesterase activity [GO:0003990]; cholinesterase activity [GO:0004104]; collagen binding [GO:0005518]; hydrolase activity [GO:0016787]; identical protein binding [GO:0042802]; laminin binding [GO:0043236]; protein homodimerization activity [GO:0042803]; serine hydrolase activity [GO:0017171] g14602.t1 P21836 33.622 577 1.87e-93 303.0 sp|P21836|ACES_MOUSE Acetylcholinesterase OS=Mus musculus OX=10090 GN=Ache PE=1 SV=1 ACES_MOUSE reviewed Acetylcholinesterase (AChE) (EC 3.1.1.7) Mus musculus (Mouse) GO:0001919; GO:0002076; GO:0003990; GO:0004104; GO:0005518; GO:0005576; GO:0005604; GO:0005615; GO:0005635; GO:0005788; GO:0005794; GO:0005886; GO:0006581; GO:0007155; GO:0007416; GO:0008291; GO:0009986; GO:0016020; GO:0016787; GO:0017171; GO:0019695; GO:0030424; GO:0030425; GO:0031594; GO:0031623; GO:0032868; GO:0042166; GO:0042734; GO:0042802; GO:0042803; GO:0043025; GO:0043083; GO:0043236; GO:0045121; GO:0045202; GO:0045211; GO:0048471; GO:0050772; GO:0050775; GO:0060041; GO:0095500; GO:0098552; GO:0120162 acetylcholine catabolic process [GO:0006581]; acetylcholine metabolic process [GO:0008291]; acetylcholine receptor signaling pathway [GO:0095500]; cell adhesion [GO:0007155]; choline metabolic process [GO:0019695]; osteoblast development [GO:0002076]; positive regulation of axonogenesis [GO:0050772]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of dendrite morphogenesis [GO:0050775]; receptor internalization [GO:0031623]; regulation of receptor recycling [GO:0001919]; response to insulin [GO:0032868]; retina development in camera-type eye [GO:0060041]; synapse assembly [GO:0007416] axon [GO:0030424]; basement membrane [GO:0005604]; cell surface [GO:0009986]; dendrite [GO:0030425]; endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; membrane raft [GO:0045121]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; nuclear envelope [GO:0005635]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; side of membrane [GO:0098552]; synapse [GO:0045202]; synaptic cleft [GO:0043083] acetylcholine binding [GO:0042166]; acetylcholinesterase activity [GO:0003990]; cholinesterase activity [GO:0004104]; collagen binding [GO:0005518]; hydrolase activity [GO:0016787]; identical protein binding [GO:0042802]; laminin binding [GO:0043236]; protein homodimerization activity [GO:0042803]; serine hydrolase activity [GO:0017171] g14603.t1 P21836 36.691 139 2.0600000000000001e-22 95.5 sp|P21836|ACES_MOUSE Acetylcholinesterase OS=Mus musculus OX=10090 GN=Ache PE=1 SV=1 ACES_MOUSE reviewed Acetylcholinesterase (AChE) (EC 3.1.1.7) Mus musculus (Mouse) GO:0001919; GO:0002076; GO:0003990; GO:0004104; GO:0005518; GO:0005576; GO:0005604; GO:0005615; GO:0005635; GO:0005788; GO:0005794; GO:0005886; GO:0006581; GO:0007155; GO:0007416; GO:0008291; GO:0009986; GO:0016020; GO:0016787; GO:0017171; GO:0019695; GO:0030424; GO:0030425; GO:0031594; GO:0031623; GO:0032868; GO:0042166; GO:0042734; GO:0042802; GO:0042803; GO:0043025; GO:0043083; GO:0043236; GO:0045121; GO:0045202; GO:0045211; GO:0048471; GO:0050772; GO:0050775; GO:0060041; GO:0095500; GO:0098552; GO:0120162 acetylcholine catabolic process [GO:0006581]; acetylcholine metabolic process [GO:0008291]; acetylcholine receptor signaling pathway [GO:0095500]; cell adhesion [GO:0007155]; choline metabolic process [GO:0019695]; osteoblast development [GO:0002076]; positive regulation of axonogenesis [GO:0050772]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of dendrite morphogenesis [GO:0050775]; receptor internalization [GO:0031623]; regulation of receptor recycling [GO:0001919]; response to insulin [GO:0032868]; retina development in camera-type eye [GO:0060041]; synapse assembly [GO:0007416] axon [GO:0030424]; basement membrane [GO:0005604]; cell surface [GO:0009986]; dendrite [GO:0030425]; endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; membrane raft [GO:0045121]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; nuclear envelope [GO:0005635]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; side of membrane [GO:0098552]; synapse [GO:0045202]; synaptic cleft [GO:0043083] acetylcholine binding [GO:0042166]; acetylcholinesterase activity [GO:0003990]; cholinesterase activity [GO:0004104]; collagen binding [GO:0005518]; hydrolase activity [GO:0016787]; identical protein binding [GO:0042802]; laminin binding [GO:0043236]; protein homodimerization activity [GO:0042803]; serine hydrolase activity [GO:0017171] g14604.t1 O62760 37.176 347 1.86e-67 228.0 sp|O62760|CHLE_FELCA Cholinesterase OS=Felis catus OX=9685 GN=BCHE PE=2 SV=1 g14605.t1 P21836 35.327 535 9.269999999999999e-95 305.0 sp|P21836|ACES_MOUSE Acetylcholinesterase OS=Mus musculus OX=10090 GN=Ache PE=1 SV=1 ACES_MOUSE reviewed Acetylcholinesterase (AChE) (EC 3.1.1.7) Mus musculus (Mouse) GO:0001919; GO:0002076; GO:0003990; GO:0004104; GO:0005518; GO:0005576; GO:0005604; GO:0005615; GO:0005635; GO:0005788; GO:0005794; GO:0005886; GO:0006581; GO:0007155; GO:0007416; GO:0008291; GO:0009986; GO:0016020; GO:0016787; GO:0017171; GO:0019695; GO:0030424; GO:0030425; GO:0031594; GO:0031623; GO:0032868; GO:0042166; GO:0042734; GO:0042802; GO:0042803; GO:0043025; GO:0043083; GO:0043236; GO:0045121; GO:0045202; GO:0045211; GO:0048471; GO:0050772; GO:0050775; GO:0060041; GO:0095500; GO:0098552; GO:0120162 acetylcholine catabolic process [GO:0006581]; acetylcholine metabolic process [GO:0008291]; acetylcholine receptor signaling pathway [GO:0095500]; cell adhesion [GO:0007155]; choline metabolic process [GO:0019695]; osteoblast development [GO:0002076]; positive regulation of axonogenesis [GO:0050772]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of dendrite morphogenesis [GO:0050775]; receptor internalization [GO:0031623]; regulation of receptor recycling [GO:0001919]; response to insulin [GO:0032868]; retina development in camera-type eye [GO:0060041]; synapse assembly [GO:0007416] axon [GO:0030424]; basement membrane [GO:0005604]; cell surface [GO:0009986]; dendrite [GO:0030425]; endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; membrane raft [GO:0045121]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; nuclear envelope [GO:0005635]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; side of membrane [GO:0098552]; synapse [GO:0045202]; synaptic cleft [GO:0043083] acetylcholine binding [GO:0042166]; acetylcholinesterase activity [GO:0003990]; cholinesterase activity [GO:0004104]; collagen binding [GO:0005518]; hydrolase activity [GO:0016787]; identical protein binding [GO:0042802]; laminin binding [GO:0043236]; protein homodimerization activity [GO:0042803]; serine hydrolase activity [GO:0017171] g14606.t1 P81908 35.622 539 2.11e-84 278.0 sp|P81908|CHLE_HORSE Cholinesterase OS=Equus caballus OX=9796 GN=BCHE PE=1 SV=1 g14607.t1 Q5NVK7 81.163 361 0.0 596.0 sp|Q5NVK7|SPOP_PONAB Speckle-type POZ protein OS=Pongo abelii OX=9601 GN=SPOP PE=2 SV=1 g14607.t2 Q5NVK7 80.939 362 0.0 592.0 sp|Q5NVK7|SPOP_PONAB Speckle-type POZ protein OS=Pongo abelii OX=9601 GN=SPOP PE=2 SV=1 g14608.t1 Q5U3W3 35.747 442 2.9e-61 211.0 sp|Q5U3W3|RUN3B_DANRE RUN domain-containing protein 3B OS=Danio rerio OX=7955 GN=rundc3b PE=2 SV=1 g14610.t1 Q9D4H9 68.293 123 1.12e-45 174.0 sp|Q9D4H9|PHF14_MOUSE PHD finger protein 14 OS=Mus musculus OX=10090 GN=Phf14 PE=1 SV=2 PHF14_MOUSE reviewed PHD finger protein 14 Mus musculus (Mouse) GO:0000122; GO:0000785; GO:0002314; GO:0005634; GO:0005737; GO:0006357; GO:0008270; GO:0008285; GO:0042393; GO:0048286; GO:0072201; GO:0140566; GO:2000584; GO:2000791 germinal center B cell differentiation [GO:0002314]; lung alveolus development [GO:0048286]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of mesenchymal cell proliferation [GO:0072201]; negative regulation of mesenchymal cell proliferation involved in lung development [GO:2000791]; negative regulation of platelet-derived growth factor receptor-alpha signaling pathway [GO:2000584]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleus [GO:0005634] histone binding [GO:0042393]; histone reader activity [GO:0140566]; zinc ion binding [GO:0008270] g14612.t1 P14618 64.217 517 0.0 681.0 sp|P14618|KPYM_HUMAN Pyruvate kinase PKM OS=Homo sapiens OX=9606 GN=PKM PE=1 SV=4 KPYM_HUMAN reviewed Pyruvate kinase PKM (EC 2.7.1.40) (Cytosolic thyroid hormone-binding protein) (CTHBP) (Opa-interacting protein 3) (OIP-3) (Pyruvate kinase 2/3) (Pyruvate kinase muscle isozyme) (Threonine-protein kinase PKM2) (EC 2.7.11.1) (Thyroid hormone-binding protein 1) (THBP1) (Tumor M2-PK) (Tyrosine-protein kinase PKM2) (EC 2.7.10.2) (p58) Homo sapiens (Human) GO:0000287; GO:0003713; GO:0003723; GO:0003729; GO:0004674; GO:0004713; GO:0004715; GO:0004743; GO:0005524; GO:0005576; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005791; GO:0005829; GO:0006096; GO:0012501; GO:0023026; GO:0030955; GO:0031982; GO:0032869; GO:0034774; GO:0035402; GO:0042803; GO:0045296; GO:0045944; GO:0061621; GO:0070062; GO:0097228; GO:1903561; GO:1903672; GO:1904813; GO:2000767 canonical glycolysis [GO:0061621]; cellular response to insulin stimulus [GO:0032869]; glycolytic process [GO:0006096]; positive regulation of cytoplasmic translation [GO:2000767]; positive regulation of sprouting angiogenesis [GO:1903672]; positive regulation of transcription by RNA polymerase II [GO:0045944]; programmed cell death [GO:0012501] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular vesicle [GO:1903561]; ficolin-1-rich granule lumen [GO:1904813]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; rough endoplasmic reticulum [GO:0005791]; secretory granule lumen [GO:0034774]; sperm principal piece [GO:0097228]; vesicle [GO:0031982] ATP binding [GO:0005524]; cadherin binding [GO:0045296]; histone H3T11 kinase activity [GO:0035402]; magnesium ion binding [GO:0000287]; MHC class II protein complex binding [GO:0023026]; mRNA binding [GO:0003729]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; potassium ion binding [GO:0030955]; protein homodimerization activity [GO:0042803]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; pyruvate kinase activity [GO:0004743]; RNA binding [GO:0003723]; transcription coactivator activity [GO:0003713] g14613.t1 Q6NS52 64.544 691 0.0 941.0 sp|Q6NS52|DGKB_MOUSE Diacylglycerol kinase beta OS=Mus musculus OX=10090 GN=Dgkb PE=1 SV=2 DGKB_MOUSE reviewed Diacylglycerol kinase beta (DAG kinase beta) (EC 2.7.1.107) (Diglyceride kinase beta) (DGK-beta) Mus musculus (Mouse) GO:0004143; GO:0005509; GO:0005524; GO:0005654; GO:0005829; GO:0005886; GO:0006654; GO:0007200; GO:0008270; GO:0008289; GO:0009617; GO:0016607; GO:0035556; GO:0046339; GO:0046473; GO:0046486; GO:0046834; GO:0050804; GO:0098685; GO:0098978; GO:0099147; GO:0099175 diacylglycerol metabolic process [GO:0046339]; glycerolipid metabolic process [GO:0046486]; intracellular signal transduction [GO:0035556]; lipid phosphorylation [GO:0046834]; modulation of chemical synaptic transmission [GO:0050804]; phosphatidic acid biosynthetic process [GO:0006654]; phosphatidic acid metabolic process [GO:0046473]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; regulation of postsynapse organization [GO:0099175]; response to bacterium [GO:0009617] cytosol [GO:0005829]; extrinsic component of postsynaptic density membrane [GO:0099147]; glutamatergic synapse [GO:0098978]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; Schaffer collateral - CA1 synapse [GO:0098685] ATP binding [GO:0005524]; ATP-dependent diacylglycerol kinase activity [GO:0004143]; calcium ion binding [GO:0005509]; lipid binding [GO:0008289]; zinc ion binding [GO:0008270] g14613.t1 Q6NS52 57.471 87 2.32e-22 107.0 sp|Q6NS52|DGKB_MOUSE Diacylglycerol kinase beta OS=Mus musculus OX=10090 GN=Dgkb PE=1 SV=2 DGKB_MOUSE reviewed Diacylglycerol kinase beta (DAG kinase beta) (EC 2.7.1.107) (Diglyceride kinase beta) (DGK-beta) Mus musculus (Mouse) GO:0004143; GO:0005509; GO:0005524; GO:0005654; GO:0005829; GO:0005886; GO:0006654; GO:0007200; GO:0008270; GO:0008289; GO:0009617; GO:0016607; GO:0035556; GO:0046339; GO:0046473; GO:0046486; GO:0046834; GO:0050804; GO:0098685; GO:0098978; GO:0099147; GO:0099175 diacylglycerol metabolic process [GO:0046339]; glycerolipid metabolic process [GO:0046486]; intracellular signal transduction [GO:0035556]; lipid phosphorylation [GO:0046834]; modulation of chemical synaptic transmission [GO:0050804]; phosphatidic acid biosynthetic process [GO:0006654]; phosphatidic acid metabolic process [GO:0046473]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; regulation of postsynapse organization [GO:0099175]; response to bacterium [GO:0009617] cytosol [GO:0005829]; extrinsic component of postsynaptic density membrane [GO:0099147]; glutamatergic synapse [GO:0098978]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; Schaffer collateral - CA1 synapse [GO:0098685] ATP binding [GO:0005524]; ATP-dependent diacylglycerol kinase activity [GO:0004143]; calcium ion binding [GO:0005509]; lipid binding [GO:0008289]; zinc ion binding [GO:0008270] g14613.t2 Q6NS52 64.544 691 0.0 941.0 sp|Q6NS52|DGKB_MOUSE Diacylglycerol kinase beta OS=Mus musculus OX=10090 GN=Dgkb PE=1 SV=2 DGKB_MOUSE reviewed Diacylglycerol kinase beta (DAG kinase beta) (EC 2.7.1.107) (Diglyceride kinase beta) (DGK-beta) Mus musculus (Mouse) GO:0004143; GO:0005509; GO:0005524; GO:0005654; GO:0005829; GO:0005886; GO:0006654; GO:0007200; GO:0008270; GO:0008289; GO:0009617; GO:0016607; GO:0035556; GO:0046339; GO:0046473; GO:0046486; GO:0046834; GO:0050804; GO:0098685; GO:0098978; GO:0099147; GO:0099175 diacylglycerol metabolic process [GO:0046339]; glycerolipid metabolic process [GO:0046486]; intracellular signal transduction [GO:0035556]; lipid phosphorylation [GO:0046834]; modulation of chemical synaptic transmission [GO:0050804]; phosphatidic acid biosynthetic process [GO:0006654]; phosphatidic acid metabolic process [GO:0046473]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; regulation of postsynapse organization [GO:0099175]; response to bacterium [GO:0009617] cytosol [GO:0005829]; extrinsic component of postsynaptic density membrane [GO:0099147]; glutamatergic synapse [GO:0098978]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; Schaffer collateral - CA1 synapse [GO:0098685] ATP binding [GO:0005524]; ATP-dependent diacylglycerol kinase activity [GO:0004143]; calcium ion binding [GO:0005509]; lipid binding [GO:0008289]; zinc ion binding [GO:0008270] g14613.t2 Q6NS52 57.471 87 2.0600000000000001e-22 107.0 sp|Q6NS52|DGKB_MOUSE Diacylglycerol kinase beta OS=Mus musculus OX=10090 GN=Dgkb PE=1 SV=2 DGKB_MOUSE reviewed Diacylglycerol kinase beta (DAG kinase beta) (EC 2.7.1.107) (Diglyceride kinase beta) (DGK-beta) Mus musculus (Mouse) GO:0004143; GO:0005509; GO:0005524; GO:0005654; GO:0005829; GO:0005886; GO:0006654; GO:0007200; GO:0008270; GO:0008289; GO:0009617; GO:0016607; GO:0035556; GO:0046339; GO:0046473; GO:0046486; GO:0046834; GO:0050804; GO:0098685; GO:0098978; GO:0099147; GO:0099175 diacylglycerol metabolic process [GO:0046339]; glycerolipid metabolic process [GO:0046486]; intracellular signal transduction [GO:0035556]; lipid phosphorylation [GO:0046834]; modulation of chemical synaptic transmission [GO:0050804]; phosphatidic acid biosynthetic process [GO:0006654]; phosphatidic acid metabolic process [GO:0046473]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; regulation of postsynapse organization [GO:0099175]; response to bacterium [GO:0009617] cytosol [GO:0005829]; extrinsic component of postsynaptic density membrane [GO:0099147]; glutamatergic synapse [GO:0098978]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; Schaffer collateral - CA1 synapse [GO:0098685] ATP binding [GO:0005524]; ATP-dependent diacylglycerol kinase activity [GO:0004143]; calcium ion binding [GO:0005509]; lipid binding [GO:0008289]; zinc ion binding [GO:0008270] g14613.t3 Q6NS52 60.521 499 0.0 632.0 sp|Q6NS52|DGKB_MOUSE Diacylglycerol kinase beta OS=Mus musculus OX=10090 GN=Dgkb PE=1 SV=2 DGKB_MOUSE reviewed Diacylglycerol kinase beta (DAG kinase beta) (EC 2.7.1.107) (Diglyceride kinase beta) (DGK-beta) Mus musculus (Mouse) GO:0004143; GO:0005509; GO:0005524; GO:0005654; GO:0005829; GO:0005886; GO:0006654; GO:0007200; GO:0008270; GO:0008289; GO:0009617; GO:0016607; GO:0035556; GO:0046339; GO:0046473; GO:0046486; GO:0046834; GO:0050804; GO:0098685; GO:0098978; GO:0099147; GO:0099175 diacylglycerol metabolic process [GO:0046339]; glycerolipid metabolic process [GO:0046486]; intracellular signal transduction [GO:0035556]; lipid phosphorylation [GO:0046834]; modulation of chemical synaptic transmission [GO:0050804]; phosphatidic acid biosynthetic process [GO:0006654]; phosphatidic acid metabolic process [GO:0046473]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; regulation of postsynapse organization [GO:0099175]; response to bacterium [GO:0009617] cytosol [GO:0005829]; extrinsic component of postsynaptic density membrane [GO:0099147]; glutamatergic synapse [GO:0098978]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; Schaffer collateral - CA1 synapse [GO:0098685] ATP binding [GO:0005524]; ATP-dependent diacylglycerol kinase activity [GO:0004143]; calcium ion binding [GO:0005509]; lipid binding [GO:0008289]; zinc ion binding [GO:0008270] g14614.t1 Q9HAB8 45.378 238 1.05e-48 165.0 sp|Q9HAB8|PPCS_HUMAN Phosphopantothenate--cysteine ligase OS=Homo sapiens OX=9606 GN=PPCS PE=1 SV=2 g14616.t1 Q04467 71.619 451 0.0 675.0 sp|Q04467|IDHP_BOVIN Isocitrate dehydrogenase [NADP], mitochondrial OS=Bos taurus OX=9913 GN=IDH2 PE=1 SV=2 IDHP_BOVIN reviewed Isocitrate dehydrogenase [NADP], mitochondrial (IDH) (EC 1.1.1.42) (ICD-M) (IDP) (NADP(+)-specific ICDH) (Oxalosuccinate decarboxylase) Bos taurus (Bovine) GO:0000287; GO:0004450; GO:0005739; GO:0005743; GO:0005777; GO:0005829; GO:0006097; GO:0006099; GO:0006102; GO:0006103; GO:0006739; GO:0051287 2-oxoglutarate metabolic process [GO:0006103]; glyoxylate cycle [GO:0006097]; isocitrate metabolic process [GO:0006102]; NADP+ metabolic process [GO:0006739]; tricarboxylic acid cycle [GO:0006099] cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; peroxisome [GO:0005777] isocitrate dehydrogenase (NADP+) activity [GO:0004450]; magnesium ion binding [GO:0000287]; NAD binding [GO:0051287] g14617.t1 Q13423 67.788 1040 0.0 1287.0 sp|Q13423|NNTM_HUMAN NAD(P) transhydrogenase, mitochondrial OS=Homo sapiens OX=9606 GN=NNT PE=1 SV=3 NNTM_HUMAN reviewed NAD(P) transhydrogenase, mitochondrial (EC 7.1.1.1) (Nicotinamide nucleotide transhydrogenase) (Pyridine nucleotide transhydrogenase) Homo sapiens (Human) GO:0003957; GO:0005739; GO:0005743; GO:0006099; GO:0006740; GO:0008750; GO:0010918; GO:0016020; GO:0032364; GO:0033273; GO:0043066; GO:0045454; GO:0050661; GO:0051287; GO:0072593; GO:0098803; GO:0098869; GO:1902600; GO:1903285 cell redox homeostasis [GO:0045454]; cellular oxidant detoxification [GO:0098869]; intracellular oxygen homeostasis [GO:0032364]; NADPH regeneration [GO:0006740]; negative regulation of apoptotic process [GO:0043066]; positive regulation of hydrogen peroxide catabolic process [GO:1903285]; positive regulation of mitochondrial membrane potential [GO:0010918]; proton transmembrane transport [GO:1902600]; reactive oxygen species metabolic process [GO:0072593]; response to vitamin [GO:0033273]; tricarboxylic acid cycle [GO:0006099] membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; respiratory chain complex [GO:0098803] NAD binding [GO:0051287]; NAD(P)+ transhydrogenase (Si-specific) activity [GO:0003957]; NADP binding [GO:0050661]; proton-translocating NAD(P)+ transhydrogenase activity [GO:0008750] g14618.t1 Q4R6V2 78.652 534 0.0 849.0 sp|Q4R6V2|TCPE_MACFA T-complex protein 1 subunit epsilon OS=Macaca fascicularis OX=9541 GN=CCT5 PE=2 SV=1 TCPE_MACFA reviewed T-complex protein 1 subunit epsilon (TCP-1-epsilon) (EC 3.6.1.-) (CCT-epsilon) Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey) GO:0003730; GO:0005524; GO:0005813; GO:0005832; GO:0005874; GO:0007339; GO:0009615; GO:0016887; GO:0031681; GO:0032212; GO:0044297; GO:0046872; GO:0048027; GO:0048487; GO:0050821; GO:0051082; GO:0140662 binding of sperm to zona pellucida [GO:0007339]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein stabilization [GO:0050821]; response to virus [GO:0009615] cell body [GO:0044297]; centrosome [GO:0005813]; chaperonin-containing T-complex [GO:0005832]; microtubule [GO:0005874] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent protein folding chaperone [GO:0140662]; beta-tubulin binding [GO:0048487]; G-protein beta-subunit binding [GO:0031681]; metal ion binding [GO:0046872]; mRNA 3'-UTR binding [GO:0003730]; mRNA 5'-UTR binding [GO:0048027]; unfolded protein binding [GO:0051082] g14620.t1 E1BD52 58.333 84 1.35e-23 97.8 sp|E1BD52|TM245_BOVIN Transmembrane protein 245 OS=Bos taurus OX=9913 GN=TMEM245 PE=3 SV=1 g14622.t1 Q9H330 33.895 475 3.22e-65 229.0 sp|Q9H330|TM245_HUMAN Transmembrane protein 245 OS=Homo sapiens OX=9606 GN=TMEM245 PE=1 SV=3 g14623.t1 O15541 55.758 330 1.08e-119 351.0 sp|O15541|R113A_HUMAN E3 ubiquitin-protein ligase RNF113A OS=Homo sapiens OX=9606 GN=RNF113A PE=1 SV=1 R113A_HUMAN reviewed E3 ubiquitin-protein ligase RNF113A (EC 2.3.2.27) (Cwc24 homolog) (RING finger protein 113A) (Zinc finger protein 183) Homo sapiens (Human) GO:0000398; GO:0005634; GO:0005654; GO:0005684; GO:0006281; GO:0008270; GO:0016567; GO:0016607; GO:0034247; GO:0061630; GO:0070100; GO:0071005 DNA repair [GO:0006281]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of chemokine-mediated signaling pathway [GO:0070100]; protein ubiquitination [GO:0016567]; snoRNA splicing [GO:0034247] nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U2-type precatalytic spliceosome [GO:0071005]; U2-type spliceosomal complex [GO:0005684] ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] g14624.t1 P22897 24.361 587 8.44e-24 112.0 sp|P22897|MRC1_HUMAN Macrophage mannose receptor 1 OS=Homo sapiens OX=9606 GN=MRC1 PE=1 SV=1 MRC1_HUMAN reviewed Macrophage mannose receptor 1 (MMR) (C-type lectin domain family 13 member D) (C-type lectin domain family 13 member D-like) (Human mannose receptor) (hMR) (Macrophage mannose receptor 1-like protein 1) (CD antigen CD206) Homo sapiens (Human) GO:0001618; GO:0004888; GO:0005537; GO:0005886; GO:0006898; GO:0009986; GO:0010008; GO:0038023; GO:0038024; GO:0071222; GO:0071346; GO:0071353 cellular response to interleukin-4 [GO:0071353]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to type II interferon [GO:0071346]; receptor-mediated endocytosis [GO:0006898] cell surface [GO:0009986]; endosome membrane [GO:0010008]; plasma membrane [GO:0005886] cargo receptor activity [GO:0038024]; D-mannose binding [GO:0005537]; signaling receptor activity [GO:0038023]; transmembrane signaling receptor activity [GO:0004888]; virus receptor activity [GO:0001618] g14625.t1 P61644 41.667 252 3.94e-62 208.0 sp|P61644|SIA8C_PANTR Alpha-N-acetylneuraminate alpha-2,8-sialyltransferase ST8SIA3 OS=Pan troglodytes OX=9598 GN=ST8SIA3 PE=2 SV=1 SIA8C_PANTR reviewed Alpha-N-acetylneuraminate alpha-2,8-sialyltransferase ST8SIA3 (EC 2.4.3.-) (Alpha-2,8-sialyltransferase 8C) (Alpha-2,8-sialyltransferase III) (Ganglioside GD3 synthase ST8SIA3) (EC 2.4.3.8) (ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 3) (Sia-a2,3-Gal-b1,4-Glc-NAc-R:a2,8-sialyltransferase) (Sialyltransferase 8C) (SIAT8-C) (Sialyltransferase St8Sia III) (ST8SiaIII) Pan troglodytes (Chimpanzee) GO:0000139; GO:0003828; GO:0006491; GO:0008373; GO:0009311; GO:0097503 N-glycan processing [GO:0006491]; oligosaccharide metabolic process [GO:0009311]; sialylation [GO:0097503] Golgi membrane [GO:0000139] alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity [GO:0003828]; sialyltransferase activity [GO:0008373] g14626.t1 P18293 41.182 981 0.0 692.0 sp|P18293|ANPRA_MOUSE Atrial natriuretic peptide receptor 1 OS=Mus musculus OX=10090 GN=Npr1 PE=1 SV=2 ANPRA_MOUSE reviewed Atrial natriuretic peptide receptor 1 (EC 4.6.1.2) (Atrial natriuretic peptide receptor type A) (ANP-A) (ANPR-A) (NPR-A) (Guanylate cyclase A) (GC-A) Mus musculus (Mouse) GO:0001653; GO:0004383; GO:0004672; GO:0005524; GO:0005525; GO:0005886; GO:0006182; GO:0007166; GO:0007168; GO:0008217; GO:0010753; GO:0016941; GO:0017046; GO:0019934; GO:0035556; GO:0042417; GO:0042562; GO:0043114; GO:0043235; GO:0048662; GO:0097746; GO:1990620 blood vessel diameter maintenance [GO:0097746]; cell surface receptor signaling pathway [GO:0007166]; cGMP biosynthetic process [GO:0006182]; cGMP-mediated signaling [GO:0019934]; dopamine metabolic process [GO:0042417]; intracellular signal transduction [GO:0035556]; negative regulation of smooth muscle cell proliferation [GO:0048662]; positive regulation of cGMP-mediated signaling [GO:0010753]; receptor guanylyl cyclase signaling pathway [GO:0007168]; regulation of blood pressure [GO:0008217]; regulation of vascular permeability [GO:0043114] ANPR-A receptor complex [GO:1990620]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] ATP binding [GO:0005524]; GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; hormone binding [GO:0042562]; natriuretic peptide receptor activity [GO:0016941]; peptide hormone binding [GO:0017046]; peptide receptor activity [GO:0001653]; protein kinase activity [GO:0004672] g14631.t1 Q2KHY7 35.233 386 1.5299999999999998e-67 227.0 sp|Q2KHY7|TTC23_BOVIN Tetratricopeptide repeat protein 23 OS=Bos taurus OX=9913 GN=TTC23 PE=2 SV=1 g14632.t1 Q6A044 36.275 204 6.93e-25 114.0 sp|Q6A044|EREP2_MOUSE Protein ENTREP2 OS=Mus musculus OX=10090 GN=Entrep2 PE=2 SV=3 g14633.t1 Q921J2 60.656 183 8.530000000000001e-73 220.0 sp|Q921J2|RHEB_MOUSE GTP-binding protein Rheb OS=Mus musculus OX=10090 GN=Rheb PE=1 SV=1 RHEB_MOUSE reviewed GTP-binding protein Rheb (EC 3.6.5.-) (Ras homolog enriched in brain) Mus musculus (Mouse) GO:0000045; GO:0000139; GO:0000287; GO:0002181; GO:0003924; GO:0005525; GO:0005681; GO:0005765; GO:0005789; GO:0005829; GO:0005886; GO:0007264; GO:0009615; GO:0010507; GO:0012505; GO:0014069; GO:0019003; GO:0019901; GO:0030295; GO:0030425; GO:0031669; GO:0032006; GO:0032008; GO:0038202; GO:0043025; GO:0043539; GO:0045202; GO:0045947; GO:0045948; GO:0048714; GO:0098978; GO:0099175; GO:0120163; GO:1904263; GO:2000074 autophagosome assembly [GO:0000045]; cellular response to nutrient levels [GO:0031669]; cytoplasmic translation [GO:0002181]; negative regulation of autophagy [GO:0010507]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of translational initiation [GO:0045947]; positive regulation of oligodendrocyte differentiation [GO:0048714]; positive regulation of TOR signaling [GO:0032008]; positive regulation of TORC1 signaling [GO:1904263]; positive regulation of translational initiation [GO:0045948]; regulation of postsynapse organization [GO:0099175]; regulation of TOR signaling [GO:0032006]; regulation of type B pancreatic cell development [GO:2000074]; response to virus [GO:0009615]; small GTPase-mediated signal transduction [GO:0007264]; TORC1 signaling [GO:0038202] cytosol [GO:0005829]; dendrite [GO:0030425]; endomembrane system [GO:0012505]; endoplasmic reticulum membrane [GO:0005789]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; lysosomal membrane [GO:0005765]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; spliceosomal complex [GO:0005681]; synapse [GO:0045202] GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; magnesium ion binding [GO:0000287]; protein kinase activator activity [GO:0030295]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activator activity [GO:0043539] g14642.t1 Q9WVK3 59.191 272 1.0199999999999999e-108 320.0 sp|Q9WVK3|PECR_RAT Peroxisomal trans-2-enoyl-CoA reductase OS=Rattus norvegicus OX=10116 GN=Pecr PE=2 SV=1 PECR_RAT reviewed Peroxisomal trans-2-enoyl-CoA reductase (TERP) (EC 1.3.1.38) (PX-2,4-DCR1) (Peroxisomal 2,4-dienoyl-CoA reductase) (RLF98) Rattus norvegicus (Rat) GO:0005102; GO:0005739; GO:0005777; GO:0005778; GO:0006633; GO:0019166; GO:0033306; GO:0043231 fatty acid biosynthetic process [GO:0006633]; phytol metabolic process [GO:0033306] intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777] signaling receptor binding [GO:0005102]; trans-2-enoyl-CoA reductase (NADPH) activity [GO:0019166] g14643.t1 Q13873 45.353 538 1.6899999999999999e-147 459.0 sp|Q13873|BMPR2_HUMAN Bone morphogenetic protein receptor type-2 OS=Homo sapiens OX=9606 GN=BMPR2 PE=1 SV=2 BMPR2_HUMAN reviewed Bone morphogenetic protein receptor type-2 (BMP type-2 receptor) (BMPR-2) (EC 2.7.11.30) (Bone morphogenetic protein receptor type II) (BMP type II receptor) (BMPR-II) Homo sapiens (Human) GO:0000165; GO:0001525; GO:0001568; GO:0001649; GO:0001707; GO:0001708; GO:0001893; GO:0001935; GO:0001946; GO:0001974; GO:0002063; GO:0003085; GO:0003151; GO:0003176; GO:0003177; GO:0003183; GO:0003186; GO:0003197; GO:0003252; GO:0005024; GO:0005524; GO:0005615; GO:0005654; GO:0005886; GO:0005901; GO:0005905; GO:0005912; GO:0006606; GO:0007178; GO:0009267; GO:0009925; GO:0009952; GO:0009986; GO:0010628; GO:0010634; GO:0014069; GO:0014916; GO:0016324; GO:0016362; GO:0019838; GO:0030154; GO:0030166; GO:0030308; GO:0030424; GO:0030425; GO:0030501; GO:0030509; GO:0036122; GO:0042127; GO:0043025; GO:0043235; GO:0045296; GO:0045669; GO:0045778; GO:0045906; GO:0045944; GO:0046872; GO:0048286; GO:0048662; GO:0048842; GO:0048863; GO:0051148; GO:0060173; GO:0060350; GO:0060391; GO:0060412; GO:0060413; GO:0060426; GO:0060836; GO:0060840; GO:0060841; GO:0061036; GO:0061298; GO:0071363; GO:0071773; GO:0072577; GO:0098821; GO:1902731; GO:1905314; GO:1990782 angiogenesis [GO:0001525]; anterior/posterior pattern specification [GO:0009952]; aortic valve development [GO:0003176]; artery development [GO:0060840]; atrial septum morphogenesis [GO:0060413]; blood vessel development [GO:0001568]; blood vessel remodeling [GO:0001974]; BMP signaling pathway [GO:0030509]; cell differentiation [GO:0030154]; cell fate specification [GO:0001708]; cell surface receptor protein serine/threonine kinase signaling pathway [GO:0007178]; cellular response to BMP stimulus [GO:0071773]; cellular response to growth factor stimulus [GO:0071363]; cellular response to starvation [GO:0009267]; chondrocyte development [GO:0002063]; endocardial cushion development [GO:0003197]; endochondral bone morphogenesis [GO:0060350]; endothelial cell apoptotic process [GO:0072577]; endothelial cell proliferation [GO:0001935]; limb development [GO:0060173]; lung alveolus development [GO:0048286]; lung vasculature development [GO:0060426]; lymphangiogenesis [GO:0001946]; lymphatic endothelial cell differentiation [GO:0060836]; MAPK cascade [GO:0000165]; maternal placenta development [GO:0001893]; mesoderm formation [GO:0001707]; mitral valve morphogenesis [GO:0003183]; negative regulation of cell growth [GO:0030308]; negative regulation of cell proliferation involved in heart valve morphogenesis [GO:0003252]; negative regulation of chondrocyte proliferation [GO:1902731]; negative regulation of muscle cell differentiation [GO:0051148]; negative regulation of smooth muscle cell proliferation [GO:0048662]; negative regulation of systemic arterial blood pressure [GO:0003085]; negative regulation of vasoconstriction [GO:0045906]; osteoblast differentiation [GO:0001649]; outflow tract morphogenesis [GO:0003151]; positive regulation of axon extension involved in axon guidance [GO:0048842]; positive regulation of bone mineralization [GO:0030501]; positive regulation of cartilage development [GO:0061036]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of gene expression [GO:0010628]; positive regulation of ossification [GO:0045778]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of SMAD protein signal transduction [GO:0060391]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein import into nucleus [GO:0006606]; proteoglycan biosynthetic process [GO:0030166]; pulmonary valve development [GO:0003177]; regulation of cell population proliferation [GO:0042127]; regulation of lung blood pressure [GO:0014916]; retina vasculature development in camera-type eye [GO:0061298]; semi-lunar valve development [GO:1905314]; stem cell differentiation [GO:0048863]; tricuspid valve morphogenesis [GO:0003186]; venous blood vessel development [GO:0060841]; ventricular septum morphogenesis [GO:0060412] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; axon [GO:0030424]; basal plasma membrane [GO:0009925]; caveola [GO:0005901]; cell surface [GO:0009986]; clathrin-coated pit [GO:0005905]; dendrite [GO:0030425]; extracellular space [GO:0005615]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; receptor complex [GO:0043235] activin receptor activity, type II [GO:0016362]; ATP binding [GO:0005524]; BMP binding [GO:0036122]; BMP receptor activity [GO:0098821]; cadherin binding [GO:0045296]; growth factor binding [GO:0019838]; metal ion binding [GO:0046872]; protein tyrosine kinase binding [GO:1990782]; transforming growth factor beta receptor activity [GO:0005024] g14647.t1 Q9H269 54.034 533 0.0 558.0 sp|Q9H269|VPS16_HUMAN Vacuolar protein sorting-associated protein 16 homolog OS=Homo sapiens OX=9606 GN=VPS16 PE=1 SV=2 VPS16_HUMAN reviewed Vacuolar protein sorting-associated protein 16 homolog (hVPS16) Homo sapiens (Human) GO:0003779; GO:0005764; GO:0005765; GO:0005768; GO:0005769; GO:0005770; GO:0005776; GO:0006886; GO:0008333; GO:0010008; GO:0016197; GO:0030136; GO:0030424; GO:0030897; GO:0031902; GO:0033263; GO:0034058; GO:0035542; GO:0042144; GO:0043025; GO:0051015; GO:0055037; GO:0097352; GO:0098793 autophagosome maturation [GO:0097352]; endosomal transport [GO:0016197]; endosomal vesicle fusion [GO:0034058]; endosome to lysosome transport [GO:0008333]; intracellular protein transport [GO:0006886]; regulation of SNARE complex assembly [GO:0035542]; vacuole fusion, non-autophagic [GO:0042144] autophagosome [GO:0005776]; axon [GO:0030424]; clathrin-coated vesicle [GO:0030136]; CORVET complex [GO:0033263]; early endosome [GO:0005769]; endosome [GO:0005768]; endosome membrane [GO:0010008]; HOPS complex [GO:0030897]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; neuronal cell body [GO:0043025]; presynapse [GO:0098793]; recycling endosome [GO:0055037] actin binding [GO:0003779]; actin filament binding [GO:0051015] g14648.t1 Q920Q4 44.408 304 5.720000000000001e-79 259.0 sp|Q920Q4|VPS16_MOUSE Vacuolar protein sorting-associated protein 16 homolog OS=Mus musculus OX=10090 GN=Vps16 PE=1 SV=3 VPS16_MOUSE reviewed Vacuolar protein sorting-associated protein 16 homolog (mVPS16) Mus musculus (Mouse) GO:0003779; GO:0005764; GO:0005765; GO:0005768; GO:0005769; GO:0005770; GO:0005776; GO:0005884; GO:0006886; GO:0008333; GO:0016197; GO:0030136; GO:0030424; GO:0030897; GO:0031901; GO:0031902; GO:0033263; GO:0042144; GO:0043025; GO:0046718; GO:0051015; GO:0055037; GO:0097352; GO:0098793 autophagosome maturation [GO:0097352]; endosomal transport [GO:0016197]; endosome to lysosome transport [GO:0008333]; intracellular protein transport [GO:0006886]; symbiont entry into host cell [GO:0046718]; vacuole fusion, non-autophagic [GO:0042144] actin filament [GO:0005884]; autophagosome [GO:0005776]; axon [GO:0030424]; clathrin-coated vesicle [GO:0030136]; CORVET complex [GO:0033263]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; HOPS complex [GO:0030897]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; neuronal cell body [GO:0043025]; presynapse [GO:0098793]; recycling endosome [GO:0055037] actin binding [GO:0003779]; actin filament binding [GO:0051015] g14649.t1 Q90YK5 32.29 511 1.47e-75 249.0 sp|Q90YK5|HPSE_CHICK Heparanase OS=Gallus gallus OX=9031 GN=HPSE PE=1 SV=1 HPSE_CHICK reviewed Heparanase (EC 3.2.1.166) Gallus gallus (Chicken) GO:0005615; GO:0007160; GO:0016020; GO:0030200; GO:0030305; GO:0031012; GO:0060055 angiogenesis involved in wound healing [GO:0060055]; cell-matrix adhesion [GO:0007160]; heparan sulfate proteoglycan catabolic process [GO:0030200] extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; membrane [GO:0016020] heparanase activity [GO:0030305] g14650.t1 Q9VCA2 36.182 550 1.6e-85 278.0 sp|Q9VCA2|ORCT_DROME Organic cation transporter protein OS=Drosophila melanogaster OX=7227 GN=Orct PE=1 SV=1 g14652.t1 Q9VCA2 39.488 547 1.84e-101 321.0 sp|Q9VCA2|ORCT_DROME Organic cation transporter protein OS=Drosophila melanogaster OX=7227 GN=Orct PE=1 SV=1 g14653.t1 Q96PH1 39.962 528 4.53e-102 337.0 sp|Q96PH1|NOX5_HUMAN NADPH oxidase 5 OS=Homo sapiens OX=9606 GN=NOX5 PE=1 SV=1 g14653.t1 Q96PH1 50.0 238 1.82e-70 251.0 sp|Q96PH1|NOX5_HUMAN NADPH oxidase 5 OS=Homo sapiens OX=9606 GN=NOX5 PE=1 SV=1 g14654.t1 Q96PH1 35.101 547 1.01e-78 275.0 sp|Q96PH1|NOX5_HUMAN NADPH oxidase 5 OS=Homo sapiens OX=9606 GN=NOX5 PE=1 SV=1 g14654.t1 Q96PH1 54.146 205 2.11e-68 246.0 sp|Q96PH1|NOX5_HUMAN NADPH oxidase 5 OS=Homo sapiens OX=9606 GN=NOX5 PE=1 SV=1 g14655.t1 Q8IYE1 47.418 213 1.4e-46 179.0 sp|Q8IYE1|CCD13_HUMAN Coiled-coil domain-containing protein 13 OS=Homo sapiens OX=9606 GN=CCDC13 PE=1 SV=2 g14657.t1 Q9ULF5 33.475 469 3.82e-64 230.0 sp|Q9ULF5|S39AA_HUMAN Zinc transporter ZIP10 OS=Homo sapiens OX=9606 GN=SLC39A10 PE=1 SV=2 S39AA_HUMAN reviewed Zinc transporter ZIP10 (Solute carrier family 39 member 10) (Zrt- and Irt-like protein 10) (ZIP-10) Homo sapiens (Human) GO:0001837; GO:0002903; GO:0005385; GO:0005886; GO:0006882; GO:0008160; GO:0016324; GO:0030003; GO:0030890; GO:0050861; GO:0071577; GO:0071578; GO:0140410 epithelial to mesenchymal transition [GO:0001837]; intracellular monoatomic cation homeostasis [GO:0030003]; intracellular zinc ion homeostasis [GO:0006882]; negative regulation of B cell apoptotic process [GO:0002903]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of B cell receptor signaling pathway [GO:0050861]; zinc ion import across plasma membrane [GO:0071578]; zinc ion transmembrane transport [GO:0071577] apical plasma membrane [GO:0016324]; plasma membrane [GO:0005886] monoatomic cation:bicarbonate symporter activity [GO:0140410]; protein tyrosine phosphatase activator activity [GO:0008160]; zinc ion transmembrane transporter activity [GO:0005385] g14658.t1 Q2HJ10 43.147 394 1.5699999999999998e-81 260.0 sp|Q2HJ10|ZNT2_MOUSE Proton-coupled zinc antiporter SLC30A2 OS=Mus musculus OX=10090 GN=Slc30a2 PE=1 SV=1 ZNT2_MOUSE reviewed Proton-coupled zinc antiporter SLC30A2 (Solute carrier family 30 member 2) (Zinc transporter 2) (ZnT-2) Mus musculus (Mouse) GO:0005385; GO:0005737; GO:0005743; GO:0005765; GO:0005770; GO:0005886; GO:0006829; GO:0006882; GO:0010008; GO:0010043; GO:0030658; GO:0042589; GO:0042802; GO:0046872; GO:0062111; GO:0071577; GO:0099503; GO:0140826; GO:0140882; GO:0140914; GO:0140915; GO:0140916; GO:0140917 intracellular zinc ion homeostasis [GO:0006882]; response to zinc ion [GO:0010043]; zinc export across plasma membrane [GO:0140882]; zinc ion import into lysosome [GO:0140916]; zinc ion import into mitochondrion [GO:0140917]; zinc ion import into organelle [GO:0062111]; zinc ion import into secretory vesicle [GO:0140914]; zinc ion import into zymogen granule [GO:0140915]; zinc ion transmembrane transport [GO:0071577]; zinc ion transport [GO:0006829] cytoplasm [GO:0005737]; endosome membrane [GO:0010008]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; mitochondrial inner membrane [GO:0005743]; plasma membrane [GO:0005886]; secretory vesicle [GO:0099503]; transport vesicle membrane [GO:0030658]; zymogen granule membrane [GO:0042589] identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; zinc ion transmembrane transporter activity [GO:0005385]; zinc:proton antiporter activity [GO:0140826] g14659.t1 Q9VCA2 41.724 580 1.53e-118 365.0 sp|Q9VCA2|ORCT_DROME Organic cation transporter protein OS=Drosophila melanogaster OX=7227 GN=Orct PE=1 SV=1 g14661.t1 Q80V94 43.203 537 8.39e-125 395.0 sp|Q80V94|AP4E1_MOUSE AP-4 complex subunit epsilon-1 OS=Mus musculus OX=10090 GN=Ap4e1 PE=1 SV=3 g14662.t1 Q2KJF9 53.357 283 5.82e-99 295.0 sp|Q2KJF9|T2EB_BOVIN General transcription factor IIE subunit 2 OS=Bos taurus OX=9913 GN=GTF2E2 PE=2 SV=1 g14663.t1 Q8CDN6 52.158 278 1.27e-101 301.0 sp|Q8CDN6|TXNL1_MOUSE Thioredoxin-like protein 1 OS=Mus musculus OX=10090 GN=Txnl1 PE=1 SV=3 g14664.t1 P18264 74.138 58 1.54e-23 100.0 sp|P18264|ROUGH_DROVI Homeobox protein rough OS=Drosophila virilis OX=7244 GN=ro PE=3 SV=2 g14667.t1 Q9QZW9 83.117 77 9.999999999999999e-31 119.0 sp|Q9QZW9|MNX1_MOUSE Motor neuron and pancreas homeobox protein 1 OS=Mus musculus OX=10090 GN=Mnx1 PE=1 SV=2 MNX1_MOUSE reviewed Motor neuron and pancreas homeobox protein 1 (Homeobox protein HB9) Mus musculus (Mouse) GO:0000122; GO:0000785; GO:0001227; GO:0001764; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0007417; GO:0008045; GO:0009791; GO:0021520; GO:0021675; GO:0021904; GO:0021953; GO:0030182; GO:0031016; GO:0031018; GO:0048667; GO:0048812; GO:0060539; GO:0060541; GO:1990837 cell morphogenesis involved in neuron differentiation [GO:0048667]; central nervous system development [GO:0007417]; central nervous system neuron differentiation [GO:0021953]; diaphragm development [GO:0060539]; dorsal/ventral neural tube patterning [GO:0021904]; endocrine pancreas development [GO:0031018]; motor neuron axon guidance [GO:0008045]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nerve development [GO:0021675]; neuron differentiation [GO:0030182]; neuron migration [GO:0001764]; neuron projection morphogenesis [GO:0048812]; pancreas development [GO:0031016]; post-embryonic development [GO:0009791]; respiratory system development [GO:0060541]; spinal cord motor neuron cell fate specification [GO:0021520] chromatin [GO:0000785]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; sequence-specific double-stranded DNA binding [GO:1990837] g14669.t1 Q9ZSJ0 30.112 269 1.3099999999999999e-30 122.0 sp|Q9ZSJ0|RGXT2_ARATH UDP-D-xylose:L-fucose alpha-1,3-D-xylosyltransferase OS=Arabidopsis thaliana OX=3702 GN=RGXT2 PE=1 SV=1 RGXT2_ARATH reviewed UDP-D-xylose:L-fucose alpha-1,3-D-xylosyltransferase (EC 2.4.2.-) (Rhamnogalacturonan xylosyltransferase 2) Arabidopsis thaliana (Mouse-ear cress) GO:0000139; GO:0005794; GO:0010306; GO:0035252 rhamnogalacturonan II biosynthetic process [GO:0010306] Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139] UDP-xylosyltransferase activity [GO:0035252] g14671.t1 Q5REV9 51.429 630 1.87e-174 517.0 sp|Q5REV9|NPT2B_PONAB Sodium-dependent phosphate transport protein 2B OS=Pongo abelii OX=9601 GN=SLC34A2 PE=2 SV=1 g14672.t1 Q06496 55.488 492 7.480000000000001e-132 405.0 sp|Q06496|NPT2A_RAT Sodium-dependent phosphate transport protein 2A OS=Rattus norvegicus OX=10116 GN=Slc34a1 PE=1 SV=1 NPT2A_RAT reviewed Sodium-dependent phosphate transport protein 2A (Sodium-phosphate transport protein 2A) (Na(+)-dependent phosphate cotransporter 2A) (Sodium/phosphate cotransporter 2A) (Na(+)/Pi cotransporter 2A) (NaPi-2a) (Solute carrier family 34 member 1) Rattus norvegicus (Rat) GO:0001503; GO:0001822; GO:0005436; GO:0005654; GO:0005768; GO:0005829; GO:0005886; GO:0005903; GO:0006817; GO:0007584; GO:0009410; GO:0009986; GO:0010288; GO:0010467; GO:0016036; GO:0016323; GO:0016324; GO:0016607; GO:0030165; GO:0030505; GO:0030643; GO:0031526; GO:0031982; GO:0032026; GO:0032355; GO:0033189; GO:0035435; GO:0035864; GO:0042802; GO:0043434; GO:0044341; GO:0044877; GO:0045838; GO:0046686; GO:0046689; GO:0046849; GO:0048471; GO:0055062; GO:0055074; GO:0060416; GO:0071107; GO:0071248; GO:0071374; GO:0072350; GO:0072686; GO:0072734; GO:0097066; GO:0097187; GO:0098719; GO:1901652; GO:1901684; GO:1904383; GO:2000120; GO:2000187 arsenate ion transmembrane transport [GO:1901684]; bone remodeling [GO:0046849]; calcium ion homeostasis [GO:0055074]; cellular response to metal ion [GO:0071248]; cellular response to parathyroid hormone stimulus [GO:0071374]; cellular response to phosphate starvation [GO:0016036]; cellular response to staurosporine [GO:0072734]; dentinogenesis [GO:0097187]; gene expression [GO:0010467]; inorganic diphosphate transport [GO:0030505]; intracellular phosphate ion homeostasis [GO:0030643]; kidney development [GO:0001822]; ossification [GO:0001503]; phosphate ion homeostasis [GO:0055062]; phosphate ion transmembrane transport [GO:0035435]; phosphate ion transport [GO:0006817]; positive regulation of membrane potential [GO:0045838]; positive regulation of phosphate transmembrane transport [GO:2000187]; positive regulation of sodium-dependent phosphate transport [GO:2000120]; response to cadmium ion [GO:0046686]; response to estradiol [GO:0032355]; response to growth hormone [GO:0060416]; response to lead ion [GO:0010288]; response to magnesium ion [GO:0032026]; response to mercury ion [GO:0046689]; response to nutrient [GO:0007584]; response to parathyroid hormone [GO:0071107]; response to peptide [GO:1901652]; response to peptide hormone [GO:0043434]; response to potassium ion [GO:0035864]; response to sodium phosphate [GO:1904383]; response to thyroid hormone [GO:0097066]; response to vitamin A [GO:0033189]; response to xenobiotic stimulus [GO:0009410]; sodium ion import across plasma membrane [GO:0098719]; sodium-dependent phosphate transport [GO:0044341]; tricarboxylic acid metabolic process [GO:0072350] apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; brush border [GO:0005903]; brush border membrane [GO:0031526]; cell surface [GO:0009986]; cytosol [GO:0005829]; endosome [GO:0005768]; mitotic spindle [GO:0072686]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; vesicle [GO:0031982] identical protein binding [GO:0042802]; PDZ domain binding [GO:0030165]; protein-containing complex binding [GO:0044877]; sodium:phosphate symporter activity [GO:0005436] g14673.t1 Q96CG8 47.101 138 2.45e-35 127.0 sp|Q96CG8|CTHR1_HUMAN Collagen triple helix repeat-containing protein 1 OS=Homo sapiens OX=9606 GN=CTHRC1 PE=1 SV=1 CTHR1_HUMAN reviewed Collagen triple helix repeat-containing protein 1 Homo sapiens (Human) GO:0001649; GO:0004666; GO:0005109; GO:0005576; GO:0005581; GO:0005615; GO:0005737; GO:0016528; GO:0017147; GO:0019371; GO:0031012; GO:0033687; GO:0033690; GO:0043005; GO:0043932; GO:0045669; GO:0060071; GO:0060122; GO:0090090; GO:0090103; GO:0090177 cochlea morphogenesis [GO:0090103]; cyclooxygenase pathway [GO:0019371]; establishment of planar polarity involved in neural tube closure [GO:0090177]; inner ear receptor cell stereocilium organization [GO:0060122]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; ossification involved in bone remodeling [GO:0043932]; osteoblast differentiation [GO:0001649]; osteoblast proliferation [GO:0033687]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of osteoblast proliferation [GO:0033690]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071] collagen trimer [GO:0005581]; cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; neuron projection [GO:0043005]; sarcoplasm [GO:0016528] frizzled binding [GO:0005109]; prostaglandin-endoperoxide synthase activity [GO:0004666]; Wnt-protein binding [GO:0017147] g14674.t1 Q96CG8 47.101 138 2.25e-36 130.0 sp|Q96CG8|CTHR1_HUMAN Collagen triple helix repeat-containing protein 1 OS=Homo sapiens OX=9606 GN=CTHRC1 PE=1 SV=1 CTHR1_HUMAN reviewed Collagen triple helix repeat-containing protein 1 Homo sapiens (Human) GO:0001649; GO:0004666; GO:0005109; GO:0005576; GO:0005581; GO:0005615; GO:0005737; GO:0016528; GO:0017147; GO:0019371; GO:0031012; GO:0033687; GO:0033690; GO:0043005; GO:0043932; GO:0045669; GO:0060071; GO:0060122; GO:0090090; GO:0090103; GO:0090177 cochlea morphogenesis [GO:0090103]; cyclooxygenase pathway [GO:0019371]; establishment of planar polarity involved in neural tube closure [GO:0090177]; inner ear receptor cell stereocilium organization [GO:0060122]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; ossification involved in bone remodeling [GO:0043932]; osteoblast differentiation [GO:0001649]; osteoblast proliferation [GO:0033687]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of osteoblast proliferation [GO:0033690]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071] collagen trimer [GO:0005581]; cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; neuron projection [GO:0043005]; sarcoplasm [GO:0016528] frizzled binding [GO:0005109]; prostaglandin-endoperoxide synthase activity [GO:0004666]; Wnt-protein binding [GO:0017147] g14675.t1 Q96CG8 46.377 138 2.56e-29 112.0 sp|Q96CG8|CTHR1_HUMAN Collagen triple helix repeat-containing protein 1 OS=Homo sapiens OX=9606 GN=CTHRC1 PE=1 SV=1 CTHR1_HUMAN reviewed Collagen triple helix repeat-containing protein 1 Homo sapiens (Human) GO:0001649; GO:0004666; GO:0005109; GO:0005576; GO:0005581; GO:0005615; GO:0005737; GO:0016528; GO:0017147; GO:0019371; GO:0031012; GO:0033687; GO:0033690; GO:0043005; GO:0043932; GO:0045669; GO:0060071; GO:0060122; GO:0090090; GO:0090103; GO:0090177 cochlea morphogenesis [GO:0090103]; cyclooxygenase pathway [GO:0019371]; establishment of planar polarity involved in neural tube closure [GO:0090177]; inner ear receptor cell stereocilium organization [GO:0060122]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; ossification involved in bone remodeling [GO:0043932]; osteoblast differentiation [GO:0001649]; osteoblast proliferation [GO:0033687]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of osteoblast proliferation [GO:0033690]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071] collagen trimer [GO:0005581]; cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; neuron projection [GO:0043005]; sarcoplasm [GO:0016528] frizzled binding [GO:0005109]; prostaglandin-endoperoxide synthase activity [GO:0004666]; Wnt-protein binding [GO:0017147] g14677.t1 Q8BLB8 57.368 190 5.92e-56 198.0 sp|Q8BLB8|AN34C_MOUSE Ankyrin repeat domain-containing protein 34C OS=Mus musculus OX=10090 GN=Ankrd34c PE=1 SV=1 g14679.t1 Q90473 79.365 378 0.0 591.0 sp|Q90473|HSP7C_DANRE Heat shock cognate 71 kDa protein OS=Danio rerio OX=7955 GN=hspa8 PE=2 SV=1 g14680.t1 P19378 85.366 205 1.52e-125 374.0 sp|P19378|HSP7C_CRIGR Heat shock cognate 71 kDa protein OS=Cricetulus griseus OX=10029 GN=HSPA8 PE=2 SV=1 g14681.t1 Q8BGF9 47.785 316 1.14e-102 305.0 sp|Q8BGF9|S2544_MOUSE Solute carrier family 25 member 44 OS=Mus musculus OX=10090 GN=Slc25a44 PE=1 SV=1 g14682.t1 Q4QQV8 71.689 219 4.87e-98 287.0 sp|Q4QQV8|CHMP5_RAT Charged multivesicular body protein 5 OS=Rattus norvegicus OX=10116 GN=Chmp5 PE=2 SV=1 CHMP5_RAT reviewed Charged multivesicular body protein 5 (Chromatin-modifying protein 5) Rattus norvegicus (Rat) GO:0000421; GO:0000776; GO:0001778; GO:0001919; GO:0005634; GO:0005643; GO:0005765; GO:0005771; GO:0005828; GO:0005829; GO:0005886; GO:0006900; GO:0006914; GO:0006997; GO:0007040; GO:0007080; GO:0008333; GO:0010824; GO:0015031; GO:0030218; GO:0030496; GO:0031468; GO:0032511; GO:0032585; GO:0039702; GO:0043162; GO:0046761; GO:0061952; GO:0071222; GO:0071225; GO:0071985; GO:0097352; GO:1901673; GO:1902774; GO:1904930 autophagosome maturation [GO:0097352]; autophagy [GO:0006914]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to muramyl dipeptide [GO:0071225]; endosome to lysosome transport [GO:0008333]; erythrocyte differentiation [GO:0030218]; late endosome to lysosome transport [GO:1902774]; late endosome to vacuole transport via multivesicular body sorting pathway [GO:0032511]; lysosome organization [GO:0007040]; midbody abscission [GO:0061952]; mitotic metaphase chromosome alignment [GO:0007080]; multivesicular body sorting pathway [GO:0071985]; nuclear membrane reassembly [GO:0031468]; nucleus organization [GO:0006997]; plasma membrane repair [GO:0001778]; protein transport [GO:0015031]; regulation of centrosome duplication [GO:0010824]; regulation of mitotic spindle assembly [GO:1901673]; regulation of receptor recycling [GO:0001919]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]; vesicle budding from membrane [GO:0006900]; viral budding from plasma membrane [GO:0046761]; viral budding via host ESCRT complex [GO:0039702] amphisome membrane [GO:1904930]; autophagosome membrane [GO:0000421]; cytosol [GO:0005829]; kinetochore [GO:0000776]; kinetochore microtubule [GO:0005828]; lysosomal membrane [GO:0005765]; midbody [GO:0030496]; multivesicular body [GO:0005771]; multivesicular body membrane [GO:0032585]; nuclear pore [GO:0005643]; nucleus [GO:0005634]; plasma membrane [GO:0005886] g14683.t1 Q66PG4 34.014 294 6.59e-42 165.0 sp|Q66PG4|LARG2_CHICK Xylosyl- and glucuronyltransferase LARGE2s OS=Gallus gallus OX=9031 GN=LARGE2 PE=2 SV=1 LARG2_CHICK reviewed Xylosyl- and glucuronyltransferase LARGE2s (EC 2.4.-.-) (Glycosyltransferase-like 1B) (LARGE xylosyl- and glucuronyltransferase 2) [Includes: Alpha-1,3-xylosyltransferase LARGE2 (EC 2.4.2.-); Beta-1,3-glucuronyltransferase LARGE2 (EC 2.4.1.-)] Gallus gallus (Chicken) GO:0000139; GO:0005794; GO:0015020; GO:0035269; GO:0042285; GO:0046872 protein O-linked glycosylation via mannose [GO:0035269] Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139] glucuronosyltransferase activity [GO:0015020]; metal ion binding [GO:0046872]; xylosyltransferase activity [GO:0042285] g14684.t1 O08539 38.281 256 8.72e-50 181.0 sp|O08539|BIN1_MOUSE Myc box-dependent-interacting protein 1 OS=Mus musculus OX=10090 GN=Bin1 PE=1 SV=1 BIN1_MOUSE reviewed Myc box-dependent-interacting protein 1 (Amphiphysin II) (Amphiphysin-like protein) (Bridging integrator 1) (SH3 domain-containing protein 9) Mus musculus (Mouse) GO:0000122; GO:0002020; GO:0005543; GO:0005634; GO:0005635; GO:0005737; GO:0005768; GO:0005829; GO:0005874; GO:0005886; GO:0006997; GO:0008021; GO:0008289; GO:0008333; GO:0010564; GO:0016020; GO:0019828; GO:0030018; GO:0030315; GO:0030424; GO:0030425; GO:0030838; GO:0031674; GO:0031982; GO:0033268; GO:0033292; GO:0042692; GO:0042802; GO:0043065; GO:0043194; GO:0043196; GO:0043679; GO:0044300; GO:0044877; GO:0045202; GO:0045664; GO:0045807; GO:0048156; GO:0048488; GO:0048711; GO:0051015; GO:0051020; GO:0051087; GO:0051647; GO:0060987; GO:0060988; GO:0070063; GO:0086091; GO:0090571; GO:0098793; GO:0098794; GO:0098850; GO:0098978; GO:1901380; GO:1902430; GO:1903946; GO:1904878 endosome to lysosome transport [GO:0008333]; lipid tube assembly [GO:0060988]; muscle cell differentiation [GO:0042692]; negative regulation of amyloid-beta formation [GO:1902430]; negative regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904878]; negative regulation of potassium ion transmembrane transport [GO:1901380]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of ventricular cardiac muscle cell action potential [GO:1903946]; nucleus localization [GO:0051647]; nucleus organization [GO:0006997]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of apoptotic process [GO:0043065]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of endocytosis [GO:0045807]; regulation of cell cycle process [GO:0010564]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of neuron differentiation [GO:0045664]; synaptic vesicle endocytosis [GO:0048488]; T-tubule organization [GO:0033292] axon [GO:0030424]; axon initial segment [GO:0043194]; axon terminus [GO:0043679]; cerebellar mossy fiber [GO:0044300]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; endosome [GO:0005768]; extrinsic component of synaptic vesicle membrane [GO:0098850]; glutamatergic synapse [GO:0098978]; I band [GO:0031674]; lipid tube [GO:0060987]; membrane [GO:0016020]; microtubule [GO:0005874]; node of Ranvier [GO:0033268]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; presynapse [GO:0098793]; RNA polymerase II transcription repressor complex [GO:0090571]; synapse [GO:0045202]; synaptic vesicle [GO:0008021]; T-tubule [GO:0030315]; varicosity [GO:0043196]; vesicle [GO:0031982]; Z disc [GO:0030018] actin filament binding [GO:0051015]; aspartic-type endopeptidase inhibitor activity [GO:0019828]; GTPase binding [GO:0051020]; identical protein binding [GO:0042802]; lipid binding [GO:0008289]; phospholipid binding [GO:0005543]; protease binding [GO:0002020]; protein-containing complex binding [GO:0044877]; protein-folding chaperone binding [GO:0051087]; RNA polymerase binding [GO:0070063]; tau protein binding [GO:0048156] g14686.t1 Q2VWP7 30.526 1045 6.48e-138 451.0 sp|Q2VWP7|PRTG_HUMAN Protogenin OS=Homo sapiens OX=9606 GN=PRTG PE=1 SV=1 PRTG_HUMAN reviewed Protogenin (Protein Shen-Dan) Homo sapiens (Human) GO:0005615; GO:0005886; GO:0038023; GO:0042802; GO:0050768; GO:0098609 cell-cell adhesion [GO:0098609]; negative regulation of neurogenesis [GO:0050768] extracellular space [GO:0005615]; plasma membrane [GO:0005886] identical protein binding [GO:0042802]; signaling receptor activity [GO:0038023] g14688.t1 Q28DE0 30.409 832 1.09e-107 355.0 sp|Q28DE0|FAKD1_XENTR FAST kinase domain-containing protein 1, mitochondrial OS=Xenopus tropicalis OX=8364 GN=fastkd1 PE=2 SV=1 g14689.t1 Q71U34 83.361 613 0.0 1033.0 sp|Q71U34|HSP7C_SAGOE Heat shock cognate 71 kDa protein OS=Saguinus oedipus OX=9490 GN=HSPA8 PE=2 SV=1 g14690.t1 Q16706 44.776 1206 0.0 1018.0 sp|Q16706|MA2A1_HUMAN Alpha-mannosidase 2 OS=Homo sapiens OX=9606 GN=MAN2A1 PE=1 SV=2 g14690.t2 Q16706 45.416 1189 0.0 1025.0 sp|Q16706|MA2A1_HUMAN Alpha-mannosidase 2 OS=Homo sapiens OX=9606 GN=MAN2A1 PE=1 SV=2 g14692.t1 Q8BIW1 40.691 376 8.96e-83 273.0 sp|Q8BIW1|PRUN1_MOUSE Exopolyphosphatase PRUNE1 OS=Mus musculus OX=10090 GN=Prune1 PE=1 SV=1 g14696.t1 Q0IHU9 63.087 149 7.92e-67 224.0 sp|Q0IHU9|PRUN2_XENTR Protein prune homolog 2 OS=Xenopus tropicalis OX=8364 GN=Prune2 PE=2 SV=1 g14696.t2 Q0IHU9 62.581 155 2.2200000000000002e-66 227.0 sp|Q0IHU9|PRUN2_XENTR Protein prune homolog 2 OS=Xenopus tropicalis OX=8364 GN=Prune2 PE=2 SV=1 g14697.t1 Q8BZH4 32.337 368 9.52e-51 197.0 sp|Q8BZH4|POGZ_MOUSE Pogo transposable element with ZNF domain OS=Mus musculus OX=10090 GN=Pogz PE=1 SV=2 g14698.t1 O15182 81.325 166 4.09e-96 278.0 sp|O15182|CETN3_HUMAN Centrin-3 OS=Homo sapiens OX=9606 GN=CETN3 PE=1 SV=2 CETN3_HUMAN reviewed Centrin-3 Homo sapiens (Human) GO:0000226; GO:0005509; GO:0005730; GO:0005813; GO:0005814; GO:0005815; GO:0007098; GO:0008017; GO:0015031; GO:0031683; GO:0032391; GO:0036064; GO:0044615; GO:0051028; GO:0051301; GO:0070390 cell division [GO:0051301]; centrosome cycle [GO:0007098]; microtubule cytoskeleton organization [GO:0000226]; mRNA transport [GO:0051028]; protein transport [GO:0015031] centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; microtubule organizing center [GO:0005815]; nuclear pore nuclear basket [GO:0044615]; nucleolus [GO:0005730]; photoreceptor connecting cilium [GO:0032391]; transcription export complex 2 [GO:0070390] calcium ion binding [GO:0005509]; G-protein beta/gamma-subunit complex binding [GO:0031683]; microtubule binding [GO:0008017] g14701.t1 P80912 61.538 130 2.4899999999999997e-54 169.0 sp|P80912|HINT1_RABIT Adenosine 5'-monophosphoramidase HINT1 OS=Oryctolagus cuniculus OX=9986 GN=HINT1 PE=1 SV=2 g14702.t1 P35280 78.846 208 1.0900000000000001e-117 336.0 sp|P35280|RAB8A_RAT Ras-related protein Rab-8A OS=Rattus norvegicus OX=10116 GN=Rab8a PE=1 SV=2 RAB8A_RAT reviewed Ras-related protein Rab-8A (EC 3.6.5.2) Rattus norvegicus (Rat) GO:0003924; GO:0003925; GO:0005525; GO:0005654; GO:0005730; GO:0005764; GO:0005768; GO:0005794; GO:0005813; GO:0005814; GO:0005829; GO:0005886; GO:0005929; GO:0006887; GO:0006904; GO:0006914; GO:0007030; GO:0007409; GO:0008021; GO:0010008; GO:0010506; GO:0015629; GO:0019003; GO:0019901; GO:0030140; GO:0030425; GO:0030496; GO:0030659; GO:0030670; GO:0031410; GO:0031489; GO:0032456; GO:0032869; GO:0032880; GO:0034451; GO:0036064; GO:0042593; GO:0043005; GO:0043025; GO:0045202; GO:0045335; GO:0046326; GO:0046872; GO:0048169; GO:0048210; GO:0051223; GO:0055037; GO:0055038; GO:0060170; GO:0060271; GO:0061512; GO:0070382; GO:0072659; GO:0097546; GO:0097730; GO:0098887; GO:0098969; GO:0098978; GO:1990782 autophagy [GO:0006914]; axonogenesis [GO:0007409]; cellular response to insulin stimulus [GO:0032869]; cilium assembly [GO:0060271]; endocytic recycling [GO:0032456]; exocytosis [GO:0006887]; glucose homeostasis [GO:0042593]; Golgi organization [GO:0007030]; Golgi vesicle fusion to target membrane [GO:0048210]; neurotransmitter receptor transport to postsynaptic membrane [GO:0098969]; neurotransmitter receptor transport, endosome to postsynaptic membrane [GO:0098887]; positive regulation of D-glucose import [GO:0046326]; protein localization to cilium [GO:0061512]; protein localization to plasma membrane [GO:0072659]; regulation of autophagy [GO:0010506]; regulation of long-term neuronal synaptic plasticity [GO:0048169]; regulation of protein localization [GO:0032880]; regulation of protein transport [GO:0051223]; vesicle docking involved in exocytosis [GO:0006904] actin cytoskeleton [GO:0015629]; centriolar satellite [GO:0034451]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary base [GO:0097546]; ciliary membrane [GO:0060170]; cilium [GO:0005929]; cytoplasmic vesicle [GO:0031410]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; dendrite [GO:0030425]; endosome [GO:0005768]; endosome membrane [GO:0010008]; exocytic vesicle [GO:0070382]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; lysosome [GO:0005764]; midbody [GO:0030496]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; non-motile cilium [GO:0097730]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; synapse [GO:0045202]; synaptic vesicle [GO:0008021]; trans-Golgi network transport vesicle [GO:0030140] G protein activity [GO:0003925]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; myosin V binding [GO:0031489]; protein kinase binding [GO:0019901]; protein tyrosine kinase binding [GO:1990782] g14704.t1 Q3T0B7 92.857 84 2.8e-49 153.0 sp|Q3T0B7|RS27L_BOVIN Small ribosomal subunit protein eS27-like OS=Bos taurus OX=9913 GN=RPS27L PE=3 SV=3 g14707.t1 Q92000 65.025 203 4.43e-91 278.0 sp|Q92000|SHH_XENLA Sonic hedgehog protein OS=Xenopus laevis OX=8355 GN=shh PE=2 SV=1 g14709.t1 Q6NV18 29.87 308 7.19e-21 94.7 sp|Q6NV18|NHEJ1_DANRE Non-homologous end-joining factor 1 OS=Danio rerio OX=7955 GN=nhej1 PE=2 SV=1 NHEJ1_DANRE reviewed Non-homologous end-joining factor 1 (Protein cernunnos) (XRCC4-like factor) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000723; GO:0006303; GO:0032807; GO:0033152; GO:0035861; GO:0045027; GO:0070419 double-strand break repair via nonhomologous end joining [GO:0006303]; immunoglobulin V(D)J recombination [GO:0033152]; telomere maintenance [GO:0000723] DNA ligase IV complex [GO:0032807]; nonhomologous end joining complex [GO:0070419]; site of double-strand break [GO:0035861] DNA end binding [GO:0045027] g14710.t1 Q6P316 56.548 336 2.73e-138 400.0 sp|Q6P316|S2540_XENTR Mitochondrial glutathione transporter SLC25A40 OS=Xenopus tropicalis OX=8364 GN=slc25a40 PE=2 SV=1 g14710.t2 Q6P316 56.716 335 3.5199999999999997e-140 404.0 sp|Q6P316|S2540_XENTR Mitochondrial glutathione transporter SLC25A40 OS=Xenopus tropicalis OX=8364 GN=slc25a40 PE=2 SV=1 g14711.t1 Q1L8G7 50.0 242 2.04e-79 242.0 sp|Q1L8G7|GATD1_DANRE GATA zinc finger domain-containing protein 1 OS=Danio rerio OX=7955 GN=gatad1 PE=2 SV=1 g14712.t1 Q6ZNB7 46.667 120 2.89e-26 105.0 sp|Q6ZNB7|ALKMO_HUMAN Alkylglycerol monooxygenase OS=Homo sapiens OX=9606 GN=AGMO PE=1 SV=1 ALKMO_HUMAN reviewed Alkylglycerol monooxygenase (EC 1.14.16.5) (Transmembrane protein 195) Homo sapiens (Human) GO:0005506; GO:0005783; GO:0005789; GO:0006643; GO:0019432; GO:0046485; GO:0050479 ether lipid metabolic process [GO:0046485]; membrane lipid metabolic process [GO:0006643]; triglyceride biosynthetic process [GO:0019432] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789] glyceryl-ether monooxygenase activity [GO:0050479]; iron ion binding [GO:0005506] g14713.t1 A0JPQ8 51.19 252 5.05e-91 281.0 sp|A0JPQ8|ALKMO_RAT Alkylglycerol monooxygenase OS=Rattus norvegicus OX=10116 GN=Agmo PE=2 SV=1 g14714.t1 Q7ZUB3 50.237 211 1.16e-59 188.0 sp|Q7ZUB3|TSN31_DANRE Tetraspanin-31 OS=Danio rerio OX=7955 GN=tspan31 PE=2 SV=2 g14716.t1 P34275 55.2 375 7.309999999999999e-150 434.0 sp|P34275|IVD_CAEEL Probable acyl-CoA dehydrogenase 6 OS=Caenorhabditis elegans OX=6239 GN=acdh-6 PE=3 SV=2 g14717.t1 Q28D99 55.208 480 0.0 579.0 sp|Q28D99|GADL1_XENTR Acidic amino acid decarboxylase GADL1 (Fragment) OS=Xenopus tropicalis OX=8364 GN=gadl1 PE=2 SV=2 g14719.t1 Q96M20 31.579 437 6.960000000000001e-59 214.0 sp|Q96M20|CNBD2_HUMAN Cyclic nucleotide-binding domain-containing protein 2 OS=Homo sapiens OX=9606 GN=CNBD2 PE=1 SV=2 g14720.t1 Q8R344 57.258 124 3.7e-39 134.0 sp|Q8R344|CCD12_MOUSE Coiled-coil domain-containing protein 12 OS=Mus musculus OX=10090 GN=Ccdc12 PE=1 SV=2 g14721.t1 P23437 75.593 295 3.7999999999999997e-165 463.0 sp|P23437|CDK2_XENLA Cyclin-dependent kinase 2 OS=Xenopus laevis OX=8355 GN=cdk2 PE=1 SV=3 g14725.t1 Q5ZL42 53.511 413 3.47e-157 453.0 sp|Q5ZL42|5MP1_CHICK eIF5-mimic protein 1 OS=Gallus gallus OX=9031 GN=BZW2 PE=2 SV=1 g14727.t1 Q5R4M2 42.504 1294 0.0 986.0 sp|Q5R4M2|ULK4_PONAB Serine/threonine-protein kinase ULK4 OS=Pongo abelii OX=9601 GN=ULK4 PE=2 SV=1 g14729.t1 A2VDC2 79.775 89 1.46e-44 150.0 sp|A2VDC2|HIBCH_XENLA 3-hydroxyisobutyryl-CoA hydrolase, mitochondrial OS=Xenopus laevis OX=8355 GN=hibch PE=2 SV=1 g14730.t1 A2VDC2 52.0 175 1.29e-49 167.0 sp|A2VDC2|HIBCH_XENLA 3-hydroxyisobutyryl-CoA hydrolase, mitochondrial OS=Xenopus laevis OX=8355 GN=hibch PE=2 SV=1 g14733.t1 Q28ZA9 77.174 92 5.76e-40 150.0 sp|Q28ZA9|UNPG_DROPS Homeobox protein unplugged OS=Drosophila pseudoobscura pseudoobscura OX=46245 GN=unpg PE=3 SV=1 g14736.t1 Q61542 32.272 471 1.42e-60 210.0 sp|Q61542|STAR3_MOUSE StAR-related lipid transfer protein 3 OS=Mus musculus OX=10090 GN=Stard3 PE=1 SV=1 g14739.t1 P31335 68.602 465 0.0 701.0 sp|P31335|PUR9_CHICK Bifunctional purine biosynthesis protein ATIC OS=Gallus gallus OX=9031 GN=ATIC PE=1 SV=1 g14743.t1 P31335 65.625 128 7.57e-53 178.0 sp|P31335|PUR9_CHICK Bifunctional purine biosynthesis protein ATIC OS=Gallus gallus OX=9031 GN=ATIC PE=1 SV=1 g14744.t1 Q96IG2 65.574 427 0.0 554.0 sp|Q96IG2|FXL20_HUMAN F-box/LRR-repeat protein 20 OS=Homo sapiens OX=9606 GN=FBXL20 PE=1 SV=2 g14746.t1 Q5PQQ9 41.481 135 7.5e-24 105.0 sp|Q5PQQ9|CEP70_RAT Centrosomal protein of 70 kDa OS=Rattus norvegicus OX=10116 GN=Cep70 PE=2 SV=1 CEP70_RAT reviewed Centrosomal protein of 70 kDa (Cep70) Rattus norvegicus (Rat) GO:0005813; GO:0005815; GO:0042802; GO:0043015; GO:0060271; GO:0070507 cilium assembly [GO:0060271]; regulation of microtubule cytoskeleton organization [GO:0070507] centrosome [GO:0005813]; microtubule organizing center [GO:0005815] gamma-tubulin binding [GO:0043015]; identical protein binding [GO:0042802] g14747.t1 Q92547 43.164 746 0.0 605.0 sp|Q92547|TOPB1_HUMAN DNA topoisomerase 2-binding protein 1 OS=Homo sapiens OX=9606 GN=TOPBP1 PE=1 SV=3 TOPB1_HUMAN reviewed DNA topoisomerase 2-binding protein 1 (DNA topoisomerase II-beta-binding protein 1) (TopBP1) (DNA topoisomerase II-binding protein 1) Homo sapiens (Human) GO:0000076; GO:0000077; GO:0000724; GO:0000794; GO:0000922; GO:0001673; GO:0003677; GO:0005634; GO:0005654; GO:0005694; GO:0005813; GO:0005886; GO:0006259; GO:0006270; GO:0006281; GO:0006974; GO:0007095; GO:0010212; GO:0015629; GO:0016604; GO:0016605; GO:0033314; GO:0035825; GO:0035861; GO:0042802; GO:0043539; GO:0051276; GO:0070532; GO:0090734; GO:0097680; GO:0097681; GO:0140031; GO:0140463; GO:0141112; GO:1990166 broken chromosome clustering [GO:0141112]; chromosome organization [GO:0051276]; DNA damage checkpoint signaling [GO:0000077]; DNA damage response [GO:0006974]; DNA metabolic process [GO:0006259]; DNA repair [GO:0006281]; DNA replication checkpoint signaling [GO:0000076]; DNA replication initiation [GO:0006270]; double-strand break repair via alternative nonhomologous end joining [GO:0097681]; double-strand break repair via classical nonhomologous end joining [GO:0097680]; double-strand break repair via homologous recombination [GO:0000724]; homologous recombination [GO:0035825]; mitotic DNA replication checkpoint signaling [GO:0033314]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; protein localization to site of double-strand break [GO:1990166]; response to ionizing radiation [GO:0010212] actin cytoskeleton [GO:0015629]; BRCA1-B complex [GO:0070532]; centrosome [GO:0005813]; chromosome [GO:0005694]; condensed nuclear chromosome [GO:0000794]; male germ cell nucleus [GO:0001673]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; PML body [GO:0016605]; site of DNA damage [GO:0090734]; site of double-strand break [GO:0035861]; spindle pole [GO:0000922] chromatin-protein adaptor activity [GO:0140463]; DNA binding [GO:0003677]; identical protein binding [GO:0042802]; phosphorylation-dependent protein binding [GO:0140031]; protein serine/threonine kinase activator activity [GO:0043539] g14747.t1 Q92547 38.71 496 1.4e-85 313.0 sp|Q92547|TOPB1_HUMAN DNA topoisomerase 2-binding protein 1 OS=Homo sapiens OX=9606 GN=TOPBP1 PE=1 SV=3 TOPB1_HUMAN reviewed DNA topoisomerase 2-binding protein 1 (DNA topoisomerase II-beta-binding protein 1) (TopBP1) (DNA topoisomerase II-binding protein 1) Homo sapiens (Human) GO:0000076; GO:0000077; GO:0000724; GO:0000794; GO:0000922; GO:0001673; GO:0003677; GO:0005634; GO:0005654; GO:0005694; GO:0005813; GO:0005886; GO:0006259; GO:0006270; GO:0006281; GO:0006974; GO:0007095; GO:0010212; GO:0015629; GO:0016604; GO:0016605; GO:0033314; GO:0035825; GO:0035861; GO:0042802; GO:0043539; GO:0051276; GO:0070532; GO:0090734; GO:0097680; GO:0097681; GO:0140031; GO:0140463; GO:0141112; GO:1990166 broken chromosome clustering [GO:0141112]; chromosome organization [GO:0051276]; DNA damage checkpoint signaling [GO:0000077]; DNA damage response [GO:0006974]; DNA metabolic process [GO:0006259]; DNA repair [GO:0006281]; DNA replication checkpoint signaling [GO:0000076]; DNA replication initiation [GO:0006270]; double-strand break repair via alternative nonhomologous end joining [GO:0097681]; double-strand break repair via classical nonhomologous end joining [GO:0097680]; double-strand break repair via homologous recombination [GO:0000724]; homologous recombination [GO:0035825]; mitotic DNA replication checkpoint signaling [GO:0033314]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; protein localization to site of double-strand break [GO:1990166]; response to ionizing radiation [GO:0010212] actin cytoskeleton [GO:0015629]; BRCA1-B complex [GO:0070532]; centrosome [GO:0005813]; chromosome [GO:0005694]; condensed nuclear chromosome [GO:0000794]; male germ cell nucleus [GO:0001673]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; PML body [GO:0016605]; site of DNA damage [GO:0090734]; site of double-strand break [GO:0035861]; spindle pole [GO:0000922] chromatin-protein adaptor activity [GO:0140463]; DNA binding [GO:0003677]; identical protein binding [GO:0042802]; phosphorylation-dependent protein binding [GO:0140031]; protein serine/threonine kinase activator activity [GO:0043539] g14747.t1 Q92547 37.681 276 3.43e-40 167.0 sp|Q92547|TOPB1_HUMAN DNA topoisomerase 2-binding protein 1 OS=Homo sapiens OX=9606 GN=TOPBP1 PE=1 SV=3 TOPB1_HUMAN reviewed DNA topoisomerase 2-binding protein 1 (DNA topoisomerase II-beta-binding protein 1) (TopBP1) (DNA topoisomerase II-binding protein 1) Homo sapiens (Human) GO:0000076; GO:0000077; GO:0000724; GO:0000794; GO:0000922; GO:0001673; GO:0003677; GO:0005634; GO:0005654; GO:0005694; GO:0005813; GO:0005886; GO:0006259; GO:0006270; GO:0006281; GO:0006974; GO:0007095; GO:0010212; GO:0015629; GO:0016604; GO:0016605; GO:0033314; GO:0035825; GO:0035861; GO:0042802; GO:0043539; GO:0051276; GO:0070532; GO:0090734; GO:0097680; GO:0097681; GO:0140031; GO:0140463; GO:0141112; GO:1990166 broken chromosome clustering [GO:0141112]; chromosome organization [GO:0051276]; DNA damage checkpoint signaling [GO:0000077]; DNA damage response [GO:0006974]; DNA metabolic process [GO:0006259]; DNA repair [GO:0006281]; DNA replication checkpoint signaling [GO:0000076]; DNA replication initiation [GO:0006270]; double-strand break repair via alternative nonhomologous end joining [GO:0097681]; double-strand break repair via classical nonhomologous end joining [GO:0097680]; double-strand break repair via homologous recombination [GO:0000724]; homologous recombination [GO:0035825]; mitotic DNA replication checkpoint signaling [GO:0033314]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; protein localization to site of double-strand break [GO:1990166]; response to ionizing radiation [GO:0010212] actin cytoskeleton [GO:0015629]; BRCA1-B complex [GO:0070532]; centrosome [GO:0005813]; chromosome [GO:0005694]; condensed nuclear chromosome [GO:0000794]; male germ cell nucleus [GO:0001673]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; PML body [GO:0016605]; site of DNA damage [GO:0090734]; site of double-strand break [GO:0035861]; spindle pole [GO:0000922] chromatin-protein adaptor activity [GO:0140463]; DNA binding [GO:0003677]; identical protein binding [GO:0042802]; phosphorylation-dependent protein binding [GO:0140031]; protein serine/threonine kinase activator activity [GO:0043539] g14747.t2 Q92547 43.029 746 0.0 603.0 sp|Q92547|TOPB1_HUMAN DNA topoisomerase 2-binding protein 1 OS=Homo sapiens OX=9606 GN=TOPBP1 PE=1 SV=3 TOPB1_HUMAN reviewed DNA topoisomerase 2-binding protein 1 (DNA topoisomerase II-beta-binding protein 1) (TopBP1) (DNA topoisomerase II-binding protein 1) Homo sapiens (Human) GO:0000076; GO:0000077; GO:0000724; GO:0000794; GO:0000922; GO:0001673; GO:0003677; GO:0005634; GO:0005654; GO:0005694; GO:0005813; GO:0005886; GO:0006259; GO:0006270; GO:0006281; GO:0006974; GO:0007095; GO:0010212; GO:0015629; GO:0016604; GO:0016605; GO:0033314; GO:0035825; GO:0035861; GO:0042802; GO:0043539; GO:0051276; GO:0070532; GO:0090734; GO:0097680; GO:0097681; GO:0140031; GO:0140463; GO:0141112; GO:1990166 broken chromosome clustering [GO:0141112]; chromosome organization [GO:0051276]; DNA damage checkpoint signaling [GO:0000077]; DNA damage response [GO:0006974]; DNA metabolic process [GO:0006259]; DNA repair [GO:0006281]; DNA replication checkpoint signaling [GO:0000076]; DNA replication initiation [GO:0006270]; double-strand break repair via alternative nonhomologous end joining [GO:0097681]; double-strand break repair via classical nonhomologous end joining [GO:0097680]; double-strand break repair via homologous recombination [GO:0000724]; homologous recombination [GO:0035825]; mitotic DNA replication checkpoint signaling [GO:0033314]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; protein localization to site of double-strand break [GO:1990166]; response to ionizing radiation [GO:0010212] actin cytoskeleton [GO:0015629]; BRCA1-B complex [GO:0070532]; centrosome [GO:0005813]; chromosome [GO:0005694]; condensed nuclear chromosome [GO:0000794]; male germ cell nucleus [GO:0001673]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; PML body [GO:0016605]; site of DNA damage [GO:0090734]; site of double-strand break [GO:0035861]; spindle pole [GO:0000922] chromatin-protein adaptor activity [GO:0140463]; DNA binding [GO:0003677]; identical protein binding [GO:0042802]; phosphorylation-dependent protein binding [GO:0140031]; protein serine/threonine kinase activator activity [GO:0043539] g14747.t2 Q92547 38.71 496 1.41e-85 313.0 sp|Q92547|TOPB1_HUMAN DNA topoisomerase 2-binding protein 1 OS=Homo sapiens OX=9606 GN=TOPBP1 PE=1 SV=3 TOPB1_HUMAN reviewed DNA topoisomerase 2-binding protein 1 (DNA topoisomerase II-beta-binding protein 1) (TopBP1) (DNA topoisomerase II-binding protein 1) Homo sapiens (Human) GO:0000076; GO:0000077; GO:0000724; GO:0000794; GO:0000922; GO:0001673; GO:0003677; GO:0005634; GO:0005654; GO:0005694; GO:0005813; GO:0005886; GO:0006259; GO:0006270; GO:0006281; GO:0006974; GO:0007095; GO:0010212; GO:0015629; GO:0016604; GO:0016605; GO:0033314; GO:0035825; GO:0035861; GO:0042802; GO:0043539; GO:0051276; GO:0070532; GO:0090734; GO:0097680; GO:0097681; GO:0140031; GO:0140463; GO:0141112; GO:1990166 broken chromosome clustering [GO:0141112]; chromosome organization [GO:0051276]; DNA damage checkpoint signaling [GO:0000077]; DNA damage response [GO:0006974]; DNA metabolic process [GO:0006259]; DNA repair [GO:0006281]; DNA replication checkpoint signaling [GO:0000076]; DNA replication initiation [GO:0006270]; double-strand break repair via alternative nonhomologous end joining [GO:0097681]; double-strand break repair via classical nonhomologous end joining [GO:0097680]; double-strand break repair via homologous recombination [GO:0000724]; homologous recombination [GO:0035825]; mitotic DNA replication checkpoint signaling [GO:0033314]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; protein localization to site of double-strand break [GO:1990166]; response to ionizing radiation [GO:0010212] actin cytoskeleton [GO:0015629]; BRCA1-B complex [GO:0070532]; centrosome [GO:0005813]; chromosome [GO:0005694]; condensed nuclear chromosome [GO:0000794]; male germ cell nucleus [GO:0001673]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; PML body [GO:0016605]; site of DNA damage [GO:0090734]; site of double-strand break [GO:0035861]; spindle pole [GO:0000922] chromatin-protein adaptor activity [GO:0140463]; DNA binding [GO:0003677]; identical protein binding [GO:0042802]; phosphorylation-dependent protein binding [GO:0140031]; protein serine/threonine kinase activator activity [GO:0043539] g14747.t2 Q92547 37.681 276 3.4599999999999997e-40 167.0 sp|Q92547|TOPB1_HUMAN DNA topoisomerase 2-binding protein 1 OS=Homo sapiens OX=9606 GN=TOPBP1 PE=1 SV=3 TOPB1_HUMAN reviewed DNA topoisomerase 2-binding protein 1 (DNA topoisomerase II-beta-binding protein 1) (TopBP1) (DNA topoisomerase II-binding protein 1) Homo sapiens (Human) GO:0000076; GO:0000077; GO:0000724; GO:0000794; GO:0000922; GO:0001673; GO:0003677; GO:0005634; GO:0005654; GO:0005694; GO:0005813; GO:0005886; GO:0006259; GO:0006270; GO:0006281; GO:0006974; GO:0007095; GO:0010212; GO:0015629; GO:0016604; GO:0016605; GO:0033314; GO:0035825; GO:0035861; GO:0042802; GO:0043539; GO:0051276; GO:0070532; GO:0090734; GO:0097680; GO:0097681; GO:0140031; GO:0140463; GO:0141112; GO:1990166 broken chromosome clustering [GO:0141112]; chromosome organization [GO:0051276]; DNA damage checkpoint signaling [GO:0000077]; DNA damage response [GO:0006974]; DNA metabolic process [GO:0006259]; DNA repair [GO:0006281]; DNA replication checkpoint signaling [GO:0000076]; DNA replication initiation [GO:0006270]; double-strand break repair via alternative nonhomologous end joining [GO:0097681]; double-strand break repair via classical nonhomologous end joining [GO:0097680]; double-strand break repair via homologous recombination [GO:0000724]; homologous recombination [GO:0035825]; mitotic DNA replication checkpoint signaling [GO:0033314]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; protein localization to site of double-strand break [GO:1990166]; response to ionizing radiation [GO:0010212] actin cytoskeleton [GO:0015629]; BRCA1-B complex [GO:0070532]; centrosome [GO:0005813]; chromosome [GO:0005694]; condensed nuclear chromosome [GO:0000794]; male germ cell nucleus [GO:0001673]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; PML body [GO:0016605]; site of DNA damage [GO:0090734]; site of double-strand break [GO:0035861]; spindle pole [GO:0000922] chromatin-protein adaptor activity [GO:0140463]; DNA binding [GO:0003677]; identical protein binding [GO:0042802]; phosphorylation-dependent protein binding [GO:0140031]; protein serine/threonine kinase activator activity [GO:0043539] g14749.t1 Q56A18 49.55 111 1.18e-24 99.0 sp|Q56A18|SMCE1_RAT SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily E member 1 OS=Rattus norvegicus OX=10116 GN=Smarce1 PE=1 SV=1 SMCE1_RAT reviewed SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily E member 1 (BRG1-associated factor 57) (BAF57) Rattus norvegicus (Rat) GO:0003677; GO:0003723; GO:0005634; GO:0005654; GO:0006337; GO:0006338; GO:0007286; GO:0008080; GO:0016514; GO:0016922; GO:0022008; GO:0045892; GO:0071564; GO:0071565 chromatin remodeling [GO:0006338]; negative regulation of DNA-templated transcription [GO:0045892]; neurogenesis [GO:0022008]; nucleosome disassembly [GO:0006337]; spermatid development [GO:0007286] nBAF complex [GO:0071565]; npBAF complex [GO:0071564]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SWI/SNF complex [GO:0016514] DNA binding [GO:0003677]; N-acetyltransferase activity [GO:0008080]; nuclear receptor binding [GO:0016922]; RNA binding [GO:0003723] g14751.t1 A1A4L0 55.583 412 5.62e-159 460.0 sp|A1A4L0|SNX4_BOVIN Sorting nexin-4 OS=Bos taurus OX=9913 GN=SNX4 PE=2 SV=1 SNX4_BOVIN reviewed Sorting nexin-4 Bos taurus (Bovine) GO:0005769; GO:0005868; GO:0005886; GO:0015031; GO:0031201; GO:0031901; GO:0032266; GO:0032456; GO:0035091; GO:2000786 endocytic recycling [GO:0032456]; positive regulation of autophagosome assembly [GO:2000786]; protein transport [GO:0015031] cytoplasmic dynein complex [GO:0005868]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; plasma membrane [GO:0005886]; SNARE complex [GO:0031201] phosphatidylinositol binding [GO:0035091]; phosphatidylinositol-3-phosphate binding [GO:0032266] g14753.t1 Q90999 49.351 308 4.54e-99 314.0 sp|Q90999|TGFR2_CHICK TGF-beta receptor type-2 OS=Gallus gallus OX=9031 GN=TGFBR2 PE=1 SV=1 TGFR2_CHICK reviewed TGF-beta receptor type-2 (TGFR-2) (EC 2.7.11.30) (TGF-beta type II receptor) (Transforming growth factor-beta receptor type II) (TGF-beta receptor type II) (TbetaR-II) Gallus gallus (Chicken) GO:0001654; GO:0001666; GO:0001775; GO:0004675; GO:0005024; GO:0005026; GO:0005524; GO:0005539; GO:0005886; GO:0005901; GO:0006468; GO:0006915; GO:0007179; GO:0007399; GO:0007507; GO:0009410; GO:0009897; GO:0010628; GO:0010718; GO:0010936; GO:0016020; GO:0016361; GO:0016477; GO:0030324; GO:0030335; GO:0031012; GO:0032570; GO:0032924; GO:0034713; GO:0034714; GO:0043235; GO:0045121; GO:0045216; GO:0046872; GO:0048179; GO:0048185; GO:0048568; GO:0048762; GO:0050431; GO:0050714; GO:0051496; GO:0060317; GO:0060325; GO:0070483; GO:0070723; GO:0071363; GO:1905075; GO:2000379 activin receptor signaling pathway [GO:0032924]; apoptotic process [GO:0006915]; cardiac epithelial to mesenchymal transition [GO:0060317]; cell activation [GO:0001775]; cell migration [GO:0016477]; cell-cell junction organization [GO:0045216]; cellular response to growth factor stimulus [GO:0071363]; detection of hypoxia [GO:0070483]; embryonic organ development [GO:0048568]; eye development [GO:0001654]; face morphogenesis [GO:0060325]; heart development [GO:0007507]; lung development [GO:0030324]; mesenchymal cell differentiation [GO:0048762]; negative regulation of macrophage cytokine production [GO:0010936]; nervous system development [GO:0007399]; positive regulation of cell migration [GO:0030335]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of tight junction disassembly [GO:1905075]; protein phosphorylation [GO:0006468]; response to cholesterol [GO:0070723]; response to hypoxia [GO:0001666]; response to progesterone [GO:0032570]; response to xenobiotic stimulus [GO:0009410]; transforming growth factor beta receptor signaling pathway [GO:0007179] activin receptor complex [GO:0048179]; caveola [GO:0005901]; external side of plasma membrane [GO:0009897]; extracellular matrix [GO:0031012]; membrane [GO:0016020]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] activin binding [GO:0048185]; activin receptor activity, type I [GO:0016361]; ATP binding [GO:0005524]; glycosaminoglycan binding [GO:0005539]; metal ion binding [GO:0046872]; transforming growth factor beta binding [GO:0050431]; transforming growth factor beta receptor activity [GO:0005024]; transforming growth factor beta receptor activity, type II [GO:0005026]; transmembrane receptor protein serine/threonine kinase activity [GO:0004675]; type I transforming growth factor beta receptor binding [GO:0034713]; type III transforming growth factor beta receptor binding [GO:0034714] g14757.t1 Q66I06 47.552 143 1.9199999999999998e-40 137.0 sp|Q66I06|GGACB_DANRE Gamma-glutamylaminecyclotransferase B OS=Danio rerio OX=7955 GN=ggact.2 PE=2 SV=1 GGACB_DANRE reviewed Gamma-glutamylaminecyclotransferase B (GGACT B) (EC 4.3.2.8) (AIG2-like domain-containing protein 1-B) (Gamma-glutamylamine cyclotransferase B) (Gamma-glutamylamine cyclotransferase, tandem duplicate 2) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005829; GO:0042219; GO:0061929 modified amino acid catabolic process [GO:0042219] cytosol [GO:0005829] gamma-glutamylaminecyclotransferase activity [GO:0061929] g14759.t1 Q8BFP9 46.436 463 6.5e-139 409.0 sp|Q8BFP9|PDK1_MOUSE [Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 1, mitochondrial OS=Mus musculus OX=10090 GN=Pdk1 PE=1 SV=2 PDK1_MOUSE reviewed [Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 1, mitochondrial (EC 2.7.11.2) (Pyruvate dehydrogenase kinase isoform 1) (PDH kinase 1) Mus musculus (Mouse) GO:0004672; GO:0004674; GO:0004740; GO:0005524; GO:0005739; GO:0005759; GO:0005886; GO:0007166; GO:0008283; GO:0008631; GO:0010510; GO:0010906; GO:0035556; GO:0042802; GO:0044877; GO:0045254; GO:0097411 cell population proliferation [GO:0008283]; cell surface receptor signaling pathway [GO:0007166]; hypoxia-inducible factor-1alpha signaling pathway [GO:0097411]; intracellular signal transduction [GO:0035556]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; regulation of glucose metabolic process [GO:0010906]; regulation of pyruvate decarboxylation to acetyl-CoA [GO:0010510] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; pyruvate dehydrogenase complex [GO:0045254] ATP binding [GO:0005524]; identical protein binding [GO:0042802]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; protein-containing complex binding [GO:0044877]; pyruvate dehydrogenase (acetyl-transferring) kinase activity [GO:0004740] g14759.t2 Q64536 59.698 397 1.5500000000000002e-167 478.0 sp|Q64536|PDK2_RAT [Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 2, mitochondrial OS=Rattus norvegicus OX=10116 GN=Pdk2 PE=1 SV=1 PDK2_RAT reviewed [Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 2, mitochondrial (EC 2.7.11.2) (PDK P45) (Pyruvate dehydrogenase kinase isoform 2) (PDH kinase 2) Rattus norvegicus (Rat) GO:0004674; GO:0004740; GO:0005524; GO:0005654; GO:0005739; GO:0005759; GO:0005829; GO:0006111; GO:0006885; GO:0008286; GO:0010510; GO:0010565; GO:0010906; GO:0018105; GO:0031670; GO:0034614; GO:0042593; GO:0042802; GO:0042803; GO:0044877; GO:0045254; GO:0050848; GO:0072332 cellular response to nutrient [GO:0031670]; cellular response to reactive oxygen species [GO:0034614]; glucose homeostasis [GO:0042593]; insulin receptor signaling pathway [GO:0008286]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; peptidyl-serine phosphorylation [GO:0018105]; regulation of calcium-mediated signaling [GO:0050848]; regulation of gluconeogenesis [GO:0006111]; regulation of glucose metabolic process [GO:0010906]; regulation of ketone metabolic process [GO:0010565]; regulation of pH [GO:0006885]; regulation of pyruvate decarboxylation to acetyl-CoA [GO:0010510] cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; pyruvate dehydrogenase complex [GO:0045254] ATP binding [GO:0005524]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; protein serine/threonine kinase activity [GO:0004674]; protein-containing complex binding [GO:0044877]; pyruvate dehydrogenase (acetyl-transferring) kinase activity [GO:0004740] g14760.t1 Q3ULD5 71.639 543 0.0 823.0 sp|Q3ULD5|MCCB_MOUSE Methylcrotonoyl-CoA carboxylase beta chain, mitochondrial OS=Mus musculus OX=10090 GN=Mccc2 PE=1 SV=1 g14762.t1 A0A1L8H0H2 45.625 160 9.76e-28 120.0 sp|A0A1L8H0H2|RFX7_XENLA DNA-binding protein RFX7 OS=Xenopus laevis OX=8355 GN=rfx7.L PE=2 SV=1 g14764.t1 Q2KIC2 66.845 187 5.93e-73 242.0 sp|Q2KIC2|ETV1_BOVIN ETS translocation variant 1 OS=Bos taurus OX=9913 GN=ETV1 PE=2 SV=1 g14766.t1 A0JPF9 45.6 250 2.68e-68 226.0 sp|A0JPF9|ISPD_DANRE D-ribitol-5-phosphate cytidylyltransferase OS=Danio rerio OX=7955 GN=crppa PE=2 SV=2 ISPD_DANRE reviewed D-ribitol-5-phosphate cytidylyltransferase (EC 2.7.7.40) (2-C-methyl-D-erythritol 4-phosphate cytidylyltransferase-like protein) (Isoprenoid synthase domain-containing protein) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005829; GO:0008299; GO:0035269; GO:0042803; GO:0047349; GO:0048854; GO:0055001; GO:0070567 brain morphogenesis [GO:0048854]; isoprenoid biosynthetic process [GO:0008299]; muscle cell development [GO:0055001]; protein O-linked glycosylation via mannose [GO:0035269] cytosol [GO:0005829] cytidylyltransferase activity [GO:0070567]; D-ribitol-5-phosphate cytidylyltransferase activity [GO:0047349]; protein homodimerization activity [GO:0042803] g14768.t1 Q6VYA3 54.128 109 1.38e-32 120.0 sp|Q6VYA3|SOSD1_CHICK Sclerostin domain-containing protein 1 OS=Gallus gallus OX=9031 GN=SOSTDC1 PE=1 SV=1 g14771.t1 Q8MYF2 46.746 169 6.54e-51 169.0 sp|Q8MYF2|RABJ_DICDI Ras-related protein RabJ OS=Dictyostelium discoideum OX=44689 GN=rabJ PE=3 SV=1 g14774.t1 P10079 52.408 353 4.24e-120 375.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g14774.t1 P10079 53.39 354 5.66e-119 372.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g14774.t1 P10079 52.975 353 8.81e-119 371.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g14774.t1 P10079 52.825 354 1.04e-115 363.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g14774.t1 P10079 51.558 353 3.6399999999999996e-115 362.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g14774.t1 P10079 53.107 354 2.1e-114 360.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g14774.t1 P10079 51.989 352 3.0299999999999998e-111 352.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g14774.t1 P10079 51.25 320 2.25e-96 312.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g14775.t1 Q3TZZ7 36.525 846 1.0699999999999999e-170 519.0 sp|Q3TZZ7|ESYT2_MOUSE Extended synaptotagmin-2 OS=Mus musculus OX=10090 GN=Esyt2 PE=1 SV=1 ESYT2_MOUSE reviewed Extended synaptotagmin-2 (E-Syt2) Mus musculus (Mouse) GO:0005509; GO:0005544; GO:0005789; GO:0005829; GO:0005886; GO:0006869; GO:0006897; GO:0008429; GO:0009898; GO:0031210; GO:0035091; GO:0042802; GO:0044232; GO:0061817; GO:0140268 endocytosis [GO:0006897]; endoplasmic reticulum-plasma membrane tethering [GO:0061817]; lipid transport [GO:0006869] cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-plasma membrane contact site [GO:0140268]; organelle membrane contact site [GO:0044232]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; identical protein binding [GO:0042802]; phosphatidylcholine binding [GO:0031210]; phosphatidylethanolamine binding [GO:0008429]; phosphatidylinositol binding [GO:0035091] g14775.t2 Q3TZZ7 37.064 831 2.5599999999999997e-172 522.0 sp|Q3TZZ7|ESYT2_MOUSE Extended synaptotagmin-2 OS=Mus musculus OX=10090 GN=Esyt2 PE=1 SV=1 ESYT2_MOUSE reviewed Extended synaptotagmin-2 (E-Syt2) Mus musculus (Mouse) GO:0005509; GO:0005544; GO:0005789; GO:0005829; GO:0005886; GO:0006869; GO:0006897; GO:0008429; GO:0009898; GO:0031210; GO:0035091; GO:0042802; GO:0044232; GO:0061817; GO:0140268 endocytosis [GO:0006897]; endoplasmic reticulum-plasma membrane tethering [GO:0061817]; lipid transport [GO:0006869] cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-plasma membrane contact site [GO:0140268]; organelle membrane contact site [GO:0044232]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; identical protein binding [GO:0042802]; phosphatidylcholine binding [GO:0031210]; phosphatidylethanolamine binding [GO:0008429]; phosphatidylinositol binding [GO:0035091] g14776.t1 P79098 34.694 931 3.97e-166 515.0 sp|P79098|AMPN_BOVIN Aminopeptidase N OS=Bos taurus OX=9913 GN=ANPEP PE=2 SV=4 AMPN_BOVIN reviewed Aminopeptidase N (AP-N) (bAPN) (EC 3.4.11.2) (Alanyl aminopeptidase) (Aminopeptidase M) (AP-M) (Microsomal aminopeptidase) (CD antigen CD13) Bos taurus (Bovine) GO:0001525; GO:0001618; GO:0002003; GO:0005615; GO:0005886; GO:0008270; GO:0016285; GO:0030154; GO:0043171; GO:0070006 angiogenesis [GO:0001525]; angiotensin maturation [GO:0002003]; cell differentiation [GO:0030154]; peptide catabolic process [GO:0043171] extracellular space [GO:0005615]; plasma membrane [GO:0005886] alanyl aminopeptidase activity [GO:0016285]; metalloaminopeptidase activity [GO:0070006]; virus receptor activity [GO:0001618]; zinc ion binding [GO:0008270] g14777.t1 P79098 29.159 535 1.02e-57 209.0 sp|P79098|AMPN_BOVIN Aminopeptidase N OS=Bos taurus OX=9913 GN=ANPEP PE=2 SV=4 AMPN_BOVIN reviewed Aminopeptidase N (AP-N) (bAPN) (EC 3.4.11.2) (Alanyl aminopeptidase) (Aminopeptidase M) (AP-M) (Microsomal aminopeptidase) (CD antigen CD13) Bos taurus (Bovine) GO:0001525; GO:0001618; GO:0002003; GO:0005615; GO:0005886; GO:0008270; GO:0016285; GO:0030154; GO:0043171; GO:0070006 angiogenesis [GO:0001525]; angiotensin maturation [GO:0002003]; cell differentiation [GO:0030154]; peptide catabolic process [GO:0043171] extracellular space [GO:0005615]; plasma membrane [GO:0005886] alanyl aminopeptidase activity [GO:0016285]; metalloaminopeptidase activity [GO:0070006]; virus receptor activity [GO:0001618]; zinc ion binding [GO:0008270] g14777.t2 P79098 28.972 535 6.13e-57 207.0 sp|P79098|AMPN_BOVIN Aminopeptidase N OS=Bos taurus OX=9913 GN=ANPEP PE=2 SV=4 AMPN_BOVIN reviewed Aminopeptidase N (AP-N) (bAPN) (EC 3.4.11.2) (Alanyl aminopeptidase) (Aminopeptidase M) (AP-M) (Microsomal aminopeptidase) (CD antigen CD13) Bos taurus (Bovine) GO:0001525; GO:0001618; GO:0002003; GO:0005615; GO:0005886; GO:0008270; GO:0016285; GO:0030154; GO:0043171; GO:0070006 angiogenesis [GO:0001525]; angiotensin maturation [GO:0002003]; cell differentiation [GO:0030154]; peptide catabolic process [GO:0043171] extracellular space [GO:0005615]; plasma membrane [GO:0005886] alanyl aminopeptidase activity [GO:0016285]; metalloaminopeptidase activity [GO:0070006]; virus receptor activity [GO:0001618]; zinc ion binding [GO:0008270] g14778.t1 P15145 37.538 325 3.4199999999999995e-55 199.0 sp|P15145|AMPN_PIG Aminopeptidase N OS=Sus scrofa OX=9823 GN=ANPEP PE=1 SV=4 g14779.t1 P15145 33.486 875 4.63e-145 456.0 sp|P15145|AMPN_PIG Aminopeptidase N OS=Sus scrofa OX=9823 GN=ANPEP PE=1 SV=4 g14781.t1 P79098 34.015 929 3.5300000000000003e-161 503.0 sp|P79098|AMPN_BOVIN Aminopeptidase N OS=Bos taurus OX=9913 GN=ANPEP PE=2 SV=4 AMPN_BOVIN reviewed Aminopeptidase N (AP-N) (bAPN) (EC 3.4.11.2) (Alanyl aminopeptidase) (Aminopeptidase M) (AP-M) (Microsomal aminopeptidase) (CD antigen CD13) Bos taurus (Bovine) GO:0001525; GO:0001618; GO:0002003; GO:0005615; GO:0005886; GO:0008270; GO:0016285; GO:0030154; GO:0043171; GO:0070006 angiogenesis [GO:0001525]; angiotensin maturation [GO:0002003]; cell differentiation [GO:0030154]; peptide catabolic process [GO:0043171] extracellular space [GO:0005615]; plasma membrane [GO:0005886] alanyl aminopeptidase activity [GO:0016285]; metalloaminopeptidase activity [GO:0070006]; virus receptor activity [GO:0001618]; zinc ion binding [GO:0008270] g14782.t1 P15145 32.609 920 2.55e-142 452.0 sp|P15145|AMPN_PIG Aminopeptidase N OS=Sus scrofa OX=9823 GN=ANPEP PE=1 SV=4 g14785.t1 Q96HA9 45.263 190 3.83e-37 134.0 sp|Q96HA9|PX11C_HUMAN Peroxisomal membrane protein 11C OS=Homo sapiens OX=9606 GN=PEX11G PE=1 SV=1 PX11C_HUMAN reviewed Peroxisomal membrane protein 11C (Peroxin-11C) (Peroxisomal biogenesis factor 11C) (Protein PEX11 homolog gamma) (PEX11-gamma) Homo sapiens (Human) GO:0005777; GO:0005778; GO:0016559; GO:0032991; GO:0044375 peroxisome fission [GO:0016559]; regulation of peroxisome size [GO:0044375] peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; protein-containing complex [GO:0032991] g14786.t1 Q02224 51.835 436 6.65e-125 428.0 sp|Q02224|CENPE_HUMAN Centromere-associated protein E OS=Homo sapiens OX=9606 GN=CENPE PE=1 SV=2 CENPE_HUMAN reviewed Centromere-associated protein E (Centromere protein E) (CENP-E) (Kinesin-7) (Kinesin-related protein CENPE) Homo sapiens (Human) GO:0000278; GO:0000775; GO:0000776; GO:0000779; GO:0003777; GO:0005524; GO:0005634; GO:0005694; GO:0005828; GO:0005829; GO:0005874; GO:0007018; GO:0007052; GO:0007059; GO:0007079; GO:0007080; GO:0008017; GO:0015630; GO:0016020; GO:0030071; GO:0030496; GO:0043515; GO:0045171; GO:0045860; GO:0051233; GO:0051301; GO:0051310; GO:0051315; GO:0051382; GO:0072686; GO:0099606; GO:0099607; GO:1990023 attachment of mitotic spindle microtubules to kinetochore [GO:0051315]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; kinetochore assembly [GO:0051382]; lateral attachment of mitotic spindle microtubules to kinetochore [GO:0099607]; metaphase chromosome alignment [GO:0051310]; microtubule plus-end directed mitotic chromosome migration [GO:0099606]; microtubule-based movement [GO:0007018]; mitotic cell cycle [GO:0000278]; mitotic chromosome movement towards spindle pole [GO:0007079]; mitotic metaphase chromosome alignment [GO:0007080]; mitotic spindle organization [GO:0007052]; positive regulation of protein kinase activity [GO:0045860]; regulation of mitotic metaphase/anaphase transition [GO:0030071] chromosome [GO:0005694]; chromosome, centromeric region [GO:0000775]; condensed chromosome, centromeric region [GO:0000779]; cytosol [GO:0005829]; intercellular bridge [GO:0045171]; kinetochore [GO:0000776]; kinetochore microtubule [GO:0005828]; membrane [GO:0016020]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; mitotic spindle midzone [GO:1990023]; nucleus [GO:0005634]; spindle midzone [GO:0051233] ATP binding [GO:0005524]; kinetochore binding [GO:0043515]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777] g14790.t1 A1A5G0 53.586 237 4.31e-80 267.0 sp|A1A5G0|CLAP1_XENTR CLIP-associating protein 1 OS=Xenopus tropicalis OX=8364 GN=clasp1 PE=1 SV=1 CLAP1_XENTR reviewed CLIP-associating protein 1 (Cytoplasmic linker-associated protein 1) Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0000776; GO:0005794; GO:0005813; GO:0005815; GO:0005876; GO:0005881; GO:0007020; GO:0007026; GO:0008017; GO:0030010; GO:0031023; GO:0034453; GO:0040001; GO:0043515; GO:0045180; GO:0051301; GO:0072686; GO:0090307 cell division [GO:0051301]; establishment of cell polarity [GO:0030010]; establishment of mitotic spindle localization [GO:0040001]; microtubule anchoring [GO:0034453]; microtubule nucleation [GO:0007020]; microtubule organizing center organization [GO:0031023]; mitotic spindle assembly [GO:0090307]; negative regulation of microtubule depolymerization [GO:0007026] basal cortex [GO:0045180]; centrosome [GO:0005813]; cytoplasmic microtubule [GO:0005881]; Golgi apparatus [GO:0005794]; kinetochore [GO:0000776]; microtubule organizing center [GO:0005815]; mitotic spindle [GO:0072686]; spindle microtubule [GO:0005876] kinetochore binding [GO:0043515]; microtubule binding [GO:0008017] g14792.t1 A1A5G0 41.764 601 9.67e-114 374.0 sp|A1A5G0|CLAP1_XENTR CLIP-associating protein 1 OS=Xenopus tropicalis OX=8364 GN=clasp1 PE=1 SV=1 CLAP1_XENTR reviewed CLIP-associating protein 1 (Cytoplasmic linker-associated protein 1) Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0000776; GO:0005794; GO:0005813; GO:0005815; GO:0005876; GO:0005881; GO:0007020; GO:0007026; GO:0008017; GO:0030010; GO:0031023; GO:0034453; GO:0040001; GO:0043515; GO:0045180; GO:0051301; GO:0072686; GO:0090307 cell division [GO:0051301]; establishment of cell polarity [GO:0030010]; establishment of mitotic spindle localization [GO:0040001]; microtubule anchoring [GO:0034453]; microtubule nucleation [GO:0007020]; microtubule organizing center organization [GO:0031023]; mitotic spindle assembly [GO:0090307]; negative regulation of microtubule depolymerization [GO:0007026] basal cortex [GO:0045180]; centrosome [GO:0005813]; cytoplasmic microtubule [GO:0005881]; Golgi apparatus [GO:0005794]; kinetochore [GO:0000776]; microtubule organizing center [GO:0005815]; mitotic spindle [GO:0072686]; spindle microtubule [GO:0005876] kinetochore binding [GO:0043515]; microtubule binding [GO:0008017] g14793.t1 A1A5G0 50.883 566 9.740000000000001e-157 488.0 sp|A1A5G0|CLAP1_XENTR CLIP-associating protein 1 OS=Xenopus tropicalis OX=8364 GN=clasp1 PE=1 SV=1 CLAP1_XENTR reviewed CLIP-associating protein 1 (Cytoplasmic linker-associated protein 1) Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0000776; GO:0005794; GO:0005813; GO:0005815; GO:0005876; GO:0005881; GO:0007020; GO:0007026; GO:0008017; GO:0030010; GO:0031023; GO:0034453; GO:0040001; GO:0043515; GO:0045180; GO:0051301; GO:0072686; GO:0090307 cell division [GO:0051301]; establishment of cell polarity [GO:0030010]; establishment of mitotic spindle localization [GO:0040001]; microtubule anchoring [GO:0034453]; microtubule nucleation [GO:0007020]; microtubule organizing center organization [GO:0031023]; mitotic spindle assembly [GO:0090307]; negative regulation of microtubule depolymerization [GO:0007026] basal cortex [GO:0045180]; centrosome [GO:0005813]; cytoplasmic microtubule [GO:0005881]; Golgi apparatus [GO:0005794]; kinetochore [GO:0000776]; microtubule organizing center [GO:0005815]; mitotic spindle [GO:0072686]; spindle microtubule [GO:0005876] kinetochore binding [GO:0043515]; microtubule binding [GO:0008017] g14794.t1 Q811S7 48.609 539 3.5299999999999997e-165 480.0 sp|Q811S7|UBIP1_MOUSE Upstream-binding protein 1 OS=Mus musculus OX=10090 GN=Ubp1 PE=1 SV=1 UBIP1_MOUSE reviewed Upstream-binding protein 1 (Nuclear factor 2d9) (NF2d9) Mus musculus (Mouse) GO:0000978; GO:0001228; GO:0001525; GO:0005634; GO:0005654; GO:0005829; GO:0006357; GO:0032897; GO:1990837 angiogenesis [GO:0001525]; negative regulation of viral transcription [GO:0032897]; regulation of transcription by RNA polymerase II [GO:0006357] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837] g14795.t1 Q6DGF4 40.0 215 7.75e-34 124.0 sp|Q6DGF4|ZFAN6_RAT AN1-type zinc finger protein 6 OS=Rattus norvegicus OX=10116 GN=Zfand6 PE=1 SV=1 ZFAN6_RAT reviewed AN1-type zinc finger protein 6 (Zinc finger A20 domain-containing protein 3) Rattus norvegicus (Rat) GO:0003677; GO:0005737; GO:0006625; GO:0006915; GO:0008270; GO:0015031; GO:0031593; GO:0043066; GO:0043122; GO:0071356 apoptotic process [GO:0006915]; cellular response to tumor necrosis factor [GO:0071356]; negative regulation of apoptotic process [GO:0043066]; protein targeting to peroxisome [GO:0006625]; protein transport [GO:0015031]; regulation of canonical NF-kappaB signal transduction [GO:0043122] cytoplasm [GO:0005737] DNA binding [GO:0003677]; polyubiquitin modification-dependent protein binding [GO:0031593]; zinc ion binding [GO:0008270] g14798.t1 Q61830 28.003 1182 1.1999999999999999e-104 370.0 sp|Q61830|MRC1_MOUSE Macrophage mannose receptor 1 OS=Mus musculus OX=10090 GN=Mrc1 PE=1 SV=2 g14798.t1 Q61830 24.003 1204 2.1599999999999998e-69 261.0 sp|Q61830|MRC1_MOUSE Macrophage mannose receptor 1 OS=Mus musculus OX=10090 GN=Mrc1 PE=1 SV=2 g14798.t1 Q61830 23.693 1186 9.65e-66 250.0 sp|Q61830|MRC1_MOUSE Macrophage mannose receptor 1 OS=Mus musculus OX=10090 GN=Mrc1 PE=1 SV=2 g14798.t1 Q61830 27.641 568 7e-36 153.0 sp|Q61830|MRC1_MOUSE Macrophage mannose receptor 1 OS=Mus musculus OX=10090 GN=Mrc1 PE=1 SV=2 g14798.t1 Q61830 23.32 729 8.26e-30 133.0 sp|Q61830|MRC1_MOUSE Macrophage mannose receptor 1 OS=Mus musculus OX=10090 GN=Mrc1 PE=1 SV=2 g14799.t1 O88487 75.369 406 0.0 632.0 sp|O88487|DC1I2_MOUSE Cytoplasmic dynein 1 intermediate chain 2 OS=Mus musculus OX=10090 GN=Dync1i2 PE=1 SV=1 DC1I2_MOUSE reviewed Cytoplasmic dynein 1 intermediate chain 2 (Cytoplasmic dynein intermediate chain 2) (Dynein intermediate chain 2, cytosolic) (DH IC-2) Mus musculus (Mouse) GO:0005813; GO:0005868; GO:0005874; GO:0010970; GO:0010977; GO:0030286; GO:0031982; GO:0036157; GO:0044877; GO:0045503; GO:0045504 negative regulation of neuron projection development [GO:0010977]; transport along microtubule [GO:0010970] centrosome [GO:0005813]; cytoplasmic dynein complex [GO:0005868]; dynein complex [GO:0030286]; microtubule [GO:0005874]; outer dynein arm [GO:0036157]; vesicle [GO:0031982] dynein heavy chain binding [GO:0045504]; dynein light chain binding [GO:0045503]; protein-containing complex binding [GO:0044877] g14799.t2 O88487 75.369 406 0.0 633.0 sp|O88487|DC1I2_MOUSE Cytoplasmic dynein 1 intermediate chain 2 OS=Mus musculus OX=10090 GN=Dync1i2 PE=1 SV=1 DC1I2_MOUSE reviewed Cytoplasmic dynein 1 intermediate chain 2 (Cytoplasmic dynein intermediate chain 2) (Dynein intermediate chain 2, cytosolic) (DH IC-2) Mus musculus (Mouse) GO:0005813; GO:0005868; GO:0005874; GO:0010970; GO:0010977; GO:0030286; GO:0031982; GO:0036157; GO:0044877; GO:0045503; GO:0045504 negative regulation of neuron projection development [GO:0010977]; transport along microtubule [GO:0010970] centrosome [GO:0005813]; cytoplasmic dynein complex [GO:0005868]; dynein complex [GO:0030286]; microtubule [GO:0005874]; outer dynein arm [GO:0036157]; vesicle [GO:0031982] dynein heavy chain binding [GO:0045504]; dynein light chain binding [GO:0045503]; protein-containing complex binding [GO:0044877] g14800.t1 P10079 43.486 545 5.55e-130 422.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g14800.t1 P10079 42.251 542 6.81e-122 400.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g14800.t1 P10079 40.813 566 1.22e-119 394.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g14800.t1 P10079 38.954 593 4.87e-116 385.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g14800.t1 P10079 41.434 502 7.62e-108 362.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g14800.t1 P10079 40.122 491 4.09e-96 330.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g14800.t1 P10079 41.803 366 3.0899999999999998e-83 294.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g14800.t1 P10079 39.143 350 4.45e-54 208.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g14802.t1 P10079 36.61 295 2.52e-45 169.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g14802.t1 P10079 35.472 265 1.76e-40 155.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g14802.t1 P10079 33.025 324 7.73e-39 150.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g14802.t1 P10079 35.762 302 1.8e-38 149.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g14802.t1 P10079 33.916 286 1.39e-37 146.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g14802.t1 P10079 34.437 302 1.85e-37 146.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g14802.t1 P10079 34.444 270 8.72e-34 135.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g14802.t1 P10079 32.727 220 1.71e-26 114.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g14803.t1 Q9QW30 48.619 181 2.49e-51 180.0 sp|Q9QW30|NOTC2_RAT Neurogenic locus notch homolog protein 2 OS=Rattus norvegicus OX=10116 GN=Notch2 PE=1 SV=1 NOTC2_RAT reviewed Neurogenic locus notch homolog protein 2 (Notch 2) [Cleaved into: Notch 2 extracellular truncation; Notch 2 intracellular domain] Rattus norvegicus (Rat) GO:0000122; GO:0001701; GO:0001889; GO:0001890; GO:0001947; GO:0002011; GO:0002315; GO:0002437; GO:0003184; GO:0003713; GO:0005509; GO:0005576; GO:0005634; GO:0005654; GO:0005794; GO:0005829; GO:0005886; GO:0005929; GO:0006357; GO:0006915; GO:0006959; GO:0007219; GO:0007368; GO:0007420; GO:0008284; GO:0009887; GO:0009986; GO:0010629; GO:0010838; GO:0019899; GO:0030326; GO:0030513; GO:0035264; GO:0035556; GO:0035622; GO:0038023; GO:0042060; GO:0042246; GO:0042742; GO:0043011; GO:0043065; GO:0043235; GO:0045672; GO:0045944; GO:0046579; GO:0046849; GO:0051059; GO:0051152; GO:0060413; GO:0060674; GO:0061073; GO:0070374; GO:0070986; GO:0071228; GO:0072014; GO:0072015; GO:0072104; GO:0072574; GO:0072576; GO:0098839; GO:0098978; GO:1902895; GO:1990705; GO:2001204 animal organ morphogenesis [GO:0009887]; apoptotic process [GO:0006915]; atrial septum morphogenesis [GO:0060413]; bone remodeling [GO:0046849]; brain development [GO:0007420]; cellular response to tumor cell [GO:0071228]; cholangiocyte proliferation [GO:1990705]; ciliary body morphogenesis [GO:0061073]; defense response to bacterium [GO:0042742]; determination of left/right symmetry [GO:0007368]; embryonic limb morphogenesis [GO:0030326]; glomerular capillary formation [GO:0072104]; heart looping [GO:0001947]; hepatocyte proliferation [GO:0072574]; humoral immune response [GO:0006959]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; intracellular signal transduction [GO:0035556]; intrahepatic bile duct development [GO:0035622]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; liver morphogenesis [GO:0072576]; marginal zone B cell differentiation [GO:0002315]; morphogenesis of an epithelial sheet [GO:0002011]; multicellular organism growth [GO:0035264]; myeloid dendritic cell differentiation [GO:0043011]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; Notch signaling pathway [GO:0007219]; placenta blood vessel development [GO:0060674]; placenta development [GO:0001890]; podocyte development [GO:0072015]; positive regulation of apoptotic process [GO:0043065]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of keratinocyte proliferation [GO:0010838]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of smooth muscle cell differentiation [GO:0051152]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proximal tubule development [GO:0072014]; pulmonary valve morphogenesis [GO:0003184]; regulation of osteoclast development [GO:2001204]; regulation of transcription by RNA polymerase II [GO:0006357]; tissue regeneration [GO:0042246]; wound healing [GO:0042060] cell surface [GO:0009986]; cilium [GO:0005929]; cytosol [GO:0005829]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; enzyme binding [GO:0019899]; NF-kappaB binding [GO:0051059]; signaling receptor activity [GO:0038023]; transcription coactivator activity [GO:0003713] g14803.t1 Q9QW30 43.716 183 1.34e-43 158.0 sp|Q9QW30|NOTC2_RAT Neurogenic locus notch homolog protein 2 OS=Rattus norvegicus OX=10116 GN=Notch2 PE=1 SV=1 NOTC2_RAT reviewed Neurogenic locus notch homolog protein 2 (Notch 2) [Cleaved into: Notch 2 extracellular truncation; Notch 2 intracellular domain] Rattus norvegicus (Rat) GO:0000122; GO:0001701; GO:0001889; GO:0001890; GO:0001947; GO:0002011; GO:0002315; GO:0002437; GO:0003184; GO:0003713; GO:0005509; GO:0005576; GO:0005634; GO:0005654; GO:0005794; GO:0005829; GO:0005886; GO:0005929; GO:0006357; GO:0006915; GO:0006959; GO:0007219; GO:0007368; GO:0007420; GO:0008284; GO:0009887; GO:0009986; GO:0010629; GO:0010838; GO:0019899; GO:0030326; GO:0030513; GO:0035264; GO:0035556; GO:0035622; GO:0038023; GO:0042060; GO:0042246; GO:0042742; GO:0043011; GO:0043065; GO:0043235; GO:0045672; GO:0045944; GO:0046579; GO:0046849; GO:0051059; GO:0051152; GO:0060413; GO:0060674; GO:0061073; GO:0070374; GO:0070986; GO:0071228; GO:0072014; GO:0072015; GO:0072104; GO:0072574; GO:0072576; GO:0098839; GO:0098978; GO:1902895; GO:1990705; GO:2001204 animal organ morphogenesis [GO:0009887]; apoptotic process [GO:0006915]; atrial septum morphogenesis [GO:0060413]; bone remodeling [GO:0046849]; brain development [GO:0007420]; cellular response to tumor cell [GO:0071228]; cholangiocyte proliferation [GO:1990705]; ciliary body morphogenesis [GO:0061073]; defense response to bacterium [GO:0042742]; determination of left/right symmetry [GO:0007368]; embryonic limb morphogenesis [GO:0030326]; glomerular capillary formation [GO:0072104]; heart looping [GO:0001947]; hepatocyte proliferation [GO:0072574]; humoral immune response [GO:0006959]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; intracellular signal transduction [GO:0035556]; intrahepatic bile duct development [GO:0035622]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; liver morphogenesis [GO:0072576]; marginal zone B cell differentiation [GO:0002315]; morphogenesis of an epithelial sheet [GO:0002011]; multicellular organism growth [GO:0035264]; myeloid dendritic cell differentiation [GO:0043011]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; Notch signaling pathway [GO:0007219]; placenta blood vessel development [GO:0060674]; placenta development [GO:0001890]; podocyte development [GO:0072015]; positive regulation of apoptotic process [GO:0043065]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of keratinocyte proliferation [GO:0010838]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of smooth muscle cell differentiation [GO:0051152]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proximal tubule development [GO:0072014]; pulmonary valve morphogenesis [GO:0003184]; regulation of osteoclast development [GO:2001204]; regulation of transcription by RNA polymerase II [GO:0006357]; tissue regeneration [GO:0042246]; wound healing [GO:0042060] cell surface [GO:0009986]; cilium [GO:0005929]; cytosol [GO:0005829]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; enzyme binding [GO:0019899]; NF-kappaB binding [GO:0051059]; signaling receptor activity [GO:0038023]; transcription coactivator activity [GO:0003713] g14803.t1 Q9QW30 46.448 183 1.2500000000000001e-37 140.0 sp|Q9QW30|NOTC2_RAT Neurogenic locus notch homolog protein 2 OS=Rattus norvegicus OX=10116 GN=Notch2 PE=1 SV=1 NOTC2_RAT reviewed Neurogenic locus notch homolog protein 2 (Notch 2) [Cleaved into: Notch 2 extracellular truncation; Notch 2 intracellular domain] Rattus norvegicus (Rat) GO:0000122; GO:0001701; GO:0001889; GO:0001890; GO:0001947; GO:0002011; GO:0002315; GO:0002437; GO:0003184; GO:0003713; GO:0005509; GO:0005576; GO:0005634; GO:0005654; GO:0005794; GO:0005829; GO:0005886; GO:0005929; GO:0006357; GO:0006915; GO:0006959; GO:0007219; GO:0007368; GO:0007420; GO:0008284; GO:0009887; GO:0009986; GO:0010629; GO:0010838; GO:0019899; GO:0030326; GO:0030513; GO:0035264; GO:0035556; GO:0035622; GO:0038023; GO:0042060; GO:0042246; GO:0042742; GO:0043011; GO:0043065; GO:0043235; GO:0045672; GO:0045944; GO:0046579; GO:0046849; GO:0051059; GO:0051152; GO:0060413; GO:0060674; GO:0061073; GO:0070374; GO:0070986; GO:0071228; GO:0072014; GO:0072015; GO:0072104; GO:0072574; GO:0072576; GO:0098839; GO:0098978; GO:1902895; GO:1990705; GO:2001204 animal organ morphogenesis [GO:0009887]; apoptotic process [GO:0006915]; atrial septum morphogenesis [GO:0060413]; bone remodeling [GO:0046849]; brain development [GO:0007420]; cellular response to tumor cell [GO:0071228]; cholangiocyte proliferation [GO:1990705]; ciliary body morphogenesis [GO:0061073]; defense response to bacterium [GO:0042742]; determination of left/right symmetry [GO:0007368]; embryonic limb morphogenesis [GO:0030326]; glomerular capillary formation [GO:0072104]; heart looping [GO:0001947]; hepatocyte proliferation [GO:0072574]; humoral immune response [GO:0006959]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; intracellular signal transduction [GO:0035556]; intrahepatic bile duct development [GO:0035622]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; liver morphogenesis [GO:0072576]; marginal zone B cell differentiation [GO:0002315]; morphogenesis of an epithelial sheet [GO:0002011]; multicellular organism growth [GO:0035264]; myeloid dendritic cell differentiation [GO:0043011]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; Notch signaling pathway [GO:0007219]; placenta blood vessel development [GO:0060674]; placenta development [GO:0001890]; podocyte development [GO:0072015]; positive regulation of apoptotic process [GO:0043065]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of keratinocyte proliferation [GO:0010838]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of smooth muscle cell differentiation [GO:0051152]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proximal tubule development [GO:0072014]; pulmonary valve morphogenesis [GO:0003184]; regulation of osteoclast development [GO:2001204]; regulation of transcription by RNA polymerase II [GO:0006357]; tissue regeneration [GO:0042246]; wound healing [GO:0042060] cell surface [GO:0009986]; cilium [GO:0005929]; cytosol [GO:0005829]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; enzyme binding [GO:0019899]; NF-kappaB binding [GO:0051059]; signaling receptor activity [GO:0038023]; transcription coactivator activity [GO:0003713] g14803.t1 Q9QW30 36.364 220 1.31e-37 140.0 sp|Q9QW30|NOTC2_RAT Neurogenic locus notch homolog protein 2 OS=Rattus norvegicus OX=10116 GN=Notch2 PE=1 SV=1 NOTC2_RAT reviewed Neurogenic locus notch homolog protein 2 (Notch 2) [Cleaved into: Notch 2 extracellular truncation; Notch 2 intracellular domain] Rattus norvegicus (Rat) GO:0000122; GO:0001701; GO:0001889; GO:0001890; GO:0001947; GO:0002011; GO:0002315; GO:0002437; GO:0003184; GO:0003713; GO:0005509; GO:0005576; GO:0005634; GO:0005654; GO:0005794; GO:0005829; GO:0005886; GO:0005929; GO:0006357; GO:0006915; GO:0006959; GO:0007219; GO:0007368; GO:0007420; GO:0008284; GO:0009887; GO:0009986; GO:0010629; GO:0010838; GO:0019899; GO:0030326; GO:0030513; GO:0035264; GO:0035556; GO:0035622; GO:0038023; GO:0042060; GO:0042246; GO:0042742; GO:0043011; GO:0043065; GO:0043235; GO:0045672; GO:0045944; GO:0046579; GO:0046849; GO:0051059; GO:0051152; GO:0060413; GO:0060674; GO:0061073; GO:0070374; GO:0070986; GO:0071228; GO:0072014; GO:0072015; GO:0072104; GO:0072574; GO:0072576; GO:0098839; GO:0098978; GO:1902895; GO:1990705; GO:2001204 animal organ morphogenesis [GO:0009887]; apoptotic process [GO:0006915]; atrial septum morphogenesis [GO:0060413]; bone remodeling [GO:0046849]; brain development [GO:0007420]; cellular response to tumor cell [GO:0071228]; cholangiocyte proliferation [GO:1990705]; ciliary body morphogenesis [GO:0061073]; defense response to bacterium [GO:0042742]; determination of left/right symmetry [GO:0007368]; embryonic limb morphogenesis [GO:0030326]; glomerular capillary formation [GO:0072104]; heart looping [GO:0001947]; hepatocyte proliferation [GO:0072574]; humoral immune response [GO:0006959]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; intracellular signal transduction [GO:0035556]; intrahepatic bile duct development [GO:0035622]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; liver morphogenesis [GO:0072576]; marginal zone B cell differentiation [GO:0002315]; morphogenesis of an epithelial sheet [GO:0002011]; multicellular organism growth [GO:0035264]; myeloid dendritic cell differentiation [GO:0043011]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; Notch signaling pathway [GO:0007219]; placenta blood vessel development [GO:0060674]; placenta development [GO:0001890]; podocyte development [GO:0072015]; positive regulation of apoptotic process [GO:0043065]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of keratinocyte proliferation [GO:0010838]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of smooth muscle cell differentiation [GO:0051152]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proximal tubule development [GO:0072014]; pulmonary valve morphogenesis [GO:0003184]; regulation of osteoclast development [GO:2001204]; regulation of transcription by RNA polymerase II [GO:0006357]; tissue regeneration [GO:0042246]; wound healing [GO:0042060] cell surface [GO:0009986]; cilium [GO:0005929]; cytosol [GO:0005829]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; enzyme binding [GO:0019899]; NF-kappaB binding [GO:0051059]; signaling receptor activity [GO:0038023]; transcription coactivator activity [GO:0003713] g14803.t1 Q9QW30 44.505 182 6.39e-35 133.0 sp|Q9QW30|NOTC2_RAT Neurogenic locus notch homolog protein 2 OS=Rattus norvegicus OX=10116 GN=Notch2 PE=1 SV=1 NOTC2_RAT reviewed Neurogenic locus notch homolog protein 2 (Notch 2) [Cleaved into: Notch 2 extracellular truncation; Notch 2 intracellular domain] Rattus norvegicus (Rat) GO:0000122; GO:0001701; GO:0001889; GO:0001890; GO:0001947; GO:0002011; GO:0002315; GO:0002437; GO:0003184; GO:0003713; GO:0005509; GO:0005576; GO:0005634; GO:0005654; GO:0005794; GO:0005829; GO:0005886; GO:0005929; GO:0006357; GO:0006915; GO:0006959; GO:0007219; GO:0007368; GO:0007420; GO:0008284; GO:0009887; GO:0009986; GO:0010629; GO:0010838; GO:0019899; GO:0030326; GO:0030513; GO:0035264; GO:0035556; GO:0035622; GO:0038023; GO:0042060; GO:0042246; GO:0042742; GO:0043011; GO:0043065; GO:0043235; GO:0045672; GO:0045944; GO:0046579; GO:0046849; GO:0051059; GO:0051152; GO:0060413; GO:0060674; GO:0061073; GO:0070374; GO:0070986; GO:0071228; GO:0072014; GO:0072015; GO:0072104; GO:0072574; GO:0072576; GO:0098839; GO:0098978; GO:1902895; GO:1990705; GO:2001204 animal organ morphogenesis [GO:0009887]; apoptotic process [GO:0006915]; atrial septum morphogenesis [GO:0060413]; bone remodeling [GO:0046849]; brain development [GO:0007420]; cellular response to tumor cell [GO:0071228]; cholangiocyte proliferation [GO:1990705]; ciliary body morphogenesis [GO:0061073]; defense response to bacterium [GO:0042742]; determination of left/right symmetry [GO:0007368]; embryonic limb morphogenesis [GO:0030326]; glomerular capillary formation [GO:0072104]; heart looping [GO:0001947]; hepatocyte proliferation [GO:0072574]; humoral immune response [GO:0006959]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; intracellular signal transduction [GO:0035556]; intrahepatic bile duct development [GO:0035622]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; liver morphogenesis [GO:0072576]; marginal zone B cell differentiation [GO:0002315]; morphogenesis of an epithelial sheet [GO:0002011]; multicellular organism growth [GO:0035264]; myeloid dendritic cell differentiation [GO:0043011]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; Notch signaling pathway [GO:0007219]; placenta blood vessel development [GO:0060674]; placenta development [GO:0001890]; podocyte development [GO:0072015]; positive regulation of apoptotic process [GO:0043065]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of keratinocyte proliferation [GO:0010838]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of smooth muscle cell differentiation [GO:0051152]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proximal tubule development [GO:0072014]; pulmonary valve morphogenesis [GO:0003184]; regulation of osteoclast development [GO:2001204]; regulation of transcription by RNA polymerase II [GO:0006357]; tissue regeneration [GO:0042246]; wound healing [GO:0042060] cell surface [GO:0009986]; cilium [GO:0005929]; cytosol [GO:0005829]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; enzyme binding [GO:0019899]; NF-kappaB binding [GO:0051059]; signaling receptor activity [GO:0038023]; transcription coactivator activity [GO:0003713] g14803.t1 Q9QW30 43.085 188 2.8799999999999997e-34 131.0 sp|Q9QW30|NOTC2_RAT Neurogenic locus notch homolog protein 2 OS=Rattus norvegicus OX=10116 GN=Notch2 PE=1 SV=1 NOTC2_RAT reviewed Neurogenic locus notch homolog protein 2 (Notch 2) [Cleaved into: Notch 2 extracellular truncation; Notch 2 intracellular domain] Rattus norvegicus (Rat) GO:0000122; GO:0001701; GO:0001889; GO:0001890; GO:0001947; GO:0002011; GO:0002315; GO:0002437; GO:0003184; GO:0003713; GO:0005509; GO:0005576; GO:0005634; GO:0005654; GO:0005794; GO:0005829; GO:0005886; GO:0005929; GO:0006357; GO:0006915; GO:0006959; GO:0007219; GO:0007368; GO:0007420; GO:0008284; GO:0009887; GO:0009986; GO:0010629; GO:0010838; GO:0019899; GO:0030326; GO:0030513; GO:0035264; GO:0035556; GO:0035622; GO:0038023; GO:0042060; GO:0042246; GO:0042742; GO:0043011; GO:0043065; GO:0043235; GO:0045672; GO:0045944; GO:0046579; GO:0046849; GO:0051059; GO:0051152; GO:0060413; GO:0060674; GO:0061073; GO:0070374; GO:0070986; GO:0071228; GO:0072014; GO:0072015; GO:0072104; GO:0072574; GO:0072576; GO:0098839; GO:0098978; GO:1902895; GO:1990705; GO:2001204 animal organ morphogenesis [GO:0009887]; apoptotic process [GO:0006915]; atrial septum morphogenesis [GO:0060413]; bone remodeling [GO:0046849]; brain development [GO:0007420]; cellular response to tumor cell [GO:0071228]; cholangiocyte proliferation [GO:1990705]; ciliary body morphogenesis [GO:0061073]; defense response to bacterium [GO:0042742]; determination of left/right symmetry [GO:0007368]; embryonic limb morphogenesis [GO:0030326]; glomerular capillary formation [GO:0072104]; heart looping [GO:0001947]; hepatocyte proliferation [GO:0072574]; humoral immune response [GO:0006959]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; intracellular signal transduction [GO:0035556]; intrahepatic bile duct development [GO:0035622]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; liver morphogenesis [GO:0072576]; marginal zone B cell differentiation [GO:0002315]; morphogenesis of an epithelial sheet [GO:0002011]; multicellular organism growth [GO:0035264]; myeloid dendritic cell differentiation [GO:0043011]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; Notch signaling pathway [GO:0007219]; placenta blood vessel development [GO:0060674]; placenta development [GO:0001890]; podocyte development [GO:0072015]; positive regulation of apoptotic process [GO:0043065]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of keratinocyte proliferation [GO:0010838]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of smooth muscle cell differentiation [GO:0051152]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proximal tubule development [GO:0072014]; pulmonary valve morphogenesis [GO:0003184]; regulation of osteoclast development [GO:2001204]; regulation of transcription by RNA polymerase II [GO:0006357]; tissue regeneration [GO:0042246]; wound healing [GO:0042060] cell surface [GO:0009986]; cilium [GO:0005929]; cytosol [GO:0005829]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; enzyme binding [GO:0019899]; NF-kappaB binding [GO:0051059]; signaling receptor activity [GO:0038023]; transcription coactivator activity [GO:0003713] g14803.t1 Q9QW30 41.071 168 1.66e-32 126.0 sp|Q9QW30|NOTC2_RAT Neurogenic locus notch homolog protein 2 OS=Rattus norvegicus OX=10116 GN=Notch2 PE=1 SV=1 NOTC2_RAT reviewed Neurogenic locus notch homolog protein 2 (Notch 2) [Cleaved into: Notch 2 extracellular truncation; Notch 2 intracellular domain] Rattus norvegicus (Rat) GO:0000122; GO:0001701; GO:0001889; GO:0001890; GO:0001947; GO:0002011; GO:0002315; GO:0002437; GO:0003184; GO:0003713; GO:0005509; GO:0005576; GO:0005634; GO:0005654; GO:0005794; GO:0005829; GO:0005886; GO:0005929; GO:0006357; GO:0006915; GO:0006959; GO:0007219; GO:0007368; GO:0007420; GO:0008284; GO:0009887; GO:0009986; GO:0010629; GO:0010838; GO:0019899; GO:0030326; GO:0030513; GO:0035264; GO:0035556; GO:0035622; GO:0038023; GO:0042060; GO:0042246; GO:0042742; GO:0043011; GO:0043065; GO:0043235; GO:0045672; GO:0045944; GO:0046579; GO:0046849; GO:0051059; GO:0051152; GO:0060413; GO:0060674; GO:0061073; GO:0070374; GO:0070986; GO:0071228; GO:0072014; GO:0072015; GO:0072104; GO:0072574; GO:0072576; GO:0098839; GO:0098978; GO:1902895; GO:1990705; GO:2001204 animal organ morphogenesis [GO:0009887]; apoptotic process [GO:0006915]; atrial septum morphogenesis [GO:0060413]; bone remodeling [GO:0046849]; brain development [GO:0007420]; cellular response to tumor cell [GO:0071228]; cholangiocyte proliferation [GO:1990705]; ciliary body morphogenesis [GO:0061073]; defense response to bacterium [GO:0042742]; determination of left/right symmetry [GO:0007368]; embryonic limb morphogenesis [GO:0030326]; glomerular capillary formation [GO:0072104]; heart looping [GO:0001947]; hepatocyte proliferation [GO:0072574]; humoral immune response [GO:0006959]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; intracellular signal transduction [GO:0035556]; intrahepatic bile duct development [GO:0035622]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; liver morphogenesis [GO:0072576]; marginal zone B cell differentiation [GO:0002315]; morphogenesis of an epithelial sheet [GO:0002011]; multicellular organism growth [GO:0035264]; myeloid dendritic cell differentiation [GO:0043011]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; Notch signaling pathway [GO:0007219]; placenta blood vessel development [GO:0060674]; placenta development [GO:0001890]; podocyte development [GO:0072015]; positive regulation of apoptotic process [GO:0043065]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of keratinocyte proliferation [GO:0010838]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of smooth muscle cell differentiation [GO:0051152]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proximal tubule development [GO:0072014]; pulmonary valve morphogenesis [GO:0003184]; regulation of osteoclast development [GO:2001204]; regulation of transcription by RNA polymerase II [GO:0006357]; tissue regeneration [GO:0042246]; wound healing [GO:0042060] cell surface [GO:0009986]; cilium [GO:0005929]; cytosol [GO:0005829]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; enzyme binding [GO:0019899]; NF-kappaB binding [GO:0051059]; signaling receptor activity [GO:0038023]; transcription coactivator activity [GO:0003713] g14803.t1 Q9QW30 46.154 156 2.17e-31 123.0 sp|Q9QW30|NOTC2_RAT Neurogenic locus notch homolog protein 2 OS=Rattus norvegicus OX=10116 GN=Notch2 PE=1 SV=1 NOTC2_RAT reviewed Neurogenic locus notch homolog protein 2 (Notch 2) [Cleaved into: Notch 2 extracellular truncation; Notch 2 intracellular domain] Rattus norvegicus (Rat) GO:0000122; GO:0001701; GO:0001889; GO:0001890; GO:0001947; GO:0002011; GO:0002315; GO:0002437; GO:0003184; GO:0003713; GO:0005509; GO:0005576; GO:0005634; GO:0005654; GO:0005794; GO:0005829; GO:0005886; GO:0005929; GO:0006357; GO:0006915; GO:0006959; GO:0007219; GO:0007368; GO:0007420; GO:0008284; GO:0009887; GO:0009986; GO:0010629; GO:0010838; GO:0019899; GO:0030326; GO:0030513; GO:0035264; GO:0035556; GO:0035622; GO:0038023; GO:0042060; GO:0042246; GO:0042742; GO:0043011; GO:0043065; GO:0043235; GO:0045672; GO:0045944; GO:0046579; GO:0046849; GO:0051059; GO:0051152; GO:0060413; GO:0060674; GO:0061073; GO:0070374; GO:0070986; GO:0071228; GO:0072014; GO:0072015; GO:0072104; GO:0072574; GO:0072576; GO:0098839; GO:0098978; GO:1902895; GO:1990705; GO:2001204 animal organ morphogenesis [GO:0009887]; apoptotic process [GO:0006915]; atrial septum morphogenesis [GO:0060413]; bone remodeling [GO:0046849]; brain development [GO:0007420]; cellular response to tumor cell [GO:0071228]; cholangiocyte proliferation [GO:1990705]; ciliary body morphogenesis [GO:0061073]; defense response to bacterium [GO:0042742]; determination of left/right symmetry [GO:0007368]; embryonic limb morphogenesis [GO:0030326]; glomerular capillary formation [GO:0072104]; heart looping [GO:0001947]; hepatocyte proliferation [GO:0072574]; humoral immune response [GO:0006959]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; intracellular signal transduction [GO:0035556]; intrahepatic bile duct development [GO:0035622]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; liver morphogenesis [GO:0072576]; marginal zone B cell differentiation [GO:0002315]; morphogenesis of an epithelial sheet [GO:0002011]; multicellular organism growth [GO:0035264]; myeloid dendritic cell differentiation [GO:0043011]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; Notch signaling pathway [GO:0007219]; placenta blood vessel development [GO:0060674]; placenta development [GO:0001890]; podocyte development [GO:0072015]; positive regulation of apoptotic process [GO:0043065]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of keratinocyte proliferation [GO:0010838]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of smooth muscle cell differentiation [GO:0051152]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proximal tubule development [GO:0072014]; pulmonary valve morphogenesis [GO:0003184]; regulation of osteoclast development [GO:2001204]; regulation of transcription by RNA polymerase II [GO:0006357]; tissue regeneration [GO:0042246]; wound healing [GO:0042060] cell surface [GO:0009986]; cilium [GO:0005929]; cytosol [GO:0005829]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; enzyme binding [GO:0019899]; NF-kappaB binding [GO:0051059]; signaling receptor activity [GO:0038023]; transcription coactivator activity [GO:0003713] g14803.t1 Q9QW30 39.655 174 5.7500000000000005e-31 122.0 sp|Q9QW30|NOTC2_RAT Neurogenic locus notch homolog protein 2 OS=Rattus norvegicus OX=10116 GN=Notch2 PE=1 SV=1 NOTC2_RAT reviewed Neurogenic locus notch homolog protein 2 (Notch 2) [Cleaved into: Notch 2 extracellular truncation; Notch 2 intracellular domain] Rattus norvegicus (Rat) GO:0000122; GO:0001701; GO:0001889; GO:0001890; GO:0001947; GO:0002011; GO:0002315; GO:0002437; GO:0003184; GO:0003713; GO:0005509; GO:0005576; GO:0005634; GO:0005654; GO:0005794; GO:0005829; GO:0005886; GO:0005929; GO:0006357; GO:0006915; GO:0006959; GO:0007219; GO:0007368; GO:0007420; GO:0008284; GO:0009887; GO:0009986; GO:0010629; GO:0010838; GO:0019899; GO:0030326; GO:0030513; GO:0035264; GO:0035556; GO:0035622; GO:0038023; GO:0042060; GO:0042246; GO:0042742; GO:0043011; GO:0043065; GO:0043235; GO:0045672; GO:0045944; GO:0046579; GO:0046849; GO:0051059; GO:0051152; GO:0060413; GO:0060674; GO:0061073; GO:0070374; GO:0070986; GO:0071228; GO:0072014; GO:0072015; GO:0072104; GO:0072574; GO:0072576; GO:0098839; GO:0098978; GO:1902895; GO:1990705; GO:2001204 animal organ morphogenesis [GO:0009887]; apoptotic process [GO:0006915]; atrial septum morphogenesis [GO:0060413]; bone remodeling [GO:0046849]; brain development [GO:0007420]; cellular response to tumor cell [GO:0071228]; cholangiocyte proliferation [GO:1990705]; ciliary body morphogenesis [GO:0061073]; defense response to bacterium [GO:0042742]; determination of left/right symmetry [GO:0007368]; embryonic limb morphogenesis [GO:0030326]; glomerular capillary formation [GO:0072104]; heart looping [GO:0001947]; hepatocyte proliferation [GO:0072574]; humoral immune response [GO:0006959]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; intracellular signal transduction [GO:0035556]; intrahepatic bile duct development [GO:0035622]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; liver morphogenesis [GO:0072576]; marginal zone B cell differentiation [GO:0002315]; morphogenesis of an epithelial sheet [GO:0002011]; multicellular organism growth [GO:0035264]; myeloid dendritic cell differentiation [GO:0043011]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; Notch signaling pathway [GO:0007219]; placenta blood vessel development [GO:0060674]; placenta development [GO:0001890]; podocyte development [GO:0072015]; positive regulation of apoptotic process [GO:0043065]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of keratinocyte proliferation [GO:0010838]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of smooth muscle cell differentiation [GO:0051152]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proximal tubule development [GO:0072014]; pulmonary valve morphogenesis [GO:0003184]; regulation of osteoclast development [GO:2001204]; regulation of transcription by RNA polymerase II [GO:0006357]; tissue regeneration [GO:0042246]; wound healing [GO:0042060] cell surface [GO:0009986]; cilium [GO:0005929]; cytosol [GO:0005829]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; enzyme binding [GO:0019899]; NF-kappaB binding [GO:0051059]; signaling receptor activity [GO:0038023]; transcription coactivator activity [GO:0003713] g14803.t1 Q9QW30 39.378 193 1.52e-30 120.0 sp|Q9QW30|NOTC2_RAT Neurogenic locus notch homolog protein 2 OS=Rattus norvegicus OX=10116 GN=Notch2 PE=1 SV=1 NOTC2_RAT reviewed Neurogenic locus notch homolog protein 2 (Notch 2) [Cleaved into: Notch 2 extracellular truncation; Notch 2 intracellular domain] Rattus norvegicus (Rat) GO:0000122; GO:0001701; GO:0001889; GO:0001890; GO:0001947; GO:0002011; GO:0002315; GO:0002437; GO:0003184; GO:0003713; GO:0005509; GO:0005576; GO:0005634; GO:0005654; GO:0005794; GO:0005829; GO:0005886; GO:0005929; GO:0006357; GO:0006915; GO:0006959; GO:0007219; GO:0007368; GO:0007420; GO:0008284; GO:0009887; GO:0009986; GO:0010629; GO:0010838; GO:0019899; GO:0030326; GO:0030513; GO:0035264; GO:0035556; GO:0035622; GO:0038023; GO:0042060; GO:0042246; GO:0042742; GO:0043011; GO:0043065; GO:0043235; GO:0045672; GO:0045944; GO:0046579; GO:0046849; GO:0051059; GO:0051152; GO:0060413; GO:0060674; GO:0061073; GO:0070374; GO:0070986; GO:0071228; GO:0072014; GO:0072015; GO:0072104; GO:0072574; GO:0072576; GO:0098839; GO:0098978; GO:1902895; GO:1990705; GO:2001204 animal organ morphogenesis [GO:0009887]; apoptotic process [GO:0006915]; atrial septum morphogenesis [GO:0060413]; bone remodeling [GO:0046849]; brain development [GO:0007420]; cellular response to tumor cell [GO:0071228]; cholangiocyte proliferation [GO:1990705]; ciliary body morphogenesis [GO:0061073]; defense response to bacterium [GO:0042742]; determination of left/right symmetry [GO:0007368]; embryonic limb morphogenesis [GO:0030326]; glomerular capillary formation [GO:0072104]; heart looping [GO:0001947]; hepatocyte proliferation [GO:0072574]; humoral immune response [GO:0006959]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; intracellular signal transduction [GO:0035556]; intrahepatic bile duct development [GO:0035622]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; liver morphogenesis [GO:0072576]; marginal zone B cell differentiation [GO:0002315]; morphogenesis of an epithelial sheet [GO:0002011]; multicellular organism growth [GO:0035264]; myeloid dendritic cell differentiation [GO:0043011]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; Notch signaling pathway [GO:0007219]; placenta blood vessel development [GO:0060674]; placenta development [GO:0001890]; podocyte development [GO:0072015]; positive regulation of apoptotic process [GO:0043065]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of keratinocyte proliferation [GO:0010838]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of smooth muscle cell differentiation [GO:0051152]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proximal tubule development [GO:0072014]; pulmonary valve morphogenesis [GO:0003184]; regulation of osteoclast development [GO:2001204]; regulation of transcription by RNA polymerase II [GO:0006357]; tissue regeneration [GO:0042246]; wound healing [GO:0042060] cell surface [GO:0009986]; cilium [GO:0005929]; cytosol [GO:0005829]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; enzyme binding [GO:0019899]; NF-kappaB binding [GO:0051059]; signaling receptor activity [GO:0038023]; transcription coactivator activity [GO:0003713] g14803.t1 Q9QW30 35.242 227 3.2300000000000003e-27 111.0 sp|Q9QW30|NOTC2_RAT Neurogenic locus notch homolog protein 2 OS=Rattus norvegicus OX=10116 GN=Notch2 PE=1 SV=1 NOTC2_RAT reviewed Neurogenic locus notch homolog protein 2 (Notch 2) [Cleaved into: Notch 2 extracellular truncation; Notch 2 intracellular domain] Rattus norvegicus (Rat) GO:0000122; GO:0001701; GO:0001889; GO:0001890; GO:0001947; GO:0002011; GO:0002315; GO:0002437; GO:0003184; GO:0003713; GO:0005509; GO:0005576; GO:0005634; GO:0005654; GO:0005794; GO:0005829; GO:0005886; GO:0005929; GO:0006357; GO:0006915; GO:0006959; GO:0007219; GO:0007368; GO:0007420; GO:0008284; GO:0009887; GO:0009986; GO:0010629; GO:0010838; GO:0019899; GO:0030326; GO:0030513; GO:0035264; GO:0035556; GO:0035622; GO:0038023; GO:0042060; GO:0042246; GO:0042742; GO:0043011; GO:0043065; GO:0043235; GO:0045672; GO:0045944; GO:0046579; GO:0046849; GO:0051059; GO:0051152; GO:0060413; GO:0060674; GO:0061073; GO:0070374; GO:0070986; GO:0071228; GO:0072014; GO:0072015; GO:0072104; GO:0072574; GO:0072576; GO:0098839; GO:0098978; GO:1902895; GO:1990705; GO:2001204 animal organ morphogenesis [GO:0009887]; apoptotic process [GO:0006915]; atrial septum morphogenesis [GO:0060413]; bone remodeling [GO:0046849]; brain development [GO:0007420]; cellular response to tumor cell [GO:0071228]; cholangiocyte proliferation [GO:1990705]; ciliary body morphogenesis [GO:0061073]; defense response to bacterium [GO:0042742]; determination of left/right symmetry [GO:0007368]; embryonic limb morphogenesis [GO:0030326]; glomerular capillary formation [GO:0072104]; heart looping [GO:0001947]; hepatocyte proliferation [GO:0072574]; humoral immune response [GO:0006959]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; intracellular signal transduction [GO:0035556]; intrahepatic bile duct development [GO:0035622]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; liver morphogenesis [GO:0072576]; marginal zone B cell differentiation [GO:0002315]; morphogenesis of an epithelial sheet [GO:0002011]; multicellular organism growth [GO:0035264]; myeloid dendritic cell differentiation [GO:0043011]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; Notch signaling pathway [GO:0007219]; placenta blood vessel development [GO:0060674]; placenta development [GO:0001890]; podocyte development [GO:0072015]; positive regulation of apoptotic process [GO:0043065]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of keratinocyte proliferation [GO:0010838]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of smooth muscle cell differentiation [GO:0051152]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proximal tubule development [GO:0072014]; pulmonary valve morphogenesis [GO:0003184]; regulation of osteoclast development [GO:2001204]; regulation of transcription by RNA polymerase II [GO:0006357]; tissue regeneration [GO:0042246]; wound healing [GO:0042060] cell surface [GO:0009986]; cilium [GO:0005929]; cytosol [GO:0005829]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; enzyme binding [GO:0019899]; NF-kappaB binding [GO:0051059]; signaling receptor activity [GO:0038023]; transcription coactivator activity [GO:0003713] g14803.t1 Q9QW30 40.476 168 1.04e-21 95.5 sp|Q9QW30|NOTC2_RAT Neurogenic locus notch homolog protein 2 OS=Rattus norvegicus OX=10116 GN=Notch2 PE=1 SV=1 NOTC2_RAT reviewed Neurogenic locus notch homolog protein 2 (Notch 2) [Cleaved into: Notch 2 extracellular truncation; Notch 2 intracellular domain] Rattus norvegicus (Rat) GO:0000122; GO:0001701; GO:0001889; GO:0001890; GO:0001947; GO:0002011; GO:0002315; GO:0002437; GO:0003184; GO:0003713; GO:0005509; GO:0005576; GO:0005634; GO:0005654; GO:0005794; GO:0005829; GO:0005886; GO:0005929; GO:0006357; GO:0006915; GO:0006959; GO:0007219; GO:0007368; GO:0007420; GO:0008284; GO:0009887; GO:0009986; GO:0010629; GO:0010838; GO:0019899; GO:0030326; GO:0030513; GO:0035264; GO:0035556; GO:0035622; GO:0038023; GO:0042060; GO:0042246; GO:0042742; GO:0043011; GO:0043065; GO:0043235; GO:0045672; GO:0045944; GO:0046579; GO:0046849; GO:0051059; GO:0051152; GO:0060413; GO:0060674; GO:0061073; GO:0070374; GO:0070986; GO:0071228; GO:0072014; GO:0072015; GO:0072104; GO:0072574; GO:0072576; GO:0098839; GO:0098978; GO:1902895; GO:1990705; GO:2001204 animal organ morphogenesis [GO:0009887]; apoptotic process [GO:0006915]; atrial septum morphogenesis [GO:0060413]; bone remodeling [GO:0046849]; brain development [GO:0007420]; cellular response to tumor cell [GO:0071228]; cholangiocyte proliferation [GO:1990705]; ciliary body morphogenesis [GO:0061073]; defense response to bacterium [GO:0042742]; determination of left/right symmetry [GO:0007368]; embryonic limb morphogenesis [GO:0030326]; glomerular capillary formation [GO:0072104]; heart looping [GO:0001947]; hepatocyte proliferation [GO:0072574]; humoral immune response [GO:0006959]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; intracellular signal transduction [GO:0035556]; intrahepatic bile duct development [GO:0035622]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; liver morphogenesis [GO:0072576]; marginal zone B cell differentiation [GO:0002315]; morphogenesis of an epithelial sheet [GO:0002011]; multicellular organism growth [GO:0035264]; myeloid dendritic cell differentiation [GO:0043011]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; Notch signaling pathway [GO:0007219]; placenta blood vessel development [GO:0060674]; placenta development [GO:0001890]; podocyte development [GO:0072015]; positive regulation of apoptotic process [GO:0043065]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of keratinocyte proliferation [GO:0010838]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of smooth muscle cell differentiation [GO:0051152]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proximal tubule development [GO:0072014]; pulmonary valve morphogenesis [GO:0003184]; regulation of osteoclast development [GO:2001204]; regulation of transcription by RNA polymerase II [GO:0006357]; tissue regeneration [GO:0042246]; wound healing [GO:0042060] cell surface [GO:0009986]; cilium [GO:0005929]; cytosol [GO:0005829]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; enzyme binding [GO:0019899]; NF-kappaB binding [GO:0051059]; signaling receptor activity [GO:0038023]; transcription coactivator activity [GO:0003713] g14803.t1 Q9QW30 39.011 182 1.18e-21 95.1 sp|Q9QW30|NOTC2_RAT Neurogenic locus notch homolog protein 2 OS=Rattus norvegicus OX=10116 GN=Notch2 PE=1 SV=1 NOTC2_RAT reviewed Neurogenic locus notch homolog protein 2 (Notch 2) [Cleaved into: Notch 2 extracellular truncation; Notch 2 intracellular domain] Rattus norvegicus (Rat) GO:0000122; GO:0001701; GO:0001889; GO:0001890; GO:0001947; GO:0002011; GO:0002315; GO:0002437; GO:0003184; GO:0003713; GO:0005509; GO:0005576; GO:0005634; GO:0005654; GO:0005794; GO:0005829; GO:0005886; GO:0005929; GO:0006357; GO:0006915; GO:0006959; GO:0007219; GO:0007368; GO:0007420; GO:0008284; GO:0009887; GO:0009986; GO:0010629; GO:0010838; GO:0019899; GO:0030326; GO:0030513; GO:0035264; GO:0035556; GO:0035622; GO:0038023; GO:0042060; GO:0042246; GO:0042742; GO:0043011; GO:0043065; GO:0043235; GO:0045672; GO:0045944; GO:0046579; GO:0046849; GO:0051059; GO:0051152; GO:0060413; GO:0060674; GO:0061073; GO:0070374; GO:0070986; GO:0071228; GO:0072014; GO:0072015; GO:0072104; GO:0072574; GO:0072576; GO:0098839; GO:0098978; GO:1902895; GO:1990705; GO:2001204 animal organ morphogenesis [GO:0009887]; apoptotic process [GO:0006915]; atrial septum morphogenesis [GO:0060413]; bone remodeling [GO:0046849]; brain development [GO:0007420]; cellular response to tumor cell [GO:0071228]; cholangiocyte proliferation [GO:1990705]; ciliary body morphogenesis [GO:0061073]; defense response to bacterium [GO:0042742]; determination of left/right symmetry [GO:0007368]; embryonic limb morphogenesis [GO:0030326]; glomerular capillary formation [GO:0072104]; heart looping [GO:0001947]; hepatocyte proliferation [GO:0072574]; humoral immune response [GO:0006959]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; intracellular signal transduction [GO:0035556]; intrahepatic bile duct development [GO:0035622]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; liver morphogenesis [GO:0072576]; marginal zone B cell differentiation [GO:0002315]; morphogenesis of an epithelial sheet [GO:0002011]; multicellular organism growth [GO:0035264]; myeloid dendritic cell differentiation [GO:0043011]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; Notch signaling pathway [GO:0007219]; placenta blood vessel development [GO:0060674]; placenta development [GO:0001890]; podocyte development [GO:0072015]; positive regulation of apoptotic process [GO:0043065]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of keratinocyte proliferation [GO:0010838]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of smooth muscle cell differentiation [GO:0051152]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proximal tubule development [GO:0072014]; pulmonary valve morphogenesis [GO:0003184]; regulation of osteoclast development [GO:2001204]; regulation of transcription by RNA polymerase II [GO:0006357]; tissue regeneration [GO:0042246]; wound healing [GO:0042060] cell surface [GO:0009986]; cilium [GO:0005929]; cytosol [GO:0005829]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; enzyme binding [GO:0019899]; NF-kappaB binding [GO:0051059]; signaling receptor activity [GO:0038023]; transcription coactivator activity [GO:0003713] g14805.t1 P10079 39.124 639 2.31e-127 421.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g14805.t1 P10079 41.794 591 3.38e-126 417.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g14805.t1 P10079 37.744 665 1.62e-122 407.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g14805.t1 P10079 42.2 500 5.26e-103 353.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g14805.t1 P10079 37.521 605 2.0699999999999998e-95 332.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g14805.t1 P10079 38.065 310 2.16e-47 189.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g14806.t1 P10079 42.481 645 2.9e-149 474.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g14806.t1 P10079 39.851 670 1.8e-142 456.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g14806.t1 P10079 40.832 649 3.03e-141 452.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g14806.t1 P10079 42.634 577 1.63e-124 408.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g14806.t1 P10079 40.054 367 2.8e-58 221.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g14809.t1 Q5RKH6 53.689 244 6.85e-84 281.0 sp|Q5RKH6|OS9_RAT Protein OS-9 OS=Rattus norvegicus OX=10116 GN=Os9 PE=1 SV=1 OS9_RAT reviewed Protein OS-9 Rattus norvegicus (Rat) GO:0000836; GO:0002020; GO:0005783; GO:0005788; GO:0006511; GO:0006605; GO:0006621; GO:0016567; GO:0030246; GO:0030968; GO:0030970; GO:0034976; GO:0036503; GO:0140032; GO:1904153 endoplasmic reticulum unfolded protein response [GO:0030968]; ERAD pathway [GO:0036503]; negative regulation of retrograde protein transport, ER to cytosol [GO:1904153]; protein retention in ER lumen [GO:0006621]; protein targeting [GO:0006605]; protein ubiquitination [GO:0016567]; response to endoplasmic reticulum stress [GO:0034976]; retrograde protein transport, ER to cytosol [GO:0030970]; ubiquitin-dependent protein catabolic process [GO:0006511] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; Hrd1p ubiquitin ligase complex [GO:0000836] carbohydrate binding [GO:0030246]; glycosylation-dependent protein binding [GO:0140032]; protease binding [GO:0002020] g14811.t1 Q9HCD6 42.563 437 5.67e-99 335.0 sp|Q9HCD6|TANC2_HUMAN Protein TANC2 OS=Homo sapiens OX=9606 GN=TANC2 PE=1 SV=3 TANC2_HUMAN reviewed Protein TANC2 (Tetratricopeptide repeat, ankyrin repeat and coiled-coil domain-containing protein 2) Homo sapiens (Human) GO:0030424; GO:0043197; GO:0060998; GO:0061001; GO:0099519 dense core granule cytoskeletal transport [GO:0099519]; regulation of dendritic spine development [GO:0060998]; regulation of dendritic spine morphogenesis [GO:0061001] axon [GO:0030424]; dendritic spine [GO:0043197] g14812.t1 F1LTE0 59.091 176 2.47e-64 218.0 sp|F1LTE0|TANC2_RAT Protein TANC2 OS=Rattus norvegicus OX=10116 GN=Tanc2 PE=1 SV=2 g14813.t1 F1LTE0 57.882 425 6.29e-158 509.0 sp|F1LTE0|TANC2_RAT Protein TANC2 OS=Rattus norvegicus OX=10116 GN=Tanc2 PE=1 SV=2 g14814.t1 F1N2W9 62.286 700 0.0 830.0 sp|F1N2W9|MCM9_BOVIN DNA helicase MCM9 OS=Bos taurus OX=9913 GN=MCM9 PE=3 SV=2 MCM9_BOVIN reviewed DNA helicase MCM9 (EC 5.6.2.4) (DNA 3'-5' helicase MCM9) (Minichromosome maintenance 9) Bos taurus (Bovine) GO:0000724; GO:0003678; GO:0003697; GO:0005524; GO:0005634; GO:0005694; GO:0006974; GO:0007276; GO:0007292; GO:0016887; GO:0036298; GO:0042555; GO:0097362 DNA damage response [GO:0006974]; double-strand break repair via homologous recombination [GO:0000724]; female gamete generation [GO:0007292]; gamete generation [GO:0007276]; recombinational interstrand cross-link repair [GO:0036298] chromosome [GO:0005694]; MCM complex [GO:0042555]; MCM8-MCM9 complex [GO:0097362]; nucleus [GO:0005634] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA helicase activity [GO:0003678]; single-stranded DNA binding [GO:0003697] g14818.t1 Q95168 36.431 538 1.16e-81 295.0 sp|Q95168|ZO2_CANLF Tight junction protein 2 OS=Canis lupus familiaris OX=9615 GN=TJP2 PE=1 SV=1 ZO2_CANLF reviewed Tight junction protein 2 (Tight junction protein ZO-2) (Zona occludens protein 2) (Zonula occludens protein 2) Canis lupus familiaris (Dog) (Canis familiaris) GO:0005634; GO:0005886; GO:0005912; GO:0005923; GO:0009986; GO:0045216; GO:0050839; GO:0090557; GO:0098609; GO:0150105; GO:1905605 cell-cell adhesion [GO:0098609]; cell-cell junction organization [GO:0045216]; establishment of endothelial intestinal barrier [GO:0090557]; positive regulation of blood-brain barrier permeability [GO:1905605]; protein localization to cell-cell junction [GO:0150105] adherens junction [GO:0005912]; bicellular tight junction [GO:0005923]; cell surface [GO:0009986]; nucleus [GO:0005634]; plasma membrane [GO:0005886] cell adhesion molecule binding [GO:0050839] g14818.t2 Q07157 36.466 266 4.4e-37 148.0 sp|Q07157|ZO1_HUMAN Tight junction protein 1 OS=Homo sapiens OX=9606 GN=TJP1 PE=1 SV=3 ZO1_HUMAN reviewed Tight junction protein 1 (Tight junction protein ZO-1) (Zona occludens protein 1) (Zonula occludens protein 1) Homo sapiens (Human) GO:0002102; GO:0005516; GO:0005737; GO:0005829; GO:0005886; GO:0005912; GO:0005921; GO:0005923; GO:0007043; GO:0008284; GO:0016323; GO:0030036; GO:0030054; GO:0030335; GO:0031032; GO:0032991; GO:0034334; GO:0035633; GO:0036305; GO:0043066; GO:0043296; GO:0045177; GO:0045216; GO:0045296; GO:0050839; GO:0051493; GO:0051497; GO:0070160; GO:0071896; GO:0090557; GO:0098609; GO:0150105; GO:1901888; GO:1902396; GO:1903672; GO:1905605; GO:2000049; GO:2000810 actin cytoskeleton organization [GO:0030036]; actomyosin structure organization [GO:0031032]; adherens junction maintenance [GO:0034334]; ameloblast differentiation [GO:0036305]; cell-cell adhesion [GO:0098609]; cell-cell junction assembly [GO:0007043]; cell-cell junction organization [GO:0045216]; establishment of endothelial intestinal barrier [GO:0090557]; maintenance of blood-brain barrier [GO:0035633]; negative regulation of apoptotic process [GO:0043066]; negative regulation of stress fiber assembly [GO:0051497]; positive regulation of blood-brain barrier permeability [GO:1905605]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cell-cell adhesion mediated by cadherin [GO:2000049]; positive regulation of sprouting angiogenesis [GO:1903672]; protein localization to adherens junction [GO:0071896]; protein localization to bicellular tight junction [GO:1902396]; protein localization to cell-cell junction [GO:0150105]; regulation of bicellular tight junction assembly [GO:2000810]; regulation of cell junction assembly [GO:1901888]; regulation of cytoskeleton organization [GO:0051493] adherens junction [GO:0005912]; apical junction complex [GO:0043296]; apical part of cell [GO:0045177]; basolateral plasma membrane [GO:0016323]; bicellular tight junction [GO:0005923]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; gap junction [GO:0005921]; plasma membrane [GO:0005886]; podosome [GO:0002102]; protein-containing complex [GO:0032991]; tight junction [GO:0070160] cadherin binding [GO:0045296]; calmodulin binding [GO:0005516]; cell adhesion molecule binding [GO:0050839] g14820.t1 P15336 40.385 416 7.63e-71 235.0 sp|P15336|ATF2_HUMAN Cyclic AMP-dependent transcription factor ATF-2 OS=Homo sapiens OX=9606 GN=ATF2 PE=1 SV=4 ATF2_HUMAN reviewed Cyclic AMP-dependent transcription factor ATF-2 (cAMP-dependent transcription factor ATF-2) (Activating transcription factor 2) (Cyclic AMP-responsive element-binding protein 2) (CREB-2) (cAMP-responsive element-binding protein 2) (HB16) (cAMP response element-binding protein CRE-BP1) Homo sapiens (Human) GO:0000122; GO:0000785; GO:0000977; GO:0000978; GO:0000981; GO:0000987; GO:0001228; GO:0001659; GO:0001701; GO:0001865; GO:0001889; GO:0002244; GO:0003151; GO:0003360; GO:0003418; GO:0003419; GO:0003700; GO:0004402; GO:0005634; GO:0005654; GO:0005737; GO:0005741; GO:0006355; GO:0006357; GO:0006606; GO:0006629; GO:0006970; GO:0006974; GO:0007033; GO:0007254; GO:0008140; GO:0008270; GO:0010485; GO:0010628; GO:0016525; GO:0018107; GO:0019901; GO:0021742; GO:0021743; GO:0021754; GO:0030509; GO:0031573; GO:0032915; GO:0034599; GO:0035497; GO:0035861; GO:0038066; GO:0042789; GO:0042802; GO:0042803; GO:0043522; GO:0044013; GO:0045815; GO:0045944; GO:0046982; GO:0050872; GO:0051091; GO:0060052; GO:0060245; GO:0060612; GO:0061629; GO:0070342; GO:0072740; GO:0090575; GO:0097009; GO:0097049; GO:0097284; GO:0098586; GO:0110024; GO:1902110; GO:1902562; GO:1902742; GO:1990144; GO:1990253; GO:1990837; GO:1990841 abducens nucleus development [GO:0021742]; adipose tissue development [GO:0060612]; apoptotic process involved in development [GO:1902742]; BMP signaling pathway [GO:0030509]; brainstem development [GO:0003360]; brown fat cell proliferation [GO:0070342]; cellular response to anisomycin [GO:0072740]; cellular response to leucine starvation [GO:1990253]; cellular response to oxidative stress [GO:0034599]; cellular response to virus [GO:0098586]; detection of cell density [GO:0060245]; DNA damage response [GO:0006974]; energy homeostasis [GO:0097009]; facial nucleus development [GO:0021754]; growth plate cartilage chondrocyte differentiation [GO:0003418]; growth plate cartilage chondrocyte proliferation [GO:0003419]; hematopoietic progenitor cell differentiation [GO:0002244]; hepatocyte apoptotic process [GO:0097284]; hypoglossal nucleus development [GO:0021743]; in utero embryonic development [GO:0001701]; intrinsic apoptotic signaling pathway in response to hypoxia [GO:1990144]; JNK cascade [GO:0007254]; lipid metabolic process [GO:0006629]; liver development [GO:0001889]; mitotic intra-S DNA damage checkpoint signaling [GO:0031573]; motor neuron apoptotic process [GO:0097049]; mRNA transcription by RNA polymerase II [GO:0042789]; negative regulation of angiogenesis [GO:0016525]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neurofilament cytoskeleton organization [GO:0060052]; NK T cell differentiation [GO:0001865]; outflow tract morphogenesis [GO:0003151]; p38MAPK cascade [GO:0038066]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of cardiac muscle myoblast proliferation [GO:0110024]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of gene expression [GO:0010628]; positive regulation of mitochondrial membrane permeability involved in apoptotic process [GO:1902110]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transforming growth factor beta2 production [GO:0032915]; protein import into nucleus [GO:0006606]; regulation of DNA-templated transcription [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; response to osmotic stress [GO:0006970]; temperature homeostasis [GO:0001659]; transcription initiation-coupled chromatin remodeling [GO:0045815]; vacuole organization [GO:0007033]; white fat cell differentiation [GO:0050872] chromatin [GO:0000785]; cytoplasm [GO:0005737]; H4 histone acetyltransferase complex [GO:1902562]; mitochondrial outer membrane [GO:0005741]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575]; site of double-strand break [GO:0035861] cAMP response element binding [GO:0035497]; cAMP response element binding protein binding [GO:0008140]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; histone acetyltransferase activity [GO:0004402]; histone H2B acetyltransferase activity [GO:0044013]; histone H4 acetyltransferase activity [GO:0010485]; identical protein binding [GO:0042802]; leucine zipper domain binding [GO:0043522]; promoter-specific chromatin binding [GO:1990841]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific double-stranded DNA binding [GO:1990837]; zinc ion binding [GO:0008270] g14820.t2 P15336 40.144 416 5.849999999999999e-69 230.0 sp|P15336|ATF2_HUMAN Cyclic AMP-dependent transcription factor ATF-2 OS=Homo sapiens OX=9606 GN=ATF2 PE=1 SV=4 ATF2_HUMAN reviewed Cyclic AMP-dependent transcription factor ATF-2 (cAMP-dependent transcription factor ATF-2) (Activating transcription factor 2) (Cyclic AMP-responsive element-binding protein 2) (CREB-2) (cAMP-responsive element-binding protein 2) (HB16) (cAMP response element-binding protein CRE-BP1) Homo sapiens (Human) GO:0000122; GO:0000785; GO:0000977; GO:0000978; GO:0000981; GO:0000987; GO:0001228; GO:0001659; GO:0001701; GO:0001865; GO:0001889; GO:0002244; GO:0003151; GO:0003360; GO:0003418; GO:0003419; GO:0003700; GO:0004402; GO:0005634; GO:0005654; GO:0005737; GO:0005741; GO:0006355; GO:0006357; GO:0006606; GO:0006629; GO:0006970; GO:0006974; GO:0007033; GO:0007254; GO:0008140; GO:0008270; GO:0010485; GO:0010628; GO:0016525; GO:0018107; GO:0019901; GO:0021742; GO:0021743; GO:0021754; GO:0030509; GO:0031573; GO:0032915; GO:0034599; GO:0035497; GO:0035861; GO:0038066; GO:0042789; GO:0042802; GO:0042803; GO:0043522; GO:0044013; GO:0045815; GO:0045944; GO:0046982; GO:0050872; GO:0051091; GO:0060052; GO:0060245; GO:0060612; GO:0061629; GO:0070342; GO:0072740; GO:0090575; GO:0097009; GO:0097049; GO:0097284; GO:0098586; GO:0110024; GO:1902110; GO:1902562; GO:1902742; GO:1990144; GO:1990253; GO:1990837; GO:1990841 abducens nucleus development [GO:0021742]; adipose tissue development [GO:0060612]; apoptotic process involved in development [GO:1902742]; BMP signaling pathway [GO:0030509]; brainstem development [GO:0003360]; brown fat cell proliferation [GO:0070342]; cellular response to anisomycin [GO:0072740]; cellular response to leucine starvation [GO:1990253]; cellular response to oxidative stress [GO:0034599]; cellular response to virus [GO:0098586]; detection of cell density [GO:0060245]; DNA damage response [GO:0006974]; energy homeostasis [GO:0097009]; facial nucleus development [GO:0021754]; growth plate cartilage chondrocyte differentiation [GO:0003418]; growth plate cartilage chondrocyte proliferation [GO:0003419]; hematopoietic progenitor cell differentiation [GO:0002244]; hepatocyte apoptotic process [GO:0097284]; hypoglossal nucleus development [GO:0021743]; in utero embryonic development [GO:0001701]; intrinsic apoptotic signaling pathway in response to hypoxia [GO:1990144]; JNK cascade [GO:0007254]; lipid metabolic process [GO:0006629]; liver development [GO:0001889]; mitotic intra-S DNA damage checkpoint signaling [GO:0031573]; motor neuron apoptotic process [GO:0097049]; mRNA transcription by RNA polymerase II [GO:0042789]; negative regulation of angiogenesis [GO:0016525]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neurofilament cytoskeleton organization [GO:0060052]; NK T cell differentiation [GO:0001865]; outflow tract morphogenesis [GO:0003151]; p38MAPK cascade [GO:0038066]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of cardiac muscle myoblast proliferation [GO:0110024]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of gene expression [GO:0010628]; positive regulation of mitochondrial membrane permeability involved in apoptotic process [GO:1902110]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transforming growth factor beta2 production [GO:0032915]; protein import into nucleus [GO:0006606]; regulation of DNA-templated transcription [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; response to osmotic stress [GO:0006970]; temperature homeostasis [GO:0001659]; transcription initiation-coupled chromatin remodeling [GO:0045815]; vacuole organization [GO:0007033]; white fat cell differentiation [GO:0050872] chromatin [GO:0000785]; cytoplasm [GO:0005737]; H4 histone acetyltransferase complex [GO:1902562]; mitochondrial outer membrane [GO:0005741]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575]; site of double-strand break [GO:0035861] cAMP response element binding [GO:0035497]; cAMP response element binding protein binding [GO:0008140]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; histone acetyltransferase activity [GO:0004402]; histone H2B acetyltransferase activity [GO:0044013]; histone H4 acetyltransferase activity [GO:0010485]; identical protein binding [GO:0042802]; leucine zipper domain binding [GO:0043522]; promoter-specific chromatin binding [GO:1990841]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific double-stranded DNA binding [GO:1990837]; zinc ion binding [GO:0008270] g14823.t1 Q8R242 38.92 352 2.05e-82 259.0 sp|Q8R242|DIAC_MOUSE Di-N-acetylchitobiase OS=Mus musculus OX=10090 GN=Ctbs PE=1 SV=2 DIAC_MOUSE reviewed Di-N-acetylchitobiase (EC 3.2.1.-) Mus musculus (Mouse) GO:0004568; GO:0005764; GO:0006032; GO:0008061; GO:0009313 chitin catabolic process [GO:0006032]; oligosaccharide catabolic process [GO:0009313] lysosome [GO:0005764] chitin binding [GO:0008061]; chitinase activity [GO:0004568] g14826.t1 Q80T91 48.864 176 1.88e-44 166.0 sp|Q80T91|MEG11_MOUSE Multiple epidermal growth factor-like domains protein 11 OS=Mus musculus OX=10090 GN=Megf11 PE=1 SV=3 g14826.t1 Q80T91 45.029 171 4.36e-40 153.0 sp|Q80T91|MEG11_MOUSE Multiple epidermal growth factor-like domains protein 11 OS=Mus musculus OX=10090 GN=Megf11 PE=1 SV=3 g14826.t1 Q80T91 44.134 179 2.55e-39 151.0 sp|Q80T91|MEG11_MOUSE Multiple epidermal growth factor-like domains protein 11 OS=Mus musculus OX=10090 GN=Megf11 PE=1 SV=3 g14826.t1 Q80T91 39.738 229 1.8299999999999999e-38 148.0 sp|Q80T91|MEG11_MOUSE Multiple epidermal growth factor-like domains protein 11 OS=Mus musculus OX=10090 GN=Megf11 PE=1 SV=3 g14826.t1 Q80T91 42.541 181 7.82e-37 144.0 sp|Q80T91|MEG11_MOUSE Multiple epidermal growth factor-like domains protein 11 OS=Mus musculus OX=10090 GN=Megf11 PE=1 SV=3 g14826.t1 Q80T91 42.541 181 8.04e-37 144.0 sp|Q80T91|MEG11_MOUSE Multiple epidermal growth factor-like domains protein 11 OS=Mus musculus OX=10090 GN=Megf11 PE=1 SV=3 g14826.t1 Q80T91 43.82 178 1.67e-35 140.0 sp|Q80T91|MEG11_MOUSE Multiple epidermal growth factor-like domains protein 11 OS=Mus musculus OX=10090 GN=Megf11 PE=1 SV=3 g14826.t1 Q80T91 40.223 179 2.1e-35 139.0 sp|Q80T91|MEG11_MOUSE Multiple epidermal growth factor-like domains protein 11 OS=Mus musculus OX=10090 GN=Megf11 PE=1 SV=3 g14826.t1 Q80T91 36.889 225 2.44e-34 136.0 sp|Q80T91|MEG11_MOUSE Multiple epidermal growth factor-like domains protein 11 OS=Mus musculus OX=10090 GN=Megf11 PE=1 SV=3 g14826.t1 Q80T91 39.665 179 8.16e-34 135.0 sp|Q80T91|MEG11_MOUSE Multiple epidermal growth factor-like domains protein 11 OS=Mus musculus OX=10090 GN=Megf11 PE=1 SV=3 g14826.t1 Q80T91 42.541 181 1.07e-32 132.0 sp|Q80T91|MEG11_MOUSE Multiple epidermal growth factor-like domains protein 11 OS=Mus musculus OX=10090 GN=Megf11 PE=1 SV=3 g14826.t1 Q80T91 42.657 143 1.9500000000000002e-27 116.0 sp|Q80T91|MEG11_MOUSE Multiple epidermal growth factor-like domains protein 11 OS=Mus musculus OX=10090 GN=Megf11 PE=1 SV=3 g14826.t1 Q80T91 40.146 137 1.32e-21 99.4 sp|Q80T91|MEG11_MOUSE Multiple epidermal growth factor-like domains protein 11 OS=Mus musculus OX=10090 GN=Megf11 PE=1 SV=3 g14827.t1 A0JM12 44.444 171 3.3699999999999997e-40 147.0 sp|A0JM12|MEG10_XENTR Multiple epidermal growth factor-like domains protein 10 OS=Xenopus tropicalis OX=8364 GN=megf10 PE=2 SV=1 g14827.t1 A0JM12 47.02 151 1.19e-38 143.0 sp|A0JM12|MEG10_XENTR Multiple epidermal growth factor-like domains protein 10 OS=Xenopus tropicalis OX=8364 GN=megf10 PE=2 SV=1 g14827.t1 A0JM12 44.706 170 1.59e-38 142.0 sp|A0JM12|MEG10_XENTR Multiple epidermal growth factor-like domains protein 10 OS=Xenopus tropicalis OX=8364 GN=megf10 PE=2 SV=1 g14827.t1 A0JM12 46.784 171 3.86e-38 141.0 sp|A0JM12|MEG10_XENTR Multiple epidermal growth factor-like domains protein 10 OS=Xenopus tropicalis OX=8364 GN=megf10 PE=2 SV=1 g14827.t1 A0JM12 41.42 169 2.7199999999999998e-34 130.0 sp|A0JM12|MEG10_XENTR Multiple epidermal growth factor-like domains protein 10 OS=Xenopus tropicalis OX=8364 GN=megf10 PE=2 SV=1 g14827.t1 A0JM12 41.916 167 5.15e-34 129.0 sp|A0JM12|MEG10_XENTR Multiple epidermal growth factor-like domains protein 10 OS=Xenopus tropicalis OX=8364 GN=megf10 PE=2 SV=1 g14827.t1 A0JM12 36.744 215 2.93e-33 127.0 sp|A0JM12|MEG10_XENTR Multiple epidermal growth factor-like domains protein 10 OS=Xenopus tropicalis OX=8364 GN=megf10 PE=2 SV=1 g14827.t1 A0JM12 41.615 161 3.67e-33 127.0 sp|A0JM12|MEG10_XENTR Multiple epidermal growth factor-like domains protein 10 OS=Xenopus tropicalis OX=8364 GN=megf10 PE=2 SV=1 g14827.t1 A0JM12 41.667 168 1.39e-32 125.0 sp|A0JM12|MEG10_XENTR Multiple epidermal growth factor-like domains protein 10 OS=Xenopus tropicalis OX=8364 GN=megf10 PE=2 SV=1 g14827.t1 A0JM12 43.103 174 3.77e-32 124.0 sp|A0JM12|MEG10_XENTR Multiple epidermal growth factor-like domains protein 10 OS=Xenopus tropicalis OX=8364 GN=megf10 PE=2 SV=1 g14828.t1 Q80V70 38.219 1112 0.0 672.0 sp|Q80V70|MEGF6_MOUSE Multiple epidermal growth factor-like domains protein 6 OS=Mus musculus OX=10090 GN=Megf6 PE=2 SV=3 g14828.t1 Q80V70 40.137 1019 0.0 671.0 sp|Q80V70|MEGF6_MOUSE Multiple epidermal growth factor-like domains protein 6 OS=Mus musculus OX=10090 GN=Megf6 PE=2 SV=3 g14828.t1 Q80V70 38.251 766 1.17e-139 465.0 sp|Q80V70|MEGF6_MOUSE Multiple epidermal growth factor-like domains protein 6 OS=Mus musculus OX=10090 GN=Megf6 PE=2 SV=3 g14828.t1 Q80V70 31.197 1170 1.9999999999999999e-115 397.0 sp|Q80V70|MEGF6_MOUSE Multiple epidermal growth factor-like domains protein 6 OS=Mus musculus OX=10090 GN=Megf6 PE=2 SV=3 g14828.t1 Q80V70 38.797 482 3.5e-78 287.0 sp|Q80V70|MEGF6_MOUSE Multiple epidermal growth factor-like domains protein 6 OS=Mus musculus OX=10090 GN=Megf6 PE=2 SV=3 g14829.t1 Q80T91 45.679 162 2.51e-39 144.0 sp|Q80T91|MEG11_MOUSE Multiple epidermal growth factor-like domains protein 11 OS=Mus musculus OX=10090 GN=Megf11 PE=1 SV=3 g14829.t1 Q80T91 42.857 161 3.2100000000000004e-33 127.0 sp|Q80T91|MEG11_MOUSE Multiple epidermal growth factor-like domains protein 11 OS=Mus musculus OX=10090 GN=Megf11 PE=1 SV=3 g14829.t1 Q80T91 42.424 165 3.71e-33 127.0 sp|Q80T91|MEG11_MOUSE Multiple epidermal growth factor-like domains protein 11 OS=Mus musculus OX=10090 GN=Megf11 PE=1 SV=3 g14829.t1 Q80T91 40.123 162 3.43e-31 121.0 sp|Q80T91|MEG11_MOUSE Multiple epidermal growth factor-like domains protein 11 OS=Mus musculus OX=10090 GN=Megf11 PE=1 SV=3 g14829.t1 Q80T91 38.889 162 7.3700000000000005e-31 120.0 sp|Q80T91|MEG11_MOUSE Multiple epidermal growth factor-like domains protein 11 OS=Mus musculus OX=10090 GN=Megf11 PE=1 SV=3 g14829.t1 Q80T91 38.509 161 1.4399999999999998e-30 119.0 sp|Q80T91|MEG11_MOUSE Multiple epidermal growth factor-like domains protein 11 OS=Mus musculus OX=10090 GN=Megf11 PE=1 SV=3 g14829.t1 Q80T91 38.037 163 3.24e-29 115.0 sp|Q80T91|MEG11_MOUSE Multiple epidermal growth factor-like domains protein 11 OS=Mus musculus OX=10090 GN=Megf11 PE=1 SV=3 g14829.t1 Q80T91 37.423 163 2.51e-28 113.0 sp|Q80T91|MEG11_MOUSE Multiple epidermal growth factor-like domains protein 11 OS=Mus musculus OX=10090 GN=Megf11 PE=1 SV=3 g14829.t1 Q80T91 39.024 164 8.1e-28 111.0 sp|Q80T91|MEG11_MOUSE Multiple epidermal growth factor-like domains protein 11 OS=Mus musculus OX=10090 GN=Megf11 PE=1 SV=3 g14829.t1 Q80T91 37.762 143 2.2399999999999998e-23 99.0 sp|Q80T91|MEG11_MOUSE Multiple epidermal growth factor-like domains protein 11 OS=Mus musculus OX=10090 GN=Megf11 PE=1 SV=3 g14830.t1 S5UH55 31.39 1115 4.07e-118 397.0 sp|S5UH55|TRPM5_DANRE Transient receptor potential cation channel subfamily M member 5 OS=Danio rerio OX=7955 GN=trpm5 PE=1 SV=2 TRPM5_DANRE reviewed Transient receptor potential cation channel subfamily M member 5 Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005227; GO:0005262; GO:0005509; GO:0005886; GO:0042802 plasma membrane [GO:0005886] calcium channel activity [GO:0005262]; calcium ion binding [GO:0005509]; calcium-activated cation channel activity [GO:0005227]; identical protein binding [GO:0042802] g14830.t2 A7T1N0 30.388 1109 3.26e-122 416.0 sp|A7T1N0|TMP2L_NEMVE Transient receptor potential cation channel subfamily M member-like 2 OS=Nematostella vectensis OX=45351 GN=TRPM2 PE=1 SV=1 TMP2L_NEMVE reviewed Transient receptor potential cation channel subfamily M member-like 2 (nvTRPM2) Nematostella vectensis (Starlet sea anemone) GO:0005886; GO:0015280; GO:0035725; GO:0046872; GO:0047631; GO:0070588; GO:0099604 calcium ion transmembrane transport [GO:0070588]; sodium ion transmembrane transport [GO:0035725] plasma membrane [GO:0005886] ADP-ribose diphosphatase activity [GO:0047631]; ligand-gated calcium channel activity [GO:0099604]; ligand-gated sodium channel activity [GO:0015280]; metal ion binding [GO:0046872] g14831.t1 A9MH27 33.051 236 1.05e-28 116.0 sp|A9MH27|GHRA_SALAR Glyoxylate/hydroxypyruvate reductase A OS=Salmonella arizonae (strain ATCC BAA-731 / CDC346-86 / RSK2980) OX=41514 GN=ghrA PE=3 SV=1 g14832.t1 Q5G266 31.173 324 8.67e-38 149.0 sp|Q5G266|NETR_TRAPH Neurotrypsin OS=Trachypithecus phayrei OX=61618 GN=PRSS12 PE=3 SV=1 NETR_TRAPH reviewed Neurotrypsin (EC 3.4.21.-) (Serine protease 12) Trachypithecus phayrei (Phayre's leaf monkey) GO:0004252; GO:0005576; GO:0005886; GO:0006508; GO:0006887; GO:0030424; GO:0098793; GO:0098978 exocytosis [GO:0006887]; proteolysis [GO:0006508] axon [GO:0030424]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; presynapse [GO:0098793] serine-type endopeptidase activity [GO:0004252] g14832.t1 Q5G266 30.328 366 2.51e-34 139.0 sp|Q5G266|NETR_TRAPH Neurotrypsin OS=Trachypithecus phayrei OX=61618 GN=PRSS12 PE=3 SV=1 NETR_TRAPH reviewed Neurotrypsin (EC 3.4.21.-) (Serine protease 12) Trachypithecus phayrei (Phayre's leaf monkey) GO:0004252; GO:0005576; GO:0005886; GO:0006508; GO:0006887; GO:0030424; GO:0098793; GO:0098978 exocytosis [GO:0006887]; proteolysis [GO:0006508] axon [GO:0030424]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; presynapse [GO:0098793] serine-type endopeptidase activity [GO:0004252] g14833.t1 Q920D2 37.363 182 1.16e-36 129.0 sp|Q920D2|DYR_RAT Dihydrofolate reductase OS=Rattus norvegicus OX=10116 GN=Dhfr PE=1 SV=3 DYR_RAT reviewed Dihydrofolate reductase (EC 1.5.1.3) Rattus norvegicus (Rat) GO:0000900; GO:0003729; GO:0004146; GO:0005542; GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0006231; GO:0006729; GO:0016646; GO:0017148; GO:0031103; GO:0031427; GO:0033560; GO:0035094; GO:0035999; GO:0046452; GO:0046653; GO:0046654; GO:0046655; GO:0050661; GO:0051871; GO:0070402; GO:1990825; GO:2000121 axon regeneration [GO:0031103]; dihydrofolate metabolic process [GO:0046452]; dTMP biosynthetic process [GO:0006231]; folic acid metabolic process [GO:0046655]; negative regulation of translation [GO:0017148]; regulation of removal of superoxide radicals [GO:2000121]; response to methotrexate [GO:0031427]; response to nicotine [GO:0035094]; tetrahydrobiopterin biosynthetic process [GO:0006729]; tetrahydrofolate biosynthetic process [GO:0046654]; tetrahydrofolate interconversion [GO:0035999]; tetrahydrofolate metabolic process [GO:0046653] cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634] dihydrofolate reductase activity [GO:0004146]; dihydrofolic acid binding [GO:0051871]; folate reductase activity [GO:0033560]; folic acid binding [GO:0005542]; mRNA binding [GO:0003729]; mRNA regulatory element binding translation repressor activity [GO:0000900]; NADP binding [GO:0050661]; NADPH binding [GO:0070402]; oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor [GO:0016646]; sequence-specific mRNA binding [GO:1990825] g14834.t1 P00378 47.253 182 1.39e-56 179.0 sp|P00378|DYR_CHICK Dihydrofolate reductase OS=Gallus gallus OX=9031 GN=DHFR PE=1 SV=1 g14839.t1 A1ZAX0 27.213 305 3e-25 110.0 sp|A1ZAX0|CCH1R_DROME Neuropeptide CCHamide-1 receptor OS=Drosophila melanogaster OX=7227 GN=CCHa1-R PE=2 SV=2 g14842.t1 Q8N865 41.083 314 2.3000000000000002e-73 241.0 sp|Q8N865|SMIP4_HUMAN Sperm-associated microtubule inner protein 4 OS=Homo sapiens OX=9606 GN=SPMIP4 PE=1 SV=3 SMIP4_HUMAN reviewed Sperm-associated microtubule inner protein 4 Homo sapiens (Human) GO:0005813 centrosome [GO:0005813] g14842.t2 Q6AYM0 40.081 247 5.4799999999999996e-42 154.0 sp|Q6AYM0|SMIP4_RAT Sperm-associated microtubule inner protein 4 OS=Rattus norvegicus OX=10116 GN=Spmip4 PE=1 SV=1 g14843.t1 Q1KKS3 41.146 576 2.04e-127 399.0 sp|Q1KKS3|PDE11_TAKRU Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A OS=Takifugu rubripes OX=31033 GN=pde11a PE=3 SV=1 g14846.t1 P0C1Q2 57.975 326 1.14e-140 425.0 sp|P0C1Q2|PDE11_MOUSE Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A OS=Mus musculus OX=10090 GN=Pde11a PE=1 SV=1 PDE11_MOUSE reviewed Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A (EC 3.1.4.35) (EC 3.1.4.53) (cAMP and cGMP phosphodiesterase 11A) Mus musculus (Mouse) GO:0004115; GO:0004118; GO:0005829; GO:0007165; GO:0010754; GO:0030553; GO:0043204; GO:0046872; GO:0047555; GO:0141162 negative regulation of cAMP/PKA signal transduction [GO:0141162]; negative regulation of cGMP-mediated signaling [GO:0010754]; signal transduction [GO:0007165] cytosol [GO:0005829]; perikaryon [GO:0043204] 3',5'-cGMP-stimulated cyclic-nucleotide phosphodiesterase activity [GO:0004118]; 3',5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; 3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; cGMP binding [GO:0030553]; metal ion binding [GO:0046872] g14847.t1 Q56232 29.67 364 1.7300000000000002e-43 160.0 sp|Q56232|AAPAT_THET8 Aspartate/prephenate aminotransferase OS=Thermus thermophilus (strain ATCC 27634 / DSM 579 / HB8) OX=300852 GN=aspC PE=1 SV=1 AAPAT_THET8 reviewed Aspartate/prephenate aminotransferase (AspAT / PAT) (EC 2.6.1.1) (EC 2.6.1.78) (Transaminase A) Thermus thermophilus (strain ATCC 27634 / DSM 579 / HB8) GO:0004069; GO:0005737; GO:0006520; GO:0030170; GO:0033853 amino acid metabolic process [GO:0006520] cytoplasm [GO:0005737] aspartate-prephenate aminotransferase activity [GO:0033853]; L-aspartate:2-oxoglutarate aminotransferase activity [GO:0004069]; pyridoxal phosphate binding [GO:0030170] g14848.t1 Q09325 60.87 345 4.15e-156 453.0 sp|Q09325|MGAT1_RAT Alpha-1,3-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase OS=Rattus norvegicus OX=10116 GN=Mgat1 PE=2 SV=1 MGAT1_RAT reviewed Alpha-1,3-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase (EC 2.4.1.101) (N-glycosyl-oligosaccharide-glycoprotein N-acetylglucosaminyltransferase I) (GNT-I) (GlcNAc-T I) Rattus norvegicus (Rat) GO:0000139; GO:0001701; GO:0003827; GO:0005794; GO:0006487; GO:0008375; GO:0018279; GO:0030145; GO:0048471 in utero embryonic development [GO:0001701]; protein N-linked glycosylation [GO:0006487]; protein N-linked glycosylation via asparagine [GO:0018279] Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; perinuclear region of cytoplasm [GO:0048471] acetylglucosaminyltransferase activity [GO:0008375]; alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity [GO:0003827]; manganese ion binding [GO:0030145] g14849.t1 P22897 31.207 878 1.69e-114 404.0 sp|P22897|MRC1_HUMAN Macrophage mannose receptor 1 OS=Homo sapiens OX=9606 GN=MRC1 PE=1 SV=1 MRC1_HUMAN reviewed Macrophage mannose receptor 1 (MMR) (C-type lectin domain family 13 member D) (C-type lectin domain family 13 member D-like) (Human mannose receptor) (hMR) (Macrophage mannose receptor 1-like protein 1) (CD antigen CD206) Homo sapiens (Human) GO:0001618; GO:0004888; GO:0005537; GO:0005886; GO:0006898; GO:0009986; GO:0010008; GO:0038023; GO:0038024; GO:0071222; GO:0071346; GO:0071353 cellular response to interleukin-4 [GO:0071353]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to type II interferon [GO:0071346]; receptor-mediated endocytosis [GO:0006898] cell surface [GO:0009986]; endosome membrane [GO:0010008]; plasma membrane [GO:0005886] cargo receptor activity [GO:0038024]; D-mannose binding [GO:0005537]; signaling receptor activity [GO:0038023]; transmembrane signaling receptor activity [GO:0004888]; virus receptor activity [GO:0001618] g14849.t1 P22897 23.951 1144 5.780000000000001e-59 229.0 sp|P22897|MRC1_HUMAN Macrophage mannose receptor 1 OS=Homo sapiens OX=9606 GN=MRC1 PE=1 SV=1 MRC1_HUMAN reviewed Macrophage mannose receptor 1 (MMR) (C-type lectin domain family 13 member D) (C-type lectin domain family 13 member D-like) (Human mannose receptor) (hMR) (Macrophage mannose receptor 1-like protein 1) (CD antigen CD206) Homo sapiens (Human) GO:0001618; GO:0004888; GO:0005537; GO:0005886; GO:0006898; GO:0009986; GO:0010008; GO:0038023; GO:0038024; GO:0071222; GO:0071346; GO:0071353 cellular response to interleukin-4 [GO:0071353]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to type II interferon [GO:0071346]; receptor-mediated endocytosis [GO:0006898] cell surface [GO:0009986]; endosome membrane [GO:0010008]; plasma membrane [GO:0005886] cargo receptor activity [GO:0038024]; D-mannose binding [GO:0005537]; signaling receptor activity [GO:0038023]; transmembrane signaling receptor activity [GO:0004888]; virus receptor activity [GO:0001618] g14849.t1 P22897 27.375 800 1.6000000000000002e-56 221.0 sp|P22897|MRC1_HUMAN Macrophage mannose receptor 1 OS=Homo sapiens OX=9606 GN=MRC1 PE=1 SV=1 MRC1_HUMAN reviewed Macrophage mannose receptor 1 (MMR) (C-type lectin domain family 13 member D) (C-type lectin domain family 13 member D-like) (Human mannose receptor) (hMR) (Macrophage mannose receptor 1-like protein 1) (CD antigen CD206) Homo sapiens (Human) GO:0001618; GO:0004888; GO:0005537; GO:0005886; GO:0006898; GO:0009986; GO:0010008; GO:0038023; GO:0038024; GO:0071222; GO:0071346; GO:0071353 cellular response to interleukin-4 [GO:0071353]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to type II interferon [GO:0071346]; receptor-mediated endocytosis [GO:0006898] cell surface [GO:0009986]; endosome membrane [GO:0010008]; plasma membrane [GO:0005886] cargo receptor activity [GO:0038024]; D-mannose binding [GO:0005537]; signaling receptor activity [GO:0038023]; transmembrane signaling receptor activity [GO:0004888]; virus receptor activity [GO:0001618] g14849.t1 P22897 25.054 918 4.51e-51 203.0 sp|P22897|MRC1_HUMAN Macrophage mannose receptor 1 OS=Homo sapiens OX=9606 GN=MRC1 PE=1 SV=1 MRC1_HUMAN reviewed Macrophage mannose receptor 1 (MMR) (C-type lectin domain family 13 member D) (C-type lectin domain family 13 member D-like) (Human mannose receptor) (hMR) (Macrophage mannose receptor 1-like protein 1) (CD antigen CD206) Homo sapiens (Human) GO:0001618; GO:0004888; GO:0005537; GO:0005886; GO:0006898; GO:0009986; GO:0010008; GO:0038023; GO:0038024; GO:0071222; GO:0071346; GO:0071353 cellular response to interleukin-4 [GO:0071353]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to type II interferon [GO:0071346]; receptor-mediated endocytosis [GO:0006898] cell surface [GO:0009986]; endosome membrane [GO:0010008]; plasma membrane [GO:0005886] cargo receptor activity [GO:0038024]; D-mannose binding [GO:0005537]; signaling receptor activity [GO:0038023]; transmembrane signaling receptor activity [GO:0004888]; virus receptor activity [GO:0001618] g14849.t1 P22897 29.22 551 3.4900000000000003e-43 177.0 sp|P22897|MRC1_HUMAN Macrophage mannose receptor 1 OS=Homo sapiens OX=9606 GN=MRC1 PE=1 SV=1 MRC1_HUMAN reviewed Macrophage mannose receptor 1 (MMR) (C-type lectin domain family 13 member D) (C-type lectin domain family 13 member D-like) (Human mannose receptor) (hMR) (Macrophage mannose receptor 1-like protein 1) (CD antigen CD206) Homo sapiens (Human) GO:0001618; GO:0004888; GO:0005537; GO:0005886; GO:0006898; GO:0009986; GO:0010008; GO:0038023; GO:0038024; GO:0071222; GO:0071346; GO:0071353 cellular response to interleukin-4 [GO:0071353]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to type II interferon [GO:0071346]; receptor-mediated endocytosis [GO:0006898] cell surface [GO:0009986]; endosome membrane [GO:0010008]; plasma membrane [GO:0005886] cargo receptor activity [GO:0038024]; D-mannose binding [GO:0005537]; signaling receptor activity [GO:0038023]; transmembrane signaling receptor activity [GO:0004888]; virus receptor activity [GO:0001618] g14849.t1 P22897 27.409 602 2.2699999999999998e-42 175.0 sp|P22897|MRC1_HUMAN Macrophage mannose receptor 1 OS=Homo sapiens OX=9606 GN=MRC1 PE=1 SV=1 MRC1_HUMAN reviewed Macrophage mannose receptor 1 (MMR) (C-type lectin domain family 13 member D) (C-type lectin domain family 13 member D-like) (Human mannose receptor) (hMR) (Macrophage mannose receptor 1-like protein 1) (CD antigen CD206) Homo sapiens (Human) GO:0001618; GO:0004888; GO:0005537; GO:0005886; GO:0006898; GO:0009986; GO:0010008; GO:0038023; GO:0038024; GO:0071222; GO:0071346; GO:0071353 cellular response to interleukin-4 [GO:0071353]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to type II interferon [GO:0071346]; receptor-mediated endocytosis [GO:0006898] cell surface [GO:0009986]; endosome membrane [GO:0010008]; plasma membrane [GO:0005886] cargo receptor activity [GO:0038024]; D-mannose binding [GO:0005537]; signaling receptor activity [GO:0038023]; transmembrane signaling receptor activity [GO:0004888]; virus receptor activity [GO:0001618] g14849.t1 P22897 27.13 575 9.660000000000001e-37 156.0 sp|P22897|MRC1_HUMAN Macrophage mannose receptor 1 OS=Homo sapiens OX=9606 GN=MRC1 PE=1 SV=1 MRC1_HUMAN reviewed Macrophage mannose receptor 1 (MMR) (C-type lectin domain family 13 member D) (C-type lectin domain family 13 member D-like) (Human mannose receptor) (hMR) (Macrophage mannose receptor 1-like protein 1) (CD antigen CD206) Homo sapiens (Human) GO:0001618; GO:0004888; GO:0005537; GO:0005886; GO:0006898; GO:0009986; GO:0010008; GO:0038023; GO:0038024; GO:0071222; GO:0071346; GO:0071353 cellular response to interleukin-4 [GO:0071353]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to type II interferon [GO:0071346]; receptor-mediated endocytosis [GO:0006898] cell surface [GO:0009986]; endosome membrane [GO:0010008]; plasma membrane [GO:0005886] cargo receptor activity [GO:0038024]; D-mannose binding [GO:0005537]; signaling receptor activity [GO:0038023]; transmembrane signaling receptor activity [GO:0004888]; virus receptor activity [GO:0001618] g14849.t1 P22897 24.599 561 3.71e-35 151.0 sp|P22897|MRC1_HUMAN Macrophage mannose receptor 1 OS=Homo sapiens OX=9606 GN=MRC1 PE=1 SV=1 MRC1_HUMAN reviewed Macrophage mannose receptor 1 (MMR) (C-type lectin domain family 13 member D) (C-type lectin domain family 13 member D-like) (Human mannose receptor) (hMR) (Macrophage mannose receptor 1-like protein 1) (CD antigen CD206) Homo sapiens (Human) GO:0001618; GO:0004888; GO:0005537; GO:0005886; GO:0006898; GO:0009986; GO:0010008; GO:0038023; GO:0038024; GO:0071222; GO:0071346; GO:0071353 cellular response to interleukin-4 [GO:0071353]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to type II interferon [GO:0071346]; receptor-mediated endocytosis [GO:0006898] cell surface [GO:0009986]; endosome membrane [GO:0010008]; plasma membrane [GO:0005886] cargo receptor activity [GO:0038024]; D-mannose binding [GO:0005537]; signaling receptor activity [GO:0038023]; transmembrane signaling receptor activity [GO:0004888]; virus receptor activity [GO:0001618] g14849.t1 P22897 30.515 272 8.37e-23 111.0 sp|P22897|MRC1_HUMAN Macrophage mannose receptor 1 OS=Homo sapiens OX=9606 GN=MRC1 PE=1 SV=1 MRC1_HUMAN reviewed Macrophage mannose receptor 1 (MMR) (C-type lectin domain family 13 member D) (C-type lectin domain family 13 member D-like) (Human mannose receptor) (hMR) (Macrophage mannose receptor 1-like protein 1) (CD antigen CD206) Homo sapiens (Human) GO:0001618; GO:0004888; GO:0005537; GO:0005886; GO:0006898; GO:0009986; GO:0010008; GO:0038023; GO:0038024; GO:0071222; GO:0071346; GO:0071353 cellular response to interleukin-4 [GO:0071353]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to type II interferon [GO:0071346]; receptor-mediated endocytosis [GO:0006898] cell surface [GO:0009986]; endosome membrane [GO:0010008]; plasma membrane [GO:0005886] cargo receptor activity [GO:0038024]; D-mannose binding [GO:0005537]; signaling receptor activity [GO:0038023]; transmembrane signaling receptor activity [GO:0004888]; virus receptor activity [GO:0001618] g14849.t1 P22897 25.231 432 9.739999999999999e-23 110.0 sp|P22897|MRC1_HUMAN Macrophage mannose receptor 1 OS=Homo sapiens OX=9606 GN=MRC1 PE=1 SV=1 MRC1_HUMAN reviewed Macrophage mannose receptor 1 (MMR) (C-type lectin domain family 13 member D) (C-type lectin domain family 13 member D-like) (Human mannose receptor) (hMR) (Macrophage mannose receptor 1-like protein 1) (CD antigen CD206) Homo sapiens (Human) GO:0001618; GO:0004888; GO:0005537; GO:0005886; GO:0006898; GO:0009986; GO:0010008; GO:0038023; GO:0038024; GO:0071222; GO:0071346; GO:0071353 cellular response to interleukin-4 [GO:0071353]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to type II interferon [GO:0071346]; receptor-mediated endocytosis [GO:0006898] cell surface [GO:0009986]; endosome membrane [GO:0010008]; plasma membrane [GO:0005886] cargo receptor activity [GO:0038024]; D-mannose binding [GO:0005537]; signaling receptor activity [GO:0038023]; transmembrane signaling receptor activity [GO:0004888]; virus receptor activity [GO:0001618] g14855.t1 Q9W6C5 47.413 715 0.0 673.0 sp|Q9W6C5|PDC6I_XENLA Programmed cell death 6-interacting protein OS=Xenopus laevis OX=8355 GN=pdcd6ip PE=1 SV=1 g14855.t2 Q9W6C5 47.546 713 0.0 672.0 sp|Q9W6C5|PDC6I_XENLA Programmed cell death 6-interacting protein OS=Xenopus laevis OX=8355 GN=pdcd6ip PE=1 SV=1 g14856.t1 P27545 42.553 282 3.92e-73 233.0 sp|P27545|CERS1_MOUSE Ceramide synthase 1 OS=Mus musculus OX=10090 GN=Cers1 PE=1 SV=1 CERS1_MOUSE reviewed Ceramide synthase 1 (CerS1) (Longevity assurance gene 1 protein homolog 1) (Protein UOG-1) (Sphingoid base N-stearoyltransferase CERS1) (EC 2.3.1.299) Mus musculus (Mouse) GO:0005783; GO:0005789; GO:0007420; GO:0010614; GO:0016410; GO:0030148; GO:0036146; GO:0046325; GO:0046513; GO:0050291; GO:0071466; GO:0071492; GO:0072721; GO:1901526 brain development [GO:0007420]; cellular response to dithiothreitol [GO:0072721]; cellular response to mycotoxin [GO:0036146]; cellular response to UV-A [GO:0071492]; cellular response to xenobiotic stimulus [GO:0071466]; ceramide biosynthetic process [GO:0046513]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of D-glucose import [GO:0046325]; positive regulation of mitophagy [GO:1901526]; sphingolipid biosynthetic process [GO:0030148] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789] N-acyltransferase activity [GO:0016410]; sphingosine N-acyltransferase activity [GO:0050291] g14857.t1 A0A140LIJ0 27.918 634 1.15e-87 300.0 sp|A0A140LIJ0|DCST2_MOUSE DC-STAMP domain-containing protein 2 OS=Mus musculus OX=10090 GN=Dcst2 PE=1 SV=1 g14858.t1 Q5BJJ5 67.181 259 3.5700000000000002e-124 357.0 sp|Q5BJJ5|HDHD2_DANRE Haloacid dehalogenase-like hydrolase domain-containing protein 2 OS=Danio rerio OX=7955 GN=hdhd2 PE=2 SV=1 g14859.t1 Q3U1G5 54.696 181 5.73e-54 184.0 sp|Q3U1G5|I20L2_MOUSE Interferon-stimulated 20 kDa exonuclease-like 2 OS=Mus musculus OX=10090 GN=Isg20l2 PE=1 SV=2 g14860.t1 Q9CR41 65.306 98 3.8100000000000006e-37 125.0 sp|Q9CR41|HYPK_MOUSE Huntingtin-interacting protein K OS=Mus musculus OX=10090 GN=Hypk PE=1 SV=3 g14861.t1 P00430 69.492 59 1.7e-26 94.4 sp|P00430|COX7C_BOVIN Cytochrome c oxidase subunit 7C, mitochondrial OS=Bos taurus OX=9913 GN=COX7C PE=1 SV=3 g14862.t1 Q80YR5 60.976 82 1.8999999999999998e-23 111.0 sp|Q80YR5|SAFB2_MOUSE Scaffold attachment factor B2 OS=Mus musculus OX=10090 GN=Safb2 PE=1 SV=2 g14863.t1 Q14151 74.359 78 2.35e-28 127.0 sp|Q14151|SAFB2_HUMAN Scaffold attachment factor B2 OS=Homo sapiens OX=9606 GN=SAFB2 PE=1 SV=1 g14864.t1 Q5F3Z7 51.651 424 9.3e-124 371.0 sp|Q5F3Z7|CTSL2_CHICK CTD small phosphatase-like protein 2 OS=Gallus gallus OX=9031 GN=CTDSPL2 PE=2 SV=2 g14868.t1 P54357 44.521 146 5.9999999999999996e-40 134.0 sp|P54357|MLC2_DROME Myosin-2 essential light chain OS=Drosophila melanogaster OX=7227 GN=Mlc-c PE=1 SV=1 g14869.t1 Q96BD0 37.5 632 2.96e-119 375.0 sp|Q96BD0|SO4A1_HUMAN Solute carrier organic anion transporter family member 4A1 OS=Homo sapiens OX=9606 GN=SLCO4A1 PE=1 SV=2 g14870.t1 Q2TBI6 38.235 170 3.76e-24 96.7 sp|Q2TBI6|RM32_BOVIN Large ribosomal subunit protein bL32m OS=Bos taurus OX=9913 GN=MRPL32 PE=1 SV=1 g14871.t1 P25787 82.203 236 2.21e-144 405.0 sp|P25787|PSA2_HUMAN Proteasome subunit alpha type-2 OS=Homo sapiens OX=9606 GN=PSMA2 PE=1 SV=2 PSA2_HUMAN reviewed Proteasome subunit alpha type-2 (Macropain subunit C3) (Multicatalytic endopeptidase complex subunit C3) (Proteasome component C3) (Proteasome subunit alpha-2) (alpha-2) Homo sapiens (Human) GO:0000502; GO:0000932; GO:0005576; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005839; GO:0009615; GO:0019773; GO:0034774; GO:0043161; GO:0070062; GO:1904813 proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; response to virus [GO:0009615] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; proteasome complex [GO:0000502]; proteasome core complex [GO:0005839]; proteasome core complex, alpha-subunit complex [GO:0019773]; secretory granule lumen [GO:0034774] g14872.t1 O93484 33.333 234 6.1599999999999995e-34 148.0 sp|O93484|CO1A2_ONCMY Collagen alpha-2(I) chain OS=Oncorhynchus mykiss OX=8022 GN=col1a2 PE=2 SV=2 g14878.t1 O93484 34.8 250 4.16e-44 181.0 sp|O93484|CO1A2_ONCMY Collagen alpha-2(I) chain OS=Oncorhynchus mykiss OX=8022 GN=col1a2 PE=2 SV=2 g14879.t1 P02460 43.21 243 8.770000000000001e-47 188.0 sp|P02460|CO2A1_CHICK Collagen alpha-1(II) chain (Fragment) OS=Gallus gallus OX=9031 GN=COL2A1 PE=2 SV=2 g14880.t1 Q8K2A1 53.158 190 1.14e-65 216.0 sp|Q8K2A1|GULP1_MOUSE PTB domain-containing engulfment adapter protein 1 OS=Mus musculus OX=10090 GN=Gulp1 PE=1 SV=1 g14880.t2 Q8K2A1 50.249 201 3.11e-62 207.0 sp|Q8K2A1|GULP1_MOUSE PTB domain-containing engulfment adapter protein 1 OS=Mus musculus OX=10090 GN=Gulp1 PE=1 SV=1 g14881.t1 Q9H3S4 54.825 228 1.5599999999999998e-89 271.0 sp|Q9H3S4|TPK1_HUMAN Thiamine pyrophosphokinase 1 OS=Homo sapiens OX=9606 GN=TPK1 PE=1 SV=1 TPK1_HUMAN reviewed Thiamine pyrophosphokinase 1 (hTPK1) (EC 2.7.6.-) (Placental protein 20) (PP20) (Thiamin pyrophosphokinase 1) Homo sapiens (Human) GO:0004788; GO:0005524; GO:0005829; GO:0006772; GO:0009229; GO:0010510; GO:0016301; GO:0030975; GO:0042802; GO:0141200 regulation of pyruvate decarboxylation to acetyl-CoA [GO:0010510]; thiamine diphosphate biosynthetic process [GO:0009229]; thiamine metabolic process [GO:0006772] cytosol [GO:0005829] ATP binding [GO:0005524]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; thiamine binding [GO:0030975]; thiamine diphosphokinase activity [GO:0004788]; UTP thiamine diphosphokinase activity [GO:0141200] g14881.t2 Q9H3S4 54.825 228 4.7e-89 271.0 sp|Q9H3S4|TPK1_HUMAN Thiamine pyrophosphokinase 1 OS=Homo sapiens OX=9606 GN=TPK1 PE=1 SV=1 TPK1_HUMAN reviewed Thiamine pyrophosphokinase 1 (hTPK1) (EC 2.7.6.-) (Placental protein 20) (PP20) (Thiamin pyrophosphokinase 1) Homo sapiens (Human) GO:0004788; GO:0005524; GO:0005829; GO:0006772; GO:0009229; GO:0010510; GO:0016301; GO:0030975; GO:0042802; GO:0141200 regulation of pyruvate decarboxylation to acetyl-CoA [GO:0010510]; thiamine diphosphate biosynthetic process [GO:0009229]; thiamine metabolic process [GO:0006772] cytosol [GO:0005829] ATP binding [GO:0005524]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; thiamine binding [GO:0030975]; thiamine diphosphokinase activity [GO:0004788]; UTP thiamine diphosphokinase activity [GO:0141200] g14882.t1 Q962X7 86.765 68 2.79e-28 99.0 sp|Q962X7|SC61G_BRABE Protein transport protein Sec61 subunit gamma OS=Branchiostoma belcheri OX=7741 GN=SEC61G PE=3 SV=1 g14884.t1 Q53TQ3 75.728 103 2e-44 177.0 sp|Q53TQ3|IN80D_HUMAN INO80 complex subunit D OS=Homo sapiens OX=9606 GN=INO80D PE=1 SV=3 IN80D_HUMAN reviewed INO80 complex subunit D Homo sapiens (Human) GO:0000723; GO:0005634; GO:0005654; GO:0006275; GO:0006281; GO:0006282; GO:0006310; GO:0006338; GO:0031011; GO:0033044; GO:0045739; GO:0045893; GO:0045995; GO:0051726; GO:0060382; GO:1904507 chromatin remodeling [GO:0006338]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; positive regulation of DNA repair [GO:0045739]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of telomere maintenance in response to DNA damage [GO:1904507]; regulation of cell cycle [GO:0051726]; regulation of chromosome organization [GO:0033044]; regulation of DNA repair [GO:0006282]; regulation of DNA replication [GO:0006275]; regulation of DNA strand elongation [GO:0060382]; regulation of embryonic development [GO:0045995]; telomere maintenance [GO:0000723] Ino80 complex [GO:0031011]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] g14885.t1 Q8CBE3 54.91 499 0.0 550.0 sp|Q8CBE3|WDR37_MOUSE WD repeat-containing protein 37 OS=Mus musculus OX=10090 GN=Wdr37 PE=1 SV=1 g14886.t1 Q91ZS8 53.506 656 0.0 616.0 sp|Q91ZS8|RED1_MOUSE Double-stranded RNA-specific editase 1 OS=Mus musculus OX=10090 GN=Adarb1 PE=1 SV=1 RED1_MOUSE reviewed Double-stranded RNA-specific editase 1 (EC 3.5.4.37) (RNA-editing deaminase 1) (RNA-editing enzyme 1) (dsRNA adenosine deaminase) Mus musculus (Mouse) GO:0003723; GO:0003725; GO:0003726; GO:0004000; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0006382; GO:0006396; GO:0006397; GO:0007274; GO:0008251; GO:0008285; GO:0016553; GO:0016556; GO:0021610; GO:0021618; GO:0021965; GO:0030336; GO:0035264; GO:0042802; GO:0044387; GO:0045070; GO:0045202; GO:0046872; GO:0050685; GO:0050884; GO:0051726; GO:0060384; GO:0060415; GO:0061744; GO:0097049 adenosine to inosine editing [GO:0006382]; base conversion or substitution editing [GO:0016553]; facial nerve morphogenesis [GO:0021610]; hypoglossal nerve morphogenesis [GO:0021618]; innervation [GO:0060384]; motor behavior [GO:0061744]; motor neuron apoptotic process [GO:0097049]; mRNA modification [GO:0016556]; mRNA processing [GO:0006397]; multicellular organism growth [GO:0035264]; muscle tissue morphogenesis [GO:0060415]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of protein kinase activity by regulation of protein phosphorylation [GO:0044387]; neuromuscular process controlling posture [GO:0050884]; neuromuscular synaptic transmission [GO:0007274]; positive regulation of mRNA processing [GO:0050685]; positive regulation of viral genome replication [GO:0045070]; regulation of cell cycle [GO:0051726]; RNA processing [GO:0006396]; spinal cord ventral commissure morphogenesis [GO:0021965] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; synapse [GO:0045202] adenosine deaminase activity [GO:0004000]; double-stranded RNA adenosine deaminase activity [GO:0003726]; double-stranded RNA binding [GO:0003725]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; tRNA-specific adenosine deaminase activity [GO:0008251] g14887.t1 Q8BP00 35.445 584 1.72e-99 317.0 sp|Q8BP00|IQCB1_MOUSE IQ calmodulin-binding motif-containing protein 1 OS=Mus musculus OX=10090 GN=Iqcb1 PE=1 SV=2 IQCB1_MOUSE reviewed IQ calmodulin-binding motif-containing protein 1 Mus musculus (Mouse) GO:0001750; GO:0005516; GO:0005813; GO:0005929; GO:0019899; GO:0030674; GO:0032391; GO:0045494; GO:0048496; GO:0060271; GO:0061824; GO:0062063 cilium assembly [GO:0060271]; cytosolic ciliogenesis [GO:0061824]; maintenance of animal organ identity [GO:0048496]; photoreceptor cell maintenance [GO:0045494] centrosome [GO:0005813]; cilium [GO:0005929]; photoreceptor connecting cilium [GO:0032391]; photoreceptor outer segment [GO:0001750] BBSome binding [GO:0062063]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; protein-macromolecule adaptor activity [GO:0030674] g14888.t1 Q9YGN6 55.785 242 4.81e-89 270.0 sp|Q9YGN6|SMUG1_XENLA Single-strand selective monofunctional uracil DNA glycosylase OS=Xenopus laevis OX=8355 GN=smug1 PE=1 SV=1 g14889.t1 Q1KKZ1 50.602 83 2.8100000000000003e-21 97.8 sp|Q1KKZ1|SKAP2_TAKRU Src kinase-associated phosphoprotein 2 OS=Takifugu rubripes OX=31033 GN=skap2 PE=3 SV=1 g14889.t2 Q1KKZ1 50.602 83 2.7800000000000003e-21 97.8 sp|Q1KKZ1|SKAP2_TAKRU Src kinase-associated phosphoprotein 2 OS=Takifugu rubripes OX=31033 GN=skap2 PE=3 SV=1 g14890.t1 Q5R6X7 56.209 153 1.9299999999999999e-53 173.0 sp|Q5R6X7|CBX3_PONAB Chromobox protein homolog 3 OS=Pongo abelii OX=9601 GN=CBX3 PE=2 SV=1 CBX3_PONAB reviewed Chromobox protein homolog 3 (Heterochromatin protein 1 homolog gamma) (HP1 gamma) Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0000779; GO:0000785; GO:0000791; GO:0000792; GO:0001221; GO:0005635; GO:0005721; GO:0005819; GO:0006974; GO:0019904; GO:0031507; GO:0042802; GO:0045892; GO:0048511; GO:0061793; GO:0090575; GO:0090734; GO:1990226 DNA damage response [GO:0006974]; heterochromatin formation [GO:0031507]; negative regulation of DNA-templated transcription [GO:0045892]; rhythmic process [GO:0048511] chromatin [GO:0000785]; chromatin lock complex [GO:0061793]; condensed chromosome, centromeric region [GO:0000779]; euchromatin [GO:0000791]; heterochromatin [GO:0000792]; nuclear envelope [GO:0005635]; pericentric heterochromatin [GO:0005721]; RNA polymerase II transcription regulator complex [GO:0090575]; site of DNA damage [GO:0090734]; spindle [GO:0005819] histone methyltransferase binding [GO:1990226]; identical protein binding [GO:0042802]; protein domain specific binding [GO:0019904]; transcription coregulator binding [GO:0001221] g14891.t1 Q8BMN4 47.386 593 0.0 583.0 sp|Q8BMN4|LMLN_MOUSE Leishmanolysin-like peptidase OS=Mus musculus OX=10090 GN=Lmln PE=2 SV=1 g14892.t1 Q9BZE4 65.335 626 0.0 800.0 sp|Q9BZE4|GTPB4_HUMAN GTP-binding protein 4 OS=Homo sapiens OX=9606 GN=GTPBP4 PE=1 SV=3 GTPB4_HUMAN reviewed GTP-binding protein 4 (Chronic renal failure gene protein) (GTP-binding protein NGB) (Nucleolar GTP-binding protein 1) Homo sapiens (Human) GO:0000463; GO:0001649; GO:0003723; GO:0003924; GO:0005525; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0008156; GO:0008285; GO:0010972; GO:0016020; GO:0022408; GO:0030336; GO:0031397; GO:0031965; GO:0042273; GO:0048471; GO:0050821; GO:1990275 maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell-cell adhesion [GO:0022408]; negative regulation of DNA replication [GO:0008156]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; negative regulation of protein ubiquitination [GO:0031397]; osteoblast differentiation [GO:0001649]; protein stabilization [GO:0050821]; ribosomal large subunit biogenesis [GO:0042273] cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471] GTP binding [GO:0005525]; GTPase activity [GO:0003924]; preribosome binding [GO:1990275]; RNA binding [GO:0003723] g14896.t1 O43586 37.5 416 3.74e-77 248.0 sp|O43586|PPIP1_HUMAN Proline-serine-threonine phosphatase-interacting protein 1 OS=Homo sapiens OX=9606 GN=PSTPIP1 PE=1 SV=1 PPIP1_HUMAN reviewed Proline-serine-threonine phosphatase-interacting protein 1 (PEST phosphatase-interacting protein 1) (CD2-binding protein 1) (H-PIP) Homo sapiens (Human) GO:0001931; GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0006897; GO:0006954; GO:0007155; GO:0007165; GO:0016020; GO:0030027; GO:0032154; GO:0042802; GO:0045087; GO:0048471 cell adhesion [GO:0007155]; endocytosis [GO:0006897]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; signal transduction [GO:0007165] cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; lamellipodium [GO:0030027]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; uropod [GO:0001931] identical protein binding [GO:0042802] g14897.t1 Q6DFB7 33.333 600 7.670000000000001e-88 286.0 sp|Q6DFB7|POC5_XENLA Centrosomal protein POC5 OS=Xenopus laevis OX=8355 GN=poc5 PE=2 SV=1 g14903.t1 Q5RBT2 58.747 463 0.0 566.0 sp|Q5RBT2|DNPEP_PONAB Aspartyl aminopeptidase OS=Pongo abelii OX=9601 GN=DNPEP PE=2 SV=1 DNPEP_PONAB reviewed Aspartyl aminopeptidase (EC 3.4.11.21) Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0004177; GO:0005737; GO:0006508; GO:0008237; GO:0008270 proteolysis [GO:0006508] cytoplasm [GO:0005737] aminopeptidase activity [GO:0004177]; metallopeptidase activity [GO:0008237]; zinc ion binding [GO:0008270] g14906.t1 C9JQI7 36.052 233 1.31e-34 138.0 sp|C9JQI7|TM232_HUMAN Transmembrane protein 232 OS=Homo sapiens OX=9606 GN=TMEM232 PE=1 SV=2 TM232_HUMAN reviewed Transmembrane protein 232 Homo sapiens (Human) GO:0001520; GO:0007283; GO:0016020; GO:0030030; GO:0030317; GO:0098544; GO:0160087 cell projection organization [GO:0030030]; flagellated sperm motility [GO:0030317]; maintenance of protein complex location [GO:0098544]; spermatid cytoplasm removal during spermiation of flagellated sperm [GO:0160087]; spermatogenesis [GO:0007283] membrane [GO:0016020]; outer dense fiber [GO:0001520] g14909.t1 P16453 64.463 121 9.51e-46 169.0 sp|P16453|DCHS_RAT Histidine decarboxylase OS=Rattus norvegicus OX=10116 GN=Hdc PE=2 SV=2 DCHS_RAT reviewed Histidine decarboxylase (HDC) (EC 4.1.1.22) Rattus norvegicus (Rat) GO:0001692; GO:0001694; GO:0004398; GO:0005737; GO:0006547; GO:0006548; GO:0016597; GO:0030170; GO:0030425; GO:0042423; GO:0042802; GO:0043025 catecholamine biosynthetic process [GO:0042423]; histamine biosynthetic process [GO:0001694]; histamine metabolic process [GO:0001692]; L-histidine catabolic process [GO:0006548]; L-histidine metabolic process [GO:0006547] cytoplasm [GO:0005737]; dendrite [GO:0030425]; neuronal cell body [GO:0043025] amino acid binding [GO:0016597]; histidine decarboxylase activity [GO:0004398]; identical protein binding [GO:0042802]; pyridoxal phosphate binding [GO:0030170] g14912.t1 Q8TAK5 67.925 159 2.11e-71 233.0 sp|Q8TAK5|GABP2_HUMAN GA-binding protein subunit beta-2 OS=Homo sapiens OX=9606 GN=GABPB2 PE=1 SV=1 g14913.t1 P59480 54.545 231 3.83e-94 284.0 sp|P59480|RM45_XENLA Large ribosomal subunit protein mL45 OS=Xenopus laevis OX=8355 GN=mrpl45 PE=2 SV=1 g14914.t1 Q91579 54.921 508 1.71e-173 501.0 sp|Q91579|CEL3A_XENLA CUGBP Elav-like family member 3-A OS=Xenopus laevis OX=8355 GN=tnrc4-a PE=2 SV=2 g14914.t2 Q91579 56.914 499 1.0999999999999999e-174 504.0 sp|Q91579|CEL3A_XENLA CUGBP Elav-like family member 3-A OS=Xenopus laevis OX=8355 GN=tnrc4-a PE=2 SV=2 g14914.t3 Q91579 53.831 522 8.539999999999999e-172 497.0 sp|Q91579|CEL3A_XENLA CUGBP Elav-like family member 3-A OS=Xenopus laevis OX=8355 GN=tnrc4-a PE=2 SV=2 g14914.t4 Q91579 55.408 527 0.0 530.0 sp|Q91579|CEL3A_XENLA CUGBP Elav-like family member 3-A OS=Xenopus laevis OX=8355 GN=tnrc4-a PE=2 SV=2 g14916.t1 P40818 41.496 682 4.679999999999999e-128 425.0 sp|P40818|UBP8_HUMAN Ubiquitin carboxyl-terminal hydrolase 8 OS=Homo sapiens OX=9606 GN=USP8 PE=1 SV=1 UBP8_HUMAN reviewed Ubiquitin carboxyl-terminal hydrolase 8 (EC 3.4.19.12) (Deubiquitinating enzyme 8) (Ubiquitin isopeptidase Y) (hUBPy) (Ubiquitin thioesterase 8) (Ubiquitin-specific-processing protease 8) Homo sapiens (Human) GO:0000281; GO:0002080; GO:0004197; GO:0004843; GO:0005634; GO:0005737; GO:0005769; GO:0005829; GO:0005886; GO:0006508; GO:0007032; GO:0007265; GO:0010008; GO:0014069; GO:0016579; GO:0017124; GO:0030496; GO:0031647; GO:0032880; GO:0045296; GO:0061578; GO:0070536; GO:0071108; GO:0071549; GO:0090263; GO:0098978; GO:0099576; GO:1905166; GO:1905908; GO:1990090; GO:1990380 cellular response to dexamethasone stimulus [GO:0071549]; cellular response to nerve growth factor stimulus [GO:1990090]; endosome organization [GO:0007032]; mitotic cytokinesis [GO:0000281]; negative regulation of lysosomal protein catabolic process [GO:1905166]; positive regulation of amyloid fibril formation [GO:1905908]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; protein deubiquitination [GO:0016579]; protein K48-linked deubiquitination [GO:0071108]; protein K63-linked deubiquitination [GO:0070536]; proteolysis [GO:0006508]; Ras protein signal transduction [GO:0007265]; regulation of protein catabolic process at postsynapse, modulating synaptic transmission [GO:0099576]; regulation of protein localization [GO:0032880]; regulation of protein stability [GO:0031647] acrosomal membrane [GO:0002080]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endosome membrane [GO:0010008]; glutamatergic synapse [GO:0098978]; midbody [GO:0030496]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069] cadherin binding [GO:0045296]; cysteine-type deubiquitinase activity [GO:0004843]; cysteine-type endopeptidase activity [GO:0004197]; K48-linked deubiquitinase activity [GO:1990380]; K63-linked deubiquitinase activity [GO:0061578]; SH3 domain binding [GO:0017124] g14916.t1 P40818 35.461 423 1.0900000000000002e-56 218.0 sp|P40818|UBP8_HUMAN Ubiquitin carboxyl-terminal hydrolase 8 OS=Homo sapiens OX=9606 GN=USP8 PE=1 SV=1 UBP8_HUMAN reviewed Ubiquitin carboxyl-terminal hydrolase 8 (EC 3.4.19.12) (Deubiquitinating enzyme 8) (Ubiquitin isopeptidase Y) (hUBPy) (Ubiquitin thioesterase 8) (Ubiquitin-specific-processing protease 8) Homo sapiens (Human) GO:0000281; GO:0002080; GO:0004197; GO:0004843; GO:0005634; GO:0005737; GO:0005769; GO:0005829; GO:0005886; GO:0006508; GO:0007032; GO:0007265; GO:0010008; GO:0014069; GO:0016579; GO:0017124; GO:0030496; GO:0031647; GO:0032880; GO:0045296; GO:0061578; GO:0070536; GO:0071108; GO:0071549; GO:0090263; GO:0098978; GO:0099576; GO:1905166; GO:1905908; GO:1990090; GO:1990380 cellular response to dexamethasone stimulus [GO:0071549]; cellular response to nerve growth factor stimulus [GO:1990090]; endosome organization [GO:0007032]; mitotic cytokinesis [GO:0000281]; negative regulation of lysosomal protein catabolic process [GO:1905166]; positive regulation of amyloid fibril formation [GO:1905908]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; protein deubiquitination [GO:0016579]; protein K48-linked deubiquitination [GO:0071108]; protein K63-linked deubiquitination [GO:0070536]; proteolysis [GO:0006508]; Ras protein signal transduction [GO:0007265]; regulation of protein catabolic process at postsynapse, modulating synaptic transmission [GO:0099576]; regulation of protein localization [GO:0032880]; regulation of protein stability [GO:0031647] acrosomal membrane [GO:0002080]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endosome membrane [GO:0010008]; glutamatergic synapse [GO:0098978]; midbody [GO:0030496]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069] cadherin binding [GO:0045296]; cysteine-type deubiquitinase activity [GO:0004843]; cysteine-type endopeptidase activity [GO:0004197]; K48-linked deubiquitinase activity [GO:1990380]; K63-linked deubiquitinase activity [GO:0061578]; SH3 domain binding [GO:0017124] g14918.t1 Q6DG60 67.568 259 5e-129 373.0 sp|Q6DG60|UBE2Z_DANRE Ubiquitin-conjugating enzyme E2 Z OS=Danio rerio OX=7955 GN=ube2z PE=2 SV=2 UBE2Z_DANRE reviewed Ubiquitin-conjugating enzyme E2 Z (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme Z) (Ubiquitin carrier protein Z) (Ubiquitin-protein ligase Z) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005524; GO:0005634; GO:0005737; GO:0006915; GO:0016567; GO:0043066; GO:0061631 apoptotic process [GO:0006915]; negative regulation of apoptotic process [GO:0043066]; protein ubiquitination [GO:0016567] cytoplasm [GO:0005737]; nucleus [GO:0005634] ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631] g14925.t1 Q5SUV2 38.532 436 8.24e-87 295.0 sp|Q5SUV2|MYBPP_MOUSE MYCBP-associated protein OS=Mus musculus OX=10090 GN=Mycbpap PE=1 SV=1 MYBPP_MOUSE reviewed MYCBP-associated protein (AMAM-1) (AMY-1-binding protein 1) (AMAP-1) Mus musculus (Mouse) GO:0001669; GO:0001675; GO:0005737; GO:0007268; GO:0007283; GO:0016020; GO:0030317; GO:0036126; GO:0045202; GO:0097225; GO:0120316; GO:1990716 acrosome assembly [GO:0001675]; chemical synaptic transmission [GO:0007268]; flagellated sperm motility [GO:0030317]; sperm flagellum assembly [GO:0120316]; spermatogenesis [GO:0007283] acrosomal vesicle [GO:0001669]; axonemal central apparatus [GO:1990716]; cytoplasm [GO:0005737]; membrane [GO:0016020]; sperm flagellum [GO:0036126]; sperm midpiece [GO:0097225]; synapse [GO:0045202] g14927.t1 P70566 46.178 314 2.13e-79 249.0 sp|P70566|TMOD2_RAT Tropomodulin-2 OS=Rattus norvegicus OX=10116 GN=Tmod2 PE=1 SV=1 g14936.t1 A2AWT3 42.571 350 1.4399999999999998e-69 225.0 sp|A2AWT3|AT7L3_MOUSE Ataxin-7-like protein 3 OS=Mus musculus OX=10090 GN=Atxn7l3 PE=1 SV=1 AT7L3_MOUSE reviewed Ataxin-7-like protein 3 (SAGA-associated factor 11 homolog) Mus musculus (Mouse) GO:0000124; GO:0003713; GO:0005634; GO:0006282; GO:0006325; GO:0006357; GO:0008270; GO:0033276; GO:0043484; GO:0045893; GO:0071819 chromatin organization [GO:0006325]; positive regulation of DNA-templated transcription [GO:0045893]; regulation of DNA repair [GO:0006282]; regulation of RNA splicing [GO:0043484]; regulation of transcription by RNA polymerase II [GO:0006357] DUBm complex [GO:0071819]; nucleus [GO:0005634]; SAGA complex [GO:0000124]; transcription factor TFTC complex [GO:0033276] transcription coactivator activity [GO:0003713]; zinc ion binding [GO:0008270] g14948.t1 Q91ZR4 43.424 479 3.2400000000000002e-109 350.0 sp|Q91ZR4|NEK8_MOUSE Serine/threonine-protein kinase Nek8 OS=Mus musculus OX=10090 GN=Nek8 PE=1 SV=1 NEK8_MOUSE reviewed Serine/threonine-protein kinase Nek8 (EC 2.7.11.1) (Never in mitosis A-related kinase 8) (NimA-related protein kinase 8) Mus musculus (Mouse) GO:0004674; GO:0005524; GO:0005813; GO:0005929; GO:0005930; GO:0007368; GO:0007507; GO:0009887; GO:0035330; GO:0046872; GO:0097543; GO:0097546; GO:0106310 animal organ morphogenesis [GO:0009887]; determination of left/right symmetry [GO:0007368]; heart development [GO:0007507]; regulation of hippo signaling [GO:0035330] axoneme [GO:0005930]; centrosome [GO:0005813]; ciliary base [GO:0097546]; ciliary inversin compartment [GO:0097543]; cilium [GO:0005929] ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g14952.t1 Q8WVS4 37.479 595 3.97e-121 396.0 sp|Q8WVS4|DC2I1_HUMAN Cytoplasmic dynein 2 intermediate chain 1 OS=Homo sapiens OX=9606 GN=DYNC2I1 PE=1 SV=3 DC2I1_HUMAN reviewed Cytoplasmic dynein 2 intermediate chain 1 (Dynein 2 intermediate chain 1) (WD repeat-containing protein 60) Homo sapiens (Human) GO:0000242; GO:0005615; GO:0005813; GO:0005829; GO:0005868; GO:0005929; GO:0035721; GO:0036064; GO:0045503; GO:0045504; GO:0048704; GO:0060271; GO:0097542; GO:0097546 cilium assembly [GO:0060271]; embryonic skeletal system morphogenesis [GO:0048704]; intraciliary retrograde transport [GO:0035721] centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary base [GO:0097546]; ciliary tip [GO:0097542]; cilium [GO:0005929]; cytoplasmic dynein complex [GO:0005868]; cytosol [GO:0005829]; extracellular space [GO:0005615]; pericentriolar material [GO:0000242] dynein heavy chain binding [GO:0045504]; dynein light chain binding [GO:0045503] g14954.t1 Q7YS91 28.767 365 6.11e-34 136.0 sp|Q7YS91|FAKD4_PIG FAST kinase domain-containing protein 4 OS=Sus scrofa OX=9823 GN=TBRG4 PE=2 SV=2 g14955.t1 Q0MQB1 57.895 171 1.88e-70 213.0 sp|Q0MQB1|NDUA8_PANTR NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 8 OS=Pan troglodytes OX=9598 GN=NDUFA8 PE=2 SV=3 g14956.t1 Q99081 39.823 565 3.9799999999999995e-62 223.0 sp|Q99081|HTF4_HUMAN Transcription factor 12 OS=Homo sapiens OX=9606 GN=TCF12 PE=1 SV=1 HTF4_HUMAN reviewed Transcription factor 12 (TCF-12) (Class B basic helix-loop-helix protein 20) (bHLHb20) (DNA-binding protein HTF4) (E-box-binding protein) (Transcription factor HTF-4) Homo sapiens (Human) GO:0000785; GO:0000978; GO:0000981; GO:0000987; GO:0001228; GO:0003700; GO:0005634; GO:0005654; GO:0005667; GO:0005737; GO:0006357; GO:0006955; GO:0007399; GO:0007517; GO:0010467; GO:0010628; GO:0016607; GO:0030154; GO:0035497; GO:0043425; GO:0045666; GO:0045944; GO:0046332; GO:0046982; GO:0070888; GO:0071837; GO:0090575; GO:0097210; GO:0140297; GO:1990837 cell differentiation [GO:0030154]; gene expression [GO:0010467]; immune response [GO:0006955]; muscle organ development [GO:0007517]; nervous system development [GO:0007399]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; response to gonadotropin-releasing hormone [GO:0097210] chromatin [GO:0000785]; cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575]; transcription regulator complex [GO:0005667] bHLH transcription factor binding [GO:0043425]; cAMP response element binding [GO:0035497]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription factor binding [GO:0140297]; E-box binding [GO:0070888]; HMG box domain binding [GO:0071837]; protein heterodimerization activity [GO:0046982]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; SMAD binding [GO:0046332] g14956.t2 Q62655 44.25 400 1.4199999999999998e-61 218.0 sp|Q62655|ITF2_RAT Transcription factor 4 OS=Rattus norvegicus OX=10116 GN=Tcf4 PE=1 SV=2 ITF2_RAT reviewed Transcription factor 4 (TCF-4) (Immunoglobulin transcription factor 2) (ITF-2) (RITF-2) (R8f DNA-binding protein) (SL3-3 enhancer factor 2) (SEF-2) Rattus norvegicus (Rat) GO:0000122; GO:0000785; GO:0000977; GO:0000978; GO:0000981; GO:0001093; GO:0001228; GO:0003677; GO:0003682; GO:0003690; GO:0003700; GO:0003714; GO:0005634; GO:0005667; GO:0006355; GO:0006357; GO:0008013; GO:0010629; GO:0016525; GO:0042118; GO:0042802; GO:0043425; GO:0045666; GO:0045893; GO:0045944; GO:0046982; GO:0065004; GO:0070369; GO:0070888; GO:1900746; GO:1990837; GO:1990907 endothelial cell activation [GO:0042118]; negative regulation of angiogenesis [GO:0016525]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein-DNA complex assembly [GO:0065004]; regulation of DNA-templated transcription [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of vascular endothelial growth factor signaling pathway [GO:1900746] beta-catenin-TCF complex [GO:1990907]; beta-catenin-TCF7L2 complex [GO:0070369]; chromatin [GO:0000785]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667] beta-catenin binding [GO:0008013]; bHLH transcription factor binding [GO:0043425]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; double-stranded DNA binding [GO:0003690]; E-box binding [GO:0070888]; identical protein binding [GO:0042802]; protein heterodimerization activity [GO:0046982]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]; TFIIB-class transcription factor binding [GO:0001093]; transcription corepressor activity [GO:0003714] g14960.t1 P70550 54.286 175 4.4500000000000003e-64 200.0 sp|P70550|RAB8B_RAT Ras-related protein Rab-8B OS=Rattus norvegicus OX=10116 GN=Rab8b PE=1 SV=1 RAB8B_RAT reviewed Ras-related protein Rab-8B (EC 3.6.5.2) Rattus norvegicus (Rat) GO:0003924; GO:0003925; GO:0005102; GO:0005525; GO:0005768; GO:0005778; GO:0005886; GO:0006887; GO:0008021; GO:0010008; GO:0019003; GO:0019882; GO:0030140; GO:0030670; GO:0030911; GO:0031346; GO:0032456; GO:0045046; GO:0045335; GO:0046872; GO:0048471; GO:0051286; GO:0051461; GO:0098793; GO:0150115 antigen processing and presentation [GO:0019882]; cell-substrate junction organization [GO:0150115]; endocytic recycling [GO:0032456]; exocytosis [GO:0006887]; positive regulation of cell projection organization [GO:0031346]; positive regulation of corticotropin secretion [GO:0051461]; protein import into peroxisome membrane [GO:0045046] cell tip [GO:0051286]; endosome [GO:0005768]; endosome membrane [GO:0010008]; perinuclear region of cytoplasm [GO:0048471]; peroxisomal membrane [GO:0005778]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; synaptic vesicle [GO:0008021]; trans-Golgi network transport vesicle [GO:0030140] G protein activity [GO:0003925]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; signaling receptor binding [GO:0005102]; TPR domain binding [GO:0030911] g14961.t1 Q8N695 32.039 618 1.95e-72 247.0 sp|Q8N695|SC5A8_HUMAN Sodium-coupled monocarboxylate transporter 1 OS=Homo sapiens OX=9606 GN=SLC5A8 PE=1 SV=2 SC5A8_HUMAN reviewed Sodium-coupled monocarboxylate transporter 1 (Apical iodide transporter) (Electrogenic sodium monocarboxylate cotransporter) (Sodium iodide-related cotransporter) (Solute carrier family 5 member 8) Homo sapiens (Human) GO:0000811; GO:0005343; GO:0005886; GO:0006811; GO:0006814; GO:0006821; GO:0006846; GO:0006848; GO:0006915; GO:0008028; GO:0015129; GO:0015552; GO:0015705; GO:0015706; GO:0015727; GO:0015730; GO:0016324; GO:0070062; GO:0090416; GO:0140161; GO:0160081; GO:1901847; GO:2001142 acetate transport [GO:0006846]; apoptotic process [GO:0006915]; chloride transport [GO:0006821]; iodide transport [GO:0015705]; lactate transport [GO:0015727]; monoatomic ion transport [GO:0006811]; nicotinate metabolic process [GO:1901847]; nicotinate transport [GO:2001142]; nitrate transmembrane transport [GO:0015706]; propanoate transmembrane transport [GO:0015730]; pyruvate transport [GO:0006848]; sodium ion transport [GO:0006814] apical plasma membrane [GO:0016324]; extracellular exosome [GO:0070062]; GINS complex [GO:0000811]; plasma membrane [GO:0005886] iodide channel activity [GO:0160081]; lactate transmembrane transporter activity [GO:0015129]; monocarboxylate:sodium symporter activity [GO:0140161]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; nicotinate transmembrane transporter activity [GO:0090416]; organic acid:sodium symporter activity [GO:0005343]; propionate transmembrane transporter activity [GO:0015552] g14964.t1 A7MBD8 35.172 290 1.0599999999999999e-34 139.0 sp|A7MBD8|SC5AC_BOVIN Sodium-coupled monocarboxylate transporter 2 OS=Bos taurus OX=9913 GN=SLC5A12 PE=2 SV=1 SC5AC_BOVIN reviewed Sodium-coupled monocarboxylate transporter 2 (Electroneutral sodium monocarboxylate cotransporter) (Low-affinity sodium-lactate cotransporter) (Solute carrier family 5 member 12) Bos taurus (Bovine) GO:0005654; GO:0006814; GO:0015129; GO:0015293; GO:0015718; GO:0016324; GO:0140161 monocarboxylic acid transport [GO:0015718]; sodium ion transport [GO:0006814] apical plasma membrane [GO:0016324]; nucleoplasm [GO:0005654] lactate transmembrane transporter activity [GO:0015129]; monocarboxylate:sodium symporter activity [GO:0140161]; symporter activity [GO:0015293] g14969.t1 P57721 60.429 326 1.44e-121 361.0 sp|P57721|PCBP3_HUMAN Poly(rC)-binding protein 3 OS=Homo sapiens OX=9606 GN=PCBP3 PE=1 SV=2 PCBP3_HUMAN reviewed Poly(rC)-binding protein 3 (Alpha-CP3) (PCBP3-overlapping transcript) (PCBP3-overlapping transcript 1) Homo sapiens (Human) GO:0000122; GO:0003723; GO:0003729; GO:0005634; GO:0005737; GO:0005829; GO:0006357; GO:0016071; GO:0039694; GO:0070062; GO:1990829; GO:1990904 mRNA metabolic process [GO:0016071]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]; viral RNA genome replication [GO:0039694] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904] C-rich single-stranded DNA binding [GO:1990829]; mRNA binding [GO:0003729]; RNA binding [GO:0003723] g14969.t2 P57722 60.429 326 1.25e-121 361.0 sp|P57722|PCBP3_MOUSE Poly(rC)-binding protein 3 OS=Mus musculus OX=10090 GN=Pcbp3 PE=1 SV=3 g14971.t1 A0JM12 47.419 833 0.0 743.0 sp|A0JM12|MEG10_XENTR Multiple epidermal growth factor-like domains protein 10 OS=Xenopus tropicalis OX=8364 GN=megf10 PE=2 SV=1 g14971.t1 A0JM12 38.085 919 2.47e-154 494.0 sp|A0JM12|MEG10_XENTR Multiple epidermal growth factor-like domains protein 10 OS=Xenopus tropicalis OX=8364 GN=megf10 PE=2 SV=1 g14971.t1 A0JM12 39.321 501 6.13e-91 320.0 sp|A0JM12|MEG10_XENTR Multiple epidermal growth factor-like domains protein 10 OS=Xenopus tropicalis OX=8364 GN=megf10 PE=2 SV=1 g14971.t1 A0JM12 40.682 440 3.41e-85 304.0 sp|A0JM12|MEG10_XENTR Multiple epidermal growth factor-like domains protein 10 OS=Xenopus tropicalis OX=8364 GN=megf10 PE=2 SV=1 g14971.t1 A0JM12 37.667 300 1.31e-44 180.0 sp|A0JM12|MEG10_XENTR Multiple epidermal growth factor-like domains protein 10 OS=Xenopus tropicalis OX=8364 GN=megf10 PE=2 SV=1 g14971.t2 A0JM12 47.419 833 0.0 743.0 sp|A0JM12|MEG10_XENTR Multiple epidermal growth factor-like domains protein 10 OS=Xenopus tropicalis OX=8364 GN=megf10 PE=2 SV=1 g14971.t2 A0JM12 42.58 721 3.79e-154 492.0 sp|A0JM12|MEG10_XENTR Multiple epidermal growth factor-like domains protein 10 OS=Xenopus tropicalis OX=8364 GN=megf10 PE=2 SV=1 g14971.t2 A0JM12 39.321 501 3.11e-91 320.0 sp|A0JM12|MEG10_XENTR Multiple epidermal growth factor-like domains protein 10 OS=Xenopus tropicalis OX=8364 GN=megf10 PE=2 SV=1 g14971.t2 A0JM12 40.682 440 2.1600000000000002e-85 304.0 sp|A0JM12|MEG10_XENTR Multiple epidermal growth factor-like domains protein 10 OS=Xenopus tropicalis OX=8364 GN=megf10 PE=2 SV=1 g14971.t2 A0JM12 37.667 300 1.29e-44 179.0 sp|A0JM12|MEG10_XENTR Multiple epidermal growth factor-like domains protein 10 OS=Xenopus tropicalis OX=8364 GN=megf10 PE=2 SV=1 g14972.t1 P22129 84.404 218 2.07e-130 369.0 sp|P22129|RB11B_DIPOM Ras-related protein Rab-11B OS=Diplobatis ommata OX=1870830 PE=2 SV=1 g14978.t1 Q95SX7 31.832 333 1.17e-25 116.0 sp|Q95SX7|RTBS_DROME Probable RNA-directed DNA polymerase from transposon BS OS=Drosophila melanogaster OX=7227 GN=RTase PE=2 SV=1 g14981.t1 E9Q4F2 60.32 562 0.0 745.0 sp|E9Q4F2|KLH18_MOUSE Kelch-like protein 18 OS=Mus musculus OX=10090 GN=Klhl18 PE=1 SV=1 g14982.t1 Q1LZ71 50.209 239 4.58e-56 187.0 sp|Q1LZ71|LFG2_BOVIN Protein lifeguard 2 OS=Bos taurus OX=9913 GN=FAIM2 PE=2 SV=1 LFG2_BOVIN reviewed Protein lifeguard 2 (Fas apoptotic inhibitory molecule 2) Bos taurus (Bovine) GO:0005262; GO:0005783; GO:0005794; GO:0016020; GO:0021549; GO:0021680; GO:0021681; GO:0021702; GO:0043523; GO:0043524; GO:0045121; GO:0045211; GO:0097190; GO:1902042 apoptotic signaling pathway [GO:0097190]; cerebellar granular layer development [GO:0021681]; cerebellar Purkinje cell differentiation [GO:0021702]; cerebellar Purkinje cell layer development [GO:0021680]; cerebellum development [GO:0021549]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; negative regulation of neuron apoptotic process [GO:0043524]; regulation of neuron apoptotic process [GO:0043523] endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; membrane raft [GO:0045121]; postsynaptic membrane [GO:0045211] calcium channel activity [GO:0005262] g14982.t2 Q1LZ71 48.178 247 8.84e-56 187.0 sp|Q1LZ71|LFG2_BOVIN Protein lifeguard 2 OS=Bos taurus OX=9913 GN=FAIM2 PE=2 SV=1 LFG2_BOVIN reviewed Protein lifeguard 2 (Fas apoptotic inhibitory molecule 2) Bos taurus (Bovine) GO:0005262; GO:0005783; GO:0005794; GO:0016020; GO:0021549; GO:0021680; GO:0021681; GO:0021702; GO:0043523; GO:0043524; GO:0045121; GO:0045211; GO:0097190; GO:1902042 apoptotic signaling pathway [GO:0097190]; cerebellar granular layer development [GO:0021681]; cerebellar Purkinje cell differentiation [GO:0021702]; cerebellar Purkinje cell layer development [GO:0021680]; cerebellum development [GO:0021549]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; negative regulation of neuron apoptotic process [GO:0043524]; regulation of neuron apoptotic process [GO:0043523] endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; membrane raft [GO:0045121]; postsynaptic membrane [GO:0045211] calcium channel activity [GO:0005262] g14983.t1 Q8JIU7 64.977 217 4.52e-75 228.0 sp|Q8JIU7|NACA_DANRE Nascent polypeptide-associated complex subunit alpha OS=Danio rerio OX=7955 GN=naca PE=1 SV=1 g14985.t1 Q9R0G7 41.994 331 6.820000000000001e-58 222.0 sp|Q9R0G7|ZEB2_MOUSE Zinc finger E-box-binding homeobox 2 OS=Mus musculus OX=10090 GN=Zeb2 PE=1 SV=2 ZEB2_MOUSE reviewed Zinc finger E-box-binding homeobox 2 (Smad-interacting protein 1) (Zinc finger homeobox protein 1b) Mus musculus (Mouse) GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0001227; GO:0001228; GO:0001755; GO:0001756; GO:0001843; GO:0001935; GO:0005634; GO:0005654; GO:0005730; GO:0005886; GO:0006357; GO:0007417; GO:0008270; GO:0010764; GO:0021540; GO:0021766; GO:0021846; GO:0021957; GO:0030177; GO:0030511; GO:0036446; GO:0043149; GO:0043542; GO:0045636; GO:0045944; GO:0048023; GO:0048066; GO:0048143; GO:0048598; GO:0048668; GO:0050772; GO:0061373; GO:0070269; GO:0070412; GO:0072537; GO:0090263; GO:0090649; GO:0097324; GO:1902748; GO:1903056; GO:1904330; GO:1904520; GO:1905603 astrocyte activation [GO:0048143]; cell proliferation in forebrain [GO:0021846]; central nervous system development [GO:0007417]; collateral sprouting [GO:0048668]; corpus callosum morphogenesis [GO:0021540]; corticospinal tract morphogenesis [GO:0021957]; developmental pigmentation [GO:0048066]; embryonic morphogenesis [GO:0048598]; endothelial cell migration [GO:0043542]; endothelial cell proliferation [GO:0001935]; fibroblast activation [GO:0072537]; hippocampus development [GO:0021766]; mammillary axonal complex development [GO:0061373]; melanocyte migration [GO:0097324]; myofibroblast differentiation [GO:0036446]; negative regulation of fibroblast migration [GO:0010764]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural crest cell migration [GO:0001755]; neural tube closure [GO:0001843]; positive regulation of axonogenesis [GO:0050772]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of lens fiber cell differentiation [GO:1902748]; positive regulation of melanin biosynthetic process [GO:0048023]; positive regulation of melanocyte differentiation [GO:0045636]; positive regulation of myofibroblast contraction [GO:1904330]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; positive regulation of Wnt signaling pathway [GO:0030177]; pyroptotic inflammatory response [GO:0070269]; regulation of blood-brain barrier permeability [GO:1905603]; regulation of melanosome organization [GO:1903056]; regulation of myofibroblast cell apoptotic process [GO:1904520]; regulation of transcription by RNA polymerase II [GO:0006357]; response to oxygen-glucose deprivation [GO:0090649]; somitogenesis [GO:0001756]; stress fiber assembly [GO:0043149] chromatin [GO:0000785]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886] DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; R-SMAD binding [GO:0070412]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270] g14986.t1 Q92609 41.512 648 4.98e-159 486.0 sp|Q92609|TBCD5_HUMAN TBC1 domain family member 5 OS=Homo sapiens OX=9606 GN=TBC1D5 PE=1 SV=1 TBCD5_HUMAN reviewed TBC1 domain family member 5 Homo sapiens (Human) GO:0002092; GO:0005096; GO:0005776; GO:0005794; GO:0005829; GO:0006914; GO:0010008; GO:0015031; GO:0016236; GO:0030904; GO:0035612; GO:0042147; GO:0042594; GO:0044877; GO:1905394 autophagy [GO:0006914]; macroautophagy [GO:0016236]; positive regulation of receptor internalization [GO:0002092]; protein transport [GO:0015031]; response to starvation [GO:0042594]; retrograde transport, endosome to Golgi [GO:0042147] autophagosome [GO:0005776]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; retromer complex [GO:0030904] AP-2 adaptor complex binding [GO:0035612]; GTPase activator activity [GO:0005096]; protein-containing complex binding [GO:0044877]; retromer complex binding [GO:1905394] g14986.t2 Q92609 40.938 640 2.01e-161 491.0 sp|Q92609|TBCD5_HUMAN TBC1 domain family member 5 OS=Homo sapiens OX=9606 GN=TBC1D5 PE=1 SV=1 TBCD5_HUMAN reviewed TBC1 domain family member 5 Homo sapiens (Human) GO:0002092; GO:0005096; GO:0005776; GO:0005794; GO:0005829; GO:0006914; GO:0010008; GO:0015031; GO:0016236; GO:0030904; GO:0035612; GO:0042147; GO:0042594; GO:0044877; GO:1905394 autophagy [GO:0006914]; macroautophagy [GO:0016236]; positive regulation of receptor internalization [GO:0002092]; protein transport [GO:0015031]; response to starvation [GO:0042594]; retrograde transport, endosome to Golgi [GO:0042147] autophagosome [GO:0005776]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; retromer complex [GO:0030904] AP-2 adaptor complex binding [GO:0035612]; GTPase activator activity [GO:0005096]; protein-containing complex binding [GO:0044877]; retromer complex binding [GO:1905394] g14987.t1 O88967 52.239 737 0.0 747.0 sp|O88967|YMEL1_MOUSE ATP-dependent zinc metalloprotease YME1L1 OS=Mus musculus OX=10090 GN=Yme1l1 PE=1 SV=1 YMEL1_MOUSE reviewed ATP-dependent zinc metalloprotease YME1L1 (EC 3.4.24.-) (EC 3.6.-.-) (ATP-dependent metalloprotease FtsH1) (YME1-like protein 1) Mus musculus (Mouse) GO:0004176; GO:0004222; GO:0005524; GO:0005739; GO:0005743; GO:0006515; GO:0007005; GO:0008283; GO:0009267; GO:0010636; GO:0016604; GO:0016887; GO:0034214; GO:0034982; GO:0035694; GO:0043066; GO:0046872; GO:0097150; GO:2000035 cell population proliferation [GO:0008283]; cellular response to starvation [GO:0009267]; mitochondrial protein catabolic process [GO:0035694]; mitochondrial protein processing [GO:0034982]; mitochondrion organization [GO:0007005]; negative regulation of apoptotic process [GO:0043066]; neuronal stem cell population maintenance [GO:0097150]; positive regulation of mitochondrial fusion [GO:0010636]; protein hexamerization [GO:0034214]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; regulation of stem cell division [GO:2000035] mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nuclear body [GO:0016604] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent peptidase activity [GO:0004176]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222] g14989.t1 Q9NVV4 40.719 501 3.1900000000000004e-117 366.0 sp|Q9NVV4|PAPD1_HUMAN Poly(A) RNA polymerase, mitochondrial OS=Homo sapiens OX=9606 GN=MTPAP PE=1 SV=1 PAPD1_HUMAN reviewed Poly(A) RNA polymerase, mitochondrial (PAP) (EC 2.7.7.19) (PAP-associated domain-containing protein 1) (Polynucleotide adenylyltransferase) (Terminal uridylyltransferase 1) (TUTase 1) (mtPAP) Homo sapiens (Human) GO:0000287; GO:0000965; GO:0002134; GO:0003723; GO:0005524; GO:0005654; GO:0005739; GO:0005759; GO:0006397; GO:0030145; GO:0031123; GO:0042802; GO:0042803; GO:0071044; GO:0097222; GO:1990817 histone mRNA catabolic process [GO:0071044]; mitochondrial mRNA polyadenylation [GO:0097222]; mitochondrial RNA 3'-end processing [GO:0000965]; mRNA processing [GO:0006397]; RNA 3'-end processing [GO:0031123] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654] ATP binding [GO:0005524]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; poly(A) RNA polymerase activity [GO:1990817]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; UTP binding [GO:0002134] g14990.t1 Q8IS64 40.341 704 2.66e-178 532.0 sp|Q8IS64|ECE_LOCMI Endothelin-converting enzyme homolog OS=Locusta migratoria OX=7004 PE=2 SV=1 g14991.t1 Q9R111 50.679 442 1.7899999999999999e-140 413.0 sp|Q9R111|GUAD_MOUSE Guanine deaminase OS=Mus musculus OX=10090 GN=Gda PE=1 SV=1 g14995.t1 P53808 51.232 203 2.8599999999999997e-74 226.0 sp|P53808|PPCT_MOUSE Phosphatidylcholine transfer protein OS=Mus musculus OX=10090 GN=Pctp PE=1 SV=2 g14996.t1 P97275 64.062 576 0.0 780.0 sp|P97275|ADAS_CAVPO Alkyldihydroxyacetonephosphate synthase, peroxisomal OS=Cavia porcellus OX=10141 GN=AGPS PE=1 SV=1 g14997.t1 E9PYK3 40.73 1014 0.0 660.0 sp|E9PYK3|PARP4_MOUSE Protein mono-ADP-ribosyltransferase PARP4 OS=Mus musculus OX=10090 GN=Parp4 PE=1 SV=1 PARP4_MOUSE reviewed Protein mono-ADP-ribosyltransferase PARP4 (EC 2.4.2.-) (ADP-ribosyltransferase diphtheria toxin-like 4) (ARTD4) (Poly [ADP-ribose] polymerase 4) (PARP-4) (Vault poly(ADP-ribose) polymerase) (VPARP) (mVparp) Mus musculus (Mouse) GO:0003950; GO:0005634; GO:0005654; GO:0005737; GO:0005819; GO:0005829; GO:0005876; GO:0006954; GO:0016779; GO:0019899; GO:0140806; GO:0140807; GO:1990404; GO:1990904 inflammatory response [GO:0006954] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; spindle [GO:0005819]; spindle microtubule [GO:0005876] enzyme binding [GO:0019899]; NAD+ poly-ADP-ribosyltransferase activity [GO:0003950]; NAD+-protein mono-ADP-ribosyltransferase activity [GO:1990404]; NAD+-protein-aspartate ADP-ribosyltransferase activity [GO:0140806]; NAD+-protein-glutamate ADP-ribosyltransferase activity [GO:0140807]; nucleotidyltransferase activity [GO:0016779] g14998.t1 Q61830 30.986 1065 7.31e-134 463.0 sp|Q61830|MRC1_MOUSE Macrophage mannose receptor 1 OS=Mus musculus OX=10090 GN=Mrc1 PE=1 SV=2 g14998.t1 Q61830 29.17 1169 2.8500000000000003e-117 413.0 sp|Q61830|MRC1_MOUSE Macrophage mannose receptor 1 OS=Mus musculus OX=10090 GN=Mrc1 PE=1 SV=2 g14998.t1 Q61830 25.954 1179 3.78e-88 323.0 sp|Q61830|MRC1_MOUSE Macrophage mannose receptor 1 OS=Mus musculus OX=10090 GN=Mrc1 PE=1 SV=2 g14998.t1 Q61830 26.772 1143 5.13e-85 313.0 sp|Q61830|MRC1_MOUSE Macrophage mannose receptor 1 OS=Mus musculus OX=10090 GN=Mrc1 PE=1 SV=2 g14998.t1 Q61830 25.849 1207 1.09e-81 303.0 sp|Q61830|MRC1_MOUSE Macrophage mannose receptor 1 OS=Mus musculus OX=10090 GN=Mrc1 PE=1 SV=2 g14998.t1 Q61830 24.855 1207 6.2e-78 291.0 sp|Q61830|MRC1_MOUSE Macrophage mannose receptor 1 OS=Mus musculus OX=10090 GN=Mrc1 PE=1 SV=2 g14998.t1 Q61830 24.363 1178 9.22e-67 255.0 sp|Q61830|MRC1_MOUSE Macrophage mannose receptor 1 OS=Mus musculus OX=10090 GN=Mrc1 PE=1 SV=2 g14998.t1 Q61830 25.941 717 1.17e-45 186.0 sp|Q61830|MRC1_MOUSE Macrophage mannose receptor 1 OS=Mus musculus OX=10090 GN=Mrc1 PE=1 SV=2 g14998.t1 Q61830 26.087 736 1.18e-44 183.0 sp|Q61830|MRC1_MOUSE Macrophage mannose receptor 1 OS=Mus musculus OX=10090 GN=Mrc1 PE=1 SV=2 g14998.t1 Q61830 25.067 746 9.61e-44 180.0 sp|Q61830|MRC1_MOUSE Macrophage mannose receptor 1 OS=Mus musculus OX=10090 GN=Mrc1 PE=1 SV=2 g14998.t1 Q61830 23.377 770 3.62e-40 168.0 sp|Q61830|MRC1_MOUSE Macrophage mannose receptor 1 OS=Mus musculus OX=10090 GN=Mrc1 PE=1 SV=2 g14998.t1 Q61830 25.0 452 1.42e-22 110.0 sp|Q61830|MRC1_MOUSE Macrophage mannose receptor 1 OS=Mus musculus OX=10090 GN=Mrc1 PE=1 SV=2 g14998.t1 Q61830 29.348 276 2.3e-22 110.0 sp|Q61830|MRC1_MOUSE Macrophage mannose receptor 1 OS=Mus musculus OX=10090 GN=Mrc1 PE=1 SV=2 g14999.t1 P22897 25.832 751 4.12e-58 218.0 sp|P22897|MRC1_HUMAN Macrophage mannose receptor 1 OS=Homo sapiens OX=9606 GN=MRC1 PE=1 SV=1 MRC1_HUMAN reviewed Macrophage mannose receptor 1 (MMR) (C-type lectin domain family 13 member D) (C-type lectin domain family 13 member D-like) (Human mannose receptor) (hMR) (Macrophage mannose receptor 1-like protein 1) (CD antigen CD206) Homo sapiens (Human) GO:0001618; GO:0004888; GO:0005537; GO:0005886; GO:0006898; GO:0009986; GO:0010008; GO:0038023; GO:0038024; GO:0071222; GO:0071346; GO:0071353 cellular response to interleukin-4 [GO:0071353]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to type II interferon [GO:0071346]; receptor-mediated endocytosis [GO:0006898] cell surface [GO:0009986]; endosome membrane [GO:0010008]; plasma membrane [GO:0005886] cargo receptor activity [GO:0038024]; D-mannose binding [GO:0005537]; signaling receptor activity [GO:0038023]; transmembrane signaling receptor activity [GO:0004888]; virus receptor activity [GO:0001618] g14999.t1 P22897 26.711 453 6.510000000000001e-32 137.0 sp|P22897|MRC1_HUMAN Macrophage mannose receptor 1 OS=Homo sapiens OX=9606 GN=MRC1 PE=1 SV=1 MRC1_HUMAN reviewed Macrophage mannose receptor 1 (MMR) (C-type lectin domain family 13 member D) (C-type lectin domain family 13 member D-like) (Human mannose receptor) (hMR) (Macrophage mannose receptor 1-like protein 1) (CD antigen CD206) Homo sapiens (Human) GO:0001618; GO:0004888; GO:0005537; GO:0005886; GO:0006898; GO:0009986; GO:0010008; GO:0038023; GO:0038024; GO:0071222; GO:0071346; GO:0071353 cellular response to interleukin-4 [GO:0071353]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to type II interferon [GO:0071346]; receptor-mediated endocytosis [GO:0006898] cell surface [GO:0009986]; endosome membrane [GO:0010008]; plasma membrane [GO:0005886] cargo receptor activity [GO:0038024]; D-mannose binding [GO:0005537]; signaling receptor activity [GO:0038023]; transmembrane signaling receptor activity [GO:0004888]; virus receptor activity [GO:0001618] g14999.t1 P22897 22.703 762 4.4200000000000004e-29 129.0 sp|P22897|MRC1_HUMAN Macrophage mannose receptor 1 OS=Homo sapiens OX=9606 GN=MRC1 PE=1 SV=1 MRC1_HUMAN reviewed Macrophage mannose receptor 1 (MMR) (C-type lectin domain family 13 member D) (C-type lectin domain family 13 member D-like) (Human mannose receptor) (hMR) (Macrophage mannose receptor 1-like protein 1) (CD antigen CD206) Homo sapiens (Human) GO:0001618; GO:0004888; GO:0005537; GO:0005886; GO:0006898; GO:0009986; GO:0010008; GO:0038023; GO:0038024; GO:0071222; GO:0071346; GO:0071353 cellular response to interleukin-4 [GO:0071353]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to type II interferon [GO:0071346]; receptor-mediated endocytosis [GO:0006898] cell surface [GO:0009986]; endosome membrane [GO:0010008]; plasma membrane [GO:0005886] cargo receptor activity [GO:0038024]; D-mannose binding [GO:0005537]; signaling receptor activity [GO:0038023]; transmembrane signaling receptor activity [GO:0004888]; virus receptor activity [GO:0001618] g14999.t1 P22897 28.333 300 3.21e-25 116.0 sp|P22897|MRC1_HUMAN Macrophage mannose receptor 1 OS=Homo sapiens OX=9606 GN=MRC1 PE=1 SV=1 MRC1_HUMAN reviewed Macrophage mannose receptor 1 (MMR) (C-type lectin domain family 13 member D) (C-type lectin domain family 13 member D-like) (Human mannose receptor) (hMR) (Macrophage mannose receptor 1-like protein 1) (CD antigen CD206) Homo sapiens (Human) GO:0001618; GO:0004888; GO:0005537; GO:0005886; GO:0006898; GO:0009986; GO:0010008; GO:0038023; GO:0038024; GO:0071222; GO:0071346; GO:0071353 cellular response to interleukin-4 [GO:0071353]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to type II interferon [GO:0071346]; receptor-mediated endocytosis [GO:0006898] cell surface [GO:0009986]; endosome membrane [GO:0010008]; plasma membrane [GO:0005886] cargo receptor activity [GO:0038024]; D-mannose binding [GO:0005537]; signaling receptor activity [GO:0038023]; transmembrane signaling receptor activity [GO:0004888]; virus receptor activity [GO:0001618] g14999.t1 P22897 24.286 420 3.49e-24 113.0 sp|P22897|MRC1_HUMAN Macrophage mannose receptor 1 OS=Homo sapiens OX=9606 GN=MRC1 PE=1 SV=1 MRC1_HUMAN reviewed Macrophage mannose receptor 1 (MMR) (C-type lectin domain family 13 member D) (C-type lectin domain family 13 member D-like) (Human mannose receptor) (hMR) (Macrophage mannose receptor 1-like protein 1) (CD antigen CD206) Homo sapiens (Human) GO:0001618; GO:0004888; GO:0005537; GO:0005886; GO:0006898; GO:0009986; GO:0010008; GO:0038023; GO:0038024; GO:0071222; GO:0071346; GO:0071353 cellular response to interleukin-4 [GO:0071353]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to type II interferon [GO:0071346]; receptor-mediated endocytosis [GO:0006898] cell surface [GO:0009986]; endosome membrane [GO:0010008]; plasma membrane [GO:0005886] cargo receptor activity [GO:0038024]; D-mannose binding [GO:0005537]; signaling receptor activity [GO:0038023]; transmembrane signaling receptor activity [GO:0004888]; virus receptor activity [GO:0001618] g15001.t1 Q61830 28.275 1061 1.96e-105 365.0 sp|Q61830|MRC1_MOUSE Macrophage mannose receptor 1 OS=Mus musculus OX=10090 GN=Mrc1 PE=1 SV=2 g15001.t1 Q61830 26.256 1055 3.33e-72 267.0 sp|Q61830|MRC1_MOUSE Macrophage mannose receptor 1 OS=Mus musculus OX=10090 GN=Mrc1 PE=1 SV=2 g15001.t1 Q61830 26.923 442 2.4300000000000002e-29 130.0 sp|Q61830|MRC1_MOUSE Macrophage mannose receptor 1 OS=Mus musculus OX=10090 GN=Mrc1 PE=1 SV=2 g15005.t1 Q32P51 48.087 183 5.5e-49 174.0 sp|Q32P51|RA1L2_HUMAN Heterogeneous nuclear ribonucleoprotein A1-like 2 OS=Homo sapiens OX=9606 GN=HNRNPA1L2 PE=1 SV=2 RA1L2_HUMAN reviewed Heterogeneous nuclear ribonucleoprotein A1-like 2 (hnRNP A1-like 2) (hnRNP core protein A1-like 2) Homo sapiens (Human) GO:0000398; GO:0003730; GO:0005737; GO:0051028; GO:0071013 mRNA splicing, via spliceosome [GO:0000398]; mRNA transport [GO:0051028] catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737] mRNA 3'-UTR binding [GO:0003730] g15006.t1 Q6PGZ3 75.238 105 9.13e-34 135.0 sp|Q6PGZ3|MIPT3_DANRE TRAF3-interacting protein 1 OS=Danio rerio OX=7955 GN=traf3ip1 PE=2 SV=1 MIPT3_DANRE reviewed TRAF3-interacting protein 1 Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005576; GO:0005930; GO:0008017; GO:0021549; GO:0030992; GO:0031113; GO:0035845; GO:0036064; GO:0042073; GO:0043010; GO:0048793; GO:0060271; GO:0061524; GO:0070507; GO:0090660 camera-type eye development [GO:0043010]; central canal development [GO:0061524]; cerebellum development [GO:0021549]; cerebrospinal fluid circulation [GO:0090660]; cilium assembly [GO:0060271]; intraciliary transport [GO:0042073]; photoreceptor cell outer segment organization [GO:0035845]; pronephros development [GO:0048793]; regulation of microtubule cytoskeleton organization [GO:0070507]; regulation of microtubule polymerization [GO:0031113] axoneme [GO:0005930]; ciliary basal body [GO:0036064]; extracellular region [GO:0005576]; intraciliary transport particle B [GO:0030992] microtubule binding [GO:0008017] g15006.t2 Q6PGZ3 75.238 105 4.05e-33 134.0 sp|Q6PGZ3|MIPT3_DANRE TRAF3-interacting protein 1 OS=Danio rerio OX=7955 GN=traf3ip1 PE=2 SV=1 MIPT3_DANRE reviewed TRAF3-interacting protein 1 Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005576; GO:0005930; GO:0008017; GO:0021549; GO:0030992; GO:0031113; GO:0035845; GO:0036064; GO:0042073; GO:0043010; GO:0048793; GO:0060271; GO:0061524; GO:0070507; GO:0090660 camera-type eye development [GO:0043010]; central canal development [GO:0061524]; cerebellum development [GO:0021549]; cerebrospinal fluid circulation [GO:0090660]; cilium assembly [GO:0060271]; intraciliary transport [GO:0042073]; photoreceptor cell outer segment organization [GO:0035845]; pronephros development [GO:0048793]; regulation of microtubule cytoskeleton organization [GO:0070507]; regulation of microtubule polymerization [GO:0031113] axoneme [GO:0005930]; ciliary basal body [GO:0036064]; extracellular region [GO:0005576]; intraciliary transport particle B [GO:0030992] microtubule binding [GO:0008017] g15006.t3 Q6PGZ3 75.238 105 1.87e-33 135.0 sp|Q6PGZ3|MIPT3_DANRE TRAF3-interacting protein 1 OS=Danio rerio OX=7955 GN=traf3ip1 PE=2 SV=1 MIPT3_DANRE reviewed TRAF3-interacting protein 1 Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005576; GO:0005930; GO:0008017; GO:0021549; GO:0030992; GO:0031113; GO:0035845; GO:0036064; GO:0042073; GO:0043010; GO:0048793; GO:0060271; GO:0061524; GO:0070507; GO:0090660 camera-type eye development [GO:0043010]; central canal development [GO:0061524]; cerebellum development [GO:0021549]; cerebrospinal fluid circulation [GO:0090660]; cilium assembly [GO:0060271]; intraciliary transport [GO:0042073]; photoreceptor cell outer segment organization [GO:0035845]; pronephros development [GO:0048793]; regulation of microtubule cytoskeleton organization [GO:0070507]; regulation of microtubule polymerization [GO:0031113] axoneme [GO:0005930]; ciliary basal body [GO:0036064]; extracellular region [GO:0005576]; intraciliary transport particle B [GO:0030992] microtubule binding [GO:0008017] g15006.t4 Q6PGZ3 60.123 163 1.71e-33 135.0 sp|Q6PGZ3|MIPT3_DANRE TRAF3-interacting protein 1 OS=Danio rerio OX=7955 GN=traf3ip1 PE=2 SV=1 MIPT3_DANRE reviewed TRAF3-interacting protein 1 Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005576; GO:0005930; GO:0008017; GO:0021549; GO:0030992; GO:0031113; GO:0035845; GO:0036064; GO:0042073; GO:0043010; GO:0048793; GO:0060271; GO:0061524; GO:0070507; GO:0090660 camera-type eye development [GO:0043010]; central canal development [GO:0061524]; cerebellum development [GO:0021549]; cerebrospinal fluid circulation [GO:0090660]; cilium assembly [GO:0060271]; intraciliary transport [GO:0042073]; photoreceptor cell outer segment organization [GO:0035845]; pronephros development [GO:0048793]; regulation of microtubule cytoskeleton organization [GO:0070507]; regulation of microtubule polymerization [GO:0031113] axoneme [GO:0005930]; ciliary basal body [GO:0036064]; extracellular region [GO:0005576]; intraciliary transport particle B [GO:0030992] microtubule binding [GO:0008017] g15007.t1 Q5XIN3 58.252 103 2.91e-34 128.0 sp|Q5XIN3|MIPT3_RAT TRAF3-interacting protein 1 OS=Rattus norvegicus OX=10116 GN=Traf3ip1 PE=1 SV=1 MIPT3_RAT reviewed TRAF3-interacting protein 1 (Intraflagellar transport protein 54 homolog) (Microtubule-interacting protein associated with TRAF3) (MIP-T3) Rattus norvegicus (Rat) GO:0001650; GO:0001738; GO:0001822; GO:0005654; GO:0005813; GO:0005929; GO:0005930; GO:0008017; GO:0016604; GO:0021532; GO:0021904; GO:0030992; GO:0031076; GO:0031333; GO:0032480; GO:0032688; GO:0035050; GO:0035869; GO:0036064; GO:0036342; GO:0042073; GO:0042733; GO:0045879; GO:0050687; GO:0060271; GO:0070507; GO:0097542; GO:0097546 cilium assembly [GO:0060271]; dorsal/ventral neural tube patterning [GO:0021904]; embryonic camera-type eye development [GO:0031076]; embryonic digit morphogenesis [GO:0042733]; embryonic heart tube development [GO:0035050]; intraciliary transport [GO:0042073]; kidney development [GO:0001822]; morphogenesis of a polarized epithelium [GO:0001738]; negative regulation of defense response to virus [GO:0050687]; negative regulation of interferon-beta production [GO:0032688]; negative regulation of protein-containing complex assembly [GO:0031333]; negative regulation of smoothened signaling pathway [GO:0045879]; negative regulation of type I interferon production [GO:0032480]; neural tube patterning [GO:0021532]; post-anal tail morphogenesis [GO:0036342]; regulation of microtubule cytoskeleton organization [GO:0070507] axoneme [GO:0005930]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary base [GO:0097546]; ciliary tip [GO:0097542]; ciliary transition zone [GO:0035869]; cilium [GO:0005929]; fibrillar center [GO:0001650]; intraciliary transport particle B [GO:0030992]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654] microtubule binding [GO:0008017] g15009.t1 P22897 24.5 1049 9.55e-63 237.0 sp|P22897|MRC1_HUMAN Macrophage mannose receptor 1 OS=Homo sapiens OX=9606 GN=MRC1 PE=1 SV=1 MRC1_HUMAN reviewed Macrophage mannose receptor 1 (MMR) (C-type lectin domain family 13 member D) (C-type lectin domain family 13 member D-like) (Human mannose receptor) (hMR) (Macrophage mannose receptor 1-like protein 1) (CD antigen CD206) Homo sapiens (Human) GO:0001618; GO:0004888; GO:0005537; GO:0005886; GO:0006898; GO:0009986; GO:0010008; GO:0038023; GO:0038024; GO:0071222; GO:0071346; GO:0071353 cellular response to interleukin-4 [GO:0071353]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to type II interferon [GO:0071346]; receptor-mediated endocytosis [GO:0006898] cell surface [GO:0009986]; endosome membrane [GO:0010008]; plasma membrane [GO:0005886] cargo receptor activity [GO:0038024]; D-mannose binding [GO:0005537]; signaling receptor activity [GO:0038023]; transmembrane signaling receptor activity [GO:0004888]; virus receptor activity [GO:0001618] g15009.t1 P22897 22.541 1047 5.660000000000001e-47 187.0 sp|P22897|MRC1_HUMAN Macrophage mannose receptor 1 OS=Homo sapiens OX=9606 GN=MRC1 PE=1 SV=1 MRC1_HUMAN reviewed Macrophage mannose receptor 1 (MMR) (C-type lectin domain family 13 member D) (C-type lectin domain family 13 member D-like) (Human mannose receptor) (hMR) (Macrophage mannose receptor 1-like protein 1) (CD antigen CD206) Homo sapiens (Human) GO:0001618; GO:0004888; GO:0005537; GO:0005886; GO:0006898; GO:0009986; GO:0010008; GO:0038023; GO:0038024; GO:0071222; GO:0071346; GO:0071353 cellular response to interleukin-4 [GO:0071353]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to type II interferon [GO:0071346]; receptor-mediated endocytosis [GO:0006898] cell surface [GO:0009986]; endosome membrane [GO:0010008]; plasma membrane [GO:0005886] cargo receptor activity [GO:0038024]; D-mannose binding [GO:0005537]; signaling receptor activity [GO:0038023]; transmembrane signaling receptor activity [GO:0004888]; virus receptor activity [GO:0001618] g15009.t1 P22897 27.58 562 3.9299999999999995e-42 172.0 sp|P22897|MRC1_HUMAN Macrophage mannose receptor 1 OS=Homo sapiens OX=9606 GN=MRC1 PE=1 SV=1 MRC1_HUMAN reviewed Macrophage mannose receptor 1 (MMR) (C-type lectin domain family 13 member D) (C-type lectin domain family 13 member D-like) (Human mannose receptor) (hMR) (Macrophage mannose receptor 1-like protein 1) (CD antigen CD206) Homo sapiens (Human) GO:0001618; GO:0004888; GO:0005537; GO:0005886; GO:0006898; GO:0009986; GO:0010008; GO:0038023; GO:0038024; GO:0071222; GO:0071346; GO:0071353 cellular response to interleukin-4 [GO:0071353]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to type II interferon [GO:0071346]; receptor-mediated endocytosis [GO:0006898] cell surface [GO:0009986]; endosome membrane [GO:0010008]; plasma membrane [GO:0005886] cargo receptor activity [GO:0038024]; D-mannose binding [GO:0005537]; signaling receptor activity [GO:0038023]; transmembrane signaling receptor activity [GO:0004888]; virus receptor activity [GO:0001618] g15009.t1 P22897 23.134 938 2.46e-38 159.0 sp|P22897|MRC1_HUMAN Macrophage mannose receptor 1 OS=Homo sapiens OX=9606 GN=MRC1 PE=1 SV=1 MRC1_HUMAN reviewed Macrophage mannose receptor 1 (MMR) (C-type lectin domain family 13 member D) (C-type lectin domain family 13 member D-like) (Human mannose receptor) (hMR) (Macrophage mannose receptor 1-like protein 1) (CD antigen CD206) Homo sapiens (Human) GO:0001618; GO:0004888; GO:0005537; GO:0005886; GO:0006898; GO:0009986; GO:0010008; GO:0038023; GO:0038024; GO:0071222; GO:0071346; GO:0071353 cellular response to interleukin-4 [GO:0071353]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to type II interferon [GO:0071346]; receptor-mediated endocytosis [GO:0006898] cell surface [GO:0009986]; endosome membrane [GO:0010008]; plasma membrane [GO:0005886] cargo receptor activity [GO:0038024]; D-mannose binding [GO:0005537]; signaling receptor activity [GO:0038023]; transmembrane signaling receptor activity [GO:0004888]; virus receptor activity [GO:0001618] g15009.t1 P22897 26.411 443 1.67e-27 124.0 sp|P22897|MRC1_HUMAN Macrophage mannose receptor 1 OS=Homo sapiens OX=9606 GN=MRC1 PE=1 SV=1 MRC1_HUMAN reviewed Macrophage mannose receptor 1 (MMR) (C-type lectin domain family 13 member D) (C-type lectin domain family 13 member D-like) (Human mannose receptor) (hMR) (Macrophage mannose receptor 1-like protein 1) (CD antigen CD206) Homo sapiens (Human) GO:0001618; GO:0004888; GO:0005537; GO:0005886; GO:0006898; GO:0009986; GO:0010008; GO:0038023; GO:0038024; GO:0071222; GO:0071346; GO:0071353 cellular response to interleukin-4 [GO:0071353]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to type II interferon [GO:0071346]; receptor-mediated endocytosis [GO:0006898] cell surface [GO:0009986]; endosome membrane [GO:0010008]; plasma membrane [GO:0005886] cargo receptor activity [GO:0038024]; D-mannose binding [GO:0005537]; signaling receptor activity [GO:0038023]; transmembrane signaling receptor activity [GO:0004888]; virus receptor activity [GO:0001618] g15010.t1 Q96DM1 30.035 283 2.45e-31 131.0 sp|Q96DM1|PGBD4_HUMAN PiggyBac transposable element-derived protein 4 OS=Homo sapiens OX=9606 GN=PGBD4 PE=1 SV=3 g15011.t1 Q6PF21 59.181 904 0.0 1054.0 sp|Q6PF21|SYMC_XENLA Methionine--tRNA ligase, cytoplasmic OS=Xenopus laevis OX=8355 GN=mars1 PE=2 SV=1 g15012.t1 P22897 30.681 1043 1.39e-134 463.0 sp|P22897|MRC1_HUMAN Macrophage mannose receptor 1 OS=Homo sapiens OX=9606 GN=MRC1 PE=1 SV=1 MRC1_HUMAN reviewed Macrophage mannose receptor 1 (MMR) (C-type lectin domain family 13 member D) (C-type lectin domain family 13 member D-like) (Human mannose receptor) (hMR) (Macrophage mannose receptor 1-like protein 1) (CD antigen CD206) Homo sapiens (Human) GO:0001618; GO:0004888; GO:0005537; GO:0005886; GO:0006898; GO:0009986; GO:0010008; GO:0038023; GO:0038024; GO:0071222; GO:0071346; GO:0071353 cellular response to interleukin-4 [GO:0071353]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to type II interferon [GO:0071346]; receptor-mediated endocytosis [GO:0006898] cell surface [GO:0009986]; endosome membrane [GO:0010008]; plasma membrane [GO:0005886] cargo receptor activity [GO:0038024]; D-mannose binding [GO:0005537]; signaling receptor activity [GO:0038023]; transmembrane signaling receptor activity [GO:0004888]; virus receptor activity [GO:0001618] g15012.t1 P22897 25.433 1097 1.38e-71 270.0 sp|P22897|MRC1_HUMAN Macrophage mannose receptor 1 OS=Homo sapiens OX=9606 GN=MRC1 PE=1 SV=1 MRC1_HUMAN reviewed Macrophage mannose receptor 1 (MMR) (C-type lectin domain family 13 member D) (C-type lectin domain family 13 member D-like) (Human mannose receptor) (hMR) (Macrophage mannose receptor 1-like protein 1) (CD antigen CD206) Homo sapiens (Human) GO:0001618; GO:0004888; GO:0005537; GO:0005886; GO:0006898; GO:0009986; GO:0010008; GO:0038023; GO:0038024; GO:0071222; GO:0071346; GO:0071353 cellular response to interleukin-4 [GO:0071353]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to type II interferon [GO:0071346]; receptor-mediated endocytosis [GO:0006898] cell surface [GO:0009986]; endosome membrane [GO:0010008]; plasma membrane [GO:0005886] cargo receptor activity [GO:0038024]; D-mannose binding [GO:0005537]; signaling receptor activity [GO:0038023]; transmembrane signaling receptor activity [GO:0004888]; virus receptor activity [GO:0001618] g15012.t1 P22897 27.76 616 1.92e-59 230.0 sp|P22897|MRC1_HUMAN Macrophage mannose receptor 1 OS=Homo sapiens OX=9606 GN=MRC1 PE=1 SV=1 MRC1_HUMAN reviewed Macrophage mannose receptor 1 (MMR) (C-type lectin domain family 13 member D) (C-type lectin domain family 13 member D-like) (Human mannose receptor) (hMR) (Macrophage mannose receptor 1-like protein 1) (CD antigen CD206) Homo sapiens (Human) GO:0001618; GO:0004888; GO:0005537; GO:0005886; GO:0006898; GO:0009986; GO:0010008; GO:0038023; GO:0038024; GO:0071222; GO:0071346; GO:0071353 cellular response to interleukin-4 [GO:0071353]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to type II interferon [GO:0071346]; receptor-mediated endocytosis [GO:0006898] cell surface [GO:0009986]; endosome membrane [GO:0010008]; plasma membrane [GO:0005886] cargo receptor activity [GO:0038024]; D-mannose binding [GO:0005537]; signaling receptor activity [GO:0038023]; transmembrane signaling receptor activity [GO:0004888]; virus receptor activity [GO:0001618] g15012.t1 P22897 26.709 629 4.31e-46 187.0 sp|P22897|MRC1_HUMAN Macrophage mannose receptor 1 OS=Homo sapiens OX=9606 GN=MRC1 PE=1 SV=1 MRC1_HUMAN reviewed Macrophage mannose receptor 1 (MMR) (C-type lectin domain family 13 member D) (C-type lectin domain family 13 member D-like) (Human mannose receptor) (hMR) (Macrophage mannose receptor 1-like protein 1) (CD antigen CD206) Homo sapiens (Human) GO:0001618; GO:0004888; GO:0005537; GO:0005886; GO:0006898; GO:0009986; GO:0010008; GO:0038023; GO:0038024; GO:0071222; GO:0071346; GO:0071353 cellular response to interleukin-4 [GO:0071353]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to type II interferon [GO:0071346]; receptor-mediated endocytosis [GO:0006898] cell surface [GO:0009986]; endosome membrane [GO:0010008]; plasma membrane [GO:0005886] cargo receptor activity [GO:0038024]; D-mannose binding [GO:0005537]; signaling receptor activity [GO:0038023]; transmembrane signaling receptor activity [GO:0004888]; virus receptor activity [GO:0001618] g15012.t1 P22897 24.844 640 2.9300000000000004e-35 152.0 sp|P22897|MRC1_HUMAN Macrophage mannose receptor 1 OS=Homo sapiens OX=9606 GN=MRC1 PE=1 SV=1 MRC1_HUMAN reviewed Macrophage mannose receptor 1 (MMR) (C-type lectin domain family 13 member D) (C-type lectin domain family 13 member D-like) (Human mannose receptor) (hMR) (Macrophage mannose receptor 1-like protein 1) (CD antigen CD206) Homo sapiens (Human) GO:0001618; GO:0004888; GO:0005537; GO:0005886; GO:0006898; GO:0009986; GO:0010008; GO:0038023; GO:0038024; GO:0071222; GO:0071346; GO:0071353 cellular response to interleukin-4 [GO:0071353]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to type II interferon [GO:0071346]; receptor-mediated endocytosis [GO:0006898] cell surface [GO:0009986]; endosome membrane [GO:0010008]; plasma membrane [GO:0005886] cargo receptor activity [GO:0038024]; D-mannose binding [GO:0005537]; signaling receptor activity [GO:0038023]; transmembrane signaling receptor activity [GO:0004888]; virus receptor activity [GO:0001618] g15012.t1 P22897 26.994 489 2.47e-32 142.0 sp|P22897|MRC1_HUMAN Macrophage mannose receptor 1 OS=Homo sapiens OX=9606 GN=MRC1 PE=1 SV=1 MRC1_HUMAN reviewed Macrophage mannose receptor 1 (MMR) (C-type lectin domain family 13 member D) (C-type lectin domain family 13 member D-like) (Human mannose receptor) (hMR) (Macrophage mannose receptor 1-like protein 1) (CD antigen CD206) Homo sapiens (Human) GO:0001618; GO:0004888; GO:0005537; GO:0005886; GO:0006898; GO:0009986; GO:0010008; GO:0038023; GO:0038024; GO:0071222; GO:0071346; GO:0071353 cellular response to interleukin-4 [GO:0071353]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to type II interferon [GO:0071346]; receptor-mediated endocytosis [GO:0006898] cell surface [GO:0009986]; endosome membrane [GO:0010008]; plasma membrane [GO:0005886] cargo receptor activity [GO:0038024]; D-mannose binding [GO:0005537]; signaling receptor activity [GO:0038023]; transmembrane signaling receptor activity [GO:0004888]; virus receptor activity [GO:0001618] g15012.t1 P22897 25.566 442 3.8600000000000003e-29 132.0 sp|P22897|MRC1_HUMAN Macrophage mannose receptor 1 OS=Homo sapiens OX=9606 GN=MRC1 PE=1 SV=1 MRC1_HUMAN reviewed Macrophage mannose receptor 1 (MMR) (C-type lectin domain family 13 member D) (C-type lectin domain family 13 member D-like) (Human mannose receptor) (hMR) (Macrophage mannose receptor 1-like protein 1) (CD antigen CD206) Homo sapiens (Human) GO:0001618; GO:0004888; GO:0005537; GO:0005886; GO:0006898; GO:0009986; GO:0010008; GO:0038023; GO:0038024; GO:0071222; GO:0071346; GO:0071353 cellular response to interleukin-4 [GO:0071353]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to type II interferon [GO:0071346]; receptor-mediated endocytosis [GO:0006898] cell surface [GO:0009986]; endosome membrane [GO:0010008]; plasma membrane [GO:0005886] cargo receptor activity [GO:0038024]; D-mannose binding [GO:0005537]; signaling receptor activity [GO:0038023]; transmembrane signaling receptor activity [GO:0004888]; virus receptor activity [GO:0001618] g15012.t1 P22897 25.843 356 1.1e-21 107.0 sp|P22897|MRC1_HUMAN Macrophage mannose receptor 1 OS=Homo sapiens OX=9606 GN=MRC1 PE=1 SV=1 MRC1_HUMAN reviewed Macrophage mannose receptor 1 (MMR) (C-type lectin domain family 13 member D) (C-type lectin domain family 13 member D-like) (Human mannose receptor) (hMR) (Macrophage mannose receptor 1-like protein 1) (CD antigen CD206) Homo sapiens (Human) GO:0001618; GO:0004888; GO:0005537; GO:0005886; GO:0006898; GO:0009986; GO:0010008; GO:0038023; GO:0038024; GO:0071222; GO:0071346; GO:0071353 cellular response to interleukin-4 [GO:0071353]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to type II interferon [GO:0071346]; receptor-mediated endocytosis [GO:0006898] cell surface [GO:0009986]; endosome membrane [GO:0010008]; plasma membrane [GO:0005886] cargo receptor activity [GO:0038024]; D-mannose binding [GO:0005537]; signaling receptor activity [GO:0038023]; transmembrane signaling receptor activity [GO:0004888]; virus receptor activity [GO:0001618] g15012.t1 P22897 28.464 267 1.88e-21 106.0 sp|P22897|MRC1_HUMAN Macrophage mannose receptor 1 OS=Homo sapiens OX=9606 GN=MRC1 PE=1 SV=1 MRC1_HUMAN reviewed Macrophage mannose receptor 1 (MMR) (C-type lectin domain family 13 member D) (C-type lectin domain family 13 member D-like) (Human mannose receptor) (hMR) (Macrophage mannose receptor 1-like protein 1) (CD antigen CD206) Homo sapiens (Human) GO:0001618; GO:0004888; GO:0005537; GO:0005886; GO:0006898; GO:0009986; GO:0010008; GO:0038023; GO:0038024; GO:0071222; GO:0071346; GO:0071353 cellular response to interleukin-4 [GO:0071353]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to type II interferon [GO:0071346]; receptor-mediated endocytosis [GO:0006898] cell surface [GO:0009986]; endosome membrane [GO:0010008]; plasma membrane [GO:0005886] cargo receptor activity [GO:0038024]; D-mannose binding [GO:0005537]; signaling receptor activity [GO:0038023]; transmembrane signaling receptor activity [GO:0004888]; virus receptor activity [GO:0001618] g15014.t1 Q61830 25.266 1223 1.82e-82 303.0 sp|Q61830|MRC1_MOUSE Macrophage mannose receptor 1 OS=Mus musculus OX=10090 GN=Mrc1 PE=1 SV=2 g15014.t1 Q61830 24.652 1221 2.76e-68 258.0 sp|Q61830|MRC1_MOUSE Macrophage mannose receptor 1 OS=Mus musculus OX=10090 GN=Mrc1 PE=1 SV=2 g15014.t1 Q61830 25.803 1089 8.969999999999999e-67 253.0 sp|Q61830|MRC1_MOUSE Macrophage mannose receptor 1 OS=Mus musculus OX=10090 GN=Mrc1 PE=1 SV=2 g15014.t1 Q61830 26.298 597 1.98e-44 181.0 sp|Q61830|MRC1_MOUSE Macrophage mannose receptor 1 OS=Mus musculus OX=10090 GN=Mrc1 PE=1 SV=2 g15014.t1 Q61830 27.002 437 1.17e-42 175.0 sp|Q61830|MRC1_MOUSE Macrophage mannose receptor 1 OS=Mus musculus OX=10090 GN=Mrc1 PE=1 SV=2 g15015.t1 P10079 40.206 194 9.699999999999999e-23 107.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g15016.t1 Q8BZ39 32.047 337 2.1800000000000003e-21 98.6 sp|Q8BZ39|NMUR2_MOUSE Neuromedin-U receptor 2 OS=Mus musculus OX=10090 GN=Nmur2 PE=2 SV=1 g15017.t1 Q9DAG6 34.409 186 5.61e-29 111.0 sp|Q9DAG6|GPRL1_MOUSE GLIPR1-like protein 1 OS=Mus musculus OX=10090 GN=Glipr1l1 PE=1 SV=1 GPRL1_MOUSE reviewed GLIPR1-like protein 1 Mus musculus (Mouse) GO:0001669; GO:0002081; GO:0005615; GO:0005886; GO:0007339; GO:0007342; GO:0045121; GO:0060090; GO:0060476; GO:0098635; GO:0120212 binding of sperm to zona pellucida [GO:0007339]; fusion of sperm to egg plasma membrane involved in single fertilization [GO:0007342]; protein localization involved in acrosome reaction [GO:0060476] acrosomal vesicle [GO:0001669]; extracellular space [GO:0005615]; membrane raft [GO:0045121]; outer acrosomal membrane [GO:0002081]; plasma membrane [GO:0005886]; protein complex involved in cell-cell adhesion [GO:0098635]; sperm head-tail coupling apparatus [GO:0120212] molecular adaptor activity [GO:0060090] g15018.t1 P00639 43.023 258 3.83e-74 234.0 sp|P00639|DNAS1_BOVIN Deoxyribonuclease-1 OS=Bos taurus OX=9913 GN=DNASE1 PE=1 SV=3 DNAS1_BOVIN reviewed Deoxyribonuclease-1 (EC 3.1.21.1) (Deoxyribonuclease I) (DNase I) Bos taurus (Bovine) GO:0002283; GO:0002673; GO:0003677; GO:0003779; GO:0004530; GO:0005576; GO:0005634; GO:0005635; GO:0006308; GO:0006915; GO:0042588; GO:0070948 apoptotic process [GO:0006915]; DNA catabolic process [GO:0006308]; neutrophil activation involved in immune response [GO:0002283]; regulation of acute inflammatory response [GO:0002673]; regulation of neutrophil mediated cytotoxicity [GO:0070948] extracellular region [GO:0005576]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; zymogen granule [GO:0042588] actin binding [GO:0003779]; deoxyribonuclease I activity [GO:0004530]; DNA binding [GO:0003677] g15019.t1 Q9GNE2 88.976 127 3.72e-79 233.0 sp|Q9GNE2|RL23_AEDAE Large ribosomal subunit protein uL14 OS=Aedes aegypti OX=7159 GN=RpL23-A PE=2 SV=1 g15020.t1 O75899 27.027 555 4.34e-49 189.0 sp|O75899|GABR2_HUMAN Gamma-aminobutyric acid type B receptor subunit 2 OS=Homo sapiens OX=9606 GN=GABBR2 PE=1 SV=1 GABR2_HUMAN reviewed Gamma-aminobutyric acid type B receptor subunit 2 (GABA-B receptor 2) (GABA-B-R2) (GABA-BR2) (GABABR2) (Gb2) (G-protein coupled receptor 51) (HG20) Homo sapiens (Human) GO:0004888; GO:0004965; GO:0005737; GO:0005886; GO:0007186; GO:0007193; GO:0007194; GO:0007214; GO:0007268; GO:0038039; GO:0043005; GO:0045211; GO:0046982; GO:0051932; GO:0150099; GO:1902710; GO:1902712 adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; chemical synaptic transmission [GO:0007268]; G protein-coupled receptor signaling pathway [GO:0007186]; gamma-aminobutyric acid signaling pathway [GO:0007214]; negative regulation of adenylate cyclase activity [GO:0007194]; neuron-glial cell signaling [GO:0150099]; synaptic transmission, GABAergic [GO:0051932] cytoplasm [GO:0005737]; G protein-coupled GABA receptor complex [GO:1902712]; G protein-coupled receptor heterodimeric complex [GO:0038039]; GABA receptor complex [GO:1902710]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211] G protein-coupled GABA receptor activity [GO:0004965]; protein heterodimerization activity [GO:0046982]; transmembrane signaling receptor activity [GO:0004888] g15023.t1 Q9HCE0 34.458 1541 0.0 734.0 sp|Q9HCE0|EPG5_HUMAN Ectopic P granules protein 5 homolog OS=Homo sapiens OX=9606 GN=EPG5 PE=1 SV=2 EPG5_HUMAN reviewed Ectopic P granules protein 5 homolog Homo sapiens (Human) GO:0002385; GO:0005737; GO:0005764; GO:0006511; GO:0006862; GO:0006954; GO:0006986; GO:0008333; GO:0010467; GO:0032456; GO:0034162; GO:0034342; GO:0046530; GO:0048471; GO:0048874; GO:0048877; GO:0051402; GO:0051607; GO:0070841; GO:0097352; GO:0098544; GO:0140454; GO:0140888; GO:1990786 autophagosome maturation [GO:0097352]; cellular response to dsDNA [GO:1990786]; defense response to virus [GO:0051607]; endocytic recycling [GO:0032456]; endosome to lysosome transport [GO:0008333]; gene expression [GO:0010467]; homeostasis of number of retina cells [GO:0048877]; host-mediated modulation of intestinal microbiota composition [GO:0048874]; inclusion body assembly [GO:0070841]; inflammatory response [GO:0006954]; interferon-mediated signaling pathway [GO:0140888]; maintenance of protein complex location [GO:0098544]; mucosal immune response [GO:0002385]; neuron apoptotic process [GO:0051402]; nucleotide transport [GO:0006862]; photoreceptor cell differentiation [GO:0046530]; protein aggregate center assembly [GO:0140454]; response to type III interferon [GO:0034342]; response to unfolded protein [GO:0006986]; toll-like receptor 9 signaling pathway [GO:0034162]; ubiquitin-dependent protein catabolic process [GO:0006511] cytoplasm [GO:0005737]; lysosome [GO:0005764]; perinuclear region of cytoplasm [GO:0048471] g15023.t2 Q9HCE0 34.575 1530 0.0 736.0 sp|Q9HCE0|EPG5_HUMAN Ectopic P granules protein 5 homolog OS=Homo sapiens OX=9606 GN=EPG5 PE=1 SV=2 EPG5_HUMAN reviewed Ectopic P granules protein 5 homolog Homo sapiens (Human) GO:0002385; GO:0005737; GO:0005764; GO:0006511; GO:0006862; GO:0006954; GO:0006986; GO:0008333; GO:0010467; GO:0032456; GO:0034162; GO:0034342; GO:0046530; GO:0048471; GO:0048874; GO:0048877; GO:0051402; GO:0051607; GO:0070841; GO:0097352; GO:0098544; GO:0140454; GO:0140888; GO:1990786 autophagosome maturation [GO:0097352]; cellular response to dsDNA [GO:1990786]; defense response to virus [GO:0051607]; endocytic recycling [GO:0032456]; endosome to lysosome transport [GO:0008333]; gene expression [GO:0010467]; homeostasis of number of retina cells [GO:0048877]; host-mediated modulation of intestinal microbiota composition [GO:0048874]; inclusion body assembly [GO:0070841]; inflammatory response [GO:0006954]; interferon-mediated signaling pathway [GO:0140888]; maintenance of protein complex location [GO:0098544]; mucosal immune response [GO:0002385]; neuron apoptotic process [GO:0051402]; nucleotide transport [GO:0006862]; photoreceptor cell differentiation [GO:0046530]; protein aggregate center assembly [GO:0140454]; response to type III interferon [GO:0034342]; response to unfolded protein [GO:0006986]; toll-like receptor 9 signaling pathway [GO:0034162]; ubiquitin-dependent protein catabolic process [GO:0006511] cytoplasm [GO:0005737]; lysosome [GO:0005764]; perinuclear region of cytoplasm [GO:0048471] g15024.t1 Q9HCE0 30.813 886 1.7999999999999998e-94 330.0 sp|Q9HCE0|EPG5_HUMAN Ectopic P granules protein 5 homolog OS=Homo sapiens OX=9606 GN=EPG5 PE=1 SV=2 EPG5_HUMAN reviewed Ectopic P granules protein 5 homolog Homo sapiens (Human) GO:0002385; GO:0005737; GO:0005764; GO:0006511; GO:0006862; GO:0006954; GO:0006986; GO:0008333; GO:0010467; GO:0032456; GO:0034162; GO:0034342; GO:0046530; GO:0048471; GO:0048874; GO:0048877; GO:0051402; GO:0051607; GO:0070841; GO:0097352; GO:0098544; GO:0140454; GO:0140888; GO:1990786 autophagosome maturation [GO:0097352]; cellular response to dsDNA [GO:1990786]; defense response to virus [GO:0051607]; endocytic recycling [GO:0032456]; endosome to lysosome transport [GO:0008333]; gene expression [GO:0010467]; homeostasis of number of retina cells [GO:0048877]; host-mediated modulation of intestinal microbiota composition [GO:0048874]; inclusion body assembly [GO:0070841]; inflammatory response [GO:0006954]; interferon-mediated signaling pathway [GO:0140888]; maintenance of protein complex location [GO:0098544]; mucosal immune response [GO:0002385]; neuron apoptotic process [GO:0051402]; nucleotide transport [GO:0006862]; photoreceptor cell differentiation [GO:0046530]; protein aggregate center assembly [GO:0140454]; response to type III interferon [GO:0034342]; response to unfolded protein [GO:0006986]; toll-like receptor 9 signaling pathway [GO:0034162]; ubiquitin-dependent protein catabolic process [GO:0006511] cytoplasm [GO:0005737]; lysosome [GO:0005764]; perinuclear region of cytoplasm [GO:0048471] g15025.t1 Q9H1K6 47.368 323 5.9099999999999995e-89 275.0 sp|Q9H1K6|TLRN1_HUMAN Talin rod domain-containing protein 1 OS=Homo sapiens OX=9606 GN=TLNRD1 PE=1 SV=1 g15028.t1 Q5ZKF4 52.367 338 5.51e-116 343.0 sp|Q5ZKF4|HM20A_CHICK High mobility group protein 20A OS=Gallus gallus OX=9031 GN=HMG20A PE=2 SV=1 g15028.t2 Q5ZKF4 52.522 337 1.0500000000000001e-117 348.0 sp|Q5ZKF4|HM20A_CHICK High mobility group protein 20A OS=Gallus gallus OX=9031 GN=HMG20A PE=2 SV=1 g15029.t1 Q02241 51.02 735 0.0 680.0 sp|Q02241|KIF23_HUMAN Kinesin-like protein KIF23 OS=Homo sapiens OX=9606 GN=KIF23 PE=1 SV=3 KIF23_HUMAN reviewed Kinesin-like protein KIF23 (Kinesin-like protein 5) (Mitotic kinesin-like protein 1) Homo sapiens (Human) GO:0000022; GO:0000281; GO:0003777; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005813; GO:0005819; GO:0005829; GO:0005871; GO:0005874; GO:0005925; GO:0007018; GO:0008017; GO:0016887; GO:0030496; GO:0032467; GO:0051256; GO:0072686; GO:0090543; GO:0097149; GO:0097225; GO:0097227; GO:0097228 microtubule-based movement [GO:0007018]; mitotic cytokinesis [GO:0000281]; mitotic spindle elongation [GO:0000022]; mitotic spindle midzone assembly [GO:0051256]; positive regulation of cytokinesis [GO:0032467] centralspindlin complex [GO:0097149]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Flemming body [GO:0090543]; focal adhesion [GO:0005925]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; midbody [GO:0030496]; mitochondrion [GO:0005739]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; sperm annulus [GO:0097227]; sperm midpiece [GO:0097225]; sperm principal piece [GO:0097228]; spindle [GO:0005819] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777] g15029.t1 Q02241 48.466 163 7.759999999999999e-34 144.0 sp|Q02241|KIF23_HUMAN Kinesin-like protein KIF23 OS=Homo sapiens OX=9606 GN=KIF23 PE=1 SV=3 KIF23_HUMAN reviewed Kinesin-like protein KIF23 (Kinesin-like protein 5) (Mitotic kinesin-like protein 1) Homo sapiens (Human) GO:0000022; GO:0000281; GO:0003777; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005813; GO:0005819; GO:0005829; GO:0005871; GO:0005874; GO:0005925; GO:0007018; GO:0008017; GO:0016887; GO:0030496; GO:0032467; GO:0051256; GO:0072686; GO:0090543; GO:0097149; GO:0097225; GO:0097227; GO:0097228 microtubule-based movement [GO:0007018]; mitotic cytokinesis [GO:0000281]; mitotic spindle elongation [GO:0000022]; mitotic spindle midzone assembly [GO:0051256]; positive regulation of cytokinesis [GO:0032467] centralspindlin complex [GO:0097149]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Flemming body [GO:0090543]; focal adhesion [GO:0005925]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; midbody [GO:0030496]; mitochondrion [GO:0005739]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; sperm annulus [GO:0097227]; sperm midpiece [GO:0097225]; sperm principal piece [GO:0097228]; spindle [GO:0005819] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777] g15029.t2 Q02241 52.15 721 0.0 689.0 sp|Q02241|KIF23_HUMAN Kinesin-like protein KIF23 OS=Homo sapiens OX=9606 GN=KIF23 PE=1 SV=3 KIF23_HUMAN reviewed Kinesin-like protein KIF23 (Kinesin-like protein 5) (Mitotic kinesin-like protein 1) Homo sapiens (Human) GO:0000022; GO:0000281; GO:0003777; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005813; GO:0005819; GO:0005829; GO:0005871; GO:0005874; GO:0005925; GO:0007018; GO:0008017; GO:0016887; GO:0030496; GO:0032467; GO:0051256; GO:0072686; GO:0090543; GO:0097149; GO:0097225; GO:0097227; GO:0097228 microtubule-based movement [GO:0007018]; mitotic cytokinesis [GO:0000281]; mitotic spindle elongation [GO:0000022]; mitotic spindle midzone assembly [GO:0051256]; positive regulation of cytokinesis [GO:0032467] centralspindlin complex [GO:0097149]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Flemming body [GO:0090543]; focal adhesion [GO:0005925]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; midbody [GO:0030496]; mitochondrion [GO:0005739]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; sperm annulus [GO:0097227]; sperm midpiece [GO:0097225]; sperm principal piece [GO:0097228]; spindle [GO:0005819] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777] g15029.t2 Q02241 48.466 163 6.27e-34 144.0 sp|Q02241|KIF23_HUMAN Kinesin-like protein KIF23 OS=Homo sapiens OX=9606 GN=KIF23 PE=1 SV=3 KIF23_HUMAN reviewed Kinesin-like protein KIF23 (Kinesin-like protein 5) (Mitotic kinesin-like protein 1) Homo sapiens (Human) GO:0000022; GO:0000281; GO:0003777; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005813; GO:0005819; GO:0005829; GO:0005871; GO:0005874; GO:0005925; GO:0007018; GO:0008017; GO:0016887; GO:0030496; GO:0032467; GO:0051256; GO:0072686; GO:0090543; GO:0097149; GO:0097225; GO:0097227; GO:0097228 microtubule-based movement [GO:0007018]; mitotic cytokinesis [GO:0000281]; mitotic spindle elongation [GO:0000022]; mitotic spindle midzone assembly [GO:0051256]; positive regulation of cytokinesis [GO:0032467] centralspindlin complex [GO:0097149]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Flemming body [GO:0090543]; focal adhesion [GO:0005925]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; midbody [GO:0030496]; mitochondrion [GO:0005739]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; sperm annulus [GO:0097227]; sperm midpiece [GO:0097225]; sperm principal piece [GO:0097228]; spindle [GO:0005819] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777] g15031.t1 Q9D3W5 40.891 247 1.0299999999999999e-52 182.0 sp|Q9D3W5|LRC71_MOUSE Leucine-rich repeat-containing protein 71 OS=Mus musculus OX=10090 GN=Lrrc71 PE=2 SV=1 g15032.t1 Q0D4Z6 28.098 573 1.9e-50 188.0 sp|Q0D4Z6|GH38_ORYSJ Indole-3-acetic acid-amido synthetase GH3.8 OS=Oryza sativa subsp. japonica OX=39947 GN=GH3.8 PE=1 SV=1 GH38_ORYSJ reviewed Indole-3-acetic acid-amido synthetase GH3.8 (EC 6.3.2.-) (Auxin-responsive GH3-like protein 8) (OsGH3-8) (OsMGH3) Oryza sativa subsp. japonica (Rice) GO:0005737; GO:0006952; GO:0009555; GO:0009851; GO:0010279; GO:0016208; GO:0016881; GO:0140964; GO:1900424 auxin biosynthetic process [GO:0009851]; defense response [GO:0006952]; intracellular auxin homeostasis [GO:0140964]; pollen development [GO:0009555]; regulation of defense response to bacterium [GO:1900424] cytoplasm [GO:0005737] acid-amino acid ligase activity [GO:0016881]; AMP binding [GO:0016208]; indole-3-acetic acid amido synthetase activity [GO:0010279] g15033.t1 Q0D4Z6 27.046 562 9.39e-46 174.0 sp|Q0D4Z6|GH38_ORYSJ Indole-3-acetic acid-amido synthetase GH3.8 OS=Oryza sativa subsp. japonica OX=39947 GN=GH3.8 PE=1 SV=1 GH38_ORYSJ reviewed Indole-3-acetic acid-amido synthetase GH3.8 (EC 6.3.2.-) (Auxin-responsive GH3-like protein 8) (OsGH3-8) (OsMGH3) Oryza sativa subsp. japonica (Rice) GO:0005737; GO:0006952; GO:0009555; GO:0009851; GO:0010279; GO:0016208; GO:0016881; GO:0140964; GO:1900424 auxin biosynthetic process [GO:0009851]; defense response [GO:0006952]; intracellular auxin homeostasis [GO:0140964]; pollen development [GO:0009555]; regulation of defense response to bacterium [GO:1900424] cytoplasm [GO:0005737] acid-amino acid ligase activity [GO:0016881]; AMP binding [GO:0016208]; indole-3-acetic acid amido synthetase activity [GO:0010279] g15034.t1 Q0D4Z6 26.799 556 4.84e-45 172.0 sp|Q0D4Z6|GH38_ORYSJ Indole-3-acetic acid-amido synthetase GH3.8 OS=Oryza sativa subsp. japonica OX=39947 GN=GH3.8 PE=1 SV=1 GH38_ORYSJ reviewed Indole-3-acetic acid-amido synthetase GH3.8 (EC 6.3.2.-) (Auxin-responsive GH3-like protein 8) (OsGH3-8) (OsMGH3) Oryza sativa subsp. japonica (Rice) GO:0005737; GO:0006952; GO:0009555; GO:0009851; GO:0010279; GO:0016208; GO:0016881; GO:0140964; GO:1900424 auxin biosynthetic process [GO:0009851]; defense response [GO:0006952]; intracellular auxin homeostasis [GO:0140964]; pollen development [GO:0009555]; regulation of defense response to bacterium [GO:1900424] cytoplasm [GO:0005737] acid-amino acid ligase activity [GO:0016881]; AMP binding [GO:0016208]; indole-3-acetic acid amido synthetase activity [GO:0010279] g15035.t1 Q0D4Z6 27.807 561 4.19e-48 181.0 sp|Q0D4Z6|GH38_ORYSJ Indole-3-acetic acid-amido synthetase GH3.8 OS=Oryza sativa subsp. japonica OX=39947 GN=GH3.8 PE=1 SV=1 GH38_ORYSJ reviewed Indole-3-acetic acid-amido synthetase GH3.8 (EC 6.3.2.-) (Auxin-responsive GH3-like protein 8) (OsGH3-8) (OsMGH3) Oryza sativa subsp. japonica (Rice) GO:0005737; GO:0006952; GO:0009555; GO:0009851; GO:0010279; GO:0016208; GO:0016881; GO:0140964; GO:1900424 auxin biosynthetic process [GO:0009851]; defense response [GO:0006952]; intracellular auxin homeostasis [GO:0140964]; pollen development [GO:0009555]; regulation of defense response to bacterium [GO:1900424] cytoplasm [GO:0005737] acid-amino acid ligase activity [GO:0016881]; AMP binding [GO:0016208]; indole-3-acetic acid amido synthetase activity [GO:0010279] g15037.t1 Q9ERH3 48.688 1524 0.0 1334.0 sp|Q9ERH3|WDR7_RAT WD repeat-containing protein 7 OS=Rattus norvegicus OX=10116 GN=Wdr7 PE=1 SV=1 g15038.t1 Q5NVI9 65.782 377 2.1800000000000002e-167 477.0 sp|Q5NVI9|DNJA1_PONAB DnaJ homolog subfamily A member 1 OS=Pongo abelii OX=9601 GN=DNAJA1 PE=2 SV=1 DNJA1_PONAB reviewed DnaJ homolog subfamily A member 1 Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0001671; GO:0005524; GO:0005634; GO:0005739; GO:0006457; GO:0008270; GO:0009408; GO:0016020; GO:0030544; GO:0043065; GO:0043066; GO:0043508; GO:0048471; GO:0051082; GO:0051087; GO:0051223; GO:0070585 negative regulation of apoptotic process [GO:0043066]; negative regulation of JUN kinase activity [GO:0043508]; positive regulation of apoptotic process [GO:0043065]; protein folding [GO:0006457]; protein localization to mitochondrion [GO:0070585]; regulation of protein transport [GO:0051223]; response to heat [GO:0009408] membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471] ATP binding [GO:0005524]; ATPase activator activity [GO:0001671]; Hsp70 protein binding [GO:0030544]; protein-folding chaperone binding [GO:0051087]; unfolded protein binding [GO:0051082]; zinc ion binding [GO:0008270] g15039.t1 Q9UNS1 50.472 953 0.0 921.0 sp|Q9UNS1|TIM_HUMAN Protein timeless homolog OS=Homo sapiens OX=9606 GN=TIMELESS PE=1 SV=2 TIM_HUMAN reviewed Protein timeless homolog (hTIM) Homo sapiens (Human) GO:0000076; GO:0000785; GO:0002009; GO:0003677; GO:0005634; GO:0005654; GO:0006281; GO:0006974; GO:0007623; GO:0008047; GO:0009582; GO:0030324; GO:0031297; GO:0031298; GO:0035861; GO:0042752; GO:0042802; GO:0043111; GO:0044770; GO:0045892; GO:0048754; GO:0051301; GO:0072711; GO:0072719; GO:1904976; GO:1905168; GO:2000781 branching morphogenesis of an epithelial tube [GO:0048754]; cell cycle phase transition [GO:0044770]; cell division [GO:0051301]; cellular response to bleomycin [GO:1904976]; cellular response to cisplatin [GO:0072719]; cellular response to hydroxyurea [GO:0072711]; circadian rhythm [GO:0007623]; detection of abiotic stimulus [GO:0009582]; DNA damage response [GO:0006974]; DNA repair [GO:0006281]; DNA replication checkpoint signaling [GO:0000076]; lung development [GO:0030324]; morphogenesis of an epithelium [GO:0002009]; negative regulation of DNA-templated transcription [GO:0045892]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; regulation of circadian rhythm [GO:0042752]; replication fork arrest [GO:0043111]; replication fork processing [GO:0031297] chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; replication fork protection complex [GO:0031298]; site of double-strand break [GO:0035861] DNA binding [GO:0003677]; enzyme activator activity [GO:0008047]; identical protein binding [GO:0042802] g15041.t1 P56476 36.612 366 4.9800000000000007e-73 237.0 sp|P56476|GBRR2_MOUSE Gamma-aminobutyric acid receptor subunit rho-2 OS=Mus musculus OX=10090 GN=Gabrr2 PE=1 SV=4 GBRR2_MOUSE reviewed Gamma-aminobutyric acid receptor subunit rho-2 (GABA(A) receptor subunit rho-2) (GABAAR subunit rho-2) (GABA(C) receptor) Mus musculus (Mouse) GO:0004890; GO:0006821; GO:0007214; GO:0007601; GO:0019904; GO:0022851; GO:0030424; GO:0034707; GO:0045211; GO:0051932; GO:0097708; GO:0098982; GO:1902476; GO:1902711; GO:1904315 chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; gamma-aminobutyric acid signaling pathway [GO:0007214]; synaptic transmission, GABAergic [GO:0051932]; visual perception [GO:0007601] axon [GO:0030424]; chloride channel complex [GO:0034707]; GABA-A receptor complex [GO:1902711]; GABA-ergic synapse [GO:0098982]; intracellular vesicle [GO:0097708]; postsynaptic membrane [GO:0045211] GABA-A receptor activity [GO:0004890]; GABA-gated chloride ion channel activity [GO:0022851]; protein domain specific binding [GO:0019904]; transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315] g15044.t1 Q2TAA2 50.649 231 2.17e-73 226.0 sp|Q2TAA2|IAH1_HUMAN Isoamyl acetate-hydrolyzing esterase 1 homolog OS=Homo sapiens OX=9606 GN=IAH1 PE=1 SV=1 IAH1_HUMAN reviewed Isoamyl acetate-hydrolyzing esterase 1 homolog (EC 3.1.-.-) Homo sapiens (Human) GO:0010467; GO:0016042; GO:0016788; GO:0042802 gene expression [GO:0010467]; lipid catabolic process [GO:0016042] hydrolase activity, acting on ester bonds [GO:0016788]; identical protein binding [GO:0042802] g15047.t1 P23640 73.182 220 3.12e-117 336.0 sp|P23640|RB27A_RAT Ras-related protein Rab-27A OS=Rattus norvegicus OX=10116 GN=Rab27a PE=1 SV=1 RB27A_RAT reviewed Ras-related protein Rab-27A (Rab-27) (EC 3.6.5.2) (GTP-binding protein Ram) (Ram p25) Rattus norvegicus (Rat) GO:0001750; GO:0003924; GO:0003925; GO:0005525; GO:0005764; GO:0005770; GO:0005794; GO:0006887; GO:0007596; GO:0009306; GO:0010628; GO:0016192; GO:0016324; GO:0019003; GO:0019882; GO:0019904; GO:0030141; GO:0030318; GO:0030425; GO:0031489; GO:0032400; GO:0032402; GO:0032585; GO:0033093; GO:0036257; GO:0042470; GO:0043316; GO:0043320; GO:0043473; GO:0045921; GO:0050766; GO:0051875; GO:0051904; GO:0070382; GO:0071985; GO:0097278; GO:1903307; GO:1903428; GO:1903435; GO:1990182 antigen processing and presentation [GO:0019882]; blood coagulation [GO:0007596]; complement-dependent cytotoxicity [GO:0097278]; cytotoxic T cell degranulation [GO:0043316]; exocytosis [GO:0006887]; exosomal secretion [GO:1990182]; melanocyte differentiation [GO:0030318]; melanosome localization [GO:0032400]; melanosome transport [GO:0032402]; multivesicular body organization [GO:0036257]; multivesicular body sorting pathway [GO:0071985]; natural killer cell degranulation [GO:0043320]; pigment granule localization [GO:0051875]; pigment granule transport [GO:0051904]; pigmentation [GO:0043473]; positive regulation of constitutive secretory pathway [GO:1903435]; positive regulation of exocytosis [GO:0045921]; positive regulation of gene expression [GO:0010628]; positive regulation of phagocytosis [GO:0050766]; positive regulation of reactive oxygen species biosynthetic process [GO:1903428]; positive regulation of regulated secretory pathway [GO:1903307]; protein secretion [GO:0009306]; vesicle-mediated transport [GO:0016192] apical plasma membrane [GO:0016324]; dendrite [GO:0030425]; exocytic vesicle [GO:0070382]; Golgi apparatus [GO:0005794]; late endosome [GO:0005770]; lysosome [GO:0005764]; melanosome [GO:0042470]; multivesicular body membrane [GO:0032585]; photoreceptor outer segment [GO:0001750]; secretory granule [GO:0030141]; Weibel-Palade body [GO:0033093] G protein activity [GO:0003925]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; myosin V binding [GO:0031489]; protein domain specific binding [GO:0019904] g15048.t1 Q9Y3E1 68.085 94 8.63e-35 135.0 sp|Q9Y3E1|HDGR3_HUMAN Hepatoma-derived growth factor-related protein 3 OS=Homo sapiens OX=9606 GN=HDGFL3 PE=1 SV=1 g15049.t1 Q15742 63.83 94 2.5200000000000002e-29 125.0 sp|Q15742|NAB2_HUMAN NGFI-A-binding protein 2 OS=Homo sapiens OX=9606 GN=NAB2 PE=1 SV=1 g15049.t1 Q15742 44.444 135 8.06e-22 102.0 sp|Q15742|NAB2_HUMAN NGFI-A-binding protein 2 OS=Homo sapiens OX=9606 GN=NAB2 PE=1 SV=1 g15051.t1 Q02290 42.522 341 9.28e-72 244.0 sp|Q02290|XYNB_NEOPA Endo-1,4-beta-xylanase B OS=Neocallimastix patriciarum OX=4758 GN=xynB PE=2 SV=1 g15051.t1 Q02290 41.935 341 6.85e-70 239.0 sp|Q02290|XYNB_NEOPA Endo-1,4-beta-xylanase B OS=Neocallimastix patriciarum OX=4758 GN=xynB PE=2 SV=1 g15051.t1 Q02290 42.012 338 1.4e-69 239.0 sp|Q02290|XYNB_NEOPA Endo-1,4-beta-xylanase B OS=Neocallimastix patriciarum OX=4758 GN=xynB PE=2 SV=1 g15051.t1 Q02290 41.124 338 1.91e-67 233.0 sp|Q02290|XYNB_NEOPA Endo-1,4-beta-xylanase B OS=Neocallimastix patriciarum OX=4758 GN=xynB PE=2 SV=1 g15051.t1 Q02290 41.124 338 1.3400000000000002e-66 231.0 sp|Q02290|XYNB_NEOPA Endo-1,4-beta-xylanase B OS=Neocallimastix patriciarum OX=4758 GN=xynB PE=2 SV=1 g15051.t1 Q02290 39.823 339 3.3700000000000004e-64 224.0 sp|Q02290|XYNB_NEOPA Endo-1,4-beta-xylanase B OS=Neocallimastix patriciarum OX=4758 GN=xynB PE=2 SV=1 g15051.t1 Q02290 39.053 338 1.4000000000000001e-59 211.0 sp|Q02290|XYNB_NEOPA Endo-1,4-beta-xylanase B OS=Neocallimastix patriciarum OX=4758 GN=xynB PE=2 SV=1 g15051.t1 Q02290 40.437 183 9.61e-31 128.0 sp|Q02290|XYNB_NEOPA Endo-1,4-beta-xylanase B OS=Neocallimastix patriciarum OX=4758 GN=xynB PE=2 SV=1 g15051.t1 Q02290 50.413 121 1.21e-28 122.0 sp|Q02290|XYNB_NEOPA Endo-1,4-beta-xylanase B OS=Neocallimastix patriciarum OX=4758 GN=xynB PE=2 SV=1 g15051.t1 Q02290 50.847 118 6.14e-28 120.0 sp|Q02290|XYNB_NEOPA Endo-1,4-beta-xylanase B OS=Neocallimastix patriciarum OX=4758 GN=xynB PE=2 SV=1 g15052.t1 Q61315 69.231 494 0.0 666.0 sp|Q61315|APC_MOUSE Adenomatous polyposis coli protein OS=Mus musculus OX=10090 GN=Apc PE=1 SV=1 g15052.t1 Q61315 41.975 162 4.91e-22 107.0 sp|Q61315|APC_MOUSE Adenomatous polyposis coli protein OS=Mus musculus OX=10090 GN=Apc PE=1 SV=1 g15055.t1 A5PKH3 70.024 417 0.0 629.0 sp|A5PKH3|FAAA_BOVIN Fumarylacetoacetase OS=Bos taurus OX=9913 GN=FAH PE=2 SV=1 g15056.t1 P70451 41.716 839 0.0 644.0 sp|P70451|FER_MOUSE Tyrosine-protein kinase Fer OS=Mus musculus OX=10090 GN=Fer PE=1 SV=2 g15058.t1 Q9DBC0 53.485 660 0.0 658.0 sp|Q9DBC0|SELO_MOUSE Protein adenylyltransferase SelO, mitochondrial OS=Mus musculus OX=10090 GN=Selenoo PE=1 SV=4 g15059.t1 Q4KML4 76.543 81 6.13e-41 132.0 sp|Q4KML4|ABRAL_MOUSE Costars family protein ABRACL OS=Mus musculus OX=10090 GN=Abracl PE=1 SV=1 g15060.t1 Q96P47 51.712 847 0.0 815.0 sp|Q96P47|AGAP3_HUMAN Arf-GAP with GTPase, ANK repeat and PH domain-containing protein 3 OS=Homo sapiens OX=9606 GN=AGAP3 PE=1 SV=2 g15061.t1 O08836 39.275 331 4.9300000000000005e-64 209.0 sp|O08836|IGBP1_RAT Immunoglobulin-binding protein 1 OS=Rattus norvegicus OX=10116 GN=Igbp1 PE=2 SV=2 IGBP1_RAT reviewed Immunoglobulin-binding protein 1 (Alpha4 phosphoprotein) (CD79a-binding protein 1) (Protein phosphatase 2/4/6 regulatory subunit) Rattus norvegicus (Rat) GO:0000122; GO:0005737; GO:0005829; GO:0005874; GO:0019888; GO:0019899; GO:0019904; GO:0031434; GO:0032873; GO:0034612; GO:0035303; GO:0035306; GO:0035556; GO:0042113; GO:0044877; GO:0045944; GO:0051721; GO:0060632; GO:0070555; GO:2001234 B cell activation [GO:0042113]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of stress-activated MAPK cascade [GO:0032873]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of dephosphorylation [GO:0035306]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of dephosphorylation [GO:0035303]; regulation of microtubule-based movement [GO:0060632]; response to interleukin-1 [GO:0070555]; response to tumor necrosis factor [GO:0034612] cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule [GO:0005874] enzyme binding [GO:0019899]; mitogen-activated protein kinase kinase binding [GO:0031434]; protein domain specific binding [GO:0019904]; protein phosphatase 2A binding [GO:0051721]; protein phosphatase regulator activity [GO:0019888]; protein-containing complex binding [GO:0044877] g15063.t1 Q96PH1 40.232 517 1.69e-96 332.0 sp|Q96PH1|NOX5_HUMAN NADPH oxidase 5 OS=Homo sapiens OX=9606 GN=NOX5 PE=1 SV=1 g15063.t1 Q96PH1 55.882 204 9.1e-60 224.0 sp|Q96PH1|NOX5_HUMAN NADPH oxidase 5 OS=Homo sapiens OX=9606 GN=NOX5 PE=1 SV=1 g15064.t1 A3KMI0 48.052 231 4.06e-63 216.0 sp|A3KMI0|DHX29_XENLA ATP-dependent RNA helicase dhx29 OS=Xenopus laevis OX=8355 GN=dhx29 PE=2 SV=1 DHX29_XENLA reviewed ATP-dependent RNA helicase dhx29 (EC 3.6.4.13) (DEAH box protein 29) Xenopus laevis (African clawed frog) GO:0003723; GO:0003724; GO:0003743; GO:0004386; GO:0005524; GO:0016282; GO:0016887; GO:0043024; GO:0045948 positive regulation of translational initiation [GO:0045948] eukaryotic 43S preinitiation complex [GO:0016282] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; helicase activity [GO:0004386]; ribosomal small subunit binding [GO:0043024]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; translation initiation factor activity [GO:0003743] g15065.t1 A3KMI0 48.736 1147 0.0 1025.0 sp|A3KMI0|DHX29_XENLA ATP-dependent RNA helicase dhx29 OS=Xenopus laevis OX=8355 GN=dhx29 PE=2 SV=1 DHX29_XENLA reviewed ATP-dependent RNA helicase dhx29 (EC 3.6.4.13) (DEAH box protein 29) Xenopus laevis (African clawed frog) GO:0003723; GO:0003724; GO:0003743; GO:0004386; GO:0005524; GO:0016282; GO:0016887; GO:0043024; GO:0045948 positive regulation of translational initiation [GO:0045948] eukaryotic 43S preinitiation complex [GO:0016282] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; helicase activity [GO:0004386]; ribosomal small subunit binding [GO:0043024]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; translation initiation factor activity [GO:0003743] g15066.t1 Q6GNV7 32.791 430 9.010000000000001e-57 199.0 sp|Q6GNV7|DIRC2_XENLA Solute carrier family 49 member 4 homolog OS=Xenopus laevis OX=8355 GN=slc49a4 PE=2 SV=1 DIRC2_XENLA reviewed Solute carrier family 49 member 4 homolog (Disrupted in renal carcinoma protein 2 homolog) Xenopus laevis (African clawed frog) GO:0005765; GO:0016020; GO:0022857; GO:0031923 pyridoxine transport [GO:0031923] lysosomal membrane [GO:0005765]; membrane [GO:0016020] transmembrane transporter activity [GO:0022857] g15067.t1 Q6GNV7 33.01 412 1.64e-62 213.0 sp|Q6GNV7|DIRC2_XENLA Solute carrier family 49 member 4 homolog OS=Xenopus laevis OX=8355 GN=slc49a4 PE=2 SV=1 DIRC2_XENLA reviewed Solute carrier family 49 member 4 homolog (Disrupted in renal carcinoma protein 2 homolog) Xenopus laevis (African clawed frog) GO:0005765; GO:0016020; GO:0022857; GO:0031923 pyridoxine transport [GO:0031923] lysosomal membrane [GO:0005765]; membrane [GO:0016020] transmembrane transporter activity [GO:0022857] g15068.t1 Q15485 55.814 215 9.490000000000001e-77 241.0 sp|Q15485|FCN2_HUMAN Ficolin-2 OS=Homo sapiens OX=9606 GN=FCN2 PE=1 SV=2 FCN2_HUMAN reviewed Ficolin-2 (37 kDa elastin-binding protein) (EBP-37) (Collagen/fibrinogen domain-containing protein 2) (Ficolin-B) (Ficolin-beta) (Hucolin) (L-ficolin) (Serum lectin p35) Homo sapiens (Human) GO:0001867; GO:0002752; GO:0003823; GO:0005102; GO:0005576; GO:0005581; GO:0005615; GO:0006508; GO:0008228; GO:0009897; GO:0038187; GO:0043394; GO:0043654; GO:0046872; GO:0048306; GO:0050829; GO:0050830; GO:0070062; GO:0070892; GO:0072562; GO:0097367; GO:0106139; GO:1903028; GO:1905370; GO:2001065 cell surface pattern recognition receptor signaling pathway [GO:0002752]; complement activation, lectin pathway [GO:0001867]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; opsonization [GO:0008228]; positive regulation of opsonization [GO:1903028]; proteolysis [GO:0006508]; recognition of apoptotic cell [GO:0043654] blood microparticle [GO:0072562]; collagen trimer [GO:0005581]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; serine-type endopeptidase complex [GO:1905370]; symbiont cell surface [GO:0106139] antigen binding [GO:0003823]; calcium-dependent protein binding [GO:0048306]; carbohydrate derivative binding [GO:0097367]; lipoteichoic acid immune receptor activity [GO:0070892]; mannan binding [GO:2001065]; metal ion binding [GO:0046872]; pattern recognition receptor activity [GO:0038187]; proteoglycan binding [GO:0043394]; signaling receptor binding [GO:0005102] g15068.t2 Q15485 56.075 214 4.67e-77 241.0 sp|Q15485|FCN2_HUMAN Ficolin-2 OS=Homo sapiens OX=9606 GN=FCN2 PE=1 SV=2 FCN2_HUMAN reviewed Ficolin-2 (37 kDa elastin-binding protein) (EBP-37) (Collagen/fibrinogen domain-containing protein 2) (Ficolin-B) (Ficolin-beta) (Hucolin) (L-ficolin) (Serum lectin p35) Homo sapiens (Human) GO:0001867; GO:0002752; GO:0003823; GO:0005102; GO:0005576; GO:0005581; GO:0005615; GO:0006508; GO:0008228; GO:0009897; GO:0038187; GO:0043394; GO:0043654; GO:0046872; GO:0048306; GO:0050829; GO:0050830; GO:0070062; GO:0070892; GO:0072562; GO:0097367; GO:0106139; GO:1903028; GO:1905370; GO:2001065 cell surface pattern recognition receptor signaling pathway [GO:0002752]; complement activation, lectin pathway [GO:0001867]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; opsonization [GO:0008228]; positive regulation of opsonization [GO:1903028]; proteolysis [GO:0006508]; recognition of apoptotic cell [GO:0043654] blood microparticle [GO:0072562]; collagen trimer [GO:0005581]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; serine-type endopeptidase complex [GO:1905370]; symbiont cell surface [GO:0106139] antigen binding [GO:0003823]; calcium-dependent protein binding [GO:0048306]; carbohydrate derivative binding [GO:0097367]; lipoteichoic acid immune receptor activity [GO:0070892]; mannan binding [GO:2001065]; metal ion binding [GO:0046872]; pattern recognition receptor activity [GO:0038187]; proteoglycan binding [GO:0043394]; signaling receptor binding [GO:0005102] g15071.t1 Q6GNV7 35.731 431 5.74e-75 246.0 sp|Q6GNV7|DIRC2_XENLA Solute carrier family 49 member 4 homolog OS=Xenopus laevis OX=8355 GN=slc49a4 PE=2 SV=1 DIRC2_XENLA reviewed Solute carrier family 49 member 4 homolog (Disrupted in renal carcinoma protein 2 homolog) Xenopus laevis (African clawed frog) GO:0005765; GO:0016020; GO:0022857; GO:0031923 pyridoxine transport [GO:0031923] lysosomal membrane [GO:0005765]; membrane [GO:0016020] transmembrane transporter activity [GO:0022857] g15072.t1 Q6GNV7 35.417 432 1.1800000000000001e-73 243.0 sp|Q6GNV7|DIRC2_XENLA Solute carrier family 49 member 4 homolog OS=Xenopus laevis OX=8355 GN=slc49a4 PE=2 SV=1 DIRC2_XENLA reviewed Solute carrier family 49 member 4 homolog (Disrupted in renal carcinoma protein 2 homolog) Xenopus laevis (African clawed frog) GO:0005765; GO:0016020; GO:0022857; GO:0031923 pyridoxine transport [GO:0031923] lysosomal membrane [GO:0005765]; membrane [GO:0016020] transmembrane transporter activity [GO:0022857] g15073.t1 Q3SZA2 50.515 97 3.3700000000000003e-22 86.7 sp|Q3SZA2|FMC1_BOVIN Protein FMC1 homolog OS=Bos taurus OX=9913 GN=FMC1 PE=3 SV=1 g15075.t1 A4IGM4 45.136 257 6.689999999999999e-69 218.0 sp|A4IGM4|DHI1L_XENTR Hydroxysteroid 11-beta-dehydrogenase 1-like protein OS=Xenopus tropicalis OX=8364 GN=hsd11b1l PE=2 SV=1 g15079.t1 A0JM12 39.535 258 1.6e-41 166.0 sp|A0JM12|MEG10_XENTR Multiple epidermal growth factor-like domains protein 10 OS=Xenopus tropicalis OX=8364 GN=megf10 PE=2 SV=1 g15079.t1 A0JM12 39.08 261 1.35e-38 157.0 sp|A0JM12|MEG10_XENTR Multiple epidermal growth factor-like domains protein 10 OS=Xenopus tropicalis OX=8364 GN=megf10 PE=2 SV=1 g15079.t1 A0JM12 39.496 238 1.5400000000000002e-37 154.0 sp|A0JM12|MEG10_XENTR Multiple epidermal growth factor-like domains protein 10 OS=Xenopus tropicalis OX=8364 GN=megf10 PE=2 SV=1 g15079.t1 A0JM12 39.464 261 3.4e-37 153.0 sp|A0JM12|MEG10_XENTR Multiple epidermal growth factor-like domains protein 10 OS=Xenopus tropicalis OX=8364 GN=megf10 PE=2 SV=1 g15079.t1 A0JM12 38.596 228 9.31e-34 142.0 sp|A0JM12|MEG10_XENTR Multiple epidermal growth factor-like domains protein 10 OS=Xenopus tropicalis OX=8364 GN=megf10 PE=2 SV=1 g15079.t1 A0JM12 37.755 196 3.7400000000000006e-27 121.0 sp|A0JM12|MEG10_XENTR Multiple epidermal growth factor-like domains protein 10 OS=Xenopus tropicalis OX=8364 GN=megf10 PE=2 SV=1 g15082.t1 O88281 42.456 1034 0.0 709.0 sp|O88281|MEGF6_RAT Multiple epidermal growth factor-like domains protein 6 OS=Rattus norvegicus OX=10116 GN=Megf6 PE=1 SV=1 g15082.t1 O88281 41.787 1041 0.0 708.0 sp|O88281|MEGF6_RAT Multiple epidermal growth factor-like domains protein 6 OS=Rattus norvegicus OX=10116 GN=Megf6 PE=1 SV=1 g15082.t1 O88281 41.023 997 0.0 676.0 sp|O88281|MEGF6_RAT Multiple epidermal growth factor-like domains protein 6 OS=Rattus norvegicus OX=10116 GN=Megf6 PE=1 SV=1 g15082.t1 O88281 41.058 1040 0.0 664.0 sp|O88281|MEGF6_RAT Multiple epidermal growth factor-like domains protein 6 OS=Rattus norvegicus OX=10116 GN=Megf6 PE=1 SV=1 g15082.t1 O88281 39.751 1044 0.0 648.0 sp|O88281|MEGF6_RAT Multiple epidermal growth factor-like domains protein 6 OS=Rattus norvegicus OX=10116 GN=Megf6 PE=1 SV=1 g15082.t1 O88281 40.421 522 1.35e-104 371.0 sp|O88281|MEGF6_RAT Multiple epidermal growth factor-like domains protein 6 OS=Rattus norvegicus OX=10116 GN=Megf6 PE=1 SV=1 g15083.t1 Q502L1 46.512 129 7.490000000000001e-35 139.0 sp|Q502L1|ACB5A_DANRE Acyl-CoA-binding domain-containing protein 5A OS=Danio rerio OX=7955 GN=acbd5a PE=2 SV=1 g15083.t2 Q502L1 52.632 114 4.94e-38 148.0 sp|Q502L1|ACB5A_DANRE Acyl-CoA-binding domain-containing protein 5A OS=Danio rerio OX=7955 GN=acbd5a PE=2 SV=1 g15084.t1 Q9DE13 41.42 338 1.6599999999999997e-67 241.0 sp|Q9DE13|BAZ2B_CHICK Bromodomain adjacent to zinc finger domain protein 2B OS=Gallus gallus OX=9031 GN=BAZ2B PE=2 SV=1 g15084.t1 Q9DE13 61.856 97 6.86e-36 147.0 sp|Q9DE13|BAZ2B_CHICK Bromodomain adjacent to zinc finger domain protein 2B OS=Gallus gallus OX=9031 GN=BAZ2B PE=2 SV=1 g15084.t2 Q9DE13 41.143 350 7.15e-67 240.0 sp|Q9DE13|BAZ2B_CHICK Bromodomain adjacent to zinc finger domain protein 2B OS=Gallus gallus OX=9031 GN=BAZ2B PE=2 SV=1 g15084.t2 Q9DE13 61.856 97 6.71e-36 148.0 sp|Q9DE13|BAZ2B_CHICK Bromodomain adjacent to zinc finger domain protein 2B OS=Gallus gallus OX=9031 GN=BAZ2B PE=2 SV=1 g15085.t1 Q9UIF8 46.043 556 1.7999999999999999e-93 341.0 sp|Q9UIF8|BAZ2B_HUMAN Bromodomain adjacent to zinc finger domain protein 2B OS=Homo sapiens OX=9606 GN=BAZ2B PE=1 SV=3 BAZ2B_HUMAN reviewed Bromodomain adjacent to zinc finger domain protein 2B (hWALp4) Homo sapiens (Human) GO:0000785; GO:0003677; GO:0005634; GO:0006338; GO:0006357; GO:0008270 chromatin remodeling [GO:0006338]; regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; nucleus [GO:0005634] DNA binding [GO:0003677]; zinc ion binding [GO:0008270] g15085.t2 Q9UIF8 46.126 555 6.12e-95 345.0 sp|Q9UIF8|BAZ2B_HUMAN Bromodomain adjacent to zinc finger domain protein 2B OS=Homo sapiens OX=9606 GN=BAZ2B PE=1 SV=3 BAZ2B_HUMAN reviewed Bromodomain adjacent to zinc finger domain protein 2B (hWALp4) Homo sapiens (Human) GO:0000785; GO:0003677; GO:0005634; GO:0006338; GO:0006357; GO:0008270 chromatin remodeling [GO:0006338]; regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; nucleus [GO:0005634] DNA binding [GO:0003677]; zinc ion binding [GO:0008270] g15085.t3 Q9UIF8 44.604 556 1.44e-89 328.0 sp|Q9UIF8|BAZ2B_HUMAN Bromodomain adjacent to zinc finger domain protein 2B OS=Homo sapiens OX=9606 GN=BAZ2B PE=1 SV=3 BAZ2B_HUMAN reviewed Bromodomain adjacent to zinc finger domain protein 2B (hWALp4) Homo sapiens (Human) GO:0000785; GO:0003677; GO:0005634; GO:0006338; GO:0006357; GO:0008270 chromatin remodeling [GO:0006338]; regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; nucleus [GO:0005634] DNA binding [GO:0003677]; zinc ion binding [GO:0008270] g15085.t4 Q9UIF8 46.043 556 1.7999999999999999e-93 341.0 sp|Q9UIF8|BAZ2B_HUMAN Bromodomain adjacent to zinc finger domain protein 2B OS=Homo sapiens OX=9606 GN=BAZ2B PE=1 SV=3 BAZ2B_HUMAN reviewed Bromodomain adjacent to zinc finger domain protein 2B (hWALp4) Homo sapiens (Human) GO:0000785; GO:0003677; GO:0005634; GO:0006338; GO:0006357; GO:0008270 chromatin remodeling [GO:0006338]; regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; nucleus [GO:0005634] DNA binding [GO:0003677]; zinc ion binding [GO:0008270] g15085.t5 Q9UIF8 44.424 556 5.04e-89 327.0 sp|Q9UIF8|BAZ2B_HUMAN Bromodomain adjacent to zinc finger domain protein 2B OS=Homo sapiens OX=9606 GN=BAZ2B PE=1 SV=3 BAZ2B_HUMAN reviewed Bromodomain adjacent to zinc finger domain protein 2B (hWALp4) Homo sapiens (Human) GO:0000785; GO:0003677; GO:0005634; GO:0006338; GO:0006357; GO:0008270 chromatin remodeling [GO:0006338]; regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; nucleus [GO:0005634] DNA binding [GO:0003677]; zinc ion binding [GO:0008270] g15085.t6 Q9UIF8 44.797 567 4.74e-91 333.0 sp|Q9UIF8|BAZ2B_HUMAN Bromodomain adjacent to zinc finger domain protein 2B OS=Homo sapiens OX=9606 GN=BAZ2B PE=1 SV=3 BAZ2B_HUMAN reviewed Bromodomain adjacent to zinc finger domain protein 2B (hWALp4) Homo sapiens (Human) GO:0000785; GO:0003677; GO:0005634; GO:0006338; GO:0006357; GO:0008270 chromatin remodeling [GO:0006338]; regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; nucleus [GO:0005634] DNA binding [GO:0003677]; zinc ion binding [GO:0008270] g15086.t1 Q7ZUA6 52.61 479 4.27e-135 403.0 sp|Q7ZUA6|LMBR1_CHICK Limb region 1 protein homolog OS=Gallus gallus OX=9031 GN=LMBR1 PE=2 SV=1 LMBR1_CHICK reviewed Limb region 1 protein homolog Gallus gallus (Chicken) GO:0004888; GO:0005886; GO:0007165 signal transduction [GO:0007165] plasma membrane [GO:0005886] transmembrane signaling receptor activity [GO:0004888] g15087.t1 Q9NQR9 33.626 342 1.9100000000000002e-56 190.0 sp|Q9NQR9|G6PC2_HUMAN Glucose-6-phosphatase 2 OS=Homo sapiens OX=9606 GN=G6PC2 PE=1 SV=1 G6PC2_HUMAN reviewed Glucose-6-phosphatase 2 (G-6-Pase 2) (G6Pase 2) (EC 3.1.3.9) (Islet-specific glucose-6-phosphatase catalytic subunit-related protein) Homo sapiens (Human) GO:0004346; GO:0005789; GO:0006094; GO:0016020; GO:0042593; GO:0050796; GO:0051156 gluconeogenesis [GO:0006094]; glucose 6-phosphate metabolic process [GO:0051156]; glucose homeostasis [GO:0042593]; regulation of insulin secretion [GO:0050796] endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020] glucose-6-phosphatase activity [GO:0004346] g15089.t1 Q5ZMD2 57.018 342 1.8599999999999997e-126 377.0 sp|Q5ZMD2|ANKY2_CHICK Ankyrin repeat and MYND domain-containing protein 2 OS=Gallus gallus OX=9031 GN=ANKMY2 PE=2 SV=1 g15090.t1 Q8CI43 53.425 146 4.69e-51 165.0 sp|Q8CI43|MYL6B_MOUSE Myosin light chain 6B OS=Mus musculus OX=10090 GN=Myl6b PE=1 SV=1 g15091.t1 Q9Y2M2 34.603 315 1.1899999999999999e-48 176.0 sp|Q9Y2M2|SSUH2_HUMAN Protein SSUH2 homolog OS=Homo sapiens OX=9606 GN=SSUH2 PE=1 SV=2 g15092.t1 Q9QZM5 64.029 139 4.89e-47 171.0 sp|Q9QZM5|ABI1_RAT Abl interactor 1 OS=Rattus norvegicus OX=10116 GN=Abi1 PE=1 SV=3 ABI1_RAT reviewed Abl interactor 1 (Abelson interactor 1) (Abi-1) (Eps8 SH3 domain-binding protein) (Eps8-binding protein) (e3B1) Rattus norvegicus (Rat) GO:0001756; GO:0001764; GO:0005634; GO:0005856; GO:0014069; GO:0017124; GO:0030027; GO:0030296; GO:0030426; GO:0031209; GO:0031252; GO:0032433; GO:0035591; GO:0035855; GO:0043005; GO:0048813; GO:0048858; GO:0072673; GO:0098858; GO:0098978; GO:0099527 cell projection morphogenesis [GO:0048858]; dendrite morphogenesis [GO:0048813]; lamellipodium morphogenesis [GO:0072673]; megakaryocyte development [GO:0035855]; neuron migration [GO:0001764]; postsynapse to nucleus signaling pathway [GO:0099527]; somitogenesis [GO:0001756] actin-based cell projection [GO:0098858]; cell leading edge [GO:0031252]; cytoskeleton [GO:0005856]; filopodium tip [GO:0032433]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; neuron projection [GO:0043005]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]; SCAR complex [GO:0031209] protein tyrosine kinase activator activity [GO:0030296]; SH3 domain binding [GO:0017124]; signaling adaptor activity [GO:0035591] g15092.t1 Q9QZM5 70.492 61 3.01e-21 99.4 sp|Q9QZM5|ABI1_RAT Abl interactor 1 OS=Rattus norvegicus OX=10116 GN=Abi1 PE=1 SV=3 ABI1_RAT reviewed Abl interactor 1 (Abelson interactor 1) (Abi-1) (Eps8 SH3 domain-binding protein) (Eps8-binding protein) (e3B1) Rattus norvegicus (Rat) GO:0001756; GO:0001764; GO:0005634; GO:0005856; GO:0014069; GO:0017124; GO:0030027; GO:0030296; GO:0030426; GO:0031209; GO:0031252; GO:0032433; GO:0035591; GO:0035855; GO:0043005; GO:0048813; GO:0048858; GO:0072673; GO:0098858; GO:0098978; GO:0099527 cell projection morphogenesis [GO:0048858]; dendrite morphogenesis [GO:0048813]; lamellipodium morphogenesis [GO:0072673]; megakaryocyte development [GO:0035855]; neuron migration [GO:0001764]; postsynapse to nucleus signaling pathway [GO:0099527]; somitogenesis [GO:0001756] actin-based cell projection [GO:0098858]; cell leading edge [GO:0031252]; cytoskeleton [GO:0005856]; filopodium tip [GO:0032433]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; neuron projection [GO:0043005]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]; SCAR complex [GO:0031209] protein tyrosine kinase activator activity [GO:0030296]; SH3 domain binding [GO:0017124]; signaling adaptor activity [GO:0035591] g15093.t1 O93479 56.429 420 3.14e-162 467.0 sp|O93479|ORC4_XENLA Origin recognition complex subunit 4 OS=Xenopus laevis OX=8355 GN=orc4 PE=2 SV=1 g15094.t1 Q90669 51.028 535 0.0 527.0 sp|Q90669|AVR2A_CHICK Activin receptor type-2A OS=Gallus gallus OX=9031 GN=ACVR2A PE=2 SV=1 AVR2A_CHICK reviewed Activin receptor type-2A (EC 2.7.11.30) (Activin receptor type IIA) (ACTR-IIA) (ACTRIIA) Gallus gallus (Chicken) GO:0005524; GO:0005737; GO:0005886; GO:0007389; GO:0008283; GO:0009798; GO:0016020; GO:0017002; GO:0032924; GO:0046872; GO:0048179; GO:0048185; GO:0048333; GO:0071363 activin receptor signaling pathway [GO:0032924]; axis specification [GO:0009798]; cell population proliferation [GO:0008283]; cellular response to growth factor stimulus [GO:0071363]; mesodermal cell differentiation [GO:0048333]; pattern specification process [GO:0007389] activin receptor complex [GO:0048179]; cytoplasm [GO:0005737]; membrane [GO:0016020]; plasma membrane [GO:0005886] activin binding [GO:0048185]; activin receptor activity [GO:0017002]; ATP binding [GO:0005524]; metal ion binding [GO:0046872] g15095.t1 O88665 37.388 559 6.67e-85 285.0 sp|O88665|BRD7_MOUSE Bromodomain-containing protein 7 OS=Mus musculus OX=10090 GN=Brd7 PE=1 SV=1 BRD7_MOUSE reviewed Bromodomain-containing protein 7 (75 kDa bromodomain protein) Mus musculus (Mouse) GO:0000776; GO:0000785; GO:0000976; GO:0002039; GO:0003713; GO:0003714; GO:0005634; GO:0005654; GO:0005829; GO:0006338; GO:0006357; GO:0007346; GO:0016055; GO:0016363; GO:0016586; GO:0030071; GO:0042393; GO:0045582; GO:0045597; GO:0045663; GO:0045815; GO:0045892; GO:0070316; GO:0140015; GO:2000045; GO:2000134; GO:2000781; GO:2000819 chromatin remodeling [GO:0006338]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; positive regulation of cell differentiation [GO:0045597]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of T cell differentiation [GO:0045582]; regulation of G0 to G1 transition [GO:0070316]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of mitotic cell cycle [GO:0007346]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; regulation of nucleotide-excision repair [GO:2000819]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription initiation-coupled chromatin remodeling [GO:0045815]; Wnt signaling pathway [GO:0016055] chromatin [GO:0000785]; cytosol [GO:0005829]; kinetochore [GO:0000776]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RSC-type complex [GO:0016586] histone binding [GO:0042393]; histone H3K14ac reader activity [GO:0140015]; p53 binding [GO:0002039]; transcription cis-regulatory region binding [GO:0000976]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714] g15095.t2 O88665 37.321 560 6.61e-85 285.0 sp|O88665|BRD7_MOUSE Bromodomain-containing protein 7 OS=Mus musculus OX=10090 GN=Brd7 PE=1 SV=1 BRD7_MOUSE reviewed Bromodomain-containing protein 7 (75 kDa bromodomain protein) Mus musculus (Mouse) GO:0000776; GO:0000785; GO:0000976; GO:0002039; GO:0003713; GO:0003714; GO:0005634; GO:0005654; GO:0005829; GO:0006338; GO:0006357; GO:0007346; GO:0016055; GO:0016363; GO:0016586; GO:0030071; GO:0042393; GO:0045582; GO:0045597; GO:0045663; GO:0045815; GO:0045892; GO:0070316; GO:0140015; GO:2000045; GO:2000134; GO:2000781; GO:2000819 chromatin remodeling [GO:0006338]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; positive regulation of cell differentiation [GO:0045597]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of T cell differentiation [GO:0045582]; regulation of G0 to G1 transition [GO:0070316]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of mitotic cell cycle [GO:0007346]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; regulation of nucleotide-excision repair [GO:2000819]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription initiation-coupled chromatin remodeling [GO:0045815]; Wnt signaling pathway [GO:0016055] chromatin [GO:0000785]; cytosol [GO:0005829]; kinetochore [GO:0000776]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RSC-type complex [GO:0016586] histone binding [GO:0042393]; histone H3K14ac reader activity [GO:0140015]; p53 binding [GO:0002039]; transcription cis-regulatory region binding [GO:0000976]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714] g15098.t1 Q9Y6N5 55.784 389 2.5900000000000003e-163 471.0 sp|Q9Y6N5|SQOR_HUMAN Sulfide:quinone oxidoreductase, mitochondrial OS=Homo sapiens OX=9606 GN=SQOR PE=1 SV=1 SQOR_HUMAN reviewed Sulfide:quinone oxidoreductase, mitochondrial (SQOR) (EC 1.8.5.8) (Sulfide dehydrogenase-like) (Sulfide quinone oxidoreductase) Homo sapiens (Human) GO:0005739; GO:0005743; GO:0048038; GO:0070221; GO:0070224; GO:0071949; GO:0106436 sulfide oxidation, using sulfide:quinone oxidoreductase [GO:0070221] mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739] FAD binding [GO:0071949]; glutathione-dependent sulfide quinone oxidoreductase activity [GO:0106436]; quinone binding [GO:0048038]; sulfide:quinone oxidoreductase activity [GO:0070224] g15100.t1 Q9DCR2 86.31 168 1.34e-97 283.0 sp|Q9DCR2|AP3S1_MOUSE AP-3 complex subunit sigma-1 OS=Mus musculus OX=10090 GN=Ap3s1 PE=1 SV=2 AP3S1_MOUSE reviewed AP-3 complex subunit sigma-1 (AP-3 complex subunit sigma-3A) (Adaptor-related protein complex 3 subunit sigma-1) (Sigma-3A-adaptin) (Sigma3A-adaptin) (Sigma-adaptin 3a) Mus musculus (Mouse) GO:0005769; GO:0005802; GO:0006886; GO:0006896; GO:0008021; GO:0008089; GO:0016020; GO:0016183; GO:0016192; GO:0030123; GO:0030659; GO:0035654; GO:0036465; GO:0048490; GO:0060155; GO:1903232; GO:1904115 anterograde axonal transport [GO:0008089]; anterograde synaptic vesicle transport [GO:0048490]; clathrin-coated vesicle cargo loading, AP-3-mediated [GO:0035654]; Golgi to vacuole transport [GO:0006896]; intracellular protein transport [GO:0006886]; melanosome assembly [GO:1903232]; platelet dense granule organization [GO:0060155]; synaptic vesicle coating [GO:0016183]; synaptic vesicle recycling [GO:0036465]; vesicle-mediated transport [GO:0016192] AP-3 adaptor complex [GO:0030123]; axon cytoplasm [GO:1904115]; cytoplasmic vesicle membrane [GO:0030659]; early endosome [GO:0005769]; membrane [GO:0016020]; synaptic vesicle [GO:0008021]; trans-Golgi network [GO:0005802] g15101.t1 Q96EN8 50.867 519 1.2500000000000001e-160 485.0 sp|Q96EN8|MOCOS_HUMAN Molybdenum cofactor sulfurase OS=Homo sapiens OX=9606 GN=MOCOS PE=1 SV=2 MOCOS_HUMAN reviewed Molybdenum cofactor sulfurase (MCS) (MOS) (MoCo sulfurase) (hMCS) (EC 2.8.1.9) (Molybdenum cofactor sulfurtransferase) Homo sapiens (Human) GO:0005829; GO:0006777; GO:0008265; GO:0016829; GO:0030151; GO:0030170; GO:0032324; GO:0043545 Mo-molybdopterin cofactor biosynthetic process [GO:0006777]; molybdopterin cofactor biosynthetic process [GO:0032324]; molybdopterin cofactor metabolic process [GO:0043545] cytosol [GO:0005829] lyase activity [GO:0016829]; molybdenum cofactor sulfurtransferase activity [GO:0008265]; molybdenum ion binding [GO:0030151]; pyridoxal phosphate binding [GO:0030170] g15102.t1 A2VD33 39.676 247 6.8199999999999995e-40 152.0 sp|A2VD33|MOCOS_DANRE Molybdenum cofactor sulfurase OS=Danio rerio OX=7955 GN=mocos PE=2 SV=2 g15103.t1 Q6DJ13 40.635 315 4.14e-52 177.0 sp|Q6DJ13|ZN830_XENTR Zinc finger protein 830 OS=Xenopus tropicalis OX=8364 GN=znf830 PE=2 SV=1 g15104.t1 Q13416 60.172 349 3.16e-139 418.0 sp|Q13416|ORC2_HUMAN Origin recognition complex subunit 2 OS=Homo sapiens OX=9606 GN=ORC2 PE=1 SV=2 ORC2_HUMAN reviewed Origin recognition complex subunit 2 Homo sapiens (Human) GO:0000122; GO:0000781; GO:0000792; GO:0000808; GO:0000939; GO:0003688; GO:0005634; GO:0005654; GO:0005664; GO:0005813; GO:0006270; GO:0016020 DNA replication initiation [GO:0006270]; negative regulation of transcription by RNA polymerase II [GO:0000122] centrosome [GO:0005813]; chromosome, telomeric region [GO:0000781]; heterochromatin [GO:0000792]; inner kinetochore [GO:0000939]; membrane [GO:0016020]; nuclear origin of replication recognition complex [GO:0005664]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; origin recognition complex [GO:0000808] DNA replication origin binding [GO:0003688] g15105.t1 Q923L3 36.09 399 1.16e-45 187.0 sp|Q923L3|CSMD1_MOUSE CUB and sushi domain-containing protein 1 OS=Mus musculus OX=10090 GN=Csmd1 PE=1 SV=2 g15105.t1 Q923L3 30.405 444 8.47e-38 161.0 sp|Q923L3|CSMD1_MOUSE CUB and sushi domain-containing protein 1 OS=Mus musculus OX=10090 GN=Csmd1 PE=1 SV=2 g15105.t1 Q923L3 29.567 416 2.68e-31 140.0 sp|Q923L3|CSMD1_MOUSE CUB and sushi domain-containing protein 1 OS=Mus musculus OX=10090 GN=Csmd1 PE=1 SV=2 g15105.t1 Q923L3 29.558 362 2.72e-22 110.0 sp|Q923L3|CSMD1_MOUSE CUB and sushi domain-containing protein 1 OS=Mus musculus OX=10090 GN=Csmd1 PE=1 SV=2 g15105.t2 Q80T79 33.263 475 1.64e-49 200.0 sp|Q80T79|CSMD3_MOUSE CUB and sushi domain-containing protein 3 OS=Mus musculus OX=10090 GN=Csmd3 PE=1 SV=3 CSMD3_MOUSE reviewed CUB and sushi domain-containing protein 3 (CUB and sushi multiple domains protein 3) Mus musculus (Mouse) GO:0005886; GO:0050773 regulation of dendrite development [GO:0050773] plasma membrane [GO:0005886] g15105.t2 Q80T79 32.724 492 2.23e-46 190.0 sp|Q80T79|CSMD3_MOUSE CUB and sushi domain-containing protein 3 OS=Mus musculus OX=10090 GN=Csmd3 PE=1 SV=3 CSMD3_MOUSE reviewed CUB and sushi domain-containing protein 3 (CUB and sushi multiple domains protein 3) Mus musculus (Mouse) GO:0005886; GO:0050773 regulation of dendrite development [GO:0050773] plasma membrane [GO:0005886] g15105.t2 Q80T79 30.247 486 8.909999999999999e-42 174.0 sp|Q80T79|CSMD3_MOUSE CUB and sushi domain-containing protein 3 OS=Mus musculus OX=10090 GN=Csmd3 PE=1 SV=3 CSMD3_MOUSE reviewed CUB and sushi domain-containing protein 3 (CUB and sushi multiple domains protein 3) Mus musculus (Mouse) GO:0005886; GO:0050773 regulation of dendrite development [GO:0050773] plasma membrane [GO:0005886] g15105.t2 Q80T79 30.601 366 5.66e-25 119.0 sp|Q80T79|CSMD3_MOUSE CUB and sushi domain-containing protein 3 OS=Mus musculus OX=10090 GN=Csmd3 PE=1 SV=3 CSMD3_MOUSE reviewed CUB and sushi domain-containing protein 3 (CUB and sushi multiple domains protein 3) Mus musculus (Mouse) GO:0005886; GO:0050773 regulation of dendrite development [GO:0050773] plasma membrane [GO:0005886] g15107.t1 Q8IV35 42.581 155 1.0499999999999999e-38 140.0 sp|Q8IV35|CF337_HUMAN Cilia- and flagella-associated protein 337 OS=Homo sapiens OX=9606 GN=CFAP337 PE=1 SV=2 g15107.t1 Q8IV35 68.0 25 1.0499999999999999e-38 41.2 sp|Q8IV35|CF337_HUMAN Cilia- and flagella-associated protein 337 OS=Homo sapiens OX=9606 GN=CFAP337 PE=1 SV=2 g15108.t1 Q8IV35 41.977 860 0.0 652.0 sp|Q8IV35|CF337_HUMAN Cilia- and flagella-associated protein 337 OS=Homo sapiens OX=9606 GN=CFAP337 PE=1 SV=2 g15108.t2 Q8IV35 41.237 873 0.0 644.0 sp|Q8IV35|CF337_HUMAN Cilia- and flagella-associated protein 337 OS=Homo sapiens OX=9606 GN=CFAP337 PE=1 SV=2 g15108.t3 Q8IV35 41.284 872 0.0 644.0 sp|Q8IV35|CF337_HUMAN Cilia- and flagella-associated protein 337 OS=Homo sapiens OX=9606 GN=CFAP337 PE=1 SV=2 g15109.t1 Q641X2 74.419 258 1.98e-106 345.0 sp|Q641X2|LEO1_RAT RNA polymerase-associated protein LEO1 OS=Rattus norvegicus OX=10116 GN=Leo1 PE=1 SV=1 g15110.t1 Q5BJZ6 49.292 353 4.77e-127 375.0 sp|Q5BJZ6|CARME_RAT Carnosine N-methyltransferase OS=Rattus norvegicus OX=10116 GN=Carnmt1 PE=1 SV=1 CARME_RAT reviewed Carnosine N-methyltransferase (EC 2.1.1.22) (Anserine-producing methyltransferase) Rattus norvegicus (Rat) GO:0005634; GO:0005829; GO:0008757; GO:0030735; GO:0032259; GO:0035498; GO:0042803 carnosine metabolic process [GO:0035498]; methylation [GO:0032259] cytosol [GO:0005829]; nucleus [GO:0005634] carnosine N-methyltransferase activity [GO:0030735]; protein homodimerization activity [GO:0042803]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757] g15110.t2 Q8N4J0 49.859 355 1.3699999999999998e-128 379.0 sp|Q8N4J0|CARME_HUMAN Carnosine N-methyltransferase OS=Homo sapiens OX=9606 GN=CARNMT1 PE=1 SV=1 CARME_HUMAN reviewed Carnosine N-methyltransferase (EC 2.1.1.22) Homo sapiens (Human) GO:0005634; GO:0005829; GO:0006548; GO:0008757; GO:0030735; GO:0032259; GO:0035498; GO:0042803 carnosine metabolic process [GO:0035498]; L-histidine catabolic process [GO:0006548]; methylation [GO:0032259] cytosol [GO:0005829]; nucleus [GO:0005634] carnosine N-methyltransferase activity [GO:0030735]; protein homodimerization activity [GO:0042803]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757] g15111.t1 Q8VDR5 40.113 177 8.119999999999999e-34 123.0 sp|Q8VDR5|TM267_MOUSE Transmembrane protein 267 OS=Mus musculus OX=10090 GN=Tmem267 PE=2 SV=1 g15115.t1 P15145 46.889 450 2.6700000000000002e-129 406.0 sp|P15145|AMPN_PIG Aminopeptidase N OS=Sus scrofa OX=9823 GN=ANPEP PE=1 SV=4 g15116.t1 O57579 40.603 431 5.13e-102 327.0 sp|O57579|AMPN_CHICK Aminopeptidase Ey OS=Gallus gallus OX=9031 GN=ANPEP PE=1 SV=2 g15120.t1 P15145 33.892 835 1.51e-143 450.0 sp|P15145|AMPN_PIG Aminopeptidase N OS=Sus scrofa OX=9823 GN=ANPEP PE=1 SV=4 g15128.t1 Q9QXM0 45.063 395 1.22e-128 380.0 sp|Q9QXM0|ABHD2_MOUSE Monoacylglycerol lipase ABHD2 OS=Mus musculus OX=10090 GN=Abhd2 PE=1 SV=1 g15129.t1 P35760 38.983 177 5.96e-31 115.0 sp|P35760|VA5_VESMC Venom allergen 5 OS=Vespula maculifrons OX=7453 PE=1 SV=1 g15130.t1 F1R8P4 36.631 374 2.0599999999999998e-69 229.0 sp|F1R8P4|GLRA2_DANRE Glycine receptor subunit alpha-2 OS=Danio rerio OX=7955 GN=glra2 PE=3 SV=2 GLRA2_DANRE reviewed Glycine receptor subunit alpha-2 Danio rerio (Zebrafish) (Brachydanio rerio) GO:0004888; GO:0005231; GO:0005254; GO:0016594; GO:0022824; GO:0034707; GO:0042995; GO:0045211; GO:0046872; GO:1902476 chloride transmembrane transport [GO:1902476] cell projection [GO:0042995]; chloride channel complex [GO:0034707]; postsynaptic membrane [GO:0045211] chloride channel activity [GO:0005254]; excitatory extracellular ligand-gated monoatomic ion channel activity [GO:0005231]; glycine binding [GO:0016594]; metal ion binding [GO:0046872]; transmembrane signaling receptor activity [GO:0004888]; transmitter-gated monoatomic ion channel activity [GO:0022824] g15131.t1 F1R8P4 37.136 412 9.129999999999999e-74 240.0 sp|F1R8P4|GLRA2_DANRE Glycine receptor subunit alpha-2 OS=Danio rerio OX=7955 GN=glra2 PE=3 SV=2 GLRA2_DANRE reviewed Glycine receptor subunit alpha-2 Danio rerio (Zebrafish) (Brachydanio rerio) GO:0004888; GO:0005231; GO:0005254; GO:0016594; GO:0022824; GO:0034707; GO:0042995; GO:0045211; GO:0046872; GO:1902476 chloride transmembrane transport [GO:1902476] cell projection [GO:0042995]; chloride channel complex [GO:0034707]; postsynaptic membrane [GO:0045211] chloride channel activity [GO:0005254]; excitatory extracellular ligand-gated monoatomic ion channel activity [GO:0005231]; glycine binding [GO:0016594]; metal ion binding [GO:0046872]; transmembrane signaling receptor activity [GO:0004888]; transmitter-gated monoatomic ion channel activity [GO:0022824] g15132.t1 Q8N0X2 46.764 618 0.0 574.0 sp|Q8N0X2|SPG16_HUMAN Sperm-associated antigen 16 protein OS=Homo sapiens OX=9606 GN=SPAG16 PE=1 SV=2 SPG16_HUMAN reviewed Sperm-associated antigen 16 protein (Pf20 protein homolog) Homo sapiens (Human) GO:0005576; GO:0005930; GO:0007288; GO:0035082; GO:0036126; GO:0060271; GO:0090660; GO:0120197; GO:1990716 axoneme assembly [GO:0035082]; cerebrospinal fluid circulation [GO:0090660]; cilium assembly [GO:0060271]; mucociliary clearance [GO:0120197]; sperm axoneme assembly [GO:0007288] axonemal central apparatus [GO:1990716]; axoneme [GO:0005930]; extracellular region [GO:0005576]; sperm flagellum [GO:0036126] g15133.t1 Q9Y2M2 37.864 309 5.52e-72 236.0 sp|Q9Y2M2|SSUH2_HUMAN Protein SSUH2 homolog OS=Homo sapiens OX=9606 GN=SSUH2 PE=1 SV=2 g15134.t1 F8WLE0 38.117 892 1.18e-176 545.0 sp|F8WLE0|KIF28_RAT Kinesin-like protein KIF28 OS=Rattus norvegicus OX=10116 GN=Kif28 PE=2 SV=1 KIF28_RAT reviewed Kinesin-like protein KIF28 (Kinesin family member 28) (Kinesin-like protein 6) Rattus norvegicus (Rat) GO:0003777; GO:0005524; GO:0005737; GO:0005871; GO:0005874; GO:0007005; GO:0008017; GO:0016887; GO:0031966; GO:0047496; GO:0072384 mitochondrion organization [GO:0007005]; organelle transport along microtubule [GO:0072384]; vesicle transport along microtubule [GO:0047496] cytoplasm [GO:0005737]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; mitochondrial membrane [GO:0031966] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777] g15134.t2 F8WLE0 38.57 853 2.1600000000000003e-173 535.0 sp|F8WLE0|KIF28_RAT Kinesin-like protein KIF28 OS=Rattus norvegicus OX=10116 GN=Kif28 PE=2 SV=1 KIF28_RAT reviewed Kinesin-like protein KIF28 (Kinesin family member 28) (Kinesin-like protein 6) Rattus norvegicus (Rat) GO:0003777; GO:0005524; GO:0005737; GO:0005871; GO:0005874; GO:0007005; GO:0008017; GO:0016887; GO:0031966; GO:0047496; GO:0072384 mitochondrion organization [GO:0007005]; organelle transport along microtubule [GO:0072384]; vesicle transport along microtubule [GO:0047496] cytoplasm [GO:0005737]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; mitochondrial membrane [GO:0031966] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777] g15135.t1 Q8HYI9 55.705 149 8.96e-55 172.0 sp|Q8HYI9|PFD5_BOVIN Prefoldin subunit 5 OS=Bos taurus OX=9913 GN=PFDN5 PE=2 SV=1 g15137.t1 Q148G7 70.286 175 2.18e-84 250.0 sp|Q148G7|DCTN6_BOVIN Dynactin subunit 6 OS=Bos taurus OX=9913 GN=DCTN6 PE=2 SV=1 g15138.t1 Q01617 73.016 126 2.27e-51 183.0 sp|Q01617|CPO_DROME Protein couch potato OS=Drosophila melanogaster OX=7227 GN=cpo PE=2 SV=4 g15138.t2 Q01617 73.016 126 2.13e-50 183.0 sp|Q01617|CPO_DROME Protein couch potato OS=Drosophila melanogaster OX=7227 GN=cpo PE=2 SV=4 g15140.t1 P27544 47.368 285 3.13e-83 260.0 sp|P27544|CERS1_HUMAN Ceramide synthase 1 OS=Homo sapiens OX=9606 GN=CERS1 PE=1 SV=1 CERS1_HUMAN reviewed Ceramide synthase 1 (CerS1) (LAG1 longevity assurance homolog 1) (Longevity assurance gene 1 protein homolog 1) (Protein UOG-1) (Sphingoid base N-stearoyltransferase CERS1) (EC 2.3.1.299) Homo sapiens (Human) GO:0005783; GO:0005789; GO:0007420; GO:0010614; GO:0016020; GO:0030148; GO:0036146; GO:0046325; GO:0046513; GO:0050291; GO:0071466; GO:0071492; GO:0072721; GO:1901526 brain development [GO:0007420]; cellular response to dithiothreitol [GO:0072721]; cellular response to mycotoxin [GO:0036146]; cellular response to UV-A [GO:0071492]; cellular response to xenobiotic stimulus [GO:0071466]; ceramide biosynthetic process [GO:0046513]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of D-glucose import [GO:0046325]; positive regulation of mitophagy [GO:1901526]; sphingolipid biosynthetic process [GO:0030148] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020] sphingosine N-acyltransferase activity [GO:0050291] g15141.t1 Q00534 61.921 302 1.19e-131 380.0 sp|Q00534|CDK6_HUMAN Cyclin-dependent kinase 6 OS=Homo sapiens OX=9606 GN=CDK6 PE=1 SV=1 CDK6_HUMAN reviewed Cyclin-dependent kinase 6 (EC 2.7.11.22) (Cell division protein kinase 6) (Serine/threonine-protein kinase PLSTIRE) Homo sapiens (Human) GO:0000082; GO:0000122; GO:0000307; GO:0001726; GO:0001954; GO:0003323; GO:0004693; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0006974; GO:0007165; GO:0007219; GO:0008285; GO:0009615; GO:0010389; GO:0010468; GO:0010628; GO:0014002; GO:0021542; GO:0021670; GO:0030332; GO:0033077; GO:0042063; GO:0043697; GO:0045596; GO:0045638; GO:0045646; GO:0045656; GO:0045668; GO:0045786; GO:0048146; GO:0048699; GO:0050680; GO:0051301; GO:0051726; GO:0060218; GO:0097131; GO:0097132; GO:0097133; GO:0098770; GO:0106310; GO:1902036; GO:2000145; GO:2000773 astrocyte development [GO:0014002]; cell dedifferentiation [GO:0043697]; cell division [GO:0051301]; dentate gyrus development [GO:0021542]; DNA damage response [GO:0006974]; G1/S transition of mitotic cell cycle [GO:0000082]; generation of neurons [GO:0048699]; gliogenesis [GO:0042063]; hematopoietic stem cell differentiation [GO:0060218]; lateral ventricle development [GO:0021670]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell differentiation [GO:0045596]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cellular senescence [GO:2000773]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of monocyte differentiation [GO:0045656]; negative regulation of myeloid cell differentiation [GO:0045638]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of transcription by RNA polymerase II [GO:0000122]; Notch signaling pathway [GO:0007219]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of gene expression [GO:0010628]; regulation of cell cycle [GO:0051726]; regulation of cell motility [GO:2000145]; regulation of erythrocyte differentiation [GO:0045646]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; regulation of gene expression [GO:0010468]; regulation of hematopoietic stem cell differentiation [GO:1902036]; response to virus [GO:0009615]; signal transduction [GO:0007165]; T cell differentiation in thymus [GO:0033077]; type B pancreatic cell development [GO:0003323] centrosome [GO:0005813]; cyclin D1-CDK6 complex [GO:0097131]; cyclin D2-CDK6 complex [GO:0097132]; cyclin D3-CDK6 complex [GO:0097133]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ruffle [GO:0001726] ATP binding [GO:0005524]; cyclin binding [GO:0030332]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; FBXO family protein binding [GO:0098770]; protein serine kinase activity [GO:0106310] g15146.t1 Q13427 70.349 172 1.0100000000000001e-79 281.0 sp|Q13427|PPIG_HUMAN Peptidyl-prolyl cis-trans isomerase G OS=Homo sapiens OX=9606 GN=PPIG PE=1 SV=2 g15147.t1 P79769 61.778 225 6.509999999999999e-104 303.0 sp|P79769|TSN_CHICK Translin OS=Gallus gallus OX=9031 GN=TSN PE=1 SV=1 g15148.t1 Q4R5T4 51.536 293 6.14e-97 298.0 sp|Q4R5T4|RNF32_MACFA RING finger protein 32 OS=Macaca fascicularis OX=9541 GN=RNF32 PE=2 SV=1 g15150.t1 Q9QXF7 42.574 505 3.25e-133 398.0 sp|Q9QXF7|CP2J4_RAT Cytochrome P450 2J4 OS=Rattus norvegicus OX=10116 GN=CYP2J4 PE=1 SV=1 g15151.t1 Q9GL24 57.812 320 1.7599999999999998e-128 375.0 sp|Q9GL24|CATL1_CANLF Procathepsin L OS=Canis lupus familiaris OX=9615 GN=CTSL PE=2 SV=1 g15152.t1 Q9QXF7 41.129 496 4.51e-124 374.0 sp|Q9QXF7|CP2J4_RAT Cytochrome P450 2J4 OS=Rattus norvegicus OX=10116 GN=CYP2J4 PE=1 SV=1 g15153.t1 Q9QXF7 39.802 505 9.220000000000001e-123 371.0 sp|Q9QXF7|CP2J4_RAT Cytochrome P450 2J4 OS=Rattus norvegicus OX=10116 GN=CYP2J4 PE=1 SV=1 g15154.t1 Q9QXF7 40.594 505 4.19e-121 367.0 sp|Q9QXF7|CP2J4_RAT Cytochrome P450 2J4 OS=Rattus norvegicus OX=10116 GN=CYP2J4 PE=1 SV=1 g15156.t1 Q05AQ3 56.637 226 5.14e-90 271.0 sp|Q05AQ3|S2542_XENTR Mitochondrial coenzyme A transporter SLC25A42 OS=Xenopus tropicalis OX=8364 GN=slc25a42 PE=2 SV=1 g15159.t1 Q9YI97 32.653 196 1.2099999999999999e-23 96.7 sp|Q9YI97|OAZ2_DANRE Ornithine decarboxylase antizyme 2 OS=Danio rerio OX=7955 GN=oaz1b PE=2 SV=1 g15160.t1 O75191 64.205 176 1.81e-79 250.0 sp|O75191|XYLB_HUMAN Xylulose kinase OS=Homo sapiens OX=9606 GN=XYLB PE=1 SV=3 XYLB_HUMAN reviewed Xylulose kinase (Xylulokinase) (EC 2.7.1.17) Homo sapiens (Human) GO:0004856; GO:0005524; GO:0005829; GO:0005975; GO:0005997; GO:0005998; GO:0006091; GO:0019640; GO:0042732 carbohydrate metabolic process [GO:0005975]; D-glucuronate catabolic process to D-xylulose 5-phosphate [GO:0019640]; D-xylose metabolic process [GO:0042732]; generation of precursor metabolites and energy [GO:0006091]; xylulose catabolic process [GO:0005998]; xylulose metabolic process [GO:0005997] cytosol [GO:0005829] ATP binding [GO:0005524]; D-xylulokinase activity [GO:0004856] g15161.t1 O75191 63.71 248 1.22e-107 325.0 sp|O75191|XYLB_HUMAN Xylulose kinase OS=Homo sapiens OX=9606 GN=XYLB PE=1 SV=3 XYLB_HUMAN reviewed Xylulose kinase (Xylulokinase) (EC 2.7.1.17) Homo sapiens (Human) GO:0004856; GO:0005524; GO:0005829; GO:0005975; GO:0005997; GO:0005998; GO:0006091; GO:0019640; GO:0042732 carbohydrate metabolic process [GO:0005975]; D-glucuronate catabolic process to D-xylulose 5-phosphate [GO:0019640]; D-xylose metabolic process [GO:0042732]; generation of precursor metabolites and energy [GO:0006091]; xylulose catabolic process [GO:0005998]; xylulose metabolic process [GO:0005997] cytosol [GO:0005829] ATP binding [GO:0005524]; D-xylulokinase activity [GO:0004856] g15162.t1 Q6P6T4 33.179 648 1.75e-107 359.0 sp|Q6P6T4|EMAL2_RAT Echinoderm microtubule-associated protein-like 2 OS=Rattus norvegicus OX=10116 GN=Eml2 PE=1 SV=1 EMAL2_RAT reviewed Echinoderm microtubule-associated protein-like 2 (EMAP-2) Rattus norvegicus (Rat) GO:0000226; GO:0005874; GO:0008017; GO:0010968; GO:0015631; GO:0031115; GO:0035255; GO:0072686 microtubule cytoskeleton organization [GO:0000226]; negative regulation of microtubule polymerization [GO:0031115]; regulation of microtubule nucleation [GO:0010968] microtubule [GO:0005874]; mitotic spindle [GO:0072686] ionotropic glutamate receptor binding [GO:0035255]; microtubule binding [GO:0008017]; tubulin binding [GO:0015631] g15163.t1 Q9I9K9 46.729 107 7.45e-22 83.2 sp|Q9I9K9|GATM_CHICK Glycine amidinotransferase, mitochondrial OS=Gallus gallus OX=9031 GN=GATM PE=2 SV=2 g15163.t1 Q9I9K9 61.538 26 7.45e-22 40.0 sp|Q9I9K9|GATM_CHICK Glycine amidinotransferase, mitochondrial OS=Gallus gallus OX=9031 GN=GATM PE=2 SV=2 g15164.t1 Q6PH19 75.556 270 9.79e-159 451.0 sp|Q6PH19|GATM_DANRE Glycine amidinotransferase, mitochondrial OS=Danio rerio OX=7955 GN=gatm PE=2 SV=1 g15165.t1 Q8C2L6 45.03 493 1.26e-140 416.0 sp|Q8C2L6|T161B_MOUSE Transmembrane protein 161B OS=Mus musculus OX=10090 GN=Tmem161b PE=2 SV=1 g15166.t1 Q6GLC5 64.0 100 2.78e-22 87.4 sp|Q6GLC5|EMC6_XENTR ER membrane protein complex subunit 6 OS=Xenopus tropicalis OX=8364 GN=emc6 PE=3 SV=1 g15167.t1 P10070 45.297 691 2.07e-122 419.0 sp|P10070|GLI2_HUMAN Zinc finger protein GLI2 OS=Homo sapiens OX=9606 GN=GLI2 PE=1 SV=4 GLI2_HUMAN reviewed Zinc finger protein GLI2 (GLI family zinc finger protein 2) (Tax helper protein) Homo sapiens (Human) GO:0000122; GO:0000978; GO:0000981; GO:0001501; GO:0001649; GO:0001822; GO:0002076; GO:0003700; GO:0005634; GO:0005654; GO:0005730; GO:0005813; GO:0005829; GO:0005929; GO:0006355; GO:0006357; GO:0007224; GO:0007389; GO:0007411; GO:0007418; GO:0007442; GO:0007507; GO:0008270; GO:0009913; GO:0009954; GO:0021508; GO:0021513; GO:0021517; GO:0021696; GO:0021965; GO:0021983; GO:0030324; GO:0030879; GO:0030902; GO:0031069; GO:0033089; GO:0035295; GO:0036064; GO:0042475; GO:0043565; GO:0045740; GO:0045893; GO:0045944; GO:0048566; GO:0048589; GO:0048666; GO:0048754; GO:0097542; GO:0097546; GO:0098586; GO:1990788; GO:1990837; GO:1990841 axon guidance [GO:0007411]; branching morphogenesis of an epithelial tube [GO:0048754]; cellular response to virus [GO:0098586]; cerebellar cortex morphogenesis [GO:0021696]; developmental growth [GO:0048589]; embryonic digestive tract development [GO:0048566]; epidermal cell differentiation [GO:0009913]; floor plate formation [GO:0021508]; hair follicle morphogenesis [GO:0031069]; heart development [GO:0007507]; hindbrain development [GO:0030902]; hindgut morphogenesis [GO:0007442]; kidney development [GO:0001822]; lung development [GO:0030324]; mammary gland development [GO:0030879]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron development [GO:0048666]; odontogenesis of dentin-containing tooth [GO:0042475]; osteoblast development [GO:0002076]; osteoblast differentiation [GO:0001649]; pattern specification process [GO:0007389]; pituitary gland development [GO:0021983]; positive regulation of DNA replication [GO:0045740]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of T cell differentiation in thymus [GO:0033089]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proximal/distal pattern formation [GO:0009954]; regulation of DNA-templated transcription [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; skeletal system development [GO:0001501]; smoothened signaling pathway [GO:0007224]; spinal cord dorsal/ventral patterning [GO:0021513]; spinal cord ventral commissure morphogenesis [GO:0021965]; tube development [GO:0035295]; ventral midline development [GO:0007418]; ventral spinal cord development [GO:0021517] centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary base [GO:0097546]; ciliary tip [GO:0097542]; cilium [GO:0005929]; cytosol [GO:0005829]; GLI-SUFU complex [GO:1990788]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; zinc ion binding [GO:0008270] g15168.t1 Q0IIF6 59.603 151 9.150000000000001e-64 197.0 sp|Q0IIF6|FAIM1_BOVIN Fas apoptotic inhibitory molecule 1 OS=Bos taurus OX=9913 GN=FAIM PE=2 SV=1 g15174.t1 Q9Y6H5 39.72 214 2.16e-42 167.0 sp|Q9Y6H5|SNCAP_HUMAN Synphilin-1 OS=Homo sapiens OX=9606 GN=SNCAIP PE=1 SV=2 SNCAP_HUMAN reviewed Synphilin-1 (Sph1) (Alpha-synuclein-interacting protein) Homo sapiens (Human) GO:0005654; GO:0005737; GO:0005829; GO:0008021; GO:0008219; GO:0031625; GO:0036464; GO:0042417; GO:0042734; GO:0042802; GO:0043025; GO:0046928; GO:0090083 cell death [GO:0008219]; dopamine metabolic process [GO:0042417]; regulation of inclusion body assembly [GO:0090083]; regulation of neurotransmitter secretion [GO:0046928] cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; presynaptic membrane [GO:0042734]; synaptic vesicle [GO:0008021] identical protein binding [GO:0042802]; ubiquitin protein ligase binding [GO:0031625] g15180.t1 P10394 29.493 217 1.5899999999999999e-24 109.0 sp|P10394|POL4_DROME Retrovirus-related Pol polyprotein from transposon 412 OS=Drosophila melanogaster OX=7227 GN=POL PE=4 SV=1 g15183.t1 Q62432 72.163 467 0.0 624.0 sp|Q62432|SMAD2_MOUSE Mothers against decapentaplegic homolog 2 OS=Mus musculus OX=10090 GN=Smad2 PE=1 SV=2 SMAD2_MOUSE reviewed SMAD family member 2 (SMAD 2) (Mad-related protein 2) (mMad2) (Mothers against decapentaplegic homolog 2) (MAD homolog 2) (Mothers against DPP homolog 2) Mus musculus (Mouse) GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0001657; GO:0001701; GO:0001706; GO:0001707; GO:0003140; GO:0003180; GO:0003184; GO:0003203; GO:0003677; GO:0003682; GO:0003690; GO:0003700; GO:0005160; GO:0005634; GO:0005654; GO:0005667; GO:0005737; GO:0006355; GO:0007179; GO:0007352; GO:0007369; GO:0007389; GO:0007492; GO:0007507; GO:0008283; GO:0008285; GO:0009653; GO:0009749; GO:0009791; GO:0009880; GO:0009952; GO:0010628; GO:0010629; GO:0010718; GO:0017015; GO:0019902; GO:0023019; GO:0030073; GO:0030154; GO:0030279; GO:0030324; GO:0030325; GO:0030513; GO:0031016; GO:0031625; GO:0032444; GO:0032924; GO:0032991; GO:0034713; GO:0035265; GO:0035556; GO:0038092; GO:0042802; GO:0045165; GO:0045892; GO:0045893; GO:0045944; GO:0046332; GO:0046872; GO:0048156; GO:0048340; GO:0048589; GO:0048617; GO:0048701; GO:0060039; GO:0060395; GO:0061450; GO:0061629; GO:0062009; GO:0070410; GO:0070411; GO:0070412; GO:0070723; GO:0071141; GO:0071142; GO:0071144; GO:0071559; GO:0071895; GO:0097718; GO:0140297 activin receptor signaling pathway [GO:0032924]; adrenal gland development [GO:0030325]; anatomical structure morphogenesis [GO:0009653]; anterior/posterior pattern specification [GO:0009952]; aortic valve morphogenesis [GO:0003180]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; cell population proliferation [GO:0008283]; determination of left/right asymmetry in lateral mesoderm [GO:0003140]; developmental growth [GO:0048589]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic foregut morphogenesis [GO:0048617]; embryonic pattern specification [GO:0009880]; endocardial cushion morphogenesis [GO:0003203]; endoderm development [GO:0007492]; endoderm formation [GO:0001706]; gastrulation [GO:0007369]; heart development [GO:0007507]; in utero embryonic development [GO:0001701]; insulin secretion [GO:0030073]; intracellular signal transduction [GO:0035556]; lung development [GO:0030324]; mesoderm formation [GO:0001707]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of gene expression [GO:0010629]; negative regulation of ossification [GO:0030279]; nodal signaling pathway [GO:0038092]; odontoblast differentiation [GO:0071895]; organ growth [GO:0035265]; pancreas development [GO:0031016]; paraxial mesoderm morphogenesis [GO:0048340]; pattern specification process [GO:0007389]; pericardium development [GO:0060039]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription by RNA polymerase II [GO:0045944]; post-embryonic development [GO:0009791]; pulmonary valve morphogenesis [GO:0003184]; regulation of DNA-templated transcription [GO:0006355]; regulation of transforming growth factor beta receptor signaling pathway [GO:0017015]; response to cholesterol [GO:0070723]; response to glucose [GO:0009749]; response to transforming growth factor beta [GO:0071559]; secondary palate development [GO:0062009]; signal transduction involved in regulation of gene expression [GO:0023019]; SMAD protein signal transduction [GO:0060395]; transforming growth factor beta receptor signaling pathway [GO:0007179]; trophoblast cell migration [GO:0061450]; ureteric bud development [GO:0001657]; zygotic specification of dorsal/ventral axis [GO:0007352] activin responsive factor complex [GO:0032444]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; heteromeric SMAD protein complex [GO:0071144]; homomeric SMAD protein complex [GO:0071142]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; SMAD protein complex [GO:0071141]; transcription regulator complex [GO:0005667] chromatin binding [GO:0003682]; co-SMAD binding [GO:0070410]; disordered domain specific binding [GO:0097718]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription factor binding [GO:0140297]; double-stranded DNA binding [GO:0003690]; I-SMAD binding [GO:0070411]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; phosphatase binding [GO:0019902]; R-SMAD binding [GO:0070412]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; SMAD binding [GO:0046332]; tau protein binding [GO:0048156]; transforming growth factor beta receptor binding [GO:0005160]; type I transforming growth factor beta receptor binding [GO:0034713]; ubiquitin protein ligase binding [GO:0031625] g15183.t2 P84023 76.347 427 0.0 630.0 sp|P84023|SMAD3_CHICK Mothers against decapentaplegic homolog 3 OS=Gallus gallus OX=9031 GN=SMAD3 PE=2 SV=1 SMAD3_CHICK reviewed SMAD family member 3 (SMAD 3) (Mothers against decapentaplegic homolog 3) (MAD homolog 3) (Mad3) (Mothers against DPP homolog 3) Gallus gallus (Chicken) GO:0000978; GO:0000981; GO:0000987; GO:0003700; GO:0005634; GO:0005667; GO:0005737; GO:0007179; GO:0009653; GO:0030154; GO:0032924; GO:0045944; GO:0046872; GO:0060395; GO:0070411; GO:0071141; GO:0071144 activin receptor signaling pathway [GO:0032924]; anatomical structure morphogenesis [GO:0009653]; cell differentiation [GO:0030154]; positive regulation of transcription by RNA polymerase II [GO:0045944]; SMAD protein signal transduction [GO:0060395]; transforming growth factor beta receptor signaling pathway [GO:0007179] cytoplasm [GO:0005737]; heteromeric SMAD protein complex [GO:0071144]; nucleus [GO:0005634]; SMAD protein complex [GO:0071141]; transcription regulator complex [GO:0005667] cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; I-SMAD binding [GO:0070411]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978] g15185.t1 Q90YG6 72.222 108 1.73e-53 165.0 sp|Q90YG6|T2AG_ONCMY Transcription initiation factor IIA subunit 2 OS=Oncorhynchus mykiss OX=8022 GN=gtf2a2 PE=3 SV=1 g15186.t1 Q9W734 52.754 345 6.53e-102 311.0 sp|Q9W734|SMAD6_CHICK Mothers against decapentaplegic homolog 6 OS=Gallus gallus OX=9031 GN=SMAD6 PE=2 SV=1 SMAD6_CHICK reviewed SMAD family member 6 (SMAD 6) (Mothers against decapentaplegic homolog 6) (MAD homolog 6) (Mothers against DPP homolog 6) Gallus gallus (Chicken) GO:0000976; GO:0003682; GO:0005634; GO:0005768; GO:0006357; GO:0009653; GO:0010693; GO:0030154; GO:0030509; GO:0030514; GO:0031589; GO:0032331; GO:0046872; GO:0050767; GO:0060395; GO:0070411; GO:0071144; GO:0090090; GO:0140416; GO:1902832 anatomical structure morphogenesis [GO:0009653]; BMP signaling pathway [GO:0030509]; cell differentiation [GO:0030154]; cell-substrate adhesion [GO:0031589]; negative regulation of alkaline phosphatase activity [GO:0010693]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell proliferation in dorsal spinal cord [GO:1902832]; negative regulation of chondrocyte differentiation [GO:0032331]; regulation of neurogenesis [GO:0050767]; regulation of transcription by RNA polymerase II [GO:0006357]; SMAD protein signal transduction [GO:0060395] endosome [GO:0005768]; heteromeric SMAD protein complex [GO:0071144]; nucleus [GO:0005634] chromatin binding [GO:0003682]; I-SMAD binding [GO:0070411]; metal ion binding [GO:0046872]; transcription cis-regulatory region binding [GO:0000976]; transcription regulator inhibitor activity [GO:0140416] g15189.t1 Q5ZLW3 50.142 704 0.0 632.0 sp|Q5ZLW3|DYM_CHICK Dymeclin OS=Gallus gallus OX=9031 GN=DYM PE=2 SV=1 g15196.t1 Q5RFL2 58.599 157 2.2199999999999998e-42 140.0 sp|Q5RFL2|AT5G3_PONAB ATP synthase F(0) complex subunit C3, mitochondrial OS=Pongo abelii OX=9601 GN=ATP5MC3 PE=2 SV=1 g15197.t1 Q80ZQ5 50.218 229 2.7499999999999998e-67 214.0 sp|Q80ZQ5|JAZF1_MOUSE Juxtaposed with another zinc finger protein 1 OS=Mus musculus OX=10090 GN=Jazf1 PE=1 SV=2 g15198.t1 Q99LM2 43.51 416 2.53e-107 328.0 sp|Q99LM2|CK5P3_MOUSE CDK5 regulatory subunit-associated protein 3 OS=Mus musculus OX=10090 GN=Cdk5rap3 PE=1 SV=1 g15199.t1 Q96JB5 63.934 61 1.2500000000000001e-22 92.8 sp|Q96JB5|CK5P3_HUMAN CDK5 regulatory subunit-associated protein 3 OS=Homo sapiens OX=9606 GN=CDK5RAP3 PE=1 SV=2 g15200.t1 O75899 31.954 701 1.9700000000000002e-79 279.0 sp|O75899|GABR2_HUMAN Gamma-aminobutyric acid type B receptor subunit 2 OS=Homo sapiens OX=9606 GN=GABBR2 PE=1 SV=1 GABR2_HUMAN reviewed Gamma-aminobutyric acid type B receptor subunit 2 (GABA-B receptor 2) (GABA-B-R2) (GABA-BR2) (GABABR2) (Gb2) (G-protein coupled receptor 51) (HG20) Homo sapiens (Human) GO:0004888; GO:0004965; GO:0005737; GO:0005886; GO:0007186; GO:0007193; GO:0007194; GO:0007214; GO:0007268; GO:0038039; GO:0043005; GO:0045211; GO:0046982; GO:0051932; GO:0150099; GO:1902710; GO:1902712 adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; chemical synaptic transmission [GO:0007268]; G protein-coupled receptor signaling pathway [GO:0007186]; gamma-aminobutyric acid signaling pathway [GO:0007214]; negative regulation of adenylate cyclase activity [GO:0007194]; neuron-glial cell signaling [GO:0150099]; synaptic transmission, GABAergic [GO:0051932] cytoplasm [GO:0005737]; G protein-coupled GABA receptor complex [GO:1902712]; G protein-coupled receptor heterodimeric complex [GO:0038039]; GABA receptor complex [GO:1902710]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211] G protein-coupled GABA receptor activity [GO:0004965]; protein heterodimerization activity [GO:0046982]; transmembrane signaling receptor activity [GO:0004888] g15201.t1 H2L0Q3 28.246 439 2.98e-41 161.0 sp|H2L0Q3|GABR1_CAEEL Gamma-aminobutyric acid type B receptor subunit 1 OS=Caenorhabditis elegans OX=6239 GN=gbb-1 PE=1 SV=2 GABR1_CAEEL reviewed Gamma-aminobutyric acid type B receptor subunit 1 Caenorhabditis elegans GO:0004965; GO:0007186; GO:0007214; GO:0009410; GO:0032223; GO:0038039; GO:0040012; GO:1902712 G protein-coupled receptor signaling pathway [GO:0007186]; gamma-aminobutyric acid signaling pathway [GO:0007214]; negative regulation of synaptic transmission, cholinergic [GO:0032223]; regulation of locomotion [GO:0040012]; response to xenobiotic stimulus [GO:0009410] G protein-coupled GABA receptor complex [GO:1902712]; G protein-coupled receptor heterodimeric complex [GO:0038039] G protein-coupled GABA receptor activity [GO:0004965] g15202.t1 G5ECB2 31.159 276 8.31e-35 136.0 sp|G5ECB2|GABR2_CAEEL Gamma-aminobutyric acid type B receptor subunit 2 OS=Caenorhabditis elegans OX=6239 GN=gbb-2 PE=1 SV=1 GABR2_CAEEL reviewed Gamma-aminobutyric acid type B receptor subunit 2 Caenorhabditis elegans GO:0004965; GO:0007186; GO:0007214; GO:0009410; GO:0032223; GO:0038039; GO:0040012; GO:1902712 G protein-coupled receptor signaling pathway [GO:0007186]; gamma-aminobutyric acid signaling pathway [GO:0007214]; negative regulation of synaptic transmission, cholinergic [GO:0032223]; regulation of locomotion [GO:0040012]; response to xenobiotic stimulus [GO:0009410] G protein-coupled GABA receptor complex [GO:1902712]; G protein-coupled receptor heterodimeric complex [GO:0038039] G protein-coupled GABA receptor activity [GO:0004965] g15203.t1 P49283 49.903 517 8.29e-156 461.0 sp|P49283|MVL_DROME Protein Malvolio OS=Drosophila melanogaster OX=7227 GN=Mvl PE=2 SV=2 g15204.t1 Q9C0G6 63.326 878 0.0 1151.0 sp|Q9C0G6|DYH6_HUMAN Dynein axonemal heavy chain 6 OS=Homo sapiens OX=9606 GN=DNAH6 PE=1 SV=3 g15204.t2 Q9C0G6 61.233 908 0.0 1141.0 sp|Q9C0G6|DYH6_HUMAN Dynein axonemal heavy chain 6 OS=Homo sapiens OX=9606 GN=DNAH6 PE=1 SV=3 g15205.t1 Q9C0G6 78.077 260 1.18e-136 431.0 sp|Q9C0G6|DYH6_HUMAN Dynein axonemal heavy chain 6 OS=Homo sapiens OX=9606 GN=DNAH6 PE=1 SV=3 g15206.t1 Q9C0G6 60.0 100 2.6600000000000003e-27 107.0 sp|Q9C0G6|DYH6_HUMAN Dynein axonemal heavy chain 6 OS=Homo sapiens OX=9606 GN=DNAH6 PE=1 SV=3 g15207.t1 Q9C0G6 78.641 103 9.31e-44 155.0 sp|Q9C0G6|DYH6_HUMAN Dynein axonemal heavy chain 6 OS=Homo sapiens OX=9606 GN=DNAH6 PE=1 SV=3 g15208.t1 Q9C0G6 75.545 1284 0.0 2017.0 sp|Q9C0G6|DYH6_HUMAN Dynein axonemal heavy chain 6 OS=Homo sapiens OX=9606 GN=DNAH6 PE=1 SV=3 g15209.t1 Q9C0G6 60.177 113 1.82e-37 137.0 sp|Q9C0G6|DYH6_HUMAN Dynein axonemal heavy chain 6 OS=Homo sapiens OX=9606 GN=DNAH6 PE=1 SV=3 g15210.t1 Q9C0G6 51.84 1223 0.0 1213.0 sp|Q9C0G6|DYH6_HUMAN Dynein axonemal heavy chain 6 OS=Homo sapiens OX=9606 GN=DNAH6 PE=1 SV=3 g15212.t1 Q2TAA2 51.082 231 2.14e-78 239.0 sp|Q2TAA2|IAH1_HUMAN Isoamyl acetate-hydrolyzing esterase 1 homolog OS=Homo sapiens OX=9606 GN=IAH1 PE=1 SV=1 IAH1_HUMAN reviewed Isoamyl acetate-hydrolyzing esterase 1 homolog (EC 3.1.-.-) Homo sapiens (Human) GO:0010467; GO:0016042; GO:0016788; GO:0042802 gene expression [GO:0010467]; lipid catabolic process [GO:0016042] hydrolase activity, acting on ester bonds [GO:0016788]; identical protein binding [GO:0042802] g15213.t1 P28024 57.613 243 2.81e-112 325.0 sp|P28024|PSB4_XENLA Proteasome subunit beta type-4 (Fragment) OS=Xenopus laevis OX=8355 GN=psmb4 PE=2 SV=2 g15214.t1 A4IJ21 52.61 498 8.37e-96 301.0 sp|A4IJ21|MNS1_XENTR Meiosis-specific nuclear structural protein 1 OS=Xenopus tropicalis OX=8364 GN=mns1 PE=2 SV=1 g15215.t1 Q15906 40.0 350 2.0799999999999998e-45 162.0 sp|Q15906|VPS72_HUMAN Vacuolar protein sorting-associated protein 72 homolog OS=Homo sapiens OX=9606 GN=VPS72 PE=1 SV=1 VPS72_HUMAN reviewed Vacuolar protein sorting-associated protein 72 homolog (Protein YL-1) (Transcription factor-like 1) Homo sapiens (Human) GO:0000122; GO:0000786; GO:0003677; GO:0005634; GO:0005654; GO:0006338; GO:0006355; GO:0016607; GO:0032991; GO:0035019; GO:0035267; GO:0042393; GO:0042981; GO:0045815; GO:0045893; GO:0051726; GO:0140713; GO:1905168; GO:2000779 chromatin remodeling [GO:0006338]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of DNA-templated transcription [GO:0006355]; regulation of double-strand break repair [GO:2000779]; somatic stem cell population maintenance [GO:0035019]; transcription initiation-coupled chromatin remodeling [GO:0045815] NuA4 histone acetyltransferase complex [GO:0035267]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634]; protein-containing complex [GO:0032991] DNA binding [GO:0003677]; histone binding [GO:0042393]; histone chaperone activity [GO:0140713] g15218.t1 O74180 48.679 265 3.7900000000000004e-73 233.0 sp|O74180|AOX_ASPNG Alternative oxidase, mitochondrial OS=Aspergillus niger OX=5061 GN=aox1 PE=2 SV=2 g15225.t1 Q8N2E2 41.704 223 2.8100000000000004e-47 182.0 sp|Q8N2E2|VWDE_HUMAN von Willebrand factor D and EGF domain-containing protein OS=Homo sapiens OX=9606 GN=VWDE PE=1 SV=4 g15225.t1 Q8N2E2 40.933 193 4.15e-38 155.0 sp|Q8N2E2|VWDE_HUMAN von Willebrand factor D and EGF domain-containing protein OS=Homo sapiens OX=9606 GN=VWDE PE=1 SV=4 g15225.t1 Q8N2E2 39.855 138 1.38e-21 103.0 sp|Q8N2E2|VWDE_HUMAN von Willebrand factor D and EGF domain-containing protein OS=Homo sapiens OX=9606 GN=VWDE PE=1 SV=4 g15227.t1 Q8BG39 26.094 594 1.03e-33 141.0 sp|Q8BG39|SV2B_MOUSE Synaptic vesicle glycoprotein 2B OS=Mus musculus OX=10090 GN=Sv2b PE=1 SV=1 SV2B_MOUSE reviewed Synaptic vesicle glycoprotein 2B (Synaptic vesicle protein 2B) Mus musculus (Mouse) GO:0001669; GO:0006836; GO:0007268; GO:0008021; GO:0022857; GO:0030672; GO:0098978; GO:0099509; GO:2000300 chemical synaptic transmission [GO:0007268]; neurotransmitter transport [GO:0006836]; regulation of presynaptic cytosolic calcium ion concentration [GO:0099509]; regulation of synaptic vesicle exocytosis [GO:2000300] acrosomal vesicle [GO:0001669]; glutamatergic synapse [GO:0098978]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672] transmembrane transporter activity [GO:0022857] g15228.t1 E1BNS0 28.125 256 1.61e-22 96.7 sp|E1BNS0|FXL15_BOVIN F-box/LRR-repeat protein 15 OS=Bos taurus OX=9913 GN=FBXL15 PE=3 SV=1 g15230.t1 Q96AT9 68.987 158 1.13e-78 236.0 sp|Q96AT9|RPE_HUMAN Ribulose-phosphate 3-epimerase OS=Homo sapiens OX=9606 GN=RPE PE=1 SV=1 g15231.t1 Q5ZI74 39.726 1022 0.0 678.0 sp|Q5ZI74|DHX30_CHICK ATP-dependent RNA helicase DHX30 OS=Gallus gallus OX=9031 GN=DHX30 PE=2 SV=1 DHX30_CHICK reviewed ATP-dependent RNA helicase DHX30 (EC 3.6.4.13) (DEAH box protein 30) Gallus gallus (Chicken) GO:0002151; GO:0003678; GO:0003682; GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005737; GO:0005739; GO:0007417; GO:0016887; GO:0042254; GO:0042645 central nervous system development [GO:0007417]; ribosome biogenesis [GO:0042254] cytoplasm [GO:0005737]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nucleus [GO:0005634] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; chromatin binding [GO:0003682]; DNA helicase activity [GO:0003678]; G-quadruplex RNA binding [GO:0002151]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724] g15234.t1 Q8IZJ3 48.528 1766 0.0 1639.0 sp|Q8IZJ3|CPMD8_HUMAN C3 and PZP-like alpha-2-macroglobulin domain-containing protein 8 OS=Homo sapiens OX=9606 GN=CPAMD8 PE=1 SV=2 CPMD8_HUMAN reviewed C3 and PZP-like alpha-2-macroglobulin domain-containing protein 8 Homo sapiens (Human) GO:0001654; GO:0004867; GO:0005615; GO:0005886 eye development [GO:0001654] extracellular space [GO:0005615]; plasma membrane [GO:0005886] serine-type endopeptidase inhibitor activity [GO:0004867] g15235.t1 Q9WUU9 33.962 318 4.570000000000001e-56 201.0 sp|Q9WUU9|GANP_MOUSE Germinal-center associated nuclear protein OS=Mus musculus OX=10090 GN=Mcm3ap PE=1 SV=2 GANP_MOUSE reviewed Germinal-center associated nuclear protein (GANP) (EC 2.3.1.48) (GC-associated DNA primase) Mus musculus (Mouse) GO:0003676; GO:0003682; GO:0004402; GO:0005634; GO:0005654; GO:0005694; GO:0005737; GO:0005829; GO:0006406; GO:0010484; GO:0015031; GO:0016446; GO:0016973; GO:0031965; GO:0034728; GO:0042393; GO:0044615; GO:0070390 mRNA export from nucleus [GO:0006406]; nucleosome organization [GO:0034728]; poly(A)+ mRNA export from nucleus [GO:0016973]; protein transport [GO:0015031]; somatic hypermutation of immunoglobulin genes [GO:0016446] chromosome [GO:0005694]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]; nuclear pore nuclear basket [GO:0044615]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription export complex 2 [GO:0070390] chromatin binding [GO:0003682]; histone acetyltransferase activity [GO:0004402]; histone binding [GO:0042393]; histone H3 acetyltransferase activity [GO:0010484]; nucleic acid binding [GO:0003676] g15236.t1 Q3U269 53.659 328 2.36e-121 366.0 sp|Q3U269|TSTD2_MOUSE Thiosulfate sulfurtransferase/rhodanese-like domain-containing protein 2 OS=Mus musculus OX=10090 GN=Tstd2 PE=2 SV=3 g15245.t1 Q6ZUX7 40.079 252 1.1100000000000001e-32 122.0 sp|Q6ZUX7|LHPL2_HUMAN LHFPL tetraspan subfamily member 2 protein OS=Homo sapiens OX=9606 GN=LHFPL2 PE=1 SV=2 LHPL2_HUMAN reviewed LHFPL tetraspan subfamily member 2 protein (Lipoma HMGIC fusion partner-like 2 protein) Homo sapiens (Human) GO:0005886; GO:0007338; GO:0016020; GO:0031092; GO:0046545; GO:0046546; GO:1905516 development of primary female sexual characteristics [GO:0046545]; development of primary male sexual characteristics [GO:0046546]; positive regulation of fertilization [GO:1905516]; single fertilization [GO:0007338] membrane [GO:0016020]; plasma membrane [GO:0005886]; platelet alpha granule membrane [GO:0031092] g15246.t1 A0A2R8QP51 50.347 864 0.0 799.0 sp|A0A2R8QP51|DPP9_DANRE Dipeptidyl peptidase 9 OS=Danio rerio OX=7955 GN=dpp9 PE=3 SV=1 DPP9_DANRE reviewed Dipeptidyl peptidase 9 (EC 3.4.14.5) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0004177; GO:0005634; GO:0006508; GO:0008236; GO:0008239; GO:0050727 proteolysis [GO:0006508]; regulation of inflammatory response [GO:0050727] nucleus [GO:0005634] aminopeptidase activity [GO:0004177]; dipeptidyl-peptidase activity [GO:0008239]; serine-type peptidase activity [GO:0008236] g15247.t1 Q4V8A6 46.497 157 1.92e-25 100.0 sp|Q4V8A6|BL1S6_RAT Biogenesis of lysosome-related organelles complex 1 subunit 6 OS=Rattus norvegicus OX=10116 GN=Bloc1s6 PE=1 SV=1 BL1S6_RAT reviewed Biogenesis of lysosome-related organelles complex 1 subunit 6 (BLOC-1 subunit 6) (Pallid protein homolog) (Pallidin) Rattus norvegicus (Rat) GO:0001725; GO:0001726; GO:0001822; GO:0002936; GO:0003016; GO:0003158; GO:0005737; GO:0005768; GO:0005925; GO:0006536; GO:0006541; GO:0006605; GO:0006644; GO:0007596; GO:0007613; GO:0008089; GO:0009410; GO:0010467; GO:0014823; GO:0016020; GO:0021542; GO:0021854; GO:0030133; GO:0030318; GO:0031083; GO:0031175; GO:0031941; GO:0032402; GO:0032816; GO:0033299; GO:0033484; GO:0035264; GO:0035646; GO:0042311; GO:0042745; GO:0042803; GO:0044291; GO:0046034; GO:0046085; GO:0048286; GO:0048490; GO:0048872; GO:0050942; GO:0051015; GO:0051017; GO:0055088; GO:0060090; GO:0060271; GO:0061025; GO:0070938; GO:0071364; GO:0071806; GO:1904115; GO:1905144; GO:1990742 actin filament bundle assembly [GO:0051017]; adenosine metabolic process [GO:0046085]; anterograde axonal transport [GO:0008089]; anterograde synaptic vesicle transport [GO:0048490]; ATP metabolic process [GO:0046034]; blood coagulation [GO:0007596]; bradykinin biosynthetic process [GO:0002936]; cellular response to epidermal growth factor stimulus [GO:0071364]; cilium assembly [GO:0060271]; circadian sleep/wake cycle [GO:0042745]; dentate gyrus development [GO:0021542]; endosome to melanosome transport [GO:0035646]; endothelium development [GO:0003158]; gene expression [GO:0010467]; glutamate metabolic process [GO:0006536]; glutamine metabolic process [GO:0006541]; homeostasis of number of cells [GO:0048872]; hypothalamus development [GO:0021854]; intracellular nitric oxide homeostasis [GO:0033484]; kidney development [GO:0001822]; lipid homeostasis [GO:0055088]; lung alveolus development [GO:0048286]; melanocyte differentiation [GO:0030318]; melanosome transport [GO:0032402]; membrane fusion [GO:0061025]; memory [GO:0007613]; multicellular organism growth [GO:0035264]; neuron projection development [GO:0031175]; phospholipid metabolic process [GO:0006644]; positive regulation of natural killer cell activation [GO:0032816]; positive regulation of pigment cell differentiation [GO:0050942]; protein targeting [GO:0006605]; protein transmembrane transport [GO:0071806]; respiratory system process [GO:0003016]; response to acetylcholine [GO:1905144]; response to activity [GO:0014823]; response to xenobiotic stimulus [GO:0009410]; secretion of lysosomal enzymes [GO:0033299]; vasodilation [GO:0042311] axon cytoplasm [GO:1904115]; BLOC-1 complex [GO:0031083]; cell-cell contact zone [GO:0044291]; contractile ring [GO:0070938]; cytoplasm [GO:0005737]; endosome [GO:0005768]; filamentous actin [GO:0031941]; focal adhesion [GO:0005925]; membrane [GO:0016020]; microvesicle [GO:1990742]; ruffle [GO:0001726]; stress fiber [GO:0001725]; transport vesicle [GO:0030133] actin filament binding [GO:0051015]; molecular adaptor activity [GO:0060090]; protein homodimerization activity [GO:0042803] g15248.t1 Q9D0F3 43.687 396 8e-87 278.0 sp|Q9D0F3|LMAN1_MOUSE Protein ERGIC-53 OS=Mus musculus OX=10090 GN=Lman1 PE=1 SV=1 LMAN1_MOUSE reviewed Protein ERGIC-53 (ER-Golgi intermediate compartment 53 kDa protein) (Lectin mannose-binding 1) (p58) Mus musculus (Mouse) GO:0000139; GO:0001701; GO:0005537; GO:0005783; GO:0005789; GO:0005793; GO:0005794; GO:0006888; GO:0007029; GO:0007030; GO:0010467; GO:0015031; GO:0030017; GO:0030134; GO:0031012; GO:0033116; GO:0042802; GO:0046872; GO:0098978; GO:0150051 endoplasmic reticulum organization [GO:0007029]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; gene expression [GO:0010467]; Golgi organization [GO:0007030]; in utero embryonic development [GO:0001701]; protein transport [GO:0015031] COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; extracellular matrix [GO:0031012]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; postsynaptic Golgi apparatus [GO:0150051]; sarcomere [GO:0030017] D-mannose binding [GO:0005537]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872] g15249.t1 P97471 70.508 295 4.4499999999999996e-119 368.0 sp|P97471|SMAD4_MOUSE Mothers against decapentaplegic homolog 4 OS=Mus musculus OX=10090 GN=Smad4 PE=1 SV=2 SMAD4_MOUSE reviewed SMAD family member 4 (SMAD 4) (Deletion target in pancreatic carcinoma 4 homolog) (Mothers against decapentaplegic homolog 4) (MAD homolog 4) (Mothers against DPP homolog 4) Mus musculus (Mouse) GO:0000122; GO:0000785; GO:0000976; GO:0000977; GO:0000978; GO:0000981; GO:0001222; GO:0001223; GO:0001228; GO:0001541; GO:0001649; GO:0001658; GO:0001666; GO:0001701; GO:0001702; GO:0001822; GO:0001837; GO:0003148; GO:0003190; GO:0003198; GO:0003220; GO:0003251; GO:0003279; GO:0003360; GO:0003677; GO:0003682; GO:0003700; GO:0005518; GO:0005634; GO:0005654; GO:0005667; GO:0005737; GO:0005813; GO:0005829; GO:0006351; GO:0006355; GO:0006357; GO:0006879; GO:0007179; GO:0007283; GO:0007338; GO:0007369; GO:0007411; GO:0007492; GO:0007498; GO:0008283; GO:0008285; GO:0008584; GO:0008585; GO:0009653; GO:0009952; GO:0010614; GO:0010628; GO:0010631; GO:0010666; GO:0010718; GO:0014033; GO:0014898; GO:0030154; GO:0030308; GO:0030325; GO:0030509; GO:0030511; GO:0031005; GO:0032444; GO:0032525; GO:0032909; GO:0032924; GO:0032991; GO:0033686; GO:0035556; GO:0036064; GO:0036302; GO:0042118; GO:0042127; GO:0042177; GO:0042733; GO:0042802; GO:0042803; GO:0043199; GO:0043565; GO:0044877; GO:0045892; GO:0045893; GO:0045944; GO:0046332; GO:0046872; GO:0046881; GO:0048589; GO:0048663; GO:0048665; GO:0048729; GO:0048733; GO:0048859; GO:0051797; GO:0060065; GO:0060391; GO:0060395; GO:0060412; GO:0060956; GO:0061040; GO:0061629; GO:0062009; GO:0070102; GO:0070371; GO:0070373; GO:0070411; GO:0070412; GO:0071141; GO:0071144; GO:0071333; GO:0071559; GO:0071560; GO:0072133; GO:0072134; GO:0072520; GO:0090090; GO:0090575; GO:0097191; GO:1901203; GO:1902895; GO:1905305 activin receptor signaling pathway [GO:0032924]; adrenal gland development [GO:0030325]; anatomical structure morphogenesis [GO:0009653]; anterior/posterior pattern specification [GO:0009952]; atrioventricular canal development [GO:0036302]; atrioventricular valve formation [GO:0003190]; axon guidance [GO:0007411]; BMP signaling pathway [GO:0030509]; brainstem development [GO:0003360]; branching involved in ureteric bud morphogenesis [GO:0001658]; cardiac muscle hypertrophy in response to stress [GO:0014898]; cardiac septum development [GO:0003279]; cell differentiation [GO:0030154]; cell population proliferation [GO:0008283]; cellular response to glucose stimulus [GO:0071333]; cellular response to transforming growth factor beta stimulus [GO:0071560]; developmental growth [GO:0048589]; DNA-templated transcription [GO:0006351]; embryonic digit morphogenesis [GO:0042733]; endocardial cell differentiation [GO:0060956]; endoderm development [GO:0007492]; endothelial cell activation [GO:0042118]; epithelial cell migration [GO:0010631]; epithelial to mesenchymal transition [GO:0001837]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; ERK1 and ERK2 cascade [GO:0070371]; extrinsic apoptotic signaling pathway [GO:0097191]; female gonad development [GO:0008585]; female gonad morphogenesis [GO:0061040]; formation of anatomical boundary [GO:0048859]; gastrulation [GO:0007369]; gastrulation with mouth forming second [GO:0001702]; in utero embryonic development [GO:0001701]; interleukin-6-mediated signaling pathway [GO:0070102]; intracellular iron ion homeostasis [GO:0006879]; intracellular signal transduction [GO:0035556]; kidney development [GO:0001822]; left ventricular cardiac muscle tissue morphogenesis [GO:0003220]; male gonad development [GO:0008584]; mesoderm development [GO:0007498]; metanephric mesenchyme morphogenesis [GO:0072133]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of cardiac myofibril assembly [GO:1905305]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nephrogenic mesenchyme morphogenesis [GO:0072134]; neural crest cell differentiation [GO:0014033]; neuron fate commitment [GO:0048663]; neuron fate specification [GO:0048665]; osteoblast differentiation [GO:0001649]; outflow tract septum morphogenesis [GO:0003148]; ovarian follicle development [GO:0001541]; positive regulation of cardiac muscle cell apoptotic process [GO:0010666]; positive regulation of cell proliferation involved in heart valve morphogenesis [GO:0003251]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of extracellular matrix assembly [GO:1901203]; positive regulation of follicle-stimulating hormone secretion [GO:0046881]; positive regulation of gene expression [GO:0010628]; positive regulation of luteinizing hormone secretion [GO:0033686]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of SMAD protein signal transduction [GO:0060391]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; regulation of cell population proliferation [GO:0042127]; regulation of DNA-templated transcription [GO:0006355]; regulation of hair follicle development [GO:0051797]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transforming growth factor beta2 production [GO:0032909]; response to hypoxia [GO:0001666]; response to transforming growth factor beta [GO:0071559]; sebaceous gland development [GO:0048733]; secondary palate development [GO:0062009]; seminiferous tubule development [GO:0072520]; single fertilization [GO:0007338]; SMAD protein signal transduction [GO:0060395]; somite rostral/caudal axis specification [GO:0032525]; spermatogenesis [GO:0007283]; tissue morphogenesis [GO:0048729]; transforming growth factor beta receptor signaling pathway [GO:0007179]; uterus development [GO:0060065]; ventricular septum morphogenesis [GO:0060412] activin responsive factor complex [GO:0032444]; centrosome [GO:0005813]; chromatin [GO:0000785]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; heteromeric SMAD protein complex [GO:0071144]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; RNA polymerase II transcription regulator complex [GO:0090575]; SMAD protein complex [GO:0071141]; transcription regulator complex [GO:0005667] chromatin binding [GO:0003682]; collagen binding [GO:0005518]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; filamin binding [GO:0031005]; I-SMAD binding [GO:0070411]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; R-SMAD binding [GO:0070412]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific DNA binding [GO:0043565]; SMAD binding [GO:0046332]; sulfate binding [GO:0043199]; transcription cis-regulatory region binding [GO:0000976]; transcription coactivator binding [GO:0001223]; transcription corepressor binding [GO:0001222] g15249.t1 P97471 87.975 158 1.9699999999999998e-81 270.0 sp|P97471|SMAD4_MOUSE Mothers against decapentaplegic homolog 4 OS=Mus musculus OX=10090 GN=Smad4 PE=1 SV=2 SMAD4_MOUSE reviewed SMAD family member 4 (SMAD 4) (Deletion target in pancreatic carcinoma 4 homolog) (Mothers against decapentaplegic homolog 4) (MAD homolog 4) (Mothers against DPP homolog 4) Mus musculus (Mouse) GO:0000122; GO:0000785; GO:0000976; GO:0000977; GO:0000978; GO:0000981; GO:0001222; GO:0001223; GO:0001228; GO:0001541; GO:0001649; GO:0001658; GO:0001666; GO:0001701; GO:0001702; GO:0001822; GO:0001837; GO:0003148; GO:0003190; GO:0003198; GO:0003220; GO:0003251; GO:0003279; GO:0003360; GO:0003677; GO:0003682; GO:0003700; GO:0005518; GO:0005634; GO:0005654; GO:0005667; GO:0005737; GO:0005813; GO:0005829; GO:0006351; GO:0006355; GO:0006357; GO:0006879; GO:0007179; GO:0007283; GO:0007338; GO:0007369; GO:0007411; GO:0007492; GO:0007498; GO:0008283; GO:0008285; GO:0008584; GO:0008585; GO:0009653; GO:0009952; GO:0010614; GO:0010628; GO:0010631; GO:0010666; GO:0010718; GO:0014033; GO:0014898; GO:0030154; GO:0030308; GO:0030325; GO:0030509; GO:0030511; GO:0031005; GO:0032444; GO:0032525; GO:0032909; GO:0032924; GO:0032991; GO:0033686; GO:0035556; GO:0036064; GO:0036302; GO:0042118; GO:0042127; GO:0042177; GO:0042733; GO:0042802; GO:0042803; GO:0043199; GO:0043565; GO:0044877; GO:0045892; GO:0045893; GO:0045944; GO:0046332; GO:0046872; GO:0046881; GO:0048589; GO:0048663; GO:0048665; GO:0048729; GO:0048733; GO:0048859; GO:0051797; GO:0060065; GO:0060391; GO:0060395; GO:0060412; GO:0060956; GO:0061040; GO:0061629; GO:0062009; GO:0070102; GO:0070371; GO:0070373; GO:0070411; GO:0070412; GO:0071141; GO:0071144; GO:0071333; GO:0071559; GO:0071560; GO:0072133; GO:0072134; GO:0072520; GO:0090090; GO:0090575; GO:0097191; GO:1901203; GO:1902895; GO:1905305 activin receptor signaling pathway [GO:0032924]; adrenal gland development [GO:0030325]; anatomical structure morphogenesis [GO:0009653]; anterior/posterior pattern specification [GO:0009952]; atrioventricular canal development [GO:0036302]; atrioventricular valve formation [GO:0003190]; axon guidance [GO:0007411]; BMP signaling pathway [GO:0030509]; brainstem development [GO:0003360]; branching involved in ureteric bud morphogenesis [GO:0001658]; cardiac muscle hypertrophy in response to stress [GO:0014898]; cardiac septum development [GO:0003279]; cell differentiation [GO:0030154]; cell population proliferation [GO:0008283]; cellular response to glucose stimulus [GO:0071333]; cellular response to transforming growth factor beta stimulus [GO:0071560]; developmental growth [GO:0048589]; DNA-templated transcription [GO:0006351]; embryonic digit morphogenesis [GO:0042733]; endocardial cell differentiation [GO:0060956]; endoderm development [GO:0007492]; endothelial cell activation [GO:0042118]; epithelial cell migration [GO:0010631]; epithelial to mesenchymal transition [GO:0001837]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; ERK1 and ERK2 cascade [GO:0070371]; extrinsic apoptotic signaling pathway [GO:0097191]; female gonad development [GO:0008585]; female gonad morphogenesis [GO:0061040]; formation of anatomical boundary [GO:0048859]; gastrulation [GO:0007369]; gastrulation with mouth forming second [GO:0001702]; in utero embryonic development [GO:0001701]; interleukin-6-mediated signaling pathway [GO:0070102]; intracellular iron ion homeostasis [GO:0006879]; intracellular signal transduction [GO:0035556]; kidney development [GO:0001822]; left ventricular cardiac muscle tissue morphogenesis [GO:0003220]; male gonad development [GO:0008584]; mesoderm development [GO:0007498]; metanephric mesenchyme morphogenesis [GO:0072133]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of cardiac myofibril assembly [GO:1905305]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nephrogenic mesenchyme morphogenesis [GO:0072134]; neural crest cell differentiation [GO:0014033]; neuron fate commitment [GO:0048663]; neuron fate specification [GO:0048665]; osteoblast differentiation [GO:0001649]; outflow tract septum morphogenesis [GO:0003148]; ovarian follicle development [GO:0001541]; positive regulation of cardiac muscle cell apoptotic process [GO:0010666]; positive regulation of cell proliferation involved in heart valve morphogenesis [GO:0003251]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of extracellular matrix assembly [GO:1901203]; positive regulation of follicle-stimulating hormone secretion [GO:0046881]; positive regulation of gene expression [GO:0010628]; positive regulation of luteinizing hormone secretion [GO:0033686]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of SMAD protein signal transduction [GO:0060391]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; regulation of cell population proliferation [GO:0042127]; regulation of DNA-templated transcription [GO:0006355]; regulation of hair follicle development [GO:0051797]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transforming growth factor beta2 production [GO:0032909]; response to hypoxia [GO:0001666]; response to transforming growth factor beta [GO:0071559]; sebaceous gland development [GO:0048733]; secondary palate development [GO:0062009]; seminiferous tubule development [GO:0072520]; single fertilization [GO:0007338]; SMAD protein signal transduction [GO:0060395]; somite rostral/caudal axis specification [GO:0032525]; spermatogenesis [GO:0007283]; tissue morphogenesis [GO:0048729]; transforming growth factor beta receptor signaling pathway [GO:0007179]; uterus development [GO:0060065]; ventricular septum morphogenesis [GO:0060412] activin responsive factor complex [GO:0032444]; centrosome [GO:0005813]; chromatin [GO:0000785]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; heteromeric SMAD protein complex [GO:0071144]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; RNA polymerase II transcription regulator complex [GO:0090575]; SMAD protein complex [GO:0071141]; transcription regulator complex [GO:0005667] chromatin binding [GO:0003682]; collagen binding [GO:0005518]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; filamin binding [GO:0031005]; I-SMAD binding [GO:0070411]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; R-SMAD binding [GO:0070412]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific DNA binding [GO:0043565]; SMAD binding [GO:0046332]; sulfate binding [GO:0043199]; transcription cis-regulatory region binding [GO:0000976]; transcription coactivator binding [GO:0001223]; transcription corepressor binding [GO:0001222] g15256.t1 Q7TQK0 71.373 255 2.5599999999999998e-113 378.0 sp|Q7TQK0|CCNT2_MOUSE Cyclin-T2 OS=Mus musculus OX=10090 GN=Ccnt2 PE=1 SV=1 CCNT2_MOUSE reviewed Cyclin-T2 (CycT2) Mus musculus (Mouse) GO:0001223; GO:0003682; GO:0005634; GO:0007519; GO:0008024; GO:0019085; GO:0019086; GO:0019901; GO:0032786; GO:0032968; GO:0045944; GO:0048471; GO:0051147; GO:0051301; GO:0061575; GO:0070063; GO:0097322 cell division [GO:0051301]; early viral transcription [GO:0019085]; late viral transcription [GO:0019086]; positive regulation of DNA-templated transcription, elongation [GO:0032786]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription elongation by RNA polymerase II [GO:0032968]; regulation of muscle cell differentiation [GO:0051147]; skeletal muscle tissue development [GO:0007519] cyclin/CDK positive transcription elongation factor complex [GO:0008024]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471] 7SK snRNA binding [GO:0097322]; chromatin binding [GO:0003682]; cyclin-dependent protein serine/threonine kinase activator activity [GO:0061575]; protein kinase binding [GO:0019901]; RNA polymerase binding [GO:0070063]; transcription coactivator binding [GO:0001223] g15256.t2 Q7TQK0 74.39 246 2.04e-116 387.0 sp|Q7TQK0|CCNT2_MOUSE Cyclin-T2 OS=Mus musculus OX=10090 GN=Ccnt2 PE=1 SV=1 CCNT2_MOUSE reviewed Cyclin-T2 (CycT2) Mus musculus (Mouse) GO:0001223; GO:0003682; GO:0005634; GO:0007519; GO:0008024; GO:0019085; GO:0019086; GO:0019901; GO:0032786; GO:0032968; GO:0045944; GO:0048471; GO:0051147; GO:0051301; GO:0061575; GO:0070063; GO:0097322 cell division [GO:0051301]; early viral transcription [GO:0019085]; late viral transcription [GO:0019086]; positive regulation of DNA-templated transcription, elongation [GO:0032786]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription elongation by RNA polymerase II [GO:0032968]; regulation of muscle cell differentiation [GO:0051147]; skeletal muscle tissue development [GO:0007519] cyclin/CDK positive transcription elongation factor complex [GO:0008024]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471] 7SK snRNA binding [GO:0097322]; chromatin binding [GO:0003682]; cyclin-dependent protein serine/threonine kinase activator activity [GO:0061575]; protein kinase binding [GO:0019901]; RNA polymerase binding [GO:0070063]; transcription coactivator binding [GO:0001223] g15257.t1 Q2NL14 44.293 368 5.4000000000000006e-86 273.0 sp|Q2NL14|KANL2_BOVIN KAT8 regulatory NSL complex subunit 2 OS=Bos taurus OX=9913 GN=KANSL2 PE=2 SV=1 g15258.t1 Q9Z1G4 71.654 127 2.3799999999999997e-54 185.0 sp|Q9Z1G4|VPP1_MOUSE V-type proton ATPase 116 kDa subunit a 1 OS=Mus musculus OX=10090 GN=Atp6v0a1 PE=1 SV=3 VPP1_MOUSE reviewed V-type proton ATPase 116 kDa subunit a 1 (V-ATPase 116 kDa subunit a 1) (Clathrin-coated vesicle/synaptic vesicle proton pump 116 kDa subunit) (Vacuolar adenosine triphosphatase subunit Ac116) (Vacuolar proton pump subunit 1) (Vacuolar proton translocating ATPase 116 kDa subunit a isoform 1) Mus musculus (Mouse) GO:0000220; GO:0005737; GO:0005794; GO:0005829; GO:0005886; GO:0007035; GO:0016020; GO:0016241; GO:0016471; GO:0016607; GO:0030665; GO:0030672; GO:0042470; GO:0046961; GO:0048471; GO:0051117; GO:0097401 regulation of macroautophagy [GO:0016241]; synaptic vesicle lumen acidification [GO:0097401]; vacuolar acidification [GO:0007035] clathrin-coated vesicle membrane [GO:0030665]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; melanosome [GO:0042470]; membrane [GO:0016020]; nuclear speck [GO:0016607]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; synaptic vesicle membrane [GO:0030672]; vacuolar proton-transporting V-type ATPase complex [GO:0016471]; vacuolar proton-transporting V-type ATPase, V0 domain [GO:0000220] ATPase binding [GO:0051117]; proton-transporting ATPase activity, rotational mechanism [GO:0046961] g15259.t1 Q5R422 58.647 665 0.0 795.0 sp|Q5R422|VPP1_PONAB V-type proton ATPase 116 kDa subunit a 1 OS=Pongo abelii OX=9601 GN=ATP6V0A1 PE=2 SV=1 g15260.t1 Q8AVM5 65.517 841 0.0 1141.0 sp|Q8AVM5|VPP1_XENLA V-type proton ATPase 116 kDa subunit a1 OS=Xenopus laevis OX=8355 GN=atp6v0a1 PE=2 SV=1 g15260.t2 Q9Z1G4 66.942 847 0.0 1159.0 sp|Q9Z1G4|VPP1_MOUSE V-type proton ATPase 116 kDa subunit a 1 OS=Mus musculus OX=10090 GN=Atp6v0a1 PE=1 SV=3 VPP1_MOUSE reviewed V-type proton ATPase 116 kDa subunit a 1 (V-ATPase 116 kDa subunit a 1) (Clathrin-coated vesicle/synaptic vesicle proton pump 116 kDa subunit) (Vacuolar adenosine triphosphatase subunit Ac116) (Vacuolar proton pump subunit 1) (Vacuolar proton translocating ATPase 116 kDa subunit a isoform 1) Mus musculus (Mouse) GO:0000220; GO:0005737; GO:0005794; GO:0005829; GO:0005886; GO:0007035; GO:0016020; GO:0016241; GO:0016471; GO:0016607; GO:0030665; GO:0030672; GO:0042470; GO:0046961; GO:0048471; GO:0051117; GO:0097401 regulation of macroautophagy [GO:0016241]; synaptic vesicle lumen acidification [GO:0097401]; vacuolar acidification [GO:0007035] clathrin-coated vesicle membrane [GO:0030665]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; melanosome [GO:0042470]; membrane [GO:0016020]; nuclear speck [GO:0016607]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; synaptic vesicle membrane [GO:0030672]; vacuolar proton-transporting V-type ATPase complex [GO:0016471]; vacuolar proton-transporting V-type ATPase, V0 domain [GO:0000220] ATPase binding [GO:0051117]; proton-transporting ATPase activity, rotational mechanism [GO:0046961] g15261.t1 Q94887 33.508 952 1.17e-150 481.0 sp|Q94887|NRX4_DROME Neurexin-4 OS=Drosophila melanogaster OX=7227 GN=Nrx-IV PE=1 SV=2 NRX4_DROME reviewed Neurexin-4 (Neurexin IV) Drosophila melanogaster (Fruit fly) GO:0003015; GO:0005886; GO:0005919; GO:0007391; GO:0008039; GO:0008104; GO:0008366; GO:0019991; GO:0021682; GO:0035151; GO:0045202; GO:0045216; GO:0048786; GO:0060857; GO:0061343; GO:0072553; GO:0097105 axon ensheathment [GO:0008366]; cell adhesion involved in heart morphogenesis [GO:0061343]; cell-cell junction organization [GO:0045216]; dorsal closure [GO:0007391]; establishment of glial blood-brain barrier [GO:0060857]; heart process [GO:0003015]; intracellular protein localization [GO:0008104]; nerve maturation [GO:0021682]; presynaptic membrane assembly [GO:0097105]; regulation of tube size, open tracheal system [GO:0035151]; septate junction assembly [GO:0019991]; synaptic target recognition [GO:0008039]; terminal button organization [GO:0072553] plasma membrane [GO:0005886]; pleated septate junction [GO:0005919]; presynaptic active zone [GO:0048786]; synapse [GO:0045202] g15262.t1 Q5RD64 33.333 336 4.8e-45 168.0 sp|Q5RD64|CNTP2_PONAB Contactin-associated protein-like 2 OS=Pongo abelii OX=9601 GN=CNTNAP2 PE=2 SV=1 CNTP2_PONAB reviewed Contactin-associated protein-like 2 Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0007155; GO:0007417; GO:0016020; GO:0033010; GO:0044224; GO:0048812; GO:0071205 cell adhesion [GO:0007155]; central nervous system development [GO:0007417]; neuron projection morphogenesis [GO:0048812]; protein localization to juxtaparanode region of axon [GO:0071205] juxtaparanode region of axon [GO:0044224]; membrane [GO:0016020]; paranodal junction [GO:0033010] g15264.t1 P23508 51.792 865 0.0 606.0 sp|P23508|CRCM_HUMAN Colorectal mutant cancer protein OS=Homo sapiens OX=9606 GN=MCC PE=1 SV=2 CRCM_HUMAN reviewed Colorectal mutant cancer protein (Protein MCC) Homo sapiens (Human) GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0007165; GO:0010633; GO:0016055; GO:0030027; GO:0038023; GO:0045184; GO:0050680; GO:0090090 establishment of protein localization [GO:0045184]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of epithelial cell migration [GO:0010633]; negative regulation of epithelial cell proliferation [GO:0050680]; signal transduction [GO:0007165]; Wnt signaling pathway [GO:0016055] cytoplasm [GO:0005737]; cytosol [GO:0005829]; lamellipodium [GO:0030027]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886] signaling receptor activity [GO:0038023] g15264.t2 P23508 51.561 865 0.0 605.0 sp|P23508|CRCM_HUMAN Colorectal mutant cancer protein OS=Homo sapiens OX=9606 GN=MCC PE=1 SV=2 CRCM_HUMAN reviewed Colorectal mutant cancer protein (Protein MCC) Homo sapiens (Human) GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0007165; GO:0010633; GO:0016055; GO:0030027; GO:0038023; GO:0045184; GO:0050680; GO:0090090 establishment of protein localization [GO:0045184]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of epithelial cell migration [GO:0010633]; negative regulation of epithelial cell proliferation [GO:0050680]; signal transduction [GO:0007165]; Wnt signaling pathway [GO:0016055] cytoplasm [GO:0005737]; cytosol [GO:0005829]; lamellipodium [GO:0030027]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886] signaling receptor activity [GO:0038023] g15265.t1 Q6P859 47.761 201 8.05e-51 179.0 sp|Q6P859|GPTC4_XENTR G patch domain-containing protein 4 OS=Xenopus tropicalis OX=8364 GN=gpatch4 PE=2 SV=1 g15267.t1 Q7ZY18 66.87 821 0.0 1060.0 sp|Q7ZY18|MC6ZB_XENLA Zygotic DNA replication licensing factor mcm6-B OS=Xenopus laevis OX=8355 GN=zmcm6-b PE=1 SV=1 MC6ZB_XENLA reviewed Zygotic DNA replication licensing factor mcm6-B (EC 3.6.4.12) (Zygotic minichromosome maintenance protein 6-B) (zMCM6-B) (zMCM6b) Xenopus laevis (African clawed frog) GO:0000727; GO:0003697; GO:0005524; GO:0005634; GO:0006270; GO:0006279; GO:0008270; GO:0016887; GO:0030174; GO:0042555; GO:1902969; GO:1990518 DNA replication initiation [GO:0006270]; double-strand break repair via break-induced replication [GO:0000727]; mitotic DNA replication [GO:1902969]; premeiotic DNA replication [GO:0006279]; regulation of DNA-templated DNA replication initiation [GO:0030174] MCM complex [GO:0042555]; nucleus [GO:0005634] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; single-stranded 3'-5' DNA helicase activity [GO:1990518]; single-stranded DNA binding [GO:0003697]; zinc ion binding [GO:0008270] g15270.t1 Q8VHI3 60.354 396 2.9199999999999996e-172 493.0 sp|Q8VHI3|OFUT2_MOUSE GDP-fucose protein O-fucosyltransferase 2 OS=Mus musculus OX=10090 GN=Pofut2 PE=1 SV=1 OFUT2_MOUSE reviewed GDP-fucose protein O-fucosyltransferase 2 (EC 2.4.1.221) (Peptide-O-fucosyltransferase 2) (O-FucT-2) Mus musculus (Mouse) GO:0001707; GO:0005789; GO:0005794; GO:0006004; GO:0008417; GO:0010468; GO:0010717; GO:0036066; GO:0046922; GO:0051046; GO:1903334 fucose metabolic process [GO:0006004]; mesoderm formation [GO:0001707]; positive regulation of protein folding [GO:1903334]; protein O-linked glycosylation via fucose [GO:0036066]; regulation of epithelial to mesenchymal transition [GO:0010717]; regulation of gene expression [GO:0010468]; regulation of secretion [GO:0051046] endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794] fucosyltransferase activity [GO:0008417]; peptide-O-fucosyltransferase activity [GO:0046922] g15270.t2 Q8VHI3 60.101 396 1.17e-171 491.0 sp|Q8VHI3|OFUT2_MOUSE GDP-fucose protein O-fucosyltransferase 2 OS=Mus musculus OX=10090 GN=Pofut2 PE=1 SV=1 OFUT2_MOUSE reviewed GDP-fucose protein O-fucosyltransferase 2 (EC 2.4.1.221) (Peptide-O-fucosyltransferase 2) (O-FucT-2) Mus musculus (Mouse) GO:0001707; GO:0005789; GO:0005794; GO:0006004; GO:0008417; GO:0010468; GO:0010717; GO:0036066; GO:0046922; GO:0051046; GO:1903334 fucose metabolic process [GO:0006004]; mesoderm formation [GO:0001707]; positive regulation of protein folding [GO:1903334]; protein O-linked glycosylation via fucose [GO:0036066]; regulation of epithelial to mesenchymal transition [GO:0010717]; regulation of gene expression [GO:0010468]; regulation of secretion [GO:0051046] endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794] fucosyltransferase activity [GO:0008417]; peptide-O-fucosyltransferase activity [GO:0046922] g15270.t3 Q8VHI3 57.554 417 3.5700000000000005e-167 481.0 sp|Q8VHI3|OFUT2_MOUSE GDP-fucose protein O-fucosyltransferase 2 OS=Mus musculus OX=10090 GN=Pofut2 PE=1 SV=1 OFUT2_MOUSE reviewed GDP-fucose protein O-fucosyltransferase 2 (EC 2.4.1.221) (Peptide-O-fucosyltransferase 2) (O-FucT-2) Mus musculus (Mouse) GO:0001707; GO:0005789; GO:0005794; GO:0006004; GO:0008417; GO:0010468; GO:0010717; GO:0036066; GO:0046922; GO:0051046; GO:1903334 fucose metabolic process [GO:0006004]; mesoderm formation [GO:0001707]; positive regulation of protein folding [GO:1903334]; protein O-linked glycosylation via fucose [GO:0036066]; regulation of epithelial to mesenchymal transition [GO:0010717]; regulation of gene expression [GO:0010468]; regulation of secretion [GO:0051046] endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794] fucosyltransferase activity [GO:0008417]; peptide-O-fucosyltransferase activity [GO:0046922] g15272.t1 P42229 49.536 755 0.0 704.0 sp|P42229|STA5A_HUMAN Signal transducer and activator of transcription 5A OS=Homo sapiens OX=9606 GN=STAT5A PE=1 SV=1 STA5A_HUMAN reviewed Signal transducer and activator of transcription 5A Homo sapiens (Human) GO:0000278; GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0001553; GO:0001779; GO:0001938; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006357; GO:0006366; GO:0006952; GO:0007259; GO:0007565; GO:0007595; GO:0019218; GO:0019221; GO:0019530; GO:0019915; GO:0030183; GO:0030218; GO:0030222; GO:0030856; GO:0032743; GO:0032825; GO:0033024; GO:0033026; GO:0033077; GO:0035723; GO:0035771; GO:0038026; GO:0038043; GO:0038110; GO:0038111; GO:0038113; GO:0038156; GO:0038163; GO:0040014; GO:0040018; GO:0042104; GO:0042127; GO:0042267; GO:0042301; GO:0042492; GO:0043029; GO:0043434; GO:0043536; GO:0045579; GO:0045588; GO:0045647; GO:0045931; GO:0045944; GO:0045954; GO:0046543; GO:0046544; GO:0048541; GO:0050729; GO:0050798; GO:0060374; GO:0060376; GO:0060397; GO:0060740; GO:0060742; GO:0061180; GO:0070662; GO:0070668; GO:0090575; GO:0097011; GO:0140297; GO:1990841; GO:2000329 activated T cell proliferation [GO:0050798]; B cell differentiation [GO:0030183]; cell surface receptor signaling pathway via JAK-STAT [GO:0007259]; cellular response to granulocyte macrophage colony-stimulating factor stimulus [GO:0097011]; cytokine-mediated signaling pathway [GO:0019221]; defense response [GO:0006952]; development of secondary female sexual characteristics [GO:0046543]; development of secondary male sexual characteristics [GO:0046544]; eosinophil differentiation [GO:0030222]; epithelial cell differentiation involved in prostate gland development [GO:0060742]; erythrocyte differentiation [GO:0030218]; female pregnancy [GO:0007565]; gamma-delta T cell differentiation [GO:0042492]; growth hormone receptor signaling pathway via JAK-STAT [GO:0060397]; interleukin-15-mediated signaling pathway [GO:0035723]; interleukin-2-mediated signaling pathway [GO:0038110]; interleukin-3-mediated signaling pathway [GO:0038156]; interleukin-4-mediated signaling pathway [GO:0035771]; interleukin-5-mediated signaling pathway [GO:0038043]; interleukin-7-mediated signaling pathway [GO:0038111]; interleukin-9-mediated signaling pathway [GO:0038113]; lactation [GO:0007595]; lipid storage [GO:0019915]; luteinization [GO:0001553]; mammary gland epithelium development [GO:0061180]; mast cell apoptotic process [GO:0033024]; mast cell differentiation [GO:0060374]; mast cell proliferation [GO:0070662]; mitotic cell cycle [GO:0000278]; natural killer cell differentiation [GO:0001779]; natural killer cell mediated cytotoxicity [GO:0042267]; negative regulation of erythrocyte differentiation [GO:0045647]; negative regulation of mast cell apoptotic process [GO:0033026]; negative regulation of T-helper 17 cell lineage commitment [GO:2000329]; Peyer's patch development [GO:0048541]; positive regulation of activated T cell proliferation [GO:0042104]; positive regulation of B cell differentiation [GO:0045579]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of gamma-delta T cell differentiation [GO:0045588]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of mast cell differentiation [GO:0060376]; positive regulation of mast cell proliferation [GO:0070668]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of natural killer cell differentiation [GO:0032825]; positive regulation of natural killer cell mediated cytotoxicity [GO:0045954]; positive regulation of transcription by RNA polymerase II [GO:0045944]; prostate gland epithelium morphogenesis [GO:0060740]; reelin-mediated signaling pathway [GO:0038026]; regulation of cell population proliferation [GO:0042127]; regulation of epithelial cell differentiation [GO:0030856]; regulation of multicellular organism growth [GO:0040014]; regulation of steroid metabolic process [GO:0019218]; regulation of transcription by RNA polymerase II [GO:0006357]; response to peptide hormone [GO:0043434]; T cell differentiation in thymus [GO:0033077]; T cell homeostasis [GO:0043029]; taurine metabolic process [GO:0019530]; thrombopoietin-mediated signaling pathway [GO:0038163]; transcription by RNA polymerase II [GO:0006366] chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575] DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription factor binding [GO:0140297]; phosphate ion binding [GO:0042301]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978] g15272.t2 P42229 47.462 788 0.0 687.0 sp|P42229|STA5A_HUMAN Signal transducer and activator of transcription 5A OS=Homo sapiens OX=9606 GN=STAT5A PE=1 SV=1 STA5A_HUMAN reviewed Signal transducer and activator of transcription 5A Homo sapiens (Human) GO:0000278; GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0001553; GO:0001779; GO:0001938; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006357; GO:0006366; GO:0006952; GO:0007259; GO:0007565; GO:0007595; GO:0019218; GO:0019221; GO:0019530; GO:0019915; GO:0030183; GO:0030218; GO:0030222; GO:0030856; GO:0032743; GO:0032825; GO:0033024; GO:0033026; GO:0033077; GO:0035723; GO:0035771; GO:0038026; GO:0038043; GO:0038110; GO:0038111; GO:0038113; GO:0038156; GO:0038163; GO:0040014; GO:0040018; GO:0042104; GO:0042127; GO:0042267; GO:0042301; GO:0042492; GO:0043029; GO:0043434; GO:0043536; GO:0045579; GO:0045588; GO:0045647; GO:0045931; GO:0045944; GO:0045954; GO:0046543; GO:0046544; GO:0048541; GO:0050729; GO:0050798; GO:0060374; GO:0060376; GO:0060397; GO:0060740; GO:0060742; GO:0061180; GO:0070662; GO:0070668; GO:0090575; GO:0097011; GO:0140297; GO:1990841; GO:2000329 activated T cell proliferation [GO:0050798]; B cell differentiation [GO:0030183]; cell surface receptor signaling pathway via JAK-STAT [GO:0007259]; cellular response to granulocyte macrophage colony-stimulating factor stimulus [GO:0097011]; cytokine-mediated signaling pathway [GO:0019221]; defense response [GO:0006952]; development of secondary female sexual characteristics [GO:0046543]; development of secondary male sexual characteristics [GO:0046544]; eosinophil differentiation [GO:0030222]; epithelial cell differentiation involved in prostate gland development [GO:0060742]; erythrocyte differentiation [GO:0030218]; female pregnancy [GO:0007565]; gamma-delta T cell differentiation [GO:0042492]; growth hormone receptor signaling pathway via JAK-STAT [GO:0060397]; interleukin-15-mediated signaling pathway [GO:0035723]; interleukin-2-mediated signaling pathway [GO:0038110]; interleukin-3-mediated signaling pathway [GO:0038156]; interleukin-4-mediated signaling pathway [GO:0035771]; interleukin-5-mediated signaling pathway [GO:0038043]; interleukin-7-mediated signaling pathway [GO:0038111]; interleukin-9-mediated signaling pathway [GO:0038113]; lactation [GO:0007595]; lipid storage [GO:0019915]; luteinization [GO:0001553]; mammary gland epithelium development [GO:0061180]; mast cell apoptotic process [GO:0033024]; mast cell differentiation [GO:0060374]; mast cell proliferation [GO:0070662]; mitotic cell cycle [GO:0000278]; natural killer cell differentiation [GO:0001779]; natural killer cell mediated cytotoxicity [GO:0042267]; negative regulation of erythrocyte differentiation [GO:0045647]; negative regulation of mast cell apoptotic process [GO:0033026]; negative regulation of T-helper 17 cell lineage commitment [GO:2000329]; Peyer's patch development [GO:0048541]; positive regulation of activated T cell proliferation [GO:0042104]; positive regulation of B cell differentiation [GO:0045579]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of gamma-delta T cell differentiation [GO:0045588]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of mast cell differentiation [GO:0060376]; positive regulation of mast cell proliferation [GO:0070668]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of natural killer cell differentiation [GO:0032825]; positive regulation of natural killer cell mediated cytotoxicity [GO:0045954]; positive regulation of transcription by RNA polymerase II [GO:0045944]; prostate gland epithelium morphogenesis [GO:0060740]; reelin-mediated signaling pathway [GO:0038026]; regulation of cell population proliferation [GO:0042127]; regulation of epithelial cell differentiation [GO:0030856]; regulation of multicellular organism growth [GO:0040014]; regulation of steroid metabolic process [GO:0019218]; regulation of transcription by RNA polymerase II [GO:0006357]; response to peptide hormone [GO:0043434]; T cell differentiation in thymus [GO:0033077]; T cell homeostasis [GO:0043029]; taurine metabolic process [GO:0019530]; thrombopoietin-mediated signaling pathway [GO:0038163]; transcription by RNA polymerase II [GO:0006366] chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575] DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription factor binding [GO:0140297]; phosphate ion binding [GO:0042301]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978] g15272.t3 P42229 47.402 789 0.0 684.0 sp|P42229|STA5A_HUMAN Signal transducer and activator of transcription 5A OS=Homo sapiens OX=9606 GN=STAT5A PE=1 SV=1 STA5A_HUMAN reviewed Signal transducer and activator of transcription 5A Homo sapiens (Human) GO:0000278; GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0001553; GO:0001779; GO:0001938; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006357; GO:0006366; GO:0006952; GO:0007259; GO:0007565; GO:0007595; GO:0019218; GO:0019221; GO:0019530; GO:0019915; GO:0030183; GO:0030218; GO:0030222; GO:0030856; GO:0032743; GO:0032825; GO:0033024; GO:0033026; GO:0033077; GO:0035723; GO:0035771; GO:0038026; GO:0038043; GO:0038110; GO:0038111; GO:0038113; GO:0038156; GO:0038163; GO:0040014; GO:0040018; GO:0042104; GO:0042127; GO:0042267; GO:0042301; GO:0042492; GO:0043029; GO:0043434; GO:0043536; GO:0045579; GO:0045588; GO:0045647; GO:0045931; GO:0045944; GO:0045954; GO:0046543; GO:0046544; GO:0048541; GO:0050729; GO:0050798; GO:0060374; GO:0060376; GO:0060397; GO:0060740; GO:0060742; GO:0061180; GO:0070662; GO:0070668; GO:0090575; GO:0097011; GO:0140297; GO:1990841; GO:2000329 activated T cell proliferation [GO:0050798]; B cell differentiation [GO:0030183]; cell surface receptor signaling pathway via JAK-STAT [GO:0007259]; cellular response to granulocyte macrophage colony-stimulating factor stimulus [GO:0097011]; cytokine-mediated signaling pathway [GO:0019221]; defense response [GO:0006952]; development of secondary female sexual characteristics [GO:0046543]; development of secondary male sexual characteristics [GO:0046544]; eosinophil differentiation [GO:0030222]; epithelial cell differentiation involved in prostate gland development [GO:0060742]; erythrocyte differentiation [GO:0030218]; female pregnancy [GO:0007565]; gamma-delta T cell differentiation [GO:0042492]; growth hormone receptor signaling pathway via JAK-STAT [GO:0060397]; interleukin-15-mediated signaling pathway [GO:0035723]; interleukin-2-mediated signaling pathway [GO:0038110]; interleukin-3-mediated signaling pathway [GO:0038156]; interleukin-4-mediated signaling pathway [GO:0035771]; interleukin-5-mediated signaling pathway [GO:0038043]; interleukin-7-mediated signaling pathway [GO:0038111]; interleukin-9-mediated signaling pathway [GO:0038113]; lactation [GO:0007595]; lipid storage [GO:0019915]; luteinization [GO:0001553]; mammary gland epithelium development [GO:0061180]; mast cell apoptotic process [GO:0033024]; mast cell differentiation [GO:0060374]; mast cell proliferation [GO:0070662]; mitotic cell cycle [GO:0000278]; natural killer cell differentiation [GO:0001779]; natural killer cell mediated cytotoxicity [GO:0042267]; negative regulation of erythrocyte differentiation [GO:0045647]; negative regulation of mast cell apoptotic process [GO:0033026]; negative regulation of T-helper 17 cell lineage commitment [GO:2000329]; Peyer's patch development [GO:0048541]; positive regulation of activated T cell proliferation [GO:0042104]; positive regulation of B cell differentiation [GO:0045579]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of gamma-delta T cell differentiation [GO:0045588]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of mast cell differentiation [GO:0060376]; positive regulation of mast cell proliferation [GO:0070668]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of natural killer cell differentiation [GO:0032825]; positive regulation of natural killer cell mediated cytotoxicity [GO:0045954]; positive regulation of transcription by RNA polymerase II [GO:0045944]; prostate gland epithelium morphogenesis [GO:0060740]; reelin-mediated signaling pathway [GO:0038026]; regulation of cell population proliferation [GO:0042127]; regulation of epithelial cell differentiation [GO:0030856]; regulation of multicellular organism growth [GO:0040014]; regulation of steroid metabolic process [GO:0019218]; regulation of transcription by RNA polymerase II [GO:0006357]; response to peptide hormone [GO:0043434]; T cell differentiation in thymus [GO:0033077]; T cell homeostasis [GO:0043029]; taurine metabolic process [GO:0019530]; thrombopoietin-mediated signaling pathway [GO:0038163]; transcription by RNA polymerase II [GO:0006366] chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575] DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription factor binding [GO:0140297]; phosphate ion binding [GO:0042301]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978] g15275.t1 P50170 46.78 295 7.33e-83 256.0 sp|P50170|RDH16_RAT Retinol dehydrogenase 16 OS=Rattus norvegicus OX=10116 GN=Rdh16 PE=1 SV=1 RDH16_RAT reviewed Retinol dehydrogenase 16 (EC 1.1.1.105) (EC 1.1.1.209) (EC 1.1.1.315) (EC 1.1.1.53) (29 kDa protein) (Retinol dehydrogenase 2) (Retinol dehydrogenase type 1) (Retinol dehydrogenase type II) (RODH II) Rattus norvegicus (Rat) GO:0004745; GO:0005789; GO:0006702; GO:0008202; GO:0031090; GO:0042572; GO:0042573; GO:0042802; GO:0047023; GO:0047044; GO:0106429; GO:1900054; GO:1904638 androgen biosynthetic process [GO:0006702]; positive regulation of retinoic acid biosynthetic process [GO:1900054]; response to resveratrol [GO:1904638]; retinoic acid metabolic process [GO:0042573]; retinol metabolic process [GO:0042572]; steroid metabolic process [GO:0008202] endoplasmic reticulum membrane [GO:0005789]; organelle membrane [GO:0031090] 11-cis-retinol dehydrogenase (NAD+) activity [GO:0106429]; all-trans-retinol dehydrogenase (NAD+) activity [GO:0004745]; androstan-3-alpha,17-beta-diol dehydrogenase (NAD+) activity [GO:0047044]; androsterone dehydrogenase [NAD(P)+] activity [GO:0047023]; identical protein binding [GO:0042802] g15276.t1 Q14674 53.846 78 1.3900000000000001e-21 90.5 sp|Q14674|ESPL1_HUMAN Separin OS=Homo sapiens OX=9606 GN=ESPL1 PE=1 SV=3 g15277.t1 P60330 31.102 463 7.14e-49 188.0 sp|P60330|ESPL1_MOUSE Separin OS=Mus musculus OX=10090 GN=Espl1 PE=1 SV=1 ESPL1_MOUSE reviewed Separin (EC 3.4.22.49) (Caspase-like protein ESPL1) (Extra spindle poles-like 1 protein) (Separase) Mus musculus (Mouse) GO:0000070; GO:0000212; GO:0000278; GO:0004197; GO:0005634; GO:0005737; GO:0005813; GO:0006508; GO:0007059; GO:0007127; GO:0008233; GO:0008234; GO:0045143; GO:0051307; GO:0072686 chromosome segregation [GO:0007059]; homologous chromosome segregation [GO:0045143]; meiosis I [GO:0007127]; meiotic chromosome separation [GO:0051307]; meiotic spindle organization [GO:0000212]; mitotic cell cycle [GO:0000278]; mitotic sister chromatid segregation [GO:0000070]; proteolysis [GO:0006508] centrosome [GO:0005813]; cytoplasm [GO:0005737]; mitotic spindle [GO:0072686]; nucleus [GO:0005634] cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]; peptidase activity [GO:0008233] g15282.t1 O43822 41.129 248 8.400000000000001e-58 187.0 sp|O43822|CF410_HUMAN Cilia- and flagella-associated protein 410 OS=Homo sapiens OX=9606 GN=CFAP410 PE=1 SV=1 CF410_HUMAN reviewed Cilia- and flagella-associated protein 410 (C21orf-HUMF09G8.5) (Leucine-rich repeat-containing protein 76) (YF5/A2) Homo sapiens (Human) GO:0001750; GO:0005654; GO:0005737; GO:0005739; GO:0005794; GO:0005829; GO:0005886; GO:0006974; GO:0007010; GO:0007224; GO:0008360; GO:0032391; GO:0035869; GO:0036064; GO:0060271 cilium assembly [GO:0060271]; cytoskeleton organization [GO:0007010]; DNA damage response [GO:0006974]; regulation of cell shape [GO:0008360]; smoothened signaling pathway [GO:0007224] ciliary basal body [GO:0036064]; ciliary transition zone [GO:0035869]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; photoreceptor connecting cilium [GO:0032391]; photoreceptor outer segment [GO:0001750]; plasma membrane [GO:0005886] g15282.t2 O43822 42.339 248 2.73e-58 188.0 sp|O43822|CF410_HUMAN Cilia- and flagella-associated protein 410 OS=Homo sapiens OX=9606 GN=CFAP410 PE=1 SV=1 CF410_HUMAN reviewed Cilia- and flagella-associated protein 410 (C21orf-HUMF09G8.5) (Leucine-rich repeat-containing protein 76) (YF5/A2) Homo sapiens (Human) GO:0001750; GO:0005654; GO:0005737; GO:0005739; GO:0005794; GO:0005829; GO:0005886; GO:0006974; GO:0007010; GO:0007224; GO:0008360; GO:0032391; GO:0035869; GO:0036064; GO:0060271 cilium assembly [GO:0060271]; cytoskeleton organization [GO:0007010]; DNA damage response [GO:0006974]; regulation of cell shape [GO:0008360]; smoothened signaling pathway [GO:0007224] ciliary basal body [GO:0036064]; ciliary transition zone [GO:0035869]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; photoreceptor connecting cilium [GO:0032391]; photoreceptor outer segment [GO:0001750]; plasma membrane [GO:0005886] g15283.t1 P18910 43.235 983 0.0 795.0 sp|P18910|ANPRA_RAT Atrial natriuretic peptide receptor 1 OS=Rattus norvegicus OX=10116 GN=Npr1 PE=1 SV=1 ANPRA_RAT reviewed Atrial natriuretic peptide receptor 1 (EC 4.6.1.2) (Atrial natriuretic peptide receptor type A) (ANP-A) (ANPR-A) (NPR-A) (Guanylate cyclase A) (GC-A) Rattus norvegicus (Rat) GO:0001653; GO:0004383; GO:0004672; GO:0005524; GO:0005525; GO:0005886; GO:0006182; GO:0007166; GO:0007168; GO:0008217; GO:0010753; GO:0016941; GO:0017046; GO:0019934; GO:0035556; GO:0042417; GO:0042562; GO:0043114; GO:0043235; GO:0048662; GO:0097746; GO:1990620 blood vessel diameter maintenance [GO:0097746]; cell surface receptor signaling pathway [GO:0007166]; cGMP biosynthetic process [GO:0006182]; cGMP-mediated signaling [GO:0019934]; dopamine metabolic process [GO:0042417]; intracellular signal transduction [GO:0035556]; negative regulation of smooth muscle cell proliferation [GO:0048662]; positive regulation of cGMP-mediated signaling [GO:0010753]; receptor guanylyl cyclase signaling pathway [GO:0007168]; regulation of blood pressure [GO:0008217]; regulation of vascular permeability [GO:0043114] ANPR-A receptor complex [GO:1990620]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] ATP binding [GO:0005524]; GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; hormone binding [GO:0042562]; natriuretic peptide receptor activity [GO:0016941]; peptide hormone binding [GO:0017046]; peptide receptor activity [GO:0001653]; protein kinase activity [GO:0004672] g15284.t1 P26797 67.105 76 1.9500000000000002e-26 106.0 sp|P26797|HM19_CAEEL Homeobox protein ceh-19 OS=Caenorhabditis elegans OX=6239 GN=ceh-19 PE=2 SV=2 g15285.t1 Q5M7D4 43.421 152 3.88e-40 137.0 sp|Q5M7D4|CNPY1_XENLA Protein canopy homolog 1 OS=Xenopus laevis OX=8355 GN=cnpy1 PE=2 SV=1 g15286.t1 E7F211 37.097 310 6.149999999999999e-48 174.0 sp|E7F211|TTC17_DANRE Tetratricopeptide repeat protein 17 OS=Danio rerio OX=7955 GN=ttc17 PE=3 SV=1 TTC17_DANRE reviewed Tetratricopeptide repeat protein 17 (TPR repeat protein 17) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005737; GO:0005886; GO:0015629; GO:0030041; GO:0044782; GO:0061371 actin filament polymerization [GO:0030041]; cilium organization [GO:0044782]; determination of heart left/right asymmetry [GO:0061371] actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886] g15288.t1 A0A2P1BRQ0 24.171 422 4.9100000000000004e-26 118.0 sp|A0A2P1BRQ0|CTXA_SCOPL Cytolytic toxin-alpha OS=Scorpaena plumieri OX=274700 PE=1 SV=1 g15288.t2 A0A2P1BRQ0 25.749 334 1.49e-25 111.0 sp|A0A2P1BRQ0|CTXA_SCOPL Cytolytic toxin-alpha OS=Scorpaena plumieri OX=274700 PE=1 SV=1 g15291.t1 A0A2P1BRQ0 26.511 513 3.2400000000000003e-43 173.0 sp|A0A2P1BRQ0|CTXA_SCOPL Cytolytic toxin-alpha OS=Scorpaena plumieri OX=274700 PE=1 SV=1 g15291.t2 A0ZSK4 29.7 367 1.2500000000000001e-37 147.0 sp|A0ZSK4|STXB_SYNVE Neoverrucotoxin subunit beta OS=Synanceia verrucosa OX=51996 PE=1 SV=1 STXB_SYNVE reviewed Neoverrucotoxin subunit beta (NeoVTX subunit beta) Synanceia verrucosa (Reef stonefish) GO:0005576; GO:0031640; GO:0090729 killing of cells of another organism [GO:0031640] extracellular region [GO:0005576] toxin activity [GO:0090729] g15291.t3 A0A2P1BRQ0 26.511 513 2.83e-44 173.0 sp|A0A2P1BRQ0|CTXA_SCOPL Cytolytic toxin-alpha OS=Scorpaena plumieri OX=274700 PE=1 SV=1 g15297.t1 Q04652 34.65 557 1.0700000000000001e-80 286.0 sp|Q04652|KELC_DROME Ring canal kelch protein OS=Drosophila melanogaster OX=7227 GN=kel PE=1 SV=4 KELC_DROME reviewed Ring canal kelch protein [Cleaved into: Kelch short protein] Drosophila melanogaster (Fruit fly) GO:0003779; GO:0005737; GO:0005856; GO:0007297; GO:0007300; GO:0007301; GO:0007349; GO:0030036; GO:0030717; GO:0030723; GO:0031463; GO:0035183; GO:0035324; GO:0043161; GO:0045172; GO:0048477; GO:1990756 actin cytoskeleton organization [GO:0030036]; cellularization [GO:0007349]; female germline ring canal formation [GO:0007301]; follicle cell of egg chamber migration [GO:0007297]; oocyte karyosome formation [GO:0030717]; oogenesis [GO:0048477]; ovarian fusome organization [GO:0030723]; ovarian nurse cell to oocyte transport [GO:0007300]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161] Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; female germline ring canal [GO:0035324]; female germline ring canal inner rim [GO:0035183]; germline ring canal [GO:0045172] actin binding [GO:0003779]; ubiquitin-like ligase-substrate adaptor activity [GO:1990756] g15299.t1 B1AT66 28.0 275 7.430000000000001e-21 97.8 sp|B1AT66|MOT7_MOUSE Monocarboxylate transporter 7 OS=Mus musculus OX=10090 GN=Slc16a6 PE=1 SV=1 g15300.t1 B1AT66 27.473 273 7.41e-22 103.0 sp|B1AT66|MOT7_MOUSE Monocarboxylate transporter 7 OS=Mus musculus OX=10090 GN=Slc16a6 PE=1 SV=1 g15301.t1 P80146 53.731 268 2.18e-78 249.0 sp|P80146|SEPR_THESR Extracellular serine proteinase OS=Thermus sp. (strain Rt41A) OX=32063 PE=1 SV=3 g15302.t1 Q4N4N8 38.889 162 4.9100000000000004e-26 106.0 sp|Q4N4N8|TXND_THEPA Thioredoxin domain-containing protein OS=Theileria parva OX=5875 GN=TP02_0602 PE=1 SV=1 g15303.t1 Q9Y5Q5 28.061 784 2.24e-56 217.0 sp|Q9Y5Q5|CORIN_HUMAN Atrial natriuretic peptide-converting enzyme OS=Homo sapiens OX=9606 GN=CORIN PE=1 SV=2 CORIN_HUMAN reviewed Atrial natriuretic peptide-converting enzyme (EC 3.4.21.-) (Corin) (Heart-specific serine proteinase ATC2) (Pro-ANP-converting enzyme) (Transmembrane protease serine 10) [Cleaved into: Atrial natriuretic peptide-converting enzyme, N-terminal propeptide; Atrial natriuretic peptide-converting enzyme, activated protease fragment; Atrial natriuretic peptide-converting enzyme, 180 kDa soluble fragment; Atrial natriuretic peptide-converting enzyme, 160 kDa soluble fragment; Atrial natriuretic peptide-converting enzyme, 100 kDa soluble fragment] Homo sapiens (Human) GO:0003050; GO:0004175; GO:0004252; GO:0005576; GO:0005886; GO:0007565; GO:0008217; GO:0009986; GO:0015629; GO:0016486; GO:0016604; GO:0035813; GO:1903779 female pregnancy [GO:0007565]; peptide hormone processing [GO:0016486]; regulation of blood pressure [GO:0008217]; regulation of cardiac conduction [GO:1903779]; regulation of renal sodium excretion [GO:0035813]; regulation of systemic arterial blood pressure by atrial natriuretic peptide [GO:0003050] actin cytoskeleton [GO:0015629]; cell surface [GO:0009986]; extracellular region [GO:0005576]; nuclear body [GO:0016604]; plasma membrane [GO:0005886] endopeptidase activity [GO:0004175]; serine-type endopeptidase activity [GO:0004252] g15303.t2 Q9Y5Q5 28.061 784 2.26e-56 217.0 sp|Q9Y5Q5|CORIN_HUMAN Atrial natriuretic peptide-converting enzyme OS=Homo sapiens OX=9606 GN=CORIN PE=1 SV=2 CORIN_HUMAN reviewed Atrial natriuretic peptide-converting enzyme (EC 3.4.21.-) (Corin) (Heart-specific serine proteinase ATC2) (Pro-ANP-converting enzyme) (Transmembrane protease serine 10) [Cleaved into: Atrial natriuretic peptide-converting enzyme, N-terminal propeptide; Atrial natriuretic peptide-converting enzyme, activated protease fragment; Atrial natriuretic peptide-converting enzyme, 180 kDa soluble fragment; Atrial natriuretic peptide-converting enzyme, 160 kDa soluble fragment; Atrial natriuretic peptide-converting enzyme, 100 kDa soluble fragment] Homo sapiens (Human) GO:0003050; GO:0004175; GO:0004252; GO:0005576; GO:0005886; GO:0007565; GO:0008217; GO:0009986; GO:0015629; GO:0016486; GO:0016604; GO:0035813; GO:1903779 female pregnancy [GO:0007565]; peptide hormone processing [GO:0016486]; regulation of blood pressure [GO:0008217]; regulation of cardiac conduction [GO:1903779]; regulation of renal sodium excretion [GO:0035813]; regulation of systemic arterial blood pressure by atrial natriuretic peptide [GO:0003050] actin cytoskeleton [GO:0015629]; cell surface [GO:0009986]; extracellular region [GO:0005576]; nuclear body [GO:0016604]; plasma membrane [GO:0005886] endopeptidase activity [GO:0004175]; serine-type endopeptidase activity [GO:0004252] g15305.t1 Q9Y251 35.863 527 8.35e-86 276.0 sp|Q9Y251|HPSE_HUMAN Heparanase OS=Homo sapiens OX=9606 GN=HPSE PE=1 SV=2 g15307.t1 Q922B2 68.0 475 0.0 655.0 sp|Q922B2|SYDC_MOUSE Aspartate--tRNA ligase, cytoplasmic OS=Mus musculus OX=10090 GN=Dars1 PE=1 SV=2 g15312.t1 P18910 47.842 811 0.0 714.0 sp|P18910|ANPRA_RAT Atrial natriuretic peptide receptor 1 OS=Rattus norvegicus OX=10116 GN=Npr1 PE=1 SV=1 ANPRA_RAT reviewed Atrial natriuretic peptide receptor 1 (EC 4.6.1.2) (Atrial natriuretic peptide receptor type A) (ANP-A) (ANPR-A) (NPR-A) (Guanylate cyclase A) (GC-A) Rattus norvegicus (Rat) GO:0001653; GO:0004383; GO:0004672; GO:0005524; GO:0005525; GO:0005886; GO:0006182; GO:0007166; GO:0007168; GO:0008217; GO:0010753; GO:0016941; GO:0017046; GO:0019934; GO:0035556; GO:0042417; GO:0042562; GO:0043114; GO:0043235; GO:0048662; GO:0097746; GO:1990620 blood vessel diameter maintenance [GO:0097746]; cell surface receptor signaling pathway [GO:0007166]; cGMP biosynthetic process [GO:0006182]; cGMP-mediated signaling [GO:0019934]; dopamine metabolic process [GO:0042417]; intracellular signal transduction [GO:0035556]; negative regulation of smooth muscle cell proliferation [GO:0048662]; positive regulation of cGMP-mediated signaling [GO:0010753]; receptor guanylyl cyclase signaling pathway [GO:0007168]; regulation of blood pressure [GO:0008217]; regulation of vascular permeability [GO:0043114] ANPR-A receptor complex [GO:1990620]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] ATP binding [GO:0005524]; GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; hormone binding [GO:0042562]; natriuretic peptide receptor activity [GO:0016941]; peptide hormone binding [GO:0017046]; peptide receptor activity [GO:0001653]; protein kinase activity [GO:0004672] g15318.t1 P18910 46.098 820 0.0 700.0 sp|P18910|ANPRA_RAT Atrial natriuretic peptide receptor 1 OS=Rattus norvegicus OX=10116 GN=Npr1 PE=1 SV=1 ANPRA_RAT reviewed Atrial natriuretic peptide receptor 1 (EC 4.6.1.2) (Atrial natriuretic peptide receptor type A) (ANP-A) (ANPR-A) (NPR-A) (Guanylate cyclase A) (GC-A) Rattus norvegicus (Rat) GO:0001653; GO:0004383; GO:0004672; GO:0005524; GO:0005525; GO:0005886; GO:0006182; GO:0007166; GO:0007168; GO:0008217; GO:0010753; GO:0016941; GO:0017046; GO:0019934; GO:0035556; GO:0042417; GO:0042562; GO:0043114; GO:0043235; GO:0048662; GO:0097746; GO:1990620 blood vessel diameter maintenance [GO:0097746]; cell surface receptor signaling pathway [GO:0007166]; cGMP biosynthetic process [GO:0006182]; cGMP-mediated signaling [GO:0019934]; dopamine metabolic process [GO:0042417]; intracellular signal transduction [GO:0035556]; negative regulation of smooth muscle cell proliferation [GO:0048662]; positive regulation of cGMP-mediated signaling [GO:0010753]; receptor guanylyl cyclase signaling pathway [GO:0007168]; regulation of blood pressure [GO:0008217]; regulation of vascular permeability [GO:0043114] ANPR-A receptor complex [GO:1990620]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] ATP binding [GO:0005524]; GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; hormone binding [GO:0042562]; natriuretic peptide receptor activity [GO:0016941]; peptide hormone binding [GO:0017046]; peptide receptor activity [GO:0001653]; protein kinase activity [GO:0004672] g15319.t1 P16066 41.831 1016 0.0 752.0 sp|P16066|ANPRA_HUMAN Atrial natriuretic peptide receptor 1 OS=Homo sapiens OX=9606 GN=NPR1 PE=1 SV=1 ANPRA_HUMAN reviewed Atrial natriuretic peptide receptor 1 (EC 4.6.1.2) (Atrial natriuretic peptide receptor type A) (ANP-A) (ANPR-A) (NPR-A) (Guanylate cyclase A) (GC-A) Homo sapiens (Human) GO:0001653; GO:0004383; GO:0004672; GO:0005524; GO:0005525; GO:0005886; GO:0006182; GO:0007166; GO:0007168; GO:0007589; GO:0008217; GO:0008528; GO:0010753; GO:0016525; GO:0016941; GO:0017046; GO:0019934; GO:0030308; GO:0035810; GO:0035815; GO:0042417; GO:0042562; GO:0043114; GO:0043235; GO:0048662; GO:0097746; GO:1990620 blood vessel diameter maintenance [GO:0097746]; body fluid secretion [GO:0007589]; cell surface receptor signaling pathway [GO:0007166]; cGMP biosynthetic process [GO:0006182]; cGMP-mediated signaling [GO:0019934]; dopamine metabolic process [GO:0042417]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell growth [GO:0030308]; negative regulation of smooth muscle cell proliferation [GO:0048662]; positive regulation of cGMP-mediated signaling [GO:0010753]; positive regulation of renal sodium excretion [GO:0035815]; positive regulation of urine volume [GO:0035810]; receptor guanylyl cyclase signaling pathway [GO:0007168]; regulation of blood pressure [GO:0008217]; regulation of vascular permeability [GO:0043114] ANPR-A receptor complex [GO:1990620]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] ATP binding [GO:0005524]; G protein-coupled peptide receptor activity [GO:0008528]; GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; hormone binding [GO:0042562]; natriuretic peptide receptor activity [GO:0016941]; peptide hormone binding [GO:0017046]; peptide receptor activity [GO:0001653]; protein kinase activity [GO:0004672] g15320.t1 P18910 41.708 1019 0.0 743.0 sp|P18910|ANPRA_RAT Atrial natriuretic peptide receptor 1 OS=Rattus norvegicus OX=10116 GN=Npr1 PE=1 SV=1 ANPRA_RAT reviewed Atrial natriuretic peptide receptor 1 (EC 4.6.1.2) (Atrial natriuretic peptide receptor type A) (ANP-A) (ANPR-A) (NPR-A) (Guanylate cyclase A) (GC-A) Rattus norvegicus (Rat) GO:0001653; GO:0004383; GO:0004672; GO:0005524; GO:0005525; GO:0005886; GO:0006182; GO:0007166; GO:0007168; GO:0008217; GO:0010753; GO:0016941; GO:0017046; GO:0019934; GO:0035556; GO:0042417; GO:0042562; GO:0043114; GO:0043235; GO:0048662; GO:0097746; GO:1990620 blood vessel diameter maintenance [GO:0097746]; cell surface receptor signaling pathway [GO:0007166]; cGMP biosynthetic process [GO:0006182]; cGMP-mediated signaling [GO:0019934]; dopamine metabolic process [GO:0042417]; intracellular signal transduction [GO:0035556]; negative regulation of smooth muscle cell proliferation [GO:0048662]; positive regulation of cGMP-mediated signaling [GO:0010753]; receptor guanylyl cyclase signaling pathway [GO:0007168]; regulation of blood pressure [GO:0008217]; regulation of vascular permeability [GO:0043114] ANPR-A receptor complex [GO:1990620]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] ATP binding [GO:0005524]; GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; hormone binding [GO:0042562]; natriuretic peptide receptor activity [GO:0016941]; peptide hormone binding [GO:0017046]; peptide receptor activity [GO:0001653]; protein kinase activity [GO:0004672] g15322.t1 A1L1K4 51.724 87 2.84e-26 95.5 sp|A1L1K4|C42S2_RAT CDC42 small effector protein 2 OS=Rattus norvegicus OX=10116 GN=Cdc42se2 PE=3 SV=2 C42S2_RAT reviewed CDC42 small effector protein 2 Rattus norvegicus (Rat) GO:0001891; GO:0005856; GO:0005886; GO:0006909; GO:0008360; GO:0009966; GO:0031267; GO:0035023; GO:0035591 phagocytosis [GO:0006909]; regulation of cell shape [GO:0008360]; regulation of Rho protein signal transduction [GO:0035023]; regulation of signal transduction [GO:0009966] cytoskeleton [GO:0005856]; phagocytic cup [GO:0001891]; plasma membrane [GO:0005886] signaling adaptor activity [GO:0035591]; small GTPase binding [GO:0031267] g15323.t1 A2A6C4 40.7 457 5.900000000000001e-72 247.0 sp|A2A6C4|SPP2C_MOUSE Signal peptide peptidase-like 2C OS=Mus musculus OX=10090 GN=Sppl2c PE=1 SV=1 SPP2C_MOUSE reviewed Signal peptide peptidase-like 2C (SPP-like 2C) (SPPL2c) (EC 3.4.23.-) (Intramembrane protease 5) (IMP-5) Mus musculus (Mouse) GO:0001675; GO:0004190; GO:0005765; GO:0005789; GO:0006874; GO:0007283; GO:0007342; GO:0030660; GO:0031293; GO:0033619; GO:0042500; GO:0042803; GO:0050821; GO:0060090; GO:0098553; GO:0098554 acrosome assembly [GO:0001675]; fusion of sperm to egg plasma membrane involved in single fertilization [GO:0007342]; intracellular calcium ion homeostasis [GO:0006874]; membrane protein intracellular domain proteolysis [GO:0031293]; membrane protein proteolysis [GO:0033619]; protein stabilization [GO:0050821]; spermatogenesis [GO:0007283] cytoplasmic side of endoplasmic reticulum membrane [GO:0098554]; endoplasmic reticulum membrane [GO:0005789]; Golgi-associated vesicle membrane [GO:0030660]; lumenal side of endoplasmic reticulum membrane [GO:0098553]; lysosomal membrane [GO:0005765] aspartic endopeptidase activity, intramembrane cleaving [GO:0042500]; aspartic-type endopeptidase activity [GO:0004190]; molecular adaptor activity [GO:0060090]; protein homodimerization activity [GO:0042803] g15330.t1 Q9UBS5 33.645 214 4.670000000000001e-21 96.7 sp|Q9UBS5|GABR1_HUMAN Gamma-aminobutyric acid type B receptor subunit 1 OS=Homo sapiens OX=9606 GN=GABBR1 PE=1 SV=1 GABR1_HUMAN reviewed Gamma-aminobutyric acid type B receptor subunit 1 (GABA-B receptor 1) (GABA-B-R1) (GABA-BR1) (GABABR1) (Gb1) Homo sapiens (Human) GO:0001649; GO:0004965; GO:0005615; GO:0005789; GO:0005886; GO:0007193; GO:0007214; GO:0008021; GO:0008285; GO:0014049; GO:0014053; GO:0030673; GO:0031966; GO:0032811; GO:0033602; GO:0035094; GO:0038039; GO:0042734; GO:0043025; GO:0043197; GO:0043198; GO:0045211; GO:0045471; GO:0046982; GO:0050805; GO:0051932; GO:0060124; GO:0098685; GO:0098978; GO:0098982; GO:0099579; GO:0150047; GO:0150099; GO:1902712; GO:1990430 adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; gamma-aminobutyric acid signaling pathway [GO:0007214]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of dopamine secretion [GO:0033602]; negative regulation of epinephrine secretion [GO:0032811]; negative regulation of gamma-aminobutyric acid secretion [GO:0014053]; negative regulation of synaptic transmission [GO:0050805]; neuron-glial cell signaling [GO:0150099]; osteoblast differentiation [GO:0001649]; positive regulation of glutamate secretion [GO:0014049]; positive regulation of growth hormone secretion [GO:0060124]; response to ethanol [GO:0045471]; response to nicotine [GO:0035094]; synaptic transmission, GABAergic [GO:0051932] axolemma [GO:0030673]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; endoplasmic reticulum membrane [GO:0005789]; extracellular space [GO:0005615]; G protein-coupled GABA receptor complex [GO:1902712]; G protein-coupled receptor heterodimeric complex [GO:0038039]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; mitochondrial membrane [GO:0031966]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; Schaffer collateral - CA1 synapse [GO:0098685]; synaptic vesicle [GO:0008021] extracellular matrix protein binding [GO:1990430]; G protein-coupled GABA receptor activity [GO:0004965]; G protein-coupled neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential [GO:0099579]; G protein-coupled neurotransmitter receptor activity involved in regulation of presynaptic membrane potential [GO:0150047]; protein heterodimerization activity [GO:0046982] g15331.t1 Q9TU53 39.029 3564 0.0 2283.0 sp|Q9TU53|CUBN_CANLF Cubilin OS=Canis lupus familiaris OX=9615 GN=CUBN PE=1 SV=1 g15331.t1 Q9TU53 29.424 2916 0.0 1094.0 sp|Q9TU53|CUBN_CANLF Cubilin OS=Canis lupus familiaris OX=9615 GN=CUBN PE=1 SV=1 g15336.t1 Q8NEZ4 49.241 461 1.8700000000000001e-97 356.0 sp|Q8NEZ4|KMT2C_HUMAN Histone-lysine N-methyltransferase 2C OS=Homo sapiens OX=9606 GN=KMT2C PE=1 SV=3 KMT2C_HUMAN reviewed Histone-lysine N-methyltransferase 2C (Lysine N-methyltransferase 2C) (EC 2.1.1.364) (Homologous to ALR protein) (Myeloid/lymphoid or mixed-lineage leukemia protein 3) Homo sapiens (Human) GO:0003677; GO:0003713; GO:0003723; GO:0005634; GO:0005654; GO:0005829; GO:0008270; GO:0016746; GO:0032259; GO:0035097; GO:0042054; GO:0042800; GO:0044666; GO:0045944; GO:0140945 methylation [GO:0032259]; positive regulation of transcription by RNA polymerase II [GO:0045944] cytosol [GO:0005829]; histone methyltransferase complex [GO:0035097]; MLL3/4 complex [GO:0044666]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] acyltransferase activity [GO:0016746]; DNA binding [GO:0003677]; histone H3K4 methyltransferase activity [GO:0042800]; histone H3K4 monomethyltransferase activity [GO:0140945]; histone methyltransferase activity [GO:0042054]; RNA binding [GO:0003723]; transcription coactivator activity [GO:0003713]; zinc ion binding [GO:0008270] g15336.t1 Q8NEZ4 54.417 283 1.6199999999999998e-95 350.0 sp|Q8NEZ4|KMT2C_HUMAN Histone-lysine N-methyltransferase 2C OS=Homo sapiens OX=9606 GN=KMT2C PE=1 SV=3 KMT2C_HUMAN reviewed Histone-lysine N-methyltransferase 2C (Lysine N-methyltransferase 2C) (EC 2.1.1.364) (Homologous to ALR protein) (Myeloid/lymphoid or mixed-lineage leukemia protein 3) Homo sapiens (Human) GO:0003677; GO:0003713; GO:0003723; GO:0005634; GO:0005654; GO:0005829; GO:0008270; GO:0016746; GO:0032259; GO:0035097; GO:0042054; GO:0042800; GO:0044666; GO:0045944; GO:0140945 methylation [GO:0032259]; positive regulation of transcription by RNA polymerase II [GO:0045944] cytosol [GO:0005829]; histone methyltransferase complex [GO:0035097]; MLL3/4 complex [GO:0044666]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] acyltransferase activity [GO:0016746]; DNA binding [GO:0003677]; histone H3K4 methyltransferase activity [GO:0042800]; histone H3K4 monomethyltransferase activity [GO:0140945]; histone methyltransferase activity [GO:0042054]; RNA binding [GO:0003723]; transcription coactivator activity [GO:0003713]; zinc ion binding [GO:0008270] g15336.t1 Q8NEZ4 35.149 202 2.02e-28 130.0 sp|Q8NEZ4|KMT2C_HUMAN Histone-lysine N-methyltransferase 2C OS=Homo sapiens OX=9606 GN=KMT2C PE=1 SV=3 KMT2C_HUMAN reviewed Histone-lysine N-methyltransferase 2C (Lysine N-methyltransferase 2C) (EC 2.1.1.364) (Homologous to ALR protein) (Myeloid/lymphoid or mixed-lineage leukemia protein 3) Homo sapiens (Human) GO:0003677; GO:0003713; GO:0003723; GO:0005634; GO:0005654; GO:0005829; GO:0008270; GO:0016746; GO:0032259; GO:0035097; GO:0042054; GO:0042800; GO:0044666; GO:0045944; GO:0140945 methylation [GO:0032259]; positive regulation of transcription by RNA polymerase II [GO:0045944] cytosol [GO:0005829]; histone methyltransferase complex [GO:0035097]; MLL3/4 complex [GO:0044666]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] acyltransferase activity [GO:0016746]; DNA binding [GO:0003677]; histone H3K4 methyltransferase activity [GO:0042800]; histone H3K4 monomethyltransferase activity [GO:0140945]; histone methyltransferase activity [GO:0042054]; RNA binding [GO:0003723]; transcription coactivator activity [GO:0003713]; zinc ion binding [GO:0008270] g15336.t2 Q8NEZ4 49.241 461 1.47e-97 357.0 sp|Q8NEZ4|KMT2C_HUMAN Histone-lysine N-methyltransferase 2C OS=Homo sapiens OX=9606 GN=KMT2C PE=1 SV=3 KMT2C_HUMAN reviewed Histone-lysine N-methyltransferase 2C (Lysine N-methyltransferase 2C) (EC 2.1.1.364) (Homologous to ALR protein) (Myeloid/lymphoid or mixed-lineage leukemia protein 3) Homo sapiens (Human) GO:0003677; GO:0003713; GO:0003723; GO:0005634; GO:0005654; GO:0005829; GO:0008270; GO:0016746; GO:0032259; GO:0035097; GO:0042054; GO:0042800; GO:0044666; GO:0045944; GO:0140945 methylation [GO:0032259]; positive regulation of transcription by RNA polymerase II [GO:0045944] cytosol [GO:0005829]; histone methyltransferase complex [GO:0035097]; MLL3/4 complex [GO:0044666]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] acyltransferase activity [GO:0016746]; DNA binding [GO:0003677]; histone H3K4 methyltransferase activity [GO:0042800]; histone H3K4 monomethyltransferase activity [GO:0140945]; histone methyltransferase activity [GO:0042054]; RNA binding [GO:0003723]; transcription coactivator activity [GO:0003713]; zinc ion binding [GO:0008270] g15336.t2 Q8NEZ4 54.417 283 1.23e-95 350.0 sp|Q8NEZ4|KMT2C_HUMAN Histone-lysine N-methyltransferase 2C OS=Homo sapiens OX=9606 GN=KMT2C PE=1 SV=3 KMT2C_HUMAN reviewed Histone-lysine N-methyltransferase 2C (Lysine N-methyltransferase 2C) (EC 2.1.1.364) (Homologous to ALR protein) (Myeloid/lymphoid or mixed-lineage leukemia protein 3) Homo sapiens (Human) GO:0003677; GO:0003713; GO:0003723; GO:0005634; GO:0005654; GO:0005829; GO:0008270; GO:0016746; GO:0032259; GO:0035097; GO:0042054; GO:0042800; GO:0044666; GO:0045944; GO:0140945 methylation [GO:0032259]; positive regulation of transcription by RNA polymerase II [GO:0045944] cytosol [GO:0005829]; histone methyltransferase complex [GO:0035097]; MLL3/4 complex [GO:0044666]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] acyltransferase activity [GO:0016746]; DNA binding [GO:0003677]; histone H3K4 methyltransferase activity [GO:0042800]; histone H3K4 monomethyltransferase activity [GO:0140945]; histone methyltransferase activity [GO:0042054]; RNA binding [GO:0003723]; transcription coactivator activity [GO:0003713]; zinc ion binding [GO:0008270] g15336.t2 Q8NEZ4 35.149 202 1.64e-28 130.0 sp|Q8NEZ4|KMT2C_HUMAN Histone-lysine N-methyltransferase 2C OS=Homo sapiens OX=9606 GN=KMT2C PE=1 SV=3 KMT2C_HUMAN reviewed Histone-lysine N-methyltransferase 2C (Lysine N-methyltransferase 2C) (EC 2.1.1.364) (Homologous to ALR protein) (Myeloid/lymphoid or mixed-lineage leukemia protein 3) Homo sapiens (Human) GO:0003677; GO:0003713; GO:0003723; GO:0005634; GO:0005654; GO:0005829; GO:0008270; GO:0016746; GO:0032259; GO:0035097; GO:0042054; GO:0042800; GO:0044666; GO:0045944; GO:0140945 methylation [GO:0032259]; positive regulation of transcription by RNA polymerase II [GO:0045944] cytosol [GO:0005829]; histone methyltransferase complex [GO:0035097]; MLL3/4 complex [GO:0044666]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] acyltransferase activity [GO:0016746]; DNA binding [GO:0003677]; histone H3K4 methyltransferase activity [GO:0042800]; histone H3K4 monomethyltransferase activity [GO:0140945]; histone methyltransferase activity [GO:0042054]; RNA binding [GO:0003723]; transcription coactivator activity [GO:0003713]; zinc ion binding [GO:0008270] g15342.t1 Q8NEZ4 62.081 567 0.0 795.0 sp|Q8NEZ4|KMT2C_HUMAN Histone-lysine N-methyltransferase 2C OS=Homo sapiens OX=9606 GN=KMT2C PE=1 SV=3 KMT2C_HUMAN reviewed Histone-lysine N-methyltransferase 2C (Lysine N-methyltransferase 2C) (EC 2.1.1.364) (Homologous to ALR protein) (Myeloid/lymphoid or mixed-lineage leukemia protein 3) Homo sapiens (Human) GO:0003677; GO:0003713; GO:0003723; GO:0005634; GO:0005654; GO:0005829; GO:0008270; GO:0016746; GO:0032259; GO:0035097; GO:0042054; GO:0042800; GO:0044666; GO:0045944; GO:0140945 methylation [GO:0032259]; positive regulation of transcription by RNA polymerase II [GO:0045944] cytosol [GO:0005829]; histone methyltransferase complex [GO:0035097]; MLL3/4 complex [GO:0044666]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] acyltransferase activity [GO:0016746]; DNA binding [GO:0003677]; histone H3K4 methyltransferase activity [GO:0042800]; histone H3K4 monomethyltransferase activity [GO:0140945]; histone methyltransferase activity [GO:0042054]; RNA binding [GO:0003723]; transcription coactivator activity [GO:0003713]; zinc ion binding [GO:0008270] g15343.t1 Q8BG39 33.862 378 7.459999999999999e-55 200.0 sp|Q8BG39|SV2B_MOUSE Synaptic vesicle glycoprotein 2B OS=Mus musculus OX=10090 GN=Sv2b PE=1 SV=1 SV2B_MOUSE reviewed Synaptic vesicle glycoprotein 2B (Synaptic vesicle protein 2B) Mus musculus (Mouse) GO:0001669; GO:0006836; GO:0007268; GO:0008021; GO:0022857; GO:0030672; GO:0098978; GO:0099509; GO:2000300 chemical synaptic transmission [GO:0007268]; neurotransmitter transport [GO:0006836]; regulation of presynaptic cytosolic calcium ion concentration [GO:0099509]; regulation of synaptic vesicle exocytosis [GO:2000300] acrosomal vesicle [GO:0001669]; glutamatergic synapse [GO:0098978]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672] transmembrane transporter activity [GO:0022857] g15344.t1 Q99PL6 46.809 329 6.72e-96 298.0 sp|Q99PL6|UBXN6_MOUSE UBX domain-containing protein 6 OS=Mus musculus OX=10090 GN=Ubxn6 PE=1 SV=1 g15345.t1 Q9BZV1 31.773 299 4.15e-49 174.0 sp|Q9BZV1|UBXN6_HUMAN UBX domain-containing protein 6 OS=Homo sapiens OX=9606 GN=UBXN6 PE=1 SV=1 UBXN6_HUMAN reviewed UBX domain-containing protein 6 (UBX domain-containing protein 1) Homo sapiens (Human) GO:0005634; GO:0005737; GO:0005765; GO:0005768; GO:0005813; GO:0005829; GO:0016020; GO:0016236; GO:0031901; GO:0031902; GO:0032510; GO:0032991; GO:0036503; GO:0051117; GO:0070062 endosome to lysosome transport via multivesicular body sorting pathway [GO:0032510]; ERAD pathway [GO:0036503]; macroautophagy [GO:0016236] centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; nucleus [GO:0005634]; protein-containing complex [GO:0032991] ATPase binding [GO:0051117] g15347.t1 Q9QZN1 35.194 412 3.54e-71 245.0 sp|Q9QZN1|FXL17_MOUSE F-box/LRR-repeat protein 17 OS=Mus musculus OX=10090 GN=Fbxl17 PE=1 SV=3 g15353.t1 Q61555 34.1 783 4.98e-81 299.0 sp|Q61555|FBN2_MOUSE Fibrillin-2 OS=Mus musculus OX=10090 GN=Fbn2 PE=1 SV=2 FBN2_MOUSE reviewed Fibrillin-2 [Cleaved into: Placensin] Mus musculus (Mouse) GO:0001527; GO:0001890; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0005615; GO:0006006; GO:0030326; GO:0030501; GO:0031012; GO:0035108; GO:0035583; GO:0042593; GO:0043010; GO:0045669; GO:0048048; GO:0060346; GO:1901163 bone trabecula formation [GO:0060346]; camera-type eye development [GO:0043010]; embryonic eye morphogenesis [GO:0048048]; embryonic limb morphogenesis [GO:0030326]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; limb morphogenesis [GO:0035108]; placenta development [GO:0001890]; positive regulation of bone mineralization [GO:0030501]; positive regulation of osteoblast differentiation [GO:0045669]; regulation of trophoblast cell migration [GO:1901163]; sequestering of TGFbeta in extracellular matrix [GO:0035583] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; microfibril [GO:0001527] calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; hormone activity [GO:0005179] g15353.t1 Q61555 33.555 751 1.3500000000000001e-75 281.0 sp|Q61555|FBN2_MOUSE Fibrillin-2 OS=Mus musculus OX=10090 GN=Fbn2 PE=1 SV=2 FBN2_MOUSE reviewed Fibrillin-2 [Cleaved into: Placensin] Mus musculus (Mouse) GO:0001527; GO:0001890; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0005615; GO:0006006; GO:0030326; GO:0030501; GO:0031012; GO:0035108; GO:0035583; GO:0042593; GO:0043010; GO:0045669; GO:0048048; GO:0060346; GO:1901163 bone trabecula formation [GO:0060346]; camera-type eye development [GO:0043010]; embryonic eye morphogenesis [GO:0048048]; embryonic limb morphogenesis [GO:0030326]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; limb morphogenesis [GO:0035108]; placenta development [GO:0001890]; positive regulation of bone mineralization [GO:0030501]; positive regulation of osteoblast differentiation [GO:0045669]; regulation of trophoblast cell migration [GO:1901163]; sequestering of TGFbeta in extracellular matrix [GO:0035583] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; microfibril [GO:0001527] calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; hormone activity [GO:0005179] g15353.t1 Q61555 34.642 713 2.16e-75 281.0 sp|Q61555|FBN2_MOUSE Fibrillin-2 OS=Mus musculus OX=10090 GN=Fbn2 PE=1 SV=2 FBN2_MOUSE reviewed Fibrillin-2 [Cleaved into: Placensin] Mus musculus (Mouse) GO:0001527; GO:0001890; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0005615; GO:0006006; GO:0030326; GO:0030501; GO:0031012; GO:0035108; GO:0035583; GO:0042593; GO:0043010; GO:0045669; GO:0048048; GO:0060346; GO:1901163 bone trabecula formation [GO:0060346]; camera-type eye development [GO:0043010]; embryonic eye morphogenesis [GO:0048048]; embryonic limb morphogenesis [GO:0030326]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; limb morphogenesis [GO:0035108]; placenta development [GO:0001890]; positive regulation of bone mineralization [GO:0030501]; positive regulation of osteoblast differentiation [GO:0045669]; regulation of trophoblast cell migration [GO:1901163]; sequestering of TGFbeta in extracellular matrix [GO:0035583] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; microfibril [GO:0001527] calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; hormone activity [GO:0005179] g15353.t1 Q61555 31.744 797 7.910000000000001e-75 279.0 sp|Q61555|FBN2_MOUSE Fibrillin-2 OS=Mus musculus OX=10090 GN=Fbn2 PE=1 SV=2 FBN2_MOUSE reviewed Fibrillin-2 [Cleaved into: Placensin] Mus musculus (Mouse) GO:0001527; GO:0001890; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0005615; GO:0006006; GO:0030326; GO:0030501; GO:0031012; GO:0035108; GO:0035583; GO:0042593; GO:0043010; GO:0045669; GO:0048048; GO:0060346; GO:1901163 bone trabecula formation [GO:0060346]; camera-type eye development [GO:0043010]; embryonic eye morphogenesis [GO:0048048]; embryonic limb morphogenesis [GO:0030326]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; limb morphogenesis [GO:0035108]; placenta development [GO:0001890]; positive regulation of bone mineralization [GO:0030501]; positive regulation of osteoblast differentiation [GO:0045669]; regulation of trophoblast cell migration [GO:1901163]; sequestering of TGFbeta in extracellular matrix [GO:0035583] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; microfibril [GO:0001527] calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; hormone activity [GO:0005179] g15353.t1 Q61555 30.952 756 5.47e-72 270.0 sp|Q61555|FBN2_MOUSE Fibrillin-2 OS=Mus musculus OX=10090 GN=Fbn2 PE=1 SV=2 FBN2_MOUSE reviewed Fibrillin-2 [Cleaved into: Placensin] Mus musculus (Mouse) GO:0001527; GO:0001890; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0005615; GO:0006006; GO:0030326; GO:0030501; GO:0031012; GO:0035108; GO:0035583; GO:0042593; GO:0043010; GO:0045669; GO:0048048; GO:0060346; GO:1901163 bone trabecula formation [GO:0060346]; camera-type eye development [GO:0043010]; embryonic eye morphogenesis [GO:0048048]; embryonic limb morphogenesis [GO:0030326]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; limb morphogenesis [GO:0035108]; placenta development [GO:0001890]; positive regulation of bone mineralization [GO:0030501]; positive regulation of osteoblast differentiation [GO:0045669]; regulation of trophoblast cell migration [GO:1901163]; sequestering of TGFbeta in extracellular matrix [GO:0035583] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; microfibril [GO:0001527] calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; hormone activity [GO:0005179] g15353.t1 Q61555 32.853 764 1.84e-71 268.0 sp|Q61555|FBN2_MOUSE Fibrillin-2 OS=Mus musculus OX=10090 GN=Fbn2 PE=1 SV=2 FBN2_MOUSE reviewed Fibrillin-2 [Cleaved into: Placensin] Mus musculus (Mouse) GO:0001527; GO:0001890; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0005615; GO:0006006; GO:0030326; GO:0030501; GO:0031012; GO:0035108; GO:0035583; GO:0042593; GO:0043010; GO:0045669; GO:0048048; GO:0060346; GO:1901163 bone trabecula formation [GO:0060346]; camera-type eye development [GO:0043010]; embryonic eye morphogenesis [GO:0048048]; embryonic limb morphogenesis [GO:0030326]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; limb morphogenesis [GO:0035108]; placenta development [GO:0001890]; positive regulation of bone mineralization [GO:0030501]; positive regulation of osteoblast differentiation [GO:0045669]; regulation of trophoblast cell migration [GO:1901163]; sequestering of TGFbeta in extracellular matrix [GO:0035583] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; microfibril [GO:0001527] calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; hormone activity [GO:0005179] g15353.t1 Q61555 31.202 782 1.5100000000000002e-70 265.0 sp|Q61555|FBN2_MOUSE Fibrillin-2 OS=Mus musculus OX=10090 GN=Fbn2 PE=1 SV=2 FBN2_MOUSE reviewed Fibrillin-2 [Cleaved into: Placensin] Mus musculus (Mouse) GO:0001527; GO:0001890; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0005615; GO:0006006; GO:0030326; GO:0030501; GO:0031012; GO:0035108; GO:0035583; GO:0042593; GO:0043010; GO:0045669; GO:0048048; GO:0060346; GO:1901163 bone trabecula formation [GO:0060346]; camera-type eye development [GO:0043010]; embryonic eye morphogenesis [GO:0048048]; embryonic limb morphogenesis [GO:0030326]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; limb morphogenesis [GO:0035108]; placenta development [GO:0001890]; positive regulation of bone mineralization [GO:0030501]; positive regulation of osteoblast differentiation [GO:0045669]; regulation of trophoblast cell migration [GO:1901163]; sequestering of TGFbeta in extracellular matrix [GO:0035583] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; microfibril [GO:0001527] calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; hormone activity [GO:0005179] g15353.t1 Q61555 31.122 784 1.3099999999999999e-68 259.0 sp|Q61555|FBN2_MOUSE Fibrillin-2 OS=Mus musculus OX=10090 GN=Fbn2 PE=1 SV=2 FBN2_MOUSE reviewed Fibrillin-2 [Cleaved into: Placensin] Mus musculus (Mouse) GO:0001527; GO:0001890; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0005615; GO:0006006; GO:0030326; GO:0030501; GO:0031012; GO:0035108; GO:0035583; GO:0042593; GO:0043010; GO:0045669; GO:0048048; GO:0060346; GO:1901163 bone trabecula formation [GO:0060346]; camera-type eye development [GO:0043010]; embryonic eye morphogenesis [GO:0048048]; embryonic limb morphogenesis [GO:0030326]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; limb morphogenesis [GO:0035108]; placenta development [GO:0001890]; positive regulation of bone mineralization [GO:0030501]; positive regulation of osteoblast differentiation [GO:0045669]; regulation of trophoblast cell migration [GO:1901163]; sequestering of TGFbeta in extracellular matrix [GO:0035583] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; microfibril [GO:0001527] calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; hormone activity [GO:0005179] g15353.t1 Q61555 32.109 735 1.92e-62 239.0 sp|Q61555|FBN2_MOUSE Fibrillin-2 OS=Mus musculus OX=10090 GN=Fbn2 PE=1 SV=2 FBN2_MOUSE reviewed Fibrillin-2 [Cleaved into: Placensin] Mus musculus (Mouse) GO:0001527; GO:0001890; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0005615; GO:0006006; GO:0030326; GO:0030501; GO:0031012; GO:0035108; GO:0035583; GO:0042593; GO:0043010; GO:0045669; GO:0048048; GO:0060346; GO:1901163 bone trabecula formation [GO:0060346]; camera-type eye development [GO:0043010]; embryonic eye morphogenesis [GO:0048048]; embryonic limb morphogenesis [GO:0030326]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; limb morphogenesis [GO:0035108]; placenta development [GO:0001890]; positive regulation of bone mineralization [GO:0030501]; positive regulation of osteoblast differentiation [GO:0045669]; regulation of trophoblast cell migration [GO:1901163]; sequestering of TGFbeta in extracellular matrix [GO:0035583] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; microfibril [GO:0001527] calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; hormone activity [GO:0005179] g15353.t1 Q61555 31.606 791 1.1199999999999999e-60 234.0 sp|Q61555|FBN2_MOUSE Fibrillin-2 OS=Mus musculus OX=10090 GN=Fbn2 PE=1 SV=2 FBN2_MOUSE reviewed Fibrillin-2 [Cleaved into: Placensin] Mus musculus (Mouse) GO:0001527; GO:0001890; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0005615; GO:0006006; GO:0030326; GO:0030501; GO:0031012; GO:0035108; GO:0035583; GO:0042593; GO:0043010; GO:0045669; GO:0048048; GO:0060346; GO:1901163 bone trabecula formation [GO:0060346]; camera-type eye development [GO:0043010]; embryonic eye morphogenesis [GO:0048048]; embryonic limb morphogenesis [GO:0030326]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; limb morphogenesis [GO:0035108]; placenta development [GO:0001890]; positive regulation of bone mineralization [GO:0030501]; positive regulation of osteoblast differentiation [GO:0045669]; regulation of trophoblast cell migration [GO:1901163]; sequestering of TGFbeta in extracellular matrix [GO:0035583] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; microfibril [GO:0001527] calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; hormone activity [GO:0005179] g15353.t1 Q61555 30.81 753 1.3e-56 221.0 sp|Q61555|FBN2_MOUSE Fibrillin-2 OS=Mus musculus OX=10090 GN=Fbn2 PE=1 SV=2 FBN2_MOUSE reviewed Fibrillin-2 [Cleaved into: Placensin] Mus musculus (Mouse) GO:0001527; GO:0001890; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0005615; GO:0006006; GO:0030326; GO:0030501; GO:0031012; GO:0035108; GO:0035583; GO:0042593; GO:0043010; GO:0045669; GO:0048048; GO:0060346; GO:1901163 bone trabecula formation [GO:0060346]; camera-type eye development [GO:0043010]; embryonic eye morphogenesis [GO:0048048]; embryonic limb morphogenesis [GO:0030326]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; limb morphogenesis [GO:0035108]; placenta development [GO:0001890]; positive regulation of bone mineralization [GO:0030501]; positive regulation of osteoblast differentiation [GO:0045669]; regulation of trophoblast cell migration [GO:1901163]; sequestering of TGFbeta in extracellular matrix [GO:0035583] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; microfibril [GO:0001527] calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; hormone activity [GO:0005179] g15353.t2 Q61555 34.1 783 3.18e-81 299.0 sp|Q61555|FBN2_MOUSE Fibrillin-2 OS=Mus musculus OX=10090 GN=Fbn2 PE=1 SV=2 FBN2_MOUSE reviewed Fibrillin-2 [Cleaved into: Placensin] Mus musculus (Mouse) GO:0001527; GO:0001890; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0005615; GO:0006006; GO:0030326; GO:0030501; GO:0031012; GO:0035108; GO:0035583; GO:0042593; GO:0043010; GO:0045669; GO:0048048; GO:0060346; GO:1901163 bone trabecula formation [GO:0060346]; camera-type eye development [GO:0043010]; embryonic eye morphogenesis [GO:0048048]; embryonic limb morphogenesis [GO:0030326]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; limb morphogenesis [GO:0035108]; placenta development [GO:0001890]; positive regulation of bone mineralization [GO:0030501]; positive regulation of osteoblast differentiation [GO:0045669]; regulation of trophoblast cell migration [GO:1901163]; sequestering of TGFbeta in extracellular matrix [GO:0035583] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; microfibril [GO:0001527] calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; hormone activity [GO:0005179] g15353.t2 Q61555 33.555 751 9.58e-76 282.0 sp|Q61555|FBN2_MOUSE Fibrillin-2 OS=Mus musculus OX=10090 GN=Fbn2 PE=1 SV=2 FBN2_MOUSE reviewed Fibrillin-2 [Cleaved into: Placensin] Mus musculus (Mouse) GO:0001527; GO:0001890; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0005615; GO:0006006; GO:0030326; GO:0030501; GO:0031012; GO:0035108; GO:0035583; GO:0042593; GO:0043010; GO:0045669; GO:0048048; GO:0060346; GO:1901163 bone trabecula formation [GO:0060346]; camera-type eye development [GO:0043010]; embryonic eye morphogenesis [GO:0048048]; embryonic limb morphogenesis [GO:0030326]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; limb morphogenesis [GO:0035108]; placenta development [GO:0001890]; positive regulation of bone mineralization [GO:0030501]; positive regulation of osteoblast differentiation [GO:0045669]; regulation of trophoblast cell migration [GO:1901163]; sequestering of TGFbeta in extracellular matrix [GO:0035583] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; microfibril [GO:0001527] calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; hormone activity [GO:0005179] g15353.t2 Q61555 34.642 713 1.56e-75 281.0 sp|Q61555|FBN2_MOUSE Fibrillin-2 OS=Mus musculus OX=10090 GN=Fbn2 PE=1 SV=2 FBN2_MOUSE reviewed Fibrillin-2 [Cleaved into: Placensin] Mus musculus (Mouse) GO:0001527; GO:0001890; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0005615; GO:0006006; GO:0030326; GO:0030501; GO:0031012; GO:0035108; GO:0035583; GO:0042593; GO:0043010; GO:0045669; GO:0048048; GO:0060346; GO:1901163 bone trabecula formation [GO:0060346]; camera-type eye development [GO:0043010]; embryonic eye morphogenesis [GO:0048048]; embryonic limb morphogenesis [GO:0030326]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; limb morphogenesis [GO:0035108]; placenta development [GO:0001890]; positive regulation of bone mineralization [GO:0030501]; positive regulation of osteoblast differentiation [GO:0045669]; regulation of trophoblast cell migration [GO:1901163]; sequestering of TGFbeta in extracellular matrix [GO:0035583] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; microfibril [GO:0001527] calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; hormone activity [GO:0005179] g15353.t2 Q61555 31.744 797 5.37e-75 280.0 sp|Q61555|FBN2_MOUSE Fibrillin-2 OS=Mus musculus OX=10090 GN=Fbn2 PE=1 SV=2 FBN2_MOUSE reviewed Fibrillin-2 [Cleaved into: Placensin] Mus musculus (Mouse) GO:0001527; GO:0001890; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0005615; GO:0006006; GO:0030326; GO:0030501; GO:0031012; GO:0035108; GO:0035583; GO:0042593; GO:0043010; GO:0045669; GO:0048048; GO:0060346; GO:1901163 bone trabecula formation [GO:0060346]; camera-type eye development [GO:0043010]; embryonic eye morphogenesis [GO:0048048]; embryonic limb morphogenesis [GO:0030326]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; limb morphogenesis [GO:0035108]; placenta development [GO:0001890]; positive regulation of bone mineralization [GO:0030501]; positive regulation of osteoblast differentiation [GO:0045669]; regulation of trophoblast cell migration [GO:1901163]; sequestering of TGFbeta in extracellular matrix [GO:0035583] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; microfibril [GO:0001527] calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; hormone activity [GO:0005179] g15353.t2 Q61555 30.952 756 3.76e-72 271.0 sp|Q61555|FBN2_MOUSE Fibrillin-2 OS=Mus musculus OX=10090 GN=Fbn2 PE=1 SV=2 FBN2_MOUSE reviewed Fibrillin-2 [Cleaved into: Placensin] Mus musculus (Mouse) GO:0001527; GO:0001890; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0005615; GO:0006006; GO:0030326; GO:0030501; GO:0031012; GO:0035108; GO:0035583; GO:0042593; GO:0043010; GO:0045669; GO:0048048; GO:0060346; GO:1901163 bone trabecula formation [GO:0060346]; camera-type eye development [GO:0043010]; embryonic eye morphogenesis [GO:0048048]; embryonic limb morphogenesis [GO:0030326]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; limb morphogenesis [GO:0035108]; placenta development [GO:0001890]; positive regulation of bone mineralization [GO:0030501]; positive regulation of osteoblast differentiation [GO:0045669]; regulation of trophoblast cell migration [GO:1901163]; sequestering of TGFbeta in extracellular matrix [GO:0035583] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; microfibril [GO:0001527] calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; hormone activity [GO:0005179] g15353.t2 Q61555 32.853 764 1.34e-71 269.0 sp|Q61555|FBN2_MOUSE Fibrillin-2 OS=Mus musculus OX=10090 GN=Fbn2 PE=1 SV=2 FBN2_MOUSE reviewed Fibrillin-2 [Cleaved into: Placensin] Mus musculus (Mouse) GO:0001527; GO:0001890; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0005615; GO:0006006; GO:0030326; GO:0030501; GO:0031012; GO:0035108; GO:0035583; GO:0042593; GO:0043010; GO:0045669; GO:0048048; GO:0060346; GO:1901163 bone trabecula formation [GO:0060346]; camera-type eye development [GO:0043010]; embryonic eye morphogenesis [GO:0048048]; embryonic limb morphogenesis [GO:0030326]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; limb morphogenesis [GO:0035108]; placenta development [GO:0001890]; positive regulation of bone mineralization [GO:0030501]; positive regulation of osteoblast differentiation [GO:0045669]; regulation of trophoblast cell migration [GO:1901163]; sequestering of TGFbeta in extracellular matrix [GO:0035583] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; microfibril [GO:0001527] calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; hormone activity [GO:0005179] g15353.t2 Q61555 31.202 782 9.01e-71 266.0 sp|Q61555|FBN2_MOUSE Fibrillin-2 OS=Mus musculus OX=10090 GN=Fbn2 PE=1 SV=2 FBN2_MOUSE reviewed Fibrillin-2 [Cleaved into: Placensin] Mus musculus (Mouse) GO:0001527; GO:0001890; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0005615; GO:0006006; GO:0030326; GO:0030501; GO:0031012; GO:0035108; GO:0035583; GO:0042593; GO:0043010; GO:0045669; GO:0048048; GO:0060346; GO:1901163 bone trabecula formation [GO:0060346]; camera-type eye development [GO:0043010]; embryonic eye morphogenesis [GO:0048048]; embryonic limb morphogenesis [GO:0030326]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; limb morphogenesis [GO:0035108]; placenta development [GO:0001890]; positive regulation of bone mineralization [GO:0030501]; positive regulation of osteoblast differentiation [GO:0045669]; regulation of trophoblast cell migration [GO:1901163]; sequestering of TGFbeta in extracellular matrix [GO:0035583] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; microfibril [GO:0001527] calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; hormone activity [GO:0005179] g15353.t2 Q61555 31.122 784 7.6e-69 260.0 sp|Q61555|FBN2_MOUSE Fibrillin-2 OS=Mus musculus OX=10090 GN=Fbn2 PE=1 SV=2 FBN2_MOUSE reviewed Fibrillin-2 [Cleaved into: Placensin] Mus musculus (Mouse) GO:0001527; GO:0001890; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0005615; GO:0006006; GO:0030326; GO:0030501; GO:0031012; GO:0035108; GO:0035583; GO:0042593; GO:0043010; GO:0045669; GO:0048048; GO:0060346; GO:1901163 bone trabecula formation [GO:0060346]; camera-type eye development [GO:0043010]; embryonic eye morphogenesis [GO:0048048]; embryonic limb morphogenesis [GO:0030326]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; limb morphogenesis [GO:0035108]; placenta development [GO:0001890]; positive regulation of bone mineralization [GO:0030501]; positive regulation of osteoblast differentiation [GO:0045669]; regulation of trophoblast cell migration [GO:1901163]; sequestering of TGFbeta in extracellular matrix [GO:0035583] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; microfibril [GO:0001527] calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; hormone activity [GO:0005179] g15353.t2 Q61555 32.109 735 1.1399999999999999e-62 240.0 sp|Q61555|FBN2_MOUSE Fibrillin-2 OS=Mus musculus OX=10090 GN=Fbn2 PE=1 SV=2 FBN2_MOUSE reviewed Fibrillin-2 [Cleaved into: Placensin] Mus musculus (Mouse) GO:0001527; GO:0001890; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0005615; GO:0006006; GO:0030326; GO:0030501; GO:0031012; GO:0035108; GO:0035583; GO:0042593; GO:0043010; GO:0045669; GO:0048048; GO:0060346; GO:1901163 bone trabecula formation [GO:0060346]; camera-type eye development [GO:0043010]; embryonic eye morphogenesis [GO:0048048]; embryonic limb morphogenesis [GO:0030326]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; limb morphogenesis [GO:0035108]; placenta development [GO:0001890]; positive regulation of bone mineralization [GO:0030501]; positive regulation of osteoblast differentiation [GO:0045669]; regulation of trophoblast cell migration [GO:1901163]; sequestering of TGFbeta in extracellular matrix [GO:0035583] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; microfibril [GO:0001527] calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; hormone activity [GO:0005179] g15353.t2 Q61555 31.606 791 9.51e-61 234.0 sp|Q61555|FBN2_MOUSE Fibrillin-2 OS=Mus musculus OX=10090 GN=Fbn2 PE=1 SV=2 FBN2_MOUSE reviewed Fibrillin-2 [Cleaved into: Placensin] Mus musculus (Mouse) GO:0001527; GO:0001890; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0005615; GO:0006006; GO:0030326; GO:0030501; GO:0031012; GO:0035108; GO:0035583; GO:0042593; GO:0043010; GO:0045669; GO:0048048; GO:0060346; GO:1901163 bone trabecula formation [GO:0060346]; camera-type eye development [GO:0043010]; embryonic eye morphogenesis [GO:0048048]; embryonic limb morphogenesis [GO:0030326]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; limb morphogenesis [GO:0035108]; placenta development [GO:0001890]; positive regulation of bone mineralization [GO:0030501]; positive regulation of osteoblast differentiation [GO:0045669]; regulation of trophoblast cell migration [GO:1901163]; sequestering of TGFbeta in extracellular matrix [GO:0035583] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; microfibril [GO:0001527] calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; hormone activity [GO:0005179] g15353.t2 Q61555 30.943 753 1.3e-56 221.0 sp|Q61555|FBN2_MOUSE Fibrillin-2 OS=Mus musculus OX=10090 GN=Fbn2 PE=1 SV=2 FBN2_MOUSE reviewed Fibrillin-2 [Cleaved into: Placensin] Mus musculus (Mouse) GO:0001527; GO:0001890; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0005615; GO:0006006; GO:0030326; GO:0030501; GO:0031012; GO:0035108; GO:0035583; GO:0042593; GO:0043010; GO:0045669; GO:0048048; GO:0060346; GO:1901163 bone trabecula formation [GO:0060346]; camera-type eye development [GO:0043010]; embryonic eye morphogenesis [GO:0048048]; embryonic limb morphogenesis [GO:0030326]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; limb morphogenesis [GO:0035108]; placenta development [GO:0001890]; positive regulation of bone mineralization [GO:0030501]; positive regulation of osteoblast differentiation [GO:0045669]; regulation of trophoblast cell migration [GO:1901163]; sequestering of TGFbeta in extracellular matrix [GO:0035583] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; microfibril [GO:0001527] calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; hormone activity [GO:0005179] g15354.t1 P35604 64.407 177 1.2e-71 216.0 sp|P35604|COPZ1_BOVIN Coatomer subunit zeta-1 OS=Bos taurus OX=9913 GN=COPZ1 PE=1 SV=2 g15356.t1 Q5ZL67 29.717 636 1.37e-53 199.0 sp|Q5ZL67|NF2L1_CHICK Endoplasmic reticulum membrane sensor NFE2L1 OS=Gallus gallus OX=9031 GN=NFE2L1 PE=2 SV=1 NF2L1_CHICK reviewed Endoplasmic reticulum membrane sensor NFE2L1 (Nuclear factor erythroid 2-related factor 1) (NF-E2-related factor 1) (NFE2-related factor 1) (Nuclear factor, erythroid derived 2, like 1) [Cleaved into: Transcription factor NRF1] Gallus gallus (Chicken) GO:0000978; GO:0000981; GO:0005634; GO:0005789; GO:0006357; GO:0008203; GO:0008289 cholesterol metabolic process [GO:0008203]; regulation of transcription by RNA polymerase II [GO:0006357] endoplasmic reticulum membrane [GO:0005789]; nucleus [GO:0005634] DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; lipid binding [GO:0008289]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978] g15356.t2 Q5ZL67 28.607 804 6.780000000000001e-64 230.0 sp|Q5ZL67|NF2L1_CHICK Endoplasmic reticulum membrane sensor NFE2L1 OS=Gallus gallus OX=9031 GN=NFE2L1 PE=2 SV=1 NF2L1_CHICK reviewed Endoplasmic reticulum membrane sensor NFE2L1 (Nuclear factor erythroid 2-related factor 1) (NF-E2-related factor 1) (NFE2-related factor 1) (Nuclear factor, erythroid derived 2, like 1) [Cleaved into: Transcription factor NRF1] Gallus gallus (Chicken) GO:0000978; GO:0000981; GO:0005634; GO:0005789; GO:0006357; GO:0008203; GO:0008289 cholesterol metabolic process [GO:0008203]; regulation of transcription by RNA polymerase II [GO:0006357] endoplasmic reticulum membrane [GO:0005789]; nucleus [GO:0005634] DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; lipid binding [GO:0008289]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978] g15357.t1 Q6ZQE4 31.72 372 5.93e-51 179.0 sp|Q6ZQE4|NEMP1_MOUSE Nuclear envelope integral membrane protein 1 OS=Mus musculus OX=10090 GN=Nemp1 PE=1 SV=2 NEMP1_MOUSE reviewed Nuclear envelope integral membrane protein 1 Mus musculus (Mouse) GO:0005635; GO:0005637; GO:0043131; GO:0043249; GO:0071763 erythrocyte enucleation [GO:0043131]; erythrocyte maturation [GO:0043249]; nuclear membrane organization [GO:0071763] nuclear envelope [GO:0005635]; nuclear inner membrane [GO:0005637] g15358.t1 Q4KMD7 32.005 753 2.56e-98 328.0 sp|Q4KMD7|STPAP_DANRE Speckle targeted PIP5K1A-regulated poly(A) polymerase OS=Danio rerio OX=7955 GN=tut1 PE=2 SV=1 STPAP_DANRE reviewed Speckle targeted PIP5K1A-regulated poly(A) polymerase (Star-PAP) (EC 2.7.7.19) (RNA-binding motif protein 21) (RNA-binding protein 21) (U6 snRNA-specific terminal uridylyltransferase 1) (U6-TUTase) (EC 2.7.7.52) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0003723; GO:0003730; GO:0005524; GO:0005730; GO:0005847; GO:0008270; GO:0016180; GO:0016607; GO:0031123; GO:0050265; GO:0140767; GO:0180010; GO:1990817 co-transcriptional mRNA 3'-end processing, cleavage and polyadenylation pathway [GO:0180010]; RNA 3'-end processing [GO:0031123]; snRNA processing [GO:0016180] mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; nuclear speck [GO:0016607]; nucleolus [GO:0005730] ATP binding [GO:0005524]; enzyme-substrate adaptor activity [GO:0140767]; mRNA 3'-UTR binding [GO:0003730]; poly(A) RNA polymerase activity [GO:1990817]; RNA binding [GO:0003723]; RNA uridylyltransferase activity [GO:0050265]; zinc ion binding [GO:0008270] g15362.t1 O43242 65.868 501 0.0 587.0 sp|O43242|PSMD3_HUMAN 26S proteasome non-ATPase regulatory subunit 3 OS=Homo sapiens OX=9606 GN=PSMD3 PE=1 SV=2 PSMD3_HUMAN reviewed 26S proteasome non-ATPase regulatory subunit 3 (26S proteasome regulatory subunit RPN3) (26S proteasome regulatory subunit S3) (Proteasome subunit p58) Homo sapiens (Human) GO:0000502; GO:0005576; GO:0005634; GO:0005654; GO:0005829; GO:0006511; GO:0008541; GO:0016020; GO:0022624; GO:0030234; GO:0034774; GO:0042176; GO:0043161; GO:0070062; GO:1904813 proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of protein catabolic process [GO:0042176]; ubiquitin-dependent protein catabolic process [GO:0006511] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; proteasome regulatory particle, lid subcomplex [GO:0008541]; secretory granule lumen [GO:0034774] enzyme regulator activity [GO:0030234] g15363.t1 Q14847 46.067 267 2.52e-54 179.0 sp|Q14847|LASP1_HUMAN LIM and SH3 domain protein 1 OS=Homo sapiens OX=9606 GN=LASP1 PE=1 SV=2 LASP1_HUMAN reviewed LIM and SH3 domain protein 1 (LASP-1) (Metastatic lymph node gene 50 protein) (MLN 50) Homo sapiens (Human) GO:0005737; GO:0005925; GO:0006811; GO:0015075; GO:0030864; GO:0045296; GO:0046872; GO:0051015; GO:0098794 monoatomic ion transport [GO:0006811] cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; postsynapse [GO:0098794] actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; metal ion binding [GO:0046872]; monoatomic ion transmembrane transporter activity [GO:0015075] g15363.t2 Q14847 56.557 122 2.76e-41 144.0 sp|Q14847|LASP1_HUMAN LIM and SH3 domain protein 1 OS=Homo sapiens OX=9606 GN=LASP1 PE=1 SV=2 LASP1_HUMAN reviewed LIM and SH3 domain protein 1 (LASP-1) (Metastatic lymph node gene 50 protein) (MLN 50) Homo sapiens (Human) GO:0005737; GO:0005925; GO:0006811; GO:0015075; GO:0030864; GO:0045296; GO:0046872; GO:0051015; GO:0098794 monoatomic ion transport [GO:0006811] cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; postsynapse [GO:0098794] actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; metal ion binding [GO:0046872]; monoatomic ion transmembrane transporter activity [GO:0015075] g15364.t1 Q6P135 40.816 147 4.1000000000000003e-32 125.0 sp|Q6P135|TMUB1_DANRE Transmembrane and ubiquitin-like domain-containing protein 1 OS=Danio rerio OX=7955 GN=tmub1 PE=2 SV=1 g15365.t1 Q1HQK8 76.522 115 9.08e-52 162.0 sp|Q1HQK8|VATF_AEDAE V-type proton ATPase subunit F OS=Aedes aegypti OX=7159 GN=AAEL002464 PE=2 SV=1 g15366.t1 Q9WV74 35.235 298 1.1399999999999998e-42 152.0 sp|Q9WV74|ASB1_MOUSE Ankyrin repeat and SOCS box protein 1 OS=Mus musculus OX=10090 GN=Asb1 PE=2 SV=1 g15368.t1 Q9UKJ3 64.8 125 1.37e-31 139.0 sp|Q9UKJ3|GPTC8_HUMAN G patch domain-containing protein 8 OS=Homo sapiens OX=9606 GN=GPATCH8 PE=1 SV=2 g15373.t1 Q96DP5 41.477 352 3.14e-88 275.0 sp|Q96DP5|FMT_HUMAN Methionyl-tRNA formyltransferase, mitochondrial OS=Homo sapiens OX=9606 GN=MTFMT PE=1 SV=2 FMT_HUMAN reviewed Methionyl-tRNA formyltransferase, mitochondrial (MtFMT) (EC 2.1.2.9) Homo sapiens (Human) GO:0004479; GO:0005739; GO:0071951 conversion of methionyl-tRNA to N-formyl-methionyl-tRNA [GO:0071951] mitochondrion [GO:0005739] methionyl-tRNA formyltransferase activity [GO:0004479] g15374.t1 Q9Y490 59.725 1162 0.0 1215.0 sp|Q9Y490|TLN1_HUMAN Talin-1 OS=Homo sapiens OX=9606 GN=TLN1 PE=1 SV=3 TLN1_HUMAN reviewed Talin-1 Homo sapiens (Human) GO:0001726; GO:0001786; GO:0005178; GO:0005200; GO:0005576; GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0005912; GO:0005925; GO:0007043; GO:0007044; GO:0007229; GO:0009986; GO:0017166; GO:0030036; GO:0030274; GO:0030866; GO:0032587; GO:0033622; GO:0035091; GO:0043622; GO:0045296; GO:0051015; GO:0051893; GO:0070062; GO:0070527; GO:0098609 actin cytoskeleton organization [GO:0030036]; cell-cell adhesion [GO:0098609]; cell-cell junction assembly [GO:0007043]; cell-substrate junction assembly [GO:0007044]; cortical actin cytoskeleton organization [GO:0030866]; cortical microtubule organization [GO:0043622]; integrin activation [GO:0033622]; integrin-mediated signaling pathway [GO:0007229]; platelet aggregation [GO:0070527]; regulation of focal adhesion assembly [GO:0051893] adherens junction [GO:0005912]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; ruffle membrane [GO:0032587] actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; integrin binding [GO:0005178]; LIM domain binding [GO:0030274]; phosphatidylinositol binding [GO:0035091]; phosphatidylserine binding [GO:0001786]; structural constituent of cytoskeleton [GO:0005200]; vinculin binding [GO:0017166] g15374.t2 Q9Y490 59.862 1161 0.0 1217.0 sp|Q9Y490|TLN1_HUMAN Talin-1 OS=Homo sapiens OX=9606 GN=TLN1 PE=1 SV=3 TLN1_HUMAN reviewed Talin-1 Homo sapiens (Human) GO:0001726; GO:0001786; GO:0005178; GO:0005200; GO:0005576; GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0005912; GO:0005925; GO:0007043; GO:0007044; GO:0007229; GO:0009986; GO:0017166; GO:0030036; GO:0030274; GO:0030866; GO:0032587; GO:0033622; GO:0035091; GO:0043622; GO:0045296; GO:0051015; GO:0051893; GO:0070062; GO:0070527; GO:0098609 actin cytoskeleton organization [GO:0030036]; cell-cell adhesion [GO:0098609]; cell-cell junction assembly [GO:0007043]; cell-substrate junction assembly [GO:0007044]; cortical actin cytoskeleton organization [GO:0030866]; cortical microtubule organization [GO:0043622]; integrin activation [GO:0033622]; integrin-mediated signaling pathway [GO:0007229]; platelet aggregation [GO:0070527]; regulation of focal adhesion assembly [GO:0051893] adherens junction [GO:0005912]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; ruffle membrane [GO:0032587] actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; integrin binding [GO:0005178]; LIM domain binding [GO:0030274]; phosphatidylinositol binding [GO:0035091]; phosphatidylserine binding [GO:0001786]; structural constituent of cytoskeleton [GO:0005200]; vinculin binding [GO:0017166] g15374.t3 Q9Y490 60.087 1155 0.0 1222.0 sp|Q9Y490|TLN1_HUMAN Talin-1 OS=Homo sapiens OX=9606 GN=TLN1 PE=1 SV=3 TLN1_HUMAN reviewed Talin-1 Homo sapiens (Human) GO:0001726; GO:0001786; GO:0005178; GO:0005200; GO:0005576; GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0005912; GO:0005925; GO:0007043; GO:0007044; GO:0007229; GO:0009986; GO:0017166; GO:0030036; GO:0030274; GO:0030866; GO:0032587; GO:0033622; GO:0035091; GO:0043622; GO:0045296; GO:0051015; GO:0051893; GO:0070062; GO:0070527; GO:0098609 actin cytoskeleton organization [GO:0030036]; cell-cell adhesion [GO:0098609]; cell-cell junction assembly [GO:0007043]; cell-substrate junction assembly [GO:0007044]; cortical actin cytoskeleton organization [GO:0030866]; cortical microtubule organization [GO:0043622]; integrin activation [GO:0033622]; integrin-mediated signaling pathway [GO:0007229]; platelet aggregation [GO:0070527]; regulation of focal adhesion assembly [GO:0051893] adherens junction [GO:0005912]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; ruffle membrane [GO:0032587] actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; integrin binding [GO:0005178]; LIM domain binding [GO:0030274]; phosphatidylinositol binding [GO:0035091]; phosphatidylserine binding [GO:0001786]; structural constituent of cytoskeleton [GO:0005200]; vinculin binding [GO:0017166] g15375.t1 Q9Y490 53.552 366 1.6e-121 390.0 sp|Q9Y490|TLN1_HUMAN Talin-1 OS=Homo sapiens OX=9606 GN=TLN1 PE=1 SV=3 TLN1_HUMAN reviewed Talin-1 Homo sapiens (Human) GO:0001726; GO:0001786; GO:0005178; GO:0005200; GO:0005576; GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0005912; GO:0005925; GO:0007043; GO:0007044; GO:0007229; GO:0009986; GO:0017166; GO:0030036; GO:0030274; GO:0030866; GO:0032587; GO:0033622; GO:0035091; GO:0043622; GO:0045296; GO:0051015; GO:0051893; GO:0070062; GO:0070527; GO:0098609 actin cytoskeleton organization [GO:0030036]; cell-cell adhesion [GO:0098609]; cell-cell junction assembly [GO:0007043]; cell-substrate junction assembly [GO:0007044]; cortical actin cytoskeleton organization [GO:0030866]; cortical microtubule organization [GO:0043622]; integrin activation [GO:0033622]; integrin-mediated signaling pathway [GO:0007229]; platelet aggregation [GO:0070527]; regulation of focal adhesion assembly [GO:0051893] adherens junction [GO:0005912]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; ruffle membrane [GO:0032587] actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; integrin binding [GO:0005178]; LIM domain binding [GO:0030274]; phosphatidylinositol binding [GO:0035091]; phosphatidylserine binding [GO:0001786]; structural constituent of cytoskeleton [GO:0005200]; vinculin binding [GO:0017166] g15375.t2 Q9Y490 47.573 412 9.78e-114 370.0 sp|Q9Y490|TLN1_HUMAN Talin-1 OS=Homo sapiens OX=9606 GN=TLN1 PE=1 SV=3 TLN1_HUMAN reviewed Talin-1 Homo sapiens (Human) GO:0001726; GO:0001786; GO:0005178; GO:0005200; GO:0005576; GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0005912; GO:0005925; GO:0007043; GO:0007044; GO:0007229; GO:0009986; GO:0017166; GO:0030036; GO:0030274; GO:0030866; GO:0032587; GO:0033622; GO:0035091; GO:0043622; GO:0045296; GO:0051015; GO:0051893; GO:0070062; GO:0070527; GO:0098609 actin cytoskeleton organization [GO:0030036]; cell-cell adhesion [GO:0098609]; cell-cell junction assembly [GO:0007043]; cell-substrate junction assembly [GO:0007044]; cortical actin cytoskeleton organization [GO:0030866]; cortical microtubule organization [GO:0043622]; integrin activation [GO:0033622]; integrin-mediated signaling pathway [GO:0007229]; platelet aggregation [GO:0070527]; regulation of focal adhesion assembly [GO:0051893] adherens junction [GO:0005912]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; ruffle membrane [GO:0032587] actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; integrin binding [GO:0005178]; LIM domain binding [GO:0030274]; phosphatidylinositol binding [GO:0035091]; phosphatidylserine binding [GO:0001786]; structural constituent of cytoskeleton [GO:0005200]; vinculin binding [GO:0017166] g15376.t1 P54939 64.048 331 1.46e-96 317.0 sp|P54939|TLN1_CHICK Talin-1 OS=Gallus gallus OX=9031 GN=TLN1 PE=1 SV=2 g15377.t1 P26039 60.601 599 0.0 773.0 sp|P26039|TLN1_MOUSE Talin-1 OS=Mus musculus OX=10090 GN=Tln1 PE=1 SV=2 TLN1_MOUSE reviewed Talin-1 Mus musculus (Mouse) GO:0001726; GO:0001786; GO:0005178; GO:0005200; GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0005912; GO:0005925; GO:0007044; GO:0007229; GO:0009986; GO:0017166; GO:0030036; GO:0030274; GO:0030866; GO:0032587; GO:0033622; GO:0035091; GO:0043622; GO:0051015; GO:0098609 actin cytoskeleton organization [GO:0030036]; cell-cell adhesion [GO:0098609]; cell-substrate junction assembly [GO:0007044]; cortical actin cytoskeleton organization [GO:0030866]; cortical microtubule organization [GO:0043622]; integrin activation [GO:0033622]; integrin-mediated signaling pathway [GO:0007229] adherens junction [GO:0005912]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; ruffle membrane [GO:0032587] actin filament binding [GO:0051015]; integrin binding [GO:0005178]; LIM domain binding [GO:0030274]; phosphatidylinositol binding [GO:0035091]; phosphatidylserine binding [GO:0001786]; structural constituent of cytoskeleton [GO:0005200]; vinculin binding [GO:0017166] g15378.t1 Q5T2R2 66.8 250 1.13e-120 353.0 sp|Q5T2R2|DPS1_HUMAN All trans-polyprenyl-diphosphate synthase PDSS1 OS=Homo sapiens OX=9606 GN=PDSS1 PE=1 SV=1 DPS1_HUMAN reviewed All trans-polyprenyl-diphosphate synthase PDSS1 (All-trans-decaprenyl-diphosphate synthase subunit 1) (EC 2.5.1.91) (Decaprenyl pyrophosphate synthase subunit 1) (Decaprenyl-diphosphate synthase subunit 1) (Solanesyl-diphosphate synthase subunit 1) (Trans-prenyltransferase 1) (TPT 1) Homo sapiens (Human) GO:0004659; GO:0005739; GO:0005759; GO:0006744; GO:0008299; GO:0032476; GO:0032478; GO:0046872; GO:0046982; GO:0052923; GO:0097269; GO:0110142 isoprenoid biosynthetic process [GO:0008299]; ubiquinone biosynthetic process [GO:0006744] heterotetrameric polyprenyl diphosphate synthase complex [GO:0032478]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; polyprenyl diphosphate synthase complex [GO:0032476]; ubiquinone biosynthesis complex [GO:0110142] all-trans-decaprenyl-diphosphate synthase activity [GO:0097269]; all-trans-nonaprenyl-diphosphate synthase (geranyl-diphosphate specific) activity [GO:0052923]; metal ion binding [GO:0046872]; prenyltransferase activity [GO:0004659]; protein heterodimerization activity [GO:0046982] g15380.t1 Q15032 43.23 421 1.17e-61 234.0 sp|Q15032|R3HD1_HUMAN R3H domain-containing protein 1 OS=Homo sapiens OX=9606 GN=R3HDM1 PE=1 SV=3 g15381.t1 O60921 50.357 280 4.0399999999999997e-106 312.0 sp|O60921|HUS1_HUMAN Checkpoint protein HUS1 OS=Homo sapiens OX=9606 GN=HUS1 PE=1 SV=1 HUS1_HUMAN reviewed Checkpoint protein HUS1 (hHUS1) Homo sapiens (Human) GO:0000077; GO:0000723; GO:0000724; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0006281; GO:0006289; GO:0006974; GO:0009411; GO:0009792; GO:0030896; GO:0031573; GO:0033314; GO:0035861; GO:0044778; GO:0071479 cellular response to ionizing radiation [GO:0071479]; DNA damage checkpoint signaling [GO:0000077]; DNA damage response [GO:0006974]; DNA repair [GO:0006281]; double-strand break repair via homologous recombination [GO:0000724]; embryo development ending in birth or egg hatching [GO:0009792]; meiotic DNA integrity checkpoint signaling [GO:0044778]; mitotic DNA replication checkpoint signaling [GO:0033314]; mitotic intra-S DNA damage checkpoint signaling [GO:0031573]; nucleotide-excision repair [GO:0006289]; response to UV [GO:0009411]; telomere maintenance [GO:0000723] checkpoint clamp complex [GO:0030896]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of double-strand break [GO:0035861] g15382.t1 O95045 54.639 291 1.01e-109 324.0 sp|O95045|UPP2_HUMAN Uridine phosphorylase 2 OS=Homo sapiens OX=9606 GN=UPP2 PE=1 SV=1 UPP2_HUMAN reviewed Uridine phosphorylase 2 (UPase 2) (UrdPase 2) (EC 2.4.2.3) Homo sapiens (Human) GO:0004850; GO:0005829; GO:0006218; GO:0006248; GO:0006249; GO:0009032; GO:0009116; GO:0016154; GO:0042178; GO:0042802; GO:0044206; GO:0045098; GO:0046050; GO:0046074; GO:0046079; GO:0046108; GO:0047847 CMP catabolic process [GO:0006248]; dCMP catabolic process [GO:0006249]; dTMP catabolic process [GO:0046074]; dUMP catabolic process [GO:0046079]; nucleoside metabolic process [GO:0009116]; UMP catabolic process [GO:0046050]; UMP salvage [GO:0044206]; uridine catabolic process [GO:0006218]; uridine metabolic process [GO:0046108]; xenobiotic catabolic process [GO:0042178] cytosol [GO:0005829]; type III intermediate filament [GO:0045098] deoxyuridine phosphorylase activity [GO:0047847]; identical protein binding [GO:0042802]; pyrimidine-nucleoside phosphorylase activity [GO:0016154]; thymidine phosphorylase activity [GO:0009032]; uridine phosphorylase activity [GO:0004850] g15384.t1 Q60519 38.506 1031 0.0 691.0 sp|Q60519|SEM5B_MOUSE Semaphorin-5B OS=Mus musculus OX=10090 GN=Sema5b PE=2 SV=2 SEM5B_MOUSE reviewed Semaphorin-5B (Semaphorin-G) (Sema G) Mus musculus (Mouse) GO:0001755; GO:0005886; GO:0007411; GO:0030215; GO:0030335; GO:0045499; GO:0048675; GO:0050908; GO:0071526; GO:0097485; GO:1990138 axon extension [GO:0048675]; axon guidance [GO:0007411]; detection of light stimulus involved in visual perception [GO:0050908]; neural crest cell migration [GO:0001755]; neuron projection extension [GO:1990138]; neuron projection guidance [GO:0097485]; positive regulation of cell migration [GO:0030335]; semaphorin-plexin signaling pathway [GO:0071526] plasma membrane [GO:0005886] chemorepellent activity [GO:0045499]; semaphorin receptor binding [GO:0030215] g15384.t2 Q60519 38.781 1034 0.0 695.0 sp|Q60519|SEM5B_MOUSE Semaphorin-5B OS=Mus musculus OX=10090 GN=Sema5b PE=2 SV=2 SEM5B_MOUSE reviewed Semaphorin-5B (Semaphorin-G) (Sema G) Mus musculus (Mouse) GO:0001755; GO:0005886; GO:0007411; GO:0030215; GO:0030335; GO:0045499; GO:0048675; GO:0050908; GO:0071526; GO:0097485; GO:1990138 axon extension [GO:0048675]; axon guidance [GO:0007411]; detection of light stimulus involved in visual perception [GO:0050908]; neural crest cell migration [GO:0001755]; neuron projection extension [GO:1990138]; neuron projection guidance [GO:0097485]; positive regulation of cell migration [GO:0030335]; semaphorin-plexin signaling pathway [GO:0071526] plasma membrane [GO:0005886] chemorepellent activity [GO:0045499]; semaphorin receptor binding [GO:0030215] g15385.t1 Q6PDG5 92.308 52 3.13e-24 104.0 sp|Q6PDG5|SMRC2_MOUSE SWI/SNF complex subunit SMARCC2 OS=Mus musculus OX=10090 GN=Smarcc2 PE=1 SV=2 SMRC2_MOUSE reviewed SWI/SNF complex subunit SMARCC2 (BRG1-associated factor 170) (BAF170) (SWI/SNF complex 170 kDa subunit) (SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily C member 2) Mus musculus (Mouse) GO:0000122; GO:0000776; GO:0000785; GO:0003682; GO:0005654; GO:0006337; GO:0006338; GO:0006357; GO:0007399; GO:0016363; GO:0016514; GO:0016586; GO:0030071; GO:0035060; GO:0042393; GO:0045582; GO:0045597; GO:0045663; GO:0045892; GO:0045893; GO:0070316; GO:0071564; GO:0071565; GO:0140092; GO:2000045; GO:2000781; GO:2000819 chromatin remodeling [GO:0006338]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]; nucleosome disassembly [GO:0006337]; positive regulation of cell differentiation [GO:0045597]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of T cell differentiation [GO:0045582]; regulation of G0 to G1 transition [GO:0070316]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; regulation of nucleotide-excision repair [GO:2000819]; regulation of transcription by RNA polymerase II [GO:0006357] bBAF complex [GO:0140092]; brahma complex [GO:0035060]; chromatin [GO:0000785]; kinetochore [GO:0000776]; nBAF complex [GO:0071565]; npBAF complex [GO:0071564]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; RSC-type complex [GO:0016586]; SWI/SNF complex [GO:0016514] chromatin binding [GO:0003682]; histone binding [GO:0042393] g15385.t2 Q6PDG5 92.308 52 2.8299999999999997e-24 104.0 sp|Q6PDG5|SMRC2_MOUSE SWI/SNF complex subunit SMARCC2 OS=Mus musculus OX=10090 GN=Smarcc2 PE=1 SV=2 SMRC2_MOUSE reviewed SWI/SNF complex subunit SMARCC2 (BRG1-associated factor 170) (BAF170) (SWI/SNF complex 170 kDa subunit) (SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily C member 2) Mus musculus (Mouse) GO:0000122; GO:0000776; GO:0000785; GO:0003682; GO:0005654; GO:0006337; GO:0006338; GO:0006357; GO:0007399; GO:0016363; GO:0016514; GO:0016586; GO:0030071; GO:0035060; GO:0042393; GO:0045582; GO:0045597; GO:0045663; GO:0045892; GO:0045893; GO:0070316; GO:0071564; GO:0071565; GO:0140092; GO:2000045; GO:2000781; GO:2000819 chromatin remodeling [GO:0006338]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]; nucleosome disassembly [GO:0006337]; positive regulation of cell differentiation [GO:0045597]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of T cell differentiation [GO:0045582]; regulation of G0 to G1 transition [GO:0070316]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; regulation of nucleotide-excision repair [GO:2000819]; regulation of transcription by RNA polymerase II [GO:0006357] bBAF complex [GO:0140092]; brahma complex [GO:0035060]; chromatin [GO:0000785]; kinetochore [GO:0000776]; nBAF complex [GO:0071565]; npBAF complex [GO:0071564]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; RSC-type complex [GO:0016586]; SWI/SNF complex [GO:0016514] chromatin binding [GO:0003682]; histone binding [GO:0042393] g15386.t1 Q8TAQ2 63.908 737 0.0 879.0 sp|Q8TAQ2|SMRC2_HUMAN SWI/SNF complex subunit SMARCC2 OS=Homo sapiens OX=9606 GN=SMARCC2 PE=1 SV=1 SMRC2_HUMAN reviewed SWI/SNF complex subunit SMARCC2 (BRG1-associated factor 170) (BAF170) (SWI/SNF complex 170 kDa subunit) (SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily C member 2) Homo sapiens (Human) GO:0000776; GO:0000785; GO:0003713; GO:0005654; GO:0006337; GO:0006338; GO:0006357; GO:0007399; GO:0016363; GO:0016514; GO:0016586; GO:0030071; GO:0032991; GO:0035060; GO:0042393; GO:0045582; GO:0045597; GO:0045663; GO:0045892; GO:0045893; GO:0070316; GO:0071564; GO:0071565; GO:0140092; GO:2000045; GO:2000781; GO:2000819 chromatin remodeling [GO:0006338]; negative regulation of DNA-templated transcription [GO:0045892]; nervous system development [GO:0007399]; nucleosome disassembly [GO:0006337]; positive regulation of cell differentiation [GO:0045597]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of T cell differentiation [GO:0045582]; regulation of G0 to G1 transition [GO:0070316]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; regulation of nucleotide-excision repair [GO:2000819]; regulation of transcription by RNA polymerase II [GO:0006357] bBAF complex [GO:0140092]; brahma complex [GO:0035060]; chromatin [GO:0000785]; kinetochore [GO:0000776]; nBAF complex [GO:0071565]; npBAF complex [GO:0071564]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991]; RSC-type complex [GO:0016586]; SWI/SNF complex [GO:0016514] histone binding [GO:0042393]; transcription coactivator activity [GO:0003713] g15386.t2 Q8TAQ2 62.302 756 0.0 872.0 sp|Q8TAQ2|SMRC2_HUMAN SWI/SNF complex subunit SMARCC2 OS=Homo sapiens OX=9606 GN=SMARCC2 PE=1 SV=1 SMRC2_HUMAN reviewed SWI/SNF complex subunit SMARCC2 (BRG1-associated factor 170) (BAF170) (SWI/SNF complex 170 kDa subunit) (SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily C member 2) Homo sapiens (Human) GO:0000776; GO:0000785; GO:0003713; GO:0005654; GO:0006337; GO:0006338; GO:0006357; GO:0007399; GO:0016363; GO:0016514; GO:0016586; GO:0030071; GO:0032991; GO:0035060; GO:0042393; GO:0045582; GO:0045597; GO:0045663; GO:0045892; GO:0045893; GO:0070316; GO:0071564; GO:0071565; GO:0140092; GO:2000045; GO:2000781; GO:2000819 chromatin remodeling [GO:0006338]; negative regulation of DNA-templated transcription [GO:0045892]; nervous system development [GO:0007399]; nucleosome disassembly [GO:0006337]; positive regulation of cell differentiation [GO:0045597]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of T cell differentiation [GO:0045582]; regulation of G0 to G1 transition [GO:0070316]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; regulation of nucleotide-excision repair [GO:2000819]; regulation of transcription by RNA polymerase II [GO:0006357] bBAF complex [GO:0140092]; brahma complex [GO:0035060]; chromatin [GO:0000785]; kinetochore [GO:0000776]; nBAF complex [GO:0071565]; npBAF complex [GO:0071564]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991]; RSC-type complex [GO:0016586]; SWI/SNF complex [GO:0016514] histone binding [GO:0042393]; transcription coactivator activity [GO:0003713] g15387.t1 Q5FVN8 40.726 496 1.64e-115 351.0 sp|Q5FVN8|WSDU1_RAT WD repeat, SAM and U-box domain-containing protein 1 OS=Rattus norvegicus OX=10116 GN=Wdsub1 PE=2 SV=1 g15390.t1 A1DWM3 38.396 586 3.1300000000000003e-117 371.0 sp|A1DWM3|MFSD6_PIG Major facilitator superfamily domain-containing protein 6 OS=Sus scrofa OX=9823 GN=MFSD6 PE=2 SV=1 g15391.t1 Q9K7A0 27.723 404 2.99e-23 106.0 sp|Q9K7A0|CSD_HALH5 Probable cysteine desulfurase OS=Halalkalibacterium halodurans (strain ATCC BAA-125 / DSM 18197 / FERM 7344 / JCM 9153 / C-125) OX=272558 GN=csd PE=3 SV=2 g15393.t1 Q61458 45.141 319 1.35e-90 276.0 sp|Q61458|CCNH_MOUSE Cyclin-H OS=Mus musculus OX=10090 GN=Ccnh PE=1 SV=2 CCNH_MOUSE reviewed Cyclin-H Mus musculus (Mouse) GO:0000307; GO:0000439; GO:0004693; GO:0005634; GO:0005654; GO:0005675; GO:0006357; GO:0006367; GO:0016251; GO:0016301; GO:0016538; GO:0050821; GO:0070516; GO:0070985; GO:2000045 protein stabilization [GO:0050821]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription initiation at RNA polymerase II promoter [GO:0006367] CAK-ERCC2 complex [GO:0070516]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor TFIIH core complex [GO:0000439]; transcription factor TFIIH holo complex [GO:0005675]; transcription factor TFIIK complex [GO:0070985] cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]; kinase activity [GO:0016301]; RNA polymerase II general transcription initiation factor activity [GO:0016251] g15394.t1 Q99973 28.815 1350 2.5100000000000002e-144 497.0 sp|Q99973|TEP1_HUMAN Telomerase protein component 1 OS=Homo sapiens OX=9606 GN=TEP1 PE=1 SV=2 TEP1_HUMAN reviewed Telomerase protein component 1 (Telomerase-associated protein 1) (Telomerase protein 1) (p240) (p80 telomerase homolog) Homo sapiens (Human) GO:0000722; GO:0000781; GO:0002039; GO:0003720; GO:0003723; GO:0005524; GO:0005697; GO:0005737; GO:0016363; GO:0019899; GO:0070034; GO:1990904 telomere maintenance via recombination [GO:0000722] chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; nuclear matrix [GO:0016363]; ribonucleoprotein complex [GO:1990904]; telomerase holoenzyme complex [GO:0005697] ATP binding [GO:0005524]; enzyme binding [GO:0019899]; p53 binding [GO:0002039]; RNA binding [GO:0003723]; telomerase activity [GO:0003720]; telomerase RNA binding [GO:0070034] g15395.t1 O08653 38.679 318 6.0499999999999996e-52 188.0 sp|O08653|TEP1_RAT Telomerase protein component 1 OS=Rattus norvegicus OX=10116 GN=Tep1 PE=1 SV=1 g15396.t1 Q99973 34.795 342 1.3e-60 214.0 sp|Q99973|TEP1_HUMAN Telomerase protein component 1 OS=Homo sapiens OX=9606 GN=TEP1 PE=1 SV=2 TEP1_HUMAN reviewed Telomerase protein component 1 (Telomerase-associated protein 1) (Telomerase protein 1) (p240) (p80 telomerase homolog) Homo sapiens (Human) GO:0000722; GO:0000781; GO:0002039; GO:0003720; GO:0003723; GO:0005524; GO:0005697; GO:0005737; GO:0016363; GO:0019899; GO:0070034; GO:1990904 telomere maintenance via recombination [GO:0000722] chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; nuclear matrix [GO:0016363]; ribonucleoprotein complex [GO:1990904]; telomerase holoenzyme complex [GO:0005697] ATP binding [GO:0005524]; enzyme binding [GO:0019899]; p53 binding [GO:0002039]; RNA binding [GO:0003723]; telomerase activity [GO:0003720]; telomerase RNA binding [GO:0070034] g15399.t1 Q9C098 58.879 321 2.8e-111 358.0 sp|Q9C098|DCLK3_HUMAN Serine/threonine-protein kinase DCLK3 OS=Homo sapiens OX=9606 GN=DCLK3 PE=1 SV=2 DCLK3_HUMAN reviewed Serine/threonine-protein kinase DCLK3 (EC 2.7.11.1) (Doublecortin domain-containing protein 3C) (Doublecortin-like and CAM kinase-like 3) (Doublecortin-like kinase 3) Homo sapiens (Human) GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0034504; GO:0106310 protein localization to nucleus [GO:0034504] cytoplasm [GO:0005737]; nucleus [GO:0005634] ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g15400.t1 Q99755 55.534 524 0.0 560.0 sp|Q99755|PI51A_HUMAN Phosphatidylinositol 4-phosphate 5-kinase type-1 alpha OS=Homo sapiens OX=9606 GN=PIP5K1A PE=1 SV=1 PI51A_HUMAN reviewed Phosphatidylinositol 4-phosphate 5-kinase type-1 alpha (PIP5K1-alpha) (PtdIns(4)P-5-kinase 1 alpha) (EC 2.7.1.68) (68 kDa type I phosphatidylinositol 4-phosphate 5-kinase alpha) (Phosphatidylinositol 4-phosphate 5-kinase type I alpha) (PIP5KIalpha) Homo sapiens (Human) GO:0000285; GO:0005524; GO:0005634; GO:0005654; GO:0005829; GO:0005886; GO:0005925; GO:0006650; GO:0006661; GO:0006909; GO:0007165; GO:0008654; GO:0010761; GO:0016308; GO:0016477; GO:0016607; GO:0019900; GO:0030027; GO:0030036; GO:0030216; GO:0032587; GO:0046854; GO:0048041; GO:0051896; GO:0052742; GO:0052810; GO:0060326; GO:0072659; GO:0090630; GO:0097178 actin cytoskeleton organization [GO:0030036]; activation of GTPase activity [GO:0090630]; cell chemotaxis [GO:0060326]; cell migration [GO:0016477]; fibroblast migration [GO:0010761]; focal adhesion assembly [GO:0048041]; glycerophospholipid metabolic process [GO:0006650]; keratinocyte differentiation [GO:0030216]; phagocytosis [GO:0006909]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; phospholipid biosynthetic process [GO:0008654]; protein localization to plasma membrane [GO:0072659]; regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051896]; ruffle assembly [GO:0097178]; signal transduction [GO:0007165] cytosol [GO:0005829]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587] 1-phosphatidylinositol-3-phosphate 5-kinase activity [GO:0000285]; 1-phosphatidylinositol-4-phosphate 5-kinase activity [GO:0016308]; 1-phosphatidylinositol-5-kinase activity [GO:0052810]; ATP binding [GO:0005524]; kinase binding [GO:0019900]; phosphatidylinositol kinase activity [GO:0052742] g15401.t1 Q059Y8 26.332 638 1.22e-59 217.0 sp|Q059Y8|DCST1_MOUSE E3 ubiquitin-protein ligase DCST1 OS=Mus musculus OX=10090 GN=Dcst1 PE=1 SV=1 DCST1_MOUSE reviewed E3 ubiquitin-protein ligase DCST1 (EC 2.3.2.27) (DC-STAMP domain-containing protein 1) (RING-type E3 ubiquitin transferase) Mus musculus (Mouse) GO:0002080; GO:0005886; GO:0006511; GO:0007342; GO:0008270; GO:0016567; GO:0035036; GO:0045087; GO:0060339; GO:0061630 fusion of sperm to egg plasma membrane involved in single fertilization [GO:0007342]; innate immune response [GO:0045087]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; protein ubiquitination [GO:0016567]; sperm-egg recognition [GO:0035036]; ubiquitin-dependent protein catabolic process [GO:0006511] acrosomal membrane [GO:0002080]; plasma membrane [GO:0005886] ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] g15404.t1 Q32MH5 61.658 193 4.05e-76 249.0 sp|Q32MH5|ATOSA_HUMAN Atos homolog protein A OS=Homo sapiens OX=9606 GN=ATOSA PE=1 SV=2 ATOSA_HUMAN reviewed Atos homolog protein A Homo sapiens (Human) GO:0005634 nucleus [GO:0005634] g15404.t2 Q32MH5 50.855 234 1.8499999999999998e-68 230.0 sp|Q32MH5|ATOSA_HUMAN Atos homolog protein A OS=Homo sapiens OX=9606 GN=ATOSA PE=1 SV=2 ATOSA_HUMAN reviewed Atos homolog protein A Homo sapiens (Human) GO:0005634 nucleus [GO:0005634] g15404.t3 Q1LV22 74.194 93 4.78e-43 152.0 sp|Q1LV22|ATOSA_DANRE Atos homolog protein A OS=Danio rerio OX=7955 GN=atosa PE=2 SV=2 g15406.t1 Q5FW46 42.727 220 8.87e-44 172.0 sp|Q5FW46|ATOSA_XENTR Atos homolog protein A OS=Xenopus tropicalis OX=8364 GN=atosa PE=2 SV=1 g15407.t1 Q8N6V9 60.5 200 3.85e-74 234.0 sp|Q8N6V9|TEX9_HUMAN Testis-expressed protein 9 OS=Homo sapiens OX=9606 GN=TEX9 PE=1 SV=1 g15411.t1 Q2EG98 22.89 616 1.26e-32 142.0 sp|Q2EG98|PK1L3_MOUSE Polycystin-1-like protein 3 OS=Mus musculus OX=10090 GN=Pkd1l3 PE=1 SV=3 PK1L3_MOUSE reviewed Polycystin-1-like protein 3 (Polycystin-1L3) (PC1-like 3 protein) (Polycystic kidney disease protein 1-like 3) Mus musculus (Mouse) GO:0001581; GO:0005227; GO:0005262; GO:0005509; GO:0005886; GO:0006812; GO:0016020; GO:0030246; GO:0034703; GO:0043235; GO:0044325; GO:0050915; GO:0050982; GO:0070588; GO:0071468; GO:0098655; GO:0160128 calcium ion transmembrane transport [GO:0070588]; cellular response to acidic pH [GO:0071468]; detection of chemical stimulus involved in sensory perception of sour taste [GO:0001581]; detection of mechanical stimulus [GO:0050982]; monoatomic cation transmembrane transport [GO:0098655]; monoatomic cation transport [GO:0006812]; sensory perception of sour taste [GO:0050915] cation channel complex [GO:0034703]; membrane [GO:0016020]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] calcium channel activity [GO:0005262]; calcium ion binding [GO:0005509]; calcium-activated cation channel activity [GO:0005227]; carbohydrate binding [GO:0030246]; pH-gated monoatomic ion channel activity [GO:0160128]; transmembrane transporter binding [GO:0044325] g15412.t1 Q26627 27.512 418 2.16e-22 108.0 sp|Q26627|SUREJ_STRPU Sperm receptor for egg jelly OS=Strongylocentrotus purpuratus OX=7668 GN=REJ PE=1 SV=1 SUREJ_STRPU reviewed Sperm receptor for egg jelly (suREJ) Strongylocentrotus purpuratus (Purple sea urchin) GO:0005262; GO:0005509; GO:0005886; GO:0016020; GO:0030246; GO:0050982 detection of mechanical stimulus [GO:0050982] membrane [GO:0016020]; plasma membrane [GO:0005886] calcium channel activity [GO:0005262]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246] g15414.t1 Q2VWP7 30.854 995 1.21e-106 365.0 sp|Q2VWP7|PRTG_HUMAN Protogenin OS=Homo sapiens OX=9606 GN=PRTG PE=1 SV=1 PRTG_HUMAN reviewed Protogenin (Protein Shen-Dan) Homo sapiens (Human) GO:0005615; GO:0005886; GO:0038023; GO:0042802; GO:0050768; GO:0098609 cell-cell adhesion [GO:0098609]; negative regulation of neurogenesis [GO:0050768] extracellular space [GO:0005615]; plasma membrane [GO:0005886] identical protein binding [GO:0042802]; signaling receptor activity [GO:0038023] g15414.t2 Q2VWP7 30.754 995 1.36e-106 365.0 sp|Q2VWP7|PRTG_HUMAN Protogenin OS=Homo sapiens OX=9606 GN=PRTG PE=1 SV=1 PRTG_HUMAN reviewed Protogenin (Protein Shen-Dan) Homo sapiens (Human) GO:0005615; GO:0005886; GO:0038023; GO:0042802; GO:0050768; GO:0098609 cell-cell adhesion [GO:0098609]; negative regulation of neurogenesis [GO:0050768] extracellular space [GO:0005615]; plasma membrane [GO:0005886] identical protein binding [GO:0042802]; signaling receptor activity [GO:0038023] g15415.t1 Q6INC1 56.604 212 1.22e-79 263.0 sp|Q6INC1|TT21B_XENLA Tetratricopeptide repeat protein 21B OS=Xenopus laevis OX=8355 GN=ttc21b PE=2 SV=1 g15416.t1 Q7Z4L5 57.729 1048 0.0 1276.0 sp|Q7Z4L5|TT21B_HUMAN Tetratricopeptide repeat protein 21B OS=Homo sapiens OX=9606 GN=TTC21B PE=1 SV=2 TT21B_HUMAN reviewed Tetratricopeptide repeat protein 21B (TPR repeat protein 21B) (Intraflagellar transport 139 homolog) Homo sapiens (Human) GO:0003682; GO:0005929; GO:0005930; GO:0006357; GO:0007224; GO:0008589; GO:0010628; GO:0021591; GO:0021702; GO:0021798; GO:0030991; GO:0035721; GO:0060020; GO:0060271; GO:0061512; GO:0090263; GO:0097499; GO:0097542; GO:1903999; GO:1905799 Bergmann glial cell differentiation [GO:0060020]; cerebellar Purkinje cell differentiation [GO:0021702]; cilium assembly [GO:0060271]; forebrain dorsal/ventral pattern formation [GO:0021798]; intraciliary retrograde transport [GO:0035721]; negative regulation of eating behavior [GO:1903999]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of gene expression [GO:0010628]; protein localization to cilium [GO:0061512]; protein localization to non-motile cilium [GO:0097499]; regulation of intraciliary retrograde transport [GO:1905799]; regulation of smoothened signaling pathway [GO:0008589]; regulation of transcription by RNA polymerase II [GO:0006357]; smoothened signaling pathway [GO:0007224]; ventricular system development [GO:0021591] axoneme [GO:0005930]; ciliary tip [GO:0097542]; cilium [GO:0005929]; intraciliary transport particle A [GO:0030991] chromatin binding [GO:0003682] g15418.t1 P97798 34.264 788 5.45e-119 395.0 sp|P97798|NEO1_MOUSE Neogenin OS=Mus musculus OX=10090 GN=Neo1 PE=1 SV=2 NEO1_MOUSE reviewed Neogenin Mus musculus (Mouse) GO:0001764; GO:0005654; GO:0005794; GO:0005886; GO:0006355; GO:0006879; GO:0007411; GO:0007520; GO:0009986; GO:0016020; GO:0030426; GO:0030513; GO:0038023; GO:0039706; GO:0043025; GO:0045296; GO:0048679; GO:0048681; GO:0050709; GO:0060586; GO:0070700; GO:0097708; GO:0098609; GO:0098797; GO:0098839; GO:0098978; GO:0099550 axon guidance [GO:0007411]; cell-cell adhesion [GO:0098609]; intracellular iron ion homeostasis [GO:0006879]; multicellular organismal-level iron ion homeostasis [GO:0060586]; myoblast fusion [GO:0007520]; negative regulation of axon regeneration [GO:0048681]; negative regulation of protein secretion [GO:0050709]; neuron migration [GO:0001764]; positive regulation of BMP signaling pathway [GO:0030513]; regulation of axon regeneration [GO:0048679]; regulation of DNA-templated transcription [GO:0006355]; trans-synaptic signaling, modulating synaptic transmission [GO:0099550] cell surface [GO:0009986]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; growth cone [GO:0030426]; intracellular vesicle [GO:0097708]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; plasma membrane protein complex [GO:0098797]; postsynaptic density membrane [GO:0098839] BMP receptor binding [GO:0070700]; cadherin binding [GO:0045296]; co-receptor binding [GO:0039706]; signaling receptor activity [GO:0038023] g15418.t2 P97798 32.41 830 3.77e-103 369.0 sp|P97798|NEO1_MOUSE Neogenin OS=Mus musculus OX=10090 GN=Neo1 PE=1 SV=2 NEO1_MOUSE reviewed Neogenin Mus musculus (Mouse) GO:0001764; GO:0005654; GO:0005794; GO:0005886; GO:0006355; GO:0006879; GO:0007411; GO:0007520; GO:0009986; GO:0016020; GO:0030426; GO:0030513; GO:0038023; GO:0039706; GO:0043025; GO:0045296; GO:0048679; GO:0048681; GO:0050709; GO:0060586; GO:0070700; GO:0097708; GO:0098609; GO:0098797; GO:0098839; GO:0098978; GO:0099550 axon guidance [GO:0007411]; cell-cell adhesion [GO:0098609]; intracellular iron ion homeostasis [GO:0006879]; multicellular organismal-level iron ion homeostasis [GO:0060586]; myoblast fusion [GO:0007520]; negative regulation of axon regeneration [GO:0048681]; negative regulation of protein secretion [GO:0050709]; neuron migration [GO:0001764]; positive regulation of BMP signaling pathway [GO:0030513]; regulation of axon regeneration [GO:0048679]; regulation of DNA-templated transcription [GO:0006355]; trans-synaptic signaling, modulating synaptic transmission [GO:0099550] cell surface [GO:0009986]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; growth cone [GO:0030426]; intracellular vesicle [GO:0097708]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; plasma membrane protein complex [GO:0098797]; postsynaptic density membrane [GO:0098839] BMP receptor binding [GO:0070700]; cadherin binding [GO:0045296]; co-receptor binding [GO:0039706]; signaling receptor activity [GO:0038023] g15418.t2 P97798 27.558 987 1.1799999999999998e-68 260.0 sp|P97798|NEO1_MOUSE Neogenin OS=Mus musculus OX=10090 GN=Neo1 PE=1 SV=2 NEO1_MOUSE reviewed Neogenin Mus musculus (Mouse) GO:0001764; GO:0005654; GO:0005794; GO:0005886; GO:0006355; GO:0006879; GO:0007411; GO:0007520; GO:0009986; GO:0016020; GO:0030426; GO:0030513; GO:0038023; GO:0039706; GO:0043025; GO:0045296; GO:0048679; GO:0048681; GO:0050709; GO:0060586; GO:0070700; GO:0097708; GO:0098609; GO:0098797; GO:0098839; GO:0098978; GO:0099550 axon guidance [GO:0007411]; cell-cell adhesion [GO:0098609]; intracellular iron ion homeostasis [GO:0006879]; multicellular organismal-level iron ion homeostasis [GO:0060586]; myoblast fusion [GO:0007520]; negative regulation of axon regeneration [GO:0048681]; negative regulation of protein secretion [GO:0050709]; neuron migration [GO:0001764]; positive regulation of BMP signaling pathway [GO:0030513]; regulation of axon regeneration [GO:0048679]; regulation of DNA-templated transcription [GO:0006355]; trans-synaptic signaling, modulating synaptic transmission [GO:0099550] cell surface [GO:0009986]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; growth cone [GO:0030426]; intracellular vesicle [GO:0097708]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; plasma membrane protein complex [GO:0098797]; postsynaptic density membrane [GO:0098839] BMP receptor binding [GO:0070700]; cadherin binding [GO:0045296]; co-receptor binding [GO:0039706]; signaling receptor activity [GO:0038023] g15418.t3 P97603 39.691 194 1.73e-30 135.0 sp|P97603|NEO1_RAT Neogenin (Fragment) OS=Rattus norvegicus OX=10116 GN=Neo1 PE=1 SV=1 NEO1_RAT reviewed Neogenin Rattus norvegicus (Rat) GO:0001764; GO:0005654; GO:0005794; GO:0005886; GO:0006355; GO:0006879; GO:0007411; GO:0007520; GO:0009986; GO:0016020; GO:0030426; GO:0030513; GO:0038023; GO:0039706; GO:0043025; GO:0045296; GO:0048679; GO:0048681; GO:0050709; GO:0060586; GO:0070700; GO:0097708; GO:0098609; GO:0098797; GO:0098839; GO:0098978; GO:0099550 axon guidance [GO:0007411]; cell-cell adhesion [GO:0098609]; intracellular iron ion homeostasis [GO:0006879]; multicellular organismal-level iron ion homeostasis [GO:0060586]; myoblast fusion [GO:0007520]; negative regulation of axon regeneration [GO:0048681]; negative regulation of protein secretion [GO:0050709]; neuron migration [GO:0001764]; positive regulation of BMP signaling pathway [GO:0030513]; regulation of axon regeneration [GO:0048679]; regulation of DNA-templated transcription [GO:0006355]; trans-synaptic signaling, modulating synaptic transmission [GO:0099550] cell surface [GO:0009986]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; growth cone [GO:0030426]; intracellular vesicle [GO:0097708]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; plasma membrane protein complex [GO:0098797]; postsynaptic density membrane [GO:0098839] BMP receptor binding [GO:0070700]; cadherin binding [GO:0045296]; co-receptor binding [GO:0039706]; signaling receptor activity [GO:0038023] g15418.t4 P97603 39.691 194 1.74e-30 135.0 sp|P97603|NEO1_RAT Neogenin (Fragment) OS=Rattus norvegicus OX=10116 GN=Neo1 PE=1 SV=1 NEO1_RAT reviewed Neogenin Rattus norvegicus (Rat) GO:0001764; GO:0005654; GO:0005794; GO:0005886; GO:0006355; GO:0006879; GO:0007411; GO:0007520; GO:0009986; GO:0016020; GO:0030426; GO:0030513; GO:0038023; GO:0039706; GO:0043025; GO:0045296; GO:0048679; GO:0048681; GO:0050709; GO:0060586; GO:0070700; GO:0097708; GO:0098609; GO:0098797; GO:0098839; GO:0098978; GO:0099550 axon guidance [GO:0007411]; cell-cell adhesion [GO:0098609]; intracellular iron ion homeostasis [GO:0006879]; multicellular organismal-level iron ion homeostasis [GO:0060586]; myoblast fusion [GO:0007520]; negative regulation of axon regeneration [GO:0048681]; negative regulation of protein secretion [GO:0050709]; neuron migration [GO:0001764]; positive regulation of BMP signaling pathway [GO:0030513]; regulation of axon regeneration [GO:0048679]; regulation of DNA-templated transcription [GO:0006355]; trans-synaptic signaling, modulating synaptic transmission [GO:0099550] cell surface [GO:0009986]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; growth cone [GO:0030426]; intracellular vesicle [GO:0097708]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; plasma membrane protein complex [GO:0098797]; postsynaptic density membrane [GO:0098839] BMP receptor binding [GO:0070700]; cadherin binding [GO:0045296]; co-receptor binding [GO:0039706]; signaling receptor activity [GO:0038023] g15418.t5 P97603 39.691 194 1.5099999999999999e-30 135.0 sp|P97603|NEO1_RAT Neogenin (Fragment) OS=Rattus norvegicus OX=10116 GN=Neo1 PE=1 SV=1 NEO1_RAT reviewed Neogenin Rattus norvegicus (Rat) GO:0001764; GO:0005654; GO:0005794; GO:0005886; GO:0006355; GO:0006879; GO:0007411; GO:0007520; GO:0009986; GO:0016020; GO:0030426; GO:0030513; GO:0038023; GO:0039706; GO:0043025; GO:0045296; GO:0048679; GO:0048681; GO:0050709; GO:0060586; GO:0070700; GO:0097708; GO:0098609; GO:0098797; GO:0098839; GO:0098978; GO:0099550 axon guidance [GO:0007411]; cell-cell adhesion [GO:0098609]; intracellular iron ion homeostasis [GO:0006879]; multicellular organismal-level iron ion homeostasis [GO:0060586]; myoblast fusion [GO:0007520]; negative regulation of axon regeneration [GO:0048681]; negative regulation of protein secretion [GO:0050709]; neuron migration [GO:0001764]; positive regulation of BMP signaling pathway [GO:0030513]; regulation of axon regeneration [GO:0048679]; regulation of DNA-templated transcription [GO:0006355]; trans-synaptic signaling, modulating synaptic transmission [GO:0099550] cell surface [GO:0009986]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; growth cone [GO:0030426]; intracellular vesicle [GO:0097708]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; plasma membrane protein complex [GO:0098797]; postsynaptic density membrane [GO:0098839] BMP receptor binding [GO:0070700]; cadherin binding [GO:0045296]; co-receptor binding [GO:0039706]; signaling receptor activity [GO:0038023] g15422.t1 Q9NPH0 37.069 348 5.5e-70 229.0 sp|Q9NPH0|PPA6_HUMAN Lysophosphatidic acid phosphatase type 6 OS=Homo sapiens OX=9606 GN=ACP6 PE=1 SV=3 PPA6_HUMAN reviewed Lysophosphatidic acid phosphatase type 6 (EC 3.1.3.2) (Acid phosphatase 6, lysophosphatidic) (Acid phosphatase-like protein 1) (PACPL1) Homo sapiens (Human) GO:0002244; GO:0003993; GO:0005737; GO:0005739; GO:0005759; GO:0006644; GO:0006654; GO:0052642; GO:2001311 hematopoietic progenitor cell differentiation [GO:0002244]; lysobisphosphatidic acid metabolic process [GO:2001311]; phosphatidic acid biosynthetic process [GO:0006654]; phospholipid metabolic process [GO:0006644] cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] acid phosphatase activity [GO:0003993]; lysophosphatidic acid phosphatase activity [GO:0052642] g15425.t1 Q9VCA2 39.099 555 3.17e-105 331.0 sp|Q9VCA2|ORCT_DROME Organic cation transporter protein OS=Drosophila melanogaster OX=7227 GN=Orct PE=1 SV=1 g15426.t1 O57478 71.703 364 0.0 535.0 sp|O57478|HEMH_XENLA Ferrochelatase, mitochondrial OS=Xenopus laevis OX=8355 GN=fech PE=1 SV=1 g15427.t1 Q93073 45.521 413 1.82e-69 254.0 sp|Q93073|SBP2L_HUMAN Selenocysteine insertion sequence-binding protein 2-like OS=Homo sapiens OX=9606 GN=SECISBP2L PE=1 SV=3 g15429.t1 Q9Y2P0 31.556 225 1.52e-26 113.0 sp|Q9Y2P0|ZN835_HUMAN Zinc finger protein 835 OS=Homo sapiens OX=9606 GN=ZNF835 PE=1 SV=2 g15429.t1 Q9Y2P0 28.185 259 4.91e-21 97.4 sp|Q9Y2P0|ZN835_HUMAN Zinc finger protein 835 OS=Homo sapiens OX=9606 GN=ZNF835 PE=1 SV=2 g15430.t1 Q6P3P1 31.683 404 3.29e-47 180.0 sp|Q6P3P1|TAXB1_XENTR Tax1-binding protein 1 homolog OS=Xenopus tropicalis OX=8364 GN=tax1bp1 PE=2 SV=1 g15436.t1 Q5DTI6 32.0 300 1.88e-24 115.0 sp|Q5DTI6|KAL1L_MOUSE KAT8 regulatory NSL complex subunit 1-like protein OS=Mus musculus OX=10090 GN=Kansl1l PE=1 SV=3 KAL1L_MOUSE reviewed KAT8 regulatory NSL complex subunit 1-like protein Mus musculus (Mouse) GO:0035035; GO:0044545 NSL complex [GO:0044545] histone acetyltransferase binding [GO:0035035] g15437.t1 Q66H56 36.798 356 6.989999999999999e-68 229.0 sp|Q66H56|TTI2_RAT TELO2-interacting protein 2 OS=Rattus norvegicus OX=10116 GN=Tti2 PE=2 SV=1 g15437.t2 Q66H56 36.798 356 6.81e-68 229.0 sp|Q66H56|TTI2_RAT TELO2-interacting protein 2 OS=Rattus norvegicus OX=10116 GN=Tti2 PE=2 SV=1 g15439.t1 Q9DAA6 61.14 193 1.37e-80 241.0 sp|Q9DAA6|EXOS1_MOUSE Exosome complex component CSL4 OS=Mus musculus OX=10090 GN=Exosc1 PE=1 SV=1 g15442.t1 A2AG06 41.975 162 4.3e-30 130.0 sp|A2AG06|MEIOC_MOUSE Meiosis-specific coiled-coil domain-containing protein MEIOC OS=Mus musculus OX=10090 GN=Meioc PE=1 SV=1 MEIOC_MOUSE reviewed Meiosis-specific coiled-coil domain-containing protein MEIOC (Meiosis-specific with coiled-coil domain protein) Mus musculus (Mouse) GO:0005634; GO:0005737; GO:0006302; GO:0007130; GO:0007141; GO:0007144; GO:0007283; GO:0007286; GO:0048255; GO:0048599; GO:0051310; GO:0051729; GO:0070192 chromosome organization involved in meiotic cell cycle [GO:0070192]; double-strand break repair [GO:0006302]; female meiosis I [GO:0007144]; germline cell cycle switching, mitotic to meiotic cell cycle [GO:0051729]; male meiosis I [GO:0007141]; metaphase chromosome alignment [GO:0051310]; mRNA stabilization [GO:0048255]; oocyte development [GO:0048599]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; synaptonemal complex assembly [GO:0007130] cytoplasm [GO:0005737]; nucleus [GO:0005634] g15443.t1 Q91WN1 50.417 240 4.5799999999999995e-67 211.0 sp|Q91WN1|DNJC9_MOUSE DnaJ homolog subfamily C member 9 OS=Mus musculus OX=10090 GN=Dnajc9 PE=1 SV=2 g15444.t1 P57756 41.126 231 8.16e-41 148.0 sp|P57756|FCN2_RAT Ficolin-2 OS=Rattus norvegicus OX=10116 GN=Fcn2 PE=2 SV=1 FCN2_RAT reviewed Ficolin-2 (Collagen/fibrinogen domain-containing protein 2) (Ficolin-B) (Ficolin-beta) (L-ficolin) Rattus norvegicus (Rat) GO:0001664; GO:0001867; GO:0001905; GO:0002233; GO:0002752; GO:0003823; GO:0005102; GO:0005581; GO:0005615; GO:0005886; GO:0006508; GO:0006956; GO:0007186; GO:0008228; GO:0030246; GO:0031638; GO:0031640; GO:0032757; GO:0033691; GO:0034394; GO:0038187; GO:0043654; GO:0046597; GO:0046872; GO:0051604; GO:0070892; GO:0097367; GO:0106139; GO:1903028; GO:1905370 activation of membrane attack complex [GO:0001905]; cell surface pattern recognition receptor signaling pathway [GO:0002752]; complement activation [GO:0006956]; complement activation, lectin pathway [GO:0001867]; G protein-coupled receptor signaling pathway [GO:0007186]; host-mediated suppression of symbiont invasion [GO:0046597]; killing of cells of another organism [GO:0031640]; leukocyte chemotaxis involved in immune response [GO:0002233]; opsonization [GO:0008228]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of opsonization [GO:1903028]; protein localization to cell surface [GO:0034394]; protein maturation [GO:0051604]; proteolysis [GO:0006508]; recognition of apoptotic cell [GO:0043654]; zymogen activation [GO:0031638] collagen trimer [GO:0005581]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; serine-type endopeptidase complex [GO:1905370]; symbiont cell surface [GO:0106139] antigen binding [GO:0003823]; carbohydrate binding [GO:0030246]; carbohydrate derivative binding [GO:0097367]; G protein-coupled receptor binding [GO:0001664]; lipoteichoic acid immune receptor activity [GO:0070892]; metal ion binding [GO:0046872]; pattern recognition receptor activity [GO:0038187]; sialic acid binding [GO:0033691]; signaling receptor binding [GO:0005102] g15446.t1 A8MV24 47.059 136 2.1399999999999997e-34 122.0 sp|A8MV24|SPMA1_HUMAN Sperm microtubule associated protein 1 OS=Homo sapiens OX=9606 GN=SPMAP1 PE=1 SV=1 g15448.t1 P56179 73.913 92 1.4100000000000001e-36 134.0 sp|P56179|DLX6_HUMAN Homeobox protein DLX-6 OS=Homo sapiens OX=9606 GN=DLX6 PE=1 SV=2 DLX6_HUMAN reviewed Homeobox protein DLX-6 Homo sapiens (Human) GO:0000785; GO:0000978; GO:0000981; GO:0001501; GO:0003700; GO:0005634; GO:0006357; GO:0007399; GO:0030154; GO:0030326; GO:0030855; GO:0042472; GO:0048646; GO:0048706; GO:0050679; GO:0060021; GO:0060322; GO:1990837 anatomical structure formation involved in morphogenesis [GO:0048646]; cell differentiation [GO:0030154]; embryonic limb morphogenesis [GO:0030326]; embryonic skeletal system development [GO:0048706]; epithelial cell differentiation [GO:0030855]; head development [GO:0060322]; inner ear morphogenesis [GO:0042472]; nervous system development [GO:0007399]; positive regulation of epithelial cell proliferation [GO:0050679]; regulation of transcription by RNA polymerase II [GO:0006357]; roof of mouth development [GO:0060021]; skeletal system development [GO:0001501] chromatin [GO:0000785]; nucleus [GO:0005634] DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837] g15449.t1 Q04896 48.718 234 2.85e-48 162.0 sp|Q04896|HME1A_DANRE Homeobox protein engrailed-1a OS=Danio rerio OX=7955 GN=eng1a PE=2 SV=1 g15450.t1 Q4VBS4 44.776 335 1.41e-98 300.0 sp|Q4VBS4|MAP12_DANRE Methionine aminopeptidase 1D, mitochondrial OS=Danio rerio OX=7955 GN=metap1d PE=2 SV=1 MAP12_DANRE reviewed Methionine aminopeptidase 1D, mitochondrial (MAP 1D) (MetAP 1D) (EC 3.4.11.18) (Methionyl aminopeptidase type 1D, mitochondrial) (Peptidase M 1D) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0004239; GO:0005739; GO:0006508; GO:0046872; GO:0070006 proteolysis [GO:0006508] mitochondrion [GO:0005739] initiator methionyl aminopeptidase activity [GO:0004239]; metal ion binding [GO:0046872]; metalloaminopeptidase activity [GO:0070006] g15452.t1 P09241 30.279 251 3.46e-22 102.0 sp|P09241|OPSD_ENTDO Rhodopsin OS=Enteroctopus dofleini OX=267067 GN=RHO PE=2 SV=1 g15456.t1 Q6IRU7 40.541 592 4.27e-108 356.0 sp|Q6IRU7|CEP78_MOUSE Centrosomal protein of 78 kDa OS=Mus musculus OX=10090 GN=Cep78 PE=1 SV=1 CEP78_MOUSE reviewed Centrosomal protein of 78 kDa (Cep78) Mus musculus (Mouse) GO:0005813; GO:0005814; GO:0030317; GO:0031397; GO:0036064; GO:0044782; GO:0061512; GO:0071539 cilium organization [GO:0044782]; flagellated sperm motility [GO:0030317]; negative regulation of protein ubiquitination [GO:0031397]; protein localization to centrosome [GO:0071539]; protein localization to cilium [GO:0061512] centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064] g15457.t1 P28271 68.831 385 0.0 571.0 sp|P28271|ACOHC_MOUSE Cytoplasmic aconitate hydratase OS=Mus musculus OX=10090 GN=Aco1 PE=1 SV=3 ACOHC_MOUSE reviewed Cytoplasmic aconitate hydratase (Aconitase) (EC 4.2.1.3) (Citrate hydro-lyase) (Iron regulatory protein 1) (IRP1) (Iron-responsive element-binding protein 1) (IRE-BP 1) Mus musculus (Mouse) GO:0000900; GO:0003723; GO:0003994; GO:0005737; GO:0005739; GO:0005783; GO:0005794; GO:0005829; GO:0006099; GO:0006101; GO:0006417; GO:0006740; GO:0006879; GO:0009791; GO:0010040; GO:0010468; GO:0030350; GO:0046872; GO:0048027; GO:0050892; GO:0051536; GO:0051538; GO:0051539 citrate metabolic process [GO:0006101]; intestinal absorption [GO:0050892]; intracellular iron ion homeostasis [GO:0006879]; NADPH regeneration [GO:0006740]; post-embryonic development [GO:0009791]; regulation of gene expression [GO:0010468]; regulation of translation [GO:0006417]; response to iron(II) ion [GO:0010040]; tricarboxylic acid cycle [GO:0006099] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; mitochondrion [GO:0005739] 3 iron, 4 sulfur cluster binding [GO:0051538]; 4 iron, 4 sulfur cluster binding [GO:0051539]; aconitate hydratase activity [GO:0003994]; iron-responsive element binding [GO:0030350]; iron-sulfur cluster binding [GO:0051536]; metal ion binding [GO:0046872]; mRNA 5'-UTR binding [GO:0048027]; mRNA regulatory element binding translation repressor activity [GO:0000900]; RNA binding [GO:0003723] g15457.t1 P28271 71.186 118 1.99e-47 187.0 sp|P28271|ACOHC_MOUSE Cytoplasmic aconitate hydratase OS=Mus musculus OX=10090 GN=Aco1 PE=1 SV=3 ACOHC_MOUSE reviewed Cytoplasmic aconitate hydratase (Aconitase) (EC 4.2.1.3) (Citrate hydro-lyase) (Iron regulatory protein 1) (IRP1) (Iron-responsive element-binding protein 1) (IRE-BP 1) Mus musculus (Mouse) GO:0000900; GO:0003723; GO:0003994; GO:0005737; GO:0005739; GO:0005783; GO:0005794; GO:0005829; GO:0006099; GO:0006101; GO:0006417; GO:0006740; GO:0006879; GO:0009791; GO:0010040; GO:0010468; GO:0030350; GO:0046872; GO:0048027; GO:0050892; GO:0051536; GO:0051538; GO:0051539 citrate metabolic process [GO:0006101]; intestinal absorption [GO:0050892]; intracellular iron ion homeostasis [GO:0006879]; NADPH regeneration [GO:0006740]; post-embryonic development [GO:0009791]; regulation of gene expression [GO:0010468]; regulation of translation [GO:0006417]; response to iron(II) ion [GO:0010040]; tricarboxylic acid cycle [GO:0006099] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; mitochondrion [GO:0005739] 3 iron, 4 sulfur cluster binding [GO:0051538]; 4 iron, 4 sulfur cluster binding [GO:0051539]; aconitate hydratase activity [GO:0003994]; iron-responsive element binding [GO:0030350]; iron-sulfur cluster binding [GO:0051536]; metal ion binding [GO:0046872]; mRNA 5'-UTR binding [GO:0048027]; mRNA regulatory element binding translation repressor activity [GO:0000900]; RNA binding [GO:0003723] g15459.t1 Q9VBW3 48.63 292 1.63e-85 291.0 sp|Q9VBW3|CAD96_DROME Tyrosine kinase receptor Cad96Ca OS=Drosophila melanogaster OX=7227 GN=Cad96Ca PE=2 SV=2 CAD96_DROME reviewed Tyrosine kinase receptor Cad96Ca (EC 2.7.10.1) (Cadherin-96Ca) (Tyrosine kinase receptor HD-14) Drosophila melanogaster (Fruit fly) GO:0004713; GO:0004714; GO:0005509; GO:0005524; GO:0005886; GO:0006468; GO:0007030; GO:0007156; GO:0007169; GO:0016339; GO:0042060; GO:0043235; GO:0045177; GO:0045792; GO:0051897; GO:0090303 calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; Golgi organization [GO:0007030]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell size [GO:0045792]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of wound healing [GO:0090303]; protein phosphorylation [GO:0006468]; wound healing [GO:0042060] apical part of cell [GO:0045177]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; protein tyrosine kinase activity [GO:0004713]; transmembrane receptor protein tyrosine kinase activity [GO:0004714] g15463.t1 Q5F479 44.538 238 6.610000000000001e-47 188.0 sp|Q5F479|S11IP_CHICK Serine/threonine-protein kinase 11-interacting protein OS=Gallus gallus OX=9031 GN=STK11IP PE=2 SV=1 g15463.t2 Q5F479 35.979 378 2.5299999999999997e-54 211.0 sp|Q5F479|S11IP_CHICK Serine/threonine-protein kinase 11-interacting protein OS=Gallus gallus OX=9031 GN=STK11IP PE=2 SV=1 g15463.t3 Q5F479 35.979 378 2.52e-54 211.0 sp|Q5F479|S11IP_CHICK Serine/threonine-protein kinase 11-interacting protein OS=Gallus gallus OX=9031 GN=STK11IP PE=2 SV=1 g15465.t1 P21328 31.102 254 7.65e-23 104.0 sp|P21328|RTJK_DROME RNA-directed DNA polymerase from mobile element jockey OS=Drosophila melanogaster OX=7227 GN=pol PE=1 SV=1 g15468.t1 Q5E9C0 70.182 275 1.5e-137 392.0 sp|Q5E9C0|RSU1_BOVIN Ras suppressor protein 1 OS=Bos taurus OX=9913 GN=RSU1 PE=2 SV=1 g15469.t1 Q5M939 48.024 329 8.51e-94 288.0 sp|Q5M939|HAT1_RAT Histone acetyltransferase type B catalytic subunit OS=Rattus norvegicus OX=10116 GN=Hat1 PE=2 SV=1 HAT1_RAT reviewed Histone acetyltransferase type B catalytic subunit (EC 2.3.1.48) (Histone acetyltransferase 1) (Histone methacryltransferase HAT1) (EC 2.3.1.-) Rattus norvegicus (Rat) GO:0000781; GO:0000785; GO:0005654; GO:0005739; GO:0006334; GO:0007584; GO:0010485; GO:0016363; GO:0031509; GO:0032991; GO:0042393; GO:0043997; GO:0140218 nucleosome assembly [GO:0006334]; response to nutrient [GO:0007584]; subtelomeric heterochromatin formation [GO:0031509] chromatin [GO:0000785]; chromosome, telomeric region [GO:0000781]; mitochondrion [GO:0005739]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991] histone binding [GO:0042393]; histone H4 acetyltransferase activity [GO:0010485]; histone H4K12 acetyltransferase activity [GO:0043997]; histone methacryltransferase activity [GO:0140218] g15471.t1 Q5RBC8 63.518 614 0.0 738.0 sp|Q5RBC8|S2512_PONAB Electrogenic aspartate/glutamate antiporter SLC25A12, mitochondrial OS=Pongo abelii OX=9601 GN=SLC25A12 PE=2 SV=1 S2512_PONAB reviewed Electrogenic aspartate/glutamate antiporter SLC25A12, mitochondrial (Solute carrier family 25 member 12) Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0000514; GO:0000515; GO:0005509; GO:0005739; GO:0005743; GO:0006754; GO:0015810; GO:0015813; GO:0042802; GO:0043490; GO:0045333; GO:0051592 aspartate transmembrane transport [GO:0015810]; ATP biosynthetic process [GO:0006754]; cellular respiration [GO:0045333]; L-glutamate transmembrane transport [GO:0015813]; malate-aspartate shuttle [GO:0043490]; response to calcium ion [GO:0051592] mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739] 3-sulfino-L-alanine: proton, glutamate antiporter activity [GO:0000514]; aspartate:glutamate, proton antiporter activity [GO:0000515]; calcium ion binding [GO:0005509]; identical protein binding [GO:0042802] g15472.t1 Q9CRA4 65.683 271 4.95e-140 399.0 sp|Q9CRA4|MSMO1_MOUSE Methylsterol monooxygenase 1 OS=Mus musculus OX=10090 GN=Msmo1 PE=1 SV=1 MSMO1_MOUSE reviewed Methylsterol monooxygenase 1 (EC 1.14.18.9) (C-4 methylsterol oxidase) (Sterol-C4-methyl oxidase) Mus musculus (Mouse) GO:0000254; GO:0005506; GO:0005789; GO:0016126; GO:0033489; GO:0033490; GO:0036197 cholesterol biosynthetic process via desmosterol [GO:0033489]; cholesterol biosynthetic process via lathosterol [GO:0033490]; sterol biosynthetic process [GO:0016126]; zymosterol biosynthetic process [GO:0036197] endoplasmic reticulum membrane [GO:0005789] C-4 methylsterol oxidase activity [GO:0000254]; iron ion binding [GO:0005506] g15473.t1 Q6GL69 49.673 153 1.82e-41 153.0 sp|Q6GL69|MK67I_XENTR MKI67 FHA domain-interacting nucleolar phosphoprotein-like OS=Xenopus tropicalis OX=8364 GN=nifk PE=2 SV=1 g15474.t1 Q8T773 47.222 504 3.89e-166 483.0 sp|Q8T773|MDH1B_BRAFL Putative malate dehydrogenase 1B OS=Branchiostoma floridae OX=7739 GN=MDH1B PE=3 SV=1 g15476.t1 Q8T773 49.244 463 1.44e-165 483.0 sp|Q8T773|MDH1B_BRAFL Putative malate dehydrogenase 1B OS=Branchiostoma floridae OX=7739 GN=MDH1B PE=3 SV=1 g15478.t1 Q8T773 49.244 463 1.44e-165 483.0 sp|Q8T773|MDH1B_BRAFL Putative malate dehydrogenase 1B OS=Branchiostoma floridae OX=7739 GN=MDH1B PE=3 SV=1 g15488.t1 P10179 91.429 70 9.389999999999999e-40 139.0 sp|P10179|HMB4_TRIGR Homeobox protein HB4 (Fragment) OS=Tripneustes gratilla OX=7673 PE=3 SV=1 g15491.t1 P13545 48.837 258 1.38e-57 189.0 sp|P13545|HMB1_STRPU Homeobox protein HB1 OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=2 g15494.t1 P09077 65.179 112 1.29e-43 155.0 sp|P09077|SCR_DROME Homeotic protein Sex combs reduced OS=Drosophila melanogaster OX=7227 GN=Scr PE=1 SV=5 SCR_DROME reviewed Homeotic protein Sex combs reduced Drosophila melanogaster (Fruit fly) GO:0000977; GO:0000978; GO:0000981; GO:0005634; GO:0005654; GO:0007432; GO:0007494; GO:0009952; GO:0042803; GO:0043565; GO:0045498; GO:0045944 anterior/posterior pattern specification [GO:0009952]; midgut development [GO:0007494]; positive regulation of transcription by RNA polymerase II [GO:0045944]; salivary gland boundary specification [GO:0007432]; sex comb development [GO:0045498] nucleoplasm [GO:0005654]; nucleus [GO:0005634] DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565] g15497.t1 P06798 75.61 82 5.87e-39 134.0 sp|P06798|HXA4_MOUSE Homeobox protein Hox-A4 OS=Mus musculus OX=10090 GN=Hoxa4 PE=2 SV=4 HXA4_MOUSE reviewed Homeobox protein Hox-A4 (Homeobox protein Hox-1.4) (Homeobox protein MH-3) Mus musculus (Mouse) GO:0000978; GO:0000981; GO:0003677; GO:0005654; GO:0009952; GO:0016604; GO:0045944; GO:0048704; GO:1990837 anterior/posterior pattern specification [GO:0009952]; embryonic skeletal system morphogenesis [GO:0048704]; positive regulation of transcription by RNA polymerase II [GO:0045944] nuclear body [GO:0016604]; nucleoplasm [GO:0005654] DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837] g15498.t1 Q3V5Z9 59.701 134 1.58e-41 151.0 sp|Q3V5Z9|HXD3_ORYLA Homeobox protein Hox-D3 OS=Oryzias latipes OX=8090 GN=hoxd3a PE=3 SV=1 g15500.t1 P31246 45.122 164 5.23e-28 117.0 sp|P31246|HXA2_RAT Homeobox protein Hox-A2 OS=Rattus norvegicus OX=10116 GN=Hoxa2 PE=2 SV=1 HXA2_RAT reviewed Homeobox protein Hox-A2 (Homeobox protein Hox-1.11) Rattus norvegicus (Rat) GO:0000122; GO:0000978; GO:0000981; GO:0001227; GO:0001709; GO:0002076; GO:0003700; GO:0005634; GO:0005654; GO:0006357; GO:0007379; GO:0007389; GO:0008045; GO:0009952; GO:0009953; GO:0021568; GO:0021569; GO:0021658; GO:0035284; GO:0042474; GO:0043565; GO:0045165; GO:0045665; GO:0045668; GO:0045944; GO:0048703; GO:0048704; GO:0048706; GO:0060037; GO:0061061; GO:0071300; GO:1990837 anterior/posterior pattern specification [GO:0009952]; brain segmentation [GO:0035284]; cell fate commitment [GO:0045165]; cell fate determination [GO:0001709]; cellular response to retinoic acid [GO:0071300]; dorsal/ventral pattern formation [GO:0009953]; embryonic skeletal system development [GO:0048706]; embryonic skeletal system morphogenesis [GO:0048704]; embryonic viscerocranium morphogenesis [GO:0048703]; middle ear morphogenesis [GO:0042474]; motor neuron axon guidance [GO:0008045]; muscle structure development [GO:0061061]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of transcription by RNA polymerase II [GO:0000122]; osteoblast development [GO:0002076]; pattern specification process [GO:0007389]; pharyngeal system development [GO:0060037]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; rhombomere 2 development [GO:0021568]; rhombomere 3 development [GO:0021569]; rhombomere 3 morphogenesis [GO:0021658]; segment specification [GO:0007379] nucleoplasm [GO:0005654]; nucleus [GO:0005634] DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837] g15503.t1 Q08821 58.511 94 7.55e-26 107.0 sp|Q08821|HXA1_XENLA Homeobox protein Hox-A1 (Fragment) OS=Xenopus laevis OX=8355 GN=hoxa1 PE=2 SV=1 g15505.t1 P50476 58.0 150 6.719999999999999e-42 154.0 sp|P50476|HOX3_XENLA Homeobox protein XHOX-3 OS=Xenopus laevis OX=8355 GN=xhox3 PE=2 SV=1 g15507.t1 P34147 42.14 458 1.34e-105 330.0 sp|P34147|RACA_DICDI Rho-related protein racA OS=Dictyostelium discoideum OX=44689 GN=racA PE=1 SV=2 g15513.t1 Q8VBV4 36.095 169 1.59e-25 105.0 sp|Q8VBV4|FBXW7_MOUSE F-box/WD repeat-containing protein 7 OS=Mus musculus OX=10090 GN=Fbxw7 PE=1 SV=2 g15513.t1 Q8VBV4 34.503 171 1.1499999999999999e-24 103.0 sp|Q8VBV4|FBXW7_MOUSE F-box/WD repeat-containing protein 7 OS=Mus musculus OX=10090 GN=Fbxw7 PE=1 SV=2 g15513.t1 Q8VBV4 32.37 173 9.71e-24 100.0 sp|Q8VBV4|FBXW7_MOUSE F-box/WD repeat-containing protein 7 OS=Mus musculus OX=10090 GN=Fbxw7 PE=1 SV=2 g15514.t1 Q9I9P9 76.106 226 2.41e-125 367.0 sp|Q9I9P9|SMAD2_DANRE Mothers against decapentaplegic homolog 2 OS=Danio rerio OX=7955 GN=smad2 PE=2 SV=1 SMAD2_DANRE reviewed SMAD family member 2 (SMAD 2) (Mothers against decapentaplegic homolog 2) (MAD homolog 2) (Mothers against DPP homolog 2) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0003700; GO:0005634; GO:0005667; GO:0005737; GO:0006355; GO:0006357; GO:0007179; GO:0009653; GO:0009880; GO:0021999; GO:0030154; GO:0032924; GO:0035556; GO:0043565; GO:0045944; GO:0046872; GO:0060028; GO:0060282; GO:0060395; GO:0070411; GO:0071144 activin receptor signaling pathway [GO:0032924]; anatomical structure morphogenesis [GO:0009653]; cell differentiation [GO:0030154]; convergent extension involved in axis elongation [GO:0060028]; embryonic pattern specification [GO:0009880]; intracellular signal transduction [GO:0035556]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural plate anterior/posterior regionalization [GO:0021999]; positive regulation of oocyte development [GO:0060282]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA-templated transcription [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; SMAD protein signal transduction [GO:0060395]; transforming growth factor beta receptor signaling pathway [GO:0007179] chromatin [GO:0000785]; cytoplasm [GO:0005737]; heteromeric SMAD protein complex [GO:0071144]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667] DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; I-SMAD binding [GO:0070411]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565] g15515.t1 Q9ESF4 38.532 218 3.59e-44 154.0 sp|Q9ESF4|LFG1_MOUSE Protein lifeguard 1 OS=Mus musculus OX=10090 GN=Grina PE=2 SV=1 g15516.t1 P52917 43.817 372 2.1000000000000002e-99 306.0 sp|P52917|VPS4_YEAST Vacuolar protein sorting-associated protein 4 OS=Saccharomyces cerevisiae (strain ATCC 204508 / S288c) OX=559292 GN=VPS4 PE=1 SV=1 VPS4_YEAST reviewed Vacuolar protein sorting-associated protein 4 (DOA4-independent degradation protein 6) (Protein END13) (Vacuolar protein-targeting protein 10) Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast) GO:0001778; GO:0005524; GO:0005643; GO:0005737; GO:0005768; GO:0005783; GO:0005886; GO:0006914; GO:0006997; GO:0007033; GO:0015031; GO:0016020; GO:0016125; GO:0016197; GO:0016236; GO:0016887; GO:0030496; GO:0031468; GO:0032511; GO:0036258; GO:0042802; GO:0042803; GO:0043162; GO:0045053; GO:0045324; GO:0061709; GO:0061764; GO:0061952; GO:0070676; GO:0071985; GO:0090148; GO:0090611; GO:0097352; GO:1904949; GO:1990621 autophagosome maturation [GO:0097352]; autophagy [GO:0006914]; endosomal transport [GO:0016197]; intralumenal vesicle formation [GO:0070676]; late endosome to lysosome transport via multivesicular body sorting pathway [GO:0061764]; late endosome to vacuole transport [GO:0045324]; late endosome to vacuole transport via multivesicular body sorting pathway [GO:0032511]; macroautophagy [GO:0016236]; membrane fission [GO:0090148]; midbody abscission [GO:0061952]; multivesicular body assembly [GO:0036258]; multivesicular body sorting pathway [GO:0071985]; nuclear membrane reassembly [GO:0031468]; nucleus organization [GO:0006997]; plasma membrane repair [GO:0001778]; protein retention in Golgi apparatus [GO:0045053]; protein transport [GO:0015031]; reticulophagy [GO:0061709]; sterol metabolic process [GO:0016125]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]; ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway [GO:0090611]; vacuole organization [GO:0007033] ATPase complex [GO:1904949]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; ESCRT IV complex [GO:1990621]; membrane [GO:0016020]; midbody [GO:0030496]; nuclear pore [GO:0005643]; plasma membrane [GO:0005886] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803] g15517.t1 J9PAS6 55.357 112 4.6299999999999994e-42 139.0 sp|J9PAS6|SRP19_CANLF Signal recognition particle 19 kDa protein OS=Canis lupus familiaris OX=9615 GN=SRP19 PE=1 SV=1 g15518.t1 Q5H8C4 32.771 1541 0.0 743.0 sp|Q5H8C4|VP13A_MOUSE Intermembrane lipid transfer protein VPS13A OS=Mus musculus OX=10090 GN=Vps13a PE=1 SV=1 VP13A_MOUSE reviewed Intermembrane lipid transfer protein VPS13A (Chorea-acanthocytosis protein homolog) (Chorein) (Vacuolar protein sorting-associated protein 13A) Mus musculus (Mouse) GO:0000902; GO:0005739; GO:0005741; GO:0005765; GO:0005783; GO:0005789; GO:0005794; GO:0005811; GO:0006623; GO:0006869; GO:0006914; GO:0007399; GO:0007626; GO:0008344; GO:0009306; GO:0010008; GO:0010467; GO:0014004; GO:0030218; GO:0030317; GO:0030382; GO:0031045; GO:0031547; GO:0031966; GO:0035176; GO:0035264; GO:0035640; GO:0043005; GO:0043025; GO:0044233; GO:0045053; GO:0048167; GO:0050885; GO:0050905; GO:0060292; GO:0061744; GO:0071470; GO:0090648; GO:0097225; GO:0099013; GO:0140058; GO:0150076; GO:1905146 adult locomotory behavior [GO:0008344]; autophagy [GO:0006914]; brain-derived neurotrophic factor receptor signaling pathway [GO:0031547]; cell morphogenesis [GO:0000902]; cellular response to osmotic stress [GO:0071470]; erythrocyte differentiation [GO:0030218]; exploration behavior [GO:0035640]; flagellated sperm motility [GO:0030317]; gene expression [GO:0010467]; lipid transport [GO:0006869]; locomotory behavior [GO:0007626]; long-term synaptic depression [GO:0060292]; lysosomal protein catabolic process [GO:1905146]; microglia differentiation [GO:0014004]; motor behavior [GO:0061744]; multicellular organism growth [GO:0035264]; nervous system development [GO:0007399]; neuroinflammatory response [GO:0150076]; neuromuscular process [GO:0050905]; neuromuscular process controlling balance [GO:0050885]; neuron projection arborization [GO:0140058]; protein retention in Golgi apparatus [GO:0045053]; protein secretion [GO:0009306]; protein targeting to vacuole [GO:0006623]; regulation of synaptic plasticity [GO:0048167]; response to environmental enrichment [GO:0090648]; social behavior [GO:0035176]; sperm mitochondrion organization [GO:0030382] dense core granule [GO:0031045]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; lipid droplet [GO:0005811]; lysosomal membrane [GO:0005765]; mitochondria-associated endoplasmic reticulum membrane contact site [GO:0044233]; mitochondrial membrane [GO:0031966]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; neuronal dense core vesicle lumen [GO:0099013]; sperm midpiece [GO:0097225] g15518.t1 Q5H8C4 26.822 947 2.5000000000000003e-79 297.0 sp|Q5H8C4|VP13A_MOUSE Intermembrane lipid transfer protein VPS13A OS=Mus musculus OX=10090 GN=Vps13a PE=1 SV=1 VP13A_MOUSE reviewed Intermembrane lipid transfer protein VPS13A (Chorea-acanthocytosis protein homolog) (Chorein) (Vacuolar protein sorting-associated protein 13A) Mus musculus (Mouse) GO:0000902; GO:0005739; GO:0005741; GO:0005765; GO:0005783; GO:0005789; GO:0005794; GO:0005811; GO:0006623; GO:0006869; GO:0006914; GO:0007399; GO:0007626; GO:0008344; GO:0009306; GO:0010008; GO:0010467; GO:0014004; GO:0030218; GO:0030317; GO:0030382; GO:0031045; GO:0031547; GO:0031966; GO:0035176; GO:0035264; GO:0035640; GO:0043005; GO:0043025; GO:0044233; GO:0045053; GO:0048167; GO:0050885; GO:0050905; GO:0060292; GO:0061744; GO:0071470; GO:0090648; GO:0097225; GO:0099013; GO:0140058; GO:0150076; GO:1905146 adult locomotory behavior [GO:0008344]; autophagy [GO:0006914]; brain-derived neurotrophic factor receptor signaling pathway [GO:0031547]; cell morphogenesis [GO:0000902]; cellular response to osmotic stress [GO:0071470]; erythrocyte differentiation [GO:0030218]; exploration behavior [GO:0035640]; flagellated sperm motility [GO:0030317]; gene expression [GO:0010467]; lipid transport [GO:0006869]; locomotory behavior [GO:0007626]; long-term synaptic depression [GO:0060292]; lysosomal protein catabolic process [GO:1905146]; microglia differentiation [GO:0014004]; motor behavior [GO:0061744]; multicellular organism growth [GO:0035264]; nervous system development [GO:0007399]; neuroinflammatory response [GO:0150076]; neuromuscular process [GO:0050905]; neuromuscular process controlling balance [GO:0050885]; neuron projection arborization [GO:0140058]; protein retention in Golgi apparatus [GO:0045053]; protein secretion [GO:0009306]; protein targeting to vacuole [GO:0006623]; regulation of synaptic plasticity [GO:0048167]; response to environmental enrichment [GO:0090648]; social behavior [GO:0035176]; sperm mitochondrion organization [GO:0030382] dense core granule [GO:0031045]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; lipid droplet [GO:0005811]; lysosomal membrane [GO:0005765]; mitochondria-associated endoplasmic reticulum membrane contact site [GO:0044233]; mitochondrial membrane [GO:0031966]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; neuronal dense core vesicle lumen [GO:0099013]; sperm midpiece [GO:0097225] g15518.t1 Q5H8C4 48.148 27 2.5000000000000003e-79 24.3 sp|Q5H8C4|VP13A_MOUSE Intermembrane lipid transfer protein VPS13A OS=Mus musculus OX=10090 GN=Vps13a PE=1 SV=1 VP13A_MOUSE reviewed Intermembrane lipid transfer protein VPS13A (Chorea-acanthocytosis protein homolog) (Chorein) (Vacuolar protein sorting-associated protein 13A) Mus musculus (Mouse) GO:0000902; GO:0005739; GO:0005741; GO:0005765; GO:0005783; GO:0005789; GO:0005794; GO:0005811; GO:0006623; GO:0006869; GO:0006914; GO:0007399; GO:0007626; GO:0008344; GO:0009306; GO:0010008; GO:0010467; GO:0014004; GO:0030218; GO:0030317; GO:0030382; GO:0031045; GO:0031547; GO:0031966; GO:0035176; GO:0035264; GO:0035640; GO:0043005; GO:0043025; GO:0044233; GO:0045053; GO:0048167; GO:0050885; GO:0050905; GO:0060292; GO:0061744; GO:0071470; GO:0090648; GO:0097225; GO:0099013; GO:0140058; GO:0150076; GO:1905146 adult locomotory behavior [GO:0008344]; autophagy [GO:0006914]; brain-derived neurotrophic factor receptor signaling pathway [GO:0031547]; cell morphogenesis [GO:0000902]; cellular response to osmotic stress [GO:0071470]; erythrocyte differentiation [GO:0030218]; exploration behavior [GO:0035640]; flagellated sperm motility [GO:0030317]; gene expression [GO:0010467]; lipid transport [GO:0006869]; locomotory behavior [GO:0007626]; long-term synaptic depression [GO:0060292]; lysosomal protein catabolic process [GO:1905146]; microglia differentiation [GO:0014004]; motor behavior [GO:0061744]; multicellular organism growth [GO:0035264]; nervous system development [GO:0007399]; neuroinflammatory response [GO:0150076]; neuromuscular process [GO:0050905]; neuromuscular process controlling balance [GO:0050885]; neuron projection arborization [GO:0140058]; protein retention in Golgi apparatus [GO:0045053]; protein secretion [GO:0009306]; protein targeting to vacuole [GO:0006623]; regulation of synaptic plasticity [GO:0048167]; response to environmental enrichment [GO:0090648]; social behavior [GO:0035176]; sperm mitochondrion organization [GO:0030382] dense core granule [GO:0031045]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; lipid droplet [GO:0005811]; lysosomal membrane [GO:0005765]; mitochondria-associated endoplasmic reticulum membrane contact site [GO:0044233]; mitochondrial membrane [GO:0031966]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; neuronal dense core vesicle lumen [GO:0099013]; sperm midpiece [GO:0097225] g15518.t2 Q5H8C4 32.576 1541 0.0 745.0 sp|Q5H8C4|VP13A_MOUSE Intermembrane lipid transfer protein VPS13A OS=Mus musculus OX=10090 GN=Vps13a PE=1 SV=1 VP13A_MOUSE reviewed Intermembrane lipid transfer protein VPS13A (Chorea-acanthocytosis protein homolog) (Chorein) (Vacuolar protein sorting-associated protein 13A) Mus musculus (Mouse) GO:0000902; GO:0005739; GO:0005741; GO:0005765; GO:0005783; GO:0005789; GO:0005794; GO:0005811; GO:0006623; GO:0006869; GO:0006914; GO:0007399; GO:0007626; GO:0008344; GO:0009306; GO:0010008; GO:0010467; GO:0014004; GO:0030218; GO:0030317; GO:0030382; GO:0031045; GO:0031547; GO:0031966; GO:0035176; GO:0035264; GO:0035640; GO:0043005; GO:0043025; GO:0044233; GO:0045053; GO:0048167; GO:0050885; GO:0050905; GO:0060292; GO:0061744; GO:0071470; GO:0090648; GO:0097225; GO:0099013; GO:0140058; GO:0150076; GO:1905146 adult locomotory behavior [GO:0008344]; autophagy [GO:0006914]; brain-derived neurotrophic factor receptor signaling pathway [GO:0031547]; cell morphogenesis [GO:0000902]; cellular response to osmotic stress [GO:0071470]; erythrocyte differentiation [GO:0030218]; exploration behavior [GO:0035640]; flagellated sperm motility [GO:0030317]; gene expression [GO:0010467]; lipid transport [GO:0006869]; locomotory behavior [GO:0007626]; long-term synaptic depression [GO:0060292]; lysosomal protein catabolic process [GO:1905146]; microglia differentiation [GO:0014004]; motor behavior [GO:0061744]; multicellular organism growth [GO:0035264]; nervous system development [GO:0007399]; neuroinflammatory response [GO:0150076]; neuromuscular process [GO:0050905]; neuromuscular process controlling balance [GO:0050885]; neuron projection arborization [GO:0140058]; protein retention in Golgi apparatus [GO:0045053]; protein secretion [GO:0009306]; protein targeting to vacuole [GO:0006623]; regulation of synaptic plasticity [GO:0048167]; response to environmental enrichment [GO:0090648]; social behavior [GO:0035176]; sperm mitochondrion organization [GO:0030382] dense core granule [GO:0031045]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; lipid droplet [GO:0005811]; lysosomal membrane [GO:0005765]; mitochondria-associated endoplasmic reticulum membrane contact site [GO:0044233]; mitochondrial membrane [GO:0031966]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; neuronal dense core vesicle lumen [GO:0099013]; sperm midpiece [GO:0097225] g15518.t2 Q5H8C4 26.822 947 2.5200000000000002e-79 297.0 sp|Q5H8C4|VP13A_MOUSE Intermembrane lipid transfer protein VPS13A OS=Mus musculus OX=10090 GN=Vps13a PE=1 SV=1 VP13A_MOUSE reviewed Intermembrane lipid transfer protein VPS13A (Chorea-acanthocytosis protein homolog) (Chorein) (Vacuolar protein sorting-associated protein 13A) Mus musculus (Mouse) GO:0000902; GO:0005739; GO:0005741; GO:0005765; GO:0005783; GO:0005789; GO:0005794; GO:0005811; GO:0006623; GO:0006869; GO:0006914; GO:0007399; GO:0007626; GO:0008344; GO:0009306; GO:0010008; GO:0010467; GO:0014004; GO:0030218; GO:0030317; GO:0030382; GO:0031045; GO:0031547; GO:0031966; GO:0035176; GO:0035264; GO:0035640; GO:0043005; GO:0043025; GO:0044233; GO:0045053; GO:0048167; GO:0050885; GO:0050905; GO:0060292; GO:0061744; GO:0071470; GO:0090648; GO:0097225; GO:0099013; GO:0140058; GO:0150076; GO:1905146 adult locomotory behavior [GO:0008344]; autophagy [GO:0006914]; brain-derived neurotrophic factor receptor signaling pathway [GO:0031547]; cell morphogenesis [GO:0000902]; cellular response to osmotic stress [GO:0071470]; erythrocyte differentiation [GO:0030218]; exploration behavior [GO:0035640]; flagellated sperm motility [GO:0030317]; gene expression [GO:0010467]; lipid transport [GO:0006869]; locomotory behavior [GO:0007626]; long-term synaptic depression [GO:0060292]; lysosomal protein catabolic process [GO:1905146]; microglia differentiation [GO:0014004]; motor behavior [GO:0061744]; multicellular organism growth [GO:0035264]; nervous system development [GO:0007399]; neuroinflammatory response [GO:0150076]; neuromuscular process [GO:0050905]; neuromuscular process controlling balance [GO:0050885]; neuron projection arborization [GO:0140058]; protein retention in Golgi apparatus [GO:0045053]; protein secretion [GO:0009306]; protein targeting to vacuole [GO:0006623]; regulation of synaptic plasticity [GO:0048167]; response to environmental enrichment [GO:0090648]; social behavior [GO:0035176]; sperm mitochondrion organization [GO:0030382] dense core granule [GO:0031045]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; lipid droplet [GO:0005811]; lysosomal membrane [GO:0005765]; mitochondria-associated endoplasmic reticulum membrane contact site [GO:0044233]; mitochondrial membrane [GO:0031966]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; neuronal dense core vesicle lumen [GO:0099013]; sperm midpiece [GO:0097225] g15518.t2 Q5H8C4 48.148 27 2.5200000000000002e-79 24.3 sp|Q5H8C4|VP13A_MOUSE Intermembrane lipid transfer protein VPS13A OS=Mus musculus OX=10090 GN=Vps13a PE=1 SV=1 VP13A_MOUSE reviewed Intermembrane lipid transfer protein VPS13A (Chorea-acanthocytosis protein homolog) (Chorein) (Vacuolar protein sorting-associated protein 13A) Mus musculus (Mouse) GO:0000902; GO:0005739; GO:0005741; GO:0005765; GO:0005783; GO:0005789; GO:0005794; GO:0005811; GO:0006623; GO:0006869; GO:0006914; GO:0007399; GO:0007626; GO:0008344; GO:0009306; GO:0010008; GO:0010467; GO:0014004; GO:0030218; GO:0030317; GO:0030382; GO:0031045; GO:0031547; GO:0031966; GO:0035176; GO:0035264; GO:0035640; GO:0043005; GO:0043025; GO:0044233; GO:0045053; GO:0048167; GO:0050885; GO:0050905; GO:0060292; GO:0061744; GO:0071470; GO:0090648; GO:0097225; GO:0099013; GO:0140058; GO:0150076; GO:1905146 adult locomotory behavior [GO:0008344]; autophagy [GO:0006914]; brain-derived neurotrophic factor receptor signaling pathway [GO:0031547]; cell morphogenesis [GO:0000902]; cellular response to osmotic stress [GO:0071470]; erythrocyte differentiation [GO:0030218]; exploration behavior [GO:0035640]; flagellated sperm motility [GO:0030317]; gene expression [GO:0010467]; lipid transport [GO:0006869]; locomotory behavior [GO:0007626]; long-term synaptic depression [GO:0060292]; lysosomal protein catabolic process [GO:1905146]; microglia differentiation [GO:0014004]; motor behavior [GO:0061744]; multicellular organism growth [GO:0035264]; nervous system development [GO:0007399]; neuroinflammatory response [GO:0150076]; neuromuscular process [GO:0050905]; neuromuscular process controlling balance [GO:0050885]; neuron projection arborization [GO:0140058]; protein retention in Golgi apparatus [GO:0045053]; protein secretion [GO:0009306]; protein targeting to vacuole [GO:0006623]; regulation of synaptic plasticity [GO:0048167]; response to environmental enrichment [GO:0090648]; social behavior [GO:0035176]; sperm mitochondrion organization [GO:0030382] dense core granule [GO:0031045]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; lipid droplet [GO:0005811]; lysosomal membrane [GO:0005765]; mitochondria-associated endoplasmic reticulum membrane contact site [GO:0044233]; mitochondrial membrane [GO:0031966]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; neuronal dense core vesicle lumen [GO:0099013]; sperm midpiece [GO:0097225] g15518.t3 Q5H8C4 32.576 1541 0.0 745.0 sp|Q5H8C4|VP13A_MOUSE Intermembrane lipid transfer protein VPS13A OS=Mus musculus OX=10090 GN=Vps13a PE=1 SV=1 VP13A_MOUSE reviewed Intermembrane lipid transfer protein VPS13A (Chorea-acanthocytosis protein homolog) (Chorein) (Vacuolar protein sorting-associated protein 13A) Mus musculus (Mouse) GO:0000902; GO:0005739; GO:0005741; GO:0005765; GO:0005783; GO:0005789; GO:0005794; GO:0005811; GO:0006623; GO:0006869; GO:0006914; GO:0007399; GO:0007626; GO:0008344; GO:0009306; GO:0010008; GO:0010467; GO:0014004; GO:0030218; GO:0030317; GO:0030382; GO:0031045; GO:0031547; GO:0031966; GO:0035176; GO:0035264; GO:0035640; GO:0043005; GO:0043025; GO:0044233; GO:0045053; GO:0048167; GO:0050885; GO:0050905; GO:0060292; GO:0061744; GO:0071470; GO:0090648; GO:0097225; GO:0099013; GO:0140058; GO:0150076; GO:1905146 adult locomotory behavior [GO:0008344]; autophagy [GO:0006914]; brain-derived neurotrophic factor receptor signaling pathway [GO:0031547]; cell morphogenesis [GO:0000902]; cellular response to osmotic stress [GO:0071470]; erythrocyte differentiation [GO:0030218]; exploration behavior [GO:0035640]; flagellated sperm motility [GO:0030317]; gene expression [GO:0010467]; lipid transport [GO:0006869]; locomotory behavior [GO:0007626]; long-term synaptic depression [GO:0060292]; lysosomal protein catabolic process [GO:1905146]; microglia differentiation [GO:0014004]; motor behavior [GO:0061744]; multicellular organism growth [GO:0035264]; nervous system development [GO:0007399]; neuroinflammatory response [GO:0150076]; neuromuscular process [GO:0050905]; neuromuscular process controlling balance [GO:0050885]; neuron projection arborization [GO:0140058]; protein retention in Golgi apparatus [GO:0045053]; protein secretion [GO:0009306]; protein targeting to vacuole [GO:0006623]; regulation of synaptic plasticity [GO:0048167]; response to environmental enrichment [GO:0090648]; social behavior [GO:0035176]; sperm mitochondrion organization [GO:0030382] dense core granule [GO:0031045]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; lipid droplet [GO:0005811]; lysosomal membrane [GO:0005765]; mitochondria-associated endoplasmic reticulum membrane contact site [GO:0044233]; mitochondrial membrane [GO:0031966]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; neuronal dense core vesicle lumen [GO:0099013]; sperm midpiece [GO:0097225] g15518.t3 Q5H8C4 26.188 947 4.0900000000000006e-79 296.0 sp|Q5H8C4|VP13A_MOUSE Intermembrane lipid transfer protein VPS13A OS=Mus musculus OX=10090 GN=Vps13a PE=1 SV=1 VP13A_MOUSE reviewed Intermembrane lipid transfer protein VPS13A (Chorea-acanthocytosis protein homolog) (Chorein) (Vacuolar protein sorting-associated protein 13A) Mus musculus (Mouse) GO:0000902; GO:0005739; GO:0005741; GO:0005765; GO:0005783; GO:0005789; GO:0005794; GO:0005811; GO:0006623; GO:0006869; GO:0006914; GO:0007399; GO:0007626; GO:0008344; GO:0009306; GO:0010008; GO:0010467; GO:0014004; GO:0030218; GO:0030317; GO:0030382; GO:0031045; GO:0031547; GO:0031966; GO:0035176; GO:0035264; GO:0035640; GO:0043005; GO:0043025; GO:0044233; GO:0045053; GO:0048167; GO:0050885; GO:0050905; GO:0060292; GO:0061744; GO:0071470; GO:0090648; GO:0097225; GO:0099013; GO:0140058; GO:0150076; GO:1905146 adult locomotory behavior [GO:0008344]; autophagy [GO:0006914]; brain-derived neurotrophic factor receptor signaling pathway [GO:0031547]; cell morphogenesis [GO:0000902]; cellular response to osmotic stress [GO:0071470]; erythrocyte differentiation [GO:0030218]; exploration behavior [GO:0035640]; flagellated sperm motility [GO:0030317]; gene expression [GO:0010467]; lipid transport [GO:0006869]; locomotory behavior [GO:0007626]; long-term synaptic depression [GO:0060292]; lysosomal protein catabolic process [GO:1905146]; microglia differentiation [GO:0014004]; motor behavior [GO:0061744]; multicellular organism growth [GO:0035264]; nervous system development [GO:0007399]; neuroinflammatory response [GO:0150076]; neuromuscular process [GO:0050905]; neuromuscular process controlling balance [GO:0050885]; neuron projection arborization [GO:0140058]; protein retention in Golgi apparatus [GO:0045053]; protein secretion [GO:0009306]; protein targeting to vacuole [GO:0006623]; regulation of synaptic plasticity [GO:0048167]; response to environmental enrichment [GO:0090648]; social behavior [GO:0035176]; sperm mitochondrion organization [GO:0030382] dense core granule [GO:0031045]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; lipid droplet [GO:0005811]; lysosomal membrane [GO:0005765]; mitochondria-associated endoplasmic reticulum membrane contact site [GO:0044233]; mitochondrial membrane [GO:0031966]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; neuronal dense core vesicle lumen [GO:0099013]; sperm midpiece [GO:0097225] g15518.t3 Q5H8C4 48.148 27 4.0900000000000006e-79 24.3 sp|Q5H8C4|VP13A_MOUSE Intermembrane lipid transfer protein VPS13A OS=Mus musculus OX=10090 GN=Vps13a PE=1 SV=1 VP13A_MOUSE reviewed Intermembrane lipid transfer protein VPS13A (Chorea-acanthocytosis protein homolog) (Chorein) (Vacuolar protein sorting-associated protein 13A) Mus musculus (Mouse) GO:0000902; GO:0005739; GO:0005741; GO:0005765; GO:0005783; GO:0005789; GO:0005794; GO:0005811; GO:0006623; GO:0006869; GO:0006914; GO:0007399; GO:0007626; GO:0008344; GO:0009306; GO:0010008; GO:0010467; GO:0014004; GO:0030218; GO:0030317; GO:0030382; GO:0031045; GO:0031547; GO:0031966; GO:0035176; GO:0035264; GO:0035640; GO:0043005; GO:0043025; GO:0044233; GO:0045053; GO:0048167; GO:0050885; GO:0050905; GO:0060292; GO:0061744; GO:0071470; GO:0090648; GO:0097225; GO:0099013; GO:0140058; GO:0150076; GO:1905146 adult locomotory behavior [GO:0008344]; autophagy [GO:0006914]; brain-derived neurotrophic factor receptor signaling pathway [GO:0031547]; cell morphogenesis [GO:0000902]; cellular response to osmotic stress [GO:0071470]; erythrocyte differentiation [GO:0030218]; exploration behavior [GO:0035640]; flagellated sperm motility [GO:0030317]; gene expression [GO:0010467]; lipid transport [GO:0006869]; locomotory behavior [GO:0007626]; long-term synaptic depression [GO:0060292]; lysosomal protein catabolic process [GO:1905146]; microglia differentiation [GO:0014004]; motor behavior [GO:0061744]; multicellular organism growth [GO:0035264]; nervous system development [GO:0007399]; neuroinflammatory response [GO:0150076]; neuromuscular process [GO:0050905]; neuromuscular process controlling balance [GO:0050885]; neuron projection arborization [GO:0140058]; protein retention in Golgi apparatus [GO:0045053]; protein secretion [GO:0009306]; protein targeting to vacuole [GO:0006623]; regulation of synaptic plasticity [GO:0048167]; response to environmental enrichment [GO:0090648]; social behavior [GO:0035176]; sperm mitochondrion organization [GO:0030382] dense core granule [GO:0031045]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; lipid droplet [GO:0005811]; lysosomal membrane [GO:0005765]; mitochondria-associated endoplasmic reticulum membrane contact site [GO:0044233]; mitochondrial membrane [GO:0031966]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; neuronal dense core vesicle lumen [GO:0099013]; sperm midpiece [GO:0097225] g15519.t1 A1Z713 47.13 575 4.9400000000000004e-144 466.0 sp|A1Z713|VPS13_DROME Intermembrane lipid transfer protein Vps13 OS=Drosophila melanogaster OX=7227 GN=Vps13 PE=1 SV=2 g15520.t1 Q8C9X6 55.531 452 1.37e-141 441.0 sp|Q8C9X6|EPC1_MOUSE Enhancer of polycomb homolog 1 OS=Mus musculus OX=10090 GN=Epc1 PE=1 SV=1 EPC1_MOUSE reviewed Enhancer of polycomb homolog 1 Mus musculus (Mouse) GO:0000122; GO:0000724; GO:0000786; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006303; GO:0006357; GO:0016604; GO:0031965; GO:0032777; GO:0035092; GO:0035267; GO:0035861; GO:0035886; GO:0042981; GO:0045814; GO:0045892; GO:0045893; GO:0045944; GO:0051155; GO:0051726; GO:0140463; GO:0140767; GO:1902275; GO:1905168; GO:2000779 double-strand break repair via homologous recombination [GO:0000724]; double-strand break repair via nonhomologous end joining [GO:0006303]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of striated muscle cell differentiation [GO:0051155]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of chromatin organization [GO:1902275]; regulation of double-strand break repair [GO:2000779]; regulation of transcription by RNA polymerase II [GO:0006357]; sperm DNA condensation [GO:0035092]; vascular associated smooth muscle cell differentiation [GO:0035886] cytoplasm [GO:0005737]; NuA4 histone acetyltransferase complex [GO:0035267]; nuclear body [GO:0016604]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634]; piccolo histone acetyltransferase complex [GO:0032777]; site of double-strand break [GO:0035861] chromatin-protein adaptor activity [GO:0140463]; enzyme-substrate adaptor activity [GO:0140767] g15521.t1 A8JR92 45.926 135 9.27e-24 114.0 sp|A8JR92|MBD56_DROME Methyl-CpG-binding domain protein 5/6 homolog sba OS=Drosophila melanogaster OX=7227 GN=sba PE=1 SV=1 MBD56_DROME reviewed Methyl-CpG-binding domain protein 5/6 homolog sba (dMBD5/6) (Protein six-banded) Drosophila melanogaster (Fruit fly) GO:0003677; GO:0003682; GO:0005634 nucleus [GO:0005634] chromatin binding [GO:0003682]; DNA binding [GO:0003677] g15522.t1 B1AYB6 43.902 123 2.2099999999999997e-23 110.0 sp|B1AYB6|MBD5_MOUSE Methyl-CpG-binding domain protein 5 OS=Mus musculus OX=10090 GN=Mbd5 PE=2 SV=1 g15523.t1 Q7ZYJ9 53.191 423 4.66e-158 454.0 sp|Q7ZYJ9|AASDB_XENLA Alanyl-tRNA editing protein Aarsd1-B OS=Xenopus laevis OX=8355 GN=aarsd1-b PE=2 SV=1 g15524.t1 E7FDB3 71.93 57 1.9e-22 93.6 sp|E7FDB3|NANO1_DANRE Nanos homolog 1 OS=Danio rerio OX=7955 GN=nanos1 PE=3 SV=1 g15525.t1 E7FDB3 71.93 57 5.05e-22 92.4 sp|E7FDB3|NANO1_DANRE Nanos homolog 1 OS=Danio rerio OX=7955 GN=nanos1 PE=3 SV=1 g15526.t1 Q6P8G1 53.134 335 1.39e-112 334.0 sp|Q6P8G1|ILF2_XENTR Interleukin enhancer-binding factor 2 homolog OS=Xenopus tropicalis OX=8364 GN=ilf2 PE=2 SV=1 g15529.t1 Q6ZQT0 38.235 136 1.49e-25 102.0 sp|Q6ZQT0|YD023_HUMAN Putative uncharacterized protein FLJ45035 OS=Homo sapiens OX=9606 PE=5 SV=1 g15529.t1 Q6ZQT0 38.235 136 1.49e-25 102.0 sp|Q6ZQT0|YD023_HUMAN Putative uncharacterized protein FLJ45035 OS=Homo sapiens OX=9606 PE=5 SV=1 g15529.t1 Q6ZQT0 38.235 136 1.49e-25 102.0 sp|Q6ZQT0|YD023_HUMAN Putative uncharacterized protein FLJ45035 OS=Homo sapiens OX=9606 PE=5 SV=1 g15529.t1 Q6ZQT0 37.956 137 1.73e-25 101.0 sp|Q6ZQT0|YD023_HUMAN Putative uncharacterized protein FLJ45035 OS=Homo sapiens OX=9606 PE=5 SV=1 g15529.t1 Q6ZQT0 37.5 136 3.62e-25 100.0 sp|Q6ZQT0|YD023_HUMAN Putative uncharacterized protein FLJ45035 OS=Homo sapiens OX=9606 PE=5 SV=1 g15529.t1 Q6ZQT0 37.5 136 3.62e-25 100.0 sp|Q6ZQT0|YD023_HUMAN Putative uncharacterized protein FLJ45035 OS=Homo sapiens OX=9606 PE=5 SV=1 g15529.t1 Q6ZQT0 37.778 135 8.33e-25 100.0 sp|Q6ZQT0|YD023_HUMAN Putative uncharacterized protein FLJ45035 OS=Homo sapiens OX=9606 PE=5 SV=1 g15533.t1 P16066 53.22 823 0.0 882.0 sp|P16066|ANPRA_HUMAN Atrial natriuretic peptide receptor 1 OS=Homo sapiens OX=9606 GN=NPR1 PE=1 SV=1 ANPRA_HUMAN reviewed Atrial natriuretic peptide receptor 1 (EC 4.6.1.2) (Atrial natriuretic peptide receptor type A) (ANP-A) (ANPR-A) (NPR-A) (Guanylate cyclase A) (GC-A) Homo sapiens (Human) GO:0001653; GO:0004383; GO:0004672; GO:0005524; GO:0005525; GO:0005886; GO:0006182; GO:0007166; GO:0007168; GO:0007589; GO:0008217; GO:0008528; GO:0010753; GO:0016525; GO:0016941; GO:0017046; GO:0019934; GO:0030308; GO:0035810; GO:0035815; GO:0042417; GO:0042562; GO:0043114; GO:0043235; GO:0048662; GO:0097746; GO:1990620 blood vessel diameter maintenance [GO:0097746]; body fluid secretion [GO:0007589]; cell surface receptor signaling pathway [GO:0007166]; cGMP biosynthetic process [GO:0006182]; cGMP-mediated signaling [GO:0019934]; dopamine metabolic process [GO:0042417]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell growth [GO:0030308]; negative regulation of smooth muscle cell proliferation [GO:0048662]; positive regulation of cGMP-mediated signaling [GO:0010753]; positive regulation of renal sodium excretion [GO:0035815]; positive regulation of urine volume [GO:0035810]; receptor guanylyl cyclase signaling pathway [GO:0007168]; regulation of blood pressure [GO:0008217]; regulation of vascular permeability [GO:0043114] ANPR-A receptor complex [GO:1990620]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] ATP binding [GO:0005524]; G protein-coupled peptide receptor activity [GO:0008528]; GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; hormone binding [GO:0042562]; natriuretic peptide receptor activity [GO:0016941]; peptide hormone binding [GO:0017046]; peptide receptor activity [GO:0001653]; protein kinase activity [GO:0004672] g15536.t1 Q9UPZ6 35.171 1288 0.0 692.0 sp|Q9UPZ6|THS7A_HUMAN Thrombospondin type-1 domain-containing protein 7A OS=Homo sapiens OX=9606 GN=THSD7A PE=1 SV=4 g15536.t1 Q9UPZ6 27.241 1149 5.62e-72 268.0 sp|Q9UPZ6|THS7A_HUMAN Thrombospondin type-1 domain-containing protein 7A OS=Homo sapiens OX=9606 GN=THSD7A PE=1 SV=4 g15536.t1 Q9UPZ6 26.294 1198 8.890000000000001e-72 268.0 sp|Q9UPZ6|THS7A_HUMAN Thrombospondin type-1 domain-containing protein 7A OS=Homo sapiens OX=9606 GN=THSD7A PE=1 SV=4 g15536.t1 Q9UPZ6 26.101 908 5.0699999999999996e-45 182.0 sp|Q9UPZ6|THS7A_HUMAN Thrombospondin type-1 domain-containing protein 7A OS=Homo sapiens OX=9606 GN=THSD7A PE=1 SV=4 g15536.t1 Q9UPZ6 24.266 919 5.59e-40 166.0 sp|Q9UPZ6|THS7A_HUMAN Thrombospondin type-1 domain-containing protein 7A OS=Homo sapiens OX=9606 GN=THSD7A PE=1 SV=4 g15536.t1 Q9UPZ6 26.771 706 1.5e-36 155.0 sp|Q9UPZ6|THS7A_HUMAN Thrombospondin type-1 domain-containing protein 7A OS=Homo sapiens OX=9606 GN=THSD7A PE=1 SV=4 g15536.t2 Q9UPZ6 34.554 1311 0.0 684.0 sp|Q9UPZ6|THS7A_HUMAN Thrombospondin type-1 domain-containing protein 7A OS=Homo sapiens OX=9606 GN=THSD7A PE=1 SV=4 g15536.t2 Q9UPZ6 25.799 1221 2.85e-69 260.0 sp|Q9UPZ6|THS7A_HUMAN Thrombospondin type-1 domain-containing protein 7A OS=Homo sapiens OX=9606 GN=THSD7A PE=1 SV=4 g15536.t2 Q9UPZ6 26.706 1172 2.85e-69 260.0 sp|Q9UPZ6|THS7A_HUMAN Thrombospondin type-1 domain-containing protein 7A OS=Homo sapiens OX=9606 GN=THSD7A PE=1 SV=4 g15536.t2 Q9UPZ6 25.948 844 1.16e-44 181.0 sp|Q9UPZ6|THS7A_HUMAN Thrombospondin type-1 domain-containing protein 7A OS=Homo sapiens OX=9606 GN=THSD7A PE=1 SV=4 g15536.t2 Q9UPZ6 24.284 943 2.0199999999999998e-38 161.0 sp|Q9UPZ6|THS7A_HUMAN Thrombospondin type-1 domain-containing protein 7A OS=Homo sapiens OX=9606 GN=THSD7A PE=1 SV=4 g15536.t2 Q9UPZ6 26.771 706 1.51e-36 155.0 sp|Q9UPZ6|THS7A_HUMAN Thrombospondin type-1 domain-containing protein 7A OS=Homo sapiens OX=9606 GN=THSD7A PE=1 SV=4 g15540.t1 A7MBS7 39.614 207 4.9000000000000003e-36 141.0 sp|A7MBS7|THS7A_DANRE Thrombospondin type-1 domain-containing protein 7A OS=Danio rerio OX=7955 GN=thsd7aa PE=1 SV=2 THS7A_DANRE reviewed Thrombospondin type-1 domain-containing protein 7A Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001525; GO:0002040; GO:0003094; GO:0005886; GO:0008593; GO:0030036; GO:0032835; GO:0042995; GO:0043534; GO:0048675; GO:0072015 actin cytoskeleton organization [GO:0030036]; angiogenesis [GO:0001525]; axon extension [GO:0048675]; blood vessel endothelial cell migration [GO:0043534]; glomerular filtration [GO:0003094]; glomerulus development [GO:0032835]; podocyte development [GO:0072015]; regulation of Notch signaling pathway [GO:0008593]; sprouting angiogenesis [GO:0002040] cell projection [GO:0042995]; plasma membrane [GO:0005886] g15541.t1 P46735 49.063 907 0.0 836.0 sp|P46735|MYO1B_MOUSE Unconventional myosin-Ib OS=Mus musculus OX=10090 GN=Myo1b PE=1 SV=3 MYO1B_MOUSE reviewed Unconventional myosin-Ib (MIH-L) (Myosin I alpha) (MMI-alpha) (MMIa) Mus musculus (Mouse) GO:0000146; GO:0003774; GO:0003779; GO:0005516; GO:0005524; GO:0005546; GO:0005547; GO:0005737; GO:0005769; GO:0005884; GO:0005886; GO:0005902; GO:0005903; GO:0006892; GO:0006897; GO:0007015; GO:0010008; GO:0015629; GO:0016459; GO:0030048; GO:0030175; GO:0033572; GO:0045177; GO:0048471; GO:0051015; GO:0051017; GO:0071944 actin filament bundle assembly [GO:0051017]; actin filament organization [GO:0007015]; actin filament-based movement [GO:0030048]; endocytosis [GO:0006897]; post-Golgi vesicle-mediated transport [GO:0006892]; transferrin transport [GO:0033572] actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; apical part of cell [GO:0045177]; brush border [GO:0005903]; cell periphery [GO:0071944]; cytoplasm [GO:0005737]; early endosome [GO:0005769]; endosome membrane [GO:0010008]; filopodium [GO:0030175]; microvillus [GO:0005902]; myosin complex [GO:0016459]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886] actin binding [GO:0003779]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; cytoskeletal motor activity [GO:0003774]; microfilament motor activity [GO:0000146]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546] g15542.t1 O43795 72.067 179 3.35e-92 294.0 sp|O43795|MYO1B_HUMAN Unconventional myosin-Ib OS=Homo sapiens OX=9606 GN=MYO1B PE=1 SV=3 MYO1B_HUMAN reviewed Unconventional myosin-Ib (MYH-1c) (Myosin I alpha) (MMI-alpha) (MMIa) Homo sapiens (Human) GO:0000146; GO:0005516; GO:0005524; GO:0005546; GO:0005547; GO:0005737; GO:0005769; GO:0005884; GO:0005886; GO:0005902; GO:0005903; GO:0006892; GO:0006897; GO:0007015; GO:0010008; GO:0015629; GO:0016459; GO:0030048; GO:0030175; GO:0045296; GO:0048471; GO:0051015; GO:0051017; GO:0070062; GO:0071944 actin filament bundle assembly [GO:0051017]; actin filament organization [GO:0007015]; actin filament-based movement [GO:0030048]; endocytosis [GO:0006897]; post-Golgi vesicle-mediated transport [GO:0006892] actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; brush border [GO:0005903]; cell periphery [GO:0071944]; cytoplasm [GO:0005737]; early endosome [GO:0005769]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; filopodium [GO:0030175]; microvillus [GO:0005902]; myosin complex [GO:0016459]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886] actin filament binding [GO:0051015]; ATP binding [GO:0005524]; cadherin binding [GO:0045296]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546] g15544.t1 Q5XHF8 68.694 888 0.0 1224.0 sp|Q5XHF8|VIP2_XENLA Inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 2 OS=Xenopus laevis OX=8355 GN=ppip5k2 PE=2 SV=1 VIP2_XENLA reviewed Inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 2 (EC 2.7.4.24) (Diphosphoinositol pentakisphosphate kinase 2) (Histidine acid phosphatase domain-containing protein 1) (InsP6 and PP-IP5 kinase 2) (VIP1 homolog 2) Xenopus laevis (African clawed frog) GO:0000827; GO:0000828; GO:0000832; GO:0005524; GO:0005829; GO:0006020; GO:0032958; GO:0033857; GO:0052723 inositol metabolic process [GO:0006020]; inositol phosphate biosynthetic process [GO:0032958] cytosol [GO:0005829] 5-diphosphoinositol pentakisphosphate 1-kinase activity [GO:0033857]; ATP binding [GO:0005524]; inositol hexakisphosphate 1-kinase activity [GO:0052723]; inositol hexakisphosphate 5-kinase activity [GO:0000832]; inositol hexakisphosphate kinase activity [GO:0000828]; inositol-1,3,4,5,6-pentakisphosphate kinase activity [GO:0000827] g15544.t2 O43314 58.435 1150 0.0 1219.0 sp|O43314|VIP2_HUMAN Inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 2 OS=Homo sapiens OX=9606 GN=PPIP5K2 PE=1 SV=3 VIP2_HUMAN reviewed Inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 2 (EC 2.7.4.24) (Diphosphoinositol pentakisphosphate kinase 2) (Histidine acid phosphatase domain-containing protein 1) (InsP6 and PP-IP5 kinase 2) (VIP1 homolog 2) (hsVIP2) Homo sapiens (Human) GO:0000827; GO:0000828; GO:0000829; GO:0000832; GO:0005524; GO:0005829; GO:0006020; GO:0007605; GO:0032958; GO:0033857; GO:0043647; GO:0052723 inositol metabolic process [GO:0006020]; inositol phosphate biosynthetic process [GO:0032958]; inositol phosphate metabolic process [GO:0043647]; sensory perception of sound [GO:0007605] cytosol [GO:0005829] 5-diphosphoinositol pentakisphosphate 1-kinase activity [GO:0033857]; ATP binding [GO:0005524]; diphosphoinositol pentakisphosphate kinase activity [GO:0000829]; inositol hexakisphosphate 1-kinase activity [GO:0052723]; inositol hexakisphosphate 5-kinase activity [GO:0000832]; inositol hexakisphosphate kinase activity [GO:0000828]; inositol-1,3,4,5,6-pentakisphosphate kinase activity [GO:0000827] g15546.t1 Q5R733 67.552 339 7.93e-160 468.0 sp|Q5R733|CPEB1_PONAB Cytoplasmic polyadenylation element-binding protein 1 OS=Pongo abelii OX=9601 GN=CPEB1 PE=2 SV=1 CPEB1_PONAB reviewed Cytoplasmic polyadenylation element-binding protein 1 (CPE-BP1) (CPE-binding protein 1) (CPEB-1) Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0000900; GO:0000932; GO:0005634; GO:0005737; GO:0006397; GO:0008135; GO:0014069; GO:0016020; GO:0030425; GO:0031440; GO:0032869; GO:0035925; GO:0043022; GO:0046872; GO:0071230; GO:0071456; GO:1990904; GO:2000766 cellular response to amino acid stimulus [GO:0071230]; cellular response to hypoxia [GO:0071456]; cellular response to insulin stimulus [GO:0032869]; mRNA processing [GO:0006397]; negative regulation of cytoplasmic translation [GO:2000766]; regulation of mRNA 3'-end processing [GO:0031440] cytoplasm [GO:0005737]; dendrite [GO:0030425]; membrane [GO:0016020]; nucleus [GO:0005634]; P-body [GO:0000932]; postsynaptic density [GO:0014069]; ribonucleoprotein complex [GO:1990904] metal ion binding [GO:0046872]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; mRNA regulatory element binding translation repressor activity [GO:0000900]; ribosome binding [GO:0043022]; translation factor activity, RNA binding [GO:0008135] g15547.t1 Q54X73 42.958 142 1.05e-28 117.0 sp|Q54X73|ACOHC_DICDI Probable cytoplasmic aconitate hydratase OS=Dictyostelium discoideum OX=44689 GN=aco1 PE=3 SV=1 g5363.t1 O70165 52.198 182 1.0199999999999999e-52 180.0 sp|O70165|FCN1_MOUSE Ficolin-1 OS=Mus musculus OX=10090 GN=Fcn1 PE=1 SV=1 FCN1_MOUSE reviewed Ficolin-1 (Collagen/fibrinogen domain-containing protein 1) (Ficolin-A) (Ficolin-alpha) (M-ficolin) Mus musculus (Mouse) GO:0001664; GO:0001867; GO:0002752; GO:0003823; GO:0005102; GO:0005581; GO:0005615; GO:0005886; GO:0007186; GO:0032757; GO:0033691; GO:0038187; GO:0042802; GO:0043394; GO:0046872; GO:0048306; GO:0070892; GO:0097367; GO:0106139; GO:1905370; GO:2001065 cell surface pattern recognition receptor signaling pathway [GO:0002752]; complement activation, lectin pathway [GO:0001867]; G protein-coupled receptor signaling pathway [GO:0007186]; positive regulation of interleukin-8 production [GO:0032757] collagen trimer [GO:0005581]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; serine-type endopeptidase complex [GO:1905370]; symbiont cell surface [GO:0106139] antigen binding [GO:0003823]; calcium-dependent protein binding [GO:0048306]; carbohydrate derivative binding [GO:0097367]; G protein-coupled receptor binding [GO:0001664]; identical protein binding [GO:0042802]; lipoteichoic acid immune receptor activity [GO:0070892]; mannan binding [GO:2001065]; metal ion binding [GO:0046872]; pattern recognition receptor activity [GO:0038187]; proteoglycan binding [GO:0043394]; sialic acid binding [GO:0033691]; signaling receptor binding [GO:0005102] g5369.t1 Q39575 29.916 478 6.0900000000000005e-47 184.0 sp|Q39575|DYHG_CHLRE Dynein gamma chain, flagellar outer arm OS=Chlamydomonas reinhardtii OX=3055 GN=ODA2 PE=1 SV=1 g5369.t2 Q39575 29.916 478 8.4700000000000005e-47 184.0 sp|Q39575|DYHG_CHLRE Dynein gamma chain, flagellar outer arm OS=Chlamydomonas reinhardtii OX=3055 GN=ODA2 PE=1 SV=1 g5370.t1 M0R8U1 27.94 1267 9.43e-152 513.0 sp|M0R8U1|DYH5_RAT Dynein axonemal heavy chain 5 (Fragment) OS=Rattus norvegicus OX=10116 GN=Dnah5 PE=1 SV=1 DYH5_RAT reviewed Dynein axonemal heavy chain 5 (Axonemal beta dynein heavy chain 5) (Ciliary dynein heavy chain 5) Rattus norvegicus (Rat) GO:0003341; GO:0003351; GO:0003777; GO:0005524; GO:0005576; GO:0005737; GO:0005858; GO:0005874; GO:0005930; GO:0007368; GO:0007507; GO:0008569; GO:0021670; GO:0030317; GO:0031514; GO:0036157; GO:0036158; GO:0045505; GO:0051649; GO:0051959; GO:0060271; GO:0060294; GO:0097386; GO:0097728; GO:0097729 cilium assembly [GO:0060271]; cilium movement [GO:0003341]; cilium movement involved in cell motility [GO:0060294]; determination of left/right symmetry [GO:0007368]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; establishment of localization in cell [GO:0051649]; flagellated sperm motility [GO:0030317]; heart development [GO:0007507]; lateral ventricle development [GO:0021670]; outer dynein arm assembly [GO:0036158] 9+0 motile cilium [GO:0097728]; 9+2 motile cilium [GO:0097729]; axonemal dynein complex [GO:0005858]; axoneme [GO:0005930]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; glial cell projection [GO:0097386]; microtubule [GO:0005874]; motile cilium [GO:0031514]; outer dynein arm [GO:0036157] ATP binding [GO:0005524]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]; minus-end-directed microtubule motor activity [GO:0008569] g5370.t2 Q8VHE6 28.211 1269 1.1e-152 516.0 sp|Q8VHE6|DYH5_MOUSE Dynein axonemal heavy chain 5 OS=Mus musculus OX=10090 GN=Dnah5 PE=1 SV=2 DYH5_MOUSE reviewed Dynein axonemal heavy chain 5 (Axonemal beta dynein heavy chain 5) (mDNAH5) (Ciliary dynein heavy chain 5) Mus musculus (Mouse) GO:0003341; GO:0003351; GO:0003777; GO:0005524; GO:0005576; GO:0005737; GO:0005858; GO:0005874; GO:0005930; GO:0007368; GO:0007507; GO:0008569; GO:0021670; GO:0030317; GO:0031514; GO:0036157; GO:0036158; GO:0045505; GO:0051959; GO:0060271; GO:0060294; GO:0097728; GO:0097729 cilium assembly [GO:0060271]; cilium movement [GO:0003341]; cilium movement involved in cell motility [GO:0060294]; determination of left/right symmetry [GO:0007368]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; flagellated sperm motility [GO:0030317]; heart development [GO:0007507]; lateral ventricle development [GO:0021670]; outer dynein arm assembly [GO:0036158] 9+0 motile cilium [GO:0097728]; 9+2 motile cilium [GO:0097729]; axonemal dynein complex [GO:0005858]; axoneme [GO:0005930]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; microtubule [GO:0005874]; motile cilium [GO:0031514]; outer dynein arm [GO:0036157] ATP binding [GO:0005524]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]; minus-end-directed microtubule motor activity [GO:0008569] g5372.t1 Q9JHU4 29.816 597 1.3699999999999999e-62 229.0 sp|Q9JHU4|DYHC1_MOUSE Cytoplasmic dynein 1 heavy chain 1 OS=Mus musculus OX=10090 GN=Dync1h1 PE=1 SV=2 DYHC1_MOUSE reviewed Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic) Mus musculus (Mouse) GO:0002177; GO:0003341; GO:0005524; GO:0005635; GO:0005737; GO:0005813; GO:0005868; GO:0005874; GO:0005881; GO:0005938; GO:0007052; GO:0007097; GO:0008090; GO:0008569; GO:0030175; GO:0030286; GO:0030424; GO:0031122; GO:0032388; GO:0033962; GO:0034063; GO:0042802; GO:0043025; GO:0045505; GO:0051293; GO:0051301; GO:0051959; GO:0060236; GO:0090235; GO:0120162; GO:1904115; GO:1905832 cell division [GO:0051301]; cilium movement [GO:0003341]; cytoplasmic microtubule organization [GO:0031122]; establishment of spindle localization [GO:0051293]; mitotic spindle organization [GO:0007052]; nuclear migration [GO:0007097]; P-body assembly [GO:0033962]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of intracellular transport [GO:0032388]; positive regulation of spindle assembly [GO:1905832]; regulation of metaphase plate congression [GO:0090235]; regulation of mitotic spindle organization [GO:0060236]; retrograde axonal transport [GO:0008090]; stress granule assembly [GO:0034063] axon [GO:0030424]; axon cytoplasm [GO:1904115]; cell cortex [GO:0005938]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; cytoplasmic microtubule [GO:0005881]; dynein complex [GO:0030286]; filopodium [GO:0030175]; manchette [GO:0002177]; microtubule [GO:0005874]; neuronal cell body [GO:0043025]; nuclear envelope [GO:0005635] ATP binding [GO:0005524]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; identical protein binding [GO:0042802]; minus-end-directed microtubule motor activity [GO:0008569] g5372.t2 Q91XQ0 31.892 555 1.31e-75 266.0 sp|Q91XQ0|DYH8_MOUSE Dynein axonemal heavy chain 8 OS=Mus musculus OX=10090 GN=Dnah8 PE=1 SV=2 DYH8_MOUSE reviewed Dynein axonemal heavy chain 8 (Axonemal beta dynein heavy chain 8) (Ciliary dynein heavy chain 8) Mus musculus (Mouse) GO:0003777; GO:0005524; GO:0005874; GO:0005930; GO:0008569; GO:0036126; GO:0036157; GO:0036158; GO:0045505; GO:0051959; GO:0060294; GO:0097228 cilium movement involved in cell motility [GO:0060294]; outer dynein arm assembly [GO:0036158] axoneme [GO:0005930]; microtubule [GO:0005874]; outer dynein arm [GO:0036157]; sperm flagellum [GO:0036126]; sperm principal piece [GO:0097228] ATP binding [GO:0005524]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]; minus-end-directed microtubule motor activity [GO:0008569] g5373.t2 Q8TE73 28.631 723 3.8800000000000004e-88 324.0 sp|Q8TE73|DYH5_HUMAN Dynein axonemal heavy chain 5 OS=Homo sapiens OX=9606 GN=DNAH5 PE=1 SV=3 DYH5_HUMAN reviewed Dynein axonemal heavy chain 5 (Axonemal beta dynein heavy chain 5) (Ciliary dynein heavy chain 5) Homo sapiens (Human) GO:0003341; GO:0003351; GO:0005524; GO:0005576; GO:0005737; GO:0005874; GO:0005930; GO:0007368; GO:0007507; GO:0008569; GO:0021670; GO:0030317; GO:0031514; GO:0036157; GO:0036158; GO:0045505; GO:0051649; GO:0051959; GO:0060271; GO:0060294; GO:0097386; GO:0097728; GO:0097729 cilium assembly [GO:0060271]; cilium movement [GO:0003341]; cilium movement involved in cell motility [GO:0060294]; determination of left/right symmetry [GO:0007368]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; establishment of localization in cell [GO:0051649]; flagellated sperm motility [GO:0030317]; heart development [GO:0007507]; lateral ventricle development [GO:0021670]; outer dynein arm assembly [GO:0036158] 9+0 motile cilium [GO:0097728]; 9+2 motile cilium [GO:0097729]; axoneme [GO:0005930]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; glial cell projection [GO:0097386]; microtubule [GO:0005874]; motile cilium [GO:0031514]; outer dynein arm [GO:0036157] ATP binding [GO:0005524]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; minus-end-directed microtubule motor activity [GO:0008569] g5373.t3 Q8TE73 28.631 723 3.8800000000000004e-88 324.0 sp|Q8TE73|DYH5_HUMAN Dynein axonemal heavy chain 5 OS=Homo sapiens OX=9606 GN=DNAH5 PE=1 SV=3 DYH5_HUMAN reviewed Dynein axonemal heavy chain 5 (Axonemal beta dynein heavy chain 5) (Ciliary dynein heavy chain 5) Homo sapiens (Human) GO:0003341; GO:0003351; GO:0005524; GO:0005576; GO:0005737; GO:0005874; GO:0005930; GO:0007368; GO:0007507; GO:0008569; GO:0021670; GO:0030317; GO:0031514; GO:0036157; GO:0036158; GO:0045505; GO:0051649; GO:0051959; GO:0060271; GO:0060294; GO:0097386; GO:0097728; GO:0097729 cilium assembly [GO:0060271]; cilium movement [GO:0003341]; cilium movement involved in cell motility [GO:0060294]; determination of left/right symmetry [GO:0007368]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; establishment of localization in cell [GO:0051649]; flagellated sperm motility [GO:0030317]; heart development [GO:0007507]; lateral ventricle development [GO:0021670]; outer dynein arm assembly [GO:0036158] 9+0 motile cilium [GO:0097728]; 9+2 motile cilium [GO:0097729]; axoneme [GO:0005930]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; glial cell projection [GO:0097386]; microtubule [GO:0005874]; motile cilium [GO:0031514]; outer dynein arm [GO:0036157] ATP binding [GO:0005524]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; minus-end-directed microtubule motor activity [GO:0008569] g5373.t4 Q8TE73 28.631 723 3.8800000000000004e-88 324.0 sp|Q8TE73|DYH5_HUMAN Dynein axonemal heavy chain 5 OS=Homo sapiens OX=9606 GN=DNAH5 PE=1 SV=3 DYH5_HUMAN reviewed Dynein axonemal heavy chain 5 (Axonemal beta dynein heavy chain 5) (Ciliary dynein heavy chain 5) Homo sapiens (Human) GO:0003341; GO:0003351; GO:0005524; GO:0005576; GO:0005737; GO:0005874; GO:0005930; GO:0007368; GO:0007507; GO:0008569; GO:0021670; GO:0030317; GO:0031514; GO:0036157; GO:0036158; GO:0045505; GO:0051649; GO:0051959; GO:0060271; GO:0060294; GO:0097386; GO:0097728; GO:0097729 cilium assembly [GO:0060271]; cilium movement [GO:0003341]; cilium movement involved in cell motility [GO:0060294]; determination of left/right symmetry [GO:0007368]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; establishment of localization in cell [GO:0051649]; flagellated sperm motility [GO:0030317]; heart development [GO:0007507]; lateral ventricle development [GO:0021670]; outer dynein arm assembly [GO:0036158] 9+0 motile cilium [GO:0097728]; 9+2 motile cilium [GO:0097729]; axoneme [GO:0005930]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; glial cell projection [GO:0097386]; microtubule [GO:0005874]; motile cilium [GO:0031514]; outer dynein arm [GO:0036157] ATP binding [GO:0005524]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; minus-end-directed microtubule motor activity [GO:0008569] g5373.t5 Q8TE73 28.631 723 4.2300000000000003e-88 324.0 sp|Q8TE73|DYH5_HUMAN Dynein axonemal heavy chain 5 OS=Homo sapiens OX=9606 GN=DNAH5 PE=1 SV=3 DYH5_HUMAN reviewed Dynein axonemal heavy chain 5 (Axonemal beta dynein heavy chain 5) (Ciliary dynein heavy chain 5) Homo sapiens (Human) GO:0003341; GO:0003351; GO:0005524; GO:0005576; GO:0005737; GO:0005874; GO:0005930; GO:0007368; GO:0007507; GO:0008569; GO:0021670; GO:0030317; GO:0031514; GO:0036157; GO:0036158; GO:0045505; GO:0051649; GO:0051959; GO:0060271; GO:0060294; GO:0097386; GO:0097728; GO:0097729 cilium assembly [GO:0060271]; cilium movement [GO:0003341]; cilium movement involved in cell motility [GO:0060294]; determination of left/right symmetry [GO:0007368]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; establishment of localization in cell [GO:0051649]; flagellated sperm motility [GO:0030317]; heart development [GO:0007507]; lateral ventricle development [GO:0021670]; outer dynein arm assembly [GO:0036158] 9+0 motile cilium [GO:0097728]; 9+2 motile cilium [GO:0097729]; axoneme [GO:0005930]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; glial cell projection [GO:0097386]; microtubule [GO:0005874]; motile cilium [GO:0031514]; outer dynein arm [GO:0036157] ATP binding [GO:0005524]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; minus-end-directed microtubule motor activity [GO:0008569] g5374.t1 Q8VHE6 26.685 727 5.77e-59 221.0 sp|Q8VHE6|DYH5_MOUSE Dynein axonemal heavy chain 5 OS=Mus musculus OX=10090 GN=Dnah5 PE=1 SV=2 DYH5_MOUSE reviewed Dynein axonemal heavy chain 5 (Axonemal beta dynein heavy chain 5) (mDNAH5) (Ciliary dynein heavy chain 5) Mus musculus (Mouse) GO:0003341; GO:0003351; GO:0003777; GO:0005524; GO:0005576; GO:0005737; GO:0005858; GO:0005874; GO:0005930; GO:0007368; GO:0007507; GO:0008569; GO:0021670; GO:0030317; GO:0031514; GO:0036157; GO:0036158; GO:0045505; GO:0051959; GO:0060271; GO:0060294; GO:0097728; GO:0097729 cilium assembly [GO:0060271]; cilium movement [GO:0003341]; cilium movement involved in cell motility [GO:0060294]; determination of left/right symmetry [GO:0007368]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; flagellated sperm motility [GO:0030317]; heart development [GO:0007507]; lateral ventricle development [GO:0021670]; outer dynein arm assembly [GO:0036158] 9+0 motile cilium [GO:0097728]; 9+2 motile cilium [GO:0097729]; axonemal dynein complex [GO:0005858]; axoneme [GO:0005930]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; microtubule [GO:0005874]; motile cilium [GO:0031514]; outer dynein arm [GO:0036157] ATP binding [GO:0005524]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]; minus-end-directed microtubule motor activity [GO:0008569] g5374.t2 Q8VHE6 27.083 720 4.05e-61 228.0 sp|Q8VHE6|DYH5_MOUSE Dynein axonemal heavy chain 5 OS=Mus musculus OX=10090 GN=Dnah5 PE=1 SV=2 DYH5_MOUSE reviewed Dynein axonemal heavy chain 5 (Axonemal beta dynein heavy chain 5) (mDNAH5) (Ciliary dynein heavy chain 5) Mus musculus (Mouse) GO:0003341; GO:0003351; GO:0003777; GO:0005524; GO:0005576; GO:0005737; GO:0005858; GO:0005874; GO:0005930; GO:0007368; GO:0007507; GO:0008569; GO:0021670; GO:0030317; GO:0031514; GO:0036157; GO:0036158; GO:0045505; GO:0051959; GO:0060271; GO:0060294; GO:0097728; GO:0097729 cilium assembly [GO:0060271]; cilium movement [GO:0003341]; cilium movement involved in cell motility [GO:0060294]; determination of left/right symmetry [GO:0007368]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; flagellated sperm motility [GO:0030317]; heart development [GO:0007507]; lateral ventricle development [GO:0021670]; outer dynein arm assembly [GO:0036158] 9+0 motile cilium [GO:0097728]; 9+2 motile cilium [GO:0097729]; axonemal dynein complex [GO:0005858]; axoneme [GO:0005930]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; microtubule [GO:0005874]; motile cilium [GO:0031514]; outer dynein arm [GO:0036157] ATP binding [GO:0005524]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]; minus-end-directed microtubule motor activity [GO:0008569] g5374.t3 Q91XQ0 27.938 451 3.3300000000000004e-47 178.0 sp|Q91XQ0|DYH8_MOUSE Dynein axonemal heavy chain 8 OS=Mus musculus OX=10090 GN=Dnah8 PE=1 SV=2 DYH8_MOUSE reviewed Dynein axonemal heavy chain 8 (Axonemal beta dynein heavy chain 8) (Ciliary dynein heavy chain 8) Mus musculus (Mouse) GO:0003777; GO:0005524; GO:0005874; GO:0005930; GO:0008569; GO:0036126; GO:0036157; GO:0036158; GO:0045505; GO:0051959; GO:0060294; GO:0097228 cilium movement involved in cell motility [GO:0060294]; outer dynein arm assembly [GO:0036158] axoneme [GO:0005930]; microtubule [GO:0005874]; outer dynein arm [GO:0036157]; sperm flagellum [GO:0036126]; sperm principal piece [GO:0097228] ATP binding [GO:0005524]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]; minus-end-directed microtubule motor activity [GO:0008569] g5374.t4 Q91XQ0 27.938 451 3.3300000000000004e-47 178.0 sp|Q91XQ0|DYH8_MOUSE Dynein axonemal heavy chain 8 OS=Mus musculus OX=10090 GN=Dnah8 PE=1 SV=2 DYH8_MOUSE reviewed Dynein axonemal heavy chain 8 (Axonemal beta dynein heavy chain 8) (Ciliary dynein heavy chain 8) Mus musculus (Mouse) GO:0003777; GO:0005524; GO:0005874; GO:0005930; GO:0008569; GO:0036126; GO:0036157; GO:0036158; GO:0045505; GO:0051959; GO:0060294; GO:0097228 cilium movement involved in cell motility [GO:0060294]; outer dynein arm assembly [GO:0036158] axoneme [GO:0005930]; microtubule [GO:0005874]; outer dynein arm [GO:0036157]; sperm flagellum [GO:0036126]; sperm principal piece [GO:0097228] ATP binding [GO:0005524]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]; minus-end-directed microtubule motor activity [GO:0008569] g5376.t1 Q08DA3 41.761 443 1.14e-81 286.0 sp|Q08DA3|UBP16_BOVIN Ubiquitin carboxyl-terminal hydrolase 16 OS=Bos taurus OX=9913 GN=USP16 PE=2 SV=2 UBP16_BOVIN reviewed Ubiquitin carboxyl-terminal hydrolase 16 (EC 3.4.19.12) (Deubiquitinating enzyme 16) (Ubiquitin thioesterase 16) (Ubiquitin-specific-processing protease 16) Bos taurus (Bovine) GO:0003713; GO:0004197; GO:0004843; GO:0005634; GO:0005737; GO:0006357; GO:0006508; GO:0008270; GO:0035520; GO:0042393; GO:0043024; GO:0043130; GO:0045893; GO:0045944; GO:0051289; GO:0051301; GO:0051726; GO:0090070; GO:0140014; GO:0140950 cell division [GO:0051301]; mitotic nuclear division [GO:0140014]; monoubiquitinated protein deubiquitination [GO:0035520]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of ribosome biogenesis [GO:0090070]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein homotetramerization [GO:0051289]; proteolysis [GO:0006508]; regulation of cell cycle [GO:0051726]; regulation of transcription by RNA polymerase II [GO:0006357] cytoplasm [GO:0005737]; nucleus [GO:0005634] cysteine-type deubiquitinase activity [GO:0004843]; cysteine-type endopeptidase activity [GO:0004197]; histone binding [GO:0042393]; histone H2A deubiquitinase activity [GO:0140950]; ribosomal small subunit binding [GO:0043024]; transcription coactivator activity [GO:0003713]; ubiquitin binding [GO:0043130]; zinc ion binding [GO:0008270] g5376.t1 Q08DA3 42.339 248 4.4599999999999996e-45 179.0 sp|Q08DA3|UBP16_BOVIN Ubiquitin carboxyl-terminal hydrolase 16 OS=Bos taurus OX=9913 GN=USP16 PE=2 SV=2 UBP16_BOVIN reviewed Ubiquitin carboxyl-terminal hydrolase 16 (EC 3.4.19.12) (Deubiquitinating enzyme 16) (Ubiquitin thioesterase 16) (Ubiquitin-specific-processing protease 16) Bos taurus (Bovine) GO:0003713; GO:0004197; GO:0004843; GO:0005634; GO:0005737; GO:0006357; GO:0006508; GO:0008270; GO:0035520; GO:0042393; GO:0043024; GO:0043130; GO:0045893; GO:0045944; GO:0051289; GO:0051301; GO:0051726; GO:0090070; GO:0140014; GO:0140950 cell division [GO:0051301]; mitotic nuclear division [GO:0140014]; monoubiquitinated protein deubiquitination [GO:0035520]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of ribosome biogenesis [GO:0090070]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein homotetramerization [GO:0051289]; proteolysis [GO:0006508]; regulation of cell cycle [GO:0051726]; regulation of transcription by RNA polymerase II [GO:0006357] cytoplasm [GO:0005737]; nucleus [GO:0005634] cysteine-type deubiquitinase activity [GO:0004843]; cysteine-type endopeptidase activity [GO:0004197]; histone binding [GO:0042393]; histone H2A deubiquitinase activity [GO:0140950]; ribosomal small subunit binding [GO:0043024]; transcription coactivator activity [GO:0003713]; ubiquitin binding [GO:0043130]; zinc ion binding [GO:0008270] g5378.t1 Q9CZ57 46.624 311 4.96e-82 262.0 sp|Q9CZ57|NSUN4_MOUSE 5-cytosine rRNA methyltransferase NSUN4 OS=Mus musculus OX=10090 GN=Nsun4 PE=1 SV=1 NSUN4_MOUSE reviewed 5-cytosine rRNA methyltransferase NSUN4 (EC 2.1.1.-) (5-cytosine tRNA methyltransferase NSUN4) (EC 2.1.1.-) (NOL1/NOP2/Sun domain family member 4) (Sperm head and tail associated protein) Mus musculus (Mouse) GO:0000957; GO:0005759; GO:0009383; GO:0031167; GO:0062152; GO:0070181; GO:0180026; GO:1902775 mitochondrial large ribosomal subunit assembly [GO:1902775]; mitochondrial RNA catabolic process [GO:0000957]; mitochondrial small ribosomal subunit assembly [GO:0180026]; rRNA methylation [GO:0031167] mitochondrial matrix [GO:0005759] mRNA (cytidine-5-)-methyltransferase activity [GO:0062152]; rRNA (cytosine-C5-)-methyltransferase activity [GO:0009383]; small ribosomal subunit rRNA binding [GO:0070181] g5379.t1 Q9Y385 73.404 188 3.65e-99 298.0 sp|Q9Y385|UB2J1_HUMAN Ubiquitin-conjugating enzyme E2 J1 OS=Homo sapiens OX=9606 GN=UBE2J1 PE=1 SV=2 g5383.t1 Q5R9W6 83.333 96 2.4699999999999998e-46 148.0 sp|Q5R9W6|TAF13_PONAB Transcription initiation factor TFIID subunit 13 OS=Pongo abelii OX=9601 GN=TAF13 PE=2 SV=1 g5384.t1 Q5T5N4 25.0 460 2.59e-30 126.0 sp|Q5T5N4|CF118_HUMAN Uncharacterized protein C6orf118 OS=Homo sapiens OX=9606 GN=C6orf118 PE=1 SV=1 g5385.t1 Q14790 40.873 252 4.02e-50 178.0 sp|Q14790|CASP8_HUMAN Caspase-8 OS=Homo sapiens OX=9606 GN=CASP8 PE=1 SV=1 g5385.t2 Q14790 40.873 252 4.81e-50 178.0 sp|Q14790|CASP8_HUMAN Caspase-8 OS=Homo sapiens OX=9606 GN=CASP8 PE=1 SV=1 g5388.t1 P35761 51.304 345 2.53e-94 319.0 sp|P35761|TTK_MOUSE Dual specificity protein kinase TTK OS=Mus musculus OX=10090 GN=Ttk PE=1 SV=1 TTK_MOUSE reviewed Dual specificity protein kinase TTK (EC 2.7.12.1) (ESK) (PYT) Mus musculus (Mouse) GO:0000776; GO:0004674; GO:0004712; GO:0004713; GO:0005524; GO:0005634; GO:0005737; GO:0007059; GO:0007094; GO:0016020; GO:0016321; GO:0033316; GO:0034501; GO:0034502; GO:0042802; GO:0106310; GO:0140273; GO:1903096 chromosome segregation [GO:0007059]; female meiosis chromosome segregation [GO:0016321]; meiotic spindle assembly checkpoint signaling [GO:0033316]; mitotic spindle assembly checkpoint signaling [GO:0007094]; protein localization to chromosome [GO:0034502]; protein localization to kinetochore [GO:0034501]; protein localization to meiotic spindle midzone [GO:1903096]; repair of mitotic kinetochore microtubule attachment defect [GO:0140273] cytoplasm [GO:0005737]; kinetochore [GO:0000776]; membrane [GO:0016020]; nucleus [GO:0005634] ATP binding [GO:0005524]; identical protein binding [GO:0042802]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713] g5390.t1 Q68UT7 50.0 364 4.44e-112 355.0 sp|Q68UT7|HUNK_PANTR Hormonally up-regulated neu tumor-associated kinase OS=Pan troglodytes OX=9598 GN=HUNK PE=3 SV=1 g5393.t1 Q7ZTY4 83.023 430 0.0 719.0 sp|Q7ZTY4|RBBP7_DANRE Histone-binding protein RBBP7 OS=Danio rerio OX=7955 GN=rbbp7 PE=2 SV=1 g5394.t1 O54916 33.843 523 6.179999999999999e-48 186.0 sp|O54916|REPS1_MOUSE RalBP1-associated Eps domain-containing protein 1 OS=Mus musculus OX=10090 GN=Reps1 PE=1 SV=2 g5394.t2 O54916 33.843 523 1.0299999999999999e-48 187.0 sp|O54916|REPS1_MOUSE RalBP1-associated Eps domain-containing protein 1 OS=Mus musculus OX=10090 GN=Reps1 PE=1 SV=2 g5395.t1 Q95R48 32.477 545 1.22e-80 265.0 sp|Q95R48|OCTL_DROME Organic cation transporter-like protein OS=Drosophila melanogaster OX=7227 GN=Orct2 PE=2 SV=2 g5396.t1 O43318 56.848 387 4.42e-147 443.0 sp|O43318|M3K7_HUMAN Mitogen-activated protein kinase kinase kinase 7 OS=Homo sapiens OX=9606 GN=MAP3K7 PE=1 SV=1 M3K7_HUMAN reviewed Mitogen-activated protein kinase kinase kinase 7 (EC 2.7.11.25) (Transforming growth factor-beta-activated kinase 1) (TGF-beta-activated kinase 1) Homo sapiens (Human) GO:0000165; GO:0000287; GO:0001223; GO:0002223; GO:0002726; GO:0002753; GO:0002755; GO:0004674; GO:0004707; GO:0004709; GO:0005114; GO:0005524; GO:0005634; GO:0005737; GO:0005789; GO:0005829; GO:0005886; GO:0006954; GO:0006955; GO:0007179; GO:0007249; GO:0007252; GO:0007254; GO:0008349; GO:0010008; GO:0010629; GO:0016239; GO:0016301; GO:0030971; GO:0031625; GO:0032743; GO:0034138; GO:0034142; GO:0035173; GO:0035666; GO:0035872; GO:0038066; GO:0038095; GO:0038172; GO:0038173; GO:0042742; GO:0042770; GO:0042802; GO:0043123; GO:0043276; GO:0043507; GO:0045787; GO:0045793; GO:0050852; GO:0051403; GO:0070498; GO:0071356; GO:0071456; GO:0097110; GO:0106310; GO:0120283; GO:0140297; GO:0140672; GO:0141111; GO:1901224; GO:1904385; GO:1904707; GO:1904754; GO:1990450 anoikis [GO:0043276]; canonical NF-kappaB signal transduction [GO:0007249]; cellular response to angiotensin [GO:1904385]; cellular response to hypoxia [GO:0071456]; cellular response to tumor necrosis factor [GO:0071356]; cytoplasmic pattern recognition receptor signaling pathway [GO:0002753]; defense response to bacterium [GO:0042742]; Fc-epsilon receptor signaling pathway [GO:0038095]; I-kappaB phosphorylation [GO:0007252]; immune response [GO:0006955]; inflammatory response [GO:0006954]; interleukin-1-mediated signaling pathway [GO:0070498]; interleukin-17A-mediated signaling pathway [GO:0038173]; interleukin-33-mediated signaling pathway [GO:0038172]; JNK cascade [GO:0007254]; MAPK cascade [GO:0000165]; MyD88-dependent toll-like receptor signaling pathway [GO:0002755]; negative regulation of gene expression [GO:0010629]; nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway [GO:0035872]; p38MAPK cascade [GO:0038066]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of cell cycle [GO:0045787]; positive regulation of cell size [GO:0045793]; positive regulation of cGAS/STING signaling pathway [GO:0141111]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of macroautophagy [GO:0016239]; positive regulation of non-canonical NF-kappaB signal transduction [GO:1901224]; positive regulation of T cell cytokine production [GO:0002726]; positive regulation of vascular associated smooth muscle cell migration [GO:1904754]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; signal transduction in response to DNA damage [GO:0042770]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; stress-activated MAPK cascade [GO:0051403]; T cell receptor signaling pathway [GO:0050852]; toll-like receptor 3 signaling pathway [GO:0034138]; toll-like receptor 4 signaling pathway [GO:0034142]; transforming growth factor beta receptor signaling pathway [GO:0007179]; TRIF-dependent toll-like receptor signaling pathway [GO:0035666] ATAC complex [GO:0140672]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; nucleus [GO:0005634]; plasma membrane [GO:0005886] ATP binding [GO:0005524]; DNA-binding transcription factor binding [GO:0140297]; histone kinase activity [GO:0035173]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; linear polyubiquitin binding [GO:1990450]; magnesium ion binding [GO:0000287]; MAP kinase activity [GO:0004707]; MAP kinase kinase kinase activity [GO:0004709]; MAP kinase kinase kinase kinase activity [GO:0008349]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine kinase binding [GO:0120283]; receptor tyrosine kinase binding [GO:0030971]; scaffold protein binding [GO:0097110]; transcription coactivator binding [GO:0001223]; type II transforming growth factor beta receptor binding [GO:0005114]; ubiquitin protein ligase binding [GO:0031625] g5396.t1 O43318 45.802 131 9.61e-26 116.0 sp|O43318|M3K7_HUMAN Mitogen-activated protein kinase kinase kinase 7 OS=Homo sapiens OX=9606 GN=MAP3K7 PE=1 SV=1 M3K7_HUMAN reviewed Mitogen-activated protein kinase kinase kinase 7 (EC 2.7.11.25) (Transforming growth factor-beta-activated kinase 1) (TGF-beta-activated kinase 1) Homo sapiens (Human) GO:0000165; GO:0000287; GO:0001223; GO:0002223; GO:0002726; GO:0002753; GO:0002755; GO:0004674; GO:0004707; GO:0004709; GO:0005114; GO:0005524; GO:0005634; GO:0005737; GO:0005789; GO:0005829; GO:0005886; GO:0006954; GO:0006955; GO:0007179; GO:0007249; GO:0007252; GO:0007254; GO:0008349; GO:0010008; GO:0010629; GO:0016239; GO:0016301; GO:0030971; GO:0031625; GO:0032743; GO:0034138; GO:0034142; GO:0035173; GO:0035666; GO:0035872; GO:0038066; GO:0038095; GO:0038172; GO:0038173; GO:0042742; GO:0042770; GO:0042802; GO:0043123; GO:0043276; GO:0043507; GO:0045787; GO:0045793; GO:0050852; GO:0051403; GO:0070498; GO:0071356; GO:0071456; GO:0097110; GO:0106310; GO:0120283; GO:0140297; GO:0140672; GO:0141111; GO:1901224; GO:1904385; GO:1904707; GO:1904754; GO:1990450 anoikis [GO:0043276]; canonical NF-kappaB signal transduction [GO:0007249]; cellular response to angiotensin [GO:1904385]; cellular response to hypoxia [GO:0071456]; cellular response to tumor necrosis factor [GO:0071356]; cytoplasmic pattern recognition receptor signaling pathway [GO:0002753]; defense response to bacterium [GO:0042742]; Fc-epsilon receptor signaling pathway [GO:0038095]; I-kappaB phosphorylation [GO:0007252]; immune response [GO:0006955]; inflammatory response [GO:0006954]; interleukin-1-mediated signaling pathway [GO:0070498]; interleukin-17A-mediated signaling pathway [GO:0038173]; interleukin-33-mediated signaling pathway [GO:0038172]; JNK cascade [GO:0007254]; MAPK cascade [GO:0000165]; MyD88-dependent toll-like receptor signaling pathway [GO:0002755]; negative regulation of gene expression [GO:0010629]; nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway [GO:0035872]; p38MAPK cascade [GO:0038066]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of cell cycle [GO:0045787]; positive regulation of cell size [GO:0045793]; positive regulation of cGAS/STING signaling pathway [GO:0141111]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of macroautophagy [GO:0016239]; positive regulation of non-canonical NF-kappaB signal transduction [GO:1901224]; positive regulation of T cell cytokine production [GO:0002726]; positive regulation of vascular associated smooth muscle cell migration [GO:1904754]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; signal transduction in response to DNA damage [GO:0042770]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; stress-activated MAPK cascade [GO:0051403]; T cell receptor signaling pathway [GO:0050852]; toll-like receptor 3 signaling pathway [GO:0034138]; toll-like receptor 4 signaling pathway [GO:0034142]; transforming growth factor beta receptor signaling pathway [GO:0007179]; TRIF-dependent toll-like receptor signaling pathway [GO:0035666] ATAC complex [GO:0140672]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; nucleus [GO:0005634]; plasma membrane [GO:0005886] ATP binding [GO:0005524]; DNA-binding transcription factor binding [GO:0140297]; histone kinase activity [GO:0035173]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; linear polyubiquitin binding [GO:1990450]; magnesium ion binding [GO:0000287]; MAP kinase activity [GO:0004707]; MAP kinase kinase kinase activity [GO:0004709]; MAP kinase kinase kinase kinase activity [GO:0008349]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine kinase binding [GO:0120283]; receptor tyrosine kinase binding [GO:0030971]; scaffold protein binding [GO:0097110]; transcription coactivator binding [GO:0001223]; type II transforming growth factor beta receptor binding [GO:0005114]; ubiquitin protein ligase binding [GO:0031625] g5397.t1 Q96SZ6 60.823 559 0.0 691.0 sp|Q96SZ6|CK5P1_HUMAN Mitochondrial tRNA methylthiotransferase CDK5RAP1 OS=Homo sapiens OX=9606 GN=CDK5RAP1 PE=1 SV=2 g5398.t1 P31422 34.727 861 8.34e-151 472.0 sp|P31422|GRM3_RAT Metabotropic glutamate receptor 3 OS=Rattus norvegicus OX=10116 GN=Grm3 PE=1 SV=1 GRM3_RAT reviewed Metabotropic glutamate receptor 3 (mGluR3) Rattus norvegicus (Rat) GO:0001641; GO:0005246; GO:0005886; GO:0007193; GO:0007216; GO:0010467; GO:0014069; GO:0019233; GO:0030424; GO:0033554; GO:0042734; GO:0043005; GO:0043197; GO:0045211; GO:0050804; GO:0051966; GO:0097110; GO:0097449; GO:0098978; GO:0099170 adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; cellular response to stress [GO:0033554]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; gene expression [GO:0010467]; modulation of chemical synaptic transmission [GO:0050804]; postsynaptic modulation of chemical synaptic transmission [GO:0099170]; regulation of synaptic transmission, glutamatergic [GO:0051966]; sensory perception of pain [GO:0019233] astrocyte projection [GO:0097449]; axon [GO:0030424]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734] calcium channel regulator activity [GO:0005246]; group II metabotropic glutamate receptor activity [GO:0001641]; scaffold protein binding [GO:0097110] g5400.t1 P91685 38.351 279 5.67e-52 187.0 sp|P91685|GRM_DROME Metabotropic glutamate receptor OS=Drosophila melanogaster OX=7227 GN=mGluR PE=1 SV=2 GRM_DROME reviewed Metabotropic glutamate receptor (DmGluRA) Drosophila melanogaster (Fruit fly) GO:0001641; GO:0004930; GO:0005886; GO:0007216; GO:0007528; GO:0007612; GO:0007614; GO:0007616; GO:0008049; GO:0008066; GO:0015485; GO:0016020; GO:0016595; GO:0038038; GO:0045121; GO:0051966; GO:0072553 G protein-coupled glutamate receptor signaling pathway [GO:0007216]; learning [GO:0007612]; long-term memory [GO:0007616]; male courtship behavior [GO:0008049]; neuromuscular junction development [GO:0007528]; regulation of synaptic transmission, glutamatergic [GO:0051966]; short-term memory [GO:0007614]; terminal button organization [GO:0072553] G protein-coupled receptor homodimeric complex [GO:0038038]; membrane [GO:0016020]; membrane raft [GO:0045121]; plasma membrane [GO:0005886] cholesterol binding [GO:0015485]; G protein-coupled receptor activity [GO:0004930]; glutamate binding [GO:0016595]; glutamate receptor activity [GO:0008066]; group II metabotropic glutamate receptor activity [GO:0001641] g5401.t1 Q32LH7 39.526 549 3.16e-127 385.0 sp|Q32LH7|NB5R4_BOVIN Cytochrome b5 reductase 4 OS=Bos taurus OX=9913 GN=CYB5R4 PE=2 SV=1 NB5R4_BOVIN reviewed Cytochrome b5 reductase 4 (EC 1.6.2.2) (Flavohemoprotein b5/b5R) (b5+b5R) (cb5/cb5R) Bos taurus (Bovine) GO:0004128; GO:0005737; GO:0005783; GO:0006801; GO:0016174; GO:0020037; GO:0030073; GO:0042593; GO:0046677; GO:0046872; GO:0048468; GO:0048471; GO:0090524 cell development [GO:0048468]; glucose homeostasis [GO:0042593]; insulin secretion [GO:0030073]; response to antibiotic [GO:0046677]; superoxide metabolic process [GO:0006801] cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; perinuclear region of cytoplasm [GO:0048471] cytochrome-b5 reductase activity, acting on NAD(P)H [GO:0004128]; cytochrome-b5 reductase activity, acting on NADH [GO:0090524]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; NAD(P)H oxidase H2O2-forming activity [GO:0016174] g5404.t1 P50227 34.965 286 9.89e-51 173.0 sp|P50227|ST1A1_BOVIN Sulfotransferase 1A1 OS=Bos taurus OX=9913 GN=SULT1A1 PE=1 SV=2 ST1A1_BOVIN reviewed Sulfotransferase 1A1 (ST1A1) (EC 2.8.2.1) (Aryl sulfotransferase) (Phenol sulfotransferase) (Phenol-sulfating phenol sulfotransferase) (P-PST) Bos taurus (Bovine) GO:0004062; GO:0005737; GO:0008146; GO:0008202; GO:0042403; GO:0042420; GO:0050656; GO:0051923 dopamine catabolic process [GO:0042420]; steroid metabolic process [GO:0008202]; sulfation [GO:0051923]; thyroid hormone metabolic process [GO:0042403] cytoplasm [GO:0005737] 3'-phosphoadenosine 5'-phosphosulfate binding [GO:0050656]; aryl sulfotransferase activity [GO:0004062]; sulfotransferase activity [GO:0008146] g5411.t1 Q4R3G4 28.46 513 2.42e-43 176.0 sp|Q4R3G4|RNF17_MACFA RING finger protein 17 OS=Macaca fascicularis OX=9541 GN=RNF17 PE=2 SV=2 g5416.t1 P47751 43.318 217 1.7399999999999999e-38 142.0 sp|P47751|BRS4_BOMOR [Phe13]-bombesin receptor OS=Bombina orientalis OX=8346 GN=BB4 PE=2 SV=2 g5417.t1 Q8BYF6 31.171 632 1.95e-59 212.0 sp|Q8BYF6|SC5A8_MOUSE Sodium-coupled monocarboxylate transporter 1 OS=Mus musculus OX=10090 GN=Slc5a8 PE=1 SV=1 SC5A8_MOUSE reviewed Sodium-coupled monocarboxylate transporter 1 (Electrogenic sodium monocarboxylate cotransporter) (Solute carrier family 5 member 8) Mus musculus (Mouse) GO:0000811; GO:0005343; GO:0006814; GO:0006821; GO:0006846; GO:0006848; GO:0006915; GO:0015129; GO:0015552; GO:0015636; GO:0015705; GO:0015706; GO:0015718; GO:0015727; GO:0015730; GO:0015913; GO:0016324; GO:0031526; GO:0090416; GO:0140161; GO:2001142 acetate transport [GO:0006846]; apoptotic process [GO:0006915]; chloride transport [GO:0006821]; iodide transport [GO:0015705]; lactate transport [GO:0015727]; monocarboxylic acid transport [GO:0015718]; nicotinate transport [GO:2001142]; nitrate transmembrane transport [GO:0015706]; propanoate transmembrane transport [GO:0015730]; pyruvate transport [GO:0006848]; short-chain fatty acid transmembrane transport [GO:0015913]; sodium ion transport [GO:0006814] apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; GINS complex [GO:0000811] lactate transmembrane transporter activity [GO:0015129]; monocarboxylate:sodium symporter activity [GO:0140161]; nicotinate transmembrane transporter activity [GO:0090416]; organic acid:sodium symporter activity [GO:0005343]; propionate transmembrane transporter activity [GO:0015552]; short-chain fatty acid transmembrane transporter activity [GO:0015636] g5421.t1 Q9VUL9 32.482 274 2.2200000000000002e-32 133.0 sp|Q9VUL9|FUCTA_DROME Glycoprotein 3-alpha-L-fucosyltransferase A OS=Drosophila melanogaster OX=7227 GN=FucTA PE=1 SV=2 FUCTA_DROME reviewed Glycoprotein 3-alpha-L-fucosyltransferase A (EC 2.4.1.214) (Core alpha-(1,3)-fucosyltransferase) Drosophila melanogaster (Fruit fly) GO:0005797; GO:0006491; GO:0007399; GO:0018279; GO:0018392; GO:0032580; GO:0046920 N-glycan processing [GO:0006491]; nervous system development [GO:0007399]; protein N-linked glycosylation via asparagine [GO:0018279] Golgi cisterna membrane [GO:0032580]; Golgi medial cisterna [GO:0005797] alpha-(1->3)-fucosyltransferase activity [GO:0046920]; glycoprotein 3-alpha-L-fucosyltransferase activity [GO:0018392] g5422.t1 P63172 86.726 113 2.9500000000000003e-72 213.0 sp|P63172|DYLT1_HUMAN Dynein light chain Tctex-type 1 OS=Homo sapiens OX=9606 GN=DYNLT1 PE=1 SV=1 DYLT1_HUMAN reviewed Dynein light chain Tctex-type 1 (Protein CW-1) (T-complex testis-specific protein 1 homolog) Homo sapiens (Human) GO:0000132; GO:0005576; GO:0005737; GO:0005794; GO:0005819; GO:0005868; GO:0005881; GO:0007018; GO:0007399; GO:0008277; GO:0019060; GO:0032388; GO:0034774; GO:0042802; GO:0043657; GO:0045505; GO:0046718; GO:0050768; GO:0051301; GO:0075521; GO:0099503; GO:1904813 cell division [GO:0051301]; establishment of mitotic spindle orientation [GO:0000132]; intracellular transport of viral protein in host cell [GO:0019060]; microtubule-based movement [GO:0007018]; microtubule-dependent intracellular transport of viral material towards nucleus [GO:0075521]; negative regulation of neurogenesis [GO:0050768]; nervous system development [GO:0007399]; positive regulation of intracellular transport [GO:0032388]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; symbiont entry into host cell [GO:0046718] cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; cytoplasmic microtubule [GO:0005881]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; Golgi apparatus [GO:0005794]; host cell [GO:0043657]; secretory granule lumen [GO:0034774]; secretory vesicle [GO:0099503]; spindle [GO:0005819] dynein intermediate chain binding [GO:0045505]; identical protein binding [GO:0042802] g5423.t1 B9ENE7 85.034 147 1.05e-93 270.0 sp|B9ENE7|MGN_SALSA Protein mago nashi homolog OS=Salmo salar OX=8030 GN=magoh PE=2 SV=1 g5432.t1 Q9D1P4 47.879 330 4.01e-105 314.0 sp|Q9D1P4|CHRD1_MOUSE Cysteine and histidine-rich domain-containing protein 1 OS=Mus musculus OX=10090 GN=Chordc1 PE=1 SV=1 CHRD1_MOUSE reviewed Cysteine and histidine-rich domain-containing protein 1 (CHORD domain-containing protein 1) (CHORD-containing protein 1) (Chp-1) (Protein morgana) Mus musculus (Mouse) GO:0005524; GO:0006457; GO:0008270; GO:0010824; GO:0043531; GO:0051298; GO:0051879; GO:1900034; GO:2000299 centrosome duplication [GO:0051298]; negative regulation of Rho-dependent protein serine/threonine kinase activity [GO:2000299]; protein folding [GO:0006457]; regulation of cellular response to heat [GO:1900034]; regulation of centrosome duplication [GO:0010824] ADP binding [GO:0043531]; ATP binding [GO:0005524]; Hsp90 protein binding [GO:0051879]; zinc ion binding [GO:0008270] g5439.t1 P12617 48.434 415 6.32e-135 405.0 sp|P12617|DCMC_ANSAN Malonyl-CoA decarboxylase, mitochondrial OS=Anser anser anser OX=8844 GN=MLYCD PE=1 SV=2 g5440.t1 Q6GPY0 68.687 99 1.07e-43 140.0 sp|Q6GPY0|TI13A_XENLA Mitochondrial import inner membrane translocase subunit Tim13-A OS=Xenopus laevis OX=8355 GN=timm13-a PE=3 SV=2 g5446.t1 Q09575 32.609 184 3.87e-22 103.0 sp|Q09575|YRD6_CAEEL Uncharacterized protein K02A2.6 OS=Caenorhabditis elegans OX=6239 GN=K02A2.6 PE=4 SV=1 g5447.t1 Q7LHG5 37.121 132 9.379999999999999e-24 99.0 sp|Q7LHG5|YI31B_YEAST Transposon Ty3-I Gag-Pol polyprotein OS=Saccharomyces cerevisiae (strain ATCC 204508 / S288c) OX=559292 GN=TY3B-I PE=1 SV=2 YI31B_YEAST reviewed Transposon Ty3-I Gag-Pol polyprotein (Gag3-Pol3) (Transposon Ty3-2 TYA-TYB polyprotein) [Cleaved into: Capsid protein (CA) (p24); Spacer peptide p3; Nucleocapsid protein p11 (NC); Ty3 protease (PR) (EC 3.4.23.-) (p16); Spacer peptide J; Reverse transcriptase/ribonuclease H (RT) (RT-RH) (EC 2.7.7.49) (EC 2.7.7.7) (EC 3.1.26.4) (p55); Integrase p52 (IN); Integrase p49 (IN)] Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast) GO:0003677; GO:0003723; GO:0003887; GO:0003964; GO:0004190; GO:0004523; GO:0005524; GO:0005634; GO:0005737; GO:0006310; GO:0006508; GO:0008270; GO:0015074; GO:0075523 DNA integration [GO:0015074]; DNA recombination [GO:0006310]; proteolysis [GO:0006508]; viral translational frameshifting [GO:0075523] cytoplasm [GO:0005737]; nucleus [GO:0005634] aspartic-type endopeptidase activity [GO:0004190]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; RNA binding [GO:0003723]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; zinc ion binding [GO:0008270] g5449.t1 Q96B97 39.459 370 2.52e-63 224.0 sp|Q96B97|SH3K1_HUMAN SH3 domain-containing kinase-binding protein 1 OS=Homo sapiens OX=9606 GN=SH3KBP1 PE=1 SV=2 SH3K1_HUMAN reviewed SH3 domain-containing kinase-binding protein 1 (CD2-binding protein 3) (CD2BP3) (Cbl-interacting protein of 85 kDa) (Human Src family kinase-binding protein 1) (HSB-1) Homo sapiens (Human) GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0005911; GO:0005925; GO:0006897; GO:0006915; GO:0007010; GO:0007015; GO:0007267; GO:0008360; GO:0014069; GO:0016477; GO:0017124; GO:0030139; GO:0030659; GO:0031625; GO:0043005; GO:0050871; GO:0098978; GO:0098982 actin filament organization [GO:0007015]; apoptotic process [GO:0006915]; cell migration [GO:0016477]; cell-cell signaling [GO:0007267]; cytoskeleton organization [GO:0007010]; endocytosis [GO:0006897]; positive regulation of B cell activation [GO:0050871]; regulation of cell shape [GO:0008360] cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; focal adhesion [GO:0005925]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069] SH3 domain binding [GO:0017124]; ubiquitin protein ligase binding [GO:0031625] g5454.t1 Q9U903 61.204 299 8.29e-84 260.0 sp|Q9U903|TBXT_PATPE T-box transcription factor T homolog OS=Patiria pectinifera OX=7594 GN=TBXT PE=2 SV=1 g5455.t1 Q9U903 93.421 152 1.66e-102 304.0 sp|Q9U903|TBXT_PATPE T-box transcription factor T homolog OS=Patiria pectinifera OX=7594 GN=TBXT PE=2 SV=1 g5460.t1 Q8CE94 27.174 368 5.85e-24 106.0 sp|Q8CE94|MOT13_MOUSE Monocarboxylate transporter 13 OS=Mus musculus OX=10090 GN=Slc16a13 PE=2 SV=1 g5472.t1 O95084 38.138 333 6.08e-70 228.0 sp|O95084|PRS23_HUMAN Serine protease 23 OS=Homo sapiens OX=9606 GN=PRSS23 PE=1 SV=1 g5473.t1 P40927 62.97 532 0.0 704.0 sp|P40927|MAOX_COLLI NADP-dependent malic enzyme OS=Columba livia OX=8932 GN=ME1 PE=1 SV=1 g5474.t1 Q68FR8 95.37 432 0.0 854.0 sp|Q68FR8|TBA3_RAT Tubulin alpha-3 chain OS=Rattus norvegicus OX=10116 GN=Tuba3a PE=2 SV=1 TBA3_RAT reviewed Tubulin alpha-3 chain (EC 3.6.5.-) (Alpha-tubulin 3) [Cleaved into: Detyrosinated tubulin alpha-3 chain] Rattus norvegicus (Rat) GO:0000226; GO:0000278; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0005929; GO:0015630; GO:0016787; GO:0045121; GO:0046872 microtubule cytoskeleton organization [GO:0000226]; mitotic cell cycle [GO:0000278] cilium [GO:0005929]; cytoplasm [GO:0005737]; membrane raft [GO:0045121]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630] GTP binding [GO:0005525]; hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]; structural constituent of cytoskeleton [GO:0005200] g5475.t1 P41383 94.533 439 0.0 843.0 sp|P41383|TBA2_PATVU Tubulin alpha-2/alpha-4 chain OS=Patella vulgata OX=6465 GN=TUB2 PE=2 SV=1 g5476.t1 Q8CA95 46.095 781 0.0 711.0 sp|Q8CA95|PDE10_MOUSE cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A OS=Mus musculus OX=10090 GN=Pde10a PE=1 SV=2 PDE10_MOUSE reviewed cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A (EC 3.1.4.17) Mus musculus (Mouse) GO:0004112; GO:0004114; GO:0004115; GO:0004118; GO:0005829; GO:0006198; GO:0007165; GO:0010754; GO:0030552; GO:0030553; GO:0043025; GO:0043204; GO:0045202; GO:0046069; GO:0046872; GO:0047555; GO:0098978; GO:0099147; GO:0106070; GO:0141161; GO:0141162 cAMP catabolic process [GO:0006198]; cGMP catabolic process [GO:0046069]; negative regulation of cAMP/PKA signal transduction [GO:0141162]; negative regulation of cGMP-mediated signaling [GO:0010754]; regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0106070]; regulation of cAMP/PKA signal transduction [GO:0141161]; signal transduction [GO:0007165] cytosol [GO:0005829]; extrinsic component of postsynaptic density membrane [GO:0099147]; glutamatergic synapse [GO:0098978]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; synapse [GO:0045202] 3',5'-cGMP-stimulated cyclic-nucleotide phosphodiesterase activity [GO:0004118]; 3',5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; 3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; 3',5'-cyclic-nucleotide phosphodiesterase activity [GO:0004114]; cAMP binding [GO:0030552]; cGMP binding [GO:0030553]; cyclic-nucleotide phosphodiesterase activity [GO:0004112]; metal ion binding [GO:0046872] g5477.t1 Q7ZZN8 30.374 214 4.3800000000000004e-29 116.0 sp|Q7ZZN8|CRVP2_NAJAT Cysteine-rich venom protein natrin-2 OS=Naja atra OX=8656 PE=1 SV=1 CRVP2_NAJAT reviewed Cysteine-rich venom protein natrin-2 (Cysteine-rich venom protein 2) (NA-CRVP2) (Protein G2b) Naja atra (Chinese cobra) GO:0005246; GO:0005576; GO:0006952; GO:0090729 defense response [GO:0006952] extracellular region [GO:0005576] calcium channel regulator activity [GO:0005246]; toxin activity [GO:0090729] g5488.t1 Q2KI97 23.967 363 6.03e-22 99.4 sp|Q2KI97|GPR84_BOVIN G-protein coupled receptor 84 OS=Bos taurus OX=9913 GN=GPR84 PE=2 SV=1 g5492.t1 Q14416 30.299 703 3.03e-105 344.0 sp|Q14416|GRM2_HUMAN Metabotropic glutamate receptor 2 OS=Homo sapiens OX=9606 GN=GRM2 PE=1 SV=2 GRM2_HUMAN reviewed Metabotropic glutamate receptor 2 (mGluR2) Homo sapiens (Human) GO:0001641; GO:0004930; GO:0005246; GO:0005886; GO:0007194; GO:0007216; GO:0007268; GO:0008066; GO:0010467; GO:0014047; GO:0014048; GO:0014059; GO:0030424; GO:0030425; GO:0033554; GO:0035095; GO:0042220; GO:0042734; GO:0045211; GO:0051897; GO:0051966; GO:0060292; GO:0090461; GO:0097110; GO:0097449; GO:0098978; GO:0099171; GO:2001023 behavioral response to nicotine [GO:0035095]; cellular response to stress [GO:0033554]; chemical synaptic transmission [GO:0007268]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; gene expression [GO:0010467]; glutamate secretion [GO:0014047]; intracellular glutamate homeostasis [GO:0090461]; long-term synaptic depression [GO:0060292]; negative regulation of adenylate cyclase activity [GO:0007194]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; presynaptic modulation of chemical synaptic transmission [GO:0099171]; regulation of dopamine secretion [GO:0014059]; regulation of glutamate secretion [GO:0014048]; regulation of response to drug [GO:2001023]; regulation of synaptic transmission, glutamatergic [GO:0051966]; response to cocaine [GO:0042220] astrocyte projection [GO:0097449]; axon [GO:0030424]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734] calcium channel regulator activity [GO:0005246]; G protein-coupled receptor activity [GO:0004930]; glutamate receptor activity [GO:0008066]; group II metabotropic glutamate receptor activity [GO:0001641]; scaffold protein binding [GO:0097110] g5493.t1 O62714 28.289 912 4.04e-104 353.0 sp|O62714|CASR_PIG Extracellular calcium-sensing receptor OS=Sus scrofa OX=9823 GN=CASR PE=2 SV=3 g5494.t1 P15684 35.18 776 1.6000000000000001e-144 453.0 sp|P15684|AMPN_RAT Aminopeptidase N OS=Rattus norvegicus OX=10116 GN=Anpep PE=1 SV=2 AMPN_RAT reviewed Aminopeptidase N (AP-N) (rAPN) (EC 3.4.11.2) (Alanyl aminopeptidase) (Aminopeptidase M) (AP-M) (Kidney Zn peptidase) (KZP) (Microsomal aminopeptidase) (CD antigen CD13) Rattus norvegicus (Rat) GO:0001525; GO:0002003; GO:0004177; GO:0005615; GO:0005793; GO:0005886; GO:0008237; GO:0008270; GO:0009897; GO:0016285; GO:0016485; GO:0030154; GO:0031526; GO:0042277; GO:0043171; GO:0070006; GO:0070062; GO:0072237 angiogenesis [GO:0001525]; angiotensin maturation [GO:0002003]; cell differentiation [GO:0030154]; metanephric proximal tubule development [GO:0072237]; peptide catabolic process [GO:0043171]; protein processing [GO:0016485] brush border membrane [GO:0031526]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; plasma membrane [GO:0005886] alanyl aminopeptidase activity [GO:0016285]; aminopeptidase activity [GO:0004177]; metalloaminopeptidase activity [GO:0070006]; metallopeptidase activity [GO:0008237]; peptide binding [GO:0042277]; zinc ion binding [GO:0008270] g5496.t1 Q9D9R9 30.425 447 3.5200000000000003e-29 130.0 sp|Q9D9R9|F186A_MOUSE Protein FAM186A OS=Mus musculus OX=10090 GN=FAM186A PE=2 SV=2 g5496.t1 Q9D9R9 30.444 473 6.42e-28 126.0 sp|Q9D9R9|F186A_MOUSE Protein FAM186A OS=Mus musculus OX=10090 GN=FAM186A PE=2 SV=2 g5504.t1 B7ZCC9 29.011 617 5.809999999999999e-46 184.0 sp|B7ZCC9|AGRG4_MOUSE Adhesion G-protein coupled receptor G4 OS=Mus musculus OX=10090 GN=Adgrg4 PE=3 SV=1 AGRG4_MOUSE reviewed Adhesion G-protein coupled receptor G4 (G-protein coupled receptor 112) [Cleaved into: Adhesion G-protein coupled receptor G4, N-terminal fragment (ADGRG4 N-terminal fragment); Adhesion G-protein coupled receptor G4, C-terminal fragment (ADGRG4 C-terminal fragment)] Mus musculus (Mouse) GO:0004930; GO:0005886; GO:0007166; GO:0007186; GO:0007189 adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186] plasma membrane [GO:0005886] G protein-coupled receptor activity [GO:0004930] g5506.t1 Q08431 43.396 159 9.090000000000001e-27 110.0 sp|Q08431|MFGM_HUMAN Lactadherin OS=Homo sapiens OX=9606 GN=MFGE8 PE=1 SV=3 MFGM_HUMAN reviewed Lactadherin (Breast epithelial antigen BA46) (HMFG) (MFGM) (Milk fat globule-EGF factor 8) (MFG-E8) (SED1) [Cleaved into: Lactadherin short form; Medin] Homo sapiens (Human) GO:0001525; GO:0001786; GO:0002080; GO:0005178; GO:0005576; GO:0005615; GO:0005788; GO:0007155; GO:0007338; GO:0009897; GO:0016020; GO:0031012; GO:0043277; GO:0070062; GO:1903561 angiogenesis [GO:0001525]; apoptotic cell clearance [GO:0043277]; cell adhesion [GO:0007155]; single fertilization [GO:0007338] acrosomal membrane [GO:0002080]; endoplasmic reticulum lumen [GO:0005788]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular vesicle [GO:1903561]; membrane [GO:0016020] integrin binding [GO:0005178]; phosphatidylserine binding [GO:0001786] g5507.t1 P52170 57.853 503 0.0 609.0 sp|P52170|IMA5_XENLA Importin subunit alpha-5 OS=Xenopus laevis OX=8355 GN=kpna1 PE=1 SV=2 g5508.t1 O35347 51.064 188 1.84e-49 162.0 sp|O35347|DGCR6_MOUSE Protein DGCR6 OS=Mus musculus OX=10090 GN=Dgcr6 PE=2 SV=2 g5510.t1 P24587 28.293 205 3.32e-31 136.0 sp|P24587|AKAP5_RAT A-kinase anchor protein 5 OS=Rattus norvegicus OX=10116 GN=Akap5 PE=1 SV=2 g5510.t1 P24587 23.003 313 3.35e-29 130.0 sp|P24587|AKAP5_RAT A-kinase anchor protein 5 OS=Rattus norvegicus OX=10116 GN=Akap5 PE=1 SV=2 g5510.t1 P24587 26.699 206 4.43e-29 129.0 sp|P24587|AKAP5_RAT A-kinase anchor protein 5 OS=Rattus norvegicus OX=10116 GN=Akap5 PE=1 SV=2 g5510.t1 P24587 28.877 187 7.29e-29 129.0 sp|P24587|AKAP5_RAT A-kinase anchor protein 5 OS=Rattus norvegicus OX=10116 GN=Akap5 PE=1 SV=2 g5510.t1 P24587 28.125 192 1.3e-28 128.0 sp|P24587|AKAP5_RAT A-kinase anchor protein 5 OS=Rattus norvegicus OX=10116 GN=Akap5 PE=1 SV=2 g5510.t1 P24587 25.907 193 1.33e-28 128.0 sp|P24587|AKAP5_RAT A-kinase anchor protein 5 OS=Rattus norvegicus OX=10116 GN=Akap5 PE=1 SV=2 g5510.t1 P24587 27.027 185 1.99e-27 124.0 sp|P24587|AKAP5_RAT A-kinase anchor protein 5 OS=Rattus norvegicus OX=10116 GN=Akap5 PE=1 SV=2 g5510.t1 P24587 27.174 184 4.3700000000000004e-27 123.0 sp|P24587|AKAP5_RAT A-kinase anchor protein 5 OS=Rattus norvegicus OX=10116 GN=Akap5 PE=1 SV=2 g5510.t1 P24587 28.889 180 1.3500000000000002e-26 122.0 sp|P24587|AKAP5_RAT A-kinase anchor protein 5 OS=Rattus norvegicus OX=10116 GN=Akap5 PE=1 SV=2 g5516.t1 Q5RCJ4 48.41 692 0.0 613.0 sp|Q5RCJ4|D19L3_PONAB Protein C-mannosyl-transferase DPY19L3 OS=Pongo abelii OX=9601 GN=DPY19L3 PE=2 SV=2 D19L3_PONAB reviewed Protein C-mannosyl-transferase DPY19L3 (EC 2.4.1.-) (Dpy-19-like protein 3) (Protein dpy-19 homolog 3) Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0000030; GO:0005637; GO:0005789 endoplasmic reticulum membrane [GO:0005789]; nuclear inner membrane [GO:0005637] mannosyltransferase activity [GO:0000030] g5517.t1 Q6PII3 41.439 403 1.75e-60 209.0 sp|Q6PII3|CC174_HUMAN Coiled-coil domain-containing protein 174 OS=Homo sapiens OX=9606 GN=CCDC174 PE=1 SV=3 CC174_HUMAN reviewed Coiled-coil domain-containing protein 174 Homo sapiens (Human) GO:0005634; GO:0005654 nucleoplasm [GO:0005654]; nucleus [GO:0005634] g5522.t1 A1L0Z1 46.742 353 1.33e-75 242.0 sp|A1L0Z1|PO3F4_XENTR POU domain, class 3, transcription factor 4 OS=Xenopus tropicalis OX=8364 GN=pou3f4 PE=2 SV=1 g5523.t1 P29145 43.652 575 1.9e-145 446.0 sp|P29145|NECB_HYDVU PC3-like endoprotease variant B OS=Hydra vulgaris OX=6087 PE=2 SV=1 g5523.t2 P29145 44.582 323 2.97e-88 288.0 sp|P29145|NECB_HYDVU PC3-like endoprotease variant B OS=Hydra vulgaris OX=6087 PE=2 SV=1 g5527.t1 A2AHJ4 50.133 1500 0.0 1394.0 sp|A2AHJ4|BRWD3_MOUSE Bromodomain and WD repeat-containing protein 3 OS=Mus musculus OX=10090 GN=Brwd3 PE=1 SV=1 g5527.t2 A2AHJ4 50.133 1500 0.0 1397.0 sp|A2AHJ4|BRWD3_MOUSE Bromodomain and WD repeat-containing protein 3 OS=Mus musculus OX=10090 GN=Brwd3 PE=1 SV=1 g5528.t1 Q86SQ9 54.859 319 1.9899999999999998e-126 369.0 sp|Q86SQ9|DHDDS_HUMAN Dehydrodolichyl diphosphate synthase complex subunit DHDDS OS=Homo sapiens OX=9606 GN=DHDDS PE=1 SV=3 DHDDS_HUMAN reviewed Dehydrodolichyl diphosphate synthase complex subunit DHDDS (EC 2.5.1.87) (Cis-isoprenyltransferase) (CIT) (Cis-IPTase) (Cis-prenyltransferase subunit hCIT) (Epididymis tissue protein Li 189m) Homo sapiens (Human) GO:0005783; GO:0005789; GO:0006489; GO:0016094; GO:0043048; GO:0045547; GO:0046872; GO:1904423 dolichyl diphosphate biosynthetic process [GO:0006489]; dolichyl monophosphate biosynthetic process [GO:0043048]; polyprenol biosynthetic process [GO:0016094] dehydrodolichyl diphosphate synthase complex [GO:1904423]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789] ditrans,polycis-polyprenyl diphosphate synthase [(2E,6E)-farnesyl diphosphate specific] activity [GO:0045547]; metal ion binding [GO:0046872] g5529.t1 Q3SYV5 38.785 214 8.680000000000001e-37 134.0 sp|Q3SYV5|TSN33_BOVIN Tetraspanin-33 OS=Bos taurus OX=9913 GN=TSPAN33 PE=1 SV=1 TSN33_BOVIN reviewed Tetraspanin-33 (Tspan-33) Bos taurus (Bovine) GO:0005737; GO:0005886; GO:0005912; GO:0019899; GO:0046930; GO:0046931; GO:0051604; GO:0072659 pore complex assembly [GO:0046931]; protein localization to plasma membrane [GO:0072659]; protein maturation [GO:0051604] adherens junction [GO:0005912]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; pore complex [GO:0046930] enzyme binding [GO:0019899] g5530.t1 A0MTA1 57.5 320 9.47e-120 350.0 sp|A0MTA1|APEX1_DANRE DNA repair nuclease APEX1 OS=Danio rerio OX=7955 GN=apex1 PE=1 SV=1 APEX1_DANRE reviewed DNA repair nuclease APEX1 (EC 3.1.11.2) (EC 3.1.21.-) (APEX nuclease) (APEN) (Apurinic-apyrimidinic endonuclease 1) (AP endonuclease 1) (zAP1) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001947; GO:0003723; GO:0003906; GO:0005634; GO:0005730; GO:0005739; GO:0005783; GO:0006284; GO:0008081; GO:0008311; GO:0010628; GO:0016607; GO:0043066; GO:0044029; GO:0046872; GO:0052720; GO:0060047; GO:0140431 base-excision repair [GO:0006284]; heart contraction [GO:0060047]; heart looping [GO:0001947]; negative regulation of apoptotic process [GO:0043066]; positive regulation of gene expression [GO:0010628]; positive regulation of gene expression via chromosomal CpG island demethylation [GO:0044029] endoplasmic reticulum [GO:0005783]; mitochondrion [GO:0005739]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleus [GO:0005634] class II DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0052720]; DNA-(abasic site) binding [GO:0140431]; DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0003906]; double-stranded DNA 3'-5' DNA exonuclease activity [GO:0008311]; metal ion binding [GO:0046872]; phosphoric diester hydrolase activity [GO:0008081]; RNA binding [GO:0003723] g5531.t1 P82931 50.526 95 3.0000000000000003e-31 111.0 sp|P82931|RT06_BOVIN Small ribosomal subunit protein bS6m OS=Bos taurus OX=9913 GN=MRPS6 PE=1 SV=4 g5537.t1 Q24439 47.03 202 4.9900000000000005e-58 185.0 sp|Q24439|ATPO_DROME ATP synthase subunit O, mitochondrial OS=Drosophila melanogaster OX=7227 GN=ATPsynO PE=2 SV=2 g5538.t1 Q9Z0R4 50.714 911 0.0 906.0 sp|Q9Z0R4|ITSN1_MOUSE Intersectin-1 OS=Mus musculus OX=10090 GN=Itsn1 PE=1 SV=2 ITSN1_MOUSE reviewed Intersectin-1 (EH and SH3 domains protein 1) Mus musculus (Mouse) GO:0005085; GO:0005509; GO:0005635; GO:0005737; GO:0005829; GO:0005886; GO:0005905; GO:0006887; GO:0006897; GO:0007264; GO:0007267; GO:0008104; GO:0015031; GO:0016197; GO:0019209; GO:0030027; GO:0030139; GO:0030674; GO:0042734; GO:0043025; GO:0043197; GO:0043524; GO:0044305; GO:0048488; GO:0051897; GO:0055037; GO:0060090; GO:0060124; GO:0060999; GO:0070064; GO:0097440; GO:0097708; GO:0098833; GO:0098843; GO:0098871; GO:0098978; GO:0099175; GO:0150007; GO:1905274; GO:2001288 cell-cell signaling [GO:0007267]; clathrin-dependent synaptic vesicle endocytosis [GO:0150007]; endocytosis [GO:0006897]; endosomal transport [GO:0016197]; exocytosis [GO:0006887]; intracellular protein localization [GO:0008104]; negative regulation of neuron apoptotic process [GO:0043524]; positive regulation of caveolin-mediated endocytosis [GO:2001288]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of growth hormone secretion [GO:0060124]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; protein transport [GO:0015031]; regulation of modification of postsynaptic actin cytoskeleton [GO:1905274]; regulation of postsynapse organization [GO:0099175]; small GTPase-mediated signal transduction [GO:0007264]; synaptic vesicle endocytosis [GO:0048488] apical dendrite [GO:0097440]; calyx of Held [GO:0044305]; clathrin-coated pit [GO:0005905]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; endocytic vesicle [GO:0030139]; glutamatergic synapse [GO:0098978]; intracellular vesicle [GO:0097708]; lamellipodium [GO:0030027]; neuronal cell body [GO:0043025]; nuclear envelope [GO:0005635]; plasma membrane [GO:0005886]; postsynaptic actin cytoskeleton [GO:0098871]; postsynaptic endocytic zone [GO:0098843]; presynaptic endocytic zone [GO:0098833]; presynaptic membrane [GO:0042734]; recycling endosome [GO:0055037] calcium ion binding [GO:0005509]; guanyl-nucleotide exchange factor activity [GO:0005085]; kinase activator activity [GO:0019209]; molecular adaptor activity [GO:0060090]; proline-rich region binding [GO:0070064]; protein-macromolecule adaptor activity [GO:0030674] g5538.t1 Q9Z0R4 43.323 337 1.39e-53 212.0 sp|Q9Z0R4|ITSN1_MOUSE Intersectin-1 OS=Mus musculus OX=10090 GN=Itsn1 PE=1 SV=2 ITSN1_MOUSE reviewed Intersectin-1 (EH and SH3 domains protein 1) Mus musculus (Mouse) GO:0005085; GO:0005509; GO:0005635; GO:0005737; GO:0005829; GO:0005886; GO:0005905; GO:0006887; GO:0006897; GO:0007264; GO:0007267; GO:0008104; GO:0015031; GO:0016197; GO:0019209; GO:0030027; GO:0030139; GO:0030674; GO:0042734; GO:0043025; GO:0043197; GO:0043524; GO:0044305; GO:0048488; GO:0051897; GO:0055037; GO:0060090; GO:0060124; GO:0060999; GO:0070064; GO:0097440; GO:0097708; GO:0098833; GO:0098843; GO:0098871; GO:0098978; GO:0099175; GO:0150007; GO:1905274; GO:2001288 cell-cell signaling [GO:0007267]; clathrin-dependent synaptic vesicle endocytosis [GO:0150007]; endocytosis [GO:0006897]; endosomal transport [GO:0016197]; exocytosis [GO:0006887]; intracellular protein localization [GO:0008104]; negative regulation of neuron apoptotic process [GO:0043524]; positive regulation of caveolin-mediated endocytosis [GO:2001288]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of growth hormone secretion [GO:0060124]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; protein transport [GO:0015031]; regulation of modification of postsynaptic actin cytoskeleton [GO:1905274]; regulation of postsynapse organization [GO:0099175]; small GTPase-mediated signal transduction [GO:0007264]; synaptic vesicle endocytosis [GO:0048488] apical dendrite [GO:0097440]; calyx of Held [GO:0044305]; clathrin-coated pit [GO:0005905]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; endocytic vesicle [GO:0030139]; glutamatergic synapse [GO:0098978]; intracellular vesicle [GO:0097708]; lamellipodium [GO:0030027]; neuronal cell body [GO:0043025]; nuclear envelope [GO:0005635]; plasma membrane [GO:0005886]; postsynaptic actin cytoskeleton [GO:0098871]; postsynaptic endocytic zone [GO:0098843]; presynaptic endocytic zone [GO:0098833]; presynaptic membrane [GO:0042734]; recycling endosome [GO:0055037] calcium ion binding [GO:0005509]; guanyl-nucleotide exchange factor activity [GO:0005085]; kinase activator activity [GO:0019209]; molecular adaptor activity [GO:0060090]; proline-rich region binding [GO:0070064]; protein-macromolecule adaptor activity [GO:0030674] g5538.t2 Q9Z0R4 50.714 911 0.0 906.0 sp|Q9Z0R4|ITSN1_MOUSE Intersectin-1 OS=Mus musculus OX=10090 GN=Itsn1 PE=1 SV=2 ITSN1_MOUSE reviewed Intersectin-1 (EH and SH3 domains protein 1) Mus musculus (Mouse) GO:0005085; GO:0005509; GO:0005635; GO:0005737; GO:0005829; GO:0005886; GO:0005905; GO:0006887; GO:0006897; GO:0007264; GO:0007267; GO:0008104; GO:0015031; GO:0016197; GO:0019209; GO:0030027; GO:0030139; GO:0030674; GO:0042734; GO:0043025; GO:0043197; GO:0043524; GO:0044305; GO:0048488; GO:0051897; GO:0055037; GO:0060090; GO:0060124; GO:0060999; GO:0070064; GO:0097440; GO:0097708; GO:0098833; GO:0098843; GO:0098871; GO:0098978; GO:0099175; GO:0150007; GO:1905274; GO:2001288 cell-cell signaling [GO:0007267]; clathrin-dependent synaptic vesicle endocytosis [GO:0150007]; endocytosis [GO:0006897]; endosomal transport [GO:0016197]; exocytosis [GO:0006887]; intracellular protein localization [GO:0008104]; negative regulation of neuron apoptotic process [GO:0043524]; positive regulation of caveolin-mediated endocytosis [GO:2001288]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of growth hormone secretion [GO:0060124]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; protein transport [GO:0015031]; regulation of modification of postsynaptic actin cytoskeleton [GO:1905274]; regulation of postsynapse organization [GO:0099175]; small GTPase-mediated signal transduction [GO:0007264]; synaptic vesicle endocytosis [GO:0048488] apical dendrite [GO:0097440]; calyx of Held [GO:0044305]; clathrin-coated pit [GO:0005905]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; endocytic vesicle [GO:0030139]; glutamatergic synapse [GO:0098978]; intracellular vesicle [GO:0097708]; lamellipodium [GO:0030027]; neuronal cell body [GO:0043025]; nuclear envelope [GO:0005635]; plasma membrane [GO:0005886]; postsynaptic actin cytoskeleton [GO:0098871]; postsynaptic endocytic zone [GO:0098843]; presynaptic endocytic zone [GO:0098833]; presynaptic membrane [GO:0042734]; recycling endosome [GO:0055037] calcium ion binding [GO:0005509]; guanyl-nucleotide exchange factor activity [GO:0005085]; kinase activator activity [GO:0019209]; molecular adaptor activity [GO:0060090]; proline-rich region binding [GO:0070064]; protein-macromolecule adaptor activity [GO:0030674] g5538.t2 Q9Z0R4 43.323 337 1.39e-53 212.0 sp|Q9Z0R4|ITSN1_MOUSE Intersectin-1 OS=Mus musculus OX=10090 GN=Itsn1 PE=1 SV=2 ITSN1_MOUSE reviewed Intersectin-1 (EH and SH3 domains protein 1) Mus musculus (Mouse) GO:0005085; GO:0005509; GO:0005635; GO:0005737; GO:0005829; GO:0005886; GO:0005905; GO:0006887; GO:0006897; GO:0007264; GO:0007267; GO:0008104; GO:0015031; GO:0016197; GO:0019209; GO:0030027; GO:0030139; GO:0030674; GO:0042734; GO:0043025; GO:0043197; GO:0043524; GO:0044305; GO:0048488; GO:0051897; GO:0055037; GO:0060090; GO:0060124; GO:0060999; GO:0070064; GO:0097440; GO:0097708; GO:0098833; GO:0098843; GO:0098871; GO:0098978; GO:0099175; GO:0150007; GO:1905274; GO:2001288 cell-cell signaling [GO:0007267]; clathrin-dependent synaptic vesicle endocytosis [GO:0150007]; endocytosis [GO:0006897]; endosomal transport [GO:0016197]; exocytosis [GO:0006887]; intracellular protein localization [GO:0008104]; negative regulation of neuron apoptotic process [GO:0043524]; positive regulation of caveolin-mediated endocytosis [GO:2001288]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of growth hormone secretion [GO:0060124]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; protein transport [GO:0015031]; regulation of modification of postsynaptic actin cytoskeleton [GO:1905274]; regulation of postsynapse organization [GO:0099175]; small GTPase-mediated signal transduction [GO:0007264]; synaptic vesicle endocytosis [GO:0048488] apical dendrite [GO:0097440]; calyx of Held [GO:0044305]; clathrin-coated pit [GO:0005905]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; endocytic vesicle [GO:0030139]; glutamatergic synapse [GO:0098978]; intracellular vesicle [GO:0097708]; lamellipodium [GO:0030027]; neuronal cell body [GO:0043025]; nuclear envelope [GO:0005635]; plasma membrane [GO:0005886]; postsynaptic actin cytoskeleton [GO:0098871]; postsynaptic endocytic zone [GO:0098843]; presynaptic endocytic zone [GO:0098833]; presynaptic membrane [GO:0042734]; recycling endosome [GO:0055037] calcium ion binding [GO:0005509]; guanyl-nucleotide exchange factor activity [GO:0005085]; kinase activator activity [GO:0019209]; molecular adaptor activity [GO:0060090]; proline-rich region binding [GO:0070064]; protein-macromolecule adaptor activity [GO:0030674] g5539.t1 Q59A28 43.323 337 6.91e-98 297.0 sp|Q59A28|QORL1_BOVIN Quinone oxidoreductase-like protein 1 OS=Bos taurus OX=9913 GN=CRYZL1 PE=2 SV=1 g5540.t1 Q9C0D7 49.618 393 4.6899999999999995e-104 346.0 sp|Q9C0D7|ZC12C_HUMAN Probable ribonuclease ZC3H12C OS=Homo sapiens OX=9606 GN=ZC3H12C PE=1 SV=2 g5541.t1 P18258 96.919 357 0.0 703.0 sp|P18258|TBA1_PARLI Tubulin alpha-1 chain OS=Paracentrotus lividus OX=7656 PE=2 SV=1 g5542.t1 P06603 88.848 269 1.26e-168 481.0 sp|P06603|TBA1_DROME Tubulin alpha-1 chain OS=Drosophila melanogaster OX=7227 GN=alphaTub84B PE=1 SV=1 TBA1_DROME reviewed Tubulin alpha-1 chain (EC 3.6.5.-) Drosophila melanogaster (Fruit fly) GO:0000226; GO:0000235; GO:0000278; GO:0005200; GO:0005525; GO:0005634; GO:0005737; GO:0005813; GO:0005819; GO:0005874; GO:0016787; GO:0032418; GO:0046872; GO:0048471 lysosome localization [GO:0032418]; microtubule cytoskeleton organization [GO:0000226]; mitotic cell cycle [GO:0000278] astral microtubule [GO:0000235]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; spindle [GO:0005819] GTP binding [GO:0005525]; hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]; structural constituent of cytoskeleton [GO:0005200] g5543.t1 P41383 93.394 439 0.0 850.0 sp|P41383|TBA2_PATVU Tubulin alpha-2/alpha-4 chain OS=Patella vulgata OX=6465 GN=TUB2 PE=2 SV=1 g5544.t1 P41383 97.95 439 0.0 881.0 sp|P41383|TBA2_PATVU Tubulin alpha-2/alpha-4 chain OS=Patella vulgata OX=6465 GN=TUB2 PE=2 SV=1 g5545.t1 P18258 98.072 363 0.0 722.0 sp|P18258|TBA1_PARLI Tubulin alpha-1 chain OS=Paracentrotus lividus OX=7656 PE=2 SV=1 g5546.t1 P18258 98.045 358 0.0 713.0 sp|P18258|TBA1_PARLI Tubulin alpha-1 chain OS=Paracentrotus lividus OX=7656 PE=2 SV=1 g5547.t1 P41383 97.727 440 0.0 885.0 sp|P41383|TBA2_PATVU Tubulin alpha-2/alpha-4 chain OS=Patella vulgata OX=6465 GN=TUB2 PE=2 SV=1 g5548.t1 P41383 98.182 440 0.0 888.0 sp|P41383|TBA2_PATVU Tubulin alpha-2/alpha-4 chain OS=Patella vulgata OX=6465 GN=TUB2 PE=2 SV=1 g5549.t1 P18258 98.843 432 0.0 876.0 sp|P18258|TBA1_PARLI Tubulin alpha-1 chain OS=Paracentrotus lividus OX=7656 PE=2 SV=1 g5550.t1 P41383 96.629 356 0.0 701.0 sp|P41383|TBA2_PATVU Tubulin alpha-2/alpha-4 chain OS=Patella vulgata OX=6465 GN=TUB2 PE=2 SV=1 g5551.t1 P09645 81.2 250 2.38e-158 445.0 sp|P09645|TBA8_CHICK Tubulin alpha-8 chain (Fragment) OS=Gallus gallus OX=9031 PE=3 SV=1 g5552.t1 P18258 85.326 184 1.98e-98 295.0 sp|P18258|TBA1_PARLI Tubulin alpha-1 chain OS=Paracentrotus lividus OX=7656 PE=2 SV=1 g5553.t1 Q06331 69.032 310 1.02e-153 441.0 sp|Q06331|TBA_ENTDO Tubulin alpha chain OS=Enteroctopus dofleini OX=267067 PE=2 SV=1 g5554.t1 P41383 84.318 440 0.0 736.0 sp|P41383|TBA2_PATVU Tubulin alpha-2/alpha-4 chain OS=Patella vulgata OX=6465 GN=TUB2 PE=2 SV=1 g5555.t1 P68373 86.102 295 0.0 541.0 sp|P68373|TBA1C_MOUSE Tubulin alpha-1C chain OS=Mus musculus OX=10090 GN=Tuba1c PE=1 SV=1 g5556.t1 P02553 97.71 131 1.26e-94 273.0 sp|P02553|TBA_LYTPI Tubulin alpha chain (Fragment) OS=Lytechinus pictus OX=7653 PE=3 SV=1 g5557.t1 P18288 75.746 268 9.45e-131 379.0 sp|P18288|TBAT_ONCMY Tubulin alpha chain, testis-specific OS=Oncorhynchus mykiss OX=8022 PE=2 SV=1 g5558.t1 P18288 88.636 308 0.0 528.0 sp|P18288|TBAT_ONCMY Tubulin alpha chain, testis-specific OS=Oncorhynchus mykiss OX=8022 PE=2 SV=1 g5559.t1 P36220 95.216 439 0.0 863.0 sp|P36220|TBA_TORMA Tubulin alpha chain OS=Torpedo marmorata OX=7788 PE=2 SV=1 g5561.t1 Q9UPY6 48.131 214 2.9100000000000003e-57 202.0 sp|Q9UPY6|WASF3_HUMAN Actin-binding protein WASF3 OS=Homo sapiens OX=9606 GN=WASF3 PE=1 SV=2 WASF3_HUMAN reviewed Actin-binding protein WASF3 (Protein WAVE-3) (Verprolin homology domain-containing protein 3) (Wiskott-Aldrich syndrome protein family member 3) (WASP family protein member 3) Homo sapiens (Human) GO:0003779; GO:0005856; GO:0007010; GO:0008360; GO:0014003; GO:0030027; GO:0030032; GO:0030036; GO:0030041; GO:0031209; GO:0031643; GO:0034237; GO:0065003; GO:0070062; GO:0071933; GO:0097386; GO:0098794; GO:0098885; GO:0098978; GO:2000601 actin cytoskeleton organization [GO:0030036]; actin filament polymerization [GO:0030041]; cytoskeleton organization [GO:0007010]; lamellipodium assembly [GO:0030032]; modification of postsynaptic actin cytoskeleton [GO:0098885]; oligodendrocyte development [GO:0014003]; positive regulation of Arp2/3 complex-mediated actin nucleation [GO:2000601]; positive regulation of myelination [GO:0031643]; protein-containing complex assembly [GO:0065003]; regulation of cell shape [GO:0008360] cytoskeleton [GO:0005856]; extracellular exosome [GO:0070062]; glial cell projection [GO:0097386]; glutamatergic synapse [GO:0098978]; lamellipodium [GO:0030027]; postsynapse [GO:0098794]; SCAR complex [GO:0031209] actin binding [GO:0003779]; Arp2/3 complex binding [GO:0071933]; protein kinase A regulatory subunit binding [GO:0034237] g5561.t2 Q9UPY6 55.607 214 5.8e-72 241.0 sp|Q9UPY6|WASF3_HUMAN Actin-binding protein WASF3 OS=Homo sapiens OX=9606 GN=WASF3 PE=1 SV=2 WASF3_HUMAN reviewed Actin-binding protein WASF3 (Protein WAVE-3) (Verprolin homology domain-containing protein 3) (Wiskott-Aldrich syndrome protein family member 3) (WASP family protein member 3) Homo sapiens (Human) GO:0003779; GO:0005856; GO:0007010; GO:0008360; GO:0014003; GO:0030027; GO:0030032; GO:0030036; GO:0030041; GO:0031209; GO:0031643; GO:0034237; GO:0065003; GO:0070062; GO:0071933; GO:0097386; GO:0098794; GO:0098885; GO:0098978; GO:2000601 actin cytoskeleton organization [GO:0030036]; actin filament polymerization [GO:0030041]; cytoskeleton organization [GO:0007010]; lamellipodium assembly [GO:0030032]; modification of postsynaptic actin cytoskeleton [GO:0098885]; oligodendrocyte development [GO:0014003]; positive regulation of Arp2/3 complex-mediated actin nucleation [GO:2000601]; positive regulation of myelination [GO:0031643]; protein-containing complex assembly [GO:0065003]; regulation of cell shape [GO:0008360] cytoskeleton [GO:0005856]; extracellular exosome [GO:0070062]; glial cell projection [GO:0097386]; glutamatergic synapse [GO:0098978]; lamellipodium [GO:0030027]; postsynapse [GO:0098794]; SCAR complex [GO:0031209] actin binding [GO:0003779]; Arp2/3 complex binding [GO:0071933]; protein kinase A regulatory subunit binding [GO:0034237] g5564.t1 Q9HBY0 49.13 460 1.7000000000000001e-161 471.0 sp|Q9HBY0|NOX3_HUMAN NADPH oxidase 3 OS=Homo sapiens OX=9606 GN=NOX3 PE=1 SV=1 NOX3_HUMAN reviewed NADPH oxidase 3 (EC 1.6.3.-) (Mitogenic oxidase 2) (MOX-2) (gp91phox homolog 3) (GP91-3) Homo sapiens (Human) GO:0001659; GO:0005737; GO:0005886; GO:0006952; GO:0009590; GO:0016174; GO:0016175; GO:0020037; GO:0042554; GO:0043020; GO:0046872; GO:0048840; GO:0070062; GO:0106292 defense response [GO:0006952]; detection of gravity [GO:0009590]; otolith development [GO:0048840]; superoxide anion generation [GO:0042554]; temperature homeostasis [GO:0001659] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; NADPH oxidase complex [GO:0043020]; plasma membrane [GO:0005886] heme binding [GO:0020037]; metal ion binding [GO:0046872]; NAD(P)H oxidase H2O2-forming activity [GO:0016174]; superoxide-generating NAD(P)H oxidase activity [GO:0016175]; superoxide-generating NADPH oxidase activity [GO:0106292] g5567.t1 Q8BIQ5 79.581 191 4.69e-110 330.0 sp|Q8BIQ5|CSTF2_MOUSE Cleavage stimulation factor subunit 2 OS=Mus musculus OX=10090 GN=Cstf2 PE=1 SV=2 g5574.t1 A2VDP6 35.06 251 8.7e-51 177.0 sp|A2VDP6|NXPE3_BOVIN NXPE family member 3 OS=Bos taurus OX=9913 GN=NXPE3 PE=2 SV=1 g5574.t2 A2VDP6 31.902 489 9.16e-83 271.0 sp|A2VDP6|NXPE3_BOVIN NXPE family member 3 OS=Bos taurus OX=9913 GN=NXPE3 PE=2 SV=1 g5588.t1 Q9NRZ7 37.203 379 6.65e-84 263.0 sp|Q9NRZ7|PLCC_HUMAN 1-acyl-sn-glycerol-3-phosphate acyltransferase gamma OS=Homo sapiens OX=9606 GN=AGPAT3 PE=1 SV=1 g5589.t1 P80146 38.535 314 1.0499999999999999e-55 191.0 sp|P80146|SEPR_THESR Extracellular serine proteinase OS=Thermus sp. (strain Rt41A) OX=32063 PE=1 SV=3 g5590.t1 Q61371 66.074 731 0.0 993.0 sp|Q61371|IFT88_MOUSE Intraflagellar transport protein 88 homolog OS=Mus musculus OX=10090 GN=Ift88 PE=1 SV=2 g5590.t2 Q61371 62.408 814 0.0 993.0 sp|Q61371|IFT88_MOUSE Intraflagellar transport protein 88 homolog OS=Mus musculus OX=10090 GN=Ift88 PE=1 SV=2 g5592.t1 Q9VHK6 75.163 153 2.0900000000000003e-79 235.0 sp|Q9VHK6|ISCU_DROME Iron-sulfur cluster assembly enzyme IscU OS=Drosophila melanogaster OX=7227 GN=IscU PE=1 SV=1 g5593.t1 Q4R8Z2 62.755 196 6.61e-90 265.0 sp|Q4R8Z2|RL13A_MACFA Large ribosomal subunit protein uL13 OS=Macaca fascicularis OX=9541 GN=RPL13A PE=2 SV=3 g5595.t1 Q8R5K5 44.737 228 7.43e-50 174.0 sp|Q8R5K5|UTP11_RAT Probable U3 small nucleolar RNA-associated protein 11 OS=Rattus norvegicus OX=10116 GN=Utp11 PE=2 SV=1 g5596.t1 P0C6R2 39.448 616 1.93e-146 456.0 sp|P0C6R2|ARMC2_BOVIN Armadillo repeat-containing protein 2 OS=Bos taurus OX=9913 GN=ARMC2 PE=3 SV=1 g5599.t1 Q8N7X0 34.393 535 4.28e-88 319.0 sp|Q8N7X0|ADGB_HUMAN Androglobin OS=Homo sapiens OX=9606 GN=ADGB PE=1 SV=3 ADGB_HUMAN reviewed Androglobin Homo sapiens (Human) GO:0004198; GO:0006508; GO:0007286; GO:0019825; GO:0020037; GO:0046872; GO:0097225; GO:0097227 proteolysis [GO:0006508]; spermatid development [GO:0007286] sperm annulus [GO:0097227]; sperm midpiece [GO:0097225] calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; oxygen binding [GO:0019825] g5599.t1 Q8N7X0 41.226 359 9.14e-72 268.0 sp|Q8N7X0|ADGB_HUMAN Androglobin OS=Homo sapiens OX=9606 GN=ADGB PE=1 SV=3 ADGB_HUMAN reviewed Androglobin Homo sapiens (Human) GO:0004198; GO:0006508; GO:0007286; GO:0019825; GO:0020037; GO:0046872; GO:0097225; GO:0097227 proteolysis [GO:0006508]; spermatid development [GO:0007286] sperm annulus [GO:0097227]; sperm midpiece [GO:0097225] calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; oxygen binding [GO:0019825] g5599.t2 Q8N7X0 34.393 535 2.7e-88 319.0 sp|Q8N7X0|ADGB_HUMAN Androglobin OS=Homo sapiens OX=9606 GN=ADGB PE=1 SV=3 ADGB_HUMAN reviewed Androglobin Homo sapiens (Human) GO:0004198; GO:0006508; GO:0007286; GO:0019825; GO:0020037; GO:0046872; GO:0097225; GO:0097227 proteolysis [GO:0006508]; spermatid development [GO:0007286] sperm annulus [GO:0097227]; sperm midpiece [GO:0097225] calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; oxygen binding [GO:0019825] g5599.t2 Q8N7X0 46.835 316 3.92e-78 288.0 sp|Q8N7X0|ADGB_HUMAN Androglobin OS=Homo sapiens OX=9606 GN=ADGB PE=1 SV=3 ADGB_HUMAN reviewed Androglobin Homo sapiens (Human) GO:0004198; GO:0006508; GO:0007286; GO:0019825; GO:0020037; GO:0046872; GO:0097225; GO:0097227 proteolysis [GO:0006508]; spermatid development [GO:0007286] sperm annulus [GO:0097227]; sperm midpiece [GO:0097225] calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; oxygen binding [GO:0019825] g5605.t1 Q32L63 46.474 312 1.4200000000000002e-79 247.0 sp|Q32L63|VTA1_BOVIN Vacuolar protein sorting-associated protein VTA1 homolog OS=Bos taurus OX=9913 GN=VTA1 PE=2 SV=1 g5607.t1 Q6ZMT9 33.333 483 2.05e-61 226.0 sp|Q6ZMT9|DTHD1_HUMAN Death domain-containing protein 1 OS=Homo sapiens OX=9606 GN=DTHD1 PE=1 SV=3 g5609.t1 Q0VFI5 57.229 332 5.81e-121 361.0 sp|Q0VFI5|GATA_XENTR Glutamyl-tRNA(Gln) amidotransferase subunit A, mitochondrial OS=Xenopus tropicalis OX=8364 GN=qrsl1 PE=2 SV=1 g5610.t1 Q29RP9 60.714 168 1.59e-70 225.0 sp|Q29RP9|GATA_BOVIN Glutamyl-tRNA(Gln) amidotransferase subunit A, mitochondrial OS=Bos taurus OX=9913 GN=QRSL1 PE=2 SV=1 g5611.t1 Q8TE73 61.832 4606 0.0 5588.0 sp|Q8TE73|DYH5_HUMAN Dynein axonemal heavy chain 5 OS=Homo sapiens OX=9606 GN=DNAH5 PE=1 SV=3 DYH5_HUMAN reviewed Dynein axonemal heavy chain 5 (Axonemal beta dynein heavy chain 5) (Ciliary dynein heavy chain 5) Homo sapiens (Human) GO:0003341; GO:0003351; GO:0005524; GO:0005576; GO:0005737; GO:0005874; GO:0005930; GO:0007368; GO:0007507; GO:0008569; GO:0021670; GO:0030317; GO:0031514; GO:0036157; GO:0036158; GO:0045505; GO:0051649; GO:0051959; GO:0060271; GO:0060294; GO:0097386; GO:0097728; GO:0097729 cilium assembly [GO:0060271]; cilium movement [GO:0003341]; cilium movement involved in cell motility [GO:0060294]; determination of left/right symmetry [GO:0007368]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; establishment of localization in cell [GO:0051649]; flagellated sperm motility [GO:0030317]; heart development [GO:0007507]; lateral ventricle development [GO:0021670]; outer dynein arm assembly [GO:0036158] 9+0 motile cilium [GO:0097728]; 9+2 motile cilium [GO:0097729]; axoneme [GO:0005930]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; glial cell projection [GO:0097386]; microtubule [GO:0005874]; motile cilium [GO:0031514]; outer dynein arm [GO:0036157] ATP binding [GO:0005524]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; minus-end-directed microtubule motor activity [GO:0008569] g5611.t2 Q8TE73 61.832 4606 0.0 5590.0 sp|Q8TE73|DYH5_HUMAN Dynein axonemal heavy chain 5 OS=Homo sapiens OX=9606 GN=DNAH5 PE=1 SV=3 DYH5_HUMAN reviewed Dynein axonemal heavy chain 5 (Axonemal beta dynein heavy chain 5) (Ciliary dynein heavy chain 5) Homo sapiens (Human) GO:0003341; GO:0003351; GO:0005524; GO:0005576; GO:0005737; GO:0005874; GO:0005930; GO:0007368; GO:0007507; GO:0008569; GO:0021670; GO:0030317; GO:0031514; GO:0036157; GO:0036158; GO:0045505; GO:0051649; GO:0051959; GO:0060271; GO:0060294; GO:0097386; GO:0097728; GO:0097729 cilium assembly [GO:0060271]; cilium movement [GO:0003341]; cilium movement involved in cell motility [GO:0060294]; determination of left/right symmetry [GO:0007368]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; establishment of localization in cell [GO:0051649]; flagellated sperm motility [GO:0030317]; heart development [GO:0007507]; lateral ventricle development [GO:0021670]; outer dynein arm assembly [GO:0036158] 9+0 motile cilium [GO:0097728]; 9+2 motile cilium [GO:0097729]; axoneme [GO:0005930]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; glial cell projection [GO:0097386]; microtubule [GO:0005874]; motile cilium [GO:0031514]; outer dynein arm [GO:0036157] ATP binding [GO:0005524]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; minus-end-directed microtubule motor activity [GO:0008569] g5612.t1 Q6ZN16 47.903 1073 0.0 946.0 sp|Q6ZN16|M3K15_HUMAN Mitogen-activated protein kinase kinase kinase 15 OS=Homo sapiens OX=9606 GN=MAP3K15 PE=1 SV=2 M3K15_HUMAN reviewed Mitogen-activated protein kinase kinase kinase 15 (EC 2.7.11.25) (Apoptosis signal-regulating kinase 3) (MAPK/ERK kinase kinase 15) (MEK kinase 15) (MEKK 15) Homo sapiens (Human) GO:0004709; GO:0005524; GO:0007254; GO:0038066; GO:0046872; GO:0106310 JNK cascade [GO:0007254]; p38MAPK cascade [GO:0038066] ATP binding [GO:0005524]; MAP kinase kinase kinase activity [GO:0004709]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310] g5612.t2 Q6ZN16 47.698 1086 0.0 950.0 sp|Q6ZN16|M3K15_HUMAN Mitogen-activated protein kinase kinase kinase 15 OS=Homo sapiens OX=9606 GN=MAP3K15 PE=1 SV=2 M3K15_HUMAN reviewed Mitogen-activated protein kinase kinase kinase 15 (EC 2.7.11.25) (Apoptosis signal-regulating kinase 3) (MAPK/ERK kinase kinase 15) (MEK kinase 15) (MEKK 15) Homo sapiens (Human) GO:0004709; GO:0005524; GO:0007254; GO:0038066; GO:0046872; GO:0106310 JNK cascade [GO:0007254]; p38MAPK cascade [GO:0038066] ATP binding [GO:0005524]; MAP kinase kinase kinase activity [GO:0004709]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310] g5613.t1 P52899 69.253 348 0.0 516.0 sp|P52899|ODPA_CAEEL Probable pyruvate dehydrogenase E1 component subunit alpha, mitochondrial OS=Caenorhabditis elegans OX=6239 GN=pdha-1 PE=3 SV=1 g5617.t1 Q5U2R1 46.708 319 1.69e-91 281.0 sp|Q5U2R1|DLP1_RAT All trans-polyprenyl-diphosphate synthase PDSS2 OS=Rattus norvegicus OX=10116 GN=Pdss2 PE=2 SV=1 DLP1_RAT reviewed All trans-polyprenyl-diphosphate synthase PDSS2 (All-trans-decaprenyl-diphosphate synthase subunit 2) (EC 2.5.1.91) (Decaprenyl-diphosphate synthase subunit 2) (Solanesyl-diphosphate synthase subunit 2) Rattus norvegicus (Rat) GO:0004659; GO:0005739; GO:0005829; GO:0006744; GO:0008299; GO:0021549; GO:0032476; GO:0032478; GO:0046982; GO:0050878; GO:0097269; GO:0110142; GO:1990234 cerebellum development [GO:0021549]; isoprenoid biosynthetic process [GO:0008299]; regulation of body fluid levels [GO:0050878]; ubiquinone biosynthetic process [GO:0006744] cytosol [GO:0005829]; heterotetrameric polyprenyl diphosphate synthase complex [GO:0032478]; mitochondrion [GO:0005739]; polyprenyl diphosphate synthase complex [GO:0032476]; transferase complex [GO:1990234]; ubiquinone biosynthesis complex [GO:0110142] all-trans-decaprenyl-diphosphate synthase activity [GO:0097269]; prenyltransferase activity [GO:0004659]; protein heterodimerization activity [GO:0046982] g5618.t1 Q53FA7 55.109 274 3.17e-98 294.0 sp|Q53FA7|QORX_HUMAN Quinone oxidoreductase PIG3 OS=Homo sapiens OX=9606 GN=TP53I3 PE=1 SV=2 QORX_HUMAN reviewed Quinone oxidoreductase PIG3 (EC 1.6.5.5) (NADPH:quinone reductase PIG3) (Tumor protein p53-inducible protein 3) (Protein PIG3) (p53-induced gene 3 protein) Homo sapiens (Human) GO:0003960; GO:0005829; GO:0006915; GO:0048038; GO:0070402; GO:1903409 apoptotic process [GO:0006915]; reactive oxygen species biosynthetic process [GO:1903409] cytosol [GO:0005829] NADPH binding [GO:0070402]; quinone binding [GO:0048038]; quinone reductase (NADPH) activity [GO:0003960] g5619.t1 P21580 29.821 560 6.82e-57 215.0 sp|P21580|TNAP3_HUMAN Tumor necrosis factor alpha-induced protein 3 OS=Homo sapiens OX=9606 GN=TNFAIP3 PE=1 SV=1 TNAP3_HUMAN reviewed Tumor necrosis factor alpha-induced protein 3 (TNF alpha-induced protein 3) (EC 2.3.2.-) (EC 3.4.19.12) (OTU domain-containing protein 7C) (Putative DNA-binding protein A20) (Zinc finger protein A20) [Cleaved into: A20p50; A20p37] Homo sapiens (Human) GO:0001922; GO:0002020; GO:0002237; GO:0002634; GO:0002677; GO:0003677; GO:0004842; GO:0004843; GO:0005634; GO:0005737; GO:0005764; GO:0005829; GO:0006915; GO:0006954; GO:0007010; GO:0008270; GO:0010803; GO:0016477; GO:0016579; GO:0019900; GO:0030177; GO:0031397; GO:0032495; GO:0032691; GO:0032703; GO:0032715; GO:0032720; GO:0034136; GO:0034140; GO:0034144; GO:0034148; GO:0035871; GO:0035872; GO:0042802; GO:0043124; GO:0043130; GO:0045732; GO:0045779; GO:0045824; GO:0048662; GO:0050691; GO:0050728; GO:0050869; GO:0061043; GO:0061578; GO:0070062; GO:0070301; GO:0070429; GO:0070433; GO:0070530; GO:0070536; GO:0070936; GO:0071108; GO:0071222; GO:0071947; GO:0072573; GO:0072666; GO:0090291; GO:1902042; GO:2000347; GO:2000349; GO:2000352 apoptotic process [GO:0006915]; B-1 B cell homeostasis [GO:0001922]; cell migration [GO:0016477]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to lipopolysaccharide [GO:0071222]; cytoskeleton organization [GO:0007010]; establishment of protein localization to vacuole [GO:0072666]; inflammatory response [GO:0006954]; negative regulation of B cell activation [GO:0050869]; negative regulation of bone resorption [GO:0045779]; negative regulation of canonical NF-kappaB signal transduction [GO:0043124]; negative regulation of CD40 signaling pathway [GO:2000349]; negative regulation of chronic inflammatory response [GO:0002677]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; negative regulation of inflammatory response [GO:0050728]; negative regulation of innate immune response [GO:0045824]; negative regulation of interleukin-1 beta production [GO:0032691]; negative regulation of interleukin-2 production [GO:0032703]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway [GO:0070429]; negative regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway [GO:0070433]; negative regulation of osteoclast proliferation [GO:0090291]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of smooth muscle cell proliferation [GO:0048662]; negative regulation of toll-like receptor 2 signaling pathway [GO:0034136]; negative regulation of toll-like receptor 3 signaling pathway [GO:0034140]; negative regulation of toll-like receptor 4 signaling pathway [GO:0034144]; negative regulation of toll-like receptor 5 signaling pathway [GO:0034148]; negative regulation of tumor necrosis factor production [GO:0032720]; nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway [GO:0035872]; positive regulation of hepatocyte proliferation [GO:2000347]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of Wnt signaling pathway [GO:0030177]; protein deubiquitination [GO:0016579]; protein deubiquitination involved in ubiquitin-dependent protein catabolic process [GO:0071947]; protein K11-linked deubiquitination [GO:0035871]; protein K48-linked deubiquitination [GO:0071108]; protein K48-linked ubiquitination [GO:0070936]; protein K63-linked deubiquitination [GO:0070536]; regulation of defense response to virus by host [GO:0050691]; regulation of germinal center formation [GO:0002634]; regulation of tumor necrosis factor-mediated signaling pathway [GO:0010803]; regulation of vascular wound healing [GO:0061043]; response to molecule of bacterial origin [GO:0002237]; response to muramyl dipeptide [GO:0032495]; tolerance induction to lipopolysaccharide [GO:0072573] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; lysosome [GO:0005764]; nucleus [GO:0005634] cysteine-type deubiquitinase activity [GO:0004843]; DNA binding [GO:0003677]; identical protein binding [GO:0042802]; K63-linked deubiquitinase activity [GO:0061578]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; kinase binding [GO:0019900]; protease binding [GO:0002020]; ubiquitin binding [GO:0043130]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] g5620.t1 Q9VBW3 49.206 126 3.31e-40 149.0 sp|Q9VBW3|CAD96_DROME Tyrosine kinase receptor Cad96Ca OS=Drosophila melanogaster OX=7227 GN=Cad96Ca PE=2 SV=2 CAD96_DROME reviewed Tyrosine kinase receptor Cad96Ca (EC 2.7.10.1) (Cadherin-96Ca) (Tyrosine kinase receptor HD-14) Drosophila melanogaster (Fruit fly) GO:0004713; GO:0004714; GO:0005509; GO:0005524; GO:0005886; GO:0006468; GO:0007030; GO:0007156; GO:0007169; GO:0016339; GO:0042060; GO:0043235; GO:0045177; GO:0045792; GO:0051897; GO:0090303 calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; Golgi organization [GO:0007030]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell size [GO:0045792]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of wound healing [GO:0090303]; protein phosphorylation [GO:0006468]; wound healing [GO:0042060] apical part of cell [GO:0045177]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; protein tyrosine kinase activity [GO:0004713]; transmembrane receptor protein tyrosine kinase activity [GO:0004714] g5628.t1 A1L1W9 46.404 431 8.369999999999999e-126 382.0 sp|A1L1W9|MOT10_DANRE Monocarboxylate transporter 10 OS=Danio rerio OX=7955 GN=slc16a10 PE=2 SV=1 MOT10_DANRE reviewed Monocarboxylate transporter 10 (MCT 10) (Solute carrier family 16 member 10) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005302; GO:0005886; GO:0015173; GO:0015192; GO:0015196; GO:0015349; GO:0015801; GO:0016323; GO:0022857; GO:0070327 aromatic amino acid transport [GO:0015801]; thyroid hormone transport [GO:0070327] basolateral plasma membrane [GO:0016323]; plasma membrane [GO:0005886] aromatic amino acid transmembrane transporter activity [GO:0015173]; L-phenylalanine transmembrane transporter activity [GO:0015192]; L-tryptophan transmembrane transporter activity [GO:0015196]; L-tyrosine transmembrane transporter activity [GO:0005302]; thyroid hormone transmembrane transporter activity [GO:0015349]; transmembrane transporter activity [GO:0022857] g5629.t1 Q96GD3 67.421 221 6.46e-101 322.0 sp|Q96GD3|SCMH1_HUMAN Polycomb protein SCMH1 OS=Homo sapiens OX=9606 GN=SCMH1 PE=1 SV=1 SCMH1_HUMAN reviewed Polycomb protein SCMH1 (Sex comb on midleg homolog 1) Homo sapiens (Human) GO:0003682; GO:0005634; GO:0005654; GO:0031507; GO:0042393; GO:0045892 heterochromatin formation [GO:0031507]; negative regulation of DNA-templated transcription [GO:0045892] nucleoplasm [GO:0005654]; nucleus [GO:0005634] chromatin binding [GO:0003682]; histone binding [GO:0042393] g5632.t1 Q6TGS6 70.937 523 0.0 747.0 sp|Q6TGS6|SYYC_DANRE Tyrosine--tRNA ligase, cytoplasmic OS=Danio rerio OX=7955 GN=yars1 PE=2 SV=2 g5633.t1 Q5JWR5 43.72 1043 0.0 810.0 sp|Q5JWR5|DOP1A_HUMAN Protein DOP1A OS=Homo sapiens OX=9606 GN=DOP1A PE=1 SV=1 DOP1A_HUMAN reviewed Protein DOP1A Homo sapiens (Human) GO:0000139; GO:0005768; GO:0005798; GO:0005802; GO:0005829; GO:0006895; GO:0015031 Golgi to endosome transport [GO:0006895]; protein transport [GO:0015031] cytosol [GO:0005829]; endosome [GO:0005768]; Golgi membrane [GO:0000139]; Golgi-associated vesicle [GO:0005798]; trans-Golgi network [GO:0005802] g5633.t1 Q5JWR5 51.52 592 1.44e-147 518.0 sp|Q5JWR5|DOP1A_HUMAN Protein DOP1A OS=Homo sapiens OX=9606 GN=DOP1A PE=1 SV=1 DOP1A_HUMAN reviewed Protein DOP1A Homo sapiens (Human) GO:0000139; GO:0005768; GO:0005798; GO:0005802; GO:0005829; GO:0006895; GO:0015031 Golgi to endosome transport [GO:0006895]; protein transport [GO:0015031] cytosol [GO:0005829]; endosome [GO:0005768]; Golgi membrane [GO:0000139]; Golgi-associated vesicle [GO:0005798]; trans-Golgi network [GO:0005802] g5633.t1 Q5JWR5 41.007 278 8.499999999999999e-45 184.0 sp|Q5JWR5|DOP1A_HUMAN Protein DOP1A OS=Homo sapiens OX=9606 GN=DOP1A PE=1 SV=1 DOP1A_HUMAN reviewed Protein DOP1A Homo sapiens (Human) GO:0000139; GO:0005768; GO:0005798; GO:0005802; GO:0005829; GO:0006895; GO:0015031 Golgi to endosome transport [GO:0006895]; protein transport [GO:0015031] cytosol [GO:0005829]; endosome [GO:0005768]; Golgi membrane [GO:0000139]; Golgi-associated vesicle [GO:0005798]; trans-Golgi network [GO:0005802] g5635.t1 Q6NRQ1 34.81 474 1.15e-100 314.0 sp|Q6NRQ1|B3GL2_XENLA UDP-GalNAc:beta-1,3-N-acetylgalactosaminyltransferase 2 OS=Xenopus laevis OX=8355 GN=b3galnt2 PE=2 SV=1 B3GL2_XENLA reviewed UDP-GalNAc:beta-1,3-N-acetylgalactosaminyltransferase 2 (Beta-1,3-GalNAc-T2) (EC 2.4.1.313) (Beta-1,3-N-acetylgalactosaminyltransferase II) Xenopus laevis (African clawed frog) GO:0000139; GO:0005783; GO:0006493; GO:0008194; GO:0008376; GO:0009101 glycoprotein biosynthetic process [GO:0009101]; protein O-linked glycosylation [GO:0006493] endoplasmic reticulum [GO:0005783]; Golgi membrane [GO:0000139] acetylgalactosaminyltransferase activity [GO:0008376]; UDP-glycosyltransferase activity [GO:0008194] g5636.t1 Q969L4 48.958 96 6.130000000000001e-27 100.0 sp|Q969L4|LSM10_HUMAN U7 snRNA-associated Sm-like protein LSm10 OS=Homo sapiens OX=9606 GN=LSM10 PE=1 SV=1 LSM10_HUMAN reviewed U7 snRNA-associated Sm-like protein LSm10 Homo sapiens (Human) GO:0005654; GO:0005683; GO:0006398; GO:0008380; GO:0015030; GO:0016604; GO:0071208; GO:0071209; GO:0071254; GO:1900087 mRNA 3'-end processing by stem-loop binding and cleavage [GO:0006398]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; RNA splicing [GO:0008380] Cajal body [GO:0015030]; cytoplasmic U snRNP body [GO:0071254]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; U7 snRNP [GO:0005683] histone pre-mRNA DCP binding [GO:0071208]; U7 snRNA binding [GO:0071209] g5637.t1 A1ZAY1 37.966 295 6.529999999999999e-54 182.0 sp|A1ZAY1|DLISH_DROME SH3 domain-containing protein Dlish OS=Drosophila melanogaster OX=7227 GN=Dlish PE=1 SV=1 DLISH_DROME reviewed SH3 domain-containing protein Dlish (Dachs ligand with SH3 domains) Drosophila melanogaster (Fruit fly) GO:0001736; GO:0005737; GO:0005929; GO:0016327; GO:0032436; GO:0035331; GO:0045179; GO:0045296; GO:0090163; GO:0090251; GO:0120219 establishment of epithelial cell planar polarity [GO:0090163]; establishment of planar polarity [GO:0001736]; negative regulation of hippo signaling [GO:0035331]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein localization involved in establishment of planar polarity [GO:0090251] apical cortex [GO:0045179]; apicolateral plasma membrane [GO:0016327]; cilium [GO:0005929]; cytoplasm [GO:0005737]; subapical part of cell [GO:0120219] cadherin binding [GO:0045296] g5638.t1 Q9QZQ1 43.078 1033 0.0 773.0 sp|Q9QZQ1|AFAD_MOUSE Afadin OS=Mus musculus OX=10090 GN=Afdn PE=1 SV=3 AFAD_MOUSE reviewed Afadin (Afadin adherens junction formation factor) (Protein Af-6) Mus musculus (Mouse) GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0005911; GO:0005912; GO:0007165; GO:0010628; GO:0016607; GO:0021537; GO:0021987; GO:0022409; GO:0030054; GO:0030274; GO:0030336; GO:0030424; GO:0031267; GO:0032880; GO:0034334; GO:0036477; GO:0043296; GO:0044291; GO:0044331; GO:0045177; GO:0046930; GO:0046931; GO:0048787; GO:0048854; GO:0048872; GO:0050775; GO:0050839; GO:0051015; GO:0060019; GO:0060076; GO:0060563; GO:0061003; GO:0061885; GO:0061951; GO:0070160; GO:0070445; GO:0070830; GO:0090557; GO:0098686; GO:0098839; GO:0098978; GO:0099084; GO:0140059; GO:0150052; GO:1902414; GO:1903861; GO:2000049 adherens junction maintenance [GO:0034334]; bicellular tight junction assembly [GO:0070830]; brain morphogenesis [GO:0048854]; cell-cell adhesion mediated by cadherin [GO:0044331]; cerebral cortex development [GO:0021987]; dendrite arborization [GO:0140059]; establishment of endothelial intestinal barrier [GO:0090557]; establishment of protein localization to plasma membrane [GO:0061951]; homeostasis of number of cells [GO:0048872]; negative regulation of cell migration [GO:0030336]; neuroepithelial cell differentiation [GO:0060563]; pore complex assembly [GO:0046931]; positive regulation of cell-cell adhesion [GO:0022409]; positive regulation of cell-cell adhesion mediated by cadherin [GO:2000049]; positive regulation of dendrite extension [GO:1903861]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of gene expression [GO:0010628]; positive regulation of mini excitatory postsynaptic potential [GO:0061885]; postsynaptic specialization organization [GO:0099084]; protein localization to cell junction [GO:1902414]; radial glial cell differentiation [GO:0060019]; regulation of oligodendrocyte progenitor proliferation [GO:0070445]; regulation of postsynapse assembly [GO:0150052]; regulation of protein localization [GO:0032880]; signal transduction [GO:0007165]; telencephalon development [GO:0021537] adherens junction [GO:0005912]; apical junction complex [GO:0043296]; apical part of cell [GO:0045177]; axon [GO:0030424]; cell junction [GO:0030054]; cell-cell contact zone [GO:0044291]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; excitatory synapse [GO:0060076]; glutamatergic synapse [GO:0098978]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; pore complex [GO:0046930]; postsynaptic density membrane [GO:0098839]; presynaptic active zone membrane [GO:0048787]; somatodendritic compartment [GO:0036477]; tight junction [GO:0070160] actin filament binding [GO:0051015]; cell adhesion molecule binding [GO:0050839]; LIM domain binding [GO:0030274]; small GTPase binding [GO:0031267] g5638.t1 Q9QZQ1 41.279 172 2.97e-24 116.0 sp|Q9QZQ1|AFAD_MOUSE Afadin OS=Mus musculus OX=10090 GN=Afdn PE=1 SV=3 AFAD_MOUSE reviewed Afadin (Afadin adherens junction formation factor) (Protein Af-6) Mus musculus (Mouse) GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0005911; GO:0005912; GO:0007165; GO:0010628; GO:0016607; GO:0021537; GO:0021987; GO:0022409; GO:0030054; GO:0030274; GO:0030336; GO:0030424; GO:0031267; GO:0032880; GO:0034334; GO:0036477; GO:0043296; GO:0044291; GO:0044331; GO:0045177; GO:0046930; GO:0046931; GO:0048787; GO:0048854; GO:0048872; GO:0050775; GO:0050839; GO:0051015; GO:0060019; GO:0060076; GO:0060563; GO:0061003; GO:0061885; GO:0061951; GO:0070160; GO:0070445; GO:0070830; GO:0090557; GO:0098686; GO:0098839; GO:0098978; GO:0099084; GO:0140059; GO:0150052; GO:1902414; GO:1903861; GO:2000049 adherens junction maintenance [GO:0034334]; bicellular tight junction assembly [GO:0070830]; brain morphogenesis [GO:0048854]; cell-cell adhesion mediated by cadherin [GO:0044331]; cerebral cortex development [GO:0021987]; dendrite arborization [GO:0140059]; establishment of endothelial intestinal barrier [GO:0090557]; establishment of protein localization to plasma membrane [GO:0061951]; homeostasis of number of cells [GO:0048872]; negative regulation of cell migration [GO:0030336]; neuroepithelial cell differentiation [GO:0060563]; pore complex assembly [GO:0046931]; positive regulation of cell-cell adhesion [GO:0022409]; positive regulation of cell-cell adhesion mediated by cadherin [GO:2000049]; positive regulation of dendrite extension [GO:1903861]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of gene expression [GO:0010628]; positive regulation of mini excitatory postsynaptic potential [GO:0061885]; postsynaptic specialization organization [GO:0099084]; protein localization to cell junction [GO:1902414]; radial glial cell differentiation [GO:0060019]; regulation of oligodendrocyte progenitor proliferation [GO:0070445]; regulation of postsynapse assembly [GO:0150052]; regulation of protein localization [GO:0032880]; signal transduction [GO:0007165]; telencephalon development [GO:0021537] adherens junction [GO:0005912]; apical junction complex [GO:0043296]; apical part of cell [GO:0045177]; axon [GO:0030424]; cell junction [GO:0030054]; cell-cell contact zone [GO:0044291]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; excitatory synapse [GO:0060076]; glutamatergic synapse [GO:0098978]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; pore complex [GO:0046930]; postsynaptic density membrane [GO:0098839]; presynaptic active zone membrane [GO:0048787]; somatodendritic compartment [GO:0036477]; tight junction [GO:0070160] actin filament binding [GO:0051015]; cell adhesion molecule binding [GO:0050839]; LIM domain binding [GO:0030274]; small GTPase binding [GO:0031267] g5638.t2 Q9QZQ1 44.467 994 0.0 784.0 sp|Q9QZQ1|AFAD_MOUSE Afadin OS=Mus musculus OX=10090 GN=Afdn PE=1 SV=3 AFAD_MOUSE reviewed Afadin (Afadin adherens junction formation factor) (Protein Af-6) Mus musculus (Mouse) GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0005911; GO:0005912; GO:0007165; GO:0010628; GO:0016607; GO:0021537; GO:0021987; GO:0022409; GO:0030054; GO:0030274; GO:0030336; GO:0030424; GO:0031267; GO:0032880; GO:0034334; GO:0036477; GO:0043296; GO:0044291; GO:0044331; GO:0045177; GO:0046930; GO:0046931; GO:0048787; GO:0048854; GO:0048872; GO:0050775; GO:0050839; GO:0051015; GO:0060019; GO:0060076; GO:0060563; GO:0061003; GO:0061885; GO:0061951; GO:0070160; GO:0070445; GO:0070830; GO:0090557; GO:0098686; GO:0098839; GO:0098978; GO:0099084; GO:0140059; GO:0150052; GO:1902414; GO:1903861; GO:2000049 adherens junction maintenance [GO:0034334]; bicellular tight junction assembly [GO:0070830]; brain morphogenesis [GO:0048854]; cell-cell adhesion mediated by cadherin [GO:0044331]; cerebral cortex development [GO:0021987]; dendrite arborization [GO:0140059]; establishment of endothelial intestinal barrier [GO:0090557]; establishment of protein localization to plasma membrane [GO:0061951]; homeostasis of number of cells [GO:0048872]; negative regulation of cell migration [GO:0030336]; neuroepithelial cell differentiation [GO:0060563]; pore complex assembly [GO:0046931]; positive regulation of cell-cell adhesion [GO:0022409]; positive regulation of cell-cell adhesion mediated by cadherin [GO:2000049]; positive regulation of dendrite extension [GO:1903861]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of gene expression [GO:0010628]; positive regulation of mini excitatory postsynaptic potential [GO:0061885]; postsynaptic specialization organization [GO:0099084]; protein localization to cell junction [GO:1902414]; radial glial cell differentiation [GO:0060019]; regulation of oligodendrocyte progenitor proliferation [GO:0070445]; regulation of postsynapse assembly [GO:0150052]; regulation of protein localization [GO:0032880]; signal transduction [GO:0007165]; telencephalon development [GO:0021537] adherens junction [GO:0005912]; apical junction complex [GO:0043296]; apical part of cell [GO:0045177]; axon [GO:0030424]; cell junction [GO:0030054]; cell-cell contact zone [GO:0044291]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; excitatory synapse [GO:0060076]; glutamatergic synapse [GO:0098978]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; pore complex [GO:0046930]; postsynaptic density membrane [GO:0098839]; presynaptic active zone membrane [GO:0048787]; somatodendritic compartment [GO:0036477]; tight junction [GO:0070160] actin filament binding [GO:0051015]; cell adhesion molecule binding [GO:0050839]; LIM domain binding [GO:0030274]; small GTPase binding [GO:0031267] g5638.t2 Q9QZQ1 41.279 172 2.22e-24 116.0 sp|Q9QZQ1|AFAD_MOUSE Afadin OS=Mus musculus OX=10090 GN=Afdn PE=1 SV=3 AFAD_MOUSE reviewed Afadin (Afadin adherens junction formation factor) (Protein Af-6) Mus musculus (Mouse) GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0005911; GO:0005912; GO:0007165; GO:0010628; GO:0016607; GO:0021537; GO:0021987; GO:0022409; GO:0030054; GO:0030274; GO:0030336; GO:0030424; GO:0031267; GO:0032880; GO:0034334; GO:0036477; GO:0043296; GO:0044291; GO:0044331; GO:0045177; GO:0046930; GO:0046931; GO:0048787; GO:0048854; GO:0048872; GO:0050775; GO:0050839; GO:0051015; GO:0060019; GO:0060076; GO:0060563; GO:0061003; GO:0061885; GO:0061951; GO:0070160; GO:0070445; GO:0070830; GO:0090557; GO:0098686; GO:0098839; GO:0098978; GO:0099084; GO:0140059; GO:0150052; GO:1902414; GO:1903861; GO:2000049 adherens junction maintenance [GO:0034334]; bicellular tight junction assembly [GO:0070830]; brain morphogenesis [GO:0048854]; cell-cell adhesion mediated by cadherin [GO:0044331]; cerebral cortex development [GO:0021987]; dendrite arborization [GO:0140059]; establishment of endothelial intestinal barrier [GO:0090557]; establishment of protein localization to plasma membrane [GO:0061951]; homeostasis of number of cells [GO:0048872]; negative regulation of cell migration [GO:0030336]; neuroepithelial cell differentiation [GO:0060563]; pore complex assembly [GO:0046931]; positive regulation of cell-cell adhesion [GO:0022409]; positive regulation of cell-cell adhesion mediated by cadherin [GO:2000049]; positive regulation of dendrite extension [GO:1903861]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of gene expression [GO:0010628]; positive regulation of mini excitatory postsynaptic potential [GO:0061885]; postsynaptic specialization organization [GO:0099084]; protein localization to cell junction [GO:1902414]; radial glial cell differentiation [GO:0060019]; regulation of oligodendrocyte progenitor proliferation [GO:0070445]; regulation of postsynapse assembly [GO:0150052]; regulation of protein localization [GO:0032880]; signal transduction [GO:0007165]; telencephalon development [GO:0021537] adherens junction [GO:0005912]; apical junction complex [GO:0043296]; apical part of cell [GO:0045177]; axon [GO:0030424]; cell junction [GO:0030054]; cell-cell contact zone [GO:0044291]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; excitatory synapse [GO:0060076]; glutamatergic synapse [GO:0098978]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; pore complex [GO:0046930]; postsynaptic density membrane [GO:0098839]; presynaptic active zone membrane [GO:0048787]; somatodendritic compartment [GO:0036477]; tight junction [GO:0070160] actin filament binding [GO:0051015]; cell adhesion molecule binding [GO:0050839]; LIM domain binding [GO:0030274]; small GTPase binding [GO:0031267] g5641.t1 E7F211 33.784 222 1.7e-33 132.0 sp|E7F211|TTC17_DANRE Tetratricopeptide repeat protein 17 OS=Danio rerio OX=7955 GN=ttc17 PE=3 SV=1 TTC17_DANRE reviewed Tetratricopeptide repeat protein 17 (TPR repeat protein 17) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005737; GO:0005886; GO:0015629; GO:0030041; GO:0044782; GO:0061371 actin filament polymerization [GO:0030041]; cilium organization [GO:0044782]; determination of heart left/right asymmetry [GO:0061371] actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886] g5649.t1 Q6PWT7 57.955 88 5.65e-29 108.0 sp|Q6PWT7|CCS_PIG Copper chaperone for superoxide dismutase OS=Sus scrofa OX=9823 GN=CCS PE=2 SV=1 g5656.t1 Q8CEE0 35.0 340 8.02e-44 143.0 sp|Q8CEE0|CEP57_MOUSE Centrosomal protein of 57 kDa OS=Mus musculus OX=10090 GN=Cep57 PE=1 SV=2 CEP57_MOUSE reviewed Centrosomal protein of 57 kDa (Cep57) (Testis-specific protein 57) (Translokin) Mus musculus (Mouse) GO:0005634; GO:0005737; GO:0005794; GO:0005813; GO:0005829; GO:0005874; GO:0007286; GO:0008017; GO:0008543; GO:0017134; GO:0034451; GO:0042803; GO:0043015; GO:0051260 fibroblast growth factor receptor signaling pathway [GO:0008543]; protein homooligomerization [GO:0051260]; spermatid development [GO:0007286] centriolar satellite [GO:0034451]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; microtubule [GO:0005874]; nucleus [GO:0005634] fibroblast growth factor binding [GO:0017134]; gamma-tubulin binding [GO:0043015]; microtubule binding [GO:0008017]; protein homodimerization activity [GO:0042803] g5656.t1 Q8CEE0 60.976 41 8.02e-44 57.0 sp|Q8CEE0|CEP57_MOUSE Centrosomal protein of 57 kDa OS=Mus musculus OX=10090 GN=Cep57 PE=1 SV=2 CEP57_MOUSE reviewed Centrosomal protein of 57 kDa (Cep57) (Testis-specific protein 57) (Translokin) Mus musculus (Mouse) GO:0005634; GO:0005737; GO:0005794; GO:0005813; GO:0005829; GO:0005874; GO:0007286; GO:0008017; GO:0008543; GO:0017134; GO:0034451; GO:0042803; GO:0043015; GO:0051260 fibroblast growth factor receptor signaling pathway [GO:0008543]; protein homooligomerization [GO:0051260]; spermatid development [GO:0007286] centriolar satellite [GO:0034451]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; microtubule [GO:0005874]; nucleus [GO:0005634] fibroblast growth factor binding [GO:0017134]; gamma-tubulin binding [GO:0043015]; microtubule binding [GO:0008017]; protein homodimerization activity [GO:0042803] g5657.t1 Q6PAM1 54.743 369 1.46e-104 325.0 sp|Q6PAM1|TXLNA_MOUSE Alpha-taxilin OS=Mus musculus OX=10090 GN=Txlna PE=1 SV=1 g5659.t1 Q07243 67.982 228 1.9800000000000002e-109 343.0 sp|Q07243|MTF1_MOUSE Metal regulatory transcription factor 1 OS=Mus musculus OX=10090 GN=Mtf1 PE=1 SV=2 g5661.t1 Q5ZJ65 56.966 323 1.44e-110 327.0 sp|Q5ZJ65|FA76A_CHICK Protein FAM76A OS=Gallus gallus OX=9031 GN=FAM76A PE=2 SV=1 g5661.t2 Q5ZJ65 59.615 312 9e-113 332.0 sp|Q5ZJ65|FA76A_CHICK Protein FAM76A OS=Gallus gallus OX=9031 GN=FAM76A PE=2 SV=1 g5662.t1 Q2HJI0 46.226 212 3.44e-58 189.0 sp|Q2HJI0|RM19_BOVIN Large ribosomal subunit protein bL19m OS=Bos taurus OX=9913 GN=MRPL19 PE=1 SV=1 g5664.t1 Q8N2I9 61.667 420 4.07e-164 479.0 sp|Q8N2I9|STK40_HUMAN Serine/threonine-protein kinase 40 OS=Homo sapiens OX=9606 GN=STK40 PE=1 SV=2 g5666.t1 P58658 33.971 209 3.54e-37 137.0 sp|P58658|EVA1C_HUMAN Protein eva-1 homolog C OS=Homo sapiens OX=9606 GN=EVA1C PE=1 SV=1 g5672.t1 Q812E4 42.609 230 2.0199999999999998e-42 164.0 sp|Q812E4|SYTL5_RAT Synaptotagmin-like protein 5 OS=Rattus norvegicus OX=10116 GN=Sytl5 PE=2 SV=1 g5673.t1 A2AAE1 37.577 487 1.58e-86 306.0 sp|A2AAE1|BLTP1_MOUSE Bridge-like lipid transfer protein family member 1 OS=Mus musculus OX=10090 GN=Bltp1 PE=1 SV=4 BLTP1_MOUSE reviewed Bridge-like lipid transfer protein family member 1 (Fragile site-associated protein homolog) Mus musculus (Mouse) GO:0001558; GO:0005634; GO:0005789; GO:0005886; GO:0006629; GO:0006869; GO:0006909; GO:0007283; GO:0009409; GO:0016197; GO:0019915; GO:0031966; GO:0032456; GO:0045444; GO:0048488; GO:0051647; GO:0060612; GO:0098793; GO:0120009; GO:0140268; GO:1904121 adipose tissue development [GO:0060612]; endocytic recycling [GO:0032456]; endosomal transport [GO:0016197]; fat cell differentiation [GO:0045444]; intermembrane lipid transfer [GO:0120009]; lipid metabolic process [GO:0006629]; lipid storage [GO:0019915]; lipid transport [GO:0006869]; nucleus localization [GO:0051647]; phagocytosis [GO:0006909]; regulation of cell growth [GO:0001558]; response to cold [GO:0009409]; spermatogenesis [GO:0007283]; synaptic vesicle endocytosis [GO:0048488] endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-plasma membrane contact site [GO:0140268]; mitochondrial membrane [GO:0031966]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; presynapse [GO:0098793] phosphatidylethanolamine transfer activity [GO:1904121] g5674.t1 A0A0R4IES7 55.14 107 1.26e-32 124.0 sp|A0A0R4IES7|BLTP1_DANRE Bridge-like lipid transfer protein family member 1 OS=Danio rerio OX=7955 GN=bltp1 PE=3 SV=1 BLTP1_DANRE reviewed Bridge-like lipid transfer protein family member 1 Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005789; GO:0005886; GO:0006909; GO:0016197; GO:0031966; GO:0032456; GO:0048488; GO:0098793; GO:0120009; GO:0140268; GO:1904121 endocytic recycling [GO:0032456]; endosomal transport [GO:0016197]; intermembrane lipid transfer [GO:0120009]; phagocytosis [GO:0006909]; synaptic vesicle endocytosis [GO:0048488] endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-plasma membrane contact site [GO:0140268]; mitochondrial membrane [GO:0031966]; plasma membrane [GO:0005886]; presynapse [GO:0098793] phosphatidylethanolamine transfer activity [GO:1904121] g5679.t1 Q28HM1 63.722 317 5.62e-152 432.0 sp|Q28HM1|TFB1M_XENTR Dimethyladenosine transferase 1, mitochondrial OS=Xenopus tropicalis OX=8364 GN=tfb1m PE=2 SV=1 TFB1M_XENTR reviewed Dimethyladenosine transferase 1, mitochondrial (EC 2.1.1.-) (Mitochondrial 12S rRNA dimethylase 1) (Mitochondrial transcription factor B1) (mtTFB1) (S-adenosylmethionine-6-N', N'-adenosyl(rRNA) dimethyltransferase 1) Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0000179; GO:0003677; GO:0003723; GO:0005739; GO:0031167; GO:1904047 rRNA methylation [GO:0031167] mitochondrion [GO:0005739] DNA binding [GO:0003677]; RNA binding [GO:0003723]; rRNA (adenine-N6,N6-)-dimethyltransferase activity [GO:0000179]; S-adenosyl-L-methionine binding [GO:1904047] g5686.t1 Q5K651 28.283 792 1.11e-69 264.0 sp|Q5K651|SAMD9_HUMAN Sterile alpha motif domain-containing protein 9 OS=Homo sapiens OX=9606 GN=SAMD9 PE=1 SV=1 SAMD9_HUMAN reviewed Sterile alpha motif domain-containing protein 9 (SAM domain-containing protein 9) Homo sapiens (Human) GO:0005737; GO:0005829; GO:0034058; GO:0045087 endosomal vesicle fusion [GO:0034058]; innate immune response [GO:0045087] cytoplasm [GO:0005737]; cytosol [GO:0005829] g5687.t1 Q0IIM2 53.297 182 4.41e-57 179.0 sp|Q0IIM2|ARL6_BOVIN ADP-ribosylation factor-like protein 6 OS=Bos taurus OX=9913 GN=ARL6 PE=1 SV=1 ARL6_BOVIN reviewed ADP-ribosylation factor-like protein 6 Bos taurus (Bovine) GO:0003924; GO:0005525; GO:0005543; GO:0005654; GO:0005737; GO:0005829; GO:0005879; GO:0005930; GO:0006612; GO:0006886; GO:0007420; GO:0008589; GO:0010842; GO:0016055; GO:0016192; GO:0030117; GO:0045444; GO:0051258; GO:0060170; GO:0060271; GO:0061512; GO:0062063; GO:0097499; GO:1903445 brain development [GO:0007420]; cilium assembly [GO:0060271]; fat cell differentiation [GO:0045444]; intracellular protein transport [GO:0006886]; protein localization to cilium [GO:0061512]; protein localization to non-motile cilium [GO:0097499]; protein polymerization [GO:0051258]; protein targeting to membrane [GO:0006612]; protein transport from ciliary membrane to plasma membrane [GO:1903445]; regulation of smoothened signaling pathway [GO:0008589]; retina layer formation [GO:0010842]; vesicle-mediated transport [GO:0016192]; Wnt signaling pathway [GO:0016055] axonemal microtubule [GO:0005879]; axoneme [GO:0005930]; ciliary membrane [GO:0060170]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane coat [GO:0030117]; nucleoplasm [GO:0005654] BBSome binding [GO:0062063]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; phospholipid binding [GO:0005543] g5688.t1 P91620 42.05 1044 0.0 753.0 sp|P91620|SIF2_DROME Protein still life, isoforms C/SIF type 2 OS=Drosophila melanogaster OX=7227 GN=sif PE=2 SV=2 SIF2_DROME reviewed Protein still life, isoforms C/SIF type 2 Drosophila melanogaster (Fruit fly) GO:0005085; GO:0007264; GO:0030036; GO:0045202; GO:0050770; GO:0050803; GO:0051491 actin cytoskeleton organization [GO:0030036]; positive regulation of filopodium assembly [GO:0051491]; regulation of axonogenesis [GO:0050770]; regulation of synapse structure or activity [GO:0050803]; small GTPase-mediated signal transduction [GO:0007264] synapse [GO:0045202] guanyl-nucleotide exchange factor activity [GO:0005085] g5688.t2 P91620 41.509 1060 0.0 747.0 sp|P91620|SIF2_DROME Protein still life, isoforms C/SIF type 2 OS=Drosophila melanogaster OX=7227 GN=sif PE=2 SV=2 SIF2_DROME reviewed Protein still life, isoforms C/SIF type 2 Drosophila melanogaster (Fruit fly) GO:0005085; GO:0007264; GO:0030036; GO:0045202; GO:0050770; GO:0050803; GO:0051491 actin cytoskeleton organization [GO:0030036]; positive regulation of filopodium assembly [GO:0051491]; regulation of axonogenesis [GO:0050770]; regulation of synapse structure or activity [GO:0050803]; small GTPase-mediated signal transduction [GO:0007264] synapse [GO:0045202] guanyl-nucleotide exchange factor activity [GO:0005085] g5689.t1 A7T167 48.708 503 0.0 526.0 sp|A7T167|GDAP2_NEMVE Protein GDAP2 homolog OS=Nematostella vectensis OX=45351 GN=gdap2 PE=3 SV=1 g5691.t1 Q5SSF7 60.714 336 7.52e-145 421.0 sp|Q5SSF7|TET5C_MOUSE Terminal nucleotidyltransferase 5C OS=Mus musculus OX=10090 GN=Tent5c PE=1 SV=1 TET5C_MOUSE reviewed Terminal nucleotidyltransferase 5C (EC 2.7.7.19) Mus musculus (Mouse) GO:0001701; GO:0003723; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0045596; GO:0048255; GO:1990817 in utero embryonic development [GO:0001701]; mRNA stabilization [GO:0048255]; negative regulation of cell differentiation [GO:0045596] centrosome [GO:0005813]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] poly(A) RNA polymerase activity [GO:1990817]; RNA binding [GO:0003723] g5693.t1 P35738 78.324 346 0.0 572.0 sp|P35738|ODBB_RAT 2-oxoisovalerate dehydrogenase subunit beta, mitochondrial OS=Rattus norvegicus OX=10116 GN=Bckdhb PE=1 SV=3 g5698.t1 A7E3D8 35.681 213 6.81e-21 102.0 sp|A7E3D8|LCA5L_BOVIN Lebercilin-like protein OS=Bos taurus OX=9913 GN=LCA5L PE=2 SV=2 g5701.t1 P79888 45.638 149 2.35e-40 141.0 sp|P79888|DCAM_XENLA S-adenosylmethionine decarboxylase proenzyme OS=Xenopus laevis OX=8355 GN=amd1 PE=2 SV=1 g5702.t1 P79888 56.571 175 1.04e-55 182.0 sp|P79888|DCAM_XENLA S-adenosylmethionine decarboxylase proenzyme OS=Xenopus laevis OX=8355 GN=amd1 PE=2 SV=1 g5703.t1 Q7ZVB1 71.357 199 1.6e-83 249.0 sp|Q7ZVB1|CHM1B_DANRE Charged multivesicular body protein 1b OS=Danio rerio OX=7955 GN=chmp1b PE=2 SV=1 CHM1B_DANRE reviewed Charged multivesicular body protein 1b (Chromatin-modifying protein 1b) (CHMP1b) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000815; GO:0005771; GO:0005829; GO:0015031; GO:0031902; GO:0032509; GO:0045324 endosome transport via multivesicular body sorting pathway [GO:0032509]; late endosome to vacuole transport [GO:0045324]; protein transport [GO:0015031] cytosol [GO:0005829]; ESCRT III complex [GO:0000815]; late endosome membrane [GO:0031902]; multivesicular body [GO:0005771] g5704.t1 O55128 56.522 138 8.7e-42 138.0 sp|O55128|SAP18_MOUSE Histone deacetylase complex subunit SAP18 OS=Mus musculus OX=10090 GN=Sap18 PE=1 SV=1 SAP18_MOUSE reviewed Histone deacetylase complex subunit SAP18 (18 kDa Sin3-associated polypeptide) (Sin3-associated polypeptide p18) Mus musculus (Mouse) GO:0000118; GO:0000381; GO:0003714; GO:0005634; GO:0005654; GO:0005667; GO:0005829; GO:0006355; GO:0006397; GO:0008380; GO:0016604; GO:0016607; GO:0043065; GO:0045892; GO:0048025; GO:0061574 mRNA processing [GO:0006397]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; positive regulation of apoptotic process [GO:0043065]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of DNA-templated transcription [GO:0006355]; RNA splicing [GO:0008380] ASAP complex [GO:0061574]; cytosol [GO:0005829]; histone deacetylase complex [GO:0000118]; nuclear body [GO:0016604]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667] transcription corepressor activity [GO:0003714] g5705.t1 Q9BWD1 64.962 391 0.0 521.0 sp|Q9BWD1|THIC_HUMAN Acetyl-CoA acetyltransferase, cytosolic OS=Homo sapiens OX=9606 GN=ACAT2 PE=1 SV=2 g5706.t1 A8WHP3 35.499 631 3.47e-122 381.0 sp|A8WHP3|SC5A9_DANRE Sodium/glucose cotransporter 4 OS=Danio rerio OX=7955 GN=slc5a9 PE=2 SV=1 g5707.t1 Q5RCG9 59.884 172 4.51e-76 229.0 sp|Q5RCG9|PFD3_PONAB Prefoldin subunit 3 OS=Pongo abelii OX=9601 GN=VBP1 PE=2 SV=1 PFD3_PONAB reviewed Prefoldin subunit 3 (von Hippel-Lindau-binding protein 1) (VBP-1) (VHL-binding protein 1) Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0001540; GO:0005634; GO:0005829; GO:0006457; GO:0007017; GO:0007021; GO:0015631; GO:0016272; GO:0051082; GO:1905907 microtubule-based process [GO:0007017]; negative regulation of amyloid fibril formation [GO:1905907]; protein folding [GO:0006457]; tubulin complex assembly [GO:0007021] cytosol [GO:0005829]; nucleus [GO:0005634]; prefoldin complex [GO:0016272] amyloid-beta binding [GO:0001540]; tubulin binding [GO:0015631]; unfolded protein binding [GO:0051082] g5708.t1 Q5RB36 63.322 289 6.05e-118 359.0 sp|Q5RB36|CUL5_PONAB Cullin-5 OS=Pongo abelii OX=9601 GN=CUL5 PE=2 SV=3 CUL5_PONAB reviewed Cullin-5 (CUL-5) Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0005634; GO:0006511; GO:0010498; GO:0016567; GO:0031466; GO:0031625; GO:0038026; GO:0051895; GO:0090734; GO:0120184; GO:0160072; GO:2001222 negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of focal adhesion disassembly [GO:0120184]; proteasomal protein catabolic process [GO:0010498]; protein ubiquitination [GO:0016567]; reelin-mediated signaling pathway [GO:0038026]; regulation of neuron migration [GO:2001222]; ubiquitin-dependent protein catabolic process [GO:0006511] Cul5-RING ubiquitin ligase complex [GO:0031466]; nucleus [GO:0005634]; site of DNA damage [GO:0090734] ubiquitin ligase complex scaffold activity [GO:0160072]; ubiquitin protein ligase binding [GO:0031625] g5709.t1 Q93034 75.456 493 0.0 749.0 sp|Q93034|CUL5_HUMAN Cullin-5 OS=Homo sapiens OX=9606 GN=CUL5 PE=1 SV=4 CUL5_HUMAN reviewed Cullin-5 (CUL-5) (Vasopressin-activated calcium-mobilizing receptor 1) (VACM-1) Homo sapiens (Human) GO:0000082; GO:0004842; GO:0005262; GO:0005634; GO:0005737; GO:0005829; GO:0016477; GO:0016567; GO:0019005; GO:0030335; GO:0030674; GO:0031146; GO:0031466; GO:0031625; GO:0038023; GO:0038026; GO:0038128; GO:0043161; GO:0051895; GO:0070979; GO:0090734; GO:0097193; GO:0120184; GO:0160072; GO:2001222 cell migration [GO:0016477]; ERBB2 signaling pathway [GO:0038128]; G1/S transition of mitotic cell cycle [GO:0000082]; intrinsic apoptotic signaling pathway [GO:0097193]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of focal adhesion disassembly [GO:0120184]; positive regulation of cell migration [GO:0030335]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K11-linked ubiquitination [GO:0070979]; protein ubiquitination [GO:0016567]; reelin-mediated signaling pathway [GO:0038026]; regulation of neuron migration [GO:2001222]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146] Cul5-RING ubiquitin ligase complex [GO:0031466]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005]; site of DNA damage [GO:0090734] calcium channel activity [GO:0005262]; protein-macromolecule adaptor activity [GO:0030674]; signaling receptor activity [GO:0038023]; ubiquitin ligase complex scaffold activity [GO:0160072]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842] g5710.t1 O14777 34.351 524 9.58e-80 268.0 sp|O14777|NDC80_HUMAN Kinetochore protein NDC80 homolog OS=Homo sapiens OX=9606 GN=NDC80 PE=1 SV=1 NDC80_HUMAN reviewed Kinetochore protein NDC80 homolog (Highly expressed in cancer protein) (Kinetochore protein Hec1) (HsHec1) (Kinetochore-associated protein 2) (Retinoblastoma-associated protein HEC) Homo sapiens (Human) GO:0000070; GO:0000132; GO:0000278; GO:0000775; GO:0000776; GO:0000940; GO:0005634; GO:0005654; GO:0005813; GO:0005829; GO:0007052; GO:0007057; GO:0007059; GO:0007094; GO:0008017; GO:0008315; GO:0008608; GO:0014841; GO:0016020; GO:0016607; GO:0030332; GO:0031262; GO:0031647; GO:0042802; GO:0051298; GO:0051301; GO:0051310; GO:0051315; GO:0051383; GO:0090267; GO:0140483 attachment of mitotic spindle microtubules to kinetochore [GO:0051315]; attachment of spindle microtubules to kinetochore [GO:0008608]; cell division [GO:0051301]; centrosome duplication [GO:0051298]; chromosome segregation [GO:0007059]; establishment of mitotic spindle orientation [GO:0000132]; G2/MI transition of meiotic cell cycle [GO:0008315]; kinetochore organization [GO:0051383]; metaphase chromosome alignment [GO:0051310]; mitotic cell cycle [GO:0000278]; mitotic sister chromatid segregation [GO:0000070]; mitotic spindle assembly checkpoint signaling [GO:0007094]; mitotic spindle organization [GO:0007052]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; regulation of protein stability [GO:0031647]; skeletal muscle satellite cell proliferation [GO:0014841]; spindle assembly involved in female meiosis I [GO:0007057] centrosome [GO:0005813]; chromosome, centromeric region [GO:0000775]; cytosol [GO:0005829]; kinetochore [GO:0000776]; membrane [GO:0016020]; Ndc80 complex [GO:0031262]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; outer kinetochore [GO:0000940] cyclin binding [GO:0030332]; identical protein binding [GO:0042802]; kinetochore adaptor activity [GO:0140483]; microtubule binding [GO:0008017] g5711.t1 Q3E6S9 33.165 395 7.280000000000001e-66 220.0 sp|Q3E6S9|CNIF3_ARATH Probable L-cysteine desulfhydrase, chloroplastic OS=Arabidopsis thaliana OX=3702 GN=CpNIFS3 PE=1 SV=1 g5711.t2 Q3E6S9 29.977 437 1.0200000000000001e-58 203.0 sp|Q3E6S9|CNIF3_ARATH Probable L-cysteine desulfhydrase, chloroplastic OS=Arabidopsis thaliana OX=3702 GN=CpNIFS3 PE=1 SV=1 g5712.t1 B2GV36 32.176 547 7.76e-86 280.0 sp|B2GV36|S22AD_RAT Solute carrier family 22 member 13 OS=Rattus norvegicus OX=10116 GN=Slc22a13 PE=2 SV=1 S22AD_RAT reviewed Solute carrier family 22 member 13 (Organic anion transporter 10) (OAT10) (Organic cation transporter-like 3) (ORCTL-3) Rattus norvegicus (Rat) GO:0002854; GO:0005783; GO:0005794; GO:0005886; GO:0015143; GO:0015747; GO:0016324; GO:0045922; GO:0090416; GO:2001142 negative regulation of fatty acid metabolic process [GO:0045922]; nicotinate transport [GO:2001142]; positive regulation of T cell mediated cytotoxicity directed against tumor cell target [GO:0002854]; urate transport [GO:0015747] apical plasma membrane [GO:0016324]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; plasma membrane [GO:0005886] nicotinate transmembrane transporter activity [GO:0090416]; urate transmembrane transporter activity [GO:0015143] g5714.t1 Q9Y226 36.937 333 3.47e-65 219.0 sp|Q9Y226|S22AD_HUMAN Solute carrier family 22 member 13 OS=Homo sapiens OX=9606 GN=SLC22A13 PE=1 SV=2 g5715.t1 O76082 34.232 482 9.010000000000001e-72 242.0 sp|O76082|S22A5_HUMAN Organic cation/carnitine transporter 2 OS=Homo sapiens OX=9606 GN=SLC22A5 PE=1 SV=1 g5716.t1 Q8N0V5 46.377 345 4.54e-102 315.0 sp|Q8N0V5|GNT2A_HUMAN N-acetyllactosaminide beta-1,6-N-acetylglucosaminyl-transferase OS=Homo sapiens OX=9606 GN=GCNT2 PE=1 SV=1 GNT2A_HUMAN reviewed N-acetyllactosaminide beta-1,6-N-acetylglucosaminyl-transferase (N-acetylglucosaminyltransferase) (EC 2.4.1.150) (I-branching enzyme) (IGNT) Homo sapiens (Human) GO:0000139; GO:0006024; GO:0007179; GO:0007275; GO:0008109; GO:0008284; GO:0008375; GO:0009101; GO:0010608; GO:0010718; GO:0010812; GO:0016020; GO:0030335; GO:0034116; GO:0036438; GO:0051897; GO:0070374 glycoprotein biosynthetic process [GO:0009101]; glycosaminoglycan biosynthetic process [GO:0006024]; maintenance of lens transparency [GO:0036438]; multicellular organism development [GO:0007275]; negative regulation of cell-substrate adhesion [GO:0010812]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of heterotypic cell-cell adhesion [GO:0034116]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; post-transcriptional regulation of gene expression [GO:0010608]; transforming growth factor beta receptor signaling pathway [GO:0007179] Golgi membrane [GO:0000139]; membrane [GO:0016020] acetylglucosaminyltransferase activity [GO:0008375]; N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity [GO:0008109] g5717.t1 Q8N0V5 42.522 341 2.98e-89 281.0 sp|Q8N0V5|GNT2A_HUMAN N-acetyllactosaminide beta-1,6-N-acetylglucosaminyl-transferase OS=Homo sapiens OX=9606 GN=GCNT2 PE=1 SV=1 GNT2A_HUMAN reviewed N-acetyllactosaminide beta-1,6-N-acetylglucosaminyl-transferase (N-acetylglucosaminyltransferase) (EC 2.4.1.150) (I-branching enzyme) (IGNT) Homo sapiens (Human) GO:0000139; GO:0006024; GO:0007179; GO:0007275; GO:0008109; GO:0008284; GO:0008375; GO:0009101; GO:0010608; GO:0010718; GO:0010812; GO:0016020; GO:0030335; GO:0034116; GO:0036438; GO:0051897; GO:0070374 glycoprotein biosynthetic process [GO:0009101]; glycosaminoglycan biosynthetic process [GO:0006024]; maintenance of lens transparency [GO:0036438]; multicellular organism development [GO:0007275]; negative regulation of cell-substrate adhesion [GO:0010812]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of heterotypic cell-cell adhesion [GO:0034116]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; post-transcriptional regulation of gene expression [GO:0010608]; transforming growth factor beta receptor signaling pathway [GO:0007179] Golgi membrane [GO:0000139]; membrane [GO:0016020] acetylglucosaminyltransferase activity [GO:0008375]; N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity [GO:0008109] g5718.t1 O95807 60.588 170 9.43e-59 183.0 sp|O95807|TM50A_HUMAN Transmembrane protein 50A OS=Homo sapiens OX=9606 GN=TMEM50A PE=1 SV=1 TM50A_HUMAN reviewed Transmembrane protein 50A (Small membrane protein 1) Homo sapiens (Human) GO:0005783; GO:0016020; GO:0032511; GO:0043025; GO:0097386 late endosome to vacuole transport via multivesicular body sorting pathway [GO:0032511] endoplasmic reticulum [GO:0005783]; glial cell projection [GO:0097386]; membrane [GO:0016020]; neuronal cell body [GO:0043025] g5719.t1 Q99973 25.61 410 5.44e-24 113.0 sp|Q99973|TEP1_HUMAN Telomerase protein component 1 OS=Homo sapiens OX=9606 GN=TEP1 PE=1 SV=2 TEP1_HUMAN reviewed Telomerase protein component 1 (Telomerase-associated protein 1) (Telomerase protein 1) (p240) (p80 telomerase homolog) Homo sapiens (Human) GO:0000722; GO:0000781; GO:0002039; GO:0003720; GO:0003723; GO:0005524; GO:0005697; GO:0005737; GO:0016363; GO:0019899; GO:0070034; GO:1990904 telomere maintenance via recombination [GO:0000722] chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; nuclear matrix [GO:0016363]; ribonucleoprotein complex [GO:1990904]; telomerase holoenzyme complex [GO:0005697] ATP binding [GO:0005524]; enzyme binding [GO:0019899]; p53 binding [GO:0002039]; RNA binding [GO:0003723]; telomerase activity [GO:0003720]; telomerase RNA binding [GO:0070034] g5720.t1 Q5XXB5 58.887 934 0.0 1062.0 sp|Q5XXB5|MSH2_CHLAE DNA mismatch repair protein Msh2 OS=Chlorocebus aethiops OX=9534 GN=MSH2 PE=2 SV=1 g5723.t1 P43246 55.645 124 8.119999999999999e-34 127.0 sp|P43246|MSH2_HUMAN DNA mismatch repair protein Msh2 OS=Homo sapiens OX=9606 GN=MSH2 PE=1 SV=1 MSH2_HUMAN reviewed DNA mismatch repair protein Msh2 (hMSH2) (MutS protein homolog 2) Homo sapiens (Human) GO:0000781; GO:0001701; GO:0002204; GO:0003677; GO:0003682; GO:0003684; GO:0005524; GO:0005634; GO:0005654; GO:0006119; GO:0006281; GO:0006298; GO:0006301; GO:0006302; GO:0006312; GO:0007281; GO:0008047; GO:0008094; GO:0008340; GO:0008584; GO:0010165; GO:0010224; GO:0016020; GO:0016446; GO:0016447; GO:0016887; GO:0019237; GO:0019724; GO:0030183; GO:0031573; GO:0032137; GO:0032301; GO:0032302; GO:0042771; GO:0042803; GO:0043524; GO:0043570; GO:0045190; GO:0045910; GO:0048298; GO:0048304; GO:0140664 B cell differentiation [GO:0030183]; B cell mediated immunity [GO:0019724]; determination of adult lifespan [GO:0008340]; DNA damage tolerance [GO:0006301]; DNA repair [GO:0006281]; double-strand break repair [GO:0006302]; germ cell development [GO:0007281]; in utero embryonic development [GO:0001701]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; isotype switching [GO:0045190]; maintenance of DNA repeat elements [GO:0043570]; male gonad development [GO:0008584]; mismatch repair [GO:0006298]; mitotic intra-S DNA damage checkpoint signaling [GO:0031573]; mitotic recombination [GO:0006312]; negative regulation of DNA recombination [GO:0045910]; negative regulation of neuron apoptotic process [GO:0043524]; oxidative phosphorylation [GO:0006119]; positive regulation of isotype switching to IgA isotypes [GO:0048298]; positive regulation of isotype switching to IgG isotypes [GO:0048304]; response to UV-B [GO:0010224]; response to X-ray [GO:0010165]; somatic hypermutation of immunoglobulin genes [GO:0016446]; somatic recombination of immunoglobulin gene segments [GO:0016447]; somatic recombination of immunoglobulin genes involved in immune response [GO:0002204] chromosome, telomeric region [GO:0000781]; membrane [GO:0016020]; MutSalpha complex [GO:0032301]; MutSbeta complex [GO:0032302]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent activity, acting on DNA [GO:0008094]; ATP-dependent DNA damage sensor activity [GO:0140664]; centromeric DNA binding [GO:0019237]; chromatin binding [GO:0003682]; damaged DNA binding [GO:0003684]; DNA binding [GO:0003677]; enzyme activator activity [GO:0008047]; guanine/thymine mispair binding [GO:0032137]; protein homodimerization activity [GO:0042803] g5730.t1 Q5M9G6 64.737 190 3.25e-78 249.0 sp|Q5M9G6|SNIP1_RAT Smad nuclear interacting protein 1 OS=Rattus norvegicus OX=10116 GN=Snip1 PE=1 SV=1 SNIP1_RAT reviewed Smad nuclear interacting protein 1 Rattus norvegicus (Rat) GO:0000398; GO:0003729; GO:0005634; GO:0005654; GO:0005829; GO:0035196; GO:0043124; GO:0045944; GO:0071005; GO:0140416 miRNA processing [GO:0035196]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of canonical NF-kappaB signal transduction [GO:0043124]; positive regulation of transcription by RNA polymerase II [GO:0045944] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U2-type precatalytic spliceosome [GO:0071005] mRNA binding [GO:0003729]; transcription regulator inhibitor activity [GO:0140416] g5731.t1 F1NTD6 60.503 1471 0.0 1769.0 sp|F1NTD6|ASCC3_CHICK Activating signal cointegrator 1 complex subunit 3 OS=Gallus gallus OX=9031 GN=ascc3 PE=3 SV=2 g5731.t1 F1NTD6 33.83 671 2.33e-101 363.0 sp|F1NTD6|ASCC3_CHICK Activating signal cointegrator 1 complex subunit 3 OS=Gallus gallus OX=9031 GN=ascc3 PE=3 SV=2 g5736.t1 E1BNG3 67.579 731 0.0 1042.0 sp|E1BNG3|ASCC3_BOVIN Activating signal cointegrator 1 complex subunit 3 OS=Bos taurus OX=9913 GN=ascc3 PE=3 SV=1 ASCC3_BOVIN reviewed Activating signal cointegrator 1 complex subunit 3 (EC 5.6.2.4) Bos taurus (Bovine) GO:0003676; GO:0005524; GO:0005634; GO:0005829; GO:0006307; GO:0016607; GO:0016887; GO:0032790; GO:0043138; GO:0072344; GO:0180022; GO:1990116 DNA alkylation repair [GO:0006307]; rescue of stalled ribosome [GO:0072344]; ribosome disassembly [GO:0032790]; ribosome-associated ubiquitin-dependent protein catabolic process [GO:1990116] cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; RQC-trigger complex [GO:0180022] 3'-5' DNA helicase activity [GO:0043138]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; nucleic acid binding [GO:0003676] g5736.t1 E1BNG3 30.392 510 7.02e-69 251.0 sp|E1BNG3|ASCC3_BOVIN Activating signal cointegrator 1 complex subunit 3 OS=Bos taurus OX=9913 GN=ascc3 PE=3 SV=1 ASCC3_BOVIN reviewed Activating signal cointegrator 1 complex subunit 3 (EC 5.6.2.4) Bos taurus (Bovine) GO:0003676; GO:0005524; GO:0005634; GO:0005829; GO:0006307; GO:0016607; GO:0016887; GO:0032790; GO:0043138; GO:0072344; GO:0180022; GO:1990116 DNA alkylation repair [GO:0006307]; rescue of stalled ribosome [GO:0072344]; ribosome disassembly [GO:0032790]; ribosome-associated ubiquitin-dependent protein catabolic process [GO:1990116] cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; RQC-trigger complex [GO:0180022] 3'-5' DNA helicase activity [GO:0043138]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; nucleic acid binding [GO:0003676] g5736.t2 F1NTD6 52.147 326 3.1899999999999997e-106 345.0 sp|F1NTD6|ASCC3_CHICK Activating signal cointegrator 1 complex subunit 3 OS=Gallus gallus OX=9031 GN=ascc3 PE=3 SV=2 g5736.t3 E1BNG3 78.043 419 0.0 707.0 sp|E1BNG3|ASCC3_BOVIN Activating signal cointegrator 1 complex subunit 3 OS=Bos taurus OX=9913 GN=ascc3 PE=3 SV=1 ASCC3_BOVIN reviewed Activating signal cointegrator 1 complex subunit 3 (EC 5.6.2.4) Bos taurus (Bovine) GO:0003676; GO:0005524; GO:0005634; GO:0005829; GO:0006307; GO:0016607; GO:0016887; GO:0032790; GO:0043138; GO:0072344; GO:0180022; GO:1990116 DNA alkylation repair [GO:0006307]; rescue of stalled ribosome [GO:0072344]; ribosome disassembly [GO:0032790]; ribosome-associated ubiquitin-dependent protein catabolic process [GO:1990116] cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; RQC-trigger complex [GO:0180022] 3'-5' DNA helicase activity [GO:0043138]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; nucleic acid binding [GO:0003676] g5736.t3 E1BNG3 32.184 435 1.08e-65 232.0 sp|E1BNG3|ASCC3_BOVIN Activating signal cointegrator 1 complex subunit 3 OS=Bos taurus OX=9913 GN=ascc3 PE=3 SV=1 ASCC3_BOVIN reviewed Activating signal cointegrator 1 complex subunit 3 (EC 5.6.2.4) Bos taurus (Bovine) GO:0003676; GO:0005524; GO:0005634; GO:0005829; GO:0006307; GO:0016607; GO:0016887; GO:0032790; GO:0043138; GO:0072344; GO:0180022; GO:1990116 DNA alkylation repair [GO:0006307]; rescue of stalled ribosome [GO:0072344]; ribosome disassembly [GO:0032790]; ribosome-associated ubiquitin-dependent protein catabolic process [GO:1990116] cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; RQC-trigger complex [GO:0180022] 3'-5' DNA helicase activity [GO:0043138]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; nucleic acid binding [GO:0003676] g5737.t1 Q8BWD8 76.216 370 0.0 593.0 sp|Q8BWD8|CDK19_MOUSE Cyclin-dependent kinase 19 OS=Mus musculus OX=10090 GN=Cdk19 PE=2 SV=1 g5737.t2 Q8BWD8 76.503 366 0.0 587.0 sp|Q8BWD8|CDK19_MOUSE Cyclin-dependent kinase 19 OS=Mus musculus OX=10090 GN=Cdk19 PE=2 SV=1 g5739.t1 Q8R3L8 79.856 139 5.41e-79 240.0 sp|Q8R3L8|CDK8_MOUSE Cyclin-dependent kinase 8 OS=Mus musculus OX=10090 GN=Cdk8 PE=1 SV=3 CDK8_MOUSE reviewed Cyclin-dependent kinase 8 (EC 2.7.11.22) (EC 2.7.11.23) (Cell division protein kinase 8) (Mediator complex subunit CDK8) (Mediator of RNA polymerase II transcription subunit CDK8) Mus musculus (Mouse) GO:0000151; GO:0000307; GO:0004672; GO:0004674; GO:0004693; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0008353; GO:0016567; GO:0016592; GO:0032991; GO:0045944; GO:0061630; GO:0090209; GO:0106310; GO:1990508 negative regulation of triglyceride metabolic process [GO:0090209]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein ubiquitination [GO:0016567] CKM complex [GO:1990508]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; mediator complex [GO:0016592]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; ubiquitin ligase complex [GO:0000151] ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353]; ubiquitin protein ligase activity [GO:0061630] g5739.t1 Q8R3L8 93.103 29 5.41e-79 57.0 sp|Q8R3L8|CDK8_MOUSE Cyclin-dependent kinase 8 OS=Mus musculus OX=10090 GN=Cdk8 PE=1 SV=3 CDK8_MOUSE reviewed Cyclin-dependent kinase 8 (EC 2.7.11.22) (EC 2.7.11.23) (Cell division protein kinase 8) (Mediator complex subunit CDK8) (Mediator of RNA polymerase II transcription subunit CDK8) Mus musculus (Mouse) GO:0000151; GO:0000307; GO:0004672; GO:0004674; GO:0004693; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0008353; GO:0016567; GO:0016592; GO:0032991; GO:0045944; GO:0061630; GO:0090209; GO:0106310; GO:1990508 negative regulation of triglyceride metabolic process [GO:0090209]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein ubiquitination [GO:0016567] CKM complex [GO:1990508]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; mediator complex [GO:0016592]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; ubiquitin ligase complex [GO:0000151] ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353]; ubiquitin protein ligase activity [GO:0061630] g5739.t1 Q8R3L8 90.0 20 5.41e-79 39.3 sp|Q8R3L8|CDK8_MOUSE Cyclin-dependent kinase 8 OS=Mus musculus OX=10090 GN=Cdk8 PE=1 SV=3 CDK8_MOUSE reviewed Cyclin-dependent kinase 8 (EC 2.7.11.22) (EC 2.7.11.23) (Cell division protein kinase 8) (Mediator complex subunit CDK8) (Mediator of RNA polymerase II transcription subunit CDK8) Mus musculus (Mouse) GO:0000151; GO:0000307; GO:0004672; GO:0004674; GO:0004693; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0008353; GO:0016567; GO:0016592; GO:0032991; GO:0045944; GO:0061630; GO:0090209; GO:0106310; GO:1990508 negative regulation of triglyceride metabolic process [GO:0090209]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein ubiquitination [GO:0016567] CKM complex [GO:1990508]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; mediator complex [GO:0016592]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; ubiquitin ligase complex [GO:0000151] ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353]; ubiquitin protein ligase activity [GO:0061630] g5740.t1 A8WHP3 51.829 656 0.0 625.0 sp|A8WHP3|SC5A9_DANRE Sodium/glucose cotransporter 4 OS=Danio rerio OX=7955 GN=slc5a9 PE=2 SV=1 g5741.t1 P45700 61.688 462 0.0 624.0 sp|P45700|MA1A1_MOUSE Mannosyl-oligosaccharide 1,2-alpha-mannosidase IA OS=Mus musculus OX=10090 GN=Man1a1 PE=1 SV=1 g5744.t1 O43854 33.537 328 1.48e-35 146.0 sp|O43854|EDIL3_HUMAN EGF-like repeat and discoidin I-like domain-containing protein 3 OS=Homo sapiens OX=9606 GN=EDIL3 PE=1 SV=1 EDIL3_HUMAN reviewed EGF-like repeat and discoidin I-like domain-containing protein 3 (Developmentally-regulated endothelial cell locus 1 protein) (Integrin-binding protein DEL1) Homo sapiens (Human) GO:0005178; GO:0005509; GO:0005576; GO:0005615; GO:0007155; GO:0010811; GO:0031012; GO:0070062; GO:1903561 cell adhesion [GO:0007155]; positive regulation of cell-substrate adhesion [GO:0010811] extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular vesicle [GO:1903561] calcium ion binding [GO:0005509]; integrin binding [GO:0005178] g5744.t1 O43854 29.448 326 9.759999999999999e-23 107.0 sp|O43854|EDIL3_HUMAN EGF-like repeat and discoidin I-like domain-containing protein 3 OS=Homo sapiens OX=9606 GN=EDIL3 PE=1 SV=1 EDIL3_HUMAN reviewed EGF-like repeat and discoidin I-like domain-containing protein 3 (Developmentally-regulated endothelial cell locus 1 protein) (Integrin-binding protein DEL1) Homo sapiens (Human) GO:0005178; GO:0005509; GO:0005576; GO:0005615; GO:0007155; GO:0010811; GO:0031012; GO:0070062; GO:1903561 cell adhesion [GO:0007155]; positive regulation of cell-substrate adhesion [GO:0010811] extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular vesicle [GO:1903561] calcium ion binding [GO:0005509]; integrin binding [GO:0005178] g5746.t1 P46023 37.552 719 4.03e-123 402.0 sp|P46023|GR101_LYMST G-protein coupled receptor GRL101 OS=Lymnaea stagnalis OX=6523 PE=2 SV=1 g5747.t1 Q32NQ7 46.089 473 3.99e-136 404.0 sp|Q32NQ7|DAAF3_XENLA Dynein axonemal assembly factor 3 OS=Xenopus laevis OX=8355 GN=dnaaf3 PE=2 SV=1 g5753.t1 Q6GMR7 50.573 524 4.4900000000000006e-163 477.0 sp|Q6GMR7|FAAH2_HUMAN Fatty-acid amide hydrolase 2 OS=Homo sapiens OX=9606 GN=FAAH2 PE=1 SV=1 FAAH2_HUMAN reviewed Fatty-acid amide hydrolase 2 (EC 3.5.1.99) (Amidase domain-containing protein) (Anandamide amidohydrolase 2) (Oleamide hydrolase 2) Homo sapiens (Human) GO:0005811; GO:0016020; GO:0016042; GO:0017064; GO:0019369 arachidonate metabolic process [GO:0019369]; lipid catabolic process [GO:0016042] lipid droplet [GO:0005811]; membrane [GO:0016020] fatty acid amide hydrolase activity [GO:0017064] g5758.t1 Q9CZ62 44.766 449 2.09e-74 258.0 sp|Q9CZ62|CEP97_MOUSE Centrosomal protein of 97 kDa OS=Mus musculus OX=10090 GN=Cep97 PE=1 SV=1 g5764.t1 Q8BGC3 26.034 411 9.8e-30 124.0 sp|Q8BGC3|MOT12_MOUSE Monocarboxylate transporter 12 OS=Mus musculus OX=10090 GN=Slc16a12 PE=1 SV=1 g5767.t1 Q9Y6R7 30.198 404 5.96e-39 166.0 sp|Q9Y6R7|FCGBP_HUMAN IgGFc-binding protein OS=Homo sapiens OX=9606 GN=FCGBP PE=1 SV=3 FCGBP_HUMAN reviewed IgGFc-binding protein (Fcgamma-binding protein antigen) (FcgammaBP) Homo sapiens (Human) GO:0005201; GO:0005615; GO:0005796; GO:0031012; GO:0070062 extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796] extracellular matrix structural constituent [GO:0005201] g5767.t1 Q9Y6R7 30.025 403 7.85e-39 165.0 sp|Q9Y6R7|FCGBP_HUMAN IgGFc-binding protein OS=Homo sapiens OX=9606 GN=FCGBP PE=1 SV=3 FCGBP_HUMAN reviewed IgGFc-binding protein (Fcgamma-binding protein antigen) (FcgammaBP) Homo sapiens (Human) GO:0005201; GO:0005615; GO:0005796; GO:0031012; GO:0070062 extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796] extracellular matrix structural constituent [GO:0005201] g5767.t1 Q9Y6R7 29.455 404 9.94e-38 162.0 sp|Q9Y6R7|FCGBP_HUMAN IgGFc-binding protein OS=Homo sapiens OX=9606 GN=FCGBP PE=1 SV=3 FCGBP_HUMAN reviewed IgGFc-binding protein (Fcgamma-binding protein antigen) (FcgammaBP) Homo sapiens (Human) GO:0005201; GO:0005615; GO:0005796; GO:0031012; GO:0070062 extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796] extracellular matrix structural constituent [GO:0005201] g5767.t1 Q9Y6R7 31.442 423 1.16e-36 158.0 sp|Q9Y6R7|FCGBP_HUMAN IgGFc-binding protein OS=Homo sapiens OX=9606 GN=FCGBP PE=1 SV=3 FCGBP_HUMAN reviewed IgGFc-binding protein (Fcgamma-binding protein antigen) (FcgammaBP) Homo sapiens (Human) GO:0005201; GO:0005615; GO:0005796; GO:0031012; GO:0070062 extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796] extracellular matrix structural constituent [GO:0005201] g5767.t1 Q9Y6R7 29.648 398 1e-34 152.0 sp|Q9Y6R7|FCGBP_HUMAN IgGFc-binding protein OS=Homo sapiens OX=9606 GN=FCGBP PE=1 SV=3 FCGBP_HUMAN reviewed IgGFc-binding protein (Fcgamma-binding protein antigen) (FcgammaBP) Homo sapiens (Human) GO:0005201; GO:0005615; GO:0005796; GO:0031012; GO:0070062 extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796] extracellular matrix structural constituent [GO:0005201] g5767.t1 Q9Y6R7 31.677 322 8.38e-32 142.0 sp|Q9Y6R7|FCGBP_HUMAN IgGFc-binding protein OS=Homo sapiens OX=9606 GN=FCGBP PE=1 SV=3 FCGBP_HUMAN reviewed IgGFc-binding protein (Fcgamma-binding protein antigen) (FcgammaBP) Homo sapiens (Human) GO:0005201; GO:0005615; GO:0005796; GO:0031012; GO:0070062 extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796] extracellular matrix structural constituent [GO:0005201] g5767.t1 Q9Y6R7 31.677 322 8.38e-32 142.0 sp|Q9Y6R7|FCGBP_HUMAN IgGFc-binding protein OS=Homo sapiens OX=9606 GN=FCGBP PE=1 SV=3 FCGBP_HUMAN reviewed IgGFc-binding protein (Fcgamma-binding protein antigen) (FcgammaBP) Homo sapiens (Human) GO:0005201; GO:0005615; GO:0005796; GO:0031012; GO:0070062 extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796] extracellular matrix structural constituent [GO:0005201] g5767.t1 Q9Y6R7 27.195 467 2.4100000000000003e-31 140.0 sp|Q9Y6R7|FCGBP_HUMAN IgGFc-binding protein OS=Homo sapiens OX=9606 GN=FCGBP PE=1 SV=3 FCGBP_HUMAN reviewed IgGFc-binding protein (Fcgamma-binding protein antigen) (FcgammaBP) Homo sapiens (Human) GO:0005201; GO:0005615; GO:0005796; GO:0031012; GO:0070062 extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796] extracellular matrix structural constituent [GO:0005201] g5767.t1 Q9Y6R7 29.648 398 1.3099999999999999e-30 138.0 sp|Q9Y6R7|FCGBP_HUMAN IgGFc-binding protein OS=Homo sapiens OX=9606 GN=FCGBP PE=1 SV=3 FCGBP_HUMAN reviewed IgGFc-binding protein (Fcgamma-binding protein antigen) (FcgammaBP) Homo sapiens (Human) GO:0005201; GO:0005615; GO:0005796; GO:0031012; GO:0070062 extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796] extracellular matrix structural constituent [GO:0005201] g5767.t1 Q9Y6R7 31.79 324 1.72e-30 137.0 sp|Q9Y6R7|FCGBP_HUMAN IgGFc-binding protein OS=Homo sapiens OX=9606 GN=FCGBP PE=1 SV=3 FCGBP_HUMAN reviewed IgGFc-binding protein (Fcgamma-binding protein antigen) (FcgammaBP) Homo sapiens (Human) GO:0005201; GO:0005615; GO:0005796; GO:0031012; GO:0070062 extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796] extracellular matrix structural constituent [GO:0005201] g5767.t1 Q9Y6R7 29.648 398 4.59e-30 136.0 sp|Q9Y6R7|FCGBP_HUMAN IgGFc-binding protein OS=Homo sapiens OX=9606 GN=FCGBP PE=1 SV=3 FCGBP_HUMAN reviewed IgGFc-binding protein (Fcgamma-binding protein antigen) (FcgammaBP) Homo sapiens (Human) GO:0005201; GO:0005615; GO:0005796; GO:0031012; GO:0070062 extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796] extracellular matrix structural constituent [GO:0005201] g5767.t1 Q9Y6R7 27.011 348 2.2300000000000002e-29 134.0 sp|Q9Y6R7|FCGBP_HUMAN IgGFc-binding protein OS=Homo sapiens OX=9606 GN=FCGBP PE=1 SV=3 FCGBP_HUMAN reviewed IgGFc-binding protein (Fcgamma-binding protein antigen) (FcgammaBP) Homo sapiens (Human) GO:0005201; GO:0005615; GO:0005796; GO:0031012; GO:0070062 extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796] extracellular matrix structural constituent [GO:0005201] g5767.t1 Q9Y6R7 33.639 327 2.4100000000000002e-29 134.0 sp|Q9Y6R7|FCGBP_HUMAN IgGFc-binding protein OS=Homo sapiens OX=9606 GN=FCGBP PE=1 SV=3 FCGBP_HUMAN reviewed IgGFc-binding protein (Fcgamma-binding protein antigen) (FcgammaBP) Homo sapiens (Human) GO:0005201; GO:0005615; GO:0005796; GO:0031012; GO:0070062 extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796] extracellular matrix structural constituent [GO:0005201] g5767.t1 Q9Y6R7 35.417 336 2.64e-29 134.0 sp|Q9Y6R7|FCGBP_HUMAN IgGFc-binding protein OS=Homo sapiens OX=9606 GN=FCGBP PE=1 SV=3 FCGBP_HUMAN reviewed IgGFc-binding protein (Fcgamma-binding protein antigen) (FcgammaBP) Homo sapiens (Human) GO:0005201; GO:0005615; GO:0005796; GO:0031012; GO:0070062 extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796] extracellular matrix structural constituent [GO:0005201] g5767.t1 Q9Y6R7 28.788 330 5.300000000000001e-27 126.0 sp|Q9Y6R7|FCGBP_HUMAN IgGFc-binding protein OS=Homo sapiens OX=9606 GN=FCGBP PE=1 SV=3 FCGBP_HUMAN reviewed IgGFc-binding protein (Fcgamma-binding protein antigen) (FcgammaBP) Homo sapiens (Human) GO:0005201; GO:0005615; GO:0005796; GO:0031012; GO:0070062 extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796] extracellular matrix structural constituent [GO:0005201] g5767.t1 Q9Y6R7 26.492 419 1.66e-25 121.0 sp|Q9Y6R7|FCGBP_HUMAN IgGFc-binding protein OS=Homo sapiens OX=9606 GN=FCGBP PE=1 SV=3 FCGBP_HUMAN reviewed IgGFc-binding protein (Fcgamma-binding protein antigen) (FcgammaBP) Homo sapiens (Human) GO:0005201; GO:0005615; GO:0005796; GO:0031012; GO:0070062 extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796] extracellular matrix structural constituent [GO:0005201] g5767.t1 Q9Y6R7 26.392 413 2.74e-25 120.0 sp|Q9Y6R7|FCGBP_HUMAN IgGFc-binding protein OS=Homo sapiens OX=9606 GN=FCGBP PE=1 SV=3 FCGBP_HUMAN reviewed IgGFc-binding protein (Fcgamma-binding protein antigen) (FcgammaBP) Homo sapiens (Human) GO:0005201; GO:0005615; GO:0005796; GO:0031012; GO:0070062 extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796] extracellular matrix structural constituent [GO:0005201] g5767.t1 Q9Y6R7 31.548 336 1.0099999999999999e-24 119.0 sp|Q9Y6R7|FCGBP_HUMAN IgGFc-binding protein OS=Homo sapiens OX=9606 GN=FCGBP PE=1 SV=3 FCGBP_HUMAN reviewed IgGFc-binding protein (Fcgamma-binding protein antigen) (FcgammaBP) Homo sapiens (Human) GO:0005201; GO:0005615; GO:0005796; GO:0031012; GO:0070062 extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796] extracellular matrix structural constituent [GO:0005201] g5767.t1 Q9Y6R7 27.778 414 1.36e-24 118.0 sp|Q9Y6R7|FCGBP_HUMAN IgGFc-binding protein OS=Homo sapiens OX=9606 GN=FCGBP PE=1 SV=3 FCGBP_HUMAN reviewed IgGFc-binding protein (Fcgamma-binding protein antigen) (FcgammaBP) Homo sapiens (Human) GO:0005201; GO:0005615; GO:0005796; GO:0031012; GO:0070062 extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796] extracellular matrix structural constituent [GO:0005201] g5767.t1 Q9Y6R7 31.548 336 1.66e-24 118.0 sp|Q9Y6R7|FCGBP_HUMAN IgGFc-binding protein OS=Homo sapiens OX=9606 GN=FCGBP PE=1 SV=3 FCGBP_HUMAN reviewed IgGFc-binding protein (Fcgamma-binding protein antigen) (FcgammaBP) Homo sapiens (Human) GO:0005201; GO:0005615; GO:0005796; GO:0031012; GO:0070062 extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796] extracellular matrix structural constituent [GO:0005201] g5767.t1 Q9Y6R7 34.13 293 2.46e-24 117.0 sp|Q9Y6R7|FCGBP_HUMAN IgGFc-binding protein OS=Homo sapiens OX=9606 GN=FCGBP PE=1 SV=3 FCGBP_HUMAN reviewed IgGFc-binding protein (Fcgamma-binding protein antigen) (FcgammaBP) Homo sapiens (Human) GO:0005201; GO:0005615; GO:0005796; GO:0031012; GO:0070062 extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796] extracellular matrix structural constituent [GO:0005201] g5767.t1 Q9Y6R7 28.358 335 2.86e-23 114.0 sp|Q9Y6R7|FCGBP_HUMAN IgGFc-binding protein OS=Homo sapiens OX=9606 GN=FCGBP PE=1 SV=3 FCGBP_HUMAN reviewed IgGFc-binding protein (Fcgamma-binding protein antigen) (FcgammaBP) Homo sapiens (Human) GO:0005201; GO:0005615; GO:0005796; GO:0031012; GO:0070062 extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796] extracellular matrix structural constituent [GO:0005201] g5767.t1 Q9Y6R7 28.358 335 4.1999999999999996e-23 113.0 sp|Q9Y6R7|FCGBP_HUMAN IgGFc-binding protein OS=Homo sapiens OX=9606 GN=FCGBP PE=1 SV=3 FCGBP_HUMAN reviewed IgGFc-binding protein (Fcgamma-binding protein antigen) (FcgammaBP) Homo sapiens (Human) GO:0005201; GO:0005615; GO:0005796; GO:0031012; GO:0070062 extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796] extracellular matrix structural constituent [GO:0005201] g5767.t1 Q9Y6R7 28.06 335 1.06e-22 112.0 sp|Q9Y6R7|FCGBP_HUMAN IgGFc-binding protein OS=Homo sapiens OX=9606 GN=FCGBP PE=1 SV=3 FCGBP_HUMAN reviewed IgGFc-binding protein (Fcgamma-binding protein antigen) (FcgammaBP) Homo sapiens (Human) GO:0005201; GO:0005615; GO:0005796; GO:0031012; GO:0070062 extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796] extracellular matrix structural constituent [GO:0005201] g5768.t1 Q5SW96 36.624 314 1.32e-51 176.0 sp|Q5SW96|ARH_HUMAN Low density lipoprotein receptor adapter protein 1 OS=Homo sapiens OX=9606 GN=LDLRAP1 PE=1 SV=3 ARH_HUMAN reviewed Low density lipoprotein receptor adapter protein 1 (Autosomal recessive hypercholesterolemia protein) Homo sapiens (Human) GO:0001540; GO:0001784; GO:0005546; GO:0005769; GO:0005829; GO:0005883; GO:0005886; GO:0006898; GO:0008203; GO:0009898; GO:0009925; GO:0030159; GO:0030276; GO:0030301; GO:0030424; GO:0030669; GO:0031623; GO:0034383; GO:0035591; GO:0035612; GO:0035615; GO:0035650; GO:0042632; GO:0042982; GO:0043393; GO:0048260; GO:0050750; GO:0055037; GO:0071345; GO:0090118; GO:0090205; GO:1903076; GO:1904707; GO:1905581; GO:1905602 amyloid precursor protein metabolic process [GO:0042982]; cellular response to cytokine stimulus [GO:0071345]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; low-density lipoprotein particle clearance [GO:0034383]; positive regulation of cholesterol metabolic process [GO:0090205]; positive regulation of low-density lipoprotein particle clearance [GO:1905581]; positive regulation of receptor-mediated endocytosis [GO:0048260]; positive regulation of receptor-mediated endocytosis involved in cholesterol transport [GO:1905602]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; receptor internalization [GO:0031623]; receptor-mediated endocytosis [GO:0006898]; receptor-mediated endocytosis involved in cholesterol transport [GO:0090118]; regulation of protein binding [GO:0043393]; regulation of protein localization to plasma membrane [GO:1903076] axon [GO:0030424]; basal plasma membrane [GO:0009925]; clathrin-coated endocytic vesicle membrane [GO:0030669]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; early endosome [GO:0005769]; neurofilament [GO:0005883]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037] amyloid-beta binding [GO:0001540]; AP-1 adaptor complex binding [GO:0035650]; AP-2 adaptor complex binding [GO:0035612]; clathrin adaptor activity [GO:0035615]; clathrin binding [GO:0030276]; low-density lipoprotein particle receptor binding [GO:0050750]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphotyrosine residue binding [GO:0001784]; signaling adaptor activity [GO:0035591]; signaling receptor complex adaptor activity [GO:0030159] g5770.t1 Q60636 56.915 188 3.59e-57 213.0 sp|Q60636|PRDM1_MOUSE PR domain zinc finger protein 1 OS=Mus musculus OX=10090 GN=Prdm1 PE=1 SV=1 g5770.t1 Q60636 46.893 177 5.37e-44 174.0 sp|Q60636|PRDM1_MOUSE PR domain zinc finger protein 1 OS=Mus musculus OX=10090 GN=Prdm1 PE=1 SV=1 g5772.t1 Q6NVL7 51.131 221 4.71e-58 185.0 sp|Q6NVL7|CHM2B_XENTR Charged multivesicular body protein 2b OS=Xenopus tropicalis OX=8364 GN=chmp2b PE=2 SV=1 g5773.t1 Q91175 29.412 340 9.94e-21 96.3 sp|Q91175|ADA1A_ORYLA Alpha-1A adrenergic receptor OS=Oryzias latipes OX=8090 GN=adra1a PE=3 SV=1 ADA1A_ORYLA reviewed Alpha-1A adrenergic receptor (Alpha-1A adrenoreceptor) (Alpha-1A adrenoceptor) (MAR1) Oryzias latipes (Japanese rice fish) (Japanese killifish) GO:0004937; GO:0005886; GO:0007200; GO:0007204; GO:0007267; GO:0010613; GO:0043410; GO:0071880 adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; cell-cell signaling [GO:0007267]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of MAPK cascade [GO:0043410] plasma membrane [GO:0005886] alpha1-adrenergic receptor activity [GO:0004937] g5776.t1 A8WHP3 49.348 537 1.9200000000000002e-179 523.0 sp|A8WHP3|SC5A9_DANRE Sodium/glucose cotransporter 4 OS=Danio rerio OX=7955 GN=slc5a9 PE=2 SV=1 g5777.t1 Q8BMK0 30.252 476 1.8e-43 172.0 sp|Q8BMK0|CEP85_MOUSE Centrosomal protein of 85 kDa OS=Mus musculus OX=10090 GN=Cep85 PE=1 SV=2 g5779.t1 O54862 39.351 493 3.1e-101 314.0 sp|O54862|MBTP2_CRIGR Membrane-bound transcription factor site-2 protease OS=Cricetulus griseus OX=10029 GN=MBTPS2 PE=2 SV=1 g5785.t1 A7YVH9 58.836 481 0.0 543.0 sp|A7YVH9|PYRD1_BOVIN Pyridine nucleotide-disulfide oxidoreductase domain-containing protein 1 OS=Bos taurus OX=9913 GN=PYROXD1 PE=2 SV=1 PYRD1_BOVIN reviewed tRNA ligase complex-associated NAD(P)H dehydrogenase PYROXD1 (EC 1.6.99.1) (Pyridine nucleotide-disulfide oxidoreductase domain-containing protein 1) Bos taurus (Bovine) GO:0005634; GO:0005737; GO:0016491; GO:0030017; GO:0034599 cellular response to oxidative stress [GO:0034599] cytoplasm [GO:0005737]; nucleus [GO:0005634]; sarcomere [GO:0030017] oxidoreductase activity [GO:0016491] g5786.t1 Q5VVH5 38.34 253 1.31e-46 157.0 sp|Q5VVH5|IKBP1_HUMAN Interleukin-1 receptor-associated kinase 1-binding protein 1 OS=Homo sapiens OX=9606 GN=IRAK1BP1 PE=1 SV=1 IKBP1_HUMAN reviewed Interleukin-1 receptor-associated kinase 1-binding protein 1 (IRAK1-binding protein 1) Homo sapiens (Human) GO:0005634; GO:0005737; GO:0006955; GO:0035591; GO:0043123 immune response [GO:0006955]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123] cytoplasm [GO:0005737]; nucleus [GO:0005634] signaling adaptor activity [GO:0035591] g5804.t1 Q4R7V3 60.938 128 9.349999999999999e-45 162.0 sp|Q4R7V3|CEP43_MACFA Centrosomal protein 43 OS=Macaca fascicularis OX=9541 GN=CEP43 PE=2 SV=1 CEP43_MACFA reviewed Centrosomal protein 43 (FGFR1 oncogene partner) Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey) GO:0005813; GO:0005814; GO:0030030; GO:0034453 cell projection organization [GO:0030030]; microtubule anchoring [GO:0034453] centriole [GO:0005814]; centrosome [GO:0005813] g5804.t2 Q4R7V3 60.938 128 6.35e-45 163.0 sp|Q4R7V3|CEP43_MACFA Centrosomal protein 43 OS=Macaca fascicularis OX=9541 GN=CEP43 PE=2 SV=1 CEP43_MACFA reviewed Centrosomal protein 43 (FGFR1 oncogene partner) Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey) GO:0005813; GO:0005814; GO:0030030; GO:0034453 cell projection organization [GO:0030030]; microtubule anchoring [GO:0034453] centriole [GO:0005814]; centrosome [GO:0005813] g5805.t1 Q8BTJ4 55.385 65 1.24e-21 79.7 sp|Q8BTJ4|ENPP4_MOUSE Bis(5'-adenosyl)-triphosphatase enpp4 OS=Mus musculus OX=10090 GN=Enpp4 PE=1 SV=1 ENPP4_MOUSE reviewed Bis(5'-adenosyl)-triphosphatase enpp4 (EC 3.6.1.29) (AP3A hydrolase) (AP3Aase) (Ectonucleotide pyrophosphatase/phosphodiesterase family member 4) (E-NPP 4) (NPP-4) Mus musculus (Mouse) GO:0005886; GO:0007596; GO:0030194; GO:0046130; GO:0046872; GO:0047710 blood coagulation [GO:0007596]; positive regulation of blood coagulation [GO:0030194]; purine ribonucleoside catabolic process [GO:0046130] plasma membrane [GO:0005886] bis(5'-adenosyl)-triphosphatase activity [GO:0047710]; metal ion binding [GO:0046872] g5805.t1 Q8BTJ4 52.632 38 1.24e-21 42.7 sp|Q8BTJ4|ENPP4_MOUSE Bis(5'-adenosyl)-triphosphatase enpp4 OS=Mus musculus OX=10090 GN=Enpp4 PE=1 SV=1 ENPP4_MOUSE reviewed Bis(5'-adenosyl)-triphosphatase enpp4 (EC 3.6.1.29) (AP3A hydrolase) (AP3Aase) (Ectonucleotide pyrophosphatase/phosphodiesterase family member 4) (E-NPP 4) (NPP-4) Mus musculus (Mouse) GO:0005886; GO:0007596; GO:0030194; GO:0046130; GO:0046872; GO:0047710 blood coagulation [GO:0007596]; positive regulation of blood coagulation [GO:0030194]; purine ribonucleoside catabolic process [GO:0046130] plasma membrane [GO:0005886] bis(5'-adenosyl)-triphosphatase activity [GO:0047710]; metal ion binding [GO:0046872] g5806.t1 Q9EQG7 41.349 341 1.15e-78 252.0 sp|Q9EQG7|ENPP5_MOUSE Ectonucleotide pyrophosphatase/phosphodiesterase family member 5 OS=Mus musculus OX=10090 GN=Enpp5 PE=1 SV=3 ENPP5_MOUSE reviewed Ectonucleotide pyrophosphatase/phosphodiesterase family member 5 (E-NPP 5) (NPP-5) (EC 3.1.-.-) Mus musculus (Mouse) GO:0000210; GO:0004551; GO:0005576; GO:0005886; GO:0007154; GO:0008270; GO:0009166; GO:0016787 cell communication [GO:0007154]; nucleotide catabolic process [GO:0009166] extracellular region [GO:0005576]; plasma membrane [GO:0005886] dinucleotide phosphatase activity [GO:0004551]; hydrolase activity [GO:0016787]; NAD+ diphosphatase activity [GO:0000210]; zinc ion binding [GO:0008270] g5807.t1 Q9TZM3 32.785 729 5.45e-92 339.0 sp|Q9TZM3|LRK1_CAEEL Leucine-rich repeat serine/threonine-protein kinase 1 OS=Caenorhabditis elegans OX=6239 GN=lrk-1 PE=1 SV=6 g5807.t1 Q9TZM3 31.404 691 6.16e-78 293.0 sp|Q9TZM3|LRK1_CAEEL Leucine-rich repeat serine/threonine-protein kinase 1 OS=Caenorhabditis elegans OX=6239 GN=lrk-1 PE=1 SV=6 g5807.t1 Q9TZM3 26.728 651 1.35e-37 160.0 sp|Q9TZM3|LRK1_CAEEL Leucine-rich repeat serine/threonine-protein kinase 1 OS=Caenorhabditis elegans OX=6239 GN=lrk-1 PE=1 SV=6 g5809.t1 Q6ZN84 30.779 783 9.2e-98 319.0 sp|Q6ZN84|CCD81_HUMAN Coiled-coil domain-containing protein 81 OS=Homo sapiens OX=9606 GN=CCDC81 PE=1 SV=2 g5811.t1 Q5ZMJ9 72.358 123 6.0799999999999995e-46 182.0 sp|Q5ZMJ9|SRRM1_CHICK Serine/arginine repetitive matrix protein 1 OS=Gallus gallus OX=9031 GN=SRRM1 PE=2 SV=1 g5812.t1 O60506 55.156 417 8.8e-162 481.0 sp|O60506|HNRPQ_HUMAN Heterogeneous nuclear ribonucleoprotein Q OS=Homo sapiens OX=9606 GN=SYNCRIP PE=1 SV=2 HNRPQ_HUMAN reviewed Heterogeneous nuclear ribonucleoprotein Q (hnRNP Q) (Glycine- and tyrosine-rich RNA-binding protein) (GRY-RBP) (NS1-associated protein 1) (Synaptotagmin-binding, cytoplasmic RNA-interacting protein) Homo sapiens (Human) GO:0000398; GO:0001649; GO:0003723; GO:0005634; GO:0005654; GO:0005783; GO:0005829; GO:0006396; GO:0008380; GO:0016020; GO:0016556; GO:0017148; GO:0045293; GO:0048027; GO:0070934; GO:0070937; GO:0071013; GO:0071204; GO:0071346; GO:0097452; GO:0106002; GO:0141166; GO:1900152; GO:1990904; GO:2000623; GO:2000767 cellular response to type II interferon [GO:0071346]; chromosomal 5-methylcytosine DNA demethylation pathway [GO:0141166]; CRD-mediated mRNA stabilization [GO:0070934]; mRNA modification [GO:0016556]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900152]; negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:2000623]; negative regulation of translation [GO:0017148]; osteoblast differentiation [GO:0001649]; positive regulation of cytoplasmic translation [GO:2000767]; RNA processing [GO:0006396]; RNA splicing [GO:0008380] catalytic step 2 spliceosome [GO:0071013]; CRD-mediated mRNA stability complex [GO:0070937]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; GAIT complex [GO:0097452]; histone pre-mRNA 3'end processing complex [GO:0071204]; mCRD-mediated mRNA stability complex [GO:0106002]; membrane [GO:0016020]; mRNA editing complex [GO:0045293]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904] mRNA 5'-UTR binding [GO:0048027]; RNA binding [GO:0003723] g5813.t1 Q9H7B2 61.672 287 7.61e-110 324.0 sp|Q9H7B2|RPF2_HUMAN Ribosome production factor 2 homolog OS=Homo sapiens OX=9606 GN=RPF2 PE=1 SV=2 RPF2_HUMAN reviewed Ribosome production factor 2 homolog (Brix domain-containing protein 1) (Ribosome biogenesis protein RPF2 homolog) Homo sapiens (Human) GO:0000027; GO:0000463; GO:0003723; GO:0005654; GO:0005694; GO:0005730; GO:0008097; GO:0019843; GO:0042273; GO:1901796; GO:1902570 maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]; protein localization to nucleolus [GO:1902570]; regulation of signal transduction by p53 class mediator [GO:1901796]; ribosomal large subunit assembly [GO:0000027]; ribosomal large subunit biogenesis [GO:0042273] chromosome [GO:0005694]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654] 5S rRNA binding [GO:0008097]; RNA binding [GO:0003723]; rRNA binding [GO:0019843] g5814.t1 Q6GQB5 42.723 213 2.9800000000000002e-43 146.0 sp|Q6GQB5|AKIR2_XENLA Akirin-2 OS=Xenopus laevis OX=8355 GN=akirin2.S PE=1 SV=1 AKIR2_XENLA reviewed Akirin-2 (XAkirin2) Xenopus laevis (African clawed frog) GO:0000785; GO:0003712; GO:0005634; GO:0015031; GO:0022008; GO:0030674; GO:0045089; GO:0045944 neurogenesis [GO:0022008]; positive regulation of innate immune response [GO:0045089]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein transport [GO:0015031] chromatin [GO:0000785]; nucleus [GO:0005634] protein-macromolecule adaptor activity [GO:0030674]; transcription coregulator activity [GO:0003712] g5818.t1 Q8NBP5 40.136 147 2.5599999999999998e-23 100.0 sp|Q8NBP5|MFSD9_HUMAN Major facilitator superfamily domain-containing protein 9 OS=Homo sapiens OX=9606 GN=MFSD9 PE=1 SV=2 g5819.t1 Q8C0T7 37.813 439 1.7199999999999997e-67 224.0 sp|Q8C0T7|MFSD9_MOUSE Major facilitator superfamily domain-containing protein 9 OS=Mus musculus OX=10090 GN=Mfsd9 PE=2 SV=1 g5820.t1 Q8NBP5 37.731 432 8.450000000000001e-77 249.0 sp|Q8NBP5|MFSD9_HUMAN Major facilitator superfamily domain-containing protein 9 OS=Homo sapiens OX=9606 GN=MFSD9 PE=1 SV=2 g5821.t1 B3LYS5 53.696 257 1.2600000000000002e-73 249.0 sp|B3LYS5|FOXO_DROAN Forkhead box protein O OS=Drosophila ananassae OX=7217 GN=foxo PE=3 SV=2 FOXO_DROAN reviewed Forkhead box protein O Drosophila ananassae (Fruit fly) GO:0000978; GO:0001228; GO:0003700; GO:0005634; GO:0005737; GO:0006355; GO:0008285; GO:0008286; GO:0008340; GO:0009896; GO:0010883; GO:0019216; GO:0030154; GO:0030308; GO:0031349; GO:0034599; GO:0040015; GO:0042593; GO:0042594; GO:0046627; GO:0050778 cell differentiation [GO:0030154]; cellular response to oxidative stress [GO:0034599]; determination of adult lifespan [GO:0008340]; glucose homeostasis [GO:0042593]; insulin receptor signaling pathway [GO:0008286]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of multicellular organism growth [GO:0040015]; positive regulation of catabolic process [GO:0009896]; positive regulation of defense response [GO:0031349]; positive regulation of immune response [GO:0050778]; regulation of DNA-templated transcription [GO:0006355]; regulation of lipid metabolic process [GO:0019216]; regulation of lipid storage [GO:0010883]; response to starvation [GO:0042594] cytoplasm [GO:0005737]; nucleus [GO:0005634] DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978] g5825.t1 Q8R512 34.312 443 3.42e-70 236.0 sp|Q8R512|UBX11_RAT UBX domain-containing protein 11 OS=Rattus norvegicus OX=10116 GN=Ubxn11 PE=1 SV=1 g5826.t1 Q9VUL9 37.008 254 4.7999999999999997e-39 149.0 sp|Q9VUL9|FUCTA_DROME Glycoprotein 3-alpha-L-fucosyltransferase A OS=Drosophila melanogaster OX=7227 GN=FucTA PE=1 SV=2 FUCTA_DROME reviewed Glycoprotein 3-alpha-L-fucosyltransferase A (EC 2.4.1.214) (Core alpha-(1,3)-fucosyltransferase) Drosophila melanogaster (Fruit fly) GO:0005797; GO:0006491; GO:0007399; GO:0018279; GO:0018392; GO:0032580; GO:0046920 N-glycan processing [GO:0006491]; nervous system development [GO:0007399]; protein N-linked glycosylation via asparagine [GO:0018279] Golgi cisterna membrane [GO:0032580]; Golgi medial cisterna [GO:0005797] alpha-(1->3)-fucosyltransferase activity [GO:0046920]; glycoprotein 3-alpha-L-fucosyltransferase activity [GO:0018392] g5828.t1 Q9VUL9 42.162 185 4.25e-35 139.0 sp|Q9VUL9|FUCTA_DROME Glycoprotein 3-alpha-L-fucosyltransferase A OS=Drosophila melanogaster OX=7227 GN=FucTA PE=1 SV=2 FUCTA_DROME reviewed Glycoprotein 3-alpha-L-fucosyltransferase A (EC 2.4.1.214) (Core alpha-(1,3)-fucosyltransferase) Drosophila melanogaster (Fruit fly) GO:0005797; GO:0006491; GO:0007399; GO:0018279; GO:0018392; GO:0032580; GO:0046920 N-glycan processing [GO:0006491]; nervous system development [GO:0007399]; protein N-linked glycosylation via asparagine [GO:0018279] Golgi cisterna membrane [GO:0032580]; Golgi medial cisterna [GO:0005797] alpha-(1->3)-fucosyltransferase activity [GO:0046920]; glycoprotein 3-alpha-L-fucosyltransferase activity [GO:0018392] g5830.t1 P59235 41.562 397 9.06e-100 304.0 sp|P59235|NUP43_MOUSE Nucleoporin Nup43 OS=Mus musculus OX=10090 GN=Nup43 PE=1 SV=2 g5832.t1 Q8BYR2 61.29 465 3.05e-160 484.0 sp|Q8BYR2|LATS1_MOUSE Serine/threonine-protein kinase LATS1 OS=Mus musculus OX=10090 GN=Lats1 PE=1 SV=3 LATS1_MOUSE reviewed Serine/threonine-protein kinase LATS1 (EC 2.7.11.1) (Large tumor suppressor homolog 1) (WARTS protein kinase) Mus musculus (Mouse) GO:0000082; GO:0000086; GO:0000287; GO:0000819; GO:0000922; GO:0001827; GO:0001828; GO:0004674; GO:0005524; GO:0005737; GO:0005813; GO:0005815; GO:0006468; GO:0008104; GO:0009755; GO:0017015; GO:0019901; GO:0030216; GO:0030331; GO:0030496; GO:0030833; GO:0033146; GO:0035329; GO:0035332; GO:0043065; GO:0043254; GO:0044546; GO:0045736; GO:0046620; GO:0051301; GO:0060644; GO:0090090; GO:0098794; GO:0098978; GO:0099151; GO:0106310; GO:1900181; GO:1900227; GO:2000058 cell division [GO:0051301]; G1/S transition of mitotic cell cycle [GO:0000082]; G2/M transition of mitotic cell cycle [GO:0000086]; hippo signaling [GO:0035329]; hormone-mediated signaling pathway [GO:0009755]; inner cell mass cell fate commitment [GO:0001827]; inner cell mass cellular morphogenesis [GO:0001828]; intracellular protein localization [GO:0008104]; keratinocyte differentiation [GO:0030216]; mammary gland epithelial cell differentiation [GO:0060644]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; negative regulation of protein localization to nucleus [GO:1900181]; NLRP3 inflammasome complex assembly [GO:0044546]; positive regulation of apoptotic process [GO:0043065]; positive regulation of hippo signaling [GO:0035332]; positive regulation of NLRP3 inflammasome complex assembly [GO:1900227]; protein phosphorylation [GO:0006468]; regulation of actin filament polymerization [GO:0030833]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146]; regulation of organ growth [GO:0046620]; regulation of postsynaptic density assembly [GO:0099151]; regulation of protein-containing complex assembly [GO:0043254]; regulation of transforming growth factor beta receptor signaling pathway [GO:0017015]; regulation of ubiquitin-dependent protein catabolic process [GO:2000058]; sister chromatid segregation [GO:0000819] centrosome [GO:0005813]; cytoplasm [GO:0005737]; glutamatergic synapse [GO:0098978]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]; postsynapse [GO:0098794]; spindle pole [GO:0000922] ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; nuclear estrogen receptor binding [GO:0030331]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g5833.t1 Q9NQR8 33.146 178 1.41e-25 100.0 sp|Q9NQR8|NDUF4_RAT NADH dehydrogenase [ubiquinone] 1 alpha subcomplex assembly factor 4 OS=Rattus norvegicus OX=10116 GN=Ndufaf4 PE=1 SV=1 g5834.t1 Q99LJ8 45.673 208 1.5400000000000001e-59 193.0 sp|Q99LJ8|NGBR_MOUSE Dehydrodolichyl diphosphate synthase complex subunit Nus1 OS=Mus musculus OX=10090 GN=Nus1 PE=2 SV=1 g5835.t1 Q9JLY7 49.412 170 3.59e-50 163.0 sp|Q9JLY7|DUS14_MOUSE Dual specificity protein phosphatase 14 OS=Mus musculus OX=10090 GN=Dusp14 PE=2 SV=2 g5836.t1 P97355 48.603 358 1.49e-107 323.0 sp|P97355|SPSY_MOUSE Spermine synthase OS=Mus musculus OX=10090 GN=Sms PE=1 SV=1 g5838.t1 Q29S00 61.619 383 9.57e-165 469.0 sp|Q29S00|OSCP1_BOVIN Protein OSCP1 OS=Bos taurus OX=9913 GN=OSCP1 PE=2 SV=1 g5840.t1 Q9QXA6 42.391 460 2.69e-125 377.0 sp|Q9QXA6|BAT1_MOUSE b(0,+)-type amino acid transporter 1 OS=Mus musculus OX=10090 GN=Slc7a9 PE=1 SV=1 BAT1_MOUSE reviewed b(0,+)-type amino acid transporter 1 (b(0,+)AT1) (Glycoprotein-associated amino acid transporter b0,+AT1) (Solute carrier family 7 member 9) Mus musculus (Mouse) GO:0003333; GO:0005886; GO:0006865; GO:0015171; GO:0015175; GO:0015184; GO:0015297; GO:0015804; GO:0015811; GO:0016324; GO:0031526; GO:0042605; GO:0046982; GO:0180009 amino acid transmembrane transport [GO:0003333]; amino acid transport [GO:0006865]; L-cystine transport [GO:0015811]; neutral amino acid transport [GO:0015804] apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; plasma membrane [GO:0005886] amino acid transmembrane transporter activity [GO:0015171]; antiporter activity [GO:0015297]; broad specificity neutral L-amino acid:basic L-amino acid antiporter activity [GO:0180009]; L-cystine transmembrane transporter activity [GO:0015184]; neutral L-amino acid transmembrane transporter activity [GO:0015175]; peptide antigen binding [GO:0042605]; protein heterodimerization activity [GO:0046982] g5845.t1 Q9QXA6 42.857 441 1.41e-108 347.0 sp|Q9QXA6|BAT1_MOUSE b(0,+)-type amino acid transporter 1 OS=Mus musculus OX=10090 GN=Slc7a9 PE=1 SV=1 BAT1_MOUSE reviewed b(0,+)-type amino acid transporter 1 (b(0,+)AT1) (Glycoprotein-associated amino acid transporter b0,+AT1) (Solute carrier family 7 member 9) Mus musculus (Mouse) GO:0003333; GO:0005886; GO:0006865; GO:0015171; GO:0015175; GO:0015184; GO:0015297; GO:0015804; GO:0015811; GO:0016324; GO:0031526; GO:0042605; GO:0046982; GO:0180009 amino acid transmembrane transport [GO:0003333]; amino acid transport [GO:0006865]; L-cystine transport [GO:0015811]; neutral amino acid transport [GO:0015804] apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; plasma membrane [GO:0005886] amino acid transmembrane transporter activity [GO:0015171]; antiporter activity [GO:0015297]; broad specificity neutral L-amino acid:basic L-amino acid antiporter activity [GO:0180009]; L-cystine transmembrane transporter activity [GO:0015184]; neutral L-amino acid transmembrane transporter activity [GO:0015175]; peptide antigen binding [GO:0042605]; protein heterodimerization activity [GO:0046982] g5850.t1 Q3T106 58.333 120 1.64e-36 129.0 sp|Q3T106|SRSF7_BOVIN Serine/arginine-rich splicing factor 7 OS=Bos taurus OX=9913 GN=SRSF7 PE=2 SV=1 SRSF7_BOVIN reviewed Serine/arginine-rich splicing factor 7 (Splicing factor, arginine/serine-rich 7) Bos taurus (Bovine) GO:0000381; GO:0003729; GO:0005737; GO:0006397; GO:0008270; GO:0008380; GO:0016607; GO:0048025; GO:0051028 mRNA processing [GO:0006397]; mRNA transport [GO:0051028]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA splicing [GO:0008380] cytoplasm [GO:0005737]; nuclear speck [GO:0016607] mRNA binding [GO:0003729]; zinc ion binding [GO:0008270] g5851.t1 Q8BH60 61.29 372 1.2799999999999999e-128 384.0 sp|Q8BH60|GOPC_MOUSE Golgi-associated PDZ and coiled-coil motif-containing protein OS=Mus musculus OX=10090 GN=Gopc PE=1 SV=1 GOPC_MOUSE reviewed Golgi-associated PDZ and coiled-coil motif-containing protein (CFTR-associated ligand) (PDZ protein interacting specifically with TC10) (PIST) Mus musculus (Mouse) GO:0000139; GO:0005109; GO:0005737; GO:0005794; GO:0005886; GO:0006914; GO:0007289; GO:0010467; GO:0014069; GO:0015031; GO:0016020; GO:0019905; GO:0030140; GO:0030165; GO:0030425; GO:0030695; GO:0032991; GO:0042802; GO:0042803; GO:0044325; GO:0045202; GO:0140313; GO:2000009 autophagy [GO:0006914]; gene expression [GO:0010467]; negative regulation of protein localization to cell surface [GO:2000009]; protein transport [GO:0015031]; spermatid nucleus differentiation [GO:0007289] cytoplasm [GO:0005737]; dendrite [GO:0030425]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; protein-containing complex [GO:0032991]; synapse [GO:0045202]; trans-Golgi network transport vesicle [GO:0030140] frizzled binding [GO:0005109]; GTPase regulator activity [GO:0030695]; identical protein binding [GO:0042802]; molecular sequestering activity [GO:0140313]; PDZ domain binding [GO:0030165]; protein homodimerization activity [GO:0042803]; syntaxin binding [GO:0019905]; transmembrane transporter binding [GO:0044325] g5853.t1 P41594 52.96 642 0.0 725.0 sp|P41594|GRM5_HUMAN Metabotropic glutamate receptor 5 OS=Homo sapiens OX=9606 GN=GRM5 PE=1 SV=2 GRM5_HUMAN reviewed Metabotropic glutamate receptor 5 (mGluR5) Homo sapiens (Human) GO:0001640; GO:0001659; GO:0001975; GO:0002029; GO:0004930; GO:0005637; GO:0005737; GO:0005886; GO:0006355; GO:0007204; GO:0007206; GO:0007216; GO:0007268; GO:0007611; GO:0007626; GO:0008066; GO:0030296; GO:0030425; GO:0031687; GO:0033603; GO:0035106; GO:0036228; GO:0042802; GO:0043025; GO:0043197; GO:0043198; GO:0043278; GO:0043410; GO:0045471; GO:0046677; GO:0048170; GO:0050808; GO:0050850; GO:0050890; GO:0051412; GO:0051966; GO:0061002; GO:0062036; GO:0090394; GO:0097449; GO:0098685; GO:0098839; GO:0098978; GO:0099530; GO:0099583; GO:1900039; GO:1900452; GO:1904058; GO:1904646; GO:1990708; GO:1990782; GO:2000179 cellular response to amyloid-beta [GO:1904646]; chemical synaptic transmission [GO:0007268]; cognition [GO:0050890]; conditioned place preference [GO:1990708]; desensitization of G protein-coupled receptor signaling pathway [GO:0002029]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; learning or memory [GO:0007611]; locomotory behavior [GO:0007626]; negative regulation of dendritic spine morphogenesis [GO:0061002]; negative regulation of excitatory postsynaptic potential [GO:0090394]; operant conditioning [GO:0035106]; phospholipase C-activating G protein-coupled glutamate receptor signaling pathway [GO:0007206]; positive regulation of calcium-mediated signaling [GO:0050850]; positive regulation of cellular response to hypoxia [GO:1900039]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of dopamine secretion [GO:0033603]; positive regulation of long-term neuronal synaptic plasticity [GO:0048170]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of sensory perception of pain [GO:1904058]; protein localization to nuclear inner membrane [GO:0036228]; regulation of DNA-templated transcription [GO:0006355]; regulation of long-term synaptic depression [GO:1900452]; regulation of synaptic transmission, glutamatergic [GO:0051966]; response to amphetamine [GO:0001975]; response to antibiotic [GO:0046677]; response to corticosterone [GO:0051412]; response to ethanol [GO:0045471]; response to morphine [GO:0043278]; sensory perception of hot stimulus [GO:0062036]; synapse organization [GO:0050808]; temperature homeostasis [GO:0001659] astrocyte projection [GO:0097449]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; neuronal cell body [GO:0043025]; nuclear inner membrane [GO:0005637]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; Schaffer collateral - CA1 synapse [GO:0098685] A2A adenosine receptor binding [GO:0031687]; adenylate cyclase inhibiting G protein-coupled glutamate receptor activity [GO:0001640]; G protein-coupled receptor activity [GO:0004930]; G protein-coupled receptor activity involved in regulation of postsynaptic membrane potential [GO:0099530]; glutamate receptor activity [GO:0008066]; identical protein binding [GO:0042802]; neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration [GO:0099583]; protein tyrosine kinase activator activity [GO:0030296]; protein tyrosine kinase binding [GO:1990782] g5854.t1 Q13255 59.184 245 3.63e-83 276.0 sp|Q13255|GRM1_HUMAN Metabotropic glutamate receptor 1 OS=Homo sapiens OX=9606 GN=GRM1 PE=1 SV=3 GRM1_HUMAN reviewed Metabotropic glutamate receptor 1 (mGluR1) Homo sapiens (Human) GO:0001640; GO:0004930; GO:0005634; GO:0005886; GO:0007186; GO:0007200; GO:0007206; GO:0007216; GO:0007268; GO:0007626; GO:0008066; GO:0019233; GO:0038037; GO:0038038; GO:0043410; GO:0044293; GO:0051930; GO:0051966; GO:0071257; GO:0098685; GO:0098712; GO:0098839; GO:0098872; GO:0098978; GO:0099530; GO:0099538; GO:0099583 cellular response to electrical stimulus [GO:0071257]; chemical synaptic transmission [GO:0007268]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; G protein-coupled receptor signaling pathway [GO:0007186]; L-glutamate import across plasma membrane [GO:0098712]; locomotory behavior [GO:0007626]; phospholipase C-activating G protein-coupled glutamate receptor signaling pathway [GO:0007206]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of MAPK cascade [GO:0043410]; regulation of sensory perception of pain [GO:0051930]; regulation of synaptic transmission, glutamatergic [GO:0051966]; sensory perception of pain [GO:0019233]; synaptic signaling via neuropeptide [GO:0099538] dendriole [GO:0044293]; G protein-coupled receptor dimeric complex [GO:0038037]; G protein-coupled receptor homodimeric complex [GO:0038038]; glutamatergic synapse [GO:0098978]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; Schaffer collateral - CA1 synapse [GO:0098685] adenylate cyclase inhibiting G protein-coupled glutamate receptor activity [GO:0001640]; G protein-coupled neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration [GO:0098872]; G protein-coupled receptor activity [GO:0004930]; G protein-coupled receptor activity involved in regulation of postsynaptic membrane potential [GO:0099530]; glutamate receptor activity [GO:0008066]; neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration [GO:0099583] g5855.t1 Q01460 39.718 355 6.03e-82 259.0 sp|Q01460|DIAC_RAT Di-N-acetylchitobiase OS=Rattus norvegicus OX=10116 GN=Ctbs PE=1 SV=1 DIAC_RAT reviewed Di-N-acetylchitobiase (EC 3.2.1.-) Rattus norvegicus (Rat) GO:0004568; GO:0005764; GO:0006032; GO:0008061; GO:0009313; GO:0016798 chitin catabolic process [GO:0006032]; oligosaccharide catabolic process [GO:0009313] lysosome [GO:0005764] chitin binding [GO:0008061]; chitinase activity [GO:0004568]; hydrolase activity, acting on glycosyl bonds [GO:0016798] g5856.t1 Q8CEG5 43.636 110 5.08e-22 94.0 sp|Q8CEG5|CC28B_MOUSE Coiled-coil domain-containing protein 28B OS=Mus musculus OX=10090 GN=Ccdc28b PE=1 SV=3 g5859.t1 Q96A49 50.394 254 1.71e-56 190.0 sp|Q96A49|SYAP1_HUMAN Synapse-associated protein 1 OS=Homo sapiens OX=9606 GN=SYAP1 PE=1 SV=1 SYAP1_HUMAN reviewed Synapse-associated protein 1 (BSD domain-containing signal transducer and Akt interactor protein) (BSTA) Homo sapiens (Human) GO:0005634; GO:0005654; GO:0005737; GO:0005794; GO:0005829; GO:0009898; GO:0030154; GO:0030424; GO:0030425; GO:0030426; GO:0032869; GO:0036120; GO:0038203; GO:0042734; GO:0043204; GO:0045202; GO:0045211; GO:0045600; GO:0048172; GO:0048471; GO:0070062; GO:0071364; GO:0071902; GO:1990314 cell differentiation [GO:0030154]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to insulin stimulus [GO:0032869]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; TORC2 signaling [GO:0038203] axon [GO:0030424]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; dendrite [GO:0030425]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; growth cone [GO:0030426]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; synapse [GO:0045202] g5860.t1 Q90YS0 79.923 259 3.7700000000000005e-160 447.0 sp|Q90YS0|RS4_ICTPU Small ribosomal subunit protein eS4 OS=Ictalurus punctatus OX=7998 GN=rps4 PE=2 SV=3 g5861.t1 Q6NYU7 66.359 217 5.47e-101 295.0 sp|Q6NYU7|UPP_DANRE Uracil phosphoribosyltransferase homolog OS=Danio rerio OX=7955 GN=uprt PE=2 SV=1 g5862.t1 E7F6F7 65.203 615 0.0 773.0 sp|E7F6F7|ABCB7_DANRE Iron-sulfur clusters transporter ABCB7, mitochondrial OS=Danio rerio OX=7955 GN=abcb7 PE=3 SV=1 ABCB7_DANRE reviewed Iron-sulfur clusters transporter ABCB7, mitochondrial (ATP-binding cassette sub-family B member 7, mitochondrial) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005524; GO:0005743; GO:0006879; GO:0010312; GO:0016226; GO:0016887; GO:0042626; GO:0055085; GO:0070455; GO:0140466; GO:0140481; GO:1903427; GO:1990748 cellular detoxification [GO:1990748]; detoxification of zinc ion [GO:0010312]; intracellular iron ion homeostasis [GO:0006879]; iron-sulfur cluster assembly [GO:0016226]; iron-sulfur cluster export from the mitochondrion [GO:0140466]; negative regulation of reactive oxygen species biosynthetic process [GO:1903427]; positive regulation of heme biosynthetic process [GO:0070455]; transmembrane transport [GO:0055085] mitochondrial inner membrane [GO:0005743] ABC-type iron-sulfur cluster transporter activity [GO:0140481]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626] g5863.t1 Q92562 60.976 164 2.64e-63 212.0 sp|Q92562|FIG4_HUMAN Polyphosphoinositide phosphatase OS=Homo sapiens OX=9606 GN=FIG4 PE=1 SV=1 FIG4_HUMAN reviewed Polyphosphoinositide phosphatase (EC 3.1.3.-) (EC 3.1.3.36) (EC 3.1.3.86) (Phosphatidylinositol 3,5-bisphosphate 5-phosphatase) (SAC domain-containing protein 3) (Serine-protein phosphatase FIG4) (EC 3.1.3.16) Homo sapiens (Human) GO:0000139; GO:0004438; GO:0004439; GO:0004722; GO:0005811; GO:0006661; GO:0007033; GO:0007626; GO:0010008; GO:0010976; GO:0031642; GO:0031901; GO:0031902; GO:0032288; GO:0034485; GO:0043473; GO:0043812; GO:0043813; GO:0046856; GO:0048666; GO:0055037 locomotory behavior [GO:0007626]; myelin assembly [GO:0032288]; negative regulation of myelination [GO:0031642]; neuron development [GO:0048666]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol dephosphorylation [GO:0046856]; pigmentation [GO:0043473]; positive regulation of neuron projection development [GO:0010976]; vacuole organization [GO:0007033] early endosome membrane [GO:0031901]; endosome membrane [GO:0010008]; Golgi membrane [GO:0000139]; late endosome membrane [GO:0031902]; lipid droplet [GO:0005811]; recycling endosome [GO:0055037] phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity [GO:0034485]; phosphatidylinositol-3,5-bisphosphate 5-phosphatase activity [GO:0043813]; phosphatidylinositol-3-phosphate phosphatase activity [GO:0004438]; phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity [GO:0004439]; phosphatidylinositol-4-phosphate phosphatase activity [GO:0043812]; protein serine/threonine phosphatase activity [GO:0004722] g5864.t1 Q92562 43.978 714 0.0 563.0 sp|Q92562|FIG4_HUMAN Polyphosphoinositide phosphatase OS=Homo sapiens OX=9606 GN=FIG4 PE=1 SV=1 FIG4_HUMAN reviewed Polyphosphoinositide phosphatase (EC 3.1.3.-) (EC 3.1.3.36) (EC 3.1.3.86) (Phosphatidylinositol 3,5-bisphosphate 5-phosphatase) (SAC domain-containing protein 3) (Serine-protein phosphatase FIG4) (EC 3.1.3.16) Homo sapiens (Human) GO:0000139; GO:0004438; GO:0004439; GO:0004722; GO:0005811; GO:0006661; GO:0007033; GO:0007626; GO:0010008; GO:0010976; GO:0031642; GO:0031901; GO:0031902; GO:0032288; GO:0034485; GO:0043473; GO:0043812; GO:0043813; GO:0046856; GO:0048666; GO:0055037 locomotory behavior [GO:0007626]; myelin assembly [GO:0032288]; negative regulation of myelination [GO:0031642]; neuron development [GO:0048666]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol dephosphorylation [GO:0046856]; pigmentation [GO:0043473]; positive regulation of neuron projection development [GO:0010976]; vacuole organization [GO:0007033] early endosome membrane [GO:0031901]; endosome membrane [GO:0010008]; Golgi membrane [GO:0000139]; late endosome membrane [GO:0031902]; lipid droplet [GO:0005811]; recycling endosome [GO:0055037] phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity [GO:0034485]; phosphatidylinositol-3,5-bisphosphate 5-phosphatase activity [GO:0043813]; phosphatidylinositol-3-phosphate phosphatase activity [GO:0004438]; phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity [GO:0004439]; phosphatidylinositol-4-phosphate phosphatase activity [GO:0043812]; protein serine/threonine phosphatase activity [GO:0004722] g5864.t2 Q92562 42.368 701 2.7500000000000003e-177 530.0 sp|Q92562|FIG4_HUMAN Polyphosphoinositide phosphatase OS=Homo sapiens OX=9606 GN=FIG4 PE=1 SV=1 FIG4_HUMAN reviewed Polyphosphoinositide phosphatase (EC 3.1.3.-) (EC 3.1.3.36) (EC 3.1.3.86) (Phosphatidylinositol 3,5-bisphosphate 5-phosphatase) (SAC domain-containing protein 3) (Serine-protein phosphatase FIG4) (EC 3.1.3.16) Homo sapiens (Human) GO:0000139; GO:0004438; GO:0004439; GO:0004722; GO:0005811; GO:0006661; GO:0007033; GO:0007626; GO:0010008; GO:0010976; GO:0031642; GO:0031901; GO:0031902; GO:0032288; GO:0034485; GO:0043473; GO:0043812; GO:0043813; GO:0046856; GO:0048666; GO:0055037 locomotory behavior [GO:0007626]; myelin assembly [GO:0032288]; negative regulation of myelination [GO:0031642]; neuron development [GO:0048666]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol dephosphorylation [GO:0046856]; pigmentation [GO:0043473]; positive regulation of neuron projection development [GO:0010976]; vacuole organization [GO:0007033] early endosome membrane [GO:0031901]; endosome membrane [GO:0010008]; Golgi membrane [GO:0000139]; late endosome membrane [GO:0031902]; lipid droplet [GO:0005811]; recycling endosome [GO:0055037] phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity [GO:0034485]; phosphatidylinositol-3,5-bisphosphate 5-phosphatase activity [GO:0043813]; phosphatidylinositol-3-phosphate phosphatase activity [GO:0004438]; phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity [GO:0004439]; phosphatidylinositol-4-phosphate phosphatase activity [GO:0043812]; protein serine/threonine phosphatase activity [GO:0004722] g5869.t1 P79945 55.229 306 9.96e-102 305.0 sp|P79945|PSP24_XENLA High-affinity lysophosphatidic acid receptor OS=Xenopus laevis OX=8355 PE=2 SV=1 g5871.t1 Q6EE31 70.857 525 0.0 799.0 sp|Q6EE31|TCPQ_CHICK T-complex protein 1 subunit theta OS=Gallus gallus OX=9031 GN=CCT8 PE=1 SV=3 TCPQ_CHICK reviewed T-complex protein 1 subunit theta (TCP-1-theta) (EC 3.6.1.-) (CCT-theta) Gallus gallus (Chicken) GO:0005524; GO:0005813; GO:0005832; GO:0006457; GO:0016887; GO:0046872; GO:0051082; GO:0140662 protein folding [GO:0006457] centrosome [GO:0005813]; chaperonin-containing T-complex [GO:0005832] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent protein folding chaperone [GO:0140662]; metal ion binding [GO:0046872]; unfolded protein binding [GO:0051082] g5872.t1 Q5R8H5 42.472 445 2.51e-98 304.0 sp|Q5R8H5|T2EA_PONAB General transcription factor IIE subunit 1 OS=Pongo abelii OX=9601 GN=GTF2E1 PE=2 SV=1 g5873.t1 Q32LJ6 51.389 216 5.08e-67 209.0 sp|Q32LJ6|RABL3_BOVIN Rab-like protein 3 OS=Bos taurus OX=9913 GN=RABL3 PE=2 SV=2 RABL3_BOVIN reviewed Rab-like protein 3 (EC 3.6.5.2) Bos taurus (Bovine) GO:0001779; GO:0003924; GO:0005525; GO:0006886; GO:0012505; GO:0030183; GO:0033077; GO:0042803; GO:0045724; GO:0046578; GO:0050821; GO:1903059 B cell differentiation [GO:0030183]; intracellular protein transport [GO:0006886]; natural killer cell differentiation [GO:0001779]; positive regulation of cilium assembly [GO:0045724]; protein stabilization [GO:0050821]; regulation of protein lipidation [GO:1903059]; regulation of Ras protein signal transduction [GO:0046578]; T cell differentiation in thymus [GO:0033077] endomembrane system [GO:0012505] GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein homodimerization activity [GO:0042803] g5873.t2 Q32LJ6 48.498 233 1.59e-62 199.0 sp|Q32LJ6|RABL3_BOVIN Rab-like protein 3 OS=Bos taurus OX=9913 GN=RABL3 PE=2 SV=2 RABL3_BOVIN reviewed Rab-like protein 3 (EC 3.6.5.2) Bos taurus (Bovine) GO:0001779; GO:0003924; GO:0005525; GO:0006886; GO:0012505; GO:0030183; GO:0033077; GO:0042803; GO:0045724; GO:0046578; GO:0050821; GO:1903059 B cell differentiation [GO:0030183]; intracellular protein transport [GO:0006886]; natural killer cell differentiation [GO:0001779]; positive regulation of cilium assembly [GO:0045724]; protein stabilization [GO:0050821]; regulation of protein lipidation [GO:1903059]; regulation of Ras protein signal transduction [GO:0046578]; T cell differentiation in thymus [GO:0033077] endomembrane system [GO:0012505] GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein homodimerization activity [GO:0042803] g5875.t1 Q9QZH0 64.188 511 0.0 655.0 sp|Q9QZH0|FZD4_RAT Frizzled-4 OS=Rattus norvegicus OX=10116 GN=Fzd4 PE=2 SV=1 FZD4_RAT reviewed Frizzled-4 (Fz-4) (rFz4) (CD antigen CD344) Rattus norvegicus (Rat) GO:0001525; GO:0001540; GO:0001553; GO:0001568; GO:0001570; GO:0001666; GO:0004896; GO:0004930; GO:0005654; GO:0005886; GO:0005911; GO:0005929; GO:0007223; GO:0007605; GO:0008283; GO:0009986; GO:0010812; GO:0016055; GO:0017147; GO:0019955; GO:0030165; GO:0030177; GO:0030335; GO:0030425; GO:0030947; GO:0031625; GO:0031987; GO:0034446; GO:0035426; GO:0035567; GO:0038023; GO:0042701; GO:0042803; GO:0042813; GO:0044877; GO:0045202; GO:0045446; GO:0045893; GO:0045944; GO:0046982; GO:0050775; GO:0060070; GO:0060856; GO:0061298; GO:0061299; GO:0061301; GO:0061304; GO:0098978; GO:0110135; GO:0150012; GO:1990830 angiogenesis [GO:0001525]; blood vessel development [GO:0001568]; canonical Wnt signaling pathway [GO:0060070]; cell population proliferation [GO:0008283]; cellular response to leukemia inhibitory factor [GO:1990830]; cerebellum vasculature morphogenesis [GO:0061301]; endothelial cell differentiation [GO:0045446]; establishment of blood-brain barrier [GO:0060856]; extracellular matrix-cell signaling [GO:0035426]; locomotion involved in locomotory behavior [GO:0031987]; luteinization [GO:0001553]; negative regulation of cell-substrate adhesion [GO:0010812]; non-canonical Wnt signaling pathway [GO:0035567]; Norrin signaling pathway [GO:0110135]; positive regulation of cell migration [GO:0030335]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of neuron projection arborization [GO:0150012]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of Wnt signaling pathway [GO:0030177]; progesterone secretion [GO:0042701]; regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030947]; response to hypoxia [GO:0001666]; retina vasculature development in camera-type eye [GO:0061298]; retina vasculature morphogenesis in camera-type eye [GO:0061299]; retinal blood vessel morphogenesis [GO:0061304]; sensory perception of sound [GO:0007605]; substrate adhesion-dependent cell spreading [GO:0034446]; vasculogenesis [GO:0001570]; Wnt signaling pathway [GO:0016055]; Wnt signaling pathway, calcium modulating pathway [GO:0007223] cell surface [GO:0009986]; cell-cell junction [GO:0005911]; cilium [GO:0005929]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; synapse [GO:0045202] amyloid-beta binding [GO:0001540]; cytokine binding [GO:0019955]; cytokine receptor activity [GO:0004896]; G protein-coupled receptor activity [GO:0004930]; PDZ domain binding [GO:0030165]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; signaling receptor activity [GO:0038023]; ubiquitin protein ligase binding [GO:0031625]; Wnt receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147] g5876.t1 Q6GQ39 39.456 147 4.2600000000000004e-29 114.0 sp|Q6GQ39|TM135_XENLA Transmembrane protein 135 OS=Xenopus laevis OX=8355 GN=tmem135 PE=2 SV=1 g5876.t2 Q95QD1 41.538 130 2.55e-25 102.0 sp|Q95QD1|TM135_CAEEL Transmembrane protein 135 homolog OS=Caenorhabditis elegans OX=6239 GN=tmem-135 PE=2 SV=2 g5876.t3 Q6GQ39 38.095 147 1.22e-26 107.0 sp|Q6GQ39|TM135_XENLA Transmembrane protein 135 OS=Xenopus laevis OX=8355 GN=tmem135 PE=2 SV=1 g5878.t1 Q3ZBE6 38.768 276 1.1500000000000001e-43 158.0 sp|Q3ZBE6|TM135_BOVIN Transmembrane protein 135 OS=Bos taurus OX=9913 GN=TMEM135 PE=2 SV=1 g5879.t1 Q499Y0 51.958 383 3.9399999999999996e-136 422.0 sp|Q499Y0|XPO4_XENLA Exportin-4 OS=Xenopus laevis OX=8355 GN=xpo4 PE=2 SV=1 g5881.t1 Q9C0E2 40.433 601 7.43e-121 387.0 sp|Q9C0E2|XPO4_HUMAN Exportin-4 OS=Homo sapiens OX=9606 GN=XPO4 PE=1 SV=2 XPO4_HUMAN reviewed Exportin-4 (Exp4) Homo sapiens (Human) GO:0005049; GO:0005634; GO:0005643; GO:0005654; GO:0005737; GO:0005829; GO:0006611; GO:0031267; GO:0046827 positive regulation of protein export from nucleus [GO:0046827]; protein export from nucleus [GO:0006611] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] nuclear export signal receptor activity [GO:0005049]; small GTPase binding [GO:0031267] g5882.t1 Q9ESJ0 46.875 128 1.07e-32 124.0 sp|Q9ESJ0|XPO4_MOUSE Exportin-4 OS=Mus musculus OX=10090 GN=Xpo4 PE=1 SV=2 g5884.t1 O00628 58.252 309 2.9099999999999998e-139 400.0 sp|O00628|PEX7_HUMAN Peroxisomal targeting signal 2 receptor OS=Homo sapiens OX=9606 GN=PEX7 PE=1 SV=1 PEX7_HUMAN reviewed Peroxisomal targeting signal 2 receptor (PTS2 receptor) (Peroxin-7) Homo sapiens (Human) GO:0001764; GO:0001958; GO:0005053; GO:0005777; GO:0005778; GO:0005782; GO:0005829; GO:0006625; GO:0006635; GO:0007031; GO:0008611; GO:0016558; GO:0019899; GO:0042803 endochondral ossification [GO:0001958]; ether lipid biosynthetic process [GO:0008611]; fatty acid beta-oxidation [GO:0006635]; neuron migration [GO:0001764]; peroxisome organization [GO:0007031]; protein import into peroxisome matrix [GO:0016558]; protein targeting to peroxisome [GO:0006625] cytosol [GO:0005829]; peroxisomal matrix [GO:0005782]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777] enzyme binding [GO:0019899]; peroxisome matrix targeting signal-2 binding [GO:0005053]; protein homodimerization activity [GO:0042803] g5885.t1 O08807 78.378 222 3.45e-127 364.0 sp|O08807|PRDX4_MOUSE Peroxiredoxin-4 OS=Mus musculus OX=10090 GN=Prdx4 PE=1 SV=1 PRDX4_MOUSE reviewed Peroxiredoxin-4 (EC 1.11.1.24) (Antioxidant enzyme AOE372) (Peroxiredoxin IV) (Prx-IV) (Thioredoxin peroxidase AO372) (Thioredoxin-dependent peroxide reductase A0372) (Thioredoxin-dependent peroxiredoxin 4) Mus musculus (Mouse) GO:0005615; GO:0005737; GO:0005739; GO:0005783; GO:0005790; GO:0005829; GO:0006979; GO:0007283; GO:0008379; GO:0008584; GO:0030198; GO:0042744; GO:0042802; GO:0045454; GO:0051604; GO:0060090; GO:0072593; GO:0140313; GO:2000255 cell redox homeostasis [GO:0045454]; extracellular matrix organization [GO:0030198]; hydrogen peroxide catabolic process [GO:0042744]; male gonad development [GO:0008584]; negative regulation of male germ cell proliferation [GO:2000255]; protein maturation [GO:0051604]; reactive oxygen species metabolic process [GO:0072593]; response to oxidative stress [GO:0006979]; spermatogenesis [GO:0007283] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; mitochondrion [GO:0005739]; smooth endoplasmic reticulum [GO:0005790] identical protein binding [GO:0042802]; molecular adaptor activity [GO:0060090]; molecular sequestering activity [GO:0140313]; thioredoxin peroxidase activity [GO:0008379] g5887.t1 B2GV36 29.859 566 7.630000000000001e-75 251.0 sp|B2GV36|S22AD_RAT Solute carrier family 22 member 13 OS=Rattus norvegicus OX=10116 GN=Slc22a13 PE=2 SV=1 S22AD_RAT reviewed Solute carrier family 22 member 13 (Organic anion transporter 10) (OAT10) (Organic cation transporter-like 3) (ORCTL-3) Rattus norvegicus (Rat) GO:0002854; GO:0005783; GO:0005794; GO:0005886; GO:0015143; GO:0015747; GO:0016324; GO:0045922; GO:0090416; GO:2001142 negative regulation of fatty acid metabolic process [GO:0045922]; nicotinate transport [GO:2001142]; positive regulation of T cell mediated cytotoxicity directed against tumor cell target [GO:0002854]; urate transport [GO:0015747] apical plasma membrane [GO:0016324]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; plasma membrane [GO:0005886] nicotinate transmembrane transporter activity [GO:0090416]; urate transmembrane transporter activity [GO:0015143] g5888.t1 Q5GF25 53.591 362 1.3199999999999999e-136 404.0 sp|Q5GF25|MANEA_RAT Glycoprotein endo-alpha-1,2-mannosidase OS=Rattus norvegicus OX=10116 GN=Manea PE=1 SV=1 g5889.t1 Q58DQ5 48.83 342 4.69e-114 341.0 sp|Q58DQ5|RT09_BOVIN Small ribosomal subunit protein uS9m OS=Bos taurus OX=9913 GN=MRPS9 PE=1 SV=3 RT09_BOVIN reviewed Small ribosomal subunit protein uS9m (28S ribosomal protein S9, mitochondrial) (MRP-S9) (S9mt) Bos taurus (Bovine) GO:0003723; GO:0003735; GO:0005743; GO:0005763; GO:0006412 translation [GO:0006412] mitochondrial inner membrane [GO:0005743]; mitochondrial small ribosomal subunit [GO:0005763] RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735] g5890.t1 P50747 40.598 569 4.1799999999999996e-139 434.0 sp|P50747|BPL1_HUMAN Biotin--protein ligase OS=Homo sapiens OX=9606 GN=HLCS PE=1 SV=1 BPL1_HUMAN reviewed Biotin--protein ligase (EC 6.3.4.-) (Biotin apo-protein ligase) [Includes: Biotin--[methylmalonyl-CoA-carboxytransferase] ligase (EC 6.3.4.9); Biotin--[propionyl-CoA-carboxylase [ATP-hydrolyzing]] ligase (EC 6.3.4.10) (Holocarboxylase synthetase) (HCS); Biotin--[methylcrotonoyl-CoA-carboxylase] ligase (EC 6.3.4.11); Biotin--[acetyl-CoA-carboxylase] ligase (EC 6.3.4.15)] Homo sapiens (Human) GO:0000785; GO:0004077; GO:0005524; GO:0005652; GO:0005737; GO:0005739; GO:0005829; GO:0006768; GO:0009374; GO:0016363; GO:0019899; GO:0042802; GO:0043687; GO:0070781 biotin metabolic process [GO:0006768]; post-translational protein modification [GO:0043687]; response to biotin [GO:0070781] chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nuclear lamina [GO:0005652]; nuclear matrix [GO:0016363] ATP binding [GO:0005524]; biotin binding [GO:0009374]; biotin--[biotin carboxyl-carrier protein] ligase activity [GO:0004077]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802] g5894.t1 A1YFY6 91.525 59 1.0100000000000001e-29 112.0 sp|A1YFY6|SIM1_PANPA Single-minded homolog 1 OS=Pan paniscus OX=9597 GN=SIM1 PE=3 SV=1 g5897.t1 Q98SJ5 70.487 349 2.49e-168 508.0 sp|Q98SJ5|SIM1A_DANRE Single-minded homolog 1-A OS=Danio rerio OX=7955 GN=sim1a PE=2 SV=1 g5901.t1 Q24799 46.032 189 2.26e-53 171.0 sp|Q24799|MYPH_ECHGR Myophilin OS=Echinococcus granulosus OX=6210 PE=2 SV=1 g5901.t2 Q24799 46.032 189 7.909999999999999e-54 173.0 sp|Q24799|MYPH_ECHGR Myophilin OS=Echinococcus granulosus OX=6210 PE=2 SV=1 g5903.t1 Q8NCR3 45.985 274 1.93e-75 244.0 sp|Q8NCR3|MFI_HUMAN Protein MFI OS=Homo sapiens OX=9606 GN=MFI PE=1 SV=1 g5908.t1 Q149N8 51.058 1040 0.0 1038.0 sp|Q149N8|SHPRH_HUMAN E3 ubiquitin-protein ligase SHPRH OS=Homo sapiens OX=9606 GN=SHPRH PE=1 SV=2 SHPRH_HUMAN reviewed E3 ubiquitin-protein ligase SHPRH (EC 2.3.2.27) (EC 3.6.4.-) (RING-type E3 ubiquitin transferase SHPRH) (SNF2, histone-linker, PHD and RING finger domain-containing helicase) Homo sapiens (Human) GO:0000209; GO:0000786; GO:0003677; GO:0004386; GO:0004842; GO:0005524; GO:0005654; GO:0006281; GO:0006334; GO:0006974; GO:0008270; GO:0016567; GO:0016787; GO:0031625; GO:0061630 DNA damage response [GO:0006974]; DNA repair [GO:0006281]; nucleosome assembly [GO:0006334]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567] nucleoplasm [GO:0005654]; nucleosome [GO:0000786] ATP binding [GO:0005524]; DNA binding [GO:0003677]; helicase activity [GO:0004386]; hydrolase activity [GO:0016787]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] g5910.t1 Q99973 25.979 562 1.4300000000000002e-35 151.0 sp|Q99973|TEP1_HUMAN Telomerase protein component 1 OS=Homo sapiens OX=9606 GN=TEP1 PE=1 SV=2 TEP1_HUMAN reviewed Telomerase protein component 1 (Telomerase-associated protein 1) (Telomerase protein 1) (p240) (p80 telomerase homolog) Homo sapiens (Human) GO:0000722; GO:0000781; GO:0002039; GO:0003720; GO:0003723; GO:0005524; GO:0005697; GO:0005737; GO:0016363; GO:0019899; GO:0070034; GO:1990904 telomere maintenance via recombination [GO:0000722] chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; nuclear matrix [GO:0016363]; ribonucleoprotein complex [GO:1990904]; telomerase holoenzyme complex [GO:0005697] ATP binding [GO:0005524]; enzyme binding [GO:0019899]; p53 binding [GO:0002039]; RNA binding [GO:0003723]; telomerase activity [GO:0003720]; telomerase RNA binding [GO:0070034] g5910.t2 Q99973 25.979 562 1.3500000000000001e-35 151.0 sp|Q99973|TEP1_HUMAN Telomerase protein component 1 OS=Homo sapiens OX=9606 GN=TEP1 PE=1 SV=2 TEP1_HUMAN reviewed Telomerase protein component 1 (Telomerase-associated protein 1) (Telomerase protein 1) (p240) (p80 telomerase homolog) Homo sapiens (Human) GO:0000722; GO:0000781; GO:0002039; GO:0003720; GO:0003723; GO:0005524; GO:0005697; GO:0005737; GO:0016363; GO:0019899; GO:0070034; GO:1990904 telomere maintenance via recombination [GO:0000722] chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; nuclear matrix [GO:0016363]; ribonucleoprotein complex [GO:1990904]; telomerase holoenzyme complex [GO:0005697] ATP binding [GO:0005524]; enzyme binding [GO:0019899]; p53 binding [GO:0002039]; RNA binding [GO:0003723]; telomerase activity [GO:0003720]; telomerase RNA binding [GO:0070034] g5911.t1 Q9BQ75 38.869 283 1.36e-40 144.0 sp|Q9BQ75|CMS1_HUMAN Protein CMSS1 OS=Homo sapiens OX=9606 GN=CMSS1 PE=1 SV=2 g5913.t1 O09173 71.824 433 0.0 671.0 sp|O09173|HGD_MOUSE Homogentisate 1,2-dioxygenase OS=Mus musculus OX=10090 GN=Hgd PE=1 SV=2 HGD_MOUSE reviewed Homogentisate 1,2-dioxygenase (EC 1.13.11.5) (Homogentisate oxygenase) (Homogentisic acid oxidase) (Homogentisicase) Mus musculus (Mouse) GO:0004411; GO:0006520; GO:0006559; GO:0006572; GO:0042802; GO:0046872 amino acid metabolic process [GO:0006520]; L-phenylalanine catabolic process [GO:0006559]; L-tyrosine catabolic process [GO:0006572] homogentisate 1,2-dioxygenase activity [GO:0004411]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872] g5914.t1 A0A0D3QS98 48.819 381 9.27e-127 384.0 sp|A0A0D3QS98|NOT1P_XENLA Palmitoleoyl-protein carboxylesterase notum1' OS=Xenopus laevis OX=8355 GN=notum1' PE=2 SV=1 g5915.t1 Q9V3D2 64.724 326 1.17e-152 439.0 sp|Q9V3D2|HEM6_DROME Oxygen-dependent coproporphyrinogen-III oxidase OS=Drosophila melanogaster OX=7227 GN=Coprox PE=2 SV=1 g5915.t2 Q9V3D2 68.5 200 7.52e-95 284.0 sp|Q9V3D2|HEM6_DROME Oxygen-dependent coproporphyrinogen-III oxidase OS=Drosophila melanogaster OX=7227 GN=Coprox PE=2 SV=1 g5915.t3 Q9V3D2 58.197 122 8.549999999999999e-42 147.0 sp|Q9V3D2|HEM6_DROME Oxygen-dependent coproporphyrinogen-III oxidase OS=Drosophila melanogaster OX=7227 GN=Coprox PE=2 SV=1 g5919.t1 Q4V8S3 44.248 113 3.79e-25 97.4 sp|Q4V8S3|TM242_DANRE Transmembrane protein 242 OS=Danio rerio OX=7955 GN=tmem242 PE=2 SV=2 g5940.t1 Q58WW2 72.263 137 6.389999999999999e-61 219.0 sp|Q58WW2|DCAF6_HUMAN DDB1- and CUL4-associated factor 6 OS=Homo sapiens OX=9606 GN=DCAF6 PE=1 SV=1 DCAF6_HUMAN reviewed DDB1- and CUL4-associated factor 6 (Androgen receptor complex-associated protein) (ARCAP) (IQ motif and WD repeat-containing protein 1) (Nuclear receptor interaction protein) (NRIP) Homo sapiens (Human) GO:0003713; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0016567; GO:0045944; GO:0080008 positive regulation of transcription by RNA polymerase II [GO:0045944]; protein ubiquitination [GO:0016567] Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] transcription coactivator activity [GO:0003713] g5941.t1 Q58WW2 57.66 359 4.9e-143 432.0 sp|Q58WW2|DCAF6_HUMAN DDB1- and CUL4-associated factor 6 OS=Homo sapiens OX=9606 GN=DCAF6 PE=1 SV=1 DCAF6_HUMAN reviewed DDB1- and CUL4-associated factor 6 (Androgen receptor complex-associated protein) (ARCAP) (IQ motif and WD repeat-containing protein 1) (Nuclear receptor interaction protein) (NRIP) Homo sapiens (Human) GO:0003713; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0016567; GO:0045944; GO:0080008 positive regulation of transcription by RNA polymerase II [GO:0045944]; protein ubiquitination [GO:0016567] Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] transcription coactivator activity [GO:0003713] g5943.t1 O95563 57.944 107 4.5799999999999996e-38 132.0 sp|O95563|MPC2_HUMAN Mitochondrial pyruvate carrier 2 OS=Homo sapiens OX=9606 GN=MPC2 PE=1 SV=1 MPC2_HUMAN reviewed Mitochondrial pyruvate carrier 2 (Brain protein 44) Homo sapiens (Human) GO:0005634; GO:0005739; GO:0005743; GO:0006086; GO:0006850; GO:0035774; GO:0042802; GO:0050833; GO:0098800; GO:7770001 positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; pyruvate decarboxylation to acetyl-CoA [GO:0006086]; pyruvate import into mitochondria [GO:0006850] inner mitochondrial membrane protein complex [GO:0098800]; mitochondrial inner membrane [GO:0005743]; mitochondrial pyruvate carrier complex [GO:7770001]; mitochondrion [GO:0005739]; nucleus [GO:0005634] identical protein binding [GO:0042802]; pyruvate transmembrane transporter activity [GO:0050833] g5944.t1 P11725 62.08 327 6.01e-154 440.0 sp|P11725|OTC_MOUSE Ornithine transcarbamylase, mitochondrial OS=Mus musculus OX=10090 GN=Otc PE=1 SV=1 g5945.t1 Q9N1T2 48.087 366 3.49e-98 332.0 sp|Q9N1T2|RPGR_CANLF X-linked retinitis pigmentosa GTPase regulator OS=Canis lupus familiaris OX=9615 GN=RPGR PE=2 SV=1 g5945.t2 Q9N1T2 48.087 366 1.86e-99 333.0 sp|Q9N1T2|RPGR_CANLF X-linked retinitis pigmentosa GTPase regulator OS=Canis lupus familiaris OX=9615 GN=RPGR PE=2 SV=1 g5945.t3 Q9N1T2 48.087 366 2.3299999999999998e-98 333.0 sp|Q9N1T2|RPGR_CANLF X-linked retinitis pigmentosa GTPase regulator OS=Canis lupus familiaris OX=9615 GN=RPGR PE=2 SV=1 g5947.t1 Q8BQQ1 63.14 293 3.8099999999999996e-134 394.0 sp|Q8BQQ1|ZDH14_MOUSE Palmitoyltransferase ZDHHC14 OS=Mus musculus OX=10090 GN=Zdhhc14 PE=1 SV=1 g5947.t2 Q8BQQ1 60.328 305 1.8700000000000002e-129 382.0 sp|Q8BQQ1|ZDH14_MOUSE Palmitoyltransferase ZDHHC14 OS=Mus musculus OX=10090 GN=Zdhhc14 PE=1 SV=1 g5948.t1 P15145 38.194 919 0.0 610.0 sp|P15145|AMPN_PIG Aminopeptidase N OS=Sus scrofa OX=9823 GN=ANPEP PE=1 SV=4 g5949.t1 P15684 42.484 805 0.0 634.0 sp|P15684|AMPN_RAT Aminopeptidase N OS=Rattus norvegicus OX=10116 GN=Anpep PE=1 SV=2 AMPN_RAT reviewed Aminopeptidase N (AP-N) (rAPN) (EC 3.4.11.2) (Alanyl aminopeptidase) (Aminopeptidase M) (AP-M) (Kidney Zn peptidase) (KZP) (Microsomal aminopeptidase) (CD antigen CD13) Rattus norvegicus (Rat) GO:0001525; GO:0002003; GO:0004177; GO:0005615; GO:0005793; GO:0005886; GO:0008237; GO:0008270; GO:0009897; GO:0016285; GO:0016485; GO:0030154; GO:0031526; GO:0042277; GO:0043171; GO:0070006; GO:0070062; GO:0072237 angiogenesis [GO:0001525]; angiotensin maturation [GO:0002003]; cell differentiation [GO:0030154]; metanephric proximal tubule development [GO:0072237]; peptide catabolic process [GO:0043171]; protein processing [GO:0016485] brush border membrane [GO:0031526]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; plasma membrane [GO:0005886] alanyl aminopeptidase activity [GO:0016285]; aminopeptidase activity [GO:0004177]; metalloaminopeptidase activity [GO:0070006]; metallopeptidase activity [GO:0008237]; peptide binding [GO:0042277]; zinc ion binding [GO:0008270] g5949.t1 P15684 38.321 929 0.0 593.0 sp|P15684|AMPN_RAT Aminopeptidase N OS=Rattus norvegicus OX=10116 GN=Anpep PE=1 SV=2 AMPN_RAT reviewed Aminopeptidase N (AP-N) (rAPN) (EC 3.4.11.2) (Alanyl aminopeptidase) (Aminopeptidase M) (AP-M) (Kidney Zn peptidase) (KZP) (Microsomal aminopeptidase) (CD antigen CD13) Rattus norvegicus (Rat) GO:0001525; GO:0002003; GO:0004177; GO:0005615; GO:0005793; GO:0005886; GO:0008237; GO:0008270; GO:0009897; GO:0016285; GO:0016485; GO:0030154; GO:0031526; GO:0042277; GO:0043171; GO:0070006; GO:0070062; GO:0072237 angiogenesis [GO:0001525]; angiotensin maturation [GO:0002003]; cell differentiation [GO:0030154]; metanephric proximal tubule development [GO:0072237]; peptide catabolic process [GO:0043171]; protein processing [GO:0016485] brush border membrane [GO:0031526]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; plasma membrane [GO:0005886] alanyl aminopeptidase activity [GO:0016285]; aminopeptidase activity [GO:0004177]; metalloaminopeptidase activity [GO:0070006]; metallopeptidase activity [GO:0008237]; peptide binding [GO:0042277]; zinc ion binding [GO:0008270] g5949.t1 P15684 36.374 921 6.41e-167 545.0 sp|P15684|AMPN_RAT Aminopeptidase N OS=Rattus norvegicus OX=10116 GN=Anpep PE=1 SV=2 AMPN_RAT reviewed Aminopeptidase N (AP-N) (rAPN) (EC 3.4.11.2) (Alanyl aminopeptidase) (Aminopeptidase M) (AP-M) (Kidney Zn peptidase) (KZP) (Microsomal aminopeptidase) (CD antigen CD13) Rattus norvegicus (Rat) GO:0001525; GO:0002003; GO:0004177; GO:0005615; GO:0005793; GO:0005886; GO:0008237; GO:0008270; GO:0009897; GO:0016285; GO:0016485; GO:0030154; GO:0031526; GO:0042277; GO:0043171; GO:0070006; GO:0070062; GO:0072237 angiogenesis [GO:0001525]; angiotensin maturation [GO:0002003]; cell differentiation [GO:0030154]; metanephric proximal tubule development [GO:0072237]; peptide catabolic process [GO:0043171]; protein processing [GO:0016485] brush border membrane [GO:0031526]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; plasma membrane [GO:0005886] alanyl aminopeptidase activity [GO:0016285]; aminopeptidase activity [GO:0004177]; metalloaminopeptidase activity [GO:0070006]; metallopeptidase activity [GO:0008237]; peptide binding [GO:0042277]; zinc ion binding [GO:0008270] g5951.t1 P97449 39.495 752 5.22e-170 541.0 sp|P97449|AMPN_MOUSE Aminopeptidase N OS=Mus musculus OX=10090 GN=Anpep PE=1 SV=4 AMPN_MOUSE reviewed Aminopeptidase N (AP-N) (mAPN) (EC 3.4.11.2) (Alanyl aminopeptidase) (Aminopeptidase M) (AP-M) (Membrane protein p161) (Microsomal aminopeptidase) (CD antigen CD13) Mus musculus (Mouse) GO:0001525; GO:0002003; GO:0004177; GO:0005615; GO:0005793; GO:0005886; GO:0008237; GO:0008270; GO:0009897; GO:0016285; GO:0016485; GO:0030154; GO:0031526; GO:0042277; GO:0043171; GO:0070006; GO:0070062 angiogenesis [GO:0001525]; angiotensin maturation [GO:0002003]; cell differentiation [GO:0030154]; peptide catabolic process [GO:0043171]; protein processing [GO:0016485] brush border membrane [GO:0031526]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; plasma membrane [GO:0005886] alanyl aminopeptidase activity [GO:0016285]; aminopeptidase activity [GO:0004177]; metalloaminopeptidase activity [GO:0070006]; metallopeptidase activity [GO:0008237]; peptide binding [GO:0042277]; zinc ion binding [GO:0008270] g5951.t1 P97449 31.264 918 2.05e-137 453.0 sp|P97449|AMPN_MOUSE Aminopeptidase N OS=Mus musculus OX=10090 GN=Anpep PE=1 SV=4 AMPN_MOUSE reviewed Aminopeptidase N (AP-N) (mAPN) (EC 3.4.11.2) (Alanyl aminopeptidase) (Aminopeptidase M) (AP-M) (Membrane protein p161) (Microsomal aminopeptidase) (CD antigen CD13) Mus musculus (Mouse) GO:0001525; GO:0002003; GO:0004177; GO:0005615; GO:0005793; GO:0005886; GO:0008237; GO:0008270; GO:0009897; GO:0016285; GO:0016485; GO:0030154; GO:0031526; GO:0042277; GO:0043171; GO:0070006; GO:0070062 angiogenesis [GO:0001525]; angiotensin maturation [GO:0002003]; cell differentiation [GO:0030154]; peptide catabolic process [GO:0043171]; protein processing [GO:0016485] brush border membrane [GO:0031526]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; plasma membrane [GO:0005886] alanyl aminopeptidase activity [GO:0016285]; aminopeptidase activity [GO:0004177]; metalloaminopeptidase activity [GO:0070006]; metallopeptidase activity [GO:0008237]; peptide binding [GO:0042277]; zinc ion binding [GO:0008270] g5955.t1 P15144 37.46 630 9.41e-121 384.0 sp|P15144|AMPN_HUMAN Aminopeptidase N OS=Homo sapiens OX=9606 GN=ANPEP PE=1 SV=4 AMPN_HUMAN reviewed Aminopeptidase N (AP-N) (hAPN) (EC 3.4.11.2) (Alanyl aminopeptidase) (Aminopeptidase M) (AP-M) (Microsomal aminopeptidase) (Myeloid plasma membrane glycoprotein CD13) (gp150) (CD antigen CD13) Homo sapiens (Human) GO:0001525; GO:0001618; GO:0002003; GO:0004177; GO:0005615; GO:0005765; GO:0005793; GO:0005886; GO:0008237; GO:0008270; GO:0009897; GO:0016285; GO:0030154; GO:0030667; GO:0038023; GO:0043171; GO:0070006; GO:0070062 angiogenesis [GO:0001525]; angiotensin maturation [GO:0002003]; cell differentiation [GO:0030154]; peptide catabolic process [GO:0043171] endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667] alanyl aminopeptidase activity [GO:0016285]; aminopeptidase activity [GO:0004177]; metalloaminopeptidase activity [GO:0070006]; metallopeptidase activity [GO:0008237]; signaling receptor activity [GO:0038023]; virus receptor activity [GO:0001618]; zinc ion binding [GO:0008270] g5957.t1 Q6DRM0 34.228 149 3.71e-30 111.0 sp|Q6DRM0|GET1_DANRE Guided entry of tail-anchored proteins factor 1 OS=Danio rerio OX=7955 GN=get1 PE=2 SV=1 GET1_DANRE reviewed Guided entry of tail-anchored proteins factor 1 (Tail-anchored protein insertion receptor WRB) (Tryptophan-rich basic protein) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001964; GO:0005783; GO:0005789; GO:0007507; GO:0007605; GO:0010996; GO:0043495; GO:0043529; GO:0060041; GO:0071816 heart development [GO:0007507]; response to auditory stimulus [GO:0010996]; retina development in camera-type eye [GO:0060041]; sensory perception of sound [GO:0007605]; startle response [GO:0001964]; tail-anchored membrane protein insertion into ER membrane [GO:0071816] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; GET complex [GO:0043529] protein-membrane adaptor activity [GO:0043495] g5958.t1 O35490 35.608 337 6.56e-50 175.0 sp|O35490|BHMT1_MOUSE Betaine--homocysteine S-methyltransferase 1 OS=Mus musculus OX=10090 GN=Bhmt PE=1 SV=1 BHMT1_MOUSE reviewed Betaine--homocysteine S-methyltransferase 1 (EC 2.1.1.5) Mus musculus (Mouse) GO:0005615; GO:0005634; GO:0005829; GO:0006577; GO:0006579; GO:0008168; GO:0008270; GO:0009086; GO:0032259; GO:0032991; GO:0042802; GO:0044877; GO:0047150; GO:0070062; GO:0071266; GO:0071267 'de novo' L-methionine biosynthetic process [GO:0071266]; amino-acid betaine catabolic process [GO:0006579]; amino-acid betaine metabolic process [GO:0006577]; L-methionine salvage [GO:0071267]; methionine biosynthetic process [GO:0009086]; methylation [GO:0032259] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; nucleus [GO:0005634]; protein-containing complex [GO:0032991] betaine-homocysteine S-methyltransferase activity [GO:0047150]; identical protein binding [GO:0042802]; methyltransferase activity [GO:0008168]; protein-containing complex binding [GO:0044877]; zinc ion binding [GO:0008270] g5959.t1 Q4R918 44.781 594 1.2e-132 406.0 sp|Q4R918|KIF25_MACFA Kinesin-like protein KIF25 OS=Macaca fascicularis OX=9541 GN=KIF25 PE=1 SV=1 KIF25_MACFA reviewed Kinesin-like protein KIF25 Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey) GO:0005524; GO:0005813; GO:0005874; GO:0007018; GO:0008017; GO:0008569; GO:0046603; GO:0051289; GO:0051294; GO:0051647 establishment of spindle orientation [GO:0051294]; microtubule-based movement [GO:0007018]; negative regulation of mitotic centrosome separation [GO:0046603]; nucleus localization [GO:0051647]; protein homotetramerization [GO:0051289] centrosome [GO:0005813]; microtubule [GO:0005874] ATP binding [GO:0005524]; microtubule binding [GO:0008017]; minus-end-directed microtubule motor activity [GO:0008569] g5959.t2 Q4R918 44.781 594 7.81e-133 406.0 sp|Q4R918|KIF25_MACFA Kinesin-like protein KIF25 OS=Macaca fascicularis OX=9541 GN=KIF25 PE=1 SV=1 KIF25_MACFA reviewed Kinesin-like protein KIF25 Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey) GO:0005524; GO:0005813; GO:0005874; GO:0007018; GO:0008017; GO:0008569; GO:0046603; GO:0051289; GO:0051294; GO:0051647 establishment of spindle orientation [GO:0051294]; microtubule-based movement [GO:0007018]; negative regulation of mitotic centrosome separation [GO:0046603]; nucleus localization [GO:0051647]; protein homotetramerization [GO:0051289] centrosome [GO:0005813]; microtubule [GO:0005874] ATP binding [GO:0005524]; microtubule binding [GO:0008017]; minus-end-directed microtubule motor activity [GO:0008569] g5961.t1 Q9UNX4 55.211 355 7.340000000000001e-121 374.0 sp|Q9UNX4|WDR3_HUMAN WD repeat-containing protein 3 OS=Homo sapiens OX=9606 GN=WDR3 PE=1 SV=1 WDR3_HUMAN reviewed WD repeat-containing protein 3 Homo sapiens (Human) GO:0003723; GO:0005654; GO:0005730; GO:0030490; GO:0030515; GO:0031965; GO:0032040; GO:0034388; GO:0042274 maturation of SSU-rRNA [GO:0030490]; ribosomal small subunit biogenesis [GO:0042274] nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; Pwp2p-containing subcomplex of 90S preribosome [GO:0034388]; small-subunit processome [GO:0032040] RNA binding [GO:0003723]; snoRNA binding [GO:0030515] g5962.t1 Q9UNX4 62.075 559 0.0 686.0 sp|Q9UNX4|WDR3_HUMAN WD repeat-containing protein 3 OS=Homo sapiens OX=9606 GN=WDR3 PE=1 SV=1 WDR3_HUMAN reviewed WD repeat-containing protein 3 Homo sapiens (Human) GO:0003723; GO:0005654; GO:0005730; GO:0030490; GO:0030515; GO:0031965; GO:0032040; GO:0034388; GO:0042274 maturation of SSU-rRNA [GO:0030490]; ribosomal small subunit biogenesis [GO:0042274] nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; Pwp2p-containing subcomplex of 90S preribosome [GO:0034388]; small-subunit processome [GO:0032040] RNA binding [GO:0003723]; snoRNA binding [GO:0030515] g5964.t1 Q5RAL3 33.403 479 1.12e-64 229.0 sp|Q5RAL3|GRM3_PONAB Metabotropic glutamate receptor 3 OS=Pongo abelii OX=9601 GN=GRM3 PE=2 SV=1 g5967.t1 Q5M8Z0 30.841 214 4.2500000000000004e-21 89.4 sp|Q5M8Z0|BHMT1_XENTR Betaine--homocysteine S-methyltransferase 1 OS=Xenopus tropicalis OX=8364 GN=bhmt PE=2 SV=1 g5967.t1 Q5M8Z0 42.857 35 4.2500000000000004e-21 33.5 sp|Q5M8Z0|BHMT1_XENTR Betaine--homocysteine S-methyltransferase 1 OS=Xenopus tropicalis OX=8364 GN=bhmt PE=2 SV=1 g5970.t1 Q803X1 79.412 306 0.0 532.0 sp|Q803X1|CTU1_DANRE Cytoplasmic tRNA 2-thiolation protein 1 OS=Danio rerio OX=7955 GN=ctu1 PE=2 SV=1 g5971.t1 Q7RTU3 75.581 86 4.48e-30 119.0 sp|Q7RTU3|OLIG3_HUMAN Oligodendrocyte transcription factor 3 OS=Homo sapiens OX=9606 GN=OLIG3 PE=1 SV=2 OLIG3_HUMAN reviewed Oligodendrocyte transcription factor 3 (Oligo3) (Class B basic helix-loop-helix protein 7) (bHLHb7) (Class E basic helix-loop-helix protein 20) (bHLHe20) Homo sapiens (Human) GO:0000122; GO:0000785; GO:0000981; GO:0005634; GO:0007423; GO:0021520; GO:0045944; GO:0046983; GO:0061564; GO:0070888; GO:0097476; GO:1990837 axon development [GO:0061564]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; sensory organ development [GO:0007423]; spinal cord motor neuron cell fate specification [GO:0021520]; spinal cord motor neuron migration [GO:0097476] chromatin [GO:0000785]; nucleus [GO:0005634] DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; E-box binding [GO:0070888]; protein dimerization activity [GO:0046983]; sequence-specific double-stranded DNA binding [GO:1990837] g5972.t1 Q5R673 41.333 450 1.81e-107 333.0 sp|Q5R673|RIOX2_PONAB Ribosomal oxygenase 2 OS=Pongo abelii OX=9601 GN=RIOX2 PE=2 SV=1 RIOX2_PONAB reviewed Ribosomal oxygenase 2 (Bifunctional lysine-specific demethylase and histidyl-hydroxylase MINA) (EC 1.14.11.79) (Histone lysine demethylase MINA) (MYC-induced nuclear antigen) Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0005654; GO:0005730; GO:0032453; GO:0036139; GO:0042254; GO:0042802; GO:0046872; GO:0051864 ribosome biogenesis [GO:0042254] nucleolus [GO:0005730]; nucleoplasm [GO:0005654] histone H3K36 demethylase activity [GO:0051864]; histone H3K4 demethylase activity [GO:0032453]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; peptidyl-histidine dioxygenase activity [GO:0036139] g5973.t1 Q95K40 36.815 383 4.18e-53 186.0 sp|Q95K40|CCD83_MACFA Coiled-coil domain-containing protein 83 OS=Macaca fascicularis OX=9541 GN=CCDC83 PE=2 SV=1 g5974.t1 Q8WUA2 76.02 196 1.9e-87 268.0 sp|Q8WUA2|PPIL4_HUMAN Peptidyl-prolyl cis-trans isomerase-like 4 OS=Homo sapiens OX=9606 GN=PPIL4 PE=1 SV=1 g5975.t1 Q8WUA2 71.329 143 6.74e-53 184.0 sp|Q8WUA2|PPIL4_HUMAN Peptidyl-prolyl cis-trans isomerase-like 4 OS=Homo sapiens OX=9606 GN=PPIL4 PE=1 SV=1 g5976.t1 Q9Y2C2 40.312 320 3.5799999999999997e-62 212.0 sp|Q9Y2C2|UST_HUMAN Uronyl 2-sulfotransferase OS=Homo sapiens OX=9606 GN=UST PE=1 SV=1 UST_HUMAN reviewed Uronyl 2-sulfotransferase (EC 2.8.2.-) (Chondroitin sulfate 2-O-sulfotransferase) (CS-2OST) Homo sapiens (Human) GO:0000139; GO:0008146; GO:0016020; GO:0030010; GO:0034482; GO:0050650; GO:0050651; GO:0050656; GO:0050770; GO:0102142 chondroitin sulfate proteoglycan biosynthetic process [GO:0050650]; dermatan sulfate proteoglycan biosynthetic process [GO:0050651]; establishment of cell polarity [GO:0030010]; regulation of axonogenesis [GO:0050770] Golgi membrane [GO:0000139]; membrane [GO:0016020] 3'-phosphoadenosine 5'-phosphosulfate binding [GO:0050656]; chondroitin 2-sulfotransferase activity [GO:0034482]; dermatan 2-sulfotransferase activity [GO:0102142]; sulfotransferase activity [GO:0008146] g5978.t1 Q9JKK0 44.809 183 9.06e-45 154.0 sp|Q9JKK0|RCAN3_MOUSE Calcipressin-3 OS=Mus musculus OX=10090 GN=Rcan3 PE=2 SV=1 g5980.t1 Q7SXL7 55.462 238 1.1e-77 259.0 sp|Q7SXL7|FL2D_DANRE Pre-mRNA-splicing regulator WTAP OS=Danio rerio OX=7955 GN=wtap PE=2 SV=1 g5981.t1 Q8VZI2 49.24 329 4.1400000000000004e-73 240.0 sp|Q8VZI2|Y4370_ARATH DUF21 domain-containing protein At4g33700 OS=Arabidopsis thaliana OX=3702 GN=CBSDUF6 PE=1 SV=1 g5982.t1 Q9R0I6 35.417 240 2.71e-40 153.0 sp|Q9R0I6|XIAP_RAT E3 ubiquitin-protein ligase XIAP OS=Rattus norvegicus OX=10116 GN=Xiap PE=2 SV=1 g5984.t1 Q80W54 63.455 301 1.11e-117 352.0 sp|Q80W54|FACE1_MOUSE CAAX prenyl protease 1 homolog OS=Mus musculus OX=10090 GN=Zmpste24 PE=1 SV=2 FACE1_MOUSE reviewed CAAX prenyl protease 1 homolog (EC 3.4.24.84) (Farnesylated proteins-converting enzyme 1) (FACE-1) (Prenyl protein-specific endoprotease 1) (Zinc metalloproteinase Ste24 homolog) Mus musculus (Mouse) GO:0001889; GO:0001942; GO:0003007; GO:0003229; GO:0003231; GO:0003417; GO:0003690; GO:0004175; GO:0004222; GO:0005635; GO:0005637; GO:0005789; GO:0006281; GO:0006325; GO:0006355; GO:0006629; GO:0006925; GO:0006974; GO:0006997; GO:0006998; GO:0007346; GO:0007628; GO:0008016; GO:0008340; GO:0008360; GO:0008544; GO:0010506; GO:0010628; GO:0010629; GO:0010906; GO:0016020; GO:0016485; GO:0019216; GO:0030282; GO:0030327; GO:0030500; GO:0031901; GO:0031902; GO:0032006; GO:0032350; GO:0032991; GO:0035264; GO:0040014; GO:0040029; GO:0043007; GO:0043516; GO:0044029; GO:0046872; GO:0048145; GO:0048538; GO:0050688; GO:0050905; GO:0051276; GO:0051604; GO:0055013; GO:0060307; GO:0060993; GO:0061337; GO:0061762; GO:0070302; GO:0071480; GO:0071586; GO:0072423; GO:1903463; GO:1903522; GO:1903799; GO:1990036; GO:2000730; GO:2000772 adult walking behavior [GO:0007628]; bone mineralization [GO:0030282]; CAAX-box protein processing [GO:0071586]; calcium ion import into sarcoplasmic reticulum [GO:1990036]; CAMKK-AMPK signaling cascade [GO:0061762]; cardiac conduction [GO:0061337]; cardiac muscle cell development [GO:0055013]; cardiac ventricle development [GO:0003231]; cellular response to gamma radiation [GO:0071480]; chromatin organization [GO:0006325]; chromosome organization [GO:0051276]; determination of adult lifespan [GO:0008340]; DNA damage response [GO:0006974]; DNA repair [GO:0006281]; epidermis development [GO:0008544]; epigenetic regulation of gene expression [GO:0040029]; growth plate cartilage development [GO:0003417]; hair follicle development [GO:0001942]; heart morphogenesis [GO:0003007]; inflammatory cell apoptotic process [GO:0006925]; kidney morphogenesis [GO:0060993]; lipid metabolic process [GO:0006629]; liver development [GO:0001889]; maintenance of rDNA [GO:0043007]; multicellular organism growth [GO:0035264]; negative regulation of gene expression [GO:0010629]; negative regulation of miRNA processing [GO:1903799]; neuromuscular process [GO:0050905]; nuclear envelope organization [GO:0006998]; nucleus organization [GO:0006997]; positive regulation of gene expression [GO:0010628]; positive regulation of gene expression via chromosomal CpG island demethylation [GO:0044029]; prenylated protein catabolic process [GO:0030327]; protein maturation [GO:0051604]; protein processing [GO:0016485]; regulation of autophagy [GO:0010506]; regulation of blood circulation [GO:1903522]; regulation of bone mineralization [GO:0030500]; regulation of cell shape [GO:0008360]; regulation of cellular senescence [GO:2000772]; regulation of defense response to virus [GO:0050688]; regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043516]; regulation of DNA-templated transcription [GO:0006355]; regulation of fibroblast proliferation [GO:0048145]; regulation of glucose metabolic process [GO:0010906]; regulation of heart contraction [GO:0008016]; regulation of hormone metabolic process [GO:0032350]; regulation of lipid metabolic process [GO:0019216]; regulation of mitotic cell cycle [GO:0007346]; regulation of mitotic cell cycle DNA replication [GO:1903463]; regulation of multicellular organism growth [GO:0040014]; regulation of stress-activated protein kinase signaling cascade [GO:0070302]; regulation of termination of RNA polymerase I transcription [GO:2000730]; regulation of TOR signaling [GO:0032006]; regulation of ventricular cardiac muscle cell membrane repolarization [GO:0060307]; response to DNA damage checkpoint signaling [GO:0072423]; thymus development [GO:0048538]; ventricular cardiac muscle tissue development [GO:0003229] early endosome membrane [GO:0031901]; endoplasmic reticulum membrane [GO:0005789]; late endosome membrane [GO:0031902]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear inner membrane [GO:0005637]; protein-containing complex [GO:0032991] double-stranded DNA binding [GO:0003690]; endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222] g5985.t1 O75844 56.79 81 8.07e-29 105.0 sp|O75844|FACE1_HUMAN CAAX prenyl protease 1 homolog OS=Homo sapiens OX=9606 GN=ZMPSTE24 PE=1 SV=2 FACE1_HUMAN reviewed CAAX prenyl protease 1 homolog (EC 3.4.24.84) (Farnesylated proteins-converting enzyme 1) (FACE-1) (Prenyl protein-specific endoprotease 1) (Zinc metalloproteinase Ste24 homolog) Homo sapiens (Human) GO:0001889; GO:0001942; GO:0003007; GO:0003229; GO:0003231; GO:0003417; GO:0003690; GO:0004175; GO:0004222; GO:0005637; GO:0005789; GO:0006281; GO:0006508; GO:0006629; GO:0006925; GO:0006998; GO:0007628; GO:0008235; GO:0008340; GO:0008360; GO:0010506; GO:0010906; GO:0016020; GO:0019216; GO:0030282; GO:0030327; GO:0030500; GO:0031901; GO:0031902; GO:0032006; GO:0032350; GO:0032991; GO:0035264; GO:0040014; GO:0043007; GO:0043516; GO:0044029; GO:0046872; GO:0048145; GO:0048538; GO:0050688; GO:0050905; GO:0051604; GO:0055013; GO:0060307; GO:0060993; GO:0061337; GO:0061762; GO:0070062; GO:0070302; GO:0071480; GO:0071586; GO:0072423; GO:1903463; GO:1903799; GO:1990036; GO:2000730; GO:2000772 adult walking behavior [GO:0007628]; bone mineralization [GO:0030282]; CAAX-box protein processing [GO:0071586]; calcium ion import into sarcoplasmic reticulum [GO:1990036]; CAMKK-AMPK signaling cascade [GO:0061762]; cardiac conduction [GO:0061337]; cardiac muscle cell development [GO:0055013]; cardiac ventricle development [GO:0003231]; cellular response to gamma radiation [GO:0071480]; determination of adult lifespan [GO:0008340]; DNA repair [GO:0006281]; growth plate cartilage development [GO:0003417]; hair follicle development [GO:0001942]; heart morphogenesis [GO:0003007]; inflammatory cell apoptotic process [GO:0006925]; kidney morphogenesis [GO:0060993]; lipid metabolic process [GO:0006629]; liver development [GO:0001889]; maintenance of rDNA [GO:0043007]; multicellular organism growth [GO:0035264]; negative regulation of miRNA processing [GO:1903799]; neuromuscular process [GO:0050905]; nuclear envelope organization [GO:0006998]; positive regulation of gene expression via chromosomal CpG island demethylation [GO:0044029]; prenylated protein catabolic process [GO:0030327]; protein maturation [GO:0051604]; proteolysis [GO:0006508]; regulation of autophagy [GO:0010506]; regulation of bone mineralization [GO:0030500]; regulation of cell shape [GO:0008360]; regulation of cellular senescence [GO:2000772]; regulation of defense response to virus [GO:0050688]; regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043516]; regulation of fibroblast proliferation [GO:0048145]; regulation of glucose metabolic process [GO:0010906]; regulation of hormone metabolic process [GO:0032350]; regulation of lipid metabolic process [GO:0019216]; regulation of mitotic cell cycle DNA replication [GO:1903463]; regulation of multicellular organism growth [GO:0040014]; regulation of stress-activated protein kinase signaling cascade [GO:0070302]; regulation of termination of RNA polymerase I transcription [GO:2000730]; regulation of TOR signaling [GO:0032006]; regulation of ventricular cardiac muscle cell membrane repolarization [GO:0060307]; response to DNA damage checkpoint signaling [GO:0072423]; thymus development [GO:0048538]; ventricular cardiac muscle tissue development [GO:0003229] early endosome membrane [GO:0031901]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; late endosome membrane [GO:0031902]; membrane [GO:0016020]; nuclear inner membrane [GO:0005637]; protein-containing complex [GO:0032991] double-stranded DNA binding [GO:0003690]; endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metalloexopeptidase activity [GO:0008235] g5985.t1 O75844 60.0 30 8.07e-29 41.2 sp|O75844|FACE1_HUMAN CAAX prenyl protease 1 homolog OS=Homo sapiens OX=9606 GN=ZMPSTE24 PE=1 SV=2 FACE1_HUMAN reviewed CAAX prenyl protease 1 homolog (EC 3.4.24.84) (Farnesylated proteins-converting enzyme 1) (FACE-1) (Prenyl protein-specific endoprotease 1) (Zinc metalloproteinase Ste24 homolog) Homo sapiens (Human) GO:0001889; GO:0001942; GO:0003007; GO:0003229; GO:0003231; GO:0003417; GO:0003690; GO:0004175; GO:0004222; GO:0005637; GO:0005789; GO:0006281; GO:0006508; GO:0006629; GO:0006925; GO:0006998; GO:0007628; GO:0008235; GO:0008340; GO:0008360; GO:0010506; GO:0010906; GO:0016020; GO:0019216; GO:0030282; GO:0030327; GO:0030500; GO:0031901; GO:0031902; GO:0032006; GO:0032350; GO:0032991; GO:0035264; GO:0040014; GO:0043007; GO:0043516; GO:0044029; GO:0046872; GO:0048145; GO:0048538; GO:0050688; GO:0050905; GO:0051604; GO:0055013; GO:0060307; GO:0060993; GO:0061337; GO:0061762; GO:0070062; GO:0070302; GO:0071480; GO:0071586; GO:0072423; GO:1903463; GO:1903799; GO:1990036; GO:2000730; GO:2000772 adult walking behavior [GO:0007628]; bone mineralization [GO:0030282]; CAAX-box protein processing [GO:0071586]; calcium ion import into sarcoplasmic reticulum [GO:1990036]; CAMKK-AMPK signaling cascade [GO:0061762]; cardiac conduction [GO:0061337]; cardiac muscle cell development [GO:0055013]; cardiac ventricle development [GO:0003231]; cellular response to gamma radiation [GO:0071480]; determination of adult lifespan [GO:0008340]; DNA repair [GO:0006281]; growth plate cartilage development [GO:0003417]; hair follicle development [GO:0001942]; heart morphogenesis [GO:0003007]; inflammatory cell apoptotic process [GO:0006925]; kidney morphogenesis [GO:0060993]; lipid metabolic process [GO:0006629]; liver development [GO:0001889]; maintenance of rDNA [GO:0043007]; multicellular organism growth [GO:0035264]; negative regulation of miRNA processing [GO:1903799]; neuromuscular process [GO:0050905]; nuclear envelope organization [GO:0006998]; positive regulation of gene expression via chromosomal CpG island demethylation [GO:0044029]; prenylated protein catabolic process [GO:0030327]; protein maturation [GO:0051604]; proteolysis [GO:0006508]; regulation of autophagy [GO:0010506]; regulation of bone mineralization [GO:0030500]; regulation of cell shape [GO:0008360]; regulation of cellular senescence [GO:2000772]; regulation of defense response to virus [GO:0050688]; regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043516]; regulation of fibroblast proliferation [GO:0048145]; regulation of glucose metabolic process [GO:0010906]; regulation of hormone metabolic process [GO:0032350]; regulation of lipid metabolic process [GO:0019216]; regulation of mitotic cell cycle DNA replication [GO:1903463]; regulation of multicellular organism growth [GO:0040014]; regulation of stress-activated protein kinase signaling cascade [GO:0070302]; regulation of termination of RNA polymerase I transcription [GO:2000730]; regulation of TOR signaling [GO:0032006]; regulation of ventricular cardiac muscle cell membrane repolarization [GO:0060307]; response to DNA damage checkpoint signaling [GO:0072423]; thymus development [GO:0048538]; ventricular cardiac muscle tissue development [GO:0003229] early endosome membrane [GO:0031901]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; late endosome membrane [GO:0031902]; membrane [GO:0016020]; nuclear inner membrane [GO:0005637]; protein-containing complex [GO:0032991] double-stranded DNA binding [GO:0003690]; endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metalloexopeptidase activity [GO:0008235] g5986.t1 O94822 36.795 1011 0.0 591.0 sp|O94822|LTN1_HUMAN E3 ubiquitin-protein ligase listerin OS=Homo sapiens OX=9606 GN=LTN1 PE=1 SV=6 g5987.t1 A0JM49 37.358 795 2.87e-155 500.0 sp|A0JM49|LTN1_XENTR E3 ubiquitin-protein ligase listerin OS=Xenopus tropicalis OX=8364 GN=ltn1 PE=2 SV=1 g5989.t1 Q9CPU4 47.407 135 5.9e-31 111.0 sp|Q9CPU4|MGST3_MOUSE Glutathione S-transferase 3, mitochondrial OS=Mus musculus OX=10090 GN=Mgst3 PE=1 SV=1 g5991.t1 G1T7U7 35.671 328 6.45e-54 182.0 sp|G1T7U7|NAAA_RABIT N-acylethanolamine-hydrolyzing acid amidase OS=Oryctolagus cuniculus OX=9986 GN=NAAA PE=1 SV=2 NAAA_RABIT reviewed N-acylethanolamine-hydrolyzing acid amidase (EC 3.5.1.60) (Acylsphingosine deacylase NAAA) (EC 3.5.1.23) [Cleaved into: N-acylethanolamine-hydrolyzing acid amidase subunit alpha; N-acylethanolamine-hydrolyzing acid amidase subunit beta] Oryctolagus cuniculus (Rabbit) GO:0005764; GO:0006631; GO:0006670; GO:0016020; GO:0016042; GO:0017040; GO:0017064; GO:0047412; GO:0070291; GO:0070292 fatty acid metabolic process [GO:0006631]; lipid catabolic process [GO:0016042]; N-acylethanolamine metabolic process [GO:0070291]; N-acylphosphatidylethanolamine metabolic process [GO:0070292]; sphingosine metabolic process [GO:0006670] lysosome [GO:0005764]; membrane [GO:0016020] fatty acid amide hydrolase activity [GO:0017064]; N-(long-chain-acyl)ethanolamine deacylase activity [GO:0047412]; N-acylsphingosine amidohydrolase activity [GO:0017040] g5992.t1 P70490 36.957 184 3.3899999999999994e-23 102.0 sp|P70490|MFGM_RAT Lactadherin OS=Rattus norvegicus OX=10116 GN=Mfge8 PE=2 SV=1 MFGM_RAT reviewed Lactadherin (MFGM) (Milk fat globule-EGF factor 8) (MFG-E8) (O-acetyl GD3 ganglioside synthase) (AGS) (SED1) Rattus norvegicus (Rat) GO:0001525; GO:0001786; GO:0002080; GO:0005178; GO:0005615; GO:0006910; GO:0006911; GO:0007155; GO:0007338; GO:0008284; GO:0008429; GO:0009897; GO:0043277; GO:0043627; GO:0050766 angiogenesis [GO:0001525]; apoptotic cell clearance [GO:0043277]; cell adhesion [GO:0007155]; phagocytosis, engulfment [GO:0006911]; phagocytosis, recognition [GO:0006910]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of phagocytosis [GO:0050766]; response to estrogen [GO:0043627]; single fertilization [GO:0007338] acrosomal membrane [GO:0002080]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615] integrin binding [GO:0005178]; phosphatidylethanolamine binding [GO:0008429]; phosphatidylserine binding [GO:0001786] g6004.t1 Q96RL7 30.164 1283 6.43e-158 534.0 sp|Q96RL7|VP13A_HUMAN Intermembrane lipid transfer protein VPS13A OS=Homo sapiens OX=9606 GN=VPS13A PE=1 SV=2 g6005.t1 Q8BX70 21.23 829 5.13e-40 166.0 sp|Q8BX70|VP13C_MOUSE Intermembrane lipid transfer protein VPS13C OS=Mus musculus OX=10090 GN=Vps13c PE=1 SV=2 VP13C_MOUSE reviewed Intermembrane lipid transfer protein VPS13C (Vacuolar protein sorting-associated protein 13C) Mus musculus (Mouse) GO:0005741; GO:0005764; GO:0005765; GO:0005770; GO:0005789; GO:0005811; GO:0005829; GO:0006623; GO:0006869; GO:0007005; GO:0031902; GO:0032127; GO:0032868; GO:0045053; GO:1905090 lipid transport [GO:0006869]; mitochondrion organization [GO:0007005]; negative regulation of type 2 mitophagy [GO:1905090]; protein retention in Golgi apparatus [GO:0045053]; protein targeting to vacuole [GO:0006623]; response to insulin [GO:0032868] cytosol [GO:0005829]; dense core granule membrane [GO:0032127]; endoplasmic reticulum membrane [GO:0005789]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lipid droplet [GO:0005811]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; mitochondrial outer membrane [GO:0005741] g6011.t1 P46023 38.528 462 1.25e-104 353.0 sp|P46023|GR101_LYMST G-protein coupled receptor GRL101 OS=Lymnaea stagnalis OX=6523 PE=2 SV=1 g6014.t1 Q06852 31.325 249 9.24e-22 104.0 sp|Q06852|SLAP1_ACET2 Cell surface glycoprotein 1 OS=Acetivibrio thermocellus (strain ATCC 27405 / DSM 1237 / JCM 9322 / NBRC 103400 / NCIMB 10682 / NRRL B-4536 / VPI 7372) OX=203119 GN=olpB PE=3 SV=2 g6017.t1 E7FA21 36.77 291 5.33e-47 182.0 sp|E7FA21|SMR8A_DANRE Guanine nucleotide exchange protein smcr8a OS=Danio rerio OX=7955 GN=smcr8a PE=3 SV=1 g6017.t2 E7FA21 36.77 291 6.310000000000001e-47 182.0 sp|E7FA21|SMR8A_DANRE Guanine nucleotide exchange protein smcr8a OS=Danio rerio OX=7955 GN=smcr8a PE=3 SV=1 g6024.t1 Q61503 48.689 534 1.1e-157 466.0 sp|Q61503|5NTD_MOUSE 5'-nucleotidase OS=Mus musculus OX=10090 GN=Nt5e PE=1 SV=2 5NTD_MOUSE reviewed 5'-nucleotidase (5'-NT) (EC 3.1.3.35) (EC 3.1.3.5) (EC 3.1.3.89) (EC 3.1.3.91) (EC 3.1.3.99) (5'-deoxynucleotidase) (Ecto-5'-nucleotidase) (IMP-specific 5'-nucleotidase) (Thymidylate 5'-phosphatase) (CD antigen CD73) Mus musculus (Mouse) GO:0000166; GO:0002953; GO:0005654; GO:0005829; GO:0005886; GO:0006196; GO:0007159; GO:0008198; GO:0008253; GO:0008270; GO:0009897; GO:0009986; GO:0016020; GO:0033198; GO:0042802; GO:0046032; GO:0046034; GO:0046085; GO:0046086; GO:0050728; GO:0055074; GO:0097060; GO:0140928 adenosine biosynthetic process [GO:0046086]; adenosine metabolic process [GO:0046085]; ADP catabolic process [GO:0046032]; AMP catabolic process [GO:0006196]; ATP metabolic process [GO:0046034]; calcium ion homeostasis [GO:0055074]; inhibition of non-skeletal tissue mineralization [GO:0140928]; leukocyte cell-cell adhesion [GO:0007159]; negative regulation of inflammatory response [GO:0050728]; response to ATP [GO:0033198] cell surface [GO:0009986]; cytosol [GO:0005829]; external side of plasma membrane [GO:0009897]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; synaptic membrane [GO:0097060] 5'-deoxynucleotidase activity [GO:0002953]; 5'-nucleotidase activity [GO:0008253]; ferrous iron binding [GO:0008198]; identical protein binding [GO:0042802]; nucleotide binding [GO:0000166]; zinc ion binding [GO:0008270] g6025.t1 Q61503 47.21 466 3.89e-127 385.0 sp|Q61503|5NTD_MOUSE 5'-nucleotidase OS=Mus musculus OX=10090 GN=Nt5e PE=1 SV=2 5NTD_MOUSE reviewed 5'-nucleotidase (5'-NT) (EC 3.1.3.35) (EC 3.1.3.5) (EC 3.1.3.89) (EC 3.1.3.91) (EC 3.1.3.99) (5'-deoxynucleotidase) (Ecto-5'-nucleotidase) (IMP-specific 5'-nucleotidase) (Thymidylate 5'-phosphatase) (CD antigen CD73) Mus musculus (Mouse) GO:0000166; GO:0002953; GO:0005654; GO:0005829; GO:0005886; GO:0006196; GO:0007159; GO:0008198; GO:0008253; GO:0008270; GO:0009897; GO:0009986; GO:0016020; GO:0033198; GO:0042802; GO:0046032; GO:0046034; GO:0046085; GO:0046086; GO:0050728; GO:0055074; GO:0097060; GO:0140928 adenosine biosynthetic process [GO:0046086]; adenosine metabolic process [GO:0046085]; ADP catabolic process [GO:0046032]; AMP catabolic process [GO:0006196]; ATP metabolic process [GO:0046034]; calcium ion homeostasis [GO:0055074]; inhibition of non-skeletal tissue mineralization [GO:0140928]; leukocyte cell-cell adhesion [GO:0007159]; negative regulation of inflammatory response [GO:0050728]; response to ATP [GO:0033198] cell surface [GO:0009986]; cytosol [GO:0005829]; external side of plasma membrane [GO:0009897]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; synaptic membrane [GO:0097060] 5'-deoxynucleotidase activity [GO:0002953]; 5'-nucleotidase activity [GO:0008253]; ferrous iron binding [GO:0008198]; identical protein binding [GO:0042802]; nucleotide binding [GO:0000166]; zinc ion binding [GO:0008270] g6028.t1 Q95R48 37.538 333 5.0799999999999994e-55 194.0 sp|Q95R48|OCTL_DROME Organic cation transporter-like protein OS=Drosophila melanogaster OX=7227 GN=Orct2 PE=2 SV=2 g6029.t1 Q5XGM3 33.642 324 2.65e-44 160.0 sp|Q5XGM3|BHMT1_XENLA Betaine--homocysteine S-methyltransferase 1 OS=Xenopus laevis OX=8355 GN=bhmt PE=2 SV=1 g6030.t1 Q95332 36.697 218 4.5699999999999995e-30 118.0 sp|Q95332|BHMT1_PIG Betaine--homocysteine S-methyltransferase 1 (Fragment) OS=Sus scrofa OX=9823 GN=BHMT PE=1 SV=3 BHMT1_PIG reviewed Betaine--homocysteine S-methyltransferase 1 (EC 2.1.1.5) Sus scrofa (Pig) GO:0005634; GO:0005829; GO:0006579; GO:0008270; GO:0032259; GO:0047150; GO:0071267 amino-acid betaine catabolic process [GO:0006579]; L-methionine salvage [GO:0071267]; methylation [GO:0032259] cytosol [GO:0005829]; nucleus [GO:0005634] betaine-homocysteine S-methyltransferase activity [GO:0047150]; zinc ion binding [GO:0008270] g6031.t1 Q9UPN6 79.259 135 1.9899999999999998e-61 235.0 sp|Q9UPN6|SCAF8_HUMAN SR-related and CTD-associated factor 8 OS=Homo sapiens OX=9606 GN=SCAF8 PE=1 SV=1 g6031.t1 Q9UPN6 46.324 136 1.9100000000000002e-32 142.0 sp|Q9UPN6|SCAF8_HUMAN SR-related and CTD-associated factor 8 OS=Homo sapiens OX=9606 GN=SCAF8 PE=1 SV=1 g6033.t1 O65768 66.443 149 1.82e-64 197.0 sp|O65768|SODC_CARPA Superoxide dismutase [Cu-Zn] OS=Carica papaya OX=3649 GN=SODCC PE=2 SV=1 g6034.t1 Q0P5H7 46.404 584 0.0 527.0 sp|Q0P5H7|SYRM_BOVIN Probable arginine--tRNA ligase, mitochondrial OS=Bos taurus OX=9913 GN=RARS2 PE=2 SV=1 g6035.t1 Q6ZUK4 34.783 322 1.0800000000000001e-29 119.0 sp|Q6ZUK4|TMM26_HUMAN Transmembrane protein 26 OS=Homo sapiens OX=9606 GN=TMEM26 PE=1 SV=1 g6036.t1 Q13492 68.248 274 2.44e-140 427.0 sp|Q13492|PICAL_HUMAN Phosphatidylinositol-binding clathrin assembly protein OS=Homo sapiens OX=9606 GN=PICALM PE=1 SV=2 g6036.t2 O55012 68.248 274 2.6799999999999997e-140 427.0 sp|O55012|PICAL_RAT Phosphatidylinositol-binding clathrin assembly protein OS=Rattus norvegicus OX=10116 GN=Picalm PE=1 SV=1 PICAL_RAT reviewed Phosphatidylinositol-binding clathrin assembly protein (Clathrin assembly lymphoid myeloid leukemia protein) (rCALM) Rattus norvegicus (Rat) GO:0000149; GO:0005545; GO:0005546; GO:0005634; GO:0005768; GO:0005769; GO:0005794; GO:0005886; GO:0005905; GO:0006879; GO:0006897; GO:0006898; GO:0006900; GO:0007409; GO:0007611; GO:0008021; GO:0009986; GO:0010629; GO:0014069; GO:0016020; GO:0016188; GO:0016192; GO:0016197; GO:0017124; GO:0030097; GO:0030100; GO:0030132; GO:0030136; GO:0030276; GO:0031267; GO:0031623; GO:0031982; GO:0032050; GO:0032880; GO:0035459; GO:0042734; GO:0042802; GO:0043025; GO:0045211; GO:0045893; GO:0046579; GO:0048156; GO:0048261; GO:0048268; GO:0048471; GO:0048488; GO:0048813; GO:0050750; GO:0050772; GO:0051223; GO:0060586; GO:0070381; GO:0072583; GO:0097418; GO:0097494; GO:0097753; GO:0098685; GO:0098688; GO:0098794; GO:0098843; GO:0098894; GO:0150093; GO:1900242; GO:1900244; GO:1902004; GO:1902803; GO:1902991; GO:1902993; GO:1903077; GO:1903861; GO:2000009; GO:2000331; GO:2000809 amyloid-beta clearance by transcytosis [GO:0150093]; axonogenesis [GO:0007409]; clathrin coat assembly [GO:0048268]; clathrin-dependent endocytosis [GO:0072583]; dendrite morphogenesis [GO:0048813]; endocytosis [GO:0006897]; endosomal transport [GO:0016197]; hemopoiesis [GO:0030097]; intracellular iron ion homeostasis [GO:0006879]; learning or memory [GO:0007611]; membrane bending [GO:0097753]; multicellular organismal-level iron ion homeostasis [GO:0060586]; negative regulation of gene expression [GO:0010629]; negative regulation of protein localization to cell surface [GO:2000009]; negative regulation of protein localization to plasma membrane [GO:1903077]; negative regulation of receptor-mediated endocytosis [GO:0048261]; positive regulation of amyloid precursor protein catabolic process [GO:1902993]; positive regulation of amyloid-beta formation [GO:1902004]; positive regulation of axonogenesis [GO:0050772]; positive regulation of dendrite extension [GO:1903861]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of synaptic vesicle clustering [GO:2000809]; positive regulation of synaptic vesicle endocytosis [GO:1900244]; receptor internalization [GO:0031623]; receptor-mediated endocytosis [GO:0006898]; regulation of amyloid precursor protein catabolic process [GO:1902991]; regulation of endocytosis [GO:0030100]; regulation of protein localization [GO:0032880]; regulation of protein transport [GO:0051223]; regulation of synaptic vesicle endocytosis [GO:1900242]; regulation of synaptic vesicle transport [GO:1902803]; regulation of terminal button organization [GO:2000331]; regulation of vesicle size [GO:0097494]; synaptic vesicle endocytosis [GO:0048488]; synaptic vesicle maturation [GO:0016188]; vesicle budding from membrane [GO:0006900]; vesicle cargo loading [GO:0035459]; vesicle-mediated transport [GO:0016192] cell surface [GO:0009986]; clathrin coat of coated pit [GO:0030132]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; early endosome [GO:0005769]; endosome [GO:0005768]; endosome to plasma membrane transport vesicle [GO:0070381]; extrinsic component of presynaptic endocytic zone membrane [GO:0098894]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; neurofibrillary tangle [GO:0097418]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; parallel fiber to Purkinje cell synapse [GO:0098688]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; postsynaptic endocytic zone [GO:0098843]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; Schaffer collateral - CA1 synapse [GO:0098685]; synaptic vesicle [GO:0008021]; vesicle [GO:0031982] 1-phosphatidylinositol binding [GO:0005545]; clathrin binding [GO:0030276]; clathrin heavy chain binding [GO:0032050]; identical protein binding [GO:0042802]; low-density lipoprotein particle receptor binding [GO:0050750]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; SH3 domain binding [GO:0017124]; small GTPase binding [GO:0031267]; SNARE binding [GO:0000149]; tau protein binding [GO:0048156] g6036.t3 O55012 68.148 270 2.67e-137 421.0 sp|O55012|PICAL_RAT Phosphatidylinositol-binding clathrin assembly protein OS=Rattus norvegicus OX=10116 GN=Picalm PE=1 SV=1 PICAL_RAT reviewed Phosphatidylinositol-binding clathrin assembly protein (Clathrin assembly lymphoid myeloid leukemia protein) (rCALM) Rattus norvegicus (Rat) GO:0000149; GO:0005545; GO:0005546; GO:0005634; GO:0005768; GO:0005769; GO:0005794; GO:0005886; GO:0005905; GO:0006879; GO:0006897; GO:0006898; GO:0006900; GO:0007409; GO:0007611; GO:0008021; GO:0009986; GO:0010629; GO:0014069; GO:0016020; GO:0016188; GO:0016192; GO:0016197; GO:0017124; GO:0030097; GO:0030100; GO:0030132; GO:0030136; GO:0030276; GO:0031267; GO:0031623; GO:0031982; GO:0032050; GO:0032880; GO:0035459; GO:0042734; GO:0042802; GO:0043025; GO:0045211; GO:0045893; GO:0046579; GO:0048156; GO:0048261; GO:0048268; GO:0048471; GO:0048488; GO:0048813; GO:0050750; GO:0050772; GO:0051223; GO:0060586; GO:0070381; GO:0072583; GO:0097418; GO:0097494; GO:0097753; GO:0098685; GO:0098688; GO:0098794; GO:0098843; GO:0098894; GO:0150093; GO:1900242; GO:1900244; GO:1902004; GO:1902803; GO:1902991; GO:1902993; GO:1903077; GO:1903861; GO:2000009; GO:2000331; GO:2000809 amyloid-beta clearance by transcytosis [GO:0150093]; axonogenesis [GO:0007409]; clathrin coat assembly [GO:0048268]; clathrin-dependent endocytosis [GO:0072583]; dendrite morphogenesis [GO:0048813]; endocytosis [GO:0006897]; endosomal transport [GO:0016197]; hemopoiesis [GO:0030097]; intracellular iron ion homeostasis [GO:0006879]; learning or memory [GO:0007611]; membrane bending [GO:0097753]; multicellular organismal-level iron ion homeostasis [GO:0060586]; negative regulation of gene expression [GO:0010629]; negative regulation of protein localization to cell surface [GO:2000009]; negative regulation of protein localization to plasma membrane [GO:1903077]; negative regulation of receptor-mediated endocytosis [GO:0048261]; positive regulation of amyloid precursor protein catabolic process [GO:1902993]; positive regulation of amyloid-beta formation [GO:1902004]; positive regulation of axonogenesis [GO:0050772]; positive regulation of dendrite extension [GO:1903861]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of synaptic vesicle clustering [GO:2000809]; positive regulation of synaptic vesicle endocytosis [GO:1900244]; receptor internalization [GO:0031623]; receptor-mediated endocytosis [GO:0006898]; regulation of amyloid precursor protein catabolic process [GO:1902991]; regulation of endocytosis [GO:0030100]; regulation of protein localization [GO:0032880]; regulation of protein transport [GO:0051223]; regulation of synaptic vesicle endocytosis [GO:1900242]; regulation of synaptic vesicle transport [GO:1902803]; regulation of terminal button organization [GO:2000331]; regulation of vesicle size [GO:0097494]; synaptic vesicle endocytosis [GO:0048488]; synaptic vesicle maturation [GO:0016188]; vesicle budding from membrane [GO:0006900]; vesicle cargo loading [GO:0035459]; vesicle-mediated transport [GO:0016192] cell surface [GO:0009986]; clathrin coat of coated pit [GO:0030132]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; early endosome [GO:0005769]; endosome [GO:0005768]; endosome to plasma membrane transport vesicle [GO:0070381]; extrinsic component of presynaptic endocytic zone membrane [GO:0098894]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; neurofibrillary tangle [GO:0097418]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; parallel fiber to Purkinje cell synapse [GO:0098688]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; postsynaptic endocytic zone [GO:0098843]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; Schaffer collateral - CA1 synapse [GO:0098685]; synaptic vesicle [GO:0008021]; vesicle [GO:0031982] 1-phosphatidylinositol binding [GO:0005545]; clathrin binding [GO:0030276]; clathrin heavy chain binding [GO:0032050]; identical protein binding [GO:0042802]; low-density lipoprotein particle receptor binding [GO:0050750]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; SH3 domain binding [GO:0017124]; small GTPase binding [GO:0031267]; SNARE binding [GO:0000149]; tau protein binding [GO:0048156] g6036.t4 O55012 68.248 274 4.8e-140 428.0 sp|O55012|PICAL_RAT Phosphatidylinositol-binding clathrin assembly protein OS=Rattus norvegicus OX=10116 GN=Picalm PE=1 SV=1 PICAL_RAT reviewed Phosphatidylinositol-binding clathrin assembly protein (Clathrin assembly lymphoid myeloid leukemia protein) (rCALM) Rattus norvegicus (Rat) GO:0000149; GO:0005545; GO:0005546; GO:0005634; GO:0005768; GO:0005769; GO:0005794; GO:0005886; GO:0005905; GO:0006879; GO:0006897; GO:0006898; GO:0006900; GO:0007409; GO:0007611; GO:0008021; GO:0009986; GO:0010629; GO:0014069; GO:0016020; GO:0016188; GO:0016192; GO:0016197; GO:0017124; GO:0030097; GO:0030100; GO:0030132; GO:0030136; GO:0030276; GO:0031267; GO:0031623; GO:0031982; GO:0032050; GO:0032880; GO:0035459; GO:0042734; GO:0042802; GO:0043025; GO:0045211; GO:0045893; GO:0046579; GO:0048156; GO:0048261; GO:0048268; GO:0048471; GO:0048488; GO:0048813; GO:0050750; GO:0050772; GO:0051223; GO:0060586; GO:0070381; GO:0072583; GO:0097418; GO:0097494; GO:0097753; GO:0098685; GO:0098688; GO:0098794; GO:0098843; GO:0098894; GO:0150093; GO:1900242; GO:1900244; GO:1902004; GO:1902803; GO:1902991; GO:1902993; GO:1903077; GO:1903861; GO:2000009; GO:2000331; GO:2000809 amyloid-beta clearance by transcytosis [GO:0150093]; axonogenesis [GO:0007409]; clathrin coat assembly [GO:0048268]; clathrin-dependent endocytosis [GO:0072583]; dendrite morphogenesis [GO:0048813]; endocytosis [GO:0006897]; endosomal transport [GO:0016197]; hemopoiesis [GO:0030097]; intracellular iron ion homeostasis [GO:0006879]; learning or memory [GO:0007611]; membrane bending [GO:0097753]; multicellular organismal-level iron ion homeostasis [GO:0060586]; negative regulation of gene expression [GO:0010629]; negative regulation of protein localization to cell surface [GO:2000009]; negative regulation of protein localization to plasma membrane [GO:1903077]; negative regulation of receptor-mediated endocytosis [GO:0048261]; positive regulation of amyloid precursor protein catabolic process [GO:1902993]; positive regulation of amyloid-beta formation [GO:1902004]; positive regulation of axonogenesis [GO:0050772]; positive regulation of dendrite extension [GO:1903861]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of synaptic vesicle clustering [GO:2000809]; positive regulation of synaptic vesicle endocytosis [GO:1900244]; receptor internalization [GO:0031623]; receptor-mediated endocytosis [GO:0006898]; regulation of amyloid precursor protein catabolic process [GO:1902991]; regulation of endocytosis [GO:0030100]; regulation of protein localization [GO:0032880]; regulation of protein transport [GO:0051223]; regulation of synaptic vesicle endocytosis [GO:1900242]; regulation of synaptic vesicle transport [GO:1902803]; regulation of terminal button organization [GO:2000331]; regulation of vesicle size [GO:0097494]; synaptic vesicle endocytosis [GO:0048488]; synaptic vesicle maturation [GO:0016188]; vesicle budding from membrane [GO:0006900]; vesicle cargo loading [GO:0035459]; vesicle-mediated transport [GO:0016192] cell surface [GO:0009986]; clathrin coat of coated pit [GO:0030132]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; early endosome [GO:0005769]; endosome [GO:0005768]; endosome to plasma membrane transport vesicle [GO:0070381]; extrinsic component of presynaptic endocytic zone membrane [GO:0098894]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; neurofibrillary tangle [GO:0097418]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; parallel fiber to Purkinje cell synapse [GO:0098688]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; postsynaptic endocytic zone [GO:0098843]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; Schaffer collateral - CA1 synapse [GO:0098685]; synaptic vesicle [GO:0008021]; vesicle [GO:0031982] 1-phosphatidylinositol binding [GO:0005545]; clathrin binding [GO:0030276]; clathrin heavy chain binding [GO:0032050]; identical protein binding [GO:0042802]; low-density lipoprotein particle receptor binding [GO:0050750]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; SH3 domain binding [GO:0017124]; small GTPase binding [GO:0031267]; SNARE binding [GO:0000149]; tau protein binding [GO:0048156] g6036.t5 O55012 68.248 274 3.44e-140 428.0 sp|O55012|PICAL_RAT Phosphatidylinositol-binding clathrin assembly protein OS=Rattus norvegicus OX=10116 GN=Picalm PE=1 SV=1 PICAL_RAT reviewed Phosphatidylinositol-binding clathrin assembly protein (Clathrin assembly lymphoid myeloid leukemia protein) (rCALM) Rattus norvegicus (Rat) GO:0000149; GO:0005545; GO:0005546; GO:0005634; GO:0005768; GO:0005769; GO:0005794; GO:0005886; GO:0005905; GO:0006879; GO:0006897; GO:0006898; GO:0006900; GO:0007409; GO:0007611; GO:0008021; GO:0009986; GO:0010629; GO:0014069; GO:0016020; GO:0016188; GO:0016192; GO:0016197; GO:0017124; GO:0030097; GO:0030100; GO:0030132; GO:0030136; GO:0030276; GO:0031267; GO:0031623; GO:0031982; GO:0032050; GO:0032880; GO:0035459; GO:0042734; GO:0042802; GO:0043025; GO:0045211; GO:0045893; GO:0046579; GO:0048156; GO:0048261; GO:0048268; GO:0048471; GO:0048488; GO:0048813; GO:0050750; GO:0050772; GO:0051223; GO:0060586; GO:0070381; GO:0072583; GO:0097418; GO:0097494; GO:0097753; GO:0098685; GO:0098688; GO:0098794; GO:0098843; GO:0098894; GO:0150093; GO:1900242; GO:1900244; GO:1902004; GO:1902803; GO:1902991; GO:1902993; GO:1903077; GO:1903861; GO:2000009; GO:2000331; GO:2000809 amyloid-beta clearance by transcytosis [GO:0150093]; axonogenesis [GO:0007409]; clathrin coat assembly [GO:0048268]; clathrin-dependent endocytosis [GO:0072583]; dendrite morphogenesis [GO:0048813]; endocytosis [GO:0006897]; endosomal transport [GO:0016197]; hemopoiesis [GO:0030097]; intracellular iron ion homeostasis [GO:0006879]; learning or memory [GO:0007611]; membrane bending [GO:0097753]; multicellular organismal-level iron ion homeostasis [GO:0060586]; negative regulation of gene expression [GO:0010629]; negative regulation of protein localization to cell surface [GO:2000009]; negative regulation of protein localization to plasma membrane [GO:1903077]; negative regulation of receptor-mediated endocytosis [GO:0048261]; positive regulation of amyloid precursor protein catabolic process [GO:1902993]; positive regulation of amyloid-beta formation [GO:1902004]; positive regulation of axonogenesis [GO:0050772]; positive regulation of dendrite extension [GO:1903861]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of synaptic vesicle clustering [GO:2000809]; positive regulation of synaptic vesicle endocytosis [GO:1900244]; receptor internalization [GO:0031623]; receptor-mediated endocytosis [GO:0006898]; regulation of amyloid precursor protein catabolic process [GO:1902991]; regulation of endocytosis [GO:0030100]; regulation of protein localization [GO:0032880]; regulation of protein transport [GO:0051223]; regulation of synaptic vesicle endocytosis [GO:1900242]; regulation of synaptic vesicle transport [GO:1902803]; regulation of terminal button organization [GO:2000331]; regulation of vesicle size [GO:0097494]; synaptic vesicle endocytosis [GO:0048488]; synaptic vesicle maturation [GO:0016188]; vesicle budding from membrane [GO:0006900]; vesicle cargo loading [GO:0035459]; vesicle-mediated transport [GO:0016192] cell surface [GO:0009986]; clathrin coat of coated pit [GO:0030132]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; early endosome [GO:0005769]; endosome [GO:0005768]; endosome to plasma membrane transport vesicle [GO:0070381]; extrinsic component of presynaptic endocytic zone membrane [GO:0098894]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; neurofibrillary tangle [GO:0097418]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; parallel fiber to Purkinje cell synapse [GO:0098688]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; postsynaptic endocytic zone [GO:0098843]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; Schaffer collateral - CA1 synapse [GO:0098685]; synaptic vesicle [GO:0008021]; vesicle [GO:0031982] 1-phosphatidylinositol binding [GO:0005545]; clathrin binding [GO:0030276]; clathrin heavy chain binding [GO:0032050]; identical protein binding [GO:0042802]; low-density lipoprotein particle receptor binding [GO:0050750]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; SH3 domain binding [GO:0017124]; small GTPase binding [GO:0031267]; SNARE binding [GO:0000149]; tau protein binding [GO:0048156] g6039.t1 B3DIY3 28.91 422 3.65e-32 132.0 sp|B3DIY3|MMS22_DANRE Protein MMS22-like OS=Danio rerio OX=7955 GN=mms22l PE=2 SV=1 g6040.t1 E1C2Z0 33.461 523 3.7200000000000004e-72 252.0 sp|E1C2Z0|MMS22_CHICK Protein MMS22-like OS=Gallus gallus OX=9031 GN=MMS22L PE=3 SV=1 g6041.t1 E1C2Z0 30.462 325 9.25e-29 120.0 sp|E1C2Z0|MMS22_CHICK Protein MMS22-like OS=Gallus gallus OX=9031 GN=MMS22L PE=3 SV=1 g6042.t1 Q8N0X4 50.831 301 4.29e-97 293.0 sp|Q8N0X4|CLYBL_HUMAN Citramalyl-CoA lyase, mitochondrial OS=Homo sapiens OX=9606 GN=CLYBL PE=1 SV=2 CLYBL_HUMAN reviewed Citramalyl-CoA lyase, mitochondrial (EC 4.1.3.25) ((3S)-malyl-CoA thioesterase) (EC 3.1.2.30) (Beta-methylmalate synthase) (EC 2.3.3.-) (Citrate lyase subunit beta-like protein) (Citrate lyase beta-like) (Malate synthase) (EC 2.3.3.9) Homo sapiens (Human) GO:0000287; GO:0004474; GO:0005739; GO:0016787; GO:0047777; GO:0070207; GO:0106064; GO:0106121 positive regulation of cobalamin metabolic process [GO:0106121]; protein homotrimerization [GO:0070207]; regulation of cobalamin metabolic process [GO:0106064] mitochondrion [GO:0005739] (S)-citramalyl-CoA lyase activity [GO:0047777]; hydrolase activity [GO:0016787]; magnesium ion binding [GO:0000287]; malate synthase activity [GO:0004474] g6043.t1 Q4KLH6 37.113 388 3.6900000000000005e-43 176.0 sp|Q4KLH6|CE162_RAT Centrosomal protein of 162 kDa OS=Rattus norvegicus OX=10116 GN=Cep162 PE=1 SV=2 g6044.t1 E7F5E1 36.452 310 2.71e-53 191.0 sp|E7F5E1|CE162_DANRE Centrosomal protein of 162 kDa OS=Danio rerio OX=7955 GN=cep162 PE=2 SV=1 g6053.t1 A0JN71 40.12 167 6.72e-25 112.0 sp|A0JN71|SASH3_BOVIN SAM and SH3 domain-containing protein 3 OS=Bos taurus OX=9913 GN=SASH3 PE=2 SV=2 SASH3_BOVIN reviewed SAM and SH3 domain-containing protein 3 Bos taurus (Bovine) GO:0001782; GO:0002639; GO:0002726; GO:0002821; GO:0005634; GO:0005737; GO:0030890; GO:0032729; GO:0032733; GO:0032743; GO:0032753; GO:0032760; GO:0042098; GO:0042100; GO:0042102; GO:0043367; GO:0043372; GO:0046622; GO:0048873; GO:1902531 B cell homeostasis [GO:0001782]; B cell proliferation [GO:0042100]; CD4-positive, alpha-beta T cell differentiation [GO:0043367]; homeostasis of number of cells within a tissue [GO:0048873]; positive regulation of adaptive immune response [GO:0002821]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of CD4-positive, alpha-beta T cell differentiation [GO:0043372]; positive regulation of immunoglobulin production [GO:0002639]; positive regulation of interleukin-10 production [GO:0032733]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of interleukin-4 production [GO:0032753]; positive regulation of organ growth [GO:0046622]; positive regulation of T cell cytokine production [GO:0002726]; positive regulation of T cell proliferation [GO:0042102]; positive regulation of tumor necrosis factor production [GO:0032760]; positive regulation of type II interferon production [GO:0032729]; regulation of intracellular signal transduction [GO:1902531]; T cell proliferation [GO:0042098] cytoplasm [GO:0005737]; nucleus [GO:0005634] g6056.t1 Q8JHC4 53.191 141 9.39e-46 153.0 sp|Q8JHC4|LN28A_XENLA Protein lin-28 homolog A OS=Xenopus laevis OX=8355 GN=lin28a PE=2 SV=1 g6056.t2 Q8JHC4 52.817 142 6.39e-44 148.0 sp|Q8JHC4|LN28A_XENLA Protein lin-28 homolog A OS=Xenopus laevis OX=8355 GN=lin28a PE=2 SV=1 g6059.t1 P11717 36.905 2249 0.0 1281.0 sp|P11717|MPRI_HUMAN Cation-independent mannose-6-phosphate receptor OS=Homo sapiens OX=9606 GN=IGF2R PE=1 SV=3 MPRI_HUMAN reviewed Cation-independent mannose-6-phosphate receptor (CI Man-6-P receptor) (CI-MPR) (M6PR) (300 kDa mannose 6-phosphate receptor) (MPR 300) (Insulin-like growth factor 2 receptor) (Insulin-like growth factor II receptor) (IGF-II receptor) (M6P/IGF2 receptor) (M6P/IGF2R) (CD antigen CD222) Homo sapiens (Human) GO:0000139; GO:0001889; GO:0001965; GO:0001972; GO:0005010; GO:0005520; GO:0005537; GO:0005641; GO:0005768; GO:0005769; GO:0005770; GO:0005794; GO:0005802; GO:0005886; GO:0005925; GO:0006898; GO:0007041; GO:0007165; GO:0007186; GO:0007283; GO:0009791; GO:0009986; GO:0010008; GO:0016020; GO:0019899; GO:0030118; GO:0030133; GO:0030139; GO:0030140; GO:0030667; GO:0030669; GO:0031100; GO:0031995; GO:0032526; GO:0032588; GO:0038023; GO:0042802; GO:0043065; GO:0044794; GO:0048471; GO:0051219; GO:0070062; GO:1904772; GO:1905394 animal organ regeneration [GO:0031100]; G protein-coupled receptor signaling pathway [GO:0007186]; host-mediated activation of viral process [GO:0044794]; liver development [GO:0001889]; lysosomal transport [GO:0007041]; positive regulation of apoptotic process [GO:0043065]; post-embryonic development [GO:0009791]; receptor-mediated endocytosis [GO:0006898]; response to retinoic acid [GO:0032526]; response to tetrachloromethane [GO:1904772]; signal transduction [GO:0007165]; spermatogenesis [GO:0007283] cell surface [GO:0009986]; clathrin coat [GO:0030118]; clathrin-coated endocytic vesicle membrane [GO:0030669]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; late endosome [GO:0005770]; membrane [GO:0016020]; nuclear envelope lumen [GO:0005641]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; trans-Golgi network [GO:0005802]; trans-Golgi network membrane [GO:0032588]; trans-Golgi network transport vesicle [GO:0030140]; transport vesicle [GO:0030133] D-mannose binding [GO:0005537]; enzyme binding [GO:0019899]; G-protein alpha-subunit binding [GO:0001965]; identical protein binding [GO:0042802]; insulin-like growth factor binding [GO:0005520]; insulin-like growth factor II binding [GO:0031995]; insulin-like growth factor receptor activity [GO:0005010]; phosphoprotein binding [GO:0051219]; retinoic acid binding [GO:0001972]; retromer complex binding [GO:1905394]; signaling receptor activity [GO:0038023] g6059.t1 P11717 28.495 2060 6.38e-168 580.0 sp|P11717|MPRI_HUMAN Cation-independent mannose-6-phosphate receptor OS=Homo sapiens OX=9606 GN=IGF2R PE=1 SV=3 MPRI_HUMAN reviewed Cation-independent mannose-6-phosphate receptor (CI Man-6-P receptor) (CI-MPR) (M6PR) (300 kDa mannose 6-phosphate receptor) (MPR 300) (Insulin-like growth factor 2 receptor) (Insulin-like growth factor II receptor) (IGF-II receptor) (M6P/IGF2 receptor) (M6P/IGF2R) (CD antigen CD222) Homo sapiens (Human) GO:0000139; GO:0001889; GO:0001965; GO:0001972; GO:0005010; GO:0005520; GO:0005537; GO:0005641; GO:0005768; GO:0005769; GO:0005770; GO:0005794; GO:0005802; GO:0005886; GO:0005925; GO:0006898; GO:0007041; GO:0007165; GO:0007186; GO:0007283; GO:0009791; GO:0009986; GO:0010008; GO:0016020; GO:0019899; GO:0030118; GO:0030133; GO:0030139; GO:0030140; GO:0030667; GO:0030669; GO:0031100; GO:0031995; GO:0032526; GO:0032588; GO:0038023; GO:0042802; GO:0043065; GO:0044794; GO:0048471; GO:0051219; GO:0070062; GO:1904772; GO:1905394 animal organ regeneration [GO:0031100]; G protein-coupled receptor signaling pathway [GO:0007186]; host-mediated activation of viral process [GO:0044794]; liver development [GO:0001889]; lysosomal transport [GO:0007041]; positive regulation of apoptotic process [GO:0043065]; post-embryonic development [GO:0009791]; receptor-mediated endocytosis [GO:0006898]; response to retinoic acid [GO:0032526]; response to tetrachloromethane [GO:1904772]; signal transduction [GO:0007165]; spermatogenesis [GO:0007283] cell surface [GO:0009986]; clathrin coat [GO:0030118]; clathrin-coated endocytic vesicle membrane [GO:0030669]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; late endosome [GO:0005770]; membrane [GO:0016020]; nuclear envelope lumen [GO:0005641]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; trans-Golgi network [GO:0005802]; trans-Golgi network membrane [GO:0032588]; trans-Golgi network transport vesicle [GO:0030140]; transport vesicle [GO:0030133] D-mannose binding [GO:0005537]; enzyme binding [GO:0019899]; G-protein alpha-subunit binding [GO:0001965]; identical protein binding [GO:0042802]; insulin-like growth factor binding [GO:0005520]; insulin-like growth factor II binding [GO:0031995]; insulin-like growth factor receptor activity [GO:0005010]; phosphoprotein binding [GO:0051219]; retinoic acid binding [GO:0001972]; retromer complex binding [GO:1905394]; signaling receptor activity [GO:0038023] g6059.t1 P11717 23.882 1252 3.2000000000000003e-37 159.0 sp|P11717|MPRI_HUMAN Cation-independent mannose-6-phosphate receptor OS=Homo sapiens OX=9606 GN=IGF2R PE=1 SV=3 MPRI_HUMAN reviewed Cation-independent mannose-6-phosphate receptor (CI Man-6-P receptor) (CI-MPR) (M6PR) (300 kDa mannose 6-phosphate receptor) (MPR 300) (Insulin-like growth factor 2 receptor) (Insulin-like growth factor II receptor) (IGF-II receptor) (M6P/IGF2 receptor) (M6P/IGF2R) (CD antigen CD222) Homo sapiens (Human) GO:0000139; GO:0001889; GO:0001965; GO:0001972; GO:0005010; GO:0005520; GO:0005537; GO:0005641; GO:0005768; GO:0005769; GO:0005770; GO:0005794; GO:0005802; GO:0005886; GO:0005925; GO:0006898; GO:0007041; GO:0007165; GO:0007186; GO:0007283; GO:0009791; GO:0009986; GO:0010008; GO:0016020; GO:0019899; GO:0030118; GO:0030133; GO:0030139; GO:0030140; GO:0030667; GO:0030669; GO:0031100; GO:0031995; GO:0032526; GO:0032588; GO:0038023; GO:0042802; GO:0043065; GO:0044794; GO:0048471; GO:0051219; GO:0070062; GO:1904772; GO:1905394 animal organ regeneration [GO:0031100]; G protein-coupled receptor signaling pathway [GO:0007186]; host-mediated activation of viral process [GO:0044794]; liver development [GO:0001889]; lysosomal transport [GO:0007041]; positive regulation of apoptotic process [GO:0043065]; post-embryonic development [GO:0009791]; receptor-mediated endocytosis [GO:0006898]; response to retinoic acid [GO:0032526]; response to tetrachloromethane [GO:1904772]; signal transduction [GO:0007165]; spermatogenesis [GO:0007283] cell surface [GO:0009986]; clathrin coat [GO:0030118]; clathrin-coated endocytic vesicle membrane [GO:0030669]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; late endosome [GO:0005770]; membrane [GO:0016020]; nuclear envelope lumen [GO:0005641]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; trans-Golgi network [GO:0005802]; trans-Golgi network membrane [GO:0032588]; trans-Golgi network transport vesicle [GO:0030140]; transport vesicle [GO:0030133] D-mannose binding [GO:0005537]; enzyme binding [GO:0019899]; G-protein alpha-subunit binding [GO:0001965]; identical protein binding [GO:0042802]; insulin-like growth factor binding [GO:0005520]; insulin-like growth factor II binding [GO:0031995]; insulin-like growth factor receptor activity [GO:0005010]; phosphoprotein binding [GO:0051219]; retinoic acid binding [GO:0001972]; retromer complex binding [GO:1905394]; signaling receptor activity [GO:0038023] g6059.t1 P11717 25.283 795 6.21e-29 131.0 sp|P11717|MPRI_HUMAN Cation-independent mannose-6-phosphate receptor OS=Homo sapiens OX=9606 GN=IGF2R PE=1 SV=3 MPRI_HUMAN reviewed Cation-independent mannose-6-phosphate receptor (CI Man-6-P receptor) (CI-MPR) (M6PR) (300 kDa mannose 6-phosphate receptor) (MPR 300) (Insulin-like growth factor 2 receptor) (Insulin-like growth factor II receptor) (IGF-II receptor) (M6P/IGF2 receptor) (M6P/IGF2R) (CD antigen CD222) Homo sapiens (Human) GO:0000139; GO:0001889; GO:0001965; GO:0001972; GO:0005010; GO:0005520; GO:0005537; GO:0005641; GO:0005768; GO:0005769; GO:0005770; GO:0005794; GO:0005802; GO:0005886; GO:0005925; GO:0006898; GO:0007041; GO:0007165; GO:0007186; GO:0007283; GO:0009791; GO:0009986; GO:0010008; GO:0016020; GO:0019899; GO:0030118; GO:0030133; GO:0030139; GO:0030140; GO:0030667; GO:0030669; GO:0031100; GO:0031995; GO:0032526; GO:0032588; GO:0038023; GO:0042802; GO:0043065; GO:0044794; GO:0048471; GO:0051219; GO:0070062; GO:1904772; GO:1905394 animal organ regeneration [GO:0031100]; G protein-coupled receptor signaling pathway [GO:0007186]; host-mediated activation of viral process [GO:0044794]; liver development [GO:0001889]; lysosomal transport [GO:0007041]; positive regulation of apoptotic process [GO:0043065]; post-embryonic development [GO:0009791]; receptor-mediated endocytosis [GO:0006898]; response to retinoic acid [GO:0032526]; response to tetrachloromethane [GO:1904772]; signal transduction [GO:0007165]; spermatogenesis [GO:0007283] cell surface [GO:0009986]; clathrin coat [GO:0030118]; clathrin-coated endocytic vesicle membrane [GO:0030669]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; late endosome [GO:0005770]; membrane [GO:0016020]; nuclear envelope lumen [GO:0005641]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; trans-Golgi network [GO:0005802]; trans-Golgi network membrane [GO:0032588]; trans-Golgi network transport vesicle [GO:0030140]; transport vesicle [GO:0030133] D-mannose binding [GO:0005537]; enzyme binding [GO:0019899]; G-protein alpha-subunit binding [GO:0001965]; identical protein binding [GO:0042802]; insulin-like growth factor binding [GO:0005520]; insulin-like growth factor II binding [GO:0031995]; insulin-like growth factor receptor activity [GO:0005010]; phosphoprotein binding [GO:0051219]; retinoic acid binding [GO:0001972]; retromer complex binding [GO:1905394]; signaling receptor activity [GO:0038023] g6060.t1 Q5TCS8 38.822 662 2.3500000000000003e-110 375.0 sp|Q5TCS8|KAD9_HUMAN Adenylate kinase 9 OS=Homo sapiens OX=9606 GN=AK9 PE=1 SV=2 KAD9_HUMAN reviewed Adenylate kinase 9 (EC 2.7.4.4) (EC 2.7.4.6) (Adenylate kinase domain-containing protein 1) (Adenylate kinase domain-containing protein 2) Homo sapiens (Human) GO:0004017; GO:0004550; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006225; GO:0015630; GO:0031514; GO:0031965; GO:0033862; GO:0036430; GO:0036431; GO:0046705; GO:0047506; GO:0050145; GO:0120238 CDP biosynthetic process [GO:0046705]; UDP biosynthetic process [GO:0006225] cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule cytoskeleton [GO:0015630]; motile cilium [GO:0031514]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; sperm glycocalyx [GO:0120238] AMP kinase activity [GO:0004017]; ATP binding [GO:0005524]; CMP kinase activity [GO:0036430]; dAMP kinase activity [GO:0047506]; dCMP kinase activity [GO:0036431]; nucleoside diphosphate kinase activity [GO:0004550]; nucleoside monophosphate kinase activity [GO:0050145]; UMP kinase activity [GO:0033862] g6060.t2 Q5TCS8 50.308 650 0.0 684.0 sp|Q5TCS8|KAD9_HUMAN Adenylate kinase 9 OS=Homo sapiens OX=9606 GN=AK9 PE=1 SV=2 KAD9_HUMAN reviewed Adenylate kinase 9 (EC 2.7.4.4) (EC 2.7.4.6) (Adenylate kinase domain-containing protein 1) (Adenylate kinase domain-containing protein 2) Homo sapiens (Human) GO:0004017; GO:0004550; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006225; GO:0015630; GO:0031514; GO:0031965; GO:0033862; GO:0036430; GO:0036431; GO:0046705; GO:0047506; GO:0050145; GO:0120238 CDP biosynthetic process [GO:0046705]; UDP biosynthetic process [GO:0006225] cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule cytoskeleton [GO:0015630]; motile cilium [GO:0031514]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; sperm glycocalyx [GO:0120238] AMP kinase activity [GO:0004017]; ATP binding [GO:0005524]; CMP kinase activity [GO:0036430]; dAMP kinase activity [GO:0047506]; dCMP kinase activity [GO:0036431]; nucleoside diphosphate kinase activity [GO:0004550]; nucleoside monophosphate kinase activity [GO:0050145]; UMP kinase activity [GO:0033862] g6060.t2 Q5TCS8 36.062 452 4.760000000000001e-56 220.0 sp|Q5TCS8|KAD9_HUMAN Adenylate kinase 9 OS=Homo sapiens OX=9606 GN=AK9 PE=1 SV=2 KAD9_HUMAN reviewed Adenylate kinase 9 (EC 2.7.4.4) (EC 2.7.4.6) (Adenylate kinase domain-containing protein 1) (Adenylate kinase domain-containing protein 2) Homo sapiens (Human) GO:0004017; GO:0004550; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006225; GO:0015630; GO:0031514; GO:0031965; GO:0033862; GO:0036430; GO:0036431; GO:0046705; GO:0047506; GO:0050145; GO:0120238 CDP biosynthetic process [GO:0046705]; UDP biosynthetic process [GO:0006225] cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule cytoskeleton [GO:0015630]; motile cilium [GO:0031514]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; sperm glycocalyx [GO:0120238] AMP kinase activity [GO:0004017]; ATP binding [GO:0005524]; CMP kinase activity [GO:0036430]; dAMP kinase activity [GO:0047506]; dCMP kinase activity [GO:0036431]; nucleoside diphosphate kinase activity [GO:0004550]; nucleoside monophosphate kinase activity [GO:0050145]; UMP kinase activity [GO:0033862] g6060.t2 Q5TCS8 49.701 167 3.51e-43 177.0 sp|Q5TCS8|KAD9_HUMAN Adenylate kinase 9 OS=Homo sapiens OX=9606 GN=AK9 PE=1 SV=2 KAD9_HUMAN reviewed Adenylate kinase 9 (EC 2.7.4.4) (EC 2.7.4.6) (Adenylate kinase domain-containing protein 1) (Adenylate kinase domain-containing protein 2) Homo sapiens (Human) GO:0004017; GO:0004550; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006225; GO:0015630; GO:0031514; GO:0031965; GO:0033862; GO:0036430; GO:0036431; GO:0046705; GO:0047506; GO:0050145; GO:0120238 CDP biosynthetic process [GO:0046705]; UDP biosynthetic process [GO:0006225] cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule cytoskeleton [GO:0015630]; motile cilium [GO:0031514]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; sperm glycocalyx [GO:0120238] AMP kinase activity [GO:0004017]; ATP binding [GO:0005524]; CMP kinase activity [GO:0036430]; dAMP kinase activity [GO:0047506]; dCMP kinase activity [GO:0036431]; nucleoside diphosphate kinase activity [GO:0004550]; nucleoside monophosphate kinase activity [GO:0050145]; UMP kinase activity [GO:0033862] g6060.t3 Q5TCS8 50.308 650 0.0 684.0 sp|Q5TCS8|KAD9_HUMAN Adenylate kinase 9 OS=Homo sapiens OX=9606 GN=AK9 PE=1 SV=2 KAD9_HUMAN reviewed Adenylate kinase 9 (EC 2.7.4.4) (EC 2.7.4.6) (Adenylate kinase domain-containing protein 1) (Adenylate kinase domain-containing protein 2) Homo sapiens (Human) GO:0004017; GO:0004550; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006225; GO:0015630; GO:0031514; GO:0031965; GO:0033862; GO:0036430; GO:0036431; GO:0046705; GO:0047506; GO:0050145; GO:0120238 CDP biosynthetic process [GO:0046705]; UDP biosynthetic process [GO:0006225] cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule cytoskeleton [GO:0015630]; motile cilium [GO:0031514]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; sperm glycocalyx [GO:0120238] AMP kinase activity [GO:0004017]; ATP binding [GO:0005524]; CMP kinase activity [GO:0036430]; dAMP kinase activity [GO:0047506]; dCMP kinase activity [GO:0036431]; nucleoside diphosphate kinase activity [GO:0004550]; nucleoside monophosphate kinase activity [GO:0050145]; UMP kinase activity [GO:0033862] g6060.t3 Q5TCS8 38.822 662 5.099999999999999e-104 375.0 sp|Q5TCS8|KAD9_HUMAN Adenylate kinase 9 OS=Homo sapiens OX=9606 GN=AK9 PE=1 SV=2 KAD9_HUMAN reviewed Adenylate kinase 9 (EC 2.7.4.4) (EC 2.7.4.6) (Adenylate kinase domain-containing protein 1) (Adenylate kinase domain-containing protein 2) Homo sapiens (Human) GO:0004017; GO:0004550; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006225; GO:0015630; GO:0031514; GO:0031965; GO:0033862; GO:0036430; GO:0036431; GO:0046705; GO:0047506; GO:0050145; GO:0120238 CDP biosynthetic process [GO:0046705]; UDP biosynthetic process [GO:0006225] cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule cytoskeleton [GO:0015630]; motile cilium [GO:0031514]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; sperm glycocalyx [GO:0120238] AMP kinase activity [GO:0004017]; ATP binding [GO:0005524]; CMP kinase activity [GO:0036430]; dAMP kinase activity [GO:0047506]; dCMP kinase activity [GO:0036431]; nucleoside diphosphate kinase activity [GO:0004550]; nucleoside monophosphate kinase activity [GO:0050145]; UMP kinase activity [GO:0033862] g6060.t4 Q5TCS8 50.308 650 0.0 684.0 sp|Q5TCS8|KAD9_HUMAN Adenylate kinase 9 OS=Homo sapiens OX=9606 GN=AK9 PE=1 SV=2 KAD9_HUMAN reviewed Adenylate kinase 9 (EC 2.7.4.4) (EC 2.7.4.6) (Adenylate kinase domain-containing protein 1) (Adenylate kinase domain-containing protein 2) Homo sapiens (Human) GO:0004017; GO:0004550; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006225; GO:0015630; GO:0031514; GO:0031965; GO:0033862; GO:0036430; GO:0036431; GO:0046705; GO:0047506; GO:0050145; GO:0120238 CDP biosynthetic process [GO:0046705]; UDP biosynthetic process [GO:0006225] cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule cytoskeleton [GO:0015630]; motile cilium [GO:0031514]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; sperm glycocalyx [GO:0120238] AMP kinase activity [GO:0004017]; ATP binding [GO:0005524]; CMP kinase activity [GO:0036430]; dAMP kinase activity [GO:0047506]; dCMP kinase activity [GO:0036431]; nucleoside diphosphate kinase activity [GO:0004550]; nucleoside monophosphate kinase activity [GO:0050145]; UMP kinase activity [GO:0033862] g6060.t4 Q5TCS8 38.88 661 1.0100000000000001e-105 380.0 sp|Q5TCS8|KAD9_HUMAN Adenylate kinase 9 OS=Homo sapiens OX=9606 GN=AK9 PE=1 SV=2 KAD9_HUMAN reviewed Adenylate kinase 9 (EC 2.7.4.4) (EC 2.7.4.6) (Adenylate kinase domain-containing protein 1) (Adenylate kinase domain-containing protein 2) Homo sapiens (Human) GO:0004017; GO:0004550; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006225; GO:0015630; GO:0031514; GO:0031965; GO:0033862; GO:0036430; GO:0036431; GO:0046705; GO:0047506; GO:0050145; GO:0120238 CDP biosynthetic process [GO:0046705]; UDP biosynthetic process [GO:0006225] cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule cytoskeleton [GO:0015630]; motile cilium [GO:0031514]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; sperm glycocalyx [GO:0120238] AMP kinase activity [GO:0004017]; ATP binding [GO:0005524]; CMP kinase activity [GO:0036430]; dAMP kinase activity [GO:0047506]; dCMP kinase activity [GO:0036431]; nucleoside diphosphate kinase activity [GO:0004550]; nucleoside monophosphate kinase activity [GO:0050145]; UMP kinase activity [GO:0033862] g6061.t1 G3V7L1 53.061 196 1.3800000000000001e-65 223.0 sp|G3V7L1|UTRN_RAT Utrophin OS=Rattus norvegicus OX=10116 GN=Utrn PE=1 SV=3 UTRN_RAT reviewed Utrophin (Dystrophin-related protein 1) (DRP-1) Rattus norvegicus (Rat) GO:0001954; GO:0003779; GO:0005178; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0005929; GO:0007528; GO:0008270; GO:0014894; GO:0016010; GO:0017166; GO:0019901; GO:0030175; GO:0030426; GO:0030864; GO:0031527; GO:0031594; GO:0032991; GO:0036064; GO:0042383; GO:0045202; GO:0045211; GO:0051015; GO:0070938; GO:0099536 neuromuscular junction development [GO:0007528]; positive regulation of cell-matrix adhesion [GO:0001954]; response to denervation involved in regulation of muscle adaptation [GO:0014894]; synaptic signaling [GO:0099536] ciliary basal body [GO:0036064]; cilium [GO:0005929]; contractile ring [GO:0070938]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dystrophin-associated glycoprotein complex [GO:0016010]; filopodium [GO:0030175]; filopodium membrane [GO:0031527]; growth cone [GO:0030426]; neuromuscular junction [GO:0031594]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; protein-containing complex [GO:0032991]; sarcolemma [GO:0042383]; synapse [GO:0045202] actin binding [GO:0003779]; actin filament binding [GO:0051015]; integrin binding [GO:0005178]; protein kinase binding [GO:0019901]; vinculin binding [GO:0017166]; zinc ion binding [GO:0008270] g6062.t1 P11533 33.559 1475 0.0 747.0 sp|P11533|DMD_CHICK Dystrophin OS=Gallus gallus OX=9031 GN=DMD PE=2 SV=1 g6063.t1 P11530 28.219 567 2.14e-57 216.0 sp|P11530|DMD_RAT Dystrophin OS=Rattus norvegicus OX=10116 GN=Dmd PE=1 SV=2 DMD_RAT reviewed Dystrophin Rattus norvegicus (Rat) GO:0001954; GO:0002027; GO:0002162; GO:0003779; GO:0005178; GO:0005521; GO:0005634; GO:0005741; GO:0005840; GO:0005883; GO:0005886; GO:0006355; GO:0006915; GO:0006941; GO:0006954; GO:0007271; GO:0007517; GO:0007519; GO:0008065; GO:0008104; GO:0008270; GO:0008284; GO:0008307; GO:0008340; GO:0009410; GO:0009986; GO:0010467; GO:0010468; GO:0010880; GO:0010881; GO:0010976; GO:0014069; GO:0014809; GO:0014819; GO:0014894; GO:0014904; GO:0016010; GO:0017022; GO:0017166; GO:0021629; GO:0021987; GO:0030016; GO:0030018; GO:0030027; GO:0030054; GO:0030055; GO:0030141; GO:0030154; GO:0030165; GO:0030175; GO:0030182; GO:0030424; GO:0030672; GO:0031527; GO:0032991; GO:0035264; GO:0035994; GO:0042383; GO:0042391; GO:0042692; GO:0042995; GO:0043025; GO:0043034; GO:0043043; GO:0043403; GO:0044306; GO:0044877; GO:0045121; GO:0045202; GO:0045211; GO:0045665; GO:0045666; GO:0046716; GO:0048471; GO:0048666; GO:0048812; GO:0050998; GO:0051647; GO:0055001; GO:0055002; GO:0060048; GO:0060173; GO:0060348; GO:0060857; GO:0061448; GO:0065003; GO:0070373; GO:0086001; GO:0090257; GO:0090287; GO:0090659; GO:0097449; GO:0098794; GO:0098982; GO:0099536; GO:0099572; GO:0099617; GO:1902305; GO:1903169; GO:1903409 apoptotic process [GO:0006915]; bone development [GO:0060348]; cardiac muscle cell action potential [GO:0086001]; cardiac muscle contraction [GO:0060048]; cell differentiation [GO:0030154]; cerebral cortex development [GO:0021987]; connective tissue development [GO:0061448]; determination of adult lifespan [GO:0008340]; establishment of blood-nerve barrier [GO:0008065]; establishment of glial blood-brain barrier [GO:0060857]; gene expression [GO:0010467]; inflammatory response [GO:0006954]; intracellular protein localization [GO:0008104]; limb development [GO:0060173]; multicellular organism growth [GO:0035264]; muscle cell cellular homeostasis [GO:0046716]; muscle cell development [GO:0055001]; muscle cell differentiation [GO:0042692]; muscle organ development [GO:0007517]; myotube cell development [GO:0014904]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of neuron differentiation [GO:0045665]; neuron development [GO:0048666]; neuron differentiation [GO:0030182]; neuron projection morphogenesis [GO:0048812]; nucleus localization [GO:0051647]; olfactory nerve structural organization [GO:0021629]; peptide biosynthetic process [GO:0043043]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of neuron projection development [GO:0010976]; protein-containing complex assembly [GO:0065003]; reactive oxygen species biosynthetic process [GO:1903409]; regulation of calcium ion transmembrane transport [GO:1903169]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of cellular response to growth factor stimulus [GO:0090287]; regulation of DNA-templated transcription [GO:0006355]; regulation of gene expression [GO:0010468]; regulation of heart rate [GO:0002027]; regulation of membrane potential [GO:0042391]; regulation of muscle system process [GO:0090257]; regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0010880]; regulation of skeletal muscle contraction [GO:0014819]; regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion [GO:0014809]; regulation of sodium ion transmembrane transport [GO:1902305]; response to denervation involved in regulation of muscle adaptation [GO:0014894]; response to muscle stretch [GO:0035994]; response to xenobiotic stimulus [GO:0009410]; skeletal muscle tissue development [GO:0007519]; skeletal muscle tissue regeneration [GO:0043403]; striated muscle cell development [GO:0055002]; striated muscle contraction [GO:0006941]; synaptic signaling [GO:0099536]; synaptic transmission, cholinergic [GO:0007271]; walking behavior [GO:0090659] astrocyte projection [GO:0097449]; axon [GO:0030424]; cell junction [GO:0030054]; cell projection [GO:0042995]; cell surface [GO:0009986]; cell-substrate junction [GO:0030055]; costamere [GO:0043034]; dystrophin-associated glycoprotein complex [GO:0016010]; filopodium [GO:0030175]; filopodium membrane [GO:0031527]; GABA-ergic synapse [GO:0098982]; lamellipodium [GO:0030027]; matrix side of mitochondrial inner membrane [GO:0099617]; membrane raft [GO:0045121]; mitochondrial outer membrane [GO:0005741]; myofibril [GO:0030016]; neurofilament [GO:0005883]; neuron projection terminus [GO:0044306]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; postsynaptic specialization [GO:0099572]; protein-containing complex [GO:0032991]; ribosome [GO:0005840]; sarcolemma [GO:0042383]; secretory granule [GO:0030141]; synapse [GO:0045202]; synaptic vesicle membrane [GO:0030672]; Z disc [GO:0030018] actin binding [GO:0003779]; dystroglycan binding [GO:0002162]; integrin binding [GO:0005178]; lamin binding [GO:0005521]; myosin binding [GO:0017022]; nitric-oxide synthase binding [GO:0050998]; PDZ domain binding [GO:0030165]; protein-containing complex binding [GO:0044877]; structural constituent of muscle [GO:0008307]; vinculin binding [GO:0017166]; zinc ion binding [GO:0008270] g6064.t1 P11533 31.696 224 3.4199999999999996e-23 102.0 sp|P11533|DMD_CHICK Dystrophin OS=Gallus gallus OX=9031 GN=DMD PE=2 SV=1 g6065.t1 P11532 51.215 988 0.0 971.0 sp|P11532|DMD_HUMAN Dystrophin OS=Homo sapiens OX=9606 GN=DMD PE=1 SV=4 DMD_HUMAN reviewed Dystrophin Homo sapiens (Human) GO:0002027; GO:0002162; GO:0003779; GO:0005200; GO:0005634; GO:0005829; GO:0005856; GO:0005886; GO:0007517; GO:0007519; GO:0008104; GO:0008270; GO:0008307; GO:0009986; GO:0010880; GO:0010881; GO:0010976; GO:0014809; GO:0014819; GO:0016010; GO:0016013; GO:0017022; GO:0017166; GO:0030018; GO:0030055; GO:0030175; GO:0031527; GO:0032991; GO:0035633; GO:0035994; GO:0042383; GO:0043034; GO:0043043; GO:0044306; GO:0044458; GO:0045121; GO:0045202; GO:0045211; GO:0045666; GO:0046716; GO:0048666; GO:0050998; GO:0055001; GO:0060048; GO:0065003; GO:0086001; GO:0090257; GO:0090287; GO:0099536; GO:1902305; GO:1903169 cardiac muscle cell action potential [GO:0086001]; cardiac muscle contraction [GO:0060048]; intracellular protein localization [GO:0008104]; maintenance of blood-brain barrier [GO:0035633]; motile cilium assembly [GO:0044458]; muscle cell cellular homeostasis [GO:0046716]; muscle cell development [GO:0055001]; muscle organ development [GO:0007517]; neuron development [GO:0048666]; peptide biosynthetic process [GO:0043043]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of neuron projection development [GO:0010976]; protein-containing complex assembly [GO:0065003]; regulation of calcium ion transmembrane transport [GO:1903169]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of cellular response to growth factor stimulus [GO:0090287]; regulation of heart rate [GO:0002027]; regulation of muscle system process [GO:0090257]; regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0010880]; regulation of skeletal muscle contraction [GO:0014819]; regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion [GO:0014809]; regulation of sodium ion transmembrane transport [GO:1902305]; response to muscle stretch [GO:0035994]; skeletal muscle tissue development [GO:0007519]; synaptic signaling [GO:0099536] cell surface [GO:0009986]; cell-substrate junction [GO:0030055]; costamere [GO:0043034]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dystrophin-associated glycoprotein complex [GO:0016010]; filopodium [GO:0030175]; filopodium membrane [GO:0031527]; membrane raft [GO:0045121]; neuron projection terminus [GO:0044306]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; protein-containing complex [GO:0032991]; sarcolemma [GO:0042383]; synapse [GO:0045202]; syntrophin complex [GO:0016013]; Z disc [GO:0030018] actin binding [GO:0003779]; dystroglycan binding [GO:0002162]; myosin binding [GO:0017022]; nitric-oxide synthase binding [GO:0050998]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; vinculin binding [GO:0017166]; zinc ion binding [GO:0008270] g6069.t1 Q3UGY8 37.492 1547 0.0 803.0 sp|Q3UGY8|BIG3_MOUSE Brefeldin A-inhibited guanine nucleotide-exchange protein 3 OS=Mus musculus OX=10090 GN=Arfgef3 PE=1 SV=1 g6070.t1 Q3UGY8 39.463 484 2.32e-78 279.0 sp|Q3UGY8|BIG3_MOUSE Brefeldin A-inhibited guanine nucleotide-exchange protein 3 OS=Mus musculus OX=10090 GN=Arfgef3 PE=1 SV=1 g6071.t1 Q8N5D0 51.403 677 0.0 661.0 sp|Q8N5D0|WDTC1_HUMAN WD and tetratricopeptide repeats protein 1 OS=Homo sapiens OX=9606 GN=WDTC1 PE=1 SV=2 g6072.t1 Q6AZA0 70.588 238 1.11e-120 354.0 sp|Q6AZA0|THIL_DANRE Acetyl-CoA acetyltransferase, mitochondrial OS=Danio rerio OX=7955 GN=acat1 PE=2 SV=1 g6073.t1 Q6AZA0 67.2 125 1.31e-50 169.0 sp|Q6AZA0|THIL_DANRE Acetyl-CoA acetyltransferase, mitochondrial OS=Danio rerio OX=7955 GN=acat1 PE=2 SV=1 g6074.t1 Q9Y2G4 31.239 557 6.79e-57 213.0 sp|Q9Y2G4|ANKR6_HUMAN Ankyrin repeat domain-containing protein 6 OS=Homo sapiens OX=9606 GN=ANKRD6 PE=1 SV=3 g6074.t2 Q69ZU8 32.169 544 8.749999999999999e-67 240.0 sp|Q69ZU8|ANKR6_MOUSE Ankyrin repeat domain-containing protein 6 OS=Mus musculus OX=10090 GN=Ankrd6 PE=1 SV=2 ANKR6_MOUSE reviewed Ankyrin repeat domain-containing protein 6 (Diversin) Mus musculus (Mouse) GO:0005634; GO:0005737; GO:0007163; GO:0030111; GO:0090090; GO:2000096 establishment or maintenance of cell polarity [GO:0007163]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; positive regulation of Wnt signaling pathway, planar cell polarity pathway [GO:2000096]; regulation of Wnt signaling pathway [GO:0030111] cytoplasm [GO:0005737]; nucleus [GO:0005634] g6075.t1 Q9DEB5 60.606 132 1.3499999999999998e-54 180.0 sp|Q9DEB5|FZ10A_XENLA Frizzled-10-A OS=Xenopus laevis OX=8355 GN=fzd10-a PE=2 SV=1 g6075.t1 Q9DEB5 35.897 78 1.3499999999999998e-54 54.7 sp|Q9DEB5|FZ10A_XENLA Frizzled-10-A OS=Xenopus laevis OX=8355 GN=fzd10-a PE=2 SV=1 g6076.t1 Q9DEB5 61.616 297 3.8800000000000005e-123 368.0 sp|Q9DEB5|FZ10A_XENLA Frizzled-10-A OS=Xenopus laevis OX=8355 GN=fzd10-a PE=2 SV=1 g6077.t1 Q6DDJ5 30.827 266 4.97e-27 119.0 sp|Q6DDJ5|WDCP_XENLA WD repeat and coiled-coil-containing protein OS=Xenopus laevis OX=8355 GN=wdcp PE=2 SV=1 g6085.t1 P52757 54.241 448 1.52e-168 491.0 sp|P52757|CHIO_HUMAN Beta-chimaerin OS=Homo sapiens OX=9606 GN=CHN2 PE=1 SV=2 CHIO_HUMAN reviewed Beta-chimaerin (Beta-chimerin) (Rho GTPase-activating protein 3) Homo sapiens (Human) GO:0001675; GO:0005096; GO:0005829; GO:0007165; GO:0008270; GO:0016020; GO:0045202; GO:0051056 acrosome assembly [GO:0001675]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165] cytosol [GO:0005829]; membrane [GO:0016020]; synapse [GO:0045202] GTPase activator activity [GO:0005096]; zinc ion binding [GO:0008270] g6086.t1 Q4R367 48.992 794 0.0 733.0 sp|Q4R367|UFL1_MACFA E3 UFM1-protein ligase 1 OS=Macaca fascicularis OX=9541 GN=UFL1 PE=2 SV=1 UFL1_MACFA reviewed E3 UFM1-protein ligase 1 (EC 2.3.2.-) (E3 UFM1-protein transferase 1) Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey) GO:0000077; GO:0002841; GO:0005634; GO:0005737; GO:0005783; GO:0005789; GO:0005829; GO:0006281; GO:0006974; GO:0010508; GO:0030218; GO:0031397; GO:0032088; GO:0032434; GO:0032790; GO:0033146; GO:0034976; GO:0035861; GO:0043122; GO:0050727; GO:0050868; GO:0060218; GO:0061666; GO:0061709; GO:0071569; GO:0072344; GO:0140501; GO:1903895; GO:1990592 DNA damage checkpoint signaling [GO:0000077]; DNA damage response [GO:0006974]; DNA repair [GO:0006281]; erythrocyte differentiation [GO:0030218]; hematopoietic stem cell differentiation [GO:0060218]; negative regulation of IRE1-mediated unfolded protein response [GO:1903895]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of T cell activation [GO:0050868]; negative regulation of T cell mediated immune response to tumor cell [GO:0002841]; positive regulation of autophagy [GO:0010508]; positive regulation of reticulophagy [GO:0140501]; protein K69-linked ufmylation [GO:1990592]; protein ufmylation [GO:0071569]; regulation of canonical NF-kappaB signal transduction [GO:0043122]; regulation of inflammatory response [GO:0050727]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146]; regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032434]; rescue of stalled ribosome [GO:0072344]; response to endoplasmic reticulum stress [GO:0034976]; reticulophagy [GO:0061709]; ribosome disassembly [GO:0032790] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; nucleus [GO:0005634]; site of double-strand break [GO:0035861] UFM1 ligase activity [GO:0061666] g6087.t1 Q9JL70 27.43 1101 1.4e-90 327.0 sp|Q9JL70|FANCA_MOUSE Fanconi anemia group A protein homolog OS=Mus musculus OX=10090 GN=Fanca PE=2 SV=2 g6088.t1 Q64331 65.113 622 0.0 853.0 sp|Q64331|MYO6_MOUSE Unconventional myosin-VI OS=Mus musculus OX=10090 GN=Myo6 PE=1 SV=2 MYO6_MOUSE reviewed Unconventional myosin-VI (Protein twist) (Unconventional myosin-6) Mus musculus (Mouse) GO:0000146; GO:0001726; GO:0005516; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005794; GO:0005829; GO:0005886; GO:0005902; GO:0005903; GO:0005905; GO:0006605; GO:0006897; GO:0007015; GO:0007268; GO:0007416; GO:0007605; GO:0007626; GO:0008104; GO:0009410; GO:0012506; GO:0014047; GO:0014069; GO:0015031; GO:0015629; GO:0016358; GO:0016459; GO:0030048; GO:0030136; GO:0030139; GO:0030175; GO:0030330; GO:0030424; GO:0031410; GO:0031941; GO:0031965; GO:0032587; GO:0032991; GO:0042472; GO:0042491; GO:0042802; GO:0043025; GO:0045177; GO:0045202; GO:0048167; GO:0048471; GO:0048839; GO:0051015; GO:0051046; GO:0071257; GO:0098683; GO:0098685; GO:0098833; GO:0098871; GO:0098884; GO:0098978; GO:0099171 actin filament organization [GO:0007015]; actin filament-based movement [GO:0030048]; cellular response to electrical stimulus [GO:0071257]; chemical synaptic transmission [GO:0007268]; dendrite development [GO:0016358]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; endocytosis [GO:0006897]; glutamate secretion [GO:0014047]; inner ear auditory receptor cell differentiation [GO:0042491]; inner ear development [GO:0048839]; inner ear morphogenesis [GO:0042472]; intracellular protein localization [GO:0008104]; locomotory behavior [GO:0007626]; postsynaptic neurotransmitter receptor internalization [GO:0098884]; presynaptic modulation of chemical synaptic transmission [GO:0099171]; protein targeting [GO:0006605]; protein transport [GO:0015031]; regulation of secretion [GO:0051046]; regulation of synaptic plasticity [GO:0048167]; response to xenobiotic stimulus [GO:0009410]; sensory perception of sound [GO:0007605]; synapse assembly [GO:0007416] actin cytoskeleton [GO:0015629]; apical part of cell [GO:0045177]; axon [GO:0030424]; brush border [GO:0005903]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; cochlear hair cell ribbon synapse [GO:0098683]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; filamentous actin [GO:0031941]; filopodium [GO:0030175]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; microvillus [GO:0005902]; myosin complex [GO:0016459]; neuronal cell body [GO:0043025]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic actin cytoskeleton [GO:0098871]; postsynaptic density [GO:0014069]; presynaptic endocytic zone [GO:0098833]; protein-containing complex [GO:0032991]; ruffle [GO:0001726]; ruffle membrane [GO:0032587]; Schaffer collateral - CA1 synapse [GO:0098685]; synapse [GO:0045202]; vesicle membrane [GO:0012506] actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; identical protein binding [GO:0042802]; microfilament motor activity [GO:0000146] g6089.t1 E1BPK6 58.909 275 6.5e-100 334.0 sp|E1BPK6|MYO6_BOVIN Unconventional myosin-VI OS=Bos taurus OX=9913 GN=MYO6 PE=1 SV=4 MYO6_BOVIN reviewed Unconventional myosin-VI (Unconventional myosin-6) Bos taurus (Bovine) GO:0000146; GO:0001726; GO:0005516; GO:0005524; GO:0005654; GO:0005737; GO:0005794; GO:0005829; GO:0005886; GO:0005902; GO:0005905; GO:0006897; GO:0007015; GO:0007605; GO:0008104; GO:0015031; GO:0015629; GO:0016459; GO:0030048; GO:0030139; GO:0030175; GO:0030330; GO:0031941; GO:0031965; GO:0032587; GO:0042472; GO:0042491; GO:0045334; GO:0048471; GO:0051015; GO:0051046 actin filament organization [GO:0007015]; actin filament-based movement [GO:0030048]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; endocytosis [GO:0006897]; inner ear auditory receptor cell differentiation [GO:0042491]; inner ear morphogenesis [GO:0042472]; intracellular protein localization [GO:0008104]; protein transport [GO:0015031]; regulation of secretion [GO:0051046]; sensory perception of sound [GO:0007605] actin cytoskeleton [GO:0015629]; clathrin-coated endocytic vesicle [GO:0045334]; clathrin-coated pit [GO:0005905]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; filamentous actin [GO:0031941]; filopodium [GO:0030175]; Golgi apparatus [GO:0005794]; microvillus [GO:0005902]; myosin complex [GO:0016459]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; ruffle membrane [GO:0032587] actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146] g6089.t1 E1BPK6 54.854 206 3.57e-63 230.0 sp|E1BPK6|MYO6_BOVIN Unconventional myosin-VI OS=Bos taurus OX=9913 GN=MYO6 PE=1 SV=4 MYO6_BOVIN reviewed Unconventional myosin-VI (Unconventional myosin-6) Bos taurus (Bovine) GO:0000146; GO:0001726; GO:0005516; GO:0005524; GO:0005654; GO:0005737; GO:0005794; GO:0005829; GO:0005886; GO:0005902; GO:0005905; GO:0006897; GO:0007015; GO:0007605; GO:0008104; GO:0015031; GO:0015629; GO:0016459; GO:0030048; GO:0030139; GO:0030175; GO:0030330; GO:0031941; GO:0031965; GO:0032587; GO:0042472; GO:0042491; GO:0045334; GO:0048471; GO:0051015; GO:0051046 actin filament organization [GO:0007015]; actin filament-based movement [GO:0030048]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; endocytosis [GO:0006897]; inner ear auditory receptor cell differentiation [GO:0042491]; inner ear morphogenesis [GO:0042472]; intracellular protein localization [GO:0008104]; protein transport [GO:0015031]; regulation of secretion [GO:0051046]; sensory perception of sound [GO:0007605] actin cytoskeleton [GO:0015629]; clathrin-coated endocytic vesicle [GO:0045334]; clathrin-coated pit [GO:0005905]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; filamentous actin [GO:0031941]; filopodium [GO:0030175]; Golgi apparatus [GO:0005794]; microvillus [GO:0005902]; myosin complex [GO:0016459]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; ruffle membrane [GO:0032587] actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146] g6089.t2 E1BPK6 58.909 275 4.53e-100 334.0 sp|E1BPK6|MYO6_BOVIN Unconventional myosin-VI OS=Bos taurus OX=9913 GN=MYO6 PE=1 SV=4 MYO6_BOVIN reviewed Unconventional myosin-VI (Unconventional myosin-6) Bos taurus (Bovine) GO:0000146; GO:0001726; GO:0005516; GO:0005524; GO:0005654; GO:0005737; GO:0005794; GO:0005829; GO:0005886; GO:0005902; GO:0005905; GO:0006897; GO:0007015; GO:0007605; GO:0008104; GO:0015031; GO:0015629; GO:0016459; GO:0030048; GO:0030139; GO:0030175; GO:0030330; GO:0031941; GO:0031965; GO:0032587; GO:0042472; GO:0042491; GO:0045334; GO:0048471; GO:0051015; GO:0051046 actin filament organization [GO:0007015]; actin filament-based movement [GO:0030048]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; endocytosis [GO:0006897]; inner ear auditory receptor cell differentiation [GO:0042491]; inner ear morphogenesis [GO:0042472]; intracellular protein localization [GO:0008104]; protein transport [GO:0015031]; regulation of secretion [GO:0051046]; sensory perception of sound [GO:0007605] actin cytoskeleton [GO:0015629]; clathrin-coated endocytic vesicle [GO:0045334]; clathrin-coated pit [GO:0005905]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; filamentous actin [GO:0031941]; filopodium [GO:0030175]; Golgi apparatus [GO:0005794]; microvillus [GO:0005902]; myosin complex [GO:0016459]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; ruffle membrane [GO:0032587] actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146] g6089.t2 E1BPK6 54.854 206 2.65e-63 230.0 sp|E1BPK6|MYO6_BOVIN Unconventional myosin-VI OS=Bos taurus OX=9913 GN=MYO6 PE=1 SV=4 MYO6_BOVIN reviewed Unconventional myosin-VI (Unconventional myosin-6) Bos taurus (Bovine) GO:0000146; GO:0001726; GO:0005516; GO:0005524; GO:0005654; GO:0005737; GO:0005794; GO:0005829; GO:0005886; GO:0005902; GO:0005905; GO:0006897; GO:0007015; GO:0007605; GO:0008104; GO:0015031; GO:0015629; GO:0016459; GO:0030048; GO:0030139; GO:0030175; GO:0030330; GO:0031941; GO:0031965; GO:0032587; GO:0042472; GO:0042491; GO:0045334; GO:0048471; GO:0051015; GO:0051046 actin filament organization [GO:0007015]; actin filament-based movement [GO:0030048]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; endocytosis [GO:0006897]; inner ear auditory receptor cell differentiation [GO:0042491]; inner ear morphogenesis [GO:0042472]; intracellular protein localization [GO:0008104]; protein transport [GO:0015031]; regulation of secretion [GO:0051046]; sensory perception of sound [GO:0007605] actin cytoskeleton [GO:0015629]; clathrin-coated endocytic vesicle [GO:0045334]; clathrin-coated pit [GO:0005905]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; filamentous actin [GO:0031941]; filopodium [GO:0030175]; Golgi apparatus [GO:0005794]; microvillus [GO:0005902]; myosin complex [GO:0016459]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; ruffle membrane [GO:0032587] actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146] g6089.t3 E1BPK6 58.909 275 6.5e-100 334.0 sp|E1BPK6|MYO6_BOVIN Unconventional myosin-VI OS=Bos taurus OX=9913 GN=MYO6 PE=1 SV=4 MYO6_BOVIN reviewed Unconventional myosin-VI (Unconventional myosin-6) Bos taurus (Bovine) GO:0000146; GO:0001726; GO:0005516; GO:0005524; GO:0005654; GO:0005737; GO:0005794; GO:0005829; GO:0005886; GO:0005902; GO:0005905; GO:0006897; GO:0007015; GO:0007605; GO:0008104; GO:0015031; GO:0015629; GO:0016459; GO:0030048; GO:0030139; GO:0030175; GO:0030330; GO:0031941; GO:0031965; GO:0032587; GO:0042472; GO:0042491; GO:0045334; GO:0048471; GO:0051015; GO:0051046 actin filament organization [GO:0007015]; actin filament-based movement [GO:0030048]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; endocytosis [GO:0006897]; inner ear auditory receptor cell differentiation [GO:0042491]; inner ear morphogenesis [GO:0042472]; intracellular protein localization [GO:0008104]; protein transport [GO:0015031]; regulation of secretion [GO:0051046]; sensory perception of sound [GO:0007605] actin cytoskeleton [GO:0015629]; clathrin-coated endocytic vesicle [GO:0045334]; clathrin-coated pit [GO:0005905]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; filamentous actin [GO:0031941]; filopodium [GO:0030175]; Golgi apparatus [GO:0005794]; microvillus [GO:0005902]; myosin complex [GO:0016459]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; ruffle membrane [GO:0032587] actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146] g6089.t3 E1BPK6 54.854 206 3.57e-63 230.0 sp|E1BPK6|MYO6_BOVIN Unconventional myosin-VI OS=Bos taurus OX=9913 GN=MYO6 PE=1 SV=4 MYO6_BOVIN reviewed Unconventional myosin-VI (Unconventional myosin-6) Bos taurus (Bovine) GO:0000146; GO:0001726; GO:0005516; GO:0005524; GO:0005654; GO:0005737; GO:0005794; GO:0005829; GO:0005886; GO:0005902; GO:0005905; GO:0006897; GO:0007015; GO:0007605; GO:0008104; GO:0015031; GO:0015629; GO:0016459; GO:0030048; GO:0030139; GO:0030175; GO:0030330; GO:0031941; GO:0031965; GO:0032587; GO:0042472; GO:0042491; GO:0045334; GO:0048471; GO:0051015; GO:0051046 actin filament organization [GO:0007015]; actin filament-based movement [GO:0030048]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; endocytosis [GO:0006897]; inner ear auditory receptor cell differentiation [GO:0042491]; inner ear morphogenesis [GO:0042472]; intracellular protein localization [GO:0008104]; protein transport [GO:0015031]; regulation of secretion [GO:0051046]; sensory perception of sound [GO:0007605] actin cytoskeleton [GO:0015629]; clathrin-coated endocytic vesicle [GO:0045334]; clathrin-coated pit [GO:0005905]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; filamentous actin [GO:0031941]; filopodium [GO:0030175]; Golgi apparatus [GO:0005794]; microvillus [GO:0005902]; myosin complex [GO:0016459]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; ruffle membrane [GO:0032587] actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146] g6089.t4 E1BPK6 58.909 275 6.5e-100 334.0 sp|E1BPK6|MYO6_BOVIN Unconventional myosin-VI OS=Bos taurus OX=9913 GN=MYO6 PE=1 SV=4 MYO6_BOVIN reviewed Unconventional myosin-VI (Unconventional myosin-6) Bos taurus (Bovine) GO:0000146; GO:0001726; GO:0005516; GO:0005524; GO:0005654; GO:0005737; GO:0005794; GO:0005829; GO:0005886; GO:0005902; GO:0005905; GO:0006897; GO:0007015; GO:0007605; GO:0008104; GO:0015031; GO:0015629; GO:0016459; GO:0030048; GO:0030139; GO:0030175; GO:0030330; GO:0031941; GO:0031965; GO:0032587; GO:0042472; GO:0042491; GO:0045334; GO:0048471; GO:0051015; GO:0051046 actin filament organization [GO:0007015]; actin filament-based movement [GO:0030048]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; endocytosis [GO:0006897]; inner ear auditory receptor cell differentiation [GO:0042491]; inner ear morphogenesis [GO:0042472]; intracellular protein localization [GO:0008104]; protein transport [GO:0015031]; regulation of secretion [GO:0051046]; sensory perception of sound [GO:0007605] actin cytoskeleton [GO:0015629]; clathrin-coated endocytic vesicle [GO:0045334]; clathrin-coated pit [GO:0005905]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; filamentous actin [GO:0031941]; filopodium [GO:0030175]; Golgi apparatus [GO:0005794]; microvillus [GO:0005902]; myosin complex [GO:0016459]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; ruffle membrane [GO:0032587] actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146] g6089.t4 E1BPK6 54.854 206 3.57e-63 230.0 sp|E1BPK6|MYO6_BOVIN Unconventional myosin-VI OS=Bos taurus OX=9913 GN=MYO6 PE=1 SV=4 MYO6_BOVIN reviewed Unconventional myosin-VI (Unconventional myosin-6) Bos taurus (Bovine) GO:0000146; GO:0001726; GO:0005516; GO:0005524; GO:0005654; GO:0005737; GO:0005794; GO:0005829; GO:0005886; GO:0005902; GO:0005905; GO:0006897; GO:0007015; GO:0007605; GO:0008104; GO:0015031; GO:0015629; GO:0016459; GO:0030048; GO:0030139; GO:0030175; GO:0030330; GO:0031941; GO:0031965; GO:0032587; GO:0042472; GO:0042491; GO:0045334; GO:0048471; GO:0051015; GO:0051046 actin filament organization [GO:0007015]; actin filament-based movement [GO:0030048]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; endocytosis [GO:0006897]; inner ear auditory receptor cell differentiation [GO:0042491]; inner ear morphogenesis [GO:0042472]; intracellular protein localization [GO:0008104]; protein transport [GO:0015031]; regulation of secretion [GO:0051046]; sensory perception of sound [GO:0007605] actin cytoskeleton [GO:0015629]; clathrin-coated endocytic vesicle [GO:0045334]; clathrin-coated pit [GO:0005905]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; filamentous actin [GO:0031941]; filopodium [GO:0030175]; Golgi apparatus [GO:0005794]; microvillus [GO:0005902]; myosin complex [GO:0016459]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; ruffle membrane [GO:0032587] actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146] g6091.t1 Q9Y6P5 52.761 163 8.28e-51 175.0 sp|Q9Y6P5|SESN1_HUMAN Sestrin-1 OS=Homo sapiens OX=9606 GN=SESN1 PE=1 SV=2 SESN1_HUMAN reviewed Sestrin-1 (EC 1.11.1.-) (p53-regulated protein PA26) Homo sapiens (Human) GO:0001650; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0016239; GO:0016684; GO:0030308; GO:0034198; GO:0042149; GO:0051896; GO:0070728; GO:0071233; GO:0072593; GO:0098869; GO:1901031; GO:1904262; GO:1990253 cellular oxidant detoxification [GO:0098869]; cellular response to amino acid starvation [GO:0034198]; cellular response to glucose starvation [GO:0042149]; cellular response to L-leucine [GO:0071233]; cellular response to leucine starvation [GO:1990253]; negative regulation of cell growth [GO:0030308]; negative regulation of TORC1 signaling [GO:1904262]; positive regulation of macroautophagy [GO:0016239]; reactive oxygen species metabolic process [GO:0072593]; regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051896]; regulation of response to reactive oxygen species [GO:1901031] cytoplasm [GO:0005737]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] L-leucine binding [GO:0070728]; oxidoreductase activity, acting on peroxide as acceptor [GO:0016684] g6092.t1 P58005 60.0 160 4.3600000000000005e-64 210.0 sp|P58005|SESN3_HUMAN Sestrin-3 OS=Homo sapiens OX=9606 GN=SESN3 PE=1 SV=2 SESN3_HUMAN reviewed Sestrin-3 (EC 1.11.1.-) Homo sapiens (Human) GO:0005634; GO:0005737; GO:0016239; GO:0016684; GO:0031932; GO:0032868; GO:0034198; GO:0038203; GO:0042149; GO:0042593; GO:0046626; GO:0051896; GO:0070728; GO:0071233; GO:1901031; GO:1904262; GO:1990253 cellular response to amino acid starvation [GO:0034198]; cellular response to glucose starvation [GO:0042149]; cellular response to L-leucine [GO:0071233]; cellular response to leucine starvation [GO:1990253]; glucose homeostasis [GO:0042593]; negative regulation of TORC1 signaling [GO:1904262]; positive regulation of macroautophagy [GO:0016239]; regulation of insulin receptor signaling pathway [GO:0046626]; regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051896]; regulation of response to reactive oxygen species [GO:1901031]; response to insulin [GO:0032868]; TORC2 signaling [GO:0038203] cytoplasm [GO:0005737]; nucleus [GO:0005634]; TORC2 complex [GO:0031932] L-leucine binding [GO:0070728]; oxidoreductase activity, acting on peroxide as acceptor [GO:0016684] g6093.t1 Q8AYA4 32.653 147 3.57e-21 87.0 sp|Q8AYA4|SLB1_DEIAC Snaclec agglucetin subunit beta-1 OS=Deinagkistrodon acutus OX=36307 PE=1 SV=1 g6095.t1 P27012 36.744 215 1.32e-43 148.0 sp|P27012|SCRY4_ENTDO S-crystallin 4 OS=Enteroctopus dofleini OX=267067 PE=2 SV=1 g6096.t1 P18426 38.35 206 1.63e-39 137.0 sp|P18426|SCR11_NOTSL S-crystallin SL11 OS=Nototodarus sloanii OX=215440 PE=2 SV=1 g6102.t1 P39087 46.893 853 0.0 768.0 sp|P39087|GRIK2_MOUSE Glutamate receptor ionotropic, kainate 2 OS=Mus musculus OX=10090 GN=Grik2 PE=1 SV=4 g6104.t1 P42260 48.414 725 0.0 644.0 sp|P42260|GRIK2_RAT Glutamate receptor ionotropic, kainate 2 OS=Rattus norvegicus OX=10116 GN=Grik2 PE=1 SV=2 g6108.t1 Q8IZF6 35.843 332 4.7699999999999995e-62 220.0 sp|Q8IZF6|AGRG4_HUMAN Adhesion G-protein coupled receptor G4 OS=Homo sapiens OX=9606 GN=ADGRG4 PE=1 SV=2 AGRG4_HUMAN reviewed Adhesion G-protein coupled receptor G4 (G-protein coupled receptor 112) [Cleaved into: Adhesion G-protein coupled receptor G4, N-terminal fragment (ADGRG4 N-terminal fragment); Adhesion G-protein coupled receptor G4, C-terminal fragment (ADGRG4 C-terminal fragment)] Homo sapiens (Human) GO:0004930; GO:0005886; GO:0007166; GO:0007186; GO:0007189; GO:0016020 adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186] membrane [GO:0016020]; plasma membrane [GO:0005886] G protein-coupled receptor activity [GO:0004930] g6111.t1 Q7ZWY2 48.814 295 1.78e-102 305.0 sp|Q7ZWY2|PIHD1_XENLA PIH1 domain-containing protein 1 OS=Xenopus laevis OX=8355 GN=pih1d1 PE=2 SV=1 g6111.t2 Q7ZWY2 48.814 295 1.78e-102 305.0 sp|Q7ZWY2|PIHD1_XENLA PIH1 domain-containing protein 1 OS=Xenopus laevis OX=8355 GN=pih1d1 PE=2 SV=1 g6111.t3 Q7ZWY2 48.814 295 1.78e-102 305.0 sp|Q7ZWY2|PIHD1_XENLA PIH1 domain-containing protein 1 OS=Xenopus laevis OX=8355 GN=pih1d1 PE=2 SV=1 g6113.t1 Q8IY45 45.6 250 1.48e-77 238.0 sp|Q8IY45|AMN1_HUMAN Protein AMN1 homolog OS=Homo sapiens OX=9606 GN=AMN1 PE=1 SV=4 g6115.t1 Q80XN0 46.383 235 1.14e-72 229.0 sp|Q80XN0|BDH_MOUSE D-beta-hydroxybutyrate dehydrogenase, mitochondrial OS=Mus musculus OX=10090 GN=Bdh1 PE=1 SV=2 g6116.t1 Q05927 45.936 566 6.42e-154 457.0 sp|Q05927|5NTD_BOVIN 5'-nucleotidase OS=Bos taurus OX=9913 GN=NT5E PE=1 SV=2 5NTD_BOVIN reviewed 5'-nucleotidase (5'-NT) (EC 3.1.3.35) (EC 3.1.3.5) (EC 3.1.3.89) (EC 3.1.3.91) (EC 3.1.3.99) (5'-deoxynucleotidase) (Ecto-5'-nucleotidase) (IMP-specific 5'-nucleotidase) (Thymidylate 5'-phosphatase) (CD antigen CD73) Bos taurus (Bovine) GO:0000166; GO:0002953; GO:0005886; GO:0006196; GO:0008253; GO:0016020; GO:0042802; GO:0046872; GO:0098552 AMP catabolic process [GO:0006196] membrane [GO:0016020]; plasma membrane [GO:0005886]; side of membrane [GO:0098552] 5'-deoxynucleotidase activity [GO:0002953]; 5'-nucleotidase activity [GO:0008253]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166] g6119.t1 Q9VCA2 36.414 541 9.05e-92 296.0 sp|Q9VCA2|ORCT_DROME Organic cation transporter protein OS=Drosophila melanogaster OX=7227 GN=Orct PE=1 SV=1 g6120.t1 Q9VCA2 36.096 543 2.82e-81 268.0 sp|Q9VCA2|ORCT_DROME Organic cation transporter protein OS=Drosophila melanogaster OX=7227 GN=Orct PE=1 SV=1 g6121.t1 A4IHY1 36.934 287 4.27e-45 156.0 sp|A4IHY1|PSMG1_XENTR Proteasome assembly chaperone 1 OS=Xenopus tropicalis OX=8364 GN=psmg1 PE=2 SV=1 g6124.t1 Q3T0Q8 44.371 302 8.340000000000001e-64 229.0 sp|Q3T0Q8|UT14A_BOVIN U3 small nucleolar RNA-associated protein 14 homolog A OS=Bos taurus OX=9913 GN=UTP14A PE=2 SV=1 UT14A_BOVIN reviewed U3 small nucleolar RNA-associated protein 14 homolog A Bos taurus (Bovine) GO:0005730; GO:0006364; GO:0032040 rRNA processing [GO:0006364] nucleolus [GO:0005730]; small-subunit processome [GO:0032040] g6124.t1 Q3T0Q8 44.0 175 1.13e-25 116.0 sp|Q3T0Q8|UT14A_BOVIN U3 small nucleolar RNA-associated protein 14 homolog A OS=Bos taurus OX=9913 GN=UTP14A PE=2 SV=1 UT14A_BOVIN reviewed U3 small nucleolar RNA-associated protein 14 homolog A Bos taurus (Bovine) GO:0005730; GO:0006364; GO:0032040 rRNA processing [GO:0006364] nucleolus [GO:0005730]; small-subunit processome [GO:0032040] g6125.t1 Q6P7W0 57.265 117 9.250000000000001e-35 148.0 sp|Q6P7W0|SENP6_MOUSE Sentrin-specific protease 6 OS=Mus musculus OX=10090 GN=Senp6 PE=1 SV=3 SENP6_MOUSE reviewed Sentrin-specific protease 6 (EC 3.4.22.-) (SUMO-1-specific protease 1) (Sentrin/SUMO-specific protease SENP6) Mus musculus (Mouse) GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006508; GO:0016925; GO:0016926; GO:0070139; GO:0070646; GO:0090169; GO:0090234; GO:0099523; GO:0099524 protein desumoylation [GO:0016926]; protein modification by small protein removal [GO:0070646]; protein sumoylation [GO:0016925]; proteolysis [GO:0006508]; regulation of kinetochore assembly [GO:0090234]; regulation of spindle assembly [GO:0090169] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynaptic cytosol [GO:0099524]; presynaptic cytosol [GO:0099523] SUMO-specific endopeptidase activity [GO:0070139] g6125.t1 Q6P7W0 49.587 121 4.1499999999999996e-30 133.0 sp|Q6P7W0|SENP6_MOUSE Sentrin-specific protease 6 OS=Mus musculus OX=10090 GN=Senp6 PE=1 SV=3 SENP6_MOUSE reviewed Sentrin-specific protease 6 (EC 3.4.22.-) (SUMO-1-specific protease 1) (Sentrin/SUMO-specific protease SENP6) Mus musculus (Mouse) GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006508; GO:0016925; GO:0016926; GO:0070139; GO:0070646; GO:0090169; GO:0090234; GO:0099523; GO:0099524 protein desumoylation [GO:0016926]; protein modification by small protein removal [GO:0070646]; protein sumoylation [GO:0016925]; proteolysis [GO:0006508]; regulation of kinetochore assembly [GO:0090234]; regulation of spindle assembly [GO:0090169] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynaptic cytosol [GO:0099524]; presynaptic cytosol [GO:0099523] SUMO-specific endopeptidase activity [GO:0070139] g6126.t1 Q9UBI9 50.5 200 1.74e-62 217.0 sp|Q9UBI9|HDC_HUMAN Headcase protein homolog OS=Homo sapiens OX=9606 GN=HECA PE=1 SV=1 g6126.t1 Q9UBI9 50.476 105 7.17e-28 121.0 sp|Q9UBI9|HDC_HUMAN Headcase protein homolog OS=Homo sapiens OX=9606 GN=HECA PE=1 SV=1 g6127.t1 P20825 33.846 260 1.0400000000000001e-36 150.0 sp|P20825|POL2_DROME Retrovirus-related Pol polyprotein from transposon 297 OS=Drosophila melanogaster OX=7227 GN=pol PE=4 SV=1 g6128.t1 Q8I7P9 34.337 166 1.84e-22 96.7 sp|Q8I7P9|POL5_DROME Retrovirus-related Pol polyprotein from transposon opus OS=Drosophila melanogaster OX=7227 GN=pol PE=4 SV=1 g6129.t1 Q5XHA8 71.504 565 0.0 786.0 sp|Q5XHA8|PYG1A_XENLA CTP synthase 1-A OS=Xenopus laevis OX=8355 GN=ctps1-a PE=2 SV=1 PYG1A_XENLA reviewed CTP synthase 1-A (EC 6.3.4.2) (CTP synthetase 1-A) (Protein-asparagine deamidase CTPS1-A) (EC 3.5.1.-) (UTP--ammonia ligase 1-A) Xenopus laevis (African clawed frog) GO:0000785; GO:0003883; GO:0005524; GO:0005634; GO:0005737; GO:0006241; GO:0019856; GO:0032480; GO:0042802; GO:0044210; GO:0097268; GO:0140861; GO:0160260; GO:0160264; GO:1902340 'de novo' CTP biosynthetic process [GO:0044210]; CTP biosynthetic process [GO:0006241]; DNA repair-dependent chromatin remodeling [GO:0140861]; negative regulation of chromosome condensation [GO:1902340]; negative regulation of type I interferon production [GO:0032480]; pyrimidine nucleobase biosynthetic process [GO:0019856] chromatin [GO:0000785]; cytoophidium [GO:0097268]; cytoplasm [GO:0005737]; nucleus [GO:0005634] ATP binding [GO:0005524]; CTP synthase activity [GO:0003883]; histone H1N76/N77 asparagine deamidase activity [GO:0160264]; identical protein binding [GO:0042802]; protein asparagine deamidase activity [GO:0160260] g6130.t1 Q7SXM0 55.08 374 4.33e-118 359.0 sp|Q7SXM0|HDAC8_DANRE Histone deacetylase 8 OS=Danio rerio OX=7955 GN=hdac8 PE=2 SV=1 HDAC8_DANRE reviewed Histone deacetylase 8 (HD8) (EC 3.5.1.98) (Protein deacetylase HDAC8) (EC 3.5.1.-) (Protein decrotonylase HDAC8) (EC 3.5.1.-) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000118; GO:0004407; GO:0005694; GO:0005737; GO:0007417; GO:0031507; GO:0046872; GO:0070050; GO:0141221; GO:0160009 central nervous system development [GO:0007417]; heterochromatin formation [GO:0031507]; neuron cellular homeostasis [GO:0070050] chromosome [GO:0005694]; cytoplasm [GO:0005737]; histone deacetylase complex [GO:0000118] histone deacetylase activity [GO:0004407]; histone deacetylase activity, hydrolytic mechanism [GO:0141221]; histone decrotonylase activity [GO:0160009]; metal ion binding [GO:0046872] g6132.t1 Q9Y5B6 40.659 728 1.33e-150 469.0 sp|Q9Y5B6|PAXB1_HUMAN PAX3- and PAX7-binding protein 1 OS=Homo sapiens OX=9606 GN=PAXBP1 PE=1 SV=2 PAXB1_HUMAN reviewed PAX3- and PAX7-binding protein 1 (GC-rich sequence DNA-binding factor 1) Homo sapiens (Human) GO:0000398; GO:0003677; GO:0005634; GO:0005829; GO:0006366; GO:0007517; GO:0014842; GO:0045944; GO:1990226; GO:2000288 mRNA splicing, via spliceosome [GO:0000398]; muscle organ development [GO:0007517]; positive regulation of myoblast proliferation [GO:2000288]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of skeletal muscle satellite cell proliferation [GO:0014842]; transcription by RNA polymerase II [GO:0006366] cytosol [GO:0005829]; nucleus [GO:0005634] DNA binding [GO:0003677]; histone methyltransferase binding [GO:1990226] g6133.t1 Q8IVF2 20.301 931 5.05e-39 162.0 sp|Q8IVF2|AHNK2_HUMAN Protein AHNAK2 OS=Homo sapiens OX=9606 GN=AHNAK2 PE=1 SV=2 g6133.t1 Q8IVF2 19.409 948 8.7e-37 154.0 sp|Q8IVF2|AHNK2_HUMAN Protein AHNAK2 OS=Homo sapiens OX=9606 GN=AHNAK2 PE=1 SV=2 g6133.t1 Q8IVF2 19.343 1065 3.02e-36 153.0 sp|Q8IVF2|AHNK2_HUMAN Protein AHNAK2 OS=Homo sapiens OX=9606 GN=AHNAK2 PE=1 SV=2 g6133.t1 Q8IVF2 20.043 928 2.34e-35 150.0 sp|Q8IVF2|AHNK2_HUMAN Protein AHNAK2 OS=Homo sapiens OX=9606 GN=AHNAK2 PE=1 SV=2 g6133.t1 Q8IVF2 19.792 1056 8.24e-35 148.0 sp|Q8IVF2|AHNK2_HUMAN Protein AHNAK2 OS=Homo sapiens OX=9606 GN=AHNAK2 PE=1 SV=2 g6133.t1 Q8IVF2 19.165 1054 5.88e-34 145.0 sp|Q8IVF2|AHNK2_HUMAN Protein AHNAK2 OS=Homo sapiens OX=9606 GN=AHNAK2 PE=1 SV=2 g6133.t1 Q8IVF2 20.132 760 9.53e-32 138.0 sp|Q8IVF2|AHNK2_HUMAN Protein AHNAK2 OS=Homo sapiens OX=9606 GN=AHNAK2 PE=1 SV=2 g6135.t1 P32019 49.929 701 0.0 701.0 sp|P32019|I5P2_HUMAN Type II inositol 1,4,5-trisphosphate 5-phosphatase OS=Homo sapiens OX=9606 GN=INPP5B PE=1 SV=4 I5P2_HUMAN reviewed Type II inositol 1,4,5-trisphosphate 5-phosphatase (EC 3.1.3.36) (EC 3.1.3.56) (75 kDa inositol polyphosphate-5-phosphatase) (Phosphoinositide 5-phosphatase) (5PTase) Homo sapiens (Human) GO:0001701; GO:0004439; GO:0005737; GO:0005793; GO:0005794; GO:0005829; GO:0005886; GO:0007165; GO:0007283; GO:0016020; GO:0030317; GO:0030670; GO:0031901; GO:0043005; GO:0043647; GO:0046856; GO:0046872; GO:0052658; GO:0052659; GO:0070613; GO:0097542 flagellated sperm motility [GO:0030317]; in utero embryonic development [GO:0001701]; inositol phosphate metabolic process [GO:0043647]; phosphatidylinositol dephosphorylation [GO:0046856]; regulation of protein processing [GO:0070613]; signal transduction [GO:0007165]; spermatogenesis [GO:0007283] ciliary tip [GO:0097542]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; neuron projection [GO:0043005]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886] inositol-1,3,4,5-tetrakisphosphate 5-phosphatase activity [GO:0052659]; inositol-1,4,5-trisphosphate 5-phosphatase activity [GO:0052658]; metal ion binding [GO:0046872]; phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity [GO:0004439] g6137.t1 Q642C0 55.932 236 1.43e-60 194.0 sp|Q642C0|DNJC8_RAT DnaJ homolog subfamily C member 8 OS=Rattus norvegicus OX=10116 GN=Dnajc8 PE=2 SV=1 g6138.t1 Q9JHI8 45.0 580 1.9000000000000002e-160 474.0 sp|Q9JHI8|NOX4_MOUSE NADPH oxidase 4 OS=Mus musculus OX=10090 GN=Nox4 PE=1 SV=1 NOX4_MOUSE reviewed NADPH oxidase 4 (EC 1.6.3.1) (Kidney oxidase-1) (KOX-1) (Kidney superoxide-producing NADPH oxidase) (Renal NAD(P)H-oxidase) (Superoxide-generating NADPH oxidase 4) Mus musculus (Mouse) GO:0000902; GO:0001725; GO:0003015; GO:0005634; GO:0005730; GO:0005739; GO:0005783; GO:0005789; GO:0005886; GO:0005925; GO:0006801; GO:0006952; GO:0008285; GO:0010467; GO:0010729; GO:0014911; GO:0016174; GO:0016175; GO:0016324; GO:0016529; GO:0020037; GO:0035556; GO:0042554; GO:0043020; GO:0043065; GO:0043406; GO:0045453; GO:0048471; GO:0050664; GO:0050667; GO:0051496; GO:0051897; GO:0055007; GO:0070374; GO:0071944; GO:0072341; GO:0072593; GO:0097038; GO:0106292; GO:1990782; GO:2000379; GO:2000573 bone resorption [GO:0045453]; cardiac muscle cell differentiation [GO:0055007]; cell morphogenesis [GO:0000902]; defense response [GO:0006952]; gene expression [GO:0010467]; heart process [GO:0003015]; homocysteine metabolic process [GO:0050667]; intracellular signal transduction [GO:0035556]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of apoptotic process [GO:0043065]; positive regulation of DNA biosynthetic process [GO:2000573]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of hydrogen peroxide biosynthetic process [GO:0010729]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; positive regulation of smooth muscle cell migration [GO:0014911]; positive regulation of stress fiber assembly [GO:0051496]; reactive oxygen species metabolic process [GO:0072593]; superoxide anion generation [GO:0042554]; superoxide metabolic process [GO:0006801] apical plasma membrane [GO:0016324]; cell periphery [GO:0071944]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; focal adhesion [GO:0005925]; mitochondrion [GO:0005739]; NADPH oxidase complex [GO:0043020]; nucleolus [GO:0005730]; nucleus [GO:0005634]; perinuclear endoplasmic reticulum [GO:0097038]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; sarcoplasmic reticulum [GO:0016529]; stress fiber [GO:0001725] heme binding [GO:0020037]; modified amino acid binding [GO:0072341]; NAD(P)H oxidase H2O2-forming activity [GO:0016174]; oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor [GO:0050664]; protein tyrosine kinase binding [GO:1990782]; superoxide-generating NAD(P)H oxidase activity [GO:0016175]; superoxide-generating NADPH oxidase activity [GO:0106292] g6139.t1 Q05927 45.0 540 6.57e-145 434.0 sp|Q05927|5NTD_BOVIN 5'-nucleotidase OS=Bos taurus OX=9913 GN=NT5E PE=1 SV=2 5NTD_BOVIN reviewed 5'-nucleotidase (5'-NT) (EC 3.1.3.35) (EC 3.1.3.5) (EC 3.1.3.89) (EC 3.1.3.91) (EC 3.1.3.99) (5'-deoxynucleotidase) (Ecto-5'-nucleotidase) (IMP-specific 5'-nucleotidase) (Thymidylate 5'-phosphatase) (CD antigen CD73) Bos taurus (Bovine) GO:0000166; GO:0002953; GO:0005886; GO:0006196; GO:0008253; GO:0016020; GO:0042802; GO:0046872; GO:0098552 AMP catabolic process [GO:0006196] membrane [GO:0016020]; plasma membrane [GO:0005886]; side of membrane [GO:0098552] 5'-deoxynucleotidase activity [GO:0002953]; 5'-nucleotidase activity [GO:0008253]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166] g6139.t2 Q05927 45.0 540 5.54e-145 433.0 sp|Q05927|5NTD_BOVIN 5'-nucleotidase OS=Bos taurus OX=9913 GN=NT5E PE=1 SV=2 5NTD_BOVIN reviewed 5'-nucleotidase (5'-NT) (EC 3.1.3.35) (EC 3.1.3.5) (EC 3.1.3.89) (EC 3.1.3.91) (EC 3.1.3.99) (5'-deoxynucleotidase) (Ecto-5'-nucleotidase) (IMP-specific 5'-nucleotidase) (Thymidylate 5'-phosphatase) (CD antigen CD73) Bos taurus (Bovine) GO:0000166; GO:0002953; GO:0005886; GO:0006196; GO:0008253; GO:0016020; GO:0042802; GO:0046872; GO:0098552 AMP catabolic process [GO:0006196] membrane [GO:0016020]; plasma membrane [GO:0005886]; side of membrane [GO:0098552] 5'-deoxynucleotidase activity [GO:0002953]; 5'-nucleotidase activity [GO:0008253]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166] g6140.t1 Q8CD19 42.135 356 9.23e-85 266.0 sp|Q8CD19|LANC3_MOUSE LanC-like protein 3 OS=Mus musculus OX=10090 GN=Lancl3 PE=2 SV=2 g6142.t1 Q3T9Z9 31.497 581 8.19e-80 271.0 sp|Q3T9Z9|ZUP1_MOUSE Zinc finger-containing ubiquitin peptidase 1 OS=Mus musculus OX=10090 GN=Zup1 PE=2 SV=2 g6142.t2 Q3T9Z9 31.826 575 2.95e-82 277.0 sp|Q3T9Z9|ZUP1_MOUSE Zinc finger-containing ubiquitin peptidase 1 OS=Mus musculus OX=10090 GN=Zup1 PE=2 SV=2 g6146.t1 O35345 69.606 533 0.0 725.0 sp|O35345|IMA7_MOUSE Importin subunit alpha-7 OS=Mus musculus OX=10090 GN=Kpna6 PE=1 SV=2 IMA7_MOUSE reviewed Importin subunit alpha-7 (Importin alpha-S2) (Karyopherin subunit alpha-6) Mus musculus (Mouse) GO:0005634; GO:0005654; GO:0005829; GO:0006606; GO:0006607; GO:0008139; GO:0019079; GO:0030682; GO:0042564; GO:0043657; GO:0045944; GO:0060135; GO:0061608; GO:0075506; GO:1900017; GO:1903902 entry of viral genome into host nucleus through nuclear pore complex via importin [GO:0075506]; maternal process involved in female pregnancy [GO:0060135]; NLS-bearing protein import into nucleus [GO:0006607]; positive regulation of cytokine production involved in inflammatory response [GO:1900017]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of viral life cycle [GO:1903902]; protein import into nucleus [GO:0006606]; symbiont-mediated perturbation of host defenses [GO:0030682]; viral genome replication [GO:0019079] cytosol [GO:0005829]; host cell [GO:0043657]; NLS-dependent protein nuclear import complex [GO:0042564]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] nuclear import signal receptor activity [GO:0061608]; nuclear localization sequence binding [GO:0008139] g6147.t1 Q6PBK1 59.441 143 7.32e-57 177.0 sp|Q6PBK1|MIX23_DANRE Protein MIX23 OS=Danio rerio OX=7955 GN=mix23 PE=2 SV=2 g6147.t2 Q6PBK1 58.741 143 1.43e-56 176.0 sp|Q6PBK1|MIX23_DANRE Protein MIX23 OS=Danio rerio OX=7955 GN=mix23 PE=2 SV=2 g6148.t1 Q9D0N7 45.134 596 1.99e-152 456.0 sp|Q9D0N7|CAF1B_MOUSE Chromatin assembly factor 1 subunit B OS=Mus musculus OX=10090 GN=Chaf1b PE=1 SV=1 g6150.t1 Q9H4Q3 47.09 189 4.3600000000000004e-36 148.0 sp|Q9H4Q3|PRD13_HUMAN PR domain zinc finger protein 13 OS=Homo sapiens OX=9606 GN=PRDM13 PE=1 SV=2 PRD13_HUMAN reviewed PR domain zinc finger protein 13 (EC 2.1.1.-) (PR domain-containing protein 13) Homo sapiens (Human) GO:0000122; GO:0003677; GO:0003682; GO:0005634; GO:0008270; GO:0010468; GO:0021979; GO:0032259; GO:0042054; GO:0061629; GO:0097154 GABAergic neuron differentiation [GO:0097154]; hypothalamus cell differentiation [GO:0021979]; methylation [GO:0032259]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of gene expression [GO:0010468] nucleus [GO:0005634] chromatin binding [GO:0003682]; DNA binding [GO:0003677]; histone methyltransferase activity [GO:0042054]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; zinc ion binding [GO:0008270] g6150.t1 Q9H4Q3 38.272 162 1.37e-26 119.0 sp|Q9H4Q3|PRD13_HUMAN PR domain zinc finger protein 13 OS=Homo sapiens OX=9606 GN=PRDM13 PE=1 SV=2 PRD13_HUMAN reviewed PR domain zinc finger protein 13 (EC 2.1.1.-) (PR domain-containing protein 13) Homo sapiens (Human) GO:0000122; GO:0003677; GO:0003682; GO:0005634; GO:0008270; GO:0010468; GO:0021979; GO:0032259; GO:0042054; GO:0061629; GO:0097154 GABAergic neuron differentiation [GO:0097154]; hypothalamus cell differentiation [GO:0021979]; methylation [GO:0032259]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of gene expression [GO:0010468] nucleus [GO:0005634] chromatin binding [GO:0003682]; DNA binding [GO:0003677]; histone methyltransferase activity [GO:0042054]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; zinc ion binding [GO:0008270] g6151.t1 Q86UC2 65.103 341 5.27e-107 329.0 sp|Q86UC2|RSPH3_HUMAN Radial spoke head protein 3 homolog OS=Homo sapiens OX=9606 GN=RSPH3 PE=1 SV=1 RSPH3_HUMAN reviewed Radial spoke head protein 3 homolog (A-kinase anchor protein RSPH3) (Radial spoke head-like protein 2) Homo sapiens (Human) GO:0001535; GO:0005929; GO:0097729 9+2 motile cilium [GO:0097729]; cilium [GO:0005929]; radial spoke head [GO:0001535] g6152.t1 P13216 64.602 113 5.25e-40 137.0 sp|P13216|ADX_CHICK Adrenodoxin, mitochondrial (Fragment) OS=Gallus gallus OX=9031 GN=FDX1 PE=1 SV=1 g6153.t1 P26043 82.353 323 0.0 588.0 sp|P26043|RADI_MOUSE Radixin OS=Mus musculus OX=10090 GN=Rdx PE=1 SV=3 RADI_MOUSE reviewed Radixin (ESP10) Mus musculus (Mouse) GO:0001726; GO:0003779; GO:0005829; GO:0005886; GO:0005902; GO:0005912; GO:0005925; GO:0008360; GO:0010628; GO:0010737; GO:0016324; GO:0019904; GO:0030027; GO:0030033; GO:0030175; GO:0030315; GO:0030496; GO:0030864; GO:0032154; GO:0032420; GO:0032487; GO:0036120; GO:0043209; GO:0045176; GO:0045177; GO:0045184; GO:0045732; GO:0050839; GO:0051016; GO:0051018; GO:0051117; GO:0051286; GO:0061028; GO:0061951; GO:0071944; GO:0072659; GO:0097067; GO:0120044; GO:0150054; GO:1900087; GO:1902115; GO:1902966; GO:1903391; GO:2000643 apical protein localization [GO:0045176]; barbed-end actin filament capping [GO:0051016]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; cellular response to thyroid hormone stimulus [GO:0097067]; establishment of endothelial barrier [GO:0061028]; establishment of protein localization [GO:0045184]; establishment of protein localization to plasma membrane [GO:0061951]; microvillus assembly [GO:0030033]; positive regulation of early endosome to late endosome transport [GO:2000643]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein localization to early endosome [GO:1902966]; protein kinase A signaling [GO:0010737]; protein localization to plasma membrane [GO:0072659]; regulation of adherens junction organization [GO:1903391]; regulation of cell shape [GO:0008360]; regulation of organelle assembly [GO:1902115]; regulation of postsynaptic neurotransmitter receptor diffusion trapping [GO:0150054]; regulation of Rap protein signal transduction [GO:0032487] adherens junction [GO:0005912]; apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; cell periphery [GO:0071944]; cell tip [GO:0051286]; cleavage furrow [GO:0032154]; cortical actin cytoskeleton [GO:0030864]; cytosol [GO:0005829]; filopodium [GO:0030175]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; microvillus [GO:0005902]; midbody [GO:0030496]; myelin sheath [GO:0043209]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; stereocilium [GO:0032420]; stereocilium base [GO:0120044]; T-tubule [GO:0030315] actin binding [GO:0003779]; ATPase binding [GO:0051117]; cell adhesion molecule binding [GO:0050839]; protein domain specific binding [GO:0019904]; protein kinase A binding [GO:0051018] g6155.t1 P41976 64.545 220 1.98e-108 314.0 sp|P41976|SODM_BOVIN Superoxide dismutase [Mn], mitochondrial OS=Bos taurus OX=9913 GN=SOD2 PE=2 SV=1 g6156.t1 Q12874 71.912 502 0.0 654.0 sp|Q12874|SF3A3_HUMAN Splicing factor 3A subunit 3 OS=Homo sapiens OX=9606 GN=SF3A3 PE=1 SV=1 SF3A3_HUMAN reviewed Splicing factor 3A subunit 3 (SF3a60) (Spliceosome-associated protein 61) (SAP 61) Homo sapiens (Human) GO:0000375; GO:0000389; GO:0000398; GO:0003723; GO:0005634; GO:0005654; GO:0005681; GO:0005684; GO:0005686; GO:0006397; GO:0008270; GO:0016607; GO:0071005; GO:0071013; GO:1903241 mRNA 3'-splice site recognition [GO:0000389]; mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; RNA splicing, via transesterification reactions [GO:0000375]; U2-type prespliceosome assembly [GO:1903241] catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U2 snRNP [GO:0005686]; U2-type precatalytic spliceosome [GO:0071005]; U2-type spliceosomal complex [GO:0005684] RNA binding [GO:0003723]; zinc ion binding [GO:0008270] g6157.t1 P48553 28.149 778 6.720000000000001e-72 258.0 sp|P48553|TPC10_HUMAN Trafficking protein particle complex subunit 10 OS=Homo sapiens OX=9606 GN=TRAPPC10 PE=1 SV=2 TPC10_HUMAN reviewed Trafficking protein particle complex subunit 10 (Epilepsy holoprosencephaly candidate 1 protein) (EHOC-1) (Protein GT334) (Trafficking protein particle complex subunit TMEM1) (Transport protein particle subunit TMEM1) (TRAPP subunit TMEM1) Homo sapiens (Human) GO:0005737; GO:0005829; GO:0006888; GO:0006891; GO:0006901; GO:0030008; GO:0034498; GO:0099022; GO:1990071 early endosome to Golgi transport [GO:0034498]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intra-Golgi vesicle-mediated transport [GO:0006891]; vesicle coating [GO:0006901]; vesicle tethering [GO:0099022] cytoplasm [GO:0005737]; cytosol [GO:0005829]; TRAPP complex [GO:0030008]; TRAPPII protein complex [GO:1990071] g6158.t1 Q3TLI0 50.467 107 2.13e-28 111.0 sp|Q3TLI0|TPC10_MOUSE Trafficking protein particle complex subunit 10 OS=Mus musculus OX=10090 GN=Trappc10 PE=1 SV=3 g6159.t1 P48553 53.05 377 2.01e-133 415.0 sp|P48553|TPC10_HUMAN Trafficking protein particle complex subunit 10 OS=Homo sapiens OX=9606 GN=TRAPPC10 PE=1 SV=2 TPC10_HUMAN reviewed Trafficking protein particle complex subunit 10 (Epilepsy holoprosencephaly candidate 1 protein) (EHOC-1) (Protein GT334) (Trafficking protein particle complex subunit TMEM1) (Transport protein particle subunit TMEM1) (TRAPP subunit TMEM1) Homo sapiens (Human) GO:0005737; GO:0005829; GO:0006888; GO:0006891; GO:0006901; GO:0030008; GO:0034498; GO:0099022; GO:1990071 early endosome to Golgi transport [GO:0034498]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intra-Golgi vesicle-mediated transport [GO:0006891]; vesicle coating [GO:0006901]; vesicle tethering [GO:0099022] cytoplasm [GO:0005737]; cytosol [GO:0005829]; TRAPP complex [GO:0030008]; TRAPPII protein complex [GO:1990071] g6163.t1 Q5T5C0 53.571 84 2.58e-21 90.9 sp|Q5T5C0|STXB5_HUMAN Syntaxin-binding protein 5 OS=Homo sapiens OX=9606 GN=STXBP5 PE=1 SV=1 STXB5_HUMAN reviewed Syntaxin-binding protein 5 (Lethal(2) giant larvae protein homolog 3) (Tomosyn-1) Homo sapiens (Human) GO:0005096; GO:0005737; GO:0005829; GO:0005886; GO:0005892; GO:0006887; GO:0006893; GO:0008021; GO:0010807; GO:0015031; GO:0017075; GO:0017157; GO:0019905; GO:0031201; GO:0045159; GO:0045921; GO:0098674; GO:0098686; GO:2000300 exocytosis [GO:0006887]; Golgi to plasma membrane transport [GO:0006893]; positive regulation of exocytosis [GO:0045921]; protein transport [GO:0015031]; regulation of exocytosis [GO:0017157]; regulation of synaptic vesicle exocytosis [GO:2000300]; regulation of synaptic vesicle priming [GO:0010807] acetylcholine-gated channel complex [GO:0005892]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of neuronal dense core vesicle membrane [GO:0098674]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; plasma membrane [GO:0005886]; SNARE complex [GO:0031201]; synaptic vesicle [GO:0008021] GTPase activator activity [GO:0005096]; myosin II binding [GO:0045159]; syntaxin binding [GO:0019905]; syntaxin-1 binding [GO:0017075] g6164.t1 Q9WU70 62.64 447 0.0 578.0 sp|Q9WU70|STXB5_RAT Syntaxin-binding protein 5 OS=Rattus norvegicus OX=10116 GN=Stxbp5 PE=1 SV=1 STXB5_RAT reviewed Syntaxin-binding protein 5 (Lethal(2) giant larvae protein homolog 3) (Tomosyn-1) Rattus norvegicus (Rat) GO:0005096; GO:0005737; GO:0005829; GO:0005886; GO:0005892; GO:0006887; GO:0006893; GO:0008021; GO:0010807; GO:0015031; GO:0017075; GO:0017157; GO:0019905; GO:0030141; GO:0031201; GO:0031594; GO:0045159; GO:0045921; GO:0098674; GO:0098685; GO:0098686; GO:0098793; GO:0098888; GO:0099504; GO:0099523; GO:2000300 exocytosis [GO:0006887]; Golgi to plasma membrane transport [GO:0006893]; positive regulation of exocytosis [GO:0045921]; protein transport [GO:0015031]; regulation of exocytosis [GO:0017157]; regulation of synaptic vesicle exocytosis [GO:2000300]; regulation of synaptic vesicle priming [GO:0010807]; synaptic vesicle cycle [GO:0099504] acetylcholine-gated channel complex [GO:0005892]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of neuronal dense core vesicle membrane [GO:0098674]; extrinsic component of presynaptic membrane [GO:0098888]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; neuromuscular junction [GO:0031594]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; presynaptic cytosol [GO:0099523]; Schaffer collateral - CA1 synapse [GO:0098685]; secretory granule [GO:0030141]; SNARE complex [GO:0031201]; synaptic vesicle [GO:0008021] GTPase activator activity [GO:0005096]; myosin II binding [GO:0045159]; syntaxin binding [GO:0019905]; syntaxin-1 binding [GO:0017075] g6164.t2 Q9WU70 62.64 447 0.0 578.0 sp|Q9WU70|STXB5_RAT Syntaxin-binding protein 5 OS=Rattus norvegicus OX=10116 GN=Stxbp5 PE=1 SV=1 STXB5_RAT reviewed Syntaxin-binding protein 5 (Lethal(2) giant larvae protein homolog 3) (Tomosyn-1) Rattus norvegicus (Rat) GO:0005096; GO:0005737; GO:0005829; GO:0005886; GO:0005892; GO:0006887; GO:0006893; GO:0008021; GO:0010807; GO:0015031; GO:0017075; GO:0017157; GO:0019905; GO:0030141; GO:0031201; GO:0031594; GO:0045159; GO:0045921; GO:0098674; GO:0098685; GO:0098686; GO:0098793; GO:0098888; GO:0099504; GO:0099523; GO:2000300 exocytosis [GO:0006887]; Golgi to plasma membrane transport [GO:0006893]; positive regulation of exocytosis [GO:0045921]; protein transport [GO:0015031]; regulation of exocytosis [GO:0017157]; regulation of synaptic vesicle exocytosis [GO:2000300]; regulation of synaptic vesicle priming [GO:0010807]; synaptic vesicle cycle [GO:0099504] acetylcholine-gated channel complex [GO:0005892]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of neuronal dense core vesicle membrane [GO:0098674]; extrinsic component of presynaptic membrane [GO:0098888]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; neuromuscular junction [GO:0031594]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; presynaptic cytosol [GO:0099523]; Schaffer collateral - CA1 synapse [GO:0098685]; secretory granule [GO:0030141]; SNARE complex [GO:0031201]; synaptic vesicle [GO:0008021] GTPase activator activity [GO:0005096]; myosin II binding [GO:0045159]; syntaxin binding [GO:0019905]; syntaxin-1 binding [GO:0017075] g6167.t1 Q5T5C0 55.285 369 1.72e-121 379.0 sp|Q5T5C0|STXB5_HUMAN Syntaxin-binding protein 5 OS=Homo sapiens OX=9606 GN=STXBP5 PE=1 SV=1 STXB5_HUMAN reviewed Syntaxin-binding protein 5 (Lethal(2) giant larvae protein homolog 3) (Tomosyn-1) Homo sapiens (Human) GO:0005096; GO:0005737; GO:0005829; GO:0005886; GO:0005892; GO:0006887; GO:0006893; GO:0008021; GO:0010807; GO:0015031; GO:0017075; GO:0017157; GO:0019905; GO:0031201; GO:0045159; GO:0045921; GO:0098674; GO:0098686; GO:2000300 exocytosis [GO:0006887]; Golgi to plasma membrane transport [GO:0006893]; positive regulation of exocytosis [GO:0045921]; protein transport [GO:0015031]; regulation of exocytosis [GO:0017157]; regulation of synaptic vesicle exocytosis [GO:2000300]; regulation of synaptic vesicle priming [GO:0010807] acetylcholine-gated channel complex [GO:0005892]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of neuronal dense core vesicle membrane [GO:0098674]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; plasma membrane [GO:0005886]; SNARE complex [GO:0031201]; synaptic vesicle [GO:0008021] GTPase activator activity [GO:0005096]; myosin II binding [GO:0045159]; syntaxin binding [GO:0019905]; syntaxin-1 binding [GO:0017075] g6170.t1 Q7ZVM9 46.377 207 1.03e-51 193.0 sp|Q7ZVM9|RMI1_DANRE RecQ-mediated genome instability protein 1 OS=Danio rerio OX=7955 GN=rmi1 PE=2 SV=1 g6171.t1 Q9NU22 34.031 191 1.97e-22 97.4 sp|Q9NU22|MDN1_HUMAN Midasin OS=Homo sapiens OX=9606 GN=MDN1 PE=1 SV=2 MDN1_HUMAN reviewed Midasin (Dynein-related AAA-ATPase MDN1) (MIDAS-containing protein) Homo sapiens (Human) GO:0000027; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0016020; GO:0016887; GO:0045111 ribosomal large subunit assembly [GO:0000027] cytosol [GO:0005829]; intermediate filament cytoskeleton [GO:0045111]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887] g6172.t1 Q9NU22 59.128 1101 0.0 1348.0 sp|Q9NU22|MDN1_HUMAN Midasin OS=Homo sapiens OX=9606 GN=MDN1 PE=1 SV=2 MDN1_HUMAN reviewed Midasin (Dynein-related AAA-ATPase MDN1) (MIDAS-containing protein) Homo sapiens (Human) GO:0000027; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0016020; GO:0016887; GO:0045111 ribosomal large subunit assembly [GO:0000027] cytosol [GO:0005829]; intermediate filament cytoskeleton [GO:0045111]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887] g6172.t1 Q9NU22 30.407 615 1.14e-49 197.0 sp|Q9NU22|MDN1_HUMAN Midasin OS=Homo sapiens OX=9606 GN=MDN1 PE=1 SV=2 MDN1_HUMAN reviewed Midasin (Dynein-related AAA-ATPase MDN1) (MIDAS-containing protein) Homo sapiens (Human) GO:0000027; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0016020; GO:0016887; GO:0045111 ribosomal large subunit assembly [GO:0000027] cytosol [GO:0005829]; intermediate filament cytoskeleton [GO:0045111]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887] g6172.t1 Q9NU22 27.039 662 1.33e-40 168.0 sp|Q9NU22|MDN1_HUMAN Midasin OS=Homo sapiens OX=9606 GN=MDN1 PE=1 SV=2 MDN1_HUMAN reviewed Midasin (Dynein-related AAA-ATPase MDN1) (MIDAS-containing protein) Homo sapiens (Human) GO:0000027; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0016020; GO:0016887; GO:0045111 ribosomal large subunit assembly [GO:0000027] cytosol [GO:0005829]; intermediate filament cytoskeleton [GO:0045111]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887] g6173.t1 Q9NU22 56.413 959 0.0 1042.0 sp|Q9NU22|MDN1_HUMAN Midasin OS=Homo sapiens OX=9606 GN=MDN1 PE=1 SV=2 MDN1_HUMAN reviewed Midasin (Dynein-related AAA-ATPase MDN1) (MIDAS-containing protein) Homo sapiens (Human) GO:0000027; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0016020; GO:0016887; GO:0045111 ribosomal large subunit assembly [GO:0000027] cytosol [GO:0005829]; intermediate filament cytoskeleton [GO:0045111]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887] g6173.t1 Q9NU22 26.628 691 3.84e-49 195.0 sp|Q9NU22|MDN1_HUMAN Midasin OS=Homo sapiens OX=9606 GN=MDN1 PE=1 SV=2 MDN1_HUMAN reviewed Midasin (Dynein-related AAA-ATPase MDN1) (MIDAS-containing protein) Homo sapiens (Human) GO:0000027; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0016020; GO:0016887; GO:0045111 ribosomal large subunit assembly [GO:0000027] cytosol [GO:0005829]; intermediate filament cytoskeleton [GO:0045111]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887] g6174.t1 M9PH32 27.57 214 1.9600000000000003e-21 100.0 sp|M9PH32|MEI26_DROME Protein meiotic P26 OS=Drosophila melanogaster OX=7227 GN=mei-P26 PE=1 SV=1 MEI26_DROME reviewed Protein meiotic P26 Drosophila melanogaster (Fruit fly) GO:0004842; GO:0005737; GO:0008270; GO:0016567; GO:0036464 protein ubiquitination [GO:0016567] cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464] ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] g6175.t1 Q9NU22 34.076 1796 0.0 847.0 sp|Q9NU22|MDN1_HUMAN Midasin OS=Homo sapiens OX=9606 GN=MDN1 PE=1 SV=2 MDN1_HUMAN reviewed Midasin (Dynein-related AAA-ATPase MDN1) (MIDAS-containing protein) Homo sapiens (Human) GO:0000027; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0016020; GO:0016887; GO:0045111 ribosomal large subunit assembly [GO:0000027] cytosol [GO:0005829]; intermediate filament cytoskeleton [GO:0045111]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887] g6175.t1 Q9NU22 65.882 340 3.17e-125 450.0 sp|Q9NU22|MDN1_HUMAN Midasin OS=Homo sapiens OX=9606 GN=MDN1 PE=1 SV=2 MDN1_HUMAN reviewed Midasin (Dynein-related AAA-ATPase MDN1) (MIDAS-containing protein) Homo sapiens (Human) GO:0000027; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0016020; GO:0016887; GO:0045111 ribosomal large subunit assembly [GO:0000027] cytosol [GO:0005829]; intermediate filament cytoskeleton [GO:0045111]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887] g6175.t1 Q9NU22 22.53 830 3.57e-35 153.0 sp|Q9NU22|MDN1_HUMAN Midasin OS=Homo sapiens OX=9606 GN=MDN1 PE=1 SV=2 MDN1_HUMAN reviewed Midasin (Dynein-related AAA-ATPase MDN1) (MIDAS-containing protein) Homo sapiens (Human) GO:0000027; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0016020; GO:0016887; GO:0045111 ribosomal large subunit assembly [GO:0000027] cytosol [GO:0005829]; intermediate filament cytoskeleton [GO:0045111]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887] g6178.t1 Q6PUR6 66.327 294 1.64e-149 425.0 sp|Q6PUR6|GPN2_DANRE GPN-loop GTPase 2 OS=Danio rerio OX=7955 GN=gpn2 PE=2 SV=1 g6179.t1 O88866 45.11 317 9.89e-80 273.0 sp|O88866|HUNK_MOUSE Hormonally up-regulated neu tumor-associated kinase OS=Mus musculus OX=10090 GN=Hunk PE=2 SV=1 g6180.t1 Q9P2C4 49.585 482 3.85e-122 367.0 sp|Q9P2C4|TM181_HUMAN Transmembrane protein 181 OS=Homo sapiens OX=9606 GN=TMEM181 PE=1 SV=3 g6180.t2 Q9P2C4 50.0 476 1.16e-119 362.0 sp|Q9P2C4|TM181_HUMAN Transmembrane protein 181 OS=Homo sapiens OX=9606 GN=TMEM181 PE=1 SV=3 g6181.t1 Q9Y493 30.435 414 8.38e-48 194.0 sp|Q9Y493|ZAN_HUMAN Zonadhesin OS=Homo sapiens OX=9606 GN=ZAN PE=2 SV=5 g6181.t1 Q9Y493 30.923 401 1.07e-40 171.0 sp|Q9Y493|ZAN_HUMAN Zonadhesin OS=Homo sapiens OX=9606 GN=ZAN PE=2 SV=5 g6181.t1 Q9Y493 27.149 442 3.06e-35 153.0 sp|Q9Y493|ZAN_HUMAN Zonadhesin OS=Homo sapiens OX=9606 GN=ZAN PE=2 SV=5 g6181.t1 Q9Y493 23.501 417 4.3400000000000004e-29 133.0 sp|Q9Y493|ZAN_HUMAN Zonadhesin OS=Homo sapiens OX=9606 GN=ZAN PE=2 SV=5 g6181.t1 Q9Y493 24.731 372 4.8199999999999994e-23 113.0 sp|Q9Y493|ZAN_HUMAN Zonadhesin OS=Homo sapiens OX=9606 GN=ZAN PE=2 SV=5 g6183.t1 Q28983 33.19 232 4.65e-28 121.0 sp|Q28983|ZAN_PIG Zonadhesin OS=Sus scrofa OX=9823 GN=ZAN PE=1 SV=1 ZAN_PIG reviewed Zonadhesin Sus scrofa (Pig) GO:0005201; GO:0005615; GO:0005886; GO:0007155; GO:0007339; GO:0031012; GO:0050840 binding of sperm to zona pellucida [GO:0007339]; cell adhesion [GO:0007155] extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; plasma membrane [GO:0005886] extracellular matrix binding [GO:0050840]; extracellular matrix structural constituent [GO:0005201] g6184.t1 Q80V03 44.177 541 9.86e-148 442.0 sp|Q80V03|ADCK5_MOUSE Uncharacterized aarF domain-containing protein kinase 5 OS=Mus musculus OX=10090 GN=Adck5 PE=2 SV=2 g6187.t1 Q3T099 54.79 334 5.3e-134 390.0 sp|Q3T099|SYWM_BOVIN Tryptophan--tRNA ligase, mitochondrial OS=Bos taurus OX=9913 GN=WARS2 PE=2 SV=1 g6188.t1 Q9Y6R4 44.709 1134 0.0 875.0 sp|Q9Y6R4|M3K4_HUMAN Mitogen-activated protein kinase kinase kinase 4 OS=Homo sapiens OX=9606 GN=MAP3K4 PE=1 SV=2 M3K4_HUMAN reviewed Mitogen-activated protein kinase kinase kinase 4 (EC 2.7.11.25) (MAP three kinase 1) (MAPK/ERK kinase kinase 4) (MEK kinase 4) (MEKK 4) Homo sapiens (Human) GO:0000165; GO:0001890; GO:0004709; GO:0005524; GO:0005737; GO:0010225; GO:0010468; GO:0019100; GO:0032206; GO:0035556; GO:0038066; GO:0043507; GO:0046872; GO:0048471; GO:0060718; GO:0106310; GO:1900745 chorionic trophoblast cell differentiation [GO:0060718]; intracellular signal transduction [GO:0035556]; male germ-line sex determination [GO:0019100]; MAPK cascade [GO:0000165]; p38MAPK cascade [GO:0038066]; placenta development [GO:0001890]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of telomere maintenance [GO:0032206]; regulation of gene expression [GO:0010468]; response to UV-C [GO:0010225] cytoplasm [GO:0005737]; perinuclear region of cytoplasm [GO:0048471] ATP binding [GO:0005524]; MAP kinase kinase kinase activity [GO:0004709]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310] g6190.t1 P38278 31.557 244 1.02e-25 106.0 sp|P38278|BMT2_YEAST 25S rRNA (adenine(2142)-N(1))-methyltransferase OS=Saccharomyces cerevisiae (strain ATCC 204508 / S288c) OX=559292 GN=BMT2 PE=1 SV=2 g6192.t1 Q6IRA8 52.756 254 3.37e-83 253.0 sp|Q6IRA8|TIPRL_XENLA TIP41-like protein OS=Xenopus laevis OX=8355 GN=tiprl PE=2 SV=1 g6193.t1 O08759 43.541 418 1.92e-92 319.0 sp|O08759|UBE3A_MOUSE Ubiquitin-protein ligase E3A OS=Mus musculus OX=10090 GN=Ube3a PE=1 SV=2 UBE3A_MOUSE reviewed Ubiquitin-protein ligase E3A (EC 2.3.2.26) (HECT-type ubiquitin transferase E3A) (Oncogenic protein-associated protein E6-AP) Mus musculus (Mouse) GO:0000209; GO:0000502; GO:0001541; GO:0003713; GO:0004842; GO:0005634; GO:0005829; GO:0006511; GO:0008021; GO:0008270; GO:0016567; GO:0030521; GO:0031398; GO:0031669; GO:0032570; GO:0035037; GO:0035641; GO:0042752; GO:0043161; GO:0045944; GO:0048167; GO:0048511; GO:0050804; GO:0050847; GO:0051865; GO:0051897; GO:0060736; GO:0061002; GO:0061630; GO:0061743; GO:0070936; GO:0098978; GO:0099524; GO:0150032; GO:1904262; GO:1904263; GO:1905528; GO:2000058 androgen receptor signaling pathway [GO:0030521]; cellular response to nutrient levels [GO:0031669]; locomotory exploration behavior [GO:0035641]; modulation of chemical synaptic transmission [GO:0050804]; motor learning [GO:0061743]; negative regulation of dendritic spine morphogenesis [GO:0061002]; negative regulation of TORC1 signaling [GO:1904262]; ovarian follicle development [GO:0001541]; positive regulation of Golgi lumen acidification [GO:1905528]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of protein localization to lysosome [GO:0150032]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of TORC1 signaling [GO:1904263]; positive regulation of transcription by RNA polymerase II [GO:0045944]; progesterone receptor signaling pathway [GO:0050847]; prostate gland growth [GO:0060736]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of circadian rhythm [GO:0042752]; regulation of synaptic plasticity [GO:0048167]; regulation of ubiquitin-dependent protein catabolic process [GO:2000058]; response to progesterone [GO:0032570]; rhythmic process [GO:0048511]; sperm entry [GO:0035037]; ubiquitin-dependent protein catabolic process [GO:0006511] cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; nucleus [GO:0005634]; postsynaptic cytosol [GO:0099524]; proteasome complex [GO:0000502]; synaptic vesicle [GO:0008021] transcription coactivator activity [GO:0003713]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] g6194.t1 Q9H446 53.782 119 1.4399999999999999e-34 123.0 sp|Q9H446|RWDD1_HUMAN RWD domain-containing protein 1 OS=Homo sapiens OX=9606 GN=RWDD1 PE=1 SV=1 RWDD1_HUMAN reviewed RWD domain-containing protein 1 (DRG family-regulatory protein 2) Homo sapiens (Human) GO:0002181; GO:0003713; GO:0005829; GO:0030521; GO:0034599; GO:0071394 androgen receptor signaling pathway [GO:0030521]; cellular response to oxidative stress [GO:0034599]; cellular response to testosterone stimulus [GO:0071394]; cytoplasmic translation [GO:0002181] cytosol [GO:0005829] transcription coactivator activity [GO:0003713] g6195.t1 O61577 72.674 344 1.2300000000000001e-157 455.0 sp|O61577|KTNA1_STRPU Katanin p60 ATPase-containing subunit A1 OS=Strongylocentrotus purpuratus OX=7668 GN=KATNA1 PE=1 SV=1 g6195.t2 O61577 72.384 344 1.15e-155 450.0 sp|O61577|KTNA1_STRPU Katanin p60 ATPase-containing subunit A1 OS=Strongylocentrotus purpuratus OX=7668 GN=KATNA1 PE=1 SV=1 g6195.t3 O61577 63.59 390 1.38e-146 429.0 sp|O61577|KTNA1_STRPU Katanin p60 ATPase-containing subunit A1 OS=Strongylocentrotus purpuratus OX=7668 GN=KATNA1 PE=1 SV=1 g6196.t1 O61577 77.536 138 2.08e-61 199.0 sp|O61577|KTNA1_STRPU Katanin p60 ATPase-containing subunit A1 OS=Strongylocentrotus purpuratus OX=7668 GN=KATNA1 PE=1 SV=1 g6197.t1 Q95LD9 46.682 437 1.29e-115 384.0 sp|Q95LD9|AHR_DELLE Aryl hydrocarbon receptor OS=Delphinapterus leucas OX=9749 GN=AHR PE=2 SV=1 AHR_DELLE reviewed Aryl hydrocarbon receptor (Ah receptor) (AhR) Delphinapterus leucas (Beluga whale) GO:0001094; GO:0001223; GO:0002819; GO:0002841; GO:0004879; GO:0005634; GO:0005737; GO:0005829; GO:0006805; GO:0009410; GO:0009636; GO:0017025; GO:0030888; GO:0032922; GO:0034753; GO:0045892; GO:0045893; GO:0045944; GO:0046982; GO:0050728; GO:0051879; GO:0060729; GO:0061629; GO:0070888; GO:0071219; GO:0071320; GO:1904322; GO:1904613; GO:1990837 cellular response to 2,3,7,8-tetrachlorodibenzodioxine [GO:1904613]; cellular response to cAMP [GO:0071320]; cellular response to forskolin [GO:1904322]; cellular response to molecule of bacterial origin [GO:0071219]; circadian regulation of gene expression [GO:0032922]; intestinal epithelial structure maintenance [GO:0060729]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of inflammatory response [GO:0050728]; negative regulation of T cell mediated immune response to tumor cell [GO:0002841]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of adaptive immune response [GO:0002819]; regulation of B cell proliferation [GO:0030888]; response to toxic substance [GO:0009636]; response to xenobiotic stimulus [GO:0009410]; xenobiotic metabolic process [GO:0006805] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear aryl hydrocarbon receptor complex [GO:0034753]; nucleus [GO:0005634] E-box binding [GO:0070888]; Hsp90 protein binding [GO:0051879]; nuclear receptor activity [GO:0004879]; protein heterodimerization activity [GO:0046982]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific double-stranded DNA binding [GO:1990837]; TBP-class protein binding [GO:0017025]; TFIID-class transcription factor complex binding [GO:0001094]; transcription coactivator binding [GO:0001223] g6199.t1 Q9C102 52.763 2081 0.0 2031.0 sp|Q9C102|GLT1_SCHPO Glutamate synthase [NADH] OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) OX=284812 GN=glt1 PE=1 SV=1 g6200.t1 Q6P5U7 28.223 698 5.6e-51 202.0 sp|Q6P5U7|NWD2_MOUSE NACHT and WD repeat domain-containing protein 2 OS=Mus musculus OX=10090 GN=Nwd2 PE=1 SV=2 g6201.t1 O35115 43.599 289 2.48e-90 273.0 sp|O35115|FHL2_RAT Four and a half LIM domains protein 2 OS=Rattus norvegicus OX=10116 GN=Fhl2 PE=1 SV=1 FHL2_RAT reviewed Four and a half LIM domains protein 2 (FHL-2) (LIM domain protein DRAL) (Skeletal muscle LIM-protein 3) (SLIM-3) Rattus norvegicus (Rat) GO:0000122; GO:0001649; GO:0003714; GO:0005634; GO:0006357; GO:0008134; GO:0008270; GO:0009725; GO:0030018; GO:0031430; GO:0042802; GO:0043066; GO:0043425; GO:0055014; GO:0055015; GO:0060347; GO:0070885 atrial cardiac muscle cell development [GO:0055014]; heart trabecula formation [GO:0060347]; negative regulation of apoptotic process [GO:0043066]; negative regulation of calcineurin-NFAT signaling cascade [GO:0070885]; negative regulation of transcription by RNA polymerase II [GO:0000122]; osteoblast differentiation [GO:0001649]; regulation of transcription by RNA polymerase II [GO:0006357]; response to hormone [GO:0009725]; ventricular cardiac muscle cell development [GO:0055015] M band [GO:0031430]; nucleus [GO:0005634]; Z disc [GO:0030018] bHLH transcription factor binding [GO:0043425]; identical protein binding [GO:0042802]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; zinc ion binding [GO:0008270] g6201.t1 O35115 32.889 225 1.27e-32 124.0 sp|O35115|FHL2_RAT Four and a half LIM domains protein 2 OS=Rattus norvegicus OX=10116 GN=Fhl2 PE=1 SV=1 FHL2_RAT reviewed Four and a half LIM domains protein 2 (FHL-2) (LIM domain protein DRAL) (Skeletal muscle LIM-protein 3) (SLIM-3) Rattus norvegicus (Rat) GO:0000122; GO:0001649; GO:0003714; GO:0005634; GO:0006357; GO:0008134; GO:0008270; GO:0009725; GO:0030018; GO:0031430; GO:0042802; GO:0043066; GO:0043425; GO:0055014; GO:0055015; GO:0060347; GO:0070885 atrial cardiac muscle cell development [GO:0055014]; heart trabecula formation [GO:0060347]; negative regulation of apoptotic process [GO:0043066]; negative regulation of calcineurin-NFAT signaling cascade [GO:0070885]; negative regulation of transcription by RNA polymerase II [GO:0000122]; osteoblast differentiation [GO:0001649]; regulation of transcription by RNA polymerase II [GO:0006357]; response to hormone [GO:0009725]; ventricular cardiac muscle cell development [GO:0055015] M band [GO:0031430]; nucleus [GO:0005634]; Z disc [GO:0030018] bHLH transcription factor binding [GO:0043425]; identical protein binding [GO:0042802]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; zinc ion binding [GO:0008270] g6201.t2 O35115 45.324 278 6.97e-94 281.0 sp|O35115|FHL2_RAT Four and a half LIM domains protein 2 OS=Rattus norvegicus OX=10116 GN=Fhl2 PE=1 SV=1 FHL2_RAT reviewed Four and a half LIM domains protein 2 (FHL-2) (LIM domain protein DRAL) (Skeletal muscle LIM-protein 3) (SLIM-3) Rattus norvegicus (Rat) GO:0000122; GO:0001649; GO:0003714; GO:0005634; GO:0006357; GO:0008134; GO:0008270; GO:0009725; GO:0030018; GO:0031430; GO:0042802; GO:0043066; GO:0043425; GO:0055014; GO:0055015; GO:0060347; GO:0070885 atrial cardiac muscle cell development [GO:0055014]; heart trabecula formation [GO:0060347]; negative regulation of apoptotic process [GO:0043066]; negative regulation of calcineurin-NFAT signaling cascade [GO:0070885]; negative regulation of transcription by RNA polymerase II [GO:0000122]; osteoblast differentiation [GO:0001649]; regulation of transcription by RNA polymerase II [GO:0006357]; response to hormone [GO:0009725]; ventricular cardiac muscle cell development [GO:0055015] M band [GO:0031430]; nucleus [GO:0005634]; Z disc [GO:0030018] bHLH transcription factor binding [GO:0043425]; identical protein binding [GO:0042802]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; zinc ion binding [GO:0008270] g6201.t2 O35115 31.696 224 1.14e-32 124.0 sp|O35115|FHL2_RAT Four and a half LIM domains protein 2 OS=Rattus norvegicus OX=10116 GN=Fhl2 PE=1 SV=1 FHL2_RAT reviewed Four and a half LIM domains protein 2 (FHL-2) (LIM domain protein DRAL) (Skeletal muscle LIM-protein 3) (SLIM-3) Rattus norvegicus (Rat) GO:0000122; GO:0001649; GO:0003714; GO:0005634; GO:0006357; GO:0008134; GO:0008270; GO:0009725; GO:0030018; GO:0031430; GO:0042802; GO:0043066; GO:0043425; GO:0055014; GO:0055015; GO:0060347; GO:0070885 atrial cardiac muscle cell development [GO:0055014]; heart trabecula formation [GO:0060347]; negative regulation of apoptotic process [GO:0043066]; negative regulation of calcineurin-NFAT signaling cascade [GO:0070885]; negative regulation of transcription by RNA polymerase II [GO:0000122]; osteoblast differentiation [GO:0001649]; regulation of transcription by RNA polymerase II [GO:0006357]; response to hormone [GO:0009725]; ventricular cardiac muscle cell development [GO:0055015] M band [GO:0031430]; nucleus [GO:0005634]; Z disc [GO:0030018] bHLH transcription factor binding [GO:0043425]; identical protein binding [GO:0042802]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; zinc ion binding [GO:0008270] g6202.t1 O43900 37.209 129 1.7e-21 95.5 sp|O43900|PRIC3_HUMAN Prickle planar cell polarity protein 3 OS=Homo sapiens OX=9606 GN=PRICKLE3 PE=1 SV=2 PRIC3_HUMAN reviewed Prickle planar cell polarity protein 3 (LIM domain only protein 6) (LMO-6) (Prickle-like protein 3) (Pk3) (Triple LIM domain protein 6) Homo sapiens (Human) GO:0005739; GO:0005886; GO:0008270; GO:0030030 cell projection organization [GO:0030030] mitochondrion [GO:0005739]; plasma membrane [GO:0005886] zinc ion binding [GO:0008270] g6202.t2 O43900 37.209 129 1.54e-21 95.9 sp|O43900|PRIC3_HUMAN Prickle planar cell polarity protein 3 OS=Homo sapiens OX=9606 GN=PRICKLE3 PE=1 SV=2 PRIC3_HUMAN reviewed Prickle planar cell polarity protein 3 (LIM domain only protein 6) (LMO-6) (Prickle-like protein 3) (Pk3) (Triple LIM domain protein 6) Homo sapiens (Human) GO:0005739; GO:0005886; GO:0008270; GO:0030030 cell projection organization [GO:0030030] mitochondrion [GO:0005739]; plasma membrane [GO:0005886] zinc ion binding [GO:0008270] g6204.t1 Q6Q759 37.025 894 8.6e-124 441.0 sp|Q6Q759|SPG17_HUMAN Sperm-associated antigen 17 OS=Homo sapiens OX=9606 GN=SPAG17 PE=1 SV=1 SPG17_HUMAN reviewed Sperm-associated antigen 17 (Projection protein PF6 homolog) Homo sapiens (Human) GO:0001669; GO:0002177; GO:0003351; GO:0005576; GO:0005794; GO:0005874; GO:0007283; GO:0044458; GO:1904158; GO:1905198; GO:1990716; GO:1990953 axonemal central apparatus assembly [GO:1904158]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; intramanchette transport [GO:1990953]; manchette assembly [GO:1905198]; motile cilium assembly [GO:0044458]; spermatogenesis [GO:0007283] acrosomal vesicle [GO:0001669]; axonemal central apparatus [GO:1990716]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; manchette [GO:0002177]; microtubule [GO:0005874] g6204.t1 Q6Q759 32.33 764 2.48e-88 326.0 sp|Q6Q759|SPG17_HUMAN Sperm-associated antigen 17 OS=Homo sapiens OX=9606 GN=SPAG17 PE=1 SV=1 SPG17_HUMAN reviewed Sperm-associated antigen 17 (Projection protein PF6 homolog) Homo sapiens (Human) GO:0001669; GO:0002177; GO:0003351; GO:0005576; GO:0005794; GO:0005874; GO:0007283; GO:0044458; GO:1904158; GO:1905198; GO:1990716; GO:1990953 axonemal central apparatus assembly [GO:1904158]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; intramanchette transport [GO:1990953]; manchette assembly [GO:1905198]; motile cilium assembly [GO:0044458]; spermatogenesis [GO:0007283] acrosomal vesicle [GO:0001669]; axonemal central apparatus [GO:1990716]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; manchette [GO:0002177]; microtubule [GO:0005874] g6204.t1 Q6Q759 47.442 215 1.44e-44 183.0 sp|Q6Q759|SPG17_HUMAN Sperm-associated antigen 17 OS=Homo sapiens OX=9606 GN=SPAG17 PE=1 SV=1 SPG17_HUMAN reviewed Sperm-associated antigen 17 (Projection protein PF6 homolog) Homo sapiens (Human) GO:0001669; GO:0002177; GO:0003351; GO:0005576; GO:0005794; GO:0005874; GO:0007283; GO:0044458; GO:1904158; GO:1905198; GO:1990716; GO:1990953 axonemal central apparatus assembly [GO:1904158]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; intramanchette transport [GO:1990953]; manchette assembly [GO:1905198]; motile cilium assembly [GO:0044458]; spermatogenesis [GO:0007283] acrosomal vesicle [GO:0001669]; axonemal central apparatus [GO:1990716]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; manchette [GO:0002177]; microtubule [GO:0005874] g6206.t1 Q9DG23 36.076 316 4.53e-54 184.0 sp|Q9DG23|POPD1_CHICK Popeye domain-containing protein 1 OS=Gallus gallus OX=9031 GN=POPDC1 PE=1 SV=1 POPD1_CHICK reviewed Popeye domain-containing protein 1 (Popeye protein 1) (Blood vessel epicardial substance) Gallus gallus (Chicken) GO:0001921; GO:0002931; GO:0003201; GO:0005198; GO:0005737; GO:0005789; GO:0005886; GO:0005901; GO:0005923; GO:0007507; GO:0007519; GO:0008360; GO:0016020; GO:0016192; GO:0016328; GO:0030552; GO:0034446; GO:0040017; GO:0042383; GO:0042391; GO:0043087; GO:0048471; GO:0051146; GO:0051260; GO:0071944; GO:0090132; GO:0090136 epithelial cell-cell adhesion [GO:0090136]; epithelial to mesenchymal transition involved in coronary vasculature morphogenesis [GO:0003201]; epithelium migration [GO:0090132]; heart development [GO:0007507]; positive regulation of locomotion [GO:0040017]; positive regulation of receptor recycling [GO:0001921]; protein homooligomerization [GO:0051260]; regulation of cell shape [GO:0008360]; regulation of GTPase activity [GO:0043087]; regulation of membrane potential [GO:0042391]; response to ischemia [GO:0002931]; skeletal muscle tissue development [GO:0007519]; striated muscle cell differentiation [GO:0051146]; substrate adhesion-dependent cell spreading [GO:0034446]; vesicle-mediated transport [GO:0016192] bicellular tight junction [GO:0005923]; caveola [GO:0005901]; cell periphery [GO:0071944]; cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; lateral plasma membrane [GO:0016328]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383] cAMP binding [GO:0030552]; structural molecule activity [GO:0005198] g6207.t1 Q3BCU4 39.256 242 2.1e-47 168.0 sp|Q3BCU4|POPD1_RAT Popeye domain-containing protein 1 OS=Rattus norvegicus OX=10116 GN=Popdc1 PE=1 SV=2 POPD1_RAT reviewed Popeye domain-containing protein 1 (Popeye protein 1) (Blood vessel epicardial substance) Rattus norvegicus (Rat) GO:0001921; GO:0002027; GO:0002244; GO:0002931; GO:0005198; GO:0005886; GO:0005901; GO:0005923; GO:0007507; GO:0007519; GO:0008360; GO:0016020; GO:0016192; GO:0016328; GO:0030054; GO:0030552; GO:0031253; GO:0034446; GO:0040017; GO:0042383; GO:0042391; GO:0043087; GO:0048278; GO:0051146; GO:0060931; GO:0060973; GO:0090136; GO:2001135 cell migration involved in heart development [GO:0060973]; epithelial cell-cell adhesion [GO:0090136]; heart development [GO:0007507]; hematopoietic progenitor cell differentiation [GO:0002244]; positive regulation of locomotion [GO:0040017]; positive regulation of receptor recycling [GO:0001921]; regulation of cell shape [GO:0008360]; regulation of endocytic recycling [GO:2001135]; regulation of GTPase activity [GO:0043087]; regulation of heart rate [GO:0002027]; regulation of membrane potential [GO:0042391]; response to ischemia [GO:0002931]; sinoatrial node cell development [GO:0060931]; skeletal muscle tissue development [GO:0007519]; striated muscle cell differentiation [GO:0051146]; substrate adhesion-dependent cell spreading [GO:0034446]; vesicle docking [GO:0048278]; vesicle-mediated transport [GO:0016192] bicellular tight junction [GO:0005923]; caveola [GO:0005901]; cell junction [GO:0030054]; cell projection membrane [GO:0031253]; lateral plasma membrane [GO:0016328]; membrane [GO:0016020]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383] cAMP binding [GO:0030552]; structural molecule activity [GO:0005198] g6208.t1 D4A1J4 60.246 244 1.21e-105 308.0 sp|D4A1J4|DHRS6_RAT Dehydrogenase/reductase SDR family member 6 OS=Rattus norvegicus OX=10116 GN=Bdh2 PE=1 SV=2 DHRS6_RAT reviewed Dehydrogenase/reductase SDR family member 6 (EC 1.1.1.-) ((R)-beta-hydroxybutyrate dehydrogenase) (3-hydroxybutyrate dehydrogenase type 2) (EC 1.1.1.30) (4-oxo-L-proline reductase) (EC 1.1.1.104) (Oxidoreductase UCPA) (Short chain dehydrogenase/reductase family 15C member 1) Rattus norvegicus (Rat) GO:0003858; GO:0005737; GO:0005829; GO:0006635; GO:0016617; GO:0016628; GO:0019290; GO:0030855; GO:0042168; GO:0051287 epithelial cell differentiation [GO:0030855]; fatty acid beta-oxidation [GO:0006635]; heme metabolic process [GO:0042168]; siderophore biosynthetic process [GO:0019290] cytoplasm [GO:0005737]; cytosol [GO:0005829] 3-hydroxybutyrate dehydrogenase activity [GO:0003858]; 4-oxoproline reductase activity [GO:0016617]; NAD binding [GO:0051287]; oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor [GO:0016628] g6217.t1 O46560 51.636 275 8.8e-98 293.0 sp|O46560|PDXK_PIG Pyridoxal kinase OS=Sus scrofa OX=9823 GN=PDXK PE=1 SV=1 g6221.t1 A4IF63 28.571 231 1.66e-22 106.0 sp|A4IF63|TRIM2_BOVIN Tripartite motif-containing protein 2 OS=Bos taurus OX=9913 GN=TRIM2 PE=2 SV=1 TRIM2_BOVIN reviewed Tripartite motif-containing protein 2 (EC 2.3.2.27) (E3 ubiquitin-protein ligase TRIM2) (RING-type E3 ubiquitin transferase TRIM2) Bos taurus (Bovine) GO:0000209; GO:0004842; GO:0005737; GO:0008270; GO:0043161; GO:0043523; GO:0061630 proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; regulation of neuron apoptotic process [GO:0043523] cytoplasm [GO:0005737] ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] g6222.t1 O88828 85.714 91 1.58e-49 157.0 sp|O88828|RPAB2_RAT DNA-directed RNA polymerases I, II, and III subunit RPABC2 OS=Rattus norvegicus OX=10116 GN=Polr2f PE=1 SV=1 g6223.t1 Q2TBP7 59.596 99 2.3999999999999997e-38 127.0 sp|Q2TBP7|MYCBP_BOVIN c-Myc-binding protein OS=Bos taurus OX=9913 GN=MYCBP PE=3 SV=3 g6224.t1 Q5U2V9 46.324 408 3.9099999999999995e-104 322.0 sp|Q5U2V9|TM39A_RAT Transmembrane protein 39A OS=Rattus norvegicus OX=10116 GN=Tmem39a PE=2 SV=1 g6225.t1 Q5U2V9 54.63 216 1.11e-83 265.0 sp|Q5U2V9|TM39A_RAT Transmembrane protein 39A OS=Rattus norvegicus OX=10116 GN=Tmem39a PE=2 SV=1 g6227.t1 Q9JIL5 49.537 648 0.0 602.0 sp|Q9JIL5|TULP4_MOUSE Tubby-related protein 4 OS=Mus musculus OX=10090 GN=Tulp4 PE=1 SV=1 g6227.t1 Q9JIL5 86.25 80 4.07e-29 130.0 sp|Q9JIL5|TULP4_MOUSE Tubby-related protein 4 OS=Mus musculus OX=10090 GN=Tulp4 PE=1 SV=1 g6228.t1 Q9NVP1 68.431 510 0.0 670.0 sp|Q9NVP1|DDX18_HUMAN ATP-dependent RNA helicase DDX18 OS=Homo sapiens OX=9606 GN=DDX18 PE=1 SV=2 DDX18_HUMAN reviewed ATP-dependent RNA helicase DDX18 (EC 3.6.4.13) (DEAD box protein 18) (Myc-regulated DEAD box protein) (MrDb) Homo sapiens (Human) GO:0000463; GO:0003723; GO:0003724; GO:0005524; GO:0005694; GO:0005730; GO:0016020; GO:0016887; GO:0071392 cellular response to estradiol stimulus [GO:0071392]; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463] chromosome [GO:0005694]; membrane [GO:0016020]; nucleolus [GO:0005730] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724] g6229.t1 P24472 46.429 224 1.83e-60 192.0 sp|P24472|GSTA4_MOUSE Glutathione S-transferase A4 OS=Mus musculus OX=10090 GN=Gsta4 PE=1 SV=3 GSTA4_MOUSE reviewed Glutathione S-transferase A4 (EC 2.5.1.18) (GST A4-4) (GSTA4-4) (GST class-alpha member 4) (Glutathione S-transferase 5.7) (GST 5.7) Mus musculus (Mouse) GO:0004364; GO:0005739; GO:0006749; GO:0006805; GO:0015643; GO:0061771 glutathione metabolic process [GO:0006749]; response to caloric restriction [GO:0061771]; xenobiotic metabolic process [GO:0006805] mitochondrion [GO:0005739] glutathione transferase activity [GO:0004364]; toxic substance binding [GO:0015643] g6231.t1 Q7T3I0 51.244 201 1.4200000000000001e-47 159.0 sp|Q7T3I0|ZC4H2_DANRE Zinc finger C4H2 domain-containing protein OS=Danio rerio OX=7955 GN=zc4h2 PE=2 SV=1 ZC4H2_DANRE reviewed Zinc finger C4H2 domain-containing protein (Hepatocellular carcinoma-associated antigen 127 homolog) (Hepatocellular carcinoma-associated antigen 127-like) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005634; GO:0005737; GO:0007399; GO:0007528; GO:0008270; GO:0021522; GO:0036269; GO:0045211; GO:0045666; GO:0048665; GO:0048666; GO:0050885 nervous system development [GO:0007399]; neuromuscular junction development [GO:0007528]; neuromuscular process controlling balance [GO:0050885]; neuron development [GO:0048666]; neuron fate specification [GO:0048665]; positive regulation of neuron differentiation [GO:0045666]; spinal cord motor neuron differentiation [GO:0021522]; swimming behavior [GO:0036269] cytoplasm [GO:0005737]; nucleus [GO:0005634]; postsynaptic membrane [GO:0045211] zinc ion binding [GO:0008270] g6232.t1 Q9VCA2 41.348 549 2.05e-116 358.0 sp|Q9VCA2|ORCT_DROME Organic cation transporter protein OS=Drosophila melanogaster OX=7227 GN=Orct PE=1 SV=1 g6233.t1 P20461 85.408 466 0.0 813.0 sp|P20461|IF2G_PIG Eukaryotic translation initiation factor 2 subunit 3 OS=Sus scrofa OX=9823 GN=EIF2S3 PE=1 SV=2 g6234.t1 F1NV61 46.125 271 2.66e-78 246.0 sp|F1NV61|CASP7_CHICK Caspase-7 OS=Gallus gallus OX=9031 GN=CASP7 PE=3 SV=2 CASP7_CHICK reviewed Caspase-7 (CASP-7) (EC 3.4.22.60) [Cleaved into: Caspase-7 subunit p20; Caspase-7 subunit p11] Gallus gallus (Chicken) GO:0003723; GO:0004190; GO:0004197; GO:0005615; GO:0005634; GO:0005737; GO:0005829; GO:0006508; GO:0006915; GO:0042742; GO:0043525; GO:0070227; GO:0097194; GO:1905686 apoptotic process [GO:0006915]; defense response to bacterium [GO:0042742]; execution phase of apoptosis [GO:0097194]; lymphocyte apoptotic process [GO:0070227]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of plasma membrane repair [GO:1905686]; proteolysis [GO:0006508] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; nucleus [GO:0005634] aspartic-type endopeptidase activity [GO:0004190]; cysteine-type endopeptidase activity [GO:0004197]; RNA binding [GO:0003723] g6235.t1 Q4WUD3 41.845 466 8.069999999999999e-95 305.0 sp|Q4WUD3|AMPP1_ASPFU Probable Xaa-Pro aminopeptidase P OS=Aspergillus fumigatus (strain ATCC MYA-4609 / CBS 101355 / FGSC A1100 / Af293) OX=330879 GN=ampp PE=3 SV=1 g6236.t1 Q6P1B1 46.988 166 7.469999999999999e-48 168.0 sp|Q6P1B1|XPP1_MOUSE Xaa-Pro aminopeptidase 1 OS=Mus musculus OX=10090 GN=Xpnpep1 PE=1 SV=1 XPP1_MOUSE reviewed Xaa-Pro aminopeptidase 1 (EC 3.4.11.9) (Aminoacylproline aminopeptidase) (Cytosolic aminopeptidase P) (Soluble aminopeptidase P) (sAmp) (X-Pro aminopeptidase 1) (X-prolyl aminopeptidase 1, soluble) Mus musculus (Mouse) GO:0004177; GO:0005737; GO:0005829; GO:0006508; GO:0010815; GO:0030145; GO:0042803; GO:0043069; GO:0070006; GO:0140633 bradykinin catabolic process [GO:0010815]; CARD8 inflammasome complex assembly [GO:0140633]; negative regulation of programmed cell death [GO:0043069]; proteolysis [GO:0006508] cytoplasm [GO:0005737]; cytosol [GO:0005829] aminopeptidase activity [GO:0004177]; manganese ion binding [GO:0030145]; metalloaminopeptidase activity [GO:0070006]; protein homodimerization activity [GO:0042803] g6236.t2 Q6P1B1 43.976 166 8.18e-45 160.0 sp|Q6P1B1|XPP1_MOUSE Xaa-Pro aminopeptidase 1 OS=Mus musculus OX=10090 GN=Xpnpep1 PE=1 SV=1 XPP1_MOUSE reviewed Xaa-Pro aminopeptidase 1 (EC 3.4.11.9) (Aminoacylproline aminopeptidase) (Cytosolic aminopeptidase P) (Soluble aminopeptidase P) (sAmp) (X-Pro aminopeptidase 1) (X-prolyl aminopeptidase 1, soluble) Mus musculus (Mouse) GO:0004177; GO:0005737; GO:0005829; GO:0006508; GO:0010815; GO:0030145; GO:0042803; GO:0043069; GO:0070006; GO:0140633 bradykinin catabolic process [GO:0010815]; CARD8 inflammasome complex assembly [GO:0140633]; negative regulation of programmed cell death [GO:0043069]; proteolysis [GO:0006508] cytoplasm [GO:0005737]; cytosol [GO:0005829] aminopeptidase activity [GO:0004177]; manganese ion binding [GO:0030145]; metalloaminopeptidase activity [GO:0070006]; protein homodimerization activity [GO:0042803] g6236.t3 Q6P1B1 40.957 188 3.3299999999999995e-42 154.0 sp|Q6P1B1|XPP1_MOUSE Xaa-Pro aminopeptidase 1 OS=Mus musculus OX=10090 GN=Xpnpep1 PE=1 SV=1 XPP1_MOUSE reviewed Xaa-Pro aminopeptidase 1 (EC 3.4.11.9) (Aminoacylproline aminopeptidase) (Cytosolic aminopeptidase P) (Soluble aminopeptidase P) (sAmp) (X-Pro aminopeptidase 1) (X-prolyl aminopeptidase 1, soluble) Mus musculus (Mouse) GO:0004177; GO:0005737; GO:0005829; GO:0006508; GO:0010815; GO:0030145; GO:0042803; GO:0043069; GO:0070006; GO:0140633 bradykinin catabolic process [GO:0010815]; CARD8 inflammasome complex assembly [GO:0140633]; negative regulation of programmed cell death [GO:0043069]; proteolysis [GO:0006508] cytoplasm [GO:0005737]; cytosol [GO:0005829] aminopeptidase activity [GO:0004177]; manganese ion binding [GO:0030145]; metalloaminopeptidase activity [GO:0070006]; protein homodimerization activity [GO:0042803] g6236.t4 O54975 43.575 179 1.09e-43 157.0 sp|O54975|XPP1_RAT Xaa-Pro aminopeptidase 1 OS=Rattus norvegicus OX=10116 GN=Xpnpep1 PE=1 SV=1 XPP1_RAT reviewed Xaa-Pro aminopeptidase 1 (EC 3.4.11.9) (Aminoacylproline aminopeptidase) (Cytosolic aminopeptidase P) (Soluble aminopeptidase P) (sAmp) (X-Pro aminopeptidase 1) (X-prolyl aminopeptidase 1, soluble) Rattus norvegicus (Rat) GO:0004177; GO:0005737; GO:0005829; GO:0006508; GO:0010815; GO:0030145; GO:0042803; GO:0043069; GO:0070006; GO:0140633 bradykinin catabolic process [GO:0010815]; CARD8 inflammasome complex assembly [GO:0140633]; negative regulation of programmed cell death [GO:0043069]; proteolysis [GO:0006508] cytoplasm [GO:0005737]; cytosol [GO:0005829] aminopeptidase activity [GO:0004177]; manganese ion binding [GO:0030145]; metalloaminopeptidase activity [GO:0070006]; protein homodimerization activity [GO:0042803] g6237.t1 Q1JPJ2 33.572 697 6.35e-112 357.0 sp|Q1JPJ2|XPP1_BOVIN Xaa-Pro aminopeptidase 1 OS=Bos taurus OX=9913 GN=XPNPEP1 PE=2 SV=1 g6237.t2 Q1JPJ2 33.572 697 7.97e-112 356.0 sp|Q1JPJ2|XPP1_BOVIN Xaa-Pro aminopeptidase 1 OS=Bos taurus OX=9913 GN=XPNPEP1 PE=2 SV=1 g6238.t1 O00338 33.22 295 1.24e-49 169.0 sp|O00338|ST1C2_HUMAN Sulfotransferase 1C2 OS=Homo sapiens OX=9606 GN=SULT1C2 PE=1 SV=1 ST1C2_HUMAN reviewed Sulfotransferase 1C2 (ST1C2) (EC 2.8.2.1) (Sulfotransferase 1C1) (SULT1C#1) (humSULTC2) Homo sapiens (Human) GO:0004062; GO:0005737; GO:0005739; GO:0005764; GO:0005829; GO:0008146; GO:0009308; GO:0051922; GO:0051923 amine metabolic process [GO:0009308]; sulfation [GO:0051923] cytoplasm [GO:0005737]; cytosol [GO:0005829]; lysosome [GO:0005764]; mitochondrion [GO:0005739] aryl sulfotransferase activity [GO:0004062]; cholesterol sulfotransferase activity [GO:0051922]; sulfotransferase activity [GO:0008146] g6239.t1 Q6NRS1 43.653 969 0.0 806.0 sp|Q6NRS1|IBTK_XENLA Inhibitor of Bruton tyrosine kinase OS=Xenopus laevis OX=8355 GN=ibtk PE=2 SV=1 g6247.t1 A5PK71 49.296 213 1.5100000000000002e-66 206.0 sp|A5PK71|PACRG_BOVIN Parkin coregulated gene protein OS=Bos taurus OX=9913 GN=PACRG PE=1 SV=1 PACRG_BOVIN reviewed Parkin coregulated gene protein Bos taurus (Bovine) GO:0001664; GO:0002177; GO:0003779; GO:0005829; GO:0005879; GO:0007286; GO:0008104; GO:0030317; GO:0030544; GO:0031625; GO:0031982; GO:0043005; GO:0043014; GO:0044297; GO:0048487; GO:0051879; GO:0097225; GO:0097386; GO:0160112 flagellated sperm motility [GO:0030317]; intracellular protein localization [GO:0008104]; spermatid development [GO:0007286] axonemal B tubule inner sheath [GO:0160112]; axonemal microtubule [GO:0005879]; cell body [GO:0044297]; cytosol [GO:0005829]; glial cell projection [GO:0097386]; manchette [GO:0002177]; neuron projection [GO:0043005]; sperm midpiece [GO:0097225]; vesicle [GO:0031982] actin binding [GO:0003779]; alpha-tubulin binding [GO:0043014]; beta-tubulin binding [GO:0048487]; G protein-coupled receptor binding [GO:0001664]; Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]; ubiquitin protein ligase binding [GO:0031625] g6248.t1 Q6IRN2 51.765 340 1.19e-102 312.0 sp|Q6IRN2|QKIB_XENLA KH domain-containing RNA-binding protein qki.L OS=Xenopus laevis OX=8355 GN=qki.L PE=1 SV=1 g6248.t2 Q6IRN2 53.495 329 1.2999999999999999e-104 317.0 sp|Q6IRN2|QKIB_XENLA KH domain-containing RNA-binding protein qki.L OS=Xenopus laevis OX=8355 GN=qki.L PE=1 SV=1 g6249.t1 Q8IXU6 40.947 359 5.88e-83 259.0 sp|Q8IXU6|S35F2_HUMAN Solute carrier family 35 member F2 OS=Homo sapiens OX=9606 GN=SLC35F2 PE=1 SV=1 S35F2_HUMAN reviewed Queuine/queuosine transporter SLC35F2 (Solute carrier family 35 member F2) Homo sapiens (Human) GO:0005886; GO:0022857; GO:0160254; GO:0160255 tRNA queuosine(34) biosynthetic process from salvaged queuine [GO:0160255]; tRNA queuosine(34) biosynthetic process from salvaged queuosine or its precursors [GO:0160254] plasma membrane [GO:0005886] transmembrane transporter activity [GO:0022857] g6250.t1 Q96DA2 59.434 212 1.76e-91 270.0 sp|Q96DA2|RB39B_HUMAN Ras-related protein Rab-39B OS=Homo sapiens OX=9606 GN=RAB39B PE=1 SV=1 RB39B_HUMAN reviewed Ras-related protein Rab-39B (EC 3.6.5.2) Homo sapiens (Human) GO:0000421; GO:0003924; GO:0003925; GO:0005525; GO:0005794; GO:0005886; GO:0006914; GO:0010506; GO:0015031; GO:0016192; GO:0030659; GO:0031489; GO:0031982; GO:0032482; GO:0043005; GO:0046872; GO:0050808; GO:0120281 autophagy [GO:0006914]; protein transport [GO:0015031]; Rab protein signal transduction [GO:0032482]; regulation of autophagy [GO:0010506]; synapse organization [GO:0050808]; vesicle-mediated transport [GO:0016192] autolysosome membrane [GO:0120281]; autophagosome membrane [GO:0000421]; cytoplasmic vesicle membrane [GO:0030659]; Golgi apparatus [GO:0005794]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; vesicle [GO:0031982] G protein activity [GO:0003925]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; myosin V binding [GO:0031489] g6254.t1 Q96DM1 27.824 363 3.09e-25 110.0 sp|Q96DM1|PGBD4_HUMAN PiggyBac transposable element-derived protein 4 OS=Homo sapiens OX=9606 GN=PGBD4 PE=1 SV=3 g6255.t1 Q5ZK69 50.0 390 4.71e-139 405.0 sp|Q5ZK69|PAAF1_CHICK Proteasomal ATPase-associated factor 1 OS=Gallus gallus OX=9031 GN=PAAF1 PE=2 SV=1 g6257.t1 D3YVF0 32.673 303 4.6800000000000005e-27 117.0 sp|D3YVF0|AKAP5_MOUSE A-kinase anchor protein 5 OS=Mus musculus OX=10090 GN=Akap5 PE=1 SV=2 AKAP5_MOUSE reviewed A-kinase anchor protein 5 (AKAP-5) (A-kinase anchor protein 150 kDa) (AKAP 150) (P150) (cAMP-dependent protein kinase regulatory subunit II high affinity-binding protein) Mus musculus (Mouse) GO:0001664; GO:0003779; GO:0005516; GO:0005829; GO:0005856; GO:0005886; GO:0007193; GO:0007194; GO:0007416; GO:0008179; GO:0008287; GO:0009898; GO:0010467; GO:0010524; GO:0010738; GO:0014069; GO:0016323; GO:0017124; GO:0019900; GO:0019901; GO:0019904; GO:0030346; GO:0030425; GO:0031527; GO:0031698; GO:0032279; GO:0032590; GO:0032591; GO:0032984; GO:0033173; GO:0034237; GO:0035254; GO:0036394; GO:0042307; GO:0043025; GO:0043113; GO:0043197; GO:0043198; GO:0043267; GO:0043271; GO:0044877; GO:0045121; GO:0045163; GO:0045211; GO:0045296; GO:0048471; GO:0050775; GO:0050811; GO:0060076; GO:0060090; GO:0070073; GO:0070886; GO:0071277; GO:0071466; GO:0097110; GO:0098837; GO:0098944; GO:0098978; GO:0099092; GO:0099149; GO:0099630; GO:1900273; GO:1903078; GO:1905665; GO:1905751 adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; amylase secretion [GO:0036394]; calcineurin-NFAT signaling cascade [GO:0033173]; cellular response to calcium ion [GO:0071277]; cellular response to xenobiotic stimulus [GO:0071466]; clustering of voltage-gated calcium channels [GO:0070073]; clustering of voltage-gated potassium channels [GO:0045163]; gene expression [GO:0010467]; negative regulation of adenylate cyclase activity [GO:0007194]; negative regulation of monoatomic ion transport [GO:0043271]; negative regulation of potassium ion transport [GO:0043267]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886]; positive regulation of calcium ion import across plasma membrane [GO:1905665]; positive regulation of calcium ion transport into cytosol [GO:0010524]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of endosome to plasma membrane protein transport [GO:1905751]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of protein localization to plasma membrane [GO:1903078]; postsynaptic neurotransmitter receptor cycle [GO:0099630]; protein-containing complex disassembly [GO:0032984]; receptor clustering [GO:0043113]; regulation of postsynaptic neurotransmitter receptor internalization [GO:0099149]; regulation of protein kinase A signaling [GO:0010738]; synapse assembly [GO:0007416] asymmetric synapse [GO:0032279]; basolateral plasma membrane [GO:0016323]; cytoplasmic side of plasma membrane [GO:0009898]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendrite membrane [GO:0032590]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; dendritic spine membrane [GO:0032591]; excitatory synapse [GO:0060076]; filopodium membrane [GO:0031527]; glutamatergic synapse [GO:0098978]; membrane raft [GO:0045121]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic density, intracellular component [GO:0099092]; postsynaptic membrane [GO:0045211]; postsynaptic recycling endosome [GO:0098837]; postsynaptic recycling endosome membrane [GO:0098944]; protein serine/threonine phosphatase complex [GO:0008287] actin binding [GO:0003779]; adenylate cyclase binding [GO:0008179]; beta-2 adrenergic receptor binding [GO:0031698]; cadherin binding [GO:0045296]; calmodulin binding [GO:0005516]; G protein-coupled receptor binding [GO:0001664]; GABA receptor binding [GO:0050811]; glutamate receptor binding [GO:0035254]; kinase binding [GO:0019900]; molecular adaptor activity [GO:0060090]; protein domain specific binding [GO:0019904]; protein kinase A regulatory subunit binding [GO:0034237]; protein kinase binding [GO:0019901]; protein phosphatase 2B binding [GO:0030346]; protein-containing complex binding [GO:0044877]; scaffold protein binding [GO:0097110]; SH3 domain binding [GO:0017124] g6257.t1 D3YVF0 31.987 297 4.81e-25 111.0 sp|D3YVF0|AKAP5_MOUSE A-kinase anchor protein 5 OS=Mus musculus OX=10090 GN=Akap5 PE=1 SV=2 AKAP5_MOUSE reviewed A-kinase anchor protein 5 (AKAP-5) (A-kinase anchor protein 150 kDa) (AKAP 150) (P150) (cAMP-dependent protein kinase regulatory subunit II high affinity-binding protein) Mus musculus (Mouse) GO:0001664; GO:0003779; GO:0005516; GO:0005829; GO:0005856; GO:0005886; GO:0007193; GO:0007194; GO:0007416; GO:0008179; GO:0008287; GO:0009898; GO:0010467; GO:0010524; GO:0010738; GO:0014069; GO:0016323; GO:0017124; GO:0019900; GO:0019901; GO:0019904; GO:0030346; GO:0030425; GO:0031527; GO:0031698; GO:0032279; GO:0032590; GO:0032591; GO:0032984; GO:0033173; GO:0034237; GO:0035254; GO:0036394; GO:0042307; GO:0043025; GO:0043113; GO:0043197; GO:0043198; GO:0043267; GO:0043271; GO:0044877; GO:0045121; GO:0045163; GO:0045211; GO:0045296; GO:0048471; GO:0050775; GO:0050811; GO:0060076; GO:0060090; GO:0070073; GO:0070886; GO:0071277; GO:0071466; GO:0097110; GO:0098837; GO:0098944; GO:0098978; GO:0099092; GO:0099149; GO:0099630; GO:1900273; GO:1903078; GO:1905665; GO:1905751 adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; amylase secretion [GO:0036394]; calcineurin-NFAT signaling cascade [GO:0033173]; cellular response to calcium ion [GO:0071277]; cellular response to xenobiotic stimulus [GO:0071466]; clustering of voltage-gated calcium channels [GO:0070073]; clustering of voltage-gated potassium channels [GO:0045163]; gene expression [GO:0010467]; negative regulation of adenylate cyclase activity [GO:0007194]; negative regulation of monoatomic ion transport [GO:0043271]; negative regulation of potassium ion transport [GO:0043267]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886]; positive regulation of calcium ion import across plasma membrane [GO:1905665]; positive regulation of calcium ion transport into cytosol [GO:0010524]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of endosome to plasma membrane protein transport [GO:1905751]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of protein localization to plasma membrane [GO:1903078]; postsynaptic neurotransmitter receptor cycle [GO:0099630]; protein-containing complex disassembly [GO:0032984]; receptor clustering [GO:0043113]; regulation of postsynaptic neurotransmitter receptor internalization [GO:0099149]; regulation of protein kinase A signaling [GO:0010738]; synapse assembly [GO:0007416] asymmetric synapse [GO:0032279]; basolateral plasma membrane [GO:0016323]; cytoplasmic side of plasma membrane [GO:0009898]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendrite membrane [GO:0032590]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; dendritic spine membrane [GO:0032591]; excitatory synapse [GO:0060076]; filopodium membrane [GO:0031527]; glutamatergic synapse [GO:0098978]; membrane raft [GO:0045121]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic density, intracellular component [GO:0099092]; postsynaptic membrane [GO:0045211]; postsynaptic recycling endosome [GO:0098837]; postsynaptic recycling endosome membrane [GO:0098944]; protein serine/threonine phosphatase complex [GO:0008287] actin binding [GO:0003779]; adenylate cyclase binding [GO:0008179]; beta-2 adrenergic receptor binding [GO:0031698]; cadherin binding [GO:0045296]; calmodulin binding [GO:0005516]; G protein-coupled receptor binding [GO:0001664]; GABA receptor binding [GO:0050811]; glutamate receptor binding [GO:0035254]; kinase binding [GO:0019900]; molecular adaptor activity [GO:0060090]; protein domain specific binding [GO:0019904]; protein kinase A regulatory subunit binding [GO:0034237]; protein kinase binding [GO:0019901]; protein phosphatase 2B binding [GO:0030346]; protein-containing complex binding [GO:0044877]; scaffold protein binding [GO:0097110]; SH3 domain binding [GO:0017124] g6257.t1 D3YVF0 31.908 304 1.07e-24 110.0 sp|D3YVF0|AKAP5_MOUSE A-kinase anchor protein 5 OS=Mus musculus OX=10090 GN=Akap5 PE=1 SV=2 AKAP5_MOUSE reviewed A-kinase anchor protein 5 (AKAP-5) (A-kinase anchor protein 150 kDa) (AKAP 150) (P150) (cAMP-dependent protein kinase regulatory subunit II high affinity-binding protein) Mus musculus (Mouse) GO:0001664; GO:0003779; GO:0005516; GO:0005829; GO:0005856; GO:0005886; GO:0007193; GO:0007194; GO:0007416; GO:0008179; GO:0008287; GO:0009898; GO:0010467; GO:0010524; GO:0010738; GO:0014069; GO:0016323; GO:0017124; GO:0019900; GO:0019901; GO:0019904; GO:0030346; GO:0030425; GO:0031527; GO:0031698; GO:0032279; GO:0032590; GO:0032591; GO:0032984; GO:0033173; GO:0034237; GO:0035254; GO:0036394; GO:0042307; GO:0043025; GO:0043113; GO:0043197; GO:0043198; GO:0043267; GO:0043271; GO:0044877; GO:0045121; GO:0045163; GO:0045211; GO:0045296; GO:0048471; GO:0050775; GO:0050811; GO:0060076; GO:0060090; GO:0070073; GO:0070886; GO:0071277; GO:0071466; GO:0097110; GO:0098837; GO:0098944; GO:0098978; GO:0099092; GO:0099149; GO:0099630; GO:1900273; GO:1903078; GO:1905665; GO:1905751 adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; amylase secretion [GO:0036394]; calcineurin-NFAT signaling cascade [GO:0033173]; cellular response to calcium ion [GO:0071277]; cellular response to xenobiotic stimulus [GO:0071466]; clustering of voltage-gated calcium channels [GO:0070073]; clustering of voltage-gated potassium channels [GO:0045163]; gene expression [GO:0010467]; negative regulation of adenylate cyclase activity [GO:0007194]; negative regulation of monoatomic ion transport [GO:0043271]; negative regulation of potassium ion transport [GO:0043267]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886]; positive regulation of calcium ion import across plasma membrane [GO:1905665]; positive regulation of calcium ion transport into cytosol [GO:0010524]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of endosome to plasma membrane protein transport [GO:1905751]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of protein localization to plasma membrane [GO:1903078]; postsynaptic neurotransmitter receptor cycle [GO:0099630]; protein-containing complex disassembly [GO:0032984]; receptor clustering [GO:0043113]; regulation of postsynaptic neurotransmitter receptor internalization [GO:0099149]; regulation of protein kinase A signaling [GO:0010738]; synapse assembly [GO:0007416] asymmetric synapse [GO:0032279]; basolateral plasma membrane [GO:0016323]; cytoplasmic side of plasma membrane [GO:0009898]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendrite membrane [GO:0032590]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; dendritic spine membrane [GO:0032591]; excitatory synapse [GO:0060076]; filopodium membrane [GO:0031527]; glutamatergic synapse [GO:0098978]; membrane raft [GO:0045121]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic density, intracellular component [GO:0099092]; postsynaptic membrane [GO:0045211]; postsynaptic recycling endosome [GO:0098837]; postsynaptic recycling endosome membrane [GO:0098944]; protein serine/threonine phosphatase complex [GO:0008287] actin binding [GO:0003779]; adenylate cyclase binding [GO:0008179]; beta-2 adrenergic receptor binding [GO:0031698]; cadherin binding [GO:0045296]; calmodulin binding [GO:0005516]; G protein-coupled receptor binding [GO:0001664]; GABA receptor binding [GO:0050811]; glutamate receptor binding [GO:0035254]; kinase binding [GO:0019900]; molecular adaptor activity [GO:0060090]; protein domain specific binding [GO:0019904]; protein kinase A regulatory subunit binding [GO:0034237]; protein kinase binding [GO:0019901]; protein phosphatase 2B binding [GO:0030346]; protein-containing complex binding [GO:0044877]; scaffold protein binding [GO:0097110]; SH3 domain binding [GO:0017124] g6257.t1 D3YVF0 32.095 296 1.09e-24 110.0 sp|D3YVF0|AKAP5_MOUSE A-kinase anchor protein 5 OS=Mus musculus OX=10090 GN=Akap5 PE=1 SV=2 AKAP5_MOUSE reviewed A-kinase anchor protein 5 (AKAP-5) (A-kinase anchor protein 150 kDa) (AKAP 150) (P150) (cAMP-dependent protein kinase regulatory subunit II high affinity-binding protein) Mus musculus (Mouse) GO:0001664; GO:0003779; GO:0005516; GO:0005829; GO:0005856; GO:0005886; GO:0007193; GO:0007194; GO:0007416; GO:0008179; GO:0008287; GO:0009898; GO:0010467; GO:0010524; GO:0010738; GO:0014069; GO:0016323; GO:0017124; GO:0019900; GO:0019901; GO:0019904; GO:0030346; GO:0030425; GO:0031527; GO:0031698; GO:0032279; GO:0032590; GO:0032591; GO:0032984; GO:0033173; GO:0034237; GO:0035254; GO:0036394; GO:0042307; GO:0043025; GO:0043113; GO:0043197; GO:0043198; GO:0043267; GO:0043271; GO:0044877; GO:0045121; GO:0045163; GO:0045211; GO:0045296; GO:0048471; GO:0050775; GO:0050811; GO:0060076; GO:0060090; GO:0070073; GO:0070886; GO:0071277; GO:0071466; GO:0097110; GO:0098837; GO:0098944; GO:0098978; GO:0099092; GO:0099149; GO:0099630; GO:1900273; GO:1903078; GO:1905665; GO:1905751 adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; amylase secretion [GO:0036394]; calcineurin-NFAT signaling cascade [GO:0033173]; cellular response to calcium ion [GO:0071277]; cellular response to xenobiotic stimulus [GO:0071466]; clustering of voltage-gated calcium channels [GO:0070073]; clustering of voltage-gated potassium channels [GO:0045163]; gene expression [GO:0010467]; negative regulation of adenylate cyclase activity [GO:0007194]; negative regulation of monoatomic ion transport [GO:0043271]; negative regulation of potassium ion transport [GO:0043267]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886]; positive regulation of calcium ion import across plasma membrane [GO:1905665]; positive regulation of calcium ion transport into cytosol [GO:0010524]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of endosome to plasma membrane protein transport [GO:1905751]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of protein localization to plasma membrane [GO:1903078]; postsynaptic neurotransmitter receptor cycle [GO:0099630]; protein-containing complex disassembly [GO:0032984]; receptor clustering [GO:0043113]; regulation of postsynaptic neurotransmitter receptor internalization [GO:0099149]; regulation of protein kinase A signaling [GO:0010738]; synapse assembly [GO:0007416] asymmetric synapse [GO:0032279]; basolateral plasma membrane [GO:0016323]; cytoplasmic side of plasma membrane [GO:0009898]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendrite membrane [GO:0032590]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; dendritic spine membrane [GO:0032591]; excitatory synapse [GO:0060076]; filopodium membrane [GO:0031527]; glutamatergic synapse [GO:0098978]; membrane raft [GO:0045121]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic density, intracellular component [GO:0099092]; postsynaptic membrane [GO:0045211]; postsynaptic recycling endosome [GO:0098837]; postsynaptic recycling endosome membrane [GO:0098944]; protein serine/threonine phosphatase complex [GO:0008287] actin binding [GO:0003779]; adenylate cyclase binding [GO:0008179]; beta-2 adrenergic receptor binding [GO:0031698]; cadherin binding [GO:0045296]; calmodulin binding [GO:0005516]; G protein-coupled receptor binding [GO:0001664]; GABA receptor binding [GO:0050811]; glutamate receptor binding [GO:0035254]; kinase binding [GO:0019900]; molecular adaptor activity [GO:0060090]; protein domain specific binding [GO:0019904]; protein kinase A regulatory subunit binding [GO:0034237]; protein kinase binding [GO:0019901]; protein phosphatase 2B binding [GO:0030346]; protein-containing complex binding [GO:0044877]; scaffold protein binding [GO:0097110]; SH3 domain binding [GO:0017124] g6258.t1 Q9BG93 34.583 240 1.69e-32 129.0 sp|Q9BG93|NR0B1_MACMU Nuclear receptor subfamily 0 group B member 1 OS=Macaca mulatta OX=9544 GN=NR0B1 PE=2 SV=1 g6261.t1 Q80Y44 62.857 490 0.0 653.0 sp|Q80Y44|DDX10_MOUSE Probable ATP-dependent RNA helicase DDX10 OS=Mus musculus OX=10090 GN=Ddx10 PE=1 SV=2 g6262.t1 P98069 44.889 225 8.68e-48 177.0 sp|P98069|BMPH_STRPU Bone morphogenetic protein 1 homolog OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g6263.t1 Q8R033 61.628 86 4.56e-28 100.0 sp|Q8R033|LYRM2_MOUSE LYR motif-containing protein 2 OS=Mus musculus OX=10090 GN=Lyrm2 PE=3 SV=1 g6265.t1 Q5ZI57 63.889 180 1.93e-82 244.0 sp|Q5ZI57|TPPC3_CHICK Trafficking protein particle complex subunit 3 OS=Gallus gallus OX=9031 GN=TRAPPC3 PE=2 SV=1 g6266.t1 Q80YA9 39.249 293 4.37e-60 222.0 sp|Q80YA9|CNKR2_MOUSE Connector enhancer of kinase suppressor of ras 2 OS=Mus musculus OX=10090 GN=Cnksr2 PE=1 SV=1 CNKR2_MOUSE reviewed Connector enhancer of kinase suppressor of ras 2 (Connector enhancer of KSR 2) (CNK homolog protein 2) (CNK2) Mus musculus (Mouse) GO:0005737; GO:0005886; GO:0009966; GO:0014069; GO:0019901; GO:0035556; GO:0042802; GO:0043025; GO:0045211; GO:0098978; GO:0099084; GO:0099147; GO:0099173 intracellular signal transduction [GO:0035556]; postsynapse organization [GO:0099173]; postsynaptic specialization organization [GO:0099084]; regulation of signal transduction [GO:0009966] cytoplasm [GO:0005737]; extrinsic component of postsynaptic density membrane [GO:0099147]; glutamatergic synapse [GO:0098978]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211] identical protein binding [GO:0042802]; protein kinase binding [GO:0019901] g6268.t1 Q9WVS6 49.415 427 9.16e-135 399.0 sp|Q9WVS6|PRKN_MOUSE E3 ubiquitin-protein ligase parkin OS=Mus musculus OX=10090 GN=Prkn PE=1 SV=1 g6270.t1 Q17QR6 42.953 149 4.22e-26 114.0 sp|Q17QR6|MOT13_BOVIN Monocarboxylate transporter 13 OS=Bos taurus OX=9913 GN=SLC16A13 PE=2 SV=1 g6271.t1 Q6ZSM3 30.453 243 1.15e-30 130.0 sp|Q6ZSM3|MOT12_HUMAN Monocarboxylate transporter 12 OS=Homo sapiens OX=9606 GN=SLC16A12 PE=1 SV=3 MOT12_HUMAN reviewed Monocarboxylate transporter 12 (MCT 12) (Creatine transporter 2) (CRT2) (Solute carrier family 16 member 12) Homo sapiens (Human) GO:0005308; GO:0005886; GO:0015292; GO:0015881; GO:0016323; GO:0022857; GO:0046449; GO:0150104 creatine transmembrane transport [GO:0015881]; creatinine metabolic process [GO:0046449]; transport across blood-brain barrier [GO:0150104] basolateral plasma membrane [GO:0016323]; plasma membrane [GO:0005886] creatine transmembrane transporter activity [GO:0005308]; transmembrane transporter activity [GO:0022857]; uniporter activity [GO:0015292] g6273.t1 Q9QXP4 32.639 576 1.85e-78 262.0 sp|Q9QXP4|DONS_MOUSE Protein downstream neighbor of Son OS=Mus musculus OX=10090 GN=Donson PE=1 SV=2 g6274.t1 Q9QX47 61.386 101 3.67e-34 129.0 sp|Q9QX47|SON_MOUSE Protein SON OS=Mus musculus OX=10090 GN=Son PE=1 SV=2 SON_MOUSE reviewed Protein SON (Negative regulatory element-binding protein) (NRE-binding protein) Mus musculus (Mouse) GO:0000226; GO:0000281; GO:0003677; GO:0003723; GO:0006397; GO:0008380; GO:0016607; GO:0043066; GO:0043484; GO:0048024; GO:0050733; GO:0051726 microtubule cytoskeleton organization [GO:0000226]; mitotic cytokinesis [GO:0000281]; mRNA processing [GO:0006397]; negative regulation of apoptotic process [GO:0043066]; regulation of cell cycle [GO:0051726]; regulation of mRNA splicing, via spliceosome [GO:0048024]; regulation of RNA splicing [GO:0043484]; RNA splicing [GO:0008380] nuclear speck [GO:0016607] DNA binding [GO:0003677]; RNA binding [GO:0003723]; RS domain binding [GO:0050733] g6276.t1 Q9CPU4 54.61 141 1.3099999999999999e-48 156.0 sp|Q9CPU4|MGST3_MOUSE Glutathione S-transferase 3, mitochondrial OS=Mus musculus OX=10090 GN=Mgst3 PE=1 SV=1 g6277.t1 Q80Y75 64.762 315 4.7e-141 404.0 sp|Q80Y75|DJB13_MOUSE DnaJ homolog subfamily B member 13 OS=Mus musculus OX=10090 GN=Dnajb13 PE=1 SV=1 DJB13_MOUSE reviewed DnaJ homolog subfamily B member 13 (Testis and spermatogenesis cell-related protein 6) (Testis spermatocyte apoptosis-related gene 6 protein) (Testis spermatogenesis apoptosis-related gene 3 protein) (Testis spermatogenesis apoptosis-related gene 6 protein) Mus musculus (Mouse) GO:0001534; GO:0003351; GO:0005576; GO:0005737; GO:0005829; GO:0005930; GO:0006457; GO:0007618; GO:0030317; GO:0031514; GO:0036126; GO:0051082; GO:0051087; GO:0097729; GO:0120212; GO:1904158 axonemal central apparatus assembly [GO:1904158]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; flagellated sperm motility [GO:0030317]; mating [GO:0007618]; protein folding [GO:0006457] 9+2 motile cilium [GO:0097729]; axoneme [GO:0005930]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; motile cilium [GO:0031514]; radial spoke [GO:0001534]; sperm flagellum [GO:0036126]; sperm head-tail coupling apparatus [GO:0120212] protein-folding chaperone binding [GO:0051087]; unfolded protein binding [GO:0051082] g6278.t1 A0A0G2JEB6 35.301 3303 0.0 1911.0 sp|A0A0G2JEB6|CFA47_MOUSE Cilia and flagella-associated protein 47 OS=Mus musculus OX=10090 GN=Cfap47 PE=1 SV=2 g6278.t2 A0A0G2JEB6 35.439 3293 0.0 1917.0 sp|A0A0G2JEB6|CFA47_MOUSE Cilia and flagella-associated protein 47 OS=Mus musculus OX=10090 GN=Cfap47 PE=1 SV=2 g6279.t1 O75486 49.153 236 1.11e-75 241.0 sp|O75486|SUPT3_HUMAN Transcription initiation protein SPT3 homolog OS=Homo sapiens OX=9606 GN=SUPT3H PE=1 SV=3 g6281.t1 Q03347 45.455 341 1.17e-76 252.0 sp|Q03347|RUNX1_MOUSE Runt-related transcription factor 1 OS=Mus musculus OX=10090 GN=Runx1 PE=1 SV=1 g6282.t1 Q9Z2A5 53.036 247 5.649999999999999e-89 276.0 sp|Q9Z2A5|ATE1_MOUSE Arginyl-tRNA--protein transferase 1 OS=Mus musculus OX=10090 GN=Ate1 PE=1 SV=2 ATE1_MOUSE reviewed Arginyl-tRNA--protein transferase 1 (Arginyltransferase 1) (R-transferase 1) (EC 2.3.2.8) (Arginine-tRNA--protein transferase 1) Mus musculus (Mouse) GO:0004057; GO:0005634; GO:0005737; GO:0006511; GO:0006979; GO:0010498; GO:0044314; GO:0070534; GO:0071211; GO:0071596 proteasomal protein catabolic process [GO:0010498]; protein K27-linked ubiquitination [GO:0044314]; protein K63-linked ubiquitination [GO:0070534]; protein targeting to vacuole involved in autophagy [GO:0071211]; response to oxidative stress [GO:0006979]; ubiquitin-dependent protein catabolic process [GO:0006511]; ubiquitin-dependent protein catabolic process via the N-end rule pathway [GO:0071596] cytoplasm [GO:0005737]; nucleus [GO:0005634] arginyl-tRNA--protein transferase activity [GO:0004057] g6282.t2 Q9Z2A5 56.118 237 3.66e-91 280.0 sp|Q9Z2A5|ATE1_MOUSE Arginyl-tRNA--protein transferase 1 OS=Mus musculus OX=10090 GN=Ate1 PE=1 SV=2 ATE1_MOUSE reviewed Arginyl-tRNA--protein transferase 1 (Arginyltransferase 1) (R-transferase 1) (EC 2.3.2.8) (Arginine-tRNA--protein transferase 1) Mus musculus (Mouse) GO:0004057; GO:0005634; GO:0005737; GO:0006511; GO:0006979; GO:0010498; GO:0044314; GO:0070534; GO:0071211; GO:0071596 proteasomal protein catabolic process [GO:0010498]; protein K27-linked ubiquitination [GO:0044314]; protein K63-linked ubiquitination [GO:0070534]; protein targeting to vacuole involved in autophagy [GO:0071211]; response to oxidative stress [GO:0006979]; ubiquitin-dependent protein catabolic process [GO:0006511]; ubiquitin-dependent protein catabolic process via the N-end rule pathway [GO:0071596] cytoplasm [GO:0005737]; nucleus [GO:0005634] arginyl-tRNA--protein transferase activity [GO:0004057] g6283.t1 O95260 58.163 98 3.79e-36 137.0 sp|O95260|ATE1_HUMAN Arginyl-tRNA--protein transferase 1 OS=Homo sapiens OX=9606 GN=ATE1 PE=1 SV=2 ATE1_HUMAN reviewed Arginyl-tRNA--protein transferase 1 (Arginyltransferase 1) (R-transferase 1) (EC 2.3.2.8) (Arginine-tRNA--protein transferase 1) Homo sapiens (Human) GO:0004057; GO:0005634; GO:0005737; GO:0006511; GO:0006979; GO:0010498; GO:0016598; GO:0071596 proteasomal protein catabolic process [GO:0010498]; protein arginylation [GO:0016598]; response to oxidative stress [GO:0006979]; ubiquitin-dependent protein catabolic process [GO:0006511]; ubiquitin-dependent protein catabolic process via the N-end rule pathway [GO:0071596] cytoplasm [GO:0005737]; nucleus [GO:0005634] arginyl-tRNA--protein transferase activity [GO:0004057] g6284.t1 O60508 70.755 530 0.0 818.0 sp|O60508|PRP17_HUMAN Pre-mRNA-processing factor 17 OS=Homo sapiens OX=9606 GN=CDC40 PE=1 SV=1 PRP17_HUMAN reviewed Pre-mRNA-processing factor 17 (Cell division cycle 40 homolog) (EH-binding protein 3) (Ehb3) (PRP17 homolog) (hPRP17) Homo sapiens (Human) GO:0000398; GO:0003723; GO:0003729; GO:0005654; GO:0016607; GO:0071007; GO:0071013; GO:1990403 embryonic brain development [GO:1990403]; mRNA splicing, via spliceosome [GO:0000398] catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; U2-type catalytic step 2 spliceosome [GO:0071007] mRNA binding [GO:0003729]; RNA binding [GO:0003723] g6285.t1 Q9YGL3 43.765 409 1.02e-105 322.0 sp|Q9YGL3|NR2E1_ORYLA Nuclear receptor subfamily 2 group E member 1 OS=Oryzias latipes OX=8090 GN=nr2e1 PE=2 SV=1 g6286.t1 Q8BQJ6 45.495 455 9.319999999999999e-134 399.0 sp|Q8BQJ6|TRM2B_MOUSE tRNA (uracil-5-)-methyltransferase homolog B OS=Mus musculus OX=10090 GN=Trmt2b PE=1 SV=1 TRM2B_MOUSE reviewed tRNA (uracil-5-)-methyltransferase homolog B (EC 2.1.1.35) (TRM2 homolog B) (rRNA (uracil-5-)-methyltransferase TRMT2B) (EC 2.1.1.-) Mus musculus (Mouse) GO:0005739; GO:0005759; GO:0008033; GO:0030697; GO:0070041 tRNA processing [GO:0008033] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] rRNA (uridine-C5-)-methyltransferase activity [GO:0070041]; tRNA (uracil(54)-C5)-methyltransferase activity, S-adenosyl methionine-dependent [GO:0030697] g6287.t1 Q68ER9 47.642 212 1.75e-49 162.0 sp|Q68ER9|EAF6_XENTR Chromatin modification-related protein MEAF6 OS=Xenopus tropicalis OX=8364 GN=meaf6 PE=2 SV=1 g6287.t2 Q68ER9 51.01 198 3.06e-53 171.0 sp|Q68ER9|EAF6_XENTR Chromatin modification-related protein MEAF6 OS=Xenopus tropicalis OX=8364 GN=meaf6 PE=2 SV=1 g6288.t1 Q8BGT0 30.435 253 1.61e-34 130.0 sp|Q8BGT0|OSTM1_MOUSE Osteopetrosis-associated transmembrane protein 1 OS=Mus musculus OX=10090 GN=Ostm1 PE=1 SV=1 OSTM1_MOUSE reviewed Osteopetrosis-associated transmembrane protein 1 (Chloride channel 7 beta subunit) (Grey-lethal protein) Mus musculus (Mouse) GO:0005765; GO:0005829; GO:0030316; GO:0030321; GO:0034707 osteoclast differentiation [GO:0030316]; transepithelial chloride transport [GO:0030321] chloride channel complex [GO:0034707]; cytosol [GO:0005829]; lysosomal membrane [GO:0005765] g6289.t1 P82925 37.984 258 3.04e-50 176.0 sp|P82925|RT31_BOVIN Small ribosomal subunit protein mS31 OS=Bos taurus OX=9913 GN=MRPS31 PE=1 SV=3 g6290.t1 Q91379 53.022 364 3.81e-121 358.0 sp|Q91379|NR2E1_CHICK Nuclear receptor subfamily 2 group E member 1 OS=Gallus gallus OX=9031 GN=NR2E1 PE=2 SV=1 g6291.t1 Q3V384 53.713 404 3.6e-156 455.0 sp|Q3V384|AFG1L_MOUSE AFG1-like ATPase OS=Mus musculus OX=10090 GN=Afg1l PE=1 SV=1 g6292.t1 Q9UMY4 76.623 154 5.53e-88 257.0 sp|Q9UMY4|SNX12_HUMAN Sorting nexin-12 OS=Homo sapiens OX=9606 GN=SNX12 PE=1 SV=4 g6293.t1 Q8IXY8 48.264 288 9.93e-93 280.0 sp|Q8IXY8|PPIL6_HUMAN Probable inactive peptidyl-prolyl cis-trans isomerase-like 6 OS=Homo sapiens OX=9606 GN=PPIL6 PE=1 SV=1 g6294.t1 Q9Y2S2 45.192 312 3.75e-84 259.0 sp|Q9Y2S2|CRYL1_HUMAN Lambda-crystallin homolog OS=Homo sapiens OX=9606 GN=CRYL1 PE=1 SV=3 CRYL1_HUMAN reviewed Lambda-crystallin homolog (EC 1.1.1.45) (L-gulonate 3-dehydrogenase) (Gul3DH) Homo sapiens (Human) GO:0005829; GO:0006631; GO:0019640; GO:0042803; GO:0050104; GO:0070062; GO:0070403 D-glucuronate catabolic process to D-xylulose 5-phosphate [GO:0019640]; fatty acid metabolic process [GO:0006631] cytosol [GO:0005829]; extracellular exosome [GO:0070062] L-gulonate 3-dehydrogenase activity [GO:0050104]; NAD+ binding [GO:0070403]; protein homodimerization activity [GO:0042803] g6296.t1 Q05941 34.141 495 4.0400000000000003e-79 259.0 sp|Q05941|ACHA7_RAT Neuronal acetylcholine receptor subunit alpha-7 OS=Rattus norvegicus OX=10116 GN=Chrna7 PE=1 SV=2 ACHA7_RAT reviewed Neuronal acetylcholine receptor subunit alpha-7 (nAChR7) (Nicotinic acetylcholine receptor subunit alpha-7) Rattus norvegicus (Rat) GO:0001540; GO:0001666; GO:0001988; GO:0004888; GO:0005216; GO:0005789; GO:0005886; GO:0005892; GO:0006811; GO:0006816; GO:0006874; GO:0006897; GO:0007165; GO:0007249; GO:0007268; GO:0007271; GO:0007611; GO:0007613; GO:0008179; GO:0008284; GO:0008306; GO:0009409; GO:0009897; GO:0010628; GO:0014061; GO:0015464; GO:0015643; GO:0016020; GO:0016324; GO:0017081; GO:0019228; GO:0019901; GO:0022848; GO:0023019; GO:0030317; GO:0030424; GO:0030425; GO:0030426; GO:0030673; GO:0032094; GO:0032225; GO:0032279; GO:0032691; GO:0032715; GO:0032720; GO:0034220; GO:0034703; GO:0035094; GO:0035095; GO:0042110; GO:0042113; GO:0042166; GO:0042391; GO:0042698; GO:0042734; GO:0042803; GO:0043005; GO:0043025; GO:0043124; GO:0043197; GO:0043198; GO:0043410; GO:0044853; GO:0045202; GO:0045211; GO:0045471; GO:0045766; GO:0046681; GO:0046872; GO:0048149; GO:0050727; GO:0050728; GO:0050804; GO:0050808; GO:0050890; GO:0050893; GO:0051117; GO:0051247; GO:0051649; GO:0051823; GO:0060079; GO:0060084; GO:0060112; GO:0070373; GO:0070374; GO:0095500; GO:0097061; GO:0097110; GO:0098690; GO:0098815; GO:0098878; GO:0098897; GO:0098981; GO:0099171; GO:0099634; GO:0140059; GO:1900016; GO:1900273; GO:1902004; GO:1902430; GO:1902991; GO:1904315; GO:1904645; GO:1905144; GO:1905869; GO:1905906; GO:1990806; GO:2000463; GO:2001023 acetylcholine receptor signaling pathway [GO:0095500]; associative learning [GO:0008306]; B cell activation [GO:0042113]; behavioral response to ethanol [GO:0048149]; behavioral response to nicotine [GO:0035095]; calcium ion transport [GO:0006816]; canonical NF-kappaB signal transduction [GO:0007249]; chemical synaptic transmission [GO:0007268]; cognition [GO:0050890]; dendrite arborization [GO:0140059]; dendritic spine organization [GO:0097061]; endocytosis [GO:0006897]; establishment of localization in cell [GO:0051649]; excitatory postsynaptic potential [GO:0060079]; flagellated sperm motility [GO:0030317]; generation of ovulation cycle rhythm [GO:0060112]; intracellular calcium ion homeostasis [GO:0006874]; learning or memory [GO:0007611]; ligand-gated ion channel signaling pathway [GO:1990806]; memory [GO:0007613]; modulation of chemical synaptic transmission [GO:0050804]; modulation of excitatory postsynaptic potential [GO:0098815]; monoatomic ion transmembrane transport [GO:0034220]; monoatomic ion transport [GO:0006811]; negative regulation of 3'-UTR-mediated mRNA stabilization [GO:1905869]; negative regulation of amyloid-beta formation [GO:1902430]; negative regulation of canonical NF-kappaB signal transduction [GO:0043124]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of inflammatory response [GO:0050728]; negative regulation of interleukin-1 beta production [GO:0032691]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of tumor necrosis factor production [GO:0032720]; neuronal action potential [GO:0019228]; ovulation cycle [GO:0042698]; positive regulation of amyloid-beta formation [GO:1902004]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of gene expression [GO:0010628]; positive regulation of heart rate involved in baroreceptor response to decreased systemic arterial blood pressure [GO:0001988]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of protein metabolic process [GO:0051247]; presynaptic modulation of chemical synaptic transmission [GO:0099171]; regulation of amyloid fibril formation [GO:1905906]; regulation of amyloid precursor protein catabolic process [GO:1902991]; regulation of inflammatory response [GO:0050727]; regulation of membrane potential [GO:0042391]; regulation of norepinephrine secretion [GO:0014061]; regulation of response to drug [GO:2001023]; regulation of synapse structural plasticity [GO:0051823]; regulation of synaptic transmission, dopaminergic [GO:0032225]; response to acetylcholine [GO:1905144]; response to amyloid-beta [GO:1904645]; response to carbamate [GO:0046681]; response to cold [GO:0009409]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to hypoxia [GO:0001666]; response to nicotine [GO:0035094]; sensory processing [GO:0050893]; signal transduction [GO:0007165]; signal transduction involved in regulation of gene expression [GO:0023019]; synapse organization [GO:0050808]; synaptic transmission involved in micturition [GO:0060084]; synaptic transmission, cholinergic [GO:0007271]; T cell activation [GO:0042110] acetylcholine-gated channel complex [GO:0005892]; apical plasma membrane [GO:0016324]; asymmetric synapse [GO:0032279]; axolemma [GO:0030673]; axon [GO:0030424]; cation channel complex [GO:0034703]; cholinergic synapse [GO:0098981]; dendrite [GO:0030425]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; endoplasmic reticulum membrane [GO:0005789]; external side of plasma membrane [GO:0009897]; glycinergic synapse [GO:0098690]; growth cone [GO:0030426]; membrane [GO:0016020]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; neurotransmitter receptor complex [GO:0098878]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic membrane [GO:0045211]; postsynaptic specialization membrane [GO:0099634]; presynaptic membrane [GO:0042734]; spine apparatus membrane [GO:0098897]; synapse [GO:0045202] acetylcholine binding [GO:0042166]; acetylcholine receptor activity [GO:0015464]; acetylcholine-gated monoatomic cation-selective channel activity [GO:0022848]; adenylate cyclase binding [GO:0008179]; amyloid-beta binding [GO:0001540]; ATPase binding [GO:0051117]; chloride channel regulator activity [GO:0017081]; metal ion binding [GO:0046872]; monoatomic ion channel activity [GO:0005216]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; scaffold protein binding [GO:0097110]; toxic substance binding [GO:0015643]; transmembrane signaling receptor activity [GO:0004888]; transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315] g6297.t1 Q8JGR4 63.057 157 6.35e-50 160.0 sp|Q8JGR4|RL24_DANRE Large ribosomal subunit protein eL24 OS=Danio rerio OX=7955 GN=rpl24 PE=2 SV=1 g6298.t1 Q9Y2S2 49.492 295 2.7e-100 301.0 sp|Q9Y2S2|CRYL1_HUMAN Lambda-crystallin homolog OS=Homo sapiens OX=9606 GN=CRYL1 PE=1 SV=3 CRYL1_HUMAN reviewed Lambda-crystallin homolog (EC 1.1.1.45) (L-gulonate 3-dehydrogenase) (Gul3DH) Homo sapiens (Human) GO:0005829; GO:0006631; GO:0019640; GO:0042803; GO:0050104; GO:0070062; GO:0070403 D-glucuronate catabolic process to D-xylulose 5-phosphate [GO:0019640]; fatty acid metabolic process [GO:0006631] cytosol [GO:0005829]; extracellular exosome [GO:0070062] L-gulonate 3-dehydrogenase activity [GO:0050104]; NAD+ binding [GO:0070403]; protein homodimerization activity [GO:0042803] g6299.t1 Q9Y2S2 48.464 293 3.1e-96 290.0 sp|Q9Y2S2|CRYL1_HUMAN Lambda-crystallin homolog OS=Homo sapiens OX=9606 GN=CRYL1 PE=1 SV=3 CRYL1_HUMAN reviewed Lambda-crystallin homolog (EC 1.1.1.45) (L-gulonate 3-dehydrogenase) (Gul3DH) Homo sapiens (Human) GO:0005829; GO:0006631; GO:0019640; GO:0042803; GO:0050104; GO:0070062; GO:0070403 D-glucuronate catabolic process to D-xylulose 5-phosphate [GO:0019640]; fatty acid metabolic process [GO:0006631] cytosol [GO:0005829]; extracellular exosome [GO:0070062] L-gulonate 3-dehydrogenase activity [GO:0050104]; NAD+ binding [GO:0070403]; protein homodimerization activity [GO:0042803] g6301.t1 Q61493 58.737 887 0.0 1096.0 sp|Q61493|REV3L_MOUSE DNA polymerase zeta catalytic subunit OS=Mus musculus OX=10090 GN=Rev3l PE=1 SV=3 g6304.t1 O60673 34.641 459 3.45e-64 230.0 sp|O60673|REV3L_HUMAN DNA polymerase zeta catalytic subunit OS=Homo sapiens OX=9606 GN=REV3L PE=1 SV=2 REV3L_HUMAN reviewed DNA polymerase zeta catalytic subunit (EC 2.7.7.7) (Protein reversionless 3-like) (REV3-like) (hREV3) Homo sapiens (Human) GO:0000166; GO:0000724; GO:0000731; GO:0003677; GO:0003887; GO:0005634; GO:0005654; GO:0005730; GO:0006261; GO:0008270; GO:0016035; GO:0019985; GO:0042276; GO:0051539; GO:0071897; GO:0090734 DNA biosynthetic process [GO:0071897]; DNA synthesis involved in DNA repair [GO:0000731]; DNA-templated DNA replication [GO:0006261]; double-strand break repair via homologous recombination [GO:0000724]; error-prone translesion synthesis [GO:0042276]; translesion synthesis [GO:0019985] nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of DNA damage [GO:0090734]; zeta DNA polymerase complex [GO:0016035] 4 iron, 4 sulfur cluster binding [GO:0051539]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; nucleotide binding [GO:0000166]; zinc ion binding [GO:0008270] g6305.t1 Q766Z3 58.462 65 2.91e-24 97.8 sp|Q766Z3|REV3_ARATH DNA polymerase zeta catalytic subunit OS=Arabidopsis thaliana OX=3702 GN=REV3 PE=2 SV=1 REV3_ARATH reviewed DNA polymerase zeta catalytic subunit (EC 2.7.7.7) (Protein reversionless 3-like) (AtREV3) Arabidopsis thaliana (Mouse-ear cress) GO:0000166; GO:0000724; GO:0003677; GO:0003887; GO:0005634; GO:0006260; GO:0006281; GO:0006974; GO:0008270; GO:0009411; GO:0010224; GO:0016035; GO:0042276; GO:0051539; GO:0071494 cellular response to UV-C [GO:0071494]; DNA damage response [GO:0006974]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; double-strand break repair via homologous recombination [GO:0000724]; error-prone translesion synthesis [GO:0042276]; response to UV [GO:0009411]; response to UV-B [GO:0010224] nucleus [GO:0005634]; zeta DNA polymerase complex [GO:0016035] 4 iron, 4 sulfur cluster binding [GO:0051539]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; nucleotide binding [GO:0000166]; zinc ion binding [GO:0008270] g6306.t1 E9PYK3 37.952 830 2.33e-146 478.0 sp|E9PYK3|PARP4_MOUSE Protein mono-ADP-ribosyltransferase PARP4 OS=Mus musculus OX=10090 GN=Parp4 PE=1 SV=1 PARP4_MOUSE reviewed Protein mono-ADP-ribosyltransferase PARP4 (EC 2.4.2.-) (ADP-ribosyltransferase diphtheria toxin-like 4) (ARTD4) (Poly [ADP-ribose] polymerase 4) (PARP-4) (Vault poly(ADP-ribose) polymerase) (VPARP) (mVparp) Mus musculus (Mouse) GO:0003950; GO:0005634; GO:0005654; GO:0005737; GO:0005819; GO:0005829; GO:0005876; GO:0006954; GO:0016779; GO:0019899; GO:0140806; GO:0140807; GO:1990404; GO:1990904 inflammatory response [GO:0006954] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; spindle [GO:0005819]; spindle microtubule [GO:0005876] enzyme binding [GO:0019899]; NAD+ poly-ADP-ribosyltransferase activity [GO:0003950]; NAD+-protein mono-ADP-ribosyltransferase activity [GO:1990404]; NAD+-protein-aspartate ADP-ribosyltransferase activity [GO:0140806]; NAD+-protein-glutamate ADP-ribosyltransferase activity [GO:0140807]; nucleotidyltransferase activity [GO:0016779] g6307.t1 E9PYK3 45.526 380 8.52e-93 338.0 sp|E9PYK3|PARP4_MOUSE Protein mono-ADP-ribosyltransferase PARP4 OS=Mus musculus OX=10090 GN=Parp4 PE=1 SV=1 PARP4_MOUSE reviewed Protein mono-ADP-ribosyltransferase PARP4 (EC 2.4.2.-) (ADP-ribosyltransferase diphtheria toxin-like 4) (ARTD4) (Poly [ADP-ribose] polymerase 4) (PARP-4) (Vault poly(ADP-ribose) polymerase) (VPARP) (mVparp) Mus musculus (Mouse) GO:0003950; GO:0005634; GO:0005654; GO:0005737; GO:0005819; GO:0005829; GO:0005876; GO:0006954; GO:0016779; GO:0019899; GO:0140806; GO:0140807; GO:1990404; GO:1990904 inflammatory response [GO:0006954] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; spindle [GO:0005819]; spindle microtubule [GO:0005876] enzyme binding [GO:0019899]; NAD+ poly-ADP-ribosyltransferase activity [GO:0003950]; NAD+-protein mono-ADP-ribosyltransferase activity [GO:1990404]; NAD+-protein-aspartate ADP-ribosyltransferase activity [GO:0140806]; NAD+-protein-glutamate ADP-ribosyltransferase activity [GO:0140807]; nucleotidyltransferase activity [GO:0016779] g6308.t1 P06027 39.655 116 2.86e-24 97.4 sp|P06027|LECE_HELCR Echinoidin OS=Heliocidaris crassispina OX=1043166 PE=1 SV=1 g6309.t1 Q5ZJZ5 40.606 165 3.26e-31 119.0 sp|Q5ZJZ5|BDH_CHICK D-beta-hydroxybutyrate dehydrogenase, mitochondrial OS=Gallus gallus OX=9031 GN=BDH1 PE=2 SV=1 g6310.t1 Q18297 29.933 1196 2.36e-137 452.0 sp|Q18297|TRPA1_CAEEL Transient receptor potential cation channel subfamily A member 1 homolog OS=Caenorhabditis elegans OX=6239 GN=trpa-1 PE=2 SV=5 TRPA1_CAEEL reviewed Transient receptor potential cation channel subfamily A member 1 homolog Caenorhabditis elegans GO:0005216; GO:0005886; GO:0043025; GO:0097730 neuronal cell body [GO:0043025]; non-motile cilium [GO:0097730]; plasma membrane [GO:0005886] monoatomic ion channel activity [GO:0005216] g6310.t1 Q18297 24.056 503 5.340000000000001e-32 139.0 sp|Q18297|TRPA1_CAEEL Transient receptor potential cation channel subfamily A member 1 homolog OS=Caenorhabditis elegans OX=6239 GN=trpa-1 PE=2 SV=5 TRPA1_CAEEL reviewed Transient receptor potential cation channel subfamily A member 1 homolog Caenorhabditis elegans GO:0005216; GO:0005886; GO:0043025; GO:0097730 neuronal cell body [GO:0043025]; non-motile cilium [GO:0097730]; plasma membrane [GO:0005886] monoatomic ion channel activity [GO:0005216] g6310.t2 Q18297 29.602 1206 6.68e-136 448.0 sp|Q18297|TRPA1_CAEEL Transient receptor potential cation channel subfamily A member 1 homolog OS=Caenorhabditis elegans OX=6239 GN=trpa-1 PE=2 SV=5 TRPA1_CAEEL reviewed Transient receptor potential cation channel subfamily A member 1 homolog Caenorhabditis elegans GO:0005216; GO:0005886; GO:0043025; GO:0097730 neuronal cell body [GO:0043025]; non-motile cilium [GO:0097730]; plasma membrane [GO:0005886] monoatomic ion channel activity [GO:0005216] g6310.t2 Q18297 24.056 503 5.29e-32 139.0 sp|Q18297|TRPA1_CAEEL Transient receptor potential cation channel subfamily A member 1 homolog OS=Caenorhabditis elegans OX=6239 GN=trpa-1 PE=2 SV=5 TRPA1_CAEEL reviewed Transient receptor potential cation channel subfamily A member 1 homolog Caenorhabditis elegans GO:0005216; GO:0005886; GO:0043025; GO:0097730 neuronal cell body [GO:0043025]; non-motile cilium [GO:0097730]; plasma membrane [GO:0005886] monoatomic ion channel activity [GO:0005216] g6313.t1 Q5R660 46.931 505 2.26e-140 434.0 sp|Q5R660|SEC63_PONAB Translocation protein SEC63 homolog OS=Pongo abelii OX=9601 GN=SEC63 PE=2 SV=1 SEC63_PONAB reviewed Translocation protein SEC63 homolog (DnaJ homolog subfamily C member 23) Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0003723; GO:0006614; GO:0008320; GO:0031204; GO:0031207 post-translational protein targeting to membrane, translocation [GO:0031204]; SRP-dependent cotranslational protein targeting to membrane [GO:0006614] Sec62/Sec63 complex [GO:0031207] protein transmembrane transporter activity [GO:0008320]; RNA binding [GO:0003723] g6313.t1 Q5R660 55.263 114 3.75e-24 112.0 sp|Q5R660|SEC63_PONAB Translocation protein SEC63 homolog OS=Pongo abelii OX=9601 GN=SEC63 PE=2 SV=1 SEC63_PONAB reviewed Translocation protein SEC63 homolog (DnaJ homolog subfamily C member 23) Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0003723; GO:0006614; GO:0008320; GO:0031204; GO:0031207 post-translational protein targeting to membrane, translocation [GO:0031204]; SRP-dependent cotranslational protein targeting to membrane [GO:0006614] Sec62/Sec63 complex [GO:0031207] protein transmembrane transporter activity [GO:0008320]; RNA binding [GO:0003723] g6314.t1 Q5U3Y5 57.669 163 1.38e-53 170.0 sp|Q5U3Y5|SFT2A_RAT Vesicle transport protein SFT2A OS=Rattus norvegicus OX=10116 GN=Sft2d1 PE=2 SV=1 g6317.t1 O75382 22.672 247 1.6200000000000002e-21 102.0 sp|O75382|TRIM3_HUMAN Tripartite motif-containing protein 3 OS=Homo sapiens OX=9606 GN=TRIM3 PE=1 SV=2 TRIM3_HUMAN reviewed Tripartite motif-containing protein 3 (EC 2.3.2.27) (Brain-expressed RING finger protein) (RING finger protein 22) (RING finger protein 97) Homo sapiens (Human) GO:0000209; GO:0005737; GO:0005769; GO:0005794; GO:0007399; GO:0008270; GO:0015031; GO:0030425; GO:0034141; GO:0042802; GO:0043161; GO:0061351; GO:0061630; GO:0070534 nervous system development [GO:0007399]; neural precursor cell proliferation [GO:0061351]; positive regulation of toll-like receptor 3 signaling pathway [GO:0034141]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K63-linked ubiquitination [GO:0070534]; protein polyubiquitination [GO:0000209]; protein transport [GO:0015031] cytoplasm [GO:0005737]; dendrite [GO:0030425]; early endosome [GO:0005769]; Golgi apparatus [GO:0005794] identical protein binding [GO:0042802]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] g6320.t1 P58467 36.186 409 4.8e-80 257.0 sp|P58467|SETD4_MOUSE SET domain-containing protein 4 OS=Mus musculus OX=10090 GN=Setd4 PE=1 SV=2 SETD4_MOUSE reviewed SET domain-containing protein 4 (EC 2.1.1.-) (EC 2.1.1.364) Mus musculus (Mouse) GO:0003713; GO:0005634; GO:0005829; GO:0006338; GO:0006954; GO:0032259; GO:0032755; GO:0032760; GO:0042799; GO:0042800; GO:0045944; GO:0046975; GO:0050729; GO:0071863; GO:0140941; GO:0140944; GO:0140945 chromatin remodeling [GO:0006338]; inflammatory response [GO:0006954]; methylation [GO:0032259]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]; regulation of cell proliferation in bone marrow [GO:0071863] cytosol [GO:0005829]; nucleus [GO:0005634] histone H3K36 methyltransferase activity [GO:0046975]; histone H3K4 methyltransferase activity [GO:0042800]; histone H3K4 monomethyltransferase activity [GO:0140945]; histone H4K20 methyltransferase activity [GO:0042799]; histone H4K20 monomethyltransferase activity [GO:0140944]; histone H4K20me methyltransferase activity [GO:0140941]; transcription coactivator activity [GO:0003713] g6322.t1 Q0P5J0 42.157 306 4.99e-72 245.0 sp|Q0P5J0|QRIC1_BOVIN Transcriptional regulator QRICH1 OS=Bos taurus OX=9913 GN=QRICH1 PE=2 SV=2 QRIC1_BOVIN reviewed Transcriptional regulator QRICH1 (Glutamine-rich protein 1) Bos taurus (Bovine) GO:0003677; GO:0005634; GO:0005737; GO:0005886; GO:0030968; GO:0034976; GO:0036499; GO:0043065; GO:0045893; GO:0070059; GO:0140467 endoplasmic reticulum unfolded protein response [GO:0030968]; integrated stress response signaling [GO:0140467]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; PERK-mediated unfolded protein response [GO:0036499]; positive regulation of apoptotic process [GO:0043065]; positive regulation of DNA-templated transcription [GO:0045893]; response to endoplasmic reticulum stress [GO:0034976] cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886] DNA binding [GO:0003677] g6323.t1 Q5RDJ2 30.179 560 2.3599999999999998e-61 234.0 sp|Q5RDJ2|ZMYM2_PONAB Zinc finger MYM-type protein 2 OS=Pongo abelii OX=9601 GN=ZMYM2 PE=2 SV=1 ZMYM2_PONAB reviewed Zinc finger MYM-type protein 2 (Zinc finger protein 198) Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0005634; GO:0008270 nucleus [GO:0005634] zinc ion binding [GO:0008270] g6324.t1 Q1LZD9 62.548 259 3.2e-112 348.0 sp|Q1LZD9|PSPC1_BOVIN Paraspeckle component 1 OS=Bos taurus OX=9913 GN=PSPC1 PE=2 SV=1 PSPC1_BOVIN reviewed Paraspeckle component 1 Bos taurus (Bovine) GO:0003723; GO:0005634; GO:0005730; GO:0005737; GO:0006355; GO:0016363; GO:0016607; GO:0042382; GO:0042752; GO:0045087; GO:0045892; GO:0048511 innate immune response [GO:0045087]; negative regulation of DNA-templated transcription [GO:0045892]; regulation of circadian rhythm [GO:0042752]; regulation of DNA-templated transcription [GO:0006355]; rhythmic process [GO:0048511] cytoplasm [GO:0005737]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleus [GO:0005634]; paraspeckles [GO:0042382] RNA binding [GO:0003723] g6324.t2 Q1LZD9 62.548 259 3.33e-112 348.0 sp|Q1LZD9|PSPC1_BOVIN Paraspeckle component 1 OS=Bos taurus OX=9913 GN=PSPC1 PE=2 SV=1 PSPC1_BOVIN reviewed Paraspeckle component 1 Bos taurus (Bovine) GO:0003723; GO:0005634; GO:0005730; GO:0005737; GO:0006355; GO:0016363; GO:0016607; GO:0042382; GO:0042752; GO:0045087; GO:0045892; GO:0048511 innate immune response [GO:0045087]; negative regulation of DNA-templated transcription [GO:0045892]; regulation of circadian rhythm [GO:0042752]; regulation of DNA-templated transcription [GO:0006355]; rhythmic process [GO:0048511] cytoplasm [GO:0005737]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleus [GO:0005634]; paraspeckles [GO:0042382] RNA binding [GO:0003723] g6326.t1 Q6GN98 58.173 208 3.8399999999999995e-82 246.0 sp|Q6GN98|EFMT1_XENLA EEF1A lysine methyltransferase 1 OS=Xenopus laevis OX=8355 GN=eef1akmt1 PE=2 SV=1 EFMT1_XENLA reviewed EEF1A lysine methyltransferase 1 (EC 2.1.1.-) (N(6)-adenine-specific DNA methyltransferase 2) (Protein-lysine N-methyltransferase n6amt2) Xenopus laevis (African clawed frog) GO:0003676; GO:0005737; GO:0008168; GO:0016279; GO:0018022 peptidyl-lysine methylation [GO:0018022] cytoplasm [GO:0005737] methyltransferase activity [GO:0008168]; nucleic acid binding [GO:0003676]; protein-lysine N-methyltransferase activity [GO:0016279] g6327.t1 Q810A5 29.204 339 5.84e-42 160.0 sp|Q810A5|MACA1_MOUSE Microtubule-associated tyrosine carboxypeptidase 1 OS=Mus musculus OX=10090 GN=Matcap1 PE=2 SV=1 g6329.t1 Q63159 48.855 262 2.59e-86 266.0 sp|Q63159|COQ3_RAT Ubiquinone biosynthesis O-methyltransferase, mitochondrial OS=Rattus norvegicus OX=10116 GN=Coq3 PE=2 SV=2 COQ3_RAT reviewed Ubiquinone biosynthesis O-methyltransferase, mitochondrial (3-demethylubiquinol 3-O-methyltransferase) (EC 2.1.1.64) (3-demethylubiquinone 3-O-methyltransferase) (EC 2.1.1.-) (Polyprenyldihydroxybenzoate methyltransferase) (EC 2.1.1.114) Rattus norvegicus (Rat) GO:0005739; GO:0005743; GO:0005759; GO:0006071; GO:0006744; GO:0008171; GO:0010420; GO:0031314; GO:0032259; GO:0046872; GO:0061542; GO:0110142; GO:0120537 glycerol metabolic process [GO:0006071]; methylation [GO:0032259]; ubiquinone biosynthetic process [GO:0006744] extrinsic component of mitochondrial inner membrane [GO:0031314]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ubiquinone biosynthesis complex [GO:0110142] 3-demethylubiquinol 3-O-methyltransferase activity [GO:0061542]; 3-demethylubiquinone 3-O-methyltransferase activity [GO:0120537]; metal ion binding [GO:0046872]; O-methyltransferase activity [GO:0008171]; polyprenyldihydroxybenzoate methyltransferase activity [GO:0010420] g6332.t1 Q8BZ20 29.675 647 1.7800000000000002e-86 288.0 sp|Q8BZ20|PAR12_MOUSE Protein mono-ADP-ribosyltransferase PARP12 OS=Mus musculus OX=10090 GN=Parp12 PE=1 SV=3 PAR12_MOUSE reviewed Protein mono-ADP-ribosyltransferase PARP12 (EC 2.4.2.-) (ADP-ribosyltransferase diphtheria toxin-like 12) (ARTD12) (Poly [ADP-ribose] polymerase 12) (PARP-12) (Zinc finger CCCH domain-containing protein 1) Mus musculus (Mouse) GO:0003950; GO:0005634; GO:0005802; GO:0008270; GO:0010494; GO:0016779; GO:0044331; GO:0070213; GO:0070633; GO:0140803; GO:0140806; GO:1990404 cell-cell adhesion mediated by cadherin [GO:0044331]; protein auto-ADP-ribosylation [GO:0070213]; transepithelial transport [GO:0070633] cytoplasmic stress granule [GO:0010494]; nucleus [GO:0005634]; trans-Golgi network [GO:0005802] NAD+ poly-ADP-ribosyltransferase activity [GO:0003950]; NAD+-protein mono-ADP-ribosyltransferase activity [GO:1990404]; NAD+-protein-aspartate ADP-ribosyltransferase activity [GO:0140806]; NAD+-protein-cysteine ADP-ribosyltransferase activity [GO:0140803]; nucleotidyltransferase activity [GO:0016779]; zinc ion binding [GO:0008270] g6334.t1 P21872 62.562 1015 0.0 1233.0 sp|P21872|PUR2_CHICK Trifunctional purine biosynthetic protein adenosine-3 OS=Gallus gallus OX=9031 GN=GART PE=1 SV=1 g6335.t1 A2BH40 54.599 337 7.129999999999999e-98 347.0 sp|A2BH40|ARI1A_MOUSE AT-rich interactive domain-containing protein 1A OS=Mus musculus OX=10090 GN=Arid1a PE=1 SV=1 ARI1A_MOUSE reviewed AT-rich interactive domain-containing protein 1A (ARID domain-containing protein 1A) (BRG1-associated factor 250) (BAF250) (BRG1-associated factor 250a) (BAF250A) (Osa homolog 1) (SWI-like protein) (SWI/SNF complex protein p270) (SWI/SNF-related, matrix-associated, actin-dependent regulator of chromatin subfamily F member 1) Mus musculus (Mouse) GO:0000122; GO:0000785; GO:0001704; GO:0001843; GO:0003205; GO:0003408; GO:0003677; GO:0005654; GO:0006325; GO:0006337; GO:0006338; GO:0006357; GO:0007369; GO:0007566; GO:0016514; GO:0016922; GO:0019827; GO:0030071; GO:0030900; GO:0035060; GO:0045582; GO:0045597; GO:0045663; GO:0045893; GO:0055007; GO:0060674; GO:0070316; GO:0071564; GO:0071565; GO:0140092; GO:0140658; GO:1902459; GO:2000045; GO:2000781; GO:2000819 cardiac chamber development [GO:0003205]; cardiac muscle cell differentiation [GO:0055007]; chromatin organization [GO:0006325]; chromatin remodeling [GO:0006338]; embryo implantation [GO:0007566]; forebrain development [GO:0030900]; formation of primary germ layer [GO:0001704]; gastrulation [GO:0007369]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural tube closure [GO:0001843]; nucleosome disassembly [GO:0006337]; optic cup formation involved in camera-type eye development [GO:0003408]; placenta blood vessel development [GO:0060674]; positive regulation of cell differentiation [GO:0045597]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of T cell differentiation [GO:0045582]; regulation of G0 to G1 transition [GO:0070316]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; regulation of nucleotide-excision repair [GO:2000819]; regulation of transcription by RNA polymerase II [GO:0006357]; stem cell population maintenance [GO:0019827] bBAF complex [GO:0140092]; brahma complex [GO:0035060]; chromatin [GO:0000785]; nBAF complex [GO:0071565]; npBAF complex [GO:0071564]; nucleoplasm [GO:0005654]; SWI/SNF complex [GO:0016514] ATP-dependent chromatin remodeler activity [GO:0140658]; DNA binding [GO:0003677]; nuclear receptor binding [GO:0016922] g6335.t1 A2BH40 39.683 252 4e-37 156.0 sp|A2BH40|ARI1A_MOUSE AT-rich interactive domain-containing protein 1A OS=Mus musculus OX=10090 GN=Arid1a PE=1 SV=1 ARI1A_MOUSE reviewed AT-rich interactive domain-containing protein 1A (ARID domain-containing protein 1A) (BRG1-associated factor 250) (BAF250) (BRG1-associated factor 250a) (BAF250A) (Osa homolog 1) (SWI-like protein) (SWI/SNF complex protein p270) (SWI/SNF-related, matrix-associated, actin-dependent regulator of chromatin subfamily F member 1) Mus musculus (Mouse) GO:0000122; GO:0000785; GO:0001704; GO:0001843; GO:0003205; GO:0003408; GO:0003677; GO:0005654; GO:0006325; GO:0006337; GO:0006338; GO:0006357; GO:0007369; GO:0007566; GO:0016514; GO:0016922; GO:0019827; GO:0030071; GO:0030900; GO:0035060; GO:0045582; GO:0045597; GO:0045663; GO:0045893; GO:0055007; GO:0060674; GO:0070316; GO:0071564; GO:0071565; GO:0140092; GO:0140658; GO:1902459; GO:2000045; GO:2000781; GO:2000819 cardiac chamber development [GO:0003205]; cardiac muscle cell differentiation [GO:0055007]; chromatin organization [GO:0006325]; chromatin remodeling [GO:0006338]; embryo implantation [GO:0007566]; forebrain development [GO:0030900]; formation of primary germ layer [GO:0001704]; gastrulation [GO:0007369]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural tube closure [GO:0001843]; nucleosome disassembly [GO:0006337]; optic cup formation involved in camera-type eye development [GO:0003408]; placenta blood vessel development [GO:0060674]; positive regulation of cell differentiation [GO:0045597]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of T cell differentiation [GO:0045582]; regulation of G0 to G1 transition [GO:0070316]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; regulation of nucleotide-excision repair [GO:2000819]; regulation of transcription by RNA polymerase II [GO:0006357]; stem cell population maintenance [GO:0019827] bBAF complex [GO:0140092]; brahma complex [GO:0035060]; chromatin [GO:0000785]; nBAF complex [GO:0071565]; npBAF complex [GO:0071564]; nucleoplasm [GO:0005654]; SWI/SNF complex [GO:0016514] ATP-dependent chromatin remodeler activity [GO:0140658]; DNA binding [GO:0003677]; nuclear receptor binding [GO:0016922] g6336.t1 Q8IN94 49.565 115 1.0400000000000002e-27 126.0 sp|Q8IN94|OSA_DROME Trithorax group protein osa OS=Drosophila melanogaster OX=7227 GN=osa PE=1 SV=1 OSA_DROME reviewed Trithorax group protein osa (Protein eyelid) Drosophila melanogaster (Fruit fly) GO:0003677; GO:0005634; GO:0005654; GO:0005700; GO:0006338; GO:0006355; GO:0006357; GO:0007379; GO:0007406; GO:0007476; GO:0007480; GO:0008586; GO:0008587; GO:0014017; GO:0016055; GO:0016514; GO:0035060; GO:0045893; GO:0046530; GO:0048190; GO:0071565 chromatin remodeling [GO:0006338]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein morphogenesis [GO:0008586]; negative regulation of neuroblast proliferation [GO:0007406]; neuroblast fate commitment [GO:0014017]; photoreceptor cell differentiation [GO:0046530]; positive regulation of DNA-templated transcription [GO:0045893]; regulation of DNA-templated transcription [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; segment specification [GO:0007379]; wing disc dorsal/ventral pattern formation [GO:0048190]; Wnt signaling pathway [GO:0016055] brahma complex [GO:0035060]; nBAF complex [GO:0071565]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; SWI/SNF complex [GO:0016514] DNA binding [GO:0003677] g6336.t2 Q8IN94 47.015 134 2.56e-29 132.0 sp|Q8IN94|OSA_DROME Trithorax group protein osa OS=Drosophila melanogaster OX=7227 GN=osa PE=1 SV=1 OSA_DROME reviewed Trithorax group protein osa (Protein eyelid) Drosophila melanogaster (Fruit fly) GO:0003677; GO:0005634; GO:0005654; GO:0005700; GO:0006338; GO:0006355; GO:0006357; GO:0007379; GO:0007406; GO:0007476; GO:0007480; GO:0008586; GO:0008587; GO:0014017; GO:0016055; GO:0016514; GO:0035060; GO:0045893; GO:0046530; GO:0048190; GO:0071565 chromatin remodeling [GO:0006338]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein morphogenesis [GO:0008586]; negative regulation of neuroblast proliferation [GO:0007406]; neuroblast fate commitment [GO:0014017]; photoreceptor cell differentiation [GO:0046530]; positive regulation of DNA-templated transcription [GO:0045893]; regulation of DNA-templated transcription [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; segment specification [GO:0007379]; wing disc dorsal/ventral pattern formation [GO:0048190]; Wnt signaling pathway [GO:0016055] brahma complex [GO:0035060]; nBAF complex [GO:0071565]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; SWI/SNF complex [GO:0016514] DNA binding [GO:0003677] g6336.t3 Q8IN94 47.015 134 2.54e-29 132.0 sp|Q8IN94|OSA_DROME Trithorax group protein osa OS=Drosophila melanogaster OX=7227 GN=osa PE=1 SV=1 OSA_DROME reviewed Trithorax group protein osa (Protein eyelid) Drosophila melanogaster (Fruit fly) GO:0003677; GO:0005634; GO:0005654; GO:0005700; GO:0006338; GO:0006355; GO:0006357; GO:0007379; GO:0007406; GO:0007476; GO:0007480; GO:0008586; GO:0008587; GO:0014017; GO:0016055; GO:0016514; GO:0035060; GO:0045893; GO:0046530; GO:0048190; GO:0071565 chromatin remodeling [GO:0006338]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein morphogenesis [GO:0008586]; negative regulation of neuroblast proliferation [GO:0007406]; neuroblast fate commitment [GO:0014017]; photoreceptor cell differentiation [GO:0046530]; positive regulation of DNA-templated transcription [GO:0045893]; regulation of DNA-templated transcription [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; segment specification [GO:0007379]; wing disc dorsal/ventral pattern formation [GO:0048190]; Wnt signaling pathway [GO:0016055] brahma complex [GO:0035060]; nBAF complex [GO:0071565]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; SWI/SNF complex [GO:0016514] DNA binding [GO:0003677] g6336.t4 Q8IN94 47.015 134 2.5200000000000002e-29 132.0 sp|Q8IN94|OSA_DROME Trithorax group protein osa OS=Drosophila melanogaster OX=7227 GN=osa PE=1 SV=1 OSA_DROME reviewed Trithorax group protein osa (Protein eyelid) Drosophila melanogaster (Fruit fly) GO:0003677; GO:0005634; GO:0005654; GO:0005700; GO:0006338; GO:0006355; GO:0006357; GO:0007379; GO:0007406; GO:0007476; GO:0007480; GO:0008586; GO:0008587; GO:0014017; GO:0016055; GO:0016514; GO:0035060; GO:0045893; GO:0046530; GO:0048190; GO:0071565 chromatin remodeling [GO:0006338]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein morphogenesis [GO:0008586]; negative regulation of neuroblast proliferation [GO:0007406]; neuroblast fate commitment [GO:0014017]; photoreceptor cell differentiation [GO:0046530]; positive regulation of DNA-templated transcription [GO:0045893]; regulation of DNA-templated transcription [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; segment specification [GO:0007379]; wing disc dorsal/ventral pattern formation [GO:0048190]; Wnt signaling pathway [GO:0016055] brahma complex [GO:0035060]; nBAF complex [GO:0071565]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; SWI/SNF complex [GO:0016514] DNA binding [GO:0003677] g6338.t1 E7F1C4 64.655 116 1.1499999999999999e-42 152.0 sp|E7F1C4|SMRDB_DANRE SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A containing DEAD/H box 1B OS=Danio rerio OX=7955 GN=smarcad1b PE=3 SV=1 SMRDB_DANRE reviewed SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A containing DEAD/H box 1B (EC 3.6.4.-) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000729; GO:0000785; GO:0003677; GO:0003678; GO:0003682; GO:0005524; GO:0005634; GO:0016887; GO:0031507; GO:0035861; GO:0043130; GO:0045944; GO:0140658; GO:0140750 DNA double-strand break processing [GO:0000729]; heterochromatin formation [GO:0031507]; positive regulation of transcription by RNA polymerase II [GO:0045944] chromatin [GO:0000785]; nucleus [GO:0005634]; site of double-strand break [GO:0035861] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent chromatin remodeler activity [GO:0140658]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; nucleosome array spacer activity [GO:0140750]; ubiquitin binding [GO:0043130] g6339.t1 Q5FWR0 48.485 429 5.5599999999999996e-136 434.0 sp|Q5FWR0|SMRCD_XENTR SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A containing DEAD/H box 1 OS=Xenopus tropicalis OX=8364 GN=smarcad1 PE=2 SV=1 SMRCD_XENTR reviewed SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A containing DEAD/H box 1 (EC 3.6.4.-) Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0000729; GO:0000785; GO:0003677; GO:0003678; GO:0003682; GO:0005524; GO:0005634; GO:0016887; GO:0031507; GO:0035861; GO:0043130; GO:0045944; GO:0140658; GO:0140750 DNA double-strand break processing [GO:0000729]; heterochromatin formation [GO:0031507]; positive regulation of transcription by RNA polymerase II [GO:0045944] chromatin [GO:0000785]; nucleus [GO:0005634]; site of double-strand break [GO:0035861] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent chromatin remodeler activity [GO:0140658]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; nucleosome array spacer activity [GO:0140750]; ubiquitin binding [GO:0043130] g6340.t1 Q62388 28.916 249 4.13e-25 106.0 sp|Q62388|ATM_MOUSE Serine-protein kinase ATM OS=Mus musculus OX=10090 GN=Atm PE=1 SV=2 ATM_MOUSE reviewed Serine-protein kinase ATM (EC 2.7.11.1) (Ataxia telangiectasia mutated homolog) (A-T mutated homolog) Mus musculus (Mouse) GO:0000045; GO:0000077; GO:0000425; GO:0000723; GO:0000724; GO:0000729; GO:0000781; GO:0001541; GO:0001666; GO:0001756; GO:0002331; GO:0002376; GO:0003677; GO:0004672; GO:0004674; GO:0004677; GO:0005524; GO:0005634; GO:0005654; GO:0005694; GO:0005730; GO:0005737; GO:0005782; GO:0005813; GO:0005819; GO:0006281; GO:0006302; GO:0006513; GO:0006974; GO:0006979; GO:0007094; GO:0007095; GO:0007140; GO:0007143; GO:0007292; GO:0007420; GO:0007507; GO:0008340; GO:0008585; GO:0008630; GO:0009791; GO:0010212; GO:0010506; GO:0010628; GO:0016303; GO:0030330; GO:0030335; GO:0030889; GO:0031146; GO:0032210; GO:0032212; GO:0033151; GO:0033554; GO:0034614; GO:0035264; GO:0035861; GO:0035979; GO:0042159; GO:0042594; GO:0042770; GO:0042802; GO:0043065; GO:0043161; GO:0043517; GO:0043525; GO:0044877; GO:0045141; GO:0045785; GO:0045944; GO:0046777; GO:0048538; GO:0048599; GO:0050821; GO:0051402; GO:0051726; GO:0070192; GO:0070534; GO:0071044; GO:0071300; GO:0071479; GO:0071480; GO:0071481; GO:0071500; GO:0090399; GO:0097694; GO:0097695; GO:0098850; GO:0106310; GO:0110025; GO:1901797; GO:1903626; GO:1903978; GO:1904262; GO:1904354; GO:1904358; GO:1904884; GO:1905168; GO:1990166; GO:1990391; GO:2000042; GO:2000781; GO:2000785; GO:2000786 autophagosome assembly [GO:0000045]; brain development [GO:0007420]; cellular response to gamma radiation [GO:0071480]; cellular response to ionizing radiation [GO:0071479]; cellular response to nitrosative stress [GO:0071500]; cellular response to reactive oxygen species [GO:0034614]; cellular response to retinoic acid [GO:0071300]; cellular response to stress [GO:0033554]; cellular response to X-ray [GO:0071481]; chromosome organization involved in meiotic cell cycle [GO:0070192]; determination of adult lifespan [GO:0008340]; DNA damage checkpoint signaling [GO:0000077]; DNA damage response [GO:0006974]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; DNA double-strand break processing [GO:0000729]; DNA repair [GO:0006281]; DNA strand resection involved in replication fork processing [GO:0110025]; double-strand break repair [GO:0006302]; double-strand break repair via homologous recombination [GO:0000724]; establishment of protein-containing complex localization to telomere [GO:0097695]; establishment of RNA localization to telomere [GO:0097694]; female gamete generation [GO:0007292]; female gonad development [GO:0008585]; female meiotic nuclear division [GO:0007143]; heart development [GO:0007507]; histone mRNA catabolic process [GO:0071044]; immune system process [GO:0002376]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; lipoprotein catabolic process [GO:0042159]; male meiotic nuclear division [GO:0007140]; meiotic telomere clustering [GO:0045141]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; mitotic spindle assembly checkpoint signaling [GO:0007094]; multicellular organism growth [GO:0035264]; negative regulation of B cell proliferation [GO:0030889]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; negative regulation of signal transduction by p53 class mediator [GO:1901797]; negative regulation of telomere capping [GO:1904354]; negative regulation of TORC1 signaling [GO:1904262]; neuron apoptotic process [GO:0051402]; oocyte development [GO:0048599]; ovarian follicle development [GO:0001541]; pexophagy [GO:0000425]; positive regulation of apoptotic process [GO:0043065]; positive regulation of autophagosome assembly [GO:2000786]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cell migration [GO:0030335]; positive regulation of DNA catabolic process [GO:1903626]; positive regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043517]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of telomerase catalytic core complex assembly [GO:1904884]; positive regulation of telomere maintenance via telomerase [GO:0032212]; positive regulation of telomere maintenance via telomere lengthening [GO:1904358]; positive regulation of transcription by RNA polymerase II [GO:0045944]; post-embryonic development [GO:0009791]; pre-B cell allelic exclusion [GO:0002331]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autophosphorylation [GO:0046777]; protein K63-linked ubiquitination [GO:0070534]; protein localization to site of double-strand break [GO:1990166]; protein monoubiquitination [GO:0006513]; protein stabilization [GO:0050821]; regulation of autophagosome assembly [GO:2000785]; regulation of autophagy [GO:0010506]; regulation of cell cycle [GO:0051726]; regulation of microglial cell activation [GO:1903978]; regulation of telomere maintenance via telomerase [GO:0032210]; replicative senescence [GO:0090399]; response to hypoxia [GO:0001666]; response to ionizing radiation [GO:0010212]; response to oxidative stress [GO:0006979]; response to starvation [GO:0042594]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; signal transduction in response to DNA damage [GO:0042770]; somitogenesis [GO:0001756]; telomere maintenance [GO:0000723]; thymus development [GO:0048538]; V(D)J recombination [GO:0033151] centrosome [GO:0005813]; chromosome [GO:0005694]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; DNA repair complex [GO:1990391]; extrinsic component of synaptic vesicle membrane [GO:0098850]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; peroxisomal matrix [GO:0005782]; site of double-strand break [GO:0035861]; spindle [GO:0005819] 1-phosphatidylinositol-3-kinase activity [GO:0016303]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-dependent protein kinase activity [GO:0004677]; histone H2AXS139 kinase activity [GO:0035979]; identical protein binding [GO:0042802]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein-containing complex binding [GO:0044877] g6342.t1 Q62388 27.624 362 4.89e-27 123.0 sp|Q62388|ATM_MOUSE Serine-protein kinase ATM OS=Mus musculus OX=10090 GN=Atm PE=1 SV=2 ATM_MOUSE reviewed Serine-protein kinase ATM (EC 2.7.11.1) (Ataxia telangiectasia mutated homolog) (A-T mutated homolog) Mus musculus (Mouse) GO:0000045; GO:0000077; GO:0000425; GO:0000723; GO:0000724; GO:0000729; GO:0000781; GO:0001541; GO:0001666; GO:0001756; GO:0002331; GO:0002376; GO:0003677; GO:0004672; GO:0004674; GO:0004677; GO:0005524; GO:0005634; GO:0005654; GO:0005694; GO:0005730; GO:0005737; GO:0005782; GO:0005813; GO:0005819; GO:0006281; GO:0006302; GO:0006513; GO:0006974; GO:0006979; GO:0007094; GO:0007095; GO:0007140; GO:0007143; GO:0007292; GO:0007420; GO:0007507; GO:0008340; GO:0008585; GO:0008630; GO:0009791; GO:0010212; GO:0010506; GO:0010628; GO:0016303; GO:0030330; GO:0030335; GO:0030889; GO:0031146; GO:0032210; GO:0032212; GO:0033151; GO:0033554; GO:0034614; GO:0035264; GO:0035861; GO:0035979; GO:0042159; GO:0042594; GO:0042770; GO:0042802; GO:0043065; GO:0043161; GO:0043517; GO:0043525; GO:0044877; GO:0045141; GO:0045785; GO:0045944; GO:0046777; GO:0048538; GO:0048599; GO:0050821; GO:0051402; GO:0051726; GO:0070192; GO:0070534; GO:0071044; GO:0071300; GO:0071479; GO:0071480; GO:0071481; GO:0071500; GO:0090399; GO:0097694; GO:0097695; GO:0098850; GO:0106310; GO:0110025; GO:1901797; GO:1903626; GO:1903978; GO:1904262; GO:1904354; GO:1904358; GO:1904884; GO:1905168; GO:1990166; GO:1990391; GO:2000042; GO:2000781; GO:2000785; GO:2000786 autophagosome assembly [GO:0000045]; brain development [GO:0007420]; cellular response to gamma radiation [GO:0071480]; cellular response to ionizing radiation [GO:0071479]; cellular response to nitrosative stress [GO:0071500]; cellular response to reactive oxygen species [GO:0034614]; cellular response to retinoic acid [GO:0071300]; cellular response to stress [GO:0033554]; cellular response to X-ray [GO:0071481]; chromosome organization involved in meiotic cell cycle [GO:0070192]; determination of adult lifespan [GO:0008340]; DNA damage checkpoint signaling [GO:0000077]; DNA damage response [GO:0006974]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; DNA double-strand break processing [GO:0000729]; DNA repair [GO:0006281]; DNA strand resection involved in replication fork processing [GO:0110025]; double-strand break repair [GO:0006302]; double-strand break repair via homologous recombination [GO:0000724]; establishment of protein-containing complex localization to telomere [GO:0097695]; establishment of RNA localization to telomere [GO:0097694]; female gamete generation [GO:0007292]; female gonad development [GO:0008585]; female meiotic nuclear division [GO:0007143]; heart development [GO:0007507]; histone mRNA catabolic process [GO:0071044]; immune system process [GO:0002376]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; lipoprotein catabolic process [GO:0042159]; male meiotic nuclear division [GO:0007140]; meiotic telomere clustering [GO:0045141]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; mitotic spindle assembly checkpoint signaling [GO:0007094]; multicellular organism growth [GO:0035264]; negative regulation of B cell proliferation [GO:0030889]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; negative regulation of signal transduction by p53 class mediator [GO:1901797]; negative regulation of telomere capping [GO:1904354]; negative regulation of TORC1 signaling [GO:1904262]; neuron apoptotic process [GO:0051402]; oocyte development [GO:0048599]; ovarian follicle development [GO:0001541]; pexophagy [GO:0000425]; positive regulation of apoptotic process [GO:0043065]; positive regulation of autophagosome assembly [GO:2000786]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cell migration [GO:0030335]; positive regulation of DNA catabolic process [GO:1903626]; positive regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043517]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of telomerase catalytic core complex assembly [GO:1904884]; positive regulation of telomere maintenance via telomerase [GO:0032212]; positive regulation of telomere maintenance via telomere lengthening [GO:1904358]; positive regulation of transcription by RNA polymerase II [GO:0045944]; post-embryonic development [GO:0009791]; pre-B cell allelic exclusion [GO:0002331]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autophosphorylation [GO:0046777]; protein K63-linked ubiquitination [GO:0070534]; protein localization to site of double-strand break [GO:1990166]; protein monoubiquitination [GO:0006513]; protein stabilization [GO:0050821]; regulation of autophagosome assembly [GO:2000785]; regulation of autophagy [GO:0010506]; regulation of cell cycle [GO:0051726]; regulation of microglial cell activation [GO:1903978]; regulation of telomere maintenance via telomerase [GO:0032210]; replicative senescence [GO:0090399]; response to hypoxia [GO:0001666]; response to ionizing radiation [GO:0010212]; response to oxidative stress [GO:0006979]; response to starvation [GO:0042594]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; signal transduction in response to DNA damage [GO:0042770]; somitogenesis [GO:0001756]; telomere maintenance [GO:0000723]; thymus development [GO:0048538]; V(D)J recombination [GO:0033151] centrosome [GO:0005813]; chromosome [GO:0005694]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; DNA repair complex [GO:1990391]; extrinsic component of synaptic vesicle membrane [GO:0098850]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; peroxisomal matrix [GO:0005782]; site of double-strand break [GO:0035861]; spindle [GO:0005819] 1-phosphatidylinositol-3-kinase activity [GO:0016303]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-dependent protein kinase activity [GO:0004677]; histone H2AXS139 kinase activity [GO:0035979]; identical protein binding [GO:0042802]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein-containing complex binding [GO:0044877] g6343.t1 Q6PQD5 37.202 336 4.9899999999999995e-52 189.0 sp|Q6PQD5|ATM_PIG Serine-protein kinase ATM OS=Sus scrofa OX=9823 GN=ATM PE=3 SV=2 ATM_PIG reviewed Serine-protein kinase ATM (EC 2.7.11.1) (Ataxia telangiectasia mutated homolog) (A-T mutated homolog) Sus scrofa (Pig) GO:0000077; GO:0000425; GO:0000723; GO:0000724; GO:0002331; GO:0003677; GO:0003735; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005694; GO:0005737; GO:0005782; GO:0005813; GO:0005840; GO:0006302; GO:0006412; GO:0006468; GO:0007094; GO:0007127; GO:0008630; GO:0010212; GO:0010506; GO:0010557; GO:0016303; GO:0031410; GO:0032210; GO:0035861; GO:0035979; GO:0042770; GO:0043065; GO:0046777; GO:0071044; GO:0106310; GO:1901701; GO:1904262; GO:1904358 cellular response to oxygen-containing compound [GO:1901701]; DNA damage checkpoint signaling [GO:0000077]; double-strand break repair [GO:0006302]; double-strand break repair via homologous recombination [GO:0000724]; histone mRNA catabolic process [GO:0071044]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; meiosis I [GO:0007127]; mitotic spindle assembly checkpoint signaling [GO:0007094]; negative regulation of TORC1 signaling [GO:1904262]; pexophagy [GO:0000425]; positive regulation of apoptotic process [GO:0043065]; positive regulation of macromolecule biosynthetic process [GO:0010557]; positive regulation of telomere maintenance via telomere lengthening [GO:1904358]; pre-B cell allelic exclusion [GO:0002331]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of autophagy [GO:0010506]; regulation of telomere maintenance via telomerase [GO:0032210]; response to ionizing radiation [GO:0010212]; signal transduction in response to DNA damage [GO:0042770]; telomere maintenance [GO:0000723]; translation [GO:0006412] centrosome [GO:0005813]; chromosome [GO:0005694]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; peroxisomal matrix [GO:0005782]; ribosome [GO:0005840]; site of double-strand break [GO:0035861] 1-phosphatidylinositol-3-kinase activity [GO:0016303]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; histone H2AXS139 kinase activity [GO:0035979]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; structural constituent of ribosome [GO:0003735] g6344.t1 Q13315 44.963 1608 0.0 1240.0 sp|Q13315|ATM_HUMAN Serine-protein kinase ATM OS=Homo sapiens OX=9606 GN=ATM PE=1 SV=4 g6345.t1 Q7Z449 35.421 463 3.45e-85 275.0 sp|Q7Z449|CP2U1_HUMAN Cytochrome P450 2U1 OS=Homo sapiens OX=9606 GN=CYP2U1 PE=1 SV=1 CP2U1_HUMAN reviewed Cytochrome P450 2U1 (Long-chain fatty acid omega-monooxygenase) (EC 1.14.14.80) Homo sapiens (Human) GO:0004497; GO:0005506; GO:0005737; GO:0005743; GO:0005789; GO:0006082; GO:0006805; GO:0008202; GO:0008395; GO:0016712; GO:0020037; GO:0052869; GO:0097267; GO:0102033; GO:1903604 cytochrome metabolic process [GO:1903604]; omega-hydroxylase P450 pathway [GO:0097267]; organic acid metabolic process [GO:0006082]; steroid metabolic process [GO:0008202]; xenobiotic metabolic process [GO:0006805] cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; mitochondrial inner membrane [GO:0005743] arachidonate omega-hydroxylase activity [GO:0052869]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; long-chain fatty acid omega-hydroxylase activity [GO:0102033]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; steroid hydroxylase activity [GO:0008395] g6347.t1 Q9ET66 38.342 193 4.2799999999999995e-34 130.0 sp|Q9ET66|PI16_MOUSE Peptidase inhibitor 16 OS=Mus musculus OX=10090 GN=Pi16 PE=1 SV=2 PI16_MOUSE reviewed Peptidase inhibitor 16 (PI-16) (Cysteine-rich protease inhibitor) (CD antigen CD364) Mus musculus (Mouse) GO:0005615; GO:0030414; GO:0061052 negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052] extracellular space [GO:0005615] peptidase inhibitor activity [GO:0030414] g6348.t1 Q8BGC3 27.014 422 2.4500000000000002e-32 132.0 sp|Q8BGC3|MOT12_MOUSE Monocarboxylate transporter 12 OS=Mus musculus OX=10090 GN=Slc16a12 PE=1 SV=1 g6350.t1 Q8BGC3 27.273 451 2.76e-40 154.0 sp|Q8BGC3|MOT12_MOUSE Monocarboxylate transporter 12 OS=Mus musculus OX=10090 GN=Slc16a12 PE=1 SV=1 g6352.t1 Q8K1C7 27.018 285 5.48e-29 120.0 sp|Q8K1C7|MOT14_MOUSE Monocarboxylate transporter 14 OS=Mus musculus OX=10090 GN=Slc16a14 PE=2 SV=1 g6353.t1 Q7RTX9 24.731 465 9.83e-29 122.0 sp|Q7RTX9|MOT14_HUMAN Monocarboxylate transporter 14 OS=Homo sapiens OX=9606 GN=SLC16A14 PE=1 SV=1 g6354.t1 Q5RA42 83.673 98 1.53e-54 171.0 sp|Q5RA42|IF1AX_PONAB Eukaryotic translation initiation factor 1A, X-chromosomal OS=Pongo abelii OX=9601 GN=EIF1AX PE=2 SV=3 g6355.t1 Q5ZKH3 58.277 441 0.0 516.0 sp|Q5ZKH3|EED_CHICK Polycomb protein EED OS=Gallus gallus OX=9031 GN=EED PE=2 SV=1 g6356.t1 Q2TLZ2 50.379 659 0.0 580.0 sp|Q2TLZ2|MACOI_PIG Macoilin OS=Sus scrofa OX=9823 GN=MACO1 PE=2 SV=1 g6357.t1 P18654 69.159 749 0.0 1025.0 sp|P18654|KS6A3_MOUSE Ribosomal protein S6 kinase alpha-3 OS=Mus musculus OX=10090 GN=Rps6ka3 PE=1 SV=2 KS6A3_MOUSE reviewed Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2) Mus musculus (Mouse) GO:0000287; GO:0002224; GO:0004674; GO:0004711; GO:0005524; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0019901; GO:0032496; GO:0038202; GO:0043066; GO:0045944; GO:0106310 negative regulation of apoptotic process [GO:0043066]; positive regulation of transcription by RNA polymerase II [GO:0045944]; response to lipopolysaccharide [GO:0032496]; toll-like receptor signaling pathway [GO:0002224]; TORC1 signaling [GO:0038202] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654] ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; ribosomal protein S6 kinase activity [GO:0004711] g6358.t1 Q9CQF4 47.368 114 7.51e-22 93.6 sp|Q9CQF4|MRES1_MOUSE Mitochondrial transcription rescue factor 1 OS=Mus musculus OX=10090 GN=Mtres1 PE=1 SV=1 g6360.t1 Q5TFE4 32.584 356 3.02e-48 175.0 sp|Q5TFE4|NT5D1_HUMAN 5'-nucleotidase domain-containing protein 1 OS=Homo sapiens OX=9606 GN=NT5DC1 PE=1 SV=1 g6362.t1 Q5TFE4 45.536 112 7.39e-26 103.0 sp|Q5TFE4|NT5D1_HUMAN 5'-nucleotidase domain-containing protein 1 OS=Homo sapiens OX=9606 GN=NT5DC1 PE=1 SV=1 g6365.t1 O16264 54.605 152 4.14e-46 154.0 sp|O16264|PEBPH_CAEEL Phosphatidylethanolamine-binding protein homolog F40A3.3 OS=Caenorhabditis elegans OX=6239 GN=F40A3.3 PE=3 SV=1 g6366.t1 Q499R4 45.192 208 8.849999999999999e-54 175.0 sp|Q499R4|YRDC_RAT Threonylcarbamoyl-AMP synthase OS=Rattus norvegicus OX=10116 GN=Yrdc PE=2 SV=1 YRDC_RAT reviewed Threonylcarbamoyl-AMP synthase (EC 2.7.7.87) Rattus norvegicus (Rat) GO:0000049; GO:0002949; GO:0003725; GO:0005737; GO:0005739; GO:0005886; GO:0006450; GO:0016020; GO:0016779; GO:0051051; GO:0061710 negative regulation of transport [GO:0051051]; regulation of translational fidelity [GO:0006450]; tRNA threonylcarbamoyladenosine modification [GO:0002949] cytoplasm [GO:0005737]; membrane [GO:0016020]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886] double-stranded RNA binding [GO:0003725]; L-threonylcarbamoyladenylate synthase [GO:0061710]; nucleotidyltransferase activity [GO:0016779]; tRNA binding [GO:0000049] g6367.t1 P08941 29.873 2360 0.0 900.0 sp|P08941|ROS1_CHICK Proto-oncogene tyrosine-protein kinase ROS OS=Gallus gallus OX=9031 GN=ROS1 PE=1 SV=3 g6374.t1 E1BD59 24.324 370 2.9e-24 111.0 sp|E1BD59|TRI56_BOVIN E3 ubiquitin-protein ligase TRIM56 OS=Bos taurus OX=9913 GN=TRIM56 PE=2 SV=1 TRI56_BOVIN reviewed E3 ubiquitin-protein ligase TRIM56 (EC 2.3.2.27) (Tripartite motif-containing protein 56) Bos taurus (Bovine) GO:0005654; GO:0005737; GO:0006513; GO:0008270; GO:0032728; GO:0034340; GO:0045087; GO:0051607; GO:0060340; GO:0061630; GO:0070534 defense response to virus [GO:0051607]; innate immune response [GO:0045087]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of type I interferon-mediated signaling pathway [GO:0060340]; protein K63-linked ubiquitination [GO:0070534]; protein monoubiquitination [GO:0006513]; response to type I interferon [GO:0034340] cytoplasm [GO:0005737]; nucleoplasm [GO:0005654] ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] g937.t1 Q66K64 37.121 264 3.87e-34 142.0 sp|Q66K64|DCA15_HUMAN DDB1- and CUL4-associated factor 15 OS=Homo sapiens OX=9606 GN=DCAF15 PE=1 SV=1 DCA15_HUMAN reviewed DDB1- and CUL4-associated factor 15 Homo sapiens (Human) GO:0000209; GO:0002376; GO:0016567; GO:0032814; GO:0036094; GO:0046872; GO:0080008 immune system process [GO:0002376]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of natural killer cell activation [GO:0032814] Cul4-RING E3 ubiquitin ligase complex [GO:0080008] metal ion binding [GO:0046872]; small molecule binding [GO:0036094] g938.t1 Q6PCS4 39.644 898 1.57e-168 540.0 sp|Q6PCS4|RHG29_DANRE Rho GTPase-activating protein 29 OS=Danio rerio OX=7955 GN=arhgap29 PE=2 SV=1 g939.t1 Q4V7P7 43.0 400 1.92e-109 335.0 sp|Q4V7P7|SNX30_XENLA Sorting nexin-30 OS=Xenopus laevis OX=8355 GN=snx30 PE=2 SV=1 g939.t2 Q4V7P7 43.216 398 1.92e-111 340.0 sp|Q4V7P7|SNX30_XENLA Sorting nexin-30 OS=Xenopus laevis OX=8355 GN=snx30 PE=2 SV=1 g940.t1 Q9NRY2 48.148 108 4.08e-25 94.0 sp|Q9NRY2|SOSSC_HUMAN SOSS complex subunit C OS=Homo sapiens OX=9606 GN=INIP PE=1 SV=1 SOSSC_HUMAN reviewed SOSS complex subunit C (INTS3- and NABP-interacting protein) (Sensor of single-strand DNA complex subunit C) (Sensor of ssDNA subunit C) (SOSS-C) (Single-stranded DNA-binding protein-interacting protein 1) (SSB-interacting protein 1) (hSSBIP1) Homo sapiens (Human) GO:0000724; GO:0005634; GO:0005654; GO:0006281; GO:0006974; GO:0010212; GO:0035861; GO:0044818; GO:0070876 DNA damage response [GO:0006974]; DNA repair [GO:0006281]; double-strand break repair via homologous recombination [GO:0000724]; mitotic G2/M transition checkpoint [GO:0044818]; response to ionizing radiation [GO:0010212] nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; SOSS complex [GO:0070876] g941.t1 Q0GGW5 69.688 320 7.690000000000001e-157 453.0 sp|Q0GGW5|STK11_CHICK Serine/threonine-protein kinase STK11 OS=Gallus gallus OX=9031 GN=STK11 PE=2 SV=1 STK11_CHICK reviewed Serine/threonine-protein kinase STK11 (EC 2.7.11.1) (Liver kinase B1 homolog) (LKB1) Gallus gallus (Chicken) GO:0000287; GO:0001558; GO:0001944; GO:0002039; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0006468; GO:0006470; GO:0006974; GO:0007165; GO:0009267; GO:0009410; GO:0010212; GO:0016020; GO:0019901; GO:0030010; GO:0030111; GO:0030295; GO:0030308; GO:0032147; GO:0042593; GO:0046777; GO:0072332; GO:0090090; GO:0106310; GO:1901610 activation of protein kinase activity [GO:0032147]; cellular response to starvation [GO:0009267]; DNA damage response [GO:0006974]; establishment of cell polarity [GO:0030010]; glucose homeostasis [GO:0042593]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell growth [GO:0030308]; positive regulation of vesicle transport along microtubule [GO:1901610]; protein autophosphorylation [GO:0046777]; protein dephosphorylation [GO:0006470]; protein phosphorylation [GO:0006468]; regulation of cell growth [GO:0001558]; regulation of Wnt signaling pathway [GO:0030111]; response to ionizing radiation [GO:0010212]; response to xenobiotic stimulus [GO:0009410]; signal transduction [GO:0007165]; vasculature development [GO:0001944] cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleus [GO:0005634] ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; p53 binding [GO:0002039]; protein kinase activator activity [GO:0030295]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g943.t1 P70187 63.445 476 0.0 591.0 sp|P70187|MF14A_MOUSE Hippocampus abundant transcript 1 protein OS=Mus musculus OX=10090 GN=Mfsd14a PE=2 SV=3 S71A1_MOUSE reviewed Solute carrier family 71 member 1 (Hippocampus abundant transcript 1 protein) (Major facilitator superfamily domain-containing 14A) (Putative tetracycline transporter-like protein) Mus musculus (Mouse) GO:0000139; GO:0001675; GO:0007283; GO:0007286; GO:0007289; GO:0022857; GO:0030382 acrosome assembly [GO:0001675]; sperm mitochondrion organization [GO:0030382]; spermatid development [GO:0007286]; spermatid nucleus differentiation [GO:0007289]; spermatogenesis [GO:0007283] Golgi membrane [GO:0000139] transmembrane transporter activity [GO:0022857] g944.t1 Q6P8Y1 38.251 183 1.02e-33 121.0 sp|Q6P8Y1|CAPSL_MOUSE Calcyphosin-like protein OS=Mus musculus OX=10090 GN=Capsl PE=2 SV=4 g945.t1 Q0VCC0 40.541 185 3.52e-38 132.0 sp|Q0VCC0|CAYP1_BOVIN Calcyphosin OS=Bos taurus OX=9913 GN=CAPS PE=2 SV=1 g946.t1 Q6P8Y1 69.856 209 9.550000000000001e-109 313.0 sp|Q6P8Y1|CAPSL_MOUSE Calcyphosin-like protein OS=Mus musculus OX=10090 GN=Capsl PE=2 SV=4 g948.t1 Q8TEK3 51.287 544 5.78e-152 476.0 sp|Q8TEK3|DOT1L_HUMAN Histone-lysine N-methyltransferase, H3 lysine-79 specific OS=Homo sapiens OX=9606 GN=DOT1L PE=1 SV=3 DOT1L_HUMAN reviewed Histone-lysine N-methyltransferase, H3 lysine-79 specific (EC 2.1.1.360) (DOT1-like protein) (Disruptor of telomeric silencing 1-like histone lysine methyltransferase) (Histone H3-K79 methyltransferase) (H3-K79-HMTase) (Lysine N-methyltransferase 4) Homo sapiens (Human) GO:0000077; GO:0000781; GO:0003676; GO:0003677; GO:0003713; GO:0005634; GO:0005654; GO:0005737; GO:0006281; GO:0006814; GO:0010467; GO:0031151; GO:0031509; GO:0032200; GO:0032259; GO:0032991; GO:0042054; GO:0045944; GO:0046425; GO:0061629; GO:0140938; GO:0140956; GO:2000677 DNA damage checkpoint signaling [GO:0000077]; DNA repair [GO:0006281]; gene expression [GO:0010467]; methylation [GO:0032259]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of receptor signaling pathway via JAK-STAT [GO:0046425]; regulation of transcription regulatory region DNA binding [GO:2000677]; sodium ion transport [GO:0006814]; subtelomeric heterochromatin formation [GO:0031509]; telomere organization [GO:0032200] chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991] DNA binding [GO:0003677]; histone H3 methyltransferase activity [GO:0140938]; histone H3K79 methyltransferase activity [GO:0031151]; histone H3K79 trimethyltransferase activity [GO:0140956]; histone methyltransferase activity [GO:0042054]; nucleic acid binding [GO:0003676]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription coactivator activity [GO:0003713] g949.t1 P54731 41.026 663 2.64e-154 462.0 sp|P54731|FAF1_MOUSE FAS-associated factor 1 OS=Mus musculus OX=10090 GN=Faf1 PE=1 SV=2 g954.t1 Q18248 37.931 232 2.03e-41 150.0 sp|Q18248|DMD4_CAEEL Doublesex- and mab-3-related transcription factor dmd-4 OS=Caenorhabditis elegans OX=6239 GN=dmd-4 PE=1 SV=2 DMD4_CAEEL reviewed Doublesex- and mab-3-related transcription factor dmd-4 Caenorhabditis elegans GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0007548; GO:0043130; GO:0046872; GO:0098883 regulation of transcription by RNA polymerase II [GO:0006357]; sex differentiation [GO:0007548]; synapse pruning [GO:0098883] nucleus [GO:0005634] DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; ubiquitin binding [GO:0043130] g959.t1 A4QNP7 37.719 456 5.29e-59 203.0 sp|A4QNP7|DMTA2_XENTR Doublesex- and mab-3-related transcription factor A2 OS=Xenopus tropicalis OX=8364 GN=dmrta2 PE=2 SV=1 DMTA2_XENTR reviewed Doublesex- and mab-3-related transcription factor A2 (Doublesex- and mab-3-related transcription factor 5) Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0007548; GO:0021537; GO:0046872; GO:0060128 corticotropin hormone secreting cell differentiation [GO:0060128]; regulation of transcription by RNA polymerase II [GO:0006357]; sex differentiation [GO:0007548]; telencephalon development [GO:0021537] nucleus [GO:0005634] DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978] g960.t1 P36406 66.0 550 0.0 697.0 sp|P36406|TRI23_HUMAN E3 ubiquitin-protein ligase TRIM23 OS=Homo sapiens OX=9606 GN=TRIM23 PE=1 SV=1 TRI23_HUMAN reviewed E3 ubiquitin-protein ligase TRIM23 (EC 2.3.2.27) (ADP-ribosylation factor domain-containing protein 1) (GTP-binding protein ARD-1) (RING finger protein 46) (RING-type E3 ubiquitin transferase TRIM23) (Tripartite motif-containing protein 23) Homo sapiens (Human) GO:0000139; GO:0003924; GO:0004842; GO:0005525; GO:0005634; GO:0005737; GO:0005765; GO:0005886; GO:0006886; GO:0008047; GO:0008270; GO:0010508; GO:0016192; GO:0016567; GO:0019003; GO:0042802; GO:0045087; GO:0061630 innate immune response [GO:0045087]; intracellular protein transport [GO:0006886]; positive regulation of autophagy [GO:0010508]; protein ubiquitination [GO:0016567]; vesicle-mediated transport [GO:0016192] cytoplasm [GO:0005737]; Golgi membrane [GO:0000139]; lysosomal membrane [GO:0005765]; nucleus [GO:0005634]; plasma membrane [GO:0005886] enzyme activator activity [GO:0008047]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] g962.t1 Q9H6X5 45.299 117 4.5500000000000003e-26 115.0 sp|Q9H6X5|CS044_HUMAN Uncharacterized protein C19orf44 OS=Homo sapiens OX=9606 GN=C19orf44 PE=1 SV=1 g963.t1 Q6DNG6 33.55 307 1.64e-41 153.0 sp|Q6DNG6|SIA8A_XENTR Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase OS=Xenopus tropicalis OX=8364 GN=st8sia1 PE=2 SV=2 SIA8A_XENTR reviewed Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase (EC 2.4.3.8) (Alpha-2,8-sialyltransferase 8A) (Ganglioside GD3 synthase) (Sialyltransferase 8A) (SIAT8-A) (Sialyltransferase St8Sia I) (ST8SiaI) Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0000139; GO:0001574; GO:0003828; GO:0006491; GO:0006688; GO:0009311 ganglioside biosynthetic process [GO:0001574]; glycosphingolipid biosynthetic process [GO:0006688]; N-glycan processing [GO:0006491]; oligosaccharide metabolic process [GO:0009311] Golgi membrane [GO:0000139] alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity [GO:0003828] g967.t1 Q6ZXA0 32.298 322 2.3400000000000003e-43 156.0 sp|Q6ZXA0|SIA8A_XENLA Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase OS=Xenopus laevis OX=8355 GN=st8sia1 PE=1 SV=1 g969.t1 O35696 31.908 304 1.1999999999999999e-42 157.0 sp|O35696|SIA8B_MOUSE Alpha-2,8-sialyltransferase 8B OS=Mus musculus OX=10090 GN=St8sia2 PE=1 SV=2 g970.t1 O13076 30.449 312 2.34e-25 108.0 sp|O13076|AA2BR_CHICK Adenosine receptor A2b OS=Gallus gallus OX=9031 GN=ADORA2B PE=2 SV=1 g972.t1 Q6GPB9 48.34 753 0.0 698.0 sp|Q6GPB9|DNAI4_XENLA Dynein axonemal intermediate chain 4 OS=Xenopus laevis OX=8355 GN=dnai4 PE=2 SV=1 g973.t1 Q5UAK0 42.746 386 9.480000000000001e-85 273.0 sp|Q5UAK0|MIER1_MOUSE Mesoderm induction early response protein 1 OS=Mus musculus OX=10090 GN=Mier1 PE=1 SV=2 MIER1_MOUSE reviewed Mesoderm induction early response protein 1 (Early response 1) (Er1) (Mi-er1) Mus musculus (Mouse) GO:0000122; GO:0003714; GO:0004407; GO:0005634; GO:0005654; GO:0006338; GO:0006355; GO:0017053; GO:0032991; GO:0042826 chromatin remodeling [GO:0006338]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of DNA-templated transcription [GO:0006355] nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcription repressor complex [GO:0017053] histone deacetylase activity [GO:0004407]; histone deacetylase binding [GO:0042826]; transcription corepressor activity [GO:0003714] g975.t1 Q9D0D4 77.316 313 1.58e-178 498.0 sp|Q9D0D4|DIM1_MOUSE Dimethyladenosine transferase OS=Mus musculus OX=10090 GN=Dimt1 PE=2 SV=1 DIM1_MOUSE reviewed Dimethyladenosine transferase (EC 2.1.1.183) (18S rRNA (adenine(1779)-N(6)/adenine(1780)-N(6))-dimethyltransferase) (18S rRNA dimethylase) (DIM1 dimethyladenosine transferase 1 homolog) (DIM1 dimethyladenosine transferase 1-like) (S-adenosylmethionine-6-N',N'-adenosyl(rRNA) dimethyltransferase) Mus musculus (Mouse) GO:0000179; GO:0003723; GO:0005654; GO:0005730; GO:0005829; GO:0031167; GO:0032040; GO:0042274; GO:0052909; GO:2000234 positive regulation of rRNA processing [GO:2000234]; ribosomal small subunit biogenesis [GO:0042274]; rRNA methylation [GO:0031167] cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; small-subunit processome [GO:0032040] 18S rRNA (adenine(1779)-N(6)/adenine(1780)-N(6))-dimethyltransferase activity [GO:0052909]; RNA binding [GO:0003723]; rRNA (adenine-N6,N6-)-dimethyltransferase activity [GO:0000179] g976.t1 Q05752 50.0 114 1.46e-28 103.0 sp|Q05752|NDUA7_BOVIN NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 7 OS=Bos taurus OX=9913 GN=NDUFA7 PE=1 SV=2 NDUA7_BOVIN reviewed NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 7 (Complex I-B14.5a) (CI-B14.5a) (NADH-ubiquinone oxidoreductase subunit B14.5a) Bos taurus (Bovine) GO:0005739; GO:0005743; GO:0006120; GO:0016491; GO:0042773; GO:0045271 ATP synthesis coupled electron transport [GO:0042773]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120] mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; respiratory chain complex I [GO:0045271] oxidoreductase activity [GO:0016491] g977.t1 Q9Y5R5 44.712 208 2.07e-39 146.0 sp|Q9Y5R5|DMRT2_HUMAN Doublesex- and mab-3-related transcription factor 2 OS=Homo sapiens OX=9606 GN=DMRT2 PE=1 SV=2 DMRT2_HUMAN reviewed Doublesex- and mab-3-related transcription factor 2 (Doublesex-like 2 protein) (DSXL-2) Homo sapiens (Human) GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0005634; GO:0006357; GO:0007548; GO:0014807; GO:0042802; GO:0046872; GO:0048706; GO:0061055; GO:2000287 embryonic skeletal system development [GO:0048706]; myotome development [GO:0061055]; positive regulation of myotome development [GO:2000287]; regulation of somitogenesis [GO:0014807]; regulation of transcription by RNA polymerase II [GO:0006357]; sex differentiation [GO:0007548] chromatin [GO:0000785]; nucleus [GO:0005634] DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978] g981.t1 P70031 26.566 399 1.7e-35 140.0 sp|P70031|CCKAR_XENLA Cholecystokinin receptor OS=Xenopus laevis OX=8355 GN=cckar PE=2 SV=1 g985.t1 P70031 26.816 358 3.12e-35 139.0 sp|P70031|CCKAR_XENLA Cholecystokinin receptor OS=Xenopus laevis OX=8355 GN=cckar PE=2 SV=1 g999.t1 Q5XIY2 31.646 237 1.1000000000000001e-29 115.0 sp|Q5XIY2|TLC4B_DANRE TLC domain-containing protein 4-B OS=Danio rerio OX=7955 GN=tlcd4b PE=2 SV=1 g1000.t1 Q6AY85 53.846 182 1.87e-73 224.0 sp|Q6AY85|ALG14_RAT UDP-N-acetylglucosamine transferase subunit ALG14 OS=Rattus norvegicus OX=10116 GN=Alg14 PE=2 SV=1 g1002.t1 Q9H4F1 41.667 252 1.27e-63 209.0 sp|Q9H4F1|SIA7D_HUMAN Alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1,3-N-acetyl-galactosaminide alpha-2,6-sialyltransferase OS=Homo sapiens OX=9606 GN=ST6GALNAC4 PE=1 SV=2 g1003.t1 Q9H4F1 37.549 253 2.4299999999999997e-54 185.0 sp|Q9H4F1|SIA7D_HUMAN Alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1,3-N-acetyl-galactosaminide alpha-2,6-sialyltransferase OS=Homo sapiens OX=9606 GN=ST6GALNAC4 PE=1 SV=2 g1004.t1 Q9H4F1 35.766 274 3.48e-50 174.0 sp|Q9H4F1|SIA7D_HUMAN Alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1,3-N-acetyl-galactosaminide alpha-2,6-sialyltransferase OS=Homo sapiens OX=9606 GN=ST6GALNAC4 PE=1 SV=2 g1005.t1 Q9BVH7 39.085 284 9.12e-60 202.0 sp|Q9BVH7|SIA7E_HUMAN Alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 5 OS=Homo sapiens OX=9606 GN=ST6GALNAC5 PE=1 SV=1 SIA7E_HUMAN reviewed Alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 5 (EC 2.4.99.-) (GD1 alpha synthase) (GalNAc alpha-2,6-sialyltransferase V) (ST6GalNAc V) (ST6GalNAcV) (Sialyltransferase 7E) (SIAT7-E) Homo sapiens (Human) GO:0000139; GO:0001574; GO:0001665; GO:0006688; GO:0008373; GO:0009311; GO:0009312 ganglioside biosynthetic process [GO:0001574]; glycosphingolipid biosynthetic process [GO:0006688]; oligosaccharide biosynthetic process [GO:0009312]; oligosaccharide metabolic process [GO:0009311] Golgi membrane [GO:0000139] alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity [GO:0001665]; sialyltransferase activity [GO:0008373] g1005.t2 Q9QYJ1 40.081 247 2.3e-56 194.0 sp|Q9QYJ1|SIA7E_MOUSE Alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 5 OS=Mus musculus OX=10090 GN=St6galnac5 PE=1 SV=1 SIA7E_MOUSE reviewed Alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 5 (EC 2.4.99.-) (GD1 alpha synthase) (GalNAc alpha-2,6-sialyltransferase V) (ST6GalNAc V) (ST6GalNAcV) (Sialyltransferase 7E) (SIAT7-E) Mus musculus (Mouse) GO:0000139; GO:0001574; GO:0001665; GO:0006688; GO:0008373; GO:0009311; GO:0009312 ganglioside biosynthetic process [GO:0001574]; glycosphingolipid biosynthetic process [GO:0006688]; oligosaccharide biosynthetic process [GO:0009312]; oligosaccharide metabolic process [GO:0009311] Golgi membrane [GO:0000139] alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity [GO:0001665]; sialyltransferase activity [GO:0008373] g1005.t3 Q9BVH7 39.085 284 3.7400000000000002e-59 202.0 sp|Q9BVH7|SIA7E_HUMAN Alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 5 OS=Homo sapiens OX=9606 GN=ST6GALNAC5 PE=1 SV=1 SIA7E_HUMAN reviewed Alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 5 (EC 2.4.99.-) (GD1 alpha synthase) (GalNAc alpha-2,6-sialyltransferase V) (ST6GalNAc V) (ST6GalNAcV) (Sialyltransferase 7E) (SIAT7-E) Homo sapiens (Human) GO:0000139; GO:0001574; GO:0001665; GO:0006688; GO:0008373; GO:0009311; GO:0009312 ganglioside biosynthetic process [GO:0001574]; glycosphingolipid biosynthetic process [GO:0006688]; oligosaccharide biosynthetic process [GO:0009312]; oligosaccharide metabolic process [GO:0009311] Golgi membrane [GO:0000139] alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity [GO:0001665]; sialyltransferase activity [GO:0008373] g1006.t1 Q9H8E8 61.765 340 2.8200000000000005e-132 415.0 sp|Q9H8E8|CSR2B_HUMAN Cysteine-rich protein 2-binding protein OS=Homo sapiens OX=9606 GN=KAT14 PE=1 SV=3 g1006.t1 Q9H8E8 52.683 205 2.1000000000000002e-58 216.0 sp|Q9H8E8|CSR2B_HUMAN Cysteine-rich protein 2-binding protein OS=Homo sapiens OX=9606 GN=KAT14 PE=1 SV=3 g1006.t2 Q9H8E8 61.765 340 5.21e-132 415.0 sp|Q9H8E8|CSR2B_HUMAN Cysteine-rich protein 2-binding protein OS=Homo sapiens OX=9606 GN=KAT14 PE=1 SV=3 g1006.t2 Q9H8E8 47.788 226 5.38e-54 204.0 sp|Q9H8E8|CSR2B_HUMAN Cysteine-rich protein 2-binding protein OS=Homo sapiens OX=9606 GN=KAT14 PE=1 SV=3 g1007.t1 Q80Z37 37.38 313 3.66e-53 203.0 sp|Q80Z37|TOPRS_MOUSE E3 ubiquitin-protein ligase Topors OS=Mus musculus OX=10090 GN=Topors PE=1 SV=1 TOPRS_MOUSE reviewed E3 ubiquitin-protein ligase Topors (EC 2.3.2.27) (RING-type E3 ubiquitin transferase Topors) (SUMO1-protein E3 ligase Topors) (Topoisomerase I-binding RING finger protein) (Topoisomerase I-binding arginine/serine-rich protein) (Tumor suppressor p53-binding protein 3) (p53-binding protein 3) (p53BP3) Mus musculus (Mouse) GO:0000151; GO:0000209; GO:0000922; GO:0000930; GO:0003677; GO:0003823; GO:0004842; GO:0005634; GO:0005654; GO:0005814; GO:0006511; GO:0006513; GO:0006974; GO:0008270; GO:0008630; GO:0016605; GO:0016607; GO:0016925; GO:0019789; GO:0032391; GO:0034504; GO:0036064; GO:0042127; GO:0042771; GO:0043161; GO:0044547; GO:0045893; GO:0051457; GO:0061630; GO:0070936 DNA damage response [GO:0006974]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; maintenance of protein location in nucleus [GO:0051457]; positive regulation of DNA-templated transcription [GO:0045893]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K48-linked ubiquitination [GO:0070936]; protein localization to nucleus [GO:0034504]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; protein sumoylation [GO:0016925]; regulation of cell population proliferation [GO:0042127]; ubiquitin-dependent protein catabolic process [GO:0006511] centriole [GO:0005814]; ciliary basal body [GO:0036064]; gamma-tubulin complex [GO:0000930]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; photoreceptor connecting cilium [GO:0032391]; PML body [GO:0016605]; spindle pole [GO:0000922]; ubiquitin ligase complex [GO:0000151] antigen binding [GO:0003823]; DNA binding [GO:0003677]; DNA topoisomerase binding [GO:0044547]; SUMO transferase activity [GO:0019789]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] g1012.t1 Q66KY0 42.291 227 2.13e-57 184.0 sp|Q66KY0|COA7A_XENLA Cytochrome c oxidase assembly factor 7A OS=Xenopus laevis OX=8355 GN=coa7-a PE=2 SV=1 g1014.t1 F7C1E2 67.857 112 2.03e-51 174.0 sp|F7C1E2|SARAF_XENTR Store-operated calcium entry-associated regulatory factor OS=Xenopus tropicalis OX=8364 GN=saraf PE=3 SV=2 g1016.t1 Q02763 35.849 424 1.72e-61 231.0 sp|Q02763|TIE2_HUMAN Angiopoietin-1 receptor OS=Homo sapiens OX=9606 GN=TEK PE=1 SV=2 TIE2_HUMAN reviewed Angiopoietin-1 receptor (EC 2.7.10.1) (Endothelial tyrosine kinase) (Tunica interna endothelial cell kinase) (Tyrosine kinase with Ig and EGF homology domains-2) (Tyrosine-protein kinase receptor TEK) (Tyrosine-protein kinase receptor TIE-2) (hTIE2) (p140 TEK) (CD antigen CD202b) Homo sapiens (Human) GO:0001525; GO:0001935; GO:0001938; GO:0002040; GO:0004672; GO:0004714; GO:0005524; GO:0005576; GO:0005813; GO:0005886; GO:0005902; GO:0005911; GO:0005925; GO:0007166; GO:0007169; GO:0007267; GO:0007507; GO:0009925; GO:0009986; GO:0010595; GO:0016323; GO:0016324; GO:0016525; GO:0019199; GO:0032878; GO:0034446; GO:0035022; GO:0035025; GO:0036064; GO:0038023; GO:0042802; GO:0043066; GO:0043114; GO:0043235; GO:0043410; GO:0045121; GO:0045766; GO:0048014; GO:0050728; GO:0051894; GO:0051897; GO:0060216; GO:0060347; GO:0070374; GO:0071260; GO:0072012; GO:1902533; GO:2000351; GO:2000352 angiogenesis [GO:0001525]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; cell surface receptor signaling pathway [GO:0007166]; cell-cell signaling [GO:0007267]; cellular response to mechanical stimulus [GO:0071260]; definitive hemopoiesis [GO:0060216]; endothelial cell proliferation [GO:0001935]; glomerulus vasculature development [GO:0072012]; heart development [GO:0007507]; heart trabecula formation [GO:0060347]; negative regulation of angiogenesis [GO:0016525]; negative regulation of apoptotic process [GO:0043066]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of inflammatory response [GO:0050728]; positive regulation of angiogenesis [GO:0045766]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of intracellular signal transduction [GO:1902533]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of Rac protein signal transduction [GO:0035022]; positive regulation of Rho protein signal transduction [GO:0035025]; regulation of endothelial cell apoptotic process [GO:2000351]; regulation of establishment or maintenance of cell polarity [GO:0032878]; regulation of vascular permeability [GO:0043114]; sprouting angiogenesis [GO:0002040]; substrate adhesion-dependent cell spreading [GO:0034446]; Tie signaling pathway [GO:0048014] apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; cell-cell junction [GO:0005911]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; membrane raft [GO:0045121]; microvillus [GO:0005902]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] ATP binding [GO:0005524]; identical protein binding [GO:0042802]; protein kinase activity [GO:0004672]; signaling receptor activity [GO:0038023]; transmembrane receptor protein kinase activity [GO:0019199]; transmembrane receptor protein tyrosine kinase activity [GO:0004714] g1016.t2 Q02763 36.235 425 3.3699999999999998e-62 233.0 sp|Q02763|TIE2_HUMAN Angiopoietin-1 receptor OS=Homo sapiens OX=9606 GN=TEK PE=1 SV=2 TIE2_HUMAN reviewed Angiopoietin-1 receptor (EC 2.7.10.1) (Endothelial tyrosine kinase) (Tunica interna endothelial cell kinase) (Tyrosine kinase with Ig and EGF homology domains-2) (Tyrosine-protein kinase receptor TEK) (Tyrosine-protein kinase receptor TIE-2) (hTIE2) (p140 TEK) (CD antigen CD202b) Homo sapiens (Human) GO:0001525; GO:0001935; GO:0001938; GO:0002040; GO:0004672; GO:0004714; GO:0005524; GO:0005576; GO:0005813; GO:0005886; GO:0005902; GO:0005911; GO:0005925; GO:0007166; GO:0007169; GO:0007267; GO:0007507; GO:0009925; GO:0009986; GO:0010595; GO:0016323; GO:0016324; GO:0016525; GO:0019199; GO:0032878; GO:0034446; GO:0035022; GO:0035025; GO:0036064; GO:0038023; GO:0042802; GO:0043066; GO:0043114; GO:0043235; GO:0043410; GO:0045121; GO:0045766; GO:0048014; GO:0050728; GO:0051894; GO:0051897; GO:0060216; GO:0060347; GO:0070374; GO:0071260; GO:0072012; GO:1902533; GO:2000351; GO:2000352 angiogenesis [GO:0001525]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; cell surface receptor signaling pathway [GO:0007166]; cell-cell signaling [GO:0007267]; cellular response to mechanical stimulus [GO:0071260]; definitive hemopoiesis [GO:0060216]; endothelial cell proliferation [GO:0001935]; glomerulus vasculature development [GO:0072012]; heart development [GO:0007507]; heart trabecula formation [GO:0060347]; negative regulation of angiogenesis [GO:0016525]; negative regulation of apoptotic process [GO:0043066]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of inflammatory response [GO:0050728]; positive regulation of angiogenesis [GO:0045766]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of intracellular signal transduction [GO:1902533]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of Rac protein signal transduction [GO:0035022]; positive regulation of Rho protein signal transduction [GO:0035025]; regulation of endothelial cell apoptotic process [GO:2000351]; regulation of establishment or maintenance of cell polarity [GO:0032878]; regulation of vascular permeability [GO:0043114]; sprouting angiogenesis [GO:0002040]; substrate adhesion-dependent cell spreading [GO:0034446]; Tie signaling pathway [GO:0048014] apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; cell-cell junction [GO:0005911]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; membrane raft [GO:0045121]; microvillus [GO:0005902]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] ATP binding [GO:0005524]; identical protein binding [GO:0042802]; protein kinase activity [GO:0004672]; signaling receptor activity [GO:0038023]; transmembrane receptor protein kinase activity [GO:0019199]; transmembrane receptor protein tyrosine kinase activity [GO:0004714] g1020.t1 Q5H8C1 39.956 1837 0.0 1261.0 sp|Q5H8C1|FREM1_HUMAN FRAS1-related extracellular matrix protein 1 OS=Homo sapiens OX=9606 GN=FREM1 PE=1 SV=3 FREM1_HUMAN reviewed FRAS1-related extracellular matrix protein 1 (Protein QBRICK) Homo sapiens (Human) GO:0005604; GO:0007154; GO:0007160; GO:0009653; GO:0016020; GO:0030246; GO:0046872; GO:0097094 anatomical structure morphogenesis [GO:0009653]; cell communication [GO:0007154]; cell-matrix adhesion [GO:0007160]; craniofacial suture morphogenesis [GO:0097094] basement membrane [GO:0005604]; membrane [GO:0016020] carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872] g1020.t1 Q5H8C1 29.078 282 1.0700000000000001e-29 134.0 sp|Q5H8C1|FREM1_HUMAN FRAS1-related extracellular matrix protein 1 OS=Homo sapiens OX=9606 GN=FREM1 PE=1 SV=3 FREM1_HUMAN reviewed FRAS1-related extracellular matrix protein 1 (Protein QBRICK) Homo sapiens (Human) GO:0005604; GO:0007154; GO:0007160; GO:0009653; GO:0016020; GO:0030246; GO:0046872; GO:0097094 anatomical structure morphogenesis [GO:0009653]; cell communication [GO:0007154]; cell-matrix adhesion [GO:0007160]; craniofacial suture morphogenesis [GO:0097094] basement membrane [GO:0005604]; membrane [GO:0016020] carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872] g1021.t1 Q6QI06 48.544 103 3.26e-28 120.0 sp|Q6QI06|RICTR_MOUSE Rapamycin-insensitive companion of mTOR OS=Mus musculus OX=10090 GN=Rictor PE=1 SV=2 RICTR_MOUSE reviewed Rapamycin-insensitive companion of mTOR (AVO3 homolog) (mAVO3) (Protein pianissimo) Mus musculus (Mouse) GO:0001932; GO:0001938; GO:0005524; GO:0005764; GO:0005765; GO:0005783; GO:0005789; GO:0005886; GO:0007010; GO:0008270; GO:0008610; GO:0009792; GO:0010468; GO:0019901; GO:0030036; GO:0030307; GO:0030335; GO:0030838; GO:0031669; GO:0031932; GO:0032008; GO:0032956; GO:0038203; GO:0043022; GO:0043066; GO:0043491; GO:0043539; GO:0050727; GO:0051896; GO:0051897; GO:0060090; GO:0140767; GO:0140896; GO:0160049; GO:1902554; GO:2000114 actin cytoskeleton organization [GO:0030036]; cellular response to nutrient levels [GO:0031669]; cGAS/STING signaling pathway [GO:0140896]; cytoskeleton organization [GO:0007010]; embryo development ending in birth or egg hatching [GO:0009792]; lipid biosynthetic process [GO:0008610]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cGAS/STING signaling pathway [GO:0160049]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of TOR signaling [GO:0032008]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of establishment of cell polarity [GO:2000114]; regulation of gene expression [GO:0010468]; regulation of inflammatory response [GO:0050727]; regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051896]; regulation of protein phosphorylation [GO:0001932]; TORC2 signaling [GO:0038203] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; serine/threonine protein kinase complex [GO:1902554]; TORC2 complex [GO:0031932] ATP binding [GO:0005524]; enzyme-substrate adaptor activity [GO:0140767]; molecular adaptor activity [GO:0060090]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activator activity [GO:0043539]; ribosome binding [GO:0043022]; zinc ion binding [GO:0008270] g1023.t1 Q6QI06 44.996 1149 0.0 900.0 sp|Q6QI06|RICTR_MOUSE Rapamycin-insensitive companion of mTOR OS=Mus musculus OX=10090 GN=Rictor PE=1 SV=2 RICTR_MOUSE reviewed Rapamycin-insensitive companion of mTOR (AVO3 homolog) (mAVO3) (Protein pianissimo) Mus musculus (Mouse) GO:0001932; GO:0001938; GO:0005524; GO:0005764; GO:0005765; GO:0005783; GO:0005789; GO:0005886; GO:0007010; GO:0008270; GO:0008610; GO:0009792; GO:0010468; GO:0019901; GO:0030036; GO:0030307; GO:0030335; GO:0030838; GO:0031669; GO:0031932; GO:0032008; GO:0032956; GO:0038203; GO:0043022; GO:0043066; GO:0043491; GO:0043539; GO:0050727; GO:0051896; GO:0051897; GO:0060090; GO:0140767; GO:0140896; GO:0160049; GO:1902554; GO:2000114 actin cytoskeleton organization [GO:0030036]; cellular response to nutrient levels [GO:0031669]; cGAS/STING signaling pathway [GO:0140896]; cytoskeleton organization [GO:0007010]; embryo development ending in birth or egg hatching [GO:0009792]; lipid biosynthetic process [GO:0008610]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cGAS/STING signaling pathway [GO:0160049]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of TOR signaling [GO:0032008]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of establishment of cell polarity [GO:2000114]; regulation of gene expression [GO:0010468]; regulation of inflammatory response [GO:0050727]; regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051896]; regulation of protein phosphorylation [GO:0001932]; TORC2 signaling [GO:0038203] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; serine/threonine protein kinase complex [GO:1902554]; TORC2 complex [GO:0031932] ATP binding [GO:0005524]; enzyme-substrate adaptor activity [GO:0140767]; molecular adaptor activity [GO:0060090]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activator activity [GO:0043539]; ribosome binding [GO:0043022]; zinc ion binding [GO:0008270] g1024.t1 P05630 50.61 164 2.92e-41 139.0 sp|P05630|ATPD_BOVIN ATP synthase F(1) complex subunit delta, mitochondrial OS=Bos taurus OX=9913 GN=ATP5F1D PE=1 SV=2 ATPD_BOVIN reviewed ATP synthase F(1) complex subunit delta, mitochondrial (ATP synthase F1 subunit delta) (F-ATPase delta subunit) Bos taurus (Bovine) GO:0005198; GO:0005739; GO:0005740; GO:0005743; GO:0009060; GO:0015078; GO:0015986; GO:0033615; GO:0042776; GO:0045259; GO:0046933; GO:1902600 aerobic respiration [GO:0009060]; mitochondrial proton-transporting ATP synthase complex assembly [GO:0033615]; proton motive force-driven ATP synthesis [GO:0015986]; proton motive force-driven mitochondrial ATP synthesis [GO:0042776]; proton transmembrane transport [GO:1902600] mitochondrial envelope [GO:0005740]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; proton-transporting ATP synthase complex [GO:0045259] proton transmembrane transporter activity [GO:0015078]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]; structural molecule activity [GO:0005198] g1026.t1 Q12834 55.159 533 0.0 538.0 sp|Q12834|CDC20_HUMAN Cell division cycle protein 20 homolog OS=Homo sapiens OX=9606 GN=CDC20 PE=1 SV=2 CDC20_HUMAN reviewed Cell division cycle protein 20 homolog (p55CDC) Homo sapiens (Human) GO:0000776; GO:0000922; GO:0005654; GO:0005680; GO:0005813; GO:0005819; GO:0005829; GO:0007064; GO:0007094; GO:0007346; GO:0007399; GO:0008284; GO:0010997; GO:0016567; GO:0030154; GO:0031145; GO:0031915; GO:0033597; GO:0040020; GO:0042826; GO:0044784; GO:0045842; GO:0048471; GO:0050773; GO:0051301; GO:0051445; GO:0090129; GO:0090307; GO:1904668; GO:1905786; GO:1990756; GO:1990757; GO:1990949 anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell differentiation [GO:0030154]; cell division [GO:0051301]; metaphase/anaphase transition of cell cycle [GO:0044784]; metaphase/anaphase transition of meiosis I [GO:1990949]; mitotic sister chromatid cohesion [GO:0007064]; mitotic spindle assembly [GO:0090307]; mitotic spindle assembly checkpoint signaling [GO:0007094]; nervous system development [GO:0007399]; positive regulation of anaphase-promoting complex-dependent catabolic process [GO:1905786]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; positive regulation of synapse maturation [GO:0090129]; positive regulation of synaptic plasticity [GO:0031915]; positive regulation of ubiquitin protein ligase activity [GO:1904668]; protein ubiquitination [GO:0016567]; regulation of dendrite development [GO:0050773]; regulation of meiotic cell cycle [GO:0051445]; regulation of meiotic nuclear division [GO:0040020]; regulation of mitotic cell cycle [GO:0007346] anaphase-promoting complex [GO:0005680]; centrosome [GO:0005813]; cytosol [GO:0005829]; kinetochore [GO:0000776]; mitotic checkpoint complex [GO:0033597]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; spindle [GO:0005819]; spindle pole [GO:0000922] anaphase-promoting complex binding [GO:0010997]; histone deacetylase binding [GO:0042826]; ubiquitin ligase activator activity [GO:1990757]; ubiquitin-like ligase-substrate adaptor activity [GO:1990756] g1027.t1 Q96SL4 34.395 157 1.64e-26 100.0 sp|Q96SL4|GPX7_HUMAN Glutathione peroxidase 7 OS=Homo sapiens OX=9606 GN=GPX7 PE=1 SV=1 GPX7_HUMAN reviewed Glutathione peroxidase 7 (GPx-7) (GSHPx-7) (EC 1.11.1.9) (CL683) Homo sapiens (Human) GO:0004096; GO:0004601; GO:0004602; GO:0005576; GO:0005783; GO:0005788; GO:0034599 cellular response to oxidative stress [GO:0034599] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576] catalase activity [GO:0004096]; glutathione peroxidase activity [GO:0004602]; peroxidase activity [GO:0004601] g1030.t1 Q8NBN7 57.6 125 5.570000000000001e-31 117.0 sp|Q8NBN7|RDH13_HUMAN Retinol dehydrogenase 13 OS=Homo sapiens OX=9606 GN=RDH13 PE=1 SV=2 g1035.t1 Q9NYY3 41.041 653 3.89e-176 523.0 sp|Q9NYY3|PLK2_HUMAN Serine/threonine-protein kinase PLK2 OS=Homo sapiens OX=9606 GN=PLK2 PE=1 SV=3 g1036.t1 Q9NZ01 57.895 304 4.8100000000000005e-124 360.0 sp|Q9NZ01|TECR_HUMAN Very-long-chain enoyl-CoA reductase OS=Homo sapiens OX=9606 GN=TECR PE=1 SV=1 TECR_HUMAN reviewed Very-long-chain enoyl-CoA reductase (EC 1.3.1.93) (Synaptic glycoprotein SC2) (Trans-2,3-enoyl-CoA reductase) (TER) Homo sapiens (Human) GO:0005634; GO:0005783; GO:0005789; GO:0006665; GO:0017099; GO:0030497; GO:0035338; GO:0042761; GO:0102758 fatty acid elongation [GO:0030497]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; sphingolipid metabolic process [GO:0006665]; very long-chain fatty acid biosynthetic process [GO:0042761] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; nucleus [GO:0005634] very-long-chain enoyl-CoA reductase activity [GO:0102758]; very-long-chain fatty acyl-CoA dehydrogenase activity [GO:0017099] g1037.t1 O89114 54.598 348 7.93e-120 352.0 sp|O89114|DNJB5_MOUSE DnaJ homolog subfamily B member 5 OS=Mus musculus OX=10090 GN=Dnajb5 PE=2 SV=1 g1038.t1 A2VDD2 36.17 141 2.61e-25 100.0 sp|A2VDD2|DYL5B_XENLA Dynein light chain Tctex-type 5-B (Fragment) OS=Xenopus laevis OX=8355 GN=Dynlt5-b PE=2 SV=1 g1040.t1 Q06806 50.909 220 1.81e-60 230.0 sp|Q06806|TIE1_MOUSE Tyrosine-protein kinase receptor Tie-1 OS=Mus musculus OX=10090 GN=Tie1 PE=1 SV=3 TIE1_MOUSE reviewed Tyrosine-protein kinase receptor Tie-1 (EC 2.7.10.1) Mus musculus (Mouse) GO:0001525; GO:0001568; GO:0001570; GO:0001701; GO:0001936; GO:0003180; GO:0004714; GO:0005524; GO:0005886; GO:0007169; GO:0016020; GO:0016525; GO:0030336; GO:0032526; GO:0043235; GO:0045026; GO:0045766; GO:0048771; GO:0060836; GO:0060854; GO:1901201 angiogenesis [GO:0001525]; aortic valve morphogenesis [GO:0003180]; blood vessel development [GO:0001568]; branching involved in lymph vessel morphogenesis [GO:0060854]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; in utero embryonic development [GO:0001701]; lymphatic endothelial cell differentiation [GO:0060836]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell migration [GO:0030336]; plasma membrane fusion [GO:0045026]; positive regulation of angiogenesis [GO:0045766]; regulation of endothelial cell proliferation [GO:0001936]; regulation of extracellular matrix assembly [GO:1901201]; response to retinoic acid [GO:0032526]; tissue remodeling [GO:0048771]; vasculogenesis [GO:0001570] membrane [GO:0016020]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] ATP binding [GO:0005524]; transmembrane receptor protein tyrosine kinase activity [GO:0004714] g1040.t1 Q06806 35.379 277 9.05e-38 158.0 sp|Q06806|TIE1_MOUSE Tyrosine-protein kinase receptor Tie-1 OS=Mus musculus OX=10090 GN=Tie1 PE=1 SV=3 TIE1_MOUSE reviewed Tyrosine-protein kinase receptor Tie-1 (EC 2.7.10.1) Mus musculus (Mouse) GO:0001525; GO:0001568; GO:0001570; GO:0001701; GO:0001936; GO:0003180; GO:0004714; GO:0005524; GO:0005886; GO:0007169; GO:0016020; GO:0016525; GO:0030336; GO:0032526; GO:0043235; GO:0045026; GO:0045766; GO:0048771; GO:0060836; GO:0060854; GO:1901201 angiogenesis [GO:0001525]; aortic valve morphogenesis [GO:0003180]; blood vessel development [GO:0001568]; branching involved in lymph vessel morphogenesis [GO:0060854]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; in utero embryonic development [GO:0001701]; lymphatic endothelial cell differentiation [GO:0060836]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell migration [GO:0030336]; plasma membrane fusion [GO:0045026]; positive regulation of angiogenesis [GO:0045766]; regulation of endothelial cell proliferation [GO:0001936]; regulation of extracellular matrix assembly [GO:1901201]; response to retinoic acid [GO:0032526]; tissue remodeling [GO:0048771]; vasculogenesis [GO:0001570] membrane [GO:0016020]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] ATP binding [GO:0005524]; transmembrane receptor protein tyrosine kinase activity [GO:0004714] g1041.t1 Q06806 47.157 299 1.06e-82 288.0 sp|Q06806|TIE1_MOUSE Tyrosine-protein kinase receptor Tie-1 OS=Mus musculus OX=10090 GN=Tie1 PE=1 SV=3 TIE1_MOUSE reviewed Tyrosine-protein kinase receptor Tie-1 (EC 2.7.10.1) Mus musculus (Mouse) GO:0001525; GO:0001568; GO:0001570; GO:0001701; GO:0001936; GO:0003180; GO:0004714; GO:0005524; GO:0005886; GO:0007169; GO:0016020; GO:0016525; GO:0030336; GO:0032526; GO:0043235; GO:0045026; GO:0045766; GO:0048771; GO:0060836; GO:0060854; GO:1901201 angiogenesis [GO:0001525]; aortic valve morphogenesis [GO:0003180]; blood vessel development [GO:0001568]; branching involved in lymph vessel morphogenesis [GO:0060854]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; in utero embryonic development [GO:0001701]; lymphatic endothelial cell differentiation [GO:0060836]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell migration [GO:0030336]; plasma membrane fusion [GO:0045026]; positive regulation of angiogenesis [GO:0045766]; regulation of endothelial cell proliferation [GO:0001936]; regulation of extracellular matrix assembly [GO:1901201]; response to retinoic acid [GO:0032526]; tissue remodeling [GO:0048771]; vasculogenesis [GO:0001570] membrane [GO:0016020]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] ATP binding [GO:0005524]; transmembrane receptor protein tyrosine kinase activity [GO:0004714] g1043.t1 Q15262 50.0 134 4.3400000000000005e-37 149.0 sp|Q15262|PTPRK_HUMAN Receptor-type tyrosine-protein phosphatase kappa OS=Homo sapiens OX=9606 GN=PTPRK PE=1 SV=2 PTPRK_HUMAN reviewed Receptor-type tyrosine-protein phosphatase kappa (Protein-tyrosine phosphatase kappa) (R-PTP-kappa) (EC 3.1.3.48) Homo sapiens (Human) GO:0004725; GO:0005001; GO:0005814; GO:0005886; GO:0005911; GO:0005912; GO:0006470; GO:0007155; GO:0007165; GO:0007179; GO:0008013; GO:0008285; GO:0009986; GO:0010839; GO:0016020; GO:0016477; GO:0019901; GO:0030054; GO:0030336; GO:0031175; GO:0031256; GO:0034394; GO:0034614; GO:0034644; GO:0045295; GO:0045786; GO:0045892; GO:0048041; GO:0120212 cell adhesion [GO:0007155]; cell migration [GO:0016477]; cellular response to reactive oxygen species [GO:0034614]; cellular response to UV [GO:0034644]; focal adhesion assembly [GO:0048041]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of keratinocyte proliferation [GO:0010839]; neuron projection development [GO:0031175]; protein dephosphorylation [GO:0006470]; protein localization to cell surface [GO:0034394]; signal transduction [GO:0007165]; transforming growth factor beta receptor signaling pathway [GO:0007179] adherens junction [GO:0005912]; cell junction [GO:0030054]; cell surface [GO:0009986]; cell-cell junction [GO:0005911]; centriole [GO:0005814]; leading edge membrane [GO:0031256]; membrane [GO:0016020]; plasma membrane [GO:0005886]; sperm head-tail coupling apparatus [GO:0120212] beta-catenin binding [GO:0008013]; gamma-catenin binding [GO:0045295]; protein kinase binding [GO:0019901]; protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001] g1043.t1 Q15262 36.458 192 8.38e-31 130.0 sp|Q15262|PTPRK_HUMAN Receptor-type tyrosine-protein phosphatase kappa OS=Homo sapiens OX=9606 GN=PTPRK PE=1 SV=2 PTPRK_HUMAN reviewed Receptor-type tyrosine-protein phosphatase kappa (Protein-tyrosine phosphatase kappa) (R-PTP-kappa) (EC 3.1.3.48) Homo sapiens (Human) GO:0004725; GO:0005001; GO:0005814; GO:0005886; GO:0005911; GO:0005912; GO:0006470; GO:0007155; GO:0007165; GO:0007179; GO:0008013; GO:0008285; GO:0009986; GO:0010839; GO:0016020; GO:0016477; GO:0019901; GO:0030054; GO:0030336; GO:0031175; GO:0031256; GO:0034394; GO:0034614; GO:0034644; GO:0045295; GO:0045786; GO:0045892; GO:0048041; GO:0120212 cell adhesion [GO:0007155]; cell migration [GO:0016477]; cellular response to reactive oxygen species [GO:0034614]; cellular response to UV [GO:0034644]; focal adhesion assembly [GO:0048041]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of keratinocyte proliferation [GO:0010839]; neuron projection development [GO:0031175]; protein dephosphorylation [GO:0006470]; protein localization to cell surface [GO:0034394]; signal transduction [GO:0007165]; transforming growth factor beta receptor signaling pathway [GO:0007179] adherens junction [GO:0005912]; cell junction [GO:0030054]; cell surface [GO:0009986]; cell-cell junction [GO:0005911]; centriole [GO:0005814]; leading edge membrane [GO:0031256]; membrane [GO:0016020]; plasma membrane [GO:0005886]; sperm head-tail coupling apparatus [GO:0120212] beta-catenin binding [GO:0008013]; gamma-catenin binding [GO:0045295]; protein kinase binding [GO:0019901]; protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001] g1044.t1 Q06806 48.214 280 9.38e-76 278.0 sp|Q06806|TIE1_MOUSE Tyrosine-protein kinase receptor Tie-1 OS=Mus musculus OX=10090 GN=Tie1 PE=1 SV=3 TIE1_MOUSE reviewed Tyrosine-protein kinase receptor Tie-1 (EC 2.7.10.1) Mus musculus (Mouse) GO:0001525; GO:0001568; GO:0001570; GO:0001701; GO:0001936; GO:0003180; GO:0004714; GO:0005524; GO:0005886; GO:0007169; GO:0016020; GO:0016525; GO:0030336; GO:0032526; GO:0043235; GO:0045026; GO:0045766; GO:0048771; GO:0060836; GO:0060854; GO:1901201 angiogenesis [GO:0001525]; aortic valve morphogenesis [GO:0003180]; blood vessel development [GO:0001568]; branching involved in lymph vessel morphogenesis [GO:0060854]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; in utero embryonic development [GO:0001701]; lymphatic endothelial cell differentiation [GO:0060836]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell migration [GO:0030336]; plasma membrane fusion [GO:0045026]; positive regulation of angiogenesis [GO:0045766]; regulation of endothelial cell proliferation [GO:0001936]; regulation of extracellular matrix assembly [GO:1901201]; response to retinoic acid [GO:0032526]; tissue remodeling [GO:0048771]; vasculogenesis [GO:0001570] membrane [GO:0016020]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] ATP binding [GO:0005524]; transmembrane receptor protein tyrosine kinase activity [GO:0004714] g1047.t1 Q06806 48.161 299 7.879999999999999e-81 290.0 sp|Q06806|TIE1_MOUSE Tyrosine-protein kinase receptor Tie-1 OS=Mus musculus OX=10090 GN=Tie1 PE=1 SV=3 TIE1_MOUSE reviewed Tyrosine-protein kinase receptor Tie-1 (EC 2.7.10.1) Mus musculus (Mouse) GO:0001525; GO:0001568; GO:0001570; GO:0001701; GO:0001936; GO:0003180; GO:0004714; GO:0005524; GO:0005886; GO:0007169; GO:0016020; GO:0016525; GO:0030336; GO:0032526; GO:0043235; GO:0045026; GO:0045766; GO:0048771; GO:0060836; GO:0060854; GO:1901201 angiogenesis [GO:0001525]; aortic valve morphogenesis [GO:0003180]; blood vessel development [GO:0001568]; branching involved in lymph vessel morphogenesis [GO:0060854]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; in utero embryonic development [GO:0001701]; lymphatic endothelial cell differentiation [GO:0060836]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell migration [GO:0030336]; plasma membrane fusion [GO:0045026]; positive regulation of angiogenesis [GO:0045766]; regulation of endothelial cell proliferation [GO:0001936]; regulation of extracellular matrix assembly [GO:1901201]; response to retinoic acid [GO:0032526]; tissue remodeling [GO:0048771]; vasculogenesis [GO:0001570] membrane [GO:0016020]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] ATP binding [GO:0005524]; transmembrane receptor protein tyrosine kinase activity [GO:0004714] g1048.t1 Q15262 37.694 581 2.94e-118 392.0 sp|Q15262|PTPRK_HUMAN Receptor-type tyrosine-protein phosphatase kappa OS=Homo sapiens OX=9606 GN=PTPRK PE=1 SV=2 PTPRK_HUMAN reviewed Receptor-type tyrosine-protein phosphatase kappa (Protein-tyrosine phosphatase kappa) (R-PTP-kappa) (EC 3.1.3.48) Homo sapiens (Human) GO:0004725; GO:0005001; GO:0005814; GO:0005886; GO:0005911; GO:0005912; GO:0006470; GO:0007155; GO:0007165; GO:0007179; GO:0008013; GO:0008285; GO:0009986; GO:0010839; GO:0016020; GO:0016477; GO:0019901; GO:0030054; GO:0030336; GO:0031175; GO:0031256; GO:0034394; GO:0034614; GO:0034644; GO:0045295; GO:0045786; GO:0045892; GO:0048041; GO:0120212 cell adhesion [GO:0007155]; cell migration [GO:0016477]; cellular response to reactive oxygen species [GO:0034614]; cellular response to UV [GO:0034644]; focal adhesion assembly [GO:0048041]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of keratinocyte proliferation [GO:0010839]; neuron projection development [GO:0031175]; protein dephosphorylation [GO:0006470]; protein localization to cell surface [GO:0034394]; signal transduction [GO:0007165]; transforming growth factor beta receptor signaling pathway [GO:0007179] adherens junction [GO:0005912]; cell junction [GO:0030054]; cell surface [GO:0009986]; cell-cell junction [GO:0005911]; centriole [GO:0005814]; leading edge membrane [GO:0031256]; membrane [GO:0016020]; plasma membrane [GO:0005886]; sperm head-tail coupling apparatus [GO:0120212] beta-catenin binding [GO:0008013]; gamma-catenin binding [GO:0045295]; protein kinase binding [GO:0019901]; protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001] g1049.t1 Q15262 40.792 581 1e-130 445.0 sp|Q15262|PTPRK_HUMAN Receptor-type tyrosine-protein phosphatase kappa OS=Homo sapiens OX=9606 GN=PTPRK PE=1 SV=2 PTPRK_HUMAN reviewed Receptor-type tyrosine-protein phosphatase kappa (Protein-tyrosine phosphatase kappa) (R-PTP-kappa) (EC 3.1.3.48) Homo sapiens (Human) GO:0004725; GO:0005001; GO:0005814; GO:0005886; GO:0005911; GO:0005912; GO:0006470; GO:0007155; GO:0007165; GO:0007179; GO:0008013; GO:0008285; GO:0009986; GO:0010839; GO:0016020; GO:0016477; GO:0019901; GO:0030054; GO:0030336; GO:0031175; GO:0031256; GO:0034394; GO:0034614; GO:0034644; GO:0045295; GO:0045786; GO:0045892; GO:0048041; GO:0120212 cell adhesion [GO:0007155]; cell migration [GO:0016477]; cellular response to reactive oxygen species [GO:0034614]; cellular response to UV [GO:0034644]; focal adhesion assembly [GO:0048041]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of keratinocyte proliferation [GO:0010839]; neuron projection development [GO:0031175]; protein dephosphorylation [GO:0006470]; protein localization to cell surface [GO:0034394]; signal transduction [GO:0007165]; transforming growth factor beta receptor signaling pathway [GO:0007179] adherens junction [GO:0005912]; cell junction [GO:0030054]; cell surface [GO:0009986]; cell-cell junction [GO:0005911]; centriole [GO:0005814]; leading edge membrane [GO:0031256]; membrane [GO:0016020]; plasma membrane [GO:0005886]; sperm head-tail coupling apparatus [GO:0120212] beta-catenin binding [GO:0008013]; gamma-catenin binding [GO:0045295]; protein kinase binding [GO:0019901]; protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001] g1050.t1 Q9Z248 44.444 243 4.9e-61 204.0 sp|Q9Z248|AEBP2_MOUSE Zinc finger protein AEBP2 OS=Mus musculus OX=10090 GN=Aebp2 PE=1 SV=2 AEBP2_MOUSE reviewed Zinc finger protein AEBP2 (Adipocyte enhancer-binding protein 2) (AE-binding protein 2) Mus musculus (Mouse) GO:0000122; GO:0003677; GO:0003712; GO:0005634; GO:0005654; GO:0006325; GO:0006355; GO:0006357; GO:0008270; GO:0035098 chromatin organization [GO:0006325]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of DNA-templated transcription [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357] ESC/E(Z) complex [GO:0035098]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] DNA binding [GO:0003677]; transcription coregulator activity [GO:0003712]; zinc ion binding [GO:0008270] g1051.t1 Q3SZN3 41.228 342 2.69e-84 268.0 sp|Q3SZN3|OMA1_BOVIN Metalloendopeptidase OMA1, mitochondrial OS=Bos taurus OX=9913 GN=OMA1 PE=2 SV=2 OMA1_BOVIN reviewed Metalloendopeptidase OMA1, mitochondrial (EC 3.4.24.-) (Overlapping with the m-AAA protease 1 homolog) Bos taurus (Bovine) GO:0000423; GO:0002024; GO:0004222; GO:0005743; GO:0005758; GO:0006006; GO:0006413; GO:0006515; GO:0006629; GO:0008289; GO:0010637; GO:0016540; GO:0031638; GO:0031966; GO:0033108; GO:0034982; GO:0043065; GO:0046872; GO:0070585; GO:0097009; GO:0140467; GO:0140468; GO:1901526; GO:1903850 diet induced thermogenesis [GO:0002024]; energy homeostasis [GO:0097009]; glucose metabolic process [GO:0006006]; HRI-mediated signaling [GO:0140468]; integrated stress response signaling [GO:0140467]; lipid metabolic process [GO:0006629]; mitochondrial protein processing [GO:0034982]; mitochondrial respiratory chain complex assembly [GO:0033108]; mitophagy [GO:0000423]; negative regulation of mitochondrial fusion [GO:0010637]; positive regulation of apoptotic process [GO:0043065]; positive regulation of mitophagy [GO:1901526]; protein autoprocessing [GO:0016540]; protein localization to mitochondrion [GO:0070585]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; regulation of cristae formation [GO:1903850]; translational initiation [GO:0006413]; zymogen activation [GO:0031638] mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrial membrane [GO:0031966] lipid binding [GO:0008289]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222] g1052.t1 O35134 45.676 902 0.0 749.0 sp|O35134|RPA1_MOUSE DNA-directed RNA polymerase I subunit RPA1 OS=Mus musculus OX=10090 GN=Polr1a PE=1 SV=2 RPA1_MOUSE reviewed DNA-directed RNA polymerase I subunit RPA1 (RNA polymerase I subunit A1) (EC 2.7.7.6) (DNA-directed RNA polymerase I largest subunit) (DNA-directed RNA polymerase I subunit A) (RNA polymerase I 194 kDa subunit) (RPA194) Mus musculus (Mouse) GO:0000287; GO:0000785; GO:0003677; GO:0003682; GO:0003899; GO:0005634; GO:0005654; GO:0005694; GO:0005736; GO:0006360; GO:0008270; GO:0009303; GO:0042790; GO:0071667; GO:1904750 negative regulation of protein localization to nucleolus [GO:1904750]; nucleolar large rRNA transcription by RNA polymerase I [GO:0042790]; rRNA transcription [GO:0009303]; transcription by RNA polymerase I [GO:0006360] chromatin [GO:0000785]; chromosome [GO:0005694]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase I complex [GO:0005736] chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-directed RNA polymerase activity [GO:0003899]; DNA/RNA hybrid binding [GO:0071667]; magnesium ion binding [GO:0000287]; zinc ion binding [GO:0008270] g1052.t2 O95602 47.978 1434 0.0 1232.0 sp|O95602|RPA1_HUMAN DNA-directed RNA polymerase I subunit RPA1 OS=Homo sapiens OX=9606 GN=POLR1A PE=1 SV=2 RPA1_HUMAN reviewed DNA-directed RNA polymerase I subunit RPA1 (RNA polymerase I subunit A1) (EC 2.7.7.6) (A190) (DNA-directed RNA polymerase I largest subunit) (DNA-directed RNA polymerase I subunit A) (RNA polymerase I 194 kDa subunit) (RPA194) Homo sapiens (Human) GO:0000287; GO:0000785; GO:0003677; GO:0003682; GO:0003899; GO:0005654; GO:0005694; GO:0005736; GO:0006360; GO:0008270; GO:0042790; GO:0071667; GO:1904750 negative regulation of protein localization to nucleolus [GO:1904750]; nucleolar large rRNA transcription by RNA polymerase I [GO:0042790]; transcription by RNA polymerase I [GO:0006360] chromatin [GO:0000785]; chromosome [GO:0005694]; nucleoplasm [GO:0005654]; RNA polymerase I complex [GO:0005736] chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-directed RNA polymerase activity [GO:0003899]; DNA/RNA hybrid binding [GO:0071667]; magnesium ion binding [GO:0000287]; zinc ion binding [GO:0008270] g1052.t2 O95602 47.308 260 2.71e-57 223.0 sp|O95602|RPA1_HUMAN DNA-directed RNA polymerase I subunit RPA1 OS=Homo sapiens OX=9606 GN=POLR1A PE=1 SV=2 RPA1_HUMAN reviewed DNA-directed RNA polymerase I subunit RPA1 (RNA polymerase I subunit A1) (EC 2.7.7.6) (A190) (DNA-directed RNA polymerase I largest subunit) (DNA-directed RNA polymerase I subunit A) (RNA polymerase I 194 kDa subunit) (RPA194) Homo sapiens (Human) GO:0000287; GO:0000785; GO:0003677; GO:0003682; GO:0003899; GO:0005654; GO:0005694; GO:0005736; GO:0006360; GO:0008270; GO:0042790; GO:0071667; GO:1904750 negative regulation of protein localization to nucleolus [GO:1904750]; nucleolar large rRNA transcription by RNA polymerase I [GO:0042790]; transcription by RNA polymerase I [GO:0006360] chromatin [GO:0000785]; chromosome [GO:0005694]; nucleoplasm [GO:0005654]; RNA polymerase I complex [GO:0005736] chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-directed RNA polymerase activity [GO:0003899]; DNA/RNA hybrid binding [GO:0071667]; magnesium ion binding [GO:0000287]; zinc ion binding [GO:0008270] g1053.t1 Q09LZ8 70.67 433 0.0 684.0 sp|Q09LZ8|CBPC6_MOUSE Cytosolic carboxypeptidase 6 OS=Mus musculus OX=10090 GN=Agbl4 PE=1 SV=1 CBPC6_MOUSE reviewed Cytosolic carboxypeptidase 6 (EC 3.4.17.-) (EC 3.4.17.24) (ATP/GTP-binding protein-like 4) (Protein deglutamylase CCP6) Mus musculus (Mouse) GO:0004181; GO:0005737; GO:0005794; GO:0005814; GO:0005829; GO:0006508; GO:0008270; GO:0008285; GO:0015630; GO:0015631; GO:0021954; GO:0035608; GO:0035609; GO:0035610; GO:0036064; GO:0051607; GO:0098930; GO:0098957; GO:0098958; GO:0120222; GO:1904115; GO:2000060 anterograde axonal transport of mitochondrion [GO:0098957]; axonal transport [GO:0098930]; C-terminal protein deglutamylation [GO:0035609]; central nervous system neuron development [GO:0021954]; defense response to virus [GO:0051607]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; protein deglutamylation [GO:0035608]; protein side chain deglutamylation [GO:0035610]; proteolysis [GO:0006508]; regulation of blastocyst development [GO:0120222]; retrograde axonal transport of mitochondrion [GO:0098958] axon cytoplasm [GO:1904115]; centriole [GO:0005814]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; microtubule cytoskeleton [GO:0015630] metallocarboxypeptidase activity [GO:0004181]; tubulin binding [GO:0015631]; zinc ion binding [GO:0008270] g1054.t1 A0A0R4IEW8 58.551 345 5.4e-137 400.0 sp|A0A0R4IEW8|ELAV4_DANRE ELAV-like protein 4 OS=Danio rerio OX=7955 GN=elavl4 PE=1 SV=2 ELAV4_DANRE reviewed ELAV-like protein 4 (Protein elrD) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0003723; GO:0005737; GO:0006397; GO:0007409; GO:0008380; GO:0030424; GO:0030425; GO:0030426; GO:0032991; GO:0043204; GO:1990904 axonogenesis [GO:0007409]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380] axon [GO:0030424]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; growth cone [GO:0030426]; perikaryon [GO:0043204]; protein-containing complex [GO:0032991]; ribonucleoprotein complex [GO:1990904] RNA binding [GO:0003723] g1062.t1 Q15392 65.953 514 0.0 708.0 sp|Q15392|DHC24_HUMAN Delta(24)-sterol reductase OS=Homo sapiens OX=9606 GN=DHCR24 PE=1 SV=2 g1063.t1 Q96T60 43.711 318 1.26e-87 277.0 sp|Q96T60|PNKP_HUMAN Bifunctional polynucleotide phosphatase/kinase OS=Homo sapiens OX=9606 GN=PNKP PE=1 SV=1 g1064.t1 Q4R3P6 46.723 595 3.69e-172 503.0 sp|Q4R3P6|LRC40_MACFA Leucine-rich repeat-containing protein 40 OS=Macaca fascicularis OX=9541 GN=LRRC40 PE=2 SV=1 g1065.t1 Q16740 71.364 220 1.24e-117 340.0 sp|Q16740|CLPP_HUMAN ATP-dependent Clp protease proteolytic subunit, mitochondrial OS=Homo sapiens OX=9606 GN=CLPP PE=1 SV=1 CLPP_HUMAN reviewed ATP-dependent Clp protease proteolytic subunit, mitochondrial (EC 3.4.21.92) (Caseinolytic mitochondrial matrix peptidase proteolytic subunit) (Endopeptidase Clp) Homo sapiens (Human) GO:0004175; GO:0004176; GO:0004252; GO:0005739; GO:0005759; GO:0006508; GO:0006515; GO:0008233; GO:0009368; GO:0033619; GO:0035694; GO:0042802; GO:0051117; GO:0051603 membrane protein proteolysis [GO:0033619]; mitochondrial protein catabolic process [GO:0035694]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; proteolysis [GO:0006508]; proteolysis involved in protein catabolic process [GO:0051603] endopeptidase Clp complex [GO:0009368]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] ATP-dependent peptidase activity [GO:0004176]; ATPase binding [GO:0051117]; endopeptidase activity [GO:0004175]; identical protein binding [GO:0042802]; peptidase activity [GO:0008233]; serine-type endopeptidase activity [GO:0004252] g1066.t1 Q32LM2 40.876 274 2.73e-56 189.0 sp|Q32LM2|SGTA_BOVIN Small glutamine-rich tetratricopeptide repeat-containing protein alpha OS=Bos taurus OX=9913 GN=SGTA PE=2 SV=1 SGTA_BOVIN reviewed Small glutamine-rich tetratricopeptide repeat-containing protein alpha (Alpha-SGT) Bos taurus (Bovine) GO:0005634; GO:0006620; GO:0016020; GO:0036503; GO:0042802; GO:0060090; GO:0071816; GO:0072380; GO:1904293; GO:2000059 ERAD pathway [GO:0036503]; negative regulation of ERAD pathway [GO:1904293]; negative regulation of ubiquitin-dependent protein catabolic process [GO:2000059]; post-translational protein targeting to endoplasmic reticulum membrane [GO:0006620]; tail-anchored membrane protein insertion into ER membrane [GO:0071816] membrane [GO:0016020]; nucleus [GO:0005634]; TRC complex [GO:0072380] identical protein binding [GO:0042802]; molecular adaptor activity [GO:0060090] g1067.t1 Q5RCG0 58.894 416 5.97e-159 456.0 sp|Q5RCG0|TPC13_PONAB Trafficking protein particle complex subunit 13 OS=Pongo abelii OX=9601 GN=TRAPPC13 PE=2 SV=1 g1067.t2 Q6PBY7 60.0 400 1.8500000000000002e-160 460.0 sp|Q6PBY7|TPC13_DANRE Trafficking protein particle complex subunit 13 OS=Danio rerio OX=7955 GN=trappc13 PE=2 SV=2 g1068.t1 Q8K3H7 75.224 335 8.6e-171 488.0 sp|Q8K3H7|CALR_CRIGR Calreticulin OS=Cricetulus griseus OX=10029 GN=CALR PE=1 SV=1 CALR_CRIGR reviewed Calreticulin (CRP55) (Calregulin) (Endoplasmic reticulum resident protein 60) (ERp60) (HACBP) Cricetulus griseus (Chinese hamster) (Cricetulus barabensis griseus) GO:0005509; GO:0005789; GO:0005829; GO:0006457; GO:0009986; GO:0030246; GO:0030496; GO:0033018; GO:0036503; GO:0044194; GO:0050821; GO:0051082; GO:0060473 ERAD pathway [GO:0036503]; protein folding [GO:0006457]; protein stabilization [GO:0050821] cell surface [GO:0009986]; cortical granule [GO:0060473]; cytolytic granule [GO:0044194]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; midbody [GO:0030496]; sarcoplasmic reticulum lumen [GO:0033018] calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; unfolded protein binding [GO:0051082] g1069.t1 Q5ZKE7 60.0 195 2.9399999999999997e-82 246.0 sp|Q5ZKE7|KCY_CHICK UMP-CMP kinase OS=Gallus gallus OX=9031 GN=CMPK PE=2 SV=1 KCY_CHICK reviewed UMP-CMP kinase (EC 2.7.4.14) (Deoxycytidylate kinase) (CK) (dCMP kinase) (Nucleoside-diphosphate kinase) (EC 2.7.4.6) (Uridine monophosphate/cytidine monophosphate kinase) (UMP/CMP kinase) (UMP/CMPK) Gallus gallus (Chicken) GO:0004550; GO:0005524; GO:0005634; GO:0005737; GO:0006207; GO:0006225; GO:0033862; GO:0036430; GO:0036431; GO:0046705 'de novo' pyrimidine nucleobase biosynthetic process [GO:0006207]; CDP biosynthetic process [GO:0046705]; UDP biosynthetic process [GO:0006225] cytoplasm [GO:0005737]; nucleus [GO:0005634] ATP binding [GO:0005524]; CMP kinase activity [GO:0036430]; dCMP kinase activity [GO:0036431]; nucleoside diphosphate kinase activity [GO:0004550]; UMP kinase activity [GO:0033862] g1070.t1 Q3SZZ0 62.264 265 3.58e-126 368.0 sp|Q3SZZ0|BRX1_BOVIN Ribosome biogenesis protein BRX1 homolog OS=Bos taurus OX=9913 GN=BRIX1 PE=2 SV=1 g1071.t1 Q8VE62 30.65 323 6.030000000000001e-32 129.0 sp|Q8VE62|PAIP1_MOUSE Polyadenylate-binding protein-interacting protein 1 OS=Mus musculus OX=10090 GN=Paip1 PE=1 SV=1 g1072.t1 Q6DJK9 57.98 307 1.1000000000000001e-125 373.0 sp|Q6DJK9|YJU2B_XENLA Probable splicing factor YJU2B OS=Xenopus laevis OX=8355 GN=yju2b PE=2 SV=1 g1073.t1 P98078 57.364 129 1.94e-37 154.0 sp|P98078|DAB2_MOUSE Disabled homolog 2 OS=Mus musculus OX=10090 GN=Dab2 PE=1 SV=2 g1074.t1 Q6NWH0 33.175 211 9.719999999999999e-24 99.4 sp|Q6NWH0|CK068_DANRE UPF0696 protein C11orf68 homolog OS=Danio rerio OX=7955 GN=P5436 PE=2 SV=1 g1075.t1 Q7TMR7 32.353 170 3.45e-21 94.4 sp|Q7TMR7|MOT7_RAT Monocarboxylate transporter 7 OS=Rattus norvegicus OX=10116 GN=Slc16a6 PE=1 SV=1 g1077.t1 Q98ST6 34.685 222 5.21e-34 128.0 sp|Q98ST6|PI15_CHICK Peptidase inhibitor 15 OS=Gallus gallus OX=9031 GN=PI15 PE=2 SV=1 g1078.t1 Q6UWM5 38.421 190 1.02e-32 128.0 sp|Q6UWM5|GPRL1_HUMAN GLIPR1-like protein 1 OS=Homo sapiens OX=9606 GN=GLIPR1L1 PE=1 SV=2 g1082.t1 Q9Y3C5 64.706 153 5.1900000000000003e-64 195.0 sp|Q9Y3C5|RNF11_HUMAN RING finger protein 11 OS=Homo sapiens OX=9606 GN=RNF11 PE=1 SV=1 g1083.t1 Q8BKE9 52.549 510 1.3000000000000002e-163 481.0 sp|Q8BKE9|IFT74_MOUSE Intraflagellar transport protein 74 homolog OS=Mus musculus OX=10090 GN=Ift74 PE=1 SV=2 IFT74_MOUSE reviewed Intraflagellar transport protein 74 homolog (Capillary morphogenesis gene 1 protein) (CMG-1) (Coiled-coil domain-containing protein 2) Mus musculus (Mouse) GO:0001669; GO:0003334; GO:0003682; GO:0005634; GO:0005813; GO:0005929; GO:0007219; GO:0007368; GO:0007507; GO:0008544; GO:0030992; GO:0031514; GO:0033630; GO:0035720; GO:0035735; GO:0042073; GO:0045944; GO:0048487; GO:0050680; GO:0060271; GO:1905515 cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; epidermis development [GO:0008544]; heart development [GO:0007507]; intraciliary anterograde transport [GO:0035720]; intraciliary transport [GO:0042073]; intraciliary transport involved in cilium assembly [GO:0035735]; keratinocyte development [GO:0003334]; negative regulation of epithelial cell proliferation [GO:0050680]; non-motile cilium assembly [GO:1905515]; Notch signaling pathway [GO:0007219]; positive regulation of cell adhesion mediated by integrin [GO:0033630]; positive regulation of transcription by RNA polymerase II [GO:0045944] acrosomal vesicle [GO:0001669]; centrosome [GO:0005813]; cilium [GO:0005929]; intraciliary transport particle B [GO:0030992]; motile cilium [GO:0031514]; nucleus [GO:0005634] beta-tubulin binding [GO:0048487]; chromatin binding [GO:0003682] g1084.t1 Q9PTS8 40.878 296 3.0100000000000003e-65 215.0 sp|Q9PTS8|ACHA9_CHICK Neuronal acetylcholine receptor subunit alpha-9 OS=Gallus gallus OX=9031 GN=CHRNA9 PE=1 SV=1 g1089.t1 Q5PR73 68.844 199 1.57e-95 280.0 sp|Q5PR73|DIRA2_MOUSE GTP-binding protein Di-Ras2 OS=Mus musculus OX=10090 GN=Diras2 PE=1 SV=1 g1090.t1 Q8BFY9 79.157 902 0.0 1460.0 sp|Q8BFY9|TNPO1_MOUSE Transportin-1 OS=Mus musculus OX=10090 GN=Tnpo1 PE=1 SV=2 TNPO1_MOUSE reviewed Transportin-1 (Importin beta-2) (Karyopherin beta-2) Mus musculus (Mouse) GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006606; GO:0008139; GO:0031267; GO:0061608 protein import into nucleus [GO:0006606] cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] nuclear import signal receptor activity [GO:0061608]; nuclear localization sequence binding [GO:0008139]; small GTPase binding [GO:0031267] g1091.t1 Q2T9T9 38.814 371 3.0699999999999998e-90 285.0 sp|Q2T9T9|FBXW9_BOVIN F-box/WD repeat-containing protein 9 OS=Bos taurus OX=9913 GN=FBXW9 PE=2 SV=1 g1092.t1 Q5R9T5 56.197 468 3.43e-163 473.0 sp|Q5R9T5|SPTC1_PONAB Serine palmitoyltransferase 1 OS=Pongo abelii OX=9601 GN=SPTLC1 PE=2 SV=1 SPTC1_PONAB reviewed Serine palmitoyltransferase 1 (EC 2.3.1.50) (Long chain base biosynthesis protein 1) (LCB 1) (Serine-palmitoyl-CoA transferase 1) (SPT 1) (SPT1) Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0004758; GO:0005789; GO:0006665; GO:0017059; GO:0030170; GO:0046512; GO:0046513; GO:1904504; GO:1904649 ceramide biosynthetic process [GO:0046513]; positive regulation of lipophagy [GO:1904504]; regulation of fat cell apoptotic process [GO:1904649]; sphingolipid metabolic process [GO:0006665]; sphingosine biosynthetic process [GO:0046512] endoplasmic reticulum membrane [GO:0005789]; serine palmitoyltransferase complex [GO:0017059] pyridoxal phosphate binding [GO:0030170]; serine C-palmitoyltransferase activity [GO:0004758] g1094.t1 Q9VXX8 81.818 88 3.63e-40 131.0 sp|Q9VXX8|RL371_DROME Large ribosomal subunit protein eL37A OS=Drosophila melanogaster OX=7227 GN=RpL37-1 PE=1 SV=1 g1095.t1 Q9H6L4 57.576 132 8e-44 149.0 sp|Q9H6L4|ARMC7_HUMAN Armadillo repeat-containing protein 7 OS=Homo sapiens OX=9606 GN=ARMC7 PE=1 SV=1 ARMC7_HUMAN reviewed Armadillo repeat-containing protein 7 Homo sapiens (Human) GO:0005681; GO:0006397; GO:0008380 mRNA processing [GO:0006397]; RNA splicing [GO:0008380] spliceosomal complex [GO:0005681] g1096.t1 Q8BRK8 81.955 266 1.16e-163 469.0 sp|Q8BRK8|AAPK2_MOUSE 5'-AMP-activated protein kinase catalytic subunit alpha-2 OS=Mus musculus OX=10090 GN=Prkaa2 PE=1 SV=3 AAPK2_MOUSE reviewed 5'-AMP-activated protein kinase catalytic subunit alpha-2 (AMPK subunit alpha-2) (EC 2.7.11.1) (Acetyl-CoA carboxylase kinase) (ACACA kinase) (Hydroxymethylglutaryl-CoA reductase kinase) (HMGCR kinase) (EC 2.7.11.31) Mus musculus (Mouse) GO:0002181; GO:0003682; GO:0004672; GO:0004674; GO:0004679; GO:0004712; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005794; GO:0005829; GO:0006468; GO:0006633; GO:0006646; GO:0006656; GO:0006695; GO:0006914; GO:0008610; GO:0009267; GO:0010468; GO:0010494; GO:0010508; GO:0010629; GO:0014823; GO:0014850; GO:0016055; GO:0016241; GO:0016324; GO:0016607; GO:0019216; GO:0030424; GO:0030425; GO:0030674; GO:0031000; GO:0031588; GO:0031669; GO:0032007; GO:0032991; GO:0034198; GO:0034599; GO:0036064; GO:0038202; GO:0042149; GO:0042593; GO:0042752; GO:0043025; GO:0043066; GO:0044877; GO:0045821; GO:0045947; GO:0045948; GO:0046872; GO:0047322; GO:0048511; GO:0055089; GO:0061462; GO:0062028; GO:0070507; GO:0071277; GO:0071333; GO:0071380; GO:0071466; GO:0085020; GO:0090200; GO:0097009; GO:0097284; GO:0106310; GO:0140823; GO:1903829; GO:1903944; GO:1904262; GO:1904263; GO:1904428; GO:1905691; GO:1990044 autophagy [GO:0006914]; cellular response to amino acid starvation [GO:0034198]; cellular response to calcium ion [GO:0071277]; cellular response to glucose starvation [GO:0042149]; cellular response to glucose stimulus [GO:0071333]; cellular response to nutrient levels [GO:0031669]; cellular response to oxidative stress [GO:0034599]; cellular response to prostaglandin E stimulus [GO:0071380]; cellular response to starvation [GO:0009267]; cellular response to xenobiotic stimulus [GO:0071466]; cholesterol biosynthetic process [GO:0006695]; cytoplasmic translation [GO:0002181]; energy homeostasis [GO:0097009]; fatty acid biosynthetic process [GO:0006633]; fatty acid homeostasis [GO:0055089]; glucose homeostasis [GO:0042593]; hepatocyte apoptotic process [GO:0097284]; lipid biosynthetic process [GO:0008610]; lipid droplet disassembly [GO:1905691]; negative regulation of apoptotic process [GO:0043066]; negative regulation of gene expression [GO:0010629]; negative regulation of hepatocyte apoptotic process [GO:1903944]; negative regulation of TOR signaling [GO:0032007]; negative regulation of TORC1 signaling [GO:1904262]; negative regulation of translational initiation [GO:0045947]; negative regulation of tubulin deacetylation [GO:1904428]; phosphatidylcholine biosynthetic process [GO:0006656]; phosphatidylethanolamine biosynthetic process [GO:0006646]; positive regulation of autophagy [GO:0010508]; positive regulation of glycolytic process [GO:0045821]; positive regulation of protein localization [GO:1903829]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; positive regulation of TORC1 signaling [GO:1904263]; positive regulation of translational initiation [GO:0045948]; protein K6-linked ubiquitination [GO:0085020]; protein localization to lipid droplet [GO:1990044]; protein localization to lysosome [GO:0061462]; protein phosphorylation [GO:0006468]; regulation of circadian rhythm [GO:0042752]; regulation of gene expression [GO:0010468]; regulation of lipid metabolic process [GO:0019216]; regulation of macroautophagy [GO:0016241]; regulation of microtubule cytoskeleton organization [GO:0070507]; regulation of stress granule assembly [GO:0062028]; response to activity [GO:0014823]; response to caffeine [GO:0031000]; response to muscle activity [GO:0014850]; rhythmic process [GO:0048511]; TORC1 signaling [GO:0038202]; Wnt signaling pathway [GO:0016055] apical plasma membrane [GO:0016324]; axon [GO:0030424]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; dendrite [GO:0030425]; Golgi apparatus [GO:0005794]; neuronal cell body [GO:0043025]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleotide-activated protein kinase complex [GO:0031588]; nucleus [GO:0005634]; protein-containing complex [GO:0032991] [hydroxymethylglutaryl-CoA reductase (NADPH)] kinase activity [GO:0047322]; AMP-activated protein kinase activity [GO:0004679]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; histone H2BS36 kinase activity [GO:0140823]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein-containing complex binding [GO:0044877]; protein-macromolecule adaptor activity [GO:0030674] g1097.t1 Q5RD00 41.2 250 2.8399999999999998e-42 153.0 sp|Q5RD00|AAPK2_PONAB 5'-AMP-activated protein kinase catalytic subunit alpha-2 OS=Pongo abelii OX=9601 GN=PRKAA2 PE=2 SV=1 AAPK2_PONAB reviewed 5'-AMP-activated protein kinase catalytic subunit alpha-2 (AMPK subunit alpha-2) (EC 2.7.11.1) (Acetyl-CoA carboxylase kinase) (ACACA kinase) (Hydroxymethylglutaryl-CoA reductase kinase) (HMGCR kinase) (EC 2.7.11.31) Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0003682; GO:0004674; GO:0004679; GO:0005524; GO:0005737; GO:0006468; GO:0006633; GO:0006695; GO:0006914; GO:0008610; GO:0010508; GO:0016055; GO:0016241; GO:0016607; GO:0031588; GO:0031669; GO:0032007; GO:0035556; GO:0036064; GO:0042149; GO:0042593; GO:0042752; GO:0043066; GO:0045821; GO:0046872; GO:0047322; GO:0048511; GO:0055089; GO:0097009; GO:0106310; GO:0140823; GO:1903944; GO:1904262; GO:1905691; GO:1990044 autophagy [GO:0006914]; cellular response to glucose starvation [GO:0042149]; cellular response to nutrient levels [GO:0031669]; cholesterol biosynthetic process [GO:0006695]; energy homeostasis [GO:0097009]; fatty acid biosynthetic process [GO:0006633]; fatty acid homeostasis [GO:0055089]; glucose homeostasis [GO:0042593]; intracellular signal transduction [GO:0035556]; lipid biosynthetic process [GO:0008610]; lipid droplet disassembly [GO:1905691]; negative regulation of apoptotic process [GO:0043066]; negative regulation of hepatocyte apoptotic process [GO:1903944]; negative regulation of TOR signaling [GO:0032007]; negative regulation of TORC1 signaling [GO:1904262]; positive regulation of autophagy [GO:0010508]; positive regulation of glycolytic process [GO:0045821]; protein localization to lipid droplet [GO:1990044]; protein phosphorylation [GO:0006468]; regulation of circadian rhythm [GO:0042752]; regulation of macroautophagy [GO:0016241]; rhythmic process [GO:0048511]; Wnt signaling pathway [GO:0016055] ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleotide-activated protein kinase complex [GO:0031588] [hydroxymethylglutaryl-CoA reductase (NADPH)] kinase activity [GO:0047322]; AMP-activated protein kinase activity [GO:0004679]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; histone H2BS36 kinase activity [GO:0140823]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g1097.t2 P54646 42.739 241 7.87e-44 157.0 sp|P54646|AAPK2_HUMAN 5'-AMP-activated protein kinase catalytic subunit alpha-2 OS=Homo sapiens OX=9606 GN=PRKAA2 PE=1 SV=2 AAPK2_HUMAN reviewed 5'-AMP-activated protein kinase catalytic subunit alpha-2 (AMPK subunit alpha-2) (EC 2.7.11.1) (Acetyl-CoA carboxylase kinase) (ACACA kinase) (Hydroxymethylglutaryl-CoA reductase kinase) (HMGCR kinase) (EC 2.7.11.31) Homo sapiens (Human) GO:0003682; GO:0004672; GO:0004674; GO:0004679; GO:0004712; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005794; GO:0005829; GO:0006633; GO:0006695; GO:0006914; GO:0007165; GO:0008610; GO:0010494; GO:0010508; GO:0010629; GO:0014850; GO:0016055; GO:0016239; GO:0016241; GO:0016607; GO:0030424; GO:0030425; GO:0031588; GO:0031669; GO:0032007; GO:0034599; GO:0036064; GO:0042149; GO:0042593; GO:0042752; GO:0043025; GO:0043066; GO:0045821; GO:0046872; GO:0047322; GO:0048511; GO:0055089; GO:0062028; GO:0070507; GO:0071277; GO:0071333; GO:0071380; GO:0071466; GO:0097009; GO:0106310; GO:0140823; GO:1903829; GO:1903944; GO:1904262; GO:1904428; GO:1905691; GO:1990044 autophagy [GO:0006914]; cellular response to calcium ion [GO:0071277]; cellular response to glucose starvation [GO:0042149]; cellular response to glucose stimulus [GO:0071333]; cellular response to nutrient levels [GO:0031669]; cellular response to oxidative stress [GO:0034599]; cellular response to prostaglandin E stimulus [GO:0071380]; cellular response to xenobiotic stimulus [GO:0071466]; cholesterol biosynthetic process [GO:0006695]; energy homeostasis [GO:0097009]; fatty acid biosynthetic process [GO:0006633]; fatty acid homeostasis [GO:0055089]; glucose homeostasis [GO:0042593]; lipid biosynthetic process [GO:0008610]; lipid droplet disassembly [GO:1905691]; negative regulation of apoptotic process [GO:0043066]; negative regulation of gene expression [GO:0010629]; negative regulation of hepatocyte apoptotic process [GO:1903944]; negative regulation of TOR signaling [GO:0032007]; negative regulation of TORC1 signaling [GO:1904262]; negative regulation of tubulin deacetylation [GO:1904428]; positive regulation of autophagy [GO:0010508]; positive regulation of glycolytic process [GO:0045821]; positive regulation of macroautophagy [GO:0016239]; positive regulation of protein localization [GO:1903829]; protein localization to lipid droplet [GO:1990044]; regulation of circadian rhythm [GO:0042752]; regulation of macroautophagy [GO:0016241]; regulation of microtubule cytoskeleton organization [GO:0070507]; regulation of stress granule assembly [GO:0062028]; response to muscle activity [GO:0014850]; rhythmic process [GO:0048511]; signal transduction [GO:0007165]; Wnt signaling pathway [GO:0016055] axon [GO:0030424]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; dendrite [GO:0030425]; Golgi apparatus [GO:0005794]; neuronal cell body [GO:0043025]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleotide-activated protein kinase complex [GO:0031588]; nucleus [GO:0005634] [hydroxymethylglutaryl-CoA reductase (NADPH)] kinase activity [GO:0047322]; AMP-activated protein kinase activity [GO:0004679]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; histone H2BS36 kinase activity [GO:0140823]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712] g1099.t1 Q28DB0 46.138 479 1.9400000000000003e-163 477.0 sp|Q28DB0|TT39B_XENTR Tetratricopeptide repeat protein 39B OS=Xenopus tropicalis OX=8364 GN=ttc39b PE=2 SV=1 g1100.t1 B0BNE2 79.724 217 3.4699999999999996e-126 358.0 sp|B0BNE2|RPAB1_RAT DNA-directed RNA polymerases I, II, and III subunit RPABC1 OS=Rattus norvegicus OX=10116 GN=Polr2e PE=2 SV=1 RPAB1_RAT reviewed DNA-directed RNA polymerases I, II, and III subunit RPABC1 (RNA polymerases I, II, and III subunit ABC1) (DNA-directed RNA polymerase II subunit E) (RPB5 homolog) Rattus norvegicus (Rat) GO:0003677; GO:0003899; GO:0005634; GO:0005654; GO:0005665; GO:0005666; GO:0005736; GO:0006362; GO:0006366; GO:0042797; GO:1990062 transcription by RNA polymerase II [GO:0006366]; transcription elongation by RNA polymerase I [GO:0006362]; tRNA transcription by RNA polymerase III [GO:0042797] nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase I complex [GO:0005736]; RNA polymerase II, core complex [GO:0005665]; RNA polymerase III complex [GO:0005666]; RPAP3/R2TP/prefoldin-like complex [GO:1990062] DNA binding [GO:0003677]; DNA-directed RNA polymerase activity [GO:0003899] g1101.t1 Q9HCJ5 58.939 509 0.0 580.0 sp|Q9HCJ5|ZSWM6_HUMAN Zinc finger SWIM domain-containing protein 6 OS=Homo sapiens OX=9606 GN=ZSWIM6 PE=1 SV=2 g1102.t1 Q9P217 53.488 516 6.05e-162 490.0 sp|Q9P217|ZSWM5_HUMAN Zinc finger SWIM domain-containing protein 5 OS=Homo sapiens OX=9606 GN=ZSWIM5 PE=1 SV=2 g1105.t1 Q9UBC2 43.056 936 1.2999999999999999e-170 524.0 sp|Q9UBC2|EP15R_HUMAN Epidermal growth factor receptor substrate 15-like 1 OS=Homo sapiens OX=9606 GN=EPS15L1 PE=1 SV=1 EP15R_HUMAN reviewed Epidermal growth factor receptor substrate 15-like 1 (Eps15-related protein) (Eps15R) Homo sapiens (Human) GO:0005509; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0006897; GO:0016020; GO:0016197; GO:0030132; GO:0030674; GO:0045296; GO:0048488; GO:0098793 endocytosis [GO:0006897]; endosomal transport [GO:0016197]; synaptic vesicle endocytosis [GO:0048488] clathrin coat of coated pit [GO:0030132]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; presynapse [GO:0098793] cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; protein-macromolecule adaptor activity [GO:0030674] g1109.t1 Q28691 25.344 363 1.8800000000000002e-27 117.0 sp|Q28691|PE2R4_RABIT Prostaglandin E2 receptor EP4 subtype OS=Oryctolagus cuniculus OX=9986 GN=PTGER4 PE=2 SV=1 PE2R4_RABIT reviewed Prostaglandin E2 receptor EP4 subtype (PGE receptor EP4 subtype) (PGE2 receptor EP4 subtype) (Prostanoid EP4 receptor) Oryctolagus cuniculus (Rabbit) GO:0000165; GO:0001818; GO:0004957; GO:0005886; GO:0006954; GO:0006955; GO:0007188; GO:0007189; GO:0007193; GO:0007204; GO:0009612; GO:0033624; GO:0050728; GO:0050729; GO:0071380; GO:2000420 adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; cellular response to prostaglandin E stimulus [GO:0071380]; immune response [GO:0006955]; inflammatory response [GO:0006954]; MAPK cascade [GO:0000165]; negative regulation of cytokine production [GO:0001818]; negative regulation of eosinophil extravasation [GO:2000420]; negative regulation of inflammatory response [GO:0050728]; negative regulation of integrin activation [GO:0033624]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of inflammatory response [GO:0050729]; response to mechanical stimulus [GO:0009612] plasma membrane [GO:0005886] prostaglandin E receptor activity [GO:0004957] g1118.t1 Q5U243 47.303 241 1.06e-60 202.0 sp|Q5U243|CLIP3_XENLA CAP-Gly domain-containing linker protein 3 OS=Xenopus laevis OX=8355 GN=clip3 PE=2 SV=1 g1119.t1 Q5U243 42.328 189 1.09e-37 138.0 sp|Q5U243|CLIP3_XENLA CAP-Gly domain-containing linker protein 3 OS=Xenopus laevis OX=8355 GN=clip3 PE=2 SV=1 g1120.t1 Q8HXD5 37.371 388 1.79e-53 192.0 sp|Q8HXD5|RN220_MACFA E3 ubiquitin-protein ligase RNF220 OS=Macaca fascicularis OX=9541 GN=RNF220 PE=2 SV=1 g1135.t1 Q9Y672 51.782 477 6.77e-155 454.0 sp|Q9Y672|ALG6_HUMAN Dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferase OS=Homo sapiens OX=9606 GN=ALG6 PE=1 SV=2 ALG6_HUMAN reviewed Dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferase (EC 2.4.1.267) (Asparagine-linked glycosylation protein 6 homolog) (Dol-P-Glc:Man(9)GlcNAc(2)-PP-Dol alpha-1,3-glucosyltransferase) (Dolichyl-P-Glc:Man9GlcNAc2-PP-dolichyl glucosyltransferase) Homo sapiens (Human) GO:0004583; GO:0005789; GO:0006487; GO:0006488; GO:0016020; GO:0042281; GO:0046527; GO:0098553 dolichol-linked oligosaccharide biosynthetic process [GO:0006488]; protein N-linked glycosylation [GO:0006487] endoplasmic reticulum membrane [GO:0005789]; lumenal side of endoplasmic reticulum membrane [GO:0098553]; membrane [GO:0016020] dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferase activity [GO:0042281]; dolichyl-phosphate-glucose-glycolipid alpha-glucosyltransferase activity [GO:0004583]; glucosyltransferase activity [GO:0046527] g1136.t1 Q4R4T9 34.761 397 9.61e-50 182.0 sp|Q4R4T9|RANB3_MACFA Ran-binding protein 3 OS=Macaca fascicularis OX=9541 GN=RANBP3 PE=2 SV=1 g1136.t2 Q9H6Z4 34.39 410 1.57e-50 186.0 sp|Q9H6Z4|RANB3_HUMAN Ran-binding protein 3 OS=Homo sapiens OX=9606 GN=RANBP3 PE=1 SV=1 RANB3_HUMAN reviewed Ran-binding protein 3 (RanBP3) Homo sapiens (Human) GO:0005634; GO:0005654; GO:0005737; GO:0006611; GO:0031267; GO:0070412 protein export from nucleus [GO:0006611] cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] R-SMAD binding [GO:0070412]; small GTPase binding [GO:0031267] g1137.t1 Q9Y5Q9 41.016 768 0.0 609.0 sp|Q9Y5Q9|TF3C3_HUMAN General transcription factor 3C polypeptide 3 OS=Homo sapiens OX=9606 GN=GTF3C3 PE=1 SV=1 g1141.t1 Q96MU7 51.14 307 5.34e-79 271.0 sp|Q96MU7|YTDC1_HUMAN YTH domain-containing protein 1 OS=Homo sapiens OX=9606 GN=YTHDC1 PE=1 SV=3 YTDC1_HUMAN reviewed YTH domain-containing protein 1 (Splicing factor YT521) (YT521-B) Homo sapiens (Human) GO:0000381; GO:0000398; GO:0001701; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0005886; GO:0006376; GO:0006406; GO:0007283; GO:0009048; GO:0010608; GO:0016607; GO:0048024; GO:0048160; GO:0050873; GO:0110104; GO:0140313; GO:1990247 brown fat cell differentiation [GO:0050873]; dosage compensation by inactivation of X chromosome [GO:0009048]; in utero embryonic development [GO:0001701]; mRNA alternative polyadenylation [GO:0110104]; mRNA export from nucleus [GO:0006406]; mRNA splice site recognition [GO:0006376]; mRNA splicing, via spliceosome [GO:0000398]; post-transcriptional regulation of gene expression [GO:0010608]; primary follicle stage [GO:0048160]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of mRNA splicing, via spliceosome [GO:0048024]; spermatogenesis [GO:0007283] nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886] molecular sequestering activity [GO:0140313]; mRNA binding [GO:0003729]; N6-methyladenosine-containing RNA reader activity [GO:1990247]; RNA binding [GO:0003723] g1141.t2 Q96MU7 51.14 307 5.44e-79 271.0 sp|Q96MU7|YTDC1_HUMAN YTH domain-containing protein 1 OS=Homo sapiens OX=9606 GN=YTHDC1 PE=1 SV=3 YTDC1_HUMAN reviewed YTH domain-containing protein 1 (Splicing factor YT521) (YT521-B) Homo sapiens (Human) GO:0000381; GO:0000398; GO:0001701; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0005886; GO:0006376; GO:0006406; GO:0007283; GO:0009048; GO:0010608; GO:0016607; GO:0048024; GO:0048160; GO:0050873; GO:0110104; GO:0140313; GO:1990247 brown fat cell differentiation [GO:0050873]; dosage compensation by inactivation of X chromosome [GO:0009048]; in utero embryonic development [GO:0001701]; mRNA alternative polyadenylation [GO:0110104]; mRNA export from nucleus [GO:0006406]; mRNA splice site recognition [GO:0006376]; mRNA splicing, via spliceosome [GO:0000398]; post-transcriptional regulation of gene expression [GO:0010608]; primary follicle stage [GO:0048160]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of mRNA splicing, via spliceosome [GO:0048024]; spermatogenesis [GO:0007283] nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886] molecular sequestering activity [GO:0140313]; mRNA binding [GO:0003729]; N6-methyladenosine-containing RNA reader activity [GO:1990247]; RNA binding [GO:0003723] g1144.t1 P16066 45.439 581 2.51e-161 498.0 sp|P16066|ANPRA_HUMAN Atrial natriuretic peptide receptor 1 OS=Homo sapiens OX=9606 GN=NPR1 PE=1 SV=1 ANPRA_HUMAN reviewed Atrial natriuretic peptide receptor 1 (EC 4.6.1.2) (Atrial natriuretic peptide receptor type A) (ANP-A) (ANPR-A) (NPR-A) (Guanylate cyclase A) (GC-A) Homo sapiens (Human) GO:0001653; GO:0004383; GO:0004672; GO:0005524; GO:0005525; GO:0005886; GO:0006182; GO:0007166; GO:0007168; GO:0007589; GO:0008217; GO:0008528; GO:0010753; GO:0016525; GO:0016941; GO:0017046; GO:0019934; GO:0030308; GO:0035810; GO:0035815; GO:0042417; GO:0042562; GO:0043114; GO:0043235; GO:0048662; GO:0097746; GO:1990620 blood vessel diameter maintenance [GO:0097746]; body fluid secretion [GO:0007589]; cell surface receptor signaling pathway [GO:0007166]; cGMP biosynthetic process [GO:0006182]; cGMP-mediated signaling [GO:0019934]; dopamine metabolic process [GO:0042417]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell growth [GO:0030308]; negative regulation of smooth muscle cell proliferation [GO:0048662]; positive regulation of cGMP-mediated signaling [GO:0010753]; positive regulation of renal sodium excretion [GO:0035815]; positive regulation of urine volume [GO:0035810]; receptor guanylyl cyclase signaling pathway [GO:0007168]; regulation of blood pressure [GO:0008217]; regulation of vascular permeability [GO:0043114] ANPR-A receptor complex [GO:1990620]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] ATP binding [GO:0005524]; G protein-coupled peptide receptor activity [GO:0008528]; GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; hormone binding [GO:0042562]; natriuretic peptide receptor activity [GO:0016941]; peptide hormone binding [GO:0017046]; peptide receptor activity [GO:0001653]; protein kinase activity [GO:0004672] g1144.t2 P16066 45.439 581 2.0400000000000002e-161 497.0 sp|P16066|ANPRA_HUMAN Atrial natriuretic peptide receptor 1 OS=Homo sapiens OX=9606 GN=NPR1 PE=1 SV=1 ANPRA_HUMAN reviewed Atrial natriuretic peptide receptor 1 (EC 4.6.1.2) (Atrial natriuretic peptide receptor type A) (ANP-A) (ANPR-A) (NPR-A) (Guanylate cyclase A) (GC-A) Homo sapiens (Human) GO:0001653; GO:0004383; GO:0004672; GO:0005524; GO:0005525; GO:0005886; GO:0006182; GO:0007166; GO:0007168; GO:0007589; GO:0008217; GO:0008528; GO:0010753; GO:0016525; GO:0016941; GO:0017046; GO:0019934; GO:0030308; GO:0035810; GO:0035815; GO:0042417; GO:0042562; GO:0043114; GO:0043235; GO:0048662; GO:0097746; GO:1990620 blood vessel diameter maintenance [GO:0097746]; body fluid secretion [GO:0007589]; cell surface receptor signaling pathway [GO:0007166]; cGMP biosynthetic process [GO:0006182]; cGMP-mediated signaling [GO:0019934]; dopamine metabolic process [GO:0042417]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell growth [GO:0030308]; negative regulation of smooth muscle cell proliferation [GO:0048662]; positive regulation of cGMP-mediated signaling [GO:0010753]; positive regulation of renal sodium excretion [GO:0035815]; positive regulation of urine volume [GO:0035810]; receptor guanylyl cyclase signaling pathway [GO:0007168]; regulation of blood pressure [GO:0008217]; regulation of vascular permeability [GO:0043114] ANPR-A receptor complex [GO:1990620]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] ATP binding [GO:0005524]; G protein-coupled peptide receptor activity [GO:0008528]; GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; hormone binding [GO:0042562]; natriuretic peptide receptor activity [GO:0016941]; peptide hormone binding [GO:0017046]; peptide receptor activity [GO:0001653]; protein kinase activity [GO:0004672] g1146.t1 Q9BVH7 36.531 271 1.35e-51 186.0 sp|Q9BVH7|SIA7E_HUMAN Alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 5 OS=Homo sapiens OX=9606 GN=ST6GALNAC5 PE=1 SV=1 SIA7E_HUMAN reviewed Alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 5 (EC 2.4.99.-) (GD1 alpha synthase) (GalNAc alpha-2,6-sialyltransferase V) (ST6GalNAc V) (ST6GalNAcV) (Sialyltransferase 7E) (SIAT7-E) Homo sapiens (Human) GO:0000139; GO:0001574; GO:0001665; GO:0006688; GO:0008373; GO:0009311; GO:0009312 ganglioside biosynthetic process [GO:0001574]; glycosphingolipid biosynthetic process [GO:0006688]; oligosaccharide biosynthetic process [GO:0009312]; oligosaccharide metabolic process [GO:0009311] Golgi membrane [GO:0000139] alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity [GO:0001665]; sialyltransferase activity [GO:0008373] g1147.t1 Q8C1A5 63.262 656 0.0 870.0 sp|Q8C1A5|THOP1_MOUSE Thimet oligopeptidase OS=Mus musculus OX=10090 GN=Thop1 PE=1 SV=1 g1147.t2 Q8C1A5 63.567 656 0.0 871.0 sp|Q8C1A5|THOP1_MOUSE Thimet oligopeptidase OS=Mus musculus OX=10090 GN=Thop1 PE=1 SV=1 g1147.t3 Q8C1A5 59.571 700 0.0 850.0 sp|Q8C1A5|THOP1_MOUSE Thimet oligopeptidase OS=Mus musculus OX=10090 GN=Thop1 PE=1 SV=1 g1147.t4 Q8C1A5 58.714 700 0.0 837.0 sp|Q8C1A5|THOP1_MOUSE Thimet oligopeptidase OS=Mus musculus OX=10090 GN=Thop1 PE=1 SV=1 g1148.t1 Q13635 49.442 1165 0.0 1004.0 sp|Q13635|PTC1_HUMAN Protein patched homolog 1 OS=Homo sapiens OX=9606 GN=PTCH1 PE=1 SV=2 g1148.t2 Q13635 49.313 1164 0.0 999.0 sp|Q13635|PTC1_HUMAN Protein patched homolog 1 OS=Homo sapiens OX=9606 GN=PTCH1 PE=1 SV=2 g1148.t3 Q13635 48.938 1177 0.0 997.0 sp|Q13635|PTC1_HUMAN Protein patched homolog 1 OS=Homo sapiens OX=9606 GN=PTCH1 PE=1 SV=2 g1149.t1 Q5ZKV8 55.278 720 0.0 743.0 sp|Q5ZKV8|KIF2A_CHICK Kinesin-like protein KIF2A OS=Gallus gallus OX=9031 GN=KIF2A PE=2 SV=2 KIF2A_CHICK reviewed Kinesin-like protein KIF2A Gallus gallus (Chicken) GO:0000922; GO:0003777; GO:0005524; GO:0005737; GO:0005813; GO:0005819; GO:0005871; GO:0005874; GO:0007018; GO:0007052; GO:0007399; GO:0008017; GO:0016887; GO:0030154; GO:0051301 cell differentiation [GO:0030154]; cell division [GO:0051301]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; nervous system development [GO:0007399] centrosome [GO:0005813]; cytoplasm [GO:0005737]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; spindle [GO:0005819]; spindle pole [GO:0000922] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777] g1151.t1 O55164 40.559 895 4.8e-156 539.0 sp|O55164|MPDZ_RAT Multiple PDZ domain protein OS=Rattus norvegicus OX=10116 GN=Mpdz PE=1 SV=1 MPDZ_RAT reviewed Multiple PDZ domain protein (Multi-PDZ domain protein 1) Rattus norvegicus (Rat) GO:0005737; GO:0005886; GO:0005923; GO:0006886; GO:0007155; GO:0012505; GO:0014069; GO:0016324; GO:0016327; GO:0016358; GO:0030425; GO:0031410; GO:0035003; GO:0035556; GO:0042552; GO:0043220; GO:0045177; GO:0045202; GO:0098978; GO:0120192 cell adhesion [GO:0007155]; dendrite development [GO:0016358]; intracellular protein transport [GO:0006886]; intracellular signal transduction [GO:0035556]; myelination [GO:0042552]; tight junction assembly [GO:0120192] apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; dendrite [GO:0030425]; endomembrane system [GO:0012505]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; Schmidt-Lanterman incisure [GO:0043220]; subapical complex [GO:0035003]; synapse [GO:0045202] g1151.t1 O55164 42.293 532 3.07e-101 368.0 sp|O55164|MPDZ_RAT Multiple PDZ domain protein OS=Rattus norvegicus OX=10116 GN=Mpdz PE=1 SV=1 MPDZ_RAT reviewed Multiple PDZ domain protein (Multi-PDZ domain protein 1) Rattus norvegicus (Rat) GO:0005737; GO:0005886; GO:0005923; GO:0006886; GO:0007155; GO:0012505; GO:0014069; GO:0016324; GO:0016327; GO:0016358; GO:0030425; GO:0031410; GO:0035003; GO:0035556; GO:0042552; GO:0043220; GO:0045177; GO:0045202; GO:0098978; GO:0120192 cell adhesion [GO:0007155]; dendrite development [GO:0016358]; intracellular protein transport [GO:0006886]; intracellular signal transduction [GO:0035556]; myelination [GO:0042552]; tight junction assembly [GO:0120192] apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; dendrite [GO:0030425]; endomembrane system [GO:0012505]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; Schmidt-Lanterman incisure [GO:0043220]; subapical complex [GO:0035003]; synapse [GO:0045202] g1151.t1 O55164 35.484 279 6.310000000000001e-32 141.0 sp|O55164|MPDZ_RAT Multiple PDZ domain protein OS=Rattus norvegicus OX=10116 GN=Mpdz PE=1 SV=1 MPDZ_RAT reviewed Multiple PDZ domain protein (Multi-PDZ domain protein 1) Rattus norvegicus (Rat) GO:0005737; GO:0005886; GO:0005923; GO:0006886; GO:0007155; GO:0012505; GO:0014069; GO:0016324; GO:0016327; GO:0016358; GO:0030425; GO:0031410; GO:0035003; GO:0035556; GO:0042552; GO:0043220; GO:0045177; GO:0045202; GO:0098978; GO:0120192 cell adhesion [GO:0007155]; dendrite development [GO:0016358]; intracellular protein transport [GO:0006886]; intracellular signal transduction [GO:0035556]; myelination [GO:0042552]; tight junction assembly [GO:0120192] apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; dendrite [GO:0030425]; endomembrane system [GO:0012505]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; Schmidt-Lanterman incisure [GO:0043220]; subapical complex [GO:0035003]; synapse [GO:0045202] g1151.t1 O55164 57.576 99 3.35e-23 112.0 sp|O55164|MPDZ_RAT Multiple PDZ domain protein OS=Rattus norvegicus OX=10116 GN=Mpdz PE=1 SV=1 MPDZ_RAT reviewed Multiple PDZ domain protein (Multi-PDZ domain protein 1) Rattus norvegicus (Rat) GO:0005737; GO:0005886; GO:0005923; GO:0006886; GO:0007155; GO:0012505; GO:0014069; GO:0016324; GO:0016327; GO:0016358; GO:0030425; GO:0031410; GO:0035003; GO:0035556; GO:0042552; GO:0043220; GO:0045177; GO:0045202; GO:0098978; GO:0120192 cell adhesion [GO:0007155]; dendrite development [GO:0016358]; intracellular protein transport [GO:0006886]; intracellular signal transduction [GO:0035556]; myelination [GO:0042552]; tight junction assembly [GO:0120192] apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; dendrite [GO:0030425]; endomembrane system [GO:0012505]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; Schmidt-Lanterman incisure [GO:0043220]; subapical complex [GO:0035003]; synapse [GO:0045202] g1151.t1 O55164 46.457 127 7.12e-21 105.0 sp|O55164|MPDZ_RAT Multiple PDZ domain protein OS=Rattus norvegicus OX=10116 GN=Mpdz PE=1 SV=1 MPDZ_RAT reviewed Multiple PDZ domain protein (Multi-PDZ domain protein 1) Rattus norvegicus (Rat) GO:0005737; GO:0005886; GO:0005923; GO:0006886; GO:0007155; GO:0012505; GO:0014069; GO:0016324; GO:0016327; GO:0016358; GO:0030425; GO:0031410; GO:0035003; GO:0035556; GO:0042552; GO:0043220; GO:0045177; GO:0045202; GO:0098978; GO:0120192 cell adhesion [GO:0007155]; dendrite development [GO:0016358]; intracellular protein transport [GO:0006886]; intracellular signal transduction [GO:0035556]; myelination [GO:0042552]; tight junction assembly [GO:0120192] apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; dendrite [GO:0030425]; endomembrane system [GO:0012505]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; Schmidt-Lanterman incisure [GO:0043220]; subapical complex [GO:0035003]; synapse [GO:0045202] g1152.t1 P14314 49.265 272 1.1600000000000001e-70 239.0 sp|P14314|GLU2B_HUMAN Glucosidase 2 subunit beta OS=Homo sapiens OX=9606 GN=PRKCSH PE=1 SV=2 GLU2B_HUMAN reviewed Glucosidase 2 subunit beta (80K-H protein) (Glucosidase II subunit beta) (Protein kinase C substrate 60.1 kDa protein heavy chain) (PKCSH) Homo sapiens (Human) GO:0001889; GO:0005080; GO:0005509; GO:0005783; GO:0005788; GO:0006491; GO:0017177; GO:0035556; GO:0043231; GO:0044325; GO:0051219 intracellular signal transduction [GO:0035556]; liver development [GO:0001889]; N-glycan processing [GO:0006491] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; glucosidase II complex [GO:0017177]; intracellular membrane-bounded organelle [GO:0043231] calcium ion binding [GO:0005509]; phosphoprotein binding [GO:0051219]; protein kinase C binding [GO:0005080]; transmembrane transporter binding [GO:0044325] g1152.t1 P14314 50.331 151 4.81e-43 164.0 sp|P14314|GLU2B_HUMAN Glucosidase 2 subunit beta OS=Homo sapiens OX=9606 GN=PRKCSH PE=1 SV=2 GLU2B_HUMAN reviewed Glucosidase 2 subunit beta (80K-H protein) (Glucosidase II subunit beta) (Protein kinase C substrate 60.1 kDa protein heavy chain) (PKCSH) Homo sapiens (Human) GO:0001889; GO:0005080; GO:0005509; GO:0005783; GO:0005788; GO:0006491; GO:0017177; GO:0035556; GO:0043231; GO:0044325; GO:0051219 intracellular signal transduction [GO:0035556]; liver development [GO:0001889]; N-glycan processing [GO:0006491] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; glucosidase II complex [GO:0017177]; intracellular membrane-bounded organelle [GO:0043231] calcium ion binding [GO:0005509]; phosphoprotein binding [GO:0051219]; protein kinase C binding [GO:0005080]; transmembrane transporter binding [GO:0044325] g1153.t1 Q5XJW2 39.496 119 1.18e-21 91.3 sp|Q5XJW2|G45IP_RAT Large ribosomal subunit protein mL64 OS=Rattus norvegicus OX=10116 GN=Gadd45gip1 PE=2 SV=2 G45IP_RAT reviewed Large ribosomal subunit protein mL64 (39S ribosomal protein L59, mitochondrial) (MRP-L59) (Growth arrest and DNA damage-inducible proteins-interacting protein 1) Rattus norvegicus (Rat) GO:0005654; GO:0005739; GO:0005840; GO:1990904 mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; ribonucleoprotein complex [GO:1990904]; ribosome [GO:0005840] g1154.t1 O76050 34.839 155 6.25e-25 112.0 sp|O76050|NEUL1_HUMAN E3 ubiquitin-protein ligase NEURL1 OS=Homo sapiens OX=9606 GN=NEURL1 PE=1 SV=1 g1156.t1 P49453 38.318 214 4.55e-31 130.0 sp|P49453|CENPC_SHEEP Centromere protein C (Fragment) OS=Ovis aries OX=9940 GN=CENPC PE=2 SV=1 g1157.t1 Q68CZ6 27.769 641 4.2399999999999996e-67 234.0 sp|Q68CZ6|HAUS3_HUMAN HAUS augmin-like complex subunit 3 OS=Homo sapiens OX=9606 GN=HAUS3 PE=1 SV=1 HAUS3_HUMAN reviewed HAUS augmin-like complex subunit 3 Homo sapiens (Human) GO:0005654; GO:0005739; GO:0005813; GO:0005815; GO:0005829; GO:0005929; GO:0007098; GO:0010968; GO:0015630; GO:0031023; GO:0036064; GO:0045171; GO:0051225; GO:0051301; GO:0070652; GO:0072686; GO:1990498 cell division [GO:0051301]; centrosome cycle [GO:0007098]; microtubule organizing center organization [GO:0031023]; regulation of microtubule nucleation [GO:0010968]; spindle assembly [GO:0051225] centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytosol [GO:0005829]; HAUS complex [GO:0070652]; intercellular bridge [GO:0045171]; microtubule cytoskeleton [GO:0015630]; microtubule organizing center [GO:0005815]; mitochondrion [GO:0005739]; mitotic spindle [GO:0072686]; mitotic spindle microtubule [GO:1990498]; nucleoplasm [GO:0005654] g1158.t1 Q80TZ3 44.333 300 6.379999999999999e-52 199.0 sp|Q80TZ3|AUXI_MOUSE Auxilin OS=Mus musculus OX=10090 GN=Dnajc6 PE=1 SV=2 AUXI_MOUSE reviewed Auxilin (EC 3.1.3.-) (DnaJ homolog subfamily C member 6) Mus musculus (Mouse) GO:0004721; GO:0005737; GO:0014069; GO:0016191; GO:0017124; GO:0030136; GO:0030276; GO:0031072; GO:0031982; GO:0032050; GO:0036465; GO:0045202; GO:0046907; GO:0072318; GO:0072583; GO:0098894; GO:1905443; GO:2000369 clathrin coat disassembly [GO:0072318]; clathrin-dependent endocytosis [GO:0072583]; intracellular transport [GO:0046907]; regulation of clathrin coat assembly [GO:1905443]; regulation of clathrin-dependent endocytosis [GO:2000369]; synaptic vesicle recycling [GO:0036465]; synaptic vesicle uncoating [GO:0016191] clathrin-coated vesicle [GO:0030136]; cytoplasm [GO:0005737]; extrinsic component of presynaptic endocytic zone membrane [GO:0098894]; postsynaptic density [GO:0014069]; synapse [GO:0045202]; vesicle [GO:0031982] clathrin binding [GO:0030276]; clathrin heavy chain binding [GO:0032050]; heat shock protein binding [GO:0031072]; phosphoprotein phosphatase activity [GO:0004721]; SH3 domain binding [GO:0017124] g1158.t1 Q80TZ3 31.179 263 7.28e-38 155.0 sp|Q80TZ3|AUXI_MOUSE Auxilin OS=Mus musculus OX=10090 GN=Dnajc6 PE=1 SV=2 AUXI_MOUSE reviewed Auxilin (EC 3.1.3.-) (DnaJ homolog subfamily C member 6) Mus musculus (Mouse) GO:0004721; GO:0005737; GO:0014069; GO:0016191; GO:0017124; GO:0030136; GO:0030276; GO:0031072; GO:0031982; GO:0032050; GO:0036465; GO:0045202; GO:0046907; GO:0072318; GO:0072583; GO:0098894; GO:1905443; GO:2000369 clathrin coat disassembly [GO:0072318]; clathrin-dependent endocytosis [GO:0072583]; intracellular transport [GO:0046907]; regulation of clathrin coat assembly [GO:1905443]; regulation of clathrin-dependent endocytosis [GO:2000369]; synaptic vesicle recycling [GO:0036465]; synaptic vesicle uncoating [GO:0016191] clathrin-coated vesicle [GO:0030136]; cytoplasm [GO:0005737]; extrinsic component of presynaptic endocytic zone membrane [GO:0098894]; postsynaptic density [GO:0014069]; synapse [GO:0045202]; vesicle [GO:0031982] clathrin binding [GO:0030276]; clathrin heavy chain binding [GO:0032050]; heat shock protein binding [GO:0031072]; phosphoprotein phosphatase activity [GO:0004721]; SH3 domain binding [GO:0017124] g1159.t1 O14976 55.114 352 1.0500000000000001e-122 387.0 sp|O14976|GAK_HUMAN Cyclin-G-associated kinase OS=Homo sapiens OX=9606 GN=GAK PE=1 SV=2 GAK_HUMAN reviewed Cyclin-G-associated kinase (EC 2.7.11.1) (DnaJ homolog subfamily C member 26) Homo sapiens (Human) GO:0004674; GO:0005524; GO:0005737; GO:0005794; GO:0005829; GO:0005925; GO:0006457; GO:0006898; GO:0007029; GO:0007030; GO:0010977; GO:0016020; GO:0016191; GO:0030136; GO:0030276; GO:0030332; GO:0031982; GO:0034067; GO:0044183; GO:0046907; GO:0048268; GO:0048471; GO:0072318; GO:0072583; GO:0072659; GO:0090160; GO:0098793; GO:0106310; GO:1905443 clathrin coat assembly [GO:0048268]; clathrin coat disassembly [GO:0072318]; clathrin-dependent endocytosis [GO:0072583]; endoplasmic reticulum organization [GO:0007029]; Golgi organization [GO:0007030]; Golgi to lysosome transport [GO:0090160]; intracellular transport [GO:0046907]; negative regulation of neuron projection development [GO:0010977]; protein folding [GO:0006457]; protein localization to Golgi apparatus [GO:0034067]; protein localization to plasma membrane [GO:0072659]; receptor-mediated endocytosis [GO:0006898]; regulation of clathrin coat assembly [GO:1905443]; synaptic vesicle uncoating [GO:0016191] clathrin-coated vesicle [GO:0030136]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; presynapse [GO:0098793]; vesicle [GO:0031982] ATP binding [GO:0005524]; clathrin binding [GO:0030276]; cyclin binding [GO:0030332]; protein folding chaperone [GO:0044183]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g1160.t1 Q99KY4 65.789 152 1.04e-54 189.0 sp|Q99KY4|GAK_MOUSE Cyclin-G-associated kinase OS=Mus musculus OX=10090 GN=Gak PE=1 SV=2 g1161.t1 Q9Y2P8 67.989 378 0.0 521.0 sp|Q9Y2P8|RCL1_HUMAN RNA 3'-terminal phosphate cyclase-like protein OS=Homo sapiens OX=9606 GN=RCL1 PE=1 SV=3 g1162.t1 E7E2N8 44.304 237 2.52e-62 201.0 sp|E7E2N8|GILT_CARAU Gamma-interferon-inducible lysosomal thiol reductase OS=Carassius auratus OX=7957 GN=ifi30 PE=1 SV=1 g1163.t1 Q5ZL21 53.017 232 3.27e-90 269.0 sp|Q5ZL21|MMAC_CHICK Cyanocobalamin reductase / alkylcobalamin dealkylase OS=Gallus gallus OX=9031 GN=MMACHC PE=2 SV=1 MMAC_CHICK reviewed Cyanocobalamin reductase / alkylcobalamin dealkylase (Alkylcobalamin:glutathione S-alkyltransferase) (EC 2.5.1.151) (CblC) (Cyanocobalamin reductase (cyanide-eliminating)) (EC 1.16.1.6) (Methylmalonic aciduria and homocystinuria type C protein) (MMACHC) Gallus gallus (Chicken) GO:0005737; GO:0005829; GO:0006749; GO:0009235; GO:0016491; GO:0016740; GO:0031419; GO:0032451; GO:0033787; GO:0043295; GO:0070988; GO:0071949 cobalamin metabolic process [GO:0009235]; demethylation [GO:0070988]; glutathione metabolic process [GO:0006749] cytoplasm [GO:0005737]; cytosol [GO:0005829] cobalamin binding [GO:0031419]; cyanocobalamin reductase (cyanide-eliminating) (NADP+) activity [GO:0033787]; demethylase activity [GO:0032451]; FAD binding [GO:0071949]; glutathione binding [GO:0043295]; oxidoreductase activity [GO:0016491]; transferase activity [GO:0016740] g1164.t1 P00949 67.514 551 0.0 747.0 sp|P00949|PGM1_RABIT Phosphoglucomutase-1 OS=Oryctolagus cuniculus OX=9986 GN=PGM1 PE=1 SV=2 g1165.t1 Q96PH1 60.204 98 8.44e-39 140.0 sp|Q96PH1|NOX5_HUMAN NADPH oxidase 5 OS=Homo sapiens OX=9606 GN=NOX5 PE=1 SV=1 g1167.t1 Q96PH1 46.654 523 1.6999999999999998e-119 376.0 sp|Q96PH1|NOX5_HUMAN NADPH oxidase 5 OS=Homo sapiens OX=9606 GN=NOX5 PE=1 SV=1 g1170.t1 Q8YTC2 26.406 409 7.65e-29 130.0 sp|Q8YTC2|Y2800_NOSS1 Uncharacterized WD repeat-containing protein alr2800 OS=Nostoc sp. (strain PCC 7120 / SAG 25.82 / UTEX 2576) OX=103690 GN=alr2800 PE=4 SV=1 g1170.t1 Q8YTC2 25.787 508 7.72e-27 123.0 sp|Q8YTC2|Y2800_NOSS1 Uncharacterized WD repeat-containing protein alr2800 OS=Nostoc sp. (strain PCC 7120 / SAG 25.82 / UTEX 2576) OX=103690 GN=alr2800 PE=4 SV=1 g1171.t1 B8JI71 27.79 2267 0.0 633.0 sp|B8JI71|EYS_DANRE Protein eyes shut homolog OS=Danio rerio OX=7955 GN=eys PE=1 SV=2 EYS_DANRE reviewed Protein eyes shut homolog Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005112; GO:0005509; GO:0005886; GO:0005930; GO:0007417; GO:0007601; GO:0033165; GO:0045597; GO:0048589; GO:0051240; GO:0051241; GO:0060218; GO:1901222 central nervous system development [GO:0007417]; developmental growth [GO:0048589]; hematopoietic stem cell differentiation [GO:0060218]; negative regulation of multicellular organismal process [GO:0051241]; positive regulation of cell differentiation [GO:0045597]; positive regulation of multicellular organismal process [GO:0051240]; regulation of non-canonical NF-kappaB signal transduction [GO:1901222]; visual perception [GO:0007601] axoneme [GO:0005930]; interphotoreceptor matrix [GO:0033165]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; Notch binding [GO:0005112] g1171.t1 B8JI71 34.056 969 2.71e-127 452.0 sp|B8JI71|EYS_DANRE Protein eyes shut homolog OS=Danio rerio OX=7955 GN=eys PE=1 SV=2 EYS_DANRE reviewed Protein eyes shut homolog Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005112; GO:0005509; GO:0005886; GO:0005930; GO:0007417; GO:0007601; GO:0033165; GO:0045597; GO:0048589; GO:0051240; GO:0051241; GO:0060218; GO:1901222 central nervous system development [GO:0007417]; developmental growth [GO:0048589]; hematopoietic stem cell differentiation [GO:0060218]; negative regulation of multicellular organismal process [GO:0051241]; positive regulation of cell differentiation [GO:0045597]; positive regulation of multicellular organismal process [GO:0051240]; regulation of non-canonical NF-kappaB signal transduction [GO:1901222]; visual perception [GO:0007601] axoneme [GO:0005930]; interphotoreceptor matrix [GO:0033165]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; Notch binding [GO:0005112] g1171.t1 B8JI71 33.925 1014 2.36e-123 439.0 sp|B8JI71|EYS_DANRE Protein eyes shut homolog OS=Danio rerio OX=7955 GN=eys PE=1 SV=2 EYS_DANRE reviewed Protein eyes shut homolog Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005112; GO:0005509; GO:0005886; GO:0005930; GO:0007417; GO:0007601; GO:0033165; GO:0045597; GO:0048589; GO:0051240; GO:0051241; GO:0060218; GO:1901222 central nervous system development [GO:0007417]; developmental growth [GO:0048589]; hematopoietic stem cell differentiation [GO:0060218]; negative regulation of multicellular organismal process [GO:0051241]; positive regulation of cell differentiation [GO:0045597]; positive regulation of multicellular organismal process [GO:0051240]; regulation of non-canonical NF-kappaB signal transduction [GO:1901222]; visual perception [GO:0007601] axoneme [GO:0005930]; interphotoreceptor matrix [GO:0033165]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; Notch binding [GO:0005112] g1171.t1 B8JI71 35.166 873 1e-117 421.0 sp|B8JI71|EYS_DANRE Protein eyes shut homolog OS=Danio rerio OX=7955 GN=eys PE=1 SV=2 EYS_DANRE reviewed Protein eyes shut homolog Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005112; GO:0005509; GO:0005886; GO:0005930; GO:0007417; GO:0007601; GO:0033165; GO:0045597; GO:0048589; GO:0051240; GO:0051241; GO:0060218; GO:1901222 central nervous system development [GO:0007417]; developmental growth [GO:0048589]; hematopoietic stem cell differentiation [GO:0060218]; negative regulation of multicellular organismal process [GO:0051241]; positive regulation of cell differentiation [GO:0045597]; positive regulation of multicellular organismal process [GO:0051240]; regulation of non-canonical NF-kappaB signal transduction [GO:1901222]; visual perception [GO:0007601] axoneme [GO:0005930]; interphotoreceptor matrix [GO:0033165]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; Notch binding [GO:0005112] g1171.t1 B8JI71 32.944 1114 3.0399999999999997e-115 413.0 sp|B8JI71|EYS_DANRE Protein eyes shut homolog OS=Danio rerio OX=7955 GN=eys PE=1 SV=2 EYS_DANRE reviewed Protein eyes shut homolog Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005112; GO:0005509; GO:0005886; GO:0005930; GO:0007417; GO:0007601; GO:0033165; GO:0045597; GO:0048589; GO:0051240; GO:0051241; GO:0060218; GO:1901222 central nervous system development [GO:0007417]; developmental growth [GO:0048589]; hematopoietic stem cell differentiation [GO:0060218]; negative regulation of multicellular organismal process [GO:0051241]; positive regulation of cell differentiation [GO:0045597]; positive regulation of multicellular organismal process [GO:0051240]; regulation of non-canonical NF-kappaB signal transduction [GO:1901222]; visual perception [GO:0007601] axoneme [GO:0005930]; interphotoreceptor matrix [GO:0033165]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; Notch binding [GO:0005112] g1171.t1 B8JI71 33.2 1000 1.08e-108 392.0 sp|B8JI71|EYS_DANRE Protein eyes shut homolog OS=Danio rerio OX=7955 GN=eys PE=1 SV=2 EYS_DANRE reviewed Protein eyes shut homolog Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005112; GO:0005509; GO:0005886; GO:0005930; GO:0007417; GO:0007601; GO:0033165; GO:0045597; GO:0048589; GO:0051240; GO:0051241; GO:0060218; GO:1901222 central nervous system development [GO:0007417]; developmental growth [GO:0048589]; hematopoietic stem cell differentiation [GO:0060218]; negative regulation of multicellular organismal process [GO:0051241]; positive regulation of cell differentiation [GO:0045597]; positive regulation of multicellular organismal process [GO:0051240]; regulation of non-canonical NF-kappaB signal transduction [GO:1901222]; visual perception [GO:0007601] axoneme [GO:0005930]; interphotoreceptor matrix [GO:0033165]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; Notch binding [GO:0005112] g1171.t1 B8JI71 27.75 800 1.0899999999999999e-68 262.0 sp|B8JI71|EYS_DANRE Protein eyes shut homolog OS=Danio rerio OX=7955 GN=eys PE=1 SV=2 EYS_DANRE reviewed Protein eyes shut homolog Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005112; GO:0005509; GO:0005886; GO:0005930; GO:0007417; GO:0007601; GO:0033165; GO:0045597; GO:0048589; GO:0051240; GO:0051241; GO:0060218; GO:1901222 central nervous system development [GO:0007417]; developmental growth [GO:0048589]; hematopoietic stem cell differentiation [GO:0060218]; negative regulation of multicellular organismal process [GO:0051241]; positive regulation of cell differentiation [GO:0045597]; positive regulation of multicellular organismal process [GO:0051240]; regulation of non-canonical NF-kappaB signal transduction [GO:1901222]; visual perception [GO:0007601] axoneme [GO:0005930]; interphotoreceptor matrix [GO:0033165]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; Notch binding [GO:0005112] g1171.t1 B8JI71 22.971 875 4.37e-29 132.0 sp|B8JI71|EYS_DANRE Protein eyes shut homolog OS=Danio rerio OX=7955 GN=eys PE=1 SV=2 EYS_DANRE reviewed Protein eyes shut homolog Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005112; GO:0005509; GO:0005886; GO:0005930; GO:0007417; GO:0007601; GO:0033165; GO:0045597; GO:0048589; GO:0051240; GO:0051241; GO:0060218; GO:1901222 central nervous system development [GO:0007417]; developmental growth [GO:0048589]; hematopoietic stem cell differentiation [GO:0060218]; negative regulation of multicellular organismal process [GO:0051241]; positive regulation of cell differentiation [GO:0045597]; positive regulation of multicellular organismal process [GO:0051240]; regulation of non-canonical NF-kappaB signal transduction [GO:1901222]; visual perception [GO:0007601] axoneme [GO:0005930]; interphotoreceptor matrix [GO:0033165]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; Notch binding [GO:0005112] g1172.t1 P21783 41.02 980 0.0 665.0 sp|P21783|NOTC1_XENLA Neurogenic locus notch homolog protein 1 OS=Xenopus laevis OX=8355 GN=notch1 PE=1 SV=3 g1172.t1 P21783 40.078 1028 0.0 644.0 sp|P21783|NOTC1_XENLA Neurogenic locus notch homolog protein 1 OS=Xenopus laevis OX=8355 GN=notch1 PE=1 SV=3 g1172.t1 P21783 39.091 990 0.0 619.0 sp|P21783|NOTC1_XENLA Neurogenic locus notch homolog protein 1 OS=Xenopus laevis OX=8355 GN=notch1 PE=1 SV=3 g1172.t1 P21783 38.469 1006 0.0 607.0 sp|P21783|NOTC1_XENLA Neurogenic locus notch homolog protein 1 OS=Xenopus laevis OX=8355 GN=notch1 PE=1 SV=3 g1172.t1 P21783 35.671 1155 0.0 594.0 sp|P21783|NOTC1_XENLA Neurogenic locus notch homolog protein 1 OS=Xenopus laevis OX=8355 GN=notch1 PE=1 SV=3 g1172.t1 P21783 38.077 1061 7.709999999999999e-180 581.0 sp|P21783|NOTC1_XENLA Neurogenic locus notch homolog protein 1 OS=Xenopus laevis OX=8355 GN=notch1 PE=1 SV=3 g1172.t1 P21783 38.068 859 1.5099999999999998e-150 498.0 sp|P21783|NOTC1_XENLA Neurogenic locus notch homolog protein 1 OS=Xenopus laevis OX=8355 GN=notch1 PE=1 SV=3 g1175.t1 P49013 50.847 177 4.89e-50 173.0 sp|P49013|FBP3_STRPU Fibropellin-3 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF3 PE=1 SV=1 g1175.t1 P49013 49.693 163 5.0999999999999995e-48 167.0 sp|P49013|FBP3_STRPU Fibropellin-3 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF3 PE=1 SV=1 g1175.t1 P49013 45.763 177 1.47e-46 164.0 sp|P49013|FBP3_STRPU Fibropellin-3 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF3 PE=1 SV=1 g1175.t1 P49013 54.11 146 1.8e-46 163.0 sp|P49013|FBP3_STRPU Fibropellin-3 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF3 PE=1 SV=1 g1175.t1 P49013 46.565 131 5.6900000000000005e-31 121.0 sp|P49013|FBP3_STRPU Fibropellin-3 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF3 PE=1 SV=1 g1175.t1 P49013 55.556 108 7.08e-31 121.0 sp|P49013|FBP3_STRPU Fibropellin-3 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF3 PE=1 SV=1 g1176.t1 P07207 42.361 1296 0.0 959.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g1176.t1 P07207 41.557 1297 0.0 926.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g1176.t1 P07207 42.356 1197 0.0 887.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g1176.t1 P07207 42.096 1183 0.0 875.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g1176.t1 P07207 40.59 1254 0.0 849.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g1176.t1 P07207 40.0 1075 0.0 763.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g1176.t1 P07207 42.474 970 0.0 732.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g1176.t1 P07207 36.906 737 4.1599999999999996e-128 440.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g1177.t1 P10079 47.034 236 4.9800000000000006e-58 212.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g1177.t1 P10079 48.085 235 1.4e-55 204.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g1177.t1 P10079 45.982 224 8.979999999999999e-54 199.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g1177.t1 P10079 48.444 225 2.63e-53 198.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g1177.t1 P10079 47.748 222 7.83e-53 197.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g1177.t1 P10079 47.111 225 1.4499999999999999e-52 196.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g1177.t1 P10079 47.556 225 2.48e-51 192.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g1177.t1 P10079 47.059 221 1.18e-50 190.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g1177.t1 P10079 46.429 224 6.06e-49 185.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g1177.t1 P10079 44.271 192 2.54e-35 145.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g1178.t1 D3ZYR1 60.351 285 4.42e-112 364.0 sp|D3ZYR1|FCHO2_RAT F-BAR domain only protein 2 OS=Rattus norvegicus OX=10116 GN=Fcho2 PE=1 SV=1 FCHO2_RAT reviewed F-BAR domain only protein 2 Rattus norvegicus (Rat) GO:0001786; GO:0005546; GO:0005737; GO:0005886; GO:0005905; GO:0010324; GO:0030136; GO:0035091; GO:0042802; GO:0045202; GO:0048268; GO:0048488; GO:0072583; GO:0072659; GO:0098793 clathrin coat assembly [GO:0048268]; clathrin-dependent endocytosis [GO:0072583]; membrane invagination [GO:0010324]; protein localization to plasma membrane [GO:0072659]; synaptic vesicle endocytosis [GO:0048488] clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; synapse [GO:0045202] identical protein binding [GO:0042802]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphatidylserine binding [GO:0001786] g1178.t1 D3ZYR1 44.125 417 1.88e-84 290.0 sp|D3ZYR1|FCHO2_RAT F-BAR domain only protein 2 OS=Rattus norvegicus OX=10116 GN=Fcho2 PE=1 SV=1 FCHO2_RAT reviewed F-BAR domain only protein 2 Rattus norvegicus (Rat) GO:0001786; GO:0005546; GO:0005737; GO:0005886; GO:0005905; GO:0010324; GO:0030136; GO:0035091; GO:0042802; GO:0045202; GO:0048268; GO:0048488; GO:0072583; GO:0072659; GO:0098793 clathrin coat assembly [GO:0048268]; clathrin-dependent endocytosis [GO:0072583]; membrane invagination [GO:0010324]; protein localization to plasma membrane [GO:0072659]; synaptic vesicle endocytosis [GO:0048488] clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; synapse [GO:0045202] identical protein binding [GO:0042802]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphatidylserine binding [GO:0001786] g1178.t2 D3ZYR1 60.351 285 1.9999999999999998e-111 363.0 sp|D3ZYR1|FCHO2_RAT F-BAR domain only protein 2 OS=Rattus norvegicus OX=10116 GN=Fcho2 PE=1 SV=1 FCHO2_RAT reviewed F-BAR domain only protein 2 Rattus norvegicus (Rat) GO:0001786; GO:0005546; GO:0005737; GO:0005886; GO:0005905; GO:0010324; GO:0030136; GO:0035091; GO:0042802; GO:0045202; GO:0048268; GO:0048488; GO:0072583; GO:0072659; GO:0098793 clathrin coat assembly [GO:0048268]; clathrin-dependent endocytosis [GO:0072583]; membrane invagination [GO:0010324]; protein localization to plasma membrane [GO:0072659]; synaptic vesicle endocytosis [GO:0048488] clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; synapse [GO:0045202] identical protein binding [GO:0042802]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphatidylserine binding [GO:0001786] g1178.t2 D3ZYR1 55.6 250 5.9e-74 262.0 sp|D3ZYR1|FCHO2_RAT F-BAR domain only protein 2 OS=Rattus norvegicus OX=10116 GN=Fcho2 PE=1 SV=1 FCHO2_RAT reviewed F-BAR domain only protein 2 Rattus norvegicus (Rat) GO:0001786; GO:0005546; GO:0005737; GO:0005886; GO:0005905; GO:0010324; GO:0030136; GO:0035091; GO:0042802; GO:0045202; GO:0048268; GO:0048488; GO:0072583; GO:0072659; GO:0098793 clathrin coat assembly [GO:0048268]; clathrin-dependent endocytosis [GO:0072583]; membrane invagination [GO:0010324]; protein localization to plasma membrane [GO:0072659]; synaptic vesicle endocytosis [GO:0048488] clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; synapse [GO:0045202] identical protein binding [GO:0042802]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphatidylserine binding [GO:0001786] g1178.t3 D3ZYR1 60.351 285 6.46e-112 364.0 sp|D3ZYR1|FCHO2_RAT F-BAR domain only protein 2 OS=Rattus norvegicus OX=10116 GN=Fcho2 PE=1 SV=1 FCHO2_RAT reviewed F-BAR domain only protein 2 Rattus norvegicus (Rat) GO:0001786; GO:0005546; GO:0005737; GO:0005886; GO:0005905; GO:0010324; GO:0030136; GO:0035091; GO:0042802; GO:0045202; GO:0048268; GO:0048488; GO:0072583; GO:0072659; GO:0098793 clathrin coat assembly [GO:0048268]; clathrin-dependent endocytosis [GO:0072583]; membrane invagination [GO:0010324]; protein localization to plasma membrane [GO:0072659]; synaptic vesicle endocytosis [GO:0048488] clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; synapse [GO:0045202] identical protein binding [GO:0042802]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphatidylserine binding [GO:0001786] g1178.t3 D3ZYR1 55.6 250 3.89e-74 262.0 sp|D3ZYR1|FCHO2_RAT F-BAR domain only protein 2 OS=Rattus norvegicus OX=10116 GN=Fcho2 PE=1 SV=1 FCHO2_RAT reviewed F-BAR domain only protein 2 Rattus norvegicus (Rat) GO:0001786; GO:0005546; GO:0005737; GO:0005886; GO:0005905; GO:0010324; GO:0030136; GO:0035091; GO:0042802; GO:0045202; GO:0048268; GO:0048488; GO:0072583; GO:0072659; GO:0098793 clathrin coat assembly [GO:0048268]; clathrin-dependent endocytosis [GO:0072583]; membrane invagination [GO:0010324]; protein localization to plasma membrane [GO:0072659]; synaptic vesicle endocytosis [GO:0048488] clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; synapse [GO:0045202] identical protein binding [GO:0042802]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphatidylserine binding [GO:0001786] g1181.t1 Q8NBS3 45.0 780 0.0 640.0 sp|Q8NBS3|S4A11_HUMAN Solute carrier family 4 member 11 OS=Homo sapiens OX=9606 GN=SLC4A11 PE=1 SV=3 g1181.t2 Q8NBS3 45.128 780 0.0 643.0 sp|Q8NBS3|S4A11_HUMAN Solute carrier family 4 member 11 OS=Homo sapiens OX=9606 GN=SLC4A11 PE=1 SV=3 g1183.t1 Q567C6 47.325 243 2.78e-64 207.0 sp|Q567C6|ZN367_DANRE Zinc finger protein 367 OS=Danio rerio OX=7955 GN=znf367 PE=2 SV=1 g1185.t1 P10949 78.947 228 1.7800000000000002e-132 375.0 sp|P10949|RAB3C_BOVIN Ras-related protein Rab-3C OS=Bos taurus OX=9913 GN=RAB3C PE=1 SV=3 RAB3C_BOVIN reviewed Ras-related protein Rab-3C (EC 3.6.5.2) (SMG P25C) Bos taurus (Bovine) GO:0003924; GO:0003925; GO:0005525; GO:0005768; GO:0005886; GO:0006887; GO:0008021; GO:0015031; GO:0031489 exocytosis [GO:0006887]; protein transport [GO:0015031] endosome [GO:0005768]; plasma membrane [GO:0005886]; synaptic vesicle [GO:0008021] G protein activity [GO:0003925]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; myosin V binding [GO:0031489] g1186.t1 Q2NKS3 44.262 122 2.99e-31 110.0 sp|Q2NKS3|PSMG3_BOVIN Proteasome assembly chaperone 3 OS=Bos taurus OX=9913 GN=PSMG3 PE=2 SV=1 g1187.t1 Q9NXG6 37.64 356 4.08e-72 238.0 sp|Q9NXG6|P4HTM_HUMAN Transmembrane prolyl 4-hydroxylase OS=Homo sapiens OX=9606 GN=P4HTM PE=1 SV=2 g1188.t1 Q86V40 68.732 339 8.080000000000001e-163 474.0 sp|Q86V40|TIKI1_HUMAN Metalloprotease TIKI1 OS=Homo sapiens OX=9606 GN=TRABD2A PE=1 SV=3 TIKI1_HUMAN reviewed Metalloprotease TIKI1 (EC 3.4.-.-) (TRAB domain-containing protein 2A) Homo sapiens (Human) GO:0004175; GO:0004222; GO:0005886; GO:0006508; GO:0016020; GO:0016055; GO:0017147; GO:0030178; GO:0031090; GO:0031334; GO:0046872; GO:0060322 head development [GO:0060322]; negative regulation of Wnt signaling pathway [GO:0030178]; positive regulation of protein-containing complex assembly [GO:0031334]; proteolysis [GO:0006508]; Wnt signaling pathway [GO:0016055] membrane [GO:0016020]; organelle membrane [GO:0031090]; plasma membrane [GO:0005886] endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; Wnt-protein binding [GO:0017147] g1189.t1 Q9Y4Z0 95.349 86 1.49e-57 178.0 sp|Q9Y4Z0|LSM4_HUMAN U6 snRNA-associated Sm-like protein LSm4 OS=Homo sapiens OX=9606 GN=LSM4 PE=1 SV=1 g1190.t1 Q7TQK4 45.896 268 3.7800000000000005e-73 227.0 sp|Q7TQK4|EXOS3_MOUSE Exosome complex component RRP40 OS=Mus musculus OX=10090 GN=Exosc3 PE=1 SV=3 EXOS3_MOUSE reviewed Exosome complex component RRP40 (EC 3.1.13.-) (Exosome component 3) (Ribosomal RNA-processing protein 40) Mus musculus (Mouse) GO:0000176; GO:0000177; GO:0000178; GO:0000467; GO:0000791; GO:0000956; GO:0003723; GO:0004527; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0006364; GO:0006396; GO:0006401; GO:0006402; GO:0034475; GO:0045006; GO:0045190; GO:0045830; GO:0071034; GO:0071035; GO:0071038; GO:0071051; GO:0101019 CUT catabolic process [GO:0071034]; DNA deamination [GO:0045006]; exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000467]; isotype switching [GO:0045190]; mRNA catabolic process [GO:0006402]; nuclear polyadenylation-dependent rRNA catabolic process [GO:0071035]; nuclear-transcribed mRNA catabolic process [GO:0000956]; poly(A)-dependent snoRNA 3'-end processing [GO:0071051]; positive regulation of isotype switching [GO:0045830]; RNA catabolic process [GO:0006401]; RNA processing [GO:0006396]; rRNA processing [GO:0006364]; TRAMP-dependent tRNA surveillance pathway [GO:0071038]; U4 snRNA 3'-end processing [GO:0034475] cytoplasm [GO:0005737]; cytoplasmic exosome (RNase complex) [GO:0000177]; cytosol [GO:0005829]; euchromatin [GO:0000791]; exosome (RNase complex) [GO:0000178]; nuclear exosome (RNase complex) [GO:0000176]; nucleolar exosome (RNase complex) [GO:0101019]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] exonuclease activity [GO:0004527]; RNA binding [GO:0003723] g1194.t1 P28575 39.912 228 7.26e-51 177.0 sp|P28575|IPP_MOUSE Actin-binding protein IPP OS=Mus musculus OX=10090 GN=Ipp PE=2 SV=3 g1195.t1 P28575 47.445 137 2.49e-40 145.0 sp|P28575|IPP_MOUSE Actin-binding protein IPP OS=Mus musculus OX=10090 GN=Ipp PE=2 SV=3 g1196.t1 Q9NA75 39.316 234 1.65e-55 183.0 sp|Q9NA75|T38B1_CAEEL Trimeric intracellular cation channel type 1B.1 OS=Caenorhabditis elegans OX=6239 GN=tric-1B.1 PE=1 SV=2 g1199.t1 Q14957 27.938 451 9.79e-47 176.0 sp|Q14957|NMDE3_HUMAN Glutamate receptor ionotropic, NMDA 2C OS=Homo sapiens OX=9606 GN=GRIN2C PE=1 SV=3 NMDE3_HUMAN reviewed Glutamate receptor ionotropic, NMDA 2C (GluN2C) (Glutamate [NMDA] receptor subunit epsilon-3) (N-methyl D-aspartate receptor subtype 2C) (NMDAR2C) (NR2C) Homo sapiens (Human) GO:0004972; GO:0005261; GO:0005789; GO:0005886; GO:0007215; GO:0007420; GO:0009611; GO:0017146; GO:0033058; GO:0035235; GO:0035249; GO:0042177; GO:0045211; GO:0048167; GO:0048168; GO:0050885; GO:0051968; GO:0060079; GO:0060291; GO:0097553; GO:0098655; GO:0098839; GO:0098976; GO:0098978; GO:1903539; GO:1904062; GO:1904315; GO:2000463 brain development [GO:0007420]; calcium ion transmembrane import into cytosol [GO:0097553]; directional locomotion [GO:0033058]; excitatory chemical synaptic transmission [GO:0098976]; excitatory postsynaptic potential [GO:0060079]; glutamate receptor signaling pathway [GO:0007215]; ionotropic glutamate receptor signaling pathway [GO:0035235]; long-term synaptic potentiation [GO:0060291]; monoatomic cation transmembrane transport [GO:0098655]; negative regulation of protein catabolic process [GO:0042177]; neuromuscular process controlling balance [GO:0050885]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; protein localization to postsynaptic membrane [GO:1903539]; regulation of monoatomic cation transmembrane transport [GO:1904062]; regulation of neuronal synaptic plasticity [GO:0048168]; regulation of synaptic plasticity [GO:0048167]; response to wounding [GO:0009611]; synaptic transmission, glutamatergic [GO:0035249] endoplasmic reticulum membrane [GO:0005789]; glutamatergic synapse [GO:0098978]; NMDA selective glutamate receptor complex [GO:0017146]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; postsynaptic membrane [GO:0045211] monoatomic cation channel activity [GO:0005261]; NMDA glutamate receptor activity [GO:0004972]; transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315] g1199.t2 Q14957 28.378 444 6.149999999999999e-48 180.0 sp|Q14957|NMDE3_HUMAN Glutamate receptor ionotropic, NMDA 2C OS=Homo sapiens OX=9606 GN=GRIN2C PE=1 SV=3 NMDE3_HUMAN reviewed Glutamate receptor ionotropic, NMDA 2C (GluN2C) (Glutamate [NMDA] receptor subunit epsilon-3) (N-methyl D-aspartate receptor subtype 2C) (NMDAR2C) (NR2C) Homo sapiens (Human) GO:0004972; GO:0005261; GO:0005789; GO:0005886; GO:0007215; GO:0007420; GO:0009611; GO:0017146; GO:0033058; GO:0035235; GO:0035249; GO:0042177; GO:0045211; GO:0048167; GO:0048168; GO:0050885; GO:0051968; GO:0060079; GO:0060291; GO:0097553; GO:0098655; GO:0098839; GO:0098976; GO:0098978; GO:1903539; GO:1904062; GO:1904315; GO:2000463 brain development [GO:0007420]; calcium ion transmembrane import into cytosol [GO:0097553]; directional locomotion [GO:0033058]; excitatory chemical synaptic transmission [GO:0098976]; excitatory postsynaptic potential [GO:0060079]; glutamate receptor signaling pathway [GO:0007215]; ionotropic glutamate receptor signaling pathway [GO:0035235]; long-term synaptic potentiation [GO:0060291]; monoatomic cation transmembrane transport [GO:0098655]; negative regulation of protein catabolic process [GO:0042177]; neuromuscular process controlling balance [GO:0050885]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; protein localization to postsynaptic membrane [GO:1903539]; regulation of monoatomic cation transmembrane transport [GO:1904062]; regulation of neuronal synaptic plasticity [GO:0048168]; regulation of synaptic plasticity [GO:0048167]; response to wounding [GO:0009611]; synaptic transmission, glutamatergic [GO:0035249] endoplasmic reticulum membrane [GO:0005789]; glutamatergic synapse [GO:0098978]; NMDA selective glutamate receptor complex [GO:0017146]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; postsynaptic membrane [GO:0045211] monoatomic cation channel activity [GO:0005261]; NMDA glutamate receptor activity [GO:0004972]; transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315] g1200.t1 O60391 50.495 101 2.75e-29 113.0 sp|O60391|NMD3B_HUMAN Glutamate receptor ionotropic, NMDA 3B OS=Homo sapiens OX=9606 GN=GRIN3B PE=1 SV=2 NMD3B_HUMAN reviewed Glutamate receptor ionotropic, NMDA 3B (GluN3B) (N-methyl-D-aspartate receptor subtype 3B) (NMDAR3B) (NR3B) Homo sapiens (Human) GO:0005261; GO:0005262; GO:0005886; GO:0008066; GO:0016594; GO:0017146; GO:0030594; GO:0035235; GO:0035249; GO:0042734; GO:0043025; GO:0048167; GO:0050804; GO:0051205; GO:0051924; GO:0098655; GO:0098839; GO:0098878; GO:0099507; GO:0160212; GO:1904315 ionotropic glutamate receptor signaling pathway [GO:0035235]; modulation of chemical synaptic transmission [GO:0050804]; monoatomic cation transmembrane transport [GO:0098655]; protein insertion into membrane [GO:0051205]; regulation of calcium ion transport [GO:0051924]; regulation of synaptic plasticity [GO:0048167]; synaptic transmission, glutamatergic [GO:0035249] neuronal cell body [GO:0043025]; neurotransmitter receptor complex [GO:0098878]; NMDA selective glutamate receptor complex [GO:0017146]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; presynaptic membrane [GO:0042734] calcium channel activity [GO:0005262]; glutamate receptor activity [GO:0008066]; glycine binding [GO:0016594]; glycine-gated cation channel activity [GO:0160212]; ligand-gated monoatomic ion channel activity involved in regulation of presynaptic membrane potential [GO:0099507]; monoatomic cation channel activity [GO:0005261]; neurotransmitter receptor activity [GO:0030594]; transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315] g1201.t1 Q9R1M7 33.173 208 1.84e-22 105.0 sp|Q9R1M7|NMD3A_RAT Glutamate receptor ionotropic, NMDA 3A OS=Rattus norvegicus OX=10116 GN=Grin3a PE=1 SV=1 NMD3A_RAT reviewed Glutamate receptor ionotropic, NMDA 3A (GluN3A) (Glutamate receptor chi-1) (N-methyl-D-aspartate receptor) (N-methyl-D-aspartate receptor subtype 3A) (NMDAR3A) (NR3A) (NMDAR-L) (NMDAR-L1) Rattus norvegicus (Rat) GO:0004970; GO:0004972; GO:0005262; GO:0005737; GO:0005789; GO:0005886; GO:0006816; GO:0008066; GO:0016020; GO:0016358; GO:0016594; GO:0017146; GO:0022824; GO:0034702; GO:0035235; GO:0035249; GO:0042802; GO:0043005; GO:0043025; GO:0045202; GO:0045211; GO:0045471; GO:0048167; GO:0048511; GO:0048666; GO:0050804; GO:0051721; GO:0060134; GO:0061000; GO:0070905; GO:0098655; GO:0098793; GO:0098839; GO:0098878; GO:0098978; GO:0099171; GO:1904315 calcium ion transport [GO:0006816]; dendrite development [GO:0016358]; ionotropic glutamate receptor signaling pathway [GO:0035235]; modulation of chemical synaptic transmission [GO:0050804]; monoatomic cation transmembrane transport [GO:0098655]; negative regulation of dendritic spine development [GO:0061000]; neuron development [GO:0048666]; prepulse inhibition [GO:0060134]; presynaptic modulation of chemical synaptic transmission [GO:0099171]; regulation of synaptic plasticity [GO:0048167]; response to ethanol [GO:0045471]; rhythmic process [GO:0048511]; synaptic transmission, glutamatergic [GO:0035249] cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; monoatomic ion channel complex [GO:0034702]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; neurotransmitter receptor complex [GO:0098878]; NMDA selective glutamate receptor complex [GO:0017146]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; postsynaptic membrane [GO:0045211]; presynapse [GO:0098793]; synapse [GO:0045202] calcium channel activity [GO:0005262]; glutamate receptor activity [GO:0008066]; glutamate-gated receptor activity [GO:0004970]; glycine binding [GO:0016594]; identical protein binding [GO:0042802]; NMDA glutamate receptor activity [GO:0004972]; protein phosphatase 2A binding [GO:0051721]; serine binding [GO:0070905]; transmitter-gated monoatomic ion channel activity [GO:0022824]; transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315] g1204.t1 Q98TB4 28.909 339 6.27e-28 119.0 sp|Q98TB4|GDF8_OREMO Growth/differentiation factor 8 OS=Oreochromis mossambicus OX=8127 GN=gdf-8 PE=2 SV=1 g1205.t1 Q8BFS9 57.055 326 1.46e-102 334.0 sp|Q8BFS9|ASND1_MOUSE Asparagine synthetase domain-containing protein 1 OS=Mus musculus OX=10090 GN=Asnsd1 PE=2 SV=1 g1205.t1 Q8BFS9 38.356 292 1.37e-44 174.0 sp|Q8BFS9|ASND1_MOUSE Asparagine synthetase domain-containing protein 1 OS=Mus musculus OX=10090 GN=Asnsd1 PE=2 SV=1 g1206.t1 P17200 24.211 475 1.45e-31 130.0 sp|P17200|ACM4_CHICK Muscarinic acetylcholine receptor M4 OS=Gallus gallus OX=9031 GN=CHRM4 PE=2 SV=1 g1208.t1 Q9BXS4 37.024 289 4.12e-59 196.0 sp|Q9BXS4|TMM59_HUMAN Transmembrane protein 59 OS=Homo sapiens OX=9606 GN=TMEM59 PE=1 SV=1 TMM59_HUMAN reviewed Transmembrane protein 59 (Liver membrane-bound protein) Homo sapiens (Human) GO:0000137; GO:0000138; GO:0000139; GO:0004175; GO:0005764; GO:0005765; GO:0005770; GO:0005797; GO:0005886; GO:0006914; GO:0009101; GO:0010508; GO:0031902; GO:0070062; GO:1903077 autophagy [GO:0006914]; glycoprotein biosynthetic process [GO:0009101]; negative regulation of protein localization to plasma membrane [GO:1903077]; positive regulation of autophagy [GO:0010508] extracellular exosome [GO:0070062]; Golgi cis cisterna [GO:0000137]; Golgi medial cisterna [GO:0005797]; Golgi membrane [GO:0000139]; Golgi trans cisterna [GO:0000138]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; plasma membrane [GO:0005886] endopeptidase activity [GO:0004175] g1209.t1 O62742 64.829 526 0.0 722.0 sp|O62742|SCP2_RABIT Sterol carrier protein 2 OS=Oryctolagus cuniculus OX=9986 GN=SCP2 PE=1 SV=1 g1210.t1 P29693 83.333 84 6.19e-44 152.0 sp|P29693|EF1D_XENLA Elongation factor 1-delta OS=Xenopus laevis OX=8355 GN=eef1d PE=1 SV=1 g1210.t2 P29693 83.333 84 2.71e-44 152.0 sp|P29693|EF1D_XENLA Elongation factor 1-delta OS=Xenopus laevis OX=8355 GN=eef1d PE=1 SV=1 g1213.t1 Q9WYJ1 40.051 392 4.24e-81 259.0 sp|Q9WYJ1|TSAL_THEMA L-threonine ammonia-lyase OS=Thermotoga maritima (strain ATCC 43589 / DSM 3109 / JCM 10099 / NBRC 100826 / MSB8) OX=243274 GN=TM_0356 PE=1 SV=1 g1214.t1 Q1L987 40.741 243 2.7100000000000002e-58 192.0 sp|Q1L987|ATPF1_DANRE ATP synthase mitochondrial F1 complex assembly factor 1 OS=Danio rerio OX=7955 GN=atpaf1 PE=2 SV=2 g1215.t1 O77592 63.889 324 2.8200000000000002e-123 360.0 sp|O77592|S35A3_CANLF UDP-N-acetylglucosamine transporter OS=Canis lupus familiaris OX=9615 GN=SLC35A3 PE=2 SV=1 g1216.t1 Q75LJ4 28.839 267 5.06e-26 113.0 sp|Q75LJ4|ACBP6_ORYSJ Acyl-CoA-binding domain-containing protein 6 OS=Oryza sativa subsp. japonica OX=39947 GN=ACBP6 PE=2 SV=1 g1216.t1 Q75LJ4 29.603 277 1.47e-23 106.0 sp|Q75LJ4|ACBP6_ORYSJ Acyl-CoA-binding domain-containing protein 6 OS=Oryza sativa subsp. japonica OX=39947 GN=ACBP6 PE=2 SV=1 g1218.t1 Q6P6G5 44.751 181 1.03e-41 146.0 sp|Q6P6G5|YIPF1_RAT Protein YIPF1 OS=Rattus norvegicus OX=10116 GN=Yipf1 PE=2 SV=1 g1219.t1 Q1JPX3 89.32 206 1.15e-135 392.0 sp|Q1JPX3|SYFA_DANRE Phenylalanine--tRNA ligase alpha subunit OS=Danio rerio OX=7955 GN=farsa PE=2 SV=2 g1220.t1 Q7SYV0 54.902 255 1.31e-83 261.0 sp|Q7SYV0|SYFAB_XENLA Phenylalanine--tRNA ligase alpha subunit B OS=Xenopus laevis OX=8355 GN=farsa-b PE=2 SV=1 g1222.t1 Q9D180 67.097 310 2.39e-123 385.0 sp|Q9D180|CFA57_MOUSE Cilia- and flagella-associated protein 57 OS=Mus musculus OX=10090 GN=Cfap57 PE=1 SV=3 g1224.t1 Q96MR6 46.885 610 3.45e-170 516.0 sp|Q96MR6|CFA57_HUMAN Cilia- and flagella-associated protein 57 OS=Homo sapiens OX=9606 GN=CFAP57 PE=1 SV=3 CFA57_HUMAN reviewed Cilia- and flagella-associated protein 57 (WD repeat-containing protein 65) Homo sapiens (Human) GO:0005930; GO:0007338; GO:0036126; GO:0070286; GO:0120316 axonemal dynein complex assembly [GO:0070286]; single fertilization [GO:0007338]; sperm flagellum assembly [GO:0120316] axoneme [GO:0005930]; sperm flagellum [GO:0036126] g1225.t1 Q96MR6 53.6 125 1.13e-39 144.0 sp|Q96MR6|CFA57_HUMAN Cilia- and flagella-associated protein 57 OS=Homo sapiens OX=9606 GN=CFAP57 PE=1 SV=3 CFA57_HUMAN reviewed Cilia- and flagella-associated protein 57 (WD repeat-containing protein 65) Homo sapiens (Human) GO:0005930; GO:0007338; GO:0036126; GO:0070286; GO:0120316 axonemal dynein complex assembly [GO:0070286]; single fertilization [GO:0007338]; sperm flagellum assembly [GO:0120316] axoneme [GO:0005930]; sperm flagellum [GO:0036126] g1226.t1 Q3B8G0 60.163 123 2.6e-50 160.0 sp|Q3B8G0|CZIB_XENLA CXXC motif containing zinc binding protein OS=Xenopus laevis OX=8355 GN=czib PE=2 SV=1 g1228.t1 A4IIC5 45.977 174 8.59e-33 124.0 sp|A4IIC5|S39A3_XENTR Zinc transporter ZIP3 OS=Xenopus tropicalis OX=8364 GN=slc39a3 PE=2 SV=1 S39A3_XENTR reviewed Zinc transporter ZIP3 (Solute carrier family 39 member 3) (Zrt- and Irt-like protein 3) (ZIP-3) Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0005385; GO:0005886; GO:0016324; GO:0071577 zinc ion transmembrane transport [GO:0071577] apical plasma membrane [GO:0016324]; plasma membrane [GO:0005886] zinc ion transmembrane transporter activity [GO:0005385] g1229.t1 Q3MI03 46.768 526 1.5400000000000002e-157 464.0 sp|Q3MI03|OGFD1_BOVIN Prolyl 3-hydroxylase OGFOD1 OS=Bos taurus OX=9913 GN=OGFOD1 PE=2 SV=2 OGFD1_BOVIN reviewed Prolyl 3-hydroxylase OGFOD1 (EC 1.14.11.-) (2-oxoglutarate and iron-dependent oxygenase domain-containing protein 1) (uS12 prolyl 3-hydroxylase) Bos taurus (Bovine) GO:0005506; GO:0005634; GO:0005737; GO:0006449; GO:0008283; GO:0010494; GO:0018126; GO:0031418; GO:0031543; GO:0031544; GO:0034063 cell population proliferation [GO:0008283]; protein hydroxylation [GO:0018126]; regulation of translational termination [GO:0006449]; stress granule assembly [GO:0034063] cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; nucleus [GO:0005634] iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; peptidyl-proline 3-dioxygenase activity [GO:0031544]; peptidyl-proline dioxygenase activity [GO:0031543] g1232.t1 Q9BX74 48.101 158 3.2299999999999995e-42 147.0 sp|Q9BX74|TM2D1_HUMAN TM2 domain-containing protein 1 OS=Homo sapiens OX=9606 GN=TM2D1 PE=1 SV=1 TM2D1_HUMAN reviewed TM2 domain-containing protein 1 (Amyloid-beta-binding protein) (hBBP) Homo sapiens (Human) GO:0001540; GO:0004930; GO:0005886; GO:0097190 apoptotic signaling pathway [GO:0097190] plasma membrane [GO:0005886] amyloid-beta binding [GO:0001540]; G protein-coupled receptor activity [GO:0004930] g1233.t1 Q96RT1 49.167 480 4.1599999999999996e-128 436.0 sp|Q96RT1|ERBIN_HUMAN Erbin OS=Homo sapiens OX=9606 GN=ERBIN PE=1 SV=2 g1234.t1 Q9CZU3 69.847 1048 0.0 1462.0 sp|Q9CZU3|MTREX_MOUSE Exosome RNA helicase MTR4 OS=Mus musculus OX=10090 GN=Mtrex PE=1 SV=1 MTREX_MOUSE reviewed Exosome RNA helicase MTR4 (EC 3.6.4.13) (ATP-dependent helicase SKIV2L2) (Superkiller viralicidic activity 2-like 2) (TRAMP-like complex helicase) Mus musculus (Mouse) GO:0000176; GO:0000460; GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0006364; GO:0006397; GO:0006401; GO:0006974; GO:0008380; GO:0016607; GO:0016887; GO:0031499; GO:0071013 DNA damage response [GO:0006974]; maturation of 5.8S rRNA [GO:0000460]; mRNA processing [GO:0006397]; RNA catabolic process [GO:0006401]; RNA splicing [GO:0008380]; rRNA processing [GO:0006364] catalytic step 2 spliceosome [GO:0071013]; nuclear exosome (RNase complex) [GO:0000176]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; TRAMP complex [GO:0031499] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724] g1246.t1 Q64176 36.59 522 1.5499999999999999e-90 291.0 sp|Q64176|EST1E_MOUSE Carboxylesterase 1E OS=Mus musculus OX=10090 GN=Ces1e PE=1 SV=1 EST1E_MOUSE reviewed Carboxylesterase 1E (EC 3.1.1.1) (Egasyn) (Liver carboxylesterase 22) (Es-22) (Esterase-22) Mus musculus (Mouse) GO:0001523; GO:0004771; GO:0005737; GO:0005783; GO:0005788; GO:0005811; GO:0006695; GO:0008203; GO:0010875; GO:0010887; GO:0016042; GO:0030855; GO:0035238; GO:0042632; GO:0043691; GO:0047376; GO:0050253; GO:0051791; GO:0052689; GO:0070857; GO:0071397; GO:0071404; GO:0090205; GO:0106435; GO:0120188 cellular response to cholesterol [GO:0071397]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; cholesterol biosynthetic process [GO:0006695]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; epithelial cell differentiation [GO:0030855]; lipid catabolic process [GO:0016042]; medium-chain fatty acid metabolic process [GO:0051791]; negative regulation of cholesterol storage [GO:0010887]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of cholesterol metabolic process [GO:0090205]; regulation of bile acid biosynthetic process [GO:0070857]; regulation of bile acid secretion [GO:0120188]; retinoid metabolic process [GO:0001523]; reverse cholesterol transport [GO:0043691]; vitamin A biosynthetic process [GO:0035238] cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; lipid droplet [GO:0005811] all-trans-retinyl-palmitate hydrolase, all-trans-retinol forming activity [GO:0047376]; carboxylesterase activity [GO:0106435]; carboxylic ester hydrolase activity [GO:0052689]; retinyl-palmitate esterase activity [GO:0050253]; sterol ester esterase activity [GO:0004771] g1247.t1 Q9Y5W3 91.667 84 1.48e-49 173.0 sp|Q9Y5W3|KLF2_HUMAN Krueppel-like factor 2 OS=Homo sapiens OX=9606 GN=KLF2 PE=1 SV=2 KLF2_HUMAN reviewed Krueppel-like factor 2 (Lung krueppel-like factor) Homo sapiens (Human) GO:0000122; GO:0000785; GO:0000902; GO:0000978; GO:0000981; GO:0001701; GO:0003677; GO:0003700; GO:0005634; GO:0006357; GO:0008270; GO:0032715; GO:0035264; GO:0040029; GO:0042311; GO:0043249; GO:0045429; GO:0045893; GO:0045944; GO:0048386; GO:0051247; GO:0060509; GO:0070301; GO:0071347; GO:0071356; GO:0071498; GO:0071499; GO:0097533; GO:1903671; GO:1990837; GO:1990859 cell morphogenesis [GO:0000902]; cellular response to endothelin [GO:1990859]; cellular response to fluid shear stress [GO:0071498]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to interleukin-1 [GO:0071347]; cellular response to laminar fluid shear stress [GO:0071499]; cellular response to tumor necrosis factor [GO:0071356]; cellular stress response to acid chemical [GO:0097533]; epigenetic regulation of gene expression [GO:0040029]; erythrocyte maturation [GO:0043249]; in utero embryonic development [GO:0001701]; multicellular organism growth [GO:0035264]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of sprouting angiogenesis [GO:1903671]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of protein metabolic process [GO:0051247]; positive regulation of retinoic acid receptor signaling pathway [GO:0048386]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; type I pneumocyte differentiation [GO:0060509]; vasodilation [GO:0042311] chromatin [GO:0000785]; nucleus [GO:0005634] DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; zinc ion binding [GO:0008270] g1249.t1 Q19425 52.778 144 1.86e-33 132.0 sp|Q19425|S38A9_CAEEL Sodium-coupled neutral amino acid transporter 9 homolog OS=Caenorhabditis elegans OX=6239 GN=F13H10.3 PE=3 SV=2 g1250.t1 Q19425 49.64 278 7.239999999999999e-89 279.0 sp|Q19425|S38A9_CAEEL Sodium-coupled neutral amino acid transporter 9 homolog OS=Caenorhabditis elegans OX=6239 GN=F13H10.3 PE=3 SV=2 g1250.t2 Q19425 49.281 278 1.2700000000000001e-86 273.0 sp|Q19425|S38A9_CAEEL Sodium-coupled neutral amino acid transporter 9 homolog OS=Caenorhabditis elegans OX=6239 GN=F13H10.3 PE=3 SV=2 g1250.t3 Q19425 45.098 306 6.47e-83 265.0 sp|Q19425|S38A9_CAEEL Sodium-coupled neutral amino acid transporter 9 homolog OS=Caenorhabditis elegans OX=6239 GN=F13H10.3 PE=3 SV=2 g1251.t1 P43403 51.14 307 6.3e-92 301.0 sp|P43403|ZAP70_HUMAN Tyrosine-protein kinase ZAP-70 OS=Homo sapiens OX=9606 GN=ZAP70 PE=1 SV=1 ZAP70_HUMAN reviewed Tyrosine-protein kinase ZAP-70 (EC 2.7.10.2) (70 kDa zeta-chain associated protein) (Syk-related tyrosine kinase) Homo sapiens (Human) GO:0001772; GO:0001784; GO:0002250; GO:0004713; GO:0004715; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0005911; GO:0006468; GO:0006955; GO:0018108; GO:0019722; GO:0030217; GO:0035556; GO:0042101; GO:0042110; GO:0042113; GO:0043366; GO:0045059; GO:0045060; GO:0045582; GO:0046638; GO:0046641; GO:0050850; GO:0050852; GO:0070489; GO:0072678 adaptive immune response [GO:0002250]; B cell activation [GO:0042113]; beta selection [GO:0043366]; calcium-mediated signaling [GO:0019722]; immune response [GO:0006955]; intracellular signal transduction [GO:0035556]; negative thymic T cell selection [GO:0045060]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of alpha-beta T cell differentiation [GO:0046638]; positive regulation of alpha-beta T cell proliferation [GO:0046641]; positive regulation of calcium-mediated signaling [GO:0050850]; positive regulation of T cell differentiation [GO:0045582]; positive thymic T cell selection [GO:0045059]; protein phosphorylation [GO:0006468]; T cell activation [GO:0042110]; T cell aggregation [GO:0070489]; T cell differentiation [GO:0030217]; T cell migration [GO:0072678]; T cell receptor signaling pathway [GO:0050852] cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; immunological synapse [GO:0001772]; plasma membrane [GO:0005886]; T cell receptor complex [GO:0042101] ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; phosphotyrosine residue binding [GO:0001784]; protein tyrosine kinase activity [GO:0004713] g1251.t1 P43403 37.5 256 3.5000000000000003e-47 180.0 sp|P43403|ZAP70_HUMAN Tyrosine-protein kinase ZAP-70 OS=Homo sapiens OX=9606 GN=ZAP70 PE=1 SV=1 ZAP70_HUMAN reviewed Tyrosine-protein kinase ZAP-70 (EC 2.7.10.2) (70 kDa zeta-chain associated protein) (Syk-related tyrosine kinase) Homo sapiens (Human) GO:0001772; GO:0001784; GO:0002250; GO:0004713; GO:0004715; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0005911; GO:0006468; GO:0006955; GO:0018108; GO:0019722; GO:0030217; GO:0035556; GO:0042101; GO:0042110; GO:0042113; GO:0043366; GO:0045059; GO:0045060; GO:0045582; GO:0046638; GO:0046641; GO:0050850; GO:0050852; GO:0070489; GO:0072678 adaptive immune response [GO:0002250]; B cell activation [GO:0042113]; beta selection [GO:0043366]; calcium-mediated signaling [GO:0019722]; immune response [GO:0006955]; intracellular signal transduction [GO:0035556]; negative thymic T cell selection [GO:0045060]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of alpha-beta T cell differentiation [GO:0046638]; positive regulation of alpha-beta T cell proliferation [GO:0046641]; positive regulation of calcium-mediated signaling [GO:0050850]; positive regulation of T cell differentiation [GO:0045582]; positive thymic T cell selection [GO:0045059]; protein phosphorylation [GO:0006468]; T cell activation [GO:0042110]; T cell aggregation [GO:0070489]; T cell differentiation [GO:0030217]; T cell migration [GO:0072678]; T cell receptor signaling pathway [GO:0050852] cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; immunological synapse [GO:0001772]; plasma membrane [GO:0005886]; T cell receptor complex [GO:0042101] ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; phosphotyrosine residue binding [GO:0001784]; protein tyrosine kinase activity [GO:0004713] g1252.t1 Q8C9J3 37.284 464 1.5200000000000001e-77 290.0 sp|Q8C9J3|SPEF2_MOUSE Sperm flagellar protein 2 OS=Mus musculus OX=10090 GN=Spef2 PE=1 SV=3 SPEF2_MOUSE reviewed Sperm flagellar protein 2 (Protein KPL2) Mus musculus (Mouse) GO:0002177; GO:0003351; GO:0005576; GO:0005737; GO:0005794; GO:0005829; GO:0005929; GO:0007283; GO:0007288; GO:0016604; GO:0036126; GO:0044458; GO:0048705; GO:0048854; GO:0060541; GO:0090660; GO:0097225; GO:0120197 brain morphogenesis [GO:0048854]; cerebrospinal fluid circulation [GO:0090660]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; motile cilium assembly [GO:0044458]; mucociliary clearance [GO:0120197]; respiratory system development [GO:0060541]; skeletal system morphogenesis [GO:0048705]; sperm axoneme assembly [GO:0007288]; spermatogenesis [GO:0007283] cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; manchette [GO:0002177]; nuclear body [GO:0016604]; sperm flagellum [GO:0036126]; sperm midpiece [GO:0097225] g1252.t1 Q8C9J3 38.872 337 4.0499999999999995e-55 217.0 sp|Q8C9J3|SPEF2_MOUSE Sperm flagellar protein 2 OS=Mus musculus OX=10090 GN=Spef2 PE=1 SV=3 SPEF2_MOUSE reviewed Sperm flagellar protein 2 (Protein KPL2) Mus musculus (Mouse) GO:0002177; GO:0003351; GO:0005576; GO:0005737; GO:0005794; GO:0005829; GO:0005929; GO:0007283; GO:0007288; GO:0016604; GO:0036126; GO:0044458; GO:0048705; GO:0048854; GO:0060541; GO:0090660; GO:0097225; GO:0120197 brain morphogenesis [GO:0048854]; cerebrospinal fluid circulation [GO:0090660]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; motile cilium assembly [GO:0044458]; mucociliary clearance [GO:0120197]; respiratory system development [GO:0060541]; skeletal system morphogenesis [GO:0048705]; sperm axoneme assembly [GO:0007288]; spermatogenesis [GO:0007283] cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; manchette [GO:0002177]; nuclear body [GO:0016604]; sperm flagellum [GO:0036126]; sperm midpiece [GO:0097225] g1252.t1 Q8C9J3 48.148 189 5.18e-55 216.0 sp|Q8C9J3|SPEF2_MOUSE Sperm flagellar protein 2 OS=Mus musculus OX=10090 GN=Spef2 PE=1 SV=3 SPEF2_MOUSE reviewed Sperm flagellar protein 2 (Protein KPL2) Mus musculus (Mouse) GO:0002177; GO:0003351; GO:0005576; GO:0005737; GO:0005794; GO:0005829; GO:0005929; GO:0007283; GO:0007288; GO:0016604; GO:0036126; GO:0044458; GO:0048705; GO:0048854; GO:0060541; GO:0090660; GO:0097225; GO:0120197 brain morphogenesis [GO:0048854]; cerebrospinal fluid circulation [GO:0090660]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; motile cilium assembly [GO:0044458]; mucociliary clearance [GO:0120197]; respiratory system development [GO:0060541]; skeletal system morphogenesis [GO:0048705]; sperm axoneme assembly [GO:0007288]; spermatogenesis [GO:0007283] cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; manchette [GO:0002177]; nuclear body [GO:0016604]; sperm flagellum [GO:0036126]; sperm midpiece [GO:0097225] g1252.t1 Q8C9J3 34.225 374 6.48e-49 196.0 sp|Q8C9J3|SPEF2_MOUSE Sperm flagellar protein 2 OS=Mus musculus OX=10090 GN=Spef2 PE=1 SV=3 SPEF2_MOUSE reviewed Sperm flagellar protein 2 (Protein KPL2) Mus musculus (Mouse) GO:0002177; GO:0003351; GO:0005576; GO:0005737; GO:0005794; GO:0005829; GO:0005929; GO:0007283; GO:0007288; GO:0016604; GO:0036126; GO:0044458; GO:0048705; GO:0048854; GO:0060541; GO:0090660; GO:0097225; GO:0120197 brain morphogenesis [GO:0048854]; cerebrospinal fluid circulation [GO:0090660]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; motile cilium assembly [GO:0044458]; mucociliary clearance [GO:0120197]; respiratory system development [GO:0060541]; skeletal system morphogenesis [GO:0048705]; sperm axoneme assembly [GO:0007288]; spermatogenesis [GO:0007283] cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; manchette [GO:0002177]; nuclear body [GO:0016604]; sperm flagellum [GO:0036126]; sperm midpiece [GO:0097225] g1252.t2 Q8C9J3 37.069 464 1.88e-77 289.0 sp|Q8C9J3|SPEF2_MOUSE Sperm flagellar protein 2 OS=Mus musculus OX=10090 GN=Spef2 PE=1 SV=3 SPEF2_MOUSE reviewed Sperm flagellar protein 2 (Protein KPL2) Mus musculus (Mouse) GO:0002177; GO:0003351; GO:0005576; GO:0005737; GO:0005794; GO:0005829; GO:0005929; GO:0007283; GO:0007288; GO:0016604; GO:0036126; GO:0044458; GO:0048705; GO:0048854; GO:0060541; GO:0090660; GO:0097225; GO:0120197 brain morphogenesis [GO:0048854]; cerebrospinal fluid circulation [GO:0090660]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; motile cilium assembly [GO:0044458]; mucociliary clearance [GO:0120197]; respiratory system development [GO:0060541]; skeletal system morphogenesis [GO:0048705]; sperm axoneme assembly [GO:0007288]; spermatogenesis [GO:0007283] cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; manchette [GO:0002177]; nuclear body [GO:0016604]; sperm flagellum [GO:0036126]; sperm midpiece [GO:0097225] g1252.t2 Q8C9J3 38.872 337 4.03e-55 217.0 sp|Q8C9J3|SPEF2_MOUSE Sperm flagellar protein 2 OS=Mus musculus OX=10090 GN=Spef2 PE=1 SV=3 SPEF2_MOUSE reviewed Sperm flagellar protein 2 (Protein KPL2) Mus musculus (Mouse) GO:0002177; GO:0003351; GO:0005576; GO:0005737; GO:0005794; GO:0005829; GO:0005929; GO:0007283; GO:0007288; GO:0016604; GO:0036126; GO:0044458; GO:0048705; GO:0048854; GO:0060541; GO:0090660; GO:0097225; GO:0120197 brain morphogenesis [GO:0048854]; cerebrospinal fluid circulation [GO:0090660]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; motile cilium assembly [GO:0044458]; mucociliary clearance [GO:0120197]; respiratory system development [GO:0060541]; skeletal system morphogenesis [GO:0048705]; sperm axoneme assembly [GO:0007288]; spermatogenesis [GO:0007283] cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; manchette [GO:0002177]; nuclear body [GO:0016604]; sperm flagellum [GO:0036126]; sperm midpiece [GO:0097225] g1252.t2 Q8C9J3 48.148 189 5.19e-55 216.0 sp|Q8C9J3|SPEF2_MOUSE Sperm flagellar protein 2 OS=Mus musculus OX=10090 GN=Spef2 PE=1 SV=3 SPEF2_MOUSE reviewed Sperm flagellar protein 2 (Protein KPL2) Mus musculus (Mouse) GO:0002177; GO:0003351; GO:0005576; GO:0005737; GO:0005794; GO:0005829; GO:0005929; GO:0007283; GO:0007288; GO:0016604; GO:0036126; GO:0044458; GO:0048705; GO:0048854; GO:0060541; GO:0090660; GO:0097225; GO:0120197 brain morphogenesis [GO:0048854]; cerebrospinal fluid circulation [GO:0090660]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; motile cilium assembly [GO:0044458]; mucociliary clearance [GO:0120197]; respiratory system development [GO:0060541]; skeletal system morphogenesis [GO:0048705]; sperm axoneme assembly [GO:0007288]; spermatogenesis [GO:0007283] cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; manchette [GO:0002177]; nuclear body [GO:0016604]; sperm flagellum [GO:0036126]; sperm midpiece [GO:0097225] g1252.t2 Q8C9J3 34.225 374 6.44e-49 196.0 sp|Q8C9J3|SPEF2_MOUSE Sperm flagellar protein 2 OS=Mus musculus OX=10090 GN=Spef2 PE=1 SV=3 SPEF2_MOUSE reviewed Sperm flagellar protein 2 (Protein KPL2) Mus musculus (Mouse) GO:0002177; GO:0003351; GO:0005576; GO:0005737; GO:0005794; GO:0005829; GO:0005929; GO:0007283; GO:0007288; GO:0016604; GO:0036126; GO:0044458; GO:0048705; GO:0048854; GO:0060541; GO:0090660; GO:0097225; GO:0120197 brain morphogenesis [GO:0048854]; cerebrospinal fluid circulation [GO:0090660]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; motile cilium assembly [GO:0044458]; mucociliary clearance [GO:0120197]; respiratory system development [GO:0060541]; skeletal system morphogenesis [GO:0048705]; sperm axoneme assembly [GO:0007288]; spermatogenesis [GO:0007283] cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; manchette [GO:0002177]; nuclear body [GO:0016604]; sperm flagellum [GO:0036126]; sperm midpiece [GO:0097225] g1252.t3 Q8C9J3 37.284 464 6.19e-82 289.0 sp|Q8C9J3|SPEF2_MOUSE Sperm flagellar protein 2 OS=Mus musculus OX=10090 GN=Spef2 PE=1 SV=3 SPEF2_MOUSE reviewed Sperm flagellar protein 2 (Protein KPL2) Mus musculus (Mouse) GO:0002177; GO:0003351; GO:0005576; GO:0005737; GO:0005794; GO:0005829; GO:0005929; GO:0007283; GO:0007288; GO:0016604; GO:0036126; GO:0044458; GO:0048705; GO:0048854; GO:0060541; GO:0090660; GO:0097225; GO:0120197 brain morphogenesis [GO:0048854]; cerebrospinal fluid circulation [GO:0090660]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; motile cilium assembly [GO:0044458]; mucociliary clearance [GO:0120197]; respiratory system development [GO:0060541]; skeletal system morphogenesis [GO:0048705]; sperm axoneme assembly [GO:0007288]; spermatogenesis [GO:0007283] cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; manchette [GO:0002177]; nuclear body [GO:0016604]; sperm flagellum [GO:0036126]; sperm midpiece [GO:0097225] g1254.t1 Q8CDY7 32.487 197 9.390000000000001e-26 102.0 sp|Q8CDY7|DYLT4_MOUSE Dynein light chain Tctex-type 4 OS=Mus musculus OX=10090 GN=Dynlt4 PE=1 SV=1 g1255.t1 Q5RBW0 52.432 185 9.23e-53 181.0 sp|Q5RBW0|SETD9_PONAB SET domain-containing protein 9 OS=Pongo abelii OX=9601 GN=SETD9 PE=2 SV=1 g1257.t1 Q9HBL7 42.647 136 5.35e-36 124.0 sp|Q9HBL7|PLRKT_HUMAN Plasminogen receptor (KT) OS=Homo sapiens OX=9606 GN=PLGRKT PE=1 SV=1 g1263.t1 P18715 43.571 140 2.28e-34 129.0 sp|P18715|ZG26_XENLA Gastrula zinc finger protein XlCGF26.1 (Fragment) OS=Xenopus laevis OX=8355 PE=3 SV=1 g1263.t1 P18715 40.714 140 7.099999999999999e-30 117.0 sp|P18715|ZG26_XENLA Gastrula zinc finger protein XlCGF26.1 (Fragment) OS=Xenopus laevis OX=8355 PE=3 SV=1 g1263.t1 P18715 41.429 140 3.47e-29 115.0 sp|P18715|ZG26_XENLA Gastrula zinc finger protein XlCGF26.1 (Fragment) OS=Xenopus laevis OX=8355 PE=3 SV=1 g1263.t1 P18715 42.857 140 6.81e-29 115.0 sp|P18715|ZG26_XENLA Gastrula zinc finger protein XlCGF26.1 (Fragment) OS=Xenopus laevis OX=8355 PE=3 SV=1 g1263.t1 P18715 41.429 140 2.8100000000000002e-27 110.0 sp|P18715|ZG26_XENLA Gastrula zinc finger protein XlCGF26.1 (Fragment) OS=Xenopus laevis OX=8355 PE=3 SV=1 g1263.t1 P18715 42.754 138 9.67e-27 109.0 sp|P18715|ZG26_XENLA Gastrula zinc finger protein XlCGF26.1 (Fragment) OS=Xenopus laevis OX=8355 PE=3 SV=1 g1263.t1 P18715 40.714 140 1.69e-26 108.0 sp|P18715|ZG26_XENLA Gastrula zinc finger protein XlCGF26.1 (Fragment) OS=Xenopus laevis OX=8355 PE=3 SV=1 g1268.t1 Q9PTS2 59.444 360 1.61e-157 462.0 sp|Q9PTS2|DCUP_DANRE Uroporphyrinogen decarboxylase OS=Danio rerio OX=7955 GN=urod PE=1 SV=1 g1269.t1 Q8WPD0 39.865 148 1.76e-28 106.0 sp|Q8WPD0|LECG_PATPE Alpha-N-acetylgalactosamine-specific lectin OS=Patiria pectinifera OX=7594 PE=1 SV=1 g1273.t1 Q9NPF5 65.473 391 5.9900000000000005e-167 483.0 sp|Q9NPF5|DMAP1_HUMAN DNA methyltransferase 1-associated protein 1 OS=Homo sapiens OX=9606 GN=DMAP1 PE=1 SV=1 DMAP1_HUMAN reviewed DNA methyltransferase 1-associated protein 1 (DNMAP1) (DNMT1-associated protein 1) Homo sapiens (Human) GO:0000122; GO:0000786; GO:0000812; GO:0003714; GO:0005634; GO:0005654; GO:0005657; GO:0005737; GO:0005829; GO:0006281; GO:0006338; GO:0006355; GO:0035267; GO:0042307; GO:0042981; GO:0045471; GO:0045892; GO:0045893; GO:0051726; GO:0061629; GO:1905168; GO:2000779 chromatin remodeling [GO:0006338]; DNA repair [GO:0006281]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of protein import into nucleus [GO:0042307]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of DNA-templated transcription [GO:0006355]; regulation of double-strand break repair [GO:2000779]; response to ethanol [GO:0045471] cytoplasm [GO:0005737]; cytosol [GO:0005829]; NuA4 histone acetyltransferase complex [GO:0035267]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634]; replication fork [GO:0005657]; Swr1 complex [GO:0000812] RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription corepressor activity [GO:0003714] g1274.t1 B1H283 39.529 382 9.14e-74 239.0 sp|B1H283|CMAP2_RAT Ciliary microtubule-associated protein 2 OS=Rattus norvegicus OX=10116 GN=Cimap2 PE=2 SV=1 g1275.t1 P10079 47.009 234 3.1399999999999997e-54 212.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g1275.t1 P10079 46.61 236 2.94e-53 209.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g1275.t1 P10079 49.362 235 4.8e-53 208.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g1275.t1 P10079 48.23 226 1.89e-52 206.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g1275.t1 P10079 47.458 236 2.9799999999999998e-52 206.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g1275.t1 P10079 45.339 236 2.59e-51 202.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g1275.t1 P10079 45.064 233 2.82e-51 202.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g1275.t1 P10079 48.696 230 3.11e-51 202.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g1275.t1 P10079 46.383 235 8.24e-51 201.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g1275.t1 P10079 49.339 227 4.34e-50 199.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g1275.t1 P10079 44.915 236 1.7999999999999998e-48 194.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g1275.t1 P10079 44.017 234 3.8300000000000004e-43 176.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g1275.t1 P10079 46.561 189 1.93e-40 168.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g1275.t1 P10079 46.927 179 2.3900000000000002e-35 151.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g1275.t1 P10079 42.484 153 5.850000000000001e-26 121.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g1289.t1 Q5VYK3 74.775 111 1.49e-49 171.0 sp|Q5VYK3|ECM29_HUMAN Proteasome adapter and scaffold protein ECM29 OS=Homo sapiens OX=9606 GN=ECPAS PE=1 SV=2 ECM29_HUMAN reviewed Proteasome adapter and scaffold protein ECM29 (Ecm29 proteasome adapter and scaffold) (Proteasome-associated protein ECM29 homolog) Homo sapiens (Human) GO:0000502; GO:0005634; GO:0005654; GO:0005737; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005793; GO:0005813; GO:0016020; GO:0030134; GO:0030139; GO:0031410; GO:0036503; GO:0043248; GO:0060090; GO:0070628 ERAD pathway [GO:0036503]; proteasome assembly [GO:0043248] centrosome [GO:0005813]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome complex [GO:0000502] molecular adaptor activity [GO:0060090]; proteasome binding [GO:0070628] g1290.t1 Q5VYK3 48.295 1466 0.0 1346.0 sp|Q5VYK3|ECM29_HUMAN Proteasome adapter and scaffold protein ECM29 OS=Homo sapiens OX=9606 GN=ECPAS PE=1 SV=2 ECM29_HUMAN reviewed Proteasome adapter and scaffold protein ECM29 (Ecm29 proteasome adapter and scaffold) (Proteasome-associated protein ECM29 homolog) Homo sapiens (Human) GO:0000502; GO:0005634; GO:0005654; GO:0005737; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005793; GO:0005813; GO:0016020; GO:0030134; GO:0030139; GO:0031410; GO:0036503; GO:0043248; GO:0060090; GO:0070628 ERAD pathway [GO:0036503]; proteasome assembly [GO:0043248] centrosome [GO:0005813]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome complex [GO:0000502] molecular adaptor activity [GO:0060090]; proteasome binding [GO:0070628] g1293.t1 Q8K0C1 45.321 951 0.0 818.0 sp|Q8K0C1|IPO13_MOUSE Importin-13 OS=Mus musculus OX=10090 GN=Ipo13 PE=1 SV=1 g1294.t1 Q7TMA5 28.935 1099 1.67e-107 378.0 sp|Q7TMA5|APOB_RAT Apolipoprotein B-100 OS=Rattus norvegicus OX=10116 GN=Apob PE=1 SV=1 APOB_RAT reviewed Apolipoprotein B-100 (Apo B-100) [Cleaved into: Apolipoprotein B-48 (Apo B-48)] Rattus norvegicus (Rat) GO:0001701; GO:0005543; GO:0005615; GO:0005737; GO:0005783; GO:0005811; GO:0005829; GO:0006629; GO:0006642; GO:0007283; GO:0007399; GO:0008201; GO:0008203; GO:0009566; GO:0009615; GO:0009743; GO:0009791; GO:0010269; GO:0010628; GO:0010744; GO:0010884; GO:0010886; GO:0016042; GO:0019433; GO:0030301; GO:0030317; GO:0031983; GO:0032355; GO:0032496; GO:0033344; GO:0034359; GO:0034361; GO:0034362; GO:0034363; GO:0034364; GO:0034374; GO:0034383; GO:0035473; GO:0042157; GO:0042158; GO:0042159; GO:0042627; GO:0042632; GO:0042953; GO:0043025; GO:0045540; GO:0048018; GO:0048844; GO:0050750; GO:0051649; GO:0070971; GO:0071356; GO:0071379; GO:0071402; GO:0120020; GO:1904646 artery morphogenesis [GO:0048844]; cellular response to amyloid-beta [GO:1904646]; cellular response to lipoprotein particle stimulus [GO:0071402]; cellular response to prostaglandin stimulus [GO:0071379]; cellular response to tumor necrosis factor [GO:0071356]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; establishment of localization in cell [GO:0051649]; fertilization [GO:0009566]; flagellated sperm motility [GO:0030317]; in utero embryonic development [GO:0001701]; lipid catabolic process [GO:0016042]; lipid metabolic process [GO:0006629]; lipoprotein biosynthetic process [GO:0042158]; lipoprotein catabolic process [GO:0042159]; lipoprotein metabolic process [GO:0042157]; lipoprotein transport [GO:0042953]; low-density lipoprotein particle clearance [GO:0034383]; low-density lipoprotein particle remodeling [GO:0034374]; nervous system development [GO:0007399]; positive regulation of cholesterol storage [GO:0010886]; positive regulation of gene expression [GO:0010628]; positive regulation of lipid storage [GO:0010884]; positive regulation of macrophage derived foam cell differentiation [GO:0010744]; post-embryonic development [GO:0009791]; regulation of cholesterol biosynthetic process [GO:0045540]; response to carbohydrate [GO:0009743]; response to estradiol [GO:0032355]; response to lipopolysaccharide [GO:0032496]; response to selenium ion [GO:0010269]; response to virus [GO:0009615]; spermatogenesis [GO:0007283]; triglyceride catabolic process [GO:0019433]; triglyceride mobilization [GO:0006642] chylomicron [GO:0042627]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum exit site [GO:0070971]; extracellular space [GO:0005615]; high-density lipoprotein particle [GO:0034364]; intermediate-density lipoprotein particle [GO:0034363]; lipid droplet [GO:0005811]; low-density lipoprotein particle [GO:0034362]; mature chylomicron [GO:0034359]; neuronal cell body [GO:0043025]; very-low-density lipoprotein particle [GO:0034361]; vesicle lumen [GO:0031983] cholesterol transfer activity [GO:0120020]; heparin binding [GO:0008201]; lipase binding [GO:0035473]; low-density lipoprotein particle receptor binding [GO:0050750]; phospholipid binding [GO:0005543]; receptor ligand activity [GO:0048018] g1296.t1 Q9U943 24.162 567 3.74e-25 119.0 sp|Q9U943|APLP_LOCMI Apolipophorins OS=Locusta migratoria OX=7004 PE=1 SV=2 g1299.t2 E1BD59 27.682 289 8.100000000000001e-21 100.0 sp|E1BD59|TRI56_BOVIN E3 ubiquitin-protein ligase TRIM56 OS=Bos taurus OX=9913 GN=TRIM56 PE=2 SV=1 TRI56_BOVIN reviewed E3 ubiquitin-protein ligase TRIM56 (EC 2.3.2.27) (Tripartite motif-containing protein 56) Bos taurus (Bovine) GO:0005654; GO:0005737; GO:0006513; GO:0008270; GO:0032728; GO:0034340; GO:0045087; GO:0051607; GO:0060340; GO:0061630; GO:0070534 defense response to virus [GO:0051607]; innate immune response [GO:0045087]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of type I interferon-mediated signaling pathway [GO:0060340]; protein K63-linked ubiquitination [GO:0070534]; protein monoubiquitination [GO:0006513]; response to type I interferon [GO:0034340] cytoplasm [GO:0005737]; nucleoplasm [GO:0005654] ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] g1303.t1 Q17RR3 38.873 355 6.300000000000001e-70 230.0 sp|Q17RR3|LIPR3_HUMAN Pancreatic lipase-related protein 3 OS=Homo sapiens OX=9606 GN=PNLIPRP3 PE=1 SV=2 LIPR3_HUMAN reviewed Pancreatic lipase-related protein 3 (PL-RP3) (EC 3.1.1.3) Homo sapiens (Human) GO:0004465; GO:0005576; GO:0006633; GO:0008970; GO:0019433; GO:0034375; GO:0042632 cholesterol homeostasis [GO:0042632]; fatty acid biosynthetic process [GO:0006633]; high-density lipoprotein particle remodeling [GO:0034375]; triglyceride catabolic process [GO:0019433] extracellular region [GO:0005576] lipoprotein lipase activity [GO:0004465]; phospholipase A1 activity [GO:0008970] g1304.t1 Q8R4F0 44.693 537 3.42e-153 456.0 sp|Q8R4F0|MCLN3_MOUSE Mucolipin-3 OS=Mus musculus OX=10090 GN=Mcoln3 PE=1 SV=1 MCLN3_MOUSE reviewed Mucolipin-3 (Transient receptor potential channel mucolipin 3) (TRPML3) Mus musculus (Mouse) GO:0000421; GO:0005253; GO:0005267; GO:0005272; GO:0005737; GO:0005765; GO:0005886; GO:0007626; GO:0008289; GO:0031901; GO:0031902; GO:0042491; GO:0060171; GO:0072345 inner ear auditory receptor cell differentiation [GO:0042491]; locomotory behavior [GO:0007626] autophagosome membrane [GO:0000421]; cytoplasm [GO:0005737]; early endosome membrane [GO:0031901]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; stereocilium membrane [GO:0060171] lipid binding [GO:0008289]; monoatomic anion channel activity [GO:0005253]; NAADP-sensitive calcium-release channel activity [GO:0072345]; potassium channel activity [GO:0005267]; sodium channel activity [GO:0005272] g1305.t1 Q66KE8 34.242 330 1.2899999999999999e-45 174.0 sp|Q66KE8|CCD78_XENLA Coiled-coil domain-containing protein 78 OS=Xenopus laevis OX=8355 GN=ccdc78 PE=2 SV=1 g1306.t1 Q66KE8 35.838 173 3.96e-21 92.8 sp|Q66KE8|CCD78_XENLA Coiled-coil domain-containing protein 78 OS=Xenopus laevis OX=8355 GN=ccdc78 PE=2 SV=1 g1307.t1 A0PJE2 45.294 170 3.6399999999999995e-46 156.0 sp|A0PJE2|DHR12_HUMAN Dehydrogenase/reductase SDR family member 12 OS=Homo sapiens OX=9606 GN=DHRS12 PE=1 SV=2 DHR12_HUMAN reviewed Dehydrogenase/reductase SDR family member 12 (EC 1.1.-.-) (Short-chain dehydrogenase/reductase family 40C member 1) (Protein SDR40C1) Homo sapiens (Human) GO:0016491 oxidoreductase activity [GO:0016491] g1307.t2 A0PJE2 45.087 173 2.39e-46 157.0 sp|A0PJE2|DHR12_HUMAN Dehydrogenase/reductase SDR family member 12 OS=Homo sapiens OX=9606 GN=DHRS12 PE=1 SV=2 DHR12_HUMAN reviewed Dehydrogenase/reductase SDR family member 12 (EC 1.1.-.-) (Short-chain dehydrogenase/reductase family 40C member 1) (Protein SDR40C1) Homo sapiens (Human) GO:0016491 oxidoreductase activity [GO:0016491] g1309.t1 Q71SG7 41.399 343 1.62e-85 270.0 sp|Q71SG7|GCNT4_DANRE Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase 4 OS=Danio rerio OX=7955 GN=gcnt4 PE=2 SV=2 g1310.t1 Q03168 52.368 380 4.8399999999999995e-136 397.0 sp|Q03168|ASPP_AEDAE Lysosomal aspartic protease OS=Aedes aegypti OX=7159 GN=AAEL006169 PE=1 SV=2 g1312.t1 Q7T3T8 43.434 99 1.3600000000000001e-21 89.7 sp|Q7T3T8|ZAR1_DANRE Zygote arrest protein 1 OS=Danio rerio OX=7955 GN=zar1 PE=1 SV=1 ZAR1_DANRE reviewed Zygote arrest protein 1 Danio rerio (Zebrafish) (Brachydanio rerio) GO:0003729; GO:0005737; GO:0006412; GO:0008270; GO:0017148; GO:0030371; GO:0032991; GO:0036464; GO:0048477; GO:1905881 negative regulation of translation [GO:0017148]; oogenesis [GO:0048477]; positive regulation of oogenesis [GO:1905881]; translation [GO:0006412] cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; protein-containing complex [GO:0032991] mRNA binding [GO:0003729]; translation repressor activity [GO:0030371]; zinc ion binding [GO:0008270] g1313.t1 Q96RW7 42.222 360 3.43e-74 274.0 sp|Q96RW7|HMCN1_HUMAN Hemicentin-1 OS=Homo sapiens OX=9606 GN=HMCN1 PE=1 SV=2 HMCN1_HUMAN reviewed Hemicentin-1 (Fibulin-6) (FIBL-6) Homo sapiens (Human) GO:0005201; GO:0005509; GO:0005604; GO:0005737; GO:0005886; GO:0005912; GO:0005927; GO:0005938; GO:0007156; GO:0007157; GO:0007601; GO:0009617; GO:0030036; GO:0031012; GO:0032154; GO:0051301; GO:0070062; GO:0071711; GO:0098631 actin cytoskeleton organization [GO:0030036]; basement membrane organization [GO:0071711]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601] adherens junction [GO:0005912]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; muscle tendon junction [GO:0005927]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; cell adhesion mediator activity [GO:0098631]; extracellular matrix structural constituent [GO:0005201] g1313.t1 Q96RW7 38.071 394 2.67e-70 262.0 sp|Q96RW7|HMCN1_HUMAN Hemicentin-1 OS=Homo sapiens OX=9606 GN=HMCN1 PE=1 SV=2 HMCN1_HUMAN reviewed Hemicentin-1 (Fibulin-6) (FIBL-6) Homo sapiens (Human) GO:0005201; GO:0005509; GO:0005604; GO:0005737; GO:0005886; GO:0005912; GO:0005927; GO:0005938; GO:0007156; GO:0007157; GO:0007601; GO:0009617; GO:0030036; GO:0031012; GO:0032154; GO:0051301; GO:0070062; GO:0071711; GO:0098631 actin cytoskeleton organization [GO:0030036]; basement membrane organization [GO:0071711]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601] adherens junction [GO:0005912]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; muscle tendon junction [GO:0005927]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; cell adhesion mediator activity [GO:0098631]; extracellular matrix structural constituent [GO:0005201] g1313.t1 Q96RW7 40.719 334 1.34e-68 256.0 sp|Q96RW7|HMCN1_HUMAN Hemicentin-1 OS=Homo sapiens OX=9606 GN=HMCN1 PE=1 SV=2 HMCN1_HUMAN reviewed Hemicentin-1 (Fibulin-6) (FIBL-6) Homo sapiens (Human) GO:0005201; GO:0005509; GO:0005604; GO:0005737; GO:0005886; GO:0005912; GO:0005927; GO:0005938; GO:0007156; GO:0007157; GO:0007601; GO:0009617; GO:0030036; GO:0031012; GO:0032154; GO:0051301; GO:0070062; GO:0071711; GO:0098631 actin cytoskeleton organization [GO:0030036]; basement membrane organization [GO:0071711]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601] adherens junction [GO:0005912]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; muscle tendon junction [GO:0005927]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; cell adhesion mediator activity [GO:0098631]; extracellular matrix structural constituent [GO:0005201] g1313.t1 Q96RW7 41.62 358 1.5399999999999998e-67 253.0 sp|Q96RW7|HMCN1_HUMAN Hemicentin-1 OS=Homo sapiens OX=9606 GN=HMCN1 PE=1 SV=2 HMCN1_HUMAN reviewed Hemicentin-1 (Fibulin-6) (FIBL-6) Homo sapiens (Human) GO:0005201; GO:0005509; GO:0005604; GO:0005737; GO:0005886; GO:0005912; GO:0005927; GO:0005938; GO:0007156; GO:0007157; GO:0007601; GO:0009617; GO:0030036; GO:0031012; GO:0032154; GO:0051301; GO:0070062; GO:0071711; GO:0098631 actin cytoskeleton organization [GO:0030036]; basement membrane organization [GO:0071711]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601] adherens junction [GO:0005912]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; muscle tendon junction [GO:0005927]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; cell adhesion mediator activity [GO:0098631]; extracellular matrix structural constituent [GO:0005201] g1313.t1 Q96RW7 37.534 373 2.53e-62 237.0 sp|Q96RW7|HMCN1_HUMAN Hemicentin-1 OS=Homo sapiens OX=9606 GN=HMCN1 PE=1 SV=2 HMCN1_HUMAN reviewed Hemicentin-1 (Fibulin-6) (FIBL-6) Homo sapiens (Human) GO:0005201; GO:0005509; GO:0005604; GO:0005737; GO:0005886; GO:0005912; GO:0005927; GO:0005938; GO:0007156; GO:0007157; GO:0007601; GO:0009617; GO:0030036; GO:0031012; GO:0032154; GO:0051301; GO:0070062; GO:0071711; GO:0098631 actin cytoskeleton organization [GO:0030036]; basement membrane organization [GO:0071711]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601] adherens junction [GO:0005912]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; muscle tendon junction [GO:0005927]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; cell adhesion mediator activity [GO:0098631]; extracellular matrix structural constituent [GO:0005201] g1313.t1 Q96RW7 39.249 293 1.63e-57 222.0 sp|Q96RW7|HMCN1_HUMAN Hemicentin-1 OS=Homo sapiens OX=9606 GN=HMCN1 PE=1 SV=2 HMCN1_HUMAN reviewed Hemicentin-1 (Fibulin-6) (FIBL-6) Homo sapiens (Human) GO:0005201; GO:0005509; GO:0005604; GO:0005737; GO:0005886; GO:0005912; GO:0005927; GO:0005938; GO:0007156; GO:0007157; GO:0007601; GO:0009617; GO:0030036; GO:0031012; GO:0032154; GO:0051301; GO:0070062; GO:0071711; GO:0098631 actin cytoskeleton organization [GO:0030036]; basement membrane organization [GO:0071711]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601] adherens junction [GO:0005912]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; muscle tendon junction [GO:0005927]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; cell adhesion mediator activity [GO:0098631]; extracellular matrix structural constituent [GO:0005201] g1314.t1 Q96C11 55.172 551 0.0 588.0 sp|Q96C11|FGGY_HUMAN FGGY carbohydrate kinase domain-containing protein OS=Homo sapiens OX=9606 GN=FGGY PE=1 SV=2 g1315.t1 P09889 43.953 339 4.38e-92 282.0 sp|P09889|PPA5_PIG Tartrate-resistant acid phosphatase type 5 OS=Sus scrofa OX=9823 GN=ACP5 PE=1 SV=4 g1316.t1 Q5ZLX5 68.75 112 9.84e-50 171.0 sp|Q5ZLX5|ZRAB2_CHICK Zinc finger Ran-binding domain-containing protein 2 OS=Gallus gallus OX=9031 GN=ZRANB2 PE=2 SV=1 g1317.t1 O97817 41.805 665 1.36e-142 469.0 sp|O97817|AGRL2_BOVIN Adhesion G protein-coupled receptor L2 OS=Bos taurus OX=9913 GN=ADGRL2 PE=2 SV=1 g1317.t1 O97817 41.221 131 6.28e-22 107.0 sp|O97817|AGRL2_BOVIN Adhesion G protein-coupled receptor L2 OS=Bos taurus OX=9913 GN=ADGRL2 PE=2 SV=1 g1317.t2 O95490 42.331 652 1.02e-141 466.0 sp|O95490|AGRL2_HUMAN Adhesion G protein-coupled receptor L2 OS=Homo sapiens OX=9606 GN=ADGRL2 PE=1 SV=2 g1317.t2 O95490 41.985 131 4.45e-22 107.0 sp|O95490|AGRL2_HUMAN Adhesion G protein-coupled receptor L2 OS=Homo sapiens OX=9606 GN=ADGRL2 PE=1 SV=2 g1318.t1 O95490 35.294 680 3.4e-95 336.0 sp|O95490|AGRL2_HUMAN Adhesion G protein-coupled receptor L2 OS=Homo sapiens OX=9606 GN=ADGRL2 PE=1 SV=2 g1320.t1 Q0VCA2 26.506 332 3.61e-27 117.0 sp|Q0VCA2|ARRD3_BOVIN Arrestin domain-containing protein 3 OS=Bos taurus OX=9913 GN=ARRDC3 PE=2 SV=1 ARRD3_BOVIN reviewed Arrestin domain-containing protein 3 Bos taurus (Bovine) GO:0005737; GO:0005764; GO:0005768; GO:0005769; GO:0005886; GO:0015031; GO:0031649; GO:0031651; GO:0031699; GO:0035332; GO:0043588; GO:0060613; GO:0071878; GO:0090327; GO:0120163 fat pad development [GO:0060613]; heat generation [GO:0031649]; negative regulation of adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071878]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of heat generation [GO:0031651]; negative regulation of locomotion involved in locomotory behavior [GO:0090327]; positive regulation of hippo signaling [GO:0035332]; protein transport [GO:0015031]; skin development [GO:0043588] cytoplasm [GO:0005737]; early endosome [GO:0005769]; endosome [GO:0005768]; lysosome [GO:0005764]; plasma membrane [GO:0005886] beta-3 adrenergic receptor binding [GO:0031699] g1321.t1 Q6IQU6 68.0 300 3.09e-137 395.0 sp|Q6IQU6|RPF1_DANRE Ribosome production factor 1 OS=Danio rerio OX=7955 GN=rpf1 PE=2 SV=1 g1325.t1 A7MBF6 54.726 402 1.75e-151 439.0 sp|A7MBF6|ARMD1_BOVIN Armadillo-like helical domain containing protein 1 OS=Bos taurus OX=9913 GN=ARMH1 PE=2 SV=1 g1326.t1 Q94637 21.079 1001 1.7100000000000001e-31 139.0 sp|Q94637|VIT6_OSCTI Vitellogenin-6 OS=Oscheius tipulae OX=141969 GN=vit-6 PE=1 SV=2 g1328.t1 Q90243 20.867 877 5.11e-32 140.0 sp|Q90243|VIT_ACITR Vitellogenin (Fragment) OS=Acipenser transmontanus OX=7904 PE=2 SV=1 g1331.t1 Q8BHG1 52.89 571 0.0 645.0 sp|Q8BHG1|NRDC_MOUSE Nardilysin OS=Mus musculus OX=10090 GN=Nrdc PE=1 SV=1 NRDC_MOUSE reviewed Nardilysin (EC 3.4.24.61) (N-arginine dibasic convertase) (NRD convertase) (NRD-C) (Nardilysin convertase) Mus musculus (Mouse) GO:0004222; GO:0005739; GO:0005759; GO:0006508; GO:0008233; GO:0030425; GO:0031643; GO:0032760; GO:0046872; GO:0050772; GO:0051044; GO:0061133; GO:0120163; GO:1903265 negative regulation of cold-induced thermogenesis [GO:0120163]; positive regulation of axonogenesis [GO:0050772]; positive regulation of membrane protein ectodomain proteolysis [GO:0051044]; positive regulation of myelination [GO:0031643]; positive regulation of tumor necrosis factor production [GO:0032760]; positive regulation of tumor necrosis factor-mediated signaling pathway [GO:1903265]; proteolysis [GO:0006508] dendrite [GO:0030425]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] endopeptidase activator activity [GO:0061133]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; peptidase activity [GO:0008233] g1332.t1 P47245 45.028 362 1.16e-90 298.0 sp|P47245|NRDC_RAT Nardilysin OS=Rattus norvegicus OX=10116 GN=Nrdc PE=1 SV=1 NRDC_RAT reviewed Nardilysin (EC 3.4.24.61) (N-arginine dibasic convertase) (NRD convertase) (NRD-C) (Nardilysin convertase) Rattus norvegicus (Rat) GO:0004222; GO:0005759; GO:0006508; GO:0008233; GO:0030425; GO:0031643; GO:0032760; GO:0046872; GO:0050772; GO:0051044; GO:0061133; GO:0120163; GO:1903265 negative regulation of cold-induced thermogenesis [GO:0120163]; positive regulation of axonogenesis [GO:0050772]; positive regulation of membrane protein ectodomain proteolysis [GO:0051044]; positive regulation of myelination [GO:0031643]; positive regulation of tumor necrosis factor production [GO:0032760]; positive regulation of tumor necrosis factor-mediated signaling pathway [GO:1903265]; proteolysis [GO:0006508] dendrite [GO:0030425]; mitochondrial matrix [GO:0005759] endopeptidase activator activity [GO:0061133]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; peptidase activity [GO:0008233] g1333.t1 P23378 65.424 966 0.0 1307.0 sp|P23378|GCSP_HUMAN Glycine dehydrogenase (decarboxylating), mitochondrial OS=Homo sapiens OX=9606 GN=GLDC PE=1 SV=2 GCSP_HUMAN reviewed Glycine dehydrogenase (decarboxylating), mitochondrial (EC 1.4.4.2) (Glycine cleavage system P protein) (Glycine decarboxylase) (Glycine dehydrogenase (aminomethyl-transferring)) Homo sapiens (Human) GO:0004375; GO:0005654; GO:0005739; GO:0005759; GO:0005886; GO:0005960; GO:0006546; GO:0009055; GO:0016594; GO:0016829; GO:0019464; GO:0030170; GO:0036255; GO:0042803; GO:0070280; GO:1903442; GO:1990830 cellular response to leukemia inhibitory factor [GO:1990830]; glycine catabolic process [GO:0006546]; glycine decarboxylation via glycine cleavage system [GO:0019464]; response to lipoic acid [GO:1903442]; response to methylamine [GO:0036255] glycine cleavage complex [GO:0005960]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] electron transfer activity [GO:0009055]; glycine binding [GO:0016594]; glycine dehydrogenase (decarboxylating) activity [GO:0004375]; lyase activity [GO:0016829]; protein homodimerization activity [GO:0042803]; pyridoxal binding [GO:0070280]; pyridoxal phosphate binding [GO:0030170] g1334.t1 Q60HG7 63.918 388 0.0 517.0 sp|Q60HG7|CGL_MACFA Cystathionine gamma-lyase OS=Macaca fascicularis OX=9541 GN=CTH PE=2 SV=1 g1336.t1 Q5MNV6 61.111 378 6.5e-137 397.0 sp|Q5MNV6|ZNT7_CHICK Zinc transporter 7 OS=Gallus gallus OX=9031 GN=SLC30A7 PE=2 SV=1 ZNT7_CHICK reviewed Zinc transporter 7 (Solute carrier family 30 member 7) Gallus gallus (Chicken) GO:0000139; GO:0005385; GO:0005739; GO:0005794; GO:0006882; GO:0031410; GO:0033017; GO:0042802; GO:0048471; GO:1904257; GO:1990674 intracellular zinc ion homeostasis [GO:0006882]; zinc ion import into Golgi lumen [GO:1904257] cytoplasmic vesicle [GO:0031410]; Golgi apparatus [GO:0005794]; Golgi cis cisterna membrane [GO:1990674]; Golgi membrane [GO:0000139]; mitochondrion [GO:0005739]; perinuclear region of cytoplasm [GO:0048471]; sarcoplasmic reticulum membrane [GO:0033017] identical protein binding [GO:0042802]; zinc ion transmembrane transporter activity [GO:0005385] g1337.t1 Q9CWQ0 69.675 277 1.4e-148 420.0 sp|Q9CWQ0|DPH5_MOUSE Diphthine methyl ester synthase OS=Mus musculus OX=10090 GN=Dph5 PE=1 SV=2 DPH5_MOUSE reviewed Diphthine methyl ester synthase (EC 2.1.1.314) (Diphthamide biosynthesis methyltransferase) Mus musculus (Mouse) GO:0004164; GO:0005829; GO:0017183; GO:0032259; GO:0141133 methylation [GO:0032259]; protein histidyl modification to diphthamide [GO:0017183] cytosol [GO:0005829] diphthine methyl ester synthase activity [GO:0141133]; diphthine synthase activity [GO:0004164] g1340.t1 Q6P317 65.385 78 3.5200000000000003e-29 102.0 sp|Q6P317|SMIM7_XENTR Small integral membrane protein 7 OS=Xenopus tropicalis OX=8364 GN=smim7 PE=3 SV=1 g1343.t1 A2AV25 41.981 212 8.29e-48 170.0 sp|A2AV25|FBCD1_MOUSE Fibrinogen C domain-containing protein 1 OS=Mus musculus OX=10090 GN=Fibcd1 PE=2 SV=1 g1344.t1 P55096 72.444 577 0.0 899.0 sp|P55096|ABCD3_MOUSE ATP-binding cassette sub-family D member 3 OS=Mus musculus OX=10090 GN=Abcd3 PE=1 SV=2 g1344.t2 P55096 71.453 578 0.0 891.0 sp|P55096|ABCD3_MOUSE ATP-binding cassette sub-family D member 3 OS=Mus musculus OX=10090 GN=Abcd3 PE=1 SV=2 g1344.t3 P55096 72.318 578 0.0 899.0 sp|P55096|ABCD3_MOUSE ATP-binding cassette sub-family D member 3 OS=Mus musculus OX=10090 GN=Abcd3 PE=1 SV=2 g1344.t4 P55096 71.21 587 0.0 890.0 sp|P55096|ABCD3_MOUSE ATP-binding cassette sub-family D member 3 OS=Mus musculus OX=10090 GN=Abcd3 PE=1 SV=2 g1346.t1 Q6U736 40.613 261 5.4e-60 202.0 sp|Q6U736|OPN5_HUMAN Opsin-5 OS=Homo sapiens OX=9606 GN=OPN5 PE=1 SV=3 OPN5_HUMAN reviewed Opsin-5 (G-protein coupled receptor 136) (G-protein coupled receptor PGR12) (Neuropsin) (Transmembrane protein 13) Homo sapiens (Human) GO:0001750; GO:0005502; GO:0005737; GO:0005886; GO:0007186; GO:0007601; GO:0007602; GO:0007604; GO:0008020; GO:0043153; GO:0071482; GO:0071492; GO:1990384 cellular response to light stimulus [GO:0071482]; cellular response to UV-A [GO:0071492]; entrainment of circadian clock by photoperiod [GO:0043153]; G protein-coupled receptor signaling pathway [GO:0007186]; hyaloid vascular plexus regression [GO:1990384]; phototransduction [GO:0007602]; phototransduction, UV [GO:0007604]; visual perception [GO:0007601] cytoplasm [GO:0005737]; photoreceptor outer segment [GO:0001750]; plasma membrane [GO:0005886] 11-cis retinal binding [GO:0005502]; G protein-coupled photoreceptor activity [GO:0008020] g1347.t1 Q60HG0 47.733 419 3.55e-130 388.0 sp|Q60HG0|FKTN_MACFA Ribitol-5-phosphate transferase FKTN OS=Macaca fascicularis OX=9541 GN=FKTN PE=1 SV=1 g1358.t1 Q9U943 29.26 581 8.95e-56 220.0 sp|Q9U943|APLP_LOCMI Apolipophorins OS=Locusta migratoria OX=7004 PE=1 SV=2 g1359.t1 Q9U943 25.592 1141 7.68e-88 318.0 sp|Q9U943|APLP_LOCMI Apolipophorins OS=Locusta migratoria OX=7004 PE=1 SV=2 g1360.t1 B6MUN4 44.504 373 4.4699999999999996e-91 311.0 sp|B6MUN4|MYSM1_BRAFL Histone H2A deubiquitinase MYSM1 OS=Branchiostoma floridae OX=7739 GN=MYSM1 PE=3 SV=1 g1361.t1 Q96D70 41.014 217 3.22e-44 154.0 sp|Q96D70|R3HD4_HUMAN R3H domain-containing protein 4 OS=Homo sapiens OX=9606 GN=R3HDM4 PE=1 SV=3 g1363.t1 F1Q8K0 70.471 701 0.0 1036.0 sp|F1Q8K0|RAD54_DANRE DNA repair and recombination protein RAD54-like OS=Danio rerio OX=7955 GN=rad54l PE=1 SV=1 RAD54_DANRE reviewed DNA repair and recombination protein RAD54-like (EC 3.6.4.-) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0003677; GO:0003678; GO:0005524; GO:0005634; GO:0007131; GO:0008094; GO:0015616; GO:0016787; GO:0045003 double-strand break repair via synthesis-dependent strand annealing [GO:0045003]; reciprocal meiotic recombination [GO:0007131] nucleus [GO:0005634] ATP binding [GO:0005524]; ATP-dependent activity, acting on DNA [GO:0008094]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; DNA translocase activity [GO:0015616]; hydrolase activity [GO:0016787] g1364.t1 Q8R1Q3 41.589 214 2.09e-42 152.0 sp|Q8R1Q3|ANGL7_MOUSE Angiopoietin-related protein 7 OS=Mus musculus OX=10090 GN=Angptl7 PE=2 SV=1 g1365.t1 O70497 42.534 221 2.92e-44 157.0 sp|O70497|FCN2_MOUSE Ficolin-2 OS=Mus musculus OX=10090 GN=Fcn2 PE=2 SV=2 g1366.t1 O70497 43.348 233 1.4e-46 163.0 sp|O70497|FCN2_MOUSE Ficolin-2 OS=Mus musculus OX=10090 GN=Fcn2 PE=2 SV=2 g1368.t1 Q15262 40.48 583 2.0399999999999998e-134 434.0 sp|Q15262|PTPRK_HUMAN Receptor-type tyrosine-protein phosphatase kappa OS=Homo sapiens OX=9606 GN=PTPRK PE=1 SV=2 PTPRK_HUMAN reviewed Receptor-type tyrosine-protein phosphatase kappa (Protein-tyrosine phosphatase kappa) (R-PTP-kappa) (EC 3.1.3.48) Homo sapiens (Human) GO:0004725; GO:0005001; GO:0005814; GO:0005886; GO:0005911; GO:0005912; GO:0006470; GO:0007155; GO:0007165; GO:0007179; GO:0008013; GO:0008285; GO:0009986; GO:0010839; GO:0016020; GO:0016477; GO:0019901; GO:0030054; GO:0030336; GO:0031175; GO:0031256; GO:0034394; GO:0034614; GO:0034644; GO:0045295; GO:0045786; GO:0045892; GO:0048041; GO:0120212 cell adhesion [GO:0007155]; cell migration [GO:0016477]; cellular response to reactive oxygen species [GO:0034614]; cellular response to UV [GO:0034644]; focal adhesion assembly [GO:0048041]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of keratinocyte proliferation [GO:0010839]; neuron projection development [GO:0031175]; protein dephosphorylation [GO:0006470]; protein localization to cell surface [GO:0034394]; signal transduction [GO:0007165]; transforming growth factor beta receptor signaling pathway [GO:0007179] adherens junction [GO:0005912]; cell junction [GO:0030054]; cell surface [GO:0009986]; cell-cell junction [GO:0005911]; centriole [GO:0005814]; leading edge membrane [GO:0031256]; membrane [GO:0016020]; plasma membrane [GO:0005886]; sperm head-tail coupling apparatus [GO:0120212] beta-catenin binding [GO:0008013]; gamma-catenin binding [GO:0045295]; protein kinase binding [GO:0019901]; protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001] g1369.t1 P35590 35.593 236 5.400000000000001e-35 147.0 sp|P35590|TIE1_HUMAN Tyrosine-protein kinase receptor Tie-1 OS=Homo sapiens OX=9606 GN=TIE1 PE=1 SV=1 TIE1_HUMAN reviewed Tyrosine-protein kinase receptor Tie-1 (EC 2.7.10.1) Homo sapiens (Human) GO:0001525; GO:0001570; GO:0001701; GO:0001936; GO:0003180; GO:0004714; GO:0005524; GO:0005886; GO:0007165; GO:0007169; GO:0007498; GO:0016525; GO:0030336; GO:0032526; GO:0043235; GO:0045026; GO:0045766; GO:0048771; GO:0060836; GO:0060854; GO:1901201 angiogenesis [GO:0001525]; aortic valve morphogenesis [GO:0003180]; branching involved in lymph vessel morphogenesis [GO:0060854]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; in utero embryonic development [GO:0001701]; lymphatic endothelial cell differentiation [GO:0060836]; mesoderm development [GO:0007498]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell migration [GO:0030336]; plasma membrane fusion [GO:0045026]; positive regulation of angiogenesis [GO:0045766]; regulation of endothelial cell proliferation [GO:0001936]; regulation of extracellular matrix assembly [GO:1901201]; response to retinoic acid [GO:0032526]; signal transduction [GO:0007165]; tissue remodeling [GO:0048771]; vasculogenesis [GO:0001570] plasma membrane [GO:0005886]; receptor complex [GO:0043235] ATP binding [GO:0005524]; transmembrane receptor protein tyrosine kinase activity [GO:0004714] g1371.t1 Q06806 45.033 302 1.51e-83 276.0 sp|Q06806|TIE1_MOUSE Tyrosine-protein kinase receptor Tie-1 OS=Mus musculus OX=10090 GN=Tie1 PE=1 SV=3 TIE1_MOUSE reviewed Tyrosine-protein kinase receptor Tie-1 (EC 2.7.10.1) Mus musculus (Mouse) GO:0001525; GO:0001568; GO:0001570; GO:0001701; GO:0001936; GO:0003180; GO:0004714; GO:0005524; GO:0005886; GO:0007169; GO:0016020; GO:0016525; GO:0030336; GO:0032526; GO:0043235; GO:0045026; GO:0045766; GO:0048771; GO:0060836; GO:0060854; GO:1901201 angiogenesis [GO:0001525]; aortic valve morphogenesis [GO:0003180]; blood vessel development [GO:0001568]; branching involved in lymph vessel morphogenesis [GO:0060854]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; in utero embryonic development [GO:0001701]; lymphatic endothelial cell differentiation [GO:0060836]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell migration [GO:0030336]; plasma membrane fusion [GO:0045026]; positive regulation of angiogenesis [GO:0045766]; regulation of endothelial cell proliferation [GO:0001936]; regulation of extracellular matrix assembly [GO:1901201]; response to retinoic acid [GO:0032526]; tissue remodeling [GO:0048771]; vasculogenesis [GO:0001570] membrane [GO:0016020]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] ATP binding [GO:0005524]; transmembrane receptor protein tyrosine kinase activity [GO:0004714] g1372.t1 A7S5D9 58.744 223 2.35e-95 285.0 sp|A7S5D9|IYD_NEMVE Iodotyrosine deiodinase OS=Nematostella vectensis OX=45351 GN=v1g105379 PE=1 SV=1 IYD_NEMVE reviewed Iodotyrosine deiodinase (EC 1.21.1.1) (Halotyrosine dehalogenase) Nematostella vectensis (Starlet sea anemone) GO:0005886; GO:0006570; GO:0010181; GO:0016491; GO:0140616 tyrosine metabolic process [GO:0006570] plasma membrane [GO:0005886] FMN binding [GO:0010181]; iodotyrosine deiodinase activity [GO:0140616]; oxidoreductase activity [GO:0016491] g1374.t1 Q5EAB6 57.887 653 0.0 787.0 sp|Q5EAB6|PMGT1_BOVIN Protein O-linked-mannose beta-1,2-N-acetylglucosaminyltransferase 1 OS=Bos taurus OX=9913 GN=POMGNT1 PE=2 SV=1 PMGT1_BOVIN reviewed Protein O-linked-mannose beta-1,2-N-acetylglucosaminyltransferase 1 (POMGnT1) (EC 2.4.1.-) Bos taurus (Bovine) GO:0000139; GO:0006493; GO:0008375; GO:0016020; GO:0016266; GO:0030145; GO:0030246; GO:0047223 protein O-linked glycosylation [GO:0006493]; protein O-linked glycosylation via N-acetyl-galactosamine [GO:0016266] Golgi membrane [GO:0000139]; membrane [GO:0016020] acetylglucosaminyltransferase activity [GO:0008375]; beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity [GO:0047223]; carbohydrate binding [GO:0030246]; manganese ion binding [GO:0030145] g1375.t1 A3KN33 43.825 664 0.0 580.0 sp|A3KN33|EGFLA_BOVIN Pikachurin OS=Bos taurus OX=9913 GN=EGFLAM PE=2 SV=1 EGFLA_BOVIN reviewed Pikachurin (EGF-like, fibronectin type-III and laminin G-like domain-containing protein) Bos taurus (Bovine) GO:0005509; GO:0005604; GO:0043083; GO:0048786 basement membrane [GO:0005604]; presynaptic active zone [GO:0048786]; synaptic cleft [GO:0043083] calcium ion binding [GO:0005509] g1376.t1 Q60561 70.605 347 0.0 519.0 sp|Q60561|RIR2_MESAU Ribonucleoside-diphosphate reductase subunit M2 OS=Mesocricetus auratus OX=10036 GN=RRM2 PE=2 SV=1 g1377.t1 P54725 41.912 408 8.98e-76 242.0 sp|P54725|RD23A_HUMAN UV excision repair protein RAD23 homolog A OS=Homo sapiens OX=9606 GN=RAD23A PE=1 SV=1 RD23A_HUMAN reviewed Lysine-specific demethylase RAD23A (EC 1.14.11.-) (UV excision repair protein RAD23 homolog A) (HR23A) (hHR23A) Homo sapiens (Human) GO:0000502; GO:0003684; GO:0003697; GO:0005634; GO:0005654; GO:0005737; GO:0005794; GO:0005829; GO:0006289; GO:0019900; GO:0031593; GO:0031648; GO:0032434; GO:0032436; GO:0032991; GO:0035575; GO:0043130; GO:0043161; GO:0045070; GO:0045787; GO:0070628; GO:0070914; GO:1990381 nucleotide-excision repair [GO:0006289]; positive regulation of cell cycle [GO:0045787]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of viral genome replication [GO:0045070]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein destabilization [GO:0031648]; regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032434]; UV-damage excision repair [GO:0070914] cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; protein-containing complex [GO:0032991] damaged DNA binding [GO:0003684]; histone H4K20 demethylase activity [GO:0035575]; kinase binding [GO:0019900]; polyubiquitin modification-dependent protein binding [GO:0031593]; proteasome binding [GO:0070628]; single-stranded DNA binding [GO:0003697]; ubiquitin binding [GO:0043130]; ubiquitin-specific protease binding [GO:1990381] g1379.t1 Q6AY22 42.336 137 1.06e-22 106.0 sp|Q6AY22|SPAT1_RAT Spermatogenesis-associated protein 1 OS=Rattus norvegicus OX=10116 GN=Spata1 PE=2 SV=1 g1379.t2 Q6AY22 42.336 137 1.05e-22 106.0 sp|Q6AY22|SPAT1_RAT Spermatogenesis-associated protein 1 OS=Rattus norvegicus OX=10116 GN=Spata1 PE=2 SV=1 g1380.t1 P55809 72.994 511 0.0 732.0 sp|P55809|SCOT1_HUMAN Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial OS=Homo sapiens OX=9606 GN=OXCT1 PE=1 SV=1 SCOT1_HUMAN reviewed Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial (SCOT) (EC 2.8.3.5) (3-oxoacid CoA-transferase 1) (Somatic-type succinyl-CoA:3-oxoacid CoA-transferase) (SCOT-s) (Succinyl-CoA:3-oxoacid CoA transferase) Homo sapiens (Human) GO:0005739; GO:0005759; GO:0007507; GO:0007584; GO:0008260; GO:0009410; GO:0009725; GO:0014823; GO:0035774; GO:0042182; GO:0042594; GO:0042802; GO:0045471; GO:0046952; GO:0060612; GO:1902224 adipose tissue development [GO:0060612]; heart development [GO:0007507]; ketone body catabolic process [GO:0046952]; ketone body metabolic process [GO:1902224]; ketone catabolic process [GO:0042182]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; response to activity [GO:0014823]; response to ethanol [GO:0045471]; response to hormone [GO:0009725]; response to nutrient [GO:0007584]; response to starvation [GO:0042594]; response to xenobiotic stimulus [GO:0009410] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] identical protein binding [GO:0042802]; succinyl-CoA:3-oxo-acid CoA-transferase activity [GO:0008260] g1382.t1 Q9BT30 62.759 145 4.66e-65 206.0 sp|Q9BT30|ALKB7_HUMAN Alpha-ketoglutarate-dependent dioxygenase alkB homolog 7, mitochondrial OS=Homo sapiens OX=9606 GN=ALKBH7 PE=1 SV=1 ALKB7_HUMAN reviewed RNA demethylase ALKBH7, mitochondrial (EC 1.14.11.-) (Alkylated DNA repair protein alkB homolog 7) (Alpha-ketoglutarate-dependent dioxygenase alkB homolog 7, mitochondrial) (Spermatogenesis cell proliferation-related protein) (Spermatogenesis-associated protein 11) (pre-tRNA N1-methyl adenine demethylase ALKBH7) (pre-tRNA N2-dimethyl guanosine demethylase ALKBH7) Homo sapiens (Human) GO:0005739; GO:0005759; GO:0006631; GO:0006974; GO:0010883; GO:0035513; GO:0035515; GO:0046872; GO:1902445; GO:1990984 DNA damage response [GO:0006974]; fatty acid metabolic process [GO:0006631]; oxidative RNA demethylation [GO:0035513]; regulation of lipid storage [GO:0010883]; regulation of mitochondrial membrane permeability involved in programmed necrotic cell death [GO:1902445] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] metal ion binding [GO:0046872]; oxidative RNA demethylase activity [GO:0035515]; tRNA demethylase activity [GO:1990984] g1383.t1 Q6KCD5 54.001 1487 0.0 1520.0 sp|Q6KCD5|NIPBL_MOUSE Nipped-B-like protein OS=Mus musculus OX=10090 GN=Nipbl PE=1 SV=1 NIPBL_MOUSE reviewed Nipped-B-like protein (Delangin homolog) (SCC2 homolog) Mus musculus (Mouse) GO:0000070; GO:0000122; GO:0000785; GO:0003007; GO:0003151; GO:0003682; GO:0003714; GO:0005634; GO:0005654; GO:0005829; GO:0006338; GO:0006357; GO:0006974; GO:0007064; GO:0007420; GO:0007507; GO:0007605; GO:0008104; GO:0019827; GO:0032039; GO:0032116; GO:0034087; GO:0034088; GO:0035115; GO:0035136; GO:0035261; GO:0036033; GO:0040018; GO:0042471; GO:0042634; GO:0042826; GO:0045444; GO:0045778; GO:0045944; GO:0045995; GO:0048557; GO:0048565; GO:0048589; GO:0048592; GO:0048638; GO:0048701; GO:0048703; GO:0050890; GO:0060325; GO:0061010; GO:0061038; GO:0061775; GO:0070087; GO:0071169; GO:0071481; GO:0090694; GO:0140588; GO:1990414; GO:1990841; GO:2001224 brain development [GO:0007420]; cellular response to X-ray [GO:0071481]; chromatin looping [GO:0140588]; chromatin remodeling [GO:0006338]; cognition [GO:0050890]; developmental growth [GO:0048589]; digestive tract development [GO:0048565]; DNA damage response [GO:0006974]; ear morphogenesis [GO:0042471]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic digestive tract morphogenesis [GO:0048557]; embryonic forelimb morphogenesis [GO:0035115]; embryonic viscerocranium morphogenesis [GO:0048703]; establishment of mitotic sister chromatid cohesion [GO:0034087]; establishment of protein localization to chromatin [GO:0071169]; external genitalia morphogenesis [GO:0035261]; eye morphogenesis [GO:0048592]; face morphogenesis [GO:0060325]; fat cell differentiation [GO:0045444]; forelimb morphogenesis [GO:0035136]; gallbladder development [GO:0061010]; heart development [GO:0007507]; heart morphogenesis [GO:0003007]; intracellular protein localization [GO:0008104]; maintenance of mitotic sister chromatid cohesion [GO:0034088]; mitotic sister chromatid cohesion [GO:0007064]; mitotic sister chromatid segregation [GO:0000070]; negative regulation of transcription by RNA polymerase II [GO:0000122]; outflow tract morphogenesis [GO:0003151]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of neuron migration [GO:2001224]; positive regulation of ossification [GO:0045778]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of developmental growth [GO:0048638]; regulation of embryonic development [GO:0045995]; regulation of hair cycle [GO:0042634]; regulation of transcription by RNA polymerase II [GO:0006357]; replication-born double-strand break repair via sister chromatid exchange [GO:1990414]; sensory perception of sound [GO:0007605]; stem cell population maintenance [GO:0019827]; uterus morphogenesis [GO:0061038] chromatin [GO:0000785]; cytosol [GO:0005829]; integrator complex [GO:0032039]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Scc2-Scc4 cohesin loading complex [GO:0090694]; SMC loading complex [GO:0032116] chromatin binding [GO:0003682]; chromo shadow domain binding [GO:0070087]; cohesin loader activity [GO:0061775]; histone deacetylase binding [GO:0042826]; mediator complex binding [GO:0036033]; promoter-specific chromatin binding [GO:1990841]; transcription corepressor activity [GO:0003714] g1383.t1 Q6KCD5 48.315 178 4.4299999999999996e-24 115.0 sp|Q6KCD5|NIPBL_MOUSE Nipped-B-like protein OS=Mus musculus OX=10090 GN=Nipbl PE=1 SV=1 NIPBL_MOUSE reviewed Nipped-B-like protein (Delangin homolog) (SCC2 homolog) Mus musculus (Mouse) GO:0000070; GO:0000122; GO:0000785; GO:0003007; GO:0003151; GO:0003682; GO:0003714; GO:0005634; GO:0005654; GO:0005829; GO:0006338; GO:0006357; GO:0006974; GO:0007064; GO:0007420; GO:0007507; GO:0007605; GO:0008104; GO:0019827; GO:0032039; GO:0032116; GO:0034087; GO:0034088; GO:0035115; GO:0035136; GO:0035261; GO:0036033; GO:0040018; GO:0042471; GO:0042634; GO:0042826; GO:0045444; GO:0045778; GO:0045944; GO:0045995; GO:0048557; GO:0048565; GO:0048589; GO:0048592; GO:0048638; GO:0048701; GO:0048703; GO:0050890; GO:0060325; GO:0061010; GO:0061038; GO:0061775; GO:0070087; GO:0071169; GO:0071481; GO:0090694; GO:0140588; GO:1990414; GO:1990841; GO:2001224 brain development [GO:0007420]; cellular response to X-ray [GO:0071481]; chromatin looping [GO:0140588]; chromatin remodeling [GO:0006338]; cognition [GO:0050890]; developmental growth [GO:0048589]; digestive tract development [GO:0048565]; DNA damage response [GO:0006974]; ear morphogenesis [GO:0042471]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic digestive tract morphogenesis [GO:0048557]; embryonic forelimb morphogenesis [GO:0035115]; embryonic viscerocranium morphogenesis [GO:0048703]; establishment of mitotic sister chromatid cohesion [GO:0034087]; establishment of protein localization to chromatin [GO:0071169]; external genitalia morphogenesis [GO:0035261]; eye morphogenesis [GO:0048592]; face morphogenesis [GO:0060325]; fat cell differentiation [GO:0045444]; forelimb morphogenesis [GO:0035136]; gallbladder development [GO:0061010]; heart development [GO:0007507]; heart morphogenesis [GO:0003007]; intracellular protein localization [GO:0008104]; maintenance of mitotic sister chromatid cohesion [GO:0034088]; mitotic sister chromatid cohesion [GO:0007064]; mitotic sister chromatid segregation [GO:0000070]; negative regulation of transcription by RNA polymerase II [GO:0000122]; outflow tract morphogenesis [GO:0003151]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of neuron migration [GO:2001224]; positive regulation of ossification [GO:0045778]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of developmental growth [GO:0048638]; regulation of embryonic development [GO:0045995]; regulation of hair cycle [GO:0042634]; regulation of transcription by RNA polymerase II [GO:0006357]; replication-born double-strand break repair via sister chromatid exchange [GO:1990414]; sensory perception of sound [GO:0007605]; stem cell population maintenance [GO:0019827]; uterus morphogenesis [GO:0061038] chromatin [GO:0000785]; cytosol [GO:0005829]; integrator complex [GO:0032039]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Scc2-Scc4 cohesin loading complex [GO:0090694]; SMC loading complex [GO:0032116] chromatin binding [GO:0003682]; chromo shadow domain binding [GO:0070087]; cohesin loader activity [GO:0061775]; histone deacetylase binding [GO:0042826]; mediator complex binding [GO:0036033]; promoter-specific chromatin binding [GO:1990841]; transcription corepressor activity [GO:0003714] g1389.t1 P54802 44.355 744 0.0 635.0 sp|P54802|ANAG_HUMAN Alpha-N-acetylglucosaminidase OS=Homo sapiens OX=9606 GN=NAGLU PE=1 SV=2 ANAG_HUMAN reviewed Alpha-N-acetylglucosaminidase (EC 3.2.1.50) (N-acetyl-alpha-glucosaminidase) (NAG) [Cleaved into: Alpha-N-acetylglucosaminidase 82 kDa form; Alpha-N-acetylglucosaminidase 77 kDa form] Homo sapiens (Human) GO:0001573; GO:0001774; GO:0001889; GO:0003158; GO:0003183; GO:0003220; GO:0004561; GO:0005764; GO:0006801; GO:0006914; GO:0007028; GO:0007030; GO:0007040; GO:0007399; GO:0008340; GO:0009611; GO:0014004; GO:0016020; GO:0016042; GO:0016485; GO:0021675; GO:0021680; GO:0030200; GO:0030202; GO:0030203; GO:0030534; GO:0031069; GO:0032496; GO:0032963; GO:0034142; GO:0034285; GO:0034599; GO:0035633; GO:0035640; GO:0035909; GO:0042445; GO:0042474; GO:0042982; GO:0043161; GO:0043202; GO:0045475; GO:0046548; GO:0048143; GO:0055013; GO:0060119; GO:0060173; GO:0060586; GO:0061744; GO:0070062; GO:0097009; GO:0097696; GO:0099022; GO:0140315; GO:1904389; GO:1904390 adult behavior [GO:0030534]; amyloid precursor protein metabolic process [GO:0042982]; aorta morphogenesis [GO:0035909]; astrocyte activation [GO:0048143]; autophagy [GO:0006914]; cardiac muscle cell development [GO:0055013]; cell surface receptor signaling pathway via STAT [GO:0097696]; cellular response to oxidative stress [GO:0034599]; cerebellar Purkinje cell layer development [GO:0021680]; collagen metabolic process [GO:0032963]; cone retinal bipolar cell differentiation [GO:1904390]; cytoplasm organization [GO:0007028]; determination of adult lifespan [GO:0008340]; endothelium development [GO:0003158]; energy homeostasis [GO:0097009]; exploration behavior [GO:0035640]; ganglioside metabolic process [GO:0001573]; glycosaminoglycan metabolic process [GO:0030203]; Golgi organization [GO:0007030]; hair follicle morphogenesis [GO:0031069]; heparan sulfate proteoglycan catabolic process [GO:0030200]; heparin proteoglycan metabolic process [GO:0030202]; hormone metabolic process [GO:0042445]; inner ear receptor cell development [GO:0060119]; left ventricular cardiac muscle tissue morphogenesis [GO:0003220]; limb development [GO:0060173]; lipid catabolic process [GO:0016042]; liver development [GO:0001889]; locomotor rhythm [GO:0045475]; lysosome organization [GO:0007040]; maintenance of blood-brain barrier [GO:0035633]; microglia differentiation [GO:0014004]; microglial cell activation [GO:0001774]; middle ear morphogenesis [GO:0042474]; mitral valve morphogenesis [GO:0003183]; motor behavior [GO:0061744]; multicellular organismal-level iron ion homeostasis [GO:0060586]; nerve development [GO:0021675]; nervous system development [GO:0007399]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein processing [GO:0016485]; response to disaccharide [GO:0034285]; response to lipopolysaccharide [GO:0032496]; response to wounding [GO:0009611]; retinal rod cell development [GO:0046548]; rod bipolar cell differentiation [GO:1904389]; superoxide metabolic process [GO:0006801]; toll-like receptor 4 signaling pathway [GO:0034142]; vesicle tethering [GO:0099022] extracellular exosome [GO:0070062]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764]; membrane [GO:0016020] alpha-N-acetylglucosaminidase activity [GO:0004561]; iron ion sequestering activity [GO:0140315] g1390.t1 P51906 52.656 433 3.94e-126 382.0 sp|P51906|EAA3_MOUSE Excitatory amino acid transporter 3 OS=Mus musculus OX=10090 GN=Slc1a1 PE=1 SV=2 g1391.t1 Q5R4R7 34.286 280 4.94e-39 149.0 sp|Q5R4R7|PHF24_PONAB PHD finger protein 24 OS=Pongo abelii OX=9601 GN=PHF24 PE=2 SV=2 g1392.t1 Q6DGV7 42.857 133 1.74e-39 137.0 sp|Q6DGV7|M17L2_DANRE Mpv17-like protein 2 OS=Danio rerio OX=7955 GN=mpv17l2 PE=2 SV=1 g1395.t1 Q60614 31.329 316 3.06e-38 142.0 sp|Q60614|AA2BR_MOUSE Adenosine receptor A2b OS=Mus musculus OX=10090 GN=Adora2b PE=2 SV=2 AA2BR_MOUSE reviewed Adenosine receptor A2b Mus musculus (Mouse) GO:0001609; GO:0001938; GO:0001973; GO:0002882; GO:0004930; GO:0005886; GO:0007189; GO:0008284; GO:0008285; GO:0009986; GO:0010575; GO:0010595; GO:0010701; GO:0010753; GO:0010893; GO:0010906; GO:0032722; GO:0032755; GO:0032966; GO:0033605; GO:0042311; GO:0043306; GO:0045202; GO:0060087; GO:0098685; GO:0098793; GO:0098978; GO:0099171; GO:0141163; GO:1990776 adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; G protein-coupled adenosine receptor signaling pathway [GO:0001973]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of collagen biosynthetic process [GO:0032966]; positive regulation of cAMP/PKA signal transduction [GO:0141163]; positive regulation of catecholamine secretion [GO:0033605]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cGMP-mediated signaling [GO:0010753]; positive regulation of chemokine production [GO:0032722]; positive regulation of chronic inflammatory response to non-antigenic stimulus [GO:0002882]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of mast cell degranulation [GO:0043306]; positive regulation of norepinephrine secretion [GO:0010701]; positive regulation of steroid biosynthetic process [GO:0010893]; positive regulation of vascular endothelial growth factor production [GO:0010575]; presynaptic modulation of chemical synaptic transmission [GO:0099171]; regulation of glucose metabolic process [GO:0010906]; relaxation of vascular associated smooth muscle [GO:0060087]; response to angiotensin [GO:1990776]; vasodilation [GO:0042311] cell surface [GO:0009986]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; Schaffer collateral - CA1 synapse [GO:0098685]; synapse [GO:0045202] G protein-coupled adenosine receptor activity [GO:0001609]; G protein-coupled receptor activity [GO:0004930] g1396.t1 Q9QZU7 35.404 322 3.6100000000000003e-63 223.0 sp|Q9QZU7|BODG_RAT Gamma-butyrobetaine dioxygenase OS=Rattus norvegicus OX=10116 GN=Bbox1 PE=1 SV=1 g1397.t1 P22045 44.151 265 1.4199999999999999e-74 232.0 sp|P22045|PGFS_LEIMA 9,11-endoperoxide prostaglandin H2 reductase OS=Leishmania major OX=5664 GN=P100/11E PE=1 SV=3 g1398.t1 O75899 32.338 603 7.87e-94 317.0 sp|O75899|GABR2_HUMAN Gamma-aminobutyric acid type B receptor subunit 2 OS=Homo sapiens OX=9606 GN=GABBR2 PE=1 SV=1 GABR2_HUMAN reviewed Gamma-aminobutyric acid type B receptor subunit 2 (GABA-B receptor 2) (GABA-B-R2) (GABA-BR2) (GABABR2) (Gb2) (G-protein coupled receptor 51) (HG20) Homo sapiens (Human) GO:0004888; GO:0004965; GO:0005737; GO:0005886; GO:0007186; GO:0007193; GO:0007194; GO:0007214; GO:0007268; GO:0038039; GO:0043005; GO:0045211; GO:0046982; GO:0051932; GO:0150099; GO:1902710; GO:1902712 adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; chemical synaptic transmission [GO:0007268]; G protein-coupled receptor signaling pathway [GO:0007186]; gamma-aminobutyric acid signaling pathway [GO:0007214]; negative regulation of adenylate cyclase activity [GO:0007194]; neuron-glial cell signaling [GO:0150099]; synaptic transmission, GABAergic [GO:0051932] cytoplasm [GO:0005737]; G protein-coupled GABA receptor complex [GO:1902712]; G protein-coupled receptor heterodimeric complex [GO:0038039]; GABA receptor complex [GO:1902710]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211] G protein-coupled GABA receptor activity [GO:0004965]; protein heterodimerization activity [GO:0046982]; transmembrane signaling receptor activity [GO:0004888] g1399.t1 Q99973 25.726 723 2.3e-50 199.0 sp|Q99973|TEP1_HUMAN Telomerase protein component 1 OS=Homo sapiens OX=9606 GN=TEP1 PE=1 SV=2 TEP1_HUMAN reviewed Telomerase protein component 1 (Telomerase-associated protein 1) (Telomerase protein 1) (p240) (p80 telomerase homolog) Homo sapiens (Human) GO:0000722; GO:0000781; GO:0002039; GO:0003720; GO:0003723; GO:0005524; GO:0005697; GO:0005737; GO:0016363; GO:0019899; GO:0070034; GO:1990904 telomere maintenance via recombination [GO:0000722] chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; nuclear matrix [GO:0016363]; ribonucleoprotein complex [GO:1990904]; telomerase holoenzyme complex [GO:0005697] ATP binding [GO:0005524]; enzyme binding [GO:0019899]; p53 binding [GO:0002039]; RNA binding [GO:0003723]; telomerase activity [GO:0003720]; telomerase RNA binding [GO:0070034] g1402.t1 A2VDD2 37.063 143 1.1900000000000001e-27 105.0 sp|A2VDD2|DYL5B_XENLA Dynein light chain Tctex-type 5-B (Fragment) OS=Xenopus laevis OX=8355 GN=Dynlt5-b PE=2 SV=1 g1403.t1 O95801 44.886 352 2.8299999999999996e-104 317.0 sp|O95801|TTC4_HUMAN Tetratricopeptide repeat protein 4 OS=Homo sapiens OX=9606 GN=TTC4 PE=1 SV=3 CNS1_HUMAN reviewed Hsp70/Hsp90 co-chaperone CNS1 homolog (Tetratricopeptide repeat protein 4) (TPR repeat protein 4) Homo sapiens (Human) GO:0005634; GO:0005654; GO:0005737; GO:0006457; GO:0030544; GO:0045087; GO:0051607; GO:0051879 defense response to virus [GO:0051607]; innate immune response [GO:0045087]; protein folding [GO:0006457] cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879] g1404.t1 Q9VUL9 31.148 305 2.85e-40 154.0 sp|Q9VUL9|FUCTA_DROME Glycoprotein 3-alpha-L-fucosyltransferase A OS=Drosophila melanogaster OX=7227 GN=FucTA PE=1 SV=2 FUCTA_DROME reviewed Glycoprotein 3-alpha-L-fucosyltransferase A (EC 2.4.1.214) (Core alpha-(1,3)-fucosyltransferase) Drosophila melanogaster (Fruit fly) GO:0005797; GO:0006491; GO:0007399; GO:0018279; GO:0018392; GO:0032580; GO:0046920 N-glycan processing [GO:0006491]; nervous system development [GO:0007399]; protein N-linked glycosylation via asparagine [GO:0018279] Golgi cisterna membrane [GO:0032580]; Golgi medial cisterna [GO:0005797] alpha-(1->3)-fucosyltransferase activity [GO:0046920]; glycoprotein 3-alpha-L-fucosyltransferase activity [GO:0018392] g1407.t1 Q7SYS9 28.125 288 3.45e-32 124.0 sp|Q7SYS9|HNMTB_XENLA Histamine N-methyltransferase B OS=Xenopus laevis OX=8355 GN=hnmt-b PE=2 SV=1 g1408.t1 Q6DC37 28.956 297 3.04e-32 124.0 sp|Q6DC37|HNMT_DANRE Histamine N-methyltransferase OS=Danio rerio OX=7955 GN=hnmt PE=2 SV=1 g1409.t1 O43196 48.866 794 0.0 788.0 sp|O43196|MSH5_HUMAN MutS protein homolog 5 OS=Homo sapiens OX=9606 GN=MSH5 PE=1 SV=1 MSH5_HUMAN reviewed MutS protein homolog 5 (hMSH5) Homo sapiens (Human) GO:0003690; GO:0005524; GO:0005634; GO:0006298; GO:0030983; GO:0051026; GO:0140664 chiasma assembly [GO:0051026]; mismatch repair [GO:0006298] nucleus [GO:0005634] ATP binding [GO:0005524]; ATP-dependent DNA damage sensor activity [GO:0140664]; double-stranded DNA binding [GO:0003690]; mismatched DNA binding [GO:0030983] g1410.t1 P54864 44.918 305 5.87e-72 228.0 sp|P54864|JUN_SERCA Transcription factor Jun OS=Serinus canaria OX=9135 GN=JUN PE=2 SV=1 g1411.t1 Q9D531 44.966 149 1.63e-44 146.0 sp|Q9D531|NXNL2_MOUSE Nucleoredoxin-like protein 2 OS=Mus musculus OX=10090 GN=Nxnl2 PE=1 SV=1 g1413.t1 Q8BG58 36.745 381 1.32e-60 209.0 sp|Q8BG58|P4HTM_MOUSE Transmembrane prolyl 4-hydroxylase OS=Mus musculus OX=10090 GN=P4htm PE=1 SV=1 P4HTM_MOUSE reviewed Transmembrane prolyl 4-hydroxylase (P4H-TM) (EC 1.14.11.29) (Hypoxia-inducible factor prolyl hydroxylase 4) (HIF-PH4) (HIF-prolyl hydroxylase 4) (HPH-4) Mus musculus (Mouse) GO:0004656; GO:0005506; GO:0005509; GO:0005783; GO:0005789; GO:0008270; GO:0016706; GO:0031418; GO:0045646; GO:0160082 regulation of erythrocyte differentiation [GO:0045646] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789] 2-oxoglutarate-dependent dioxygenase activity [GO:0016706]; calcium ion binding [GO:0005509]; hypoxia-inducible factor-proline dioxygenase activity [GO:0160082]; iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; procollagen-proline 4-dioxygenase activity [GO:0004656]; zinc ion binding [GO:0008270] g1414.t1 Q8BG58 37.565 386 4.4e-63 216.0 sp|Q8BG58|P4HTM_MOUSE Transmembrane prolyl 4-hydroxylase OS=Mus musculus OX=10090 GN=P4htm PE=1 SV=1 P4HTM_MOUSE reviewed Transmembrane prolyl 4-hydroxylase (P4H-TM) (EC 1.14.11.29) (Hypoxia-inducible factor prolyl hydroxylase 4) (HIF-PH4) (HIF-prolyl hydroxylase 4) (HPH-4) Mus musculus (Mouse) GO:0004656; GO:0005506; GO:0005509; GO:0005783; GO:0005789; GO:0008270; GO:0016706; GO:0031418; GO:0045646; GO:0160082 regulation of erythrocyte differentiation [GO:0045646] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789] 2-oxoglutarate-dependent dioxygenase activity [GO:0016706]; calcium ion binding [GO:0005509]; hypoxia-inducible factor-proline dioxygenase activity [GO:0160082]; iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; procollagen-proline 4-dioxygenase activity [GO:0004656]; zinc ion binding [GO:0008270] g1415.t1 Q96DM1 28.974 390 2.08e-35 145.0 sp|Q96DM1|PGBD4_HUMAN PiggyBac transposable element-derived protein 4 OS=Homo sapiens OX=9606 GN=PGBD4 PE=1 SV=3 g1416.t1 Q9NRA2 36.87 377 3.99e-69 230.0 sp|Q9NRA2|S17A5_HUMAN Sialin OS=Homo sapiens OX=9606 GN=SLC17A5 PE=1 SV=2 g1417.t1 Q98893 25.824 364 6.71e-28 127.0 sp|Q98893|VIT2_FUNHE Vitellogenin-2 OS=Fundulus heteroclitus OX=8078 PE=1 SV=1 g1418.t1 Q6TFL4 26.071 560 1.3499999999999998e-54 199.0 sp|Q6TFL4|KLH24_HUMAN Kelch-like protein 24 OS=Homo sapiens OX=9606 GN=KLHL24 PE=1 SV=1 KLH24_HUMAN reviewed Kelch-like protein 24 (Kainate receptor-interacting protein for GluR6) (KRIP6) (Protein DRE1) Homo sapiens (Human) GO:0005737; GO:0005912; GO:0016567; GO:0030057; GO:0030424; GO:0031463; GO:0043161; GO:0043204; GO:0045109; GO:0051865; GO:1990756 intermediate filament organization [GO:0045109]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein ubiquitination [GO:0016567] adherens junction [GO:0005912]; axon [GO:0030424]; Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; desmosome [GO:0030057]; perikaryon [GO:0043204] ubiquitin-like ligase-substrate adaptor activity [GO:1990756] g1419.t1 P41214 45.363 593 6.0099999999999995e-146 437.0 sp|P41214|EIF2D_HUMAN Eukaryotic translation initiation factor 2D OS=Homo sapiens OX=9606 GN=EIF2D PE=1 SV=3 EIF2D_HUMAN reviewed Eukaryotic translation initiation factor 2D (eIF2d) (Hepatocellular carcinoma-associated antigen 56) (Ligatin) Homo sapiens (Human) GO:0001731; GO:0003723; GO:0003743; GO:0005737; GO:0005829; GO:0006886; GO:0016604; GO:0032790; GO:0038023; GO:0075522 formation of translation preinitiation complex [GO:0001731]; intracellular protein transport [GO:0006886]; IRES-dependent viral translational initiation [GO:0075522]; ribosome disassembly [GO:0032790] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear body [GO:0016604] RNA binding [GO:0003723]; signaling receptor activity [GO:0038023]; translation initiation factor activity [GO:0003743] g1419.t2 P41214 45.363 593 6.0099999999999995e-146 437.0 sp|P41214|EIF2D_HUMAN Eukaryotic translation initiation factor 2D OS=Homo sapiens OX=9606 GN=EIF2D PE=1 SV=3 EIF2D_HUMAN reviewed Eukaryotic translation initiation factor 2D (eIF2d) (Hepatocellular carcinoma-associated antigen 56) (Ligatin) Homo sapiens (Human) GO:0001731; GO:0003723; GO:0003743; GO:0005737; GO:0005829; GO:0006886; GO:0016604; GO:0032790; GO:0038023; GO:0075522 formation of translation preinitiation complex [GO:0001731]; intracellular protein transport [GO:0006886]; IRES-dependent viral translational initiation [GO:0075522]; ribosome disassembly [GO:0032790] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear body [GO:0016604] RNA binding [GO:0003723]; signaling receptor activity [GO:0038023]; translation initiation factor activity [GO:0003743] g1421.t1 Q5F339 52.941 289 6.199999999999999e-89 270.0 sp|Q5F339|CCHL_CHICK Holocytochrome c-type synthase OS=Gallus gallus OX=9031 GN=HCCS PE=2 SV=1 g1423.t1 Q15386 48.457 1102 0.0 953.0 sp|Q15386|UBE3C_HUMAN Ubiquitin-protein ligase E3C OS=Homo sapiens OX=9606 GN=UBE3C PE=1 SV=3 UBE3C_HUMAN reviewed Ubiquitin-protein ligase E3C (EC 2.3.2.26) (HECT-type ubiquitin transferase E3C) (Homologous to E6AP carboxyl terminus homologous protein 2) (HectH2) (RTA-associated ubiquitin ligase) (RAUL) Homo sapiens (Human) GO:0000209; GO:0000502; GO:0006511; GO:0035519; GO:0061630; GO:0070936 protein K29-linked ubiquitination [GO:0035519]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511] proteasome complex [GO:0000502] ubiquitin protein ligase activity [GO:0061630] g1424.t1 Q2M2T6 72.381 105 5.829999999999999e-45 144.0 sp|Q2M2T6|ASTER_BOVIN PAT complex subunit Asterix OS=Bos taurus OX=9913 GN=WDR83OS PE=3 SV=1 g1425.t1 Q00277 57.595 158 6.0899999999999995e-55 174.0 sp|Q00277|GPX1_SCHMA Glutathione peroxidase OS=Schistosoma mansoni OX=6183 GN=GPX1 PE=1 SV=2 g1425.t2 Q00277 57.595 158 9.08e-55 175.0 sp|Q00277|GPX1_SCHMA Glutathione peroxidase OS=Schistosoma mansoni OX=6183 GN=GPX1 PE=1 SV=2 g1426.t1 Q02368 55.446 101 6.46e-35 120.0 sp|Q02368|NDUB7_BOVIN NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7 OS=Bos taurus OX=9913 GN=NDUFB7 PE=1 SV=2 g1427.t1 D4ADY9 50.542 277 6.85e-102 301.0 sp|D4ADY9|ELOV7_RAT Very long chain fatty acid elongase 7 OS=Rattus norvegicus OX=10116 GN=Elovl7 PE=3 SV=1 ELOV7_RAT reviewed Very long chain fatty acid elongase 7 (EC 2.3.1.199) (3-keto acyl-CoA synthase Elovl7) (ELOVL fatty acid elongase 7) (ELOVL FA elongase 7) (Elongation of very long chain fatty acids protein 7) (Very long chain 3-ketoacyl-CoA synthase 7) (Very long chain 3-oxoacyl-CoA synthase 7) Rattus norvegicus (Rat) GO:0005783; GO:0005789; GO:0006636; GO:0009922; GO:0019367; GO:0030148; GO:0034625; GO:0034626; GO:0035338; GO:0042761 fatty acid elongation, monounsaturated fatty acid [GO:0034625]; fatty acid elongation, polyunsaturated fatty acid [GO:0034626]; fatty acid elongation, saturated fatty acid [GO:0019367]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; sphingolipid biosynthetic process [GO:0030148]; unsaturated fatty acid biosynthetic process [GO:0006636]; very long-chain fatty acid biosynthetic process [GO:0042761] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789] fatty acid elongase activity [GO:0009922] g1429.t1 Q96WV6 24.378 603 8.37e-21 100.0 sp|Q96WV6|YHU2_SCHPO Uncharacterized threonine-rich GPI-anchored glycoprotein PJ4664.02 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) OX=284812 GN=SPBPJ4664.02 PE=3 SV=1 g1431.t1 Q96WV6 24.92 626 1.9099999999999998e-23 108.0 sp|Q96WV6|YHU2_SCHPO Uncharacterized threonine-rich GPI-anchored glycoprotein PJ4664.02 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) OX=284812 GN=SPBPJ4664.02 PE=3 SV=1 g1431.t1 Q96WV6 23.547 688 3.55e-22 104.0 sp|Q96WV6|YHU2_SCHPO Uncharacterized threonine-rich GPI-anchored glycoprotein PJ4664.02 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) OX=284812 GN=SPBPJ4664.02 PE=3 SV=1 g1431.t1 Q96WV6 24.256 672 8.43e-22 103.0 sp|Q96WV6|YHU2_SCHPO Uncharacterized threonine-rich GPI-anchored glycoprotein PJ4664.02 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) OX=284812 GN=SPBPJ4664.02 PE=3 SV=1 g1431.t1 Q96WV6 24.757 618 2.3700000000000003e-21 102.0 sp|Q96WV6|YHU2_SCHPO Uncharacterized threonine-rich GPI-anchored glycoprotein PJ4664.02 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) OX=284812 GN=SPBPJ4664.02 PE=3 SV=1 g1435.t1 P54802 47.776 697 0.0 680.0 sp|P54802|ANAG_HUMAN Alpha-N-acetylglucosaminidase OS=Homo sapiens OX=9606 GN=NAGLU PE=1 SV=2 ANAG_HUMAN reviewed Alpha-N-acetylglucosaminidase (EC 3.2.1.50) (N-acetyl-alpha-glucosaminidase) (NAG) [Cleaved into: Alpha-N-acetylglucosaminidase 82 kDa form; Alpha-N-acetylglucosaminidase 77 kDa form] Homo sapiens (Human) GO:0001573; GO:0001774; GO:0001889; GO:0003158; GO:0003183; GO:0003220; GO:0004561; GO:0005764; GO:0006801; GO:0006914; GO:0007028; GO:0007030; GO:0007040; GO:0007399; GO:0008340; GO:0009611; GO:0014004; GO:0016020; GO:0016042; GO:0016485; GO:0021675; GO:0021680; GO:0030200; GO:0030202; GO:0030203; GO:0030534; GO:0031069; GO:0032496; GO:0032963; GO:0034142; GO:0034285; GO:0034599; GO:0035633; GO:0035640; GO:0035909; GO:0042445; GO:0042474; GO:0042982; GO:0043161; GO:0043202; GO:0045475; GO:0046548; GO:0048143; GO:0055013; GO:0060119; GO:0060173; GO:0060586; GO:0061744; GO:0070062; GO:0097009; GO:0097696; GO:0099022; GO:0140315; GO:1904389; GO:1904390 adult behavior [GO:0030534]; amyloid precursor protein metabolic process [GO:0042982]; aorta morphogenesis [GO:0035909]; astrocyte activation [GO:0048143]; autophagy [GO:0006914]; cardiac muscle cell development [GO:0055013]; cell surface receptor signaling pathway via STAT [GO:0097696]; cellular response to oxidative stress [GO:0034599]; cerebellar Purkinje cell layer development [GO:0021680]; collagen metabolic process [GO:0032963]; cone retinal bipolar cell differentiation [GO:1904390]; cytoplasm organization [GO:0007028]; determination of adult lifespan [GO:0008340]; endothelium development [GO:0003158]; energy homeostasis [GO:0097009]; exploration behavior [GO:0035640]; ganglioside metabolic process [GO:0001573]; glycosaminoglycan metabolic process [GO:0030203]; Golgi organization [GO:0007030]; hair follicle morphogenesis [GO:0031069]; heparan sulfate proteoglycan catabolic process [GO:0030200]; heparin proteoglycan metabolic process [GO:0030202]; hormone metabolic process [GO:0042445]; inner ear receptor cell development [GO:0060119]; left ventricular cardiac muscle tissue morphogenesis [GO:0003220]; limb development [GO:0060173]; lipid catabolic process [GO:0016042]; liver development [GO:0001889]; locomotor rhythm [GO:0045475]; lysosome organization [GO:0007040]; maintenance of blood-brain barrier [GO:0035633]; microglia differentiation [GO:0014004]; microglial cell activation [GO:0001774]; middle ear morphogenesis [GO:0042474]; mitral valve morphogenesis [GO:0003183]; motor behavior [GO:0061744]; multicellular organismal-level iron ion homeostasis [GO:0060586]; nerve development [GO:0021675]; nervous system development [GO:0007399]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein processing [GO:0016485]; response to disaccharide [GO:0034285]; response to lipopolysaccharide [GO:0032496]; response to wounding [GO:0009611]; retinal rod cell development [GO:0046548]; rod bipolar cell differentiation [GO:1904389]; superoxide metabolic process [GO:0006801]; toll-like receptor 4 signaling pathway [GO:0034142]; vesicle tethering [GO:0099022] extracellular exosome [GO:0070062]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764]; membrane [GO:0016020] alpha-N-acetylglucosaminidase activity [GO:0004561]; iron ion sequestering activity [GO:0140315] g1436.t1 P56520 77.882 425 0.0 717.0 sp|P56520|HDAC3_CHICK Histone deacetylase 3 OS=Gallus gallus OX=9031 GN=HDAC3 PE=2 SV=1 g1437.t1 A2VDD2 40.0 115 4.39e-28 105.0 sp|A2VDD2|DYL5B_XENLA Dynein light chain Tctex-type 5-B (Fragment) OS=Xenopus laevis OX=8355 GN=Dynlt5-b PE=2 SV=1 g1438.t1 Q99P88 47.795 1406 0.0 1295.0 sp|Q99P88|NU155_MOUSE Nuclear pore complex protein Nup155 OS=Mus musculus OX=10090 GN=Nup155 PE=1 SV=1 NU155_MOUSE reviewed Nuclear pore complex protein Nup155 (155 kDa nucleoporin) (Nucleoporin Nup155) Mus musculus (Mouse) GO:0000972; GO:0005635; GO:0005643; GO:0006405; GO:0006406; GO:0006606; GO:0006913; GO:0006998; GO:0017056; GO:0031965; GO:0034504; GO:0035196; GO:0036228; GO:0044611; GO:0086014 atrial cardiac muscle cell action potential [GO:0086014]; miRNA processing [GO:0035196]; mRNA export from nucleus [GO:0006406]; nuclear envelope organization [GO:0006998]; nucleocytoplasmic transport [GO:0006913]; protein import into nucleus [GO:0006606]; protein localization to nuclear inner membrane [GO:0036228]; protein localization to nucleus [GO:0034504]; RNA export from nucleus [GO:0006405]; transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery [GO:0000972] nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nuclear pore inner ring [GO:0044611] structural constituent of nuclear pore [GO:0017056] g1439.t1 A2VDD2 35.252 139 1.9e-25 102.0 sp|A2VDD2|DYL5B_XENLA Dynein light chain Tctex-type 5-B (Fragment) OS=Xenopus laevis OX=8355 GN=Dynlt5-b PE=2 SV=1 g1440.t1 Q5RJI4 31.25 272 7.61e-35 137.0 sp|Q5RJI4|PKDCC_MOUSE Extracellular tyrosine-protein kinase PKDCC OS=Mus musculus OX=10090 GN=Pkdcc PE=1 SV=2 PKDCC_MOUSE reviewed Extracellular tyrosine-protein kinase PKDCC (EC 2.7.10.2) (Protein kinase domain-containing protein, cytoplasmic) (Protein kinase-like protein SgK493) (Sugen kinase 493) (Vertebrate lonesome kinase) Mus musculus (Mouse) GO:0001501; GO:0004672; GO:0004715; GO:0005524; GO:0005576; GO:0005794; GO:0015031; GO:0018108; GO:0030154; GO:0030282; GO:0030501; GO:0032332; GO:0035108; GO:0035264; GO:0042997; GO:0048286; GO:0048566; GO:0060021 bone mineralization [GO:0030282]; cell differentiation [GO:0030154]; embryonic digestive tract development [GO:0048566]; limb morphogenesis [GO:0035108]; lung alveolus development [GO:0048286]; multicellular organism growth [GO:0035264]; negative regulation of Golgi to plasma membrane protein transport [GO:0042997]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of bone mineralization [GO:0030501]; positive regulation of chondrocyte differentiation [GO:0032332]; protein transport [GO:0015031]; roof of mouth development [GO:0060021]; skeletal system development [GO:0001501] extracellular region [GO:0005576]; Golgi apparatus [GO:0005794] ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein kinase activity [GO:0004672] g1442.t1 Q7TT28 42.229 637 3.5800000000000005e-144 477.0 sp|Q7TT28|REXO1_MOUSE RNA exonuclease 1 homolog OS=Mus musculus OX=10090 GN=Rexo1 PE=1 SV=1 g1442.t2 Q7TT28 42.229 637 4.0800000000000004e-145 477.0 sp|Q7TT28|REXO1_MOUSE RNA exonuclease 1 homolog OS=Mus musculus OX=10090 GN=Rexo1 PE=1 SV=1 g1442.t3 Q7TT28 41.641 646 8.91e-143 474.0 sp|Q7TT28|REXO1_MOUSE RNA exonuclease 1 homolog OS=Mus musculus OX=10090 GN=Rexo1 PE=1 SV=1 g1443.t1 F6UA42 60.884 611 0.0 722.0 sp|F6UA42|UHRF1_XENTR E3 ubiquitin-protein ligase UHRF1 OS=Xenopus tropicalis OX=8364 GN=uhrf1 PE=3 SV=2 UHRF1_XENTR reviewed E3 ubiquitin-protein ligase UHRF1 (EC 2.3.2.27) (RING-type E3 ubiquitin transferase UHRF1) (Ubiquitin-like PHD and RING finger domain-containing protein 1) (Ubiquitin-like-containing PHD and RING finger domains protein 1) Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0000122; GO:0000785; GO:0000791; GO:0000792; GO:0004842; GO:0005634; GO:0005657; GO:0006511; GO:0008270; GO:0016567; GO:0031507; GO:0042393; GO:0044027; GO:0044729; GO:0061630; GO:0062072; GO:0140234; GO:0140248; GO:0140851; GO:0141119 chromosomal DNA methylation maintenance following DNA replication [GO:0141119]; heterochromatin formation [GO:0031507]; negative regulation of gene expression via chromosomal CpG island methylation [GO:0044027]; negative regulation of transcription by RNA polymerase II [GO:0000122]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511] chromatin [GO:0000785]; euchromatin [GO:0000791]; heterochromatin [GO:0000792]; nucleus [GO:0005634]; replication fork [GO:0005657] hemi-methylated DNA-binding [GO:0044729]; histone binding [GO:0042393]; histone H3K14 ubiquitin ligase activity [GO:0140851]; histone H3K18 ubiquitin ligase activity [GO:0140248]; histone H3K23 ubiquitin ligase activity [GO:0140234]; histone H3K9me2/3 reader activity [GO:0062072]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] g1443.t1 F6UA42 46.296 162 3.9400000000000003e-33 140.0 sp|F6UA42|UHRF1_XENTR E3 ubiquitin-protein ligase UHRF1 OS=Xenopus tropicalis OX=8364 GN=uhrf1 PE=3 SV=2 UHRF1_XENTR reviewed E3 ubiquitin-protein ligase UHRF1 (EC 2.3.2.27) (RING-type E3 ubiquitin transferase UHRF1) (Ubiquitin-like PHD and RING finger domain-containing protein 1) (Ubiquitin-like-containing PHD and RING finger domains protein 1) Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0000122; GO:0000785; GO:0000791; GO:0000792; GO:0004842; GO:0005634; GO:0005657; GO:0006511; GO:0008270; GO:0016567; GO:0031507; GO:0042393; GO:0044027; GO:0044729; GO:0061630; GO:0062072; GO:0140234; GO:0140248; GO:0140851; GO:0141119 chromosomal DNA methylation maintenance following DNA replication [GO:0141119]; heterochromatin formation [GO:0031507]; negative regulation of gene expression via chromosomal CpG island methylation [GO:0044027]; negative regulation of transcription by RNA polymerase II [GO:0000122]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511] chromatin [GO:0000785]; euchromatin [GO:0000791]; heterochromatin [GO:0000792]; nucleus [GO:0005634]; replication fork [GO:0005657] hemi-methylated DNA-binding [GO:0044729]; histone binding [GO:0042393]; histone H3K14 ubiquitin ligase activity [GO:0140851]; histone H3K18 ubiquitin ligase activity [GO:0140248]; histone H3K23 ubiquitin ligase activity [GO:0140234]; histone H3K9me2/3 reader activity [GO:0062072]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] g1445.t1 Q8N6S4 63.573 431 0.0 587.0 sp|Q8N6S4|AN13C_HUMAN Ankyrin repeat domain-containing protein 13C OS=Homo sapiens OX=9606 GN=ANKRD13C PE=1 SV=2 AN13C_HUMAN reviewed Ankyrin repeat domain-containing protein 13C Homo sapiens (Human) GO:0005102; GO:0005737; GO:0005783; GO:0005789; GO:0006612; GO:0048471; GO:0071799; GO:0140597; GO:2000209 cellular response to prostaglandin D stimulus [GO:0071799]; protein targeting to membrane [GO:0006612]; regulation of anoikis [GO:2000209] cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; perinuclear region of cytoplasm [GO:0048471] protein carrier chaperone [GO:0140597]; signaling receptor binding [GO:0005102] g1445.t2 Q8N6S4 62.471 437 0.0 581.0 sp|Q8N6S4|AN13C_HUMAN Ankyrin repeat domain-containing protein 13C OS=Homo sapiens OX=9606 GN=ANKRD13C PE=1 SV=2 AN13C_HUMAN reviewed Ankyrin repeat domain-containing protein 13C Homo sapiens (Human) GO:0005102; GO:0005737; GO:0005783; GO:0005789; GO:0006612; GO:0048471; GO:0071799; GO:0140597; GO:2000209 cellular response to prostaglandin D stimulus [GO:0071799]; protein targeting to membrane [GO:0006612]; regulation of anoikis [GO:2000209] cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; perinuclear region of cytoplasm [GO:0048471] protein carrier chaperone [GO:0140597]; signaling receptor binding [GO:0005102] g1446.t1 Q5U4S8 51.175 383 9.079999999999999e-142 412.0 sp|Q5U4S8|CEGTB_XENLA Ceramide glucosyltransferase-B OS=Xenopus laevis OX=8355 GN=ugcg-b PE=2 SV=1 g1447.t1 P23787 87.223 767 0.0 1330.0 sp|P23787|TERA_XENLA Transitional endoplasmic reticulum ATPase OS=Xenopus laevis OX=8355 GN=vcp PE=1 SV=3 g1448.t1 Q32PD8 53.125 128 5e-41 137.0 sp|Q32PD8|LERL1_BOVIN Leptin receptor overlapping transcript-like 1 OS=Bos taurus OX=9913 GN=LEPROTL1 PE=2 SV=1 g1449.t1 B2RX14 50.427 468 2.34e-134 463.0 sp|B2RX14|TUT4_MOUSE Terminal uridylyltransferase 4 OS=Mus musculus OX=10090 GN=Tut4 PE=1 SV=2 TUT4_MOUSE reviewed Terminal uridylyltransferase 4 (TUTase 4) (EC 2.7.7.52) (Zinc finger CCHC domain-containing protein 11) Mus musculus (Mouse) GO:0001556; GO:0005634; GO:0005730; GO:0005737; GO:0005829; GO:0008270; GO:0010586; GO:0010587; GO:0019827; GO:0031054; GO:0031123; GO:0031664; GO:0032755; GO:0035198; GO:0036464; GO:0050265; GO:0070102; GO:0070569; GO:0141008; GO:1990074 interleukin-6-mediated signaling pathway [GO:0070102]; miRNA catabolic process [GO:0010587]; miRNA metabolic process [GO:0010586]; oocyte maturation [GO:0001556]; polyuridylation-dependent mRNA catabolic process [GO:1990074]; positive regulation of interleukin-6 production [GO:0032755]; pre-miRNA processing [GO:0031054]; regulation of lipopolysaccharide-mediated signaling pathway [GO:0031664]; RNA 3'-end processing [GO:0031123]; stem cell population maintenance [GO:0019827]; transposable element silencing by mRNA destabilization [GO:0141008] cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleus [GO:0005634] miRNA binding [GO:0035198]; RNA uridylyltransferase activity [GO:0050265]; uridylyltransferase activity [GO:0070569]; zinc ion binding [GO:0008270] g1449.t1 B2RX14 35.632 261 3.7499999999999996e-48 194.0 sp|B2RX14|TUT4_MOUSE Terminal uridylyltransferase 4 OS=Mus musculus OX=10090 GN=Tut4 PE=1 SV=2 TUT4_MOUSE reviewed Terminal uridylyltransferase 4 (TUTase 4) (EC 2.7.7.52) (Zinc finger CCHC domain-containing protein 11) Mus musculus (Mouse) GO:0001556; GO:0005634; GO:0005730; GO:0005737; GO:0005829; GO:0008270; GO:0010586; GO:0010587; GO:0019827; GO:0031054; GO:0031123; GO:0031664; GO:0032755; GO:0035198; GO:0036464; GO:0050265; GO:0070102; GO:0070569; GO:0141008; GO:1990074 interleukin-6-mediated signaling pathway [GO:0070102]; miRNA catabolic process [GO:0010587]; miRNA metabolic process [GO:0010586]; oocyte maturation [GO:0001556]; polyuridylation-dependent mRNA catabolic process [GO:1990074]; positive regulation of interleukin-6 production [GO:0032755]; pre-miRNA processing [GO:0031054]; regulation of lipopolysaccharide-mediated signaling pathway [GO:0031664]; RNA 3'-end processing [GO:0031123]; stem cell population maintenance [GO:0019827]; transposable element silencing by mRNA destabilization [GO:0141008] cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleus [GO:0005634] miRNA binding [GO:0035198]; RNA uridylyltransferase activity [GO:0050265]; uridylyltransferase activity [GO:0070569]; zinc ion binding [GO:0008270] g1449.t1 B2RX14 28.763 299 5.8599999999999994e-30 134.0 sp|B2RX14|TUT4_MOUSE Terminal uridylyltransferase 4 OS=Mus musculus OX=10090 GN=Tut4 PE=1 SV=2 TUT4_MOUSE reviewed Terminal uridylyltransferase 4 (TUTase 4) (EC 2.7.7.52) (Zinc finger CCHC domain-containing protein 11) Mus musculus (Mouse) GO:0001556; GO:0005634; GO:0005730; GO:0005737; GO:0005829; GO:0008270; GO:0010586; GO:0010587; GO:0019827; GO:0031054; GO:0031123; GO:0031664; GO:0032755; GO:0035198; GO:0036464; GO:0050265; GO:0070102; GO:0070569; GO:0141008; GO:1990074 interleukin-6-mediated signaling pathway [GO:0070102]; miRNA catabolic process [GO:0010587]; miRNA metabolic process [GO:0010586]; oocyte maturation [GO:0001556]; polyuridylation-dependent mRNA catabolic process [GO:1990074]; positive regulation of interleukin-6 production [GO:0032755]; pre-miRNA processing [GO:0031054]; regulation of lipopolysaccharide-mediated signaling pathway [GO:0031664]; RNA 3'-end processing [GO:0031123]; stem cell population maintenance [GO:0019827]; transposable element silencing by mRNA destabilization [GO:0141008] cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleus [GO:0005634] miRNA binding [GO:0035198]; RNA uridylyltransferase activity [GO:0050265]; uridylyltransferase activity [GO:0070569]; zinc ion binding [GO:0008270] g1449.t2 B2RX14 50.427 468 5.13e-135 463.0 sp|B2RX14|TUT4_MOUSE Terminal uridylyltransferase 4 OS=Mus musculus OX=10090 GN=Tut4 PE=1 SV=2 TUT4_MOUSE reviewed Terminal uridylyltransferase 4 (TUTase 4) (EC 2.7.7.52) (Zinc finger CCHC domain-containing protein 11) Mus musculus (Mouse) GO:0001556; GO:0005634; GO:0005730; GO:0005737; GO:0005829; GO:0008270; GO:0010586; GO:0010587; GO:0019827; GO:0031054; GO:0031123; GO:0031664; GO:0032755; GO:0035198; GO:0036464; GO:0050265; GO:0070102; GO:0070569; GO:0141008; GO:1990074 interleukin-6-mediated signaling pathway [GO:0070102]; miRNA catabolic process [GO:0010587]; miRNA metabolic process [GO:0010586]; oocyte maturation [GO:0001556]; polyuridylation-dependent mRNA catabolic process [GO:1990074]; positive regulation of interleukin-6 production [GO:0032755]; pre-miRNA processing [GO:0031054]; regulation of lipopolysaccharide-mediated signaling pathway [GO:0031664]; RNA 3'-end processing [GO:0031123]; stem cell population maintenance [GO:0019827]; transposable element silencing by mRNA destabilization [GO:0141008] cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleus [GO:0005634] miRNA binding [GO:0035198]; RNA uridylyltransferase activity [GO:0050265]; uridylyltransferase activity [GO:0070569]; zinc ion binding [GO:0008270] g1449.t2 B2RX14 35.632 261 3.2299999999999997e-48 194.0 sp|B2RX14|TUT4_MOUSE Terminal uridylyltransferase 4 OS=Mus musculus OX=10090 GN=Tut4 PE=1 SV=2 TUT4_MOUSE reviewed Terminal uridylyltransferase 4 (TUTase 4) (EC 2.7.7.52) (Zinc finger CCHC domain-containing protein 11) Mus musculus (Mouse) GO:0001556; GO:0005634; GO:0005730; GO:0005737; GO:0005829; GO:0008270; GO:0010586; GO:0010587; GO:0019827; GO:0031054; GO:0031123; GO:0031664; GO:0032755; GO:0035198; GO:0036464; GO:0050265; GO:0070102; GO:0070569; GO:0141008; GO:1990074 interleukin-6-mediated signaling pathway [GO:0070102]; miRNA catabolic process [GO:0010587]; miRNA metabolic process [GO:0010586]; oocyte maturation [GO:0001556]; polyuridylation-dependent mRNA catabolic process [GO:1990074]; positive regulation of interleukin-6 production [GO:0032755]; pre-miRNA processing [GO:0031054]; regulation of lipopolysaccharide-mediated signaling pathway [GO:0031664]; RNA 3'-end processing [GO:0031123]; stem cell population maintenance [GO:0019827]; transposable element silencing by mRNA destabilization [GO:0141008] cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleus [GO:0005634] miRNA binding [GO:0035198]; RNA uridylyltransferase activity [GO:0050265]; uridylyltransferase activity [GO:0070569]; zinc ion binding [GO:0008270] g1449.t2 B2RX14 28.763 299 5.2199999999999996e-30 134.0 sp|B2RX14|TUT4_MOUSE Terminal uridylyltransferase 4 OS=Mus musculus OX=10090 GN=Tut4 PE=1 SV=2 TUT4_MOUSE reviewed Terminal uridylyltransferase 4 (TUTase 4) (EC 2.7.7.52) (Zinc finger CCHC domain-containing protein 11) Mus musculus (Mouse) GO:0001556; GO:0005634; GO:0005730; GO:0005737; GO:0005829; GO:0008270; GO:0010586; GO:0010587; GO:0019827; GO:0031054; GO:0031123; GO:0031664; GO:0032755; GO:0035198; GO:0036464; GO:0050265; GO:0070102; GO:0070569; GO:0141008; GO:1990074 interleukin-6-mediated signaling pathway [GO:0070102]; miRNA catabolic process [GO:0010587]; miRNA metabolic process [GO:0010586]; oocyte maturation [GO:0001556]; polyuridylation-dependent mRNA catabolic process [GO:1990074]; positive regulation of interleukin-6 production [GO:0032755]; pre-miRNA processing [GO:0031054]; regulation of lipopolysaccharide-mediated signaling pathway [GO:0031664]; RNA 3'-end processing [GO:0031123]; stem cell population maintenance [GO:0019827]; transposable element silencing by mRNA destabilization [GO:0141008] cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleus [GO:0005634] miRNA binding [GO:0035198]; RNA uridylyltransferase activity [GO:0050265]; uridylyltransferase activity [GO:0070569]; zinc ion binding [GO:0008270] g1450.t1 Q8WXA9 62.366 186 7.36e-61 213.0 sp|Q8WXA9|SREK1_HUMAN Splicing regulatory glutamine/lysine-rich protein 1 OS=Homo sapiens OX=9606 GN=SREK1 PE=1 SV=1 SREK1_HUMAN reviewed Splicing regulatory glutamine/lysine-rich protein 1 (Serine/arginine-rich-splicing regulatory protein 86) (SRrp86) (Splicing factor, arginine/serine-rich 12) (Splicing regulatory protein 508) (SRrp508) Homo sapiens (Human) GO:0003723; GO:0005654; GO:0005681; GO:0006397; GO:0008380; GO:0016607 mRNA processing [GO:0006397]; RNA splicing [GO:0008380] nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; spliceosomal complex [GO:0005681] RNA binding [GO:0003723] g1451.t1 Q5VXU9 31.33 233 5.0000000000000005e-22 107.0 sp|Q5VXU9|SHOC1_HUMAN Protein shortage in chiasmata 1 ortholog OS=Homo sapiens OX=9606 GN=SHOC1 PE=1 SV=1 SHOC1_HUMAN reviewed Protein shortage in chiasmata 1 ortholog (EC 3.6.-.-) (Protein ZIP2 homolog) (MZIP2) Homo sapiens (Human) GO:0000712; GO:0000794; GO:0003697; GO:0005694; GO:0007130; GO:0007131; GO:0016887 reciprocal meiotic recombination [GO:0007131]; resolution of meiotic recombination intermediates [GO:0000712]; synaptonemal complex assembly [GO:0007130] chromosome [GO:0005694]; condensed nuclear chromosome [GO:0000794] ATP hydrolysis activity [GO:0016887]; single-stranded DNA binding [GO:0003697] g1452.t1 A7MB63 48.127 347 5.26e-99 302.0 sp|A7MB63|CTNS_BOVIN Cystinosin OS=Bos taurus OX=9913 GN=CTNS PE=2 SV=1 CTNS_BOVIN reviewed Cystinosin Bos taurus (Bovine) GO:0005765; GO:0015031; GO:0015184; GO:0015295; GO:0015811; GO:0033162; GO:0042438; GO:0042470; GO:0048021; GO:0048513; GO:0048731; GO:0050890; GO:1903432 animal organ development [GO:0048513]; cognition [GO:0050890]; L-cystine transport [GO:0015811]; melanin biosynthetic process [GO:0042438]; protein transport [GO:0015031]; regulation of melanin biosynthetic process [GO:0048021]; regulation of TORC1 signaling [GO:1903432]; system development [GO:0048731] lysosomal membrane [GO:0005765]; melanosome [GO:0042470]; melanosome membrane [GO:0033162] L-cystine transmembrane transporter activity [GO:0015184]; solute:proton symporter activity [GO:0015295] g1454.t1 Q9H3R0 69.643 336 9.760000000000001e-166 525.0 sp|Q9H3R0|KDM4C_HUMAN Lysine-specific demethylase 4C OS=Homo sapiens OX=9606 GN=KDM4C PE=1 SV=2 g1454.t1 Q9H3R0 44.039 411 6.43e-101 349.0 sp|Q9H3R0|KDM4C_HUMAN Lysine-specific demethylase 4C OS=Homo sapiens OX=9606 GN=KDM4C PE=1 SV=2 g1455.t1 Q13332 41.647 2089 0.0 1356.0 sp|Q13332|PTPRS_HUMAN Receptor-type tyrosine-protein phosphatase S OS=Homo sapiens OX=9606 GN=PTPRS PE=1 SV=3 g1464.t1 P0C6F1 71.04 4040 0.0 6038.0 sp|P0C6F1|DYH2_MOUSE Dynein axonemal heavy chain 2 OS=Mus musculus OX=10090 GN=Dnah2 PE=1 SV=1 DYH2_MOUSE reviewed Dynein axonemal heavy chain 2 (Axonemal beta dynein heavy chain 2) (Ciliary dynein heavy chain 2) Mus musculus (Mouse) GO:0003341; GO:0005524; GO:0005858; GO:0005874; GO:0005929; GO:0005930; GO:0008569; GO:0030286; GO:0031514; GO:0036126; GO:0036156; GO:0036159; GO:0045505; GO:0051959; GO:0060285; GO:0060294; GO:0097729 cilium movement [GO:0003341]; cilium movement involved in cell motility [GO:0060294]; cilium-dependent cell motility [GO:0060285]; inner dynein arm assembly [GO:0036159] 9+2 motile cilium [GO:0097729]; axonemal dynein complex [GO:0005858]; axoneme [GO:0005930]; cilium [GO:0005929]; dynein complex [GO:0030286]; inner dynein arm [GO:0036156]; microtubule [GO:0005874]; motile cilium [GO:0031514]; sperm flagellum [GO:0036126] ATP binding [GO:0005524]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; minus-end-directed microtubule motor activity [GO:0008569] g1464.t1 P0C6F1 56.311 309 1.51e-97 360.0 sp|P0C6F1|DYH2_MOUSE Dynein axonemal heavy chain 2 OS=Mus musculus OX=10090 GN=Dnah2 PE=1 SV=1 DYH2_MOUSE reviewed Dynein axonemal heavy chain 2 (Axonemal beta dynein heavy chain 2) (Ciliary dynein heavy chain 2) Mus musculus (Mouse) GO:0003341; GO:0005524; GO:0005858; GO:0005874; GO:0005929; GO:0005930; GO:0008569; GO:0030286; GO:0031514; GO:0036126; GO:0036156; GO:0036159; GO:0045505; GO:0051959; GO:0060285; GO:0060294; GO:0097729 cilium movement [GO:0003341]; cilium movement involved in cell motility [GO:0060294]; cilium-dependent cell motility [GO:0060285]; inner dynein arm assembly [GO:0036159] 9+2 motile cilium [GO:0097729]; axonemal dynein complex [GO:0005858]; axoneme [GO:0005930]; cilium [GO:0005929]; dynein complex [GO:0030286]; inner dynein arm [GO:0036156]; microtubule [GO:0005874]; motile cilium [GO:0031514]; sperm flagellum [GO:0036126] ATP binding [GO:0005524]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; minus-end-directed microtubule motor activity [GO:0008569] g1466.t1 Q562C7 45.543 516 6.64e-151 454.0 sp|Q562C7|PUM3_RAT Pumilio homolog 3 OS=Rattus norvegicus OX=10116 GN=Pum3 PE=2 SV=1 g1468.t1 P50430 49.598 498 6.070000000000001e-160 469.0 sp|P50430|ARSB_RAT Arylsulfatase B OS=Rattus norvegicus OX=10116 GN=Arsb PE=2 SV=2 g1469.t1 Q9UGM3 37.153 541 6.059999999999999e-90 309.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g1469.t1 Q9UGM3 36.804 557 1.6399999999999998e-89 308.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g1469.t1 Q9UGM3 35.714 588 6.039999999999999e-89 306.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g1469.t1 Q9UGM3 37.524 525 1.75e-88 305.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g1469.t1 Q9UGM3 36.549 539 7.8e-87 300.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g1469.t1 Q9UGM3 35.495 586 1.3300000000000002e-85 296.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g1469.t1 Q9UGM3 35.971 556 1.22e-84 294.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g1469.t1 Q9UGM3 38.577 267 1.6499999999999998e-42 169.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g1469.t1 Q9UGM3 29.194 459 1.3200000000000001e-36 151.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g1480.t1 P53395 56.751 474 0.0 526.0 sp|P53395|ODB2_MOUSE Lipoamide acyltransferase component of branched-chain alpha-keto acid dehydrogenase complex, mitochondrial OS=Mus musculus OX=10090 GN=Dbt PE=1 SV=2 g1483.t1 O00442 58.974 78 2.3400000000000003e-27 105.0 sp|O00442|RTCA_HUMAN RNA 3'-terminal phosphate cyclase OS=Homo sapiens OX=9606 GN=RTCA PE=1 SV=1 RTCA_HUMAN reviewed RNA 3'-terminal phosphate cyclase (RNA cyclase) (RNA-3'-phosphate cyclase) (EC 6.5.1.4) (RNA terminal phosphate cyclase domain-containing protein 1) (RTC domain-containing protein 1) Homo sapiens (Human) GO:0003723; GO:0003963; GO:0005524; GO:0005634; GO:0005654; GO:0006396; GO:1905592 negative regulation of optical nerve axon regeneration [GO:1905592]; RNA processing [GO:0006396] nucleoplasm [GO:0005654]; nucleus [GO:0005634] ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA-3'-phosphate cyclase activity [GO:0003963] g1484.t1 Q9D7H3 57.511 233 8.8e-90 271.0 sp|Q9D7H3|RTCA_MOUSE RNA 3'-terminal phosphate cyclase OS=Mus musculus OX=10090 GN=RtcA PE=1 SV=2 RTCA_MOUSE reviewed RNA 3'-terminal phosphate cyclase (RNA cyclase) (RNA-3'-phosphate cyclase) (EC 6.5.1.4) (RNA terminal phosphate cyclase domain-containing protein 1) Mus musculus (Mouse) GO:0003963; GO:0005524; GO:0005634; GO:0005654; GO:0006396; GO:1905592 negative regulation of optical nerve axon regeneration [GO:1905592]; RNA processing [GO:0006396] nucleoplasm [GO:0005654]; nucleus [GO:0005634] ATP binding [GO:0005524]; RNA-3'-phosphate cyclase activity [GO:0003963] g1488.t1 Q99848 47.351 302 3.6099999999999996e-60 198.0 sp|Q99848|EBP2_HUMAN Probable rRNA-processing protein EBP2 OS=Homo sapiens OX=9606 GN=EBNA1BP2 PE=1 SV=2 EBP2_HUMAN reviewed Probable rRNA-processing protein EBP2 (EBNA1-binding protein 2) (Nucleolar protein p40) Homo sapiens (Human) GO:0003723; GO:0005694; GO:0005730; GO:0006364; GO:0030687; GO:0034399; GO:0042273 ribosomal large subunit biogenesis [GO:0042273]; rRNA processing [GO:0006364] chromosome [GO:0005694]; nuclear periphery [GO:0034399]; nucleolus [GO:0005730]; preribosome, large subunit precursor [GO:0030687] RNA binding [GO:0003723] g1489.t1 F1P3Y5 47.692 130 1.62e-35 122.0 sp|F1P3Y5|CF144_CHICK Cilia- and flagella-associated protein 144 OS=Gallus gallus OX=9031 GN=CFAP144 PE=1 SV=2 g1492.t1 Q9R1K5 74.245 497 0.0 724.0 sp|Q9R1K5|FZR1_MOUSE Fizzy-related protein homolog OS=Mus musculus OX=10090 GN=Fzr1 PE=1 SV=1 FZR1_MOUSE reviewed Fizzy-related protein homolog (Fzr) (Cdh1/Hct1 homolog) Mus musculus (Mouse) GO:0005634; GO:0005654; GO:0005680; GO:0006281; GO:0007095; GO:0008284; GO:0010997; GO:0016567; GO:0031145; GO:0031965; GO:0040020; GO:0046105; GO:0051301; GO:0051603; GO:0070306; GO:1904668; GO:1904860; GO:1905786; GO:1990756; GO:1990757; GO:2000773 anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell division [GO:0051301]; DNA repair [GO:0006281]; DNA synthesis involved in mitotic DNA replication [GO:1904860]; lens fiber cell differentiation [GO:0070306]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; negative regulation of cellular senescence [GO:2000773]; positive regulation of anaphase-promoting complex-dependent catabolic process [GO:1905786]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ubiquitin protein ligase activity [GO:1904668]; protein ubiquitination [GO:0016567]; proteolysis involved in protein catabolic process [GO:0051603]; regulation of meiotic nuclear division [GO:0040020]; thymidine biosynthetic process [GO:0046105] anaphase-promoting complex [GO:0005680]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] anaphase-promoting complex binding [GO:0010997]; ubiquitin ligase activator activity [GO:1990757]; ubiquitin-like ligase-substrate adaptor activity [GO:1990756] g1492.t2 Q9R1K5 74.141 495 0.0 724.0 sp|Q9R1K5|FZR1_MOUSE Fizzy-related protein homolog OS=Mus musculus OX=10090 GN=Fzr1 PE=1 SV=1 FZR1_MOUSE reviewed Fizzy-related protein homolog (Fzr) (Cdh1/Hct1 homolog) Mus musculus (Mouse) GO:0005634; GO:0005654; GO:0005680; GO:0006281; GO:0007095; GO:0008284; GO:0010997; GO:0016567; GO:0031145; GO:0031965; GO:0040020; GO:0046105; GO:0051301; GO:0051603; GO:0070306; GO:1904668; GO:1904860; GO:1905786; GO:1990756; GO:1990757; GO:2000773 anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell division [GO:0051301]; DNA repair [GO:0006281]; DNA synthesis involved in mitotic DNA replication [GO:1904860]; lens fiber cell differentiation [GO:0070306]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; negative regulation of cellular senescence [GO:2000773]; positive regulation of anaphase-promoting complex-dependent catabolic process [GO:1905786]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ubiquitin protein ligase activity [GO:1904668]; protein ubiquitination [GO:0016567]; proteolysis involved in protein catabolic process [GO:0051603]; regulation of meiotic nuclear division [GO:0040020]; thymidine biosynthetic process [GO:0046105] anaphase-promoting complex [GO:0005680]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] anaphase-promoting complex binding [GO:0010997]; ubiquitin ligase activator activity [GO:1990757]; ubiquitin-like ligase-substrate adaptor activity [GO:1990756] g1494.t1 Q8CE72 28.398 743 7.220000000000001e-73 263.0 sp|Q8CE72|CPLN1_MOUSE Ciliogenesis and planar polarity effector 1 OS=Mus musculus OX=10090 GN=Cplane1 PE=1 SV=4 CPLN1_MOUSE reviewed Ciliogenesis and planar polarity effector 1 (Protein C5orf42 homolog) (Protein JBTS17) Mus musculus (Mouse) GO:0001736; GO:0001822; GO:0003279; GO:0003281; GO:0007507; GO:0016020; GO:0021549; GO:0035869; GO:0042733; GO:0060021; GO:0060271; GO:0060976; GO:1904491 cardiac septum development [GO:0003279]; cerebellum development [GO:0021549]; cilium assembly [GO:0060271]; coronary vasculature development [GO:0060976]; embryonic digit morphogenesis [GO:0042733]; establishment of planar polarity [GO:0001736]; heart development [GO:0007507]; kidney development [GO:0001822]; protein localization to ciliary transition zone [GO:1904491]; roof of mouth development [GO:0060021]; ventricular septum development [GO:0003281] ciliary transition zone [GO:0035869]; membrane [GO:0016020] g1497.t1 Q9UGU5 49.254 201 1.3999999999999998e-42 167.0 sp|Q9UGU5|HMGX4_HUMAN HMG domain-containing protein 4 OS=Homo sapiens OX=9606 GN=HMGXB4 PE=1 SV=2 HMGX4_HUMAN reviewed HMG domain-containing protein 4 (HMG box-containing protein 4) (High mobility group protein 2-like 1) (Protein HMGBCG) Homo sapiens (Human) GO:0003677; GO:0008333; GO:0016055; GO:0016589; GO:0030178; GO:0042802 endosome to lysosome transport [GO:0008333]; negative regulation of Wnt signaling pathway [GO:0030178]; Wnt signaling pathway [GO:0016055] NURF complex [GO:0016589] DNA binding [GO:0003677]; identical protein binding [GO:0042802] g1498.t1 P17542 65.476 84 4.21e-26 110.0 sp|P17542|TAL1_HUMAN T-cell acute lymphocytic leukemia protein 1 OS=Homo sapiens OX=9606 GN=TAL1 PE=1 SV=2 TAL1_HUMAN reviewed T-cell acute lymphocytic leukemia protein 1 (TAL-1) (Class A basic helix-loop-helix protein 17) (bHLHa17) (Stem cell protein) (T-cell leukemia/lymphoma protein 5) Homo sapiens (Human) GO:0000122; GO:0000785; GO:0000976; GO:0000978; GO:0000981; GO:0001525; GO:0003682; GO:0003700; GO:0005634; GO:0005654; GO:0005667; GO:0006357; GO:0006366; GO:0007626; GO:0019899; GO:0021527; GO:0030097; GO:0030218; GO:0030219; GO:0030220; GO:0030221; GO:0031334; GO:0035162; GO:0035855; GO:0042127; GO:0042826; GO:0043249; GO:0045165; GO:0045648; GO:0045893; GO:0045931; GO:0045944; GO:0046983; GO:0051781; GO:0060018; GO:0060216; GO:0060217; GO:0060218; GO:0060375; GO:0061629; GO:0070888; GO:1904672; GO:1905269 angiogenesis [GO:0001525]; astrocyte fate commitment [GO:0060018]; basophil differentiation [GO:0030221]; cell fate commitment [GO:0045165]; definitive hemopoiesis [GO:0060216]; embryonic hemopoiesis [GO:0035162]; erythrocyte differentiation [GO:0030218]; erythrocyte maturation [GO:0043249]; hemangioblast cell differentiation [GO:0060217]; hematopoietic stem cell differentiation [GO:0060218]; hemopoiesis [GO:0030097]; locomotory behavior [GO:0007626]; megakaryocyte development [GO:0035855]; megakaryocyte differentiation [GO:0030219]; negative regulation of transcription by RNA polymerase II [GO:0000122]; platelet formation [GO:0030220]; positive regulation of cell division [GO:0051781]; positive regulation of chromatin organization [GO:1905269]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of protein-containing complex assembly [GO:0031334]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell population proliferation [GO:0042127]; regulation of mast cell differentiation [GO:0060375]; regulation of somatic stem cell population maintenance [GO:1904672]; regulation of transcription by RNA polymerase II [GO:0006357]; spinal cord association neuron differentiation [GO:0021527]; transcription by RNA polymerase II [GO:0006366] chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667] chromatin binding [GO:0003682]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; E-box binding [GO:0070888]; enzyme binding [GO:0019899]; histone deacetylase binding [GO:0042826]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription cis-regulatory region binding [GO:0000976] g1499.t1 Q7ZW86 55.215 489 4.93e-139 411.0 sp|Q7ZW86|CWC27_DANRE Spliceosome-associated protein CWC27 homolog OS=Danio rerio OX=7955 GN=cwc27 PE=2 SV=1 CWC27_DANRE reviewed Spliceosome-associated protein CWC27 homolog (Probable inactive peptidyl-prolyl cis-trans isomerase CWC27 homolog) (PPIase CWC27) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0003755; GO:0006457; GO:0071005; GO:0071013 protein folding [GO:0006457] catalytic step 2 spliceosome [GO:0071013]; U2-type precatalytic spliceosome [GO:0071005] peptidyl-prolyl cis-trans isomerase activity [GO:0003755] g1502.t1 B2GV87 40.823 583 6.25e-132 427.0 sp|B2GV87|PTPRE_RAT Receptor-type tyrosine-protein phosphatase epsilon OS=Rattus norvegicus OX=10116 GN=Ptpre PE=2 SV=1 PTPRE_RAT reviewed Receptor-type tyrosine-protein phosphatase epsilon (Protein-tyrosine phosphatase epsilon) (R-PTP-epsilon) (EC 3.1.3.48) Rattus norvegicus (Rat) GO:0004725; GO:0005634; GO:0005737; GO:0005886; GO:0007165; GO:0007185; GO:0033003; GO:0042802; GO:0046627 cell surface receptor protein tyrosine phosphatase signaling pathway [GO:0007185]; negative regulation of insulin receptor signaling pathway [GO:0046627]; regulation of mast cell activation [GO:0033003]; signal transduction [GO:0007165] cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886] identical protein binding [GO:0042802]; protein tyrosine phosphatase activity [GO:0004725] g1502.t2 B2GV87 40.823 583 7.68e-132 427.0 sp|B2GV87|PTPRE_RAT Receptor-type tyrosine-protein phosphatase epsilon OS=Rattus norvegicus OX=10116 GN=Ptpre PE=2 SV=1 PTPRE_RAT reviewed Receptor-type tyrosine-protein phosphatase epsilon (Protein-tyrosine phosphatase epsilon) (R-PTP-epsilon) (EC 3.1.3.48) Rattus norvegicus (Rat) GO:0004725; GO:0005634; GO:0005737; GO:0005886; GO:0007165; GO:0007185; GO:0033003; GO:0042802; GO:0046627 cell surface receptor protein tyrosine phosphatase signaling pathway [GO:0007185]; negative regulation of insulin receptor signaling pathway [GO:0046627]; regulation of mast cell activation [GO:0033003]; signal transduction [GO:0007165] cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886] identical protein binding [GO:0042802]; protein tyrosine phosphatase activity [GO:0004725] g1512.t1 Q0KIA2 47.111 225 9.46e-53 193.0 sp|Q0KIA2|Y9801_DROME PP2C-like domain-containing protein CG9801 OS=Drosophila melanogaster OX=7227 GN=CG9801 PE=2 SV=1 g1513.t1 Q15262 45.756 271 1.65e-64 243.0 sp|Q15262|PTPRK_HUMAN Receptor-type tyrosine-protein phosphatase kappa OS=Homo sapiens OX=9606 GN=PTPRK PE=1 SV=2 PTPRK_HUMAN reviewed Receptor-type tyrosine-protein phosphatase kappa (Protein-tyrosine phosphatase kappa) (R-PTP-kappa) (EC 3.1.3.48) Homo sapiens (Human) GO:0004725; GO:0005001; GO:0005814; GO:0005886; GO:0005911; GO:0005912; GO:0006470; GO:0007155; GO:0007165; GO:0007179; GO:0008013; GO:0008285; GO:0009986; GO:0010839; GO:0016020; GO:0016477; GO:0019901; GO:0030054; GO:0030336; GO:0031175; GO:0031256; GO:0034394; GO:0034614; GO:0034644; GO:0045295; GO:0045786; GO:0045892; GO:0048041; GO:0120212 cell adhesion [GO:0007155]; cell migration [GO:0016477]; cellular response to reactive oxygen species [GO:0034614]; cellular response to UV [GO:0034644]; focal adhesion assembly [GO:0048041]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of keratinocyte proliferation [GO:0010839]; neuron projection development [GO:0031175]; protein dephosphorylation [GO:0006470]; protein localization to cell surface [GO:0034394]; signal transduction [GO:0007165]; transforming growth factor beta receptor signaling pathway [GO:0007179] adherens junction [GO:0005912]; cell junction [GO:0030054]; cell surface [GO:0009986]; cell-cell junction [GO:0005911]; centriole [GO:0005814]; leading edge membrane [GO:0031256]; membrane [GO:0016020]; plasma membrane [GO:0005886]; sperm head-tail coupling apparatus [GO:0120212] beta-catenin binding [GO:0008013]; gamma-catenin binding [GO:0045295]; protein kinase binding [GO:0019901]; protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001] g1513.t1 Q15262 29.104 268 1.2e-26 122.0 sp|Q15262|PTPRK_HUMAN Receptor-type tyrosine-protein phosphatase kappa OS=Homo sapiens OX=9606 GN=PTPRK PE=1 SV=2 PTPRK_HUMAN reviewed Receptor-type tyrosine-protein phosphatase kappa (Protein-tyrosine phosphatase kappa) (R-PTP-kappa) (EC 3.1.3.48) Homo sapiens (Human) GO:0004725; GO:0005001; GO:0005814; GO:0005886; GO:0005911; GO:0005912; GO:0006470; GO:0007155; GO:0007165; GO:0007179; GO:0008013; GO:0008285; GO:0009986; GO:0010839; GO:0016020; GO:0016477; GO:0019901; GO:0030054; GO:0030336; GO:0031175; GO:0031256; GO:0034394; GO:0034614; GO:0034644; GO:0045295; GO:0045786; GO:0045892; GO:0048041; GO:0120212 cell adhesion [GO:0007155]; cell migration [GO:0016477]; cellular response to reactive oxygen species [GO:0034614]; cellular response to UV [GO:0034644]; focal adhesion assembly [GO:0048041]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of keratinocyte proliferation [GO:0010839]; neuron projection development [GO:0031175]; protein dephosphorylation [GO:0006470]; protein localization to cell surface [GO:0034394]; signal transduction [GO:0007165]; transforming growth factor beta receptor signaling pathway [GO:0007179] adherens junction [GO:0005912]; cell junction [GO:0030054]; cell surface [GO:0009986]; cell-cell junction [GO:0005911]; centriole [GO:0005814]; leading edge membrane [GO:0031256]; membrane [GO:0016020]; plasma membrane [GO:0005886]; sperm head-tail coupling apparatus [GO:0120212] beta-catenin binding [GO:0008013]; gamma-catenin binding [GO:0045295]; protein kinase binding [GO:0019901]; protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001] g1514.t1 P35590 37.611 226 4.49e-40 153.0 sp|P35590|TIE1_HUMAN Tyrosine-protein kinase receptor Tie-1 OS=Homo sapiens OX=9606 GN=TIE1 PE=1 SV=1 TIE1_HUMAN reviewed Tyrosine-protein kinase receptor Tie-1 (EC 2.7.10.1) Homo sapiens (Human) GO:0001525; GO:0001570; GO:0001701; GO:0001936; GO:0003180; GO:0004714; GO:0005524; GO:0005886; GO:0007165; GO:0007169; GO:0007498; GO:0016525; GO:0030336; GO:0032526; GO:0043235; GO:0045026; GO:0045766; GO:0048771; GO:0060836; GO:0060854; GO:1901201 angiogenesis [GO:0001525]; aortic valve morphogenesis [GO:0003180]; branching involved in lymph vessel morphogenesis [GO:0060854]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; in utero embryonic development [GO:0001701]; lymphatic endothelial cell differentiation [GO:0060836]; mesoderm development [GO:0007498]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell migration [GO:0030336]; plasma membrane fusion [GO:0045026]; positive regulation of angiogenesis [GO:0045766]; regulation of endothelial cell proliferation [GO:0001936]; regulation of extracellular matrix assembly [GO:1901201]; response to retinoic acid [GO:0032526]; signal transduction [GO:0007165]; tissue remodeling [GO:0048771]; vasculogenesis [GO:0001570] plasma membrane [GO:0005886]; receptor complex [GO:0043235] ATP binding [GO:0005524]; transmembrane receptor protein tyrosine kinase activity [GO:0004714] g1514.t2 P35590 37.778 225 3.61e-40 154.0 sp|P35590|TIE1_HUMAN Tyrosine-protein kinase receptor Tie-1 OS=Homo sapiens OX=9606 GN=TIE1 PE=1 SV=1 TIE1_HUMAN reviewed Tyrosine-protein kinase receptor Tie-1 (EC 2.7.10.1) Homo sapiens (Human) GO:0001525; GO:0001570; GO:0001701; GO:0001936; GO:0003180; GO:0004714; GO:0005524; GO:0005886; GO:0007165; GO:0007169; GO:0007498; GO:0016525; GO:0030336; GO:0032526; GO:0043235; GO:0045026; GO:0045766; GO:0048771; GO:0060836; GO:0060854; GO:1901201 angiogenesis [GO:0001525]; aortic valve morphogenesis [GO:0003180]; branching involved in lymph vessel morphogenesis [GO:0060854]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; in utero embryonic development [GO:0001701]; lymphatic endothelial cell differentiation [GO:0060836]; mesoderm development [GO:0007498]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell migration [GO:0030336]; plasma membrane fusion [GO:0045026]; positive regulation of angiogenesis [GO:0045766]; regulation of endothelial cell proliferation [GO:0001936]; regulation of extracellular matrix assembly [GO:1901201]; response to retinoic acid [GO:0032526]; signal transduction [GO:0007165]; tissue remodeling [GO:0048771]; vasculogenesis [GO:0001570] plasma membrane [GO:0005886]; receptor complex [GO:0043235] ATP binding [GO:0005524]; transmembrane receptor protein tyrosine kinase activity [GO:0004714] g1516.t1 Q96MB7 39.754 244 2e-51 176.0 sp|Q96MB7|HARB1_HUMAN Putative nuclease HARBI1 OS=Homo sapiens OX=9606 GN=HARBI1 PE=1 SV=1 HARB1_HUMAN reviewed Putative nuclease HARBI1 (EC 3.1.-.-) (Harbinger transposase-derived nuclease) Homo sapiens (Human) GO:0004518; GO:0005634; GO:0005829; GO:0005886; GO:0016787; GO:0034451; GO:0046872 centriolar satellite [GO:0034451]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886] hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]; nuclease activity [GO:0004518] g1522.t1 Q02858 42.079 202 1.1399999999999999e-46 171.0 sp|Q02858|TIE2_MOUSE Angiopoietin-1 receptor OS=Mus musculus OX=10090 GN=Tek PE=1 SV=2 TIE2_MOUSE reviewed Angiopoietin-1 receptor (EC 2.7.10.1) (Endothelial tyrosine kinase) (HYK) (STK1) (Tunica interna endothelial cell kinase) (Tyrosine kinase with Ig and EGF homology domains-2) (Tyrosine-protein kinase receptor TEK) (Tyrosine-protein kinase receptor TIE-2) (mTIE2) (p140 TEK) (CD antigen CD202b) Mus musculus (Mouse) GO:0001525; GO:0001569; GO:0001570; GO:0001666; GO:0001935; GO:0001936; GO:0002040; GO:0002720; GO:0004713; GO:0004714; GO:0005524; GO:0005576; GO:0005813; GO:0005886; GO:0005902; GO:0005911; GO:0005925; GO:0007160; GO:0007166; GO:0007169; GO:0007507; GO:0009925; GO:0009986; GO:0010595; GO:0016020; GO:0016323; GO:0016324; GO:0016525; GO:0018108; GO:0019838; GO:0030097; GO:0030334; GO:0030949; GO:0032526; GO:0032878; GO:0034446; GO:0036064; GO:0038023; GO:0042307; GO:0042802; GO:0043066; GO:0043235; GO:0043410; GO:0043627; GO:0045121; GO:0045765; GO:0045766; GO:0045785; GO:0048014; GO:0048471; GO:0051894; GO:0051897; GO:0060347; GO:0070374; GO:0071260; GO:0072012; GO:0098609; GO:1901222; GO:1902533; GO:2000352 angiogenesis [GO:0001525]; branching involved in blood vessel morphogenesis [GO:0001569]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; cell surface receptor signaling pathway [GO:0007166]; cell-cell adhesion [GO:0098609]; cell-matrix adhesion [GO:0007160]; cellular response to mechanical stimulus [GO:0071260]; endothelial cell proliferation [GO:0001935]; glomerulus vasculature development [GO:0072012]; heart development [GO:0007507]; heart trabecula formation [GO:0060347]; hemopoiesis [GO:0030097]; negative regulation of angiogenesis [GO:0016525]; negative regulation of apoptotic process [GO:0043066]; negative regulation of endothelial cell apoptotic process [GO:2000352]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cytokine production involved in immune response [GO:0002720]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of intracellular signal transduction [GO:1902533]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030949]; regulation of angiogenesis [GO:0045765]; regulation of cell migration [GO:0030334]; regulation of endothelial cell proliferation [GO:0001936]; regulation of establishment or maintenance of cell polarity [GO:0032878]; regulation of non-canonical NF-kappaB signal transduction [GO:1901222]; response to estrogen [GO:0043627]; response to hypoxia [GO:0001666]; response to retinoic acid [GO:0032526]; sprouting angiogenesis [GO:0002040]; substrate adhesion-dependent cell spreading [GO:0034446]; Tie signaling pathway [GO:0048014]; vasculogenesis [GO:0001570] apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; cell-cell junction [GO:0005911]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; membrane [GO:0016020]; membrane raft [GO:0045121]; microvillus [GO:0005902]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] ATP binding [GO:0005524]; growth factor binding [GO:0019838]; identical protein binding [GO:0042802]; protein tyrosine kinase activity [GO:0004713]; signaling receptor activity [GO:0038023]; transmembrane receptor protein tyrosine kinase activity [GO:0004714] g1524.t1 Q02858 46.403 278 1.17e-76 276.0 sp|Q02858|TIE2_MOUSE Angiopoietin-1 receptor OS=Mus musculus OX=10090 GN=Tek PE=1 SV=2 TIE2_MOUSE reviewed Angiopoietin-1 receptor (EC 2.7.10.1) (Endothelial tyrosine kinase) (HYK) (STK1) (Tunica interna endothelial cell kinase) (Tyrosine kinase with Ig and EGF homology domains-2) (Tyrosine-protein kinase receptor TEK) (Tyrosine-protein kinase receptor TIE-2) (mTIE2) (p140 TEK) (CD antigen CD202b) Mus musculus (Mouse) GO:0001525; GO:0001569; GO:0001570; GO:0001666; GO:0001935; GO:0001936; GO:0002040; GO:0002720; GO:0004713; GO:0004714; GO:0005524; GO:0005576; GO:0005813; GO:0005886; GO:0005902; GO:0005911; GO:0005925; GO:0007160; GO:0007166; GO:0007169; GO:0007507; GO:0009925; GO:0009986; GO:0010595; GO:0016020; GO:0016323; GO:0016324; GO:0016525; GO:0018108; GO:0019838; GO:0030097; GO:0030334; GO:0030949; GO:0032526; GO:0032878; GO:0034446; GO:0036064; GO:0038023; GO:0042307; GO:0042802; GO:0043066; GO:0043235; GO:0043410; GO:0043627; GO:0045121; GO:0045765; GO:0045766; GO:0045785; GO:0048014; GO:0048471; GO:0051894; GO:0051897; GO:0060347; GO:0070374; GO:0071260; GO:0072012; GO:0098609; GO:1901222; GO:1902533; GO:2000352 angiogenesis [GO:0001525]; branching involved in blood vessel morphogenesis [GO:0001569]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; cell surface receptor signaling pathway [GO:0007166]; cell-cell adhesion [GO:0098609]; cell-matrix adhesion [GO:0007160]; cellular response to mechanical stimulus [GO:0071260]; endothelial cell proliferation [GO:0001935]; glomerulus vasculature development [GO:0072012]; heart development [GO:0007507]; heart trabecula formation [GO:0060347]; hemopoiesis [GO:0030097]; negative regulation of angiogenesis [GO:0016525]; negative regulation of apoptotic process [GO:0043066]; negative regulation of endothelial cell apoptotic process [GO:2000352]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cytokine production involved in immune response [GO:0002720]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of intracellular signal transduction [GO:1902533]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030949]; regulation of angiogenesis [GO:0045765]; regulation of cell migration [GO:0030334]; regulation of endothelial cell proliferation [GO:0001936]; regulation of establishment or maintenance of cell polarity [GO:0032878]; regulation of non-canonical NF-kappaB signal transduction [GO:1901222]; response to estrogen [GO:0043627]; response to hypoxia [GO:0001666]; response to retinoic acid [GO:0032526]; sprouting angiogenesis [GO:0002040]; substrate adhesion-dependent cell spreading [GO:0034446]; Tie signaling pathway [GO:0048014]; vasculogenesis [GO:0001570] apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; cell-cell junction [GO:0005911]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; membrane [GO:0016020]; membrane raft [GO:0045121]; microvillus [GO:0005902]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] ATP binding [GO:0005524]; growth factor binding [GO:0019838]; identical protein binding [GO:0042802]; protein tyrosine kinase activity [GO:0004713]; signaling receptor activity [GO:0038023]; transmembrane receptor protein tyrosine kinase activity [GO:0004714] g1524.t2 Q02858 46.403 278 2.29e-76 276.0 sp|Q02858|TIE2_MOUSE Angiopoietin-1 receptor OS=Mus musculus OX=10090 GN=Tek PE=1 SV=2 TIE2_MOUSE reviewed Angiopoietin-1 receptor (EC 2.7.10.1) (Endothelial tyrosine kinase) (HYK) (STK1) (Tunica interna endothelial cell kinase) (Tyrosine kinase with Ig and EGF homology domains-2) (Tyrosine-protein kinase receptor TEK) (Tyrosine-protein kinase receptor TIE-2) (mTIE2) (p140 TEK) (CD antigen CD202b) Mus musculus (Mouse) GO:0001525; GO:0001569; GO:0001570; GO:0001666; GO:0001935; GO:0001936; GO:0002040; GO:0002720; GO:0004713; GO:0004714; GO:0005524; GO:0005576; GO:0005813; GO:0005886; GO:0005902; GO:0005911; GO:0005925; GO:0007160; GO:0007166; GO:0007169; GO:0007507; GO:0009925; GO:0009986; GO:0010595; GO:0016020; GO:0016323; GO:0016324; GO:0016525; GO:0018108; GO:0019838; GO:0030097; GO:0030334; GO:0030949; GO:0032526; GO:0032878; GO:0034446; GO:0036064; GO:0038023; GO:0042307; GO:0042802; GO:0043066; GO:0043235; GO:0043410; GO:0043627; GO:0045121; GO:0045765; GO:0045766; GO:0045785; GO:0048014; GO:0048471; GO:0051894; GO:0051897; GO:0060347; GO:0070374; GO:0071260; GO:0072012; GO:0098609; GO:1901222; GO:1902533; GO:2000352 angiogenesis [GO:0001525]; branching involved in blood vessel morphogenesis [GO:0001569]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; cell surface receptor signaling pathway [GO:0007166]; cell-cell adhesion [GO:0098609]; cell-matrix adhesion [GO:0007160]; cellular response to mechanical stimulus [GO:0071260]; endothelial cell proliferation [GO:0001935]; glomerulus vasculature development [GO:0072012]; heart development [GO:0007507]; heart trabecula formation [GO:0060347]; hemopoiesis [GO:0030097]; negative regulation of angiogenesis [GO:0016525]; negative regulation of apoptotic process [GO:0043066]; negative regulation of endothelial cell apoptotic process [GO:2000352]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cytokine production involved in immune response [GO:0002720]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of intracellular signal transduction [GO:1902533]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030949]; regulation of angiogenesis [GO:0045765]; regulation of cell migration [GO:0030334]; regulation of endothelial cell proliferation [GO:0001936]; regulation of establishment or maintenance of cell polarity [GO:0032878]; regulation of non-canonical NF-kappaB signal transduction [GO:1901222]; response to estrogen [GO:0043627]; response to hypoxia [GO:0001666]; response to retinoic acid [GO:0032526]; sprouting angiogenesis [GO:0002040]; substrate adhesion-dependent cell spreading [GO:0034446]; Tie signaling pathway [GO:0048014]; vasculogenesis [GO:0001570] apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; cell-cell junction [GO:0005911]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; membrane [GO:0016020]; membrane raft [GO:0045121]; microvillus [GO:0005902]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] ATP binding [GO:0005524]; growth factor binding [GO:0019838]; identical protein binding [GO:0042802]; protein tyrosine kinase activity [GO:0004713]; signaling receptor activity [GO:0038023]; transmembrane receptor protein tyrosine kinase activity [GO:0004714] g1525.t1 Q06806 35.185 270 1.43e-37 155.0 sp|Q06806|TIE1_MOUSE Tyrosine-protein kinase receptor Tie-1 OS=Mus musculus OX=10090 GN=Tie1 PE=1 SV=3 TIE1_MOUSE reviewed Tyrosine-protein kinase receptor Tie-1 (EC 2.7.10.1) Mus musculus (Mouse) GO:0001525; GO:0001568; GO:0001570; GO:0001701; GO:0001936; GO:0003180; GO:0004714; GO:0005524; GO:0005886; GO:0007169; GO:0016020; GO:0016525; GO:0030336; GO:0032526; GO:0043235; GO:0045026; GO:0045766; GO:0048771; GO:0060836; GO:0060854; GO:1901201 angiogenesis [GO:0001525]; aortic valve morphogenesis [GO:0003180]; blood vessel development [GO:0001568]; branching involved in lymph vessel morphogenesis [GO:0060854]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; in utero embryonic development [GO:0001701]; lymphatic endothelial cell differentiation [GO:0060836]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell migration [GO:0030336]; plasma membrane fusion [GO:0045026]; positive regulation of angiogenesis [GO:0045766]; regulation of endothelial cell proliferation [GO:0001936]; regulation of extracellular matrix assembly [GO:1901201]; response to retinoic acid [GO:0032526]; tissue remodeling [GO:0048771]; vasculogenesis [GO:0001570] membrane [GO:0016020]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] ATP binding [GO:0005524]; transmembrane receptor protein tyrosine kinase activity [GO:0004714] g1525.t2 Q06806 34.926 272 2.61e-37 155.0 sp|Q06806|TIE1_MOUSE Tyrosine-protein kinase receptor Tie-1 OS=Mus musculus OX=10090 GN=Tie1 PE=1 SV=3 TIE1_MOUSE reviewed Tyrosine-protein kinase receptor Tie-1 (EC 2.7.10.1) Mus musculus (Mouse) GO:0001525; GO:0001568; GO:0001570; GO:0001701; GO:0001936; GO:0003180; GO:0004714; GO:0005524; GO:0005886; GO:0007169; GO:0016020; GO:0016525; GO:0030336; GO:0032526; GO:0043235; GO:0045026; GO:0045766; GO:0048771; GO:0060836; GO:0060854; GO:1901201 angiogenesis [GO:0001525]; aortic valve morphogenesis [GO:0003180]; blood vessel development [GO:0001568]; branching involved in lymph vessel morphogenesis [GO:0060854]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; in utero embryonic development [GO:0001701]; lymphatic endothelial cell differentiation [GO:0060836]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell migration [GO:0030336]; plasma membrane fusion [GO:0045026]; positive regulation of angiogenesis [GO:0045766]; regulation of endothelial cell proliferation [GO:0001936]; regulation of extracellular matrix assembly [GO:1901201]; response to retinoic acid [GO:0032526]; tissue remodeling [GO:0048771]; vasculogenesis [GO:0001570] membrane [GO:0016020]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] ATP binding [GO:0005524]; transmembrane receptor protein tyrosine kinase activity [GO:0004714] g1526.t1 P35590 35.115 262 3.0800000000000004e-37 152.0 sp|P35590|TIE1_HUMAN Tyrosine-protein kinase receptor Tie-1 OS=Homo sapiens OX=9606 GN=TIE1 PE=1 SV=1 TIE1_HUMAN reviewed Tyrosine-protein kinase receptor Tie-1 (EC 2.7.10.1) Homo sapiens (Human) GO:0001525; GO:0001570; GO:0001701; GO:0001936; GO:0003180; GO:0004714; GO:0005524; GO:0005886; GO:0007165; GO:0007169; GO:0007498; GO:0016525; GO:0030336; GO:0032526; GO:0043235; GO:0045026; GO:0045766; GO:0048771; GO:0060836; GO:0060854; GO:1901201 angiogenesis [GO:0001525]; aortic valve morphogenesis [GO:0003180]; branching involved in lymph vessel morphogenesis [GO:0060854]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; in utero embryonic development [GO:0001701]; lymphatic endothelial cell differentiation [GO:0060836]; mesoderm development [GO:0007498]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell migration [GO:0030336]; plasma membrane fusion [GO:0045026]; positive regulation of angiogenesis [GO:0045766]; regulation of endothelial cell proliferation [GO:0001936]; regulation of extracellular matrix assembly [GO:1901201]; response to retinoic acid [GO:0032526]; signal transduction [GO:0007165]; tissue remodeling [GO:0048771]; vasculogenesis [GO:0001570] plasma membrane [GO:0005886]; receptor complex [GO:0043235] ATP binding [GO:0005524]; transmembrane receptor protein tyrosine kinase activity [GO:0004714] g1526.t2 P35590 35.385 260 1.99e-37 153.0 sp|P35590|TIE1_HUMAN Tyrosine-protein kinase receptor Tie-1 OS=Homo sapiens OX=9606 GN=TIE1 PE=1 SV=1 TIE1_HUMAN reviewed Tyrosine-protein kinase receptor Tie-1 (EC 2.7.10.1) Homo sapiens (Human) GO:0001525; GO:0001570; GO:0001701; GO:0001936; GO:0003180; GO:0004714; GO:0005524; GO:0005886; GO:0007165; GO:0007169; GO:0007498; GO:0016525; GO:0030336; GO:0032526; GO:0043235; GO:0045026; GO:0045766; GO:0048771; GO:0060836; GO:0060854; GO:1901201 angiogenesis [GO:0001525]; aortic valve morphogenesis [GO:0003180]; branching involved in lymph vessel morphogenesis [GO:0060854]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; in utero embryonic development [GO:0001701]; lymphatic endothelial cell differentiation [GO:0060836]; mesoderm development [GO:0007498]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell migration [GO:0030336]; plasma membrane fusion [GO:0045026]; positive regulation of angiogenesis [GO:0045766]; regulation of endothelial cell proliferation [GO:0001936]; regulation of extracellular matrix assembly [GO:1901201]; response to retinoic acid [GO:0032526]; signal transduction [GO:0007165]; tissue remodeling [GO:0048771]; vasculogenesis [GO:0001570] plasma membrane [GO:0005886]; receptor complex [GO:0043235] ATP binding [GO:0005524]; transmembrane receptor protein tyrosine kinase activity [GO:0004714] g1528.t1 Q06806 39.535 301 6.09e-63 219.0 sp|Q06806|TIE1_MOUSE Tyrosine-protein kinase receptor Tie-1 OS=Mus musculus OX=10090 GN=Tie1 PE=1 SV=3 TIE1_MOUSE reviewed Tyrosine-protein kinase receptor Tie-1 (EC 2.7.10.1) Mus musculus (Mouse) GO:0001525; GO:0001568; GO:0001570; GO:0001701; GO:0001936; GO:0003180; GO:0004714; GO:0005524; GO:0005886; GO:0007169; GO:0016020; GO:0016525; GO:0030336; GO:0032526; GO:0043235; GO:0045026; GO:0045766; GO:0048771; GO:0060836; GO:0060854; GO:1901201 angiogenesis [GO:0001525]; aortic valve morphogenesis [GO:0003180]; blood vessel development [GO:0001568]; branching involved in lymph vessel morphogenesis [GO:0060854]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; in utero embryonic development [GO:0001701]; lymphatic endothelial cell differentiation [GO:0060836]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell migration [GO:0030336]; plasma membrane fusion [GO:0045026]; positive regulation of angiogenesis [GO:0045766]; regulation of endothelial cell proliferation [GO:0001936]; regulation of extracellular matrix assembly [GO:1901201]; response to retinoic acid [GO:0032526]; tissue remodeling [GO:0048771]; vasculogenesis [GO:0001570] membrane [GO:0016020]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] ATP binding [GO:0005524]; transmembrane receptor protein tyrosine kinase activity [GO:0004714] g1531.t1 O14522 43.281 573 7.17e-145 474.0 sp|O14522|PTPRT_HUMAN Receptor-type tyrosine-protein phosphatase T OS=Homo sapiens OX=9606 GN=PTPRT PE=1 SV=6 PTPRT_HUMAN reviewed Receptor-type tyrosine-protein phosphatase T (R-PTP-T) (EC 3.1.3.48) (Receptor-type tyrosine-protein phosphatase rho) (RPTP-rho) Homo sapiens (Human) GO:0004725; GO:0005001; GO:0005886; GO:0006470; GO:0007155; GO:0007156; GO:0007165; GO:0007169; GO:0008013; GO:0009986; GO:0016020; GO:0016790; GO:0019903; GO:0030336; GO:0031175; GO:0042803; GO:0045294; GO:0045295; GO:0045296; GO:0051393; GO:0070097; GO:0071354; GO:0097677; GO:1904893 cell adhesion [GO:0007155]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; cellular response to interleukin-6 [GO:0071354]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell migration [GO:0030336]; negative regulation of receptor signaling pathway via STAT [GO:1904893]; neuron projection development [GO:0031175]; protein dephosphorylation [GO:0006470]; signal transduction [GO:0007165] cell surface [GO:0009986]; membrane [GO:0016020]; plasma membrane [GO:0005886] alpha-actinin binding [GO:0051393]; alpha-catenin binding [GO:0045294]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; delta-catenin binding [GO:0070097]; gamma-catenin binding [GO:0045295]; protein homodimerization activity [GO:0042803]; protein phosphatase binding [GO:0019903]; protein tyrosine phosphatase activity [GO:0004725]; STAT family protein binding [GO:0097677]; thiolester hydrolase activity [GO:0016790]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001] g1536.t1 Q06805 39.768 259 1.22e-48 183.0 sp|Q06805|TIE1_BOVIN Tyrosine-protein kinase receptor Tie-1 OS=Bos taurus OX=9913 GN=TIE1 PE=2 SV=1 g1539.t1 O14522 40.909 242 3.92e-49 181.0 sp|O14522|PTPRT_HUMAN Receptor-type tyrosine-protein phosphatase T OS=Homo sapiens OX=9606 GN=PTPRT PE=1 SV=6 PTPRT_HUMAN reviewed Receptor-type tyrosine-protein phosphatase T (R-PTP-T) (EC 3.1.3.48) (Receptor-type tyrosine-protein phosphatase rho) (RPTP-rho) Homo sapiens (Human) GO:0004725; GO:0005001; GO:0005886; GO:0006470; GO:0007155; GO:0007156; GO:0007165; GO:0007169; GO:0008013; GO:0009986; GO:0016020; GO:0016790; GO:0019903; GO:0030336; GO:0031175; GO:0042803; GO:0045294; GO:0045295; GO:0045296; GO:0051393; GO:0070097; GO:0071354; GO:0097677; GO:1904893 cell adhesion [GO:0007155]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; cellular response to interleukin-6 [GO:0071354]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell migration [GO:0030336]; negative regulation of receptor signaling pathway via STAT [GO:1904893]; neuron projection development [GO:0031175]; protein dephosphorylation [GO:0006470]; signal transduction [GO:0007165] cell surface [GO:0009986]; membrane [GO:0016020]; plasma membrane [GO:0005886] alpha-actinin binding [GO:0051393]; alpha-catenin binding [GO:0045294]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; delta-catenin binding [GO:0070097]; gamma-catenin binding [GO:0045295]; protein homodimerization activity [GO:0042803]; protein phosphatase binding [GO:0019903]; protein tyrosine phosphatase activity [GO:0004725]; STAT family protein binding [GO:0097677]; thiolester hydrolase activity [GO:0016790]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001] g1539.t1 O14522 32.5 240 2.39e-32 132.0 sp|O14522|PTPRT_HUMAN Receptor-type tyrosine-protein phosphatase T OS=Homo sapiens OX=9606 GN=PTPRT PE=1 SV=6 PTPRT_HUMAN reviewed Receptor-type tyrosine-protein phosphatase T (R-PTP-T) (EC 3.1.3.48) (Receptor-type tyrosine-protein phosphatase rho) (RPTP-rho) Homo sapiens (Human) GO:0004725; GO:0005001; GO:0005886; GO:0006470; GO:0007155; GO:0007156; GO:0007165; GO:0007169; GO:0008013; GO:0009986; GO:0016020; GO:0016790; GO:0019903; GO:0030336; GO:0031175; GO:0042803; GO:0045294; GO:0045295; GO:0045296; GO:0051393; GO:0070097; GO:0071354; GO:0097677; GO:1904893 cell adhesion [GO:0007155]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; cellular response to interleukin-6 [GO:0071354]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell migration [GO:0030336]; negative regulation of receptor signaling pathway via STAT [GO:1904893]; neuron projection development [GO:0031175]; protein dephosphorylation [GO:0006470]; signal transduction [GO:0007165] cell surface [GO:0009986]; membrane [GO:0016020]; plasma membrane [GO:0005886] alpha-actinin binding [GO:0051393]; alpha-catenin binding [GO:0045294]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; delta-catenin binding [GO:0070097]; gamma-catenin binding [GO:0045295]; protein homodimerization activity [GO:0042803]; protein phosphatase binding [GO:0019903]; protein tyrosine phosphatase activity [GO:0004725]; STAT family protein binding [GO:0097677]; thiolester hydrolase activity [GO:0016790]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001] g1540.t1 Q01063 56.14 684 0.0 709.0 sp|Q01063|PDE4D_MOUSE 3',5'-cyclic-AMP phosphodiesterase 4D OS=Mus musculus OX=10090 GN=Pde4d PE=1 SV=2 PDE4D_MOUSE reviewed 3',5'-cyclic-AMP phosphodiesterase 4D (EC 3.1.4.53) (DPDE3) (cAMP-specific phosphodiesterase 4D) Mus musculus (Mouse) GO:0001542; GO:0002027; GO:0004112; GO:0004114; GO:0004115; GO:0005246; GO:0005654; GO:0005813; GO:0005829; GO:0005886; GO:0005891; GO:0005929; GO:0006198; GO:0006939; GO:0007613; GO:0008277; GO:0010460; GO:0010880; GO:0014911; GO:0016020; GO:0016324; GO:0019899; GO:0022409; GO:0030016; GO:0030545; GO:0030552; GO:0030593; GO:0031698; GO:0031965; GO:0032729; GO:0032743; GO:0032754; GO:0032991; GO:0034704; GO:0034705; GO:0035264; GO:0044325; GO:0045822; GO:0046872; GO:0047555; GO:0048661; GO:0050852; GO:0050900; GO:0051117; GO:0061028; GO:0065003; GO:0071222; GO:0071320; GO:0071372; GO:0071872; GO:0071875; GO:0086004; GO:0097110; GO:0106072; GO:0141156; GO:0141161; GO:0141162; GO:1901363; GO:1901844; GO:1901898; GO:1902514 adrenergic receptor signaling pathway [GO:0071875]; cAMP catabolic process [GO:0006198]; cAMP/PKA signal transduction [GO:0141156]; cellular response to cAMP [GO:0071320]; cellular response to epinephrine stimulus [GO:0071872]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to lipopolysaccharide [GO:0071222]; establishment of endothelial barrier [GO:0061028]; leukocyte migration [GO:0050900]; memory [GO:0007613]; multicellular organism growth [GO:0035264]; negative regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0106072]; negative regulation of cAMP/PKA signal transduction [GO:0141162]; negative regulation of heart contraction [GO:0045822]; negative regulation of relaxation of cardiac muscle [GO:1901898]; neutrophil chemotaxis [GO:0030593]; ovulation from ovarian follicle [GO:0001542]; positive regulation of cell-cell adhesion [GO:0022409]; positive regulation of heart rate [GO:0010460]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of interleukin-5 production [GO:0032754]; positive regulation of smooth muscle cell migration [GO:0014911]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of type II interferon production [GO:0032729]; protein-containing complex assembly [GO:0065003]; regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1902514]; regulation of cAMP/PKA signal transduction [GO:0141161]; regulation of cardiac muscle cell contraction [GO:0086004]; regulation of cell communication by electrical coupling involved in cardiac conduction [GO:1901844]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; regulation of heart rate [GO:0002027]; regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0010880]; smooth muscle contraction [GO:0006939]; T cell receptor signaling pathway [GO:0050852] apical plasma membrane [GO:0016324]; calcium channel complex [GO:0034704]; centrosome [GO:0005813]; cilium [GO:0005929]; cytosol [GO:0005829]; membrane [GO:0016020]; myofibril [GO:0030016]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; potassium channel complex [GO:0034705]; protein-containing complex [GO:0032991]; voltage-gated calcium channel complex [GO:0005891] 3',5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; 3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; 3',5'-cyclic-nucleotide phosphodiesterase activity [GO:0004114]; ATPase binding [GO:0051117]; beta-2 adrenergic receptor binding [GO:0031698]; calcium channel regulator activity [GO:0005246]; cAMP binding [GO:0030552]; cyclic-nucleotide phosphodiesterase activity [GO:0004112]; enzyme binding [GO:0019899]; heterocyclic compound binding [GO:1901363]; metal ion binding [GO:0046872]; scaffold protein binding [GO:0097110]; signaling receptor regulator activity [GO:0030545]; transmembrane transporter binding [GO:0044325] g1540.t2 Q01063 56.176 680 0.0 716.0 sp|Q01063|PDE4D_MOUSE 3',5'-cyclic-AMP phosphodiesterase 4D OS=Mus musculus OX=10090 GN=Pde4d PE=1 SV=2 PDE4D_MOUSE reviewed 3',5'-cyclic-AMP phosphodiesterase 4D (EC 3.1.4.53) (DPDE3) (cAMP-specific phosphodiesterase 4D) Mus musculus (Mouse) GO:0001542; GO:0002027; GO:0004112; GO:0004114; GO:0004115; GO:0005246; GO:0005654; GO:0005813; GO:0005829; GO:0005886; GO:0005891; GO:0005929; GO:0006198; GO:0006939; GO:0007613; GO:0008277; GO:0010460; GO:0010880; GO:0014911; GO:0016020; GO:0016324; GO:0019899; GO:0022409; GO:0030016; GO:0030545; GO:0030552; GO:0030593; GO:0031698; GO:0031965; GO:0032729; GO:0032743; GO:0032754; GO:0032991; GO:0034704; GO:0034705; GO:0035264; GO:0044325; GO:0045822; GO:0046872; GO:0047555; GO:0048661; GO:0050852; GO:0050900; GO:0051117; GO:0061028; GO:0065003; GO:0071222; GO:0071320; GO:0071372; GO:0071872; GO:0071875; GO:0086004; GO:0097110; GO:0106072; GO:0141156; GO:0141161; GO:0141162; GO:1901363; GO:1901844; GO:1901898; GO:1902514 adrenergic receptor signaling pathway [GO:0071875]; cAMP catabolic process [GO:0006198]; cAMP/PKA signal transduction [GO:0141156]; cellular response to cAMP [GO:0071320]; cellular response to epinephrine stimulus [GO:0071872]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to lipopolysaccharide [GO:0071222]; establishment of endothelial barrier [GO:0061028]; leukocyte migration [GO:0050900]; memory [GO:0007613]; multicellular organism growth [GO:0035264]; negative regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0106072]; negative regulation of cAMP/PKA signal transduction [GO:0141162]; negative regulation of heart contraction [GO:0045822]; negative regulation of relaxation of cardiac muscle [GO:1901898]; neutrophil chemotaxis [GO:0030593]; ovulation from ovarian follicle [GO:0001542]; positive regulation of cell-cell adhesion [GO:0022409]; positive regulation of heart rate [GO:0010460]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of interleukin-5 production [GO:0032754]; positive regulation of smooth muscle cell migration [GO:0014911]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of type II interferon production [GO:0032729]; protein-containing complex assembly [GO:0065003]; regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1902514]; regulation of cAMP/PKA signal transduction [GO:0141161]; regulation of cardiac muscle cell contraction [GO:0086004]; regulation of cell communication by electrical coupling involved in cardiac conduction [GO:1901844]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; regulation of heart rate [GO:0002027]; regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0010880]; smooth muscle contraction [GO:0006939]; T cell receptor signaling pathway [GO:0050852] apical plasma membrane [GO:0016324]; calcium channel complex [GO:0034704]; centrosome [GO:0005813]; cilium [GO:0005929]; cytosol [GO:0005829]; membrane [GO:0016020]; myofibril [GO:0030016]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; potassium channel complex [GO:0034705]; protein-containing complex [GO:0032991]; voltage-gated calcium channel complex [GO:0005891] 3',5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; 3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; 3',5'-cyclic-nucleotide phosphodiesterase activity [GO:0004114]; ATPase binding [GO:0051117]; beta-2 adrenergic receptor binding [GO:0031698]; calcium channel regulator activity [GO:0005246]; cAMP binding [GO:0030552]; cyclic-nucleotide phosphodiesterase activity [GO:0004112]; enzyme binding [GO:0019899]; heterocyclic compound binding [GO:1901363]; metal ion binding [GO:0046872]; scaffold protein binding [GO:0097110]; signaling receptor regulator activity [GO:0030545]; transmembrane transporter binding [GO:0044325] g1544.t1 Q8CFD5 51.435 418 5.86e-150 434.0 sp|Q8CFD5|ERCC8_MOUSE DNA excision repair protein ERCC-8 OS=Mus musculus OX=10090 GN=Ercc8 PE=1 SV=2 ERCC8_MOUSE reviewed DNA excision repair protein ERCC-8 (Cockayne syndrome WD repeat protein CSA homolog) Mus musculus (Mouse) GO:0000012; GO:0000109; GO:0000209; GO:0005634; GO:0006283; GO:0006974; GO:0006979; GO:0009411; GO:0010165; GO:0010996; GO:0016363; GO:0016567; GO:0031464; GO:0032991; GO:0043161; GO:0043204; GO:0045739; GO:0051865; GO:0080008; GO:0090262; GO:0090734; GO:0097680; GO:1990756 DNA damage response [GO:0006974]; double-strand break repair via classical nonhomologous end joining [GO:0097680]; positive regulation of DNA repair [GO:0045739]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of transcription-coupled nucleotide-excision repair [GO:0090262]; response to auditory stimulus [GO:0010996]; response to oxidative stress [GO:0006979]; response to UV [GO:0009411]; response to X-ray [GO:0010165]; single strand break repair [GO:0000012]; transcription-coupled nucleotide-excision repair [GO:0006283] Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]; nuclear matrix [GO:0016363]; nucleotide-excision repair complex [GO:0000109]; nucleus [GO:0005634]; perikaryon [GO:0043204]; protein-containing complex [GO:0032991]; site of DNA damage [GO:0090734] ubiquitin-like ligase-substrate adaptor activity [GO:1990756] g1545.t1 Q32P65 40.426 141 1.82e-22 90.5 sp|Q32P65|NDUF2_BOVIN NADH dehydrogenase [ubiquinone] 1 alpha subcomplex assembly factor 2 OS=Bos taurus OX=9913 GN=NDUFAF2 PE=2 SV=1 g1546.t1 A0A0R4IVA4 65.342 453 0.0 609.0 sp|A0A0R4IVA4|CC14A_DANRE Dual specificity protein phosphatase CDC14AB OS=Danio rerio OX=7955 GN=cdc14ab PE=3 SV=1 CC14A_DANRE reviewed Dual specificity protein phosphatase CDC14AB (EC 3.1.3.16) (EC 3.1.3.48) (CDC14 cell division cycle 14 homolog AB) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000226; GO:0000922; GO:0004722; GO:0004725; GO:0005730; GO:0005737; GO:0005813; GO:0007096; GO:0007605; GO:0032467; GO:0051301; GO:0060091; GO:0060271; GO:0072686 cell division [GO:0051301]; cilium assembly [GO:0060271]; microtubule cytoskeleton organization [GO:0000226]; positive regulation of cytokinesis [GO:0032467]; regulation of exit from mitosis [GO:0007096]; sensory perception of sound [GO:0007605] centrosome [GO:0005813]; cytoplasm [GO:0005737]; kinocilium [GO:0060091]; mitotic spindle [GO:0072686]; nucleolus [GO:0005730]; spindle pole [GO:0000922] protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine phosphatase activity [GO:0004725] g1546.t2 A0A0R4IVA4 67.426 439 0.0 620.0 sp|A0A0R4IVA4|CC14A_DANRE Dual specificity protein phosphatase CDC14AB OS=Danio rerio OX=7955 GN=cdc14ab PE=3 SV=1 CC14A_DANRE reviewed Dual specificity protein phosphatase CDC14AB (EC 3.1.3.16) (EC 3.1.3.48) (CDC14 cell division cycle 14 homolog AB) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000226; GO:0000922; GO:0004722; GO:0004725; GO:0005730; GO:0005737; GO:0005813; GO:0007096; GO:0007605; GO:0032467; GO:0051301; GO:0060091; GO:0060271; GO:0072686 cell division [GO:0051301]; cilium assembly [GO:0060271]; microtubule cytoskeleton organization [GO:0000226]; positive regulation of cytokinesis [GO:0032467]; regulation of exit from mitosis [GO:0007096]; sensory perception of sound [GO:0007605] centrosome [GO:0005813]; cytoplasm [GO:0005737]; kinocilium [GO:0060091]; mitotic spindle [GO:0072686]; nucleolus [GO:0005730]; spindle pole [GO:0000922] protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine phosphatase activity [GO:0004725] g1546.t3 A0A0R4IVA4 67.426 439 0.0 619.0 sp|A0A0R4IVA4|CC14A_DANRE Dual specificity protein phosphatase CDC14AB OS=Danio rerio OX=7955 GN=cdc14ab PE=3 SV=1 CC14A_DANRE reviewed Dual specificity protein phosphatase CDC14AB (EC 3.1.3.16) (EC 3.1.3.48) (CDC14 cell division cycle 14 homolog AB) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000226; GO:0000922; GO:0004722; GO:0004725; GO:0005730; GO:0005737; GO:0005813; GO:0007096; GO:0007605; GO:0032467; GO:0051301; GO:0060091; GO:0060271; GO:0072686 cell division [GO:0051301]; cilium assembly [GO:0060271]; microtubule cytoskeleton organization [GO:0000226]; positive regulation of cytokinesis [GO:0032467]; regulation of exit from mitosis [GO:0007096]; sensory perception of sound [GO:0007605] centrosome [GO:0005813]; cytoplasm [GO:0005737]; kinocilium [GO:0060091]; mitotic spindle [GO:0072686]; nucleolus [GO:0005730]; spindle pole [GO:0000922] protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine phosphatase activity [GO:0004725] g1547.t1 Q9V9S7 37.267 161 1.35e-21 100.0 sp|Q9V9S7|SYDE_DROME Rho GTPase-activating protein 100F OS=Drosophila melanogaster OX=7227 GN=RhoGAP100F PE=1 SV=2 g1548.t1 Q9V9S7 38.142 409 1.33e-79 280.0 sp|Q9V9S7|SYDE_DROME Rho GTPase-activating protein 100F OS=Drosophila melanogaster OX=7227 GN=RhoGAP100F PE=1 SV=2 g1549.t1 O35870 23.899 477 5.540000000000001e-21 100.0 sp|O35870|FANCC_RAT Fanconi anemia group C protein homolog OS=Rattus norvegicus OX=10116 GN=Fancc PE=2 SV=1 g1550.t1 Q6DIC0 68.697 1182 0.0 1496.0 sp|Q6DIC0|SMCA2_MOUSE SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A member 2 OS=Mus musculus OX=10090 GN=Smarca2 PE=1 SV=1 SMCA2_MOUSE reviewed SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A member 2 (SAMRCA2) (EC 3.6.4.-) (BRG1-associated factor 190B) (BAF190B) (Probable global transcription activator SNF2L2) (Protein brahma homolog) (SNF2-alpha) Mus musculus (Mouse) GO:0000785; GO:0000976; GO:0003677; GO:0003682; GO:0003713; GO:0005524; GO:0005634; GO:0005654; GO:0006325; GO:0006334; GO:0006338; GO:0006357; GO:0007399; GO:0008284; GO:0008285; GO:0016514; GO:0016887; GO:0030071; GO:0030308; GO:0031507; GO:0035060; GO:0035887; GO:0042393; GO:0045111; GO:0045582; GO:0045596; GO:0045597; GO:0045663; GO:0045892; GO:0045893; GO:0045944; GO:0061484; GO:0070316; GO:0071564; GO:0071565; GO:0140092; GO:0140288; GO:0140750; GO:1902459; GO:2000045; GO:2000781; GO:2000819 aortic smooth muscle cell differentiation [GO:0035887]; chromatin organization [GO:0006325]; chromatin remodeling [GO:0006338]; hematopoietic stem cell homeostasis [GO:0061484]; heterochromatin formation [GO:0031507]; negative regulation of cell differentiation [GO:0045596]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of DNA-templated transcription [GO:0045892]; nervous system development [GO:0007399]; nucleosome assembly [GO:0006334]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of T cell differentiation [GO:0045582]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of G0 to G1 transition [GO:0070316]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; regulation of nucleotide-excision repair [GO:2000819]; regulation of transcription by RNA polymerase II [GO:0006357] bBAF complex [GO:0140092]; brahma complex [GO:0035060]; chromatin [GO:0000785]; GBAF complex [GO:0140288]; intermediate filament cytoskeleton [GO:0045111]; nBAF complex [GO:0071565]; npBAF complex [GO:0071564]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SWI/SNF complex [GO:0016514] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; histone binding [GO:0042393]; nucleosome array spacer activity [GO:0140750]; transcription cis-regulatory region binding [GO:0000976]; transcription coactivator activity [GO:0003713] g1550.t2 Q6DIC0 68.782 1182 0.0 1499.0 sp|Q6DIC0|SMCA2_MOUSE SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A member 2 OS=Mus musculus OX=10090 GN=Smarca2 PE=1 SV=1 SMCA2_MOUSE reviewed SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A member 2 (SAMRCA2) (EC 3.6.4.-) (BRG1-associated factor 190B) (BAF190B) (Probable global transcription activator SNF2L2) (Protein brahma homolog) (SNF2-alpha) Mus musculus (Mouse) GO:0000785; GO:0000976; GO:0003677; GO:0003682; GO:0003713; GO:0005524; GO:0005634; GO:0005654; GO:0006325; GO:0006334; GO:0006338; GO:0006357; GO:0007399; GO:0008284; GO:0008285; GO:0016514; GO:0016887; GO:0030071; GO:0030308; GO:0031507; GO:0035060; GO:0035887; GO:0042393; GO:0045111; GO:0045582; GO:0045596; GO:0045597; GO:0045663; GO:0045892; GO:0045893; GO:0045944; GO:0061484; GO:0070316; GO:0071564; GO:0071565; GO:0140092; GO:0140288; GO:0140750; GO:1902459; GO:2000045; GO:2000781; GO:2000819 aortic smooth muscle cell differentiation [GO:0035887]; chromatin organization [GO:0006325]; chromatin remodeling [GO:0006338]; hematopoietic stem cell homeostasis [GO:0061484]; heterochromatin formation [GO:0031507]; negative regulation of cell differentiation [GO:0045596]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of DNA-templated transcription [GO:0045892]; nervous system development [GO:0007399]; nucleosome assembly [GO:0006334]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of T cell differentiation [GO:0045582]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of G0 to G1 transition [GO:0070316]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; regulation of nucleotide-excision repair [GO:2000819]; regulation of transcription by RNA polymerase II [GO:0006357] bBAF complex [GO:0140092]; brahma complex [GO:0035060]; chromatin [GO:0000785]; GBAF complex [GO:0140288]; intermediate filament cytoskeleton [GO:0045111]; nBAF complex [GO:0071565]; npBAF complex [GO:0071564]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SWI/SNF complex [GO:0016514] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; histone binding [GO:0042393]; nucleosome array spacer activity [GO:0140750]; transcription cis-regulatory region binding [GO:0000976]; transcription coactivator activity [GO:0003713] g1550.t3 Q6DIC0 68.782 1182 0.0 1499.0 sp|Q6DIC0|SMCA2_MOUSE SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A member 2 OS=Mus musculus OX=10090 GN=Smarca2 PE=1 SV=1 SMCA2_MOUSE reviewed SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A member 2 (SAMRCA2) (EC 3.6.4.-) (BRG1-associated factor 190B) (BAF190B) (Probable global transcription activator SNF2L2) (Protein brahma homolog) (SNF2-alpha) Mus musculus (Mouse) GO:0000785; GO:0000976; GO:0003677; GO:0003682; GO:0003713; GO:0005524; GO:0005634; GO:0005654; GO:0006325; GO:0006334; GO:0006338; GO:0006357; GO:0007399; GO:0008284; GO:0008285; GO:0016514; GO:0016887; GO:0030071; GO:0030308; GO:0031507; GO:0035060; GO:0035887; GO:0042393; GO:0045111; GO:0045582; GO:0045596; GO:0045597; GO:0045663; GO:0045892; GO:0045893; GO:0045944; GO:0061484; GO:0070316; GO:0071564; GO:0071565; GO:0140092; GO:0140288; GO:0140750; GO:1902459; GO:2000045; GO:2000781; GO:2000819 aortic smooth muscle cell differentiation [GO:0035887]; chromatin organization [GO:0006325]; chromatin remodeling [GO:0006338]; hematopoietic stem cell homeostasis [GO:0061484]; heterochromatin formation [GO:0031507]; negative regulation of cell differentiation [GO:0045596]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of DNA-templated transcription [GO:0045892]; nervous system development [GO:0007399]; nucleosome assembly [GO:0006334]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of T cell differentiation [GO:0045582]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of G0 to G1 transition [GO:0070316]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; regulation of nucleotide-excision repair [GO:2000819]; regulation of transcription by RNA polymerase II [GO:0006357] bBAF complex [GO:0140092]; brahma complex [GO:0035060]; chromatin [GO:0000785]; GBAF complex [GO:0140288]; intermediate filament cytoskeleton [GO:0045111]; nBAF complex [GO:0071565]; npBAF complex [GO:0071564]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SWI/SNF complex [GO:0016514] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; histone binding [GO:0042393]; nucleosome array spacer activity [GO:0140750]; transcription cis-regulatory region binding [GO:0000976]; transcription coactivator activity [GO:0003713] g1553.t1 P05090 36.782 174 1.7499999999999998e-30 113.0 sp|P05090|APOD_HUMAN Apolipoprotein D OS=Homo sapiens OX=9606 GN=APOD PE=1 SV=1 APOD_HUMAN reviewed Apolipoprotein D (Apo-D) (ApoD) Homo sapiens (Human) GO:0000302; GO:0001525; GO:0005319; GO:0005576; GO:0005615; GO:0005737; GO:0006006; GO:0006629; GO:0007420; GO:0010642; GO:0014012; GO:0015485; GO:0022626; GO:0030425; GO:0042246; GO:0042308; GO:0043025; GO:0048471; GO:0048662; GO:0048678; GO:0051895; GO:0060588; GO:0070062; GO:0071638; GO:1900016; GO:2000098; GO:2000405 angiogenesis [GO:0001525]; brain development [GO:0007420]; glucose metabolic process [GO:0006006]; lipid metabolic process [GO:0006629]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of lipoprotein lipid oxidation [GO:0060588]; negative regulation of monocyte chemotactic protein-1 production [GO:0071638]; negative regulation of platelet-derived growth factor receptor signaling pathway [GO:0010642]; negative regulation of protein import into nucleus [GO:0042308]; negative regulation of smooth muscle cell proliferation [GO:0048662]; negative regulation of smooth muscle cell-matrix adhesion [GO:2000098]; negative regulation of T cell migration [GO:2000405]; peripheral nervous system axon regeneration [GO:0014012]; response to axon injury [GO:0048678]; response to reactive oxygen species [GO:0000302]; tissue regeneration [GO:0042246] cytoplasm [GO:0005737]; cytosolic ribosome [GO:0022626]; dendrite [GO:0030425]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471] cholesterol binding [GO:0015485]; lipid transporter activity [GO:0005319] g1554.t1 Q5NVL7 62.312 597 0.0 800.0 sp|Q5NVL7|PPWD1_PONAB Peptidylprolyl isomerase domain and WD repeat-containing protein 1 OS=Pongo abelii OX=9601 GN=PPWD1 PE=2 SV=1 g1557.t1 Q06807 46.128 297 1.5200000000000002e-79 290.0 sp|Q06807|TIE2_BOVIN Angiopoietin-1 receptor OS=Bos taurus OX=9913 GN=TEK PE=2 SV=1 TIE2_BOVIN reviewed Angiopoietin-1 receptor (EC 2.7.10.1) (Endothelial tyrosine kinase) (Tyrosine kinase with Ig and EGF homology domains-2) (Tyrosine-protein kinase receptor TIE-2) (CD antigen CD202b) Bos taurus (Bovine) GO:0001525; GO:0001935; GO:0001936; GO:0002040; GO:0004714; GO:0005524; GO:0005576; GO:0005856; GO:0005886; GO:0005925; GO:0007169; GO:0007507; GO:0010595; GO:0016525; GO:0030097; GO:0032878; GO:0034446; GO:0043235; GO:0043410; GO:0045766; GO:0048014; GO:0051894; GO:0051897; GO:0060347; GO:0070374; GO:1902533; GO:2000352 angiogenesis [GO:0001525]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; endothelial cell proliferation [GO:0001935]; heart development [GO:0007507]; heart trabecula formation [GO:0060347]; hemopoiesis [GO:0030097]; negative regulation of angiogenesis [GO:0016525]; negative regulation of endothelial cell apoptotic process [GO:2000352]; positive regulation of angiogenesis [GO:0045766]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of intracellular signal transduction [GO:1902533]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; regulation of endothelial cell proliferation [GO:0001936]; regulation of establishment or maintenance of cell polarity [GO:0032878]; sprouting angiogenesis [GO:0002040]; substrate adhesion-dependent cell spreading [GO:0034446]; Tie signaling pathway [GO:0048014] cytoskeleton [GO:0005856]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] ATP binding [GO:0005524]; transmembrane receptor protein tyrosine kinase activity [GO:0004714] g1558.t1 P08575 40.0 215 1.38e-47 163.0 sp|P08575|PTPRC_HUMAN Receptor-type tyrosine-protein phosphatase C OS=Homo sapiens OX=9606 GN=PTPRC PE=1 SV=3 PTPRC_HUMAN reviewed Receptor-type tyrosine-protein phosphatase C (EC 3.1.3.48) (Leukocyte common antigen) (L-CA) (T200) (CD antigen CD45) Homo sapiens (Human) GO:0000122; GO:0000165; GO:0001779; GO:0001915; GO:0001916; GO:0001960; GO:0002244; GO:0002639; GO:0002925; GO:0004725; GO:0005001; GO:0005102; GO:0005886; GO:0005925; GO:0006469; GO:0006470; GO:0006933; GO:0007159; GO:0007165; GO:0007166; GO:0008201; GO:0009897; GO:0009898; GO:0009986; GO:0010332; GO:0010468; GO:0016020; GO:0016311; GO:0019901; GO:0030183; GO:0030217; GO:0030292; GO:0030506; GO:0030507; GO:0030667; GO:0030890; GO:0032059; GO:0032677; GO:0032703; GO:0032743; GO:0032760; GO:0034113; GO:0042100; GO:0042102; GO:0042110; GO:0042492; GO:0043395; GO:0043410; GO:0044770; GO:0044855; GO:0045059; GO:0045060; GO:0045121; GO:0045202; GO:0045588; GO:0045860; GO:0046426; GO:0046633; GO:0046641; GO:0048304; GO:0048539; GO:0048864; GO:0050764; GO:0050766; GO:0050850; GO:0050852; GO:0050853; GO:0050856; GO:0050857; GO:0051209; GO:0051607; GO:0051726; GO:0060369; GO:0070062; GO:0070373; GO:0070374; GO:0097191; GO:0098857; GO:1902215; GO:1903979; GO:1904044; GO:1904155; GO:2000473; GO:2000648; GO:2001238 alpha-beta T cell proliferation [GO:0046633]; B cell differentiation [GO:0030183]; B cell proliferation [GO:0042100]; B cell receptor signaling pathway [GO:0050853]; bone marrow development [GO:0048539]; cell cycle phase transition [GO:0044770]; cell surface receptor signaling pathway [GO:0007166]; defense response to virus [GO:0051607]; dephosphorylation [GO:0016311]; DN2 thymocyte differentiation [GO:1904155]; extrinsic apoptotic signaling pathway [GO:0097191]; gamma-delta T cell differentiation [GO:0042492]; hematopoietic progenitor cell differentiation [GO:0002244]; heterotypic cell-cell adhesion [GO:0034113]; leukocyte cell-cell adhesion [GO:0007159]; MAPK cascade [GO:0000165]; natural killer cell differentiation [GO:0001779]; negative regulation of cell adhesion involved in substrate-bound cell migration [GO:0006933]; negative regulation of cytokine-mediated signaling pathway [GO:0001960]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of interleukin-2 production [GO:0032703]; negative regulation of interleukin-4-mediated signaling pathway [GO:1902215]; negative regulation of microglial cell activation [GO:1903979]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of receptor signaling pathway via JAK-STAT [GO:0046426]; negative regulation of T cell mediated cytotoxicity [GO:0001915]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative thymic T cell selection [GO:0045060]; plasma membrane raft distribution [GO:0044855]; positive regulation of alpha-beta T cell proliferation [GO:0046641]; positive regulation of antigen receptor-mediated signaling pathway [GO:0050857]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of calcium-mediated signaling [GO:0050850]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; positive regulation of Fc receptor mediated stimulatory signaling pathway [GO:0060369]; positive regulation of gamma-delta T cell differentiation [GO:0045588]; positive regulation of hematopoietic stem cell migration [GO:2000473]; positive regulation of humoral immune response mediated by circulating immunoglobulin [GO:0002925]; positive regulation of immunoglobulin production [GO:0002639]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of isotype switching to IgG isotypes [GO:0048304]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of phagocytosis [GO:0050766]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of stem cell proliferation [GO:2000648]; positive regulation of T cell mediated cytotoxicity [GO:0001916]; positive regulation of T cell proliferation [GO:0042102]; positive regulation of tumor necrosis factor production [GO:0032760]; positive thymic T cell selection [GO:0045059]; protein dephosphorylation [GO:0006470]; regulation of cell cycle [GO:0051726]; regulation of gene expression [GO:0010468]; regulation of interleukin-8 production [GO:0032677]; regulation of phagocytosis [GO:0050764]; regulation of T cell receptor signaling pathway [GO:0050856]; release of sequestered calcium ion into cytosol [GO:0051209]; response to aldosterone [GO:1904044]; response to gamma radiation [GO:0010332]; signal transduction [GO:0007165]; stem cell development [GO:0048864]; T cell activation [GO:0042110]; T cell differentiation [GO:0030217]; T cell receptor signaling pathway [GO:0050852] bleb [GO:0032059]; cell surface [GO:0009986]; cytoplasmic side of plasma membrane [GO:0009898]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; membrane [GO:0016020]; membrane microdomain [GO:0098857]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; synapse [GO:0045202] ankyrin binding [GO:0030506]; heparan sulfate proteoglycan binding [GO:0043395]; heparin binding [GO:0008201]; protein kinase binding [GO:0019901]; protein tyrosine kinase inhibitor activity [GO:0030292]; protein tyrosine phosphatase activity [GO:0004725]; signaling receptor binding [GO:0005102]; spectrin binding [GO:0030507]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001] g1558.t1 P08575 54.348 46 1.38e-47 50.8 sp|P08575|PTPRC_HUMAN Receptor-type tyrosine-protein phosphatase C OS=Homo sapiens OX=9606 GN=PTPRC PE=1 SV=3 PTPRC_HUMAN reviewed Receptor-type tyrosine-protein phosphatase C (EC 3.1.3.48) (Leukocyte common antigen) (L-CA) (T200) (CD antigen CD45) Homo sapiens (Human) GO:0000122; GO:0000165; GO:0001779; GO:0001915; GO:0001916; GO:0001960; GO:0002244; GO:0002639; GO:0002925; GO:0004725; GO:0005001; GO:0005102; GO:0005886; GO:0005925; GO:0006469; GO:0006470; GO:0006933; GO:0007159; GO:0007165; GO:0007166; GO:0008201; GO:0009897; GO:0009898; GO:0009986; GO:0010332; GO:0010468; GO:0016020; GO:0016311; GO:0019901; GO:0030183; GO:0030217; GO:0030292; GO:0030506; GO:0030507; GO:0030667; GO:0030890; GO:0032059; GO:0032677; GO:0032703; GO:0032743; GO:0032760; GO:0034113; GO:0042100; GO:0042102; GO:0042110; GO:0042492; GO:0043395; GO:0043410; GO:0044770; GO:0044855; GO:0045059; GO:0045060; GO:0045121; GO:0045202; GO:0045588; GO:0045860; GO:0046426; GO:0046633; GO:0046641; GO:0048304; GO:0048539; GO:0048864; GO:0050764; GO:0050766; GO:0050850; GO:0050852; GO:0050853; GO:0050856; GO:0050857; GO:0051209; GO:0051607; GO:0051726; GO:0060369; GO:0070062; GO:0070373; GO:0070374; GO:0097191; GO:0098857; GO:1902215; GO:1903979; GO:1904044; GO:1904155; GO:2000473; GO:2000648; GO:2001238 alpha-beta T cell proliferation [GO:0046633]; B cell differentiation [GO:0030183]; B cell proliferation [GO:0042100]; B cell receptor signaling pathway [GO:0050853]; bone marrow development [GO:0048539]; cell cycle phase transition [GO:0044770]; cell surface receptor signaling pathway [GO:0007166]; defense response to virus [GO:0051607]; dephosphorylation [GO:0016311]; DN2 thymocyte differentiation [GO:1904155]; extrinsic apoptotic signaling pathway [GO:0097191]; gamma-delta T cell differentiation [GO:0042492]; hematopoietic progenitor cell differentiation [GO:0002244]; heterotypic cell-cell adhesion [GO:0034113]; leukocyte cell-cell adhesion [GO:0007159]; MAPK cascade [GO:0000165]; natural killer cell differentiation [GO:0001779]; negative regulation of cell adhesion involved in substrate-bound cell migration [GO:0006933]; negative regulation of cytokine-mediated signaling pathway [GO:0001960]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of interleukin-2 production [GO:0032703]; negative regulation of interleukin-4-mediated signaling pathway [GO:1902215]; negative regulation of microglial cell activation [GO:1903979]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of receptor signaling pathway via JAK-STAT [GO:0046426]; negative regulation of T cell mediated cytotoxicity [GO:0001915]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative thymic T cell selection [GO:0045060]; plasma membrane raft distribution [GO:0044855]; positive regulation of alpha-beta T cell proliferation [GO:0046641]; positive regulation of antigen receptor-mediated signaling pathway [GO:0050857]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of calcium-mediated signaling [GO:0050850]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; positive regulation of Fc receptor mediated stimulatory signaling pathway [GO:0060369]; positive regulation of gamma-delta T cell differentiation [GO:0045588]; positive regulation of hematopoietic stem cell migration [GO:2000473]; positive regulation of humoral immune response mediated by circulating immunoglobulin [GO:0002925]; positive regulation of immunoglobulin production [GO:0002639]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of isotype switching to IgG isotypes [GO:0048304]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of phagocytosis [GO:0050766]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of stem cell proliferation [GO:2000648]; positive regulation of T cell mediated cytotoxicity [GO:0001916]; positive regulation of T cell proliferation [GO:0042102]; positive regulation of tumor necrosis factor production [GO:0032760]; positive thymic T cell selection [GO:0045059]; protein dephosphorylation [GO:0006470]; regulation of cell cycle [GO:0051726]; regulation of gene expression [GO:0010468]; regulation of interleukin-8 production [GO:0032677]; regulation of phagocytosis [GO:0050764]; regulation of T cell receptor signaling pathway [GO:0050856]; release of sequestered calcium ion into cytosol [GO:0051209]; response to aldosterone [GO:1904044]; response to gamma radiation [GO:0010332]; signal transduction [GO:0007165]; stem cell development [GO:0048864]; T cell activation [GO:0042110]; T cell differentiation [GO:0030217]; T cell receptor signaling pathway [GO:0050852] bleb [GO:0032059]; cell surface [GO:0009986]; cytoplasmic side of plasma membrane [GO:0009898]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; membrane [GO:0016020]; membrane microdomain [GO:0098857]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; synapse [GO:0045202] ankyrin binding [GO:0030506]; heparan sulfate proteoglycan binding [GO:0043395]; heparin binding [GO:0008201]; protein kinase binding [GO:0019901]; protein tyrosine kinase inhibitor activity [GO:0030292]; protein tyrosine phosphatase activity [GO:0004725]; signaling receptor binding [GO:0005102]; spectrin binding [GO:0030507]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001] g1559.t1 P18433 50.585 342 3.11e-124 378.0 sp|P18433|PTPRA_HUMAN Receptor-type tyrosine-protein phosphatase alpha OS=Homo sapiens OX=9606 GN=PTPRA PE=1 SV=3 PTPRA_HUMAN reviewed Receptor-type tyrosine-protein phosphatase alpha (Protein-tyrosine phosphatase alpha) (R-PTP-alpha) (EC 3.1.3.48) Homo sapiens (Human) GO:0004725; GO:0005001; GO:0005886; GO:0005925; GO:0007165; GO:0007229; GO:0016020; GO:0043235; GO:0051893; GO:0070062 integrin-mediated signaling pathway [GO:0007229]; regulation of focal adhesion assembly [GO:0051893]; signal transduction [GO:0007165] extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; membrane [GO:0016020]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001] g1559.t1 P18433 38.168 262 2.68e-52 187.0 sp|P18433|PTPRA_HUMAN Receptor-type tyrosine-protein phosphatase alpha OS=Homo sapiens OX=9606 GN=PTPRA PE=1 SV=3 PTPRA_HUMAN reviewed Receptor-type tyrosine-protein phosphatase alpha (Protein-tyrosine phosphatase alpha) (R-PTP-alpha) (EC 3.1.3.48) Homo sapiens (Human) GO:0004725; GO:0005001; GO:0005886; GO:0005925; GO:0007165; GO:0007229; GO:0016020; GO:0043235; GO:0051893; GO:0070062 integrin-mediated signaling pathway [GO:0007229]; regulation of focal adhesion assembly [GO:0051893]; signal transduction [GO:0007165] extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; membrane [GO:0016020]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001] g1560.t1 Q9MYM7 34.241 257 4.650000000000001e-43 155.0 sp|Q9MYM7|B3GT1_PONPY Beta-1,3-galactosyltransferase 1 OS=Pongo pygmaeus OX=9600 GN=B3GALT1 PE=3 SV=1 g1561.t1 Q924U5 50.168 297 1.02e-95 307.0 sp|Q924U5|TESK2_RAT Dual specificity testis-specific protein kinase 2 OS=Rattus norvegicus OX=10116 GN=Tesk2 PE=2 SV=1 g1563.t1 Q66KC4 60.337 416 9.51e-155 447.0 sp|Q66KC4|HSDL2_XENTR Hydroxysteroid dehydrogenase-like protein 2 OS=Xenopus tropicalis OX=8364 GN=hsdl2 PE=2 SV=1 g1564.t1 P69527 34.762 840 4.12e-146 451.0 sp|P69527|AMPO_RAT Aminopeptidase O OS=Rattus norvegicus OX=10116 GN=Aopep PE=2 SV=2 g1565.t1 P56719 28.082 438 1.0200000000000001e-29 124.0 sp|P56719|OX2R_RAT Orexin receptor type 2 OS=Rattus norvegicus OX=10116 GN=Hcrtr2 PE=2 SV=1 g1568.t1 Q6GNQ1 70.997 331 8.870000000000001e-164 464.0 sp|Q6GNQ1|GET3_XENLA ATPase GET3 OS=Xenopus laevis OX=8355 GN=get3 PE=2 SV=1 g1570.t1 Q5ZLR1 50.0 552 0.0 536.0 sp|Q5ZLR1|WLS_CHICK Protein wntless homolog OS=Gallus gallus OX=9031 GN=WLS PE=2 SV=1 WLS_CHICK reviewed Protein wntless homolog (Integral membrane protein GPR177) Gallus gallus (Chicken) GO:0000139; GO:0006886; GO:0012505; GO:0016055; GO:0017147; GO:0030177; GO:0030659; GO:0031090; GO:0061355; GO:0061357 intracellular protein transport [GO:0006886]; positive regulation of Wnt protein secretion [GO:0061357]; positive regulation of Wnt signaling pathway [GO:0030177]; Wnt protein secretion [GO:0061355]; Wnt signaling pathway [GO:0016055] cytoplasmic vesicle membrane [GO:0030659]; endomembrane system [GO:0012505]; Golgi membrane [GO:0000139]; organelle membrane [GO:0031090] Wnt-protein binding [GO:0017147] g1571.t1 Q0V8M0 52.051 390 1.74e-84 288.0 sp|Q0V8M0|KRI1_BOVIN Protein KRI1 homolog OS=Bos taurus OX=9913 GN=KRI1 PE=2 SV=3 g1572.t1 Q6DRJ4 44.706 170 1.55e-23 101.0 sp|Q6DRJ4|KRI1_DANRE Protein KRI1 homolog OS=Danio rerio OX=7955 GN=kri1 PE=2 SV=1 g1574.t1 Q5H8A4 57.143 224 4.51e-71 236.0 sp|Q5H8A4|PIGG_HUMAN GPI ethanolamine phosphate transferase 2, catalytic subunit OS=Homo sapiens OX=9606 GN=PIGG PE=1 SV=1 PIGG_HUMAN reviewed GPI ethanolamine phosphate transferase 2, catalytic subunit (EC 2.-.-.-) (GPI7 homolog) (hGPI7) (Phosphatidylinositol-glycan biosynthesis class G protein) (PIG-G) Homo sapiens (Human) GO:0005783; GO:0005789; GO:0006506; GO:0016020; GO:0016740; GO:0016780; GO:0051267 GPI anchor biosynthetic process [GO:0006506] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020] CP2 mannose-ethanolamine phosphotransferase activity [GO:0051267]; phosphotransferase activity, for other substituted phosphate groups [GO:0016780]; transferase activity [GO:0016740] g1579.t1 Q5T447 53.371 875 0.0 922.0 sp|Q5T447|HECD3_HUMAN E3 ubiquitin-protein ligase HECTD3 OS=Homo sapiens OX=9606 GN=HECTD3 PE=1 SV=1 HECD3_HUMAN reviewed E3 ubiquitin-protein ligase HECTD3 (EC 2.3.2.26) (HECT domain-containing protein 3) (HECT-type E3 ubiquitin transferase HECTD3) Homo sapiens (Human) GO:0004842; GO:0016567; GO:0019905; GO:0043161; GO:0048471; GO:0061630 proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567] perinuclear region of cytoplasm [GO:0048471] syntaxin binding [GO:0019905]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842] g1580.t1 Q4ZIN3 63.721 430 6.65e-168 498.0 sp|Q4ZIN3|MBRL_HUMAN Membralin OS=Homo sapiens OX=9606 GN=TMEM259 PE=1 SV=1 MBRL_HUMAN reviewed Membralin (Transmembrane protein 259) Homo sapiens (Human) GO:0005783; GO:0005789; GO:0034976; GO:1904294 positive regulation of ERAD pathway [GO:1904294]; response to endoplasmic reticulum stress [GO:0034976] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789] g1581.t1 Q6AXK4 40.833 240 3.45e-55 188.0 sp|Q6AXK4|BABA1_DANRE BRISC and BRCA1-A complex member 1 OS=Danio rerio OX=7955 GN=babam1 PE=1 SV=2 BABA1_DANRE reviewed BRISC and BRCA1-A complex member 1 (Mediator of RAP80 interactions and targeting subunit of 40 kDa) (New component of the BRCA1-A complex) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005634; GO:0005737; GO:0006302; GO:0007095; GO:0010212; GO:0016604; GO:0045739; GO:0051301; GO:0070531; GO:0070552; GO:0140861 cell division [GO:0051301]; DNA repair-dependent chromatin remodeling [GO:0140861]; double-strand break repair [GO:0006302]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; positive regulation of DNA repair [GO:0045739]; response to ionizing radiation [GO:0010212] BRCA1-A complex [GO:0070531]; BRISC complex [GO:0070552]; cytoplasm [GO:0005737]; nuclear body [GO:0016604]; nucleus [GO:0005634] g1582.t1 Q9HBK9 44.562 377 9.16e-111 332.0 sp|Q9HBK9|AS3MT_HUMAN Arsenite methyltransferase OS=Homo sapiens OX=9606 GN=AS3MT PE=1 SV=3 AS3MT_HUMAN reviewed Arsenite methyltransferase (EC 2.1.1.137) (Methylarsonite methyltransferase) (S-adenosyl-L-methionine:arsenic(III) methyltransferase) Homo sapiens (Human) GO:0005829; GO:0009404; GO:0018872; GO:0030791; GO:0032259 arsonoacetate metabolic process [GO:0018872]; methylation [GO:0032259]; toxin metabolic process [GO:0009404] cytosol [GO:0005829] arsenite methyltransferase activity [GO:0030791] g1583.t1 E3TDS3 56.958 309 1.08e-123 360.0 sp|E3TDS3|MTG1_ICTPU Mitochondrial ribosome-associated GTPase 1 OS=Ictalurus punctatus OX=7998 GN=mtg1 PE=2 SV=1 g1585.t1 Q63787 44.409 626 5.2e-159 489.0 sp|Q63787|P85A_RAT Phosphatidylinositol 3-kinase regulatory subunit alpha OS=Rattus norvegicus OX=10116 GN=Pik3r1 PE=1 SV=1 g1585.t2 Q63787 44.409 626 1.48e-159 489.0 sp|Q63787|P85A_RAT Phosphatidylinositol 3-kinase regulatory subunit alpha OS=Rattus norvegicus OX=10116 GN=Pik3r1 PE=1 SV=1 g1587.t1 Q4R6T3 47.198 464 2.51e-133 395.0 sp|Q4R6T3|EI2BG_MACFA Translation initiation factor eIF2B subunit gamma OS=Macaca fascicularis OX=9541 GN=EIF2B3 PE=2 SV=1 g1591.t1 P31597 54.518 332 9.79e-105 332.0 sp|P31597|EAA3_RABIT Excitatory amino acid transporter 3 OS=Oryctolagus cuniculus OX=9986 GN=SLC1A1 PE=1 SV=1 g1592.t1 Q0II91 46.307 352 2.04e-86 280.0 sp|Q0II91|DJC21_BOVIN DnaJ homolog subfamily C member 21 OS=Bos taurus OX=9913 GN=DNAJC21 PE=2 SV=2 DJC21_BOVIN reviewed DnaJ homolog subfamily C member 21 Bos taurus (Bovine) GO:0003676; GO:0005730; GO:0005737; GO:0008270 cytoplasm [GO:0005737]; nucleolus [GO:0005730] nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270] g1593.t1 Q1WG82 42.138 159 2.54e-28 112.0 sp|Q1WG82|ZGLP1_MOUSE GATA-type zinc finger protein 1 OS=Mus musculus OX=10090 GN=Zglp1 PE=2 SV=1 ZGLP1_MOUSE reviewed GATA-type zinc finger protein 1 (GATA-like protein 1) (GLP-1) Mus musculus (Mouse) GO:0000122; GO:0000981; GO:0005634; GO:0006357; GO:0007283; GO:0008270; GO:0043565; GO:0045944; GO:0048599 negative regulation of transcription by RNA polymerase II [GO:0000122]; oocyte development [GO:0048599]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283] nucleus [GO:0005634] DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270] g1594.t1 Q9Z139 49.536 755 0.0 739.0 sp|Q9Z139|ROR1_MOUSE Inactive tyrosine-protein kinase transmembrane receptor ROR1 OS=Mus musculus OX=10090 GN=Ror1 PE=2 SV=2 g1594.t1 Q9Z139 37.247 247 4.69e-44 177.0 sp|Q9Z139|ROR1_MOUSE Inactive tyrosine-protein kinase transmembrane receptor ROR1 OS=Mus musculus OX=10090 GN=Ror1 PE=2 SV=2 g1596.t1 Q9NXK8 29.778 225 2.49e-30 120.0 sp|Q9NXK8|FXL12_HUMAN F-box/LRR-repeat protein 12 OS=Homo sapiens OX=9606 GN=FBXL12 PE=1 SV=1 FXL12_HUMAN reviewed F-box/LRR-repeat protein 12 (F-box and leucine-rich repeat protein 12) (F-box protein FBL12) Homo sapiens (Human) GO:0000151; GO:0005829; GO:0006511; GO:0016567 protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511] cytosol [GO:0005829]; ubiquitin ligase complex [GO:0000151] g1597.t1 Q95LM1 32.749 342 4.61e-41 148.0 sp|Q95LM1|UBE2U_MACFA Ubiquitin-conjugating enzyme E2 U OS=Macaca fascicularis OX=9541 GN=UBE2U PE=2 SV=1 g1599.t1 P00687 54.808 520 0.0 539.0 sp|P00687|AMY1_MOUSE Alpha-amylase 1 OS=Mus musculus OX=10090 GN=Amy1 PE=1 SV=2 AMY1_MOUSE reviewed Alpha-amylase 1 (EC 3.2.1.1) (1,4-alpha-D-glucan glucanohydrolase 1) (Salivary and hepatic alpha-amylase) Mus musculus (Mouse) GO:0004556; GO:0005509; GO:0005615; GO:0005975; GO:0009617; GO:0016160; GO:0031404 carbohydrate metabolic process [GO:0005975]; response to bacterium [GO:0009617] extracellular space [GO:0005615] alpha-amylase activity [GO:0004556]; amylase activity [GO:0016160]; calcium ion binding [GO:0005509]; chloride ion binding [GO:0031404] g1600.t1 H2N0D4 60.742 512 0.0 605.0 sp|H2N0D4|AMY_ORYLA Alpha-amylase OS=Oryzias latipes OX=8090 PE=1 SV=1 AMY_ORYLA reviewed Alpha-amylase (EC 3.2.1.1) Oryzias latipes (Japanese rice fish) (Japanese killifish) GO:0004556; GO:0005615; GO:0005975; GO:0046872 carbohydrate metabolic process [GO:0005975] extracellular space [GO:0005615] alpha-amylase activity [GO:0004556]; metal ion binding [GO:0046872] g1601.t1 H2N0D4 58.203 512 0.0 593.0 sp|H2N0D4|AMY_ORYLA Alpha-amylase OS=Oryzias latipes OX=8090 PE=1 SV=1 AMY_ORYLA reviewed Alpha-amylase (EC 3.2.1.1) Oryzias latipes (Japanese rice fish) (Japanese killifish) GO:0004556; GO:0005615; GO:0005975; GO:0046872 carbohydrate metabolic process [GO:0005975] extracellular space [GO:0005615] alpha-amylase activity [GO:0004556]; metal ion binding [GO:0046872] g1602.t1 P00687 43.984 507 1.41e-137 417.0 sp|P00687|AMY1_MOUSE Alpha-amylase 1 OS=Mus musculus OX=10090 GN=Amy1 PE=1 SV=2 AMY1_MOUSE reviewed Alpha-amylase 1 (EC 3.2.1.1) (1,4-alpha-D-glucan glucanohydrolase 1) (Salivary and hepatic alpha-amylase) Mus musculus (Mouse) GO:0004556; GO:0005509; GO:0005615; GO:0005975; GO:0009617; GO:0016160; GO:0031404 carbohydrate metabolic process [GO:0005975]; response to bacterium [GO:0009617] extracellular space [GO:0005615] alpha-amylase activity [GO:0004556]; amylase activity [GO:0016160]; calcium ion binding [GO:0005509]; chloride ion binding [GO:0031404] g1603.t1 Q5M7W7 54.422 441 1.1500000000000001e-163 474.0 sp|Q5M7W7|SYPM_RAT Probable proline--tRNA ligase, mitochondrial OS=Rattus norvegicus OX=10116 GN=Pars2 PE=2 SV=1 g1604.t1 Q5PPS7 33.446 296 1.67e-43 152.0 sp|Q5PPS7|TM53A_XENLA Transmembrane protein 53-A OS=Xenopus laevis OX=8355 GN=tmem53-a PE=2 SV=1 g1605.t1 P26599 68.212 151 1.73e-64 209.0 sp|P26599|PTBP1_HUMAN Polypyrimidine tract-binding protein 1 OS=Homo sapiens OX=9606 GN=PTBP1 PE=1 SV=2 PTBP1_HUMAN reviewed Polypyrimidine tract-binding protein 1 (PTB) (57 kDa RNA-binding protein PPTB-1) (Heterogeneous nuclear ribonucleoprotein I) (hnRNP I) Homo sapiens (Human) GO:0000381; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0005730; GO:0006397; GO:0008187; GO:0008380; GO:0016020; GO:0022008; GO:0033119; GO:0036002; GO:0043484; GO:0045595; GO:0045665; GO:0045944; GO:0048025; GO:0051148; GO:0070062; GO:0070886; GO:0075522 IRES-dependent viral translational initiation [GO:0075522]; mRNA processing [GO:0006397]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; negative regulation of muscle cell differentiation [GO:0051148]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of RNA splicing [GO:0033119]; neurogenesis [GO:0022008]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of cell differentiation [GO:0045595]; regulation of RNA splicing [GO:0043484]; RNA splicing [GO:0008380] extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] mRNA binding [GO:0003729]; poly-pyrimidine tract binding [GO:0008187]; pre-mRNA binding [GO:0036002]; RNA binding [GO:0003723] g1606.t1 Q29099 45.994 337 4.7200000000000006e-79 258.0 sp|Q29099|PTBP1_PIG Polypyrimidine tract-binding protein 1 OS=Sus scrofa OX=9823 GN=PTBP1 PE=2 SV=2 g1606.t2 Q9Z118 53.459 159 2.6699999999999998e-39 152.0 sp|Q9Z118|PTBP3_RAT Polypyrimidine tract-binding protein 3 OS=Rattus norvegicus OX=10116 GN=Ptbp3 PE=2 SV=1 g1606.t2 Q9Z118 51.0 100 2.88e-24 109.0 sp|Q9Z118|PTBP3_RAT Polypyrimidine tract-binding protein 3 OS=Rattus norvegicus OX=10116 GN=Ptbp3 PE=2 SV=1 g1609.t1 P22455 34.921 315 1.08e-47 186.0 sp|P22455|FGFR4_HUMAN Fibroblast growth factor receptor 4 OS=Homo sapiens OX=9606 GN=FGFR4 PE=1 SV=2 FGFR4_HUMAN reviewed Fibroblast growth factor receptor 4 (FGFR-4) (EC 2.7.10.1) (CD antigen CD334) Homo sapiens (Human) GO:0005007; GO:0005524; GO:0005576; GO:0005768; GO:0005783; GO:0005794; GO:0005886; GO:0008201; GO:0008284; GO:0008543; GO:0010628; GO:0010715; GO:0016477; GO:0017134; GO:0018108; GO:0019216; GO:0030133; GO:0042593; GO:0042632; GO:0043085; GO:0043235; GO:0045862; GO:0046777; GO:0055062; GO:0070374; GO:0070857; GO:2000573 cell migration [GO:0016477]; cholesterol homeostasis [GO:0042632]; fibroblast growth factor receptor signaling pathway [GO:0008543]; glucose homeostasis [GO:0042593]; peptidyl-tyrosine phosphorylation [GO:0018108]; phosphate ion homeostasis [GO:0055062]; positive regulation of catalytic activity [GO:0043085]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA biosynthetic process [GO:2000573]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of proteolysis [GO:0045862]; protein autophosphorylation [GO:0046777]; regulation of bile acid biosynthetic process [GO:0070857]; regulation of extracellular matrix disassembly [GO:0010715]; regulation of lipid metabolic process [GO:0019216] endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; transport vesicle [GO:0030133] ATP binding [GO:0005524]; fibroblast growth factor binding [GO:0017134]; fibroblast growth factor receptor activity [GO:0005007]; heparin binding [GO:0008201] g1618.t1 Q09575 44.134 179 8.01e-44 158.0 sp|Q09575|YRD6_CAEEL Uncharacterized protein K02A2.6 OS=Caenorhabditis elegans OX=6239 GN=K02A2.6 PE=4 SV=1 g1623.t1 Q6XP49 61.801 322 2.14e-113 369.0 sp|Q6XP49|GLIS3_MOUSE Zinc finger protein GLIS3 OS=Mus musculus OX=10090 GN=Glis3 PE=1 SV=2 GLIS3_MOUSE reviewed Zinc finger protein GLIS3 (GLI-similar 3) Mus musculus (Mouse) GO:0000122; GO:0000977; GO:0000978; GO:0000981; GO:0001227; GO:0001228; GO:0003677; GO:0003700; GO:0005634; GO:0006357; GO:0006366; GO:0008270; GO:0045944 negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription by RNA polymerase II [GO:0006366] nucleus [GO:0005634] DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; zinc ion binding [GO:0008270] g1626.t1 Q6ZT98 49.244 794 0.0 753.0 sp|Q6ZT98|TTLL7_HUMAN Tubulin polyglutamylase TTLL7 OS=Homo sapiens OX=9606 GN=TTLL7 PE=1 SV=2 TTLL7_HUMAN reviewed Tubulin polyglutamylase TTLL7 (EC 6.3.2.-) (Testis development protein NYD-SP30) (Tubulin--tyrosine ligase-like protein 7) Homo sapiens (Human) GO:0000226; GO:0005524; GO:0005829; GO:0005874; GO:0007399; GO:0015631; GO:0018095; GO:0030154; GO:0030425; GO:0036064; GO:0043014; GO:0043204; GO:0046872; GO:0048487; GO:0070740; GO:0106437; GO:0106438 cell differentiation [GO:0030154]; microtubule cytoskeleton organization [GO:0000226]; nervous system development [GO:0007399]; protein polyglutamylation [GO:0018095] ciliary basal body [GO:0036064]; cytosol [GO:0005829]; dendrite [GO:0030425]; microtubule [GO:0005874]; perikaryon [GO:0043204] alpha-tubulin binding [GO:0043014]; ATP binding [GO:0005524]; beta-tubulin binding [GO:0048487]; metal ion binding [GO:0046872]; protein-glutamic acid ligase activity, elongating [GO:0106438]; protein-glutamic acid ligase activity, initiating [GO:0106437]; tubulin binding [GO:0015631]; tubulin-glutamic acid ligase activity [GO:0070740] g1627.t1 Q99437 73.099 171 8.09e-85 252.0 sp|Q99437|VATO_HUMAN V-type proton ATPase 21 kDa proteolipid subunit c'' OS=Homo sapiens OX=9606 GN=ATP6V0B PE=1 SV=1 VATO_HUMAN reviewed V-type proton ATPase 21 kDa proteolipid subunit c'' (V-ATPase 21 kDa proteolipid subunit c'') (Vacuolar proton pump 21 kDa proteolipid subunit c'') (hATPL) Homo sapiens (Human) GO:0000139; GO:0000220; GO:0005765; GO:0005886; GO:0007035; GO:0007042; GO:0010008; GO:0016020; GO:0016241; GO:0030665; GO:0030670; GO:0033176; GO:0046961; GO:0048388; GO:0051452; GO:0061795; GO:1902600 endosomal lumen acidification [GO:0048388]; Golgi lumen acidification [GO:0061795]; intracellular pH reduction [GO:0051452]; lysosomal lumen acidification [GO:0007042]; proton transmembrane transport [GO:1902600]; regulation of macroautophagy [GO:0016241]; vacuolar acidification [GO:0007035] clathrin-coated vesicle membrane [GO:0030665]; endosome membrane [GO:0010008]; Golgi membrane [GO:0000139]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; proton-transporting V-type ATPase complex [GO:0033176]; vacuolar proton-transporting V-type ATPase, V0 domain [GO:0000220] proton-transporting ATPase activity, rotational mechanism [GO:0046961] g1628.t1 Q8BJ52 35.401 274 1.79e-41 151.0 sp|Q8BJ52|PLPR5_MOUSE Phospholipid phosphatase-related protein type 5 OS=Mus musculus OX=10090 GN=Plppr5 PE=2 SV=1 g1629.t1 Q8BFZ2 36.559 279 1.1e-39 146.0 sp|Q8BFZ2|PLPR1_MOUSE Phospholipid phosphatase-related protein type 1 OS=Mus musculus OX=10090 GN=Plppr1 PE=1 SV=1 g1632.t1 C9JJ37 38.078 281 4.5599999999999996e-46 158.0 sp|C9JJ37|BTBDJ_HUMAN BTB/POZ domain-containing protein 19 OS=Homo sapiens OX=9606 GN=BTBD19 PE=1 SV=1 g1634.t1 Q99P21 48.767 527 1.9499999999999998e-150 445.0 sp|Q99P21|MUTYH_MOUSE Adenine DNA glycosylase OS=Mus musculus OX=10090 GN=Mutyh PE=1 SV=2 g1635.t1 Q96GM8 42.857 294 6.41e-73 242.0 sp|Q96GM8|TOE1_HUMAN Target of EGR1 protein 1 OS=Homo sapiens OX=9606 GN=TOE1 PE=1 SV=1 TOE1_HUMAN reviewed Target of EGR1 protein 1 Homo sapiens (Human) GO:0000175; GO:0004535; GO:0005654; GO:0005730; GO:0005737; GO:0008270; GO:0015030; GO:0016604; GO:0016607; GO:0017069; GO:0034472 snRNA 3'-end processing [GO:0034472] Cajal body [GO:0015030]; cytoplasm [GO:0005737]; nuclear body [GO:0016604]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654] 3'-5'-RNA exonuclease activity [GO:0000175]; poly(A)-specific ribonuclease activity [GO:0004535]; snRNA binding [GO:0017069]; zinc ion binding [GO:0008270] g1636.t1 P49321 37.743 257 1.9e-38 154.0 sp|P49321|NASP_HUMAN Nuclear autoantigenic sperm protein OS=Homo sapiens OX=9606 GN=NASP PE=1 SV=2 NASP_HUMAN reviewed Nuclear autoantigenic sperm protein (NASP) Homo sapiens (Human) GO:0000785; GO:0001824; GO:0005634; GO:0005654; GO:0005737; GO:0006260; GO:0006334; GO:0006335; GO:0008584; GO:0015031; GO:0032991; GO:0033574; GO:0034080; GO:0042393; GO:0044877 blastocyst development [GO:0001824]; CENP-A containing chromatin assembly [GO:0034080]; DNA replication [GO:0006260]; DNA replication-dependent chromatin assembly [GO:0006335]; male gonad development [GO:0008584]; nucleosome assembly [GO:0006334]; protein transport [GO:0015031]; response to testosterone [GO:0033574] chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991] histone binding [GO:0042393]; protein-containing complex binding [GO:0044877] g1636.t1 P49321 53.774 106 1.01e-22 106.0 sp|P49321|NASP_HUMAN Nuclear autoantigenic sperm protein OS=Homo sapiens OX=9606 GN=NASP PE=1 SV=2 NASP_HUMAN reviewed Nuclear autoantigenic sperm protein (NASP) Homo sapiens (Human) GO:0000785; GO:0001824; GO:0005634; GO:0005654; GO:0005737; GO:0006260; GO:0006334; GO:0006335; GO:0008584; GO:0015031; GO:0032991; GO:0033574; GO:0034080; GO:0042393; GO:0044877 blastocyst development [GO:0001824]; CENP-A containing chromatin assembly [GO:0034080]; DNA replication [GO:0006260]; DNA replication-dependent chromatin assembly [GO:0006335]; male gonad development [GO:0008584]; nucleosome assembly [GO:0006334]; protein transport [GO:0015031]; response to testosterone [GO:0033574] chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991] histone binding [GO:0042393]; protein-containing complex binding [GO:0044877] g1637.t1 Q6PC91 70.513 156 3.0999999999999996e-67 204.0 sp|Q6PC91|BT3L4_DANRE Transcription factor BTF3 homolog 4 OS=Danio rerio OX=7955 GN=btf3l4 PE=2 SV=1 g1638.t1 Q17Q97 36.879 141 4.09e-25 97.8 sp|Q17Q97|REX1B_BOVIN Required for excision 1-B domain-containing protein OS=Bos taurus OX=9913 GN=REX1BD PE=2 SV=1 g1639.t1 Q7TSN4 33.268 514 2.02e-65 222.0 sp|Q7TSN4|PIGW_RAT Glucosaminyl-phosphatidylinositol-acyltransferase PIGW OS=Rattus norvegicus OX=10116 GN=Pigw PE=1 SV=1 g1641.t1 Q8WYB5 28.976 459 3.23e-36 147.0 sp|Q8WYB5|KAT6B_HUMAN Histone acetyltransferase KAT6B OS=Homo sapiens OX=9606 GN=KAT6B PE=1 SV=3 KAT6B_HUMAN reviewed Histone acetyltransferase KAT6B (EC 2.3.1.48) (Histone acetyltransferase MOZ2) (MOZ, YBF2/SAS3, SAS2 and TIP60 protein 4) (MYST-4) (Monocytic leukemia zinc finger protein-related factor) Homo sapiens (Human) GO:0000785; GO:0000786; GO:0003677; GO:0003682; GO:0003712; GO:0003713; GO:0004402; GO:0005634; GO:0005654; GO:0006334; GO:0006355; GO:0006357; GO:0008270; GO:0010484; GO:0036408; GO:0044877; GO:0045892; GO:0045893; GO:0045944; GO:0050793; GO:0061733; GO:0070776; GO:1903706 negative regulation of DNA-templated transcription [GO:0045892]; nucleosome assembly [GO:0006334]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of developmental process [GO:0050793]; regulation of DNA-templated transcription [GO:0006355]; regulation of hemopoiesis [GO:1903706]; regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; MOZ/MORF histone acetyltransferase complex [GO:0070776]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634] chromatin binding [GO:0003682]; DNA binding [GO:0003677]; histone acetyltransferase activity [GO:0004402]; histone H3 acetyltransferase activity [GO:0010484]; histone H3K14 acetyltransferase activity [GO:0036408]; protein-containing complex binding [GO:0044877]; protein-lysine-acetyltransferase activity [GO:0061733]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; zinc ion binding [GO:0008270] g1643.t1 O70497 43.22 236 6.229999999999999e-45 159.0 sp|O70497|FCN2_MOUSE Ficolin-2 OS=Mus musculus OX=10090 GN=Fcn2 PE=2 SV=2 g1644.t1 Q8R1Q3 41.379 232 8.34e-45 158.0 sp|Q8R1Q3|ANGL7_MOUSE Angiopoietin-related protein 7 OS=Mus musculus OX=10090 GN=Angptl7 PE=2 SV=1 g1645.t1 Q9H583 30.941 1031 1.2999999999999999e-141 473.0 sp|Q9H583|HEAT1_HUMAN HEAT repeat-containing protein 1 OS=Homo sapiens OX=9606 GN=HEATR1 PE=1 SV=3 HEAT1_HUMAN reviewed HEAT repeat-containing protein 1 (Protein BAP28) (U3 small nucleolar RNA-associated protein 10 homolog) [Cleaved into: HEAT repeat-containing protein 1, N-terminally processed] Homo sapiens (Human) GO:0000462; GO:0001650; GO:0003723; GO:0005654; GO:0005730; GO:0005739; GO:0016020; GO:0016072; GO:0030515; GO:0030686; GO:0032040; GO:0034455; GO:0042274; GO:0045943; GO:0061351; GO:1902570; GO:2000234 maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; neural precursor cell proliferation [GO:0061351]; positive regulation of rRNA processing [GO:2000234]; positive regulation of transcription by RNA polymerase I [GO:0045943]; protein localization to nucleolus [GO:1902570]; ribosomal small subunit biogenesis [GO:0042274]; rRNA metabolic process [GO:0016072] 90S preribosome [GO:0030686]; fibrillar center [GO:0001650]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; small-subunit processome [GO:0032040]; t-UTP complex [GO:0034455] RNA binding [GO:0003723]; snoRNA binding [GO:0030515] g1646.t1 Q9H583 43.127 1113 0.0 741.0 sp|Q9H583|HEAT1_HUMAN HEAT repeat-containing protein 1 OS=Homo sapiens OX=9606 GN=HEATR1 PE=1 SV=3 HEAT1_HUMAN reviewed HEAT repeat-containing protein 1 (Protein BAP28) (U3 small nucleolar RNA-associated protein 10 homolog) [Cleaved into: HEAT repeat-containing protein 1, N-terminally processed] Homo sapiens (Human) GO:0000462; GO:0001650; GO:0003723; GO:0005654; GO:0005730; GO:0005739; GO:0016020; GO:0016072; GO:0030515; GO:0030686; GO:0032040; GO:0034455; GO:0042274; GO:0045943; GO:0061351; GO:1902570; GO:2000234 maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; neural precursor cell proliferation [GO:0061351]; positive regulation of rRNA processing [GO:2000234]; positive regulation of transcription by RNA polymerase I [GO:0045943]; protein localization to nucleolus [GO:1902570]; ribosomal small subunit biogenesis [GO:0042274]; rRNA metabolic process [GO:0016072] 90S preribosome [GO:0030686]; fibrillar center [GO:0001650]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; small-subunit processome [GO:0032040]; t-UTP complex [GO:0034455] RNA binding [GO:0003723]; snoRNA binding [GO:0030515] g1651.t1 Q9UGM3 48.727 275 5.33e-72 244.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g1651.t1 Q9UGM3 46.552 290 6.1e-72 244.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g1651.t1 Q9UGM3 46.207 290 5.13e-71 242.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g1651.t1 Q9UGM3 48.529 272 1.19e-69 238.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g1651.t1 Q9UGM3 46.233 292 1.2299999999999999e-69 238.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g1651.t1 Q9UGM3 45.548 292 1.8499999999999999e-69 237.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g1651.t1 Q9UGM3 45.392 293 7.53e-69 236.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g1651.t1 Q9UGM3 51.037 241 3.59e-64 222.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g1651.t1 Q9UGM3 35.231 281 1.29e-32 131.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g1651.t1 Q9UGM3 53.922 102 3.3300000000000003e-26 112.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g1651.t1 Q9UGM3 50.485 103 1.0600000000000001e-21 99.4 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g1652.t1 Q9UGM3 44.836 1249 0.0 912.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g1652.t1 Q9UGM3 42.552 1356 0.0 910.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g1652.t1 Q9UGM3 42.68 1291 0.0 859.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g1652.t1 Q9UGM3 38.738 1252 0.0 707.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g1652.t1 Q9UGM3 42.288 953 0.0 647.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g1652.t1 Q9UGM3 44.651 645 1.03e-139 470.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g1652.t1 Q9UGM3 40.167 717 4.3600000000000005e-124 424.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g1652.t1 Q9UGM3 40.847 590 6.46e-105 367.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g1652.t1 Q9UGM3 59.783 92 3.4299999999999996e-23 111.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g1653.t1 Q9UBW7 29.231 260 2.2100000000000003e-21 100.0 sp|Q9UBW7|ZMYM2_HUMAN Zinc finger MYM-type protein 2 OS=Homo sapiens OX=9606 GN=ZMYM2 PE=1 SV=1 ZMYM2_HUMAN reviewed Zinc finger MYM-type protein 2 (Fused in myeloproliferative disorders protein) (Rearranged in atypical myeloproliferative disorder protein) (Zinc finger protein 198) Homo sapiens (Human) GO:0005634; GO:0005829; GO:0008270; GO:0016605; GO:0031624; GO:0045892 negative regulation of DNA-templated transcription [GO:0045892] cytosol [GO:0005829]; nucleus [GO:0005634]; PML body [GO:0016605] ubiquitin conjugating enzyme binding [GO:0031624]; zinc ion binding [GO:0008270] g1656.t1 Q0R4F1 53.229 573 0.0 609.0 sp|Q0R4F1|PIF1_XENLA ATP-dependent DNA helicase PIF1 OS=Xenopus laevis OX=8355 GN=pif1 PE=2 SV=1 PIF1_XENLA reviewed ATP-dependent DNA helicase PIF1 (EC 5.6.2.3) (DNA 5'-3' helicase PIF1) (DNA repair and recombination helicase PIF1) Xenopus laevis (African clawed frog) GO:0000723; GO:0003677; GO:0005524; GO:0005634; GO:0005739; GO:0006281; GO:0006310; GO:0016887; GO:0043139 DNA recombination [GO:0006310]; DNA repair [GO:0006281]; telomere maintenance [GO:0000723] mitochondrion [GO:0005739]; nucleus [GO:0005634] 5'-3' DNA helicase activity [GO:0043139]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA binding [GO:0003677] g1657.t1 Q6DI40 51.741 201 7.819999999999999e-54 187.0 sp|Q6DI40|TTC33_DANRE Tetratricopeptide repeat protein 33 OS=Danio rerio OX=7955 GN=ttc33 PE=2 SV=1 g1658.t1 Q9JI69 61.916 407 9.93e-150 464.0 sp|Q9JI69|ORC1_CRIGR Origin recognition complex subunit 1 OS=Cricetulus griseus OX=10029 GN=ORC1 PE=2 SV=1 g1660.t1 Q5RDD2 81.768 181 2.86e-108 322.0 sp|Q5RDD2|PR38A_PONAB Pre-mRNA-splicing factor 38A OS=Pongo abelii OX=9601 GN=PRPF38A PE=2 SV=1 g1663.t1 Q8IY84 66.391 363 1.26e-175 501.0 sp|Q8IY84|NIM1_HUMAN Serine/threonine-protein kinase NIM1 OS=Homo sapiens OX=9606 GN=NIM1K PE=1 SV=1 NIM1_HUMAN reviewed Serine/threonine-protein kinase NIM1 (EC 2.7.11.1) (NIM1 serine/threonine-protein kinase) Homo sapiens (Human) GO:0000287; GO:0004674; GO:0005524; GO:0006468; GO:0035556; GO:0106310 intracellular signal transduction [GO:0035556]; protein phosphorylation [GO:0006468] ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g1664.t1 Q7ZWX9 39.206 403 3.93e-59 203.0 sp|Q7ZWX9|MIDNB_XENLA Midnolin-B OS=Xenopus laevis OX=8355 GN=midn-b PE=2 SV=1 g1667.t1 Q1JPB9 38.251 183 3.54e-33 132.0 sp|Q1JPB9|PA2G3_BOVIN Group 3 secretory phospholipase A2 OS=Bos taurus OX=9913 GN=PLA2G3 PE=2 SV=1 PA2G3_BOVIN reviewed Group 3 secretory phospholipase A2 (EC 3.1.1.4) (Group III secretory phospholipase A2) (GIII sPLA2) (sPLA2-III) (Phosphatidylcholine 2-acylhydrolase 3) Bos taurus (Bovine) GO:0005576; GO:0005814; GO:0005886; GO:0006658; GO:0010629; GO:0010744; GO:0010976; GO:0031394; GO:0034374; GO:0034375; GO:0043303; GO:0043524; GO:0046337; GO:0046470; GO:0046471; GO:0046473; GO:0046488; GO:0046872; GO:0047498; GO:0050482; GO:0055037; GO:0060271; GO:1903595; GO:2001135 arachidonate secretion [GO:0050482]; cilium assembly [GO:0060271]; high-density lipoprotein particle remodeling [GO:0034375]; low-density lipoprotein particle remodeling [GO:0034374]; mast cell degranulation [GO:0043303]; negative regulation of gene expression [GO:0010629]; negative regulation of neuron apoptotic process [GO:0043524]; phosphatidic acid metabolic process [GO:0046473]; phosphatidylcholine metabolic process [GO:0046470]; phosphatidylethanolamine metabolic process [GO:0046337]; phosphatidylglycerol metabolic process [GO:0046471]; phosphatidylinositol metabolic process [GO:0046488]; phosphatidylserine metabolic process [GO:0006658]; positive regulation of histamine secretion by mast cell [GO:1903595]; positive regulation of macrophage derived foam cell differentiation [GO:0010744]; positive regulation of neuron projection development [GO:0010976]; positive regulation of prostaglandin biosynthetic process [GO:0031394]; regulation of endocytic recycling [GO:2001135] centriole [GO:0005814]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037] calcium-dependent phospholipase A2 activity [GO:0047498]; metal ion binding [GO:0046872] g1668.t1 Q9QZU7 31.429 385 4.2500000000000006e-59 202.0 sp|Q9QZU7|BODG_RAT Gamma-butyrobetaine dioxygenase OS=Rattus norvegicus OX=10116 GN=Bbox1 PE=1 SV=1 g1669.t1 Q9Z254 72.897 107 2.89e-50 167.0 sp|Q9Z254|GIPC1_RAT PDZ domain-containing protein GIPC1 OS=Rattus norvegicus OX=10116 GN=Gipc1 PE=1 SV=2 GIPC1_RAT reviewed PDZ domain-containing protein GIPC1 (GAIP C-terminus-interacting protein) (GLUT1 C-terminal-binding protein) (GLUT1CBP) (RGS-GAIP-interacting protein) (RGS19-interacting protein 1) (Synectin) Rattus norvegicus (Rat) GO:0003779; GO:0005102; GO:0005737; GO:0005829; GO:0005903; GO:0005938; GO:0006605; GO:0007268; GO:0008021; GO:0012506; GO:0014047; GO:0016020; GO:0017022; GO:0030139; GO:0030165; GO:0030511; GO:0031410; GO:0031647; GO:0032435; GO:0032467; GO:0042802; GO:0043197; GO:0043198; GO:0043542; GO:0048023; GO:0048167; GO:0098685; GO:0098761; GO:0098793; GO:0098794; GO:0098978; GO:0099171 cellular response to interleukin-7 [GO:0098761]; chemical synaptic transmission [GO:0007268]; endothelial cell migration [GO:0043542]; glutamate secretion [GO:0014047]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; positive regulation of cytokinesis [GO:0032467]; positive regulation of melanin biosynthetic process [GO:0048023]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; presynaptic modulation of chemical synaptic transmission [GO:0099171]; protein targeting [GO:0006605]; regulation of protein stability [GO:0031647]; regulation of synaptic plasticity [GO:0048167] brush border [GO:0005903]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; endocytic vesicle [GO:0030139]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; postsynapse [GO:0098794]; presynapse [GO:0098793]; Schaffer collateral - CA1 synapse [GO:0098685]; synaptic vesicle [GO:0008021]; vesicle membrane [GO:0012506] actin binding [GO:0003779]; identical protein binding [GO:0042802]; myosin binding [GO:0017022]; PDZ domain binding [GO:0030165]; signaling receptor binding [GO:0005102] g1670.t1 Q9Z254 49.032 155 2.3100000000000002e-29 112.0 sp|Q9Z254|GIPC1_RAT PDZ domain-containing protein GIPC1 OS=Rattus norvegicus OX=10116 GN=Gipc1 PE=1 SV=2 GIPC1_RAT reviewed PDZ domain-containing protein GIPC1 (GAIP C-terminus-interacting protein) (GLUT1 C-terminal-binding protein) (GLUT1CBP) (RGS-GAIP-interacting protein) (RGS19-interacting protein 1) (Synectin) Rattus norvegicus (Rat) GO:0003779; GO:0005102; GO:0005737; GO:0005829; GO:0005903; GO:0005938; GO:0006605; GO:0007268; GO:0008021; GO:0012506; GO:0014047; GO:0016020; GO:0017022; GO:0030139; GO:0030165; GO:0030511; GO:0031410; GO:0031647; GO:0032435; GO:0032467; GO:0042802; GO:0043197; GO:0043198; GO:0043542; GO:0048023; GO:0048167; GO:0098685; GO:0098761; GO:0098793; GO:0098794; GO:0098978; GO:0099171 cellular response to interleukin-7 [GO:0098761]; chemical synaptic transmission [GO:0007268]; endothelial cell migration [GO:0043542]; glutamate secretion [GO:0014047]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; positive regulation of cytokinesis [GO:0032467]; positive regulation of melanin biosynthetic process [GO:0048023]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; presynaptic modulation of chemical synaptic transmission [GO:0099171]; protein targeting [GO:0006605]; regulation of protein stability [GO:0031647]; regulation of synaptic plasticity [GO:0048167] brush border [GO:0005903]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; endocytic vesicle [GO:0030139]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; postsynapse [GO:0098794]; presynapse [GO:0098793]; Schaffer collateral - CA1 synapse [GO:0098685]; synaptic vesicle [GO:0008021]; vesicle membrane [GO:0012506] actin binding [GO:0003779]; identical protein binding [GO:0042802]; myosin binding [GO:0017022]; PDZ domain binding [GO:0030165]; signaling receptor binding [GO:0005102] g1677.t1 Q6NRG6 45.817 502 7.68e-127 391.0 sp|Q6NRG6|SAS6_XENLA Spindle assembly abnormal protein 6 homolog OS=Xenopus laevis OX=8355 GN=sas6 PE=2 SV=1 g1678.t1 P13623 47.807 456 2.55e-114 353.0 sp|P13623|NFIX_MESAU Nuclear factor 1 X-type OS=Mesocricetus auratus OX=10036 GN=NFIX PE=2 SV=1 g1679.t1 B1H1H3 40.873 252 6.0099999999999995e-55 182.0 sp|B1H1H3|ZDH21_DANRE Palmitoyltransferase ZDHHC21 OS=Danio rerio OX=7955 GN=zdhhc21 PE=2 SV=2 ZDH21_DANRE reviewed Palmitoyltransferase ZDHHC21 (EC 2.3.1.225) (DHHC domain-containing cysteine-rich protein 21) (Zinc finger DHHC domain-containing protein 21) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000139; GO:0005783; GO:0005794; GO:0005886; GO:0006612; GO:0018230; GO:0019706 peptidyl-L-cysteine S-palmitoylation [GO:0018230]; protein targeting to membrane [GO:0006612] endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886] protein-cysteine S-palmitoyltransferase activity [GO:0019706] g1680.t1 Q8AXY6 36.213 845 6.95e-159 494.0 sp|Q8AXY6|MUSK_CHICK Muscle, skeletal receptor tyrosine protein kinase OS=Gallus gallus OX=9031 GN=MUSK PE=2 SV=1 MUSK_CHICK reviewed Muscle, skeletal receptor tyrosine protein kinase (EC 2.7.10.1) (Muscle-specific tyrosine protein kinase receptor) (MuSK) (Muscle-specific kinase receptor) Gallus gallus (Chicken) GO:0004714; GO:0005524; GO:0005886; GO:0007169; GO:0007528; GO:0008582; GO:0010604; GO:0017147; GO:0030154; GO:0043235; GO:0045211 cell differentiation [GO:0030154]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; neuromuscular junction development [GO:0007528]; positive regulation of macromolecule metabolic process [GO:0010604]; regulation of synaptic assembly at neuromuscular junction [GO:0008582] plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; receptor complex [GO:0043235] ATP binding [GO:0005524]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; Wnt-protein binding [GO:0017147] g1681.t1 O73791 34.471 293 2.66e-35 145.0 sp|O73791|TIE2_DANRE Angiopoietin-1 receptor OS=Danio rerio OX=7955 GN=tek PE=1 SV=1 g1682.t1 O14522 51.299 154 6.09e-39 153.0 sp|O14522|PTPRT_HUMAN Receptor-type tyrosine-protein phosphatase T OS=Homo sapiens OX=9606 GN=PTPRT PE=1 SV=6 PTPRT_HUMAN reviewed Receptor-type tyrosine-protein phosphatase T (R-PTP-T) (EC 3.1.3.48) (Receptor-type tyrosine-protein phosphatase rho) (RPTP-rho) Homo sapiens (Human) GO:0004725; GO:0005001; GO:0005886; GO:0006470; GO:0007155; GO:0007156; GO:0007165; GO:0007169; GO:0008013; GO:0009986; GO:0016020; GO:0016790; GO:0019903; GO:0030336; GO:0031175; GO:0042803; GO:0045294; GO:0045295; GO:0045296; GO:0051393; GO:0070097; GO:0071354; GO:0097677; GO:1904893 cell adhesion [GO:0007155]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; cellular response to interleukin-6 [GO:0071354]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell migration [GO:0030336]; negative regulation of receptor signaling pathway via STAT [GO:1904893]; neuron projection development [GO:0031175]; protein dephosphorylation [GO:0006470]; signal transduction [GO:0007165] cell surface [GO:0009986]; membrane [GO:0016020]; plasma membrane [GO:0005886] alpha-actinin binding [GO:0051393]; alpha-catenin binding [GO:0045294]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; delta-catenin binding [GO:0070097]; gamma-catenin binding [GO:0045295]; protein homodimerization activity [GO:0042803]; protein phosphatase binding [GO:0019903]; protein tyrosine phosphatase activity [GO:0004725]; STAT family protein binding [GO:0097677]; thiolester hydrolase activity [GO:0016790]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001] g1682.t1 O14522 37.931 29 6.09e-39 32.0 sp|O14522|PTPRT_HUMAN Receptor-type tyrosine-protein phosphatase T OS=Homo sapiens OX=9606 GN=PTPRT PE=1 SV=6 PTPRT_HUMAN reviewed Receptor-type tyrosine-protein phosphatase T (R-PTP-T) (EC 3.1.3.48) (Receptor-type tyrosine-protein phosphatase rho) (RPTP-rho) Homo sapiens (Human) GO:0004725; GO:0005001; GO:0005886; GO:0006470; GO:0007155; GO:0007156; GO:0007165; GO:0007169; GO:0008013; GO:0009986; GO:0016020; GO:0016790; GO:0019903; GO:0030336; GO:0031175; GO:0042803; GO:0045294; GO:0045295; GO:0045296; GO:0051393; GO:0070097; GO:0071354; GO:0097677; GO:1904893 cell adhesion [GO:0007155]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; cellular response to interleukin-6 [GO:0071354]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell migration [GO:0030336]; negative regulation of receptor signaling pathway via STAT [GO:1904893]; neuron projection development [GO:0031175]; protein dephosphorylation [GO:0006470]; signal transduction [GO:0007165] cell surface [GO:0009986]; membrane [GO:0016020]; plasma membrane [GO:0005886] alpha-actinin binding [GO:0051393]; alpha-catenin binding [GO:0045294]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; delta-catenin binding [GO:0070097]; gamma-catenin binding [GO:0045295]; protein homodimerization activity [GO:0042803]; protein phosphatase binding [GO:0019903]; protein tyrosine phosphatase activity [GO:0004725]; STAT family protein binding [GO:0097677]; thiolester hydrolase activity [GO:0016790]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001] g1683.t1 Q99M80 30.579 363 2.86e-49 179.0 sp|Q99M80|PTPRT_MOUSE Receptor-type tyrosine-protein phosphatase T OS=Mus musculus OX=10090 GN=Ptprt PE=1 SV=2 g1684.t1 Q06806 34.574 188 1.2600000000000002e-21 105.0 sp|Q06806|TIE1_MOUSE Tyrosine-protein kinase receptor Tie-1 OS=Mus musculus OX=10090 GN=Tie1 PE=1 SV=3 TIE1_MOUSE reviewed Tyrosine-protein kinase receptor Tie-1 (EC 2.7.10.1) Mus musculus (Mouse) GO:0001525; GO:0001568; GO:0001570; GO:0001701; GO:0001936; GO:0003180; GO:0004714; GO:0005524; GO:0005886; GO:0007169; GO:0016020; GO:0016525; GO:0030336; GO:0032526; GO:0043235; GO:0045026; GO:0045766; GO:0048771; GO:0060836; GO:0060854; GO:1901201 angiogenesis [GO:0001525]; aortic valve morphogenesis [GO:0003180]; blood vessel development [GO:0001568]; branching involved in lymph vessel morphogenesis [GO:0060854]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; in utero embryonic development [GO:0001701]; lymphatic endothelial cell differentiation [GO:0060836]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell migration [GO:0030336]; plasma membrane fusion [GO:0045026]; positive regulation of angiogenesis [GO:0045766]; regulation of endothelial cell proliferation [GO:0001936]; regulation of extracellular matrix assembly [GO:1901201]; response to retinoic acid [GO:0032526]; tissue remodeling [GO:0048771]; vasculogenesis [GO:0001570] membrane [GO:0016020]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] ATP binding [GO:0005524]; transmembrane receptor protein tyrosine kinase activity [GO:0004714] g1685.t1 O73791 33.438 320 7.509999999999999e-34 142.0 sp|O73791|TIE2_DANRE Angiopoietin-1 receptor OS=Danio rerio OX=7955 GN=tek PE=1 SV=1 g1686.t1 O14522 37.851 605 2.71e-130 436.0 sp|O14522|PTPRT_HUMAN Receptor-type tyrosine-protein phosphatase T OS=Homo sapiens OX=9606 GN=PTPRT PE=1 SV=6 PTPRT_HUMAN reviewed Receptor-type tyrosine-protein phosphatase T (R-PTP-T) (EC 3.1.3.48) (Receptor-type tyrosine-protein phosphatase rho) (RPTP-rho) Homo sapiens (Human) GO:0004725; GO:0005001; GO:0005886; GO:0006470; GO:0007155; GO:0007156; GO:0007165; GO:0007169; GO:0008013; GO:0009986; GO:0016020; GO:0016790; GO:0019903; GO:0030336; GO:0031175; GO:0042803; GO:0045294; GO:0045295; GO:0045296; GO:0051393; GO:0070097; GO:0071354; GO:0097677; GO:1904893 cell adhesion [GO:0007155]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; cellular response to interleukin-6 [GO:0071354]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell migration [GO:0030336]; negative regulation of receptor signaling pathway via STAT [GO:1904893]; neuron projection development [GO:0031175]; protein dephosphorylation [GO:0006470]; signal transduction [GO:0007165] cell surface [GO:0009986]; membrane [GO:0016020]; plasma membrane [GO:0005886] alpha-actinin binding [GO:0051393]; alpha-catenin binding [GO:0045294]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; delta-catenin binding [GO:0070097]; gamma-catenin binding [GO:0045295]; protein homodimerization activity [GO:0042803]; protein phosphatase binding [GO:0019903]; protein tyrosine phosphatase activity [GO:0004725]; STAT family protein binding [GO:0097677]; thiolester hydrolase activity [GO:0016790]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001] g1694.t1 O14522 31.395 344 1.3099999999999998e-55 199.0 sp|O14522|PTPRT_HUMAN Receptor-type tyrosine-protein phosphatase T OS=Homo sapiens OX=9606 GN=PTPRT PE=1 SV=6 PTPRT_HUMAN reviewed Receptor-type tyrosine-protein phosphatase T (R-PTP-T) (EC 3.1.3.48) (Receptor-type tyrosine-protein phosphatase rho) (RPTP-rho) Homo sapiens (Human) GO:0004725; GO:0005001; GO:0005886; GO:0006470; GO:0007155; GO:0007156; GO:0007165; GO:0007169; GO:0008013; GO:0009986; GO:0016020; GO:0016790; GO:0019903; GO:0030336; GO:0031175; GO:0042803; GO:0045294; GO:0045295; GO:0045296; GO:0051393; GO:0070097; GO:0071354; GO:0097677; GO:1904893 cell adhesion [GO:0007155]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; cellular response to interleukin-6 [GO:0071354]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell migration [GO:0030336]; negative regulation of receptor signaling pathway via STAT [GO:1904893]; neuron projection development [GO:0031175]; protein dephosphorylation [GO:0006470]; signal transduction [GO:0007165] cell surface [GO:0009986]; membrane [GO:0016020]; plasma membrane [GO:0005886] alpha-actinin binding [GO:0051393]; alpha-catenin binding [GO:0045294]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; delta-catenin binding [GO:0070097]; gamma-catenin binding [GO:0045295]; protein homodimerization activity [GO:0042803]; protein phosphatase binding [GO:0019903]; protein tyrosine phosphatase activity [GO:0004725]; STAT family protein binding [GO:0097677]; thiolester hydrolase activity [GO:0016790]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001] g1694.t1 O14522 28.03 264 1.0800000000000001e-26 115.0 sp|O14522|PTPRT_HUMAN Receptor-type tyrosine-protein phosphatase T OS=Homo sapiens OX=9606 GN=PTPRT PE=1 SV=6 PTPRT_HUMAN reviewed Receptor-type tyrosine-protein phosphatase T (R-PTP-T) (EC 3.1.3.48) (Receptor-type tyrosine-protein phosphatase rho) (RPTP-rho) Homo sapiens (Human) GO:0004725; GO:0005001; GO:0005886; GO:0006470; GO:0007155; GO:0007156; GO:0007165; GO:0007169; GO:0008013; GO:0009986; GO:0016020; GO:0016790; GO:0019903; GO:0030336; GO:0031175; GO:0042803; GO:0045294; GO:0045295; GO:0045296; GO:0051393; GO:0070097; GO:0071354; GO:0097677; GO:1904893 cell adhesion [GO:0007155]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; cellular response to interleukin-6 [GO:0071354]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell migration [GO:0030336]; negative regulation of receptor signaling pathway via STAT [GO:1904893]; neuron projection development [GO:0031175]; protein dephosphorylation [GO:0006470]; signal transduction [GO:0007165] cell surface [GO:0009986]; membrane [GO:0016020]; plasma membrane [GO:0005886] alpha-actinin binding [GO:0051393]; alpha-catenin binding [GO:0045294]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; delta-catenin binding [GO:0070097]; gamma-catenin binding [GO:0045295]; protein homodimerization activity [GO:0042803]; protein phosphatase binding [GO:0019903]; protein tyrosine phosphatase activity [GO:0004725]; STAT family protein binding [GO:0097677]; thiolester hydrolase activity [GO:0016790]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001] g1699.t1 O14522 38.739 555 6.330000000000001e-122 419.0 sp|O14522|PTPRT_HUMAN Receptor-type tyrosine-protein phosphatase T OS=Homo sapiens OX=9606 GN=PTPRT PE=1 SV=6 PTPRT_HUMAN reviewed Receptor-type tyrosine-protein phosphatase T (R-PTP-T) (EC 3.1.3.48) (Receptor-type tyrosine-protein phosphatase rho) (RPTP-rho) Homo sapiens (Human) GO:0004725; GO:0005001; GO:0005886; GO:0006470; GO:0007155; GO:0007156; GO:0007165; GO:0007169; GO:0008013; GO:0009986; GO:0016020; GO:0016790; GO:0019903; GO:0030336; GO:0031175; GO:0042803; GO:0045294; GO:0045295; GO:0045296; GO:0051393; GO:0070097; GO:0071354; GO:0097677; GO:1904893 cell adhesion [GO:0007155]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; cellular response to interleukin-6 [GO:0071354]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell migration [GO:0030336]; negative regulation of receptor signaling pathway via STAT [GO:1904893]; neuron projection development [GO:0031175]; protein dephosphorylation [GO:0006470]; signal transduction [GO:0007165] cell surface [GO:0009986]; membrane [GO:0016020]; plasma membrane [GO:0005886] alpha-actinin binding [GO:0051393]; alpha-catenin binding [GO:0045294]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; delta-catenin binding [GO:0070097]; gamma-catenin binding [GO:0045295]; protein homodimerization activity [GO:0042803]; protein phosphatase binding [GO:0019903]; protein tyrosine phosphatase activity [GO:0004725]; STAT family protein binding [GO:0097677]; thiolester hydrolase activity [GO:0016790]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001] g1699.t1 O14522 30.165 242 2.24e-26 122.0 sp|O14522|PTPRT_HUMAN Receptor-type tyrosine-protein phosphatase T OS=Homo sapiens OX=9606 GN=PTPRT PE=1 SV=6 PTPRT_HUMAN reviewed Receptor-type tyrosine-protein phosphatase T (R-PTP-T) (EC 3.1.3.48) (Receptor-type tyrosine-protein phosphatase rho) (RPTP-rho) Homo sapiens (Human) GO:0004725; GO:0005001; GO:0005886; GO:0006470; GO:0007155; GO:0007156; GO:0007165; GO:0007169; GO:0008013; GO:0009986; GO:0016020; GO:0016790; GO:0019903; GO:0030336; GO:0031175; GO:0042803; GO:0045294; GO:0045295; GO:0045296; GO:0051393; GO:0070097; GO:0071354; GO:0097677; GO:1904893 cell adhesion [GO:0007155]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; cellular response to interleukin-6 [GO:0071354]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell migration [GO:0030336]; negative regulation of receptor signaling pathway via STAT [GO:1904893]; neuron projection development [GO:0031175]; protein dephosphorylation [GO:0006470]; signal transduction [GO:0007165] cell surface [GO:0009986]; membrane [GO:0016020]; plasma membrane [GO:0005886] alpha-actinin binding [GO:0051393]; alpha-catenin binding [GO:0045294]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; delta-catenin binding [GO:0070097]; gamma-catenin binding [GO:0045295]; protein homodimerization activity [GO:0042803]; protein phosphatase binding [GO:0019903]; protein tyrosine phosphatase activity [GO:0004725]; STAT family protein binding [GO:0097677]; thiolester hydrolase activity [GO:0016790]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001] g1699.t1 O14522 28.727 275 6.9899999999999995e-25 117.0 sp|O14522|PTPRT_HUMAN Receptor-type tyrosine-protein phosphatase T OS=Homo sapiens OX=9606 GN=PTPRT PE=1 SV=6 PTPRT_HUMAN reviewed Receptor-type tyrosine-protein phosphatase T (R-PTP-T) (EC 3.1.3.48) (Receptor-type tyrosine-protein phosphatase rho) (RPTP-rho) Homo sapiens (Human) GO:0004725; GO:0005001; GO:0005886; GO:0006470; GO:0007155; GO:0007156; GO:0007165; GO:0007169; GO:0008013; GO:0009986; GO:0016020; GO:0016790; GO:0019903; GO:0030336; GO:0031175; GO:0042803; GO:0045294; GO:0045295; GO:0045296; GO:0051393; GO:0070097; GO:0071354; GO:0097677; GO:1904893 cell adhesion [GO:0007155]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; cellular response to interleukin-6 [GO:0071354]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell migration [GO:0030336]; negative regulation of receptor signaling pathway via STAT [GO:1904893]; neuron projection development [GO:0031175]; protein dephosphorylation [GO:0006470]; signal transduction [GO:0007165] cell surface [GO:0009986]; membrane [GO:0016020]; plasma membrane [GO:0005886] alpha-actinin binding [GO:0051393]; alpha-catenin binding [GO:0045294]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; delta-catenin binding [GO:0070097]; gamma-catenin binding [GO:0045295]; protein homodimerization activity [GO:0042803]; protein phosphatase binding [GO:0019903]; protein tyrosine phosphatase activity [GO:0004725]; STAT family protein binding [GO:0097677]; thiolester hydrolase activity [GO:0016790]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001] g1704.t1 A2VE55 57.98 307 3.0700000000000003e-125 366.0 sp|A2VE55|S35D2_BOVIN Nucleotide sugar transporter SLC35D2 OS=Bos taurus OX=9913 GN=SLC35D2 PE=2 SV=1 S35D2_BOVIN reviewed Nucleotide sugar transporter SLC35D2 (Solute carrier family 35 member D2) Bos taurus (Bovine) GO:0000139; GO:0005338; GO:0005461; GO:0005462; GO:0005463; GO:0005783; GO:0005794; GO:0015012; GO:0015297; GO:0015780; GO:0048706; GO:0050650 chondroitin sulfate proteoglycan biosynthetic process [GO:0050650]; embryonic skeletal system development [GO:0048706]; heparan sulfate proteoglycan biosynthetic process [GO:0015012]; nucleotide-sugar transmembrane transport [GO:0015780] endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139] antiporter activity [GO:0015297]; nucleotide-sugar transmembrane transporter activity [GO:0005338]; UDP-glucuronate transmembrane transporter activity [GO:0005461]; UDP-N-acetylgalactosamine transmembrane transporter activity [GO:0005463]; UDP-N-acetylglucosamine transmembrane transporter activity [GO:0005462] g1704.t2 A2VE55 57.98 307 6.07e-125 367.0 sp|A2VE55|S35D2_BOVIN Nucleotide sugar transporter SLC35D2 OS=Bos taurus OX=9913 GN=SLC35D2 PE=2 SV=1 S35D2_BOVIN reviewed Nucleotide sugar transporter SLC35D2 (Solute carrier family 35 member D2) Bos taurus (Bovine) GO:0000139; GO:0005338; GO:0005461; GO:0005462; GO:0005463; GO:0005783; GO:0005794; GO:0015012; GO:0015297; GO:0015780; GO:0048706; GO:0050650 chondroitin sulfate proteoglycan biosynthetic process [GO:0050650]; embryonic skeletal system development [GO:0048706]; heparan sulfate proteoglycan biosynthetic process [GO:0015012]; nucleotide-sugar transmembrane transport [GO:0015780] endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139] antiporter activity [GO:0015297]; nucleotide-sugar transmembrane transporter activity [GO:0005338]; UDP-glucuronate transmembrane transporter activity [GO:0005461]; UDP-N-acetylgalactosamine transmembrane transporter activity [GO:0005463]; UDP-N-acetylglucosamine transmembrane transporter activity [GO:0005462] g1705.t1 B6MFW3 53.736 348 1.05e-105 330.0 sp|B6MFW3|HOOK_BRAFL Protein Hook homolog OS=Branchiostoma floridae OX=7739 GN=BRAFLDRAFT_281537 PE=3 SV=1 g1705.t2 B6MFW3 55.102 343 1.83e-109 339.0 sp|B6MFW3|HOOK_BRAFL Protein Hook homolog OS=Branchiostoma floridae OX=7739 GN=BRAFLDRAFT_281537 PE=3 SV=1 g1706.t1 Q86VS8 57.049 305 2.6499999999999998e-115 352.0 sp|Q86VS8|HOOK3_HUMAN Protein Hook homolog 3 OS=Homo sapiens OX=9606 GN=HOOK3 PE=1 SV=2 HOOK3_HUMAN reviewed Protein Hook homolog 3 (h-hook3) (hHK3) Homo sapiens (Human) GO:0000242; GO:0005737; GO:0005801; GO:0005813; GO:0005874; GO:0007032; GO:0007040; GO:0008017; GO:0008333; GO:0015031; GO:0022027; GO:0030705; GO:0031122; GO:0034451; GO:0034452; GO:0034454; GO:0042802; GO:0045022; GO:0045503; GO:0045505; GO:0050768; GO:0051645; GO:0051959; GO:0070695; GO:0071539; GO:0097150; GO:1905719 cytoplasmic microtubule organization [GO:0031122]; cytoskeleton-dependent intracellular transport [GO:0030705]; early endosome to late endosome transport [GO:0045022]; endosome organization [GO:0007032]; endosome to lysosome transport [GO:0008333]; Golgi localization [GO:0051645]; interkinetic nuclear migration [GO:0022027]; lysosome organization [GO:0007040]; microtubule anchoring at centrosome [GO:0034454]; negative regulation of neurogenesis [GO:0050768]; neuronal stem cell population maintenance [GO:0097150]; protein localization to centrosome [GO:0071539]; protein localization to perinuclear region of cytoplasm [GO:1905719]; protein transport [GO:0015031] centriolar satellite [GO:0034451]; centrosome [GO:0005813]; cis-Golgi network [GO:0005801]; cytoplasm [GO:0005737]; FHF complex [GO:0070695]; microtubule [GO:0005874]; pericentriolar material [GO:0000242] dynactin binding [GO:0034452]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017] g1706.t2 Q86VS8 55.063 316 5.98e-112 343.0 sp|Q86VS8|HOOK3_HUMAN Protein Hook homolog 3 OS=Homo sapiens OX=9606 GN=HOOK3 PE=1 SV=2 HOOK3_HUMAN reviewed Protein Hook homolog 3 (h-hook3) (hHK3) Homo sapiens (Human) GO:0000242; GO:0005737; GO:0005801; GO:0005813; GO:0005874; GO:0007032; GO:0007040; GO:0008017; GO:0008333; GO:0015031; GO:0022027; GO:0030705; GO:0031122; GO:0034451; GO:0034452; GO:0034454; GO:0042802; GO:0045022; GO:0045503; GO:0045505; GO:0050768; GO:0051645; GO:0051959; GO:0070695; GO:0071539; GO:0097150; GO:1905719 cytoplasmic microtubule organization [GO:0031122]; cytoskeleton-dependent intracellular transport [GO:0030705]; early endosome to late endosome transport [GO:0045022]; endosome organization [GO:0007032]; endosome to lysosome transport [GO:0008333]; Golgi localization [GO:0051645]; interkinetic nuclear migration [GO:0022027]; lysosome organization [GO:0007040]; microtubule anchoring at centrosome [GO:0034454]; negative regulation of neurogenesis [GO:0050768]; neuronal stem cell population maintenance [GO:0097150]; protein localization to centrosome [GO:0071539]; protein localization to perinuclear region of cytoplasm [GO:1905719]; protein transport [GO:0015031] centriolar satellite [GO:0034451]; centrosome [GO:0005813]; cis-Golgi network [GO:0005801]; cytoplasm [GO:0005737]; FHF complex [GO:0070695]; microtubule [GO:0005874]; pericentriolar material [GO:0000242] dynactin binding [GO:0034452]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017] g1707.t1 Q28DS3 50.397 252 1.03e-76 236.0 sp|Q28DS3|RN170_XENTR E3 ubiquitin-protein ligase RNF170 OS=Xenopus tropicalis OX=8364 GN=rnf170 PE=2 SV=1 g1708.t1 Q9UPU5 44.423 1058 0.0 820.0 sp|Q9UPU5|UBP24_HUMAN Ubiquitin carboxyl-terminal hydrolase 24 OS=Homo sapiens OX=9606 GN=USP24 PE=1 SV=3 UBP24_HUMAN reviewed Ubiquitin carboxyl-terminal hydrolase 24 (EC 3.4.19.12) (Deubiquitinating enzyme 24) (Ubiquitin thioesterase 24) (Ubiquitin-specific-processing protease 24) Homo sapiens (Human) GO:0004843; GO:0005634; GO:0005654; GO:0005829; GO:0006508; GO:0016579; GO:0031647 protein deubiquitination [GO:0016579]; proteolysis [GO:0006508]; regulation of protein stability [GO:0031647] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cysteine-type deubiquitinase activity [GO:0004843] g1709.t1 Q9UPU5 46.68 1521 0.0 1243.0 sp|Q9UPU5|UBP24_HUMAN Ubiquitin carboxyl-terminal hydrolase 24 OS=Homo sapiens OX=9606 GN=USP24 PE=1 SV=3 UBP24_HUMAN reviewed Ubiquitin carboxyl-terminal hydrolase 24 (EC 3.4.19.12) (Deubiquitinating enzyme 24) (Ubiquitin thioesterase 24) (Ubiquitin-specific-processing protease 24) Homo sapiens (Human) GO:0004843; GO:0005634; GO:0005654; GO:0005829; GO:0006508; GO:0016579; GO:0031647 protein deubiquitination [GO:0016579]; proteolysis [GO:0006508]; regulation of protein stability [GO:0031647] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cysteine-type deubiquitinase activity [GO:0004843] g1709.t2 Q9UPU5 46.074 1452 0.0 1157.0 sp|Q9UPU5|UBP24_HUMAN Ubiquitin carboxyl-terminal hydrolase 24 OS=Homo sapiens OX=9606 GN=USP24 PE=1 SV=3 UBP24_HUMAN reviewed Ubiquitin carboxyl-terminal hydrolase 24 (EC 3.4.19.12) (Deubiquitinating enzyme 24) (Ubiquitin thioesterase 24) (Ubiquitin-specific-processing protease 24) Homo sapiens (Human) GO:0004843; GO:0005634; GO:0005654; GO:0005829; GO:0006508; GO:0016579; GO:0031647 protein deubiquitination [GO:0016579]; proteolysis [GO:0006508]; regulation of protein stability [GO:0031647] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cysteine-type deubiquitinase activity [GO:0004843] g1710.t1 Q8HXX8 74.048 420 0.0 670.0 sp|Q8HXX8|GCDH_MACFA Glutaryl-CoA dehydrogenase, mitochondrial OS=Macaca fascicularis OX=9541 GN=GCDH PE=2 SV=1 g1711.t1 Q66JF3 58.629 394 1.2e-152 445.0 sp|Q66JF3|MKNK1_XENTR MAP kinase-interacting serine/threonine-protein kinase 1 OS=Xenopus tropicalis OX=8364 GN=mknk1 PE=2 SV=1 MKNK1_XENTR reviewed MAP kinase-interacting serine/threonine-protein kinase 1 (EC 2.7.11.1) (MAP kinase signal-integrating kinase 1) (MAPK signal-integrating kinase 1) (Mnk1) Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0004683; GO:0005516; GO:0005524; GO:0005634; GO:0005737; GO:0006417; GO:0009931; GO:0035556; GO:0046872; GO:0106310 intracellular signal transduction [GO:0035556]; regulation of translation [GO:0006417] cytoplasm [GO:0005737]; nucleus [GO:0005634] ATP binding [GO:0005524]; calcium-dependent protein serine/threonine kinase activity [GO:0009931]; calcium/calmodulin-dependent protein kinase activity [GO:0004683]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310] g1713.t1 A4QN59 50.0 508 7.15e-174 502.0 sp|A4QN59|DPH2_DANRE 2-(3-amino-3-carboxypropyl)histidine synthase subunit 2 OS=Danio rerio OX=7955 GN=dph2 PE=2 SV=1 DPH2_DANRE reviewed 2-(3-amino-3-carboxypropyl)histidine synthase subunit 2 (Diphthamide biosynthesis protein 2) (Diphtheria toxin resistance protein 2) (S-adenosyl-L-methionine:L-histidine 3-amino-3-carboxypropyltransferase 2) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0017183; GO:0046872; GO:0051539; GO:0090560; GO:0120513 protein histidyl modification to diphthamide [GO:0017183] 2-(3-amino-3-carboxypropyl)histidine synthase complex [GO:0120513] 2-(3-amino-3-carboxypropyl)histidine synthase activity [GO:0090560]; 4 iron, 4 sulfur cluster binding [GO:0051539]; metal ion binding [GO:0046872] g1714.t1 P50533 60.22 1091 0.0 1296.0 sp|P50533|SMC2_XENLA Structural maintenance of chromosomes protein 2 OS=Xenopus laevis OX=8355 GN=smc2 PE=1 SV=1 g1715.t1 P50533 95.312 64 4.87e-35 129.0 sp|P50533|SMC2_XENLA Structural maintenance of chromosomes protein 2 OS=Xenopus laevis OX=8355 GN=smc2 PE=1 SV=1 g1717.t1 Q06807 45.522 268 5.2e-71 260.0 sp|Q06807|TIE2_BOVIN Angiopoietin-1 receptor OS=Bos taurus OX=9913 GN=TEK PE=2 SV=1 TIE2_BOVIN reviewed Angiopoietin-1 receptor (EC 2.7.10.1) (Endothelial tyrosine kinase) (Tyrosine kinase with Ig and EGF homology domains-2) (Tyrosine-protein kinase receptor TIE-2) (CD antigen CD202b) Bos taurus (Bovine) GO:0001525; GO:0001935; GO:0001936; GO:0002040; GO:0004714; GO:0005524; GO:0005576; GO:0005856; GO:0005886; GO:0005925; GO:0007169; GO:0007507; GO:0010595; GO:0016525; GO:0030097; GO:0032878; GO:0034446; GO:0043235; GO:0043410; GO:0045766; GO:0048014; GO:0051894; GO:0051897; GO:0060347; GO:0070374; GO:1902533; GO:2000352 angiogenesis [GO:0001525]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; endothelial cell proliferation [GO:0001935]; heart development [GO:0007507]; heart trabecula formation [GO:0060347]; hemopoiesis [GO:0030097]; negative regulation of angiogenesis [GO:0016525]; negative regulation of endothelial cell apoptotic process [GO:2000352]; positive regulation of angiogenesis [GO:0045766]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of intracellular signal transduction [GO:1902533]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; regulation of endothelial cell proliferation [GO:0001936]; regulation of establishment or maintenance of cell polarity [GO:0032878]; sprouting angiogenesis [GO:0002040]; substrate adhesion-dependent cell spreading [GO:0034446]; Tie signaling pathway [GO:0048014] cytoskeleton [GO:0005856]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] ATP binding [GO:0005524]; transmembrane receptor protein tyrosine kinase activity [GO:0004714] g1718.t1 Q06807 26.224 572 1.8e-38 156.0 sp|Q06807|TIE2_BOVIN Angiopoietin-1 receptor OS=Bos taurus OX=9913 GN=TEK PE=2 SV=1 TIE2_BOVIN reviewed Angiopoietin-1 receptor (EC 2.7.10.1) (Endothelial tyrosine kinase) (Tyrosine kinase with Ig and EGF homology domains-2) (Tyrosine-protein kinase receptor TIE-2) (CD antigen CD202b) Bos taurus (Bovine) GO:0001525; GO:0001935; GO:0001936; GO:0002040; GO:0004714; GO:0005524; GO:0005576; GO:0005856; GO:0005886; GO:0005925; GO:0007169; GO:0007507; GO:0010595; GO:0016525; GO:0030097; GO:0032878; GO:0034446; GO:0043235; GO:0043410; GO:0045766; GO:0048014; GO:0051894; GO:0051897; GO:0060347; GO:0070374; GO:1902533; GO:2000352 angiogenesis [GO:0001525]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; endothelial cell proliferation [GO:0001935]; heart development [GO:0007507]; heart trabecula formation [GO:0060347]; hemopoiesis [GO:0030097]; negative regulation of angiogenesis [GO:0016525]; negative regulation of endothelial cell apoptotic process [GO:2000352]; positive regulation of angiogenesis [GO:0045766]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of intracellular signal transduction [GO:1902533]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; regulation of endothelial cell proliferation [GO:0001936]; regulation of establishment or maintenance of cell polarity [GO:0032878]; sprouting angiogenesis [GO:0002040]; substrate adhesion-dependent cell spreading [GO:0034446]; Tie signaling pathway [GO:0048014] cytoskeleton [GO:0005856]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] ATP binding [GO:0005524]; transmembrane receptor protein tyrosine kinase activity [GO:0004714] g1719.t1 Q02763 46.875 288 9.44e-84 290.0 sp|Q02763|TIE2_HUMAN Angiopoietin-1 receptor OS=Homo sapiens OX=9606 GN=TEK PE=1 SV=2 TIE2_HUMAN reviewed Angiopoietin-1 receptor (EC 2.7.10.1) (Endothelial tyrosine kinase) (Tunica interna endothelial cell kinase) (Tyrosine kinase with Ig and EGF homology domains-2) (Tyrosine-protein kinase receptor TEK) (Tyrosine-protein kinase receptor TIE-2) (hTIE2) (p140 TEK) (CD antigen CD202b) Homo sapiens (Human) GO:0001525; GO:0001935; GO:0001938; GO:0002040; GO:0004672; GO:0004714; GO:0005524; GO:0005576; GO:0005813; GO:0005886; GO:0005902; GO:0005911; GO:0005925; GO:0007166; GO:0007169; GO:0007267; GO:0007507; GO:0009925; GO:0009986; GO:0010595; GO:0016323; GO:0016324; GO:0016525; GO:0019199; GO:0032878; GO:0034446; GO:0035022; GO:0035025; GO:0036064; GO:0038023; GO:0042802; GO:0043066; GO:0043114; GO:0043235; GO:0043410; GO:0045121; GO:0045766; GO:0048014; GO:0050728; GO:0051894; GO:0051897; GO:0060216; GO:0060347; GO:0070374; GO:0071260; GO:0072012; GO:1902533; GO:2000351; GO:2000352 angiogenesis [GO:0001525]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; cell surface receptor signaling pathway [GO:0007166]; cell-cell signaling [GO:0007267]; cellular response to mechanical stimulus [GO:0071260]; definitive hemopoiesis [GO:0060216]; endothelial cell proliferation [GO:0001935]; glomerulus vasculature development [GO:0072012]; heart development [GO:0007507]; heart trabecula formation [GO:0060347]; negative regulation of angiogenesis [GO:0016525]; negative regulation of apoptotic process [GO:0043066]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of inflammatory response [GO:0050728]; positive regulation of angiogenesis [GO:0045766]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of intracellular signal transduction [GO:1902533]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of Rac protein signal transduction [GO:0035022]; positive regulation of Rho protein signal transduction [GO:0035025]; regulation of endothelial cell apoptotic process [GO:2000351]; regulation of establishment or maintenance of cell polarity [GO:0032878]; regulation of vascular permeability [GO:0043114]; sprouting angiogenesis [GO:0002040]; substrate adhesion-dependent cell spreading [GO:0034446]; Tie signaling pathway [GO:0048014] apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; cell-cell junction [GO:0005911]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; membrane raft [GO:0045121]; microvillus [GO:0005902]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] ATP binding [GO:0005524]; identical protein binding [GO:0042802]; protein kinase activity [GO:0004672]; signaling receptor activity [GO:0038023]; transmembrane receptor protein kinase activity [GO:0019199]; transmembrane receptor protein tyrosine kinase activity [GO:0004714] g1719.t1 Q02763 44.538 119 2.68e-23 109.0 sp|Q02763|TIE2_HUMAN Angiopoietin-1 receptor OS=Homo sapiens OX=9606 GN=TEK PE=1 SV=2 TIE2_HUMAN reviewed Angiopoietin-1 receptor (EC 2.7.10.1) (Endothelial tyrosine kinase) (Tunica interna endothelial cell kinase) (Tyrosine kinase with Ig and EGF homology domains-2) (Tyrosine-protein kinase receptor TEK) (Tyrosine-protein kinase receptor TIE-2) (hTIE2) (p140 TEK) (CD antigen CD202b) Homo sapiens (Human) GO:0001525; GO:0001935; GO:0001938; GO:0002040; GO:0004672; GO:0004714; GO:0005524; GO:0005576; GO:0005813; GO:0005886; GO:0005902; GO:0005911; GO:0005925; GO:0007166; GO:0007169; GO:0007267; GO:0007507; GO:0009925; GO:0009986; GO:0010595; GO:0016323; GO:0016324; GO:0016525; GO:0019199; GO:0032878; GO:0034446; GO:0035022; GO:0035025; GO:0036064; GO:0038023; GO:0042802; GO:0043066; GO:0043114; GO:0043235; GO:0043410; GO:0045121; GO:0045766; GO:0048014; GO:0050728; GO:0051894; GO:0051897; GO:0060216; GO:0060347; GO:0070374; GO:0071260; GO:0072012; GO:1902533; GO:2000351; GO:2000352 angiogenesis [GO:0001525]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; cell surface receptor signaling pathway [GO:0007166]; cell-cell signaling [GO:0007267]; cellular response to mechanical stimulus [GO:0071260]; definitive hemopoiesis [GO:0060216]; endothelial cell proliferation [GO:0001935]; glomerulus vasculature development [GO:0072012]; heart development [GO:0007507]; heart trabecula formation [GO:0060347]; negative regulation of angiogenesis [GO:0016525]; negative regulation of apoptotic process [GO:0043066]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of inflammatory response [GO:0050728]; positive regulation of angiogenesis [GO:0045766]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of intracellular signal transduction [GO:1902533]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of Rac protein signal transduction [GO:0035022]; positive regulation of Rho protein signal transduction [GO:0035025]; regulation of endothelial cell apoptotic process [GO:2000351]; regulation of establishment or maintenance of cell polarity [GO:0032878]; regulation of vascular permeability [GO:0043114]; sprouting angiogenesis [GO:0002040]; substrate adhesion-dependent cell spreading [GO:0034446]; Tie signaling pathway [GO:0048014] apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; cell-cell junction [GO:0005911]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; membrane raft [GO:0045121]; microvillus [GO:0005902]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] ATP binding [GO:0005524]; identical protein binding [GO:0042802]; protein kinase activity [GO:0004672]; signaling receptor activity [GO:0038023]; transmembrane receptor protein kinase activity [GO:0019199]; transmembrane receptor protein tyrosine kinase activity [GO:0004714] g1720.t1 Q02858 34.382 477 2.41e-83 284.0 sp|Q02858|TIE2_MOUSE Angiopoietin-1 receptor OS=Mus musculus OX=10090 GN=Tek PE=1 SV=2 TIE2_MOUSE reviewed Angiopoietin-1 receptor (EC 2.7.10.1) (Endothelial tyrosine kinase) (HYK) (STK1) (Tunica interna endothelial cell kinase) (Tyrosine kinase with Ig and EGF homology domains-2) (Tyrosine-protein kinase receptor TEK) (Tyrosine-protein kinase receptor TIE-2) (mTIE2) (p140 TEK) (CD antigen CD202b) Mus musculus (Mouse) GO:0001525; GO:0001569; GO:0001570; GO:0001666; GO:0001935; GO:0001936; GO:0002040; GO:0002720; GO:0004713; GO:0004714; GO:0005524; GO:0005576; GO:0005813; GO:0005886; GO:0005902; GO:0005911; GO:0005925; GO:0007160; GO:0007166; GO:0007169; GO:0007507; GO:0009925; GO:0009986; GO:0010595; GO:0016020; GO:0016323; GO:0016324; GO:0016525; GO:0018108; GO:0019838; GO:0030097; GO:0030334; GO:0030949; GO:0032526; GO:0032878; GO:0034446; GO:0036064; GO:0038023; GO:0042307; GO:0042802; GO:0043066; GO:0043235; GO:0043410; GO:0043627; GO:0045121; GO:0045765; GO:0045766; GO:0045785; GO:0048014; GO:0048471; GO:0051894; GO:0051897; GO:0060347; GO:0070374; GO:0071260; GO:0072012; GO:0098609; GO:1901222; GO:1902533; GO:2000352 angiogenesis [GO:0001525]; branching involved in blood vessel morphogenesis [GO:0001569]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; cell surface receptor signaling pathway [GO:0007166]; cell-cell adhesion [GO:0098609]; cell-matrix adhesion [GO:0007160]; cellular response to mechanical stimulus [GO:0071260]; endothelial cell proliferation [GO:0001935]; glomerulus vasculature development [GO:0072012]; heart development [GO:0007507]; heart trabecula formation [GO:0060347]; hemopoiesis [GO:0030097]; negative regulation of angiogenesis [GO:0016525]; negative regulation of apoptotic process [GO:0043066]; negative regulation of endothelial cell apoptotic process [GO:2000352]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cytokine production involved in immune response [GO:0002720]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of intracellular signal transduction [GO:1902533]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030949]; regulation of angiogenesis [GO:0045765]; regulation of cell migration [GO:0030334]; regulation of endothelial cell proliferation [GO:0001936]; regulation of establishment or maintenance of cell polarity [GO:0032878]; regulation of non-canonical NF-kappaB signal transduction [GO:1901222]; response to estrogen [GO:0043627]; response to hypoxia [GO:0001666]; response to retinoic acid [GO:0032526]; sprouting angiogenesis [GO:0002040]; substrate adhesion-dependent cell spreading [GO:0034446]; Tie signaling pathway [GO:0048014]; vasculogenesis [GO:0001570] apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; cell-cell junction [GO:0005911]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; membrane [GO:0016020]; membrane raft [GO:0045121]; microvillus [GO:0005902]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] ATP binding [GO:0005524]; growth factor binding [GO:0019838]; identical protein binding [GO:0042802]; protein tyrosine kinase activity [GO:0004713]; signaling receptor activity [GO:0038023]; transmembrane receptor protein tyrosine kinase activity [GO:0004714] g1721.t1 Q02858 39.062 128 1.1200000000000002e-21 104.0 sp|Q02858|TIE2_MOUSE Angiopoietin-1 receptor OS=Mus musculus OX=10090 GN=Tek PE=1 SV=2 TIE2_MOUSE reviewed Angiopoietin-1 receptor (EC 2.7.10.1) (Endothelial tyrosine kinase) (HYK) (STK1) (Tunica interna endothelial cell kinase) (Tyrosine kinase with Ig and EGF homology domains-2) (Tyrosine-protein kinase receptor TEK) (Tyrosine-protein kinase receptor TIE-2) (mTIE2) (p140 TEK) (CD antigen CD202b) Mus musculus (Mouse) GO:0001525; GO:0001569; GO:0001570; GO:0001666; GO:0001935; GO:0001936; GO:0002040; GO:0002720; GO:0004713; GO:0004714; GO:0005524; GO:0005576; GO:0005813; GO:0005886; GO:0005902; GO:0005911; GO:0005925; GO:0007160; GO:0007166; GO:0007169; GO:0007507; GO:0009925; GO:0009986; GO:0010595; GO:0016020; GO:0016323; GO:0016324; GO:0016525; GO:0018108; GO:0019838; GO:0030097; GO:0030334; GO:0030949; GO:0032526; GO:0032878; GO:0034446; GO:0036064; GO:0038023; GO:0042307; GO:0042802; GO:0043066; GO:0043235; GO:0043410; GO:0043627; GO:0045121; GO:0045765; GO:0045766; GO:0045785; GO:0048014; GO:0048471; GO:0051894; GO:0051897; GO:0060347; GO:0070374; GO:0071260; GO:0072012; GO:0098609; GO:1901222; GO:1902533; GO:2000352 angiogenesis [GO:0001525]; branching involved in blood vessel morphogenesis [GO:0001569]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; cell surface receptor signaling pathway [GO:0007166]; cell-cell adhesion [GO:0098609]; cell-matrix adhesion [GO:0007160]; cellular response to mechanical stimulus [GO:0071260]; endothelial cell proliferation [GO:0001935]; glomerulus vasculature development [GO:0072012]; heart development [GO:0007507]; heart trabecula formation [GO:0060347]; hemopoiesis [GO:0030097]; negative regulation of angiogenesis [GO:0016525]; negative regulation of apoptotic process [GO:0043066]; negative regulation of endothelial cell apoptotic process [GO:2000352]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cytokine production involved in immune response [GO:0002720]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of intracellular signal transduction [GO:1902533]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030949]; regulation of angiogenesis [GO:0045765]; regulation of cell migration [GO:0030334]; regulation of endothelial cell proliferation [GO:0001936]; regulation of establishment or maintenance of cell polarity [GO:0032878]; regulation of non-canonical NF-kappaB signal transduction [GO:1901222]; response to estrogen [GO:0043627]; response to hypoxia [GO:0001666]; response to retinoic acid [GO:0032526]; sprouting angiogenesis [GO:0002040]; substrate adhesion-dependent cell spreading [GO:0034446]; Tie signaling pathway [GO:0048014]; vasculogenesis [GO:0001570] apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; cell-cell junction [GO:0005911]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; membrane [GO:0016020]; membrane raft [GO:0045121]; microvillus [GO:0005902]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] ATP binding [GO:0005524]; growth factor binding [GO:0019838]; identical protein binding [GO:0042802]; protein tyrosine kinase activity [GO:0004713]; signaling receptor activity [GO:0038023]; transmembrane receptor protein tyrosine kinase activity [GO:0004714] g1722.t1 P35590 36.29 248 7.539999999999999e-30 127.0 sp|P35590|TIE1_HUMAN Tyrosine-protein kinase receptor Tie-1 OS=Homo sapiens OX=9606 GN=TIE1 PE=1 SV=1 TIE1_HUMAN reviewed Tyrosine-protein kinase receptor Tie-1 (EC 2.7.10.1) Homo sapiens (Human) GO:0001525; GO:0001570; GO:0001701; GO:0001936; GO:0003180; GO:0004714; GO:0005524; GO:0005886; GO:0007165; GO:0007169; GO:0007498; GO:0016525; GO:0030336; GO:0032526; GO:0043235; GO:0045026; GO:0045766; GO:0048771; GO:0060836; GO:0060854; GO:1901201 angiogenesis [GO:0001525]; aortic valve morphogenesis [GO:0003180]; branching involved in lymph vessel morphogenesis [GO:0060854]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; in utero embryonic development [GO:0001701]; lymphatic endothelial cell differentiation [GO:0060836]; mesoderm development [GO:0007498]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell migration [GO:0030336]; plasma membrane fusion [GO:0045026]; positive regulation of angiogenesis [GO:0045766]; regulation of endothelial cell proliferation [GO:0001936]; regulation of extracellular matrix assembly [GO:1901201]; response to retinoic acid [GO:0032526]; signal transduction [GO:0007165]; tissue remodeling [GO:0048771]; vasculogenesis [GO:0001570] plasma membrane [GO:0005886]; receptor complex [GO:0043235] ATP binding [GO:0005524]; transmembrane receptor protein tyrosine kinase activity [GO:0004714] g1723.t1 Q06807 47.222 288 7.73e-87 292.0 sp|Q06807|TIE2_BOVIN Angiopoietin-1 receptor OS=Bos taurus OX=9913 GN=TEK PE=2 SV=1 TIE2_BOVIN reviewed Angiopoietin-1 receptor (EC 2.7.10.1) (Endothelial tyrosine kinase) (Tyrosine kinase with Ig and EGF homology domains-2) (Tyrosine-protein kinase receptor TIE-2) (CD antigen CD202b) Bos taurus (Bovine) GO:0001525; GO:0001935; GO:0001936; GO:0002040; GO:0004714; GO:0005524; GO:0005576; GO:0005856; GO:0005886; GO:0005925; GO:0007169; GO:0007507; GO:0010595; GO:0016525; GO:0030097; GO:0032878; GO:0034446; GO:0043235; GO:0043410; GO:0045766; GO:0048014; GO:0051894; GO:0051897; GO:0060347; GO:0070374; GO:1902533; GO:2000352 angiogenesis [GO:0001525]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; endothelial cell proliferation [GO:0001935]; heart development [GO:0007507]; heart trabecula formation [GO:0060347]; hemopoiesis [GO:0030097]; negative regulation of angiogenesis [GO:0016525]; negative regulation of endothelial cell apoptotic process [GO:2000352]; positive regulation of angiogenesis [GO:0045766]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of intracellular signal transduction [GO:1902533]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; regulation of endothelial cell proliferation [GO:0001936]; regulation of establishment or maintenance of cell polarity [GO:0032878]; sprouting angiogenesis [GO:0002040]; substrate adhesion-dependent cell spreading [GO:0034446]; Tie signaling pathway [GO:0048014] cytoskeleton [GO:0005856]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] ATP binding [GO:0005524]; transmembrane receptor protein tyrosine kinase activity [GO:0004714] g1725.t1 Q02763 34.351 262 1.8799999999999997e-40 154.0 sp|Q02763|TIE2_HUMAN Angiopoietin-1 receptor OS=Homo sapiens OX=9606 GN=TEK PE=1 SV=2 TIE2_HUMAN reviewed Angiopoietin-1 receptor (EC 2.7.10.1) (Endothelial tyrosine kinase) (Tunica interna endothelial cell kinase) (Tyrosine kinase with Ig and EGF homology domains-2) (Tyrosine-protein kinase receptor TEK) (Tyrosine-protein kinase receptor TIE-2) (hTIE2) (p140 TEK) (CD antigen CD202b) Homo sapiens (Human) GO:0001525; GO:0001935; GO:0001938; GO:0002040; GO:0004672; GO:0004714; GO:0005524; GO:0005576; GO:0005813; GO:0005886; GO:0005902; GO:0005911; GO:0005925; GO:0007166; GO:0007169; GO:0007267; GO:0007507; GO:0009925; GO:0009986; GO:0010595; GO:0016323; GO:0016324; GO:0016525; GO:0019199; GO:0032878; GO:0034446; GO:0035022; GO:0035025; GO:0036064; GO:0038023; GO:0042802; GO:0043066; GO:0043114; GO:0043235; GO:0043410; GO:0045121; GO:0045766; GO:0048014; GO:0050728; GO:0051894; GO:0051897; GO:0060216; GO:0060347; GO:0070374; GO:0071260; GO:0072012; GO:1902533; GO:2000351; GO:2000352 angiogenesis [GO:0001525]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; cell surface receptor signaling pathway [GO:0007166]; cell-cell signaling [GO:0007267]; cellular response to mechanical stimulus [GO:0071260]; definitive hemopoiesis [GO:0060216]; endothelial cell proliferation [GO:0001935]; glomerulus vasculature development [GO:0072012]; heart development [GO:0007507]; heart trabecula formation [GO:0060347]; negative regulation of angiogenesis [GO:0016525]; negative regulation of apoptotic process [GO:0043066]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of inflammatory response [GO:0050728]; positive regulation of angiogenesis [GO:0045766]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of intracellular signal transduction [GO:1902533]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of Rac protein signal transduction [GO:0035022]; positive regulation of Rho protein signal transduction [GO:0035025]; regulation of endothelial cell apoptotic process [GO:2000351]; regulation of establishment or maintenance of cell polarity [GO:0032878]; regulation of vascular permeability [GO:0043114]; sprouting angiogenesis [GO:0002040]; substrate adhesion-dependent cell spreading [GO:0034446]; Tie signaling pathway [GO:0048014] apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; cell-cell junction [GO:0005911]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; membrane raft [GO:0045121]; microvillus [GO:0005902]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] ATP binding [GO:0005524]; identical protein binding [GO:0042802]; protein kinase activity [GO:0004672]; signaling receptor activity [GO:0038023]; transmembrane receptor protein kinase activity [GO:0019199]; transmembrane receptor protein tyrosine kinase activity [GO:0004714] g1726.t1 P28828 34.926 544 4.5899999999999995e-89 310.0 sp|P28828|PTPRM_MOUSE Receptor-type tyrosine-protein phosphatase mu OS=Mus musculus OX=10090 GN=Ptprm PE=1 SV=2 PTPRM_MOUSE reviewed Receptor-type tyrosine-protein phosphatase mu (Protein-tyrosine phosphatase mu) (R-PTP-mu) (EC 3.1.3.48) Mus musculus (Mouse) GO:0001937; GO:0004725; GO:0005001; GO:0005737; GO:0005886; GO:0005911; GO:0005912; GO:0007156; GO:0007165; GO:0009410; GO:0010596; GO:0010828; GO:0010829; GO:0010842; GO:0016525; GO:0016791; GO:0030027; GO:0031175; GO:0031290; GO:0042311; GO:0042802; GO:0045296; GO:0048471 homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of angiogenesis [GO:0016525]; negative regulation of D-glucose transmembrane transport [GO:0010829]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of endothelial cell proliferation [GO:0001937]; neuron projection development [GO:0031175]; positive regulation of D-glucose transmembrane transport [GO:0010828]; response to xenobiotic stimulus [GO:0009410]; retina layer formation [GO:0010842]; retinal ganglion cell axon guidance [GO:0031290]; signal transduction [GO:0007165]; vasodilation [GO:0042311] adherens junction [GO:0005912]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; lamellipodium [GO:0030027]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886] cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; phosphatase activity [GO:0016791]; protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001] g1729.t1 Q9D032 65.899 217 6.27e-76 238.0 sp|Q9D032|SSBP3_MOUSE Single-stranded DNA-binding protein 3 OS=Mus musculus OX=10090 GN=Ssbp3 PE=1 SV=2 SSBP3_MOUSE reviewed Single-stranded DNA-binding protein 3 (Lck-associated signal transducer) (Sequence-specific single-stranded-DNA-binding protein) Mus musculus (Mouse) GO:0002244; GO:0003697; GO:0003713; GO:0005634; GO:0005667; GO:0008284; GO:0021501; GO:0021547; GO:0030154; GO:0032991; GO:0045893; GO:0045944; GO:0060322; GO:0060323; GO:0065003; GO:2000744 cell differentiation [GO:0030154]; head development [GO:0060322]; head morphogenesis [GO:0060323]; hematopoietic progenitor cell differentiation [GO:0002244]; midbrain-hindbrain boundary initiation [GO:0021547]; positive regulation of anterior head development [GO:2000744]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; prechordal plate formation [GO:0021501]; protein-containing complex assembly [GO:0065003] nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcription regulator complex [GO:0005667] single-stranded DNA binding [GO:0003697]; transcription coactivator activity [GO:0003713] g1729.t2 Q9D032 57.724 246 7.890000000000001e-72 229.0 sp|Q9D032|SSBP3_MOUSE Single-stranded DNA-binding protein 3 OS=Mus musculus OX=10090 GN=Ssbp3 PE=1 SV=2 SSBP3_MOUSE reviewed Single-stranded DNA-binding protein 3 (Lck-associated signal transducer) (Sequence-specific single-stranded-DNA-binding protein) Mus musculus (Mouse) GO:0002244; GO:0003697; GO:0003713; GO:0005634; GO:0005667; GO:0008284; GO:0021501; GO:0021547; GO:0030154; GO:0032991; GO:0045893; GO:0045944; GO:0060322; GO:0060323; GO:0065003; GO:2000744 cell differentiation [GO:0030154]; head development [GO:0060322]; head morphogenesis [GO:0060323]; hematopoietic progenitor cell differentiation [GO:0002244]; midbrain-hindbrain boundary initiation [GO:0021547]; positive regulation of anterior head development [GO:2000744]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; prechordal plate formation [GO:0021501]; protein-containing complex assembly [GO:0065003] nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcription regulator complex [GO:0005667] single-stranded DNA binding [GO:0003697]; transcription coactivator activity [GO:0003713] g1729.t3 Q9BWG4 48.263 259 3.77e-60 200.0 sp|Q9BWG4|SSBP4_HUMAN Single-stranded DNA-binding protein 4 OS=Homo sapiens OX=9606 GN=SSBP4 PE=1 SV=1 g1731.t1 Q9H0Y0 48.031 127 1.82e-25 99.8 sp|Q9H0Y0|ATG10_HUMAN Ubiquitin-like-conjugating enzyme ATG10 OS=Homo sapiens OX=9606 GN=ATG10 PE=1 SV=1 ATG10_HUMAN reviewed Ubiquitin-like-conjugating enzyme ATG10 (EC 2.3.2.-) (Autophagy-related protein 10) (APG10-like) Homo sapiens (Human) GO:0000045; GO:0000423; GO:0005829; GO:0006914; GO:0006983; GO:0015031; GO:0019777; GO:0032446; GO:0061651 autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; ER overload response [GO:0006983]; mitophagy [GO:0000423]; protein modification by small protein conjugation [GO:0032446]; protein transport [GO:0015031] cytosol [GO:0005829] Atg12 conjugating enzyme activity [GO:0061651]; Atg12 transferase activity [GO:0019777] g1738.t1 Q2KJG1 42.384 151 1.72e-30 127.0 sp|Q2KJG1|SPAT6_BOVIN Spermatogenesis-associated protein 6 OS=Bos taurus OX=9913 GN=SPATA6 PE=2 SV=2 g1741.t1 E9Q238 56.777 273 4.0900000000000006e-79 293.0 sp|E9Q238|KANK1_MOUSE KN motif and ankyrin repeat domains 1 OS=Mus musculus OX=10090 GN=Kank1 PE=1 SV=1 KANK1_MOUSE reviewed KN motif and ankyrin repeat domains 1 (Ankyrin repeat domain-containing protein 15) (Kidney ankyrin repeat-containing protein) Mus musculus (Mouse) GO:0005634; GO:0005737; GO:0005856; GO:0005886; GO:0005938; GO:0008013; GO:0008283; GO:0010977; GO:0030036; GO:0030177; GO:0030336; GO:0030674; GO:0030837; GO:0032587; GO:0035023; GO:0035024; GO:0043622; GO:0046627; GO:0090263; GO:0090303; GO:0090521; GO:1900025; GO:1900028; GO:2000114; GO:2000393 actin cytoskeleton organization [GO:0030036]; cell population proliferation [GO:0008283]; cortical microtubule organization [GO:0043622]; negative regulation of actin filament polymerization [GO:0030837]; negative regulation of cell migration [GO:0030336]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of lamellipodium morphogenesis [GO:2000393]; negative regulation of neuron projection development [GO:0010977]; negative regulation of Rho protein signal transduction [GO:0035024]; negative regulation of ruffle assembly [GO:1900028]; negative regulation of substrate adhesion-dependent cell spreading [GO:1900025]; podocyte cell migration [GO:0090521]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of Wnt signaling pathway [GO:0030177]; positive regulation of wound healing [GO:0090303]; regulation of establishment of cell polarity [GO:2000114]; regulation of Rho protein signal transduction [GO:0035023] cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587] beta-catenin binding [GO:0008013]; protein-macromolecule adaptor activity [GO:0030674] g1741.t2 E9Q238 57.576 264 5.94e-79 292.0 sp|E9Q238|KANK1_MOUSE KN motif and ankyrin repeat domains 1 OS=Mus musculus OX=10090 GN=Kank1 PE=1 SV=1 KANK1_MOUSE reviewed KN motif and ankyrin repeat domains 1 (Ankyrin repeat domain-containing protein 15) (Kidney ankyrin repeat-containing protein) Mus musculus (Mouse) GO:0005634; GO:0005737; GO:0005856; GO:0005886; GO:0005938; GO:0008013; GO:0008283; GO:0010977; GO:0030036; GO:0030177; GO:0030336; GO:0030674; GO:0030837; GO:0032587; GO:0035023; GO:0035024; GO:0043622; GO:0046627; GO:0090263; GO:0090303; GO:0090521; GO:1900025; GO:1900028; GO:2000114; GO:2000393 actin cytoskeleton organization [GO:0030036]; cell population proliferation [GO:0008283]; cortical microtubule organization [GO:0043622]; negative regulation of actin filament polymerization [GO:0030837]; negative regulation of cell migration [GO:0030336]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of lamellipodium morphogenesis [GO:2000393]; negative regulation of neuron projection development [GO:0010977]; negative regulation of Rho protein signal transduction [GO:0035024]; negative regulation of ruffle assembly [GO:1900028]; negative regulation of substrate adhesion-dependent cell spreading [GO:1900025]; podocyte cell migration [GO:0090521]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of Wnt signaling pathway [GO:0030177]; positive regulation of wound healing [GO:0090303]; regulation of establishment of cell polarity [GO:2000114]; regulation of Rho protein signal transduction [GO:0035023] cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587] beta-catenin binding [GO:0008013]; protein-macromolecule adaptor activity [GO:0030674] g1742.t1 Q95J56 43.704 135 4.35e-32 126.0 sp|Q95J56|DJC14_BOVIN DnaJ homolog subfamily C member 14 OS=Bos taurus OX=9913 GN=DNAJC14 PE=1 SV=1 g1747.t1 Q06806 39.203 301 2.85e-60 224.0 sp|Q06806|TIE1_MOUSE Tyrosine-protein kinase receptor Tie-1 OS=Mus musculus OX=10090 GN=Tie1 PE=1 SV=3 TIE1_MOUSE reviewed Tyrosine-protein kinase receptor Tie-1 (EC 2.7.10.1) Mus musculus (Mouse) GO:0001525; GO:0001568; GO:0001570; GO:0001701; GO:0001936; GO:0003180; GO:0004714; GO:0005524; GO:0005886; GO:0007169; GO:0016020; GO:0016525; GO:0030336; GO:0032526; GO:0043235; GO:0045026; GO:0045766; GO:0048771; GO:0060836; GO:0060854; GO:1901201 angiogenesis [GO:0001525]; aortic valve morphogenesis [GO:0003180]; blood vessel development [GO:0001568]; branching involved in lymph vessel morphogenesis [GO:0060854]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; in utero embryonic development [GO:0001701]; lymphatic endothelial cell differentiation [GO:0060836]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell migration [GO:0030336]; plasma membrane fusion [GO:0045026]; positive regulation of angiogenesis [GO:0045766]; regulation of endothelial cell proliferation [GO:0001936]; regulation of extracellular matrix assembly [GO:1901201]; response to retinoic acid [GO:0032526]; tissue remodeling [GO:0048771]; vasculogenesis [GO:0001570] membrane [GO:0016020]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] ATP binding [GO:0005524]; transmembrane receptor protein tyrosine kinase activity [GO:0004714] g1747.t1 Q06806 31.944 288 9.53e-34 143.0 sp|Q06806|TIE1_MOUSE Tyrosine-protein kinase receptor Tie-1 OS=Mus musculus OX=10090 GN=Tie1 PE=1 SV=3 TIE1_MOUSE reviewed Tyrosine-protein kinase receptor Tie-1 (EC 2.7.10.1) Mus musculus (Mouse) GO:0001525; GO:0001568; GO:0001570; GO:0001701; GO:0001936; GO:0003180; GO:0004714; GO:0005524; GO:0005886; GO:0007169; GO:0016020; GO:0016525; GO:0030336; GO:0032526; GO:0043235; GO:0045026; GO:0045766; GO:0048771; GO:0060836; GO:0060854; GO:1901201 angiogenesis [GO:0001525]; aortic valve morphogenesis [GO:0003180]; blood vessel development [GO:0001568]; branching involved in lymph vessel morphogenesis [GO:0060854]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; in utero embryonic development [GO:0001701]; lymphatic endothelial cell differentiation [GO:0060836]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell migration [GO:0030336]; plasma membrane fusion [GO:0045026]; positive regulation of angiogenesis [GO:0045766]; regulation of endothelial cell proliferation [GO:0001936]; regulation of extracellular matrix assembly [GO:1901201]; response to retinoic acid [GO:0032526]; tissue remodeling [GO:0048771]; vasculogenesis [GO:0001570] membrane [GO:0016020]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] ATP binding [GO:0005524]; transmembrane receptor protein tyrosine kinase activity [GO:0004714] g1748.t1 Q06806 46.333 300 4.94e-77 281.0 sp|Q06806|TIE1_MOUSE Tyrosine-protein kinase receptor Tie-1 OS=Mus musculus OX=10090 GN=Tie1 PE=1 SV=3 TIE1_MOUSE reviewed Tyrosine-protein kinase receptor Tie-1 (EC 2.7.10.1) Mus musculus (Mouse) GO:0001525; GO:0001568; GO:0001570; GO:0001701; GO:0001936; GO:0003180; GO:0004714; GO:0005524; GO:0005886; GO:0007169; GO:0016020; GO:0016525; GO:0030336; GO:0032526; GO:0043235; GO:0045026; GO:0045766; GO:0048771; GO:0060836; GO:0060854; GO:1901201 angiogenesis [GO:0001525]; aortic valve morphogenesis [GO:0003180]; blood vessel development [GO:0001568]; branching involved in lymph vessel morphogenesis [GO:0060854]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; in utero embryonic development [GO:0001701]; lymphatic endothelial cell differentiation [GO:0060836]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell migration [GO:0030336]; plasma membrane fusion [GO:0045026]; positive regulation of angiogenesis [GO:0045766]; regulation of endothelial cell proliferation [GO:0001936]; regulation of extracellular matrix assembly [GO:1901201]; response to retinoic acid [GO:0032526]; tissue remodeling [GO:0048771]; vasculogenesis [GO:0001570] membrane [GO:0016020]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] ATP binding [GO:0005524]; transmembrane receptor protein tyrosine kinase activity [GO:0004714] g1748.t1 Q06806 31.387 274 1.52e-31 138.0 sp|Q06806|TIE1_MOUSE Tyrosine-protein kinase receptor Tie-1 OS=Mus musculus OX=10090 GN=Tie1 PE=1 SV=3 TIE1_MOUSE reviewed Tyrosine-protein kinase receptor Tie-1 (EC 2.7.10.1) Mus musculus (Mouse) GO:0001525; GO:0001568; GO:0001570; GO:0001701; GO:0001936; GO:0003180; GO:0004714; GO:0005524; GO:0005886; GO:0007169; GO:0016020; GO:0016525; GO:0030336; GO:0032526; GO:0043235; GO:0045026; GO:0045766; GO:0048771; GO:0060836; GO:0060854; GO:1901201 angiogenesis [GO:0001525]; aortic valve morphogenesis [GO:0003180]; blood vessel development [GO:0001568]; branching involved in lymph vessel morphogenesis [GO:0060854]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; in utero embryonic development [GO:0001701]; lymphatic endothelial cell differentiation [GO:0060836]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell migration [GO:0030336]; plasma membrane fusion [GO:0045026]; positive regulation of angiogenesis [GO:0045766]; regulation of endothelial cell proliferation [GO:0001936]; regulation of extracellular matrix assembly [GO:1901201]; response to retinoic acid [GO:0032526]; tissue remodeling [GO:0048771]; vasculogenesis [GO:0001570] membrane [GO:0016020]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] ATP binding [GO:0005524]; transmembrane receptor protein tyrosine kinase activity [GO:0004714] g1750.t1 Q7ZV22 63.235 272 3.3599999999999996e-128 368.0 sp|Q7ZV22|MTAP_DANRE S-methyl-5'-thioadenosine phosphorylase OS=Danio rerio OX=7955 GN=mtap PE=2 SV=2 g1751.t1 P18735 42.262 168 8.99e-39 139.0 sp|P18735|ZG7_XENLA Gastrula zinc finger protein XlCGF7.1 (Fragment) OS=Xenopus laevis OX=8355 PE=3 SV=1 g1752.t1 Q865S1 49.16 238 2.03e-61 213.0 sp|Q865S1|AP3D1_BOVIN AP-3 complex subunit delta-1 OS=Bos taurus OX=9913 GN=AP3D1 PE=1 SV=2 AP3D1_BOVIN reviewed AP-3 complex subunit delta-1 (AP-3 complex subunit delta) (Adaptor-related protein complex 3 subunit delta-1) (BLVPCP1) (Bovine leukemia virus cell receptor) (BLV-R) (Delta-adaptin) Bos taurus (Bovine) GO:0000139; GO:0006623; GO:0006896; GO:0008089; GO:0010008; GO:0016182; GO:0030123; GO:0043195; GO:0048490; GO:0048499; GO:0098830; GO:0098943; GO:1904115 anterograde axonal transport [GO:0008089]; anterograde synaptic vesicle transport [GO:0048490]; Golgi to vacuole transport [GO:0006896]; neurotransmitter receptor transport, postsynaptic endosome to lysosome [GO:0098943]; protein targeting to vacuole [GO:0006623]; synaptic vesicle budding from endosome [GO:0016182]; synaptic vesicle membrane organization [GO:0048499] AP-3 adaptor complex [GO:0030123]; axon cytoplasm [GO:1904115]; endosome membrane [GO:0010008]; Golgi membrane [GO:0000139]; presynaptic endosome [GO:0098830]; terminal bouton [GO:0043195] g1753.t1 O14617 68.975 722 0.0 903.0 sp|O14617|AP3D1_HUMAN AP-3 complex subunit delta-1 OS=Homo sapiens OX=9606 GN=AP3D1 PE=1 SV=1 AP3D1_HUMAN reviewed AP-3 complex subunit delta-1 (AP-3 complex subunit delta) (Adaptor-related protein complex 3 subunit delta-1) (Delta-adaptin) Homo sapiens (Human) GO:0000139; GO:0005765; GO:0005769; GO:0005794; GO:0006623; GO:0006886; GO:0006896; GO:0008089; GO:0010008; GO:0016020; GO:0016182; GO:0016183; GO:0016192; GO:0030123; GO:0032438; GO:0035646; GO:0035654; GO:0036465; GO:0043195; GO:0045944; GO:0048007; GO:0048490; GO:0048499; GO:0051138; GO:0060155; GO:0072657; GO:0098794; GO:0098830; GO:0098943; GO:0098978; GO:0140916; GO:1903232; GO:1904115 anterograde axonal transport [GO:0008089]; anterograde synaptic vesicle transport [GO:0048490]; antigen processing and presentation, exogenous lipid antigen via MHC class Ib [GO:0048007]; clathrin-coated vesicle cargo loading, AP-3-mediated [GO:0035654]; endosome to melanosome transport [GO:0035646]; Golgi to vacuole transport [GO:0006896]; intracellular protein transport [GO:0006886]; melanosome assembly [GO:1903232]; melanosome organization [GO:0032438]; neurotransmitter receptor transport, postsynaptic endosome to lysosome [GO:0098943]; platelet dense granule organization [GO:0060155]; positive regulation of NK T cell differentiation [GO:0051138]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein localization to membrane [GO:0072657]; protein targeting to vacuole [GO:0006623]; synaptic vesicle budding from endosome [GO:0016182]; synaptic vesicle coating [GO:0016183]; synaptic vesicle membrane organization [GO:0048499]; synaptic vesicle recycling [GO:0036465]; vesicle-mediated transport [GO:0016192]; zinc ion import into lysosome [GO:0140916] AP-3 adaptor complex [GO:0030123]; axon cytoplasm [GO:1904115]; early endosome [GO:0005769]; endosome membrane [GO:0010008]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; postsynapse [GO:0098794]; presynaptic endosome [GO:0098830]; terminal bouton [GO:0043195] g1753.t2 O14617 69.806 722 0.0 921.0 sp|O14617|AP3D1_HUMAN AP-3 complex subunit delta-1 OS=Homo sapiens OX=9606 GN=AP3D1 PE=1 SV=1 AP3D1_HUMAN reviewed AP-3 complex subunit delta-1 (AP-3 complex subunit delta) (Adaptor-related protein complex 3 subunit delta-1) (Delta-adaptin) Homo sapiens (Human) GO:0000139; GO:0005765; GO:0005769; GO:0005794; GO:0006623; GO:0006886; GO:0006896; GO:0008089; GO:0010008; GO:0016020; GO:0016182; GO:0016183; GO:0016192; GO:0030123; GO:0032438; GO:0035646; GO:0035654; GO:0036465; GO:0043195; GO:0045944; GO:0048007; GO:0048490; GO:0048499; GO:0051138; GO:0060155; GO:0072657; GO:0098794; GO:0098830; GO:0098943; GO:0098978; GO:0140916; GO:1903232; GO:1904115 anterograde axonal transport [GO:0008089]; anterograde synaptic vesicle transport [GO:0048490]; antigen processing and presentation, exogenous lipid antigen via MHC class Ib [GO:0048007]; clathrin-coated vesicle cargo loading, AP-3-mediated [GO:0035654]; endosome to melanosome transport [GO:0035646]; Golgi to vacuole transport [GO:0006896]; intracellular protein transport [GO:0006886]; melanosome assembly [GO:1903232]; melanosome organization [GO:0032438]; neurotransmitter receptor transport, postsynaptic endosome to lysosome [GO:0098943]; platelet dense granule organization [GO:0060155]; positive regulation of NK T cell differentiation [GO:0051138]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein localization to membrane [GO:0072657]; protein targeting to vacuole [GO:0006623]; synaptic vesicle budding from endosome [GO:0016182]; synaptic vesicle coating [GO:0016183]; synaptic vesicle membrane organization [GO:0048499]; synaptic vesicle recycling [GO:0036465]; vesicle-mediated transport [GO:0016192]; zinc ion import into lysosome [GO:0140916] AP-3 adaptor complex [GO:0030123]; axon cytoplasm [GO:1904115]; early endosome [GO:0005769]; endosome membrane [GO:0010008]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; postsynapse [GO:0098794]; presynaptic endosome [GO:0098830]; terminal bouton [GO:0043195] g1753.t3 O14617 69.764 721 0.0 915.0 sp|O14617|AP3D1_HUMAN AP-3 complex subunit delta-1 OS=Homo sapiens OX=9606 GN=AP3D1 PE=1 SV=1 AP3D1_HUMAN reviewed AP-3 complex subunit delta-1 (AP-3 complex subunit delta) (Adaptor-related protein complex 3 subunit delta-1) (Delta-adaptin) Homo sapiens (Human) GO:0000139; GO:0005765; GO:0005769; GO:0005794; GO:0006623; GO:0006886; GO:0006896; GO:0008089; GO:0010008; GO:0016020; GO:0016182; GO:0016183; GO:0016192; GO:0030123; GO:0032438; GO:0035646; GO:0035654; GO:0036465; GO:0043195; GO:0045944; GO:0048007; GO:0048490; GO:0048499; GO:0051138; GO:0060155; GO:0072657; GO:0098794; GO:0098830; GO:0098943; GO:0098978; GO:0140916; GO:1903232; GO:1904115 anterograde axonal transport [GO:0008089]; anterograde synaptic vesicle transport [GO:0048490]; antigen processing and presentation, exogenous lipid antigen via MHC class Ib [GO:0048007]; clathrin-coated vesicle cargo loading, AP-3-mediated [GO:0035654]; endosome to melanosome transport [GO:0035646]; Golgi to vacuole transport [GO:0006896]; intracellular protein transport [GO:0006886]; melanosome assembly [GO:1903232]; melanosome organization [GO:0032438]; neurotransmitter receptor transport, postsynaptic endosome to lysosome [GO:0098943]; platelet dense granule organization [GO:0060155]; positive regulation of NK T cell differentiation [GO:0051138]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein localization to membrane [GO:0072657]; protein targeting to vacuole [GO:0006623]; synaptic vesicle budding from endosome [GO:0016182]; synaptic vesicle coating [GO:0016183]; synaptic vesicle membrane organization [GO:0048499]; synaptic vesicle recycling [GO:0036465]; vesicle-mediated transport [GO:0016192]; zinc ion import into lysosome [GO:0140916] AP-3 adaptor complex [GO:0030123]; axon cytoplasm [GO:1904115]; early endosome [GO:0005769]; endosome membrane [GO:0010008]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; postsynapse [GO:0098794]; presynaptic endosome [GO:0098830]; terminal bouton [GO:0043195] g1753.t4 O14617 69.565 713 0.0 906.0 sp|O14617|AP3D1_HUMAN AP-3 complex subunit delta-1 OS=Homo sapiens OX=9606 GN=AP3D1 PE=1 SV=1 AP3D1_HUMAN reviewed AP-3 complex subunit delta-1 (AP-3 complex subunit delta) (Adaptor-related protein complex 3 subunit delta-1) (Delta-adaptin) Homo sapiens (Human) GO:0000139; GO:0005765; GO:0005769; GO:0005794; GO:0006623; GO:0006886; GO:0006896; GO:0008089; GO:0010008; GO:0016020; GO:0016182; GO:0016183; GO:0016192; GO:0030123; GO:0032438; GO:0035646; GO:0035654; GO:0036465; GO:0043195; GO:0045944; GO:0048007; GO:0048490; GO:0048499; GO:0051138; GO:0060155; GO:0072657; GO:0098794; GO:0098830; GO:0098943; GO:0098978; GO:0140916; GO:1903232; GO:1904115 anterograde axonal transport [GO:0008089]; anterograde synaptic vesicle transport [GO:0048490]; antigen processing and presentation, exogenous lipid antigen via MHC class Ib [GO:0048007]; clathrin-coated vesicle cargo loading, AP-3-mediated [GO:0035654]; endosome to melanosome transport [GO:0035646]; Golgi to vacuole transport [GO:0006896]; intracellular protein transport [GO:0006886]; melanosome assembly [GO:1903232]; melanosome organization [GO:0032438]; neurotransmitter receptor transport, postsynaptic endosome to lysosome [GO:0098943]; platelet dense granule organization [GO:0060155]; positive regulation of NK T cell differentiation [GO:0051138]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein localization to membrane [GO:0072657]; protein targeting to vacuole [GO:0006623]; synaptic vesicle budding from endosome [GO:0016182]; synaptic vesicle coating [GO:0016183]; synaptic vesicle membrane organization [GO:0048499]; synaptic vesicle recycling [GO:0036465]; vesicle-mediated transport [GO:0016192]; zinc ion import into lysosome [GO:0140916] AP-3 adaptor complex [GO:0030123]; axon cytoplasm [GO:1904115]; early endosome [GO:0005769]; endosome membrane [GO:0010008]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; postsynapse [GO:0098794]; presynaptic endosome [GO:0098830]; terminal bouton [GO:0043195] g1754.t1 Q865S1 82.192 73 2.83e-34 126.0 sp|Q865S1|AP3D1_BOVIN AP-3 complex subunit delta-1 OS=Bos taurus OX=9913 GN=AP3D1 PE=1 SV=2 AP3D1_BOVIN reviewed AP-3 complex subunit delta-1 (AP-3 complex subunit delta) (Adaptor-related protein complex 3 subunit delta-1) (BLVPCP1) (Bovine leukemia virus cell receptor) (BLV-R) (Delta-adaptin) Bos taurus (Bovine) GO:0000139; GO:0006623; GO:0006896; GO:0008089; GO:0010008; GO:0016182; GO:0030123; GO:0043195; GO:0048490; GO:0048499; GO:0098830; GO:0098943; GO:1904115 anterograde axonal transport [GO:0008089]; anterograde synaptic vesicle transport [GO:0048490]; Golgi to vacuole transport [GO:0006896]; neurotransmitter receptor transport, postsynaptic endosome to lysosome [GO:0098943]; protein targeting to vacuole [GO:0006623]; synaptic vesicle budding from endosome [GO:0016182]; synaptic vesicle membrane organization [GO:0048499] AP-3 adaptor complex [GO:0030123]; axon cytoplasm [GO:1904115]; endosome membrane [GO:0010008]; Golgi membrane [GO:0000139]; presynaptic endosome [GO:0098830]; terminal bouton [GO:0043195] g1762.t1 Q8R1A4 57.23 1314 0.0 1361.0 sp|Q8R1A4|DOCK7_MOUSE Dedicator of cytokinesis protein 7 OS=Mus musculus OX=10090 GN=Dock7 PE=1 SV=3 DOCK7_MOUSE reviewed Dedicator of cytokinesis protein 7 (Protein moonlight) Mus musculus (Mouse) GO:0000226; GO:0002244; GO:0005085; GO:0005096; GO:0007409; GO:0016601; GO:0022027; GO:0030424; GO:0031175; GO:0031267; GO:0031594; GO:0035023; GO:0043473; GO:0045200; GO:0050767; GO:0098698; GO:0120163; GO:1904754 axonogenesis [GO:0007409]; establishment of neuroblast polarity [GO:0045200]; hematopoietic progenitor cell differentiation [GO:0002244]; interkinetic nuclear migration [GO:0022027]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of cold-induced thermogenesis [GO:0120163]; neuron projection development [GO:0031175]; pigmentation [GO:0043473]; positive regulation of vascular associated smooth muscle cell migration [GO:1904754]; postsynaptic specialization assembly [GO:0098698]; Rac protein signal transduction [GO:0016601]; regulation of neurogenesis [GO:0050767]; regulation of Rho protein signal transduction [GO:0035023] axon [GO:0030424]; neuromuscular junction [GO:0031594] GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; small GTPase binding [GO:0031267] g1763.t1 Q96N67 53.224 791 0.0 806.0 sp|Q96N67|DOCK7_HUMAN Dedicator of cytokinesis protein 7 OS=Homo sapiens OX=9606 GN=DOCK7 PE=1 SV=4 g1763.t2 Q96N67 52.104 808 0.0 795.0 sp|Q96N67|DOCK7_HUMAN Dedicator of cytokinesis protein 7 OS=Homo sapiens OX=9606 GN=DOCK7 PE=1 SV=4 g1764.t1 Q5T890 51.534 163 1.7899999999999998e-38 160.0 sp|Q5T890|ER6L2_HUMAN DNA excision repair protein ERCC-6-like 2 OS=Homo sapiens OX=9606 GN=ERCC6L2 PE=1 SV=3 ER6L2_HUMAN reviewed DNA excision repair protein ERCC-6-like 2 (EC 3.6.4.-) (DNA repair and recombination protein RAD26-like) (Excision repair cross-complementation group 6-like 2) Homo sapiens (Human) GO:0000775; GO:0003677; GO:0004386; GO:0005524; GO:0005634; GO:0005737; GO:0005739; GO:0005813; GO:0006974; GO:0016787; GO:0019901; GO:0032991; GO:0034614; GO:0036297; GO:0097680 cellular response to reactive oxygen species [GO:0034614]; DNA damage response [GO:0006974]; double-strand break repair via classical nonhomologous end joining [GO:0097680]; interstrand cross-link repair [GO:0036297] centrosome [GO:0005813]; chromosome, centromeric region [GO:0000775]; cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; protein-containing complex [GO:0032991] ATP binding [GO:0005524]; DNA binding [GO:0003677]; helicase activity [GO:0004386]; hydrolase activity [GO:0016787]; protein kinase binding [GO:0019901] g1764.t2 Q5T890 51.534 163 2.95e-38 159.0 sp|Q5T890|ER6L2_HUMAN DNA excision repair protein ERCC-6-like 2 OS=Homo sapiens OX=9606 GN=ERCC6L2 PE=1 SV=3 ER6L2_HUMAN reviewed DNA excision repair protein ERCC-6-like 2 (EC 3.6.4.-) (DNA repair and recombination protein RAD26-like) (Excision repair cross-complementation group 6-like 2) Homo sapiens (Human) GO:0000775; GO:0003677; GO:0004386; GO:0005524; GO:0005634; GO:0005737; GO:0005739; GO:0005813; GO:0006974; GO:0016787; GO:0019901; GO:0032991; GO:0034614; GO:0036297; GO:0097680 cellular response to reactive oxygen species [GO:0034614]; DNA damage response [GO:0006974]; double-strand break repair via classical nonhomologous end joining [GO:0097680]; interstrand cross-link repair [GO:0036297] centrosome [GO:0005813]; chromosome, centromeric region [GO:0000775]; cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; protein-containing complex [GO:0032991] ATP binding [GO:0005524]; DNA binding [GO:0003677]; helicase activity [GO:0004386]; hydrolase activity [GO:0016787]; protein kinase binding [GO:0019901] g1765.t1 A3KMX0 44.764 487 1.17e-135 436.0 sp|A3KMX0|ER6L2_BOVIN DNA excision repair protein ERCC-6-like 2 OS=Bos taurus OX=9913 GN=ERCC6L2 PE=2 SV=4 ER6L2_BOVIN reviewed DNA excision repair protein ERCC-6-like 2 (EC 3.6.4.-) Bos taurus (Bovine) GO:0000775; GO:0003677; GO:0004386; GO:0005524; GO:0005634; GO:0005739; GO:0005813; GO:0006974; GO:0016787; GO:0036297; GO:0097680 DNA damage response [GO:0006974]; double-strand break repair via classical nonhomologous end joining [GO:0097680]; interstrand cross-link repair [GO:0036297] centrosome [GO:0005813]; chromosome, centromeric region [GO:0000775]; mitochondrion [GO:0005739]; nucleus [GO:0005634] ATP binding [GO:0005524]; DNA binding [GO:0003677]; helicase activity [GO:0004386]; hydrolase activity [GO:0016787] g1769.t1 A2VDD2 61.151 139 1.2e-58 184.0 sp|A2VDD2|DYL5B_XENLA Dynein light chain Tctex-type 5-B (Fragment) OS=Xenopus laevis OX=8355 GN=Dynlt5-b PE=2 SV=1 g1769.t2 A2VDD2 57.955 176 7.989999999999999e-67 204.0 sp|A2VDD2|DYL5B_XENLA Dynein light chain Tctex-type 5-B (Fragment) OS=Xenopus laevis OX=8355 GN=Dynlt5-b PE=2 SV=1 g1770.t1 Q4ADV7 41.201 1432 0.0 1041.0 sp|Q4ADV7|RIC1_HUMAN Guanine nucleotide exchange factor subunit RIC1 OS=Homo sapiens OX=9606 GN=RIC1 PE=1 SV=2 RIC1_HUMAN reviewed Guanine nucleotide exchange factor subunit RIC1 (Connexin-43-interacting protein of 150 kDa) (Protein RIC1 homolog) (RAB6A-GEF complex partner protein 1) Homo sapiens (Human) GO:0000139; GO:0003330; GO:0005085; GO:0005829; GO:0006886; GO:0016020; GO:0031267; GO:0032588; GO:0032991; GO:0034066; GO:0042147; GO:0042177; GO:0043547; GO:1904888 cranial skeletal system development [GO:1904888]; intracellular protein transport [GO:0006886]; negative regulation of protein catabolic process [GO:0042177]; positive regulation of GTPase activity [GO:0043547]; regulation of extracellular matrix constituent secretion [GO:0003330]; retrograde transport, endosome to Golgi [GO:0042147] cytosol [GO:0005829]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; protein-containing complex [GO:0032991]; Ric1-Rgp1 guanyl-nucleotide exchange factor complex [GO:0034066]; trans-Golgi network membrane [GO:0032588] guanyl-nucleotide exchange factor activity [GO:0005085]; small GTPase binding [GO:0031267] g1772.t1 Q684M4 54.545 572 0.0 630.0 sp|Q684M4|KEAP1_PIG Kelch-like ECH-associated protein 1 OS=Sus scrofa OX=9823 GN=KEAP1 PE=3 SV=1 KEAP1_PIG reviewed Kelch-like ECH-associated protein 1 Sus scrofa (Pig) GO:0000122; GO:0001701; GO:0005654; GO:0005737; GO:0005783; GO:0005829; GO:0005884; GO:0006511; GO:0010506; GO:0016234; GO:0016567; GO:0030496; GO:0031463; GO:0034451; GO:0034599; GO:0042802; GO:0043161; GO:0045604; GO:0061629; GO:0070936; GO:0071353; GO:0097718; GO:0140416; GO:1902883; GO:1990756 cellular response to interleukin-4 [GO:0071353]; cellular response to oxidative stress [GO:0034599]; in utero embryonic development [GO:0001701]; negative regulation of response to oxidative stress [GO:1902883]; negative regulation of transcription by RNA polymerase II [GO:0000122]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K48-linked ubiquitination [GO:0070936]; protein ubiquitination [GO:0016567]; regulation of autophagy [GO:0010506]; regulation of epidermal cell differentiation [GO:0045604]; ubiquitin-dependent protein catabolic process [GO:0006511] actin filament [GO:0005884]; centriolar satellite [GO:0034451]; Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; inclusion body [GO:0016234]; midbody [GO:0030496]; nucleoplasm [GO:0005654] disordered domain specific binding [GO:0097718]; identical protein binding [GO:0042802]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription regulator inhibitor activity [GO:0140416]; ubiquitin-like ligase-substrate adaptor activity [GO:1990756] g1773.t1 Q90511 62.393 351 1.73e-156 446.0 sp|Q90511|EI2BB_TAKRU Translation initiation factor eIF2B subunit beta OS=Takifugu rubripes OX=31033 GN=eif2b2 PE=3 SV=1 g1774.t1 O95405 57.374 556 0.0 677.0 sp|O95405|ZFYV9_HUMAN Zinc finger FYVE domain-containing protein 9 OS=Homo sapiens OX=9606 GN=ZFYVE9 PE=1 SV=2 ZFYV9_HUMAN reviewed Zinc finger FYVE domain-containing protein 9 (Mothers against decapentaplegic homolog-interacting protein) (Madh-interacting protein) (Novel serine protease) (NSP) (Receptor activation anchor) (hSARA) (Smad anchor for receptor activation) Homo sapiens (Human) GO:0005545; GO:0005769; GO:0005829; GO:0006897; GO:0007179; GO:0008270; GO:0016197; GO:0019904; GO:0031901; GO:0032991 endocytosis [GO:0006897]; endosomal transport [GO:0016197]; transforming growth factor beta receptor signaling pathway [GO:0007179] cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; protein-containing complex [GO:0032991] 1-phosphatidylinositol binding [GO:0005545]; protein domain specific binding [GO:0019904]; zinc ion binding [GO:0008270] g1774.t1 O95405 57.143 98 1.6899999999999999e-28 128.0 sp|O95405|ZFYV9_HUMAN Zinc finger FYVE domain-containing protein 9 OS=Homo sapiens OX=9606 GN=ZFYVE9 PE=1 SV=2 ZFYV9_HUMAN reviewed Zinc finger FYVE domain-containing protein 9 (Mothers against decapentaplegic homolog-interacting protein) (Madh-interacting protein) (Novel serine protease) (NSP) (Receptor activation anchor) (hSARA) (Smad anchor for receptor activation) Homo sapiens (Human) GO:0005545; GO:0005769; GO:0005829; GO:0006897; GO:0007179; GO:0008270; GO:0016197; GO:0019904; GO:0031901; GO:0032991 endocytosis [GO:0006897]; endosomal transport [GO:0016197]; transforming growth factor beta receptor signaling pathway [GO:0007179] cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; protein-containing complex [GO:0032991] 1-phosphatidylinositol binding [GO:0005545]; protein domain specific binding [GO:0019904]; zinc ion binding [GO:0008270] g1774.t2 O95405 54.29 606 0.0 681.0 sp|O95405|ZFYV9_HUMAN Zinc finger FYVE domain-containing protein 9 OS=Homo sapiens OX=9606 GN=ZFYVE9 PE=1 SV=2 ZFYV9_HUMAN reviewed Zinc finger FYVE domain-containing protein 9 (Mothers against decapentaplegic homolog-interacting protein) (Madh-interacting protein) (Novel serine protease) (NSP) (Receptor activation anchor) (hSARA) (Smad anchor for receptor activation) Homo sapiens (Human) GO:0005545; GO:0005769; GO:0005829; GO:0006897; GO:0007179; GO:0008270; GO:0016197; GO:0019904; GO:0031901; GO:0032991 endocytosis [GO:0006897]; endosomal transport [GO:0016197]; transforming growth factor beta receptor signaling pathway [GO:0007179] cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; protein-containing complex [GO:0032991] 1-phosphatidylinositol binding [GO:0005545]; protein domain specific binding [GO:0019904]; zinc ion binding [GO:0008270] g1774.t2 O95405 65.823 79 1.62e-28 129.0 sp|O95405|ZFYV9_HUMAN Zinc finger FYVE domain-containing protein 9 OS=Homo sapiens OX=9606 GN=ZFYVE9 PE=1 SV=2 ZFYV9_HUMAN reviewed Zinc finger FYVE domain-containing protein 9 (Mothers against decapentaplegic homolog-interacting protein) (Madh-interacting protein) (Novel serine protease) (NSP) (Receptor activation anchor) (hSARA) (Smad anchor for receptor activation) Homo sapiens (Human) GO:0005545; GO:0005769; GO:0005829; GO:0006897; GO:0007179; GO:0008270; GO:0016197; GO:0019904; GO:0031901; GO:0032991 endocytosis [GO:0006897]; endosomal transport [GO:0016197]; transforming growth factor beta receptor signaling pathway [GO:0007179] cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; protein-containing complex [GO:0032991] 1-phosphatidylinositol binding [GO:0005545]; protein domain specific binding [GO:0019904]; zinc ion binding [GO:0008270] g1776.t1 Q9C0D3 45.672 751 0.0 575.0 sp|Q9C0D3|ZY11B_HUMAN Protein zyg-11 homolog B OS=Homo sapiens OX=9606 GN=ZYG11B PE=1 SV=2 g1777.t1 P37193 67.91 134 6.21e-63 195.0 sp|P37193|ADXH1_DROME Adrenodoxin-like protein 1, mitochondrial OS=Drosophila melanogaster OX=7227 GN=Fdx1 PE=2 SV=3 g1778.t1 Q5VU97 45.877 946 0.0 889.0 sp|Q5VU97|CAHD1_HUMAN VWFA and cache domain-containing protein 1 OS=Homo sapiens OX=9606 GN=CACHD1 PE=1 SV=2 CAHD1_HUMAN reviewed VWFA and cache domain-containing protein 1 (Cache domain-containing protein 1) Homo sapiens (Human) GO:0005245; GO:0005891 voltage-gated calcium channel complex [GO:0005891] voltage-gated calcium channel activity [GO:0005245] g1779.t1 Q5VU97 36.842 190 6.83e-27 97.4 sp|Q5VU97|CAHD1_HUMAN VWFA and cache domain-containing protein 1 OS=Homo sapiens OX=9606 GN=CACHD1 PE=1 SV=2 CAHD1_HUMAN reviewed VWFA and cache domain-containing protein 1 (Cache domain-containing protein 1) Homo sapiens (Human) GO:0005245; GO:0005891 voltage-gated calcium channel complex [GO:0005891] voltage-gated calcium channel activity [GO:0005245] g1779.t1 Q5VU97 42.105 57 6.83e-27 45.4 sp|Q5VU97|CAHD1_HUMAN VWFA and cache domain-containing protein 1 OS=Homo sapiens OX=9606 GN=CACHD1 PE=1 SV=2 CAHD1_HUMAN reviewed VWFA and cache domain-containing protein 1 (Cache domain-containing protein 1) Homo sapiens (Human) GO:0005245; GO:0005891 voltage-gated calcium channel complex [GO:0005891] voltage-gated calcium channel activity [GO:0005245] g1780.t1 Q15417 49.246 199 7.02e-57 185.0 sp|Q15417|CNN3_HUMAN Calponin-3 OS=Homo sapiens OX=9606 GN=CNN3 PE=1 SV=1 CNN3_HUMAN reviewed Calponin-3 (Calponin, acidic isoform) Homo sapiens (Human) GO:0005516; GO:0005829; GO:0005912; GO:0005925; GO:0007015; GO:0015629; GO:0030855; GO:0031032; GO:0051015; GO:0098641 actin filament organization [GO:0007015]; actomyosin structure organization [GO:0031032]; epithelial cell differentiation [GO:0030855] actin cytoskeleton [GO:0015629]; adherens junction [GO:0005912]; cytosol [GO:0005829]; focal adhesion [GO:0005925] actin filament binding [GO:0051015]; cadherin binding involved in cell-cell adhesion [GO:0098641]; calmodulin binding [GO:0005516] g1781.t1 P26932 47.568 185 1.41e-55 180.0 sp|P26932|CNN1_CHICK Calponin-1 OS=Gallus gallus OX=9031 GN=CNN1 PE=1 SV=2 g1785.t1 O14522 35.433 889 2.49e-158 532.0 sp|O14522|PTPRT_HUMAN Receptor-type tyrosine-protein phosphatase T OS=Homo sapiens OX=9606 GN=PTPRT PE=1 SV=6 PTPRT_HUMAN reviewed Receptor-type tyrosine-protein phosphatase T (R-PTP-T) (EC 3.1.3.48) (Receptor-type tyrosine-protein phosphatase rho) (RPTP-rho) Homo sapiens (Human) GO:0004725; GO:0005001; GO:0005886; GO:0006470; GO:0007155; GO:0007156; GO:0007165; GO:0007169; GO:0008013; GO:0009986; GO:0016020; GO:0016790; GO:0019903; GO:0030336; GO:0031175; GO:0042803; GO:0045294; GO:0045295; GO:0045296; GO:0051393; GO:0070097; GO:0071354; GO:0097677; GO:1904893 cell adhesion [GO:0007155]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; cellular response to interleukin-6 [GO:0071354]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell migration [GO:0030336]; negative regulation of receptor signaling pathway via STAT [GO:1904893]; neuron projection development [GO:0031175]; protein dephosphorylation [GO:0006470]; signal transduction [GO:0007165] cell surface [GO:0009986]; membrane [GO:0016020]; plasma membrane [GO:0005886] alpha-actinin binding [GO:0051393]; alpha-catenin binding [GO:0045294]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; delta-catenin binding [GO:0070097]; gamma-catenin binding [GO:0045295]; protein homodimerization activity [GO:0042803]; protein phosphatase binding [GO:0019903]; protein tyrosine phosphatase activity [GO:0004725]; STAT family protein binding [GO:0097677]; thiolester hydrolase activity [GO:0016790]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001] g1786.t1 Q28024 61.29 62 1.1e-23 87.4 sp|Q28024|GBG12_BOVIN Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-12 OS=Bos taurus OX=9913 GN=GNG12 PE=1 SV=2 GBG12_BOVIN reviewed Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-12 (Gamma-S1) Bos taurus (Bovine) GO:0005834; GO:0007186; GO:0030165; GO:0031681 G protein-coupled receptor signaling pathway [GO:0007186] heterotrimeric G-protein complex [GO:0005834] G-protein beta-subunit binding [GO:0031681]; PDZ domain binding [GO:0030165] g1787.t1 Q6NXW6 36.254 582 9.059999999999999e-115 360.0 sp|Q6NXW6|RAD17_MOUSE Cell cycle checkpoint protein RAD17 OS=Mus musculus OX=10090 GN=Rad17 PE=1 SV=2 RAD17_MOUSE reviewed Cell cycle checkpoint protein RAD17 Mus musculus (Mouse) GO:0000077; GO:0000781; GO:0003682; GO:0003689; GO:0005524; GO:0005654; GO:0005730; GO:0006281; GO:0006974; GO:0008156; GO:0031389; GO:0031573; GO:0033314; GO:0035861; GO:0140463; GO:1990166 DNA damage checkpoint signaling [GO:0000077]; DNA damage response [GO:0006974]; DNA repair [GO:0006281]; mitotic DNA replication checkpoint signaling [GO:0033314]; mitotic intra-S DNA damage checkpoint signaling [GO:0031573]; negative regulation of DNA replication [GO:0008156]; protein localization to site of double-strand break [GO:1990166] chromosome, telomeric region [GO:0000781]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; Rad17 RFC-like complex [GO:0031389]; site of double-strand break [GO:0035861] ATP binding [GO:0005524]; chromatin binding [GO:0003682]; chromatin-protein adaptor activity [GO:0140463]; DNA clamp loader activity [GO:0003689] g1789.t1 Q66IC8 41.085 129 1.34e-31 115.0 sp|Q66IC8|DYLT5_DANRE Dynein light chain Tctex-type 5 OS=Danio rerio OX=7955 GN=dynlt5 PE=2 SV=1 g1790.t1 P98157 47.619 168 1.17e-30 122.0 sp|P98157|LRP1_CHICK Low-density lipoprotein receptor-related protein 1 OS=Gallus gallus OX=9031 GN=LRP1 PE=2 SV=1 g1790.t1 P98157 44.633 177 6.72e-25 105.0 sp|P98157|LRP1_CHICK Low-density lipoprotein receptor-related protein 1 OS=Gallus gallus OX=9031 GN=LRP1 PE=2 SV=1 g1790.t1 P98157 46.154 156 1.0300000000000001e-22 99.4 sp|P98157|LRP1_CHICK Low-density lipoprotein receptor-related protein 1 OS=Gallus gallus OX=9031 GN=LRP1 PE=2 SV=1 g1790.t1 P98157 45.122 164 4.4e-22 97.4 sp|P98157|LRP1_CHICK Low-density lipoprotein receptor-related protein 1 OS=Gallus gallus OX=9031 GN=LRP1 PE=2 SV=1 g1791.t1 P35951 35.967 734 5.19e-124 412.0 sp|P35951|LDLR_MOUSE Low-density lipoprotein receptor OS=Mus musculus OX=10090 GN=Ldlr PE=1 SV=2 LDLR_MOUSE reviewed Low-density lipoprotein receptor (LDL receptor) Mus musculus (Mouse) GO:0001523; GO:0001540; GO:0001920; GO:0002020; GO:0005041; GO:0005509; GO:0005615; GO:0005764; GO:0005768; GO:0005769; GO:0005770; GO:0005794; GO:0005886; GO:0005901; GO:0005905; GO:0006629; GO:0006897; GO:0006898; GO:0006909; GO:0007616; GO:0008203; GO:0009897; GO:0009986; GO:0010628; GO:0010629; GO:0010867; GO:0010898; GO:0010899; GO:0010989; GO:0015914; GO:0016323; GO:0030169; GO:0030229; GO:0030299; GO:0030301; GO:0034362; GO:0034381; GO:0034383; GO:0034384; GO:0036477; GO:0042157; GO:0042159; GO:0042632; GO:0042802; GO:0043235; GO:0045177; GO:0048844; GO:0050729; GO:0051246; GO:0051248; GO:0055038; GO:0060090; GO:0060840; GO:0061771; GO:0061889; GO:0070508; GO:0071398; GO:0071404; GO:0071813; GO:0090118; GO:0090181; GO:0097242; GO:0097443; GO:0150094; GO:1903979; GO:1905167; GO:1905907; GO:1990666 amyloid-beta clearance [GO:0097242]; amyloid-beta clearance by cellular catabolic process [GO:0150094]; artery development [GO:0060840]; artery morphogenesis [GO:0048844]; cellular response to fatty acid [GO:0071398]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; cholesterol homeostasis [GO:0042632]; cholesterol import [GO:0070508]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; endocytosis [GO:0006897]; high-density lipoprotein particle clearance [GO:0034384]; intestinal cholesterol absorption [GO:0030299]; lipid metabolic process [GO:0006629]; lipoprotein catabolic process [GO:0042159]; lipoprotein metabolic process [GO:0042157]; long-term memory [GO:0007616]; low-density lipoprotein particle clearance [GO:0034383]; negative regulation of amyloid fibril formation [GO:1905907]; negative regulation of astrocyte activation [GO:0061889]; negative regulation of gene expression [GO:0010629]; negative regulation of low-density lipoprotein particle clearance [GO:0010989]; negative regulation of microglial cell activation [GO:1903979]; negative regulation of protein metabolic process [GO:0051248]; negative regulation of receptor recycling [GO:0001920]; phagocytosis [GO:0006909]; phospholipid transport [GO:0015914]; plasma lipoprotein particle clearance [GO:0034381]; positive regulation of gene expression [GO:0010628]; positive regulation of inflammatory response [GO:0050729]; positive regulation of lysosomal protein catabolic process [GO:1905167]; positive regulation of triglyceride biosynthetic process [GO:0010867]; positive regulation of triglyceride catabolic process [GO:0010898]; receptor-mediated endocytosis [GO:0006898]; receptor-mediated endocytosis involved in cholesterol transport [GO:0090118]; regulation of cholesterol metabolic process [GO:0090181]; regulation of phosphatidylcholine catabolic process [GO:0010899]; regulation of protein metabolic process [GO:0051246]; response to caloric restriction [GO:0061771]; retinoid metabolic process [GO:0001523] apical part of cell [GO:0045177]; basolateral plasma membrane [GO:0016323]; caveola [GO:0005901]; cell surface [GO:0009986]; clathrin-coated pit [GO:0005905]; early endosome [GO:0005769]; endosome [GO:0005768]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; late endosome [GO:0005770]; low-density lipoprotein particle [GO:0034362]; lysosome [GO:0005764]; PCSK9-LDLR complex [GO:1990666]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; recycling endosome membrane [GO:0055038]; somatodendritic compartment [GO:0036477]; sorting endosome [GO:0097443] amyloid-beta binding [GO:0001540]; calcium ion binding [GO:0005509]; identical protein binding [GO:0042802]; lipoprotein particle binding [GO:0071813]; low-density lipoprotein particle binding [GO:0030169]; low-density lipoprotein particle receptor activity [GO:0005041]; molecular adaptor activity [GO:0060090]; protease binding [GO:0002020]; very-low-density lipoprotein particle receptor activity [GO:0030229] g1791.t1 P35951 31.405 363 5.96e-42 171.0 sp|P35951|LDLR_MOUSE Low-density lipoprotein receptor OS=Mus musculus OX=10090 GN=Ldlr PE=1 SV=2 LDLR_MOUSE reviewed Low-density lipoprotein receptor (LDL receptor) Mus musculus (Mouse) GO:0001523; GO:0001540; GO:0001920; GO:0002020; GO:0005041; GO:0005509; GO:0005615; GO:0005764; GO:0005768; GO:0005769; GO:0005770; GO:0005794; GO:0005886; GO:0005901; GO:0005905; GO:0006629; GO:0006897; GO:0006898; GO:0006909; GO:0007616; GO:0008203; GO:0009897; GO:0009986; GO:0010628; GO:0010629; GO:0010867; GO:0010898; GO:0010899; GO:0010989; GO:0015914; GO:0016323; GO:0030169; GO:0030229; GO:0030299; GO:0030301; GO:0034362; GO:0034381; GO:0034383; GO:0034384; GO:0036477; GO:0042157; GO:0042159; GO:0042632; GO:0042802; GO:0043235; GO:0045177; GO:0048844; GO:0050729; GO:0051246; GO:0051248; GO:0055038; GO:0060090; GO:0060840; GO:0061771; GO:0061889; GO:0070508; GO:0071398; GO:0071404; GO:0071813; GO:0090118; GO:0090181; GO:0097242; GO:0097443; GO:0150094; GO:1903979; GO:1905167; GO:1905907; GO:1990666 amyloid-beta clearance [GO:0097242]; amyloid-beta clearance by cellular catabolic process [GO:0150094]; artery development [GO:0060840]; artery morphogenesis [GO:0048844]; cellular response to fatty acid [GO:0071398]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; cholesterol homeostasis [GO:0042632]; cholesterol import [GO:0070508]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; endocytosis [GO:0006897]; high-density lipoprotein particle clearance [GO:0034384]; intestinal cholesterol absorption [GO:0030299]; lipid metabolic process [GO:0006629]; lipoprotein catabolic process [GO:0042159]; lipoprotein metabolic process [GO:0042157]; long-term memory [GO:0007616]; low-density lipoprotein particle clearance [GO:0034383]; negative regulation of amyloid fibril formation [GO:1905907]; negative regulation of astrocyte activation [GO:0061889]; negative regulation of gene expression [GO:0010629]; negative regulation of low-density lipoprotein particle clearance [GO:0010989]; negative regulation of microglial cell activation [GO:1903979]; negative regulation of protein metabolic process [GO:0051248]; negative regulation of receptor recycling [GO:0001920]; phagocytosis [GO:0006909]; phospholipid transport [GO:0015914]; plasma lipoprotein particle clearance [GO:0034381]; positive regulation of gene expression [GO:0010628]; positive regulation of inflammatory response [GO:0050729]; positive regulation of lysosomal protein catabolic process [GO:1905167]; positive regulation of triglyceride biosynthetic process [GO:0010867]; positive regulation of triglyceride catabolic process [GO:0010898]; receptor-mediated endocytosis [GO:0006898]; receptor-mediated endocytosis involved in cholesterol transport [GO:0090118]; regulation of cholesterol metabolic process [GO:0090181]; regulation of phosphatidylcholine catabolic process [GO:0010899]; regulation of protein metabolic process [GO:0051246]; response to caloric restriction [GO:0061771]; retinoid metabolic process [GO:0001523] apical part of cell [GO:0045177]; basolateral plasma membrane [GO:0016323]; caveola [GO:0005901]; cell surface [GO:0009986]; clathrin-coated pit [GO:0005905]; early endosome [GO:0005769]; endosome [GO:0005768]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; late endosome [GO:0005770]; low-density lipoprotein particle [GO:0034362]; lysosome [GO:0005764]; PCSK9-LDLR complex [GO:1990666]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; recycling endosome membrane [GO:0055038]; somatodendritic compartment [GO:0036477]; sorting endosome [GO:0097443] amyloid-beta binding [GO:0001540]; calcium ion binding [GO:0005509]; identical protein binding [GO:0042802]; lipoprotein particle binding [GO:0071813]; low-density lipoprotein particle binding [GO:0030169]; low-density lipoprotein particle receptor activity [GO:0005041]; molecular adaptor activity [GO:0060090]; protease binding [GO:0002020]; very-low-density lipoprotein particle receptor activity [GO:0030229] g1791.t1 P35951 28.095 420 3.38e-37 156.0 sp|P35951|LDLR_MOUSE Low-density lipoprotein receptor OS=Mus musculus OX=10090 GN=Ldlr PE=1 SV=2 LDLR_MOUSE reviewed Low-density lipoprotein receptor (LDL receptor) Mus musculus (Mouse) GO:0001523; GO:0001540; GO:0001920; GO:0002020; GO:0005041; GO:0005509; GO:0005615; GO:0005764; GO:0005768; GO:0005769; GO:0005770; GO:0005794; GO:0005886; GO:0005901; GO:0005905; GO:0006629; GO:0006897; GO:0006898; GO:0006909; GO:0007616; GO:0008203; GO:0009897; GO:0009986; GO:0010628; GO:0010629; GO:0010867; GO:0010898; GO:0010899; GO:0010989; GO:0015914; GO:0016323; GO:0030169; GO:0030229; GO:0030299; GO:0030301; GO:0034362; GO:0034381; GO:0034383; GO:0034384; GO:0036477; GO:0042157; GO:0042159; GO:0042632; GO:0042802; GO:0043235; GO:0045177; GO:0048844; GO:0050729; GO:0051246; GO:0051248; GO:0055038; GO:0060090; GO:0060840; GO:0061771; GO:0061889; GO:0070508; GO:0071398; GO:0071404; GO:0071813; GO:0090118; GO:0090181; GO:0097242; GO:0097443; GO:0150094; GO:1903979; GO:1905167; GO:1905907; GO:1990666 amyloid-beta clearance [GO:0097242]; amyloid-beta clearance by cellular catabolic process [GO:0150094]; artery development [GO:0060840]; artery morphogenesis [GO:0048844]; cellular response to fatty acid [GO:0071398]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; cholesterol homeostasis [GO:0042632]; cholesterol import [GO:0070508]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; endocytosis [GO:0006897]; high-density lipoprotein particle clearance [GO:0034384]; intestinal cholesterol absorption [GO:0030299]; lipid metabolic process [GO:0006629]; lipoprotein catabolic process [GO:0042159]; lipoprotein metabolic process [GO:0042157]; long-term memory [GO:0007616]; low-density lipoprotein particle clearance [GO:0034383]; negative regulation of amyloid fibril formation [GO:1905907]; negative regulation of astrocyte activation [GO:0061889]; negative regulation of gene expression [GO:0010629]; negative regulation of low-density lipoprotein particle clearance [GO:0010989]; negative regulation of microglial cell activation [GO:1903979]; negative regulation of protein metabolic process [GO:0051248]; negative regulation of receptor recycling [GO:0001920]; phagocytosis [GO:0006909]; phospholipid transport [GO:0015914]; plasma lipoprotein particle clearance [GO:0034381]; positive regulation of gene expression [GO:0010628]; positive regulation of inflammatory response [GO:0050729]; positive regulation of lysosomal protein catabolic process [GO:1905167]; positive regulation of triglyceride biosynthetic process [GO:0010867]; positive regulation of triglyceride catabolic process [GO:0010898]; receptor-mediated endocytosis [GO:0006898]; receptor-mediated endocytosis involved in cholesterol transport [GO:0090118]; regulation of cholesterol metabolic process [GO:0090181]; regulation of phosphatidylcholine catabolic process [GO:0010899]; regulation of protein metabolic process [GO:0051246]; response to caloric restriction [GO:0061771]; retinoid metabolic process [GO:0001523] apical part of cell [GO:0045177]; basolateral plasma membrane [GO:0016323]; caveola [GO:0005901]; cell surface [GO:0009986]; clathrin-coated pit [GO:0005905]; early endosome [GO:0005769]; endosome [GO:0005768]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; late endosome [GO:0005770]; low-density lipoprotein particle [GO:0034362]; lysosome [GO:0005764]; PCSK9-LDLR complex [GO:1990666]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; recycling endosome membrane [GO:0055038]; somatodendritic compartment [GO:0036477]; sorting endosome [GO:0097443] amyloid-beta binding [GO:0001540]; calcium ion binding [GO:0005509]; identical protein binding [GO:0042802]; lipoprotein particle binding [GO:0071813]; low-density lipoprotein particle binding [GO:0030169]; low-density lipoprotein particle receptor activity [GO:0005041]; molecular adaptor activity [GO:0060090]; protease binding [GO:0002020]; very-low-density lipoprotein particle receptor activity [GO:0030229] g1794.t1 P98165 33.5 400 1.09e-57 208.0 sp|P98165|VLDLR_CHICK Very low-density lipoprotein receptor OS=Gallus gallus OX=9031 GN=VLDLR PE=1 SV=1 g1794.t1 P98165 43.373 83 1.09e-57 40.0 sp|P98165|VLDLR_CHICK Very low-density lipoprotein receptor OS=Gallus gallus OX=9031 GN=VLDLR PE=1 SV=1 g1794.t1 P98165 28.252 492 8.17e-38 158.0 sp|P98165|VLDLR_CHICK Very low-density lipoprotein receptor OS=Gallus gallus OX=9031 GN=VLDLR PE=1 SV=1 g1794.t1 P98165 29.157 439 1.79e-37 157.0 sp|P98165|VLDLR_CHICK Very low-density lipoprotein receptor OS=Gallus gallus OX=9031 GN=VLDLR PE=1 SV=1 g1797.t1 Q06807 49.388 245 9.75e-73 243.0 sp|Q06807|TIE2_BOVIN Angiopoietin-1 receptor OS=Bos taurus OX=9913 GN=TEK PE=2 SV=1 TIE2_BOVIN reviewed Angiopoietin-1 receptor (EC 2.7.10.1) (Endothelial tyrosine kinase) (Tyrosine kinase with Ig and EGF homology domains-2) (Tyrosine-protein kinase receptor TIE-2) (CD antigen CD202b) Bos taurus (Bovine) GO:0001525; GO:0001935; GO:0001936; GO:0002040; GO:0004714; GO:0005524; GO:0005576; GO:0005856; GO:0005886; GO:0005925; GO:0007169; GO:0007507; GO:0010595; GO:0016525; GO:0030097; GO:0032878; GO:0034446; GO:0043235; GO:0043410; GO:0045766; GO:0048014; GO:0051894; GO:0051897; GO:0060347; GO:0070374; GO:1902533; GO:2000352 angiogenesis [GO:0001525]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; endothelial cell proliferation [GO:0001935]; heart development [GO:0007507]; heart trabecula formation [GO:0060347]; hemopoiesis [GO:0030097]; negative regulation of angiogenesis [GO:0016525]; negative regulation of endothelial cell apoptotic process [GO:2000352]; positive regulation of angiogenesis [GO:0045766]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of intracellular signal transduction [GO:1902533]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; regulation of endothelial cell proliferation [GO:0001936]; regulation of establishment or maintenance of cell polarity [GO:0032878]; sprouting angiogenesis [GO:0002040]; substrate adhesion-dependent cell spreading [GO:0034446]; Tie signaling pathway [GO:0048014] cytoskeleton [GO:0005856]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] ATP binding [GO:0005524]; transmembrane receptor protein tyrosine kinase activity [GO:0004714] g1798.t1 Q06806 25.493 710 1.29e-34 147.0 sp|Q06806|TIE1_MOUSE Tyrosine-protein kinase receptor Tie-1 OS=Mus musculus OX=10090 GN=Tie1 PE=1 SV=3 TIE1_MOUSE reviewed Tyrosine-protein kinase receptor Tie-1 (EC 2.7.10.1) Mus musculus (Mouse) GO:0001525; GO:0001568; GO:0001570; GO:0001701; GO:0001936; GO:0003180; GO:0004714; GO:0005524; GO:0005886; GO:0007169; GO:0016020; GO:0016525; GO:0030336; GO:0032526; GO:0043235; GO:0045026; GO:0045766; GO:0048771; GO:0060836; GO:0060854; GO:1901201 angiogenesis [GO:0001525]; aortic valve morphogenesis [GO:0003180]; blood vessel development [GO:0001568]; branching involved in lymph vessel morphogenesis [GO:0060854]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; in utero embryonic development [GO:0001701]; lymphatic endothelial cell differentiation [GO:0060836]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell migration [GO:0030336]; plasma membrane fusion [GO:0045026]; positive regulation of angiogenesis [GO:0045766]; regulation of endothelial cell proliferation [GO:0001936]; regulation of extracellular matrix assembly [GO:1901201]; response to retinoic acid [GO:0032526]; tissue remodeling [GO:0048771]; vasculogenesis [GO:0001570] membrane [GO:0016020]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] ATP binding [GO:0005524]; transmembrane receptor protein tyrosine kinase activity [GO:0004714] g1802.t1 O73792 47.934 121 7.930000000000001e-35 122.0 sp|O73792|TIE1_DANRE Tyrosine-protein kinase receptor Tie-1 (Fragment) OS=Danio rerio OX=7955 GN=tie1 PE=1 SV=1 g1802.t2 O73792 47.154 123 1.11e-34 124.0 sp|O73792|TIE1_DANRE Tyrosine-protein kinase receptor Tie-1 (Fragment) OS=Danio rerio OX=7955 GN=tie1 PE=1 SV=1 g1805.t1 Q90XC2 57.797 699 0.0 782.0 sp|Q90XC2|NEK8_DANRE Serine/threonine-protein kinase Nek8 OS=Danio rerio OX=7955 GN=nek8 PE=2 SV=1 NEK8_DANRE reviewed Serine/threonine-protein kinase Nek8 (EC 2.7.11.1) (Never in mitosis A-related kinase 8) (NimA-related protein kinase 8) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001947; GO:0004674; GO:0005524; GO:0005813; GO:0005929; GO:0005930; GO:0009887; GO:0046872; GO:0048793; GO:0051301; GO:0061326; GO:0061371; GO:0072116; GO:0106310 animal organ morphogenesis [GO:0009887]; cell division [GO:0051301]; determination of heart left/right asymmetry [GO:0061371]; heart looping [GO:0001947]; pronephros development [GO:0048793]; pronephros formation [GO:0072116]; renal tubule development [GO:0061326] axoneme [GO:0005930]; centrosome [GO:0005813]; cilium [GO:0005929] ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g1806.t1 Q4R8Y8 67.949 234 2.92e-91 273.0 sp|Q4R8Y8|RU2A_MACFA U2 small nuclear ribonucleoprotein A' OS=Macaca fascicularis OX=9541 GN=SNRPA1 PE=2 SV=1 g1807.t1 P41233 47.395 998 0.0 865.0 sp|P41233|ABCA1_MOUSE Phospholipid-transporting ATPase ABCA1 OS=Mus musculus OX=10090 GN=Abca1 PE=1 SV=4 ABCA1_MOUSE reviewed Phospholipid-transporting ATPase ABCA1 (EC 7.6.2.1) (ATP-binding cassette sub-family A member 1) (ATP-binding cassette transporter 1) (ABC-1) (ATP-binding cassette 1) Mus musculus (Mouse) GO:0002790; GO:0005102; GO:0005524; GO:0005548; GO:0005768; GO:0005794; GO:0005886; GO:0006911; GO:0007040; GO:0007186; GO:0007189; GO:0008035; GO:0008203; GO:0008320; GO:0009306; GO:0009897; GO:0009986; GO:0010875; GO:0015914; GO:0016197; GO:0016323; GO:0016887; GO:0019905; GO:0023061; GO:0030139; GO:0030301; GO:0031210; GO:0031267; GO:0032367; GO:0032489; GO:0033344; GO:0033552; GO:0033700; GO:0034185; GO:0034186; GO:0034188; GO:0034380; GO:0034616; GO:0042157; GO:0042158; GO:0042626; GO:0042632; GO:0043691; GO:0045121; GO:0045332; GO:0045335; GO:0046623; GO:0048471; GO:0051117; GO:0055091; GO:0060155; GO:0071222; GO:0071300; GO:0071345; GO:0071397; GO:0071466; GO:0071806; GO:0090108; GO:0090554; GO:0090556; GO:0097708; GO:0120020; GO:0140115; GO:0140328; GO:0140359 adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cellular response to cholesterol [GO:0071397]; cellular response to cytokine stimulus [GO:0071345]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to retinoic acid [GO:0071300]; cellular response to xenobiotic stimulus [GO:0071466]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; endosomal transport [GO:0016197]; export across plasma membrane [GO:0140115]; G protein-coupled receptor signaling pathway [GO:0007186]; high-density lipoprotein particle assembly [GO:0034380]; intracellular cholesterol transport [GO:0032367]; lipoprotein biosynthetic process [GO:0042158]; lipoprotein metabolic process [GO:0042157]; lysosome organization [GO:0007040]; peptide secretion [GO:0002790]; phagocytosis, engulfment [GO:0006911]; phospholipid efflux [GO:0033700]; phospholipid homeostasis [GO:0055091]; phospholipid translocation [GO:0045332]; phospholipid transport [GO:0015914]; platelet dense granule organization [GO:0060155]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of high-density lipoprotein particle assembly [GO:0090108]; protein secretion [GO:0009306]; protein transmembrane transport [GO:0071806]; regulation of Cdc42 protein signal transduction [GO:0032489]; response to laminar fluid shear stress [GO:0034616]; response to vitamin B3 [GO:0033552]; reverse cholesterol transport [GO:0043691]; signal release [GO:0023061] basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; external side of plasma membrane [GO:0009897]; Golgi apparatus [GO:0005794]; intracellular vesicle [GO:0097708]; membrane raft [GO:0045121]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886] ABC-type transporter activity [GO:0140359]; apolipoprotein A-I binding [GO:0034186]; apolipoprotein A-I receptor activity [GO:0034188]; apolipoprotein binding [GO:0034185]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase binding [GO:0051117]; ATPase-coupled transmembrane transporter activity [GO:0042626]; cholesterol transfer activity [GO:0120020]; floppase activity [GO:0140328]; high-density lipoprotein particle binding [GO:0008035]; phosphatidylcholine binding [GO:0031210]; phosphatidylcholine floppase activity [GO:0090554]; phosphatidylserine floppase activity [GO:0090556]; phospholipid transporter activity [GO:0005548]; protein transmembrane transporter activity [GO:0008320]; signaling receptor binding [GO:0005102]; small GTPase binding [GO:0031267]; sphingolipid floppase activity [GO:0046623]; syntaxin binding [GO:0019905] g1807.t1 P41233 43.501 977 0.0 789.0 sp|P41233|ABCA1_MOUSE Phospholipid-transporting ATPase ABCA1 OS=Mus musculus OX=10090 GN=Abca1 PE=1 SV=4 ABCA1_MOUSE reviewed Phospholipid-transporting ATPase ABCA1 (EC 7.6.2.1) (ATP-binding cassette sub-family A member 1) (ATP-binding cassette transporter 1) (ABC-1) (ATP-binding cassette 1) Mus musculus (Mouse) GO:0002790; GO:0005102; GO:0005524; GO:0005548; GO:0005768; GO:0005794; GO:0005886; GO:0006911; GO:0007040; GO:0007186; GO:0007189; GO:0008035; GO:0008203; GO:0008320; GO:0009306; GO:0009897; GO:0009986; GO:0010875; GO:0015914; GO:0016197; GO:0016323; GO:0016887; GO:0019905; GO:0023061; GO:0030139; GO:0030301; GO:0031210; GO:0031267; GO:0032367; GO:0032489; GO:0033344; GO:0033552; GO:0033700; GO:0034185; GO:0034186; GO:0034188; GO:0034380; GO:0034616; GO:0042157; GO:0042158; GO:0042626; GO:0042632; GO:0043691; GO:0045121; GO:0045332; GO:0045335; GO:0046623; GO:0048471; GO:0051117; GO:0055091; GO:0060155; GO:0071222; GO:0071300; GO:0071345; GO:0071397; GO:0071466; GO:0071806; GO:0090108; GO:0090554; GO:0090556; GO:0097708; GO:0120020; GO:0140115; GO:0140328; GO:0140359 adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cellular response to cholesterol [GO:0071397]; cellular response to cytokine stimulus [GO:0071345]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to retinoic acid [GO:0071300]; cellular response to xenobiotic stimulus [GO:0071466]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; endosomal transport [GO:0016197]; export across plasma membrane [GO:0140115]; G protein-coupled receptor signaling pathway [GO:0007186]; high-density lipoprotein particle assembly [GO:0034380]; intracellular cholesterol transport [GO:0032367]; lipoprotein biosynthetic process [GO:0042158]; lipoprotein metabolic process [GO:0042157]; lysosome organization [GO:0007040]; peptide secretion [GO:0002790]; phagocytosis, engulfment [GO:0006911]; phospholipid efflux [GO:0033700]; phospholipid homeostasis [GO:0055091]; phospholipid translocation [GO:0045332]; phospholipid transport [GO:0015914]; platelet dense granule organization [GO:0060155]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of high-density lipoprotein particle assembly [GO:0090108]; protein secretion [GO:0009306]; protein transmembrane transport [GO:0071806]; regulation of Cdc42 protein signal transduction [GO:0032489]; response to laminar fluid shear stress [GO:0034616]; response to vitamin B3 [GO:0033552]; reverse cholesterol transport [GO:0043691]; signal release [GO:0023061] basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; external side of plasma membrane [GO:0009897]; Golgi apparatus [GO:0005794]; intracellular vesicle [GO:0097708]; membrane raft [GO:0045121]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886] ABC-type transporter activity [GO:0140359]; apolipoprotein A-I binding [GO:0034186]; apolipoprotein A-I receptor activity [GO:0034188]; apolipoprotein binding [GO:0034185]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase binding [GO:0051117]; ATPase-coupled transmembrane transporter activity [GO:0042626]; cholesterol transfer activity [GO:0120020]; floppase activity [GO:0140328]; high-density lipoprotein particle binding [GO:0008035]; phosphatidylcholine binding [GO:0031210]; phosphatidylcholine floppase activity [GO:0090554]; phosphatidylserine floppase activity [GO:0090556]; phospholipid transporter activity [GO:0005548]; protein transmembrane transporter activity [GO:0008320]; signaling receptor binding [GO:0005102]; small GTPase binding [GO:0031267]; sphingolipid floppase activity [GO:0046623]; syntaxin binding [GO:0019905] g1807.t1 P41233 24.827 721 2.5e-47 192.0 sp|P41233|ABCA1_MOUSE Phospholipid-transporting ATPase ABCA1 OS=Mus musculus OX=10090 GN=Abca1 PE=1 SV=4 ABCA1_MOUSE reviewed Phospholipid-transporting ATPase ABCA1 (EC 7.6.2.1) (ATP-binding cassette sub-family A member 1) (ATP-binding cassette transporter 1) (ABC-1) (ATP-binding cassette 1) Mus musculus (Mouse) GO:0002790; GO:0005102; GO:0005524; GO:0005548; GO:0005768; GO:0005794; GO:0005886; GO:0006911; GO:0007040; GO:0007186; GO:0007189; GO:0008035; GO:0008203; GO:0008320; GO:0009306; GO:0009897; GO:0009986; GO:0010875; GO:0015914; GO:0016197; GO:0016323; GO:0016887; GO:0019905; GO:0023061; GO:0030139; GO:0030301; GO:0031210; GO:0031267; GO:0032367; GO:0032489; GO:0033344; GO:0033552; GO:0033700; GO:0034185; GO:0034186; GO:0034188; GO:0034380; GO:0034616; GO:0042157; GO:0042158; GO:0042626; GO:0042632; GO:0043691; GO:0045121; GO:0045332; GO:0045335; GO:0046623; GO:0048471; GO:0051117; GO:0055091; GO:0060155; GO:0071222; GO:0071300; GO:0071345; GO:0071397; GO:0071466; GO:0071806; GO:0090108; GO:0090554; GO:0090556; GO:0097708; GO:0120020; GO:0140115; GO:0140328; GO:0140359 adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cellular response to cholesterol [GO:0071397]; cellular response to cytokine stimulus [GO:0071345]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to retinoic acid [GO:0071300]; cellular response to xenobiotic stimulus [GO:0071466]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; endosomal transport [GO:0016197]; export across plasma membrane [GO:0140115]; G protein-coupled receptor signaling pathway [GO:0007186]; high-density lipoprotein particle assembly [GO:0034380]; intracellular cholesterol transport [GO:0032367]; lipoprotein biosynthetic process [GO:0042158]; lipoprotein metabolic process [GO:0042157]; lysosome organization [GO:0007040]; peptide secretion [GO:0002790]; phagocytosis, engulfment [GO:0006911]; phospholipid efflux [GO:0033700]; phospholipid homeostasis [GO:0055091]; phospholipid translocation [GO:0045332]; phospholipid transport [GO:0015914]; platelet dense granule organization [GO:0060155]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of high-density lipoprotein particle assembly [GO:0090108]; protein secretion [GO:0009306]; protein transmembrane transport [GO:0071806]; regulation of Cdc42 protein signal transduction [GO:0032489]; response to laminar fluid shear stress [GO:0034616]; response to vitamin B3 [GO:0033552]; reverse cholesterol transport [GO:0043691]; signal release [GO:0023061] basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; external side of plasma membrane [GO:0009897]; Golgi apparatus [GO:0005794]; intracellular vesicle [GO:0097708]; membrane raft [GO:0045121]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886] ABC-type transporter activity [GO:0140359]; apolipoprotein A-I binding [GO:0034186]; apolipoprotein A-I receptor activity [GO:0034188]; apolipoprotein binding [GO:0034185]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase binding [GO:0051117]; ATPase-coupled transmembrane transporter activity [GO:0042626]; cholesterol transfer activity [GO:0120020]; floppase activity [GO:0140328]; high-density lipoprotein particle binding [GO:0008035]; phosphatidylcholine binding [GO:0031210]; phosphatidylcholine floppase activity [GO:0090554]; phosphatidylserine floppase activity [GO:0090556]; phospholipid transporter activity [GO:0005548]; protein transmembrane transporter activity [GO:0008320]; signaling receptor binding [GO:0005102]; small GTPase binding [GO:0031267]; sphingolipid floppase activity [GO:0046623]; syntaxin binding [GO:0019905] g1807.t1 P41233 39.526 253 2.5399999999999998e-45 186.0 sp|P41233|ABCA1_MOUSE Phospholipid-transporting ATPase ABCA1 OS=Mus musculus OX=10090 GN=Abca1 PE=1 SV=4 ABCA1_MOUSE reviewed Phospholipid-transporting ATPase ABCA1 (EC 7.6.2.1) (ATP-binding cassette sub-family A member 1) (ATP-binding cassette transporter 1) (ABC-1) (ATP-binding cassette 1) Mus musculus (Mouse) GO:0002790; GO:0005102; GO:0005524; GO:0005548; GO:0005768; GO:0005794; GO:0005886; GO:0006911; GO:0007040; GO:0007186; GO:0007189; GO:0008035; GO:0008203; GO:0008320; GO:0009306; GO:0009897; GO:0009986; GO:0010875; GO:0015914; GO:0016197; GO:0016323; GO:0016887; GO:0019905; GO:0023061; GO:0030139; GO:0030301; GO:0031210; GO:0031267; GO:0032367; GO:0032489; GO:0033344; GO:0033552; GO:0033700; GO:0034185; GO:0034186; GO:0034188; GO:0034380; GO:0034616; GO:0042157; GO:0042158; GO:0042626; GO:0042632; GO:0043691; GO:0045121; GO:0045332; GO:0045335; GO:0046623; GO:0048471; GO:0051117; GO:0055091; GO:0060155; GO:0071222; GO:0071300; GO:0071345; GO:0071397; GO:0071466; GO:0071806; GO:0090108; GO:0090554; GO:0090556; GO:0097708; GO:0120020; GO:0140115; GO:0140328; GO:0140359 adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cellular response to cholesterol [GO:0071397]; cellular response to cytokine stimulus [GO:0071345]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to retinoic acid [GO:0071300]; cellular response to xenobiotic stimulus [GO:0071466]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; endosomal transport [GO:0016197]; export across plasma membrane [GO:0140115]; G protein-coupled receptor signaling pathway [GO:0007186]; high-density lipoprotein particle assembly [GO:0034380]; intracellular cholesterol transport [GO:0032367]; lipoprotein biosynthetic process [GO:0042158]; lipoprotein metabolic process [GO:0042157]; lysosome organization [GO:0007040]; peptide secretion [GO:0002790]; phagocytosis, engulfment [GO:0006911]; phospholipid efflux [GO:0033700]; phospholipid homeostasis [GO:0055091]; phospholipid translocation [GO:0045332]; phospholipid transport [GO:0015914]; platelet dense granule organization [GO:0060155]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of high-density lipoprotein particle assembly [GO:0090108]; protein secretion [GO:0009306]; protein transmembrane transport [GO:0071806]; regulation of Cdc42 protein signal transduction [GO:0032489]; response to laminar fluid shear stress [GO:0034616]; response to vitamin B3 [GO:0033552]; reverse cholesterol transport [GO:0043691]; signal release [GO:0023061] basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; external side of plasma membrane [GO:0009897]; Golgi apparatus [GO:0005794]; intracellular vesicle [GO:0097708]; membrane raft [GO:0045121]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886] ABC-type transporter activity [GO:0140359]; apolipoprotein A-I binding [GO:0034186]; apolipoprotein A-I receptor activity [GO:0034188]; apolipoprotein binding [GO:0034185]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase binding [GO:0051117]; ATPase-coupled transmembrane transporter activity [GO:0042626]; cholesterol transfer activity [GO:0120020]; floppase activity [GO:0140328]; high-density lipoprotein particle binding [GO:0008035]; phosphatidylcholine binding [GO:0031210]; phosphatidylcholine floppase activity [GO:0090554]; phosphatidylserine floppase activity [GO:0090556]; phospholipid transporter activity [GO:0005548]; protein transmembrane transporter activity [GO:0008320]; signaling receptor binding [GO:0005102]; small GTPase binding [GO:0031267]; sphingolipid floppase activity [GO:0046623]; syntaxin binding [GO:0019905] g1807.t2 P41233 47.395 998 0.0 865.0 sp|P41233|ABCA1_MOUSE Phospholipid-transporting ATPase ABCA1 OS=Mus musculus OX=10090 GN=Abca1 PE=1 SV=4 ABCA1_MOUSE reviewed Phospholipid-transporting ATPase ABCA1 (EC 7.6.2.1) (ATP-binding cassette sub-family A member 1) (ATP-binding cassette transporter 1) (ABC-1) (ATP-binding cassette 1) Mus musculus (Mouse) GO:0002790; GO:0005102; GO:0005524; GO:0005548; GO:0005768; GO:0005794; GO:0005886; GO:0006911; GO:0007040; GO:0007186; GO:0007189; GO:0008035; GO:0008203; GO:0008320; GO:0009306; GO:0009897; GO:0009986; GO:0010875; GO:0015914; GO:0016197; GO:0016323; GO:0016887; GO:0019905; GO:0023061; GO:0030139; GO:0030301; GO:0031210; GO:0031267; GO:0032367; GO:0032489; GO:0033344; GO:0033552; GO:0033700; GO:0034185; GO:0034186; GO:0034188; GO:0034380; GO:0034616; GO:0042157; GO:0042158; GO:0042626; GO:0042632; GO:0043691; GO:0045121; GO:0045332; GO:0045335; GO:0046623; GO:0048471; GO:0051117; GO:0055091; GO:0060155; GO:0071222; GO:0071300; GO:0071345; GO:0071397; GO:0071466; GO:0071806; GO:0090108; GO:0090554; GO:0090556; GO:0097708; GO:0120020; GO:0140115; GO:0140328; GO:0140359 adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cellular response to cholesterol [GO:0071397]; cellular response to cytokine stimulus [GO:0071345]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to retinoic acid [GO:0071300]; cellular response to xenobiotic stimulus [GO:0071466]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; endosomal transport [GO:0016197]; export across plasma membrane [GO:0140115]; G protein-coupled receptor signaling pathway [GO:0007186]; high-density lipoprotein particle assembly [GO:0034380]; intracellular cholesterol transport [GO:0032367]; lipoprotein biosynthetic process [GO:0042158]; lipoprotein metabolic process [GO:0042157]; lysosome organization [GO:0007040]; peptide secretion [GO:0002790]; phagocytosis, engulfment [GO:0006911]; phospholipid efflux [GO:0033700]; phospholipid homeostasis [GO:0055091]; phospholipid translocation [GO:0045332]; phospholipid transport [GO:0015914]; platelet dense granule organization [GO:0060155]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of high-density lipoprotein particle assembly [GO:0090108]; protein secretion [GO:0009306]; protein transmembrane transport [GO:0071806]; regulation of Cdc42 protein signal transduction [GO:0032489]; response to laminar fluid shear stress [GO:0034616]; response to vitamin B3 [GO:0033552]; reverse cholesterol transport [GO:0043691]; signal release [GO:0023061] basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; external side of plasma membrane [GO:0009897]; Golgi apparatus [GO:0005794]; intracellular vesicle [GO:0097708]; membrane raft [GO:0045121]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886] ABC-type transporter activity [GO:0140359]; apolipoprotein A-I binding [GO:0034186]; apolipoprotein A-I receptor activity [GO:0034188]; apolipoprotein binding [GO:0034185]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase binding [GO:0051117]; ATPase-coupled transmembrane transporter activity [GO:0042626]; cholesterol transfer activity [GO:0120020]; floppase activity [GO:0140328]; high-density lipoprotein particle binding [GO:0008035]; phosphatidylcholine binding [GO:0031210]; phosphatidylcholine floppase activity [GO:0090554]; phosphatidylserine floppase activity [GO:0090556]; phospholipid transporter activity [GO:0005548]; protein transmembrane transporter activity [GO:0008320]; signaling receptor binding [GO:0005102]; small GTPase binding [GO:0031267]; sphingolipid floppase activity [GO:0046623]; syntaxin binding [GO:0019905] g1807.t2 P41233 47.97 788 0.0 754.0 sp|P41233|ABCA1_MOUSE Phospholipid-transporting ATPase ABCA1 OS=Mus musculus OX=10090 GN=Abca1 PE=1 SV=4 ABCA1_MOUSE reviewed Phospholipid-transporting ATPase ABCA1 (EC 7.6.2.1) (ATP-binding cassette sub-family A member 1) (ATP-binding cassette transporter 1) (ABC-1) (ATP-binding cassette 1) Mus musculus (Mouse) GO:0002790; GO:0005102; GO:0005524; GO:0005548; GO:0005768; GO:0005794; GO:0005886; GO:0006911; GO:0007040; GO:0007186; GO:0007189; GO:0008035; GO:0008203; GO:0008320; GO:0009306; GO:0009897; GO:0009986; GO:0010875; GO:0015914; GO:0016197; GO:0016323; GO:0016887; GO:0019905; GO:0023061; GO:0030139; GO:0030301; GO:0031210; GO:0031267; GO:0032367; GO:0032489; GO:0033344; GO:0033552; GO:0033700; GO:0034185; GO:0034186; GO:0034188; GO:0034380; GO:0034616; GO:0042157; GO:0042158; GO:0042626; GO:0042632; GO:0043691; GO:0045121; GO:0045332; GO:0045335; GO:0046623; GO:0048471; GO:0051117; GO:0055091; GO:0060155; GO:0071222; GO:0071300; GO:0071345; GO:0071397; GO:0071466; GO:0071806; GO:0090108; GO:0090554; GO:0090556; GO:0097708; GO:0120020; GO:0140115; GO:0140328; GO:0140359 adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cellular response to cholesterol [GO:0071397]; cellular response to cytokine stimulus [GO:0071345]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to retinoic acid [GO:0071300]; cellular response to xenobiotic stimulus [GO:0071466]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; endosomal transport [GO:0016197]; export across plasma membrane [GO:0140115]; G protein-coupled receptor signaling pathway [GO:0007186]; high-density lipoprotein particle assembly [GO:0034380]; intracellular cholesterol transport [GO:0032367]; lipoprotein biosynthetic process [GO:0042158]; lipoprotein metabolic process [GO:0042157]; lysosome organization [GO:0007040]; peptide secretion [GO:0002790]; phagocytosis, engulfment [GO:0006911]; phospholipid efflux [GO:0033700]; phospholipid homeostasis [GO:0055091]; phospholipid translocation [GO:0045332]; phospholipid transport [GO:0015914]; platelet dense granule organization [GO:0060155]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of high-density lipoprotein particle assembly [GO:0090108]; protein secretion [GO:0009306]; protein transmembrane transport [GO:0071806]; regulation of Cdc42 protein signal transduction [GO:0032489]; response to laminar fluid shear stress [GO:0034616]; response to vitamin B3 [GO:0033552]; reverse cholesterol transport [GO:0043691]; signal release [GO:0023061] basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; external side of plasma membrane [GO:0009897]; Golgi apparatus [GO:0005794]; intracellular vesicle [GO:0097708]; membrane raft [GO:0045121]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886] ABC-type transporter activity [GO:0140359]; apolipoprotein A-I binding [GO:0034186]; apolipoprotein A-I receptor activity [GO:0034188]; apolipoprotein binding [GO:0034185]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase binding [GO:0051117]; ATPase-coupled transmembrane transporter activity [GO:0042626]; cholesterol transfer activity [GO:0120020]; floppase activity [GO:0140328]; high-density lipoprotein particle binding [GO:0008035]; phosphatidylcholine binding [GO:0031210]; phosphatidylcholine floppase activity [GO:0090554]; phosphatidylserine floppase activity [GO:0090556]; phospholipid transporter activity [GO:0005548]; protein transmembrane transporter activity [GO:0008320]; signaling receptor binding [GO:0005102]; small GTPase binding [GO:0031267]; sphingolipid floppase activity [GO:0046623]; syntaxin binding [GO:0019905] g1807.t2 P41233 24.827 721 1.85e-47 193.0 sp|P41233|ABCA1_MOUSE Phospholipid-transporting ATPase ABCA1 OS=Mus musculus OX=10090 GN=Abca1 PE=1 SV=4 ABCA1_MOUSE reviewed Phospholipid-transporting ATPase ABCA1 (EC 7.6.2.1) (ATP-binding cassette sub-family A member 1) (ATP-binding cassette transporter 1) (ABC-1) (ATP-binding cassette 1) Mus musculus (Mouse) GO:0002790; GO:0005102; GO:0005524; GO:0005548; GO:0005768; GO:0005794; GO:0005886; GO:0006911; GO:0007040; GO:0007186; GO:0007189; GO:0008035; GO:0008203; GO:0008320; GO:0009306; GO:0009897; GO:0009986; GO:0010875; GO:0015914; GO:0016197; GO:0016323; GO:0016887; GO:0019905; GO:0023061; GO:0030139; GO:0030301; GO:0031210; GO:0031267; GO:0032367; GO:0032489; GO:0033344; GO:0033552; GO:0033700; GO:0034185; GO:0034186; GO:0034188; GO:0034380; GO:0034616; GO:0042157; GO:0042158; GO:0042626; GO:0042632; GO:0043691; GO:0045121; GO:0045332; GO:0045335; GO:0046623; GO:0048471; GO:0051117; GO:0055091; GO:0060155; GO:0071222; GO:0071300; GO:0071345; GO:0071397; GO:0071466; GO:0071806; GO:0090108; GO:0090554; GO:0090556; GO:0097708; GO:0120020; GO:0140115; GO:0140328; GO:0140359 adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cellular response to cholesterol [GO:0071397]; cellular response to cytokine stimulus [GO:0071345]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to retinoic acid [GO:0071300]; cellular response to xenobiotic stimulus [GO:0071466]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; endosomal transport [GO:0016197]; export across plasma membrane [GO:0140115]; G protein-coupled receptor signaling pathway [GO:0007186]; high-density lipoprotein particle assembly [GO:0034380]; intracellular cholesterol transport [GO:0032367]; lipoprotein biosynthetic process [GO:0042158]; lipoprotein metabolic process [GO:0042157]; lysosome organization [GO:0007040]; peptide secretion [GO:0002790]; phagocytosis, engulfment [GO:0006911]; phospholipid efflux [GO:0033700]; phospholipid homeostasis [GO:0055091]; phospholipid translocation [GO:0045332]; phospholipid transport [GO:0015914]; platelet dense granule organization [GO:0060155]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of high-density lipoprotein particle assembly [GO:0090108]; protein secretion [GO:0009306]; protein transmembrane transport [GO:0071806]; regulation of Cdc42 protein signal transduction [GO:0032489]; response to laminar fluid shear stress [GO:0034616]; response to vitamin B3 [GO:0033552]; reverse cholesterol transport [GO:0043691]; signal release [GO:0023061] basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; external side of plasma membrane [GO:0009897]; Golgi apparatus [GO:0005794]; intracellular vesicle [GO:0097708]; membrane raft [GO:0045121]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886] ABC-type transporter activity [GO:0140359]; apolipoprotein A-I binding [GO:0034186]; apolipoprotein A-I receptor activity [GO:0034188]; apolipoprotein binding [GO:0034185]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase binding [GO:0051117]; ATPase-coupled transmembrane transporter activity [GO:0042626]; cholesterol transfer activity [GO:0120020]; floppase activity [GO:0140328]; high-density lipoprotein particle binding [GO:0008035]; phosphatidylcholine binding [GO:0031210]; phosphatidylcholine floppase activity [GO:0090554]; phosphatidylserine floppase activity [GO:0090556]; phospholipid transporter activity [GO:0005548]; protein transmembrane transporter activity [GO:0008320]; signaling receptor binding [GO:0005102]; small GTPase binding [GO:0031267]; sphingolipid floppase activity [GO:0046623]; syntaxin binding [GO:0019905] g1807.t2 P41233 39.526 253 2.41e-45 186.0 sp|P41233|ABCA1_MOUSE Phospholipid-transporting ATPase ABCA1 OS=Mus musculus OX=10090 GN=Abca1 PE=1 SV=4 ABCA1_MOUSE reviewed Phospholipid-transporting ATPase ABCA1 (EC 7.6.2.1) (ATP-binding cassette sub-family A member 1) (ATP-binding cassette transporter 1) (ABC-1) (ATP-binding cassette 1) Mus musculus (Mouse) GO:0002790; GO:0005102; GO:0005524; GO:0005548; GO:0005768; GO:0005794; GO:0005886; GO:0006911; GO:0007040; GO:0007186; GO:0007189; GO:0008035; GO:0008203; GO:0008320; GO:0009306; GO:0009897; GO:0009986; GO:0010875; GO:0015914; GO:0016197; GO:0016323; GO:0016887; GO:0019905; GO:0023061; GO:0030139; GO:0030301; GO:0031210; GO:0031267; GO:0032367; GO:0032489; GO:0033344; GO:0033552; GO:0033700; GO:0034185; GO:0034186; GO:0034188; GO:0034380; GO:0034616; GO:0042157; GO:0042158; GO:0042626; GO:0042632; GO:0043691; GO:0045121; GO:0045332; GO:0045335; GO:0046623; GO:0048471; GO:0051117; GO:0055091; GO:0060155; GO:0071222; GO:0071300; GO:0071345; GO:0071397; GO:0071466; GO:0071806; GO:0090108; GO:0090554; GO:0090556; GO:0097708; GO:0120020; GO:0140115; GO:0140328; GO:0140359 adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cellular response to cholesterol [GO:0071397]; cellular response to cytokine stimulus [GO:0071345]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to retinoic acid [GO:0071300]; cellular response to xenobiotic stimulus [GO:0071466]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; endosomal transport [GO:0016197]; export across plasma membrane [GO:0140115]; G protein-coupled receptor signaling pathway [GO:0007186]; high-density lipoprotein particle assembly [GO:0034380]; intracellular cholesterol transport [GO:0032367]; lipoprotein biosynthetic process [GO:0042158]; lipoprotein metabolic process [GO:0042157]; lysosome organization [GO:0007040]; peptide secretion [GO:0002790]; phagocytosis, engulfment [GO:0006911]; phospholipid efflux [GO:0033700]; phospholipid homeostasis [GO:0055091]; phospholipid translocation [GO:0045332]; phospholipid transport [GO:0015914]; platelet dense granule organization [GO:0060155]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of high-density lipoprotein particle assembly [GO:0090108]; protein secretion [GO:0009306]; protein transmembrane transport [GO:0071806]; regulation of Cdc42 protein signal transduction [GO:0032489]; response to laminar fluid shear stress [GO:0034616]; response to vitamin B3 [GO:0033552]; reverse cholesterol transport [GO:0043691]; signal release [GO:0023061] basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; external side of plasma membrane [GO:0009897]; Golgi apparatus [GO:0005794]; intracellular vesicle [GO:0097708]; membrane raft [GO:0045121]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886] ABC-type transporter activity [GO:0140359]; apolipoprotein A-I binding [GO:0034186]; apolipoprotein A-I receptor activity [GO:0034188]; apolipoprotein binding [GO:0034185]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase binding [GO:0051117]; ATPase-coupled transmembrane transporter activity [GO:0042626]; cholesterol transfer activity [GO:0120020]; floppase activity [GO:0140328]; high-density lipoprotein particle binding [GO:0008035]; phosphatidylcholine binding [GO:0031210]; phosphatidylcholine floppase activity [GO:0090554]; phosphatidylserine floppase activity [GO:0090556]; phospholipid transporter activity [GO:0005548]; protein transmembrane transporter activity [GO:0008320]; signaling receptor binding [GO:0005102]; small GTPase binding [GO:0031267]; sphingolipid floppase activity [GO:0046623]; syntaxin binding [GO:0019905] g1807.t3 P41233 47.395 998 0.0 865.0 sp|P41233|ABCA1_MOUSE Phospholipid-transporting ATPase ABCA1 OS=Mus musculus OX=10090 GN=Abca1 PE=1 SV=4 ABCA1_MOUSE reviewed Phospholipid-transporting ATPase ABCA1 (EC 7.6.2.1) (ATP-binding cassette sub-family A member 1) (ATP-binding cassette transporter 1) (ABC-1) (ATP-binding cassette 1) Mus musculus (Mouse) GO:0002790; GO:0005102; GO:0005524; GO:0005548; GO:0005768; GO:0005794; GO:0005886; GO:0006911; GO:0007040; GO:0007186; GO:0007189; GO:0008035; GO:0008203; GO:0008320; GO:0009306; GO:0009897; GO:0009986; GO:0010875; GO:0015914; GO:0016197; GO:0016323; GO:0016887; GO:0019905; GO:0023061; GO:0030139; GO:0030301; GO:0031210; GO:0031267; GO:0032367; GO:0032489; GO:0033344; GO:0033552; GO:0033700; GO:0034185; GO:0034186; GO:0034188; GO:0034380; GO:0034616; GO:0042157; GO:0042158; GO:0042626; GO:0042632; GO:0043691; GO:0045121; GO:0045332; GO:0045335; GO:0046623; GO:0048471; GO:0051117; GO:0055091; GO:0060155; GO:0071222; GO:0071300; GO:0071345; GO:0071397; GO:0071466; GO:0071806; GO:0090108; GO:0090554; GO:0090556; GO:0097708; GO:0120020; GO:0140115; GO:0140328; GO:0140359 adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cellular response to cholesterol [GO:0071397]; cellular response to cytokine stimulus [GO:0071345]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to retinoic acid [GO:0071300]; cellular response to xenobiotic stimulus [GO:0071466]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; endosomal transport [GO:0016197]; export across plasma membrane [GO:0140115]; G protein-coupled receptor signaling pathway [GO:0007186]; high-density lipoprotein particle assembly [GO:0034380]; intracellular cholesterol transport [GO:0032367]; lipoprotein biosynthetic process [GO:0042158]; lipoprotein metabolic process [GO:0042157]; lysosome organization [GO:0007040]; peptide secretion [GO:0002790]; phagocytosis, engulfment [GO:0006911]; phospholipid efflux [GO:0033700]; phospholipid homeostasis [GO:0055091]; phospholipid translocation [GO:0045332]; phospholipid transport [GO:0015914]; platelet dense granule organization [GO:0060155]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of high-density lipoprotein particle assembly [GO:0090108]; protein secretion [GO:0009306]; protein transmembrane transport [GO:0071806]; regulation of Cdc42 protein signal transduction [GO:0032489]; response to laminar fluid shear stress [GO:0034616]; response to vitamin B3 [GO:0033552]; reverse cholesterol transport [GO:0043691]; signal release [GO:0023061] basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; external side of plasma membrane [GO:0009897]; Golgi apparatus [GO:0005794]; intracellular vesicle [GO:0097708]; membrane raft [GO:0045121]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886] ABC-type transporter activity [GO:0140359]; apolipoprotein A-I binding [GO:0034186]; apolipoprotein A-I receptor activity [GO:0034188]; apolipoprotein binding [GO:0034185]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase binding [GO:0051117]; ATPase-coupled transmembrane transporter activity [GO:0042626]; cholesterol transfer activity [GO:0120020]; floppase activity [GO:0140328]; high-density lipoprotein particle binding [GO:0008035]; phosphatidylcholine binding [GO:0031210]; phosphatidylcholine floppase activity [GO:0090554]; phosphatidylserine floppase activity [GO:0090556]; phospholipid transporter activity [GO:0005548]; protein transmembrane transporter activity [GO:0008320]; signaling receptor binding [GO:0005102]; small GTPase binding [GO:0031267]; sphingolipid floppase activity [GO:0046623]; syntaxin binding [GO:0019905] g1807.t3 P41233 47.97 788 0.0 754.0 sp|P41233|ABCA1_MOUSE Phospholipid-transporting ATPase ABCA1 OS=Mus musculus OX=10090 GN=Abca1 PE=1 SV=4 ABCA1_MOUSE reviewed Phospholipid-transporting ATPase ABCA1 (EC 7.6.2.1) (ATP-binding cassette sub-family A member 1) (ATP-binding cassette transporter 1) (ABC-1) (ATP-binding cassette 1) Mus musculus (Mouse) GO:0002790; GO:0005102; GO:0005524; GO:0005548; GO:0005768; GO:0005794; GO:0005886; GO:0006911; GO:0007040; GO:0007186; GO:0007189; GO:0008035; GO:0008203; GO:0008320; GO:0009306; GO:0009897; GO:0009986; GO:0010875; GO:0015914; GO:0016197; GO:0016323; GO:0016887; GO:0019905; GO:0023061; GO:0030139; GO:0030301; GO:0031210; GO:0031267; GO:0032367; GO:0032489; GO:0033344; GO:0033552; GO:0033700; GO:0034185; GO:0034186; GO:0034188; GO:0034380; GO:0034616; GO:0042157; GO:0042158; GO:0042626; GO:0042632; GO:0043691; GO:0045121; GO:0045332; GO:0045335; GO:0046623; GO:0048471; GO:0051117; GO:0055091; GO:0060155; GO:0071222; GO:0071300; GO:0071345; GO:0071397; GO:0071466; GO:0071806; GO:0090108; GO:0090554; GO:0090556; GO:0097708; GO:0120020; GO:0140115; GO:0140328; GO:0140359 adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cellular response to cholesterol [GO:0071397]; cellular response to cytokine stimulus [GO:0071345]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to retinoic acid [GO:0071300]; cellular response to xenobiotic stimulus [GO:0071466]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; endosomal transport [GO:0016197]; export across plasma membrane [GO:0140115]; G protein-coupled receptor signaling pathway [GO:0007186]; high-density lipoprotein particle assembly [GO:0034380]; intracellular cholesterol transport [GO:0032367]; lipoprotein biosynthetic process [GO:0042158]; lipoprotein metabolic process [GO:0042157]; lysosome organization [GO:0007040]; peptide secretion [GO:0002790]; phagocytosis, engulfment [GO:0006911]; phospholipid efflux [GO:0033700]; phospholipid homeostasis [GO:0055091]; phospholipid translocation [GO:0045332]; phospholipid transport [GO:0015914]; platelet dense granule organization [GO:0060155]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of high-density lipoprotein particle assembly [GO:0090108]; protein secretion [GO:0009306]; protein transmembrane transport [GO:0071806]; regulation of Cdc42 protein signal transduction [GO:0032489]; response to laminar fluid shear stress [GO:0034616]; response to vitamin B3 [GO:0033552]; reverse cholesterol transport [GO:0043691]; signal release [GO:0023061] basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; external side of plasma membrane [GO:0009897]; Golgi apparatus [GO:0005794]; intracellular vesicle [GO:0097708]; membrane raft [GO:0045121]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886] ABC-type transporter activity [GO:0140359]; apolipoprotein A-I binding [GO:0034186]; apolipoprotein A-I receptor activity [GO:0034188]; apolipoprotein binding [GO:0034185]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase binding [GO:0051117]; ATPase-coupled transmembrane transporter activity [GO:0042626]; cholesterol transfer activity [GO:0120020]; floppase activity [GO:0140328]; high-density lipoprotein particle binding [GO:0008035]; phosphatidylcholine binding [GO:0031210]; phosphatidylcholine floppase activity [GO:0090554]; phosphatidylserine floppase activity [GO:0090556]; phospholipid transporter activity [GO:0005548]; protein transmembrane transporter activity [GO:0008320]; signaling receptor binding [GO:0005102]; small GTPase binding [GO:0031267]; sphingolipid floppase activity [GO:0046623]; syntaxin binding [GO:0019905] g1807.t3 P41233 24.827 721 1.85e-47 193.0 sp|P41233|ABCA1_MOUSE Phospholipid-transporting ATPase ABCA1 OS=Mus musculus OX=10090 GN=Abca1 PE=1 SV=4 ABCA1_MOUSE reviewed Phospholipid-transporting ATPase ABCA1 (EC 7.6.2.1) (ATP-binding cassette sub-family A member 1) (ATP-binding cassette transporter 1) (ABC-1) (ATP-binding cassette 1) Mus musculus (Mouse) GO:0002790; GO:0005102; GO:0005524; GO:0005548; GO:0005768; GO:0005794; GO:0005886; GO:0006911; GO:0007040; GO:0007186; GO:0007189; GO:0008035; GO:0008203; GO:0008320; GO:0009306; GO:0009897; GO:0009986; GO:0010875; GO:0015914; GO:0016197; GO:0016323; GO:0016887; GO:0019905; GO:0023061; GO:0030139; GO:0030301; GO:0031210; GO:0031267; GO:0032367; GO:0032489; GO:0033344; GO:0033552; GO:0033700; GO:0034185; GO:0034186; GO:0034188; GO:0034380; GO:0034616; GO:0042157; GO:0042158; GO:0042626; GO:0042632; GO:0043691; GO:0045121; GO:0045332; GO:0045335; GO:0046623; GO:0048471; GO:0051117; GO:0055091; GO:0060155; GO:0071222; GO:0071300; GO:0071345; GO:0071397; GO:0071466; GO:0071806; GO:0090108; GO:0090554; GO:0090556; GO:0097708; GO:0120020; GO:0140115; GO:0140328; GO:0140359 adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cellular response to cholesterol [GO:0071397]; cellular response to cytokine stimulus [GO:0071345]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to retinoic acid [GO:0071300]; cellular response to xenobiotic stimulus [GO:0071466]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; endosomal transport [GO:0016197]; export across plasma membrane [GO:0140115]; G protein-coupled receptor signaling pathway [GO:0007186]; high-density lipoprotein particle assembly [GO:0034380]; intracellular cholesterol transport [GO:0032367]; lipoprotein biosynthetic process [GO:0042158]; lipoprotein metabolic process [GO:0042157]; lysosome organization [GO:0007040]; peptide secretion [GO:0002790]; phagocytosis, engulfment [GO:0006911]; phospholipid efflux [GO:0033700]; phospholipid homeostasis [GO:0055091]; phospholipid translocation [GO:0045332]; phospholipid transport [GO:0015914]; platelet dense granule organization [GO:0060155]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of high-density lipoprotein particle assembly [GO:0090108]; protein secretion [GO:0009306]; protein transmembrane transport [GO:0071806]; regulation of Cdc42 protein signal transduction [GO:0032489]; response to laminar fluid shear stress [GO:0034616]; response to vitamin B3 [GO:0033552]; reverse cholesterol transport [GO:0043691]; signal release [GO:0023061] basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; external side of plasma membrane [GO:0009897]; Golgi apparatus [GO:0005794]; intracellular vesicle [GO:0097708]; membrane raft [GO:0045121]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886] ABC-type transporter activity [GO:0140359]; apolipoprotein A-I binding [GO:0034186]; apolipoprotein A-I receptor activity [GO:0034188]; apolipoprotein binding [GO:0034185]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase binding [GO:0051117]; ATPase-coupled transmembrane transporter activity [GO:0042626]; cholesterol transfer activity [GO:0120020]; floppase activity [GO:0140328]; high-density lipoprotein particle binding [GO:0008035]; phosphatidylcholine binding [GO:0031210]; phosphatidylcholine floppase activity [GO:0090554]; phosphatidylserine floppase activity [GO:0090556]; phospholipid transporter activity [GO:0005548]; protein transmembrane transporter activity [GO:0008320]; signaling receptor binding [GO:0005102]; small GTPase binding [GO:0031267]; sphingolipid floppase activity [GO:0046623]; syntaxin binding [GO:0019905] g1807.t3 P41233 39.526 253 2.3899999999999998e-45 186.0 sp|P41233|ABCA1_MOUSE Phospholipid-transporting ATPase ABCA1 OS=Mus musculus OX=10090 GN=Abca1 PE=1 SV=4 ABCA1_MOUSE reviewed Phospholipid-transporting ATPase ABCA1 (EC 7.6.2.1) (ATP-binding cassette sub-family A member 1) (ATP-binding cassette transporter 1) (ABC-1) (ATP-binding cassette 1) Mus musculus (Mouse) GO:0002790; GO:0005102; GO:0005524; GO:0005548; GO:0005768; GO:0005794; GO:0005886; GO:0006911; GO:0007040; GO:0007186; GO:0007189; GO:0008035; GO:0008203; GO:0008320; GO:0009306; GO:0009897; GO:0009986; GO:0010875; GO:0015914; GO:0016197; GO:0016323; GO:0016887; GO:0019905; GO:0023061; GO:0030139; GO:0030301; GO:0031210; GO:0031267; GO:0032367; GO:0032489; GO:0033344; GO:0033552; GO:0033700; GO:0034185; GO:0034186; GO:0034188; GO:0034380; GO:0034616; GO:0042157; GO:0042158; GO:0042626; GO:0042632; GO:0043691; GO:0045121; GO:0045332; GO:0045335; GO:0046623; GO:0048471; GO:0051117; GO:0055091; GO:0060155; GO:0071222; GO:0071300; GO:0071345; GO:0071397; GO:0071466; GO:0071806; GO:0090108; GO:0090554; GO:0090556; GO:0097708; GO:0120020; GO:0140115; GO:0140328; GO:0140359 adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cellular response to cholesterol [GO:0071397]; cellular response to cytokine stimulus [GO:0071345]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to retinoic acid [GO:0071300]; cellular response to xenobiotic stimulus [GO:0071466]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; endosomal transport [GO:0016197]; export across plasma membrane [GO:0140115]; G protein-coupled receptor signaling pathway [GO:0007186]; high-density lipoprotein particle assembly [GO:0034380]; intracellular cholesterol transport [GO:0032367]; lipoprotein biosynthetic process [GO:0042158]; lipoprotein metabolic process [GO:0042157]; lysosome organization [GO:0007040]; peptide secretion [GO:0002790]; phagocytosis, engulfment [GO:0006911]; phospholipid efflux [GO:0033700]; phospholipid homeostasis [GO:0055091]; phospholipid translocation [GO:0045332]; phospholipid transport [GO:0015914]; platelet dense granule organization [GO:0060155]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of high-density lipoprotein particle assembly [GO:0090108]; protein secretion [GO:0009306]; protein transmembrane transport [GO:0071806]; regulation of Cdc42 protein signal transduction [GO:0032489]; response to laminar fluid shear stress [GO:0034616]; response to vitamin B3 [GO:0033552]; reverse cholesterol transport [GO:0043691]; signal release [GO:0023061] basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; external side of plasma membrane [GO:0009897]; Golgi apparatus [GO:0005794]; intracellular vesicle [GO:0097708]; membrane raft [GO:0045121]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886] ABC-type transporter activity [GO:0140359]; apolipoprotein A-I binding [GO:0034186]; apolipoprotein A-I receptor activity [GO:0034188]; apolipoprotein binding [GO:0034185]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase binding [GO:0051117]; ATPase-coupled transmembrane transporter activity [GO:0042626]; cholesterol transfer activity [GO:0120020]; floppase activity [GO:0140328]; high-density lipoprotein particle binding [GO:0008035]; phosphatidylcholine binding [GO:0031210]; phosphatidylcholine floppase activity [GO:0090554]; phosphatidylserine floppase activity [GO:0090556]; phospholipid transporter activity [GO:0005548]; protein transmembrane transporter activity [GO:0008320]; signaling receptor binding [GO:0005102]; small GTPase binding [GO:0031267]; sphingolipid floppase activity [GO:0046623]; syntaxin binding [GO:0019905] g1807.t4 P41233 47.992 971 0.0 862.0 sp|P41233|ABCA1_MOUSE Phospholipid-transporting ATPase ABCA1 OS=Mus musculus OX=10090 GN=Abca1 PE=1 SV=4 ABCA1_MOUSE reviewed Phospholipid-transporting ATPase ABCA1 (EC 7.6.2.1) (ATP-binding cassette sub-family A member 1) (ATP-binding cassette transporter 1) (ABC-1) (ATP-binding cassette 1) Mus musculus (Mouse) GO:0002790; GO:0005102; GO:0005524; GO:0005548; GO:0005768; GO:0005794; GO:0005886; GO:0006911; GO:0007040; GO:0007186; GO:0007189; GO:0008035; GO:0008203; GO:0008320; GO:0009306; GO:0009897; GO:0009986; GO:0010875; GO:0015914; GO:0016197; GO:0016323; GO:0016887; GO:0019905; GO:0023061; GO:0030139; GO:0030301; GO:0031210; GO:0031267; GO:0032367; GO:0032489; GO:0033344; GO:0033552; GO:0033700; GO:0034185; GO:0034186; GO:0034188; GO:0034380; GO:0034616; GO:0042157; GO:0042158; GO:0042626; GO:0042632; GO:0043691; GO:0045121; GO:0045332; GO:0045335; GO:0046623; GO:0048471; GO:0051117; GO:0055091; GO:0060155; GO:0071222; GO:0071300; GO:0071345; GO:0071397; GO:0071466; GO:0071806; GO:0090108; GO:0090554; GO:0090556; GO:0097708; GO:0120020; GO:0140115; GO:0140328; GO:0140359 adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cellular response to cholesterol [GO:0071397]; cellular response to cytokine stimulus [GO:0071345]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to retinoic acid [GO:0071300]; cellular response to xenobiotic stimulus [GO:0071466]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; endosomal transport [GO:0016197]; export across plasma membrane [GO:0140115]; G protein-coupled receptor signaling pathway [GO:0007186]; high-density lipoprotein particle assembly [GO:0034380]; intracellular cholesterol transport [GO:0032367]; lipoprotein biosynthetic process [GO:0042158]; lipoprotein metabolic process [GO:0042157]; lysosome organization [GO:0007040]; peptide secretion [GO:0002790]; phagocytosis, engulfment [GO:0006911]; phospholipid efflux [GO:0033700]; phospholipid homeostasis [GO:0055091]; phospholipid translocation [GO:0045332]; phospholipid transport [GO:0015914]; platelet dense granule organization [GO:0060155]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of high-density lipoprotein particle assembly [GO:0090108]; protein secretion [GO:0009306]; protein transmembrane transport [GO:0071806]; regulation of Cdc42 protein signal transduction [GO:0032489]; response to laminar fluid shear stress [GO:0034616]; response to vitamin B3 [GO:0033552]; reverse cholesterol transport [GO:0043691]; signal release [GO:0023061] basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; external side of plasma membrane [GO:0009897]; Golgi apparatus [GO:0005794]; intracellular vesicle [GO:0097708]; membrane raft [GO:0045121]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886] ABC-type transporter activity [GO:0140359]; apolipoprotein A-I binding [GO:0034186]; apolipoprotein A-I receptor activity [GO:0034188]; apolipoprotein binding [GO:0034185]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase binding [GO:0051117]; ATPase-coupled transmembrane transporter activity [GO:0042626]; cholesterol transfer activity [GO:0120020]; floppase activity [GO:0140328]; high-density lipoprotein particle binding [GO:0008035]; phosphatidylcholine binding [GO:0031210]; phosphatidylcholine floppase activity [GO:0090554]; phosphatidylserine floppase activity [GO:0090556]; phospholipid transporter activity [GO:0005548]; protein transmembrane transporter activity [GO:0008320]; signaling receptor binding [GO:0005102]; small GTPase binding [GO:0031267]; sphingolipid floppase activity [GO:0046623]; syntaxin binding [GO:0019905] g1807.t4 P41233 47.97 788 0.0 753.0 sp|P41233|ABCA1_MOUSE Phospholipid-transporting ATPase ABCA1 OS=Mus musculus OX=10090 GN=Abca1 PE=1 SV=4 ABCA1_MOUSE reviewed Phospholipid-transporting ATPase ABCA1 (EC 7.6.2.1) (ATP-binding cassette sub-family A member 1) (ATP-binding cassette transporter 1) (ABC-1) (ATP-binding cassette 1) Mus musculus (Mouse) GO:0002790; GO:0005102; GO:0005524; GO:0005548; GO:0005768; GO:0005794; GO:0005886; GO:0006911; GO:0007040; GO:0007186; GO:0007189; GO:0008035; GO:0008203; GO:0008320; GO:0009306; GO:0009897; GO:0009986; GO:0010875; GO:0015914; GO:0016197; GO:0016323; GO:0016887; GO:0019905; GO:0023061; GO:0030139; GO:0030301; GO:0031210; GO:0031267; GO:0032367; GO:0032489; GO:0033344; GO:0033552; GO:0033700; GO:0034185; GO:0034186; GO:0034188; GO:0034380; GO:0034616; GO:0042157; GO:0042158; GO:0042626; GO:0042632; GO:0043691; GO:0045121; GO:0045332; GO:0045335; GO:0046623; GO:0048471; GO:0051117; GO:0055091; GO:0060155; GO:0071222; GO:0071300; GO:0071345; GO:0071397; GO:0071466; GO:0071806; GO:0090108; GO:0090554; GO:0090556; GO:0097708; GO:0120020; GO:0140115; GO:0140328; GO:0140359 adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cellular response to cholesterol [GO:0071397]; cellular response to cytokine stimulus [GO:0071345]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to retinoic acid [GO:0071300]; cellular response to xenobiotic stimulus [GO:0071466]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; endosomal transport [GO:0016197]; export across plasma membrane [GO:0140115]; G protein-coupled receptor signaling pathway [GO:0007186]; high-density lipoprotein particle assembly [GO:0034380]; intracellular cholesterol transport [GO:0032367]; lipoprotein biosynthetic process [GO:0042158]; lipoprotein metabolic process [GO:0042157]; lysosome organization [GO:0007040]; peptide secretion [GO:0002790]; phagocytosis, engulfment [GO:0006911]; phospholipid efflux [GO:0033700]; phospholipid homeostasis [GO:0055091]; phospholipid translocation [GO:0045332]; phospholipid transport [GO:0015914]; platelet dense granule organization [GO:0060155]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of high-density lipoprotein particle assembly [GO:0090108]; protein secretion [GO:0009306]; protein transmembrane transport [GO:0071806]; regulation of Cdc42 protein signal transduction [GO:0032489]; response to laminar fluid shear stress [GO:0034616]; response to vitamin B3 [GO:0033552]; reverse cholesterol transport [GO:0043691]; signal release [GO:0023061] basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; external side of plasma membrane [GO:0009897]; Golgi apparatus [GO:0005794]; intracellular vesicle [GO:0097708]; membrane raft [GO:0045121]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886] ABC-type transporter activity [GO:0140359]; apolipoprotein A-I binding [GO:0034186]; apolipoprotein A-I receptor activity [GO:0034188]; apolipoprotein binding [GO:0034185]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase binding [GO:0051117]; ATPase-coupled transmembrane transporter activity [GO:0042626]; cholesterol transfer activity [GO:0120020]; floppase activity [GO:0140328]; high-density lipoprotein particle binding [GO:0008035]; phosphatidylcholine binding [GO:0031210]; phosphatidylcholine floppase activity [GO:0090554]; phosphatidylserine floppase activity [GO:0090556]; phospholipid transporter activity [GO:0005548]; protein transmembrane transporter activity [GO:0008320]; signaling receptor binding [GO:0005102]; small GTPase binding [GO:0031267]; sphingolipid floppase activity [GO:0046623]; syntaxin binding [GO:0019905] g1807.t4 P41233 24.827 721 2.99e-47 192.0 sp|P41233|ABCA1_MOUSE Phospholipid-transporting ATPase ABCA1 OS=Mus musculus OX=10090 GN=Abca1 PE=1 SV=4 ABCA1_MOUSE reviewed Phospholipid-transporting ATPase ABCA1 (EC 7.6.2.1) (ATP-binding cassette sub-family A member 1) (ATP-binding cassette transporter 1) (ABC-1) (ATP-binding cassette 1) Mus musculus (Mouse) GO:0002790; GO:0005102; GO:0005524; GO:0005548; GO:0005768; GO:0005794; GO:0005886; GO:0006911; GO:0007040; GO:0007186; GO:0007189; GO:0008035; GO:0008203; GO:0008320; GO:0009306; GO:0009897; GO:0009986; GO:0010875; GO:0015914; GO:0016197; GO:0016323; GO:0016887; GO:0019905; GO:0023061; GO:0030139; GO:0030301; GO:0031210; GO:0031267; GO:0032367; GO:0032489; GO:0033344; GO:0033552; GO:0033700; GO:0034185; GO:0034186; GO:0034188; GO:0034380; GO:0034616; GO:0042157; GO:0042158; GO:0042626; GO:0042632; GO:0043691; GO:0045121; GO:0045332; GO:0045335; GO:0046623; GO:0048471; GO:0051117; GO:0055091; GO:0060155; GO:0071222; GO:0071300; GO:0071345; GO:0071397; GO:0071466; GO:0071806; GO:0090108; GO:0090554; GO:0090556; GO:0097708; GO:0120020; GO:0140115; GO:0140328; GO:0140359 adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cellular response to cholesterol [GO:0071397]; cellular response to cytokine stimulus [GO:0071345]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to retinoic acid [GO:0071300]; cellular response to xenobiotic stimulus [GO:0071466]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; endosomal transport [GO:0016197]; export across plasma membrane [GO:0140115]; G protein-coupled receptor signaling pathway [GO:0007186]; high-density lipoprotein particle assembly [GO:0034380]; intracellular cholesterol transport [GO:0032367]; lipoprotein biosynthetic process [GO:0042158]; lipoprotein metabolic process [GO:0042157]; lysosome organization [GO:0007040]; peptide secretion [GO:0002790]; phagocytosis, engulfment [GO:0006911]; phospholipid efflux [GO:0033700]; phospholipid homeostasis [GO:0055091]; phospholipid translocation [GO:0045332]; phospholipid transport [GO:0015914]; platelet dense granule organization [GO:0060155]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of high-density lipoprotein particle assembly [GO:0090108]; protein secretion [GO:0009306]; protein transmembrane transport [GO:0071806]; regulation of Cdc42 protein signal transduction [GO:0032489]; response to laminar fluid shear stress [GO:0034616]; response to vitamin B3 [GO:0033552]; reverse cholesterol transport [GO:0043691]; signal release [GO:0023061] basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; external side of plasma membrane [GO:0009897]; Golgi apparatus [GO:0005794]; intracellular vesicle [GO:0097708]; membrane raft [GO:0045121]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886] ABC-type transporter activity [GO:0140359]; apolipoprotein A-I binding [GO:0034186]; apolipoprotein A-I receptor activity [GO:0034188]; apolipoprotein binding [GO:0034185]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase binding [GO:0051117]; ATPase-coupled transmembrane transporter activity [GO:0042626]; cholesterol transfer activity [GO:0120020]; floppase activity [GO:0140328]; high-density lipoprotein particle binding [GO:0008035]; phosphatidylcholine binding [GO:0031210]; phosphatidylcholine floppase activity [GO:0090554]; phosphatidylserine floppase activity [GO:0090556]; phospholipid transporter activity [GO:0005548]; protein transmembrane transporter activity [GO:0008320]; signaling receptor binding [GO:0005102]; small GTPase binding [GO:0031267]; sphingolipid floppase activity [GO:0046623]; syntaxin binding [GO:0019905] g1807.t4 P41233 39.526 253 3.14e-45 185.0 sp|P41233|ABCA1_MOUSE Phospholipid-transporting ATPase ABCA1 OS=Mus musculus OX=10090 GN=Abca1 PE=1 SV=4 ABCA1_MOUSE reviewed Phospholipid-transporting ATPase ABCA1 (EC 7.6.2.1) (ATP-binding cassette sub-family A member 1) (ATP-binding cassette transporter 1) (ABC-1) (ATP-binding cassette 1) Mus musculus (Mouse) GO:0002790; GO:0005102; GO:0005524; GO:0005548; GO:0005768; GO:0005794; GO:0005886; GO:0006911; GO:0007040; GO:0007186; GO:0007189; GO:0008035; GO:0008203; GO:0008320; GO:0009306; GO:0009897; GO:0009986; GO:0010875; GO:0015914; GO:0016197; GO:0016323; GO:0016887; GO:0019905; GO:0023061; GO:0030139; GO:0030301; GO:0031210; GO:0031267; GO:0032367; GO:0032489; GO:0033344; GO:0033552; GO:0033700; GO:0034185; GO:0034186; GO:0034188; GO:0034380; GO:0034616; GO:0042157; GO:0042158; GO:0042626; GO:0042632; GO:0043691; GO:0045121; GO:0045332; GO:0045335; GO:0046623; GO:0048471; GO:0051117; GO:0055091; GO:0060155; GO:0071222; GO:0071300; GO:0071345; GO:0071397; GO:0071466; GO:0071806; GO:0090108; GO:0090554; GO:0090556; GO:0097708; GO:0120020; GO:0140115; GO:0140328; GO:0140359 adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cellular response to cholesterol [GO:0071397]; cellular response to cytokine stimulus [GO:0071345]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to retinoic acid [GO:0071300]; cellular response to xenobiotic stimulus [GO:0071466]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; endosomal transport [GO:0016197]; export across plasma membrane [GO:0140115]; G protein-coupled receptor signaling pathway [GO:0007186]; high-density lipoprotein particle assembly [GO:0034380]; intracellular cholesterol transport [GO:0032367]; lipoprotein biosynthetic process [GO:0042158]; lipoprotein metabolic process [GO:0042157]; lysosome organization [GO:0007040]; peptide secretion [GO:0002790]; phagocytosis, engulfment [GO:0006911]; phospholipid efflux [GO:0033700]; phospholipid homeostasis [GO:0055091]; phospholipid translocation [GO:0045332]; phospholipid transport [GO:0015914]; platelet dense granule organization [GO:0060155]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of high-density lipoprotein particle assembly [GO:0090108]; protein secretion [GO:0009306]; protein transmembrane transport [GO:0071806]; regulation of Cdc42 protein signal transduction [GO:0032489]; response to laminar fluid shear stress [GO:0034616]; response to vitamin B3 [GO:0033552]; reverse cholesterol transport [GO:0043691]; signal release [GO:0023061] basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; external side of plasma membrane [GO:0009897]; Golgi apparatus [GO:0005794]; intracellular vesicle [GO:0097708]; membrane raft [GO:0045121]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886] ABC-type transporter activity [GO:0140359]; apolipoprotein A-I binding [GO:0034186]; apolipoprotein A-I receptor activity [GO:0034188]; apolipoprotein binding [GO:0034185]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase binding [GO:0051117]; ATPase-coupled transmembrane transporter activity [GO:0042626]; cholesterol transfer activity [GO:0120020]; floppase activity [GO:0140328]; high-density lipoprotein particle binding [GO:0008035]; phosphatidylcholine binding [GO:0031210]; phosphatidylcholine floppase activity [GO:0090554]; phosphatidylserine floppase activity [GO:0090556]; phospholipid transporter activity [GO:0005548]; protein transmembrane transporter activity [GO:0008320]; signaling receptor binding [GO:0005102]; small GTPase binding [GO:0031267]; sphingolipid floppase activity [GO:0046623]; syntaxin binding [GO:0019905] g1808.t1 Q3ULD5 48.704 540 1.42e-162 480.0 sp|Q3ULD5|MCCB_MOUSE Methylcrotonoyl-CoA carboxylase beta chain, mitochondrial OS=Mus musculus OX=10090 GN=Mccc2 PE=1 SV=1 g1810.t1 Q6INU7 31.618 408 6.27e-41 162.0 sp|Q6INU7|FRRS1_XENLA Putative ferric-chelate reductase 1 OS=Xenopus laevis OX=8355 GN=frrs1 PE=2 SV=1 g1813.t1 Q6INU7 33.607 366 9.46e-39 156.0 sp|Q6INU7|FRRS1_XENLA Putative ferric-chelate reductase 1 OS=Xenopus laevis OX=8355 GN=frrs1 PE=2 SV=1 g1813.t2 Q6INU7 33.607 366 7.09e-39 156.0 sp|Q6INU7|FRRS1_XENLA Putative ferric-chelate reductase 1 OS=Xenopus laevis OX=8355 GN=frrs1 PE=2 SV=1 g1814.t1 Q0IJ05 53.752 733 0.0 743.0 sp|Q0IJ05|OSBL9_XENTR Oxysterol-binding protein-related protein 9 OS=Xenopus tropicalis OX=8364 GN=osbpl9 PE=2 SV=1 g1815.t1 Q5TB30 37.651 332 2.03e-51 198.0 sp|Q5TB30|DEP1A_HUMAN DEP domain-containing protein 1A OS=Homo sapiens OX=9606 GN=DEPDC1 PE=1 SV=2 DEP1A_HUMAN reviewed DEP domain-containing protein 1A Homo sapiens (Human) GO:0005096; GO:0005634; GO:0017053; GO:0035556; GO:0045892 intracellular signal transduction [GO:0035556]; negative regulation of DNA-templated transcription [GO:0045892] nucleus [GO:0005634]; transcription repressor complex [GO:0017053] GTPase activator activity [GO:0005096] g1815.t1 Q5TB30 45.545 202 8.720000000000001e-36 150.0 sp|Q5TB30|DEP1A_HUMAN DEP domain-containing protein 1A OS=Homo sapiens OX=9606 GN=DEPDC1 PE=1 SV=2 DEP1A_HUMAN reviewed DEP domain-containing protein 1A Homo sapiens (Human) GO:0005096; GO:0005634; GO:0017053; GO:0035556; GO:0045892 intracellular signal transduction [GO:0035556]; negative regulation of DNA-templated transcription [GO:0045892] nucleus [GO:0005634]; transcription repressor complex [GO:0017053] GTPase activator activity [GO:0005096] g1816.t1 Q71S21 34.591 318 1.72e-38 157.0 sp|Q71S21|INVSB_XENLA Inversin-B OS=Xenopus laevis OX=8355 GN=invs-b PE=1 SV=1 g1816.t1 Q71S21 28.012 332 5.58e-25 114.0 sp|Q71S21|INVSB_XENLA Inversin-B OS=Xenopus laevis OX=8355 GN=invs-b PE=1 SV=1 g1816.t1 Q71S21 25.635 394 8.78e-24 110.0 sp|Q71S21|INVSB_XENLA Inversin-B OS=Xenopus laevis OX=8355 GN=invs-b PE=1 SV=1 g1816.t1 Q71S21 29.259 270 1.75e-23 110.0 sp|Q71S21|INVSB_XENLA Inversin-B OS=Xenopus laevis OX=8355 GN=invs-b PE=1 SV=1 g1827.t1 Q96K37 54.985 331 3.54e-109 327.0 sp|Q96K37|S35E1_HUMAN Solute carrier family 35 member E1 OS=Homo sapiens OX=9606 GN=SLC35E1 PE=1 SV=2 g1832.t1 Q6X893 43.291 626 2.49e-146 444.0 sp|Q6X893|CTL1_MOUSE Choline transporter-like protein 1 OS=Mus musculus OX=10090 GN=Slc44a1 PE=1 SV=3 CTL1_MOUSE reviewed Choline transporter-like protein 1 (Solute carrier family 44 member 1) (CD antigen CD92) Mus musculus (Mouse) GO:0005654; GO:0005739; GO:0005741; GO:0005829; GO:0005886; GO:0015220; GO:0015297; GO:0015871; GO:0016020; GO:0034228; GO:0034229; GO:0055085 choline transport [GO:0015871]; ethanolamine transport [GO:0034229]; transmembrane transport [GO:0055085] cytosol [GO:0005829]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] antiporter activity [GO:0015297]; choline transmembrane transporter activity [GO:0015220]; ethanolamine transmembrane transporter activity [GO:0034228] g1832.t2 Q6X893 43.291 626 1.06e-146 445.0 sp|Q6X893|CTL1_MOUSE Choline transporter-like protein 1 OS=Mus musculus OX=10090 GN=Slc44a1 PE=1 SV=3 CTL1_MOUSE reviewed Choline transporter-like protein 1 (Solute carrier family 44 member 1) (CD antigen CD92) Mus musculus (Mouse) GO:0005654; GO:0005739; GO:0005741; GO:0005829; GO:0005886; GO:0015220; GO:0015297; GO:0015871; GO:0016020; GO:0034228; GO:0034229; GO:0055085 choline transport [GO:0015871]; ethanolamine transport [GO:0034229]; transmembrane transport [GO:0055085] cytosol [GO:0005829]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] antiporter activity [GO:0015297]; choline transmembrane transporter activity [GO:0015220]; ethanolamine transmembrane transporter activity [GO:0034228] g1833.t1 Q0VC53 61.589 302 3.1700000000000005e-123 358.0 sp|Q0VC53|DOHH_BOVIN Deoxyhypusine hydroxylase OS=Bos taurus OX=9913 GN=DOHH PE=1 SV=1 DOHH_BOVIN reviewed Deoxyhypusine hydroxylase (DOHH) (EC 1.14.99.29) (Deoxyhypusine dioxygenase) (Deoxyhypusine monooxygenase) Bos taurus (Bovine) GO:0005506; GO:0019135 deoxyhypusine monooxygenase activity [GO:0019135]; iron ion binding [GO:0005506] g1836.t1 Q96LT7 32.151 451 3.3e-73 242.0 sp|Q96LT7|CI072_HUMAN Guanine nucleotide exchange factor C9orf72 OS=Homo sapiens OX=9606 GN=C9orf72 PE=1 SV=2 CI072_HUMAN reviewed Guanine nucleotide exchange factor C9orf72 Homo sapiens (Human) GO:0000932; GO:0001933; GO:0005085; GO:0005096; GO:0005615; GO:0005634; GO:0005737; GO:0005764; GO:0005768; GO:0005776; GO:0005829; GO:0006897; GO:0006914; GO:0010494; GO:0010506; GO:0016239; GO:0030425; GO:0031267; GO:0031965; GO:0032045; GO:0032880; GO:0034063; GO:0043204; GO:0044295; GO:0044304; GO:0044754; GO:0045920; GO:0048675; GO:0050777; GO:0061909; GO:0090543; GO:0098686; GO:0098693; GO:0098794; GO:0098978; GO:0099523; GO:0110053; GO:1902774; GO:1903432; GO:2000785 autophagosome-lysosome fusion [GO:0061909]; autophagy [GO:0006914]; axon extension [GO:0048675]; endocytosis [GO:0006897]; late endosome to lysosome transport [GO:1902774]; negative regulation of exocytosis [GO:0045920]; negative regulation of immune response [GO:0050777]; negative regulation of protein phosphorylation [GO:0001933]; positive regulation of macroautophagy [GO:0016239]; regulation of actin filament organization [GO:0110053]; regulation of autophagosome assembly [GO:2000785]; regulation of autophagy [GO:0010506]; regulation of protein localization [GO:0032880]; regulation of synaptic vesicle cycle [GO:0098693]; regulation of TORC1 signaling [GO:1903432]; stress granule assembly [GO:0034063] autolysosome [GO:0044754]; autophagosome [GO:0005776]; axonal growth cone [GO:0044295]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; dendrite [GO:0030425]; endosome [GO:0005768]; extracellular space [GO:0005615]; Flemming body [GO:0090543]; glutamatergic synapse [GO:0098978]; guanyl-nucleotide exchange factor complex [GO:0032045]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; lysosome [GO:0005764]; main axon [GO:0044304]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; P-body [GO:0000932]; perikaryon [GO:0043204]; postsynapse [GO:0098794]; presynaptic cytosol [GO:0099523] GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; small GTPase binding [GO:0031267] g1838.t1 P58295 46.791 592 1.17e-161 488.0 sp|P58295|SC6A5_RAT Sodium- and chloride-dependent glycine transporter 2 OS=Rattus norvegicus OX=10116 GN=Slc6a5 PE=1 SV=2 g1840.t1 P17612 82.386 352 0.0 591.0 sp|P17612|KAPCA_HUMAN cAMP-dependent protein kinase catalytic subunit alpha OS=Homo sapiens OX=9606 GN=PRKACA PE=1 SV=2 KAPCA_HUMAN reviewed cAMP-dependent protein kinase catalytic subunit alpha (PKA C-alpha) (EC 2.7.11.11) Homo sapiens (Human) GO:0000287; GO:0001669; GO:0001707; GO:0001843; GO:0002027; GO:0003091; GO:0004674; GO:0004691; GO:0004712; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005759; GO:0005813; GO:0005829; GO:0005886; GO:0005952; GO:0006397; GO:0006611; GO:0007189; GO:0007193; GO:0010881; GO:0016241; GO:0016607; GO:0019221; GO:0019870; GO:0019901; GO:0019904; GO:0021904; GO:0030007; GO:0030145; GO:0031588; GO:0031594; GO:0031625; GO:0032024; GO:0032703; GO:0034237; GO:0034380; GO:0034605; GO:0034704; GO:0035694; GO:0036126; GO:0044853; GO:0045542; GO:0045667; GO:0045722; GO:0045879; GO:0046827; GO:0048240; GO:0048471; GO:0050766; GO:0050850; GO:0051726; GO:0055117; GO:0061136; GO:0070062; GO:0070417; GO:0070507; GO:0070613; GO:0071333; GO:0071374; GO:0071377; GO:0071872; GO:0086064; GO:0097225; GO:0097546; GO:0097700; GO:0098794; GO:0098978; GO:0099103; GO:0099170; GO:0106310; GO:0120186; GO:0140198; GO:0141156; GO:1903779; GO:1904262; GO:1904539; GO:1990044; GO:2000810 adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; cAMP/PKA signal transduction [GO:0141156]; cell communication by electrical coupling involved in cardiac conduction [GO:0086064]; cellular response to cold [GO:0070417]; cellular response to epinephrine stimulus [GO:0071872]; cellular response to glucagon stimulus [GO:0071377]; cellular response to glucose stimulus [GO:0071333]; cellular response to heat [GO:0034605]; cellular response to parathyroid hormone stimulus [GO:0071374]; cytokine-mediated signaling pathway [GO:0019221]; dorsal/ventral neural tube patterning [GO:0021904]; high-density lipoprotein particle assembly [GO:0034380]; intracellular potassium ion homeostasis [GO:0030007]; mesoderm formation [GO:0001707]; mitochondrial protein catabolic process [GO:0035694]; mRNA processing [GO:0006397]; negative regulation of glycolytic process through fructose-6-phosphate [GO:1904539]; negative regulation of interleukin-2 production [GO:0032703]; negative regulation of protein localization to chromatin [GO:0120186]; negative regulation of smoothened signaling pathway [GO:0045879]; negative regulation of TORC1 signaling [GO:1904262]; neural tube closure [GO:0001843]; positive regulation of calcium-mediated signaling [GO:0050850]; positive regulation of cholesterol biosynthetic process [GO:0045542]; positive regulation of gluconeogenesis [GO:0045722]; positive regulation of insulin secretion [GO:0032024]; positive regulation of phagocytosis [GO:0050766]; positive regulation of protein export from nucleus [GO:0046827]; postsynaptic modulation of chemical synaptic transmission [GO:0099170]; protein export from nucleus [GO:0006611]; protein localization to lipid droplet [GO:1990044]; regulation of bicellular tight junction assembly [GO:2000810]; regulation of cardiac conduction [GO:1903779]; regulation of cardiac muscle contraction [GO:0055117]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of cell cycle [GO:0051726]; regulation of heart rate [GO:0002027]; regulation of macroautophagy [GO:0016241]; regulation of microtubule cytoskeleton organization [GO:0070507]; regulation of osteoblast differentiation [GO:0045667]; regulation of proteasomal protein catabolic process [GO:0061136]; regulation of protein processing [GO:0070613]; renal water homeostasis [GO:0003091]; sperm capacitation [GO:0048240]; vascular endothelial cell response to laminar fluid shear stress [GO:0097700] acrosomal vesicle [GO:0001669]; calcium channel complex [GO:0034704]; cAMP-dependent protein kinase complex [GO:0005952]; centrosome [GO:0005813]; ciliary base [GO:0097546]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; mitochondrial matrix [GO:0005759]; neuromuscular junction [GO:0031594]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleotide-activated protein kinase complex [GO:0031588]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynapse [GO:0098794]; sperm flagellum [GO:0036126]; sperm midpiece [GO:0097225] ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]; channel activator activity [GO:0099103]; histone H1-4S35 kinase activity [GO:0140198]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; potassium channel inhibitor activity [GO:0019870]; protein domain specific binding [GO:0019904]; protein kinase A regulatory subunit binding [GO:0034237]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; ubiquitin protein ligase binding [GO:0031625] g1841.t1 Q9H553 60.0 400 1.5900000000000002e-160 461.0 sp|Q9H553|ALG2_HUMAN Alpha-1,3/1,6-mannosyltransferase ALG2 OS=Homo sapiens OX=9606 GN=ALG2 PE=1 SV=1 ALG2_HUMAN reviewed Alpha-1,3/1,6-mannosyltransferase ALG2 (EC 2.4.1.132) (EC 2.4.1.257) (Asparagine-linked glycosylation protein 2 homolog) (GDP-Man:Man(1)GlcNAc(2)-PP-Dol alpha-1,3-mannosyltransferase) (GDP-Man:Man(1)GlcNAc(2)-PP-dolichol mannosyltransferase) (GDP-Man:Man(2)GlcNAc(2)-PP-Dol alpha-1,6-mannosyltransferase) Homo sapiens (Human) GO:0000033; GO:0004378; GO:0005789; GO:0006487; GO:0006488; GO:0009101; GO:0012505; GO:0016020; GO:0098554; GO:0102704 dolichol-linked oligosaccharide biosynthetic process [GO:0006488]; glycoprotein biosynthetic process [GO:0009101]; protein N-linked glycosylation [GO:0006487] cytoplasmic side of endoplasmic reticulum membrane [GO:0098554]; endomembrane system [GO:0012505]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020] alpha-1,3-mannosyltransferase activity [GO:0000033]; GDP-Man:Man(1)GlcNAc(2)-PP-Dol alpha-1,3-mannosyltransferase activity [GO:0004378]; GDP-Man:Man(2)GlcNAc(2)-PP-Dol alpha-1,6-mannosyltransferase activity [GO:0102704] g1842.t1 Q0VA16 59.397 431 2.33e-179 519.0 sp|Q0VA16|WDR70_XENTR WD repeat-containing protein 70 OS=Xenopus tropicalis OX=8364 GN=wdr70 PE=2 SV=1 g1844.t1 A5PJU6 31.407 398 7.69e-47 169.0 sp|A5PJU6|HYKK_BOVIN Hydroxylysine kinase OS=Bos taurus OX=9913 GN=HYKK PE=2 SV=1 g1845.t1 H9D1R1 59.848 132 7.799999999999999e-48 156.0 sp|H9D1R1|TXD12_EPICO Thioredoxin domain-containing protein 12 OS=Epinephelus coioides OX=94232 GN=Txndc12 PE=1 SV=1 g1846.t1 P35431 50.758 132 1.1e-45 154.0 sp|P35431|CAV1_CHICK Caveolin-1 OS=Gallus gallus OX=9031 GN=CAV1 PE=2 SV=1 g1855.t1 Q9DEN3 60.891 202 2.16e-66 218.0 sp|Q9DEN3|FXD3B_XENLA Forkhead box protein D3-B OS=Xenopus laevis OX=8355 GN=foxd3-b PE=2 SV=1 g1860.t1 Q99MB4 62.783 309 8.31e-135 393.0 sp|Q99MB4|ZNG1_RAT Zinc-regulated GTPase metalloprotein activator 1 OS=Rattus norvegicus OX=10116 GN=Zng1 PE=2 SV=2 g1861.t1 Q15468 43.721 430 1.59e-101 359.0 sp|Q15468|STIL_HUMAN SCL-interrupting locus protein OS=Homo sapiens OX=9606 GN=STIL PE=1 SV=2 STIL_HUMAN reviewed SCL-interrupting locus protein (TAL-1-interrupting locus protein) Homo sapiens (Human) GO:0000578; GO:0001701; GO:0001843; GO:0001947; GO:0005654; GO:0005737; GO:0005813; GO:0005814; GO:0005815; GO:0005829; GO:0005938; GO:0007052; GO:0007224; GO:0007368; GO:0021915; GO:0030900; GO:0030903; GO:0031023; GO:0033504; GO:0035264; GO:0036064; GO:0042802; GO:0043066; GO:0046599; GO:0046601; GO:0051298; GO:0060236; GO:0071539; GO:0120099; GO:1900087; GO:1905832 centrosome duplication [GO:0051298]; determination of left/right symmetry [GO:0007368]; embryonic axis specification [GO:0000578]; floor plate development [GO:0033504]; forebrain development [GO:0030900]; heart looping [GO:0001947]; in utero embryonic development [GO:0001701]; microtubule organizing center organization [GO:0031023]; mitotic spindle organization [GO:0007052]; multicellular organism growth [GO:0035264]; negative regulation of apoptotic process [GO:0043066]; neural tube closure [GO:0001843]; neural tube development [GO:0021915]; notochord development [GO:0030903]; positive regulation of centriole replication [GO:0046601]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of spindle assembly [GO:1905832]; protein localization to centrosome [GO:0071539]; regulation of centriole replication [GO:0046599]; regulation of mitotic spindle organization [GO:0060236]; smoothened signaling pathway [GO:0007224] cell cortex [GO:0005938]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule organizing center [GO:0005815]; nucleoplasm [GO:0005654]; procentriole replication complex [GO:0120099] identical protein binding [GO:0042802] g1863.t1 Q8N0N3 45.687 313 1.8699999999999998e-81 254.0 sp|Q8N0N3|BGBP_PENMO Beta-1,3-glucan-binding protein OS=Penaeus monodon OX=6687 PE=2 SV=1 g1864.t1 A0A1I9LN01 26.325 566 7.35e-27 118.0 sp|A0A1I9LN01|LAF3_ARATH Protein LONG AFTER FAR-RED 3 OS=Arabidopsis thaliana OX=3702 GN=LAF3 PE=2 SV=1 LAF3_ARATH reviewed Protein LONG AFTER FAR-RED 3 (EC 3.5.-.-) Arabidopsis thaliana (Mouse-ear cress) GO:0005783; GO:0009704; GO:0009845; GO:0010218; GO:0016020; GO:0016810; GO:0048471 de-etiolation [GO:0009704]; response to far red light [GO:0010218]; seed germination [GO:0009845] endoplasmic reticulum [GO:0005783]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471] hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds [GO:0016810] g1865.t1 Q5R7Z9 68.644 472 0.0 658.0 sp|Q5R7Z9|HMCS1_PONAB Hydroxymethylglutaryl-CoA synthase, cytoplasmic OS=Pongo abelii OX=9601 GN=HMGCS1 PE=2 SV=1 g1866.t1 Q9DGI3 50.467 107 2.04e-27 100.0 sp|Q9DGI3|THIO_ICTPU Thioredoxin OS=Ictalurus punctatus OX=7998 GN=txn PE=3 SV=1 g1867.t1 A8K855 40.902 599 1.99e-152 455.0 sp|A8K855|EFCB7_HUMAN EF-hand calcium-binding domain-containing protein 7 OS=Homo sapiens OX=9606 GN=EFCAB7 PE=1 SV=1 EFCB7_HUMAN reviewed EF-hand calcium-binding domain-containing protein 7 Homo sapiens (Human) GO:0005509; GO:0005929; GO:0008589; GO:0009898; GO:0042307; GO:0045944; GO:0060170; GO:0098797; GO:0120229; GO:1903569 positive regulation of protein import into nucleus [GO:0042307]; positive regulation of protein localization to ciliary membrane [GO:1903569]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein localization to motile cilium [GO:0120229]; regulation of smoothened signaling pathway [GO:0008589] ciliary membrane [GO:0060170]; cilium [GO:0005929]; cytoplasmic side of plasma membrane [GO:0009898]; plasma membrane protein complex [GO:0098797] calcium ion binding [GO:0005509] g1868.t1 P19971 48.465 456 1.47e-131 392.0 sp|P19971|TYPH_HUMAN Thymidine phosphorylase OS=Homo sapiens OX=9606 GN=TYMP PE=1 SV=2 TYPH_HUMAN reviewed Thymidine phosphorylase (TP) (EC 2.4.2.4) (Gliostatin) (Platelet-derived endothelial cell growth factor) (PD-ECGF) (TdRPase) Homo sapiens (Human) GO:0001525; GO:0004645; GO:0005829; GO:0006206; GO:0006213; GO:0006935; GO:0008083; GO:0009032; GO:0030154; GO:0042803; GO:0046074 angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; chemotaxis [GO:0006935]; dTMP catabolic process [GO:0046074]; pyrimidine nucleobase metabolic process [GO:0006206]; pyrimidine nucleoside metabolic process [GO:0006213] cytosol [GO:0005829] 1,4-alpha-oligoglucan phosphorylase activity [GO:0004645]; growth factor activity [GO:0008083]; protein homodimerization activity [GO:0042803]; thymidine phosphorylase activity [GO:0009032] g1869.t1 Q9Y547 44.118 136 3.6700000000000002e-37 127.0 sp|Q9Y547|IFT25_HUMAN Intraflagellar transport protein 25 homolog OS=Homo sapiens OX=9606 GN=IFT25 PE=1 SV=1 IFT25_HUMAN reviewed Intraflagellar transport protein 25 homolog (Heat shock protein beta-11) (Hspb11) (Heat shock protein family B member 11) (Placental protein 25) (PP25) Homo sapiens (Human) GO:0001501; GO:0001822; GO:0005813; GO:0005929; GO:0007224; GO:0007283; GO:0007507; GO:0015031; GO:0030154; GO:0030324; GO:0030991; GO:0030992; GO:0035720; GO:0046872; GO:0060271; GO:0070986; GO:0097542 cell differentiation [GO:0030154]; cilium assembly [GO:0060271]; heart development [GO:0007507]; intraciliary anterograde transport [GO:0035720]; kidney development [GO:0001822]; left/right axis specification [GO:0070986]; lung development [GO:0030324]; protein transport [GO:0015031]; skeletal system development [GO:0001501]; smoothened signaling pathway [GO:0007224]; spermatogenesis [GO:0007283] centrosome [GO:0005813]; ciliary tip [GO:0097542]; cilium [GO:0005929]; intraciliary transport particle A [GO:0030991]; intraciliary transport particle B [GO:0030992] metal ion binding [GO:0046872] g1870.t1 Q9BSF4 38.554 166 2.34e-37 133.0 sp|Q9BSF4|TIM29_HUMAN Mitochondrial import inner membrane translocase subunit Tim29 OS=Homo sapiens OX=9606 GN=TIMM29 PE=1 SV=2 TIM29_HUMAN reviewed Mitochondrial import inner membrane translocase subunit Tim29 (TIM29) Homo sapiens (Human) GO:0005739; GO:0005743; GO:0005758; GO:0015031; GO:0042721; GO:0045039; GO:0140318 protein insertion into mitochondrial inner membrane [GO:0045039]; protein transport [GO:0015031] mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; TIM22 mitochondrial import inner membrane insertion complex [GO:0042721] protein transporter activity [GO:0140318] g1871.t1 Q8CGZ0 39.409 203 1.8e-45 181.0 sp|Q8CGZ0|CHERP_MOUSE Calcium homeostasis endoplasmic reticulum protein OS=Mus musculus OX=10090 GN=Cherp PE=1 SV=1 g1871.t1 Q8CGZ0 82.051 78 8.38e-32 137.0 sp|Q8CGZ0|CHERP_MOUSE Calcium homeostasis endoplasmic reticulum protein OS=Mus musculus OX=10090 GN=Cherp PE=1 SV=1 g1871.t1 Q8CGZ0 63.636 77 2.61e-24 114.0 sp|Q8CGZ0|CHERP_MOUSE Calcium homeostasis endoplasmic reticulum protein OS=Mus musculus OX=10090 GN=Cherp PE=1 SV=1 g1872.t1 Q99570 53.89 1414 0.0 1424.0 sp|Q99570|PI3R4_HUMAN Phosphoinositide 3-kinase regulatory subunit 4 OS=Homo sapiens OX=9606 GN=PIK3R4 PE=1 SV=3 PI3R4_HUMAN reviewed Phosphoinositide 3-kinase regulatory subunit 4 (PI3-kinase regulatory subunit 4) (EC 2.7.11.1) (PI3-kinase p150 subunit) (Phosphoinositide 3-kinase adaptor protein) Homo sapiens (Human) GO:0000425; GO:0004672; GO:0004674; GO:0005524; GO:0005770; GO:0005776; GO:0005829; GO:0005929; GO:0005930; GO:0006468; GO:0006622; GO:0006623; GO:0010506; GO:0015630; GO:0016020; GO:0016241; GO:0030670; GO:0032465; GO:0032801; GO:0034271; GO:0034272; GO:0035032; GO:0036064; GO:0036092; GO:0042149; GO:0043491; GO:0045022; GO:0045171; GO:0045324; GO:0071561; GO:0097352; GO:0106310 autophagosome maturation [GO:0097352]; cellular response to glucose starvation [GO:0042149]; early endosome to late endosome transport [GO:0045022]; late endosome to vacuole transport [GO:0045324]; pexophagy [GO:0000425]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; phosphatidylinositol-3-phosphate biosynthetic process [GO:0036092]; protein phosphorylation [GO:0006468]; protein targeting to lysosome [GO:0006622]; protein targeting to vacuole [GO:0006623]; receptor catabolic process [GO:0032801]; regulation of autophagy [GO:0010506]; regulation of cytokinesis [GO:0032465]; regulation of macroautophagy [GO:0016241] autophagosome [GO:0005776]; axoneme [GO:0005930]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytosol [GO:0005829]; intercellular bridge [GO:0045171]; late endosome [GO:0005770]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; nucleus-vacuole junction [GO:0071561]; phagocytic vesicle membrane [GO:0030670]; phosphatidylinositol 3-kinase complex, class III [GO:0035032]; phosphatidylinositol 3-kinase complex, class III, type I [GO:0034271]; phosphatidylinositol 3-kinase complex, class III, type II [GO:0034272] ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g1873.t1 P35573 48.039 1555 0.0 1455.0 sp|P35573|GDE_HUMAN Glycogen debranching enzyme OS=Homo sapiens OX=9606 GN=AGL PE=1 SV=3 GDE_HUMAN reviewed Glycogen debranching enzyme (Glycogen debrancher) [Includes: 4-alpha-glucanotransferase (EC 2.4.1.25) (Oligo-1,4-1,4-glucantransferase); Amylo-alpha-1,6-glucosidase (Amylo-1,6-glucosidase) (EC 3.2.1.33) (Dextrin 6-alpha-D-glucosidase)] Homo sapiens (Human) GO:0004134; GO:0004135; GO:0005576; GO:0005634; GO:0005737; GO:0005829; GO:0005978; GO:0005980; GO:0007584; GO:0016234; GO:0016529; GO:0030247; GO:0031593; GO:0034774; GO:0043033; GO:0051384; GO:1904813 glycogen biosynthetic process [GO:0005978]; glycogen catabolic process [GO:0005980]; response to glucocorticoid [GO:0051384]; response to nutrient [GO:0007584] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; inclusion body [GO:0016234]; isoamylase complex [GO:0043033]; nucleus [GO:0005634]; sarcoplasmic reticulum [GO:0016529]; secretory granule lumen [GO:0034774] 4-alpha-glucanotransferase activity [GO:0004134]; amylo-alpha-1,6-glucosidase activity [GO:0004135]; polysaccharide binding [GO:0030247]; polyubiquitin modification-dependent protein binding [GO:0031593] g1874.t1 Q5UR67 42.169 166 4.15e-28 106.0 sp|Q5UR67|RIBX_MIMIV N-glycosidase R617 OS=Acanthamoeba polyphaga mimivirus OX=212035 GN=MIMI_R617 PE=3 SV=1 g1875.t1 Q9Z0Z3 33.616 354 6.96e-48 174.0 sp|Q9Z0Z3|SKP2_MOUSE S-phase kinase-associated protein 2 OS=Mus musculus OX=10090 GN=Skp2 PE=1 SV=1 SKP2_MOUSE reviewed S-phase kinase-associated protein 2 (Cyclin-A/CDK2-associated protein p45) (F-box protein Skp2) (F-box/WD-40 protein 1) (FWD1) Mus musculus (Mouse) GO:0000082; GO:0000086; GO:0000209; GO:0000729; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0006511; GO:0019005; GO:0031146; GO:0033148; GO:0042802; GO:0042981; GO:0043161; GO:0045087; GO:0048661; GO:0051607; GO:0051726; GO:0070534; GO:0070936; GO:0071460; GO:1902916; GO:1905168; GO:1990166; GO:1990756 cellular response to cell-matrix adhesion [GO:0071460]; defense response to virus [GO:0051607]; DNA double-strand break processing [GO:0000729]; G1/S transition of mitotic cell cycle [GO:0000082]; G2/M transition of mitotic cell cycle [GO:0000086]; innate immune response [GO:0045087]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of intracellular estrogen receptor signaling pathway [GO:0033148]; positive regulation of protein polyubiquitination [GO:1902916]; positive regulation of smooth muscle cell proliferation [GO:0048661]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K48-linked ubiquitination [GO:0070936]; protein K63-linked ubiquitination [GO:0070534]; protein localization to site of double-strand break [GO:1990166]; protein polyubiquitination [GO:0000209]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; ubiquitin-dependent protein catabolic process [GO:0006511] cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005] identical protein binding [GO:0042802]; ubiquitin-like ligase-substrate adaptor activity [GO:1990756] g1876.t1 A2VE52 63.934 183 2.99e-89 266.0 sp|A2VE52|ORN_BOVIN Oligoribonuclease, mitochondrial OS=Bos taurus OX=9913 GN=REXO2 PE=2 SV=1 ORN_BOVIN reviewed Oligoribonuclease, mitochondrial (EC 3.1.15.-) (RNA exonuclease 2 homolog) (Small fragment nuclease) Bos taurus (Bovine) GO:0000175; GO:0000287; GO:0003676; GO:0005634; GO:0005730; GO:0005737; GO:0005739; GO:0005758; GO:0005759; GO:0005925; GO:0008296; GO:0008408; GO:2000827 mitochondrial RNA surveillance [GO:2000827] cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; mitochondrial intermembrane space [GO:0005758]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleus [GO:0005634] 3'-5' exonuclease activity [GO:0008408]; 3'-5'-DNA exonuclease activity [GO:0008296]; 3'-5'-RNA exonuclease activity [GO:0000175]; magnesium ion binding [GO:0000287]; nucleic acid binding [GO:0003676] g1877.t1 Q7ZYA0 48.563 696 0.0 596.0 sp|Q7ZYA0|LMBD2_XENLA G-protein coupled receptor-associated protein LMBRD2 OS=Xenopus laevis OX=8355 GN=lmbrd2 PE=2 SV=1 g1878.t1 P98156 43.403 864 0.0 649.0 sp|P98156|VLDLR_MOUSE Very low-density lipoprotein receptor OS=Mus musculus OX=10090 GN=Vldlr PE=1 SV=1 VLDLR_MOUSE reviewed Very low-density lipoprotein receptor (VLDL receptor) (VLDL-R) Mus musculus (Mouse) GO:0005509; GO:0005615; GO:0005886; GO:0005905; GO:0006869; GO:0006898; GO:0008203; GO:0009986; GO:0016020; GO:0021517; GO:0030229; GO:0034185; GO:0034189; GO:0034361; GO:0034436; GO:0034447; GO:0038024; GO:0038025; GO:0038026; GO:0043235; GO:0045177; GO:0045202; GO:0048306; GO:0048471; GO:0048813; GO:0051963; GO:0071456; GO:0098978; GO:1900006 cellular response to hypoxia [GO:0071456]; cholesterol metabolic process [GO:0008203]; dendrite morphogenesis [GO:0048813]; glycoprotein transport [GO:0034436]; lipid transport [GO:0006869]; positive regulation of dendrite development [GO:1900006]; receptor-mediated endocytosis [GO:0006898]; reelin-mediated signaling pathway [GO:0038026]; regulation of synapse assembly [GO:0051963]; ventral spinal cord development [GO:0021517]; very-low-density lipoprotein particle clearance [GO:0034447] apical part of cell [GO:0045177]; cell surface [GO:0009986]; clathrin-coated pit [GO:0005905]; extracellular space [GO:0005615]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; synapse [GO:0045202]; very-low-density lipoprotein particle [GO:0034361] apolipoprotein binding [GO:0034185]; calcium ion binding [GO:0005509]; calcium-dependent protein binding [GO:0048306]; cargo receptor activity [GO:0038024]; reelin receptor activity [GO:0038025]; very-low-density lipoprotein particle binding [GO:0034189]; very-low-density lipoprotein particle receptor activity [GO:0030229] g1880.t1 Q6P0Q8 45.325 492 6.84e-103 331.0 sp|Q6P0Q8|MAST2_HUMAN Microtubule-associated serine/threonine-protein kinase 2 OS=Homo sapiens OX=9606 GN=MAST2 PE=1 SV=2 MAST2_HUMAN reviewed Microtubule-associated serine/threonine-protein kinase 2 (EC 2.7.11.1) Homo sapiens (Human) GO:0000287; GO:0004674; GO:0005524; GO:0005886; GO:0006468; GO:0007010; GO:0008017; GO:0015630; GO:0019902; GO:0032655; GO:0035556; GO:0048515; GO:0106310 cytoskeleton organization [GO:0007010]; intracellular signal transduction [GO:0035556]; protein phosphorylation [GO:0006468]; regulation of interleukin-12 production [GO:0032655]; spermatid differentiation [GO:0048515] microtubule cytoskeleton [GO:0015630]; plasma membrane [GO:0005886] ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; microtubule binding [GO:0008017]; phosphatase binding [GO:0019902]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g1880.t1 Q6P0Q8 84.375 32 6.84e-103 66.6 sp|Q6P0Q8|MAST2_HUMAN Microtubule-associated serine/threonine-protein kinase 2 OS=Homo sapiens OX=9606 GN=MAST2 PE=1 SV=2 MAST2_HUMAN reviewed Microtubule-associated serine/threonine-protein kinase 2 (EC 2.7.11.1) Homo sapiens (Human) GO:0000287; GO:0004674; GO:0005524; GO:0005886; GO:0006468; GO:0007010; GO:0008017; GO:0015630; GO:0019902; GO:0032655; GO:0035556; GO:0048515; GO:0106310 cytoskeleton organization [GO:0007010]; intracellular signal transduction [GO:0035556]; protein phosphorylation [GO:0006468]; regulation of interleukin-12 production [GO:0032655]; spermatid differentiation [GO:0048515] microtubule cytoskeleton [GO:0015630]; plasma membrane [GO:0005886] ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; microtubule binding [GO:0008017]; phosphatase binding [GO:0019902]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g1880.t2 Q6P0Q8 45.325 492 5.740000000000001e-103 331.0 sp|Q6P0Q8|MAST2_HUMAN Microtubule-associated serine/threonine-protein kinase 2 OS=Homo sapiens OX=9606 GN=MAST2 PE=1 SV=2 MAST2_HUMAN reviewed Microtubule-associated serine/threonine-protein kinase 2 (EC 2.7.11.1) Homo sapiens (Human) GO:0000287; GO:0004674; GO:0005524; GO:0005886; GO:0006468; GO:0007010; GO:0008017; GO:0015630; GO:0019902; GO:0032655; GO:0035556; GO:0048515; GO:0106310 cytoskeleton organization [GO:0007010]; intracellular signal transduction [GO:0035556]; protein phosphorylation [GO:0006468]; regulation of interleukin-12 production [GO:0032655]; spermatid differentiation [GO:0048515] microtubule cytoskeleton [GO:0015630]; plasma membrane [GO:0005886] ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; microtubule binding [GO:0008017]; phosphatase binding [GO:0019902]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g1880.t2 Q6P0Q8 84.375 32 5.740000000000001e-103 66.6 sp|Q6P0Q8|MAST2_HUMAN Microtubule-associated serine/threonine-protein kinase 2 OS=Homo sapiens OX=9606 GN=MAST2 PE=1 SV=2 MAST2_HUMAN reviewed Microtubule-associated serine/threonine-protein kinase 2 (EC 2.7.11.1) Homo sapiens (Human) GO:0000287; GO:0004674; GO:0005524; GO:0005886; GO:0006468; GO:0007010; GO:0008017; GO:0015630; GO:0019902; GO:0032655; GO:0035556; GO:0048515; GO:0106310 cytoskeleton organization [GO:0007010]; intracellular signal transduction [GO:0035556]; protein phosphorylation [GO:0006468]; regulation of interleukin-12 production [GO:0032655]; spermatid differentiation [GO:0048515] microtubule cytoskeleton [GO:0015630]; plasma membrane [GO:0005886] ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; microtubule binding [GO:0008017]; phosphatase binding [GO:0019902]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g1880.t3 Q6P0Q8 45.098 510 1.22e-101 327.0 sp|Q6P0Q8|MAST2_HUMAN Microtubule-associated serine/threonine-protein kinase 2 OS=Homo sapiens OX=9606 GN=MAST2 PE=1 SV=2 MAST2_HUMAN reviewed Microtubule-associated serine/threonine-protein kinase 2 (EC 2.7.11.1) Homo sapiens (Human) GO:0000287; GO:0004674; GO:0005524; GO:0005886; GO:0006468; GO:0007010; GO:0008017; GO:0015630; GO:0019902; GO:0032655; GO:0035556; GO:0048515; GO:0106310 cytoskeleton organization [GO:0007010]; intracellular signal transduction [GO:0035556]; protein phosphorylation [GO:0006468]; regulation of interleukin-12 production [GO:0032655]; spermatid differentiation [GO:0048515] microtubule cytoskeleton [GO:0015630]; plasma membrane [GO:0005886] ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; microtubule binding [GO:0008017]; phosphatase binding [GO:0019902]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g1880.t3 Q6P0Q8 84.375 32 1.22e-101 66.6 sp|Q6P0Q8|MAST2_HUMAN Microtubule-associated serine/threonine-protein kinase 2 OS=Homo sapiens OX=9606 GN=MAST2 PE=1 SV=2 MAST2_HUMAN reviewed Microtubule-associated serine/threonine-protein kinase 2 (EC 2.7.11.1) Homo sapiens (Human) GO:0000287; GO:0004674; GO:0005524; GO:0005886; GO:0006468; GO:0007010; GO:0008017; GO:0015630; GO:0019902; GO:0032655; GO:0035556; GO:0048515; GO:0106310 cytoskeleton organization [GO:0007010]; intracellular signal transduction [GO:0035556]; protein phosphorylation [GO:0006468]; regulation of interleukin-12 production [GO:0032655]; spermatid differentiation [GO:0048515] microtubule cytoskeleton [GO:0015630]; plasma membrane [GO:0005886] ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; microtubule binding [GO:0008017]; phosphatase binding [GO:0019902]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g1881.t1 Q6AX33 74.528 212 4.13e-98 341.0 sp|Q6AX33|MAST3_XENLA Microtubule-associated serine/threonine-protein kinase 3 OS=Xenopus laevis OX=8355 GN=mast3 PE=2 SV=1 g1881.t1 Q6AX33 47.899 238 6.22e-33 142.0 sp|Q6AX33|MAST3_XENLA Microtubule-associated serine/threonine-protein kinase 3 OS=Xenopus laevis OX=8355 GN=mast3 PE=2 SV=1 g1883.t1 Q761V0 53.419 468 1.06e-142 431.0 sp|Q761V0|SC6A5_MOUSE Sodium- and chloride-dependent glycine transporter 2 OS=Mus musculus OX=10090 GN=Slc6a5 PE=1 SV=1 SC6A5_MOUSE reviewed Sodium- and chloride-dependent glycine transporter 2 (GlyT-2) (GlyT2) (Solute carrier family 6 member 5) Mus musculus (Mouse) GO:0001504; GO:0005768; GO:0005886; GO:0015187; GO:0015375; GO:0015816; GO:0031045; GO:0035725; GO:0042734; GO:0046872; GO:0060012; GO:0098690; GO:0098810; GO:1903804 glycine import across plasma membrane [GO:1903804]; glycine transport [GO:0015816]; neurotransmitter reuptake [GO:0098810]; neurotransmitter uptake [GO:0001504]; sodium ion transmembrane transport [GO:0035725]; synaptic transmission, glycinergic [GO:0060012] dense core granule [GO:0031045]; endosome [GO:0005768]; glycinergic synapse [GO:0098690]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734] glycine transmembrane transporter activity [GO:0015187]; glycine:sodium symporter activity [GO:0015375]; metal ion binding [GO:0046872] g1884.t1 Q6P5J6 36.576 257 1.46e-33 135.0 sp|Q6P5J6|LRC42_DANRE Leucine-rich repeat-containing protein 42 OS=Danio rerio OX=7955 GN=lrrc42 PE=2 SV=1 g1886.t1 Q3UVK0 39.571 839 0.0 604.0 sp|Q3UVK0|ERMP1_MOUSE Endoplasmic reticulum metallopeptidase 1 OS=Mus musculus OX=10090 GN=Ermp1 PE=1 SV=2 ERMP1_MOUSE reviewed Endoplasmic reticulum metallopeptidase 1 (EC 3.4.-.-) (Felix-ina) Mus musculus (Mouse) GO:0001541; GO:0005789; GO:0006508; GO:0008235; GO:0030968; GO:0034599; GO:0046872 cellular response to oxidative stress [GO:0034599]; endoplasmic reticulum unfolded protein response [GO:0030968]; ovarian follicle development [GO:0001541]; proteolysis [GO:0006508] endoplasmic reticulum membrane [GO:0005789] metal ion binding [GO:0046872]; metalloexopeptidase activity [GO:0008235] g1887.t1 Q7YU29 35.181 469 2.2599999999999997e-82 287.0 sp|Q7YU29|DMDE_DROME Dystrophin, isoform E OS=Drosophila melanogaster OX=7227 GN=Dys PE=1 SV=1 g1888.t1 Q9QZD4 52.481 907 0.0 847.0 sp|Q9QZD4|XPF_MOUSE DNA repair endonuclease XPF OS=Mus musculus OX=10090 GN=Ercc4 PE=1 SV=3 XPF_MOUSE reviewed DNA repair endonuclease XPF (EC 3.1.-.-) (DNA excision repair protein ERCC-4) Mus musculus (Mouse) GO:0000014; GO:0000109; GO:0000110; GO:0000712; GO:0000723; GO:0000724; GO:0000781; GO:0001094; GO:0003684; GO:0003697; GO:0004520; GO:0005634; GO:0006281; GO:0006289; GO:0006303; GO:0009411; GO:0009650; GO:0010506; GO:0032205; GO:0034644; GO:0042802; GO:0061819; GO:0070522; GO:1901255; GO:1904357; GO:1905765; GO:1990599; GO:1990841 cellular response to UV [GO:0034644]; DNA repair [GO:0006281]; double-strand break repair via homologous recombination [GO:0000724]; double-strand break repair via nonhomologous end joining [GO:0006303]; negative regulation of protection from non-homologous end joining at telomere [GO:1905765]; negative regulation of telomere maintenance [GO:0032205]; negative regulation of telomere maintenance via telomere lengthening [GO:1904357]; nucleotide-excision repair [GO:0006289]; nucleotide-excision repair involved in interstrand cross-link repair [GO:1901255]; regulation of autophagy [GO:0010506]; resolution of meiotic recombination intermediates [GO:0000712]; response to UV [GO:0009411]; telomere maintenance [GO:0000723]; telomeric DNA-containing double minutes formation [GO:0061819]; UV protection [GO:0009650] chromosome, telomeric region [GO:0000781]; ERCC4-ERCC1 complex [GO:0070522]; nucleotide-excision repair complex [GO:0000109]; nucleotide-excision repair factor 1 complex [GO:0000110]; nucleus [GO:0005634] 3' overhang single-stranded DNA endodeoxyribonuclease activity [GO:1990599]; damaged DNA binding [GO:0003684]; DNA endonuclease activity [GO:0004520]; identical protein binding [GO:0042802]; promoter-specific chromatin binding [GO:1990841]; single-stranded DNA binding [GO:0003697]; single-stranded DNA endodeoxyribonuclease activity [GO:0000014]; TFIID-class transcription factor complex binding [GO:0001094] g1889.t1 B1AS42 40.836 311 1.1199999999999999e-82 256.0 sp|B1AS42|NB5R5_MOUSE NADH-cytochrome b5 reductase-like OS=Mus musculus OX=10090 GN=Cyb5rl PE=2 SV=1 NB5R5_MOUSE reviewed NADH-cytochrome b5 reductase-like (EC 1.6.2.2) Mus musculus (Mouse) GO:0005654; GO:0005789; GO:0016491; GO:0090524 endoplasmic reticulum membrane [GO:0005789]; nucleoplasm [GO:0005654] cytochrome-b5 reductase activity, acting on NADH [GO:0090524]; oxidoreductase activity [GO:0016491] g1891.t1 P0C6B8 32.853 1595 0.0 766.0 sp|P0C6B8|SVEP1_RAT Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 OS=Rattus norvegicus OX=10116 GN=Svep1 PE=1 SV=1 SVEP1_RAT reviewed Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 Rattus norvegicus (Rat) GO:0001945; GO:0003017; GO:0003682; GO:0005178; GO:0005509; GO:0005576; GO:0005615; GO:0005634; GO:0005737; GO:0008544; GO:0010467; GO:0010572; GO:0016020; GO:0031012; GO:0031099; GO:0036303; GO:0045906; GO:0048014; GO:0098640; GO:0120193 epidermis development [GO:0008544]; gene expression [GO:0010467]; lymph circulation [GO:0003017]; lymph vessel development [GO:0001945]; lymph vessel morphogenesis [GO:0036303]; negative regulation of vasoconstriction [GO:0045906]; positive regulation of platelet activation [GO:0010572]; regeneration [GO:0031099]; Tie signaling pathway [GO:0048014]; tight junction organization [GO:0120193] cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; nucleus [GO:0005634] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; integrin binding [GO:0005178]; integrin binding involved in cell-matrix adhesion [GO:0098640] g1891.t1 P0C6B8 28.927 643 5.33e-62 239.0 sp|P0C6B8|SVEP1_RAT Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 OS=Rattus norvegicus OX=10116 GN=Svep1 PE=1 SV=1 SVEP1_RAT reviewed Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 Rattus norvegicus (Rat) GO:0001945; GO:0003017; GO:0003682; GO:0005178; GO:0005509; GO:0005576; GO:0005615; GO:0005634; GO:0005737; GO:0008544; GO:0010467; GO:0010572; GO:0016020; GO:0031012; GO:0031099; GO:0036303; GO:0045906; GO:0048014; GO:0098640; GO:0120193 epidermis development [GO:0008544]; gene expression [GO:0010467]; lymph circulation [GO:0003017]; lymph vessel development [GO:0001945]; lymph vessel morphogenesis [GO:0036303]; negative regulation of vasoconstriction [GO:0045906]; positive regulation of platelet activation [GO:0010572]; regeneration [GO:0031099]; Tie signaling pathway [GO:0048014]; tight junction organization [GO:0120193] cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; nucleus [GO:0005634] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; integrin binding [GO:0005178]; integrin binding involved in cell-matrix adhesion [GO:0098640] g1891.t1 P0C6B8 30.197 457 1.15e-54 215.0 sp|P0C6B8|SVEP1_RAT Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 OS=Rattus norvegicus OX=10116 GN=Svep1 PE=1 SV=1 SVEP1_RAT reviewed Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 Rattus norvegicus (Rat) GO:0001945; GO:0003017; GO:0003682; GO:0005178; GO:0005509; GO:0005576; GO:0005615; GO:0005634; GO:0005737; GO:0008544; GO:0010467; GO:0010572; GO:0016020; GO:0031012; GO:0031099; GO:0036303; GO:0045906; GO:0048014; GO:0098640; GO:0120193 epidermis development [GO:0008544]; gene expression [GO:0010467]; lymph circulation [GO:0003017]; lymph vessel development [GO:0001945]; lymph vessel morphogenesis [GO:0036303]; negative regulation of vasoconstriction [GO:0045906]; positive regulation of platelet activation [GO:0010572]; regeneration [GO:0031099]; Tie signaling pathway [GO:0048014]; tight junction organization [GO:0120193] cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; nucleus [GO:0005634] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; integrin binding [GO:0005178]; integrin binding involved in cell-matrix adhesion [GO:0098640] g1891.t1 P0C6B8 25.629 636 1.81e-54 214.0 sp|P0C6B8|SVEP1_RAT Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 OS=Rattus norvegicus OX=10116 GN=Svep1 PE=1 SV=1 SVEP1_RAT reviewed Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 Rattus norvegicus (Rat) GO:0001945; GO:0003017; GO:0003682; GO:0005178; GO:0005509; GO:0005576; GO:0005615; GO:0005634; GO:0005737; GO:0008544; GO:0010467; GO:0010572; GO:0016020; GO:0031012; GO:0031099; GO:0036303; GO:0045906; GO:0048014; GO:0098640; GO:0120193 epidermis development [GO:0008544]; gene expression [GO:0010467]; lymph circulation [GO:0003017]; lymph vessel development [GO:0001945]; lymph vessel morphogenesis [GO:0036303]; negative regulation of vasoconstriction [GO:0045906]; positive regulation of platelet activation [GO:0010572]; regeneration [GO:0031099]; Tie signaling pathway [GO:0048014]; tight junction organization [GO:0120193] cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; nucleus [GO:0005634] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; integrin binding [GO:0005178]; integrin binding involved in cell-matrix adhesion [GO:0098640] g1891.t1 P0C6B8 28.866 582 2.9799999999999998e-53 211.0 sp|P0C6B8|SVEP1_RAT Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 OS=Rattus norvegicus OX=10116 GN=Svep1 PE=1 SV=1 SVEP1_RAT reviewed Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 Rattus norvegicus (Rat) GO:0001945; GO:0003017; GO:0003682; GO:0005178; GO:0005509; GO:0005576; GO:0005615; GO:0005634; GO:0005737; GO:0008544; GO:0010467; GO:0010572; GO:0016020; GO:0031012; GO:0031099; GO:0036303; GO:0045906; GO:0048014; GO:0098640; GO:0120193 epidermis development [GO:0008544]; gene expression [GO:0010467]; lymph circulation [GO:0003017]; lymph vessel development [GO:0001945]; lymph vessel morphogenesis [GO:0036303]; negative regulation of vasoconstriction [GO:0045906]; positive regulation of platelet activation [GO:0010572]; regeneration [GO:0031099]; Tie signaling pathway [GO:0048014]; tight junction organization [GO:0120193] cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; nucleus [GO:0005634] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; integrin binding [GO:0005178]; integrin binding involved in cell-matrix adhesion [GO:0098640] g1891.t1 P0C6B8 26.589 598 3.95e-53 210.0 sp|P0C6B8|SVEP1_RAT Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 OS=Rattus norvegicus OX=10116 GN=Svep1 PE=1 SV=1 SVEP1_RAT reviewed Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 Rattus norvegicus (Rat) GO:0001945; GO:0003017; GO:0003682; GO:0005178; GO:0005509; GO:0005576; GO:0005615; GO:0005634; GO:0005737; GO:0008544; GO:0010467; GO:0010572; GO:0016020; GO:0031012; GO:0031099; GO:0036303; GO:0045906; GO:0048014; GO:0098640; GO:0120193 epidermis development [GO:0008544]; gene expression [GO:0010467]; lymph circulation [GO:0003017]; lymph vessel development [GO:0001945]; lymph vessel morphogenesis [GO:0036303]; negative regulation of vasoconstriction [GO:0045906]; positive regulation of platelet activation [GO:0010572]; regeneration [GO:0031099]; Tie signaling pathway [GO:0048014]; tight junction organization [GO:0120193] cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; nucleus [GO:0005634] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; integrin binding [GO:0005178]; integrin binding involved in cell-matrix adhesion [GO:0098640] g1891.t1 P0C6B8 27.632 608 1.05e-50 202.0 sp|P0C6B8|SVEP1_RAT Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 OS=Rattus norvegicus OX=10116 GN=Svep1 PE=1 SV=1 SVEP1_RAT reviewed Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 Rattus norvegicus (Rat) GO:0001945; GO:0003017; GO:0003682; GO:0005178; GO:0005509; GO:0005576; GO:0005615; GO:0005634; GO:0005737; GO:0008544; GO:0010467; GO:0010572; GO:0016020; GO:0031012; GO:0031099; GO:0036303; GO:0045906; GO:0048014; GO:0098640; GO:0120193 epidermis development [GO:0008544]; gene expression [GO:0010467]; lymph circulation [GO:0003017]; lymph vessel development [GO:0001945]; lymph vessel morphogenesis [GO:0036303]; negative regulation of vasoconstriction [GO:0045906]; positive regulation of platelet activation [GO:0010572]; regeneration [GO:0031099]; Tie signaling pathway [GO:0048014]; tight junction organization [GO:0120193] cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; nucleus [GO:0005634] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; integrin binding [GO:0005178]; integrin binding involved in cell-matrix adhesion [GO:0098640] g1891.t1 P0C6B8 28.546 557 1.36e-47 192.0 sp|P0C6B8|SVEP1_RAT Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 OS=Rattus norvegicus OX=10116 GN=Svep1 PE=1 SV=1 SVEP1_RAT reviewed Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 Rattus norvegicus (Rat) GO:0001945; GO:0003017; GO:0003682; GO:0005178; GO:0005509; GO:0005576; GO:0005615; GO:0005634; GO:0005737; GO:0008544; GO:0010467; GO:0010572; GO:0016020; GO:0031012; GO:0031099; GO:0036303; GO:0045906; GO:0048014; GO:0098640; GO:0120193 epidermis development [GO:0008544]; gene expression [GO:0010467]; lymph circulation [GO:0003017]; lymph vessel development [GO:0001945]; lymph vessel morphogenesis [GO:0036303]; negative regulation of vasoconstriction [GO:0045906]; positive regulation of platelet activation [GO:0010572]; regeneration [GO:0031099]; Tie signaling pathway [GO:0048014]; tight junction organization [GO:0120193] cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; nucleus [GO:0005634] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; integrin binding [GO:0005178]; integrin binding involved in cell-matrix adhesion [GO:0098640] g1891.t1 P0C6B8 25.331 604 6.4e-39 164.0 sp|P0C6B8|SVEP1_RAT Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 OS=Rattus norvegicus OX=10116 GN=Svep1 PE=1 SV=1 SVEP1_RAT reviewed Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 Rattus norvegicus (Rat) GO:0001945; GO:0003017; GO:0003682; GO:0005178; GO:0005509; GO:0005576; GO:0005615; GO:0005634; GO:0005737; GO:0008544; GO:0010467; GO:0010572; GO:0016020; GO:0031012; GO:0031099; GO:0036303; GO:0045906; GO:0048014; GO:0098640; GO:0120193 epidermis development [GO:0008544]; gene expression [GO:0010467]; lymph circulation [GO:0003017]; lymph vessel development [GO:0001945]; lymph vessel morphogenesis [GO:0036303]; negative regulation of vasoconstriction [GO:0045906]; positive regulation of platelet activation [GO:0010572]; regeneration [GO:0031099]; Tie signaling pathway [GO:0048014]; tight junction organization [GO:0120193] cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; nucleus [GO:0005634] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; integrin binding [GO:0005178]; integrin binding involved in cell-matrix adhesion [GO:0098640] g1891.t1 P0C6B8 25.647 464 3.52e-35 151.0 sp|P0C6B8|SVEP1_RAT Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 OS=Rattus norvegicus OX=10116 GN=Svep1 PE=1 SV=1 SVEP1_RAT reviewed Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 Rattus norvegicus (Rat) GO:0001945; GO:0003017; GO:0003682; GO:0005178; GO:0005509; GO:0005576; GO:0005615; GO:0005634; GO:0005737; GO:0008544; GO:0010467; GO:0010572; GO:0016020; GO:0031012; GO:0031099; GO:0036303; GO:0045906; GO:0048014; GO:0098640; GO:0120193 epidermis development [GO:0008544]; gene expression [GO:0010467]; lymph circulation [GO:0003017]; lymph vessel development [GO:0001945]; lymph vessel morphogenesis [GO:0036303]; negative regulation of vasoconstriction [GO:0045906]; positive regulation of platelet activation [GO:0010572]; regeneration [GO:0031099]; Tie signaling pathway [GO:0048014]; tight junction organization [GO:0120193] cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; nucleus [GO:0005634] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; integrin binding [GO:0005178]; integrin binding involved in cell-matrix adhesion [GO:0098640] g1891.t1 P0C6B8 45.946 148 4.19e-26 113.0 sp|P0C6B8|SVEP1_RAT Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 OS=Rattus norvegicus OX=10116 GN=Svep1 PE=1 SV=1 SVEP1_RAT reviewed Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 Rattus norvegicus (Rat) GO:0001945; GO:0003017; GO:0003682; GO:0005178; GO:0005509; GO:0005576; GO:0005615; GO:0005634; GO:0005737; GO:0008544; GO:0010467; GO:0010572; GO:0016020; GO:0031012; GO:0031099; GO:0036303; GO:0045906; GO:0048014; GO:0098640; GO:0120193 epidermis development [GO:0008544]; gene expression [GO:0010467]; lymph circulation [GO:0003017]; lymph vessel development [GO:0001945]; lymph vessel morphogenesis [GO:0036303]; negative regulation of vasoconstriction [GO:0045906]; positive regulation of platelet activation [GO:0010572]; regeneration [GO:0031099]; Tie signaling pathway [GO:0048014]; tight junction organization [GO:0120193] cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; nucleus [GO:0005634] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; integrin binding [GO:0005178]; integrin binding involved in cell-matrix adhesion [GO:0098640] g1891.t1 P0C6B8 73.333 15 4.19e-26 29.3 sp|P0C6B8|SVEP1_RAT Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 OS=Rattus norvegicus OX=10116 GN=Svep1 PE=1 SV=1 SVEP1_RAT reviewed Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 Rattus norvegicus (Rat) GO:0001945; GO:0003017; GO:0003682; GO:0005178; GO:0005509; GO:0005576; GO:0005615; GO:0005634; GO:0005737; GO:0008544; GO:0010467; GO:0010572; GO:0016020; GO:0031012; GO:0031099; GO:0036303; GO:0045906; GO:0048014; GO:0098640; GO:0120193 epidermis development [GO:0008544]; gene expression [GO:0010467]; lymph circulation [GO:0003017]; lymph vessel development [GO:0001945]; lymph vessel morphogenesis [GO:0036303]; negative regulation of vasoconstriction [GO:0045906]; positive regulation of platelet activation [GO:0010572]; regeneration [GO:0031099]; Tie signaling pathway [GO:0048014]; tight junction organization [GO:0120193] cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; nucleus [GO:0005634] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; integrin binding [GO:0005178]; integrin binding involved in cell-matrix adhesion [GO:0098640] g1892.t1 A2AVA0 52.339 449 3.9999999999999997e-134 435.0 sp|A2AVA0|SVEP1_MOUSE Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 OS=Mus musculus OX=10090 GN=Svep1 PE=1 SV=1 SVEP1_MOUSE reviewed Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 (Polydom) Mus musculus (Mouse) GO:0001945; GO:0003017; GO:0003682; GO:0005178; GO:0005509; GO:0005576; GO:0005615; GO:0005634; GO:0005737; GO:0008544; GO:0010467; GO:0010572; GO:0016020; GO:0016477; GO:0031012; GO:0036303; GO:0045906; GO:0048014; GO:0090136; GO:0098640; GO:0120193 cell migration [GO:0016477]; epidermis development [GO:0008544]; epithelial cell-cell adhesion [GO:0090136]; gene expression [GO:0010467]; lymph circulation [GO:0003017]; lymph vessel development [GO:0001945]; lymph vessel morphogenesis [GO:0036303]; negative regulation of vasoconstriction [GO:0045906]; positive regulation of platelet activation [GO:0010572]; Tie signaling pathway [GO:0048014]; tight junction organization [GO:0120193] cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; nucleus [GO:0005634] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; integrin binding [GO:0005178]; integrin binding involved in cell-matrix adhesion [GO:0098640] g1893.t1 Q9NR33 45.455 110 3.32e-29 105.0 sp|Q9NR33|DPOE4_HUMAN DNA polymerase epsilon subunit 4 OS=Homo sapiens OX=9606 GN=POLE4 PE=1 SV=2 DPOE4_HUMAN reviewed DNA polymerase epsilon subunit 4 (DNA polymerase II subunit 4) (DNA polymerase epsilon subunit p12) Homo sapiens (Human) GO:0003677; GO:0003887; GO:0005634; GO:0005654; GO:0006261; GO:0008622; GO:0046982; GO:0140672 DNA-templated DNA replication [GO:0006261] ATAC complex [GO:0140672]; epsilon DNA polymerase complex [GO:0008622]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; protein heterodimerization activity [GO:0046982] g1894.t1 P06857 38.534 423 2.0399999999999999e-82 266.0 sp|P06857|LIPR1_CANLF Inactive pancreatic lipase-related protein 1 OS=Canis lupus familiaris OX=9615 GN=PNLIPRP1 PE=1 SV=2 g1895.t1 Q6P8U6 38.107 412 2.13e-80 261.0 sp|Q6P8U6|LIPP_MOUSE Pancreatic triacylglycerol lipase OS=Mus musculus OX=10090 GN=Pnlip PE=1 SV=1 LIPP_MOUSE reviewed Pancreatic triacylglycerol lipase (PL) (PTL) (Pancreatic lipase) (EC 3.1.1.3) Mus musculus (Mouse) GO:0001523; GO:0004465; GO:0004806; GO:0005615; GO:0006629; GO:0006633; GO:0008970; GO:0009791; GO:0016298; GO:0019433; GO:0030299; GO:0034375; GO:0042632; GO:0046872; GO:0047376; GO:0050253 cholesterol homeostasis [GO:0042632]; fatty acid biosynthetic process [GO:0006633]; high-density lipoprotein particle remodeling [GO:0034375]; intestinal cholesterol absorption [GO:0030299]; lipid metabolic process [GO:0006629]; post-embryonic development [GO:0009791]; retinoid metabolic process [GO:0001523]; triglyceride catabolic process [GO:0019433] extracellular space [GO:0005615] all-trans-retinyl-palmitate hydrolase, all-trans-retinol forming activity [GO:0047376]; lipase activity [GO:0016298]; lipoprotein lipase activity [GO:0004465]; metal ion binding [GO:0046872]; phospholipase A1 activity [GO:0008970]; retinyl-palmitate esterase activity [GO:0050253]; triacylglycerol lipase activity [GO:0004806] g1895.t2 Q6P8U6 38.107 412 1.88e-80 261.0 sp|Q6P8U6|LIPP_MOUSE Pancreatic triacylglycerol lipase OS=Mus musculus OX=10090 GN=Pnlip PE=1 SV=1 LIPP_MOUSE reviewed Pancreatic triacylglycerol lipase (PL) (PTL) (Pancreatic lipase) (EC 3.1.1.3) Mus musculus (Mouse) GO:0001523; GO:0004465; GO:0004806; GO:0005615; GO:0006629; GO:0006633; GO:0008970; GO:0009791; GO:0016298; GO:0019433; GO:0030299; GO:0034375; GO:0042632; GO:0046872; GO:0047376; GO:0050253 cholesterol homeostasis [GO:0042632]; fatty acid biosynthetic process [GO:0006633]; high-density lipoprotein particle remodeling [GO:0034375]; intestinal cholesterol absorption [GO:0030299]; lipid metabolic process [GO:0006629]; post-embryonic development [GO:0009791]; retinoid metabolic process [GO:0001523]; triglyceride catabolic process [GO:0019433] extracellular space [GO:0005615] all-trans-retinyl-palmitate hydrolase, all-trans-retinol forming activity [GO:0047376]; lipase activity [GO:0016298]; lipoprotein lipase activity [GO:0004465]; metal ion binding [GO:0046872]; phospholipase A1 activity [GO:0008970]; retinyl-palmitate esterase activity [GO:0050253]; triacylglycerol lipase activity [GO:0004806] g1907.t1 P08760 55.556 216 6.540000000000001e-86 256.0 sp|P08760|KAD3_BOVIN GTP:AMP phosphotransferase AK3, mitochondrial OS=Bos taurus OX=9913 GN=AK3 PE=1 SV=3 g1908.t1 Q9VUL9 32.847 274 1.42e-33 136.0 sp|Q9VUL9|FUCTA_DROME Glycoprotein 3-alpha-L-fucosyltransferase A OS=Drosophila melanogaster OX=7227 GN=FucTA PE=1 SV=2 FUCTA_DROME reviewed Glycoprotein 3-alpha-L-fucosyltransferase A (EC 2.4.1.214) (Core alpha-(1,3)-fucosyltransferase) Drosophila melanogaster (Fruit fly) GO:0005797; GO:0006491; GO:0007399; GO:0018279; GO:0018392; GO:0032580; GO:0046920 N-glycan processing [GO:0006491]; nervous system development [GO:0007399]; protein N-linked glycosylation via asparagine [GO:0018279] Golgi cisterna membrane [GO:0032580]; Golgi medial cisterna [GO:0005797] alpha-(1->3)-fucosyltransferase activity [GO:0046920]; glycoprotein 3-alpha-L-fucosyltransferase activity [GO:0018392] g1909.t1 P16621 26.838 544 4.3899999999999995e-25 117.0 sp|P16621|LAR_DROME Tyrosine-protein phosphatase Lar OS=Drosophila melanogaster OX=7227 GN=Lar PE=1 SV=2 g1910.t1 P16621 23.514 1110 1.39e-45 184.0 sp|P16621|LAR_DROME Tyrosine-protein phosphatase Lar OS=Drosophila melanogaster OX=7227 GN=Lar PE=1 SV=2 g1910.t1 P16621 23.481 856 5.4e-22 107.0 sp|P16621|LAR_DROME Tyrosine-protein phosphatase Lar OS=Drosophila melanogaster OX=7227 GN=Lar PE=1 SV=2 g1910.t2 P16621 23.75 1040 1.8899999999999998e-46 186.0 sp|P16621|LAR_DROME Tyrosine-protein phosphatase Lar OS=Drosophila melanogaster OX=7227 GN=Lar PE=1 SV=2 g1911.t1 P28828 40.775 542 3.45e-126 409.0 sp|P28828|PTPRM_MOUSE Receptor-type tyrosine-protein phosphatase mu OS=Mus musculus OX=10090 GN=Ptprm PE=1 SV=2 PTPRM_MOUSE reviewed Receptor-type tyrosine-protein phosphatase mu (Protein-tyrosine phosphatase mu) (R-PTP-mu) (EC 3.1.3.48) Mus musculus (Mouse) GO:0001937; GO:0004725; GO:0005001; GO:0005737; GO:0005886; GO:0005911; GO:0005912; GO:0007156; GO:0007165; GO:0009410; GO:0010596; GO:0010828; GO:0010829; GO:0010842; GO:0016525; GO:0016791; GO:0030027; GO:0031175; GO:0031290; GO:0042311; GO:0042802; GO:0045296; GO:0048471 homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of angiogenesis [GO:0016525]; negative regulation of D-glucose transmembrane transport [GO:0010829]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of endothelial cell proliferation [GO:0001937]; neuron projection development [GO:0031175]; positive regulation of D-glucose transmembrane transport [GO:0010828]; response to xenobiotic stimulus [GO:0009410]; retina layer formation [GO:0010842]; retinal ganglion cell axon guidance [GO:0031290]; signal transduction [GO:0007165]; vasodilation [GO:0042311] adherens junction [GO:0005912]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; lamellipodium [GO:0030027]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886] cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; phosphatase activity [GO:0016791]; protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001] g1911.t1 P28828 32.78 241 2.74e-31 134.0 sp|P28828|PTPRM_MOUSE Receptor-type tyrosine-protein phosphatase mu OS=Mus musculus OX=10090 GN=Ptprm PE=1 SV=2 PTPRM_MOUSE reviewed Receptor-type tyrosine-protein phosphatase mu (Protein-tyrosine phosphatase mu) (R-PTP-mu) (EC 3.1.3.48) Mus musculus (Mouse) GO:0001937; GO:0004725; GO:0005001; GO:0005737; GO:0005886; GO:0005911; GO:0005912; GO:0007156; GO:0007165; GO:0009410; GO:0010596; GO:0010828; GO:0010829; GO:0010842; GO:0016525; GO:0016791; GO:0030027; GO:0031175; GO:0031290; GO:0042311; GO:0042802; GO:0045296; GO:0048471 homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of angiogenesis [GO:0016525]; negative regulation of D-glucose transmembrane transport [GO:0010829]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of endothelial cell proliferation [GO:0001937]; neuron projection development [GO:0031175]; positive regulation of D-glucose transmembrane transport [GO:0010828]; response to xenobiotic stimulus [GO:0009410]; retina layer formation [GO:0010842]; retinal ganglion cell axon guidance [GO:0031290]; signal transduction [GO:0007165]; vasodilation [GO:0042311] adherens junction [GO:0005912]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; lamellipodium [GO:0030027]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886] cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; phosphatase activity [GO:0016791]; protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001] g1912.t1 P49908 37.654 162 7.7e-28 115.0 sp|P49908|SEPP1_HUMAN Selenoprotein P OS=Homo sapiens OX=9606 GN=SELENOP PE=1 SV=3 SEPP1_HUMAN reviewed Selenoprotein P (SeP) Homo sapiens (Human) GO:0001887; GO:0005576; GO:0006979; GO:0007420; GO:0007626; GO:0008430; GO:0009791; GO:0010269; GO:0031089; GO:0040008; GO:0070062 brain development [GO:0007420]; locomotory behavior [GO:0007626]; post-embryonic development [GO:0009791]; regulation of growth [GO:0040008]; response to oxidative stress [GO:0006979]; response to selenium ion [GO:0010269]; selenium compound metabolic process [GO:0001887] extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; platelet dense granule lumen [GO:0031089] selenium binding [GO:0008430] g1916.t1 Q8IUR0 62.234 188 3.6e-88 259.0 sp|Q8IUR0|TPPC5_HUMAN Trafficking protein particle complex subunit 5 OS=Homo sapiens OX=9606 GN=TRAPPC5 PE=1 SV=1 g1917.t1 Q9UKP5 51.208 869 0.0 909.0 sp|Q9UKP5|ATS6_HUMAN A disintegrin and metalloproteinase with thrombospondin motifs 6 OS=Homo sapiens OX=9606 GN=ADAMTS6 PE=1 SV=2 ATS6_HUMAN reviewed A disintegrin and metalloproteinase with thrombospondin motifs 6 (ADAM-TS 6) (ADAM-TS6) (ADAMTS-6) (EC 3.4.24.-) Homo sapiens (Human) GO:0001822; GO:0003279; GO:0004222; GO:0006508; GO:0008237; GO:0030198; GO:0031012; GO:0035904; GO:0046872; GO:0060976 aorta development [GO:0035904]; cardiac septum development [GO:0003279]; coronary vasculature development [GO:0060976]; extracellular matrix organization [GO:0030198]; kidney development [GO:0001822]; proteolysis [GO:0006508] extracellular matrix [GO:0031012] metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237] g1917.t2 Q9UKP5 47.965 1130 0.0 1050.0 sp|Q9UKP5|ATS6_HUMAN A disintegrin and metalloproteinase with thrombospondin motifs 6 OS=Homo sapiens OX=9606 GN=ADAMTS6 PE=1 SV=2 ATS6_HUMAN reviewed A disintegrin and metalloproteinase with thrombospondin motifs 6 (ADAM-TS 6) (ADAM-TS6) (ADAMTS-6) (EC 3.4.24.-) Homo sapiens (Human) GO:0001822; GO:0003279; GO:0004222; GO:0006508; GO:0008237; GO:0030198; GO:0031012; GO:0035904; GO:0046872; GO:0060976 aorta development [GO:0035904]; cardiac septum development [GO:0003279]; coronary vasculature development [GO:0060976]; extracellular matrix organization [GO:0030198]; kidney development [GO:0001822]; proteolysis [GO:0006508] extracellular matrix [GO:0031012] metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237] g1917.t3 Q9UKP5 38.776 196 8.61e-37 140.0 sp|Q9UKP5|ATS6_HUMAN A disintegrin and metalloproteinase with thrombospondin motifs 6 OS=Homo sapiens OX=9606 GN=ADAMTS6 PE=1 SV=2 ATS6_HUMAN reviewed A disintegrin and metalloproteinase with thrombospondin motifs 6 (ADAM-TS 6) (ADAM-TS6) (ADAMTS-6) (EC 3.4.24.-) Homo sapiens (Human) GO:0001822; GO:0003279; GO:0004222; GO:0006508; GO:0008237; GO:0030198; GO:0031012; GO:0035904; GO:0046872; GO:0060976 aorta development [GO:0035904]; cardiac septum development [GO:0003279]; coronary vasculature development [GO:0060976]; extracellular matrix organization [GO:0030198]; kidney development [GO:0001822]; proteolysis [GO:0006508] extracellular matrix [GO:0031012] metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237] g1918.t1 Q8IWG1 48.212 867 0.0 803.0 sp|Q8IWG1|DNAI3_HUMAN Dynein axonemal intermediate chain 3 OS=Homo sapiens OX=9606 GN=DNAI3 PE=1 SV=1 DNAI3_HUMAN reviewed Dynein axonemal intermediate chain 3 (Testis development protein NYD-SP29) (WD repeat-containing protein 63) Homo sapiens (Human) GO:0005737; GO:0005858; GO:0030336; GO:0034316; GO:0036156; GO:0036159; GO:0045503; GO:0045504; GO:0045669; GO:0060294; GO:0071933 cilium movement involved in cell motility [GO:0060294]; inner dynein arm assembly [GO:0036159]; negative regulation of Arp2/3 complex-mediated actin nucleation [GO:0034316]; negative regulation of cell migration [GO:0030336]; positive regulation of osteoblast differentiation [GO:0045669] axonemal dynein complex [GO:0005858]; cytoplasm [GO:0005737]; inner dynein arm [GO:0036156] Arp2/3 complex binding [GO:0071933]; dynein heavy chain binding [GO:0045504]; dynein light chain binding [GO:0045503] g1918.t2 Q8IWG1 47.771 875 0.0 800.0 sp|Q8IWG1|DNAI3_HUMAN Dynein axonemal intermediate chain 3 OS=Homo sapiens OX=9606 GN=DNAI3 PE=1 SV=1 DNAI3_HUMAN reviewed Dynein axonemal intermediate chain 3 (Testis development protein NYD-SP29) (WD repeat-containing protein 63) Homo sapiens (Human) GO:0005737; GO:0005858; GO:0030336; GO:0034316; GO:0036156; GO:0036159; GO:0045503; GO:0045504; GO:0045669; GO:0060294; GO:0071933 cilium movement involved in cell motility [GO:0060294]; inner dynein arm assembly [GO:0036159]; negative regulation of Arp2/3 complex-mediated actin nucleation [GO:0034316]; negative regulation of cell migration [GO:0030336]; positive regulation of osteoblast differentiation [GO:0045669] axonemal dynein complex [GO:0005858]; cytoplasm [GO:0005737]; inner dynein arm [GO:0036156] Arp2/3 complex binding [GO:0071933]; dynein heavy chain binding [GO:0045504]; dynein light chain binding [GO:0045503] g1919.t1 Q6NY34 72.327 159 9.310000000000001e-85 252.0 sp|Q6NY34|AS1BB_DANRE Histone chaperone asf1b-B OS=Danio rerio OX=7955 GN=asf1bb PE=2 SV=1 g1920.t1 Q9Y263 50.873 802 0.0 819.0 sp|Q9Y263|PLAP_HUMAN Phospholipase A-2-activating protein OS=Homo sapiens OX=9606 GN=PLAA PE=1 SV=2 PLAP_HUMAN reviewed Phospholipase A-2-activating protein (PLA2P) (PLAP) Homo sapiens (Human) GO:0000153; GO:0005634; GO:0005737; GO:0006644; GO:0006954; GO:0007165; GO:0007399; GO:0010992; GO:0016005; GO:0016236; GO:0031394; GO:0043130; GO:0043161; GO:0043162; GO:0045202; GO:0070062; GO:0071222; GO:1900045; GO:1903423; GO:1903861; GO:2001224 cellular response to lipopolysaccharide [GO:0071222]; inflammatory response [GO:0006954]; macroautophagy [GO:0016236]; negative regulation of protein K63-linked ubiquitination [GO:1900045]; nervous system development [GO:0007399]; phospholipid metabolic process [GO:0006644]; positive regulation of dendrite extension [GO:1903861]; positive regulation of neuron migration [GO:2001224]; positive regulation of prostaglandin biosynthetic process [GO:0031394]; positive regulation of synaptic vesicle recycling [GO:1903423]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; signal transduction [GO:0007165]; ubiquitin recycling [GO:0010992]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162] cytoplasm [GO:0005737]; cytoplasmic ubiquitin ligase complex [GO:0000153]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; synapse [GO:0045202] phospholipase A2 activator activity [GO:0016005]; ubiquitin binding [GO:0043130] g1921.t1 P60003 80.597 67 1.0900000000000001e-36 121.0 sp|P60003|ELOF1_MOUSE Transcription elongation factor 1 homolog OS=Mus musculus OX=10090 GN=Elof1 PE=1 SV=1 g1922.t1 Q9BXS5 84.634 423 0.0 712.0 sp|Q9BXS5|AP1M1_HUMAN AP-1 complex subunit mu-1 OS=Homo sapiens OX=9606 GN=AP1M1 PE=1 SV=3 AP1M1_HUMAN reviewed AP-1 complex subunit mu-1 (AP-mu chain family member mu1A) (Adaptor protein complex AP-1 subunit mu-1) (Adaptor-related protein complex 1 subunit mu-1) (Clathrin assembly protein complex 1 mu-1 medium chain 1) (Clathrin coat assembly protein AP47) (Clathrin coat-associated protein AP47) (Golgi adaptor HA1/AP1 adaptin mu-1 subunit) (Mu-adaptin 1) (Mu1A-adaptin) Homo sapiens (Human) GO:0000139; GO:0005765; GO:0005769; GO:0005829; GO:0005886; GO:0006886; GO:0016020; GO:0016192; GO:0030121; GO:0030136; GO:0030659; GO:0032438; GO:0032588; GO:0035579; GO:0035615; GO:0035646; GO:0045202; GO:0060155; GO:0070062; GO:1903232 endosome to melanosome transport [GO:0035646]; intracellular protein transport [GO:0006886]; melanosome assembly [GO:1903232]; melanosome organization [GO:0032438]; platelet dense granule organization [GO:0060155]; vesicle-mediated transport [GO:0016192] AP-1 adaptor complex [GO:0030121]; clathrin-coated vesicle [GO:0030136]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; early endosome [GO:0005769]; extracellular exosome [GO:0070062]; Golgi membrane [GO:0000139]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; synapse [GO:0045202]; trans-Golgi network membrane [GO:0032588] clathrin adaptor activity [GO:0035615] g1924.t1 Q5R9E5 56.962 79 5.24e-24 91.7 sp|Q5R9E5|FA32A_PONAB Protein FAM32A OS=Pongo abelii OX=9601 GN=FAM32A PE=3 SV=1 g1925.t1 Q6NRK1 39.301 458 4.34e-87 287.0 sp|Q6NRK1|ADIPA_XENLA Afadin- and alpha-actinin-binding protein A OS=Xenopus laevis OX=8355 GN=ssx2ip-a PE=1 SV=1 ADIPA_XENLA reviewed Afadin- and alpha-actinin-binding protein A (ADIP-A) (Afadin DIL domain-interacting protein A) (SSX2-interacting protein A) (XSSX2IP) Xenopus laevis (African clawed frog) GO:0005874; GO:0005912; GO:0007098; GO:0007155; GO:0034451; GO:0035735; GO:0036064; GO:0051011 cell adhesion [GO:0007155]; centrosome cycle [GO:0007098]; intraciliary transport involved in cilium assembly [GO:0035735] adherens junction [GO:0005912]; centriolar satellite [GO:0034451]; ciliary basal body [GO:0036064]; microtubule [GO:0005874] microtubule minus-end binding [GO:0051011] g1927.t1 B2GV87 37.943 593 2.54e-141 431.0 sp|B2GV87|PTPRE_RAT Receptor-type tyrosine-protein phosphatase epsilon OS=Rattus norvegicus OX=10116 GN=Ptpre PE=2 SV=1 PTPRE_RAT reviewed Receptor-type tyrosine-protein phosphatase epsilon (Protein-tyrosine phosphatase epsilon) (R-PTP-epsilon) (EC 3.1.3.48) Rattus norvegicus (Rat) GO:0004725; GO:0005634; GO:0005737; GO:0005886; GO:0007165; GO:0007185; GO:0033003; GO:0042802; GO:0046627 cell surface receptor protein tyrosine phosphatase signaling pathway [GO:0007185]; negative regulation of insulin receptor signaling pathway [GO:0046627]; regulation of mast cell activation [GO:0033003]; signal transduction [GO:0007165] cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886] identical protein binding [GO:0042802]; protein tyrosine phosphatase activity [GO:0004725] g1927.t2 B2GV87 37.943 593 2.03e-141 431.0 sp|B2GV87|PTPRE_RAT Receptor-type tyrosine-protein phosphatase epsilon OS=Rattus norvegicus OX=10116 GN=Ptpre PE=2 SV=1 PTPRE_RAT reviewed Receptor-type tyrosine-protein phosphatase epsilon (Protein-tyrosine phosphatase epsilon) (R-PTP-epsilon) (EC 3.1.3.48) Rattus norvegicus (Rat) GO:0004725; GO:0005634; GO:0005737; GO:0005886; GO:0007165; GO:0007185; GO:0033003; GO:0042802; GO:0046627 cell surface receptor protein tyrosine phosphatase signaling pathway [GO:0007185]; negative regulation of insulin receptor signaling pathway [GO:0046627]; regulation of mast cell activation [GO:0033003]; signal transduction [GO:0007165] cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886] identical protein binding [GO:0042802]; protein tyrosine phosphatase activity [GO:0004725] g1931.t1 P35590 30.028 353 2.78e-33 142.0 sp|P35590|TIE1_HUMAN Tyrosine-protein kinase receptor Tie-1 OS=Homo sapiens OX=9606 GN=TIE1 PE=1 SV=1 TIE1_HUMAN reviewed Tyrosine-protein kinase receptor Tie-1 (EC 2.7.10.1) Homo sapiens (Human) GO:0001525; GO:0001570; GO:0001701; GO:0001936; GO:0003180; GO:0004714; GO:0005524; GO:0005886; GO:0007165; GO:0007169; GO:0007498; GO:0016525; GO:0030336; GO:0032526; GO:0043235; GO:0045026; GO:0045766; GO:0048771; GO:0060836; GO:0060854; GO:1901201 angiogenesis [GO:0001525]; aortic valve morphogenesis [GO:0003180]; branching involved in lymph vessel morphogenesis [GO:0060854]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; in utero embryonic development [GO:0001701]; lymphatic endothelial cell differentiation [GO:0060836]; mesoderm development [GO:0007498]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell migration [GO:0030336]; plasma membrane fusion [GO:0045026]; positive regulation of angiogenesis [GO:0045766]; regulation of endothelial cell proliferation [GO:0001936]; regulation of extracellular matrix assembly [GO:1901201]; response to retinoic acid [GO:0032526]; signal transduction [GO:0007165]; tissue remodeling [GO:0048771]; vasculogenesis [GO:0001570] plasma membrane [GO:0005886]; receptor complex [GO:0043235] ATP binding [GO:0005524]; transmembrane receptor protein tyrosine kinase activity [GO:0004714] g1931.t2 O73791 35.587 281 2.51e-33 141.0 sp|O73791|TIE2_DANRE Angiopoietin-1 receptor OS=Danio rerio OX=7955 GN=tek PE=1 SV=1 g1933.t1 Q02763 31.707 164 8.030000000000001e-21 95.9 sp|Q02763|TIE2_HUMAN Angiopoietin-1 receptor OS=Homo sapiens OX=9606 GN=TEK PE=1 SV=2 TIE2_HUMAN reviewed Angiopoietin-1 receptor (EC 2.7.10.1) (Endothelial tyrosine kinase) (Tunica interna endothelial cell kinase) (Tyrosine kinase with Ig and EGF homology domains-2) (Tyrosine-protein kinase receptor TEK) (Tyrosine-protein kinase receptor TIE-2) (hTIE2) (p140 TEK) (CD antigen CD202b) Homo sapiens (Human) GO:0001525; GO:0001935; GO:0001938; GO:0002040; GO:0004672; GO:0004714; GO:0005524; GO:0005576; GO:0005813; GO:0005886; GO:0005902; GO:0005911; GO:0005925; GO:0007166; GO:0007169; GO:0007267; GO:0007507; GO:0009925; GO:0009986; GO:0010595; GO:0016323; GO:0016324; GO:0016525; GO:0019199; GO:0032878; GO:0034446; GO:0035022; GO:0035025; GO:0036064; GO:0038023; GO:0042802; GO:0043066; GO:0043114; GO:0043235; GO:0043410; GO:0045121; GO:0045766; GO:0048014; GO:0050728; GO:0051894; GO:0051897; GO:0060216; GO:0060347; GO:0070374; GO:0071260; GO:0072012; GO:1902533; GO:2000351; GO:2000352 angiogenesis [GO:0001525]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; cell surface receptor signaling pathway [GO:0007166]; cell-cell signaling [GO:0007267]; cellular response to mechanical stimulus [GO:0071260]; definitive hemopoiesis [GO:0060216]; endothelial cell proliferation [GO:0001935]; glomerulus vasculature development [GO:0072012]; heart development [GO:0007507]; heart trabecula formation [GO:0060347]; negative regulation of angiogenesis [GO:0016525]; negative regulation of apoptotic process [GO:0043066]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of inflammatory response [GO:0050728]; positive regulation of angiogenesis [GO:0045766]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of intracellular signal transduction [GO:1902533]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of Rac protein signal transduction [GO:0035022]; positive regulation of Rho protein signal transduction [GO:0035025]; regulation of endothelial cell apoptotic process [GO:2000351]; regulation of establishment or maintenance of cell polarity [GO:0032878]; regulation of vascular permeability [GO:0043114]; sprouting angiogenesis [GO:0002040]; substrate adhesion-dependent cell spreading [GO:0034446]; Tie signaling pathway [GO:0048014] apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; cell-cell junction [GO:0005911]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; membrane raft [GO:0045121]; microvillus [GO:0005902]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] ATP binding [GO:0005524]; identical protein binding [GO:0042802]; protein kinase activity [GO:0004672]; signaling receptor activity [GO:0038023]; transmembrane receptor protein kinase activity [GO:0019199]; transmembrane receptor protein tyrosine kinase activity [GO:0004714] g1934.t1 Q06806 44.667 300 1.02e-77 274.0 sp|Q06806|TIE1_MOUSE Tyrosine-protein kinase receptor Tie-1 OS=Mus musculus OX=10090 GN=Tie1 PE=1 SV=3 TIE1_MOUSE reviewed Tyrosine-protein kinase receptor Tie-1 (EC 2.7.10.1) Mus musculus (Mouse) GO:0001525; GO:0001568; GO:0001570; GO:0001701; GO:0001936; GO:0003180; GO:0004714; GO:0005524; GO:0005886; GO:0007169; GO:0016020; GO:0016525; GO:0030336; GO:0032526; GO:0043235; GO:0045026; GO:0045766; GO:0048771; GO:0060836; GO:0060854; GO:1901201 angiogenesis [GO:0001525]; aortic valve morphogenesis [GO:0003180]; blood vessel development [GO:0001568]; branching involved in lymph vessel morphogenesis [GO:0060854]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; in utero embryonic development [GO:0001701]; lymphatic endothelial cell differentiation [GO:0060836]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell migration [GO:0030336]; plasma membrane fusion [GO:0045026]; positive regulation of angiogenesis [GO:0045766]; regulation of endothelial cell proliferation [GO:0001936]; regulation of extracellular matrix assembly [GO:1901201]; response to retinoic acid [GO:0032526]; tissue remodeling [GO:0048771]; vasculogenesis [GO:0001570] membrane [GO:0016020]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] ATP binding [GO:0005524]; transmembrane receptor protein tyrosine kinase activity [GO:0004714] g1939.t1 Q06807 45.0 300 3.32e-74 274.0 sp|Q06807|TIE2_BOVIN Angiopoietin-1 receptor OS=Bos taurus OX=9913 GN=TEK PE=2 SV=1 TIE2_BOVIN reviewed Angiopoietin-1 receptor (EC 2.7.10.1) (Endothelial tyrosine kinase) (Tyrosine kinase with Ig and EGF homology domains-2) (Tyrosine-protein kinase receptor TIE-2) (CD antigen CD202b) Bos taurus (Bovine) GO:0001525; GO:0001935; GO:0001936; GO:0002040; GO:0004714; GO:0005524; GO:0005576; GO:0005856; GO:0005886; GO:0005925; GO:0007169; GO:0007507; GO:0010595; GO:0016525; GO:0030097; GO:0032878; GO:0034446; GO:0043235; GO:0043410; GO:0045766; GO:0048014; GO:0051894; GO:0051897; GO:0060347; GO:0070374; GO:1902533; GO:2000352 angiogenesis [GO:0001525]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; endothelial cell proliferation [GO:0001935]; heart development [GO:0007507]; heart trabecula formation [GO:0060347]; hemopoiesis [GO:0030097]; negative regulation of angiogenesis [GO:0016525]; negative regulation of endothelial cell apoptotic process [GO:2000352]; positive regulation of angiogenesis [GO:0045766]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of intracellular signal transduction [GO:1902533]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; regulation of endothelial cell proliferation [GO:0001936]; regulation of establishment or maintenance of cell polarity [GO:0032878]; sprouting angiogenesis [GO:0002040]; substrate adhesion-dependent cell spreading [GO:0034446]; Tie signaling pathway [GO:0048014] cytoskeleton [GO:0005856]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] ATP binding [GO:0005524]; transmembrane receptor protein tyrosine kinase activity [GO:0004714] g1943.t1 Q06807 45.0 300 2.05e-72 269.0 sp|Q06807|TIE2_BOVIN Angiopoietin-1 receptor OS=Bos taurus OX=9913 GN=TEK PE=2 SV=1 TIE2_BOVIN reviewed Angiopoietin-1 receptor (EC 2.7.10.1) (Endothelial tyrosine kinase) (Tyrosine kinase with Ig and EGF homology domains-2) (Tyrosine-protein kinase receptor TIE-2) (CD antigen CD202b) Bos taurus (Bovine) GO:0001525; GO:0001935; GO:0001936; GO:0002040; GO:0004714; GO:0005524; GO:0005576; GO:0005856; GO:0005886; GO:0005925; GO:0007169; GO:0007507; GO:0010595; GO:0016525; GO:0030097; GO:0032878; GO:0034446; GO:0043235; GO:0043410; GO:0045766; GO:0048014; GO:0051894; GO:0051897; GO:0060347; GO:0070374; GO:1902533; GO:2000352 angiogenesis [GO:0001525]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; endothelial cell proliferation [GO:0001935]; heart development [GO:0007507]; heart trabecula formation [GO:0060347]; hemopoiesis [GO:0030097]; negative regulation of angiogenesis [GO:0016525]; negative regulation of endothelial cell apoptotic process [GO:2000352]; positive regulation of angiogenesis [GO:0045766]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of intracellular signal transduction [GO:1902533]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; regulation of endothelial cell proliferation [GO:0001936]; regulation of establishment or maintenance of cell polarity [GO:0032878]; sprouting angiogenesis [GO:0002040]; substrate adhesion-dependent cell spreading [GO:0034446]; Tie signaling pathway [GO:0048014] cytoskeleton [GO:0005856]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] ATP binding [GO:0005524]; transmembrane receptor protein tyrosine kinase activity [GO:0004714] g1943.t1 Q06807 29.961 257 1.1500000000000002e-27 126.0 sp|Q06807|TIE2_BOVIN Angiopoietin-1 receptor OS=Bos taurus OX=9913 GN=TEK PE=2 SV=1 TIE2_BOVIN reviewed Angiopoietin-1 receptor (EC 2.7.10.1) (Endothelial tyrosine kinase) (Tyrosine kinase with Ig and EGF homology domains-2) (Tyrosine-protein kinase receptor TIE-2) (CD antigen CD202b) Bos taurus (Bovine) GO:0001525; GO:0001935; GO:0001936; GO:0002040; GO:0004714; GO:0005524; GO:0005576; GO:0005856; GO:0005886; GO:0005925; GO:0007169; GO:0007507; GO:0010595; GO:0016525; GO:0030097; GO:0032878; GO:0034446; GO:0043235; GO:0043410; GO:0045766; GO:0048014; GO:0051894; GO:0051897; GO:0060347; GO:0070374; GO:1902533; GO:2000352 angiogenesis [GO:0001525]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; endothelial cell proliferation [GO:0001935]; heart development [GO:0007507]; heart trabecula formation [GO:0060347]; hemopoiesis [GO:0030097]; negative regulation of angiogenesis [GO:0016525]; negative regulation of endothelial cell apoptotic process [GO:2000352]; positive regulation of angiogenesis [GO:0045766]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of intracellular signal transduction [GO:1902533]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; regulation of endothelial cell proliferation [GO:0001936]; regulation of establishment or maintenance of cell polarity [GO:0032878]; sprouting angiogenesis [GO:0002040]; substrate adhesion-dependent cell spreading [GO:0034446]; Tie signaling pathway [GO:0048014] cytoskeleton [GO:0005856]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] ATP binding [GO:0005524]; transmembrane receptor protein tyrosine kinase activity [GO:0004714] g1946.t1 Q7T3H9 49.064 267 3.61e-95 284.0 sp|Q7T3H9|HYI_DANRE Putative hydroxypyruvate isomerase OS=Danio rerio OX=7955 GN=hyi PE=2 SV=2 g1947.t1 P48380 59.091 682 0.0 726.0 sp|P48380|RFX3_HUMAN Transcription factor RFX3 OS=Homo sapiens OX=9606 GN=RFX3 PE=1 SV=2 RFX3_HUMAN reviewed Transcription factor RFX3 (Regulatory factor X 3) Homo sapiens (Human) GO:0000785; GO:0000976; GO:0000978; GO:0000981; GO:0003677; GO:0003700; GO:0005576; GO:0005634; GO:0005667; GO:0006351; GO:0006355; GO:0006357; GO:0031018; GO:0045892; GO:0045893; GO:0045944; GO:0048469; GO:0050796; GO:0060271; GO:0060285; GO:0060287; GO:0072560; GO:1990837; GO:2000078 cell maturation [GO:0048469]; cilium assembly [GO:0060271]; cilium-dependent cell motility [GO:0060285]; DNA-templated transcription [GO:0006351]; endocrine pancreas development [GO:0031018]; epithelial cilium movement involved in determination of left/right asymmetry [GO:0060287]; negative regulation of DNA-templated transcription [GO:0045892]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of type B pancreatic cell development [GO:2000078]; regulation of DNA-templated transcription [GO:0006355]; regulation of insulin secretion [GO:0050796]; regulation of transcription by RNA polymerase II [GO:0006357]; type B pancreatic cell maturation [GO:0072560] chromatin [GO:0000785]; extracellular region [GO:0005576]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667] DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976] g1947.t2 P48381 59.238 682 0.0 727.0 sp|P48381|RFX3_MOUSE Transcription factor RFX3 OS=Mus musculus OX=10090 GN=Rfx3 PE=1 SV=2 RFX3_MOUSE reviewed Transcription factor RFX3 (Regulatory factor X 3) Mus musculus (Mouse) GO:0000785; GO:0000976; GO:0000978; GO:0000981; GO:0003700; GO:0005576; GO:0005634; GO:0005667; GO:0006351; GO:0006355; GO:0006357; GO:0007368; GO:0031018; GO:0043565; GO:0045892; GO:0045893; GO:0045944; GO:0048469; GO:0050796; GO:0060271; GO:0060285; GO:0060287; GO:0072560; GO:1990837; GO:2000078 cell maturation [GO:0048469]; cilium assembly [GO:0060271]; cilium-dependent cell motility [GO:0060285]; determination of left/right symmetry [GO:0007368]; DNA-templated transcription [GO:0006351]; endocrine pancreas development [GO:0031018]; epithelial cilium movement involved in determination of left/right asymmetry [GO:0060287]; negative regulation of DNA-templated transcription [GO:0045892]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of type B pancreatic cell development [GO:2000078]; regulation of DNA-templated transcription [GO:0006355]; regulation of insulin secretion [GO:0050796]; regulation of transcription by RNA polymerase II [GO:0006357]; type B pancreatic cell maturation [GO:0072560] chromatin [GO:0000785]; extracellular region [GO:0005576]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667] DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976] g1949.t1 Q6AX31 39.891 183 2.4100000000000003e-32 127.0 sp|Q6AX31|NDC1_XENLA Nucleoporin NDC1 OS=Xenopus laevis OX=8355 GN=ndc1 PE=1 SV=1 g1950.t1 Q7SZC5 38.624 378 2.0300000000000002e-80 264.0 sp|Q7SZC5|NDC1_DANRE Nucleoporin NDC1 OS=Danio rerio OX=7955 GN=ndc1 PE=2 SV=1 g1951.t1 Q4G0N4 44.297 377 1.83e-99 305.0 sp|Q4G0N4|NADK2_HUMAN NAD kinase 2, mitochondrial OS=Homo sapiens OX=9606 GN=NADK2 PE=1 SV=2 NADK2_HUMAN reviewed NAD kinase 2, mitochondrial (EC 2.7.1.23) (Mitochondrial NAD kinase) (NAD kinase domain-containing protein 1, mitochondrial) Homo sapiens (Human) GO:0003951; GO:0005524; GO:0005739; GO:0005759; GO:0006741; GO:0019674; GO:0042803 NAD+ metabolic process [GO:0019674]; NADP+ biosynthetic process [GO:0006741] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] ATP binding [GO:0005524]; NAD+ kinase activity [GO:0003951]; protein homodimerization activity [GO:0042803] g1952.t1 Q13233 53.47 389 5.84e-116 392.0 sp|Q13233|M3K1_HUMAN Mitogen-activated protein kinase kinase kinase 1 OS=Homo sapiens OX=9606 GN=MAP3K1 PE=1 SV=4 M3K1_HUMAN reviewed Mitogen-activated protein kinase kinase kinase 1 (EC 2.7.11.25) (MAPK/ERK kinase kinase 1) (MEK kinase 1) (MEKK 1) (EC 2.3.2.27) Homo sapiens (Human) GO:0004672; GO:0004674; GO:0004709; GO:0005524; GO:0005737; GO:0005829; GO:0006468; GO:0008270; GO:0019901; GO:0038095; GO:0061630; GO:0070160; GO:0071260; GO:0106310 cellular response to mechanical stimulus [GO:0071260]; Fc-epsilon receptor signaling pathway [GO:0038095]; protein phosphorylation [GO:0006468] cytoplasm [GO:0005737]; cytosol [GO:0005829]; tight junction [GO:0070160] ATP binding [GO:0005524]; MAP kinase kinase kinase activity [GO:0004709]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] g1952.t1 Q13233 36.571 525 5.370000000000001e-88 312.0 sp|Q13233|M3K1_HUMAN Mitogen-activated protein kinase kinase kinase 1 OS=Homo sapiens OX=9606 GN=MAP3K1 PE=1 SV=4 M3K1_HUMAN reviewed Mitogen-activated protein kinase kinase kinase 1 (EC 2.7.11.25) (MAPK/ERK kinase kinase 1) (MEK kinase 1) (MEKK 1) (EC 2.3.2.27) Homo sapiens (Human) GO:0004672; GO:0004674; GO:0004709; GO:0005524; GO:0005737; GO:0005829; GO:0006468; GO:0008270; GO:0019901; GO:0038095; GO:0061630; GO:0070160; GO:0071260; GO:0106310 cellular response to mechanical stimulus [GO:0071260]; Fc-epsilon receptor signaling pathway [GO:0038095]; protein phosphorylation [GO:0006468] cytoplasm [GO:0005737]; cytosol [GO:0005829]; tight junction [GO:0070160] ATP binding [GO:0005524]; MAP kinase kinase kinase activity [GO:0004709]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] g1955.t1 Q6B4U9 75.253 198 5.7e-112 320.0 sp|Q6B4U9|PRDX1_MYOLU Peroxiredoxin-1 OS=Myotis lucifugus OX=59463 GN=PRDX1 PE=1 SV=1 PRDX1_MYOLU reviewed Peroxiredoxin-1 (EC 1.11.1.24) (Thioredoxin-dependent peroxiredoxin 1) Myotis lucifugus (Little brown bat) GO:0005634; GO:0005829; GO:0007249; GO:0008379; GO:0019430; GO:0030101; GO:0032872; GO:0034101; GO:0042267; GO:0042744; GO:0042802; GO:0045454; GO:0048144; GO:1901222 canonical NF-kappaB signal transduction [GO:0007249]; cell redox homeostasis [GO:0045454]; erythrocyte homeostasis [GO:0034101]; fibroblast proliferation [GO:0048144]; hydrogen peroxide catabolic process [GO:0042744]; natural killer cell activation [GO:0030101]; natural killer cell mediated cytotoxicity [GO:0042267]; regulation of non-canonical NF-kappaB signal transduction [GO:1901222]; regulation of stress-activated MAPK cascade [GO:0032872]; removal of superoxide radicals [GO:0019430] cytosol [GO:0005829]; nucleus [GO:0005634] identical protein binding [GO:0042802]; thioredoxin peroxidase activity [GO:0008379] g1957.t1 Q8NI36 50.676 888 0.0 922.0 sp|Q8NI36|WDR36_HUMAN WD repeat-containing protein 36 OS=Homo sapiens OX=9606 GN=WDR36 PE=1 SV=2 WDR36_HUMAN reviewed WD repeat-containing protein 36 (T-cell activation WD repeat-containing protein) (TA-WDRP) Homo sapiens (Human) GO:0003723; GO:0005654; GO:0006364; GO:0007601; GO:0032040; GO:0034388; GO:0042274 ribosomal small subunit biogenesis [GO:0042274]; rRNA processing [GO:0006364]; visual perception [GO:0007601] nucleoplasm [GO:0005654]; Pwp2p-containing subcomplex of 90S preribosome [GO:0034388]; small-subunit processome [GO:0032040] RNA binding [GO:0003723] g1961.t1 P0CG82 29.588 267 5.04e-22 103.0 sp|P0CG82|UBIQP_TETPY Polyubiquitin OS=Tetrahymena pyriformis OX=5908 GN=TU20 PE=3 SV=1 g1961.t1 P0CG82 29.588 267 5.04e-22 103.0 sp|P0CG82|UBIQP_TETPY Polyubiquitin OS=Tetrahymena pyriformis OX=5908 GN=TU20 PE=3 SV=1 g1962.t1 Q9JKF8 35.938 192 6.880000000000001e-31 117.0 sp|Q9JKF8|RASD1_RAT Dexamethasone-induced Ras-related protein 1 OS=Rattus norvegicus OX=10116 GN=Rasd1 PE=1 SV=1 RASD1_RAT reviewed Dexamethasone-induced Ras-related protein 1 Rattus norvegicus (Rat) GO:0003924; GO:0005525; GO:0005634; GO:0005737; GO:0005886; GO:0007165; GO:0007263; GO:0016529; GO:0031681; GO:0045892; GO:0048471 negative regulation of DNA-templated transcription [GO:0045892]; nitric oxide mediated signal transduction [GO:0007263]; signal transduction [GO:0007165] cytoplasm [GO:0005737]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; sarcoplasmic reticulum [GO:0016529] G-protein beta-subunit binding [GO:0031681]; GTP binding [GO:0005525]; GTPase activity [GO:0003924] g1968.t1 A2A9C3 33.293 817 1.2400000000000001e-100 344.0 sp|A2A9C3|SZT2_MOUSE KICSTOR complex protein SZT2 OS=Mus musculus OX=10090 GN=Szt2 PE=1 SV=1 SZT2_MOUSE reviewed KICSTOR complex protein SZT2 (Seizure threshold 2 protein) (Transcript increased in glutamate resistance) (TIGR) Mus musculus (Mouse) GO:0005765; GO:0005777; GO:0007417; GO:0009791; GO:0021540; GO:0031667; GO:0034198; GO:0042149; GO:0043473; GO:0061462; GO:0061700; GO:0140007; GO:1901668; GO:1904262; GO:1990130 cellular response to amino acid starvation [GO:0034198]; cellular response to glucose starvation [GO:0042149]; central nervous system development [GO:0007417]; corpus callosum morphogenesis [GO:0021540]; negative regulation of TORC1 signaling [GO:1904262]; pigmentation [GO:0043473]; post-embryonic development [GO:0009791]; protein localization to lysosome [GO:0061462]; regulation of superoxide dismutase activity [GO:1901668]; response to nutrient levels [GO:0031667] GATOR1 complex [GO:1990130]; GATOR2 complex [GO:0061700]; KICSTOR complex [GO:0140007]; lysosomal membrane [GO:0005765]; peroxisome [GO:0005777] g1968.t2 Q5T011 34.985 646 1.89e-87 306.0 sp|Q5T011|SZT2_HUMAN KICSTOR complex protein SZT2 OS=Homo sapiens OX=9606 GN=SZT2 PE=1 SV=3 SZT2_HUMAN reviewed KICSTOR complex protein SZT2 (Seizure threshold 2 protein homolog) Homo sapiens (Human) GO:0005765; GO:0005777; GO:0007417; GO:0009791; GO:0021540; GO:0034198; GO:0042149; GO:0043473; GO:0061462; GO:0140007; GO:1901668; GO:1904262 cellular response to amino acid starvation [GO:0034198]; cellular response to glucose starvation [GO:0042149]; central nervous system development [GO:0007417]; corpus callosum morphogenesis [GO:0021540]; negative regulation of TORC1 signaling [GO:1904262]; pigmentation [GO:0043473]; post-embryonic development [GO:0009791]; protein localization to lysosome [GO:0061462]; regulation of superoxide dismutase activity [GO:1901668] KICSTOR complex [GO:0140007]; lysosomal membrane [GO:0005765]; peroxisome [GO:0005777] g1970.t1 Q5T011 36.298 551 5.06e-77 280.0 sp|Q5T011|SZT2_HUMAN KICSTOR complex protein SZT2 OS=Homo sapiens OX=9606 GN=SZT2 PE=1 SV=3 SZT2_HUMAN reviewed KICSTOR complex protein SZT2 (Seizure threshold 2 protein homolog) Homo sapiens (Human) GO:0005765; GO:0005777; GO:0007417; GO:0009791; GO:0021540; GO:0034198; GO:0042149; GO:0043473; GO:0061462; GO:0140007; GO:1901668; GO:1904262 cellular response to amino acid starvation [GO:0034198]; cellular response to glucose starvation [GO:0042149]; central nervous system development [GO:0007417]; corpus callosum morphogenesis [GO:0021540]; negative regulation of TORC1 signaling [GO:1904262]; pigmentation [GO:0043473]; post-embryonic development [GO:0009791]; protein localization to lysosome [GO:0061462]; regulation of superoxide dismutase activity [GO:1901668] KICSTOR complex [GO:0140007]; lysosomal membrane [GO:0005765]; peroxisome [GO:0005777] g1972.t1 A2A9C3 37.715 1278 0.0 783.0 sp|A2A9C3|SZT2_MOUSE KICSTOR complex protein SZT2 OS=Mus musculus OX=10090 GN=Szt2 PE=1 SV=1 SZT2_MOUSE reviewed KICSTOR complex protein SZT2 (Seizure threshold 2 protein) (Transcript increased in glutamate resistance) (TIGR) Mus musculus (Mouse) GO:0005765; GO:0005777; GO:0007417; GO:0009791; GO:0021540; GO:0031667; GO:0034198; GO:0042149; GO:0043473; GO:0061462; GO:0061700; GO:0140007; GO:1901668; GO:1904262; GO:1990130 cellular response to amino acid starvation [GO:0034198]; cellular response to glucose starvation [GO:0042149]; central nervous system development [GO:0007417]; corpus callosum morphogenesis [GO:0021540]; negative regulation of TORC1 signaling [GO:1904262]; pigmentation [GO:0043473]; post-embryonic development [GO:0009791]; protein localization to lysosome [GO:0061462]; regulation of superoxide dismutase activity [GO:1901668]; response to nutrient levels [GO:0031667] GATOR1 complex [GO:1990130]; GATOR2 complex [GO:0061700]; KICSTOR complex [GO:0140007]; lysosomal membrane [GO:0005765]; peroxisome [GO:0005777] g1973.t1 Q9WVG6 53.265 582 0.0 621.0 sp|Q9WVG6|CARM1_MOUSE Histone-arginine methyltransferase CARM1 OS=Mus musculus OX=10090 GN=Carm1 PE=1 SV=2 CARM1_MOUSE reviewed Histone-arginine methyltransferase CARM1 (EC 2.1.1.319) (Coactivator-associated arginine methyltransferase 1) (Protein arginine N-methyltransferase 4) Mus musculus (Mouse) GO:0000976; GO:0003420; GO:0003713; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006338; GO:0006355; GO:0006915; GO:0008276; GO:0008284; GO:0010467; GO:0016274; GO:0030518; GO:0030520; GO:0032259; GO:0032991; GO:0033146; GO:0035242; GO:0035642; GO:0042054; GO:0043596; GO:0045600; GO:0045944; GO:0051591; GO:0060350; GO:0070611; GO:0071168; GO:0071932; GO:0090575; GO:0140903; GO:1904037; GO:2000171 apoptotic process [GO:0006915]; chromatin remodeling [GO:0006338]; endochondral bone morphogenesis [GO:0060350]; estrogen receptor signaling pathway [GO:0030520]; gene expression [GO:0010467]; methylation [GO:0032259]; negative regulation of dendrite development [GO:2000171]; nuclear receptor-mediated steroid hormone signaling pathway [GO:0030518]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of epithelial cell apoptotic process [GO:1904037]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein localization to chromatin [GO:0071168]; regulation of DNA-templated transcription [GO:0006355]; regulation of growth plate cartilage chondrocyte proliferation [GO:0003420]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146]; replication fork reversal [GO:0071932]; response to cAMP [GO:0051591] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear replication fork [GO:0043596]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; RNA polymerase II transcription regulator complex [GO:0090575] histone H3R17 methyltransferase activity [GO:0035642]; histone H3R2 methyltransferase activity [GO:0070611]; histone H3R26 methyltransferase activity [GO:0140903]; histone methyltransferase activity [GO:0042054]; protein methyltransferase activity [GO:0008276]; protein-arginine N-methyltransferase activity [GO:0016274]; protein-arginine omega-N asymmetric methyltransferase activity [GO:0035242]; transcription cis-regulatory region binding [GO:0000976]; transcription coactivator activity [GO:0003713] g1974.t1 Q08BU1 51.673 269 5.2600000000000007e-79 242.0 sp|Q08BU1|MED8_XENTR Mediator of RNA polymerase II transcription subunit 8 OS=Xenopus tropicalis OX=8364 GN=med8 PE=2 SV=1 g1977.t1 O75936 36.772 378 6.53e-85 267.0 sp|O75936|BODG_HUMAN Gamma-butyrobetaine dioxygenase OS=Homo sapiens OX=9606 GN=BBOX1 PE=1 SV=1 BODG_HUMAN reviewed Gamma-butyrobetaine dioxygenase (EC 1.14.11.1) (Gamma-butyrobetaine hydroxylase) (Gamma-BBH) (Gamma-butyrobetaine,2-oxoglutarate dioxygenase) Homo sapiens (Human) GO:0005506; GO:0005739; GO:0005829; GO:0008270; GO:0008336; GO:0042802; GO:0045329; GO:0070062 carnitine biosynthetic process [GO:0045329] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; mitochondrion [GO:0005739] gamma-butyrobetaine dioxygenase activity [GO:0008336]; identical protein binding [GO:0042802]; iron ion binding [GO:0005506]; zinc ion binding [GO:0008270] g1977.t2 O75936 36.772 378 5.65e-85 266.0 sp|O75936|BODG_HUMAN Gamma-butyrobetaine dioxygenase OS=Homo sapiens OX=9606 GN=BBOX1 PE=1 SV=1 BODG_HUMAN reviewed Gamma-butyrobetaine dioxygenase (EC 1.14.11.1) (Gamma-butyrobetaine hydroxylase) (Gamma-BBH) (Gamma-butyrobetaine,2-oxoglutarate dioxygenase) Homo sapiens (Human) GO:0005506; GO:0005739; GO:0005829; GO:0008270; GO:0008336; GO:0042802; GO:0045329; GO:0070062 carnitine biosynthetic process [GO:0045329] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; mitochondrion [GO:0005739] gamma-butyrobetaine dioxygenase activity [GO:0008336]; identical protein binding [GO:0042802]; iron ion binding [GO:0005506]; zinc ion binding [GO:0008270] g1978.t1 Q6UWH4 32.0 325 1.9999999999999998e-30 129.0 sp|Q6UWH4|GAK1B_HUMAN Golgi-associated kinase 1B OS=Homo sapiens OX=9606 GN=GASK1B PE=1 SV=1 GAK1B_HUMAN reviewed Golgi-associated kinase 1B (Expressed in nerve and epithelium during development) (Protein FAM198B) Homo sapiens (Human) GO:0000139; GO:0005794 Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139] g1982.t1 Q8CHR6 72.611 471 0.0 721.0 sp|Q8CHR6|DPYD_MOUSE Dihydropyrimidine dehydrogenase [NADP(+)] OS=Mus musculus OX=10090 GN=Dpyd PE=1 SV=1 DPYD_MOUSE reviewed Dihydropyrimidine dehydrogenase [NADP(+)] (DHPDHase) (DPD) (EC 1.3.1.2) (Dihydrothymine dehydrogenase) (Dihydrouracil dehydrogenase) Mus musculus (Mouse) GO:0002058; GO:0005506; GO:0005737; GO:0005829; GO:0006145; GO:0006208; GO:0006210; GO:0006212; GO:0006214; GO:0006248; GO:0006249; GO:0007584; GO:0007623; GO:0009410; GO:0017113; GO:0019483; GO:0019860; GO:0042802; GO:0042803; GO:0046050; GO:0046074; GO:0046079; GO:0050661; GO:0051539; GO:0071949 beta-alanine biosynthetic process [GO:0019483]; circadian rhythm [GO:0007623]; CMP catabolic process [GO:0006248]; dCMP catabolic process [GO:0006249]; dTMP catabolic process [GO:0046074]; dUMP catabolic process [GO:0046079]; purine nucleobase catabolic process [GO:0006145]; pyrimidine nucleobase catabolic process [GO:0006208]; response to nutrient [GO:0007584]; response to xenobiotic stimulus [GO:0009410]; thymidine catabolic process [GO:0006214]; thymine catabolic process [GO:0006210]; UMP catabolic process [GO:0046050]; uracil catabolic process [GO:0006212]; uracil metabolic process [GO:0019860] cytoplasm [GO:0005737]; cytosol [GO:0005829] 4 iron, 4 sulfur cluster binding [GO:0051539]; dihydropyrimidine dehydrogenase (NADP+) activity [GO:0017113]; FAD binding [GO:0071949]; identical protein binding [GO:0042802]; iron ion binding [GO:0005506]; NADP binding [GO:0050661]; protein homodimerization activity [GO:0042803]; uracil binding [GO:0002058] g1983.t1 Q6NYG8 72.832 519 0.0 798.0 sp|Q6NYG8|DPYD_DANRE Dihydropyrimidine dehydrogenase [NADP(+)] OS=Danio rerio OX=7955 GN=dpyd PE=2 SV=1 DPYD_DANRE reviewed Dihydropyrimidine dehydrogenase [NADP(+)] (DHPDHase) (DPD) (EC 1.3.1.2) (Dihydrothymine dehydrogenase) (Dihydrouracil dehydrogenase) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0002058; GO:0005737; GO:0005829; GO:0006210; GO:0006212; GO:0006214; GO:0017113; GO:0019483; GO:0046872; GO:0050661; GO:0051539 beta-alanine biosynthetic process [GO:0019483]; thymidine catabolic process [GO:0006214]; thymine catabolic process [GO:0006210]; uracil catabolic process [GO:0006212] cytoplasm [GO:0005737]; cytosol [GO:0005829] 4 iron, 4 sulfur cluster binding [GO:0051539]; dihydropyrimidine dehydrogenase (NADP+) activity [GO:0017113]; metal ion binding [GO:0046872]; NADP binding [GO:0050661]; uracil binding [GO:0002058] g1984.t1 Q5W5U4 62.302 443 5e-180 551.0 sp|Q5W5U4|DDX4_BOVIN Probable ATP-dependent RNA helicase DDX4 OS=Bos taurus OX=9913 GN=DDX4 PE=2 SV=1 DDX4_BOVIN reviewed Probable ATP-dependent RNA helicase DDX4 (EC 3.6.4.13) (DEAD box protein 4) Bos taurus (Bovine) GO:0003724; GO:0003729; GO:0005524; GO:0005634; GO:0005737; GO:0007140; GO:0007141; GO:0007276; GO:0007281; GO:0007283; GO:0016887; GO:0030154; GO:0033391; GO:0034587; GO:0043186; GO:0048471; GO:0071546; GO:0071547; GO:0141006; GO:0141196 cell differentiation [GO:0030154]; gamete generation [GO:0007276]; germ cell development [GO:0007281]; male meiosis I [GO:0007141]; male meiotic nuclear division [GO:0007140]; piRNA processing [GO:0034587]; spermatogenesis [GO:0007283]; transposable element silencing by piRNA-mediated DNA methylation [GO:0141196]; transposable element silencing by piRNA-mediated heterochromatin formation [GO:0141006] chromatoid body [GO:0033391]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; P granule [GO:0043186]; perinuclear region of cytoplasm [GO:0048471]; pi-body [GO:0071546]; piP-body [GO:0071547] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; mRNA binding [GO:0003729]; RNA helicase activity [GO:0003724] g1984.t2 Q5W5U4 62.302 443 2.05e-180 552.0 sp|Q5W5U4|DDX4_BOVIN Probable ATP-dependent RNA helicase DDX4 OS=Bos taurus OX=9913 GN=DDX4 PE=2 SV=1 DDX4_BOVIN reviewed Probable ATP-dependent RNA helicase DDX4 (EC 3.6.4.13) (DEAD box protein 4) Bos taurus (Bovine) GO:0003724; GO:0003729; GO:0005524; GO:0005634; GO:0005737; GO:0007140; GO:0007141; GO:0007276; GO:0007281; GO:0007283; GO:0016887; GO:0030154; GO:0033391; GO:0034587; GO:0043186; GO:0048471; GO:0071546; GO:0071547; GO:0141006; GO:0141196 cell differentiation [GO:0030154]; gamete generation [GO:0007276]; germ cell development [GO:0007281]; male meiosis I [GO:0007141]; male meiotic nuclear division [GO:0007140]; piRNA processing [GO:0034587]; spermatogenesis [GO:0007283]; transposable element silencing by piRNA-mediated DNA methylation [GO:0141196]; transposable element silencing by piRNA-mediated heterochromatin formation [GO:0141006] chromatoid body [GO:0033391]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; P granule [GO:0043186]; perinuclear region of cytoplasm [GO:0048471]; pi-body [GO:0071546]; piP-body [GO:0071547] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; mRNA binding [GO:0003729]; RNA helicase activity [GO:0003724] g1984.t3 Q5W5U4 62.302 443 1.3099999999999999e-180 551.0 sp|Q5W5U4|DDX4_BOVIN Probable ATP-dependent RNA helicase DDX4 OS=Bos taurus OX=9913 GN=DDX4 PE=2 SV=1 DDX4_BOVIN reviewed Probable ATP-dependent RNA helicase DDX4 (EC 3.6.4.13) (DEAD box protein 4) Bos taurus (Bovine) GO:0003724; GO:0003729; GO:0005524; GO:0005634; GO:0005737; GO:0007140; GO:0007141; GO:0007276; GO:0007281; GO:0007283; GO:0016887; GO:0030154; GO:0033391; GO:0034587; GO:0043186; GO:0048471; GO:0071546; GO:0071547; GO:0141006; GO:0141196 cell differentiation [GO:0030154]; gamete generation [GO:0007276]; germ cell development [GO:0007281]; male meiosis I [GO:0007141]; male meiotic nuclear division [GO:0007140]; piRNA processing [GO:0034587]; spermatogenesis [GO:0007283]; transposable element silencing by piRNA-mediated DNA methylation [GO:0141196]; transposable element silencing by piRNA-mediated heterochromatin formation [GO:0141006] chromatoid body [GO:0033391]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; P granule [GO:0043186]; perinuclear region of cytoplasm [GO:0048471]; pi-body [GO:0071546]; piP-body [GO:0071547] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; mRNA binding [GO:0003729]; RNA helicase activity [GO:0003724] g1986.t1 Q96DT6 41.791 268 2.4899999999999998e-62 221.0 sp|Q96DT6|ATG4C_HUMAN Cysteine protease ATG4C OS=Homo sapiens OX=9606 GN=ATG4C PE=1 SV=1 ATG4C_HUMAN reviewed Cysteine protease ATG4C (EC 3.4.22.-) (AUT-like 3 cysteine endopeptidase) (Autophagy-related cysteine endopeptidase 3) (Autophagin-3) (Autophagy-related protein 4 homolog C) (HsAPG4C) Homo sapiens (Human) GO:0000045; GO:0000423; GO:0004197; GO:0005737; GO:0006508; GO:0006914; GO:0008234; GO:0015031; GO:0016485; GO:0019786; GO:0034727; GO:0035973; GO:0051697 aggrephagy [GO:0035973]; autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; mitophagy [GO:0000423]; piecemeal microautophagy of the nucleus [GO:0034727]; protein delipidation [GO:0051697]; protein processing [GO:0016485]; protein transport [GO:0015031]; proteolysis [GO:0006508] cytoplasm [GO:0005737] cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]; protein-phosphatidylethanolamide deconjugating activity [GO:0019786] g1986.t1 Q96DT6 47.917 144 6.5e-42 163.0 sp|Q96DT6|ATG4C_HUMAN Cysteine protease ATG4C OS=Homo sapiens OX=9606 GN=ATG4C PE=1 SV=1 ATG4C_HUMAN reviewed Cysteine protease ATG4C (EC 3.4.22.-) (AUT-like 3 cysteine endopeptidase) (Autophagy-related cysteine endopeptidase 3) (Autophagin-3) (Autophagy-related protein 4 homolog C) (HsAPG4C) Homo sapiens (Human) GO:0000045; GO:0000423; GO:0004197; GO:0005737; GO:0006508; GO:0006914; GO:0008234; GO:0015031; GO:0016485; GO:0019786; GO:0034727; GO:0035973; GO:0051697 aggrephagy [GO:0035973]; autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; mitophagy [GO:0000423]; piecemeal microautophagy of the nucleus [GO:0034727]; protein delipidation [GO:0051697]; protein processing [GO:0016485]; protein transport [GO:0015031]; proteolysis [GO:0006508] cytoplasm [GO:0005737] cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]; protein-phosphatidylethanolamide deconjugating activity [GO:0019786] g1988.t1 Q02858 33.205 259 4.07e-37 149.0 sp|Q02858|TIE2_MOUSE Angiopoietin-1 receptor OS=Mus musculus OX=10090 GN=Tek PE=1 SV=2 TIE2_MOUSE reviewed Angiopoietin-1 receptor (EC 2.7.10.1) (Endothelial tyrosine kinase) (HYK) (STK1) (Tunica interna endothelial cell kinase) (Tyrosine kinase with Ig and EGF homology domains-2) (Tyrosine-protein kinase receptor TEK) (Tyrosine-protein kinase receptor TIE-2) (mTIE2) (p140 TEK) (CD antigen CD202b) Mus musculus (Mouse) GO:0001525; GO:0001569; GO:0001570; GO:0001666; GO:0001935; GO:0001936; GO:0002040; GO:0002720; GO:0004713; GO:0004714; GO:0005524; GO:0005576; GO:0005813; GO:0005886; GO:0005902; GO:0005911; GO:0005925; GO:0007160; GO:0007166; GO:0007169; GO:0007507; GO:0009925; GO:0009986; GO:0010595; GO:0016020; GO:0016323; GO:0016324; GO:0016525; GO:0018108; GO:0019838; GO:0030097; GO:0030334; GO:0030949; GO:0032526; GO:0032878; GO:0034446; GO:0036064; GO:0038023; GO:0042307; GO:0042802; GO:0043066; GO:0043235; GO:0043410; GO:0043627; GO:0045121; GO:0045765; GO:0045766; GO:0045785; GO:0048014; GO:0048471; GO:0051894; GO:0051897; GO:0060347; GO:0070374; GO:0071260; GO:0072012; GO:0098609; GO:1901222; GO:1902533; GO:2000352 angiogenesis [GO:0001525]; branching involved in blood vessel morphogenesis [GO:0001569]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; cell surface receptor signaling pathway [GO:0007166]; cell-cell adhesion [GO:0098609]; cell-matrix adhesion [GO:0007160]; cellular response to mechanical stimulus [GO:0071260]; endothelial cell proliferation [GO:0001935]; glomerulus vasculature development [GO:0072012]; heart development [GO:0007507]; heart trabecula formation [GO:0060347]; hemopoiesis [GO:0030097]; negative regulation of angiogenesis [GO:0016525]; negative regulation of apoptotic process [GO:0043066]; negative regulation of endothelial cell apoptotic process [GO:2000352]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cytokine production involved in immune response [GO:0002720]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of intracellular signal transduction [GO:1902533]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030949]; regulation of angiogenesis [GO:0045765]; regulation of cell migration [GO:0030334]; regulation of endothelial cell proliferation [GO:0001936]; regulation of establishment or maintenance of cell polarity [GO:0032878]; regulation of non-canonical NF-kappaB signal transduction [GO:1901222]; response to estrogen [GO:0043627]; response to hypoxia [GO:0001666]; response to retinoic acid [GO:0032526]; sprouting angiogenesis [GO:0002040]; substrate adhesion-dependent cell spreading [GO:0034446]; Tie signaling pathway [GO:0048014]; vasculogenesis [GO:0001570] apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; cell-cell junction [GO:0005911]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; membrane [GO:0016020]; membrane raft [GO:0045121]; microvillus [GO:0005902]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] ATP binding [GO:0005524]; growth factor binding [GO:0019838]; identical protein binding [GO:0042802]; protein tyrosine kinase activity [GO:0004713]; signaling receptor activity [GO:0038023]; transmembrane receptor protein tyrosine kinase activity [GO:0004714] g1988.t2 Q02858 31.93 285 6.52e-36 147.0 sp|Q02858|TIE2_MOUSE Angiopoietin-1 receptor OS=Mus musculus OX=10090 GN=Tek PE=1 SV=2 TIE2_MOUSE reviewed Angiopoietin-1 receptor (EC 2.7.10.1) (Endothelial tyrosine kinase) (HYK) (STK1) (Tunica interna endothelial cell kinase) (Tyrosine kinase with Ig and EGF homology domains-2) (Tyrosine-protein kinase receptor TEK) (Tyrosine-protein kinase receptor TIE-2) (mTIE2) (p140 TEK) (CD antigen CD202b) Mus musculus (Mouse) GO:0001525; GO:0001569; GO:0001570; GO:0001666; GO:0001935; GO:0001936; GO:0002040; GO:0002720; GO:0004713; GO:0004714; GO:0005524; GO:0005576; GO:0005813; GO:0005886; GO:0005902; GO:0005911; GO:0005925; GO:0007160; GO:0007166; GO:0007169; GO:0007507; GO:0009925; GO:0009986; GO:0010595; GO:0016020; GO:0016323; GO:0016324; GO:0016525; GO:0018108; GO:0019838; GO:0030097; GO:0030334; GO:0030949; GO:0032526; GO:0032878; GO:0034446; GO:0036064; GO:0038023; GO:0042307; GO:0042802; GO:0043066; GO:0043235; GO:0043410; GO:0043627; GO:0045121; GO:0045765; GO:0045766; GO:0045785; GO:0048014; GO:0048471; GO:0051894; GO:0051897; GO:0060347; GO:0070374; GO:0071260; GO:0072012; GO:0098609; GO:1901222; GO:1902533; GO:2000352 angiogenesis [GO:0001525]; branching involved in blood vessel morphogenesis [GO:0001569]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; cell surface receptor signaling pathway [GO:0007166]; cell-cell adhesion [GO:0098609]; cell-matrix adhesion [GO:0007160]; cellular response to mechanical stimulus [GO:0071260]; endothelial cell proliferation [GO:0001935]; glomerulus vasculature development [GO:0072012]; heart development [GO:0007507]; heart trabecula formation [GO:0060347]; hemopoiesis [GO:0030097]; negative regulation of angiogenesis [GO:0016525]; negative regulation of apoptotic process [GO:0043066]; negative regulation of endothelial cell apoptotic process [GO:2000352]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cytokine production involved in immune response [GO:0002720]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of intracellular signal transduction [GO:1902533]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030949]; regulation of angiogenesis [GO:0045765]; regulation of cell migration [GO:0030334]; regulation of endothelial cell proliferation [GO:0001936]; regulation of establishment or maintenance of cell polarity [GO:0032878]; regulation of non-canonical NF-kappaB signal transduction [GO:1901222]; response to estrogen [GO:0043627]; response to hypoxia [GO:0001666]; response to retinoic acid [GO:0032526]; sprouting angiogenesis [GO:0002040]; substrate adhesion-dependent cell spreading [GO:0034446]; Tie signaling pathway [GO:0048014]; vasculogenesis [GO:0001570] apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; cell-cell junction [GO:0005911]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; membrane [GO:0016020]; membrane raft [GO:0045121]; microvillus [GO:0005902]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] ATP binding [GO:0005524]; growth factor binding [GO:0019838]; identical protein binding [GO:0042802]; protein tyrosine kinase activity [GO:0004713]; signaling receptor activity [GO:0038023]; transmembrane receptor protein tyrosine kinase activity [GO:0004714] g12456.t1 Q7YQK4 41.772 158 3.27e-32 125.0 sp|Q7YQK4|LAT1_RABIT Large neutral amino acids transporter small subunit 1 OS=Oryctolagus cuniculus OX=9986 GN=SLC7A5 PE=1 SV=1 g12457.t1 Q92536 45.808 489 1.5e-133 399.0 sp|Q92536|YLAT2_HUMAN Y+L amino acid transporter 2 OS=Homo sapiens OX=9606 GN=SLC7A6 PE=1 SV=3 YLAT2_HUMAN reviewed Y+L amino acid transporter 2 (Cationic amino acid transporter, y+ system) (Solute carrier family 7 member 6) (y(+)L-type amino acid transporter 2) (Y+LAT2) (y+LAT-2) Homo sapiens (Human) GO:0003333; GO:0005886; GO:0006809; GO:0015171; GO:0015174; GO:0015179; GO:0015804; GO:0015820; GO:0015822; GO:0031460; GO:0034618; GO:0061459; GO:0106439; GO:1903826 amino acid transmembrane transport [GO:0003333]; glycine betaine transport [GO:0031460]; L-arginine transmembrane transport [GO:1903826]; L-leucine transport [GO:0015820]; neutral amino acid transport [GO:0015804]; nitric oxide biosynthetic process [GO:0006809]; ornithine transport [GO:0015822] plasma membrane [GO:0005886] amino acid transmembrane transporter activity [GO:0015171]; arginine binding [GO:0034618]; basic amino acid transmembrane transporter activity [GO:0015174]; L-amino acid transmembrane transporter activity [GO:0015179]; L-arginine transmembrane transporter activity [GO:0061459]; L-lysine:L-arginine antiporter activity [GO:0106439] g12458.t1 Q92536 45.582 498 1e-135 404.0 sp|Q92536|YLAT2_HUMAN Y+L amino acid transporter 2 OS=Homo sapiens OX=9606 GN=SLC7A6 PE=1 SV=3 YLAT2_HUMAN reviewed Y+L amino acid transporter 2 (Cationic amino acid transporter, y+ system) (Solute carrier family 7 member 6) (y(+)L-type amino acid transporter 2) (Y+LAT2) (y+LAT-2) Homo sapiens (Human) GO:0003333; GO:0005886; GO:0006809; GO:0015171; GO:0015174; GO:0015179; GO:0015804; GO:0015820; GO:0015822; GO:0031460; GO:0034618; GO:0061459; GO:0106439; GO:1903826 amino acid transmembrane transport [GO:0003333]; glycine betaine transport [GO:0031460]; L-arginine transmembrane transport [GO:1903826]; L-leucine transport [GO:0015820]; neutral amino acid transport [GO:0015804]; nitric oxide biosynthetic process [GO:0006809]; ornithine transport [GO:0015822] plasma membrane [GO:0005886] amino acid transmembrane transporter activity [GO:0015171]; arginine binding [GO:0034618]; basic amino acid transmembrane transporter activity [GO:0015174]; L-amino acid transmembrane transporter activity [GO:0015179]; L-arginine transmembrane transporter activity [GO:0061459]; L-lysine:L-arginine antiporter activity [GO:0106439] g12459.t1 Q28FF3 39.872 469 1.1699999999999999e-94 298.0 sp|Q28FF3|S49A3_XENTR Solute carrier family 49 member A3 OS=Xenopus tropicalis OX=8364 GN=slc49a3 PE=2 SV=2 g12460.t1 A7MB10 32.349 1388 1.5999999999999999e-180 599.0 sp|A7MB10|RRP5_BOVIN Protein RRP5 homolog OS=Bos taurus OX=9913 GN=PDCD11 PE=2 SV=1 RRP5_BOVIN reviewed Protein RRP5 homolog (Programmed cell death protein 11) Bos taurus (Bovine) GO:0003723; GO:0005730; GO:0006364; GO:0032040 rRNA processing [GO:0006364] nucleolus [GO:0005730]; small-subunit processome [GO:0032040] RNA binding [GO:0003723] g12460.t1 A7MB10 52.432 370 2.52e-96 350.0 sp|A7MB10|RRP5_BOVIN Protein RRP5 homolog OS=Bos taurus OX=9913 GN=PDCD11 PE=2 SV=1 RRP5_BOVIN reviewed Protein RRP5 homolog (Programmed cell death protein 11) Bos taurus (Bovine) GO:0003723; GO:0005730; GO:0006364; GO:0032040 rRNA processing [GO:0006364] nucleolus [GO:0005730]; small-subunit processome [GO:0032040] RNA binding [GO:0003723] g12461.t1 A2AAY5 42.353 425 7.000000000000001e-109 351.0 sp|A2AAY5|SPD2B_MOUSE SH3 and PX domain-containing protein 2B OS=Mus musculus OX=10090 GN=Sh3pxd2b PE=1 SV=1 SPD2B_MOUSE reviewed SH3 and PX domain-containing protein 2B (Factor for adipocyte differentiation 49) (Tyrosine kinase substrate with four SH3 domains) Mus musculus (Mouse) GO:0001501; GO:0001654; GO:0002051; GO:0002102; GO:0005737; GO:0006801; GO:0007507; GO:0010314; GO:0010628; GO:0016176; GO:0022617; GO:0032266; GO:0040018; GO:0042169; GO:0042554; GO:0045600; GO:0048705; GO:0051496; GO:0060348; GO:0060378; GO:0060612; GO:0070273; GO:0071800; GO:0072657; GO:0080025; GO:1904179; GO:1904888 adipose tissue development [GO:0060612]; bone development [GO:0060348]; cranial skeletal system development [GO:1904888]; extracellular matrix disassembly [GO:0022617]; eye development [GO:0001654]; heart development [GO:0007507]; osteoblast fate commitment [GO:0002051]; podosome assembly [GO:0071800]; positive regulation of adipose tissue development [GO:1904179]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of gene expression [GO:0010628]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of stress fiber assembly [GO:0051496]; protein localization to membrane [GO:0072657]; regulation of brood size [GO:0060378]; skeletal system development [GO:0001501]; skeletal system morphogenesis [GO:0048705]; superoxide anion generation [GO:0042554]; superoxide metabolic process [GO:0006801] cytoplasm [GO:0005737]; podosome [GO:0002102] phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol-4-phosphate binding [GO:0070273]; phosphatidylinositol-5-phosphate binding [GO:0010314]; SH2 domain binding [GO:0042169]; superoxide-generating NADPH oxidase activator activity [GO:0016176] g12463.t1 Q5ZJT0 62.726 719 0.0 952.0 sp|Q5ZJT0|SUV3_CHICK ATP-dependent RNA helicase SUPV3L1, mitochondrial OS=Gallus gallus OX=9031 GN=SUPV3L1 PE=2 SV=1 SUV3_CHICK reviewed ATP-dependent RNA helicase SUPV3L1, mitochondrial (EC 3.6.4.13) (Suppressor of var1 3-like protein 1) (SUV3-like protein 1) Gallus gallus (Chicken) GO:0000958; GO:0000962; GO:0000965; GO:0003677; GO:0003678; GO:0003724; GO:0003725; GO:0005524; GO:0005634; GO:0005739; GO:0005759; GO:0006310; GO:0006401; GO:0007005; GO:0016887; GO:0030307; GO:0034458; GO:0035945; GO:0035946; GO:0042645; GO:0043066; GO:0045025; GO:2000827 DNA recombination [GO:0006310]; mitochondrial mRNA catabolic process [GO:0000958]; mitochondrial mRNA surveillance [GO:0035946]; mitochondrial ncRNA surveillance [GO:0035945]; mitochondrial RNA 3'-end processing [GO:0000965]; mitochondrial RNA surveillance [GO:2000827]; mitochondrion organization [GO:0007005]; negative regulation of apoptotic process [GO:0043066]; positive regulation of cell growth [GO:0030307]; positive regulation of mitochondrial RNA catabolic process [GO:0000962]; RNA catabolic process [GO:0006401] mitochondrial degradosome [GO:0045025]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nucleus [GO:0005634] 3'-5' RNA helicase activity [GO:0034458]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; double-stranded RNA binding [GO:0003725]; RNA helicase activity [GO:0003724] g12465.t1 Q8BH74 48.539 958 0.0 827.0 sp|Q8BH74|NU107_MOUSE Nuclear pore complex protein Nup107 OS=Mus musculus OX=10090 GN=Nup107 PE=1 SV=1 g12466.t1 Q6PBV6 50.376 133 5.59e-28 103.0 sp|Q6PBV6|NHP2_DANRE H/ACA ribonucleoprotein complex subunit 2-like protein OS=Danio rerio OX=7955 GN=nhp2 PE=2 SV=1 g12467.t1 Q8BUL6 56.637 113 2.81e-40 142.0 sp|Q8BUL6|PKHA1_MOUSE Pleckstrin homology domain-containing family A member 1 OS=Mus musculus OX=10090 GN=Plekha1 PE=1 SV=1 g12468.t1 Q9HB21 51.724 116 2.73e-30 117.0 sp|Q9HB21|PKHA1_HUMAN Pleckstrin homology domain-containing family A member 1 OS=Homo sapiens OX=9606 GN=PLEKHA1 PE=1 SV=2 PKHA1_HUMAN reviewed Pleckstrin homology domain-containing family A member 1 (PH domain-containing family A member 1) (Tandem PH domain-containing protein 1) (TAPP-1) Homo sapiens (Human) GO:0001553; GO:0005543; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0007283; GO:0008209; GO:0008210; GO:0009791; GO:0030165; GO:0031529; GO:0032587; GO:0033327; GO:0035264; GO:0043325; GO:0043491; GO:0045184; GO:0048008; GO:0048705; GO:0050853; GO:0051898; GO:0060021; GO:0060325; GO:0070062; GO:0070301 androgen metabolic process [GO:0008209]; B cell receptor signaling pathway [GO:0050853]; cellular response to hydrogen peroxide [GO:0070301]; establishment of protein localization [GO:0045184]; estrogen metabolic process [GO:0008210]; face morphogenesis [GO:0060325]; Leydig cell differentiation [GO:0033327]; luteinization [GO:0001553]; multicellular organism growth [GO:0035264]; negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051898]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; post-embryonic development [GO:0009791]; roof of mouth development [GO:0060021]; ruffle organization [GO:0031529]; skeletal system morphogenesis [GO:0048705]; spermatogenesis [GO:0007283] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587] PDZ domain binding [GO:0030165]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; phospholipid binding [GO:0005543] g12470.t1 Q49AM3 48.182 110 3.13e-22 104.0 sp|Q49AM3|TTC31_HUMAN Tetratricopeptide repeat protein 31 OS=Homo sapiens OX=9606 GN=TTC31 PE=1 SV=3 g12470.t2 Q49AM3 48.182 110 2.41e-22 104.0 sp|Q49AM3|TTC31_HUMAN Tetratricopeptide repeat protein 31 OS=Homo sapiens OX=9606 GN=TTC31 PE=1 SV=3 g12470.t3 Q49AM3 48.182 110 2.57e-22 104.0 sp|Q49AM3|TTC31_HUMAN Tetratricopeptide repeat protein 31 OS=Homo sapiens OX=9606 GN=TTC31 PE=1 SV=3 g12471.t1 Q9JMJ2 36.317 391 1.63e-79 253.0 sp|Q9JMJ2|FBXW4_MOUSE F-box/WD repeat-containing protein 4 OS=Mus musculus OX=10090 GN=Fbxw4 PE=1 SV=1 g12473.t1 Q9W735 33.962 795 2.12e-135 426.0 sp|Q9W735|PRM1A_DANRE Prominin-1-A OS=Danio rerio OX=7955 GN=prom1a PE=2 SV=2 g12475.t1 Q5U4F6 41.752 491 1.15e-137 410.0 sp|Q5U4F6|DC2I2_MOUSE Cytoplasmic dynein 2 intermediate chain 2 OS=Mus musculus OX=10090 GN=Dync2i2 PE=1 SV=3 DC2I2_MOUSE reviewed Cytoplasmic dynein 2 intermediate chain 2 (Dynein 2 intermediate chain 2) (WD repeat-containing protein 34) Mus musculus (Mouse) GO:0005654; GO:0005730; GO:0005737; GO:0005813; GO:0005814; GO:0005829; GO:0005868; GO:0005929; GO:0005930; GO:0016604; GO:0030175; GO:0031965; GO:0035721; GO:0036064; GO:0042073; GO:0045503; GO:0045504; GO:0060271; GO:0097014 cilium assembly [GO:0060271]; intraciliary retrograde transport [GO:0035721]; intraciliary transport [GO:0042073] axoneme [GO:0005930]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary plasm [GO:0097014]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; cytosol [GO:0005829]; filopodium [GO:0030175]; nuclear body [GO:0016604]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654] dynein heavy chain binding [GO:0045504]; dynein light chain binding [GO:0045503] g12478.t1 Q5XFW6 29.99 1017 8.81e-119 397.0 sp|Q5XFW6|WDR6_RAT tRNA (34-2'-O)-methyltransferase regulator WDR6 OS=Rattus norvegicus OX=10116 GN=Wdr6 PE=1 SV=2 WDR6_RAT reviewed tRNA (34-2'-O)-methyltransferase regulator WDR6 (WD repeat-containing protein 6) Rattus norvegicus (Rat) GO:0000049; GO:0002130; GO:0005737; GO:0005829; GO:0005886; GO:0008180; GO:0008285; GO:0008286; GO:0010507; GO:0030234; GO:0030488; GO:0032991; GO:0043560; GO:0048009; GO:0070314 G1 to G0 transition [GO:0070314]; insulin receptor signaling pathway [GO:0008286]; insulin-like growth factor receptor signaling pathway [GO:0048009]; negative regulation of autophagy [GO:0010507]; negative regulation of cell population proliferation [GO:0008285]; tRNA methylation [GO:0030488]; wobble position ribose methylation [GO:0002130] COP9 signalosome [GO:0008180]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] enzyme regulator activity [GO:0030234]; insulin receptor substrate binding [GO:0043560]; tRNA binding [GO:0000049] g12479.t1 B4JXX2 59.358 748 0.0 911.0 sp|B4JXX2|PDE6_DROGR cGMP-specific 3',5'-cyclic phosphodiesterase OS=Drosophila grimshawi OX=7222 GN=Pde6 PE=3 SV=1 PDE6_DROGR reviewed cGMP-specific 3',5'-cyclic phosphodiesterase (EC 3.1.4.35) Drosophila grimshawi (Hawaiian fruit fly) (Idiomyia grimshawi) GO:0005886; GO:0007165; GO:0016020; GO:0046068; GO:0046872; GO:0047555 cGMP metabolic process [GO:0046068]; signal transduction [GO:0007165] membrane [GO:0016020]; plasma membrane [GO:0005886] 3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; metal ion binding [GO:0046872] g12480.t1 Q8BP78 56.828 227 9.21e-86 264.0 sp|Q8BP78|F10C1_MOUSE Protein FRA10AC1 homolog OS=Mus musculus OX=10090 GN=Fra10ac1 PE=1 SV=3 g12481.t1 P81799 52.632 342 1.72e-115 341.0 sp|P81799|NAGK_RAT N-acetyl-D-glucosamine kinase OS=Rattus norvegicus OX=10116 GN=Nagk PE=1 SV=4 NAGK_RAT reviewed N-acetyl-D-glucosamine kinase (N-acetylglucosamine kinase) (EC 2.7.1.59) (GlcNAc kinase) (Muramyl dipeptide kinase) (EC 2.7.1.-) (N-acetyl-D-mannosamine kinase) (EC 2.7.1.60) Rattus norvegicus (Rat) GO:0005524; GO:0006044; GO:0006046; GO:0006048; GO:0007249; GO:0009384; GO:0019262; GO:0032495; GO:0038066; GO:0042742; GO:0043123; GO:0043124; GO:0045087; GO:0045127; GO:0070431; GO:0070434; GO:0070534; GO:0097039; GO:0160047 canonical NF-kappaB signal transduction [GO:0007249]; defense response to bacterium [GO:0042742]; innate immune response [GO:0045087]; N-acetylglucosamine catabolic process [GO:0006046]; N-acetylglucosamine metabolic process [GO:0006044]; N-acetylneuraminate catabolic process [GO:0019262]; negative regulation of canonical NF-kappaB signal transduction [GO:0043124]; nucleotide-binding oligomerization domain containing 2 signaling pathway [GO:0070431]; p38MAPK cascade [GO:0038066]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway [GO:0070434]; protein K63-linked ubiquitination [GO:0070534]; protein linear polyubiquitination [GO:0097039]; response to muramyl dipeptide [GO:0032495]; UDP-N-acetylglucosamine biosynthetic process [GO:0006048] ATP binding [GO:0005524]; muramyl dipeptide kinase activity [GO:0160047]; N-acetylglucosamine kinase activity [GO:0045127]; N-acylmannosamine kinase activity [GO:0009384] g12482.t1 Q9NQW7 60.289 622 0.0 778.0 sp|Q9NQW7|XPP1_HUMAN Xaa-Pro aminopeptidase 1 OS=Homo sapiens OX=9606 GN=XPNPEP1 PE=1 SV=3 XPP1_HUMAN reviewed Xaa-Pro aminopeptidase 1 (EC 3.4.11.9) (Aminoacylproline aminopeptidase) (Cytosolic aminopeptidase P) (Soluble aminopeptidase P) (sAmp) (X-Pro aminopeptidase 1) (X-prolyl aminopeptidase 1, soluble) Homo sapiens (Human) GO:0004177; GO:0005737; GO:0005829; GO:0006508; GO:0010815; GO:0030145; GO:0042803; GO:0043069; GO:0070006; GO:0070062 bradykinin catabolic process [GO:0010815]; negative regulation of programmed cell death [GO:0043069]; proteolysis [GO:0006508] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062] aminopeptidase activity [GO:0004177]; manganese ion binding [GO:0030145]; metalloaminopeptidase activity [GO:0070006]; protein homodimerization activity [GO:0042803] g12483.t1 P48441 46.764 618 0.0 554.0 sp|P48441|IDUA_MOUSE Alpha-L-iduronidase OS=Mus musculus OX=10090 GN=Idua PE=1 SV=2 IDUA_MOUSE reviewed Alpha-L-iduronidase (EC 3.2.1.76) Mus musculus (Mouse) GO:0000902; GO:0003940; GO:0005102; GO:0005615; GO:0005764; GO:0005975; GO:0006027; GO:0007040; GO:0007613; GO:0007626; GO:0007628; GO:0008344; GO:0008542; GO:0030198; GO:0030200; GO:0030209; GO:0030211; GO:0035108; GO:0043202; GO:0045780; GO:0048705; GO:0048878; GO:0060348; GO:0061037; GO:0090341; GO:0120158; GO:1990079 adult locomotory behavior [GO:0008344]; adult walking behavior [GO:0007628]; bone development [GO:0060348]; carbohydrate metabolic process [GO:0005975]; cartilage homeostasis [GO:1990079]; cell morphogenesis [GO:0000902]; chemical homeostasis [GO:0048878]; dermatan sulfate proteoglycan catabolic process [GO:0030209]; extracellular matrix organization [GO:0030198]; glycosaminoglycan catabolic process [GO:0006027]; heparan sulfate proteoglycan catabolic process [GO:0030200]; heparin proteoglycan catabolic process [GO:0030211]; limb morphogenesis [GO:0035108]; locomotory behavior [GO:0007626]; lysosome organization [GO:0007040]; memory [GO:0007613]; negative regulation of cartilage development [GO:0061037]; negative regulation of secretion of lysosomal enzymes [GO:0090341]; positive regulation of bone resorption [GO:0045780]; positive regulation of collagen catabolic process [GO:0120158]; skeletal system morphogenesis [GO:0048705]; visual learning [GO:0008542] extracellular space [GO:0005615]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764] L-iduronidase activity [GO:0003940]; signaling receptor binding [GO:0005102] g12485.t1 Q9DBH5 54.959 242 5.22e-93 283.0 sp|Q9DBH5|LMAN2_MOUSE Vesicular integral-membrane protein VIP36 OS=Mus musculus OX=10090 GN=Lman2 PE=1 SV=2 LMAN2_MOUSE reviewed Vesicular integral-membrane protein VIP36 (Lectin mannose-binding 2) (Vesicular integral-membrane protein 36) (VIP36) Mus musculus (Mouse) GO:0000139; GO:0005537; GO:0005615; GO:0005789; GO:0005793; GO:0005794; GO:0005886; GO:0006888; GO:0006890; GO:0009986; GO:0015031; GO:0030134; GO:0030246; GO:0031072; GO:0046872; GO:0050766 endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; positive regulation of phagocytosis [GO:0050766]; protein transport [GO:0015031]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890] cell surface [GO:0009986]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886] carbohydrate binding [GO:0030246]; D-mannose binding [GO:0005537]; heat shock protein binding [GO:0031072]; metal ion binding [GO:0046872] g12486.t1 A2VE15 48.048 333 6.86e-108 322.0 sp|A2VE15|FADS6_BOVIN Fatty acid desaturase 6 OS=Bos taurus OX=9913 GN=FADS6 PE=2 SV=1 g12490.t1 Q5EAE3 64.831 236 2.27e-109 317.0 sp|Q5EAE3|UBTD2_BOVIN Ubiquitin domain-containing protein 2 OS=Bos taurus OX=9913 GN=UBTD2 PE=2 SV=1 g12494.t1 P35362 29.595 321 3.79e-33 130.0 sp|P35362|OPSD_SPHSP Rhodopsin OS=Sphodromantis sp. OX=27433 PE=2 SV=1 g12495.t1 O54782 44.592 1054 0.0 858.0 sp|O54782|MA2B2_MOUSE Epididymis-specific alpha-mannosidase OS=Mus musculus OX=10090 GN=Man2b2 PE=1 SV=2 g12495.t2 O54782 43.559 1079 0.0 849.0 sp|O54782|MA2B2_MOUSE Epididymis-specific alpha-mannosidase OS=Mus musculus OX=10090 GN=Man2b2 PE=1 SV=2 g12495.t3 O54782 43.559 1079 0.0 849.0 sp|O54782|MA2B2_MOUSE Epididymis-specific alpha-mannosidase OS=Mus musculus OX=10090 GN=Man2b2 PE=1 SV=2 g12495.t4 O54782 43.559 1079 0.0 849.0 sp|O54782|MA2B2_MOUSE Epididymis-specific alpha-mannosidase OS=Mus musculus OX=10090 GN=Man2b2 PE=1 SV=2 g12499.t1 Q0P563 72.667 150 1.27e-59 184.0 sp|Q0P563|FUCM_BOVIN Fucose mutarotase OS=Bos taurus OX=9913 GN=FUOM PE=2 SV=1 FUCM_BOVIN reviewed Fucose mutarotase (EC 5.1.3.29) Bos taurus (Bovine) GO:0005829; GO:0006004; GO:0016857; GO:0036373; GO:0042806 fucose metabolic process [GO:0006004] cytosol [GO:0005829] fucose binding [GO:0042806]; L-fucose mutarotase activity [GO:0036373]; racemase and epimerase activity, acting on carbohydrates and derivatives [GO:0016857] g12500.t1 Q4VBI7 57.68 319 5.41e-105 312.0 sp|Q4VBI7|STX18_DANRE Syntaxin-18 OS=Danio rerio OX=7955 GN=stx18 PE=2 SV=1 STX18_DANRE reviewed Syntaxin-18 Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005484; GO:0005783; GO:0005789; GO:0006886; GO:0006890; GO:0031201 intracellular protein transport [GO:0006886]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; SNARE complex [GO:0031201] SNAP receptor activity [GO:0005484] g12502.t1 Q5FVR4 54.088 159 7.23e-53 174.0 sp|Q5FVR4|ERI1_RAT 3'-5' exoribonuclease 1 OS=Rattus norvegicus OX=10116 GN=Eri1 PE=2 SV=1 ERI1_RAT reviewed 3'-5' exoribonuclease 1 (EC 3.1.13.1) (Histone mRNA 3'-exonuclease 1) Rattus norvegicus (Rat) GO:0000175; GO:0000460; GO:0000467; GO:0005634; GO:0005730; GO:0005737; GO:0008408; GO:0008859; GO:0019843; GO:0031047; GO:0031125; GO:0043022; GO:0046872; GO:0071204; GO:0071207 exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000467]; maturation of 5.8S rRNA [GO:0000460]; regulatory ncRNA-mediated gene silencing [GO:0031047]; rRNA 3'-end processing [GO:0031125] cytoplasm [GO:0005737]; histone pre-mRNA 3'end processing complex [GO:0071204]; nucleolus [GO:0005730]; nucleus [GO:0005634] 3'-5' exonuclease activity [GO:0008408]; 3'-5'-RNA exonuclease activity [GO:0000175]; exoribonuclease II activity [GO:0008859]; histone pre-mRNA stem-loop binding [GO:0071207]; metal ion binding [GO:0046872]; ribosome binding [GO:0043022]; rRNA binding [GO:0019843] g12503.t1 Q5RD78 55.053 752 0.0 779.0 sp|Q5RD78|HECD2_PONAB Probable E3 ubiquitin-protein ligase HECTD2 OS=Pongo abelii OX=9601 GN=HECTD2 PE=2 SV=1 g12505.t1 D3ZZX1 47.805 410 1.0799999999999999e-137 403.0 sp|D3ZZX1|I5P1_RAT Inositol polyphosphate-5-phosphatase A OS=Rattus norvegicus OX=10116 GN=Inpp5a PE=1 SV=1 I5P1_RAT reviewed Inositol polyphosphate-5-phosphatase A (EC 3.1.3.56) (Type I inositol 1,4,5-trisphosphate 5-phosphatase) (5PTase) Rattus norvegicus (Rat) GO:0004445; GO:0005886; GO:0016020; GO:0030425; GO:0042731; GO:0043647; GO:0046856; GO:0050849; GO:0052658; GO:0052659; GO:1900737 inositol phosphate metabolic process [GO:0043647]; negative regulation of calcium-mediated signaling [GO:0050849]; negative regulation of phospholipase C-activating G protein-coupled receptor signaling pathway [GO:1900737]; phosphatidylinositol dephosphorylation [GO:0046856] dendrite [GO:0030425]; membrane [GO:0016020]; plasma membrane [GO:0005886] inositol-1,3,4,5-tetrakisphosphate 5-phosphatase activity [GO:0052659]; inositol-1,4,5-trisphosphate 5-phosphatase activity [GO:0052658]; inositol-polyphosphate 5-phosphatase activity [GO:0004445]; PH domain binding [GO:0042731] g12505.t2 Q29467 48.139 403 2.46e-133 392.0 sp|Q29467|I5P1_CANLF Inositol polyphosphate-5-phosphatase A OS=Canis lupus familiaris OX=9615 GN=INPP5A PE=1 SV=1 I5P1_CANLF reviewed Inositol polyphosphate-5-phosphatase A (EC 3.1.3.56) (Type I inositol 1,4,5-trisphosphate 5-phosphatase) (5PTase) Canis lupus familiaris (Dog) (Canis familiaris) GO:0004445; GO:0005886; GO:0030425; GO:0046856; GO:0052658; GO:0052659; GO:1900737 negative regulation of phospholipase C-activating G protein-coupled receptor signaling pathway [GO:1900737]; phosphatidylinositol dephosphorylation [GO:0046856] dendrite [GO:0030425]; plasma membrane [GO:0005886] inositol-1,3,4,5-tetrakisphosphate 5-phosphatase activity [GO:0052659]; inositol-1,4,5-trisphosphate 5-phosphatase activity [GO:0052658]; inositol-polyphosphate 5-phosphatase activity [GO:0004445] g12508.t1 Q9C056 51.004 249 1.4299999999999999e-67 214.0 sp|Q9C056|NKX62_HUMAN Homeobox protein Nkx-6.2 OS=Homo sapiens OX=9606 GN=NKX6-2 PE=1 SV=2 g12511.t1 P56407 79.688 64 1.6900000000000001e-29 107.0 sp|P56407|HM09_CAEEL Homeobox protein ceh-9 OS=Caenorhabditis elegans OX=6239 GN=ceh-9 PE=3 SV=2 g12521.t1 Q9NTM9 63.75 240 3.0199999999999997e-112 326.0 sp|Q9NTM9|CUTC_HUMAN Copper homeostasis protein cutC homolog OS=Homo sapiens OX=9606 GN=CUTC PE=1 SV=1 CUTC_HUMAN reviewed Copper homeostasis protein cutC homolog Homo sapiens (Human) GO:0005507; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0006825; GO:0051262; GO:0055070 copper ion homeostasis [GO:0055070]; copper ion transport [GO:0006825]; protein tetramerization [GO:0051262] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] copper ion binding [GO:0005507] g12522.t1 Q14203 56.154 520 0.0 565.0 sp|Q14203|DCTN1_HUMAN Dynactin subunit 1 OS=Homo sapiens OX=9606 GN=DCTN1 PE=1 SV=3 g12522.t2 A0A287B8J2 49.86 714 0.0 639.0 sp|A0A287B8J2|DCTN1_PIG Dynactin subunit 1 OS=Sus scrofa OX=9823 GN=DCTN1 PE=1 SV=2 DCTN1_PIG reviewed Dynactin subunit 1 (150 kDa dynein-associated polypeptide) (p150-glued) Sus scrofa (Pig) GO:0000132; GO:0000776; GO:0000922; GO:0005635; GO:0005813; GO:0005814; GO:0005829; GO:0005875; GO:0005938; GO:0007097; GO:0007528; GO:0008017; GO:0010457; GO:0019901; GO:0021517; GO:0030286; GO:0030424; GO:0030904; GO:0031252; GO:0032402; GO:0034454; GO:0035371; GO:0036064; GO:0042147; GO:0043025; GO:0045171; GO:0050905; GO:0051081; GO:0051301; GO:0060236; GO:0061744; GO:0070050; GO:0072686; GO:0090063; GO:0120103; GO:1904398; GO:1905515; GO:1990535 cell division [GO:0051301]; centriole-centriole cohesion [GO:0010457]; establishment of mitotic spindle orientation [GO:0000132]; melanosome transport [GO:0032402]; microtubule anchoring at centrosome [GO:0034454]; motor behavior [GO:0061744]; neuromuscular junction development [GO:0007528]; neuromuscular process [GO:0050905]; neuron cellular homeostasis [GO:0070050]; neuron projection maintenance [GO:1990535]; non-motile cilium assembly [GO:1905515]; nuclear membrane disassembly [GO:0051081]; nuclear migration [GO:0007097]; positive regulation of microtubule nucleation [GO:0090063]; positive regulation of neuromuscular junction development [GO:1904398]; regulation of mitotic spindle organization [GO:0060236]; retrograde transport, endosome to Golgi [GO:0042147]; ventral spinal cord development [GO:0021517] axon [GO:0030424]; cell cortex [GO:0005938]; cell leading edge [GO:0031252]; centriolar subdistal appendage [GO:0120103]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytosol [GO:0005829]; dynein complex [GO:0030286]; intercellular bridge [GO:0045171]; kinetochore [GO:0000776]; microtubule associated complex [GO:0005875]; microtubule plus-end [GO:0035371]; mitotic spindle [GO:0072686]; neuronal cell body [GO:0043025]; nuclear envelope [GO:0005635]; retromer complex [GO:0030904]; spindle pole [GO:0000922] microtubule binding [GO:0008017]; protein kinase binding [GO:0019901] g12523.t1 Q6PCJ1 33.581 539 2.42e-41 162.0 sp|Q6PCJ1|DCTN1_XENLA Dynactin subunit 1 OS=Xenopus laevis OX=8355 GN=dctn1 PE=2 SV=1 g12523.t2 Q6PCJ1 33.905 525 4.25e-46 176.0 sp|Q6PCJ1|DCTN1_XENLA Dynactin subunit 1 OS=Xenopus laevis OX=8355 GN=dctn1 PE=2 SV=1 g12524.t1 Q6P1Z5 50.923 271 1.48e-97 301.0 sp|Q6P1Z5|PED1A_MOUSE PC-esterase domain-containing protein 1A OS=Mus musculus OX=10090 GN=Pced1a PE=2 SV=2 g12528.t1 Q7SXR3 63.281 384 3.3e-178 504.0 sp|Q7SXR3|MAEA_DANRE E3 ubiquitin-protein transferase MAEA OS=Danio rerio OX=7955 GN=maea PE=2 SV=2 g12530.t1 Q20595 81.132 53 9.71e-26 104.0 sp|Q20595|CTBP1_CAEEL C-terminal-binding protein 1 OS=Caenorhabditis elegans OX=6239 GN=ctbp-1 PE=1 SV=3 CTBP1_CAEEL reviewed C-terminal-binding protein 1 Caenorhabditis elegans GO:0000122; GO:0001221; GO:0003677; GO:0003713; GO:0003714; GO:0005634; GO:0006357; GO:0008270; GO:0016616; GO:0051287; GO:0061629; GO:0140297 negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] DNA binding [GO:0003677]; DNA-binding transcription factor binding [GO:0140297]; NAD binding [GO:0051287]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription coactivator activity [GO:0003713]; transcription coregulator binding [GO:0001221]; transcription corepressor activity [GO:0003714]; zinc ion binding [GO:0008270] g12531.t1 Q9EQH5 67.269 443 0.0 595.0 sp|Q9EQH5|CTBP2_RAT C-terminal-binding protein 2 OS=Rattus norvegicus OX=10116 GN=Ctbp2 PE=1 SV=2 CTBP2_RAT reviewed C-terminal-binding protein 2 (CtBP2) Rattus norvegicus (Rat) GO:0001221; GO:0001222; GO:0003682; GO:0003713; GO:0003714; GO:0005634; GO:0006357; GO:0016081; GO:0016616; GO:0017053; GO:0019901; GO:0042802; GO:0042974; GO:0044877; GO:0045202; GO:0045892; GO:0045944; GO:0048386; GO:0050872; GO:0051287; GO:0097470; GO:0098684; GO:0098831; GO:0098882; GO:0098978; GO:0098982; GO:0099523; GO:0140297; GO:1990830 cellular response to leukemia inhibitory factor [GO:1990830]; negative regulation of DNA-templated transcription [GO:0045892]; positive regulation of retinoic acid receptor signaling pathway [GO:0048386]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; synaptic vesicle docking [GO:0016081]; white fat cell differentiation [GO:0050872] GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; nucleus [GO:0005634]; photoreceptor ribbon synapse [GO:0098684]; presynaptic active zone cytoplasmic component [GO:0098831]; presynaptic cytosol [GO:0099523]; ribbon synapse [GO:0097470]; synapse [GO:0045202]; transcription repressor complex [GO:0017053] chromatin binding [GO:0003682]; DNA-binding transcription factor binding [GO:0140297]; identical protein binding [GO:0042802]; NAD binding [GO:0051287]; nuclear retinoic acid receptor binding [GO:0042974]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; structural constituent of presynaptic active zone [GO:0098882]; transcription coactivator activity [GO:0003713]; transcription coregulator binding [GO:0001221]; transcription corepressor activity [GO:0003714]; transcription corepressor binding [GO:0001222] g12532.t1 Q9Y606 62.136 103 3.89e-42 150.0 sp|Q9Y606|PUS1_HUMAN Pseudouridylate synthase 1 homolog OS=Homo sapiens OX=9606 GN=PUS1 PE=1 SV=3 PUS1_HUMAN reviewed Pseudouridylate synthase 1 homolog (EC 5.4.99.-) (tRNA pseudouridine synthase 1) (EC 5.4.99.12) (tRNA pseudouridine(38-40) synthase) (tRNA pseudouridylate synthase I) (tRNA-uridine isomerase I) Homo sapiens (Human) GO:0000049; GO:0002153; GO:0003682; GO:0003713; GO:0003723; GO:0005634; GO:0005654; GO:0005667; GO:0005730; GO:0005737; GO:0005739; GO:0005759; GO:0006397; GO:0008380; GO:0009982; GO:0031119; GO:0045944; GO:0070902; GO:0160147; GO:0160153; GO:1990481 mitochondrial tRNA pseudouridine synthesis [GO:0070902]; mRNA processing [GO:0006397]; mRNA pseudouridine synthesis [GO:1990481]; positive regulation of transcription by RNA polymerase II [GO:0045944]; RNA splicing [GO:0008380]; tRNA pseudouridine synthesis [GO:0031119] cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667] chromatin binding [GO:0003682]; mitochondrial tRNA pseudouridine(27/28) synthase activity [GO:0160153]; pseudouridine synthase activity [GO:0009982]; RNA binding [GO:0003723]; steroid receptor RNA activator RNA binding [GO:0002153]; transcription coactivator activity [GO:0003713]; tRNA binding [GO:0000049]; tRNA pseudouridine(38-40) synthase activity [GO:0160147] g12533.t1 Q9Y606 52.525 198 2.2e-65 213.0 sp|Q9Y606|PUS1_HUMAN Pseudouridylate synthase 1 homolog OS=Homo sapiens OX=9606 GN=PUS1 PE=1 SV=3 PUS1_HUMAN reviewed Pseudouridylate synthase 1 homolog (EC 5.4.99.-) (tRNA pseudouridine synthase 1) (EC 5.4.99.12) (tRNA pseudouridine(38-40) synthase) (tRNA pseudouridylate synthase I) (tRNA-uridine isomerase I) Homo sapiens (Human) GO:0000049; GO:0002153; GO:0003682; GO:0003713; GO:0003723; GO:0005634; GO:0005654; GO:0005667; GO:0005730; GO:0005737; GO:0005739; GO:0005759; GO:0006397; GO:0008380; GO:0009982; GO:0031119; GO:0045944; GO:0070902; GO:0160147; GO:0160153; GO:1990481 mitochondrial tRNA pseudouridine synthesis [GO:0070902]; mRNA processing [GO:0006397]; mRNA pseudouridine synthesis [GO:1990481]; positive regulation of transcription by RNA polymerase II [GO:0045944]; RNA splicing [GO:0008380]; tRNA pseudouridine synthesis [GO:0031119] cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667] chromatin binding [GO:0003682]; mitochondrial tRNA pseudouridine(27/28) synthase activity [GO:0160153]; pseudouridine synthase activity [GO:0009982]; RNA binding [GO:0003723]; steroid receptor RNA activator RNA binding [GO:0002153]; transcription coactivator activity [GO:0003713]; tRNA binding [GO:0000049]; tRNA pseudouridine(38-40) synthase activity [GO:0160147] g12535.t1 Q9WTK3 41.429 420 2.24e-89 287.0 sp|Q9WTK3|GPAA1_MOUSE GPI-anchor transamidase component GPAA1 OS=Mus musculus OX=10090 GN=Gpaa1 PE=1 SV=3 GPAA1_MOUSE reviewed GPI-anchor transamidase component GPAA1 (GAA1 protein homolog) (mGAA1) (Glycosylphosphatidylinositol anchor attachment 1 protein) (GPI anchor attachment protein 1) Mus musculus (Mouse) GO:0003923; GO:0005739; GO:0005783; GO:0005813; GO:0005829; GO:0005886; GO:0006506; GO:0016255; GO:0034235; GO:0042765; GO:0046872; GO:0180046 attachment of GPI anchor to protein [GO:0016255]; GPI anchor biosynthetic process [GO:0006506]; GPI anchored protein biosynthesis [GO:0180046] centrosome [GO:0005813]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; GPI-anchor transamidase complex [GO:0042765]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886] GPI anchor binding [GO:0034235]; GPI-anchor transamidase activity [GO:0003923]; metal ion binding [GO:0046872] g12546.t1 B4QZU6 46.636 431 4.9699999999999995e-104 320.0 sp|B4QZU6|HTRA2_DROSI Serine protease HTRA2, mitochondrial OS=Drosophila simulans OX=7240 GN=HtrA2 PE=3 SV=1 HTRA2_DROSI reviewed Serine protease HTRA2, mitochondrial (EC 3.4.21.108) (High temperature requirement protein A2) Drosophila simulans (Fruit fly) GO:0004252; GO:0005758; GO:0005829; GO:0006508; GO:0006915; GO:0007005; GO:0007283; GO:0016006; GO:0031966; GO:0035234; GO:0043065 apoptotic process [GO:0006915]; ectopic germ cell programmed cell death [GO:0035234]; mitochondrion organization [GO:0007005]; positive regulation of apoptotic process [GO:0043065]; proteolysis [GO:0006508]; spermatogenesis [GO:0007283] cytosol [GO:0005829]; mitochondrial intermembrane space [GO:0005758]; mitochondrial membrane [GO:0031966]; Nebenkern [GO:0016006] serine-type endopeptidase activity [GO:0004252] g12547.t1 Q14CB8 34.038 426 5.2099999999999994e-67 227.0 sp|Q14CB8|RHG19_HUMAN Rho GTPase-activating protein 19 OS=Homo sapiens OX=9606 GN=ARHGAP19 PE=1 SV=1 g12549.t1 Q2TBT5 48.98 294 2.13e-96 288.0 sp|Q2TBT5|RNH2A_BOVIN Ribonuclease H2 subunit A OS=Bos taurus OX=9913 GN=RNASEH2A PE=1 SV=1 RNH2A_BOVIN reviewed Ribonuclease H2 subunit A (RNase H2 subunit A) (EC 3.1.26.4) (Ribonuclease HI large subunit) (RNase HI large subunit) (Ribonuclease HI subunit A) Bos taurus (Bovine) GO:0003723; GO:0004523; GO:0005654; GO:0005829; GO:0006298; GO:0006401; GO:0032299; GO:0043137; GO:0046872 DNA replication, removal of RNA primer [GO:0043137]; mismatch repair [GO:0006298]; RNA catabolic process [GO:0006401] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; ribonuclease H2 complex [GO:0032299] metal ion binding [GO:0046872]; RNA binding [GO:0003723]; RNA-DNA hybrid ribonuclease activity [GO:0004523] g12550.t1 Q6NRH3 44.635 233 1.48e-44 161.0 sp|Q6NRH3|CC149_XENLA Coiled-coil domain-containing protein 149 OS=Xenopus laevis OX=8355 GN=ccdc149 PE=2 SV=1 g12556.t1 O14639 43.218 317 1.34e-84 285.0 sp|O14639|ABLM1_HUMAN Actin-binding LIM protein 1 OS=Homo sapiens OX=9606 GN=ABLIM1 PE=1 SV=3 ABLM1_HUMAN reviewed Actin-binding LIM protein 1 (abLIM-1) (Actin-binding LIM protein family member 1) (Actin-binding double zinc finger protein) (LIMAB1) (Limatin) Homo sapiens (Human) GO:0001725; GO:0003779; GO:0005737; GO:0006366; GO:0007010; GO:0007411; GO:0007601; GO:0009887; GO:0014069; GO:0015629; GO:0030027; GO:0030032; GO:0045944; GO:0046872; GO:0051015; GO:0060271 animal organ morphogenesis [GO:0009887]; axon guidance [GO:0007411]; cilium assembly [GO:0060271]; cytoskeleton organization [GO:0007010]; lamellipodium assembly [GO:0030032]; positive regulation of transcription by RNA polymerase II [GO:0045944]; transcription by RNA polymerase II [GO:0006366]; visual perception [GO:0007601] actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; lamellipodium [GO:0030027]; postsynaptic density [GO:0014069]; stress fiber [GO:0001725] actin binding [GO:0003779]; actin filament binding [GO:0051015]; metal ion binding [GO:0046872] g12556.t2 O14639 44.702 302 3.19e-84 284.0 sp|O14639|ABLM1_HUMAN Actin-binding LIM protein 1 OS=Homo sapiens OX=9606 GN=ABLIM1 PE=1 SV=3 ABLM1_HUMAN reviewed Actin-binding LIM protein 1 (abLIM-1) (Actin-binding LIM protein family member 1) (Actin-binding double zinc finger protein) (LIMAB1) (Limatin) Homo sapiens (Human) GO:0001725; GO:0003779; GO:0005737; GO:0006366; GO:0007010; GO:0007411; GO:0007601; GO:0009887; GO:0014069; GO:0015629; GO:0030027; GO:0030032; GO:0045944; GO:0046872; GO:0051015; GO:0060271 animal organ morphogenesis [GO:0009887]; axon guidance [GO:0007411]; cilium assembly [GO:0060271]; cytoskeleton organization [GO:0007010]; lamellipodium assembly [GO:0030032]; positive regulation of transcription by RNA polymerase II [GO:0045944]; transcription by RNA polymerase II [GO:0006366]; visual perception [GO:0007601] actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; lamellipodium [GO:0030027]; postsynaptic density [GO:0014069]; stress fiber [GO:0001725] actin binding [GO:0003779]; actin filament binding [GO:0051015]; metal ion binding [GO:0046872] g12556.t3 O14639 49.815 271 5.1899999999999995e-90 299.0 sp|O14639|ABLM1_HUMAN Actin-binding LIM protein 1 OS=Homo sapiens OX=9606 GN=ABLIM1 PE=1 SV=3 ABLM1_HUMAN reviewed Actin-binding LIM protein 1 (abLIM-1) (Actin-binding LIM protein family member 1) (Actin-binding double zinc finger protein) (LIMAB1) (Limatin) Homo sapiens (Human) GO:0001725; GO:0003779; GO:0005737; GO:0006366; GO:0007010; GO:0007411; GO:0007601; GO:0009887; GO:0014069; GO:0015629; GO:0030027; GO:0030032; GO:0045944; GO:0046872; GO:0051015; GO:0060271 animal organ morphogenesis [GO:0009887]; axon guidance [GO:0007411]; cilium assembly [GO:0060271]; cytoskeleton organization [GO:0007010]; lamellipodium assembly [GO:0030032]; positive regulation of transcription by RNA polymerase II [GO:0045944]; transcription by RNA polymerase II [GO:0006366]; visual perception [GO:0007601] actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; lamellipodium [GO:0030027]; postsynaptic density [GO:0014069]; stress fiber [GO:0001725] actin binding [GO:0003779]; actin filament binding [GO:0051015]; metal ion binding [GO:0046872] g12557.t1 Q60HF3 31.429 350 5.6999999999999995e-46 178.0 sp|Q60HF3|HPS1_MACFA BLOC-3 complex member HPS1 OS=Macaca fascicularis OX=9541 GN=HPS1 PE=2 SV=1 g12557.t1 Q60HF3 33.673 294 4.9600000000000003e-26 117.0 sp|Q60HF3|HPS1_MACFA BLOC-3 complex member HPS1 OS=Macaca fascicularis OX=9541 GN=HPS1 PE=2 SV=1 g12558.t1 Q9JJG9 39.84 374 4.76e-68 230.0 sp|Q9JJG9|NOA1_MOUSE Nitric oxide-associated protein 1 OS=Mus musculus OX=10090 GN=Noa1 PE=1 SV=1 NOA1_MOUSE reviewed Nitric oxide-associated protein 1 Mus musculus (Mouse) GO:0005525; GO:0005739; GO:0005743; GO:0006915; GO:0007005; GO:0061668; GO:0099617 apoptotic process [GO:0006915]; mitochondrial ribosome assembly [GO:0061668]; mitochondrion organization [GO:0007005] matrix side of mitochondrial inner membrane [GO:0099617]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739] GTP binding [GO:0005525] g12560.t1 Q0VD50 52.0 275 6.19e-84 256.0 sp|Q0VD50|NMNA1_BOVIN Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1 OS=Bos taurus OX=9913 GN=NMNAT1 PE=2 SV=1 NMNA1_BOVIN reviewed Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1 (NMN/NaMN adenylyltransferase 1) (EC 2.7.7.1) (EC 2.7.7.18) (Nicotinamide mononucleotide adenylyltransferase 1) (NMN adenylyltransferase 1) (Nicotinate-nucleotide adenylyltransferase 1) (NaMN adenylyltransferase 1) Bos taurus (Bovine) GO:0000309; GO:0000785; GO:0004515; GO:0005524; GO:0005634; GO:0006769; GO:0009435; GO:0009611; GO:0016604; GO:0034355; GO:0042802; GO:0045892; GO:0045893; GO:0140768; GO:1904178; GO:1904179; GO:1990966 ATP generation from poly-ADP-D-ribose [GO:1990966]; NAD+ biosynthetic process [GO:0009435]; NAD+ biosynthetic process via the salvage pathway [GO:0034355]; negative regulation of adipose tissue development [GO:1904178]; negative regulation of DNA-templated transcription [GO:0045892]; nicotinamide metabolic process [GO:0006769]; positive regulation of adipose tissue development [GO:1904179]; positive regulation of DNA-templated transcription [GO:0045893]; response to wounding [GO:0009611] chromatin [GO:0000785]; nuclear body [GO:0016604]; nucleus [GO:0005634] ATP binding [GO:0005524]; identical protein binding [GO:0042802]; nicotinamide-nucleotide adenylyltransferase activity [GO:0000309]; nicotinate-nucleotide adenylyltransferase activity [GO:0004515]; protein ADP-ribosyltransferase-substrate adaptor activity [GO:0140768] g12561.t1 Q86UF1 42.085 259 1.1800000000000001e-58 192.0 sp|Q86UF1|TSN33_HUMAN Tetraspanin-33 OS=Homo sapiens OX=9606 GN=TSPAN33 PE=1 SV=1 TSN33_HUMAN reviewed Tetraspanin-33 (Tspan-33) (Penumbra) (hPen) (Proerythroblast new membrane) Homo sapiens (Human) GO:0005788; GO:0005886; GO:0005912; GO:0009986; GO:0019899; GO:0046930; GO:0046931; GO:0051604; GO:0072659; GO:0097197 pore complex assembly [GO:0046931]; protein localization to plasma membrane [GO:0072659]; protein maturation [GO:0051604] adherens junction [GO:0005912]; cell surface [GO:0009986]; endoplasmic reticulum lumen [GO:0005788]; plasma membrane [GO:0005886]; pore complex [GO:0046930]; tetraspanin-enriched microdomain [GO:0097197] enzyme binding [GO:0019899] g12572.t1 Q8BVL9 37.129 202 7.81e-28 114.0 sp|Q8BVL9|JKIP1_MOUSE Janus kinase and microtubule-interacting protein 1 OS=Mus musculus OX=10090 GN=Jakmip1 PE=1 SV=2 JKIP1_MOUSE reviewed Janus kinase and microtubule-interacting protein 1 (GABA-B receptor-binding protein) (Multiple alpha-helices and RNA-linker protein 1) (Marlin-1) Mus musculus (Mouse) GO:0003723; GO:0005874; GO:0008017; GO:0015031; GO:0015630; GO:0016020; GO:0019894; GO:0019900; GO:0050811; GO:0050890; GO:1990904 cognition [GO:0050890]; protein transport [GO:0015031] membrane [GO:0016020]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; ribonucleoprotein complex [GO:1990904] GABA receptor binding [GO:0050811]; kinase binding [GO:0019900]; kinesin binding [GO:0019894]; microtubule binding [GO:0008017]; RNA binding [GO:0003723] g12573.t1 Q7ZYZ7 51.037 241 2e-82 250.0 sp|Q7ZYZ7|PCGF1_DANRE Polycomb group RING finger protein 1 OS=Danio rerio OX=7955 GN=pcgf1 PE=3 SV=1 PCGF1_DANRE reviewed Polycomb group RING finger protein 1 Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000122; GO:0006338; GO:0008270; GO:0021915; GO:0031519; GO:0035102; GO:0048589; GO:1990841 chromatin remodeling [GO:0006338]; developmental growth [GO:0048589]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural tube development [GO:0021915] PcG protein complex [GO:0031519]; PRC1 complex [GO:0035102] promoter-specific chromatin binding [GO:1990841]; zinc ion binding [GO:0008270] g12580.t1 Q7Z7H5 77.273 198 4.6300000000000005e-105 305.0 sp|Q7Z7H5|TMED4_HUMAN Transmembrane emp24 domain-containing protein 4 OS=Homo sapiens OX=9606 GN=TMED4 PE=1 SV=1 TMED4_HUMAN reviewed Transmembrane emp24 domain-containing protein 4 (Endoplasmic reticulum stress-response protein 25) (ERS25) (GMP25iso) (Putative NF-kappa-B-activating protein 156) (p24 family protein alpha-3) (p24alpha3) Homo sapiens (Human) GO:0005783; GO:0005789; GO:0005793; GO:0005794; GO:0006886; GO:0006888; GO:0007030; GO:0030134; GO:0043123 endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; intracellular protein transport [GO:0006886]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123] COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi apparatus [GO:0005794] g12581.t1 Q8MI28 23.188 690 7.200000000000001e-21 103.0 sp|Q8MI28|LBN_BOVIN Limbin OS=Bos taurus OX=9913 GN=EVC2 PE=2 SV=1 g12588.t1 Q8QHI3 43.885 139 5.15e-28 107.0 sp|Q8QHI3|ARL3_XENLA ADP-ribosylation factor-like protein 3 OS=Xenopus laevis OX=8355 GN=arl3 PE=2 SV=1 g12589.t1 Q9BW72 59.459 74 4.5500000000000003e-26 97.1 sp|Q9BW72|HIG2A_HUMAN HIG1 domain family member 2A, mitochondrial OS=Homo sapiens OX=9606 GN=HIGD2A PE=1 SV=1 g12590.t1 Q9Y3C1 44.379 169 5.6399999999999996e-40 136.0 sp|Q9Y3C1|NOP16_HUMAN Nucleolar protein 16 OS=Homo sapiens OX=9606 GN=NOP16 PE=1 SV=2 g12591.t1 Q5PQR6 32.246 276 1.02e-21 98.2 sp|Q5PQR6|SMA2L_RAT Sperm microtubule associated protein 2-like OS=Rattus norvegicus OX=10116 GN=Spmap2l PE=2 SV=1 g12592.t1 O02228 61.05 457 5.87e-169 491.0 sp|O02228|SC5A7_CAEEL High-affinity choline transporter 1 OS=Caenorhabditis elegans OX=6239 GN=cho-1 PE=2 SV=2 SC5A7_CAEEL reviewed High-affinity choline transporter 1 Caenorhabditis elegans GO:0005307; GO:0005886; GO:0008021; GO:0008292; GO:0015220; GO:0015871; GO:0030424; GO:0043005; GO:0043025; GO:0045202 acetylcholine biosynthetic process [GO:0008292]; choline transport [GO:0015871] axon [GO:0030424]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; synapse [GO:0045202]; synaptic vesicle [GO:0008021] choline transmembrane transporter activity [GO:0015220]; choline:sodium symporter activity [GO:0005307] g12594.t1 Q9GZV3 63.215 367 2.34e-143 423.0 sp|Q9GZV3|SC5A7_HUMAN High affinity choline transporter 1 OS=Homo sapiens OX=9606 GN=SLC5A7 PE=1 SV=1 g12595.t1 Q6IND7 52.229 157 1.7299999999999997e-42 149.0 sp|Q6IND7|LR2BP_XENLA LRP2-binding protein OS=Xenopus laevis OX=8355 GN=lrp2bp PE=2 SV=1 g12596.t1 Q6IND7 48.837 86 9.04e-23 94.0 sp|Q6IND7|LR2BP_XENLA LRP2-binding protein OS=Xenopus laevis OX=8355 GN=lrp2bp PE=2 SV=1 g12597.t1 Q7SXN4 73.67 376 0.0 556.0 sp|Q7SXN4|CPEB4_DANRE Cytoplasmic polyadenylation element-binding protein 4 OS=Danio rerio OX=7955 GN=cpeb4 PE=2 SV=1 g12598.t1 Q5ZJ41 72.659 267 1.02e-153 433.0 sp|Q5ZJ41|MARH5_CHICK E3 ubiquitin-protein ligase MARCHF5 OS=Gallus gallus OX=9031 GN=MARCHF5 PE=2 SV=1 MARH5_CHICK reviewed E3 ubiquitin-protein ligase MARCHF5 (EC 2.3.2.27) (Membrane-associated RING finger protein 5) (Membrane-associated RING-CH protein V) (MARCH-V) (RING-type E3 ubiquitin transferase MARCHF5) Gallus gallus (Chicken) GO:0000209; GO:0005741; GO:0005783; GO:0005789; GO:0008270; GO:0051865; GO:0061630; GO:0090140 protein autoubiquitination [GO:0051865]; protein polyubiquitination [GO:0000209]; regulation of mitochondrial fission [GO:0090140] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; mitochondrial outer membrane [GO:0005741] ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] g12599.t1 Q24K02 62.278 395 4.77e-178 526.0 sp|Q24K02|IDE_BOVIN Insulin-degrading enzyme OS=Bos taurus OX=9913 GN=IDE PE=2 SV=1 IDE_BOVIN reviewed Insulin-degrading enzyme (EC 3.4.24.56) (Insulin protease) (Insulinase) (Insulysin) Bos taurus (Bovine) GO:0004175; GO:0004222; GO:0005524; GO:0005615; GO:0005739; GO:0005782; GO:0005829; GO:0005886; GO:0008270; GO:0010815; GO:0019885; GO:0030163; GO:0042447; GO:0042803; GO:0043171; GO:0050435; GO:0051603; GO:0097242; GO:1901143 amyloid-beta clearance [GO:0097242]; amyloid-beta metabolic process [GO:0050435]; antigen processing and presentation of endogenous peptide antigen via MHC class I [GO:0019885]; bradykinin catabolic process [GO:0010815]; hormone catabolic process [GO:0042447]; insulin catabolic process [GO:1901143]; peptide catabolic process [GO:0043171]; protein catabolic process [GO:0030163]; proteolysis involved in protein catabolic process [GO:0051603] cytosol [GO:0005829]; extracellular space [GO:0005615]; mitochondrion [GO:0005739]; peroxisomal matrix [GO:0005782]; plasma membrane [GO:0005886] ATP binding [GO:0005524]; endopeptidase activity [GO:0004175]; metalloendopeptidase activity [GO:0004222]; protein homodimerization activity [GO:0042803]; zinc ion binding [GO:0008270] g12600.t1 P35559 63.573 571 0.0 764.0 sp|P35559|IDE_RAT Insulin-degrading enzyme OS=Rattus norvegicus OX=10116 GN=Ide PE=1 SV=1 g12601.t1 Q8R536 40.637 251 6.9800000000000005e-59 191.0 sp|Q8R536|SPRE_MERUN Sepiapterin reductase OS=Meriones unguiculatus OX=10047 GN=SPR PE=2 SV=1 g12605.t1 Q64464 37.131 474 7.159999999999999e-104 321.0 sp|Q64464|CP3AD_MOUSE Cytochrome P450 3A13 OS=Mus musculus OX=10090 GN=Cyp3a13 PE=1 SV=1 CP3AD_MOUSE reviewed Cytochrome P450 3A13 (EC 1.14.14.1) (CYPIIIA13) Mus musculus (Mouse) GO:0004497; GO:0005496; GO:0005506; GO:0005737; GO:0005789; GO:0008202; GO:0008395; GO:0008401; GO:0010628; GO:0016491; GO:0019899; GO:0020037; GO:0030343; GO:0034875; GO:0042908; GO:0050649; GO:0062181; GO:0070576; GO:0070989; GO:0101020; GO:0101021 oxidative demethylation [GO:0070989]; positive regulation of gene expression [GO:0010628]; steroid metabolic process [GO:0008202]; xenobiotic transport [GO:0042908] cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789] 1-alpha,25-dihydroxyvitamin D3 23-hydroxylase activity [GO:0062181]; caffeine oxidase activity [GO:0034875]; enzyme binding [GO:0019899]; estrogen 16-alpha-hydroxylase activity [GO:0101020]; estrogen 2-hydroxylase activity [GO:0101021]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity [GO:0016491]; retinoic acid 4-hydroxylase activity [GO:0008401]; steroid binding [GO:0005496]; steroid hydroxylase activity [GO:0008395]; testosterone 6-beta-hydroxylase activity [GO:0050649]; vitamin D 24-hydroxylase activity [GO:0070576]; vitamin D3 25-hydroxylase activity [GO:0030343] g12606.t1 Q9Y4P9 45.122 246 5.16e-57 185.0 sp|Q9Y4P9|SPEF1_HUMAN Sperm flagellar protein 1 OS=Homo sapiens OX=9606 GN=SPEF1 PE=1 SV=3 SPEF1_HUMAN reviewed Sperm flagellar protein 1 Homo sapiens (Human) GO:0001578; GO:0001725; GO:0003341; GO:0003779; GO:0005737; GO:0005874; GO:0005902; GO:0005930; GO:0007026; GO:0008017; GO:0016323; GO:0016324; GO:0016477; GO:0030027; GO:0030032; GO:0030175; GO:0046847; GO:0051493; GO:0097542; GO:0097729; GO:1904158; GO:1990716; GO:2000095 axonemal central apparatus assembly [GO:1904158]; cell migration [GO:0016477]; cilium movement [GO:0003341]; filopodium assembly [GO:0046847]; lamellipodium assembly [GO:0030032]; microtubule bundle formation [GO:0001578]; negative regulation of microtubule depolymerization [GO:0007026]; regulation of cytoskeleton organization [GO:0051493]; regulation of Wnt signaling pathway, planar cell polarity pathway [GO:2000095] 9+2 motile cilium [GO:0097729]; apical plasma membrane [GO:0016324]; axonemal central apparatus [GO:1990716]; axoneme [GO:0005930]; basolateral plasma membrane [GO:0016323]; ciliary tip [GO:0097542]; cytoplasm [GO:0005737]; filopodium [GO:0030175]; lamellipodium [GO:0030027]; microtubule [GO:0005874]; microvillus [GO:0005902]; stress fiber [GO:0001725] actin binding [GO:0003779]; microtubule binding [GO:0008017] g12607.t1 Q9W735 26.425 579 1.1900000000000001e-29 128.0 sp|Q9W735|PRM1A_DANRE Prominin-1-A OS=Danio rerio OX=7955 GN=prom1a PE=2 SV=2 g12608.t1 Q9W735 31.754 211 7.080000000000001e-21 97.4 sp|Q9W735|PRM1A_DANRE Prominin-1-A OS=Danio rerio OX=7955 GN=prom1a PE=2 SV=2 g12609.t1 A0A1L8HX76 45.221 429 1.25e-128 381.0 sp|A0A1L8HX76|WDR18_XENLA WD repeat-containing protein 18 OS=Xenopus laevis OX=8355 GN=wdr18 PE=3 SV=1 g12610.t1 Q14185 51.08 1157 0.0 1128.0 sp|Q14185|DOCK1_HUMAN Dedicator of cytokinesis protein 1 OS=Homo sapiens OX=9606 GN=DOCK1 PE=1 SV=2 g12611.t1 Q14185 50.0 468 2.71e-137 446.0 sp|Q14185|DOCK1_HUMAN Dedicator of cytokinesis protein 1 OS=Homo sapiens OX=9606 GN=DOCK1 PE=1 SV=2 g12611.t2 Q14185 50.0 468 1.9099999999999998e-137 445.0 sp|Q14185|DOCK1_HUMAN Dedicator of cytokinesis protein 1 OS=Homo sapiens OX=9606 GN=DOCK1 PE=1 SV=2 g12612.t1 E1C3U7 34.948 764 4.81e-149 458.0 sp|E1C3U7|LOXL2_CHICK Lysyl oxidase homolog 2 OS=Gallus gallus OX=9031 GN=LOXL2 PE=3 SV=1 LOXL2_CHICK reviewed Lysyl oxidase homolog 2 (EC 1.4.3.13) (Lysyl oxidase-like protein 2) Gallus gallus (Chicken) GO:0000122; GO:0000785; GO:0001666; GO:0001837; GO:0001935; GO:0002040; GO:0004720; GO:0005507; GO:0005509; GO:0005604; GO:0005615; GO:0005634; GO:0005783; GO:0010718; GO:0016020; GO:0018057; GO:0030199; GO:0032332; GO:0043542; GO:0045892; GO:0070828; GO:1902455 collagen fibril organization [GO:0030199]; endothelial cell migration [GO:0043542]; endothelial cell proliferation [GO:0001935]; epithelial to mesenchymal transition [GO:0001837]; heterochromatin organization [GO:0070828]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of stem cell population maintenance [GO:1902455]; negative regulation of transcription by RNA polymerase II [GO:0000122]; peptidyl-lysine oxidation [GO:0018057]; positive regulation of chondrocyte differentiation [GO:0032332]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; response to hypoxia [GO:0001666]; sprouting angiogenesis [GO:0002040] basement membrane [GO:0005604]; chromatin [GO:0000785]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; membrane [GO:0016020]; nucleus [GO:0005634] calcium ion binding [GO:0005509]; copper ion binding [GO:0005507]; protein-lysine 6-oxidase activity [GO:0004720] g12612.t2 E1C3U7 35.209 764 9.16e-149 457.0 sp|E1C3U7|LOXL2_CHICK Lysyl oxidase homolog 2 OS=Gallus gallus OX=9031 GN=LOXL2 PE=3 SV=1 LOXL2_CHICK reviewed Lysyl oxidase homolog 2 (EC 1.4.3.13) (Lysyl oxidase-like protein 2) Gallus gallus (Chicken) GO:0000122; GO:0000785; GO:0001666; GO:0001837; GO:0001935; GO:0002040; GO:0004720; GO:0005507; GO:0005509; GO:0005604; GO:0005615; GO:0005634; GO:0005783; GO:0010718; GO:0016020; GO:0018057; GO:0030199; GO:0032332; GO:0043542; GO:0045892; GO:0070828; GO:1902455 collagen fibril organization [GO:0030199]; endothelial cell migration [GO:0043542]; endothelial cell proliferation [GO:0001935]; epithelial to mesenchymal transition [GO:0001837]; heterochromatin organization [GO:0070828]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of stem cell population maintenance [GO:1902455]; negative regulation of transcription by RNA polymerase II [GO:0000122]; peptidyl-lysine oxidation [GO:0018057]; positive regulation of chondrocyte differentiation [GO:0032332]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; response to hypoxia [GO:0001666]; sprouting angiogenesis [GO:0002040] basement membrane [GO:0005604]; chromatin [GO:0000785]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; membrane [GO:0016020]; nucleus [GO:0005634] calcium ion binding [GO:0005509]; copper ion binding [GO:0005507]; protein-lysine 6-oxidase activity [GO:0004720] g12614.t1 Q28EX9 74.112 197 1.62e-106 312.0 sp|Q28EX9|UBCP1_XENTR Ubiquitin-like domain-containing CTD phosphatase 1 OS=Xenopus tropicalis OX=8364 GN=ublcp1 PE=2 SV=1 UBCP1_XENTR reviewed Ubiquitin-like domain-containing CTD phosphatase 1 (EC 3.1.3.16) (Nuclear proteasome inhibitor UBLCP1) Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0004722; GO:0005634; GO:0046872; GO:0090364 regulation of proteasome assembly [GO:0090364] nucleus [GO:0005634] metal ion binding [GO:0046872]; protein serine/threonine phosphatase activity [GO:0004722] g12615.t1 Q0IJ33 50.833 360 5.3300000000000005e-129 377.0 sp|Q0IJ33|TM129_XENTR E3 ubiquitin-protein ligase TM129 OS=Xenopus tropicalis OX=8364 GN=tmem129 PE=2 SV=1 g12616.t1 Q07998 42.202 218 1.69e-47 177.0 sp|Q07998|TBXTA_DANRE T-box transcription factor T-A OS=Danio rerio OX=7955 GN=tbxta PE=1 SV=1 g12627.t1 P10079 39.333 300 1.35e-40 160.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g12627.t1 P10079 38.431 255 2.14e-35 144.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g12627.t1 P10079 34.328 335 1.11e-34 142.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g12627.t1 P10079 35.417 336 8.18e-34 139.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g12627.t1 P10079 35.987 314 2.2600000000000001e-32 135.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g12627.t1 P10079 38.912 239 3e-32 135.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g12627.t1 P10079 36.655 281 4.3800000000000003e-32 134.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g12627.t1 P10079 36.818 220 1.44e-25 114.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g12627.t1 P10079 34.182 275 3.07e-22 104.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g12628.t1 P41596 51.562 320 2.0999999999999998e-101 315.0 sp|P41596|DOPR1_DROME Dopamine receptor 1 OS=Drosophila melanogaster OX=7227 GN=Dop1R1 PE=2 SV=2 DOPR1_DROME reviewed Dopamine receptor 1 (D-DOP1) (DmDop1) (dDA1) (Dopamine 1-like receptor 1) Drosophila melanogaster (Fruit fly) GO:0001588; GO:0004930; GO:0004952; GO:0004993; GO:0005886; GO:0007187; GO:0007188; GO:0007191; GO:0007212; GO:0007268; GO:0007612; GO:0007613; GO:0008306; GO:0008355; GO:0008542; GO:0009744; GO:0016020; GO:0030425; GO:0030594; GO:0040040; GO:0042048; GO:0042594; GO:0043052; GO:0071329; GO:0090328; GO:0098793; GO:0099509; GO:1990834 adenylate cyclase-activating dopamine receptor signaling pathway [GO:0007191]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; associative learning [GO:0008306]; cellular response to sucrose stimulus [GO:0071329]; chemical synaptic transmission [GO:0007268]; G protein-coupled dopamine receptor signaling pathway [GO:0007212]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; learning [GO:0007612]; memory [GO:0007613]; olfactory behavior [GO:0042048]; olfactory learning [GO:0008355]; regulation of olfactory learning [GO:0090328]; regulation of presynaptic cytosolic calcium ion concentration [GO:0099509]; response to odorant [GO:1990834]; response to starvation [GO:0042594]; response to sucrose [GO:0009744]; thermosensory behavior [GO:0040040]; thermotaxis [GO:0043052]; visual learning [GO:0008542] dendrite [GO:0030425]; membrane [GO:0016020]; plasma membrane [GO:0005886]; presynapse [GO:0098793] dopamine neurotransmitter receptor activity [GO:0004952]; dopamine neurotransmitter receptor activity, coupled via Gs [GO:0001588]; G protein-coupled receptor activity [GO:0004930]; G protein-coupled serotonin receptor activity [GO:0004993]; neurotransmitter receptor activity [GO:0030594] g12630.t1 Q9UA35 43.091 550 4.71e-118 369.0 sp|Q9UA35|S28A3_EPTST Solute carrier family 28 member 3 OS=Eptatretus stoutii OX=7765 GN=SLC28A3 PE=2 SV=1 g12630.t2 Q9UA35 43.091 550 5.54e-118 369.0 sp|Q9UA35|S28A3_EPTST Solute carrier family 28 member 3 OS=Eptatretus stoutii OX=7765 GN=SLC28A3 PE=2 SV=1 g12631.t1 P70579 25.979 562 3.83e-51 196.0 sp|P70579|GRM8_RAT Metabotropic glutamate receptor 8 OS=Rattus norvegicus OX=10116 GN=Grm8 PE=1 SV=1 GRM8_RAT reviewed Metabotropic glutamate receptor 8 (mGluR8) Rattus norvegicus (Rat) GO:0001642; GO:0004930; GO:0005886; GO:0007193; GO:0007196; GO:0007216; GO:0007268; GO:0008066; GO:0019233; GO:0035249; GO:0042734; GO:0043025; GO:0045211; GO:0046928; GO:0048787; GO:0050966; GO:0051966; GO:0098978; GO:0098982; GO:0099171 adenylate cyclase-inhibiting G protein-coupled glutamate receptor signaling pathway [GO:0007196]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; chemical synaptic transmission [GO:0007268]; detection of mechanical stimulus involved in sensory perception of pain [GO:0050966]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; presynaptic modulation of chemical synaptic transmission [GO:0099171]; regulation of neurotransmitter secretion [GO:0046928]; regulation of synaptic transmission, glutamatergic [GO:0051966]; sensory perception of pain [GO:0019233]; synaptic transmission, glutamatergic [GO:0035249] GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic active zone membrane [GO:0048787]; presynaptic membrane [GO:0042734] G protein-coupled receptor activity [GO:0004930]; glutamate receptor activity [GO:0008066]; group III metabotropic glutamate receptor activity [GO:0001642] g12634.t1 Q9BSG0 44.311 167 5.39e-52 168.0 sp|Q9BSG0|PADC1_HUMAN Protease-associated domain-containing protein 1 OS=Homo sapiens OX=9606 GN=PRADC1 PE=1 SV=1 g12635.t1 Q5R9R1 50.781 384 1.16e-105 354.0 sp|Q5R9R1|EDRF1_PONAB Erythroid differentiation-related factor 1 OS=Pongo abelii OX=9601 GN=EDRF1 PE=2 SV=1 g12636.t1 Q3B7T1 41.253 383 1.66e-87 298.0 sp|Q3B7T1|EDRF1_HUMAN Erythroid differentiation-related factor 1 OS=Homo sapiens OX=9606 GN=EDRF1 PE=1 SV=1 EDRF1_HUMAN reviewed Erythroid differentiation-related factor 1 Homo sapiens (Human) GO:0005634; GO:0045893 positive regulation of DNA-templated transcription [GO:0045893] nucleus [GO:0005634] g12637.t1 Q8K3F2 33.763 465 4.45e-67 236.0 sp|Q8K3F2|MMP21_MOUSE Matrix metalloproteinase-21 OS=Mus musculus OX=10090 GN=Mmp21 PE=1 SV=1 MMP21_MOUSE reviewed Matrix metalloproteinase-21 (MMP-21) (EC 3.4.24.-) Mus musculus (Mouse) GO:0002244; GO:0004222; GO:0005576; GO:0006508; GO:0007368; GO:0008237; GO:0008270; GO:0030198; GO:0030574; GO:0031012; GO:0060976; GO:0061371 collagen catabolic process [GO:0030574]; coronary vasculature development [GO:0060976]; determination of heart left/right asymmetry [GO:0061371]; determination of left/right symmetry [GO:0007368]; extracellular matrix organization [GO:0030198]; hematopoietic progenitor cell differentiation [GO:0002244]; proteolysis [GO:0006508] extracellular matrix [GO:0031012]; extracellular region [GO:0005576] metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; zinc ion binding [GO:0008270] g12641.t1 P10746 35.955 267 6.88e-44 153.0 sp|P10746|HEM4_HUMAN Uroporphyrinogen-III synthase OS=Homo sapiens OX=9606 GN=Mgu PE=1 SV=1 HEM4_HUMAN reviewed Uroporphyrinogen-III synthase (UROIIIS) (UROS) (EC 4.2.1.75) (Hydroxymethylbilane hydrolyase [cyclizing]) (Uroporphyrinogen-III cosynthase) Homo sapiens (Human) GO:0004852; GO:0005542; GO:0005739; GO:0005829; GO:0006780; GO:0006782; GO:0006783; GO:0006784; GO:0006785; GO:0070541; GO:0071243; GO:0071418 cellular response to amine stimulus [GO:0071418]; cellular response to arsenic-containing substance [GO:0071243]; heme A biosynthetic process [GO:0006784]; heme B biosynthetic process [GO:0006785]; heme biosynthetic process [GO:0006783]; protoporphyrinogen IX biosynthetic process [GO:0006782]; response to platinum ion [GO:0070541]; uroporphyrinogen III biosynthetic process [GO:0006780] cytosol [GO:0005829]; mitochondrion [GO:0005739] folic acid binding [GO:0005542]; uroporphyrinogen-III synthase activity [GO:0004852] g12642.t1 Q2NL37 44.615 260 3.11e-64 208.0 sp|Q2NL37|BCCIP_BOVIN BRCA2 and CDKN1A-interacting protein OS=Bos taurus OX=9913 GN=BCCIP PE=2 SV=1 g12643.t1 Q5RAZ4 81.884 690 0.0 1167.0 sp|Q5RAZ4|DHX15_PONAB ATP-dependent RNA helicase DHX15 OS=Pongo abelii OX=9601 GN=DHX15 PE=2 SV=2 DHX15_PONAB reviewed ATP-dependent RNA helicase DHX15 (EC 3.6.4.13) (DEAH box protein 15) Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0003724; GO:0003725; GO:0005524; GO:0005689; GO:0005730; GO:0006397; GO:0008380; GO:0016607; GO:0016887; GO:0042742; GO:0043123; GO:0051607; GO:0071008; GO:0140374 antiviral innate immune response [GO:0140374]; defense response to bacterium [GO:0042742]; defense response to virus [GO:0051607]; mRNA processing [GO:0006397]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; RNA splicing [GO:0008380] nuclear speck [GO:0016607]; nucleolus [GO:0005730]; U12-type spliceosomal complex [GO:0005689]; U2-type post-mRNA release spliceosomal complex [GO:0071008] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; double-stranded RNA binding [GO:0003725]; RNA helicase activity [GO:0003724] g12644.t1 Q9NY93 56.801 544 0.0 587.0 sp|Q9NY93|DDX56_HUMAN Probable ATP-dependent RNA helicase DDX56 OS=Homo sapiens OX=9606 GN=DDX56 PE=1 SV=1 DDX56_HUMAN reviewed Probable ATP-dependent RNA helicase DDX56 (EC 3.6.4.13) (ATP-dependent 61 kDa nucleolar RNA helicase) (DEAD box protein 21) (DEAD box protein 56) Homo sapiens (Human) GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005730; GO:0005829; GO:0006364; GO:0010976; GO:0016020; GO:0016887; GO:0032480; GO:0035613; GO:0044830; GO:0051607; GO:0140311 defense response to virus [GO:0051607]; host-mediated perturbation of viral RNA genome replication [GO:0044830]; negative regulation of type I interferon production [GO:0032480]; positive regulation of neuron projection development [GO:0010976]; rRNA processing [GO:0006364] cytosol [GO:0005829]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleus [GO:0005634] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; protein sequestering activity [GO:0140311]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; RNA stem-loop binding [GO:0035613] g12645.t1 Q9P0J7 60.641 343 8.4e-130 380.0 sp|Q9P0J7|KCMF1_HUMAN E3 ubiquitin-protein ligase KCMF1 OS=Homo sapiens OX=9606 GN=KCMF1 PE=1 SV=2 KCMF1_HUMAN reviewed E3 ubiquitin-protein ligase KCMF1 (EC 2.3.2.27) (FGF-induced in gastric cancer) (Potassium channel modulatory factor) (PCMF) (ZZ-type zinc finger-containing protein 1) Homo sapiens (Human) GO:0005576; GO:0005737; GO:0005764; GO:0005770; GO:0005829; GO:0005886; GO:0006511; GO:0006979; GO:0008270; GO:0043161; GO:0045202; GO:0061630; GO:0070534; GO:0070936; GO:0099536; GO:0141191; GO:1904813 negative regulation of HRI-mediated signaling [GO:0141191]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K48-linked ubiquitination [GO:0070936]; protein K63-linked ubiquitination [GO:0070534]; response to oxidative stress [GO:0006979]; synaptic signaling [GO:0099536]; ubiquitin-dependent protein catabolic process [GO:0006511] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; late endosome [GO:0005770]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; synapse [GO:0045202] ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] g12646.t1 P11348 58.921 241 1.07e-85 257.0 sp|P11348|DHPR_RAT Dihydropteridine reductase OS=Rattus norvegicus OX=10116 GN=Qdpr PE=1 SV=1 DHPR_RAT reviewed Dihydropteridine reductase (EC 1.5.1.34) (HDHPR) (Quinoid dihydropteridine reductase) Rattus norvegicus (Rat) GO:0001889; GO:0004155; GO:0005737; GO:0006559; GO:0006729; GO:0010044; GO:0010288; GO:0033762; GO:0042802; GO:0070402; GO:0070404; GO:0071466 cellular response to xenobiotic stimulus [GO:0071466]; L-phenylalanine catabolic process [GO:0006559]; liver development [GO:0001889]; response to aluminum ion [GO:0010044]; response to glucagon [GO:0033762]; response to lead ion [GO:0010288]; tetrahydrobiopterin biosynthetic process [GO:0006729] cytoplasm [GO:0005737] 6,7-dihydropteridine reductase activity [GO:0004155]; identical protein binding [GO:0042802]; NADH binding [GO:0070404]; NADPH binding [GO:0070402] g12647.t1 Q7TT36 32.473 1201 3.8100000000000004e-166 532.0 sp|Q7TT36|AGRA3_MOUSE Adhesion G protein-coupled receptor A3 OS=Mus musculus OX=10090 GN=Adgra3 PE=2 SV=3 g12650.t1 Q9EPZ8 36.264 455 1.69e-87 285.0 sp|Q9EPZ8|RN103_RAT E3 ubiquitin-protein ligase RNF103 OS=Rattus norvegicus OX=10116 GN=Rnf103 PE=2 SV=1 g12653.t1 Q5RBI7 46.818 220 1.3199999999999998e-52 205.0 sp|Q5RBI7|PDZD7_PONAB PDZ domain-containing protein 7 OS=Pongo abelii OX=9601 GN=PDZD7 PE=2 SV=2 g12653.t1 Q5RBI7 45.669 127 2.39e-22 108.0 sp|Q5RBI7|PDZD7_PONAB PDZ domain-containing protein 7 OS=Pongo abelii OX=9601 GN=PDZD7 PE=2 SV=2 g12653.t2 Q5RBI7 46.818 220 4.7e-52 203.0 sp|Q5RBI7|PDZD7_PONAB PDZ domain-containing protein 7 OS=Pongo abelii OX=9601 GN=PDZD7 PE=2 SV=2 g12657.t1 Q5R416 67.473 910 0.0 1168.0 sp|Q5R416|CTNA2_PONAB Catenin alpha-2 OS=Pongo abelii OX=9601 GN=CTNNA2 PE=2 SV=3 CTNA2_PONAB reviewed Catenin alpha-2 (Alpha N-catenin) Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0005198; GO:0005634; GO:0005737; GO:0005912; GO:0007409; GO:0008013; GO:0010975; GO:0015629; GO:0016342; GO:0021942; GO:0030424; GO:0034316; GO:0045296; GO:0048813; GO:0048854; GO:0051015; GO:0051823; GO:0060134; GO:0098609; GO:2001222 axonogenesis [GO:0007409]; brain morphogenesis [GO:0048854]; cell-cell adhesion [GO:0098609]; dendrite morphogenesis [GO:0048813]; negative regulation of Arp2/3 complex-mediated actin nucleation [GO:0034316]; prepulse inhibition [GO:0060134]; radial glia guided migration of Purkinje cell [GO:0021942]; regulation of neuron migration [GO:2001222]; regulation of neuron projection development [GO:0010975]; regulation of synapse structural plasticity [GO:0051823] actin cytoskeleton [GO:0015629]; adherens junction [GO:0005912]; axon [GO:0030424]; catenin complex [GO:0016342]; cytoplasm [GO:0005737]; nucleus [GO:0005634] actin filament binding [GO:0051015]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; structural molecule activity [GO:0005198] g12658.t1 Q28H54 38.583 381 1.0300000000000001e-71 233.0 sp|Q28H54|CEPT1_XENTR Choline/ethanolaminephosphotransferase 1 OS=Xenopus tropicalis OX=8364 GN=cept1 PE=2 SV=1 CEPT1_XENTR reviewed Choline/ethanolaminephosphotransferase 1 (EC 2.7.8.1) (EC 2.7.8.2) (1-alkenyl-2-acylglycerol choline phosphotransferase) (EC 2.7.8.22) Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0004142; GO:0004307; GO:0005789; GO:0006646; GO:0031965; GO:0046872; GO:0047359 phosphatidylethanolamine biosynthetic process [GO:0006646] endoplasmic reticulum membrane [GO:0005789]; nuclear membrane [GO:0031965] 1-alkenyl-2-acylglycerol choline phosphotransferase activity [GO:0047359]; diacylglycerol cholinephosphotransferase activity [GO:0004142]; ethanolaminephosphotransferase activity [GO:0004307]; metal ion binding [GO:0046872] g12659.t1 P80146 44.643 392 2.64e-96 297.0 sp|P80146|SEPR_THESR Extracellular serine proteinase OS=Thermus sp. (strain Rt41A) OX=32063 PE=1 SV=3 g12659.t2 P80146 44.643 392 2.64e-96 297.0 sp|P80146|SEPR_THESR Extracellular serine proteinase OS=Thermus sp. (strain Rt41A) OX=32063 PE=1 SV=3 g12661.t1 P36512 40.0 115 4.4299999999999994e-23 96.7 sp|P36512|UDB13_RABIT UDP-glucuronosyltransferase 2B13 OS=Oryctolagus cuniculus OX=9986 GN=UGT2B13 PE=2 SV=1 g12662.t1 Q68EF4 31.114 871 1.14e-124 402.0 sp|Q68EF4|GRM4_MOUSE Metabotropic glutamate receptor 4 OS=Mus musculus OX=10090 GN=Grm4 PE=1 SV=2 GRM4_MOUSE reviewed Metabotropic glutamate receptor 4 (mGluR4) Mus musculus (Mouse) GO:0001640; GO:0001642; GO:0004930; GO:0005516; GO:0005886; GO:0007193; GO:0007196; GO:0007216; GO:0007268; GO:0007612; GO:0008066; GO:0031410; GO:0043005; GO:0043195; GO:0043198; GO:0043410; GO:0048306; GO:0048787; GO:0051966; GO:0098688; GO:0098978; GO:0099171; GO:0150048 adenylate cyclase-inhibiting G protein-coupled glutamate receptor signaling pathway [GO:0007196]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; chemical synaptic transmission [GO:0007268]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; learning [GO:0007612]; positive regulation of MAPK cascade [GO:0043410]; presynaptic modulation of chemical synaptic transmission [GO:0099171]; regulation of synaptic transmission, glutamatergic [GO:0051966] cerebellar granule cell to Purkinje cell synapse [GO:0150048]; cytoplasmic vesicle [GO:0031410]; dendritic shaft [GO:0043198]; glutamatergic synapse [GO:0098978]; neuron projection [GO:0043005]; parallel fiber to Purkinje cell synapse [GO:0098688]; plasma membrane [GO:0005886]; presynaptic active zone membrane [GO:0048787]; terminal bouton [GO:0043195] adenylate cyclase inhibiting G protein-coupled glutamate receptor activity [GO:0001640]; calcium-dependent protein binding [GO:0048306]; calmodulin binding [GO:0005516]; G protein-coupled receptor activity [GO:0004930]; glutamate receptor activity [GO:0008066]; group III metabotropic glutamate receptor activity [GO:0001642] g12663.t1 Q9D3X5 59.5 200 1.7200000000000002e-73 226.0 sp|Q9D3X5|PACRL_MOUSE PACRG-like protein OS=Mus musculus OX=10090 GN=Pacrgl PE=1 SV=1 g12664.t1 Q8IYW2 42.222 270 1.5999999999999999e-62 219.0 sp|Q8IYW2|CFA46_HUMAN Cilia- and flagella-associated protein 46 OS=Homo sapiens OX=9606 GN=CFAP46 PE=1 SV=3 g12665.t1 Q8IYW2 42.363 982 0.0 766.0 sp|Q8IYW2|CFA46_HUMAN Cilia- and flagella-associated protein 46 OS=Homo sapiens OX=9606 GN=CFAP46 PE=1 SV=3 g12665.t1 Q8IYW2 27.869 1281 7.79e-101 368.0 sp|Q8IYW2|CFA46_HUMAN Cilia- and flagella-associated protein 46 OS=Homo sapiens OX=9606 GN=CFAP46 PE=1 SV=3 g12665.t2 Q8IYW2 41.534 1004 0.0 756.0 sp|Q8IYW2|CFA46_HUMAN Cilia- and flagella-associated protein 46 OS=Homo sapiens OX=9606 GN=CFAP46 PE=1 SV=3 g12665.t2 Q8IYW2 27.869 1281 1e-100 367.0 sp|Q8IYW2|CFA46_HUMAN Cilia- and flagella-associated protein 46 OS=Homo sapiens OX=9606 GN=CFAP46 PE=1 SV=3 g12666.t1 A5PJW8 85.852 933 0.0 1708.0 sp|A5PJW8|RPB2_BOVIN DNA-directed RNA polymerase II subunit RPB2 OS=Bos taurus OX=9913 GN=POLR2B PE=1 SV=1 RPB2_BOVIN reviewed DNA-directed RNA polymerase II subunit RPB2 (EC 2.7.7.6) (3'-5' exoribonuclease) (EC 3.1.13.-) (RNA-directed RNA polymerase II subunit RPB2) (EC 2.7.7.48) Bos taurus (Bovine) GO:0000781; GO:0003677; GO:0003682; GO:0003899; GO:0003968; GO:0005665; GO:0006366; GO:0008270; GO:0016787; GO:0032549; GO:0071667 transcription by RNA polymerase II [GO:0006366] chromosome, telomeric region [GO:0000781]; RNA polymerase II, core complex [GO:0005665] chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-directed RNA polymerase activity [GO:0003899]; DNA/RNA hybrid binding [GO:0071667]; hydrolase activity [GO:0016787]; ribonucleoside binding [GO:0032549]; RNA-directed RNA polymerase activity [GO:0003968]; zinc ion binding [GO:0008270] g12667.t1 Q8CFI7 86.061 165 4.29e-96 305.0 sp|Q8CFI7|RPB2_MOUSE DNA-directed RNA polymerase II subunit RPB2 OS=Mus musculus OX=10090 GN=Polr2b PE=1 SV=2 RPB2_MOUSE reviewed DNA-directed RNA polymerase II subunit RPB2 (EC 2.7.7.6) (3'-5' exoribonuclease) (EC 3.1.13.-) (DNA-directed RNA polymerase II 140 kDa polypeptide) (DNA-directed RNA polymerase II subunit B) (RNA polymerase II subunit 2) (RNA polymerase II subunit B2) (RNA-directed RNA polymerase II subunit RPB2) (EC 2.7.7.48) Mus musculus (Mouse) GO:0000781; GO:0003677; GO:0003682; GO:0003899; GO:0003968; GO:0005634; GO:0005654; GO:0005665; GO:0006366; GO:0008270; GO:0016787; GO:0032549 transcription by RNA polymerase II [GO:0006366] chromosome, telomeric region [GO:0000781]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II, core complex [GO:0005665] chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-directed RNA polymerase activity [GO:0003899]; hydrolase activity [GO:0016787]; ribonucleoside binding [GO:0032549]; RNA-directed RNA polymerase activity [GO:0003968]; zinc ion binding [GO:0008270] g12669.t1 Q29RT6 39.658 643 4.95e-135 427.0 sp|Q29RT6|KI20A_BOVIN Kinesin-like protein KIF20A OS=Bos taurus OX=9913 GN=KIF20A PE=2 SV=1 KI20A_BOVIN reviewed Kinesin-like protein KIF20A Bos taurus (Bovine) GO:0000281; GO:0001578; GO:0003777; GO:0005524; GO:0005634; GO:0005737; GO:0005794; GO:0005819; GO:0005871; GO:0005874; GO:0007018; GO:0008017; GO:0015031; GO:0016887; GO:0030496; GO:0032465; GO:0061952 microtubule bundle formation [GO:0001578]; microtubule-based movement [GO:0007018]; midbody abscission [GO:0061952]; mitotic cytokinesis [GO:0000281]; protein transport [GO:0015031]; regulation of cytokinesis [GO:0032465] cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; midbody [GO:0030496]; nucleus [GO:0005634]; spindle [GO:0005819] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777] g12671.t1 Q3SZ21 44.583 240 2.1399999999999998e-67 215.0 sp|Q3SZ21|RPP30_BOVIN Ribonuclease P protein subunit p30 OS=Bos taurus OX=9913 GN=RPP30 PE=2 SV=1 RPP30_BOVIN reviewed Ribonuclease P protein subunit p30 (RNaseP protein p30) (RNase P subunit 2) Bos taurus (Bovine) GO:0000172; GO:0001682; GO:0003723; GO:0004526; GO:0005655; GO:0006364; GO:0008033; GO:0033204 rRNA processing [GO:0006364]; tRNA 5'-leader removal [GO:0001682]; tRNA processing [GO:0008033] nucleolar ribonuclease P complex [GO:0005655]; ribonuclease MRP complex [GO:0000172] ribonuclease P activity [GO:0004526]; ribonuclease P RNA binding [GO:0033204]; RNA binding [GO:0003723] g12672.t1 Q9BVG4 59.06 149 1.4199999999999998e-61 193.0 sp|Q9BVG4|PBDC1_HUMAN Protein PBDC1 OS=Homo sapiens OX=9606 GN=PBDC1 PE=1 SV=1 g12673.t1 Q3ULA2 74.409 508 0.0 787.0 sp|Q3ULA2|FBW1A_MOUSE F-box/WD repeat-containing protein 1A OS=Mus musculus OX=10090 GN=Btrc PE=1 SV=2 FBW1A_MOUSE reviewed F-box/WD repeat-containing protein 1A (Beta-TrCP protein E3RS-IkappaB) (Beta-transducin repeat-containing protein) (Beta-TrCP) (E3RSIkappaB) (mE3RS-IkappaB) (F-box and WD repeats protein beta-TrCP) (HOS) (Ubiquitin ligase FWD1) (pIkappaB-E3 receptor subunit) Mus musculus (Mouse) GO:0000045; GO:0000209; GO:0004842; GO:0005634; GO:0005737; GO:0005829; GO:0006470; GO:0006508; GO:0006511; GO:0007040; GO:0008013; GO:0010507; GO:0010508; GO:0016055; GO:0016567; GO:0019005; GO:0030163; GO:0031146; GO:0031648; GO:0031669; GO:0033598; GO:0038061; GO:0038202; GO:0042752; GO:0042753; GO:0043122; GO:0043161; GO:0045309; GO:0045862; GO:0045893; GO:0046983; GO:0048511; GO:0050852; GO:0050860; GO:0050862; GO:0051726; GO:0060444; GO:0060828; GO:0061136; GO:0061630; GO:0070534; GO:0070936; GO:1904262; GO:1990756; GO:1990757 autophagosome assembly [GO:0000045]; branching involved in mammary gland duct morphogenesis [GO:0060444]; cellular response to nutrient levels [GO:0031669]; lysosome organization [GO:0007040]; mammary gland epithelial cell proliferation [GO:0033598]; negative regulation of autophagy [GO:0010507]; negative regulation of T cell receptor signaling pathway [GO:0050860]; negative regulation of TORC1 signaling [GO:1904262]; non-canonical NF-kappaB signal transduction [GO:0038061]; positive regulation of autophagy [GO:0010508]; positive regulation of circadian rhythm [GO:0042753]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of proteolysis [GO:0045862]; positive regulation of T cell receptor signaling pathway [GO:0050862]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein catabolic process [GO:0030163]; protein dephosphorylation [GO:0006470]; protein destabilization [GO:0031648]; protein K48-linked ubiquitination [GO:0070936]; protein K63-linked ubiquitination [GO:0070534]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; proteolysis [GO:0006508]; regulation of canonical NF-kappaB signal transduction [GO:0043122]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; regulation of proteasomal protein catabolic process [GO:0061136]; rhythmic process [GO:0048511]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; T cell receptor signaling pathway [GO:0050852]; TORC1 signaling [GO:0038202]; ubiquitin-dependent protein catabolic process [GO:0006511]; Wnt signaling pathway [GO:0016055] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005] beta-catenin binding [GO:0008013]; protein dimerization activity [GO:0046983]; protein phosphorylated amino acid binding [GO:0045309]; ubiquitin ligase activator activity [GO:1990757]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-like ligase-substrate adaptor activity [GO:1990756]; ubiquitin-protein transferase activity [GO:0004842] g12674.t1 Q76NI1 38.193 631 2.98e-105 377.0 sp|Q76NI1|KNDC1_HUMAN Kinase non-catalytic C-lobe domain-containing protein 1 OS=Homo sapiens OX=9606 GN=KNDC1 PE=1 SV=2 KNDC1_HUMAN reviewed Kinase non-catalytic C-lobe domain-containing protein 1 (KIND domain-containing protein 1) (Cerebral protein 9) (Protein very KIND) (v-KIND) (Ras-GEF domain-containing family member 2) Homo sapiens (Human) GO:0005085; GO:0007264; GO:0021707; GO:0030425; GO:0032045; GO:0043025; GO:0043204; GO:0048814; GO:0050773 cerebellar granule cell differentiation [GO:0021707]; regulation of dendrite development [GO:0050773]; regulation of dendrite morphogenesis [GO:0048814]; small GTPase-mediated signal transduction [GO:0007264] dendrite [GO:0030425]; guanyl-nucleotide exchange factor complex [GO:0032045]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204] guanyl-nucleotide exchange factor activity [GO:0005085] g12675.t1 Q0KK55 42.781 187 3.81e-33 137.0 sp|Q0KK55|KNDC1_MOUSE Kinase non-catalytic C-lobe domain-containing protein 1 OS=Mus musculus OX=10090 GN=Kndc1 PE=1 SV=2 KNDC1_MOUSE reviewed Kinase non-catalytic C-lobe domain-containing protein 1 (KIND domain-containing protein 1) (Protein very KIND) (v-KIND) (Ras-GEF domain-containing family member 2) Mus musculus (Mouse) GO:0005085; GO:0007264; GO:0021707; GO:0030425; GO:0032045; GO:0043025; GO:0043204; GO:0048814; GO:0050773 cerebellar granule cell differentiation [GO:0021707]; regulation of dendrite development [GO:0050773]; regulation of dendrite morphogenesis [GO:0048814]; small GTPase-mediated signal transduction [GO:0007264] dendrite [GO:0030425]; guanyl-nucleotide exchange factor complex [GO:0032045]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204] guanyl-nucleotide exchange factor activity [GO:0005085] g12676.t1 O93295 32.723 437 2.07e-67 226.0 sp|O93295|ENTP8_CHICK Ectonucleoside triphosphate diphosphohydrolase 8 OS=Gallus gallus OX=9031 GN=ENTPD8 PE=1 SV=1 g12680.t1 Q9MYM7 35.862 290 1.5599999999999999e-52 186.0 sp|Q9MYM7|B3GT1_PONPY Beta-1,3-galactosyltransferase 1 OS=Pongo pygmaeus OX=9600 GN=B3GALT1 PE=3 SV=1 g12680.t1 Q9MYM7 32.8 250 2.18e-37 144.0 sp|Q9MYM7|B3GT1_PONPY Beta-1,3-galactosyltransferase 1 OS=Pongo pygmaeus OX=9600 GN=B3GALT1 PE=3 SV=1 g12681.t1 Q6ZMB0 35.714 266 3.31e-49 179.0 sp|Q6ZMB0|B3GN6_HUMAN Acetylgalactosaminyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase OS=Homo sapiens OX=9606 GN=B3GNT6 PE=1 SV=2 B3GN6_HUMAN reviewed Acetylgalactosaminyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase (EC 2.4.1.147) (Core 3 synthase) (UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 6) (BGnT-6) (Beta-1,3-Gn-T6) (Beta-1,3-N-acetylglucosaminyltransferase 6) (Beta3Gn-T6) Homo sapiens (Human) GO:0000139; GO:0006493; GO:0008194; GO:0008378; GO:0008499; GO:0009101; GO:0016020; GO:0016266; GO:0030311; GO:0047223; GO:0047224 glycoprotein biosynthetic process [GO:0009101]; poly-N-acetyllactosamine biosynthetic process [GO:0030311]; protein O-linked glycosylation [GO:0006493]; protein O-linked glycosylation via N-acetyl-galactosamine [GO:0016266] Golgi membrane [GO:0000139]; membrane [GO:0016020] acetylgalactosaminyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity [GO:0047224]; beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity [GO:0047223]; galactosyltransferase activity [GO:0008378]; N-acetyl-beta-D-glucosaminide beta-(1,3)-galactosyltransferase activity [GO:0008499]; UDP-glycosyltransferase activity [GO:0008194] g12682.t1 Q8NFL0 33.772 228 3.9299999999999995e-40 152.0 sp|Q8NFL0|B3GN7_HUMAN UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7 OS=Homo sapiens OX=9606 GN=B3GNT7 PE=1 SV=1 B3GN7_HUMAN reviewed UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7 (BGnT-7) (Beta-1,3-Gn-T7) (Beta-1,3-N-acetylglucosaminyltransferase 7) (Beta3Gn-T7) (EC 2.4.1.-) Homo sapiens (Human) GO:0000139; GO:0006493; GO:0008194; GO:0008375; GO:0008532; GO:0018146; GO:0030311 keratan sulfate proteoglycan biosynthetic process [GO:0018146]; poly-N-acetyllactosamine biosynthetic process [GO:0030311]; protein O-linked glycosylation [GO:0006493] Golgi membrane [GO:0000139] acetylglucosaminyltransferase activity [GO:0008375]; N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity [GO:0008532]; UDP-glycosyltransferase activity [GO:0008194] g12683.t1 P12717 100.0 376 0.0 778.0 sp|P12717|ACTM_PISOC Actin, muscle OS=Pisaster ochraceus OX=7612 PE=3 SV=1 g12685.t1 Q9Y2C3 31.636 275 8.339999999999999e-38 144.0 sp|Q9Y2C3|B3GT5_HUMAN Beta-1,3-galactosyltransferase 5 OS=Homo sapiens OX=9606 GN=B3GALT5 PE=1 SV=1 B3GT5_HUMAN reviewed Beta-1,3-galactosyltransferase 5 (Beta-1,3-GalTase 5) (Beta3Gal-T5) (Beta3GalT5) (b3Gal-T5) (EC 2.4.1.-) (Beta-3-Gx-T5) (UDP-Gal:beta-GlcNAc beta-1,3-galactosyltransferase 5) (UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase 5) Homo sapiens (Human) GO:0000139; GO:0005783; GO:0005794; GO:0006493; GO:0006629; GO:0008499; GO:0009101; GO:0009312; GO:0009617 glycoprotein biosynthetic process [GO:0009101]; lipid metabolic process [GO:0006629]; oligosaccharide biosynthetic process [GO:0009312]; protein O-linked glycosylation [GO:0006493]; response to bacterium [GO:0009617] endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139] N-acetyl-beta-D-glucosaminide beta-(1,3)-galactosyltransferase activity [GO:0008499] g12687.t1 Q6PD19 60.496 686 0.0 817.0 sp|Q6PD19|ARMD3_MOUSE Armadillo-like helical domain-containing protein 3 OS=Mus musculus OX=10090 GN=Armh3 PE=1 SV=2 ARMD3_MOUSE reviewed Armadillo-like helical domain-containing protein 3 Mus musculus (Mouse) GO:0000139; GO:0005794; GO:0005829; GO:0006895; GO:0009615; GO:0045184; GO:0048471; GO:0072376; GO:1903358 establishment of protein localization [GO:0045184]; Golgi to endosome transport [GO:0006895]; protein activation cascade [GO:0072376]; regulation of Golgi organization [GO:1903358]; response to virus [GO:0009615] cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; perinuclear region of cytoplasm [GO:0048471] g12691.t1 Q8HYN7 66.489 188 2.38e-97 285.0 sp|Q8HYN7|KCIP4_MACFA Kv channel-interacting protein 4 OS=Macaca fascicularis OX=9541 GN=KCNIP4 PE=2 SV=1 g12694.t1 P35384 34.783 322 2.2000000000000002e-29 129.0 sp|P35384|CASR_BOVIN Extracellular calcium-sensing receptor OS=Bos taurus OX=9913 GN=CASR PE=2 SV=1 CASR_BOVIN reviewed Extracellular calcium-sensing receptor (CaSR) (Parathyroid cell calcium-sensing receptor) (BoPCaR1) (PCaR1) Bos taurus (Bovine) GO:0001503; GO:0004930; GO:0005509; GO:0005513; GO:0005886; GO:0006816; GO:0006874; GO:0007186; GO:0007193; GO:0007200; GO:0007254; GO:0008284; GO:0010628; GO:0016597; GO:0042311; GO:0042803; GO:0043679; GO:0051924; GO:0098978; GO:0099505; GO:1900227 adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; calcium ion transport [GO:0006816]; detection of calcium ion [GO:0005513]; G protein-coupled receptor signaling pathway [GO:0007186]; intracellular calcium ion homeostasis [GO:0006874]; JNK cascade [GO:0007254]; ossification [GO:0001503]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of NLRP3 inflammasome complex assembly [GO:1900227]; regulation of calcium ion transport [GO:0051924]; regulation of presynaptic membrane potential [GO:0099505]; vasodilation [GO:0042311] axon terminus [GO:0043679]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886] amino acid binding [GO:0016597]; calcium ion binding [GO:0005509]; G protein-coupled receptor activity [GO:0004930]; protein homodimerization activity [GO:0042803] g12696.t1 Q6P5B0 44.948 861 0.0 616.0 sp|Q6P5B0|RRP12_MOUSE RRP12-like protein OS=Mus musculus OX=10090 GN=Rrp12 PE=1 SV=1 g12698.t1 Q5ZKD5 50.763 459 1.1700000000000001e-154 475.0 sp|Q5ZKD5|RRP12_CHICK RRP12-like protein OS=Gallus gallus OX=9031 GN=RRP12 PE=2 SV=1 g12700.t1 Q9YGD2 77.667 300 1.09e-136 393.0 sp|Q9YGD2|SUCA_COLLI Succinate--CoA ligase [ADP/GDP-forming] subunit alpha, mitochondrial (Fragment) OS=Columba livia OX=8932 GN=SUCLG1 PE=1 SV=1 g12701.t1 O95271 68.644 236 1.5e-112 353.0 sp|O95271|TNKS1_HUMAN Poly [ADP-ribose] polymerase tankyrase-1 OS=Homo sapiens OX=9606 GN=TNKS PE=1 SV=2 TNKS1_HUMAN reviewed Poly [ADP-ribose] polymerase tankyrase-1 (EC 2.4.2.30) (ADP-ribosyltransferase diphtheria toxin-like 5) (ARTD5) (Poly [ADP-ribose] polymerase 5A) (Protein poly-ADP-ribosyltransferase tankyrase-1) (EC 2.4.2.-) (TNKS-1) (TRF1-interacting ankyrin-related ADP-ribose polymerase) (Tankyrase I) (Tankyrase-1) (TANK1) Homo sapiens (Human) GO:0000139; GO:0000209; GO:0000242; GO:0000781; GO:0003950; GO:0005634; GO:0005643; GO:0005654; GO:0005737; GO:0005794; GO:0005829; GO:0007052; GO:0008270; GO:0010521; GO:0015031; GO:0016055; GO:0016604; GO:0016779; GO:0018105; GO:0018107; GO:0031965; GO:0032210; GO:0032212; GO:0042393; GO:0045944; GO:0051028; GO:0051225; GO:0051301; GO:0070198; GO:0070212; GO:0070213; GO:0090263; GO:0097431; GO:0140806; GO:0140807; GO:1904355; GO:1904357; GO:1904358; GO:1904908; GO:1990404 cell division [GO:0051301]; mitotic spindle organization [GO:0007052]; mRNA transport [GO:0051028]; negative regulation of maintenance of mitotic sister chromatid cohesion, telomeric [GO:1904908]; negative regulation of telomere maintenance via telomere lengthening [GO:1904357]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of telomere capping [GO:1904355]; positive regulation of telomere maintenance via telomerase [GO:0032212]; positive regulation of telomere maintenance via telomere lengthening [GO:1904358]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein auto-ADP-ribosylation [GO:0070213]; protein localization to chromosome, telomeric region [GO:0070198]; protein poly-ADP-ribosylation [GO:0070212]; protein polyubiquitination [GO:0000209]; protein transport [GO:0015031]; regulation of telomere maintenance via telomerase [GO:0032210]; spindle assembly [GO:0051225]; Wnt signaling pathway [GO:0016055] chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; mitotic spindle pole [GO:0097431]; nuclear body [GO:0016604]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pericentriolar material [GO:0000242] histone binding [GO:0042393]; NAD+ poly-ADP-ribosyltransferase activity [GO:0003950]; NAD+-protein mono-ADP-ribosyltransferase activity [GO:1990404]; NAD+-protein-aspartate ADP-ribosyltransferase activity [GO:0140806]; NAD+-protein-glutamate ADP-ribosyltransferase activity [GO:0140807]; nucleotidyltransferase activity [GO:0016779]; telomerase inhibitor activity [GO:0010521]; zinc ion binding [GO:0008270] g12702.t1 Q86WI1 41.304 874 0.0 647.0 sp|Q86WI1|PKHL1_HUMAN Fibrocystin-L OS=Homo sapiens OX=9606 GN=PKHD1L1 PE=1 SV=2 PKHL1_HUMAN reviewed Fibrocystin-L (Polycystic kidney and hepatic disease 1-like protein 1) (PKHD1-like protein 1) Homo sapiens (Human) GO:0005615; GO:0005829; GO:0006955; GO:0007605; GO:0016020; GO:0032426; GO:0038023; GO:0060171; GO:0120234 immune response [GO:0006955]; sensory perception of sound [GO:0007605] cytosol [GO:0005829]; extracellular space [GO:0005615]; membrane [GO:0016020]; stereocilium coat [GO:0120234]; stereocilium membrane [GO:0060171]; stereocilium tip [GO:0032426] signaling receptor activity [GO:0038023] g12703.t1 Q86WI1 39.031 3282 0.0 2104.0 sp|Q86WI1|PKHL1_HUMAN Fibrocystin-L OS=Homo sapiens OX=9606 GN=PKHD1L1 PE=1 SV=2 PKHL1_HUMAN reviewed Fibrocystin-L (Polycystic kidney and hepatic disease 1-like protein 1) (PKHD1-like protein 1) Homo sapiens (Human) GO:0005615; GO:0005829; GO:0006955; GO:0007605; GO:0016020; GO:0032426; GO:0038023; GO:0060171; GO:0120234 immune response [GO:0006955]; sensory perception of sound [GO:0007605] cytosol [GO:0005829]; extracellular space [GO:0005615]; membrane [GO:0016020]; stereocilium coat [GO:0120234]; stereocilium membrane [GO:0060171]; stereocilium tip [GO:0032426] signaling receptor activity [GO:0038023] g12703.t1 Q86WI1 27.366 486 1.68e-26 124.0 sp|Q86WI1|PKHL1_HUMAN Fibrocystin-L OS=Homo sapiens OX=9606 GN=PKHD1L1 PE=1 SV=2 PKHL1_HUMAN reviewed Fibrocystin-L (Polycystic kidney and hepatic disease 1-like protein 1) (PKHD1-like protein 1) Homo sapiens (Human) GO:0005615; GO:0005829; GO:0006955; GO:0007605; GO:0016020; GO:0032426; GO:0038023; GO:0060171; GO:0120234 immune response [GO:0006955]; sensory perception of sound [GO:0007605] cytosol [GO:0005829]; extracellular space [GO:0005615]; membrane [GO:0016020]; stereocilium coat [GO:0120234]; stereocilium membrane [GO:0060171]; stereocilium tip [GO:0032426] signaling receptor activity [GO:0038023] g12704.t1 Q9NYB5 29.128 642 3.96e-84 283.0 sp|Q9NYB5|SO1C1_HUMAN Solute carrier organic anion transporter family member 1C1 OS=Homo sapiens OX=9606 GN=SLCO1C1 PE=1 SV=1 g12705.t1 Q5SNX7 54.685 651 0.0 646.0 sp|Q5SNX7|GALC_DANRE Galactocerebrosidase OS=Danio rerio OX=7955 GN=galc PE=2 SV=1 GALC_DANRE reviewed Galactocerebrosidase (GALCERase) (EC 3.2.1.46) (Galactosylceramidase) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0004336; GO:0005764; GO:0006683; GO:0016020 galactosylceramide catabolic process [GO:0006683] lysosome [GO:0005764]; membrane [GO:0016020] galactosylceramidase activity [GO:0004336] g12705.t2 Q498K0 54.423 667 0.0 654.0 sp|Q498K0|GALC_XENLA Galactocerebrosidase OS=Xenopus laevis OX=8355 GN=galc PE=2 SV=2 g12705.t3 Q498K0 63.519 233 1.09e-81 260.0 sp|Q498K0|GALC_XENLA Galactocerebrosidase OS=Xenopus laevis OX=8355 GN=galc PE=2 SV=2 g12705.t4 B5X3C1 50.102 491 4.81e-148 442.0 sp|B5X3C1|GALC_SALSA Galactocerebrosidase OS=Salmo salar OX=8030 GN=galc PE=2 SV=1 g12706.t1 Q01085 55.516 281 1.02e-98 303.0 sp|Q01085|TIAR_HUMAN Nucleolysin TIAR OS=Homo sapiens OX=9606 GN=TIAL1 PE=1 SV=1 TIAR_HUMAN reviewed Nucleolysin TIAR (TIA-1-related protein) Homo sapiens (Human) GO:0003677; GO:0003723; GO:0003730; GO:0005634; GO:0005654; GO:0005737; GO:0005764; GO:0005829; GO:0006357; GO:0006915; GO:0006952; GO:0008285; GO:0010494; GO:0035332; GO:0044194; GO:0140517; GO:2000637 apoptotic process [GO:0006915]; defense response [GO:0006952]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of hippo signaling [GO:0035332]; positive regulation of miRNA-mediated gene silencing [GO:2000637]; regulation of transcription by RNA polymerase II [GO:0006357] cytolytic granule [GO:0044194]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; lysosome [GO:0005764]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] DNA binding [GO:0003677]; mRNA 3'-UTR binding [GO:0003730]; protein-RNA adaptor activity [GO:0140517]; RNA binding [GO:0003723] g12706.t2 Q01085 56.115 278 8.03e-101 308.0 sp|Q01085|TIAR_HUMAN Nucleolysin TIAR OS=Homo sapiens OX=9606 GN=TIAL1 PE=1 SV=1 TIAR_HUMAN reviewed Nucleolysin TIAR (TIA-1-related protein) Homo sapiens (Human) GO:0003677; GO:0003723; GO:0003730; GO:0005634; GO:0005654; GO:0005737; GO:0005764; GO:0005829; GO:0006357; GO:0006915; GO:0006952; GO:0008285; GO:0010494; GO:0035332; GO:0044194; GO:0140517; GO:2000637 apoptotic process [GO:0006915]; defense response [GO:0006952]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of hippo signaling [GO:0035332]; positive regulation of miRNA-mediated gene silencing [GO:2000637]; regulation of transcription by RNA polymerase II [GO:0006357] cytolytic granule [GO:0044194]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; lysosome [GO:0005764]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] DNA binding [GO:0003677]; mRNA 3'-UTR binding [GO:0003730]; protein-RNA adaptor activity [GO:0140517]; RNA binding [GO:0003723] g12709.t1 P78312 30.855 269 4.01e-28 127.0 sp|P78312|F193A_HUMAN Protein FAM193A OS=Homo sapiens OX=9606 GN=FAM193A PE=1 SV=2 F193A_HUMAN reviewed Protein FAM193A (Protein IT14) Homo sapiens (Human) g12709.t2 P78312 30.597 268 8.2e-28 126.0 sp|P78312|F193A_HUMAN Protein FAM193A OS=Homo sapiens OX=9606 GN=FAM193A PE=1 SV=2 F193A_HUMAN reviewed Protein FAM193A (Protein IT14) Homo sapiens (Human) g12710.t1 P30937 44.906 265 3.93e-68 220.0 sp|P30937|SSR4_RAT Somatostatin receptor type 4 OS=Rattus norvegicus OX=10116 GN=Sstr4 PE=1 SV=1 SSR4_RAT reviewed Somatostatin receptor type 4 (SS-4-R) (SS4-R) (SS4R) Rattus norvegicus (Rat) GO:0004994; GO:0005886; GO:0007218; GO:0016477; GO:0030900; GO:0042923; GO:0043005; GO:0070374; GO:0071385; GO:0090238; GO:0106072 cell migration [GO:0016477]; cellular response to glucocorticoid stimulus [GO:0071385]; forebrain development [GO:0030900]; negative regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0106072]; neuropeptide signaling pathway [GO:0007218]; positive regulation of arachidonate secretion [GO:0090238]; positive regulation of ERK1 and ERK2 cascade [GO:0070374] neuron projection [GO:0043005]; plasma membrane [GO:0005886] neuropeptide binding [GO:0042923]; somatostatin receptor activity [GO:0004994] g12711.t1 A5A761 67.834 314 4.74e-151 430.0 sp|A5A761|SFXN1_PIG Sideroflexin-1 OS=Sus scrofa OX=9823 GN=SFXN1 PE=2 SV=1 g12712.t1 Q5EAJ7 46.012 865 0.0 769.0 sp|Q5EAJ7|MVP_STRPU Major vault protein OS=Strongylocentrotus purpuratus OX=7668 GN=MVP PE=1 SV=1 g12713.t1 O77784 62.368 380 7.28e-154 441.0 sp|O77784|IDH3B_BOVIN Isocitrate dehydrogenase [NAD] subunit beta, mitochondrial OS=Bos taurus OX=9913 GN=IDH3B PE=2 SV=2 g12717.t1 Q91WD2 30.017 583 4.44e-64 231.0 sp|Q91WD2|TRPV6_MOUSE Transient receptor potential cation channel subfamily V member 6 OS=Mus musculus OX=10090 GN=Trpv6 PE=1 SV=2 TRPV6_MOUSE reviewed Transient receptor potential cation channel subfamily V member 6 (TrpV6) (Calcium transport protein 1) (CaT1) (Epithelial calcium channel 2) (ECaC2) Mus musculus (Mouse) GO:0005262; GO:0005516; GO:0005886; GO:0006816; GO:0016020; GO:0034704; GO:0035898; GO:0042802; GO:0046872; GO:0051289; GO:0051592; GO:0055074; GO:0070509; GO:0070588; GO:0098703 calcium ion homeostasis [GO:0055074]; calcium ion import [GO:0070509]; calcium ion import across plasma membrane [GO:0098703]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; parathyroid hormone secretion [GO:0035898]; protein homotetramerization [GO:0051289]; response to calcium ion [GO:0051592] calcium channel complex [GO:0034704]; membrane [GO:0016020]; plasma membrane [GO:0005886] calcium channel activity [GO:0005262]; calmodulin binding [GO:0005516]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872] g12721.t1 Q8C9S4 45.199 677 1.8499999999999998e-147 470.0 sp|Q8C9S4|CC186_MOUSE Coiled-coil domain-containing protein 186 OS=Mus musculus OX=10090 GN=Ccdc186 PE=1 SV=2 g12722.t1 Q6AYQ1 50.769 130 1.7e-43 143.0 sp|Q6AYQ1|GOGA7_RAT Golgin subfamily A member 7 OS=Rattus norvegicus OX=10116 GN=Golga7 PE=2 SV=1 GOGA7_RAT reviewed Golgin subfamily A member 7 Rattus norvegicus (Rat) GO:0000139; GO:0002178; GO:0005795; GO:0006612; GO:0006893; GO:0043001; GO:0043687; GO:0050821 Golgi to plasma membrane protein transport [GO:0043001]; Golgi to plasma membrane transport [GO:0006893]; post-translational protein modification [GO:0043687]; protein stabilization [GO:0050821]; protein targeting to membrane [GO:0006612] Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; palmitoyltransferase complex [GO:0002178] g12725.t1 Q8CDA1 35.743 249 2.3099999999999998e-39 152.0 sp|Q8CDA1|SAC2_MOUSE Phosphatidylinositide phosphatase SAC2 OS=Mus musculus OX=10090 GN=Inpp5f PE=1 SV=1 g12726.t1 A8E7C5 50.383 522 3.8099999999999996e-170 513.0 sp|A8E7C5|SAC2_DANRE Phosphatidylinositide phosphatase SAC2 OS=Danio rerio OX=7955 GN=inpp5f PE=3 SV=1 SAC2_DANRE reviewed Phosphatidylinositide 4-phosphatase SAC2 (EC 3.1.3.-) (Inositol polyphosphate 5-phosphatase F) (Sac domain-containing inositol phosphatase 2) (Sac domain-containing phosphoinositide 4-phosphatase 2) (hSAC2) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005769; GO:0005905; GO:0042803; GO:0043812; GO:0045334; GO:0046856; GO:0052833; GO:0055037; GO:0072583; GO:2001135 clathrin-dependent endocytosis [GO:0072583]; phosphatidylinositol dephosphorylation [GO:0046856]; regulation of endocytic recycling [GO:2001135] clathrin-coated endocytic vesicle [GO:0045334]; clathrin-coated pit [GO:0005905]; early endosome [GO:0005769]; recycling endosome [GO:0055037] inositol monophosphate 4-phosphatase activity [GO:0052833]; phosphatidylinositol-4-phosphate phosphatase activity [GO:0043812]; protein homodimerization activity [GO:0042803] g12729.t1 Q8N5Y2 35.427 398 3.61e-40 156.0 sp|Q8N5Y2|MS3L1_HUMAN MSL complex subunit 3 OS=Homo sapiens OX=9606 GN=MSL3 PE=1 SV=1 g12729.t1 Q8N5Y2 58.511 94 7.21e-27 117.0 sp|Q8N5Y2|MS3L1_HUMAN MSL complex subunit 3 OS=Homo sapiens OX=9606 GN=MSL3 PE=1 SV=1 g12730.t1 Q96IZ5 41.791 134 3.01e-29 122.0 sp|Q96IZ5|RBM41_HUMAN RNA-binding protein 41 OS=Homo sapiens OX=9606 GN=RBM41 PE=1 SV=2 g12732.t1 P97292 42.353 340 1.77e-83 264.0 sp|P97292|HRH2_MOUSE Histamine H2 receptor OS=Mus musculus OX=10090 GN=Hrh2 PE=2 SV=2 HRH2_MOUSE reviewed Histamine H2 receptor (H2R) (HH2R) (Gastric receptor I) Mus musculus (Mouse) GO:0001696; GO:0001697; GO:0001698; GO:0003382; GO:0004969; GO:0005886; GO:0007187; GO:0007268; GO:0007613; GO:0008542; GO:0030425; GO:0030594; GO:0045202; GO:0045907; GO:0048167; GO:0048565; GO:0048732; GO:1900139; GO:1901363 chemical synaptic transmission [GO:0007268]; digestive tract development [GO:0048565]; epithelial cell morphogenesis [GO:0003382]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; gastric acid secretion [GO:0001696]; gastrin-induced gastric acid secretion [GO:0001698]; gland development [GO:0048732]; histamine-induced gastric acid secretion [GO:0001697]; memory [GO:0007613]; negative regulation of arachidonate secretion [GO:1900139]; positive regulation of vasoconstriction [GO:0045907]; regulation of synaptic plasticity [GO:0048167]; visual learning [GO:0008542] dendrite [GO:0030425]; plasma membrane [GO:0005886]; synapse [GO:0045202] heterocyclic compound binding [GO:1901363]; histamine receptor activity [GO:0004969]; neurotransmitter receptor activity [GO:0030594] g12733.t1 Q8BK63 81.373 306 0.0 510.0 sp|Q8BK63|KC1A_MOUSE Casein kinase I isoform alpha OS=Mus musculus OX=10090 GN=Csnk1a1 PE=1 SV=2 KC1A_MOUSE reviewed Casein kinase I isoform alpha (CKI-alpha) (EC 2.7.11.1) (CK1) Mus musculus (Mouse) GO:0000045; GO:0000287; GO:0000776; GO:0000902; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005813; GO:0005819; GO:0005829; GO:0005929; GO:0006468; GO:0007030; GO:0007165; GO:0010507; GO:0010508; GO:0016055; GO:0016607; GO:0030877; GO:0031146; GO:0031669; GO:0031670; GO:0032436; GO:0035025; GO:0036064; GO:0038202; GO:0042277; GO:0043161; GO:0044546; GO:0045104; GO:0051219; GO:0051301; GO:0090090; GO:0106310; GO:1900226; GO:1900227; GO:1904262; GO:1904263; GO:1990904 autophagosome assembly [GO:0000045]; cell division [GO:0051301]; cell morphogenesis [GO:0000902]; cellular response to nutrient [GO:0031670]; cellular response to nutrient levels [GO:0031669]; Golgi organization [GO:0007030]; intermediate filament cytoskeleton organization [GO:0045104]; negative regulation of autophagy [GO:0010507]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of NLRP3 inflammasome complex assembly [GO:1900226]; negative regulation of TORC1 signaling [GO:1904262]; NLRP3 inflammasome complex assembly [GO:0044546]; positive regulation of autophagy [GO:0010508]; positive regulation of NLRP3 inflammasome complex assembly [GO:1900227]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of Rho protein signal transduction [GO:0035025]; positive regulation of TORC1 signaling [GO:1904263]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein phosphorylation [GO:0006468]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; signal transduction [GO:0007165]; TORC1 signaling [GO:0038202]; Wnt signaling pathway [GO:0016055] beta-catenin destruction complex [GO:0030877]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; kinetochore [GO:0000776]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; spindle [GO:0005819] ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; peptide binding [GO:0042277]; phosphoprotein binding [GO:0051219]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g12735.t1 Q5RKI3 39.593 442 2.46e-90 288.0 sp|Q5RKI3|DPOLL_RAT DNA polymerase lambda OS=Rattus norvegicus OX=10116 GN=Poll PE=2 SV=1 DPOLL_RAT reviewed DNA polymerase lambda (Pol Lambda) (EC 2.7.7.7) (EC 4.2.99.-) Rattus norvegicus (Rat) GO:0000724; GO:0003677; GO:0003887; GO:0005634; GO:0005654; GO:0006260; GO:0006287; GO:0006289; GO:0006303; GO:0035861; GO:0046872; GO:0051575; GO:0071897 base-excision repair, gap-filling [GO:0006287]; DNA biosynthetic process [GO:0071897]; DNA replication [GO:0006260]; double-strand break repair via homologous recombination [GO:0000724]; double-strand break repair via nonhomologous end joining [GO:0006303]; nucleotide-excision repair [GO:0006289] nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of double-strand break [GO:0035861] 5'-deoxyribose-5-phosphate lyase activity [GO:0051575]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; metal ion binding [GO:0046872] g12736.t1 Q5ZJK8 79.658 526 0.0 893.0 sp|Q5ZJK8|TCPH_CHICK T-complex protein 1 subunit eta OS=Gallus gallus OX=9031 GN=CCT7 PE=1 SV=1 g12739.t1 O08791 60.858 373 8.79e-139 410.0 sp|O08791|COE3_MOUSE Transcription factor COE3 OS=Mus musculus OX=10090 GN=Ebf3 PE=1 SV=1 g12743.t1 O08791 71.223 139 9.900000000000001e-64 207.0 sp|O08791|COE3_MOUSE Transcription factor COE3 OS=Mus musculus OX=10090 GN=Ebf3 PE=1 SV=1 g12745.t1 E9PVX6 55.556 99 5.85e-28 125.0 sp|E9PVX6|KI67_MOUSE Proliferation marker protein Ki-67 OS=Mus musculus OX=10090 GN=Mki67 PE=1 SV=1 KI67_MOUSE reviewed Proliferation marker protein Ki-67 (Antigen identified by monoclonal antibody Ki-67 homolog) (Antigen KI-67 homolog) (Antigen Ki67 homolog) Mus musculus (Mouse) GO:0000775; GO:0000793; GO:0003677; GO:0003723; GO:0005524; GO:0005634; GO:0005654; GO:0005694; GO:0005730; GO:0005737; GO:0007059; GO:0007088; GO:0008283; GO:0050673; GO:0051321; GO:0072574; GO:0140693; GO:1902275; GO:1990705 cell population proliferation [GO:0008283]; cholangiocyte proliferation [GO:1990705]; chromosome segregation [GO:0007059]; epithelial cell proliferation [GO:0050673]; hepatocyte proliferation [GO:0072574]; meiotic cell cycle [GO:0051321]; regulation of chromatin organization [GO:1902275]; regulation of mitotic nuclear division [GO:0007088] chromosome [GO:0005694]; chromosome, centromeric region [GO:0000775]; condensed chromosome [GO:0000793]; cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] ATP binding [GO:0005524]; DNA binding [GO:0003677]; molecular condensate scaffold activity [GO:0140693]; RNA binding [GO:0003723] g12746.t1 Q6DDU8 80.069 291 3.0300000000000002e-148 433.0 sp|Q6DDU8|FIGL1_XENLA Fidgetin-like protein 1 OS=Xenopus laevis OX=8355 GN=fignl1 PE=2 SV=1 g12748.t1 Q5RCC0 55.294 170 2.71e-40 139.0 sp|Q5RCC0|TM2D2_PONAB TM2 domain-containing protein 2 OS=Pongo abelii OX=9601 GN=TM2D2 PE=2 SV=1 g12750.t1 Q26614 48.475 918 0.0 794.0 sp|Q26614|FGFR_STRPU Fibroblast growth factor receptor OS=Strongylocentrotus purpuratus OX=7668 GN=FGFR PE=2 SV=1 FGFR_STRPU reviewed Fibroblast growth factor receptor (SpFGFR) (EC 2.7.10.1) Strongylocentrotus purpuratus (Purple sea urchin) GO:0005007; GO:0005524; GO:0005886; GO:0008284; GO:0008543; GO:0017134; GO:0043235; GO:0043410 fibroblast growth factor receptor signaling pathway [GO:0008543]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of MAPK cascade [GO:0043410] plasma membrane [GO:0005886]; receptor complex [GO:0043235] ATP binding [GO:0005524]; fibroblast growth factor binding [GO:0017134]; fibroblast growth factor receptor activity [GO:0005007] g12752.t1 A0A1L8GXY4 39.308 1272 0.0 726.0 sp|A0A1L8GXY4|CFA43_XENLA Cilia- and flagella-associated protein 43 OS=Xenopus laevis OX=8355 GN=cfap43 PE=2 SV=1 g12753.t1 A0A1L8GXY4 32.414 145 2.66e-25 105.0 sp|A0A1L8GXY4|CFA43_XENLA Cilia- and flagella-associated protein 43 OS=Xenopus laevis OX=8355 GN=cfap43 PE=2 SV=1 g12756.t1 Q8R1R3 43.692 325 3.11e-93 287.0 sp|Q8R1R3|STAR7_MOUSE StAR-related lipid transfer protein 7, mitochondrial OS=Mus musculus OX=10090 GN=Stard7 PE=1 SV=2 STAR7_MOUSE reviewed StAR-related lipid transfer protein 7, mitochondrial (START domain-containing protein 7) (StARD7) Mus musculus (Mouse) GO:0001773; GO:0005576; GO:0005737; GO:0005739; GO:0006954; GO:0008289; GO:0042092; GO:0061436; GO:0120197; GO:0140104 establishment of skin barrier [GO:0061436]; inflammatory response [GO:0006954]; mucociliary clearance [GO:0120197]; myeloid dendritic cell activation [GO:0001773]; type 2 immune response [GO:0042092] cytoplasm [GO:0005737]; extracellular region [GO:0005576]; mitochondrion [GO:0005739] lipid binding [GO:0008289]; molecular carrier activity [GO:0140104] g12758.t1 Q7T2H2 53.252 246 1.0599999999999999e-90 279.0 sp|Q7T2H2|FGRL1_CHICK Fibroblast growth factor receptor-like 1 OS=Gallus gallus OX=9031 GN=FGFRL1 PE=1 SV=1 g12759.t1 Q7T2H2 83.051 59 1.32e-26 110.0 sp|Q7T2H2|FGRL1_CHICK Fibroblast growth factor receptor-like 1 OS=Gallus gallus OX=9031 GN=FGFRL1 PE=1 SV=1 g12760.t1 Q80WQ9 22.315 838 3.61e-27 123.0 sp|Q80WQ9|ZBED4_MOUSE Zinc finger BED domain-containing protein 4 OS=Mus musculus OX=10090 GN=Zbed4 PE=2 SV=1 ZBED4_MOUSE reviewed Zinc finger BED domain-containing protein 4 Mus musculus (Mouse) GO:0000976; GO:0000977; GO:0001228; GO:0001917; GO:0003723; GO:0005634; GO:0005654; GO:0005737; GO:0008270; GO:0042802; GO:0045944; GO:0046983 positive regulation of transcription by RNA polymerase II [GO:0045944] cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; photoreceptor inner segment [GO:0001917] DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; identical protein binding [GO:0042802]; protein dimerization activity [GO:0046983]; RNA binding [GO:0003723]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; transcription cis-regulatory region binding [GO:0000976]; zinc ion binding [GO:0008270] g12761.t1 O00567 76.24 383 0.0 599.0 sp|O00567|NOP56_HUMAN Nucleolar protein 56 OS=Homo sapiens OX=9606 GN=NOP56 PE=1 SV=4 NOP56_HUMAN reviewed Nucleolar protein 56 (Nucleolar protein 5A) Homo sapiens (Human) GO:0001650; GO:0003723; GO:0005654; GO:0005730; GO:0005732; GO:0005737; GO:0006364; GO:0016020; GO:0030515; GO:0031428; GO:0032040; GO:0042274; GO:0045296; GO:0070761; GO:1990226 ribosomal small subunit biogenesis [GO:0042274]; rRNA processing [GO:0006364] box C/D methylation guide snoRNP complex [GO:0031428]; cytoplasm [GO:0005737]; fibrillar center [GO:0001650]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; pre-snoRNP complex [GO:0070761]; small-subunit processome [GO:0032040]; sno(s)RNA-containing ribonucleoprotein complex [GO:0005732] cadherin binding [GO:0045296]; histone methyltransferase binding [GO:1990226]; RNA binding [GO:0003723]; snoRNA binding [GO:0030515] g12762.t1 Q4QR06 48.98 98 4.03e-31 120.0 sp|Q4QR06|PCGF1_XENLA Polycomb group RING finger protein 1 OS=Xenopus laevis OX=8355 GN=pcgf1 PE=2 SV=2 g12763.t1 Q8BTQ0 57.438 242 4.0499999999999996e-94 278.0 sp|Q8BTQ0|PCGF3_MOUSE Polycomb group RING finger protein 3 OS=Mus musculus OX=10090 GN=PcgF3 PE=1 SV=1 PCGF3_MOUSE reviewed Polycomb group RING finger protein 3 (RING finger protein 3A) Mus musculus (Mouse) GO:0005634; GO:0005654; GO:0006357; GO:0008270; GO:0031519; GO:0035102; GO:0060816; GO:0140862 random inactivation of X chromosome [GO:0060816]; regulation of transcription by RNA polymerase II [GO:0006357] nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; PRC1 complex [GO:0035102] histone H2AK119 ubiquitin ligase activity [GO:0140862]; zinc ion binding [GO:0008270] g12766.t1 Q3TZI6 47.879 165 2.68e-33 125.0 sp|Q3TZI6|CCNJ_MOUSE Cyclin-J OS=Mus musculus OX=10090 GN=Ccnj PE=2 SV=2 g12768.t1 Q5RKI0 46.932 603 0.0 565.0 sp|Q5RKI0|WDR1_RAT WD repeat-containing protein 1 OS=Rattus norvegicus OX=10116 GN=Wdr1 PE=1 SV=3 WDR1_RAT reviewed WD repeat-containing protein 1 Rattus norvegicus (Rat) GO:0002102; GO:0002446; GO:0005829; GO:0005886; GO:0005911; GO:0008360; GO:0015629; GO:0030036; GO:0030042; GO:0030043; GO:0030054; GO:0030220; GO:0030834; GO:0030836; GO:0030864; GO:0030865; GO:0040011; GO:0042247; GO:0043297; GO:0045199; GO:0045202; GO:0045214; GO:0048713; GO:0051015; GO:0060307; GO:0098978; GO:1990266 actin cytoskeleton organization [GO:0030036]; actin filament depolymerization [GO:0030042]; actin filament fragmentation [GO:0030043]; apical junction assembly [GO:0043297]; cortical cytoskeleton organization [GO:0030865]; establishment of planar polarity of follicular epithelium [GO:0042247]; locomotion [GO:0040011]; maintenance of epithelial cell apical/basal polarity [GO:0045199]; neutrophil mediated immunity [GO:0002446]; neutrophil migration [GO:1990266]; platelet formation [GO:0030220]; positive regulation of actin filament depolymerization [GO:0030836]; regulation of actin filament depolymerization [GO:0030834]; regulation of cell shape [GO:0008360]; regulation of oligodendrocyte differentiation [GO:0048713]; regulation of ventricular cardiac muscle cell membrane repolarization [GO:0060307]; sarcomere organization [GO:0045214] actin cytoskeleton [GO:0015629]; cell junction [GO:0030054]; cell-cell junction [GO:0005911]; cortical actin cytoskeleton [GO:0030864]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; podosome [GO:0002102]; synapse [GO:0045202] actin filament binding [GO:0051015] g12772.t1 E7FDB3 52.874 87 5.33e-26 102.0 sp|E7FDB3|NANO1_DANRE Nanos homolog 1 OS=Danio rerio OX=7955 GN=nanos1 PE=3 SV=1 g12775.t1 Q63679 44.96 883 0.0 713.0 sp|Q63679|KDM3A_RAT Lysine-specific demethylase 3A OS=Rattus norvegicus OX=10116 GN=Kdm3a PE=2 SV=1 KDM3A_RAT reviewed Lysine-specific demethylase 3A (EC 1.14.11.65) (JmjC domain-containing histone demethylation protein 2A) (Jumonji domain-containing protein 1A) (Testis-specific gene A protein) (Zinc finger protein TSGA) ([histone H3]-dimethyl-L-lysine(9) demethylase 3A) Rattus norvegicus (Rat) GO:0000118; GO:0000785; GO:0001666; GO:0001673; GO:0003682; GO:0003712; GO:0005506; GO:0005634; GO:0005654; GO:0005737; GO:0006357; GO:0007283; GO:0007290; GO:0008270; GO:0008584; GO:0009755; GO:0010468; GO:0010628; GO:0030521; GO:0031490; GO:0032454; GO:0045893; GO:0045944; GO:0046293; GO:0050681; GO:0120162; GO:0140683; GO:1990830; GO:2000036; GO:2000736 androgen receptor signaling pathway [GO:0030521]; cellular response to leukemia inhibitory factor [GO:1990830]; formaldehyde biosynthetic process [GO:0046293]; hormone-mediated signaling pathway [GO:0009755]; male gonad development [GO:0008584]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; regulation of stem cell differentiation [GO:2000736]; regulation of stem cell population maintenance [GO:2000036]; regulation of transcription by RNA polymerase II [GO:0006357]; response to hypoxia [GO:0001666]; spermatid nucleus elongation [GO:0007290]; spermatogenesis [GO:0007283] chromatin [GO:0000785]; cytoplasm [GO:0005737]; histone deacetylase complex [GO:0000118]; male germ cell nucleus [GO:0001673]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; histone H3K9 demethylase activity [GO:0032454]; histone H3K9me/H3K9me2 demethylase activity [GO:0140683]; iron ion binding [GO:0005506]; nuclear androgen receptor binding [GO:0050681]; transcription coregulator activity [GO:0003712]; zinc ion binding [GO:0008270] g12776.t1 Q2KI30 55.866 179 3.06e-56 188.0 sp|Q2KI30|REEP2_BOVIN Receptor expression-enhancing protein 2 OS=Bos taurus OX=9913 GN=REEP2 PE=2 SV=1 g12777.t1 Q9EQQ9 45.788 273 1.04e-67 228.0 sp|Q9EQQ9|OGA_MOUSE Protein O-GlcNAcase OS=Mus musculus OX=10090 GN=Oga PE=1 SV=2 OGA_MOUSE reviewed Protein O-GlcNAcase (OGA) (EC 3.2.1.169) (Beta-N-acetylhexosaminidase) (Beta-hexosaminidase) (Bifunctional protein NCOAT) (Meningioma-expressed antigen 5) (N-acetyl-beta-D-glucosaminidase) (N-acetyl-beta-glucosaminidase) Mus musculus (Mouse) GO:0004402; GO:0005634; GO:0005829; GO:0006044; GO:0006612; GO:0009100; GO:0010524; GO:0010616; GO:0015929; GO:0016231; GO:0031343; GO:0032024; GO:0042802; GO:0043065; GO:0043243; GO:0045862; GO:0046060; GO:0046326; GO:0051054; GO:0051901; GO:0051928; GO:0060124; GO:0102571 dATP metabolic process [GO:0046060]; glycoprotein metabolic process [GO:0009100]; N-acetylglucosamine metabolic process [GO:0006044]; negative regulation of cardiac muscle adaptation [GO:0010616]; positive regulation of apoptotic process [GO:0043065]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of calcium ion transport into cytosol [GO:0010524]; positive regulation of cell killing [GO:0031343]; positive regulation of D-glucose import [GO:0046326]; positive regulation of DNA metabolic process [GO:0051054]; positive regulation of growth hormone secretion [GO:0060124]; positive regulation of insulin secretion [GO:0032024]; positive regulation of mitochondrial depolarization [GO:0051901]; positive regulation of protein-containing complex disassembly [GO:0043243]; positive regulation of proteolysis [GO:0045862]; protein targeting to membrane [GO:0006612] cytosol [GO:0005829]; nucleus [GO:0005634] [protein]-3-O-(N-acetyl-D-glucosaminyl)-L-serine/L-threonine O-N-acetyl-alpha-D-glucosaminase activity [GO:0102571]; beta-N-acetylglucosaminidase activity [GO:0016231]; hexosaminidase activity [GO:0015929]; histone acetyltransferase activity [GO:0004402]; identical protein binding [GO:0042802] g12778.t1 Q8VIJ5 61.834 338 3.01e-134 420.0 sp|Q8VIJ5|OGA_RAT Protein O-GlcNAcase OS=Rattus norvegicus OX=10116 GN=Oga PE=1 SV=1 OGA_RAT reviewed Protein O-GlcNAcase (OGA) (EC 3.2.1.169) (Beta-N-acetylhexosaminidase) (Beta-hexosaminidase) (Bifunctional protein NCOAT) (Meningioma-expressed antigen 5) (N-acetyl-beta-D-glucosaminidase) (N-acetyl-beta-glucosaminidase) Rattus norvegicus (Rat) GO:0004402; GO:0005634; GO:0005829; GO:0006044; GO:0006612; GO:0009100; GO:0010524; GO:0010616; GO:0015929; GO:0016231; GO:0031343; GO:0032024; GO:0042802; GO:0043065; GO:0043243; GO:0045862; GO:0046060; GO:0046326; GO:0048545; GO:0051054; GO:0051901; GO:0051928; GO:0060124; GO:0102571 dATP metabolic process [GO:0046060]; glycoprotein metabolic process [GO:0009100]; N-acetylglucosamine metabolic process [GO:0006044]; negative regulation of cardiac muscle adaptation [GO:0010616]; positive regulation of apoptotic process [GO:0043065]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of calcium ion transport into cytosol [GO:0010524]; positive regulation of cell killing [GO:0031343]; positive regulation of D-glucose import [GO:0046326]; positive regulation of DNA metabolic process [GO:0051054]; positive regulation of growth hormone secretion [GO:0060124]; positive regulation of insulin secretion [GO:0032024]; positive regulation of mitochondrial depolarization [GO:0051901]; positive regulation of protein-containing complex disassembly [GO:0043243]; positive regulation of proteolysis [GO:0045862]; protein targeting to membrane [GO:0006612]; response to steroid hormone [GO:0048545] cytosol [GO:0005829]; nucleus [GO:0005634] [protein]-3-O-(N-acetyl-D-glucosaminyl)-L-serine/L-threonine O-N-acetyl-alpha-D-glucosaminase activity [GO:0102571]; beta-N-acetylglucosaminidase activity [GO:0016231]; hexosaminidase activity [GO:0015929]; histone acetyltransferase activity [GO:0004402]; identical protein binding [GO:0042802] g12779.t1 P62309 78.947 76 1.5300000000000002e-37 123.0 sp|P62309|RUXG_MOUSE Small nuclear ribonucleoprotein G OS=Mus musculus OX=10090 GN=Snrpg PE=1 SV=1 RUXG_MOUSE reviewed Small nuclear ribonucleoprotein G (snRNP-G) (Sm protein G) (Sm-G) (SmG) Mus musculus (Mouse) GO:0000387; GO:0000398; GO:0003723; GO:0005634; GO:0005654; GO:0005681; GO:0005682; GO:0005683; GO:0005684; GO:0005685; GO:0005686; GO:0005687; GO:0005689; GO:0005829; GO:0034709; GO:0034719; GO:0043186; GO:0046540; GO:0071004; GO:0071005; GO:0071007; GO:0071011; GO:0071013; GO:0097526; GO:1990446 mRNA splicing, via spliceosome [GO:0000398]; spliceosomal snRNP assembly [GO:0000387] catalytic step 2 spliceosome [GO:0071013]; cytosol [GO:0005829]; methylosome [GO:0034709]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P granule [GO:0043186]; precatalytic spliceosome [GO:0071011]; SMN-Sm protein complex [GO:0034719]; spliceosomal complex [GO:0005681]; spliceosomal tri-snRNP complex [GO:0097526]; U1 snRNP [GO:0005685]; U12-type spliceosomal complex [GO:0005689]; U2 snRNP [GO:0005686]; U2-type catalytic step 2 spliceosome [GO:0071007]; U2-type precatalytic spliceosome [GO:0071005]; U2-type prespliceosome [GO:0071004]; U2-type spliceosomal complex [GO:0005684]; U4 snRNP [GO:0005687]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682]; U7 snRNP [GO:0005683] RNA binding [GO:0003723]; U1 snRNP binding [GO:1990446] g12780.t1 Q96DM1 26.329 395 3.26e-31 132.0 sp|Q96DM1|PGBD4_HUMAN PiggyBac transposable element-derived protein 4 OS=Homo sapiens OX=9606 GN=PGBD4 PE=1 SV=3 g12781.t1 P85515 89.096 376 0.0 717.0 sp|P85515|ACTZ_RAT Alpha-centractin OS=Rattus norvegicus OX=10116 GN=Actr1a PE=1 SV=1 g12782.t1 F4HTM3 49.153 472 4.15e-145 438.0 sp|F4HTM3|GCS1_ARATH Mannosyl-oligosaccharide glucosidase GCS1 OS=Arabidopsis thaliana OX=3702 GN=GCS1 PE=1 SV=1 GCS1_ARATH reviewed Mannosyl-oligosaccharide glucosidase GCS1 (EC 3.2.1.106) (Alpha-glucosidase 1) (Glucosidase 1) (Protein KNOPF) (Protein MUNCHKIN) Arabidopsis thaliana (Mouse-ear cress) GO:0004558; GO:0004573; GO:0005739; GO:0005783; GO:0005789; GO:0006487; GO:0009311; GO:0010053; GO:0090627 oligosaccharide metabolic process [GO:0009311]; plant epidermal cell differentiation [GO:0090627]; protein N-linked glycosylation [GO:0006487]; root epidermal cell differentiation [GO:0010053] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; mitochondrion [GO:0005739] alpha-1,4-glucosidase activity [GO:0004558]; Glc3Man9GlcNAc2 oligosaccharide glucosidase activity [GO:0004573] g12783.t1 Q13724 38.019 313 5.28e-51 192.0 sp|Q13724|MOGS_HUMAN Mannosyl-oligosaccharide glucosidase OS=Homo sapiens OX=9606 GN=MOGS PE=1 SV=5 g12785.t1 A6QLU6 28.433 619 1.2699999999999999e-55 213.0 sp|A6QLU6|AGRD1_BOVIN Adhesion G-protein coupled receptor D1 OS=Bos taurus OX=9913 GN=ADGRD1 PE=2 SV=1 AGRD1_BOVIN reviewed Adhesion G-protein coupled receptor D1 (G-protein coupled receptor 133) [Cleaved into: Adhesion G-protein coupled receptor D1, N-terminal fragment (ADGRD1 N-terminal fragment); Adhesion G-protein coupled receptor D1, C-terminal fragment (ADGRD1 C-terminal fragment)] Bos taurus (Bovine) GO:0004930; GO:0005886; GO:0007166; GO:0007186; GO:0007189 adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186] plasma membrane [GO:0005886] G protein-coupled receptor activity [GO:0004930] g12785.t2 A6QLU6 28.433 619 1.5799999999999999e-55 213.0 sp|A6QLU6|AGRD1_BOVIN Adhesion G-protein coupled receptor D1 OS=Bos taurus OX=9913 GN=ADGRD1 PE=2 SV=1 AGRD1_BOVIN reviewed Adhesion G-protein coupled receptor D1 (G-protein coupled receptor 133) [Cleaved into: Adhesion G-protein coupled receptor D1, N-terminal fragment (ADGRD1 N-terminal fragment); Adhesion G-protein coupled receptor D1, C-terminal fragment (ADGRD1 C-terminal fragment)] Bos taurus (Bovine) GO:0004930; GO:0005886; GO:0007166; GO:0007186; GO:0007189 adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186] plasma membrane [GO:0005886] G protein-coupled receptor activity [GO:0004930] g12785.t3 A6QLU6 29.926 538 8.4e-56 214.0 sp|A6QLU6|AGRD1_BOVIN Adhesion G-protein coupled receptor D1 OS=Bos taurus OX=9913 GN=ADGRD1 PE=2 SV=1 AGRD1_BOVIN reviewed Adhesion G-protein coupled receptor D1 (G-protein coupled receptor 133) [Cleaved into: Adhesion G-protein coupled receptor D1, N-terminal fragment (ADGRD1 N-terminal fragment); Adhesion G-protein coupled receptor D1, C-terminal fragment (ADGRD1 C-terminal fragment)] Bos taurus (Bovine) GO:0004930; GO:0005886; GO:0007166; GO:0007186; GO:0007189 adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186] plasma membrane [GO:0005886] G protein-coupled receptor activity [GO:0004930] g12787.t1 Q2EMV9 28.197 610 2.75e-46 178.0 sp|Q2EMV9|PAR14_MOUSE Protein mono-ADP-ribosyltransferase PARP14 OS=Mus musculus OX=10090 GN=Parp14 PE=1 SV=3 PAR14_MOUSE reviewed Protein mono-ADP-ribosyltransferase PARP14 (EC 2.4.2.-) (ADP-ribosyltransferase diphtheria toxin-like 8) (ARTD8) (Collaborator of STAT6) (CoaSt6) (Poly [ADP-ribose] polymerase 14) (PARP-14) Mus musculus (Mouse) GO:0003714; GO:0003950; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0010629; GO:0016779; GO:0019677; GO:0019899; GO:0045087; GO:0060336; GO:0070212; GO:0070403; GO:0140807; GO:1902216; GO:1990404 innate immune response [GO:0045087]; NAD+ catabolic process [GO:0019677]; negative regulation of gene expression [GO:0010629]; negative regulation of type II interferon-mediated signaling pathway [GO:0060336]; positive regulation of interleukin-4-mediated signaling pathway [GO:1902216]; protein poly-ADP-ribosylation [GO:0070212] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886] enzyme binding [GO:0019899]; NAD+ binding [GO:0070403]; NAD+ poly-ADP-ribosyltransferase activity [GO:0003950]; NAD+-protein mono-ADP-ribosyltransferase activity [GO:1990404]; NAD+-protein-glutamate ADP-ribosyltransferase activity [GO:0140807]; nucleotidyltransferase activity [GO:0016779]; transcription corepressor activity [GO:0003714] g12790.t1 Q460N3 41.546 207 2.4199999999999998e-42 169.0 sp|Q460N3|PAR15_HUMAN Protein mono-ADP-ribosyltransferase PARP15 OS=Homo sapiens OX=9606 GN=PARP15 PE=1 SV=2 PAR15_HUMAN reviewed Protein mono-ADP-ribosyltransferase PARP15 (EC 2.4.2.-) (ADP-ribosyltransferase diphtheria toxin-like 7) (ARTD7) (B-aggressive lymphoma protein 3) (Poly [ADP-ribose] polymerase 15) (PARP-15) Homo sapiens (Human) GO:0000122; GO:0003714; GO:0003950; GO:0005634; GO:0005737; GO:0010629; GO:0016779; GO:0070212; GO:0070403; GO:0140806; GO:0140807; GO:1990404 negative regulation of gene expression [GO:0010629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; protein poly-ADP-ribosylation [GO:0070212] cytoplasm [GO:0005737]; nucleus [GO:0005634] NAD+ binding [GO:0070403]; NAD+ poly-ADP-ribosyltransferase activity [GO:0003950]; NAD+-protein mono-ADP-ribosyltransferase activity [GO:1990404]; NAD+-protein-aspartate ADP-ribosyltransferase activity [GO:0140806]; NAD+-protein-glutamate ADP-ribosyltransferase activity [GO:0140807]; nucleotidyltransferase activity [GO:0016779]; transcription corepressor activity [GO:0003714] g12791.t1 Q2EMV9 30.322 808 2.62e-95 345.0 sp|Q2EMV9|PAR14_MOUSE Protein mono-ADP-ribosyltransferase PARP14 OS=Mus musculus OX=10090 GN=Parp14 PE=1 SV=3 PAR14_MOUSE reviewed Protein mono-ADP-ribosyltransferase PARP14 (EC 2.4.2.-) (ADP-ribosyltransferase diphtheria toxin-like 8) (ARTD8) (Collaborator of STAT6) (CoaSt6) (Poly [ADP-ribose] polymerase 14) (PARP-14) Mus musculus (Mouse) GO:0003714; GO:0003950; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0010629; GO:0016779; GO:0019677; GO:0019899; GO:0045087; GO:0060336; GO:0070212; GO:0070403; GO:0140807; GO:1902216; GO:1990404 innate immune response [GO:0045087]; NAD+ catabolic process [GO:0019677]; negative regulation of gene expression [GO:0010629]; negative regulation of type II interferon-mediated signaling pathway [GO:0060336]; positive regulation of interleukin-4-mediated signaling pathway [GO:1902216]; protein poly-ADP-ribosylation [GO:0070212] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886] enzyme binding [GO:0019899]; NAD+ binding [GO:0070403]; NAD+ poly-ADP-ribosyltransferase activity [GO:0003950]; NAD+-protein mono-ADP-ribosyltransferase activity [GO:1990404]; NAD+-protein-glutamate ADP-ribosyltransferase activity [GO:0140807]; nucleotidyltransferase activity [GO:0016779]; transcription corepressor activity [GO:0003714] g12793.t1 Q8TDB6 53.591 181 2.6499999999999997e-54 204.0 sp|Q8TDB6|DTX3L_HUMAN E3 ubiquitin-protein ligase DTX3L OS=Homo sapiens OX=9606 GN=DTX3L PE=1 SV=1 DTX3L_HUMAN reviewed E3 ubiquitin-protein ligase DTX3L (EC 2.3.2.27) (B-lymphoma- and BAL-associated protein) (Protein deltex-3-like) (RING-type E3 ubiquitin transferase DTX3L) (Rhysin-2) (Rhysin2) Homo sapiens (Human) GO:0000077; GO:0002230; GO:0004842; GO:0004857; GO:0005634; GO:0005654; GO:0005737; GO:0005764; GO:0005765; GO:0005829; GO:0006302; GO:0006511; GO:0007219; GO:0008270; GO:0008333; GO:0015031; GO:0016567; GO:0019899; GO:0031901; GO:0032092; GO:0032991; GO:0035563; GO:0042393; GO:0044389; GO:0045087; GO:0045893; GO:0051444; GO:0051607; GO:0051865; GO:0061630; GO:0070936; GO:0097677; GO:0140768; GO:0140852; GO:0140861; GO:0141000; GO:1900182; GO:1902966; GO:2000646 defense response to virus [GO:0051607]; DNA damage checkpoint signaling [GO:0000077]; DNA repair-dependent chromatin remodeling [GO:0140861]; double-strand break repair [GO:0006302]; endosome to lysosome transport [GO:0008333]; innate immune response [GO:0045087]; negative regulation of ubiquitin-protein transferase activity [GO:0051444]; Notch signaling pathway [GO:0007219]; positive regulation of chromatin binding [GO:0035563]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of protein binding [GO:0032092]; positive regulation of protein localization to early endosome [GO:1902966]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of receptor catabolic process [GO:2000646]; protein autoubiquitination [GO:0051865]; protein K48-linked ubiquitination [GO:0070936]; protein transport [GO:0015031]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511] cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991] enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; histone binding [GO:0042393]; histone H4K91 ubiquitin ligase activity [GO:0141000]; histone ubiquitin ligase activity [GO:0140852]; protein ADP-ribosyltransferase-substrate adaptor activity [GO:0140768]; STAT family protein binding [GO:0097677]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-like protein ligase binding [GO:0044389]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] g12796.t1 Q460N5 48.75 160 1.17e-47 169.0 sp|Q460N5|PAR14_HUMAN Protein mono-ADP-ribosyltransferase PARP14 OS=Homo sapiens OX=9606 GN=PARP14 PE=1 SV=3 PAR14_HUMAN reviewed Protein mono-ADP-ribosyltransferase PARP14 (EC 2.4.2.-) (ADP-ribosyltransferase diphtheria toxin-like 8) (ARTD8) (B aggressive lymphoma protein 2) (Poly [ADP-ribose] polymerase 14) (PARP-14) Homo sapiens (Human) GO:0003714; GO:0003950; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0010629; GO:0016020; GO:0016779; GO:0019677; GO:0019899; GO:0042531; GO:0042532; GO:0045087; GO:0060336; GO:0070212; GO:0070403; GO:0140807; GO:1902216; GO:1990404 innate immune response [GO:0045087]; NAD+ catabolic process [GO:0019677]; negative regulation of gene expression [GO:0010629]; negative regulation of type II interferon-mediated signaling pathway [GO:0060336]; negative regulation of tyrosine phosphorylation of STAT protein [GO:0042532]; positive regulation of interleukin-4-mediated signaling pathway [GO:1902216]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; protein poly-ADP-ribosylation [GO:0070212] cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886] enzyme binding [GO:0019899]; NAD+ binding [GO:0070403]; NAD+ poly-ADP-ribosyltransferase activity [GO:0003950]; NAD+-protein mono-ADP-ribosyltransferase activity [GO:1990404]; NAD+-protein-glutamate ADP-ribosyltransferase activity [GO:0140807]; nucleotidyltransferase activity [GO:0016779]; transcription corepressor activity [GO:0003714] g12800.t1 Q460N5 23.096 788 3.3000000000000002e-37 157.0 sp|Q460N5|PAR14_HUMAN Protein mono-ADP-ribosyltransferase PARP14 OS=Homo sapiens OX=9606 GN=PARP14 PE=1 SV=3 PAR14_HUMAN reviewed Protein mono-ADP-ribosyltransferase PARP14 (EC 2.4.2.-) (ADP-ribosyltransferase diphtheria toxin-like 8) (ARTD8) (B aggressive lymphoma protein 2) (Poly [ADP-ribose] polymerase 14) (PARP-14) Homo sapiens (Human) GO:0003714; GO:0003950; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0010629; GO:0016020; GO:0016779; GO:0019677; GO:0019899; GO:0042531; GO:0042532; GO:0045087; GO:0060336; GO:0070212; GO:0070403; GO:0140807; GO:1902216; GO:1990404 innate immune response [GO:0045087]; NAD+ catabolic process [GO:0019677]; negative regulation of gene expression [GO:0010629]; negative regulation of type II interferon-mediated signaling pathway [GO:0060336]; negative regulation of tyrosine phosphorylation of STAT protein [GO:0042532]; positive regulation of interleukin-4-mediated signaling pathway [GO:1902216]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; protein poly-ADP-ribosylation [GO:0070212] cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886] enzyme binding [GO:0019899]; NAD+ binding [GO:0070403]; NAD+ poly-ADP-ribosyltransferase activity [GO:0003950]; NAD+-protein mono-ADP-ribosyltransferase activity [GO:1990404]; NAD+-protein-glutamate ADP-ribosyltransferase activity [GO:0140807]; nucleotidyltransferase activity [GO:0016779]; transcription corepressor activity [GO:0003714] g12801.t1 Q460N5 25.548 1734 8.11e-143 490.0 sp|Q460N5|PAR14_HUMAN Protein mono-ADP-ribosyltransferase PARP14 OS=Homo sapiens OX=9606 GN=PARP14 PE=1 SV=3 PAR14_HUMAN reviewed Protein mono-ADP-ribosyltransferase PARP14 (EC 2.4.2.-) (ADP-ribosyltransferase diphtheria toxin-like 8) (ARTD8) (B aggressive lymphoma protein 2) (Poly [ADP-ribose] polymerase 14) (PARP-14) Homo sapiens (Human) GO:0003714; GO:0003950; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0010629; GO:0016020; GO:0016779; GO:0019677; GO:0019899; GO:0042531; GO:0042532; GO:0045087; GO:0060336; GO:0070212; GO:0070403; GO:0140807; GO:1902216; GO:1990404 innate immune response [GO:0045087]; NAD+ catabolic process [GO:0019677]; negative regulation of gene expression [GO:0010629]; negative regulation of type II interferon-mediated signaling pathway [GO:0060336]; negative regulation of tyrosine phosphorylation of STAT protein [GO:0042532]; positive regulation of interleukin-4-mediated signaling pathway [GO:1902216]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; protein poly-ADP-ribosylation [GO:0070212] cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886] enzyme binding [GO:0019899]; NAD+ binding [GO:0070403]; NAD+ poly-ADP-ribosyltransferase activity [GO:0003950]; NAD+-protein mono-ADP-ribosyltransferase activity [GO:1990404]; NAD+-protein-glutamate ADP-ribosyltransferase activity [GO:0140807]; nucleotidyltransferase activity [GO:0016779]; transcription corepressor activity [GO:0003714] g12803.t1 Q5REG4 50.526 190 2.64e-55 198.0 sp|Q5REG4|DTX3_PONAB Probable E3 ubiquitin-protein ligase DTX3 OS=Pongo abelii OX=9601 GN=DTX3 PE=2 SV=1 DTX3_PONAB reviewed E3 ubiquitin-protein ligase DTX3 (EC 2.3.2.27) (Protein deltex-3) (Deltex3) (RING-type E3 ubiquitin transferase DTX3) Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0005634; GO:0005737; GO:0007219; GO:0008270; GO:0008593; GO:0016567; GO:0061630 Notch signaling pathway [GO:0007219]; protein ubiquitination [GO:0016567]; regulation of Notch signaling pathway [GO:0008593] cytoplasm [GO:0005737]; nucleus [GO:0005634] ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] g12803.t2 Q5REG4 50.526 190 2.6499999999999998e-55 198.0 sp|Q5REG4|DTX3_PONAB Probable E3 ubiquitin-protein ligase DTX3 OS=Pongo abelii OX=9601 GN=DTX3 PE=2 SV=1 DTX3_PONAB reviewed E3 ubiquitin-protein ligase DTX3 (EC 2.3.2.27) (Protein deltex-3) (Deltex3) (RING-type E3 ubiquitin transferase DTX3) Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0005634; GO:0005737; GO:0007219; GO:0008270; GO:0008593; GO:0016567; GO:0061630 Notch signaling pathway [GO:0007219]; protein ubiquitination [GO:0016567]; regulation of Notch signaling pathway [GO:0008593] cytoplasm [GO:0005737]; nucleus [GO:0005634] ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] g12805.t1 Q8TDB6 64.211 95 9.430000000000001e-26 112.0 sp|Q8TDB6|DTX3L_HUMAN E3 ubiquitin-protein ligase DTX3L OS=Homo sapiens OX=9606 GN=DTX3L PE=1 SV=1 DTX3L_HUMAN reviewed E3 ubiquitin-protein ligase DTX3L (EC 2.3.2.27) (B-lymphoma- and BAL-associated protein) (Protein deltex-3-like) (RING-type E3 ubiquitin transferase DTX3L) (Rhysin-2) (Rhysin2) Homo sapiens (Human) GO:0000077; GO:0002230; GO:0004842; GO:0004857; GO:0005634; GO:0005654; GO:0005737; GO:0005764; GO:0005765; GO:0005829; GO:0006302; GO:0006511; GO:0007219; GO:0008270; GO:0008333; GO:0015031; GO:0016567; GO:0019899; GO:0031901; GO:0032092; GO:0032991; GO:0035563; GO:0042393; GO:0044389; GO:0045087; GO:0045893; GO:0051444; GO:0051607; GO:0051865; GO:0061630; GO:0070936; GO:0097677; GO:0140768; GO:0140852; GO:0140861; GO:0141000; GO:1900182; GO:1902966; GO:2000646 defense response to virus [GO:0051607]; DNA damage checkpoint signaling [GO:0000077]; DNA repair-dependent chromatin remodeling [GO:0140861]; double-strand break repair [GO:0006302]; endosome to lysosome transport [GO:0008333]; innate immune response [GO:0045087]; negative regulation of ubiquitin-protein transferase activity [GO:0051444]; Notch signaling pathway [GO:0007219]; positive regulation of chromatin binding [GO:0035563]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of protein binding [GO:0032092]; positive regulation of protein localization to early endosome [GO:1902966]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of receptor catabolic process [GO:2000646]; protein autoubiquitination [GO:0051865]; protein K48-linked ubiquitination [GO:0070936]; protein transport [GO:0015031]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511] cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991] enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; histone binding [GO:0042393]; histone H4K91 ubiquitin ligase activity [GO:0141000]; histone ubiquitin ligase activity [GO:0140852]; protein ADP-ribosyltransferase-substrate adaptor activity [GO:0140768]; STAT family protein binding [GO:0097677]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-like protein ligase binding [GO:0044389]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] g12806.t1 Q3UIR3 55.495 182 1.3399999999999998e-54 206.0 sp|Q3UIR3|DTX3L_MOUSE E3 ubiquitin-protein ligase DTX3L OS=Mus musculus OX=10090 GN=Dtx3l PE=1 SV=1 DTX3L_MOUSE reviewed E3 ubiquitin-protein ligase DTX3L (EC 2.3.2.27) (Protein deltex-3-like) (RING-type E3 ubiquitin transferase DTX3L) Mus musculus (Mouse) GO:0000077; GO:0002230; GO:0004842; GO:0004857; GO:0005634; GO:0005654; GO:0005737; GO:0005764; GO:0005765; GO:0005829; GO:0006302; GO:0006511; GO:0007219; GO:0008270; GO:0008333; GO:0015031; GO:0016567; GO:0019899; GO:0031901; GO:0032991; GO:0042393; GO:0044389; GO:0045087; GO:0045893; GO:0051607; GO:0051865; GO:0061630; GO:0070936; GO:0097677; GO:0140768; GO:0140852; GO:0140861; GO:0141000; GO:1900182; GO:1902966; GO:2000646 defense response to virus [GO:0051607]; DNA damage checkpoint signaling [GO:0000077]; DNA repair-dependent chromatin remodeling [GO:0140861]; double-strand break repair [GO:0006302]; endosome to lysosome transport [GO:0008333]; innate immune response [GO:0045087]; Notch signaling pathway [GO:0007219]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of protein localization to early endosome [GO:1902966]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of receptor catabolic process [GO:2000646]; protein autoubiquitination [GO:0051865]; protein K48-linked ubiquitination [GO:0070936]; protein transport [GO:0015031]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511] cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991] enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; histone binding [GO:0042393]; histone H4K91 ubiquitin ligase activity [GO:0141000]; histone ubiquitin ligase activity [GO:0140852]; protein ADP-ribosyltransferase-substrate adaptor activity [GO:0140768]; STAT family protein binding [GO:0097677]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-like protein ligase binding [GO:0044389]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] g12807.t1 Q5REG4 50.267 187 6.9e-63 201.0 sp|Q5REG4|DTX3_PONAB Probable E3 ubiquitin-protein ligase DTX3 OS=Pongo abelii OX=9601 GN=DTX3 PE=2 SV=1 DTX3_PONAB reviewed E3 ubiquitin-protein ligase DTX3 (EC 2.3.2.27) (Protein deltex-3) (Deltex3) (RING-type E3 ubiquitin transferase DTX3) Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0005634; GO:0005737; GO:0007219; GO:0008270; GO:0008593; GO:0016567; GO:0061630 Notch signaling pathway [GO:0007219]; protein ubiquitination [GO:0016567]; regulation of Notch signaling pathway [GO:0008593] cytoplasm [GO:0005737]; nucleus [GO:0005634] ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] g12812.t1 Q3ZCF5 72.5 440 0.0 652.0 sp|Q3ZCF5|OAT_BOVIN Ornithine aminotransferase, mitochondrial OS=Bos taurus OX=9913 GN=OAT PE=2 SV=1 g12814.t1 B0I564 45.626 846 0.0 619.0 sp|B0I564|FANCI_CHICK Fanconi anemia group I protein OS=Gallus gallus OX=9031 GN=FANCI PE=1 SV=1 FANCI_CHICK reviewed Fanconi anemia group I protein Gallus gallus (Chicken) GO:0005654; GO:0006281; GO:0031398; GO:0043240 DNA repair [GO:0006281]; positive regulation of protein ubiquitination [GO:0031398] Fanconi anaemia nuclear complex [GO:0043240]; nucleoplasm [GO:0005654] g12815.t1 Q8K368 33.649 422 2.39e-56 204.0 sp|Q8K368|FANCI_MOUSE Fanconi anemia group I protein homolog OS=Mus musculus OX=10090 GN=Fanci PE=1 SV=2 FANCI_MOUSE reviewed Fanconi anemia group I protein homolog (Protein FACI) Mus musculus (Mouse) GO:0005654; GO:0005737; GO:0005829; GO:0006281; GO:0031398; GO:0043240; GO:0070182; GO:1990391 DNA repair [GO:0006281]; positive regulation of protein ubiquitination [GO:0031398] cytoplasm [GO:0005737]; cytosol [GO:0005829]; DNA repair complex [GO:1990391]; Fanconi anaemia nuclear complex [GO:0043240]; nucleoplasm [GO:0005654] DNA polymerase binding [GO:0070182] g12815.t2 Q8K368 33.562 438 1.3e-59 214.0 sp|Q8K368|FANCI_MOUSE Fanconi anemia group I protein homolog OS=Mus musculus OX=10090 GN=Fanci PE=1 SV=2 FANCI_MOUSE reviewed Fanconi anemia group I protein homolog (Protein FACI) Mus musculus (Mouse) GO:0005654; GO:0005737; GO:0005829; GO:0006281; GO:0031398; GO:0043240; GO:0070182; GO:1990391 DNA repair [GO:0006281]; positive regulation of protein ubiquitination [GO:0031398] cytoplasm [GO:0005737]; cytosol [GO:0005829]; DNA repair complex [GO:1990391]; Fanconi anaemia nuclear complex [GO:0043240]; nucleoplasm [GO:0005654] DNA polymerase binding [GO:0070182] g12819.t1 P79739 42.457 464 5.52e-125 377.0 sp|P79739|CP26A_DANRE Cytochrome P450 26A1 OS=Danio rerio OX=7955 GN=cyp26a1 PE=1 SV=1 CP26A_DANRE reviewed Cytochrome P450 26A1 (EC 1.14.13.-) (Cytochrome P450RAI) (Retinoic acid 4-hydroxylase) (Retinoic acid-metabolizing cytochrome) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001568; GO:0001756; GO:0001944; GO:0003131; GO:0003151; GO:0004497; GO:0005506; GO:0005789; GO:0007417; GO:0007507; GO:0008401; GO:0020037; GO:0021661; GO:0021797; GO:0030902; GO:0030917; GO:0031016; GO:0034653; GO:0034672; GO:0042573; GO:0042574; GO:0048384; GO:0048854; GO:0055014; GO:0062182; GO:0071299 anterior/posterior pattern specification involved in pronephros development [GO:0034672]; atrial cardiac muscle cell development [GO:0055014]; blood vessel development [GO:0001568]; brain morphogenesis [GO:0048854]; cellular response to vitamin A [GO:0071299]; central nervous system development [GO:0007417]; forebrain anterior/posterior pattern specification [GO:0021797]; heart development [GO:0007507]; hindbrain development [GO:0030902]; mesodermal-endodermal cell signaling [GO:0003131]; midbrain-hindbrain boundary development [GO:0030917]; outflow tract morphogenesis [GO:0003151]; pancreas development [GO:0031016]; retinal metabolic process [GO:0042574]; retinoic acid catabolic process [GO:0034653]; retinoic acid metabolic process [GO:0042573]; retinoic acid receptor signaling pathway [GO:0048384]; rhombomere 4 morphogenesis [GO:0021661]; somitogenesis [GO:0001756]; vasculature development [GO:0001944] endoplasmic reticulum membrane [GO:0005789] all-trans retinoic acid 4-hydrolase activity [GO:0062182]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; retinoic acid 4-hydroxylase activity [GO:0008401] g12820.t1 B3DLH6 60.268 224 4.39e-85 280.0 sp|B3DLH6|MYOF_XENTR Myoferlin OS=Xenopus tropicalis OX=8364 GN=myof PE=2 SV=1 g12821.t1 O75923 43.734 1612 0.0 1273.0 sp|O75923|DYSF_HUMAN Dysferlin OS=Homo sapiens OX=9606 GN=DYSF PE=1 SV=1 g12821.t2 O75923 44.166 1594 0.0 1281.0 sp|O75923|DYSF_HUMAN Dysferlin OS=Homo sapiens OX=9606 GN=DYSF PE=1 SV=1 g12821.t3 Q69ZN7 45.209 1221 0.0 1004.0 sp|Q69ZN7|MYOF_MOUSE Myoferlin OS=Mus musculus OX=10090 GN=Myof PE=1 SV=2 MYOF_MOUSE reviewed Myoferlin (Fer-1-like protein 3) Mus musculus (Mouse) GO:0001778; GO:0005543; GO:0005886; GO:0005901; GO:0005929; GO:0006071; GO:0030947; GO:0031410; GO:0031902; GO:0031965; GO:0033292; GO:0034451; GO:0034605; GO:0036064; GO:0046872; GO:0055001; GO:0061025 cellular response to heat [GO:0034605]; glycerol metabolic process [GO:0006071]; membrane fusion [GO:0061025]; muscle cell development [GO:0055001]; plasma membrane repair [GO:0001778]; regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030947]; T-tubule organization [GO:0033292] caveola [GO:0005901]; centriolar satellite [GO:0034451]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasmic vesicle [GO:0031410]; late endosome membrane [GO:0031902]; nuclear membrane [GO:0031965]; plasma membrane [GO:0005886] metal ion binding [GO:0046872]; phospholipid binding [GO:0005543] g12823.t1 P91685 32.628 331 1.98e-47 179.0 sp|P91685|GRM_DROME Metabotropic glutamate receptor OS=Drosophila melanogaster OX=7227 GN=mGluR PE=1 SV=2 GRM_DROME reviewed Metabotropic glutamate receptor (DmGluRA) Drosophila melanogaster (Fruit fly) GO:0001641; GO:0004930; GO:0005886; GO:0007216; GO:0007528; GO:0007612; GO:0007614; GO:0007616; GO:0008049; GO:0008066; GO:0015485; GO:0016020; GO:0016595; GO:0038038; GO:0045121; GO:0051966; GO:0072553 G protein-coupled glutamate receptor signaling pathway [GO:0007216]; learning [GO:0007612]; long-term memory [GO:0007616]; male courtship behavior [GO:0008049]; neuromuscular junction development [GO:0007528]; regulation of synaptic transmission, glutamatergic [GO:0051966]; short-term memory [GO:0007614]; terminal button organization [GO:0072553] G protein-coupled receptor homodimeric complex [GO:0038038]; membrane [GO:0016020]; membrane raft [GO:0045121]; plasma membrane [GO:0005886] cholesterol binding [GO:0015485]; G protein-coupled receptor activity [GO:0004930]; glutamate binding [GO:0016595]; glutamate receptor activity [GO:0008066]; group II metabotropic glutamate receptor activity [GO:0001641] g12826.t1 Q9H173 46.015 389 4.7100000000000004e-117 354.0 sp|Q9H173|SIL1_HUMAN Nucleotide exchange factor SIL1 OS=Homo sapiens OX=9606 GN=SIL1 PE=1 SV=1 SIL1_HUMAN reviewed Nucleotide exchange factor SIL1 (BiP-associated protein) (BAP) Homo sapiens (Human) GO:0000774; GO:0005615; GO:0005783; GO:0005788; GO:0006457; GO:0006613; GO:0006886; GO:0042802; GO:0051082 cotranslational protein targeting to membrane [GO:0006613]; intracellular protein transport [GO:0006886]; protein folding [GO:0006457] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; extracellular space [GO:0005615] adenyl-nucleotide exchange factor activity [GO:0000774]; identical protein binding [GO:0042802]; unfolded protein binding [GO:0051082] g12828.t1 I6LDA6 58.824 510 0.0 580.0 sp|I6LDA6|GPMI_ONCVO 2,3-bisphosphoglycerate-independent phosphoglycerate mutase OS=Onchocerca volvulus OX=6282 GN=ipgm-1 PE=1 SV=1 g12829.t1 Q5ZLG8 50.357 560 0.0 547.0 sp|Q5ZLG8|TAPT1_CHICK Transmembrane anterior posterior transformation protein 1 homolog OS=Gallus gallus OX=9031 GN=TAPT1 PE=2 SV=2 TAPT1_CHICK reviewed Transmembrane anterior posterior transformation protein 1 homolog Gallus gallus (Chicken) GO:0001503; GO:0005813; GO:0014032; GO:0016020; GO:0030030; GO:0036064; GO:0045724; GO:0051216; GO:0061036; GO:1903012 cartilage development [GO:0051216]; cell projection organization [GO:0030030]; neural crest cell development [GO:0014032]; ossification [GO:0001503]; positive regulation of bone development [GO:1903012]; positive regulation of cartilage development [GO:0061036]; positive regulation of cilium assembly [GO:0045724] centrosome [GO:0005813]; ciliary basal body [GO:0036064]; membrane [GO:0016020] g12830.t1 Q2WEA5 28.909 1311 7.61e-126 430.0 sp|Q2WEA5|TRPM1_RAT Transient receptor potential cation channel subfamily M member 1 OS=Rattus norvegicus OX=10116 GN=Trpm1 PE=2 SV=2 TRPM1_RAT reviewed Transient receptor potential cation channel subfamily M member 1 (Melastatin-1) Rattus norvegicus (Rat) GO:0005216; GO:0005261; GO:0005262; GO:0005783; GO:0005789; GO:0005886; GO:0006816; GO:0007165; GO:0007216; GO:0007601; GO:0008104; GO:0008324; GO:0030424; GO:0030425; GO:0035841; GO:0046548; GO:0051262; GO:0051286; GO:0071482; GO:0098655; GO:0098703 calcium ion import across plasma membrane [GO:0098703]; calcium ion transport [GO:0006816]; cellular response to light stimulus [GO:0071482]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; intracellular protein localization [GO:0008104]; monoatomic cation transmembrane transport [GO:0098655]; protein tetramerization [GO:0051262]; retinal rod cell development [GO:0046548]; signal transduction [GO:0007165]; visual perception [GO:0007601] axon [GO:0030424]; cell tip [GO:0051286]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; new growing cell tip [GO:0035841]; plasma membrane [GO:0005886] calcium channel activity [GO:0005262]; monoatomic cation channel activity [GO:0005261]; monoatomic cation transmembrane transporter activity [GO:0008324]; monoatomic ion channel activity [GO:0005216] g12832.t1 Q8AW42 46.377 345 2.6399999999999997e-89 274.0 sp|Q8AW42|S39AD_DANRE Zinc transporter ZIP13 OS=Danio rerio OX=7955 GN=slc39a13 PE=2 SV=1 g12834.t1 Q5ZLT0 76.202 832 0.0 1316.0 sp|Q5ZLT0|XPO7_CHICK Exportin-7 OS=Gallus gallus OX=9031 GN=XPO7 PE=2 SV=1 g12835.t1 Q9EPK7 71.667 240 1.44e-104 330.0 sp|Q9EPK7|XPO7_MOUSE Exportin-7 OS=Mus musculus OX=10090 GN=Xpo7 PE=1 SV=3 g12835.t2 Q9EPK7 73.504 234 5.16e-107 336.0 sp|Q9EPK7|XPO7_MOUSE Exportin-7 OS=Mus musculus OX=10090 GN=Xpo7 PE=1 SV=3 g12836.t1 Q6IQE0 56.554 534 1.46e-151 472.0 sp|Q6IQE0|PU60B_DANRE Poly(U)-binding-splicing factor PUF60-B OS=Danio rerio OX=7955 GN=puf60b PE=2 SV=2 PU60B_DANRE reviewed Poly(U)-binding-splicing factor PUF60-B Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000380; GO:0000381; GO:0003677; GO:0003723; GO:0005634; GO:0006376; GO:0006915; GO:1990904 alternative mRNA splicing, via spliceosome [GO:0000380]; apoptotic process [GO:0006915]; mRNA splice site recognition [GO:0006376]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381] nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904] DNA binding [GO:0003677]; RNA binding [GO:0003723] g12840.t1 A8DYE2 31.126 453 2.52e-44 170.0 sp|A8DYE2|TRPCG_DROME Transient receptor potential cation channel trpm OS=Drosophila melanogaster OX=7227 GN=Trpm PE=1 SV=1 TRPCG_DROME reviewed Transient receptor potential cation channel trpm (Transient receptor potential cation channel, subfamily M ortholog) Drosophila melanogaster (Fruit fly) GO:0005261; GO:0005385; GO:0005886; GO:0006882; GO:0010960; GO:0022890; GO:0030001; GO:0034703; GO:0051262; GO:0097682; GO:0098655 intracellular zinc ion homeostasis [GO:0006882]; magnesium ion homeostasis [GO:0010960]; metal ion transport [GO:0030001]; monoatomic cation transmembrane transport [GO:0098655]; protein tetramerization [GO:0051262] cation channel complex [GO:0034703]; plasma membrane [GO:0005886] inorganic cation transmembrane transporter activity [GO:0022890]; intracellularly phosphatidylinositol-3,5-bisphosphate-gated monatomic cation channel activity [GO:0097682]; monoatomic cation channel activity [GO:0005261]; zinc ion transmembrane transporter activity [GO:0005385] g12841.t1 Q2WEA5 29.167 528 1.78e-47 182.0 sp|Q2WEA5|TRPM1_RAT Transient receptor potential cation channel subfamily M member 1 OS=Rattus norvegicus OX=10116 GN=Trpm1 PE=2 SV=2 TRPM1_RAT reviewed Transient receptor potential cation channel subfamily M member 1 (Melastatin-1) Rattus norvegicus (Rat) GO:0005216; GO:0005261; GO:0005262; GO:0005783; GO:0005789; GO:0005886; GO:0006816; GO:0007165; GO:0007216; GO:0007601; GO:0008104; GO:0008324; GO:0030424; GO:0030425; GO:0035841; GO:0046548; GO:0051262; GO:0051286; GO:0071482; GO:0098655; GO:0098703 calcium ion import across plasma membrane [GO:0098703]; calcium ion transport [GO:0006816]; cellular response to light stimulus [GO:0071482]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; intracellular protein localization [GO:0008104]; monoatomic cation transmembrane transport [GO:0098655]; protein tetramerization [GO:0051262]; retinal rod cell development [GO:0046548]; signal transduction [GO:0007165]; visual perception [GO:0007601] axon [GO:0030424]; cell tip [GO:0051286]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; new growing cell tip [GO:0035841]; plasma membrane [GO:0005886] calcium channel activity [GO:0005262]; monoatomic cation channel activity [GO:0005261]; monoatomic cation transmembrane transporter activity [GO:0008324]; monoatomic ion channel activity [GO:0005216] g12842.t1 Q0VCA3 60.949 274 7.62e-102 323.0 sp|Q0VCA3|LETM1_BOVIN Mitochondrial proton/calcium exchanger protein OS=Bos taurus OX=9913 GN=LETM1 PE=2 SV=1 LETM1_BOVIN reviewed Mitochondrial proton/calcium exchanger protein (Electroneutral mitochondrial K(+)/H(+)exchanger) (KHE) (Leucine zipper-EF-hand-containing transmembrane protein 1) Bos taurus (Bovine) GO:0005509; GO:0005739; GO:0005743; GO:0006851; GO:0007005; GO:0007007; GO:0015369; GO:0034214; GO:0043022; GO:0051260; GO:0051560; GO:0051562; GO:0099093; GO:0140141; GO:1900069 calcium export from the mitochondrion [GO:0099093]; inner mitochondrial membrane organization [GO:0007007]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrial calcium ion transmembrane transport [GO:0006851]; mitochondrial potassium ion transmembrane transport [GO:0140141]; mitochondrion organization [GO:0007005]; negative regulation of mitochondrial calcium ion concentration [GO:0051562]; protein hexamerization [GO:0034214]; protein homooligomerization [GO:0051260]; regulation of cellular hyperosmotic salinity response [GO:1900069] mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739] calcium ion binding [GO:0005509]; calcium:proton antiporter activity [GO:0015369]; ribosome binding [GO:0043022] g12845.t1 P41594 29.34 818 1.1000000000000001e-96 331.0 sp|P41594|GRM5_HUMAN Metabotropic glutamate receptor 5 OS=Homo sapiens OX=9606 GN=GRM5 PE=1 SV=2 GRM5_HUMAN reviewed Metabotropic glutamate receptor 5 (mGluR5) Homo sapiens (Human) GO:0001640; GO:0001659; GO:0001975; GO:0002029; GO:0004930; GO:0005637; GO:0005737; GO:0005886; GO:0006355; GO:0007204; GO:0007206; GO:0007216; GO:0007268; GO:0007611; GO:0007626; GO:0008066; GO:0030296; GO:0030425; GO:0031687; GO:0033603; GO:0035106; GO:0036228; GO:0042802; GO:0043025; GO:0043197; GO:0043198; GO:0043278; GO:0043410; GO:0045471; GO:0046677; GO:0048170; GO:0050808; GO:0050850; GO:0050890; GO:0051412; GO:0051966; GO:0061002; GO:0062036; GO:0090394; GO:0097449; GO:0098685; GO:0098839; GO:0098978; GO:0099530; GO:0099583; GO:1900039; GO:1900452; GO:1904058; GO:1904646; GO:1990708; GO:1990782; GO:2000179 cellular response to amyloid-beta [GO:1904646]; chemical synaptic transmission [GO:0007268]; cognition [GO:0050890]; conditioned place preference [GO:1990708]; desensitization of G protein-coupled receptor signaling pathway [GO:0002029]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; learning or memory [GO:0007611]; locomotory behavior [GO:0007626]; negative regulation of dendritic spine morphogenesis [GO:0061002]; negative regulation of excitatory postsynaptic potential [GO:0090394]; operant conditioning [GO:0035106]; phospholipase C-activating G protein-coupled glutamate receptor signaling pathway [GO:0007206]; positive regulation of calcium-mediated signaling [GO:0050850]; positive regulation of cellular response to hypoxia [GO:1900039]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of dopamine secretion [GO:0033603]; positive regulation of long-term neuronal synaptic plasticity [GO:0048170]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of sensory perception of pain [GO:1904058]; protein localization to nuclear inner membrane [GO:0036228]; regulation of DNA-templated transcription [GO:0006355]; regulation of long-term synaptic depression [GO:1900452]; regulation of synaptic transmission, glutamatergic [GO:0051966]; response to amphetamine [GO:0001975]; response to antibiotic [GO:0046677]; response to corticosterone [GO:0051412]; response to ethanol [GO:0045471]; response to morphine [GO:0043278]; sensory perception of hot stimulus [GO:0062036]; synapse organization [GO:0050808]; temperature homeostasis [GO:0001659] astrocyte projection [GO:0097449]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; neuronal cell body [GO:0043025]; nuclear inner membrane [GO:0005637]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; Schaffer collateral - CA1 synapse [GO:0098685] A2A adenosine receptor binding [GO:0031687]; adenylate cyclase inhibiting G protein-coupled glutamate receptor activity [GO:0001640]; G protein-coupled receptor activity [GO:0004930]; G protein-coupled receptor activity involved in regulation of postsynaptic membrane potential [GO:0099530]; glutamate receptor activity [GO:0008066]; identical protein binding [GO:0042802]; neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration [GO:0099583]; protein tyrosine kinase activator activity [GO:0030296]; protein tyrosine kinase binding [GO:1990782] g12846.t1 P70579 29.545 220 1.7199999999999998e-23 101.0 sp|P70579|GRM8_RAT Metabotropic glutamate receptor 8 OS=Rattus norvegicus OX=10116 GN=Grm8 PE=1 SV=1 GRM8_RAT reviewed Metabotropic glutamate receptor 8 (mGluR8) Rattus norvegicus (Rat) GO:0001642; GO:0004930; GO:0005886; GO:0007193; GO:0007196; GO:0007216; GO:0007268; GO:0008066; GO:0019233; GO:0035249; GO:0042734; GO:0043025; GO:0045211; GO:0046928; GO:0048787; GO:0050966; GO:0051966; GO:0098978; GO:0098982; GO:0099171 adenylate cyclase-inhibiting G protein-coupled glutamate receptor signaling pathway [GO:0007196]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; chemical synaptic transmission [GO:0007268]; detection of mechanical stimulus involved in sensory perception of pain [GO:0050966]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; presynaptic modulation of chemical synaptic transmission [GO:0099171]; regulation of neurotransmitter secretion [GO:0046928]; regulation of synaptic transmission, glutamatergic [GO:0051966]; sensory perception of pain [GO:0019233]; synaptic transmission, glutamatergic [GO:0035249] GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic active zone membrane [GO:0048787]; presynaptic membrane [GO:0042734] G protein-coupled receptor activity [GO:0004930]; glutamate receptor activity [GO:0008066]; group III metabotropic glutamate receptor activity [GO:0001642] g12847.t1 P91685 29.794 339 1.07e-42 162.0 sp|P91685|GRM_DROME Metabotropic glutamate receptor OS=Drosophila melanogaster OX=7227 GN=mGluR PE=1 SV=2 GRM_DROME reviewed Metabotropic glutamate receptor (DmGluRA) Drosophila melanogaster (Fruit fly) GO:0001641; GO:0004930; GO:0005886; GO:0007216; GO:0007528; GO:0007612; GO:0007614; GO:0007616; GO:0008049; GO:0008066; GO:0015485; GO:0016020; GO:0016595; GO:0038038; GO:0045121; GO:0051966; GO:0072553 G protein-coupled glutamate receptor signaling pathway [GO:0007216]; learning [GO:0007612]; long-term memory [GO:0007616]; male courtship behavior [GO:0008049]; neuromuscular junction development [GO:0007528]; regulation of synaptic transmission, glutamatergic [GO:0051966]; short-term memory [GO:0007614]; terminal button organization [GO:0072553] G protein-coupled receptor homodimeric complex [GO:0038038]; membrane [GO:0016020]; membrane raft [GO:0045121]; plasma membrane [GO:0005886] cholesterol binding [GO:0015485]; G protein-coupled receptor activity [GO:0004930]; glutamate binding [GO:0016595]; glutamate receptor activity [GO:0008066]; group II metabotropic glutamate receptor activity [GO:0001641] g12848.t1 P97772 33.099 284 3.1100000000000003e-31 127.0 sp|P97772|GRM1_MOUSE Metabotropic glutamate receptor 1 OS=Mus musculus OX=10090 GN=Grm1 PE=1 SV=2 g12850.t1 P91685 34.118 170 1.03e-24 103.0 sp|P91685|GRM_DROME Metabotropic glutamate receptor OS=Drosophila melanogaster OX=7227 GN=mGluR PE=1 SV=2 GRM_DROME reviewed Metabotropic glutamate receptor (DmGluRA) Drosophila melanogaster (Fruit fly) GO:0001641; GO:0004930; GO:0005886; GO:0007216; GO:0007528; GO:0007612; GO:0007614; GO:0007616; GO:0008049; GO:0008066; GO:0015485; GO:0016020; GO:0016595; GO:0038038; GO:0045121; GO:0051966; GO:0072553 G protein-coupled glutamate receptor signaling pathway [GO:0007216]; learning [GO:0007612]; long-term memory [GO:0007616]; male courtship behavior [GO:0008049]; neuromuscular junction development [GO:0007528]; regulation of synaptic transmission, glutamatergic [GO:0051966]; short-term memory [GO:0007614]; terminal button organization [GO:0072553] G protein-coupled receptor homodimeric complex [GO:0038038]; membrane [GO:0016020]; membrane raft [GO:0045121]; plasma membrane [GO:0005886] cholesterol binding [GO:0015485]; G protein-coupled receptor activity [GO:0004930]; glutamate binding [GO:0016595]; glutamate receptor activity [GO:0008066]; group II metabotropic glutamate receptor activity [GO:0001641] g12855.t1 O15303 30.625 320 8.7e-24 105.0 sp|O15303|GRM6_HUMAN Metabotropic glutamate receptor 6 OS=Homo sapiens OX=9606 GN=GRM6 PE=1 SV=2 g12858.t1 P53452 46.429 308 3.81e-87 276.0 sp|P53452|DRD1L_TAKRU D(1)-like dopamine receptor OS=Takifugu rubripes OX=31033 GN=d14 PE=3 SV=1 g12861.t1 P53452 50.0 122 7.41e-37 134.0 sp|P53452|DRD1L_TAKRU D(1)-like dopamine receptor OS=Takifugu rubripes OX=31033 GN=d14 PE=3 SV=1 g12862.t1 P53454 39.286 196 5.69e-33 127.0 sp|P53454|DRD5L_TAKRU D(5)-like dopamine receptor OS=Takifugu rubripes OX=31033 GN=dl PE=3 SV=1 g12863.t1 P41596 37.879 264 1.7e-44 159.0 sp|P41596|DOPR1_DROME Dopamine receptor 1 OS=Drosophila melanogaster OX=7227 GN=Dop1R1 PE=2 SV=2 DOPR1_DROME reviewed Dopamine receptor 1 (D-DOP1) (DmDop1) (dDA1) (Dopamine 1-like receptor 1) Drosophila melanogaster (Fruit fly) GO:0001588; GO:0004930; GO:0004952; GO:0004993; GO:0005886; GO:0007187; GO:0007188; GO:0007191; GO:0007212; GO:0007268; GO:0007612; GO:0007613; GO:0008306; GO:0008355; GO:0008542; GO:0009744; GO:0016020; GO:0030425; GO:0030594; GO:0040040; GO:0042048; GO:0042594; GO:0043052; GO:0071329; GO:0090328; GO:0098793; GO:0099509; GO:1990834 adenylate cyclase-activating dopamine receptor signaling pathway [GO:0007191]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; associative learning [GO:0008306]; cellular response to sucrose stimulus [GO:0071329]; chemical synaptic transmission [GO:0007268]; G protein-coupled dopamine receptor signaling pathway [GO:0007212]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; learning [GO:0007612]; memory [GO:0007613]; olfactory behavior [GO:0042048]; olfactory learning [GO:0008355]; regulation of olfactory learning [GO:0090328]; regulation of presynaptic cytosolic calcium ion concentration [GO:0099509]; response to odorant [GO:1990834]; response to starvation [GO:0042594]; response to sucrose [GO:0009744]; thermosensory behavior [GO:0040040]; thermotaxis [GO:0043052]; visual learning [GO:0008542] dendrite [GO:0030425]; membrane [GO:0016020]; plasma membrane [GO:0005886]; presynapse [GO:0098793] dopamine neurotransmitter receptor activity [GO:0004952]; dopamine neurotransmitter receptor activity, coupled via Gs [GO:0001588]; G protein-coupled receptor activity [GO:0004930]; G protein-coupled serotonin receptor activity [GO:0004993]; neurotransmitter receptor activity [GO:0030594] g12865.t1 Q0IHP3 34.375 256 1.67e-44 168.0 sp|Q0IHP3|PTCD3_XENTR Small ribosomal subunit protein mS39 OS=Xenopus tropicalis OX=8364 GN=ptcd3 PE=2 SV=1 g12869.t1 Q32N55 40.561 392 5.39e-91 291.0 sp|Q32N55|PTCD3_XENLA Small ribosomal subunit protein mS39 OS=Xenopus laevis OX=8355 GN=ptcd3 PE=2 SV=1 g12870.t1 Q6GQ34 40.65 246 1.82e-57 197.0 sp|Q6GQ34|F124A_XENLA Protein FAM124A OS=Xenopus laevis OX=8355 GN=fam124a PE=2 SV=1 g12882.t1 Q5G267 33.476 233 1.53e-25 108.0 sp|Q5G267|NETR_MACMU Neurotrypsin OS=Macaca mulatta OX=9544 GN=PRSS12 PE=3 SV=1 NETR_MACMU reviewed Neurotrypsin (EC 3.4.21.-) (Serine protease 12) Macaca mulatta (Rhesus macaque) GO:0004252; GO:0005886; GO:0006508; GO:0006887; GO:0030424; GO:0030425; GO:0043083; GO:0043195; GO:0098978 exocytosis [GO:0006887]; proteolysis [GO:0006508] axon [GO:0030424]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; synaptic cleft [GO:0043083]; terminal bouton [GO:0043195] serine-type endopeptidase activity [GO:0004252] g12883.t1 Q9WVC1 56.838 234 1.1e-75 248.0 sp|Q9WVC1|SLIT2_RAT Slit homolog 2 protein (Fragment) OS=Rattus norvegicus OX=10116 GN=Slit2 PE=1 SV=3 SLIT2_RAT reviewed Slit homolog 2 protein (Slit-2) Rattus norvegicus (Rat) GO:0001656; GO:0001657; GO:0001701; GO:0001822; GO:0002042; GO:0002689; GO:0003180; GO:0003184; GO:0004963; GO:0005095; GO:0005615; GO:0005737; GO:0007409; GO:0007411; GO:0008045; GO:0008201; GO:0008285; GO:0009986; GO:0010593; GO:0010596; GO:0010629; GO:0014912; GO:0016020; GO:0021510; GO:0021772; GO:0021836; GO:0021972; GO:0022029; GO:0030308; GO:0030336; GO:0030424; GO:0030425; GO:0030517; GO:0030837; GO:0031290; GO:0031667; GO:0032870; GO:0033563; GO:0035385; GO:0036120; GO:0042802; GO:0042803; GO:0042995; GO:0043025; GO:0043065; GO:0043116; GO:0043237; GO:0043394; GO:0043395; GO:0044297; GO:0045499; GO:0048495; GO:0048754; GO:0048812; GO:0048846; GO:0050919; GO:0050929; GO:0051058; GO:0051414; GO:0051965; GO:0060074; GO:0060412; GO:0060603; GO:0060763; GO:0061364; GO:0070100; GO:0071456; GO:0071504; GO:0071672; GO:0071676; GO:0090024; GO:0090027; GO:0090260; GO:0090288; GO:0098609; GO:0098966; GO:1990138 aortic valve morphogenesis [GO:0003180]; apoptotic process involved in luteolysis [GO:0061364]; axon extension involved in axon guidance [GO:0048846]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; branching morphogenesis of an epithelial tube [GO:0048754]; cell migration involved in sprouting angiogenesis [GO:0002042]; cell-cell adhesion [GO:0098609]; cellular response to heparin [GO:0071504]; cellular response to hormone stimulus [GO:0032870]; cellular response to hypoxia [GO:0071456]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; chemorepulsion involved in postnatal olfactory bulb interneuron migration [GO:0021836]; corticospinal neuron axon guidance through spinal cord [GO:0021972]; dorsal/ventral axon guidance [GO:0033563]; in utero embryonic development [GO:0001701]; induction of negative chemotaxis [GO:0050929]; kidney development [GO:0001822]; mammary duct terminal end bud growth [GO:0060763]; mammary gland duct morphogenesis [GO:0060603]; metanephros development [GO:0001656]; motor neuron axon guidance [GO:0008045]; negative chemotaxis [GO:0050919]; negative regulation of actin filament polymerization [GO:0030837]; negative regulation of axon extension [GO:0030517]; negative regulation of cell growth [GO:0030308]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cellular response to growth factor stimulus [GO:0090288]; negative regulation of chemokine-mediated signaling pathway [GO:0070100]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellipodium assembly [GO:0010593]; negative regulation of leukocyte chemotaxis [GO:0002689]; negative regulation of monocyte chemotaxis [GO:0090027]; negative regulation of mononuclear cell migration [GO:0071676]; negative regulation of neutrophil chemotaxis [GO:0090024]; negative regulation of retinal ganglion cell axon guidance [GO:0090260]; negative regulation of small GTPase mediated signal transduction [GO:0051058]; negative regulation of smooth muscle cell chemotaxis [GO:0071672]; negative regulation of smooth muscle cell migration [GO:0014912]; negative regulation of vascular permeability [GO:0043116]; neuron projection extension [GO:1990138]; neuron projection morphogenesis [GO:0048812]; olfactory bulb development [GO:0021772]; positive regulation of apoptotic process [GO:0043065]; positive regulation of synapse assembly [GO:0051965]; pulmonary valve morphogenesis [GO:0003184]; response to cortisol [GO:0051414]; response to nutrient levels [GO:0031667]; retinal ganglion cell axon guidance [GO:0031290]; Roundabout signaling pathway [GO:0035385]; spinal cord development [GO:0021510]; synapse maturation [GO:0060074]; telencephalon cell migration [GO:0022029]; ureteric bud development [GO:0001657]; ventricular septum morphogenesis [GO:0060412] axon [GO:0030424]; cell body [GO:0044297]; cell projection [GO:0042995]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; extracellular space [GO:0005615]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; perisynaptic extracellular matrix [GO:0098966] chemorepellent activity [GO:0045499]; follicle-stimulating hormone receptor activity [GO:0004963]; GTPase inhibitor activity [GO:0005095]; heparan sulfate proteoglycan binding [GO:0043395]; heparin binding [GO:0008201]; identical protein binding [GO:0042802]; laminin-1 binding [GO:0043237]; protein homodimerization activity [GO:0042803]; proteoglycan binding [GO:0043394]; Roundabout binding [GO:0048495] g12883.t1 Q9WVC1 31.746 252 6.45e-31 125.0 sp|Q9WVC1|SLIT2_RAT Slit homolog 2 protein (Fragment) OS=Rattus norvegicus OX=10116 GN=Slit2 PE=1 SV=3 SLIT2_RAT reviewed Slit homolog 2 protein (Slit-2) Rattus norvegicus (Rat) GO:0001656; GO:0001657; GO:0001701; GO:0001822; GO:0002042; GO:0002689; GO:0003180; GO:0003184; GO:0004963; GO:0005095; GO:0005615; GO:0005737; GO:0007409; GO:0007411; GO:0008045; GO:0008201; GO:0008285; GO:0009986; GO:0010593; GO:0010596; GO:0010629; GO:0014912; GO:0016020; GO:0021510; GO:0021772; GO:0021836; GO:0021972; GO:0022029; GO:0030308; GO:0030336; GO:0030424; GO:0030425; GO:0030517; GO:0030837; GO:0031290; GO:0031667; GO:0032870; GO:0033563; GO:0035385; GO:0036120; GO:0042802; GO:0042803; GO:0042995; GO:0043025; GO:0043065; GO:0043116; GO:0043237; GO:0043394; GO:0043395; GO:0044297; GO:0045499; GO:0048495; GO:0048754; GO:0048812; GO:0048846; GO:0050919; GO:0050929; GO:0051058; GO:0051414; GO:0051965; GO:0060074; GO:0060412; GO:0060603; GO:0060763; GO:0061364; GO:0070100; GO:0071456; GO:0071504; GO:0071672; GO:0071676; GO:0090024; GO:0090027; GO:0090260; GO:0090288; GO:0098609; GO:0098966; GO:1990138 aortic valve morphogenesis [GO:0003180]; apoptotic process involved in luteolysis [GO:0061364]; axon extension involved in axon guidance [GO:0048846]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; branching morphogenesis of an epithelial tube [GO:0048754]; cell migration involved in sprouting angiogenesis [GO:0002042]; cell-cell adhesion [GO:0098609]; cellular response to heparin [GO:0071504]; cellular response to hormone stimulus [GO:0032870]; cellular response to hypoxia [GO:0071456]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; chemorepulsion involved in postnatal olfactory bulb interneuron migration [GO:0021836]; corticospinal neuron axon guidance through spinal cord [GO:0021972]; dorsal/ventral axon guidance [GO:0033563]; in utero embryonic development [GO:0001701]; induction of negative chemotaxis [GO:0050929]; kidney development [GO:0001822]; mammary duct terminal end bud growth [GO:0060763]; mammary gland duct morphogenesis [GO:0060603]; metanephros development [GO:0001656]; motor neuron axon guidance [GO:0008045]; negative chemotaxis [GO:0050919]; negative regulation of actin filament polymerization [GO:0030837]; negative regulation of axon extension [GO:0030517]; negative regulation of cell growth [GO:0030308]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cellular response to growth factor stimulus [GO:0090288]; negative regulation of chemokine-mediated signaling pathway [GO:0070100]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellipodium assembly [GO:0010593]; negative regulation of leukocyte chemotaxis [GO:0002689]; negative regulation of monocyte chemotaxis [GO:0090027]; negative regulation of mononuclear cell migration [GO:0071676]; negative regulation of neutrophil chemotaxis [GO:0090024]; negative regulation of retinal ganglion cell axon guidance [GO:0090260]; negative regulation of small GTPase mediated signal transduction [GO:0051058]; negative regulation of smooth muscle cell chemotaxis [GO:0071672]; negative regulation of smooth muscle cell migration [GO:0014912]; negative regulation of vascular permeability [GO:0043116]; neuron projection extension [GO:1990138]; neuron projection morphogenesis [GO:0048812]; olfactory bulb development [GO:0021772]; positive regulation of apoptotic process [GO:0043065]; positive regulation of synapse assembly [GO:0051965]; pulmonary valve morphogenesis [GO:0003184]; response to cortisol [GO:0051414]; response to nutrient levels [GO:0031667]; retinal ganglion cell axon guidance [GO:0031290]; Roundabout signaling pathway [GO:0035385]; spinal cord development [GO:0021510]; synapse maturation [GO:0060074]; telencephalon cell migration [GO:0022029]; ureteric bud development [GO:0001657]; ventricular septum morphogenesis [GO:0060412] axon [GO:0030424]; cell body [GO:0044297]; cell projection [GO:0042995]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; extracellular space [GO:0005615]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; perisynaptic extracellular matrix [GO:0098966] chemorepellent activity [GO:0045499]; follicle-stimulating hormone receptor activity [GO:0004963]; GTPase inhibitor activity [GO:0005095]; heparan sulfate proteoglycan binding [GO:0043395]; heparin binding [GO:0008201]; identical protein binding [GO:0042802]; laminin-1 binding [GO:0043237]; protein homodimerization activity [GO:0042803]; proteoglycan binding [GO:0043394]; Roundabout binding [GO:0048495] g12883.t1 Q9WVC1 29.804 255 4.2800000000000004e-29 119.0 sp|Q9WVC1|SLIT2_RAT Slit homolog 2 protein (Fragment) OS=Rattus norvegicus OX=10116 GN=Slit2 PE=1 SV=3 SLIT2_RAT reviewed Slit homolog 2 protein (Slit-2) Rattus norvegicus (Rat) GO:0001656; GO:0001657; GO:0001701; GO:0001822; GO:0002042; GO:0002689; GO:0003180; GO:0003184; GO:0004963; GO:0005095; GO:0005615; GO:0005737; GO:0007409; GO:0007411; GO:0008045; GO:0008201; GO:0008285; GO:0009986; GO:0010593; GO:0010596; GO:0010629; GO:0014912; GO:0016020; GO:0021510; GO:0021772; GO:0021836; GO:0021972; GO:0022029; GO:0030308; GO:0030336; GO:0030424; GO:0030425; GO:0030517; GO:0030837; GO:0031290; GO:0031667; GO:0032870; GO:0033563; GO:0035385; GO:0036120; GO:0042802; GO:0042803; GO:0042995; GO:0043025; GO:0043065; GO:0043116; GO:0043237; GO:0043394; GO:0043395; GO:0044297; GO:0045499; GO:0048495; GO:0048754; GO:0048812; GO:0048846; GO:0050919; GO:0050929; GO:0051058; GO:0051414; GO:0051965; GO:0060074; GO:0060412; GO:0060603; GO:0060763; GO:0061364; GO:0070100; GO:0071456; GO:0071504; GO:0071672; GO:0071676; GO:0090024; GO:0090027; GO:0090260; GO:0090288; GO:0098609; GO:0098966; GO:1990138 aortic valve morphogenesis [GO:0003180]; apoptotic process involved in luteolysis [GO:0061364]; axon extension involved in axon guidance [GO:0048846]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; branching morphogenesis of an epithelial tube [GO:0048754]; cell migration involved in sprouting angiogenesis [GO:0002042]; cell-cell adhesion [GO:0098609]; cellular response to heparin [GO:0071504]; cellular response to hormone stimulus [GO:0032870]; cellular response to hypoxia [GO:0071456]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; chemorepulsion involved in postnatal olfactory bulb interneuron migration [GO:0021836]; corticospinal neuron axon guidance through spinal cord [GO:0021972]; dorsal/ventral axon guidance [GO:0033563]; in utero embryonic development [GO:0001701]; induction of negative chemotaxis [GO:0050929]; kidney development [GO:0001822]; mammary duct terminal end bud growth [GO:0060763]; mammary gland duct morphogenesis [GO:0060603]; metanephros development [GO:0001656]; motor neuron axon guidance [GO:0008045]; negative chemotaxis [GO:0050919]; negative regulation of actin filament polymerization [GO:0030837]; negative regulation of axon extension [GO:0030517]; negative regulation of cell growth [GO:0030308]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cellular response to growth factor stimulus [GO:0090288]; negative regulation of chemokine-mediated signaling pathway [GO:0070100]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellipodium assembly [GO:0010593]; negative regulation of leukocyte chemotaxis [GO:0002689]; negative regulation of monocyte chemotaxis [GO:0090027]; negative regulation of mononuclear cell migration [GO:0071676]; negative regulation of neutrophil chemotaxis [GO:0090024]; negative regulation of retinal ganglion cell axon guidance [GO:0090260]; negative regulation of small GTPase mediated signal transduction [GO:0051058]; negative regulation of smooth muscle cell chemotaxis [GO:0071672]; negative regulation of smooth muscle cell migration [GO:0014912]; negative regulation of vascular permeability [GO:0043116]; neuron projection extension [GO:1990138]; neuron projection morphogenesis [GO:0048812]; olfactory bulb development [GO:0021772]; positive regulation of apoptotic process [GO:0043065]; positive regulation of synapse assembly [GO:0051965]; pulmonary valve morphogenesis [GO:0003184]; response to cortisol [GO:0051414]; response to nutrient levels [GO:0031667]; retinal ganglion cell axon guidance [GO:0031290]; Roundabout signaling pathway [GO:0035385]; spinal cord development [GO:0021510]; synapse maturation [GO:0060074]; telencephalon cell migration [GO:0022029]; ureteric bud development [GO:0001657]; ventricular septum morphogenesis [GO:0060412] axon [GO:0030424]; cell body [GO:0044297]; cell projection [GO:0042995]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; extracellular space [GO:0005615]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; perisynaptic extracellular matrix [GO:0098966] chemorepellent activity [GO:0045499]; follicle-stimulating hormone receptor activity [GO:0004963]; GTPase inhibitor activity [GO:0005095]; heparan sulfate proteoglycan binding [GO:0043395]; heparin binding [GO:0008201]; identical protein binding [GO:0042802]; laminin-1 binding [GO:0043237]; protein homodimerization activity [GO:0042803]; proteoglycan binding [GO:0043394]; Roundabout binding [GO:0048495] g12884.t1 Q9WVC1 57.107 401 4.41e-155 461.0 sp|Q9WVC1|SLIT2_RAT Slit homolog 2 protein (Fragment) OS=Rattus norvegicus OX=10116 GN=Slit2 PE=1 SV=3 SLIT2_RAT reviewed Slit homolog 2 protein (Slit-2) Rattus norvegicus (Rat) GO:0001656; GO:0001657; GO:0001701; GO:0001822; GO:0002042; GO:0002689; GO:0003180; GO:0003184; GO:0004963; GO:0005095; GO:0005615; GO:0005737; GO:0007409; GO:0007411; GO:0008045; GO:0008201; GO:0008285; GO:0009986; GO:0010593; GO:0010596; GO:0010629; GO:0014912; GO:0016020; GO:0021510; GO:0021772; GO:0021836; GO:0021972; GO:0022029; GO:0030308; GO:0030336; GO:0030424; GO:0030425; GO:0030517; GO:0030837; GO:0031290; GO:0031667; GO:0032870; GO:0033563; GO:0035385; GO:0036120; GO:0042802; GO:0042803; GO:0042995; GO:0043025; GO:0043065; GO:0043116; GO:0043237; GO:0043394; GO:0043395; GO:0044297; GO:0045499; GO:0048495; GO:0048754; GO:0048812; GO:0048846; GO:0050919; GO:0050929; GO:0051058; GO:0051414; GO:0051965; GO:0060074; GO:0060412; GO:0060603; GO:0060763; GO:0061364; GO:0070100; GO:0071456; GO:0071504; GO:0071672; GO:0071676; GO:0090024; GO:0090027; GO:0090260; GO:0090288; GO:0098609; GO:0098966; GO:1990138 aortic valve morphogenesis [GO:0003180]; apoptotic process involved in luteolysis [GO:0061364]; axon extension involved in axon guidance [GO:0048846]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; branching morphogenesis of an epithelial tube [GO:0048754]; cell migration involved in sprouting angiogenesis [GO:0002042]; cell-cell adhesion [GO:0098609]; cellular response to heparin [GO:0071504]; cellular response to hormone stimulus [GO:0032870]; cellular response to hypoxia [GO:0071456]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; chemorepulsion involved in postnatal olfactory bulb interneuron migration [GO:0021836]; corticospinal neuron axon guidance through spinal cord [GO:0021972]; dorsal/ventral axon guidance [GO:0033563]; in utero embryonic development [GO:0001701]; induction of negative chemotaxis [GO:0050929]; kidney development [GO:0001822]; mammary duct terminal end bud growth [GO:0060763]; mammary gland duct morphogenesis [GO:0060603]; metanephros development [GO:0001656]; motor neuron axon guidance [GO:0008045]; negative chemotaxis [GO:0050919]; negative regulation of actin filament polymerization [GO:0030837]; negative regulation of axon extension [GO:0030517]; negative regulation of cell growth [GO:0030308]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cellular response to growth factor stimulus [GO:0090288]; negative regulation of chemokine-mediated signaling pathway [GO:0070100]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellipodium assembly [GO:0010593]; negative regulation of leukocyte chemotaxis [GO:0002689]; negative regulation of monocyte chemotaxis [GO:0090027]; negative regulation of mononuclear cell migration [GO:0071676]; negative regulation of neutrophil chemotaxis [GO:0090024]; negative regulation of retinal ganglion cell axon guidance [GO:0090260]; negative regulation of small GTPase mediated signal transduction [GO:0051058]; negative regulation of smooth muscle cell chemotaxis [GO:0071672]; negative regulation of smooth muscle cell migration [GO:0014912]; negative regulation of vascular permeability [GO:0043116]; neuron projection extension [GO:1990138]; neuron projection morphogenesis [GO:0048812]; olfactory bulb development [GO:0021772]; positive regulation of apoptotic process [GO:0043065]; positive regulation of synapse assembly [GO:0051965]; pulmonary valve morphogenesis [GO:0003184]; response to cortisol [GO:0051414]; response to nutrient levels [GO:0031667]; retinal ganglion cell axon guidance [GO:0031290]; Roundabout signaling pathway [GO:0035385]; spinal cord development [GO:0021510]; synapse maturation [GO:0060074]; telencephalon cell migration [GO:0022029]; ureteric bud development [GO:0001657]; ventricular septum morphogenesis [GO:0060412] axon [GO:0030424]; cell body [GO:0044297]; cell projection [GO:0042995]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; extracellular space [GO:0005615]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; perisynaptic extracellular matrix [GO:0098966] chemorepellent activity [GO:0045499]; follicle-stimulating hormone receptor activity [GO:0004963]; GTPase inhibitor activity [GO:0005095]; heparan sulfate proteoglycan binding [GO:0043395]; heparin binding [GO:0008201]; identical protein binding [GO:0042802]; laminin-1 binding [GO:0043237]; protein homodimerization activity [GO:0042803]; proteoglycan binding [GO:0043394]; Roundabout binding [GO:0048495] g12884.t1 Q9WVC1 33.573 417 4.3e-66 229.0 sp|Q9WVC1|SLIT2_RAT Slit homolog 2 protein (Fragment) OS=Rattus norvegicus OX=10116 GN=Slit2 PE=1 SV=3 SLIT2_RAT reviewed Slit homolog 2 protein (Slit-2) Rattus norvegicus (Rat) GO:0001656; GO:0001657; GO:0001701; GO:0001822; GO:0002042; GO:0002689; GO:0003180; GO:0003184; GO:0004963; GO:0005095; GO:0005615; GO:0005737; GO:0007409; GO:0007411; GO:0008045; GO:0008201; GO:0008285; GO:0009986; GO:0010593; GO:0010596; GO:0010629; GO:0014912; GO:0016020; GO:0021510; GO:0021772; GO:0021836; GO:0021972; GO:0022029; GO:0030308; GO:0030336; GO:0030424; GO:0030425; GO:0030517; GO:0030837; GO:0031290; GO:0031667; GO:0032870; GO:0033563; GO:0035385; GO:0036120; GO:0042802; GO:0042803; GO:0042995; GO:0043025; GO:0043065; GO:0043116; GO:0043237; GO:0043394; GO:0043395; GO:0044297; GO:0045499; GO:0048495; GO:0048754; GO:0048812; GO:0048846; GO:0050919; GO:0050929; GO:0051058; GO:0051414; GO:0051965; GO:0060074; GO:0060412; GO:0060603; GO:0060763; GO:0061364; GO:0070100; GO:0071456; GO:0071504; GO:0071672; GO:0071676; GO:0090024; GO:0090027; GO:0090260; GO:0090288; GO:0098609; GO:0098966; GO:1990138 aortic valve morphogenesis [GO:0003180]; apoptotic process involved in luteolysis [GO:0061364]; axon extension involved in axon guidance [GO:0048846]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; branching morphogenesis of an epithelial tube [GO:0048754]; cell migration involved in sprouting angiogenesis [GO:0002042]; cell-cell adhesion [GO:0098609]; cellular response to heparin [GO:0071504]; cellular response to hormone stimulus [GO:0032870]; cellular response to hypoxia [GO:0071456]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; chemorepulsion involved in postnatal olfactory bulb interneuron migration [GO:0021836]; corticospinal neuron axon guidance through spinal cord [GO:0021972]; dorsal/ventral axon guidance [GO:0033563]; in utero embryonic development [GO:0001701]; induction of negative chemotaxis [GO:0050929]; kidney development [GO:0001822]; mammary duct terminal end bud growth [GO:0060763]; mammary gland duct morphogenesis [GO:0060603]; metanephros development [GO:0001656]; motor neuron axon guidance [GO:0008045]; negative chemotaxis [GO:0050919]; negative regulation of actin filament polymerization [GO:0030837]; negative regulation of axon extension [GO:0030517]; negative regulation of cell growth [GO:0030308]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cellular response to growth factor stimulus [GO:0090288]; negative regulation of chemokine-mediated signaling pathway [GO:0070100]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellipodium assembly [GO:0010593]; negative regulation of leukocyte chemotaxis [GO:0002689]; negative regulation of monocyte chemotaxis [GO:0090027]; negative regulation of mononuclear cell migration [GO:0071676]; negative regulation of neutrophil chemotaxis [GO:0090024]; negative regulation of retinal ganglion cell axon guidance [GO:0090260]; negative regulation of small GTPase mediated signal transduction [GO:0051058]; negative regulation of smooth muscle cell chemotaxis [GO:0071672]; negative regulation of smooth muscle cell migration [GO:0014912]; negative regulation of vascular permeability [GO:0043116]; neuron projection extension [GO:1990138]; neuron projection morphogenesis [GO:0048812]; olfactory bulb development [GO:0021772]; positive regulation of apoptotic process [GO:0043065]; positive regulation of synapse assembly [GO:0051965]; pulmonary valve morphogenesis [GO:0003184]; response to cortisol [GO:0051414]; response to nutrient levels [GO:0031667]; retinal ganglion cell axon guidance [GO:0031290]; Roundabout signaling pathway [GO:0035385]; spinal cord development [GO:0021510]; synapse maturation [GO:0060074]; telencephalon cell migration [GO:0022029]; ureteric bud development [GO:0001657]; ventricular septum morphogenesis [GO:0060412] axon [GO:0030424]; cell body [GO:0044297]; cell projection [GO:0042995]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; extracellular space [GO:0005615]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; perisynaptic extracellular matrix [GO:0098966] chemorepellent activity [GO:0045499]; follicle-stimulating hormone receptor activity [GO:0004963]; GTPase inhibitor activity [GO:0005095]; heparan sulfate proteoglycan binding [GO:0043395]; heparin binding [GO:0008201]; identical protein binding [GO:0042802]; laminin-1 binding [GO:0043237]; protein homodimerization activity [GO:0042803]; proteoglycan binding [GO:0043394]; Roundabout binding [GO:0048495] g12884.t1 Q9WVC1 34.322 236 1.45e-33 137.0 sp|Q9WVC1|SLIT2_RAT Slit homolog 2 protein (Fragment) OS=Rattus norvegicus OX=10116 GN=Slit2 PE=1 SV=3 SLIT2_RAT reviewed Slit homolog 2 protein (Slit-2) Rattus norvegicus (Rat) GO:0001656; GO:0001657; GO:0001701; GO:0001822; GO:0002042; GO:0002689; GO:0003180; GO:0003184; GO:0004963; GO:0005095; GO:0005615; GO:0005737; GO:0007409; GO:0007411; GO:0008045; GO:0008201; GO:0008285; GO:0009986; GO:0010593; GO:0010596; GO:0010629; GO:0014912; GO:0016020; GO:0021510; GO:0021772; GO:0021836; GO:0021972; GO:0022029; GO:0030308; GO:0030336; GO:0030424; GO:0030425; GO:0030517; GO:0030837; GO:0031290; GO:0031667; GO:0032870; GO:0033563; GO:0035385; GO:0036120; GO:0042802; GO:0042803; GO:0042995; GO:0043025; GO:0043065; GO:0043116; GO:0043237; GO:0043394; GO:0043395; GO:0044297; GO:0045499; GO:0048495; GO:0048754; GO:0048812; GO:0048846; GO:0050919; GO:0050929; GO:0051058; GO:0051414; GO:0051965; GO:0060074; GO:0060412; GO:0060603; GO:0060763; GO:0061364; GO:0070100; GO:0071456; GO:0071504; GO:0071672; GO:0071676; GO:0090024; GO:0090027; GO:0090260; GO:0090288; GO:0098609; GO:0098966; GO:1990138 aortic valve morphogenesis [GO:0003180]; apoptotic process involved in luteolysis [GO:0061364]; axon extension involved in axon guidance [GO:0048846]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; branching morphogenesis of an epithelial tube [GO:0048754]; cell migration involved in sprouting angiogenesis [GO:0002042]; cell-cell adhesion [GO:0098609]; cellular response to heparin [GO:0071504]; cellular response to hormone stimulus [GO:0032870]; cellular response to hypoxia [GO:0071456]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; chemorepulsion involved in postnatal olfactory bulb interneuron migration [GO:0021836]; corticospinal neuron axon guidance through spinal cord [GO:0021972]; dorsal/ventral axon guidance [GO:0033563]; in utero embryonic development [GO:0001701]; induction of negative chemotaxis [GO:0050929]; kidney development [GO:0001822]; mammary duct terminal end bud growth [GO:0060763]; mammary gland duct morphogenesis [GO:0060603]; metanephros development [GO:0001656]; motor neuron axon guidance [GO:0008045]; negative chemotaxis [GO:0050919]; negative regulation of actin filament polymerization [GO:0030837]; negative regulation of axon extension [GO:0030517]; negative regulation of cell growth [GO:0030308]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cellular response to growth factor stimulus [GO:0090288]; negative regulation of chemokine-mediated signaling pathway [GO:0070100]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellipodium assembly [GO:0010593]; negative regulation of leukocyte chemotaxis [GO:0002689]; negative regulation of monocyte chemotaxis [GO:0090027]; negative regulation of mononuclear cell migration [GO:0071676]; negative regulation of neutrophil chemotaxis [GO:0090024]; negative regulation of retinal ganglion cell axon guidance [GO:0090260]; negative regulation of small GTPase mediated signal transduction [GO:0051058]; negative regulation of smooth muscle cell chemotaxis [GO:0071672]; negative regulation of smooth muscle cell migration [GO:0014912]; negative regulation of vascular permeability [GO:0043116]; neuron projection extension [GO:1990138]; neuron projection morphogenesis [GO:0048812]; olfactory bulb development [GO:0021772]; positive regulation of apoptotic process [GO:0043065]; positive regulation of synapse assembly [GO:0051965]; pulmonary valve morphogenesis [GO:0003184]; response to cortisol [GO:0051414]; response to nutrient levels [GO:0031667]; retinal ganglion cell axon guidance [GO:0031290]; Roundabout signaling pathway [GO:0035385]; spinal cord development [GO:0021510]; synapse maturation [GO:0060074]; telencephalon cell migration [GO:0022029]; ureteric bud development [GO:0001657]; ventricular septum morphogenesis [GO:0060412] axon [GO:0030424]; cell body [GO:0044297]; cell projection [GO:0042995]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; extracellular space [GO:0005615]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; perisynaptic extracellular matrix [GO:0098966] chemorepellent activity [GO:0045499]; follicle-stimulating hormone receptor activity [GO:0004963]; GTPase inhibitor activity [GO:0005095]; heparan sulfate proteoglycan binding [GO:0043395]; heparin binding [GO:0008201]; identical protein binding [GO:0042802]; laminin-1 binding [GO:0043237]; protein homodimerization activity [GO:0042803]; proteoglycan binding [GO:0043394]; Roundabout binding [GO:0048495] g12884.t1 Q9WVC1 33.906 233 1.2400000000000001e-29 125.0 sp|Q9WVC1|SLIT2_RAT Slit homolog 2 protein (Fragment) OS=Rattus norvegicus OX=10116 GN=Slit2 PE=1 SV=3 SLIT2_RAT reviewed Slit homolog 2 protein (Slit-2) Rattus norvegicus (Rat) GO:0001656; GO:0001657; GO:0001701; GO:0001822; GO:0002042; GO:0002689; GO:0003180; GO:0003184; GO:0004963; GO:0005095; GO:0005615; GO:0005737; GO:0007409; GO:0007411; GO:0008045; GO:0008201; GO:0008285; GO:0009986; GO:0010593; GO:0010596; GO:0010629; GO:0014912; GO:0016020; GO:0021510; GO:0021772; GO:0021836; GO:0021972; GO:0022029; GO:0030308; GO:0030336; GO:0030424; GO:0030425; GO:0030517; GO:0030837; GO:0031290; GO:0031667; GO:0032870; GO:0033563; GO:0035385; GO:0036120; GO:0042802; GO:0042803; GO:0042995; GO:0043025; GO:0043065; GO:0043116; GO:0043237; GO:0043394; GO:0043395; GO:0044297; GO:0045499; GO:0048495; GO:0048754; GO:0048812; GO:0048846; GO:0050919; GO:0050929; GO:0051058; GO:0051414; GO:0051965; GO:0060074; GO:0060412; GO:0060603; GO:0060763; GO:0061364; GO:0070100; GO:0071456; GO:0071504; GO:0071672; GO:0071676; GO:0090024; GO:0090027; GO:0090260; GO:0090288; GO:0098609; GO:0098966; GO:1990138 aortic valve morphogenesis [GO:0003180]; apoptotic process involved in luteolysis [GO:0061364]; axon extension involved in axon guidance [GO:0048846]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; branching morphogenesis of an epithelial tube [GO:0048754]; cell migration involved in sprouting angiogenesis [GO:0002042]; cell-cell adhesion [GO:0098609]; cellular response to heparin [GO:0071504]; cellular response to hormone stimulus [GO:0032870]; cellular response to hypoxia [GO:0071456]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; chemorepulsion involved in postnatal olfactory bulb interneuron migration [GO:0021836]; corticospinal neuron axon guidance through spinal cord [GO:0021972]; dorsal/ventral axon guidance [GO:0033563]; in utero embryonic development [GO:0001701]; induction of negative chemotaxis [GO:0050929]; kidney development [GO:0001822]; mammary duct terminal end bud growth [GO:0060763]; mammary gland duct morphogenesis [GO:0060603]; metanephros development [GO:0001656]; motor neuron axon guidance [GO:0008045]; negative chemotaxis [GO:0050919]; negative regulation of actin filament polymerization [GO:0030837]; negative regulation of axon extension [GO:0030517]; negative regulation of cell growth [GO:0030308]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cellular response to growth factor stimulus [GO:0090288]; negative regulation of chemokine-mediated signaling pathway [GO:0070100]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellipodium assembly [GO:0010593]; negative regulation of leukocyte chemotaxis [GO:0002689]; negative regulation of monocyte chemotaxis [GO:0090027]; negative regulation of mononuclear cell migration [GO:0071676]; negative regulation of neutrophil chemotaxis [GO:0090024]; negative regulation of retinal ganglion cell axon guidance [GO:0090260]; negative regulation of small GTPase mediated signal transduction [GO:0051058]; negative regulation of smooth muscle cell chemotaxis [GO:0071672]; negative regulation of smooth muscle cell migration [GO:0014912]; negative regulation of vascular permeability [GO:0043116]; neuron projection extension [GO:1990138]; neuron projection morphogenesis [GO:0048812]; olfactory bulb development [GO:0021772]; positive regulation of apoptotic process [GO:0043065]; positive regulation of synapse assembly [GO:0051965]; pulmonary valve morphogenesis [GO:0003184]; response to cortisol [GO:0051414]; response to nutrient levels [GO:0031667]; retinal ganglion cell axon guidance [GO:0031290]; Roundabout signaling pathway [GO:0035385]; spinal cord development [GO:0021510]; synapse maturation [GO:0060074]; telencephalon cell migration [GO:0022029]; ureteric bud development [GO:0001657]; ventricular septum morphogenesis [GO:0060412] axon [GO:0030424]; cell body [GO:0044297]; cell projection [GO:0042995]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; extracellular space [GO:0005615]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; perisynaptic extracellular matrix [GO:0098966] chemorepellent activity [GO:0045499]; follicle-stimulating hormone receptor activity [GO:0004963]; GTPase inhibitor activity [GO:0005095]; heparan sulfate proteoglycan binding [GO:0043395]; heparin binding [GO:0008201]; identical protein binding [GO:0042802]; laminin-1 binding [GO:0043237]; protein homodimerization activity [GO:0042803]; proteoglycan binding [GO:0043394]; Roundabout binding [GO:0048495] g12885.t1 Q9R1B9 46.429 476 2.13e-149 466.0 sp|Q9R1B9|SLIT2_MOUSE Slit homolog 2 protein OS=Mus musculus OX=10090 GN=Slit2 PE=2 SV=2 SLIT2_MOUSE reviewed Slit homolog 2 protein (Slit-2) [Cleaved into: Slit homolog 2 protein N-product; Slit homolog 2 protein C-product] Mus musculus (Mouse) GO:0001656; GO:0001657; GO:0001701; GO:0001822; GO:0002042; GO:0002689; GO:0003180; GO:0003184; GO:0005095; GO:0005102; GO:0005509; GO:0005615; GO:0005737; GO:0005886; GO:0007409; GO:0007411; GO:0008045; GO:0008201; GO:0008285; GO:0009986; GO:0010593; GO:0010596; GO:0010629; GO:0014912; GO:0021772; GO:0021836; GO:0021972; GO:0022029; GO:0030308; GO:0030336; GO:0030424; GO:0030425; GO:0030517; GO:0030837; GO:0031012; GO:0031290; GO:0033563; GO:0035385; GO:0042802; GO:0042803; GO:0042995; GO:0043025; GO:0043065; GO:0043116; GO:0043237; GO:0043394; GO:0043395; GO:0044297; GO:0045499; GO:0048495; GO:0048754; GO:0048812; GO:0048846; GO:0050919; GO:0050929; GO:0051058; GO:0051965; GO:0060074; GO:0060412; GO:0060603; GO:0060763; GO:0070100; GO:0071504; GO:0071672; GO:0071676; GO:0090024; GO:0090027; GO:0090260; GO:0090288; GO:0098609; GO:0098966; GO:1990138 aortic valve morphogenesis [GO:0003180]; axon extension involved in axon guidance [GO:0048846]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; branching morphogenesis of an epithelial tube [GO:0048754]; cell migration involved in sprouting angiogenesis [GO:0002042]; cell-cell adhesion [GO:0098609]; cellular response to heparin [GO:0071504]; chemorepulsion involved in postnatal olfactory bulb interneuron migration [GO:0021836]; corticospinal neuron axon guidance through spinal cord [GO:0021972]; dorsal/ventral axon guidance [GO:0033563]; in utero embryonic development [GO:0001701]; induction of negative chemotaxis [GO:0050929]; kidney development [GO:0001822]; mammary duct terminal end bud growth [GO:0060763]; mammary gland duct morphogenesis [GO:0060603]; metanephros development [GO:0001656]; motor neuron axon guidance [GO:0008045]; negative chemotaxis [GO:0050919]; negative regulation of actin filament polymerization [GO:0030837]; negative regulation of axon extension [GO:0030517]; negative regulation of cell growth [GO:0030308]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cellular response to growth factor stimulus [GO:0090288]; negative regulation of chemokine-mediated signaling pathway [GO:0070100]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellipodium assembly [GO:0010593]; negative regulation of leukocyte chemotaxis [GO:0002689]; negative regulation of monocyte chemotaxis [GO:0090027]; negative regulation of mononuclear cell migration [GO:0071676]; negative regulation of neutrophil chemotaxis [GO:0090024]; negative regulation of retinal ganglion cell axon guidance [GO:0090260]; negative regulation of small GTPase mediated signal transduction [GO:0051058]; negative regulation of smooth muscle cell chemotaxis [GO:0071672]; negative regulation of smooth muscle cell migration [GO:0014912]; negative regulation of vascular permeability [GO:0043116]; neuron projection extension [GO:1990138]; neuron projection morphogenesis [GO:0048812]; olfactory bulb development [GO:0021772]; positive regulation of apoptotic process [GO:0043065]; positive regulation of synapse assembly [GO:0051965]; pulmonary valve morphogenesis [GO:0003184]; retinal ganglion cell axon guidance [GO:0031290]; Roundabout signaling pathway [GO:0035385]; synapse maturation [GO:0060074]; telencephalon cell migration [GO:0022029]; ureteric bud development [GO:0001657]; ventricular septum morphogenesis [GO:0060412] axon [GO:0030424]; cell body [GO:0044297]; cell projection [GO:0042995]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; neuronal cell body [GO:0043025]; perisynaptic extracellular matrix [GO:0098966]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; chemorepellent activity [GO:0045499]; GTPase inhibitor activity [GO:0005095]; heparan sulfate proteoglycan binding [GO:0043395]; heparin binding [GO:0008201]; identical protein binding [GO:0042802]; laminin-1 binding [GO:0043237]; protein homodimerization activity [GO:0042803]; proteoglycan binding [GO:0043394]; Roundabout binding [GO:0048495]; signaling receptor binding [GO:0005102] g12888.t1 Q8ITC7 26.059 307 7.28e-21 97.4 sp|Q8ITC7|CAPAR_DROME Neuropeptides capa receptor OS=Drosophila melanogaster OX=7227 GN=CapaR PE=2 SV=3 CAPAR_DROME reviewed Neuropeptides capa receptor (Cap2b receptor) (Capability receptor) Drosophila melanogaster (Fruit fly) GO:0001607; GO:0005886; GO:0007186; GO:0007218; GO:0007589; GO:0008188; GO:0016020; GO:0016323; GO:0051928; GO:0071465 body fluid secretion [GO:0007589]; cellular response to desiccation [GO:0071465]; G protein-coupled receptor signaling pathway [GO:0007186]; neuropeptide signaling pathway [GO:0007218]; positive regulation of calcium ion transport [GO:0051928] basolateral plasma membrane [GO:0016323]; membrane [GO:0016020]; plasma membrane [GO:0005886] neuromedin U receptor activity [GO:0001607]; neuropeptide receptor activity [GO:0008188] g12890.t1 B2RW38 68.068 880 0.0 1092.0 sp|B2RW38|CFA58_MOUSE Cilia- and flagella-associated protein 58 OS=Mus musculus OX=10090 GN=Cfap58 PE=1 SV=1 CFA58_MOUSE reviewed Cilia- and flagella-associated protein 58 Mus musculus (Mouse) GO:0005813; GO:0005856; GO:0007219; GO:0007288; GO:0030317; GO:0036126; GO:0060271; GO:0097225; GO:0120229; GO:0120316; GO:0120317 cilium assembly [GO:0060271]; flagellated sperm motility [GO:0030317]; Notch signaling pathway [GO:0007219]; protein localization to motile cilium [GO:0120229]; sperm axoneme assembly [GO:0007288]; sperm flagellum assembly [GO:0120316]; sperm mitochondrial sheath assembly [GO:0120317] centrosome [GO:0005813]; cytoskeleton [GO:0005856]; sperm flagellum [GO:0036126]; sperm midpiece [GO:0097225] g12891.t1 P97576 50.216 231 8.639999999999999e-61 193.0 sp|P97576|GRPE1_RAT GrpE protein homolog 1, mitochondrial OS=Rattus norvegicus OX=10116 GN=Grpel1 PE=1 SV=2 g12893.t1 A4II09 61.724 789 0.0 957.0 sp|A4II09|EIF3A_XENTR Eukaryotic translation initiation factor 3 subunit A OS=Xenopus tropicalis OX=8364 GN=eif3a PE=2 SV=1 EIF3A_XENTR reviewed Eukaryotic translation initiation factor 3 subunit A (eIF3a) (Eukaryotic translation initiation factor 3 subunit 10) (eIF-3-theta) Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0001732; GO:0002188; GO:0003729; GO:0003743; GO:0005852; GO:0016282; GO:0033290; GO:0043226; GO:0043614; GO:0071540; GO:0071541 formation of cytoplasmic translation initiation complex [GO:0001732]; translation reinitiation [GO:0002188] eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; eukaryotic translation initiation factor 3 complex, eIF3e [GO:0071540]; eukaryotic translation initiation factor 3 complex, eIF3m [GO:0071541]; multi-eIF complex [GO:0043614]; organelle [GO:0043226] mRNA binding [GO:0003729]; translation initiation factor activity [GO:0003743] g12894.t1 A8E7G4 50.144 347 7.43e-132 383.0 sp|A8E7G4|DEN10_DANRE DENN domain-containing protein 10 OS=Danio rerio OX=7955 GN=dennd10 PE=2 SV=1 g12895.t1 Q03181 37.795 381 5.77e-63 211.0 sp|Q03181|PPARD_HUMAN Peroxisome proliferator-activated receptor delta OS=Homo sapiens OX=9606 GN=PPARD PE=1 SV=1 PPARD_HUMAN reviewed Peroxisome proliferator-activated receptor delta (PPAR-delta) (NUCI) (Nuclear hormone receptor 1) (NUC1) (Nuclear receptor subfamily 1 group C member 2) (Peroxisome proliferator-activated receptor beta) (PPAR-beta) Homo sapiens (Human) GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0001223; GO:0001227; GO:0003677; GO:0003700; GO:0003707; GO:0004879; GO:0005634; GO:0005654; GO:0006006; GO:0006029; GO:0006091; GO:0006357; GO:0006629; GO:0006631; GO:0006635; GO:0006915; GO:0007507; GO:0007566; GO:0008203; GO:0008270; GO:0008283; GO:0008289; GO:0008366; GO:0008654; GO:0009062; GO:0009749; GO:0009755; GO:0010628; GO:0010887; GO:0014823; GO:0014842; GO:0014912; GO:0015908; GO:0030154; GO:0030308; GO:0030522; GO:0031589; GO:0031669; GO:0032966; GO:0033189; GO:0035774; GO:0042060; GO:0042311; GO:0043066; GO:0043415; GO:0043491; GO:0043616; GO:0045600; GO:0045662; GO:0045684; GO:0045892; GO:0045893; GO:0045923; GO:0045944; GO:0046321; GO:0046697; GO:0048662; GO:0050680; GO:0050728; GO:0051059; GO:0051546; GO:0051897; GO:0060612; GO:0070341; GO:0070346; GO:0070539; GO:0071222; GO:0071456; GO:0090575; GO:0097009; GO:0097190; GO:1902894; GO:1904659; GO:1990837; GO:2000288 adipose tissue development [GO:0060612]; apoptotic process [GO:0006915]; apoptotic signaling pathway [GO:0097190]; axon ensheathment [GO:0008366]; cell differentiation [GO:0030154]; cell population proliferation [GO:0008283]; cell-substrate adhesion [GO:0031589]; cellular response to hypoxia [GO:0071456]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to nutrient levels [GO:0031669]; cholesterol metabolic process [GO:0008203]; D-glucose transmembrane transport [GO:1904659]; decidualization [GO:0046697]; embryo implantation [GO:0007566]; energy homeostasis [GO:0097009]; fat cell proliferation [GO:0070341]; fatty acid beta-oxidation [GO:0006635]; fatty acid catabolic process [GO:0009062]; fatty acid metabolic process [GO:0006631]; fatty acid transport [GO:0015908]; generation of precursor metabolites and energy [GO:0006091]; glucose metabolic process [GO:0006006]; heart development [GO:0007507]; hormone-mediated signaling pathway [GO:0009755]; intracellular receptor signaling pathway [GO:0030522]; keratinocyte migration [GO:0051546]; keratinocyte proliferation [GO:0043616]; lipid metabolic process [GO:0006629]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell growth [GO:0030308]; negative regulation of cholesterol storage [GO:0010887]; negative regulation of collagen biosynthetic process [GO:0032966]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of inflammatory response [GO:0050728]; negative regulation of miRNA transcription [GO:1902894]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of smooth muscle cell migration [GO:0014912]; negative regulation of smooth muscle cell proliferation [GO:0048662]; negative regulation of transcription by RNA polymerase II [GO:0000122]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; phospholipid biosynthetic process [GO:0008654]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of epidermis development [GO:0045684]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of fat cell proliferation [GO:0070346]; positive regulation of fatty acid metabolic process [GO:0045923]; positive regulation of fatty acid oxidation [GO:0046321]; positive regulation of gene expression [GO:0010628]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of myoblast proliferation [GO:2000288]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of skeletal muscle tissue regeneration [GO:0043415]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteoglycan metabolic process [GO:0006029]; regulation of skeletal muscle satellite cell proliferation [GO:0014842]; regulation of transcription by RNA polymerase II [GO:0006357]; response to activity [GO:0014823]; response to glucose [GO:0009749]; response to vitamin A [GO:0033189]; vasodilation [GO:0042311]; wound healing [GO:0042060] chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575] DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; linoleic acid binding [GO:0070539]; lipid binding [GO:0008289]; NF-kappaB binding [GO:0051059]; nuclear receptor activity [GO:0004879]; nuclear steroid receptor activity [GO:0003707]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription coactivator binding [GO:0001223]; zinc ion binding [GO:0008270] g12896.t1 Q3THE2 71.523 151 2.12e-76 231.0 sp|Q3THE2|ML12B_MOUSE Myosin regulatory light chain 12B OS=Mus musculus OX=10090 GN=Myl12b PE=1 SV=2 ML12B_MOUSE reviewed Myosin regulatory light chain 12B (Myosin regulatory light chain 2-B, smooth muscle isoform) (Myosin regulatory light chain 20 kDa) (MLC20) (Myosin regulatory light chain MRLC2) Mus musculus (Mouse) GO:0001725; GO:0005509; GO:0005737; GO:0005903; GO:0005938; GO:0008360; GO:0016460; GO:0030016; GO:0030018; GO:0032036; GO:0032991; GO:0045177 regulation of cell shape [GO:0008360] apical part of cell [GO:0045177]; brush border [GO:0005903]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; myofibril [GO:0030016]; myosin II complex [GO:0016460]; protein-containing complex [GO:0032991]; stress fiber [GO:0001725]; Z disc [GO:0030018] calcium ion binding [GO:0005509]; myosin heavy chain binding [GO:0032036] g12898.t1 Q504G0 36.486 222 1.16e-40 144.0 sp|Q504G0|TM127_DANRE Transmembrane protein 127 OS=Danio rerio OX=7955 GN=tmem127 PE=2 SV=1 g12899.t1 Q5ZIG2 64.384 438 0.0 548.0 sp|Q5ZIG2|SLU7_CHICK Pre-mRNA-splicing factor SLU7 OS=Gallus gallus OX=9031 GN=SLU7 PE=2 SV=1 SLU7_CHICK reviewed Pre-mRNA-splicing factor SLU7 Gallus gallus (Chicken) GO:0000398; GO:0005681; GO:0005737; GO:0008270; GO:0008380; GO:0016607; GO:0030628 mRNA splicing, via spliceosome [GO:0000398]; RNA splicing [GO:0008380] cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; spliceosomal complex [GO:0005681] pre-mRNA 3'-splice site binding [GO:0030628]; zinc ion binding [GO:0008270] g12900.t1 Q8CGS4 61.435 223 2.96e-66 206.0 sp|Q8CGS4|CHMP3_RAT Charged multivesicular body protein 3 OS=Rattus norvegicus OX=10116 GN=Chmp3 PE=1 SV=3 CHMP3_RAT reviewed Charged multivesicular body protein 3 (Chromatin-modifying protein 3) (Vacuolar protein sorting-associated protein 24) (rVps24p) Rattus norvegicus (Rat) GO:0000421; GO:0000776; GO:0000815; GO:0001778; GO:0005546; GO:0005643; GO:0005765; GO:0005769; GO:0005770; GO:0005771; GO:0005828; GO:0005829; GO:0005886; GO:0006914; GO:0006997; GO:0007080; GO:0008333; GO:0010824; GO:0015031; GO:0030496; GO:0031210; GO:0031410; GO:0031468; GO:0032467; GO:0032509; GO:0032585; GO:0039702; GO:0042802; GO:0043162; GO:0044790; GO:0045324; GO:0046761; GO:0051036; GO:0051258; GO:0061763; GO:0061952; GO:0071985; GO:0097352; GO:0140678; GO:1901673; GO:1902774; GO:1904930; GO:1990381; GO:2000641 autophagosome maturation [GO:0097352]; autophagy [GO:0006914]; endosome to lysosome transport [GO:0008333]; endosome transport via multivesicular body sorting pathway [GO:0032509]; late endosome to lysosome transport [GO:1902774]; late endosome to vacuole transport [GO:0045324]; midbody abscission [GO:0061952]; mitotic metaphase chromosome alignment [GO:0007080]; multivesicular body sorting pathway [GO:0071985]; multivesicular body-lysosome fusion [GO:0061763]; nuclear membrane reassembly [GO:0031468]; nucleus organization [GO:0006997]; plasma membrane repair [GO:0001778]; positive regulation of cytokinesis [GO:0032467]; protein polymerization [GO:0051258]; protein transport [GO:0015031]; regulation of centrosome duplication [GO:0010824]; regulation of early endosome to late endosome transport [GO:2000641]; regulation of endosome size [GO:0051036]; regulation of mitotic spindle assembly [GO:1901673]; suppression of viral release by host [GO:0044790]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]; viral budding from plasma membrane [GO:0046761]; viral budding via host ESCRT complex [GO:0039702] amphisome membrane [GO:1904930]; autophagosome membrane [GO:0000421]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; early endosome [GO:0005769]; ESCRT III complex [GO:0000815]; kinetochore [GO:0000776]; kinetochore microtubule [GO:0005828]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; midbody [GO:0030496]; multivesicular body [GO:0005771]; multivesicular body membrane [GO:0032585]; nuclear pore [GO:0005643]; plasma membrane [GO:0005886] identical protein binding [GO:0042802]; molecular function inhibitor activity [GO:0140678]; phosphatidylcholine binding [GO:0031210]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; ubiquitin-specific protease binding [GO:1990381] g12901.t1 P16066 35.23 1107 0.0 581.0 sp|P16066|ANPRA_HUMAN Atrial natriuretic peptide receptor 1 OS=Homo sapiens OX=9606 GN=NPR1 PE=1 SV=1 ANPRA_HUMAN reviewed Atrial natriuretic peptide receptor 1 (EC 4.6.1.2) (Atrial natriuretic peptide receptor type A) (ANP-A) (ANPR-A) (NPR-A) (Guanylate cyclase A) (GC-A) Homo sapiens (Human) GO:0001653; GO:0004383; GO:0004672; GO:0005524; GO:0005525; GO:0005886; GO:0006182; GO:0007166; GO:0007168; GO:0007589; GO:0008217; GO:0008528; GO:0010753; GO:0016525; GO:0016941; GO:0017046; GO:0019934; GO:0030308; GO:0035810; GO:0035815; GO:0042417; GO:0042562; GO:0043114; GO:0043235; GO:0048662; GO:0097746; GO:1990620 blood vessel diameter maintenance [GO:0097746]; body fluid secretion [GO:0007589]; cell surface receptor signaling pathway [GO:0007166]; cGMP biosynthetic process [GO:0006182]; cGMP-mediated signaling [GO:0019934]; dopamine metabolic process [GO:0042417]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell growth [GO:0030308]; negative regulation of smooth muscle cell proliferation [GO:0048662]; positive regulation of cGMP-mediated signaling [GO:0010753]; positive regulation of renal sodium excretion [GO:0035815]; positive regulation of urine volume [GO:0035810]; receptor guanylyl cyclase signaling pathway [GO:0007168]; regulation of blood pressure [GO:0008217]; regulation of vascular permeability [GO:0043114] ANPR-A receptor complex [GO:1990620]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] ATP binding [GO:0005524]; G protein-coupled peptide receptor activity [GO:0008528]; GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; hormone binding [GO:0042562]; natriuretic peptide receptor activity [GO:0016941]; peptide hormone binding [GO:0017046]; peptide receptor activity [GO:0001653]; protein kinase activity [GO:0004672] g12902.t1 C3YWU0 60.36 444 0.0 566.0 sp|C3YWU0|FUCO_BRAFL Alpha-L-fucosidase OS=Branchiostoma floridae OX=7739 GN=BRAFLDRAFT_56888 PE=3 SV=2 g12903.t1 P82917 46.457 127 9.580000000000001e-31 113.0 sp|P82917|RT18C_BOVIN Small ribosomal subunit protein bS18m OS=Bos taurus OX=9913 GN=MRPS18C PE=1 SV=2 g12904.t1 Q3ZBR5 56.731 208 1.0799999999999999e-69 223.0 sp|Q3ZBR5|TTC1_BOVIN Tetratricopeptide repeat protein 1 OS=Bos taurus OX=9913 GN=TTC1 PE=2 SV=1 g12907.t1 Q9VGY6 35.417 432 5.93e-83 281.0 sp|Q9VGY6|SKEL1_DROME Protein Skeletor, isoforms B/C OS=Drosophila melanogaster OX=7227 GN=Skel PE=1 SV=2 SKEL1_DROME reviewed Protein Skeletor, isoforms B/C Drosophila melanogaster (Fruit fly) GO:0005634; GO:0005700; GO:0005730; GO:0005819; GO:0005874; GO:0006997; GO:0051225; GO:0051301; GO:0051321 cell division [GO:0051301]; meiotic cell cycle [GO:0051321]; nucleus organization [GO:0006997]; spindle assembly [GO:0051225] microtubule [GO:0005874]; nucleolus [GO:0005730]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; spindle [GO:0005819] g12907.t1 Q9VGY6 48.529 204 6.61e-52 196.0 sp|Q9VGY6|SKEL1_DROME Protein Skeletor, isoforms B/C OS=Drosophila melanogaster OX=7227 GN=Skel PE=1 SV=2 SKEL1_DROME reviewed Protein Skeletor, isoforms B/C Drosophila melanogaster (Fruit fly) GO:0005634; GO:0005700; GO:0005730; GO:0005819; GO:0005874; GO:0006997; GO:0051225; GO:0051301; GO:0051321 cell division [GO:0051301]; meiotic cell cycle [GO:0051321]; nucleus organization [GO:0006997]; spindle assembly [GO:0051225] microtubule [GO:0005874]; nucleolus [GO:0005730]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; spindle [GO:0005819] g12908.t1 Q9BUD6 37.662 308 1.5600000000000002e-66 217.0 sp|Q9BUD6|SPON2_HUMAN Spondin-2 OS=Homo sapiens OX=9606 GN=SPON2 PE=1 SV=4 g12908.t2 Q9BUD6 39.597 298 1.9199999999999998e-69 224.0 sp|Q9BUD6|SPON2_HUMAN Spondin-2 OS=Homo sapiens OX=9606 GN=SPON2 PE=1 SV=4 g12909.t1 Q9W676 80.169 237 3.26e-143 413.0 sp|Q9W676|LDB2_CHICK LIM domain-binding protein 2 OS=Gallus gallus OX=9031 GN=LDB2 PE=2 SV=1 g12909.t2 Q9W676 80.426 235 4.59e-142 410.0 sp|Q9W676|LDB2_CHICK LIM domain-binding protein 2 OS=Gallus gallus OX=9031 GN=LDB2 PE=2 SV=1 g12909.t3 Q9W676 80.591 237 7.1499999999999995e-146 420.0 sp|Q9W676|LDB2_CHICK LIM domain-binding protein 2 OS=Gallus gallus OX=9031 GN=LDB2 PE=2 SV=1 g12911.t1 Q9VGY6 36.623 456 1.11e-75 261.0 sp|Q9VGY6|SKEL1_DROME Protein Skeletor, isoforms B/C OS=Drosophila melanogaster OX=7227 GN=Skel PE=1 SV=2 SKEL1_DROME reviewed Protein Skeletor, isoforms B/C Drosophila melanogaster (Fruit fly) GO:0005634; GO:0005700; GO:0005730; GO:0005819; GO:0005874; GO:0006997; GO:0051225; GO:0051301; GO:0051321 cell division [GO:0051301]; meiotic cell cycle [GO:0051321]; nucleus organization [GO:0006997]; spindle assembly [GO:0051225] microtubule [GO:0005874]; nucleolus [GO:0005730]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; spindle [GO:0005819] g12911.t1 Q9VGY6 46.154 195 4.96e-46 178.0 sp|Q9VGY6|SKEL1_DROME Protein Skeletor, isoforms B/C OS=Drosophila melanogaster OX=7227 GN=Skel PE=1 SV=2 SKEL1_DROME reviewed Protein Skeletor, isoforms B/C Drosophila melanogaster (Fruit fly) GO:0005634; GO:0005700; GO:0005730; GO:0005819; GO:0005874; GO:0006997; GO:0051225; GO:0051301; GO:0051321 cell division [GO:0051301]; meiotic cell cycle [GO:0051321]; nucleus organization [GO:0006997]; spindle assembly [GO:0051225] microtubule [GO:0005874]; nucleolus [GO:0005730]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; spindle [GO:0005819] g12912.t1 Q9VGY6 32.333 433 5.23e-61 221.0 sp|Q9VGY6|SKEL1_DROME Protein Skeletor, isoforms B/C OS=Drosophila melanogaster OX=7227 GN=Skel PE=1 SV=2 SKEL1_DROME reviewed Protein Skeletor, isoforms B/C Drosophila melanogaster (Fruit fly) GO:0005634; GO:0005700; GO:0005730; GO:0005819; GO:0005874; GO:0006997; GO:0051225; GO:0051301; GO:0051321 cell division [GO:0051301]; meiotic cell cycle [GO:0051321]; nucleus organization [GO:0006997]; spindle assembly [GO:0051225] microtubule [GO:0005874]; nucleolus [GO:0005730]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; spindle [GO:0005819] g12912.t1 Q9VGY6 37.791 172 3.58e-26 118.0 sp|Q9VGY6|SKEL1_DROME Protein Skeletor, isoforms B/C OS=Drosophila melanogaster OX=7227 GN=Skel PE=1 SV=2 SKEL1_DROME reviewed Protein Skeletor, isoforms B/C Drosophila melanogaster (Fruit fly) GO:0005634; GO:0005700; GO:0005730; GO:0005819; GO:0005874; GO:0006997; GO:0051225; GO:0051301; GO:0051321 cell division [GO:0051301]; meiotic cell cycle [GO:0051321]; nucleus organization [GO:0006997]; spindle assembly [GO:0051225] microtubule [GO:0005874]; nucleolus [GO:0005730]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; spindle [GO:0005819] g12913.t1 P55035 45.038 131 8.76e-22 94.4 sp|P55035|PSMD4_DROME 26S proteasome non-ATPase regulatory subunit 4 OS=Drosophila melanogaster OX=7227 GN=Rpn10 PE=1 SV=2 PSMD4_DROME reviewed 26S proteasome non-ATPase regulatory subunit 4 (26S proteasome regulatory subunit RPN10) (26S proteasome regulatory subunit S5A) (54 kDa subunit of mu particle) (Multiubiquitin chain-binding protein) (p54) Drosophila melanogaster (Fruit fly) GO:0000070; GO:0000502; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005838; GO:0008270; GO:0008540; GO:0031593; GO:0031624; GO:0043161 mitotic sister chromatid segregation [GO:0000070]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; proteasome regulatory particle [GO:0005838]; proteasome regulatory particle, base subcomplex [GO:0008540] polyubiquitin modification-dependent protein binding [GO:0031593]; ubiquitin conjugating enzyme binding [GO:0031624]; zinc ion binding [GO:0008270] g12914.t1 P55036 74.719 178 6.26e-86 260.0 sp|P55036|PSMD4_HUMAN 26S proteasome non-ATPase regulatory subunit 4 OS=Homo sapiens OX=9606 GN=PSMD4 PE=1 SV=1 PSMD4_HUMAN reviewed 26S proteasome non-ATPase regulatory subunit 4 (26S proteasome regulatory subunit RPN10) (26S proteasome regulatory subunit S5A) (Antisecretory factor 1) (AF) (ASF) (Multiubiquitin chain-binding protein) Homo sapiens (Human) GO:0000502; GO:0003723; GO:0005634; GO:0005654; GO:0005829; GO:0008540; GO:0022624; GO:0031593; GO:0042802; GO:0043161; GO:0060090 proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; proteasome regulatory particle, base subcomplex [GO:0008540] identical protein binding [GO:0042802]; molecular adaptor activity [GO:0060090]; polyubiquitin modification-dependent protein binding [GO:0031593]; RNA binding [GO:0003723] g12915.t1 A6NED2 34.513 226 4.8200000000000004e-29 122.0 sp|A6NED2|RCCD1_HUMAN RCC1 domain-containing protein 1 OS=Homo sapiens OX=9606 GN=RCCD1 PE=1 SV=1 RCCD1_HUMAN reviewed RCC1 domain-containing protein 1 Homo sapiens (Human) GO:0005694; GO:0005829; GO:0005886; GO:0006325 chromatin organization [GO:0006325] chromosome [GO:0005694]; cytosol [GO:0005829]; plasma membrane [GO:0005886] g12915.t1 A6NED2 51.064 94 2.1800000000000003e-21 99.8 sp|A6NED2|RCCD1_HUMAN RCC1 domain-containing protein 1 OS=Homo sapiens OX=9606 GN=RCCD1 PE=1 SV=1 RCCD1_HUMAN reviewed RCC1 domain-containing protein 1 Homo sapiens (Human) GO:0005694; GO:0005829; GO:0005886; GO:0006325 chromatin organization [GO:0006325] chromosome [GO:0005694]; cytosol [GO:0005829]; plasma membrane [GO:0005886] g12919.t1 Q969Q5 71.264 174 8.8e-80 239.0 sp|Q969Q5|RAB24_HUMAN Ras-related protein Rab-24 OS=Homo sapiens OX=9606 GN=RAB24 PE=1 SV=1 RAB24_HUMAN reviewed Ras-related protein Rab-24 (EC 3.6.5.2) Homo sapiens (Human) GO:0000421; GO:0001556; GO:0003924; GO:0003925; GO:0005525; GO:0005739; GO:0005768; GO:0005776; GO:0005819; GO:0005829; GO:0005886; GO:0006886; GO:0006914; GO:0008608; GO:0012505; GO:0030139; GO:0030667; GO:0046872; GO:0048471; GO:0140013 attachment of spindle microtubules to kinetochore [GO:0008608]; autophagy [GO:0006914]; intracellular protein transport [GO:0006886]; meiotic nuclear division [GO:0140013]; oocyte maturation [GO:0001556] autophagosome [GO:0005776]; autophagosome membrane [GO:0000421]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; endomembrane system [GO:0012505]; endosome [GO:0005768]; mitochondrion [GO:0005739]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; spindle [GO:0005819] G protein activity [GO:0003925]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872] g12920.t1 Q05B50 60.0 265 3.71e-111 325.0 sp|Q05B50|THG1_BOVIN Probable tRNA(His) guanylyltransferase OS=Bos taurus OX=9913 GN=THG1L PE=2 SV=1 g12922.t1 Q95JJ0 50.725 276 2.52e-93 285.0 sp|Q95JJ0|SG196_MACFA Protein O-mannose kinase OS=Macaca fascicularis OX=9541 GN=POMK PE=2 SV=2 g12923.t1 Q91YP6 49.511 307 1.42e-96 299.0 sp|Q91YP6|ELMD3_MOUSE ELMO domain-containing protein 3 OS=Mus musculus OX=10090 GN=Elmod3 PE=1 SV=1 g12923.t2 Q91YP6 49.671 304 2.26e-98 303.0 sp|Q91YP6|ELMD3_MOUSE ELMO domain-containing protein 3 OS=Mus musculus OX=10090 GN=Elmod3 PE=1 SV=1 g12925.t1 P26187 42.614 176 8.4e-35 124.0 sp|P26187|MGMT_MOUSE Methylated-DNA--protein-cysteine methyltransferase OS=Mus musculus OX=10090 GN=Mgmt PE=1 SV=3 MGMT_MOUSE reviewed Methylated-DNA--protein-cysteine methyltransferase (EC 2.1.1.63) (6-O-methylguanine-DNA methyltransferase) (MGMT) (O-6-methylguanine-DNA-alkyltransferase) Mus musculus (Mouse) GO:0003677; GO:0003908; GO:0005509; GO:0005654; GO:0006281; GO:0006307; GO:0006974; GO:0008168; GO:0032259; GO:0043066; GO:0045739; GO:2000781 DNA alkylation repair [GO:0006307]; DNA damage response [GO:0006974]; DNA repair [GO:0006281]; methylation [GO:0032259]; negative regulation of apoptotic process [GO:0043066]; positive regulation of DNA repair [GO:0045739]; positive regulation of double-strand break repair [GO:2000781] nucleoplasm [GO:0005654] calcium ion binding [GO:0005509]; DNA binding [GO:0003677]; methylated-DNA-[protein]-cysteine S-methyltransferase activity [GO:0003908]; methyltransferase activity [GO:0008168] g12927.t1 O96028 58.468 679 0.0 832.0 sp|O96028|NSD2_HUMAN Histone-lysine N-methyltransferase NSD2 OS=Homo sapiens OX=9606 GN=NSD2 PE=1 SV=1 g12927.t1 O96028 28.733 442 2.4599999999999998e-40 167.0 sp|O96028|NSD2_HUMAN Histone-lysine N-methyltransferase NSD2 OS=Homo sapiens OX=9606 GN=NSD2 PE=1 SV=1 g12928.t1 Q6QD59 49.558 226 4.49e-56 181.0 sp|Q6QD59|SEC20_MOUSE Vesicle transport protein SEC20 OS=Mus musculus OX=10090 GN=Bnip1 PE=1 SV=1 g12929.t1 Q9Y227 53.806 578 0.0 625.0 sp|Q9Y227|ENTP4_HUMAN Ectonucleoside triphosphate diphosphohydrolase 4 OS=Homo sapiens OX=9606 GN=ENTPD4 PE=1 SV=1 ENTP4_HUMAN reviewed Ectonucleoside triphosphate diphosphohydrolase 4 (NTPDase 4) (EC 3.6.1.15) (EC 3.6.1.6) (Golgi UDPase) (Lysosomal apyrase-like protein of 70 kDa) (Uridine-diphosphatase) (UDPase) (EC 3.6.1.42) Homo sapiens (Human) GO:0000139; GO:0000421; GO:0003924; GO:0004382; GO:0005765; GO:0005794; GO:0006256; GO:0016020; GO:0017110; GO:0017111; GO:0031410; GO:0034656; GO:0036384; GO:0043273; GO:0045134; GO:0046036; GO:0046712 CTP metabolic process [GO:0046036]; GDP catabolic process [GO:0046712]; nucleobase-containing small molecule catabolic process [GO:0034656]; UDP catabolic process [GO:0006256] autophagosome membrane [GO:0000421]; cytoplasmic vesicle [GO:0031410]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; lysosomal membrane [GO:0005765]; membrane [GO:0016020] CDP phosphatase activity [GO:0036384]; CTPase activity [GO:0043273]; GDP phosphatase activity [GO:0004382]; GTPase activity [GO:0003924]; nucleoside diphosphate phosphatase activity [GO:0017110]; ribonucleoside triphosphate phosphatase activity [GO:0017111]; UDP phosphatase activity [GO:0045134] g12929.t2 Q9Y227 54.231 579 0.0 633.0 sp|Q9Y227|ENTP4_HUMAN Ectonucleoside triphosphate diphosphohydrolase 4 OS=Homo sapiens OX=9606 GN=ENTPD4 PE=1 SV=1 ENTP4_HUMAN reviewed Ectonucleoside triphosphate diphosphohydrolase 4 (NTPDase 4) (EC 3.6.1.15) (EC 3.6.1.6) (Golgi UDPase) (Lysosomal apyrase-like protein of 70 kDa) (Uridine-diphosphatase) (UDPase) (EC 3.6.1.42) Homo sapiens (Human) GO:0000139; GO:0000421; GO:0003924; GO:0004382; GO:0005765; GO:0005794; GO:0006256; GO:0016020; GO:0017110; GO:0017111; GO:0031410; GO:0034656; GO:0036384; GO:0043273; GO:0045134; GO:0046036; GO:0046712 CTP metabolic process [GO:0046036]; GDP catabolic process [GO:0046712]; nucleobase-containing small molecule catabolic process [GO:0034656]; UDP catabolic process [GO:0006256] autophagosome membrane [GO:0000421]; cytoplasmic vesicle [GO:0031410]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; lysosomal membrane [GO:0005765]; membrane [GO:0016020] CDP phosphatase activity [GO:0036384]; CTPase activity [GO:0043273]; GDP phosphatase activity [GO:0004382]; GTPase activity [GO:0003924]; nucleoside diphosphate phosphatase activity [GO:0017110]; ribonucleoside triphosphate phosphatase activity [GO:0017111]; UDP phosphatase activity [GO:0045134] g12930.t1 Q8IUR6 61.538 156 8.819999999999999e-48 179.0 sp|Q8IUR6|CRERF_HUMAN CREB3 regulatory factor OS=Homo sapiens OX=9606 GN=CREBRF PE=1 SV=2 g12932.t1 P10394 40.0 195 1.67e-40 139.0 sp|P10394|POL4_DROME Retrovirus-related Pol polyprotein from transposon 412 OS=Drosophila melanogaster OX=7227 GN=POL PE=4 SV=1 g12932.t1 P10394 26.415 106 1.67e-40 52.0 sp|P10394|POL4_DROME Retrovirus-related Pol polyprotein from transposon 412 OS=Drosophila melanogaster OX=7227 GN=POL PE=4 SV=1 g12933.t1 Q5QJC4 52.478 343 8.44e-127 414.0 sp|Q5QJC4|DCR1A_CHICK DNA cross-link repair 1A protein OS=Gallus gallus OX=9031 GN=DCLRE1A PE=1 SV=1 DCR1A_CHICK reviewed DNA cross-link repair 1A protein (Beta-lactamase MBLAC2) (EC 3.5.2.6) (SNM1 homolog A) (chSNM1A) Gallus gallus (Chicken) GO:0003684; GO:0005634; GO:0005654; GO:0006303; GO:0008270; GO:0008800; GO:0035312; GO:0036297 double-strand break repair via nonhomologous end joining [GO:0006303]; interstrand cross-link repair [GO:0036297] nucleoplasm [GO:0005654]; nucleus [GO:0005634] 5'-3' DNA exonuclease activity [GO:0035312]; beta-lactamase activity [GO:0008800]; damaged DNA binding [GO:0003684]; zinc ion binding [GO:0008270] g12935.t1 P31401 87.835 485 0.0 875.0 sp|P31401|VATB_MANSE V-type proton ATPase subunit B OS=Manduca sexta OX=7130 GN=VHA55 PE=2 SV=1 g12939.t1 Q8BLD6 49.405 336 2.82e-96 315.0 sp|Q8BLD6|ANR55_MOUSE Ankyrin repeat domain-containing protein 55 OS=Mus musculus OX=10090 GN=Ankrd55 PE=1 SV=2 g12943.t1 Q98TX3 48.736 435 2.46e-98 306.0 sp|Q98TX3|PDCD4_CHICK Programmed cell death protein 4 OS=Gallus gallus OX=9031 GN=PDCD4 PE=2 SV=1 g12944.t1 Q9JIW4 38.443 411 6.04e-87 283.0 sp|Q9JIW4|DPOLM_MOUSE DNA-directed DNA/RNA polymerase mu OS=Mus musculus OX=10090 GN=Polm PE=1 SV=2 DPOLM_MOUSE reviewed DNA-directed DNA/RNA polymerase mu (Pol Mu) (EC 2.7.7.7) (Terminal transferase) Mus musculus (Mouse) GO:0003677; GO:0003887; GO:0005634; GO:0006303; GO:0006310; GO:0016446; GO:0030183; GO:0046872 B cell differentiation [GO:0030183]; DNA recombination [GO:0006310]; double-strand break repair via nonhomologous end joining [GO:0006303]; somatic hypermutation of immunoglobulin genes [GO:0016446] nucleus [GO:0005634] DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; metal ion binding [GO:0046872] g12945.t1 Q5REX0 61.333 75 2.89e-24 91.3 sp|Q5REX0|SMIM8_PONAB Small integral membrane protein 8 OS=Pongo abelii OX=9601 GN=SMIM8 PE=3 SV=1 g12946.t1 G4V4G1 36.364 231 2.3199999999999997e-41 146.0 sp|G4V4G1|IGFBP_CUPSA Insulin-like growth factor-binding protein-related protein 1 OS=Cupiennius salei OX=6928 PE=2 SV=1 g12949.t1 Q61581 36.123 227 3.7500000000000003e-31 119.0 sp|Q61581|IBP7_MOUSE Insulin-like growth factor-binding protein 7 OS=Mus musculus OX=10090 GN=Igfbp7 PE=1 SV=3 IBP7_MOUSE reviewed Insulin-like growth factor-binding protein 7 (IBP-7) (IGF-binding protein 7) (IGFBP-7) (MAC25 protein) Mus musculus (Mouse) GO:0001525; GO:0001558; GO:0005520; GO:0005615; GO:0007155; GO:0009966; GO:0031012; GO:0048018; GO:0048839; GO:0050810 angiogenesis [GO:0001525]; cell adhesion [GO:0007155]; inner ear development [GO:0048839]; regulation of cell growth [GO:0001558]; regulation of signal transduction [GO:0009966]; regulation of steroid biosynthetic process [GO:0050810] extracellular matrix [GO:0031012]; extracellular space [GO:0005615] insulin-like growth factor binding [GO:0005520]; receptor ligand activity [GO:0048018] g12950.t1 Q6AYK5 49.432 176 3.64e-53 182.0 sp|Q6AYK5|LYAR_RAT Cell growth-regulating nucleolar protein OS=Rattus norvegicus OX=10116 GN=Lyar PE=1 SV=1 LYAR_RAT reviewed Cell growth-regulating nucleolar protein Rattus norvegicus (Rat) GO:0000122; GO:0001750; GO:0003677; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006364; GO:0008270; GO:0042802; GO:0045087; GO:0045824; GO:0045943; GO:0048821; GO:0050766; GO:0140297; GO:0140416 erythrocyte development [GO:0048821]; innate immune response [GO:0045087]; negative regulation of innate immune response [GO:0045824]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of phagocytosis [GO:0050766]; positive regulation of transcription by RNA polymerase I [GO:0045943]; rRNA processing [GO:0006364] cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; photoreceptor outer segment [GO:0001750] DNA binding [GO:0003677]; DNA-binding transcription factor binding [GO:0140297]; identical protein binding [GO:0042802]; transcription regulator inhibitor activity [GO:0140416]; zinc ion binding [GO:0008270] g12952.t1 Q2TBI1 33.438 317 1.9e-39 146.0 sp|Q2TBI1|NSE4A_BOVIN Non-structural maintenance of chromosomes element 4 homolog A OS=Bos taurus OX=9913 GN=NSMCE4A PE=2 SV=1 g12956.t1 Q6Y685 46.269 201 6.59e-45 165.0 sp|Q6Y685|TACC1_MOUSE Transforming acidic coiled-coil-containing protein 1 OS=Mus musculus OX=10090 GN=Tacc1 PE=1 SV=1 TACC1_MOUSE reviewed Transforming acidic coiled-coil-containing protein 1 Mus musculus (Mouse) GO:0000226; GO:0003713; GO:0005634; GO:0005737; GO:0005813; GO:0005829; GO:0007052; GO:0007097; GO:0008283; GO:0016922; GO:0019904; GO:0021987; GO:0022008; GO:0022027; GO:0030331; GO:0030496; GO:0032886; GO:0035259; GO:0042974; GO:0042975; GO:0046965; GO:0046966; GO:0051301 cell division [GO:0051301]; cell population proliferation [GO:0008283]; cerebral cortex development [GO:0021987]; interkinetic nuclear migration [GO:0022027]; microtubule cytoskeleton organization [GO:0000226]; mitotic spindle organization [GO:0007052]; neurogenesis [GO:0022008]; nuclear migration [GO:0007097]; regulation of microtubule-based process [GO:0032886] centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; midbody [GO:0030496]; nucleus [GO:0005634] nuclear estrogen receptor binding [GO:0030331]; nuclear glucocorticoid receptor binding [GO:0035259]; nuclear receptor binding [GO:0016922]; nuclear retinoic acid receptor binding [GO:0042974]; nuclear retinoid X receptor binding [GO:0046965]; nuclear thyroid hormone receptor binding [GO:0046966]; peroxisome proliferator activated receptor binding [GO:0042975]; protein domain specific binding [GO:0019904]; transcription coactivator activity [GO:0003713] g12958.t1 B2GU58 42.244 1025 0.0 633.0 sp|B2GU58|KIF11_XENTR Kinesin-like protein KIF11 OS=Xenopus tropicalis OX=8364 GN=kif11 PE=2 SV=1 g12959.t1 E1C760 37.215 790 3.3599999999999995e-126 398.0 sp|E1C760|UVSSA_CHICK UV-stimulated scaffold protein A OS=Gallus gallus OX=9031 GN=UVSSA PE=3 SV=1 g12961.t1 Q28DV7 49.115 452 3.88e-124 377.0 sp|Q28DV7|MCMBP_XENTR Mini-chromosome maintenance complex-binding protein OS=Xenopus tropicalis OX=8364 GN=mcmbp PE=2 SV=2 g12962.t1 Q5ZJV4 52.74 146 5.2e-52 180.0 sp|Q5ZJV4|MCMBP_CHICK Mini-chromosome maintenance complex-binding protein OS=Gallus gallus OX=9031 GN=MCMBP PE=2 SV=2 g12963.t1 Q9QYS2 29.754 447 1.53e-54 199.0 sp|Q9QYS2|GRM3_MOUSE Metabotropic glutamate receptor 3 OS=Mus musculus OX=10090 GN=Grm3 PE=1 SV=1 GRM3_MOUSE reviewed Metabotropic glutamate receptor 3 (mGluR3) Mus musculus (Mouse) GO:0001641; GO:0005246; GO:0005886; GO:0007193; GO:0007216; GO:0010467; GO:0014069; GO:0019233; GO:0030424; GO:0033554; GO:0035249; GO:0042734; GO:0043005; GO:0043197; GO:0045211; GO:0048786; GO:0050804; GO:0051930; GO:0051966; GO:0097110; GO:0097449; GO:0098978; GO:0099170 adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; cellular response to stress [GO:0033554]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; gene expression [GO:0010467]; modulation of chemical synaptic transmission [GO:0050804]; postsynaptic modulation of chemical synaptic transmission [GO:0099170]; regulation of sensory perception of pain [GO:0051930]; regulation of synaptic transmission, glutamatergic [GO:0051966]; sensory perception of pain [GO:0019233]; synaptic transmission, glutamatergic [GO:0035249] astrocyte projection [GO:0097449]; axon [GO:0030424]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; presynaptic active zone [GO:0048786]; presynaptic membrane [GO:0042734] calcium channel regulator activity [GO:0005246]; group II metabotropic glutamate receptor activity [GO:0001641]; scaffold protein binding [GO:0097110] g12964.t1 P41594 34.076 314 2.2900000000000002e-35 140.0 sp|P41594|GRM5_HUMAN Metabotropic glutamate receptor 5 OS=Homo sapiens OX=9606 GN=GRM5 PE=1 SV=2 GRM5_HUMAN reviewed Metabotropic glutamate receptor 5 (mGluR5) Homo sapiens (Human) GO:0001640; GO:0001659; GO:0001975; GO:0002029; GO:0004930; GO:0005637; GO:0005737; GO:0005886; GO:0006355; GO:0007204; GO:0007206; GO:0007216; GO:0007268; GO:0007611; GO:0007626; GO:0008066; GO:0030296; GO:0030425; GO:0031687; GO:0033603; GO:0035106; GO:0036228; GO:0042802; GO:0043025; GO:0043197; GO:0043198; GO:0043278; GO:0043410; GO:0045471; GO:0046677; GO:0048170; GO:0050808; GO:0050850; GO:0050890; GO:0051412; GO:0051966; GO:0061002; GO:0062036; GO:0090394; GO:0097449; GO:0098685; GO:0098839; GO:0098978; GO:0099530; GO:0099583; GO:1900039; GO:1900452; GO:1904058; GO:1904646; GO:1990708; GO:1990782; GO:2000179 cellular response to amyloid-beta [GO:1904646]; chemical synaptic transmission [GO:0007268]; cognition [GO:0050890]; conditioned place preference [GO:1990708]; desensitization of G protein-coupled receptor signaling pathway [GO:0002029]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; learning or memory [GO:0007611]; locomotory behavior [GO:0007626]; negative regulation of dendritic spine morphogenesis [GO:0061002]; negative regulation of excitatory postsynaptic potential [GO:0090394]; operant conditioning [GO:0035106]; phospholipase C-activating G protein-coupled glutamate receptor signaling pathway [GO:0007206]; positive regulation of calcium-mediated signaling [GO:0050850]; positive regulation of cellular response to hypoxia [GO:1900039]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of dopamine secretion [GO:0033603]; positive regulation of long-term neuronal synaptic plasticity [GO:0048170]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of sensory perception of pain [GO:1904058]; protein localization to nuclear inner membrane [GO:0036228]; regulation of DNA-templated transcription [GO:0006355]; regulation of long-term synaptic depression [GO:1900452]; regulation of synaptic transmission, glutamatergic [GO:0051966]; response to amphetamine [GO:0001975]; response to antibiotic [GO:0046677]; response to corticosterone [GO:0051412]; response to ethanol [GO:0045471]; response to morphine [GO:0043278]; sensory perception of hot stimulus [GO:0062036]; synapse organization [GO:0050808]; temperature homeostasis [GO:0001659] astrocyte projection [GO:0097449]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; neuronal cell body [GO:0043025]; nuclear inner membrane [GO:0005637]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; Schaffer collateral - CA1 synapse [GO:0098685] A2A adenosine receptor binding [GO:0031687]; adenylate cyclase inhibiting G protein-coupled glutamate receptor activity [GO:0001640]; G protein-coupled receptor activity [GO:0004930]; G protein-coupled receptor activity involved in regulation of postsynaptic membrane potential [GO:0099530]; glutamate receptor activity [GO:0008066]; identical protein binding [GO:0042802]; neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration [GO:0099583]; protein tyrosine kinase activator activity [GO:0030296]; protein tyrosine kinase binding [GO:1990782] g12969.t1 Q99MV1 25.442 904 9.440000000000001e-59 227.0 sp|Q99MV1|TDRD1_MOUSE Tudor domain-containing protein 1 OS=Mus musculus OX=10090 GN=Tdrd1 PE=1 SV=2 TDRD1_MOUSE reviewed Tudor domain-containing protein 1 Mus musculus (Mouse) GO:0005737; GO:0005829; GO:0007281; GO:0007283; GO:0008270; GO:0030719; GO:0033391; GO:0034587; GO:0043186; GO:0045202; GO:0051321; GO:0071546; GO:0141196; GO:1990904 germ cell development [GO:0007281]; meiotic cell cycle [GO:0051321]; P granule organization [GO:0030719]; piRNA processing [GO:0034587]; spermatogenesis [GO:0007283]; transposable element silencing by piRNA-mediated DNA methylation [GO:0141196] chromatoid body [GO:0033391]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; P granule [GO:0043186]; pi-body [GO:0071546]; ribonucleoprotein complex [GO:1990904]; synapse [GO:0045202] zinc ion binding [GO:0008270] g12984.t1 Q5VV67 53.535 99 3.19e-25 116.0 sp|Q5VV67|PPRC1_HUMAN Peroxisome proliferator-activated receptor gamma coactivator-related protein 1 OS=Homo sapiens OX=9606 GN=PPRC1 PE=1 SV=1 PPRC1_HUMAN reviewed Peroxisome proliferator-activated receptor gamma coactivator-related protein 1 (PGC-1-related coactivator) (PRC) Homo sapiens (Human) GO:0003713; GO:0003723; GO:0005634; GO:0005654; GO:0045944; GO:0097009 energy homeostasis [GO:0097009]; positive regulation of transcription by RNA polymerase II [GO:0045944] nucleoplasm [GO:0005654]; nucleus [GO:0005634] RNA binding [GO:0003723]; transcription coactivator activity [GO:0003713] g12985.t1 Q14677 46.851 397 1.63e-75 258.0 sp|Q14677|EPN4_HUMAN Clathrin interactor 1 OS=Homo sapiens OX=9606 GN=CLINT1 PE=1 SV=1 g12985.t2 Q14677 46.851 397 2.97e-75 258.0 sp|Q14677|EPN4_HUMAN Clathrin interactor 1 OS=Homo sapiens OX=9606 GN=CLINT1 PE=1 SV=1 g12986.t1 O54991 33.624 229 3.39e-28 127.0 sp|O54991|CNTP1_MOUSE Contactin-associated protein 1 OS=Mus musculus OX=10090 GN=Cntnap1 PE=1 SV=2 CNTP1_MOUSE reviewed Contactin-associated protein 1 (Caspr) (Caspr1) (MHDNIV) (NCP1) (Neurexin IV) (Neurexin-4) (Paranodin) Mus musculus (Mouse) GO:0002175; GO:0005886; GO:0005918; GO:0007005; GO:0007010; GO:0007155; GO:0007409; GO:0017124; GO:0019227; GO:0022010; GO:0022011; GO:0030424; GO:0030913; GO:0031175; GO:0033010; GO:0033270; GO:0042552; GO:0043209; GO:0048786; GO:0048812; GO:0050884; GO:0050885; GO:0050905; GO:0071205; GO:0090128; GO:0097106; GO:0098529; GO:0098978; GO:1990227 axonogenesis [GO:0007409]; cell adhesion [GO:0007155]; central nervous system myelination [GO:0022010]; cytoskeleton organization [GO:0007010]; mitochondrion organization [GO:0007005]; myelination [GO:0042552]; myelination in peripheral nervous system [GO:0022011]; neuromuscular junction development, skeletal muscle fiber [GO:0098529]; neuromuscular process [GO:0050905]; neuromuscular process controlling balance [GO:0050885]; neuromuscular process controlling posture [GO:0050884]; neuron projection development [GO:0031175]; neuron projection morphogenesis [GO:0048812]; neuronal action potential propagation [GO:0019227]; paranodal junction assembly [GO:0030913]; paranodal junction maintenance [GO:1990227]; postsynaptic density organization [GO:0097106]; protein localization to juxtaparanode region of axon [GO:0071205]; protein localization to paranode region of axon [GO:0002175]; regulation of synapse maturation [GO:0090128] axon [GO:0030424]; glutamatergic synapse [GO:0098978]; myelin sheath [GO:0043209]; paranodal junction [GO:0033010]; paranode region of axon [GO:0033270]; plasma membrane [GO:0005886]; presynaptic active zone [GO:0048786]; septate junction [GO:0005918] SH3 domain binding [GO:0017124] g12989.t1 P30306 41.349 341 5.22e-70 239.0 sp|P30306|MPIP2_MOUSE M-phase inducer phosphatase 2 OS=Mus musculus OX=10090 GN=Cdc25b PE=1 SV=1 MPIP2_MOUSE reviewed M-phase inducer phosphatase 2 (EC 3.1.3.48) (Dual specificity phosphatase Cdc25B) Mus musculus (Mouse) GO:0000086; GO:0000922; GO:0001556; GO:0004721; GO:0004725; GO:0005634; GO:0005737; GO:0005813; GO:0007144; GO:0010971; GO:0019901; GO:0032467; GO:0045931; GO:0051301; GO:0110032 cell division [GO:0051301]; female meiosis I [GO:0007144]; G2/M transition of mitotic cell cycle [GO:0000086]; oocyte maturation [GO:0001556]; positive regulation of cytokinesis [GO:0032467]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of G2/MI transition of meiotic cell cycle [GO:0110032]; positive regulation of mitotic cell cycle [GO:0045931] centrosome [GO:0005813]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; spindle pole [GO:0000922] phosphoprotein phosphatase activity [GO:0004721]; protein kinase binding [GO:0019901]; protein tyrosine phosphatase activity [GO:0004725] g12990.t1 P79943 34.896 192 1.55e-25 108.0 sp|P79943|SLBP1_XENLA Histone RNA hairpin-binding protein OS=Xenopus laevis OX=8355 GN=slbp1 PE=1 SV=1 g12991.t1 Q969W1 40.356 337 9.09e-77 243.0 sp|Q969W1|ZDH16_HUMAN Palmitoyltransferase ZDHHC16 OS=Homo sapiens OX=9606 GN=ZDHHC16 PE=1 SV=1 g12992.t1 D3ZX63 41.317 334 2.2e-85 263.0 sp|D3ZX63|WDR54_RAT WD repeat domain 54 OS=Rattus norvegicus OX=10116 GN=Wdr54 PE=1 SV=1 WDR54_RAT reviewed WD repeat domain 54 Rattus norvegicus (Rat) GO:0002091; GO:0005737; GO:0005886; GO:0007338; GO:0007342; GO:0031514; GO:0031982; GO:0042058; GO:0042803; GO:0043408 fusion of sperm to egg plasma membrane involved in single fertilization [GO:0007342]; negative regulation of receptor internalization [GO:0002091]; regulation of epidermal growth factor receptor signaling pathway [GO:0042058]; regulation of MAPK cascade [GO:0043408]; single fertilization [GO:0007338] cytoplasm [GO:0005737]; motile cilium [GO:0031514]; plasma membrane [GO:0005886]; vesicle [GO:0031982] protein homodimerization activity [GO:0042803] g12993.t1 Q6P4T2 77.132 2134 0.0 3258.0 sp|Q6P4T2|U520_MOUSE U5 small nuclear ribonucleoprotein 200 kDa helicase OS=Mus musculus OX=10090 GN=Snrnp200 PE=1 SV=1 U520_MOUSE reviewed U5 small nuclear ribonucleoprotein 200 kDa helicase (EC 3.6.4.13) (BRR2 homolog) (U5 snRNP-specific 200 kDa protein) (U5-200KD) Mus musculus (Mouse) GO:0000388; GO:0000398; GO:0003676; GO:0003724; GO:0004386; GO:0005524; GO:0005634; GO:0005654; GO:0005681; GO:0005682; GO:0005886; GO:0005929; GO:0016887; GO:0042802; GO:0046540; GO:0071005; GO:0071006; GO:0071013 mRNA splicing, via spliceosome [GO:0000398]; spliceosome conformational change to release U4 (or U4atac) and U1 (or U11) [GO:0000388] catalytic step 2 spliceosome [GO:0071013]; cilium [GO:0005929]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; spliceosomal complex [GO:0005681]; U2-type catalytic step 1 spliceosome [GO:0071006]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; helicase activity [GO:0004386]; identical protein binding [GO:0042802]; nucleic acid binding [GO:0003676]; RNA helicase activity [GO:0003724] g12994.t1 F1QCN0 65.37 257 6.53e-123 353.0 sp|F1QCN0|GAL3A_DANRE Glutamine amidotransferase-like class 1 domain-containing protein 3, mitochondrial OS=Danio rerio OX=7955 GN=gatd3 PE=3 SV=1 g12996.t1 Q8IVU9 32.127 221 4.660000000000001e-27 108.0 sp|Q8IVU9|CBCO1_HUMAN Ciliary-associated calcium-binding coiled-coil protein 1 OS=Homo sapiens OX=9606 GN=CABCOCO1 PE=1 SV=1 g12997.t1 Q9NZJ5 36.289 609 5.21e-89 313.0 sp|Q9NZJ5|E2AK3_HUMAN Eukaryotic translation initiation factor 2-alpha kinase 3 OS=Homo sapiens OX=9606 GN=EIF2AK3 PE=1 SV=3 E2AK3_HUMAN reviewed Eukaryotic translation initiation factor 2-alpha kinase 3 (EC 2.7.11.1) (PRKR-like endoplasmic reticulum kinase) (Pancreatic eIF2-alpha kinase) (HsPEK) (Protein tyrosine kinase EIF2AK3) (EC 2.7.10.2) Homo sapiens (Human) GO:0001501; GO:0001503; GO:0001525; GO:0002063; GO:0004672; GO:0004674; GO:0004694; GO:0004713; GO:0004715; GO:0005524; GO:0005634; GO:0005737; GO:0005783; GO:0005789; GO:0005829; GO:0006446; GO:0006983; GO:0007029; GO:0010575; GO:0010628; GO:0016020; GO:0017148; GO:0019722; GO:0019899; GO:0019903; GO:0030282; GO:0030968; GO:0031018; GO:0031642; GO:0032055; GO:0032057; GO:0034198; GO:0034976; GO:0036491; GO:0036499; GO:0042149; GO:0042802; GO:0044233; GO:0045182; GO:0045943; GO:0045947; GO:0048009; GO:0048471; GO:0051787; GO:0051879; GO:0070417; GO:0106310; GO:1900182; GO:1902235; GO:1990737 angiogenesis [GO:0001525]; bone mineralization [GO:0030282]; calcium-mediated signaling [GO:0019722]; cellular response to amino acid starvation [GO:0034198]; cellular response to cold [GO:0070417]; cellular response to glucose starvation [GO:0042149]; chondrocyte development [GO:0002063]; endocrine pancreas development [GO:0031018]; endoplasmic reticulum organization [GO:0007029]; endoplasmic reticulum unfolded protein response [GO:0030968]; ER overload response [GO:0006983]; insulin-like growth factor receptor signaling pathway [GO:0048009]; negative regulation of myelination [GO:0031642]; negative regulation of translation [GO:0017148]; negative regulation of translation in response to stress [GO:0032055]; negative regulation of translational initiation [GO:0045947]; negative regulation of translational initiation in response to stress [GO:0032057]; ossification [GO:0001503]; PERK-mediated unfolded protein response [GO:0036499]; positive regulation of gene expression [GO:0010628]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of transcription by RNA polymerase I [GO:0045943]; positive regulation of vascular endothelial growth factor production [GO:0010575]; regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902235]; regulation of translation initiation in response to endoplasmic reticulum stress [GO:0036491]; regulation of translational initiation [GO:0006446]; response to endoplasmic reticulum stress [GO:0034976]; response to manganese-induced endoplasmic reticulum stress [GO:1990737]; skeletal system development [GO:0001501] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; mitochondria-associated endoplasmic reticulum membrane contact site [GO:0044233]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471] ATP binding [GO:0005524]; enzyme binding [GO:0019899]; eukaryotic translation initiation factor 2alpha kinase activity [GO:0004694]; Hsp90 protein binding [GO:0051879]; identical protein binding [GO:0042802]; misfolded protein binding [GO:0051787]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein kinase activity [GO:0004672]; protein phosphatase binding [GO:0019903]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; translation regulator activity [GO:0045182] g12997.t1 Q9NZJ5 54.634 205 1.63e-57 220.0 sp|Q9NZJ5|E2AK3_HUMAN Eukaryotic translation initiation factor 2-alpha kinase 3 OS=Homo sapiens OX=9606 GN=EIF2AK3 PE=1 SV=3 E2AK3_HUMAN reviewed Eukaryotic translation initiation factor 2-alpha kinase 3 (EC 2.7.11.1) (PRKR-like endoplasmic reticulum kinase) (Pancreatic eIF2-alpha kinase) (HsPEK) (Protein tyrosine kinase EIF2AK3) (EC 2.7.10.2) Homo sapiens (Human) GO:0001501; GO:0001503; GO:0001525; GO:0002063; GO:0004672; GO:0004674; GO:0004694; GO:0004713; GO:0004715; GO:0005524; GO:0005634; GO:0005737; GO:0005783; GO:0005789; GO:0005829; GO:0006446; GO:0006983; GO:0007029; GO:0010575; GO:0010628; GO:0016020; GO:0017148; GO:0019722; GO:0019899; GO:0019903; GO:0030282; GO:0030968; GO:0031018; GO:0031642; GO:0032055; GO:0032057; GO:0034198; GO:0034976; GO:0036491; GO:0036499; GO:0042149; GO:0042802; GO:0044233; GO:0045182; GO:0045943; GO:0045947; GO:0048009; GO:0048471; GO:0051787; GO:0051879; GO:0070417; GO:0106310; GO:1900182; GO:1902235; GO:1990737 angiogenesis [GO:0001525]; bone mineralization [GO:0030282]; calcium-mediated signaling [GO:0019722]; cellular response to amino acid starvation [GO:0034198]; cellular response to cold [GO:0070417]; cellular response to glucose starvation [GO:0042149]; chondrocyte development [GO:0002063]; endocrine pancreas development [GO:0031018]; endoplasmic reticulum organization [GO:0007029]; endoplasmic reticulum unfolded protein response [GO:0030968]; ER overload response [GO:0006983]; insulin-like growth factor receptor signaling pathway [GO:0048009]; negative regulation of myelination [GO:0031642]; negative regulation of translation [GO:0017148]; negative regulation of translation in response to stress [GO:0032055]; negative regulation of translational initiation [GO:0045947]; negative regulation of translational initiation in response to stress [GO:0032057]; ossification [GO:0001503]; PERK-mediated unfolded protein response [GO:0036499]; positive regulation of gene expression [GO:0010628]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of transcription by RNA polymerase I [GO:0045943]; positive regulation of vascular endothelial growth factor production [GO:0010575]; regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902235]; regulation of translation initiation in response to endoplasmic reticulum stress [GO:0036491]; regulation of translational initiation [GO:0006446]; response to endoplasmic reticulum stress [GO:0034976]; response to manganese-induced endoplasmic reticulum stress [GO:1990737]; skeletal system development [GO:0001501] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; mitochondria-associated endoplasmic reticulum membrane contact site [GO:0044233]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471] ATP binding [GO:0005524]; enzyme binding [GO:0019899]; eukaryotic translation initiation factor 2alpha kinase activity [GO:0004694]; Hsp90 protein binding [GO:0051879]; identical protein binding [GO:0042802]; misfolded protein binding [GO:0051787]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein kinase activity [GO:0004672]; protein phosphatase binding [GO:0019903]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; translation regulator activity [GO:0045182] g12998.t1 Q86WZ0 32.245 490 4.960000000000001e-72 263.0 sp|Q86WZ0|HEAT4_HUMAN HEAT repeat-containing protein 4 OS=Homo sapiens OX=9606 GN=HEATR4 PE=1 SV=2 g12999.t1 Q9NZE8 45.217 115 1.5800000000000002e-27 107.0 sp|Q9NZE8|RM35_HUMAN Large ribosomal subunit protein bL35m OS=Homo sapiens OX=9606 GN=MRPL35 PE=1 SV=3 RM35_HUMAN reviewed Large ribosomal subunit protein bL35m (39S ribosomal protein L35, mitochondrial) (L35mt) (MRP-L35) Homo sapiens (Human) GO:0003735; GO:0005739; GO:0005743; GO:0005761; GO:0005762; GO:0006412; GO:0032543 mitochondrial translation [GO:0032543]; translation [GO:0006412] mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrial ribosome [GO:0005761]; mitochondrion [GO:0005739] structural constituent of ribosome [GO:0003735] g13000.t1 A4IF63 37.818 275 3.14e-53 199.0 sp|A4IF63|TRIM2_BOVIN Tripartite motif-containing protein 2 OS=Bos taurus OX=9913 GN=TRIM2 PE=2 SV=1 TRIM2_BOVIN reviewed Tripartite motif-containing protein 2 (EC 2.3.2.27) (E3 ubiquitin-protein ligase TRIM2) (RING-type E3 ubiquitin transferase TRIM2) Bos taurus (Bovine) GO:0000209; GO:0004842; GO:0005737; GO:0008270; GO:0043161; GO:0043523; GO:0061630 proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; regulation of neuron apoptotic process [GO:0043523] cytoplasm [GO:0005737] ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] g13000.t1 A4IF63 27.187 320 4.55e-35 145.0 sp|A4IF63|TRIM2_BOVIN Tripartite motif-containing protein 2 OS=Bos taurus OX=9913 GN=TRIM2 PE=2 SV=1 TRIM2_BOVIN reviewed Tripartite motif-containing protein 2 (EC 2.3.2.27) (E3 ubiquitin-protein ligase TRIM2) (RING-type E3 ubiquitin transferase TRIM2) Bos taurus (Bovine) GO:0000209; GO:0004842; GO:0005737; GO:0008270; GO:0043161; GO:0043523; GO:0061630 proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; regulation of neuron apoptotic process [GO:0043523] cytoplasm [GO:0005737] ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] g13001.t1 Q61824 39.175 776 2.04e-162 504.0 sp|Q61824|ADA12_MOUSE Disintegrin and metalloproteinase domain-containing protein 12 OS=Mus musculus OX=10090 GN=Adam12 PE=1 SV=2 g13001.t2 Q61824 41.0 700 1.09e-160 500.0 sp|Q61824|ADA12_MOUSE Disintegrin and metalloproteinase domain-containing protein 12 OS=Mus musculus OX=10090 GN=Adam12 PE=1 SV=2 g13004.t1 Q5MJS3 39.045 356 5.75e-76 252.0 sp|Q5MJS3|FA20C_MOUSE Extracellular serine/threonine protein kinase FAM20C OS=Mus musculus OX=10090 GN=Fam20c PE=1 SV=1 FA20C_MOUSE reviewed Extracellular serine/threonine protein kinase FAM20C (EC 2.7.11.1) (Dentin matrix protein 4) (DMP-4) (Golgi-enriched fraction casein kinase) (GEF-CK) Mus musculus (Mouse) GO:0000139; GO:0001501; GO:0002020; GO:0004672; GO:0004674; GO:0005509; GO:0005524; GO:0005615; GO:0005654; GO:0005737; GO:0005783; GO:0005794; GO:0006468; GO:0030145; GO:0030501; GO:0031214; GO:0036179; GO:0040036; GO:0045669; GO:0051174; GO:0070166; GO:0071895; GO:0097187; GO:0106310 biomineral tissue development [GO:0031214]; dentinogenesis [GO:0097187]; enamel mineralization [GO:0070166]; odontoblast differentiation [GO:0071895]; osteoclast maturation [GO:0036179]; positive regulation of bone mineralization [GO:0030501]; positive regulation of osteoblast differentiation [GO:0045669]; protein phosphorylation [GO:0006468]; regulation of fibroblast growth factor receptor signaling pathway [GO:0040036]; regulation of phosphorus metabolic process [GO:0051174]; skeletal system development [GO:0001501] cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; nucleoplasm [GO:0005654] ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; manganese ion binding [GO:0030145]; protease binding [GO:0002020]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g13005.t1 Q6V7V2 36.401 489 8.779999999999999e-89 287.0 sp|Q6V7V2|RTKN_RAT Rhotekin OS=Rattus norvegicus OX=10116 GN=Rtkn PE=1 SV=1 g13009.t1 Q6NS09 36.957 230 4.84e-44 154.0 sp|Q6NS09|TM45B_XENLA Transmembrane protein 45B OS=Xenopus laevis OX=8355 GN=tmem45b PE=2 SV=1 g13010.t1 Q5XGD7 32.959 267 3.38e-46 159.0 sp|Q5XGD7|TM45B_XENTR Transmembrane protein 45B OS=Xenopus tropicalis OX=8364 GN=tmem45b PE=2 SV=1 g13011.t1 Q24732 68.421 133 1.55e-51 189.0 sp|Q24732|GLAS_DROVI Protein glass OS=Drosophila virilis OX=7244 GN=gl PE=3 SV=1 g13011.t1 Q24732 49.107 112 7.42e-28 121.0 sp|Q24732|GLAS_DROVI Protein glass OS=Drosophila virilis OX=7244 GN=gl PE=3 SV=1 g13012.t1 A2RUV0 38.889 234 3.16e-30 131.0 sp|A2RUV0|NOTC1_XENTR Neurogenic locus notch homolog protein 1 OS=Xenopus tropicalis OX=8364 GN=notch1 PE=1 SV=2 NOTC1_XENTR reviewed Neurogenic locus notch homolog protein 1 (Notch 1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0001525; GO:0005509; GO:0005634; GO:0005886; GO:0006355; GO:0007219; GO:0007411; GO:0009986; GO:0038023; GO:0043235; GO:0050793; GO:0060271; GO:0061314 angiogenesis [GO:0001525]; axon guidance [GO:0007411]; cilium assembly [GO:0060271]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; regulation of developmental process [GO:0050793]; regulation of DNA-templated transcription [GO:0006355] cell surface [GO:0009986]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; signaling receptor activity [GO:0038023] g13012.t1 A2RUV0 36.771 223 6.88e-28 124.0 sp|A2RUV0|NOTC1_XENTR Neurogenic locus notch homolog protein 1 OS=Xenopus tropicalis OX=8364 GN=notch1 PE=1 SV=2 NOTC1_XENTR reviewed Neurogenic locus notch homolog protein 1 (Notch 1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0001525; GO:0005509; GO:0005634; GO:0005886; GO:0006355; GO:0007219; GO:0007411; GO:0009986; GO:0038023; GO:0043235; GO:0050793; GO:0060271; GO:0061314 angiogenesis [GO:0001525]; axon guidance [GO:0007411]; cilium assembly [GO:0060271]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; regulation of developmental process [GO:0050793]; regulation of DNA-templated transcription [GO:0006355] cell surface [GO:0009986]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; signaling receptor activity [GO:0038023] g13012.t1 A2RUV0 37.004 227 1.1900000000000001e-27 123.0 sp|A2RUV0|NOTC1_XENTR Neurogenic locus notch homolog protein 1 OS=Xenopus tropicalis OX=8364 GN=notch1 PE=1 SV=2 NOTC1_XENTR reviewed Neurogenic locus notch homolog protein 1 (Notch 1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0001525; GO:0005509; GO:0005634; GO:0005886; GO:0006355; GO:0007219; GO:0007411; GO:0009986; GO:0038023; GO:0043235; GO:0050793; GO:0060271; GO:0061314 angiogenesis [GO:0001525]; axon guidance [GO:0007411]; cilium assembly [GO:0060271]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; regulation of developmental process [GO:0050793]; regulation of DNA-templated transcription [GO:0006355] cell surface [GO:0009986]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; signaling receptor activity [GO:0038023] g13012.t1 A2RUV0 36.161 224 8.79e-26 117.0 sp|A2RUV0|NOTC1_XENTR Neurogenic locus notch homolog protein 1 OS=Xenopus tropicalis OX=8364 GN=notch1 PE=1 SV=2 NOTC1_XENTR reviewed Neurogenic locus notch homolog protein 1 (Notch 1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0001525; GO:0005509; GO:0005634; GO:0005886; GO:0006355; GO:0007219; GO:0007411; GO:0009986; GO:0038023; GO:0043235; GO:0050793; GO:0060271; GO:0061314 angiogenesis [GO:0001525]; axon guidance [GO:0007411]; cilium assembly [GO:0060271]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; regulation of developmental process [GO:0050793]; regulation of DNA-templated transcription [GO:0006355] cell surface [GO:0009986]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; signaling receptor activity [GO:0038023] g13012.t1 A2RUV0 34.513 226 9.05e-25 114.0 sp|A2RUV0|NOTC1_XENTR Neurogenic locus notch homolog protein 1 OS=Xenopus tropicalis OX=8364 GN=notch1 PE=1 SV=2 NOTC1_XENTR reviewed Neurogenic locus notch homolog protein 1 (Notch 1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0001525; GO:0005509; GO:0005634; GO:0005886; GO:0006355; GO:0007219; GO:0007411; GO:0009986; GO:0038023; GO:0043235; GO:0050793; GO:0060271; GO:0061314 angiogenesis [GO:0001525]; axon guidance [GO:0007411]; cilium assembly [GO:0060271]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; regulation of developmental process [GO:0050793]; regulation of DNA-templated transcription [GO:0006355] cell surface [GO:0009986]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; signaling receptor activity [GO:0038023] g13012.t1 A2RUV0 32.7 263 2.19e-24 113.0 sp|A2RUV0|NOTC1_XENTR Neurogenic locus notch homolog protein 1 OS=Xenopus tropicalis OX=8364 GN=notch1 PE=1 SV=2 NOTC1_XENTR reviewed Neurogenic locus notch homolog protein 1 (Notch 1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0001525; GO:0005509; GO:0005634; GO:0005886; GO:0006355; GO:0007219; GO:0007411; GO:0009986; GO:0038023; GO:0043235; GO:0050793; GO:0060271; GO:0061314 angiogenesis [GO:0001525]; axon guidance [GO:0007411]; cilium assembly [GO:0060271]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; regulation of developmental process [GO:0050793]; regulation of DNA-templated transcription [GO:0006355] cell surface [GO:0009986]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; signaling receptor activity [GO:0038023] g13012.t1 A2RUV0 36.087 230 1.4999999999999997e-23 110.0 sp|A2RUV0|NOTC1_XENTR Neurogenic locus notch homolog protein 1 OS=Xenopus tropicalis OX=8364 GN=notch1 PE=1 SV=2 NOTC1_XENTR reviewed Neurogenic locus notch homolog protein 1 (Notch 1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0001525; GO:0005509; GO:0005634; GO:0005886; GO:0006355; GO:0007219; GO:0007411; GO:0009986; GO:0038023; GO:0043235; GO:0050793; GO:0060271; GO:0061314 angiogenesis [GO:0001525]; axon guidance [GO:0007411]; cilium assembly [GO:0060271]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; regulation of developmental process [GO:0050793]; regulation of DNA-templated transcription [GO:0006355] cell surface [GO:0009986]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; signaling receptor activity [GO:0038023] g13012.t1 A2RUV0 35.78 218 2.5699999999999998e-23 109.0 sp|A2RUV0|NOTC1_XENTR Neurogenic locus notch homolog protein 1 OS=Xenopus tropicalis OX=8364 GN=notch1 PE=1 SV=2 NOTC1_XENTR reviewed Neurogenic locus notch homolog protein 1 (Notch 1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0001525; GO:0005509; GO:0005634; GO:0005886; GO:0006355; GO:0007219; GO:0007411; GO:0009986; GO:0038023; GO:0043235; GO:0050793; GO:0060271; GO:0061314 angiogenesis [GO:0001525]; axon guidance [GO:0007411]; cilium assembly [GO:0060271]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; regulation of developmental process [GO:0050793]; regulation of DNA-templated transcription [GO:0006355] cell surface [GO:0009986]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; signaling receptor activity [GO:0038023] g13012.t1 A2RUV0 31.449 283 9.499999999999999e-23 107.0 sp|A2RUV0|NOTC1_XENTR Neurogenic locus notch homolog protein 1 OS=Xenopus tropicalis OX=8364 GN=notch1 PE=1 SV=2 NOTC1_XENTR reviewed Neurogenic locus notch homolog protein 1 (Notch 1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0001525; GO:0005509; GO:0005634; GO:0005886; GO:0006355; GO:0007219; GO:0007411; GO:0009986; GO:0038023; GO:0043235; GO:0050793; GO:0060271; GO:0061314 angiogenesis [GO:0001525]; axon guidance [GO:0007411]; cilium assembly [GO:0060271]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; regulation of developmental process [GO:0050793]; regulation of DNA-templated transcription [GO:0006355] cell surface [GO:0009986]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; signaling receptor activity [GO:0038023] g13012.t1 A2RUV0 34.615 234 7.53e-22 105.0 sp|A2RUV0|NOTC1_XENTR Neurogenic locus notch homolog protein 1 OS=Xenopus tropicalis OX=8364 GN=notch1 PE=1 SV=2 NOTC1_XENTR reviewed Neurogenic locus notch homolog protein 1 (Notch 1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0001525; GO:0005509; GO:0005634; GO:0005886; GO:0006355; GO:0007219; GO:0007411; GO:0009986; GO:0038023; GO:0043235; GO:0050793; GO:0060271; GO:0061314 angiogenesis [GO:0001525]; axon guidance [GO:0007411]; cilium assembly [GO:0060271]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; regulation of developmental process [GO:0050793]; regulation of DNA-templated transcription [GO:0006355] cell surface [GO:0009986]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; signaling receptor activity [GO:0038023] g13012.t1 A2RUV0 32.389 247 5.0000000000000005e-21 102.0 sp|A2RUV0|NOTC1_XENTR Neurogenic locus notch homolog protein 1 OS=Xenopus tropicalis OX=8364 GN=notch1 PE=1 SV=2 NOTC1_XENTR reviewed Neurogenic locus notch homolog protein 1 (Notch 1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0001525; GO:0005509; GO:0005634; GO:0005886; GO:0006355; GO:0007219; GO:0007411; GO:0009986; GO:0038023; GO:0043235; GO:0050793; GO:0060271; GO:0061314 angiogenesis [GO:0001525]; axon guidance [GO:0007411]; cilium assembly [GO:0060271]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; regulation of developmental process [GO:0050793]; regulation of DNA-templated transcription [GO:0006355] cell surface [GO:0009986]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; signaling receptor activity [GO:0038023] g13012.t2 A2RUV0 38.889 234 4.23e-30 130.0 sp|A2RUV0|NOTC1_XENTR Neurogenic locus notch homolog protein 1 OS=Xenopus tropicalis OX=8364 GN=notch1 PE=1 SV=2 NOTC1_XENTR reviewed Neurogenic locus notch homolog protein 1 (Notch 1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0001525; GO:0005509; GO:0005634; GO:0005886; GO:0006355; GO:0007219; GO:0007411; GO:0009986; GO:0038023; GO:0043235; GO:0050793; GO:0060271; GO:0061314 angiogenesis [GO:0001525]; axon guidance [GO:0007411]; cilium assembly [GO:0060271]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; regulation of developmental process [GO:0050793]; regulation of DNA-templated transcription [GO:0006355] cell surface [GO:0009986]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; signaling receptor activity [GO:0038023] g13012.t2 A2RUV0 36.771 223 9.94e-28 123.0 sp|A2RUV0|NOTC1_XENTR Neurogenic locus notch homolog protein 1 OS=Xenopus tropicalis OX=8364 GN=notch1 PE=1 SV=2 NOTC1_XENTR reviewed Neurogenic locus notch homolog protein 1 (Notch 1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0001525; GO:0005509; GO:0005634; GO:0005886; GO:0006355; GO:0007219; GO:0007411; GO:0009986; GO:0038023; GO:0043235; GO:0050793; GO:0060271; GO:0061314 angiogenesis [GO:0001525]; axon guidance [GO:0007411]; cilium assembly [GO:0060271]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; regulation of developmental process [GO:0050793]; regulation of DNA-templated transcription [GO:0006355] cell surface [GO:0009986]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; signaling receptor activity [GO:0038023] g13012.t2 A2RUV0 37.004 227 1.67e-27 122.0 sp|A2RUV0|NOTC1_XENTR Neurogenic locus notch homolog protein 1 OS=Xenopus tropicalis OX=8364 GN=notch1 PE=1 SV=2 NOTC1_XENTR reviewed Neurogenic locus notch homolog protein 1 (Notch 1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0001525; GO:0005509; GO:0005634; GO:0005886; GO:0006355; GO:0007219; GO:0007411; GO:0009986; GO:0038023; GO:0043235; GO:0050793; GO:0060271; GO:0061314 angiogenesis [GO:0001525]; axon guidance [GO:0007411]; cilium assembly [GO:0060271]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; regulation of developmental process [GO:0050793]; regulation of DNA-templated transcription [GO:0006355] cell surface [GO:0009986]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; signaling receptor activity [GO:0038023] g13012.t2 A2RUV0 36.161 224 1.17e-25 117.0 sp|A2RUV0|NOTC1_XENTR Neurogenic locus notch homolog protein 1 OS=Xenopus tropicalis OX=8364 GN=notch1 PE=1 SV=2 NOTC1_XENTR reviewed Neurogenic locus notch homolog protein 1 (Notch 1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0001525; GO:0005509; GO:0005634; GO:0005886; GO:0006355; GO:0007219; GO:0007411; GO:0009986; GO:0038023; GO:0043235; GO:0050793; GO:0060271; GO:0061314 angiogenesis [GO:0001525]; axon guidance [GO:0007411]; cilium assembly [GO:0060271]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; regulation of developmental process [GO:0050793]; regulation of DNA-templated transcription [GO:0006355] cell surface [GO:0009986]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; signaling receptor activity [GO:0038023] g13012.t2 A2RUV0 34.513 226 1.19e-24 114.0 sp|A2RUV0|NOTC1_XENTR Neurogenic locus notch homolog protein 1 OS=Xenopus tropicalis OX=8364 GN=notch1 PE=1 SV=2 NOTC1_XENTR reviewed Neurogenic locus notch homolog protein 1 (Notch 1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0001525; GO:0005509; GO:0005634; GO:0005886; GO:0006355; GO:0007219; GO:0007411; GO:0009986; GO:0038023; GO:0043235; GO:0050793; GO:0060271; GO:0061314 angiogenesis [GO:0001525]; axon guidance [GO:0007411]; cilium assembly [GO:0060271]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; regulation of developmental process [GO:0050793]; regulation of DNA-templated transcription [GO:0006355] cell surface [GO:0009986]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; signaling receptor activity [GO:0038023] g13012.t2 A2RUV0 32.7 263 2.87e-24 112.0 sp|A2RUV0|NOTC1_XENTR Neurogenic locus notch homolog protein 1 OS=Xenopus tropicalis OX=8364 GN=notch1 PE=1 SV=2 NOTC1_XENTR reviewed Neurogenic locus notch homolog protein 1 (Notch 1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0001525; GO:0005509; GO:0005634; GO:0005886; GO:0006355; GO:0007219; GO:0007411; GO:0009986; GO:0038023; GO:0043235; GO:0050793; GO:0060271; GO:0061314 angiogenesis [GO:0001525]; axon guidance [GO:0007411]; cilium assembly [GO:0060271]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; regulation of developmental process [GO:0050793]; regulation of DNA-templated transcription [GO:0006355] cell surface [GO:0009986]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; signaling receptor activity [GO:0038023] g13012.t2 A2RUV0 36.087 230 2.0899999999999997e-23 110.0 sp|A2RUV0|NOTC1_XENTR Neurogenic locus notch homolog protein 1 OS=Xenopus tropicalis OX=8364 GN=notch1 PE=1 SV=2 NOTC1_XENTR reviewed Neurogenic locus notch homolog protein 1 (Notch 1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0001525; GO:0005509; GO:0005634; GO:0005886; GO:0006355; GO:0007219; GO:0007411; GO:0009986; GO:0038023; GO:0043235; GO:0050793; GO:0060271; GO:0061314 angiogenesis [GO:0001525]; axon guidance [GO:0007411]; cilium assembly [GO:0060271]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; regulation of developmental process [GO:0050793]; regulation of DNA-templated transcription [GO:0006355] cell surface [GO:0009986]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; signaling receptor activity [GO:0038023] g13012.t2 A2RUV0 35.78 218 3.1699999999999996e-23 109.0 sp|A2RUV0|NOTC1_XENTR Neurogenic locus notch homolog protein 1 OS=Xenopus tropicalis OX=8364 GN=notch1 PE=1 SV=2 NOTC1_XENTR reviewed Neurogenic locus notch homolog protein 1 (Notch 1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0001525; GO:0005509; GO:0005634; GO:0005886; GO:0006355; GO:0007219; GO:0007411; GO:0009986; GO:0038023; GO:0043235; GO:0050793; GO:0060271; GO:0061314 angiogenesis [GO:0001525]; axon guidance [GO:0007411]; cilium assembly [GO:0060271]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; regulation of developmental process [GO:0050793]; regulation of DNA-templated transcription [GO:0006355] cell surface [GO:0009986]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; signaling receptor activity [GO:0038023] g13012.t2 A2RUV0 31.449 283 1.22e-22 107.0 sp|A2RUV0|NOTC1_XENTR Neurogenic locus notch homolog protein 1 OS=Xenopus tropicalis OX=8364 GN=notch1 PE=1 SV=2 NOTC1_XENTR reviewed Neurogenic locus notch homolog protein 1 (Notch 1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0001525; GO:0005509; GO:0005634; GO:0005886; GO:0006355; GO:0007219; GO:0007411; GO:0009986; GO:0038023; GO:0043235; GO:0050793; GO:0060271; GO:0061314 angiogenesis [GO:0001525]; axon guidance [GO:0007411]; cilium assembly [GO:0060271]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; regulation of developmental process [GO:0050793]; regulation of DNA-templated transcription [GO:0006355] cell surface [GO:0009986]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; signaling receptor activity [GO:0038023] g13012.t2 A2RUV0 34.615 234 1.24e-21 104.0 sp|A2RUV0|NOTC1_XENTR Neurogenic locus notch homolog protein 1 OS=Xenopus tropicalis OX=8364 GN=notch1 PE=1 SV=2 NOTC1_XENTR reviewed Neurogenic locus notch homolog protein 1 (Notch 1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0001525; GO:0005509; GO:0005634; GO:0005886; GO:0006355; GO:0007219; GO:0007411; GO:0009986; GO:0038023; GO:0043235; GO:0050793; GO:0060271; GO:0061314 angiogenesis [GO:0001525]; axon guidance [GO:0007411]; cilium assembly [GO:0060271]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; regulation of developmental process [GO:0050793]; regulation of DNA-templated transcription [GO:0006355] cell surface [GO:0009986]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; signaling receptor activity [GO:0038023] g13012.t2 A2RUV0 32.389 247 7.06e-21 102.0 sp|A2RUV0|NOTC1_XENTR Neurogenic locus notch homolog protein 1 OS=Xenopus tropicalis OX=8364 GN=notch1 PE=1 SV=2 NOTC1_XENTR reviewed Neurogenic locus notch homolog protein 1 (Notch 1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0001525; GO:0005509; GO:0005634; GO:0005886; GO:0006355; GO:0007219; GO:0007411; GO:0009986; GO:0038023; GO:0043235; GO:0050793; GO:0060271; GO:0061314 angiogenesis [GO:0001525]; axon guidance [GO:0007411]; cilium assembly [GO:0060271]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; regulation of developmental process [GO:0050793]; regulation of DNA-templated transcription [GO:0006355] cell surface [GO:0009986]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; signaling receptor activity [GO:0038023] g13013.t1 Q9I926 41.085 129 6.52e-24 103.0 sp|Q9I926|FUCL6_ANGJA Fucolectin-6 OS=Anguilla japonica OX=7937 PE=2 SV=1 g13013.t1 Q9I926 40.323 124 2.51e-22 99.0 sp|Q9I926|FUCL6_ANGJA Fucolectin-6 OS=Anguilla japonica OX=7937 PE=2 SV=1 g13017.t1 O08774 48.193 166 2.8e-40 166.0 sp|O08774|RGS12_RAT Regulator of G-protein signaling 12 OS=Rattus norvegicus OX=10116 GN=Rgs12 PE=1 SV=1 RGS12_RAT reviewed Regulator of G-protein signaling 12 (RGS12) Rattus norvegicus (Rat) GO:0001965; GO:0005096; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0005886; GO:0007165; GO:0008277; GO:0030425; GO:0030695; GO:0032991; GO:0038032; GO:0043025; GO:0045202; GO:0045744; GO:0097440 negative regulation of G protein-coupled receptor signaling pathway [GO:0045744]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; signal transduction [GO:0007165]; termination of G protein-coupled receptor signaling pathway [GO:0038032] apical dendrite [GO:0097440]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; neuronal cell body [GO:0043025]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; synapse [GO:0045202] G-protein alpha-subunit binding [GO:0001965]; GTPase activator activity [GO:0005096]; GTPase regulator activity [GO:0030695] g13017.t1 O08774 56.522 138 1.96e-38 160.0 sp|O08774|RGS12_RAT Regulator of G-protein signaling 12 OS=Rattus norvegicus OX=10116 GN=Rgs12 PE=1 SV=1 RGS12_RAT reviewed Regulator of G-protein signaling 12 (RGS12) Rattus norvegicus (Rat) GO:0001965; GO:0005096; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0005886; GO:0007165; GO:0008277; GO:0030425; GO:0030695; GO:0032991; GO:0038032; GO:0043025; GO:0045202; GO:0045744; GO:0097440 negative regulation of G protein-coupled receptor signaling pathway [GO:0045744]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; signal transduction [GO:0007165]; termination of G protein-coupled receptor signaling pathway [GO:0038032] apical dendrite [GO:0097440]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; neuronal cell body [GO:0043025]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; synapse [GO:0045202] G-protein alpha-subunit binding [GO:0001965]; GTPase activator activity [GO:0005096]; GTPase regulator activity [GO:0030695] g13017.t1 O08774 56.41 78 4.61e-22 107.0 sp|O08774|RGS12_RAT Regulator of G-protein signaling 12 OS=Rattus norvegicus OX=10116 GN=Rgs12 PE=1 SV=1 RGS12_RAT reviewed Regulator of G-protein signaling 12 (RGS12) Rattus norvegicus (Rat) GO:0001965; GO:0005096; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0005886; GO:0007165; GO:0008277; GO:0030425; GO:0030695; GO:0032991; GO:0038032; GO:0043025; GO:0045202; GO:0045744; GO:0097440 negative regulation of G protein-coupled receptor signaling pathway [GO:0045744]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; signal transduction [GO:0007165]; termination of G protein-coupled receptor signaling pathway [GO:0038032] apical dendrite [GO:0097440]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; neuronal cell body [GO:0043025]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; synapse [GO:0045202] G-protein alpha-subunit binding [GO:0001965]; GTPase activator activity [GO:0005096]; GTPase regulator activity [GO:0030695] g13017.t2 O08774 56.522 138 9.9e-43 158.0 sp|O08774|RGS12_RAT Regulator of G-protein signaling 12 OS=Rattus norvegicus OX=10116 GN=Rgs12 PE=1 SV=1 RGS12_RAT reviewed Regulator of G-protein signaling 12 (RGS12) Rattus norvegicus (Rat) GO:0001965; GO:0005096; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0005886; GO:0007165; GO:0008277; GO:0030425; GO:0030695; GO:0032991; GO:0038032; GO:0043025; GO:0045202; GO:0045744; GO:0097440 negative regulation of G protein-coupled receptor signaling pathway [GO:0045744]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; signal transduction [GO:0007165]; termination of G protein-coupled receptor signaling pathway [GO:0038032] apical dendrite [GO:0097440]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; neuronal cell body [GO:0043025]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; synapse [GO:0045202] G-protein alpha-subunit binding [GO:0001965]; GTPase activator activity [GO:0005096]; GTPase regulator activity [GO:0030695] g13017.t3 O14924 34.111 557 7.05e-74 276.0 sp|O14924|RGS12_HUMAN Regulator of G-protein signaling 12 OS=Homo sapiens OX=9606 GN=RGS12 PE=1 SV=1 g13017.t3 O14924 48.193 166 1.12e-39 165.0 sp|O14924|RGS12_HUMAN Regulator of G-protein signaling 12 OS=Homo sapiens OX=9606 GN=RGS12 PE=1 SV=1 g13017.t3 O14924 55.128 78 2.7e-21 105.0 sp|O14924|RGS12_HUMAN Regulator of G-protein signaling 12 OS=Homo sapiens OX=9606 GN=RGS12 PE=1 SV=1 g13019.t1 Q95KE5 53.191 141 2.3599999999999998e-48 157.0 sp|Q95KE5|RM43_BOVIN Large ribosomal subunit protein mL43 OS=Bos taurus OX=9913 GN=MRPL43 PE=2 SV=2 g13020.t1 Q6DRN3 46.774 682 2.19e-178 538.0 sp|Q6DRN3|NOC3L_DANRE Nucleolar complex protein 3 homolog OS=Danio rerio OX=7955 GN=noc3l PE=2 SV=1 NOC3L_DANRE reviewed Nucleolar complex protein 3 homolog (NOC3 protein homolog) (NOC3-like protein) (Nucleolar complex-associated protein 3-like protein) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0003682; GO:0005634; GO:0005730; GO:0006270; GO:0007517; GO:0019216 DNA replication initiation [GO:0006270]; muscle organ development [GO:0007517]; regulation of lipid metabolic process [GO:0019216] nucleolus [GO:0005730]; nucleus [GO:0005634] chromatin binding [GO:0003682] g13021.t1 Q5VV63 38.636 660 3.4400000000000003e-133 443.0 sp|Q5VV63|ATRN1_HUMAN Attractin-like protein 1 OS=Homo sapiens OX=9606 GN=ATRNL1 PE=1 SV=2 ATRN1_HUMAN reviewed Attractin-like protein 1 Homo sapiens (Human) GO:0005112; GO:0007186; GO:0016020; GO:0030246 G protein-coupled receptor signaling pathway [GO:0007186] membrane [GO:0016020] carbohydrate binding [GO:0030246]; Notch binding [GO:0005112] g13021.t1 Q5VV63 39.579 475 5.73e-82 297.0 sp|Q5VV63|ATRN1_HUMAN Attractin-like protein 1 OS=Homo sapiens OX=9606 GN=ATRNL1 PE=1 SV=2 ATRN1_HUMAN reviewed Attractin-like protein 1 Homo sapiens (Human) GO:0005112; GO:0007186; GO:0016020; GO:0030246 G protein-coupled receptor signaling pathway [GO:0007186] membrane [GO:0016020] carbohydrate binding [GO:0030246]; Notch binding [GO:0005112] g13021.t2 Q5VV63 38.636 660 2.25e-133 443.0 sp|Q5VV63|ATRN1_HUMAN Attractin-like protein 1 OS=Homo sapiens OX=9606 GN=ATRNL1 PE=1 SV=2 ATRN1_HUMAN reviewed Attractin-like protein 1 Homo sapiens (Human) GO:0005112; GO:0007186; GO:0016020; GO:0030246 G protein-coupled receptor signaling pathway [GO:0007186] membrane [GO:0016020] carbohydrate binding [GO:0030246]; Notch binding [GO:0005112] g13021.t2 Q5VV63 37.895 475 4.2e-85 306.0 sp|Q5VV63|ATRN1_HUMAN Attractin-like protein 1 OS=Homo sapiens OX=9606 GN=ATRNL1 PE=1 SV=2 ATRN1_HUMAN reviewed Attractin-like protein 1 Homo sapiens (Human) GO:0005112; GO:0007186; GO:0016020; GO:0030246 G protein-coupled receptor signaling pathway [GO:0007186] membrane [GO:0016020] carbohydrate binding [GO:0030246]; Notch binding [GO:0005112] g13021.t3 Q5VV63 38.636 660 5.61e-133 443.0 sp|Q5VV63|ATRN1_HUMAN Attractin-like protein 1 OS=Homo sapiens OX=9606 GN=ATRNL1 PE=1 SV=2 ATRN1_HUMAN reviewed Attractin-like protein 1 Homo sapiens (Human) GO:0005112; GO:0007186; GO:0016020; GO:0030246 G protein-coupled receptor signaling pathway [GO:0007186] membrane [GO:0016020] carbohydrate binding [GO:0030246]; Notch binding [GO:0005112] g13021.t3 Q5VV63 35.0 520 1.72e-79 290.0 sp|Q5VV63|ATRN1_HUMAN Attractin-like protein 1 OS=Homo sapiens OX=9606 GN=ATRNL1 PE=1 SV=2 ATRN1_HUMAN reviewed Attractin-like protein 1 Homo sapiens (Human) GO:0005112; GO:0007186; GO:0016020; GO:0030246 G protein-coupled receptor signaling pathway [GO:0007186] membrane [GO:0016020] carbohydrate binding [GO:0030246]; Notch binding [GO:0005112] g13021.t4 Q5VV63 38.636 660 5.18e-133 443.0 sp|Q5VV63|ATRN1_HUMAN Attractin-like protein 1 OS=Homo sapiens OX=9606 GN=ATRNL1 PE=1 SV=2 ATRN1_HUMAN reviewed Attractin-like protein 1 Homo sapiens (Human) GO:0005112; GO:0007186; GO:0016020; GO:0030246 G protein-coupled receptor signaling pathway [GO:0007186] membrane [GO:0016020] carbohydrate binding [GO:0030246]; Notch binding [GO:0005112] g13021.t4 Q5VV63 36.154 520 2.42e-76 281.0 sp|Q5VV63|ATRN1_HUMAN Attractin-like protein 1 OS=Homo sapiens OX=9606 GN=ATRNL1 PE=1 SV=2 ATRN1_HUMAN reviewed Attractin-like protein 1 Homo sapiens (Human) GO:0005112; GO:0007186; GO:0016020; GO:0030246 G protein-coupled receptor signaling pathway [GO:0007186] membrane [GO:0016020] carbohydrate binding [GO:0030246]; Notch binding [GO:0005112] g13024.t1 Q9NR45 72.159 352 0.0 549.0 sp|Q9NR45|SIAS_HUMAN N-acetylneuraminate-9-phosphate synthase OS=Homo sapiens OX=9606 GN=NANS PE=1 SV=2 SIAS_HUMAN reviewed N-acetylneuraminate-9-phosphate synthase (EC 2.5.1.57) (3-deoxy-D-glycero-D-galacto-nononate 9-phosphate synthase) (EC 2.5.1.132) (N-acetylneuraminic acid phosphate synthase) (NANS) (Sialic acid phosphate synthase) (Sialic acid synthase) Homo sapiens (Human) GO:0005737; GO:0005829; GO:0006055; GO:0016051; GO:0046380; GO:0047444; GO:0070062 carbohydrate biosynthetic process [GO:0016051]; CMP-N-acetylneuraminate biosynthetic process [GO:0006055]; N-acetylneuraminate biosynthetic process [GO:0046380] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062] N-acylneuraminate-9-phosphate synthase activity [GO:0047444] g13025.t1 Q96FH0 46.154 104 3.4000000000000004e-27 102.0 sp|Q96FH0|BORC8_HUMAN BLOC-1-related complex subunit 8 OS=Homo sapiens OX=9606 GN=BORCS8 PE=1 SV=1 g13026.t1 P41596 36.458 192 9.879999999999999e-30 119.0 sp|P41596|DOPR1_DROME Dopamine receptor 1 OS=Drosophila melanogaster OX=7227 GN=Dop1R1 PE=2 SV=2 DOPR1_DROME reviewed Dopamine receptor 1 (D-DOP1) (DmDop1) (dDA1) (Dopamine 1-like receptor 1) Drosophila melanogaster (Fruit fly) GO:0001588; GO:0004930; GO:0004952; GO:0004993; GO:0005886; GO:0007187; GO:0007188; GO:0007191; GO:0007212; GO:0007268; GO:0007612; GO:0007613; GO:0008306; GO:0008355; GO:0008542; GO:0009744; GO:0016020; GO:0030425; GO:0030594; GO:0040040; GO:0042048; GO:0042594; GO:0043052; GO:0071329; GO:0090328; GO:0098793; GO:0099509; GO:1990834 adenylate cyclase-activating dopamine receptor signaling pathway [GO:0007191]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; associative learning [GO:0008306]; cellular response to sucrose stimulus [GO:0071329]; chemical synaptic transmission [GO:0007268]; G protein-coupled dopamine receptor signaling pathway [GO:0007212]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; learning [GO:0007612]; memory [GO:0007613]; olfactory behavior [GO:0042048]; olfactory learning [GO:0008355]; regulation of olfactory learning [GO:0090328]; regulation of presynaptic cytosolic calcium ion concentration [GO:0099509]; response to odorant [GO:1990834]; response to starvation [GO:0042594]; response to sucrose [GO:0009744]; thermosensory behavior [GO:0040040]; thermotaxis [GO:0043052]; visual learning [GO:0008542] dendrite [GO:0030425]; membrane [GO:0016020]; plasma membrane [GO:0005886]; presynapse [GO:0098793] dopamine neurotransmitter receptor activity [GO:0004952]; dopamine neurotransmitter receptor activity, coupled via Gs [GO:0001588]; G protein-coupled receptor activity [GO:0004930]; G protein-coupled serotonin receptor activity [GO:0004993]; neurotransmitter receptor activity [GO:0030594] g13027.t1 Q24563 53.571 84 8.32e-26 108.0 sp|Q24563|DOPR2_DROME Dopamine receptor 2 OS=Drosophila melanogaster OX=7227 GN=Dop1R2 PE=2 SV=1 DOPR2_DROME reviewed Dopamine receptor 2 (Dopamine 1-like receptor 2) Drosophila melanogaster (Fruit fly) GO:0001588; GO:0004930; GO:0004935; GO:0004952; GO:0005886; GO:0007186; GO:0007191; GO:0007212; GO:0008226; GO:0008227; GO:0016020; GO:0030672; GO:0042321; GO:0043410; GO:0071880; GO:0099509; GO:1903351; GO:1990834 adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; adenylate cyclase-activating dopamine receptor signaling pathway [GO:0007191]; cellular response to dopamine [GO:1903351]; G protein-coupled dopamine receptor signaling pathway [GO:0007212]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of circadian sleep/wake cycle, sleep [GO:0042321]; positive regulation of MAPK cascade [GO:0043410]; regulation of presynaptic cytosolic calcium ion concentration [GO:0099509]; response to odorant [GO:1990834] membrane [GO:0016020]; plasma membrane [GO:0005886]; synaptic vesicle membrane [GO:0030672] adrenergic receptor activity [GO:0004935]; dopamine neurotransmitter receptor activity [GO:0004952]; dopamine neurotransmitter receptor activity, coupled via Gs [GO:0001588]; G protein-coupled amine receptor activity [GO:0008227]; G protein-coupled receptor activity [GO:0004930]; tyramine receptor activity [GO:0008226] g13028.t1 Q27245 46.589 513 3.09e-149 440.0 sp|Q27245|YH24_CAEEL Putative aminopeptidase W07G4.4 OS=Caenorhabditis elegans OX=6239 GN=lap-2 PE=3 SV=1 g13029.t1 Q6GLT8 62.63 289 1.14e-135 389.0 sp|Q6GLT8|FAHD2_XENLA Oxaloacetate tautomerase fahd2, mitochondrial OS=Xenopus laevis OX=8355 GN=fahd2 PE=2 SV=1 FAHD2_XENLA reviewed Oxaloacetate tautomerase fahd2, mitochondrial (EC 5.3.2.2) (Fumarylacetoacetate hydrolase domain-containing protein 2) Xenopus laevis (African clawed frog) GO:0005739; GO:0006107; GO:0046872; GO:0050163 oxaloacetate metabolic process [GO:0006107] mitochondrion [GO:0005739] metal ion binding [GO:0046872]; oxaloacetate tautomerase activity [GO:0050163] g13032.t1 Q8R0X2 43.668 229 1.3699999999999998e-60 199.0 sp|Q8R0X2|CACL1_MOUSE CDK2-associated and cullin domain-containing protein 1 OS=Mus musculus OX=10090 GN=Cacul1 PE=2 SV=1 g13033.t1 Q91085 32.353 272 7.200000000000001e-29 121.0 sp|Q91085|VIPR_MELGA Vasoactive intestinal polypeptide receptor OS=Meleagris gallopavo OX=9103 GN=VIPR1 PE=2 SV=2 VIPR_MELGA reviewed Vasoactive intestinal polypeptide receptor (VIP receptor) (VIP-R) Meleagris gallopavo (Wild turkey) GO:0004999; GO:0005886; GO:0007166; GO:0007188; GO:0008528; GO:0017046 adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; cell surface receptor signaling pathway [GO:0007166] plasma membrane [GO:0005886] G protein-coupled peptide receptor activity [GO:0008528]; peptide hormone binding [GO:0017046]; vasoactive intestinal polypeptide receptor activity [GO:0004999] g13033.t2 Q91085 32.841 271 9.89e-29 121.0 sp|Q91085|VIPR_MELGA Vasoactive intestinal polypeptide receptor OS=Meleagris gallopavo OX=9103 GN=VIPR1 PE=2 SV=2 VIPR_MELGA reviewed Vasoactive intestinal polypeptide receptor (VIP receptor) (VIP-R) Meleagris gallopavo (Wild turkey) GO:0004999; GO:0005886; GO:0007166; GO:0007188; GO:0008528; GO:0017046 adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; cell surface receptor signaling pathway [GO:0007166] plasma membrane [GO:0005886] G protein-coupled peptide receptor activity [GO:0008528]; peptide hormone binding [GO:0017046]; vasoactive intestinal polypeptide receptor activity [GO:0004999] g13034.t1 Q9Z0R0 54.259 317 5.44e-107 349.0 sp|Q9Z0R0|HASP_MOUSE Serine/threonine-protein kinase haspin OS=Mus musculus OX=10090 GN=Haspin PE=1 SV=3 g13035.t1 Q7Z9I4 28.881 277 4.43e-26 105.0 sp|Q7Z9I4|YCP6_SCHPO Uncharacterized oxidoreductase C663.06c OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) OX=284812 GN=SPCC663.06c PE=3 SV=1 g13037.t1 Q64686 35.521 259 9.33e-50 170.0 sp|Q64686|SIA7C_RAT Alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 3 OS=Rattus norvegicus OX=10116 GN=St6galnac3 PE=1 SV=1 SIA7C_RAT reviewed Alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 3 (EC 2.4.3.7) (GalNAc alpha-2,6-sialyltransferase III) (ST6GalNAc III) (ST6GalNAcIII) (STY) (Sialyltransferase 7C) (SIAT7-C) Rattus norvegicus (Rat) GO:0000139; GO:0001574; GO:0001665; GO:0005654; GO:0006677; GO:0006687; GO:0008373; GO:0009100; GO:0009311; GO:0047290 ganglioside biosynthetic process [GO:0001574]; glycoprotein metabolic process [GO:0009100]; glycosphingolipid metabolic process [GO:0006687]; glycosylceramide metabolic process [GO:0006677]; oligosaccharide metabolic process [GO:0009311] Golgi membrane [GO:0000139]; nucleoplasm [GO:0005654] alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity [GO:0001665]; alpha-N-acetylneuraminyl-2,3-beta-galactosyl-1,3-N-acetyl-galactosaminide 6-alpha-sialyltransferase activity [GO:0047290]; sialyltransferase activity [GO:0008373] g13041.t1 Q969X5 61.092 293 2.22e-128 370.0 sp|Q969X5|ERGI1_HUMAN Endoplasmic reticulum-Golgi intermediate compartment protein 1 OS=Homo sapiens OX=9606 GN=ERGIC1 PE=1 SV=1 ERGI1_HUMAN reviewed Endoplasmic reticulum-Golgi intermediate compartment protein 1 (ER-Golgi intermediate compartment 32 kDa protein) (ERGIC-32) Homo sapiens (Human) GO:0000139; GO:0005654; GO:0005783; GO:0005789; GO:0005793; GO:0006888; GO:0006890; GO:0016020; GO:0030134; GO:0033116 endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890] COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; nucleoplasm [GO:0005654] g13042.t1 Q62767 42.388 335 1.41e-81 259.0 sp|Q62767|DUS4_RAT Dual specificity protein phosphatase 4 OS=Rattus norvegicus OX=10116 GN=Dusp4 PE=1 SV=1 g13045.t1 Q91770 70.0 70 2.8000000000000003e-27 110.0 sp|Q91770|NOT2_XENLA Homeobox protein not2 OS=Xenopus laevis OX=8355 GN=not2 PE=2 SV=1 g13046.t1 Q8NB25 35.105 1091 0.0 572.0 sp|Q8NB25|F184A_HUMAN Protein FAM184A OS=Homo sapiens OX=9606 GN=FAM184A PE=1 SV=3 g13047.t1 Q8BGZ4 56.971 581 0.0 674.0 sp|Q8BGZ4|CDC23_MOUSE Cell division cycle protein 23 homolog OS=Mus musculus OX=10090 GN=Cdc23 PE=1 SV=2 g13048.t1 Q9NLA3 67.442 172 9.6e-63 206.0 sp|Q9NLA3|ANO39_PATPE Nucleoplasmin-like protein ANO39 OS=Patiria pectinifera OX=7594 PE=1 SV=1 g13048.t1 Q9NLA3 62.651 83 8.749999999999999e-23 100.0 sp|Q9NLA3|ANO39_PATPE Nucleoplasmin-like protein ANO39 OS=Patiria pectinifera OX=7594 PE=1 SV=1 g13051.t1 O76093 36.29 124 5.99e-23 95.5 sp|O76093|FGF18_HUMAN Fibroblast growth factor 18 OS=Homo sapiens OX=9606 GN=FGF18 PE=1 SV=1 FGF18_HUMAN reviewed Fibroblast growth factor 18 (FGF-18) (zFGF5) Homo sapiens (Human) GO:0001525; GO:0001957; GO:0001958; GO:0002063; GO:0005105; GO:0005111; GO:0005576; GO:0005615; GO:0005730; GO:0005737; GO:0007165; GO:0007267; GO:0008083; GO:0008283; GO:0008284; GO:0008543; GO:0009653; GO:0022008; GO:0030324; GO:0030334; GO:0030949; GO:0032332; GO:0043406; GO:0043410; GO:0043536; GO:0045766; GO:0048010; GO:0070371; GO:0070374; GO:2000546 anatomical structure morphogenesis [GO:0009653]; angiogenesis [GO:0001525]; cell population proliferation [GO:0008283]; cell-cell signaling [GO:0007267]; chondrocyte development [GO:0002063]; endochondral ossification [GO:0001958]; ERK1 and ERK2 cascade [GO:0070371]; fibroblast growth factor receptor signaling pathway [GO:0008543]; intramembranous ossification [GO:0001957]; lung development [GO:0030324]; neurogenesis [GO:0022008]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of chondrocyte differentiation [GO:0032332]; positive regulation of endothelial cell chemotaxis to fibroblast growth factor [GO:2000546]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030949]; regulation of cell migration [GO:0030334]; signal transduction [GO:0007165]; vascular endothelial growth factor receptor signaling pathway [GO:0048010] cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; nucleolus [GO:0005730] growth factor activity [GO:0008083]; type 1 fibroblast growth factor receptor binding [GO:0005105]; type 2 fibroblast growth factor receptor binding [GO:0005111] g13052.t1 P27652 49.653 288 3.26e-104 311.0 sp|P27652|LUCI_RENRE Coelenterazine h 2-monooxygenase OS=Renilla reniformis OX=6136 PE=1 SV=1 g13057.t1 B3S3D5 55.33 197 7.56e-47 162.0 sp|B3S3D5|DDRGK_TRIAD DDRGK domain-containing protein 1 OS=Trichoplax adhaerens OX=10228 GN=TRIADDRAFT_58679 PE=3 SV=1 g13062.t1 Q32PJ6 57.593 349 7e-142 408.0 sp|Q32PJ6|CIAO1_BOVIN Probable cytosolic iron-sulfur protein assembly protein CIAO1 OS=Bos taurus OX=9913 GN=CIAO1 PE=2 SV=1 g13062.t2 Q32PJ6 57.429 350 1.31e-141 407.0 sp|Q32PJ6|CIAO1_BOVIN Probable cytosolic iron-sulfur protein assembly protein CIAO1 OS=Bos taurus OX=9913 GN=CIAO1 PE=2 SV=1 g13076.t1 Q09575 30.03 333 4.84e-41 161.0 sp|Q09575|YRD6_CAEEL Uncharacterized protein K02A2.6 OS=Caenorhabditis elegans OX=6239 GN=K02A2.6 PE=4 SV=1 g13083.t1 Q29RH4 77.389 314 0.0 518.0 sp|Q29RH4|THOC3_BOVIN THO complex subunit 3 OS=Bos taurus OX=9913 GN=THOC3 PE=2 SV=1 THOC3_BOVIN reviewed THO complex subunit 3 (Tho3) Bos taurus (Bovine) GO:0000445; GO:0000781; GO:0003723; GO:0006397; GO:0006406; GO:0008380; GO:0016607 mRNA export from nucleus [GO:0006406]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380] chromosome, telomeric region [GO:0000781]; nuclear speck [GO:0016607]; THO complex part of transcription export complex [GO:0000445] RNA binding [GO:0003723] g13085.t1 Q96N64 53.659 123 4.56e-41 154.0 sp|Q96N64|PWP2A_HUMAN PWWP domain-containing protein 2A OS=Homo sapiens OX=9606 GN=PWWP2A PE=1 SV=2 PWP2A_HUMAN reviewed PWWP domain-containing protein 2A Homo sapiens (Human) GO:0001178; GO:0003682; GO:0005634; GO:0006338; GO:0032968; GO:0042393; GO:0120325; GO:0140003 chromatin remodeling [GO:0006338]; positive regulation of transcription elongation by RNA polymerase II [GO:0032968]; regulation of transcriptional start site selection at RNA polymerase II promoter [GO:0001178] nucleus [GO:0005634] chromatin binding [GO:0003682]; histone binding [GO:0042393]; histone H3K36me3 reader activity [GO:0140003]; NuRD complex binding [GO:0120325] g13090.t1 Q09575 34.595 185 3.58e-24 103.0 sp|Q09575|YRD6_CAEEL Uncharacterized protein K02A2.6 OS=Caenorhabditis elegans OX=6239 GN=K02A2.6 PE=4 SV=1 g13091.t1 P04323 39.766 171 6.04e-29 116.0 sp|P04323|POL3_DROME Retrovirus-related Pol polyprotein from transposon 17.6 OS=Drosophila melanogaster OX=7227 GN=pol PE=4 SV=1 g13099.t1 Q7L273 58.647 399 1.3700000000000002e-166 475.0 sp|Q7L273|KCTD9_HUMAN BTB/POZ domain-containing protein KCTD9 OS=Homo sapiens OX=9606 GN=KCTD9 PE=1 SV=1 KCTD9_HUMAN reviewed BTB/POZ domain-containing protein KCTD9 Homo sapiens (Human) GO:0016567; GO:0035556; GO:0042802; GO:0051260; GO:0097602 intracellular signal transduction [GO:0035556]; protein homooligomerization [GO:0051260]; protein ubiquitination [GO:0016567] cullin family protein binding [GO:0097602]; identical protein binding [GO:0042802] g13102.t1 Q90WY5 57.471 87 1.83e-26 115.0 sp|Q90WY5|ADA2B_DANRE Alpha-2B adrenergic receptor OS=Danio rerio OX=7955 GN=adra2b PE=3 SV=1 ADA2B_DANRE reviewed Alpha-2B adrenergic receptor (Alpha-2B adrenoreceptor) (Alpha-2B adrenoceptor) (Alpha-2BAR) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0004936; GO:0004938; GO:0005886; GO:0007186; GO:0051379; GO:0071881 adenylate cyclase-inhibiting adrenergic receptor signaling pathway [GO:0071881]; G protein-coupled receptor signaling pathway [GO:0007186] plasma membrane [GO:0005886] alpha-adrenergic receptor activity [GO:0004936]; alpha2-adrenergic receptor activity [GO:0004938]; epinephrine binding [GO:0051379] g13103.t1 Q4KM79 40.529 227 1.19e-44 161.0 sp|Q4KM79|DUS11_RAT RNA/RNP complex-1-interacting phosphatase OS=Rattus norvegicus OX=10116 GN=Dusp11 PE=2 SV=1 g13105.t1 Q91W96 44.468 470 3.32e-114 358.0 sp|Q91W96|APC4_MOUSE Anaphase-promoting complex subunit 4 OS=Mus musculus OX=10090 GN=Anapc4 PE=1 SV=1 g13106.t1 Q86NP2 49.635 274 5.05e-71 250.0 sp|Q86NP2|NELFA_DROME Negative elongation factor A OS=Drosophila melanogaster OX=7227 GN=Nelf-A PE=1 SV=2 NELFA_DROME reviewed Negative elongation factor A Drosophila melanogaster (Fruit fly) GO:0000122; GO:0003723; GO:0005634; GO:0005694; GO:0017053; GO:0032021; GO:0034244 negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription elongation by RNA polymerase II [GO:0034244] chromosome [GO:0005694]; NELF complex [GO:0032021]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053] RNA binding [GO:0003723] g13107.t1 P51112 51.404 356 1.96e-94 327.0 sp|P51112|HD_TAKRU Huntingtin OS=Takifugu rubripes OX=31033 GN=htt PE=3 SV=1 g13107.t1 P51112 43.421 228 2.0999999999999999e-38 158.0 sp|P51112|HD_TAKRU Huntingtin OS=Takifugu rubripes OX=31033 GN=htt PE=3 SV=1 g13108.t1 P42859 42.296 2291 0.0 1571.0 sp|P42859|HD_MOUSE Huntingtin OS=Mus musculus OX=10090 GN=Htt PE=1 SV=2 g13109.t1 Q6VVW5 57.018 228 1.42e-77 268.0 sp|Q6VVW5|ANPRB_MOUSE Atrial natriuretic peptide receptor 2 OS=Mus musculus OX=10090 GN=Npr2 PE=1 SV=2 ANPRB_MOUSE reviewed Atrial natriuretic peptide receptor 2 (EC 4.6.1.2) (Atrial natriuretic peptide receptor type B) (ANP-B) (ANPR-B) (NPR-B) (Guanylate cyclase B) (GC-B) Mus musculus (Mouse) GO:0000165; GO:0001541; GO:0001549; GO:0001568; GO:0001570; GO:0001945; GO:0001958; GO:0001964; GO:0001974; GO:0002062; GO:0003417; GO:0004383; GO:0004672; GO:0005524; GO:0005525; GO:0005634; GO:0005737; GO:0005886; GO:0005929; GO:0006182; GO:0007033; GO:0007168; GO:0007173; GO:0007268; GO:0007281; GO:0007283; GO:0007338; GO:0007409; GO:0007605; GO:0008015; GO:0009611; GO:0009725; GO:0010641; GO:0010753; GO:0016941; GO:0017046; GO:0019228; GO:0019934; GO:0021562; GO:0021647; GO:0021675; GO:0030540; GO:0034699; GO:0035108; GO:0035112; GO:0035264; GO:0035483; GO:0035988; GO:0036342; GO:0042060; GO:0042562; GO:0042802; GO:0043005; GO:0045202; GO:0046068; GO:0048546; GO:0048565; GO:0048599; GO:0048668; GO:0048745; GO:0050872; GO:0051216; GO:0051276; GO:0051402; GO:0051447; GO:0060173; GO:0060348; GO:0060385; GO:0060466; GO:0061042; GO:0061939; GO:0071321; GO:0071774; GO:0097011; GO:0097194; GO:0098868; GO:1900194; GO:1901653; GO:1902074; GO:1903537 activation of meiosis involved in egg activation [GO:0060466]; axonogenesis [GO:0007409]; axonogenesis involved in innervation [GO:0060385]; blood circulation [GO:0008015]; blood vessel development [GO:0001568]; blood vessel remodeling [GO:0001974]; bone development [GO:0060348]; bone growth [GO:0098868]; c-di-GMP signaling [GO:0061939]; cartilage development [GO:0051216]; cellular response to cGMP [GO:0071321]; cellular response to granulocyte macrophage colony-stimulating factor stimulus [GO:0097011]; cellular response to peptide [GO:1901653]; cGMP biosynthetic process [GO:0006182]; cGMP metabolic process [GO:0046068]; cGMP-mediated signaling [GO:0019934]; chemical synaptic transmission [GO:0007268]; chondrocyte differentiation [GO:0002062]; chondrocyte proliferation [GO:0035988]; chromosome organization [GO:0051276]; collateral sprouting [GO:0048668]; cumulus cell differentiation [GO:0001549]; digestive tract development [GO:0048565]; digestive tract morphogenesis [GO:0048546]; endochondral ossification [GO:0001958]; epidermal growth factor receptor signaling pathway [GO:0007173]; execution phase of apoptosis [GO:0097194]; female genitalia development [GO:0030540]; gastric emptying [GO:0035483]; genitalia morphogenesis [GO:0035112]; germ cell development [GO:0007281]; growth plate cartilage development [GO:0003417]; limb development [GO:0060173]; limb morphogenesis [GO:0035108]; lymph vessel development [GO:0001945]; MAPK cascade [GO:0000165]; meiotic cell cycle process involved in oocyte maturation [GO:1903537]; multicellular organism growth [GO:0035264]; negative regulation of meiotic cell cycle [GO:0051447]; negative regulation of oocyte maturation [GO:1900194]; nerve development [GO:0021675]; neuron apoptotic process [GO:0051402]; neuronal action potential [GO:0019228]; oocyte development [GO:0048599]; ovarian follicle development [GO:0001541]; positive regulation of cGMP-mediated signaling [GO:0010753]; positive regulation of platelet-derived growth factor receptor signaling pathway [GO:0010641]; post-anal tail morphogenesis [GO:0036342]; receptor guanylyl cyclase signaling pathway [GO:0007168]; response to fibroblast growth factor [GO:0071774]; response to hormone [GO:0009725]; response to luteinizing hormone [GO:0034699]; response to salt [GO:1902074]; response to wounding [GO:0009611]; sensory perception of sound [GO:0007605]; single fertilization [GO:0007338]; smooth muscle tissue development [GO:0048745]; spermatogenesis [GO:0007283]; startle response [GO:0001964]; vacuole organization [GO:0007033]; vascular wound healing [GO:0061042]; vasculogenesis [GO:0001570]; vestibulocochlear nerve development [GO:0021562]; vestibulocochlear nerve maturation [GO:0021647]; white fat cell differentiation [GO:0050872]; wound healing [GO:0042060] cilium [GO:0005929]; cytoplasm [GO:0005737]; neuron projection [GO:0043005]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; synapse [GO:0045202] ATP binding [GO:0005524]; GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; hormone binding [GO:0042562]; identical protein binding [GO:0042802]; natriuretic peptide receptor activity [GO:0016941]; peptide hormone binding [GO:0017046]; protein kinase activity [GO:0004672] g13110.t1 P17538 39.516 248 1.4200000000000001e-44 164.0 sp|P17538|CTRB1_HUMAN Chymotrypsinogen B OS=Homo sapiens OX=9606 GN=CTRB1 PE=1 SV=2 g13111.t1 A0A0D2YG10 31.469 769 1.3200000000000001e-79 297.0 sp|A0A0D2YG10|FUB1_FUSO4 Reducing polyketide synthase FUB1 OS=Fusarium oxysporum f. sp. lycopersici (strain 4287 / CBS 123668 / FGSC 9935 / NRRL 34936) OX=426428 GN=FUB1 PE=1 SV=2 g13111.t1 A0A0D2YG10 27.149 663 3.2400000000000003e-47 191.0 sp|A0A0D2YG10|FUB1_FUSO4 Reducing polyketide synthase FUB1 OS=Fusarium oxysporum f. sp. lycopersici (strain 4287 / CBS 123668 / FGSC 9935 / NRRL 34936) OX=426428 GN=FUB1 PE=1 SV=2 g13112.t1 Q7SHI6 42.759 435 6.32e-112 366.0 sp|Q7SHI6|SRDA_NEUCR Highly reducing polyketide synthase srdA OS=Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) OX=367110 GN=srdA PE=2 SV=1 g13113.t1 A5ABG0 32.17 659 2.67e-71 254.0 sp|A5ABG0|PYNA_ASPNC Hybrid PKS-NRPS synthetase pynA OS=Aspergillus niger (strain ATCC MYA-4892 / CBS 513.88 / FGSC A1513) OX=425011 GN=pynA PE=1 SV=1 PYNA_ASPNC reviewed Hybrid PKS-NRPS synthetase pynA (EC 2.3.1.-) (EC 6.3.2.-) (Pyranonigrin biosynthesis cluster protein A) Aspergillus niger (strain ATCC MYA-4892 / CBS 513.88 / FGSC A1513) GO:0004312; GO:0005737; GO:0005886; GO:0006633; GO:0016491; GO:0016874; GO:0019748; GO:0031177; GO:0044550; GO:1901336 fatty acid biosynthetic process [GO:0006633]; lactone biosynthetic process [GO:1901336]; secondary metabolic process [GO:0019748]; secondary metabolite biosynthetic process [GO:0044550] cytoplasm [GO:0005737]; plasma membrane [GO:0005886] fatty acid synthase activity [GO:0004312]; ligase activity [GO:0016874]; oxidoreductase activity [GO:0016491]; phosphopantetheine binding [GO:0031177] g13115.t1 A5ABG0 31.895 1182 1.02e-156 524.0 sp|A5ABG0|PYNA_ASPNC Hybrid PKS-NRPS synthetase pynA OS=Aspergillus niger (strain ATCC MYA-4892 / CBS 513.88 / FGSC A1513) OX=425011 GN=pynA PE=1 SV=1 PYNA_ASPNC reviewed Hybrid PKS-NRPS synthetase pynA (EC 2.3.1.-) (EC 6.3.2.-) (Pyranonigrin biosynthesis cluster protein A) Aspergillus niger (strain ATCC MYA-4892 / CBS 513.88 / FGSC A1513) GO:0004312; GO:0005737; GO:0005886; GO:0006633; GO:0016491; GO:0016874; GO:0019748; GO:0031177; GO:0044550; GO:1901336 fatty acid biosynthetic process [GO:0006633]; lactone biosynthetic process [GO:1901336]; secondary metabolic process [GO:0019748]; secondary metabolite biosynthetic process [GO:0044550] cytoplasm [GO:0005737]; plasma membrane [GO:0005886] fatty acid synthase activity [GO:0004312]; ligase activity [GO:0016874]; oxidoreductase activity [GO:0016491]; phosphopantetheine binding [GO:0031177] g13117.t1 P9WEZ4 33.66 306 1.09e-30 125.0 sp|P9WEZ4|PYTA_ASPTE Hybrid PKS-NRPS synthetase pytA OS=Aspergillus terreus OX=33178 GN=pytA PE=2 SV=1 g13120.t1 P96202 38.356 219 2.14e-37 144.0 sp|P96202|PPSC_MYCTU Phenolphthiocerol/phthiocerol polyketide synthase subunit C OS=Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv) OX=83332 GN=ppsC PE=1 SV=2 g13122.t1 A5ABG0 29.023 1044 7.409999999999999e-94 335.0 sp|A5ABG0|PYNA_ASPNC Hybrid PKS-NRPS synthetase pynA OS=Aspergillus niger (strain ATCC MYA-4892 / CBS 513.88 / FGSC A1513) OX=425011 GN=pynA PE=1 SV=1 PYNA_ASPNC reviewed Hybrid PKS-NRPS synthetase pynA (EC 2.3.1.-) (EC 6.3.2.-) (Pyranonigrin biosynthesis cluster protein A) Aspergillus niger (strain ATCC MYA-4892 / CBS 513.88 / FGSC A1513) GO:0004312; GO:0005737; GO:0005886; GO:0006633; GO:0016491; GO:0016874; GO:0019748; GO:0031177; GO:0044550; GO:1901336 fatty acid biosynthetic process [GO:0006633]; lactone biosynthetic process [GO:1901336]; secondary metabolic process [GO:0019748]; secondary metabolite biosynthetic process [GO:0044550] cytoplasm [GO:0005737]; plasma membrane [GO:0005886] fatty acid synthase activity [GO:0004312]; ligase activity [GO:0016874]; oxidoreductase activity [GO:0016491]; phosphopantetheine binding [GO:0031177] g13123.t1 P9WQE3 48.402 219 7.2e-62 213.0 sp|P9WQE3|PPSD_MYCTU Phenolphthiocerol/phthiocerol polyketide synthase subunit D OS=Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv) OX=83332 GN=ppsD PE=1 SV=1 g13125.t1 Q8BJ03 58.809 403 1.4799999999999999e-147 428.0 sp|Q8BJ03|COX15_MOUSE Heme A synthase COX15 OS=Mus musculus OX=10090 GN=Cox15 PE=1 SV=1 g13126.t1 Q66JG3 52.14 514 2.85e-176 509.0 sp|Q66JG3|SYEM_XENTR Nondiscriminating glutamyl-tRNA synthetase EARS2, mitochondrial OS=Xenopus tropicalis OX=8364 GN=ears2 PE=2 SV=1 SYEM_XENTR reviewed Nondiscriminating glutamyl-tRNA synthetase EARS2, mitochondrial (EC 6.1.1.24) (Glutamate--tRNA(Gln) ligase EARS2, mitochondrial) (EC 6.1.1.17) (Glutamyl-tRNA synthetase) (GluRS) (Mitochondrial glutamyl-tRNA synthetase) (mtGluRS) Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0000049; GO:0004818; GO:0005524; GO:0005739; GO:0005759; GO:0006424; GO:0008270; GO:0050561 glutamyl-tRNA aminoacylation [GO:0006424] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] ATP binding [GO:0005524]; glutamate-tRNA ligase activity [GO:0004818]; glutamate-tRNA(Gln) ligase activity [GO:0050561]; tRNA binding [GO:0000049]; zinc ion binding [GO:0008270] g13126.t2 Q66JG3 51.845 515 4.14e-176 509.0 sp|Q66JG3|SYEM_XENTR Nondiscriminating glutamyl-tRNA synthetase EARS2, mitochondrial OS=Xenopus tropicalis OX=8364 GN=ears2 PE=2 SV=1 SYEM_XENTR reviewed Nondiscriminating glutamyl-tRNA synthetase EARS2, mitochondrial (EC 6.1.1.24) (Glutamate--tRNA(Gln) ligase EARS2, mitochondrial) (EC 6.1.1.17) (Glutamyl-tRNA synthetase) (GluRS) (Mitochondrial glutamyl-tRNA synthetase) (mtGluRS) Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0000049; GO:0004818; GO:0005524; GO:0005739; GO:0005759; GO:0006424; GO:0008270; GO:0050561 glutamyl-tRNA aminoacylation [GO:0006424] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] ATP binding [GO:0005524]; glutamate-tRNA ligase activity [GO:0004818]; glutamate-tRNA(Gln) ligase activity [GO:0050561]; tRNA binding [GO:0000049]; zinc ion binding [GO:0008270] g13127.t1 Q9UGT4 34.639 485 6.07e-72 261.0 sp|Q9UGT4|SUSD2_HUMAN Sushi domain-containing protein 2 OS=Homo sapiens OX=9606 GN=SUSD2 PE=1 SV=1 SUSD2_HUMAN reviewed Sushi domain-containing protein 2 Homo sapiens (Human) GO:0005615; GO:0005886; GO:0051782; GO:0070062; GO:1902807 negative regulation of cell cycle G1/S phase transition [GO:1902807]; negative regulation of cell division [GO:0051782] extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; plasma membrane [GO:0005886] g13127.t2 Q9UGT4 34.639 485 6.7e-73 261.0 sp|Q9UGT4|SUSD2_HUMAN Sushi domain-containing protein 2 OS=Homo sapiens OX=9606 GN=SUSD2 PE=1 SV=1 SUSD2_HUMAN reviewed Sushi domain-containing protein 2 Homo sapiens (Human) GO:0005615; GO:0005886; GO:0051782; GO:0070062; GO:1902807 negative regulation of cell cycle G1/S phase transition [GO:1902807]; negative regulation of cell division [GO:0051782] extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; plasma membrane [GO:0005886] g13128.t1 P70579 28.256 814 5.66e-84 291.0 sp|P70579|GRM8_RAT Metabotropic glutamate receptor 8 OS=Rattus norvegicus OX=10116 GN=Grm8 PE=1 SV=1 GRM8_RAT reviewed Metabotropic glutamate receptor 8 (mGluR8) Rattus norvegicus (Rat) GO:0001642; GO:0004930; GO:0005886; GO:0007193; GO:0007196; GO:0007216; GO:0007268; GO:0008066; GO:0019233; GO:0035249; GO:0042734; GO:0043025; GO:0045211; GO:0046928; GO:0048787; GO:0050966; GO:0051966; GO:0098978; GO:0098982; GO:0099171 adenylate cyclase-inhibiting G protein-coupled glutamate receptor signaling pathway [GO:0007196]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; chemical synaptic transmission [GO:0007268]; detection of mechanical stimulus involved in sensory perception of pain [GO:0050966]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; presynaptic modulation of chemical synaptic transmission [GO:0099171]; regulation of neurotransmitter secretion [GO:0046928]; regulation of synaptic transmission, glutamatergic [GO:0051966]; sensory perception of pain [GO:0019233]; synaptic transmission, glutamatergic [GO:0035249] GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic active zone membrane [GO:0048787]; presynaptic membrane [GO:0042734] G protein-coupled receptor activity [GO:0004930]; glutamate receptor activity [GO:0008066]; group III metabotropic glutamate receptor activity [GO:0001642] g13135.t1 P61648 33.446 296 2.49e-51 179.0 sp|P61648|SIA8F_PANTR Alpha-2,8-sialyltransferase 8F OS=Pan troglodytes OX=9598 GN=ST8SIA6 PE=2 SV=1 SIA8F_PANTR reviewed Alpha-2,8-sialyltransferase 8F (EC 2.4.99.-) (Sialyltransferase 8F) (SIAT8-F) (Sialyltransferase St8Sia VI) (ST8SiaVI) Pan troglodytes (Chimpanzee) GO:0000139; GO:0001574; GO:0001835; GO:0003828; GO:0006491; GO:0006493; GO:0009311; GO:0016051 blastocyst hatching [GO:0001835]; carbohydrate biosynthetic process [GO:0016051]; ganglioside biosynthetic process [GO:0001574]; N-glycan processing [GO:0006491]; oligosaccharide metabolic process [GO:0009311]; protein O-linked glycosylation [GO:0006493] Golgi membrane [GO:0000139] alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity [GO:0003828] g13142.t1 Q99P84 38.939 1112 0.0 691.0 sp|Q99P84|PLCE1_RAT 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase epsilon-1 OS=Rattus norvegicus OX=10116 GN=Plce1 PE=1 SV=1 g13142.t1 Q99P84 32.47 579 1.02e-61 240.0 sp|Q99P84|PLCE1_RAT 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase epsilon-1 OS=Rattus norvegicus OX=10116 GN=Plce1 PE=1 SV=1 g13142.t2 Q99P84 37.895 1140 0.0 680.0 sp|Q99P84|PLCE1_RAT 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase epsilon-1 OS=Rattus norvegicus OX=10116 GN=Plce1 PE=1 SV=1 g13142.t2 Q99P84 32.47 579 1.26e-61 240.0 sp|Q99P84|PLCE1_RAT 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase epsilon-1 OS=Rattus norvegicus OX=10116 GN=Plce1 PE=1 SV=1 g13143.t1 Q28FF3 36.162 495 1.96e-67 226.0 sp|Q28FF3|S49A3_XENTR Solute carrier family 49 member A3 OS=Xenopus tropicalis OX=8364 GN=slc49a3 PE=2 SV=2 g13145.t1 P08594 45.932 381 1.44e-78 254.0 sp|P08594|AQL1_THEAQ Aqualysin-1 OS=Thermus aquaticus OX=271 GN=pstI PE=1 SV=2 g13145.t2 P08594 44.059 404 6.63e-76 248.0 sp|P08594|AQL1_THEAQ Aqualysin-1 OS=Thermus aquaticus OX=271 GN=pstI PE=1 SV=2 g13146.t1 P08594 53.371 356 1.36e-107 327.0 sp|P08594|AQL1_THEAQ Aqualysin-1 OS=Thermus aquaticus OX=271 GN=pstI PE=1 SV=2 g13147.t1 Q0P4P2 38.672 256 1.37e-54 185.0 sp|Q0P4P2|FBCD1_XENTR Fibrinogen C domain-containing protein 1 OS=Xenopus tropicalis OX=8364 GN=fibcd1 PE=2 SV=1 g13148.t1 Q0P4P2 39.231 260 3.31e-51 180.0 sp|Q0P4P2|FBCD1_XENTR Fibrinogen C domain-containing protein 1 OS=Xenopus tropicalis OX=8364 GN=fibcd1 PE=2 SV=1 g13150.t1 Q0P4P2 32.685 257 5.68e-34 133.0 sp|Q0P4P2|FBCD1_XENTR Fibrinogen C domain-containing protein 1 OS=Xenopus tropicalis OX=8364 GN=fibcd1 PE=2 SV=1 g13151.t1 Q15485 47.768 224 6.91e-54 189.0 sp|Q15485|FCN2_HUMAN Ficolin-2 OS=Homo sapiens OX=9606 GN=FCN2 PE=1 SV=2 FCN2_HUMAN reviewed Ficolin-2 (37 kDa elastin-binding protein) (EBP-37) (Collagen/fibrinogen domain-containing protein 2) (Ficolin-B) (Ficolin-beta) (Hucolin) (L-ficolin) (Serum lectin p35) Homo sapiens (Human) GO:0001867; GO:0002752; GO:0003823; GO:0005102; GO:0005576; GO:0005581; GO:0005615; GO:0006508; GO:0008228; GO:0009897; GO:0038187; GO:0043394; GO:0043654; GO:0046872; GO:0048306; GO:0050829; GO:0050830; GO:0070062; GO:0070892; GO:0072562; GO:0097367; GO:0106139; GO:1903028; GO:1905370; GO:2001065 cell surface pattern recognition receptor signaling pathway [GO:0002752]; complement activation, lectin pathway [GO:0001867]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; opsonization [GO:0008228]; positive regulation of opsonization [GO:1903028]; proteolysis [GO:0006508]; recognition of apoptotic cell [GO:0043654] blood microparticle [GO:0072562]; collagen trimer [GO:0005581]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; serine-type endopeptidase complex [GO:1905370]; symbiont cell surface [GO:0106139] antigen binding [GO:0003823]; calcium-dependent protein binding [GO:0048306]; carbohydrate derivative binding [GO:0097367]; lipoteichoic acid immune receptor activity [GO:0070892]; mannan binding [GO:2001065]; metal ion binding [GO:0046872]; pattern recognition receptor activity [GO:0038187]; proteoglycan binding [GO:0043394]; signaling receptor binding [GO:0005102] g13151.t1 Q15485 48.039 204 6.42e-46 168.0 sp|Q15485|FCN2_HUMAN Ficolin-2 OS=Homo sapiens OX=9606 GN=FCN2 PE=1 SV=2 FCN2_HUMAN reviewed Ficolin-2 (37 kDa elastin-binding protein) (EBP-37) (Collagen/fibrinogen domain-containing protein 2) (Ficolin-B) (Ficolin-beta) (Hucolin) (L-ficolin) (Serum lectin p35) Homo sapiens (Human) GO:0001867; GO:0002752; GO:0003823; GO:0005102; GO:0005576; GO:0005581; GO:0005615; GO:0006508; GO:0008228; GO:0009897; GO:0038187; GO:0043394; GO:0043654; GO:0046872; GO:0048306; GO:0050829; GO:0050830; GO:0070062; GO:0070892; GO:0072562; GO:0097367; GO:0106139; GO:1903028; GO:1905370; GO:2001065 cell surface pattern recognition receptor signaling pathway [GO:0002752]; complement activation, lectin pathway [GO:0001867]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; opsonization [GO:0008228]; positive regulation of opsonization [GO:1903028]; proteolysis [GO:0006508]; recognition of apoptotic cell [GO:0043654] blood microparticle [GO:0072562]; collagen trimer [GO:0005581]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; serine-type endopeptidase complex [GO:1905370]; symbiont cell surface [GO:0106139] antigen binding [GO:0003823]; calcium-dependent protein binding [GO:0048306]; carbohydrate derivative binding [GO:0097367]; lipoteichoic acid immune receptor activity [GO:0070892]; mannan binding [GO:2001065]; metal ion binding [GO:0046872]; pattern recognition receptor activity [GO:0038187]; proteoglycan binding [GO:0043394]; signaling receptor binding [GO:0005102] g13154.t1 Q15485 47.321 224 6.84e-53 186.0 sp|Q15485|FCN2_HUMAN Ficolin-2 OS=Homo sapiens OX=9606 GN=FCN2 PE=1 SV=2 FCN2_HUMAN reviewed Ficolin-2 (37 kDa elastin-binding protein) (EBP-37) (Collagen/fibrinogen domain-containing protein 2) (Ficolin-B) (Ficolin-beta) (Hucolin) (L-ficolin) (Serum lectin p35) Homo sapiens (Human) GO:0001867; GO:0002752; GO:0003823; GO:0005102; GO:0005576; GO:0005581; GO:0005615; GO:0006508; GO:0008228; GO:0009897; GO:0038187; GO:0043394; GO:0043654; GO:0046872; GO:0048306; GO:0050829; GO:0050830; GO:0070062; GO:0070892; GO:0072562; GO:0097367; GO:0106139; GO:1903028; GO:1905370; GO:2001065 cell surface pattern recognition receptor signaling pathway [GO:0002752]; complement activation, lectin pathway [GO:0001867]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; opsonization [GO:0008228]; positive regulation of opsonization [GO:1903028]; proteolysis [GO:0006508]; recognition of apoptotic cell [GO:0043654] blood microparticle [GO:0072562]; collagen trimer [GO:0005581]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; serine-type endopeptidase complex [GO:1905370]; symbiont cell surface [GO:0106139] antigen binding [GO:0003823]; calcium-dependent protein binding [GO:0048306]; carbohydrate derivative binding [GO:0097367]; lipoteichoic acid immune receptor activity [GO:0070892]; mannan binding [GO:2001065]; metal ion binding [GO:0046872]; pattern recognition receptor activity [GO:0038187]; proteoglycan binding [GO:0043394]; signaling receptor binding [GO:0005102] g13154.t1 Q15485 48.966 145 3.07e-25 109.0 sp|Q15485|FCN2_HUMAN Ficolin-2 OS=Homo sapiens OX=9606 GN=FCN2 PE=1 SV=2 FCN2_HUMAN reviewed Ficolin-2 (37 kDa elastin-binding protein) (EBP-37) (Collagen/fibrinogen domain-containing protein 2) (Ficolin-B) (Ficolin-beta) (Hucolin) (L-ficolin) (Serum lectin p35) Homo sapiens (Human) GO:0001867; GO:0002752; GO:0003823; GO:0005102; GO:0005576; GO:0005581; GO:0005615; GO:0006508; GO:0008228; GO:0009897; GO:0038187; GO:0043394; GO:0043654; GO:0046872; GO:0048306; GO:0050829; GO:0050830; GO:0070062; GO:0070892; GO:0072562; GO:0097367; GO:0106139; GO:1903028; GO:1905370; GO:2001065 cell surface pattern recognition receptor signaling pathway [GO:0002752]; complement activation, lectin pathway [GO:0001867]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; opsonization [GO:0008228]; positive regulation of opsonization [GO:1903028]; proteolysis [GO:0006508]; recognition of apoptotic cell [GO:0043654] blood microparticle [GO:0072562]; collagen trimer [GO:0005581]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; serine-type endopeptidase complex [GO:1905370]; symbiont cell surface [GO:0106139] antigen binding [GO:0003823]; calcium-dependent protein binding [GO:0048306]; carbohydrate derivative binding [GO:0097367]; lipoteichoic acid immune receptor activity [GO:0070892]; mannan binding [GO:2001065]; metal ion binding [GO:0046872]; pattern recognition receptor activity [GO:0038187]; proteoglycan binding [GO:0043394]; signaling receptor binding [GO:0005102] g13155.t1 Q6AX44 47.297 222 1.42e-54 186.0 sp|Q6AX44|FBCDA_XENLA Fibrinogen C domain-containing protein 1-A OS=Xenopus laevis OX=8355 GN=fibcd1-a PE=2 SV=1 g13158.t1 Q4SBY6 28.519 270 2.71e-24 102.0 sp|Q4SBY6|HNMT_TETNG Histamine N-methyltransferase OS=Tetraodon nigroviridis OX=99883 GN=hnmt PE=3 SV=1 g13159.t1 Q0P4P2 46.818 220 4.11e-57 199.0 sp|Q0P4P2|FBCD1_XENTR Fibrinogen C domain-containing protein 1 OS=Xenopus tropicalis OX=8364 GN=fibcd1 PE=2 SV=1 g13160.t1 Q15485 48.444 225 1.0799999999999999e-54 195.0 sp|Q15485|FCN2_HUMAN Ficolin-2 OS=Homo sapiens OX=9606 GN=FCN2 PE=1 SV=2 FCN2_HUMAN reviewed Ficolin-2 (37 kDa elastin-binding protein) (EBP-37) (Collagen/fibrinogen domain-containing protein 2) (Ficolin-B) (Ficolin-beta) (Hucolin) (L-ficolin) (Serum lectin p35) Homo sapiens (Human) GO:0001867; GO:0002752; GO:0003823; GO:0005102; GO:0005576; GO:0005581; GO:0005615; GO:0006508; GO:0008228; GO:0009897; GO:0038187; GO:0043394; GO:0043654; GO:0046872; GO:0048306; GO:0050829; GO:0050830; GO:0070062; GO:0070892; GO:0072562; GO:0097367; GO:0106139; GO:1903028; GO:1905370; GO:2001065 cell surface pattern recognition receptor signaling pathway [GO:0002752]; complement activation, lectin pathway [GO:0001867]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; opsonization [GO:0008228]; positive regulation of opsonization [GO:1903028]; proteolysis [GO:0006508]; recognition of apoptotic cell [GO:0043654] blood microparticle [GO:0072562]; collagen trimer [GO:0005581]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; serine-type endopeptidase complex [GO:1905370]; symbiont cell surface [GO:0106139] antigen binding [GO:0003823]; calcium-dependent protein binding [GO:0048306]; carbohydrate derivative binding [GO:0097367]; lipoteichoic acid immune receptor activity [GO:0070892]; mannan binding [GO:2001065]; metal ion binding [GO:0046872]; pattern recognition receptor activity [GO:0038187]; proteoglycan binding [GO:0043394]; signaling receptor binding [GO:0005102] g13160.t1 Q15485 47.442 215 4.39e-42 159.0 sp|Q15485|FCN2_HUMAN Ficolin-2 OS=Homo sapiens OX=9606 GN=FCN2 PE=1 SV=2 FCN2_HUMAN reviewed Ficolin-2 (37 kDa elastin-binding protein) (EBP-37) (Collagen/fibrinogen domain-containing protein 2) (Ficolin-B) (Ficolin-beta) (Hucolin) (L-ficolin) (Serum lectin p35) Homo sapiens (Human) GO:0001867; GO:0002752; GO:0003823; GO:0005102; GO:0005576; GO:0005581; GO:0005615; GO:0006508; GO:0008228; GO:0009897; GO:0038187; GO:0043394; GO:0043654; GO:0046872; GO:0048306; GO:0050829; GO:0050830; GO:0070062; GO:0070892; GO:0072562; GO:0097367; GO:0106139; GO:1903028; GO:1905370; GO:2001065 cell surface pattern recognition receptor signaling pathway [GO:0002752]; complement activation, lectin pathway [GO:0001867]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; opsonization [GO:0008228]; positive regulation of opsonization [GO:1903028]; proteolysis [GO:0006508]; recognition of apoptotic cell [GO:0043654] blood microparticle [GO:0072562]; collagen trimer [GO:0005581]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; serine-type endopeptidase complex [GO:1905370]; symbiont cell surface [GO:0106139] antigen binding [GO:0003823]; calcium-dependent protein binding [GO:0048306]; carbohydrate derivative binding [GO:0097367]; lipoteichoic acid immune receptor activity [GO:0070892]; mannan binding [GO:2001065]; metal ion binding [GO:0046872]; pattern recognition receptor activity [GO:0038187]; proteoglycan binding [GO:0043394]; signaling receptor binding [GO:0005102] g13161.t1 Q8ITC9 28.947 380 4.12e-36 141.0 sp|Q8ITC9|PK1R_DROME Pyrokinin-1 receptor OS=Drosophila melanogaster OX=7227 GN=PK1-R PE=2 SV=1 PK1R_DROME reviewed Pyrokinin-1 receptor Drosophila melanogaster (Fruit fly) GO:0004930; GO:0005886; GO:0007186; GO:0007218; GO:0008188; GO:0016020; GO:0036401; GO:0070328; GO:0090278 G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of peptide hormone secretion [GO:0090278]; neuropeptide signaling pathway [GO:0007218]; triglyceride homeostasis [GO:0070328] membrane [GO:0016020]; plasma membrane [GO:0005886] G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; pyrokinin receptor activity [GO:0036401] g13164.t1 A9CB34 25.769 1106 2.94e-75 278.0 sp|A9CB34|SFI1_PAPAN Protein SFI1 homolog OS=Papio anubis OX=9555 GN=SFI1 PE=3 SV=2 g13168.t1 P23359 28.504 421 2.2700000000000003e-31 128.0 sp|P23359|BMP7_MOUSE Bone morphogenetic protein 7 OS=Mus musculus OX=10090 GN=Bmp7 PE=1 SV=2 BMP7_MOUSE reviewed Bone morphogenetic protein 7 (BMP-7) (Osteogenic protein 1) (OP-1) Mus musculus (Mouse) GO:0001649; GO:0001654; GO:0001657; GO:0001707; GO:0001822; GO:0003272; GO:0003344; GO:0005125; GO:0005615; GO:0007389; GO:0007411; GO:0007435; GO:0007507; GO:0008083; GO:0008201; GO:0008285; GO:0009880; GO:0009887; GO:0010628; GO:0010718; GO:0021502; GO:0030326; GO:0030501; GO:0030509; GO:0030855; GO:0030902; GO:0031012; GO:0031982; GO:0032355; GO:0033280; GO:0034116; GO:0035239; GO:0042475; GO:0043065; GO:0043434; GO:0043539; GO:0045597; GO:0045665; GO:0045666; GO:0045669; GO:0045746; GO:0045786; GO:0045839; GO:0045892; GO:0045893; GO:0045944; GO:0048468; GO:0048593; GO:0048596; GO:0048646; GO:0048738; GO:0048754; GO:0048762; GO:0048812; GO:0050768; GO:0051216; GO:0060037; GO:0060272; GO:0060391; GO:0060411; GO:0060445; GO:0060485; GO:0060686; GO:0060687; GO:0060710; GO:0061384; GO:0070487; GO:0070700; GO:0071773; GO:0072040; GO:0072125; GO:0072133; GO:0072134; GO:0072136; GO:0090336; GO:1900006; GO:1900106; GO:1905069; GO:1905312 allantois development [GO:1905069]; anatomical structure formation involved in morphogenesis [GO:0048646]; animal organ morphogenesis [GO:0009887]; axon guidance [GO:0007411]; BMP signaling pathway [GO:0030509]; branching involved in salivary gland morphogenesis [GO:0060445]; branching morphogenesis of an epithelial tube [GO:0048754]; camera-type eye morphogenesis [GO:0048593]; cardiac muscle tissue development [GO:0048738]; cardiac septum morphogenesis [GO:0060411]; cartilage development [GO:0051216]; cell development [GO:0048468]; cellular response to BMP stimulus [GO:0071773]; chorio-allantoic fusion [GO:0060710]; embryonic camera-type eye morphogenesis [GO:0048596]; embryonic limb morphogenesis [GO:0030326]; embryonic pattern specification [GO:0009880]; embryonic skeletal joint morphogenesis [GO:0060272]; endocardial cushion formation [GO:0003272]; epithelial cell differentiation [GO:0030855]; eye development [GO:0001654]; heart development [GO:0007507]; heart trabecula morphogenesis [GO:0061384]; hindbrain development [GO:0030902]; kidney development [GO:0001822]; mesenchymal cell differentiation [GO:0048762]; mesenchyme development [GO:0060485]; mesoderm formation [GO:0001707]; metanephric mesenchymal cell proliferation involved in metanephros development [GO:0072136]; metanephric mesenchyme morphogenesis [GO:0072133]; monocyte aggregation [GO:0070487]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of glomerular mesangial cell proliferation [GO:0072125]; negative regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis [GO:0072040]; negative regulation of mitotic nuclear division [GO:0045839]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of prostatic bud formation [GO:0060686]; nephrogenic mesenchyme morphogenesis [GO:0072134]; neural fold elevation formation [GO:0021502]; neuron projection morphogenesis [GO:0048812]; odontogenesis of dentin-containing tooth [GO:0042475]; osteoblast differentiation [GO:0001649]; pattern specification process [GO:0007389]; pericardium morphogenesis [GO:0003344]; pharyngeal system development [GO:0060037]; positive regulation of apoptotic process [GO:0043065]; positive regulation of bone mineralization [GO:0030501]; positive regulation of brown fat cell differentiation [GO:0090336]; positive regulation of cardiac neural crest cell migration involved in outflow tract morphogenesis [GO:1905312]; positive regulation of cell differentiation [GO:0045597]; positive regulation of dendrite development [GO:1900006]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of gene expression [GO:0010628]; positive regulation of heterotypic cell-cell adhesion [GO:0034116]; positive regulation of hyaluranon cable assembly [GO:1900106]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of SMAD protein signal transduction [GO:0060391]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of branching involved in prostate gland morphogenesis [GO:0060687]; response to estradiol [GO:0032355]; response to peptide hormone [GO:0043434]; response to vitamin D [GO:0033280]; salivary gland morphogenesis [GO:0007435]; tube morphogenesis [GO:0035239]; ureteric bud development [GO:0001657] extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; vesicle [GO:0031982] BMP receptor binding [GO:0070700]; cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; heparin binding [GO:0008201]; protein serine/threonine kinase activator activity [GO:0043539] g13170.t1 Q90673 49.102 167 6.42e-54 174.0 sp|Q90673|PRLD1_CHICK PRELI domain-containing protein 1, mitochondrial OS=Gallus gallus OX=9031 GN=PRELID1 PE=2 SV=1 g13171.t1 Q7Z5Q5 38.543 659 1.0099999999999999e-119 392.0 sp|Q7Z5Q5|DPOLN_HUMAN DNA polymerase nu OS=Homo sapiens OX=9606 GN=POLN PE=1 SV=2 DPOLN_HUMAN reviewed DNA polymerase nu (EC 2.7.7.7) Homo sapiens (Human) GO:0000724; GO:0000731; GO:0003677; GO:0003887; GO:0005634; GO:0005654; GO:0006261; GO:0006302; GO:0019985; GO:0030332; GO:0036297 DNA synthesis involved in DNA repair [GO:0000731]; DNA-templated DNA replication [GO:0006261]; double-strand break repair [GO:0006302]; double-strand break repair via homologous recombination [GO:0000724]; interstrand cross-link repair [GO:0036297]; translesion synthesis [GO:0019985] nucleoplasm [GO:0005654]; nucleus [GO:0005634] cyclin binding [GO:0030332]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887] g13173.t1 Q9WTR6 45.0 440 4.3199999999999996e-120 364.0 sp|Q9WTR6|XCT_MOUSE Cystine/glutamate transporter OS=Mus musculus OX=10090 GN=Slc7a11 PE=1 SV=1 XCT_MOUSE reviewed Cystine/glutamate transporter (Amino acid transport system xc-) (Solute carrier family 7 member 11) (Subtle gray protein) (xCT) Mus musculus (Mouse) GO:0003333; GO:0005765; GO:0005886; GO:0006749; GO:0007420; GO:0008542; GO:0009636; GO:0009986; GO:0015179; GO:0015252; GO:0015327; GO:0015811; GO:0015813; GO:0016020; GO:0021591; GO:0021756; GO:0022840; GO:0030534; GO:0031526; GO:0031528; GO:0033029; GO:0033554; GO:0034599; GO:0034775; GO:0035752; GO:0042127; GO:0045177; GO:0048021; GO:0048286; GO:0050804; GO:0050807; GO:0051223; GO:0051775; GO:0060173; GO:0070527; GO:0090461; GO:0097449; GO:0098712; GO:0110076; GO:0140206; GO:0140924; GO:0140926; GO:1900407; GO:1901494; GO:1902600; GO:1903786; GO:1904717; GO:2000211 adult behavior [GO:0030534]; amino acid transmembrane transport [GO:0003333]; brain development [GO:0007420]; cellular response to oxidative stress [GO:0034599]; cellular response to stress [GO:0033554]; dipeptide import across plasma membrane [GO:0140206]; glutathione metabolic process [GO:0006749]; glutathione transmembrane transport [GO:0034775]; intracellular glutamate homeostasis [GO:0090461]; L-cystine transport [GO:0015811]; L-glutamate import across plasma membrane [GO:0098712]; L-glutamate transmembrane transport [GO:0015813]; L-kynurenine transmembrane transport [GO:0140924]; limb development [GO:0060173]; lung alveolus development [GO:0048286]; lysosomal lumen pH elevation [GO:0035752]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of ferroptosis [GO:0110076]; platelet aggregation [GO:0070527]; proton transmembrane transport [GO:1902600]; regulation of AMPA glutamate receptor clustering [GO:1904717]; regulation of cell population proliferation [GO:0042127]; regulation of cellular response to oxidative stress [GO:1900407]; regulation of cysteine metabolic process [GO:1901494]; regulation of glutamate metabolic process [GO:2000211]; regulation of glutathione biosynthetic process [GO:1903786]; regulation of melanin biosynthetic process [GO:0048021]; regulation of neutrophil apoptotic process [GO:0033029]; regulation of protein transport [GO:0051223]; regulation of synapse organization [GO:0050807]; response to redox state [GO:0051775]; response to toxic substance [GO:0009636]; striatum development [GO:0021756]; ventricular system development [GO:0021591]; visual learning [GO:0008542] apical part of cell [GO:0045177]; astrocyte projection [GO:0097449]; brush border membrane [GO:0031526]; cell surface [GO:0009986]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; microvillus membrane [GO:0031528]; plasma membrane [GO:0005886] cystine:glutamate antiporter activity [GO:0015327]; L-amino acid transmembrane transporter activity [GO:0015179]; L-kynurenine transmembrane transporter activity [GO:0140926]; leak channel activity [GO:0022840]; proton channel activity [GO:0015252] g13174.t1 Q9UMX1 59.56 455 0.0 543.0 sp|Q9UMX1|SUFU_HUMAN Suppressor of fused homolog OS=Homo sapiens OX=9606 GN=SUFU PE=1 SV=2 g13176.t1 Q6AYJ2 60.526 114 4.12e-43 158.0 sp|Q6AYJ2|BOD1_RAT Biorientation of chromosomes in cell division protein 1 OS=Rattus norvegicus OX=10116 GN=Bod1 PE=2 SV=1 BOD1_RAT reviewed Biorientation of chromosomes in cell division protein 1 (Biorientation defective protein 1) (Protein FAM44B) Rattus norvegicus (Rat) GO:0000922; GO:0000940; GO:0004864; GO:0005813; GO:0005876; GO:0007080; GO:0048188; GO:0051301; GO:0051721; GO:0071459; GO:0071962; GO:1990758 cell division [GO:0051301]; mitotic metaphase chromosome alignment [GO:0007080]; mitotic sister chromatid biorientation [GO:1990758]; mitotic sister chromatid cohesion, centromeric [GO:0071962]; protein localization to chromosome, centromeric region [GO:0071459] centrosome [GO:0005813]; outer kinetochore [GO:0000940]; Set1C/COMPASS complex [GO:0048188]; spindle microtubule [GO:0005876]; spindle pole [GO:0000922] protein phosphatase 2A binding [GO:0051721]; protein phosphatase inhibitor activity [GO:0004864] g13177.t1 P05708 53.196 438 4.09e-139 424.0 sp|P05708|HXK1_RAT Hexokinase-1 OS=Rattus norvegicus OX=10116 GN=Hk1 PE=1 SV=4 HXK1_RAT reviewed Hexokinase-1 (EC 2.7.1.1) (Brain form hexokinase) (Hexokinase type I) (HK I) (Hexokinase-A) Rattus norvegicus (Rat) GO:0001666; GO:0001678; GO:0002720; GO:0002931; GO:0004340; GO:0004396; GO:0004672; GO:0005524; GO:0005536; GO:0005739; GO:0005741; GO:0005829; GO:0005901; GO:0005929; GO:0006002; GO:0006006; GO:0006013; GO:0006096; GO:0006954; GO:0008865; GO:0009741; GO:0016887; GO:0019158; GO:0032731; GO:0032991; GO:0042802; GO:0042834; GO:0043066; GO:0044877; GO:0045087; GO:0045121; GO:0046835; GO:0047931; GO:0051156; GO:0061621; GO:0061728; GO:0072655; GO:0072656; GO:0097228; GO:1901986 canonical glycolysis [GO:0061621]; carbohydrate phosphorylation [GO:0046835]; establishment of protein localization to mitochondrion [GO:0072655]; fructose 6-phosphate metabolic process [GO:0006002]; GDP-mannose biosynthetic process from mannose [GO:0061728]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glycolytic process [GO:0006096]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; intracellular glucose homeostasis [GO:0001678]; maintenance of protein location in mitochondrion [GO:0072656]; mannose metabolic process [GO:0006013]; negative regulation of apoptotic process [GO:0043066]; positive regulation of cytokine production involved in immune response [GO:0002720]; positive regulation of interleukin-1 beta production [GO:0032731]; response to brassinosteroid [GO:0009741]; response to hypoxia [GO:0001666]; response to ischemia [GO:0002931]; response to ketamine [GO:1901986] caveola [GO:0005901]; cilium [GO:0005929]; cytosol [GO:0005829]; membrane raft [GO:0045121]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; protein-containing complex [GO:0032991]; sperm principal piece [GO:0097228] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; D-glucose binding [GO:0005536]; fructokinase activity [GO:0008865]; glucokinase activity [GO:0004340]; glucosamine kinase activity [GO:0047931]; hexokinase activity [GO:0004396]; identical protein binding [GO:0042802]; mannokinase activity [GO:0019158]; peptidoglycan binding [GO:0042834]; protein kinase activity [GO:0004672]; protein-containing complex binding [GO:0044877] g13177.t1 P05708 47.706 436 1.39e-120 376.0 sp|P05708|HXK1_RAT Hexokinase-1 OS=Rattus norvegicus OX=10116 GN=Hk1 PE=1 SV=4 HXK1_RAT reviewed Hexokinase-1 (EC 2.7.1.1) (Brain form hexokinase) (Hexokinase type I) (HK I) (Hexokinase-A) Rattus norvegicus (Rat) GO:0001666; GO:0001678; GO:0002720; GO:0002931; GO:0004340; GO:0004396; GO:0004672; GO:0005524; GO:0005536; GO:0005739; GO:0005741; GO:0005829; GO:0005901; GO:0005929; GO:0006002; GO:0006006; GO:0006013; GO:0006096; GO:0006954; GO:0008865; GO:0009741; GO:0016887; GO:0019158; GO:0032731; GO:0032991; GO:0042802; GO:0042834; GO:0043066; GO:0044877; GO:0045087; GO:0045121; GO:0046835; GO:0047931; GO:0051156; GO:0061621; GO:0061728; GO:0072655; GO:0072656; GO:0097228; GO:1901986 canonical glycolysis [GO:0061621]; carbohydrate phosphorylation [GO:0046835]; establishment of protein localization to mitochondrion [GO:0072655]; fructose 6-phosphate metabolic process [GO:0006002]; GDP-mannose biosynthetic process from mannose [GO:0061728]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glycolytic process [GO:0006096]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; intracellular glucose homeostasis [GO:0001678]; maintenance of protein location in mitochondrion [GO:0072656]; mannose metabolic process [GO:0006013]; negative regulation of apoptotic process [GO:0043066]; positive regulation of cytokine production involved in immune response [GO:0002720]; positive regulation of interleukin-1 beta production [GO:0032731]; response to brassinosteroid [GO:0009741]; response to hypoxia [GO:0001666]; response to ischemia [GO:0002931]; response to ketamine [GO:1901986] caveola [GO:0005901]; cilium [GO:0005929]; cytosol [GO:0005829]; membrane raft [GO:0045121]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; protein-containing complex [GO:0032991]; sperm principal piece [GO:0097228] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; D-glucose binding [GO:0005536]; fructokinase activity [GO:0008865]; glucokinase activity [GO:0004340]; glucosamine kinase activity [GO:0047931]; hexokinase activity [GO:0004396]; identical protein binding [GO:0042802]; mannokinase activity [GO:0019158]; peptidoglycan binding [GO:0042834]; protein kinase activity [GO:0004672]; protein-containing complex binding [GO:0044877] g13179.t1 Q640V2 59.184 392 3.64e-167 476.0 sp|Q640V2|RMD5A_XENTR E3 ubiquitin-protein ligase RMND5A OS=Xenopus tropicalis OX=8364 GN=rmnd5a PE=2 SV=1 g13181.t1 P52789 41.686 427 2.16e-91 300.0 sp|P52789|HXK2_HUMAN Hexokinase-2 OS=Homo sapiens OX=9606 GN=HK2 PE=1 SV=2 HXK2_HUMAN reviewed Hexokinase-2 (EC 2.7.1.1) (Hexokinase type II) (HK II) (Hexokinase-B) (Muscle form hexokinase) Homo sapiens (Human) GO:0001666; GO:0001678; GO:0002931; GO:0004340; GO:0004396; GO:0005524; GO:0005536; GO:0005739; GO:0005741; GO:0005813; GO:0005829; GO:0006002; GO:0006006; GO:0006096; GO:0007595; GO:0008637; GO:0008865; GO:0016020; GO:0016529; GO:0035795; GO:0045766; GO:0046324; GO:0051156; GO:0061621; GO:0072655; GO:0072656; GO:1905091; GO:1990830; GO:2000378 apoptotic mitochondrial changes [GO:0008637]; canonical glycolysis [GO:0061621]; cellular response to leukemia inhibitory factor [GO:1990830]; establishment of protein localization to mitochondrion [GO:0072655]; fructose 6-phosphate metabolic process [GO:0006002]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glycolytic process [GO:0006096]; intracellular glucose homeostasis [GO:0001678]; lactation [GO:0007595]; maintenance of protein location in mitochondrion [GO:0072656]; negative regulation of mitochondrial membrane permeability [GO:0035795]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; positive regulation of angiogenesis [GO:0045766]; positive regulation of type 2 mitophagy [GO:1905091]; regulation of D-glucose import [GO:0046324]; response to hypoxia [GO:0001666]; response to ischemia [GO:0002931] centrosome [GO:0005813]; cytosol [GO:0005829]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; sarcoplasmic reticulum [GO:0016529] ATP binding [GO:0005524]; D-glucose binding [GO:0005536]; fructokinase activity [GO:0008865]; glucokinase activity [GO:0004340]; hexokinase activity [GO:0004396] g13181.t1 P52789 38.372 430 1.4800000000000001e-80 271.0 sp|P52789|HXK2_HUMAN Hexokinase-2 OS=Homo sapiens OX=9606 GN=HK2 PE=1 SV=2 HXK2_HUMAN reviewed Hexokinase-2 (EC 2.7.1.1) (Hexokinase type II) (HK II) (Hexokinase-B) (Muscle form hexokinase) Homo sapiens (Human) GO:0001666; GO:0001678; GO:0002931; GO:0004340; GO:0004396; GO:0005524; GO:0005536; GO:0005739; GO:0005741; GO:0005813; GO:0005829; GO:0006002; GO:0006006; GO:0006096; GO:0007595; GO:0008637; GO:0008865; GO:0016020; GO:0016529; GO:0035795; GO:0045766; GO:0046324; GO:0051156; GO:0061621; GO:0072655; GO:0072656; GO:1905091; GO:1990830; GO:2000378 apoptotic mitochondrial changes [GO:0008637]; canonical glycolysis [GO:0061621]; cellular response to leukemia inhibitory factor [GO:1990830]; establishment of protein localization to mitochondrion [GO:0072655]; fructose 6-phosphate metabolic process [GO:0006002]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glycolytic process [GO:0006096]; intracellular glucose homeostasis [GO:0001678]; lactation [GO:0007595]; maintenance of protein location in mitochondrion [GO:0072656]; negative regulation of mitochondrial membrane permeability [GO:0035795]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; positive regulation of angiogenesis [GO:0045766]; positive regulation of type 2 mitophagy [GO:1905091]; regulation of D-glucose import [GO:0046324]; response to hypoxia [GO:0001666]; response to ischemia [GO:0002931] centrosome [GO:0005813]; cytosol [GO:0005829]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; sarcoplasmic reticulum [GO:0016529] ATP binding [GO:0005524]; D-glucose binding [GO:0005536]; fructokinase activity [GO:0008865]; glucokinase activity [GO:0004340]; hexokinase activity [GO:0004396] g13182.t1 Q5E9Z8 67.424 132 9.6e-57 176.0 sp|Q5E9Z8|LSM1_BOVIN U6 snRNA-associated Sm-like protein LSm1 OS=Bos taurus OX=9913 GN=LSM1 PE=2 SV=1 g13183.t1 Q6NS60 46.221 344 1.12e-89 301.0 sp|Q6NS60|FBX41_MOUSE F-box only protein 41 OS=Mus musculus OX=10090 GN=Fbxo41 PE=1 SV=3 FBX41_MOUSE reviewed F-box only protein 41 Mus musculus (Mouse) GO:0001764; GO:0007268; GO:0010467; GO:0021542; GO:0021766; GO:0042551; GO:0045202 chemical synaptic transmission [GO:0007268]; dentate gyrus development [GO:0021542]; gene expression [GO:0010467]; hippocampus development [GO:0021766]; neuron maturation [GO:0042551]; neuron migration [GO:0001764] synapse [GO:0045202] g13185.t1 Q9W735 26.399 822 6.21e-64 234.0 sp|Q9W735|PRM1A_DANRE Prominin-1-A OS=Danio rerio OX=7955 GN=prom1a PE=2 SV=2 g13186.t1 Q59990 28.431 306 4.6500000000000005e-27 113.0 sp|Q59990|CP120_SYNY3 Putative cytochrome P450 120 OS=Synechocystis sp. (strain ATCC 27184 / PCC 6803 / Kazusa) OX=1111708 GN=cyp120 PE=1 SV=1 g13188.t1 P13051 40.303 330 2.0800000000000002e-70 224.0 sp|P13051|UNG_HUMAN Uracil-DNA glycosylase OS=Homo sapiens OX=9606 GN=UNG PE=1 SV=2 UNG_HUMAN reviewed Uracil-DNA glycosylase (UDG) (EC 3.2.2.27) Homo sapiens (Human) GO:0000012; GO:0003684; GO:0004844; GO:0005634; GO:0005654; GO:0005739; GO:0006284; GO:0016446; GO:0043024; GO:0043066; GO:0045008; GO:0045190; GO:0097510 base-excision repair [GO:0006284]; base-excision repair, AP site formation via deaminated base removal [GO:0097510]; depyrimidination [GO:0045008]; isotype switching [GO:0045190]; negative regulation of apoptotic process [GO:0043066]; single strand break repair [GO:0000012]; somatic hypermutation of immunoglobulin genes [GO:0016446] mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] damaged DNA binding [GO:0003684]; ribosomal small subunit binding [GO:0043024]; uracil DNA N-glycosylase activity [GO:0004844] g13189.t1 Q8CAQ8 38.086 533 6.77e-105 341.0 sp|Q8CAQ8|MIC60_MOUSE MICOS complex subunit Mic60 OS=Mus musculus OX=10090 GN=Immt PE=1 SV=1 g13191.t1 A8KBY2 26.341 410 6.7e-35 137.0 sp|A8KBY2|BRF2_DANRE Transcription factor IIIB 50 kDa subunit OS=Danio rerio OX=7955 GN=brf2 PE=2 SV=1 BRF2_DANRE reviewed Transcription factor IIIB 50 kDa subunit (B-related factor 2) (BRF-2) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000126; GO:0001006; GO:0001964; GO:0005634; GO:0006359; GO:0008270; GO:0016251; GO:0017025; GO:0034599; GO:0036268; GO:0070897; GO:0097550; GO:1904888 cellular response to oxidative stress [GO:0034599]; cranial skeletal system development [GO:1904888]; regulation of transcription by RNA polymerase III [GO:0006359]; startle response [GO:0001964]; swimming [GO:0036268]; transcription preinitiation complex assembly [GO:0070897] nucleus [GO:0005634]; transcription factor TFIIIB complex [GO:0000126]; transcription preinitiation complex [GO:0097550] RNA polymerase II general transcription initiation factor activity [GO:0016251]; RNA polymerase III type 3 promoter sequence-specific DNA binding [GO:0001006]; TBP-class protein binding [GO:0017025]; zinc ion binding [GO:0008270] g13193.t1 Q0VD26 60.0 140 1.14e-58 181.0 sp|Q0VD26|MORN4_BOVIN MORN repeat-containing protein 4 OS=Bos taurus OX=9913 GN=MORN4 PE=2 SV=1 g13194.t1 Q1L8Y6 73.214 56 3.410000000000001e-21 81.6 sp|Q1L8Y6|BBIP1_DANRE BBSome-interacting protein 1 OS=Danio rerio OX=7955 GN=bbip1 PE=3 SV=1 BBIP1_DANRE reviewed BBSome-interacting protein 1 (BBSome-interacting protein of 10 kDa) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005737; GO:0032402; GO:0034464; GO:0060271; GO:0070121; GO:0097500 cilium assembly [GO:0060271]; Kupffer's vesicle development [GO:0070121]; melanosome transport [GO:0032402]; receptor localization to non-motile cilium [GO:0097500] BBSome [GO:0034464]; cytoplasm [GO:0005737] g13195.t1 Q155U0 55.762 807 0.0 854.0 sp|Q155U0|VPS51_DANRE Vacuolar protein sorting-associated protein 51 homolog OS=Danio rerio OX=7955 GN=vps51 PE=2 SV=1 g13196.t1 Q8BGC3 22.293 471 6.36e-28 120.0 sp|Q8BGC3|MOT12_MOUSE Monocarboxylate transporter 12 OS=Mus musculus OX=10090 GN=Slc16a12 PE=1 SV=1 g13199.t1 O95394 53.519 540 0.0 555.0 sp|O95394|AGM1_HUMAN Phosphoacetylglucosamine mutase OS=Homo sapiens OX=9606 GN=PGM3 PE=1 SV=1 AGM1_HUMAN reviewed Phosphoacetylglucosamine mutase (PAGM) (EC 5.4.2.3) (Acetylglucosamine phosphomutase) (N-acetylglucosamine-phosphate mutase) (Phosphoglucomutase-3) (PGM 3) Homo sapiens (Human) GO:0000287; GO:0004610; GO:0005829; GO:0005975; GO:0006041; GO:0006048; GO:0006487; GO:0006493; GO:0007283; GO:0030097 carbohydrate metabolic process [GO:0005975]; glucosamine metabolic process [GO:0006041]; hemopoiesis [GO:0030097]; protein N-linked glycosylation [GO:0006487]; protein O-linked glycosylation [GO:0006493]; spermatogenesis [GO:0007283]; UDP-N-acetylglucosamine biosynthetic process [GO:0006048] cytosol [GO:0005829] magnesium ion binding [GO:0000287]; phosphoacetylglucosamine mutase activity [GO:0004610] g13201.t1 Q8TF32 37.143 315 3.18e-60 216.0 sp|Q8TF32|ZN431_HUMAN Zinc finger protein 431 OS=Homo sapiens OX=9606 GN=ZNF431 PE=1 SV=2 g13201.t1 Q8TF32 35.357 280 1.65e-48 184.0 sp|Q8TF32|ZN431_HUMAN Zinc finger protein 431 OS=Homo sapiens OX=9606 GN=ZNF431 PE=1 SV=2 g13201.t1 Q8TF32 33.113 302 8.33e-48 182.0 sp|Q8TF32|ZN431_HUMAN Zinc finger protein 431 OS=Homo sapiens OX=9606 GN=ZNF431 PE=1 SV=2 g13201.t1 Q8TF32 38.117 223 1.88e-43 169.0 sp|Q8TF32|ZN431_HUMAN Zinc finger protein 431 OS=Homo sapiens OX=9606 GN=ZNF431 PE=1 SV=2 g13208.t1 Q95J53 36.989 465 1.88e-103 328.0 sp|Q95J53|BTBDG_MACFA BTB/POZ domain-containing protein 16 OS=Macaca fascicularis OX=9541 GN=BTBD16 PE=2 SV=1 g13209.t1 P47866 29.452 292 5.670000000000001e-21 96.7 sp|P47866|CRFR2_RAT Corticotropin-releasing factor receptor 2 OS=Rattus norvegicus OX=10116 GN=Crhr2 PE=1 SV=2 CRFR2_RAT reviewed Corticotropin-releasing factor receptor 2 (CRF-R-2) (CRF-R2) (CRFR-2) (Corticotropin-releasing hormone receptor 2) (CRH-R-2) (CRH-R2) Rattus norvegicus (Rat) GO:0004930; GO:0005179; GO:0005886; GO:0007015; GO:0007166; GO:0007186; GO:0007188; GO:0007200; GO:0008528; GO:0009986; GO:0010460; GO:0010628; GO:0010629; GO:0010700; GO:0014064; GO:0015056; GO:0016525; GO:0017046; GO:0021549; GO:0021854; GO:0030424; GO:0030425; GO:0030855; GO:0032755; GO:0032811; GO:0032874; GO:0033685; GO:0035482; GO:0042423; GO:0043025; GO:0043196; GO:0043204; GO:0043404; GO:0043679; GO:0045777; GO:0046882; GO:0048630; GO:0060291; GO:0061179; GO:0070372; GO:0070852; GO:0071385; GO:0090281; GO:0106071; GO:0141163; GO:2000252; GO:2000293; GO:2000573 actin filament organization [GO:0007015]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; catecholamine biosynthetic process [GO:0042423]; cell surface receptor signaling pathway [GO:0007166]; cellular response to glucocorticoid stimulus [GO:0071385]; cerebellum development [GO:0021549]; epithelial cell differentiation [GO:0030855]; G protein-coupled receptor signaling pathway [GO:0007186]; gastric motility [GO:0035482]; hypothalamus development [GO:0021854]; long-term synaptic potentiation [GO:0060291]; negative regulation of angiogenesis [GO:0016525]; negative regulation of calcium ion import [GO:0090281]; negative regulation of defecation [GO:2000293]; negative regulation of epinephrine secretion [GO:0032811]; negative regulation of feeding behavior [GO:2000252]; negative regulation of follicle-stimulating hormone secretion [GO:0046882]; negative regulation of gene expression [GO:0010629]; negative regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061179]; negative regulation of luteinizing hormone secretion [GO:0033685]; negative regulation of norepinephrine secretion [GO:0010700]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0106071]; positive regulation of blood pressure [GO:0045777]; positive regulation of cAMP/PKA signal transduction [GO:0141163]; positive regulation of DNA biosynthetic process [GO:2000573]; positive regulation of gene expression [GO:0010628]; positive regulation of heart rate [GO:0010460]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of serotonin secretion [GO:0014064]; positive regulation of stress-activated MAPK cascade [GO:0032874]; regulation of ERK1 and ERK2 cascade [GO:0070372]; skeletal muscle tissue growth [GO:0048630] axon [GO:0030424]; axon terminus [GO:0043679]; cell body fiber [GO:0070852]; cell surface [GO:0009986]; dendrite [GO:0030425]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; varicosity [GO:0043196] corticotrophin-releasing factor receptor activity [GO:0015056]; corticotropin-releasing hormone receptor activity [GO:0043404]; G protein-coupled peptide receptor activity [GO:0008528]; G protein-coupled receptor activity [GO:0004930]; hormone activity [GO:0005179]; peptide hormone binding [GO:0017046] g13213.t1 O93366 66.484 182 1.01e-61 201.0 sp|O93366|TLX1_CHICK T-cell leukemia homeobox protein 1 OS=Gallus gallus OX=9031 GN=TLX1 PE=2 SV=1 g13214.t1 Q2PYN8 56.643 143 7.030000000000001e-43 154.0 sp|Q2PYN8|LBX1_XENLA Transcription factor LBX1 OS=Xenopus laevis OX=8355 GN=lbx1 PE=2 SV=1 LBX1_XENLA reviewed Transcription factor LBX1 (Ladybird homeobox protein homolog 1) Xenopus laevis (African clawed frog) GO:0000122; GO:0000981; GO:0003700; GO:0005634; GO:0005667; GO:0006355; GO:0006357; GO:0007517; GO:0030154; GO:0051450; GO:1990837 cell differentiation [GO:0030154]; muscle organ development [GO:0007517]; myoblast proliferation [GO:0051450]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of DNA-templated transcription [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634]; transcription regulator complex [GO:0005667] DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific double-stranded DNA binding [GO:1990837] g13219.t1 P52953 96.386 83 1.25e-49 166.0 sp|P52953|MSX2_RAT Homeobox protein MSX-2 (Fragment) OS=Rattus norvegicus OX=10116 GN=Msx2 PE=3 SV=1 g13220.t1 P97334 44.672 244 6.01e-33 128.0 sp|P97334|NKX23_MOUSE Homeobox protein Nkx-2.3 OS=Mus musculus OX=10090 GN=Nkx2-3 PE=2 SV=2 NKX23_MOUSE reviewed Homeobox protein Nkx-2.3 (Homeobox protein NK-2 homolog 3) (Homeobox protein NK-2 homolog C) (Nkx2-C) Mus musculus (Mouse) GO:0000978; GO:0000981; GO:0001708; GO:0001776; GO:0002317; GO:0005634; GO:0006357; GO:0006641; GO:0006955; GO:0009791; GO:0010467; GO:0022612; GO:0030154; GO:0030183; GO:0030225; GO:0042127; GO:0042475; GO:0043367; GO:0045944; GO:0046541; GO:0048535; GO:0048536; GO:0048537; GO:0048541; GO:0048565; GO:0048621; GO:0050900; GO:1990837 B cell differentiation [GO:0030183]; CD4-positive, alpha-beta T cell differentiation [GO:0043367]; cell differentiation [GO:0030154]; cell fate specification [GO:0001708]; digestive tract development [GO:0048565]; gene expression [GO:0010467]; gland morphogenesis [GO:0022612]; immune response [GO:0006955]; leukocyte homeostasis [GO:0001776]; leukocyte migration [GO:0050900]; lymph node development [GO:0048535]; macrophage differentiation [GO:0030225]; mucosa-associated lymphoid tissue development [GO:0048537]; odontogenesis of dentin-containing tooth [GO:0042475]; Peyer's patch development [GO:0048541]; plasma cell differentiation [GO:0002317]; positive regulation of transcription by RNA polymerase II [GO:0045944]; post-embryonic development [GO:0009791]; post-embryonic digestive tract morphogenesis [GO:0048621]; regulation of cell population proliferation [GO:0042127]; regulation of transcription by RNA polymerase II [GO:0006357]; saliva secretion [GO:0046541]; spleen development [GO:0048536]; triglyceride metabolic process [GO:0006641] nucleus [GO:0005634] DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837] g13223.t1 P78367 70.909 110 7.109999999999999e-42 151.0 sp|P78367|NKX32_HUMAN Homeobox protein Nkx-3.2 OS=Homo sapiens OX=9606 GN=NKX3-2 PE=1 SV=2 NKX32_HUMAN reviewed Homeobox protein Nkx-3.2 (Bagpipe homeobox protein homolog 1) (Homeobox protein NK-3 homolog B) Homo sapiens (Human) GO:0000785; GO:0000978; GO:0000981; GO:0001227; GO:0001501; GO:0005634; GO:0006357; GO:0006366; GO:0007368; GO:0030154; GO:0031016; GO:0032331; GO:0042474; GO:0043066; GO:0048536; GO:0048645; GO:0048705; GO:0048706; GO:0060576; GO:1990837 animal organ formation [GO:0048645]; cell differentiation [GO:0030154]; determination of left/right symmetry [GO:0007368]; embryonic skeletal system development [GO:0048706]; intestinal epithelial cell development [GO:0060576]; middle ear morphogenesis [GO:0042474]; negative regulation of apoptotic process [GO:0043066]; negative regulation of chondrocyte differentiation [GO:0032331]; pancreas development [GO:0031016]; regulation of transcription by RNA polymerase II [GO:0006357]; skeletal system development [GO:0001501]; skeletal system morphogenesis [GO:0048705]; spleen development [GO:0048536]; transcription by RNA polymerase II [GO:0006366] chromatin [GO:0000785]; nucleus [GO:0005634] DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837] g13225.t1 Q6PBQ2 37.004 227 1.2e-50 174.0 sp|Q6PBQ2|CHMP7_DANRE Charged multivesicular body protein 7 OS=Danio rerio OX=7955 GN=chmp7 PE=2 SV=1 g13226.t1 Q9UNY4 45.992 761 0.0 615.0 sp|Q9UNY4|TTF2_HUMAN Transcription termination factor 2 OS=Homo sapiens OX=9606 GN=TTF2 PE=1 SV=2 TTF2_HUMAN reviewed Transcription termination factor 2 (EC 3.6.4.-) (Lodestar homolog) (RNA polymerase II termination factor) (Transcription release factor 2) (F2) (HuF2) Homo sapiens (Human) GO:0003677; GO:0004386; GO:0005524; GO:0005634; GO:0005681; GO:0005829; GO:0006281; GO:0006353; GO:0006369; GO:0006397; GO:0008023; GO:0008094; GO:0008270; GO:0008380; GO:0016787 DNA repair [GO:0006281]; DNA-templated transcription termination [GO:0006353]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380]; termination of RNA polymerase II transcription [GO:0006369] cytosol [GO:0005829]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; transcription elongation factor complex [GO:0008023] ATP binding [GO:0005524]; ATP-dependent activity, acting on DNA [GO:0008094]; DNA binding [GO:0003677]; helicase activity [GO:0004386]; hydrolase activity [GO:0016787]; zinc ion binding [GO:0008270] g13228.t1 Q5NC05 46.634 609 4.32e-152 477.0 sp|Q5NC05|TTF2_MOUSE Transcription termination factor 2 OS=Mus musculus OX=10090 GN=Ttf2 PE=1 SV=2 TTF2_MOUSE reviewed Transcription termination factor 2 (EC 3.6.4.-) (RNA polymerase II termination factor) (Transcription release factor 2) Mus musculus (Mouse) GO:0003677; GO:0004386; GO:0005524; GO:0005634; GO:0005681; GO:0005829; GO:0006281; GO:0006353; GO:0006397; GO:0008094; GO:0008270; GO:0008380; GO:0016787 DNA repair [GO:0006281]; DNA-templated transcription termination [GO:0006353]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380] cytosol [GO:0005829]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681] ATP binding [GO:0005524]; ATP-dependent activity, acting on DNA [GO:0008094]; DNA binding [GO:0003677]; helicase activity [GO:0004386]; hydrolase activity [GO:0016787]; zinc ion binding [GO:0008270] g13229.t1 Q0P4S0 67.692 260 1.8e-117 387.0 sp|Q0P4S0|LST2_XENTR Lateral signaling target protein 2 homolog OS=Xenopus tropicalis OX=8364 GN=zfyve28 PE=2 SV=1 g13229.t1 Q0P4S0 67.123 73 5.55e-28 125.0 sp|Q0P4S0|LST2_XENTR Lateral signaling target protein 2 homolog OS=Xenopus tropicalis OX=8364 GN=zfyve28 PE=2 SV=1 g13230.t1 A4QNL6 41.489 94 1.4400000000000001e-21 84.7 sp|A4QNL6|SMI19_XENTR Small integral membrane protein 19 OS=Xenopus tropicalis OX=8364 GN=smim19 PE=3 SV=2 g13232.t1 Q86WI1 42.826 2328 0.0 1810.0 sp|Q86WI1|PKHL1_HUMAN Fibrocystin-L OS=Homo sapiens OX=9606 GN=PKHD1L1 PE=1 SV=2 PKHL1_HUMAN reviewed Fibrocystin-L (Polycystic kidney and hepatic disease 1-like protein 1) (PKHD1-like protein 1) Homo sapiens (Human) GO:0005615; GO:0005829; GO:0006955; GO:0007605; GO:0016020; GO:0032426; GO:0038023; GO:0060171; GO:0120234 immune response [GO:0006955]; sensory perception of sound [GO:0007605] cytosol [GO:0005829]; extracellular space [GO:0005615]; membrane [GO:0016020]; stereocilium coat [GO:0120234]; stereocilium membrane [GO:0060171]; stereocilium tip [GO:0032426] signaling receptor activity [GO:0038023] g13233.t1 Q80ZA4 31.481 162 1.4e-29 98.2 sp|Q80ZA4|PKHL1_MOUSE Fibrocystin-L OS=Mus musculus OX=10090 GN=Pkhd1l1 PE=1 SV=1 PKHL1_MOUSE reviewed Fibrocystin-L (Polycystic kidney and hepatic disease 1-like protein 1) (PKHD1-like protein 1) (Protein D86) Mus musculus (Mouse) GO:0007605; GO:0032426; GO:0060171; GO:0120234 sensory perception of sound [GO:0007605] stereocilium coat [GO:0120234]; stereocilium membrane [GO:0060171]; stereocilium tip [GO:0032426] g13233.t1 Q80ZA4 42.857 49 1.4e-29 52.8 sp|Q80ZA4|PKHL1_MOUSE Fibrocystin-L OS=Mus musculus OX=10090 GN=Pkhd1l1 PE=1 SV=1 PKHL1_MOUSE reviewed Fibrocystin-L (Polycystic kidney and hepatic disease 1-like protein 1) (PKHD1-like protein 1) (Protein D86) Mus musculus (Mouse) GO:0007605; GO:0032426; GO:0060171; GO:0120234 sensory perception of sound [GO:0007605] stereocilium coat [GO:0120234]; stereocilium membrane [GO:0060171]; stereocilium tip [GO:0032426] g13234.t1 Q86WI1 31.026 809 8.42e-98 339.0 sp|Q86WI1|PKHL1_HUMAN Fibrocystin-L OS=Homo sapiens OX=9606 GN=PKHD1L1 PE=1 SV=2 PKHL1_HUMAN reviewed Fibrocystin-L (Polycystic kidney and hepatic disease 1-like protein 1) (PKHD1-like protein 1) Homo sapiens (Human) GO:0005615; GO:0005829; GO:0006955; GO:0007605; GO:0016020; GO:0032426; GO:0038023; GO:0060171; GO:0120234 immune response [GO:0006955]; sensory perception of sound [GO:0007605] cytosol [GO:0005829]; extracellular space [GO:0005615]; membrane [GO:0016020]; stereocilium coat [GO:0120234]; stereocilium membrane [GO:0060171]; stereocilium tip [GO:0032426] signaling receptor activity [GO:0038023] g13234.t1 Q86WI1 31.022 274 4.1700000000000006e-21 103.0 sp|Q86WI1|PKHL1_HUMAN Fibrocystin-L OS=Homo sapiens OX=9606 GN=PKHD1L1 PE=1 SV=2 PKHL1_HUMAN reviewed Fibrocystin-L (Polycystic kidney and hepatic disease 1-like protein 1) (PKHD1-like protein 1) Homo sapiens (Human) GO:0005615; GO:0005829; GO:0006955; GO:0007605; GO:0016020; GO:0032426; GO:0038023; GO:0060171; GO:0120234 immune response [GO:0006955]; sensory perception of sound [GO:0007605] cytosol [GO:0005829]; extracellular space [GO:0005615]; membrane [GO:0016020]; stereocilium coat [GO:0120234]; stereocilium membrane [GO:0060171]; stereocilium tip [GO:0032426] signaling receptor activity [GO:0038023] g13235.t1 Q86WI1 38.177 406 4.76e-62 229.0 sp|Q86WI1|PKHL1_HUMAN Fibrocystin-L OS=Homo sapiens OX=9606 GN=PKHD1L1 PE=1 SV=2 PKHL1_HUMAN reviewed Fibrocystin-L (Polycystic kidney and hepatic disease 1-like protein 1) (PKHD1-like protein 1) Homo sapiens (Human) GO:0005615; GO:0005829; GO:0006955; GO:0007605; GO:0016020; GO:0032426; GO:0038023; GO:0060171; GO:0120234 immune response [GO:0006955]; sensory perception of sound [GO:0007605] cytosol [GO:0005829]; extracellular space [GO:0005615]; membrane [GO:0016020]; stereocilium coat [GO:0120234]; stereocilium membrane [GO:0060171]; stereocilium tip [GO:0032426] signaling receptor activity [GO:0038023] g13235.t1 Q86WI1 40.647 278 3.8299999999999995e-45 178.0 sp|Q86WI1|PKHL1_HUMAN Fibrocystin-L OS=Homo sapiens OX=9606 GN=PKHD1L1 PE=1 SV=2 PKHL1_HUMAN reviewed Fibrocystin-L (Polycystic kidney and hepatic disease 1-like protein 1) (PKHD1-like protein 1) Homo sapiens (Human) GO:0005615; GO:0005829; GO:0006955; GO:0007605; GO:0016020; GO:0032426; GO:0038023; GO:0060171; GO:0120234 immune response [GO:0006955]; sensory perception of sound [GO:0007605] cytosol [GO:0005829]; extracellular space [GO:0005615]; membrane [GO:0016020]; stereocilium coat [GO:0120234]; stereocilium membrane [GO:0060171]; stereocilium tip [GO:0032426] signaling receptor activity [GO:0038023] g13238.t1 Q5ZKJ5 52.686 484 2.13e-155 453.0 sp|Q5ZKJ5|MF13A_CHICK Transmembrane protein 180 OS=Gallus gallus OX=9031 GN=MFSD13A PE=2 SV=1 g13241.t1 Q9EPI1 31.604 212 2.1200000000000003e-21 103.0 sp|Q9EPI1|XYLT1_RAT Xylosyltransferase 1 (Fragment) OS=Rattus norvegicus OX=10116 GN=Xylt1 PE=2 SV=1 XYLT1_RAT reviewed Xylosyltransferase 1 (EC 2.4.2.26) (Peptide O-xylosyltransferase 1) (Xylosyltransferase I) Rattus norvegicus (Rat) GO:0000137; GO:0000139; GO:0005615; GO:0005794; GO:0006024; GO:0015012; GO:0030158; GO:0030166; GO:0034605; GO:0043931; GO:0046872; GO:0048681; GO:0048706; GO:0050650; GO:0070555 cellular response to heat [GO:0034605]; chondroitin sulfate proteoglycan biosynthetic process [GO:0050650]; embryonic skeletal system development [GO:0048706]; glycosaminoglycan biosynthetic process [GO:0006024]; heparan sulfate proteoglycan biosynthetic process [GO:0015012]; negative regulation of axon regeneration [GO:0048681]; ossification involved in bone maturation [GO:0043931]; proteoglycan biosynthetic process [GO:0030166]; response to interleukin-1 [GO:0070555] extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; Golgi cis cisterna [GO:0000137]; Golgi membrane [GO:0000139] metal ion binding [GO:0046872]; protein xylosyltransferase activity [GO:0030158] g13241.t2 Q5QQ53 30.375 293 3e-29 129.0 sp|Q5QQ53|XYLT_DROPS Xylosyltransferase oxt OS=Drosophila pseudoobscura pseudoobscura OX=46245 GN=oxt PE=2 SV=1 XYLT_DROPS reviewed Xylosyltransferase Oxt (EC 2.4.2.26) (Peptide O-xylosyltransferase) Drosophila pseudoobscura pseudoobscura (Fruit fly) GO:0000139; GO:0005789; GO:0015012; GO:0030158; GO:0046872; GO:0050650 chondroitin sulfate proteoglycan biosynthetic process [GO:0050650]; heparan sulfate proteoglycan biosynthetic process [GO:0015012] endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139] metal ion binding [GO:0046872]; protein xylosyltransferase activity [GO:0030158] g13242.t1 F1S5L4 29.796 490 3.28e-54 197.0 sp|F1S5L4|GPAT1_PIG Glycerol-3-phosphate acyltransferase 1, mitochondrial OS=Sus scrofa OX=9823 GN=GPAM PE=2 SV=3 GPAT1_PIG reviewed Glycerol-3-phosphate acyltransferase 1, mitochondrial (GPAT-1) (EC 2.3.1.15) Sus scrofa (Pig) GO:0004366; GO:0005739; GO:0005741; GO:0005886; GO:0006650; GO:0006651; GO:0006654; GO:0006655; GO:0016024; GO:0019432 CDP-diacylglycerol biosynthetic process [GO:0016024]; diacylglycerol biosynthetic process [GO:0006651]; glycerophospholipid metabolic process [GO:0006650]; phosphatidic acid biosynthetic process [GO:0006654]; phosphatidylglycerol biosynthetic process [GO:0006655]; triglyceride biosynthetic process [GO:0019432] mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886] glycerol-3-phosphate O-acyltransferase activity [GO:0004366] g13243.t1 Q61586 40.604 298 1.26e-67 233.0 sp|Q61586|GPAT1_MOUSE Glycerol-3-phosphate acyltransferase 1, mitochondrial OS=Mus musculus OX=10090 GN=Gpam PE=1 SV=2 g13244.t1 Q86WI1 31.883 1471 9.280000000000001e-177 591.0 sp|Q86WI1|PKHL1_HUMAN Fibrocystin-L OS=Homo sapiens OX=9606 GN=PKHD1L1 PE=1 SV=2 PKHL1_HUMAN reviewed Fibrocystin-L (Polycystic kidney and hepatic disease 1-like protein 1) (PKHD1-like protein 1) Homo sapiens (Human) GO:0005615; GO:0005829; GO:0006955; GO:0007605; GO:0016020; GO:0032426; GO:0038023; GO:0060171; GO:0120234 immune response [GO:0006955]; sensory perception of sound [GO:0007605] cytosol [GO:0005829]; extracellular space [GO:0005615]; membrane [GO:0016020]; stereocilium coat [GO:0120234]; stereocilium membrane [GO:0060171]; stereocilium tip [GO:0032426] signaling receptor activity [GO:0038023] g13244.t1 Q86WI1 31.136 273 1.08e-21 107.0 sp|Q86WI1|PKHL1_HUMAN Fibrocystin-L OS=Homo sapiens OX=9606 GN=PKHD1L1 PE=1 SV=2 PKHL1_HUMAN reviewed Fibrocystin-L (Polycystic kidney and hepatic disease 1-like protein 1) (PKHD1-like protein 1) Homo sapiens (Human) GO:0005615; GO:0005829; GO:0006955; GO:0007605; GO:0016020; GO:0032426; GO:0038023; GO:0060171; GO:0120234 immune response [GO:0006955]; sensory perception of sound [GO:0007605] cytosol [GO:0005829]; extracellular space [GO:0005615]; membrane [GO:0016020]; stereocilium coat [GO:0120234]; stereocilium membrane [GO:0060171]; stereocilium tip [GO:0032426] signaling receptor activity [GO:0038023] g13244.t2 Q86WI1 31.271 1503 1.15e-170 573.0 sp|Q86WI1|PKHL1_HUMAN Fibrocystin-L OS=Homo sapiens OX=9606 GN=PKHD1L1 PE=1 SV=2 PKHL1_HUMAN reviewed Fibrocystin-L (Polycystic kidney and hepatic disease 1-like protein 1) (PKHD1-like protein 1) Homo sapiens (Human) GO:0005615; GO:0005829; GO:0006955; GO:0007605; GO:0016020; GO:0032426; GO:0038023; GO:0060171; GO:0120234 immune response [GO:0006955]; sensory perception of sound [GO:0007605] cytosol [GO:0005829]; extracellular space [GO:0005615]; membrane [GO:0016020]; stereocilium coat [GO:0120234]; stereocilium membrane [GO:0060171]; stereocilium tip [GO:0032426] signaling receptor activity [GO:0038023] g13244.t2 Q86WI1 31.136 273 1.24e-21 107.0 sp|Q86WI1|PKHL1_HUMAN Fibrocystin-L OS=Homo sapiens OX=9606 GN=PKHD1L1 PE=1 SV=2 PKHL1_HUMAN reviewed Fibrocystin-L (Polycystic kidney and hepatic disease 1-like protein 1) (PKHD1-like protein 1) Homo sapiens (Human) GO:0005615; GO:0005829; GO:0006955; GO:0007605; GO:0016020; GO:0032426; GO:0038023; GO:0060171; GO:0120234 immune response [GO:0006955]; sensory perception of sound [GO:0007605] cytosol [GO:0005829]; extracellular space [GO:0005615]; membrane [GO:0016020]; stereocilium coat [GO:0120234]; stereocilium membrane [GO:0060171]; stereocilium tip [GO:0032426] signaling receptor activity [GO:0038023] g13246.t1 Q8K194 75.472 53 3.5400000000000006e-21 87.0 sp|Q8K194|SNR27_MOUSE U4/U6.U5 small nuclear ribonucleoprotein 27 kDa protein OS=Mus musculus OX=10090 GN=Snrnp27 PE=1 SV=1 g13246.t2 Q8K194 75.472 53 3.65e-21 87.0 sp|Q8K194|SNR27_MOUSE U4/U6.U5 small nuclear ribonucleoprotein 27 kDa protein OS=Mus musculus OX=10090 GN=Snrnp27 PE=1 SV=1 g13249.t1 Q86WI1 49.869 383 7.72e-116 394.0 sp|Q86WI1|PKHL1_HUMAN Fibrocystin-L OS=Homo sapiens OX=9606 GN=PKHD1L1 PE=1 SV=2 PKHL1_HUMAN reviewed Fibrocystin-L (Polycystic kidney and hepatic disease 1-like protein 1) (PKHD1-like protein 1) Homo sapiens (Human) GO:0005615; GO:0005829; GO:0006955; GO:0007605; GO:0016020; GO:0032426; GO:0038023; GO:0060171; GO:0120234 immune response [GO:0006955]; sensory perception of sound [GO:0007605] cytosol [GO:0005829]; extracellular space [GO:0005615]; membrane [GO:0016020]; stereocilium coat [GO:0120234]; stereocilium membrane [GO:0060171]; stereocilium tip [GO:0032426] signaling receptor activity [GO:0038023] g13249.t1 Q86WI1 31.207 439 1.83e-47 188.0 sp|Q86WI1|PKHL1_HUMAN Fibrocystin-L OS=Homo sapiens OX=9606 GN=PKHD1L1 PE=1 SV=2 PKHL1_HUMAN reviewed Fibrocystin-L (Polycystic kidney and hepatic disease 1-like protein 1) (PKHD1-like protein 1) Homo sapiens (Human) GO:0005615; GO:0005829; GO:0006955; GO:0007605; GO:0016020; GO:0032426; GO:0038023; GO:0060171; GO:0120234 immune response [GO:0006955]; sensory perception of sound [GO:0007605] cytosol [GO:0005829]; extracellular space [GO:0005615]; membrane [GO:0016020]; stereocilium coat [GO:0120234]; stereocilium membrane [GO:0060171]; stereocilium tip [GO:0032426] signaling receptor activity [GO:0038023] g13249.t2 Q86WI1 47.512 402 7.21e-112 383.0 sp|Q86WI1|PKHL1_HUMAN Fibrocystin-L OS=Homo sapiens OX=9606 GN=PKHD1L1 PE=1 SV=2 PKHL1_HUMAN reviewed Fibrocystin-L (Polycystic kidney and hepatic disease 1-like protein 1) (PKHD1-like protein 1) Homo sapiens (Human) GO:0005615; GO:0005829; GO:0006955; GO:0007605; GO:0016020; GO:0032426; GO:0038023; GO:0060171; GO:0120234 immune response [GO:0006955]; sensory perception of sound [GO:0007605] cytosol [GO:0005829]; extracellular space [GO:0005615]; membrane [GO:0016020]; stereocilium coat [GO:0120234]; stereocilium membrane [GO:0060171]; stereocilium tip [GO:0032426] signaling receptor activity [GO:0038023] g13249.t2 Q86WI1 31.207 439 2.45e-47 188.0 sp|Q86WI1|PKHL1_HUMAN Fibrocystin-L OS=Homo sapiens OX=9606 GN=PKHD1L1 PE=1 SV=2 PKHL1_HUMAN reviewed Fibrocystin-L (Polycystic kidney and hepatic disease 1-like protein 1) (PKHD1-like protein 1) Homo sapiens (Human) GO:0005615; GO:0005829; GO:0006955; GO:0007605; GO:0016020; GO:0032426; GO:0038023; GO:0060171; GO:0120234 immune response [GO:0006955]; sensory perception of sound [GO:0007605] cytosol [GO:0005829]; extracellular space [GO:0005615]; membrane [GO:0016020]; stereocilium coat [GO:0120234]; stereocilium membrane [GO:0060171]; stereocilium tip [GO:0032426] signaling receptor activity [GO:0038023] g13250.t1 Q86WI1 32.247 583 1.2799999999999999e-61 224.0 sp|Q86WI1|PKHL1_HUMAN Fibrocystin-L OS=Homo sapiens OX=9606 GN=PKHD1L1 PE=1 SV=2 PKHL1_HUMAN reviewed Fibrocystin-L (Polycystic kidney and hepatic disease 1-like protein 1) (PKHD1-like protein 1) Homo sapiens (Human) GO:0005615; GO:0005829; GO:0006955; GO:0007605; GO:0016020; GO:0032426; GO:0038023; GO:0060171; GO:0120234 immune response [GO:0006955]; sensory perception of sound [GO:0007605] cytosol [GO:0005829]; extracellular space [GO:0005615]; membrane [GO:0016020]; stereocilium coat [GO:0120234]; stereocilium membrane [GO:0060171]; stereocilium tip [GO:0032426] signaling receptor activity [GO:0038023] g13255.t1 P29702 58.086 303 2.4699999999999997e-131 382.0 sp|P29702|FNTA_BOVIN Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha OS=Bos taurus OX=9913 GN=FNTA PE=2 SV=2 FNTA_BOVIN reviewed Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha (EC 2.5.1.58) (EC 2.5.1.59) (CAAX farnesyltransferase subunit alpha) (FTase-alpha) (Ras proteins prenyltransferase subunit alpha) (Type I protein geranyl-geranyltransferase subunit alpha) (GGTase-I-alpha) Bos taurus (Bovine) GO:0004660; GO:0004661; GO:0004662; GO:0005737; GO:0005953; GO:0005965; GO:0007323; GO:0018343; GO:0018344 peptide pheromone maturation [GO:0007323]; protein farnesylation [GO:0018343]; protein geranylgeranylation [GO:0018344] CAAX-protein geranylgeranyltransferase complex [GO:0005953]; cytoplasm [GO:0005737]; protein farnesyltransferase complex [GO:0005965] CAAX-protein geranylgeranyltransferase activity [GO:0004662]; protein farnesyltransferase activity [GO:0004660]; protein geranylgeranyltransferase activity [GO:0004661] g13260.t1 Q66H23 64.655 232 2.75e-100 298.0 sp|Q66H23|MFRN1_RAT Mitoferrin-1 OS=Rattus norvegicus OX=10116 GN=Slc25a37 PE=2 SV=1 g13261.t1 Q3SYV9 43.452 336 8.1e-80 251.0 sp|Q3SYV9|ADPRS_BOVIN ADP-ribosylhydrolase ARH3 OS=Bos taurus OX=9913 GN=ADPRS PE=2 SV=1 ADPRS_BOVIN reviewed ADP-ribosylhydrolase ARH3 (ADP-ribose glycohydrolase ARH3) (ADP-ribosylhydrolase 3) (O-acetyl-ADP-ribose deacetylase ARH3) (EC 3.5.1.-) (Poly(ADP-ribose) glycohydrolase ARH3) (EC 3.2.1.143) ([Protein ADP-ribosylarginine] hydrolase-like protein 2) ([Protein ADP-ribosylserine] hydrolase) (EC 3.2.2.-) Bos taurus (Bovine) GO:0000287; GO:0004553; GO:0004649; GO:0005634; GO:0005739; GO:0005759; GO:0006281; GO:0060546; GO:0061463; GO:0071451; GO:0090734; GO:0140290; GO:0140292 cellular response to superoxide [GO:0071451]; DNA repair [GO:0006281]; negative regulation of necroptotic process [GO:0060546]; peptidyl-serine ADP-deribosylation [GO:0140290] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; site of DNA damage [GO:0090734] ADP-ribosylserine hydrolase activity [GO:0140292]; hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]; magnesium ion binding [GO:0000287]; O-acetyl-ADP-ribose deacetylase activity [GO:0061463]; poly(ADP-ribose) glycohydrolase activity [GO:0004649] g13262.t1 Q7M760 52.381 714 0.0 694.0 sp|Q7M760|ZRAN1_MOUSE Ubiquitin thioesterase Zranb1 OS=Mus musculus OX=10090 GN=Zranb1 PE=2 SV=1 ZRAN1_MOUSE reviewed Ubiquitin thioesterase Zranb1 (EC 3.4.19.12) (Zinc finger Ran-binding domain-containing protein 1) Mus musculus (Mouse) GO:0000045; GO:0004843; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007010; GO:0008270; GO:0016055; GO:0016477; GO:0016579; GO:0022604; GO:0030177; GO:0031593; GO:0035523; GO:0046854; GO:0070530; GO:0070536; GO:0071947; GO:0101005; GO:1990168 autophagosome assembly [GO:0000045]; cell migration [GO:0016477]; cytoskeleton organization [GO:0007010]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; positive regulation of Wnt signaling pathway [GO:0030177]; protein deubiquitination [GO:0016579]; protein deubiquitination involved in ubiquitin-dependent protein catabolic process [GO:0071947]; protein K29-linked deubiquitination [GO:0035523]; protein K33-linked deubiquitination [GO:1990168]; protein K63-linked deubiquitination [GO:0070536]; regulation of cell morphogenesis [GO:0022604]; Wnt signaling pathway [GO:0016055] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cysteine-type deubiquitinase activity [GO:0004843]; deubiquitinase activity [GO:0101005]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; polyubiquitin modification-dependent protein binding [GO:0031593]; zinc ion binding [GO:0008270] g13263.t1 O43301 55.821 627 0.0 730.0 sp|O43301|HS12A_HUMAN Heat shock 70 kDa protein 12A OS=Homo sapiens OX=9606 GN=HSPA12A PE=1 SV=2 g13263.t2 O43301 56.0 625 0.0 735.0 sp|O43301|HS12A_HUMAN Heat shock 70 kDa protein 12A OS=Homo sapiens OX=9606 GN=HSPA12A PE=1 SV=2 g13264.t1 Q5BJP5 56.881 109 6.54e-34 117.0 sp|Q5BJP5|TM230_RAT Transmembrane protein 230 OS=Rattus norvegicus OX=10116 GN=Tmem230 PE=1 SV=1 g13266.t1 Q6NY64 76.471 442 0.0 696.0 sp|Q6NY64|2ABD_DANRE Serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B delta isoform OS=Danio rerio OX=7955 GN=ppp2r2d PE=2 SV=1 2ABD_DANRE reviewed Serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B delta isoform (PP2A subunit B isoform B55-delta) (PP2A subunit B isoform PR55-delta) (PP2A subunit B isoform R2-delta) (PP2A subunit B isoform delta) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000159; GO:0000278; GO:0005829; GO:0007520; GO:0010458; GO:0019888; GO:0051301; GO:0051983; GO:0140767 cell division [GO:0051301]; exit from mitosis [GO:0010458]; mitotic cell cycle [GO:0000278]; myoblast fusion [GO:0007520]; regulation of chromosome segregation [GO:0051983] cytosol [GO:0005829]; protein phosphatase type 2A complex [GO:0000159] enzyme-substrate adaptor activity [GO:0140767]; protein phosphatase regulator activity [GO:0019888] g13267.t1 Q86WI1 39.685 3994 0.0 2681.0 sp|Q86WI1|PKHL1_HUMAN Fibrocystin-L OS=Homo sapiens OX=9606 GN=PKHD1L1 PE=1 SV=2 PKHL1_HUMAN reviewed Fibrocystin-L (Polycystic kidney and hepatic disease 1-like protein 1) (PKHD1-like protein 1) Homo sapiens (Human) GO:0005615; GO:0005829; GO:0006955; GO:0007605; GO:0016020; GO:0032426; GO:0038023; GO:0060171; GO:0120234 immune response [GO:0006955]; sensory perception of sound [GO:0007605] cytosol [GO:0005829]; extracellular space [GO:0005615]; membrane [GO:0016020]; stereocilium coat [GO:0120234]; stereocilium membrane [GO:0060171]; stereocilium tip [GO:0032426] signaling receptor activity [GO:0038023] g13269.t1 Q5EBF1 60.909 550 0.0 672.0 sp|Q5EBF1|5NTC_XENTR Cytosolic purine 5'-nucleotidase OS=Xenopus tropicalis OX=8364 GN=nt5c2 PE=2 SV=1 5NTC_XENTR reviewed Cytosolic purine 5'-nucleotidase (EC 3.1.3.5) (EC 3.1.3.99) (Cytosolic nucleoside phosphotransferase 5'N) (EC 2.7.1.77) Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0005524; GO:0005829; GO:0008253; GO:0042802; GO:0046037; GO:0046040; GO:0046054; GO:0046085; GO:0046872; GO:0050146 adenosine metabolic process [GO:0046085]; dGMP metabolic process [GO:0046054]; GMP metabolic process [GO:0046037]; IMP metabolic process [GO:0046040] cytosol [GO:0005829] 5'-nucleotidase activity [GO:0008253]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; nucleoside phosphotransferase activity [GO:0050146] g13272.t1 Q8BI21 76.316 114 1.28e-50 182.0 sp|Q8BI21|RNF38_MOUSE E3 ubiquitin-protein ligase RNF38 OS=Mus musculus OX=10090 GN=Rnf38 PE=2 SV=2 g13272.t2 Q9H0F5 76.316 114 1.32e-50 183.0 sp|Q9H0F5|RNF38_HUMAN E3 ubiquitin-protein ligase RNF38 OS=Homo sapiens OX=9606 GN=RNF38 PE=1 SV=4 g13273.t1 Q5ZI67 48.011 704 0.0 620.0 sp|Q5ZI67|NHLC2_CHICK NHL repeat-containing protein 2 OS=Gallus gallus OX=9031 GN=NHLRC2 PE=2 SV=1 g13274.t1 Q76NI1 45.631 103 7.329999999999999e-25 101.0 sp|Q76NI1|KNDC1_HUMAN Kinase non-catalytic C-lobe domain-containing protein 1 OS=Homo sapiens OX=9606 GN=KNDC1 PE=1 SV=2 KNDC1_HUMAN reviewed Kinase non-catalytic C-lobe domain-containing protein 1 (KIND domain-containing protein 1) (Cerebral protein 9) (Protein very KIND) (v-KIND) (Ras-GEF domain-containing family member 2) Homo sapiens (Human) GO:0005085; GO:0007264; GO:0021707; GO:0030425; GO:0032045; GO:0043025; GO:0043204; GO:0048814; GO:0050773 cerebellar granule cell differentiation [GO:0021707]; regulation of dendrite development [GO:0050773]; regulation of dendrite morphogenesis [GO:0048814]; small GTPase-mediated signal transduction [GO:0007264] dendrite [GO:0030425]; guanyl-nucleotide exchange factor complex [GO:0032045]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204] guanyl-nucleotide exchange factor activity [GO:0005085] g13276.t1 Q14865 47.031 421 1.67e-109 375.0 sp|Q14865|ARI5B_HUMAN AT-rich interactive domain-containing protein 5B OS=Homo sapiens OX=9606 GN=ARID5B PE=1 SV=3 ARI5B_HUMAN reviewed AT-rich interactive domain-containing protein 5B (ARID domain-containing protein 5B) (MRF1-like protein) (Modulator recognition factor 2) (MRF-2) Homo sapiens (Human) GO:0000122; GO:0000976; GO:0001822; GO:0001889; GO:0003677; GO:0003713; GO:0005634; GO:0005654; GO:0006357; GO:0008584; GO:0008585; GO:0009791; GO:0010761; GO:0030325; GO:0035264; GO:0045444; GO:0045892; GO:0048008; GO:0048468; GO:0048644; GO:0048705; GO:0051091; GO:0060021; GO:0060325; GO:0060612; GO:0060613; GO:1990830 adipose tissue development [GO:0060612]; adrenal gland development [GO:0030325]; cell development [GO:0048468]; cellular response to leukemia inhibitory factor [GO:1990830]; face morphogenesis [GO:0060325]; fat cell differentiation [GO:0045444]; fat pad development [GO:0060613]; female gonad development [GO:0008585]; fibroblast migration [GO:0010761]; kidney development [GO:0001822]; liver development [GO:0001889]; male gonad development [GO:0008584]; multicellular organism growth [GO:0035264]; muscle organ morphogenesis [GO:0048644]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; post-embryonic development [GO:0009791]; regulation of transcription by RNA polymerase II [GO:0006357]; roof of mouth development [GO:0060021]; skeletal system morphogenesis [GO:0048705] nucleoplasm [GO:0005654]; nucleus [GO:0005634] DNA binding [GO:0003677]; transcription cis-regulatory region binding [GO:0000976]; transcription coactivator activity [GO:0003713] g13277.t1 P55772 34.586 532 1.18e-91 295.0 sp|P55772|ENTP1_MOUSE Ectonucleoside triphosphate diphosphohydrolase 1 OS=Mus musculus OX=10090 GN=Entpd1 PE=1 SV=1 g13278.t1 Q9NWW7 45.917 551 1.6499999999999999e-149 442.0 sp|Q9NWW7|CB042_HUMAN Uncharacterized protein C2orf42 OS=Homo sapiens OX=9606 GN=C2orf42 PE=1 SV=1 g13280.t1 Q2TBM9 44.373 622 4.38e-170 504.0 sp|Q2TBM9|SRAC1_BOVIN Protein SERAC1 OS=Bos taurus OX=9913 GN=SERAC1 PE=2 SV=1 g13281.t1 D6REC4 41.343 566 4.5699999999999996e-119 372.0 sp|D6REC4|CFA99_HUMAN Cilia- and flagella-associated protein 99 OS=Homo sapiens OX=9606 GN=CFAP99 PE=1 SV=3 g13281.t2 D6REC4 38.859 561 2.58e-99 320.0 sp|D6REC4|CFA99_HUMAN Cilia- and flagella-associated protein 99 OS=Homo sapiens OX=9606 GN=CFAP99 PE=1 SV=3 g13282.t1 F7EZ75 69.231 247 4.15e-127 367.0 sp|F7EZ75|SIR5_MACMU NAD-dependent protein deacylase sirtuin-5, mitochondrial OS=Macaca mulatta OX=9544 GN=SIRT5 PE=3 SV=1 g13287.t1 Q6NYD4 81.053 190 3.9e-103 306.0 sp|Q6NYD4|MAK16_DANRE Protein MAK16 homolog OS=Danio rerio OX=7955 GN=mak16 PE=2 SV=1 g13288.t1 A5D8N2 55.276 199 1.39e-82 247.0 sp|A5D8N2|DPCD_XENLA Protein DPCD OS=Xenopus laevis OX=8355 GN=dpcd PE=2 SV=1 g13289.t1 O93295 36.25 480 3.13e-80 263.0 sp|O93295|ENTP8_CHICK Ectonucleoside triphosphate diphosphohydrolase 8 OS=Gallus gallus OX=9031 GN=ENTPD8 PE=1 SV=1 g13290.t1 Q9UJU6 53.125 192 1.1600000000000001e-64 218.0 sp|Q9UJU6|DBNL_HUMAN Drebrin-like protein OS=Homo sapiens OX=9606 GN=DBNL PE=1 SV=1 DBNL_HUMAN reviewed Drebrin-like protein (Cervical SH3P7) (Cervical mucin-associated protein) (Drebrin-F) (HPK1-interacting protein of 55 kDa) (HIP-55) (SH3 domain-containing protein 7) Homo sapiens (Human) GO:0000139; GO:0001726; GO:0002102; GO:0002250; GO:0003779; GO:0005576; GO:0005737; GO:0005769; GO:0005829; GO:0005886; GO:0005938; GO:0006897; GO:0007416; GO:0008047; GO:0014069; GO:0016020; GO:0016601; GO:0019904; GO:0030027; GO:0030425; GO:0030665; GO:0034774; GO:0043204; GO:0045296; GO:0048812; GO:0051015; GO:0061024; GO:0070062; GO:0071800; GO:0098793; GO:0098973; GO:0098978; GO:1904724; GO:1904813 adaptive immune response [GO:0002250]; endocytosis [GO:0006897]; membrane organization [GO:0061024]; neuron projection morphogenesis [GO:0048812]; podosome assembly [GO:0071800]; Rac protein signal transduction [GO:0016601]; synapse assembly [GO:0007416] cell cortex [GO:0005938]; clathrin-coated vesicle membrane [GO:0030665]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; early endosome [GO:0005769]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; lamellipodium [GO:0030027]; membrane [GO:0016020]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; podosome [GO:0002102]; postsynaptic density [GO:0014069]; presynapse [GO:0098793]; ruffle [GO:0001726]; secretory granule lumen [GO:0034774]; tertiary granule lumen [GO:1904724] actin binding [GO:0003779]; actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; enzyme activator activity [GO:0008047]; protein domain specific binding [GO:0019904]; structural constituent of postsynaptic actin cytoskeleton [GO:0098973] g13292.t1 Q6GLB9 70.149 134 4.6400000000000004e-57 186.0 sp|Q6GLB9|EMX1_XENTR Homeobox protein EMX1 OS=Xenopus tropicalis OX=8364 GN=emx1 PE=2 SV=1 g13294.t1 Q925N0 65.732 321 5.869999999999999e-146 418.0 sp|Q925N0|SFXN5_MOUSE Sideroflexin-5 OS=Mus musculus OX=10090 GN=Sfxn5 PE=1 SV=2 g13296.t1 P50540 53.741 147 1.7899999999999998e-38 135.0 sp|P50540|MXI1_MOUSE Max-interacting protein 1 OS=Mus musculus OX=10090 GN=Mxi1 PE=1 SV=1 g13298.t1 Q9PU20 55.303 132 1.19e-38 140.0 sp|Q9PU20|VAX2A_XENLA Ventral anterior homeobox 2a OS=Xenopus laevis OX=8355 GN=vax2-a PE=2 SV=1 g13299.t1 Q28G26 66.892 148 2.07e-69 220.0 sp|Q28G26|P4K2B_XENTR Phosphatidylinositol 4-kinase type 2-beta OS=Xenopus tropicalis OX=8364 GN=pi4k2b PE=2 SV=1 P4K2B_XENTR reviewed Phosphatidylinositol 4-kinase type 2-beta (EC 2.7.1.67) (Phosphatidylinositol 4-kinase type II-beta) Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0000139; GO:0004430; GO:0005524; GO:0005768; GO:0005789; GO:0005802; GO:0005829; GO:0005886; GO:0007030; GO:0007032; GO:0031901; GO:0046854 endosome organization [GO:0007032]; Golgi organization [GO:0007030]; phosphatidylinositol phosphate biosynthetic process [GO:0046854] cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802] 1-phosphatidylinositol 4-kinase activity [GO:0004430]; ATP binding [GO:0005524] g13300.t1 Q28G26 71.56 218 1.1199999999999999e-113 340.0 sp|Q28G26|P4K2B_XENTR Phosphatidylinositol 4-kinase type 2-beta OS=Xenopus tropicalis OX=8364 GN=pi4k2b PE=2 SV=1 P4K2B_XENTR reviewed Phosphatidylinositol 4-kinase type 2-beta (EC 2.7.1.67) (Phosphatidylinositol 4-kinase type II-beta) Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0000139; GO:0004430; GO:0005524; GO:0005768; GO:0005789; GO:0005802; GO:0005829; GO:0005886; GO:0007030; GO:0007032; GO:0031901; GO:0046854 endosome organization [GO:0007032]; Golgi organization [GO:0007030]; phosphatidylinositol phosphate biosynthetic process [GO:0046854] cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802] 1-phosphatidylinositol 4-kinase activity [GO:0004430]; ATP binding [GO:0005524] g13301.t1 A6H5Z3 55.263 798 0.0 922.0 sp|A6H5Z3|EXC6B_MOUSE Exocyst complex component 6B OS=Mus musculus OX=10090 GN=Exoc6b PE=1 SV=1 EXC6B_MOUSE reviewed Exocyst complex component 6B (Exocyst complex component Sec15B) (SEC15-like protein 2) Mus musculus (Mouse) GO:0000145; GO:0000281; GO:0005886; GO:0006886; GO:0006887; GO:0006893; GO:0006904; GO:0090148; GO:0090522 exocytosis [GO:0006887]; Golgi to plasma membrane transport [GO:0006893]; intracellular protein transport [GO:0006886]; membrane fission [GO:0090148]; mitotic cytokinesis [GO:0000281]; vesicle docking involved in exocytosis [GO:0006904]; vesicle tethering involved in exocytosis [GO:0090522] exocyst [GO:0000145]; plasma membrane [GO:0005886] g13301.t2 A6H5Z3 55.155 805 0.0 925.0 sp|A6H5Z3|EXC6B_MOUSE Exocyst complex component 6B OS=Mus musculus OX=10090 GN=Exoc6b PE=1 SV=1 EXC6B_MOUSE reviewed Exocyst complex component 6B (Exocyst complex component Sec15B) (SEC15-like protein 2) Mus musculus (Mouse) GO:0000145; GO:0000281; GO:0005886; GO:0006886; GO:0006887; GO:0006893; GO:0006904; GO:0090148; GO:0090522 exocytosis [GO:0006887]; Golgi to plasma membrane transport [GO:0006893]; intracellular protein transport [GO:0006886]; membrane fission [GO:0090148]; mitotic cytokinesis [GO:0000281]; vesicle docking involved in exocytosis [GO:0006904]; vesicle tethering involved in exocytosis [GO:0090522] exocyst [GO:0000145]; plasma membrane [GO:0005886] g13305.t1 P42674 32.685 257 2.85e-38 152.0 sp|P42674|BP10_PARLI Blastula protease 10 OS=Paracentrotus lividus OX=7656 GN=BP10 PE=2 SV=1 g13308.t1 Q91081 37.946 224 1.67e-34 130.0 sp|Q91081|ADRA2_LABOS Alpha-2 adrenergic receptor OS=Labrus ossifagus OX=30800 PE=3 SV=1 g13309.t1 Q25188 52.381 105 6.46e-29 115.0 sp|Q25188|OAR_HELVI Octopamine receptor OS=Heliothis virescens OX=7102 PE=2 SV=1 g13312.t1 Q01827 53.385 517 1.27e-143 426.0 sp|Q01827|VMAT2_RAT Synaptic vesicular amine transporter OS=Rattus norvegicus OX=10116 GN=Slc18a2 PE=1 SV=2 g13317.t1 P67963 87.842 329 0.0 585.0 sp|P67963|KC1A_XENLA Casein kinase I isoform alpha OS=Xenopus laevis OX=8355 GN=csnk1a1 PE=1 SV=1 g13318.t1 P67963 78.788 330 0.0 507.0 sp|P67963|KC1A_XENLA Casein kinase I isoform alpha OS=Xenopus laevis OX=8355 GN=csnk1a1 PE=1 SV=1 g13319.t1 Q8R0F8 47.706 218 5.19e-71 219.0 sp|Q8R0F8|FAHD1_MOUSE Oxaloacetate tautomerase FAHD1, mitochondrial OS=Mus musculus OX=10090 GN=Fahd1 PE=1 SV=3 FAHD1_MOUSE reviewed Oxaloacetate tautomerase FAHD1, mitochondrial (EC 5.3.2.2) (Acylpyruvase FAHD1) (EC 3.7.1.5) (Acylpyruvate hydrolase) (ApH) (Fumarylacetoacetate hydrolase domain-containing protein 1) (Oxaloacetate decarboxylase) (OAA decarboxylase) (ODx) (EC 4.1.1.112) Mus musculus (Mouse) GO:0005654; GO:0005739; GO:0005743; GO:0005759; GO:0005829; GO:0006107; GO:0008948; GO:0018773; GO:0034545; GO:0046872; GO:0047621; GO:0050163 oxaloacetate metabolic process [GO:0006107] cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654] acetylpyruvate hydrolase activity [GO:0018773]; acylpyruvate hydrolase activity [GO:0047621]; fumarylpyruvate hydrolase activity [GO:0034545]; metal ion binding [GO:0046872]; oxaloacetate decarboxylase activity [GO:0008948]; oxaloacetate tautomerase activity [GO:0050163] g13321.t1 Q99KL7 63.229 223 7.54e-99 289.0 sp|Q99KL7|RAB28_MOUSE Ras-related protein Rab-28 OS=Mus musculus OX=10090 GN=Rab28 PE=1 SV=1 g13322.t1 Q2HJE1 55.233 172 9.87e-65 214.0 sp|Q2HJE1|WDR91_BOVIN WD repeat-containing protein 91 OS=Bos taurus OX=9913 GN=WDR91 PE=2 SV=2 g13323.t1 Q6TEN6 53.388 369 5.75e-126 391.0 sp|Q6TEN6|WDR91_DANRE WD repeat-containing protein 91 OS=Danio rerio OX=7955 GN=wdr91 PE=1 SV=2 g13324.t1 Q8VHD7 39.94 333 6.7e-68 226.0 sp|Q8VHD7|GPR83_RAT G-protein coupled receptor 83 OS=Rattus norvegicus OX=10116 GN=Gpr83 PE=2 SV=1 g13327.t1 Q93127 38.082 365 1.62e-63 211.0 sp|Q93127|GPR18_AMPAM Probable G-protein coupled receptor No18 OS=Amphibalanus amphitrite OX=1232801 PE=3 SV=1 g13328.t1 O77680 38.73 315 9.68e-48 170.0 sp|O77680|DRD1_MACMU D(1A) dopamine receptor OS=Macaca mulatta OX=9544 GN=DRD1 PE=3 SV=1 g13329.t1 Q9DAM9 50.0 324 3.35e-113 335.0 sp|Q9DAM9|FANK1_MOUSE Fibronectin type 3 and ankyrin repeat domains 1 protein OS=Mus musculus OX=10090 GN=Fank1 PE=1 SV=1 FANK1_MOUSE reviewed Fibronectin type 3 and ankyrin repeat domains 1 protein (Germ cell-specific gene 1 protein) (GSG1) Mus musculus (Mouse) GO:0000785; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005929; GO:0036064; GO:0043065; GO:0043066; GO:0045893; GO:0051091; GO:0097546 negative regulation of apoptotic process [GO:0043066]; positive regulation of apoptotic process [GO:0043065]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of DNA-templated transcription [GO:0045893] chromatin [GO:0000785]; ciliary basal body [GO:0036064]; ciliary base [GO:0097546]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] g13330.t1 O13067 39.193 694 5.4699999999999995e-139 427.0 sp|O13067|CND2_XENLA Condensin complex subunit 2 OS=Xenopus laevis OX=8355 GN=ncaph PE=1 SV=1 g13332.t1 Q6P926 30.052 193 4.76e-21 89.7 sp|Q6P926|SPA24_MOUSE Spermatogenesis-associated protein 24 OS=Mus musculus OX=10090 GN=Spata24 PE=1 SV=1 SPA24_MOUSE reviewed Spermatogenesis-associated protein 24 (TATA-binding protein-like factor-interacting protein) (TLF-interacting protein) (TRF2-interacting protein in testis) (Testis protein T6441 homolog) Mus musculus (Mouse) GO:0003677; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0007283; GO:0030154; GO:0042802 cell differentiation [GO:0030154]; spermatogenesis [GO:0007283] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] DNA binding [GO:0003677]; identical protein binding [GO:0042802] g13333.t1 Q9Y223 63.866 714 0.0 893.0 sp|Q9Y223|GLCNE_HUMAN Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase OS=Homo sapiens OX=9606 GN=GNE PE=1 SV=1 GLCNE_HUMAN reviewed Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase (UDP-GlcNAc-2-epimerase/ManAc kinase) [Includes: UDP-N-acetylglucosamine 2-epimerase (hydrolyzing) (EC 3.2.1.183) (UDP-GlcNAc-2-epimerase) (Uridine diphosphate-N-acetylglucosamine-2-epimerase); N-acetylmannosamine kinase (EC 2.7.1.60) (ManAc kinase)] Homo sapiens (Human) GO:0004553; GO:0005524; GO:0005829; GO:0006045; GO:0006047; GO:0006055; GO:0008761; GO:0009384; GO:0046380; GO:0046872 CMP-N-acetylneuraminate biosynthetic process [GO:0006055]; N-acetylglucosamine biosynthetic process [GO:0006045]; N-acetylneuraminate biosynthetic process [GO:0046380]; UDP-N-acetylglucosamine metabolic process [GO:0006047] cytosol [GO:0005829] ATP binding [GO:0005524]; hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]; metal ion binding [GO:0046872]; N-acylmannosamine kinase activity [GO:0009384]; UDP-N-acetylglucosamine 2-epimerase activity [GO:0008761] g13335.t1 P20905 43.37 362 9.55e-78 255.0 sp|P20905|5HT1R_DROME 5-hydroxytryptamine receptor 1 OS=Drosophila melanogaster OX=7227 GN=5-HT7 PE=2 SV=1 g13336.t1 Q5VZY2 58.197 244 2.77e-102 302.0 sp|Q5VZY2|PLPP4_HUMAN Phospholipid phosphatase 4 OS=Homo sapiens OX=9606 GN=PLPP4 PE=1 SV=2 PLPP4_HUMAN reviewed Phospholipid phosphatase 4 (EC 3.1.3.4) (EC 3.6.1.75) (Phosphatidic acid phosphatase type 2 domain-containing protein 1A) Homo sapiens (Human) GO:0000810; GO:0001835; GO:0005886; GO:0006644; GO:0008195; GO:0016020; GO:0038096; GO:0042802; GO:0046839; GO:0090279 blastocyst hatching [GO:0001835]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; phospholipid dephosphorylation [GO:0046839]; phospholipid metabolic process [GO:0006644]; regulation of calcium ion import [GO:0090279] membrane [GO:0016020]; plasma membrane [GO:0005886] diacylglycerol diphosphate phosphatase activity [GO:0000810]; identical protein binding [GO:0042802]; phosphatidate phosphatase activity [GO:0008195] g13338.t1 Q02589 44.358 257 2.9300000000000003e-66 213.0 sp|Q02589|ADPRH_RAT ADP-ribosylhydrolase ARH1 OS=Rattus norvegicus OX=10116 GN=Adprh PE=1 SV=2 g13341.t1 Q8BGW6 71.724 145 5.9e-75 231.0 sp|Q8BGW6|ST32A_MOUSE Serine/threonine-protein kinase 32A OS=Mus musculus OX=10090 GN=Stk32a PE=2 SV=1 g13342.t1 Q9NY57 46.032 252 1.77e-60 201.0 sp|Q9NY57|ST32B_HUMAN Serine/threonine-protein kinase 32B OS=Homo sapiens OX=9606 GN=STK32B PE=1 SV=1 g13343.t1 Q8K1X1 46.407 1308 0.0 1129.0 sp|Q8K1X1|WDR11_MOUSE WD repeat-containing protein 11 OS=Mus musculus OX=10090 GN=Wdr11 PE=1 SV=1 WDR11_MOUSE reviewed WD repeat-containing protein 11 (Bromodomain and WD repeat-containing protein 2) Mus musculus (Mouse) GO:0005634; GO:0005737; GO:0005802; GO:0005829; GO:0005886; GO:0005929; GO:0005930; GO:0006886; GO:0007507; GO:0008589; GO:0015630; GO:0031410; GO:0035264; GO:0036064; GO:0060271; GO:0060322; GO:0099041 cilium assembly [GO:0060271]; head development [GO:0060322]; heart development [GO:0007507]; intracellular protein transport [GO:0006886]; multicellular organism growth [GO:0035264]; regulation of smoothened signaling pathway [GO:0008589]; vesicle tethering to Golgi [GO:0099041] axoneme [GO:0005930]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; microtubule cytoskeleton [GO:0015630]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802] g13343.t2 Q9BZH6 45.952 1297 0.0 1126.0 sp|Q9BZH6|WDR11_HUMAN WD repeat-containing protein 11 OS=Homo sapiens OX=9606 GN=WDR11 PE=1 SV=1 WDR11_HUMAN reviewed WD repeat-containing protein 11 (Bromodomain and WD repeat-containing protein 2) (WD repeat-containing protein 15) Homo sapiens (Human) GO:0005634; GO:0005737; GO:0005765; GO:0005802; GO:0005814; GO:0005829; GO:0005886; GO:0005929; GO:0005930; GO:0006886; GO:0007507; GO:0008589; GO:0015630; GO:0016020; GO:0031410; GO:0035264; GO:0036064; GO:0060271; GO:0060322; GO:0097228; GO:0097229; GO:0099041 cilium assembly [GO:0060271]; head development [GO:0060322]; heart development [GO:0007507]; intracellular protein transport [GO:0006886]; multicellular organism growth [GO:0035264]; regulation of smoothened signaling pathway [GO:0008589]; vesicle tethering to Golgi [GO:0099041] axoneme [GO:0005930]; centriole [GO:0005814]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; sperm end piece [GO:0097229]; sperm principal piece [GO:0097228]; trans-Golgi network [GO:0005802] g13343.t3 Q8K1X1 46.09 1317 0.0 1120.0 sp|Q8K1X1|WDR11_MOUSE WD repeat-containing protein 11 OS=Mus musculus OX=10090 GN=Wdr11 PE=1 SV=1 WDR11_MOUSE reviewed WD repeat-containing protein 11 (Bromodomain and WD repeat-containing protein 2) Mus musculus (Mouse) GO:0005634; GO:0005737; GO:0005802; GO:0005829; GO:0005886; GO:0005929; GO:0005930; GO:0006886; GO:0007507; GO:0008589; GO:0015630; GO:0031410; GO:0035264; GO:0036064; GO:0060271; GO:0060322; GO:0099041 cilium assembly [GO:0060271]; head development [GO:0060322]; heart development [GO:0007507]; intracellular protein transport [GO:0006886]; multicellular organism growth [GO:0035264]; regulation of smoothened signaling pathway [GO:0008589]; vesicle tethering to Golgi [GO:0099041] axoneme [GO:0005930]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; microtubule cytoskeleton [GO:0015630]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802] g13345.t1 Q5M934 55.417 240 4.52e-87 265.0 sp|Q5M934|TRUB1_RAT Pseudouridylate synthase TRUB1 OS=Rattus norvegicus OX=10116 GN=Trub1 PE=2 SV=1 TRUB1_RAT reviewed Pseudouridylate synthase TRUB1 (EC 5.4.99.-) (TruB pseudouridine synthase homolog 1) (tRNA pseudouridine 55 synthase TRUB1) (Psi55 synthase TRUB1) (EC 5.4.99.25) Rattus norvegicus (Rat) GO:0005634; GO:0005829; GO:0006397; GO:0006400; GO:0009982; GO:0070883; GO:0160148; GO:1990481; GO:2000633 mRNA processing [GO:0006397]; mRNA pseudouridine synthesis [GO:1990481]; positive regulation of pre-miRNA processing [GO:2000633]; tRNA modification [GO:0006400] cytosol [GO:0005829]; nucleus [GO:0005634] pre-miRNA binding [GO:0070883]; pseudouridine synthase activity [GO:0009982]; tRNA pseudouridine(55) synthase activity [GO:0160148] g13346.t1 O94844 54.237 295 1.68e-90 300.0 sp|O94844|RHBT1_HUMAN Rho-related BTB domain-containing protein 1 OS=Homo sapiens OX=9606 GN=RHOBTB1 PE=1 SV=2 RHBT1_HUMAN reviewed Rho-related BTB domain-containing protein 1 Homo sapiens (Human) GO:0003924; GO:0005525; GO:0005856; GO:0005886; GO:0007015; GO:0007163; GO:0007165; GO:0007264; GO:0008360; GO:0010008; GO:0019901; GO:0030865; GO:0031410; GO:0032956; GO:0042995 actin filament organization [GO:0007015]; cortical cytoskeleton organization [GO:0030865]; establishment or maintenance of cell polarity [GO:0007163]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell shape [GO:0008360]; signal transduction [GO:0007165]; small GTPase-mediated signal transduction [GO:0007264] cell projection [GO:0042995]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; endosome membrane [GO:0010008]; plasma membrane [GO:0005886] GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein kinase binding [GO:0019901] g13346.t1 O94844 38.494 239 7.449999999999999e-30 129.0 sp|O94844|RHBT1_HUMAN Rho-related BTB domain-containing protein 1 OS=Homo sapiens OX=9606 GN=RHOBTB1 PE=1 SV=2 RHBT1_HUMAN reviewed Rho-related BTB domain-containing protein 1 Homo sapiens (Human) GO:0003924; GO:0005525; GO:0005856; GO:0005886; GO:0007015; GO:0007163; GO:0007165; GO:0007264; GO:0008360; GO:0010008; GO:0019901; GO:0030865; GO:0031410; GO:0032956; GO:0042995 actin filament organization [GO:0007015]; cortical cytoskeleton organization [GO:0030865]; establishment or maintenance of cell polarity [GO:0007163]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell shape [GO:0008360]; signal transduction [GO:0007165]; small GTPase-mediated signal transduction [GO:0007264] cell projection [GO:0042995]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; endosome membrane [GO:0010008]; plasma membrane [GO:0005886] GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein kinase binding [GO:0019901] g13347.t1 Q02645 40.315 635 2.4399999999999997e-146 461.0 sp|Q02645|HTS_DROME Protein hu-li tai shao OS=Drosophila melanogaster OX=7227 GN=hts PE=1 SV=2 g13347.t2 Q02645 40.252 636 6.56e-146 459.0 sp|Q02645|HTS_DROME Protein hu-li tai shao OS=Drosophila melanogaster OX=7227 GN=hts PE=1 SV=2 g13347.t3 Q02645 40.872 619 1.31e-147 463.0 sp|Q02645|HTS_DROME Protein hu-li tai shao OS=Drosophila melanogaster OX=7227 GN=hts PE=1 SV=2 g13351.t1 A8MZ26 48.538 171 9.01e-51 166.0 sp|A8MZ26|EFCB9_HUMAN EF-hand calcium-binding domain-containing protein 9 OS=Homo sapiens OX=9606 GN=EFCAB9 PE=1 SV=2 EFCB9_HUMAN reviewed EF-hand calcium-binding domain-containing protein 9 Homo sapiens (Human) GO:0005509; GO:0005737; GO:0007283; GO:0030317; GO:0036128; GO:0048240; GO:0061891; GO:0097228 flagellated sperm motility [GO:0030317]; sperm capacitation [GO:0048240]; spermatogenesis [GO:0007283] CatSper complex [GO:0036128]; cytoplasm [GO:0005737]; sperm principal piece [GO:0097228] calcium ion binding [GO:0005509]; calcium ion sensor activity [GO:0061891] g13352.t1 Q5M8W9 59.247 292 5.720000000000001e-129 376.0 sp|Q5M8W9|HOGA1_XENTR 4-hydroxy-2-oxoglutarate aldolase, mitochondrial OS=Xenopus tropicalis OX=8364 GN=hoga1 PE=2 SV=2 g13359.t1 O43663 40.865 624 2.73e-130 400.0 sp|O43663|PRC1_HUMAN Protein regulator of cytokinesis 1 OS=Homo sapiens OX=9606 GN=PRC1 PE=1 SV=2 PRC1_HUMAN reviewed Protein regulator of cytokinesis 1 Homo sapiens (Human) GO:0000022; GO:0000226; GO:0000922; GO:0005634; GO:0005654; GO:0005694; GO:0005737; GO:0005819; GO:0005829; GO:0005876; GO:0005886; GO:0008017; GO:0008284; GO:0015630; GO:0019894; GO:0019901; GO:0030496; GO:0032465; GO:0042802; GO:0045171; GO:0051256; GO:0051301; GO:0070938; GO:1990023 cell division [GO:0051301]; microtubule cytoskeleton organization [GO:0000226]; mitotic spindle elongation [GO:0000022]; mitotic spindle midzone assembly [GO:0051256]; positive regulation of cell population proliferation [GO:0008284]; regulation of cytokinesis [GO:0032465] chromosome [GO:0005694]; contractile ring [GO:0070938]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intercellular bridge [GO:0045171]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; mitotic spindle midzone [GO:1990023]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; spindle [GO:0005819]; spindle microtubule [GO:0005876]; spindle pole [GO:0000922] identical protein binding [GO:0042802]; kinesin binding [GO:0019894]; microtubule binding [GO:0008017]; protein kinase binding [GO:0019901] g13359.t2 O43663 41.625 603 3.25e-134 409.0 sp|O43663|PRC1_HUMAN Protein regulator of cytokinesis 1 OS=Homo sapiens OX=9606 GN=PRC1 PE=1 SV=2 PRC1_HUMAN reviewed Protein regulator of cytokinesis 1 Homo sapiens (Human) GO:0000022; GO:0000226; GO:0000922; GO:0005634; GO:0005654; GO:0005694; GO:0005737; GO:0005819; GO:0005829; GO:0005876; GO:0005886; GO:0008017; GO:0008284; GO:0015630; GO:0019894; GO:0019901; GO:0030496; GO:0032465; GO:0042802; GO:0045171; GO:0051256; GO:0051301; GO:0070938; GO:1990023 cell division [GO:0051301]; microtubule cytoskeleton organization [GO:0000226]; mitotic spindle elongation [GO:0000022]; mitotic spindle midzone assembly [GO:0051256]; positive regulation of cell population proliferation [GO:0008284]; regulation of cytokinesis [GO:0032465] chromosome [GO:0005694]; contractile ring [GO:0070938]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intercellular bridge [GO:0045171]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; mitotic spindle midzone [GO:1990023]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; spindle [GO:0005819]; spindle microtubule [GO:0005876]; spindle pole [GO:0000922] identical protein binding [GO:0042802]; kinesin binding [GO:0019894]; microtubule binding [GO:0008017]; protein kinase binding [GO:0019901] g13364.t1 Q9H2G2 37.856 457 9.83e-78 274.0 sp|Q9H2G2|SLK_HUMAN STE20-like serine/threonine-protein kinase OS=Homo sapiens OX=9606 GN=SLK PE=1 SV=1 g13365.t1 E9PTG8 63.83 329 9.95e-148 447.0 sp|E9PTG8|STK10_RAT Serine/threonine-protein kinase 10 OS=Rattus norvegicus OX=10116 GN=Stk10 PE=1 SV=1 g13365.t2 E1BK52 63.063 333 4.6600000000000004e-148 448.0 sp|E1BK52|STK10_BOVIN Serine/threonine-protein kinase 10 OS=Bos taurus OX=9913 GN=STK10 PE=3 SV=3 STK10_BOVIN reviewed Serine/threonine-protein kinase 10 (EC 2.7.11.1) Bos taurus (Bovine) GO:0004674; GO:0005524; GO:0005886; GO:0042803; GO:0046777; GO:0106310; GO:2000401 protein autophosphorylation [GO:0046777]; regulation of lymphocyte migration [GO:2000401] plasma membrane [GO:0005886] ATP binding [GO:0005524]; protein homodimerization activity [GO:0042803]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g13366.t1 P53621 72.647 340 2.63e-176 526.0 sp|P53621|COPA_HUMAN Coatomer subunit alpha OS=Homo sapiens OX=9606 GN=COPA PE=1 SV=2 COPA_HUMAN reviewed Coatomer subunit alpha (Alpha-coat protein) (Alpha-COP) (HEP-COP) (HEPCOP) [Cleaved into: Xenin (Xenopsin-related peptide); Proxenin] Homo sapiens (Human) GO:0000139; GO:0003729; GO:0005179; GO:0005198; GO:0005615; GO:0005737; GO:0005789; GO:0005829; GO:0006886; GO:0006888; GO:0006890; GO:0006891; GO:0016020; GO:0030126; GO:0030133; GO:0030157; GO:0030426; GO:0070062; GO:0099612; GO:1902463 endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intra-Golgi vesicle-mediated transport [GO:0006891]; intracellular protein transport [GO:0006886]; pancreatic juice secretion [GO:0030157]; protein localization to axon [GO:0099612]; protein localization to cell leading edge [GO:1902463]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890] COPI vesicle coat [GO:0030126]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; Golgi membrane [GO:0000139]; growth cone [GO:0030426]; membrane [GO:0016020]; transport vesicle [GO:0030133] hormone activity [GO:0005179]; mRNA binding [GO:0003729]; structural molecule activity [GO:0005198] g13367.t1 Q8CIE6 82.345 759 0.0 1360.0 sp|Q8CIE6|COPA_MOUSE Coatomer subunit alpha OS=Mus musculus OX=10090 GN=Copa PE=1 SV=2 COPA_MOUSE reviewed Coatomer subunit alpha (Alpha-coat protein) (Alpha-COP) [Cleaved into: Xenin (Xenopsin-related peptide); Proxenin] Mus musculus (Mouse) GO:0000139; GO:0003729; GO:0005179; GO:0005198; GO:0005615; GO:0005737; GO:0005794; GO:0006886; GO:0006888; GO:0006890; GO:0006891; GO:0030126; GO:0030137; GO:0030157; GO:0030424; GO:0030426; GO:0044297; GO:0099612; GO:1902463 endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intra-Golgi vesicle-mediated transport [GO:0006891]; intracellular protein transport [GO:0006886]; pancreatic juice secretion [GO:0030157]; protein localization to axon [GO:0099612]; protein localization to cell leading edge [GO:1902463]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890] axon [GO:0030424]; cell body [GO:0044297]; COPI vesicle coat [GO:0030126]; COPI-coated vesicle [GO:0030137]; cytoplasm [GO:0005737]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; growth cone [GO:0030426] hormone activity [GO:0005179]; mRNA binding [GO:0003729]; structural molecule activity [GO:0005198] g13371.t1 Q8K2H6 68.605 172 1.06e-88 261.0 sp|Q8K2H6|APC10_MOUSE Anaphase-promoting complex subunit 10 OS=Mus musculus OX=10090 GN=Anapc10 PE=1 SV=1 g13372.t1 F1RET2 52.432 370 1.41e-138 405.0 sp|F1RET2|SMYD5_DANRE Protein-lysine N-trimethyltransferase SMYD5 OS=Danio rerio OX=7955 GN=smyd5 PE=2 SV=3 SMYD5_DANRE reviewed Protein-lysine N-trimethyltransferase SMYD5 (EC 2.1.1.-) (SET and MYND domain-containing protein 5) ([histone H3]-lysine20 N-trimethyltransferase SMYD5) (EC 2.1.1.372) ([histone H4]-lysine36 N-trimethyltransferase SMYD5) (EC 2.1.1.359) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005737; GO:0008270; GO:0016279; GO:0032259; GO:0042799; GO:0045638; GO:0045814; GO:0060215; GO:0060216; GO:0140943; GO:0140955; GO:1900249; GO:2000035; GO:2000736 definitive hemopoiesis [GO:0060216]; methylation [GO:0032259]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of myeloid cell differentiation [GO:0045638]; positive regulation of cytoplasmic translational elongation [GO:1900249]; primitive hemopoiesis [GO:0060215]; regulation of stem cell differentiation [GO:2000736]; regulation of stem cell division [GO:2000035] cytoplasm [GO:0005737] histone H3K36 trimethyltransferase activity [GO:0140955]; histone H4K20 methyltransferase activity [GO:0042799]; histone H4K20 trimethyltransferase activity [GO:0140943]; protein-lysine N-methyltransferase activity [GO:0016279]; zinc ion binding [GO:0008270] g13373.t1 Q9Z110 54.595 729 0.0 779.0 sp|Q9Z110|P5CS_MOUSE Delta-1-pyrroline-5-carboxylate synthase OS=Mus musculus OX=10090 GN=Aldh18a1 PE=1 SV=2 g13375.t1 P00504 56.691 411 3.1199999999999998e-180 511.0 sp|P00504|AATC_CHICK Aspartate aminotransferase, cytoplasmic OS=Gallus gallus OX=9031 GN=GOT1 PE=1 SV=3 g13376.t1 Q9YHB5 43.287 998 0.0 687.0 sp|Q9YHB5|CND3_XENLA Condensin complex subunit 3 OS=Xenopus laevis OX=8355 GN=ncapg PE=1 SV=1 g13377.t1 Q63ZH2 61.494 174 4.13e-63 209.0 sp|Q63ZH2|FXI2B_XENLA Forkhead box protein I2-B OS=Xenopus laevis OX=8355 GN=foxi2-b PE=2 SV=2 g13380.t1 Q0IHY4 51.983 479 1.3e-149 460.0 sp|Q0IHY4|TBC12_XENTR TBC1 domain family member 12 OS=Xenopus tropicalis OX=8364 GN=tbc1d12 PE=2 SV=1 TBC12_XENTR reviewed TBC1 domain family member 12 Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0005096; GO:0005773; GO:0016192; GO:0031267; GO:0031410 vesicle-mediated transport [GO:0016192] cytoplasmic vesicle [GO:0031410]; vacuole [GO:0005773] GTPase activator activity [GO:0005096]; small GTPase binding [GO:0031267] g13381.t1 Q9D2Y4 33.992 253 4.1199999999999995e-30 125.0 sp|Q9D2Y4|MLKL_MOUSE Mixed lineage kinase domain-like protein OS=Mus musculus OX=10090 GN=Mlkl PE=1 SV=1 MLKL_MOUSE reviewed Mixed lineage kinase domain-like protein Mus musculus (Mouse) GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0007166; GO:0019901; GO:0030054; GO:0042802; GO:0044877; GO:0051607; GO:0070207; GO:0070266; GO:0097527; GO:0097528 cell surface receptor signaling pathway [GO:0007166]; defense response to virus [GO:0051607]; execution phase of necroptosis [GO:0097528]; necroptotic process [GO:0070266]; necroptotic signaling pathway [GO:0097527]; protein homotrimerization [GO:0070207] cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886] ATP binding [GO:0005524]; identical protein binding [GO:0042802]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877] g13382.t1 P69478 31.474 251 5.15e-34 129.0 sp|P69478|CHSTB_RAT Carbohydrate sulfotransferase 11 OS=Rattus norvegicus OX=10116 GN=Chst11 PE=1 SV=1 CHSTB_RAT reviewed Carbohydrate sulfotransferase 11 (EC 2.8.2.5) (Chondroitin 4-O-sulfotransferase 1) (Chondroitin 4-sulfotransferase 1) (C4S-1) (C4ST-1) (C4ST1) Rattus norvegicus (Rat) GO:0000139; GO:0001537; GO:0001701; GO:0002063; GO:0007585; GO:0008146; GO:0009791; GO:0016051; GO:0030166; GO:0030326; GO:0030512; GO:0033037; GO:0036342; GO:0042127; GO:0042733; GO:0043066; GO:0047756; GO:0048589; GO:0048703; GO:0048704; GO:0050650; GO:0050654; GO:0050659; GO:0051216 carbohydrate biosynthetic process [GO:0016051]; cartilage development [GO:0051216]; chondrocyte development [GO:0002063]; chondroitin sulfate proteoglycan biosynthetic process [GO:0050650]; chondroitin sulfate proteoglycan metabolic process [GO:0050654]; developmental growth [GO:0048589]; embryonic digit morphogenesis [GO:0042733]; embryonic limb morphogenesis [GO:0030326]; embryonic skeletal system morphogenesis [GO:0048704]; embryonic viscerocranium morphogenesis [GO:0048703]; in utero embryonic development [GO:0001701]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; polysaccharide localization [GO:0033037]; post-anal tail morphogenesis [GO:0036342]; post-embryonic development [GO:0009791]; proteoglycan biosynthetic process [GO:0030166]; regulation of cell population proliferation [GO:0042127]; respiratory gaseous exchange by respiratory system [GO:0007585] Golgi membrane [GO:0000139] chondroitin 4-sulfotransferase activity [GO:0047756]; dermatan 4-sulfotransferase activity [GO:0001537]; N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity [GO:0050659]; sulfotransferase activity [GO:0008146] g13383.t1 O95786 30.074 951 2.69e-102 345.0 sp|O95786|RIGI_HUMAN Antiviral innate immune response receptor RIG-I OS=Homo sapiens OX=9606 GN=RIGI PE=1 SV=2 RIGI_HUMAN reviewed Antiviral innate immune response receptor RIG-I (ATP-dependent RNA helicase DDX58) (EC 3.6.4.13) (DEAD box protein 58) (RIG-I-like receptor 1) (RLR-1) (RNA sensor RIG-I) (Retinoic acid-inducible gene 1 protein) (RIG-1) (Retinoic acid-inducible gene I protein) (RIG-I) Homo sapiens (Human) GO:0002230; GO:0002735; GO:0002753; GO:0003690; GO:0003724; GO:0003725; GO:0003727; GO:0005524; GO:0005525; GO:0005737; GO:0005829; GO:0005923; GO:0008270; GO:0009597; GO:0009615; GO:0010467; GO:0010628; GO:0015629; GO:0016887; GO:0030334; GO:0031625; GO:0032587; GO:0032725; GO:0032727; GO:0032728; GO:0032755; GO:0032757; GO:0032760; GO:0034344; GO:0038187; GO:0039529; GO:0042802; GO:0043330; GO:0045087; GO:0045944; GO:0051607; GO:0060760; GO:0071360; GO:0140374; GO:1990904 antiviral innate immune response [GO:0140374]; cellular response to exogenous dsRNA [GO:0071360]; cytoplasmic pattern recognition receptor signaling pathway [GO:0002753]; defense response to virus [GO:0051607]; detection of virus [GO:0009597]; gene expression [GO:0010467]; innate immune response [GO:0045087]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of gene expression [GO:0010628]; positive regulation of granulocyte macrophage colony-stimulating factor production [GO:0032725]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of myeloid dendritic cell cytokine production [GO:0002735]; positive regulation of response to cytokine stimulus [GO:0060760]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]; regulation of cell migration [GO:0030334]; regulation of type III interferon production [GO:0034344]; response to exogenous dsRNA [GO:0043330]; response to virus [GO:0009615]; RIG-I signaling pathway [GO:0039529] actin cytoskeleton [GO:0015629]; bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; ribonucleoprotein complex [GO:1990904]; ruffle membrane [GO:0032587] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; double-stranded DNA binding [GO:0003690]; double-stranded RNA binding [GO:0003725]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; pattern recognition receptor activity [GO:0038187]; RNA helicase activity [GO:0003724]; single-stranded RNA binding [GO:0003727]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270] g13383.t2 O95786 29.316 979 1.53e-98 335.0 sp|O95786|RIGI_HUMAN Antiviral innate immune response receptor RIG-I OS=Homo sapiens OX=9606 GN=RIGI PE=1 SV=2 RIGI_HUMAN reviewed Antiviral innate immune response receptor RIG-I (ATP-dependent RNA helicase DDX58) (EC 3.6.4.13) (DEAD box protein 58) (RIG-I-like receptor 1) (RLR-1) (RNA sensor RIG-I) (Retinoic acid-inducible gene 1 protein) (RIG-1) (Retinoic acid-inducible gene I protein) (RIG-I) Homo sapiens (Human) GO:0002230; GO:0002735; GO:0002753; GO:0003690; GO:0003724; GO:0003725; GO:0003727; GO:0005524; GO:0005525; GO:0005737; GO:0005829; GO:0005923; GO:0008270; GO:0009597; GO:0009615; GO:0010467; GO:0010628; GO:0015629; GO:0016887; GO:0030334; GO:0031625; GO:0032587; GO:0032725; GO:0032727; GO:0032728; GO:0032755; GO:0032757; GO:0032760; GO:0034344; GO:0038187; GO:0039529; GO:0042802; GO:0043330; GO:0045087; GO:0045944; GO:0051607; GO:0060760; GO:0071360; GO:0140374; GO:1990904 antiviral innate immune response [GO:0140374]; cellular response to exogenous dsRNA [GO:0071360]; cytoplasmic pattern recognition receptor signaling pathway [GO:0002753]; defense response to virus [GO:0051607]; detection of virus [GO:0009597]; gene expression [GO:0010467]; innate immune response [GO:0045087]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of gene expression [GO:0010628]; positive regulation of granulocyte macrophage colony-stimulating factor production [GO:0032725]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of myeloid dendritic cell cytokine production [GO:0002735]; positive regulation of response to cytokine stimulus [GO:0060760]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]; regulation of cell migration [GO:0030334]; regulation of type III interferon production [GO:0034344]; response to exogenous dsRNA [GO:0043330]; response to virus [GO:0009615]; RIG-I signaling pathway [GO:0039529] actin cytoskeleton [GO:0015629]; bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; ribonucleoprotein complex [GO:1990904]; ruffle membrane [GO:0032587] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; double-stranded DNA binding [GO:0003690]; double-stranded RNA binding [GO:0003725]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; pattern recognition receptor activity [GO:0038187]; RNA helicase activity [GO:0003724]; single-stranded RNA binding [GO:0003727]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270] g13386.t1 O95786 36.382 492 1.55e-80 273.0 sp|O95786|RIGI_HUMAN Antiviral innate immune response receptor RIG-I OS=Homo sapiens OX=9606 GN=RIGI PE=1 SV=2 RIGI_HUMAN reviewed Antiviral innate immune response receptor RIG-I (ATP-dependent RNA helicase DDX58) (EC 3.6.4.13) (DEAD box protein 58) (RIG-I-like receptor 1) (RLR-1) (RNA sensor RIG-I) (Retinoic acid-inducible gene 1 protein) (RIG-1) (Retinoic acid-inducible gene I protein) (RIG-I) Homo sapiens (Human) GO:0002230; GO:0002735; GO:0002753; GO:0003690; GO:0003724; GO:0003725; GO:0003727; GO:0005524; GO:0005525; GO:0005737; GO:0005829; GO:0005923; GO:0008270; GO:0009597; GO:0009615; GO:0010467; GO:0010628; GO:0015629; GO:0016887; GO:0030334; GO:0031625; GO:0032587; GO:0032725; GO:0032727; GO:0032728; GO:0032755; GO:0032757; GO:0032760; GO:0034344; GO:0038187; GO:0039529; GO:0042802; GO:0043330; GO:0045087; GO:0045944; GO:0051607; GO:0060760; GO:0071360; GO:0140374; GO:1990904 antiviral innate immune response [GO:0140374]; cellular response to exogenous dsRNA [GO:0071360]; cytoplasmic pattern recognition receptor signaling pathway [GO:0002753]; defense response to virus [GO:0051607]; detection of virus [GO:0009597]; gene expression [GO:0010467]; innate immune response [GO:0045087]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of gene expression [GO:0010628]; positive regulation of granulocyte macrophage colony-stimulating factor production [GO:0032725]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of myeloid dendritic cell cytokine production [GO:0002735]; positive regulation of response to cytokine stimulus [GO:0060760]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]; regulation of cell migration [GO:0030334]; regulation of type III interferon production [GO:0034344]; response to exogenous dsRNA [GO:0043330]; response to virus [GO:0009615]; RIG-I signaling pathway [GO:0039529] actin cytoskeleton [GO:0015629]; bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; ribonucleoprotein complex [GO:1990904]; ruffle membrane [GO:0032587] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; double-stranded DNA binding [GO:0003690]; double-stranded RNA binding [GO:0003725]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; pattern recognition receptor activity [GO:0038187]; RNA helicase activity [GO:0003724]; single-stranded RNA binding [GO:0003727]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270] g13386.t1 O95786 56.757 37 1.55e-80 50.4 sp|O95786|RIGI_HUMAN Antiviral innate immune response receptor RIG-I OS=Homo sapiens OX=9606 GN=RIGI PE=1 SV=2 RIGI_HUMAN reviewed Antiviral innate immune response receptor RIG-I (ATP-dependent RNA helicase DDX58) (EC 3.6.4.13) (DEAD box protein 58) (RIG-I-like receptor 1) (RLR-1) (RNA sensor RIG-I) (Retinoic acid-inducible gene 1 protein) (RIG-1) (Retinoic acid-inducible gene I protein) (RIG-I) Homo sapiens (Human) GO:0002230; GO:0002735; GO:0002753; GO:0003690; GO:0003724; GO:0003725; GO:0003727; GO:0005524; GO:0005525; GO:0005737; GO:0005829; GO:0005923; GO:0008270; GO:0009597; GO:0009615; GO:0010467; GO:0010628; GO:0015629; GO:0016887; GO:0030334; GO:0031625; GO:0032587; GO:0032725; GO:0032727; GO:0032728; GO:0032755; GO:0032757; GO:0032760; GO:0034344; GO:0038187; GO:0039529; GO:0042802; GO:0043330; GO:0045087; GO:0045944; GO:0051607; GO:0060760; GO:0071360; GO:0140374; GO:1990904 antiviral innate immune response [GO:0140374]; cellular response to exogenous dsRNA [GO:0071360]; cytoplasmic pattern recognition receptor signaling pathway [GO:0002753]; defense response to virus [GO:0051607]; detection of virus [GO:0009597]; gene expression [GO:0010467]; innate immune response [GO:0045087]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of gene expression [GO:0010628]; positive regulation of granulocyte macrophage colony-stimulating factor production [GO:0032725]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of myeloid dendritic cell cytokine production [GO:0002735]; positive regulation of response to cytokine stimulus [GO:0060760]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]; regulation of cell migration [GO:0030334]; regulation of type III interferon production [GO:0034344]; response to exogenous dsRNA [GO:0043330]; response to virus [GO:0009615]; RIG-I signaling pathway [GO:0039529] actin cytoskeleton [GO:0015629]; bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; ribonucleoprotein complex [GO:1990904]; ruffle membrane [GO:0032587] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; double-stranded DNA binding [GO:0003690]; double-stranded RNA binding [GO:0003725]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; pattern recognition receptor activity [GO:0038187]; RNA helicase activity [GO:0003724]; single-stranded RNA binding [GO:0003727]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270] g13390.t1 P33731 49.84 624 0.0 600.0 sp|P33731|SRP72_CANLF Signal recognition particle subunit SRP72 OS=Canis lupus familiaris OX=9615 GN=SRP72 PE=1 SV=3 g13391.t1 O93309 89.262 149 4.07e-92 293.0 sp|O93309|SMC3_XENLA Structural maintenance of chromosomes protein 3 OS=Xenopus laevis OX=8355 GN=smc3 PE=1 SV=2 g13392.t1 Q5R4K5 51.724 1015 0.0 928.0 sp|Q5R4K5|SMC3_PONAB Structural maintenance of chromosomes protein 3 OS=Pongo abelii OX=9601 GN=SMC3 PE=2 SV=1 SMC3_PONAB reviewed Structural maintenance of chromosomes protein 3 (SMC protein 3) (SMC-3) (Chondroitin sulfate proteoglycan 6) Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0000775; GO:0000785; GO:0000800; GO:0000987; GO:0003682; GO:0005524; GO:0005654; GO:0006275; GO:0006281; GO:0007062; GO:0016363; GO:0016887; GO:0019827; GO:0030892; GO:0030893; GO:0036033; GO:0046982; GO:0048487; GO:0051301; GO:0051321; GO:0070840; GO:0090307; GO:0097431 cell division [GO:0051301]; DNA repair [GO:0006281]; meiotic cell cycle [GO:0051321]; mitotic spindle assembly [GO:0090307]; regulation of DNA replication [GO:0006275]; sister chromatid cohesion [GO:0007062]; stem cell population maintenance [GO:0019827] chromatin [GO:0000785]; chromosome, centromeric region [GO:0000775]; lateral element [GO:0000800]; meiotic cohesin complex [GO:0030893]; mitotic cohesin complex [GO:0030892]; mitotic spindle pole [GO:0097431]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; beta-tubulin binding [GO:0048487]; chromatin binding [GO:0003682]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; dynein complex binding [GO:0070840]; mediator complex binding [GO:0036033]; protein heterodimerization activity [GO:0046982] g13393.t1 Q7M753 65.468 278 8.11e-109 326.0 sp|Q7M753|PANK2_MOUSE Pantothenate kinase 2, mitochondrial OS=Mus musculus OX=10090 GN=Pank2 PE=1 SV=1 PANK2_MOUSE reviewed Pantothenate kinase 2, mitochondrial (hPanK2) (EC 2.7.1.33) (Pantothenic acid kinase 2) Mus musculus (Mouse) GO:0001525; GO:0004594; GO:0005524; GO:0005634; GO:0005739; GO:0005758; GO:0005829; GO:0007005; GO:0007286; GO:0009060; GO:0015937; GO:0019217; GO:0051881; GO:0090207; GO:1904251 aerobic respiration [GO:0009060]; angiogenesis [GO:0001525]; coenzyme A biosynthetic process [GO:0015937]; mitochondrion organization [GO:0007005]; regulation of bile acid metabolic process [GO:1904251]; regulation of fatty acid metabolic process [GO:0019217]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of triglyceride metabolic process [GO:0090207]; spermatid development [GO:0007286] cytosol [GO:0005829]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; nucleus [GO:0005634] ATP binding [GO:0005524]; pantothenate kinase activity [GO:0004594] g13395.t1 O94903 54.579 273 3.6899999999999994e-104 308.0 sp|O94903|PLPHP_HUMAN Pyridoxal phosphate homeostasis protein OS=Homo sapiens OX=9606 GN=PLPBP PE=1 SV=1 g13396.t1 Q3ZCH0 85.113 618 0.0 1050.0 sp|Q3ZCH0|HSPA9_BOVIN Stress-70 protein, mitochondrial OS=Bos taurus OX=9913 GN=HSPA9 PE=2 SV=1 HSPA9_BOVIN reviewed Stress-70 protein, mitochondrial (EC 3.6.4.10) (75 kDa glucose-regulated protein) (GRP-75) (Heat shock 70 kDa protein 9) Bos taurus (Bovine) GO:0005524; GO:0005730; GO:0005737; GO:0005739; GO:0005759; GO:0006611; GO:0016226; GO:0016887; GO:0030218; GO:0031072; GO:0031625; GO:0036444; GO:0042026; GO:0042645; GO:0043065; GO:0044183; GO:0045646; GO:0045647; GO:0051082; GO:0140662; GO:1902037; GO:1903707 calcium import into the mitochondrion [GO:0036444]; erythrocyte differentiation [GO:0030218]; iron-sulfur cluster assembly [GO:0016226]; negative regulation of erythrocyte differentiation [GO:0045647]; negative regulation of hematopoietic stem cell differentiation [GO:1902037]; negative regulation of hemopoiesis [GO:1903707]; positive regulation of apoptotic process [GO:0043065]; protein export from nucleus [GO:0006611]; protein refolding [GO:0042026]; regulation of erythrocyte differentiation [GO:0045646] cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nucleolus [GO:0005730] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent protein folding chaperone [GO:0140662]; heat shock protein binding [GO:0031072]; protein folding chaperone [GO:0044183]; ubiquitin protein ligase binding [GO:0031625]; unfolded protein binding [GO:0051082] g13397.t1 P30048 69.231 208 4.6e-107 313.0 sp|P30048|PRDX3_HUMAN Thioredoxin-dependent peroxide reductase, mitochondrial OS=Homo sapiens OX=9606 GN=PRDX3 PE=1 SV=3 PRDX3_HUMAN reviewed Thioredoxin-dependent peroxide reductase, mitochondrial (EC 1.11.1.24) (Antioxidant protein 1) (AOP-1) (HBC189) (Peroxiredoxin III) (Prx-III) (Peroxiredoxin-3) (Protein MER5 homolog) (Thioredoxin-dependent peroxiredoxin 3) Homo sapiens (Human) GO:0001893; GO:0005654; GO:0005737; GO:0005739; GO:0005759; GO:0005769; GO:0005829; GO:0005886; GO:0006979; GO:0007005; GO:0008284; GO:0008379; GO:0019901; GO:0030099; GO:0032496; GO:0032991; GO:0033673; GO:0034599; GO:0034614; GO:0042542; GO:0042744; GO:0042802; GO:0043027; GO:0043066; GO:0045454; GO:0051092; GO:0051881; GO:0102039 cell redox homeostasis [GO:0045454]; cellular response to oxidative stress [GO:0034599]; cellular response to reactive oxygen species [GO:0034614]; hydrogen peroxide catabolic process [GO:0042744]; maternal placenta development [GO:0001893]; mitochondrion organization [GO:0007005]; myeloid cell differentiation [GO:0030099]; negative regulation of apoptotic process [GO:0043066]; negative regulation of kinase activity [GO:0033673]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; regulation of mitochondrial membrane potential [GO:0051881]; response to hydrogen peroxide [GO:0042542]; response to lipopolysaccharide [GO:0032496]; response to oxidative stress [GO:0006979] cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; identical protein binding [GO:0042802]; NADH-dependent peroxiredoxin activity [GO:0102039]; protein kinase binding [GO:0019901]; thioredoxin peroxidase activity [GO:0008379] g13398.t1 Q6AZW2 53.846 208 2.86e-68 214.0 sp|Q6AZW2|A1A1A_DANRE Aldo-keto reductase family 1 member A1-A OS=Danio rerio OX=7955 GN=akr1a1a PE=2 SV=2 A1A1A_DANRE reviewed Aldo-keto reductase family 1 member A1-A (Alcohol dehydrogenase [NADP(+)] A) (EC 1.1.1.2) (Aldehyde reductase-A) (S-nitroso-CoA reductase) (ScorR) (EC 1.6.-.-) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0002040; GO:0004032; GO:0005829; GO:0016324; GO:0042593; GO:0046185; GO:0110095; GO:0160163 aldehyde catabolic process [GO:0046185]; cellular detoxification of aldehyde [GO:0110095]; glucose homeostasis [GO:0042593]; sprouting angiogenesis [GO:0002040] apical plasma membrane [GO:0016324]; cytosol [GO:0005829] aldose reductase (NADPH) activity [GO:0004032]; S-nitrosoglutathione reductase (NADPH) activity [GO:0160163] g13399.t1 Q6AZW2 53.279 122 4.4799999999999997e-38 134.0 sp|Q6AZW2|A1A1A_DANRE Aldo-keto reductase family 1 member A1-A OS=Danio rerio OX=7955 GN=akr1a1a PE=2 SV=2 A1A1A_DANRE reviewed Aldo-keto reductase family 1 member A1-A (Alcohol dehydrogenase [NADP(+)] A) (EC 1.1.1.2) (Aldehyde reductase-A) (S-nitroso-CoA reductase) (ScorR) (EC 1.6.-.-) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0002040; GO:0004032; GO:0005829; GO:0016324; GO:0042593; GO:0046185; GO:0110095; GO:0160163 aldehyde catabolic process [GO:0046185]; cellular detoxification of aldehyde [GO:0110095]; glucose homeostasis [GO:0042593]; sprouting angiogenesis [GO:0002040] apical plasma membrane [GO:0016324]; cytosol [GO:0005829] aldose reductase (NADPH) activity [GO:0004032]; S-nitrosoglutathione reductase (NADPH) activity [GO:0160163] g13401.t1 A4II20 90.385 104 1.5e-62 215.0 sp|A4II20|EGR1_XENTR Early growth response protein 1 OS=Xenopus tropicalis OX=8364 GN=egr1 PE=2 SV=2 EGR1_XENTR reviewed Early growth response protein 1 (EGR-1) Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0000978; GO:0000981; GO:0003700; GO:0005634; GO:0005737; GO:0006355; GO:0006357; GO:0008270; GO:0010385; GO:0032922; GO:0043565; GO:0044729; GO:0045893; GO:0045944; GO:1990841 circadian regulation of gene expression [GO:0032922]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA-templated transcription [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357] cytoplasm [GO:0005737]; nucleus [GO:0005634] DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; double-stranded methylated DNA binding [GO:0010385]; hemi-methylated DNA-binding [GO:0044729]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270] g13402.t1 Q6PDY2 39.3 257 1.5899999999999999e-46 158.0 sp|Q6PDY2|AEDO_MOUSE 2-aminoethanethiol dioxygenase OS=Mus musculus OX=10090 GN=Ado PE=1 SV=2 AEDO_MOUSE reviewed 2-aminoethanethiol dioxygenase (EC 1.13.11.19) (Cysteamine dioxygenase) Mus musculus (Mouse) GO:0005506; GO:0005739; GO:0047800; GO:0071456 cellular response to hypoxia [GO:0071456] mitochondrion [GO:0005739] cysteamine dioxygenase activity [GO:0047800]; iron ion binding [GO:0005506] g13403.t1 Q9JI08 41.176 204 1.6600000000000002e-43 150.0 sp|Q9JI08|BIN3_MOUSE Bridging integrator 3 OS=Mus musculus OX=10090 GN=Bin3 PE=1 SV=1 g13404.t1 A0JPG1 49.231 780 0.0 692.0 sp|A0JPG1|FHI2A_XENLA FHF complex subunit HOOK interacting protein 2A OS=Xenopus laevis OX=8355 GN=fhip2a PE=2 SV=1 g13404.t2 A0JPG1 49.741 772 0.0 685.0 sp|A0JPG1|FHI2A_XENLA FHF complex subunit HOOK interacting protein 2A OS=Xenopus laevis OX=8355 GN=fhip2a PE=2 SV=1 g13404.t3 A0JPG1 50.656 762 0.0 690.0 sp|A0JPG1|FHI2A_XENLA FHF complex subunit HOOK interacting protein 2A OS=Xenopus laevis OX=8355 GN=fhip2a PE=2 SV=1 g13405.t1 Q62824 40.603 564 1.68e-107 347.0 sp|Q62824|EXOC4_RAT Exocyst complex component 4 OS=Rattus norvegicus OX=10116 GN=Exoc4 PE=1 SV=1 EXOC4_RAT reviewed Exocyst complex component 4 (Exocyst complex component Sec8) (rSec8) Rattus norvegicus (Rat) GO:0000145; GO:0005737; GO:0005768; GO:0005813; GO:0005902; GO:0006612; GO:0006887; GO:0006893; GO:0006903; GO:0006904; GO:0007268; GO:0008021; GO:0014069; GO:0030010; GO:0030165; GO:0030425; GO:0030426; GO:0031252; GO:0032584; GO:0032991; GO:0035748; GO:0043005; GO:0043025; GO:0043198; GO:0044091; GO:0044877; GO:0045202; GO:0048341; GO:0048709; GO:0050850; GO:0051223; GO:0055108; GO:0071806; GO:0090522; GO:0090543; GO:0098685; GO:0098696; GO:0099092 chemical synaptic transmission [GO:0007268]; establishment of cell polarity [GO:0030010]; exocytosis [GO:0006887]; Golgi to plasma membrane transport [GO:0006893]; Golgi to transport vesicle transport [GO:0055108]; membrane biogenesis [GO:0044091]; oligodendrocyte differentiation [GO:0048709]; paraxial mesoderm formation [GO:0048341]; positive regulation of calcium-mediated signaling [GO:0050850]; protein targeting to membrane [GO:0006612]; protein transmembrane transport [GO:0071806]; regulation of neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0098696]; regulation of protein transport [GO:0051223]; vesicle docking involved in exocytosis [GO:0006904]; vesicle targeting [GO:0006903]; vesicle tethering involved in exocytosis [GO:0090522] cell leading edge [GO:0031252]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; dendritic shaft [GO:0043198]; endosome [GO:0005768]; exocyst [GO:0000145]; Flemming body [GO:0090543]; growth cone [GO:0030426]; growth cone membrane [GO:0032584]; microvillus [GO:0005902]; myelin sheath abaxonal region [GO:0035748]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; postsynaptic density [GO:0014069]; postsynaptic density, intracellular component [GO:0099092]; protein-containing complex [GO:0032991]; Schaffer collateral - CA1 synapse [GO:0098685]; synapse [GO:0045202]; synaptic vesicle [GO:0008021] PDZ domain binding [GO:0030165]; protein-containing complex binding [GO:0044877] g13406.t1 Q62824 46.531 245 3.4200000000000003e-59 204.0 sp|Q62824|EXOC4_RAT Exocyst complex component 4 OS=Rattus norvegicus OX=10116 GN=Exoc4 PE=1 SV=1 EXOC4_RAT reviewed Exocyst complex component 4 (Exocyst complex component Sec8) (rSec8) Rattus norvegicus (Rat) GO:0000145; GO:0005737; GO:0005768; GO:0005813; GO:0005902; GO:0006612; GO:0006887; GO:0006893; GO:0006903; GO:0006904; GO:0007268; GO:0008021; GO:0014069; GO:0030010; GO:0030165; GO:0030425; GO:0030426; GO:0031252; GO:0032584; GO:0032991; GO:0035748; GO:0043005; GO:0043025; GO:0043198; GO:0044091; GO:0044877; GO:0045202; GO:0048341; GO:0048709; GO:0050850; GO:0051223; GO:0055108; GO:0071806; GO:0090522; GO:0090543; GO:0098685; GO:0098696; GO:0099092 chemical synaptic transmission [GO:0007268]; establishment of cell polarity [GO:0030010]; exocytosis [GO:0006887]; Golgi to plasma membrane transport [GO:0006893]; Golgi to transport vesicle transport [GO:0055108]; membrane biogenesis [GO:0044091]; oligodendrocyte differentiation [GO:0048709]; paraxial mesoderm formation [GO:0048341]; positive regulation of calcium-mediated signaling [GO:0050850]; protein targeting to membrane [GO:0006612]; protein transmembrane transport [GO:0071806]; regulation of neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0098696]; regulation of protein transport [GO:0051223]; vesicle docking involved in exocytosis [GO:0006904]; vesicle targeting [GO:0006903]; vesicle tethering involved in exocytosis [GO:0090522] cell leading edge [GO:0031252]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; dendritic shaft [GO:0043198]; endosome [GO:0005768]; exocyst [GO:0000145]; Flemming body [GO:0090543]; growth cone [GO:0030426]; growth cone membrane [GO:0032584]; microvillus [GO:0005902]; myelin sheath abaxonal region [GO:0035748]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; postsynaptic density [GO:0014069]; postsynaptic density, intracellular component [GO:0099092]; protein-containing complex [GO:0032991]; Schaffer collateral - CA1 synapse [GO:0098685]; synapse [GO:0045202]; synaptic vesicle [GO:0008021] PDZ domain binding [GO:0030165]; protein-containing complex binding [GO:0044877] g13408.t1 B0BN94 46.923 130 2.3100000000000002e-33 117.0 sp|B0BN94|F136A_RAT Protein FAM136A OS=Rattus norvegicus OX=10116 GN=Fam136a PE=1 SV=1 g13409.t1 P47968 65.432 243 7.23e-110 323.0 sp|P47968|RPIA_MOUSE Ribose-5-phosphate isomerase OS=Mus musculus OX=10090 GN=Rpia PE=1 SV=2 g13415.t1 Q9D742 40.385 156 1.34e-26 102.0 sp|Q9D742|AP5S1_MOUSE AP-5 complex subunit sigma-1 OS=Mus musculus OX=10090 GN=Ap5s1 PE=1 SV=1 g13416.t1 Q95LD9 29.562 274 1.93e-32 138.0 sp|Q95LD9|AHR_DELLE Aryl hydrocarbon receptor OS=Delphinapterus leucas OX=9749 GN=AHR PE=2 SV=1 AHR_DELLE reviewed Aryl hydrocarbon receptor (Ah receptor) (AhR) Delphinapterus leucas (Beluga whale) GO:0001094; GO:0001223; GO:0002819; GO:0002841; GO:0004879; GO:0005634; GO:0005737; GO:0005829; GO:0006805; GO:0009410; GO:0009636; GO:0017025; GO:0030888; GO:0032922; GO:0034753; GO:0045892; GO:0045893; GO:0045944; GO:0046982; GO:0050728; GO:0051879; GO:0060729; GO:0061629; GO:0070888; GO:0071219; GO:0071320; GO:1904322; GO:1904613; GO:1990837 cellular response to 2,3,7,8-tetrachlorodibenzodioxine [GO:1904613]; cellular response to cAMP [GO:0071320]; cellular response to forskolin [GO:1904322]; cellular response to molecule of bacterial origin [GO:0071219]; circadian regulation of gene expression [GO:0032922]; intestinal epithelial structure maintenance [GO:0060729]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of inflammatory response [GO:0050728]; negative regulation of T cell mediated immune response to tumor cell [GO:0002841]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of adaptive immune response [GO:0002819]; regulation of B cell proliferation [GO:0030888]; response to toxic substance [GO:0009636]; response to xenobiotic stimulus [GO:0009410]; xenobiotic metabolic process [GO:0006805] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear aryl hydrocarbon receptor complex [GO:0034753]; nucleus [GO:0005634] E-box binding [GO:0070888]; Hsp90 protein binding [GO:0051879]; nuclear receptor activity [GO:0004879]; protein heterodimerization activity [GO:0046982]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific double-stranded DNA binding [GO:1990837]; TBP-class protein binding [GO:0017025]; TFIID-class transcription factor complex binding [GO:0001094]; transcription coactivator binding [GO:0001223] g13419.t1 Q91VN6 68.948 599 0.0 789.0 sp|Q91VN6|DDX41_MOUSE Probable ATP-dependent RNA helicase DDX41 OS=Mus musculus OX=10090 GN=Ddx41 PE=1 SV=2 DDX41_MOUSE reviewed Probable ATP-dependent RNA helicase DDX41 (EC 3.6.4.13) (DEAD box protein 41) Mus musculus (Mouse) GO:0000398; GO:0003677; GO:0003724; GO:0003729; GO:0005524; GO:0005634; GO:0005681; GO:0005783; GO:0005829; GO:0008270; GO:0008283; GO:0016887; GO:0030154; GO:0032481; GO:0035458; GO:0045944; GO:0051607; GO:0071013; GO:0140896 cell differentiation [GO:0030154]; cell population proliferation [GO:0008283]; cellular response to interferon-beta [GO:0035458]; cGAS/STING signaling pathway [GO:0140896]; defense response to virus [GO:0051607]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of type I interferon production [GO:0032481] catalytic step 2 spliceosome [GO:0071013]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA binding [GO:0003677]; mRNA binding [GO:0003729]; RNA helicase activity [GO:0003724]; zinc ion binding [GO:0008270] g13420.t1 Q7TT23 41.602 387 3.86e-91 300.0 sp|Q7TT23|DAAF9_MOUSE Dynein axonemal assembly factor 9 OS=Mus musculus OX=10090 GN=Dnaaf9 PE=1 SV=2 g13421.t1 Q5TEA3 38.442 796 2.4800000000000003e-161 502.0 sp|Q5TEA3|DAAF9_HUMAN Dynein axonemal assembly factor 9 OS=Homo sapiens OX=9606 GN=DNAAF9 PE=1 SV=1 g13424.t1 Q9GR88 88.095 420 0.0 785.0 sp|Q9GR88|ERF1_POLMI Eukaryotic peptide chain release factor subunit 1 OS=Polyandrocarpa misakiensis OX=7723 GN=ERF1 PE=2 SV=1 g13426.t1 Q8BP74 39.779 181 2.25e-36 135.0 sp|Q8BP74|PSTK_MOUSE L-seryl-tRNA(Sec) kinase OS=Mus musculus OX=10090 GN=Pstk PE=1 SV=2 g13427.t1 A9ULG4 40.426 376 1.6400000000000003e-79 254.0 sp|A9ULG4|AUP1_XENTR Lipid droplet-regulating VLDL assembly factor AUP1 OS=Xenopus tropicalis OX=8364 GN=aup1 PE=2 SV=1 g13431.t1 Q8R3B7 51.942 206 8.23e-51 197.0 sp|Q8R3B7|BRD8_MOUSE Bromodomain-containing protein 8 OS=Mus musculus OX=10090 GN=Brd8 PE=1 SV=2 BRD8_MOUSE reviewed Bromodomain-containing protein 8 Mus musculus (Mouse) GO:0000786; GO:0000812; GO:0003713; GO:0005634; GO:0005654; GO:0005739; GO:0006325; GO:0035267; GO:0042981; GO:0045893; GO:0045944; GO:0046966; GO:0051726; GO:0097067; GO:1905168; GO:2000779 cellular response to thyroid hormone stimulus [GO:0097067]; chromatin organization [GO:0006325]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of double-strand break repair [GO:2000779] mitochondrion [GO:0005739]; NuA4 histone acetyltransferase complex [GO:0035267]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634]; Swr1 complex [GO:0000812] nuclear thyroid hormone receptor binding [GO:0046966]; transcription coactivator activity [GO:0003713] g13431.t1 Q8R3B7 61.832 131 3.13e-40 164.0 sp|Q8R3B7|BRD8_MOUSE Bromodomain-containing protein 8 OS=Mus musculus OX=10090 GN=Brd8 PE=1 SV=2 BRD8_MOUSE reviewed Bromodomain-containing protein 8 Mus musculus (Mouse) GO:0000786; GO:0000812; GO:0003713; GO:0005634; GO:0005654; GO:0005739; GO:0006325; GO:0035267; GO:0042981; GO:0045893; GO:0045944; GO:0046966; GO:0051726; GO:0097067; GO:1905168; GO:2000779 cellular response to thyroid hormone stimulus [GO:0097067]; chromatin organization [GO:0006325]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of double-strand break repair [GO:2000779] mitochondrion [GO:0005739]; NuA4 histone acetyltransferase complex [GO:0035267]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634]; Swr1 complex [GO:0000812] nuclear thyroid hormone receptor binding [GO:0046966]; transcription coactivator activity [GO:0003713] g13435.t1 Q5QP82 53.333 150 1.45e-49 169.0 sp|Q5QP82|DCA10_HUMAN DDB1- and CUL4-associated factor 10 OS=Homo sapiens OX=9606 GN=DCAF10 PE=1 SV=1 DCA10_HUMAN reviewed DDB1- and CUL4-associated factor 10 (WD repeat-containing protein 32) Homo sapiens (Human) GO:0005654; GO:0016567; GO:0080008 protein ubiquitination [GO:0016567] Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; nucleoplasm [GO:0005654] g13435.t1 Q5QP82 50.0 36 1.45e-49 48.1 sp|Q5QP82|DCA10_HUMAN DDB1- and CUL4-associated factor 10 OS=Homo sapiens OX=9606 GN=DCAF10 PE=1 SV=1 DCA10_HUMAN reviewed DDB1- and CUL4-associated factor 10 (WD repeat-containing protein 32) Homo sapiens (Human) GO:0005654; GO:0016567; GO:0080008 protein ubiquitination [GO:0016567] Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; nucleoplasm [GO:0005654] g13436.t1 Q8AVS9 45.745 188 4.89e-47 163.0 sp|Q8AVS9|DCA10_XENLA DDB1- and CUL4-associated factor 10 OS=Xenopus laevis OX=8355 GN=dcaf10 PE=2 SV=1 g13437.t1 Q3TWN3 50.296 338 5.1899999999999995e-104 329.0 sp|Q3TWN3|CNNM2_MOUSE Metal transporter CNNM2 OS=Mus musculus OX=10090 GN=Cnnm2 PE=1 SV=3 CNNM2_MOUSE reviewed Metal transporter CNNM2 (Ancient conserved domain-containing protein 2) (mACDP2) (Cyclin-M2) Mus musculus (Mouse) GO:0005524; GO:0005886; GO:0010960; GO:0015095; GO:0015693; GO:0016323; GO:0045202; GO:0098978 magnesium ion homeostasis [GO:0010960]; magnesium ion transport [GO:0015693] basolateral plasma membrane [GO:0016323]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; synapse [GO:0045202] ATP binding [GO:0005524]; magnesium ion transmembrane transporter activity [GO:0015095] g13439.t1 B5FYQ0 59.116 181 2.07e-59 185.0 sp|B5FYQ0|ARL3_TAEGU ADP-ribosylation factor-like protein 3 OS=Taeniopygia guttata OX=59729 GN=ARL3 PE=2 SV=1 ARL3_TAEGU reviewed ADP-ribosylation factor-like protein 3 Taeniopygia guttata (Zebra finch) (Poephila guttata) GO:0000139; GO:0000281; GO:0000287; GO:0001822; GO:0003924; GO:0005525; GO:0005634; GO:0005654; GO:0005794; GO:0005813; GO:0005876; GO:0005881; GO:0005929; GO:0005930; GO:0006893; GO:0007224; GO:0007264; GO:0008017; GO:0015031; GO:0019003; GO:0030496; GO:0032391; GO:0036064; GO:0042073; GO:0042461; GO:0060271; GO:1903441 cilium assembly [GO:0060271]; Golgi to plasma membrane transport [GO:0006893]; intraciliary transport [GO:0042073]; kidney development [GO:0001822]; mitotic cytokinesis [GO:0000281]; photoreceptor cell development [GO:0042461]; protein localization to ciliary membrane [GO:1903441]; protein transport [GO:0015031]; small GTPase-mediated signal transduction [GO:0007264]; smoothened signaling pathway [GO:0007224] axoneme [GO:0005930]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasmic microtubule [GO:0005881]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; midbody [GO:0030496]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; photoreceptor connecting cilium [GO:0032391]; spindle microtubule [GO:0005876] GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; magnesium ion binding [GO:0000287]; microtubule binding [GO:0008017] g13440.t1 Q9WVA3 72.897 321 2.61e-176 493.0 sp|Q9WVA3|BUB3_MOUSE Mitotic checkpoint protein BUB3 OS=Mus musculus OX=10090 GN=Bub3 PE=1 SV=2 BUB3_MOUSE reviewed Mitotic checkpoint protein BUB3 (WD repeat type I transmembrane protein A72.5) Mus musculus (Mouse) GO:0000776; GO:0005654; GO:0007094; GO:0008608; GO:0033597; GO:0034501; GO:0043130; GO:0051301; GO:0051321; GO:0051983; GO:1990298 attachment of spindle microtubules to kinetochore [GO:0008608]; cell division [GO:0051301]; meiotic cell cycle [GO:0051321]; mitotic spindle assembly checkpoint signaling [GO:0007094]; protein localization to kinetochore [GO:0034501]; regulation of chromosome segregation [GO:0051983] bub1-bub3 complex [GO:1990298]; kinetochore [GO:0000776]; mitotic checkpoint complex [GO:0033597]; nucleoplasm [GO:0005654] ubiquitin binding [GO:0043130] g13441.t1 Q9CQW1 61.929 197 2.23e-82 246.0 sp|Q9CQW1|YKT6_MOUSE Synaptobrevin homolog YKT6 OS=Mus musculus OX=10090 GN=Ykt6 PE=1 SV=1 YKT6_MOUSE reviewed Synaptobrevin homolog YKT6 (EC 2.3.1.-) Mus musculus (Mouse) GO:0000139; GO:0005484; GO:0005737; GO:0005739; GO:0005768; GO:0005783; GO:0005794; GO:0005829; GO:0005886; GO:0006888; GO:0006903; GO:0006904; GO:0015031; GO:0019706; GO:0030659; GO:0031201; GO:0042147; GO:0043025; GO:0097440; GO:0097441 endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; protein transport [GO:0015031]; retrograde transport, endosome to Golgi [GO:0042147]; vesicle docking involved in exocytosis [GO:0006904]; vesicle targeting [GO:0006903] apical dendrite [GO:0097440]; basal dendrite [GO:0097441]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; SNARE complex [GO:0031201] protein-cysteine S-palmitoyltransferase activity [GO:0019706]; SNAP receptor activity [GO:0005484] g13442.t1 Q3T0S0 32.53 166 1.99e-26 102.0 sp|Q3T0S0|TM128_BOVIN Transmembrane protein 128 OS=Bos taurus OX=9913 GN=TMEM128 PE=2 SV=1 g13443.t1 Q8N9H8 29.22 551 4.92e-53 198.0 sp|Q8N9H8|MUT7_HUMAN Exonuclease mut-7 homolog OS=Homo sapiens OX=9606 GN=EXD3 PE=1 SV=3 g13444.t1 F6NXI9 57.494 407 5.4300000000000005e-167 478.0 sp|F6NXI9|TRNT1_DANRE CCA tRNA nucleotidyltransferase 1, mitochondrial OS=Danio rerio OX=7955 GN=trnt1 PE=2 SV=1 TRNT1_DANRE reviewed CCA tRNA nucleotidyltransferase 1, mitochondrial (EC 2.7.7.72) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000049; GO:0001654; GO:0001680; GO:0001966; GO:0004810; GO:0005524; GO:0005634; GO:0005739; GO:0007632; GO:0008033; GO:0046872; GO:0160016; GO:1990180 eye development [GO:0001654]; mitochondrial tRNA 3'-end processing [GO:1990180]; thigmotaxis [GO:0001966]; tRNA 3'-terminal CCA addition [GO:0001680]; tRNA processing [GO:0008033]; visual behavior [GO:0007632] mitochondrion [GO:0005739]; nucleus [GO:0005634] ATP binding [GO:0005524]; CCA tRNA nucleotidyltransferase activity [GO:0004810]; CCACCA tRNA nucleotidyltransferase activity [GO:0160016]; metal ion binding [GO:0046872]; tRNA binding [GO:0000049] g13445.t1 Q8N9H8 32.939 677 4.4e-101 340.0 sp|Q8N9H8|MUT7_HUMAN Exonuclease mut-7 homolog OS=Homo sapiens OX=9606 GN=EXD3 PE=1 SV=3 g13446.t1 P34947 70.683 556 0.0 671.0 sp|P34947|GRK5_HUMAN G protein-coupled receptor kinase 5 OS=Homo sapiens OX=9606 GN=GRK5 PE=1 SV=1 GRK5_HUMAN reviewed G protein-coupled receptor kinase 5 (EC 2.7.11.16) (G protein-coupled receptor kinase GRK5) Homo sapiens (Human) GO:0004672; GO:0004674; GO:0004703; GO:0005080; GO:0005524; GO:0005543; GO:0005737; GO:0005829; GO:0005886; GO:0006915; GO:0007186; GO:0007188; GO:0007217; GO:0008277; GO:0008284; GO:0009966; GO:0016055; GO:0016607; GO:0031965; GO:0043066; GO:0045444; GO:0046777; GO:0047696; GO:0051726 adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; apoptotic process [GO:0006915]; fat cell differentiation [GO:0045444]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of apoptotic process [GO:0043066]; positive regulation of cell population proliferation [GO:0008284]; protein autophosphorylation [GO:0046777]; regulation of cell cycle [GO:0051726]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; regulation of signal transduction [GO:0009966]; tachykinin receptor signaling pathway [GO:0007217]; Wnt signaling pathway [GO:0016055] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]; nuclear speck [GO:0016607]; plasma membrane [GO:0005886] ATP binding [GO:0005524]; beta-adrenergic receptor kinase activity [GO:0047696]; G protein-coupled receptor kinase activity [GO:0004703]; phospholipid binding [GO:0005543]; protein kinase activity [GO:0004672]; protein kinase C binding [GO:0005080]; protein serine/threonine kinase activity [GO:0004674] g13446.t2 Q62833 69.366 568 0.0 677.0 sp|Q62833|GRK5_RAT G protein-coupled receptor kinase 5 OS=Rattus norvegicus OX=10116 GN=Grk5 PE=1 SV=1 g13446.t3 Q62833 66.906 556 0.0 608.0 sp|Q62833|GRK5_RAT G protein-coupled receptor kinase 5 OS=Rattus norvegicus OX=10116 GN=Grk5 PE=1 SV=1 g13447.t1 Q5EAD4 52.339 449 4.1e-170 488.0 sp|Q5EAD4|ACDSB_BOVIN Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial OS=Bos taurus OX=9913 GN=ACADSB PE=2 SV=1 ACDSB_BOVIN reviewed Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial (SBCAD) (EC 1.3.8.1) (EC 1.3.8.5) (2-methyl branched chain acyl-CoA dehydrogenase) (2-MEBCAD) (2-methylbutyryl-coenzyme A dehydrogenase) (2-methylbutyryl-CoA dehydrogenase) Bos taurus (Bovine) GO:0003853; GO:0003995; GO:0005739; GO:0005759; GO:0006550; GO:0006631; GO:0016937; GO:0042802; GO:0050660 fatty acid metabolic process [GO:0006631]; L-isoleucine catabolic process [GO:0006550] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] acyl-CoA dehydrogenase activity [GO:0003995]; flavin adenine dinucleotide binding [GO:0050660]; identical protein binding [GO:0042802]; short-chain 2-methyl fatty acyl-CoA dehydrogenase activity [GO:0003853]; short-chain fatty acyl-CoA dehydrogenase activity [GO:0016937] g13448.t1 G1SQH0 78.014 141 2.5e-43 142.0 sp|G1SQH0|RL26_RABIT Large ribosomal subunit protein uL24 OS=Oryctolagus cuniculus OX=9986 GN=RPL26 PE=1 SV=1 g13450.t1 Q9D7I5 56.391 266 1.6700000000000002e-103 305.0 sp|Q9D7I5|LHPP_MOUSE Phospholysine phosphohistidine inorganic pyrophosphate phosphatase OS=Mus musculus OX=10090 GN=Lhpp PE=1 SV=1 LHPP_MOUSE reviewed Phospholysine phosphohistidine inorganic pyrophosphate phosphatase (EC 3.1.3.-) (EC 3.6.1.1) Mus musculus (Mouse) GO:0004427; GO:0005634; GO:0005737; GO:0005829; GO:0006796; GO:0016607; GO:0016791; GO:0042803; GO:0046872 phosphate-containing compound metabolic process [GO:0006796] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleus [GO:0005634] inorganic diphosphate phosphatase activity [GO:0004427]; metal ion binding [GO:0046872]; phosphatase activity [GO:0016791]; protein homodimerization activity [GO:0042803] g13451.t1 Q0P5M9 49.508 305 2.5600000000000003e-80 258.0 sp|Q0P5M9|MFS10_BOVIN Major facilitator superfamily domain-containing protein 10 OS=Bos taurus OX=9913 GN=MFSD10 PE=2 SV=1 g13453.t1 D2KQB0 80.42 286 1.0900000000000001e-129 372.0 sp|D2KQB0|HHEX_PATMI Hematopoietically-expressed homeobox protein HHEX homolog OS=Patiria miniata OX=46514 GN=hhex PE=2 SV=1 g13455.t1 Q504H8 56.886 167 4.26e-34 131.0 sp|Q504H8|HMX3_DANRE Homeobox protein HMX3 OS=Danio rerio OX=7955 GN=hmx3 PE=2 SV=1 HMX3_DANRE reviewed Homeobox protein HMX3 (Homeobox protein H6 family member 3) (Homeobox protein Nkx-5.1) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000977; GO:0000981; GO:0005634; GO:0006357; GO:0021510; GO:0030154; GO:0042472; GO:0048840; GO:0048916; GO:0048920 cell differentiation [GO:0030154]; inner ear morphogenesis [GO:0042472]; otolith development [GO:0048840]; posterior lateral line development [GO:0048916]; posterior lateral line neuromast primordium migration [GO:0048920]; regulation of transcription by RNA polymerase II [GO:0006357]; spinal cord development [GO:0021510] nucleus [GO:0005634] DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977] g13459.t1 Q75W95 40.938 320 1.43e-45 162.0 sp|Q75W95|NKX11_DANRE NK1 transcription factor-related protein 1 OS=Danio rerio OX=7955 GN=nkx1.2lb PE=2 SV=1 g13462.t1 Q9UBV7 55.274 237 1.9400000000000002e-88 271.0 sp|Q9UBV7|B4GT7_HUMAN Beta-1,4-galactosyltransferase 7 OS=Homo sapiens OX=9606 GN=B4GALT7 PE=1 SV=1 B4GT7_HUMAN reviewed Beta-1,4-galactosyltransferase 7 (Beta-1,4-GalTase 7) (Beta4Gal-T7) (b4Gal-T7) (EC 2.4.1.-) (Proteoglycan UDP-galactose:beta-xylose beta1,4-galactosyltransferase I) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 7) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 7) (UDP-galactose:beta-xylose beta-1,4-galactosyltransferase) (XGPT) (XGalT-1) (Xylosylprotein 4-beta-galactosyltransferase) (EC 2.4.1.133) (Xylosylprotein beta-1,4-galactosyltransferase) Homo sapiens (Human) GO:0000139; GO:0003831; GO:0005794; GO:0005975; GO:0006024; GO:0006029; GO:0006487; GO:0008378; GO:0016020; GO:0030145; GO:0030166; GO:0032580; GO:0036211; GO:0046525; GO:0048147; GO:0097435; GO:0120532 carbohydrate metabolic process [GO:0005975]; glycosaminoglycan biosynthetic process [GO:0006024]; glycosaminoglycan-protein linkage region biosynthetic process [GO:0120532]; negative regulation of fibroblast proliferation [GO:0048147]; protein modification process [GO:0036211]; protein N-linked glycosylation [GO:0006487]; proteoglycan biosynthetic process [GO:0030166]; proteoglycan metabolic process [GO:0006029]; supramolecular fiber organization [GO:0097435] Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; membrane [GO:0016020] beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity [GO:0003831]; galactosyltransferase activity [GO:0008378]; manganese ion binding [GO:0030145]; xylosylprotein 4-beta-galactosyltransferase activity [GO:0046525] g13464.t1 A0A4Y5X186 45.69 116 3.57e-30 110.0 sp|A0A4Y5X186|CESS2_CONMO Conopressin/conophysin, isoform 2 (Fragment) OS=Conus monile OX=351660 PE=2 SV=1 g13469.t1 O76050 34.729 406 7.45e-65 224.0 sp|O76050|NEUL1_HUMAN E3 ubiquitin-protein ligase NEURL1 OS=Homo sapiens OX=9606 GN=NEURL1 PE=1 SV=1 g13470.t1 Q5BJW3 52.5 200 9.199999999999999e-55 176.0 sp|Q5BJW3|TX261_RAT Protein TEX261 OS=Rattus norvegicus OX=10116 GN=Tex261 PE=2 SV=1 g13471.t1 Q3V0J4 31.984 247 2.1900000000000003e-31 128.0 sp|Q3V0J4|ANR53_MOUSE Ankyrin repeat domain-containing protein 53 OS=Mus musculus OX=10090 GN=Ankrd53 PE=2 SV=2 g13472.t1 A9UMP7 37.853 354 1.63e-66 229.0 sp|A9UMP7|ENO4_XENLA Enolase 4 OS=Xenopus laevis OX=8355 GN=eno4 PE=2 SV=2 g13472.t1 A9UMP7 46.465 99 1.6100000000000001e-21 102.0 sp|A9UMP7|ENO4_XENLA Enolase 4 OS=Xenopus laevis OX=8355 GN=eno4 PE=2 SV=2 g13473.t1 Q68FT3 65.534 206 9.18e-92 283.0 sp|Q68FT3|PYRD2_RAT Pyridine nucleotide-disulfide oxidoreductase domain-containing protein 2 OS=Rattus norvegicus OX=10116 GN=Pyroxd2 PE=2 SV=1 g13474.t1 Q68FT3 53.881 219 1.88e-64 214.0 sp|Q68FT3|PYRD2_RAT Pyridine nucleotide-disulfide oxidoreductase domain-containing protein 2 OS=Rattus norvegicus OX=10116 GN=Pyroxd2 PE=2 SV=1 g13475.t1 Q92597 34.629 283 8.73e-51 176.0 sp|Q92597|NDRG1_HUMAN Protein NDRG1 OS=Homo sapiens OX=9606 GN=NDRG1 PE=1 SV=1 g13475.t2 Q92597 34.629 283 1.49e-50 176.0 sp|Q92597|NDRG1_HUMAN Protein NDRG1 OS=Homo sapiens OX=9606 GN=NDRG1 PE=1 SV=1 g13476.t1 A3KGT9 51.957 460 9.930000000000001e-166 477.0 sp|A3KGT9|GPT3L_DANRE Glycerol-3-phosphate acyltransferase 3-like OS=Danio rerio OX=7955 GN=agpat9l PE=3 SV=1 g13478.t1 P97772 31.742 775 5.6e-103 347.0 sp|P97772|GRM1_MOUSE Metabotropic glutamate receptor 1 OS=Mus musculus OX=10090 GN=Grm1 PE=1 SV=2 g13479.t1 P31421 29.915 819 8.83e-104 343.0 sp|P31421|GRM2_RAT Metabotropic glutamate receptor 2 OS=Rattus norvegicus OX=10116 GN=Grm2 PE=1 SV=1 GRM2_RAT reviewed Metabotropic glutamate receptor 2 (mGluR2) Rattus norvegicus (Rat) GO:0001641; GO:0005246; GO:0005886; GO:0007193; GO:0007215; GO:0007216; GO:0008066; GO:0010467; GO:0014047; GO:0014048; GO:0014059; GO:0030424; GO:0030425; GO:0033554; GO:0035095; GO:0042220; GO:0042734; GO:0043005; GO:0045211; GO:0046928; GO:0051897; GO:0051966; GO:0060292; GO:0090461; GO:0097110; GO:0097449; GO:0098978; GO:0099171; GO:2001023 adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; behavioral response to nicotine [GO:0035095]; cellular response to stress [GO:0033554]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; gene expression [GO:0010467]; glutamate receptor signaling pathway [GO:0007215]; glutamate secretion [GO:0014047]; intracellular glutamate homeostasis [GO:0090461]; long-term synaptic depression [GO:0060292]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; presynaptic modulation of chemical synaptic transmission [GO:0099171]; regulation of dopamine secretion [GO:0014059]; regulation of glutamate secretion [GO:0014048]; regulation of neurotransmitter secretion [GO:0046928]; regulation of response to drug [GO:2001023]; regulation of synaptic transmission, glutamatergic [GO:0051966]; response to cocaine [GO:0042220] astrocyte projection [GO:0097449]; axon [GO:0030424]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734] calcium channel regulator activity [GO:0005246]; glutamate receptor activity [GO:0008066]; group II metabotropic glutamate receptor activity [GO:0001641]; scaffold protein binding [GO:0097110] g13480.t1 P41594 32.743 339 4.37e-46 173.0 sp|P41594|GRM5_HUMAN Metabotropic glutamate receptor 5 OS=Homo sapiens OX=9606 GN=GRM5 PE=1 SV=2 GRM5_HUMAN reviewed Metabotropic glutamate receptor 5 (mGluR5) Homo sapiens (Human) GO:0001640; GO:0001659; GO:0001975; GO:0002029; GO:0004930; GO:0005637; GO:0005737; GO:0005886; GO:0006355; GO:0007204; GO:0007206; GO:0007216; GO:0007268; GO:0007611; GO:0007626; GO:0008066; GO:0030296; GO:0030425; GO:0031687; GO:0033603; GO:0035106; GO:0036228; GO:0042802; GO:0043025; GO:0043197; GO:0043198; GO:0043278; GO:0043410; GO:0045471; GO:0046677; GO:0048170; GO:0050808; GO:0050850; GO:0050890; GO:0051412; GO:0051966; GO:0061002; GO:0062036; GO:0090394; GO:0097449; GO:0098685; GO:0098839; GO:0098978; GO:0099530; GO:0099583; GO:1900039; GO:1900452; GO:1904058; GO:1904646; GO:1990708; GO:1990782; GO:2000179 cellular response to amyloid-beta [GO:1904646]; chemical synaptic transmission [GO:0007268]; cognition [GO:0050890]; conditioned place preference [GO:1990708]; desensitization of G protein-coupled receptor signaling pathway [GO:0002029]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; learning or memory [GO:0007611]; locomotory behavior [GO:0007626]; negative regulation of dendritic spine morphogenesis [GO:0061002]; negative regulation of excitatory postsynaptic potential [GO:0090394]; operant conditioning [GO:0035106]; phospholipase C-activating G protein-coupled glutamate receptor signaling pathway [GO:0007206]; positive regulation of calcium-mediated signaling [GO:0050850]; positive regulation of cellular response to hypoxia [GO:1900039]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of dopamine secretion [GO:0033603]; positive regulation of long-term neuronal synaptic plasticity [GO:0048170]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of sensory perception of pain [GO:1904058]; protein localization to nuclear inner membrane [GO:0036228]; regulation of DNA-templated transcription [GO:0006355]; regulation of long-term synaptic depression [GO:1900452]; regulation of synaptic transmission, glutamatergic [GO:0051966]; response to amphetamine [GO:0001975]; response to antibiotic [GO:0046677]; response to corticosterone [GO:0051412]; response to ethanol [GO:0045471]; response to morphine [GO:0043278]; sensory perception of hot stimulus [GO:0062036]; synapse organization [GO:0050808]; temperature homeostasis [GO:0001659] astrocyte projection [GO:0097449]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; neuronal cell body [GO:0043025]; nuclear inner membrane [GO:0005637]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; Schaffer collateral - CA1 synapse [GO:0098685] A2A adenosine receptor binding [GO:0031687]; adenylate cyclase inhibiting G protein-coupled glutamate receptor activity [GO:0001640]; G protein-coupled receptor activity [GO:0004930]; G protein-coupled receptor activity involved in regulation of postsynaptic membrane potential [GO:0099530]; glutamate receptor activity [GO:0008066]; identical protein binding [GO:0042802]; neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration [GO:0099583]; protein tyrosine kinase activator activity [GO:0030296]; protein tyrosine kinase binding [GO:1990782] g13481.t1 P91685 34.241 257 8.75e-34 136.0 sp|P91685|GRM_DROME Metabotropic glutamate receptor OS=Drosophila melanogaster OX=7227 GN=mGluR PE=1 SV=2 GRM_DROME reviewed Metabotropic glutamate receptor (DmGluRA) Drosophila melanogaster (Fruit fly) GO:0001641; GO:0004930; GO:0005886; GO:0007216; GO:0007528; GO:0007612; GO:0007614; GO:0007616; GO:0008049; GO:0008066; GO:0015485; GO:0016020; GO:0016595; GO:0038038; GO:0045121; GO:0051966; GO:0072553 G protein-coupled glutamate receptor signaling pathway [GO:0007216]; learning [GO:0007612]; long-term memory [GO:0007616]; male courtship behavior [GO:0008049]; neuromuscular junction development [GO:0007528]; regulation of synaptic transmission, glutamatergic [GO:0051966]; short-term memory [GO:0007614]; terminal button organization [GO:0072553] G protein-coupled receptor homodimeric complex [GO:0038038]; membrane [GO:0016020]; membrane raft [GO:0045121]; plasma membrane [GO:0005886] cholesterol binding [GO:0015485]; G protein-coupled receptor activity [GO:0004930]; glutamate binding [GO:0016595]; glutamate receptor activity [GO:0008066]; group II metabotropic glutamate receptor activity [GO:0001641] g13482.t1 Q8R3N1 38.991 436 8.91e-84 283.0 sp|Q8R3N1|NOP14_MOUSE Nucleolar protein 14 OS=Mus musculus OX=10090 GN=Nop14 PE=1 SV=2 g13483.t1 Q8R3N1 52.361 233 1.0999999999999999e-61 210.0 sp|Q8R3N1|NOP14_MOUSE Nucleolar protein 14 OS=Mus musculus OX=10090 GN=Nop14 PE=1 SV=2 g13484.t1 O14776 57.788 443 4.48e-154 489.0 sp|O14776|TCRG1_HUMAN Transcription elongation regulator 1 OS=Homo sapiens OX=9606 GN=TCERG1 PE=1 SV=2 TCRG1_HUMAN reviewed Transcription elongation regulator 1 (TATA box-binding protein-associated factor 2S) (Transcription factor CA150) Homo sapiens (Human) GO:0000122; GO:0003711; GO:0003712; GO:0003713; GO:0003714; GO:0003723; GO:0005634; GO:0005654; GO:0006397; GO:0008380; GO:0016607; GO:0032968; GO:0034244; GO:0042802; GO:0044390; GO:0045944; GO:0061629; GO:0070063 mRNA processing [GO:0006397]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription elongation by RNA polymerase II [GO:0034244]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription elongation by RNA polymerase II [GO:0032968]; RNA splicing [GO:0008380] nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] identical protein binding [GO:0042802]; RNA binding [GO:0003723]; RNA polymerase binding [GO:0070063]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; transcription corepressor activity [GO:0003714]; transcription elongation factor activity [GO:0003711]; ubiquitin-like protein conjugating enzyme binding [GO:0044390] g13484.t1 O14776 66.667 66 2.6599999999999997e-23 110.0 sp|O14776|TCRG1_HUMAN Transcription elongation regulator 1 OS=Homo sapiens OX=9606 GN=TCERG1 PE=1 SV=2 TCRG1_HUMAN reviewed Transcription elongation regulator 1 (TATA box-binding protein-associated factor 2S) (Transcription factor CA150) Homo sapiens (Human) GO:0000122; GO:0003711; GO:0003712; GO:0003713; GO:0003714; GO:0003723; GO:0005634; GO:0005654; GO:0006397; GO:0008380; GO:0016607; GO:0032968; GO:0034244; GO:0042802; GO:0044390; GO:0045944; GO:0061629; GO:0070063 mRNA processing [GO:0006397]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription elongation by RNA polymerase II [GO:0034244]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription elongation by RNA polymerase II [GO:0032968]; RNA splicing [GO:0008380] nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] identical protein binding [GO:0042802]; RNA binding [GO:0003723]; RNA polymerase binding [GO:0070063]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; transcription corepressor activity [GO:0003714]; transcription elongation factor activity [GO:0003711]; ubiquitin-like protein conjugating enzyme binding [GO:0044390] g13486.t1 Q4G055 39.259 540 7.62e-90 288.0 sp|Q4G055|RNPC3_RAT RNA-binding region-containing protein 3 OS=Rattus norvegicus OX=10116 GN=Rnpc3 PE=1 SV=2 g13487.t1 Q29RL1 60.897 624 0.0 793.0 sp|Q29RL1|CF206_BOVIN Cilia- and flagella-associated protein 206 OS=Bos taurus OX=9913 GN=CFAP206 PE=2 SV=2 CF206_BOVIN reviewed Cilia- and flagella-associated protein 206 Bos taurus (Bovine) GO:0001534; GO:0003341; GO:0003356; GO:0005930; GO:0007288; GO:0031514; GO:0035082; GO:0036064; GO:1901317 axoneme assembly [GO:0035082]; cilium movement [GO:0003341]; regulation of cilium beat frequency [GO:0003356]; regulation of flagellated sperm motility [GO:1901317]; sperm axoneme assembly [GO:0007288] axoneme [GO:0005930]; ciliary basal body [GO:0036064]; motile cilium [GO:0031514]; radial spoke [GO:0001534] g13488.t1 O94941 30.354 537 4.4299999999999995e-48 178.0 sp|O94941|RNF37_HUMAN RING finger protein 37 OS=Homo sapiens OX=9606 GN=UBOX5 PE=1 SV=1 g13490.t1 Q8TDB6 53.886 193 1.78e-59 223.0 sp|Q8TDB6|DTX3L_HUMAN E3 ubiquitin-protein ligase DTX3L OS=Homo sapiens OX=9606 GN=DTX3L PE=1 SV=1 DTX3L_HUMAN reviewed E3 ubiquitin-protein ligase DTX3L (EC 2.3.2.27) (B-lymphoma- and BAL-associated protein) (Protein deltex-3-like) (RING-type E3 ubiquitin transferase DTX3L) (Rhysin-2) (Rhysin2) Homo sapiens (Human) GO:0000077; GO:0002230; GO:0004842; GO:0004857; GO:0005634; GO:0005654; GO:0005737; GO:0005764; GO:0005765; GO:0005829; GO:0006302; GO:0006511; GO:0007219; GO:0008270; GO:0008333; GO:0015031; GO:0016567; GO:0019899; GO:0031901; GO:0032092; GO:0032991; GO:0035563; GO:0042393; GO:0044389; GO:0045087; GO:0045893; GO:0051444; GO:0051607; GO:0051865; GO:0061630; GO:0070936; GO:0097677; GO:0140768; GO:0140852; GO:0140861; GO:0141000; GO:1900182; GO:1902966; GO:2000646 defense response to virus [GO:0051607]; DNA damage checkpoint signaling [GO:0000077]; DNA repair-dependent chromatin remodeling [GO:0140861]; double-strand break repair [GO:0006302]; endosome to lysosome transport [GO:0008333]; innate immune response [GO:0045087]; negative regulation of ubiquitin-protein transferase activity [GO:0051444]; Notch signaling pathway [GO:0007219]; positive regulation of chromatin binding [GO:0035563]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of protein binding [GO:0032092]; positive regulation of protein localization to early endosome [GO:1902966]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of receptor catabolic process [GO:2000646]; protein autoubiquitination [GO:0051865]; protein K48-linked ubiquitination [GO:0070936]; protein transport [GO:0015031]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511] cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991] enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; histone binding [GO:0042393]; histone H4K91 ubiquitin ligase activity [GO:0141000]; histone ubiquitin ligase activity [GO:0140852]; protein ADP-ribosyltransferase-substrate adaptor activity [GO:0140768]; STAT family protein binding [GO:0097677]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-like protein ligase binding [GO:0044389]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] g13491.t1 Q7TMV1 38.498 639 2.52e-130 401.0 sp|Q7TMV1|RN139_MOUSE E3 ubiquitin-protein ligase RNF139 OS=Mus musculus OX=10090 GN=Rnf139 PE=1 SV=1 RN139_MOUSE reviewed E3 ubiquitin-protein ligase RNF139 (EC 2.3.2.27) (RING finger protein 139) (RING-type E3 ubiquitin transferase RNF139) (Translocation in renal carcinoma on chromosome 8 protein) Mus musculus (Mouse) GO:0002020; GO:0004842; GO:0005783; GO:0008270; GO:0008285; GO:0012505; GO:0016567; GO:0017148; GO:0019787; GO:0031648; GO:0036503; GO:0036513; GO:0043161; GO:0060628; GO:0061630; GO:0070613; GO:2000060 ERAD pathway [GO:0036503]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of translation [GO:0017148]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein destabilization [GO:0031648]; protein ubiquitination [GO:0016567]; regulation of ER to Golgi vesicle-mediated transport [GO:0060628]; regulation of protein processing [GO:0070613] Derlin-1 retrotranslocation complex [GO:0036513]; endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783] protease binding [GO:0002020]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-like protein transferase activity [GO:0019787]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] g13493.t1 Q7ZWF4 39.167 600 1.56e-147 445.0 sp|Q7ZWF4|RN145_DANRE RING finger protein 145 OS=Danio rerio OX=7955 GN=rnf145 PE=2 SV=1 RN145_DANRE reviewed RING finger protein 145 Danio rerio (Zebrafish) (Brachydanio rerio) GO:0008270; GO:0012505; GO:0016020; GO:0030097; GO:0036503; GO:0043161; GO:0061515; GO:0061630 ERAD pathway [GO:0036503]; hemopoiesis [GO:0030097]; myeloid cell development [GO:0061515]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161] endomembrane system [GO:0012505]; membrane [GO:0016020] ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] g13494.t1 Q28ID3 55.022 229 1.54e-92 278.0 sp|Q28ID3|GLRX3_XENTR Glutaredoxin-3 OS=Xenopus tropicalis OX=8364 GN=glrx3 PE=2 SV=2 g13494.t1 Q28ID3 59.434 106 2.35e-39 141.0 sp|Q28ID3|GLRX3_XENTR Glutaredoxin-3 OS=Xenopus tropicalis OX=8364 GN=glrx3 PE=2 SV=2 g13494.t2 Q28ID3 53.067 326 7.049999999999999e-126 366.0 sp|Q28ID3|GLRX3_XENTR Glutaredoxin-3 OS=Xenopus tropicalis OX=8364 GN=glrx3 PE=2 SV=2 g13494.t2 Q28ID3 60.87 69 5.0099999999999994e-24 103.0 sp|Q28ID3|GLRX3_XENTR Glutaredoxin-3 OS=Xenopus tropicalis OX=8364 GN=glrx3 PE=2 SV=2 g13496.t1 Q9UGM1 31.317 463 3.84e-76 250.0 sp|Q9UGM1|ACHA9_HUMAN Neuronal acetylcholine receptor subunit alpha-9 OS=Homo sapiens OX=9606 GN=CHRNA9 PE=1 SV=2 ACHA9_HUMAN reviewed Neuronal acetylcholine receptor subunit alpha-9 (Nicotinic acetylcholine receptor subunit alpha-9) (NACHR alpha-9) Homo sapiens (Human) GO:0005231; GO:0005262; GO:0005886; GO:0005892; GO:0007204; GO:0007268; GO:0010996; GO:0022848; GO:0022850; GO:0034220; GO:0042391; GO:0042472; GO:0043005; GO:0045202; GO:0050910; GO:0051899; GO:0070373; GO:0095500; GO:0098981; GO:0099634; GO:1902495; GO:1904315 acetylcholine receptor signaling pathway [GO:0095500]; chemical synaptic transmission [GO:0007268]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; inner ear morphogenesis [GO:0042472]; membrane depolarization [GO:0051899]; monoatomic ion transmembrane transport [GO:0034220]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; regulation of membrane potential [GO:0042391]; response to auditory stimulus [GO:0010996] acetylcholine-gated channel complex [GO:0005892]; cholinergic synapse [GO:0098981]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic specialization membrane [GO:0099634]; synapse [GO:0045202]; transmembrane transporter complex [GO:1902495] acetylcholine-gated monoatomic cation-selective channel activity [GO:0022848]; calcium channel activity [GO:0005262]; excitatory extracellular ligand-gated monoatomic ion channel activity [GO:0005231]; serotonin-gated monoatomic cation channel activity [GO:0022850]; transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315] g13497.t1 P04757 34.989 443 3.14e-69 231.0 sp|P04757|ACHA3_RAT Neuronal acetylcholine receptor subunit alpha-3 OS=Rattus norvegicus OX=10116 GN=Chrna3 PE=1 SV=1 ACHA3_RAT reviewed Neuronal acetylcholine receptor subunit alpha-3 Rattus norvegicus (Rat) GO:0005730; GO:0005783; GO:0005794; GO:0005829; GO:0005886; GO:0005892; GO:0006937; GO:0006940; GO:0007165; GO:0007271; GO:0007274; GO:0007399; GO:0007507; GO:0007626; GO:0009410; GO:0014056; GO:0015464; GO:0016607; GO:0022848; GO:0030425; GO:0032991; GO:0034220; GO:0034465; GO:0034703; GO:0035094; GO:0035095; GO:0036064; GO:0042166; GO:0042391; GO:0043005; GO:0043025; GO:0044853; GO:0044877; GO:0045202; GO:0046872; GO:0048814; GO:0051899; GO:0060079; GO:0060084; GO:0095500; GO:0098691; GO:0098793; GO:0098878; GO:0098981; GO:0099171; GO:0099634; GO:1901363; GO:1904315; GO:1905144 acetylcholine receptor signaling pathway [GO:0095500]; behavioral response to nicotine [GO:0035095]; excitatory postsynaptic potential [GO:0060079]; heart development [GO:0007507]; locomotory behavior [GO:0007626]; membrane depolarization [GO:0051899]; monoatomic ion transmembrane transport [GO:0034220]; nervous system development [GO:0007399]; neuromuscular synaptic transmission [GO:0007274]; presynaptic modulation of chemical synaptic transmission [GO:0099171]; regulation of acetylcholine secretion, neurotransmission [GO:0014056]; regulation of dendrite morphogenesis [GO:0048814]; regulation of membrane potential [GO:0042391]; regulation of muscle contraction [GO:0006937]; regulation of smooth muscle contraction [GO:0006940]; response to acetylcholine [GO:1905144]; response to carbon monoxide [GO:0034465]; response to nicotine [GO:0035094]; response to xenobiotic stimulus [GO:0009410]; signal transduction [GO:0007165]; synaptic transmission involved in micturition [GO:0060084]; synaptic transmission, cholinergic [GO:0007271] acetylcholine-gated channel complex [GO:0005892]; cation channel complex [GO:0034703]; cholinergic synapse [GO:0098981]; ciliary basal body [GO:0036064]; cytosol [GO:0005829]; dendrite [GO:0030425]; dopaminergic synapse [GO:0098691]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; neurotransmitter receptor complex [GO:0098878]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic specialization membrane [GO:0099634]; presynapse [GO:0098793]; protein-containing complex [GO:0032991]; synapse [GO:0045202] acetylcholine binding [GO:0042166]; acetylcholine receptor activity [GO:0015464]; acetylcholine-gated monoatomic cation-selective channel activity [GO:0022848]; heterocyclic compound binding [GO:1901363]; metal ion binding [GO:0046872]; protein-containing complex binding [GO:0044877]; transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315] g13497.t2 P04757 35.484 434 3.82e-72 238.0 sp|P04757|ACHA3_RAT Neuronal acetylcholine receptor subunit alpha-3 OS=Rattus norvegicus OX=10116 GN=Chrna3 PE=1 SV=1 ACHA3_RAT reviewed Neuronal acetylcholine receptor subunit alpha-3 Rattus norvegicus (Rat) GO:0005730; GO:0005783; GO:0005794; GO:0005829; GO:0005886; GO:0005892; GO:0006937; GO:0006940; GO:0007165; GO:0007271; GO:0007274; GO:0007399; GO:0007507; GO:0007626; GO:0009410; GO:0014056; GO:0015464; GO:0016607; GO:0022848; GO:0030425; GO:0032991; GO:0034220; GO:0034465; GO:0034703; GO:0035094; GO:0035095; GO:0036064; GO:0042166; GO:0042391; GO:0043005; GO:0043025; GO:0044853; GO:0044877; GO:0045202; GO:0046872; GO:0048814; GO:0051899; GO:0060079; GO:0060084; GO:0095500; GO:0098691; GO:0098793; GO:0098878; GO:0098981; GO:0099171; GO:0099634; GO:1901363; GO:1904315; GO:1905144 acetylcholine receptor signaling pathway [GO:0095500]; behavioral response to nicotine [GO:0035095]; excitatory postsynaptic potential [GO:0060079]; heart development [GO:0007507]; locomotory behavior [GO:0007626]; membrane depolarization [GO:0051899]; monoatomic ion transmembrane transport [GO:0034220]; nervous system development [GO:0007399]; neuromuscular synaptic transmission [GO:0007274]; presynaptic modulation of chemical synaptic transmission [GO:0099171]; regulation of acetylcholine secretion, neurotransmission [GO:0014056]; regulation of dendrite morphogenesis [GO:0048814]; regulation of membrane potential [GO:0042391]; regulation of muscle contraction [GO:0006937]; regulation of smooth muscle contraction [GO:0006940]; response to acetylcholine [GO:1905144]; response to carbon monoxide [GO:0034465]; response to nicotine [GO:0035094]; response to xenobiotic stimulus [GO:0009410]; signal transduction [GO:0007165]; synaptic transmission involved in micturition [GO:0060084]; synaptic transmission, cholinergic [GO:0007271] acetylcholine-gated channel complex [GO:0005892]; cation channel complex [GO:0034703]; cholinergic synapse [GO:0098981]; ciliary basal body [GO:0036064]; cytosol [GO:0005829]; dendrite [GO:0030425]; dopaminergic synapse [GO:0098691]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; neurotransmitter receptor complex [GO:0098878]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic specialization membrane [GO:0099634]; presynapse [GO:0098793]; protein-containing complex [GO:0032991]; synapse [GO:0045202] acetylcholine binding [GO:0042166]; acetylcholine receptor activity [GO:0015464]; acetylcholine-gated monoatomic cation-selective channel activity [GO:0022848]; heterocyclic compound binding [GO:1901363]; metal ion binding [GO:0046872]; protein-containing complex binding [GO:0044877]; transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315] g13498.t1 Q9I8C7 35.233 386 2.09e-64 219.0 sp|Q9I8C7|ACH10_CHICK Neuronal acetylcholine receptor subunit alpha-10 OS=Gallus gallus OX=9031 GN=CHRNA10 PE=3 SV=1 ACH10_CHICK reviewed Neuronal acetylcholine receptor subunit alpha-10 (Alpha 10 nAChR) (Nicotinic acetylcholine receptor subunit alpha-10) (NACHR alpha-10) Gallus gallus (Chicken) GO:0005231; GO:0005262; GO:0005886; GO:0005892; GO:0007268; GO:0022848; GO:0022850; GO:0034220; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0050910; GO:1902495; GO:1904315 chemical synaptic transmission [GO:0007268]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; monoatomic ion transmembrane transport [GO:0034220]; regulation of membrane potential [GO:0042391] acetylcholine-gated channel complex [GO:0005892]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; transmembrane transporter complex [GO:1902495] acetylcholine-gated monoatomic cation-selective channel activity [GO:0022848]; calcium channel activity [GO:0005262]; excitatory extracellular ligand-gated monoatomic ion channel activity [GO:0005231]; serotonin-gated monoatomic cation channel activity [GO:0022850]; transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315] g13499.t1 P13360 82.222 135 6.68e-74 248.0 sp|P13360|GLAS_DROME Protein glass OS=Drosophila melanogaster OX=7227 GN=gl PE=1 SV=2 GLAS_DROME reviewed Protein glass Drosophila melanogaster (Fruit fly) GO:0000978; GO:0000981; GO:0001745; GO:0001751; GO:0001752; GO:0003677; GO:0005634; GO:0006355; GO:0006357; GO:0007601; GO:0007605; GO:0008270; GO:0009649; GO:0010114; GO:0035271; GO:0043153; GO:0045466; GO:0045944; GO:0046530; GO:0048052; GO:0060086 circadian temperature homeostasis [GO:0060086]; compound eye morphogenesis [GO:0001745]; compound eye photoreceptor cell differentiation [GO:0001751]; compound eye photoreceptor fate commitment [GO:0001752]; entrainment of circadian clock [GO:0009649]; entrainment of circadian clock by photoperiod [GO:0043153]; photoreceptor cell differentiation [GO:0046530]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R7 cell differentiation [GO:0045466]; regulation of DNA-templated transcription [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; response to red light [GO:0010114]; ring gland development [GO:0035271]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601] nucleus [GO:0005634] DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270] g13502.t1 Q9W6S5 50.773 388 8.729999999999999e-147 424.0 sp|Q9W6S5|ALLC_XENLA Allantoicase OS=Xenopus laevis OX=8355 GN=allc PE=2 SV=1 g13503.t1 A2RSY1 58.205 390 3.55e-139 423.0 sp|A2RSY1|KANL3_MOUSE KAT8 regulatory NSL complex subunit 3 OS=Mus musculus OX=10090 GN=Kansl3 PE=1 SV=1 KANL3_MOUSE reviewed KAT8 regulatory NSL complex subunit 3 (NSL complex protein NSL3) (Non-specific lethal 3 homolog) Mus musculus (Mouse) GO:0000123; GO:0000922; GO:0005654; GO:0005739; GO:0005874; GO:0006325; GO:0044545; GO:0045893; GO:0045944; GO:1903108 chromatin organization [GO:0006325]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of mitochondrial transcription [GO:1903108] histone acetyltransferase complex [GO:0000123]; microtubule [GO:0005874]; mitochondrion [GO:0005739]; NSL complex [GO:0044545]; nucleoplasm [GO:0005654]; spindle pole [GO:0000922] g13505.t1 D2CLZ9 61.29 124 5.810000000000001e-43 153.0 sp|D2CLZ9|ATOH8_DANRE Transcription factor atoh8 OS=Danio rerio OX=7955 GN=atoh8 PE=2 SV=1 ATOH8_DANRE reviewed Transcription factor atoh8 (Atonal bHLH transcription factor 8) (Protein atonal homolog 8) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001947; GO:0003700; GO:0005634; GO:0005737; GO:0007399; GO:0007507; GO:0009653; GO:0016607; GO:0030154; GO:0045944; GO:0046983; GO:0048797; GO:0061074; GO:0070888; GO:2001014 anatomical structure morphogenesis [GO:0009653]; cell differentiation [GO:0030154]; heart development [GO:0007507]; heart looping [GO:0001947]; nervous system development [GO:0007399]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of neural retina development [GO:0061074]; regulation of skeletal muscle cell differentiation [GO:2001014]; swim bladder formation [GO:0048797] cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634] DNA-binding transcription factor activity [GO:0003700]; E-box binding [GO:0070888]; protein dimerization activity [GO:0046983] g13506.t1 P80146 45.288 382 1.56e-98 302.0 sp|P80146|SEPR_THESR Extracellular serine proteinase OS=Thermus sp. (strain Rt41A) OX=32063 PE=1 SV=3 g22396.t1 Q66I21 59.751 482 0.0 637.0 sp|Q66I21|AL8A1_DANRE 2-aminomuconic semialdehyde dehydrogenase OS=Danio rerio OX=7955 GN=aldh8a1 PE=2 SV=1 g22398.t1 Q8L7C8 41.839 435 1.84e-108 339.0 sp|Q8L7C8|RWA1_ARATH Protein REDUCED WALL ACETYLATION 1 OS=Arabidopsis thaliana OX=3702 GN=RWA1 PE=2 SV=1 RWA1_ARATH reviewed Protein REDUCED WALL ACETYLATION 1 (EC 2.3.1.-) Arabidopsis thaliana (Mouse-ear cress) GO:0000139; GO:0005794; GO:0009834; GO:0010411; GO:0016407; GO:0016491; GO:0045491; GO:0045492 plant-type secondary cell wall biogenesis [GO:0009834]; xylan biosynthetic process [GO:0045492]; xylan metabolic process [GO:0045491]; xyloglucan metabolic process [GO:0010411] Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139] acetyltransferase activity [GO:0016407]; oxidoreductase activity [GO:0016491] g22399.t1 O95071 64.444 450 1.19e-171 538.0 sp|O95071|UBR5_HUMAN E3 ubiquitin-protein ligase UBR5 OS=Homo sapiens OX=9606 GN=UBR5 PE=1 SV=2 g22399.t2 O95071 60.291 481 9.3e-166 522.0 sp|O95071|UBR5_HUMAN E3 ubiquitin-protein ligase UBR5 OS=Homo sapiens OX=9606 GN=UBR5 PE=1 SV=2 g22399.t3 O95071 60.291 481 9.3e-166 522.0 sp|O95071|UBR5_HUMAN E3 ubiquitin-protein ligase UBR5 OS=Homo sapiens OX=9606 GN=UBR5 PE=1 SV=2 g22400.t1 Q80TP3 46.526 1612 0.0 1072.0 sp|Q80TP3|UBR5_MOUSE E3 ubiquitin-protein ligase UBR5 OS=Mus musculus OX=10090 GN=Ubr5 PE=1 SV=2 UBR5_MOUSE reviewed E3 ubiquitin-protein ligase UBR5 (EC 2.3.2.26) (E3 ubiquitin-protein ligase, HECT domain-containing 1) (Hyperplastic discs protein homolog) Mus musculus (Mouse) GO:0000209; GO:0000785; GO:0003723; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006281; GO:0006974; GO:0006979; GO:0008270; GO:0010498; GO:0010628; GO:0016567; GO:0019904; GO:0030520; GO:0031647; GO:0032700; GO:0032991; GO:0033696; GO:0034450; GO:0035519; GO:0042307; GO:0043130; GO:0043161; GO:0045879; GO:0048384; GO:0048471; GO:0050847; GO:0061630; GO:0070561; GO:0070936; GO:0070979; GO:0071596; GO:0071629; GO:0071630; GO:0090263; GO:0140455; GO:0140861; GO:0141198 cytoplasm protein quality control [GO:0140455]; cytoplasm protein quality control by the ubiquitin-proteasome system [GO:0071629]; DNA damage response [GO:0006974]; DNA repair [GO:0006281]; DNA repair-dependent chromatin remodeling [GO:0140861]; estrogen receptor signaling pathway [GO:0030520]; heterochromatin boundary formation [GO:0033696]; negative regulation of interleukin-17 production [GO:0032700]; negative regulation of smoothened signaling pathway [GO:0045879]; nuclear protein quality control by the ubiquitin-proteasome system [GO:0071630]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of gene expression [GO:0010628]; positive regulation of protein import into nucleus [GO:0042307]; progesterone receptor signaling pathway [GO:0050847]; proteasomal protein catabolic process [GO:0010498]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein branched polyubiquitination [GO:0141198]; protein K11-linked ubiquitination [GO:0070979]; protein K29-linked ubiquitination [GO:0035519]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of protein stability [GO:0031647]; response to oxidative stress [GO:0006979]; retinoic acid receptor signaling pathway [GO:0048384]; ubiquitin-dependent protein catabolic process via the N-end rule pathway [GO:0071596]; vitamin D receptor signaling pathway [GO:0070561] chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991] protein domain specific binding [GO:0019904]; RNA binding [GO:0003723]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-ubiquitin ligase activity [GO:0034450]; zinc ion binding [GO:0008270] g22400.t1 Q80TP3 43.468 421 3.21e-67 258.0 sp|Q80TP3|UBR5_MOUSE E3 ubiquitin-protein ligase UBR5 OS=Mus musculus OX=10090 GN=Ubr5 PE=1 SV=2 UBR5_MOUSE reviewed E3 ubiquitin-protein ligase UBR5 (EC 2.3.2.26) (E3 ubiquitin-protein ligase, HECT domain-containing 1) (Hyperplastic discs protein homolog) Mus musculus (Mouse) GO:0000209; GO:0000785; GO:0003723; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006281; GO:0006974; GO:0006979; GO:0008270; GO:0010498; GO:0010628; GO:0016567; GO:0019904; GO:0030520; GO:0031647; GO:0032700; GO:0032991; GO:0033696; GO:0034450; GO:0035519; GO:0042307; GO:0043130; GO:0043161; GO:0045879; GO:0048384; GO:0048471; GO:0050847; GO:0061630; GO:0070561; GO:0070936; GO:0070979; GO:0071596; GO:0071629; GO:0071630; GO:0090263; GO:0140455; GO:0140861; GO:0141198 cytoplasm protein quality control [GO:0140455]; cytoplasm protein quality control by the ubiquitin-proteasome system [GO:0071629]; DNA damage response [GO:0006974]; DNA repair [GO:0006281]; DNA repair-dependent chromatin remodeling [GO:0140861]; estrogen receptor signaling pathway [GO:0030520]; heterochromatin boundary formation [GO:0033696]; negative regulation of interleukin-17 production [GO:0032700]; negative regulation of smoothened signaling pathway [GO:0045879]; nuclear protein quality control by the ubiquitin-proteasome system [GO:0071630]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of gene expression [GO:0010628]; positive regulation of protein import into nucleus [GO:0042307]; progesterone receptor signaling pathway [GO:0050847]; proteasomal protein catabolic process [GO:0010498]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein branched polyubiquitination [GO:0141198]; protein K11-linked ubiquitination [GO:0070979]; protein K29-linked ubiquitination [GO:0035519]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of protein stability [GO:0031647]; response to oxidative stress [GO:0006979]; retinoic acid receptor signaling pathway [GO:0048384]; ubiquitin-dependent protein catabolic process via the N-end rule pathway [GO:0071596]; vitamin D receptor signaling pathway [GO:0070561] chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991] protein domain specific binding [GO:0019904]; RNA binding [GO:0003723]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-ubiquitin ligase activity [GO:0034450]; zinc ion binding [GO:0008270] g22401.t1 E1BD59 28.879 232 9.939999999999999e-24 106.0 sp|E1BD59|TRI56_BOVIN E3 ubiquitin-protein ligase TRIM56 OS=Bos taurus OX=9913 GN=TRIM56 PE=2 SV=1 TRI56_BOVIN reviewed E3 ubiquitin-protein ligase TRIM56 (EC 2.3.2.27) (Tripartite motif-containing protein 56) Bos taurus (Bovine) GO:0005654; GO:0005737; GO:0006513; GO:0008270; GO:0032728; GO:0034340; GO:0045087; GO:0051607; GO:0060340; GO:0061630; GO:0070534 defense response to virus [GO:0051607]; innate immune response [GO:0045087]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of type I interferon-mediated signaling pathway [GO:0060340]; protein K63-linked ubiquitination [GO:0070534]; protein monoubiquitination [GO:0006513]; response to type I interferon [GO:0034340] cytoplasm [GO:0005737]; nucleoplasm [GO:0005654] ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] g22402.t1 Q80VI1 26.774 310 2.8700000000000003e-21 98.6 sp|Q80VI1|TRI56_MOUSE E3 ubiquitin-protein ligase TRIM56 OS=Mus musculus OX=10090 GN=Trim56 PE=1 SV=1 TRI56_MOUSE reviewed E3 ubiquitin-protein ligase TRIM56 (EC 2.3.2.27) (Tripartite motif-containing protein 56) Mus musculus (Mouse) GO:0005654; GO:0005737; GO:0006513; GO:0008270; GO:0032728; GO:0034340; GO:0044790; GO:0045087; GO:0045089; GO:0046597; GO:0051607; GO:0060340; GO:0061630; GO:0070534; GO:0140896; GO:1901224 cGAS/STING signaling pathway [GO:0140896]; defense response to virus [GO:0051607]; host-mediated suppression of symbiont invasion [GO:0046597]; innate immune response [GO:0045087]; positive regulation of innate immune response [GO:0045089]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of non-canonical NF-kappaB signal transduction [GO:1901224]; positive regulation of type I interferon-mediated signaling pathway [GO:0060340]; protein K63-linked ubiquitination [GO:0070534]; protein monoubiquitination [GO:0006513]; response to type I interferon [GO:0034340]; suppression of viral release by host [GO:0044790] cytoplasm [GO:0005737]; nucleoplasm [GO:0005654] ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] g22405.t1 Q9VQX4 62.36 534 0.0 680.0 sp|Q9VQX4|PNCB_DROME Nicotinate phosphoribosyltransferase OS=Drosophila melanogaster OX=7227 GN=Naprt PE=2 SV=2 g22406.t1 Q62941 44.025 318 2.4600000000000002e-88 273.0 sp|Q62941|ZNT2_RAT Proton-coupled zinc antiporter SLC30A2 OS=Rattus norvegicus OX=10116 GN=Slc30a2 PE=1 SV=1 ZNT2_RAT reviewed Proton-coupled zinc antiporter SLC30A2 (Solute carrier family 30 member 2) (Zinc transporter 2) (ZnT-2) Rattus norvegicus (Rat) GO:0005385; GO:0005737; GO:0005743; GO:0005765; GO:0005770; GO:0005886; GO:0006829; GO:0006882; GO:0010008; GO:0010043; GO:0030658; GO:0042589; GO:0042802; GO:0046872; GO:0062111; GO:0071577; GO:0099503; GO:0140826; GO:0140882; GO:0140914; GO:0140915; GO:0140916; GO:0140917 intracellular zinc ion homeostasis [GO:0006882]; response to zinc ion [GO:0010043]; zinc export across plasma membrane [GO:0140882]; zinc ion import into lysosome [GO:0140916]; zinc ion import into mitochondrion [GO:0140917]; zinc ion import into organelle [GO:0062111]; zinc ion import into secretory vesicle [GO:0140914]; zinc ion import into zymogen granule [GO:0140915]; zinc ion transmembrane transport [GO:0071577]; zinc ion transport [GO:0006829] cytoplasm [GO:0005737]; endosome membrane [GO:0010008]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; mitochondrial inner membrane [GO:0005743]; plasma membrane [GO:0005886]; secretory vesicle [GO:0099503]; transport vesicle membrane [GO:0030658]; zymogen granule membrane [GO:0042589] identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; zinc ion transmembrane transporter activity [GO:0005385]; zinc:proton antiporter activity [GO:0140826] g22409.t1 P14314 42.593 162 1.7099999999999998e-23 103.0 sp|P14314|GLU2B_HUMAN Glucosidase 2 subunit beta OS=Homo sapiens OX=9606 GN=PRKCSH PE=1 SV=2 GLU2B_HUMAN reviewed Glucosidase 2 subunit beta (80K-H protein) (Glucosidase II subunit beta) (Protein kinase C substrate 60.1 kDa protein heavy chain) (PKCSH) Homo sapiens (Human) GO:0001889; GO:0005080; GO:0005509; GO:0005783; GO:0005788; GO:0006491; GO:0017177; GO:0035556; GO:0043231; GO:0044325; GO:0051219 intracellular signal transduction [GO:0035556]; liver development [GO:0001889]; N-glycan processing [GO:0006491] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; glucosidase II complex [GO:0017177]; intracellular membrane-bounded organelle [GO:0043231] calcium ion binding [GO:0005509]; phosphoprotein binding [GO:0051219]; protein kinase C binding [GO:0005080]; transmembrane transporter binding [GO:0044325] g22410.t1 Q9NV58 56.314 586 2.86e-176 530.0 sp|Q9NV58|RN19A_HUMAN E3 ubiquitin-protein ligase RNF19A OS=Homo sapiens OX=9606 GN=RNF19A PE=1 SV=3 g22411.t1 Q3USS3 45.443 779 0.0 588.0 sp|Q3USS3|DRC1_MOUSE Dynein regulatory complex protein 1 OS=Mus musculus OX=10090 GN=Drc1 PE=1 SV=1 DRC1_MOUSE reviewed Dynein regulatory complex protein 1 (Coiled-coil domain-containing protein 164) Mus musculus (Mouse) GO:0003352; GO:0005829; GO:0005858; GO:0005929; GO:0005930; GO:0007338; GO:0007368; GO:0007507; GO:0035082; GO:0036126; GO:0044782; GO:0060285; GO:0065003; GO:0070286; GO:0120316 axonemal dynein complex assembly [GO:0070286]; axoneme assembly [GO:0035082]; cilium organization [GO:0044782]; cilium-dependent cell motility [GO:0060285]; determination of left/right symmetry [GO:0007368]; heart development [GO:0007507]; protein-containing complex assembly [GO:0065003]; regulation of cilium movement [GO:0003352]; single fertilization [GO:0007338]; sperm flagellum assembly [GO:0120316] axonemal dynein complex [GO:0005858]; axoneme [GO:0005930]; cilium [GO:0005929]; cytosol [GO:0005829]; sperm flagellum [GO:0036126] g22412.t1 P62914 86.932 176 6.450000000000001e-103 296.0 sp|P62914|RL11_RAT Large ribosomal subunit protein uL5 OS=Rattus norvegicus OX=10116 GN=Rpl11 PE=1 SV=2 RL11_RAT reviewed Large ribosomal subunit protein uL5 (60S ribosomal protein L11) Rattus norvegicus (Rat) GO:0000027; GO:0002181; GO:0003723; GO:0003735; GO:0005654; GO:0005730; GO:0005737; GO:0005840; GO:0006364; GO:0006412; GO:0006605; GO:0008097; GO:0010628; GO:0015934; GO:0022625; GO:0022626; GO:0031625; GO:0032435; GO:0032991; GO:0034504; GO:0042273; GO:0042975; GO:0045202; GO:0050821; GO:0098556; GO:0098793; GO:0098794; GO:0140236; GO:0140242; GO:1901796; GO:1901798; GO:1990948; GO:2000059; GO:2000435 cytoplasmic translation [GO:0002181]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of protein neddylation [GO:2000435]; negative regulation of ubiquitin-dependent protein catabolic process [GO:2000059]; positive regulation of gene expression [GO:0010628]; positive regulation of signal transduction by p53 class mediator [GO:1901798]; protein localization to nucleus [GO:0034504]; protein stabilization [GO:0050821]; protein targeting [GO:0006605]; regulation of signal transduction by p53 class mediator [GO:1901796]; ribosomal large subunit assembly [GO:0000027]; ribosomal large subunit biogenesis [GO:0042273]; rRNA processing [GO:0006364]; translation [GO:0006412]; translation at postsynapse [GO:0140242]; translation at presynapse [GO:0140236] cytoplasm [GO:0005737]; cytoplasmic side of rough endoplasmic reticulum membrane [GO:0098556]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; large ribosomal subunit [GO:0015934]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; postsynapse [GO:0098794]; presynapse [GO:0098793]; protein-containing complex [GO:0032991]; ribosome [GO:0005840]; synapse [GO:0045202] 5S rRNA binding [GO:0008097]; peroxisome proliferator activated receptor binding [GO:0042975]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; ubiquitin ligase inhibitor activity [GO:1990948]; ubiquitin protein ligase binding [GO:0031625] g22413.t1 Q8IWA6 26.84 462 3.01e-29 127.0 sp|Q8IWA6|CCD60_HUMAN Coiled-coil domain-containing protein 60 OS=Homo sapiens OX=9606 GN=CCDC60 PE=1 SV=2 g22414.t1 Q5R616 75.472 636 0.0 996.0 sp|Q5R616|SDHA_PONAB Succinate dehydrogenase [ubiquinone] flavoprotein subunit, mitochondrial OS=Pongo abelii OX=9601 GN=SDHA PE=2 SV=1 SDHA_PONAB reviewed Succinate dehydrogenase [ubiquinone] flavoprotein subunit, mitochondrial (EC 1.3.5.1) (Flavoprotein subunit of complex II) (Fp) (Malate dehydrogenase [quinone] flavoprotein subunit) (EC 1.1.5.-) Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0005739; GO:0005743; GO:0006099; GO:0006105; GO:0006121; GO:0008177; GO:0009055; GO:0022904; GO:0045273; GO:0050660 mitochondrial electron transport, succinate to ubiquinone [GO:0006121]; respiratory electron transport chain [GO:0022904]; succinate metabolic process [GO:0006105]; tricarboxylic acid cycle [GO:0006099] mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; respiratory chain complex II (succinate dehydrogenase) [GO:0045273] electron transfer activity [GO:0009055]; flavin adenine dinucleotide binding [GO:0050660]; succinate dehydrogenase (quinone) activity [GO:0008177] g22417.t1 Q8BK06 44.865 370 3.7099999999999995e-108 334.0 sp|Q8BK06|FBX9_MOUSE F-box only protein 9 OS=Mus musculus OX=10090 GN=Fbxo9 PE=1 SV=1 FBX9_MOUSE reviewed F-box only protein 9 Mus musculus (Mouse) GO:0005737; GO:0006915; GO:0016567; GO:0019005; GO:0031146; GO:0032006; GO:0043161; GO:0045087; GO:0045444; GO:0070936; GO:1904037; GO:1990756 apoptotic process [GO:0006915]; fat cell differentiation [GO:0045444]; innate immune response [GO:0045087]; positive regulation of epithelial cell apoptotic process [GO:1904037]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K48-linked ubiquitination [GO:0070936]; protein ubiquitination [GO:0016567]; regulation of TOR signaling [GO:0032006]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146] cytoplasm [GO:0005737]; SCF ubiquitin ligase complex [GO:0019005] ubiquitin-like ligase-substrate adaptor activity [GO:1990756] g22420.t1 Q96JE9 25.446 224 2e-23 103.0 sp|Q96JE9|MAP6_HUMAN Microtubule-associated protein 6 OS=Homo sapiens OX=9606 GN=MAP6 PE=1 SV=2 MAP6_HUMAN reviewed Microtubule-associated protein 6 (MAP-6) (Stable tubule-only polypeptide) (STOP) Homo sapiens (Human) GO:0000226; GO:0005516; GO:0005798; GO:0005801; GO:0005874; GO:0008017; GO:0030424; GO:0030425; GO:0030658; GO:0030705; GO:0032418; GO:0048471; GO:0048813; GO:0050772; GO:0070507 cytoskeleton-dependent intracellular transport [GO:0030705]; dendrite morphogenesis [GO:0048813]; lysosome localization [GO:0032418]; microtubule cytoskeleton organization [GO:0000226]; positive regulation of axonogenesis [GO:0050772]; regulation of microtubule cytoskeleton organization [GO:0070507] axon [GO:0030424]; cis-Golgi network [GO:0005801]; dendrite [GO:0030425]; Golgi-associated vesicle [GO:0005798]; microtubule [GO:0005874]; perinuclear region of cytoplasm [GO:0048471]; transport vesicle membrane [GO:0030658] calmodulin binding [GO:0005516]; microtubule binding [GO:0008017] g22420.t1 Q96JE9 24.885 217 7.85e-22 99.4 sp|Q96JE9|MAP6_HUMAN Microtubule-associated protein 6 OS=Homo sapiens OX=9606 GN=MAP6 PE=1 SV=2 MAP6_HUMAN reviewed Microtubule-associated protein 6 (MAP-6) (Stable tubule-only polypeptide) (STOP) Homo sapiens (Human) GO:0000226; GO:0005516; GO:0005798; GO:0005801; GO:0005874; GO:0008017; GO:0030424; GO:0030425; GO:0030658; GO:0030705; GO:0032418; GO:0048471; GO:0048813; GO:0050772; GO:0070507 cytoskeleton-dependent intracellular transport [GO:0030705]; dendrite morphogenesis [GO:0048813]; lysosome localization [GO:0032418]; microtubule cytoskeleton organization [GO:0000226]; positive regulation of axonogenesis [GO:0050772]; regulation of microtubule cytoskeleton organization [GO:0070507] axon [GO:0030424]; cis-Golgi network [GO:0005801]; dendrite [GO:0030425]; Golgi-associated vesicle [GO:0005798]; microtubule [GO:0005874]; perinuclear region of cytoplasm [GO:0048471]; transport vesicle membrane [GO:0030658] calmodulin binding [GO:0005516]; microtubule binding [GO:0008017] g22421.t1 P07687 50.926 432 1.25e-149 437.0 sp|P07687|HYEP_RAT Epoxide hydrolase 1 OS=Rattus norvegicus OX=10116 GN=Ephx1 PE=1 SV=1 HYEP_RAT reviewed Epoxide hydrolase 1 (EC 3.3.2.9) (Epoxide hydratase) (Microsomal epoxide hydrolase) (mEH) Rattus norvegicus (Rat) GO:0001889; GO:0004301; GO:0005789; GO:0008142; GO:0009636; GO:0016020; GO:0019369; GO:0019899; GO:0033961; GO:0034312; GO:0043231; GO:0071385; GO:0097176; GO:0120253 arachidonate metabolic process [GO:0019369]; cellular response to glucocorticoid stimulus [GO:0071385]; diol biosynthetic process [GO:0034312]; epoxide metabolic process [GO:0097176]; hydrocarbon catabolic process [GO:0120253]; liver development [GO:0001889]; response to toxic substance [GO:0009636] endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020] cis-stilbene-oxide hydrolase activity [GO:0033961]; enzyme binding [GO:0019899]; epoxide hydrolase activity [GO:0004301]; oxysterol binding [GO:0008142] g22422.t1 P07687 51.869 428 1.77e-150 439.0 sp|P07687|HYEP_RAT Epoxide hydrolase 1 OS=Rattus norvegicus OX=10116 GN=Ephx1 PE=1 SV=1 HYEP_RAT reviewed Epoxide hydrolase 1 (EC 3.3.2.9) (Epoxide hydratase) (Microsomal epoxide hydrolase) (mEH) Rattus norvegicus (Rat) GO:0001889; GO:0004301; GO:0005789; GO:0008142; GO:0009636; GO:0016020; GO:0019369; GO:0019899; GO:0033961; GO:0034312; GO:0043231; GO:0071385; GO:0097176; GO:0120253 arachidonate metabolic process [GO:0019369]; cellular response to glucocorticoid stimulus [GO:0071385]; diol biosynthetic process [GO:0034312]; epoxide metabolic process [GO:0097176]; hydrocarbon catabolic process [GO:0120253]; liver development [GO:0001889]; response to toxic substance [GO:0009636] endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020] cis-stilbene-oxide hydrolase activity [GO:0033961]; enzyme binding [GO:0019899]; epoxide hydrolase activity [GO:0004301]; oxysterol binding [GO:0008142] g22423.t1 C1AED7 38.989 277 1.0800000000000001e-57 196.0 sp|C1AED7|SELO_GEMAT Protein nucleotidyltransferase YdiU OS=Gemmatimonas aurantiaca (strain DSM 14586 / JCM 11422 / NBRC 100505 / T-27) OX=379066 GN=ydiU PE=3 SV=1 SELO_GEMAT reviewed Protein nucleotidyltransferase YdiU (EC 2.7.7.-) (Protein adenylyltransferase YdiU) (EC 2.7.7.108) (Protein uridylyltransferase YdiU) (EC 2.7.7.-) Gemmatimonas aurantiaca (strain DSM 14586 / JCM 11422 / NBRC 100505 / T-27) GO:0000287; GO:0005524; GO:0030145; GO:0070733 AMPylase activity [GO:0070733]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145] g22424.t1 P07099 51.333 150 1.45e-37 137.0 sp|P07099|HYEP_HUMAN Epoxide hydrolase 1 OS=Homo sapiens OX=9606 GN=EPHX1 PE=1 SV=1 HYEP_HUMAN reviewed Epoxide hydrolase 1 (EC 3.3.2.9) (Epoxide hydratase) (Microsomal epoxide hydrolase) (mEH) Homo sapiens (Human) GO:0004301; GO:0005789; GO:0006805; GO:0008142; GO:0009636; GO:0019369; GO:0033961; GO:0097176; GO:0120253 arachidonate metabolic process [GO:0019369]; epoxide metabolic process [GO:0097176]; hydrocarbon catabolic process [GO:0120253]; response to toxic substance [GO:0009636]; xenobiotic metabolic process [GO:0006805] endoplasmic reticulum membrane [GO:0005789] cis-stilbene-oxide hydrolase activity [GO:0033961]; epoxide hydrolase activity [GO:0004301]; oxysterol binding [GO:0008142] g22425.t1 P07687 55.462 238 4.66e-99 300.0 sp|P07687|HYEP_RAT Epoxide hydrolase 1 OS=Rattus norvegicus OX=10116 GN=Ephx1 PE=1 SV=1 HYEP_RAT reviewed Epoxide hydrolase 1 (EC 3.3.2.9) (Epoxide hydratase) (Microsomal epoxide hydrolase) (mEH) Rattus norvegicus (Rat) GO:0001889; GO:0004301; GO:0005789; GO:0008142; GO:0009636; GO:0016020; GO:0019369; GO:0019899; GO:0033961; GO:0034312; GO:0043231; GO:0071385; GO:0097176; GO:0120253 arachidonate metabolic process [GO:0019369]; cellular response to glucocorticoid stimulus [GO:0071385]; diol biosynthetic process [GO:0034312]; epoxide metabolic process [GO:0097176]; hydrocarbon catabolic process [GO:0120253]; liver development [GO:0001889]; response to toxic substance [GO:0009636] endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020] cis-stilbene-oxide hydrolase activity [GO:0033961]; enzyme binding [GO:0019899]; epoxide hydrolase activity [GO:0004301]; oxysterol binding [GO:0008142] g22434.t1 D4A9K4 34.515 423 6.340000000000001e-59 205.0 sp|D4A9K4|S18B1_RAT MFS-type transporter SLC18B1 OS=Rattus norvegicus OX=10116 GN=Slc18b1 PE=1 SV=3 S18B1_RAT reviewed MFS-type transporter SLC18B1 (Solute carrier family 18 member B1) (Vesicular polyamine transporter) (VPAT) Rattus norvegicus (Rat) GO:0000296; GO:0015311; GO:0015312; GO:0015848; GO:0022857; GO:0030667; GO:0030672; GO:0051610 serotonin uptake [GO:0051610]; spermidine transport [GO:0015848]; spermine transport [GO:0000296] secretory granule membrane [GO:0030667]; synaptic vesicle membrane [GO:0030672] monoamine:proton antiporter activity [GO:0015311]; polyamine:proton antiporter activity [GO:0015312]; transmembrane transporter activity [GO:0022857] g22435.t1 Q15637 62.682 343 3.2899999999999996e-134 414.0 sp|Q15637|SF01_HUMAN Splicing factor 1 OS=Homo sapiens OX=9606 GN=SF1 PE=1 SV=4 SF01_HUMAN reviewed Splicing factor 1 (Mammalian branch point-binding protein) (BBP) (mBBP) (Transcription factor ZFM1) (Zinc finger gene in MEN1 locus) (Zinc finger protein 162) Homo sapiens (Human) GO:0000245; GO:0000389; GO:0000398; GO:0003714; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0005681; GO:0005840; GO:0008270; GO:0042802; GO:0045292; GO:0048662; GO:0089701 mRNA 3'-splice site recognition [GO:0000389]; mRNA cis splicing, via spliceosome [GO:0045292]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of smooth muscle cell proliferation [GO:0048662]; spliceosomal complex assembly [GO:0000245] nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribosome [GO:0005840]; spliceosomal complex [GO:0005681]; U2AF complex [GO:0089701] identical protein binding [GO:0042802]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; transcription corepressor activity [GO:0003714]; zinc ion binding [GO:0008270] g22435.t2 Q15637 62.682 343 1.7399999999999999e-134 414.0 sp|Q15637|SF01_HUMAN Splicing factor 1 OS=Homo sapiens OX=9606 GN=SF1 PE=1 SV=4 SF01_HUMAN reviewed Splicing factor 1 (Mammalian branch point-binding protein) (BBP) (mBBP) (Transcription factor ZFM1) (Zinc finger gene in MEN1 locus) (Zinc finger protein 162) Homo sapiens (Human) GO:0000245; GO:0000389; GO:0000398; GO:0003714; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0005681; GO:0005840; GO:0008270; GO:0042802; GO:0045292; GO:0048662; GO:0089701 mRNA 3'-splice site recognition [GO:0000389]; mRNA cis splicing, via spliceosome [GO:0045292]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of smooth muscle cell proliferation [GO:0048662]; spliceosomal complex assembly [GO:0000245] nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribosome [GO:0005840]; spliceosomal complex [GO:0005681]; U2AF complex [GO:0089701] identical protein binding [GO:0042802]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; transcription corepressor activity [GO:0003714]; zinc ion binding [GO:0008270] g22436.t1 D4A9K4 35.351 413 5.07e-64 218.0 sp|D4A9K4|S18B1_RAT MFS-type transporter SLC18B1 OS=Rattus norvegicus OX=10116 GN=Slc18b1 PE=1 SV=3 S18B1_RAT reviewed MFS-type transporter SLC18B1 (Solute carrier family 18 member B1) (Vesicular polyamine transporter) (VPAT) Rattus norvegicus (Rat) GO:0000296; GO:0015311; GO:0015312; GO:0015848; GO:0022857; GO:0030667; GO:0030672; GO:0051610 serotonin uptake [GO:0051610]; spermidine transport [GO:0015848]; spermine transport [GO:0000296] secretory granule membrane [GO:0030667]; synaptic vesicle membrane [GO:0030672] monoamine:proton antiporter activity [GO:0015311]; polyamine:proton antiporter activity [GO:0015312]; transmembrane transporter activity [GO:0022857] g22442.t1 Q9NBX4 23.529 493 1.9799999999999998e-23 110.0 sp|Q9NBX4|RTXE_DROME Probable RNA-directed DNA polymerase from transposon X-element OS=Drosophila melanogaster OX=7227 GN=X-element\ORF2 PE=3 SV=1 g22444.t1 Q6NT16 38.539 397 1.7e-63 217.0 sp|Q6NT16|S18B1_HUMAN MFS-type transporter SLC18B1 OS=Homo sapiens OX=9606 GN=SLC18B1 PE=1 SV=1 S18B1_HUMAN reviewed MFS-type transporter SLC18B1 (Solute carrier family 18 member B1) (Vesicular polyamine transporter) (VPAT) Homo sapiens (Human) GO:0000296; GO:0015311; GO:0015312; GO:0015848; GO:0022857; GO:0030667; GO:0030672; GO:0051610 serotonin uptake [GO:0051610]; spermidine transport [GO:0015848]; spermine transport [GO:0000296] secretory granule membrane [GO:0030667]; synaptic vesicle membrane [GO:0030672] monoamine:proton antiporter activity [GO:0015311]; polyamine:proton antiporter activity [GO:0015312]; transmembrane transporter activity [GO:0022857] g22445.t1 A2RT67 31.226 1313 4.5e-177 566.0 sp|A2RT67|DEND3_MOUSE DENN domain-containing protein 3 OS=Mus musculus OX=10090 GN=Dennd3 PE=1 SV=2 DEND3_MOUSE reviewed DENN domain-containing protein 3 Mus musculus (Mouse) GO:0005085; GO:0008333; GO:0030163; GO:0031410; GO:0032483 endosome to lysosome transport [GO:0008333]; protein catabolic process [GO:0030163]; regulation of Rab protein signal transduction [GO:0032483] cytoplasmic vesicle [GO:0031410] guanyl-nucleotide exchange factor activity [GO:0005085] g22447.t1 Q5REN4 38.916 203 1.28e-34 132.0 sp|Q5REN4|ZN248_PONAB Zinc finger protein 248 OS=Pongo abelii OX=9601 GN=ZNF248 PE=2 SV=1 g22447.t1 Q5REN4 39.216 153 2.9099999999999996e-23 100.0 sp|Q5REN4|ZN248_PONAB Zinc finger protein 248 OS=Pongo abelii OX=9601 GN=ZNF248 PE=2 SV=1 g22449.t1 Q52M93 24.721 716 2.11e-55 208.0 sp|Q52M93|Z585B_HUMAN Zinc finger protein 585B OS=Homo sapiens OX=9606 GN=ZNF585B PE=1 SV=1 Z585B_HUMAN reviewed Zinc finger protein 585B (zinc finger protein 41-like protein) Homo sapiens (Human) GO:0005634; GO:0006357; GO:0008270; GO:0032502 developmental process [GO:0032502]; regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] zinc ion binding [GO:0008270] g22449.t1 Q52M93 37.818 275 3.7200000000000004e-43 171.0 sp|Q52M93|Z585B_HUMAN Zinc finger protein 585B OS=Homo sapiens OX=9606 GN=ZNF585B PE=1 SV=1 Z585B_HUMAN reviewed Zinc finger protein 585B (zinc finger protein 41-like protein) Homo sapiens (Human) GO:0005634; GO:0006357; GO:0008270; GO:0032502 developmental process [GO:0032502]; regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] zinc ion binding [GO:0008270] g22449.t1 Q52M93 36.434 258 3.76e-41 166.0 sp|Q52M93|Z585B_HUMAN Zinc finger protein 585B OS=Homo sapiens OX=9606 GN=ZNF585B PE=1 SV=1 Z585B_HUMAN reviewed Zinc finger protein 585B (zinc finger protein 41-like protein) Homo sapiens (Human) GO:0005634; GO:0006357; GO:0008270; GO:0032502 developmental process [GO:0032502]; regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] zinc ion binding [GO:0008270] g22449.t1 Q52M93 34.828 290 1.02e-39 161.0 sp|Q52M93|Z585B_HUMAN Zinc finger protein 585B OS=Homo sapiens OX=9606 GN=ZNF585B PE=1 SV=1 Z585B_HUMAN reviewed Zinc finger protein 585B (zinc finger protein 41-like protein) Homo sapiens (Human) GO:0005634; GO:0006357; GO:0008270; GO:0032502 developmental process [GO:0032502]; regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] zinc ion binding [GO:0008270] g22449.t1 Q52M93 32.197 264 9.020000000000001e-37 152.0 sp|Q52M93|Z585B_HUMAN Zinc finger protein 585B OS=Homo sapiens OX=9606 GN=ZNF585B PE=1 SV=1 Z585B_HUMAN reviewed Zinc finger protein 585B (zinc finger protein 41-like protein) Homo sapiens (Human) GO:0005634; GO:0006357; GO:0008270; GO:0032502 developmental process [GO:0032502]; regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] zinc ion binding [GO:0008270] g22449.t1 Q52M93 33.086 269 9.6e-34 142.0 sp|Q52M93|Z585B_HUMAN Zinc finger protein 585B OS=Homo sapiens OX=9606 GN=ZNF585B PE=1 SV=1 Z585B_HUMAN reviewed Zinc finger protein 585B (zinc finger protein 41-like protein) Homo sapiens (Human) GO:0005634; GO:0006357; GO:0008270; GO:0032502 developmental process [GO:0032502]; regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] zinc ion binding [GO:0008270] g22449.t1 Q52M93 32.53 249 7.87e-33 140.0 sp|Q52M93|Z585B_HUMAN Zinc finger protein 585B OS=Homo sapiens OX=9606 GN=ZNF585B PE=1 SV=1 Z585B_HUMAN reviewed Zinc finger protein 585B (zinc finger protein 41-like protein) Homo sapiens (Human) GO:0005634; GO:0006357; GO:0008270; GO:0032502 developmental process [GO:0032502]; regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] zinc ion binding [GO:0008270] g22449.t1 Q52M93 33.463 257 5.51e-31 134.0 sp|Q52M93|Z585B_HUMAN Zinc finger protein 585B OS=Homo sapiens OX=9606 GN=ZNF585B PE=1 SV=1 Z585B_HUMAN reviewed Zinc finger protein 585B (zinc finger protein 41-like protein) Homo sapiens (Human) GO:0005634; GO:0006357; GO:0008270; GO:0032502 developmental process [GO:0032502]; regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] zinc ion binding [GO:0008270] g22450.t1 A1L3G4 36.052 233 1.48e-39 144.0 sp|A1L3G4|TM241_XENLA UDP-N-acetylglucosamine transporter TMEM241 homolog OS=Xenopus laevis OX=8355 GN=tmem241 PE=2 SV=1 g22453.t1 P48969 47.674 86 6.31e-33 82.4 sp|P48969|DVR1_STRPU Protein DVR-1 homolog OS=Strongylocentrotus purpuratus OX=7668 GN=DVR1 PE=2 SV=1 g22453.t1 P48969 70.37 54 6.31e-33 78.2 sp|P48969|DVR1_STRPU Protein DVR-1 homolog OS=Strongylocentrotus purpuratus OX=7668 GN=DVR1 PE=2 SV=1 g22454.t1 P23359 71.429 119 1.65e-57 188.0 sp|P23359|BMP7_MOUSE Bone morphogenetic protein 7 OS=Mus musculus OX=10090 GN=Bmp7 PE=1 SV=2 BMP7_MOUSE reviewed Bone morphogenetic protein 7 (BMP-7) (Osteogenic protein 1) (OP-1) Mus musculus (Mouse) GO:0001649; GO:0001654; GO:0001657; GO:0001707; GO:0001822; GO:0003272; GO:0003344; GO:0005125; GO:0005615; GO:0007389; GO:0007411; GO:0007435; GO:0007507; GO:0008083; GO:0008201; GO:0008285; GO:0009880; GO:0009887; GO:0010628; GO:0010718; GO:0021502; GO:0030326; GO:0030501; GO:0030509; GO:0030855; GO:0030902; GO:0031012; GO:0031982; GO:0032355; GO:0033280; GO:0034116; GO:0035239; GO:0042475; GO:0043065; GO:0043434; GO:0043539; GO:0045597; GO:0045665; GO:0045666; GO:0045669; GO:0045746; GO:0045786; GO:0045839; GO:0045892; GO:0045893; GO:0045944; GO:0048468; GO:0048593; GO:0048596; GO:0048646; GO:0048738; GO:0048754; GO:0048762; GO:0048812; GO:0050768; GO:0051216; GO:0060037; GO:0060272; GO:0060391; GO:0060411; GO:0060445; GO:0060485; GO:0060686; GO:0060687; GO:0060710; GO:0061384; GO:0070487; GO:0070700; GO:0071773; GO:0072040; GO:0072125; GO:0072133; GO:0072134; GO:0072136; GO:0090336; GO:1900006; GO:1900106; GO:1905069; GO:1905312 allantois development [GO:1905069]; anatomical structure formation involved in morphogenesis [GO:0048646]; animal organ morphogenesis [GO:0009887]; axon guidance [GO:0007411]; BMP signaling pathway [GO:0030509]; branching involved in salivary gland morphogenesis [GO:0060445]; branching morphogenesis of an epithelial tube [GO:0048754]; camera-type eye morphogenesis [GO:0048593]; cardiac muscle tissue development [GO:0048738]; cardiac septum morphogenesis [GO:0060411]; cartilage development [GO:0051216]; cell development [GO:0048468]; cellular response to BMP stimulus [GO:0071773]; chorio-allantoic fusion [GO:0060710]; embryonic camera-type eye morphogenesis [GO:0048596]; embryonic limb morphogenesis [GO:0030326]; embryonic pattern specification [GO:0009880]; embryonic skeletal joint morphogenesis [GO:0060272]; endocardial cushion formation [GO:0003272]; epithelial cell differentiation [GO:0030855]; eye development [GO:0001654]; heart development [GO:0007507]; heart trabecula morphogenesis [GO:0061384]; hindbrain development [GO:0030902]; kidney development [GO:0001822]; mesenchymal cell differentiation [GO:0048762]; mesenchyme development [GO:0060485]; mesoderm formation [GO:0001707]; metanephric mesenchymal cell proliferation involved in metanephros development [GO:0072136]; metanephric mesenchyme morphogenesis [GO:0072133]; monocyte aggregation [GO:0070487]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of glomerular mesangial cell proliferation [GO:0072125]; negative regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis [GO:0072040]; negative regulation of mitotic nuclear division [GO:0045839]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of prostatic bud formation [GO:0060686]; nephrogenic mesenchyme morphogenesis [GO:0072134]; neural fold elevation formation [GO:0021502]; neuron projection morphogenesis [GO:0048812]; odontogenesis of dentin-containing tooth [GO:0042475]; osteoblast differentiation [GO:0001649]; pattern specification process [GO:0007389]; pericardium morphogenesis [GO:0003344]; pharyngeal system development [GO:0060037]; positive regulation of apoptotic process [GO:0043065]; positive regulation of bone mineralization [GO:0030501]; positive regulation of brown fat cell differentiation [GO:0090336]; positive regulation of cardiac neural crest cell migration involved in outflow tract morphogenesis [GO:1905312]; positive regulation of cell differentiation [GO:0045597]; positive regulation of dendrite development [GO:1900006]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of gene expression [GO:0010628]; positive regulation of heterotypic cell-cell adhesion [GO:0034116]; positive regulation of hyaluranon cable assembly [GO:1900106]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of SMAD protein signal transduction [GO:0060391]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of branching involved in prostate gland morphogenesis [GO:0060687]; response to estradiol [GO:0032355]; response to peptide hormone [GO:0043434]; response to vitamin D [GO:0033280]; salivary gland morphogenesis [GO:0007435]; tube morphogenesis [GO:0035239]; ureteric bud development [GO:0001657] extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; vesicle [GO:0031982] BMP receptor binding [GO:0070700]; cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; heparin binding [GO:0008201]; protein serine/threonine kinase activator activity [GO:0043539] g22457.t1 Q8WUA4 30.159 504 7.75e-50 195.0 sp|Q8WUA4|TF3C2_HUMAN General transcription factor 3C polypeptide 2 OS=Homo sapiens OX=9606 GN=GTF3C2 PE=1 SV=2 TF3C2_HUMAN reviewed General transcription factor 3C polypeptide 2 (TF3C-beta) (Transcription factor IIIC 110 kDa subunit) (TFIIIC 110 kDa subunit) (TFIIIC110) (Transcription factor IIIC subunit beta) Homo sapiens (Human) GO:0000127; GO:0000995; GO:0005654; GO:0006383; GO:0042791; GO:0042797 5S class rRNA transcription by RNA polymerase III [GO:0042791]; transcription by RNA polymerase III [GO:0006383]; tRNA transcription by RNA polymerase III [GO:0042797] nucleoplasm [GO:0005654]; transcription factor TFIIIC complex [GO:0000127] RNA polymerase III general transcription initiation factor activity [GO:0000995] g22458.t1 Q9CWY4 50.617 81 5.53e-23 89.0 sp|Q9CWY4|GEMI7_MOUSE Gem-associated protein 7 OS=Mus musculus OX=10090 GN=Gemin7 PE=2 SV=1 g22459.t1 Q0VC00 47.354 359 5.49e-115 344.0 sp|Q0VC00|ABHD3_BOVIN Phospholipase ABHD3 OS=Bos taurus OX=9913 GN=ABHD3 PE=2 SV=1 ABHD3_BOVIN reviewed Phospholipase ABHD3 (EC 3.1.1.32) (EC 3.1.1.4) (Abhydrolase domain-containing protein 3) Bos taurus (Bovine) GO:0004623; GO:0008126; GO:0008970; GO:0016020; GO:0046470; GO:0047372; GO:0051792; GO:0051793 medium-chain fatty acid biosynthetic process [GO:0051792]; medium-chain fatty acid catabolic process [GO:0051793]; phosphatidylcholine metabolic process [GO:0046470] membrane [GO:0016020] acetylesterase activity [GO:0008126]; monoacylglycerol lipase activity [GO:0047372]; phospholipase A1 activity [GO:0008970]; phospholipase A2 activity [GO:0004623] g22460.t1 P44849 26.822 343 4.4900000000000005e-21 97.4 sp|P44849|Y736_HAEIN Uncharacterized sodium-dependent transporter HI_0736 OS=Haemophilus influenzae (strain ATCC 51907 / DSM 11121 / KW20 / Rd) OX=71421 GN=HI_0736 PE=3 SV=1 g22460.t1 P44849 76.923 13 4.4900000000000005e-21 26.6 sp|P44849|Y736_HAEIN Uncharacterized sodium-dependent transporter HI_0736 OS=Haemophilus influenzae (strain ATCC 51907 / DSM 11121 / KW20 / Rd) OX=71421 GN=HI_0736 PE=3 SV=1 g22465.t1 Q8IWU5 55.118 254 8.11e-88 290.0 sp|Q8IWU5|SULF2_HUMAN Extracellular sulfatase Sulf-2 OS=Homo sapiens OX=9606 GN=SULF2 PE=1 SV=1 SULF2_HUMAN reviewed Extracellular sulfatase Sulf-2 (hSulf-2) (Arylsulfatase) (EC 3.1.6.1) (N-acetylglucosamine-6-sulfatase) (EC 3.1.6.14) [Cleaved into: Extracellular sulfatase Sulf-2 secreted form] Homo sapiens (Human) GO:0001822; GO:0002063; GO:0003094; GO:0004065; GO:0005509; GO:0005539; GO:0005576; GO:0005615; GO:0005783; GO:0005795; GO:0005886; GO:0008449; GO:0009611; GO:0009986; GO:0010575; GO:0014846; GO:0030177; GO:0030201; GO:0032836; GO:0035860; GO:0040037; GO:0048706; GO:0051216; GO:0060348; GO:0060384; GO:0090263; GO:0097421; GO:1904472; GO:2000345 bone development [GO:0060348]; cartilage development [GO:0051216]; chondrocyte development [GO:0002063]; embryonic skeletal system development [GO:0048706]; esophagus smooth muscle contraction [GO:0014846]; glial cell-derived neurotrophic factor receptor signaling pathway [GO:0035860]; glomerular basement membrane development [GO:0032836]; glomerular filtration [GO:0003094]; heparan sulfate proteoglycan metabolic process [GO:0030201]; innervation [GO:0060384]; kidney development [GO:0001822]; liver regeneration [GO:0097421]; negative regulation of fibroblast growth factor receptor signaling pathway [GO:0040037]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of endothelin production [GO:1904472]; positive regulation of vascular endothelial growth factor production [GO:0010575]; positive regulation of Wnt signaling pathway [GO:0030177]; regulation of hepatocyte proliferation [GO:2000345]; response to wounding [GO:0009611] cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi stack [GO:0005795]; plasma membrane [GO:0005886] arylsulfatase activity [GO:0004065]; calcium ion binding [GO:0005509]; glycosaminoglycan binding [GO:0005539]; N-acetylglucosamine-6-sulfatase activity [GO:0008449] g22466.t1 Q8IWU5 32.362 686 3.6e-90 309.0 sp|Q8IWU5|SULF2_HUMAN Extracellular sulfatase Sulf-2 OS=Homo sapiens OX=9606 GN=SULF2 PE=1 SV=1 SULF2_HUMAN reviewed Extracellular sulfatase Sulf-2 (hSulf-2) (Arylsulfatase) (EC 3.1.6.1) (N-acetylglucosamine-6-sulfatase) (EC 3.1.6.14) [Cleaved into: Extracellular sulfatase Sulf-2 secreted form] Homo sapiens (Human) GO:0001822; GO:0002063; GO:0003094; GO:0004065; GO:0005509; GO:0005539; GO:0005576; GO:0005615; GO:0005783; GO:0005795; GO:0005886; GO:0008449; GO:0009611; GO:0009986; GO:0010575; GO:0014846; GO:0030177; GO:0030201; GO:0032836; GO:0035860; GO:0040037; GO:0048706; GO:0051216; GO:0060348; GO:0060384; GO:0090263; GO:0097421; GO:1904472; GO:2000345 bone development [GO:0060348]; cartilage development [GO:0051216]; chondrocyte development [GO:0002063]; embryonic skeletal system development [GO:0048706]; esophagus smooth muscle contraction [GO:0014846]; glial cell-derived neurotrophic factor receptor signaling pathway [GO:0035860]; glomerular basement membrane development [GO:0032836]; glomerular filtration [GO:0003094]; heparan sulfate proteoglycan metabolic process [GO:0030201]; innervation [GO:0060384]; kidney development [GO:0001822]; liver regeneration [GO:0097421]; negative regulation of fibroblast growth factor receptor signaling pathway [GO:0040037]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of endothelin production [GO:1904472]; positive regulation of vascular endothelial growth factor production [GO:0010575]; positive regulation of Wnt signaling pathway [GO:0030177]; regulation of hepatocyte proliferation [GO:2000345]; response to wounding [GO:0009611] cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi stack [GO:0005795]; plasma membrane [GO:0005886] arylsulfatase activity [GO:0004065]; calcium ion binding [GO:0005509]; glycosaminoglycan binding [GO:0005539]; N-acetylglucosamine-6-sulfatase activity [GO:0008449] g22466.t2 Q8CFG0 33.491 636 1.8099999999999997e-89 306.0 sp|Q8CFG0|SULF2_MOUSE Extracellular sulfatase Sulf-2 OS=Mus musculus OX=10090 GN=Sulf2 PE=1 SV=2 SULF2_MOUSE reviewed Extracellular sulfatase Sulf-2 (mSulf-2) (Arylsulfatase) (EC 3.1.6.1) (N-acetylglucosamine-6-sulfatase) (EC 3.1.6.14) [Cleaved into: Extracellular sulfatase Sulf-2 secreted form] Mus musculus (Mouse) GO:0001822; GO:0002063; GO:0003094; GO:0004065; GO:0005509; GO:0005539; GO:0005576; GO:0005615; GO:0005783; GO:0005795; GO:0005886; GO:0006790; GO:0008449; GO:0009611; GO:0009986; GO:0010575; GO:0014846; GO:0030177; GO:0030201; GO:0032836; GO:0035860; GO:0040037; GO:0048706; GO:0051216; GO:0060348; GO:0060384; GO:0090263; GO:0097421; GO:1904472; GO:2000345 bone development [GO:0060348]; cartilage development [GO:0051216]; chondrocyte development [GO:0002063]; embryonic skeletal system development [GO:0048706]; esophagus smooth muscle contraction [GO:0014846]; glial cell-derived neurotrophic factor receptor signaling pathway [GO:0035860]; glomerular basement membrane development [GO:0032836]; glomerular filtration [GO:0003094]; heparan sulfate proteoglycan metabolic process [GO:0030201]; innervation [GO:0060384]; kidney development [GO:0001822]; liver regeneration [GO:0097421]; negative regulation of fibroblast growth factor receptor signaling pathway [GO:0040037]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of endothelin production [GO:1904472]; positive regulation of vascular endothelial growth factor production [GO:0010575]; positive regulation of Wnt signaling pathway [GO:0030177]; regulation of hepatocyte proliferation [GO:2000345]; response to wounding [GO:0009611]; sulfur compound metabolic process [GO:0006790] cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi stack [GO:0005795]; plasma membrane [GO:0005886] arylsulfatase activity [GO:0004065]; calcium ion binding [GO:0005509]; glycosaminoglycan binding [GO:0005539]; N-acetylglucosamine-6-sulfatase activity [GO:0008449] g22469.t1 Q6P2Z6 60.971 515 0.0 632.0 sp|Q6P2Z6|NMD3_XENTR 60S ribosomal export protein NMD3 OS=Xenopus tropicalis OX=8364 GN=nmd3 PE=2 SV=1 g22472.t1 Q68D06 24.023 512 8.83e-24 112.0 sp|Q68D06|SLN13_HUMAN Schlafen family member 13 OS=Homo sapiens OX=9606 GN=SLFN13 PE=1 SV=1 SLN13_HUMAN reviewed Schlafen family member 13 (EC 3.1.-.-) (Schlafen-13) (hSLFN13) Homo sapiens (Human) GO:0000049; GO:0004521; GO:0005524; GO:0005737; GO:0008270; GO:0016075; GO:0016078; GO:0016787; GO:0051607 defense response to virus [GO:0051607]; rRNA catabolic process [GO:0016075]; tRNA decay [GO:0016078] cytoplasm [GO:0005737] ATP binding [GO:0005524]; hydrolase activity [GO:0016787]; RNA endonuclease activity [GO:0004521]; tRNA binding [GO:0000049]; zinc ion binding [GO:0008270] g22473.t1 P70297 50.691 434 2.01e-142 425.0 sp|P70297|STAM1_MOUSE Signal transducing adapter molecule 1 OS=Mus musculus OX=10090 GN=Stam PE=1 SV=3 STAM1_MOUSE reviewed Signal transducing adapter molecule 1 (STAM-1) Mus musculus (Mouse) GO:0005829; GO:0016236; GO:0031901; GO:0033565; GO:0035091; GO:0036258; GO:0043130; GO:0043328; GO:0044389; GO:1903543; GO:1903551 macroautophagy [GO:0016236]; multivesicular body assembly [GO:0036258]; positive regulation of exosomal secretion [GO:1903543]; protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043328]; regulation of extracellular exosome assembly [GO:1903551] cytosol [GO:0005829]; early endosome membrane [GO:0031901]; ESCRT-0 complex [GO:0033565] phosphatidylinositol binding [GO:0035091]; ubiquitin binding [GO:0043130]; ubiquitin-like protein ligase binding [GO:0044389] g22474.t1 Q6IRP4 45.399 326 2.42e-93 287.0 sp|Q6IRP4|ABHDD_XENLA Protein ABHD13 OS=Xenopus laevis OX=8355 GN=abhd13 PE=2 SV=1 g22477.t1 Q9CWH4 31.2 250 9.040000000000001e-27 106.0 sp|Q9CWH4|RE114_MOUSE Meiotic recombination protein REC114 OS=Mus musculus OX=10090 GN=Rec114 PE=1 SV=1 RE114_MOUSE reviewed Meiotic recombination protein REC114 Mus musculus (Mouse) GO:0005694; GO:0006310; GO:0007283; GO:0042138; GO:0048477 DNA recombination [GO:0006310]; meiotic DNA double-strand break formation [GO:0042138]; oogenesis [GO:0048477]; spermatogenesis [GO:0007283] chromosome [GO:0005694] g22481.t1 Q6A4L1 42.816 689 7.859999999999999e-159 477.0 sp|Q6A4L1|S12A8_XENLA Solute carrier family 12 member 8 OS=Xenopus laevis OX=8355 GN=slc12a8 PE=2 SV=1 g22482.t1 Q6Y1H2 58.108 222 1.09e-95 283.0 sp|Q6Y1H2|HACD2_HUMAN Very-long-chain (3R)-3-hydroxyacyl-CoA dehydratase 2 OS=Homo sapiens OX=9606 GN=HACD2 PE=1 SV=1 HACD2_HUMAN reviewed Very-long-chain (3R)-3-hydroxyacyl-CoA dehydratase 2 (EC 4.2.1.134) (3-hydroxyacyl-CoA dehydratase 2) (HACD2) (Protein-tyrosine phosphatase-like member B) Homo sapiens (Human) GO:0005783; GO:0005789; GO:0018812; GO:0019899; GO:0030148; GO:0030497; GO:0035338; GO:0042761; GO:0102158 fatty acid elongation [GO:0030497]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; sphingolipid biosynthetic process [GO:0030148]; very long-chain fatty acid biosynthetic process [GO:0042761] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789] 3-hydroxyacyl-CoA dehydratase activity [GO:0018812]; enzyme binding [GO:0019899]; very-long-chain (3R)-3-hydroxyacyl-CoA dehydratase activity [GO:0102158] g22483.t1 Q9CZE3 68.692 214 9.93e-107 309.0 sp|Q9CZE3|RAB32_MOUSE Ras-related protein Rab-32 OS=Mus musculus OX=10090 GN=Rab32 PE=1 SV=3 RAB32_MOUSE reviewed Ras-related protein Rab-32 (EC 3.6.5.2) Mus musculus (Mouse) GO:0003924; GO:0003925; GO:0005525; GO:0005739; GO:0005741; GO:0005769; GO:0005783; GO:0005802; GO:0006886; GO:0007005; GO:0012505; GO:0016020; GO:0016192; GO:0019882; GO:0030670; GO:0030742; GO:0032438; GO:0033162; GO:0035646; GO:0035650; GO:0035651; GO:0036461; GO:0042470; GO:0044233; GO:0045335; GO:0046872; GO:0072657; GO:0090382; GO:1903232 antigen processing and presentation [GO:0019882]; endosome to melanosome transport [GO:0035646]; intracellular protein transport [GO:0006886]; melanosome assembly [GO:1903232]; melanosome organization [GO:0032438]; mitochondrion organization [GO:0007005]; phagosome maturation [GO:0090382]; protein localization to membrane [GO:0072657]; vesicle-mediated transport [GO:0016192] early endosome [GO:0005769]; endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; melanosome [GO:0042470]; melanosome membrane [GO:0033162]; membrane [GO:0016020]; mitochondria-associated endoplasmic reticulum membrane contact site [GO:0044233]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; trans-Golgi network [GO:0005802] AP-1 adaptor complex binding [GO:0035650]; AP-3 adaptor complex binding [GO:0035651]; BLOC-2 complex binding [GO:0036461]; G protein activity [GO:0003925]; GTP binding [GO:0005525]; GTP-dependent protein binding [GO:0030742]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872] g22484.t1 Q13310 42.667 375 2.68e-76 252.0 sp|Q13310|PABP4_HUMAN Polyadenylate-binding protein 4 OS=Homo sapiens OX=9606 GN=PABPC4 PE=1 SV=1 g22484.t1 Q13310 65.979 97 9.54e-31 127.0 sp|Q13310|PABP4_HUMAN Polyadenylate-binding protein 4 OS=Homo sapiens OX=9606 GN=PABPC4 PE=1 SV=1 g22486.t1 Q6IP09 54.525 442 9.420000000000001e-144 428.0 sp|Q6IP09|PABPB_XENLA Polyadenylate-binding protein 1-B OS=Xenopus laevis OX=8355 GN=pabpc1-b PE=2 SV=1 g22488.t1 Q7ZV80 50.209 239 3.18e-39 139.0 sp|Q7ZV80|SPF30_DANRE Survival of motor neuron-related-splicing factor 30 OS=Danio rerio OX=7955 GN=smndc1 PE=2 SV=1 SPF30_DANRE reviewed Survival of motor neuron-related-splicing factor 30 (Survival motor neuron domain-containing protein 1) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0003723; GO:0005634; GO:0005681; GO:0005737; GO:0006397; GO:0008380; GO:0015030; GO:0016607 mRNA processing [GO:0006397]; RNA splicing [GO:0008380] Cajal body [GO:0015030]; cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681] RNA binding [GO:0003723] g22490.t1 Q6ZMS4 32.938 337 2.1499999999999998e-52 190.0 sp|Q6ZMS4|ZN852_HUMAN Zinc finger protein 852 OS=Homo sapiens OX=9606 GN=ZNF852 PE=1 SV=4 g22490.t1 Q6ZMS4 32.883 222 1.5e-32 134.0 sp|Q6ZMS4|ZN852_HUMAN Zinc finger protein 852 OS=Homo sapiens OX=9606 GN=ZNF852 PE=1 SV=4 g22490.t1 Q6ZMS4 34.731 167 5.96e-23 106.0 sp|Q6ZMS4|ZN852_HUMAN Zinc finger protein 852 OS=Homo sapiens OX=9606 GN=ZNF852 PE=1 SV=4 g22491.t1 Q3SZM6 62.069 87 1.5299999999999999e-34 118.0 sp|Q3SZM6|COXM1_BOVIN COX assembly mitochondrial protein homolog OS=Bos taurus OX=9913 GN=CMC1 PE=3 SV=1 g22492.t1 Q19749 54.139 447 6.2e-152 445.0 sp|Q19749|ODP2_CAEEL Dihydrolipoyllysine-residue acetyltransferase component of pyruvate dehydrogenase complex, mitochondrial OS=Caenorhabditis elegans OX=6239 GN=dlat-1 PE=1 SV=1 g22493.t1 Q499Z3 44.444 162 1.84e-35 137.0 sp|Q499Z3|SLNL1_HUMAN Schlafen-like protein 1 OS=Homo sapiens OX=9606 GN=SLFNL1 PE=1 SV=2 g22494.t1 Q6GN16 58.182 715 0.0 799.0 sp|Q6GN16|PI4KB_XENLA Phosphatidylinositol 4-kinase beta OS=Xenopus laevis OX=8355 GN=pi4kb PE=2 SV=1 PI4KB_XENLA reviewed Phosphatidylinositol 4-kinase beta (PI4K-beta) (PI4Kbeta) (PtdIns 4-kinase beta) (EC 2.7.1.67) Xenopus laevis (African clawed frog) GO:0004430; GO:0005524; GO:0005737; GO:0005741; GO:0016020; GO:0030867; GO:0046854; GO:0048015; GO:0048839 inner ear development [GO:0048839]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; phosphatidylinositol-mediated signaling [GO:0048015] cytoplasm [GO:0005737]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; rough endoplasmic reticulum membrane [GO:0030867] 1-phosphatidylinositol 4-kinase activity [GO:0004430]; ATP binding [GO:0005524] g22495.t1 P21522 42.268 194 2.9500000000000003e-27 112.0 sp|P21522|ROA1_SCHAM Heterogeneous nuclear ribonucleoprotein A1, A2/B1 homolog OS=Schistocerca americana OX=7009 GN=HNRNP PE=2 SV=1 g22496.t1 P21522 43.094 181 3.7200000000000004e-37 139.0 sp|P21522|ROA1_SCHAM Heterogeneous nuclear ribonucleoprotein A1, A2/B1 homolog OS=Schistocerca americana OX=7009 GN=HNRNP PE=2 SV=1 g22497.t1 Q91W86 58.513 928 0.0 1107.0 sp|Q91W86|VPS11_MOUSE Vacuolar protein sorting-associated protein 11 homolog OS=Mus musculus OX=10090 GN=Vps11 PE=1 SV=3 VPS11_MOUSE reviewed Vacuolar protein sorting-associated protein 11 homolog Mus musculus (Mouse) GO:0000166; GO:0005764; GO:0005765; GO:0005768; GO:0005769; GO:0005770; GO:0005776; GO:0005884; GO:0006886; GO:0006904; GO:0006914; GO:0007032; GO:0007033; GO:0008270; GO:0008333; GO:0016567; GO:0019904; GO:0019905; GO:0030136; GO:0030139; GO:0030674; GO:0030897; GO:0031902; GO:0033147; GO:0033263; GO:0034058; GO:0045732; GO:0048284; GO:0048786; GO:0061630; GO:1902115; GO:2000643 autophagy [GO:0006914]; endosomal vesicle fusion [GO:0034058]; endosome organization [GO:0007032]; endosome to lysosome transport [GO:0008333]; intracellular protein transport [GO:0006886]; negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; organelle fusion [GO:0048284]; positive regulation of early endosome to late endosome transport [GO:2000643]; positive regulation of protein catabolic process [GO:0045732]; protein ubiquitination [GO:0016567]; regulation of organelle assembly [GO:1902115]; vacuole organization [GO:0007033]; vesicle docking involved in exocytosis [GO:0006904] actin filament [GO:0005884]; autophagosome [GO:0005776]; clathrin-coated vesicle [GO:0030136]; CORVET complex [GO:0033263]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; HOPS complex [GO:0030897]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; presynaptic active zone [GO:0048786] nucleotide binding [GO:0000166]; protein domain specific binding [GO:0019904]; protein-macromolecule adaptor activity [GO:0030674]; syntaxin binding [GO:0019905]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] g22497.t2 Q91W86 57.934 939 0.0 1102.0 sp|Q91W86|VPS11_MOUSE Vacuolar protein sorting-associated protein 11 homolog OS=Mus musculus OX=10090 GN=Vps11 PE=1 SV=3 VPS11_MOUSE reviewed Vacuolar protein sorting-associated protein 11 homolog Mus musculus (Mouse) GO:0000166; GO:0005764; GO:0005765; GO:0005768; GO:0005769; GO:0005770; GO:0005776; GO:0005884; GO:0006886; GO:0006904; GO:0006914; GO:0007032; GO:0007033; GO:0008270; GO:0008333; GO:0016567; GO:0019904; GO:0019905; GO:0030136; GO:0030139; GO:0030674; GO:0030897; GO:0031902; GO:0033147; GO:0033263; GO:0034058; GO:0045732; GO:0048284; GO:0048786; GO:0061630; GO:1902115; GO:2000643 autophagy [GO:0006914]; endosomal vesicle fusion [GO:0034058]; endosome organization [GO:0007032]; endosome to lysosome transport [GO:0008333]; intracellular protein transport [GO:0006886]; negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; organelle fusion [GO:0048284]; positive regulation of early endosome to late endosome transport [GO:2000643]; positive regulation of protein catabolic process [GO:0045732]; protein ubiquitination [GO:0016567]; regulation of organelle assembly [GO:1902115]; vacuole organization [GO:0007033]; vesicle docking involved in exocytosis [GO:0006904] actin filament [GO:0005884]; autophagosome [GO:0005776]; clathrin-coated vesicle [GO:0030136]; CORVET complex [GO:0033263]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; HOPS complex [GO:0030897]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; presynaptic active zone [GO:0048786] nucleotide binding [GO:0000166]; protein domain specific binding [GO:0019904]; protein-macromolecule adaptor activity [GO:0030674]; syntaxin binding [GO:0019905]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] g22499.t1 A9JS71 63.922 255 3.8399999999999996e-114 334.0 sp|A9JS71|ECHD3_XENLA Enoyl-CoA hydratase domain-containing protein 3, mitochondrial OS=Xenopus laevis OX=8355 GN=echdc3 PE=2 SV=1 g22502.t1 Q9UHX3 28.213 319 8.7e-22 105.0 sp|Q9UHX3|AGRE2_HUMAN Adhesion G protein-coupled receptor E2 OS=Homo sapiens OX=9606 GN=ADGRE2 PE=1 SV=2 g22503.t1 Q9CQY6 51.695 118 1.58e-41 137.0 sp|Q9CQY6|UQCC2_MOUSE Ubiquinol-cytochrome c reductase complex assembly factor 2 OS=Mus musculus OX=10090 GN=Uqcc2 PE=1 SV=1 UQCC2_MOUSE reviewed Ubiquinol-cytochrome c reductase complex assembly factor 2 (Mitochondrial nucleoid factor 1) (Mitochondrial protein M19) Mus musculus (Mouse) GO:0002082; GO:0005739; GO:0005743; GO:0005758; GO:0005759; GO:0016604; GO:0034551; GO:0042645; GO:0050796; GO:0070131; GO:2001014 mitochondrial respiratory chain complex III assembly [GO:0034551]; positive regulation of mitochondrial translation [GO:0070131]; regulation of insulin secretion [GO:0050796]; regulation of oxidative phosphorylation [GO:0002082]; regulation of skeletal muscle cell differentiation [GO:2001014] mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nuclear body [GO:0016604] g22505.t1 Q5R6T1 57.373 434 3.08e-169 485.0 sp|Q5R6T1|PDIA6_PONAB Protein disulfide-isomerase A6 OS=Pongo abelii OX=9601 GN=PDIA6 PE=2 SV=1 g22511.t1 O60266 52.495 461 3.39e-127 404.0 sp|O60266|ADCY3_HUMAN Adenylate cyclase type 3 OS=Homo sapiens OX=9606 GN=ADCY3 PE=1 SV=3 ADCY3_HUMAN reviewed Adenylate cyclase type 3 (EC 4.6.1.1) (ATP pyrophosphate-lyase 3) (Adenylate cyclase type III) (AC-III) (Adenylate cyclase, olfactive type) (Adenylyl cyclase 3) (AC3) Homo sapiens (Human) GO:0003091; GO:0004016; GO:0005516; GO:0005524; GO:0005737; GO:0005794; GO:0005886; GO:0005929; GO:0006171; GO:0007165; GO:0007189; GO:0007338; GO:0007340; GO:0007608; GO:0008355; GO:0016020; GO:0030317; GO:0035556; GO:0046872; GO:0060170; GO:0071377; GO:0097700; GO:1904322 acrosome reaction [GO:0007340]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cAMP biosynthetic process [GO:0006171]; cellular response to forskolin [GO:1904322]; cellular response to glucagon stimulus [GO:0071377]; flagellated sperm motility [GO:0030317]; intracellular signal transduction [GO:0035556]; olfactory learning [GO:0008355]; renal water homeostasis [GO:0003091]; sensory perception of smell [GO:0007608]; signal transduction [GO:0007165]; single fertilization [GO:0007338]; vascular endothelial cell response to laminar fluid shear stress [GO:0097700] ciliary membrane [GO:0060170]; cilium [GO:0005929]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; plasma membrane [GO:0005886] adenylate cyclase activity [GO:0004016]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872] g22512.t1 P21932 47.253 455 2.88e-131 409.0 sp|P21932|ADCY3_RAT Adenylate cyclase type 3 OS=Rattus norvegicus OX=10116 GN=Adcy3 PE=1 SV=1 ADCY3_RAT reviewed Adenylate cyclase type 3 (EC 4.6.1.1) (ATP pyrophosphate-lyase 3) (Adenylate cyclase type III) (AC-III) (Adenylate cyclase, olfactive type) (Adenylyl cyclase 3) (AC3) Rattus norvegicus (Rat) GO:0001669; GO:0004016; GO:0005516; GO:0005524; GO:0005634; GO:0005737; GO:0005794; GO:0005886; GO:0005929; GO:0006171; GO:0007189; GO:0007338; GO:0007340; GO:0007608; GO:0008294; GO:0008355; GO:0016020; GO:0030317; GO:0035556; GO:0043025; GO:0046872; GO:0048471; GO:0060170; GO:0090651; GO:0097225; GO:0097538; GO:0098788; GO:1904322 acrosome reaction [GO:0007340]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cAMP biosynthetic process [GO:0006171]; cellular response to forskolin [GO:1904322]; flagellated sperm motility [GO:0030317]; intracellular signal transduction [GO:0035556]; olfactory learning [GO:0008355]; sensory perception of smell [GO:0007608]; single fertilization [GO:0007338] acrosomal vesicle [GO:0001669]; apical cytoplasm [GO:0090651]; ciliary membrane [GO:0060170]; ciliary necklace [GO:0097538]; cilium [GO:0005929]; cytoplasm [GO:0005737]; dendritic knob [GO:0098788]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; sperm midpiece [GO:0097225] adenylate cyclase activity [GO:0004016]; ATP binding [GO:0005524]; calcium- and calmodulin-responsive adenylate cyclase activity [GO:0008294]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872] g22514.t1 B6CZ61 46.914 162 5.17e-44 149.0 sp|B6CZ61|LRC51_RAT Leucine-rich repeat-containing protein 51 OS=Rattus norvegicus OX=10116 GN=Lrrc51 PE=2 SV=1 g22516.t1 Q91W90 48.698 384 9.310000000000001e-132 394.0 sp|Q91W90|TXND5_MOUSE Thioredoxin domain-containing protein 5 OS=Mus musculus OX=10090 GN=Txndc5 PE=1 SV=2 TXND5_MOUSE reviewed Thioredoxin domain-containing protein 5 (EC 1.8.4.-) (EC 5.3.4.1) (Endoplasmic reticulum resident protein 46) (ER protein 46) (ERp46) (Plasma cell-specific thioredoxin-related protein) (PC-TRP) (Thioredoxin-like protein p46) Mus musculus (Mouse) GO:0003756; GO:0005783; GO:0005788; GO:0006457; GO:0015035 protein folding [GO:0006457] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788] protein disulfide isomerase activity [GO:0003756]; protein-disulfide reductase activity [GO:0015035] g22520.t1 P82151 41.463 246 6.68e-23 97.1 sp|P82151|LEC6_TACTR Lectin L6 OS=Tachypleus tridentatus OX=6853 PE=1 SV=1 g22524.t1 P82151 35.514 214 3.14e-24 100.0 sp|P82151|LEC6_TACTR Lectin L6 OS=Tachypleus tridentatus OX=6853 PE=1 SV=1 g22524.t1 P82151 35.981 214 1.91e-21 92.8 sp|P82151|LEC6_TACTR Lectin L6 OS=Tachypleus tridentatus OX=6853 PE=1 SV=1 g22525.t1 P82151 30.924 249 3.55e-22 94.7 sp|P82151|LEC6_TACTR Lectin L6 OS=Tachypleus tridentatus OX=6853 PE=1 SV=1 g22526.t1 P82151 37.097 248 2.9e-29 114.0 sp|P82151|LEC6_TACTR Lectin L6 OS=Tachypleus tridentatus OX=6853 PE=1 SV=1 g22527.t1 P82151 40.081 247 2.24e-37 135.0 sp|P82151|LEC6_TACTR Lectin L6 OS=Tachypleus tridentatus OX=6853 PE=1 SV=1 g22531.t1 Q9UKD2 65.741 216 1.14e-103 303.0 sp|Q9UKD2|MRT4_HUMAN mRNA turnover protein 4 homolog OS=Homo sapiens OX=9606 GN=MRTO4 PE=1 SV=2 g22532.t1 P41932 71.02 245 5.49e-120 345.0 sp|P41932|14331_CAEEL 14-3-3-like protein 1 OS=Caenorhabditis elegans OX=6239 GN=par-5 PE=1 SV=2 g22533.t1 H3BPM6 29.048 210 1.2900000000000001e-31 118.0 sp|H3BPM6|MKROS_HUMAN MKRN2 opposite strand protein OS=Homo sapiens OX=9606 GN=MKRN2OS PE=1 SV=1 g22534.t1 Q15036 44.919 492 1.38e-141 417.0 sp|Q15036|SNX17_HUMAN Sorting nexin-17 OS=Homo sapiens OX=9606 GN=SNX17 PE=1 SV=1 g22535.t1 Q9WTP6 66.667 225 2.07e-116 335.0 sp|Q9WTP6|KAD2_MOUSE Adenylate kinase 2, mitochondrial OS=Mus musculus OX=10090 GN=Ak2 PE=1 SV=5 KAD2_MOUSE reviewed Adenylate kinase 2, mitochondrial (AK 2) (EC 2.7.4.3) (ATP-AMP transphosphorylase 2) (ATP:AMP phosphotransferase) (Adenylate monophosphate kinase) Mus musculus (Mouse) GO:0004017; GO:0005524; GO:0005737; GO:0005739; GO:0005743; GO:0005758; GO:0006172; GO:0036126; GO:0046033; GO:0046034; GO:0097226 ADP biosynthetic process [GO:0006172]; AMP metabolic process [GO:0046033]; ATP metabolic process [GO:0046034] cytoplasm [GO:0005737]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; sperm flagellum [GO:0036126]; sperm mitochondrial sheath [GO:0097226] AMP kinase activity [GO:0004017]; ATP binding [GO:0005524] g22536.t1 Q63186 52.561 449 9.34e-143 424.0 sp|Q63186|EI2BD_RAT Translation initiation factor eIF2B subunit delta OS=Rattus norvegicus OX=10116 GN=Eif2b4 PE=2 SV=1 EI2BD_RAT reviewed Translation initiation factor eIF2B subunit delta (eIF2B GDP-GTP exchange factor subunit delta) Rattus norvegicus (Rat) GO:0001541; GO:0002183; GO:0003743; GO:0005085; GO:0005737; GO:0005829; GO:0005851; GO:0006413; GO:0009408; GO:0009749; GO:0014003; GO:0021766; GO:0031369; GO:0042552; GO:0043434; GO:0050852 cytoplasmic translational initiation [GO:0002183]; hippocampus development [GO:0021766]; myelination [GO:0042552]; oligodendrocyte development [GO:0014003]; ovarian follicle development [GO:0001541]; response to glucose [GO:0009749]; response to heat [GO:0009408]; response to peptide hormone [GO:0043434]; T cell receptor signaling pathway [GO:0050852]; translational initiation [GO:0006413] cytoplasm [GO:0005737]; cytosol [GO:0005829]; eukaryotic translation initiation factor 2B complex [GO:0005851] guanyl-nucleotide exchange factor activity [GO:0005085]; translation initiation factor activity [GO:0003743]; translation initiation factor binding [GO:0031369] g22538.t1 Q8N584 46.667 585 0.0 535.0 sp|Q8N584|TT39C_HUMAN Tetratricopeptide repeat protein 39C OS=Homo sapiens OX=9606 GN=TTC39C PE=1 SV=2 g22539.t1 Q9I9K9 62.249 249 1.67e-100 306.0 sp|Q9I9K9|GATM_CHICK Glycine amidinotransferase, mitochondrial OS=Gallus gallus OX=9031 GN=GATM PE=2 SV=2 g22540.t1 Q2HJ74 72.727 121 2.53e-63 201.0 sp|Q2HJ74|GATM_BOVIN Glycine amidinotransferase, mitochondrial OS=Bos taurus OX=9913 GN=GATM PE=2 SV=1 GATM_BOVIN reviewed Glycine amidinotransferase, mitochondrial (EC 2.1.4.1) (L-arginine:glycine amidinotransferase) (Transamidinase) Bos taurus (Bovine) GO:0005739; GO:0005743; GO:0005758; GO:0006601; GO:0007611; GO:0014889; GO:0015067; GO:0015068; GO:0120162 creatine biosynthetic process [GO:0006601]; learning or memory [GO:0007611]; muscle atrophy [GO:0014889]; positive regulation of cold-induced thermogenesis [GO:0120162] mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739] amidinotransferase activity [GO:0015067]; glycine amidinotransferase activity [GO:0015068] g22551.t1 Q9D855 63.725 102 2.23e-40 132.0 sp|Q9D855|QCR7_MOUSE Cytochrome b-c1 complex subunit 7 OS=Mus musculus OX=10090 GN=Uqcrb PE=1 SV=3 QCR7_MOUSE reviewed Cytochrome b-c1 complex subunit 7 (Complex III subunit 7) (Complex III subunit VII) (Ubiquinol-cytochrome c reductase complex 14 kDa protein) Mus musculus (Mouse) GO:0005739; GO:0005743; GO:0006122; GO:0044877; GO:0045275; GO:0045333 cellular respiration [GO:0045333]; mitochondrial electron transport, ubiquinol to cytochrome c [GO:0006122] mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; respiratory chain complex III [GO:0045275] protein-containing complex binding [GO:0044877] g22552.t1 Q96MF7 31.602 231 1.5300000000000001e-27 108.0 sp|Q96MF7|NSE2_HUMAN E3 SUMO-protein ligase NSE2 OS=Homo sapiens OX=9606 GN=NSMCE2 PE=1 SV=2 NSE2_HUMAN reviewed E3 SUMO-protein ligase NSE2 (EC 2.3.2.-) (E3 SUMO-protein transferase NSE2) (MMS21 homolog) (hMMS21) (Non-structural maintenance of chromosomes element 2 homolog) (Non-SMC element 2 homolog) Homo sapiens (Human) GO:0000722; GO:0000724; GO:0000781; GO:0005634; GO:0005654; GO:0008270; GO:0016604; GO:0016605; GO:0016925; GO:0019789; GO:0030915; GO:0032204; GO:0034184; GO:0045842; GO:0051301; GO:0061665; GO:0090398; GO:0140588 cell division [GO:0051301]; cellular senescence [GO:0090398]; chromatin looping [GO:0140588]; double-strand break repair via homologous recombination [GO:0000724]; positive regulation of maintenance of mitotic sister chromatid cohesion [GO:0034184]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; protein sumoylation [GO:0016925]; regulation of telomere maintenance [GO:0032204]; telomere maintenance via recombination [GO:0000722] chromosome, telomeric region [GO:0000781]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; Smc5-Smc6 complex [GO:0030915] SUMO ligase activity [GO:0061665]; SUMO transferase activity [GO:0019789]; zinc ion binding [GO:0008270] g22553.t1 Q62825 46.314 719 0.0 633.0 sp|Q62825|EXOC3_RAT Exocyst complex component 3 OS=Rattus norvegicus OX=10116 GN=Exoc3 PE=1 SV=1 g22556.t1 Q4WVW4 41.223 507 1.95e-88 285.0 sp|Q4WVW4|VAC8_ASPFU Vacuolar protein 8 OS=Aspergillus fumigatus (strain ATCC MYA-4609 / CBS 101355 / FGSC A1100 / Af293) OX=330879 GN=vac8 PE=3 SV=1 VAC8_ASPFU reviewed Vacuolar protein 8 Aspergillus fumigatus (strain ATCC MYA-4609 / CBS 101355 / FGSC A1100 / Af293) (Neosartorya fumigata) GO:0000011; GO:0000045; GO:0000329; GO:0000407; GO:0000425; GO:0031503; GO:0031965; GO:0034497; GO:0034517; GO:0034727; GO:0042144; GO:0042802; GO:0043495; GO:0045121; GO:0051656; GO:0061724; GO:0071561; GO:0071562; GO:0071563; GO:1903044 autophagosome assembly [GO:0000045]; establishment of organelle localization [GO:0051656]; lipophagy [GO:0061724]; nucleus-vacuole junction assembly [GO:0071562]; pexophagy [GO:0000425]; piecemeal microautophagy of the nucleus [GO:0034727]; protein localization to membrane raft [GO:1903044]; protein localization to phagophore assembly site [GO:0034497]; protein-containing complex localization [GO:0031503]; ribophagy [GO:0034517]; vacuole fusion, non-autophagic [GO:0042144]; vacuole inheritance [GO:0000011] fungal-type vacuole membrane [GO:0000329]; membrane raft [GO:0045121]; Myo2p-Vac17p-Vac8p transport complex [GO:0071563]; nuclear membrane [GO:0031965]; nucleus-vacuole junction [GO:0071561]; phagophore assembly site [GO:0000407] identical protein binding [GO:0042802]; protein-membrane adaptor activity [GO:0043495] g22557.t1 Q8JG30 32.857 280 1.5100000000000002e-35 133.0 sp|Q8JG30|ST1B1_CHICK Sulfotransferase 1B1 OS=Gallus gallus OX=9031 GN=SULT1B1 PE=1 SV=1 g22558.t1 Q5JVL4 53.882 644 0.0 670.0 sp|Q5JVL4|EFHC1_HUMAN EF-hand domain-containing protein 1 OS=Homo sapiens OX=9606 GN=EFHC1 PE=1 SV=1 EFHC1_HUMAN reviewed EF-hand domain-containing protein 1 (Myoclonin-1) Homo sapiens (Human) GO:0000281; GO:0000922; GO:0005509; GO:0005813; GO:0005879; GO:0005930; GO:0007052; GO:0021795; GO:0030317; GO:0036126; GO:0043014; GO:0043025; GO:0051302; GO:0060285; GO:0072686; GO:0160111 cerebral cortex cell migration [GO:0021795]; cilium-dependent cell motility [GO:0060285]; flagellated sperm motility [GO:0030317]; mitotic cytokinesis [GO:0000281]; mitotic spindle organization [GO:0007052]; regulation of cell division [GO:0051302] axonemal A tubule inner sheath [GO:0160111]; axonemal microtubule [GO:0005879]; axoneme [GO:0005930]; centrosome [GO:0005813]; mitotic spindle [GO:0072686]; neuronal cell body [GO:0043025]; sperm flagellum [GO:0036126]; spindle pole [GO:0000922] alpha-tubulin binding [GO:0043014]; calcium ion binding [GO:0005509] g22560.t1 Q9WUI9 36.264 364 3.13e-50 198.0 sp|Q9WUI9|NCOA2_RAT Nuclear receptor coactivator 2 OS=Rattus norvegicus OX=10116 GN=Ncoa2 PE=1 SV=1 NCOA2_RAT reviewed Nuclear receptor coactivator 2 (NCoA-2) (Transcriptional intermediary factor 2) Rattus norvegicus (Rat) GO:0000122; GO:0000978; GO:0001162; GO:0003682; GO:0003713; GO:0005102; GO:0005634; GO:0005654; GO:0005667; GO:0005737; GO:0006355; GO:0007623; GO:0008584; GO:0010468; GO:0010906; GO:0016604; GO:0016922; GO:0017162; GO:0019216; GO:0019904; GO:0021549; GO:0030331; GO:0032355; GO:0032570; GO:0032870; GO:0032922; GO:0032991; GO:0035259; GO:0042974; GO:0043197; GO:0044877; GO:0045475; GO:0045879; GO:0045892; GO:0045925; GO:0045944; GO:0046965; GO:0046966; GO:0046983; GO:0061629; GO:0070182; GO:0090575; GO:0140416; GO:1904017; GO:2000324 cellular response to hormone stimulus [GO:0032870]; cellular response to Thyroglobulin triiodothyronine [GO:1904017]; cerebellum development [GO:0021549]; circadian regulation of gene expression [GO:0032922]; circadian rhythm [GO:0007623]; locomotor rhythm [GO:0045475]; male gonad development [GO:0008584]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of smoothened signaling pathway [GO:0045879]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of female receptivity [GO:0045925]; positive regulation of nuclear receptor-mediated glucocorticoid signaling pathway [GO:2000324]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA-templated transcription [GO:0006355]; regulation of gene expression [GO:0010468]; regulation of glucose metabolic process [GO:0010906]; regulation of lipid metabolic process [GO:0019216]; response to estradiol [GO:0032355]; response to progesterone [GO:0032570] cytoplasm [GO:0005737]; dendritic spine [GO:0043197]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; RNA polymerase II transcription regulator complex [GO:0090575]; transcription regulator complex [GO:0005667] aryl hydrocarbon receptor binding [GO:0017162]; chromatin binding [GO:0003682]; DNA polymerase binding [GO:0070182]; nuclear estrogen receptor binding [GO:0030331]; nuclear glucocorticoid receptor binding [GO:0035259]; nuclear receptor binding [GO:0016922]; nuclear retinoic acid receptor binding [GO:0042974]; nuclear retinoid X receptor binding [GO:0046965]; nuclear thyroid hormone receptor binding [GO:0046966]; protein dimerization activity [GO:0046983]; protein domain specific binding [GO:0019904]; protein-containing complex binding [GO:0044877]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding [GO:0001162]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; signaling receptor binding [GO:0005102]; transcription coactivator activity [GO:0003713]; transcription regulator inhibitor activity [GO:0140416] g22560.t2 Q9WUI9 35.013 377 3.52e-47 188.0 sp|Q9WUI9|NCOA2_RAT Nuclear receptor coactivator 2 OS=Rattus norvegicus OX=10116 GN=Ncoa2 PE=1 SV=1 NCOA2_RAT reviewed Nuclear receptor coactivator 2 (NCoA-2) (Transcriptional intermediary factor 2) Rattus norvegicus (Rat) GO:0000122; GO:0000978; GO:0001162; GO:0003682; GO:0003713; GO:0005102; GO:0005634; GO:0005654; GO:0005667; GO:0005737; GO:0006355; GO:0007623; GO:0008584; GO:0010468; GO:0010906; GO:0016604; GO:0016922; GO:0017162; GO:0019216; GO:0019904; GO:0021549; GO:0030331; GO:0032355; GO:0032570; GO:0032870; GO:0032922; GO:0032991; GO:0035259; GO:0042974; GO:0043197; GO:0044877; GO:0045475; GO:0045879; GO:0045892; GO:0045925; GO:0045944; GO:0046965; GO:0046966; GO:0046983; GO:0061629; GO:0070182; GO:0090575; GO:0140416; GO:1904017; GO:2000324 cellular response to hormone stimulus [GO:0032870]; cellular response to Thyroglobulin triiodothyronine [GO:1904017]; cerebellum development [GO:0021549]; circadian regulation of gene expression [GO:0032922]; circadian rhythm [GO:0007623]; locomotor rhythm [GO:0045475]; male gonad development [GO:0008584]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of smoothened signaling pathway [GO:0045879]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of female receptivity [GO:0045925]; positive regulation of nuclear receptor-mediated glucocorticoid signaling pathway [GO:2000324]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA-templated transcription [GO:0006355]; regulation of gene expression [GO:0010468]; regulation of glucose metabolic process [GO:0010906]; regulation of lipid metabolic process [GO:0019216]; response to estradiol [GO:0032355]; response to progesterone [GO:0032570] cytoplasm [GO:0005737]; dendritic spine [GO:0043197]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; RNA polymerase II transcription regulator complex [GO:0090575]; transcription regulator complex [GO:0005667] aryl hydrocarbon receptor binding [GO:0017162]; chromatin binding [GO:0003682]; DNA polymerase binding [GO:0070182]; nuclear estrogen receptor binding [GO:0030331]; nuclear glucocorticoid receptor binding [GO:0035259]; nuclear receptor binding [GO:0016922]; nuclear retinoic acid receptor binding [GO:0042974]; nuclear retinoid X receptor binding [GO:0046965]; nuclear thyroid hormone receptor binding [GO:0046966]; protein dimerization activity [GO:0046983]; protein domain specific binding [GO:0019904]; protein-containing complex binding [GO:0044877]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding [GO:0001162]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; signaling receptor binding [GO:0005102]; transcription coactivator activity [GO:0003713]; transcription regulator inhibitor activity [GO:0140416] g22568.t1 Q9JHA8 28.809 781 2.32e-71 259.0 sp|Q9JHA8|VWA7_MOUSE von Willebrand factor A domain-containing protein 7 OS=Mus musculus OX=10090 GN=Vwa7 PE=2 SV=1 g22571.t1 Q4G073 59.77 174 3.84e-55 193.0 sp|Q4G073|TRDMT_RAT tRNA (cytosine(38)-C(5))-methyltransferase OS=Rattus norvegicus OX=10116 GN=Trdmt1 PE=2 SV=1 g22571.t1 Q4G073 44.531 128 3.6300000000000006e-27 116.0 sp|Q4G073|TRDMT_RAT tRNA (cytosine(38)-C(5))-methyltransferase OS=Rattus norvegicus OX=10116 GN=Trdmt1 PE=2 SV=1 g22578.t1 Q6P4Y6 46.691 272 6.17e-69 228.0 sp|Q6P4Y6|IRS1_XENTR Insulin receptor substrate 1 OS=Xenopus tropicalis OX=8364 GN=irs1 PE=2 SV=1 g22587.t1 Q9H2Y9 35.222 653 5.46e-103 340.0 sp|Q9H2Y9|SO5A1_HUMAN Solute carrier organic anion transporter family member 5A1 OS=Homo sapiens OX=9606 GN=SLCO5A1 PE=1 SV=2 g22589.t1 Q8CJ11 27.316 626 4.81e-39 162.0 sp|Q8CJ11|AGRG2_RAT Adhesion G-protein coupled receptor G2 OS=Rattus norvegicus OX=10116 GN=Adgrg2 PE=1 SV=1 AGRG2_RAT reviewed Adhesion G-protein coupled receptor G2 (G-protein coupled receptor 64) (Rat epididymis-specific protein 6) (Re6) [Cleaved into: Adhesion G-protein coupled receptor G2, N-terminal fragment (ADGRG2 N-terminal fragment); Adhesion G-protein coupled receptor G2, C-terminal fragment (ADGRG2 C-terminal fragment)] Rattus norvegicus (Rat) GO:0004930; GO:0005829; GO:0005886; GO:0007166; GO:0007186; GO:0007189; GO:0007200; GO:0007286; GO:0016324 adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; spermatid development [GO:0007286] apical plasma membrane [GO:0016324]; cytosol [GO:0005829]; plasma membrane [GO:0005886] G protein-coupled receptor activity [GO:0004930] g22591.t1 P29274 28.808 302 2.6200000000000003e-21 97.4 sp|P29274|AA2AR_HUMAN Adenosine receptor A2a OS=Homo sapiens OX=9606 GN=ADORA2A PE=1 SV=2 AA2AR_HUMAN reviewed Adenosine receptor A2a Homo sapiens (Human) GO:0001609; GO:0001963; GO:0001973; GO:0001975; GO:0005516; GO:0005882; GO:0005886; GO:0006355; GO:0006909; GO:0006915; GO:0006954; GO:0006968; GO:0007188; GO:0007189; GO:0007200; GO:0007267; GO:0007271; GO:0007417; GO:0007596; GO:0007600; GO:0007626; GO:0008015; GO:0008285; GO:0008289; GO:0009410; GO:0014049; GO:0014057; GO:0014061; GO:0014074; GO:0016020; GO:0019899; GO:0030425; GO:0030673; GO:0031000; GO:0031802; GO:0032230; GO:0032279; GO:0035249; GO:0035810; GO:0042311; GO:0042734; GO:0042755; GO:0042802; GO:0043025; GO:0043116; GO:0043524; GO:0044877; GO:0045211; GO:0045938; GO:0046636; GO:0048143; GO:0048786; GO:0048812; GO:0050714; GO:0050728; GO:0051393; GO:0051881; GO:0051899; GO:0051924; GO:0051968; GO:0060079; GO:0060080; GO:0060134; GO:0070374; GO:0097190; GO:0098978; GO:0099171; GO:1900273; GO:2001235 adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; apoptotic process [GO:0006915]; apoptotic signaling pathway [GO:0097190]; astrocyte activation [GO:0048143]; blood circulation [GO:0008015]; blood coagulation [GO:0007596]; cell-cell signaling [GO:0007267]; cellular defense response [GO:0006968]; central nervous system development [GO:0007417]; eating behavior [GO:0042755]; excitatory postsynaptic potential [GO:0060079]; G protein-coupled adenosine receptor signaling pathway [GO:0001973]; inflammatory response [GO:0006954]; inhibitory postsynaptic potential [GO:0060080]; locomotory behavior [GO:0007626]; membrane depolarization [GO:0051899]; negative regulation of alpha-beta T cell activation [GO:0046636]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of inflammatory response [GO:0050728]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of vascular permeability [GO:0043116]; neuron projection morphogenesis [GO:0048812]; phagocytosis [GO:0006909]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of acetylcholine secretion, neurotransmission [GO:0014057]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of circadian sleep/wake cycle, sleep [GO:0045938]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of glutamate secretion [GO:0014049]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of protein secretion [GO:0050714]; positive regulation of synaptic transmission, GABAergic [GO:0032230]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; positive regulation of urine volume [GO:0035810]; prepulse inhibition [GO:0060134]; presynaptic modulation of chemical synaptic transmission [GO:0099171]; regulation of calcium ion transport [GO:0051924]; regulation of DNA-templated transcription [GO:0006355]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of norepinephrine secretion [GO:0014061]; response to amphetamine [GO:0001975]; response to caffeine [GO:0031000]; response to purine-containing compound [GO:0014074]; response to xenobiotic stimulus [GO:0009410]; sensory perception [GO:0007600]; synaptic transmission, cholinergic [GO:0007271]; synaptic transmission, dopaminergic [GO:0001963]; synaptic transmission, glutamatergic [GO:0035249]; vasodilation [GO:0042311] asymmetric synapse [GO:0032279]; axolemma [GO:0030673]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; intermediate filament [GO:0005882]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic active zone [GO:0048786]; presynaptic membrane [GO:0042734] alpha-actinin binding [GO:0051393]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; G protein-coupled adenosine receptor activity [GO:0001609]; identical protein binding [GO:0042802]; lipid binding [GO:0008289]; protein-containing complex binding [GO:0044877]; type 5 metabotropic glutamate receptor binding [GO:0031802] g22596.t1 Q91ZD1 75.635 197 7.17e-97 294.0 sp|Q91ZD1|OSR2_MOUSE Protein odd-skipped-related 2 OS=Mus musculus OX=10090 GN=Osr2 PE=1 SV=1 OSR2_MOUSE reviewed Protein odd-skipped-related 2 Mus musculus (Mouse) GO:0000122; GO:0000977; GO:0000981; GO:0001227; GO:0001228; GO:0001655; GO:0001656; GO:0001823; GO:0002062; GO:0005634; GO:0007389; GO:0008270; GO:0008284; GO:0009792; GO:0010628; GO:0030154; GO:0030501; GO:0033687; GO:0035115; GO:0035116; GO:0036023; GO:0042474; GO:0042476; GO:0042733; GO:0043565; GO:0045893; GO:0045944; GO:0048704; GO:0048793; GO:0050679; GO:0060021; GO:0060272; GO:0060322; GO:0060349; GO:0061029; GO:0072498; GO:1990837; GO:2000543 bone morphogenesis [GO:0060349]; cell differentiation [GO:0030154]; chondrocyte differentiation [GO:0002062]; embryo development ending in birth or egg hatching [GO:0009792]; embryonic digit morphogenesis [GO:0042733]; embryonic forelimb morphogenesis [GO:0035115]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic skeletal joint development [GO:0072498]; embryonic skeletal joint morphogenesis [GO:0060272]; embryonic skeletal limb joint morphogenesis [GO:0036023]; embryonic skeletal system morphogenesis [GO:0048704]; eyelid development in camera-type eye [GO:0061029]; head development [GO:0060322]; mesonephros development [GO:0001823]; metanephros development [GO:0001656]; middle ear morphogenesis [GO:0042474]; negative regulation of transcription by RNA polymerase II [GO:0000122]; odontogenesis [GO:0042476]; osteoblast proliferation [GO:0033687]; pattern specification process [GO:0007389]; positive regulation of bone mineralization [GO:0030501]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of gastrulation [GO:2000543]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription by RNA polymerase II [GO:0045944]; pronephros development [GO:0048793]; roof of mouth development [GO:0060021]; urogenital system development [GO:0001655] nucleus [GO:0005634] DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; zinc ion binding [GO:0008270] g22598.t1 P13264 47.092 533 1.69e-151 452.0 sp|P13264|GLSK_RAT Glutaminase kidney isoform, mitochondrial OS=Rattus norvegicus OX=10116 GN=Gls PE=1 SV=2 g22598.t2 D3Z7P3 44.76 563 3.16e-145 438.0 sp|D3Z7P3|GLSK_MOUSE Glutaminase kidney isoform, mitochondrial OS=Mus musculus OX=10090 GN=Gls PE=1 SV=1 GLSK_MOUSE reviewed Glutaminase kidney isoform, mitochondrial (GLS) (EC 3.5.1.2) [Cleaved into: Glutaminase kidney isoform, mitochondrial 68 kDa chain; Glutaminase kidney isoform, mitochondrial 65 kDa chain] Mus musculus (Mouse) GO:0001967; GO:0002087; GO:0004359; GO:0005739; GO:0005759; GO:0005829; GO:0006537; GO:0006543; GO:0007268; GO:0042802; GO:0045202; GO:0051289; GO:0090461 chemical synaptic transmission [GO:0007268]; glutamate biosynthetic process [GO:0006537]; intracellular glutamate homeostasis [GO:0090461]; L-glutamine catabolic process [GO:0006543]; protein homotetramerization [GO:0051289]; regulation of respiratory gaseous exchange by nervous system process [GO:0002087]; suckling behavior [GO:0001967] cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; synapse [GO:0045202] glutaminase activity [GO:0004359]; identical protein binding [GO:0042802] g22599.t1 Q96C36 48.913 276 7.520000000000001e-79 244.0 sp|Q96C36|P5CR2_HUMAN Pyrroline-5-carboxylate reductase 2 OS=Homo sapiens OX=9606 GN=PYCR2 PE=1 SV=1 g22601.t1 Q11205 44.027 293 1.35e-84 263.0 sp|Q11205|SIA4B_RAT CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 2 OS=Rattus norvegicus OX=10116 GN=St3gal2 PE=1 SV=1 SIA4B_RAT reviewed CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 2 (Alpha 2,3-ST 2) (Beta-galactoside alpha-2,3-sialyltransferase 2) (EC 2.4.3.4) (Gal-NAc6S) (Gal-beta-1,3-GalNAc-alpha-2,3-sialyltransferase) (Monosialoganglioside sialyltransferase) (EC 2.4.3.2) (ST3Gal II) (ST3GalII) (ST3GalA.2) (Sialyltransferase 4B) (SIAT4-B) Rattus norvegicus (Rat) GO:0000139; GO:0001574; GO:0001576; GO:0003836; GO:0005576; GO:0008373; GO:0009101; GO:0009247; GO:0009312; GO:0016020; GO:0032580; GO:0042803; GO:0047288; GO:0097503 ganglioside biosynthetic process [GO:0001574]; globoside biosynthetic process [GO:0001576]; glycolipid biosynthetic process [GO:0009247]; glycoprotein biosynthetic process [GO:0009101]; oligosaccharide biosynthetic process [GO:0009312]; sialylation [GO:0097503] extracellular region [GO:0005576]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; membrane [GO:0016020] beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminide alpha-2,3- sialyltransferase [GO:0047288]; beta-galactoside (CMP) alpha-2,3-sialyltransferase activity [GO:0003836]; protein homodimerization activity [GO:0042803]; sialyltransferase activity [GO:0008373] g22603.t1 Q11205 43.564 303 2.94e-85 264.0 sp|Q11205|SIA4B_RAT CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 2 OS=Rattus norvegicus OX=10116 GN=St3gal2 PE=1 SV=1 SIA4B_RAT reviewed CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 2 (Alpha 2,3-ST 2) (Beta-galactoside alpha-2,3-sialyltransferase 2) (EC 2.4.3.4) (Gal-NAc6S) (Gal-beta-1,3-GalNAc-alpha-2,3-sialyltransferase) (Monosialoganglioside sialyltransferase) (EC 2.4.3.2) (ST3Gal II) (ST3GalII) (ST3GalA.2) (Sialyltransferase 4B) (SIAT4-B) Rattus norvegicus (Rat) GO:0000139; GO:0001574; GO:0001576; GO:0003836; GO:0005576; GO:0008373; GO:0009101; GO:0009247; GO:0009312; GO:0016020; GO:0032580; GO:0042803; GO:0047288; GO:0097503 ganglioside biosynthetic process [GO:0001574]; globoside biosynthetic process [GO:0001576]; glycolipid biosynthetic process [GO:0009247]; glycoprotein biosynthetic process [GO:0009101]; oligosaccharide biosynthetic process [GO:0009312]; sialylation [GO:0097503] extracellular region [GO:0005576]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; membrane [GO:0016020] beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminide alpha-2,3- sialyltransferase [GO:0047288]; beta-galactoside (CMP) alpha-2,3-sialyltransferase activity [GO:0003836]; protein homodimerization activity [GO:0042803]; sialyltransferase activity [GO:0008373] g22604.t1 Q96DM1 26.478 389 3.0000000000000003e-31 132.0 sp|Q96DM1|PGBD4_HUMAN PiggyBac transposable element-derived protein 4 OS=Homo sapiens OX=9606 GN=PGBD4 PE=1 SV=3 g22605.t1 Q9N294 39.394 198 1.28e-46 164.0 sp|Q9N294|B3GT5_PANPA Beta-1,3-galactosyltransferase 5 (Fragment) OS=Pan paniscus OX=9597 GN=B3GALT5 PE=3 SV=1 g22609.t1 D3Z5L6 38.071 197 1.4300000000000001e-31 125.0 sp|D3Z5L6|S18B1_MOUSE MFS-type transporter SLC18B1 OS=Mus musculus OX=10090 GN=Slc18b1 PE=1 SV=2 S18B1_MOUSE reviewed MFS-type transporter SLC18B1 (Solute carrier family 18 member B1) (Vesicular polyamine transporter) (VPAT) Mus musculus (Mouse) GO:0000296; GO:0015311; GO:0015312; GO:0015848; GO:0022857; GO:0030667; GO:0030672; GO:0051610 serotonin uptake [GO:0051610]; spermidine transport [GO:0015848]; spermine transport [GO:0000296] secretory granule membrane [GO:0030667]; synaptic vesicle membrane [GO:0030672] monoamine:proton antiporter activity [GO:0015311]; polyamine:proton antiporter activity [GO:0015312]; transmembrane transporter activity [GO:0022857] g22611.t1 Q8N5C7 61.29 93 5.7e-33 128.0 sp|Q8N5C7|DTWD1_HUMAN tRNA-uridine aminocarboxypropyltransferase 1 OS=Homo sapiens OX=9606 GN=DTWD1 PE=1 SV=1 g22611.t1 Q8N5C7 48.624 109 4.44e-27 112.0 sp|Q8N5C7|DTWD1_HUMAN tRNA-uridine aminocarboxypropyltransferase 1 OS=Homo sapiens OX=9606 GN=DTWD1 PE=1 SV=1 g22613.t1 Q8R015 38.776 147 4.44e-25 97.8 sp|Q8R015|BL1S5_MOUSE Biogenesis of lysosome-related organelles complex 1 subunit 5 OS=Mus musculus OX=10090 GN=Bloc1s5 PE=1 SV=1 g22614.t1 Q8K0Q5 35.608 674 1.4999999999999998e-104 335.0 sp|Q8K0Q5|RHG18_MOUSE Rho GTPase-activating protein 18 OS=Mus musculus OX=10090 GN=Arhgap18 PE=1 SV=1 g22615.t1 G5ECX0 36.944 360 6.289999999999999e-42 167.0 sp|G5ECX0|LPLT2_CAEEL Latrophilin-like protein LAT-2 OS=Caenorhabditis elegans OX=6239 GN=lat-2 PE=2 SV=1 LPLT2_CAEEL reviewed Latrophilin-like protein LAT-2 Caenorhabditis elegans GO:0004175; GO:0004930; GO:0005886; GO:0007166; GO:0030246; GO:0097264 cell surface receptor signaling pathway [GO:0007166]; self proteolysis [GO:0097264] plasma membrane [GO:0005886] carbohydrate binding [GO:0030246]; endopeptidase activity [GO:0004175]; G protein-coupled receptor activity [GO:0004930] g22616.t1 G5ECX0 35.526 380 1.0599999999999999e-42 171.0 sp|G5ECX0|LPLT2_CAEEL Latrophilin-like protein LAT-2 OS=Caenorhabditis elegans OX=6239 GN=lat-2 PE=2 SV=1 LPLT2_CAEEL reviewed Latrophilin-like protein LAT-2 Caenorhabditis elegans GO:0004175; GO:0004930; GO:0005886; GO:0007166; GO:0030246; GO:0097264 cell surface receptor signaling pathway [GO:0007166]; self proteolysis [GO:0097264] plasma membrane [GO:0005886] carbohydrate binding [GO:0030246]; endopeptidase activity [GO:0004175]; G protein-coupled receptor activity [GO:0004930] g22617.t1 B7Z0W9 27.155 464 1.64e-35 147.0 sp|B7Z0W9|OTOP_DROME Proton channel OtopLc OS=Drosophila melanogaster OX=7227 GN=OtopLc PE=3 SV=2 OTOP_DROME reviewed Proton channel OtopLc (Otopetrin-Lc) (DmOtopLc) Drosophila melanogaster (Fruit fly) GO:0005886; GO:0015252; GO:1902600 proton transmembrane transport [GO:1902600] plasma membrane [GO:0005886] proton channel activity [GO:0015252] g22618.t1 Q7TNK0 46.313 434 2.99e-126 375.0 sp|Q7TNK0|SERC1_RAT Serine incorporator 1 OS=Rattus norvegicus OX=10116 GN=Serinc1 PE=1 SV=1 SERC1_RAT reviewed Serine incorporator 1 (Tumor differentially expressed protein 1-like) (Tumor differentially expressed protein 2) Rattus norvegicus (Rat) GO:0005789; GO:0005886; GO:0006658; GO:0006665; GO:0008654; GO:0010698; GO:0016020; GO:0019899; GO:0030674; GO:0044091 membrane biogenesis [GO:0044091]; phosphatidylserine metabolic process [GO:0006658]; phospholipid biosynthetic process [GO:0008654]; sphingolipid metabolic process [GO:0006665] endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; plasma membrane [GO:0005886] acetyltransferase activator activity [GO:0010698]; enzyme binding [GO:0019899]; protein-macromolecule adaptor activity [GO:0030674] g22618.t2 Q7TNK0 46.838 427 8.18e-127 376.0 sp|Q7TNK0|SERC1_RAT Serine incorporator 1 OS=Rattus norvegicus OX=10116 GN=Serinc1 PE=1 SV=1 SERC1_RAT reviewed Serine incorporator 1 (Tumor differentially expressed protein 1-like) (Tumor differentially expressed protein 2) Rattus norvegicus (Rat) GO:0005789; GO:0005886; GO:0006658; GO:0006665; GO:0008654; GO:0010698; GO:0016020; GO:0019899; GO:0030674; GO:0044091 membrane biogenesis [GO:0044091]; phosphatidylserine metabolic process [GO:0006658]; phospholipid biosynthetic process [GO:0008654]; sphingolipid metabolic process [GO:0006665] endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; plasma membrane [GO:0005886] acetyltransferase activator activity [GO:0010698]; enzyme binding [GO:0019899]; protein-macromolecule adaptor activity [GO:0030674] g22619.t1 Q7ZXD6 78.049 123 1.28e-56 194.0 sp|Q7ZXD6|ADM1B_XENLA Proteasomal ubiquitin receptor ADRM1-B OS=Xenopus laevis OX=8355 GN=adrm1-b PE=2 SV=1 g22619.t1 Q7ZXD6 60.769 130 1.26e-40 152.0 sp|Q7ZXD6|ADM1B_XENLA Proteasomal ubiquitin receptor ADRM1-B OS=Xenopus laevis OX=8355 GN=adrm1-b PE=2 SV=1 g22619.t2 Q7ZXD6 78.049 123 1.54e-56 194.0 sp|Q7ZXD6|ADM1B_XENLA Proteasomal ubiquitin receptor ADRM1-B OS=Xenopus laevis OX=8355 GN=adrm1-b PE=2 SV=1 g22619.t2 Q7ZXD6 61.24 129 1.37e-41 154.0 sp|Q7ZXD6|ADM1B_XENLA Proteasomal ubiquitin receptor ADRM1-B OS=Xenopus laevis OX=8355 GN=adrm1-b PE=2 SV=1 g22620.t1 Q8N3Y7 44.964 278 1.25e-76 239.0 sp|Q8N3Y7|RDHE2_HUMAN Epidermal retinol dehydrogenase 2 OS=Homo sapiens OX=9606 GN=SDR16C5 PE=1 SV=2 RDHE2_HUMAN reviewed Epidermal retinol dehydrogenase 2 (EPHD-2) (RDH-E2) (EC 1.1.1.105) (Retinal short-chain dehydrogenase reductase 2) (retSDR2) (Short-chain dehydrogenase/reductase family 16C member 5) Homo sapiens (Human) GO:0000122; GO:0000785; GO:0003714; GO:0004745; GO:0005634; GO:0005789; GO:0005811; GO:0017053; GO:0042572; GO:0042574; GO:0043616; GO:0045814; GO:0061629; GO:0140297 keratinocyte proliferation [GO:0043616]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of transcription by RNA polymerase II [GO:0000122]; retinal metabolic process [GO:0042574]; retinol metabolic process [GO:0042572] chromatin [GO:0000785]; endoplasmic reticulum membrane [GO:0005789]; lipid droplet [GO:0005811]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053] all-trans-retinol dehydrogenase (NAD+) activity [GO:0004745]; DNA-binding transcription factor binding [GO:0140297]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription corepressor activity [GO:0003714] g22621.t1 Q58DT1 63.673 245 2.5100000000000003e-103 303.0 sp|Q58DT1|RL7_BOVIN Large ribosomal subunit protein uL30 OS=Bos taurus OX=9913 GN=RPL7 PE=2 SV=1 RL7_BOVIN reviewed Large ribosomal subunit protein uL30 (60S ribosomal protein L7) Bos taurus (Bovine) GO:0000463; GO:0003723; GO:0003735; GO:0022625 maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463] cytosolic large ribosomal subunit [GO:0022625] RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735] g22624.t1 Q2PC93 34.068 1180 1.0500000000000001e-166 577.0 sp|Q2PC93|SSPO_CHICK SCO-spondin OS=Gallus gallus OX=9031 GN=SSPO PE=2 SV=1 g22624.t1 Q2PC93 34.267 464 1.16e-55 220.0 sp|Q2PC93|SSPO_CHICK SCO-spondin OS=Gallus gallus OX=9031 GN=SSPO PE=2 SV=1 g22624.t1 Q2PC93 26.069 725 9.459999999999999e-42 174.0 sp|Q2PC93|SSPO_CHICK SCO-spondin OS=Gallus gallus OX=9031 GN=SSPO PE=2 SV=1 g22624.t1 Q2PC93 28.535 396 1.34e-37 160.0 sp|Q2PC93|SSPO_CHICK SCO-spondin OS=Gallus gallus OX=9031 GN=SSPO PE=2 SV=1 g22624.t1 Q2PC93 28.841 371 2.55e-35 152.0 sp|Q2PC93|SSPO_CHICK SCO-spondin OS=Gallus gallus OX=9031 GN=SSPO PE=2 SV=1 g22625.t1 P21783 29.099 433 5.31e-30 130.0 sp|P21783|NOTC1_XENLA Neurogenic locus notch homolog protein 1 OS=Xenopus laevis OX=8355 GN=notch1 PE=1 SV=3 g22625.t1 P21783 29.337 392 2.0900000000000002e-22 106.0 sp|P21783|NOTC1_XENLA Neurogenic locus notch homolog protein 1 OS=Xenopus laevis OX=8355 GN=notch1 PE=1 SV=3 g22625.t1 P21783 28.784 403 2.36e-22 106.0 sp|P21783|NOTC1_XENLA Neurogenic locus notch homolog protein 1 OS=Xenopus laevis OX=8355 GN=notch1 PE=1 SV=3 g22628.t1 Q78EG7 62.428 173 7.01e-78 233.0 sp|Q78EG7|TP4A1_RAT Protein tyrosine phosphatase type IVA 1 OS=Rattus norvegicus OX=10116 GN=Ptp4a1 PE=1 SV=1 TP4A1_RAT reviewed Protein tyrosine phosphatase type IVA 1 (EC 3.1.3.48) (Protein-tyrosine phosphatase 4a1) (Protein-tyrosine phosphatase of regenerating liver 1) (PRL-1) Rattus norvegicus (Rat) GO:0004725; GO:0005634; GO:0005737; GO:0005769; GO:0005783; GO:0005819; GO:0009898; GO:0030335 positive regulation of cell migration [GO:0030335] cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634]; spindle [GO:0005819] protein tyrosine phosphatase activity [GO:0004725] g22630.t1 O97902 50.216 695 0.0 661.0 sp|O97902|ASAP1_BOVIN Arf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 1 OS=Bos taurus OX=9913 GN=ASAP1 PE=1 SV=1 g22632.t1 Q9CQI9 50.92 163 1.14e-43 146.0 sp|Q9CQI9|MED30_MOUSE Mediator of RNA polymerase II transcription subunit 30 OS=Mus musculus OX=10090 GN=Med30 PE=1 SV=1 MED30_MOUSE reviewed Mediator of RNA polymerase II transcription subunit 30 (Mediator complex subunit 30) (Thyroid hormone receptor-associated protein 6) (Thyroid hormone receptor-associated protein complex 25 kDa component) (Trap25) Mus musculus (Mouse) GO:0000151; GO:0003712; GO:0003713; GO:0005634; GO:0005654; GO:0016567; GO:0016592; GO:0019827; GO:0032968; GO:0045893; GO:0046966; GO:0051123; GO:0060261; GO:0061630; GO:0070847 positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription elongation by RNA polymerase II [GO:0032968]; positive regulation of transcription initiation by RNA polymerase II [GO:0060261]; protein ubiquitination [GO:0016567]; RNA polymerase II preinitiation complex assembly [GO:0051123]; stem cell population maintenance [GO:0019827] core mediator complex [GO:0070847]; mediator complex [GO:0016592]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151] nuclear thyroid hormone receptor binding [GO:0046966]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; ubiquitin protein ligase activity [GO:0061630] g22633.t1 Q9NPF2 35.395 291 5.27e-57 192.0 sp|Q9NPF2|CHSTB_HUMAN Carbohydrate sulfotransferase 11 OS=Homo sapiens OX=9606 GN=CHST11 PE=1 SV=1 CHSTB_HUMAN reviewed Carbohydrate sulfotransferase 11 (EC 2.8.2.5) (Chondroitin 4-O-sulfotransferase 1) (Chondroitin 4-sulfotransferase 1) (C4S-1) (C4ST-1) (C4ST1) Homo sapiens (Human) GO:0000139; GO:0001537; GO:0001701; GO:0002063; GO:0006915; GO:0007179; GO:0007585; GO:0008146; GO:0009791; GO:0016020; GO:0016051; GO:0030166; GO:0030512; GO:0033037; GO:0036342; GO:0042127; GO:0042733; GO:0043066; GO:0047756; GO:0048589; GO:0048703; GO:0050650; GO:0050659 apoptotic process [GO:0006915]; carbohydrate biosynthetic process [GO:0016051]; chondrocyte development [GO:0002063]; chondroitin sulfate proteoglycan biosynthetic process [GO:0050650]; developmental growth [GO:0048589]; embryonic digit morphogenesis [GO:0042733]; embryonic viscerocranium morphogenesis [GO:0048703]; in utero embryonic development [GO:0001701]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; polysaccharide localization [GO:0033037]; post-anal tail morphogenesis [GO:0036342]; post-embryonic development [GO:0009791]; proteoglycan biosynthetic process [GO:0030166]; regulation of cell population proliferation [GO:0042127]; respiratory gaseous exchange by respiratory system [GO:0007585]; transforming growth factor beta receptor signaling pathway [GO:0007179] Golgi membrane [GO:0000139]; membrane [GO:0016020] chondroitin 4-sulfotransferase activity [GO:0047756]; dermatan 4-sulfotransferase activity [GO:0001537]; N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity [GO:0050659]; sulfotransferase activity [GO:0008146] g22634.t1 Q5F477 39.252 321 8.730000000000001e-79 246.0 sp|Q5F477|LDAH_CHICK Lipid droplet-associated hydrolase OS=Gallus gallus OX=9031 GN=LDAH PE=2 SV=2 g22634.t2 Q5F477 35.635 362 3.39e-71 228.0 sp|Q5F477|LDAH_CHICK Lipid droplet-associated hydrolase OS=Gallus gallus OX=9031 GN=LDAH PE=2 SV=2 g22635.t1 Q9W6I0 47.739 199 1.75e-67 213.0 sp|Q9W6I0|UQCC1_XENLA Ubiquinol-cytochrome-c reductase complex assembly factor 1 OS=Xenopus laevis OX=8355 GN=uqcc1 PE=2 SV=1 g22641.t1 Q96EL3 37.963 108 7.76e-23 88.2 sp|Q96EL3|RM53_HUMAN Large ribosomal subunit protein mL53 OS=Homo sapiens OX=9606 GN=MRPL53 PE=1 SV=1 RM53_HUMAN reviewed Large ribosomal subunit protein mL53 (39S ribosomal protein L53, mitochondrial) (L53mt) (MRP-L53) Homo sapiens (Human) GO:0005739; GO:0005743; GO:0005762; GO:0032543 mitochondrial translation [GO:0032543] mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739] g22642.t1 Q5ZJC8 49.466 281 1.36e-94 295.0 sp|Q5ZJC8|MTEF3_CHICK Transcription termination factor 3, mitochondrial OS=Gallus gallus OX=9031 GN=MTERF3 PE=2 SV=1 g22643.t1 Q803C9 49.892 461 2.62e-158 459.0 sp|Q803C9|PTSS1_DANRE Phosphatidylserine synthase 1 OS=Danio rerio OX=7955 GN=ptdss1 PE=2 SV=2 PTSS1_DANRE reviewed Phosphatidylserine synthase 1 (PSS-1) (PtdSer synthase 1) (EC 2.7.8.29) (Serine-exchange enzyme I) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005789; GO:0006659; GO:0106245; GO:0106258 phosphatidylserine biosynthetic process [GO:0006659] endoplasmic reticulum membrane [GO:0005789] L-serine-phosphatidylcholine phosphatidyltransferase activity [GO:0106258]; L-serine-phosphatidylethanolamine phosphatidyltransferase activity [GO:0106245] g22644.t1 P00787 58.333 252 2e-95 287.0 sp|P00787|CATB_RAT Cathepsin B OS=Rattus norvegicus OX=10116 GN=Ctsb PE=1 SV=2 CATB_RAT reviewed Cathepsin B (EC 3.4.22.1) (Cathepsin B1) (RSG-2) [Cleaved into: Cathepsin B light chain; Cathepsin B heavy chain] Rattus norvegicus (Rat) GO:0004175; GO:0004197; GO:0005518; GO:0005576; GO:0005615; GO:0005764; GO:0005901; GO:0006508; GO:0006590; GO:0006914; GO:0007283; GO:0007519; GO:0008233; GO:0008234; GO:0009612; GO:0009749; GO:0009897; GO:0009986; GO:0014075; GO:0016324; GO:0030163; GO:0030574; GO:0030855; GO:0030984; GO:0034097; GO:0042277; GO:0042383; GO:0042470; GO:0042802; GO:0043394; GO:0043434; GO:0044877; GO:0045471; GO:0046697; GO:0046718; GO:0048471; GO:0051402; GO:0051603; GO:0070670; GO:0071260; GO:0071548; GO:0097067; GO:1904090; GO:1904373 autophagy [GO:0006914]; cellular response to mechanical stimulus [GO:0071260]; cellular response to thyroid hormone stimulus [GO:0097067]; collagen catabolic process [GO:0030574]; decidualization [GO:0046697]; epithelial cell differentiation [GO:0030855]; neuron apoptotic process [GO:0051402]; protein catabolic process [GO:0030163]; proteolysis [GO:0006508]; proteolysis involved in protein catabolic process [GO:0051603]; response to amine [GO:0014075]; response to cytokine [GO:0034097]; response to dexamethasone [GO:0071548]; response to ethanol [GO:0045471]; response to glucose [GO:0009749]; response to interleukin-4 [GO:0070670]; response to kainic acid [GO:1904373]; response to mechanical stimulus [GO:0009612]; response to peptide hormone [GO:0043434]; skeletal muscle tissue development [GO:0007519]; spermatogenesis [GO:0007283]; symbiont entry into host cell [GO:0046718]; thyroid hormone generation [GO:0006590] apical plasma membrane [GO:0016324]; caveola [GO:0005901]; cell surface [GO:0009986]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; lysosome [GO:0005764]; melanosome [GO:0042470]; peptidase inhibitor complex [GO:1904090]; perinuclear region of cytoplasm [GO:0048471]; sarcolemma [GO:0042383] collagen binding [GO:0005518]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]; endopeptidase activity [GO:0004175]; identical protein binding [GO:0042802]; kininogen binding [GO:0030984]; peptidase activity [GO:0008233]; peptide binding [GO:0042277]; protein-containing complex binding [GO:0044877]; proteoglycan binding [GO:0043394] g22645.t1 Q96DM1 24.101 556 2.3100000000000002e-32 136.0 sp|Q96DM1|PGBD4_HUMAN PiggyBac transposable element-derived protein 4 OS=Homo sapiens OX=9606 GN=PGBD4 PE=1 SV=3 g22649.t1 Q26630 93.822 259 1.4899999999999999e-165 461.0 sp|Q26630|IDLC_STRPU 33 kDa inner dynein arm light chain, axonemal OS=Strongylocentrotus purpuratus OX=7668 PE=1 SV=1 g22650.t1 Q9CRD2 53.125 288 1.34e-112 330.0 sp|Q9CRD2|EMC2_MOUSE ER membrane protein complex subunit 2 OS=Mus musculus OX=10090 GN=Emc2 PE=1 SV=1 g22651.t1 Q6NS23 41.935 341 1.79e-93 259.0 sp|Q6NS23|TRM11_XENLA tRNA (guanine(10)-N(2))-methyltransferase TRMT11 OS=Xenopus laevis OX=8355 GN=trmt11.L PE=2 SV=1 g22651.t1 Q6NS23 64.0 75 1.79e-93 106.0 sp|Q6NS23|TRM11_XENLA tRNA (guanine(10)-N(2))-methyltransferase TRMT11 OS=Xenopus laevis OX=8355 GN=trmt11.L PE=2 SV=1 g22651.t2 Q6NS23 44.037 327 1.69e-97 272.0 sp|Q6NS23|TRM11_XENLA tRNA (guanine(10)-N(2))-methyltransferase TRMT11 OS=Xenopus laevis OX=8355 GN=trmt11.L PE=2 SV=1 g22651.t2 Q6NS23 64.0 75 1.69e-97 106.0 sp|Q6NS23|TRM11_XENLA tRNA (guanine(10)-N(2))-methyltransferase TRMT11 OS=Xenopus laevis OX=8355 GN=trmt11.L PE=2 SV=1 g22653.t1 Q9NHW7 39.091 220 1.56e-34 129.0 sp|Q9NHW7|AQP_AEDAE Aquaporin AQPAe.a OS=Aedes aegypti OX=7159 GN=AAEL003512 PE=2 SV=2 g22658.t1 Q9VAC5 36.932 352 1.35e-63 219.0 sp|Q9VAC5|ADA17_DROME ADAM 17-like protease OS=Drosophila melanogaster OX=7227 GN=Tace PE=2 SV=2 g22659.t1 Q9VAC5 38.849 278 3.6099999999999995e-48 174.0 sp|Q9VAC5|ADA17_DROME ADAM 17-like protease OS=Drosophila melanogaster OX=7227 GN=Tace PE=2 SV=2 g22662.t1 Q641M3 39.344 122 1.0700000000000001e-29 108.0 sp|Q641M3|TMM18_DANRE Transmembrane protein 18 OS=Danio rerio OX=7955 GN=tmem18 PE=2 SV=1 g22663.t1 Q9Z1J2 45.076 264 1.82e-74 254.0 sp|Q9Z1J2|NEK4_MOUSE Serine/threonine-protein kinase Nek4 OS=Mus musculus OX=10090 GN=Nek4 PE=1 SV=1 g22664.t1 P48147 68.794 705 0.0 1049.0 sp|P48147|PPCE_HUMAN Prolyl endopeptidase OS=Homo sapiens OX=9606 GN=PREP PE=1 SV=2 PPCE_HUMAN reviewed Prolyl endopeptidase (PE) (EC 3.4.21.26) (Post-proline cleaving enzyme) Homo sapiens (Human) GO:0002003; GO:0004181; GO:0004252; GO:0005576; GO:0005634; GO:0005737; GO:0005829; GO:0006508; GO:0008236; GO:0016020; GO:0070012 angiotensin maturation [GO:0002003]; proteolysis [GO:0006508] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; membrane [GO:0016020]; nucleus [GO:0005634] metallocarboxypeptidase activity [GO:0004181]; oligopeptidase activity [GO:0070012]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236] g22666.t1 P21522 36.842 190 4.62e-28 115.0 sp|P21522|ROA1_SCHAM Heterogeneous nuclear ribonucleoprotein A1, A2/B1 homolog OS=Schistocerca americana OX=7009 GN=HNRNP PE=2 SV=1 g22666.t2 P21522 36.842 190 4.83e-28 115.0 sp|P21522|ROA1_SCHAM Heterogeneous nuclear ribonucleoprotein A1, A2/B1 homolog OS=Schistocerca americana OX=7009 GN=HNRNP PE=2 SV=1 g22666.t3 P21522 36.842 190 5.32e-28 115.0 sp|P21522|ROA1_SCHAM Heterogeneous nuclear ribonucleoprotein A1, A2/B1 homolog OS=Schistocerca americana OX=7009 GN=HNRNP PE=2 SV=1 g22666.t4 P21522 39.106 179 9.21e-31 122.0 sp|P21522|ROA1_SCHAM Heterogeneous nuclear ribonucleoprotein A1, A2/B1 homolog OS=Schistocerca americana OX=7009 GN=HNRNP PE=2 SV=1 g22669.t1 P21522 39.306 173 1.3099999999999999e-30 120.0 sp|P21522|ROA1_SCHAM Heterogeneous nuclear ribonucleoprotein A1, A2/B1 homolog OS=Schistocerca americana OX=7009 GN=HNRNP PE=2 SV=1 g22672.t1 Q5RFR0 39.442 251 2.82e-62 203.0 sp|Q5RFR0|TTPAL_PONAB Alpha-tocopherol transfer protein-like OS=Pongo abelii OX=9601 GN=TTPAL PE=2 SV=1 g22673.t1 Q9ESG5 34.307 274 1.41e-51 179.0 sp|Q9ESG5|HS3S1_RAT Heparan sulfate glucosamine 3-O-sulfotransferase 1 OS=Rattus norvegicus OX=10116 GN=Hs3st1 PE=2 SV=1 g22674.t1 Q9ESG5 31.894 301 4.34e-53 182.0 sp|Q9ESG5|HS3S1_RAT Heparan sulfate glucosamine 3-O-sulfotransferase 1 OS=Rattus norvegicus OX=10116 GN=Hs3st1 PE=2 SV=1 g22675.t1 Q9ESG5 34.386 285 1.11e-53 185.0 sp|Q9ESG5|HS3S1_RAT Heparan sulfate glucosamine 3-O-sulfotransferase 1 OS=Rattus norvegicus OX=10116 GN=Hs3st1 PE=2 SV=1 g22677.t1 Q91YT0 83.032 442 0.0 754.0 sp|Q91YT0|NDUV1_MOUSE NADH dehydrogenase [ubiquinone] flavoprotein 1, mitochondrial OS=Mus musculus OX=10090 GN=Ndufv1 PE=1 SV=1 NDUV1_MOUSE reviewed NADH dehydrogenase [ubiquinone] flavoprotein 1, mitochondrial (NDUFV1) (EC 7.1.1.2) (Complex I-51kD) (CI-51kD) (NADH-ubiquinone oxidoreductase 51 kDa subunit) Mus musculus (Mouse) GO:0005739; GO:0005743; GO:0006120; GO:0008137; GO:0009060; GO:0010181; GO:0016491; GO:0042775; GO:0042776; GO:0045271; GO:0046872; GO:0051287; GO:0051539 aerobic respiration [GO:0009060]; mitochondrial ATP synthesis coupled electron transport [GO:0042775]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; proton motive force-driven mitochondrial ATP synthesis [GO:0042776] mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; respiratory chain complex I [GO:0045271] 4 iron, 4 sulfur cluster binding [GO:0051539]; FMN binding [GO:0010181]; metal ion binding [GO:0046872]; NAD binding [GO:0051287]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; oxidoreductase activity [GO:0016491] g22678.t1 Q9JKZ2 56.304 460 2.6400000000000002e-164 489.0 sp|Q9JKZ2|SC5A3_MOUSE Sodium/myo-inositol cotransporter OS=Mus musculus OX=10090 GN=Slc5a3 PE=1 SV=2 SC5A3_MOUSE reviewed Sodium/myo-inositol cotransporter (Na(+)/myo-inositol cotransporter) (Sodium/myo-inositol transporter 1) (SMIT1) (Solute carrier family 5 member 3) Mus musculus (Mouse) GO:0005367; GO:0005412; GO:0005886; GO:0006020; GO:0007422; GO:0008076; GO:0015459; GO:0015798; GO:0016323; GO:0016324; GO:0043576; GO:0044325; GO:0048471; GO:1903428; GO:1905477 inositol metabolic process [GO:0006020]; myo-inositol transport [GO:0015798]; peripheral nervous system development [GO:0007422]; positive regulation of protein localization to membrane [GO:1905477]; positive regulation of reactive oxygen species biosynthetic process [GO:1903428]; regulation of respiratory gaseous exchange [GO:0043576] apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076] D-glucose:sodium symporter activity [GO:0005412]; myo-inositol:sodium symporter activity [GO:0005367]; potassium channel regulator activity [GO:0015459]; transmembrane transporter binding [GO:0044325] g22679.t1 Q66L17 52.632 190 4.26e-71 217.0 sp|Q66L17|HDDC2_XENLA 5'-deoxynucleotidase HDDC2 OS=Xenopus laevis OX=8355 GN=hddc2 PE=2 SV=1 g22680.t1 Q9CY16 46.923 130 4.33e-36 127.0 sp|Q9CY16|RT28_MOUSE Small ribosomal subunit protein bS1m OS=Mus musculus OX=10090 GN=Mrps28 PE=1 SV=1 g22681.t1 Q2KIN4 45.89 292 1.0999999999999999e-52 178.0 sp|Q2KIN4|HEY1_BOVIN Hairy/enhancer-of-split related with YRPW motif protein 1 OS=Bos taurus OX=9913 GN=HEY1 PE=2 SV=1 HEY1_BOVIN reviewed Hairy/enhancer-of-split related with YRPW motif protein 1 Bos taurus (Bovine) GO:0000122; GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0007219; GO:0009653; GO:0009952; GO:0045665; GO:0046983; GO:0050767; GO:0072359 anatomical structure morphogenesis [GO:0009653]; anterior/posterior pattern specification [GO:0009952]; circulatory system development [GO:0072359]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of transcription by RNA polymerase II [GO:0000122]; Notch signaling pathway [GO:0007219]; regulation of neurogenesis [GO:0050767]; regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978] g22684.t1 Q6NZL0 30.606 330 9.95e-26 119.0 sp|Q6NZL0|MTCL3_MOUSE Microtubule cross-linking factor 3 OS=Mus musculus OX=10090 GN=Mtcl3 PE=1 SV=2 g22693.t1 Q9NR82 47.469 573 6.56e-164 502.0 sp|Q9NR82|KCNQ5_HUMAN Potassium voltage-gated channel subfamily KQT member 5 OS=Homo sapiens OX=9606 GN=KCNQ5 PE=1 SV=3 g22693.t2 Q9NR82 47.818 573 6.04e-165 505.0 sp|Q9NR82|KCNQ5_HUMAN Potassium voltage-gated channel subfamily KQT member 5 OS=Homo sapiens OX=9606 GN=KCNQ5 PE=1 SV=3 g22696.t1 Q9NY99 40.612 490 2.67e-126 382.0 sp|Q9NY99|SNTG2_HUMAN Gamma-2-syntrophin OS=Homo sapiens OX=9606 GN=SNTG2 PE=1 SV=2 SNTG2_HUMAN reviewed Gamma-2-syntrophin (G2SYN) (Syntrophin-5) (SYN5) Homo sapiens (Human) GO:0003779; GO:0005198; GO:0005654; GO:0005856; GO:0005886; GO:0007417; GO:0016010; GO:0016013; GO:0030165; GO:0042383; GO:0097109 central nervous system development [GO:0007417] cytoskeleton [GO:0005856]; dystrophin-associated glycoprotein complex [GO:0016010]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; syntrophin complex [GO:0016013] actin binding [GO:0003779]; neuroligin family protein binding [GO:0097109]; PDZ domain binding [GO:0030165]; structural molecule activity [GO:0005198] g22696.t2 Q9NY99 40.779 488 5.5e-127 382.0 sp|Q9NY99|SNTG2_HUMAN Gamma-2-syntrophin OS=Homo sapiens OX=9606 GN=SNTG2 PE=1 SV=2 SNTG2_HUMAN reviewed Gamma-2-syntrophin (G2SYN) (Syntrophin-5) (SYN5) Homo sapiens (Human) GO:0003779; GO:0005198; GO:0005654; GO:0005856; GO:0005886; GO:0007417; GO:0016010; GO:0016013; GO:0030165; GO:0042383; GO:0097109 central nervous system development [GO:0007417] cytoskeleton [GO:0005856]; dystrophin-associated glycoprotein complex [GO:0016010]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; syntrophin complex [GO:0016013] actin binding [GO:0003779]; neuroligin family protein binding [GO:0097109]; PDZ domain binding [GO:0030165]; structural molecule activity [GO:0005198] g22697.t1 Q0V9A9 60.305 131 4.36e-53 172.0 sp|Q0V9A9|LACB2_XENTR Endoribonuclease LACTB2 OS=Xenopus tropicalis OX=8364 GN=lactb2 PE=2 SV=1 g22697.t2 Q5XGR8 60.627 287 2.28e-122 354.0 sp|Q5XGR8|LACB2_XENLA Endoribonuclease LACTB2 OS=Xenopus laevis OX=8355 GN=lactb2 PE=2 SV=1 g22697.t3 Q5XGR8 60.714 140 2.6199999999999998e-52 170.0 sp|Q5XGR8|LACB2_XENLA Endoribonuclease LACTB2 OS=Xenopus laevis OX=8355 GN=lactb2 PE=2 SV=1 g22699.t1 Q6IMK3 64.231 260 2.56e-130 373.0 sp|Q6IMK3|DJC27_DANRE DnaJ homolog subfamily C member 27 OS=Danio rerio OX=7955 GN=dnajc27 PE=2 SV=1 g22704.t1 Q13310 62.733 644 0.0 752.0 sp|Q13310|PABP4_HUMAN Polyadenylate-binding protein 4 OS=Homo sapiens OX=9606 GN=PABPC4 PE=1 SV=1 g22706.t1 Q91677 54.485 301 2.09e-81 265.0 sp|Q91677|GATA4_XENLA Transcription factor GATA-4 OS=Xenopus laevis OX=8355 GN=gata4 PE=2 SV=1 g22706.t2 Q91677 48.955 335 5.5e-76 252.0 sp|Q91677|GATA4_XENLA Transcription factor GATA-4 OS=Xenopus laevis OX=8355 GN=gata4 PE=2 SV=1 g22707.t1 Q32KR6 59.0 400 1.68e-172 491.0 sp|Q32KR6|FDFT_BOVIN Squalene synthase OS=Bos taurus OX=9913 GN=FDFT1 PE=2 SV=1 FDFT_BOVIN reviewed Squalene synthase (SQS) (SS) (EC 2.5.1.21) (FPP:FPP farnesyltransferase) (Farnesyl-diphosphate farnesyltransferase) Bos taurus (Bovine) GO:0005789; GO:0006695; GO:0008299; GO:0045338; GO:0046872; GO:0051996 cholesterol biosynthetic process [GO:0006695]; farnesyl diphosphate metabolic process [GO:0045338]; isoprenoid biosynthetic process [GO:0008299] endoplasmic reticulum membrane [GO:0005789] metal ion binding [GO:0046872]; squalene synthase [NAD(P)H] activity [GO:0051996] g22709.t1 Q8IWT0 52.258 155 4.46e-51 165.0 sp|Q8IWT0|ARCH_HUMAN Protein archease OS=Homo sapiens OX=9606 GN=ZBTB8OS PE=1 SV=2 ARCH_HUMAN reviewed tRNA-splicing ligase-activating factor archease (EC 2.7.7.-) (Zinc finger and BTB domain-containing opposite strand protein 8) Homo sapiens (Human) GO:0000394; GO:0000968; GO:0005634; GO:0005654; GO:0005737; GO:0006388; GO:0044600; GO:0046872; GO:0072669; GO:1902494 RNA splicing, via endonucleolytic cleavage and ligation [GO:0000394]; tRNA exon ligation [GO:0000968]; tRNA splicing, via endonucleolytic cleavage and ligation [GO:0006388] catalytic complex [GO:1902494]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; tRNA-splicing ligase complex [GO:0072669] metal ion binding [GO:0046872]; protein guanylyltransferase activity [GO:0044600] g22710.t1 P49760 65.812 117 6.37e-44 158.0 sp|P49760|CLK2_HUMAN Dual specificity protein kinase CLK2 OS=Homo sapiens OX=9606 GN=CLK2 PE=1 SV=1 CLK2_HUMAN reviewed Dual specificity protein kinase CLK2 (EC 2.7.12.1) (CDC-like kinase 2) Homo sapiens (Human) GO:0004674; GO:0004712; GO:0004713; GO:0005524; GO:0005634; GO:0005654; GO:0006468; GO:0010212; GO:0016604; GO:0016607; GO:0042802; GO:0043484; GO:0045721; GO:0046777; GO:0106310 negative regulation of gluconeogenesis [GO:0045721]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of RNA splicing [GO:0043484]; response to ionizing radiation [GO:0010212] nuclear body [GO:0016604]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] ATP binding [GO:0005524]; identical protein binding [GO:0042802]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713] g22710.t1 P49760 69.565 69 3.3500000000000006e-27 112.0 sp|P49760|CLK2_HUMAN Dual specificity protein kinase CLK2 OS=Homo sapiens OX=9606 GN=CLK2 PE=1 SV=1 CLK2_HUMAN reviewed Dual specificity protein kinase CLK2 (EC 2.7.12.1) (CDC-like kinase 2) Homo sapiens (Human) GO:0004674; GO:0004712; GO:0004713; GO:0005524; GO:0005634; GO:0005654; GO:0006468; GO:0010212; GO:0016604; GO:0016607; GO:0042802; GO:0043484; GO:0045721; GO:0046777; GO:0106310 negative regulation of gluconeogenesis [GO:0045721]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of RNA splicing [GO:0043484]; response to ionizing radiation [GO:0010212] nuclear body [GO:0016604]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] ATP binding [GO:0005524]; identical protein binding [GO:0042802]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713] g22713.t1 Q8BI55 52.354 531 0.0 582.0 sp|Q8BI55|DYRK4_MOUSE Dual specificity tyrosine-phosphorylation-regulated kinase 4 OS=Mus musculus OX=10090 GN=Dyrk4 PE=2 SV=1 DYRK4_MOUSE reviewed Dual specificity tyrosine-phosphorylation-regulated kinase 4 (EC 2.7.12.1) Mus musculus (Mouse) GO:0004674; GO:0004712; GO:0004713; GO:0005524; GO:0005634; GO:0005737; GO:0005856; GO:0046872; GO:0106310 cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; nucleus [GO:0005634] ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713] g22713.t2 Q8BI55 52.354 531 0.0 582.0 sp|Q8BI55|DYRK4_MOUSE Dual specificity tyrosine-phosphorylation-regulated kinase 4 OS=Mus musculus OX=10090 GN=Dyrk4 PE=2 SV=1 DYRK4_MOUSE reviewed Dual specificity tyrosine-phosphorylation-regulated kinase 4 (EC 2.7.12.1) Mus musculus (Mouse) GO:0004674; GO:0004712; GO:0004713; GO:0005524; GO:0005634; GO:0005737; GO:0005856; GO:0046872; GO:0106310 cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; nucleus [GO:0005634] ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713] g22714.t1 P07858 45.223 314 1.56e-70 224.0 sp|P07858|CATB_HUMAN Cathepsin B OS=Homo sapiens OX=9606 GN=CTSB PE=1 SV=3 CATB_HUMAN reviewed Cathepsin B (EC 3.4.22.1) (APP secretase) (APPS) (Cathepsin B1) [Cleaved into: Cathepsin B light chain; Cathepsin B heavy chain] Homo sapiens (Human) GO:0004197; GO:0005518; GO:0005576; GO:0005615; GO:0005764; GO:0006508; GO:0006590; GO:0008233; GO:0008234; GO:0009897; GO:0016324; GO:0030574; GO:0030855; GO:0031012; GO:0036021; GO:0042470; GO:0042981; GO:0043394; GO:0046697; GO:0046718; GO:0048471; GO:0051603; GO:0070062; GO:0097067; GO:1904090; GO:1904813 cellular response to thyroid hormone stimulus [GO:0097067]; collagen catabolic process [GO:0030574]; decidualization [GO:0046697]; epithelial cell differentiation [GO:0030855]; proteolysis [GO:0006508]; proteolysis involved in protein catabolic process [GO:0051603]; regulation of apoptotic process [GO:0042981]; symbiont entry into host cell [GO:0046718]; thyroid hormone generation [GO:0006590] apical plasma membrane [GO:0016324]; endolysosome lumen [GO:0036021]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; ficolin-1-rich granule lumen [GO:1904813]; lysosome [GO:0005764]; melanosome [GO:0042470]; peptidase inhibitor complex [GO:1904090]; perinuclear region of cytoplasm [GO:0048471] collagen binding [GO:0005518]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]; peptidase activity [GO:0008233]; proteoglycan binding [GO:0043394] g22717.t1 Q14693 34.88 668 1.07e-89 307.0 sp|Q14693|LPIN1_HUMAN Phosphatidate phosphatase LPIN1 OS=Homo sapiens OX=9606 GN=LPIN1 PE=1 SV=2 g22717.t1 Q14693 60.656 122 1.56e-34 146.0 sp|Q14693|LPIN1_HUMAN Phosphatidate phosphatase LPIN1 OS=Homo sapiens OX=9606 GN=LPIN1 PE=1 SV=2 g22717.t2 Q99PI5 39.484 504 4.89e-86 297.0 sp|Q99PI5|LPIN2_MOUSE Phosphatidate phosphatase LPIN2 OS=Mus musculus OX=10090 GN=Lpin2 PE=1 SV=2 LPIN2_MOUSE reviewed Phosphatidate phosphatase LPIN2 (EC 3.1.3.4) (Lipin-2) Mus musculus (Mouse) GO:0003713; GO:0005634; GO:0005789; GO:0005829; GO:0006629; GO:0008195; GO:0009062; GO:0019432; GO:0032869; GO:0045944 cellular response to insulin stimulus [GO:0032869]; fatty acid catabolic process [GO:0009062]; lipid metabolic process [GO:0006629]; positive regulation of transcription by RNA polymerase II [GO:0045944]; triglyceride biosynthetic process [GO:0019432] cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; nucleus [GO:0005634] phosphatidate phosphatase activity [GO:0008195]; transcription coactivator activity [GO:0003713] g22717.t2 Q99PI5 62.037 108 9.12e-32 137.0 sp|Q99PI5|LPIN2_MOUSE Phosphatidate phosphatase LPIN2 OS=Mus musculus OX=10090 GN=Lpin2 PE=1 SV=2 LPIN2_MOUSE reviewed Phosphatidate phosphatase LPIN2 (EC 3.1.3.4) (Lipin-2) Mus musculus (Mouse) GO:0003713; GO:0005634; GO:0005789; GO:0005829; GO:0006629; GO:0008195; GO:0009062; GO:0019432; GO:0032869; GO:0045944 cellular response to insulin stimulus [GO:0032869]; fatty acid catabolic process [GO:0009062]; lipid metabolic process [GO:0006629]; positive regulation of transcription by RNA polymerase II [GO:0045944]; triglyceride biosynthetic process [GO:0019432] cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; nucleus [GO:0005634] phosphatidate phosphatase activity [GO:0008195]; transcription coactivator activity [GO:0003713] g22720.t1 Q5XHF9 31.415 417 1.59e-47 177.0 sp|Q5XHF9|S20A2_XENLA Sodium-dependent phosphate transporter 2 OS=Xenopus laevis OX=8355 GN=slc20a2 PE=2 SV=1 g22721.t1 Q63488 54.822 197 2.71e-63 222.0 sp|Q63488|S20A2_RAT Sodium-dependent phosphate transporter 2 OS=Rattus norvegicus OX=10116 GN=Slc20a2 PE=1 SV=1 S20A2_RAT reviewed Sodium-dependent phosphate transporter 2 (Phosphate transporter 2) (PiT-2) (Receptor for amphotropic viruses 1) (RAM-1) (Solute carrier family 20 member 2) Rattus norvegicus (Rat) GO:0001618; GO:0005315; GO:0005436; GO:0005886; GO:0016324; GO:0030501; GO:0031526; GO:0035435 phosphate ion transmembrane transport [GO:0035435]; positive regulation of bone mineralization [GO:0030501] apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; plasma membrane [GO:0005886] phosphate transmembrane transporter activity [GO:0005315]; sodium:phosphate symporter activity [GO:0005436]; virus receptor activity [GO:0001618] g22721.t1 Q63488 42.91 268 4.27e-45 172.0 sp|Q63488|S20A2_RAT Sodium-dependent phosphate transporter 2 OS=Rattus norvegicus OX=10116 GN=Slc20a2 PE=1 SV=1 S20A2_RAT reviewed Sodium-dependent phosphate transporter 2 (Phosphate transporter 2) (PiT-2) (Receptor for amphotropic viruses 1) (RAM-1) (Solute carrier family 20 member 2) Rattus norvegicus (Rat) GO:0001618; GO:0005315; GO:0005436; GO:0005886; GO:0016324; GO:0030501; GO:0031526; GO:0035435 phosphate ion transmembrane transport [GO:0035435]; positive regulation of bone mineralization [GO:0030501] apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; plasma membrane [GO:0005886] phosphate transmembrane transporter activity [GO:0005315]; sodium:phosphate symporter activity [GO:0005436]; virus receptor activity [GO:0001618] g22722.t1 Q9NL40 57.386 528 1.71e-168 507.0 sp|Q9NL40|TBR1_PATPE T-box protein 1 OS=Patiria pectinifera OX=7594 GN=tbr1 PE=2 SV=1 g22725.t1 P46023 31.558 507 9.11e-82 285.0 sp|P46023|GR101_LYMST G-protein coupled receptor GRL101 OS=Lymnaea stagnalis OX=6523 PE=2 SV=1 g22726.t1 O97578 46.29 283 5.78e-72 233.0 sp|O97578|CATC_CANLF Dipeptidyl peptidase 1 (Fragment) OS=Canis lupus familiaris OX=9615 GN=CTSC PE=1 SV=1 g22727.t1 P80067 61.905 105 1.94e-40 142.0 sp|P80067|CATC_RAT Dipeptidyl peptidase 1 OS=Rattus norvegicus OX=10116 GN=Ctsc PE=1 SV=3 CATC_RAT reviewed Dipeptidyl peptidase 1 (EC 3.4.14.1) (Cathepsin C) (Cathepsin J) (Dipeptidyl peptidase I) (DPP-I) (DPPI) (Dipeptidyl transferase) [Cleaved into: Dipeptidyl peptidase 1 exclusion domain chain (Dipeptidyl peptidase I exclusion domain chain); Dipeptidyl peptidase 1 heavy chain (Dipeptidyl peptidase I heavy chain); Dipeptidyl peptidase 1 light chain (Dipeptidyl peptidase I light chain)] Rattus norvegicus (Rat) GO:0001913; GO:0004197; GO:0004252; GO:0005615; GO:0005654; GO:0005737; GO:0005764; GO:0005813; GO:0006508; GO:0008234; GO:0008239; GO:0016505; GO:0019902; GO:0031404; GO:0031642; GO:0042802; GO:0051087; GO:0051603; GO:1903052; GO:1903980; GO:2001235 negative regulation of myelination [GO:0031642]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of microglial cell activation [GO:1903980]; positive regulation of proteolysis involved in protein catabolic process [GO:1903052]; proteolysis [GO:0006508]; proteolysis involved in protein catabolic process [GO:0051603]; T cell mediated cytotoxicity [GO:0001913] centrosome [GO:0005813]; cytoplasm [GO:0005737]; extracellular space [GO:0005615]; lysosome [GO:0005764]; nucleoplasm [GO:0005654] chloride ion binding [GO:0031404]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]; dipeptidyl-peptidase activity [GO:0008239]; identical protein binding [GO:0042802]; peptidase activator activity involved in apoptotic process [GO:0016505]; phosphatase binding [GO:0019902]; protein-folding chaperone binding [GO:0051087]; serine-type endopeptidase activity [GO:0004252] g22730.t1 Q5I0X7 42.105 133 2.6e-28 105.0 sp|Q5I0X7|TTC32_HUMAN Tetratricopeptide repeat protein 32 OS=Homo sapiens OX=9606 GN=TTC32 PE=1 SV=1 g22731.t1 Q9D361 34.657 277 9.710000000000001e-37 140.0 sp|Q9D361|SNR48_MOUSE U11/U12 small nuclear ribonucleoprotein 48 kDa protein OS=Mus musculus OX=10090 GN=Snrnp48 PE=2 SV=2 g22731.t2 Q9D361 33.564 289 2.3700000000000002e-35 137.0 sp|Q9D361|SNR48_MOUSE U11/U12 small nuclear ribonucleoprotein 48 kDa protein OS=Mus musculus OX=10090 GN=Snrnp48 PE=2 SV=2 g22733.t1 Q8BND3 66.833 1206 0.0 1681.0 sp|Q8BND3|WDR35_MOUSE WD repeat-containing protein 35 OS=Mus musculus OX=10090 GN=Wdr35 PE=1 SV=3 WDR35_MOUSE reviewed WD repeat-containing protein 35 Mus musculus (Mouse) GO:0005813; GO:0005929; GO:0005930; GO:0010629; GO:0030991; GO:0035721; GO:0036064; GO:0042073; GO:0045019; GO:0045907; GO:0060271; GO:0061512; GO:0071356; GO:0090200; GO:1990830; GO:2001238 cellular response to leukemia inhibitory factor [GO:1990830]; cellular response to tumor necrosis factor [GO:0071356]; cilium assembly [GO:0060271]; intraciliary retrograde transport [GO:0035721]; intraciliary transport [GO:0042073]; negative regulation of gene expression [GO:0010629]; negative regulation of nitric oxide biosynthetic process [GO:0045019]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; positive regulation of vasoconstriction [GO:0045907]; protein localization to cilium [GO:0061512] axoneme [GO:0005930]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; intraciliary transport particle A [GO:0030991] g22733.t2 A6N6J5 67.28 1195 0.0 1684.0 sp|A6N6J5|WDR35_RAT WD repeat-containing protein 35 OS=Rattus norvegicus OX=10116 GN=Wdr35 PE=1 SV=1 WDR35_RAT reviewed WD repeat-containing protein 35 (Naofen) Rattus norvegicus (Rat) GO:0005813; GO:0005930; GO:0009636; GO:0010629; GO:0030991; GO:0032496; GO:0035721; GO:0036064; GO:0042073; GO:0045019; GO:0045907; GO:0060271; GO:0061512; GO:0071333; GO:0071356; GO:0071466; GO:0090200; GO:0097421; GO:1990830; GO:2001238 cellular response to glucose stimulus [GO:0071333]; cellular response to leukemia inhibitory factor [GO:1990830]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to xenobiotic stimulus [GO:0071466]; cilium assembly [GO:0060271]; intraciliary retrograde transport [GO:0035721]; intraciliary transport [GO:0042073]; liver regeneration [GO:0097421]; negative regulation of gene expression [GO:0010629]; negative regulation of nitric oxide biosynthetic process [GO:0045019]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; positive regulation of vasoconstriction [GO:0045907]; protein localization to cilium [GO:0061512]; response to lipopolysaccharide [GO:0032496]; response to toxic substance [GO:0009636] axoneme [GO:0005930]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; intraciliary transport particle A [GO:0030991] g22734.t1 P58375 79.104 67 1.2600000000000002e-31 108.0 sp|P58375|RL30_SPOFR Large ribosomal subunit protein eL30 OS=Spodoptera frugiperda OX=7108 GN=RpL30 PE=3 SV=1 g22735.t1 Q9D6T1 64.523 482 0.0 584.0 sp|Q9D6T1|TBE_MOUSE Tubulin epsilon chain OS=Mus musculus OX=10090 GN=Tube1 PE=1 SV=1 g22736.t1 Q52KK3 49.776 223 2.2000000000000002e-79 243.0 sp|Q52KK3|S2551_RAT Mitochondrial nicotinamide adenine dinucleotide transporter SLC25A51 OS=Rattus norvegicus OX=10116 GN=Slc25a51 PE=2 SV=1 g22739.t1 P82151 36.929 241 6.04e-28 112.0 sp|P82151|LEC6_TACTR Lectin L6 OS=Tachypleus tridentatus OX=6853 PE=1 SV=1 g22740.t1 Q8BGC3 28.022 364 1.2400000000000001e-29 123.0 sp|Q8BGC3|MOT12_MOUSE Monocarboxylate transporter 12 OS=Mus musculus OX=10090 GN=Slc16a12 PE=1 SV=1 g22741.t1 Q9H2Y9 27.08 613 7.97e-56 206.0 sp|Q9H2Y9|SO5A1_HUMAN Solute carrier organic anion transporter family member 5A1 OS=Homo sapiens OX=9606 GN=SLCO5A1 PE=1 SV=2 g22742.t1 Q9H2Y9 30.971 649 6.11e-82 278.0 sp|Q9H2Y9|SO5A1_HUMAN Solute carrier organic anion transporter family member 5A1 OS=Homo sapiens OX=9606 GN=SLCO5A1 PE=1 SV=2 g22742.t2 Q9H2Y9 30.971 649 6.64e-82 279.0 sp|Q9H2Y9|SO5A1_HUMAN Solute carrier organic anion transporter family member 5A1 OS=Homo sapiens OX=9606 GN=SLCO5A1 PE=1 SV=2 g22743.t1 Q8BXB6 28.384 687 1.8199999999999998e-81 276.0 sp|Q8BXB6|SO2B1_MOUSE Solute carrier organic anion transporter family member 2B1 OS=Mus musculus OX=10090 GN=Slco2b1 PE=1 SV=1 SO2B1_MOUSE reviewed Solute carrier organic anion transporter family member 2B1 (Organic anion transporting polypeptide 2B1) (OATP2B1) (Solute carrier family 21 member 9) Mus musculus (Mouse) GO:0005886; GO:0006879; GO:0008283; GO:0008514; GO:0009925; GO:0010106; GO:0010496; GO:0015125; GO:0015132; GO:0015347; GO:0015711; GO:0015721; GO:0016323; GO:0016324; GO:0022857; GO:0042908; GO:0043252; GO:0055085; GO:0071718; GO:0140420 bile acid and bile salt transport [GO:0015721]; cell population proliferation [GO:0008283]; cellular response to iron ion starvation [GO:0010106]; heme import into cell [GO:0140420]; intercellular transport [GO:0010496]; intracellular iron ion homeostasis [GO:0006879]; organic anion transport [GO:0015711]; sodium-independent icosanoid transport [GO:0071718]; sodium-independent organic anion transport [GO:0043252]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908] apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; plasma membrane [GO:0005886] bile acid transmembrane transporter activity [GO:0015125]; organic anion transmembrane transporter activity [GO:0008514]; prostaglandin transmembrane transporter activity [GO:0015132]; sodium-independent organic anion transmembrane transporter activity [GO:0015347]; transmembrane transporter activity [GO:0022857] g22745.t1 Q9EPT5 30.354 593 7.18e-63 230.0 sp|Q9EPT5|SO2A1_MOUSE Solute carrier organic anion transporter family member 2A1 OS=Mus musculus OX=10090 GN=Slco2a1 PE=1 SV=2 SO2A1_MOUSE reviewed Solute carrier organic anion transporter family member 2A1 (SLCO2A1) (OATP2A1) (PHOAR2) (Prostaglandin transporter) (PGT) (Solute carrier family 21 member 2) (SLC21A2) Mus musculus (Mouse) GO:0005764; GO:0005886; GO:0009925; GO:0015132; GO:0015347; GO:0015732; GO:0016323; GO:0043252 prostaglandin transport [GO:0015732]; sodium-independent organic anion transport [GO:0043252] basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; lysosome [GO:0005764]; plasma membrane [GO:0005886] prostaglandin transmembrane transporter activity [GO:0015132]; sodium-independent organic anion transmembrane transporter activity [GO:0015347] g22750.t1 Q9GMU6 27.675 542 8.9e-46 174.0 sp|Q9GMU6|SO1C1_MACFA Solute carrier organic anion transporter family member 1C1 OS=Macaca fascicularis OX=9541 GN=SLCO1C1 PE=2 SV=1 g22761.t2 Q8K1T0 39.576 283 9.559999999999999e-48 179.0 sp|Q8K1T0|TMPS3_MOUSE Transmembrane protease serine 3 OS=Mus musculus OX=10090 GN=Tmprss3 PE=1 SV=2 TMPS3_MOUSE reviewed Transmembrane protease serine 3 (EC 3.4.21.-) Mus musculus (Mouse) GO:0004252; GO:0005783; GO:0005789; GO:0006508; GO:0006883; GO:0007605; GO:0008236; GO:0017080; GO:0043025 intracellular sodium ion homeostasis [GO:0006883]; proteolysis [GO:0006508]; sensory perception of sound [GO:0007605] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; neuronal cell body [GO:0043025] serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]; sodium channel regulator activity [GO:0017080] g22761.t3 Q8K1T0 39.576 283 4.32e-47 179.0 sp|Q8K1T0|TMPS3_MOUSE Transmembrane protease serine 3 OS=Mus musculus OX=10090 GN=Tmprss3 PE=1 SV=2 TMPS3_MOUSE reviewed Transmembrane protease serine 3 (EC 3.4.21.-) Mus musculus (Mouse) GO:0004252; GO:0005783; GO:0005789; GO:0006508; GO:0006883; GO:0007605; GO:0008236; GO:0017080; GO:0043025 intracellular sodium ion homeostasis [GO:0006883]; proteolysis [GO:0006508]; sensory perception of sound [GO:0007605] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; neuronal cell body [GO:0043025] serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]; sodium channel regulator activity [GO:0017080] g22762.t1 A0A182C2Z2 35.0 340 1.0499999999999999e-41 171.0 sp|A0A182C2Z2|OVCH_HALRO Ovochymase OS=Halocynthia roretzi OX=7729 GN=OVCH PE=1 SV=1 g22762.t1 A0A182C2Z2 25.937 347 2.01e-21 105.0 sp|A0A182C2Z2|OVCH_HALRO Ovochymase OS=Halocynthia roretzi OX=7729 GN=OVCH PE=1 SV=1 g22765.t1 Q5GLH2 55.814 344 2.2400000000000002e-125 366.0 sp|Q5GLH2|TRIB2_BOVIN Tribbles homolog 2 OS=Bos taurus OX=9913 GN=TRIB2 PE=2 SV=1 g22767.t1 F1R983 52.174 92 1.2299999999999998e-23 109.0 sp|F1R983|CTIP_DANRE DNA endonuclease RBBP8 OS=Danio rerio OX=7955 GN=rbbp8 PE=2 SV=1 g22768.t1 Q66H59 41.503 306 1.7e-75 248.0 sp|Q66H59|NPL_RAT N-acetylneuraminate lyase OS=Rattus norvegicus OX=10116 GN=Npl PE=2 SV=1 g22771.t1 O08725 35.862 290 1.7500000000000002e-43 159.0 sp|O08725|GHSR_RAT Growth hormone secretagogue receptor type 1 OS=Rattus norvegicus OX=10116 GN=Ghsr PE=2 SV=1 g22772.t1 Q53T59 37.121 132 7.75e-29 116.0 sp|Q53T59|H1BP3_HUMAN HCLS1-binding protein 3 OS=Homo sapiens OX=9606 GN=HS1BP3 PE=1 SV=1 H1BP3_HUMAN reviewed HCLS1-binding protein 3 (HS1-binding protein 3) (HSP1BP-3) Homo sapiens (Human) GO:0005739; GO:0005783; GO:0035091; GO:0042981 regulation of apoptotic process [GO:0042981] endoplasmic reticulum [GO:0005783]; mitochondrion [GO:0005739] phosphatidylinositol binding [GO:0035091] g22773.t1 Q803I2 66.41 390 0.0 544.0 sp|Q803I2|ERGI3_DANRE Endoplasmic reticulum-Golgi intermediate compartment protein 3 OS=Danio rerio OX=7955 GN=ergic3 PE=2 SV=1 ERGI3_DANRE reviewed Endoplasmic reticulum-Golgi intermediate compartment protein 3 Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000139; GO:0005783; GO:0005789; GO:0006888; GO:0006890; GO:0030134; GO:0033116 endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890] COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi membrane [GO:0000139] g22774.t1 A4QNF3 65.854 82 2.89e-27 97.4 sp|A4QNF3|ROMO1_XENTR Reactive oxygen species modulator 1 OS=Xenopus tropicalis OX=8364 GN=romo1 PE=3 SV=1 g22775.t1 Q58D08 38.258 264 1.71e-62 202.0 sp|Q58D08|P5CR3_BOVIN Pyrroline-5-carboxylate reductase 3 OS=Bos taurus OX=9913 GN=PYCR3 PE=2 SV=1 g22776.t1 Q9JKP8 48.936 94 4.58e-25 94.4 sp|Q9JKP8|CHRC1_MOUSE Chromatin accessibility complex protein 1 OS=Mus musculus OX=10090 GN=Chrac1 PE=1 SV=1 g22777.t1 Q3U0M1 40.722 1164 0.0 843.0 sp|Q3U0M1|TPPC9_MOUSE Trafficking protein particle complex subunit 9 OS=Mus musculus OX=10090 GN=Trappc9 PE=1 SV=2 TPPC9_MOUSE reviewed Trafficking protein particle complex subunit 9 (NIK- and IKBKB-binding protein) Mus musculus (Mouse) GO:0005737; GO:0005783; GO:0005802; GO:0006888; GO:0006901; GO:0021987; GO:0030008; GO:0030182; GO:0099022; GO:1990071 cerebral cortex development [GO:0021987]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; neuron differentiation [GO:0030182]; vesicle coating [GO:0006901]; vesicle tethering [GO:0099022] cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; trans-Golgi network [GO:0005802]; TRAPP complex [GO:0030008]; TRAPPII protein complex [GO:1990071] g22778.t1 Q63187 44.762 210 1.6e-46 182.0 sp|Q63187|ELOA1_RAT Elongin-A OS=Rattus norvegicus OX=10116 GN=Eloa PE=1 SV=1 g22779.t1 Q9DBU0 64.202 514 0.0 611.0 sp|Q9DBU0|TM9S1_MOUSE Transmembrane 9 superfamily member 1 OS=Mus musculus OX=10090 GN=Tm9sf1 PE=2 SV=2 g22781.t1 Q5ZJX4 50.0 190 2.45e-46 156.0 sp|Q5ZJX4|RBM38_CHICK RNA-binding protein 38 OS=Gallus gallus OX=9031 GN=RBM38 PE=2 SV=1 g22781.t2 Q5ZJX4 49.735 189 2.13e-46 156.0 sp|Q5ZJX4|RBM38_CHICK RNA-binding protein 38 OS=Gallus gallus OX=9031 GN=RBM38 PE=2 SV=1 g22783.t1 A1X158 31.713 432 2.44e-61 219.0 sp|A1X158|FP1V1_PERVI Foot protein 1 variant 1 OS=Perna viridis OX=73031 GN=fp-1 PE=1 SV=1 g22783.t1 A1X158 31.481 432 5.9799999999999996e-61 218.0 sp|A1X158|FP1V1_PERVI Foot protein 1 variant 1 OS=Perna viridis OX=73031 GN=fp-1 PE=1 SV=1 g22783.t1 A1X158 31.481 432 5.9799999999999996e-61 218.0 sp|A1X158|FP1V1_PERVI Foot protein 1 variant 1 OS=Perna viridis OX=73031 GN=fp-1 PE=1 SV=1 g22783.t1 A1X158 31.25 432 9.04e-61 218.0 sp|A1X158|FP1V1_PERVI Foot protein 1 variant 1 OS=Perna viridis OX=73031 GN=fp-1 PE=1 SV=1 g22783.t1 A1X158 31.25 432 9.04e-61 218.0 sp|A1X158|FP1V1_PERVI Foot protein 1 variant 1 OS=Perna viridis OX=73031 GN=fp-1 PE=1 SV=1 g22783.t1 A1X158 31.293 441 1.06e-60 217.0 sp|A1X158|FP1V1_PERVI Foot protein 1 variant 1 OS=Perna viridis OX=73031 GN=fp-1 PE=1 SV=1 g22783.t1 A1X158 31.25 432 1.19e-60 217.0 sp|A1X158|FP1V1_PERVI Foot protein 1 variant 1 OS=Perna viridis OX=73031 GN=fp-1 PE=1 SV=1 g22783.t1 A1X158 31.25 432 1.47e-60 217.0 sp|A1X158|FP1V1_PERVI Foot protein 1 variant 1 OS=Perna viridis OX=73031 GN=fp-1 PE=1 SV=1 g22783.t1 A1X158 31.25 432 1.47e-60 217.0 sp|A1X158|FP1V1_PERVI Foot protein 1 variant 1 OS=Perna viridis OX=73031 GN=fp-1 PE=1 SV=1 g22783.t1 A1X158 31.019 432 1.7899999999999998e-60 217.0 sp|A1X158|FP1V1_PERVI Foot protein 1 variant 1 OS=Perna viridis OX=73031 GN=fp-1 PE=1 SV=1 g22783.t1 A1X158 31.019 432 1.7899999999999998e-60 217.0 sp|A1X158|FP1V1_PERVI Foot protein 1 variant 1 OS=Perna viridis OX=73031 GN=fp-1 PE=1 SV=1 g22783.t1 A1X158 31.019 432 2.22e-60 216.0 sp|A1X158|FP1V1_PERVI Foot protein 1 variant 1 OS=Perna viridis OX=73031 GN=fp-1 PE=1 SV=1 g22783.t1 A1X158 31.019 432 2.22e-60 216.0 sp|A1X158|FP1V1_PERVI Foot protein 1 variant 1 OS=Perna viridis OX=73031 GN=fp-1 PE=1 SV=1 g22783.t1 A1X158 31.019 432 2.91e-60 216.0 sp|A1X158|FP1V1_PERVI Foot protein 1 variant 1 OS=Perna viridis OX=73031 GN=fp-1 PE=1 SV=1 g22783.t1 A1X158 31.25 432 4.2199999999999996e-60 216.0 sp|A1X158|FP1V1_PERVI Foot protein 1 variant 1 OS=Perna viridis OX=73031 GN=fp-1 PE=1 SV=1 g22783.t1 A1X158 31.25 432 5.539999999999999e-60 215.0 sp|A1X158|FP1V1_PERVI Foot protein 1 variant 1 OS=Perna viridis OX=73031 GN=fp-1 PE=1 SV=1 g22783.t1 A1X158 30.787 432 7.12e-60 215.0 sp|A1X158|FP1V1_PERVI Foot protein 1 variant 1 OS=Perna viridis OX=73031 GN=fp-1 PE=1 SV=1 g22783.t1 A1X158 30.787 432 7.12e-60 215.0 sp|A1X158|FP1V1_PERVI Foot protein 1 variant 1 OS=Perna viridis OX=73031 GN=fp-1 PE=1 SV=1 g22783.t1 A1X158 30.556 432 1.08e-59 214.0 sp|A1X158|FP1V1_PERVI Foot protein 1 variant 1 OS=Perna viridis OX=73031 GN=fp-1 PE=1 SV=1 g22783.t1 A1X158 31.354 421 2.63e-59 213.0 sp|A1X158|FP1V1_PERVI Foot protein 1 variant 1 OS=Perna viridis OX=73031 GN=fp-1 PE=1 SV=1 g22783.t1 A1X158 31.116 421 7.0400000000000005e-59 212.0 sp|A1X158|FP1V1_PERVI Foot protein 1 variant 1 OS=Perna viridis OX=73031 GN=fp-1 PE=1 SV=1 g22784.t1 Q01518 43.707 437 1.66e-109 342.0 sp|Q01518|CAP1_HUMAN Adenylyl cyclase-associated protein 1 OS=Homo sapiens OX=9606 GN=CAP1 PE=1 SV=5 CAP1_HUMAN reviewed Adenylyl cyclase-associated protein 1 (CAP 1) Homo sapiens (Human) GO:0000902; GO:0001667; GO:0003779; GO:0005576; GO:0005737; GO:0005886; GO:0005925; GO:0006898; GO:0007015; GO:0007163; GO:0007165; GO:0007190; GO:0008179; GO:0019933; GO:0030864; GO:0035578; GO:0070062; GO:0098793; GO:0098794; GO:0098885; GO:0098978 actin filament organization [GO:0007015]; activation of adenylate cyclase activity [GO:0007190]; ameboidal-type cell migration [GO:0001667]; cAMP-mediated signaling [GO:0019933]; cell morphogenesis [GO:0000902]; establishment or maintenance of cell polarity [GO:0007163]; modification of postsynaptic actin cytoskeleton [GO:0098885]; receptor-mediated endocytosis [GO:0006898]; signal transduction [GO:0007165] azurophil granule lumen [GO:0035578]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; presynapse [GO:0098793] actin binding [GO:0003779]; adenylate cyclase binding [GO:0008179] g22784.t1 Q01518 35.266 207 3.12e-36 145.0 sp|Q01518|CAP1_HUMAN Adenylyl cyclase-associated protein 1 OS=Homo sapiens OX=9606 GN=CAP1 PE=1 SV=5 CAP1_HUMAN reviewed Adenylyl cyclase-associated protein 1 (CAP 1) Homo sapiens (Human) GO:0000902; GO:0001667; GO:0003779; GO:0005576; GO:0005737; GO:0005886; GO:0005925; GO:0006898; GO:0007015; GO:0007163; GO:0007165; GO:0007190; GO:0008179; GO:0019933; GO:0030864; GO:0035578; GO:0070062; GO:0098793; GO:0098794; GO:0098885; GO:0098978 actin filament organization [GO:0007015]; activation of adenylate cyclase activity [GO:0007190]; ameboidal-type cell migration [GO:0001667]; cAMP-mediated signaling [GO:0019933]; cell morphogenesis [GO:0000902]; establishment or maintenance of cell polarity [GO:0007163]; modification of postsynaptic actin cytoskeleton [GO:0098885]; receptor-mediated endocytosis [GO:0006898]; signal transduction [GO:0007165] azurophil granule lumen [GO:0035578]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; presynapse [GO:0098793] actin binding [GO:0003779]; adenylate cyclase binding [GO:0008179] g22786.t1 Q91YR7 69.288 941 0.0 1254.0 sp|Q91YR7|PRP6_MOUSE Pre-mRNA-processing factor 6 OS=Mus musculus OX=10090 GN=Prpf6 PE=1 SV=1 PRP6_MOUSE reviewed Pre-mRNA-processing factor 6 (PRP6 homolog) (U5 snRNP-associated 102 kDa protein) (U5-102 kDa protein) Mus musculus (Mouse) GO:0000244; GO:0000398; GO:0003713; GO:0003723; GO:0005634; GO:0005654; GO:0005681; GO:0005682; GO:0005813; GO:0005829; GO:0006403; GO:0016607; GO:0030674; GO:0036064; GO:0042802; GO:0043021; GO:0045944; GO:0046540; GO:0050681; GO:0071005; GO:0071013 mRNA splicing, via spliceosome [GO:0000398]; positive regulation of transcription by RNA polymerase II [GO:0045944]; RNA localization [GO:0006403]; spliceosomal tri-snRNP complex assembly [GO:0000244] catalytic step 2 spliceosome [GO:0071013]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682] identical protein binding [GO:0042802]; nuclear androgen receptor binding [GO:0050681]; protein-macromolecule adaptor activity [GO:0030674]; ribonucleoprotein complex binding [GO:0043021]; RNA binding [GO:0003723]; transcription coactivator activity [GO:0003713] g22787.t1 Q8NF86 33.333 267 1.72e-30 123.0 sp|Q8NF86|PRS33_HUMAN Serine protease 33 OS=Homo sapiens OX=9606 GN=PRSS33 PE=1 SV=3 g22791.t1 Q8CB19 55.714 350 6.430000000000001e-103 338.0 sp|Q8CB19|PHTF2_MOUSE Protein PHTF2 OS=Mus musculus OX=10090 GN=Phtf2 PE=1 SV=2 g22791.t1 Q8CB19 40.506 158 5.2600000000000004e-21 102.0 sp|Q8CB19|PHTF2_MOUSE Protein PHTF2 OS=Mus musculus OX=10090 GN=Phtf2 PE=1 SV=2 g22795.t1 Q8WQI5 77.404 208 5.37e-110 316.0 sp|Q8WQI5|RS8_SPOFR Small ribosomal subunit protein eS8 OS=Spodoptera frugiperda OX=7108 GN=RpS8 PE=2 SV=1 g22796.t1 Q8BKN5 35.86 1082 0.0 576.0 sp|Q8BKN5|GCP5_MOUSE Gamma-tubulin complex component 5 OS=Mus musculus OX=10090 GN=Tubgcp5 PE=2 SV=2 g22800.t1 Q9H2Y9 25.21 476 3.1900000000000004e-27 120.0 sp|Q9H2Y9|SO5A1_HUMAN Solute carrier organic anion transporter family member 5A1 OS=Homo sapiens OX=9606 GN=SLCO5A1 PE=1 SV=2 g22801.t1 Q8K078 39.801 603 6.03e-148 448.0 sp|Q8K078|SO4A1_MOUSE Solute carrier organic anion transporter family member 4A1 OS=Mus musculus OX=10090 GN=Slco4a1 PE=1 SV=2 SO4A1_MOUSE reviewed Solute carrier organic anion transporter family member 4A1 (Organic anion-transporting polypeptide E) (OATP-E) (Sodium-independent organic anion transporter E) (Solute carrier family 21 member 12) Mus musculus (Mouse) GO:0005886; GO:0006811; GO:0008514; GO:0015132; GO:0015347; GO:0015349; GO:0015711; GO:0016323; GO:0042403; GO:0043252 monoatomic ion transport [GO:0006811]; organic anion transport [GO:0015711]; sodium-independent organic anion transport [GO:0043252]; thyroid hormone metabolic process [GO:0042403] basolateral plasma membrane [GO:0016323]; plasma membrane [GO:0005886] organic anion transmembrane transporter activity [GO:0008514]; prostaglandin transmembrane transporter activity [GO:0015132]; sodium-independent organic anion transmembrane transporter activity [GO:0015347]; thyroid hormone transmembrane transporter activity [GO:0015349] g22805.t1 Q5DU00 40.097 207 1.59e-42 160.0 sp|Q5DU00|DCDC2_MOUSE Doublecortin domain-containing protein 2 OS=Mus musculus OX=10090 GN=Dcdc2 PE=1 SV=2 DCDC2_MOUSE reviewed Doublecortin domain-containing protein 2 Mus musculus (Mouse) GO:0001764; GO:0005737; GO:0005815; GO:0005874; GO:0005929; GO:0005930; GO:0007605; GO:0008542; GO:0019228; GO:0019894; GO:0030111; GO:0035249; GO:0035556; GO:0045202; GO:0048813; GO:0060091; GO:0060271; GO:1902017 cilium assembly [GO:0060271]; dendrite morphogenesis [GO:0048813]; intracellular signal transduction [GO:0035556]; neuron migration [GO:0001764]; neuronal action potential [GO:0019228]; regulation of cilium assembly [GO:1902017]; regulation of Wnt signaling pathway [GO:0030111]; sensory perception of sound [GO:0007605]; synaptic transmission, glutamatergic [GO:0035249]; visual learning [GO:0008542] axoneme [GO:0005930]; cilium [GO:0005929]; cytoplasm [GO:0005737]; kinocilium [GO:0060091]; microtubule [GO:0005874]; microtubule organizing center [GO:0005815]; synapse [GO:0045202] kinesin binding [GO:0019894] g22806.t1 Q96BD0 41.978 455 2.09e-103 327.0 sp|Q96BD0|SO4A1_HUMAN Solute carrier organic anion transporter family member 4A1 OS=Homo sapiens OX=9606 GN=SLCO4A1 PE=1 SV=2 g22807.t1 Q99N01 54.737 95 3.47e-29 117.0 sp|Q99N01|SO4A1_RAT Solute carrier organic anion transporter family member 4A1 OS=Rattus norvegicus OX=10116 GN=Slco4a1 PE=2 SV=1 SO4A1_RAT reviewed Solute carrier organic anion transporter family member 4A1 (Organic anion-transporting polypeptide E) (OATP-E) (Sodium-independent organic anion transporter E) (Solute carrier family 21 member 12) Rattus norvegicus (Rat) GO:0006811; GO:0008514; GO:0015132; GO:0015347; GO:0015349; GO:0016323; GO:0042403; GO:0043252 monoatomic ion transport [GO:0006811]; sodium-independent organic anion transport [GO:0043252]; thyroid hormone metabolic process [GO:0042403] basolateral plasma membrane [GO:0016323] organic anion transmembrane transporter activity [GO:0008514]; prostaglandin transmembrane transporter activity [GO:0015132]; sodium-independent organic anion transmembrane transporter activity [GO:0015347]; thyroid hormone transmembrane transporter activity [GO:0015349] g22808.t1 Q9DBU3 50.797 502 8.34e-160 469.0 sp|Q9DBU3|RIOK3_MOUSE Serine/threonine-protein kinase RIO3 OS=Mus musculus OX=10090 GN=Riok3 PE=1 SV=3 RIOK3_MOUSE reviewed Serine/threonine-protein kinase RIO3 (EC 2.7.11.1) (RIO kinase 3) Mus musculus (Mouse) GO:0004674; GO:0005524; GO:0005829; GO:0030490; GO:0030688; GO:0031333; GO:0032728; GO:0039534; GO:0043124; GO:0045087; GO:0045089; GO:0046872; GO:0051607; GO:0071359; GO:0089720; GO:0098586; GO:0106310; GO:1990786 cellular response to dsDNA [GO:1990786]; cellular response to dsRNA [GO:0071359]; cellular response to virus [GO:0098586]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; maturation of SSU-rRNA [GO:0030490]; negative regulation of canonical NF-kappaB signal transduction [GO:0043124]; negative regulation of MDA-5 signaling pathway [GO:0039534]; negative regulation of protein-containing complex assembly [GO:0031333]; positive regulation of innate immune response [GO:0045089]; positive regulation of interferon-beta production [GO:0032728] cytosol [GO:0005829]; preribosome, small subunit precursor [GO:0030688] ATP binding [GO:0005524]; caspase binding [GO:0089720]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g22809.t1 Q28BP9 53.691 447 7.780000000000001e-144 421.0 sp|Q28BP9|FAF2_XENTR FAS-associated factor 2 OS=Xenopus tropicalis OX=8364 GN=faf2 PE=2 SV=1 g22810.t1 Q9Y2Y1 78.704 108 1.31e-66 199.0 sp|Q9Y2Y1|RPC10_HUMAN DNA-directed RNA polymerase III subunit RPC10 OS=Homo sapiens OX=9606 GN=POLR3K PE=1 SV=3 RPC10_HUMAN reviewed DNA-directed RNA polymerase III subunit RPC10 (RNA polymerase III subunit C10) (DNA-directed RNA polymerase III subunit K) (RNA polymerase III 12.5 kDa subunit) (RPC12.5) (RNA polymerase III subunit C11) (HsC11p) (RPC11) (hRPC11) Homo sapiens (Human) GO:0003676; GO:0003899; GO:0005654; GO:0005666; GO:0005829; GO:0006383; GO:0008270; GO:0045087; GO:0051607 defense response to virus [GO:0051607]; innate immune response [GO:0045087]; transcription by RNA polymerase III [GO:0006383] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; RNA polymerase III complex [GO:0005666] DNA-directed RNA polymerase activity [GO:0003899]; nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270] g22811.t1 Q9BV90 59.69 129 2.81e-44 145.0 sp|Q9BV90|SNR25_HUMAN U11/U12 small nuclear ribonucleoprotein 25 kDa protein OS=Homo sapiens OX=9606 GN=SNRNP25 PE=1 SV=1 SNR25_HUMAN reviewed U11/U12 small nuclear ribonucleoprotein 25 kDa protein (U11/U12 snRNP 25 kDa protein) (U11/U12-25K) (Minus-99 protein) Homo sapiens (Human) GO:0000398; GO:0005634; GO:0005654; GO:0005689; GO:0005829; GO:0008380; GO:0045171 mRNA splicing, via spliceosome [GO:0000398]; RNA splicing [GO:0008380] cytosol [GO:0005829]; intercellular bridge [GO:0045171]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U12-type spliceosomal complex [GO:0005689] g22819.t1 Q5PQJ7 27.708 397 3.75e-29 120.0 sp|Q5PQJ7|TBCEL_RAT Tubulin-specific chaperone cofactor E-like protein OS=Rattus norvegicus OX=10116 GN=Tbcel PE=1 SV=1 TBCEL_RAT reviewed Tubulin-specific chaperone cofactor E-like protein (Leucine-rich repeat-containing protein 35) Rattus norvegicus (Rat) GO:0000226; GO:0005737; GO:0005856; GO:0007021; GO:0007023; GO:0043014 microtubule cytoskeleton organization [GO:0000226]; post-chaperonin tubulin folding pathway [GO:0007023]; tubulin complex assembly [GO:0007021] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856] alpha-tubulin binding [GO:0043014] g22822.t1 Q6DGE9 42.795 923 0.0 720.0 sp|Q6DGE9|UN45B_DANRE Protein unc-45 homolog B OS=Danio rerio OX=7955 GN=unc45b PE=1 SV=2 UN45B_DANRE reviewed Protein unc-45 homolog B (Unc-45B) (UNC45-related protein) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0002088; GO:0005737; GO:0007519; GO:0030018; GO:0030239; GO:0031672; GO:0048471; GO:0048738; GO:0051879; GO:0055001; GO:0055002; GO:0060538 cardiac muscle tissue development [GO:0048738]; lens development in camera-type eye [GO:0002088]; muscle cell development [GO:0055001]; myofibril assembly [GO:0030239]; skeletal muscle organ development [GO:0060538]; skeletal muscle tissue development [GO:0007519]; striated muscle cell development [GO:0055002] A band [GO:0031672]; cytoplasm [GO:0005737]; perinuclear region of cytoplasm [GO:0048471]; Z disc [GO:0030018] Hsp90 protein binding [GO:0051879] g22825.t1 Q9Z0U4 35.193 753 7.06e-139 437.0 sp|Q9Z0U4|GABR1_RAT Gamma-aminobutyric acid type B receptor subunit 1 OS=Rattus norvegicus OX=10116 GN=Gabbr1 PE=1 SV=2 GABR1_RAT reviewed Gamma-aminobutyric acid type B receptor subunit 1 (GABA-B receptor 1) (GABA-B-R1) (GABA-BR1) (GABABR1) (Gb1) Rattus norvegicus (Rat) GO:0001649; GO:0004965; GO:0005615; GO:0005737; GO:0005789; GO:0005886; GO:0007193; GO:0007214; GO:0008021; GO:0008285; GO:0014048; GO:0014049; GO:0014053; GO:0016020; GO:0030673; GO:0031966; GO:0032811; GO:0033602; GO:0035094; GO:0038037; GO:0038039; GO:0042734; GO:0043025; GO:0043197; GO:0043198; GO:0043204; GO:0045211; GO:0045471; GO:0046982; GO:0050805; GO:0051932; GO:0060124; GO:0097060; GO:0098685; GO:0098793; GO:0098978; GO:0098982; GO:0099579; GO:0150047; GO:0150099; GO:1902710; GO:1902712; GO:1990430 adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; gamma-aminobutyric acid signaling pathway [GO:0007214]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of dopamine secretion [GO:0033602]; negative regulation of epinephrine secretion [GO:0032811]; negative regulation of gamma-aminobutyric acid secretion [GO:0014053]; negative regulation of synaptic transmission [GO:0050805]; neuron-glial cell signaling [GO:0150099]; osteoblast differentiation [GO:0001649]; positive regulation of glutamate secretion [GO:0014049]; positive regulation of growth hormone secretion [GO:0060124]; regulation of glutamate secretion [GO:0014048]; response to ethanol [GO:0045471]; response to nicotine [GO:0035094]; synaptic transmission, GABAergic [GO:0051932] axolemma [GO:0030673]; cytoplasm [GO:0005737]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; endoplasmic reticulum membrane [GO:0005789]; extracellular space [GO:0005615]; G protein-coupled GABA receptor complex [GO:1902712]; G protein-coupled receptor dimeric complex [GO:0038037]; G protein-coupled receptor heterodimeric complex [GO:0038039]; GABA receptor complex [GO:1902710]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; mitochondrial membrane [GO:0031966]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynapse [GO:0098793]; presynaptic membrane [GO:0042734]; Schaffer collateral - CA1 synapse [GO:0098685]; synaptic membrane [GO:0097060]; synaptic vesicle [GO:0008021] extracellular matrix protein binding [GO:1990430]; G protein-coupled GABA receptor activity [GO:0004965]; G protein-coupled neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential [GO:0099579]; G protein-coupled neurotransmitter receptor activity involved in regulation of presynaptic membrane potential [GO:0150047]; protein heterodimerization activity [GO:0046982] g22827.t1 Q9Z0U4 35.637 738 2.28e-137 433.0 sp|Q9Z0U4|GABR1_RAT Gamma-aminobutyric acid type B receptor subunit 1 OS=Rattus norvegicus OX=10116 GN=Gabbr1 PE=1 SV=2 GABR1_RAT reviewed Gamma-aminobutyric acid type B receptor subunit 1 (GABA-B receptor 1) (GABA-B-R1) (GABA-BR1) (GABABR1) (Gb1) Rattus norvegicus (Rat) GO:0001649; GO:0004965; GO:0005615; GO:0005737; GO:0005789; GO:0005886; GO:0007193; GO:0007214; GO:0008021; GO:0008285; GO:0014048; GO:0014049; GO:0014053; GO:0016020; GO:0030673; GO:0031966; GO:0032811; GO:0033602; GO:0035094; GO:0038037; GO:0038039; GO:0042734; GO:0043025; GO:0043197; GO:0043198; GO:0043204; GO:0045211; GO:0045471; GO:0046982; GO:0050805; GO:0051932; GO:0060124; GO:0097060; GO:0098685; GO:0098793; GO:0098978; GO:0098982; GO:0099579; GO:0150047; GO:0150099; GO:1902710; GO:1902712; GO:1990430 adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; gamma-aminobutyric acid signaling pathway [GO:0007214]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of dopamine secretion [GO:0033602]; negative regulation of epinephrine secretion [GO:0032811]; negative regulation of gamma-aminobutyric acid secretion [GO:0014053]; negative regulation of synaptic transmission [GO:0050805]; neuron-glial cell signaling [GO:0150099]; osteoblast differentiation [GO:0001649]; positive regulation of glutamate secretion [GO:0014049]; positive regulation of growth hormone secretion [GO:0060124]; regulation of glutamate secretion [GO:0014048]; response to ethanol [GO:0045471]; response to nicotine [GO:0035094]; synaptic transmission, GABAergic [GO:0051932] axolemma [GO:0030673]; cytoplasm [GO:0005737]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; endoplasmic reticulum membrane [GO:0005789]; extracellular space [GO:0005615]; G protein-coupled GABA receptor complex [GO:1902712]; G protein-coupled receptor dimeric complex [GO:0038037]; G protein-coupled receptor heterodimeric complex [GO:0038039]; GABA receptor complex [GO:1902710]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; mitochondrial membrane [GO:0031966]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynapse [GO:0098793]; presynaptic membrane [GO:0042734]; Schaffer collateral - CA1 synapse [GO:0098685]; synaptic membrane [GO:0097060]; synaptic vesicle [GO:0008021] extracellular matrix protein binding [GO:1990430]; G protein-coupled GABA receptor activity [GO:0004965]; G protein-coupled neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential [GO:0099579]; G protein-coupled neurotransmitter receptor activity involved in regulation of presynaptic membrane potential [GO:0150047]; protein heterodimerization activity [GO:0046982] g22828.t1 P52034 57.895 380 7.38e-142 426.0 sp|P52034|PFKA_DROME ATP-dependent 6-phosphofructokinase OS=Drosophila melanogaster OX=7227 GN=Pfk PE=2 SV=2 g22831.t1 Q80X72 31.579 247 2e-27 119.0 sp|Q80X72|LRC15_MOUSE Leucine-rich repeat-containing protein 15 OS=Mus musculus OX=10090 GN=Lrrc15 PE=1 SV=1 g22832.t1 Q8IZF6 27.287 634 1.38e-50 199.0 sp|Q8IZF6|AGRG4_HUMAN Adhesion G-protein coupled receptor G4 OS=Homo sapiens OX=9606 GN=ADGRG4 PE=1 SV=2 AGRG4_HUMAN reviewed Adhesion G-protein coupled receptor G4 (G-protein coupled receptor 112) [Cleaved into: Adhesion G-protein coupled receptor G4, N-terminal fragment (ADGRG4 N-terminal fragment); Adhesion G-protein coupled receptor G4, C-terminal fragment (ADGRG4 C-terminal fragment)] Homo sapiens (Human) GO:0004930; GO:0005886; GO:0007166; GO:0007186; GO:0007189; GO:0016020 adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186] membrane [GO:0016020]; plasma membrane [GO:0005886] G protein-coupled receptor activity [GO:0004930] g22834.t1 Q9JME2 34.397 282 7.340000000000001e-58 196.0 sp|Q9JME2|CHSTB_MOUSE Carbohydrate sulfotransferase 11 OS=Mus musculus OX=10090 GN=Chst11 PE=2 SV=1 CHSTB_MOUSE reviewed Carbohydrate sulfotransferase 11 (EC 2.8.2.5) (Chondroitin 4-O-sulfotransferase 1) (Chondroitin 4-sulfotransferase 1) (C4S-1) (C4ST-1) (C4ST1) Mus musculus (Mouse) GO:0000139; GO:0001537; GO:0001701; GO:0002063; GO:0007585; GO:0008146; GO:0009791; GO:0016051; GO:0030166; GO:0030326; GO:0030512; GO:0033037; GO:0036342; GO:0042127; GO:0042733; GO:0043066; GO:0047756; GO:0048589; GO:0048703; GO:0048704; GO:0050650; GO:0050654; GO:0050659; GO:0051216 carbohydrate biosynthetic process [GO:0016051]; cartilage development [GO:0051216]; chondrocyte development [GO:0002063]; chondroitin sulfate proteoglycan biosynthetic process [GO:0050650]; chondroitin sulfate proteoglycan metabolic process [GO:0050654]; developmental growth [GO:0048589]; embryonic digit morphogenesis [GO:0042733]; embryonic limb morphogenesis [GO:0030326]; embryonic skeletal system morphogenesis [GO:0048704]; embryonic viscerocranium morphogenesis [GO:0048703]; in utero embryonic development [GO:0001701]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; polysaccharide localization [GO:0033037]; post-anal tail morphogenesis [GO:0036342]; post-embryonic development [GO:0009791]; proteoglycan biosynthetic process [GO:0030166]; regulation of cell population proliferation [GO:0042127]; respiratory gaseous exchange by respiratory system [GO:0007585] Golgi membrane [GO:0000139] chondroitin 4-sulfotransferase activity [GO:0047756]; dermatan 4-sulfotransferase activity [GO:0001537]; N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity [GO:0050659]; sulfotransferase activity [GO:0008146] g22835.t1 Q6B860 51.37 146 4.0500000000000005e-43 141.0 sp|Q6B860|RT14_BOVIN Small ribosomal subunit protein uS14m OS=Bos taurus OX=9913 GN=MRPS14 PE=1 SV=1 RT14_BOVIN reviewed Small ribosomal subunit protein uS14m (28S ribosomal protein S14, mitochondrial) (MRP-S14) (S14mt) Bos taurus (Bovine) GO:0003735; GO:0005743; GO:0005763; GO:0006412; GO:0032543 mitochondrial translation [GO:0032543]; translation [GO:0006412] mitochondrial inner membrane [GO:0005743]; mitochondrial small ribosomal subunit [GO:0005763] structural constituent of ribosome [GO:0003735] g22838.t1 Q9JIF3 40.909 330 8.52e-63 213.0 sp|Q9JIF3|SL2A8_MOUSE Solute carrier family 2, facilitated glucose transporter member 8 OS=Mus musculus OX=10090 GN=Slc2a8 PE=1 SV=2 SL2A8_MOUSE reviewed Solute carrier family 2, facilitated glucose transporter member 8 (Glucose transporter type 8) (GLUT-8) (Glucose transporter type X1) Mus musculus (Mouse) GO:0001666; GO:0005353; GO:0005354; GO:0005536; GO:0005886; GO:0006006; GO:0007141; GO:0008021; GO:0008286; GO:0015284; GO:0015755; GO:0015757; GO:0016020; GO:0030659; GO:0033300; GO:0055056; GO:0070837; GO:1904659 D-glucose transmembrane transport [GO:1904659]; dehydroascorbic acid transport [GO:0070837]; fructose transmembrane transport [GO:0015755]; galactose transmembrane transport [GO:0015757]; glucose metabolic process [GO:0006006]; insulin receptor signaling pathway [GO:0008286]; male meiosis I [GO:0007141]; response to hypoxia [GO:0001666] cytoplasmic vesicle membrane [GO:0030659]; membrane [GO:0016020]; plasma membrane [GO:0005886]; synaptic vesicle [GO:0008021] D-glucose binding [GO:0005536]; D-glucose transmembrane transporter activity [GO:0055056]; dehydroascorbic acid transmembrane transporter activity [GO:0033300]; fructose transmembrane transporter activity [GO:0005353]; fructose uniporter activity [GO:0015284]; galactose transmembrane transporter activity [GO:0005354] g22839.t1 P19039 41.761 443 2.7499999999999997e-115 350.0 sp|P19039|EF1A_APIME Elongation factor 1-alpha OS=Apis mellifera OX=7460 PE=3 SV=1 g22842.t1 Q29488 37.701 435 1.6400000000000003e-79 259.0 sp|Q29488|CP2DH_MACFA Cytochrome P450 2D17 OS=Macaca fascicularis OX=9541 GN=CYP2D17 PE=2 SV=1 g22843.t1 Q1LZI2 37.94 369 3.69e-65 220.0 sp|Q1LZI2|S35F3_MOUSE Solute carrier family 35 member F3 OS=Mus musculus OX=10090 GN=Slc35f3 PE=2 SV=1 g22845.t1 P04323 43.293 164 3.23e-31 131.0 sp|P04323|POL3_DROME Retrovirus-related Pol polyprotein from transposon 17.6 OS=Drosophila melanogaster OX=7227 GN=pol PE=4 SV=1 g22849.t1 Q6GM59 23.129 441 3.7e-24 107.0 sp|Q6GM59|MOT12_XENLA Monocarboxylate transporter 12 OS=Xenopus laevis OX=8355 GN=slc16a12 PE=2 SV=1 g22851.t1 Q6GM59 24.384 406 6e-24 107.0 sp|Q6GM59|MOT12_XENLA Monocarboxylate transporter 12 OS=Xenopus laevis OX=8355 GN=slc16a12 PE=2 SV=1 g22855.t1 Q6GM59 24.384 406 5.3999999999999994e-24 107.0 sp|Q6GM59|MOT12_XENLA Monocarboxylate transporter 12 OS=Xenopus laevis OX=8355 GN=slc16a12 PE=2 SV=1 g22856.t1 O70451 24.757 412 7.85e-24 107.0 sp|O70451|MOT2_MOUSE Monocarboxylate transporter 2 OS=Mus musculus OX=10090 GN=Slc16a7 PE=1 SV=1 MOT2_MOUSE reviewed Monocarboxylate transporter 2 (MCT 2) (Solute carrier family 16 member 7) Mus musculus (Mouse) GO:0005654; GO:0005829; GO:0005886; GO:0015129; GO:0015293; GO:0016323; GO:0035873; GO:0035879; GO:0042802; GO:0050833; GO:0098685; GO:0098686; GO:0098688; GO:0098839; GO:0098978; GO:1901475 lactate transmembrane transport [GO:0035873]; plasma membrane lactate transport [GO:0035879]; pyruvate transmembrane transport [GO:1901475] basolateral plasma membrane [GO:0016323]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; nucleoplasm [GO:0005654]; parallel fiber to Purkinje cell synapse [GO:0098688]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; Schaffer collateral - CA1 synapse [GO:0098685] identical protein binding [GO:0042802]; lactate transmembrane transporter activity [GO:0015129]; pyruvate transmembrane transporter activity [GO:0050833]; symporter activity [GO:0015293] g22857.t1 Q6ZSM3 24.048 420 1.11e-25 112.0 sp|Q6ZSM3|MOT12_HUMAN Monocarboxylate transporter 12 OS=Homo sapiens OX=9606 GN=SLC16A12 PE=1 SV=3 MOT12_HUMAN reviewed Monocarboxylate transporter 12 (MCT 12) (Creatine transporter 2) (CRT2) (Solute carrier family 16 member 12) Homo sapiens (Human) GO:0005308; GO:0005886; GO:0015292; GO:0015881; GO:0016323; GO:0022857; GO:0046449; GO:0150104 creatine transmembrane transport [GO:0015881]; creatinine metabolic process [GO:0046449]; transport across blood-brain barrier [GO:0150104] basolateral plasma membrane [GO:0016323]; plasma membrane [GO:0005886] creatine transmembrane transporter activity [GO:0005308]; transmembrane transporter activity [GO:0022857]; uniporter activity [GO:0015292] g22862.t1 Q9GZV8 65.257 331 2.2800000000000003e-157 465.0 sp|Q9GZV8|PRD14_HUMAN PR domain zinc finger protein 14 OS=Homo sapiens OX=9606 GN=PRDM14 PE=1 SV=1 PRD14_HUMAN reviewed PR domain zinc finger protein 14 (EC 2.1.1.-) (PR domain-containing protein 14) Homo sapiens (Human) GO:0000122; GO:0000902; GO:0000977; GO:0001708; GO:0001827; GO:0003723; GO:0005634; GO:0005654; GO:0006357; GO:0007281; GO:0007566; GO:0008168; GO:0008270; GO:0008543; GO:0009566; GO:0030718; GO:0031490; GO:0032259; GO:0040037; GO:0045814; GO:0048873; GO:0141107; GO:1902093; GO:1902459; GO:1990226 cell fate specification [GO:0001708]; cell morphogenesis [GO:0000902]; embryo implantation [GO:0007566]; fertilization [GO:0009566]; fibroblast growth factor receptor signaling pathway [GO:0008543]; germ cell development [GO:0007281]; germ-line stem cell population maintenance [GO:0030718]; homeostasis of number of cells within a tissue [GO:0048873]; inner cell mass cell fate commitment [GO:0001827]; methylation [GO:0032259]; negative regulation of fibroblast growth factor receptor signaling pathway [GO:0040037]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of flagellated sperm motility [GO:1902093]; positive regulation of stem cell population maintenance [GO:1902459]; regulation of transcription by RNA polymerase II [GO:0006357] nucleoplasm [GO:0005654]; nucleus [GO:0005634] chromatin DNA binding [GO:0031490]; histone methyltransferase binding [GO:1990226]; methyltransferase activity [GO:0008168]; methyltransferase regulator activity [GO:0141107]; RNA binding [GO:0003723]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; zinc ion binding [GO:0008270] g22863.t1 Q17FR9 56.897 232 8.56e-74 265.0 sp|Q17FR9|SRRT_AEDAE Serrate RNA effector molecule homolog OS=Aedes aegypti OX=7159 GN=Ars2 PE=3 SV=1 g22863.t1 Q17FR9 58.4 125 6.52e-43 173.0 sp|Q17FR9|SRRT_AEDAE Serrate RNA effector molecule homolog OS=Aedes aegypti OX=7159 GN=Ars2 PE=3 SV=1 g22863.t1 Q17FR9 46.789 109 6.4e-23 98.6 sp|Q17FR9|SRRT_AEDAE Serrate RNA effector molecule homolog OS=Aedes aegypti OX=7159 GN=Ars2 PE=3 SV=1 g22863.t1 Q17FR9 63.636 22 6.4e-23 32.7 sp|Q17FR9|SRRT_AEDAE Serrate RNA effector molecule homolog OS=Aedes aegypti OX=7159 GN=Ars2 PE=3 SV=1 g22864.t1 F1NW29 33.333 192 2.98e-25 104.0 sp|F1NW29|TYDP2_CHICK Tyrosyl-DNA phosphodiesterase 2 OS=Gallus gallus OX=9031 GN=TDP2 PE=3 SV=2 g22865.t1 A5D8M0 50.704 142 2.1999999999999997e-42 147.0 sp|A5D8M0|TYDP2_XENLA Tyrosyl-DNA phosphodiesterase 2 OS=Xenopus laevis OX=8355 GN=tdp2 PE=2 SV=1 g22866.t1 P06352 75.581 86 1.35e-38 132.0 sp|P06352|H3_STRPU Histone H3, embryonic OS=Strongylocentrotus purpuratus OX=7668 PE=1 SV=2 g22868.t1 Q5ZKP6 48.235 340 4.33e-114 339.0 sp|Q5ZKP6|ADA_CHICK Adenosine deaminase OS=Gallus gallus OX=9031 GN=ADA PE=2 SV=1 ADA_CHICK reviewed Adenosine deaminase (EC 3.5.4.4) (Adenosine aminohydrolase) Gallus gallus (Chicken) GO:0004000; GO:0005764; GO:0005829; GO:0006154; GO:0008270; GO:0009117; GO:0009168; GO:0009897; GO:0042110; GO:0043103; GO:0045187; GO:0046103; GO:0046936; GO:0060169; GO:0060205; GO:0070161 adenosine catabolic process [GO:0006154]; hypoxanthine salvage [GO:0043103]; inosine biosynthetic process [GO:0046103]; negative regulation of adenosine receptor signaling pathway [GO:0060169]; nucleotide metabolic process [GO:0009117]; purine ribonucleoside monophosphate biosynthetic process [GO:0009168]; regulation of circadian sleep/wake cycle, sleep [GO:0045187]; T cell activation [GO:0042110] anchoring junction [GO:0070161]; cytoplasmic vesicle lumen [GO:0060205]; cytosol [GO:0005829]; external side of plasma membrane [GO:0009897]; lysosome [GO:0005764] 2'-deoxyadenosine deaminase activity [GO:0046936]; adenosine deaminase activity [GO:0004000]; zinc ion binding [GO:0008270] g22869.t1 O76536 32.811 1149 4.3899999999999997e-98 350.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g22869.t1 O76536 34.113 1155 3.89e-97 347.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g22869.t1 O76536 34.002 1147 2.05e-96 345.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g22869.t1 O76536 33.418 1185 6.8e-93 334.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g22869.t1 O76536 33.665 1206 3.3e-86 313.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g22869.t1 O76536 33.152 1101 2.72e-84 308.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g22869.t1 O76536 33.565 1007 3.86e-82 301.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g22869.t1 O76536 33.947 869 1.7200000000000002e-72 271.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g22869.t1 O76536 34.067 772 3.2199999999999997e-69 261.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g22870.t1 O76536 31.138 1169 4.4399999999999997e-94 338.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g22870.t1 O76536 31.654 1191 2.57e-93 336.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g22870.t1 O76536 33.009 1130 1.38e-88 322.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g22870.t1 O76536 32.346 1215 9.51e-86 313.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g22870.t1 O76536 32.655 1179 1.85e-83 306.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g22870.t1 O76536 31.378 1074 4.55e-65 248.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g22870.t1 O76536 28.451 833 4.42e-38 162.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g22870.t1 O76536 29.052 833 2.0700000000000003e-37 159.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g22870.t1 O76536 27.863 847 1.33e-35 154.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g22870.t1 O76536 28.489 867 6.69e-32 141.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g22870.t1 O76536 28.327 819 1.0299999999999999e-30 137.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g22870.t1 O76536 34.146 328 3.89e-24 116.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g22871.t1 Q8K078 36.825 630 1.33e-122 384.0 sp|Q8K078|SO4A1_MOUSE Solute carrier organic anion transporter family member 4A1 OS=Mus musculus OX=10090 GN=Slco4a1 PE=1 SV=2 SO4A1_MOUSE reviewed Solute carrier organic anion transporter family member 4A1 (Organic anion-transporting polypeptide E) (OATP-E) (Sodium-independent organic anion transporter E) (Solute carrier family 21 member 12) Mus musculus (Mouse) GO:0005886; GO:0006811; GO:0008514; GO:0015132; GO:0015347; GO:0015349; GO:0015711; GO:0016323; GO:0042403; GO:0043252 monoatomic ion transport [GO:0006811]; organic anion transport [GO:0015711]; sodium-independent organic anion transport [GO:0043252]; thyroid hormone metabolic process [GO:0042403] basolateral plasma membrane [GO:0016323]; plasma membrane [GO:0005886] organic anion transmembrane transporter activity [GO:0008514]; prostaglandin transmembrane transporter activity [GO:0015132]; sodium-independent organic anion transmembrane transporter activity [GO:0015347]; thyroid hormone transmembrane transporter activity [GO:0015349] g22875.t1 Q9Y5N5 50.0 210 2.47e-53 173.0 sp|Q9Y5N5|HEMK2_HUMAN Methyltransferase HEMK2 OS=Homo sapiens OX=9606 GN=HEMK2 PE=1 SV=4 g22876.t1 Q80X72 31.325 249 3.1900000000000003e-21 100.0 sp|Q80X72|LRC15_MOUSE Leucine-rich repeat-containing protein 15 OS=Mus musculus OX=10090 GN=Lrrc15 PE=1 SV=1 g22877.t1 B7PRF6 53.889 180 1.13e-59 187.0 sp|B7PRF6|MTND_IXOSC Acireductone dioxygenase OS=Ixodes scapularis OX=6945 GN=IscW_ISCW007295 PE=3 SV=1 g22878.t1 C3ZAH2 47.429 175 5.829999999999999e-48 156.0 sp|C3ZAH2|MTND_BRAFL Acireductone dioxygenase OS=Branchiostoma floridae OX=7739 GN=BRAFLDRAFT_119977 PE=3 SV=1 g22879.t1 C3ZAH2 56.571 175 3.39e-60 188.0 sp|C3ZAH2|MTND_BRAFL Acireductone dioxygenase OS=Branchiostoma floridae OX=7739 GN=BRAFLDRAFT_119977 PE=3 SV=1 g22882.t1 C3ZAH2 69.143 175 1.22e-85 252.0 sp|C3ZAH2|MTND_BRAFL Acireductone dioxygenase OS=Branchiostoma floridae OX=7739 GN=BRAFLDRAFT_119977 PE=3 SV=1 g22883.t1 P26262 38.023 263 3.34e-46 180.0 sp|P26262|KLKB1_MOUSE Plasma kallikrein OS=Mus musculus OX=10090 GN=Klkb1 PE=1 SV=2 KLKB1_MOUSE reviewed Plasma kallikrein (EC 3.4.21.34) (Fletcher factor) (Kininogenin) (Plasma prekallikrein) [Cleaved into: Plasma kallikrein heavy chain; Plasma kallikrein light chain] Mus musculus (Mouse) GO:0004252; GO:0005615; GO:0006954; GO:0007596; GO:0008236; GO:0031639; GO:0042730; GO:0051919 blood coagulation [GO:0007596]; fibrinolysis [GO:0042730]; inflammatory response [GO:0006954]; plasminogen activation [GO:0031639]; positive regulation of fibrinolysis [GO:0051919] extracellular space [GO:0005615] serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236] g22884.t1 P81286 40.09 222 4.86e-39 141.0 sp|P81286|PLMN_SHEEP Plasminogen (Fragment) OS=Ovis aries OX=9940 GN=PLG PE=1 SV=1 g22886.t1 Q9Y6M0 36.364 275 4.69e-44 166.0 sp|Q9Y6M0|TEST_HUMAN Testisin OS=Homo sapiens OX=9606 GN=PRSS21 PE=1 SV=1 TEST_HUMAN reviewed Testisin (EC 3.4.21.-) (Eosinophil serine protease 1) (ESP-1) (Serine protease 21) Homo sapiens (Human) GO:0004252; GO:0005576; GO:0005615; GO:0005737; GO:0005886; GO:0006508; GO:0007283; GO:0008236; GO:0016020; GO:0098552 proteolysis [GO:0006508]; spermatogenesis [GO:0007283] cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; plasma membrane [GO:0005886]; side of membrane [GO:0098552] serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236] g22893.t1 Q9WV18 33.081 792 5.17e-134 424.0 sp|Q9WV18|GABR1_MOUSE Gamma-aminobutyric acid type B receptor subunit 1 OS=Mus musculus OX=10090 GN=Gabbr1 PE=1 SV=1 GABR1_MOUSE reviewed Gamma-aminobutyric acid type B receptor subunit 1 (GABA-B receptor 1) (GABA-B-R1) (GABA-BR1) (GABABR1) (Gb1) Mus musculus (Mouse) GO:0001649; GO:0004965; GO:0005615; GO:0005737; GO:0005789; GO:0005886; GO:0007193; GO:0007214; GO:0008021; GO:0008285; GO:0014048; GO:0014049; GO:0014053; GO:0016020; GO:0030673; GO:0031966; GO:0032811; GO:0033602; GO:0035094; GO:0038037; GO:0038039; GO:0042734; GO:0043025; GO:0043197; GO:0043198; GO:0045211; GO:0045471; GO:0046982; GO:0050805; GO:0051932; GO:0060124; GO:0097060; GO:0098685; GO:0098793; GO:0098978; GO:0098982; GO:0099579; GO:0150047; GO:0150099; GO:1902710; GO:1902712; GO:1990430 adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; gamma-aminobutyric acid signaling pathway [GO:0007214]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of dopamine secretion [GO:0033602]; negative regulation of epinephrine secretion [GO:0032811]; negative regulation of gamma-aminobutyric acid secretion [GO:0014053]; negative regulation of synaptic transmission [GO:0050805]; neuron-glial cell signaling [GO:0150099]; osteoblast differentiation [GO:0001649]; positive regulation of glutamate secretion [GO:0014049]; positive regulation of growth hormone secretion [GO:0060124]; regulation of glutamate secretion [GO:0014048]; response to ethanol [GO:0045471]; response to nicotine [GO:0035094]; synaptic transmission, GABAergic [GO:0051932] axolemma [GO:0030673]; cytoplasm [GO:0005737]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; endoplasmic reticulum membrane [GO:0005789]; extracellular space [GO:0005615]; G protein-coupled GABA receptor complex [GO:1902712]; G protein-coupled receptor dimeric complex [GO:0038037]; G protein-coupled receptor heterodimeric complex [GO:0038039]; GABA receptor complex [GO:1902710]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; mitochondrial membrane [GO:0031966]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynapse [GO:0098793]; presynaptic membrane [GO:0042734]; Schaffer collateral - CA1 synapse [GO:0098685]; synaptic membrane [GO:0097060]; synaptic vesicle [GO:0008021] extracellular matrix protein binding [GO:1990430]; G protein-coupled GABA receptor activity [GO:0004965]; G protein-coupled neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential [GO:0099579]; G protein-coupled neurotransmitter receptor activity involved in regulation of presynaptic membrane potential [GO:0150047]; protein heterodimerization activity [GO:0046982] g22896.t1 P32247 31.818 308 3.8800000000000006e-27 114.0 sp|P32247|BRS3_HUMAN Bombesin receptor subtype-3 OS=Homo sapiens OX=9606 GN=BRS3 PE=1 SV=1 BRS3_HUMAN reviewed Bombesin receptor subtype-3 (BRS-3) Homo sapiens (Human) GO:0004946; GO:0005886; GO:0006006; GO:0007186; GO:0008188; GO:0008217; GO:0008343; GO:0016020 adult feeding behavior [GO:0008343]; G protein-coupled receptor signaling pathway [GO:0007186]; glucose metabolic process [GO:0006006]; regulation of blood pressure [GO:0008217] membrane [GO:0016020]; plasma membrane [GO:0005886] bombesin receptor activity [GO:0004946]; neuropeptide receptor activity [GO:0008188] g22899.t1 P08736 83.333 462 0.0 807.0 sp|P08736|EF1A1_DROME Elongation factor 1-alpha 1 OS=Drosophila melanogaster OX=7227 GN=eEF1alpha1 PE=1 SV=2 g22900.t1 Q5TZ51 45.143 175 4.79e-49 160.0 sp|Q5TZ51|MPV17_DANRE Mitochondrial inner membrane protein Mpv17 OS=Danio rerio OX=7955 GN=mpv17 PE=2 SV=1 MPV17_DANRE reviewed Mitochondrial inner membrane protein Mpv17 (Protein Mpv17) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001889; GO:0005737; GO:0005739; GO:0005743; GO:0010821; GO:0015267; GO:0048066; GO:0048742; GO:0050935; GO:0090207; GO:1901858 developmental pigmentation [GO:0048066]; iridophore differentiation [GO:0050935]; liver development [GO:0001889]; regulation of mitochondrial DNA metabolic process [GO:1901858]; regulation of mitochondrion organization [GO:0010821]; regulation of skeletal muscle fiber development [GO:0048742]; regulation of triglyceride metabolic process [GO:0090207] cytoplasm [GO:0005737]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739] channel activity [GO:0015267] g22901.t1 Q58D00 45.217 460 1.3200000000000001e-129 385.0 sp|Q58D00|FBXW2_BOVIN F-box/WD repeat-containing protein 2 OS=Bos taurus OX=9913 GN=FBXW2 PE=2 SV=1 g22902.t1 Q8S2E5 58.571 70 3.39e-22 90.9 sp|Q8S2E5|KPRS3_ORYSJ Ribose-phosphate pyrophosphokinase 3, chloroplastic OS=Oryza sativa subsp. japonica OX=39947 GN=Os01g0723600 PE=2 SV=1 g22903.t1 Q93Z66 53.846 143 5.0799999999999996e-48 165.0 sp|Q93Z66|KPRS3_ARATH Ribose-phosphate pyrophosphokinase 3, chloroplastic OS=Arabidopsis thaliana OX=3702 GN=PRS3 PE=2 SV=1 g22905.t1 P22124 75.253 198 5.86e-107 308.0 sp|P22124|RAL_DIPOM Ras-related protein O-RAL OS=Diplobatis ommata OX=1870830 PE=2 SV=1 g22906.t1 P97494 60.87 506 0.0 644.0 sp|P97494|GSH1_MOUSE Glutamate--cysteine ligase catalytic subunit OS=Mus musculus OX=10090 GN=Gclc PE=1 SV=4 GSH1_MOUSE reviewed Glutamate--cysteine ligase catalytic subunit (EC 6.3.2.2) (GCS heavy chain) (Gamma-ECS) (Gamma-glutamylcysteine synthetase) Mus musculus (Mouse) GO:0000287; GO:0004357; GO:0005524; GO:0005739; GO:0005829; GO:0006534; GO:0006536; GO:0006749; GO:0006750; GO:0006979; GO:0007584; GO:0009408; GO:0009410; GO:0009725; GO:0014823; GO:0016595; GO:0017109; GO:0019852; GO:0031397; GO:0032436; GO:0032869; GO:0035729; GO:0043066; GO:0043524; GO:0043531; GO:0044344; GO:0044752; GO:0044877; GO:0045454; GO:0045892; GO:0046685; GO:0046686; GO:0051409; GO:0051900; GO:0070555; GO:0071260; GO:0071333; GO:0071372; GO:0097069; GO:0097746; GO:1901029; GO:2000490; GO:2001237 blood vessel diameter maintenance [GO:0097746]; cell redox homeostasis [GO:0045454]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to glucose stimulus [GO:0071333]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cellular response to insulin stimulus [GO:0032869]; cellular response to mechanical stimulus [GO:0071260]; cellular response to thyroxine stimulus [GO:0097069]; cysteine metabolic process [GO:0006534]; glutamate metabolic process [GO:0006536]; glutathione biosynthetic process [GO:0006750]; glutathione metabolic process [GO:0006749]; L-ascorbic acid metabolic process [GO:0019852]; negative regulation of apoptotic process [GO:0043066]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of hepatic stellate cell activation [GO:2000490]; negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901029]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of protein ubiquitination [GO:0031397]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; regulation of mitochondrial depolarization [GO:0051900]; response to activity [GO:0014823]; response to arsenic-containing substance [GO:0046685]; response to cadmium ion [GO:0046686]; response to heat [GO:0009408]; response to hormone [GO:0009725]; response to human chorionic gonadotropin [GO:0044752]; response to interleukin-1 [GO:0070555]; response to nitrosative stress [GO:0051409]; response to nutrient [GO:0007584]; response to oxidative stress [GO:0006979]; response to xenobiotic stimulus [GO:0009410] cytosol [GO:0005829]; glutamate-cysteine ligase complex [GO:0017109]; mitochondrion [GO:0005739] ADP binding [GO:0043531]; ATP binding [GO:0005524]; glutamate binding [GO:0016595]; glutamate-cysteine ligase activity [GO:0004357]; magnesium ion binding [GO:0000287]; protein-containing complex binding [GO:0044877] g22907.t1 Q9W3K5 57.843 102 3.63e-31 119.0 sp|Q9W3K5|GSH1_DROME Glutamate--cysteine ligase OS=Drosophila melanogaster OX=7227 GN=Gclc PE=2 SV=1 GSH1_DROME reviewed Glutamate--cysteine ligase (EC 6.3.2.2) (Gamma-ECS) (GCS) (Gamma-glutamylcysteine synthetase) Drosophila melanogaster (Fruit fly) GO:0004357; GO:0005524; GO:0005634; GO:0006749; GO:0006750; GO:0007409; GO:0007476; GO:0017109; GO:0046688; GO:0048471 axonogenesis [GO:0007409]; glutathione biosynthetic process [GO:0006750]; glutathione metabolic process [GO:0006749]; imaginal disc-derived wing morphogenesis [GO:0007476]; response to copper ion [GO:0046688] glutamate-cysteine ligase complex [GO:0017109]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471] ATP binding [GO:0005524]; glutamate-cysteine ligase activity [GO:0004357] g22908.t1 Q8NI08 51.78 309 1.67e-86 302.0 sp|Q8NI08|NCOA7_HUMAN Nuclear receptor coactivator 7 OS=Homo sapiens OX=9606 GN=NCOA7 PE=1 SV=2 g22909.t1 O54748 60.768 469 0.0 545.0 sp|O54748|STK3_RAT Serine/threonine-protein kinase 3 OS=Rattus norvegicus OX=10116 GN=Stk3 PE=1 SV=1 g22909.t2 O54748 63.478 460 0.0 549.0 sp|O54748|STK3_RAT Serine/threonine-protein kinase 3 OS=Rattus norvegicus OX=10116 GN=Stk3 PE=1 SV=1 g22910.t1 Q4QQW3 64.78 477 0.0 607.0 sp|Q4QQW3|HOT_RAT Hydroxyacid-oxoacid transhydrogenase, mitochondrial OS=Rattus norvegicus OX=10116 GN=Adhfe1 PE=1 SV=1 HOT_RAT reviewed Hydroxyacid-oxoacid transhydrogenase, mitochondrial (HOT) (EC 1.1.99.24) (Alcohol dehydrogenase iron-containing protein 1) (ADHFe1) Rattus norvegicus (Rat) GO:0004022; GO:0005739; GO:0019552; GO:0046872; GO:0046952; GO:0047988 ketone body catabolic process [GO:0046952]; L-glutamate catabolic process via 2-hydroxyglutarate [GO:0019552] mitochondrion [GO:0005739] alcohol dehydrogenase (NAD+) activity [GO:0004022]; hydroxyacid-oxoacid transhydrogenase activity [GO:0047988]; metal ion binding [GO:0046872] g22911.t1 Q9Z108 36.614 508 7.69e-72 246.0 sp|Q9Z108|STAU1_MOUSE Double-stranded RNA-binding protein Staufen homolog 1 OS=Mus musculus OX=10090 GN=Stau1 PE=1 SV=1 g22911.t2 Q9Z108 36.614 508 8.110000000000001e-72 246.0 sp|Q9Z108|STAU1_MOUSE Double-stranded RNA-binding protein Staufen homolog 1 OS=Mus musculus OX=10090 GN=Stau1 PE=1 SV=1 g22912.t1 Q9QZM9 45.02 251 9.88e-69 223.0 sp|Q9QZM9|FBX16_MOUSE F-box only protein 16 OS=Mus musculus OX=10090 GN=Fbxo16 PE=2 SV=1 g22913.t1 Q6UWM5 37.43 179 3.9e-31 119.0 sp|Q6UWM5|GPRL1_HUMAN GLIPR1-like protein 1 OS=Homo sapiens OX=9606 GN=GLIPR1L1 PE=1 SV=2 g22918.t1 Q91YT7 74.129 201 3.99e-104 332.0 sp|Q91YT7|YTHD2_MOUSE YTH domain-containing family protein 2 OS=Mus musculus OX=10090 GN=Ythdf2 PE=1 SV=1 YTHD2_MOUSE reviewed YTH domain-containing family protein 2 Mus musculus (Mouse) GO:0000932; GO:0001556; GO:0003729; GO:0005634; GO:0005737; GO:0005829; GO:0006402; GO:0007276; GO:0007284; GO:0010494; GO:0030155; GO:0034063; GO:0034451; GO:0036464; GO:0043488; GO:0045087; GO:0045746; GO:0048598; GO:0050767; GO:0060339; GO:0061157; GO:0062153; GO:0070925; GO:0071425; GO:0098508; GO:1902036; GO:1903538; GO:1903679; GO:1990247; GO:2000232; GO:2000737 embryonic morphogenesis [GO:0048598]; endothelial to hematopoietic transition [GO:0098508]; gamete generation [GO:0007276]; hematopoietic stem cell proliferation [GO:0071425]; innate immune response [GO:0045087]; mRNA catabolic process [GO:0006402]; mRNA destabilization [GO:0061157]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; oocyte maturation [GO:0001556]; organelle assembly [GO:0070925]; positive regulation of cap-independent translational initiation [GO:1903679]; regulation of cell adhesion [GO:0030155]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of meiotic cell cycle process involved in oocyte maturation [GO:1903538]; regulation of mRNA stability [GO:0043488]; regulation of neurogenesis [GO:0050767]; regulation of rRNA processing [GO:2000232]; spermatogonial cell division [GO:0007284]; stress granule assembly [GO:0034063] centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; nucleus [GO:0005634]; P-body [GO:0000932] C5-methylcytidine-containing RNA reader activity [GO:0062153]; mRNA binding [GO:0003729]; N6-methyladenosine-containing RNA reader activity [GO:1990247] g22920.t1 Q8N3Y7 51.211 289 1.78e-99 298.0 sp|Q8N3Y7|RDHE2_HUMAN Epidermal retinol dehydrogenase 2 OS=Homo sapiens OX=9606 GN=SDR16C5 PE=1 SV=2 RDHE2_HUMAN reviewed Epidermal retinol dehydrogenase 2 (EPHD-2) (RDH-E2) (EC 1.1.1.105) (Retinal short-chain dehydrogenase reductase 2) (retSDR2) (Short-chain dehydrogenase/reductase family 16C member 5) Homo sapiens (Human) GO:0000122; GO:0000785; GO:0003714; GO:0004745; GO:0005634; GO:0005789; GO:0005811; GO:0017053; GO:0042572; GO:0042574; GO:0043616; GO:0045814; GO:0061629; GO:0140297 keratinocyte proliferation [GO:0043616]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of transcription by RNA polymerase II [GO:0000122]; retinal metabolic process [GO:0042574]; retinol metabolic process [GO:0042572] chromatin [GO:0000785]; endoplasmic reticulum membrane [GO:0005789]; lipid droplet [GO:0005811]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053] all-trans-retinol dehydrogenase (NAD+) activity [GO:0004745]; DNA-binding transcription factor binding [GO:0140297]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription corepressor activity [GO:0003714] g22922.t1 Q66KI6 61.265 648 0.0 664.0 sp|Q66KI6|PUM1_XENLA Pumilio homolog 1 OS=Xenopus laevis OX=8355 GN=pum1 PE=1 SV=1 PUM1_XENLA reviewed Pumilio homolog 1 (Pumilio-1) (XPum) Xenopus laevis (African clawed frog) GO:0000932; GO:0003730; GO:0005737; GO:0005829; GO:0006417; GO:0035196; GO:0043488 miRNA processing [GO:0035196]; regulation of mRNA stability [GO:0043488]; regulation of translation [GO:0006417] cytoplasm [GO:0005737]; cytosol [GO:0005829]; P-body [GO:0000932] mRNA 3'-UTR binding [GO:0003730] g22922.t2 Q66KI6 61.42 648 0.0 671.0 sp|Q66KI6|PUM1_XENLA Pumilio homolog 1 OS=Xenopus laevis OX=8355 GN=pum1 PE=1 SV=1 PUM1_XENLA reviewed Pumilio homolog 1 (Pumilio-1) (XPum) Xenopus laevis (African clawed frog) GO:0000932; GO:0003730; GO:0005737; GO:0005829; GO:0006417; GO:0035196; GO:0043488 miRNA processing [GO:0035196]; regulation of mRNA stability [GO:0043488]; regulation of translation [GO:0006417] cytoplasm [GO:0005737]; cytosol [GO:0005829]; P-body [GO:0000932] mRNA 3'-UTR binding [GO:0003730] g22926.t1 Q6P268 51.818 220 8.28e-62 196.0 sp|Q6P268|PDCL3_DANRE Phosducin-like protein 3 OS=Danio rerio OX=7955 GN=pdcl3 PE=2 SV=1 PDCL3_DANRE reviewed Phosducin-like protein 3 (Viral IAP-associated factor 1 homolog) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001525; GO:0005737; GO:0005783; GO:0006457; GO:0006915; GO:0010628; GO:0043184; GO:0044183; GO:0048471 angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; positive regulation of gene expression [GO:0010628]; protein folding [GO:0006457] cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; perinuclear region of cytoplasm [GO:0048471] protein folding chaperone [GO:0044183]; vascular endothelial growth factor receptor 2 binding [GO:0043184] g22932.t1 Q0P4M4 49.561 456 2.52e-145 470.0 sp|Q0P4M4|CBPC2_XENTR Cytosolic carboxypeptidase 2 OS=Xenopus tropicalis OX=8364 GN=agbl2 PE=2 SV=1 CBPC2_XENTR reviewed Cytosolic carboxypeptidase 2 (EC 3.4.17.-) (ATP/GTP-binding protein-like 2) (Protein deglutamylase CCP2) Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0004181; GO:0005737; GO:0005814; GO:0005829; GO:0006508; GO:0008270; GO:0015630; GO:0015631; GO:0035610; GO:0036064 protein side chain deglutamylation [GO:0035610]; proteolysis [GO:0006508] centriole [GO:0005814]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule cytoskeleton [GO:0015630] metallocarboxypeptidase activity [GO:0004181]; tubulin binding [GO:0015631]; zinc ion binding [GO:0008270] g22932.t2 Q0P4M4 49.561 456 1.7499999999999999e-146 471.0 sp|Q0P4M4|CBPC2_XENTR Cytosolic carboxypeptidase 2 OS=Xenopus tropicalis OX=8364 GN=agbl2 PE=2 SV=1 CBPC2_XENTR reviewed Cytosolic carboxypeptidase 2 (EC 3.4.17.-) (ATP/GTP-binding protein-like 2) (Protein deglutamylase CCP2) Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0004181; GO:0005737; GO:0005814; GO:0005829; GO:0006508; GO:0008270; GO:0015630; GO:0015631; GO:0035610; GO:0036064 protein side chain deglutamylation [GO:0035610]; proteolysis [GO:0006508] centriole [GO:0005814]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule cytoskeleton [GO:0015630] metallocarboxypeptidase activity [GO:0004181]; tubulin binding [GO:0015631]; zinc ion binding [GO:0008270] g22933.t1 Q8IZA0 47.376 686 0.0 622.0 sp|Q8IZA0|K319L_HUMAN Dyslexia-associated protein KIAA0319-like protein OS=Homo sapiens OX=9606 GN=KIAA0319L PE=1 SV=2 K319L_HUMAN reviewed Dyslexia-associated protein KIAA0319-like protein (Adeno-associated virus receptor) (AAVR) Homo sapiens (Human) GO:0000139; GO:0001764; GO:0005730; GO:0005794; GO:0005886; GO:0010996; GO:0016020; GO:0019065; GO:0030317; GO:0031410; GO:0032588; GO:0120211 flagellated sperm motility [GO:0030317]; neuron migration [GO:0001764]; proacrosomal vesicle fusion [GO:0120211]; receptor-mediated endocytosis of virus by host cell [GO:0019065]; response to auditory stimulus [GO:0010996] cytoplasmic vesicle [GO:0031410]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; trans-Golgi network membrane [GO:0032588] g22933.t2 Q8IZA0 47.376 686 0.0 623.0 sp|Q8IZA0|K319L_HUMAN Dyslexia-associated protein KIAA0319-like protein OS=Homo sapiens OX=9606 GN=KIAA0319L PE=1 SV=2 K319L_HUMAN reviewed Dyslexia-associated protein KIAA0319-like protein (Adeno-associated virus receptor) (AAVR) Homo sapiens (Human) GO:0000139; GO:0001764; GO:0005730; GO:0005794; GO:0005886; GO:0010996; GO:0016020; GO:0019065; GO:0030317; GO:0031410; GO:0032588; GO:0120211 flagellated sperm motility [GO:0030317]; neuron migration [GO:0001764]; proacrosomal vesicle fusion [GO:0120211]; receptor-mediated endocytosis of virus by host cell [GO:0019065]; response to auditory stimulus [GO:0010996] cytoplasmic vesicle [GO:0031410]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; trans-Golgi network membrane [GO:0032588] g22933.t3 Q8IZA0 47.376 686 0.0 623.0 sp|Q8IZA0|K319L_HUMAN Dyslexia-associated protein KIAA0319-like protein OS=Homo sapiens OX=9606 GN=KIAA0319L PE=1 SV=2 K319L_HUMAN reviewed Dyslexia-associated protein KIAA0319-like protein (Adeno-associated virus receptor) (AAVR) Homo sapiens (Human) GO:0000139; GO:0001764; GO:0005730; GO:0005794; GO:0005886; GO:0010996; GO:0016020; GO:0019065; GO:0030317; GO:0031410; GO:0032588; GO:0120211 flagellated sperm motility [GO:0030317]; neuron migration [GO:0001764]; proacrosomal vesicle fusion [GO:0120211]; receptor-mediated endocytosis of virus by host cell [GO:0019065]; response to auditory stimulus [GO:0010996] cytoplasmic vesicle [GO:0031410]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; trans-Golgi network membrane [GO:0032588] g22933.t4 Q8IZA0 47.376 686 0.0 622.0 sp|Q8IZA0|K319L_HUMAN Dyslexia-associated protein KIAA0319-like protein OS=Homo sapiens OX=9606 GN=KIAA0319L PE=1 SV=2 K319L_HUMAN reviewed Dyslexia-associated protein KIAA0319-like protein (Adeno-associated virus receptor) (AAVR) Homo sapiens (Human) GO:0000139; GO:0001764; GO:0005730; GO:0005794; GO:0005886; GO:0010996; GO:0016020; GO:0019065; GO:0030317; GO:0031410; GO:0032588; GO:0120211 flagellated sperm motility [GO:0030317]; neuron migration [GO:0001764]; proacrosomal vesicle fusion [GO:0120211]; receptor-mediated endocytosis of virus by host cell [GO:0019065]; response to auditory stimulus [GO:0010996] cytoplasmic vesicle [GO:0031410]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; trans-Golgi network membrane [GO:0032588] g22934.t1 E1BYJ2 51.448 1312 0.0 1267.0 sp|E1BYJ2|MSH6_CHICK DNA mismatch repair protein Msh6 OS=Gallus gallus OX=9031 GN=MSH6 PE=3 SV=2 g22935.t1 A4FUD9 63.488 797 0.0 939.0 sp|A4FUD9|MCM3_BOVIN DNA replication licensing factor MCM3 OS=Bos taurus OX=9913 GN=MCM3 PE=2 SV=1 MCM3_BOVIN reviewed DNA replication licensing factor MCM3 (EC 3.6.4.12) Bos taurus (Bovine) GO:0000727; GO:0003678; GO:0003697; GO:0005524; GO:0005634; GO:0005737; GO:0006271; GO:0016887; GO:0042555; GO:0071162; GO:1902975 DNA strand elongation involved in DNA replication [GO:0006271]; double-strand break repair via break-induced replication [GO:0000727]; mitotic DNA replication initiation [GO:1902975] CMG complex [GO:0071162]; cytoplasm [GO:0005737]; MCM complex [GO:0042555]; nucleus [GO:0005634] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA helicase activity [GO:0003678]; single-stranded DNA binding [GO:0003697] g22937.t1 Q9H1H9 57.058 1523 0.0 1594.0 sp|Q9H1H9|KI13A_HUMAN Kinesin-like protein KIF13A OS=Homo sapiens OX=9606 GN=KIF13A PE=1 SV=2 g22937.t2 Q9H1H9 57.588 1509 0.0 1600.0 sp|Q9H1H9|KI13A_HUMAN Kinesin-like protein KIF13A OS=Homo sapiens OX=9606 GN=KIF13A PE=1 SV=2 g22937.t3 Q9H1H9 63.57 818 0.0 998.0 sp|Q9H1H9|KI13A_HUMAN Kinesin-like protein KIF13A OS=Homo sapiens OX=9606 GN=KIF13A PE=1 SV=2 g22937.t3 Q9H1H9 51.048 668 0.0 619.0 sp|Q9H1H9|KI13A_HUMAN Kinesin-like protein KIF13A OS=Homo sapiens OX=9606 GN=KIF13A PE=1 SV=2 g22937.t4 Q9H1H9 63.57 818 0.0 998.0 sp|Q9H1H9|KI13A_HUMAN Kinesin-like protein KIF13A OS=Homo sapiens OX=9606 GN=KIF13A PE=1 SV=2 g22937.t4 Q9H1H9 51.048 668 0.0 619.0 sp|Q9H1H9|KI13A_HUMAN Kinesin-like protein KIF13A OS=Homo sapiens OX=9606 GN=KIF13A PE=1 SV=2 g22938.t1 P15305 35.185 378 3.31e-48 174.0 sp|P15305|DYHC_ONCMY Dynein heavy chain (Fragment) OS=Oncorhynchus mykiss OX=8022 PE=2 SV=1 g22938.t1 P15305 37.117 326 5.32e-39 149.0 sp|P15305|DYHC_ONCMY Dynein heavy chain (Fragment) OS=Oncorhynchus mykiss OX=8022 PE=2 SV=1 g22938.t1 P15305 34.53 362 1.69e-37 145.0 sp|P15305|DYHC_ONCMY Dynein heavy chain (Fragment) OS=Oncorhynchus mykiss OX=8022 PE=2 SV=1 g22938.t1 P15305 34.808 339 1.02e-31 129.0 sp|P15305|DYHC_ONCMY Dynein heavy chain (Fragment) OS=Oncorhynchus mykiss OX=8022 PE=2 SV=1 g22941.t1 P50053 44.595 296 4.72e-80 248.0 sp|P50053|KHK_HUMAN Ketohexokinase OS=Homo sapiens OX=9606 GN=KHK PE=1 SV=2 KHK_HUMAN reviewed Ketohexokinase (EC 2.7.1.3) (Hepatic fructokinase) Homo sapiens (Human) GO:0004454; GO:0005524; GO:0005737; GO:0005829; GO:0006000; GO:0009744; GO:0009749; GO:0009750; GO:0010043; GO:0032868; GO:0042802; GO:0042803; GO:0070061; GO:0070062; GO:0070873 fructose metabolic process [GO:0006000]; regulation of glycogen metabolic process [GO:0070873]; response to fructose [GO:0009750]; response to glucose [GO:0009749]; response to insulin [GO:0032868]; response to sucrose [GO:0009744]; response to zinc ion [GO:0010043] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062] ATP binding [GO:0005524]; fructose binding [GO:0070061]; identical protein binding [GO:0042802]; ketohexokinase activity [GO:0004454]; protein homodimerization activity [GO:0042803] g22942.t1 Q8BMG8 61.278 266 8.62e-112 328.0 sp|Q8BMG8|S2532_MOUSE Solute carrier family 25 member 32 OS=Mus musculus OX=10090 GN=Slc25a32 PE=1 SV=1 S2532_MOUSE reviewed Solute carrier family 25 member 32 (Mitochondrial FAD transporter) Mus musculus (Mouse) GO:0005739; GO:0005743; GO:0008517; GO:0015230; GO:0055085; GO:1904947; GO:1990548 folate import into mitochondrion [GO:1904947]; mitochondrial FAD transmembrane transport [GO:1990548]; transmembrane transport [GO:0055085] mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739] FAD transmembrane transporter activity [GO:0015230]; folic acid transmembrane transporter activity [GO:0008517] g22943.t1 P15919 28.425 489 4.070000000000001e-43 175.0 sp|P15919|RAG1_MOUSE V(D)J recombination-activating protein 1 OS=Mus musculus OX=10090 GN=Rag1 PE=1 SV=2 RAG1_MOUSE reviewed V(D)J recombination-activating protein 1 (RAG-1) [Includes: Endonuclease RAG1 (EC 3.1.-.-); E3 ubiquitin-protein ligase RAG1 (EC 2.3.2.27) (RING-type E3 ubiquitin transferase RAG1)] Mus musculus (Mouse) GO:0002250; GO:0002331; GO:0004519; GO:0004842; GO:0005634; GO:0005654; GO:0006310; GO:0006325; GO:0008270; GO:0008542; GO:0016787; GO:0030183; GO:0033077; GO:0033151; GO:0042393; GO:0042802; GO:0042803; GO:0043029; GO:0043565; GO:0045580; GO:0045582; GO:0046872; GO:0048538; GO:0051865; GO:0061630; GO:0070233; GO:0070244; GO:0097519; GO:1905347; GO:2000822 adaptive immune response [GO:0002250]; B cell differentiation [GO:0030183]; chromatin organization [GO:0006325]; DNA recombination [GO:0006310]; negative regulation of T cell apoptotic process [GO:0070233]; negative regulation of thymocyte apoptotic process [GO:0070244]; positive regulation of T cell differentiation [GO:0045582]; pre-B cell allelic exclusion [GO:0002331]; protein autoubiquitination [GO:0051865]; regulation of behavioral fear response [GO:2000822]; regulation of T cell differentiation [GO:0045580]; T cell differentiation in thymus [GO:0033077]; T cell homeostasis [GO:0043029]; thymus development [GO:0048538]; V(D)J recombination [GO:0033151]; visual learning [GO:0008542] DNA recombinase complex [GO:0097519]; endodeoxyribonuclease complex [GO:1905347]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] endonuclease activity [GO:0004519]; histone binding [GO:0042393]; hydrolase activity [GO:0016787]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; sequence-specific DNA binding [GO:0043565]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] g22945.t1 Q6DDS9 39.836 733 2.3599999999999998e-142 437.0 sp|Q6DDS9|XRCC5_XENLA X-ray repair cross-complementing protein 5 OS=Xenopus laevis OX=8355 GN=xrcc5.L PE=1 SV=1 XRCC5_XENLA reviewed DNA repair protein Ku80 (EC 4.2.99.18) (EC 5.6.2.4) (Ku80) Xenopus laevis (African clawed frog) GO:0000723; GO:0003678; GO:0003684; GO:0003690; GO:0005524; GO:0005737; GO:0006303; GO:0006310; GO:0016787; GO:0042162; GO:0043564 DNA recombination [GO:0006310]; double-strand break repair via nonhomologous end joining [GO:0006303]; telomere maintenance [GO:0000723] cytoplasm [GO:0005737]; Ku70:Ku80 complex [GO:0043564] ATP binding [GO:0005524]; damaged DNA binding [GO:0003684]; DNA helicase activity [GO:0003678]; double-stranded DNA binding [GO:0003690]; hydrolase activity [GO:0016787]; telomeric DNA binding [GO:0042162] g22947.t1 Q4KLM5 39.437 213 5.81e-42 147.0 sp|Q4KLM5|ABT1_RAT Activator of basal transcription 1 OS=Rattus norvegicus OX=10116 GN=Abt1 PE=1 SV=1 g22948.t1 Q94AT3 26.761 355 9.980000000000001e-32 127.0 sp|Q94AT3|PUKI_ARATH Pseudouridine kinase OS=Arabidopsis thaliana OX=3702 GN=PUKI PE=1 SV=1 PUKI_ARATH reviewed Pseudouridine kinase (EC 2.7.1.83) Arabidopsis thaliana (Mouse-ear cress) GO:0005524; GO:0005777; GO:0016301; GO:0046131; GO:0046872; GO:0050225 pyrimidine ribonucleoside metabolic process [GO:0046131] peroxisome [GO:0005777] ATP binding [GO:0005524]; kinase activity [GO:0016301]; metal ion binding [GO:0046872]; pseudouridine kinase activity [GO:0050225] g22949.t1 Q84K35 52.857 280 4.57e-77 241.0 sp|Q84K35|PUMY_ARATH Pseudouridine-5'-phosphate glycosidase OS=Arabidopsis thaliana OX=3702 GN=PUMY PE=1 SV=1 g22950.t1 P05388 73.091 275 2.3799999999999998e-141 404.0 sp|P05388|RLA0_HUMAN Large ribosomal subunit protein uL10 OS=Homo sapiens OX=9606 GN=RPLP0 PE=1 SV=1 RLA0_HUMAN reviewed Large ribosomal subunit protein uL10 (60S acidic ribosomal protein P0) (60S ribosomal protein L10E) Homo sapiens (Human) GO:0002181; GO:0003723; GO:0003735; GO:0005634; GO:0005737; GO:0005783; GO:0005829; GO:0005925; GO:0006412; GO:0014069; GO:0016020; GO:0022625; GO:0022626; GO:0036464; GO:0042254; GO:0070062; GO:0070180; GO:0098794; GO:1990904 cytoplasmic translation [GO:0002181]; ribosome biogenesis [GO:0042254]; translation [GO:0006412] cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; membrane [GO:0016020]; nucleus [GO:0005634]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; ribonucleoprotein complex [GO:1990904] large ribosomal subunit rRNA binding [GO:0070180]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735] g22952.t1 Q6ZQ38 73.534 1228 0.0 1803.0 sp|Q6ZQ38|CAND1_MOUSE Cullin-associated NEDD8-dissociated protein 1 OS=Mus musculus OX=10090 GN=Cand1 PE=1 SV=2 g22955.t1 Q6P5D8 45.816 1960 0.0 1748.0 sp|Q6P5D8|SMHD1_MOUSE Structural maintenance of chromosomes flexible hinge domain-containing protein 1 OS=Mus musculus OX=10090 GN=Smchd1 PE=1 SV=2 SMHD1_MOUSE reviewed Structural maintenance of chromosomes flexible hinge domain-containing protein 1 (SMC hinge domain-containing protein 1) (EC 3.6.1.-) Mus musculus (Mouse) GO:0000781; GO:0001740; GO:0003677; GO:0005524; GO:0005654; GO:0006302; GO:0009048; GO:0016604; GO:0016887; GO:0035861; GO:0042803; GO:0043584; GO:0045739; GO:0051276; GO:0060818; GO:2000042; GO:2001034 chromosome organization [GO:0051276]; dosage compensation by inactivation of X chromosome [GO:0009048]; double-strand break repair [GO:0006302]; inactivation of paternal X chromosome by genomic imprinting [GO:0060818]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; nose development [GO:0043584]; positive regulation of DNA repair [GO:0045739]; positive regulation of double-strand break repair via nonhomologous end joining [GO:2001034] Barr body [GO:0001740]; chromosome, telomeric region [GO:0000781]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; site of double-strand break [GO:0035861] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA binding [GO:0003677]; protein homodimerization activity [GO:0042803] g22956.t1 O08585 44.635 233 4.55e-53 173.0 sp|O08585|CLCA_MOUSE Clathrin light chain A OS=Mus musculus OX=10090 GN=Clta PE=1 SV=2 g22958.t1 Q8BMZ5 34.597 211 7.880000000000001e-31 126.0 sp|Q8BMZ5|SEN34_MOUSE tRNA-splicing endonuclease subunit Sen34 OS=Mus musculus OX=10090 GN=Tsen34 PE=2 SV=2 g22960.t1 Q5RBM1 40.938 640 9.7e-145 437.0 sp|Q5RBM1|RPN2_PONAB Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit 2 OS=Pongo abelii OX=9601 GN=RPN2 PE=2 SV=1 g22963.t1 Q06807 38.043 276 2.0900000000000001e-57 219.0 sp|Q06807|TIE2_BOVIN Angiopoietin-1 receptor OS=Bos taurus OX=9913 GN=TEK PE=2 SV=1 TIE2_BOVIN reviewed Angiopoietin-1 receptor (EC 2.7.10.1) (Endothelial tyrosine kinase) (Tyrosine kinase with Ig and EGF homology domains-2) (Tyrosine-protein kinase receptor TIE-2) (CD antigen CD202b) Bos taurus (Bovine) GO:0001525; GO:0001935; GO:0001936; GO:0002040; GO:0004714; GO:0005524; GO:0005576; GO:0005856; GO:0005886; GO:0005925; GO:0007169; GO:0007507; GO:0010595; GO:0016525; GO:0030097; GO:0032878; GO:0034446; GO:0043235; GO:0043410; GO:0045766; GO:0048014; GO:0051894; GO:0051897; GO:0060347; GO:0070374; GO:1902533; GO:2000352 angiogenesis [GO:0001525]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; endothelial cell proliferation [GO:0001935]; heart development [GO:0007507]; heart trabecula formation [GO:0060347]; hemopoiesis [GO:0030097]; negative regulation of angiogenesis [GO:0016525]; negative regulation of endothelial cell apoptotic process [GO:2000352]; positive regulation of angiogenesis [GO:0045766]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of intracellular signal transduction [GO:1902533]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; regulation of endothelial cell proliferation [GO:0001936]; regulation of establishment or maintenance of cell polarity [GO:0032878]; sprouting angiogenesis [GO:0002040]; substrate adhesion-dependent cell spreading [GO:0034446]; Tie signaling pathway [GO:0048014] cytoskeleton [GO:0005856]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] ATP binding [GO:0005524]; transmembrane receptor protein tyrosine kinase activity [GO:0004714] g22967.t1 P10079 38.925 465 1.87e-67 252.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g22967.t1 P10079 39.31 435 1.67e-64 243.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g22967.t1 P10079 37.854 494 1.02e-63 241.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g22967.t1 P10079 44.785 326 1.24e-60 231.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g22967.t1 P10079 50.746 201 2.49e-51 202.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g22967.t1 P10079 35.835 413 4.35e-48 191.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g22968.t1 Q8IZF6 27.395 668 4.9199999999999996e-48 191.0 sp|Q8IZF6|AGRG4_HUMAN Adhesion G-protein coupled receptor G4 OS=Homo sapiens OX=9606 GN=ADGRG4 PE=1 SV=2 AGRG4_HUMAN reviewed Adhesion G-protein coupled receptor G4 (G-protein coupled receptor 112) [Cleaved into: Adhesion G-protein coupled receptor G4, N-terminal fragment (ADGRG4 N-terminal fragment); Adhesion G-protein coupled receptor G4, C-terminal fragment (ADGRG4 C-terminal fragment)] Homo sapiens (Human) GO:0004930; GO:0005886; GO:0007166; GO:0007186; GO:0007189; GO:0016020 adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186] membrane [GO:0016020]; plasma membrane [GO:0005886] G protein-coupled receptor activity [GO:0004930] g22970.t1 Q7KRS9 35.842 279 1.3e-48 194.0 sp|Q7KRS9|ZMYD8_DROME MYND-type zinc finger-containing chromatin reader Zmynd8 OS=Drosophila melanogaster OX=7227 GN=Zmynd8 PE=2 SV=1 g22970.t1 Q7KRS9 27.778 216 9.37e-22 107.0 sp|Q7KRS9|ZMYD8_DROME MYND-type zinc finger-containing chromatin reader Zmynd8 OS=Drosophila melanogaster OX=7227 GN=Zmynd8 PE=2 SV=1 g22970.t2 Q7KRS9 35.842 279 1.1899999999999999e-48 194.0 sp|Q7KRS9|ZMYD8_DROME MYND-type zinc finger-containing chromatin reader Zmynd8 OS=Drosophila melanogaster OX=7227 GN=Zmynd8 PE=2 SV=1 g22970.t2 Q7KRS9 29.167 216 1.24e-21 106.0 sp|Q7KRS9|ZMYD8_DROME MYND-type zinc finger-containing chromatin reader Zmynd8 OS=Drosophila melanogaster OX=7227 GN=Zmynd8 PE=2 SV=1 g22972.t1 Q6DED0 51.17 342 3.65e-117 348.0 sp|Q6DED0|TR1L1_XENLA Translocating chain-associated membrane protein 1-like 1 OS=Xenopus laevis OX=8355 GN=tram1l1 PE=2 SV=1 g22974.t1 Q5RFZ7 37.634 186 3.2600000000000004e-27 107.0 sp|Q5RFZ7|F167A_DANRE Protein FAM167A OS=Danio rerio OX=7955 GN=fam167a PE=2 SV=1 g22976.t1 P79401 35.742 512 3.91e-112 344.0 sp|P79401|CP3AT_PIG Cytochrome P450 3A29 OS=Sus scrofa OX=9823 GN=CYP3A29 PE=2 SV=1 g22979.t1 Q29496 37.634 465 4.85e-111 340.0 sp|Q29496|CP3AO_SHEEP Cytochrome P450 3A24 OS=Ovis aries OX=9940 GN=CYP3A24 PE=2 SV=1 g22980.t1 P21328 29.73 333 1.79e-32 135.0 sp|P21328|RTJK_DROME RNA-directed DNA polymerase from mobile element jockey OS=Drosophila melanogaster OX=7227 GN=pol PE=1 SV=1 g22982.t1 Q5PQ50 37.017 362 9.280000000000001e-79 250.0 sp|Q5PQ50|NUD19_XENLA Acyl-coenzyme A diphosphatase NUDT19 OS=Xenopus laevis OX=8355 GN=nudt19 PE=2 SV=1 NUD19_XENLA reviewed Acyl-coenzyme A diphosphatase NUDT19 (EC 3.6.1.-) (EC 3.6.1.77) (Nucleoside diphosphate-linked moiety X motif 19) (Nudix motif 19) Xenopus laevis (African clawed frog) GO:0000287; GO:0005739; GO:0005777; GO:0010945; GO:0015938; GO:0036114; GO:0044580; GO:1901289; GO:1902858; GO:2001294 butyryl-CoA catabolic process [GO:0044580]; coenzyme A catabolic process [GO:0015938]; malonyl-CoA catabolic process [GO:2001294]; medium-chain fatty-acyl-CoA catabolic process [GO:0036114]; propionyl-CoA metabolic process [GO:1902858]; succinyl-CoA catabolic process [GO:1901289] mitochondrion [GO:0005739]; peroxisome [GO:0005777] coenzyme A diphosphatase activity [GO:0010945]; magnesium ion binding [GO:0000287] g22983.t1 Q2KJI2 84.294 694 0.0 1161.0 sp|Q2KJI2|STT3A_BOVIN Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit STT3A OS=Bos taurus OX=9913 GN=STT3A PE=2 SV=1 STT3A_BOVIN reviewed Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit STT3A (Oligosaccharyl transferase subunit STT3A) (STT3-A) (EC 2.4.99.18) Bos taurus (Bovine) GO:0004579; GO:0008250; GO:0018279; GO:0043687; GO:0046872 post-translational protein modification [GO:0043687]; protein N-linked glycosylation via asparagine [GO:0018279] oligosaccharyltransferase complex [GO:0008250] dolichyl-diphosphooligosaccharide-protein glycotransferase activity [GO:0004579]; metal ion binding [GO:0046872] g22984.t1 P70712 51.299 462 1.22e-178 513.0 sp|P70712|KYNU_RAT Kynureninase OS=Rattus norvegicus OX=10116 GN=Kynu PE=1 SV=2 KYNU_RAT reviewed Kynureninase (EC 3.7.1.3) (L-kynurenine hydrolase) Rattus norvegicus (Rat) GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0006569; GO:0009435; GO:0019441; GO:0019442; GO:0019805; GO:0030170; GO:0030429; GO:0034341; GO:0034354; GO:0034516; GO:0042803; GO:0043420; GO:0097053 'de novo' NAD+ biosynthetic process from L-tryptophan [GO:0034354]; anthranilate metabolic process [GO:0043420]; L-kynurenine catabolic process [GO:0097053]; L-tryptophan catabolic process [GO:0006569]; L-tryptophan catabolic process to acetyl-CoA [GO:0019442]; L-tryptophan catabolic process to kynurenine [GO:0019441]; NAD+ biosynthetic process [GO:0009435]; quinolinate biosynthetic process [GO:0019805]; response to type II interferon [GO:0034341]; response to vitamin B6 [GO:0034516] cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654] kynureninase activity [GO:0030429]; protein homodimerization activity [GO:0042803]; pyridoxal phosphate binding [GO:0030170] g22986.t1 Q9Y210 37.877 895 0.0 589.0 sp|Q9Y210|TRPC6_HUMAN Short transient receptor potential channel 6 OS=Homo sapiens OX=9606 GN=TRPC6 PE=1 SV=1 g22986.t2 Q9Y210 37.637 914 0.0 590.0 sp|Q9Y210|TRPC6_HUMAN Short transient receptor potential channel 6 OS=Homo sapiens OX=9606 GN=TRPC6 PE=1 SV=1 g22989.t1 Q9Z2D0 65.517 551 0.0 770.0 sp|Q9Z2D0|MTMR9_MOUSE Myotubularin-related protein 9 OS=Mus musculus OX=10090 GN=Mtmr9 PE=1 SV=2 MTMR9_MOUSE reviewed Myotubularin-related protein 9 (Inactive phosphatidylinositol 3-phosphatase 9) Mus musculus (Mouse) GO:0005737; GO:0005783; GO:0005829; GO:0006897; GO:0010507; GO:0019903; GO:0030234; GO:0032587; GO:0032991; GO:0046856; GO:0048471; GO:0050821; GO:0060304 endocytosis [GO:0006897]; negative regulation of autophagy [GO:0010507]; phosphatidylinositol dephosphorylation [GO:0046856]; protein stabilization [GO:0050821]; regulation of phosphatidylinositol dephosphorylation [GO:0060304] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; ruffle membrane [GO:0032587] enzyme regulator activity [GO:0030234]; protein phosphatase binding [GO:0019903] g22989.t2 Q9Z2D0 66.605 542 0.0 778.0 sp|Q9Z2D0|MTMR9_MOUSE Myotubularin-related protein 9 OS=Mus musculus OX=10090 GN=Mtmr9 PE=1 SV=2 MTMR9_MOUSE reviewed Myotubularin-related protein 9 (Inactive phosphatidylinositol 3-phosphatase 9) Mus musculus (Mouse) GO:0005737; GO:0005783; GO:0005829; GO:0006897; GO:0010507; GO:0019903; GO:0030234; GO:0032587; GO:0032991; GO:0046856; GO:0048471; GO:0050821; GO:0060304 endocytosis [GO:0006897]; negative regulation of autophagy [GO:0010507]; phosphatidylinositol dephosphorylation [GO:0046856]; protein stabilization [GO:0050821]; regulation of phosphatidylinositol dephosphorylation [GO:0060304] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; ruffle membrane [GO:0032587] enzyme regulator activity [GO:0030234]; protein phosphatase binding [GO:0019903] g22991.t1 Q7SXT7 47.929 169 1.25e-36 138.0 sp|Q7SXT7|ZC21A_DANRE Zinc finger C2HC domain-containing protein 1A OS=Danio rerio OX=7955 GN=zc2hc1a PE=2 SV=1 g22991.t2 Q7SXT7 47.929 169 2.0900000000000002e-36 137.0 sp|Q7SXT7|ZC21A_DANRE Zinc finger C2HC domain-containing protein 1A OS=Danio rerio OX=7955 GN=zc2hc1a PE=2 SV=1 g22991.t3 Q7SXT7 47.929 169 2.32e-36 137.0 sp|Q7SXT7|ZC21A_DANRE Zinc finger C2HC domain-containing protein 1A OS=Danio rerio OX=7955 GN=zc2hc1a PE=2 SV=1 g22994.t1 Q09225 31.174 247 5.830000000000001e-27 120.0 sp|Q09225|NRF6_CAEEL Nose resistant to fluoxetine protein 6 OS=Caenorhabditis elegans OX=6239 GN=nrf-6 PE=1 SV=3 NRF6_CAEEL reviewed Nose resistant to fluoxetine protein 6 (Protein nrf-6) Caenorhabditis elegans GO:0006869; GO:0008289; GO:0016020; GO:0016747 lipid transport [GO:0006869] membrane [GO:0016020] acyltransferase activity, transferring groups other than amino-acyl groups [GO:0016747]; lipid binding [GO:0008289] g22995.t1 Q09225 32.826 460 1.58e-56 212.0 sp|Q09225|NRF6_CAEEL Nose resistant to fluoxetine protein 6 OS=Caenorhabditis elegans OX=6239 GN=nrf-6 PE=1 SV=3 NRF6_CAEEL reviewed Nose resistant to fluoxetine protein 6 (Protein nrf-6) Caenorhabditis elegans GO:0006869; GO:0008289; GO:0016020; GO:0016747 lipid transport [GO:0006869] membrane [GO:0016020] acyltransferase activity, transferring groups other than amino-acyl groups [GO:0016747]; lipid binding [GO:0008289] g22997.t1 Q9GLP1 35.135 333 8.349999999999999e-42 168.0 sp|Q9GLP1|FA5_PIG Coagulation factor V OS=Sus scrofa OX=9823 GN=F5 PE=2 SV=1 g22997.t1 Q9GLP1 32.827 329 3.43e-35 148.0 sp|Q9GLP1|FA5_PIG Coagulation factor V OS=Sus scrofa OX=9823 GN=F5 PE=2 SV=1 g22997.t1 Q9GLP1 31.858 339 5.2e-25 115.0 sp|Q9GLP1|FA5_PIG Coagulation factor V OS=Sus scrofa OX=9823 GN=F5 PE=2 SV=1 g22997.t2 Q7SZN0 31.928 332 6.1e-39 158.0 sp|Q7SZN0|FA5V_PSETE Venom prothrombin activator pseutarin-C non-catalytic subunit OS=Pseudonaja textilis OX=8673 PE=1 SV=1 FA5V_PSETE reviewed Venom prothrombin activator pseutarin-C non-catalytic subunit (PCNS) (vPA) (Venom coagulation factor Va-like protein) [Cleaved into: Pseutarin-C non-catalytic subunit heavy chain; Pseutarin-C non-catalytic subunit light chain] Pseudonaja textilis (Eastern brown snake) GO:0005507; GO:0005576; GO:0005886; GO:0016504; GO:0032991; GO:0038023; GO:0044469; GO:0090729 venom-mediated blood coagulation [GO:0044469] extracellular region [GO:0005576]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] copper ion binding [GO:0005507]; peptidase activator activity [GO:0016504]; signaling receptor activity [GO:0038023]; toxin activity [GO:0090729] g22997.t2 Q7SZN0 36.614 254 4.95e-31 134.0 sp|Q7SZN0|FA5V_PSETE Venom prothrombin activator pseutarin-C non-catalytic subunit OS=Pseudonaja textilis OX=8673 PE=1 SV=1 FA5V_PSETE reviewed Venom prothrombin activator pseutarin-C non-catalytic subunit (PCNS) (vPA) (Venom coagulation factor Va-like protein) [Cleaved into: Pseutarin-C non-catalytic subunit heavy chain; Pseutarin-C non-catalytic subunit light chain] Pseudonaja textilis (Eastern brown snake) GO:0005507; GO:0005576; GO:0005886; GO:0016504; GO:0032991; GO:0038023; GO:0044469; GO:0090729 venom-mediated blood coagulation [GO:0044469] extracellular region [GO:0005576]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] copper ion binding [GO:0005507]; peptidase activator activity [GO:0016504]; signaling receptor activity [GO:0038023]; toxin activity [GO:0090729] g22997.t2 Q7SZN0 33.939 330 4.49e-28 124.0 sp|Q7SZN0|FA5V_PSETE Venom prothrombin activator pseutarin-C non-catalytic subunit OS=Pseudonaja textilis OX=8673 PE=1 SV=1 FA5V_PSETE reviewed Venom prothrombin activator pseutarin-C non-catalytic subunit (PCNS) (vPA) (Venom coagulation factor Va-like protein) [Cleaved into: Pseutarin-C non-catalytic subunit heavy chain; Pseutarin-C non-catalytic subunit light chain] Pseudonaja textilis (Eastern brown snake) GO:0005507; GO:0005576; GO:0005886; GO:0016504; GO:0032991; GO:0038023; GO:0044469; GO:0090729 venom-mediated blood coagulation [GO:0044469] extracellular region [GO:0005576]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] copper ion binding [GO:0005507]; peptidase activator activity [GO:0016504]; signaling receptor activity [GO:0038023]; toxin activity [GO:0090729] g23000.t1 P04323 40.411 292 2.2999999999999998e-69 238.0 sp|P04323|POL3_DROME Retrovirus-related Pol polyprotein from transposon 17.6 OS=Drosophila melanogaster OX=7227 GN=pol PE=4 SV=1 g23001.t1 P10394 42.683 164 1.5e-37 148.0 sp|P10394|POL4_DROME Retrovirus-related Pol polyprotein from transposon 412 OS=Drosophila melanogaster OX=7227 GN=POL PE=4 SV=1 g23003.t1 Q01813 62.208 770 0.0 971.0 sp|Q01813|PFKAP_HUMAN ATP-dependent 6-phosphofructokinase, platelet type OS=Homo sapiens OX=9606 GN=PFKP PE=1 SV=2 PFKAP_HUMAN reviewed ATP-dependent 6-phosphofructokinase, platelet type (ATP-PFK) (PFK-P) (EC 2.7.1.11) (6-phosphofructokinase type C) (Phosphofructo-1-kinase isozyme C) (PFK-C) (Phosphohexokinase) Homo sapiens (Human) GO:0003872; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005945; GO:0006002; GO:0016020; GO:0030388; GO:0042802; GO:0044877; GO:0045296; GO:0046872; GO:0061621; GO:0070062; GO:0070095; GO:1990830 canonical glycolysis [GO:0061621]; cellular response to leukemia inhibitory factor [GO:1990830]; fructose 1,6-bisphosphate metabolic process [GO:0030388]; fructose 6-phosphate metabolic process [GO:0006002] 6-phosphofructokinase complex [GO:0005945]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleus [GO:0005634] 6-phosphofructokinase activity [GO:0003872]; ATP binding [GO:0005524]; cadherin binding [GO:0045296]; fructose-6-phosphate binding [GO:0070095]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein-containing complex binding [GO:0044877] g23003.t2 Q01813 63.276 757 0.0 979.0 sp|Q01813|PFKAP_HUMAN ATP-dependent 6-phosphofructokinase, platelet type OS=Homo sapiens OX=9606 GN=PFKP PE=1 SV=2 PFKAP_HUMAN reviewed ATP-dependent 6-phosphofructokinase, platelet type (ATP-PFK) (PFK-P) (EC 2.7.1.11) (6-phosphofructokinase type C) (Phosphofructo-1-kinase isozyme C) (PFK-C) (Phosphohexokinase) Homo sapiens (Human) GO:0003872; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005945; GO:0006002; GO:0016020; GO:0030388; GO:0042802; GO:0044877; GO:0045296; GO:0046872; GO:0061621; GO:0070062; GO:0070095; GO:1990830 canonical glycolysis [GO:0061621]; cellular response to leukemia inhibitory factor [GO:1990830]; fructose 1,6-bisphosphate metabolic process [GO:0030388]; fructose 6-phosphate metabolic process [GO:0006002] 6-phosphofructokinase complex [GO:0005945]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleus [GO:0005634] 6-phosphofructokinase activity [GO:0003872]; ATP binding [GO:0005524]; cadherin binding [GO:0045296]; fructose-6-phosphate binding [GO:0070095]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein-containing complex binding [GO:0044877] g23007.t1 Q5PQ53 47.561 164 1.01e-54 182.0 sp|Q5PQ53|PEF1_XENLA Peflin OS=Xenopus laevis OX=8355 GN=pef1 PE=1 SV=1 PEF1_XENLA reviewed Peflin (PEF protein with a long N-terminal hydrophobic domain) (Penta-EF hand domain-containing protein 1) Xenopus laevis (African clawed frog) GO:0005509; GO:0005783; GO:0006888; GO:0014029; GO:0014032; GO:0030127; GO:0031463; GO:0048208; GO:0048306; GO:1902527; GO:1990756 COPII vesicle coating [GO:0048208]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; neural crest cell development [GO:0014032]; neural crest formation [GO:0014029]; positive regulation of protein monoubiquitination [GO:1902527] COPII vesicle coat [GO:0030127]; Cul3-RING ubiquitin ligase complex [GO:0031463]; endoplasmic reticulum [GO:0005783] calcium ion binding [GO:0005509]; calcium-dependent protein binding [GO:0048306]; ubiquitin-like ligase-substrate adaptor activity [GO:1990756] g23008.t1 Q8K4L0 54.62 736 0.0 768.0 sp|Q8K4L0|DDX54_MOUSE ATP-dependent RNA helicase DDX54 OS=Mus musculus OX=10090 GN=Ddx54 PE=1 SV=1 DDX54_MOUSE reviewed ATP-dependent RNA helicase DDX54 (EC 3.6.4.13) (DEAD box protein 54) Mus musculus (Mouse) GO:0003714; GO:0003723; GO:0003724; GO:0005102; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005794; GO:0006364; GO:0006396; GO:0016070; GO:0016887; GO:0030331 RNA metabolic process [GO:0016070]; RNA processing [GO:0006396]; rRNA processing [GO:0006364] Golgi apparatus [GO:0005794]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; nuclear estrogen receptor binding [GO:0030331]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; signaling receptor binding [GO:0005102]; transcription corepressor activity [GO:0003714] g23012.t1 C6KFA3 26.655 589 1.7099999999999998e-34 145.0 sp|C6KFA3|AGRG6_DANRE Adhesion G-protein coupled receptor G6 OS=Danio rerio OX=7955 GN=adgrg6 PE=1 SV=1 AGRG6_DANRE reviewed Adhesion G-protein coupled receptor G6 (G-protein coupled receptor 126) [Cleaved into: Adhesion G-protein coupled receptor G6, N-terminal fragment (ADGRG6 N-terminal fragment) (ADGRG6-NTF); Adhesion G-protein coupled receptor G6, C-terminal fragment (ADGRG6 C-terminal fragment) (ADGRG6-CTF)] Danio rerio (Zebrafish) (Brachydanio rerio) GO:0004930; GO:0005518; GO:0005886; GO:0007166; GO:0007188; GO:0007189; GO:0007193; GO:0007507; GO:0014037; GO:0022011; GO:0030500; GO:0042552; GO:0043236; GO:0043583; GO:0050840; GO:0051216; GO:0060347 adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; cartilage development [GO:0051216]; cell surface receptor signaling pathway [GO:0007166]; ear development [GO:0043583]; heart development [GO:0007507]; heart trabecula formation [GO:0060347]; myelination [GO:0042552]; myelination in peripheral nervous system [GO:0022011]; regulation of bone mineralization [GO:0030500]; Schwann cell differentiation [GO:0014037] plasma membrane [GO:0005886] collagen binding [GO:0005518]; extracellular matrix binding [GO:0050840]; G protein-coupled receptor activity [GO:0004930]; laminin binding [GO:0043236] g23017.t1 Q96DM1 29.9 301 3.23e-35 140.0 sp|Q96DM1|PGBD4_HUMAN PiggyBac transposable element-derived protein 4 OS=Homo sapiens OX=9606 GN=PGBD4 PE=1 SV=3 g23030.t1 Q96DM1 32.573 307 9.44e-50 181.0 sp|Q96DM1|PGBD4_HUMAN PiggyBac transposable element-derived protein 4 OS=Homo sapiens OX=9606 GN=PGBD4 PE=1 SV=3 g23046.t1 O97967 27.616 344 5.66e-23 102.0 sp|O97967|BRS3_SHEEP Bombesin receptor subtype-3 OS=Ovis aries OX=9940 GN=BRS3 PE=2 SV=1 g23049.t1 Q9NQL2 73.611 360 0.0 516.0 sp|Q9NQL2|RRAGD_HUMAN Ras-related GTP-binding protein D OS=Homo sapiens OX=9606 GN=RRAGD PE=1 SV=1 RRAGD_HUMAN reviewed Ras-related GTP-binding protein D (Rag D) (RagD) (EC 3.6.5.-) Homo sapiens (Human) GO:0003924; GO:0005525; GO:0005634; GO:0005654; GO:0005737; GO:0005764; GO:0005765; GO:0005813; GO:0005829; GO:0008104; GO:0009267; GO:0010507; GO:0019003; GO:0032008; GO:0046982; GO:0051020; GO:0060090; GO:0071230; GO:0071233; GO:1904263; GO:1990131; GO:1990253 cellular response to amino acid stimulus [GO:0071230]; cellular response to L-leucine [GO:0071233]; cellular response to leucine starvation [GO:1990253]; cellular response to starvation [GO:0009267]; intracellular protein localization [GO:0008104]; negative regulation of autophagy [GO:0010507]; positive regulation of TOR signaling [GO:0032008]; positive regulation of TORC1 signaling [GO:1904263] centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Gtr1-Gtr2 GTPase complex [GO:1990131]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; GTPase binding [GO:0051020]; molecular adaptor activity [GO:0060090]; protein heterodimerization activity [GO:0046982] g23051.t1 O94876 41.214 313 3.9299999999999995e-40 151.0 sp|O94876|TMCC1_HUMAN Transmembrane and coiled-coil domains protein 1 OS=Homo sapiens OX=9606 GN=TMCC1 PE=1 SV=3 TMCC1_HUMAN reviewed Transmembrane and coiled-coil domains protein 1 Homo sapiens (Human) GO:0005789; GO:0005791; GO:0005829; GO:0007029; GO:0012505; GO:0016197; GO:0042802; GO:0090148; GO:0097750; GO:0140284; GO:0140285 endoplasmic reticulum organization [GO:0007029]; endosomal transport [GO:0016197]; endosome fission [GO:0140285]; endosome membrane tubulation [GO:0097750]; membrane fission [GO:0090148] cytosol [GO:0005829]; endomembrane system [GO:0012505]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-endosome membrane contact site [GO:0140284]; rough endoplasmic reticulum [GO:0005791] identical protein binding [GO:0042802] g23052.t1 Q9WVL6 74.016 254 1.52e-132 398.0 sp|Q9WVL6|EXTL3_MOUSE Exostosin-like 3 OS=Mus musculus OX=10090 GN=Extl3 PE=1 SV=2 EXTL3_MOUSE reviewed Exostosin-like 3 (EC 2.4.1.223) (Glucuronyl-galactosyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase) (Multiple exostosis-like protein 3) Mus musculus (Mouse) GO:0000287; GO:0001888; GO:0005634; GO:0005783; GO:0005789; GO:0005794; GO:0005886; GO:0010838; GO:0015012; GO:0016020; GO:0016500; GO:0016757; GO:0030307; GO:0043491; GO:0045617; GO:0050728; GO:0051897; GO:0090594; GO:0106015; GO:1900016; GO:1900017; GO:2000972 heparan sulfate proteoglycan biosynthetic process [GO:0015012]; inflammatory response to wounding [GO:0090594]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of inflammatory response [GO:0050728]; negative regulation of inflammatory response to wounding [GO:0106015]; negative regulation of keratinocyte differentiation [GO:0045617]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; positive regulation of cell growth [GO:0030307]; positive regulation of cytokine production involved in inflammatory response [GO:1900017]; positive regulation of detection of glucose [GO:2000972]; positive regulation of keratinocyte proliferation [GO:0010838]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886] glucuronyl-galactosyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity [GO:0001888]; glycosyltransferase activity [GO:0016757]; magnesium ion binding [GO:0000287]; protein-hormone receptor activity [GO:0016500] g23053.t1 Q9WVL6 45.622 217 4.16e-44 162.0 sp|Q9WVL6|EXTL3_MOUSE Exostosin-like 3 OS=Mus musculus OX=10090 GN=Extl3 PE=1 SV=2 EXTL3_MOUSE reviewed Exostosin-like 3 (EC 2.4.1.223) (Glucuronyl-galactosyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase) (Multiple exostosis-like protein 3) Mus musculus (Mouse) GO:0000287; GO:0001888; GO:0005634; GO:0005783; GO:0005789; GO:0005794; GO:0005886; GO:0010838; GO:0015012; GO:0016020; GO:0016500; GO:0016757; GO:0030307; GO:0043491; GO:0045617; GO:0050728; GO:0051897; GO:0090594; GO:0106015; GO:1900016; GO:1900017; GO:2000972 heparan sulfate proteoglycan biosynthetic process [GO:0015012]; inflammatory response to wounding [GO:0090594]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of inflammatory response [GO:0050728]; negative regulation of inflammatory response to wounding [GO:0106015]; negative regulation of keratinocyte differentiation [GO:0045617]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; positive regulation of cell growth [GO:0030307]; positive regulation of cytokine production involved in inflammatory response [GO:1900017]; positive regulation of detection of glucose [GO:2000972]; positive regulation of keratinocyte proliferation [GO:0010838]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886] glucuronyl-galactosyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity [GO:0001888]; glycosyltransferase activity [GO:0016757]; magnesium ion binding [GO:0000287]; protein-hormone receptor activity [GO:0016500] g23054.t1 O43909 40.476 210 2.99e-46 170.0 sp|O43909|EXTL3_HUMAN Exostosin-like 3 OS=Homo sapiens OX=9606 GN=EXTL3 PE=1 SV=1 EXTL3_HUMAN reviewed Exostosin-like 3 (EC 2.4.1.223) (EXT-related protein 1) (Glucuronyl-galactosyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase) (Hereditary multiple exostoses gene isolog) (Multiple exostosis-like protein 3) (Putative tumor suppressor protein EXTL3) Homo sapiens (Human) GO:0000139; GO:0000287; GO:0001888; GO:0005634; GO:0005783; GO:0005789; GO:0005794; GO:0005886; GO:0010838; GO:0015012; GO:0016500; GO:0016757; GO:0019805; GO:0030307; GO:0032496; GO:0045617; GO:0051897; GO:0106015; GO:1900016; GO:2000972 heparan sulfate proteoglycan biosynthetic process [GO:0015012]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of inflammatory response to wounding [GO:0106015]; negative regulation of keratinocyte differentiation [GO:0045617]; positive regulation of cell growth [GO:0030307]; positive regulation of detection of glucose [GO:2000972]; positive regulation of keratinocyte proliferation [GO:0010838]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; quinolinate biosynthetic process [GO:0019805]; response to lipopolysaccharide [GO:0032496] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; nucleus [GO:0005634]; plasma membrane [GO:0005886] glucuronyl-galactosyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity [GO:0001888]; glycosyltransferase activity [GO:0016757]; magnesium ion binding [GO:0000287]; protein-hormone receptor activity [GO:0016500] g23055.t1 Q0IHA2 43.123 269 4.62e-59 191.0 sp|Q0IHA2|ELP6_XENLA Elongator complex protein 6 OS=Xenopus laevis OX=8355 GN=elp6 PE=2 SV=1 g23056.t1 O76536 31.467 750 1.5799999999999998e-46 186.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g23056.t1 O76536 33.087 677 3.89e-45 182.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g23056.t1 O76536 30.343 758 3.75e-43 175.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g23056.t1 O76536 31.928 664 6.970000000000001e-43 174.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g23056.t1 O76536 32.094 726 6.769999999999999e-42 171.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g23057.t1 Q5BJU6 58.242 91 2.25e-32 114.0 sp|Q5BJU6|CRBL2_RAT cAMP-responsive element-binding protein-like 2 OS=Rattus norvegicus OX=10116 GN=Crebl2 PE=2 SV=1 g23059.t1 Q32PP1 69.841 63 8.13e-24 103.0 sp|Q32PP1|MRNIP_DANRE MRN complex-interacting protein OS=Danio rerio OX=7955 GN=mrnip PE=2 SV=1 MRNIP_DANRE reviewed MRN complex-interacting protein (MRN-interacting protein) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0003682; GO:0005634; GO:0005654; GO:0006281; GO:0006974; GO:0007095; GO:0010212; GO:0045860; GO:0071168; GO:1905168; GO:2001032 DNA damage response [GO:0006974]; DNA repair [GO:0006281]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of protein kinase activity [GO:0045860]; protein localization to chromatin [GO:0071168]; regulation of double-strand break repair via nonhomologous end joining [GO:2001032]; response to ionizing radiation [GO:0010212] nucleoplasm [GO:0005654]; nucleus [GO:0005634] chromatin binding [GO:0003682] g23060.t1 Q4R8M9 42.857 112 2.14e-24 101.0 sp|Q4R8M9|GTSF1_MACFA Gametocyte-specific factor 1 OS=Macaca fascicularis OX=9541 GN=GTSF1 PE=2 SV=1 g23063.t1 Q8NCE0 49.162 179 2.06e-59 197.0 sp|Q8NCE0|SEN2_HUMAN tRNA-splicing endonuclease subunit Sen2 OS=Homo sapiens OX=9606 GN=TSEN2 PE=1 SV=2 SEN2_HUMAN reviewed tRNA-splicing endonuclease subunit Sen2 (EC 4.6.1.16) (tRNA-intron endonuclease Sen2) (HsSen2) Homo sapiens (Human) GO:0000213; GO:0000214; GO:0000379; GO:0003676; GO:0005654; GO:0005730; GO:0005737; GO:0005813; GO:0005829; GO:0006388; GO:0006397; GO:0008033 mRNA processing [GO:0006397]; tRNA processing [GO:0008033]; tRNA splicing, via endonucleolytic cleavage and ligation [GO:0006388]; tRNA-type intron splice site recognition and cleavage [GO:0000379] centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; tRNA-intron endonuclease complex [GO:0000214] nucleic acid binding [GO:0003676]; tRNA-intron lyase activity [GO:0000213] g23065.t1 Q9BXW6 43.151 1022 0.0 794.0 sp|Q9BXW6|OSBL1_HUMAN Oxysterol-binding protein-related protein 1 OS=Homo sapiens OX=9606 GN=OSBPL1A PE=1 SV=2 g23065.t2 Q9BXW6 43.304 1023 0.0 796.0 sp|Q9BXW6|OSBL1_HUMAN Oxysterol-binding protein-related protein 1 OS=Homo sapiens OX=9606 GN=OSBPL1A PE=1 SV=2 g23065.t3 Q9BXW6 43.824 1020 0.0 797.0 sp|Q9BXW6|OSBL1_HUMAN Oxysterol-binding protein-related protein 1 OS=Homo sapiens OX=9606 GN=OSBPL1A PE=1 SV=2 g23066.t1 Q6PFM9 72.055 365 6.699999999999999e-176 507.0 sp|Q6PFM9|WDR48_DANRE WD repeat-containing protein 48 OS=Danio rerio OX=7955 GN=wdr48 PE=2 SV=2 g23067.t1 Q5F3K4 65.233 279 7.57e-113 342.0 sp|Q5F3K4|WDR48_CHICK WD repeat-containing protein 48 OS=Gallus gallus OX=9031 GN=WDR48 PE=2 SV=1 WDR48_CHICK reviewed WD repeat-containing protein 48 (USP1-associated factor 1) Gallus gallus (Chicken) GO:0000724; GO:0003677; GO:0003690; GO:0003697; GO:0005634; GO:0005764; GO:0005770; GO:0006974; GO:0007259; GO:0007283; GO:0007338; GO:0035264; GO:0035800; GO:0043130; GO:0043588; GO:0046427; GO:0048568; GO:0048705; GO:0048872; GO:0050679; GO:0072520; GO:1902525; GO:1905168 cell surface receptor signaling pathway via JAK-STAT [GO:0007259]; DNA damage response [GO:0006974]; double-strand break repair via homologous recombination [GO:0000724]; embryonic organ development [GO:0048568]; homeostasis of number of cells [GO:0048872]; multicellular organism growth [GO:0035264]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; regulation of protein monoubiquitination [GO:1902525]; seminiferous tubule development [GO:0072520]; single fertilization [GO:0007338]; skeletal system morphogenesis [GO:0048705]; skin development [GO:0043588]; spermatogenesis [GO:0007283] late endosome [GO:0005770]; lysosome [GO:0005764]; nucleus [GO:0005634] deubiquitinase activator activity [GO:0035800]; DNA binding [GO:0003677]; double-stranded DNA binding [GO:0003690]; single-stranded DNA binding [GO:0003697]; ubiquitin binding [GO:0043130] g23068.t1 Q99835 54.032 620 0.0 688.0 sp|Q99835|SMO_HUMAN Protein smoothened OS=Homo sapiens OX=9606 GN=SMO PE=1 SV=1 SMO_HUMAN reviewed Protein smoothened (Protein Gx) Homo sapiens (Human) GO:0000122; GO:0001570; GO:0001649; GO:0001701; GO:0001708; GO:0001755; GO:0001933; GO:0001947; GO:0002052; GO:0002053; GO:0003140; GO:0003323; GO:0004862; GO:0004930; GO:0005113; GO:0005770; GO:0005783; GO:0005793; GO:0005794; GO:0005814; GO:0005886; GO:0005929; GO:0006606; GO:0006915; GO:0007224; GO:0007371; GO:0007389; GO:0007405; GO:0007417; GO:0007494; GO:0008142; GO:0009952; GO:0010467; GO:0010628; GO:0010629; GO:0021513; GO:0021542; GO:0021696; GO:0021794; GO:0021904; GO:0021936; GO:0021953; GO:0021987; GO:0030335; GO:0030425; GO:0030666; GO:0030857; GO:0031069; GO:0034236; GO:0035264; GO:0040018; GO:0042307; GO:0042475; GO:0043066; GO:0043392; GO:0045880; GO:0045944; GO:0046622; GO:0048143; GO:0048741; GO:0048745; GO:0048853; GO:0048873; GO:0050673; GO:0050679; GO:0050821; GO:0051451; GO:0051799; GO:0060170; GO:0060242; GO:0060413; GO:0060644; GO:0060684; GO:0061053; GO:0061113; GO:0070062; GO:0070986; GO:0071397; GO:0071542; GO:0071679; GO:0072285; GO:0090190; GO:0097542; GO:0097731; GO:0140311; GO:1902140; GO:1904672; GO:2000826 anterior/posterior pattern specification [GO:0009952]; apoptotic process [GO:0006915]; astrocyte activation [GO:0048143]; atrial septum morphogenesis [GO:0060413]; cell fate specification [GO:0001708]; cellular response to cholesterol [GO:0071397]; central nervous system development [GO:0007417]; central nervous system neuron differentiation [GO:0021953]; cerebellar cortex morphogenesis [GO:0021696]; cerebral cortex development [GO:0021987]; commissural neuron axon guidance [GO:0071679]; contact inhibition [GO:0060242]; dentate gyrus development [GO:0021542]; determination of left/right asymmetry in lateral mesoderm [GO:0003140]; dopaminergic neuron differentiation [GO:0071542]; dorsal/ventral neural tube patterning [GO:0021904]; epithelial cell proliferation [GO:0050673]; epithelial-mesenchymal cell signaling [GO:0060684]; forebrain morphogenesis [GO:0048853]; gene expression [GO:0010467]; hair follicle morphogenesis [GO:0031069]; heart looping [GO:0001947]; homeostasis of number of cells within a tissue [GO:0048873]; in utero embryonic development [GO:0001701]; left/right axis specification [GO:0070986]; mammary gland epithelial cell differentiation [GO:0060644]; mesenchymal to epithelial transition involved in metanephric renal vesicle formation [GO:0072285]; midgut development [GO:0007494]; multicellular organism growth [GO:0035264]; myoblast migration [GO:0051451]; negative regulation of apoptotic process [GO:0043066]; negative regulation of DNA binding [GO:0043392]; negative regulation of epithelial cell differentiation [GO:0030857]; negative regulation of gene expression [GO:0010629]; negative regulation of hair follicle development [GO:0051799]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural crest cell migration [GO:0001755]; neuroblast proliferation [GO:0007405]; odontogenesis of dentin-containing tooth [GO:0042475]; osteoblast differentiation [GO:0001649]; pancreas morphogenesis [GO:0061113]; pattern specification process [GO:0007389]; positive regulation of branching involved in ureteric bud morphogenesis [GO:0090190]; positive regulation of cell migration [GO:0030335]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of gene expression [GO:0010628]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of organ growth [GO:0046622]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of smoothened signaling pathway [GO:0045880]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein import into nucleus [GO:0006606]; protein stabilization [GO:0050821]; regulation of cerebellar granule cell precursor proliferation [GO:0021936]; regulation of heart morphogenesis [GO:2000826]; regulation of somatic stem cell population maintenance [GO:1904672]; response to inositol [GO:1902140]; skeletal muscle fiber development [GO:0048741]; smooth muscle tissue development [GO:0048745]; smoothened signaling pathway [GO:0007224]; somite development [GO:0061053]; spinal cord dorsal/ventral patterning [GO:0021513]; thalamus development [GO:0021794]; type B pancreatic cell development [GO:0003323]; vasculogenesis [GO:0001570]; ventral midline determination [GO:0007371] 9+0 non-motile cilium [GO:0097731]; centriole [GO:0005814]; ciliary membrane [GO:0060170]; ciliary tip [GO:0097542]; cilium [GO:0005929]; dendrite [GO:0030425]; endocytic vesicle membrane [GO:0030666]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; late endosome [GO:0005770]; plasma membrane [GO:0005886] cAMP-dependent protein kinase inhibitor activity [GO:0004862]; G protein-coupled receptor activity [GO:0004930]; oxysterol binding [GO:0008142]; patched binding [GO:0005113]; protein kinase A catalytic subunit binding [GO:0034236]; protein sequestering activity [GO:0140311] g23071.t1 O75899 35.244 698 2.1100000000000002e-133 419.0 sp|O75899|GABR2_HUMAN Gamma-aminobutyric acid type B receptor subunit 2 OS=Homo sapiens OX=9606 GN=GABBR2 PE=1 SV=1 GABR2_HUMAN reviewed Gamma-aminobutyric acid type B receptor subunit 2 (GABA-B receptor 2) (GABA-B-R2) (GABA-BR2) (GABABR2) (Gb2) (G-protein coupled receptor 51) (HG20) Homo sapiens (Human) GO:0004888; GO:0004965; GO:0005737; GO:0005886; GO:0007186; GO:0007193; GO:0007194; GO:0007214; GO:0007268; GO:0038039; GO:0043005; GO:0045211; GO:0046982; GO:0051932; GO:0150099; GO:1902710; GO:1902712 adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; chemical synaptic transmission [GO:0007268]; G protein-coupled receptor signaling pathway [GO:0007186]; gamma-aminobutyric acid signaling pathway [GO:0007214]; negative regulation of adenylate cyclase activity [GO:0007194]; neuron-glial cell signaling [GO:0150099]; synaptic transmission, GABAergic [GO:0051932] cytoplasm [GO:0005737]; G protein-coupled GABA receptor complex [GO:1902712]; G protein-coupled receptor heterodimeric complex [GO:0038039]; GABA receptor complex [GO:1902710]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211] G protein-coupled GABA receptor activity [GO:0004965]; protein heterodimerization activity [GO:0046982]; transmembrane signaling receptor activity [GO:0004888] g23072.t1 O75899 35.053 756 8.39e-127 405.0 sp|O75899|GABR2_HUMAN Gamma-aminobutyric acid type B receptor subunit 2 OS=Homo sapiens OX=9606 GN=GABBR2 PE=1 SV=1 GABR2_HUMAN reviewed Gamma-aminobutyric acid type B receptor subunit 2 (GABA-B receptor 2) (GABA-B-R2) (GABA-BR2) (GABABR2) (Gb2) (G-protein coupled receptor 51) (HG20) Homo sapiens (Human) GO:0004888; GO:0004965; GO:0005737; GO:0005886; GO:0007186; GO:0007193; GO:0007194; GO:0007214; GO:0007268; GO:0038039; GO:0043005; GO:0045211; GO:0046982; GO:0051932; GO:0150099; GO:1902710; GO:1902712 adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; chemical synaptic transmission [GO:0007268]; G protein-coupled receptor signaling pathway [GO:0007186]; gamma-aminobutyric acid signaling pathway [GO:0007214]; negative regulation of adenylate cyclase activity [GO:0007194]; neuron-glial cell signaling [GO:0150099]; synaptic transmission, GABAergic [GO:0051932] cytoplasm [GO:0005737]; G protein-coupled GABA receptor complex [GO:1902712]; G protein-coupled receptor heterodimeric complex [GO:0038039]; GABA receptor complex [GO:1902710]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211] G protein-coupled GABA receptor activity [GO:0004965]; protein heterodimerization activity [GO:0046982]; transmembrane signaling receptor activity [GO:0004888] g23072.t2 O75899 32.54 756 1.08e-104 345.0 sp|O75899|GABR2_HUMAN Gamma-aminobutyric acid type B receptor subunit 2 OS=Homo sapiens OX=9606 GN=GABBR2 PE=1 SV=1 GABR2_HUMAN reviewed Gamma-aminobutyric acid type B receptor subunit 2 (GABA-B receptor 2) (GABA-B-R2) (GABA-BR2) (GABABR2) (Gb2) (G-protein coupled receptor 51) (HG20) Homo sapiens (Human) GO:0004888; GO:0004965; GO:0005737; GO:0005886; GO:0007186; GO:0007193; GO:0007194; GO:0007214; GO:0007268; GO:0038039; GO:0043005; GO:0045211; GO:0046982; GO:0051932; GO:0150099; GO:1902710; GO:1902712 adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; chemical synaptic transmission [GO:0007268]; G protein-coupled receptor signaling pathway [GO:0007186]; gamma-aminobutyric acid signaling pathway [GO:0007214]; negative regulation of adenylate cyclase activity [GO:0007194]; neuron-glial cell signaling [GO:0150099]; synaptic transmission, GABAergic [GO:0051932] cytoplasm [GO:0005737]; G protein-coupled GABA receptor complex [GO:1902712]; G protein-coupled receptor heterodimeric complex [GO:0038039]; GABA receptor complex [GO:1902710]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211] G protein-coupled GABA receptor activity [GO:0004965]; protein heterodimerization activity [GO:0046982]; transmembrane signaling receptor activity [GO:0004888] g23073.t1 P35859 28.871 381 2.94e-28 121.0 sp|P35859|ALS_RAT Insulin-like growth factor-binding protein complex acid labile subunit OS=Rattus norvegicus OX=10116 GN=Igfals PE=1 SV=1 g23085.t1 Q9WV18 37.221 763 1.29e-143 450.0 sp|Q9WV18|GABR1_MOUSE Gamma-aminobutyric acid type B receptor subunit 1 OS=Mus musculus OX=10090 GN=Gabbr1 PE=1 SV=1 GABR1_MOUSE reviewed Gamma-aminobutyric acid type B receptor subunit 1 (GABA-B receptor 1) (GABA-B-R1) (GABA-BR1) (GABABR1) (Gb1) Mus musculus (Mouse) GO:0001649; GO:0004965; GO:0005615; GO:0005737; GO:0005789; GO:0005886; GO:0007193; GO:0007214; GO:0008021; GO:0008285; GO:0014048; GO:0014049; GO:0014053; GO:0016020; GO:0030673; GO:0031966; GO:0032811; GO:0033602; GO:0035094; GO:0038037; GO:0038039; GO:0042734; GO:0043025; GO:0043197; GO:0043198; GO:0045211; GO:0045471; GO:0046982; GO:0050805; GO:0051932; GO:0060124; GO:0097060; GO:0098685; GO:0098793; GO:0098978; GO:0098982; GO:0099579; GO:0150047; GO:0150099; GO:1902710; GO:1902712; GO:1990430 adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; gamma-aminobutyric acid signaling pathway [GO:0007214]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of dopamine secretion [GO:0033602]; negative regulation of epinephrine secretion [GO:0032811]; negative regulation of gamma-aminobutyric acid secretion [GO:0014053]; negative regulation of synaptic transmission [GO:0050805]; neuron-glial cell signaling [GO:0150099]; osteoblast differentiation [GO:0001649]; positive regulation of glutamate secretion [GO:0014049]; positive regulation of growth hormone secretion [GO:0060124]; regulation of glutamate secretion [GO:0014048]; response to ethanol [GO:0045471]; response to nicotine [GO:0035094]; synaptic transmission, GABAergic [GO:0051932] axolemma [GO:0030673]; cytoplasm [GO:0005737]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; endoplasmic reticulum membrane [GO:0005789]; extracellular space [GO:0005615]; G protein-coupled GABA receptor complex [GO:1902712]; G protein-coupled receptor dimeric complex [GO:0038037]; G protein-coupled receptor heterodimeric complex [GO:0038039]; GABA receptor complex [GO:1902710]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; mitochondrial membrane [GO:0031966]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynapse [GO:0098793]; presynaptic membrane [GO:0042734]; Schaffer collateral - CA1 synapse [GO:0098685]; synaptic membrane [GO:0097060]; synaptic vesicle [GO:0008021] extracellular matrix protein binding [GO:1990430]; G protein-coupled GABA receptor activity [GO:0004965]; G protein-coupled neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential [GO:0099579]; G protein-coupled neurotransmitter receptor activity involved in regulation of presynaptic membrane potential [GO:0150047]; protein heterodimerization activity [GO:0046982] g23086.t1 O75899 37.251 553 2.49e-108 350.0 sp|O75899|GABR2_HUMAN Gamma-aminobutyric acid type B receptor subunit 2 OS=Homo sapiens OX=9606 GN=GABBR2 PE=1 SV=1 GABR2_HUMAN reviewed Gamma-aminobutyric acid type B receptor subunit 2 (GABA-B receptor 2) (GABA-B-R2) (GABA-BR2) (GABABR2) (Gb2) (G-protein coupled receptor 51) (HG20) Homo sapiens (Human) GO:0004888; GO:0004965; GO:0005737; GO:0005886; GO:0007186; GO:0007193; GO:0007194; GO:0007214; GO:0007268; GO:0038039; GO:0043005; GO:0045211; GO:0046982; GO:0051932; GO:0150099; GO:1902710; GO:1902712 adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; chemical synaptic transmission [GO:0007268]; G protein-coupled receptor signaling pathway [GO:0007186]; gamma-aminobutyric acid signaling pathway [GO:0007214]; negative regulation of adenylate cyclase activity [GO:0007194]; neuron-glial cell signaling [GO:0150099]; synaptic transmission, GABAergic [GO:0051932] cytoplasm [GO:0005737]; G protein-coupled GABA receptor complex [GO:1902712]; G protein-coupled receptor heterodimeric complex [GO:0038039]; GABA receptor complex [GO:1902710]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211] G protein-coupled GABA receptor activity [GO:0004965]; protein heterodimerization activity [GO:0046982]; transmembrane signaling receptor activity [GO:0004888] g23089.t1 Q9UBS5 36.46 757 1.5500000000000002e-157 491.0 sp|Q9UBS5|GABR1_HUMAN Gamma-aminobutyric acid type B receptor subunit 1 OS=Homo sapiens OX=9606 GN=GABBR1 PE=1 SV=1 GABR1_HUMAN reviewed Gamma-aminobutyric acid type B receptor subunit 1 (GABA-B receptor 1) (GABA-B-R1) (GABA-BR1) (GABABR1) (Gb1) Homo sapiens (Human) GO:0001649; GO:0004965; GO:0005615; GO:0005789; GO:0005886; GO:0007193; GO:0007214; GO:0008021; GO:0008285; GO:0014049; GO:0014053; GO:0030673; GO:0031966; GO:0032811; GO:0033602; GO:0035094; GO:0038039; GO:0042734; GO:0043025; GO:0043197; GO:0043198; GO:0045211; GO:0045471; GO:0046982; GO:0050805; GO:0051932; GO:0060124; GO:0098685; GO:0098978; GO:0098982; GO:0099579; GO:0150047; GO:0150099; GO:1902712; GO:1990430 adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; gamma-aminobutyric acid signaling pathway [GO:0007214]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of dopamine secretion [GO:0033602]; negative regulation of epinephrine secretion [GO:0032811]; negative regulation of gamma-aminobutyric acid secretion [GO:0014053]; negative regulation of synaptic transmission [GO:0050805]; neuron-glial cell signaling [GO:0150099]; osteoblast differentiation [GO:0001649]; positive regulation of glutamate secretion [GO:0014049]; positive regulation of growth hormone secretion [GO:0060124]; response to ethanol [GO:0045471]; response to nicotine [GO:0035094]; synaptic transmission, GABAergic [GO:0051932] axolemma [GO:0030673]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; endoplasmic reticulum membrane [GO:0005789]; extracellular space [GO:0005615]; G protein-coupled GABA receptor complex [GO:1902712]; G protein-coupled receptor heterodimeric complex [GO:0038039]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; mitochondrial membrane [GO:0031966]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; Schaffer collateral - CA1 synapse [GO:0098685]; synaptic vesicle [GO:0008021] extracellular matrix protein binding [GO:1990430]; G protein-coupled GABA receptor activity [GO:0004965]; G protein-coupled neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential [GO:0099579]; G protein-coupled neurotransmitter receptor activity involved in regulation of presynaptic membrane potential [GO:0150047]; protein heterodimerization activity [GO:0046982] g23092.t1 Q6P0I8 45.902 122 1.21e-28 108.0 sp|Q6P0I8|EXOS6_DANRE Exosome complex component MTR3 OS=Danio rerio OX=7955 GN=exosc6 PE=2 SV=2 g23093.t1 Q8WXR4 43.511 786 0.0 598.0 sp|Q8WXR4|MYO3B_HUMAN Myosin-IIIb OS=Homo sapiens OX=9606 GN=MYO3B PE=1 SV=4 g23093.t2 Q8WXR4 43.511 786 0.0 598.0 sp|Q8WXR4|MYO3B_HUMAN Myosin-IIIb OS=Homo sapiens OX=9606 GN=MYO3B PE=1 SV=4 g23094.t1 Q9CYF5 57.042 426 3.4999999999999997e-172 494.0 sp|Q9CYF5|RCC1L_MOUSE RCC1-like G exchanging factor-like protein OS=Mus musculus OX=10090 GN=Rcc1l PE=1 SV=1 g23095.t1 Q5ZMM5 72.368 76 3.75e-27 96.7 sp|Q5ZMM5|ZN706_CHICK Zinc finger protein 706 OS=Gallus gallus OX=9031 GN=ZNF706 PE=3 SV=1 g23096.t1 Q5U2X2 42.776 353 1.41e-75 272.0 sp|Q5U2X2|SPAG1_RAT Sperm-associated antigen 1 OS=Rattus norvegicus OX=10116 GN=Spag1 PE=1 SV=1 SPAG1_RAT reviewed Sperm-associated antigen 1 (HSD-3.8) (Infertility-related sperm protein Spag-1) Rattus norvegicus (Rat) GO:0005525; GO:0005654; GO:0005737; GO:0005829; GO:0005929; GO:0007338; GO:0016787; GO:0070286; GO:0101031; GO:0120293 axonemal dynein complex assembly [GO:0070286]; single fertilization [GO:0007338] cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dynein axonemal particle [GO:0120293]; nucleoplasm [GO:0005654]; protein folding chaperone complex [GO:0101031] GTP binding [GO:0005525]; hydrolase activity [GO:0016787] g23096.t1 Q5U2X2 49.254 134 3.9e-32 139.0 sp|Q5U2X2|SPAG1_RAT Sperm-associated antigen 1 OS=Rattus norvegicus OX=10116 GN=Spag1 PE=1 SV=1 SPAG1_RAT reviewed Sperm-associated antigen 1 (HSD-3.8) (Infertility-related sperm protein Spag-1) Rattus norvegicus (Rat) GO:0005525; GO:0005654; GO:0005737; GO:0005829; GO:0005929; GO:0007338; GO:0016787; GO:0070286; GO:0101031; GO:0120293 axonemal dynein complex assembly [GO:0070286]; single fertilization [GO:0007338] cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dynein axonemal particle [GO:0120293]; nucleoplasm [GO:0005654]; protein folding chaperone complex [GO:0101031] GTP binding [GO:0005525]; hydrolase activity [GO:0016787] g23096.t2 Q5U2X2 42.776 353 4.15e-75 271.0 sp|Q5U2X2|SPAG1_RAT Sperm-associated antigen 1 OS=Rattus norvegicus OX=10116 GN=Spag1 PE=1 SV=1 SPAG1_RAT reviewed Sperm-associated antigen 1 (HSD-3.8) (Infertility-related sperm protein Spag-1) Rattus norvegicus (Rat) GO:0005525; GO:0005654; GO:0005737; GO:0005829; GO:0005929; GO:0007338; GO:0016787; GO:0070286; GO:0101031; GO:0120293 axonemal dynein complex assembly [GO:0070286]; single fertilization [GO:0007338] cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dynein axonemal particle [GO:0120293]; nucleoplasm [GO:0005654]; protein folding chaperone complex [GO:0101031] GTP binding [GO:0005525]; hydrolase activity [GO:0016787] g23096.t2 Q5U2X2 49.254 134 5.35e-32 139.0 sp|Q5U2X2|SPAG1_RAT Sperm-associated antigen 1 OS=Rattus norvegicus OX=10116 GN=Spag1 PE=1 SV=1 SPAG1_RAT reviewed Sperm-associated antigen 1 (HSD-3.8) (Infertility-related sperm protein Spag-1) Rattus norvegicus (Rat) GO:0005525; GO:0005654; GO:0005737; GO:0005829; GO:0005929; GO:0007338; GO:0016787; GO:0070286; GO:0101031; GO:0120293 axonemal dynein complex assembly [GO:0070286]; single fertilization [GO:0007338] cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dynein axonemal particle [GO:0120293]; nucleoplasm [GO:0005654]; protein folding chaperone complex [GO:0101031] GTP binding [GO:0005525]; hydrolase activity [GO:0016787] g23098.t1 Q8BUZ3 43.077 130 3.89e-26 109.0 sp|Q8BUZ3|TIGD4_MOUSE Tigger transposable element-derived protein 4 OS=Mus musculus OX=10090 GN=Tigd4 PE=2 SV=1 g23103.t1 P22105 32.897 687 1.2299999999999999e-30 133.0 sp|P22105|TENX_HUMAN Tenascin-X OS=Homo sapiens OX=9606 GN=TNXB PE=1 SV=5 TENX_HUMAN reviewed Tenascin-X (TN-X) (Hexabrachion-like protein) Homo sapiens (Human) GO:0005178; GO:0005201; GO:0005518; GO:0005576; GO:0005615; GO:0006631; GO:0006641; GO:0007155; GO:0007160; GO:0008201; GO:0008284; GO:0010718; GO:0030036; GO:0030155; GO:0030199; GO:0030334; GO:0031012; GO:0031175; GO:0032963; GO:0045595; GO:0046328; GO:0048251; GO:0070062; GO:0090733; GO:0098609; GO:0098633; GO:1900748; GO:1904028; GO:1905935 actin cytoskeleton organization [GO:0030036]; cell adhesion [GO:0007155]; cell-cell adhesion [GO:0098609]; cell-matrix adhesion [GO:0007160]; collagen fibril organization [GO:0030199]; collagen metabolic process [GO:0032963]; elastic fiber assembly [GO:0048251]; fatty acid metabolic process [GO:0006631]; neuron projection development [GO:0031175]; positive regulation of cell fate determination [GO:1905935]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of collagen fibril organization [GO:1904028]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of vascular endothelial growth factor signaling pathway [GO:1900748]; regulation of cell adhesion [GO:0030155]; regulation of cell differentiation [GO:0045595]; regulation of cell migration [GO:0030334]; regulation of JNK cascade [GO:0046328]; triglyceride metabolic process [GO:0006641] extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; tenascin complex [GO:0090733] collagen binding [GO:0005518]; collagen fibril binding [GO:0098633]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; integrin binding [GO:0005178] g23104.t1 Q29116 30.396 556 4.6500000000000005e-27 125.0 sp|Q29116|TENA_PIG Tenascin OS=Sus scrofa OX=9823 GN=TNC PE=1 SV=1 TENA_PIG reviewed Tenascin (TN) (Cytotactin) (GMEM) (GP 150-225) (Glioma-associated-extracellular matrix antigen) (Hexabrachion) (JI) (Myotendinous antigen) (Neuronectin) (P230) (Tenascin-C) (TN-C) Sus scrofa (Pig) GO:0005178; GO:0005615; GO:0007155; GO:0009611; GO:0030155; GO:0098966 cell adhesion [GO:0007155]; regulation of cell adhesion [GO:0030155]; response to wounding [GO:0009611] extracellular space [GO:0005615]; perisynaptic extracellular matrix [GO:0098966] integrin binding [GO:0005178] g23111.t1 Q6DCX2 72.45 853 0.0 1275.0 sp|Q6DCX2|AGO2_XENLA Protein argonaute-2 OS=Xenopus laevis OX=8355 GN=ago2 PE=2 SV=1 AGO2_XENLA reviewed Protein argonaute-2 (Argonaute2) (EC 3.1.26.n2) (Argonaute RISC catalytic component 2) (Eukaryotic translation initiation factor 2C 2) (eIF-2C 2) (eIF2C 2) (Protein slicer) Xenopus laevis (African clawed frog) GO:0000340; GO:0000932; GO:0003727; GO:0004521; GO:0005634; GO:0005737; GO:0006355; GO:0016442; GO:0031047; GO:0031054; GO:0035194; GO:0035197; GO:0035198; GO:0035278; GO:0035279; GO:0036464; GO:0045947; GO:0046872; GO:0060213; GO:0070551; GO:0070578; GO:0098808; GO:1900153 miRNA-mediated gene silencing by inhibition of translation [GO:0035278]; miRNA-mediated gene silencing by mRNA destabilization [GO:0035279]; negative regulation of translational initiation [GO:0045947]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; pre-miRNA processing [GO:0031054]; regulation of DNA-templated transcription [GO:0006355]; regulatory ncRNA-mediated gene silencing [GO:0031047]; regulatory ncRNA-mediated post-transcriptional gene silencing [GO:0035194] cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; nucleus [GO:0005634]; P-body [GO:0000932]; RISC complex [GO:0016442]; RISC-loading complex [GO:0070578] endoribonuclease activity, cleaving siRNA-paired mRNA [GO:0070551]; metal ion binding [GO:0046872]; miRNA binding [GO:0035198]; mRNA cap binding [GO:0098808]; RNA 7-methylguanosine cap binding [GO:0000340]; RNA endonuclease activity [GO:0004521]; single-stranded RNA binding [GO:0003727]; siRNA binding [GO:0035197] g23112.t1 P36241 77.157 197 2.8e-86 256.0 sp|P36241|RL19_DROME Large ribosomal subunit protein eL19 OS=Drosophila melanogaster OX=7227 GN=RpL19 PE=1 SV=2 g23117.t1 Q8JFQ4 32.5 280 8.47e-36 133.0 sp|Q8JFQ4|RDM1_CHICK RAD52 motif-containing protein 1 OS=Gallus gallus OX=9031 GN=RDM1 PE=1 SV=1 g23118.t1 Q6DFF4 58.621 667 0.0 790.0 sp|Q6DFF4|INT9_XENLA Integrator complex subunit 9 OS=Xenopus laevis OX=8355 GN=ints9 PE=2 SV=1 g23120.t1 Q5G267 35.106 188 1.21e-25 115.0 sp|Q5G267|NETR_MACMU Neurotrypsin OS=Macaca mulatta OX=9544 GN=PRSS12 PE=3 SV=1 NETR_MACMU reviewed Neurotrypsin (EC 3.4.21.-) (Serine protease 12) Macaca mulatta (Rhesus macaque) GO:0004252; GO:0005886; GO:0006508; GO:0006887; GO:0030424; GO:0030425; GO:0043083; GO:0043195; GO:0098978 exocytosis [GO:0006887]; proteolysis [GO:0006508] axon [GO:0030424]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; synaptic cleft [GO:0043083]; terminal bouton [GO:0043195] serine-type endopeptidase activity [GO:0004252] g23120.t2 Q9UGM3 35.775 587 3.7400000000000005e-79 282.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g23120.t2 Q9UGM3 34.05 605 6.46e-78 278.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g23120.t2 Q9UGM3 33.719 605 1.03e-77 278.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g23120.t2 Q9UGM3 33.223 605 6.7300000000000004e-77 275.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g23120.t2 Q9UGM3 33.901 587 4.39e-76 273.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g23120.t2 Q9UGM3 31.157 536 1.5699999999999998e-52 202.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g23120.t2 Q9UGM3 43.836 219 4.58e-37 154.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g23120.t2 Q9UGM3 34.322 236 9.69e-28 124.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g23121.t1 Q7Z7G8 32.061 917 1.63e-120 417.0 sp|Q7Z7G8|VP13B_HUMAN Intermembrane lipid transfer protein VPS13B OS=Homo sapiens OX=9606 GN=VPS13B PE=1 SV=2 VP13B_HUMAN reviewed Intermembrane lipid transfer protein VPS13B (Cohen syndrome protein 1) (Vacuolar protein sorting-associated protein 13B) Homo sapiens (Human) GO:0000139; GO:0001675; GO:0002080; GO:0005765; GO:0006869; GO:0007030; GO:0007399; GO:0007417; GO:0007517; GO:0007613; GO:0016192; GO:0021542; GO:0031175; GO:0031901; GO:0032266; GO:0032458; GO:0032588; GO:0033106; GO:0033116; GO:0035176; GO:0035264; GO:0036438; GO:0055038; GO:0060323; GO:0060612; GO:0090168 acrosome assembly [GO:0001675]; adipose tissue development [GO:0060612]; central nervous system development [GO:0007417]; dentate gyrus development [GO:0021542]; Golgi organization [GO:0007030]; Golgi reassembly [GO:0090168]; head morphogenesis [GO:0060323]; lipid transport [GO:0006869]; maintenance of lens transparency [GO:0036438]; memory [GO:0007613]; multicellular organism growth [GO:0035264]; muscle organ development [GO:0007517]; nervous system development [GO:0007399]; neuron projection development [GO:0031175]; slow endocytic recycling [GO:0032458]; social behavior [GO:0035176]; vesicle-mediated transport [GO:0016192] acrosomal membrane [GO:0002080]; cis-Golgi network membrane [GO:0033106]; early endosome membrane [GO:0031901]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi membrane [GO:0000139]; lysosomal membrane [GO:0005765]; recycling endosome membrane [GO:0055038]; trans-Golgi network membrane [GO:0032588] phosphatidylinositol-3-phosphate binding [GO:0032266] g23121.t1 Q7Z7G8 62.1 219 3.1500000000000003e-65 248.0 sp|Q7Z7G8|VP13B_HUMAN Intermembrane lipid transfer protein VPS13B OS=Homo sapiens OX=9606 GN=VPS13B PE=1 SV=2 VP13B_HUMAN reviewed Intermembrane lipid transfer protein VPS13B (Cohen syndrome protein 1) (Vacuolar protein sorting-associated protein 13B) Homo sapiens (Human) GO:0000139; GO:0001675; GO:0002080; GO:0005765; GO:0006869; GO:0007030; GO:0007399; GO:0007417; GO:0007517; GO:0007613; GO:0016192; GO:0021542; GO:0031175; GO:0031901; GO:0032266; GO:0032458; GO:0032588; GO:0033106; GO:0033116; GO:0035176; GO:0035264; GO:0036438; GO:0055038; GO:0060323; GO:0060612; GO:0090168 acrosome assembly [GO:0001675]; adipose tissue development [GO:0060612]; central nervous system development [GO:0007417]; dentate gyrus development [GO:0021542]; Golgi organization [GO:0007030]; Golgi reassembly [GO:0090168]; head morphogenesis [GO:0060323]; lipid transport [GO:0006869]; maintenance of lens transparency [GO:0036438]; memory [GO:0007613]; multicellular organism growth [GO:0035264]; muscle organ development [GO:0007517]; nervous system development [GO:0007399]; neuron projection development [GO:0031175]; slow endocytic recycling [GO:0032458]; social behavior [GO:0035176]; vesicle-mediated transport [GO:0016192] acrosomal membrane [GO:0002080]; cis-Golgi network membrane [GO:0033106]; early endosome membrane [GO:0031901]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi membrane [GO:0000139]; lysosomal membrane [GO:0005765]; recycling endosome membrane [GO:0055038]; trans-Golgi network membrane [GO:0032588] phosphatidylinositol-3-phosphate binding [GO:0032266] g23122.t1 Q7Z7G8 31.477 1185 4.0900000000000003e-166 581.0 sp|Q7Z7G8|VP13B_HUMAN Intermembrane lipid transfer protein VPS13B OS=Homo sapiens OX=9606 GN=VPS13B PE=1 SV=2 VP13B_HUMAN reviewed Intermembrane lipid transfer protein VPS13B (Cohen syndrome protein 1) (Vacuolar protein sorting-associated protein 13B) Homo sapiens (Human) GO:0000139; GO:0001675; GO:0002080; GO:0005765; GO:0006869; GO:0007030; GO:0007399; GO:0007417; GO:0007517; GO:0007613; GO:0016192; GO:0021542; GO:0031175; GO:0031901; GO:0032266; GO:0032458; GO:0032588; GO:0033106; GO:0033116; GO:0035176; GO:0035264; GO:0036438; GO:0055038; GO:0060323; GO:0060612; GO:0090168 acrosome assembly [GO:0001675]; adipose tissue development [GO:0060612]; central nervous system development [GO:0007417]; dentate gyrus development [GO:0021542]; Golgi organization [GO:0007030]; Golgi reassembly [GO:0090168]; head morphogenesis [GO:0060323]; lipid transport [GO:0006869]; maintenance of lens transparency [GO:0036438]; memory [GO:0007613]; multicellular organism growth [GO:0035264]; muscle organ development [GO:0007517]; nervous system development [GO:0007399]; neuron projection development [GO:0031175]; slow endocytic recycling [GO:0032458]; social behavior [GO:0035176]; vesicle-mediated transport [GO:0016192] acrosomal membrane [GO:0002080]; cis-Golgi network membrane [GO:0033106]; early endosome membrane [GO:0031901]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi membrane [GO:0000139]; lysosomal membrane [GO:0005765]; recycling endosome membrane [GO:0055038]; trans-Golgi network membrane [GO:0032588] phosphatidylinositol-3-phosphate binding [GO:0032266] g23122.t1 Q7Z7G8 37.906 678 2.21e-96 354.0 sp|Q7Z7G8|VP13B_HUMAN Intermembrane lipid transfer protein VPS13B OS=Homo sapiens OX=9606 GN=VPS13B PE=1 SV=2 VP13B_HUMAN reviewed Intermembrane lipid transfer protein VPS13B (Cohen syndrome protein 1) (Vacuolar protein sorting-associated protein 13B) Homo sapiens (Human) GO:0000139; GO:0001675; GO:0002080; GO:0005765; GO:0006869; GO:0007030; GO:0007399; GO:0007417; GO:0007517; GO:0007613; GO:0016192; GO:0021542; GO:0031175; GO:0031901; GO:0032266; GO:0032458; GO:0032588; GO:0033106; GO:0033116; GO:0035176; GO:0035264; GO:0036438; GO:0055038; GO:0060323; GO:0060612; GO:0090168 acrosome assembly [GO:0001675]; adipose tissue development [GO:0060612]; central nervous system development [GO:0007417]; dentate gyrus development [GO:0021542]; Golgi organization [GO:0007030]; Golgi reassembly [GO:0090168]; head morphogenesis [GO:0060323]; lipid transport [GO:0006869]; maintenance of lens transparency [GO:0036438]; memory [GO:0007613]; multicellular organism growth [GO:0035264]; muscle organ development [GO:0007517]; nervous system development [GO:0007399]; neuron projection development [GO:0031175]; slow endocytic recycling [GO:0032458]; social behavior [GO:0035176]; vesicle-mediated transport [GO:0016192] acrosomal membrane [GO:0002080]; cis-Golgi network membrane [GO:0033106]; early endosome membrane [GO:0031901]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi membrane [GO:0000139]; lysosomal membrane [GO:0005765]; recycling endosome membrane [GO:0055038]; trans-Golgi network membrane [GO:0032588] phosphatidylinositol-3-phosphate binding [GO:0032266] g23122.t1 Q7Z7G8 31.092 357 2.45e-37 160.0 sp|Q7Z7G8|VP13B_HUMAN Intermembrane lipid transfer protein VPS13B OS=Homo sapiens OX=9606 GN=VPS13B PE=1 SV=2 VP13B_HUMAN reviewed Intermembrane lipid transfer protein VPS13B (Cohen syndrome protein 1) (Vacuolar protein sorting-associated protein 13B) Homo sapiens (Human) GO:0000139; GO:0001675; GO:0002080; GO:0005765; GO:0006869; GO:0007030; GO:0007399; GO:0007417; GO:0007517; GO:0007613; GO:0016192; GO:0021542; GO:0031175; GO:0031901; GO:0032266; GO:0032458; GO:0032588; GO:0033106; GO:0033116; GO:0035176; GO:0035264; GO:0036438; GO:0055038; GO:0060323; GO:0060612; GO:0090168 acrosome assembly [GO:0001675]; adipose tissue development [GO:0060612]; central nervous system development [GO:0007417]; dentate gyrus development [GO:0021542]; Golgi organization [GO:0007030]; Golgi reassembly [GO:0090168]; head morphogenesis [GO:0060323]; lipid transport [GO:0006869]; maintenance of lens transparency [GO:0036438]; memory [GO:0007613]; multicellular organism growth [GO:0035264]; muscle organ development [GO:0007517]; nervous system development [GO:0007399]; neuron projection development [GO:0031175]; slow endocytic recycling [GO:0032458]; social behavior [GO:0035176]; vesicle-mediated transport [GO:0016192] acrosomal membrane [GO:0002080]; cis-Golgi network membrane [GO:0033106]; early endosome membrane [GO:0031901]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi membrane [GO:0000139]; lysosomal membrane [GO:0005765]; recycling endosome membrane [GO:0055038]; trans-Golgi network membrane [GO:0032588] phosphatidylinositol-3-phosphate binding [GO:0032266] g23123.t1 Q8BVE3 56.345 394 1.56e-151 441.0 sp|Q8BVE3|VATH_MOUSE V-type proton ATPase subunit H OS=Mus musculus OX=10090 GN=Atp6v1h PE=1 SV=1 g23124.t1 Q7TQA3 39.13 299 1.78e-71 227.0 sp|Q7TQA3|RDHE2_MOUSE Epidermal retinol dehydrogenase 2 OS=Mus musculus OX=10090 GN=Sdr16c5 PE=2 SV=1 g23128.t1 Q9WUU9 37.302 252 7.440000000000001e-29 127.0 sp|Q9WUU9|GANP_MOUSE Germinal-center associated nuclear protein OS=Mus musculus OX=10090 GN=Mcm3ap PE=1 SV=2 GANP_MOUSE reviewed Germinal-center associated nuclear protein (GANP) (EC 2.3.1.48) (GC-associated DNA primase) Mus musculus (Mouse) GO:0003676; GO:0003682; GO:0004402; GO:0005634; GO:0005654; GO:0005694; GO:0005737; GO:0005829; GO:0006406; GO:0010484; GO:0015031; GO:0016446; GO:0016973; GO:0031965; GO:0034728; GO:0042393; GO:0044615; GO:0070390 mRNA export from nucleus [GO:0006406]; nucleosome organization [GO:0034728]; poly(A)+ mRNA export from nucleus [GO:0016973]; protein transport [GO:0015031]; somatic hypermutation of immunoglobulin genes [GO:0016446] chromosome [GO:0005694]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]; nuclear pore nuclear basket [GO:0044615]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription export complex 2 [GO:0070390] chromatin binding [GO:0003682]; histone acetyltransferase activity [GO:0004402]; histone binding [GO:0042393]; histone H3 acetyltransferase activity [GO:0010484]; nucleic acid binding [GO:0003676] g23129.t1 O60318 56.667 120 2.03e-46 163.0 sp|O60318|GANP_HUMAN Germinal-center associated nuclear protein OS=Homo sapiens OX=9606 GN=MCM3AP PE=1 SV=2 g23130.t1 Q496Z2 31.449 283 3.33e-27 120.0 sp|Q496Z2|TRIL_RAT TLR4 interactor with leucine rich repeats OS=Rattus norvegicus OX=10116 GN=Tril PE=1 SV=1 TRIL_RAT reviewed TLR4 interactor with leucine rich repeats (Leucine-rich repeat-containing protein KIAA0644 homolog) Rattus norvegicus (Rat) GO:0001530; GO:0002718; GO:0005886; GO:0006954; GO:0034142; GO:0038023; GO:0045087; GO:0046696 inflammatory response [GO:0006954]; innate immune response [GO:0045087]; regulation of cytokine production involved in immune response [GO:0002718]; toll-like receptor 4 signaling pathway [GO:0034142] lipopolysaccharide receptor complex [GO:0046696]; plasma membrane [GO:0005886] lipopolysaccharide binding [GO:0001530]; signaling receptor activity [GO:0038023] g23131.t1 O15335 27.362 307 1.35e-28 120.0 sp|O15335|CHAD_HUMAN Chondroadherin OS=Homo sapiens OX=9606 GN=CHAD PE=1 SV=2 g23132.t1 O15335 26.471 306 6.42e-27 116.0 sp|O15335|CHAD_HUMAN Chondroadherin OS=Homo sapiens OX=9606 GN=CHAD PE=1 SV=2 g23133.t1 O75325 29.74 269 9.939999999999999e-23 108.0 sp|O75325|LRRN2_HUMAN Leucine-rich repeat neuronal protein 2 OS=Homo sapiens OX=9606 GN=LRRN2 PE=1 SV=2 g23134.t1 O60318 26.162 753 1.3299999999999998e-48 194.0 sp|O60318|GANP_HUMAN Germinal-center associated nuclear protein OS=Homo sapiens OX=9606 GN=MCM3AP PE=1 SV=2 g23134.t1 O60318 42.703 185 7.150000000000001e-37 155.0 sp|O60318|GANP_HUMAN Germinal-center associated nuclear protein OS=Homo sapiens OX=9606 GN=MCM3AP PE=1 SV=2 g23135.t1 J9VHE9 57.055 163 2.29e-57 194.0 sp|J9VHE9|UHRF1_CRYNH UHRF1-like protein OS=Cryptococcus neoformans var. grubii serotype A (strain H99 / ATCC 208821 / CBS 10515 / FGSC 9487) OX=235443 GN=UHF1 PE=3 SV=2 g23137.t1 Q92576 41.603 262 2.45e-44 181.0 sp|Q92576|PHF3_HUMAN PHD finger protein 3 OS=Homo sapiens OX=9606 GN=PHF3 PE=1 SV=3 g23137.t1 Q92576 46.853 143 3.7600000000000004e-37 157.0 sp|Q92576|PHF3_HUMAN PHD finger protein 3 OS=Homo sapiens OX=9606 GN=PHF3 PE=1 SV=3 g23138.t1 Q4H4B6 60.896 491 8.24e-162 533.0 sp|Q4H4B6|SCRIB_DANRE Protein scribble homolog OS=Danio rerio OX=7955 GN=scrib PE=1 SV=1 SCRIB_DANRE reviewed Protein scribble homolog (Scribble1) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000132; GO:0001736; GO:0001764; GO:0001841; GO:0001944; GO:0005737; GO:0005886; GO:0005911; GO:0005912; GO:0008283; GO:0014069; GO:0016020; GO:0016323; GO:0016477; GO:0019901; GO:0030027; GO:0033564; GO:0035089; GO:0043065; GO:0043113; GO:0045197; GO:0045930; GO:0046982; GO:0048884; GO:0050918; GO:0060027; GO:0060561; GO:0071679; GO:0090630; GO:0097475; GO:0098609; GO:0098793; GO:0098887 activation of GTPase activity [GO:0090630]; anterior/posterior axon guidance [GO:0033564]; apoptotic process involved in morphogenesis [GO:0060561]; cell migration [GO:0016477]; cell population proliferation [GO:0008283]; cell-cell adhesion [GO:0098609]; commissural neuron axon guidance [GO:0071679]; convergent extension involved in gastrulation [GO:0060027]; establishment of apical/basal cell polarity [GO:0035089]; establishment of mitotic spindle orientation [GO:0000132]; establishment of planar polarity [GO:0001736]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; motor neuron migration [GO:0097475]; negative regulation of mitotic cell cycle [GO:0045930]; neural tube formation [GO:0001841]; neuromast development [GO:0048884]; neuron migration [GO:0001764]; neurotransmitter receptor transport, endosome to postsynaptic membrane [GO:0098887]; positive chemotaxis [GO:0050918]; positive regulation of apoptotic process [GO:0043065]; receptor clustering [GO:0043113]; vasculature development [GO:0001944] adherens junction [GO:0005912]; basolateral plasma membrane [GO:0016323]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; lamellipodium [GO:0030027]; membrane [GO:0016020]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; presynapse [GO:0098793] protein heterodimerization activity [GO:0046982]; protein kinase binding [GO:0019901] g23138.t1 Q4H4B6 49.609 512 8.189999999999999e-128 437.0 sp|Q4H4B6|SCRIB_DANRE Protein scribble homolog OS=Danio rerio OX=7955 GN=scrib PE=1 SV=1 SCRIB_DANRE reviewed Protein scribble homolog (Scribble1) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000132; GO:0001736; GO:0001764; GO:0001841; GO:0001944; GO:0005737; GO:0005886; GO:0005911; GO:0005912; GO:0008283; GO:0014069; GO:0016020; GO:0016323; GO:0016477; GO:0019901; GO:0030027; GO:0033564; GO:0035089; GO:0043065; GO:0043113; GO:0045197; GO:0045930; GO:0046982; GO:0048884; GO:0050918; GO:0060027; GO:0060561; GO:0071679; GO:0090630; GO:0097475; GO:0098609; GO:0098793; GO:0098887 activation of GTPase activity [GO:0090630]; anterior/posterior axon guidance [GO:0033564]; apoptotic process involved in morphogenesis [GO:0060561]; cell migration [GO:0016477]; cell population proliferation [GO:0008283]; cell-cell adhesion [GO:0098609]; commissural neuron axon guidance [GO:0071679]; convergent extension involved in gastrulation [GO:0060027]; establishment of apical/basal cell polarity [GO:0035089]; establishment of mitotic spindle orientation [GO:0000132]; establishment of planar polarity [GO:0001736]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; motor neuron migration [GO:0097475]; negative regulation of mitotic cell cycle [GO:0045930]; neural tube formation [GO:0001841]; neuromast development [GO:0048884]; neuron migration [GO:0001764]; neurotransmitter receptor transport, endosome to postsynaptic membrane [GO:0098887]; positive chemotaxis [GO:0050918]; positive regulation of apoptotic process [GO:0043065]; receptor clustering [GO:0043113]; vasculature development [GO:0001944] adherens junction [GO:0005912]; basolateral plasma membrane [GO:0016323]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; lamellipodium [GO:0030027]; membrane [GO:0016020]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; presynapse [GO:0098793] protein heterodimerization activity [GO:0046982]; protein kinase binding [GO:0019901] g23138.t2 Q4H4B6 60.896 491 3.5500000000000004e-161 533.0 sp|Q4H4B6|SCRIB_DANRE Protein scribble homolog OS=Danio rerio OX=7955 GN=scrib PE=1 SV=1 SCRIB_DANRE reviewed Protein scribble homolog (Scribble1) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000132; GO:0001736; GO:0001764; GO:0001841; GO:0001944; GO:0005737; GO:0005886; GO:0005911; GO:0005912; GO:0008283; GO:0014069; GO:0016020; GO:0016323; GO:0016477; GO:0019901; GO:0030027; GO:0033564; GO:0035089; GO:0043065; GO:0043113; GO:0045197; GO:0045930; GO:0046982; GO:0048884; GO:0050918; GO:0060027; GO:0060561; GO:0071679; GO:0090630; GO:0097475; GO:0098609; GO:0098793; GO:0098887 activation of GTPase activity [GO:0090630]; anterior/posterior axon guidance [GO:0033564]; apoptotic process involved in morphogenesis [GO:0060561]; cell migration [GO:0016477]; cell population proliferation [GO:0008283]; cell-cell adhesion [GO:0098609]; commissural neuron axon guidance [GO:0071679]; convergent extension involved in gastrulation [GO:0060027]; establishment of apical/basal cell polarity [GO:0035089]; establishment of mitotic spindle orientation [GO:0000132]; establishment of planar polarity [GO:0001736]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; motor neuron migration [GO:0097475]; negative regulation of mitotic cell cycle [GO:0045930]; neural tube formation [GO:0001841]; neuromast development [GO:0048884]; neuron migration [GO:0001764]; neurotransmitter receptor transport, endosome to postsynaptic membrane [GO:0098887]; positive chemotaxis [GO:0050918]; positive regulation of apoptotic process [GO:0043065]; receptor clustering [GO:0043113]; vasculature development [GO:0001944] adherens junction [GO:0005912]; basolateral plasma membrane [GO:0016323]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; lamellipodium [GO:0030027]; membrane [GO:0016020]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; presynapse [GO:0098793] protein heterodimerization activity [GO:0046982]; protein kinase binding [GO:0019901] g23138.t2 Q4H4B6 48.289 526 4.83e-130 446.0 sp|Q4H4B6|SCRIB_DANRE Protein scribble homolog OS=Danio rerio OX=7955 GN=scrib PE=1 SV=1 SCRIB_DANRE reviewed Protein scribble homolog (Scribble1) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000132; GO:0001736; GO:0001764; GO:0001841; GO:0001944; GO:0005737; GO:0005886; GO:0005911; GO:0005912; GO:0008283; GO:0014069; GO:0016020; GO:0016323; GO:0016477; GO:0019901; GO:0030027; GO:0033564; GO:0035089; GO:0043065; GO:0043113; GO:0045197; GO:0045930; GO:0046982; GO:0048884; GO:0050918; GO:0060027; GO:0060561; GO:0071679; GO:0090630; GO:0097475; GO:0098609; GO:0098793; GO:0098887 activation of GTPase activity [GO:0090630]; anterior/posterior axon guidance [GO:0033564]; apoptotic process involved in morphogenesis [GO:0060561]; cell migration [GO:0016477]; cell population proliferation [GO:0008283]; cell-cell adhesion [GO:0098609]; commissural neuron axon guidance [GO:0071679]; convergent extension involved in gastrulation [GO:0060027]; establishment of apical/basal cell polarity [GO:0035089]; establishment of mitotic spindle orientation [GO:0000132]; establishment of planar polarity [GO:0001736]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; motor neuron migration [GO:0097475]; negative regulation of mitotic cell cycle [GO:0045930]; neural tube formation [GO:0001841]; neuromast development [GO:0048884]; neuron migration [GO:0001764]; neurotransmitter receptor transport, endosome to postsynaptic membrane [GO:0098887]; positive chemotaxis [GO:0050918]; positive regulation of apoptotic process [GO:0043065]; receptor clustering [GO:0043113]; vasculature development [GO:0001944] adherens junction [GO:0005912]; basolateral plasma membrane [GO:0016323]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; lamellipodium [GO:0030027]; membrane [GO:0016020]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; presynapse [GO:0098793] protein heterodimerization activity [GO:0046982]; protein kinase binding [GO:0019901] g23138.t3 Q4H4B6 60.896 491 9.21e-162 533.0 sp|Q4H4B6|SCRIB_DANRE Protein scribble homolog OS=Danio rerio OX=7955 GN=scrib PE=1 SV=1 SCRIB_DANRE reviewed Protein scribble homolog (Scribble1) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000132; GO:0001736; GO:0001764; GO:0001841; GO:0001944; GO:0005737; GO:0005886; GO:0005911; GO:0005912; GO:0008283; GO:0014069; GO:0016020; GO:0016323; GO:0016477; GO:0019901; GO:0030027; GO:0033564; GO:0035089; GO:0043065; GO:0043113; GO:0045197; GO:0045930; GO:0046982; GO:0048884; GO:0050918; GO:0060027; GO:0060561; GO:0071679; GO:0090630; GO:0097475; GO:0098609; GO:0098793; GO:0098887 activation of GTPase activity [GO:0090630]; anterior/posterior axon guidance [GO:0033564]; apoptotic process involved in morphogenesis [GO:0060561]; cell migration [GO:0016477]; cell population proliferation [GO:0008283]; cell-cell adhesion [GO:0098609]; commissural neuron axon guidance [GO:0071679]; convergent extension involved in gastrulation [GO:0060027]; establishment of apical/basal cell polarity [GO:0035089]; establishment of mitotic spindle orientation [GO:0000132]; establishment of planar polarity [GO:0001736]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; motor neuron migration [GO:0097475]; negative regulation of mitotic cell cycle [GO:0045930]; neural tube formation [GO:0001841]; neuromast development [GO:0048884]; neuron migration [GO:0001764]; neurotransmitter receptor transport, endosome to postsynaptic membrane [GO:0098887]; positive chemotaxis [GO:0050918]; positive regulation of apoptotic process [GO:0043065]; receptor clustering [GO:0043113]; vasculature development [GO:0001944] adherens junction [GO:0005912]; basolateral plasma membrane [GO:0016323]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; lamellipodium [GO:0030027]; membrane [GO:0016020]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; presynapse [GO:0098793] protein heterodimerization activity [GO:0046982]; protein kinase binding [GO:0019901] g23138.t3 Q4H4B6 48.289 526 2.04e-130 446.0 sp|Q4H4B6|SCRIB_DANRE Protein scribble homolog OS=Danio rerio OX=7955 GN=scrib PE=1 SV=1 SCRIB_DANRE reviewed Protein scribble homolog (Scribble1) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000132; GO:0001736; GO:0001764; GO:0001841; GO:0001944; GO:0005737; GO:0005886; GO:0005911; GO:0005912; GO:0008283; GO:0014069; GO:0016020; GO:0016323; GO:0016477; GO:0019901; GO:0030027; GO:0033564; GO:0035089; GO:0043065; GO:0043113; GO:0045197; GO:0045930; GO:0046982; GO:0048884; GO:0050918; GO:0060027; GO:0060561; GO:0071679; GO:0090630; GO:0097475; GO:0098609; GO:0098793; GO:0098887 activation of GTPase activity [GO:0090630]; anterior/posterior axon guidance [GO:0033564]; apoptotic process involved in morphogenesis [GO:0060561]; cell migration [GO:0016477]; cell population proliferation [GO:0008283]; cell-cell adhesion [GO:0098609]; commissural neuron axon guidance [GO:0071679]; convergent extension involved in gastrulation [GO:0060027]; establishment of apical/basal cell polarity [GO:0035089]; establishment of mitotic spindle orientation [GO:0000132]; establishment of planar polarity [GO:0001736]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; motor neuron migration [GO:0097475]; negative regulation of mitotic cell cycle [GO:0045930]; neural tube formation [GO:0001841]; neuromast development [GO:0048884]; neuron migration [GO:0001764]; neurotransmitter receptor transport, endosome to postsynaptic membrane [GO:0098887]; positive chemotaxis [GO:0050918]; positive regulation of apoptotic process [GO:0043065]; receptor clustering [GO:0043113]; vasculature development [GO:0001944] adherens junction [GO:0005912]; basolateral plasma membrane [GO:0016323]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; lamellipodium [GO:0030027]; membrane [GO:0016020]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; presynapse [GO:0098793] protein heterodimerization activity [GO:0046982]; protein kinase binding [GO:0019901] g23138.t4 Q4H4B6 60.896 491 5.9800000000000005e-161 534.0 sp|Q4H4B6|SCRIB_DANRE Protein scribble homolog OS=Danio rerio OX=7955 GN=scrib PE=1 SV=1 SCRIB_DANRE reviewed Protein scribble homolog (Scribble1) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000132; GO:0001736; GO:0001764; GO:0001841; GO:0001944; GO:0005737; GO:0005886; GO:0005911; GO:0005912; GO:0008283; GO:0014069; GO:0016020; GO:0016323; GO:0016477; GO:0019901; GO:0030027; GO:0033564; GO:0035089; GO:0043065; GO:0043113; GO:0045197; GO:0045930; GO:0046982; GO:0048884; GO:0050918; GO:0060027; GO:0060561; GO:0071679; GO:0090630; GO:0097475; GO:0098609; GO:0098793; GO:0098887 activation of GTPase activity [GO:0090630]; anterior/posterior axon guidance [GO:0033564]; apoptotic process involved in morphogenesis [GO:0060561]; cell migration [GO:0016477]; cell population proliferation [GO:0008283]; cell-cell adhesion [GO:0098609]; commissural neuron axon guidance [GO:0071679]; convergent extension involved in gastrulation [GO:0060027]; establishment of apical/basal cell polarity [GO:0035089]; establishment of mitotic spindle orientation [GO:0000132]; establishment of planar polarity [GO:0001736]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; motor neuron migration [GO:0097475]; negative regulation of mitotic cell cycle [GO:0045930]; neural tube formation [GO:0001841]; neuromast development [GO:0048884]; neuron migration [GO:0001764]; neurotransmitter receptor transport, endosome to postsynaptic membrane [GO:0098887]; positive chemotaxis [GO:0050918]; positive regulation of apoptotic process [GO:0043065]; receptor clustering [GO:0043113]; vasculature development [GO:0001944] adherens junction [GO:0005912]; basolateral plasma membrane [GO:0016323]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; lamellipodium [GO:0030027]; membrane [GO:0016020]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; presynapse [GO:0098793] protein heterodimerization activity [GO:0046982]; protein kinase binding [GO:0019901] g23138.t4 Q4H4B6 49.105 503 6.59e-130 447.0 sp|Q4H4B6|SCRIB_DANRE Protein scribble homolog OS=Danio rerio OX=7955 GN=scrib PE=1 SV=1 SCRIB_DANRE reviewed Protein scribble homolog (Scribble1) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000132; GO:0001736; GO:0001764; GO:0001841; GO:0001944; GO:0005737; GO:0005886; GO:0005911; GO:0005912; GO:0008283; GO:0014069; GO:0016020; GO:0016323; GO:0016477; GO:0019901; GO:0030027; GO:0033564; GO:0035089; GO:0043065; GO:0043113; GO:0045197; GO:0045930; GO:0046982; GO:0048884; GO:0050918; GO:0060027; GO:0060561; GO:0071679; GO:0090630; GO:0097475; GO:0098609; GO:0098793; GO:0098887 activation of GTPase activity [GO:0090630]; anterior/posterior axon guidance [GO:0033564]; apoptotic process involved in morphogenesis [GO:0060561]; cell migration [GO:0016477]; cell population proliferation [GO:0008283]; cell-cell adhesion [GO:0098609]; commissural neuron axon guidance [GO:0071679]; convergent extension involved in gastrulation [GO:0060027]; establishment of apical/basal cell polarity [GO:0035089]; establishment of mitotic spindle orientation [GO:0000132]; establishment of planar polarity [GO:0001736]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; motor neuron migration [GO:0097475]; negative regulation of mitotic cell cycle [GO:0045930]; neural tube formation [GO:0001841]; neuromast development [GO:0048884]; neuron migration [GO:0001764]; neurotransmitter receptor transport, endosome to postsynaptic membrane [GO:0098887]; positive chemotaxis [GO:0050918]; positive regulation of apoptotic process [GO:0043065]; receptor clustering [GO:0043113]; vasculature development [GO:0001944] adherens junction [GO:0005912]; basolateral plasma membrane [GO:0016323]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; lamellipodium [GO:0030027]; membrane [GO:0016020]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; presynapse [GO:0098793] protein heterodimerization activity [GO:0046982]; protein kinase binding [GO:0019901] g23138.t5 Q4H4B6 60.896 491 1.6600000000000002e-161 533.0 sp|Q4H4B6|SCRIB_DANRE Protein scribble homolog OS=Danio rerio OX=7955 GN=scrib PE=1 SV=1 SCRIB_DANRE reviewed Protein scribble homolog (Scribble1) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000132; GO:0001736; GO:0001764; GO:0001841; GO:0001944; GO:0005737; GO:0005886; GO:0005911; GO:0005912; GO:0008283; GO:0014069; GO:0016020; GO:0016323; GO:0016477; GO:0019901; GO:0030027; GO:0033564; GO:0035089; GO:0043065; GO:0043113; GO:0045197; GO:0045930; GO:0046982; GO:0048884; GO:0050918; GO:0060027; GO:0060561; GO:0071679; GO:0090630; GO:0097475; GO:0098609; GO:0098793; GO:0098887 activation of GTPase activity [GO:0090630]; anterior/posterior axon guidance [GO:0033564]; apoptotic process involved in morphogenesis [GO:0060561]; cell migration [GO:0016477]; cell population proliferation [GO:0008283]; cell-cell adhesion [GO:0098609]; commissural neuron axon guidance [GO:0071679]; convergent extension involved in gastrulation [GO:0060027]; establishment of apical/basal cell polarity [GO:0035089]; establishment of mitotic spindle orientation [GO:0000132]; establishment of planar polarity [GO:0001736]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; motor neuron migration [GO:0097475]; negative regulation of mitotic cell cycle [GO:0045930]; neural tube formation [GO:0001841]; neuromast development [GO:0048884]; neuron migration [GO:0001764]; neurotransmitter receptor transport, endosome to postsynaptic membrane [GO:0098887]; positive chemotaxis [GO:0050918]; positive regulation of apoptotic process [GO:0043065]; receptor clustering [GO:0043113]; vasculature development [GO:0001944] adherens junction [GO:0005912]; basolateral plasma membrane [GO:0016323]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; lamellipodium [GO:0030027]; membrane [GO:0016020]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; presynapse [GO:0098793] protein heterodimerization activity [GO:0046982]; protein kinase binding [GO:0019901] g23138.t5 Q4H4B6 49.105 503 4.34e-130 445.0 sp|Q4H4B6|SCRIB_DANRE Protein scribble homolog OS=Danio rerio OX=7955 GN=scrib PE=1 SV=1 SCRIB_DANRE reviewed Protein scribble homolog (Scribble1) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000132; GO:0001736; GO:0001764; GO:0001841; GO:0001944; GO:0005737; GO:0005886; GO:0005911; GO:0005912; GO:0008283; GO:0014069; GO:0016020; GO:0016323; GO:0016477; GO:0019901; GO:0030027; GO:0033564; GO:0035089; GO:0043065; GO:0043113; GO:0045197; GO:0045930; GO:0046982; GO:0048884; GO:0050918; GO:0060027; GO:0060561; GO:0071679; GO:0090630; GO:0097475; GO:0098609; GO:0098793; GO:0098887 activation of GTPase activity [GO:0090630]; anterior/posterior axon guidance [GO:0033564]; apoptotic process involved in morphogenesis [GO:0060561]; cell migration [GO:0016477]; cell population proliferation [GO:0008283]; cell-cell adhesion [GO:0098609]; commissural neuron axon guidance [GO:0071679]; convergent extension involved in gastrulation [GO:0060027]; establishment of apical/basal cell polarity [GO:0035089]; establishment of mitotic spindle orientation [GO:0000132]; establishment of planar polarity [GO:0001736]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; motor neuron migration [GO:0097475]; negative regulation of mitotic cell cycle [GO:0045930]; neural tube formation [GO:0001841]; neuromast development [GO:0048884]; neuron migration [GO:0001764]; neurotransmitter receptor transport, endosome to postsynaptic membrane [GO:0098887]; positive chemotaxis [GO:0050918]; positive regulation of apoptotic process [GO:0043065]; receptor clustering [GO:0043113]; vasculature development [GO:0001944] adherens junction [GO:0005912]; basolateral plasma membrane [GO:0016323]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; lamellipodium [GO:0030027]; membrane [GO:0016020]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; presynapse [GO:0098793] protein heterodimerization activity [GO:0046982]; protein kinase binding [GO:0019901] g23140.t1 Q8HYW2 37.5 240 9.11e-33 134.0 sp|Q8HYW2|SO3A1_BOVIN Solute carrier organic anion transporter family member 3A1 OS=Bos taurus OX=9913 GN=SLCO3A1 PE=2 SV=1 SO3A1_BOVIN reviewed Solute carrier organic anion transporter family member 3A1 (Organic anion-transporting polypeptide D) (OATP-D) Bos taurus (Bovine) GO:0006811; GO:0008514; GO:0009925; GO:0015132; GO:0015347; GO:0015732; GO:0015823; GO:0015827; GO:0015828; GO:0016323; GO:0016324; GO:0043252 monoatomic ion transport [GO:0006811]; phenylalanine transport [GO:0015823]; prostaglandin transport [GO:0015732]; sodium-independent organic anion transport [GO:0043252]; tryptophan transport [GO:0015827]; tyrosine transport [GO:0015828] apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323] organic anion transmembrane transporter activity [GO:0008514]; prostaglandin transmembrane transporter activity [GO:0015132]; sodium-independent organic anion transmembrane transporter activity [GO:0015347] g23141.t1 P45878 40.0 130 3.01e-26 102.0 sp|P45878|FKBP2_MOUSE Peptidyl-prolyl cis-trans isomerase FKBP2 OS=Mus musculus OX=10090 GN=Fkbp2 PE=1 SV=1 g23142.t1 Q6CGG3 58.416 101 4.9600000000000004e-33 118.0 sp|Q6CGG3|FKBP2_YARLI FK506-binding protein 2 OS=Yarrowia lipolytica (strain CLIB 122 / E 150) OX=284591 GN=FPR2 PE=3 SV=1 g23143.t1 Q6P5E8 37.783 929 0.0 617.0 sp|Q6P5E8|DGKQ_MOUSE Diacylglycerol kinase theta OS=Mus musculus OX=10090 GN=Dgkq PE=1 SV=1 DGKQ_MOUSE reviewed Diacylglycerol kinase theta (DAG kinase theta) (EC 2.7.1.107) (EC 2.7.1.93) (Diglyceride kinase theta) (DGK-theta) Mus musculus (Mouse) GO:0004143; GO:0004697; GO:0005524; GO:0005634; GO:0005730; GO:0005737; GO:0005768; GO:0005829; GO:0005856; GO:0005886; GO:0006111; GO:0006357; GO:0006654; GO:0007173; GO:0007186; GO:0007189; GO:0007200; GO:0008270; GO:0010628; GO:0010629; GO:0012506; GO:0016020; GO:0016363; GO:0016607; GO:0019900; GO:0030297; GO:0030971; GO:0035556; GO:0043274; GO:0046339; GO:0046486; GO:0046834; GO:0047649; GO:0051591; GO:0070493; GO:0090037; GO:0090181; GO:0098793; GO:0098794; GO:0098978; GO:0140297; GO:1900242; GO:1903413; GO:1903432; GO:2000064; GO:2000182 adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cellular response to bile acid [GO:1903413]; diacylglycerol metabolic process [GO:0046339]; epidermal growth factor receptor signaling pathway [GO:0007173]; G protein-coupled receptor signaling pathway [GO:0007186]; glycerolipid metabolic process [GO:0046486]; intracellular signal transduction [GO:0035556]; lipid phosphorylation [GO:0046834]; negative regulation of gene expression [GO:0010629]; phosphatidic acid biosynthetic process [GO:0006654]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of gene expression [GO:0010628]; positive regulation of protein kinase C signaling [GO:0090037]; regulation of cholesterol metabolic process [GO:0090181]; regulation of cortisol biosynthetic process [GO:2000064]; regulation of gluconeogenesis [GO:0006111]; regulation of progesterone biosynthetic process [GO:2000182]; regulation of synaptic vesicle endocytosis [GO:1900242]; regulation of TORC1 signaling [GO:1903432]; regulation of transcription by RNA polymerase II [GO:0006357]; response to cAMP [GO:0051591]; thrombin-activated receptor signaling pathway [GO:0070493] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endosome [GO:0005768]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; presynapse [GO:0098793]; vesicle membrane [GO:0012506] alkylglycerol kinase activity [GO:0047649]; ATP binding [GO:0005524]; ATP-dependent diacylglycerol kinase activity [GO:0004143]; diacylglycerol-dependent serine/threonine kinase activity [GO:0004697]; DNA-binding transcription factor binding [GO:0140297]; kinase binding [GO:0019900]; phospholipase binding [GO:0043274]; receptor tyrosine kinase binding [GO:0030971]; transmembrane receptor protein tyrosine kinase activator activity [GO:0030297]; zinc ion binding [GO:0008270] g23143.t2 Q6P5E8 38.71 651 7.319999999999999e-137 429.0 sp|Q6P5E8|DGKQ_MOUSE Diacylglycerol kinase theta OS=Mus musculus OX=10090 GN=Dgkq PE=1 SV=1 DGKQ_MOUSE reviewed Diacylglycerol kinase theta (DAG kinase theta) (EC 2.7.1.107) (EC 2.7.1.93) (Diglyceride kinase theta) (DGK-theta) Mus musculus (Mouse) GO:0004143; GO:0004697; GO:0005524; GO:0005634; GO:0005730; GO:0005737; GO:0005768; GO:0005829; GO:0005856; GO:0005886; GO:0006111; GO:0006357; GO:0006654; GO:0007173; GO:0007186; GO:0007189; GO:0007200; GO:0008270; GO:0010628; GO:0010629; GO:0012506; GO:0016020; GO:0016363; GO:0016607; GO:0019900; GO:0030297; GO:0030971; GO:0035556; GO:0043274; GO:0046339; GO:0046486; GO:0046834; GO:0047649; GO:0051591; GO:0070493; GO:0090037; GO:0090181; GO:0098793; GO:0098794; GO:0098978; GO:0140297; GO:1900242; GO:1903413; GO:1903432; GO:2000064; GO:2000182 adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cellular response to bile acid [GO:1903413]; diacylglycerol metabolic process [GO:0046339]; epidermal growth factor receptor signaling pathway [GO:0007173]; G protein-coupled receptor signaling pathway [GO:0007186]; glycerolipid metabolic process [GO:0046486]; intracellular signal transduction [GO:0035556]; lipid phosphorylation [GO:0046834]; negative regulation of gene expression [GO:0010629]; phosphatidic acid biosynthetic process [GO:0006654]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of gene expression [GO:0010628]; positive regulation of protein kinase C signaling [GO:0090037]; regulation of cholesterol metabolic process [GO:0090181]; regulation of cortisol biosynthetic process [GO:2000064]; regulation of gluconeogenesis [GO:0006111]; regulation of progesterone biosynthetic process [GO:2000182]; regulation of synaptic vesicle endocytosis [GO:1900242]; regulation of TORC1 signaling [GO:1903432]; regulation of transcription by RNA polymerase II [GO:0006357]; response to cAMP [GO:0051591]; thrombin-activated receptor signaling pathway [GO:0070493] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endosome [GO:0005768]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; presynapse [GO:0098793]; vesicle membrane [GO:0012506] alkylglycerol kinase activity [GO:0047649]; ATP binding [GO:0005524]; ATP-dependent diacylglycerol kinase activity [GO:0004143]; diacylglycerol-dependent serine/threonine kinase activity [GO:0004697]; DNA-binding transcription factor binding [GO:0140297]; kinase binding [GO:0019900]; phospholipase binding [GO:0043274]; receptor tyrosine kinase binding [GO:0030971]; transmembrane receptor protein tyrosine kinase activator activity [GO:0030297]; zinc ion binding [GO:0008270] g23143.t3 Q6P5E8 42.995 207 2.02e-54 194.0 sp|Q6P5E8|DGKQ_MOUSE Diacylglycerol kinase theta OS=Mus musculus OX=10090 GN=Dgkq PE=1 SV=1 DGKQ_MOUSE reviewed Diacylglycerol kinase theta (DAG kinase theta) (EC 2.7.1.107) (EC 2.7.1.93) (Diglyceride kinase theta) (DGK-theta) Mus musculus (Mouse) GO:0004143; GO:0004697; GO:0005524; GO:0005634; GO:0005730; GO:0005737; GO:0005768; GO:0005829; GO:0005856; GO:0005886; GO:0006111; GO:0006357; GO:0006654; GO:0007173; GO:0007186; GO:0007189; GO:0007200; GO:0008270; GO:0010628; GO:0010629; GO:0012506; GO:0016020; GO:0016363; GO:0016607; GO:0019900; GO:0030297; GO:0030971; GO:0035556; GO:0043274; GO:0046339; GO:0046486; GO:0046834; GO:0047649; GO:0051591; GO:0070493; GO:0090037; GO:0090181; GO:0098793; GO:0098794; GO:0098978; GO:0140297; GO:1900242; GO:1903413; GO:1903432; GO:2000064; GO:2000182 adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cellular response to bile acid [GO:1903413]; diacylglycerol metabolic process [GO:0046339]; epidermal growth factor receptor signaling pathway [GO:0007173]; G protein-coupled receptor signaling pathway [GO:0007186]; glycerolipid metabolic process [GO:0046486]; intracellular signal transduction [GO:0035556]; lipid phosphorylation [GO:0046834]; negative regulation of gene expression [GO:0010629]; phosphatidic acid biosynthetic process [GO:0006654]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of gene expression [GO:0010628]; positive regulation of protein kinase C signaling [GO:0090037]; regulation of cholesterol metabolic process [GO:0090181]; regulation of cortisol biosynthetic process [GO:2000064]; regulation of gluconeogenesis [GO:0006111]; regulation of progesterone biosynthetic process [GO:2000182]; regulation of synaptic vesicle endocytosis [GO:1900242]; regulation of TORC1 signaling [GO:1903432]; regulation of transcription by RNA polymerase II [GO:0006357]; response to cAMP [GO:0051591]; thrombin-activated receptor signaling pathway [GO:0070493] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endosome [GO:0005768]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; presynapse [GO:0098793]; vesicle membrane [GO:0012506] alkylglycerol kinase activity [GO:0047649]; ATP binding [GO:0005524]; ATP-dependent diacylglycerol kinase activity [GO:0004143]; diacylglycerol-dependent serine/threonine kinase activity [GO:0004697]; DNA-binding transcription factor binding [GO:0140297]; kinase binding [GO:0019900]; phospholipase binding [GO:0043274]; receptor tyrosine kinase binding [GO:0030971]; transmembrane receptor protein tyrosine kinase activator activity [GO:0030297]; zinc ion binding [GO:0008270] g23144.t1 Q6NT16 30.073 409 4.79e-44 163.0 sp|Q6NT16|S18B1_HUMAN MFS-type transporter SLC18B1 OS=Homo sapiens OX=9606 GN=SLC18B1 PE=1 SV=1 S18B1_HUMAN reviewed MFS-type transporter SLC18B1 (Solute carrier family 18 member B1) (Vesicular polyamine transporter) (VPAT) Homo sapiens (Human) GO:0000296; GO:0015311; GO:0015312; GO:0015848; GO:0022857; GO:0030667; GO:0030672; GO:0051610 serotonin uptake [GO:0051610]; spermidine transport [GO:0015848]; spermine transport [GO:0000296] secretory granule membrane [GO:0030667]; synaptic vesicle membrane [GO:0030672] monoamine:proton antiporter activity [GO:0015311]; polyamine:proton antiporter activity [GO:0015312]; transmembrane transporter activity [GO:0022857] g23146.t1 Q5IGR7 61.192 688 0.0 900.0 sp|Q5IGR7|EXT1B_DANRE Exostosin-1b OS=Danio rerio OX=7955 GN=ext1b PE=2 SV=1 EXT1B_DANRE reviewed Exostosin-1b (EC 2.4.1.224) (EC 2.4.1.225) (Glucuronosyl-N-acetylglucosaminyl-proteoglycan/N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase 1b) (Multiple exostoses protein 1 homolog b) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001503; GO:0005789; GO:0005794; GO:0008375; GO:0015012; GO:0015020; GO:0046872; GO:0050508; GO:0050509 heparan sulfate proteoglycan biosynthetic process [GO:0015012]; ossification [GO:0001503] endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794] acetylglucosaminyltransferase activity [GO:0008375]; glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity [GO:0050508]; glucuronosyltransferase activity [GO:0015020]; metal ion binding [GO:0046872]; N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase activity [GO:0050509] g23150.t1 Q5Q0U0 45.428 339 2.02e-100 310.0 sp|Q5Q0U0|S17A5_RAT Sialin OS=Rattus norvegicus OX=10116 GN=Slc17a5 PE=1 SV=1 S17A5_RAT reviewed Sialin (H(+)/nitrate cotransporter) (H(+)/sialic acid cotransporter) (AST) (Solute carrier family 17 (Anion/sugar transporter), member 5) (Vesicular excitatory amino acid transporter) (VEAT) Rattus norvegicus (Rat) GO:0005764; GO:0005765; GO:0005829; GO:0005886; GO:0009617; GO:0015136; GO:0015293; GO:0015739; GO:0016323; GO:0016324; GO:0030672; GO:0031410; GO:0042880; GO:0098700; GO:0098978 neurotransmitter loading into synaptic vesicle [GO:0098700]; response to bacterium [GO:0009617]; sialic acid transport [GO:0015739] apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; synaptic vesicle membrane [GO:0030672] D-glucuronate transmembrane transporter activity [GO:0042880]; sialic acid transmembrane transporter activity [GO:0015136]; symporter activity [GO:0015293] g23156.t1 P14272 43.162 234 4.42e-57 211.0 sp|P14272|KLKB1_RAT Plasma kallikrein OS=Rattus norvegicus OX=10116 GN=Klkb1 PE=1 SV=1 KLKB1_RAT reviewed Plasma kallikrein (EC 3.4.21.34) (Fletcher factor) (Kininogenin) (Plasma prekallikrein) [Cleaved into: Plasma kallikrein heavy chain; Plasma kallikrein light chain] Rattus norvegicus (Rat) GO:0004252; GO:0005615; GO:0006954; GO:0007596; GO:0008236; GO:0031639; GO:0042730; GO:0051919; GO:0097421 blood coagulation [GO:0007596]; fibrinolysis [GO:0042730]; inflammatory response [GO:0006954]; liver regeneration [GO:0097421]; plasminogen activation [GO:0031639]; positive regulation of fibrinolysis [GO:0051919] extracellular space [GO:0005615] serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236] g23157.t1 P80646 32.468 231 1.13e-22 102.0 sp|P80646|CTRB_GADMO Chymotrypsin B OS=Gadus morhua OX=8049 PE=1 SV=1 g23160.t1 P17405 46.78 528 4.85e-142 429.0 sp|P17405|ASM_HUMAN Sphingomyelin phosphodiesterase OS=Homo sapiens OX=9606 GN=SMPD1 PE=1 SV=5 ASM_HUMAN reviewed Sphingomyelin phosphodiesterase (EC 3.1.4.12) (EC 3.1.4.3) (Acid sphingomyelinase) (aSMase) [Cleaved into: Sphingomyelin phosphodiesterase, processed form] Homo sapiens (Human) GO:0001778; GO:0004767; GO:0005615; GO:0005764; GO:0005768; GO:0005811; GO:0005886; GO:0006684; GO:0006685; GO:0007165; GO:0007399; GO:0008203; GO:0008270; GO:0009410; GO:0009615; GO:0010212; GO:0016798; GO:0023021; GO:0034340; GO:0034480; GO:0034612; GO:0034644; GO:0036019; GO:0042060; GO:0042220; GO:0042599; GO:0043065; GO:0043202; GO:0043409; GO:0045807; GO:0046479; GO:0046513; GO:0046598; GO:0046718; GO:0061750; GO:0070062; GO:0070555; GO:0071277 cellular response to calcium ion [GO:0071277]; cellular response to UV [GO:0034644]; ceramide biosynthetic process [GO:0046513]; cholesterol metabolic process [GO:0008203]; glycosphingolipid catabolic process [GO:0046479]; negative regulation of MAPK cascade [GO:0043409]; nervous system development [GO:0007399]; plasma membrane repair [GO:0001778]; positive regulation of apoptotic process [GO:0043065]; positive regulation of endocytosis [GO:0045807]; positive regulation of viral entry into host cell [GO:0046598]; response to cocaine [GO:0042220]; response to interleukin-1 [GO:0070555]; response to ionizing radiation [GO:0010212]; response to tumor necrosis factor [GO:0034612]; response to type I interferon [GO:0034340]; response to virus [GO:0009615]; response to xenobiotic stimulus [GO:0009410]; signal transduction [GO:0007165]; sphingomyelin catabolic process [GO:0006685]; sphingomyelin metabolic process [GO:0006684]; symbiont entry into host cell [GO:0046718]; termination of signal transduction [GO:0023021]; wound healing [GO:0042060] endolysosome [GO:0036019]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; lamellar body [GO:0042599]; lipid droplet [GO:0005811]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764]; plasma membrane [GO:0005886] acid sphingomyelin phosphodiesterase activity [GO:0061750]; hydrolase activity, acting on glycosyl bonds [GO:0016798]; phosphatidylcholine phospholipase C activity [GO:0034480]; sphingomyelin phosphodiesterase activity [GO:0004767]; zinc ion binding [GO:0008270] g23161.t1 P46023 42.41 1087 0.0 714.0 sp|P46023|GR101_LYMST G-protein coupled receptor GRL101 OS=Lymnaea stagnalis OX=6523 PE=2 SV=1 g23167.t1 Q8IZF6 28.221 652 4.83e-50 199.0 sp|Q8IZF6|AGRG4_HUMAN Adhesion G-protein coupled receptor G4 OS=Homo sapiens OX=9606 GN=ADGRG4 PE=1 SV=2 AGRG4_HUMAN reviewed Adhesion G-protein coupled receptor G4 (G-protein coupled receptor 112) [Cleaved into: Adhesion G-protein coupled receptor G4, N-terminal fragment (ADGRG4 N-terminal fragment); Adhesion G-protein coupled receptor G4, C-terminal fragment (ADGRG4 C-terminal fragment)] Homo sapiens (Human) GO:0004930; GO:0005886; GO:0007166; GO:0007186; GO:0007189; GO:0016020 adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186] membrane [GO:0016020]; plasma membrane [GO:0005886] G protein-coupled receptor activity [GO:0004930] g23168.t1 C6KFA3 26.91 602 1.5499999999999999e-46 185.0 sp|C6KFA3|AGRG6_DANRE Adhesion G-protein coupled receptor G6 OS=Danio rerio OX=7955 GN=adgrg6 PE=1 SV=1 AGRG6_DANRE reviewed Adhesion G-protein coupled receptor G6 (G-protein coupled receptor 126) [Cleaved into: Adhesion G-protein coupled receptor G6, N-terminal fragment (ADGRG6 N-terminal fragment) (ADGRG6-NTF); Adhesion G-protein coupled receptor G6, C-terminal fragment (ADGRG6 C-terminal fragment) (ADGRG6-CTF)] Danio rerio (Zebrafish) (Brachydanio rerio) GO:0004930; GO:0005518; GO:0005886; GO:0007166; GO:0007188; GO:0007189; GO:0007193; GO:0007507; GO:0014037; GO:0022011; GO:0030500; GO:0042552; GO:0043236; GO:0043583; GO:0050840; GO:0051216; GO:0060347 adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; cartilage development [GO:0051216]; cell surface receptor signaling pathway [GO:0007166]; ear development [GO:0043583]; heart development [GO:0007507]; heart trabecula formation [GO:0060347]; myelination [GO:0042552]; myelination in peripheral nervous system [GO:0022011]; regulation of bone mineralization [GO:0030500]; Schwann cell differentiation [GO:0014037] plasma membrane [GO:0005886] collagen binding [GO:0005518]; extracellular matrix binding [GO:0050840]; G protein-coupled receptor activity [GO:0004930]; laminin binding [GO:0043236] g23169.t1 Q8CJ11 32.207 444 3.34e-51 195.0 sp|Q8CJ11|AGRG2_RAT Adhesion G-protein coupled receptor G2 OS=Rattus norvegicus OX=10116 GN=Adgrg2 PE=1 SV=1 AGRG2_RAT reviewed Adhesion G-protein coupled receptor G2 (G-protein coupled receptor 64) (Rat epididymis-specific protein 6) (Re6) [Cleaved into: Adhesion G-protein coupled receptor G2, N-terminal fragment (ADGRG2 N-terminal fragment); Adhesion G-protein coupled receptor G2, C-terminal fragment (ADGRG2 C-terminal fragment)] Rattus norvegicus (Rat) GO:0004930; GO:0005829; GO:0005886; GO:0007166; GO:0007186; GO:0007189; GO:0007200; GO:0007286; GO:0016324 adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; spermatid development [GO:0007286] apical plasma membrane [GO:0016324]; cytosol [GO:0005829]; plasma membrane [GO:0005886] G protein-coupled receptor activity [GO:0004930] g23170.t1 P10079 45.37 216 2.26e-40 164.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g23170.t1 P10079 39.004 241 4.11e-39 160.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g23170.t1 P10079 41.784 213 1.2300000000000001e-36 152.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g23170.t1 P10079 39.662 237 9.43e-36 150.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g23170.t1 P10079 37.021 235 1.17e-35 149.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g23170.t1 P10079 40.278 216 4.6700000000000004e-35 147.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g23170.t1 P10079 38.756 209 3.25e-32 139.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g23171.t1 Q9QYP1 31.348 638 9.92e-77 287.0 sp|Q9QYP1|LRP4_RAT Low-density lipoprotein receptor-related protein 4 OS=Rattus norvegicus OX=10116 GN=Lrp4 PE=1 SV=2 LRP4_RAT reviewed Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7) Rattus norvegicus (Rat) GO:0001822; GO:0001942; GO:0005509; GO:0005886; GO:0006897; GO:0007167; GO:0008104; GO:0009953; GO:0009954; GO:0009986; GO:0014069; GO:0015026; GO:0016055; GO:0016601; GO:0030279; GO:0030326; GO:0030425; GO:0030971; GO:0031594; GO:0034185; GO:0035022; GO:0042475; GO:0042733; GO:0042803; GO:0043025; GO:0043113; GO:0044853; GO:0045202; GO:0048699; GO:0048813; GO:0050771; GO:0050808; GO:0051124; GO:0060173; GO:0071340; GO:0090090; GO:0097060; GO:0097104; GO:0097105; GO:0097110; GO:0150052; GO:0150094; GO:1901631; GO:1904395 amyloid-beta clearance by cellular catabolic process [GO:0150094]; dendrite morphogenesis [GO:0048813]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; embryonic limb morphogenesis [GO:0030326]; endocytosis [GO:0006897]; enzyme-linked receptor protein signaling pathway [GO:0007167]; generation of neurons [GO:0048699]; hair follicle development [GO:0001942]; intracellular protein localization [GO:0008104]; kidney development [GO:0001822]; limb development [GO:0060173]; negative regulation of axonogenesis [GO:0050771]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of ossification [GO:0030279]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of presynaptic membrane organization [GO:1901631]; positive regulation of Rac protein signal transduction [GO:0035022]; positive regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904395]; postsynaptic membrane assembly [GO:0097104]; presynaptic membrane assembly [GO:0097105]; proximal/distal pattern formation [GO:0009954]; Rac protein signal transduction [GO:0016601]; receptor clustering [GO:0043113]; regulation of postsynapse assembly [GO:0150052]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; synapse organization [GO:0050808]; synaptic assembly at neuromuscular junction [GO:0051124]; Wnt signaling pathway [GO:0016055] cell surface [GO:0009986]; dendrite [GO:0030425]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic density [GO:0014069]; synapse [GO:0045202]; synaptic membrane [GO:0097060] apolipoprotein binding [GO:0034185]; calcium ion binding [GO:0005509]; coreceptor activity [GO:0015026]; protein homodimerization activity [GO:0042803]; receptor tyrosine kinase binding [GO:0030971]; scaffold protein binding [GO:0097110] g23171.t1 Q9QYP1 32.948 519 6.2300000000000004e-58 226.0 sp|Q9QYP1|LRP4_RAT Low-density lipoprotein receptor-related protein 4 OS=Rattus norvegicus OX=10116 GN=Lrp4 PE=1 SV=2 LRP4_RAT reviewed Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7) Rattus norvegicus (Rat) GO:0001822; GO:0001942; GO:0005509; GO:0005886; GO:0006897; GO:0007167; GO:0008104; GO:0009953; GO:0009954; GO:0009986; GO:0014069; GO:0015026; GO:0016055; GO:0016601; GO:0030279; GO:0030326; GO:0030425; GO:0030971; GO:0031594; GO:0034185; GO:0035022; GO:0042475; GO:0042733; GO:0042803; GO:0043025; GO:0043113; GO:0044853; GO:0045202; GO:0048699; GO:0048813; GO:0050771; GO:0050808; GO:0051124; GO:0060173; GO:0071340; GO:0090090; GO:0097060; GO:0097104; GO:0097105; GO:0097110; GO:0150052; GO:0150094; GO:1901631; GO:1904395 amyloid-beta clearance by cellular catabolic process [GO:0150094]; dendrite morphogenesis [GO:0048813]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; embryonic limb morphogenesis [GO:0030326]; endocytosis [GO:0006897]; enzyme-linked receptor protein signaling pathway [GO:0007167]; generation of neurons [GO:0048699]; hair follicle development [GO:0001942]; intracellular protein localization [GO:0008104]; kidney development [GO:0001822]; limb development [GO:0060173]; negative regulation of axonogenesis [GO:0050771]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of ossification [GO:0030279]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of presynaptic membrane organization [GO:1901631]; positive regulation of Rac protein signal transduction [GO:0035022]; positive regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904395]; postsynaptic membrane assembly [GO:0097104]; presynaptic membrane assembly [GO:0097105]; proximal/distal pattern formation [GO:0009954]; Rac protein signal transduction [GO:0016601]; receptor clustering [GO:0043113]; regulation of postsynapse assembly [GO:0150052]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; synapse organization [GO:0050808]; synaptic assembly at neuromuscular junction [GO:0051124]; Wnt signaling pathway [GO:0016055] cell surface [GO:0009986]; dendrite [GO:0030425]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic density [GO:0014069]; synapse [GO:0045202]; synaptic membrane [GO:0097060] apolipoprotein binding [GO:0034185]; calcium ion binding [GO:0005509]; coreceptor activity [GO:0015026]; protein homodimerization activity [GO:0042803]; receptor tyrosine kinase binding [GO:0030971]; scaffold protein binding [GO:0097110] g23171.t1 Q9QYP1 40.755 265 9.760000000000001e-47 189.0 sp|Q9QYP1|LRP4_RAT Low-density lipoprotein receptor-related protein 4 OS=Rattus norvegicus OX=10116 GN=Lrp4 PE=1 SV=2 LRP4_RAT reviewed Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7) Rattus norvegicus (Rat) GO:0001822; GO:0001942; GO:0005509; GO:0005886; GO:0006897; GO:0007167; GO:0008104; GO:0009953; GO:0009954; GO:0009986; GO:0014069; GO:0015026; GO:0016055; GO:0016601; GO:0030279; GO:0030326; GO:0030425; GO:0030971; GO:0031594; GO:0034185; GO:0035022; GO:0042475; GO:0042733; GO:0042803; GO:0043025; GO:0043113; GO:0044853; GO:0045202; GO:0048699; GO:0048813; GO:0050771; GO:0050808; GO:0051124; GO:0060173; GO:0071340; GO:0090090; GO:0097060; GO:0097104; GO:0097105; GO:0097110; GO:0150052; GO:0150094; GO:1901631; GO:1904395 amyloid-beta clearance by cellular catabolic process [GO:0150094]; dendrite morphogenesis [GO:0048813]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; embryonic limb morphogenesis [GO:0030326]; endocytosis [GO:0006897]; enzyme-linked receptor protein signaling pathway [GO:0007167]; generation of neurons [GO:0048699]; hair follicle development [GO:0001942]; intracellular protein localization [GO:0008104]; kidney development [GO:0001822]; limb development [GO:0060173]; negative regulation of axonogenesis [GO:0050771]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of ossification [GO:0030279]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of presynaptic membrane organization [GO:1901631]; positive regulation of Rac protein signal transduction [GO:0035022]; positive regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904395]; postsynaptic membrane assembly [GO:0097104]; presynaptic membrane assembly [GO:0097105]; proximal/distal pattern formation [GO:0009954]; Rac protein signal transduction [GO:0016601]; receptor clustering [GO:0043113]; regulation of postsynapse assembly [GO:0150052]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; synapse organization [GO:0050808]; synaptic assembly at neuromuscular junction [GO:0051124]; Wnt signaling pathway [GO:0016055] cell surface [GO:0009986]; dendrite [GO:0030425]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic density [GO:0014069]; synapse [GO:0045202]; synaptic membrane [GO:0097060] apolipoprotein binding [GO:0034185]; calcium ion binding [GO:0005509]; coreceptor activity [GO:0015026]; protein homodimerization activity [GO:0042803]; receptor tyrosine kinase binding [GO:0030971]; scaffold protein binding [GO:0097110] g23171.t1 Q9QYP1 27.858 621 3.9299999999999995e-42 174.0 sp|Q9QYP1|LRP4_RAT Low-density lipoprotein receptor-related protein 4 OS=Rattus norvegicus OX=10116 GN=Lrp4 PE=1 SV=2 LRP4_RAT reviewed Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7) Rattus norvegicus (Rat) GO:0001822; GO:0001942; GO:0005509; GO:0005886; GO:0006897; GO:0007167; GO:0008104; GO:0009953; GO:0009954; GO:0009986; GO:0014069; GO:0015026; GO:0016055; GO:0016601; GO:0030279; GO:0030326; GO:0030425; GO:0030971; GO:0031594; GO:0034185; GO:0035022; GO:0042475; GO:0042733; GO:0042803; GO:0043025; GO:0043113; GO:0044853; GO:0045202; GO:0048699; GO:0048813; GO:0050771; GO:0050808; GO:0051124; GO:0060173; GO:0071340; GO:0090090; GO:0097060; GO:0097104; GO:0097105; GO:0097110; GO:0150052; GO:0150094; GO:1901631; GO:1904395 amyloid-beta clearance by cellular catabolic process [GO:0150094]; dendrite morphogenesis [GO:0048813]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; embryonic limb morphogenesis [GO:0030326]; endocytosis [GO:0006897]; enzyme-linked receptor protein signaling pathway [GO:0007167]; generation of neurons [GO:0048699]; hair follicle development [GO:0001942]; intracellular protein localization [GO:0008104]; kidney development [GO:0001822]; limb development [GO:0060173]; negative regulation of axonogenesis [GO:0050771]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of ossification [GO:0030279]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of presynaptic membrane organization [GO:1901631]; positive regulation of Rac protein signal transduction [GO:0035022]; positive regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904395]; postsynaptic membrane assembly [GO:0097104]; presynaptic membrane assembly [GO:0097105]; proximal/distal pattern formation [GO:0009954]; Rac protein signal transduction [GO:0016601]; receptor clustering [GO:0043113]; regulation of postsynapse assembly [GO:0150052]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; synapse organization [GO:0050808]; synaptic assembly at neuromuscular junction [GO:0051124]; Wnt signaling pathway [GO:0016055] cell surface [GO:0009986]; dendrite [GO:0030425]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic density [GO:0014069]; synapse [GO:0045202]; synaptic membrane [GO:0097060] apolipoprotein binding [GO:0034185]; calcium ion binding [GO:0005509]; coreceptor activity [GO:0015026]; protein homodimerization activity [GO:0042803]; receptor tyrosine kinase binding [GO:0030971]; scaffold protein binding [GO:0097110] g23171.t1 Q9QYP1 30.808 396 4.86e-39 164.0 sp|Q9QYP1|LRP4_RAT Low-density lipoprotein receptor-related protein 4 OS=Rattus norvegicus OX=10116 GN=Lrp4 PE=1 SV=2 LRP4_RAT reviewed Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7) Rattus norvegicus (Rat) GO:0001822; GO:0001942; GO:0005509; GO:0005886; GO:0006897; GO:0007167; GO:0008104; GO:0009953; GO:0009954; GO:0009986; GO:0014069; GO:0015026; GO:0016055; GO:0016601; GO:0030279; GO:0030326; GO:0030425; GO:0030971; GO:0031594; GO:0034185; GO:0035022; GO:0042475; GO:0042733; GO:0042803; GO:0043025; GO:0043113; GO:0044853; GO:0045202; GO:0048699; GO:0048813; GO:0050771; GO:0050808; GO:0051124; GO:0060173; GO:0071340; GO:0090090; GO:0097060; GO:0097104; GO:0097105; GO:0097110; GO:0150052; GO:0150094; GO:1901631; GO:1904395 amyloid-beta clearance by cellular catabolic process [GO:0150094]; dendrite morphogenesis [GO:0048813]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; embryonic limb morphogenesis [GO:0030326]; endocytosis [GO:0006897]; enzyme-linked receptor protein signaling pathway [GO:0007167]; generation of neurons [GO:0048699]; hair follicle development [GO:0001942]; intracellular protein localization [GO:0008104]; kidney development [GO:0001822]; limb development [GO:0060173]; negative regulation of axonogenesis [GO:0050771]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of ossification [GO:0030279]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of presynaptic membrane organization [GO:1901631]; positive regulation of Rac protein signal transduction [GO:0035022]; positive regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904395]; postsynaptic membrane assembly [GO:0097104]; presynaptic membrane assembly [GO:0097105]; proximal/distal pattern formation [GO:0009954]; Rac protein signal transduction [GO:0016601]; receptor clustering [GO:0043113]; regulation of postsynapse assembly [GO:0150052]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; synapse organization [GO:0050808]; synaptic assembly at neuromuscular junction [GO:0051124]; Wnt signaling pathway [GO:0016055] cell surface [GO:0009986]; dendrite [GO:0030425]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic density [GO:0014069]; synapse [GO:0045202]; synaptic membrane [GO:0097060] apolipoprotein binding [GO:0034185]; calcium ion binding [GO:0005509]; coreceptor activity [GO:0015026]; protein homodimerization activity [GO:0042803]; receptor tyrosine kinase binding [GO:0030971]; scaffold protein binding [GO:0097110] g23171.t1 Q9QYP1 36.97 165 3.27e-26 122.0 sp|Q9QYP1|LRP4_RAT Low-density lipoprotein receptor-related protein 4 OS=Rattus norvegicus OX=10116 GN=Lrp4 PE=1 SV=2 LRP4_RAT reviewed Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7) Rattus norvegicus (Rat) GO:0001822; GO:0001942; GO:0005509; GO:0005886; GO:0006897; GO:0007167; GO:0008104; GO:0009953; GO:0009954; GO:0009986; GO:0014069; GO:0015026; GO:0016055; GO:0016601; GO:0030279; GO:0030326; GO:0030425; GO:0030971; GO:0031594; GO:0034185; GO:0035022; GO:0042475; GO:0042733; GO:0042803; GO:0043025; GO:0043113; GO:0044853; GO:0045202; GO:0048699; GO:0048813; GO:0050771; GO:0050808; GO:0051124; GO:0060173; GO:0071340; GO:0090090; GO:0097060; GO:0097104; GO:0097105; GO:0097110; GO:0150052; GO:0150094; GO:1901631; GO:1904395 amyloid-beta clearance by cellular catabolic process [GO:0150094]; dendrite morphogenesis [GO:0048813]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; embryonic limb morphogenesis [GO:0030326]; endocytosis [GO:0006897]; enzyme-linked receptor protein signaling pathway [GO:0007167]; generation of neurons [GO:0048699]; hair follicle development [GO:0001942]; intracellular protein localization [GO:0008104]; kidney development [GO:0001822]; limb development [GO:0060173]; negative regulation of axonogenesis [GO:0050771]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of ossification [GO:0030279]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of presynaptic membrane organization [GO:1901631]; positive regulation of Rac protein signal transduction [GO:0035022]; positive regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904395]; postsynaptic membrane assembly [GO:0097104]; presynaptic membrane assembly [GO:0097105]; proximal/distal pattern formation [GO:0009954]; Rac protein signal transduction [GO:0016601]; receptor clustering [GO:0043113]; regulation of postsynapse assembly [GO:0150052]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; synapse organization [GO:0050808]; synaptic assembly at neuromuscular junction [GO:0051124]; Wnt signaling pathway [GO:0016055] cell surface [GO:0009986]; dendrite [GO:0030425]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic density [GO:0014069]; synapse [GO:0045202]; synaptic membrane [GO:0097060] apolipoprotein binding [GO:0034185]; calcium ion binding [GO:0005509]; coreceptor activity [GO:0015026]; protein homodimerization activity [GO:0042803]; receptor tyrosine kinase binding [GO:0030971]; scaffold protein binding [GO:0097110] g23172.t1 Q9QYP1 35.274 584 3.66e-91 331.0 sp|Q9QYP1|LRP4_RAT Low-density lipoprotein receptor-related protein 4 OS=Rattus norvegicus OX=10116 GN=Lrp4 PE=1 SV=2 LRP4_RAT reviewed Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7) Rattus norvegicus (Rat) GO:0001822; GO:0001942; GO:0005509; GO:0005886; GO:0006897; GO:0007167; GO:0008104; GO:0009953; GO:0009954; GO:0009986; GO:0014069; GO:0015026; GO:0016055; GO:0016601; GO:0030279; GO:0030326; GO:0030425; GO:0030971; GO:0031594; GO:0034185; GO:0035022; GO:0042475; GO:0042733; GO:0042803; GO:0043025; GO:0043113; GO:0044853; GO:0045202; GO:0048699; GO:0048813; GO:0050771; GO:0050808; GO:0051124; GO:0060173; GO:0071340; GO:0090090; GO:0097060; GO:0097104; GO:0097105; GO:0097110; GO:0150052; GO:0150094; GO:1901631; GO:1904395 amyloid-beta clearance by cellular catabolic process [GO:0150094]; dendrite morphogenesis [GO:0048813]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; embryonic limb morphogenesis [GO:0030326]; endocytosis [GO:0006897]; enzyme-linked receptor protein signaling pathway [GO:0007167]; generation of neurons [GO:0048699]; hair follicle development [GO:0001942]; intracellular protein localization [GO:0008104]; kidney development [GO:0001822]; limb development [GO:0060173]; negative regulation of axonogenesis [GO:0050771]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of ossification [GO:0030279]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of presynaptic membrane organization [GO:1901631]; positive regulation of Rac protein signal transduction [GO:0035022]; positive regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904395]; postsynaptic membrane assembly [GO:0097104]; presynaptic membrane assembly [GO:0097105]; proximal/distal pattern formation [GO:0009954]; Rac protein signal transduction [GO:0016601]; receptor clustering [GO:0043113]; regulation of postsynapse assembly [GO:0150052]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; synapse organization [GO:0050808]; synaptic assembly at neuromuscular junction [GO:0051124]; Wnt signaling pathway [GO:0016055] cell surface [GO:0009986]; dendrite [GO:0030425]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic density [GO:0014069]; synapse [GO:0045202]; synaptic membrane [GO:0097060] apolipoprotein binding [GO:0034185]; calcium ion binding [GO:0005509]; coreceptor activity [GO:0015026]; protein homodimerization activity [GO:0042803]; receptor tyrosine kinase binding [GO:0030971]; scaffold protein binding [GO:0097110] g23172.t1 Q9QYP1 35.811 592 2.7599999999999998e-89 325.0 sp|Q9QYP1|LRP4_RAT Low-density lipoprotein receptor-related protein 4 OS=Rattus norvegicus OX=10116 GN=Lrp4 PE=1 SV=2 LRP4_RAT reviewed Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7) Rattus norvegicus (Rat) GO:0001822; GO:0001942; GO:0005509; GO:0005886; GO:0006897; GO:0007167; GO:0008104; GO:0009953; GO:0009954; GO:0009986; GO:0014069; GO:0015026; GO:0016055; GO:0016601; GO:0030279; GO:0030326; GO:0030425; GO:0030971; GO:0031594; GO:0034185; GO:0035022; GO:0042475; GO:0042733; GO:0042803; GO:0043025; GO:0043113; GO:0044853; GO:0045202; GO:0048699; GO:0048813; GO:0050771; GO:0050808; GO:0051124; GO:0060173; GO:0071340; GO:0090090; GO:0097060; GO:0097104; GO:0097105; GO:0097110; GO:0150052; GO:0150094; GO:1901631; GO:1904395 amyloid-beta clearance by cellular catabolic process [GO:0150094]; dendrite morphogenesis [GO:0048813]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; embryonic limb morphogenesis [GO:0030326]; endocytosis [GO:0006897]; enzyme-linked receptor protein signaling pathway [GO:0007167]; generation of neurons [GO:0048699]; hair follicle development [GO:0001942]; intracellular protein localization [GO:0008104]; kidney development [GO:0001822]; limb development [GO:0060173]; negative regulation of axonogenesis [GO:0050771]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of ossification [GO:0030279]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of presynaptic membrane organization [GO:1901631]; positive regulation of Rac protein signal transduction [GO:0035022]; positive regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904395]; postsynaptic membrane assembly [GO:0097104]; presynaptic membrane assembly [GO:0097105]; proximal/distal pattern formation [GO:0009954]; Rac protein signal transduction [GO:0016601]; receptor clustering [GO:0043113]; regulation of postsynapse assembly [GO:0150052]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; synapse organization [GO:0050808]; synaptic assembly at neuromuscular junction [GO:0051124]; Wnt signaling pathway [GO:0016055] cell surface [GO:0009986]; dendrite [GO:0030425]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic density [GO:0014069]; synapse [GO:0045202]; synaptic membrane [GO:0097060] apolipoprotein binding [GO:0034185]; calcium ion binding [GO:0005509]; coreceptor activity [GO:0015026]; protein homodimerization activity [GO:0042803]; receptor tyrosine kinase binding [GO:0030971]; scaffold protein binding [GO:0097110] g23172.t1 Q9QYP1 34.458 563 1.86e-82 303.0 sp|Q9QYP1|LRP4_RAT Low-density lipoprotein receptor-related protein 4 OS=Rattus norvegicus OX=10116 GN=Lrp4 PE=1 SV=2 LRP4_RAT reviewed Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7) Rattus norvegicus (Rat) GO:0001822; GO:0001942; GO:0005509; GO:0005886; GO:0006897; GO:0007167; GO:0008104; GO:0009953; GO:0009954; GO:0009986; GO:0014069; GO:0015026; GO:0016055; GO:0016601; GO:0030279; GO:0030326; GO:0030425; GO:0030971; GO:0031594; GO:0034185; GO:0035022; GO:0042475; GO:0042733; GO:0042803; GO:0043025; GO:0043113; GO:0044853; GO:0045202; GO:0048699; GO:0048813; GO:0050771; GO:0050808; GO:0051124; GO:0060173; GO:0071340; GO:0090090; GO:0097060; GO:0097104; GO:0097105; GO:0097110; GO:0150052; GO:0150094; GO:1901631; GO:1904395 amyloid-beta clearance by cellular catabolic process [GO:0150094]; dendrite morphogenesis [GO:0048813]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; embryonic limb morphogenesis [GO:0030326]; endocytosis [GO:0006897]; enzyme-linked receptor protein signaling pathway [GO:0007167]; generation of neurons [GO:0048699]; hair follicle development [GO:0001942]; intracellular protein localization [GO:0008104]; kidney development [GO:0001822]; limb development [GO:0060173]; negative regulation of axonogenesis [GO:0050771]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of ossification [GO:0030279]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of presynaptic membrane organization [GO:1901631]; positive regulation of Rac protein signal transduction [GO:0035022]; positive regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904395]; postsynaptic membrane assembly [GO:0097104]; presynaptic membrane assembly [GO:0097105]; proximal/distal pattern formation [GO:0009954]; Rac protein signal transduction [GO:0016601]; receptor clustering [GO:0043113]; regulation of postsynapse assembly [GO:0150052]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; synapse organization [GO:0050808]; synaptic assembly at neuromuscular junction [GO:0051124]; Wnt signaling pathway [GO:0016055] cell surface [GO:0009986]; dendrite [GO:0030425]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic density [GO:0014069]; synapse [GO:0045202]; synaptic membrane [GO:0097060] apolipoprotein binding [GO:0034185]; calcium ion binding [GO:0005509]; coreceptor activity [GO:0015026]; protein homodimerization activity [GO:0042803]; receptor tyrosine kinase binding [GO:0030971]; scaffold protein binding [GO:0097110] g23172.t1 Q9QYP1 32.482 548 5.82e-72 270.0 sp|Q9QYP1|LRP4_RAT Low-density lipoprotein receptor-related protein 4 OS=Rattus norvegicus OX=10116 GN=Lrp4 PE=1 SV=2 LRP4_RAT reviewed Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7) Rattus norvegicus (Rat) GO:0001822; GO:0001942; GO:0005509; GO:0005886; GO:0006897; GO:0007167; GO:0008104; GO:0009953; GO:0009954; GO:0009986; GO:0014069; GO:0015026; GO:0016055; GO:0016601; GO:0030279; GO:0030326; GO:0030425; GO:0030971; GO:0031594; GO:0034185; GO:0035022; GO:0042475; GO:0042733; GO:0042803; GO:0043025; GO:0043113; GO:0044853; GO:0045202; GO:0048699; GO:0048813; GO:0050771; GO:0050808; GO:0051124; GO:0060173; GO:0071340; GO:0090090; GO:0097060; GO:0097104; GO:0097105; GO:0097110; GO:0150052; GO:0150094; GO:1901631; GO:1904395 amyloid-beta clearance by cellular catabolic process [GO:0150094]; dendrite morphogenesis [GO:0048813]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; embryonic limb morphogenesis [GO:0030326]; endocytosis [GO:0006897]; enzyme-linked receptor protein signaling pathway [GO:0007167]; generation of neurons [GO:0048699]; hair follicle development [GO:0001942]; intracellular protein localization [GO:0008104]; kidney development [GO:0001822]; limb development [GO:0060173]; negative regulation of axonogenesis [GO:0050771]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of ossification [GO:0030279]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of presynaptic membrane organization [GO:1901631]; positive regulation of Rac protein signal transduction [GO:0035022]; positive regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904395]; postsynaptic membrane assembly [GO:0097104]; presynaptic membrane assembly [GO:0097105]; proximal/distal pattern formation [GO:0009954]; Rac protein signal transduction [GO:0016601]; receptor clustering [GO:0043113]; regulation of postsynapse assembly [GO:0150052]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; synapse organization [GO:0050808]; synaptic assembly at neuromuscular junction [GO:0051124]; Wnt signaling pathway [GO:0016055] cell surface [GO:0009986]; dendrite [GO:0030425]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic density [GO:0014069]; synapse [GO:0045202]; synaptic membrane [GO:0097060] apolipoprotein binding [GO:0034185]; calcium ion binding [GO:0005509]; coreceptor activity [GO:0015026]; protein homodimerization activity [GO:0042803]; receptor tyrosine kinase binding [GO:0030971]; scaffold protein binding [GO:0097110] g23172.t1 Q9QYP1 31.227 554 1.7800000000000002e-64 246.0 sp|Q9QYP1|LRP4_RAT Low-density lipoprotein receptor-related protein 4 OS=Rattus norvegicus OX=10116 GN=Lrp4 PE=1 SV=2 LRP4_RAT reviewed Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7) Rattus norvegicus (Rat) GO:0001822; GO:0001942; GO:0005509; GO:0005886; GO:0006897; GO:0007167; GO:0008104; GO:0009953; GO:0009954; GO:0009986; GO:0014069; GO:0015026; GO:0016055; GO:0016601; GO:0030279; GO:0030326; GO:0030425; GO:0030971; GO:0031594; GO:0034185; GO:0035022; GO:0042475; GO:0042733; GO:0042803; GO:0043025; GO:0043113; GO:0044853; GO:0045202; GO:0048699; GO:0048813; GO:0050771; GO:0050808; GO:0051124; GO:0060173; GO:0071340; GO:0090090; GO:0097060; GO:0097104; GO:0097105; GO:0097110; GO:0150052; GO:0150094; GO:1901631; GO:1904395 amyloid-beta clearance by cellular catabolic process [GO:0150094]; dendrite morphogenesis [GO:0048813]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; embryonic limb morphogenesis [GO:0030326]; endocytosis [GO:0006897]; enzyme-linked receptor protein signaling pathway [GO:0007167]; generation of neurons [GO:0048699]; hair follicle development [GO:0001942]; intracellular protein localization [GO:0008104]; kidney development [GO:0001822]; limb development [GO:0060173]; negative regulation of axonogenesis [GO:0050771]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of ossification [GO:0030279]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of presynaptic membrane organization [GO:1901631]; positive regulation of Rac protein signal transduction [GO:0035022]; positive regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904395]; postsynaptic membrane assembly [GO:0097104]; presynaptic membrane assembly [GO:0097105]; proximal/distal pattern formation [GO:0009954]; Rac protein signal transduction [GO:0016601]; receptor clustering [GO:0043113]; regulation of postsynapse assembly [GO:0150052]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; synapse organization [GO:0050808]; synaptic assembly at neuromuscular junction [GO:0051124]; Wnt signaling pathway [GO:0016055] cell surface [GO:0009986]; dendrite [GO:0030425]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic density [GO:0014069]; synapse [GO:0045202]; synaptic membrane [GO:0097060] apolipoprotein binding [GO:0034185]; calcium ion binding [GO:0005509]; coreceptor activity [GO:0015026]; protein homodimerization activity [GO:0042803]; receptor tyrosine kinase binding [GO:0030971]; scaffold protein binding [GO:0097110] g23172.t1 Q9QYP1 36.426 291 3.64e-41 170.0 sp|Q9QYP1|LRP4_RAT Low-density lipoprotein receptor-related protein 4 OS=Rattus norvegicus OX=10116 GN=Lrp4 PE=1 SV=2 LRP4_RAT reviewed Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7) Rattus norvegicus (Rat) GO:0001822; GO:0001942; GO:0005509; GO:0005886; GO:0006897; GO:0007167; GO:0008104; GO:0009953; GO:0009954; GO:0009986; GO:0014069; GO:0015026; GO:0016055; GO:0016601; GO:0030279; GO:0030326; GO:0030425; GO:0030971; GO:0031594; GO:0034185; GO:0035022; GO:0042475; GO:0042733; GO:0042803; GO:0043025; GO:0043113; GO:0044853; GO:0045202; GO:0048699; GO:0048813; GO:0050771; GO:0050808; GO:0051124; GO:0060173; GO:0071340; GO:0090090; GO:0097060; GO:0097104; GO:0097105; GO:0097110; GO:0150052; GO:0150094; GO:1901631; GO:1904395 amyloid-beta clearance by cellular catabolic process [GO:0150094]; dendrite morphogenesis [GO:0048813]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; embryonic limb morphogenesis [GO:0030326]; endocytosis [GO:0006897]; enzyme-linked receptor protein signaling pathway [GO:0007167]; generation of neurons [GO:0048699]; hair follicle development [GO:0001942]; intracellular protein localization [GO:0008104]; kidney development [GO:0001822]; limb development [GO:0060173]; negative regulation of axonogenesis [GO:0050771]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of ossification [GO:0030279]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of presynaptic membrane organization [GO:1901631]; positive regulation of Rac protein signal transduction [GO:0035022]; positive regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904395]; postsynaptic membrane assembly [GO:0097104]; presynaptic membrane assembly [GO:0097105]; proximal/distal pattern formation [GO:0009954]; Rac protein signal transduction [GO:0016601]; receptor clustering [GO:0043113]; regulation of postsynapse assembly [GO:0150052]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; synapse organization [GO:0050808]; synaptic assembly at neuromuscular junction [GO:0051124]; Wnt signaling pathway [GO:0016055] cell surface [GO:0009986]; dendrite [GO:0030425]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic density [GO:0014069]; synapse [GO:0045202]; synaptic membrane [GO:0097060] apolipoprotein binding [GO:0034185]; calcium ion binding [GO:0005509]; coreceptor activity [GO:0015026]; protein homodimerization activity [GO:0042803]; receptor tyrosine kinase binding [GO:0030971]; scaffold protein binding [GO:0097110] g23172.t1 Q9QYP1 33.234 334 1.2999999999999999e-40 169.0 sp|Q9QYP1|LRP4_RAT Low-density lipoprotein receptor-related protein 4 OS=Rattus norvegicus OX=10116 GN=Lrp4 PE=1 SV=2 LRP4_RAT reviewed Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7) Rattus norvegicus (Rat) GO:0001822; GO:0001942; GO:0005509; GO:0005886; GO:0006897; GO:0007167; GO:0008104; GO:0009953; GO:0009954; GO:0009986; GO:0014069; GO:0015026; GO:0016055; GO:0016601; GO:0030279; GO:0030326; GO:0030425; GO:0030971; GO:0031594; GO:0034185; GO:0035022; GO:0042475; GO:0042733; GO:0042803; GO:0043025; GO:0043113; GO:0044853; GO:0045202; GO:0048699; GO:0048813; GO:0050771; GO:0050808; GO:0051124; GO:0060173; GO:0071340; GO:0090090; GO:0097060; GO:0097104; GO:0097105; GO:0097110; GO:0150052; GO:0150094; GO:1901631; GO:1904395 amyloid-beta clearance by cellular catabolic process [GO:0150094]; dendrite morphogenesis [GO:0048813]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; embryonic limb morphogenesis [GO:0030326]; endocytosis [GO:0006897]; enzyme-linked receptor protein signaling pathway [GO:0007167]; generation of neurons [GO:0048699]; hair follicle development [GO:0001942]; intracellular protein localization [GO:0008104]; kidney development [GO:0001822]; limb development [GO:0060173]; negative regulation of axonogenesis [GO:0050771]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of ossification [GO:0030279]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of presynaptic membrane organization [GO:1901631]; positive regulation of Rac protein signal transduction [GO:0035022]; positive regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904395]; postsynaptic membrane assembly [GO:0097104]; presynaptic membrane assembly [GO:0097105]; proximal/distal pattern formation [GO:0009954]; Rac protein signal transduction [GO:0016601]; receptor clustering [GO:0043113]; regulation of postsynapse assembly [GO:0150052]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; synapse organization [GO:0050808]; synaptic assembly at neuromuscular junction [GO:0051124]; Wnt signaling pathway [GO:0016055] cell surface [GO:0009986]; dendrite [GO:0030425]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic density [GO:0014069]; synapse [GO:0045202]; synaptic membrane [GO:0097060] apolipoprotein binding [GO:0034185]; calcium ion binding [GO:0005509]; coreceptor activity [GO:0015026]; protein homodimerization activity [GO:0042803]; receptor tyrosine kinase binding [GO:0030971]; scaffold protein binding [GO:0097110] g23173.t1 Q9Z1N0 49.327 669 0.0 677.0 sp|Q9Z1N0|ACOX1_CAVPO Peroxisomal acyl-coenzyme A oxidase 1 OS=Cavia porcellus OX=10141 GN=ACOX1 PE=2 SV=1 g23173.t2 Q15067 49.094 662 0.0 675.0 sp|Q15067|ACOX1_HUMAN Peroxisomal acyl-coenzyme A oxidase 1 OS=Homo sapiens OX=9606 GN=ACOX1 PE=1 SV=3 ACOX1_HUMAN reviewed Peroxisomal acyl-coenzyme A oxidase 1 (AOX) (EC 1.3.3.6) (Palmitoyl-CoA oxidase) (Peroxisomal fatty acyl-CoA oxidase) (Straight-chain acyl-CoA oxidase) (SCOX) [Cleaved into: Peroxisomal acyl-CoA oxidase 1, A chain; Peroxisomal acyl-CoA oxidase 1, B chain; Peroxisomal acyl-CoA oxidase 1, C chain] Homo sapiens (Human) GO:0000038; GO:0003997; GO:0005504; GO:0005777; GO:0005778; GO:0005782; GO:0005829; GO:0006091; GO:0006629; GO:0006636; GO:0006693; GO:0007283; GO:0009062; GO:0016020; GO:0016559; GO:0019395; GO:0030165; GO:0033540; GO:0036109; GO:0042632; GO:0042759; GO:0042803; GO:0050660; GO:0050665; GO:0055088; GO:0071949; GO:0120524; GO:0140493; GO:1901570 alpha-linolenic acid metabolic process [GO:0036109]; cholesterol homeostasis [GO:0042632]; fatty acid beta-oxidation using acyl-CoA oxidase [GO:0033540]; fatty acid catabolic process [GO:0009062]; fatty acid derivative biosynthetic process [GO:1901570]; fatty acid oxidation [GO:0019395]; generation of precursor metabolites and energy [GO:0006091]; hydrogen peroxide biosynthetic process [GO:0050665]; lipid homeostasis [GO:0055088]; lipid metabolic process [GO:0006629]; long-chain fatty acid biosynthetic process [GO:0042759]; peroxisome fission [GO:0016559]; prostaglandin metabolic process [GO:0006693]; spermatogenesis [GO:0007283]; unsaturated fatty acid biosynthetic process [GO:0006636]; very long-chain fatty acid beta-oxidation [GO:0140493]; very long-chain fatty acid metabolic process [GO:0000038] cytosol [GO:0005829]; membrane [GO:0016020]; peroxisomal matrix [GO:0005782]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777] acyl-CoA oxidase activity [GO:0003997]; FAD binding [GO:0071949]; fatty acid binding [GO:0005504]; flavin adenine dinucleotide binding [GO:0050660]; long-chain fatty acyl-CoA oxidase activity [GO:0120524]; PDZ domain binding [GO:0030165]; protein homodimerization activity [GO:0042803] g23173.t3 Q15067 46.304 717 0.0 657.0 sp|Q15067|ACOX1_HUMAN Peroxisomal acyl-coenzyme A oxidase 1 OS=Homo sapiens OX=9606 GN=ACOX1 PE=1 SV=3 ACOX1_HUMAN reviewed Peroxisomal acyl-coenzyme A oxidase 1 (AOX) (EC 1.3.3.6) (Palmitoyl-CoA oxidase) (Peroxisomal fatty acyl-CoA oxidase) (Straight-chain acyl-CoA oxidase) (SCOX) [Cleaved into: Peroxisomal acyl-CoA oxidase 1, A chain; Peroxisomal acyl-CoA oxidase 1, B chain; Peroxisomal acyl-CoA oxidase 1, C chain] Homo sapiens (Human) GO:0000038; GO:0003997; GO:0005504; GO:0005777; GO:0005778; GO:0005782; GO:0005829; GO:0006091; GO:0006629; GO:0006636; GO:0006693; GO:0007283; GO:0009062; GO:0016020; GO:0016559; GO:0019395; GO:0030165; GO:0033540; GO:0036109; GO:0042632; GO:0042759; GO:0042803; GO:0050660; GO:0050665; GO:0055088; GO:0071949; GO:0120524; GO:0140493; GO:1901570 alpha-linolenic acid metabolic process [GO:0036109]; cholesterol homeostasis [GO:0042632]; fatty acid beta-oxidation using acyl-CoA oxidase [GO:0033540]; fatty acid catabolic process [GO:0009062]; fatty acid derivative biosynthetic process [GO:1901570]; fatty acid oxidation [GO:0019395]; generation of precursor metabolites and energy [GO:0006091]; hydrogen peroxide biosynthetic process [GO:0050665]; lipid homeostasis [GO:0055088]; lipid metabolic process [GO:0006629]; long-chain fatty acid biosynthetic process [GO:0042759]; peroxisome fission [GO:0016559]; prostaglandin metabolic process [GO:0006693]; spermatogenesis [GO:0007283]; unsaturated fatty acid biosynthetic process [GO:0006636]; very long-chain fatty acid beta-oxidation [GO:0140493]; very long-chain fatty acid metabolic process [GO:0000038] cytosol [GO:0005829]; membrane [GO:0016020]; peroxisomal matrix [GO:0005782]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777] acyl-CoA oxidase activity [GO:0003997]; FAD binding [GO:0071949]; fatty acid binding [GO:0005504]; flavin adenine dinucleotide binding [GO:0050660]; long-chain fatty acyl-CoA oxidase activity [GO:0120524]; PDZ domain binding [GO:0030165]; protein homodimerization activity [GO:0042803] g23174.t1 O54818 48.951 143 4.72e-35 129.0 sp|O54818|TPD53_MOUSE Tumor protein D53 OS=Mus musculus OX=10090 GN=Tpd52l1 PE=1 SV=1 g23174.t2 Q5RCT1 54.032 124 7.08e-39 140.0 sp|Q5RCT1|TPD54_PONAB Tumor protein D54 OS=Pongo abelii OX=9601 GN=TPD52L2 PE=2 SV=1 g23175.t1 P59708 60.331 121 4.94e-43 139.0 sp|P59708|SF3B6_MOUSE Splicing factor 3B subunit 6 OS=Mus musculus OX=10090 GN=Sf3b6 PE=1 SV=1 g23176.t1 Q9NX57 38.119 202 1.12e-43 149.0 sp|Q9NX57|RAB20_HUMAN Ras-related protein Rab-20 OS=Homo sapiens OX=9606 GN=RAB20 PE=1 SV=1 g23177.t1 Q78KK3 36.676 349 9.99e-55 191.0 sp|Q78KK3|S67A1_MOUSE Solute carrier family 22 member 18 OS=Mus musculus OX=10090 GN=Slc67a1 PE=1 SV=2 S67A1_MOUSE reviewed Solute carrier family 22 member 18 (Imprinted multi-membrane-spanning polyspecific transporter-related protein 1) (Multi-membrane-spanning polyspecific transporter) (Organic cation transporter-like protein 2) (ORCTL-2) Mus musculus (Mouse) GO:0005635; GO:0005737; GO:0005886; GO:0006820; GO:0008514; GO:0015293; GO:0016324; GO:0031625; GO:0042908; GO:1990961 monoatomic anion transport [GO:0006820]; xenobiotic detoxification by transmembrane export across the plasma membrane [GO:1990961]; xenobiotic transport [GO:0042908] apical plasma membrane [GO:0016324]; cytoplasm [GO:0005737]; nuclear envelope [GO:0005635]; plasma membrane [GO:0005886] organic anion transmembrane transporter activity [GO:0008514]; symporter activity [GO:0015293]; ubiquitin protein ligase binding [GO:0031625] g23178.t1 Q5RHP9 50.311 161 1.74e-34 148.0 sp|Q5RHP9|ERIC3_HUMAN Glutamate-rich protein 3 OS=Homo sapiens OX=9606 GN=ERICH3 PE=1 SV=1 ERIC3_HUMAN reviewed Glutamate-rich protein 3 Homo sapiens (Human) GO:0005737; GO:0005929; GO:0005930; GO:0060271; GO:0097730 cilium assembly [GO:0060271] axoneme [GO:0005930]; cilium [GO:0005929]; cytoplasm [GO:0005737]; non-motile cilium [GO:0097730] g23178.t1 Q5RHP9 43.75 144 1.9500000000000002e-29 132.0 sp|Q5RHP9|ERIC3_HUMAN Glutamate-rich protein 3 OS=Homo sapiens OX=9606 GN=ERICH3 PE=1 SV=1 ERIC3_HUMAN reviewed Glutamate-rich protein 3 Homo sapiens (Human) GO:0005737; GO:0005929; GO:0005930; GO:0060271; GO:0097730 cilium assembly [GO:0060271] axoneme [GO:0005930]; cilium [GO:0005929]; cytoplasm [GO:0005737]; non-motile cilium [GO:0097730] g23179.t1 Q5E9N0 63.133 415 9.32e-174 495.0 sp|Q5E9N0|BYST_BOVIN Bystin OS=Bos taurus OX=9913 GN=BYSL PE=2 SV=1 g23180.t1 Q9H2Y9 29.904 729 2.68e-82 283.0 sp|Q9H2Y9|SO5A1_HUMAN Solute carrier organic anion transporter family member 5A1 OS=Homo sapiens OX=9606 GN=SLCO5A1 PE=1 SV=2 g23181.t1 Q9H2Y9 28.12 601 5.32e-61 221.0 sp|Q9H2Y9|SO5A1_HUMAN Solute carrier organic anion transporter family member 5A1 OS=Homo sapiens OX=9606 GN=SLCO5A1 PE=1 SV=2 g23183.t1 P04813 45.85 253 1.11e-62 201.0 sp|P04813|CTR2_CANLF Chymotrypsinogen 2 OS=Canis lupus familiaris OX=9615 GN=CTRB1 PE=2 SV=1 g23185.t1 P25962 27.64 322 5.400000000000001e-26 110.0 sp|P25962|ADRB3_MOUSE Beta-3 adrenergic receptor OS=Mus musculus OX=10090 GN=Adrb3 PE=2 SV=2 ADRB3_MOUSE reviewed Beta-3 adrenergic receptor (Beta-3 adrenoreceptor) (Beta-3 adrenoceptor) Mus musculus (Mouse) GO:0002024; GO:0002025; GO:0003925; GO:0004939; GO:0005886; GO:0007189; GO:0007193; GO:0009409; GO:0015052; GO:0016020; GO:0031649; GO:0031699; GO:0040015; GO:0042755; GO:0042803; GO:0043235; GO:0043410; GO:0045986; GO:0050873; GO:0050996; GO:0051379; GO:0051380; GO:0055118; GO:0070374; GO:0071880; GO:0120162 adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; brown fat cell differentiation [GO:0050873]; diet induced thermogenesis [GO:0002024]; eating behavior [GO:0042755]; heat generation [GO:0031649]; negative regulation of cardiac muscle contraction [GO:0055118]; negative regulation of multicellular organism growth [GO:0040015]; negative regulation of smooth muscle contraction [GO:0045986]; norepinephrine-epinephrine-mediated vasodilation involved in regulation of systemic arterial blood pressure [GO:0002025]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of lipid catabolic process [GO:0050996]; positive regulation of MAPK cascade [GO:0043410]; response to cold [GO:0009409] membrane [GO:0016020]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] beta-3 adrenergic receptor binding [GO:0031699]; beta-adrenergic receptor activity [GO:0004939]; beta3-adrenergic receptor activity [GO:0015052]; epinephrine binding [GO:0051379]; G protein activity [GO:0003925]; norepinephrine binding [GO:0051380]; protein homodimerization activity [GO:0042803] g23191.t1 Q8NB78 48.251 829 0.0 825.0 sp|Q8NB78|KDM1B_HUMAN Lysine-specific histone demethylase 2 OS=Homo sapiens OX=9606 GN=KDM1B PE=1 SV=3 g23192.t1 Q8IUQ0 46.462 325 6.29e-103 309.0 sp|Q8IUQ0|CLVS1_HUMAN Clavesin-1 OS=Homo sapiens OX=9606 GN=CLVS1 PE=1 SV=1 CLVS1_HUMAN reviewed Clavesin-1 (Cellular retinaldehyde-binding protein-like) (Retinaldehyde-binding protein 1-like 1) (clathrin vesicle-associated Sec14 protein 1) Homo sapiens (Human) GO:0005768; GO:0005802; GO:0007040; GO:0030136; GO:0031901; GO:0032588; GO:0080025; GO:1902936 lysosome organization [GO:0007040] clathrin-coated vesicle [GO:0030136]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; trans-Golgi network [GO:0005802]; trans-Golgi network membrane [GO:0032588] phosphatidylinositol bisphosphate binding [GO:1902936]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025] g23193.t1 Q4KMZ8 41.589 214 1.89e-47 158.0 sp|Q4KMZ8|NKAI1_HUMAN Sodium/potassium-transporting ATPase subunit beta-1-interacting protein 1 OS=Homo sapiens OX=9606 GN=NKAIN1 PE=2 SV=3 g23194.t1 O00716 50.292 342 4.46e-85 270.0 sp|O00716|E2F3_HUMAN Transcription factor E2F3 OS=Homo sapiens OX=9606 GN=E2F3 PE=1 SV=1 E2F3_HUMAN reviewed Transcription factor E2F3 (E2F-3) Homo sapiens (Human) GO:0000082; GO:0000785; GO:0000978; GO:0000981; GO:0000987; GO:0001216; GO:0001228; GO:0003700; GO:0005634; GO:0005654; GO:0005829; GO:0006357; GO:0006367; GO:0006606; GO:0008284; GO:0043565; GO:0045944; GO:0046983; GO:0070345; GO:0090575; GO:1905461; GO:1990837 G1/S transition of mitotic cell cycle [GO:0000082]; negative regulation of fat cell proliferation [GO:0070345]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of vascular associated smooth muscle cell apoptotic process [GO:1905461]; protein import into nucleus [GO:0006606]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription initiation at RNA polymerase II promoter [GO:0006367] chromatin [GO:0000785]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575] cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA-binding transcription activator activity [GO:0001216]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837] g23195.t1 O35604 47.153 1317 0.0 1100.0 sp|O35604|NPC1_MOUSE NPC intracellular cholesterol transporter 1 OS=Mus musculus OX=10090 GN=Npc1 PE=1 SV=2 NPC1_MOUSE reviewed NPC intracellular cholesterol transporter 1 (Niemann-Pick C1 protein) Mus musculus (Mouse) GO:0001889; GO:0005576; GO:0005635; GO:0005764; GO:0005765; GO:0005768; GO:0005783; GO:0005794; GO:0005886; GO:0006897; GO:0006914; GO:0007041; GO:0007628; GO:0008203; GO:0008206; GO:0009410; GO:0010467; GO:0010878; GO:0012501; GO:0015485; GO:0015918; GO:0016020; GO:0016125; GO:0016242; GO:0022008; GO:0030299; GO:0030301; GO:0031579; GO:0031902; GO:0031982; GO:0032365; GO:0032367; GO:0033344; GO:0042632; GO:0045121; GO:0046686; GO:0046718; GO:0048471; GO:0071383; GO:0071404; GO:0090150; GO:0120020; GO:1904036; GO:1904262; GO:2000900 adult walking behavior [GO:0007628]; autophagy [GO:0006914]; bile acid metabolic process [GO:0008206]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; cellular response to steroid hormone stimulus [GO:0071383]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; cholesterol storage [GO:0010878]; cholesterol transport [GO:0030301]; cyclodextrin metabolic process [GO:2000900]; endocytosis [GO:0006897]; establishment of protein localization to membrane [GO:0090150]; gene expression [GO:0010467]; intestinal cholesterol absorption [GO:0030299]; intracellular cholesterol transport [GO:0032367]; intracellular lipid transport [GO:0032365]; liver development [GO:0001889]; lysosomal transport [GO:0007041]; membrane raft organization [GO:0031579]; negative regulation of epithelial cell apoptotic process [GO:1904036]; negative regulation of macroautophagy [GO:0016242]; negative regulation of TORC1 signaling [GO:1904262]; neurogenesis [GO:0022008]; programmed cell death [GO:0012501]; response to cadmium ion [GO:0046686]; response to xenobiotic stimulus [GO:0009410]; sterol metabolic process [GO:0016125]; sterol transport [GO:0015918]; symbiont entry into host cell [GO:0046718] endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; membrane raft [GO:0045121]; nuclear envelope [GO:0005635]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; vesicle [GO:0031982] cholesterol binding [GO:0015485]; cholesterol transfer activity [GO:0120020] g23196.t1 P49219 26.198 313 6.18e-30 122.0 sp|P49219|MTR1C_XENLA Melatonin receptor type 1C OS=Xenopus laevis OX=8355 GN=mtnr1c PE=2 SV=1 g23197.t1 P49219 29.48 346 1.14e-36 140.0 sp|P49219|MTR1C_XENLA Melatonin receptor type 1C OS=Xenopus laevis OX=8355 GN=mtnr1c PE=2 SV=1 g23199.t1 Q9D8B1 41.758 182 9.36e-44 150.0 sp|Q9D8B1|AIG1_MOUSE Androgen-induced gene 1 protein OS=Mus musculus OX=10090 GN=Aig1 PE=2 SV=2 AIG1_MOUSE reviewed Androgen-induced gene 1 protein (AIG-1) (Fatty acid esters of hydroxy fatty acids hydrolase AIG1) (FAHFA hydrolase AIG1) (EC 3.1.-.-) Mus musculus (Mouse) GO:0005886; GO:0012505; GO:0016020; GO:0016787; GO:0042758 long-chain fatty acid catabolic process [GO:0042758] endomembrane system [GO:0012505]; membrane [GO:0016020]; plasma membrane [GO:0005886] hydrolase activity [GO:0016787] g23199.t2 Q9D8B1 39.344 183 3.6699999999999996e-42 147.0 sp|Q9D8B1|AIG1_MOUSE Androgen-induced gene 1 protein OS=Mus musculus OX=10090 GN=Aig1 PE=2 SV=2 AIG1_MOUSE reviewed Androgen-induced gene 1 protein (AIG-1) (Fatty acid esters of hydroxy fatty acids hydrolase AIG1) (FAHFA hydrolase AIG1) (EC 3.1.-.-) Mus musculus (Mouse) GO:0005886; GO:0012505; GO:0016020; GO:0016787; GO:0042758 long-chain fatty acid catabolic process [GO:0042758] endomembrane system [GO:0012505]; membrane [GO:0016020]; plasma membrane [GO:0005886] hydrolase activity [GO:0016787] g23199.t3 Q9D8B1 40.704 199 1.05e-45 155.0 sp|Q9D8B1|AIG1_MOUSE Androgen-induced gene 1 protein OS=Mus musculus OX=10090 GN=Aig1 PE=2 SV=2 AIG1_MOUSE reviewed Androgen-induced gene 1 protein (AIG-1) (Fatty acid esters of hydroxy fatty acids hydrolase AIG1) (FAHFA hydrolase AIG1) (EC 3.1.-.-) Mus musculus (Mouse) GO:0005886; GO:0012505; GO:0016020; GO:0016787; GO:0042758 long-chain fatty acid catabolic process [GO:0042758] endomembrane system [GO:0012505]; membrane [GO:0016020]; plasma membrane [GO:0005886] hydrolase activity [GO:0016787] g23203.t1 Q9NRA2 50.382 393 6.94e-125 374.0 sp|Q9NRA2|S17A5_HUMAN Sialin OS=Homo sapiens OX=9606 GN=SLC17A5 PE=1 SV=2 g23205.t1 O75346 51.163 215 1.63e-71 229.0 sp|O75346|ZN253_HUMAN Zinc finger protein 253 OS=Homo sapiens OX=9606 GN=ZNF253 PE=1 SV=2 g23205.t1 O75346 46.809 235 2.2999999999999997e-67 219.0 sp|O75346|ZN253_HUMAN Zinc finger protein 253 OS=Homo sapiens OX=9606 GN=ZNF253 PE=1 SV=2 g23205.t1 O75346 48.636 220 4.65e-67 218.0 sp|O75346|ZN253_HUMAN Zinc finger protein 253 OS=Homo sapiens OX=9606 GN=ZNF253 PE=1 SV=2 g23205.t1 O75346 44.206 233 1.02e-57 194.0 sp|O75346|ZN253_HUMAN Zinc finger protein 253 OS=Homo sapiens OX=9606 GN=ZNF253 PE=1 SV=2 g23205.t2 A0A1W2PQL4 48.619 181 1.28e-55 183.0 sp|A0A1W2PQL4|ZN722_HUMAN Zinc finger protein 722 OS=Homo sapiens OX=9606 GN=ZNF722 PE=3 SV=1 g23205.t2 A0A1W2PQL4 45.732 164 4.17e-44 153.0 sp|A0A1W2PQL4|ZN722_HUMAN Zinc finger protein 722 OS=Homo sapiens OX=9606 GN=ZNF722 PE=3 SV=1 g23205.t2 A0A1W2PQL4 47.945 146 2.19e-42 149.0 sp|A0A1W2PQL4|ZN722_HUMAN Zinc finger protein 722 OS=Homo sapiens OX=9606 GN=ZNF722 PE=3 SV=1 g23205.t2 A0A1W2PQL4 39.779 181 3.73e-37 135.0 sp|A0A1W2PQL4|ZN722_HUMAN Zinc finger protein 722 OS=Homo sapiens OX=9606 GN=ZNF722 PE=3 SV=1 g23207.t1 O55236 55.092 599 0.0 674.0 sp|O55236|MCE1_MOUSE mRNA-capping enzyme OS=Mus musculus OX=10090 GN=Rngtt PE=1 SV=1 MCE1_MOUSE reviewed mRNA-capping enzyme (HCE) (MCE1) [Includes: mRNA 5'-triphosphate monophosphatase (EC 3.6.1.74) (mRNA 5'-phosphatase); mRNA guanylyltransferase (EC 2.7.7.50) (GTP--RNA guanylyltransferase) (GTase)] Mus musculus (Mouse) GO:0004484; GO:0004721; GO:0005524; GO:0005525; GO:0005634; GO:0006370; GO:0006396; GO:0008192; GO:0050355; GO:0140818 7-methylguanosine mRNA capping [GO:0006370]; RNA processing [GO:0006396] nucleus [GO:0005634] ATP binding [GO:0005524]; GTP binding [GO:0005525]; inorganic triphosphate phosphatase activity [GO:0050355]; mRNA 5'-triphosphate monophosphatase activity [GO:0140818]; mRNA guanylyltransferase activity [GO:0004484]; phosphoprotein phosphatase activity [GO:0004721]; RNA guanylyltransferase activity [GO:0008192] g23215.t1 Q23551 37.224 3170 0.0 2014.0 sp|Q23551|UNC22_CAEEL Twitchin OS=Caenorhabditis elegans OX=6239 GN=unc-22 PE=1 SV=3 UNC22_CAEEL reviewed Twitchin (EC 2.7.11.1) (Uncoordinated protein 22) Caenorhabditis elegans GO:0004674; GO:0005516; GO:0005524; GO:0008344; GO:0019899; GO:0031430; GO:0031672; GO:0040017; GO:0045214; GO:0045989; GO:0046872; GO:0051782; GO:0060298; GO:0106310 adult locomotory behavior [GO:0008344]; negative regulation of cell division [GO:0051782]; positive regulation of locomotion [GO:0040017]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of striated muscle contraction [GO:0045989]; sarcomere organization [GO:0045214] A band [GO:0031672]; M band [GO:0031430] ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g23215.t1 Q23551 29.493 2821 0.0 938.0 sp|Q23551|UNC22_CAEEL Twitchin OS=Caenorhabditis elegans OX=6239 GN=unc-22 PE=1 SV=3 UNC22_CAEEL reviewed Twitchin (EC 2.7.11.1) (Uncoordinated protein 22) Caenorhabditis elegans GO:0004674; GO:0005516; GO:0005524; GO:0008344; GO:0019899; GO:0031430; GO:0031672; GO:0040017; GO:0045214; GO:0045989; GO:0046872; GO:0051782; GO:0060298; GO:0106310 adult locomotory behavior [GO:0008344]; negative regulation of cell division [GO:0051782]; positive regulation of locomotion [GO:0040017]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of striated muscle contraction [GO:0045989]; sarcomere organization [GO:0045214] A band [GO:0031672]; M band [GO:0031430] ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g23215.t1 Q23551 32.587 1608 0.0 696.0 sp|Q23551|UNC22_CAEEL Twitchin OS=Caenorhabditis elegans OX=6239 GN=unc-22 PE=1 SV=3 UNC22_CAEEL reviewed Twitchin (EC 2.7.11.1) (Uncoordinated protein 22) Caenorhabditis elegans GO:0004674; GO:0005516; GO:0005524; GO:0008344; GO:0019899; GO:0031430; GO:0031672; GO:0040017; GO:0045214; GO:0045989; GO:0046872; GO:0051782; GO:0060298; GO:0106310 adult locomotory behavior [GO:0008344]; negative regulation of cell division [GO:0051782]; positive regulation of locomotion [GO:0040017]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of striated muscle contraction [GO:0045989]; sarcomere organization [GO:0045214] A band [GO:0031672]; M band [GO:0031430] ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g23215.t1 Q23551 31.61 1547 0.0 647.0 sp|Q23551|UNC22_CAEEL Twitchin OS=Caenorhabditis elegans OX=6239 GN=unc-22 PE=1 SV=3 UNC22_CAEEL reviewed Twitchin (EC 2.7.11.1) (Uncoordinated protein 22) Caenorhabditis elegans GO:0004674; GO:0005516; GO:0005524; GO:0008344; GO:0019899; GO:0031430; GO:0031672; GO:0040017; GO:0045214; GO:0045989; GO:0046872; GO:0051782; GO:0060298; GO:0106310 adult locomotory behavior [GO:0008344]; negative regulation of cell division [GO:0051782]; positive regulation of locomotion [GO:0040017]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of striated muscle contraction [GO:0045989]; sarcomere organization [GO:0045214] A band [GO:0031672]; M band [GO:0031430] ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g23215.t1 Q23551 33.687 1413 0.0 637.0 sp|Q23551|UNC22_CAEEL Twitchin OS=Caenorhabditis elegans OX=6239 GN=unc-22 PE=1 SV=3 UNC22_CAEEL reviewed Twitchin (EC 2.7.11.1) (Uncoordinated protein 22) Caenorhabditis elegans GO:0004674; GO:0005516; GO:0005524; GO:0008344; GO:0019899; GO:0031430; GO:0031672; GO:0040017; GO:0045214; GO:0045989; GO:0046872; GO:0051782; GO:0060298; GO:0106310 adult locomotory behavior [GO:0008344]; negative regulation of cell division [GO:0051782]; positive regulation of locomotion [GO:0040017]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of striated muscle contraction [GO:0045989]; sarcomere organization [GO:0045214] A band [GO:0031672]; M band [GO:0031430] ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g23215.t1 Q23551 37.362 993 6.7699999999999995e-168 592.0 sp|Q23551|UNC22_CAEEL Twitchin OS=Caenorhabditis elegans OX=6239 GN=unc-22 PE=1 SV=3 UNC22_CAEEL reviewed Twitchin (EC 2.7.11.1) (Uncoordinated protein 22) Caenorhabditis elegans GO:0004674; GO:0005516; GO:0005524; GO:0008344; GO:0019899; GO:0031430; GO:0031672; GO:0040017; GO:0045214; GO:0045989; GO:0046872; GO:0051782; GO:0060298; GO:0106310 adult locomotory behavior [GO:0008344]; negative regulation of cell division [GO:0051782]; positive regulation of locomotion [GO:0040017]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of striated muscle contraction [GO:0045989]; sarcomere organization [GO:0045214] A band [GO:0031672]; M band [GO:0031430] ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g23215.t1 Q23551 31.383 1265 7.37e-149 529.0 sp|Q23551|UNC22_CAEEL Twitchin OS=Caenorhabditis elegans OX=6239 GN=unc-22 PE=1 SV=3 UNC22_CAEEL reviewed Twitchin (EC 2.7.11.1) (Uncoordinated protein 22) Caenorhabditis elegans GO:0004674; GO:0005516; GO:0005524; GO:0008344; GO:0019899; GO:0031430; GO:0031672; GO:0040017; GO:0045214; GO:0045989; GO:0046872; GO:0051782; GO:0060298; GO:0106310 adult locomotory behavior [GO:0008344]; negative regulation of cell division [GO:0051782]; positive regulation of locomotion [GO:0040017]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of striated muscle contraction [GO:0045989]; sarcomere organization [GO:0045214] A band [GO:0031672]; M band [GO:0031430] ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g23215.t1 Q23551 26.136 1695 3.35e-108 395.0 sp|Q23551|UNC22_CAEEL Twitchin OS=Caenorhabditis elegans OX=6239 GN=unc-22 PE=1 SV=3 UNC22_CAEEL reviewed Twitchin (EC 2.7.11.1) (Uncoordinated protein 22) Caenorhabditis elegans GO:0004674; GO:0005516; GO:0005524; GO:0008344; GO:0019899; GO:0031430; GO:0031672; GO:0040017; GO:0045214; GO:0045989; GO:0046872; GO:0051782; GO:0060298; GO:0106310 adult locomotory behavior [GO:0008344]; negative regulation of cell division [GO:0051782]; positive regulation of locomotion [GO:0040017]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of striated muscle contraction [GO:0045989]; sarcomere organization [GO:0045214] A band [GO:0031672]; M band [GO:0031430] ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g23215.t1 Q23551 34.804 612 2.19e-81 306.0 sp|Q23551|UNC22_CAEEL Twitchin OS=Caenorhabditis elegans OX=6239 GN=unc-22 PE=1 SV=3 UNC22_CAEEL reviewed Twitchin (EC 2.7.11.1) (Uncoordinated protein 22) Caenorhabditis elegans GO:0004674; GO:0005516; GO:0005524; GO:0008344; GO:0019899; GO:0031430; GO:0031672; GO:0040017; GO:0045214; GO:0045989; GO:0046872; GO:0051782; GO:0060298; GO:0106310 adult locomotory behavior [GO:0008344]; negative regulation of cell division [GO:0051782]; positive regulation of locomotion [GO:0040017]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of striated muscle contraction [GO:0045989]; sarcomere organization [GO:0045214] A band [GO:0031672]; M band [GO:0031430] ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g23215.t1 Q23551 27.362 921 2.88e-70 269.0 sp|Q23551|UNC22_CAEEL Twitchin OS=Caenorhabditis elegans OX=6239 GN=unc-22 PE=1 SV=3 UNC22_CAEEL reviewed Twitchin (EC 2.7.11.1) (Uncoordinated protein 22) Caenorhabditis elegans GO:0004674; GO:0005516; GO:0005524; GO:0008344; GO:0019899; GO:0031430; GO:0031672; GO:0040017; GO:0045214; GO:0045989; GO:0046872; GO:0051782; GO:0060298; GO:0106310 adult locomotory behavior [GO:0008344]; negative regulation of cell division [GO:0051782]; positive regulation of locomotion [GO:0040017]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of striated muscle contraction [GO:0045989]; sarcomere organization [GO:0045214] A band [GO:0031672]; M band [GO:0031430] ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g23215.t1 Q23551 25.621 886 8.96e-59 231.0 sp|Q23551|UNC22_CAEEL Twitchin OS=Caenorhabditis elegans OX=6239 GN=unc-22 PE=1 SV=3 UNC22_CAEEL reviewed Twitchin (EC 2.7.11.1) (Uncoordinated protein 22) Caenorhabditis elegans GO:0004674; GO:0005516; GO:0005524; GO:0008344; GO:0019899; GO:0031430; GO:0031672; GO:0040017; GO:0045214; GO:0045989; GO:0046872; GO:0051782; GO:0060298; GO:0106310 adult locomotory behavior [GO:0008344]; negative regulation of cell division [GO:0051782]; positive regulation of locomotion [GO:0040017]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of striated muscle contraction [GO:0045989]; sarcomere organization [GO:0045214] A band [GO:0031672]; M band [GO:0031430] ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g23215.t1 Q23551 26.86 793 2.99e-58 229.0 sp|Q23551|UNC22_CAEEL Twitchin OS=Caenorhabditis elegans OX=6239 GN=unc-22 PE=1 SV=3 UNC22_CAEEL reviewed Twitchin (EC 2.7.11.1) (Uncoordinated protein 22) Caenorhabditis elegans GO:0004674; GO:0005516; GO:0005524; GO:0008344; GO:0019899; GO:0031430; GO:0031672; GO:0040017; GO:0045214; GO:0045989; GO:0046872; GO:0051782; GO:0060298; GO:0106310 adult locomotory behavior [GO:0008344]; negative regulation of cell division [GO:0051782]; positive regulation of locomotion [GO:0040017]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of striated muscle contraction [GO:0045989]; sarcomere organization [GO:0045214] A band [GO:0031672]; M band [GO:0031430] ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g23215.t1 Q23551 27.699 704 2.62e-56 223.0 sp|Q23551|UNC22_CAEEL Twitchin OS=Caenorhabditis elegans OX=6239 GN=unc-22 PE=1 SV=3 UNC22_CAEEL reviewed Twitchin (EC 2.7.11.1) (Uncoordinated protein 22) Caenorhabditis elegans GO:0004674; GO:0005516; GO:0005524; GO:0008344; GO:0019899; GO:0031430; GO:0031672; GO:0040017; GO:0045214; GO:0045989; GO:0046872; GO:0051782; GO:0060298; GO:0106310 adult locomotory behavior [GO:0008344]; negative regulation of cell division [GO:0051782]; positive regulation of locomotion [GO:0040017]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of striated muscle contraction [GO:0045989]; sarcomere organization [GO:0045214] A band [GO:0031672]; M band [GO:0031430] ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g23215.t1 Q23551 26.725 681 3.89e-54 216.0 sp|Q23551|UNC22_CAEEL Twitchin OS=Caenorhabditis elegans OX=6239 GN=unc-22 PE=1 SV=3 UNC22_CAEEL reviewed Twitchin (EC 2.7.11.1) (Uncoordinated protein 22) Caenorhabditis elegans GO:0004674; GO:0005516; GO:0005524; GO:0008344; GO:0019899; GO:0031430; GO:0031672; GO:0040017; GO:0045214; GO:0045989; GO:0046872; GO:0051782; GO:0060298; GO:0106310 adult locomotory behavior [GO:0008344]; negative regulation of cell division [GO:0051782]; positive regulation of locomotion [GO:0040017]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of striated muscle contraction [GO:0045989]; sarcomere organization [GO:0045214] A band [GO:0031672]; M band [GO:0031430] ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g23215.t1 Q23551 27.166 681 2.56e-53 213.0 sp|Q23551|UNC22_CAEEL Twitchin OS=Caenorhabditis elegans OX=6239 GN=unc-22 PE=1 SV=3 UNC22_CAEEL reviewed Twitchin (EC 2.7.11.1) (Uncoordinated protein 22) Caenorhabditis elegans GO:0004674; GO:0005516; GO:0005524; GO:0008344; GO:0019899; GO:0031430; GO:0031672; GO:0040017; GO:0045214; GO:0045989; GO:0046872; GO:0051782; GO:0060298; GO:0106310 adult locomotory behavior [GO:0008344]; negative regulation of cell division [GO:0051782]; positive regulation of locomotion [GO:0040017]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of striated muscle contraction [GO:0045989]; sarcomere organization [GO:0045214] A band [GO:0031672]; M band [GO:0031430] ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g23215.t1 Q23551 29.442 591 5.1e-38 162.0 sp|Q23551|UNC22_CAEEL Twitchin OS=Caenorhabditis elegans OX=6239 GN=unc-22 PE=1 SV=3 UNC22_CAEEL reviewed Twitchin (EC 2.7.11.1) (Uncoordinated protein 22) Caenorhabditis elegans GO:0004674; GO:0005516; GO:0005524; GO:0008344; GO:0019899; GO:0031430; GO:0031672; GO:0040017; GO:0045214; GO:0045989; GO:0046872; GO:0051782; GO:0060298; GO:0106310 adult locomotory behavior [GO:0008344]; negative regulation of cell division [GO:0051782]; positive regulation of locomotion [GO:0040017]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of striated muscle contraction [GO:0045989]; sarcomere organization [GO:0045214] A band [GO:0031672]; M band [GO:0031430] ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g23222.t1 Q23551 33.182 220 7.34e-27 118.0 sp|Q23551|UNC22_CAEEL Twitchin OS=Caenorhabditis elegans OX=6239 GN=unc-22 PE=1 SV=3 UNC22_CAEEL reviewed Twitchin (EC 2.7.11.1) (Uncoordinated protein 22) Caenorhabditis elegans GO:0004674; GO:0005516; GO:0005524; GO:0008344; GO:0019899; GO:0031430; GO:0031672; GO:0040017; GO:0045214; GO:0045989; GO:0046872; GO:0051782; GO:0060298; GO:0106310 adult locomotory behavior [GO:0008344]; negative regulation of cell division [GO:0051782]; positive regulation of locomotion [GO:0040017]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of striated muscle contraction [GO:0045989]; sarcomere organization [GO:0045214] A band [GO:0031672]; M band [GO:0031430] ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g23223.t1 Q18066 29.31 232 5.8e-24 104.0 sp|Q18066|DIM_CAEEL Disorganized muscle protein 1 OS=Caenorhabditis elegans OX=6239 GN=dim-1 PE=1 SV=3 g23226.t1 Q8CCJ9 42.963 135 7.68e-27 119.0 sp|Q8CCJ9|P20L1_MOUSE PHD finger protein 20-like protein 1 OS=Mus musculus OX=10090 GN=Phf20l1 PE=1 SV=2 P20L1_MOUSE reviewed PHD finger protein 20-like protein 1 Mus musculus (Mouse) GO:0005654; GO:0006325; GO:0006357; GO:0008270; GO:0032435; GO:0042177; GO:0044545; GO:0140034 chromatin organization [GO:0006325]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of protein catabolic process [GO:0042177]; regulation of transcription by RNA polymerase II [GO:0006357] NSL complex [GO:0044545]; nucleoplasm [GO:0005654] methylation-dependent protein binding [GO:0140034]; zinc ion binding [GO:0008270] g23227.t1 A2VE56 45.522 134 9.15e-36 142.0 sp|A2VE56|P20L1_BOVIN PHD finger protein 20-like protein 1 OS=Bos taurus OX=9913 GN=PHF20L1 PE=2 SV=1 g23227.t2 A2VE56 45.522 134 6.01e-36 142.0 sp|A2VE56|P20L1_BOVIN PHD finger protein 20-like protein 1 OS=Bos taurus OX=9913 GN=PHF20L1 PE=2 SV=1 g23229.t1 Q9DCT5 61.582 177 5.19e-75 228.0 sp|Q9DCT5|SDF2_MOUSE Stromal cell-derived factor 2 OS=Mus musculus OX=10090 GN=Sdf2 PE=1 SV=1 g23230.t1 Q8K4K7 45.752 153 8.86e-32 120.0 sp|Q8K4K7|ABRA_RAT Actin-binding Rho-activating protein OS=Rattus norvegicus OX=10116 GN=Abra PE=1 SV=2 g23231.t1 A5WUN7 34.231 520 2.68e-76 285.0 sp|A5WUN7|CAM1B_DANRE Calmodulin-regulated spectrin-associated protein 1-B OS=Danio rerio OX=7955 GN=camsap1b PE=3 SV=1 g23231.t1 A5WUN7 56.115 139 2.52e-40 168.0 sp|A5WUN7|CAM1B_DANRE Calmodulin-regulated spectrin-associated protein 1-B OS=Danio rerio OX=7955 GN=camsap1b PE=3 SV=1 g23231.t2 A5WUN7 34.601 526 1.0700000000000001e-79 296.0 sp|A5WUN7|CAM1B_DANRE Calmodulin-regulated spectrin-associated protein 1-B OS=Danio rerio OX=7955 GN=camsap1b PE=3 SV=1 g23231.t2 A5WUN7 56.115 139 2.5999999999999997e-40 168.0 sp|A5WUN7|CAM1B_DANRE Calmodulin-regulated spectrin-associated protein 1-B OS=Danio rerio OX=7955 GN=camsap1b PE=3 SV=1 g23232.t1 Q12797 51.896 422 1.6599999999999999e-150 471.0 sp|Q12797|ASPH_HUMAN Aspartyl/asparaginyl beta-hydroxylase OS=Homo sapiens OX=9606 GN=ASPH PE=1 SV=3 g23234.t1 Q8K430 33.63 562 7.75e-103 324.0 sp|Q8K430|KLH17_RAT Kelch-like protein 17 OS=Rattus norvegicus OX=10116 GN=Klhl17 PE=1 SV=1 KLH17_RAT reviewed Kelch-like protein 17 (Actinfilin) Rattus norvegicus (Rat) GO:0005737; GO:0014069; GO:0015629; GO:0016567; GO:0030036; GO:0031208; GO:0031463; GO:0032839; GO:0043025; GO:0043161; GO:0051015; GO:0060090; GO:0098794; GO:0098978; GO:0140252; GO:1990756 actin cytoskeleton organization [GO:0030036]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation protein catabolic process at postsynapse [GO:0140252] actin cytoskeleton [GO:0015629]; Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; dendrite cytoplasm [GO:0032839]; glutamatergic synapse [GO:0098978]; neuronal cell body [GO:0043025]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069] actin filament binding [GO:0051015]; molecular adaptor activity [GO:0060090]; POZ domain binding [GO:0031208]; ubiquitin-like ligase-substrate adaptor activity [GO:1990756] g23235.t1 Q4KLT0 50.0 148 2.11e-47 167.0 sp|Q4KLT0|RN217_XENLA E3 ubiquitin-protein ligase RNF217 OS=Xenopus laevis OX=8355 GN=rnf217 PE=2 SV=1 g23238.t1 Q4KLT0 42.742 248 1.77e-59 200.0 sp|Q4KLT0|RN217_XENLA E3 ubiquitin-protein ligase RNF217 OS=Xenopus laevis OX=8355 GN=rnf217 PE=2 SV=1 g23241.t1 Q9M0G0 37.721 509 4.43e-92 300.0 sp|Q9M0G0|GAGT3_ARATH Glutathione hydrolase 3 OS=Arabidopsis thaliana OX=3702 GN=GGT3 PE=2 SV=1 GAGT3_ARATH reviewed Glutathione hydrolase 3 (EC 3.4.19.13) (Gamma-glutamyltransferase 3) (Gamma-glutamyltranspeptidase 3) (EC 2.3.2.2) (Gamma-glutamyltranspeptidase 4) Arabidopsis thaliana (Mouse-ear cress) GO:0005773; GO:0005774; GO:0005886; GO:0006751; GO:0006805; GO:0009636; GO:0016756; GO:0036374; GO:0103068 glutathione catabolic process [GO:0006751]; response to toxic substance [GO:0009636]; xenobiotic metabolic process [GO:0006805] plasma membrane [GO:0005886]; vacuolar membrane [GO:0005774]; vacuole [GO:0005773] glutathione gamma-glutamylcysteinyltransferase activity [GO:0016756]; glutathione hydrolase activity [GO:0036374]; leukotriene C4 gamma-glutamyl transferase activity [GO:0103068] g23242.t1 P25977 40.506 158 2.37e-34 131.0 sp|P25977|UBF1_RAT Nucleolar transcription factor 1 OS=Rattus norvegicus OX=10116 GN=Ubtf PE=1 SV=1 UBF1_RAT reviewed Nucleolar transcription factor 1 (Upstream-binding factor 1) (UBF-1) Rattus norvegicus (Rat) GO:0000183; GO:0001164; GO:0001165; GO:0001181; GO:0001650; GO:0003682; GO:0005634; GO:0005730; GO:0006360; GO:0006361; GO:0006362; GO:0045943; GO:0097110; GO:1990830 cellular response to leukemia inhibitory factor [GO:1990830]; positive regulation of transcription by RNA polymerase I [GO:0045943]; rDNA heterochromatin formation [GO:0000183]; transcription by RNA polymerase I [GO:0006360]; transcription elongation by RNA polymerase I [GO:0006362]; transcription initiation at RNA polymerase I promoter [GO:0006361] fibrillar center [GO:0001650]; nucleolus [GO:0005730]; nucleus [GO:0005634] chromatin binding [GO:0003682]; RNA polymerase I cis-regulatory region sequence-specific DNA binding [GO:0001165]; RNA polymerase I core promoter sequence-specific DNA binding [GO:0001164]; RNA polymerase I general transcription initiation factor activity [GO:0001181]; scaffold protein binding [GO:0097110] g23243.t1 P17480 30.958 449 1.54e-45 176.0 sp|P17480|UBF1_HUMAN Nucleolar transcription factor 1 OS=Homo sapiens OX=9606 GN=UBTF PE=1 SV=1 UBF1_HUMAN reviewed Nucleolar transcription factor 1 (Autoantigen NOR-90) (Upstream-binding factor 1) (UBF-1) Homo sapiens (Human) GO:0001164; GO:0001165; GO:0001181; GO:0001650; GO:0003682; GO:0003723; GO:0005634; GO:0005654; GO:0005730; GO:0006360; GO:0006361; GO:0045943; GO:0097110 positive regulation of transcription by RNA polymerase I [GO:0045943]; transcription by RNA polymerase I [GO:0006360]; transcription initiation at RNA polymerase I promoter [GO:0006361] fibrillar center [GO:0001650]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] chromatin binding [GO:0003682]; RNA binding [GO:0003723]; RNA polymerase I cis-regulatory region sequence-specific DNA binding [GO:0001165]; RNA polymerase I core promoter sequence-specific DNA binding [GO:0001164]; RNA polymerase I general transcription initiation factor activity [GO:0001181]; scaffold protein binding [GO:0097110] g23243.t2 P25980 28.351 388 7.600000000000001e-36 146.0 sp|P25980|UBF1B_XENLA Nucleolar transcription factor 1-B OS=Xenopus laevis OX=8355 GN=ubtf-b PE=2 SV=1 g23244.t1 Q1L8F9 42.825 439 1.62e-100 311.0 sp|Q1L8F9|KICS2_DANRE KICSTOR subunit 2 OS=Danio rerio OX=7955 GN=kics2 PE=2 SV=2 KICS2_DANRE reviewed KICSTOR subunit 2 Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005765; GO:0034198; GO:0042149; GO:0044782; GO:0061462; GO:0140007; GO:1903432; GO:1904262 cellular response to amino acid starvation [GO:0034198]; cellular response to glucose starvation [GO:0042149]; cilium organization [GO:0044782]; negative regulation of TORC1 signaling [GO:1904262]; protein localization to lysosome [GO:0061462]; regulation of TORC1 signaling [GO:1903432] KICSTOR complex [GO:0140007]; lysosomal membrane [GO:0005765] g23245.t1 Q5ZLK1 72.135 445 0.0 691.0 sp|Q5ZLK1|DCA13_CHICK DDB1- and CUL4-associated factor 13 OS=Gallus gallus OX=9031 GN=DCAF13 PE=2 SV=1 DCA13_CHICK reviewed DDB1- and CUL4-associated factor 13 (WD repeat and SOF domain-containing protein 1) Gallus gallus (Chicken) GO:0000462; GO:0001555; GO:0005730; GO:0006364; GO:0016567; GO:0032040; GO:0080008; GO:1990756 maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; oocyte growth [GO:0001555]; protein ubiquitination [GO:0016567]; rRNA processing [GO:0006364] Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; nucleolus [GO:0005730]; small-subunit processome [GO:0032040] ubiquitin-like ligase-substrate adaptor activity [GO:1990756] g23246.t1 Q9W790 77.695 538 0.0 840.0 sp|Q9W790|TCPA_PALPA T-complex protein 1 subunit alpha OS=Paleosuchus palpebrosus OX=84099 GN=TCP1 PE=2 SV=1 g23247.t1 O53561 36.082 194 6.17e-33 125.0 sp|O53561|ECH19_MYCTU Enoyl-CoA hydratase EchA19 OS=Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv) OX=83332 GN=echA19 PE=1 SV=2 g23248.t1 A4IH82 53.184 267 2.92e-84 265.0 sp|A4IH82|3BP5L_XENTR SH3 domain-binding protein 5-like OS=Xenopus tropicalis OX=8364 GN=sh3bp5l PE=2 SV=1 g23250.t1 Q9JIS1 48.148 513 1.36e-108 386.0 sp|Q9JIS1|RIMS2_RAT Regulating synaptic membrane exocytosis protein 2 OS=Rattus norvegicus OX=10116 GN=Rims2 PE=1 SV=1 RIMS2_RAT reviewed Regulating synaptic membrane exocytosis protein 2 (Rab-3-interacting molecule 2) (RIM 2) Rattus norvegicus (Rat) GO:0006886; GO:0006887; GO:0007188; GO:0007269; GO:0008270; GO:0010628; GO:0016081; GO:0016082; GO:0017156; GO:0017157; GO:0019904; GO:0030073; GO:0030154; GO:0030674; GO:0031267; GO:0032991; GO:0042391; GO:0042734; GO:0044325; GO:0044877; GO:0048791; GO:0051649; GO:0060077; GO:0061669; GO:0097151; GO:0098684; GO:0098831; GO:0098882; GO:0098978; GO:0098982; GO:0150037; GO:1903861; GO:2000300; GO:2000463 adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; calcium ion-regulated exocytosis of neurotransmitter [GO:0048791]; calcium-ion regulated exocytosis [GO:0017156]; cell differentiation [GO:0030154]; establishment of localization in cell [GO:0051649]; exocytosis [GO:0006887]; insulin secretion [GO:0030073]; intracellular protein transport [GO:0006886]; neurotransmitter secretion [GO:0007269]; positive regulation of dendrite extension [GO:1903861]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of gene expression [GO:0010628]; positive regulation of inhibitory postsynaptic potential [GO:0097151]; regulation of calcium-dependent activation of synaptic vesicle fusion [GO:0150037]; regulation of exocytosis [GO:0017157]; regulation of membrane potential [GO:0042391]; regulation of synaptic vesicle exocytosis [GO:2000300]; spontaneous neurotransmitter secretion [GO:0061669]; synaptic vesicle docking [GO:0016081]; synaptic vesicle priming [GO:0016082] GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; inhibitory synapse [GO:0060077]; photoreceptor ribbon synapse [GO:0098684]; presynaptic active zone cytoplasmic component [GO:0098831]; presynaptic membrane [GO:0042734]; protein-containing complex [GO:0032991] protein domain specific binding [GO:0019904]; protein-containing complex binding [GO:0044877]; protein-macromolecule adaptor activity [GO:0030674]; small GTPase binding [GO:0031267]; structural constituent of presynaptic active zone [GO:0098882]; transmembrane transporter binding [GO:0044325]; zinc ion binding [GO:0008270] g23250.t1 Q9JIS1 46.436 463 7.630000000000001e-88 322.0 sp|Q9JIS1|RIMS2_RAT Regulating synaptic membrane exocytosis protein 2 OS=Rattus norvegicus OX=10116 GN=Rims2 PE=1 SV=1 RIMS2_RAT reviewed Regulating synaptic membrane exocytosis protein 2 (Rab-3-interacting molecule 2) (RIM 2) Rattus norvegicus (Rat) GO:0006886; GO:0006887; GO:0007188; GO:0007269; GO:0008270; GO:0010628; GO:0016081; GO:0016082; GO:0017156; GO:0017157; GO:0019904; GO:0030073; GO:0030154; GO:0030674; GO:0031267; GO:0032991; GO:0042391; GO:0042734; GO:0044325; GO:0044877; GO:0048791; GO:0051649; GO:0060077; GO:0061669; GO:0097151; GO:0098684; GO:0098831; GO:0098882; GO:0098978; GO:0098982; GO:0150037; GO:1903861; GO:2000300; GO:2000463 adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; calcium ion-regulated exocytosis of neurotransmitter [GO:0048791]; calcium-ion regulated exocytosis [GO:0017156]; cell differentiation [GO:0030154]; establishment of localization in cell [GO:0051649]; exocytosis [GO:0006887]; insulin secretion [GO:0030073]; intracellular protein transport [GO:0006886]; neurotransmitter secretion [GO:0007269]; positive regulation of dendrite extension [GO:1903861]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of gene expression [GO:0010628]; positive regulation of inhibitory postsynaptic potential [GO:0097151]; regulation of calcium-dependent activation of synaptic vesicle fusion [GO:0150037]; regulation of exocytosis [GO:0017157]; regulation of membrane potential [GO:0042391]; regulation of synaptic vesicle exocytosis [GO:2000300]; spontaneous neurotransmitter secretion [GO:0061669]; synaptic vesicle docking [GO:0016081]; synaptic vesicle priming [GO:0016082] GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; inhibitory synapse [GO:0060077]; photoreceptor ribbon synapse [GO:0098684]; presynaptic active zone cytoplasmic component [GO:0098831]; presynaptic membrane [GO:0042734]; protein-containing complex [GO:0032991] protein domain specific binding [GO:0019904]; protein-containing complex binding [GO:0044877]; protein-macromolecule adaptor activity [GO:0030674]; small GTPase binding [GO:0031267]; structural constituent of presynaptic active zone [GO:0098882]; transmembrane transporter binding [GO:0044325]; zinc ion binding [GO:0008270] g23250.t2 Q9EQZ7 48.142 565 1.4800000000000002e-124 434.0 sp|Q9EQZ7|RIMS2_MOUSE Regulating synaptic membrane exocytosis protein 2 OS=Mus musculus OX=10090 GN=Rims2 PE=1 SV=1 RIMS2_MOUSE reviewed Regulating synaptic membrane exocytosis protein 2 (Rab-3-interacting molecule 2) (RIM 2) (Rab-3-interacting protein 2) Mus musculus (Mouse) GO:0006886; GO:0007188; GO:0007269; GO:0008270; GO:0010628; GO:0016081; GO:0016082; GO:0017156; GO:0017157; GO:0019904; GO:0030073; GO:0030154; GO:0030674; GO:0031267; GO:0032991; GO:0042391; GO:0042734; GO:0043005; GO:0044325; GO:0044877; GO:0048791; GO:0060077; GO:0061669; GO:0097151; GO:0098684; GO:0098831; GO:0098882; GO:0098978; GO:0098982; GO:0150037; GO:1903861; GO:2000300; GO:2000463 adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; calcium ion-regulated exocytosis of neurotransmitter [GO:0048791]; calcium-ion regulated exocytosis [GO:0017156]; cell differentiation [GO:0030154]; insulin secretion [GO:0030073]; intracellular protein transport [GO:0006886]; neurotransmitter secretion [GO:0007269]; positive regulation of dendrite extension [GO:1903861]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of gene expression [GO:0010628]; positive regulation of inhibitory postsynaptic potential [GO:0097151]; regulation of calcium-dependent activation of synaptic vesicle fusion [GO:0150037]; regulation of exocytosis [GO:0017157]; regulation of membrane potential [GO:0042391]; regulation of synaptic vesicle exocytosis [GO:2000300]; spontaneous neurotransmitter secretion [GO:0061669]; synaptic vesicle docking [GO:0016081]; synaptic vesicle priming [GO:0016082] GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; inhibitory synapse [GO:0060077]; neuron projection [GO:0043005]; photoreceptor ribbon synapse [GO:0098684]; presynaptic active zone cytoplasmic component [GO:0098831]; presynaptic membrane [GO:0042734]; protein-containing complex [GO:0032991] protein domain specific binding [GO:0019904]; protein-containing complex binding [GO:0044877]; protein-macromolecule adaptor activity [GO:0030674]; small GTPase binding [GO:0031267]; structural constituent of presynaptic active zone [GO:0098882]; transmembrane transporter binding [GO:0044325]; zinc ion binding [GO:0008270] g23250.t2 Q9EQZ7 47.439 449 1.9099999999999997e-89 327.0 sp|Q9EQZ7|RIMS2_MOUSE Regulating synaptic membrane exocytosis protein 2 OS=Mus musculus OX=10090 GN=Rims2 PE=1 SV=1 RIMS2_MOUSE reviewed Regulating synaptic membrane exocytosis protein 2 (Rab-3-interacting molecule 2) (RIM 2) (Rab-3-interacting protein 2) Mus musculus (Mouse) GO:0006886; GO:0007188; GO:0007269; GO:0008270; GO:0010628; GO:0016081; GO:0016082; GO:0017156; GO:0017157; GO:0019904; GO:0030073; GO:0030154; GO:0030674; GO:0031267; GO:0032991; GO:0042391; GO:0042734; GO:0043005; GO:0044325; GO:0044877; GO:0048791; GO:0060077; GO:0061669; GO:0097151; GO:0098684; GO:0098831; GO:0098882; GO:0098978; GO:0098982; GO:0150037; GO:1903861; GO:2000300; GO:2000463 adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; calcium ion-regulated exocytosis of neurotransmitter [GO:0048791]; calcium-ion regulated exocytosis [GO:0017156]; cell differentiation [GO:0030154]; insulin secretion [GO:0030073]; intracellular protein transport [GO:0006886]; neurotransmitter secretion [GO:0007269]; positive regulation of dendrite extension [GO:1903861]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of gene expression [GO:0010628]; positive regulation of inhibitory postsynaptic potential [GO:0097151]; regulation of calcium-dependent activation of synaptic vesicle fusion [GO:0150037]; regulation of exocytosis [GO:0017157]; regulation of membrane potential [GO:0042391]; regulation of synaptic vesicle exocytosis [GO:2000300]; spontaneous neurotransmitter secretion [GO:0061669]; synaptic vesicle docking [GO:0016081]; synaptic vesicle priming [GO:0016082] GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; inhibitory synapse [GO:0060077]; neuron projection [GO:0043005]; photoreceptor ribbon synapse [GO:0098684]; presynaptic active zone cytoplasmic component [GO:0098831]; presynaptic membrane [GO:0042734]; protein-containing complex [GO:0032991] protein domain specific binding [GO:0019904]; protein-containing complex binding [GO:0044877]; protein-macromolecule adaptor activity [GO:0030674]; small GTPase binding [GO:0031267]; structural constituent of presynaptic active zone [GO:0098882]; transmembrane transporter binding [GO:0044325]; zinc ion binding [GO:0008270] g23250.t3 Q9EQZ7 48.142 565 1.3600000000000001e-124 434.0 sp|Q9EQZ7|RIMS2_MOUSE Regulating synaptic membrane exocytosis protein 2 OS=Mus musculus OX=10090 GN=Rims2 PE=1 SV=1 RIMS2_MOUSE reviewed Regulating synaptic membrane exocytosis protein 2 (Rab-3-interacting molecule 2) (RIM 2) (Rab-3-interacting protein 2) Mus musculus (Mouse) GO:0006886; GO:0007188; GO:0007269; GO:0008270; GO:0010628; GO:0016081; GO:0016082; GO:0017156; GO:0017157; GO:0019904; GO:0030073; GO:0030154; GO:0030674; GO:0031267; GO:0032991; GO:0042391; GO:0042734; GO:0043005; GO:0044325; GO:0044877; GO:0048791; GO:0060077; GO:0061669; GO:0097151; GO:0098684; GO:0098831; GO:0098882; GO:0098978; GO:0098982; GO:0150037; GO:1903861; GO:2000300; GO:2000463 adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; calcium ion-regulated exocytosis of neurotransmitter [GO:0048791]; calcium-ion regulated exocytosis [GO:0017156]; cell differentiation [GO:0030154]; insulin secretion [GO:0030073]; intracellular protein transport [GO:0006886]; neurotransmitter secretion [GO:0007269]; positive regulation of dendrite extension [GO:1903861]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of gene expression [GO:0010628]; positive regulation of inhibitory postsynaptic potential [GO:0097151]; regulation of calcium-dependent activation of synaptic vesicle fusion [GO:0150037]; regulation of exocytosis [GO:0017157]; regulation of membrane potential [GO:0042391]; regulation of synaptic vesicle exocytosis [GO:2000300]; spontaneous neurotransmitter secretion [GO:0061669]; synaptic vesicle docking [GO:0016081]; synaptic vesicle priming [GO:0016082] GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; inhibitory synapse [GO:0060077]; neuron projection [GO:0043005]; photoreceptor ribbon synapse [GO:0098684]; presynaptic active zone cytoplasmic component [GO:0098831]; presynaptic membrane [GO:0042734]; protein-containing complex [GO:0032991] protein domain specific binding [GO:0019904]; protein-containing complex binding [GO:0044877]; protein-macromolecule adaptor activity [GO:0030674]; small GTPase binding [GO:0031267]; structural constituent of presynaptic active zone [GO:0098882]; transmembrane transporter binding [GO:0044325]; zinc ion binding [GO:0008270] g23250.t3 Q9EQZ7 47.439 449 1.87e-89 327.0 sp|Q9EQZ7|RIMS2_MOUSE Regulating synaptic membrane exocytosis protein 2 OS=Mus musculus OX=10090 GN=Rims2 PE=1 SV=1 RIMS2_MOUSE reviewed Regulating synaptic membrane exocytosis protein 2 (Rab-3-interacting molecule 2) (RIM 2) (Rab-3-interacting protein 2) Mus musculus (Mouse) GO:0006886; GO:0007188; GO:0007269; GO:0008270; GO:0010628; GO:0016081; GO:0016082; GO:0017156; GO:0017157; GO:0019904; GO:0030073; GO:0030154; GO:0030674; GO:0031267; GO:0032991; GO:0042391; GO:0042734; GO:0043005; GO:0044325; GO:0044877; GO:0048791; GO:0060077; GO:0061669; GO:0097151; GO:0098684; GO:0098831; GO:0098882; GO:0098978; GO:0098982; GO:0150037; GO:1903861; GO:2000300; GO:2000463 adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; calcium ion-regulated exocytosis of neurotransmitter [GO:0048791]; calcium-ion regulated exocytosis [GO:0017156]; cell differentiation [GO:0030154]; insulin secretion [GO:0030073]; intracellular protein transport [GO:0006886]; neurotransmitter secretion [GO:0007269]; positive regulation of dendrite extension [GO:1903861]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of gene expression [GO:0010628]; positive regulation of inhibitory postsynaptic potential [GO:0097151]; regulation of calcium-dependent activation of synaptic vesicle fusion [GO:0150037]; regulation of exocytosis [GO:0017157]; regulation of membrane potential [GO:0042391]; regulation of synaptic vesicle exocytosis [GO:2000300]; spontaneous neurotransmitter secretion [GO:0061669]; synaptic vesicle docking [GO:0016081]; synaptic vesicle priming [GO:0016082] GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; inhibitory synapse [GO:0060077]; neuron projection [GO:0043005]; photoreceptor ribbon synapse [GO:0098684]; presynaptic active zone cytoplasmic component [GO:0098831]; presynaptic membrane [GO:0042734]; protein-containing complex [GO:0032991] protein domain specific binding [GO:0019904]; protein-containing complex binding [GO:0044877]; protein-macromolecule adaptor activity [GO:0030674]; small GTPase binding [GO:0031267]; structural constituent of presynaptic active zone [GO:0098882]; transmembrane transporter binding [GO:0044325]; zinc ion binding [GO:0008270] g23250.t4 Q9EQZ7 48.142 565 1.21e-125 434.0 sp|Q9EQZ7|RIMS2_MOUSE Regulating synaptic membrane exocytosis protein 2 OS=Mus musculus OX=10090 GN=Rims2 PE=1 SV=1 RIMS2_MOUSE reviewed Regulating synaptic membrane exocytosis protein 2 (Rab-3-interacting molecule 2) (RIM 2) (Rab-3-interacting protein 2) Mus musculus (Mouse) GO:0006886; GO:0007188; GO:0007269; GO:0008270; GO:0010628; GO:0016081; GO:0016082; GO:0017156; GO:0017157; GO:0019904; GO:0030073; GO:0030154; GO:0030674; GO:0031267; GO:0032991; GO:0042391; GO:0042734; GO:0043005; GO:0044325; GO:0044877; GO:0048791; GO:0060077; GO:0061669; GO:0097151; GO:0098684; GO:0098831; GO:0098882; GO:0098978; GO:0098982; GO:0150037; GO:1903861; GO:2000300; GO:2000463 adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; calcium ion-regulated exocytosis of neurotransmitter [GO:0048791]; calcium-ion regulated exocytosis [GO:0017156]; cell differentiation [GO:0030154]; insulin secretion [GO:0030073]; intracellular protein transport [GO:0006886]; neurotransmitter secretion [GO:0007269]; positive regulation of dendrite extension [GO:1903861]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of gene expression [GO:0010628]; positive regulation of inhibitory postsynaptic potential [GO:0097151]; regulation of calcium-dependent activation of synaptic vesicle fusion [GO:0150037]; regulation of exocytosis [GO:0017157]; regulation of membrane potential [GO:0042391]; regulation of synaptic vesicle exocytosis [GO:2000300]; spontaneous neurotransmitter secretion [GO:0061669]; synaptic vesicle docking [GO:0016081]; synaptic vesicle priming [GO:0016082] GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; inhibitory synapse [GO:0060077]; neuron projection [GO:0043005]; photoreceptor ribbon synapse [GO:0098684]; presynaptic active zone cytoplasmic component [GO:0098831]; presynaptic membrane [GO:0042734]; protein-containing complex [GO:0032991] protein domain specific binding [GO:0019904]; protein-containing complex binding [GO:0044877]; protein-macromolecule adaptor activity [GO:0030674]; small GTPase binding [GO:0031267]; structural constituent of presynaptic active zone [GO:0098882]; transmembrane transporter binding [GO:0044325]; zinc ion binding [GO:0008270] g23250.t5 Q9EQZ7 48.214 560 2.8100000000000002e-123 431.0 sp|Q9EQZ7|RIMS2_MOUSE Regulating synaptic membrane exocytosis protein 2 OS=Mus musculus OX=10090 GN=Rims2 PE=1 SV=1 RIMS2_MOUSE reviewed Regulating synaptic membrane exocytosis protein 2 (Rab-3-interacting molecule 2) (RIM 2) (Rab-3-interacting protein 2) Mus musculus (Mouse) GO:0006886; GO:0007188; GO:0007269; GO:0008270; GO:0010628; GO:0016081; GO:0016082; GO:0017156; GO:0017157; GO:0019904; GO:0030073; GO:0030154; GO:0030674; GO:0031267; GO:0032991; GO:0042391; GO:0042734; GO:0043005; GO:0044325; GO:0044877; GO:0048791; GO:0060077; GO:0061669; GO:0097151; GO:0098684; GO:0098831; GO:0098882; GO:0098978; GO:0098982; GO:0150037; GO:1903861; GO:2000300; GO:2000463 adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; calcium ion-regulated exocytosis of neurotransmitter [GO:0048791]; calcium-ion regulated exocytosis [GO:0017156]; cell differentiation [GO:0030154]; insulin secretion [GO:0030073]; intracellular protein transport [GO:0006886]; neurotransmitter secretion [GO:0007269]; positive regulation of dendrite extension [GO:1903861]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of gene expression [GO:0010628]; positive regulation of inhibitory postsynaptic potential [GO:0097151]; regulation of calcium-dependent activation of synaptic vesicle fusion [GO:0150037]; regulation of exocytosis [GO:0017157]; regulation of membrane potential [GO:0042391]; regulation of synaptic vesicle exocytosis [GO:2000300]; spontaneous neurotransmitter secretion [GO:0061669]; synaptic vesicle docking [GO:0016081]; synaptic vesicle priming [GO:0016082] GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; inhibitory synapse [GO:0060077]; neuron projection [GO:0043005]; photoreceptor ribbon synapse [GO:0098684]; presynaptic active zone cytoplasmic component [GO:0098831]; presynaptic membrane [GO:0042734]; protein-containing complex [GO:0032991] protein domain specific binding [GO:0019904]; protein-containing complex binding [GO:0044877]; protein-macromolecule adaptor activity [GO:0030674]; small GTPase binding [GO:0031267]; structural constituent of presynaptic active zone [GO:0098882]; transmembrane transporter binding [GO:0044325]; zinc ion binding [GO:0008270] g23250.t5 Q9EQZ7 47.439 449 2.1699999999999997e-89 327.0 sp|Q9EQZ7|RIMS2_MOUSE Regulating synaptic membrane exocytosis protein 2 OS=Mus musculus OX=10090 GN=Rims2 PE=1 SV=1 RIMS2_MOUSE reviewed Regulating synaptic membrane exocytosis protein 2 (Rab-3-interacting molecule 2) (RIM 2) (Rab-3-interacting protein 2) Mus musculus (Mouse) GO:0006886; GO:0007188; GO:0007269; GO:0008270; GO:0010628; GO:0016081; GO:0016082; GO:0017156; GO:0017157; GO:0019904; GO:0030073; GO:0030154; GO:0030674; GO:0031267; GO:0032991; GO:0042391; GO:0042734; GO:0043005; GO:0044325; GO:0044877; GO:0048791; GO:0060077; GO:0061669; GO:0097151; GO:0098684; GO:0098831; GO:0098882; GO:0098978; GO:0098982; GO:0150037; GO:1903861; GO:2000300; GO:2000463 adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; calcium ion-regulated exocytosis of neurotransmitter [GO:0048791]; calcium-ion regulated exocytosis [GO:0017156]; cell differentiation [GO:0030154]; insulin secretion [GO:0030073]; intracellular protein transport [GO:0006886]; neurotransmitter secretion [GO:0007269]; positive regulation of dendrite extension [GO:1903861]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of gene expression [GO:0010628]; positive regulation of inhibitory postsynaptic potential [GO:0097151]; regulation of calcium-dependent activation of synaptic vesicle fusion [GO:0150037]; regulation of exocytosis [GO:0017157]; regulation of membrane potential [GO:0042391]; regulation of synaptic vesicle exocytosis [GO:2000300]; spontaneous neurotransmitter secretion [GO:0061669]; synaptic vesicle docking [GO:0016081]; synaptic vesicle priming [GO:0016082] GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; inhibitory synapse [GO:0060077]; neuron projection [GO:0043005]; photoreceptor ribbon synapse [GO:0098684]; presynaptic active zone cytoplasmic component [GO:0098831]; presynaptic membrane [GO:0042734]; protein-containing complex [GO:0032991] protein domain specific binding [GO:0019904]; protein-containing complex binding [GO:0044877]; protein-macromolecule adaptor activity [GO:0030674]; small GTPase binding [GO:0031267]; structural constituent of presynaptic active zone [GO:0098882]; transmembrane transporter binding [GO:0044325]; zinc ion binding [GO:0008270] g23256.t1 Q68EX9 49.127 401 6.9200000000000004e-130 382.0 sp|Q68EX9|CHID1_XENLA Chitinase domain-containing protein 1 OS=Xenopus laevis OX=8355 GN=chid1 PE=2 SV=1 g23258.t1 Q9DBX3 29.487 312 2.68e-33 134.0 sp|Q9DBX3|SUSD2_MOUSE Sushi domain-containing protein 2 OS=Mus musculus OX=10090 GN=Susd2 PE=1 SV=1 g23260.t1 Q9R1R2 30.233 172 9.609999999999999e-23 97.8 sp|Q9R1R2|TRIM3_MOUSE Tripartite motif-containing protein 3 OS=Mus musculus OX=10090 GN=Trim3 PE=1 SV=1 TRIM3_MOUSE reviewed Tripartite motif-containing protein 3 (EC 2.3.2.27) (RING finger protein 22) (RING finger protein HAC1) Mus musculus (Mouse) GO:0000209; GO:0002224; GO:0004842; GO:0005737; GO:0005769; GO:0005794; GO:0008270; GO:0015031; GO:0016567; GO:0030425; GO:0034141; GO:0042802; GO:0043161; GO:0061351; GO:0061630; GO:0070534; GO:0098794; GO:0098978; GO:0140252 neural precursor cell proliferation [GO:0061351]; positive regulation of toll-like receptor 3 signaling pathway [GO:0034141]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K63-linked ubiquitination [GO:0070534]; protein polyubiquitination [GO:0000209]; protein transport [GO:0015031]; protein ubiquitination [GO:0016567]; regulation protein catabolic process at postsynapse [GO:0140252]; toll-like receptor signaling pathway [GO:0002224] cytoplasm [GO:0005737]; dendrite [GO:0030425]; early endosome [GO:0005769]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; postsynapse [GO:0098794] identical protein binding [GO:0042802]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] g23263.t1 Q9BRZ2 26.481 287 1.1700000000000001e-21 98.6 sp|Q9BRZ2|TRI56_HUMAN E3 ubiquitin-protein ligase TRIM56 OS=Homo sapiens OX=9606 GN=TRIM56 PE=1 SV=3 g23266.t1 Q593B6 31.25 384 3.28e-38 159.0 sp|Q593B6|FA5_PSETE Coagulation factor V OS=Pseudonaja textilis OX=8673 GN=F5 PE=1 SV=1 FA5_PSETE reviewed Coagulation factor V [Cleaved into: Coagulation factor V heavy chain; Coagulation factor V light chain] Pseudonaja textilis (Eastern brown snake) GO:0005507; GO:0005576; GO:0005886; GO:0007596; GO:0016504; GO:0032991; GO:0038023; GO:0044469; GO:0090729 blood coagulation [GO:0007596]; venom-mediated blood coagulation [GO:0044469] extracellular region [GO:0005576]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] copper ion binding [GO:0005507]; peptidase activator activity [GO:0016504]; signaling receptor activity [GO:0038023]; toxin activity [GO:0090729] g23266.t1 Q593B6 34.796 319 1.29e-34 147.0 sp|Q593B6|FA5_PSETE Coagulation factor V OS=Pseudonaja textilis OX=8673 GN=F5 PE=1 SV=1 FA5_PSETE reviewed Coagulation factor V [Cleaved into: Coagulation factor V heavy chain; Coagulation factor V light chain] Pseudonaja textilis (Eastern brown snake) GO:0005507; GO:0005576; GO:0005886; GO:0007596; GO:0016504; GO:0032991; GO:0038023; GO:0044469; GO:0090729 blood coagulation [GO:0007596]; venom-mediated blood coagulation [GO:0044469] extracellular region [GO:0005576]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] copper ion binding [GO:0005507]; peptidase activator activity [GO:0016504]; signaling receptor activity [GO:0038023]; toxin activity [GO:0090729] g23266.t1 Q593B6 33.639 327 1.72e-27 124.0 sp|Q593B6|FA5_PSETE Coagulation factor V OS=Pseudonaja textilis OX=8673 GN=F5 PE=1 SV=1 FA5_PSETE reviewed Coagulation factor V [Cleaved into: Coagulation factor V heavy chain; Coagulation factor V light chain] Pseudonaja textilis (Eastern brown snake) GO:0005507; GO:0005576; GO:0005886; GO:0007596; GO:0016504; GO:0032991; GO:0038023; GO:0044469; GO:0090729 blood coagulation [GO:0007596]; venom-mediated blood coagulation [GO:0044469] extracellular region [GO:0005576]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] copper ion binding [GO:0005507]; peptidase activator activity [GO:0016504]; signaling receptor activity [GO:0038023]; toxin activity [GO:0090729] g23267.t1 Q08431 32.806 253 1.24e-32 134.0 sp|Q08431|MFGM_HUMAN Lactadherin OS=Homo sapiens OX=9606 GN=MFGE8 PE=1 SV=3 MFGM_HUMAN reviewed Lactadherin (Breast epithelial antigen BA46) (HMFG) (MFGM) (Milk fat globule-EGF factor 8) (MFG-E8) (SED1) [Cleaved into: Lactadherin short form; Medin] Homo sapiens (Human) GO:0001525; GO:0001786; GO:0002080; GO:0005178; GO:0005576; GO:0005615; GO:0005788; GO:0007155; GO:0007338; GO:0009897; GO:0016020; GO:0031012; GO:0043277; GO:0070062; GO:1903561 angiogenesis [GO:0001525]; apoptotic cell clearance [GO:0043277]; cell adhesion [GO:0007155]; single fertilization [GO:0007338] acrosomal membrane [GO:0002080]; endoplasmic reticulum lumen [GO:0005788]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular vesicle [GO:1903561]; membrane [GO:0016020] integrin binding [GO:0005178]; phosphatidylserine binding [GO:0001786] g23267.t1 Q08431 31.329 316 8.4e-26 114.0 sp|Q08431|MFGM_HUMAN Lactadherin OS=Homo sapiens OX=9606 GN=MFGE8 PE=1 SV=3 MFGM_HUMAN reviewed Lactadherin (Breast epithelial antigen BA46) (HMFG) (MFGM) (Milk fat globule-EGF factor 8) (MFG-E8) (SED1) [Cleaved into: Lactadherin short form; Medin] Homo sapiens (Human) GO:0001525; GO:0001786; GO:0002080; GO:0005178; GO:0005576; GO:0005615; GO:0005788; GO:0007155; GO:0007338; GO:0009897; GO:0016020; GO:0031012; GO:0043277; GO:0070062; GO:1903561 angiogenesis [GO:0001525]; apoptotic cell clearance [GO:0043277]; cell adhesion [GO:0007155]; single fertilization [GO:0007338] acrosomal membrane [GO:0002080]; endoplasmic reticulum lumen [GO:0005788]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular vesicle [GO:1903561]; membrane [GO:0016020] integrin binding [GO:0005178]; phosphatidylserine binding [GO:0001786] g23267.t2 Q08431 32.806 253 1.6100000000000002e-32 134.0 sp|Q08431|MFGM_HUMAN Lactadherin OS=Homo sapiens OX=9606 GN=MFGE8 PE=1 SV=3 MFGM_HUMAN reviewed Lactadherin (Breast epithelial antigen BA46) (HMFG) (MFGM) (Milk fat globule-EGF factor 8) (MFG-E8) (SED1) [Cleaved into: Lactadherin short form; Medin] Homo sapiens (Human) GO:0001525; GO:0001786; GO:0002080; GO:0005178; GO:0005576; GO:0005615; GO:0005788; GO:0007155; GO:0007338; GO:0009897; GO:0016020; GO:0031012; GO:0043277; GO:0070062; GO:1903561 angiogenesis [GO:0001525]; apoptotic cell clearance [GO:0043277]; cell adhesion [GO:0007155]; single fertilization [GO:0007338] acrosomal membrane [GO:0002080]; endoplasmic reticulum lumen [GO:0005788]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular vesicle [GO:1903561]; membrane [GO:0016020] integrin binding [GO:0005178]; phosphatidylserine binding [GO:0001786] g23267.t2 Q08431 30.887 327 9.94e-25 110.0 sp|Q08431|MFGM_HUMAN Lactadherin OS=Homo sapiens OX=9606 GN=MFGE8 PE=1 SV=3 MFGM_HUMAN reviewed Lactadherin (Breast epithelial antigen BA46) (HMFG) (MFGM) (Milk fat globule-EGF factor 8) (MFG-E8) (SED1) [Cleaved into: Lactadherin short form; Medin] Homo sapiens (Human) GO:0001525; GO:0001786; GO:0002080; GO:0005178; GO:0005576; GO:0005615; GO:0005788; GO:0007155; GO:0007338; GO:0009897; GO:0016020; GO:0031012; GO:0043277; GO:0070062; GO:1903561 angiogenesis [GO:0001525]; apoptotic cell clearance [GO:0043277]; cell adhesion [GO:0007155]; single fertilization [GO:0007338] acrosomal membrane [GO:0002080]; endoplasmic reticulum lumen [GO:0005788]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular vesicle [GO:1903561]; membrane [GO:0016020] integrin binding [GO:0005178]; phosphatidylserine binding [GO:0001786] g23268.t1 Q5ZKL6 40.043 462 1.5100000000000001e-109 338.0 sp|Q5ZKL6|MBOA2_CHICK Membrane-bound glycerophospholipid O-acyltransferase 2 OS=Gallus gallus OX=9031 GN=mboat2 PE=2 SV=1 MBOA2_CHICK reviewed Membrane-bound glycerophospholipid O-acyltransferase 2 (EC 2.3.1.-) (1-acylglycerophosphate O-acyltransferase) (EC 2.3.1.51) (1-acylglycerophosphocholine O-acyltransferase) (EC 2.3.1.23) (1-acylglycerophosphoethanolamine O-acyltransferase) (EC 2.3.1.n7) (Lysophospholipid acyltransferase 2) (LPLAT 2) (Membrane-bound O-acyltransferase domain-containing protein 2) (O-acyltransferase domain-containing protein 2) Gallus gallus (Chicken) GO:0003841; GO:0005789; GO:0008654; GO:0016020; GO:0016746; GO:0030258; GO:0032330; GO:0036150; GO:0036151; GO:0036152; GO:0047184; GO:0106262; GO:0106263 lipid modification [GO:0030258]; phosphatidylcholine acyl-chain remodeling [GO:0036151]; phosphatidylethanolamine acyl-chain remodeling [GO:0036152]; phosphatidylserine acyl-chain remodeling [GO:0036150]; phospholipid biosynthetic process [GO:0008654]; regulation of chondrocyte differentiation [GO:0032330] endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020] 1-acylglycerol-3-phosphate O-acyltransferase activity [GO:0003841]; 1-acylglycerophosphocholine O-acyltransferase activity [GO:0047184]; 1-acylglycerophosphoethanolamine O-acyltransferase activity [GO:0106262]; 1-acylglycerophosphoserine O-acyltransferase activity [GO:0106263]; acyltransferase activity [GO:0016746] g23269.t1 O54912 50.296 169 6.3299999999999994e-46 161.0 sp|O54912|KCNK3_RAT Potassium channel subfamily K member 3 OS=Rattus norvegicus OX=10116 GN=Kcnk3 PE=1 SV=1 KCNK3_RAT reviewed Potassium channel subfamily K member 3 (Acid-sensitive potassium channel protein TASK-1) (TWIK-related acid-sensitive K(+) channel 1) (Two pore potassium channel KT3.1) (Two pore K(+) channel KT3.1) Rattus norvegicus (Rat) GO:0003029; GO:0005216; GO:0005252; GO:0005272; GO:0005886; GO:0006813; GO:0009410; GO:0015271; GO:0022841; GO:0034220; GO:0044548; GO:0046982; GO:0051481; GO:0060075; GO:0071294; GO:0071456; GO:0071468; GO:0071805; GO:0090102; GO:0099605 cellular response to acidic pH [GO:0071468]; cellular response to hypoxia [GO:0071456]; cellular response to zinc ion [GO:0071294]; cochlea development [GO:0090102]; detection of hypoxic conditions in blood by carotid body chemoreceptor signaling [GO:0003029]; monoatomic ion transmembrane transport [GO:0034220]; negative regulation of cytosolic calcium ion concentration [GO:0051481]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; regulation of action potential firing rate [GO:0099605]; regulation of resting membrane potential [GO:0060075]; response to xenobiotic stimulus [GO:0009410] plasma membrane [GO:0005886] monoatomic ion channel activity [GO:0005216]; open rectifier potassium channel activity [GO:0005252]; outward rectifier potassium channel activity [GO:0015271]; potassium ion leak channel activity [GO:0022841]; protein heterodimerization activity [GO:0046982]; S100 protein binding [GO:0044548]; sodium channel activity [GO:0005272] g23271.t1 Q00900 47.49 259 2.2699999999999997e-54 214.0 sp|Q00900|ZEP2_RAT Human immunodeficiency virus type I enhancer-binding protein 2 homolog OS=Rattus norvegicus OX=10116 GN=Hivep2 PE=1 SV=2 ZEP2_RAT reviewed Human immunodeficiency virus type I enhancer-binding protein 2 homolog (Angiotensinogen gene-inducible enhancer-binding protein 1) (DNA-binding protein AGIE-BP1) (Myc intron-binding protein 1) (MIBP-1) Rattus norvegicus (Rat) GO:0000978; GO:0000981; GO:0001228; GO:0005634; GO:0005654; GO:0006357; GO:0008270; GO:0045944 positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357] nucleoplasm [GO:0005654]; nucleus [GO:0005634] DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270] g23272.t1 P15822 55.046 109 7.250000000000001e-27 123.0 sp|P15822|ZEP1_HUMAN Zinc finger protein 40 OS=Homo sapiens OX=9606 GN=HIVEP1 PE=1 SV=4 ZEP1_HUMAN reviewed Zinc finger protein 40 (Cirhin interaction protein) (CIRIP) (Gate keeper of apoptosis-activating protein) (GAAP) (Human immunodeficiency virus type I enhancer-binding protein 1) (HIV-EP1) (Major histocompatibility complex-binding protein 1) (MBP-1) (Positive regulatory domain II-binding factor 1) (PRDII-BF1) Homo sapiens (Human) GO:0000122; GO:0000978; GO:0000981; GO:0001227; GO:0005634; GO:0005654; GO:0005739; GO:0005829; GO:0006357; GO:0008270; GO:0016604; GO:0030509; GO:0045944; GO:1990837 BMP signaling pathway [GO:0030509]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357] cytosol [GO:0005829]; mitochondrion [GO:0005739]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; zinc ion binding [GO:0008270] g23273.t1 Q9UJM8 50.416 361 7.13e-130 379.0 sp|Q9UJM8|HAOX1_HUMAN 2-Hydroxyacid oxidase 1 OS=Homo sapiens OX=9606 GN=HAO1 PE=1 SV=1 g23280.t1 Q5ZID2 40.476 210 6.079999999999999e-38 145.0 sp|Q5ZID2|PDD2L_CHICK Programmed cell death protein 2-like OS=Gallus gallus OX=9031 GN=PDCD2L PE=2 SV=1 g23281.t1 Q8CEE6 49.747 396 4.14e-115 397.0 sp|Q8CEE6|PASK_MOUSE PAS domain-containing serine/threonine-protein kinase OS=Mus musculus OX=10090 GN=Pask PE=1 SV=3 PASK_MOUSE reviewed PAS domain-containing serine/threonine-protein kinase (PAS-kinase) (PASKIN) (EC 2.7.11.1) Mus musculus (Mouse) GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006355; GO:0006468; GO:0035091; GO:0035556; GO:0043576; GO:0045719; GO:0046777; GO:0070092; GO:0097009; GO:0106310 energy homeostasis [GO:0097009]; intracellular signal transduction [GO:0035556]; negative regulation of glycogen biosynthetic process [GO:0045719]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of DNA-templated transcription [GO:0006355]; regulation of glucagon secretion [GO:0070092]; regulation of respiratory gaseous exchange [GO:0043576] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634] ATP binding [GO:0005524]; phosphatidylinositol binding [GO:0035091]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g23281.t1 Q8CEE6 42.857 308 4.1600000000000004e-70 263.0 sp|Q8CEE6|PASK_MOUSE PAS domain-containing serine/threonine-protein kinase OS=Mus musculus OX=10090 GN=Pask PE=1 SV=3 PASK_MOUSE reviewed PAS domain-containing serine/threonine-protein kinase (PAS-kinase) (PASKIN) (EC 2.7.11.1) Mus musculus (Mouse) GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006355; GO:0006468; GO:0035091; GO:0035556; GO:0043576; GO:0045719; GO:0046777; GO:0070092; GO:0097009; GO:0106310 energy homeostasis [GO:0097009]; intracellular signal transduction [GO:0035556]; negative regulation of glycogen biosynthetic process [GO:0045719]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of DNA-templated transcription [GO:0006355]; regulation of glucagon secretion [GO:0070092]; regulation of respiratory gaseous exchange [GO:0043576] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634] ATP binding [GO:0005524]; phosphatidylinositol binding [GO:0035091]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g23281.t2 Q8CEE6 49.747 396 4.25e-115 397.0 sp|Q8CEE6|PASK_MOUSE PAS domain-containing serine/threonine-protein kinase OS=Mus musculus OX=10090 GN=Pask PE=1 SV=3 PASK_MOUSE reviewed PAS domain-containing serine/threonine-protein kinase (PAS-kinase) (PASKIN) (EC 2.7.11.1) Mus musculus (Mouse) GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006355; GO:0006468; GO:0035091; GO:0035556; GO:0043576; GO:0045719; GO:0046777; GO:0070092; GO:0097009; GO:0106310 energy homeostasis [GO:0097009]; intracellular signal transduction [GO:0035556]; negative regulation of glycogen biosynthetic process [GO:0045719]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of DNA-templated transcription [GO:0006355]; regulation of glucagon secretion [GO:0070092]; regulation of respiratory gaseous exchange [GO:0043576] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634] ATP binding [GO:0005524]; phosphatidylinositol binding [GO:0035091]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g23281.t2 Q8CEE6 42.581 310 1.08e-70 265.0 sp|Q8CEE6|PASK_MOUSE PAS domain-containing serine/threonine-protein kinase OS=Mus musculus OX=10090 GN=Pask PE=1 SV=3 PASK_MOUSE reviewed PAS domain-containing serine/threonine-protein kinase (PAS-kinase) (PASKIN) (EC 2.7.11.1) Mus musculus (Mouse) GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006355; GO:0006468; GO:0035091; GO:0035556; GO:0043576; GO:0045719; GO:0046777; GO:0070092; GO:0097009; GO:0106310 energy homeostasis [GO:0097009]; intracellular signal transduction [GO:0035556]; negative regulation of glycogen biosynthetic process [GO:0045719]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of DNA-templated transcription [GO:0006355]; regulation of glucagon secretion [GO:0070092]; regulation of respiratory gaseous exchange [GO:0043576] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634] ATP binding [GO:0005524]; phosphatidylinositol binding [GO:0035091]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g23283.t1 P35601 58.35 509 0.0 620.0 sp|P35601|RFC1_MOUSE Replication factor C subunit 1 OS=Mus musculus OX=10090 GN=Rfc1 PE=1 SV=2 RFC1_MOUSE reviewed Replication factor C subunit 1 (A1-P145) (Activator 1 140 kDa subunit) (A1 140 kDa subunit) (Activator 1 large subunit) (Activator 1 subunit 1) (Differentiation-specific element-binding protein) (ISRE-binding protein) (Replication factor C 140 kDa subunit) (RF-C 140 kDa subunit) (RFC140) (Replication factor C large subunit) Mus musculus (Mouse) GO:0000122; GO:0003677; GO:0003689; GO:0003690; GO:0005524; GO:0005634; GO:0005654; GO:0005663; GO:0006261; GO:0006281; GO:0016887; GO:0019904; GO:0031391; GO:0032991; GO:0043565; GO:0045892; GO:0045893; GO:0061860; GO:0140297 DNA repair [GO:0006281]; DNA-templated DNA replication [GO:0006261]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of DNA-templated transcription [GO:0045893] DNA replication factor C complex [GO:0005663]; Elg1 RFC-like complex [GO:0031391]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA binding [GO:0003677]; DNA clamp loader activity [GO:0003689]; DNA clamp unloader activity [GO:0061860]; DNA-binding transcription factor binding [GO:0140297]; double-stranded DNA binding [GO:0003690]; protein domain specific binding [GO:0019904]; sequence-specific DNA binding [GO:0043565] g23283.t1 P35601 56.618 136 4.7200000000000004e-36 152.0 sp|P35601|RFC1_MOUSE Replication factor C subunit 1 OS=Mus musculus OX=10090 GN=Rfc1 PE=1 SV=2 RFC1_MOUSE reviewed Replication factor C subunit 1 (A1-P145) (Activator 1 140 kDa subunit) (A1 140 kDa subunit) (Activator 1 large subunit) (Activator 1 subunit 1) (Differentiation-specific element-binding protein) (ISRE-binding protein) (Replication factor C 140 kDa subunit) (RF-C 140 kDa subunit) (RFC140) (Replication factor C large subunit) Mus musculus (Mouse) GO:0000122; GO:0003677; GO:0003689; GO:0003690; GO:0005524; GO:0005634; GO:0005654; GO:0005663; GO:0006261; GO:0006281; GO:0016887; GO:0019904; GO:0031391; GO:0032991; GO:0043565; GO:0045892; GO:0045893; GO:0061860; GO:0140297 DNA repair [GO:0006281]; DNA-templated DNA replication [GO:0006261]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of DNA-templated transcription [GO:0045893] DNA replication factor C complex [GO:0005663]; Elg1 RFC-like complex [GO:0031391]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA binding [GO:0003677]; DNA clamp loader activity [GO:0003689]; DNA clamp unloader activity [GO:0061860]; DNA-binding transcription factor binding [GO:0140297]; double-stranded DNA binding [GO:0003690]; protein domain specific binding [GO:0019904]; sequence-specific DNA binding [GO:0043565] g23284.t1 Q9NVH0 40.892 538 1.1700000000000001e-110 345.0 sp|Q9NVH0|EXD2_HUMAN Exonuclease 3'-5' domain-containing protein 2 OS=Homo sapiens OX=9606 GN=EXD2 PE=1 SV=2 EXD2_HUMAN reviewed Exonuclease 3'-5' domain-containing protein 2 (EC 3.1.11.1) (3'-5' exoribonuclease EXD2) (EC 3.1.13.-) (Exonuclease 3'-5' domain-like-containing protein 2) Homo sapiens (Human) GO:0000175; GO:0000287; GO:0000724; GO:0000729; GO:0003676; GO:0005634; GO:0005737; GO:0005739; GO:0005741; GO:0005759; GO:0006302; GO:0008296; GO:0008310; GO:0008408; GO:0030145; GO:0031297; GO:0042803; GO:0045111; GO:0090304; GO:0090734 DNA double-strand break processing [GO:0000729]; double-strand break repair [GO:0006302]; double-strand break repair via homologous recombination [GO:0000724]; nucleic acid metabolic process [GO:0090304]; replication fork processing [GO:0031297] cytoplasm [GO:0005737]; intermediate filament cytoskeleton [GO:0045111]; mitochondrial matrix [GO:0005759]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; site of DNA damage [GO:0090734] 3'-5' exonuclease activity [GO:0008408]; 3'-5'-DNA exonuclease activity [GO:0008296]; 3'-5'-RNA exonuclease activity [GO:0000175]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; nucleic acid binding [GO:0003676]; protein homodimerization activity [GO:0042803]; single-stranded DNA 3'-5' DNA exonuclease activity [GO:0008310] g23285.t1 Q9V3H2 86.495 311 0.0 566.0 sp|Q9V3H2|PSDE_DROME 26S proteasome non-ATPase regulatory subunit 14 OS=Drosophila melanogaster OX=7227 GN=Rpn11 PE=1 SV=1 g23292.t1 Q96DI7 69.405 353 5.25e-180 505.0 sp|Q96DI7|SNR40_HUMAN U5 small nuclear ribonucleoprotein 40 kDa protein OS=Homo sapiens OX=9606 GN=SNRNP40 PE=1 SV=1 SNR40_HUMAN reviewed U5 small nuclear ribonucleoprotein 40 kDa protein (U5 snRNP 40 kDa protein) (U5-40K) (38 kDa-splicing factor) (Prp8-binding protein) (hPRP8BP) (U5 snRNP-specific 40 kDa protein) (WD repeat-containing protein 57) Homo sapiens (Human) GO:0000375; GO:0000398; GO:0003723; GO:0005634; GO:0005654; GO:0005681; GO:0005682; GO:0005732; GO:0005829; GO:0006396; GO:0008380; GO:0016607; GO:0046540; GO:0071007; GO:0071013 mRNA splicing, via spliceosome [GO:0000398]; RNA processing [GO:0006396]; RNA splicing [GO:0008380]; RNA splicing, via transesterification reactions [GO:0000375] catalytic step 2 spliceosome [GO:0071013]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; sno(s)RNA-containing ribonucleoprotein complex [GO:0005732]; spliceosomal complex [GO:0005681]; U2-type catalytic step 2 spliceosome [GO:0071007]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682] RNA binding [GO:0003723] g23296.t1 D3Z4S3 53.913 115 1.14e-28 104.0 sp|D3Z4S3|PTRD1_MOUSE Putative peptidyl-tRNA hydrolase PTRHD1 OS=Mus musculus OX=10090 GN=Ptrhd1 PE=1 SV=1 g23299.t1 Q3SWX9 60.099 406 4.7e-152 447.0 sp|Q3SWX9|RAD21_BOVIN Double-strand-break repair protein rad21 homolog OS=Bos taurus OX=9913 GN=RAD21 PE=2 SV=1 RAD21_BOVIN reviewed Double-strand-break repair protein rad21 homolog [Cleaved into: 64-kDa C-terminal product (64-kDa carboxy-terminal product)] Bos taurus (Bovine) GO:0000775; GO:0000785; GO:0000794; GO:0000922; GO:0000987; GO:0003682; GO:0005654; GO:0005829; GO:0006357; GO:0006915; GO:0007059; GO:0007062; GO:0010972; GO:0016363; GO:0030496; GO:0030892; GO:0030893; GO:0045841; GO:0045876; GO:0051301; GO:0071168; GO:0140588; GO:1990414 apoptotic process [GO:0006915]; cell division [GO:0051301]; chromatin looping [GO:0140588]; chromosome segregation [GO:0007059]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; negative regulation of mitotic metaphase/anaphase transition [GO:0045841]; positive regulation of sister chromatid cohesion [GO:0045876]; protein localization to chromatin [GO:0071168]; regulation of transcription by RNA polymerase II [GO:0006357]; replication-born double-strand break repair via sister chromatid exchange [GO:1990414]; sister chromatid cohesion [GO:0007062] chromatin [GO:0000785]; chromosome, centromeric region [GO:0000775]; condensed nuclear chromosome [GO:0000794]; cytosol [GO:0005829]; meiotic cohesin complex [GO:0030893]; midbody [GO:0030496]; mitotic cohesin complex [GO:0030892]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; spindle pole [GO:0000922] chromatin binding [GO:0003682]; cis-regulatory region sequence-specific DNA binding [GO:0000987] g23301.t1 Q96KS9 32.804 189 2.4299999999999998e-23 95.9 sp|Q96KS9|F167A_HUMAN Protein FAM167A OS=Homo sapiens OX=9606 GN=FAM167A PE=1 SV=1 g23302.t1 P51589 38.809 487 8.26e-106 327.0 sp|P51589|CP2J2_HUMAN Cytochrome P450 2J2 OS=Homo sapiens OX=9606 GN=CYP2J2 PE=1 SV=2 CP2J2_HUMAN reviewed Cytochrome P450 2J2 (EC 1.14.14.-) (Albendazole monooxygenase (hydroxylating)) (EC 1.14.14.74) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Arachidonic acid epoxygenase) (CYPIIJ2) (Hydroperoxy icosatetraenoate isomerase) (EC 5.4.4.7) Homo sapiens (Human) GO:0004497; GO:0005506; GO:0005737; GO:0005789; GO:0006082; GO:0006631; GO:0006690; GO:0006805; GO:0008016; GO:0008392; GO:0008404; GO:0008405; GO:0016712; GO:0016853; GO:0019373; GO:0020037; GO:0043651; GO:0070062; GO:0071614; GO:0106255; GO:0106301 epoxygenase P450 pathway [GO:0019373]; fatty acid metabolic process [GO:0006631]; icosanoid metabolic process [GO:0006690]; linoleic acid metabolic process [GO:0043651]; organic acid metabolic process [GO:0006082]; regulation of heart contraction [GO:0008016]; xenobiotic metabolic process [GO:0006805] cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062] arachidonate 11,12-epoxygenase activity [GO:0008405]; arachidonate 14,15-epoxygenase activity [GO:0008404]; arachidonate 5,6-epoxygenase activity [GO:0106301]; arachidonate epoxygenase activity [GO:0008392]; heme binding [GO:0020037]; hydroperoxy icosatetraenoate isomerase activity [GO:0106255]; iron ion binding [GO:0005506]; isomerase activity [GO:0016853]; linoleic acid epoxygenase activity [GO:0071614]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712] g23303.t1 O54749 38.114 509 4.83e-96 303.0 sp|O54749|CP2J5_MOUSE Cytochrome P450 2J5 OS=Mus musculus OX=10090 GN=Cyp2j5 PE=1 SV=1 g23304.t1 Q9UGT4 28.652 705 1.99e-67 247.0 sp|Q9UGT4|SUSD2_HUMAN Sushi domain-containing protein 2 OS=Homo sapiens OX=9606 GN=SUSD2 PE=1 SV=1 SUSD2_HUMAN reviewed Sushi domain-containing protein 2 Homo sapiens (Human) GO:0005615; GO:0005886; GO:0051782; GO:0070062; GO:1902807 negative regulation of cell cycle G1/S phase transition [GO:1902807]; negative regulation of cell division [GO:0051782] extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; plasma membrane [GO:0005886] g37.t1 M9PH32 24.317 366 6.75e-25 114.0 sp|M9PH32|MEI26_DROME Protein meiotic P26 OS=Drosophila melanogaster OX=7227 GN=mei-P26 PE=1 SV=1 MEI26_DROME reviewed Protein meiotic P26 Drosophila melanogaster (Fruit fly) GO:0004842; GO:0005737; GO:0008270; GO:0016567; GO:0036464 protein ubiquitination [GO:0016567] cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464] ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] g39.t1 Q96DM1 24.955 553 1.2e-34 144.0 sp|Q96DM1|PGBD4_HUMAN PiggyBac transposable element-derived protein 4 OS=Homo sapiens OX=9606 GN=PGBD4 PE=1 SV=3 g41.t1 Q9BRZ2 26.523 279 7.26e-24 106.0 sp|Q9BRZ2|TRI56_HUMAN E3 ubiquitin-protein ligase TRIM56 OS=Homo sapiens OX=9606 GN=TRIM56 PE=1 SV=3 g44.t1 E1BD59 24.586 362 3.98e-26 115.0 sp|E1BD59|TRI56_BOVIN E3 ubiquitin-protein ligase TRIM56 OS=Bos taurus OX=9913 GN=TRIM56 PE=2 SV=1 TRI56_BOVIN reviewed E3 ubiquitin-protein ligase TRIM56 (EC 2.3.2.27) (Tripartite motif-containing protein 56) Bos taurus (Bovine) GO:0005654; GO:0005737; GO:0006513; GO:0008270; GO:0032728; GO:0034340; GO:0045087; GO:0051607; GO:0060340; GO:0061630; GO:0070534 defense response to virus [GO:0051607]; innate immune response [GO:0045087]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of type I interferon-mediated signaling pathway [GO:0060340]; protein K63-linked ubiquitination [GO:0070534]; protein monoubiquitination [GO:0006513]; response to type I interferon [GO:0034340] cytoplasm [GO:0005737]; nucleoplasm [GO:0005654] ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] g53.t1 E1BD59 26.165 279 1.03e-23 110.0 sp|E1BD59|TRI56_BOVIN E3 ubiquitin-protein ligase TRIM56 OS=Bos taurus OX=9913 GN=TRIM56 PE=2 SV=1 TRI56_BOVIN reviewed E3 ubiquitin-protein ligase TRIM56 (EC 2.3.2.27) (Tripartite motif-containing protein 56) Bos taurus (Bovine) GO:0005654; GO:0005737; GO:0006513; GO:0008270; GO:0032728; GO:0034340; GO:0045087; GO:0051607; GO:0060340; GO:0061630; GO:0070534 defense response to virus [GO:0051607]; innate immune response [GO:0045087]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of type I interferon-mediated signaling pathway [GO:0060340]; protein K63-linked ubiquitination [GO:0070534]; protein monoubiquitination [GO:0006513]; response to type I interferon [GO:0034340] cytoplasm [GO:0005737]; nucleoplasm [GO:0005654] ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] g58.t1 Q9UBS5 31.384 701 7.38e-91 314.0 sp|Q9UBS5|GABR1_HUMAN Gamma-aminobutyric acid type B receptor subunit 1 OS=Homo sapiens OX=9606 GN=GABBR1 PE=1 SV=1 GABR1_HUMAN reviewed Gamma-aminobutyric acid type B receptor subunit 1 (GABA-B receptor 1) (GABA-B-R1) (GABA-BR1) (GABABR1) (Gb1) Homo sapiens (Human) GO:0001649; GO:0004965; GO:0005615; GO:0005789; GO:0005886; GO:0007193; GO:0007214; GO:0008021; GO:0008285; GO:0014049; GO:0014053; GO:0030673; GO:0031966; GO:0032811; GO:0033602; GO:0035094; GO:0038039; GO:0042734; GO:0043025; GO:0043197; GO:0043198; GO:0045211; GO:0045471; GO:0046982; GO:0050805; GO:0051932; GO:0060124; GO:0098685; GO:0098978; GO:0098982; GO:0099579; GO:0150047; GO:0150099; GO:1902712; GO:1990430 adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; gamma-aminobutyric acid signaling pathway [GO:0007214]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of dopamine secretion [GO:0033602]; negative regulation of epinephrine secretion [GO:0032811]; negative regulation of gamma-aminobutyric acid secretion [GO:0014053]; negative regulation of synaptic transmission [GO:0050805]; neuron-glial cell signaling [GO:0150099]; osteoblast differentiation [GO:0001649]; positive regulation of glutamate secretion [GO:0014049]; positive regulation of growth hormone secretion [GO:0060124]; response to ethanol [GO:0045471]; response to nicotine [GO:0035094]; synaptic transmission, GABAergic [GO:0051932] axolemma [GO:0030673]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; endoplasmic reticulum membrane [GO:0005789]; extracellular space [GO:0005615]; G protein-coupled GABA receptor complex [GO:1902712]; G protein-coupled receptor heterodimeric complex [GO:0038039]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; mitochondrial membrane [GO:0031966]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; Schaffer collateral - CA1 synapse [GO:0098685]; synaptic vesicle [GO:0008021] extracellular matrix protein binding [GO:1990430]; G protein-coupled GABA receptor activity [GO:0004965]; G protein-coupled neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential [GO:0099579]; G protein-coupled neurotransmitter receptor activity involved in regulation of presynaptic membrane potential [GO:0150047]; protein heterodimerization activity [GO:0046982] g59.t1 D3ZHV2 55.385 455 2.27e-164 525.0 sp|D3ZHV2|MACF1_RAT Microtubule-actin cross-linking factor 1 OS=Rattus norvegicus OX=10116 GN=Macf1 PE=1 SV=1 MACF1_RAT reviewed Microtubule-actin cross-linking factor 1 (Actin cross-linking family 7) Rattus norvegicus (Rat) GO:0001707; GO:0003779; GO:0005198; GO:0005509; GO:0005737; GO:0005794; GO:0005874; GO:0005886; GO:0006620; GO:0007163; GO:0008017; GO:0010632; GO:0014069; GO:0015629; GO:0015630; GO:0016020; GO:0016055; GO:0016477; GO:0016887; GO:0030054; GO:0030177; GO:0030334; GO:0032587; GO:0032886; GO:0036064; GO:0042060; GO:0043001; GO:0045104; GO:0045773; GO:0051011; GO:0051015; GO:0051893; GO:0150011 cell migration [GO:0016477]; establishment or maintenance of cell polarity [GO:0007163]; Golgi to plasma membrane protein transport [GO:0043001]; intermediate filament cytoskeleton organization [GO:0045104]; mesoderm formation [GO:0001707]; positive regulation of axon extension [GO:0045773]; positive regulation of Wnt signaling pathway [GO:0030177]; post-translational protein targeting to endoplasmic reticulum membrane [GO:0006620]; regulation of cell migration [GO:0030334]; regulation of epithelial cell migration [GO:0010632]; regulation of focal adhesion assembly [GO:0051893]; regulation of microtubule-based process [GO:0032886]; regulation of neuron projection arborization [GO:0150011]; Wnt signaling pathway [GO:0016055]; wound healing [GO:0042060] actin cytoskeleton [GO:0015629]; cell junction [GO:0030054]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; ruffle membrane [GO:0032587] actin binding [GO:0003779]; actin filament binding [GO:0051015]; ATP hydrolysis activity [GO:0016887]; calcium ion binding [GO:0005509]; microtubule binding [GO:0008017]; microtubule minus-end binding [GO:0051011]; structural molecule activity [GO:0005198] g60.t1 Q03001 32.669 2308 0.0 1250.0 sp|Q03001|DYST_HUMAN Dystonin OS=Homo sapiens OX=9606 GN=DST PE=1 SV=4 DYST_HUMAN reviewed Dystonin (230 kDa bullous pemphigoid antigen) (230/240 kDa bullous pemphigoid antigen) (Bullous pemphigoid antigen 1) (BPA) (Bullous pemphigoid antigen) (Dystonia musculorum protein) (Hemidesmosomal plaque protein) Homo sapiens (Human) GO:0000226; GO:0001725; GO:0003779; GO:0005178; GO:0005198; GO:0005509; GO:0005604; GO:0005634; GO:0005635; GO:0005654; GO:0005737; GO:0005789; GO:0005829; GO:0005882; GO:0005925; GO:0005938; GO:0007010; GO:0007155; GO:0007229; GO:0008017; GO:0008090; GO:0009611; GO:0009925; GO:0015629; GO:0015630; GO:0016020; GO:0030011; GO:0030018; GO:0030056; GO:0030424; GO:0031252; GO:0031410; GO:0031581; GO:0031673; GO:0035371; GO:0042060; GO:0042803; GO:0045104; GO:0045111; GO:0048870; GO:0051010; GO:1904115 cell adhesion [GO:0007155]; cell motility [GO:0048870]; cytoskeleton organization [GO:0007010]; hemidesmosome assembly [GO:0031581]; integrin-mediated signaling pathway [GO:0007229]; intermediate filament cytoskeleton organization [GO:0045104]; maintenance of cell polarity [GO:0030011]; microtubule cytoskeleton organization [GO:0000226]; response to wounding [GO:0009611]; retrograde axonal transport [GO:0008090]; wound healing [GO:0042060] actin cytoskeleton [GO:0015629]; axon [GO:0030424]; axon cytoplasm [GO:1904115]; basal plasma membrane [GO:0009925]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; focal adhesion [GO:0005925]; H zone [GO:0031673]; hemidesmosome [GO:0030056]; intermediate filament [GO:0005882]; intermediate filament cytoskeleton [GO:0045111]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; microtubule plus-end [GO:0035371]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; stress fiber [GO:0001725]; Z disc [GO:0030018] actin binding [GO:0003779]; calcium ion binding [GO:0005509]; integrin binding [GO:0005178]; microtubule binding [GO:0008017]; microtubule plus-end binding [GO:0051010]; protein homodimerization activity [GO:0042803]; structural molecule activity [GO:0005198] g60.t1 Q03001 20.68 2384 9.390000000000001e-99 362.0 sp|Q03001|DYST_HUMAN Dystonin OS=Homo sapiens OX=9606 GN=DST PE=1 SV=4 DYST_HUMAN reviewed Dystonin (230 kDa bullous pemphigoid antigen) (230/240 kDa bullous pemphigoid antigen) (Bullous pemphigoid antigen 1) (BPA) (Bullous pemphigoid antigen) (Dystonia musculorum protein) (Hemidesmosomal plaque protein) Homo sapiens (Human) GO:0000226; GO:0001725; GO:0003779; GO:0005178; GO:0005198; GO:0005509; GO:0005604; GO:0005634; GO:0005635; GO:0005654; GO:0005737; GO:0005789; GO:0005829; GO:0005882; GO:0005925; GO:0005938; GO:0007010; GO:0007155; GO:0007229; GO:0008017; GO:0008090; GO:0009611; GO:0009925; GO:0015629; GO:0015630; GO:0016020; GO:0030011; GO:0030018; GO:0030056; GO:0030424; GO:0031252; GO:0031410; GO:0031581; GO:0031673; GO:0035371; GO:0042060; GO:0042803; GO:0045104; GO:0045111; GO:0048870; GO:0051010; GO:1904115 cell adhesion [GO:0007155]; cell motility [GO:0048870]; cytoskeleton organization [GO:0007010]; hemidesmosome assembly [GO:0031581]; integrin-mediated signaling pathway [GO:0007229]; intermediate filament cytoskeleton organization [GO:0045104]; maintenance of cell polarity [GO:0030011]; microtubule cytoskeleton organization [GO:0000226]; response to wounding [GO:0009611]; retrograde axonal transport [GO:0008090]; wound healing [GO:0042060] actin cytoskeleton [GO:0015629]; axon [GO:0030424]; axon cytoplasm [GO:1904115]; basal plasma membrane [GO:0009925]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; focal adhesion [GO:0005925]; H zone [GO:0031673]; hemidesmosome [GO:0030056]; intermediate filament [GO:0005882]; intermediate filament cytoskeleton [GO:0045111]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; microtubule plus-end [GO:0035371]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; stress fiber [GO:0001725]; Z disc [GO:0030018] actin binding [GO:0003779]; calcium ion binding [GO:0005509]; integrin binding [GO:0005178]; microtubule binding [GO:0008017]; microtubule plus-end binding [GO:0051010]; protein homodimerization activity [GO:0042803]; structural molecule activity [GO:0005198] g60.t1 Q03001 20.664 2318 1.4e-83 312.0 sp|Q03001|DYST_HUMAN Dystonin OS=Homo sapiens OX=9606 GN=DST PE=1 SV=4 DYST_HUMAN reviewed Dystonin (230 kDa bullous pemphigoid antigen) (230/240 kDa bullous pemphigoid antigen) (Bullous pemphigoid antigen 1) (BPA) (Bullous pemphigoid antigen) (Dystonia musculorum protein) (Hemidesmosomal plaque protein) Homo sapiens (Human) GO:0000226; GO:0001725; GO:0003779; GO:0005178; GO:0005198; GO:0005509; GO:0005604; GO:0005634; GO:0005635; GO:0005654; GO:0005737; GO:0005789; GO:0005829; GO:0005882; GO:0005925; GO:0005938; GO:0007010; GO:0007155; GO:0007229; GO:0008017; GO:0008090; GO:0009611; GO:0009925; GO:0015629; GO:0015630; GO:0016020; GO:0030011; GO:0030018; GO:0030056; GO:0030424; GO:0031252; GO:0031410; GO:0031581; GO:0031673; GO:0035371; GO:0042060; GO:0042803; GO:0045104; GO:0045111; GO:0048870; GO:0051010; GO:1904115 cell adhesion [GO:0007155]; cell motility [GO:0048870]; cytoskeleton organization [GO:0007010]; hemidesmosome assembly [GO:0031581]; integrin-mediated signaling pathway [GO:0007229]; intermediate filament cytoskeleton organization [GO:0045104]; maintenance of cell polarity [GO:0030011]; microtubule cytoskeleton organization [GO:0000226]; response to wounding [GO:0009611]; retrograde axonal transport [GO:0008090]; wound healing [GO:0042060] actin cytoskeleton [GO:0015629]; axon [GO:0030424]; axon cytoplasm [GO:1904115]; basal plasma membrane [GO:0009925]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; focal adhesion [GO:0005925]; H zone [GO:0031673]; hemidesmosome [GO:0030056]; intermediate filament [GO:0005882]; intermediate filament cytoskeleton [GO:0045111]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; microtubule plus-end [GO:0035371]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; stress fiber [GO:0001725]; Z disc [GO:0030018] actin binding [GO:0003779]; calcium ion binding [GO:0005509]; integrin binding [GO:0005178]; microtubule binding [GO:0008017]; microtubule plus-end binding [GO:0051010]; protein homodimerization activity [GO:0042803]; structural molecule activity [GO:0005198] g60.t1 Q03001 20.2 2203 9.93e-79 296.0 sp|Q03001|DYST_HUMAN Dystonin OS=Homo sapiens OX=9606 GN=DST PE=1 SV=4 DYST_HUMAN reviewed Dystonin (230 kDa bullous pemphigoid antigen) (230/240 kDa bullous pemphigoid antigen) (Bullous pemphigoid antigen 1) (BPA) (Bullous pemphigoid antigen) (Dystonia musculorum protein) (Hemidesmosomal plaque protein) Homo sapiens (Human) GO:0000226; GO:0001725; GO:0003779; GO:0005178; GO:0005198; GO:0005509; GO:0005604; GO:0005634; GO:0005635; GO:0005654; GO:0005737; GO:0005789; GO:0005829; GO:0005882; GO:0005925; GO:0005938; GO:0007010; GO:0007155; GO:0007229; GO:0008017; GO:0008090; GO:0009611; GO:0009925; GO:0015629; GO:0015630; GO:0016020; GO:0030011; GO:0030018; GO:0030056; GO:0030424; GO:0031252; GO:0031410; GO:0031581; GO:0031673; GO:0035371; GO:0042060; GO:0042803; GO:0045104; GO:0045111; GO:0048870; GO:0051010; GO:1904115 cell adhesion [GO:0007155]; cell motility [GO:0048870]; cytoskeleton organization [GO:0007010]; hemidesmosome assembly [GO:0031581]; integrin-mediated signaling pathway [GO:0007229]; intermediate filament cytoskeleton organization [GO:0045104]; maintenance of cell polarity [GO:0030011]; microtubule cytoskeleton organization [GO:0000226]; response to wounding [GO:0009611]; retrograde axonal transport [GO:0008090]; wound healing [GO:0042060] actin cytoskeleton [GO:0015629]; axon [GO:0030424]; axon cytoplasm [GO:1904115]; basal plasma membrane [GO:0009925]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; focal adhesion [GO:0005925]; H zone [GO:0031673]; hemidesmosome [GO:0030056]; intermediate filament [GO:0005882]; intermediate filament cytoskeleton [GO:0045111]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; microtubule plus-end [GO:0035371]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; stress fiber [GO:0001725]; Z disc [GO:0030018] actin binding [GO:0003779]; calcium ion binding [GO:0005509]; integrin binding [GO:0005178]; microtubule binding [GO:0008017]; microtubule plus-end binding [GO:0051010]; protein homodimerization activity [GO:0042803]; structural molecule activity [GO:0005198] g60.t1 Q03001 19.568 2315 3.1299999999999997e-55 219.0 sp|Q03001|DYST_HUMAN Dystonin OS=Homo sapiens OX=9606 GN=DST PE=1 SV=4 DYST_HUMAN reviewed Dystonin (230 kDa bullous pemphigoid antigen) (230/240 kDa bullous pemphigoid antigen) (Bullous pemphigoid antigen 1) (BPA) (Bullous pemphigoid antigen) (Dystonia musculorum protein) (Hemidesmosomal plaque protein) Homo sapiens (Human) GO:0000226; GO:0001725; GO:0003779; GO:0005178; GO:0005198; GO:0005509; GO:0005604; GO:0005634; GO:0005635; GO:0005654; GO:0005737; GO:0005789; GO:0005829; GO:0005882; GO:0005925; GO:0005938; GO:0007010; GO:0007155; GO:0007229; GO:0008017; GO:0008090; GO:0009611; GO:0009925; GO:0015629; GO:0015630; GO:0016020; GO:0030011; GO:0030018; GO:0030056; GO:0030424; GO:0031252; GO:0031410; GO:0031581; GO:0031673; GO:0035371; GO:0042060; GO:0042803; GO:0045104; GO:0045111; GO:0048870; GO:0051010; GO:1904115 cell adhesion [GO:0007155]; cell motility [GO:0048870]; cytoskeleton organization [GO:0007010]; hemidesmosome assembly [GO:0031581]; integrin-mediated signaling pathway [GO:0007229]; intermediate filament cytoskeleton organization [GO:0045104]; maintenance of cell polarity [GO:0030011]; microtubule cytoskeleton organization [GO:0000226]; response to wounding [GO:0009611]; retrograde axonal transport [GO:0008090]; wound healing [GO:0042060] actin cytoskeleton [GO:0015629]; axon [GO:0030424]; axon cytoplasm [GO:1904115]; basal plasma membrane [GO:0009925]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; focal adhesion [GO:0005925]; H zone [GO:0031673]; hemidesmosome [GO:0030056]; intermediate filament [GO:0005882]; intermediate filament cytoskeleton [GO:0045111]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; microtubule plus-end [GO:0035371]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; stress fiber [GO:0001725]; Z disc [GO:0030018] actin binding [GO:0003779]; calcium ion binding [GO:0005509]; integrin binding [GO:0005178]; microtubule binding [GO:0008017]; microtubule plus-end binding [GO:0051010]; protein homodimerization activity [GO:0042803]; structural molecule activity [GO:0005198] g63.t1 Q03001 24.726 639 1.93e-51 206.0 sp|Q03001|DYST_HUMAN Dystonin OS=Homo sapiens OX=9606 GN=DST PE=1 SV=4 DYST_HUMAN reviewed Dystonin (230 kDa bullous pemphigoid antigen) (230/240 kDa bullous pemphigoid antigen) (Bullous pemphigoid antigen 1) (BPA) (Bullous pemphigoid antigen) (Dystonia musculorum protein) (Hemidesmosomal plaque protein) Homo sapiens (Human) GO:0000226; GO:0001725; GO:0003779; GO:0005178; GO:0005198; GO:0005509; GO:0005604; GO:0005634; GO:0005635; GO:0005654; GO:0005737; GO:0005789; GO:0005829; GO:0005882; GO:0005925; GO:0005938; GO:0007010; GO:0007155; GO:0007229; GO:0008017; GO:0008090; GO:0009611; GO:0009925; GO:0015629; GO:0015630; GO:0016020; GO:0030011; GO:0030018; GO:0030056; GO:0030424; GO:0031252; GO:0031410; GO:0031581; GO:0031673; GO:0035371; GO:0042060; GO:0042803; GO:0045104; GO:0045111; GO:0048870; GO:0051010; GO:1904115 cell adhesion [GO:0007155]; cell motility [GO:0048870]; cytoskeleton organization [GO:0007010]; hemidesmosome assembly [GO:0031581]; integrin-mediated signaling pathway [GO:0007229]; intermediate filament cytoskeleton organization [GO:0045104]; maintenance of cell polarity [GO:0030011]; microtubule cytoskeleton organization [GO:0000226]; response to wounding [GO:0009611]; retrograde axonal transport [GO:0008090]; wound healing [GO:0042060] actin cytoskeleton [GO:0015629]; axon [GO:0030424]; axon cytoplasm [GO:1904115]; basal plasma membrane [GO:0009925]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; focal adhesion [GO:0005925]; H zone [GO:0031673]; hemidesmosome [GO:0030056]; intermediate filament [GO:0005882]; intermediate filament cytoskeleton [GO:0045111]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; microtubule plus-end [GO:0035371]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; stress fiber [GO:0001725]; Z disc [GO:0030018] actin binding [GO:0003779]; calcium ion binding [GO:0005509]; integrin binding [GO:0005178]; microtubule binding [GO:0008017]; microtubule plus-end binding [GO:0051010]; protein homodimerization activity [GO:0042803]; structural molecule activity [GO:0005198] g63.t1 Q03001 23.597 695 5.07e-36 155.0 sp|Q03001|DYST_HUMAN Dystonin OS=Homo sapiens OX=9606 GN=DST PE=1 SV=4 DYST_HUMAN reviewed Dystonin (230 kDa bullous pemphigoid antigen) (230/240 kDa bullous pemphigoid antigen) (Bullous pemphigoid antigen 1) (BPA) (Bullous pemphigoid antigen) (Dystonia musculorum protein) (Hemidesmosomal plaque protein) Homo sapiens (Human) GO:0000226; GO:0001725; GO:0003779; GO:0005178; GO:0005198; GO:0005509; GO:0005604; GO:0005634; GO:0005635; GO:0005654; GO:0005737; GO:0005789; GO:0005829; GO:0005882; GO:0005925; GO:0005938; GO:0007010; GO:0007155; GO:0007229; GO:0008017; GO:0008090; GO:0009611; GO:0009925; GO:0015629; GO:0015630; GO:0016020; GO:0030011; GO:0030018; GO:0030056; GO:0030424; GO:0031252; GO:0031410; GO:0031581; GO:0031673; GO:0035371; GO:0042060; GO:0042803; GO:0045104; GO:0045111; GO:0048870; GO:0051010; GO:1904115 cell adhesion [GO:0007155]; cell motility [GO:0048870]; cytoskeleton organization [GO:0007010]; hemidesmosome assembly [GO:0031581]; integrin-mediated signaling pathway [GO:0007229]; intermediate filament cytoskeleton organization [GO:0045104]; maintenance of cell polarity [GO:0030011]; microtubule cytoskeleton organization [GO:0000226]; response to wounding [GO:0009611]; retrograde axonal transport [GO:0008090]; wound healing [GO:0042060] actin cytoskeleton [GO:0015629]; axon [GO:0030424]; axon cytoplasm [GO:1904115]; basal plasma membrane [GO:0009925]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; focal adhesion [GO:0005925]; H zone [GO:0031673]; hemidesmosome [GO:0030056]; intermediate filament [GO:0005882]; intermediate filament cytoskeleton [GO:0045111]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; microtubule plus-end [GO:0035371]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; stress fiber [GO:0001725]; Z disc [GO:0030018] actin binding [GO:0003779]; calcium ion binding [GO:0005509]; integrin binding [GO:0005178]; microtubule binding [GO:0008017]; microtubule plus-end binding [GO:0051010]; protein homodimerization activity [GO:0042803]; structural molecule activity [GO:0005198] g63.t1 Q03001 21.361 1264 5.03e-33 145.0 sp|Q03001|DYST_HUMAN Dystonin OS=Homo sapiens OX=9606 GN=DST PE=1 SV=4 DYST_HUMAN reviewed Dystonin (230 kDa bullous pemphigoid antigen) (230/240 kDa bullous pemphigoid antigen) (Bullous pemphigoid antigen 1) (BPA) (Bullous pemphigoid antigen) (Dystonia musculorum protein) (Hemidesmosomal plaque protein) Homo sapiens (Human) GO:0000226; GO:0001725; GO:0003779; GO:0005178; GO:0005198; GO:0005509; GO:0005604; GO:0005634; GO:0005635; GO:0005654; GO:0005737; GO:0005789; GO:0005829; GO:0005882; GO:0005925; GO:0005938; GO:0007010; GO:0007155; GO:0007229; GO:0008017; GO:0008090; GO:0009611; GO:0009925; GO:0015629; GO:0015630; GO:0016020; GO:0030011; GO:0030018; GO:0030056; GO:0030424; GO:0031252; GO:0031410; GO:0031581; GO:0031673; GO:0035371; GO:0042060; GO:0042803; GO:0045104; GO:0045111; GO:0048870; GO:0051010; GO:1904115 cell adhesion [GO:0007155]; cell motility [GO:0048870]; cytoskeleton organization [GO:0007010]; hemidesmosome assembly [GO:0031581]; integrin-mediated signaling pathway [GO:0007229]; intermediate filament cytoskeleton organization [GO:0045104]; maintenance of cell polarity [GO:0030011]; microtubule cytoskeleton organization [GO:0000226]; response to wounding [GO:0009611]; retrograde axonal transport [GO:0008090]; wound healing [GO:0042060] actin cytoskeleton [GO:0015629]; axon [GO:0030424]; axon cytoplasm [GO:1904115]; basal plasma membrane [GO:0009925]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; focal adhesion [GO:0005925]; H zone [GO:0031673]; hemidesmosome [GO:0030056]; intermediate filament [GO:0005882]; intermediate filament cytoskeleton [GO:0045111]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; microtubule plus-end [GO:0035371]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; stress fiber [GO:0001725]; Z disc [GO:0030018] actin binding [GO:0003779]; calcium ion binding [GO:0005509]; integrin binding [GO:0005178]; microtubule binding [GO:0008017]; microtubule plus-end binding [GO:0051010]; protein homodimerization activity [GO:0042803]; structural molecule activity [GO:0005198] g63.t1 Q03001 22.894 926 1.9699999999999999e-28 130.0 sp|Q03001|DYST_HUMAN Dystonin OS=Homo sapiens OX=9606 GN=DST PE=1 SV=4 DYST_HUMAN reviewed Dystonin (230 kDa bullous pemphigoid antigen) (230/240 kDa bullous pemphigoid antigen) (Bullous pemphigoid antigen 1) (BPA) (Bullous pemphigoid antigen) (Dystonia musculorum protein) (Hemidesmosomal plaque protein) Homo sapiens (Human) GO:0000226; GO:0001725; GO:0003779; GO:0005178; GO:0005198; GO:0005509; GO:0005604; GO:0005634; GO:0005635; GO:0005654; GO:0005737; GO:0005789; GO:0005829; GO:0005882; GO:0005925; GO:0005938; GO:0007010; GO:0007155; GO:0007229; GO:0008017; GO:0008090; GO:0009611; GO:0009925; GO:0015629; GO:0015630; GO:0016020; GO:0030011; GO:0030018; GO:0030056; GO:0030424; GO:0031252; GO:0031410; GO:0031581; GO:0031673; GO:0035371; GO:0042060; GO:0042803; GO:0045104; GO:0045111; GO:0048870; GO:0051010; GO:1904115 cell adhesion [GO:0007155]; cell motility [GO:0048870]; cytoskeleton organization [GO:0007010]; hemidesmosome assembly [GO:0031581]; integrin-mediated signaling pathway [GO:0007229]; intermediate filament cytoskeleton organization [GO:0045104]; maintenance of cell polarity [GO:0030011]; microtubule cytoskeleton organization [GO:0000226]; response to wounding [GO:0009611]; retrograde axonal transport [GO:0008090]; wound healing [GO:0042060] actin cytoskeleton [GO:0015629]; axon [GO:0030424]; axon cytoplasm [GO:1904115]; basal plasma membrane [GO:0009925]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; focal adhesion [GO:0005925]; H zone [GO:0031673]; hemidesmosome [GO:0030056]; intermediate filament [GO:0005882]; intermediate filament cytoskeleton [GO:0045111]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; microtubule plus-end [GO:0035371]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; stress fiber [GO:0001725]; Z disc [GO:0030018] actin binding [GO:0003779]; calcium ion binding [GO:0005509]; integrin binding [GO:0005178]; microtubule binding [GO:0008017]; microtubule plus-end binding [GO:0051010]; protein homodimerization activity [GO:0042803]; structural molecule activity [GO:0005198] g63.t1 Q03001 20.0 1110 1.03e-24 117.0 sp|Q03001|DYST_HUMAN Dystonin OS=Homo sapiens OX=9606 GN=DST PE=1 SV=4 DYST_HUMAN reviewed Dystonin (230 kDa bullous pemphigoid antigen) (230/240 kDa bullous pemphigoid antigen) (Bullous pemphigoid antigen 1) (BPA) (Bullous pemphigoid antigen) (Dystonia musculorum protein) (Hemidesmosomal plaque protein) Homo sapiens (Human) GO:0000226; GO:0001725; GO:0003779; GO:0005178; GO:0005198; GO:0005509; GO:0005604; GO:0005634; GO:0005635; GO:0005654; GO:0005737; GO:0005789; GO:0005829; GO:0005882; GO:0005925; GO:0005938; GO:0007010; GO:0007155; GO:0007229; GO:0008017; GO:0008090; GO:0009611; GO:0009925; GO:0015629; GO:0015630; GO:0016020; GO:0030011; GO:0030018; GO:0030056; GO:0030424; GO:0031252; GO:0031410; GO:0031581; GO:0031673; GO:0035371; GO:0042060; GO:0042803; GO:0045104; GO:0045111; GO:0048870; GO:0051010; GO:1904115 cell adhesion [GO:0007155]; cell motility [GO:0048870]; cytoskeleton organization [GO:0007010]; hemidesmosome assembly [GO:0031581]; integrin-mediated signaling pathway [GO:0007229]; intermediate filament cytoskeleton organization [GO:0045104]; maintenance of cell polarity [GO:0030011]; microtubule cytoskeleton organization [GO:0000226]; response to wounding [GO:0009611]; retrograde axonal transport [GO:0008090]; wound healing [GO:0042060] actin cytoskeleton [GO:0015629]; axon [GO:0030424]; axon cytoplasm [GO:1904115]; basal plasma membrane [GO:0009925]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; focal adhesion [GO:0005925]; H zone [GO:0031673]; hemidesmosome [GO:0030056]; intermediate filament [GO:0005882]; intermediate filament cytoskeleton [GO:0045111]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; microtubule plus-end [GO:0035371]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; stress fiber [GO:0001725]; Z disc [GO:0030018] actin binding [GO:0003779]; calcium ion binding [GO:0005509]; integrin binding [GO:0005178]; microtubule binding [GO:0008017]; microtubule plus-end binding [GO:0051010]; protein homodimerization activity [GO:0042803]; structural molecule activity [GO:0005198] g63.t1 Q03001 20.22 910 1.1e-23 114.0 sp|Q03001|DYST_HUMAN Dystonin OS=Homo sapiens OX=9606 GN=DST PE=1 SV=4 DYST_HUMAN reviewed Dystonin (230 kDa bullous pemphigoid antigen) (230/240 kDa bullous pemphigoid antigen) (Bullous pemphigoid antigen 1) (BPA) (Bullous pemphigoid antigen) (Dystonia musculorum protein) (Hemidesmosomal plaque protein) Homo sapiens (Human) GO:0000226; GO:0001725; GO:0003779; GO:0005178; GO:0005198; GO:0005509; GO:0005604; GO:0005634; GO:0005635; GO:0005654; GO:0005737; GO:0005789; GO:0005829; GO:0005882; GO:0005925; GO:0005938; GO:0007010; GO:0007155; GO:0007229; GO:0008017; GO:0008090; GO:0009611; GO:0009925; GO:0015629; GO:0015630; GO:0016020; GO:0030011; GO:0030018; GO:0030056; GO:0030424; GO:0031252; GO:0031410; GO:0031581; GO:0031673; GO:0035371; GO:0042060; GO:0042803; GO:0045104; GO:0045111; GO:0048870; GO:0051010; GO:1904115 cell adhesion [GO:0007155]; cell motility [GO:0048870]; cytoskeleton organization [GO:0007010]; hemidesmosome assembly [GO:0031581]; integrin-mediated signaling pathway [GO:0007229]; intermediate filament cytoskeleton organization [GO:0045104]; maintenance of cell polarity [GO:0030011]; microtubule cytoskeleton organization [GO:0000226]; response to wounding [GO:0009611]; retrograde axonal transport [GO:0008090]; wound healing [GO:0042060] actin cytoskeleton [GO:0015629]; axon [GO:0030424]; axon cytoplasm [GO:1904115]; basal plasma membrane [GO:0009925]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; focal adhesion [GO:0005925]; H zone [GO:0031673]; hemidesmosome [GO:0030056]; intermediate filament [GO:0005882]; intermediate filament cytoskeleton [GO:0045111]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; microtubule plus-end [GO:0035371]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; stress fiber [GO:0001725]; Z disc [GO:0030018] actin binding [GO:0003779]; calcium ion binding [GO:0005509]; integrin binding [GO:0005178]; microtubule binding [GO:0008017]; microtubule plus-end binding [GO:0051010]; protein homodimerization activity [GO:0042803]; structural molecule activity [GO:0005198] g63.t1 Q03001 23.182 440 4.72e-22 109.0 sp|Q03001|DYST_HUMAN Dystonin OS=Homo sapiens OX=9606 GN=DST PE=1 SV=4 DYST_HUMAN reviewed Dystonin (230 kDa bullous pemphigoid antigen) (230/240 kDa bullous pemphigoid antigen) (Bullous pemphigoid antigen 1) (BPA) (Bullous pemphigoid antigen) (Dystonia musculorum protein) (Hemidesmosomal plaque protein) Homo sapiens (Human) GO:0000226; GO:0001725; GO:0003779; GO:0005178; GO:0005198; GO:0005509; GO:0005604; GO:0005634; GO:0005635; GO:0005654; GO:0005737; GO:0005789; GO:0005829; GO:0005882; GO:0005925; GO:0005938; GO:0007010; GO:0007155; GO:0007229; GO:0008017; GO:0008090; GO:0009611; GO:0009925; GO:0015629; GO:0015630; GO:0016020; GO:0030011; GO:0030018; GO:0030056; GO:0030424; GO:0031252; GO:0031410; GO:0031581; GO:0031673; GO:0035371; GO:0042060; GO:0042803; GO:0045104; GO:0045111; GO:0048870; GO:0051010; GO:1904115 cell adhesion [GO:0007155]; cell motility [GO:0048870]; cytoskeleton organization [GO:0007010]; hemidesmosome assembly [GO:0031581]; integrin-mediated signaling pathway [GO:0007229]; intermediate filament cytoskeleton organization [GO:0045104]; maintenance of cell polarity [GO:0030011]; microtubule cytoskeleton organization [GO:0000226]; response to wounding [GO:0009611]; retrograde axonal transport [GO:0008090]; wound healing [GO:0042060] actin cytoskeleton [GO:0015629]; axon [GO:0030424]; axon cytoplasm [GO:1904115]; basal plasma membrane [GO:0009925]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; focal adhesion [GO:0005925]; H zone [GO:0031673]; hemidesmosome [GO:0030056]; intermediate filament [GO:0005882]; intermediate filament cytoskeleton [GO:0045111]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; microtubule plus-end [GO:0035371]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; stress fiber [GO:0001725]; Z disc [GO:0030018] actin binding [GO:0003779]; calcium ion binding [GO:0005509]; integrin binding [GO:0005178]; microtubule binding [GO:0008017]; microtubule plus-end binding [GO:0051010]; protein homodimerization activity [GO:0042803]; structural molecule activity [GO:0005198] g63.t1 Q03001 20.082 981 8.18e-21 105.0 sp|Q03001|DYST_HUMAN Dystonin OS=Homo sapiens OX=9606 GN=DST PE=1 SV=4 DYST_HUMAN reviewed Dystonin (230 kDa bullous pemphigoid antigen) (230/240 kDa bullous pemphigoid antigen) (Bullous pemphigoid antigen 1) (BPA) (Bullous pemphigoid antigen) (Dystonia musculorum protein) (Hemidesmosomal plaque protein) Homo sapiens (Human) GO:0000226; GO:0001725; GO:0003779; GO:0005178; GO:0005198; GO:0005509; GO:0005604; GO:0005634; GO:0005635; GO:0005654; GO:0005737; GO:0005789; GO:0005829; GO:0005882; GO:0005925; GO:0005938; GO:0007010; GO:0007155; GO:0007229; GO:0008017; GO:0008090; GO:0009611; GO:0009925; GO:0015629; GO:0015630; GO:0016020; GO:0030011; GO:0030018; GO:0030056; GO:0030424; GO:0031252; GO:0031410; GO:0031581; GO:0031673; GO:0035371; GO:0042060; GO:0042803; GO:0045104; GO:0045111; GO:0048870; GO:0051010; GO:1904115 cell adhesion [GO:0007155]; cell motility [GO:0048870]; cytoskeleton organization [GO:0007010]; hemidesmosome assembly [GO:0031581]; integrin-mediated signaling pathway [GO:0007229]; intermediate filament cytoskeleton organization [GO:0045104]; maintenance of cell polarity [GO:0030011]; microtubule cytoskeleton organization [GO:0000226]; response to wounding [GO:0009611]; retrograde axonal transport [GO:0008090]; wound healing [GO:0042060] actin cytoskeleton [GO:0015629]; axon [GO:0030424]; axon cytoplasm [GO:1904115]; basal plasma membrane [GO:0009925]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; focal adhesion [GO:0005925]; H zone [GO:0031673]; hemidesmosome [GO:0030056]; intermediate filament [GO:0005882]; intermediate filament cytoskeleton [GO:0045111]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; microtubule plus-end [GO:0035371]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; stress fiber [GO:0001725]; Z disc [GO:0030018] actin binding [GO:0003779]; calcium ion binding [GO:0005509]; integrin binding [GO:0005178]; microtubule binding [GO:0008017]; microtubule plus-end binding [GO:0051010]; protein homodimerization activity [GO:0042803]; structural molecule activity [GO:0005198] g65.t1 Q91ZU6 24.11 618 1.14e-37 157.0 sp|Q91ZU6|DYST_MOUSE Dystonin OS=Mus musculus OX=10090 GN=Dst PE=1 SV=2 g67.t1 Q91ZU6 22.815 675 1.06e-30 136.0 sp|Q91ZU6|DYST_MOUSE Dystonin OS=Mus musculus OX=10090 GN=Dst PE=1 SV=2 g67.t2 D3ZHV2 20.877 661 4.11e-32 140.0 sp|D3ZHV2|MACF1_RAT Microtubule-actin cross-linking factor 1 OS=Rattus norvegicus OX=10116 GN=Macf1 PE=1 SV=1 MACF1_RAT reviewed Microtubule-actin cross-linking factor 1 (Actin cross-linking family 7) Rattus norvegicus (Rat) GO:0001707; GO:0003779; GO:0005198; GO:0005509; GO:0005737; GO:0005794; GO:0005874; GO:0005886; GO:0006620; GO:0007163; GO:0008017; GO:0010632; GO:0014069; GO:0015629; GO:0015630; GO:0016020; GO:0016055; GO:0016477; GO:0016887; GO:0030054; GO:0030177; GO:0030334; GO:0032587; GO:0032886; GO:0036064; GO:0042060; GO:0043001; GO:0045104; GO:0045773; GO:0051011; GO:0051015; GO:0051893; GO:0150011 cell migration [GO:0016477]; establishment or maintenance of cell polarity [GO:0007163]; Golgi to plasma membrane protein transport [GO:0043001]; intermediate filament cytoskeleton organization [GO:0045104]; mesoderm formation [GO:0001707]; positive regulation of axon extension [GO:0045773]; positive regulation of Wnt signaling pathway [GO:0030177]; post-translational protein targeting to endoplasmic reticulum membrane [GO:0006620]; regulation of cell migration [GO:0030334]; regulation of epithelial cell migration [GO:0010632]; regulation of focal adhesion assembly [GO:0051893]; regulation of microtubule-based process [GO:0032886]; regulation of neuron projection arborization [GO:0150011]; Wnt signaling pathway [GO:0016055]; wound healing [GO:0042060] actin cytoskeleton [GO:0015629]; cell junction [GO:0030054]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; ruffle membrane [GO:0032587] actin binding [GO:0003779]; actin filament binding [GO:0051015]; ATP hydrolysis activity [GO:0016887]; calcium ion binding [GO:0005509]; microtubule binding [GO:0008017]; microtubule minus-end binding [GO:0051011]; structural molecule activity [GO:0005198] g69.t1 Q91ZU6 24.886 659 6.17e-46 186.0 sp|Q91ZU6|DYST_MOUSE Dystonin OS=Mus musculus OX=10090 GN=Dst PE=1 SV=2 g69.t1 Q91ZU6 21.441 583 9.34e-24 114.0 sp|Q91ZU6|DYST_MOUSE Dystonin OS=Mus musculus OX=10090 GN=Dst PE=1 SV=2 g72.t1 Q91ZU6 22.953 806 8.61e-45 184.0 sp|Q91ZU6|DYST_MOUSE Dystonin OS=Mus musculus OX=10090 GN=Dst PE=1 SV=2 g72.t1 Q91ZU6 21.566 830 2.0699999999999998e-42 176.0 sp|Q91ZU6|DYST_MOUSE Dystonin OS=Mus musculus OX=10090 GN=Dst PE=1 SV=2 g72.t1 Q91ZU6 22.254 701 1.67e-41 174.0 sp|Q91ZU6|DYST_MOUSE Dystonin OS=Mus musculus OX=10090 GN=Dst PE=1 SV=2 g73.t1 Q9QXS1 34.769 929 2.2200000000000002e-154 545.0 sp|Q9QXS1|PLEC_MOUSE Plectin OS=Mus musculus OX=10090 GN=Plec PE=1 SV=3 g75.t1 Q05AY2 67.342 444 0.0 623.0 sp|Q05AY2|EI3EA_XENLA Eukaryotic translation initiation factor 3 subunit E-A OS=Xenopus laevis OX=8355 GN=eif3e-a PE=2 SV=1 g76.t1 E1B7X3 57.962 157 1.32e-57 196.0 sp|E1B7X3|R146A_BOVIN E3 ubiquitin-protein ligase RNF146-A OS=Bos taurus OX=9913 GN=RNF146A PE=3 SV=1 R146A_BOVIN reviewed E3 ubiquitin-protein ligase RNF146-A (EC 2.3.2.27) (RING finger protein 146-A) (RING-type E3 ubiquitin transferase RNF146-A) Bos taurus (Bovine) GO:0004842; GO:0005634; GO:0005737; GO:0005829; GO:0006511; GO:0008270; GO:0016055; GO:0051865; GO:0061630; GO:0070936; GO:0072572; GO:0090263 positive regulation of canonical Wnt signaling pathway [GO:0090263]; protein autoubiquitination [GO:0051865]; protein K48-linked ubiquitination [GO:0070936]; ubiquitin-dependent protein catabolic process [GO:0006511]; Wnt signaling pathway [GO:0016055] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634] poly-ADP-D-ribose binding [GO:0072572]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] g77.t1 Q2NL11 31.008 258 2.4600000000000002e-29 117.0 sp|Q2NL11|CH074_BOVIN Uncharacterized protein C8orf74 homolog OS=Bos taurus OX=9913 PE=2 SV=1 g78.t1 P45478 65.942 276 4.7699999999999997e-138 395.0 sp|P45478|PPT1_BOVIN Palmitoyl-protein thioesterase 1 OS=Bos taurus OX=9913 GN=PPT1 PE=1 SV=1 g80.t1 A0JMW6 36.196 489 1.5400000000000001e-105 335.0 sp|A0JMW6|T214A_XENLA Transmembrane protein 214-A OS=Xenopus laevis OX=8355 GN=tmem214-a PE=2 SV=1 g81.t1 Q9PWA0 66.917 133 2.9400000000000003e-64 202.0 sp|Q9PWA0|RGS17_CHICK Regulator of G-protein signaling 17 OS=Gallus gallus OX=9031 GN=RGS17 PE=2 SV=1 g83.t1 Q8K2L8 42.256 594 1.82e-133 420.0 sp|Q8K2L8|TPC12_MOUSE Trafficking protein particle complex subunit 12 OS=Mus musculus OX=10090 GN=Trappc12 PE=1 SV=2 g84.t1 D4A2Y9 59.414 239 2.05e-97 302.0 sp|D4A2Y9|PEX13_RAT Peroxisomal membrane protein PEX13 OS=Rattus norvegicus OX=10116 GN=Pex13 PE=1 SV=3 g85.t1 Q66JF1 71.277 94 1.37e-39 148.0 sp|Q66JF1|SOX11_XENTR Transcription factor Sox-11 OS=Xenopus tropicalis OX=8364 GN=sox11 PE=2 SV=1 g88.t1 A1ADJ6 65.934 91 5.62e-22 92.8 sp|A1ADJ6|NEUO_ECOK1 Polysialic acid O-acetyltransferase OS=Escherichia coli O1:K1 / APEC OX=405955 GN=neuO PE=1 SV=1 NEUO_ECOK1 reviewed Polysialic acid O-acetyltransferase (EC 2.3.1.136) (Capsule O-acetyl transferase) Escherichia coli O1:K1 / APEC GO:0050208 polysialic-acid O-acetyltransferase activity [GO:0050208] g88.t1 A1ADJ6 64.835 91 1.3700000000000002e-21 91.7 sp|A1ADJ6|NEUO_ECOK1 Polysialic acid O-acetyltransferase OS=Escherichia coli O1:K1 / APEC OX=405955 GN=neuO PE=1 SV=1 NEUO_ECOK1 reviewed Polysialic acid O-acetyltransferase (EC 2.3.1.136) (Capsule O-acetyl transferase) Escherichia coli O1:K1 / APEC GO:0050208 polysialic-acid O-acetyltransferase activity [GO:0050208] g89.t1 Q6NSM8 50.0 224 1.9e-60 221.0 sp|Q6NSM8|SIK3_DANRE Serine/threonine-protein kinase SIK3 homolog OS=Danio rerio OX=7955 GN=zgc:66101 PE=2 SV=1 SIK3_DANRE reviewed Serine/threonine-protein kinase SIK3 homolog (EC 2.7.11.1) (Serine/threonine-protein kinase QSK homolog) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000226; GO:0000287; GO:0004674; GO:0005524; GO:0005737; GO:0006468; GO:0035556; GO:0050321; GO:0106310 intracellular signal transduction [GO:0035556]; microtubule cytoskeleton organization [GO:0000226]; protein phosphorylation [GO:0006468] cytoplasm [GO:0005737] ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; tau-protein kinase activity [GO:0050321] g92.t1 Q9QXF7 48.319 238 6.07e-62 210.0 sp|Q9QXF7|CP2J4_RAT Cytochrome P450 2J4 OS=Rattus norvegicus OX=10116 GN=CYP2J4 PE=1 SV=1 g93.t1 Q9QXF7 38.248 468 4.97e-118 359.0 sp|Q9QXF7|CP2J4_RAT Cytochrome P450 2J4 OS=Rattus norvegicus OX=10116 GN=CYP2J4 PE=1 SV=1 g94.t1 Q6AYQ8 58.986 217 6.6e-84 251.0 sp|Q6AYQ8|FAHD1_RAT Oxaloacetate tautomerase FAHD1, mitochondrial OS=Rattus norvegicus OX=10116 GN=Fahd1 PE=1 SV=1 FAHD1_RAT reviewed Oxaloacetate tautomerase FAHD1, mitochondrial (EC 5.3.2.2) (Acylpyruvase FAHD1) (EC 3.7.1.5) (Fumarylacetoacetate hydrolase domain-containing protein 1) (Oxaloacetate decarboxylase) (OAA decarboxylase) (EC 4.1.1.112) Rattus norvegicus (Rat) GO:0005654; GO:0005739; GO:0005829; GO:0006107; GO:0008948; GO:0018773; GO:0034545; GO:0046872; GO:0047621; GO:0050163 oxaloacetate metabolic process [GO:0006107] cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654] acetylpyruvate hydrolase activity [GO:0018773]; acylpyruvate hydrolase activity [GO:0047621]; fumarylpyruvate hydrolase activity [GO:0034545]; metal ion binding [GO:0046872]; oxaloacetate decarboxylase activity [GO:0008948]; oxaloacetate tautomerase activity [GO:0050163] g97.t1 P40939 62.01 766 0.0 968.0 sp|P40939|ECHA_HUMAN Trifunctional enzyme subunit alpha, mitochondrial OS=Homo sapiens OX=9606 GN=HADHA PE=1 SV=2 ECHA_HUMAN reviewed Trifunctional enzyme subunit alpha, mitochondrial (78 kDa gastrin-binding protein) (Monolysocardiolipin acyltransferase) (MLCL AT) (EC 2.3.1.-) (TP-alpha) [Includes: Long-chain enoyl-CoA hydratase (EC 4.2.1.17); Long chain 3-hydroxyacyl-CoA dehydrogenase (EC 1.1.1.211)] Homo sapiens (Human) GO:0003857; GO:0003985; GO:0004300; GO:0005739; GO:0005743; GO:0006635; GO:0016507; GO:0016509; GO:0018812; GO:0032868; GO:0035965; GO:0042645; GO:0052816; GO:0070403 cardiolipin acyl-chain remodeling [GO:0035965]; fatty acid beta-oxidation [GO:0006635]; response to insulin [GO:0032868] mitochondrial fatty acid beta-oxidation multienzyme complex [GO:0016507]; mitochondrial inner membrane [GO:0005743]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739] (3S)-3-hydroxyacyl-CoA dehydrogenase (NAD+) activity [GO:0003857]; 3-hydroxyacyl-CoA dehydratase activity [GO:0018812]; acetyl-CoA C-acetyltransferase activity [GO:0003985]; enoyl-CoA hydratase activity [GO:0004300]; long-chain (3S)-3-hydroxyacyl-CoA dehydrogenase (NAD+) activity [GO:0016509]; long-chain fatty acyl-CoA hydrolase activity [GO:0052816]; NAD+ binding [GO:0070403] g98.t1 Q9NUQ2 41.935 372 1.73e-113 338.0 sp|Q9NUQ2|PLCE_HUMAN 1-acyl-sn-glycerol-3-phosphate acyltransferase epsilon OS=Homo sapiens OX=9606 GN=AGPAT5 PE=1 SV=3 PLCE_HUMAN reviewed 1-acyl-sn-glycerol-3-phosphate acyltransferase epsilon (EC 2.3.1.51) (1-acylglycerol-3-phosphate O-acyltransferase 5) (1-AGP acyltransferase 5) (1-AGPAT 5) (Lysophosphatidic acid acyltransferase epsilon) (LPAAT-epsilon) Homo sapiens (Human) GO:0002244; GO:0003841; GO:0005635; GO:0005730; GO:0005739; GO:0005741; GO:0005783; GO:0005789; GO:0006639; GO:0006654; GO:0008654; GO:0012505; GO:0016024; GO:0016746; GO:0036149 acylglycerol metabolic process [GO:0006639]; CDP-diacylglycerol biosynthetic process [GO:0016024]; hematopoietic progenitor cell differentiation [GO:0002244]; phosphatidic acid biosynthetic process [GO:0006654]; phosphatidylinositol acyl-chain remodeling [GO:0036149]; phospholipid biosynthetic process [GO:0008654] endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nuclear envelope [GO:0005635]; nucleolus [GO:0005730] 1-acylglycerol-3-phosphate O-acyltransferase activity [GO:0003841]; acyltransferase activity [GO:0016746] g99.t1 Q99JY0 71.918 438 0.0 616.0 sp|Q99JY0|ECHB_MOUSE Trifunctional enzyme subunit beta, mitochondrial OS=Mus musculus OX=10090 GN=Hadhb PE=1 SV=1 g102.t1 P56716 39.459 185 4.6e-30 120.0 sp|P56716|RP1_MOUSE Oxygen-regulated protein 1 OS=Mus musculus OX=10090 GN=Rp1 PE=1 SV=2 RP1_MOUSE reviewed Oxygen-regulated protein 1 (Retinitis pigmentosa RP1 protein homolog) Mus musculus (Mouse) GO:0001750; GO:0001917; GO:0005875; GO:0005929; GO:0005930; GO:0007026; GO:0007601; GO:0008017; GO:0032391; GO:0035082; GO:0035556; GO:0035845; GO:0042461; GO:0045494; GO:0046548; GO:0046549; GO:0046785; GO:0060041; GO:0060042; GO:0071482; GO:0097542; GO:0097733; GO:1902857 axoneme assembly [GO:0035082]; cellular response to light stimulus [GO:0071482]; intracellular signal transduction [GO:0035556]; microtubule polymerization [GO:0046785]; negative regulation of microtubule depolymerization [GO:0007026]; photoreceptor cell development [GO:0042461]; photoreceptor cell maintenance [GO:0045494]; photoreceptor cell outer segment organization [GO:0035845]; positive regulation of non-motile cilium assembly [GO:1902857]; retina development in camera-type eye [GO:0060041]; retina morphogenesis in camera-type eye [GO:0060042]; retinal cone cell development [GO:0046549]; retinal rod cell development [GO:0046548]; visual perception [GO:0007601] axoneme [GO:0005930]; ciliary tip [GO:0097542]; cilium [GO:0005929]; microtubule associated complex [GO:0005875]; photoreceptor cell cilium [GO:0097733]; photoreceptor connecting cilium [GO:0032391]; photoreceptor inner segment [GO:0001917]; photoreceptor outer segment [GO:0001750] microtubule binding [GO:0008017] g103.t1 Q8IVV2 28.42 943 9.979999999999999e-104 375.0 sp|Q8IVV2|LOXH1_HUMAN Lipoxygenase homology domain-containing protein 1 OS=Homo sapiens OX=9606 GN=LOXHD1 PE=2 SV=4 g103.t1 Q8IVV2 26.771 960 9.63e-91 333.0 sp|Q8IVV2|LOXH1_HUMAN Lipoxygenase homology domain-containing protein 1 OS=Homo sapiens OX=9606 GN=LOXHD1 PE=2 SV=4 g103.t1 Q8IVV2 26.956 946 3.44e-86 318.0 sp|Q8IVV2|LOXH1_HUMAN Lipoxygenase homology domain-containing protein 1 OS=Homo sapiens OX=9606 GN=LOXHD1 PE=2 SV=4 g103.t1 Q8IVV2 26.203 977 2.26e-83 309.0 sp|Q8IVV2|LOXH1_HUMAN Lipoxygenase homology domain-containing protein 1 OS=Homo sapiens OX=9606 GN=LOXHD1 PE=2 SV=4 g103.t1 Q8IVV2 25.099 1008 1.71e-74 280.0 sp|Q8IVV2|LOXH1_HUMAN Lipoxygenase homology domain-containing protein 1 OS=Homo sapiens OX=9606 GN=LOXHD1 PE=2 SV=4 g103.t1 Q8IVV2 28.0 675 3.6900000000000005e-70 266.0 sp|Q8IVV2|LOXH1_HUMAN Lipoxygenase homology domain-containing protein 1 OS=Homo sapiens OX=9606 GN=LOXHD1 PE=2 SV=4 g103.t1 Q8IVV2 25.694 829 1.7999999999999997e-61 238.0 sp|Q8IVV2|LOXH1_HUMAN Lipoxygenase homology domain-containing protein 1 OS=Homo sapiens OX=9606 GN=LOXHD1 PE=2 SV=4 g103.t1 Q8IVV2 26.172 768 6.89e-57 223.0 sp|Q8IVV2|LOXH1_HUMAN Lipoxygenase homology domain-containing protein 1 OS=Homo sapiens OX=9606 GN=LOXHD1 PE=2 SV=4 g103.t1 Q8IVV2 25.339 663 1.42e-45 186.0 sp|Q8IVV2|LOXH1_HUMAN Lipoxygenase homology domain-containing protein 1 OS=Homo sapiens OX=9606 GN=LOXHD1 PE=2 SV=4 g103.t1 Q8IVV2 26.433 541 1.6199999999999998e-40 169.0 sp|Q8IVV2|LOXH1_HUMAN Lipoxygenase homology domain-containing protein 1 OS=Homo sapiens OX=9606 GN=LOXHD1 PE=2 SV=4 g103.t1 Q8IVV2 23.037 764 1.02e-39 166.0 sp|Q8IVV2|LOXH1_HUMAN Lipoxygenase homology domain-containing protein 1 OS=Homo sapiens OX=9606 GN=LOXHD1 PE=2 SV=4 g103.t1 Q8IVV2 25.214 583 4.3e-35 151.0 sp|Q8IVV2|LOXH1_HUMAN Lipoxygenase homology domain-containing protein 1 OS=Homo sapiens OX=9606 GN=LOXHD1 PE=2 SV=4 g103.t1 Q8IVV2 25.135 557 1.33e-34 150.0 sp|Q8IVV2|LOXH1_HUMAN Lipoxygenase homology domain-containing protein 1 OS=Homo sapiens OX=9606 GN=LOXHD1 PE=2 SV=4 g103.t1 Q8IVV2 22.813 583 7.82e-30 134.0 sp|Q8IVV2|LOXH1_HUMAN Lipoxygenase homology domain-containing protein 1 OS=Homo sapiens OX=9606 GN=LOXHD1 PE=2 SV=4 g103.t1 Q8IVV2 24.289 387 1.73e-26 123.0 sp|Q8IVV2|LOXH1_HUMAN Lipoxygenase homology domain-containing protein 1 OS=Homo sapiens OX=9606 GN=LOXHD1 PE=2 SV=4 g103.t1 Q8IVV2 23.975 488 4.04e-26 122.0 sp|Q8IVV2|LOXH1_HUMAN Lipoxygenase homology domain-containing protein 1 OS=Homo sapiens OX=9606 GN=LOXHD1 PE=2 SV=4 g104.t1 Q0VCR6 54.093 281 3.5200000000000004e-109 324.0 sp|Q0VCR6|DIESL_BOVIN DGAT1/2-independent enzyme synthesizing storage lipids OS=Bos taurus OX=9913 GN=TMEM68 PE=2 SV=1 DIESL_BOVIN reviewed DGAT1/2-independent enzyme synthesizing storage lipids (DIESL) (EC 2.3.1.-) (2-acylglycerol/1,2-diacylglycerol O-acyltransferase) (Monoacylglycerol/Diacylglycerol O-acyltransferase) (MGAT/DGAT) (EC 2.3.1.20, EC 2.3.1.22) (Transmembrane protein 68) Bos taurus (Bovine) GO:0003846; GO:0004144; GO:0005789; GO:0016020; GO:0019432; GO:0046027 triglyceride biosynthetic process [GO:0019432] endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020] 2-acylglycerol O-acyltransferase activity [GO:0003846]; diacylglycerol O-acyltransferase activity [GO:0004144]; phospholipid:diacylglycerol acyltransferase activity [GO:0046027] g105.t1 Q9C0D9 51.429 105 3.65e-29 113.0 sp|Q9C0D9|EPT1_HUMAN Ethanolaminephosphotransferase 1 OS=Homo sapiens OX=9606 GN=SELENOI PE=1 SV=3 EPT1_HUMAN reviewed Ethanolaminephosphotransferase 1 (hEPT1) (EC 2.7.8.1) (Selenoprotein I) (SelI) Homo sapiens (Human) GO:0004307; GO:0005789; GO:0005794; GO:0006646; GO:0008611; GO:0042552; GO:0046872 ether lipid biosynthetic process [GO:0008611]; myelination [GO:0042552]; phosphatidylethanolamine biosynthetic process [GO:0006646] endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794] ethanolaminephosphotransferase activity [GO:0004307]; metal ion binding [GO:0046872] g107.t1 Q17QM4 42.152 223 1.33e-57 190.0 sp|Q17QM4|EPT1_BOVIN Ethanolaminephosphotransferase 1 OS=Bos taurus OX=9913 GN=SELENOI PE=2 SV=3 EPT1_BOVIN reviewed Ethanolaminephosphotransferase 1 (EC 2.7.8.1) (Selenoprotein I) (SelI) Bos taurus (Bovine) GO:0004307; GO:0005789; GO:0005794; GO:0006646; GO:0008611; GO:0042552; GO:0046872 ether lipid biosynthetic process [GO:0008611]; myelination [GO:0042552]; phosphatidylethanolamine biosynthetic process [GO:0006646] endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794] ethanolaminephosphotransferase activity [GO:0004307]; metal ion binding [GO:0046872] g109.t1 Q5FWF5 56.612 242 1.98e-89 291.0 sp|Q5FWF5|ESCO1_HUMAN N-acetyltransferase ESCO1 OS=Homo sapiens OX=9606 GN=ESCO1 PE=1 SV=3 ESCO1_HUMAN reviewed N-acetyltransferase ESCO1 (EC 2.3.1.-) (CTF7 homolog 1) (Establishment factor-like protein 1) (EFO1) (EFO1p) (hEFO1) (Establishment of cohesion 1 homolog 1) (ECO1 homolog 1) (ESO1 homolog 1) Homo sapiens (Human) GO:0000785; GO:0005634; GO:0005654; GO:0005694; GO:0006275; GO:0007062; GO:0007064; GO:0008080; GO:0008270; GO:0016407; GO:0018394; GO:0034421; GO:0042802; GO:0061733 mitotic sister chromatid cohesion [GO:0007064]; peptidyl-lysine acetylation [GO:0018394]; post-translational protein acetylation [GO:0034421]; regulation of DNA replication [GO:0006275]; sister chromatid cohesion [GO:0007062] chromatin [GO:0000785]; chromosome [GO:0005694]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] acetyltransferase activity [GO:0016407]; identical protein binding [GO:0042802]; N-acetyltransferase activity [GO:0008080]; protein-lysine-acetyltransferase activity [GO:0061733]; zinc ion binding [GO:0008270] g111.t1 O57525 38.915 424 8.170000000000001e-103 320.0 sp|O57525|CP17A_RANDY Steroid 17-alpha-hydroxylase/17,20 lyase OS=Rana dybowskii OX=71582 GN=CYP17A1 PE=2 SV=1 g118.t1 E1BD59 25.914 301 4.4e-24 108.0 sp|E1BD59|TRI56_BOVIN E3 ubiquitin-protein ligase TRIM56 OS=Bos taurus OX=9913 GN=TRIM56 PE=2 SV=1 TRI56_BOVIN reviewed E3 ubiquitin-protein ligase TRIM56 (EC 2.3.2.27) (Tripartite motif-containing protein 56) Bos taurus (Bovine) GO:0005654; GO:0005737; GO:0006513; GO:0008270; GO:0032728; GO:0034340; GO:0045087; GO:0051607; GO:0060340; GO:0061630; GO:0070534 defense response to virus [GO:0051607]; innate immune response [GO:0045087]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of type I interferon-mediated signaling pathway [GO:0060340]; protein K63-linked ubiquitination [GO:0070534]; protein monoubiquitination [GO:0006513]; response to type I interferon [GO:0034340] cytoplasm [GO:0005737]; nucleoplasm [GO:0005654] ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] g122.t1 Q6DI51 55.689 167 1.72e-65 201.0 sp|Q6DI51|NDK6_DANRE Nucleoside diphosphate kinase 6 OS=Danio rerio OX=7955 GN=nme6 PE=2 SV=1 NDK6_DANRE reviewed Nucleoside diphosphate kinase 6, mitochondrial (NDK6) (NDP kinase 6) (EC 2.7.4.6) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0004550; GO:0005524; GO:0005739; GO:0006183; GO:0006228; GO:0006241; GO:0009117; GO:0010138; GO:0030308; GO:0045839; GO:0046872 CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; negative regulation of cell growth [GO:0030308]; negative regulation of mitotic nuclear division [GO:0045839]; nucleotide metabolic process [GO:0009117]; pyrimidine ribonucleotide salvage [GO:0010138]; UTP biosynthetic process [GO:0006228] mitochondrion [GO:0005739] ATP binding [GO:0005524]; metal ion binding [GO:0046872]; nucleoside diphosphate kinase activity [GO:0004550] g124.t1 P20107 36.675 379 3.96e-57 195.0 sp|P20107|ZRC1_YEAST Vacuolar zinc transporter ZRC1 OS=Saccharomyces cerevisiae (strain ATCC 204508 / S288c) OX=559292 GN=ZRC1 PE=1 SV=2 g128.t1 P20107 36.842 380 5.84e-58 197.0 sp|P20107|ZRC1_YEAST Vacuolar zinc transporter ZRC1 OS=Saccharomyces cerevisiae (strain ATCC 204508 / S288c) OX=559292 GN=ZRC1 PE=1 SV=2 g129.t1 Q26365 75.641 78 2.8e-37 122.0 sp|Q26365|ADT_DROME ADP,ATP carrier protein OS=Drosophila melanogaster OX=7227 GN=sesB PE=2 SV=4 ADT_DROME reviewed ADP/ATP translocase (ADP,ATP carrier protein) (Adenine nucleotide translocator) (ANT) (Stress-sensitive protein B) Drosophila melanogaster (Fruit fly) GO:0001508; GO:0005471; GO:0005739; GO:0005743; GO:0006839; GO:0007268; GO:0008340; GO:0010507; GO:0034599; GO:0040011; GO:0045202; GO:0046716; GO:0048477; GO:0048489; GO:0051124; GO:0051480; GO:0051560; GO:0051900; GO:0070050; GO:0140021; GO:1901029; GO:1990544; GO:2001171 action potential [GO:0001508]; cellular response to oxidative stress [GO:0034599]; chemical synaptic transmission [GO:0007268]; determination of adult lifespan [GO:0008340]; locomotion [GO:0040011]; mitochondrial ADP transmembrane transport [GO:0140021]; mitochondrial ATP transmembrane transport [GO:1990544]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrial transport [GO:0006839]; muscle cell cellular homeostasis [GO:0046716]; negative regulation of autophagy [GO:0010507]; negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901029]; neuron cellular homeostasis [GO:0070050]; oogenesis [GO:0048477]; positive regulation of ATP biosynthetic process [GO:2001171]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of mitochondrial depolarization [GO:0051900]; synaptic assembly at neuromuscular junction [GO:0051124]; synaptic vesicle transport [GO:0048489] mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; synapse [GO:0045202] ATP:ADP antiporter activity [GO:0005471] g129.t1 Q26365 67.857 28 2.8e-37 40.8 sp|Q26365|ADT_DROME ADP,ATP carrier protein OS=Drosophila melanogaster OX=7227 GN=sesB PE=2 SV=4 ADT_DROME reviewed ADP/ATP translocase (ADP,ATP carrier protein) (Adenine nucleotide translocator) (ANT) (Stress-sensitive protein B) Drosophila melanogaster (Fruit fly) GO:0001508; GO:0005471; GO:0005739; GO:0005743; GO:0006839; GO:0007268; GO:0008340; GO:0010507; GO:0034599; GO:0040011; GO:0045202; GO:0046716; GO:0048477; GO:0048489; GO:0051124; GO:0051480; GO:0051560; GO:0051900; GO:0070050; GO:0140021; GO:1901029; GO:1990544; GO:2001171 action potential [GO:0001508]; cellular response to oxidative stress [GO:0034599]; chemical synaptic transmission [GO:0007268]; determination of adult lifespan [GO:0008340]; locomotion [GO:0040011]; mitochondrial ADP transmembrane transport [GO:0140021]; mitochondrial ATP transmembrane transport [GO:1990544]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrial transport [GO:0006839]; muscle cell cellular homeostasis [GO:0046716]; negative regulation of autophagy [GO:0010507]; negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901029]; neuron cellular homeostasis [GO:0070050]; oogenesis [GO:0048477]; positive regulation of ATP biosynthetic process [GO:2001171]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of mitochondrial depolarization [GO:0051900]; synaptic assembly at neuromuscular junction [GO:0051124]; synaptic vesicle transport [GO:0048489] mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; synapse [GO:0045202] ATP:ADP antiporter activity [GO:0005471] g129.t1 Q26365 75.0 24 2.8e-37 33.1 sp|Q26365|ADT_DROME ADP,ATP carrier protein OS=Drosophila melanogaster OX=7227 GN=sesB PE=2 SV=4 ADT_DROME reviewed ADP/ATP translocase (ADP,ATP carrier protein) (Adenine nucleotide translocator) (ANT) (Stress-sensitive protein B) Drosophila melanogaster (Fruit fly) GO:0001508; GO:0005471; GO:0005739; GO:0005743; GO:0006839; GO:0007268; GO:0008340; GO:0010507; GO:0034599; GO:0040011; GO:0045202; GO:0046716; GO:0048477; GO:0048489; GO:0051124; GO:0051480; GO:0051560; GO:0051900; GO:0070050; GO:0140021; GO:1901029; GO:1990544; GO:2001171 action potential [GO:0001508]; cellular response to oxidative stress [GO:0034599]; chemical synaptic transmission [GO:0007268]; determination of adult lifespan [GO:0008340]; locomotion [GO:0040011]; mitochondrial ADP transmembrane transport [GO:0140021]; mitochondrial ATP transmembrane transport [GO:1990544]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrial transport [GO:0006839]; muscle cell cellular homeostasis [GO:0046716]; negative regulation of autophagy [GO:0010507]; negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901029]; neuron cellular homeostasis [GO:0070050]; oogenesis [GO:0048477]; positive regulation of ATP biosynthetic process [GO:2001171]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of mitochondrial depolarization [GO:0051900]; synaptic assembly at neuromuscular junction [GO:0051124]; synaptic vesicle transport [GO:0048489] mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; synapse [GO:0045202] ATP:ADP antiporter activity [GO:0005471] g130.t1 Q7SYB2 51.835 654 0.0 649.0 sp|Q7SYB2|THOC1_DANRE THO complex subunit 1 OS=Danio rerio OX=7955 GN=thoc1 PE=2 SV=1 g131.t1 O95477 37.689 1921 0.0 1177.0 sp|O95477|ABCA1_HUMAN Phospholipid-transporting ATPase ABCA1 OS=Homo sapiens OX=9606 GN=ABCA1 PE=1 SV=3 ABCA1_HUMAN reviewed Phospholipid-transporting ATPase ABCA1 (EC 7.6.2.1) (ATP-binding cassette sub-family A member 1) (ATP-binding cassette transporter 1) (ABC-1) (ATP-binding cassette 1) (Cholesterol efflux regulatory protein) Homo sapiens (Human) GO:0002790; GO:0005102; GO:0005524; GO:0005548; GO:0005768; GO:0005789; GO:0005794; GO:0005886; GO:0006911; GO:0007040; GO:0007186; GO:0007189; GO:0008035; GO:0008203; GO:0008320; GO:0009306; GO:0009897; GO:0010745; GO:0010875; GO:0010887; GO:0015485; GO:0016197; GO:0016323; GO:0016887; GO:0019905; GO:0023061; GO:0030139; GO:0031210; GO:0031267; GO:0032367; GO:0032489; GO:0033344; GO:0033552; GO:0033700; GO:0034185; GO:0034186; GO:0034188; GO:0034380; GO:0034616; GO:0042158; GO:0042626; GO:0042632; GO:0043691; GO:0045121; GO:0045332; GO:0045335; GO:0046623; GO:0048471; GO:0051117; GO:0055091; GO:0060155; GO:0071222; GO:0071300; GO:0071345; GO:0071397; GO:0071404; GO:0071466; GO:0071806; GO:0090107; GO:0090108; GO:0090554; GO:0090556; GO:0097708; GO:0120020; GO:0140115; GO:0140328; GO:0140359 adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cellular response to cholesterol [GO:0071397]; cellular response to cytokine stimulus [GO:0071345]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; cellular response to retinoic acid [GO:0071300]; cellular response to xenobiotic stimulus [GO:0071466]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; endosomal transport [GO:0016197]; export across plasma membrane [GO:0140115]; G protein-coupled receptor signaling pathway [GO:0007186]; high-density lipoprotein particle assembly [GO:0034380]; intracellular cholesterol transport [GO:0032367]; lipoprotein biosynthetic process [GO:0042158]; lysosome organization [GO:0007040]; negative regulation of cholesterol storage [GO:0010887]; negative regulation of macrophage derived foam cell differentiation [GO:0010745]; peptide secretion [GO:0002790]; phagocytosis, engulfment [GO:0006911]; phospholipid efflux [GO:0033700]; phospholipid homeostasis [GO:0055091]; phospholipid translocation [GO:0045332]; platelet dense granule organization [GO:0060155]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of high-density lipoprotein particle assembly [GO:0090108]; protein secretion [GO:0009306]; protein transmembrane transport [GO:0071806]; regulation of Cdc42 protein signal transduction [GO:0032489]; regulation of high-density lipoprotein particle assembly [GO:0090107]; response to laminar fluid shear stress [GO:0034616]; response to vitamin B3 [GO:0033552]; reverse cholesterol transport [GO:0043691]; signal release [GO:0023061] basolateral plasma membrane [GO:0016323]; endocytic vesicle [GO:0030139]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; external side of plasma membrane [GO:0009897]; Golgi apparatus [GO:0005794]; intracellular vesicle [GO:0097708]; membrane raft [GO:0045121]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886] ABC-type transporter activity [GO:0140359]; apolipoprotein A-I binding [GO:0034186]; apolipoprotein A-I receptor activity [GO:0034188]; apolipoprotein binding [GO:0034185]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase binding [GO:0051117]; ATPase-coupled transmembrane transporter activity [GO:0042626]; cholesterol binding [GO:0015485]; cholesterol transfer activity [GO:0120020]; floppase activity [GO:0140328]; high-density lipoprotein particle binding [GO:0008035]; phosphatidylcholine binding [GO:0031210]; phosphatidylcholine floppase activity [GO:0090554]; phosphatidylserine floppase activity [GO:0090556]; phospholipid transporter activity [GO:0005548]; protein transmembrane transporter activity [GO:0008320]; signaling receptor binding [GO:0005102]; small GTPase binding [GO:0031267]; sphingolipid floppase activity [GO:0046623]; syntaxin binding [GO:0019905] g133.t1 Q9R1R2 30.0 180 9.56e-21 97.4 sp|Q9R1R2|TRIM3_MOUSE Tripartite motif-containing protein 3 OS=Mus musculus OX=10090 GN=Trim3 PE=1 SV=1 TRIM3_MOUSE reviewed Tripartite motif-containing protein 3 (EC 2.3.2.27) (RING finger protein 22) (RING finger protein HAC1) Mus musculus (Mouse) GO:0000209; GO:0002224; GO:0004842; GO:0005737; GO:0005769; GO:0005794; GO:0008270; GO:0015031; GO:0016567; GO:0030425; GO:0034141; GO:0042802; GO:0043161; GO:0061351; GO:0061630; GO:0070534; GO:0098794; GO:0098978; GO:0140252 neural precursor cell proliferation [GO:0061351]; positive regulation of toll-like receptor 3 signaling pathway [GO:0034141]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K63-linked ubiquitination [GO:0070534]; protein polyubiquitination [GO:0000209]; protein transport [GO:0015031]; protein ubiquitination [GO:0016567]; regulation protein catabolic process at postsynapse [GO:0140252]; toll-like receptor signaling pathway [GO:0002224] cytoplasm [GO:0005737]; dendrite [GO:0030425]; early endosome [GO:0005769]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; postsynapse [GO:0098794] identical protein binding [GO:0042802]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] g137.t1 P32007 80.405 296 3.35e-158 446.0 sp|P32007|ADT3_BOVIN ADP/ATP translocase 3 OS=Bos taurus OX=9913 GN=SLC25A6 PE=1 SV=3 ADT3_BOVIN reviewed ADP/ATP translocase 3 (ADP,ATP carrier protein 3) (ADP,ATP carrier protein, isoform T2) (ANT 2) (Adenine nucleotide translocator 3) (ANT 3) (Solute carrier family 25 member 6) [Cleaved into: ADP/ATP translocase 3, N-terminally processed] Bos taurus (Bovine) GO:0005471; GO:0005743; GO:0006915; GO:0016020; GO:0140021; GO:1901029; GO:1990544 apoptotic process [GO:0006915]; mitochondrial ADP transmembrane transport [GO:0140021]; mitochondrial ATP transmembrane transport [GO:1990544]; negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901029] membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743] ATP:ADP antiporter activity [GO:0005471] g139.t1 Q6P9I7 39.855 1104 0.0 808.0 sp|Q6P9I7|SMC6_XENLA Structural maintenance of chromosomes protein 6 OS=Xenopus laevis OX=8355 GN=smc6 PE=2 SV=1 SMC6_XENLA reviewed Structural maintenance of chromosomes protein 6 (SMC protein 6) (SMC-6) (xSMC6) Xenopus laevis (African clawed frog) GO:0000722; GO:0000724; GO:0000781; GO:0003684; GO:0003697; GO:0005524; GO:0005634; GO:0016605; GO:0030915; GO:0035861; GO:0090398 cellular senescence [GO:0090398]; double-strand break repair via homologous recombination [GO:0000724]; telomere maintenance via recombination [GO:0000722] chromosome, telomeric region [GO:0000781]; nucleus [GO:0005634]; PML body [GO:0016605]; site of double-strand break [GO:0035861]; Smc5-Smc6 complex [GO:0030915] ATP binding [GO:0005524]; damaged DNA binding [GO:0003684]; single-stranded DNA binding [GO:0003697] g140.t1 Q6P9I7 38.302 1107 0.0 748.0 sp|Q6P9I7|SMC6_XENLA Structural maintenance of chromosomes protein 6 OS=Xenopus laevis OX=8355 GN=smc6 PE=2 SV=1 SMC6_XENLA reviewed Structural maintenance of chromosomes protein 6 (SMC protein 6) (SMC-6) (xSMC6) Xenopus laevis (African clawed frog) GO:0000722; GO:0000724; GO:0000781; GO:0003684; GO:0003697; GO:0005524; GO:0005634; GO:0016605; GO:0030915; GO:0035861; GO:0090398 cellular senescence [GO:0090398]; double-strand break repair via homologous recombination [GO:0000724]; telomere maintenance via recombination [GO:0000722] chromosome, telomeric region [GO:0000781]; nucleus [GO:0005634]; PML body [GO:0016605]; site of double-strand break [GO:0035861]; Smc5-Smc6 complex [GO:0030915] ATP binding [GO:0005524]; damaged DNA binding [GO:0003684]; single-stranded DNA binding [GO:0003697] g142.t1 Q9NV56 39.247 186 5.4600000000000006e-27 103.0 sp|Q9NV56|MRGBP_HUMAN MRG/MORF4L-binding protein OS=Homo sapiens OX=9606 GN=MRGBP PE=1 SV=1 g143.t1 Q0IIF7 62.677 493 0.0 613.0 sp|Q0IIF7|UBP14_BOVIN Ubiquitin carboxyl-terminal hydrolase 14 OS=Bos taurus OX=9913 GN=USP14 PE=2 SV=3 UBP14_BOVIN reviewed Ubiquitin carboxyl-terminal hydrolase 14 (EC 3.4.19.12) (Deubiquitinating enzyme 14) (Ubiquitin thioesterase 14) (Ubiquitin-specific-processing protease 14) Bos taurus (Bovine) GO:0000502; GO:0004843; GO:0005737; GO:0005886; GO:0016579; GO:0043161; GO:0045087; GO:0070628; GO:1904293 innate immune response [GO:0045087]; negative regulation of ERAD pathway [GO:1904293]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deubiquitination [GO:0016579] cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; proteasome complex [GO:0000502] cysteine-type deubiquitinase activity [GO:0004843]; proteasome binding [GO:0070628] g144.t1 O95816 30.488 164 2.58e-25 102.0 sp|O95816|BAG2_HUMAN BAG family molecular chaperone regulator 2 OS=Homo sapiens OX=9606 GN=BAG2 PE=1 SV=1 BAG2_HUMAN reviewed BAG family molecular chaperone regulator 2 (BAG-2) (Bcl-2-associated athanogene 2) Homo sapiens (Human) GO:0000774; GO:0005829; GO:0006457; GO:0010954; GO:0019538; GO:0030424; GO:0030425; GO:0031072; GO:0031397; GO:0031625; GO:0042802; GO:0044325; GO:0048156; GO:0050821; GO:0051087; GO:0101031; GO:1901588; GO:1901800 negative regulation of protein ubiquitination [GO:0031397]; positive regulation of proteasomal protein catabolic process [GO:1901800]; positive regulation of protein processing [GO:0010954]; protein folding [GO:0006457]; protein metabolic process [GO:0019538]; protein stabilization [GO:0050821] axon [GO:0030424]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendritic microtubule [GO:1901588]; protein folding chaperone complex [GO:0101031] adenyl-nucleotide exchange factor activity [GO:0000774]; heat shock protein binding [GO:0031072]; identical protein binding [GO:0042802]; protein-folding chaperone binding [GO:0051087]; tau protein binding [GO:0048156]; transmembrane transporter binding [GO:0044325]; ubiquitin protein ligase binding [GO:0031625] g145.t1 Q9ULC3 70.815 233 4.29e-113 327.0 sp|Q9ULC3|RAB23_HUMAN Ras-related protein Rab-23 OS=Homo sapiens OX=9606 GN=RAB23 PE=1 SV=1 RAB23_HUMAN reviewed Ras-related protein Rab-23 (EC 3.6.5.2) Homo sapiens (Human) GO:0000045; GO:0003924; GO:0003925; GO:0005525; GO:0005737; GO:0005776; GO:0005813; GO:0005829; GO:0005886; GO:0005929; GO:0006886; GO:0006968; GO:0010008; GO:0012505; GO:0030054; GO:0030670; GO:0036064; GO:0042308; GO:0045335; GO:0046039; GO:0046872; GO:0060271; GO:0097094 autophagosome assembly [GO:0000045]; cellular defense response [GO:0006968]; cilium assembly [GO:0060271]; craniofacial suture morphogenesis [GO:0097094]; GTP metabolic process [GO:0046039]; intracellular protein transport [GO:0006886]; negative regulation of protein import into nucleus [GO:0042308] autophagosome [GO:0005776]; cell junction [GO:0030054]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; endosome membrane [GO:0010008]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886] G protein activity [GO:0003925]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872] g146.t1 Q05481 38.149 616 8.54e-132 419.0 sp|Q05481|ZNF91_HUMAN Zinc finger protein 91 OS=Homo sapiens OX=9606 GN=ZNF91 PE=1 SV=2 ZNF91_HUMAN reviewed Zinc finger protein 91 (Zinc finger protein HPF7) (Zinc finger protein HTF10) Homo sapiens (Human) GO:0001227; GO:0003677; GO:0003700; GO:0005634; GO:0006357; GO:0008270; GO:0010526 regulation of transcription by RNA polymerase II [GO:0006357]; transposable element silencing [GO:0010526] nucleus [GO:0005634] DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; zinc ion binding [GO:0008270] g146.t1 Q05481 37.013 616 1.63e-124 400.0 sp|Q05481|ZNF91_HUMAN Zinc finger protein 91 OS=Homo sapiens OX=9606 GN=ZNF91 PE=1 SV=2 ZNF91_HUMAN reviewed Zinc finger protein 91 (Zinc finger protein HPF7) (Zinc finger protein HTF10) Homo sapiens (Human) GO:0001227; GO:0003677; GO:0003700; GO:0005634; GO:0006357; GO:0008270; GO:0010526 regulation of transcription by RNA polymerase II [GO:0006357]; transposable element silencing [GO:0010526] nucleus [GO:0005634] DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; zinc ion binding [GO:0008270] g146.t1 Q05481 35.494 617 1.21e-119 387.0 sp|Q05481|ZNF91_HUMAN Zinc finger protein 91 OS=Homo sapiens OX=9606 GN=ZNF91 PE=1 SV=2 ZNF91_HUMAN reviewed Zinc finger protein 91 (Zinc finger protein HPF7) (Zinc finger protein HTF10) Homo sapiens (Human) GO:0001227; GO:0003677; GO:0003700; GO:0005634; GO:0006357; GO:0008270; GO:0010526 regulation of transcription by RNA polymerase II [GO:0006357]; transposable element silencing [GO:0010526] nucleus [GO:0005634] DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; zinc ion binding [GO:0008270] g146.t1 Q05481 35.247 627 2.36e-117 381.0 sp|Q05481|ZNF91_HUMAN Zinc finger protein 91 OS=Homo sapiens OX=9606 GN=ZNF91 PE=1 SV=2 ZNF91_HUMAN reviewed Zinc finger protein 91 (Zinc finger protein HPF7) (Zinc finger protein HTF10) Homo sapiens (Human) GO:0001227; GO:0003677; GO:0003700; GO:0005634; GO:0006357; GO:0008270; GO:0010526 regulation of transcription by RNA polymerase II [GO:0006357]; transposable element silencing [GO:0010526] nucleus [GO:0005634] DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; zinc ion binding [GO:0008270] g146.t1 Q05481 34.722 648 7.07e-116 377.0 sp|Q05481|ZNF91_HUMAN Zinc finger protein 91 OS=Homo sapiens OX=9606 GN=ZNF91 PE=1 SV=2 ZNF91_HUMAN reviewed Zinc finger protein 91 (Zinc finger protein HPF7) (Zinc finger protein HTF10) Homo sapiens (Human) GO:0001227; GO:0003677; GO:0003700; GO:0005634; GO:0006357; GO:0008270; GO:0010526 regulation of transcription by RNA polymerase II [GO:0006357]; transposable element silencing [GO:0010526] nucleus [GO:0005634] DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; zinc ion binding [GO:0008270] g146.t1 Q05481 35.714 476 2.81e-90 307.0 sp|Q05481|ZNF91_HUMAN Zinc finger protein 91 OS=Homo sapiens OX=9606 GN=ZNF91 PE=1 SV=2 ZNF91_HUMAN reviewed Zinc finger protein 91 (Zinc finger protein HPF7) (Zinc finger protein HTF10) Homo sapiens (Human) GO:0001227; GO:0003677; GO:0003700; GO:0005634; GO:0006357; GO:0008270; GO:0010526 regulation of transcription by RNA polymerase II [GO:0006357]; transposable element silencing [GO:0010526] nucleus [GO:0005634] DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; zinc ion binding [GO:0008270] g146.t1 Q05481 33.274 559 6.33e-85 292.0 sp|Q05481|ZNF91_HUMAN Zinc finger protein 91 OS=Homo sapiens OX=9606 GN=ZNF91 PE=1 SV=2 ZNF91_HUMAN reviewed Zinc finger protein 91 (Zinc finger protein HPF7) (Zinc finger protein HTF10) Homo sapiens (Human) GO:0001227; GO:0003677; GO:0003700; GO:0005634; GO:0006357; GO:0008270; GO:0010526 regulation of transcription by RNA polymerase II [GO:0006357]; transposable element silencing [GO:0010526] nucleus [GO:0005634] DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; zinc ion binding [GO:0008270] g148.t1 O70277 28.682 258 1.52e-22 106.0 sp|O70277|TRIM3_RAT Tripartite motif-containing protein 3 OS=Rattus norvegicus OX=10116 GN=Trim3 PE=1 SV=1 TRIM3_RAT reviewed Tripartite motif-containing protein 3 (EC 2.3.2.27) (Brain-expressed RING finger protein) (RING finger protein 22) Rattus norvegicus (Rat) GO:0000209; GO:0002224; GO:0004842; GO:0005737; GO:0005769; GO:0005794; GO:0008270; GO:0015031; GO:0016567; GO:0030425; GO:0034141; GO:0042802; GO:0043161; GO:0061351; GO:0061630; GO:0070534; GO:0098794; GO:0098978; GO:0140252 neural precursor cell proliferation [GO:0061351]; positive regulation of toll-like receptor 3 signaling pathway [GO:0034141]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K63-linked ubiquitination [GO:0070534]; protein polyubiquitination [GO:0000209]; protein transport [GO:0015031]; protein ubiquitination [GO:0016567]; regulation protein catabolic process at postsynapse [GO:0140252]; toll-like receptor signaling pathway [GO:0002224] cytoplasm [GO:0005737]; dendrite [GO:0030425]; early endosome [GO:0005769]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; postsynapse [GO:0098794] identical protein binding [GO:0042802]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] g153.t1 P16157 32.161 796 2.85e-84 310.0 sp|P16157|ANK1_HUMAN Ankyrin-1 OS=Homo sapiens OX=9606 GN=ANK1 PE=1 SV=3 ANK1_HUMAN reviewed Ankyrin-1 (ANK-1) (Ankyrin-R) (Erythrocyte ankyrin) Homo sapiens (Human) GO:0005198; GO:0005200; GO:0005829; GO:0005856; GO:0005886; GO:0006887; GO:0006888; GO:0007010; GO:0007165; GO:0008093; GO:0009898; GO:0014731; GO:0016323; GO:0016529; GO:0019899; GO:0019903; GO:0030018; GO:0030507; GO:0030673; GO:0031430; GO:0042383; GO:0043005; GO:0044325; GO:0045199; GO:0045211; GO:0051117; GO:0072659; GO:0170014 cytoskeleton organization [GO:0007010]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; exocytosis [GO:0006887]; maintenance of epithelial cell apical/basal polarity [GO:0045199]; protein localization to plasma membrane [GO:0072659]; signal transduction [GO:0007165] ankyrin-1 complex [GO:0170014]; axolemma [GO:0030673]; basolateral plasma membrane [GO:0016323]; cytoplasmic side of plasma membrane [GO:0009898]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; M band [GO:0031430]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; sarcoplasmic reticulum [GO:0016529]; spectrin-associated cytoskeleton [GO:0014731]; Z disc [GO:0030018] ATPase binding [GO:0051117]; cytoskeletal anchor activity [GO:0008093]; enzyme binding [GO:0019899]; protein phosphatase binding [GO:0019903]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]; structural molecule activity [GO:0005198]; transmembrane transporter binding [GO:0044325] g153.t1 P16157 31.079 769 1.4200000000000002e-79 295.0 sp|P16157|ANK1_HUMAN Ankyrin-1 OS=Homo sapiens OX=9606 GN=ANK1 PE=1 SV=3 ANK1_HUMAN reviewed Ankyrin-1 (ANK-1) (Ankyrin-R) (Erythrocyte ankyrin) Homo sapiens (Human) GO:0005198; GO:0005200; GO:0005829; GO:0005856; GO:0005886; GO:0006887; GO:0006888; GO:0007010; GO:0007165; GO:0008093; GO:0009898; GO:0014731; GO:0016323; GO:0016529; GO:0019899; GO:0019903; GO:0030018; GO:0030507; GO:0030673; GO:0031430; GO:0042383; GO:0043005; GO:0044325; GO:0045199; GO:0045211; GO:0051117; GO:0072659; GO:0170014 cytoskeleton organization [GO:0007010]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; exocytosis [GO:0006887]; maintenance of epithelial cell apical/basal polarity [GO:0045199]; protein localization to plasma membrane [GO:0072659]; signal transduction [GO:0007165] ankyrin-1 complex [GO:0170014]; axolemma [GO:0030673]; basolateral plasma membrane [GO:0016323]; cytoplasmic side of plasma membrane [GO:0009898]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; M band [GO:0031430]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; sarcoplasmic reticulum [GO:0016529]; spectrin-associated cytoskeleton [GO:0014731]; Z disc [GO:0030018] ATPase binding [GO:0051117]; cytoskeletal anchor activity [GO:0008093]; enzyme binding [GO:0019899]; protein phosphatase binding [GO:0019903]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]; structural molecule activity [GO:0005198]; transmembrane transporter binding [GO:0044325] g153.t1 P16157 30.075 798 2.11e-73 275.0 sp|P16157|ANK1_HUMAN Ankyrin-1 OS=Homo sapiens OX=9606 GN=ANK1 PE=1 SV=3 ANK1_HUMAN reviewed Ankyrin-1 (ANK-1) (Ankyrin-R) (Erythrocyte ankyrin) Homo sapiens (Human) GO:0005198; GO:0005200; GO:0005829; GO:0005856; GO:0005886; GO:0006887; GO:0006888; GO:0007010; GO:0007165; GO:0008093; GO:0009898; GO:0014731; GO:0016323; GO:0016529; GO:0019899; GO:0019903; GO:0030018; GO:0030507; GO:0030673; GO:0031430; GO:0042383; GO:0043005; GO:0044325; GO:0045199; GO:0045211; GO:0051117; GO:0072659; GO:0170014 cytoskeleton organization [GO:0007010]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; exocytosis [GO:0006887]; maintenance of epithelial cell apical/basal polarity [GO:0045199]; protein localization to plasma membrane [GO:0072659]; signal transduction [GO:0007165] ankyrin-1 complex [GO:0170014]; axolemma [GO:0030673]; basolateral plasma membrane [GO:0016323]; cytoplasmic side of plasma membrane [GO:0009898]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; M band [GO:0031430]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; sarcoplasmic reticulum [GO:0016529]; spectrin-associated cytoskeleton [GO:0014731]; Z disc [GO:0030018] ATPase binding [GO:0051117]; cytoskeletal anchor activity [GO:0008093]; enzyme binding [GO:0019899]; protein phosphatase binding [GO:0019903]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]; structural molecule activity [GO:0005198]; transmembrane transporter binding [GO:0044325] g153.t1 P16157 32.703 529 8.129999999999999e-48 192.0 sp|P16157|ANK1_HUMAN Ankyrin-1 OS=Homo sapiens OX=9606 GN=ANK1 PE=1 SV=3 ANK1_HUMAN reviewed Ankyrin-1 (ANK-1) (Ankyrin-R) (Erythrocyte ankyrin) Homo sapiens (Human) GO:0005198; GO:0005200; GO:0005829; GO:0005856; GO:0005886; GO:0006887; GO:0006888; GO:0007010; GO:0007165; GO:0008093; GO:0009898; GO:0014731; GO:0016323; GO:0016529; GO:0019899; GO:0019903; GO:0030018; GO:0030507; GO:0030673; GO:0031430; GO:0042383; GO:0043005; GO:0044325; GO:0045199; GO:0045211; GO:0051117; GO:0072659; GO:0170014 cytoskeleton organization [GO:0007010]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; exocytosis [GO:0006887]; maintenance of epithelial cell apical/basal polarity [GO:0045199]; protein localization to plasma membrane [GO:0072659]; signal transduction [GO:0007165] ankyrin-1 complex [GO:0170014]; axolemma [GO:0030673]; basolateral plasma membrane [GO:0016323]; cytoplasmic side of plasma membrane [GO:0009898]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; M band [GO:0031430]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; sarcoplasmic reticulum [GO:0016529]; spectrin-associated cytoskeleton [GO:0014731]; Z disc [GO:0030018] ATPase binding [GO:0051117]; cytoskeletal anchor activity [GO:0008093]; enzyme binding [GO:0019899]; protein phosphatase binding [GO:0019903]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]; structural molecule activity [GO:0005198]; transmembrane transporter binding [GO:0044325] g155.t1 Q8N3Y7 43.357 286 6.84e-79 245.0 sp|Q8N3Y7|RDHE2_HUMAN Epidermal retinol dehydrogenase 2 OS=Homo sapiens OX=9606 GN=SDR16C5 PE=1 SV=2 RDHE2_HUMAN reviewed Epidermal retinol dehydrogenase 2 (EPHD-2) (RDH-E2) (EC 1.1.1.105) (Retinal short-chain dehydrogenase reductase 2) (retSDR2) (Short-chain dehydrogenase/reductase family 16C member 5) Homo sapiens (Human) GO:0000122; GO:0000785; GO:0003714; GO:0004745; GO:0005634; GO:0005789; GO:0005811; GO:0017053; GO:0042572; GO:0042574; GO:0043616; GO:0045814; GO:0061629; GO:0140297 keratinocyte proliferation [GO:0043616]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of transcription by RNA polymerase II [GO:0000122]; retinal metabolic process [GO:0042574]; retinol metabolic process [GO:0042572] chromatin [GO:0000785]; endoplasmic reticulum membrane [GO:0005789]; lipid droplet [GO:0005811]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053] all-trans-retinol dehydrogenase (NAD+) activity [GO:0004745]; DNA-binding transcription factor binding [GO:0140297]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription corepressor activity [GO:0003714] g156.t1 Q7TQA3 47.445 274 1.03e-83 257.0 sp|Q7TQA3|RDHE2_MOUSE Epidermal retinol dehydrogenase 2 OS=Mus musculus OX=10090 GN=Sdr16c5 PE=2 SV=1 g157.t1 Q2YDR3 45.143 350 4.26e-93 284.0 sp|Q2YDR3|IMPA3_DANRE Inositol monophosphatase 3 OS=Danio rerio OX=7955 GN=bpnt2 PE=2 SV=1 g162.t1 R9UTQ8 31.551 187 1.1e-21 95.9 sp|R9UTQ8|PROHY_STRGD L-proline trans-4-hydroxylase OS=Streptomyces griseoviridis OX=45398 PE=1 SV=1 g163.t1 A6QLU6 39.683 315 1.17e-56 204.0 sp|A6QLU6|AGRD1_BOVIN Adhesion G-protein coupled receptor D1 OS=Bos taurus OX=9913 GN=ADGRD1 PE=2 SV=1 AGRD1_BOVIN reviewed Adhesion G-protein coupled receptor D1 (G-protein coupled receptor 133) [Cleaved into: Adhesion G-protein coupled receptor D1, N-terminal fragment (ADGRD1 N-terminal fragment); Adhesion G-protein coupled receptor D1, C-terminal fragment (ADGRD1 C-terminal fragment)] Bos taurus (Bovine) GO:0004930; GO:0005886; GO:0007166; GO:0007186; GO:0007189 adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186] plasma membrane [GO:0005886] G protein-coupled receptor activity [GO:0004930] g166.t1 Q17QQ2 45.161 217 7.02e-64 201.0 sp|Q17QQ2|TPMT_BOVIN Thiopurine S-methyltransferase OS=Bos taurus OX=9913 GN=TPMT PE=2 SV=1 TPMT_BOVIN reviewed Thiopurine S-methyltransferase (EC 2.1.1.67) (Thiopurine methyltransferase) Bos taurus (Bovine) GO:0005737; GO:0006805; GO:0008119; GO:0032259; GO:1904047 methylation [GO:0032259]; xenobiotic metabolic process [GO:0006805] cytoplasm [GO:0005737] S-adenosyl-L-methionine binding [GO:1904047]; thiopurine S-methyltransferase activity [GO:0008119] g167.t1 Q66HE2 21.689 438 2.37e-24 109.0 sp|Q66HE2|MOT13_RAT Monocarboxylate transporter 13 OS=Rattus norvegicus OX=10116 GN=Slc16a13 PE=2 SV=1 g168.t1 Q86WJ1 59.487 585 0.0 692.0 sp|Q86WJ1|CHD1L_HUMAN Chromodomain-helicase-DNA-binding protein 1-like OS=Homo sapiens OX=9606 GN=CHD1L PE=1 SV=3 CHD1L_HUMAN reviewed ATP-dependent chromatin remodeler CHD1L (EC 3.6.4.-) (Amplified in liver cancer protein 1) (Chromo domain-containing protein 1-like) Homo sapiens (Human) GO:0000166; GO:0003678; GO:0005524; GO:0005634; GO:0005654; GO:0006281; GO:0006338; GO:0006974; GO:0016887; GO:0031491; GO:0035861; GO:0090734; GO:0140566; GO:0140658; GO:0160004 chromatin remodeling [GO:0006338]; DNA damage response [GO:0006974]; DNA repair [GO:0006281] nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of DNA damage [GO:0090734]; site of double-strand break [GO:0035861] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent chromatin remodeler activity [GO:0140658]; DNA helicase activity [GO:0003678]; histone reader activity [GO:0140566]; nucleosome binding [GO:0031491]; nucleotide binding [GO:0000166]; poly-ADP-D-ribose modification-dependent protein binding [GO:0160004] g169.t1 Q05B79 59.085 831 0.0 953.0 sp|Q05B79|DHX36_BOVIN ATP-dependent DNA/RNA helicase DHX36 OS=Bos taurus OX=9913 GN=DHX36 PE=1 SV=1 DHX36_BOVIN reviewed ATP-dependent DNA/RNA helicase DHX36 (EC 3.6.4.12) (EC 3.6.4.13) (DEAD/H box polypeptide 36) (DEAH-box protein 36) (G4-resolvase-1) (G4R1) (MLE-like protein 1) (RNA helicase associated with AU-rich element protein) Bos taurus (Bovine) GO:0000287; GO:0000781; GO:0000978; GO:0001503; GO:0002151; GO:0002735; GO:0003678; GO:0003697; GO:0003723; GO:0003724; GO:0003725; GO:0003730; GO:0005524; GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0006359; GO:0007283; GO:0010494; GO:0010628; GO:0016607; GO:0016887; GO:0017148; GO:0030154; GO:0030424; GO:0030425; GO:0031442; GO:0032727; GO:0034605; GO:0034644; GO:0035925; GO:0042826; GO:0043123; GO:0043204; GO:0043330; GO:0043488; GO:0045087; GO:0045944; GO:0045995; GO:0048027; GO:0051607; GO:0051880; GO:0051891; GO:0060261; GO:0061003; GO:0061158; GO:0070034; GO:0070883; GO:0090669; GO:0140640; GO:1900153; GO:1901534; GO:1903843; GO:1904358; GO:1904582; GO:2000767 3'-UTR-mediated mRNA destabilization [GO:0061158]; cell differentiation [GO:0030154]; cellular response to arsenite ion [GO:1903843]; cellular response to heat [GO:0034605]; cellular response to UV [GO:0034644]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; negative regulation of translation [GO:0017148]; ossification [GO:0001503]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of cardioblast differentiation [GO:0051891]; positive regulation of cytoplasmic translation [GO:2000767]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of gene expression [GO:0010628]; positive regulation of hematopoietic progenitor cell differentiation [GO:1901534]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of intracellular mRNA localization [GO:1904582]; positive regulation of mRNA 3'-end processing [GO:0031442]; positive regulation of myeloid dendritic cell cytokine production [GO:0002735]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; positive regulation of telomere maintenance via telomere lengthening [GO:1904358]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription initiation by RNA polymerase II [GO:0060261]; regulation of embryonic development [GO:0045995]; regulation of mRNA stability [GO:0043488]; regulation of transcription by RNA polymerase III [GO:0006359]; response to exogenous dsRNA [GO:0043330]; spermatogenesis [GO:0007283]; telomerase RNA stabilization [GO:0090669] axon [GO:0030424]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; dendrite [GO:0030425]; mitochondrion [GO:0005739]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; perikaryon [GO:0043204] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; catalytic activity, acting on a nucleic acid [GO:0140640]; DNA helicase activity [GO:0003678]; double-stranded RNA binding [GO:0003725]; G-quadruplex DNA binding [GO:0051880]; G-quadruplex RNA binding [GO:0002151]; histone deacetylase binding [GO:0042826]; magnesium ion binding [GO:0000287]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; mRNA 3'-UTR binding [GO:0003730]; mRNA 5'-UTR binding [GO:0048027]; pre-miRNA binding [GO:0070883]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; single-stranded DNA binding [GO:0003697]; telomerase RNA binding [GO:0070034] g170.t1 Q0D289 34.615 156 8.67e-27 102.0 sp|Q0D289|MOSMO_DANRE Modulator of smoothened protein OS=Danio rerio OX=7955 GN=mosmob PE=2 SV=1 g172.t1 Q99575 37.162 592 8.230000000000001e-107 347.0 sp|Q99575|POP1_HUMAN Ribonucleases P/MRP protein subunit POP1 OS=Homo sapiens OX=9606 GN=POP1 PE=1 SV=2 POP1_HUMAN reviewed Ribonucleases P/MRP protein subunit POP1 (hPOP1) Homo sapiens (Human) GO:0000172; GO:0001682; GO:0003723; GO:0005615; GO:0005654; GO:0005655; GO:0005730; GO:0008033; GO:0016078; GO:0030681; GO:0033204 tRNA 5'-leader removal [GO:0001682]; tRNA decay [GO:0016078]; tRNA processing [GO:0008033] extracellular space [GO:0005615]; multimeric ribonuclease P complex [GO:0030681]; nucleolar ribonuclease P complex [GO:0005655]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; ribonuclease MRP complex [GO:0000172] ribonuclease P RNA binding [GO:0033204]; RNA binding [GO:0003723] g177.t1 E1C2V1 44.844 834 0.0 650.0 sp|E1C2V1|LMBL1_CHICK Lethal(3)malignant brain tumor-like protein 1 OS=Gallus gallus OX=9031 GN=L3MBTL1 PE=3 SV=1 g177.t2 E1C2V1 44.898 833 0.0 651.0 sp|E1C2V1|LMBL1_CHICK Lethal(3)malignant brain tumor-like protein 1 OS=Gallus gallus OX=9031 GN=L3MBTL1 PE=3 SV=1 g178.t1 P59913 73.054 167 1.0000000000000001e-88 266.0 sp|P59913|PCMD1_MOUSE Protein-L-isoaspartate O-methyltransferase domain-containing protein 1 OS=Mus musculus OX=10090 GN=Pcmtd1 PE=1 SV=1 g180.t1 P97500 54.682 267 3.61e-83 278.0 sp|P97500|MYT1L_MOUSE Myelin transcription factor 1-like protein OS=Mus musculus OX=10090 GN=Myt1l PE=1 SV=3 MYT1L_MOUSE reviewed Myelin transcription factor 1-like protein (MyT1-L) (MyT1L) (Neural zinc finger factor 1) (NZF-1) (Postmitotic neural gene 1 protein) (Zinc finger protein Png-1) Mus musculus (Mouse) GO:0000122; GO:0000977; GO:0000978; GO:0000981; GO:0001227; GO:0001228; GO:0003677; GO:0003700; GO:0003713; GO:0005634; GO:0005694; GO:0006357; GO:0007399; GO:0008270; GO:0030182; GO:0044323; GO:0045944; GO:0048663; GO:0048665; GO:0048666; GO:0050897; GO:0140487 negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]; neuron development [GO:0048666]; neuron differentiation [GO:0030182]; neuron fate commitment [GO:0048663]; neuron fate specification [GO:0048665]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357] chromosome [GO:0005694]; nucleus [GO:0005634] cobalt ion binding [GO:0050897]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion sequestering activity [GO:0140487]; retinoic acid-responsive element binding [GO:0044323]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; transcription coactivator activity [GO:0003713]; zinc ion binding [GO:0008270] g180.t2 Q01538 52.805 303 2.17e-93 308.0 sp|Q01538|MYT1_HUMAN Myelin transcription factor 1 OS=Homo sapiens OX=9606 GN=MYT1 PE=1 SV=2 MYT1_HUMAN reviewed Myelin transcription factor 1 (MyT1) (Myelin transcription factor I) (MyTI) (PLPB1) (Proteolipid protein-binding protein) Homo sapiens (Human) GO:0000785; GO:0000981; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0005829; GO:0006355; GO:0007399; GO:0008270; GO:0030154 cell differentiation [GO:0030154]; nervous system development [GO:0007399]; regulation of DNA-templated transcription [GO:0006355] chromatin [GO:0000785]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; zinc ion binding [GO:0008270] g180.t2 Q01538 55.556 90 4.27e-21 100.0 sp|Q01538|MYT1_HUMAN Myelin transcription factor 1 OS=Homo sapiens OX=9606 GN=MYT1 PE=1 SV=2 MYT1_HUMAN reviewed Myelin transcription factor 1 (MyT1) (Myelin transcription factor I) (MyTI) (PLPB1) (Proteolipid protein-binding protein) Homo sapiens (Human) GO:0000785; GO:0000981; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0005829; GO:0006355; GO:0007399; GO:0008270; GO:0030154 cell differentiation [GO:0030154]; nervous system development [GO:0007399]; regulation of DNA-templated transcription [GO:0006355] chromatin [GO:0000785]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; zinc ion binding [GO:0008270] g181.t1 P97500 51.111 180 9.77e-44 176.0 sp|P97500|MYT1L_MOUSE Myelin transcription factor 1-like protein OS=Mus musculus OX=10090 GN=Myt1l PE=1 SV=3 MYT1L_MOUSE reviewed Myelin transcription factor 1-like protein (MyT1-L) (MyT1L) (Neural zinc finger factor 1) (NZF-1) (Postmitotic neural gene 1 protein) (Zinc finger protein Png-1) Mus musculus (Mouse) GO:0000122; GO:0000977; GO:0000978; GO:0000981; GO:0001227; GO:0001228; GO:0003677; GO:0003700; GO:0003713; GO:0005634; GO:0005694; GO:0006357; GO:0007399; GO:0008270; GO:0030182; GO:0044323; GO:0045944; GO:0048663; GO:0048665; GO:0048666; GO:0050897; GO:0140487 negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]; neuron development [GO:0048666]; neuron differentiation [GO:0030182]; neuron fate commitment [GO:0048663]; neuron fate specification [GO:0048665]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357] chromosome [GO:0005694]; nucleus [GO:0005634] cobalt ion binding [GO:0050897]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion sequestering activity [GO:0140487]; retinoic acid-responsive element binding [GO:0044323]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; transcription coactivator activity [GO:0003713]; zinc ion binding [GO:0008270] g181.t2 P70475 50.276 181 6.119999999999999e-42 170.0 sp|P70475|MYT1L_RAT Myelin transcription factor 1-like protein OS=Rattus norvegicus OX=10116 GN=Myt1l PE=1 SV=3 MYT1L_RAT reviewed Myelin transcription factor 1-like protein (MyT1-L) (MyT1L) (Neural zinc finger factor 1) (NZF-1) Rattus norvegicus (Rat) GO:0000122; GO:0000977; GO:0000978; GO:0000981; GO:0001227; GO:0001228; GO:0003677; GO:0003700; GO:0003713; GO:0005634; GO:0005694; GO:0006357; GO:0007399; GO:0008270; GO:0030182; GO:0044323; GO:0045944; GO:0048663; GO:0048665; GO:0048666; GO:0050897; GO:0140487 negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]; neuron development [GO:0048666]; neuron differentiation [GO:0030182]; neuron fate commitment [GO:0048663]; neuron fate specification [GO:0048665]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357] chromosome [GO:0005694]; nucleus [GO:0005634] cobalt ion binding [GO:0050897]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion sequestering activity [GO:0140487]; retinoic acid-responsive element binding [GO:0044323]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; transcription coactivator activity [GO:0003713]; zinc ion binding [GO:0008270] g181.t3 P97500 51.111 180 9.77e-44 176.0 sp|P97500|MYT1L_MOUSE Myelin transcription factor 1-like protein OS=Mus musculus OX=10090 GN=Myt1l PE=1 SV=3 MYT1L_MOUSE reviewed Myelin transcription factor 1-like protein (MyT1-L) (MyT1L) (Neural zinc finger factor 1) (NZF-1) (Postmitotic neural gene 1 protein) (Zinc finger protein Png-1) Mus musculus (Mouse) GO:0000122; GO:0000977; GO:0000978; GO:0000981; GO:0001227; GO:0001228; GO:0003677; GO:0003700; GO:0003713; GO:0005634; GO:0005694; GO:0006357; GO:0007399; GO:0008270; GO:0030182; GO:0044323; GO:0045944; GO:0048663; GO:0048665; GO:0048666; GO:0050897; GO:0140487 negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]; neuron development [GO:0048666]; neuron differentiation [GO:0030182]; neuron fate commitment [GO:0048663]; neuron fate specification [GO:0048665]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357] chromosome [GO:0005694]; nucleus [GO:0005634] cobalt ion binding [GO:0050897]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion sequestering activity [GO:0140487]; retinoic acid-responsive element binding [GO:0044323]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; transcription coactivator activity [GO:0003713]; zinc ion binding [GO:0008270] g184.t1 Q8K0G5 65.206 388 7.36e-175 495.0 sp|Q8K0G5|EIPR1_MOUSE EARP and GARP complex-interacting protein 1 OS=Mus musculus OX=10090 GN=Eipr1 PE=1 SV=2 g185.t1 P79774 34.132 167 2.39e-21 89.4 sp|P79774|SNAT_CHICK Serotonin N-acetyltransferase OS=Gallus gallus OX=9031 GN=AANAT PE=2 SV=1 g186.t1 Q6R5J2 39.643 560 1.81e-128 422.0 sp|Q6R5J2|DISP1_DANRE Protein dispatched homolog 1 OS=Danio rerio OX=7955 GN=disp1 PE=2 SV=1 DISP1_DANRE reviewed Protein dispatched homolog 1 (Protein chameleon) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0007224; GO:0007519; GO:0008015; GO:0009887; GO:0009952; GO:0016020; GO:0021984; GO:0031290; GO:0042694; GO:0048701; GO:0048839 adenohypophysis development [GO:0021984]; animal organ morphogenesis [GO:0009887]; anterior/posterior pattern specification [GO:0009952]; blood circulation [GO:0008015]; embryonic cranial skeleton morphogenesis [GO:0048701]; inner ear development [GO:0048839]; muscle cell fate specification [GO:0042694]; retinal ganglion cell axon guidance [GO:0031290]; skeletal muscle tissue development [GO:0007519]; smoothened signaling pathway [GO:0007224] membrane [GO:0016020] g187.t1 Q5RIW8 60.704 1336 0.0 1653.0 sp|Q5RIW8|MED23_DANRE Mediator of RNA polymerase II transcription subunit 23 OS=Danio rerio OX=7955 GN=med23 PE=2 SV=2 g190.t1 O08992 52.288 306 5.3099999999999995e-104 308.0 sp|O08992|SDCB1_MOUSE Syntenin-1 OS=Mus musculus OX=10090 GN=Sdcbp PE=1 SV=1 g191.t1 M9PE65 30.851 188 1.36e-22 109.0 sp|M9PE65|AXO_DROME Axotactin OS=Drosophila melanogaster OX=7227 GN=axo PE=1 SV=1 AXO_DROME reviewed Axotactin Drosophila melanogaster (Fruit fly) GO:0004867; GO:0016020; GO:0019226; GO:0030424 transmission of nerve impulse [GO:0019226] axon [GO:0030424]; membrane [GO:0016020] serine-type endopeptidase inhibitor activity [GO:0004867] g192.t1 Q28107 25.926 270 2.5e-26 120.0 sp|Q28107|FA5_BOVIN Coagulation factor V OS=Bos taurus OX=9913 GN=F5 PE=1 SV=1 FA5_BOVIN reviewed Coagulation factor V (Activated protein C cofactor) [Cleaved into: Coagulation factor V heavy chain; Coagulation factor V light chain] Bos taurus (Bovine) GO:0005507; GO:0005615; GO:0007596; GO:0008015; GO:0031091 blood circulation [GO:0008015]; blood coagulation [GO:0007596] extracellular space [GO:0005615]; platelet alpha granule [GO:0031091] copper ion binding [GO:0005507] g192.t1 Q28107 26.23 244 3.23e-26 120.0 sp|Q28107|FA5_BOVIN Coagulation factor V OS=Bos taurus OX=9913 GN=F5 PE=1 SV=1 FA5_BOVIN reviewed Coagulation factor V (Activated protein C cofactor) [Cleaved into: Coagulation factor V heavy chain; Coagulation factor V light chain] Bos taurus (Bovine) GO:0005507; GO:0005615; GO:0007596; GO:0008015; GO:0031091 blood circulation [GO:0008015]; blood coagulation [GO:0007596] extracellular space [GO:0005615]; platelet alpha granule [GO:0031091] copper ion binding [GO:0005507] g192.t1 Q28107 26.23 244 3.23e-26 120.0 sp|Q28107|FA5_BOVIN Coagulation factor V OS=Bos taurus OX=9913 GN=F5 PE=1 SV=1 FA5_BOVIN reviewed Coagulation factor V (Activated protein C cofactor) [Cleaved into: Coagulation factor V heavy chain; Coagulation factor V light chain] Bos taurus (Bovine) GO:0005507; GO:0005615; GO:0007596; GO:0008015; GO:0031091 blood circulation [GO:0008015]; blood coagulation [GO:0007596] extracellular space [GO:0005615]; platelet alpha granule [GO:0031091] copper ion binding [GO:0005507] g199.t1 Q921M7 62.195 328 1.3e-146 419.0 sp|Q921M7|CYRIB_MOUSE CYFIP-related Rac1 interactor B OS=Mus musculus OX=10090 GN=Cyrib PE=1 SV=1 CYRIB_MOUSE reviewed CYFIP-related Rac1 interactor B (Protein FAM49B) Mus musculus (Mouse) GO:0001916; GO:0005739; GO:0005929; GO:0016020; GO:0023030; GO:0030334; GO:0030837; GO:0031267; GO:0032729; GO:0050870; GO:0050920; GO:0051058; GO:0071219; GO:0090140; GO:2000114; GO:2000568 cellular response to molecule of bacterial origin [GO:0071219]; negative regulation of actin filament polymerization [GO:0030837]; negative regulation of small GTPase mediated signal transduction [GO:0051058]; positive regulation of memory T cell activation [GO:2000568]; positive regulation of T cell activation [GO:0050870]; positive regulation of T cell mediated cytotoxicity [GO:0001916]; positive regulation of type II interferon production [GO:0032729]; regulation of cell migration [GO:0030334]; regulation of chemotaxis [GO:0050920]; regulation of establishment of cell polarity [GO:2000114]; regulation of mitochondrial fission [GO:0090140] cilium [GO:0005929]; membrane [GO:0016020]; mitochondrion [GO:0005739] MHC class Ib protein binding, via antigen binding groove [GO:0023030]; small GTPase binding [GO:0031267] g201.t1 Q17103 82.544 401 0.0 566.0 sp|Q17103|MYC_ASTRU Myc protein (Fragment) OS=Asterias rubens OX=7604 GN=MYC PE=2 SV=1 g205.t1 Q80UN9 51.556 225 4.2699999999999995e-62 214.0 sp|Q80UN9|MOD5_MOUSE tRNA dimethylallyltransferase OS=Mus musculus OX=10090 GN=Trit1 PE=1 SV=2 MOD5_MOUSE reviewed tRNA dimethylallyltransferase (EC 2.5.1.75) (Isopentenyl-diphosphate:tRNA isopentenyltransferase) (IPP transferase) (IPPT) (tRNA isopentenyltransferase) (IPTase) Mus musculus (Mouse) GO:0005524; GO:0005634; GO:0005739; GO:0006400; GO:0008270; GO:0052381; GO:0070900 mitochondrial tRNA modification [GO:0070900]; tRNA modification [GO:0006400] mitochondrion [GO:0005739]; nucleus [GO:0005634] ATP binding [GO:0005524]; tRNA dimethylallyltransferase activity [GO:0052381]; zinc ion binding [GO:0008270] g205.t1 Q80UN9 50.262 191 4.5999999999999995e-48 176.0 sp|Q80UN9|MOD5_MOUSE tRNA dimethylallyltransferase OS=Mus musculus OX=10090 GN=Trit1 PE=1 SV=2 MOD5_MOUSE reviewed tRNA dimethylallyltransferase (EC 2.5.1.75) (Isopentenyl-diphosphate:tRNA isopentenyltransferase) (IPP transferase) (IPPT) (tRNA isopentenyltransferase) (IPTase) Mus musculus (Mouse) GO:0005524; GO:0005634; GO:0005739; GO:0006400; GO:0008270; GO:0052381; GO:0070900 mitochondrial tRNA modification [GO:0070900]; tRNA modification [GO:0006400] mitochondrion [GO:0005739]; nucleus [GO:0005634] ATP binding [GO:0005524]; tRNA dimethylallyltransferase activity [GO:0052381]; zinc ion binding [GO:0008270] g206.t1 A4IF63 29.208 202 5.33e-22 103.0 sp|A4IF63|TRIM2_BOVIN Tripartite motif-containing protein 2 OS=Bos taurus OX=9913 GN=TRIM2 PE=2 SV=1 TRIM2_BOVIN reviewed Tripartite motif-containing protein 2 (EC 2.3.2.27) (E3 ubiquitin-protein ligase TRIM2) (RING-type E3 ubiquitin transferase TRIM2) Bos taurus (Bovine) GO:0000209; GO:0004842; GO:0005737; GO:0008270; GO:0043161; GO:0043523; GO:0061630 proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; regulation of neuron apoptotic process [GO:0043523] cytoplasm [GO:0005737] ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] g209.t1 Q9X248 38.153 249 1.07e-37 136.0 sp|Q9X248|FABG_THEMA 3-oxoacyl-[acyl-carrier-protein] reductase FabG OS=Thermotoga maritima (strain ATCC 43589 / DSM 3109 / JCM 10099 / NBRC 100826 / MSB8) OX=243274 GN=fabG PE=3 SV=1 g215.t1 A1A5H8 56.637 452 0.0 529.0 sp|A1A5H8|YES_DANRE Tyrosine-protein kinase yes OS=Danio rerio OX=7955 GN=yes1 PE=1 SV=1 YES_DANRE reviewed Tyrosine-protein kinase yes (EC 2.7.10.2) (p61-Yes) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0004713; GO:0004715; GO:0005102; GO:0005524; GO:0005813; GO:0005829; GO:0005886; GO:0007169; GO:0030154; GO:0034334; GO:0060027; GO:0070161 adherens junction maintenance [GO:0034334]; cell differentiation [GO:0030154]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; convergent extension involved in gastrulation [GO:0060027] anchoring junction [GO:0070161]; centrosome [GO:0005813]; cytosol [GO:0005829]; plasma membrane [GO:0005886] ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein tyrosine kinase activity [GO:0004713]; signaling receptor binding [GO:0005102] g217.t1 Q8NFI3 47.253 182 5.57e-44 163.0 sp|Q8NFI3|ENASE_HUMAN Cytosolic endo-beta-N-acetylglucosaminidase OS=Homo sapiens OX=9606 GN=ENGASE PE=1 SV=1 g218.t1 Q95SX7 35.897 234 7.190000000000001e-27 114.0 sp|Q95SX7|RTBS_DROME Probable RNA-directed DNA polymerase from transposon BS OS=Drosophila melanogaster OX=7227 GN=RTase PE=2 SV=1 g225.t1 P12270 40.441 1543 0.0 854.0 sp|P12270|TPR_HUMAN Nucleoprotein TPR OS=Homo sapiens OX=9606 GN=TPR PE=1 SV=3 TPR_HUMAN reviewed Nucleoprotein TPR (Megator) (NPC-associated intranuclear protein) (Translocated promoter region protein) Homo sapiens (Human) GO:0000122; GO:0000776; GO:0003682; GO:0003723; GO:0003729; GO:0005634; GO:0005635; GO:0005643; GO:0005654; GO:0005737; GO:0005868; GO:0006404; GO:0006405; GO:0006406; GO:0006606; GO:0006913; GO:0006999; GO:0007094; GO:0010965; GO:0015631; GO:0017056; GO:0031072; GO:0031453; GO:0031965; GO:0031990; GO:0032880; GO:0034399; GO:0034605; GO:0035457; GO:0042307; GO:0042405; GO:0042803; GO:0044615; GO:0045947; GO:0046827; GO:0046832; GO:0051019; GO:0051301; GO:0070840; GO:0070849; GO:0072686; GO:0090267; GO:0090316; GO:1901673 cell division [GO:0051301]; cellular response to heat [GO:0034605]; cellular response to interferon-alpha [GO:0035457]; mitotic spindle assembly checkpoint signaling [GO:0007094]; mRNA export from nucleus [GO:0006406]; mRNA export from nucleus in response to heat stress [GO:0031990]; negative regulation of RNA export from nucleus [GO:0046832]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of translational initiation [GO:0045947]; nuclear pore organization [GO:0006999]; nucleocytoplasmic transport [GO:0006913]; positive regulation of heterochromatin formation [GO:0031453]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of protein import into nucleus [GO:0042307]; protein import into nucleus [GO:0006606]; regulation of mitotic sister chromatid separation [GO:0010965]; regulation of mitotic spindle assembly [GO:1901673]; regulation of protein localization [GO:0032880]; response to epidermal growth factor [GO:0070849]; RNA export from nucleus [GO:0006405]; RNA import into nucleus [GO:0006404] cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; kinetochore [GO:0000776]; mitotic spindle [GO:0072686]; nuclear envelope [GO:0005635]; nuclear inclusion body [GO:0042405]; nuclear membrane [GO:0031965]; nuclear periphery [GO:0034399]; nuclear pore [GO:0005643]; nuclear pore nuclear basket [GO:0044615]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] chromatin binding [GO:0003682]; dynein complex binding [GO:0070840]; heat shock protein binding [GO:0031072]; mitogen-activated protein kinase binding [GO:0051019]; mRNA binding [GO:0003729]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; structural constituent of nuclear pore [GO:0017056]; tubulin binding [GO:0015631] g225.t2 P12270 40.441 1543 0.0 854.0 sp|P12270|TPR_HUMAN Nucleoprotein TPR OS=Homo sapiens OX=9606 GN=TPR PE=1 SV=3 TPR_HUMAN reviewed Nucleoprotein TPR (Megator) (NPC-associated intranuclear protein) (Translocated promoter region protein) Homo sapiens (Human) GO:0000122; GO:0000776; GO:0003682; GO:0003723; GO:0003729; GO:0005634; GO:0005635; GO:0005643; GO:0005654; GO:0005737; GO:0005868; GO:0006404; GO:0006405; GO:0006406; GO:0006606; GO:0006913; GO:0006999; GO:0007094; GO:0010965; GO:0015631; GO:0017056; GO:0031072; GO:0031453; GO:0031965; GO:0031990; GO:0032880; GO:0034399; GO:0034605; GO:0035457; GO:0042307; GO:0042405; GO:0042803; GO:0044615; GO:0045947; GO:0046827; GO:0046832; GO:0051019; GO:0051301; GO:0070840; GO:0070849; GO:0072686; GO:0090267; GO:0090316; GO:1901673 cell division [GO:0051301]; cellular response to heat [GO:0034605]; cellular response to interferon-alpha [GO:0035457]; mitotic spindle assembly checkpoint signaling [GO:0007094]; mRNA export from nucleus [GO:0006406]; mRNA export from nucleus in response to heat stress [GO:0031990]; negative regulation of RNA export from nucleus [GO:0046832]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of translational initiation [GO:0045947]; nuclear pore organization [GO:0006999]; nucleocytoplasmic transport [GO:0006913]; positive regulation of heterochromatin formation [GO:0031453]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of protein import into nucleus [GO:0042307]; protein import into nucleus [GO:0006606]; regulation of mitotic sister chromatid separation [GO:0010965]; regulation of mitotic spindle assembly [GO:1901673]; regulation of protein localization [GO:0032880]; response to epidermal growth factor [GO:0070849]; RNA export from nucleus [GO:0006405]; RNA import into nucleus [GO:0006404] cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; kinetochore [GO:0000776]; mitotic spindle [GO:0072686]; nuclear envelope [GO:0005635]; nuclear inclusion body [GO:0042405]; nuclear membrane [GO:0031965]; nuclear periphery [GO:0034399]; nuclear pore [GO:0005643]; nuclear pore nuclear basket [GO:0044615]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] chromatin binding [GO:0003682]; dynein complex binding [GO:0070840]; heat shock protein binding [GO:0031072]; mitogen-activated protein kinase binding [GO:0051019]; mRNA binding [GO:0003729]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; structural constituent of nuclear pore [GO:0017056]; tubulin binding [GO:0015631] g229.t1 P51589 35.433 508 5.63e-102 317.0 sp|P51589|CP2J2_HUMAN Cytochrome P450 2J2 OS=Homo sapiens OX=9606 GN=CYP2J2 PE=1 SV=2 CP2J2_HUMAN reviewed Cytochrome P450 2J2 (EC 1.14.14.-) (Albendazole monooxygenase (hydroxylating)) (EC 1.14.14.74) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Arachidonic acid epoxygenase) (CYPIIJ2) (Hydroperoxy icosatetraenoate isomerase) (EC 5.4.4.7) Homo sapiens (Human) GO:0004497; GO:0005506; GO:0005737; GO:0005789; GO:0006082; GO:0006631; GO:0006690; GO:0006805; GO:0008016; GO:0008392; GO:0008404; GO:0008405; GO:0016712; GO:0016853; GO:0019373; GO:0020037; GO:0043651; GO:0070062; GO:0071614; GO:0106255; GO:0106301 epoxygenase P450 pathway [GO:0019373]; fatty acid metabolic process [GO:0006631]; icosanoid metabolic process [GO:0006690]; linoleic acid metabolic process [GO:0043651]; organic acid metabolic process [GO:0006082]; regulation of heart contraction [GO:0008016]; xenobiotic metabolic process [GO:0006805] cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062] arachidonate 11,12-epoxygenase activity [GO:0008405]; arachidonate 14,15-epoxygenase activity [GO:0008404]; arachidonate 5,6-epoxygenase activity [GO:0106301]; arachidonate epoxygenase activity [GO:0008392]; heme binding [GO:0020037]; hydroperoxy icosatetraenoate isomerase activity [GO:0106255]; iron ion binding [GO:0005506]; isomerase activity [GO:0016853]; linoleic acid epoxygenase activity [GO:0071614]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712] g230.t1 Q5RA75 58.786 313 2.46e-107 367.0 sp|Q5RA75|F135A_PONAB Protein FAM135A OS=Pongo abelii OX=9601 GN=FAM135A PE=2 SV=1 g230.t1 Q5RA75 39.956 458 9.6e-92 323.0 sp|Q5RA75|F135A_PONAB Protein FAM135A OS=Pongo abelii OX=9601 GN=FAM135A PE=2 SV=1 g232.t1 Q6P2X9 29.155 343 9.149999999999999e-34 136.0 sp|Q6P2X9|MOT12_XENTR Monocarboxylate transporter 12 OS=Xenopus tropicalis OX=8364 GN=slc16a12 PE=2 SV=1 g233.t1 Q96DM3 68.367 98 1.06e-41 147.0 sp|Q96DM3|RMC1_HUMAN Regulator of MON1-CCZ1 complex OS=Homo sapiens OX=9606 GN=RMC1 PE=1 SV=2 RMC1_HUMAN reviewed Regulator of MON1-CCZ1 complex (Colon cancer-associated protein Mic1) (Mic-1) (WD repeat-containing protein 98) Homo sapiens (Human) GO:0005765; GO:0006914; GO:0010506; GO:0031902; GO:0035658 autophagy [GO:0006914]; regulation of autophagy [GO:0010506] late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; Mon1-Ccz1 complex [GO:0035658] g234.t1 Q96DM3 52.216 519 2.71e-176 515.0 sp|Q96DM3|RMC1_HUMAN Regulator of MON1-CCZ1 complex OS=Homo sapiens OX=9606 GN=RMC1 PE=1 SV=2 RMC1_HUMAN reviewed Regulator of MON1-CCZ1 complex (Colon cancer-associated protein Mic1) (Mic-1) (WD repeat-containing protein 98) Homo sapiens (Human) GO:0005765; GO:0006914; GO:0010506; GO:0031902; GO:0035658 autophagy [GO:0006914]; regulation of autophagy [GO:0010506] late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; Mon1-Ccz1 complex [GO:0035658] g235.t1 Q6GMG6 40.314 382 1.82e-63 213.0 sp|Q6GMG6|S5A3B_DANRE Solute carrier family 52, riboflavin transporter, member 3-B OS=Danio rerio OX=7955 GN=slc52a3b PE=2 SV=1 g236.t1 P00428 43.75 96 2.65e-24 93.2 sp|P00428|COX5B_BOVIN Cytochrome c oxidase subunit 5B, mitochondrial OS=Bos taurus OX=9913 GN=COX5B PE=1 SV=2 g237.t1 Q5R833 41.985 131 1.8700000000000002e-37 128.0 sp|Q5R833|ACO13_PONAB Acyl-coenzyme A thioesterase 13 OS=Pongo abelii OX=9601 GN=ACOT13 PE=2 SV=1 ACO13_PONAB reviewed Acyl-coenzyme A thioesterase 13 (Acyl-CoA thioesterase 13) (EC 3.1.2.-) (Hotdog-fold thioesterase superfamily member 2) (Palmitoyl-CoA hydrolase) (EC 3.1.2.2) (Thioesterase superfamily member 2) (THEM2) [Cleaved into: Acyl-coenzyme A thioesterase 13, N-terminally processed] Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0005634; GO:0005739; GO:0005819; GO:0005829; GO:0006629; GO:0047617 lipid metabolic process [GO:0006629] cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; spindle [GO:0005819] fatty acyl-CoA hydrolase activity [GO:0047617] g238.t1 Q5R833 48.148 135 8.58e-41 136.0 sp|Q5R833|ACO13_PONAB Acyl-coenzyme A thioesterase 13 OS=Pongo abelii OX=9601 GN=ACOT13 PE=2 SV=1 ACO13_PONAB reviewed Acyl-coenzyme A thioesterase 13 (Acyl-CoA thioesterase 13) (EC 3.1.2.-) (Hotdog-fold thioesterase superfamily member 2) (Palmitoyl-CoA hydrolase) (EC 3.1.2.2) (Thioesterase superfamily member 2) (THEM2) [Cleaved into: Acyl-coenzyme A thioesterase 13, N-terminally processed] Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0005634; GO:0005739; GO:0005819; GO:0005829; GO:0006629; GO:0047617 lipid metabolic process [GO:0006629] cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; spindle [GO:0005819] fatty acyl-CoA hydrolase activity [GO:0047617] g240.t1 Q9ERC5 68.605 344 1.87e-168 519.0 sp|Q9ERC5|OTOF_RAT Otoferlin OS=Rattus norvegicus OX=10116 GN=Otof PE=1 SV=2 OTOF_RAT reviewed Otoferlin (Fer-1-like protein 2) Rattus norvegicus (Rat) GO:0000139; GO:0005509; GO:0005783; GO:0005789; GO:0005802; GO:0007009; GO:0007605; GO:0016079; GO:0016082; GO:0016323; GO:0030672; GO:0035612; GO:0036465; GO:0044877; GO:0045177; GO:0045178; GO:0048787; GO:0090102; GO:0098683 cochlea development [GO:0090102]; plasma membrane organization [GO:0007009]; sensory perception of sound [GO:0007605]; synaptic vesicle exocytosis [GO:0016079]; synaptic vesicle priming [GO:0016082]; synaptic vesicle recycling [GO:0036465] apical part of cell [GO:0045177]; basal part of cell [GO:0045178]; basolateral plasma membrane [GO:0016323]; cochlear hair cell ribbon synapse [GO:0098683]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; presynaptic active zone membrane [GO:0048787]; synaptic vesicle membrane [GO:0030672]; trans-Golgi network [GO:0005802] AP-2 adaptor complex binding [GO:0035612]; calcium ion binding [GO:0005509]; protein-containing complex binding [GO:0044877] g240.t2 Q9ERC5 70.058 344 2.02e-166 513.0 sp|Q9ERC5|OTOF_RAT Otoferlin OS=Rattus norvegicus OX=10116 GN=Otof PE=1 SV=2 OTOF_RAT reviewed Otoferlin (Fer-1-like protein 2) Rattus norvegicus (Rat) GO:0000139; GO:0005509; GO:0005783; GO:0005789; GO:0005802; GO:0007009; GO:0007605; GO:0016079; GO:0016082; GO:0016323; GO:0030672; GO:0035612; GO:0036465; GO:0044877; GO:0045177; GO:0045178; GO:0048787; GO:0090102; GO:0098683 cochlea development [GO:0090102]; plasma membrane organization [GO:0007009]; sensory perception of sound [GO:0007605]; synaptic vesicle exocytosis [GO:0016079]; synaptic vesicle priming [GO:0016082]; synaptic vesicle recycling [GO:0036465] apical part of cell [GO:0045177]; basal part of cell [GO:0045178]; basolateral plasma membrane [GO:0016323]; cochlear hair cell ribbon synapse [GO:0098683]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; presynaptic active zone membrane [GO:0048787]; synaptic vesicle membrane [GO:0030672]; trans-Golgi network [GO:0005802] AP-2 adaptor complex binding [GO:0035612]; calcium ion binding [GO:0005509]; protein-containing complex binding [GO:0044877] g241.t1 Q9HC10 56.576 403 9.58e-136 475.0 sp|Q9HC10|OTOF_HUMAN Otoferlin OS=Homo sapiens OX=9606 GN=OTOF PE=1 SV=3 g241.t1 Q9HC10 43.369 558 6e-128 451.0 sp|Q9HC10|OTOF_HUMAN Otoferlin OS=Homo sapiens OX=9606 GN=OTOF PE=1 SV=3 g241.t1 Q9HC10 46.614 251 8.17e-51 203.0 sp|Q9HC10|OTOF_HUMAN Otoferlin OS=Homo sapiens OX=9606 GN=OTOF PE=1 SV=3 g241.t2 Q9HC10 56.576 403 9.19e-136 475.0 sp|Q9HC10|OTOF_HUMAN Otoferlin OS=Homo sapiens OX=9606 GN=OTOF PE=1 SV=3 g241.t2 Q9HC10 48.198 444 3.96e-125 443.0 sp|Q9HC10|OTOF_HUMAN Otoferlin OS=Homo sapiens OX=9606 GN=OTOF PE=1 SV=3 g241.t2 Q9HC10 46.614 251 6.93e-51 203.0 sp|Q9HC10|OTOF_HUMAN Otoferlin OS=Homo sapiens OX=9606 GN=OTOF PE=1 SV=3 g241.t3 Q9HC10 56.576 403 9.99e-136 475.0 sp|Q9HC10|OTOF_HUMAN Otoferlin OS=Homo sapiens OX=9606 GN=OTOF PE=1 SV=3 g241.t3 Q9HC10 42.681 567 8.049999999999999e-126 445.0 sp|Q9HC10|OTOF_HUMAN Otoferlin OS=Homo sapiens OX=9606 GN=OTOF PE=1 SV=3 g241.t3 Q9HC10 46.614 251 7.31e-51 203.0 sp|Q9HC10|OTOF_HUMAN Otoferlin OS=Homo sapiens OX=9606 GN=OTOF PE=1 SV=3 g242.t1 Q5SPC5 40.496 121 2.18e-27 111.0 sp|Q5SPC5|OTOF_DANRE Otoferlin OS=Danio rerio OX=7955 GN=otof PE=3 SV=1 OTOF_DANRE reviewed Otoferlin (Fer-1-like protein 2) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000139; GO:0001964; GO:0005509; GO:0005789; GO:0005802; GO:0007009; GO:0007605; GO:0010996; GO:0016079; GO:0016082; GO:0016323; GO:0030672; GO:0035612; GO:0036465; GO:0048787; GO:0050885 neuromuscular process controlling balance [GO:0050885]; plasma membrane organization [GO:0007009]; response to auditory stimulus [GO:0010996]; sensory perception of sound [GO:0007605]; startle response [GO:0001964]; synaptic vesicle exocytosis [GO:0016079]; synaptic vesicle priming [GO:0016082]; synaptic vesicle recycling [GO:0036465] basolateral plasma membrane [GO:0016323]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; presynaptic active zone membrane [GO:0048787]; synaptic vesicle membrane [GO:0030672]; trans-Golgi network [GO:0005802] AP-2 adaptor complex binding [GO:0035612]; calcium ion binding [GO:0005509] g243.t1 Q9GKT2 44.231 312 1.75e-94 286.0 sp|Q9GKT2|FXDC2_MACFA Fatty acid hydroxylase domain-containing protein 2 OS=Macaca fascicularis OX=9541 GN=FAXDC2 PE=2 SV=1 g245.t1 Q9GKT2 52.201 159 6.080000000000001e-57 184.0 sp|Q9GKT2|FXDC2_MACFA Fatty acid hydroxylase domain-containing protein 2 OS=Macaca fascicularis OX=9541 GN=FAXDC2 PE=2 SV=1 g246.t1 A6QLU6 46.104 308 1.22e-66 247.0 sp|A6QLU6|AGRD1_BOVIN Adhesion G-protein coupled receptor D1 OS=Bos taurus OX=9913 GN=ADGRD1 PE=2 SV=1 AGRD1_BOVIN reviewed Adhesion G-protein coupled receptor D1 (G-protein coupled receptor 133) [Cleaved into: Adhesion G-protein coupled receptor D1, N-terminal fragment (ADGRD1 N-terminal fragment); Adhesion G-protein coupled receptor D1, C-terminal fragment (ADGRD1 C-terminal fragment)] Bos taurus (Bovine) GO:0004930; GO:0005886; GO:0007166; GO:0007186; GO:0007189 adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186] plasma membrane [GO:0005886] G protein-coupled receptor activity [GO:0004930] g250.t1 Q6DIY4 58.757 177 9.19e-72 224.0 sp|Q6DIY4|TBPL1_XENTR TATA box-binding protein-like 1 OS=Xenopus tropicalis OX=8364 GN=tbpl1 PE=2 SV=1 g252.t1 B0JZV4 64.327 342 1.62e-155 474.0 sp|B0JZV4|CBPC5_XENTR Cytosolic carboxypeptidase-like protein 5 OS=Xenopus tropicalis OX=8364 GN=agbl5 PE=2 SV=1 CBPC5_XENTR reviewed Cytosolic carboxypeptidase-like protein 5 (EC 3.4.17.-) (EC 3.4.17.24) (ATP/GTP-binding protein-like 5) (Protein deglutamylase CCP5) Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0004181; GO:0005634; GO:0005737; GO:0005829; GO:0006508; GO:0008270; GO:0015630; GO:0015631; GO:0030496; GO:0035608; GO:0035609; GO:0035610; GO:0035611; GO:0051607; GO:0072686 C-terminal protein deglutamylation [GO:0035609]; defense response to virus [GO:0051607]; protein branching point deglutamylation [GO:0035611]; protein deglutamylation [GO:0035608]; protein side chain deglutamylation [GO:0035610]; proteolysis [GO:0006508] cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; nucleus [GO:0005634] metallocarboxypeptidase activity [GO:0004181]; tubulin binding [GO:0015631]; zinc ion binding [GO:0008270] g252.t1 B0JZV4 74.684 79 5.96e-36 138.0 sp|B0JZV4|CBPC5_XENTR Cytosolic carboxypeptidase-like protein 5 OS=Xenopus tropicalis OX=8364 GN=agbl5 PE=2 SV=1 CBPC5_XENTR reviewed Cytosolic carboxypeptidase-like protein 5 (EC 3.4.17.-) (EC 3.4.17.24) (ATP/GTP-binding protein-like 5) (Protein deglutamylase CCP5) Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0004181; GO:0005634; GO:0005737; GO:0005829; GO:0006508; GO:0008270; GO:0015630; GO:0015631; GO:0030496; GO:0035608; GO:0035609; GO:0035610; GO:0035611; GO:0051607; GO:0072686 C-terminal protein deglutamylation [GO:0035609]; defense response to virus [GO:0051607]; protein branching point deglutamylation [GO:0035611]; protein deglutamylation [GO:0035608]; protein side chain deglutamylation [GO:0035610]; proteolysis [GO:0006508] cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; nucleus [GO:0005634] metallocarboxypeptidase activity [GO:0004181]; tubulin binding [GO:0015631]; zinc ion binding [GO:0008270] g252.t1 B0JZV4 94.118 17 5.96e-36 35.8 sp|B0JZV4|CBPC5_XENTR Cytosolic carboxypeptidase-like protein 5 OS=Xenopus tropicalis OX=8364 GN=agbl5 PE=2 SV=1 CBPC5_XENTR reviewed Cytosolic carboxypeptidase-like protein 5 (EC 3.4.17.-) (EC 3.4.17.24) (ATP/GTP-binding protein-like 5) (Protein deglutamylase CCP5) Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0004181; GO:0005634; GO:0005737; GO:0005829; GO:0006508; GO:0008270; GO:0015630; GO:0015631; GO:0030496; GO:0035608; GO:0035609; GO:0035610; GO:0035611; GO:0051607; GO:0072686 C-terminal protein deglutamylation [GO:0035609]; defense response to virus [GO:0051607]; protein branching point deglutamylation [GO:0035611]; protein deglutamylation [GO:0035608]; protein side chain deglutamylation [GO:0035610]; proteolysis [GO:0006508] cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; nucleus [GO:0005634] metallocarboxypeptidase activity [GO:0004181]; tubulin binding [GO:0015631]; zinc ion binding [GO:0008270] g253.t1 A2A5R2 58.264 726 0.0 679.0 sp|A2A5R2|BIG2_MOUSE Brefeldin A-inhibited guanine nucleotide-exchange protein 2 OS=Mus musculus OX=10090 GN=Arfgef2 PE=1 SV=1 BIG2_MOUSE reviewed Brefeldin A-inhibited guanine nucleotide-exchange protein 2 (Brefeldin A-inhibited GEP 2) (ADP-ribosylation factor guanine nucleotide-exchange factor 2) Mus musculus (Mouse) GO:0000139; GO:0001881; GO:0005085; GO:0005802; GO:0005813; GO:0005815; GO:0005829; GO:0005879; GO:0006887; GO:0006893; GO:0007032; GO:0010256; GO:0015031; GO:0016020; GO:0016192; GO:0017022; GO:0031410; GO:0032012; GO:0032279; GO:0032280; GO:0032760; GO:0034237; GO:0035556; GO:0043197; GO:0048471; GO:0050811; GO:0055037; GO:0098793; GO:0098794; GO:0098978; GO:0098982 endomembrane system organization [GO:0010256]; endosome organization [GO:0007032]; exocytosis [GO:0006887]; Golgi to plasma membrane transport [GO:0006893]; intracellular signal transduction [GO:0035556]; positive regulation of tumor necrosis factor production [GO:0032760]; protein transport [GO:0015031]; receptor recycling [GO:0001881]; regulation of ARF protein signal transduction [GO:0032012]; vesicle-mediated transport [GO:0016192] asymmetric synapse [GO:0032279]; axonemal microtubule [GO:0005879]; centrosome [GO:0005813]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; perinuclear region of cytoplasm [GO:0048471]; postsynapse [GO:0098794]; presynapse [GO:0098793]; recycling endosome [GO:0055037]; symmetric synapse [GO:0032280]; trans-Golgi network [GO:0005802] GABA receptor binding [GO:0050811]; guanyl-nucleotide exchange factor activity [GO:0005085]; myosin binding [GO:0017022]; protein kinase A regulatory subunit binding [GO:0034237] g254.t1 G3X9K3 65.827 1112 0.0 1405.0 sp|G3X9K3|BIG1_MOUSE Brefeldin A-inhibited guanine nucleotide-exchange protein 1 OS=Mus musculus OX=10090 GN=Arfgef1 PE=1 SV=1 BIG1_MOUSE reviewed Brefeldin A-inhibited guanine nucleotide-exchange protein 1 (BIG1) (Brefeldin A-inhibited GEP 1) (ADP-ribosylation factor guanine nucleotide-exchange factor 1) Mus musculus (Mouse) GO:0000139; GO:0005085; GO:0005654; GO:0005730; GO:0005794; GO:0005802; GO:0005829; GO:0007030; GO:0009101; GO:0010256; GO:0015031; GO:0016363; GO:0017022; GO:0030532; GO:0030837; GO:0031175; GO:0032012; GO:0034237; GO:0034260; GO:0048471; GO:0051897; GO:0090303; GO:2000114 endomembrane system organization [GO:0010256]; glycoprotein biosynthetic process [GO:0009101]; Golgi organization [GO:0007030]; negative regulation of actin filament polymerization [GO:0030837]; negative regulation of GTPase activity [GO:0034260]; neuron projection development [GO:0031175]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of wound healing [GO:0090303]; protein transport [GO:0015031]; regulation of ARF protein signal transduction [GO:0032012]; regulation of establishment of cell polarity [GO:2000114] cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; nuclear matrix [GO:0016363]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; small nuclear ribonucleoprotein complex [GO:0030532]; trans-Golgi network [GO:0005802] guanyl-nucleotide exchange factor activity [GO:0005085]; myosin binding [GO:0017022]; protein kinase A regulatory subunit binding [GO:0034237] g256.t1 Q01705 37.055 1433 0.0 724.0 sp|Q01705|NOTC1_MOUSE Neurogenic locus notch homolog protein 1 OS=Mus musculus OX=10090 GN=Notch1 PE=1 SV=3 NOTC1_MOUSE reviewed Neurogenic locus notch homolog protein 1 (Notch 1) (Motch A) (mT14) (p300) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Mus musculus (Mouse) GO:0000122; GO:0000139; GO:0001554; GO:0001669; GO:0001701; GO:0001708; GO:0001726; GO:0001837; GO:0001889; GO:0001947; GO:0002040; GO:0002051; GO:0002052; GO:0002193; GO:0002437; GO:0003151; GO:0003157; GO:0003160; GO:0003162; GO:0003169; GO:0003180; GO:0003181; GO:0003182; GO:0003184; GO:0003192; GO:0003197; GO:0003198; GO:0003203; GO:0003207; GO:0003208; GO:0003209; GO:0003213; GO:0003214; GO:0003219; GO:0003222; GO:0003241; GO:0003252; GO:0003264; GO:0003273; GO:0003332; GO:0003344; GO:0003682; GO:0003713; GO:0004857; GO:0004888; GO:0005112; GO:0005509; GO:0005576; GO:0005634; GO:0005654; GO:0005737; GO:0005783; GO:0005789; GO:0005829; GO:0005856; GO:0005886; GO:0005912; GO:0006357; GO:0006606; GO:0006959; GO:0007219; GO:0007221; GO:0007283; GO:0007368; GO:0007386; GO:0007409; GO:0007411; GO:0007440; GO:0007492; GO:0007507; GO:0008284; GO:0008285; GO:0008544; GO:0008593; GO:0009912; GO:0009986; GO:0010001; GO:0010008; GO:0010467; GO:0010468; GO:0010614; GO:0010628; GO:0010629; GO:0010667; GO:0010718; GO:0010812; GO:0010832; GO:0014031; GO:0014807; GO:0016324; GO:0019899; GO:0021515; GO:0021915; GO:0030027; GO:0030154; GO:0030163; GO:0030182; GO:0030216; GO:0030279; GO:0030324; GO:0030326; GO:0030334; GO:0030335; GO:0030513; GO:0030514; GO:0030900; GO:0031069; GO:0031100; GO:0031410; GO:0031490; GO:0031902; GO:0032495; GO:0032496; GO:0032966; GO:0035116; GO:0035148; GO:0035914; GO:0035924; GO:0042127; GO:0042246; GO:0042802; GO:0043065; GO:0043069; GO:0043086; GO:0043235; GO:0045070; GO:0045165; GO:0045596; GO:0045603; GO:0045607; GO:0045608; GO:0045618; GO:0045662; GO:0045665; GO:0045668; GO:0045687; GO:0045747; GO:0045892; GO:0045893; GO:0045944; GO:0045955; GO:0046427; GO:0046533; GO:0046579; GO:0048103; GO:0048593; GO:0048663; GO:0048708; GO:0048709; GO:0048711; GO:0048715; GO:0048754; GO:0048845; GO:0048873; GO:0050678; GO:0050679; GO:0050767; GO:0050768; GO:0051152; GO:0055008; GO:0060038; GO:0060045; GO:0060253; GO:0060271; GO:0060317; GO:0060354; GO:0060379; GO:0060411; GO:0060412; GO:0060528; GO:0060740; GO:0060768; GO:0060842; GO:0060843; GO:0060948; GO:0060956; GO:0060979; GO:0060982; GO:0061344; GO:0061384; GO:0062043; GO:0070168; GO:0070374; GO:0070986; GO:0071228; GO:0071372; GO:0071456; GO:0071944; GO:0072017; GO:0072044; GO:0072144; GO:0072538; GO:0090051; GO:0090090; GO:0097150; GO:0097400; GO:0098685; GO:0098839; GO:0098978; GO:0099565; GO:0120163; GO:0140537; GO:1901189; GO:1901201; GO:1902263; GO:1902339; GO:1903849; GO:2000048; GO:2000737; GO:2000811; GO:2000974; GO:2001027 animal organ regeneration [GO:0031100]; aortic valve morphogenesis [GO:0003180]; apoptotic process involved in embryonic digit morphogenesis [GO:1902263]; arterial endothelial cell differentiation [GO:0060842]; astrocyte differentiation [GO:0048708]; atrioventricular node development [GO:0003162]; atrioventricular valve morphogenesis [GO:0003181]; auditory receptor cell fate commitment [GO:0009912]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; branching morphogenesis of an epithelial tube [GO:0048754]; camera-type eye morphogenesis [GO:0048593]; cardiac atrium morphogenesis [GO:0003209]; cardiac chamber formation [GO:0003207]; cardiac epithelial to mesenchymal transition [GO:0060317]; cardiac left ventricle morphogenesis [GO:0003214]; cardiac muscle cell myoblast differentiation [GO:0060379]; cardiac muscle cell proliferation [GO:0060038]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac right atrium morphogenesis [GO:0003213]; cardiac right ventricle formation [GO:0003219]; cardiac septum morphogenesis [GO:0060411]; cardiac vascular smooth muscle cell development [GO:0060948]; cardiac ventricle morphogenesis [GO:0003208]; cell differentiation [GO:0030154]; cell differentiation in spinal cord [GO:0021515]; cell fate commitment [GO:0045165]; cell fate specification [GO:0001708]; cell migration involved in endocardial cushion formation [GO:0003273]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to hypoxia [GO:0071456]; cellular response to tumor cell [GO:0071228]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; chemical synaptic transmission, postsynaptic [GO:0099565]; cilium assembly [GO:0060271]; collecting duct development [GO:0072044]; compartment pattern specification [GO:0007386]; coronary artery morphogenesis [GO:0060982]; coronary sinus valve morphogenesis [GO:0003182]; coronary vein morphogenesis [GO:0003169]; determination of left/right symmetry [GO:0007368]; distal tubule development [GO:0072017]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic limb morphogenesis [GO:0030326]; endocardial cell differentiation [GO:0060956]; endocardial cushion development [GO:0003197]; endocardial cushion morphogenesis [GO:0003203]; endocardium development [GO:0003157]; endocardium morphogenesis [GO:0003160]; endoderm development [GO:0007492]; epidermis development [GO:0008544]; epithelial to mesenchymal transition [GO:0001837]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; forebrain development [GO:0030900]; foregut morphogenesis [GO:0007440]; gene expression [GO:0010467]; glial cell differentiation [GO:0010001]; glomerular mesangial cell development [GO:0072144]; growth involved in heart morphogenesis [GO:0003241]; hair follicle morphogenesis [GO:0031069]; heart development [GO:0007507]; heart looping [GO:0001947]; heart trabecula morphogenesis [GO:0061384]; homeostasis of number of cells within a tissue [GO:0048873]; humoral immune response [GO:0006959]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; interleukin-17-mediated signaling pathway [GO:0097400]; keratinocyte differentiation [GO:0030216]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; lung development [GO:0030324]; luteolysis [GO:0001554]; mesenchymal cell development [GO:0014031]; mitral valve formation [GO:0003192]; negative regulation of anoikis [GO:2000811]; negative regulation of biomineral tissue development [GO:0070168]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of catalytic activity [GO:0043086]; negative regulation of cell adhesion molecule production [GO:0060354]; negative regulation of cell differentiation [GO:0045596]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell proliferation involved in heart valve morphogenesis [GO:0003252]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of collagen biosynthetic process [GO:0032966]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of endothelial cell chemotaxis [GO:2001027]; negative regulation of extracellular matrix constituent secretion [GO:0003332]; negative regulation of gene expression [GO:0010629]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of inner ear auditory receptor cell differentiation [GO:0045608]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of ossification [GO:0030279]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of photoreceptor cell differentiation [GO:0046533]; negative regulation of pro-B cell differentiation [GO:2000974]; negative regulation of programmed cell death [GO:0043069]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural tube development [GO:0021915]; neuron differentiation [GO:0030182]; neuron fate commitment [GO:0048663]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; oligodendrocyte differentiation [GO:0048709]; osteoblast fate commitment [GO:0002051]; outflow tract morphogenesis [GO:0003151]; pericardium morphogenesis [GO:0003344]; positive regulation of aorta morphogenesis [GO:1903849]; positive regulation of apoptotic process [GO:0043065]; positive regulation of apoptotic process involved in morphogenesis [GO:1902339]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cardiac epithelial to mesenchymal transition [GO:0062043]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of ephrin receptor signaling pathway [GO:1901189]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of glial cell differentiation [GO:0045687]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of smooth muscle cell differentiation [GO:0051152]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription of Notch receptor target [GO:0007221]; positive regulation of viral genome replication [GO:0045070]; prostate gland epithelium morphogenesis [GO:0060740]; protein catabolic process [GO:0030163]; protein import into nucleus [GO:0006606]; pulmonary valve morphogenesis [GO:0003184]; regulation of cardioblast proliferation [GO:0003264]; regulation of cell adhesion involved in heart morphogenesis [GO:0061344]; regulation of cell migration [GO:0030334]; regulation of cell population proliferation [GO:0042127]; regulation of epithelial cell proliferation [GO:0050678]; regulation of epithelial cell proliferation involved in prostate gland development [GO:0060768]; regulation of extracellular matrix assembly [GO:1901201]; regulation of gene expression [GO:0010468]; regulation of inner ear auditory receptor cell differentiation [GO:0045607]; regulation of neurogenesis [GO:0050767]; regulation of Notch signaling pathway [GO:0008593]; regulation of somitogenesis [GO:0014807]; regulation of transcription by RNA polymerase II [GO:0006357]; response to lipopolysaccharide [GO:0032496]; response to muramyl dipeptide [GO:0032495]; secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development [GO:0060528]; skeletal muscle cell differentiation [GO:0035914]; somatic stem cell division [GO:0048103]; spermatogenesis [GO:0007283]; sprouting angiogenesis [GO:0002040]; T-helper 17 type immune response [GO:0072538]; tissue regeneration [GO:0042246]; tube formation [GO:0035148]; vasculogenesis involved in coronary vascular morphogenesis [GO:0060979]; venous blood vessel morphogenesis [GO:0048845]; venous endothelial cell differentiation [GO:0060843]; ventricular septum morphogenesis [GO:0060412]; ventricular trabecula myocardium morphogenesis [GO:0003222] acrosomal vesicle [GO:0001669]; adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell periphery [GO:0071944]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; lamellipodium [GO:0030027]; late endosome membrane [GO:0031902]; MAML1-RBP-Jkappa- ICN1 complex [GO:0002193]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; receptor complex [GO:0043235]; ruffle [GO:0001726]; Schaffer collateral - CA1 synapse [GO:0098685] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; identical protein binding [GO:0042802]; Notch binding [GO:0005112]; transcription coactivator activity [GO:0003713]; transcription regulator activator activity [GO:0140537]; transmembrane signaling receptor activity [GO:0004888] g256.t1 Q01705 35.424 1451 0.0 658.0 sp|Q01705|NOTC1_MOUSE Neurogenic locus notch homolog protein 1 OS=Mus musculus OX=10090 GN=Notch1 PE=1 SV=3 NOTC1_MOUSE reviewed Neurogenic locus notch homolog protein 1 (Notch 1) (Motch A) (mT14) (p300) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Mus musculus (Mouse) GO:0000122; GO:0000139; GO:0001554; GO:0001669; GO:0001701; GO:0001708; GO:0001726; GO:0001837; GO:0001889; GO:0001947; GO:0002040; GO:0002051; GO:0002052; GO:0002193; GO:0002437; GO:0003151; GO:0003157; GO:0003160; GO:0003162; GO:0003169; GO:0003180; GO:0003181; GO:0003182; GO:0003184; GO:0003192; GO:0003197; GO:0003198; GO:0003203; GO:0003207; GO:0003208; GO:0003209; GO:0003213; GO:0003214; GO:0003219; GO:0003222; GO:0003241; GO:0003252; GO:0003264; GO:0003273; GO:0003332; GO:0003344; GO:0003682; GO:0003713; GO:0004857; GO:0004888; GO:0005112; GO:0005509; GO:0005576; GO:0005634; GO:0005654; GO:0005737; GO:0005783; GO:0005789; GO:0005829; GO:0005856; GO:0005886; GO:0005912; GO:0006357; GO:0006606; GO:0006959; GO:0007219; GO:0007221; GO:0007283; GO:0007368; GO:0007386; GO:0007409; GO:0007411; GO:0007440; GO:0007492; GO:0007507; GO:0008284; GO:0008285; GO:0008544; GO:0008593; GO:0009912; GO:0009986; GO:0010001; GO:0010008; GO:0010467; GO:0010468; GO:0010614; GO:0010628; GO:0010629; GO:0010667; GO:0010718; GO:0010812; GO:0010832; GO:0014031; GO:0014807; GO:0016324; GO:0019899; GO:0021515; GO:0021915; GO:0030027; GO:0030154; GO:0030163; GO:0030182; GO:0030216; GO:0030279; GO:0030324; GO:0030326; GO:0030334; GO:0030335; GO:0030513; GO:0030514; GO:0030900; GO:0031069; GO:0031100; GO:0031410; GO:0031490; GO:0031902; GO:0032495; GO:0032496; GO:0032966; GO:0035116; GO:0035148; GO:0035914; GO:0035924; GO:0042127; GO:0042246; GO:0042802; GO:0043065; GO:0043069; GO:0043086; GO:0043235; GO:0045070; GO:0045165; GO:0045596; GO:0045603; GO:0045607; GO:0045608; GO:0045618; GO:0045662; GO:0045665; GO:0045668; GO:0045687; GO:0045747; GO:0045892; GO:0045893; GO:0045944; GO:0045955; GO:0046427; GO:0046533; GO:0046579; GO:0048103; GO:0048593; GO:0048663; GO:0048708; GO:0048709; GO:0048711; GO:0048715; GO:0048754; GO:0048845; GO:0048873; GO:0050678; GO:0050679; GO:0050767; GO:0050768; GO:0051152; GO:0055008; GO:0060038; GO:0060045; GO:0060253; GO:0060271; GO:0060317; GO:0060354; GO:0060379; GO:0060411; GO:0060412; GO:0060528; GO:0060740; GO:0060768; GO:0060842; GO:0060843; GO:0060948; GO:0060956; GO:0060979; GO:0060982; GO:0061344; GO:0061384; GO:0062043; GO:0070168; GO:0070374; GO:0070986; GO:0071228; GO:0071372; GO:0071456; GO:0071944; GO:0072017; GO:0072044; GO:0072144; GO:0072538; GO:0090051; GO:0090090; GO:0097150; GO:0097400; GO:0098685; GO:0098839; GO:0098978; GO:0099565; GO:0120163; GO:0140537; GO:1901189; GO:1901201; GO:1902263; GO:1902339; GO:1903849; GO:2000048; GO:2000737; GO:2000811; GO:2000974; GO:2001027 animal organ regeneration [GO:0031100]; aortic valve morphogenesis [GO:0003180]; apoptotic process involved in embryonic digit morphogenesis [GO:1902263]; arterial endothelial cell differentiation [GO:0060842]; astrocyte differentiation [GO:0048708]; atrioventricular node development [GO:0003162]; atrioventricular valve morphogenesis [GO:0003181]; auditory receptor cell fate commitment [GO:0009912]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; branching morphogenesis of an epithelial tube [GO:0048754]; camera-type eye morphogenesis [GO:0048593]; cardiac atrium morphogenesis [GO:0003209]; cardiac chamber formation [GO:0003207]; cardiac epithelial to mesenchymal transition [GO:0060317]; cardiac left ventricle morphogenesis [GO:0003214]; cardiac muscle cell myoblast differentiation [GO:0060379]; cardiac muscle cell proliferation [GO:0060038]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac right atrium morphogenesis [GO:0003213]; cardiac right ventricle formation [GO:0003219]; cardiac septum morphogenesis [GO:0060411]; cardiac vascular smooth muscle cell development [GO:0060948]; cardiac ventricle morphogenesis [GO:0003208]; cell differentiation [GO:0030154]; cell differentiation in spinal cord [GO:0021515]; cell fate commitment [GO:0045165]; cell fate specification [GO:0001708]; cell migration involved in endocardial cushion formation [GO:0003273]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to hypoxia [GO:0071456]; cellular response to tumor cell [GO:0071228]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; chemical synaptic transmission, postsynaptic [GO:0099565]; cilium assembly [GO:0060271]; collecting duct development [GO:0072044]; compartment pattern specification [GO:0007386]; coronary artery morphogenesis [GO:0060982]; coronary sinus valve morphogenesis [GO:0003182]; coronary vein morphogenesis [GO:0003169]; determination of left/right symmetry [GO:0007368]; distal tubule development [GO:0072017]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic limb morphogenesis [GO:0030326]; endocardial cell differentiation [GO:0060956]; endocardial cushion development [GO:0003197]; endocardial cushion morphogenesis [GO:0003203]; endocardium development [GO:0003157]; endocardium morphogenesis [GO:0003160]; endoderm development [GO:0007492]; epidermis development [GO:0008544]; epithelial to mesenchymal transition [GO:0001837]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; forebrain development [GO:0030900]; foregut morphogenesis [GO:0007440]; gene expression [GO:0010467]; glial cell differentiation [GO:0010001]; glomerular mesangial cell development [GO:0072144]; growth involved in heart morphogenesis [GO:0003241]; hair follicle morphogenesis [GO:0031069]; heart development [GO:0007507]; heart looping [GO:0001947]; heart trabecula morphogenesis [GO:0061384]; homeostasis of number of cells within a tissue [GO:0048873]; humoral immune response [GO:0006959]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; interleukin-17-mediated signaling pathway [GO:0097400]; keratinocyte differentiation [GO:0030216]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; lung development [GO:0030324]; luteolysis [GO:0001554]; mesenchymal cell development [GO:0014031]; mitral valve formation [GO:0003192]; negative regulation of anoikis [GO:2000811]; negative regulation of biomineral tissue development [GO:0070168]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of catalytic activity [GO:0043086]; negative regulation of cell adhesion molecule production [GO:0060354]; negative regulation of cell differentiation [GO:0045596]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell proliferation involved in heart valve morphogenesis [GO:0003252]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of collagen biosynthetic process [GO:0032966]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of endothelial cell chemotaxis [GO:2001027]; negative regulation of extracellular matrix constituent secretion [GO:0003332]; negative regulation of gene expression [GO:0010629]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of inner ear auditory receptor cell differentiation [GO:0045608]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of ossification [GO:0030279]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of photoreceptor cell differentiation [GO:0046533]; negative regulation of pro-B cell differentiation [GO:2000974]; negative regulation of programmed cell death [GO:0043069]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural tube development [GO:0021915]; neuron differentiation [GO:0030182]; neuron fate commitment [GO:0048663]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; oligodendrocyte differentiation [GO:0048709]; osteoblast fate commitment [GO:0002051]; outflow tract morphogenesis [GO:0003151]; pericardium morphogenesis [GO:0003344]; positive regulation of aorta morphogenesis [GO:1903849]; positive regulation of apoptotic process [GO:0043065]; positive regulation of apoptotic process involved in morphogenesis [GO:1902339]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cardiac epithelial to mesenchymal transition [GO:0062043]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of ephrin receptor signaling pathway [GO:1901189]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of glial cell differentiation [GO:0045687]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of smooth muscle cell differentiation [GO:0051152]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription of Notch receptor target [GO:0007221]; positive regulation of viral genome replication [GO:0045070]; prostate gland epithelium morphogenesis [GO:0060740]; protein catabolic process [GO:0030163]; protein import into nucleus [GO:0006606]; pulmonary valve morphogenesis [GO:0003184]; regulation of cardioblast proliferation [GO:0003264]; regulation of cell adhesion involved in heart morphogenesis [GO:0061344]; regulation of cell migration [GO:0030334]; regulation of cell population proliferation [GO:0042127]; regulation of epithelial cell proliferation [GO:0050678]; regulation of epithelial cell proliferation involved in prostate gland development [GO:0060768]; regulation of extracellular matrix assembly [GO:1901201]; regulation of gene expression [GO:0010468]; regulation of inner ear auditory receptor cell differentiation [GO:0045607]; regulation of neurogenesis [GO:0050767]; regulation of Notch signaling pathway [GO:0008593]; regulation of somitogenesis [GO:0014807]; regulation of transcription by RNA polymerase II [GO:0006357]; response to lipopolysaccharide [GO:0032496]; response to muramyl dipeptide [GO:0032495]; secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development [GO:0060528]; skeletal muscle cell differentiation [GO:0035914]; somatic stem cell division [GO:0048103]; spermatogenesis [GO:0007283]; sprouting angiogenesis [GO:0002040]; T-helper 17 type immune response [GO:0072538]; tissue regeneration [GO:0042246]; tube formation [GO:0035148]; vasculogenesis involved in coronary vascular morphogenesis [GO:0060979]; venous blood vessel morphogenesis [GO:0048845]; venous endothelial cell differentiation [GO:0060843]; ventricular septum morphogenesis [GO:0060412]; ventricular trabecula myocardium morphogenesis [GO:0003222] acrosomal vesicle [GO:0001669]; adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell periphery [GO:0071944]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; lamellipodium [GO:0030027]; late endosome membrane [GO:0031902]; MAML1-RBP-Jkappa- ICN1 complex [GO:0002193]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; receptor complex [GO:0043235]; ruffle [GO:0001726]; Schaffer collateral - CA1 synapse [GO:0098685] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; identical protein binding [GO:0042802]; Notch binding [GO:0005112]; transcription coactivator activity [GO:0003713]; transcription regulator activator activity [GO:0140537]; transmembrane signaling receptor activity [GO:0004888] g256.t1 Q01705 35.144 1454 0.0 645.0 sp|Q01705|NOTC1_MOUSE Neurogenic locus notch homolog protein 1 OS=Mus musculus OX=10090 GN=Notch1 PE=1 SV=3 NOTC1_MOUSE reviewed Neurogenic locus notch homolog protein 1 (Notch 1) (Motch A) (mT14) (p300) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Mus musculus (Mouse) GO:0000122; GO:0000139; GO:0001554; GO:0001669; GO:0001701; GO:0001708; GO:0001726; GO:0001837; GO:0001889; GO:0001947; GO:0002040; GO:0002051; GO:0002052; GO:0002193; GO:0002437; GO:0003151; GO:0003157; GO:0003160; GO:0003162; GO:0003169; GO:0003180; GO:0003181; GO:0003182; GO:0003184; GO:0003192; GO:0003197; GO:0003198; GO:0003203; GO:0003207; GO:0003208; GO:0003209; GO:0003213; GO:0003214; GO:0003219; GO:0003222; GO:0003241; GO:0003252; GO:0003264; GO:0003273; GO:0003332; GO:0003344; GO:0003682; GO:0003713; GO:0004857; GO:0004888; GO:0005112; GO:0005509; GO:0005576; GO:0005634; GO:0005654; GO:0005737; GO:0005783; GO:0005789; GO:0005829; GO:0005856; GO:0005886; GO:0005912; GO:0006357; GO:0006606; GO:0006959; GO:0007219; GO:0007221; GO:0007283; GO:0007368; GO:0007386; GO:0007409; GO:0007411; GO:0007440; GO:0007492; GO:0007507; GO:0008284; GO:0008285; GO:0008544; GO:0008593; GO:0009912; GO:0009986; GO:0010001; GO:0010008; GO:0010467; GO:0010468; GO:0010614; GO:0010628; GO:0010629; GO:0010667; GO:0010718; GO:0010812; GO:0010832; GO:0014031; GO:0014807; GO:0016324; GO:0019899; GO:0021515; GO:0021915; GO:0030027; GO:0030154; GO:0030163; GO:0030182; GO:0030216; GO:0030279; GO:0030324; GO:0030326; GO:0030334; GO:0030335; GO:0030513; GO:0030514; GO:0030900; GO:0031069; GO:0031100; GO:0031410; GO:0031490; GO:0031902; GO:0032495; GO:0032496; GO:0032966; GO:0035116; GO:0035148; GO:0035914; GO:0035924; GO:0042127; GO:0042246; GO:0042802; GO:0043065; GO:0043069; GO:0043086; GO:0043235; GO:0045070; GO:0045165; GO:0045596; GO:0045603; GO:0045607; GO:0045608; GO:0045618; GO:0045662; GO:0045665; GO:0045668; GO:0045687; GO:0045747; GO:0045892; GO:0045893; GO:0045944; GO:0045955; GO:0046427; GO:0046533; GO:0046579; GO:0048103; GO:0048593; GO:0048663; GO:0048708; GO:0048709; GO:0048711; GO:0048715; GO:0048754; GO:0048845; GO:0048873; GO:0050678; GO:0050679; GO:0050767; GO:0050768; GO:0051152; GO:0055008; GO:0060038; GO:0060045; GO:0060253; GO:0060271; GO:0060317; GO:0060354; GO:0060379; GO:0060411; GO:0060412; GO:0060528; GO:0060740; GO:0060768; GO:0060842; GO:0060843; GO:0060948; GO:0060956; GO:0060979; GO:0060982; GO:0061344; GO:0061384; GO:0062043; GO:0070168; GO:0070374; GO:0070986; GO:0071228; GO:0071372; GO:0071456; GO:0071944; GO:0072017; GO:0072044; GO:0072144; GO:0072538; GO:0090051; GO:0090090; GO:0097150; GO:0097400; GO:0098685; GO:0098839; GO:0098978; GO:0099565; GO:0120163; GO:0140537; GO:1901189; GO:1901201; GO:1902263; GO:1902339; GO:1903849; GO:2000048; GO:2000737; GO:2000811; GO:2000974; GO:2001027 animal organ regeneration [GO:0031100]; aortic valve morphogenesis [GO:0003180]; apoptotic process involved in embryonic digit morphogenesis [GO:1902263]; arterial endothelial cell differentiation [GO:0060842]; astrocyte differentiation [GO:0048708]; atrioventricular node development [GO:0003162]; atrioventricular valve morphogenesis [GO:0003181]; auditory receptor cell fate commitment [GO:0009912]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; branching morphogenesis of an epithelial tube [GO:0048754]; camera-type eye morphogenesis [GO:0048593]; cardiac atrium morphogenesis [GO:0003209]; cardiac chamber formation [GO:0003207]; cardiac epithelial to mesenchymal transition [GO:0060317]; cardiac left ventricle morphogenesis [GO:0003214]; cardiac muscle cell myoblast differentiation [GO:0060379]; cardiac muscle cell proliferation [GO:0060038]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac right atrium morphogenesis [GO:0003213]; cardiac right ventricle formation [GO:0003219]; cardiac septum morphogenesis [GO:0060411]; cardiac vascular smooth muscle cell development [GO:0060948]; cardiac ventricle morphogenesis [GO:0003208]; cell differentiation [GO:0030154]; cell differentiation in spinal cord [GO:0021515]; cell fate commitment [GO:0045165]; cell fate specification [GO:0001708]; cell migration involved in endocardial cushion formation [GO:0003273]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to hypoxia [GO:0071456]; cellular response to tumor cell [GO:0071228]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; chemical synaptic transmission, postsynaptic [GO:0099565]; cilium assembly [GO:0060271]; collecting duct development [GO:0072044]; compartment pattern specification [GO:0007386]; coronary artery morphogenesis [GO:0060982]; coronary sinus valve morphogenesis [GO:0003182]; coronary vein morphogenesis [GO:0003169]; determination of left/right symmetry [GO:0007368]; distal tubule development [GO:0072017]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic limb morphogenesis [GO:0030326]; endocardial cell differentiation [GO:0060956]; endocardial cushion development [GO:0003197]; endocardial cushion morphogenesis [GO:0003203]; endocardium development [GO:0003157]; endocardium morphogenesis [GO:0003160]; endoderm development [GO:0007492]; epidermis development [GO:0008544]; epithelial to mesenchymal transition [GO:0001837]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; forebrain development [GO:0030900]; foregut morphogenesis [GO:0007440]; gene expression [GO:0010467]; glial cell differentiation [GO:0010001]; glomerular mesangial cell development [GO:0072144]; growth involved in heart morphogenesis [GO:0003241]; hair follicle morphogenesis [GO:0031069]; heart development [GO:0007507]; heart looping [GO:0001947]; heart trabecula morphogenesis [GO:0061384]; homeostasis of number of cells within a tissue [GO:0048873]; humoral immune response [GO:0006959]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; interleukin-17-mediated signaling pathway [GO:0097400]; keratinocyte differentiation [GO:0030216]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; lung development [GO:0030324]; luteolysis [GO:0001554]; mesenchymal cell development [GO:0014031]; mitral valve formation [GO:0003192]; negative regulation of anoikis [GO:2000811]; negative regulation of biomineral tissue development [GO:0070168]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of catalytic activity [GO:0043086]; negative regulation of cell adhesion molecule production [GO:0060354]; negative regulation of cell differentiation [GO:0045596]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell proliferation involved in heart valve morphogenesis [GO:0003252]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of collagen biosynthetic process [GO:0032966]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of endothelial cell chemotaxis [GO:2001027]; negative regulation of extracellular matrix constituent secretion [GO:0003332]; negative regulation of gene expression [GO:0010629]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of inner ear auditory receptor cell differentiation [GO:0045608]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of ossification [GO:0030279]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of photoreceptor cell differentiation [GO:0046533]; negative regulation of pro-B cell differentiation [GO:2000974]; negative regulation of programmed cell death [GO:0043069]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural tube development [GO:0021915]; neuron differentiation [GO:0030182]; neuron fate commitment [GO:0048663]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; oligodendrocyte differentiation [GO:0048709]; osteoblast fate commitment [GO:0002051]; outflow tract morphogenesis [GO:0003151]; pericardium morphogenesis [GO:0003344]; positive regulation of aorta morphogenesis [GO:1903849]; positive regulation of apoptotic process [GO:0043065]; positive regulation of apoptotic process involved in morphogenesis [GO:1902339]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cardiac epithelial to mesenchymal transition [GO:0062043]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of ephrin receptor signaling pathway [GO:1901189]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of glial cell differentiation [GO:0045687]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of smooth muscle cell differentiation [GO:0051152]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription of Notch receptor target [GO:0007221]; positive regulation of viral genome replication [GO:0045070]; prostate gland epithelium morphogenesis [GO:0060740]; protein catabolic process [GO:0030163]; protein import into nucleus [GO:0006606]; pulmonary valve morphogenesis [GO:0003184]; regulation of cardioblast proliferation [GO:0003264]; regulation of cell adhesion involved in heart morphogenesis [GO:0061344]; regulation of cell migration [GO:0030334]; regulation of cell population proliferation [GO:0042127]; regulation of epithelial cell proliferation [GO:0050678]; regulation of epithelial cell proliferation involved in prostate gland development [GO:0060768]; regulation of extracellular matrix assembly [GO:1901201]; regulation of gene expression [GO:0010468]; regulation of inner ear auditory receptor cell differentiation [GO:0045607]; regulation of neurogenesis [GO:0050767]; regulation of Notch signaling pathway [GO:0008593]; regulation of somitogenesis [GO:0014807]; regulation of transcription by RNA polymerase II [GO:0006357]; response to lipopolysaccharide [GO:0032496]; response to muramyl dipeptide [GO:0032495]; secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development [GO:0060528]; skeletal muscle cell differentiation [GO:0035914]; somatic stem cell division [GO:0048103]; spermatogenesis [GO:0007283]; sprouting angiogenesis [GO:0002040]; T-helper 17 type immune response [GO:0072538]; tissue regeneration [GO:0042246]; tube formation [GO:0035148]; vasculogenesis involved in coronary vascular morphogenesis [GO:0060979]; venous blood vessel morphogenesis [GO:0048845]; venous endothelial cell differentiation [GO:0060843]; ventricular septum morphogenesis [GO:0060412]; ventricular trabecula myocardium morphogenesis [GO:0003222] acrosomal vesicle [GO:0001669]; adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell periphery [GO:0071944]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; lamellipodium [GO:0030027]; late endosome membrane [GO:0031902]; MAML1-RBP-Jkappa- ICN1 complex [GO:0002193]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; receptor complex [GO:0043235]; ruffle [GO:0001726]; Schaffer collateral - CA1 synapse [GO:0098685] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; identical protein binding [GO:0042802]; Notch binding [GO:0005112]; transcription coactivator activity [GO:0003713]; transcription regulator activator activity [GO:0140537]; transmembrane signaling receptor activity [GO:0004888] g256.t1 Q01705 35.784 1442 0.0 642.0 sp|Q01705|NOTC1_MOUSE Neurogenic locus notch homolog protein 1 OS=Mus musculus OX=10090 GN=Notch1 PE=1 SV=3 NOTC1_MOUSE reviewed Neurogenic locus notch homolog protein 1 (Notch 1) (Motch A) (mT14) (p300) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Mus musculus (Mouse) GO:0000122; GO:0000139; GO:0001554; GO:0001669; GO:0001701; GO:0001708; GO:0001726; GO:0001837; GO:0001889; GO:0001947; GO:0002040; GO:0002051; GO:0002052; GO:0002193; GO:0002437; GO:0003151; GO:0003157; GO:0003160; GO:0003162; GO:0003169; GO:0003180; GO:0003181; GO:0003182; GO:0003184; GO:0003192; GO:0003197; GO:0003198; GO:0003203; GO:0003207; GO:0003208; GO:0003209; GO:0003213; GO:0003214; GO:0003219; GO:0003222; GO:0003241; GO:0003252; GO:0003264; GO:0003273; GO:0003332; GO:0003344; GO:0003682; GO:0003713; GO:0004857; GO:0004888; GO:0005112; GO:0005509; GO:0005576; GO:0005634; GO:0005654; GO:0005737; GO:0005783; GO:0005789; GO:0005829; GO:0005856; GO:0005886; GO:0005912; GO:0006357; GO:0006606; GO:0006959; GO:0007219; GO:0007221; GO:0007283; GO:0007368; GO:0007386; GO:0007409; GO:0007411; GO:0007440; GO:0007492; GO:0007507; GO:0008284; GO:0008285; GO:0008544; GO:0008593; GO:0009912; GO:0009986; GO:0010001; GO:0010008; GO:0010467; GO:0010468; GO:0010614; GO:0010628; GO:0010629; GO:0010667; GO:0010718; GO:0010812; GO:0010832; GO:0014031; GO:0014807; GO:0016324; GO:0019899; GO:0021515; GO:0021915; GO:0030027; GO:0030154; GO:0030163; GO:0030182; GO:0030216; GO:0030279; GO:0030324; GO:0030326; GO:0030334; GO:0030335; GO:0030513; GO:0030514; GO:0030900; GO:0031069; GO:0031100; GO:0031410; GO:0031490; GO:0031902; GO:0032495; GO:0032496; GO:0032966; GO:0035116; GO:0035148; GO:0035914; GO:0035924; GO:0042127; GO:0042246; GO:0042802; GO:0043065; GO:0043069; GO:0043086; GO:0043235; GO:0045070; GO:0045165; GO:0045596; GO:0045603; GO:0045607; GO:0045608; GO:0045618; GO:0045662; GO:0045665; GO:0045668; GO:0045687; GO:0045747; GO:0045892; GO:0045893; GO:0045944; GO:0045955; GO:0046427; GO:0046533; GO:0046579; GO:0048103; GO:0048593; GO:0048663; GO:0048708; GO:0048709; GO:0048711; GO:0048715; GO:0048754; GO:0048845; GO:0048873; GO:0050678; GO:0050679; GO:0050767; GO:0050768; GO:0051152; GO:0055008; GO:0060038; GO:0060045; GO:0060253; GO:0060271; GO:0060317; GO:0060354; GO:0060379; GO:0060411; GO:0060412; GO:0060528; GO:0060740; GO:0060768; GO:0060842; GO:0060843; GO:0060948; GO:0060956; GO:0060979; GO:0060982; GO:0061344; GO:0061384; GO:0062043; GO:0070168; GO:0070374; GO:0070986; GO:0071228; GO:0071372; GO:0071456; GO:0071944; GO:0072017; GO:0072044; GO:0072144; GO:0072538; GO:0090051; GO:0090090; GO:0097150; GO:0097400; GO:0098685; GO:0098839; GO:0098978; GO:0099565; GO:0120163; GO:0140537; GO:1901189; GO:1901201; GO:1902263; GO:1902339; GO:1903849; GO:2000048; GO:2000737; GO:2000811; GO:2000974; GO:2001027 animal organ regeneration [GO:0031100]; aortic valve morphogenesis [GO:0003180]; apoptotic process involved in embryonic digit morphogenesis [GO:1902263]; arterial endothelial cell differentiation [GO:0060842]; astrocyte differentiation [GO:0048708]; atrioventricular node development [GO:0003162]; atrioventricular valve morphogenesis [GO:0003181]; auditory receptor cell fate commitment [GO:0009912]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; branching morphogenesis of an epithelial tube [GO:0048754]; camera-type eye morphogenesis [GO:0048593]; cardiac atrium morphogenesis [GO:0003209]; cardiac chamber formation [GO:0003207]; cardiac epithelial to mesenchymal transition [GO:0060317]; cardiac left ventricle morphogenesis [GO:0003214]; cardiac muscle cell myoblast differentiation [GO:0060379]; cardiac muscle cell proliferation [GO:0060038]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac right atrium morphogenesis [GO:0003213]; cardiac right ventricle formation [GO:0003219]; cardiac septum morphogenesis [GO:0060411]; cardiac vascular smooth muscle cell development [GO:0060948]; cardiac ventricle morphogenesis [GO:0003208]; cell differentiation [GO:0030154]; cell differentiation in spinal cord [GO:0021515]; cell fate commitment [GO:0045165]; cell fate specification [GO:0001708]; cell migration involved in endocardial cushion formation [GO:0003273]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to hypoxia [GO:0071456]; cellular response to tumor cell [GO:0071228]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; chemical synaptic transmission, postsynaptic [GO:0099565]; cilium assembly [GO:0060271]; collecting duct development [GO:0072044]; compartment pattern specification [GO:0007386]; coronary artery morphogenesis [GO:0060982]; coronary sinus valve morphogenesis [GO:0003182]; coronary vein morphogenesis [GO:0003169]; determination of left/right symmetry [GO:0007368]; distal tubule development [GO:0072017]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic limb morphogenesis [GO:0030326]; endocardial cell differentiation [GO:0060956]; endocardial cushion development [GO:0003197]; endocardial cushion morphogenesis [GO:0003203]; endocardium development [GO:0003157]; endocardium morphogenesis [GO:0003160]; endoderm development [GO:0007492]; epidermis development [GO:0008544]; epithelial to mesenchymal transition [GO:0001837]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; forebrain development [GO:0030900]; foregut morphogenesis [GO:0007440]; gene expression [GO:0010467]; glial cell differentiation [GO:0010001]; glomerular mesangial cell development [GO:0072144]; growth involved in heart morphogenesis [GO:0003241]; hair follicle morphogenesis [GO:0031069]; heart development [GO:0007507]; heart looping [GO:0001947]; heart trabecula morphogenesis [GO:0061384]; homeostasis of number of cells within a tissue [GO:0048873]; humoral immune response [GO:0006959]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; interleukin-17-mediated signaling pathway [GO:0097400]; keratinocyte differentiation [GO:0030216]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; lung development [GO:0030324]; luteolysis [GO:0001554]; mesenchymal cell development [GO:0014031]; mitral valve formation [GO:0003192]; negative regulation of anoikis [GO:2000811]; negative regulation of biomineral tissue development [GO:0070168]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of catalytic activity [GO:0043086]; negative regulation of cell adhesion molecule production [GO:0060354]; negative regulation of cell differentiation [GO:0045596]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell proliferation involved in heart valve morphogenesis [GO:0003252]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of collagen biosynthetic process [GO:0032966]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of endothelial cell chemotaxis [GO:2001027]; negative regulation of extracellular matrix constituent secretion [GO:0003332]; negative regulation of gene expression [GO:0010629]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of inner ear auditory receptor cell differentiation [GO:0045608]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of ossification [GO:0030279]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of photoreceptor cell differentiation [GO:0046533]; negative regulation of pro-B cell differentiation [GO:2000974]; negative regulation of programmed cell death [GO:0043069]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural tube development [GO:0021915]; neuron differentiation [GO:0030182]; neuron fate commitment [GO:0048663]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; oligodendrocyte differentiation [GO:0048709]; osteoblast fate commitment [GO:0002051]; outflow tract morphogenesis [GO:0003151]; pericardium morphogenesis [GO:0003344]; positive regulation of aorta morphogenesis [GO:1903849]; positive regulation of apoptotic process [GO:0043065]; positive regulation of apoptotic process involved in morphogenesis [GO:1902339]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cardiac epithelial to mesenchymal transition [GO:0062043]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of ephrin receptor signaling pathway [GO:1901189]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of glial cell differentiation [GO:0045687]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of smooth muscle cell differentiation [GO:0051152]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription of Notch receptor target [GO:0007221]; positive regulation of viral genome replication [GO:0045070]; prostate gland epithelium morphogenesis [GO:0060740]; protein catabolic process [GO:0030163]; protein import into nucleus [GO:0006606]; pulmonary valve morphogenesis [GO:0003184]; regulation of cardioblast proliferation [GO:0003264]; regulation of cell adhesion involved in heart morphogenesis [GO:0061344]; regulation of cell migration [GO:0030334]; regulation of cell population proliferation [GO:0042127]; regulation of epithelial cell proliferation [GO:0050678]; regulation of epithelial cell proliferation involved in prostate gland development [GO:0060768]; regulation of extracellular matrix assembly [GO:1901201]; regulation of gene expression [GO:0010468]; regulation of inner ear auditory receptor cell differentiation [GO:0045607]; regulation of neurogenesis [GO:0050767]; regulation of Notch signaling pathway [GO:0008593]; regulation of somitogenesis [GO:0014807]; regulation of transcription by RNA polymerase II [GO:0006357]; response to lipopolysaccharide [GO:0032496]; response to muramyl dipeptide [GO:0032495]; secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development [GO:0060528]; skeletal muscle cell differentiation [GO:0035914]; somatic stem cell division [GO:0048103]; spermatogenesis [GO:0007283]; sprouting angiogenesis [GO:0002040]; T-helper 17 type immune response [GO:0072538]; tissue regeneration [GO:0042246]; tube formation [GO:0035148]; vasculogenesis involved in coronary vascular morphogenesis [GO:0060979]; venous blood vessel morphogenesis [GO:0048845]; venous endothelial cell differentiation [GO:0060843]; ventricular septum morphogenesis [GO:0060412]; ventricular trabecula myocardium morphogenesis [GO:0003222] acrosomal vesicle [GO:0001669]; adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell periphery [GO:0071944]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; lamellipodium [GO:0030027]; late endosome membrane [GO:0031902]; MAML1-RBP-Jkappa- ICN1 complex [GO:0002193]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; receptor complex [GO:0043235]; ruffle [GO:0001726]; Schaffer collateral - CA1 synapse [GO:0098685] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; identical protein binding [GO:0042802]; Notch binding [GO:0005112]; transcription coactivator activity [GO:0003713]; transcription regulator activator activity [GO:0140537]; transmembrane signaling receptor activity [GO:0004888] g256.t1 Q01705 35.749 1449 0.0 632.0 sp|Q01705|NOTC1_MOUSE Neurogenic locus notch homolog protein 1 OS=Mus musculus OX=10090 GN=Notch1 PE=1 SV=3 NOTC1_MOUSE reviewed Neurogenic locus notch homolog protein 1 (Notch 1) (Motch A) (mT14) (p300) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Mus musculus (Mouse) GO:0000122; GO:0000139; GO:0001554; GO:0001669; GO:0001701; GO:0001708; GO:0001726; GO:0001837; GO:0001889; GO:0001947; GO:0002040; GO:0002051; GO:0002052; GO:0002193; GO:0002437; GO:0003151; GO:0003157; GO:0003160; GO:0003162; GO:0003169; GO:0003180; GO:0003181; GO:0003182; GO:0003184; GO:0003192; GO:0003197; GO:0003198; GO:0003203; GO:0003207; GO:0003208; GO:0003209; GO:0003213; GO:0003214; GO:0003219; GO:0003222; GO:0003241; GO:0003252; GO:0003264; GO:0003273; GO:0003332; GO:0003344; GO:0003682; GO:0003713; GO:0004857; GO:0004888; GO:0005112; GO:0005509; GO:0005576; GO:0005634; GO:0005654; GO:0005737; GO:0005783; GO:0005789; GO:0005829; GO:0005856; GO:0005886; GO:0005912; GO:0006357; GO:0006606; GO:0006959; GO:0007219; GO:0007221; GO:0007283; GO:0007368; GO:0007386; GO:0007409; GO:0007411; GO:0007440; GO:0007492; GO:0007507; GO:0008284; GO:0008285; GO:0008544; GO:0008593; GO:0009912; GO:0009986; GO:0010001; GO:0010008; GO:0010467; GO:0010468; GO:0010614; GO:0010628; GO:0010629; GO:0010667; GO:0010718; GO:0010812; GO:0010832; GO:0014031; GO:0014807; GO:0016324; GO:0019899; GO:0021515; GO:0021915; GO:0030027; GO:0030154; GO:0030163; GO:0030182; GO:0030216; GO:0030279; GO:0030324; GO:0030326; GO:0030334; GO:0030335; GO:0030513; GO:0030514; GO:0030900; GO:0031069; GO:0031100; GO:0031410; GO:0031490; GO:0031902; GO:0032495; GO:0032496; GO:0032966; GO:0035116; GO:0035148; GO:0035914; GO:0035924; GO:0042127; GO:0042246; GO:0042802; GO:0043065; GO:0043069; GO:0043086; GO:0043235; GO:0045070; GO:0045165; GO:0045596; GO:0045603; GO:0045607; GO:0045608; GO:0045618; GO:0045662; GO:0045665; GO:0045668; GO:0045687; GO:0045747; GO:0045892; GO:0045893; GO:0045944; GO:0045955; GO:0046427; GO:0046533; GO:0046579; GO:0048103; GO:0048593; GO:0048663; GO:0048708; GO:0048709; GO:0048711; GO:0048715; GO:0048754; GO:0048845; GO:0048873; GO:0050678; GO:0050679; GO:0050767; GO:0050768; GO:0051152; GO:0055008; GO:0060038; GO:0060045; GO:0060253; GO:0060271; GO:0060317; GO:0060354; GO:0060379; GO:0060411; GO:0060412; GO:0060528; GO:0060740; GO:0060768; GO:0060842; GO:0060843; GO:0060948; GO:0060956; GO:0060979; GO:0060982; GO:0061344; GO:0061384; GO:0062043; GO:0070168; GO:0070374; GO:0070986; GO:0071228; GO:0071372; GO:0071456; GO:0071944; GO:0072017; GO:0072044; GO:0072144; GO:0072538; GO:0090051; GO:0090090; GO:0097150; GO:0097400; GO:0098685; GO:0098839; GO:0098978; GO:0099565; GO:0120163; GO:0140537; GO:1901189; GO:1901201; GO:1902263; GO:1902339; GO:1903849; GO:2000048; GO:2000737; GO:2000811; GO:2000974; GO:2001027 animal organ regeneration [GO:0031100]; aortic valve morphogenesis [GO:0003180]; apoptotic process involved in embryonic digit morphogenesis [GO:1902263]; arterial endothelial cell differentiation [GO:0060842]; astrocyte differentiation [GO:0048708]; atrioventricular node development [GO:0003162]; atrioventricular valve morphogenesis [GO:0003181]; auditory receptor cell fate commitment [GO:0009912]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; branching morphogenesis of an epithelial tube [GO:0048754]; camera-type eye morphogenesis [GO:0048593]; cardiac atrium morphogenesis [GO:0003209]; cardiac chamber formation [GO:0003207]; cardiac epithelial to mesenchymal transition [GO:0060317]; cardiac left ventricle morphogenesis [GO:0003214]; cardiac muscle cell myoblast differentiation [GO:0060379]; cardiac muscle cell proliferation [GO:0060038]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac right atrium morphogenesis [GO:0003213]; cardiac right ventricle formation [GO:0003219]; cardiac septum morphogenesis [GO:0060411]; cardiac vascular smooth muscle cell development [GO:0060948]; cardiac ventricle morphogenesis [GO:0003208]; cell differentiation [GO:0030154]; cell differentiation in spinal cord [GO:0021515]; cell fate commitment [GO:0045165]; cell fate specification [GO:0001708]; cell migration involved in endocardial cushion formation [GO:0003273]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to hypoxia [GO:0071456]; cellular response to tumor cell [GO:0071228]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; chemical synaptic transmission, postsynaptic [GO:0099565]; cilium assembly [GO:0060271]; collecting duct development [GO:0072044]; compartment pattern specification [GO:0007386]; coronary artery morphogenesis [GO:0060982]; coronary sinus valve morphogenesis [GO:0003182]; coronary vein morphogenesis [GO:0003169]; determination of left/right symmetry [GO:0007368]; distal tubule development [GO:0072017]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic limb morphogenesis [GO:0030326]; endocardial cell differentiation [GO:0060956]; endocardial cushion development [GO:0003197]; endocardial cushion morphogenesis [GO:0003203]; endocardium development [GO:0003157]; endocardium morphogenesis [GO:0003160]; endoderm development [GO:0007492]; epidermis development [GO:0008544]; epithelial to mesenchymal transition [GO:0001837]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; forebrain development [GO:0030900]; foregut morphogenesis [GO:0007440]; gene expression [GO:0010467]; glial cell differentiation [GO:0010001]; glomerular mesangial cell development [GO:0072144]; growth involved in heart morphogenesis [GO:0003241]; hair follicle morphogenesis [GO:0031069]; heart development [GO:0007507]; heart looping [GO:0001947]; heart trabecula morphogenesis [GO:0061384]; homeostasis of number of cells within a tissue [GO:0048873]; humoral immune response [GO:0006959]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; interleukin-17-mediated signaling pathway [GO:0097400]; keratinocyte differentiation [GO:0030216]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; lung development [GO:0030324]; luteolysis [GO:0001554]; mesenchymal cell development [GO:0014031]; mitral valve formation [GO:0003192]; negative regulation of anoikis [GO:2000811]; negative regulation of biomineral tissue development [GO:0070168]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of catalytic activity [GO:0043086]; negative regulation of cell adhesion molecule production [GO:0060354]; negative regulation of cell differentiation [GO:0045596]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell proliferation involved in heart valve morphogenesis [GO:0003252]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of collagen biosynthetic process [GO:0032966]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of endothelial cell chemotaxis [GO:2001027]; negative regulation of extracellular matrix constituent secretion [GO:0003332]; negative regulation of gene expression [GO:0010629]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of inner ear auditory receptor cell differentiation [GO:0045608]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of ossification [GO:0030279]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of photoreceptor cell differentiation [GO:0046533]; negative regulation of pro-B cell differentiation [GO:2000974]; negative regulation of programmed cell death [GO:0043069]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural tube development [GO:0021915]; neuron differentiation [GO:0030182]; neuron fate commitment [GO:0048663]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; oligodendrocyte differentiation [GO:0048709]; osteoblast fate commitment [GO:0002051]; outflow tract morphogenesis [GO:0003151]; pericardium morphogenesis [GO:0003344]; positive regulation of aorta morphogenesis [GO:1903849]; positive regulation of apoptotic process [GO:0043065]; positive regulation of apoptotic process involved in morphogenesis [GO:1902339]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cardiac epithelial to mesenchymal transition [GO:0062043]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of ephrin receptor signaling pathway [GO:1901189]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of glial cell differentiation [GO:0045687]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of smooth muscle cell differentiation [GO:0051152]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription of Notch receptor target [GO:0007221]; positive regulation of viral genome replication [GO:0045070]; prostate gland epithelium morphogenesis [GO:0060740]; protein catabolic process [GO:0030163]; protein import into nucleus [GO:0006606]; pulmonary valve morphogenesis [GO:0003184]; regulation of cardioblast proliferation [GO:0003264]; regulation of cell adhesion involved in heart morphogenesis [GO:0061344]; regulation of cell migration [GO:0030334]; regulation of cell population proliferation [GO:0042127]; regulation of epithelial cell proliferation [GO:0050678]; regulation of epithelial cell proliferation involved in prostate gland development [GO:0060768]; regulation of extracellular matrix assembly [GO:1901201]; regulation of gene expression [GO:0010468]; regulation of inner ear auditory receptor cell differentiation [GO:0045607]; regulation of neurogenesis [GO:0050767]; regulation of Notch signaling pathway [GO:0008593]; regulation of somitogenesis [GO:0014807]; regulation of transcription by RNA polymerase II [GO:0006357]; response to lipopolysaccharide [GO:0032496]; response to muramyl dipeptide [GO:0032495]; secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development [GO:0060528]; skeletal muscle cell differentiation [GO:0035914]; somatic stem cell division [GO:0048103]; spermatogenesis [GO:0007283]; sprouting angiogenesis [GO:0002040]; T-helper 17 type immune response [GO:0072538]; tissue regeneration [GO:0042246]; tube formation [GO:0035148]; vasculogenesis involved in coronary vascular morphogenesis [GO:0060979]; venous blood vessel morphogenesis [GO:0048845]; venous endothelial cell differentiation [GO:0060843]; ventricular septum morphogenesis [GO:0060412]; ventricular trabecula myocardium morphogenesis [GO:0003222] acrosomal vesicle [GO:0001669]; adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell periphery [GO:0071944]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; lamellipodium [GO:0030027]; late endosome membrane [GO:0031902]; MAML1-RBP-Jkappa- ICN1 complex [GO:0002193]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; receptor complex [GO:0043235]; ruffle [GO:0001726]; Schaffer collateral - CA1 synapse [GO:0098685] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; identical protein binding [GO:0042802]; Notch binding [GO:0005112]; transcription coactivator activity [GO:0003713]; transcription regulator activator activity [GO:0140537]; transmembrane signaling receptor activity [GO:0004888] g256.t1 Q01705 34.318 1591 0.0 626.0 sp|Q01705|NOTC1_MOUSE Neurogenic locus notch homolog protein 1 OS=Mus musculus OX=10090 GN=Notch1 PE=1 SV=3 NOTC1_MOUSE reviewed Neurogenic locus notch homolog protein 1 (Notch 1) (Motch A) (mT14) (p300) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Mus musculus (Mouse) GO:0000122; GO:0000139; GO:0001554; GO:0001669; GO:0001701; GO:0001708; GO:0001726; GO:0001837; GO:0001889; GO:0001947; GO:0002040; GO:0002051; GO:0002052; GO:0002193; GO:0002437; GO:0003151; GO:0003157; GO:0003160; GO:0003162; GO:0003169; GO:0003180; GO:0003181; GO:0003182; GO:0003184; GO:0003192; GO:0003197; GO:0003198; GO:0003203; GO:0003207; GO:0003208; GO:0003209; GO:0003213; GO:0003214; GO:0003219; GO:0003222; GO:0003241; GO:0003252; GO:0003264; GO:0003273; GO:0003332; GO:0003344; GO:0003682; GO:0003713; GO:0004857; GO:0004888; GO:0005112; GO:0005509; GO:0005576; GO:0005634; GO:0005654; GO:0005737; GO:0005783; GO:0005789; GO:0005829; GO:0005856; GO:0005886; GO:0005912; GO:0006357; GO:0006606; GO:0006959; GO:0007219; GO:0007221; GO:0007283; GO:0007368; GO:0007386; GO:0007409; GO:0007411; GO:0007440; GO:0007492; GO:0007507; GO:0008284; GO:0008285; GO:0008544; GO:0008593; GO:0009912; GO:0009986; GO:0010001; GO:0010008; GO:0010467; GO:0010468; GO:0010614; GO:0010628; GO:0010629; GO:0010667; GO:0010718; GO:0010812; GO:0010832; GO:0014031; GO:0014807; GO:0016324; GO:0019899; GO:0021515; GO:0021915; GO:0030027; GO:0030154; GO:0030163; GO:0030182; GO:0030216; GO:0030279; GO:0030324; GO:0030326; GO:0030334; GO:0030335; GO:0030513; GO:0030514; GO:0030900; GO:0031069; GO:0031100; GO:0031410; GO:0031490; GO:0031902; GO:0032495; GO:0032496; GO:0032966; GO:0035116; GO:0035148; GO:0035914; GO:0035924; GO:0042127; GO:0042246; GO:0042802; GO:0043065; GO:0043069; GO:0043086; GO:0043235; GO:0045070; GO:0045165; GO:0045596; GO:0045603; GO:0045607; GO:0045608; GO:0045618; GO:0045662; GO:0045665; GO:0045668; GO:0045687; GO:0045747; GO:0045892; GO:0045893; GO:0045944; GO:0045955; GO:0046427; GO:0046533; GO:0046579; GO:0048103; GO:0048593; GO:0048663; GO:0048708; GO:0048709; GO:0048711; GO:0048715; GO:0048754; GO:0048845; GO:0048873; GO:0050678; GO:0050679; GO:0050767; GO:0050768; GO:0051152; GO:0055008; GO:0060038; GO:0060045; GO:0060253; GO:0060271; GO:0060317; GO:0060354; GO:0060379; GO:0060411; GO:0060412; GO:0060528; GO:0060740; GO:0060768; GO:0060842; GO:0060843; GO:0060948; GO:0060956; GO:0060979; GO:0060982; GO:0061344; GO:0061384; GO:0062043; GO:0070168; GO:0070374; GO:0070986; GO:0071228; GO:0071372; GO:0071456; GO:0071944; GO:0072017; GO:0072044; GO:0072144; GO:0072538; GO:0090051; GO:0090090; GO:0097150; GO:0097400; GO:0098685; GO:0098839; GO:0098978; GO:0099565; GO:0120163; GO:0140537; GO:1901189; GO:1901201; GO:1902263; GO:1902339; GO:1903849; GO:2000048; GO:2000737; GO:2000811; GO:2000974; GO:2001027 animal organ regeneration [GO:0031100]; aortic valve morphogenesis [GO:0003180]; apoptotic process involved in embryonic digit morphogenesis [GO:1902263]; arterial endothelial cell differentiation [GO:0060842]; astrocyte differentiation [GO:0048708]; atrioventricular node development [GO:0003162]; atrioventricular valve morphogenesis [GO:0003181]; auditory receptor cell fate commitment [GO:0009912]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; branching morphogenesis of an epithelial tube [GO:0048754]; camera-type eye morphogenesis [GO:0048593]; cardiac atrium morphogenesis [GO:0003209]; cardiac chamber formation [GO:0003207]; cardiac epithelial to mesenchymal transition [GO:0060317]; cardiac left ventricle morphogenesis [GO:0003214]; cardiac muscle cell myoblast differentiation [GO:0060379]; cardiac muscle cell proliferation [GO:0060038]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac right atrium morphogenesis [GO:0003213]; cardiac right ventricle formation [GO:0003219]; cardiac septum morphogenesis [GO:0060411]; cardiac vascular smooth muscle cell development [GO:0060948]; cardiac ventricle morphogenesis [GO:0003208]; cell differentiation [GO:0030154]; cell differentiation in spinal cord [GO:0021515]; cell fate commitment [GO:0045165]; cell fate specification [GO:0001708]; cell migration involved in endocardial cushion formation [GO:0003273]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to hypoxia [GO:0071456]; cellular response to tumor cell [GO:0071228]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; chemical synaptic transmission, postsynaptic [GO:0099565]; cilium assembly [GO:0060271]; collecting duct development [GO:0072044]; compartment pattern specification [GO:0007386]; coronary artery morphogenesis [GO:0060982]; coronary sinus valve morphogenesis [GO:0003182]; coronary vein morphogenesis [GO:0003169]; determination of left/right symmetry [GO:0007368]; distal tubule development [GO:0072017]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic limb morphogenesis [GO:0030326]; endocardial cell differentiation [GO:0060956]; endocardial cushion development [GO:0003197]; endocardial cushion morphogenesis [GO:0003203]; endocardium development [GO:0003157]; endocardium morphogenesis [GO:0003160]; endoderm development [GO:0007492]; epidermis development [GO:0008544]; epithelial to mesenchymal transition [GO:0001837]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; forebrain development [GO:0030900]; foregut morphogenesis [GO:0007440]; gene expression [GO:0010467]; glial cell differentiation [GO:0010001]; glomerular mesangial cell development [GO:0072144]; growth involved in heart morphogenesis [GO:0003241]; hair follicle morphogenesis [GO:0031069]; heart development [GO:0007507]; heart looping [GO:0001947]; heart trabecula morphogenesis [GO:0061384]; homeostasis of number of cells within a tissue [GO:0048873]; humoral immune response [GO:0006959]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; interleukin-17-mediated signaling pathway [GO:0097400]; keratinocyte differentiation [GO:0030216]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; lung development [GO:0030324]; luteolysis [GO:0001554]; mesenchymal cell development [GO:0014031]; mitral valve formation [GO:0003192]; negative regulation of anoikis [GO:2000811]; negative regulation of biomineral tissue development [GO:0070168]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of catalytic activity [GO:0043086]; negative regulation of cell adhesion molecule production [GO:0060354]; negative regulation of cell differentiation [GO:0045596]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell proliferation involved in heart valve morphogenesis [GO:0003252]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of collagen biosynthetic process [GO:0032966]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of endothelial cell chemotaxis [GO:2001027]; negative regulation of extracellular matrix constituent secretion [GO:0003332]; negative regulation of gene expression [GO:0010629]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of inner ear auditory receptor cell differentiation [GO:0045608]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of ossification [GO:0030279]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of photoreceptor cell differentiation [GO:0046533]; negative regulation of pro-B cell differentiation [GO:2000974]; negative regulation of programmed cell death [GO:0043069]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural tube development [GO:0021915]; neuron differentiation [GO:0030182]; neuron fate commitment [GO:0048663]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; oligodendrocyte differentiation [GO:0048709]; osteoblast fate commitment [GO:0002051]; outflow tract morphogenesis [GO:0003151]; pericardium morphogenesis [GO:0003344]; positive regulation of aorta morphogenesis [GO:1903849]; positive regulation of apoptotic process [GO:0043065]; positive regulation of apoptotic process involved in morphogenesis [GO:1902339]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cardiac epithelial to mesenchymal transition [GO:0062043]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of ephrin receptor signaling pathway [GO:1901189]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of glial cell differentiation [GO:0045687]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of smooth muscle cell differentiation [GO:0051152]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription of Notch receptor target [GO:0007221]; positive regulation of viral genome replication [GO:0045070]; prostate gland epithelium morphogenesis [GO:0060740]; protein catabolic process [GO:0030163]; protein import into nucleus [GO:0006606]; pulmonary valve morphogenesis [GO:0003184]; regulation of cardioblast proliferation [GO:0003264]; regulation of cell adhesion involved in heart morphogenesis [GO:0061344]; regulation of cell migration [GO:0030334]; regulation of cell population proliferation [GO:0042127]; regulation of epithelial cell proliferation [GO:0050678]; regulation of epithelial cell proliferation involved in prostate gland development [GO:0060768]; regulation of extracellular matrix assembly [GO:1901201]; regulation of gene expression [GO:0010468]; regulation of inner ear auditory receptor cell differentiation [GO:0045607]; regulation of neurogenesis [GO:0050767]; regulation of Notch signaling pathway [GO:0008593]; regulation of somitogenesis [GO:0014807]; regulation of transcription by RNA polymerase II [GO:0006357]; response to lipopolysaccharide [GO:0032496]; response to muramyl dipeptide [GO:0032495]; secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development [GO:0060528]; skeletal muscle cell differentiation [GO:0035914]; somatic stem cell division [GO:0048103]; spermatogenesis [GO:0007283]; sprouting angiogenesis [GO:0002040]; T-helper 17 type immune response [GO:0072538]; tissue regeneration [GO:0042246]; tube formation [GO:0035148]; vasculogenesis involved in coronary vascular morphogenesis [GO:0060979]; venous blood vessel morphogenesis [GO:0048845]; venous endothelial cell differentiation [GO:0060843]; ventricular septum morphogenesis [GO:0060412]; ventricular trabecula myocardium morphogenesis [GO:0003222] acrosomal vesicle [GO:0001669]; adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell periphery [GO:0071944]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; lamellipodium [GO:0030027]; late endosome membrane [GO:0031902]; MAML1-RBP-Jkappa- ICN1 complex [GO:0002193]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; receptor complex [GO:0043235]; ruffle [GO:0001726]; Schaffer collateral - CA1 synapse [GO:0098685] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; identical protein binding [GO:0042802]; Notch binding [GO:0005112]; transcription coactivator activity [GO:0003713]; transcription regulator activator activity [GO:0140537]; transmembrane signaling receptor activity [GO:0004888] g256.t1 Q01705 33.937 1435 0.0 622.0 sp|Q01705|NOTC1_MOUSE Neurogenic locus notch homolog protein 1 OS=Mus musculus OX=10090 GN=Notch1 PE=1 SV=3 NOTC1_MOUSE reviewed Neurogenic locus notch homolog protein 1 (Notch 1) (Motch A) (mT14) (p300) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Mus musculus (Mouse) GO:0000122; GO:0000139; GO:0001554; GO:0001669; GO:0001701; GO:0001708; GO:0001726; GO:0001837; GO:0001889; GO:0001947; GO:0002040; GO:0002051; GO:0002052; GO:0002193; GO:0002437; GO:0003151; GO:0003157; GO:0003160; GO:0003162; GO:0003169; GO:0003180; GO:0003181; GO:0003182; GO:0003184; GO:0003192; GO:0003197; GO:0003198; GO:0003203; GO:0003207; GO:0003208; GO:0003209; GO:0003213; GO:0003214; GO:0003219; GO:0003222; GO:0003241; GO:0003252; GO:0003264; GO:0003273; GO:0003332; GO:0003344; GO:0003682; GO:0003713; GO:0004857; GO:0004888; GO:0005112; GO:0005509; GO:0005576; GO:0005634; GO:0005654; GO:0005737; GO:0005783; GO:0005789; GO:0005829; GO:0005856; GO:0005886; GO:0005912; GO:0006357; GO:0006606; GO:0006959; GO:0007219; GO:0007221; GO:0007283; GO:0007368; GO:0007386; GO:0007409; GO:0007411; GO:0007440; GO:0007492; GO:0007507; GO:0008284; GO:0008285; GO:0008544; GO:0008593; GO:0009912; GO:0009986; GO:0010001; GO:0010008; GO:0010467; GO:0010468; GO:0010614; GO:0010628; GO:0010629; GO:0010667; GO:0010718; GO:0010812; GO:0010832; GO:0014031; GO:0014807; GO:0016324; GO:0019899; GO:0021515; GO:0021915; GO:0030027; GO:0030154; GO:0030163; GO:0030182; GO:0030216; GO:0030279; GO:0030324; GO:0030326; GO:0030334; GO:0030335; GO:0030513; GO:0030514; GO:0030900; GO:0031069; GO:0031100; GO:0031410; GO:0031490; GO:0031902; GO:0032495; GO:0032496; GO:0032966; GO:0035116; GO:0035148; GO:0035914; GO:0035924; GO:0042127; GO:0042246; GO:0042802; GO:0043065; GO:0043069; GO:0043086; GO:0043235; GO:0045070; GO:0045165; GO:0045596; GO:0045603; GO:0045607; GO:0045608; GO:0045618; GO:0045662; GO:0045665; GO:0045668; GO:0045687; GO:0045747; GO:0045892; GO:0045893; GO:0045944; GO:0045955; GO:0046427; GO:0046533; GO:0046579; GO:0048103; GO:0048593; GO:0048663; GO:0048708; GO:0048709; GO:0048711; GO:0048715; GO:0048754; GO:0048845; GO:0048873; GO:0050678; GO:0050679; GO:0050767; GO:0050768; GO:0051152; GO:0055008; GO:0060038; GO:0060045; GO:0060253; GO:0060271; GO:0060317; GO:0060354; GO:0060379; GO:0060411; GO:0060412; GO:0060528; GO:0060740; GO:0060768; GO:0060842; GO:0060843; GO:0060948; GO:0060956; GO:0060979; GO:0060982; GO:0061344; GO:0061384; GO:0062043; GO:0070168; GO:0070374; GO:0070986; GO:0071228; GO:0071372; GO:0071456; GO:0071944; GO:0072017; GO:0072044; GO:0072144; GO:0072538; GO:0090051; GO:0090090; GO:0097150; GO:0097400; GO:0098685; GO:0098839; GO:0098978; GO:0099565; GO:0120163; GO:0140537; GO:1901189; GO:1901201; GO:1902263; GO:1902339; GO:1903849; GO:2000048; GO:2000737; GO:2000811; GO:2000974; GO:2001027 animal organ regeneration [GO:0031100]; aortic valve morphogenesis [GO:0003180]; apoptotic process involved in embryonic digit morphogenesis [GO:1902263]; arterial endothelial cell differentiation [GO:0060842]; astrocyte differentiation [GO:0048708]; atrioventricular node development [GO:0003162]; atrioventricular valve morphogenesis [GO:0003181]; auditory receptor cell fate commitment [GO:0009912]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; branching morphogenesis of an epithelial tube [GO:0048754]; camera-type eye morphogenesis [GO:0048593]; cardiac atrium morphogenesis [GO:0003209]; cardiac chamber formation [GO:0003207]; cardiac epithelial to mesenchymal transition [GO:0060317]; cardiac left ventricle morphogenesis [GO:0003214]; cardiac muscle cell myoblast differentiation [GO:0060379]; cardiac muscle cell proliferation [GO:0060038]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac right atrium morphogenesis [GO:0003213]; cardiac right ventricle formation [GO:0003219]; cardiac septum morphogenesis [GO:0060411]; cardiac vascular smooth muscle cell development [GO:0060948]; cardiac ventricle morphogenesis [GO:0003208]; cell differentiation [GO:0030154]; cell differentiation in spinal cord [GO:0021515]; cell fate commitment [GO:0045165]; cell fate specification [GO:0001708]; cell migration involved in endocardial cushion formation [GO:0003273]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to hypoxia [GO:0071456]; cellular response to tumor cell [GO:0071228]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; chemical synaptic transmission, postsynaptic [GO:0099565]; cilium assembly [GO:0060271]; collecting duct development [GO:0072044]; compartment pattern specification [GO:0007386]; coronary artery morphogenesis [GO:0060982]; coronary sinus valve morphogenesis [GO:0003182]; coronary vein morphogenesis [GO:0003169]; determination of left/right symmetry [GO:0007368]; distal tubule development [GO:0072017]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic limb morphogenesis [GO:0030326]; endocardial cell differentiation [GO:0060956]; endocardial cushion development [GO:0003197]; endocardial cushion morphogenesis [GO:0003203]; endocardium development [GO:0003157]; endocardium morphogenesis [GO:0003160]; endoderm development [GO:0007492]; epidermis development [GO:0008544]; epithelial to mesenchymal transition [GO:0001837]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; forebrain development [GO:0030900]; foregut morphogenesis [GO:0007440]; gene expression [GO:0010467]; glial cell differentiation [GO:0010001]; glomerular mesangial cell development [GO:0072144]; growth involved in heart morphogenesis [GO:0003241]; hair follicle morphogenesis [GO:0031069]; heart development [GO:0007507]; heart looping [GO:0001947]; heart trabecula morphogenesis [GO:0061384]; homeostasis of number of cells within a tissue [GO:0048873]; humoral immune response [GO:0006959]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; interleukin-17-mediated signaling pathway [GO:0097400]; keratinocyte differentiation [GO:0030216]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; lung development [GO:0030324]; luteolysis [GO:0001554]; mesenchymal cell development [GO:0014031]; mitral valve formation [GO:0003192]; negative regulation of anoikis [GO:2000811]; negative regulation of biomineral tissue development [GO:0070168]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of catalytic activity [GO:0043086]; negative regulation of cell adhesion molecule production [GO:0060354]; negative regulation of cell differentiation [GO:0045596]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell proliferation involved in heart valve morphogenesis [GO:0003252]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of collagen biosynthetic process [GO:0032966]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of endothelial cell chemotaxis [GO:2001027]; negative regulation of extracellular matrix constituent secretion [GO:0003332]; negative regulation of gene expression [GO:0010629]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of inner ear auditory receptor cell differentiation [GO:0045608]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of ossification [GO:0030279]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of photoreceptor cell differentiation [GO:0046533]; negative regulation of pro-B cell differentiation [GO:2000974]; negative regulation of programmed cell death [GO:0043069]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural tube development [GO:0021915]; neuron differentiation [GO:0030182]; neuron fate commitment [GO:0048663]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; oligodendrocyte differentiation [GO:0048709]; osteoblast fate commitment [GO:0002051]; outflow tract morphogenesis [GO:0003151]; pericardium morphogenesis [GO:0003344]; positive regulation of aorta morphogenesis [GO:1903849]; positive regulation of apoptotic process [GO:0043065]; positive regulation of apoptotic process involved in morphogenesis [GO:1902339]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cardiac epithelial to mesenchymal transition [GO:0062043]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of ephrin receptor signaling pathway [GO:1901189]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of glial cell differentiation [GO:0045687]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of smooth muscle cell differentiation [GO:0051152]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription of Notch receptor target [GO:0007221]; positive regulation of viral genome replication [GO:0045070]; prostate gland epithelium morphogenesis [GO:0060740]; protein catabolic process [GO:0030163]; protein import into nucleus [GO:0006606]; pulmonary valve morphogenesis [GO:0003184]; regulation of cardioblast proliferation [GO:0003264]; regulation of cell adhesion involved in heart morphogenesis [GO:0061344]; regulation of cell migration [GO:0030334]; regulation of cell population proliferation [GO:0042127]; regulation of epithelial cell proliferation [GO:0050678]; regulation of epithelial cell proliferation involved in prostate gland development [GO:0060768]; regulation of extracellular matrix assembly [GO:1901201]; regulation of gene expression [GO:0010468]; regulation of inner ear auditory receptor cell differentiation [GO:0045607]; regulation of neurogenesis [GO:0050767]; regulation of Notch signaling pathway [GO:0008593]; regulation of somitogenesis [GO:0014807]; regulation of transcription by RNA polymerase II [GO:0006357]; response to lipopolysaccharide [GO:0032496]; response to muramyl dipeptide [GO:0032495]; secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development [GO:0060528]; skeletal muscle cell differentiation [GO:0035914]; somatic stem cell division [GO:0048103]; spermatogenesis [GO:0007283]; sprouting angiogenesis [GO:0002040]; T-helper 17 type immune response [GO:0072538]; tissue regeneration [GO:0042246]; tube formation [GO:0035148]; vasculogenesis involved in coronary vascular morphogenesis [GO:0060979]; venous blood vessel morphogenesis [GO:0048845]; venous endothelial cell differentiation [GO:0060843]; ventricular septum morphogenesis [GO:0060412]; ventricular trabecula myocardium morphogenesis [GO:0003222] acrosomal vesicle [GO:0001669]; adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell periphery [GO:0071944]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; lamellipodium [GO:0030027]; late endosome membrane [GO:0031902]; MAML1-RBP-Jkappa- ICN1 complex [GO:0002193]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; receptor complex [GO:0043235]; ruffle [GO:0001726]; Schaffer collateral - CA1 synapse [GO:0098685] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; identical protein binding [GO:0042802]; Notch binding [GO:0005112]; transcription coactivator activity [GO:0003713]; transcription regulator activator activity [GO:0140537]; transmembrane signaling receptor activity [GO:0004888] g256.t1 Q01705 34.901 1318 7.06e-160 558.0 sp|Q01705|NOTC1_MOUSE Neurogenic locus notch homolog protein 1 OS=Mus musculus OX=10090 GN=Notch1 PE=1 SV=3 NOTC1_MOUSE reviewed Neurogenic locus notch homolog protein 1 (Notch 1) (Motch A) (mT14) (p300) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Mus musculus (Mouse) GO:0000122; GO:0000139; GO:0001554; GO:0001669; GO:0001701; GO:0001708; GO:0001726; GO:0001837; GO:0001889; GO:0001947; GO:0002040; GO:0002051; GO:0002052; GO:0002193; GO:0002437; GO:0003151; GO:0003157; GO:0003160; GO:0003162; GO:0003169; GO:0003180; GO:0003181; GO:0003182; GO:0003184; GO:0003192; GO:0003197; GO:0003198; GO:0003203; GO:0003207; GO:0003208; GO:0003209; GO:0003213; GO:0003214; GO:0003219; GO:0003222; GO:0003241; GO:0003252; GO:0003264; GO:0003273; GO:0003332; GO:0003344; GO:0003682; GO:0003713; GO:0004857; GO:0004888; GO:0005112; GO:0005509; GO:0005576; GO:0005634; GO:0005654; GO:0005737; GO:0005783; GO:0005789; GO:0005829; GO:0005856; GO:0005886; GO:0005912; GO:0006357; GO:0006606; GO:0006959; GO:0007219; GO:0007221; GO:0007283; GO:0007368; GO:0007386; GO:0007409; GO:0007411; GO:0007440; GO:0007492; GO:0007507; GO:0008284; GO:0008285; GO:0008544; GO:0008593; GO:0009912; GO:0009986; GO:0010001; GO:0010008; GO:0010467; GO:0010468; GO:0010614; GO:0010628; GO:0010629; GO:0010667; GO:0010718; GO:0010812; GO:0010832; GO:0014031; GO:0014807; GO:0016324; GO:0019899; GO:0021515; GO:0021915; GO:0030027; GO:0030154; GO:0030163; GO:0030182; GO:0030216; GO:0030279; GO:0030324; GO:0030326; GO:0030334; GO:0030335; GO:0030513; GO:0030514; GO:0030900; GO:0031069; GO:0031100; GO:0031410; GO:0031490; GO:0031902; GO:0032495; GO:0032496; GO:0032966; GO:0035116; GO:0035148; GO:0035914; GO:0035924; GO:0042127; GO:0042246; GO:0042802; GO:0043065; GO:0043069; GO:0043086; GO:0043235; GO:0045070; GO:0045165; GO:0045596; GO:0045603; GO:0045607; GO:0045608; GO:0045618; GO:0045662; GO:0045665; GO:0045668; GO:0045687; GO:0045747; GO:0045892; GO:0045893; GO:0045944; GO:0045955; GO:0046427; GO:0046533; GO:0046579; GO:0048103; GO:0048593; GO:0048663; GO:0048708; GO:0048709; GO:0048711; GO:0048715; GO:0048754; GO:0048845; GO:0048873; GO:0050678; GO:0050679; GO:0050767; GO:0050768; GO:0051152; GO:0055008; GO:0060038; GO:0060045; GO:0060253; GO:0060271; GO:0060317; GO:0060354; GO:0060379; GO:0060411; GO:0060412; GO:0060528; GO:0060740; GO:0060768; GO:0060842; GO:0060843; GO:0060948; GO:0060956; GO:0060979; GO:0060982; GO:0061344; GO:0061384; GO:0062043; GO:0070168; GO:0070374; GO:0070986; GO:0071228; GO:0071372; GO:0071456; GO:0071944; GO:0072017; GO:0072044; GO:0072144; GO:0072538; GO:0090051; GO:0090090; GO:0097150; GO:0097400; GO:0098685; GO:0098839; GO:0098978; GO:0099565; GO:0120163; GO:0140537; GO:1901189; GO:1901201; GO:1902263; GO:1902339; GO:1903849; GO:2000048; GO:2000737; GO:2000811; GO:2000974; GO:2001027 animal organ regeneration [GO:0031100]; aortic valve morphogenesis [GO:0003180]; apoptotic process involved in embryonic digit morphogenesis [GO:1902263]; arterial endothelial cell differentiation [GO:0060842]; astrocyte differentiation [GO:0048708]; atrioventricular node development [GO:0003162]; atrioventricular valve morphogenesis [GO:0003181]; auditory receptor cell fate commitment [GO:0009912]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; branching morphogenesis of an epithelial tube [GO:0048754]; camera-type eye morphogenesis [GO:0048593]; cardiac atrium morphogenesis [GO:0003209]; cardiac chamber formation [GO:0003207]; cardiac epithelial to mesenchymal transition [GO:0060317]; cardiac left ventricle morphogenesis [GO:0003214]; cardiac muscle cell myoblast differentiation [GO:0060379]; cardiac muscle cell proliferation [GO:0060038]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac right atrium morphogenesis [GO:0003213]; cardiac right ventricle formation [GO:0003219]; cardiac septum morphogenesis [GO:0060411]; cardiac vascular smooth muscle cell development [GO:0060948]; cardiac ventricle morphogenesis [GO:0003208]; cell differentiation [GO:0030154]; cell differentiation in spinal cord [GO:0021515]; cell fate commitment [GO:0045165]; cell fate specification [GO:0001708]; cell migration involved in endocardial cushion formation [GO:0003273]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to hypoxia [GO:0071456]; cellular response to tumor cell [GO:0071228]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; chemical synaptic transmission, postsynaptic [GO:0099565]; cilium assembly [GO:0060271]; collecting duct development [GO:0072044]; compartment pattern specification [GO:0007386]; coronary artery morphogenesis [GO:0060982]; coronary sinus valve morphogenesis [GO:0003182]; coronary vein morphogenesis [GO:0003169]; determination of left/right symmetry [GO:0007368]; distal tubule development [GO:0072017]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic limb morphogenesis [GO:0030326]; endocardial cell differentiation [GO:0060956]; endocardial cushion development [GO:0003197]; endocardial cushion morphogenesis [GO:0003203]; endocardium development [GO:0003157]; endocardium morphogenesis [GO:0003160]; endoderm development [GO:0007492]; epidermis development [GO:0008544]; epithelial to mesenchymal transition [GO:0001837]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; forebrain development [GO:0030900]; foregut morphogenesis [GO:0007440]; gene expression [GO:0010467]; glial cell differentiation [GO:0010001]; glomerular mesangial cell development [GO:0072144]; growth involved in heart morphogenesis [GO:0003241]; hair follicle morphogenesis [GO:0031069]; heart development [GO:0007507]; heart looping [GO:0001947]; heart trabecula morphogenesis [GO:0061384]; homeostasis of number of cells within a tissue [GO:0048873]; humoral immune response [GO:0006959]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; interleukin-17-mediated signaling pathway [GO:0097400]; keratinocyte differentiation [GO:0030216]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; lung development [GO:0030324]; luteolysis [GO:0001554]; mesenchymal cell development [GO:0014031]; mitral valve formation [GO:0003192]; negative regulation of anoikis [GO:2000811]; negative regulation of biomineral tissue development [GO:0070168]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of catalytic activity [GO:0043086]; negative regulation of cell adhesion molecule production [GO:0060354]; negative regulation of cell differentiation [GO:0045596]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell proliferation involved in heart valve morphogenesis [GO:0003252]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of collagen biosynthetic process [GO:0032966]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of endothelial cell chemotaxis [GO:2001027]; negative regulation of extracellular matrix constituent secretion [GO:0003332]; negative regulation of gene expression [GO:0010629]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of inner ear auditory receptor cell differentiation [GO:0045608]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of ossification [GO:0030279]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of photoreceptor cell differentiation [GO:0046533]; negative regulation of pro-B cell differentiation [GO:2000974]; negative regulation of programmed cell death [GO:0043069]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural tube development [GO:0021915]; neuron differentiation [GO:0030182]; neuron fate commitment [GO:0048663]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; oligodendrocyte differentiation [GO:0048709]; osteoblast fate commitment [GO:0002051]; outflow tract morphogenesis [GO:0003151]; pericardium morphogenesis [GO:0003344]; positive regulation of aorta morphogenesis [GO:1903849]; positive regulation of apoptotic process [GO:0043065]; positive regulation of apoptotic process involved in morphogenesis [GO:1902339]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cardiac epithelial to mesenchymal transition [GO:0062043]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of ephrin receptor signaling pathway [GO:1901189]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of glial cell differentiation [GO:0045687]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of smooth muscle cell differentiation [GO:0051152]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription of Notch receptor target [GO:0007221]; positive regulation of viral genome replication [GO:0045070]; prostate gland epithelium morphogenesis [GO:0060740]; protein catabolic process [GO:0030163]; protein import into nucleus [GO:0006606]; pulmonary valve morphogenesis [GO:0003184]; regulation of cardioblast proliferation [GO:0003264]; regulation of cell adhesion involved in heart morphogenesis [GO:0061344]; regulation of cell migration [GO:0030334]; regulation of cell population proliferation [GO:0042127]; regulation of epithelial cell proliferation [GO:0050678]; regulation of epithelial cell proliferation involved in prostate gland development [GO:0060768]; regulation of extracellular matrix assembly [GO:1901201]; regulation of gene expression [GO:0010468]; regulation of inner ear auditory receptor cell differentiation [GO:0045607]; regulation of neurogenesis [GO:0050767]; regulation of Notch signaling pathway [GO:0008593]; regulation of somitogenesis [GO:0014807]; regulation of transcription by RNA polymerase II [GO:0006357]; response to lipopolysaccharide [GO:0032496]; response to muramyl dipeptide [GO:0032495]; secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development [GO:0060528]; skeletal muscle cell differentiation [GO:0035914]; somatic stem cell division [GO:0048103]; spermatogenesis [GO:0007283]; sprouting angiogenesis [GO:0002040]; T-helper 17 type immune response [GO:0072538]; tissue regeneration [GO:0042246]; tube formation [GO:0035148]; vasculogenesis involved in coronary vascular morphogenesis [GO:0060979]; venous blood vessel morphogenesis [GO:0048845]; venous endothelial cell differentiation [GO:0060843]; ventricular septum morphogenesis [GO:0060412]; ventricular trabecula myocardium morphogenesis [GO:0003222] acrosomal vesicle [GO:0001669]; adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell periphery [GO:0071944]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; lamellipodium [GO:0030027]; late endosome membrane [GO:0031902]; MAML1-RBP-Jkappa- ICN1 complex [GO:0002193]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; receptor complex [GO:0043235]; ruffle [GO:0001726]; Schaffer collateral - CA1 synapse [GO:0098685] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; identical protein binding [GO:0042802]; Notch binding [GO:0005112]; transcription coactivator activity [GO:0003713]; transcription regulator activator activity [GO:0140537]; transmembrane signaling receptor activity [GO:0004888] g256.t1 Q01705 37.978 445 4.26e-59 231.0 sp|Q01705|NOTC1_MOUSE Neurogenic locus notch homolog protein 1 OS=Mus musculus OX=10090 GN=Notch1 PE=1 SV=3 NOTC1_MOUSE reviewed Neurogenic locus notch homolog protein 1 (Notch 1) (Motch A) (mT14) (p300) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Mus musculus (Mouse) GO:0000122; GO:0000139; GO:0001554; GO:0001669; GO:0001701; GO:0001708; GO:0001726; GO:0001837; GO:0001889; GO:0001947; GO:0002040; GO:0002051; GO:0002052; GO:0002193; GO:0002437; GO:0003151; GO:0003157; GO:0003160; GO:0003162; GO:0003169; GO:0003180; GO:0003181; GO:0003182; GO:0003184; GO:0003192; GO:0003197; GO:0003198; GO:0003203; GO:0003207; GO:0003208; GO:0003209; GO:0003213; GO:0003214; GO:0003219; GO:0003222; GO:0003241; GO:0003252; GO:0003264; GO:0003273; GO:0003332; GO:0003344; GO:0003682; GO:0003713; GO:0004857; GO:0004888; GO:0005112; GO:0005509; GO:0005576; GO:0005634; GO:0005654; GO:0005737; GO:0005783; GO:0005789; GO:0005829; GO:0005856; GO:0005886; GO:0005912; GO:0006357; GO:0006606; GO:0006959; GO:0007219; GO:0007221; GO:0007283; GO:0007368; GO:0007386; GO:0007409; GO:0007411; GO:0007440; GO:0007492; GO:0007507; GO:0008284; GO:0008285; GO:0008544; GO:0008593; GO:0009912; GO:0009986; GO:0010001; GO:0010008; GO:0010467; GO:0010468; GO:0010614; GO:0010628; GO:0010629; GO:0010667; GO:0010718; GO:0010812; GO:0010832; GO:0014031; GO:0014807; GO:0016324; GO:0019899; GO:0021515; GO:0021915; GO:0030027; GO:0030154; GO:0030163; GO:0030182; GO:0030216; GO:0030279; GO:0030324; GO:0030326; GO:0030334; GO:0030335; GO:0030513; GO:0030514; GO:0030900; GO:0031069; GO:0031100; GO:0031410; GO:0031490; GO:0031902; GO:0032495; GO:0032496; GO:0032966; GO:0035116; GO:0035148; GO:0035914; GO:0035924; GO:0042127; GO:0042246; GO:0042802; GO:0043065; GO:0043069; GO:0043086; GO:0043235; GO:0045070; GO:0045165; GO:0045596; GO:0045603; GO:0045607; GO:0045608; GO:0045618; GO:0045662; GO:0045665; GO:0045668; GO:0045687; GO:0045747; GO:0045892; GO:0045893; GO:0045944; GO:0045955; GO:0046427; GO:0046533; GO:0046579; GO:0048103; GO:0048593; GO:0048663; GO:0048708; GO:0048709; GO:0048711; GO:0048715; GO:0048754; GO:0048845; GO:0048873; GO:0050678; GO:0050679; GO:0050767; GO:0050768; GO:0051152; GO:0055008; GO:0060038; GO:0060045; GO:0060253; GO:0060271; GO:0060317; GO:0060354; GO:0060379; GO:0060411; GO:0060412; GO:0060528; GO:0060740; GO:0060768; GO:0060842; GO:0060843; GO:0060948; GO:0060956; GO:0060979; GO:0060982; GO:0061344; GO:0061384; GO:0062043; GO:0070168; GO:0070374; GO:0070986; GO:0071228; GO:0071372; GO:0071456; GO:0071944; GO:0072017; GO:0072044; GO:0072144; GO:0072538; GO:0090051; GO:0090090; GO:0097150; GO:0097400; GO:0098685; GO:0098839; GO:0098978; GO:0099565; GO:0120163; GO:0140537; GO:1901189; GO:1901201; GO:1902263; GO:1902339; GO:1903849; GO:2000048; GO:2000737; GO:2000811; GO:2000974; GO:2001027 animal organ regeneration [GO:0031100]; aortic valve morphogenesis [GO:0003180]; apoptotic process involved in embryonic digit morphogenesis [GO:1902263]; arterial endothelial cell differentiation [GO:0060842]; astrocyte differentiation [GO:0048708]; atrioventricular node development [GO:0003162]; atrioventricular valve morphogenesis [GO:0003181]; auditory receptor cell fate commitment [GO:0009912]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; branching morphogenesis of an epithelial tube [GO:0048754]; camera-type eye morphogenesis [GO:0048593]; cardiac atrium morphogenesis [GO:0003209]; cardiac chamber formation [GO:0003207]; cardiac epithelial to mesenchymal transition [GO:0060317]; cardiac left ventricle morphogenesis [GO:0003214]; cardiac muscle cell myoblast differentiation [GO:0060379]; cardiac muscle cell proliferation [GO:0060038]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac right atrium morphogenesis [GO:0003213]; cardiac right ventricle formation [GO:0003219]; cardiac septum morphogenesis [GO:0060411]; cardiac vascular smooth muscle cell development [GO:0060948]; cardiac ventricle morphogenesis [GO:0003208]; cell differentiation [GO:0030154]; cell differentiation in spinal cord [GO:0021515]; cell fate commitment [GO:0045165]; cell fate specification [GO:0001708]; cell migration involved in endocardial cushion formation [GO:0003273]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to hypoxia [GO:0071456]; cellular response to tumor cell [GO:0071228]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; chemical synaptic transmission, postsynaptic [GO:0099565]; cilium assembly [GO:0060271]; collecting duct development [GO:0072044]; compartment pattern specification [GO:0007386]; coronary artery morphogenesis [GO:0060982]; coronary sinus valve morphogenesis [GO:0003182]; coronary vein morphogenesis [GO:0003169]; determination of left/right symmetry [GO:0007368]; distal tubule development [GO:0072017]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic limb morphogenesis [GO:0030326]; endocardial cell differentiation [GO:0060956]; endocardial cushion development [GO:0003197]; endocardial cushion morphogenesis [GO:0003203]; endocardium development [GO:0003157]; endocardium morphogenesis [GO:0003160]; endoderm development [GO:0007492]; epidermis development [GO:0008544]; epithelial to mesenchymal transition [GO:0001837]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; forebrain development [GO:0030900]; foregut morphogenesis [GO:0007440]; gene expression [GO:0010467]; glial cell differentiation [GO:0010001]; glomerular mesangial cell development [GO:0072144]; growth involved in heart morphogenesis [GO:0003241]; hair follicle morphogenesis [GO:0031069]; heart development [GO:0007507]; heart looping [GO:0001947]; heart trabecula morphogenesis [GO:0061384]; homeostasis of number of cells within a tissue [GO:0048873]; humoral immune response [GO:0006959]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; interleukin-17-mediated signaling pathway [GO:0097400]; keratinocyte differentiation [GO:0030216]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; lung development [GO:0030324]; luteolysis [GO:0001554]; mesenchymal cell development [GO:0014031]; mitral valve formation [GO:0003192]; negative regulation of anoikis [GO:2000811]; negative regulation of biomineral tissue development [GO:0070168]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of catalytic activity [GO:0043086]; negative regulation of cell adhesion molecule production [GO:0060354]; negative regulation of cell differentiation [GO:0045596]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell proliferation involved in heart valve morphogenesis [GO:0003252]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of collagen biosynthetic process [GO:0032966]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of endothelial cell chemotaxis [GO:2001027]; negative regulation of extracellular matrix constituent secretion [GO:0003332]; negative regulation of gene expression [GO:0010629]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of inner ear auditory receptor cell differentiation [GO:0045608]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of ossification [GO:0030279]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of photoreceptor cell differentiation [GO:0046533]; negative regulation of pro-B cell differentiation [GO:2000974]; negative regulation of programmed cell death [GO:0043069]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural tube development [GO:0021915]; neuron differentiation [GO:0030182]; neuron fate commitment [GO:0048663]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; oligodendrocyte differentiation [GO:0048709]; osteoblast fate commitment [GO:0002051]; outflow tract morphogenesis [GO:0003151]; pericardium morphogenesis [GO:0003344]; positive regulation of aorta morphogenesis [GO:1903849]; positive regulation of apoptotic process [GO:0043065]; positive regulation of apoptotic process involved in morphogenesis [GO:1902339]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cardiac epithelial to mesenchymal transition [GO:0062043]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of ephrin receptor signaling pathway [GO:1901189]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of glial cell differentiation [GO:0045687]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of smooth muscle cell differentiation [GO:0051152]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription of Notch receptor target [GO:0007221]; positive regulation of viral genome replication [GO:0045070]; prostate gland epithelium morphogenesis [GO:0060740]; protein catabolic process [GO:0030163]; protein import into nucleus [GO:0006606]; pulmonary valve morphogenesis [GO:0003184]; regulation of cardioblast proliferation [GO:0003264]; regulation of cell adhesion involved in heart morphogenesis [GO:0061344]; regulation of cell migration [GO:0030334]; regulation of cell population proliferation [GO:0042127]; regulation of epithelial cell proliferation [GO:0050678]; regulation of epithelial cell proliferation involved in prostate gland development [GO:0060768]; regulation of extracellular matrix assembly [GO:1901201]; regulation of gene expression [GO:0010468]; regulation of inner ear auditory receptor cell differentiation [GO:0045607]; regulation of neurogenesis [GO:0050767]; regulation of Notch signaling pathway [GO:0008593]; regulation of somitogenesis [GO:0014807]; regulation of transcription by RNA polymerase II [GO:0006357]; response to lipopolysaccharide [GO:0032496]; response to muramyl dipeptide [GO:0032495]; secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development [GO:0060528]; skeletal muscle cell differentiation [GO:0035914]; somatic stem cell division [GO:0048103]; spermatogenesis [GO:0007283]; sprouting angiogenesis [GO:0002040]; T-helper 17 type immune response [GO:0072538]; tissue regeneration [GO:0042246]; tube formation [GO:0035148]; vasculogenesis involved in coronary vascular morphogenesis [GO:0060979]; venous blood vessel morphogenesis [GO:0048845]; venous endothelial cell differentiation [GO:0060843]; ventricular septum morphogenesis [GO:0060412]; ventricular trabecula myocardium morphogenesis [GO:0003222] acrosomal vesicle [GO:0001669]; adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell periphery [GO:0071944]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; lamellipodium [GO:0030027]; late endosome membrane [GO:0031902]; MAML1-RBP-Jkappa- ICN1 complex [GO:0002193]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; receptor complex [GO:0043235]; ruffle [GO:0001726]; Schaffer collateral - CA1 synapse [GO:0098685] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; identical protein binding [GO:0042802]; Notch binding [GO:0005112]; transcription coactivator activity [GO:0003713]; transcription regulator activator activity [GO:0140537]; transmembrane signaling receptor activity [GO:0004888] g256.t1 Q01705 42.484 153 6.13e-24 115.0 sp|Q01705|NOTC1_MOUSE Neurogenic locus notch homolog protein 1 OS=Mus musculus OX=10090 GN=Notch1 PE=1 SV=3 NOTC1_MOUSE reviewed Neurogenic locus notch homolog protein 1 (Notch 1) (Motch A) (mT14) (p300) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Mus musculus (Mouse) GO:0000122; GO:0000139; GO:0001554; GO:0001669; GO:0001701; GO:0001708; GO:0001726; GO:0001837; GO:0001889; GO:0001947; GO:0002040; GO:0002051; GO:0002052; GO:0002193; GO:0002437; GO:0003151; GO:0003157; GO:0003160; GO:0003162; GO:0003169; GO:0003180; GO:0003181; GO:0003182; GO:0003184; GO:0003192; GO:0003197; GO:0003198; GO:0003203; GO:0003207; GO:0003208; GO:0003209; GO:0003213; GO:0003214; GO:0003219; GO:0003222; GO:0003241; GO:0003252; GO:0003264; GO:0003273; GO:0003332; GO:0003344; GO:0003682; GO:0003713; GO:0004857; GO:0004888; GO:0005112; GO:0005509; GO:0005576; GO:0005634; GO:0005654; GO:0005737; GO:0005783; GO:0005789; GO:0005829; GO:0005856; GO:0005886; GO:0005912; GO:0006357; GO:0006606; GO:0006959; GO:0007219; GO:0007221; GO:0007283; GO:0007368; GO:0007386; GO:0007409; GO:0007411; GO:0007440; GO:0007492; GO:0007507; GO:0008284; GO:0008285; GO:0008544; GO:0008593; GO:0009912; GO:0009986; GO:0010001; GO:0010008; GO:0010467; GO:0010468; GO:0010614; GO:0010628; GO:0010629; GO:0010667; GO:0010718; GO:0010812; GO:0010832; GO:0014031; GO:0014807; GO:0016324; GO:0019899; GO:0021515; GO:0021915; GO:0030027; GO:0030154; GO:0030163; GO:0030182; GO:0030216; GO:0030279; GO:0030324; GO:0030326; GO:0030334; GO:0030335; GO:0030513; GO:0030514; GO:0030900; GO:0031069; GO:0031100; GO:0031410; GO:0031490; GO:0031902; GO:0032495; GO:0032496; GO:0032966; GO:0035116; GO:0035148; GO:0035914; GO:0035924; GO:0042127; GO:0042246; GO:0042802; GO:0043065; GO:0043069; GO:0043086; GO:0043235; GO:0045070; GO:0045165; GO:0045596; GO:0045603; GO:0045607; GO:0045608; GO:0045618; GO:0045662; GO:0045665; GO:0045668; GO:0045687; GO:0045747; GO:0045892; GO:0045893; GO:0045944; GO:0045955; GO:0046427; GO:0046533; GO:0046579; GO:0048103; GO:0048593; GO:0048663; GO:0048708; GO:0048709; GO:0048711; GO:0048715; GO:0048754; GO:0048845; GO:0048873; GO:0050678; GO:0050679; GO:0050767; GO:0050768; GO:0051152; GO:0055008; GO:0060038; GO:0060045; GO:0060253; GO:0060271; GO:0060317; GO:0060354; GO:0060379; GO:0060411; GO:0060412; GO:0060528; GO:0060740; GO:0060768; GO:0060842; GO:0060843; GO:0060948; GO:0060956; GO:0060979; GO:0060982; GO:0061344; GO:0061384; GO:0062043; GO:0070168; GO:0070374; GO:0070986; GO:0071228; GO:0071372; GO:0071456; GO:0071944; GO:0072017; GO:0072044; GO:0072144; GO:0072538; GO:0090051; GO:0090090; GO:0097150; GO:0097400; GO:0098685; GO:0098839; GO:0098978; GO:0099565; GO:0120163; GO:0140537; GO:1901189; GO:1901201; GO:1902263; GO:1902339; GO:1903849; GO:2000048; GO:2000737; GO:2000811; GO:2000974; GO:2001027 animal organ regeneration [GO:0031100]; aortic valve morphogenesis [GO:0003180]; apoptotic process involved in embryonic digit morphogenesis [GO:1902263]; arterial endothelial cell differentiation [GO:0060842]; astrocyte differentiation [GO:0048708]; atrioventricular node development [GO:0003162]; atrioventricular valve morphogenesis [GO:0003181]; auditory receptor cell fate commitment [GO:0009912]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; branching morphogenesis of an epithelial tube [GO:0048754]; camera-type eye morphogenesis [GO:0048593]; cardiac atrium morphogenesis [GO:0003209]; cardiac chamber formation [GO:0003207]; cardiac epithelial to mesenchymal transition [GO:0060317]; cardiac left ventricle morphogenesis [GO:0003214]; cardiac muscle cell myoblast differentiation [GO:0060379]; cardiac muscle cell proliferation [GO:0060038]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac right atrium morphogenesis [GO:0003213]; cardiac right ventricle formation [GO:0003219]; cardiac septum morphogenesis [GO:0060411]; cardiac vascular smooth muscle cell development [GO:0060948]; cardiac ventricle morphogenesis [GO:0003208]; cell differentiation [GO:0030154]; cell differentiation in spinal cord [GO:0021515]; cell fate commitment [GO:0045165]; cell fate specification [GO:0001708]; cell migration involved in endocardial cushion formation [GO:0003273]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to hypoxia [GO:0071456]; cellular response to tumor cell [GO:0071228]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; chemical synaptic transmission, postsynaptic [GO:0099565]; cilium assembly [GO:0060271]; collecting duct development [GO:0072044]; compartment pattern specification [GO:0007386]; coronary artery morphogenesis [GO:0060982]; coronary sinus valve morphogenesis [GO:0003182]; coronary vein morphogenesis [GO:0003169]; determination of left/right symmetry [GO:0007368]; distal tubule development [GO:0072017]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic limb morphogenesis [GO:0030326]; endocardial cell differentiation [GO:0060956]; endocardial cushion development [GO:0003197]; endocardial cushion morphogenesis [GO:0003203]; endocardium development [GO:0003157]; endocardium morphogenesis [GO:0003160]; endoderm development [GO:0007492]; epidermis development [GO:0008544]; epithelial to mesenchymal transition [GO:0001837]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; forebrain development [GO:0030900]; foregut morphogenesis [GO:0007440]; gene expression [GO:0010467]; glial cell differentiation [GO:0010001]; glomerular mesangial cell development [GO:0072144]; growth involved in heart morphogenesis [GO:0003241]; hair follicle morphogenesis [GO:0031069]; heart development [GO:0007507]; heart looping [GO:0001947]; heart trabecula morphogenesis [GO:0061384]; homeostasis of number of cells within a tissue [GO:0048873]; humoral immune response [GO:0006959]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; interleukin-17-mediated signaling pathway [GO:0097400]; keratinocyte differentiation [GO:0030216]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; lung development [GO:0030324]; luteolysis [GO:0001554]; mesenchymal cell development [GO:0014031]; mitral valve formation [GO:0003192]; negative regulation of anoikis [GO:2000811]; negative regulation of biomineral tissue development [GO:0070168]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of catalytic activity [GO:0043086]; negative regulation of cell adhesion molecule production [GO:0060354]; negative regulation of cell differentiation [GO:0045596]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell proliferation involved in heart valve morphogenesis [GO:0003252]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of collagen biosynthetic process [GO:0032966]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of endothelial cell chemotaxis [GO:2001027]; negative regulation of extracellular matrix constituent secretion [GO:0003332]; negative regulation of gene expression [GO:0010629]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of inner ear auditory receptor cell differentiation [GO:0045608]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of ossification [GO:0030279]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of photoreceptor cell differentiation [GO:0046533]; negative regulation of pro-B cell differentiation [GO:2000974]; negative regulation of programmed cell death [GO:0043069]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural tube development [GO:0021915]; neuron differentiation [GO:0030182]; neuron fate commitment [GO:0048663]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; oligodendrocyte differentiation [GO:0048709]; osteoblast fate commitment [GO:0002051]; outflow tract morphogenesis [GO:0003151]; pericardium morphogenesis [GO:0003344]; positive regulation of aorta morphogenesis [GO:1903849]; positive regulation of apoptotic process [GO:0043065]; positive regulation of apoptotic process involved in morphogenesis [GO:1902339]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cardiac epithelial to mesenchymal transition [GO:0062043]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of ephrin receptor signaling pathway [GO:1901189]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of glial cell differentiation [GO:0045687]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of smooth muscle cell differentiation [GO:0051152]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription of Notch receptor target [GO:0007221]; positive regulation of viral genome replication [GO:0045070]; prostate gland epithelium morphogenesis [GO:0060740]; protein catabolic process [GO:0030163]; protein import into nucleus [GO:0006606]; pulmonary valve morphogenesis [GO:0003184]; regulation of cardioblast proliferation [GO:0003264]; regulation of cell adhesion involved in heart morphogenesis [GO:0061344]; regulation of cell migration [GO:0030334]; regulation of cell population proliferation [GO:0042127]; regulation of epithelial cell proliferation [GO:0050678]; regulation of epithelial cell proliferation involved in prostate gland development [GO:0060768]; regulation of extracellular matrix assembly [GO:1901201]; regulation of gene expression [GO:0010468]; regulation of inner ear auditory receptor cell differentiation [GO:0045607]; regulation of neurogenesis [GO:0050767]; regulation of Notch signaling pathway [GO:0008593]; regulation of somitogenesis [GO:0014807]; regulation of transcription by RNA polymerase II [GO:0006357]; response to lipopolysaccharide [GO:0032496]; response to muramyl dipeptide [GO:0032495]; secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development [GO:0060528]; skeletal muscle cell differentiation [GO:0035914]; somatic stem cell division [GO:0048103]; spermatogenesis [GO:0007283]; sprouting angiogenesis [GO:0002040]; T-helper 17 type immune response [GO:0072538]; tissue regeneration [GO:0042246]; tube formation [GO:0035148]; vasculogenesis involved in coronary vascular morphogenesis [GO:0060979]; venous blood vessel morphogenesis [GO:0048845]; venous endothelial cell differentiation [GO:0060843]; ventricular septum morphogenesis [GO:0060412]; ventricular trabecula myocardium morphogenesis [GO:0003222] acrosomal vesicle [GO:0001669]; adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell periphery [GO:0071944]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; lamellipodium [GO:0030027]; late endosome membrane [GO:0031902]; MAML1-RBP-Jkappa- ICN1 complex [GO:0002193]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; receptor complex [GO:0043235]; ruffle [GO:0001726]; Schaffer collateral - CA1 synapse [GO:0098685] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; identical protein binding [GO:0042802]; Notch binding [GO:0005112]; transcription coactivator activity [GO:0003713]; transcription regulator activator activity [GO:0140537]; transmembrane signaling receptor activity [GO:0004888] g256.t1 Q01705 41.176 153 4.02e-22 109.0 sp|Q01705|NOTC1_MOUSE Neurogenic locus notch homolog protein 1 OS=Mus musculus OX=10090 GN=Notch1 PE=1 SV=3 NOTC1_MOUSE reviewed Neurogenic locus notch homolog protein 1 (Notch 1) (Motch A) (mT14) (p300) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Mus musculus (Mouse) GO:0000122; GO:0000139; GO:0001554; GO:0001669; GO:0001701; GO:0001708; GO:0001726; GO:0001837; GO:0001889; GO:0001947; GO:0002040; GO:0002051; GO:0002052; GO:0002193; GO:0002437; GO:0003151; GO:0003157; GO:0003160; GO:0003162; GO:0003169; GO:0003180; GO:0003181; GO:0003182; GO:0003184; GO:0003192; GO:0003197; GO:0003198; GO:0003203; GO:0003207; GO:0003208; GO:0003209; GO:0003213; GO:0003214; GO:0003219; GO:0003222; GO:0003241; GO:0003252; GO:0003264; GO:0003273; GO:0003332; GO:0003344; GO:0003682; GO:0003713; GO:0004857; GO:0004888; GO:0005112; GO:0005509; GO:0005576; GO:0005634; GO:0005654; GO:0005737; GO:0005783; GO:0005789; GO:0005829; GO:0005856; GO:0005886; GO:0005912; GO:0006357; GO:0006606; GO:0006959; GO:0007219; GO:0007221; GO:0007283; GO:0007368; GO:0007386; GO:0007409; GO:0007411; GO:0007440; GO:0007492; GO:0007507; GO:0008284; GO:0008285; GO:0008544; GO:0008593; GO:0009912; GO:0009986; GO:0010001; GO:0010008; GO:0010467; GO:0010468; GO:0010614; GO:0010628; GO:0010629; GO:0010667; GO:0010718; GO:0010812; GO:0010832; GO:0014031; GO:0014807; GO:0016324; GO:0019899; GO:0021515; GO:0021915; GO:0030027; GO:0030154; GO:0030163; GO:0030182; GO:0030216; GO:0030279; GO:0030324; GO:0030326; GO:0030334; GO:0030335; GO:0030513; GO:0030514; GO:0030900; GO:0031069; GO:0031100; GO:0031410; GO:0031490; GO:0031902; GO:0032495; GO:0032496; GO:0032966; GO:0035116; GO:0035148; GO:0035914; GO:0035924; GO:0042127; GO:0042246; GO:0042802; GO:0043065; GO:0043069; GO:0043086; GO:0043235; GO:0045070; GO:0045165; GO:0045596; GO:0045603; GO:0045607; GO:0045608; GO:0045618; GO:0045662; GO:0045665; GO:0045668; GO:0045687; GO:0045747; GO:0045892; GO:0045893; GO:0045944; GO:0045955; GO:0046427; GO:0046533; GO:0046579; GO:0048103; GO:0048593; GO:0048663; GO:0048708; GO:0048709; GO:0048711; GO:0048715; GO:0048754; GO:0048845; GO:0048873; GO:0050678; GO:0050679; GO:0050767; GO:0050768; GO:0051152; GO:0055008; GO:0060038; GO:0060045; GO:0060253; GO:0060271; GO:0060317; GO:0060354; GO:0060379; GO:0060411; GO:0060412; GO:0060528; GO:0060740; GO:0060768; GO:0060842; GO:0060843; GO:0060948; GO:0060956; GO:0060979; GO:0060982; GO:0061344; GO:0061384; GO:0062043; GO:0070168; GO:0070374; GO:0070986; GO:0071228; GO:0071372; GO:0071456; GO:0071944; GO:0072017; GO:0072044; GO:0072144; GO:0072538; GO:0090051; GO:0090090; GO:0097150; GO:0097400; GO:0098685; GO:0098839; GO:0098978; GO:0099565; GO:0120163; GO:0140537; GO:1901189; GO:1901201; GO:1902263; GO:1902339; GO:1903849; GO:2000048; GO:2000737; GO:2000811; GO:2000974; GO:2001027 animal organ regeneration [GO:0031100]; aortic valve morphogenesis [GO:0003180]; apoptotic process involved in embryonic digit morphogenesis [GO:1902263]; arterial endothelial cell differentiation [GO:0060842]; astrocyte differentiation [GO:0048708]; atrioventricular node development [GO:0003162]; atrioventricular valve morphogenesis [GO:0003181]; auditory receptor cell fate commitment [GO:0009912]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; branching morphogenesis of an epithelial tube [GO:0048754]; camera-type eye morphogenesis [GO:0048593]; cardiac atrium morphogenesis [GO:0003209]; cardiac chamber formation [GO:0003207]; cardiac epithelial to mesenchymal transition [GO:0060317]; cardiac left ventricle morphogenesis [GO:0003214]; cardiac muscle cell myoblast differentiation [GO:0060379]; cardiac muscle cell proliferation [GO:0060038]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac right atrium morphogenesis [GO:0003213]; cardiac right ventricle formation [GO:0003219]; cardiac septum morphogenesis [GO:0060411]; cardiac vascular smooth muscle cell development [GO:0060948]; cardiac ventricle morphogenesis [GO:0003208]; cell differentiation [GO:0030154]; cell differentiation in spinal cord [GO:0021515]; cell fate commitment [GO:0045165]; cell fate specification [GO:0001708]; cell migration involved in endocardial cushion formation [GO:0003273]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to hypoxia [GO:0071456]; cellular response to tumor cell [GO:0071228]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; chemical synaptic transmission, postsynaptic [GO:0099565]; cilium assembly [GO:0060271]; collecting duct development [GO:0072044]; compartment pattern specification [GO:0007386]; coronary artery morphogenesis [GO:0060982]; coronary sinus valve morphogenesis [GO:0003182]; coronary vein morphogenesis [GO:0003169]; determination of left/right symmetry [GO:0007368]; distal tubule development [GO:0072017]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic limb morphogenesis [GO:0030326]; endocardial cell differentiation [GO:0060956]; endocardial cushion development [GO:0003197]; endocardial cushion morphogenesis [GO:0003203]; endocardium development [GO:0003157]; endocardium morphogenesis [GO:0003160]; endoderm development [GO:0007492]; epidermis development [GO:0008544]; epithelial to mesenchymal transition [GO:0001837]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; forebrain development [GO:0030900]; foregut morphogenesis [GO:0007440]; gene expression [GO:0010467]; glial cell differentiation [GO:0010001]; glomerular mesangial cell development [GO:0072144]; growth involved in heart morphogenesis [GO:0003241]; hair follicle morphogenesis [GO:0031069]; heart development [GO:0007507]; heart looping [GO:0001947]; heart trabecula morphogenesis [GO:0061384]; homeostasis of number of cells within a tissue [GO:0048873]; humoral immune response [GO:0006959]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; interleukin-17-mediated signaling pathway [GO:0097400]; keratinocyte differentiation [GO:0030216]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; lung development [GO:0030324]; luteolysis [GO:0001554]; mesenchymal cell development [GO:0014031]; mitral valve formation [GO:0003192]; negative regulation of anoikis [GO:2000811]; negative regulation of biomineral tissue development [GO:0070168]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of catalytic activity [GO:0043086]; negative regulation of cell adhesion molecule production [GO:0060354]; negative regulation of cell differentiation [GO:0045596]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell proliferation involved in heart valve morphogenesis [GO:0003252]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of collagen biosynthetic process [GO:0032966]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of endothelial cell chemotaxis [GO:2001027]; negative regulation of extracellular matrix constituent secretion [GO:0003332]; negative regulation of gene expression [GO:0010629]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of inner ear auditory receptor cell differentiation [GO:0045608]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of ossification [GO:0030279]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of photoreceptor cell differentiation [GO:0046533]; negative regulation of pro-B cell differentiation [GO:2000974]; negative regulation of programmed cell death [GO:0043069]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural tube development [GO:0021915]; neuron differentiation [GO:0030182]; neuron fate commitment [GO:0048663]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; oligodendrocyte differentiation [GO:0048709]; osteoblast fate commitment [GO:0002051]; outflow tract morphogenesis [GO:0003151]; pericardium morphogenesis [GO:0003344]; positive regulation of aorta morphogenesis [GO:1903849]; positive regulation of apoptotic process [GO:0043065]; positive regulation of apoptotic process involved in morphogenesis [GO:1902339]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cardiac epithelial to mesenchymal transition [GO:0062043]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of ephrin receptor signaling pathway [GO:1901189]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of glial cell differentiation [GO:0045687]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of smooth muscle cell differentiation [GO:0051152]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription of Notch receptor target [GO:0007221]; positive regulation of viral genome replication [GO:0045070]; prostate gland epithelium morphogenesis [GO:0060740]; protein catabolic process [GO:0030163]; protein import into nucleus [GO:0006606]; pulmonary valve morphogenesis [GO:0003184]; regulation of cardioblast proliferation [GO:0003264]; regulation of cell adhesion involved in heart morphogenesis [GO:0061344]; regulation of cell migration [GO:0030334]; regulation of cell population proliferation [GO:0042127]; regulation of epithelial cell proliferation [GO:0050678]; regulation of epithelial cell proliferation involved in prostate gland development [GO:0060768]; regulation of extracellular matrix assembly [GO:1901201]; regulation of gene expression [GO:0010468]; regulation of inner ear auditory receptor cell differentiation [GO:0045607]; regulation of neurogenesis [GO:0050767]; regulation of Notch signaling pathway [GO:0008593]; regulation of somitogenesis [GO:0014807]; regulation of transcription by RNA polymerase II [GO:0006357]; response to lipopolysaccharide [GO:0032496]; response to muramyl dipeptide [GO:0032495]; secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development [GO:0060528]; skeletal muscle cell differentiation [GO:0035914]; somatic stem cell division [GO:0048103]; spermatogenesis [GO:0007283]; sprouting angiogenesis [GO:0002040]; T-helper 17 type immune response [GO:0072538]; tissue regeneration [GO:0042246]; tube formation [GO:0035148]; vasculogenesis involved in coronary vascular morphogenesis [GO:0060979]; venous blood vessel morphogenesis [GO:0048845]; venous endothelial cell differentiation [GO:0060843]; ventricular septum morphogenesis [GO:0060412]; ventricular trabecula myocardium morphogenesis [GO:0003222] acrosomal vesicle [GO:0001669]; adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell periphery [GO:0071944]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; lamellipodium [GO:0030027]; late endosome membrane [GO:0031902]; MAML1-RBP-Jkappa- ICN1 complex [GO:0002193]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; receptor complex [GO:0043235]; ruffle [GO:0001726]; Schaffer collateral - CA1 synapse [GO:0098685] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; identical protein binding [GO:0042802]; Notch binding [GO:0005112]; transcription coactivator activity [GO:0003713]; transcription regulator activator activity [GO:0140537]; transmembrane signaling receptor activity [GO:0004888] g256.t1 Q01705 41.176 153 2.3700000000000003e-21 107.0 sp|Q01705|NOTC1_MOUSE Neurogenic locus notch homolog protein 1 OS=Mus musculus OX=10090 GN=Notch1 PE=1 SV=3 NOTC1_MOUSE reviewed Neurogenic locus notch homolog protein 1 (Notch 1) (Motch A) (mT14) (p300) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Mus musculus (Mouse) GO:0000122; GO:0000139; GO:0001554; GO:0001669; GO:0001701; GO:0001708; GO:0001726; GO:0001837; GO:0001889; GO:0001947; GO:0002040; GO:0002051; GO:0002052; GO:0002193; GO:0002437; GO:0003151; GO:0003157; GO:0003160; GO:0003162; GO:0003169; GO:0003180; GO:0003181; GO:0003182; GO:0003184; GO:0003192; GO:0003197; GO:0003198; GO:0003203; GO:0003207; GO:0003208; GO:0003209; GO:0003213; GO:0003214; GO:0003219; GO:0003222; GO:0003241; GO:0003252; GO:0003264; GO:0003273; GO:0003332; GO:0003344; GO:0003682; GO:0003713; GO:0004857; GO:0004888; GO:0005112; GO:0005509; GO:0005576; GO:0005634; GO:0005654; GO:0005737; GO:0005783; GO:0005789; GO:0005829; GO:0005856; GO:0005886; GO:0005912; GO:0006357; GO:0006606; GO:0006959; GO:0007219; GO:0007221; GO:0007283; GO:0007368; GO:0007386; GO:0007409; GO:0007411; GO:0007440; GO:0007492; GO:0007507; GO:0008284; GO:0008285; GO:0008544; GO:0008593; GO:0009912; GO:0009986; GO:0010001; GO:0010008; GO:0010467; GO:0010468; GO:0010614; GO:0010628; GO:0010629; GO:0010667; GO:0010718; GO:0010812; GO:0010832; GO:0014031; GO:0014807; GO:0016324; GO:0019899; GO:0021515; GO:0021915; GO:0030027; GO:0030154; GO:0030163; GO:0030182; GO:0030216; GO:0030279; GO:0030324; GO:0030326; GO:0030334; GO:0030335; GO:0030513; GO:0030514; GO:0030900; GO:0031069; GO:0031100; GO:0031410; GO:0031490; GO:0031902; GO:0032495; GO:0032496; GO:0032966; GO:0035116; GO:0035148; GO:0035914; GO:0035924; GO:0042127; GO:0042246; GO:0042802; GO:0043065; GO:0043069; GO:0043086; GO:0043235; GO:0045070; GO:0045165; GO:0045596; GO:0045603; GO:0045607; GO:0045608; GO:0045618; GO:0045662; GO:0045665; GO:0045668; GO:0045687; GO:0045747; GO:0045892; GO:0045893; GO:0045944; GO:0045955; GO:0046427; GO:0046533; GO:0046579; GO:0048103; GO:0048593; GO:0048663; GO:0048708; GO:0048709; GO:0048711; GO:0048715; GO:0048754; GO:0048845; GO:0048873; GO:0050678; GO:0050679; GO:0050767; GO:0050768; GO:0051152; GO:0055008; GO:0060038; GO:0060045; GO:0060253; GO:0060271; GO:0060317; GO:0060354; GO:0060379; GO:0060411; GO:0060412; GO:0060528; GO:0060740; GO:0060768; GO:0060842; GO:0060843; GO:0060948; GO:0060956; GO:0060979; GO:0060982; GO:0061344; GO:0061384; GO:0062043; GO:0070168; GO:0070374; GO:0070986; GO:0071228; GO:0071372; GO:0071456; GO:0071944; GO:0072017; GO:0072044; GO:0072144; GO:0072538; GO:0090051; GO:0090090; GO:0097150; GO:0097400; GO:0098685; GO:0098839; GO:0098978; GO:0099565; GO:0120163; GO:0140537; GO:1901189; GO:1901201; GO:1902263; GO:1902339; GO:1903849; GO:2000048; GO:2000737; GO:2000811; GO:2000974; GO:2001027 animal organ regeneration [GO:0031100]; aortic valve morphogenesis [GO:0003180]; apoptotic process involved in embryonic digit morphogenesis [GO:1902263]; arterial endothelial cell differentiation [GO:0060842]; astrocyte differentiation [GO:0048708]; atrioventricular node development [GO:0003162]; atrioventricular valve morphogenesis [GO:0003181]; auditory receptor cell fate commitment [GO:0009912]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; branching morphogenesis of an epithelial tube [GO:0048754]; camera-type eye morphogenesis [GO:0048593]; cardiac atrium morphogenesis [GO:0003209]; cardiac chamber formation [GO:0003207]; cardiac epithelial to mesenchymal transition [GO:0060317]; cardiac left ventricle morphogenesis [GO:0003214]; cardiac muscle cell myoblast differentiation [GO:0060379]; cardiac muscle cell proliferation [GO:0060038]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac right atrium morphogenesis [GO:0003213]; cardiac right ventricle formation [GO:0003219]; cardiac septum morphogenesis [GO:0060411]; cardiac vascular smooth muscle cell development [GO:0060948]; cardiac ventricle morphogenesis [GO:0003208]; cell differentiation [GO:0030154]; cell differentiation in spinal cord [GO:0021515]; cell fate commitment [GO:0045165]; cell fate specification [GO:0001708]; cell migration involved in endocardial cushion formation [GO:0003273]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to hypoxia [GO:0071456]; cellular response to tumor cell [GO:0071228]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; chemical synaptic transmission, postsynaptic [GO:0099565]; cilium assembly [GO:0060271]; collecting duct development [GO:0072044]; compartment pattern specification [GO:0007386]; coronary artery morphogenesis [GO:0060982]; coronary sinus valve morphogenesis [GO:0003182]; coronary vein morphogenesis [GO:0003169]; determination of left/right symmetry [GO:0007368]; distal tubule development [GO:0072017]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic limb morphogenesis [GO:0030326]; endocardial cell differentiation [GO:0060956]; endocardial cushion development [GO:0003197]; endocardial cushion morphogenesis [GO:0003203]; endocardium development [GO:0003157]; endocardium morphogenesis [GO:0003160]; endoderm development [GO:0007492]; epidermis development [GO:0008544]; epithelial to mesenchymal transition [GO:0001837]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; forebrain development [GO:0030900]; foregut morphogenesis [GO:0007440]; gene expression [GO:0010467]; glial cell differentiation [GO:0010001]; glomerular mesangial cell development [GO:0072144]; growth involved in heart morphogenesis [GO:0003241]; hair follicle morphogenesis [GO:0031069]; heart development [GO:0007507]; heart looping [GO:0001947]; heart trabecula morphogenesis [GO:0061384]; homeostasis of number of cells within a tissue [GO:0048873]; humoral immune response [GO:0006959]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; interleukin-17-mediated signaling pathway [GO:0097400]; keratinocyte differentiation [GO:0030216]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; lung development [GO:0030324]; luteolysis [GO:0001554]; mesenchymal cell development [GO:0014031]; mitral valve formation [GO:0003192]; negative regulation of anoikis [GO:2000811]; negative regulation of biomineral tissue development [GO:0070168]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of catalytic activity [GO:0043086]; negative regulation of cell adhesion molecule production [GO:0060354]; negative regulation of cell differentiation [GO:0045596]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell proliferation involved in heart valve morphogenesis [GO:0003252]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of collagen biosynthetic process [GO:0032966]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of endothelial cell chemotaxis [GO:2001027]; negative regulation of extracellular matrix constituent secretion [GO:0003332]; negative regulation of gene expression [GO:0010629]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of inner ear auditory receptor cell differentiation [GO:0045608]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of ossification [GO:0030279]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of photoreceptor cell differentiation [GO:0046533]; negative regulation of pro-B cell differentiation [GO:2000974]; negative regulation of programmed cell death [GO:0043069]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural tube development [GO:0021915]; neuron differentiation [GO:0030182]; neuron fate commitment [GO:0048663]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; oligodendrocyte differentiation [GO:0048709]; osteoblast fate commitment [GO:0002051]; outflow tract morphogenesis [GO:0003151]; pericardium morphogenesis [GO:0003344]; positive regulation of aorta morphogenesis [GO:1903849]; positive regulation of apoptotic process [GO:0043065]; positive regulation of apoptotic process involved in morphogenesis [GO:1902339]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cardiac epithelial to mesenchymal transition [GO:0062043]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of ephrin receptor signaling pathway [GO:1901189]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of glial cell differentiation [GO:0045687]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of smooth muscle cell differentiation [GO:0051152]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription of Notch receptor target [GO:0007221]; positive regulation of viral genome replication [GO:0045070]; prostate gland epithelium morphogenesis [GO:0060740]; protein catabolic process [GO:0030163]; protein import into nucleus [GO:0006606]; pulmonary valve morphogenesis [GO:0003184]; regulation of cardioblast proliferation [GO:0003264]; regulation of cell adhesion involved in heart morphogenesis [GO:0061344]; regulation of cell migration [GO:0030334]; regulation of cell population proliferation [GO:0042127]; regulation of epithelial cell proliferation [GO:0050678]; regulation of epithelial cell proliferation involved in prostate gland development [GO:0060768]; regulation of extracellular matrix assembly [GO:1901201]; regulation of gene expression [GO:0010468]; regulation of inner ear auditory receptor cell differentiation [GO:0045607]; regulation of neurogenesis [GO:0050767]; regulation of Notch signaling pathway [GO:0008593]; regulation of somitogenesis [GO:0014807]; regulation of transcription by RNA polymerase II [GO:0006357]; response to lipopolysaccharide [GO:0032496]; response to muramyl dipeptide [GO:0032495]; secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development [GO:0060528]; skeletal muscle cell differentiation [GO:0035914]; somatic stem cell division [GO:0048103]; spermatogenesis [GO:0007283]; sprouting angiogenesis [GO:0002040]; T-helper 17 type immune response [GO:0072538]; tissue regeneration [GO:0042246]; tube formation [GO:0035148]; vasculogenesis involved in coronary vascular morphogenesis [GO:0060979]; venous blood vessel morphogenesis [GO:0048845]; venous endothelial cell differentiation [GO:0060843]; ventricular septum morphogenesis [GO:0060412]; ventricular trabecula myocardium morphogenesis [GO:0003222] acrosomal vesicle [GO:0001669]; adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell periphery [GO:0071944]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; lamellipodium [GO:0030027]; late endosome membrane [GO:0031902]; MAML1-RBP-Jkappa- ICN1 complex [GO:0002193]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; receptor complex [GO:0043235]; ruffle [GO:0001726]; Schaffer collateral - CA1 synapse [GO:0098685] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; identical protein binding [GO:0042802]; Notch binding [GO:0005112]; transcription coactivator activity [GO:0003713]; transcription regulator activator activity [GO:0140537]; transmembrane signaling receptor activity [GO:0004888] g256.t2 Q01705 37.055 1433 0.0 724.0 sp|Q01705|NOTC1_MOUSE Neurogenic locus notch homolog protein 1 OS=Mus musculus OX=10090 GN=Notch1 PE=1 SV=3 NOTC1_MOUSE reviewed Neurogenic locus notch homolog protein 1 (Notch 1) (Motch A) (mT14) (p300) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Mus musculus (Mouse) GO:0000122; GO:0000139; GO:0001554; GO:0001669; GO:0001701; GO:0001708; GO:0001726; GO:0001837; GO:0001889; GO:0001947; GO:0002040; GO:0002051; GO:0002052; GO:0002193; GO:0002437; GO:0003151; GO:0003157; GO:0003160; GO:0003162; GO:0003169; GO:0003180; GO:0003181; GO:0003182; GO:0003184; GO:0003192; GO:0003197; GO:0003198; GO:0003203; GO:0003207; GO:0003208; GO:0003209; GO:0003213; GO:0003214; GO:0003219; GO:0003222; GO:0003241; GO:0003252; GO:0003264; GO:0003273; GO:0003332; GO:0003344; GO:0003682; GO:0003713; GO:0004857; GO:0004888; GO:0005112; GO:0005509; GO:0005576; GO:0005634; GO:0005654; GO:0005737; GO:0005783; GO:0005789; GO:0005829; GO:0005856; GO:0005886; GO:0005912; GO:0006357; GO:0006606; GO:0006959; GO:0007219; GO:0007221; GO:0007283; GO:0007368; GO:0007386; GO:0007409; GO:0007411; GO:0007440; GO:0007492; GO:0007507; GO:0008284; GO:0008285; GO:0008544; GO:0008593; GO:0009912; GO:0009986; GO:0010001; GO:0010008; GO:0010467; GO:0010468; GO:0010614; GO:0010628; GO:0010629; GO:0010667; GO:0010718; GO:0010812; GO:0010832; GO:0014031; GO:0014807; GO:0016324; GO:0019899; GO:0021515; GO:0021915; GO:0030027; GO:0030154; GO:0030163; GO:0030182; GO:0030216; GO:0030279; GO:0030324; GO:0030326; GO:0030334; GO:0030335; GO:0030513; GO:0030514; GO:0030900; GO:0031069; GO:0031100; GO:0031410; GO:0031490; GO:0031902; GO:0032495; GO:0032496; GO:0032966; GO:0035116; GO:0035148; GO:0035914; GO:0035924; GO:0042127; GO:0042246; GO:0042802; GO:0043065; GO:0043069; GO:0043086; GO:0043235; GO:0045070; GO:0045165; GO:0045596; GO:0045603; GO:0045607; GO:0045608; GO:0045618; GO:0045662; GO:0045665; GO:0045668; GO:0045687; GO:0045747; GO:0045892; GO:0045893; GO:0045944; GO:0045955; GO:0046427; GO:0046533; GO:0046579; GO:0048103; GO:0048593; GO:0048663; GO:0048708; GO:0048709; GO:0048711; GO:0048715; GO:0048754; GO:0048845; GO:0048873; GO:0050678; GO:0050679; GO:0050767; GO:0050768; GO:0051152; GO:0055008; GO:0060038; GO:0060045; GO:0060253; GO:0060271; GO:0060317; GO:0060354; GO:0060379; GO:0060411; GO:0060412; GO:0060528; GO:0060740; GO:0060768; GO:0060842; GO:0060843; GO:0060948; GO:0060956; GO:0060979; GO:0060982; GO:0061344; GO:0061384; GO:0062043; GO:0070168; GO:0070374; GO:0070986; GO:0071228; GO:0071372; GO:0071456; GO:0071944; GO:0072017; GO:0072044; GO:0072144; GO:0072538; GO:0090051; GO:0090090; GO:0097150; GO:0097400; GO:0098685; GO:0098839; GO:0098978; GO:0099565; GO:0120163; GO:0140537; GO:1901189; GO:1901201; GO:1902263; GO:1902339; GO:1903849; GO:2000048; GO:2000737; GO:2000811; GO:2000974; GO:2001027 animal organ regeneration [GO:0031100]; aortic valve morphogenesis [GO:0003180]; apoptotic process involved in embryonic digit morphogenesis [GO:1902263]; arterial endothelial cell differentiation [GO:0060842]; astrocyte differentiation [GO:0048708]; atrioventricular node development [GO:0003162]; atrioventricular valve morphogenesis [GO:0003181]; auditory receptor cell fate commitment [GO:0009912]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; branching morphogenesis of an epithelial tube [GO:0048754]; camera-type eye morphogenesis [GO:0048593]; cardiac atrium morphogenesis [GO:0003209]; cardiac chamber formation [GO:0003207]; cardiac epithelial to mesenchymal transition [GO:0060317]; cardiac left ventricle morphogenesis [GO:0003214]; cardiac muscle cell myoblast differentiation [GO:0060379]; cardiac muscle cell proliferation [GO:0060038]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac right atrium morphogenesis [GO:0003213]; cardiac right ventricle formation [GO:0003219]; cardiac septum morphogenesis [GO:0060411]; cardiac vascular smooth muscle cell development [GO:0060948]; cardiac ventricle morphogenesis [GO:0003208]; cell differentiation [GO:0030154]; cell differentiation in spinal cord [GO:0021515]; cell fate commitment [GO:0045165]; cell fate specification [GO:0001708]; cell migration involved in endocardial cushion formation [GO:0003273]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to hypoxia [GO:0071456]; cellular response to tumor cell [GO:0071228]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; chemical synaptic transmission, postsynaptic [GO:0099565]; cilium assembly [GO:0060271]; collecting duct development [GO:0072044]; compartment pattern specification [GO:0007386]; coronary artery morphogenesis [GO:0060982]; coronary sinus valve morphogenesis [GO:0003182]; coronary vein morphogenesis [GO:0003169]; determination of left/right symmetry [GO:0007368]; distal tubule development [GO:0072017]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic limb morphogenesis [GO:0030326]; endocardial cell differentiation [GO:0060956]; endocardial cushion development [GO:0003197]; endocardial cushion morphogenesis [GO:0003203]; endocardium development [GO:0003157]; endocardium morphogenesis [GO:0003160]; endoderm development [GO:0007492]; epidermis development [GO:0008544]; epithelial to mesenchymal transition [GO:0001837]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; forebrain development [GO:0030900]; foregut morphogenesis [GO:0007440]; gene expression [GO:0010467]; glial cell differentiation [GO:0010001]; glomerular mesangial cell development [GO:0072144]; growth involved in heart morphogenesis [GO:0003241]; hair follicle morphogenesis [GO:0031069]; heart development [GO:0007507]; heart looping [GO:0001947]; heart trabecula morphogenesis [GO:0061384]; homeostasis of number of cells within a tissue [GO:0048873]; humoral immune response [GO:0006959]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; interleukin-17-mediated signaling pathway [GO:0097400]; keratinocyte differentiation [GO:0030216]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; lung development [GO:0030324]; luteolysis [GO:0001554]; mesenchymal cell development [GO:0014031]; mitral valve formation [GO:0003192]; negative regulation of anoikis [GO:2000811]; negative regulation of biomineral tissue development [GO:0070168]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of catalytic activity [GO:0043086]; negative regulation of cell adhesion molecule production [GO:0060354]; negative regulation of cell differentiation [GO:0045596]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell proliferation involved in heart valve morphogenesis [GO:0003252]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of collagen biosynthetic process [GO:0032966]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of endothelial cell chemotaxis [GO:2001027]; negative regulation of extracellular matrix constituent secretion [GO:0003332]; negative regulation of gene expression [GO:0010629]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of inner ear auditory receptor cell differentiation [GO:0045608]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of ossification [GO:0030279]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of photoreceptor cell differentiation [GO:0046533]; negative regulation of pro-B cell differentiation [GO:2000974]; negative regulation of programmed cell death [GO:0043069]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural tube development [GO:0021915]; neuron differentiation [GO:0030182]; neuron fate commitment [GO:0048663]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; oligodendrocyte differentiation [GO:0048709]; osteoblast fate commitment [GO:0002051]; outflow tract morphogenesis [GO:0003151]; pericardium morphogenesis [GO:0003344]; positive regulation of aorta morphogenesis [GO:1903849]; positive regulation of apoptotic process [GO:0043065]; positive regulation of apoptotic process involved in morphogenesis [GO:1902339]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cardiac epithelial to mesenchymal transition [GO:0062043]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of ephrin receptor signaling pathway [GO:1901189]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of glial cell differentiation [GO:0045687]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of smooth muscle cell differentiation [GO:0051152]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription of Notch receptor target [GO:0007221]; positive regulation of viral genome replication [GO:0045070]; prostate gland epithelium morphogenesis [GO:0060740]; protein catabolic process [GO:0030163]; protein import into nucleus [GO:0006606]; pulmonary valve morphogenesis [GO:0003184]; regulation of cardioblast proliferation [GO:0003264]; regulation of cell adhesion involved in heart morphogenesis [GO:0061344]; regulation of cell migration [GO:0030334]; regulation of cell population proliferation [GO:0042127]; regulation of epithelial cell proliferation [GO:0050678]; regulation of epithelial cell proliferation involved in prostate gland development [GO:0060768]; regulation of extracellular matrix assembly [GO:1901201]; regulation of gene expression [GO:0010468]; regulation of inner ear auditory receptor cell differentiation [GO:0045607]; regulation of neurogenesis [GO:0050767]; regulation of Notch signaling pathway [GO:0008593]; regulation of somitogenesis [GO:0014807]; regulation of transcription by RNA polymerase II [GO:0006357]; response to lipopolysaccharide [GO:0032496]; response to muramyl dipeptide [GO:0032495]; secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development [GO:0060528]; skeletal muscle cell differentiation [GO:0035914]; somatic stem cell division [GO:0048103]; spermatogenesis [GO:0007283]; sprouting angiogenesis [GO:0002040]; T-helper 17 type immune response [GO:0072538]; tissue regeneration [GO:0042246]; tube formation [GO:0035148]; vasculogenesis involved in coronary vascular morphogenesis [GO:0060979]; venous blood vessel morphogenesis [GO:0048845]; venous endothelial cell differentiation [GO:0060843]; ventricular septum morphogenesis [GO:0060412]; ventricular trabecula myocardium morphogenesis [GO:0003222] acrosomal vesicle [GO:0001669]; adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell periphery [GO:0071944]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; lamellipodium [GO:0030027]; late endosome membrane [GO:0031902]; MAML1-RBP-Jkappa- ICN1 complex [GO:0002193]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; receptor complex [GO:0043235]; ruffle [GO:0001726]; Schaffer collateral - CA1 synapse [GO:0098685] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; identical protein binding [GO:0042802]; Notch binding [GO:0005112]; transcription coactivator activity [GO:0003713]; transcription regulator activator activity [GO:0140537]; transmembrane signaling receptor activity [GO:0004888] g256.t2 Q01705 35.89 1460 0.0 671.0 sp|Q01705|NOTC1_MOUSE Neurogenic locus notch homolog protein 1 OS=Mus musculus OX=10090 GN=Notch1 PE=1 SV=3 NOTC1_MOUSE reviewed Neurogenic locus notch homolog protein 1 (Notch 1) (Motch A) (mT14) (p300) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Mus musculus (Mouse) GO:0000122; GO:0000139; GO:0001554; GO:0001669; GO:0001701; GO:0001708; GO:0001726; GO:0001837; GO:0001889; GO:0001947; GO:0002040; GO:0002051; GO:0002052; GO:0002193; GO:0002437; GO:0003151; GO:0003157; GO:0003160; GO:0003162; GO:0003169; GO:0003180; GO:0003181; GO:0003182; GO:0003184; GO:0003192; GO:0003197; GO:0003198; GO:0003203; GO:0003207; GO:0003208; GO:0003209; GO:0003213; GO:0003214; GO:0003219; GO:0003222; GO:0003241; GO:0003252; GO:0003264; GO:0003273; GO:0003332; GO:0003344; GO:0003682; GO:0003713; GO:0004857; GO:0004888; GO:0005112; GO:0005509; GO:0005576; GO:0005634; GO:0005654; GO:0005737; GO:0005783; GO:0005789; GO:0005829; GO:0005856; GO:0005886; GO:0005912; GO:0006357; GO:0006606; GO:0006959; GO:0007219; GO:0007221; GO:0007283; GO:0007368; GO:0007386; GO:0007409; GO:0007411; GO:0007440; GO:0007492; GO:0007507; GO:0008284; GO:0008285; GO:0008544; GO:0008593; GO:0009912; GO:0009986; GO:0010001; GO:0010008; GO:0010467; GO:0010468; GO:0010614; GO:0010628; GO:0010629; GO:0010667; GO:0010718; GO:0010812; GO:0010832; GO:0014031; GO:0014807; GO:0016324; GO:0019899; GO:0021515; GO:0021915; GO:0030027; GO:0030154; GO:0030163; GO:0030182; GO:0030216; GO:0030279; GO:0030324; GO:0030326; GO:0030334; GO:0030335; GO:0030513; GO:0030514; GO:0030900; GO:0031069; GO:0031100; GO:0031410; GO:0031490; GO:0031902; GO:0032495; GO:0032496; GO:0032966; GO:0035116; GO:0035148; GO:0035914; GO:0035924; GO:0042127; GO:0042246; GO:0042802; GO:0043065; GO:0043069; GO:0043086; GO:0043235; GO:0045070; GO:0045165; GO:0045596; GO:0045603; GO:0045607; GO:0045608; GO:0045618; GO:0045662; GO:0045665; GO:0045668; GO:0045687; GO:0045747; GO:0045892; GO:0045893; GO:0045944; GO:0045955; GO:0046427; GO:0046533; GO:0046579; GO:0048103; GO:0048593; GO:0048663; GO:0048708; GO:0048709; GO:0048711; GO:0048715; GO:0048754; GO:0048845; GO:0048873; GO:0050678; GO:0050679; GO:0050767; GO:0050768; GO:0051152; GO:0055008; GO:0060038; GO:0060045; GO:0060253; GO:0060271; GO:0060317; GO:0060354; GO:0060379; GO:0060411; GO:0060412; GO:0060528; GO:0060740; GO:0060768; GO:0060842; GO:0060843; GO:0060948; GO:0060956; GO:0060979; GO:0060982; GO:0061344; GO:0061384; GO:0062043; GO:0070168; GO:0070374; GO:0070986; GO:0071228; GO:0071372; GO:0071456; GO:0071944; GO:0072017; GO:0072044; GO:0072144; GO:0072538; GO:0090051; GO:0090090; GO:0097150; GO:0097400; GO:0098685; GO:0098839; GO:0098978; GO:0099565; GO:0120163; GO:0140537; GO:1901189; GO:1901201; GO:1902263; GO:1902339; GO:1903849; GO:2000048; GO:2000737; GO:2000811; GO:2000974; GO:2001027 animal organ regeneration [GO:0031100]; aortic valve morphogenesis [GO:0003180]; apoptotic process involved in embryonic digit morphogenesis [GO:1902263]; arterial endothelial cell differentiation [GO:0060842]; astrocyte differentiation [GO:0048708]; atrioventricular node development [GO:0003162]; atrioventricular valve morphogenesis [GO:0003181]; auditory receptor cell fate commitment [GO:0009912]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; branching morphogenesis of an epithelial tube [GO:0048754]; camera-type eye morphogenesis [GO:0048593]; cardiac atrium morphogenesis [GO:0003209]; cardiac chamber formation [GO:0003207]; cardiac epithelial to mesenchymal transition [GO:0060317]; cardiac left ventricle morphogenesis [GO:0003214]; cardiac muscle cell myoblast differentiation [GO:0060379]; cardiac muscle cell proliferation [GO:0060038]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac right atrium morphogenesis [GO:0003213]; cardiac right ventricle formation [GO:0003219]; cardiac septum morphogenesis [GO:0060411]; cardiac vascular smooth muscle cell development [GO:0060948]; cardiac ventricle morphogenesis [GO:0003208]; cell differentiation [GO:0030154]; cell differentiation in spinal cord [GO:0021515]; cell fate commitment [GO:0045165]; cell fate specification [GO:0001708]; cell migration involved in endocardial cushion formation [GO:0003273]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to hypoxia [GO:0071456]; cellular response to tumor cell [GO:0071228]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; chemical synaptic transmission, postsynaptic [GO:0099565]; cilium assembly [GO:0060271]; collecting duct development [GO:0072044]; compartment pattern specification [GO:0007386]; coronary artery morphogenesis [GO:0060982]; coronary sinus valve morphogenesis [GO:0003182]; coronary vein morphogenesis [GO:0003169]; determination of left/right symmetry [GO:0007368]; distal tubule development [GO:0072017]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic limb morphogenesis [GO:0030326]; endocardial cell differentiation [GO:0060956]; endocardial cushion development [GO:0003197]; endocardial cushion morphogenesis [GO:0003203]; endocardium development [GO:0003157]; endocardium morphogenesis [GO:0003160]; endoderm development [GO:0007492]; epidermis development [GO:0008544]; epithelial to mesenchymal transition [GO:0001837]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; forebrain development [GO:0030900]; foregut morphogenesis [GO:0007440]; gene expression [GO:0010467]; glial cell differentiation [GO:0010001]; glomerular mesangial cell development [GO:0072144]; growth involved in heart morphogenesis [GO:0003241]; hair follicle morphogenesis [GO:0031069]; heart development [GO:0007507]; heart looping [GO:0001947]; heart trabecula morphogenesis [GO:0061384]; homeostasis of number of cells within a tissue [GO:0048873]; humoral immune response [GO:0006959]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; interleukin-17-mediated signaling pathway [GO:0097400]; keratinocyte differentiation [GO:0030216]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; lung development [GO:0030324]; luteolysis [GO:0001554]; mesenchymal cell development [GO:0014031]; mitral valve formation [GO:0003192]; negative regulation of anoikis [GO:2000811]; negative regulation of biomineral tissue development [GO:0070168]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of catalytic activity [GO:0043086]; negative regulation of cell adhesion molecule production [GO:0060354]; negative regulation of cell differentiation [GO:0045596]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell proliferation involved in heart valve morphogenesis [GO:0003252]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of collagen biosynthetic process [GO:0032966]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of endothelial cell chemotaxis [GO:2001027]; negative regulation of extracellular matrix constituent secretion [GO:0003332]; negative regulation of gene expression [GO:0010629]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of inner ear auditory receptor cell differentiation [GO:0045608]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of ossification [GO:0030279]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of photoreceptor cell differentiation [GO:0046533]; negative regulation of pro-B cell differentiation [GO:2000974]; negative regulation of programmed cell death [GO:0043069]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural tube development [GO:0021915]; neuron differentiation [GO:0030182]; neuron fate commitment [GO:0048663]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; oligodendrocyte differentiation [GO:0048709]; osteoblast fate commitment [GO:0002051]; outflow tract morphogenesis [GO:0003151]; pericardium morphogenesis [GO:0003344]; positive regulation of aorta morphogenesis [GO:1903849]; positive regulation of apoptotic process [GO:0043065]; positive regulation of apoptotic process involved in morphogenesis [GO:1902339]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cardiac epithelial to mesenchymal transition [GO:0062043]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of ephrin receptor signaling pathway [GO:1901189]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of glial cell differentiation [GO:0045687]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of smooth muscle cell differentiation [GO:0051152]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription of Notch receptor target [GO:0007221]; positive regulation of viral genome replication [GO:0045070]; prostate gland epithelium morphogenesis [GO:0060740]; protein catabolic process [GO:0030163]; protein import into nucleus [GO:0006606]; pulmonary valve morphogenesis [GO:0003184]; regulation of cardioblast proliferation [GO:0003264]; regulation of cell adhesion involved in heart morphogenesis [GO:0061344]; regulation of cell migration [GO:0030334]; regulation of cell population proliferation [GO:0042127]; regulation of epithelial cell proliferation [GO:0050678]; regulation of epithelial cell proliferation involved in prostate gland development [GO:0060768]; regulation of extracellular matrix assembly [GO:1901201]; regulation of gene expression [GO:0010468]; regulation of inner ear auditory receptor cell differentiation [GO:0045607]; regulation of neurogenesis [GO:0050767]; regulation of Notch signaling pathway [GO:0008593]; regulation of somitogenesis [GO:0014807]; regulation of transcription by RNA polymerase II [GO:0006357]; response to lipopolysaccharide [GO:0032496]; response to muramyl dipeptide [GO:0032495]; secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development [GO:0060528]; skeletal muscle cell differentiation [GO:0035914]; somatic stem cell division [GO:0048103]; spermatogenesis [GO:0007283]; sprouting angiogenesis [GO:0002040]; T-helper 17 type immune response [GO:0072538]; tissue regeneration [GO:0042246]; tube formation [GO:0035148]; vasculogenesis involved in coronary vascular morphogenesis [GO:0060979]; venous blood vessel morphogenesis [GO:0048845]; venous endothelial cell differentiation [GO:0060843]; ventricular septum morphogenesis [GO:0060412]; ventricular trabecula myocardium morphogenesis [GO:0003222] acrosomal vesicle [GO:0001669]; adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell periphery [GO:0071944]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; lamellipodium [GO:0030027]; late endosome membrane [GO:0031902]; MAML1-RBP-Jkappa- ICN1 complex [GO:0002193]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; receptor complex [GO:0043235]; ruffle [GO:0001726]; Schaffer collateral - CA1 synapse [GO:0098685] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; identical protein binding [GO:0042802]; Notch binding [GO:0005112]; transcription coactivator activity [GO:0003713]; transcription regulator activator activity [GO:0140537]; transmembrane signaling receptor activity [GO:0004888] g256.t2 Q01705 35.209 1457 0.0 654.0 sp|Q01705|NOTC1_MOUSE Neurogenic locus notch homolog protein 1 OS=Mus musculus OX=10090 GN=Notch1 PE=1 SV=3 NOTC1_MOUSE reviewed Neurogenic locus notch homolog protein 1 (Notch 1) (Motch A) (mT14) (p300) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Mus musculus (Mouse) GO:0000122; GO:0000139; GO:0001554; GO:0001669; GO:0001701; GO:0001708; GO:0001726; GO:0001837; GO:0001889; GO:0001947; GO:0002040; GO:0002051; GO:0002052; GO:0002193; GO:0002437; GO:0003151; GO:0003157; GO:0003160; GO:0003162; GO:0003169; GO:0003180; GO:0003181; GO:0003182; GO:0003184; GO:0003192; GO:0003197; GO:0003198; GO:0003203; GO:0003207; GO:0003208; GO:0003209; GO:0003213; GO:0003214; GO:0003219; GO:0003222; GO:0003241; GO:0003252; GO:0003264; GO:0003273; GO:0003332; GO:0003344; GO:0003682; GO:0003713; GO:0004857; GO:0004888; GO:0005112; GO:0005509; GO:0005576; GO:0005634; GO:0005654; GO:0005737; GO:0005783; GO:0005789; GO:0005829; GO:0005856; GO:0005886; GO:0005912; GO:0006357; GO:0006606; GO:0006959; GO:0007219; GO:0007221; GO:0007283; GO:0007368; GO:0007386; GO:0007409; GO:0007411; GO:0007440; GO:0007492; GO:0007507; GO:0008284; GO:0008285; GO:0008544; GO:0008593; GO:0009912; GO:0009986; GO:0010001; GO:0010008; GO:0010467; GO:0010468; GO:0010614; GO:0010628; GO:0010629; GO:0010667; GO:0010718; GO:0010812; GO:0010832; GO:0014031; GO:0014807; GO:0016324; GO:0019899; GO:0021515; GO:0021915; GO:0030027; GO:0030154; GO:0030163; GO:0030182; GO:0030216; GO:0030279; GO:0030324; GO:0030326; GO:0030334; GO:0030335; GO:0030513; GO:0030514; GO:0030900; GO:0031069; GO:0031100; GO:0031410; GO:0031490; GO:0031902; GO:0032495; GO:0032496; GO:0032966; GO:0035116; GO:0035148; GO:0035914; GO:0035924; GO:0042127; GO:0042246; GO:0042802; GO:0043065; GO:0043069; GO:0043086; GO:0043235; GO:0045070; GO:0045165; GO:0045596; GO:0045603; GO:0045607; GO:0045608; GO:0045618; GO:0045662; GO:0045665; GO:0045668; GO:0045687; GO:0045747; GO:0045892; GO:0045893; GO:0045944; GO:0045955; GO:0046427; GO:0046533; GO:0046579; GO:0048103; GO:0048593; GO:0048663; GO:0048708; GO:0048709; GO:0048711; GO:0048715; GO:0048754; GO:0048845; GO:0048873; GO:0050678; GO:0050679; GO:0050767; GO:0050768; GO:0051152; GO:0055008; GO:0060038; GO:0060045; GO:0060253; GO:0060271; GO:0060317; GO:0060354; GO:0060379; GO:0060411; GO:0060412; GO:0060528; GO:0060740; GO:0060768; GO:0060842; GO:0060843; GO:0060948; GO:0060956; GO:0060979; GO:0060982; GO:0061344; GO:0061384; GO:0062043; GO:0070168; GO:0070374; GO:0070986; GO:0071228; GO:0071372; GO:0071456; GO:0071944; GO:0072017; GO:0072044; GO:0072144; GO:0072538; GO:0090051; GO:0090090; GO:0097150; GO:0097400; GO:0098685; GO:0098839; GO:0098978; GO:0099565; GO:0120163; GO:0140537; GO:1901189; GO:1901201; GO:1902263; GO:1902339; GO:1903849; GO:2000048; GO:2000737; GO:2000811; GO:2000974; GO:2001027 animal organ regeneration [GO:0031100]; aortic valve morphogenesis [GO:0003180]; apoptotic process involved in embryonic digit morphogenesis [GO:1902263]; arterial endothelial cell differentiation [GO:0060842]; astrocyte differentiation [GO:0048708]; atrioventricular node development [GO:0003162]; atrioventricular valve morphogenesis [GO:0003181]; auditory receptor cell fate commitment [GO:0009912]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; branching morphogenesis of an epithelial tube [GO:0048754]; camera-type eye morphogenesis [GO:0048593]; cardiac atrium morphogenesis [GO:0003209]; cardiac chamber formation [GO:0003207]; cardiac epithelial to mesenchymal transition [GO:0060317]; cardiac left ventricle morphogenesis [GO:0003214]; cardiac muscle cell myoblast differentiation [GO:0060379]; cardiac muscle cell proliferation [GO:0060038]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac right atrium morphogenesis [GO:0003213]; cardiac right ventricle formation [GO:0003219]; cardiac septum morphogenesis [GO:0060411]; cardiac vascular smooth muscle cell development [GO:0060948]; cardiac ventricle morphogenesis [GO:0003208]; cell differentiation [GO:0030154]; cell differentiation in spinal cord [GO:0021515]; cell fate commitment [GO:0045165]; cell fate specification [GO:0001708]; cell migration involved in endocardial cushion formation [GO:0003273]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to hypoxia [GO:0071456]; cellular response to tumor cell [GO:0071228]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; chemical synaptic transmission, postsynaptic [GO:0099565]; cilium assembly [GO:0060271]; collecting duct development [GO:0072044]; compartment pattern specification [GO:0007386]; coronary artery morphogenesis [GO:0060982]; coronary sinus valve morphogenesis [GO:0003182]; coronary vein morphogenesis [GO:0003169]; determination of left/right symmetry [GO:0007368]; distal tubule development [GO:0072017]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic limb morphogenesis [GO:0030326]; endocardial cell differentiation [GO:0060956]; endocardial cushion development [GO:0003197]; endocardial cushion morphogenesis [GO:0003203]; endocardium development [GO:0003157]; endocardium morphogenesis [GO:0003160]; endoderm development [GO:0007492]; epidermis development [GO:0008544]; epithelial to mesenchymal transition [GO:0001837]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; forebrain development [GO:0030900]; foregut morphogenesis [GO:0007440]; gene expression [GO:0010467]; glial cell differentiation [GO:0010001]; glomerular mesangial cell development [GO:0072144]; growth involved in heart morphogenesis [GO:0003241]; hair follicle morphogenesis [GO:0031069]; heart development [GO:0007507]; heart looping [GO:0001947]; heart trabecula morphogenesis [GO:0061384]; homeostasis of number of cells within a tissue [GO:0048873]; humoral immune response [GO:0006959]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; interleukin-17-mediated signaling pathway [GO:0097400]; keratinocyte differentiation [GO:0030216]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; lung development [GO:0030324]; luteolysis [GO:0001554]; mesenchymal cell development [GO:0014031]; mitral valve formation [GO:0003192]; negative regulation of anoikis [GO:2000811]; negative regulation of biomineral tissue development [GO:0070168]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of catalytic activity [GO:0043086]; negative regulation of cell adhesion molecule production [GO:0060354]; negative regulation of cell differentiation [GO:0045596]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell proliferation involved in heart valve morphogenesis [GO:0003252]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of collagen biosynthetic process [GO:0032966]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of endothelial cell chemotaxis [GO:2001027]; negative regulation of extracellular matrix constituent secretion [GO:0003332]; negative regulation of gene expression [GO:0010629]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of inner ear auditory receptor cell differentiation [GO:0045608]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of ossification [GO:0030279]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of photoreceptor cell differentiation [GO:0046533]; negative regulation of pro-B cell differentiation [GO:2000974]; negative regulation of programmed cell death [GO:0043069]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural tube development [GO:0021915]; neuron differentiation [GO:0030182]; neuron fate commitment [GO:0048663]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; oligodendrocyte differentiation [GO:0048709]; osteoblast fate commitment [GO:0002051]; outflow tract morphogenesis [GO:0003151]; pericardium morphogenesis [GO:0003344]; positive regulation of aorta morphogenesis [GO:1903849]; positive regulation of apoptotic process [GO:0043065]; positive regulation of apoptotic process involved in morphogenesis [GO:1902339]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cardiac epithelial to mesenchymal transition [GO:0062043]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of ephrin receptor signaling pathway [GO:1901189]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of glial cell differentiation [GO:0045687]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of smooth muscle cell differentiation [GO:0051152]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription of Notch receptor target [GO:0007221]; positive regulation of viral genome replication [GO:0045070]; prostate gland epithelium morphogenesis [GO:0060740]; protein catabolic process [GO:0030163]; protein import into nucleus [GO:0006606]; pulmonary valve morphogenesis [GO:0003184]; regulation of cardioblast proliferation [GO:0003264]; regulation of cell adhesion involved in heart morphogenesis [GO:0061344]; regulation of cell migration [GO:0030334]; regulation of cell population proliferation [GO:0042127]; regulation of epithelial cell proliferation [GO:0050678]; regulation of epithelial cell proliferation involved in prostate gland development [GO:0060768]; regulation of extracellular matrix assembly [GO:1901201]; regulation of gene expression [GO:0010468]; regulation of inner ear auditory receptor cell differentiation [GO:0045607]; regulation of neurogenesis [GO:0050767]; regulation of Notch signaling pathway [GO:0008593]; regulation of somitogenesis [GO:0014807]; regulation of transcription by RNA polymerase II [GO:0006357]; response to lipopolysaccharide [GO:0032496]; response to muramyl dipeptide [GO:0032495]; secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development [GO:0060528]; skeletal muscle cell differentiation [GO:0035914]; somatic stem cell division [GO:0048103]; spermatogenesis [GO:0007283]; sprouting angiogenesis [GO:0002040]; T-helper 17 type immune response [GO:0072538]; tissue regeneration [GO:0042246]; tube formation [GO:0035148]; vasculogenesis involved in coronary vascular morphogenesis [GO:0060979]; venous blood vessel morphogenesis [GO:0048845]; venous endothelial cell differentiation [GO:0060843]; ventricular septum morphogenesis [GO:0060412]; ventricular trabecula myocardium morphogenesis [GO:0003222] acrosomal vesicle [GO:0001669]; adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell periphery [GO:0071944]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; lamellipodium [GO:0030027]; late endosome membrane [GO:0031902]; MAML1-RBP-Jkappa- ICN1 complex [GO:0002193]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; receptor complex [GO:0043235]; ruffle [GO:0001726]; Schaffer collateral - CA1 synapse [GO:0098685] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; identical protein binding [GO:0042802]; Notch binding [GO:0005112]; transcription coactivator activity [GO:0003713]; transcription regulator activator activity [GO:0140537]; transmembrane signaling receptor activity [GO:0004888] g256.t2 Q01705 34.981 1598 0.0 653.0 sp|Q01705|NOTC1_MOUSE Neurogenic locus notch homolog protein 1 OS=Mus musculus OX=10090 GN=Notch1 PE=1 SV=3 NOTC1_MOUSE reviewed Neurogenic locus notch homolog protein 1 (Notch 1) (Motch A) (mT14) (p300) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Mus musculus (Mouse) GO:0000122; GO:0000139; GO:0001554; GO:0001669; GO:0001701; GO:0001708; GO:0001726; GO:0001837; GO:0001889; GO:0001947; GO:0002040; GO:0002051; GO:0002052; GO:0002193; GO:0002437; GO:0003151; GO:0003157; GO:0003160; GO:0003162; GO:0003169; GO:0003180; GO:0003181; GO:0003182; GO:0003184; GO:0003192; GO:0003197; GO:0003198; GO:0003203; GO:0003207; GO:0003208; GO:0003209; GO:0003213; GO:0003214; GO:0003219; GO:0003222; GO:0003241; GO:0003252; GO:0003264; GO:0003273; GO:0003332; GO:0003344; GO:0003682; GO:0003713; GO:0004857; GO:0004888; GO:0005112; GO:0005509; GO:0005576; GO:0005634; GO:0005654; GO:0005737; GO:0005783; GO:0005789; GO:0005829; GO:0005856; GO:0005886; GO:0005912; GO:0006357; GO:0006606; GO:0006959; GO:0007219; GO:0007221; GO:0007283; GO:0007368; GO:0007386; GO:0007409; GO:0007411; GO:0007440; GO:0007492; GO:0007507; GO:0008284; GO:0008285; GO:0008544; GO:0008593; GO:0009912; GO:0009986; GO:0010001; GO:0010008; GO:0010467; GO:0010468; GO:0010614; GO:0010628; GO:0010629; GO:0010667; GO:0010718; GO:0010812; GO:0010832; GO:0014031; GO:0014807; GO:0016324; GO:0019899; GO:0021515; GO:0021915; GO:0030027; GO:0030154; GO:0030163; GO:0030182; GO:0030216; GO:0030279; GO:0030324; GO:0030326; GO:0030334; GO:0030335; GO:0030513; GO:0030514; GO:0030900; GO:0031069; GO:0031100; GO:0031410; GO:0031490; GO:0031902; GO:0032495; GO:0032496; GO:0032966; GO:0035116; GO:0035148; GO:0035914; GO:0035924; GO:0042127; GO:0042246; GO:0042802; GO:0043065; GO:0043069; GO:0043086; GO:0043235; GO:0045070; GO:0045165; GO:0045596; GO:0045603; GO:0045607; GO:0045608; GO:0045618; GO:0045662; GO:0045665; GO:0045668; GO:0045687; GO:0045747; GO:0045892; GO:0045893; GO:0045944; GO:0045955; GO:0046427; GO:0046533; GO:0046579; GO:0048103; GO:0048593; GO:0048663; GO:0048708; GO:0048709; GO:0048711; GO:0048715; GO:0048754; GO:0048845; GO:0048873; GO:0050678; GO:0050679; GO:0050767; GO:0050768; GO:0051152; GO:0055008; GO:0060038; GO:0060045; GO:0060253; GO:0060271; GO:0060317; GO:0060354; GO:0060379; GO:0060411; GO:0060412; GO:0060528; GO:0060740; GO:0060768; GO:0060842; GO:0060843; GO:0060948; GO:0060956; GO:0060979; GO:0060982; GO:0061344; GO:0061384; GO:0062043; GO:0070168; GO:0070374; GO:0070986; GO:0071228; GO:0071372; GO:0071456; GO:0071944; GO:0072017; GO:0072044; GO:0072144; GO:0072538; GO:0090051; GO:0090090; GO:0097150; GO:0097400; GO:0098685; GO:0098839; GO:0098978; GO:0099565; GO:0120163; GO:0140537; GO:1901189; GO:1901201; GO:1902263; GO:1902339; GO:1903849; GO:2000048; GO:2000737; GO:2000811; GO:2000974; GO:2001027 animal organ regeneration [GO:0031100]; aortic valve morphogenesis [GO:0003180]; apoptotic process involved in embryonic digit morphogenesis [GO:1902263]; arterial endothelial cell differentiation [GO:0060842]; astrocyte differentiation [GO:0048708]; atrioventricular node development [GO:0003162]; atrioventricular valve morphogenesis [GO:0003181]; auditory receptor cell fate commitment [GO:0009912]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; branching morphogenesis of an epithelial tube [GO:0048754]; camera-type eye morphogenesis [GO:0048593]; cardiac atrium morphogenesis [GO:0003209]; cardiac chamber formation [GO:0003207]; cardiac epithelial to mesenchymal transition [GO:0060317]; cardiac left ventricle morphogenesis [GO:0003214]; cardiac muscle cell myoblast differentiation [GO:0060379]; cardiac muscle cell proliferation [GO:0060038]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac right atrium morphogenesis [GO:0003213]; cardiac right ventricle formation [GO:0003219]; cardiac septum morphogenesis [GO:0060411]; cardiac vascular smooth muscle cell development [GO:0060948]; cardiac ventricle morphogenesis [GO:0003208]; cell differentiation [GO:0030154]; cell differentiation in spinal cord [GO:0021515]; cell fate commitment [GO:0045165]; cell fate specification [GO:0001708]; cell migration involved in endocardial cushion formation [GO:0003273]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to hypoxia [GO:0071456]; cellular response to tumor cell [GO:0071228]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; chemical synaptic transmission, postsynaptic [GO:0099565]; cilium assembly [GO:0060271]; collecting duct development [GO:0072044]; compartment pattern specification [GO:0007386]; coronary artery morphogenesis [GO:0060982]; coronary sinus valve morphogenesis [GO:0003182]; coronary vein morphogenesis [GO:0003169]; determination of left/right symmetry [GO:0007368]; distal tubule development [GO:0072017]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic limb morphogenesis [GO:0030326]; endocardial cell differentiation [GO:0060956]; endocardial cushion development [GO:0003197]; endocardial cushion morphogenesis [GO:0003203]; endocardium development [GO:0003157]; endocardium morphogenesis [GO:0003160]; endoderm development [GO:0007492]; epidermis development [GO:0008544]; epithelial to mesenchymal transition [GO:0001837]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; forebrain development [GO:0030900]; foregut morphogenesis [GO:0007440]; gene expression [GO:0010467]; glial cell differentiation [GO:0010001]; glomerular mesangial cell development [GO:0072144]; growth involved in heart morphogenesis [GO:0003241]; hair follicle morphogenesis [GO:0031069]; heart development [GO:0007507]; heart looping [GO:0001947]; heart trabecula morphogenesis [GO:0061384]; homeostasis of number of cells within a tissue [GO:0048873]; humoral immune response [GO:0006959]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; interleukin-17-mediated signaling pathway [GO:0097400]; keratinocyte differentiation [GO:0030216]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; lung development [GO:0030324]; luteolysis [GO:0001554]; mesenchymal cell development [GO:0014031]; mitral valve formation [GO:0003192]; negative regulation of anoikis [GO:2000811]; negative regulation of biomineral tissue development [GO:0070168]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of catalytic activity [GO:0043086]; negative regulation of cell adhesion molecule production [GO:0060354]; negative regulation of cell differentiation [GO:0045596]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell proliferation involved in heart valve morphogenesis [GO:0003252]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of collagen biosynthetic process [GO:0032966]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of endothelial cell chemotaxis [GO:2001027]; negative regulation of extracellular matrix constituent secretion [GO:0003332]; negative regulation of gene expression [GO:0010629]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of inner ear auditory receptor cell differentiation [GO:0045608]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of ossification [GO:0030279]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of photoreceptor cell differentiation [GO:0046533]; negative regulation of pro-B cell differentiation [GO:2000974]; negative regulation of programmed cell death [GO:0043069]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural tube development [GO:0021915]; neuron differentiation [GO:0030182]; neuron fate commitment [GO:0048663]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; oligodendrocyte differentiation [GO:0048709]; osteoblast fate commitment [GO:0002051]; outflow tract morphogenesis [GO:0003151]; pericardium morphogenesis [GO:0003344]; positive regulation of aorta morphogenesis [GO:1903849]; positive regulation of apoptotic process [GO:0043065]; positive regulation of apoptotic process involved in morphogenesis [GO:1902339]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cardiac epithelial to mesenchymal transition [GO:0062043]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of ephrin receptor signaling pathway [GO:1901189]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of glial cell differentiation [GO:0045687]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of smooth muscle cell differentiation [GO:0051152]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription of Notch receptor target [GO:0007221]; positive regulation of viral genome replication [GO:0045070]; prostate gland epithelium morphogenesis [GO:0060740]; protein catabolic process [GO:0030163]; protein import into nucleus [GO:0006606]; pulmonary valve morphogenesis [GO:0003184]; regulation of cardioblast proliferation [GO:0003264]; regulation of cell adhesion involved in heart morphogenesis [GO:0061344]; regulation of cell migration [GO:0030334]; regulation of cell population proliferation [GO:0042127]; regulation of epithelial cell proliferation [GO:0050678]; regulation of epithelial cell proliferation involved in prostate gland development [GO:0060768]; regulation of extracellular matrix assembly [GO:1901201]; regulation of gene expression [GO:0010468]; regulation of inner ear auditory receptor cell differentiation [GO:0045607]; regulation of neurogenesis [GO:0050767]; regulation of Notch signaling pathway [GO:0008593]; regulation of somitogenesis [GO:0014807]; regulation of transcription by RNA polymerase II [GO:0006357]; response to lipopolysaccharide [GO:0032496]; response to muramyl dipeptide [GO:0032495]; secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development [GO:0060528]; skeletal muscle cell differentiation [GO:0035914]; somatic stem cell division [GO:0048103]; spermatogenesis [GO:0007283]; sprouting angiogenesis [GO:0002040]; T-helper 17 type immune response [GO:0072538]; tissue regeneration [GO:0042246]; tube formation [GO:0035148]; vasculogenesis involved in coronary vascular morphogenesis [GO:0060979]; venous blood vessel morphogenesis [GO:0048845]; venous endothelial cell differentiation [GO:0060843]; ventricular septum morphogenesis [GO:0060412]; ventricular trabecula myocardium morphogenesis [GO:0003222] acrosomal vesicle [GO:0001669]; adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell periphery [GO:0071944]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; lamellipodium [GO:0030027]; late endosome membrane [GO:0031902]; MAML1-RBP-Jkappa- ICN1 complex [GO:0002193]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; receptor complex [GO:0043235]; ruffle [GO:0001726]; Schaffer collateral - CA1 synapse [GO:0098685] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; identical protein binding [GO:0042802]; Notch binding [GO:0005112]; transcription coactivator activity [GO:0003713]; transcription regulator activator activity [GO:0140537]; transmembrane signaling receptor activity [GO:0004888] g256.t2 Q01705 35.784 1442 0.0 642.0 sp|Q01705|NOTC1_MOUSE Neurogenic locus notch homolog protein 1 OS=Mus musculus OX=10090 GN=Notch1 PE=1 SV=3 NOTC1_MOUSE reviewed Neurogenic locus notch homolog protein 1 (Notch 1) (Motch A) (mT14) (p300) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Mus musculus (Mouse) GO:0000122; GO:0000139; GO:0001554; GO:0001669; GO:0001701; GO:0001708; GO:0001726; GO:0001837; GO:0001889; GO:0001947; GO:0002040; GO:0002051; GO:0002052; GO:0002193; GO:0002437; GO:0003151; GO:0003157; GO:0003160; GO:0003162; GO:0003169; GO:0003180; GO:0003181; GO:0003182; GO:0003184; GO:0003192; GO:0003197; GO:0003198; GO:0003203; GO:0003207; GO:0003208; GO:0003209; GO:0003213; GO:0003214; GO:0003219; GO:0003222; GO:0003241; GO:0003252; GO:0003264; GO:0003273; GO:0003332; GO:0003344; GO:0003682; GO:0003713; GO:0004857; GO:0004888; GO:0005112; GO:0005509; GO:0005576; GO:0005634; GO:0005654; GO:0005737; GO:0005783; GO:0005789; GO:0005829; GO:0005856; GO:0005886; GO:0005912; GO:0006357; GO:0006606; GO:0006959; GO:0007219; GO:0007221; GO:0007283; GO:0007368; GO:0007386; GO:0007409; GO:0007411; GO:0007440; GO:0007492; GO:0007507; GO:0008284; GO:0008285; GO:0008544; GO:0008593; GO:0009912; GO:0009986; GO:0010001; GO:0010008; GO:0010467; GO:0010468; GO:0010614; GO:0010628; GO:0010629; GO:0010667; GO:0010718; GO:0010812; GO:0010832; GO:0014031; GO:0014807; GO:0016324; GO:0019899; GO:0021515; GO:0021915; GO:0030027; GO:0030154; GO:0030163; GO:0030182; GO:0030216; GO:0030279; GO:0030324; GO:0030326; GO:0030334; GO:0030335; GO:0030513; GO:0030514; GO:0030900; GO:0031069; GO:0031100; GO:0031410; GO:0031490; GO:0031902; GO:0032495; GO:0032496; GO:0032966; GO:0035116; GO:0035148; GO:0035914; GO:0035924; GO:0042127; GO:0042246; GO:0042802; GO:0043065; GO:0043069; GO:0043086; GO:0043235; GO:0045070; GO:0045165; GO:0045596; GO:0045603; GO:0045607; GO:0045608; GO:0045618; GO:0045662; GO:0045665; GO:0045668; GO:0045687; GO:0045747; GO:0045892; GO:0045893; GO:0045944; GO:0045955; GO:0046427; GO:0046533; GO:0046579; GO:0048103; GO:0048593; GO:0048663; GO:0048708; GO:0048709; GO:0048711; GO:0048715; GO:0048754; GO:0048845; GO:0048873; GO:0050678; GO:0050679; GO:0050767; GO:0050768; GO:0051152; GO:0055008; GO:0060038; GO:0060045; GO:0060253; GO:0060271; GO:0060317; GO:0060354; GO:0060379; GO:0060411; GO:0060412; GO:0060528; GO:0060740; GO:0060768; GO:0060842; GO:0060843; GO:0060948; GO:0060956; GO:0060979; GO:0060982; GO:0061344; GO:0061384; GO:0062043; GO:0070168; GO:0070374; GO:0070986; GO:0071228; GO:0071372; GO:0071456; GO:0071944; GO:0072017; GO:0072044; GO:0072144; GO:0072538; GO:0090051; GO:0090090; GO:0097150; GO:0097400; GO:0098685; GO:0098839; GO:0098978; GO:0099565; GO:0120163; GO:0140537; GO:1901189; GO:1901201; GO:1902263; GO:1902339; GO:1903849; GO:2000048; GO:2000737; GO:2000811; GO:2000974; GO:2001027 animal organ regeneration [GO:0031100]; aortic valve morphogenesis [GO:0003180]; apoptotic process involved in embryonic digit morphogenesis [GO:1902263]; arterial endothelial cell differentiation [GO:0060842]; astrocyte differentiation [GO:0048708]; atrioventricular node development [GO:0003162]; atrioventricular valve morphogenesis [GO:0003181]; auditory receptor cell fate commitment [GO:0009912]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; branching morphogenesis of an epithelial tube [GO:0048754]; camera-type eye morphogenesis [GO:0048593]; cardiac atrium morphogenesis [GO:0003209]; cardiac chamber formation [GO:0003207]; cardiac epithelial to mesenchymal transition [GO:0060317]; cardiac left ventricle morphogenesis [GO:0003214]; cardiac muscle cell myoblast differentiation [GO:0060379]; cardiac muscle cell proliferation [GO:0060038]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac right atrium morphogenesis [GO:0003213]; cardiac right ventricle formation [GO:0003219]; cardiac septum morphogenesis [GO:0060411]; cardiac vascular smooth muscle cell development [GO:0060948]; cardiac ventricle morphogenesis [GO:0003208]; cell differentiation [GO:0030154]; cell differentiation in spinal cord [GO:0021515]; cell fate commitment [GO:0045165]; cell fate specification [GO:0001708]; cell migration involved in endocardial cushion formation [GO:0003273]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to hypoxia [GO:0071456]; cellular response to tumor cell [GO:0071228]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; chemical synaptic transmission, postsynaptic [GO:0099565]; cilium assembly [GO:0060271]; collecting duct development [GO:0072044]; compartment pattern specification [GO:0007386]; coronary artery morphogenesis [GO:0060982]; coronary sinus valve morphogenesis [GO:0003182]; coronary vein morphogenesis [GO:0003169]; determination of left/right symmetry [GO:0007368]; distal tubule development [GO:0072017]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic limb morphogenesis [GO:0030326]; endocardial cell differentiation [GO:0060956]; endocardial cushion development [GO:0003197]; endocardial cushion morphogenesis [GO:0003203]; endocardium development [GO:0003157]; endocardium morphogenesis [GO:0003160]; endoderm development [GO:0007492]; epidermis development [GO:0008544]; epithelial to mesenchymal transition [GO:0001837]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; forebrain development [GO:0030900]; foregut morphogenesis [GO:0007440]; gene expression [GO:0010467]; glial cell differentiation [GO:0010001]; glomerular mesangial cell development [GO:0072144]; growth involved in heart morphogenesis [GO:0003241]; hair follicle morphogenesis [GO:0031069]; heart development [GO:0007507]; heart looping [GO:0001947]; heart trabecula morphogenesis [GO:0061384]; homeostasis of number of cells within a tissue [GO:0048873]; humoral immune response [GO:0006959]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; interleukin-17-mediated signaling pathway [GO:0097400]; keratinocyte differentiation [GO:0030216]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; lung development [GO:0030324]; luteolysis [GO:0001554]; mesenchymal cell development [GO:0014031]; mitral valve formation [GO:0003192]; negative regulation of anoikis [GO:2000811]; negative regulation of biomineral tissue development [GO:0070168]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of catalytic activity [GO:0043086]; negative regulation of cell adhesion molecule production [GO:0060354]; negative regulation of cell differentiation [GO:0045596]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell proliferation involved in heart valve morphogenesis [GO:0003252]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of collagen biosynthetic process [GO:0032966]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of endothelial cell chemotaxis [GO:2001027]; negative regulation of extracellular matrix constituent secretion [GO:0003332]; negative regulation of gene expression [GO:0010629]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of inner ear auditory receptor cell differentiation [GO:0045608]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of ossification [GO:0030279]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of photoreceptor cell differentiation [GO:0046533]; negative regulation of pro-B cell differentiation [GO:2000974]; negative regulation of programmed cell death [GO:0043069]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural tube development [GO:0021915]; neuron differentiation [GO:0030182]; neuron fate commitment [GO:0048663]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; oligodendrocyte differentiation [GO:0048709]; osteoblast fate commitment [GO:0002051]; outflow tract morphogenesis [GO:0003151]; pericardium morphogenesis [GO:0003344]; positive regulation of aorta morphogenesis [GO:1903849]; positive regulation of apoptotic process [GO:0043065]; positive regulation of apoptotic process involved in morphogenesis [GO:1902339]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cardiac epithelial to mesenchymal transition [GO:0062043]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of ephrin receptor signaling pathway [GO:1901189]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of glial cell differentiation [GO:0045687]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of smooth muscle cell differentiation [GO:0051152]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription of Notch receptor target [GO:0007221]; positive regulation of viral genome replication [GO:0045070]; prostate gland epithelium morphogenesis [GO:0060740]; protein catabolic process [GO:0030163]; protein import into nucleus [GO:0006606]; pulmonary valve morphogenesis [GO:0003184]; regulation of cardioblast proliferation [GO:0003264]; regulation of cell adhesion involved in heart morphogenesis [GO:0061344]; regulation of cell migration [GO:0030334]; regulation of cell population proliferation [GO:0042127]; regulation of epithelial cell proliferation [GO:0050678]; regulation of epithelial cell proliferation involved in prostate gland development [GO:0060768]; regulation of extracellular matrix assembly [GO:1901201]; regulation of gene expression [GO:0010468]; regulation of inner ear auditory receptor cell differentiation [GO:0045607]; regulation of neurogenesis [GO:0050767]; regulation of Notch signaling pathway [GO:0008593]; regulation of somitogenesis [GO:0014807]; regulation of transcription by RNA polymerase II [GO:0006357]; response to lipopolysaccharide [GO:0032496]; response to muramyl dipeptide [GO:0032495]; secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development [GO:0060528]; skeletal muscle cell differentiation [GO:0035914]; somatic stem cell division [GO:0048103]; spermatogenesis [GO:0007283]; sprouting angiogenesis [GO:0002040]; T-helper 17 type immune response [GO:0072538]; tissue regeneration [GO:0042246]; tube formation [GO:0035148]; vasculogenesis involved in coronary vascular morphogenesis [GO:0060979]; venous blood vessel morphogenesis [GO:0048845]; venous endothelial cell differentiation [GO:0060843]; ventricular septum morphogenesis [GO:0060412]; ventricular trabecula myocardium morphogenesis [GO:0003222] acrosomal vesicle [GO:0001669]; adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell periphery [GO:0071944]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; lamellipodium [GO:0030027]; late endosome membrane [GO:0031902]; MAML1-RBP-Jkappa- ICN1 complex [GO:0002193]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; receptor complex [GO:0043235]; ruffle [GO:0001726]; Schaffer collateral - CA1 synapse [GO:0098685] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; identical protein binding [GO:0042802]; Notch binding [GO:0005112]; transcription coactivator activity [GO:0003713]; transcription regulator activator activity [GO:0140537]; transmembrane signaling receptor activity [GO:0004888] g256.t2 Q01705 35.749 1449 0.0 633.0 sp|Q01705|NOTC1_MOUSE Neurogenic locus notch homolog protein 1 OS=Mus musculus OX=10090 GN=Notch1 PE=1 SV=3 NOTC1_MOUSE reviewed Neurogenic locus notch homolog protein 1 (Notch 1) (Motch A) (mT14) (p300) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Mus musculus (Mouse) GO:0000122; GO:0000139; GO:0001554; GO:0001669; GO:0001701; GO:0001708; GO:0001726; GO:0001837; GO:0001889; GO:0001947; GO:0002040; GO:0002051; GO:0002052; GO:0002193; GO:0002437; GO:0003151; GO:0003157; GO:0003160; GO:0003162; GO:0003169; GO:0003180; GO:0003181; GO:0003182; GO:0003184; GO:0003192; GO:0003197; GO:0003198; GO:0003203; GO:0003207; GO:0003208; GO:0003209; GO:0003213; GO:0003214; GO:0003219; GO:0003222; GO:0003241; GO:0003252; GO:0003264; GO:0003273; GO:0003332; GO:0003344; GO:0003682; GO:0003713; GO:0004857; GO:0004888; GO:0005112; GO:0005509; GO:0005576; GO:0005634; GO:0005654; GO:0005737; GO:0005783; GO:0005789; GO:0005829; GO:0005856; GO:0005886; GO:0005912; GO:0006357; GO:0006606; GO:0006959; GO:0007219; GO:0007221; GO:0007283; GO:0007368; GO:0007386; GO:0007409; GO:0007411; GO:0007440; GO:0007492; GO:0007507; GO:0008284; GO:0008285; GO:0008544; GO:0008593; GO:0009912; GO:0009986; GO:0010001; GO:0010008; GO:0010467; GO:0010468; GO:0010614; GO:0010628; GO:0010629; GO:0010667; GO:0010718; GO:0010812; GO:0010832; GO:0014031; GO:0014807; GO:0016324; GO:0019899; GO:0021515; GO:0021915; GO:0030027; GO:0030154; GO:0030163; GO:0030182; GO:0030216; GO:0030279; GO:0030324; GO:0030326; GO:0030334; GO:0030335; GO:0030513; GO:0030514; GO:0030900; GO:0031069; GO:0031100; GO:0031410; GO:0031490; GO:0031902; GO:0032495; GO:0032496; GO:0032966; GO:0035116; GO:0035148; GO:0035914; GO:0035924; GO:0042127; GO:0042246; GO:0042802; GO:0043065; GO:0043069; GO:0043086; GO:0043235; GO:0045070; GO:0045165; GO:0045596; GO:0045603; GO:0045607; GO:0045608; GO:0045618; GO:0045662; GO:0045665; GO:0045668; GO:0045687; GO:0045747; GO:0045892; GO:0045893; GO:0045944; GO:0045955; GO:0046427; GO:0046533; GO:0046579; GO:0048103; GO:0048593; GO:0048663; GO:0048708; GO:0048709; GO:0048711; GO:0048715; GO:0048754; GO:0048845; GO:0048873; GO:0050678; GO:0050679; GO:0050767; GO:0050768; GO:0051152; GO:0055008; GO:0060038; GO:0060045; GO:0060253; GO:0060271; GO:0060317; GO:0060354; GO:0060379; GO:0060411; GO:0060412; GO:0060528; GO:0060740; GO:0060768; GO:0060842; GO:0060843; GO:0060948; GO:0060956; GO:0060979; GO:0060982; GO:0061344; GO:0061384; GO:0062043; GO:0070168; GO:0070374; GO:0070986; GO:0071228; GO:0071372; GO:0071456; GO:0071944; GO:0072017; GO:0072044; GO:0072144; GO:0072538; GO:0090051; GO:0090090; GO:0097150; GO:0097400; GO:0098685; GO:0098839; GO:0098978; GO:0099565; GO:0120163; GO:0140537; GO:1901189; GO:1901201; GO:1902263; GO:1902339; GO:1903849; GO:2000048; GO:2000737; GO:2000811; GO:2000974; GO:2001027 animal organ regeneration [GO:0031100]; aortic valve morphogenesis [GO:0003180]; apoptotic process involved in embryonic digit morphogenesis [GO:1902263]; arterial endothelial cell differentiation [GO:0060842]; astrocyte differentiation [GO:0048708]; atrioventricular node development [GO:0003162]; atrioventricular valve morphogenesis [GO:0003181]; auditory receptor cell fate commitment [GO:0009912]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; branching morphogenesis of an epithelial tube [GO:0048754]; camera-type eye morphogenesis [GO:0048593]; cardiac atrium morphogenesis [GO:0003209]; cardiac chamber formation [GO:0003207]; cardiac epithelial to mesenchymal transition [GO:0060317]; cardiac left ventricle morphogenesis [GO:0003214]; cardiac muscle cell myoblast differentiation [GO:0060379]; cardiac muscle cell proliferation [GO:0060038]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac right atrium morphogenesis [GO:0003213]; cardiac right ventricle formation [GO:0003219]; cardiac septum morphogenesis [GO:0060411]; cardiac vascular smooth muscle cell development [GO:0060948]; cardiac ventricle morphogenesis [GO:0003208]; cell differentiation [GO:0030154]; cell differentiation in spinal cord [GO:0021515]; cell fate commitment [GO:0045165]; cell fate specification [GO:0001708]; cell migration involved in endocardial cushion formation [GO:0003273]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to hypoxia [GO:0071456]; cellular response to tumor cell [GO:0071228]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; chemical synaptic transmission, postsynaptic [GO:0099565]; cilium assembly [GO:0060271]; collecting duct development [GO:0072044]; compartment pattern specification [GO:0007386]; coronary artery morphogenesis [GO:0060982]; coronary sinus valve morphogenesis [GO:0003182]; coronary vein morphogenesis [GO:0003169]; determination of left/right symmetry [GO:0007368]; distal tubule development [GO:0072017]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic limb morphogenesis [GO:0030326]; endocardial cell differentiation [GO:0060956]; endocardial cushion development [GO:0003197]; endocardial cushion morphogenesis [GO:0003203]; endocardium development [GO:0003157]; endocardium morphogenesis [GO:0003160]; endoderm development [GO:0007492]; epidermis development [GO:0008544]; epithelial to mesenchymal transition [GO:0001837]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; forebrain development [GO:0030900]; foregut morphogenesis [GO:0007440]; gene expression [GO:0010467]; glial cell differentiation [GO:0010001]; glomerular mesangial cell development [GO:0072144]; growth involved in heart morphogenesis [GO:0003241]; hair follicle morphogenesis [GO:0031069]; heart development [GO:0007507]; heart looping [GO:0001947]; heart trabecula morphogenesis [GO:0061384]; homeostasis of number of cells within a tissue [GO:0048873]; humoral immune response [GO:0006959]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; interleukin-17-mediated signaling pathway [GO:0097400]; keratinocyte differentiation [GO:0030216]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; lung development [GO:0030324]; luteolysis [GO:0001554]; mesenchymal cell development [GO:0014031]; mitral valve formation [GO:0003192]; negative regulation of anoikis [GO:2000811]; negative regulation of biomineral tissue development [GO:0070168]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of catalytic activity [GO:0043086]; negative regulation of cell adhesion molecule production [GO:0060354]; negative regulation of cell differentiation [GO:0045596]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell proliferation involved in heart valve morphogenesis [GO:0003252]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of collagen biosynthetic process [GO:0032966]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of endothelial cell chemotaxis [GO:2001027]; negative regulation of extracellular matrix constituent secretion [GO:0003332]; negative regulation of gene expression [GO:0010629]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of inner ear auditory receptor cell differentiation [GO:0045608]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of ossification [GO:0030279]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of photoreceptor cell differentiation [GO:0046533]; negative regulation of pro-B cell differentiation [GO:2000974]; negative regulation of programmed cell death [GO:0043069]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural tube development [GO:0021915]; neuron differentiation [GO:0030182]; neuron fate commitment [GO:0048663]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; oligodendrocyte differentiation [GO:0048709]; osteoblast fate commitment [GO:0002051]; outflow tract morphogenesis [GO:0003151]; pericardium morphogenesis [GO:0003344]; positive regulation of aorta morphogenesis [GO:1903849]; positive regulation of apoptotic process [GO:0043065]; positive regulation of apoptotic process involved in morphogenesis [GO:1902339]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cardiac epithelial to mesenchymal transition [GO:0062043]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of ephrin receptor signaling pathway [GO:1901189]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of glial cell differentiation [GO:0045687]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of smooth muscle cell differentiation [GO:0051152]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription of Notch receptor target [GO:0007221]; positive regulation of viral genome replication [GO:0045070]; prostate gland epithelium morphogenesis [GO:0060740]; protein catabolic process [GO:0030163]; protein import into nucleus [GO:0006606]; pulmonary valve morphogenesis [GO:0003184]; regulation of cardioblast proliferation [GO:0003264]; regulation of cell adhesion involved in heart morphogenesis [GO:0061344]; regulation of cell migration [GO:0030334]; regulation of cell population proliferation [GO:0042127]; regulation of epithelial cell proliferation [GO:0050678]; regulation of epithelial cell proliferation involved in prostate gland development [GO:0060768]; regulation of extracellular matrix assembly [GO:1901201]; regulation of gene expression [GO:0010468]; regulation of inner ear auditory receptor cell differentiation [GO:0045607]; regulation of neurogenesis [GO:0050767]; regulation of Notch signaling pathway [GO:0008593]; regulation of somitogenesis [GO:0014807]; regulation of transcription by RNA polymerase II [GO:0006357]; response to lipopolysaccharide [GO:0032496]; response to muramyl dipeptide [GO:0032495]; secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development [GO:0060528]; skeletal muscle cell differentiation [GO:0035914]; somatic stem cell division [GO:0048103]; spermatogenesis [GO:0007283]; sprouting angiogenesis [GO:0002040]; T-helper 17 type immune response [GO:0072538]; tissue regeneration [GO:0042246]; tube formation [GO:0035148]; vasculogenesis involved in coronary vascular morphogenesis [GO:0060979]; venous blood vessel morphogenesis [GO:0048845]; venous endothelial cell differentiation [GO:0060843]; ventricular septum morphogenesis [GO:0060412]; ventricular trabecula myocardium morphogenesis [GO:0003222] acrosomal vesicle [GO:0001669]; adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell periphery [GO:0071944]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; lamellipodium [GO:0030027]; late endosome membrane [GO:0031902]; MAML1-RBP-Jkappa- ICN1 complex [GO:0002193]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; receptor complex [GO:0043235]; ruffle [GO:0001726]; Schaffer collateral - CA1 synapse [GO:0098685] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; identical protein binding [GO:0042802]; Notch binding [GO:0005112]; transcription coactivator activity [GO:0003713]; transcription regulator activator activity [GO:0140537]; transmembrane signaling receptor activity [GO:0004888] g256.t2 Q01705 33.937 1435 0.0 622.0 sp|Q01705|NOTC1_MOUSE Neurogenic locus notch homolog protein 1 OS=Mus musculus OX=10090 GN=Notch1 PE=1 SV=3 NOTC1_MOUSE reviewed Neurogenic locus notch homolog protein 1 (Notch 1) (Motch A) (mT14) (p300) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Mus musculus (Mouse) GO:0000122; GO:0000139; GO:0001554; GO:0001669; GO:0001701; GO:0001708; GO:0001726; GO:0001837; GO:0001889; GO:0001947; GO:0002040; GO:0002051; GO:0002052; GO:0002193; GO:0002437; GO:0003151; GO:0003157; GO:0003160; GO:0003162; GO:0003169; GO:0003180; GO:0003181; GO:0003182; GO:0003184; GO:0003192; GO:0003197; GO:0003198; GO:0003203; GO:0003207; GO:0003208; GO:0003209; GO:0003213; GO:0003214; GO:0003219; GO:0003222; GO:0003241; GO:0003252; GO:0003264; GO:0003273; GO:0003332; GO:0003344; GO:0003682; GO:0003713; GO:0004857; GO:0004888; GO:0005112; GO:0005509; GO:0005576; GO:0005634; GO:0005654; GO:0005737; GO:0005783; GO:0005789; GO:0005829; GO:0005856; GO:0005886; GO:0005912; GO:0006357; GO:0006606; GO:0006959; GO:0007219; GO:0007221; GO:0007283; GO:0007368; GO:0007386; GO:0007409; GO:0007411; GO:0007440; GO:0007492; GO:0007507; GO:0008284; GO:0008285; GO:0008544; GO:0008593; GO:0009912; GO:0009986; GO:0010001; GO:0010008; GO:0010467; GO:0010468; GO:0010614; GO:0010628; GO:0010629; GO:0010667; GO:0010718; GO:0010812; GO:0010832; GO:0014031; GO:0014807; GO:0016324; GO:0019899; GO:0021515; GO:0021915; GO:0030027; GO:0030154; GO:0030163; GO:0030182; GO:0030216; GO:0030279; GO:0030324; GO:0030326; GO:0030334; GO:0030335; GO:0030513; GO:0030514; GO:0030900; GO:0031069; GO:0031100; GO:0031410; GO:0031490; GO:0031902; GO:0032495; GO:0032496; GO:0032966; GO:0035116; GO:0035148; GO:0035914; GO:0035924; GO:0042127; GO:0042246; GO:0042802; GO:0043065; GO:0043069; GO:0043086; GO:0043235; GO:0045070; GO:0045165; GO:0045596; GO:0045603; GO:0045607; GO:0045608; GO:0045618; GO:0045662; GO:0045665; GO:0045668; GO:0045687; GO:0045747; GO:0045892; GO:0045893; GO:0045944; GO:0045955; GO:0046427; GO:0046533; GO:0046579; GO:0048103; GO:0048593; GO:0048663; GO:0048708; GO:0048709; GO:0048711; GO:0048715; GO:0048754; GO:0048845; GO:0048873; GO:0050678; GO:0050679; GO:0050767; GO:0050768; GO:0051152; GO:0055008; GO:0060038; GO:0060045; GO:0060253; GO:0060271; GO:0060317; GO:0060354; GO:0060379; GO:0060411; GO:0060412; GO:0060528; GO:0060740; GO:0060768; GO:0060842; GO:0060843; GO:0060948; GO:0060956; GO:0060979; GO:0060982; GO:0061344; GO:0061384; GO:0062043; GO:0070168; GO:0070374; GO:0070986; GO:0071228; GO:0071372; GO:0071456; GO:0071944; GO:0072017; GO:0072044; GO:0072144; GO:0072538; GO:0090051; GO:0090090; GO:0097150; GO:0097400; GO:0098685; GO:0098839; GO:0098978; GO:0099565; GO:0120163; GO:0140537; GO:1901189; GO:1901201; GO:1902263; GO:1902339; GO:1903849; GO:2000048; GO:2000737; GO:2000811; GO:2000974; GO:2001027 animal organ regeneration [GO:0031100]; aortic valve morphogenesis [GO:0003180]; apoptotic process involved in embryonic digit morphogenesis [GO:1902263]; arterial endothelial cell differentiation [GO:0060842]; astrocyte differentiation [GO:0048708]; atrioventricular node development [GO:0003162]; atrioventricular valve morphogenesis [GO:0003181]; auditory receptor cell fate commitment [GO:0009912]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; branching morphogenesis of an epithelial tube [GO:0048754]; camera-type eye morphogenesis [GO:0048593]; cardiac atrium morphogenesis [GO:0003209]; cardiac chamber formation [GO:0003207]; cardiac epithelial to mesenchymal transition [GO:0060317]; cardiac left ventricle morphogenesis [GO:0003214]; cardiac muscle cell myoblast differentiation [GO:0060379]; cardiac muscle cell proliferation [GO:0060038]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac right atrium morphogenesis [GO:0003213]; cardiac right ventricle formation [GO:0003219]; cardiac septum morphogenesis [GO:0060411]; cardiac vascular smooth muscle cell development [GO:0060948]; cardiac ventricle morphogenesis [GO:0003208]; cell differentiation [GO:0030154]; cell differentiation in spinal cord [GO:0021515]; cell fate commitment [GO:0045165]; cell fate specification [GO:0001708]; cell migration involved in endocardial cushion formation [GO:0003273]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to hypoxia [GO:0071456]; cellular response to tumor cell [GO:0071228]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; chemical synaptic transmission, postsynaptic [GO:0099565]; cilium assembly [GO:0060271]; collecting duct development [GO:0072044]; compartment pattern specification [GO:0007386]; coronary artery morphogenesis [GO:0060982]; coronary sinus valve morphogenesis [GO:0003182]; coronary vein morphogenesis [GO:0003169]; determination of left/right symmetry [GO:0007368]; distal tubule development [GO:0072017]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic limb morphogenesis [GO:0030326]; endocardial cell differentiation [GO:0060956]; endocardial cushion development [GO:0003197]; endocardial cushion morphogenesis [GO:0003203]; endocardium development [GO:0003157]; endocardium morphogenesis [GO:0003160]; endoderm development [GO:0007492]; epidermis development [GO:0008544]; epithelial to mesenchymal transition [GO:0001837]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; forebrain development [GO:0030900]; foregut morphogenesis [GO:0007440]; gene expression [GO:0010467]; glial cell differentiation [GO:0010001]; glomerular mesangial cell development [GO:0072144]; growth involved in heart morphogenesis [GO:0003241]; hair follicle morphogenesis [GO:0031069]; heart development [GO:0007507]; heart looping [GO:0001947]; heart trabecula morphogenesis [GO:0061384]; homeostasis of number of cells within a tissue [GO:0048873]; humoral immune response [GO:0006959]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; interleukin-17-mediated signaling pathway [GO:0097400]; keratinocyte differentiation [GO:0030216]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; lung development [GO:0030324]; luteolysis [GO:0001554]; mesenchymal cell development [GO:0014031]; mitral valve formation [GO:0003192]; negative regulation of anoikis [GO:2000811]; negative regulation of biomineral tissue development [GO:0070168]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of catalytic activity [GO:0043086]; negative regulation of cell adhesion molecule production [GO:0060354]; negative regulation of cell differentiation [GO:0045596]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell proliferation involved in heart valve morphogenesis [GO:0003252]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of collagen biosynthetic process [GO:0032966]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of endothelial cell chemotaxis [GO:2001027]; negative regulation of extracellular matrix constituent secretion [GO:0003332]; negative regulation of gene expression [GO:0010629]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of inner ear auditory receptor cell differentiation [GO:0045608]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of ossification [GO:0030279]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of photoreceptor cell differentiation [GO:0046533]; negative regulation of pro-B cell differentiation [GO:2000974]; negative regulation of programmed cell death [GO:0043069]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural tube development [GO:0021915]; neuron differentiation [GO:0030182]; neuron fate commitment [GO:0048663]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; oligodendrocyte differentiation [GO:0048709]; osteoblast fate commitment [GO:0002051]; outflow tract morphogenesis [GO:0003151]; pericardium morphogenesis [GO:0003344]; positive regulation of aorta morphogenesis [GO:1903849]; positive regulation of apoptotic process [GO:0043065]; positive regulation of apoptotic process involved in morphogenesis [GO:1902339]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cardiac epithelial to mesenchymal transition [GO:0062043]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of ephrin receptor signaling pathway [GO:1901189]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of glial cell differentiation [GO:0045687]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of smooth muscle cell differentiation [GO:0051152]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription of Notch receptor target [GO:0007221]; positive regulation of viral genome replication [GO:0045070]; prostate gland epithelium morphogenesis [GO:0060740]; protein catabolic process [GO:0030163]; protein import into nucleus [GO:0006606]; pulmonary valve morphogenesis [GO:0003184]; regulation of cardioblast proliferation [GO:0003264]; regulation of cell adhesion involved in heart morphogenesis [GO:0061344]; regulation of cell migration [GO:0030334]; regulation of cell population proliferation [GO:0042127]; regulation of epithelial cell proliferation [GO:0050678]; regulation of epithelial cell proliferation involved in prostate gland development [GO:0060768]; regulation of extracellular matrix assembly [GO:1901201]; regulation of gene expression [GO:0010468]; regulation of inner ear auditory receptor cell differentiation [GO:0045607]; regulation of neurogenesis [GO:0050767]; regulation of Notch signaling pathway [GO:0008593]; regulation of somitogenesis [GO:0014807]; regulation of transcription by RNA polymerase II [GO:0006357]; response to lipopolysaccharide [GO:0032496]; response to muramyl dipeptide [GO:0032495]; secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development [GO:0060528]; skeletal muscle cell differentiation [GO:0035914]; somatic stem cell division [GO:0048103]; spermatogenesis [GO:0007283]; sprouting angiogenesis [GO:0002040]; T-helper 17 type immune response [GO:0072538]; tissue regeneration [GO:0042246]; tube formation [GO:0035148]; vasculogenesis involved in coronary vascular morphogenesis [GO:0060979]; venous blood vessel morphogenesis [GO:0048845]; venous endothelial cell differentiation [GO:0060843]; ventricular septum morphogenesis [GO:0060412]; ventricular trabecula myocardium morphogenesis [GO:0003222] acrosomal vesicle [GO:0001669]; adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell periphery [GO:0071944]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; lamellipodium [GO:0030027]; late endosome membrane [GO:0031902]; MAML1-RBP-Jkappa- ICN1 complex [GO:0002193]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; receptor complex [GO:0043235]; ruffle [GO:0001726]; Schaffer collateral - CA1 synapse [GO:0098685] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; identical protein binding [GO:0042802]; Notch binding [GO:0005112]; transcription coactivator activity [GO:0003713]; transcription regulator activator activity [GO:0140537]; transmembrane signaling receptor activity [GO:0004888] g256.t2 Q01705 34.901 1318 5.91e-160 558.0 sp|Q01705|NOTC1_MOUSE Neurogenic locus notch homolog protein 1 OS=Mus musculus OX=10090 GN=Notch1 PE=1 SV=3 NOTC1_MOUSE reviewed Neurogenic locus notch homolog protein 1 (Notch 1) (Motch A) (mT14) (p300) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Mus musculus (Mouse) GO:0000122; GO:0000139; GO:0001554; GO:0001669; GO:0001701; GO:0001708; GO:0001726; GO:0001837; GO:0001889; GO:0001947; GO:0002040; GO:0002051; GO:0002052; GO:0002193; GO:0002437; GO:0003151; GO:0003157; GO:0003160; GO:0003162; GO:0003169; GO:0003180; GO:0003181; GO:0003182; GO:0003184; GO:0003192; GO:0003197; GO:0003198; GO:0003203; GO:0003207; GO:0003208; GO:0003209; GO:0003213; GO:0003214; GO:0003219; GO:0003222; GO:0003241; GO:0003252; GO:0003264; GO:0003273; GO:0003332; GO:0003344; GO:0003682; GO:0003713; GO:0004857; GO:0004888; GO:0005112; GO:0005509; GO:0005576; GO:0005634; GO:0005654; GO:0005737; GO:0005783; GO:0005789; GO:0005829; GO:0005856; GO:0005886; GO:0005912; GO:0006357; GO:0006606; GO:0006959; GO:0007219; GO:0007221; GO:0007283; GO:0007368; GO:0007386; GO:0007409; GO:0007411; GO:0007440; GO:0007492; GO:0007507; GO:0008284; GO:0008285; GO:0008544; GO:0008593; GO:0009912; GO:0009986; GO:0010001; GO:0010008; GO:0010467; GO:0010468; GO:0010614; GO:0010628; GO:0010629; GO:0010667; GO:0010718; GO:0010812; GO:0010832; GO:0014031; GO:0014807; GO:0016324; GO:0019899; GO:0021515; GO:0021915; GO:0030027; GO:0030154; GO:0030163; GO:0030182; GO:0030216; GO:0030279; GO:0030324; GO:0030326; GO:0030334; GO:0030335; GO:0030513; GO:0030514; GO:0030900; GO:0031069; GO:0031100; GO:0031410; GO:0031490; GO:0031902; GO:0032495; GO:0032496; GO:0032966; GO:0035116; GO:0035148; GO:0035914; GO:0035924; GO:0042127; GO:0042246; GO:0042802; GO:0043065; GO:0043069; GO:0043086; GO:0043235; GO:0045070; GO:0045165; GO:0045596; GO:0045603; GO:0045607; GO:0045608; GO:0045618; GO:0045662; GO:0045665; GO:0045668; GO:0045687; GO:0045747; GO:0045892; GO:0045893; GO:0045944; GO:0045955; GO:0046427; GO:0046533; GO:0046579; GO:0048103; GO:0048593; GO:0048663; GO:0048708; GO:0048709; GO:0048711; GO:0048715; GO:0048754; GO:0048845; GO:0048873; GO:0050678; GO:0050679; GO:0050767; GO:0050768; GO:0051152; GO:0055008; GO:0060038; GO:0060045; GO:0060253; GO:0060271; GO:0060317; GO:0060354; GO:0060379; GO:0060411; GO:0060412; GO:0060528; GO:0060740; GO:0060768; GO:0060842; GO:0060843; GO:0060948; GO:0060956; GO:0060979; GO:0060982; GO:0061344; GO:0061384; GO:0062043; GO:0070168; GO:0070374; GO:0070986; GO:0071228; GO:0071372; GO:0071456; GO:0071944; GO:0072017; GO:0072044; GO:0072144; GO:0072538; GO:0090051; GO:0090090; GO:0097150; GO:0097400; GO:0098685; GO:0098839; GO:0098978; GO:0099565; GO:0120163; GO:0140537; GO:1901189; GO:1901201; GO:1902263; GO:1902339; GO:1903849; GO:2000048; GO:2000737; GO:2000811; GO:2000974; GO:2001027 animal organ regeneration [GO:0031100]; aortic valve morphogenesis [GO:0003180]; apoptotic process involved in embryonic digit morphogenesis [GO:1902263]; arterial endothelial cell differentiation [GO:0060842]; astrocyte differentiation [GO:0048708]; atrioventricular node development [GO:0003162]; atrioventricular valve morphogenesis [GO:0003181]; auditory receptor cell fate commitment [GO:0009912]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; branching morphogenesis of an epithelial tube [GO:0048754]; camera-type eye morphogenesis [GO:0048593]; cardiac atrium morphogenesis [GO:0003209]; cardiac chamber formation [GO:0003207]; cardiac epithelial to mesenchymal transition [GO:0060317]; cardiac left ventricle morphogenesis [GO:0003214]; cardiac muscle cell myoblast differentiation [GO:0060379]; cardiac muscle cell proliferation [GO:0060038]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac right atrium morphogenesis [GO:0003213]; cardiac right ventricle formation [GO:0003219]; cardiac septum morphogenesis [GO:0060411]; cardiac vascular smooth muscle cell development [GO:0060948]; cardiac ventricle morphogenesis [GO:0003208]; cell differentiation [GO:0030154]; cell differentiation in spinal cord [GO:0021515]; cell fate commitment [GO:0045165]; cell fate specification [GO:0001708]; cell migration involved in endocardial cushion formation [GO:0003273]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to hypoxia [GO:0071456]; cellular response to tumor cell [GO:0071228]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; chemical synaptic transmission, postsynaptic [GO:0099565]; cilium assembly [GO:0060271]; collecting duct development [GO:0072044]; compartment pattern specification [GO:0007386]; coronary artery morphogenesis [GO:0060982]; coronary sinus valve morphogenesis [GO:0003182]; coronary vein morphogenesis [GO:0003169]; determination of left/right symmetry [GO:0007368]; distal tubule development [GO:0072017]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic limb morphogenesis [GO:0030326]; endocardial cell differentiation [GO:0060956]; endocardial cushion development [GO:0003197]; endocardial cushion morphogenesis [GO:0003203]; endocardium development [GO:0003157]; endocardium morphogenesis [GO:0003160]; endoderm development [GO:0007492]; epidermis development [GO:0008544]; epithelial to mesenchymal transition [GO:0001837]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; forebrain development [GO:0030900]; foregut morphogenesis [GO:0007440]; gene expression [GO:0010467]; glial cell differentiation [GO:0010001]; glomerular mesangial cell development [GO:0072144]; growth involved in heart morphogenesis [GO:0003241]; hair follicle morphogenesis [GO:0031069]; heart development [GO:0007507]; heart looping [GO:0001947]; heart trabecula morphogenesis [GO:0061384]; homeostasis of number of cells within a tissue [GO:0048873]; humoral immune response [GO:0006959]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; interleukin-17-mediated signaling pathway [GO:0097400]; keratinocyte differentiation [GO:0030216]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; lung development [GO:0030324]; luteolysis [GO:0001554]; mesenchymal cell development [GO:0014031]; mitral valve formation [GO:0003192]; negative regulation of anoikis [GO:2000811]; negative regulation of biomineral tissue development [GO:0070168]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of catalytic activity [GO:0043086]; negative regulation of cell adhesion molecule production [GO:0060354]; negative regulation of cell differentiation [GO:0045596]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell proliferation involved in heart valve morphogenesis [GO:0003252]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of collagen biosynthetic process [GO:0032966]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of endothelial cell chemotaxis [GO:2001027]; negative regulation of extracellular matrix constituent secretion [GO:0003332]; negative regulation of gene expression [GO:0010629]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of inner ear auditory receptor cell differentiation [GO:0045608]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of ossification [GO:0030279]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of photoreceptor cell differentiation [GO:0046533]; negative regulation of pro-B cell differentiation [GO:2000974]; negative regulation of programmed cell death [GO:0043069]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural tube development [GO:0021915]; neuron differentiation [GO:0030182]; neuron fate commitment [GO:0048663]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; oligodendrocyte differentiation [GO:0048709]; osteoblast fate commitment [GO:0002051]; outflow tract morphogenesis [GO:0003151]; pericardium morphogenesis [GO:0003344]; positive regulation of aorta morphogenesis [GO:1903849]; positive regulation of apoptotic process [GO:0043065]; positive regulation of apoptotic process involved in morphogenesis [GO:1902339]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cardiac epithelial to mesenchymal transition [GO:0062043]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of ephrin receptor signaling pathway [GO:1901189]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of glial cell differentiation [GO:0045687]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of smooth muscle cell differentiation [GO:0051152]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription of Notch receptor target [GO:0007221]; positive regulation of viral genome replication [GO:0045070]; prostate gland epithelium morphogenesis [GO:0060740]; protein catabolic process [GO:0030163]; protein import into nucleus [GO:0006606]; pulmonary valve morphogenesis [GO:0003184]; regulation of cardioblast proliferation [GO:0003264]; regulation of cell adhesion involved in heart morphogenesis [GO:0061344]; regulation of cell migration [GO:0030334]; regulation of cell population proliferation [GO:0042127]; regulation of epithelial cell proliferation [GO:0050678]; regulation of epithelial cell proliferation involved in prostate gland development [GO:0060768]; regulation of extracellular matrix assembly [GO:1901201]; regulation of gene expression [GO:0010468]; regulation of inner ear auditory receptor cell differentiation [GO:0045607]; regulation of neurogenesis [GO:0050767]; regulation of Notch signaling pathway [GO:0008593]; regulation of somitogenesis [GO:0014807]; regulation of transcription by RNA polymerase II [GO:0006357]; response to lipopolysaccharide [GO:0032496]; response to muramyl dipeptide [GO:0032495]; secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development [GO:0060528]; skeletal muscle cell differentiation [GO:0035914]; somatic stem cell division [GO:0048103]; spermatogenesis [GO:0007283]; sprouting angiogenesis [GO:0002040]; T-helper 17 type immune response [GO:0072538]; tissue regeneration [GO:0042246]; tube formation [GO:0035148]; vasculogenesis involved in coronary vascular morphogenesis [GO:0060979]; venous blood vessel morphogenesis [GO:0048845]; venous endothelial cell differentiation [GO:0060843]; ventricular septum morphogenesis [GO:0060412]; ventricular trabecula myocardium morphogenesis [GO:0003222] acrosomal vesicle [GO:0001669]; adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell periphery [GO:0071944]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; lamellipodium [GO:0030027]; late endosome membrane [GO:0031902]; MAML1-RBP-Jkappa- ICN1 complex [GO:0002193]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; receptor complex [GO:0043235]; ruffle [GO:0001726]; Schaffer collateral - CA1 synapse [GO:0098685] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; identical protein binding [GO:0042802]; Notch binding [GO:0005112]; transcription coactivator activity [GO:0003713]; transcription regulator activator activity [GO:0140537]; transmembrane signaling receptor activity [GO:0004888] g256.t2 Q01705 36.426 1013 3.5799999999999997e-128 457.0 sp|Q01705|NOTC1_MOUSE Neurogenic locus notch homolog protein 1 OS=Mus musculus OX=10090 GN=Notch1 PE=1 SV=3 NOTC1_MOUSE reviewed Neurogenic locus notch homolog protein 1 (Notch 1) (Motch A) (mT14) (p300) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Mus musculus (Mouse) GO:0000122; GO:0000139; GO:0001554; GO:0001669; GO:0001701; GO:0001708; GO:0001726; GO:0001837; GO:0001889; GO:0001947; GO:0002040; GO:0002051; GO:0002052; GO:0002193; GO:0002437; GO:0003151; GO:0003157; GO:0003160; GO:0003162; GO:0003169; GO:0003180; GO:0003181; GO:0003182; GO:0003184; GO:0003192; GO:0003197; GO:0003198; GO:0003203; GO:0003207; GO:0003208; GO:0003209; GO:0003213; GO:0003214; GO:0003219; GO:0003222; GO:0003241; GO:0003252; GO:0003264; GO:0003273; GO:0003332; GO:0003344; GO:0003682; GO:0003713; GO:0004857; GO:0004888; GO:0005112; GO:0005509; GO:0005576; GO:0005634; GO:0005654; GO:0005737; GO:0005783; GO:0005789; GO:0005829; GO:0005856; GO:0005886; GO:0005912; GO:0006357; GO:0006606; GO:0006959; GO:0007219; GO:0007221; GO:0007283; GO:0007368; GO:0007386; GO:0007409; GO:0007411; GO:0007440; GO:0007492; GO:0007507; GO:0008284; GO:0008285; GO:0008544; GO:0008593; GO:0009912; GO:0009986; GO:0010001; GO:0010008; GO:0010467; GO:0010468; GO:0010614; GO:0010628; GO:0010629; GO:0010667; GO:0010718; GO:0010812; GO:0010832; GO:0014031; GO:0014807; GO:0016324; GO:0019899; GO:0021515; GO:0021915; GO:0030027; GO:0030154; GO:0030163; GO:0030182; GO:0030216; GO:0030279; GO:0030324; GO:0030326; GO:0030334; GO:0030335; GO:0030513; GO:0030514; GO:0030900; GO:0031069; GO:0031100; GO:0031410; GO:0031490; GO:0031902; GO:0032495; GO:0032496; GO:0032966; GO:0035116; GO:0035148; GO:0035914; GO:0035924; GO:0042127; GO:0042246; GO:0042802; GO:0043065; GO:0043069; GO:0043086; GO:0043235; GO:0045070; GO:0045165; GO:0045596; GO:0045603; GO:0045607; GO:0045608; GO:0045618; GO:0045662; GO:0045665; GO:0045668; GO:0045687; GO:0045747; GO:0045892; GO:0045893; GO:0045944; GO:0045955; GO:0046427; GO:0046533; GO:0046579; GO:0048103; GO:0048593; GO:0048663; GO:0048708; GO:0048709; GO:0048711; GO:0048715; GO:0048754; GO:0048845; GO:0048873; GO:0050678; GO:0050679; GO:0050767; GO:0050768; GO:0051152; GO:0055008; GO:0060038; GO:0060045; GO:0060253; GO:0060271; GO:0060317; GO:0060354; GO:0060379; GO:0060411; GO:0060412; GO:0060528; GO:0060740; GO:0060768; GO:0060842; GO:0060843; GO:0060948; GO:0060956; GO:0060979; GO:0060982; GO:0061344; GO:0061384; GO:0062043; GO:0070168; GO:0070374; GO:0070986; GO:0071228; GO:0071372; GO:0071456; GO:0071944; GO:0072017; GO:0072044; GO:0072144; GO:0072538; GO:0090051; GO:0090090; GO:0097150; GO:0097400; GO:0098685; GO:0098839; GO:0098978; GO:0099565; GO:0120163; GO:0140537; GO:1901189; GO:1901201; GO:1902263; GO:1902339; GO:1903849; GO:2000048; GO:2000737; GO:2000811; GO:2000974; GO:2001027 animal organ regeneration [GO:0031100]; aortic valve morphogenesis [GO:0003180]; apoptotic process involved in embryonic digit morphogenesis [GO:1902263]; arterial endothelial cell differentiation [GO:0060842]; astrocyte differentiation [GO:0048708]; atrioventricular node development [GO:0003162]; atrioventricular valve morphogenesis [GO:0003181]; auditory receptor cell fate commitment [GO:0009912]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; branching morphogenesis of an epithelial tube [GO:0048754]; camera-type eye morphogenesis [GO:0048593]; cardiac atrium morphogenesis [GO:0003209]; cardiac chamber formation [GO:0003207]; cardiac epithelial to mesenchymal transition [GO:0060317]; cardiac left ventricle morphogenesis [GO:0003214]; cardiac muscle cell myoblast differentiation [GO:0060379]; cardiac muscle cell proliferation [GO:0060038]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac right atrium morphogenesis [GO:0003213]; cardiac right ventricle formation [GO:0003219]; cardiac septum morphogenesis [GO:0060411]; cardiac vascular smooth muscle cell development [GO:0060948]; cardiac ventricle morphogenesis [GO:0003208]; cell differentiation [GO:0030154]; cell differentiation in spinal cord [GO:0021515]; cell fate commitment [GO:0045165]; cell fate specification [GO:0001708]; cell migration involved in endocardial cushion formation [GO:0003273]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to hypoxia [GO:0071456]; cellular response to tumor cell [GO:0071228]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; chemical synaptic transmission, postsynaptic [GO:0099565]; cilium assembly [GO:0060271]; collecting duct development [GO:0072044]; compartment pattern specification [GO:0007386]; coronary artery morphogenesis [GO:0060982]; coronary sinus valve morphogenesis [GO:0003182]; coronary vein morphogenesis [GO:0003169]; determination of left/right symmetry [GO:0007368]; distal tubule development [GO:0072017]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic limb morphogenesis [GO:0030326]; endocardial cell differentiation [GO:0060956]; endocardial cushion development [GO:0003197]; endocardial cushion morphogenesis [GO:0003203]; endocardium development [GO:0003157]; endocardium morphogenesis [GO:0003160]; endoderm development [GO:0007492]; epidermis development [GO:0008544]; epithelial to mesenchymal transition [GO:0001837]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; forebrain development [GO:0030900]; foregut morphogenesis [GO:0007440]; gene expression [GO:0010467]; glial cell differentiation [GO:0010001]; glomerular mesangial cell development [GO:0072144]; growth involved in heart morphogenesis [GO:0003241]; hair follicle morphogenesis [GO:0031069]; heart development [GO:0007507]; heart looping [GO:0001947]; heart trabecula morphogenesis [GO:0061384]; homeostasis of number of cells within a tissue [GO:0048873]; humoral immune response [GO:0006959]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; interleukin-17-mediated signaling pathway [GO:0097400]; keratinocyte differentiation [GO:0030216]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; lung development [GO:0030324]; luteolysis [GO:0001554]; mesenchymal cell development [GO:0014031]; mitral valve formation [GO:0003192]; negative regulation of anoikis [GO:2000811]; negative regulation of biomineral tissue development [GO:0070168]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of catalytic activity [GO:0043086]; negative regulation of cell adhesion molecule production [GO:0060354]; negative regulation of cell differentiation [GO:0045596]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell proliferation involved in heart valve morphogenesis [GO:0003252]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of collagen biosynthetic process [GO:0032966]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of endothelial cell chemotaxis [GO:2001027]; negative regulation of extracellular matrix constituent secretion [GO:0003332]; negative regulation of gene expression [GO:0010629]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of inner ear auditory receptor cell differentiation [GO:0045608]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of ossification [GO:0030279]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of photoreceptor cell differentiation [GO:0046533]; negative regulation of pro-B cell differentiation [GO:2000974]; negative regulation of programmed cell death [GO:0043069]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural tube development [GO:0021915]; neuron differentiation [GO:0030182]; neuron fate commitment [GO:0048663]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; oligodendrocyte differentiation [GO:0048709]; osteoblast fate commitment [GO:0002051]; outflow tract morphogenesis [GO:0003151]; pericardium morphogenesis [GO:0003344]; positive regulation of aorta morphogenesis [GO:1903849]; positive regulation of apoptotic process [GO:0043065]; positive regulation of apoptotic process involved in morphogenesis [GO:1902339]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cardiac epithelial to mesenchymal transition [GO:0062043]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of ephrin receptor signaling pathway [GO:1901189]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of glial cell differentiation [GO:0045687]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of smooth muscle cell differentiation [GO:0051152]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription of Notch receptor target [GO:0007221]; positive regulation of viral genome replication [GO:0045070]; prostate gland epithelium morphogenesis [GO:0060740]; protein catabolic process [GO:0030163]; protein import into nucleus [GO:0006606]; pulmonary valve morphogenesis [GO:0003184]; regulation of cardioblast proliferation [GO:0003264]; regulation of cell adhesion involved in heart morphogenesis [GO:0061344]; regulation of cell migration [GO:0030334]; regulation of cell population proliferation [GO:0042127]; regulation of epithelial cell proliferation [GO:0050678]; regulation of epithelial cell proliferation involved in prostate gland development [GO:0060768]; regulation of extracellular matrix assembly [GO:1901201]; regulation of gene expression [GO:0010468]; regulation of inner ear auditory receptor cell differentiation [GO:0045607]; regulation of neurogenesis [GO:0050767]; regulation of Notch signaling pathway [GO:0008593]; regulation of somitogenesis [GO:0014807]; regulation of transcription by RNA polymerase II [GO:0006357]; response to lipopolysaccharide [GO:0032496]; response to muramyl dipeptide [GO:0032495]; secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development [GO:0060528]; skeletal muscle cell differentiation [GO:0035914]; somatic stem cell division [GO:0048103]; spermatogenesis [GO:0007283]; sprouting angiogenesis [GO:0002040]; T-helper 17 type immune response [GO:0072538]; tissue regeneration [GO:0042246]; tube formation [GO:0035148]; vasculogenesis involved in coronary vascular morphogenesis [GO:0060979]; venous blood vessel morphogenesis [GO:0048845]; venous endothelial cell differentiation [GO:0060843]; ventricular septum morphogenesis [GO:0060412]; ventricular trabecula myocardium morphogenesis [GO:0003222] acrosomal vesicle [GO:0001669]; adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell periphery [GO:0071944]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; lamellipodium [GO:0030027]; late endosome membrane [GO:0031902]; MAML1-RBP-Jkappa- ICN1 complex [GO:0002193]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; receptor complex [GO:0043235]; ruffle [GO:0001726]; Schaffer collateral - CA1 synapse [GO:0098685] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; identical protein binding [GO:0042802]; Notch binding [GO:0005112]; transcription coactivator activity [GO:0003713]; transcription regulator activator activity [GO:0140537]; transmembrane signaling receptor activity [GO:0004888] g256.t2 Q01705 37.978 445 3.9200000000000003e-59 231.0 sp|Q01705|NOTC1_MOUSE Neurogenic locus notch homolog protein 1 OS=Mus musculus OX=10090 GN=Notch1 PE=1 SV=3 NOTC1_MOUSE reviewed Neurogenic locus notch homolog protein 1 (Notch 1) (Motch A) (mT14) (p300) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Mus musculus (Mouse) GO:0000122; GO:0000139; GO:0001554; GO:0001669; GO:0001701; GO:0001708; GO:0001726; GO:0001837; GO:0001889; GO:0001947; GO:0002040; GO:0002051; GO:0002052; GO:0002193; GO:0002437; GO:0003151; GO:0003157; GO:0003160; GO:0003162; GO:0003169; GO:0003180; GO:0003181; GO:0003182; GO:0003184; GO:0003192; GO:0003197; GO:0003198; GO:0003203; GO:0003207; GO:0003208; GO:0003209; GO:0003213; GO:0003214; GO:0003219; GO:0003222; GO:0003241; GO:0003252; GO:0003264; GO:0003273; GO:0003332; GO:0003344; GO:0003682; GO:0003713; GO:0004857; GO:0004888; GO:0005112; GO:0005509; GO:0005576; GO:0005634; GO:0005654; GO:0005737; GO:0005783; GO:0005789; GO:0005829; GO:0005856; GO:0005886; GO:0005912; GO:0006357; GO:0006606; GO:0006959; GO:0007219; GO:0007221; GO:0007283; GO:0007368; GO:0007386; GO:0007409; GO:0007411; GO:0007440; GO:0007492; GO:0007507; GO:0008284; GO:0008285; GO:0008544; GO:0008593; GO:0009912; GO:0009986; GO:0010001; GO:0010008; GO:0010467; GO:0010468; GO:0010614; GO:0010628; GO:0010629; GO:0010667; GO:0010718; GO:0010812; GO:0010832; GO:0014031; GO:0014807; GO:0016324; GO:0019899; GO:0021515; GO:0021915; GO:0030027; GO:0030154; GO:0030163; GO:0030182; GO:0030216; GO:0030279; GO:0030324; GO:0030326; GO:0030334; GO:0030335; GO:0030513; GO:0030514; GO:0030900; GO:0031069; GO:0031100; GO:0031410; GO:0031490; GO:0031902; GO:0032495; GO:0032496; GO:0032966; GO:0035116; GO:0035148; GO:0035914; GO:0035924; GO:0042127; GO:0042246; GO:0042802; GO:0043065; GO:0043069; GO:0043086; GO:0043235; GO:0045070; GO:0045165; GO:0045596; GO:0045603; GO:0045607; GO:0045608; GO:0045618; GO:0045662; GO:0045665; GO:0045668; GO:0045687; GO:0045747; GO:0045892; GO:0045893; GO:0045944; GO:0045955; GO:0046427; GO:0046533; GO:0046579; GO:0048103; GO:0048593; GO:0048663; GO:0048708; GO:0048709; GO:0048711; GO:0048715; GO:0048754; GO:0048845; GO:0048873; GO:0050678; GO:0050679; GO:0050767; GO:0050768; GO:0051152; GO:0055008; GO:0060038; GO:0060045; GO:0060253; GO:0060271; GO:0060317; GO:0060354; GO:0060379; GO:0060411; GO:0060412; GO:0060528; GO:0060740; GO:0060768; GO:0060842; GO:0060843; GO:0060948; GO:0060956; GO:0060979; GO:0060982; GO:0061344; GO:0061384; GO:0062043; GO:0070168; GO:0070374; GO:0070986; GO:0071228; GO:0071372; GO:0071456; GO:0071944; GO:0072017; GO:0072044; GO:0072144; GO:0072538; GO:0090051; GO:0090090; GO:0097150; GO:0097400; GO:0098685; GO:0098839; GO:0098978; GO:0099565; GO:0120163; GO:0140537; GO:1901189; GO:1901201; GO:1902263; GO:1902339; GO:1903849; GO:2000048; GO:2000737; GO:2000811; GO:2000974; GO:2001027 animal organ regeneration [GO:0031100]; aortic valve morphogenesis [GO:0003180]; apoptotic process involved in embryonic digit morphogenesis [GO:1902263]; arterial endothelial cell differentiation [GO:0060842]; astrocyte differentiation [GO:0048708]; atrioventricular node development [GO:0003162]; atrioventricular valve morphogenesis [GO:0003181]; auditory receptor cell fate commitment [GO:0009912]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; branching morphogenesis of an epithelial tube [GO:0048754]; camera-type eye morphogenesis [GO:0048593]; cardiac atrium morphogenesis [GO:0003209]; cardiac chamber formation [GO:0003207]; cardiac epithelial to mesenchymal transition [GO:0060317]; cardiac left ventricle morphogenesis [GO:0003214]; cardiac muscle cell myoblast differentiation [GO:0060379]; cardiac muscle cell proliferation [GO:0060038]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac right atrium morphogenesis [GO:0003213]; cardiac right ventricle formation [GO:0003219]; cardiac septum morphogenesis [GO:0060411]; cardiac vascular smooth muscle cell development [GO:0060948]; cardiac ventricle morphogenesis [GO:0003208]; cell differentiation [GO:0030154]; cell differentiation in spinal cord [GO:0021515]; cell fate commitment [GO:0045165]; cell fate specification [GO:0001708]; cell migration involved in endocardial cushion formation [GO:0003273]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to hypoxia [GO:0071456]; cellular response to tumor cell [GO:0071228]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; chemical synaptic transmission, postsynaptic [GO:0099565]; cilium assembly [GO:0060271]; collecting duct development [GO:0072044]; compartment pattern specification [GO:0007386]; coronary artery morphogenesis [GO:0060982]; coronary sinus valve morphogenesis [GO:0003182]; coronary vein morphogenesis [GO:0003169]; determination of left/right symmetry [GO:0007368]; distal tubule development [GO:0072017]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic limb morphogenesis [GO:0030326]; endocardial cell differentiation [GO:0060956]; endocardial cushion development [GO:0003197]; endocardial cushion morphogenesis [GO:0003203]; endocardium development [GO:0003157]; endocardium morphogenesis [GO:0003160]; endoderm development [GO:0007492]; epidermis development [GO:0008544]; epithelial to mesenchymal transition [GO:0001837]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; forebrain development [GO:0030900]; foregut morphogenesis [GO:0007440]; gene expression [GO:0010467]; glial cell differentiation [GO:0010001]; glomerular mesangial cell development [GO:0072144]; growth involved in heart morphogenesis [GO:0003241]; hair follicle morphogenesis [GO:0031069]; heart development [GO:0007507]; heart looping [GO:0001947]; heart trabecula morphogenesis [GO:0061384]; homeostasis of number of cells within a tissue [GO:0048873]; humoral immune response [GO:0006959]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; interleukin-17-mediated signaling pathway [GO:0097400]; keratinocyte differentiation [GO:0030216]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; lung development [GO:0030324]; luteolysis [GO:0001554]; mesenchymal cell development [GO:0014031]; mitral valve formation [GO:0003192]; negative regulation of anoikis [GO:2000811]; negative regulation of biomineral tissue development [GO:0070168]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of catalytic activity [GO:0043086]; negative regulation of cell adhesion molecule production [GO:0060354]; negative regulation of cell differentiation [GO:0045596]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell proliferation involved in heart valve morphogenesis [GO:0003252]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of collagen biosynthetic process [GO:0032966]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of endothelial cell chemotaxis [GO:2001027]; negative regulation of extracellular matrix constituent secretion [GO:0003332]; negative regulation of gene expression [GO:0010629]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of inner ear auditory receptor cell differentiation [GO:0045608]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of ossification [GO:0030279]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of photoreceptor cell differentiation [GO:0046533]; negative regulation of pro-B cell differentiation [GO:2000974]; negative regulation of programmed cell death [GO:0043069]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural tube development [GO:0021915]; neuron differentiation [GO:0030182]; neuron fate commitment [GO:0048663]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; oligodendrocyte differentiation [GO:0048709]; osteoblast fate commitment [GO:0002051]; outflow tract morphogenesis [GO:0003151]; pericardium morphogenesis [GO:0003344]; positive regulation of aorta morphogenesis [GO:1903849]; positive regulation of apoptotic process [GO:0043065]; positive regulation of apoptotic process involved in morphogenesis [GO:1902339]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cardiac epithelial to mesenchymal transition [GO:0062043]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of ephrin receptor signaling pathway [GO:1901189]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of glial cell differentiation [GO:0045687]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of smooth muscle cell differentiation [GO:0051152]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription of Notch receptor target [GO:0007221]; positive regulation of viral genome replication [GO:0045070]; prostate gland epithelium morphogenesis [GO:0060740]; protein catabolic process [GO:0030163]; protein import into nucleus [GO:0006606]; pulmonary valve morphogenesis [GO:0003184]; regulation of cardioblast proliferation [GO:0003264]; regulation of cell adhesion involved in heart morphogenesis [GO:0061344]; regulation of cell migration [GO:0030334]; regulation of cell population proliferation [GO:0042127]; regulation of epithelial cell proliferation [GO:0050678]; regulation of epithelial cell proliferation involved in prostate gland development [GO:0060768]; regulation of extracellular matrix assembly [GO:1901201]; regulation of gene expression [GO:0010468]; regulation of inner ear auditory receptor cell differentiation [GO:0045607]; regulation of neurogenesis [GO:0050767]; regulation of Notch signaling pathway [GO:0008593]; regulation of somitogenesis [GO:0014807]; regulation of transcription by RNA polymerase II [GO:0006357]; response to lipopolysaccharide [GO:0032496]; response to muramyl dipeptide [GO:0032495]; secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development [GO:0060528]; skeletal muscle cell differentiation [GO:0035914]; somatic stem cell division [GO:0048103]; spermatogenesis [GO:0007283]; sprouting angiogenesis [GO:0002040]; T-helper 17 type immune response [GO:0072538]; tissue regeneration [GO:0042246]; tube formation [GO:0035148]; vasculogenesis involved in coronary vascular morphogenesis [GO:0060979]; venous blood vessel morphogenesis [GO:0048845]; venous endothelial cell differentiation [GO:0060843]; ventricular septum morphogenesis [GO:0060412]; ventricular trabecula myocardium morphogenesis [GO:0003222] acrosomal vesicle [GO:0001669]; adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell periphery [GO:0071944]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; lamellipodium [GO:0030027]; late endosome membrane [GO:0031902]; MAML1-RBP-Jkappa- ICN1 complex [GO:0002193]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; receptor complex [GO:0043235]; ruffle [GO:0001726]; Schaffer collateral - CA1 synapse [GO:0098685] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; identical protein binding [GO:0042802]; Notch binding [GO:0005112]; transcription coactivator activity [GO:0003713]; transcription regulator activator activity [GO:0140537]; transmembrane signaling receptor activity [GO:0004888] g256.t2 Q01705 42.484 153 6e-24 115.0 sp|Q01705|NOTC1_MOUSE Neurogenic locus notch homolog protein 1 OS=Mus musculus OX=10090 GN=Notch1 PE=1 SV=3 NOTC1_MOUSE reviewed Neurogenic locus notch homolog protein 1 (Notch 1) (Motch A) (mT14) (p300) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Mus musculus (Mouse) GO:0000122; GO:0000139; GO:0001554; GO:0001669; GO:0001701; GO:0001708; GO:0001726; GO:0001837; GO:0001889; GO:0001947; GO:0002040; GO:0002051; GO:0002052; GO:0002193; GO:0002437; GO:0003151; GO:0003157; GO:0003160; GO:0003162; GO:0003169; GO:0003180; GO:0003181; GO:0003182; GO:0003184; GO:0003192; GO:0003197; GO:0003198; GO:0003203; GO:0003207; GO:0003208; GO:0003209; GO:0003213; GO:0003214; GO:0003219; GO:0003222; GO:0003241; GO:0003252; GO:0003264; GO:0003273; GO:0003332; GO:0003344; GO:0003682; GO:0003713; GO:0004857; GO:0004888; GO:0005112; GO:0005509; GO:0005576; GO:0005634; GO:0005654; GO:0005737; GO:0005783; GO:0005789; GO:0005829; GO:0005856; GO:0005886; GO:0005912; GO:0006357; GO:0006606; GO:0006959; GO:0007219; GO:0007221; GO:0007283; GO:0007368; GO:0007386; GO:0007409; GO:0007411; GO:0007440; GO:0007492; GO:0007507; GO:0008284; GO:0008285; GO:0008544; GO:0008593; GO:0009912; GO:0009986; GO:0010001; GO:0010008; GO:0010467; GO:0010468; GO:0010614; GO:0010628; GO:0010629; GO:0010667; GO:0010718; GO:0010812; GO:0010832; GO:0014031; GO:0014807; GO:0016324; GO:0019899; GO:0021515; GO:0021915; GO:0030027; GO:0030154; GO:0030163; GO:0030182; GO:0030216; GO:0030279; GO:0030324; GO:0030326; GO:0030334; GO:0030335; GO:0030513; GO:0030514; GO:0030900; GO:0031069; GO:0031100; GO:0031410; GO:0031490; GO:0031902; GO:0032495; GO:0032496; GO:0032966; GO:0035116; GO:0035148; GO:0035914; GO:0035924; GO:0042127; GO:0042246; GO:0042802; GO:0043065; GO:0043069; GO:0043086; GO:0043235; GO:0045070; GO:0045165; GO:0045596; GO:0045603; GO:0045607; GO:0045608; GO:0045618; GO:0045662; GO:0045665; GO:0045668; GO:0045687; GO:0045747; GO:0045892; GO:0045893; GO:0045944; GO:0045955; GO:0046427; GO:0046533; GO:0046579; GO:0048103; GO:0048593; GO:0048663; GO:0048708; GO:0048709; GO:0048711; GO:0048715; GO:0048754; GO:0048845; GO:0048873; GO:0050678; GO:0050679; GO:0050767; GO:0050768; GO:0051152; GO:0055008; GO:0060038; GO:0060045; GO:0060253; GO:0060271; GO:0060317; GO:0060354; GO:0060379; GO:0060411; GO:0060412; GO:0060528; GO:0060740; GO:0060768; GO:0060842; GO:0060843; GO:0060948; GO:0060956; GO:0060979; GO:0060982; GO:0061344; GO:0061384; GO:0062043; GO:0070168; GO:0070374; GO:0070986; GO:0071228; GO:0071372; GO:0071456; GO:0071944; GO:0072017; GO:0072044; GO:0072144; GO:0072538; GO:0090051; GO:0090090; GO:0097150; GO:0097400; GO:0098685; GO:0098839; GO:0098978; GO:0099565; GO:0120163; GO:0140537; GO:1901189; GO:1901201; GO:1902263; GO:1902339; GO:1903849; GO:2000048; GO:2000737; GO:2000811; GO:2000974; GO:2001027 animal organ regeneration [GO:0031100]; aortic valve morphogenesis [GO:0003180]; apoptotic process involved in embryonic digit morphogenesis [GO:1902263]; arterial endothelial cell differentiation [GO:0060842]; astrocyte differentiation [GO:0048708]; atrioventricular node development [GO:0003162]; atrioventricular valve morphogenesis [GO:0003181]; auditory receptor cell fate commitment [GO:0009912]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; branching morphogenesis of an epithelial tube [GO:0048754]; camera-type eye morphogenesis [GO:0048593]; cardiac atrium morphogenesis [GO:0003209]; cardiac chamber formation [GO:0003207]; cardiac epithelial to mesenchymal transition [GO:0060317]; cardiac left ventricle morphogenesis [GO:0003214]; cardiac muscle cell myoblast differentiation [GO:0060379]; cardiac muscle cell proliferation [GO:0060038]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac right atrium morphogenesis [GO:0003213]; cardiac right ventricle formation [GO:0003219]; cardiac septum morphogenesis [GO:0060411]; cardiac vascular smooth muscle cell development [GO:0060948]; cardiac ventricle morphogenesis [GO:0003208]; cell differentiation [GO:0030154]; cell differentiation in spinal cord [GO:0021515]; cell fate commitment [GO:0045165]; cell fate specification [GO:0001708]; cell migration involved in endocardial cushion formation [GO:0003273]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to hypoxia [GO:0071456]; cellular response to tumor cell [GO:0071228]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; chemical synaptic transmission, postsynaptic [GO:0099565]; cilium assembly [GO:0060271]; collecting duct development [GO:0072044]; compartment pattern specification [GO:0007386]; coronary artery morphogenesis [GO:0060982]; coronary sinus valve morphogenesis [GO:0003182]; coronary vein morphogenesis [GO:0003169]; determination of left/right symmetry [GO:0007368]; distal tubule development [GO:0072017]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic limb morphogenesis [GO:0030326]; endocardial cell differentiation [GO:0060956]; endocardial cushion development [GO:0003197]; endocardial cushion morphogenesis [GO:0003203]; endocardium development [GO:0003157]; endocardium morphogenesis [GO:0003160]; endoderm development [GO:0007492]; epidermis development [GO:0008544]; epithelial to mesenchymal transition [GO:0001837]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; forebrain development [GO:0030900]; foregut morphogenesis [GO:0007440]; gene expression [GO:0010467]; glial cell differentiation [GO:0010001]; glomerular mesangial cell development [GO:0072144]; growth involved in heart morphogenesis [GO:0003241]; hair follicle morphogenesis [GO:0031069]; heart development [GO:0007507]; heart looping [GO:0001947]; heart trabecula morphogenesis [GO:0061384]; homeostasis of number of cells within a tissue [GO:0048873]; humoral immune response [GO:0006959]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; interleukin-17-mediated signaling pathway [GO:0097400]; keratinocyte differentiation [GO:0030216]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; lung development [GO:0030324]; luteolysis [GO:0001554]; mesenchymal cell development [GO:0014031]; mitral valve formation [GO:0003192]; negative regulation of anoikis [GO:2000811]; negative regulation of biomineral tissue development [GO:0070168]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of catalytic activity [GO:0043086]; negative regulation of cell adhesion molecule production [GO:0060354]; negative regulation of cell differentiation [GO:0045596]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell proliferation involved in heart valve morphogenesis [GO:0003252]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of collagen biosynthetic process [GO:0032966]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of endothelial cell chemotaxis [GO:2001027]; negative regulation of extracellular matrix constituent secretion [GO:0003332]; negative regulation of gene expression [GO:0010629]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of inner ear auditory receptor cell differentiation [GO:0045608]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of ossification [GO:0030279]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of photoreceptor cell differentiation [GO:0046533]; negative regulation of pro-B cell differentiation [GO:2000974]; negative regulation of programmed cell death [GO:0043069]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural tube development [GO:0021915]; neuron differentiation [GO:0030182]; neuron fate commitment [GO:0048663]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; oligodendrocyte differentiation [GO:0048709]; osteoblast fate commitment [GO:0002051]; outflow tract morphogenesis [GO:0003151]; pericardium morphogenesis [GO:0003344]; positive regulation of aorta morphogenesis [GO:1903849]; positive regulation of apoptotic process [GO:0043065]; positive regulation of apoptotic process involved in morphogenesis [GO:1902339]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cardiac epithelial to mesenchymal transition [GO:0062043]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of ephrin receptor signaling pathway [GO:1901189]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of glial cell differentiation [GO:0045687]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of smooth muscle cell differentiation [GO:0051152]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription of Notch receptor target [GO:0007221]; positive regulation of viral genome replication [GO:0045070]; prostate gland epithelium morphogenesis [GO:0060740]; protein catabolic process [GO:0030163]; protein import into nucleus [GO:0006606]; pulmonary valve morphogenesis [GO:0003184]; regulation of cardioblast proliferation [GO:0003264]; regulation of cell adhesion involved in heart morphogenesis [GO:0061344]; regulation of cell migration [GO:0030334]; regulation of cell population proliferation [GO:0042127]; regulation of epithelial cell proliferation [GO:0050678]; regulation of epithelial cell proliferation involved in prostate gland development [GO:0060768]; regulation of extracellular matrix assembly [GO:1901201]; regulation of gene expression [GO:0010468]; regulation of inner ear auditory receptor cell differentiation [GO:0045607]; regulation of neurogenesis [GO:0050767]; regulation of Notch signaling pathway [GO:0008593]; regulation of somitogenesis [GO:0014807]; regulation of transcription by RNA polymerase II [GO:0006357]; response to lipopolysaccharide [GO:0032496]; response to muramyl dipeptide [GO:0032495]; secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development [GO:0060528]; skeletal muscle cell differentiation [GO:0035914]; somatic stem cell division [GO:0048103]; spermatogenesis [GO:0007283]; sprouting angiogenesis [GO:0002040]; T-helper 17 type immune response [GO:0072538]; tissue regeneration [GO:0042246]; tube formation [GO:0035148]; vasculogenesis involved in coronary vascular morphogenesis [GO:0060979]; venous blood vessel morphogenesis [GO:0048845]; venous endothelial cell differentiation [GO:0060843]; ventricular septum morphogenesis [GO:0060412]; ventricular trabecula myocardium morphogenesis [GO:0003222] acrosomal vesicle [GO:0001669]; adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell periphery [GO:0071944]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; lamellipodium [GO:0030027]; late endosome membrane [GO:0031902]; MAML1-RBP-Jkappa- ICN1 complex [GO:0002193]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; receptor complex [GO:0043235]; ruffle [GO:0001726]; Schaffer collateral - CA1 synapse [GO:0098685] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; identical protein binding [GO:0042802]; Notch binding [GO:0005112]; transcription coactivator activity [GO:0003713]; transcription regulator activator activity [GO:0140537]; transmembrane signaling receptor activity [GO:0004888] g256.t2 Q01705 41.176 153 4.07e-22 109.0 sp|Q01705|NOTC1_MOUSE Neurogenic locus notch homolog protein 1 OS=Mus musculus OX=10090 GN=Notch1 PE=1 SV=3 NOTC1_MOUSE reviewed Neurogenic locus notch homolog protein 1 (Notch 1) (Motch A) (mT14) (p300) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Mus musculus (Mouse) GO:0000122; GO:0000139; GO:0001554; GO:0001669; GO:0001701; GO:0001708; GO:0001726; GO:0001837; GO:0001889; GO:0001947; GO:0002040; GO:0002051; GO:0002052; GO:0002193; GO:0002437; GO:0003151; GO:0003157; GO:0003160; GO:0003162; GO:0003169; GO:0003180; GO:0003181; GO:0003182; GO:0003184; GO:0003192; GO:0003197; GO:0003198; GO:0003203; GO:0003207; GO:0003208; GO:0003209; GO:0003213; GO:0003214; GO:0003219; GO:0003222; GO:0003241; GO:0003252; GO:0003264; GO:0003273; GO:0003332; GO:0003344; GO:0003682; GO:0003713; GO:0004857; GO:0004888; GO:0005112; GO:0005509; GO:0005576; GO:0005634; GO:0005654; GO:0005737; GO:0005783; GO:0005789; GO:0005829; GO:0005856; GO:0005886; GO:0005912; GO:0006357; GO:0006606; GO:0006959; GO:0007219; GO:0007221; GO:0007283; GO:0007368; GO:0007386; GO:0007409; GO:0007411; GO:0007440; GO:0007492; GO:0007507; GO:0008284; GO:0008285; GO:0008544; GO:0008593; GO:0009912; GO:0009986; GO:0010001; GO:0010008; GO:0010467; GO:0010468; GO:0010614; GO:0010628; GO:0010629; GO:0010667; GO:0010718; GO:0010812; GO:0010832; GO:0014031; GO:0014807; GO:0016324; GO:0019899; GO:0021515; GO:0021915; GO:0030027; GO:0030154; GO:0030163; GO:0030182; GO:0030216; GO:0030279; GO:0030324; GO:0030326; GO:0030334; GO:0030335; GO:0030513; GO:0030514; GO:0030900; GO:0031069; GO:0031100; GO:0031410; GO:0031490; GO:0031902; GO:0032495; GO:0032496; GO:0032966; GO:0035116; GO:0035148; GO:0035914; GO:0035924; GO:0042127; GO:0042246; GO:0042802; GO:0043065; GO:0043069; GO:0043086; GO:0043235; GO:0045070; GO:0045165; GO:0045596; GO:0045603; GO:0045607; GO:0045608; GO:0045618; GO:0045662; GO:0045665; GO:0045668; GO:0045687; GO:0045747; GO:0045892; GO:0045893; GO:0045944; GO:0045955; GO:0046427; GO:0046533; GO:0046579; GO:0048103; GO:0048593; GO:0048663; GO:0048708; GO:0048709; GO:0048711; GO:0048715; GO:0048754; GO:0048845; GO:0048873; GO:0050678; GO:0050679; GO:0050767; GO:0050768; GO:0051152; GO:0055008; GO:0060038; GO:0060045; GO:0060253; GO:0060271; GO:0060317; GO:0060354; GO:0060379; GO:0060411; GO:0060412; GO:0060528; GO:0060740; GO:0060768; GO:0060842; GO:0060843; GO:0060948; GO:0060956; GO:0060979; GO:0060982; GO:0061344; GO:0061384; GO:0062043; GO:0070168; GO:0070374; GO:0070986; GO:0071228; GO:0071372; GO:0071456; GO:0071944; GO:0072017; GO:0072044; GO:0072144; GO:0072538; GO:0090051; GO:0090090; GO:0097150; GO:0097400; GO:0098685; GO:0098839; GO:0098978; GO:0099565; GO:0120163; GO:0140537; GO:1901189; GO:1901201; GO:1902263; GO:1902339; GO:1903849; GO:2000048; GO:2000737; GO:2000811; GO:2000974; GO:2001027 animal organ regeneration [GO:0031100]; aortic valve morphogenesis [GO:0003180]; apoptotic process involved in embryonic digit morphogenesis [GO:1902263]; arterial endothelial cell differentiation [GO:0060842]; astrocyte differentiation [GO:0048708]; atrioventricular node development [GO:0003162]; atrioventricular valve morphogenesis [GO:0003181]; auditory receptor cell fate commitment [GO:0009912]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; branching morphogenesis of an epithelial tube [GO:0048754]; camera-type eye morphogenesis [GO:0048593]; cardiac atrium morphogenesis [GO:0003209]; cardiac chamber formation [GO:0003207]; cardiac epithelial to mesenchymal transition [GO:0060317]; cardiac left ventricle morphogenesis [GO:0003214]; cardiac muscle cell myoblast differentiation [GO:0060379]; cardiac muscle cell proliferation [GO:0060038]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac right atrium morphogenesis [GO:0003213]; cardiac right ventricle formation [GO:0003219]; cardiac septum morphogenesis [GO:0060411]; cardiac vascular smooth muscle cell development [GO:0060948]; cardiac ventricle morphogenesis [GO:0003208]; cell differentiation [GO:0030154]; cell differentiation in spinal cord [GO:0021515]; cell fate commitment [GO:0045165]; cell fate specification [GO:0001708]; cell migration involved in endocardial cushion formation [GO:0003273]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to hypoxia [GO:0071456]; cellular response to tumor cell [GO:0071228]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; chemical synaptic transmission, postsynaptic [GO:0099565]; cilium assembly [GO:0060271]; collecting duct development [GO:0072044]; compartment pattern specification [GO:0007386]; coronary artery morphogenesis [GO:0060982]; coronary sinus valve morphogenesis [GO:0003182]; coronary vein morphogenesis [GO:0003169]; determination of left/right symmetry [GO:0007368]; distal tubule development [GO:0072017]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic limb morphogenesis [GO:0030326]; endocardial cell differentiation [GO:0060956]; endocardial cushion development [GO:0003197]; endocardial cushion morphogenesis [GO:0003203]; endocardium development [GO:0003157]; endocardium morphogenesis [GO:0003160]; endoderm development [GO:0007492]; epidermis development [GO:0008544]; epithelial to mesenchymal transition [GO:0001837]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; forebrain development [GO:0030900]; foregut morphogenesis [GO:0007440]; gene expression [GO:0010467]; glial cell differentiation [GO:0010001]; glomerular mesangial cell development [GO:0072144]; growth involved in heart morphogenesis [GO:0003241]; hair follicle morphogenesis [GO:0031069]; heart development [GO:0007507]; heart looping [GO:0001947]; heart trabecula morphogenesis [GO:0061384]; homeostasis of number of cells within a tissue [GO:0048873]; humoral immune response [GO:0006959]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; interleukin-17-mediated signaling pathway [GO:0097400]; keratinocyte differentiation [GO:0030216]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; lung development [GO:0030324]; luteolysis [GO:0001554]; mesenchymal cell development [GO:0014031]; mitral valve formation [GO:0003192]; negative regulation of anoikis [GO:2000811]; negative regulation of biomineral tissue development [GO:0070168]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of catalytic activity [GO:0043086]; negative regulation of cell adhesion molecule production [GO:0060354]; negative regulation of cell differentiation [GO:0045596]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell proliferation involved in heart valve morphogenesis [GO:0003252]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of collagen biosynthetic process [GO:0032966]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of endothelial cell chemotaxis [GO:2001027]; negative regulation of extracellular matrix constituent secretion [GO:0003332]; negative regulation of gene expression [GO:0010629]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of inner ear auditory receptor cell differentiation [GO:0045608]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of ossification [GO:0030279]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of photoreceptor cell differentiation [GO:0046533]; negative regulation of pro-B cell differentiation [GO:2000974]; negative regulation of programmed cell death [GO:0043069]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural tube development [GO:0021915]; neuron differentiation [GO:0030182]; neuron fate commitment [GO:0048663]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; oligodendrocyte differentiation [GO:0048709]; osteoblast fate commitment [GO:0002051]; outflow tract morphogenesis [GO:0003151]; pericardium morphogenesis [GO:0003344]; positive regulation of aorta morphogenesis [GO:1903849]; positive regulation of apoptotic process [GO:0043065]; positive regulation of apoptotic process involved in morphogenesis [GO:1902339]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cardiac epithelial to mesenchymal transition [GO:0062043]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of ephrin receptor signaling pathway [GO:1901189]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of glial cell differentiation [GO:0045687]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of smooth muscle cell differentiation [GO:0051152]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription of Notch receptor target [GO:0007221]; positive regulation of viral genome replication [GO:0045070]; prostate gland epithelium morphogenesis [GO:0060740]; protein catabolic process [GO:0030163]; protein import into nucleus [GO:0006606]; pulmonary valve morphogenesis [GO:0003184]; regulation of cardioblast proliferation [GO:0003264]; regulation of cell adhesion involved in heart morphogenesis [GO:0061344]; regulation of cell migration [GO:0030334]; regulation of cell population proliferation [GO:0042127]; regulation of epithelial cell proliferation [GO:0050678]; regulation of epithelial cell proliferation involved in prostate gland development [GO:0060768]; regulation of extracellular matrix assembly [GO:1901201]; regulation of gene expression [GO:0010468]; regulation of inner ear auditory receptor cell differentiation [GO:0045607]; regulation of neurogenesis [GO:0050767]; regulation of Notch signaling pathway [GO:0008593]; regulation of somitogenesis [GO:0014807]; regulation of transcription by RNA polymerase II [GO:0006357]; response to lipopolysaccharide [GO:0032496]; response to muramyl dipeptide [GO:0032495]; secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development [GO:0060528]; skeletal muscle cell differentiation [GO:0035914]; somatic stem cell division [GO:0048103]; spermatogenesis [GO:0007283]; sprouting angiogenesis [GO:0002040]; T-helper 17 type immune response [GO:0072538]; tissue regeneration [GO:0042246]; tube formation [GO:0035148]; vasculogenesis involved in coronary vascular morphogenesis [GO:0060979]; venous blood vessel morphogenesis [GO:0048845]; venous endothelial cell differentiation [GO:0060843]; ventricular septum morphogenesis [GO:0060412]; ventricular trabecula myocardium morphogenesis [GO:0003222] acrosomal vesicle [GO:0001669]; adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell periphery [GO:0071944]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; lamellipodium [GO:0030027]; late endosome membrane [GO:0031902]; MAML1-RBP-Jkappa- ICN1 complex [GO:0002193]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; receptor complex [GO:0043235]; ruffle [GO:0001726]; Schaffer collateral - CA1 synapse [GO:0098685] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; identical protein binding [GO:0042802]; Notch binding [GO:0005112]; transcription coactivator activity [GO:0003713]; transcription regulator activator activity [GO:0140537]; transmembrane signaling receptor activity [GO:0004888] g256.t2 Q01705 41.176 153 2.3700000000000003e-21 107.0 sp|Q01705|NOTC1_MOUSE Neurogenic locus notch homolog protein 1 OS=Mus musculus OX=10090 GN=Notch1 PE=1 SV=3 NOTC1_MOUSE reviewed Neurogenic locus notch homolog protein 1 (Notch 1) (Motch A) (mT14) (p300) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Mus musculus (Mouse) GO:0000122; GO:0000139; GO:0001554; GO:0001669; GO:0001701; GO:0001708; GO:0001726; GO:0001837; GO:0001889; GO:0001947; GO:0002040; GO:0002051; GO:0002052; GO:0002193; GO:0002437; GO:0003151; GO:0003157; GO:0003160; GO:0003162; GO:0003169; GO:0003180; GO:0003181; GO:0003182; GO:0003184; GO:0003192; GO:0003197; GO:0003198; GO:0003203; GO:0003207; GO:0003208; GO:0003209; GO:0003213; GO:0003214; GO:0003219; GO:0003222; GO:0003241; GO:0003252; GO:0003264; GO:0003273; GO:0003332; GO:0003344; GO:0003682; GO:0003713; GO:0004857; GO:0004888; GO:0005112; GO:0005509; GO:0005576; GO:0005634; GO:0005654; GO:0005737; GO:0005783; GO:0005789; GO:0005829; GO:0005856; GO:0005886; GO:0005912; GO:0006357; GO:0006606; GO:0006959; GO:0007219; GO:0007221; GO:0007283; GO:0007368; GO:0007386; GO:0007409; GO:0007411; GO:0007440; GO:0007492; GO:0007507; GO:0008284; GO:0008285; GO:0008544; GO:0008593; GO:0009912; GO:0009986; GO:0010001; GO:0010008; GO:0010467; GO:0010468; GO:0010614; GO:0010628; GO:0010629; GO:0010667; GO:0010718; GO:0010812; GO:0010832; GO:0014031; GO:0014807; GO:0016324; GO:0019899; GO:0021515; GO:0021915; GO:0030027; GO:0030154; GO:0030163; GO:0030182; GO:0030216; GO:0030279; GO:0030324; GO:0030326; GO:0030334; GO:0030335; GO:0030513; GO:0030514; GO:0030900; GO:0031069; GO:0031100; GO:0031410; GO:0031490; GO:0031902; GO:0032495; GO:0032496; GO:0032966; GO:0035116; GO:0035148; GO:0035914; GO:0035924; GO:0042127; GO:0042246; GO:0042802; GO:0043065; GO:0043069; GO:0043086; GO:0043235; GO:0045070; GO:0045165; GO:0045596; GO:0045603; GO:0045607; GO:0045608; GO:0045618; GO:0045662; GO:0045665; GO:0045668; GO:0045687; GO:0045747; GO:0045892; GO:0045893; GO:0045944; GO:0045955; GO:0046427; GO:0046533; GO:0046579; GO:0048103; GO:0048593; GO:0048663; GO:0048708; GO:0048709; GO:0048711; GO:0048715; GO:0048754; GO:0048845; GO:0048873; GO:0050678; GO:0050679; GO:0050767; GO:0050768; GO:0051152; GO:0055008; GO:0060038; GO:0060045; GO:0060253; GO:0060271; GO:0060317; GO:0060354; GO:0060379; GO:0060411; GO:0060412; GO:0060528; GO:0060740; GO:0060768; GO:0060842; GO:0060843; GO:0060948; GO:0060956; GO:0060979; GO:0060982; GO:0061344; GO:0061384; GO:0062043; GO:0070168; GO:0070374; GO:0070986; GO:0071228; GO:0071372; GO:0071456; GO:0071944; GO:0072017; GO:0072044; GO:0072144; GO:0072538; GO:0090051; GO:0090090; GO:0097150; GO:0097400; GO:0098685; GO:0098839; GO:0098978; GO:0099565; GO:0120163; GO:0140537; GO:1901189; GO:1901201; GO:1902263; GO:1902339; GO:1903849; GO:2000048; GO:2000737; GO:2000811; GO:2000974; GO:2001027 animal organ regeneration [GO:0031100]; aortic valve morphogenesis [GO:0003180]; apoptotic process involved in embryonic digit morphogenesis [GO:1902263]; arterial endothelial cell differentiation [GO:0060842]; astrocyte differentiation [GO:0048708]; atrioventricular node development [GO:0003162]; atrioventricular valve morphogenesis [GO:0003181]; auditory receptor cell fate commitment [GO:0009912]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; branching morphogenesis of an epithelial tube [GO:0048754]; camera-type eye morphogenesis [GO:0048593]; cardiac atrium morphogenesis [GO:0003209]; cardiac chamber formation [GO:0003207]; cardiac epithelial to mesenchymal transition [GO:0060317]; cardiac left ventricle morphogenesis [GO:0003214]; cardiac muscle cell myoblast differentiation [GO:0060379]; cardiac muscle cell proliferation [GO:0060038]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac right atrium morphogenesis [GO:0003213]; cardiac right ventricle formation [GO:0003219]; cardiac septum morphogenesis [GO:0060411]; cardiac vascular smooth muscle cell development [GO:0060948]; cardiac ventricle morphogenesis [GO:0003208]; cell differentiation [GO:0030154]; cell differentiation in spinal cord [GO:0021515]; cell fate commitment [GO:0045165]; cell fate specification [GO:0001708]; cell migration involved in endocardial cushion formation [GO:0003273]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to hypoxia [GO:0071456]; cellular response to tumor cell [GO:0071228]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; chemical synaptic transmission, postsynaptic [GO:0099565]; cilium assembly [GO:0060271]; collecting duct development [GO:0072044]; compartment pattern specification [GO:0007386]; coronary artery morphogenesis [GO:0060982]; coronary sinus valve morphogenesis [GO:0003182]; coronary vein morphogenesis [GO:0003169]; determination of left/right symmetry [GO:0007368]; distal tubule development [GO:0072017]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic limb morphogenesis [GO:0030326]; endocardial cell differentiation [GO:0060956]; endocardial cushion development [GO:0003197]; endocardial cushion morphogenesis [GO:0003203]; endocardium development [GO:0003157]; endocardium morphogenesis [GO:0003160]; endoderm development [GO:0007492]; epidermis development [GO:0008544]; epithelial to mesenchymal transition [GO:0001837]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; forebrain development [GO:0030900]; foregut morphogenesis [GO:0007440]; gene expression [GO:0010467]; glial cell differentiation [GO:0010001]; glomerular mesangial cell development [GO:0072144]; growth involved in heart morphogenesis [GO:0003241]; hair follicle morphogenesis [GO:0031069]; heart development [GO:0007507]; heart looping [GO:0001947]; heart trabecula morphogenesis [GO:0061384]; homeostasis of number of cells within a tissue [GO:0048873]; humoral immune response [GO:0006959]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; interleukin-17-mediated signaling pathway [GO:0097400]; keratinocyte differentiation [GO:0030216]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; lung development [GO:0030324]; luteolysis [GO:0001554]; mesenchymal cell development [GO:0014031]; mitral valve formation [GO:0003192]; negative regulation of anoikis [GO:2000811]; negative regulation of biomineral tissue development [GO:0070168]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of catalytic activity [GO:0043086]; negative regulation of cell adhesion molecule production [GO:0060354]; negative regulation of cell differentiation [GO:0045596]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell proliferation involved in heart valve morphogenesis [GO:0003252]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of collagen biosynthetic process [GO:0032966]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of endothelial cell chemotaxis [GO:2001027]; negative regulation of extracellular matrix constituent secretion [GO:0003332]; negative regulation of gene expression [GO:0010629]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of inner ear auditory receptor cell differentiation [GO:0045608]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of ossification [GO:0030279]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of photoreceptor cell differentiation [GO:0046533]; negative regulation of pro-B cell differentiation [GO:2000974]; negative regulation of programmed cell death [GO:0043069]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural tube development [GO:0021915]; neuron differentiation [GO:0030182]; neuron fate commitment [GO:0048663]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; oligodendrocyte differentiation [GO:0048709]; osteoblast fate commitment [GO:0002051]; outflow tract morphogenesis [GO:0003151]; pericardium morphogenesis [GO:0003344]; positive regulation of aorta morphogenesis [GO:1903849]; positive regulation of apoptotic process [GO:0043065]; positive regulation of apoptotic process involved in morphogenesis [GO:1902339]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cardiac epithelial to mesenchymal transition [GO:0062043]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of ephrin receptor signaling pathway [GO:1901189]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of glial cell differentiation [GO:0045687]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of smooth muscle cell differentiation [GO:0051152]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription of Notch receptor target [GO:0007221]; positive regulation of viral genome replication [GO:0045070]; prostate gland epithelium morphogenesis [GO:0060740]; protein catabolic process [GO:0030163]; protein import into nucleus [GO:0006606]; pulmonary valve morphogenesis [GO:0003184]; regulation of cardioblast proliferation [GO:0003264]; regulation of cell adhesion involved in heart morphogenesis [GO:0061344]; regulation of cell migration [GO:0030334]; regulation of cell population proliferation [GO:0042127]; regulation of epithelial cell proliferation [GO:0050678]; regulation of epithelial cell proliferation involved in prostate gland development [GO:0060768]; regulation of extracellular matrix assembly [GO:1901201]; regulation of gene expression [GO:0010468]; regulation of inner ear auditory receptor cell differentiation [GO:0045607]; regulation of neurogenesis [GO:0050767]; regulation of Notch signaling pathway [GO:0008593]; regulation of somitogenesis [GO:0014807]; regulation of transcription by RNA polymerase II [GO:0006357]; response to lipopolysaccharide [GO:0032496]; response to muramyl dipeptide [GO:0032495]; secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development [GO:0060528]; skeletal muscle cell differentiation [GO:0035914]; somatic stem cell division [GO:0048103]; spermatogenesis [GO:0007283]; sprouting angiogenesis [GO:0002040]; T-helper 17 type immune response [GO:0072538]; tissue regeneration [GO:0042246]; tube formation [GO:0035148]; vasculogenesis involved in coronary vascular morphogenesis [GO:0060979]; venous blood vessel morphogenesis [GO:0048845]; venous endothelial cell differentiation [GO:0060843]; ventricular septum morphogenesis [GO:0060412]; ventricular trabecula myocardium morphogenesis [GO:0003222] acrosomal vesicle [GO:0001669]; adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell periphery [GO:0071944]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; lamellipodium [GO:0030027]; late endosome membrane [GO:0031902]; MAML1-RBP-Jkappa- ICN1 complex [GO:0002193]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; receptor complex [GO:0043235]; ruffle [GO:0001726]; Schaffer collateral - CA1 synapse [GO:0098685] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; identical protein binding [GO:0042802]; Notch binding [GO:0005112]; transcription coactivator activity [GO:0003713]; transcription regulator activator activity [GO:0140537]; transmembrane signaling receptor activity [GO:0004888] g256.t3 Q01705 37.055 1433 0.0 724.0 sp|Q01705|NOTC1_MOUSE Neurogenic locus notch homolog protein 1 OS=Mus musculus OX=10090 GN=Notch1 PE=1 SV=3 NOTC1_MOUSE reviewed Neurogenic locus notch homolog protein 1 (Notch 1) (Motch A) (mT14) (p300) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Mus musculus (Mouse) GO:0000122; GO:0000139; GO:0001554; GO:0001669; GO:0001701; GO:0001708; GO:0001726; GO:0001837; GO:0001889; GO:0001947; GO:0002040; GO:0002051; GO:0002052; GO:0002193; GO:0002437; GO:0003151; GO:0003157; GO:0003160; GO:0003162; GO:0003169; GO:0003180; GO:0003181; GO:0003182; GO:0003184; GO:0003192; GO:0003197; GO:0003198; GO:0003203; GO:0003207; GO:0003208; GO:0003209; GO:0003213; GO:0003214; GO:0003219; GO:0003222; GO:0003241; GO:0003252; GO:0003264; GO:0003273; GO:0003332; GO:0003344; GO:0003682; GO:0003713; GO:0004857; GO:0004888; GO:0005112; GO:0005509; GO:0005576; GO:0005634; GO:0005654; GO:0005737; GO:0005783; GO:0005789; GO:0005829; GO:0005856; GO:0005886; GO:0005912; GO:0006357; GO:0006606; GO:0006959; GO:0007219; GO:0007221; GO:0007283; GO:0007368; GO:0007386; GO:0007409; GO:0007411; GO:0007440; GO:0007492; GO:0007507; GO:0008284; GO:0008285; GO:0008544; GO:0008593; GO:0009912; GO:0009986; GO:0010001; GO:0010008; GO:0010467; GO:0010468; GO:0010614; GO:0010628; GO:0010629; GO:0010667; GO:0010718; GO:0010812; GO:0010832; GO:0014031; GO:0014807; GO:0016324; GO:0019899; GO:0021515; GO:0021915; GO:0030027; GO:0030154; GO:0030163; GO:0030182; GO:0030216; GO:0030279; GO:0030324; GO:0030326; GO:0030334; GO:0030335; GO:0030513; GO:0030514; GO:0030900; GO:0031069; GO:0031100; GO:0031410; GO:0031490; GO:0031902; GO:0032495; GO:0032496; GO:0032966; GO:0035116; GO:0035148; GO:0035914; GO:0035924; GO:0042127; GO:0042246; GO:0042802; GO:0043065; GO:0043069; GO:0043086; GO:0043235; GO:0045070; GO:0045165; GO:0045596; GO:0045603; GO:0045607; GO:0045608; GO:0045618; GO:0045662; GO:0045665; GO:0045668; GO:0045687; GO:0045747; GO:0045892; GO:0045893; GO:0045944; GO:0045955; GO:0046427; GO:0046533; GO:0046579; GO:0048103; GO:0048593; GO:0048663; GO:0048708; GO:0048709; GO:0048711; GO:0048715; GO:0048754; GO:0048845; GO:0048873; GO:0050678; GO:0050679; GO:0050767; GO:0050768; GO:0051152; GO:0055008; GO:0060038; GO:0060045; GO:0060253; GO:0060271; GO:0060317; GO:0060354; GO:0060379; GO:0060411; GO:0060412; GO:0060528; GO:0060740; GO:0060768; GO:0060842; GO:0060843; GO:0060948; GO:0060956; GO:0060979; GO:0060982; GO:0061344; GO:0061384; GO:0062043; GO:0070168; GO:0070374; GO:0070986; GO:0071228; GO:0071372; GO:0071456; GO:0071944; GO:0072017; GO:0072044; GO:0072144; GO:0072538; GO:0090051; GO:0090090; GO:0097150; GO:0097400; GO:0098685; GO:0098839; GO:0098978; GO:0099565; GO:0120163; GO:0140537; GO:1901189; GO:1901201; GO:1902263; GO:1902339; GO:1903849; GO:2000048; GO:2000737; GO:2000811; GO:2000974; GO:2001027 animal organ regeneration [GO:0031100]; aortic valve morphogenesis [GO:0003180]; apoptotic process involved in embryonic digit morphogenesis [GO:1902263]; arterial endothelial cell differentiation [GO:0060842]; astrocyte differentiation [GO:0048708]; atrioventricular node development [GO:0003162]; atrioventricular valve morphogenesis [GO:0003181]; auditory receptor cell fate commitment [GO:0009912]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; branching morphogenesis of an epithelial tube [GO:0048754]; camera-type eye morphogenesis [GO:0048593]; cardiac atrium morphogenesis [GO:0003209]; cardiac chamber formation [GO:0003207]; cardiac epithelial to mesenchymal transition [GO:0060317]; cardiac left ventricle morphogenesis [GO:0003214]; cardiac muscle cell myoblast differentiation [GO:0060379]; cardiac muscle cell proliferation [GO:0060038]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac right atrium morphogenesis [GO:0003213]; cardiac right ventricle formation [GO:0003219]; cardiac septum morphogenesis [GO:0060411]; cardiac vascular smooth muscle cell development [GO:0060948]; cardiac ventricle morphogenesis [GO:0003208]; cell differentiation [GO:0030154]; cell differentiation in spinal cord [GO:0021515]; cell fate commitment [GO:0045165]; cell fate specification [GO:0001708]; cell migration involved in endocardial cushion formation [GO:0003273]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to hypoxia [GO:0071456]; cellular response to tumor cell [GO:0071228]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; chemical synaptic transmission, postsynaptic [GO:0099565]; cilium assembly [GO:0060271]; collecting duct development [GO:0072044]; compartment pattern specification [GO:0007386]; coronary artery morphogenesis [GO:0060982]; coronary sinus valve morphogenesis [GO:0003182]; coronary vein morphogenesis [GO:0003169]; determination of left/right symmetry [GO:0007368]; distal tubule development [GO:0072017]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic limb morphogenesis [GO:0030326]; endocardial cell differentiation [GO:0060956]; endocardial cushion development [GO:0003197]; endocardial cushion morphogenesis [GO:0003203]; endocardium development [GO:0003157]; endocardium morphogenesis [GO:0003160]; endoderm development [GO:0007492]; epidermis development [GO:0008544]; epithelial to mesenchymal transition [GO:0001837]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; forebrain development [GO:0030900]; foregut morphogenesis [GO:0007440]; gene expression [GO:0010467]; glial cell differentiation [GO:0010001]; glomerular mesangial cell development [GO:0072144]; growth involved in heart morphogenesis [GO:0003241]; hair follicle morphogenesis [GO:0031069]; heart development [GO:0007507]; heart looping [GO:0001947]; heart trabecula morphogenesis [GO:0061384]; homeostasis of number of cells within a tissue [GO:0048873]; humoral immune response [GO:0006959]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; interleukin-17-mediated signaling pathway [GO:0097400]; keratinocyte differentiation [GO:0030216]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; lung development [GO:0030324]; luteolysis [GO:0001554]; mesenchymal cell development [GO:0014031]; mitral valve formation [GO:0003192]; negative regulation of anoikis [GO:2000811]; negative regulation of biomineral tissue development [GO:0070168]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of catalytic activity [GO:0043086]; negative regulation of cell adhesion molecule production [GO:0060354]; negative regulation of cell differentiation [GO:0045596]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell proliferation involved in heart valve morphogenesis [GO:0003252]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of collagen biosynthetic process [GO:0032966]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of endothelial cell chemotaxis [GO:2001027]; negative regulation of extracellular matrix constituent secretion [GO:0003332]; negative regulation of gene expression [GO:0010629]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of inner ear auditory receptor cell differentiation [GO:0045608]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of ossification [GO:0030279]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of photoreceptor cell differentiation [GO:0046533]; negative regulation of pro-B cell differentiation [GO:2000974]; negative regulation of programmed cell death [GO:0043069]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural tube development [GO:0021915]; neuron differentiation [GO:0030182]; neuron fate commitment [GO:0048663]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; oligodendrocyte differentiation [GO:0048709]; osteoblast fate commitment [GO:0002051]; outflow tract morphogenesis [GO:0003151]; pericardium morphogenesis [GO:0003344]; positive regulation of aorta morphogenesis [GO:1903849]; positive regulation of apoptotic process [GO:0043065]; positive regulation of apoptotic process involved in morphogenesis [GO:1902339]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cardiac epithelial to mesenchymal transition [GO:0062043]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of ephrin receptor signaling pathway [GO:1901189]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of glial cell differentiation [GO:0045687]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of smooth muscle cell differentiation [GO:0051152]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription of Notch receptor target [GO:0007221]; positive regulation of viral genome replication [GO:0045070]; prostate gland epithelium morphogenesis [GO:0060740]; protein catabolic process [GO:0030163]; protein import into nucleus [GO:0006606]; pulmonary valve morphogenesis [GO:0003184]; regulation of cardioblast proliferation [GO:0003264]; regulation of cell adhesion involved in heart morphogenesis [GO:0061344]; regulation of cell migration [GO:0030334]; regulation of cell population proliferation [GO:0042127]; regulation of epithelial cell proliferation [GO:0050678]; regulation of epithelial cell proliferation involved in prostate gland development [GO:0060768]; regulation of extracellular matrix assembly [GO:1901201]; regulation of gene expression [GO:0010468]; regulation of inner ear auditory receptor cell differentiation [GO:0045607]; regulation of neurogenesis [GO:0050767]; regulation of Notch signaling pathway [GO:0008593]; regulation of somitogenesis [GO:0014807]; regulation of transcription by RNA polymerase II [GO:0006357]; response to lipopolysaccharide [GO:0032496]; response to muramyl dipeptide [GO:0032495]; secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development [GO:0060528]; skeletal muscle cell differentiation [GO:0035914]; somatic stem cell division [GO:0048103]; spermatogenesis [GO:0007283]; sprouting angiogenesis [GO:0002040]; T-helper 17 type immune response [GO:0072538]; tissue regeneration [GO:0042246]; tube formation [GO:0035148]; vasculogenesis involved in coronary vascular morphogenesis [GO:0060979]; venous blood vessel morphogenesis [GO:0048845]; venous endothelial cell differentiation [GO:0060843]; ventricular septum morphogenesis [GO:0060412]; ventricular trabecula myocardium morphogenesis [GO:0003222] acrosomal vesicle [GO:0001669]; adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell periphery [GO:0071944]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; lamellipodium [GO:0030027]; late endosome membrane [GO:0031902]; MAML1-RBP-Jkappa- ICN1 complex [GO:0002193]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; receptor complex [GO:0043235]; ruffle [GO:0001726]; Schaffer collateral - CA1 synapse [GO:0098685] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; identical protein binding [GO:0042802]; Notch binding [GO:0005112]; transcription coactivator activity [GO:0003713]; transcription regulator activator activity [GO:0140537]; transmembrane signaling receptor activity [GO:0004888] g256.t3 Q01705 35.89 1460 0.0 671.0 sp|Q01705|NOTC1_MOUSE Neurogenic locus notch homolog protein 1 OS=Mus musculus OX=10090 GN=Notch1 PE=1 SV=3 NOTC1_MOUSE reviewed Neurogenic locus notch homolog protein 1 (Notch 1) (Motch A) (mT14) (p300) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Mus musculus (Mouse) GO:0000122; GO:0000139; GO:0001554; GO:0001669; GO:0001701; GO:0001708; GO:0001726; GO:0001837; GO:0001889; GO:0001947; GO:0002040; GO:0002051; GO:0002052; GO:0002193; GO:0002437; GO:0003151; GO:0003157; GO:0003160; GO:0003162; GO:0003169; GO:0003180; GO:0003181; GO:0003182; GO:0003184; GO:0003192; GO:0003197; GO:0003198; GO:0003203; GO:0003207; GO:0003208; GO:0003209; GO:0003213; GO:0003214; GO:0003219; GO:0003222; GO:0003241; GO:0003252; GO:0003264; GO:0003273; GO:0003332; GO:0003344; GO:0003682; GO:0003713; GO:0004857; GO:0004888; GO:0005112; GO:0005509; GO:0005576; GO:0005634; GO:0005654; GO:0005737; GO:0005783; GO:0005789; GO:0005829; GO:0005856; GO:0005886; GO:0005912; GO:0006357; GO:0006606; GO:0006959; GO:0007219; GO:0007221; GO:0007283; GO:0007368; GO:0007386; GO:0007409; GO:0007411; GO:0007440; GO:0007492; GO:0007507; GO:0008284; GO:0008285; GO:0008544; GO:0008593; GO:0009912; GO:0009986; GO:0010001; GO:0010008; GO:0010467; GO:0010468; GO:0010614; GO:0010628; GO:0010629; GO:0010667; GO:0010718; GO:0010812; GO:0010832; GO:0014031; GO:0014807; GO:0016324; GO:0019899; GO:0021515; GO:0021915; GO:0030027; GO:0030154; GO:0030163; GO:0030182; GO:0030216; GO:0030279; GO:0030324; GO:0030326; GO:0030334; GO:0030335; GO:0030513; GO:0030514; GO:0030900; GO:0031069; GO:0031100; GO:0031410; GO:0031490; GO:0031902; GO:0032495; GO:0032496; GO:0032966; GO:0035116; GO:0035148; GO:0035914; GO:0035924; GO:0042127; GO:0042246; GO:0042802; GO:0043065; GO:0043069; GO:0043086; GO:0043235; GO:0045070; GO:0045165; GO:0045596; GO:0045603; GO:0045607; GO:0045608; GO:0045618; GO:0045662; GO:0045665; GO:0045668; GO:0045687; GO:0045747; GO:0045892; GO:0045893; GO:0045944; GO:0045955; GO:0046427; GO:0046533; GO:0046579; GO:0048103; GO:0048593; GO:0048663; GO:0048708; GO:0048709; GO:0048711; GO:0048715; GO:0048754; GO:0048845; GO:0048873; GO:0050678; GO:0050679; GO:0050767; GO:0050768; GO:0051152; GO:0055008; GO:0060038; GO:0060045; GO:0060253; GO:0060271; GO:0060317; GO:0060354; GO:0060379; GO:0060411; GO:0060412; GO:0060528; GO:0060740; GO:0060768; GO:0060842; GO:0060843; GO:0060948; GO:0060956; GO:0060979; GO:0060982; GO:0061344; GO:0061384; GO:0062043; GO:0070168; GO:0070374; GO:0070986; GO:0071228; GO:0071372; GO:0071456; GO:0071944; GO:0072017; GO:0072044; GO:0072144; GO:0072538; GO:0090051; GO:0090090; GO:0097150; GO:0097400; GO:0098685; GO:0098839; GO:0098978; GO:0099565; GO:0120163; GO:0140537; GO:1901189; GO:1901201; GO:1902263; GO:1902339; GO:1903849; GO:2000048; GO:2000737; GO:2000811; GO:2000974; GO:2001027 animal organ regeneration [GO:0031100]; aortic valve morphogenesis [GO:0003180]; apoptotic process involved in embryonic digit morphogenesis [GO:1902263]; arterial endothelial cell differentiation [GO:0060842]; astrocyte differentiation [GO:0048708]; atrioventricular node development [GO:0003162]; atrioventricular valve morphogenesis [GO:0003181]; auditory receptor cell fate commitment [GO:0009912]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; branching morphogenesis of an epithelial tube [GO:0048754]; camera-type eye morphogenesis [GO:0048593]; cardiac atrium morphogenesis [GO:0003209]; cardiac chamber formation [GO:0003207]; cardiac epithelial to mesenchymal transition [GO:0060317]; cardiac left ventricle morphogenesis [GO:0003214]; cardiac muscle cell myoblast differentiation [GO:0060379]; cardiac muscle cell proliferation [GO:0060038]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac right atrium morphogenesis [GO:0003213]; cardiac right ventricle formation [GO:0003219]; cardiac septum morphogenesis [GO:0060411]; cardiac vascular smooth muscle cell development [GO:0060948]; cardiac ventricle morphogenesis [GO:0003208]; cell differentiation [GO:0030154]; cell differentiation in spinal cord [GO:0021515]; cell fate commitment [GO:0045165]; cell fate specification [GO:0001708]; cell migration involved in endocardial cushion formation [GO:0003273]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to hypoxia [GO:0071456]; cellular response to tumor cell [GO:0071228]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; chemical synaptic transmission, postsynaptic [GO:0099565]; cilium assembly [GO:0060271]; collecting duct development [GO:0072044]; compartment pattern specification [GO:0007386]; coronary artery morphogenesis [GO:0060982]; coronary sinus valve morphogenesis [GO:0003182]; coronary vein morphogenesis [GO:0003169]; determination of left/right symmetry [GO:0007368]; distal tubule development [GO:0072017]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic limb morphogenesis [GO:0030326]; endocardial cell differentiation [GO:0060956]; endocardial cushion development [GO:0003197]; endocardial cushion morphogenesis [GO:0003203]; endocardium development [GO:0003157]; endocardium morphogenesis [GO:0003160]; endoderm development [GO:0007492]; epidermis development [GO:0008544]; epithelial to mesenchymal transition [GO:0001837]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; forebrain development [GO:0030900]; foregut morphogenesis [GO:0007440]; gene expression [GO:0010467]; glial cell differentiation [GO:0010001]; glomerular mesangial cell development [GO:0072144]; growth involved in heart morphogenesis [GO:0003241]; hair follicle morphogenesis [GO:0031069]; heart development [GO:0007507]; heart looping [GO:0001947]; heart trabecula morphogenesis [GO:0061384]; homeostasis of number of cells within a tissue [GO:0048873]; humoral immune response [GO:0006959]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; interleukin-17-mediated signaling pathway [GO:0097400]; keratinocyte differentiation [GO:0030216]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; lung development [GO:0030324]; luteolysis [GO:0001554]; mesenchymal cell development [GO:0014031]; mitral valve formation [GO:0003192]; negative regulation of anoikis [GO:2000811]; negative regulation of biomineral tissue development [GO:0070168]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of catalytic activity [GO:0043086]; negative regulation of cell adhesion molecule production [GO:0060354]; negative regulation of cell differentiation [GO:0045596]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell proliferation involved in heart valve morphogenesis [GO:0003252]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of collagen biosynthetic process [GO:0032966]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of endothelial cell chemotaxis [GO:2001027]; negative regulation of extracellular matrix constituent secretion [GO:0003332]; negative regulation of gene expression [GO:0010629]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of inner ear auditory receptor cell differentiation [GO:0045608]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of ossification [GO:0030279]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of photoreceptor cell differentiation [GO:0046533]; negative regulation of pro-B cell differentiation [GO:2000974]; negative regulation of programmed cell death [GO:0043069]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural tube development [GO:0021915]; neuron differentiation [GO:0030182]; neuron fate commitment [GO:0048663]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; oligodendrocyte differentiation [GO:0048709]; osteoblast fate commitment [GO:0002051]; outflow tract morphogenesis [GO:0003151]; pericardium morphogenesis [GO:0003344]; positive regulation of aorta morphogenesis [GO:1903849]; positive regulation of apoptotic process [GO:0043065]; positive regulation of apoptotic process involved in morphogenesis [GO:1902339]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cardiac epithelial to mesenchymal transition [GO:0062043]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of ephrin receptor signaling pathway [GO:1901189]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of glial cell differentiation [GO:0045687]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of smooth muscle cell differentiation [GO:0051152]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription of Notch receptor target [GO:0007221]; positive regulation of viral genome replication [GO:0045070]; prostate gland epithelium morphogenesis [GO:0060740]; protein catabolic process [GO:0030163]; protein import into nucleus [GO:0006606]; pulmonary valve morphogenesis [GO:0003184]; regulation of cardioblast proliferation [GO:0003264]; regulation of cell adhesion involved in heart morphogenesis [GO:0061344]; regulation of cell migration [GO:0030334]; regulation of cell population proliferation [GO:0042127]; regulation of epithelial cell proliferation [GO:0050678]; regulation of epithelial cell proliferation involved in prostate gland development [GO:0060768]; regulation of extracellular matrix assembly [GO:1901201]; regulation of gene expression [GO:0010468]; regulation of inner ear auditory receptor cell differentiation [GO:0045607]; regulation of neurogenesis [GO:0050767]; regulation of Notch signaling pathway [GO:0008593]; regulation of somitogenesis [GO:0014807]; regulation of transcription by RNA polymerase II [GO:0006357]; response to lipopolysaccharide [GO:0032496]; response to muramyl dipeptide [GO:0032495]; secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development [GO:0060528]; skeletal muscle cell differentiation [GO:0035914]; somatic stem cell division [GO:0048103]; spermatogenesis [GO:0007283]; sprouting angiogenesis [GO:0002040]; T-helper 17 type immune response [GO:0072538]; tissue regeneration [GO:0042246]; tube formation [GO:0035148]; vasculogenesis involved in coronary vascular morphogenesis [GO:0060979]; venous blood vessel morphogenesis [GO:0048845]; venous endothelial cell differentiation [GO:0060843]; ventricular septum morphogenesis [GO:0060412]; ventricular trabecula myocardium morphogenesis [GO:0003222] acrosomal vesicle [GO:0001669]; adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell periphery [GO:0071944]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; lamellipodium [GO:0030027]; late endosome membrane [GO:0031902]; MAML1-RBP-Jkappa- ICN1 complex [GO:0002193]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; receptor complex [GO:0043235]; ruffle [GO:0001726]; Schaffer collateral - CA1 synapse [GO:0098685] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; identical protein binding [GO:0042802]; Notch binding [GO:0005112]; transcription coactivator activity [GO:0003713]; transcription regulator activator activity [GO:0140537]; transmembrane signaling receptor activity [GO:0004888] g256.t3 Q01705 35.209 1457 0.0 654.0 sp|Q01705|NOTC1_MOUSE Neurogenic locus notch homolog protein 1 OS=Mus musculus OX=10090 GN=Notch1 PE=1 SV=3 NOTC1_MOUSE reviewed Neurogenic locus notch homolog protein 1 (Notch 1) (Motch A) (mT14) (p300) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Mus musculus (Mouse) GO:0000122; GO:0000139; GO:0001554; GO:0001669; GO:0001701; GO:0001708; GO:0001726; GO:0001837; GO:0001889; GO:0001947; GO:0002040; GO:0002051; GO:0002052; GO:0002193; GO:0002437; GO:0003151; GO:0003157; GO:0003160; GO:0003162; GO:0003169; GO:0003180; GO:0003181; GO:0003182; GO:0003184; GO:0003192; GO:0003197; GO:0003198; GO:0003203; GO:0003207; GO:0003208; GO:0003209; GO:0003213; GO:0003214; GO:0003219; GO:0003222; GO:0003241; GO:0003252; GO:0003264; GO:0003273; GO:0003332; GO:0003344; GO:0003682; GO:0003713; GO:0004857; GO:0004888; GO:0005112; GO:0005509; GO:0005576; GO:0005634; GO:0005654; GO:0005737; GO:0005783; GO:0005789; GO:0005829; GO:0005856; GO:0005886; GO:0005912; GO:0006357; GO:0006606; GO:0006959; GO:0007219; GO:0007221; GO:0007283; GO:0007368; GO:0007386; GO:0007409; GO:0007411; GO:0007440; GO:0007492; GO:0007507; GO:0008284; GO:0008285; GO:0008544; GO:0008593; GO:0009912; GO:0009986; GO:0010001; GO:0010008; GO:0010467; GO:0010468; GO:0010614; GO:0010628; GO:0010629; GO:0010667; GO:0010718; GO:0010812; GO:0010832; GO:0014031; GO:0014807; GO:0016324; GO:0019899; GO:0021515; GO:0021915; GO:0030027; GO:0030154; GO:0030163; GO:0030182; GO:0030216; GO:0030279; GO:0030324; GO:0030326; GO:0030334; GO:0030335; GO:0030513; GO:0030514; GO:0030900; GO:0031069; GO:0031100; GO:0031410; GO:0031490; GO:0031902; GO:0032495; GO:0032496; GO:0032966; GO:0035116; GO:0035148; GO:0035914; GO:0035924; GO:0042127; GO:0042246; GO:0042802; GO:0043065; GO:0043069; GO:0043086; GO:0043235; GO:0045070; GO:0045165; GO:0045596; GO:0045603; GO:0045607; GO:0045608; GO:0045618; GO:0045662; GO:0045665; GO:0045668; GO:0045687; GO:0045747; GO:0045892; GO:0045893; GO:0045944; GO:0045955; GO:0046427; GO:0046533; GO:0046579; GO:0048103; GO:0048593; GO:0048663; GO:0048708; GO:0048709; GO:0048711; GO:0048715; GO:0048754; GO:0048845; GO:0048873; GO:0050678; GO:0050679; GO:0050767; GO:0050768; GO:0051152; GO:0055008; GO:0060038; GO:0060045; GO:0060253; GO:0060271; GO:0060317; GO:0060354; GO:0060379; GO:0060411; GO:0060412; GO:0060528; GO:0060740; GO:0060768; GO:0060842; GO:0060843; GO:0060948; GO:0060956; GO:0060979; GO:0060982; GO:0061344; GO:0061384; GO:0062043; GO:0070168; GO:0070374; GO:0070986; GO:0071228; GO:0071372; GO:0071456; GO:0071944; GO:0072017; GO:0072044; GO:0072144; GO:0072538; GO:0090051; GO:0090090; GO:0097150; GO:0097400; GO:0098685; GO:0098839; GO:0098978; GO:0099565; GO:0120163; GO:0140537; GO:1901189; GO:1901201; GO:1902263; GO:1902339; GO:1903849; GO:2000048; GO:2000737; GO:2000811; GO:2000974; GO:2001027 animal organ regeneration [GO:0031100]; aortic valve morphogenesis [GO:0003180]; apoptotic process involved in embryonic digit morphogenesis [GO:1902263]; arterial endothelial cell differentiation [GO:0060842]; astrocyte differentiation [GO:0048708]; atrioventricular node development [GO:0003162]; atrioventricular valve morphogenesis [GO:0003181]; auditory receptor cell fate commitment [GO:0009912]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; branching morphogenesis of an epithelial tube [GO:0048754]; camera-type eye morphogenesis [GO:0048593]; cardiac atrium morphogenesis [GO:0003209]; cardiac chamber formation [GO:0003207]; cardiac epithelial to mesenchymal transition [GO:0060317]; cardiac left ventricle morphogenesis [GO:0003214]; cardiac muscle cell myoblast differentiation [GO:0060379]; cardiac muscle cell proliferation [GO:0060038]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac right atrium morphogenesis [GO:0003213]; cardiac right ventricle formation [GO:0003219]; cardiac septum morphogenesis [GO:0060411]; cardiac vascular smooth muscle cell development [GO:0060948]; cardiac ventricle morphogenesis [GO:0003208]; cell differentiation [GO:0030154]; cell differentiation in spinal cord [GO:0021515]; cell fate commitment [GO:0045165]; cell fate specification [GO:0001708]; cell migration involved in endocardial cushion formation [GO:0003273]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to hypoxia [GO:0071456]; cellular response to tumor cell [GO:0071228]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; chemical synaptic transmission, postsynaptic [GO:0099565]; cilium assembly [GO:0060271]; collecting duct development [GO:0072044]; compartment pattern specification [GO:0007386]; coronary artery morphogenesis [GO:0060982]; coronary sinus valve morphogenesis [GO:0003182]; coronary vein morphogenesis [GO:0003169]; determination of left/right symmetry [GO:0007368]; distal tubule development [GO:0072017]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic limb morphogenesis [GO:0030326]; endocardial cell differentiation [GO:0060956]; endocardial cushion development [GO:0003197]; endocardial cushion morphogenesis [GO:0003203]; endocardium development [GO:0003157]; endocardium morphogenesis [GO:0003160]; endoderm development [GO:0007492]; epidermis development [GO:0008544]; epithelial to mesenchymal transition [GO:0001837]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; forebrain development [GO:0030900]; foregut morphogenesis [GO:0007440]; gene expression [GO:0010467]; glial cell differentiation [GO:0010001]; glomerular mesangial cell development [GO:0072144]; growth involved in heart morphogenesis [GO:0003241]; hair follicle morphogenesis [GO:0031069]; heart development [GO:0007507]; heart looping [GO:0001947]; heart trabecula morphogenesis [GO:0061384]; homeostasis of number of cells within a tissue [GO:0048873]; humoral immune response [GO:0006959]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; interleukin-17-mediated signaling pathway [GO:0097400]; keratinocyte differentiation [GO:0030216]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; lung development [GO:0030324]; luteolysis [GO:0001554]; mesenchymal cell development [GO:0014031]; mitral valve formation [GO:0003192]; negative regulation of anoikis [GO:2000811]; negative regulation of biomineral tissue development [GO:0070168]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of catalytic activity [GO:0043086]; negative regulation of cell adhesion molecule production [GO:0060354]; negative regulation of cell differentiation [GO:0045596]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell proliferation involved in heart valve morphogenesis [GO:0003252]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of collagen biosynthetic process [GO:0032966]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of endothelial cell chemotaxis [GO:2001027]; negative regulation of extracellular matrix constituent secretion [GO:0003332]; negative regulation of gene expression [GO:0010629]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of inner ear auditory receptor cell differentiation [GO:0045608]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of ossification [GO:0030279]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of photoreceptor cell differentiation [GO:0046533]; negative regulation of pro-B cell differentiation [GO:2000974]; negative regulation of programmed cell death [GO:0043069]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural tube development [GO:0021915]; neuron differentiation [GO:0030182]; neuron fate commitment [GO:0048663]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; oligodendrocyte differentiation [GO:0048709]; osteoblast fate commitment [GO:0002051]; outflow tract morphogenesis [GO:0003151]; pericardium morphogenesis [GO:0003344]; positive regulation of aorta morphogenesis [GO:1903849]; positive regulation of apoptotic process [GO:0043065]; positive regulation of apoptotic process involved in morphogenesis [GO:1902339]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cardiac epithelial to mesenchymal transition [GO:0062043]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of ephrin receptor signaling pathway [GO:1901189]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of glial cell differentiation [GO:0045687]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of smooth muscle cell differentiation [GO:0051152]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription of Notch receptor target [GO:0007221]; positive regulation of viral genome replication [GO:0045070]; prostate gland epithelium morphogenesis [GO:0060740]; protein catabolic process [GO:0030163]; protein import into nucleus [GO:0006606]; pulmonary valve morphogenesis [GO:0003184]; regulation of cardioblast proliferation [GO:0003264]; regulation of cell adhesion involved in heart morphogenesis [GO:0061344]; regulation of cell migration [GO:0030334]; regulation of cell population proliferation [GO:0042127]; regulation of epithelial cell proliferation [GO:0050678]; regulation of epithelial cell proliferation involved in prostate gland development [GO:0060768]; regulation of extracellular matrix assembly [GO:1901201]; regulation of gene expression [GO:0010468]; regulation of inner ear auditory receptor cell differentiation [GO:0045607]; regulation of neurogenesis [GO:0050767]; regulation of Notch signaling pathway [GO:0008593]; regulation of somitogenesis [GO:0014807]; regulation of transcription by RNA polymerase II [GO:0006357]; response to lipopolysaccharide [GO:0032496]; response to muramyl dipeptide [GO:0032495]; secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development [GO:0060528]; skeletal muscle cell differentiation [GO:0035914]; somatic stem cell division [GO:0048103]; spermatogenesis [GO:0007283]; sprouting angiogenesis [GO:0002040]; T-helper 17 type immune response [GO:0072538]; tissue regeneration [GO:0042246]; tube formation [GO:0035148]; vasculogenesis involved in coronary vascular morphogenesis [GO:0060979]; venous blood vessel morphogenesis [GO:0048845]; venous endothelial cell differentiation [GO:0060843]; ventricular septum morphogenesis [GO:0060412]; ventricular trabecula myocardium morphogenesis [GO:0003222] acrosomal vesicle [GO:0001669]; adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell periphery [GO:0071944]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; lamellipodium [GO:0030027]; late endosome membrane [GO:0031902]; MAML1-RBP-Jkappa- ICN1 complex [GO:0002193]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; receptor complex [GO:0043235]; ruffle [GO:0001726]; Schaffer collateral - CA1 synapse [GO:0098685] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; identical protein binding [GO:0042802]; Notch binding [GO:0005112]; transcription coactivator activity [GO:0003713]; transcription regulator activator activity [GO:0140537]; transmembrane signaling receptor activity [GO:0004888] g256.t3 Q01705 34.981 1598 0.0 653.0 sp|Q01705|NOTC1_MOUSE Neurogenic locus notch homolog protein 1 OS=Mus musculus OX=10090 GN=Notch1 PE=1 SV=3 NOTC1_MOUSE reviewed Neurogenic locus notch homolog protein 1 (Notch 1) (Motch A) (mT14) (p300) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Mus musculus (Mouse) GO:0000122; GO:0000139; GO:0001554; GO:0001669; GO:0001701; GO:0001708; GO:0001726; GO:0001837; GO:0001889; GO:0001947; GO:0002040; GO:0002051; GO:0002052; GO:0002193; GO:0002437; GO:0003151; GO:0003157; GO:0003160; GO:0003162; GO:0003169; GO:0003180; GO:0003181; GO:0003182; GO:0003184; GO:0003192; GO:0003197; GO:0003198; GO:0003203; GO:0003207; GO:0003208; GO:0003209; GO:0003213; GO:0003214; GO:0003219; GO:0003222; GO:0003241; GO:0003252; GO:0003264; GO:0003273; GO:0003332; GO:0003344; GO:0003682; GO:0003713; GO:0004857; GO:0004888; GO:0005112; GO:0005509; GO:0005576; GO:0005634; GO:0005654; GO:0005737; GO:0005783; GO:0005789; GO:0005829; GO:0005856; GO:0005886; GO:0005912; GO:0006357; GO:0006606; GO:0006959; GO:0007219; GO:0007221; GO:0007283; GO:0007368; GO:0007386; GO:0007409; GO:0007411; GO:0007440; GO:0007492; GO:0007507; GO:0008284; GO:0008285; GO:0008544; GO:0008593; GO:0009912; GO:0009986; GO:0010001; GO:0010008; GO:0010467; GO:0010468; GO:0010614; GO:0010628; GO:0010629; GO:0010667; GO:0010718; GO:0010812; GO:0010832; GO:0014031; GO:0014807; GO:0016324; GO:0019899; GO:0021515; GO:0021915; GO:0030027; GO:0030154; GO:0030163; GO:0030182; GO:0030216; GO:0030279; GO:0030324; GO:0030326; GO:0030334; GO:0030335; GO:0030513; GO:0030514; GO:0030900; GO:0031069; GO:0031100; GO:0031410; GO:0031490; GO:0031902; GO:0032495; GO:0032496; GO:0032966; GO:0035116; GO:0035148; GO:0035914; GO:0035924; GO:0042127; GO:0042246; GO:0042802; GO:0043065; GO:0043069; GO:0043086; GO:0043235; GO:0045070; GO:0045165; GO:0045596; GO:0045603; GO:0045607; GO:0045608; GO:0045618; GO:0045662; GO:0045665; GO:0045668; GO:0045687; GO:0045747; GO:0045892; GO:0045893; GO:0045944; GO:0045955; GO:0046427; GO:0046533; GO:0046579; GO:0048103; GO:0048593; GO:0048663; GO:0048708; GO:0048709; GO:0048711; GO:0048715; GO:0048754; GO:0048845; GO:0048873; GO:0050678; GO:0050679; GO:0050767; GO:0050768; GO:0051152; GO:0055008; GO:0060038; GO:0060045; GO:0060253; GO:0060271; GO:0060317; GO:0060354; GO:0060379; GO:0060411; GO:0060412; GO:0060528; GO:0060740; GO:0060768; GO:0060842; GO:0060843; GO:0060948; GO:0060956; GO:0060979; GO:0060982; GO:0061344; GO:0061384; GO:0062043; GO:0070168; GO:0070374; GO:0070986; GO:0071228; GO:0071372; GO:0071456; GO:0071944; GO:0072017; GO:0072044; GO:0072144; GO:0072538; GO:0090051; GO:0090090; GO:0097150; GO:0097400; GO:0098685; GO:0098839; GO:0098978; GO:0099565; GO:0120163; GO:0140537; GO:1901189; GO:1901201; GO:1902263; GO:1902339; GO:1903849; GO:2000048; GO:2000737; GO:2000811; GO:2000974; GO:2001027 animal organ regeneration [GO:0031100]; aortic valve morphogenesis [GO:0003180]; apoptotic process involved in embryonic digit morphogenesis [GO:1902263]; arterial endothelial cell differentiation [GO:0060842]; astrocyte differentiation [GO:0048708]; atrioventricular node development [GO:0003162]; atrioventricular valve morphogenesis [GO:0003181]; auditory receptor cell fate commitment [GO:0009912]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; branching morphogenesis of an epithelial tube [GO:0048754]; camera-type eye morphogenesis [GO:0048593]; cardiac atrium morphogenesis [GO:0003209]; cardiac chamber formation [GO:0003207]; cardiac epithelial to mesenchymal transition [GO:0060317]; cardiac left ventricle morphogenesis [GO:0003214]; cardiac muscle cell myoblast differentiation [GO:0060379]; cardiac muscle cell proliferation [GO:0060038]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac right atrium morphogenesis [GO:0003213]; cardiac right ventricle formation [GO:0003219]; cardiac septum morphogenesis [GO:0060411]; cardiac vascular smooth muscle cell development [GO:0060948]; cardiac ventricle morphogenesis [GO:0003208]; cell differentiation [GO:0030154]; cell differentiation in spinal cord [GO:0021515]; cell fate commitment [GO:0045165]; cell fate specification [GO:0001708]; cell migration involved in endocardial cushion formation [GO:0003273]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to hypoxia [GO:0071456]; cellular response to tumor cell [GO:0071228]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; chemical synaptic transmission, postsynaptic [GO:0099565]; cilium assembly [GO:0060271]; collecting duct development [GO:0072044]; compartment pattern specification [GO:0007386]; coronary artery morphogenesis [GO:0060982]; coronary sinus valve morphogenesis [GO:0003182]; coronary vein morphogenesis [GO:0003169]; determination of left/right symmetry [GO:0007368]; distal tubule development [GO:0072017]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic limb morphogenesis [GO:0030326]; endocardial cell differentiation [GO:0060956]; endocardial cushion development [GO:0003197]; endocardial cushion morphogenesis [GO:0003203]; endocardium development [GO:0003157]; endocardium morphogenesis [GO:0003160]; endoderm development [GO:0007492]; epidermis development [GO:0008544]; epithelial to mesenchymal transition [GO:0001837]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; forebrain development [GO:0030900]; foregut morphogenesis [GO:0007440]; gene expression [GO:0010467]; glial cell differentiation [GO:0010001]; glomerular mesangial cell development [GO:0072144]; growth involved in heart morphogenesis [GO:0003241]; hair follicle morphogenesis [GO:0031069]; heart development [GO:0007507]; heart looping [GO:0001947]; heart trabecula morphogenesis [GO:0061384]; homeostasis of number of cells within a tissue [GO:0048873]; humoral immune response [GO:0006959]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; interleukin-17-mediated signaling pathway [GO:0097400]; keratinocyte differentiation [GO:0030216]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; lung development [GO:0030324]; luteolysis [GO:0001554]; mesenchymal cell development [GO:0014031]; mitral valve formation [GO:0003192]; negative regulation of anoikis [GO:2000811]; negative regulation of biomineral tissue development [GO:0070168]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of catalytic activity [GO:0043086]; negative regulation of cell adhesion molecule production [GO:0060354]; negative regulation of cell differentiation [GO:0045596]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell proliferation involved in heart valve morphogenesis [GO:0003252]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of collagen biosynthetic process [GO:0032966]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of endothelial cell chemotaxis [GO:2001027]; negative regulation of extracellular matrix constituent secretion [GO:0003332]; negative regulation of gene expression [GO:0010629]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of inner ear auditory receptor cell differentiation [GO:0045608]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of ossification [GO:0030279]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of photoreceptor cell differentiation [GO:0046533]; negative regulation of pro-B cell differentiation [GO:2000974]; negative regulation of programmed cell death [GO:0043069]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural tube development [GO:0021915]; neuron differentiation [GO:0030182]; neuron fate commitment [GO:0048663]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; oligodendrocyte differentiation [GO:0048709]; osteoblast fate commitment [GO:0002051]; outflow tract morphogenesis [GO:0003151]; pericardium morphogenesis [GO:0003344]; positive regulation of aorta morphogenesis [GO:1903849]; positive regulation of apoptotic process [GO:0043065]; positive regulation of apoptotic process involved in morphogenesis [GO:1902339]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cardiac epithelial to mesenchymal transition [GO:0062043]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of ephrin receptor signaling pathway [GO:1901189]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of glial cell differentiation [GO:0045687]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of smooth muscle cell differentiation [GO:0051152]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription of Notch receptor target [GO:0007221]; positive regulation of viral genome replication [GO:0045070]; prostate gland epithelium morphogenesis [GO:0060740]; protein catabolic process [GO:0030163]; protein import into nucleus [GO:0006606]; pulmonary valve morphogenesis [GO:0003184]; regulation of cardioblast proliferation [GO:0003264]; regulation of cell adhesion involved in heart morphogenesis [GO:0061344]; regulation of cell migration [GO:0030334]; regulation of cell population proliferation [GO:0042127]; regulation of epithelial cell proliferation [GO:0050678]; regulation of epithelial cell proliferation involved in prostate gland development [GO:0060768]; regulation of extracellular matrix assembly [GO:1901201]; regulation of gene expression [GO:0010468]; regulation of inner ear auditory receptor cell differentiation [GO:0045607]; regulation of neurogenesis [GO:0050767]; regulation of Notch signaling pathway [GO:0008593]; regulation of somitogenesis [GO:0014807]; regulation of transcription by RNA polymerase II [GO:0006357]; response to lipopolysaccharide [GO:0032496]; response to muramyl dipeptide [GO:0032495]; secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development [GO:0060528]; skeletal muscle cell differentiation [GO:0035914]; somatic stem cell division [GO:0048103]; spermatogenesis [GO:0007283]; sprouting angiogenesis [GO:0002040]; T-helper 17 type immune response [GO:0072538]; tissue regeneration [GO:0042246]; tube formation [GO:0035148]; vasculogenesis involved in coronary vascular morphogenesis [GO:0060979]; venous blood vessel morphogenesis [GO:0048845]; venous endothelial cell differentiation [GO:0060843]; ventricular septum morphogenesis [GO:0060412]; ventricular trabecula myocardium morphogenesis [GO:0003222] acrosomal vesicle [GO:0001669]; adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell periphery [GO:0071944]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; lamellipodium [GO:0030027]; late endosome membrane [GO:0031902]; MAML1-RBP-Jkappa- ICN1 complex [GO:0002193]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; receptor complex [GO:0043235]; ruffle [GO:0001726]; Schaffer collateral - CA1 synapse [GO:0098685] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; identical protein binding [GO:0042802]; Notch binding [GO:0005112]; transcription coactivator activity [GO:0003713]; transcription regulator activator activity [GO:0140537]; transmembrane signaling receptor activity [GO:0004888] g256.t3 Q01705 35.784 1442 0.0 642.0 sp|Q01705|NOTC1_MOUSE Neurogenic locus notch homolog protein 1 OS=Mus musculus OX=10090 GN=Notch1 PE=1 SV=3 NOTC1_MOUSE reviewed Neurogenic locus notch homolog protein 1 (Notch 1) (Motch A) (mT14) (p300) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Mus musculus (Mouse) GO:0000122; GO:0000139; GO:0001554; GO:0001669; GO:0001701; GO:0001708; GO:0001726; GO:0001837; GO:0001889; GO:0001947; GO:0002040; GO:0002051; GO:0002052; GO:0002193; GO:0002437; GO:0003151; GO:0003157; GO:0003160; GO:0003162; GO:0003169; GO:0003180; GO:0003181; GO:0003182; GO:0003184; GO:0003192; GO:0003197; GO:0003198; GO:0003203; GO:0003207; GO:0003208; GO:0003209; GO:0003213; GO:0003214; GO:0003219; GO:0003222; GO:0003241; GO:0003252; GO:0003264; GO:0003273; GO:0003332; GO:0003344; GO:0003682; GO:0003713; GO:0004857; GO:0004888; GO:0005112; GO:0005509; GO:0005576; GO:0005634; GO:0005654; GO:0005737; GO:0005783; GO:0005789; GO:0005829; GO:0005856; GO:0005886; GO:0005912; GO:0006357; GO:0006606; GO:0006959; GO:0007219; GO:0007221; GO:0007283; GO:0007368; GO:0007386; GO:0007409; GO:0007411; GO:0007440; GO:0007492; GO:0007507; GO:0008284; GO:0008285; GO:0008544; GO:0008593; GO:0009912; GO:0009986; GO:0010001; GO:0010008; GO:0010467; GO:0010468; GO:0010614; GO:0010628; GO:0010629; GO:0010667; GO:0010718; GO:0010812; GO:0010832; GO:0014031; GO:0014807; GO:0016324; GO:0019899; GO:0021515; GO:0021915; GO:0030027; GO:0030154; GO:0030163; GO:0030182; GO:0030216; GO:0030279; GO:0030324; GO:0030326; GO:0030334; GO:0030335; GO:0030513; GO:0030514; GO:0030900; GO:0031069; GO:0031100; GO:0031410; GO:0031490; GO:0031902; GO:0032495; GO:0032496; GO:0032966; GO:0035116; GO:0035148; GO:0035914; GO:0035924; GO:0042127; GO:0042246; GO:0042802; GO:0043065; GO:0043069; GO:0043086; GO:0043235; GO:0045070; GO:0045165; GO:0045596; GO:0045603; GO:0045607; GO:0045608; GO:0045618; GO:0045662; GO:0045665; GO:0045668; GO:0045687; GO:0045747; GO:0045892; GO:0045893; GO:0045944; GO:0045955; GO:0046427; GO:0046533; GO:0046579; GO:0048103; GO:0048593; GO:0048663; GO:0048708; GO:0048709; GO:0048711; GO:0048715; GO:0048754; GO:0048845; GO:0048873; GO:0050678; GO:0050679; GO:0050767; GO:0050768; GO:0051152; GO:0055008; GO:0060038; GO:0060045; GO:0060253; GO:0060271; GO:0060317; GO:0060354; GO:0060379; GO:0060411; GO:0060412; GO:0060528; GO:0060740; GO:0060768; GO:0060842; GO:0060843; GO:0060948; GO:0060956; GO:0060979; GO:0060982; GO:0061344; GO:0061384; GO:0062043; GO:0070168; GO:0070374; GO:0070986; GO:0071228; GO:0071372; GO:0071456; GO:0071944; GO:0072017; GO:0072044; GO:0072144; GO:0072538; GO:0090051; GO:0090090; GO:0097150; GO:0097400; GO:0098685; GO:0098839; GO:0098978; GO:0099565; GO:0120163; GO:0140537; GO:1901189; GO:1901201; GO:1902263; GO:1902339; GO:1903849; GO:2000048; GO:2000737; GO:2000811; GO:2000974; GO:2001027 animal organ regeneration [GO:0031100]; aortic valve morphogenesis [GO:0003180]; apoptotic process involved in embryonic digit morphogenesis [GO:1902263]; arterial endothelial cell differentiation [GO:0060842]; astrocyte differentiation [GO:0048708]; atrioventricular node development [GO:0003162]; atrioventricular valve morphogenesis [GO:0003181]; auditory receptor cell fate commitment [GO:0009912]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; branching morphogenesis of an epithelial tube [GO:0048754]; camera-type eye morphogenesis [GO:0048593]; cardiac atrium morphogenesis [GO:0003209]; cardiac chamber formation [GO:0003207]; cardiac epithelial to mesenchymal transition [GO:0060317]; cardiac left ventricle morphogenesis [GO:0003214]; cardiac muscle cell myoblast differentiation [GO:0060379]; cardiac muscle cell proliferation [GO:0060038]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac right atrium morphogenesis [GO:0003213]; cardiac right ventricle formation [GO:0003219]; cardiac septum morphogenesis [GO:0060411]; cardiac vascular smooth muscle cell development [GO:0060948]; cardiac ventricle morphogenesis [GO:0003208]; cell differentiation [GO:0030154]; cell differentiation in spinal cord [GO:0021515]; cell fate commitment [GO:0045165]; cell fate specification [GO:0001708]; cell migration involved in endocardial cushion formation [GO:0003273]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to hypoxia [GO:0071456]; cellular response to tumor cell [GO:0071228]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; chemical synaptic transmission, postsynaptic [GO:0099565]; cilium assembly [GO:0060271]; collecting duct development [GO:0072044]; compartment pattern specification [GO:0007386]; coronary artery morphogenesis [GO:0060982]; coronary sinus valve morphogenesis [GO:0003182]; coronary vein morphogenesis [GO:0003169]; determination of left/right symmetry [GO:0007368]; distal tubule development [GO:0072017]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic limb morphogenesis [GO:0030326]; endocardial cell differentiation [GO:0060956]; endocardial cushion development [GO:0003197]; endocardial cushion morphogenesis [GO:0003203]; endocardium development [GO:0003157]; endocardium morphogenesis [GO:0003160]; endoderm development [GO:0007492]; epidermis development [GO:0008544]; epithelial to mesenchymal transition [GO:0001837]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; forebrain development [GO:0030900]; foregut morphogenesis [GO:0007440]; gene expression [GO:0010467]; glial cell differentiation [GO:0010001]; glomerular mesangial cell development [GO:0072144]; growth involved in heart morphogenesis [GO:0003241]; hair follicle morphogenesis [GO:0031069]; heart development [GO:0007507]; heart looping [GO:0001947]; heart trabecula morphogenesis [GO:0061384]; homeostasis of number of cells within a tissue [GO:0048873]; humoral immune response [GO:0006959]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; interleukin-17-mediated signaling pathway [GO:0097400]; keratinocyte differentiation [GO:0030216]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; lung development [GO:0030324]; luteolysis [GO:0001554]; mesenchymal cell development [GO:0014031]; mitral valve formation [GO:0003192]; negative regulation of anoikis [GO:2000811]; negative regulation of biomineral tissue development [GO:0070168]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of catalytic activity [GO:0043086]; negative regulation of cell adhesion molecule production [GO:0060354]; negative regulation of cell differentiation [GO:0045596]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell proliferation involved in heart valve morphogenesis [GO:0003252]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of collagen biosynthetic process [GO:0032966]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of endothelial cell chemotaxis [GO:2001027]; negative regulation of extracellular matrix constituent secretion [GO:0003332]; negative regulation of gene expression [GO:0010629]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of inner ear auditory receptor cell differentiation [GO:0045608]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of ossification [GO:0030279]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of photoreceptor cell differentiation [GO:0046533]; negative regulation of pro-B cell differentiation [GO:2000974]; negative regulation of programmed cell death [GO:0043069]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural tube development [GO:0021915]; neuron differentiation [GO:0030182]; neuron fate commitment [GO:0048663]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; oligodendrocyte differentiation [GO:0048709]; osteoblast fate commitment [GO:0002051]; outflow tract morphogenesis [GO:0003151]; pericardium morphogenesis [GO:0003344]; positive regulation of aorta morphogenesis [GO:1903849]; positive regulation of apoptotic process [GO:0043065]; positive regulation of apoptotic process involved in morphogenesis [GO:1902339]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cardiac epithelial to mesenchymal transition [GO:0062043]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of ephrin receptor signaling pathway [GO:1901189]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of glial cell differentiation [GO:0045687]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of smooth muscle cell differentiation [GO:0051152]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription of Notch receptor target [GO:0007221]; positive regulation of viral genome replication [GO:0045070]; prostate gland epithelium morphogenesis [GO:0060740]; protein catabolic process [GO:0030163]; protein import into nucleus [GO:0006606]; pulmonary valve morphogenesis [GO:0003184]; regulation of cardioblast proliferation [GO:0003264]; regulation of cell adhesion involved in heart morphogenesis [GO:0061344]; regulation of cell migration [GO:0030334]; regulation of cell population proliferation [GO:0042127]; regulation of epithelial cell proliferation [GO:0050678]; regulation of epithelial cell proliferation involved in prostate gland development [GO:0060768]; regulation of extracellular matrix assembly [GO:1901201]; regulation of gene expression [GO:0010468]; regulation of inner ear auditory receptor cell differentiation [GO:0045607]; regulation of neurogenesis [GO:0050767]; regulation of Notch signaling pathway [GO:0008593]; regulation of somitogenesis [GO:0014807]; regulation of transcription by RNA polymerase II [GO:0006357]; response to lipopolysaccharide [GO:0032496]; response to muramyl dipeptide [GO:0032495]; secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development [GO:0060528]; skeletal muscle cell differentiation [GO:0035914]; somatic stem cell division [GO:0048103]; spermatogenesis [GO:0007283]; sprouting angiogenesis [GO:0002040]; T-helper 17 type immune response [GO:0072538]; tissue regeneration [GO:0042246]; tube formation [GO:0035148]; vasculogenesis involved in coronary vascular morphogenesis [GO:0060979]; venous blood vessel morphogenesis [GO:0048845]; venous endothelial cell differentiation [GO:0060843]; ventricular septum morphogenesis [GO:0060412]; ventricular trabecula myocardium morphogenesis [GO:0003222] acrosomal vesicle [GO:0001669]; adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell periphery [GO:0071944]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; lamellipodium [GO:0030027]; late endosome membrane [GO:0031902]; MAML1-RBP-Jkappa- ICN1 complex [GO:0002193]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; receptor complex [GO:0043235]; ruffle [GO:0001726]; Schaffer collateral - CA1 synapse [GO:0098685] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; identical protein binding [GO:0042802]; Notch binding [GO:0005112]; transcription coactivator activity [GO:0003713]; transcription regulator activator activity [GO:0140537]; transmembrane signaling receptor activity [GO:0004888] g256.t3 Q01705 35.749 1449 0.0 633.0 sp|Q01705|NOTC1_MOUSE Neurogenic locus notch homolog protein 1 OS=Mus musculus OX=10090 GN=Notch1 PE=1 SV=3 NOTC1_MOUSE reviewed Neurogenic locus notch homolog protein 1 (Notch 1) (Motch A) (mT14) (p300) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Mus musculus (Mouse) GO:0000122; GO:0000139; GO:0001554; GO:0001669; GO:0001701; GO:0001708; GO:0001726; GO:0001837; GO:0001889; GO:0001947; GO:0002040; GO:0002051; GO:0002052; GO:0002193; GO:0002437; GO:0003151; GO:0003157; GO:0003160; GO:0003162; GO:0003169; GO:0003180; GO:0003181; GO:0003182; GO:0003184; GO:0003192; GO:0003197; GO:0003198; GO:0003203; GO:0003207; GO:0003208; GO:0003209; GO:0003213; GO:0003214; GO:0003219; GO:0003222; GO:0003241; GO:0003252; GO:0003264; GO:0003273; GO:0003332; GO:0003344; GO:0003682; GO:0003713; GO:0004857; GO:0004888; GO:0005112; GO:0005509; GO:0005576; GO:0005634; GO:0005654; GO:0005737; GO:0005783; GO:0005789; GO:0005829; GO:0005856; GO:0005886; GO:0005912; GO:0006357; GO:0006606; GO:0006959; GO:0007219; GO:0007221; GO:0007283; GO:0007368; GO:0007386; GO:0007409; GO:0007411; GO:0007440; GO:0007492; GO:0007507; GO:0008284; GO:0008285; GO:0008544; GO:0008593; GO:0009912; GO:0009986; GO:0010001; GO:0010008; GO:0010467; GO:0010468; GO:0010614; GO:0010628; GO:0010629; GO:0010667; GO:0010718; GO:0010812; GO:0010832; GO:0014031; GO:0014807; GO:0016324; GO:0019899; GO:0021515; GO:0021915; GO:0030027; GO:0030154; GO:0030163; GO:0030182; GO:0030216; GO:0030279; GO:0030324; GO:0030326; GO:0030334; GO:0030335; GO:0030513; GO:0030514; GO:0030900; GO:0031069; GO:0031100; GO:0031410; GO:0031490; GO:0031902; GO:0032495; GO:0032496; GO:0032966; GO:0035116; GO:0035148; GO:0035914; GO:0035924; GO:0042127; GO:0042246; GO:0042802; GO:0043065; GO:0043069; GO:0043086; GO:0043235; GO:0045070; GO:0045165; GO:0045596; GO:0045603; GO:0045607; GO:0045608; GO:0045618; GO:0045662; GO:0045665; GO:0045668; GO:0045687; GO:0045747; GO:0045892; GO:0045893; GO:0045944; GO:0045955; GO:0046427; GO:0046533; GO:0046579; GO:0048103; GO:0048593; GO:0048663; GO:0048708; GO:0048709; GO:0048711; GO:0048715; GO:0048754; GO:0048845; GO:0048873; GO:0050678; GO:0050679; GO:0050767; GO:0050768; GO:0051152; GO:0055008; GO:0060038; GO:0060045; GO:0060253; GO:0060271; GO:0060317; GO:0060354; GO:0060379; GO:0060411; GO:0060412; GO:0060528; GO:0060740; GO:0060768; GO:0060842; GO:0060843; GO:0060948; GO:0060956; GO:0060979; GO:0060982; GO:0061344; GO:0061384; GO:0062043; GO:0070168; GO:0070374; GO:0070986; GO:0071228; GO:0071372; GO:0071456; GO:0071944; GO:0072017; GO:0072044; GO:0072144; GO:0072538; GO:0090051; GO:0090090; GO:0097150; GO:0097400; GO:0098685; GO:0098839; GO:0098978; GO:0099565; GO:0120163; GO:0140537; GO:1901189; GO:1901201; GO:1902263; GO:1902339; GO:1903849; GO:2000048; GO:2000737; GO:2000811; GO:2000974; GO:2001027 animal organ regeneration [GO:0031100]; aortic valve morphogenesis [GO:0003180]; apoptotic process involved in embryonic digit morphogenesis [GO:1902263]; arterial endothelial cell differentiation [GO:0060842]; astrocyte differentiation [GO:0048708]; atrioventricular node development [GO:0003162]; atrioventricular valve morphogenesis [GO:0003181]; auditory receptor cell fate commitment [GO:0009912]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; branching morphogenesis of an epithelial tube [GO:0048754]; camera-type eye morphogenesis [GO:0048593]; cardiac atrium morphogenesis [GO:0003209]; cardiac chamber formation [GO:0003207]; cardiac epithelial to mesenchymal transition [GO:0060317]; cardiac left ventricle morphogenesis [GO:0003214]; cardiac muscle cell myoblast differentiation [GO:0060379]; cardiac muscle cell proliferation [GO:0060038]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac right atrium morphogenesis [GO:0003213]; cardiac right ventricle formation [GO:0003219]; cardiac septum morphogenesis [GO:0060411]; cardiac vascular smooth muscle cell development [GO:0060948]; cardiac ventricle morphogenesis [GO:0003208]; cell differentiation [GO:0030154]; cell differentiation in spinal cord [GO:0021515]; cell fate commitment [GO:0045165]; cell fate specification [GO:0001708]; cell migration involved in endocardial cushion formation [GO:0003273]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to hypoxia [GO:0071456]; cellular response to tumor cell [GO:0071228]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; chemical synaptic transmission, postsynaptic [GO:0099565]; cilium assembly [GO:0060271]; collecting duct development [GO:0072044]; compartment pattern specification [GO:0007386]; coronary artery morphogenesis [GO:0060982]; coronary sinus valve morphogenesis [GO:0003182]; coronary vein morphogenesis [GO:0003169]; determination of left/right symmetry [GO:0007368]; distal tubule development [GO:0072017]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic limb morphogenesis [GO:0030326]; endocardial cell differentiation [GO:0060956]; endocardial cushion development [GO:0003197]; endocardial cushion morphogenesis [GO:0003203]; endocardium development [GO:0003157]; endocardium morphogenesis [GO:0003160]; endoderm development [GO:0007492]; epidermis development [GO:0008544]; epithelial to mesenchymal transition [GO:0001837]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; forebrain development [GO:0030900]; foregut morphogenesis [GO:0007440]; gene expression [GO:0010467]; glial cell differentiation [GO:0010001]; glomerular mesangial cell development [GO:0072144]; growth involved in heart morphogenesis [GO:0003241]; hair follicle morphogenesis [GO:0031069]; heart development [GO:0007507]; heart looping [GO:0001947]; heart trabecula morphogenesis [GO:0061384]; homeostasis of number of cells within a tissue [GO:0048873]; humoral immune response [GO:0006959]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; interleukin-17-mediated signaling pathway [GO:0097400]; keratinocyte differentiation [GO:0030216]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; lung development [GO:0030324]; luteolysis [GO:0001554]; mesenchymal cell development [GO:0014031]; mitral valve formation [GO:0003192]; negative regulation of anoikis [GO:2000811]; negative regulation of biomineral tissue development [GO:0070168]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of catalytic activity [GO:0043086]; negative regulation of cell adhesion molecule production [GO:0060354]; negative regulation of cell differentiation [GO:0045596]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell proliferation involved in heart valve morphogenesis [GO:0003252]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of collagen biosynthetic process [GO:0032966]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of endothelial cell chemotaxis [GO:2001027]; negative regulation of extracellular matrix constituent secretion [GO:0003332]; negative regulation of gene expression [GO:0010629]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of inner ear auditory receptor cell differentiation [GO:0045608]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of ossification [GO:0030279]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of photoreceptor cell differentiation [GO:0046533]; negative regulation of pro-B cell differentiation [GO:2000974]; negative regulation of programmed cell death [GO:0043069]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural tube development [GO:0021915]; neuron differentiation [GO:0030182]; neuron fate commitment [GO:0048663]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; oligodendrocyte differentiation [GO:0048709]; osteoblast fate commitment [GO:0002051]; outflow tract morphogenesis [GO:0003151]; pericardium morphogenesis [GO:0003344]; positive regulation of aorta morphogenesis [GO:1903849]; positive regulation of apoptotic process [GO:0043065]; positive regulation of apoptotic process involved in morphogenesis [GO:1902339]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cardiac epithelial to mesenchymal transition [GO:0062043]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of ephrin receptor signaling pathway [GO:1901189]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of glial cell differentiation [GO:0045687]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of smooth muscle cell differentiation [GO:0051152]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription of Notch receptor target [GO:0007221]; positive regulation of viral genome replication [GO:0045070]; prostate gland epithelium morphogenesis [GO:0060740]; protein catabolic process [GO:0030163]; protein import into nucleus [GO:0006606]; pulmonary valve morphogenesis [GO:0003184]; regulation of cardioblast proliferation [GO:0003264]; regulation of cell adhesion involved in heart morphogenesis [GO:0061344]; regulation of cell migration [GO:0030334]; regulation of cell population proliferation [GO:0042127]; regulation of epithelial cell proliferation [GO:0050678]; regulation of epithelial cell proliferation involved in prostate gland development [GO:0060768]; regulation of extracellular matrix assembly [GO:1901201]; regulation of gene expression [GO:0010468]; regulation of inner ear auditory receptor cell differentiation [GO:0045607]; regulation of neurogenesis [GO:0050767]; regulation of Notch signaling pathway [GO:0008593]; regulation of somitogenesis [GO:0014807]; regulation of transcription by RNA polymerase II [GO:0006357]; response to lipopolysaccharide [GO:0032496]; response to muramyl dipeptide [GO:0032495]; secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development [GO:0060528]; skeletal muscle cell differentiation [GO:0035914]; somatic stem cell division [GO:0048103]; spermatogenesis [GO:0007283]; sprouting angiogenesis [GO:0002040]; T-helper 17 type immune response [GO:0072538]; tissue regeneration [GO:0042246]; tube formation [GO:0035148]; vasculogenesis involved in coronary vascular morphogenesis [GO:0060979]; venous blood vessel morphogenesis [GO:0048845]; venous endothelial cell differentiation [GO:0060843]; ventricular septum morphogenesis [GO:0060412]; ventricular trabecula myocardium morphogenesis [GO:0003222] acrosomal vesicle [GO:0001669]; adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell periphery [GO:0071944]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; lamellipodium [GO:0030027]; late endosome membrane [GO:0031902]; MAML1-RBP-Jkappa- ICN1 complex [GO:0002193]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; receptor complex [GO:0043235]; ruffle [GO:0001726]; Schaffer collateral - CA1 synapse [GO:0098685] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; identical protein binding [GO:0042802]; Notch binding [GO:0005112]; transcription coactivator activity [GO:0003713]; transcription regulator activator activity [GO:0140537]; transmembrane signaling receptor activity [GO:0004888] g256.t3 Q01705 33.937 1435 0.0 622.0 sp|Q01705|NOTC1_MOUSE Neurogenic locus notch homolog protein 1 OS=Mus musculus OX=10090 GN=Notch1 PE=1 SV=3 NOTC1_MOUSE reviewed Neurogenic locus notch homolog protein 1 (Notch 1) (Motch A) (mT14) (p300) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Mus musculus (Mouse) GO:0000122; GO:0000139; GO:0001554; GO:0001669; GO:0001701; GO:0001708; GO:0001726; GO:0001837; GO:0001889; GO:0001947; GO:0002040; GO:0002051; GO:0002052; GO:0002193; GO:0002437; GO:0003151; GO:0003157; GO:0003160; GO:0003162; GO:0003169; GO:0003180; GO:0003181; GO:0003182; GO:0003184; GO:0003192; GO:0003197; GO:0003198; GO:0003203; GO:0003207; GO:0003208; GO:0003209; GO:0003213; GO:0003214; GO:0003219; GO:0003222; GO:0003241; GO:0003252; GO:0003264; GO:0003273; GO:0003332; GO:0003344; GO:0003682; GO:0003713; GO:0004857; GO:0004888; GO:0005112; GO:0005509; GO:0005576; GO:0005634; GO:0005654; GO:0005737; GO:0005783; GO:0005789; GO:0005829; GO:0005856; GO:0005886; GO:0005912; GO:0006357; GO:0006606; GO:0006959; GO:0007219; GO:0007221; GO:0007283; GO:0007368; GO:0007386; GO:0007409; GO:0007411; GO:0007440; GO:0007492; GO:0007507; GO:0008284; GO:0008285; GO:0008544; GO:0008593; GO:0009912; GO:0009986; GO:0010001; GO:0010008; GO:0010467; GO:0010468; GO:0010614; GO:0010628; GO:0010629; GO:0010667; GO:0010718; GO:0010812; GO:0010832; GO:0014031; GO:0014807; GO:0016324; GO:0019899; GO:0021515; GO:0021915; GO:0030027; GO:0030154; GO:0030163; GO:0030182; GO:0030216; GO:0030279; GO:0030324; GO:0030326; GO:0030334; GO:0030335; GO:0030513; GO:0030514; GO:0030900; GO:0031069; GO:0031100; GO:0031410; GO:0031490; GO:0031902; GO:0032495; GO:0032496; GO:0032966; GO:0035116; GO:0035148; GO:0035914; GO:0035924; GO:0042127; GO:0042246; GO:0042802; GO:0043065; GO:0043069; GO:0043086; GO:0043235; GO:0045070; GO:0045165; GO:0045596; GO:0045603; GO:0045607; GO:0045608; GO:0045618; GO:0045662; GO:0045665; GO:0045668; GO:0045687; GO:0045747; GO:0045892; GO:0045893; GO:0045944; GO:0045955; GO:0046427; GO:0046533; GO:0046579; GO:0048103; GO:0048593; GO:0048663; GO:0048708; GO:0048709; GO:0048711; GO:0048715; GO:0048754; GO:0048845; GO:0048873; GO:0050678; GO:0050679; GO:0050767; GO:0050768; GO:0051152; GO:0055008; GO:0060038; GO:0060045; GO:0060253; GO:0060271; GO:0060317; GO:0060354; GO:0060379; GO:0060411; GO:0060412; GO:0060528; GO:0060740; GO:0060768; GO:0060842; GO:0060843; GO:0060948; GO:0060956; GO:0060979; GO:0060982; GO:0061344; GO:0061384; GO:0062043; GO:0070168; GO:0070374; GO:0070986; GO:0071228; GO:0071372; GO:0071456; GO:0071944; GO:0072017; GO:0072044; GO:0072144; GO:0072538; GO:0090051; GO:0090090; GO:0097150; GO:0097400; GO:0098685; GO:0098839; GO:0098978; GO:0099565; GO:0120163; GO:0140537; GO:1901189; GO:1901201; GO:1902263; GO:1902339; GO:1903849; GO:2000048; GO:2000737; GO:2000811; GO:2000974; GO:2001027 animal organ regeneration [GO:0031100]; aortic valve morphogenesis [GO:0003180]; apoptotic process involved in embryonic digit morphogenesis [GO:1902263]; arterial endothelial cell differentiation [GO:0060842]; astrocyte differentiation [GO:0048708]; atrioventricular node development [GO:0003162]; atrioventricular valve morphogenesis [GO:0003181]; auditory receptor cell fate commitment [GO:0009912]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; branching morphogenesis of an epithelial tube [GO:0048754]; camera-type eye morphogenesis [GO:0048593]; cardiac atrium morphogenesis [GO:0003209]; cardiac chamber formation [GO:0003207]; cardiac epithelial to mesenchymal transition [GO:0060317]; cardiac left ventricle morphogenesis [GO:0003214]; cardiac muscle cell myoblast differentiation [GO:0060379]; cardiac muscle cell proliferation [GO:0060038]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac right atrium morphogenesis [GO:0003213]; cardiac right ventricle formation [GO:0003219]; cardiac septum morphogenesis [GO:0060411]; cardiac vascular smooth muscle cell development [GO:0060948]; cardiac ventricle morphogenesis [GO:0003208]; cell differentiation [GO:0030154]; cell differentiation in spinal cord [GO:0021515]; cell fate commitment [GO:0045165]; cell fate specification [GO:0001708]; cell migration involved in endocardial cushion formation [GO:0003273]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to hypoxia [GO:0071456]; cellular response to tumor cell [GO:0071228]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; chemical synaptic transmission, postsynaptic [GO:0099565]; cilium assembly [GO:0060271]; collecting duct development [GO:0072044]; compartment pattern specification [GO:0007386]; coronary artery morphogenesis [GO:0060982]; coronary sinus valve morphogenesis [GO:0003182]; coronary vein morphogenesis [GO:0003169]; determination of left/right symmetry [GO:0007368]; distal tubule development [GO:0072017]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic limb morphogenesis [GO:0030326]; endocardial cell differentiation [GO:0060956]; endocardial cushion development [GO:0003197]; endocardial cushion morphogenesis [GO:0003203]; endocardium development [GO:0003157]; endocardium morphogenesis [GO:0003160]; endoderm development [GO:0007492]; epidermis development [GO:0008544]; epithelial to mesenchymal transition [GO:0001837]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; forebrain development [GO:0030900]; foregut morphogenesis [GO:0007440]; gene expression [GO:0010467]; glial cell differentiation [GO:0010001]; glomerular mesangial cell development [GO:0072144]; growth involved in heart morphogenesis [GO:0003241]; hair follicle morphogenesis [GO:0031069]; heart development [GO:0007507]; heart looping [GO:0001947]; heart trabecula morphogenesis [GO:0061384]; homeostasis of number of cells within a tissue [GO:0048873]; humoral immune response [GO:0006959]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; interleukin-17-mediated signaling pathway [GO:0097400]; keratinocyte differentiation [GO:0030216]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; lung development [GO:0030324]; luteolysis [GO:0001554]; mesenchymal cell development [GO:0014031]; mitral valve formation [GO:0003192]; negative regulation of anoikis [GO:2000811]; negative regulation of biomineral tissue development [GO:0070168]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of catalytic activity [GO:0043086]; negative regulation of cell adhesion molecule production [GO:0060354]; negative regulation of cell differentiation [GO:0045596]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell proliferation involved in heart valve morphogenesis [GO:0003252]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of collagen biosynthetic process [GO:0032966]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of endothelial cell chemotaxis [GO:2001027]; negative regulation of extracellular matrix constituent secretion [GO:0003332]; negative regulation of gene expression [GO:0010629]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of inner ear auditory receptor cell differentiation [GO:0045608]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of ossification [GO:0030279]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of photoreceptor cell differentiation [GO:0046533]; negative regulation of pro-B cell differentiation [GO:2000974]; negative regulation of programmed cell death [GO:0043069]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural tube development [GO:0021915]; neuron differentiation [GO:0030182]; neuron fate commitment [GO:0048663]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; oligodendrocyte differentiation [GO:0048709]; osteoblast fate commitment [GO:0002051]; outflow tract morphogenesis [GO:0003151]; pericardium morphogenesis [GO:0003344]; positive regulation of aorta morphogenesis [GO:1903849]; positive regulation of apoptotic process [GO:0043065]; positive regulation of apoptotic process involved in morphogenesis [GO:1902339]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cardiac epithelial to mesenchymal transition [GO:0062043]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of ephrin receptor signaling pathway [GO:1901189]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of glial cell differentiation [GO:0045687]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of smooth muscle cell differentiation [GO:0051152]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription of Notch receptor target [GO:0007221]; positive regulation of viral genome replication [GO:0045070]; prostate gland epithelium morphogenesis [GO:0060740]; protein catabolic process [GO:0030163]; protein import into nucleus [GO:0006606]; pulmonary valve morphogenesis [GO:0003184]; regulation of cardioblast proliferation [GO:0003264]; regulation of cell adhesion involved in heart morphogenesis [GO:0061344]; regulation of cell migration [GO:0030334]; regulation of cell population proliferation [GO:0042127]; regulation of epithelial cell proliferation [GO:0050678]; regulation of epithelial cell proliferation involved in prostate gland development [GO:0060768]; regulation of extracellular matrix assembly [GO:1901201]; regulation of gene expression [GO:0010468]; regulation of inner ear auditory receptor cell differentiation [GO:0045607]; regulation of neurogenesis [GO:0050767]; regulation of Notch signaling pathway [GO:0008593]; regulation of somitogenesis [GO:0014807]; regulation of transcription by RNA polymerase II [GO:0006357]; response to lipopolysaccharide [GO:0032496]; response to muramyl dipeptide [GO:0032495]; secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development [GO:0060528]; skeletal muscle cell differentiation [GO:0035914]; somatic stem cell division [GO:0048103]; spermatogenesis [GO:0007283]; sprouting angiogenesis [GO:0002040]; T-helper 17 type immune response [GO:0072538]; tissue regeneration [GO:0042246]; tube formation [GO:0035148]; vasculogenesis involved in coronary vascular morphogenesis [GO:0060979]; venous blood vessel morphogenesis [GO:0048845]; venous endothelial cell differentiation [GO:0060843]; ventricular septum morphogenesis [GO:0060412]; ventricular trabecula myocardium morphogenesis [GO:0003222] acrosomal vesicle [GO:0001669]; adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell periphery [GO:0071944]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; lamellipodium [GO:0030027]; late endosome membrane [GO:0031902]; MAML1-RBP-Jkappa- ICN1 complex [GO:0002193]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; receptor complex [GO:0043235]; ruffle [GO:0001726]; Schaffer collateral - CA1 synapse [GO:0098685] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; identical protein binding [GO:0042802]; Notch binding [GO:0005112]; transcription coactivator activity [GO:0003713]; transcription regulator activator activity [GO:0140537]; transmembrane signaling receptor activity [GO:0004888] g256.t3 Q01705 34.901 1318 5.91e-160 558.0 sp|Q01705|NOTC1_MOUSE Neurogenic locus notch homolog protein 1 OS=Mus musculus OX=10090 GN=Notch1 PE=1 SV=3 NOTC1_MOUSE reviewed Neurogenic locus notch homolog protein 1 (Notch 1) (Motch A) (mT14) (p300) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Mus musculus (Mouse) GO:0000122; GO:0000139; GO:0001554; GO:0001669; GO:0001701; GO:0001708; GO:0001726; GO:0001837; GO:0001889; GO:0001947; GO:0002040; GO:0002051; GO:0002052; GO:0002193; GO:0002437; GO:0003151; GO:0003157; GO:0003160; GO:0003162; GO:0003169; GO:0003180; GO:0003181; GO:0003182; GO:0003184; GO:0003192; GO:0003197; GO:0003198; GO:0003203; GO:0003207; GO:0003208; GO:0003209; GO:0003213; GO:0003214; GO:0003219; GO:0003222; GO:0003241; GO:0003252; GO:0003264; GO:0003273; GO:0003332; GO:0003344; GO:0003682; GO:0003713; GO:0004857; GO:0004888; GO:0005112; GO:0005509; GO:0005576; GO:0005634; GO:0005654; GO:0005737; GO:0005783; GO:0005789; GO:0005829; GO:0005856; GO:0005886; GO:0005912; GO:0006357; GO:0006606; GO:0006959; GO:0007219; GO:0007221; GO:0007283; GO:0007368; GO:0007386; GO:0007409; GO:0007411; GO:0007440; GO:0007492; GO:0007507; GO:0008284; GO:0008285; GO:0008544; GO:0008593; GO:0009912; GO:0009986; GO:0010001; GO:0010008; GO:0010467; GO:0010468; GO:0010614; GO:0010628; GO:0010629; GO:0010667; GO:0010718; GO:0010812; GO:0010832; GO:0014031; GO:0014807; GO:0016324; GO:0019899; GO:0021515; GO:0021915; GO:0030027; GO:0030154; GO:0030163; GO:0030182; GO:0030216; GO:0030279; GO:0030324; GO:0030326; GO:0030334; GO:0030335; GO:0030513; GO:0030514; GO:0030900; GO:0031069; GO:0031100; GO:0031410; GO:0031490; GO:0031902; GO:0032495; GO:0032496; GO:0032966; GO:0035116; GO:0035148; GO:0035914; GO:0035924; GO:0042127; GO:0042246; GO:0042802; GO:0043065; GO:0043069; GO:0043086; GO:0043235; GO:0045070; GO:0045165; GO:0045596; GO:0045603; GO:0045607; GO:0045608; GO:0045618; GO:0045662; GO:0045665; GO:0045668; GO:0045687; GO:0045747; GO:0045892; GO:0045893; GO:0045944; GO:0045955; GO:0046427; GO:0046533; GO:0046579; GO:0048103; GO:0048593; GO:0048663; GO:0048708; GO:0048709; GO:0048711; GO:0048715; GO:0048754; GO:0048845; GO:0048873; GO:0050678; GO:0050679; GO:0050767; GO:0050768; GO:0051152; GO:0055008; GO:0060038; GO:0060045; GO:0060253; GO:0060271; GO:0060317; GO:0060354; GO:0060379; GO:0060411; GO:0060412; GO:0060528; GO:0060740; GO:0060768; GO:0060842; GO:0060843; GO:0060948; GO:0060956; GO:0060979; GO:0060982; GO:0061344; GO:0061384; GO:0062043; GO:0070168; GO:0070374; GO:0070986; GO:0071228; GO:0071372; GO:0071456; GO:0071944; GO:0072017; GO:0072044; GO:0072144; GO:0072538; GO:0090051; GO:0090090; GO:0097150; GO:0097400; GO:0098685; GO:0098839; GO:0098978; GO:0099565; GO:0120163; GO:0140537; GO:1901189; GO:1901201; GO:1902263; GO:1902339; GO:1903849; GO:2000048; GO:2000737; GO:2000811; GO:2000974; GO:2001027 animal organ regeneration [GO:0031100]; aortic valve morphogenesis [GO:0003180]; apoptotic process involved in embryonic digit morphogenesis [GO:1902263]; arterial endothelial cell differentiation [GO:0060842]; astrocyte differentiation [GO:0048708]; atrioventricular node development [GO:0003162]; atrioventricular valve morphogenesis [GO:0003181]; auditory receptor cell fate commitment [GO:0009912]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; branching morphogenesis of an epithelial tube [GO:0048754]; camera-type eye morphogenesis [GO:0048593]; cardiac atrium morphogenesis [GO:0003209]; cardiac chamber formation [GO:0003207]; cardiac epithelial to mesenchymal transition [GO:0060317]; cardiac left ventricle morphogenesis [GO:0003214]; cardiac muscle cell myoblast differentiation [GO:0060379]; cardiac muscle cell proliferation [GO:0060038]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac right atrium morphogenesis [GO:0003213]; cardiac right ventricle formation [GO:0003219]; cardiac septum morphogenesis [GO:0060411]; cardiac vascular smooth muscle cell development [GO:0060948]; cardiac ventricle morphogenesis [GO:0003208]; cell differentiation [GO:0030154]; cell differentiation in spinal cord [GO:0021515]; cell fate commitment [GO:0045165]; cell fate specification [GO:0001708]; cell migration involved in endocardial cushion formation [GO:0003273]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to hypoxia [GO:0071456]; cellular response to tumor cell [GO:0071228]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; chemical synaptic transmission, postsynaptic [GO:0099565]; cilium assembly [GO:0060271]; collecting duct development [GO:0072044]; compartment pattern specification [GO:0007386]; coronary artery morphogenesis [GO:0060982]; coronary sinus valve morphogenesis [GO:0003182]; coronary vein morphogenesis [GO:0003169]; determination of left/right symmetry [GO:0007368]; distal tubule development [GO:0072017]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic limb morphogenesis [GO:0030326]; endocardial cell differentiation [GO:0060956]; endocardial cushion development [GO:0003197]; endocardial cushion morphogenesis [GO:0003203]; endocardium development [GO:0003157]; endocardium morphogenesis [GO:0003160]; endoderm development [GO:0007492]; epidermis development [GO:0008544]; epithelial to mesenchymal transition [GO:0001837]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; forebrain development [GO:0030900]; foregut morphogenesis [GO:0007440]; gene expression [GO:0010467]; glial cell differentiation [GO:0010001]; glomerular mesangial cell development [GO:0072144]; growth involved in heart morphogenesis [GO:0003241]; hair follicle morphogenesis [GO:0031069]; heart development [GO:0007507]; heart looping [GO:0001947]; heart trabecula morphogenesis [GO:0061384]; homeostasis of number of cells within a tissue [GO:0048873]; humoral immune response [GO:0006959]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; interleukin-17-mediated signaling pathway [GO:0097400]; keratinocyte differentiation [GO:0030216]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; lung development [GO:0030324]; luteolysis [GO:0001554]; mesenchymal cell development [GO:0014031]; mitral valve formation [GO:0003192]; negative regulation of anoikis [GO:2000811]; negative regulation of biomineral tissue development [GO:0070168]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of catalytic activity [GO:0043086]; negative regulation of cell adhesion molecule production [GO:0060354]; negative regulation of cell differentiation [GO:0045596]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell proliferation involved in heart valve morphogenesis [GO:0003252]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of collagen biosynthetic process [GO:0032966]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of endothelial cell chemotaxis [GO:2001027]; negative regulation of extracellular matrix constituent secretion [GO:0003332]; negative regulation of gene expression [GO:0010629]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of inner ear auditory receptor cell differentiation [GO:0045608]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of ossification [GO:0030279]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of photoreceptor cell differentiation [GO:0046533]; negative regulation of pro-B cell differentiation [GO:2000974]; negative regulation of programmed cell death [GO:0043069]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural tube development [GO:0021915]; neuron differentiation [GO:0030182]; neuron fate commitment [GO:0048663]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; oligodendrocyte differentiation [GO:0048709]; osteoblast fate commitment [GO:0002051]; outflow tract morphogenesis [GO:0003151]; pericardium morphogenesis [GO:0003344]; positive regulation of aorta morphogenesis [GO:1903849]; positive regulation of apoptotic process [GO:0043065]; positive regulation of apoptotic process involved in morphogenesis [GO:1902339]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cardiac epithelial to mesenchymal transition [GO:0062043]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of ephrin receptor signaling pathway [GO:1901189]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of glial cell differentiation [GO:0045687]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of smooth muscle cell differentiation [GO:0051152]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription of Notch receptor target [GO:0007221]; positive regulation of viral genome replication [GO:0045070]; prostate gland epithelium morphogenesis [GO:0060740]; protein catabolic process [GO:0030163]; protein import into nucleus [GO:0006606]; pulmonary valve morphogenesis [GO:0003184]; regulation of cardioblast proliferation [GO:0003264]; regulation of cell adhesion involved in heart morphogenesis [GO:0061344]; regulation of cell migration [GO:0030334]; regulation of cell population proliferation [GO:0042127]; regulation of epithelial cell proliferation [GO:0050678]; regulation of epithelial cell proliferation involved in prostate gland development [GO:0060768]; regulation of extracellular matrix assembly [GO:1901201]; regulation of gene expression [GO:0010468]; regulation of inner ear auditory receptor cell differentiation [GO:0045607]; regulation of neurogenesis [GO:0050767]; regulation of Notch signaling pathway [GO:0008593]; regulation of somitogenesis [GO:0014807]; regulation of transcription by RNA polymerase II [GO:0006357]; response to lipopolysaccharide [GO:0032496]; response to muramyl dipeptide [GO:0032495]; secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development [GO:0060528]; skeletal muscle cell differentiation [GO:0035914]; somatic stem cell division [GO:0048103]; spermatogenesis [GO:0007283]; sprouting angiogenesis [GO:0002040]; T-helper 17 type immune response [GO:0072538]; tissue regeneration [GO:0042246]; tube formation [GO:0035148]; vasculogenesis involved in coronary vascular morphogenesis [GO:0060979]; venous blood vessel morphogenesis [GO:0048845]; venous endothelial cell differentiation [GO:0060843]; ventricular septum morphogenesis [GO:0060412]; ventricular trabecula myocardium morphogenesis [GO:0003222] acrosomal vesicle [GO:0001669]; adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell periphery [GO:0071944]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; lamellipodium [GO:0030027]; late endosome membrane [GO:0031902]; MAML1-RBP-Jkappa- ICN1 complex [GO:0002193]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; receptor complex [GO:0043235]; ruffle [GO:0001726]; Schaffer collateral - CA1 synapse [GO:0098685] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; identical protein binding [GO:0042802]; Notch binding [GO:0005112]; transcription coactivator activity [GO:0003713]; transcription regulator activator activity [GO:0140537]; transmembrane signaling receptor activity [GO:0004888] g256.t3 Q01705 36.426 1013 3.5799999999999997e-128 457.0 sp|Q01705|NOTC1_MOUSE Neurogenic locus notch homolog protein 1 OS=Mus musculus OX=10090 GN=Notch1 PE=1 SV=3 NOTC1_MOUSE reviewed Neurogenic locus notch homolog protein 1 (Notch 1) (Motch A) (mT14) (p300) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Mus musculus (Mouse) GO:0000122; GO:0000139; GO:0001554; GO:0001669; GO:0001701; GO:0001708; GO:0001726; GO:0001837; GO:0001889; GO:0001947; GO:0002040; GO:0002051; GO:0002052; GO:0002193; GO:0002437; GO:0003151; GO:0003157; GO:0003160; GO:0003162; GO:0003169; GO:0003180; GO:0003181; GO:0003182; GO:0003184; GO:0003192; GO:0003197; GO:0003198; GO:0003203; GO:0003207; GO:0003208; GO:0003209; GO:0003213; GO:0003214; GO:0003219; GO:0003222; GO:0003241; GO:0003252; GO:0003264; GO:0003273; GO:0003332; GO:0003344; GO:0003682; GO:0003713; GO:0004857; GO:0004888; GO:0005112; GO:0005509; GO:0005576; GO:0005634; GO:0005654; GO:0005737; GO:0005783; GO:0005789; GO:0005829; GO:0005856; GO:0005886; GO:0005912; GO:0006357; GO:0006606; GO:0006959; GO:0007219; GO:0007221; GO:0007283; GO:0007368; GO:0007386; GO:0007409; GO:0007411; GO:0007440; GO:0007492; GO:0007507; GO:0008284; GO:0008285; GO:0008544; GO:0008593; GO:0009912; GO:0009986; GO:0010001; GO:0010008; GO:0010467; GO:0010468; GO:0010614; GO:0010628; GO:0010629; GO:0010667; GO:0010718; GO:0010812; GO:0010832; GO:0014031; GO:0014807; GO:0016324; GO:0019899; GO:0021515; GO:0021915; GO:0030027; GO:0030154; GO:0030163; GO:0030182; GO:0030216; GO:0030279; GO:0030324; GO:0030326; GO:0030334; GO:0030335; GO:0030513; GO:0030514; GO:0030900; GO:0031069; GO:0031100; GO:0031410; GO:0031490; GO:0031902; GO:0032495; GO:0032496; GO:0032966; GO:0035116; GO:0035148; GO:0035914; GO:0035924; GO:0042127; GO:0042246; GO:0042802; GO:0043065; GO:0043069; GO:0043086; GO:0043235; GO:0045070; GO:0045165; GO:0045596; GO:0045603; GO:0045607; GO:0045608; GO:0045618; GO:0045662; GO:0045665; GO:0045668; GO:0045687; GO:0045747; GO:0045892; GO:0045893; GO:0045944; GO:0045955; GO:0046427; GO:0046533; GO:0046579; GO:0048103; GO:0048593; GO:0048663; GO:0048708; GO:0048709; GO:0048711; GO:0048715; GO:0048754; GO:0048845; GO:0048873; GO:0050678; GO:0050679; GO:0050767; GO:0050768; GO:0051152; GO:0055008; GO:0060038; GO:0060045; GO:0060253; GO:0060271; GO:0060317; GO:0060354; GO:0060379; GO:0060411; GO:0060412; GO:0060528; GO:0060740; GO:0060768; GO:0060842; GO:0060843; GO:0060948; GO:0060956; GO:0060979; GO:0060982; GO:0061344; GO:0061384; GO:0062043; GO:0070168; GO:0070374; GO:0070986; GO:0071228; GO:0071372; GO:0071456; GO:0071944; GO:0072017; GO:0072044; GO:0072144; GO:0072538; GO:0090051; GO:0090090; GO:0097150; GO:0097400; GO:0098685; GO:0098839; GO:0098978; GO:0099565; GO:0120163; GO:0140537; GO:1901189; GO:1901201; GO:1902263; GO:1902339; GO:1903849; GO:2000048; GO:2000737; GO:2000811; GO:2000974; GO:2001027 animal organ regeneration [GO:0031100]; aortic valve morphogenesis [GO:0003180]; apoptotic process involved in embryonic digit morphogenesis [GO:1902263]; arterial endothelial cell differentiation [GO:0060842]; astrocyte differentiation [GO:0048708]; atrioventricular node development [GO:0003162]; atrioventricular valve morphogenesis [GO:0003181]; auditory receptor cell fate commitment [GO:0009912]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; branching morphogenesis of an epithelial tube [GO:0048754]; camera-type eye morphogenesis [GO:0048593]; cardiac atrium morphogenesis [GO:0003209]; cardiac chamber formation [GO:0003207]; cardiac epithelial to mesenchymal transition [GO:0060317]; cardiac left ventricle morphogenesis [GO:0003214]; cardiac muscle cell myoblast differentiation [GO:0060379]; cardiac muscle cell proliferation [GO:0060038]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac right atrium morphogenesis [GO:0003213]; cardiac right ventricle formation [GO:0003219]; cardiac septum morphogenesis [GO:0060411]; cardiac vascular smooth muscle cell development [GO:0060948]; cardiac ventricle morphogenesis [GO:0003208]; cell differentiation [GO:0030154]; cell differentiation in spinal cord [GO:0021515]; cell fate commitment [GO:0045165]; cell fate specification [GO:0001708]; cell migration involved in endocardial cushion formation [GO:0003273]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to hypoxia [GO:0071456]; cellular response to tumor cell [GO:0071228]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; chemical synaptic transmission, postsynaptic [GO:0099565]; cilium assembly [GO:0060271]; collecting duct development [GO:0072044]; compartment pattern specification [GO:0007386]; coronary artery morphogenesis [GO:0060982]; coronary sinus valve morphogenesis [GO:0003182]; coronary vein morphogenesis [GO:0003169]; determination of left/right symmetry [GO:0007368]; distal tubule development [GO:0072017]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic limb morphogenesis [GO:0030326]; endocardial cell differentiation [GO:0060956]; endocardial cushion development [GO:0003197]; endocardial cushion morphogenesis [GO:0003203]; endocardium development [GO:0003157]; endocardium morphogenesis [GO:0003160]; endoderm development [GO:0007492]; epidermis development [GO:0008544]; epithelial to mesenchymal transition [GO:0001837]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; forebrain development [GO:0030900]; foregut morphogenesis [GO:0007440]; gene expression [GO:0010467]; glial cell differentiation [GO:0010001]; glomerular mesangial cell development [GO:0072144]; growth involved in heart morphogenesis [GO:0003241]; hair follicle morphogenesis [GO:0031069]; heart development [GO:0007507]; heart looping [GO:0001947]; heart trabecula morphogenesis [GO:0061384]; homeostasis of number of cells within a tissue [GO:0048873]; humoral immune response [GO:0006959]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; interleukin-17-mediated signaling pathway [GO:0097400]; keratinocyte differentiation [GO:0030216]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; lung development [GO:0030324]; luteolysis [GO:0001554]; mesenchymal cell development [GO:0014031]; mitral valve formation [GO:0003192]; negative regulation of anoikis [GO:2000811]; negative regulation of biomineral tissue development [GO:0070168]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of catalytic activity [GO:0043086]; negative regulation of cell adhesion molecule production [GO:0060354]; negative regulation of cell differentiation [GO:0045596]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell proliferation involved in heart valve morphogenesis [GO:0003252]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of collagen biosynthetic process [GO:0032966]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of endothelial cell chemotaxis [GO:2001027]; negative regulation of extracellular matrix constituent secretion [GO:0003332]; negative regulation of gene expression [GO:0010629]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of inner ear auditory receptor cell differentiation [GO:0045608]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of ossification [GO:0030279]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of photoreceptor cell differentiation [GO:0046533]; negative regulation of pro-B cell differentiation [GO:2000974]; negative regulation of programmed cell death [GO:0043069]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural tube development [GO:0021915]; neuron differentiation [GO:0030182]; neuron fate commitment [GO:0048663]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; oligodendrocyte differentiation [GO:0048709]; osteoblast fate commitment [GO:0002051]; outflow tract morphogenesis [GO:0003151]; pericardium morphogenesis [GO:0003344]; positive regulation of aorta morphogenesis [GO:1903849]; positive regulation of apoptotic process [GO:0043065]; positive regulation of apoptotic process involved in morphogenesis [GO:1902339]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cardiac epithelial to mesenchymal transition [GO:0062043]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of ephrin receptor signaling pathway [GO:1901189]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of glial cell differentiation [GO:0045687]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of smooth muscle cell differentiation [GO:0051152]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription of Notch receptor target [GO:0007221]; positive regulation of viral genome replication [GO:0045070]; prostate gland epithelium morphogenesis [GO:0060740]; protein catabolic process [GO:0030163]; protein import into nucleus [GO:0006606]; pulmonary valve morphogenesis [GO:0003184]; regulation of cardioblast proliferation [GO:0003264]; regulation of cell adhesion involved in heart morphogenesis [GO:0061344]; regulation of cell migration [GO:0030334]; regulation of cell population proliferation [GO:0042127]; regulation of epithelial cell proliferation [GO:0050678]; regulation of epithelial cell proliferation involved in prostate gland development [GO:0060768]; regulation of extracellular matrix assembly [GO:1901201]; regulation of gene expression [GO:0010468]; regulation of inner ear auditory receptor cell differentiation [GO:0045607]; regulation of neurogenesis [GO:0050767]; regulation of Notch signaling pathway [GO:0008593]; regulation of somitogenesis [GO:0014807]; regulation of transcription by RNA polymerase II [GO:0006357]; response to lipopolysaccharide [GO:0032496]; response to muramyl dipeptide [GO:0032495]; secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development [GO:0060528]; skeletal muscle cell differentiation [GO:0035914]; somatic stem cell division [GO:0048103]; spermatogenesis [GO:0007283]; sprouting angiogenesis [GO:0002040]; T-helper 17 type immune response [GO:0072538]; tissue regeneration [GO:0042246]; tube formation [GO:0035148]; vasculogenesis involved in coronary vascular morphogenesis [GO:0060979]; venous blood vessel morphogenesis [GO:0048845]; venous endothelial cell differentiation [GO:0060843]; ventricular septum morphogenesis [GO:0060412]; ventricular trabecula myocardium morphogenesis [GO:0003222] acrosomal vesicle [GO:0001669]; adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell periphery [GO:0071944]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; lamellipodium [GO:0030027]; late endosome membrane [GO:0031902]; MAML1-RBP-Jkappa- ICN1 complex [GO:0002193]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; receptor complex [GO:0043235]; ruffle [GO:0001726]; Schaffer collateral - CA1 synapse [GO:0098685] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; identical protein binding [GO:0042802]; Notch binding [GO:0005112]; transcription coactivator activity [GO:0003713]; transcription regulator activator activity [GO:0140537]; transmembrane signaling receptor activity [GO:0004888] g256.t3 Q01705 37.978 445 3.9200000000000003e-59 231.0 sp|Q01705|NOTC1_MOUSE Neurogenic locus notch homolog protein 1 OS=Mus musculus OX=10090 GN=Notch1 PE=1 SV=3 NOTC1_MOUSE reviewed Neurogenic locus notch homolog protein 1 (Notch 1) (Motch A) (mT14) (p300) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Mus musculus (Mouse) GO:0000122; GO:0000139; GO:0001554; GO:0001669; GO:0001701; GO:0001708; GO:0001726; GO:0001837; GO:0001889; GO:0001947; GO:0002040; GO:0002051; GO:0002052; GO:0002193; GO:0002437; GO:0003151; GO:0003157; GO:0003160; GO:0003162; GO:0003169; GO:0003180; GO:0003181; GO:0003182; GO:0003184; GO:0003192; GO:0003197; GO:0003198; GO:0003203; GO:0003207; GO:0003208; GO:0003209; GO:0003213; GO:0003214; GO:0003219; GO:0003222; GO:0003241; GO:0003252; GO:0003264; GO:0003273; GO:0003332; GO:0003344; GO:0003682; GO:0003713; GO:0004857; GO:0004888; GO:0005112; GO:0005509; GO:0005576; GO:0005634; GO:0005654; GO:0005737; GO:0005783; GO:0005789; GO:0005829; GO:0005856; GO:0005886; GO:0005912; GO:0006357; GO:0006606; GO:0006959; GO:0007219; GO:0007221; GO:0007283; GO:0007368; GO:0007386; GO:0007409; GO:0007411; GO:0007440; GO:0007492; GO:0007507; GO:0008284; GO:0008285; GO:0008544; GO:0008593; GO:0009912; GO:0009986; GO:0010001; GO:0010008; GO:0010467; GO:0010468; GO:0010614; GO:0010628; GO:0010629; GO:0010667; GO:0010718; GO:0010812; GO:0010832; GO:0014031; GO:0014807; GO:0016324; GO:0019899; GO:0021515; GO:0021915; GO:0030027; GO:0030154; GO:0030163; GO:0030182; GO:0030216; GO:0030279; GO:0030324; GO:0030326; GO:0030334; GO:0030335; GO:0030513; GO:0030514; GO:0030900; GO:0031069; GO:0031100; GO:0031410; GO:0031490; GO:0031902; GO:0032495; GO:0032496; GO:0032966; GO:0035116; GO:0035148; GO:0035914; GO:0035924; GO:0042127; GO:0042246; GO:0042802; GO:0043065; GO:0043069; GO:0043086; GO:0043235; GO:0045070; GO:0045165; GO:0045596; GO:0045603; GO:0045607; GO:0045608; GO:0045618; GO:0045662; GO:0045665; GO:0045668; GO:0045687; GO:0045747; GO:0045892; GO:0045893; GO:0045944; GO:0045955; GO:0046427; GO:0046533; GO:0046579; GO:0048103; GO:0048593; GO:0048663; GO:0048708; GO:0048709; GO:0048711; GO:0048715; GO:0048754; GO:0048845; GO:0048873; GO:0050678; GO:0050679; GO:0050767; GO:0050768; GO:0051152; GO:0055008; GO:0060038; GO:0060045; GO:0060253; GO:0060271; GO:0060317; GO:0060354; GO:0060379; GO:0060411; GO:0060412; GO:0060528; GO:0060740; GO:0060768; GO:0060842; GO:0060843; GO:0060948; GO:0060956; GO:0060979; GO:0060982; GO:0061344; GO:0061384; GO:0062043; GO:0070168; GO:0070374; GO:0070986; GO:0071228; GO:0071372; GO:0071456; GO:0071944; GO:0072017; GO:0072044; GO:0072144; GO:0072538; GO:0090051; GO:0090090; GO:0097150; GO:0097400; GO:0098685; GO:0098839; GO:0098978; GO:0099565; GO:0120163; GO:0140537; GO:1901189; GO:1901201; GO:1902263; GO:1902339; GO:1903849; GO:2000048; GO:2000737; GO:2000811; GO:2000974; GO:2001027 animal organ regeneration [GO:0031100]; aortic valve morphogenesis [GO:0003180]; apoptotic process involved in embryonic digit morphogenesis [GO:1902263]; arterial endothelial cell differentiation [GO:0060842]; astrocyte differentiation [GO:0048708]; atrioventricular node development [GO:0003162]; atrioventricular valve morphogenesis [GO:0003181]; auditory receptor cell fate commitment [GO:0009912]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; branching morphogenesis of an epithelial tube [GO:0048754]; camera-type eye morphogenesis [GO:0048593]; cardiac atrium morphogenesis [GO:0003209]; cardiac chamber formation [GO:0003207]; cardiac epithelial to mesenchymal transition [GO:0060317]; cardiac left ventricle morphogenesis [GO:0003214]; cardiac muscle cell myoblast differentiation [GO:0060379]; cardiac muscle cell proliferation [GO:0060038]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac right atrium morphogenesis [GO:0003213]; cardiac right ventricle formation [GO:0003219]; cardiac septum morphogenesis [GO:0060411]; cardiac vascular smooth muscle cell development [GO:0060948]; cardiac ventricle morphogenesis [GO:0003208]; cell differentiation [GO:0030154]; cell differentiation in spinal cord [GO:0021515]; cell fate commitment [GO:0045165]; cell fate specification [GO:0001708]; cell migration involved in endocardial cushion formation [GO:0003273]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to hypoxia [GO:0071456]; cellular response to tumor cell [GO:0071228]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; chemical synaptic transmission, postsynaptic [GO:0099565]; cilium assembly [GO:0060271]; collecting duct development [GO:0072044]; compartment pattern specification [GO:0007386]; coronary artery morphogenesis [GO:0060982]; coronary sinus valve morphogenesis [GO:0003182]; coronary vein morphogenesis [GO:0003169]; determination of left/right symmetry [GO:0007368]; distal tubule development [GO:0072017]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic limb morphogenesis [GO:0030326]; endocardial cell differentiation [GO:0060956]; endocardial cushion development [GO:0003197]; endocardial cushion morphogenesis [GO:0003203]; endocardium development [GO:0003157]; endocardium morphogenesis [GO:0003160]; endoderm development [GO:0007492]; epidermis development [GO:0008544]; epithelial to mesenchymal transition [GO:0001837]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; forebrain development [GO:0030900]; foregut morphogenesis [GO:0007440]; gene expression [GO:0010467]; glial cell differentiation [GO:0010001]; glomerular mesangial cell development [GO:0072144]; growth involved in heart morphogenesis [GO:0003241]; hair follicle morphogenesis [GO:0031069]; heart development [GO:0007507]; heart looping [GO:0001947]; heart trabecula morphogenesis [GO:0061384]; homeostasis of number of cells within a tissue [GO:0048873]; humoral immune response [GO:0006959]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; interleukin-17-mediated signaling pathway [GO:0097400]; keratinocyte differentiation [GO:0030216]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; lung development [GO:0030324]; luteolysis [GO:0001554]; mesenchymal cell development [GO:0014031]; mitral valve formation [GO:0003192]; negative regulation of anoikis [GO:2000811]; negative regulation of biomineral tissue development [GO:0070168]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of catalytic activity [GO:0043086]; negative regulation of cell adhesion molecule production [GO:0060354]; negative regulation of cell differentiation [GO:0045596]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell proliferation involved in heart valve morphogenesis [GO:0003252]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of collagen biosynthetic process [GO:0032966]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of endothelial cell chemotaxis [GO:2001027]; negative regulation of extracellular matrix constituent secretion [GO:0003332]; negative regulation of gene expression [GO:0010629]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of inner ear auditory receptor cell differentiation [GO:0045608]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of ossification [GO:0030279]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of photoreceptor cell differentiation [GO:0046533]; negative regulation of pro-B cell differentiation [GO:2000974]; negative regulation of programmed cell death [GO:0043069]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural tube development [GO:0021915]; neuron differentiation [GO:0030182]; neuron fate commitment [GO:0048663]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; oligodendrocyte differentiation [GO:0048709]; osteoblast fate commitment [GO:0002051]; outflow tract morphogenesis [GO:0003151]; pericardium morphogenesis [GO:0003344]; positive regulation of aorta morphogenesis [GO:1903849]; positive regulation of apoptotic process [GO:0043065]; positive regulation of apoptotic process involved in morphogenesis [GO:1902339]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cardiac epithelial to mesenchymal transition [GO:0062043]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of ephrin receptor signaling pathway [GO:1901189]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of glial cell differentiation [GO:0045687]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of smooth muscle cell differentiation [GO:0051152]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription of Notch receptor target [GO:0007221]; positive regulation of viral genome replication [GO:0045070]; prostate gland epithelium morphogenesis [GO:0060740]; protein catabolic process [GO:0030163]; protein import into nucleus [GO:0006606]; pulmonary valve morphogenesis [GO:0003184]; regulation of cardioblast proliferation [GO:0003264]; regulation of cell adhesion involved in heart morphogenesis [GO:0061344]; regulation of cell migration [GO:0030334]; regulation of cell population proliferation [GO:0042127]; regulation of epithelial cell proliferation [GO:0050678]; regulation of epithelial cell proliferation involved in prostate gland development [GO:0060768]; regulation of extracellular matrix assembly [GO:1901201]; regulation of gene expression [GO:0010468]; regulation of inner ear auditory receptor cell differentiation [GO:0045607]; regulation of neurogenesis [GO:0050767]; regulation of Notch signaling pathway [GO:0008593]; regulation of somitogenesis [GO:0014807]; regulation of transcription by RNA polymerase II [GO:0006357]; response to lipopolysaccharide [GO:0032496]; response to muramyl dipeptide [GO:0032495]; secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development [GO:0060528]; skeletal muscle cell differentiation [GO:0035914]; somatic stem cell division [GO:0048103]; spermatogenesis [GO:0007283]; sprouting angiogenesis [GO:0002040]; T-helper 17 type immune response [GO:0072538]; tissue regeneration [GO:0042246]; tube formation [GO:0035148]; vasculogenesis involved in coronary vascular morphogenesis [GO:0060979]; venous blood vessel morphogenesis [GO:0048845]; venous endothelial cell differentiation [GO:0060843]; ventricular septum morphogenesis [GO:0060412]; ventricular trabecula myocardium morphogenesis [GO:0003222] acrosomal vesicle [GO:0001669]; adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell periphery [GO:0071944]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; lamellipodium [GO:0030027]; late endosome membrane [GO:0031902]; MAML1-RBP-Jkappa- ICN1 complex [GO:0002193]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; receptor complex [GO:0043235]; ruffle [GO:0001726]; Schaffer collateral - CA1 synapse [GO:0098685] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; identical protein binding [GO:0042802]; Notch binding [GO:0005112]; transcription coactivator activity [GO:0003713]; transcription regulator activator activity [GO:0140537]; transmembrane signaling receptor activity [GO:0004888] g256.t3 Q01705 42.484 153 6e-24 115.0 sp|Q01705|NOTC1_MOUSE Neurogenic locus notch homolog protein 1 OS=Mus musculus OX=10090 GN=Notch1 PE=1 SV=3 NOTC1_MOUSE reviewed Neurogenic locus notch homolog protein 1 (Notch 1) (Motch A) (mT14) (p300) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Mus musculus (Mouse) GO:0000122; GO:0000139; GO:0001554; GO:0001669; GO:0001701; GO:0001708; GO:0001726; GO:0001837; GO:0001889; GO:0001947; GO:0002040; GO:0002051; GO:0002052; GO:0002193; GO:0002437; GO:0003151; GO:0003157; GO:0003160; GO:0003162; GO:0003169; GO:0003180; GO:0003181; GO:0003182; GO:0003184; GO:0003192; GO:0003197; GO:0003198; GO:0003203; GO:0003207; GO:0003208; GO:0003209; GO:0003213; GO:0003214; GO:0003219; GO:0003222; GO:0003241; GO:0003252; GO:0003264; GO:0003273; GO:0003332; GO:0003344; GO:0003682; GO:0003713; GO:0004857; GO:0004888; GO:0005112; GO:0005509; GO:0005576; GO:0005634; GO:0005654; GO:0005737; GO:0005783; GO:0005789; GO:0005829; GO:0005856; GO:0005886; GO:0005912; GO:0006357; GO:0006606; GO:0006959; GO:0007219; GO:0007221; GO:0007283; GO:0007368; GO:0007386; GO:0007409; GO:0007411; GO:0007440; GO:0007492; GO:0007507; GO:0008284; GO:0008285; GO:0008544; GO:0008593; GO:0009912; GO:0009986; GO:0010001; GO:0010008; GO:0010467; GO:0010468; GO:0010614; GO:0010628; GO:0010629; GO:0010667; GO:0010718; GO:0010812; GO:0010832; GO:0014031; GO:0014807; GO:0016324; GO:0019899; GO:0021515; GO:0021915; GO:0030027; GO:0030154; GO:0030163; GO:0030182; GO:0030216; GO:0030279; GO:0030324; GO:0030326; GO:0030334; GO:0030335; GO:0030513; GO:0030514; GO:0030900; GO:0031069; GO:0031100; GO:0031410; GO:0031490; GO:0031902; GO:0032495; GO:0032496; GO:0032966; GO:0035116; GO:0035148; GO:0035914; GO:0035924; GO:0042127; GO:0042246; GO:0042802; GO:0043065; GO:0043069; GO:0043086; GO:0043235; GO:0045070; GO:0045165; GO:0045596; GO:0045603; GO:0045607; GO:0045608; GO:0045618; GO:0045662; GO:0045665; GO:0045668; GO:0045687; GO:0045747; GO:0045892; GO:0045893; GO:0045944; GO:0045955; GO:0046427; GO:0046533; GO:0046579; GO:0048103; GO:0048593; GO:0048663; GO:0048708; GO:0048709; GO:0048711; GO:0048715; GO:0048754; GO:0048845; GO:0048873; GO:0050678; GO:0050679; GO:0050767; GO:0050768; GO:0051152; GO:0055008; GO:0060038; GO:0060045; GO:0060253; GO:0060271; GO:0060317; GO:0060354; GO:0060379; GO:0060411; GO:0060412; GO:0060528; GO:0060740; GO:0060768; GO:0060842; GO:0060843; GO:0060948; GO:0060956; GO:0060979; GO:0060982; GO:0061344; GO:0061384; GO:0062043; GO:0070168; GO:0070374; GO:0070986; GO:0071228; GO:0071372; GO:0071456; GO:0071944; GO:0072017; GO:0072044; GO:0072144; GO:0072538; GO:0090051; GO:0090090; GO:0097150; GO:0097400; GO:0098685; GO:0098839; GO:0098978; GO:0099565; GO:0120163; GO:0140537; GO:1901189; GO:1901201; GO:1902263; GO:1902339; GO:1903849; GO:2000048; GO:2000737; GO:2000811; GO:2000974; GO:2001027 animal organ regeneration [GO:0031100]; aortic valve morphogenesis [GO:0003180]; apoptotic process involved in embryonic digit morphogenesis [GO:1902263]; arterial endothelial cell differentiation [GO:0060842]; astrocyte differentiation [GO:0048708]; atrioventricular node development [GO:0003162]; atrioventricular valve morphogenesis [GO:0003181]; auditory receptor cell fate commitment [GO:0009912]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; branching morphogenesis of an epithelial tube [GO:0048754]; camera-type eye morphogenesis [GO:0048593]; cardiac atrium morphogenesis [GO:0003209]; cardiac chamber formation [GO:0003207]; cardiac epithelial to mesenchymal transition [GO:0060317]; cardiac left ventricle morphogenesis [GO:0003214]; cardiac muscle cell myoblast differentiation [GO:0060379]; cardiac muscle cell proliferation [GO:0060038]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac right atrium morphogenesis [GO:0003213]; cardiac right ventricle formation [GO:0003219]; cardiac septum morphogenesis [GO:0060411]; cardiac vascular smooth muscle cell development [GO:0060948]; cardiac ventricle morphogenesis [GO:0003208]; cell differentiation [GO:0030154]; cell differentiation in spinal cord [GO:0021515]; cell fate commitment [GO:0045165]; cell fate specification [GO:0001708]; cell migration involved in endocardial cushion formation [GO:0003273]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to hypoxia [GO:0071456]; cellular response to tumor cell [GO:0071228]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; chemical synaptic transmission, postsynaptic [GO:0099565]; cilium assembly [GO:0060271]; collecting duct development [GO:0072044]; compartment pattern specification [GO:0007386]; coronary artery morphogenesis [GO:0060982]; coronary sinus valve morphogenesis [GO:0003182]; coronary vein morphogenesis [GO:0003169]; determination of left/right symmetry [GO:0007368]; distal tubule development [GO:0072017]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic limb morphogenesis [GO:0030326]; endocardial cell differentiation [GO:0060956]; endocardial cushion development [GO:0003197]; endocardial cushion morphogenesis [GO:0003203]; endocardium development [GO:0003157]; endocardium morphogenesis [GO:0003160]; endoderm development [GO:0007492]; epidermis development [GO:0008544]; epithelial to mesenchymal transition [GO:0001837]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; forebrain development [GO:0030900]; foregut morphogenesis [GO:0007440]; gene expression [GO:0010467]; glial cell differentiation [GO:0010001]; glomerular mesangial cell development [GO:0072144]; growth involved in heart morphogenesis [GO:0003241]; hair follicle morphogenesis [GO:0031069]; heart development [GO:0007507]; heart looping [GO:0001947]; heart trabecula morphogenesis [GO:0061384]; homeostasis of number of cells within a tissue [GO:0048873]; humoral immune response [GO:0006959]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; interleukin-17-mediated signaling pathway [GO:0097400]; keratinocyte differentiation [GO:0030216]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; lung development [GO:0030324]; luteolysis [GO:0001554]; mesenchymal cell development [GO:0014031]; mitral valve formation [GO:0003192]; negative regulation of anoikis [GO:2000811]; negative regulation of biomineral tissue development [GO:0070168]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of catalytic activity [GO:0043086]; negative regulation of cell adhesion molecule production [GO:0060354]; negative regulation of cell differentiation [GO:0045596]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell proliferation involved in heart valve morphogenesis [GO:0003252]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of collagen biosynthetic process [GO:0032966]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of endothelial cell chemotaxis [GO:2001027]; negative regulation of extracellular matrix constituent secretion [GO:0003332]; negative regulation of gene expression [GO:0010629]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of inner ear auditory receptor cell differentiation [GO:0045608]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of ossification [GO:0030279]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of photoreceptor cell differentiation [GO:0046533]; negative regulation of pro-B cell differentiation [GO:2000974]; negative regulation of programmed cell death [GO:0043069]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural tube development [GO:0021915]; neuron differentiation [GO:0030182]; neuron fate commitment [GO:0048663]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; oligodendrocyte differentiation [GO:0048709]; osteoblast fate commitment [GO:0002051]; outflow tract morphogenesis [GO:0003151]; pericardium morphogenesis [GO:0003344]; positive regulation of aorta morphogenesis [GO:1903849]; positive regulation of apoptotic process [GO:0043065]; positive regulation of apoptotic process involved in morphogenesis [GO:1902339]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cardiac epithelial to mesenchymal transition [GO:0062043]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of ephrin receptor signaling pathway [GO:1901189]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of glial cell differentiation [GO:0045687]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of smooth muscle cell differentiation [GO:0051152]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription of Notch receptor target [GO:0007221]; positive regulation of viral genome replication [GO:0045070]; prostate gland epithelium morphogenesis [GO:0060740]; protein catabolic process [GO:0030163]; protein import into nucleus [GO:0006606]; pulmonary valve morphogenesis [GO:0003184]; regulation of cardioblast proliferation [GO:0003264]; regulation of cell adhesion involved in heart morphogenesis [GO:0061344]; regulation of cell migration [GO:0030334]; regulation of cell population proliferation [GO:0042127]; regulation of epithelial cell proliferation [GO:0050678]; regulation of epithelial cell proliferation involved in prostate gland development [GO:0060768]; regulation of extracellular matrix assembly [GO:1901201]; regulation of gene expression [GO:0010468]; regulation of inner ear auditory receptor cell differentiation [GO:0045607]; regulation of neurogenesis [GO:0050767]; regulation of Notch signaling pathway [GO:0008593]; regulation of somitogenesis [GO:0014807]; regulation of transcription by RNA polymerase II [GO:0006357]; response to lipopolysaccharide [GO:0032496]; response to muramyl dipeptide [GO:0032495]; secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development [GO:0060528]; skeletal muscle cell differentiation [GO:0035914]; somatic stem cell division [GO:0048103]; spermatogenesis [GO:0007283]; sprouting angiogenesis [GO:0002040]; T-helper 17 type immune response [GO:0072538]; tissue regeneration [GO:0042246]; tube formation [GO:0035148]; vasculogenesis involved in coronary vascular morphogenesis [GO:0060979]; venous blood vessel morphogenesis [GO:0048845]; venous endothelial cell differentiation [GO:0060843]; ventricular septum morphogenesis [GO:0060412]; ventricular trabecula myocardium morphogenesis [GO:0003222] acrosomal vesicle [GO:0001669]; adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell periphery [GO:0071944]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; lamellipodium [GO:0030027]; late endosome membrane [GO:0031902]; MAML1-RBP-Jkappa- ICN1 complex [GO:0002193]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; receptor complex [GO:0043235]; ruffle [GO:0001726]; Schaffer collateral - CA1 synapse [GO:0098685] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; identical protein binding [GO:0042802]; Notch binding [GO:0005112]; transcription coactivator activity [GO:0003713]; transcription regulator activator activity [GO:0140537]; transmembrane signaling receptor activity [GO:0004888] g256.t3 Q01705 41.176 153 4.07e-22 109.0 sp|Q01705|NOTC1_MOUSE Neurogenic locus notch homolog protein 1 OS=Mus musculus OX=10090 GN=Notch1 PE=1 SV=3 NOTC1_MOUSE reviewed Neurogenic locus notch homolog protein 1 (Notch 1) (Motch A) (mT14) (p300) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Mus musculus (Mouse) GO:0000122; GO:0000139; GO:0001554; GO:0001669; GO:0001701; GO:0001708; GO:0001726; GO:0001837; GO:0001889; GO:0001947; GO:0002040; GO:0002051; GO:0002052; GO:0002193; GO:0002437; GO:0003151; GO:0003157; GO:0003160; GO:0003162; GO:0003169; GO:0003180; GO:0003181; GO:0003182; GO:0003184; GO:0003192; GO:0003197; GO:0003198; GO:0003203; GO:0003207; GO:0003208; GO:0003209; GO:0003213; GO:0003214; GO:0003219; GO:0003222; GO:0003241; GO:0003252; GO:0003264; GO:0003273; GO:0003332; GO:0003344; GO:0003682; GO:0003713; GO:0004857; GO:0004888; GO:0005112; GO:0005509; GO:0005576; GO:0005634; GO:0005654; GO:0005737; GO:0005783; GO:0005789; GO:0005829; GO:0005856; GO:0005886; GO:0005912; GO:0006357; GO:0006606; GO:0006959; GO:0007219; GO:0007221; GO:0007283; GO:0007368; GO:0007386; GO:0007409; GO:0007411; GO:0007440; GO:0007492; GO:0007507; GO:0008284; GO:0008285; GO:0008544; GO:0008593; GO:0009912; GO:0009986; GO:0010001; GO:0010008; GO:0010467; GO:0010468; GO:0010614; GO:0010628; GO:0010629; GO:0010667; GO:0010718; GO:0010812; GO:0010832; GO:0014031; GO:0014807; GO:0016324; GO:0019899; GO:0021515; GO:0021915; GO:0030027; GO:0030154; GO:0030163; GO:0030182; GO:0030216; GO:0030279; GO:0030324; GO:0030326; GO:0030334; GO:0030335; GO:0030513; GO:0030514; GO:0030900; GO:0031069; GO:0031100; GO:0031410; GO:0031490; GO:0031902; GO:0032495; GO:0032496; GO:0032966; GO:0035116; GO:0035148; GO:0035914; GO:0035924; GO:0042127; GO:0042246; GO:0042802; GO:0043065; GO:0043069; GO:0043086; GO:0043235; GO:0045070; GO:0045165; GO:0045596; GO:0045603; GO:0045607; GO:0045608; GO:0045618; GO:0045662; GO:0045665; GO:0045668; GO:0045687; GO:0045747; GO:0045892; GO:0045893; GO:0045944; GO:0045955; GO:0046427; GO:0046533; GO:0046579; GO:0048103; GO:0048593; GO:0048663; GO:0048708; GO:0048709; GO:0048711; GO:0048715; GO:0048754; GO:0048845; GO:0048873; GO:0050678; GO:0050679; GO:0050767; GO:0050768; GO:0051152; GO:0055008; GO:0060038; GO:0060045; GO:0060253; GO:0060271; GO:0060317; GO:0060354; GO:0060379; GO:0060411; GO:0060412; GO:0060528; GO:0060740; GO:0060768; GO:0060842; GO:0060843; GO:0060948; GO:0060956; GO:0060979; GO:0060982; GO:0061344; GO:0061384; GO:0062043; GO:0070168; GO:0070374; GO:0070986; GO:0071228; GO:0071372; GO:0071456; GO:0071944; GO:0072017; GO:0072044; GO:0072144; GO:0072538; GO:0090051; GO:0090090; GO:0097150; GO:0097400; GO:0098685; GO:0098839; GO:0098978; GO:0099565; GO:0120163; GO:0140537; GO:1901189; GO:1901201; GO:1902263; GO:1902339; GO:1903849; GO:2000048; GO:2000737; GO:2000811; GO:2000974; GO:2001027 animal organ regeneration [GO:0031100]; aortic valve morphogenesis [GO:0003180]; apoptotic process involved in embryonic digit morphogenesis [GO:1902263]; arterial endothelial cell differentiation [GO:0060842]; astrocyte differentiation [GO:0048708]; atrioventricular node development [GO:0003162]; atrioventricular valve morphogenesis [GO:0003181]; auditory receptor cell fate commitment [GO:0009912]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; branching morphogenesis of an epithelial tube [GO:0048754]; camera-type eye morphogenesis [GO:0048593]; cardiac atrium morphogenesis [GO:0003209]; cardiac chamber formation [GO:0003207]; cardiac epithelial to mesenchymal transition [GO:0060317]; cardiac left ventricle morphogenesis [GO:0003214]; cardiac muscle cell myoblast differentiation [GO:0060379]; cardiac muscle cell proliferation [GO:0060038]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac right atrium morphogenesis [GO:0003213]; cardiac right ventricle formation [GO:0003219]; cardiac septum morphogenesis [GO:0060411]; cardiac vascular smooth muscle cell development [GO:0060948]; cardiac ventricle morphogenesis [GO:0003208]; cell differentiation [GO:0030154]; cell differentiation in spinal cord [GO:0021515]; cell fate commitment [GO:0045165]; cell fate specification [GO:0001708]; cell migration involved in endocardial cushion formation [GO:0003273]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to hypoxia [GO:0071456]; cellular response to tumor cell [GO:0071228]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; chemical synaptic transmission, postsynaptic [GO:0099565]; cilium assembly [GO:0060271]; collecting duct development [GO:0072044]; compartment pattern specification [GO:0007386]; coronary artery morphogenesis [GO:0060982]; coronary sinus valve morphogenesis [GO:0003182]; coronary vein morphogenesis [GO:0003169]; determination of left/right symmetry [GO:0007368]; distal tubule development [GO:0072017]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic limb morphogenesis [GO:0030326]; endocardial cell differentiation [GO:0060956]; endocardial cushion development [GO:0003197]; endocardial cushion morphogenesis [GO:0003203]; endocardium development [GO:0003157]; endocardium morphogenesis [GO:0003160]; endoderm development [GO:0007492]; epidermis development [GO:0008544]; epithelial to mesenchymal transition [GO:0001837]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; forebrain development [GO:0030900]; foregut morphogenesis [GO:0007440]; gene expression [GO:0010467]; glial cell differentiation [GO:0010001]; glomerular mesangial cell development [GO:0072144]; growth involved in heart morphogenesis [GO:0003241]; hair follicle morphogenesis [GO:0031069]; heart development [GO:0007507]; heart looping [GO:0001947]; heart trabecula morphogenesis [GO:0061384]; homeostasis of number of cells within a tissue [GO:0048873]; humoral immune response [GO:0006959]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; interleukin-17-mediated signaling pathway [GO:0097400]; keratinocyte differentiation [GO:0030216]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; lung development [GO:0030324]; luteolysis [GO:0001554]; mesenchymal cell development [GO:0014031]; mitral valve formation [GO:0003192]; negative regulation of anoikis [GO:2000811]; negative regulation of biomineral tissue development [GO:0070168]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of catalytic activity [GO:0043086]; negative regulation of cell adhesion molecule production [GO:0060354]; negative regulation of cell differentiation [GO:0045596]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell proliferation involved in heart valve morphogenesis [GO:0003252]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of collagen biosynthetic process [GO:0032966]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of endothelial cell chemotaxis [GO:2001027]; negative regulation of extracellular matrix constituent secretion [GO:0003332]; negative regulation of gene expression [GO:0010629]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of inner ear auditory receptor cell differentiation [GO:0045608]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of ossification [GO:0030279]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of photoreceptor cell differentiation [GO:0046533]; negative regulation of pro-B cell differentiation [GO:2000974]; negative regulation of programmed cell death [GO:0043069]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural tube development [GO:0021915]; neuron differentiation [GO:0030182]; neuron fate commitment [GO:0048663]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; oligodendrocyte differentiation [GO:0048709]; osteoblast fate commitment [GO:0002051]; outflow tract morphogenesis [GO:0003151]; pericardium morphogenesis [GO:0003344]; positive regulation of aorta morphogenesis [GO:1903849]; positive regulation of apoptotic process [GO:0043065]; positive regulation of apoptotic process involved in morphogenesis [GO:1902339]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cardiac epithelial to mesenchymal transition [GO:0062043]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of ephrin receptor signaling pathway [GO:1901189]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of glial cell differentiation [GO:0045687]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of smooth muscle cell differentiation [GO:0051152]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription of Notch receptor target [GO:0007221]; positive regulation of viral genome replication [GO:0045070]; prostate gland epithelium morphogenesis [GO:0060740]; protein catabolic process [GO:0030163]; protein import into nucleus [GO:0006606]; pulmonary valve morphogenesis [GO:0003184]; regulation of cardioblast proliferation [GO:0003264]; regulation of cell adhesion involved in heart morphogenesis [GO:0061344]; regulation of cell migration [GO:0030334]; regulation of cell population proliferation [GO:0042127]; regulation of epithelial cell proliferation [GO:0050678]; regulation of epithelial cell proliferation involved in prostate gland development [GO:0060768]; regulation of extracellular matrix assembly [GO:1901201]; regulation of gene expression [GO:0010468]; regulation of inner ear auditory receptor cell differentiation [GO:0045607]; regulation of neurogenesis [GO:0050767]; regulation of Notch signaling pathway [GO:0008593]; regulation of somitogenesis [GO:0014807]; regulation of transcription by RNA polymerase II [GO:0006357]; response to lipopolysaccharide [GO:0032496]; response to muramyl dipeptide [GO:0032495]; secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development [GO:0060528]; skeletal muscle cell differentiation [GO:0035914]; somatic stem cell division [GO:0048103]; spermatogenesis [GO:0007283]; sprouting angiogenesis [GO:0002040]; T-helper 17 type immune response [GO:0072538]; tissue regeneration [GO:0042246]; tube formation [GO:0035148]; vasculogenesis involved in coronary vascular morphogenesis [GO:0060979]; venous blood vessel morphogenesis [GO:0048845]; venous endothelial cell differentiation [GO:0060843]; ventricular septum morphogenesis [GO:0060412]; ventricular trabecula myocardium morphogenesis [GO:0003222] acrosomal vesicle [GO:0001669]; adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell periphery [GO:0071944]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; lamellipodium [GO:0030027]; late endosome membrane [GO:0031902]; MAML1-RBP-Jkappa- ICN1 complex [GO:0002193]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; receptor complex [GO:0043235]; ruffle [GO:0001726]; Schaffer collateral - CA1 synapse [GO:0098685] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; identical protein binding [GO:0042802]; Notch binding [GO:0005112]; transcription coactivator activity [GO:0003713]; transcription regulator activator activity [GO:0140537]; transmembrane signaling receptor activity [GO:0004888] g256.t3 Q01705 41.176 153 2.3700000000000003e-21 107.0 sp|Q01705|NOTC1_MOUSE Neurogenic locus notch homolog protein 1 OS=Mus musculus OX=10090 GN=Notch1 PE=1 SV=3 NOTC1_MOUSE reviewed Neurogenic locus notch homolog protein 1 (Notch 1) (Motch A) (mT14) (p300) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Mus musculus (Mouse) GO:0000122; GO:0000139; GO:0001554; GO:0001669; GO:0001701; GO:0001708; GO:0001726; GO:0001837; GO:0001889; GO:0001947; GO:0002040; GO:0002051; GO:0002052; GO:0002193; GO:0002437; GO:0003151; GO:0003157; GO:0003160; GO:0003162; GO:0003169; GO:0003180; GO:0003181; GO:0003182; GO:0003184; GO:0003192; GO:0003197; GO:0003198; GO:0003203; GO:0003207; GO:0003208; GO:0003209; GO:0003213; GO:0003214; GO:0003219; GO:0003222; GO:0003241; GO:0003252; GO:0003264; GO:0003273; GO:0003332; GO:0003344; GO:0003682; GO:0003713; GO:0004857; GO:0004888; GO:0005112; GO:0005509; GO:0005576; GO:0005634; GO:0005654; GO:0005737; GO:0005783; GO:0005789; GO:0005829; GO:0005856; GO:0005886; GO:0005912; GO:0006357; GO:0006606; GO:0006959; GO:0007219; GO:0007221; GO:0007283; GO:0007368; GO:0007386; GO:0007409; GO:0007411; GO:0007440; GO:0007492; GO:0007507; GO:0008284; GO:0008285; GO:0008544; GO:0008593; GO:0009912; GO:0009986; GO:0010001; GO:0010008; GO:0010467; GO:0010468; GO:0010614; GO:0010628; GO:0010629; GO:0010667; GO:0010718; GO:0010812; GO:0010832; GO:0014031; GO:0014807; GO:0016324; GO:0019899; GO:0021515; GO:0021915; GO:0030027; GO:0030154; GO:0030163; GO:0030182; GO:0030216; GO:0030279; GO:0030324; GO:0030326; GO:0030334; GO:0030335; GO:0030513; GO:0030514; GO:0030900; GO:0031069; GO:0031100; GO:0031410; GO:0031490; GO:0031902; GO:0032495; GO:0032496; GO:0032966; GO:0035116; GO:0035148; GO:0035914; GO:0035924; GO:0042127; GO:0042246; GO:0042802; GO:0043065; GO:0043069; GO:0043086; GO:0043235; GO:0045070; GO:0045165; GO:0045596; GO:0045603; GO:0045607; GO:0045608; GO:0045618; GO:0045662; GO:0045665; GO:0045668; GO:0045687; GO:0045747; GO:0045892; GO:0045893; GO:0045944; GO:0045955; GO:0046427; GO:0046533; GO:0046579; GO:0048103; GO:0048593; GO:0048663; GO:0048708; GO:0048709; GO:0048711; GO:0048715; GO:0048754; GO:0048845; GO:0048873; GO:0050678; GO:0050679; GO:0050767; GO:0050768; GO:0051152; GO:0055008; GO:0060038; GO:0060045; GO:0060253; GO:0060271; GO:0060317; GO:0060354; GO:0060379; GO:0060411; GO:0060412; GO:0060528; GO:0060740; GO:0060768; GO:0060842; GO:0060843; GO:0060948; GO:0060956; GO:0060979; GO:0060982; GO:0061344; GO:0061384; GO:0062043; GO:0070168; GO:0070374; GO:0070986; GO:0071228; GO:0071372; GO:0071456; GO:0071944; GO:0072017; GO:0072044; GO:0072144; GO:0072538; GO:0090051; GO:0090090; GO:0097150; GO:0097400; GO:0098685; GO:0098839; GO:0098978; GO:0099565; GO:0120163; GO:0140537; GO:1901189; GO:1901201; GO:1902263; GO:1902339; GO:1903849; GO:2000048; GO:2000737; GO:2000811; GO:2000974; GO:2001027 animal organ regeneration [GO:0031100]; aortic valve morphogenesis [GO:0003180]; apoptotic process involved in embryonic digit morphogenesis [GO:1902263]; arterial endothelial cell differentiation [GO:0060842]; astrocyte differentiation [GO:0048708]; atrioventricular node development [GO:0003162]; atrioventricular valve morphogenesis [GO:0003181]; auditory receptor cell fate commitment [GO:0009912]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; branching morphogenesis of an epithelial tube [GO:0048754]; camera-type eye morphogenesis [GO:0048593]; cardiac atrium morphogenesis [GO:0003209]; cardiac chamber formation [GO:0003207]; cardiac epithelial to mesenchymal transition [GO:0060317]; cardiac left ventricle morphogenesis [GO:0003214]; cardiac muscle cell myoblast differentiation [GO:0060379]; cardiac muscle cell proliferation [GO:0060038]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac right atrium morphogenesis [GO:0003213]; cardiac right ventricle formation [GO:0003219]; cardiac septum morphogenesis [GO:0060411]; cardiac vascular smooth muscle cell development [GO:0060948]; cardiac ventricle morphogenesis [GO:0003208]; cell differentiation [GO:0030154]; cell differentiation in spinal cord [GO:0021515]; cell fate commitment [GO:0045165]; cell fate specification [GO:0001708]; cell migration involved in endocardial cushion formation [GO:0003273]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to hypoxia [GO:0071456]; cellular response to tumor cell [GO:0071228]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; chemical synaptic transmission, postsynaptic [GO:0099565]; cilium assembly [GO:0060271]; collecting duct development [GO:0072044]; compartment pattern specification [GO:0007386]; coronary artery morphogenesis [GO:0060982]; coronary sinus valve morphogenesis [GO:0003182]; coronary vein morphogenesis [GO:0003169]; determination of left/right symmetry [GO:0007368]; distal tubule development [GO:0072017]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic limb morphogenesis [GO:0030326]; endocardial cell differentiation [GO:0060956]; endocardial cushion development [GO:0003197]; endocardial cushion morphogenesis [GO:0003203]; endocardium development [GO:0003157]; endocardium morphogenesis [GO:0003160]; endoderm development [GO:0007492]; epidermis development [GO:0008544]; epithelial to mesenchymal transition [GO:0001837]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; forebrain development [GO:0030900]; foregut morphogenesis [GO:0007440]; gene expression [GO:0010467]; glial cell differentiation [GO:0010001]; glomerular mesangial cell development [GO:0072144]; growth involved in heart morphogenesis [GO:0003241]; hair follicle morphogenesis [GO:0031069]; heart development [GO:0007507]; heart looping [GO:0001947]; heart trabecula morphogenesis [GO:0061384]; homeostasis of number of cells within a tissue [GO:0048873]; humoral immune response [GO:0006959]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; interleukin-17-mediated signaling pathway [GO:0097400]; keratinocyte differentiation [GO:0030216]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; lung development [GO:0030324]; luteolysis [GO:0001554]; mesenchymal cell development [GO:0014031]; mitral valve formation [GO:0003192]; negative regulation of anoikis [GO:2000811]; negative regulation of biomineral tissue development [GO:0070168]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of catalytic activity [GO:0043086]; negative regulation of cell adhesion molecule production [GO:0060354]; negative regulation of cell differentiation [GO:0045596]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell proliferation involved in heart valve morphogenesis [GO:0003252]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of collagen biosynthetic process [GO:0032966]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of endothelial cell chemotaxis [GO:2001027]; negative regulation of extracellular matrix constituent secretion [GO:0003332]; negative regulation of gene expression [GO:0010629]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of inner ear auditory receptor cell differentiation [GO:0045608]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of ossification [GO:0030279]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of photoreceptor cell differentiation [GO:0046533]; negative regulation of pro-B cell differentiation [GO:2000974]; negative regulation of programmed cell death [GO:0043069]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural tube development [GO:0021915]; neuron differentiation [GO:0030182]; neuron fate commitment [GO:0048663]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; oligodendrocyte differentiation [GO:0048709]; osteoblast fate commitment [GO:0002051]; outflow tract morphogenesis [GO:0003151]; pericardium morphogenesis [GO:0003344]; positive regulation of aorta morphogenesis [GO:1903849]; positive regulation of apoptotic process [GO:0043065]; positive regulation of apoptotic process involved in morphogenesis [GO:1902339]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cardiac epithelial to mesenchymal transition [GO:0062043]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of ephrin receptor signaling pathway [GO:1901189]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of glial cell differentiation [GO:0045687]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of smooth muscle cell differentiation [GO:0051152]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription of Notch receptor target [GO:0007221]; positive regulation of viral genome replication [GO:0045070]; prostate gland epithelium morphogenesis [GO:0060740]; protein catabolic process [GO:0030163]; protein import into nucleus [GO:0006606]; pulmonary valve morphogenesis [GO:0003184]; regulation of cardioblast proliferation [GO:0003264]; regulation of cell adhesion involved in heart morphogenesis [GO:0061344]; regulation of cell migration [GO:0030334]; regulation of cell population proliferation [GO:0042127]; regulation of epithelial cell proliferation [GO:0050678]; regulation of epithelial cell proliferation involved in prostate gland development [GO:0060768]; regulation of extracellular matrix assembly [GO:1901201]; regulation of gene expression [GO:0010468]; regulation of inner ear auditory receptor cell differentiation [GO:0045607]; regulation of neurogenesis [GO:0050767]; regulation of Notch signaling pathway [GO:0008593]; regulation of somitogenesis [GO:0014807]; regulation of transcription by RNA polymerase II [GO:0006357]; response to lipopolysaccharide [GO:0032496]; response to muramyl dipeptide [GO:0032495]; secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development [GO:0060528]; skeletal muscle cell differentiation [GO:0035914]; somatic stem cell division [GO:0048103]; spermatogenesis [GO:0007283]; sprouting angiogenesis [GO:0002040]; T-helper 17 type immune response [GO:0072538]; tissue regeneration [GO:0042246]; tube formation [GO:0035148]; vasculogenesis involved in coronary vascular morphogenesis [GO:0060979]; venous blood vessel morphogenesis [GO:0048845]; venous endothelial cell differentiation [GO:0060843]; ventricular septum morphogenesis [GO:0060412]; ventricular trabecula myocardium morphogenesis [GO:0003222] acrosomal vesicle [GO:0001669]; adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell periphery [GO:0071944]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; lamellipodium [GO:0030027]; late endosome membrane [GO:0031902]; MAML1-RBP-Jkappa- ICN1 complex [GO:0002193]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; receptor complex [GO:0043235]; ruffle [GO:0001726]; Schaffer collateral - CA1 synapse [GO:0098685] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; identical protein binding [GO:0042802]; Notch binding [GO:0005112]; transcription coactivator activity [GO:0003713]; transcription regulator activator activity [GO:0140537]; transmembrane signaling receptor activity [GO:0004888] g256.t4 Q01705 37.079 1424 0.0 727.0 sp|Q01705|NOTC1_MOUSE Neurogenic locus notch homolog protein 1 OS=Mus musculus OX=10090 GN=Notch1 PE=1 SV=3 NOTC1_MOUSE reviewed Neurogenic locus notch homolog protein 1 (Notch 1) (Motch A) (mT14) (p300) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Mus musculus (Mouse) GO:0000122; GO:0000139; GO:0001554; GO:0001669; GO:0001701; GO:0001708; GO:0001726; GO:0001837; GO:0001889; GO:0001947; GO:0002040; GO:0002051; GO:0002052; GO:0002193; GO:0002437; GO:0003151; GO:0003157; GO:0003160; GO:0003162; GO:0003169; GO:0003180; GO:0003181; GO:0003182; GO:0003184; GO:0003192; GO:0003197; GO:0003198; GO:0003203; GO:0003207; GO:0003208; GO:0003209; GO:0003213; GO:0003214; GO:0003219; GO:0003222; GO:0003241; GO:0003252; GO:0003264; GO:0003273; GO:0003332; GO:0003344; GO:0003682; GO:0003713; GO:0004857; GO:0004888; GO:0005112; GO:0005509; GO:0005576; GO:0005634; GO:0005654; GO:0005737; GO:0005783; GO:0005789; GO:0005829; GO:0005856; GO:0005886; GO:0005912; GO:0006357; GO:0006606; GO:0006959; GO:0007219; GO:0007221; GO:0007283; GO:0007368; GO:0007386; GO:0007409; GO:0007411; GO:0007440; GO:0007492; GO:0007507; GO:0008284; GO:0008285; GO:0008544; GO:0008593; GO:0009912; GO:0009986; GO:0010001; GO:0010008; GO:0010467; GO:0010468; GO:0010614; GO:0010628; GO:0010629; GO:0010667; GO:0010718; GO:0010812; GO:0010832; GO:0014031; GO:0014807; GO:0016324; GO:0019899; GO:0021515; GO:0021915; GO:0030027; GO:0030154; GO:0030163; GO:0030182; GO:0030216; GO:0030279; GO:0030324; GO:0030326; GO:0030334; GO:0030335; GO:0030513; GO:0030514; GO:0030900; GO:0031069; GO:0031100; GO:0031410; GO:0031490; GO:0031902; GO:0032495; GO:0032496; GO:0032966; GO:0035116; GO:0035148; GO:0035914; GO:0035924; GO:0042127; GO:0042246; GO:0042802; GO:0043065; GO:0043069; GO:0043086; GO:0043235; GO:0045070; GO:0045165; GO:0045596; GO:0045603; GO:0045607; GO:0045608; GO:0045618; GO:0045662; GO:0045665; GO:0045668; GO:0045687; GO:0045747; GO:0045892; GO:0045893; GO:0045944; GO:0045955; GO:0046427; GO:0046533; GO:0046579; GO:0048103; GO:0048593; GO:0048663; GO:0048708; GO:0048709; GO:0048711; GO:0048715; GO:0048754; GO:0048845; GO:0048873; GO:0050678; GO:0050679; GO:0050767; GO:0050768; GO:0051152; GO:0055008; GO:0060038; GO:0060045; GO:0060253; GO:0060271; GO:0060317; GO:0060354; GO:0060379; GO:0060411; GO:0060412; GO:0060528; GO:0060740; GO:0060768; GO:0060842; GO:0060843; GO:0060948; GO:0060956; GO:0060979; GO:0060982; GO:0061344; GO:0061384; GO:0062043; GO:0070168; GO:0070374; GO:0070986; GO:0071228; GO:0071372; GO:0071456; GO:0071944; GO:0072017; GO:0072044; GO:0072144; GO:0072538; GO:0090051; GO:0090090; GO:0097150; GO:0097400; GO:0098685; GO:0098839; GO:0098978; GO:0099565; GO:0120163; GO:0140537; GO:1901189; GO:1901201; GO:1902263; GO:1902339; GO:1903849; GO:2000048; GO:2000737; GO:2000811; GO:2000974; GO:2001027 animal organ regeneration [GO:0031100]; aortic valve morphogenesis [GO:0003180]; apoptotic process involved in embryonic digit morphogenesis [GO:1902263]; arterial endothelial cell differentiation [GO:0060842]; astrocyte differentiation [GO:0048708]; atrioventricular node development [GO:0003162]; atrioventricular valve morphogenesis [GO:0003181]; auditory receptor cell fate commitment [GO:0009912]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; branching morphogenesis of an epithelial tube [GO:0048754]; camera-type eye morphogenesis [GO:0048593]; cardiac atrium morphogenesis [GO:0003209]; cardiac chamber formation [GO:0003207]; cardiac epithelial to mesenchymal transition [GO:0060317]; cardiac left ventricle morphogenesis [GO:0003214]; cardiac muscle cell myoblast differentiation [GO:0060379]; cardiac muscle cell proliferation [GO:0060038]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac right atrium morphogenesis [GO:0003213]; cardiac right ventricle formation [GO:0003219]; cardiac septum morphogenesis [GO:0060411]; cardiac vascular smooth muscle cell development [GO:0060948]; cardiac ventricle morphogenesis [GO:0003208]; cell differentiation [GO:0030154]; cell differentiation in spinal cord [GO:0021515]; cell fate commitment [GO:0045165]; cell fate specification [GO:0001708]; cell migration involved in endocardial cushion formation [GO:0003273]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to hypoxia [GO:0071456]; cellular response to tumor cell [GO:0071228]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; chemical synaptic transmission, postsynaptic [GO:0099565]; cilium assembly [GO:0060271]; collecting duct development [GO:0072044]; compartment pattern specification [GO:0007386]; coronary artery morphogenesis [GO:0060982]; coronary sinus valve morphogenesis [GO:0003182]; coronary vein morphogenesis [GO:0003169]; determination of left/right symmetry [GO:0007368]; distal tubule development [GO:0072017]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic limb morphogenesis [GO:0030326]; endocardial cell differentiation [GO:0060956]; endocardial cushion development [GO:0003197]; endocardial cushion morphogenesis [GO:0003203]; endocardium development [GO:0003157]; endocardium morphogenesis [GO:0003160]; endoderm development [GO:0007492]; epidermis development [GO:0008544]; epithelial to mesenchymal transition [GO:0001837]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; forebrain development [GO:0030900]; foregut morphogenesis [GO:0007440]; gene expression [GO:0010467]; glial cell differentiation [GO:0010001]; glomerular mesangial cell development [GO:0072144]; growth involved in heart morphogenesis [GO:0003241]; hair follicle morphogenesis [GO:0031069]; heart development [GO:0007507]; heart looping [GO:0001947]; heart trabecula morphogenesis [GO:0061384]; homeostasis of number of cells within a tissue [GO:0048873]; humoral immune response [GO:0006959]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; interleukin-17-mediated signaling pathway [GO:0097400]; keratinocyte differentiation [GO:0030216]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; lung development [GO:0030324]; luteolysis [GO:0001554]; mesenchymal cell development [GO:0014031]; mitral valve formation [GO:0003192]; negative regulation of anoikis [GO:2000811]; negative regulation of biomineral tissue development [GO:0070168]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of catalytic activity [GO:0043086]; negative regulation of cell adhesion molecule production [GO:0060354]; negative regulation of cell differentiation [GO:0045596]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell proliferation involved in heart valve morphogenesis [GO:0003252]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of collagen biosynthetic process [GO:0032966]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of endothelial cell chemotaxis [GO:2001027]; negative regulation of extracellular matrix constituent secretion [GO:0003332]; negative regulation of gene expression [GO:0010629]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of inner ear auditory receptor cell differentiation [GO:0045608]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of ossification [GO:0030279]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of photoreceptor cell differentiation [GO:0046533]; negative regulation of pro-B cell differentiation [GO:2000974]; negative regulation of programmed cell death [GO:0043069]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural tube development [GO:0021915]; neuron differentiation [GO:0030182]; neuron fate commitment [GO:0048663]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; oligodendrocyte differentiation [GO:0048709]; osteoblast fate commitment [GO:0002051]; outflow tract morphogenesis [GO:0003151]; pericardium morphogenesis [GO:0003344]; positive regulation of aorta morphogenesis [GO:1903849]; positive regulation of apoptotic process [GO:0043065]; positive regulation of apoptotic process involved in morphogenesis [GO:1902339]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cardiac epithelial to mesenchymal transition [GO:0062043]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of ephrin receptor signaling pathway [GO:1901189]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of glial cell differentiation [GO:0045687]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of smooth muscle cell differentiation [GO:0051152]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription of Notch receptor target [GO:0007221]; positive regulation of viral genome replication [GO:0045070]; prostate gland epithelium morphogenesis [GO:0060740]; protein catabolic process [GO:0030163]; protein import into nucleus [GO:0006606]; pulmonary valve morphogenesis [GO:0003184]; regulation of cardioblast proliferation [GO:0003264]; regulation of cell adhesion involved in heart morphogenesis [GO:0061344]; regulation of cell migration [GO:0030334]; regulation of cell population proliferation [GO:0042127]; regulation of epithelial cell proliferation [GO:0050678]; regulation of epithelial cell proliferation involved in prostate gland development [GO:0060768]; regulation of extracellular matrix assembly [GO:1901201]; regulation of gene expression [GO:0010468]; regulation of inner ear auditory receptor cell differentiation [GO:0045607]; regulation of neurogenesis [GO:0050767]; regulation of Notch signaling pathway [GO:0008593]; regulation of somitogenesis [GO:0014807]; regulation of transcription by RNA polymerase II [GO:0006357]; response to lipopolysaccharide [GO:0032496]; response to muramyl dipeptide [GO:0032495]; secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development [GO:0060528]; skeletal muscle cell differentiation [GO:0035914]; somatic stem cell division [GO:0048103]; spermatogenesis [GO:0007283]; sprouting angiogenesis [GO:0002040]; T-helper 17 type immune response [GO:0072538]; tissue regeneration [GO:0042246]; tube formation [GO:0035148]; vasculogenesis involved in coronary vascular morphogenesis [GO:0060979]; venous blood vessel morphogenesis [GO:0048845]; venous endothelial cell differentiation [GO:0060843]; ventricular septum morphogenesis [GO:0060412]; ventricular trabecula myocardium morphogenesis [GO:0003222] acrosomal vesicle [GO:0001669]; adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell periphery [GO:0071944]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; lamellipodium [GO:0030027]; late endosome membrane [GO:0031902]; MAML1-RBP-Jkappa- ICN1 complex [GO:0002193]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; receptor complex [GO:0043235]; ruffle [GO:0001726]; Schaffer collateral - CA1 synapse [GO:0098685] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; identical protein binding [GO:0042802]; Notch binding [GO:0005112]; transcription coactivator activity [GO:0003713]; transcription regulator activator activity [GO:0140537]; transmembrane signaling receptor activity [GO:0004888] g256.t4 Q01705 36.014 1455 0.0 675.0 sp|Q01705|NOTC1_MOUSE Neurogenic locus notch homolog protein 1 OS=Mus musculus OX=10090 GN=Notch1 PE=1 SV=3 NOTC1_MOUSE reviewed Neurogenic locus notch homolog protein 1 (Notch 1) (Motch A) (mT14) (p300) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Mus musculus (Mouse) GO:0000122; GO:0000139; GO:0001554; GO:0001669; GO:0001701; GO:0001708; GO:0001726; GO:0001837; GO:0001889; GO:0001947; GO:0002040; GO:0002051; GO:0002052; GO:0002193; GO:0002437; GO:0003151; GO:0003157; GO:0003160; GO:0003162; GO:0003169; GO:0003180; GO:0003181; GO:0003182; GO:0003184; GO:0003192; GO:0003197; GO:0003198; GO:0003203; GO:0003207; GO:0003208; GO:0003209; GO:0003213; GO:0003214; GO:0003219; GO:0003222; GO:0003241; GO:0003252; GO:0003264; GO:0003273; GO:0003332; GO:0003344; GO:0003682; GO:0003713; GO:0004857; GO:0004888; GO:0005112; GO:0005509; GO:0005576; GO:0005634; GO:0005654; GO:0005737; GO:0005783; GO:0005789; GO:0005829; GO:0005856; GO:0005886; GO:0005912; GO:0006357; GO:0006606; GO:0006959; GO:0007219; GO:0007221; GO:0007283; GO:0007368; GO:0007386; GO:0007409; GO:0007411; GO:0007440; GO:0007492; GO:0007507; GO:0008284; GO:0008285; GO:0008544; GO:0008593; GO:0009912; GO:0009986; GO:0010001; GO:0010008; GO:0010467; GO:0010468; GO:0010614; GO:0010628; GO:0010629; GO:0010667; GO:0010718; GO:0010812; GO:0010832; GO:0014031; GO:0014807; GO:0016324; GO:0019899; GO:0021515; GO:0021915; GO:0030027; GO:0030154; GO:0030163; GO:0030182; GO:0030216; GO:0030279; GO:0030324; GO:0030326; GO:0030334; GO:0030335; GO:0030513; GO:0030514; GO:0030900; GO:0031069; GO:0031100; GO:0031410; GO:0031490; GO:0031902; GO:0032495; GO:0032496; GO:0032966; GO:0035116; GO:0035148; GO:0035914; GO:0035924; GO:0042127; GO:0042246; GO:0042802; GO:0043065; GO:0043069; GO:0043086; GO:0043235; GO:0045070; GO:0045165; GO:0045596; GO:0045603; GO:0045607; GO:0045608; GO:0045618; GO:0045662; GO:0045665; GO:0045668; GO:0045687; GO:0045747; GO:0045892; GO:0045893; GO:0045944; GO:0045955; GO:0046427; GO:0046533; GO:0046579; GO:0048103; GO:0048593; GO:0048663; GO:0048708; GO:0048709; GO:0048711; GO:0048715; GO:0048754; GO:0048845; GO:0048873; GO:0050678; GO:0050679; GO:0050767; GO:0050768; GO:0051152; GO:0055008; GO:0060038; GO:0060045; GO:0060253; GO:0060271; GO:0060317; GO:0060354; GO:0060379; GO:0060411; GO:0060412; GO:0060528; GO:0060740; GO:0060768; GO:0060842; GO:0060843; GO:0060948; GO:0060956; GO:0060979; GO:0060982; GO:0061344; GO:0061384; GO:0062043; GO:0070168; GO:0070374; GO:0070986; GO:0071228; GO:0071372; GO:0071456; GO:0071944; GO:0072017; GO:0072044; GO:0072144; GO:0072538; GO:0090051; GO:0090090; GO:0097150; GO:0097400; GO:0098685; GO:0098839; GO:0098978; GO:0099565; GO:0120163; GO:0140537; GO:1901189; GO:1901201; GO:1902263; GO:1902339; GO:1903849; GO:2000048; GO:2000737; GO:2000811; GO:2000974; GO:2001027 animal organ regeneration [GO:0031100]; aortic valve morphogenesis [GO:0003180]; apoptotic process involved in embryonic digit morphogenesis [GO:1902263]; arterial endothelial cell differentiation [GO:0060842]; astrocyte differentiation [GO:0048708]; atrioventricular node development [GO:0003162]; atrioventricular valve morphogenesis [GO:0003181]; auditory receptor cell fate commitment [GO:0009912]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; branching morphogenesis of an epithelial tube [GO:0048754]; camera-type eye morphogenesis [GO:0048593]; cardiac atrium morphogenesis [GO:0003209]; cardiac chamber formation [GO:0003207]; cardiac epithelial to mesenchymal transition [GO:0060317]; cardiac left ventricle morphogenesis [GO:0003214]; cardiac muscle cell myoblast differentiation [GO:0060379]; cardiac muscle cell proliferation [GO:0060038]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac right atrium morphogenesis [GO:0003213]; cardiac right ventricle formation [GO:0003219]; cardiac septum morphogenesis [GO:0060411]; cardiac vascular smooth muscle cell development [GO:0060948]; cardiac ventricle morphogenesis [GO:0003208]; cell differentiation [GO:0030154]; cell differentiation in spinal cord [GO:0021515]; cell fate commitment [GO:0045165]; cell fate specification [GO:0001708]; cell migration involved in endocardial cushion formation [GO:0003273]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to hypoxia [GO:0071456]; cellular response to tumor cell [GO:0071228]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; chemical synaptic transmission, postsynaptic [GO:0099565]; cilium assembly [GO:0060271]; collecting duct development [GO:0072044]; compartment pattern specification [GO:0007386]; coronary artery morphogenesis [GO:0060982]; coronary sinus valve morphogenesis [GO:0003182]; coronary vein morphogenesis [GO:0003169]; determination of left/right symmetry [GO:0007368]; distal tubule development [GO:0072017]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic limb morphogenesis [GO:0030326]; endocardial cell differentiation [GO:0060956]; endocardial cushion development [GO:0003197]; endocardial cushion morphogenesis [GO:0003203]; endocardium development [GO:0003157]; endocardium morphogenesis [GO:0003160]; endoderm development [GO:0007492]; epidermis development [GO:0008544]; epithelial to mesenchymal transition [GO:0001837]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; forebrain development [GO:0030900]; foregut morphogenesis [GO:0007440]; gene expression [GO:0010467]; glial cell differentiation [GO:0010001]; glomerular mesangial cell development [GO:0072144]; growth involved in heart morphogenesis [GO:0003241]; hair follicle morphogenesis [GO:0031069]; heart development [GO:0007507]; heart looping [GO:0001947]; heart trabecula morphogenesis [GO:0061384]; homeostasis of number of cells within a tissue [GO:0048873]; humoral immune response [GO:0006959]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; interleukin-17-mediated signaling pathway [GO:0097400]; keratinocyte differentiation [GO:0030216]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; lung development [GO:0030324]; luteolysis [GO:0001554]; mesenchymal cell development [GO:0014031]; mitral valve formation [GO:0003192]; negative regulation of anoikis [GO:2000811]; negative regulation of biomineral tissue development [GO:0070168]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of catalytic activity [GO:0043086]; negative regulation of cell adhesion molecule production [GO:0060354]; negative regulation of cell differentiation [GO:0045596]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell proliferation involved in heart valve morphogenesis [GO:0003252]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of collagen biosynthetic process [GO:0032966]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of endothelial cell chemotaxis [GO:2001027]; negative regulation of extracellular matrix constituent secretion [GO:0003332]; negative regulation of gene expression [GO:0010629]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of inner ear auditory receptor cell differentiation [GO:0045608]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of ossification [GO:0030279]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of photoreceptor cell differentiation [GO:0046533]; negative regulation of pro-B cell differentiation [GO:2000974]; negative regulation of programmed cell death [GO:0043069]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural tube development [GO:0021915]; neuron differentiation [GO:0030182]; neuron fate commitment [GO:0048663]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; oligodendrocyte differentiation [GO:0048709]; osteoblast fate commitment [GO:0002051]; outflow tract morphogenesis [GO:0003151]; pericardium morphogenesis [GO:0003344]; positive regulation of aorta morphogenesis [GO:1903849]; positive regulation of apoptotic process [GO:0043065]; positive regulation of apoptotic process involved in morphogenesis [GO:1902339]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cardiac epithelial to mesenchymal transition [GO:0062043]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of ephrin receptor signaling pathway [GO:1901189]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of glial cell differentiation [GO:0045687]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of smooth muscle cell differentiation [GO:0051152]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription of Notch receptor target [GO:0007221]; positive regulation of viral genome replication [GO:0045070]; prostate gland epithelium morphogenesis [GO:0060740]; protein catabolic process [GO:0030163]; protein import into nucleus [GO:0006606]; pulmonary valve morphogenesis [GO:0003184]; regulation of cardioblast proliferation [GO:0003264]; regulation of cell adhesion involved in heart morphogenesis [GO:0061344]; regulation of cell migration [GO:0030334]; regulation of cell population proliferation [GO:0042127]; regulation of epithelial cell proliferation [GO:0050678]; regulation of epithelial cell proliferation involved in prostate gland development [GO:0060768]; regulation of extracellular matrix assembly [GO:1901201]; regulation of gene expression [GO:0010468]; regulation of inner ear auditory receptor cell differentiation [GO:0045607]; regulation of neurogenesis [GO:0050767]; regulation of Notch signaling pathway [GO:0008593]; regulation of somitogenesis [GO:0014807]; regulation of transcription by RNA polymerase II [GO:0006357]; response to lipopolysaccharide [GO:0032496]; response to muramyl dipeptide [GO:0032495]; secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development [GO:0060528]; skeletal muscle cell differentiation [GO:0035914]; somatic stem cell division [GO:0048103]; spermatogenesis [GO:0007283]; sprouting angiogenesis [GO:0002040]; T-helper 17 type immune response [GO:0072538]; tissue regeneration [GO:0042246]; tube formation [GO:0035148]; vasculogenesis involved in coronary vascular morphogenesis [GO:0060979]; venous blood vessel morphogenesis [GO:0048845]; venous endothelial cell differentiation [GO:0060843]; ventricular septum morphogenesis [GO:0060412]; ventricular trabecula myocardium morphogenesis [GO:0003222] acrosomal vesicle [GO:0001669]; adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell periphery [GO:0071944]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; lamellipodium [GO:0030027]; late endosome membrane [GO:0031902]; MAML1-RBP-Jkappa- ICN1 complex [GO:0002193]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; receptor complex [GO:0043235]; ruffle [GO:0001726]; Schaffer collateral - CA1 synapse [GO:0098685] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; identical protein binding [GO:0042802]; Notch binding [GO:0005112]; transcription coactivator activity [GO:0003713]; transcription regulator activator activity [GO:0140537]; transmembrane signaling receptor activity [GO:0004888] g256.t4 Q01705 35.221 1448 0.0 659.0 sp|Q01705|NOTC1_MOUSE Neurogenic locus notch homolog protein 1 OS=Mus musculus OX=10090 GN=Notch1 PE=1 SV=3 NOTC1_MOUSE reviewed Neurogenic locus notch homolog protein 1 (Notch 1) (Motch A) (mT14) (p300) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Mus musculus (Mouse) GO:0000122; GO:0000139; GO:0001554; GO:0001669; GO:0001701; GO:0001708; GO:0001726; GO:0001837; GO:0001889; GO:0001947; GO:0002040; GO:0002051; GO:0002052; GO:0002193; GO:0002437; GO:0003151; GO:0003157; GO:0003160; GO:0003162; GO:0003169; GO:0003180; GO:0003181; GO:0003182; GO:0003184; GO:0003192; GO:0003197; GO:0003198; GO:0003203; GO:0003207; GO:0003208; GO:0003209; GO:0003213; GO:0003214; GO:0003219; GO:0003222; GO:0003241; GO:0003252; GO:0003264; GO:0003273; GO:0003332; GO:0003344; GO:0003682; GO:0003713; GO:0004857; GO:0004888; GO:0005112; GO:0005509; GO:0005576; GO:0005634; GO:0005654; GO:0005737; GO:0005783; GO:0005789; GO:0005829; GO:0005856; GO:0005886; GO:0005912; GO:0006357; GO:0006606; GO:0006959; GO:0007219; GO:0007221; GO:0007283; GO:0007368; GO:0007386; GO:0007409; GO:0007411; GO:0007440; GO:0007492; GO:0007507; GO:0008284; GO:0008285; GO:0008544; GO:0008593; GO:0009912; GO:0009986; GO:0010001; GO:0010008; GO:0010467; GO:0010468; GO:0010614; GO:0010628; GO:0010629; GO:0010667; GO:0010718; GO:0010812; GO:0010832; GO:0014031; GO:0014807; GO:0016324; GO:0019899; GO:0021515; GO:0021915; GO:0030027; GO:0030154; GO:0030163; GO:0030182; GO:0030216; GO:0030279; GO:0030324; GO:0030326; GO:0030334; GO:0030335; GO:0030513; GO:0030514; GO:0030900; GO:0031069; GO:0031100; GO:0031410; GO:0031490; GO:0031902; GO:0032495; GO:0032496; GO:0032966; GO:0035116; GO:0035148; GO:0035914; GO:0035924; GO:0042127; GO:0042246; GO:0042802; GO:0043065; GO:0043069; GO:0043086; GO:0043235; GO:0045070; GO:0045165; GO:0045596; GO:0045603; GO:0045607; GO:0045608; GO:0045618; GO:0045662; GO:0045665; GO:0045668; GO:0045687; GO:0045747; GO:0045892; GO:0045893; GO:0045944; GO:0045955; GO:0046427; GO:0046533; GO:0046579; GO:0048103; GO:0048593; GO:0048663; GO:0048708; GO:0048709; GO:0048711; GO:0048715; GO:0048754; GO:0048845; GO:0048873; GO:0050678; GO:0050679; GO:0050767; GO:0050768; GO:0051152; GO:0055008; GO:0060038; GO:0060045; GO:0060253; GO:0060271; GO:0060317; GO:0060354; GO:0060379; GO:0060411; GO:0060412; GO:0060528; GO:0060740; GO:0060768; GO:0060842; GO:0060843; GO:0060948; GO:0060956; GO:0060979; GO:0060982; GO:0061344; GO:0061384; GO:0062043; GO:0070168; GO:0070374; GO:0070986; GO:0071228; GO:0071372; GO:0071456; GO:0071944; GO:0072017; GO:0072044; GO:0072144; GO:0072538; GO:0090051; GO:0090090; GO:0097150; GO:0097400; GO:0098685; GO:0098839; GO:0098978; GO:0099565; GO:0120163; GO:0140537; GO:1901189; GO:1901201; GO:1902263; GO:1902339; GO:1903849; GO:2000048; GO:2000737; GO:2000811; GO:2000974; GO:2001027 animal organ regeneration [GO:0031100]; aortic valve morphogenesis [GO:0003180]; apoptotic process involved in embryonic digit morphogenesis [GO:1902263]; arterial endothelial cell differentiation [GO:0060842]; astrocyte differentiation [GO:0048708]; atrioventricular node development [GO:0003162]; atrioventricular valve morphogenesis [GO:0003181]; auditory receptor cell fate commitment [GO:0009912]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; branching morphogenesis of an epithelial tube [GO:0048754]; camera-type eye morphogenesis [GO:0048593]; cardiac atrium morphogenesis [GO:0003209]; cardiac chamber formation [GO:0003207]; cardiac epithelial to mesenchymal transition [GO:0060317]; cardiac left ventricle morphogenesis [GO:0003214]; cardiac muscle cell myoblast differentiation [GO:0060379]; cardiac muscle cell proliferation [GO:0060038]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac right atrium morphogenesis [GO:0003213]; cardiac right ventricle formation [GO:0003219]; cardiac septum morphogenesis [GO:0060411]; cardiac vascular smooth muscle cell development [GO:0060948]; cardiac ventricle morphogenesis [GO:0003208]; cell differentiation [GO:0030154]; cell differentiation in spinal cord [GO:0021515]; cell fate commitment [GO:0045165]; cell fate specification [GO:0001708]; cell migration involved in endocardial cushion formation [GO:0003273]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to hypoxia [GO:0071456]; cellular response to tumor cell [GO:0071228]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; chemical synaptic transmission, postsynaptic [GO:0099565]; cilium assembly [GO:0060271]; collecting duct development [GO:0072044]; compartment pattern specification [GO:0007386]; coronary artery morphogenesis [GO:0060982]; coronary sinus valve morphogenesis [GO:0003182]; coronary vein morphogenesis [GO:0003169]; determination of left/right symmetry [GO:0007368]; distal tubule development [GO:0072017]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic limb morphogenesis [GO:0030326]; endocardial cell differentiation [GO:0060956]; endocardial cushion development [GO:0003197]; endocardial cushion morphogenesis [GO:0003203]; endocardium development [GO:0003157]; endocardium morphogenesis [GO:0003160]; endoderm development [GO:0007492]; epidermis development [GO:0008544]; epithelial to mesenchymal transition [GO:0001837]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; forebrain development [GO:0030900]; foregut morphogenesis [GO:0007440]; gene expression [GO:0010467]; glial cell differentiation [GO:0010001]; glomerular mesangial cell development [GO:0072144]; growth involved in heart morphogenesis [GO:0003241]; hair follicle morphogenesis [GO:0031069]; heart development [GO:0007507]; heart looping [GO:0001947]; heart trabecula morphogenesis [GO:0061384]; homeostasis of number of cells within a tissue [GO:0048873]; humoral immune response [GO:0006959]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; interleukin-17-mediated signaling pathway [GO:0097400]; keratinocyte differentiation [GO:0030216]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; lung development [GO:0030324]; luteolysis [GO:0001554]; mesenchymal cell development [GO:0014031]; mitral valve formation [GO:0003192]; negative regulation of anoikis [GO:2000811]; negative regulation of biomineral tissue development [GO:0070168]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of catalytic activity [GO:0043086]; negative regulation of cell adhesion molecule production [GO:0060354]; negative regulation of cell differentiation [GO:0045596]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell proliferation involved in heart valve morphogenesis [GO:0003252]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of collagen biosynthetic process [GO:0032966]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of endothelial cell chemotaxis [GO:2001027]; negative regulation of extracellular matrix constituent secretion [GO:0003332]; negative regulation of gene expression [GO:0010629]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of inner ear auditory receptor cell differentiation [GO:0045608]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of ossification [GO:0030279]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of photoreceptor cell differentiation [GO:0046533]; negative regulation of pro-B cell differentiation [GO:2000974]; negative regulation of programmed cell death [GO:0043069]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural tube development [GO:0021915]; neuron differentiation [GO:0030182]; neuron fate commitment [GO:0048663]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; oligodendrocyte differentiation [GO:0048709]; osteoblast fate commitment [GO:0002051]; outflow tract morphogenesis [GO:0003151]; pericardium morphogenesis [GO:0003344]; positive regulation of aorta morphogenesis [GO:1903849]; positive regulation of apoptotic process [GO:0043065]; positive regulation of apoptotic process involved in morphogenesis [GO:1902339]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cardiac epithelial to mesenchymal transition [GO:0062043]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of ephrin receptor signaling pathway [GO:1901189]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of glial cell differentiation [GO:0045687]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of smooth muscle cell differentiation [GO:0051152]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription of Notch receptor target [GO:0007221]; positive regulation of viral genome replication [GO:0045070]; prostate gland epithelium morphogenesis [GO:0060740]; protein catabolic process [GO:0030163]; protein import into nucleus [GO:0006606]; pulmonary valve morphogenesis [GO:0003184]; regulation of cardioblast proliferation [GO:0003264]; regulation of cell adhesion involved in heart morphogenesis [GO:0061344]; regulation of cell migration [GO:0030334]; regulation of cell population proliferation [GO:0042127]; regulation of epithelial cell proliferation [GO:0050678]; regulation of epithelial cell proliferation involved in prostate gland development [GO:0060768]; regulation of extracellular matrix assembly [GO:1901201]; regulation of gene expression [GO:0010468]; regulation of inner ear auditory receptor cell differentiation [GO:0045607]; regulation of neurogenesis [GO:0050767]; regulation of Notch signaling pathway [GO:0008593]; regulation of somitogenesis [GO:0014807]; regulation of transcription by RNA polymerase II [GO:0006357]; response to lipopolysaccharide [GO:0032496]; response to muramyl dipeptide [GO:0032495]; secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development [GO:0060528]; skeletal muscle cell differentiation [GO:0035914]; somatic stem cell division [GO:0048103]; spermatogenesis [GO:0007283]; sprouting angiogenesis [GO:0002040]; T-helper 17 type immune response [GO:0072538]; tissue regeneration [GO:0042246]; tube formation [GO:0035148]; vasculogenesis involved in coronary vascular morphogenesis [GO:0060979]; venous blood vessel morphogenesis [GO:0048845]; venous endothelial cell differentiation [GO:0060843]; ventricular septum morphogenesis [GO:0060412]; ventricular trabecula myocardium morphogenesis [GO:0003222] acrosomal vesicle [GO:0001669]; adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell periphery [GO:0071944]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; lamellipodium [GO:0030027]; late endosome membrane [GO:0031902]; MAML1-RBP-Jkappa- ICN1 complex [GO:0002193]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; receptor complex [GO:0043235]; ruffle [GO:0001726]; Schaffer collateral - CA1 synapse [GO:0098685] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; identical protein binding [GO:0042802]; Notch binding [GO:0005112]; transcription coactivator activity [GO:0003713]; transcription regulator activator activity [GO:0140537]; transmembrane signaling receptor activity [GO:0004888] g256.t4 Q01705 35.009 1591 0.0 655.0 sp|Q01705|NOTC1_MOUSE Neurogenic locus notch homolog protein 1 OS=Mus musculus OX=10090 GN=Notch1 PE=1 SV=3 NOTC1_MOUSE reviewed Neurogenic locus notch homolog protein 1 (Notch 1) (Motch A) (mT14) (p300) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Mus musculus (Mouse) GO:0000122; GO:0000139; GO:0001554; GO:0001669; GO:0001701; GO:0001708; GO:0001726; GO:0001837; GO:0001889; GO:0001947; GO:0002040; GO:0002051; GO:0002052; GO:0002193; GO:0002437; GO:0003151; GO:0003157; GO:0003160; GO:0003162; GO:0003169; GO:0003180; GO:0003181; GO:0003182; GO:0003184; GO:0003192; GO:0003197; GO:0003198; GO:0003203; GO:0003207; GO:0003208; GO:0003209; GO:0003213; GO:0003214; GO:0003219; GO:0003222; GO:0003241; GO:0003252; GO:0003264; GO:0003273; GO:0003332; GO:0003344; GO:0003682; GO:0003713; GO:0004857; GO:0004888; GO:0005112; GO:0005509; GO:0005576; GO:0005634; GO:0005654; GO:0005737; GO:0005783; GO:0005789; GO:0005829; GO:0005856; GO:0005886; GO:0005912; GO:0006357; GO:0006606; GO:0006959; GO:0007219; GO:0007221; GO:0007283; GO:0007368; GO:0007386; GO:0007409; GO:0007411; GO:0007440; GO:0007492; GO:0007507; GO:0008284; GO:0008285; GO:0008544; GO:0008593; GO:0009912; GO:0009986; GO:0010001; GO:0010008; GO:0010467; GO:0010468; GO:0010614; GO:0010628; GO:0010629; GO:0010667; GO:0010718; GO:0010812; GO:0010832; GO:0014031; GO:0014807; GO:0016324; GO:0019899; GO:0021515; GO:0021915; GO:0030027; GO:0030154; GO:0030163; GO:0030182; GO:0030216; GO:0030279; GO:0030324; GO:0030326; GO:0030334; GO:0030335; GO:0030513; GO:0030514; GO:0030900; GO:0031069; GO:0031100; GO:0031410; GO:0031490; GO:0031902; GO:0032495; GO:0032496; GO:0032966; GO:0035116; GO:0035148; GO:0035914; GO:0035924; GO:0042127; GO:0042246; GO:0042802; GO:0043065; GO:0043069; GO:0043086; GO:0043235; GO:0045070; GO:0045165; GO:0045596; GO:0045603; GO:0045607; GO:0045608; GO:0045618; GO:0045662; GO:0045665; GO:0045668; GO:0045687; GO:0045747; GO:0045892; GO:0045893; GO:0045944; GO:0045955; GO:0046427; GO:0046533; GO:0046579; GO:0048103; GO:0048593; GO:0048663; GO:0048708; GO:0048709; GO:0048711; GO:0048715; GO:0048754; GO:0048845; GO:0048873; GO:0050678; GO:0050679; GO:0050767; GO:0050768; GO:0051152; GO:0055008; GO:0060038; GO:0060045; GO:0060253; GO:0060271; GO:0060317; GO:0060354; GO:0060379; GO:0060411; GO:0060412; GO:0060528; GO:0060740; GO:0060768; GO:0060842; GO:0060843; GO:0060948; GO:0060956; GO:0060979; GO:0060982; GO:0061344; GO:0061384; GO:0062043; GO:0070168; GO:0070374; GO:0070986; GO:0071228; GO:0071372; GO:0071456; GO:0071944; GO:0072017; GO:0072044; GO:0072144; GO:0072538; GO:0090051; GO:0090090; GO:0097150; GO:0097400; GO:0098685; GO:0098839; GO:0098978; GO:0099565; GO:0120163; GO:0140537; GO:1901189; GO:1901201; GO:1902263; GO:1902339; GO:1903849; GO:2000048; GO:2000737; GO:2000811; GO:2000974; GO:2001027 animal organ regeneration [GO:0031100]; aortic valve morphogenesis [GO:0003180]; apoptotic process involved in embryonic digit morphogenesis [GO:1902263]; arterial endothelial cell differentiation [GO:0060842]; astrocyte differentiation [GO:0048708]; atrioventricular node development [GO:0003162]; atrioventricular valve morphogenesis [GO:0003181]; auditory receptor cell fate commitment [GO:0009912]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; branching morphogenesis of an epithelial tube [GO:0048754]; camera-type eye morphogenesis [GO:0048593]; cardiac atrium morphogenesis [GO:0003209]; cardiac chamber formation [GO:0003207]; cardiac epithelial to mesenchymal transition [GO:0060317]; cardiac left ventricle morphogenesis [GO:0003214]; cardiac muscle cell myoblast differentiation [GO:0060379]; cardiac muscle cell proliferation [GO:0060038]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac right atrium morphogenesis [GO:0003213]; cardiac right ventricle formation [GO:0003219]; cardiac septum morphogenesis [GO:0060411]; cardiac vascular smooth muscle cell development [GO:0060948]; cardiac ventricle morphogenesis [GO:0003208]; cell differentiation [GO:0030154]; cell differentiation in spinal cord [GO:0021515]; cell fate commitment [GO:0045165]; cell fate specification [GO:0001708]; cell migration involved in endocardial cushion formation [GO:0003273]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to hypoxia [GO:0071456]; cellular response to tumor cell [GO:0071228]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; chemical synaptic transmission, postsynaptic [GO:0099565]; cilium assembly [GO:0060271]; collecting duct development [GO:0072044]; compartment pattern specification [GO:0007386]; coronary artery morphogenesis [GO:0060982]; coronary sinus valve morphogenesis [GO:0003182]; coronary vein morphogenesis [GO:0003169]; determination of left/right symmetry [GO:0007368]; distal tubule development [GO:0072017]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic limb morphogenesis [GO:0030326]; endocardial cell differentiation [GO:0060956]; endocardial cushion development [GO:0003197]; endocardial cushion morphogenesis [GO:0003203]; endocardium development [GO:0003157]; endocardium morphogenesis [GO:0003160]; endoderm development [GO:0007492]; epidermis development [GO:0008544]; epithelial to mesenchymal transition [GO:0001837]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; forebrain development [GO:0030900]; foregut morphogenesis [GO:0007440]; gene expression [GO:0010467]; glial cell differentiation [GO:0010001]; glomerular mesangial cell development [GO:0072144]; growth involved in heart morphogenesis [GO:0003241]; hair follicle morphogenesis [GO:0031069]; heart development [GO:0007507]; heart looping [GO:0001947]; heart trabecula morphogenesis [GO:0061384]; homeostasis of number of cells within a tissue [GO:0048873]; humoral immune response [GO:0006959]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; interleukin-17-mediated signaling pathway [GO:0097400]; keratinocyte differentiation [GO:0030216]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; lung development [GO:0030324]; luteolysis [GO:0001554]; mesenchymal cell development [GO:0014031]; mitral valve formation [GO:0003192]; negative regulation of anoikis [GO:2000811]; negative regulation of biomineral tissue development [GO:0070168]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of catalytic activity [GO:0043086]; negative regulation of cell adhesion molecule production [GO:0060354]; negative regulation of cell differentiation [GO:0045596]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell proliferation involved in heart valve morphogenesis [GO:0003252]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of collagen biosynthetic process [GO:0032966]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of endothelial cell chemotaxis [GO:2001027]; negative regulation of extracellular matrix constituent secretion [GO:0003332]; negative regulation of gene expression [GO:0010629]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of inner ear auditory receptor cell differentiation [GO:0045608]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of ossification [GO:0030279]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of photoreceptor cell differentiation [GO:0046533]; negative regulation of pro-B cell differentiation [GO:2000974]; negative regulation of programmed cell death [GO:0043069]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural tube development [GO:0021915]; neuron differentiation [GO:0030182]; neuron fate commitment [GO:0048663]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; oligodendrocyte differentiation [GO:0048709]; osteoblast fate commitment [GO:0002051]; outflow tract morphogenesis [GO:0003151]; pericardium morphogenesis [GO:0003344]; positive regulation of aorta morphogenesis [GO:1903849]; positive regulation of apoptotic process [GO:0043065]; positive regulation of apoptotic process involved in morphogenesis [GO:1902339]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cardiac epithelial to mesenchymal transition [GO:0062043]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of ephrin receptor signaling pathway [GO:1901189]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of glial cell differentiation [GO:0045687]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of smooth muscle cell differentiation [GO:0051152]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription of Notch receptor target [GO:0007221]; positive regulation of viral genome replication [GO:0045070]; prostate gland epithelium morphogenesis [GO:0060740]; protein catabolic process [GO:0030163]; protein import into nucleus [GO:0006606]; pulmonary valve morphogenesis [GO:0003184]; regulation of cardioblast proliferation [GO:0003264]; regulation of cell adhesion involved in heart morphogenesis [GO:0061344]; regulation of cell migration [GO:0030334]; regulation of cell population proliferation [GO:0042127]; regulation of epithelial cell proliferation [GO:0050678]; regulation of epithelial cell proliferation involved in prostate gland development [GO:0060768]; regulation of extracellular matrix assembly [GO:1901201]; regulation of gene expression [GO:0010468]; regulation of inner ear auditory receptor cell differentiation [GO:0045607]; regulation of neurogenesis [GO:0050767]; regulation of Notch signaling pathway [GO:0008593]; regulation of somitogenesis [GO:0014807]; regulation of transcription by RNA polymerase II [GO:0006357]; response to lipopolysaccharide [GO:0032496]; response to muramyl dipeptide [GO:0032495]; secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development [GO:0060528]; skeletal muscle cell differentiation [GO:0035914]; somatic stem cell division [GO:0048103]; spermatogenesis [GO:0007283]; sprouting angiogenesis [GO:0002040]; T-helper 17 type immune response [GO:0072538]; tissue regeneration [GO:0042246]; tube formation [GO:0035148]; vasculogenesis involved in coronary vascular morphogenesis [GO:0060979]; venous blood vessel morphogenesis [GO:0048845]; venous endothelial cell differentiation [GO:0060843]; ventricular septum morphogenesis [GO:0060412]; ventricular trabecula myocardium morphogenesis [GO:0003222] acrosomal vesicle [GO:0001669]; adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell periphery [GO:0071944]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; lamellipodium [GO:0030027]; late endosome membrane [GO:0031902]; MAML1-RBP-Jkappa- ICN1 complex [GO:0002193]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; receptor complex [GO:0043235]; ruffle [GO:0001726]; Schaffer collateral - CA1 synapse [GO:0098685] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; identical protein binding [GO:0042802]; Notch binding [GO:0005112]; transcription coactivator activity [GO:0003713]; transcription regulator activator activity [GO:0140537]; transmembrane signaling receptor activity [GO:0004888] g256.t4 Q01705 35.869 1433 0.0 653.0 sp|Q01705|NOTC1_MOUSE Neurogenic locus notch homolog protein 1 OS=Mus musculus OX=10090 GN=Notch1 PE=1 SV=3 NOTC1_MOUSE reviewed Neurogenic locus notch homolog protein 1 (Notch 1) (Motch A) (mT14) (p300) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Mus musculus (Mouse) GO:0000122; GO:0000139; GO:0001554; GO:0001669; GO:0001701; GO:0001708; GO:0001726; GO:0001837; GO:0001889; GO:0001947; GO:0002040; GO:0002051; GO:0002052; GO:0002193; GO:0002437; GO:0003151; GO:0003157; GO:0003160; GO:0003162; GO:0003169; GO:0003180; GO:0003181; GO:0003182; GO:0003184; GO:0003192; GO:0003197; GO:0003198; GO:0003203; GO:0003207; GO:0003208; GO:0003209; GO:0003213; GO:0003214; GO:0003219; GO:0003222; GO:0003241; GO:0003252; GO:0003264; GO:0003273; GO:0003332; GO:0003344; GO:0003682; GO:0003713; GO:0004857; GO:0004888; GO:0005112; GO:0005509; GO:0005576; GO:0005634; GO:0005654; GO:0005737; GO:0005783; GO:0005789; GO:0005829; GO:0005856; GO:0005886; GO:0005912; GO:0006357; GO:0006606; GO:0006959; GO:0007219; GO:0007221; GO:0007283; GO:0007368; GO:0007386; GO:0007409; GO:0007411; GO:0007440; GO:0007492; GO:0007507; GO:0008284; GO:0008285; GO:0008544; GO:0008593; GO:0009912; GO:0009986; GO:0010001; GO:0010008; GO:0010467; GO:0010468; GO:0010614; GO:0010628; GO:0010629; GO:0010667; GO:0010718; GO:0010812; GO:0010832; GO:0014031; GO:0014807; GO:0016324; GO:0019899; GO:0021515; GO:0021915; GO:0030027; GO:0030154; GO:0030163; GO:0030182; GO:0030216; GO:0030279; GO:0030324; GO:0030326; GO:0030334; GO:0030335; GO:0030513; GO:0030514; GO:0030900; GO:0031069; GO:0031100; GO:0031410; GO:0031490; GO:0031902; GO:0032495; GO:0032496; GO:0032966; GO:0035116; GO:0035148; GO:0035914; GO:0035924; GO:0042127; GO:0042246; GO:0042802; GO:0043065; GO:0043069; GO:0043086; GO:0043235; GO:0045070; GO:0045165; GO:0045596; GO:0045603; GO:0045607; GO:0045608; GO:0045618; GO:0045662; GO:0045665; GO:0045668; GO:0045687; GO:0045747; GO:0045892; GO:0045893; GO:0045944; GO:0045955; GO:0046427; GO:0046533; GO:0046579; GO:0048103; GO:0048593; GO:0048663; GO:0048708; GO:0048709; GO:0048711; GO:0048715; GO:0048754; GO:0048845; GO:0048873; GO:0050678; GO:0050679; GO:0050767; GO:0050768; GO:0051152; GO:0055008; GO:0060038; GO:0060045; GO:0060253; GO:0060271; GO:0060317; GO:0060354; GO:0060379; GO:0060411; GO:0060412; GO:0060528; GO:0060740; GO:0060768; GO:0060842; GO:0060843; GO:0060948; GO:0060956; GO:0060979; GO:0060982; GO:0061344; GO:0061384; GO:0062043; GO:0070168; GO:0070374; GO:0070986; GO:0071228; GO:0071372; GO:0071456; GO:0071944; GO:0072017; GO:0072044; GO:0072144; GO:0072538; GO:0090051; GO:0090090; GO:0097150; GO:0097400; GO:0098685; GO:0098839; GO:0098978; GO:0099565; GO:0120163; GO:0140537; GO:1901189; GO:1901201; GO:1902263; GO:1902339; GO:1903849; GO:2000048; GO:2000737; GO:2000811; GO:2000974; GO:2001027 animal organ regeneration [GO:0031100]; aortic valve morphogenesis [GO:0003180]; apoptotic process involved in embryonic digit morphogenesis [GO:1902263]; arterial endothelial cell differentiation [GO:0060842]; astrocyte differentiation [GO:0048708]; atrioventricular node development [GO:0003162]; atrioventricular valve morphogenesis [GO:0003181]; auditory receptor cell fate commitment [GO:0009912]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; branching morphogenesis of an epithelial tube [GO:0048754]; camera-type eye morphogenesis [GO:0048593]; cardiac atrium morphogenesis [GO:0003209]; cardiac chamber formation [GO:0003207]; cardiac epithelial to mesenchymal transition [GO:0060317]; cardiac left ventricle morphogenesis [GO:0003214]; cardiac muscle cell myoblast differentiation [GO:0060379]; cardiac muscle cell proliferation [GO:0060038]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac right atrium morphogenesis [GO:0003213]; cardiac right ventricle formation [GO:0003219]; cardiac septum morphogenesis [GO:0060411]; cardiac vascular smooth muscle cell development [GO:0060948]; cardiac ventricle morphogenesis [GO:0003208]; cell differentiation [GO:0030154]; cell differentiation in spinal cord [GO:0021515]; cell fate commitment [GO:0045165]; cell fate specification [GO:0001708]; cell migration involved in endocardial cushion formation [GO:0003273]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to hypoxia [GO:0071456]; cellular response to tumor cell [GO:0071228]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; chemical synaptic transmission, postsynaptic [GO:0099565]; cilium assembly [GO:0060271]; collecting duct development [GO:0072044]; compartment pattern specification [GO:0007386]; coronary artery morphogenesis [GO:0060982]; coronary sinus valve morphogenesis [GO:0003182]; coronary vein morphogenesis [GO:0003169]; determination of left/right symmetry [GO:0007368]; distal tubule development [GO:0072017]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic limb morphogenesis [GO:0030326]; endocardial cell differentiation [GO:0060956]; endocardial cushion development [GO:0003197]; endocardial cushion morphogenesis [GO:0003203]; endocardium development [GO:0003157]; endocardium morphogenesis [GO:0003160]; endoderm development [GO:0007492]; epidermis development [GO:0008544]; epithelial to mesenchymal transition [GO:0001837]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; forebrain development [GO:0030900]; foregut morphogenesis [GO:0007440]; gene expression [GO:0010467]; glial cell differentiation [GO:0010001]; glomerular mesangial cell development [GO:0072144]; growth involved in heart morphogenesis [GO:0003241]; hair follicle morphogenesis [GO:0031069]; heart development [GO:0007507]; heart looping [GO:0001947]; heart trabecula morphogenesis [GO:0061384]; homeostasis of number of cells within a tissue [GO:0048873]; humoral immune response [GO:0006959]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; interleukin-17-mediated signaling pathway [GO:0097400]; keratinocyte differentiation [GO:0030216]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; lung development [GO:0030324]; luteolysis [GO:0001554]; mesenchymal cell development [GO:0014031]; mitral valve formation [GO:0003192]; negative regulation of anoikis [GO:2000811]; negative regulation of biomineral tissue development [GO:0070168]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of catalytic activity [GO:0043086]; negative regulation of cell adhesion molecule production [GO:0060354]; negative regulation of cell differentiation [GO:0045596]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell proliferation involved in heart valve morphogenesis [GO:0003252]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of collagen biosynthetic process [GO:0032966]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of endothelial cell chemotaxis [GO:2001027]; negative regulation of extracellular matrix constituent secretion [GO:0003332]; negative regulation of gene expression [GO:0010629]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of inner ear auditory receptor cell differentiation [GO:0045608]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of ossification [GO:0030279]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of photoreceptor cell differentiation [GO:0046533]; negative regulation of pro-B cell differentiation [GO:2000974]; negative regulation of programmed cell death [GO:0043069]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural tube development [GO:0021915]; neuron differentiation [GO:0030182]; neuron fate commitment [GO:0048663]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; oligodendrocyte differentiation [GO:0048709]; osteoblast fate commitment [GO:0002051]; outflow tract morphogenesis [GO:0003151]; pericardium morphogenesis [GO:0003344]; positive regulation of aorta morphogenesis [GO:1903849]; positive regulation of apoptotic process [GO:0043065]; positive regulation of apoptotic process involved in morphogenesis [GO:1902339]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cardiac epithelial to mesenchymal transition [GO:0062043]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of ephrin receptor signaling pathway [GO:1901189]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of glial cell differentiation [GO:0045687]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of smooth muscle cell differentiation [GO:0051152]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription of Notch receptor target [GO:0007221]; positive regulation of viral genome replication [GO:0045070]; prostate gland epithelium morphogenesis [GO:0060740]; protein catabolic process [GO:0030163]; protein import into nucleus [GO:0006606]; pulmonary valve morphogenesis [GO:0003184]; regulation of cardioblast proliferation [GO:0003264]; regulation of cell adhesion involved in heart morphogenesis [GO:0061344]; regulation of cell migration [GO:0030334]; regulation of cell population proliferation [GO:0042127]; regulation of epithelial cell proliferation [GO:0050678]; regulation of epithelial cell proliferation involved in prostate gland development [GO:0060768]; regulation of extracellular matrix assembly [GO:1901201]; regulation of gene expression [GO:0010468]; regulation of inner ear auditory receptor cell differentiation [GO:0045607]; regulation of neurogenesis [GO:0050767]; regulation of Notch signaling pathway [GO:0008593]; regulation of somitogenesis [GO:0014807]; regulation of transcription by RNA polymerase II [GO:0006357]; response to lipopolysaccharide [GO:0032496]; response to muramyl dipeptide [GO:0032495]; secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development [GO:0060528]; skeletal muscle cell differentiation [GO:0035914]; somatic stem cell division [GO:0048103]; spermatogenesis [GO:0007283]; sprouting angiogenesis [GO:0002040]; T-helper 17 type immune response [GO:0072538]; tissue regeneration [GO:0042246]; tube formation [GO:0035148]; vasculogenesis involved in coronary vascular morphogenesis [GO:0060979]; venous blood vessel morphogenesis [GO:0048845]; venous endothelial cell differentiation [GO:0060843]; ventricular septum morphogenesis [GO:0060412]; ventricular trabecula myocardium morphogenesis [GO:0003222] acrosomal vesicle [GO:0001669]; adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell periphery [GO:0071944]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; lamellipodium [GO:0030027]; late endosome membrane [GO:0031902]; MAML1-RBP-Jkappa- ICN1 complex [GO:0002193]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; receptor complex [GO:0043235]; ruffle [GO:0001726]; Schaffer collateral - CA1 synapse [GO:0098685] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; identical protein binding [GO:0042802]; Notch binding [GO:0005112]; transcription coactivator activity [GO:0003713]; transcription regulator activator activity [GO:0140537]; transmembrane signaling receptor activity [GO:0004888] g256.t4 Q01705 35.784 1442 0.0 636.0 sp|Q01705|NOTC1_MOUSE Neurogenic locus notch homolog protein 1 OS=Mus musculus OX=10090 GN=Notch1 PE=1 SV=3 NOTC1_MOUSE reviewed Neurogenic locus notch homolog protein 1 (Notch 1) (Motch A) (mT14) (p300) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Mus musculus (Mouse) GO:0000122; GO:0000139; GO:0001554; GO:0001669; GO:0001701; GO:0001708; GO:0001726; GO:0001837; GO:0001889; GO:0001947; GO:0002040; GO:0002051; GO:0002052; GO:0002193; GO:0002437; GO:0003151; GO:0003157; GO:0003160; GO:0003162; GO:0003169; GO:0003180; GO:0003181; GO:0003182; GO:0003184; GO:0003192; GO:0003197; GO:0003198; GO:0003203; GO:0003207; GO:0003208; GO:0003209; GO:0003213; GO:0003214; GO:0003219; GO:0003222; GO:0003241; GO:0003252; GO:0003264; GO:0003273; GO:0003332; GO:0003344; GO:0003682; GO:0003713; GO:0004857; GO:0004888; GO:0005112; GO:0005509; GO:0005576; GO:0005634; GO:0005654; GO:0005737; GO:0005783; GO:0005789; GO:0005829; GO:0005856; GO:0005886; GO:0005912; GO:0006357; GO:0006606; GO:0006959; GO:0007219; GO:0007221; GO:0007283; GO:0007368; GO:0007386; GO:0007409; GO:0007411; GO:0007440; GO:0007492; GO:0007507; GO:0008284; GO:0008285; GO:0008544; GO:0008593; GO:0009912; GO:0009986; GO:0010001; GO:0010008; GO:0010467; GO:0010468; GO:0010614; GO:0010628; GO:0010629; GO:0010667; GO:0010718; GO:0010812; GO:0010832; GO:0014031; GO:0014807; GO:0016324; GO:0019899; GO:0021515; GO:0021915; GO:0030027; GO:0030154; GO:0030163; GO:0030182; GO:0030216; GO:0030279; GO:0030324; GO:0030326; GO:0030334; GO:0030335; GO:0030513; GO:0030514; GO:0030900; GO:0031069; GO:0031100; GO:0031410; GO:0031490; GO:0031902; GO:0032495; GO:0032496; GO:0032966; GO:0035116; GO:0035148; GO:0035914; GO:0035924; GO:0042127; GO:0042246; GO:0042802; GO:0043065; GO:0043069; GO:0043086; GO:0043235; GO:0045070; GO:0045165; GO:0045596; GO:0045603; GO:0045607; GO:0045608; GO:0045618; GO:0045662; GO:0045665; GO:0045668; GO:0045687; GO:0045747; GO:0045892; GO:0045893; GO:0045944; GO:0045955; GO:0046427; GO:0046533; GO:0046579; GO:0048103; GO:0048593; GO:0048663; GO:0048708; GO:0048709; GO:0048711; GO:0048715; GO:0048754; GO:0048845; GO:0048873; GO:0050678; GO:0050679; GO:0050767; GO:0050768; GO:0051152; GO:0055008; GO:0060038; GO:0060045; GO:0060253; GO:0060271; GO:0060317; GO:0060354; GO:0060379; GO:0060411; GO:0060412; GO:0060528; GO:0060740; GO:0060768; GO:0060842; GO:0060843; GO:0060948; GO:0060956; GO:0060979; GO:0060982; GO:0061344; GO:0061384; GO:0062043; GO:0070168; GO:0070374; GO:0070986; GO:0071228; GO:0071372; GO:0071456; GO:0071944; GO:0072017; GO:0072044; GO:0072144; GO:0072538; GO:0090051; GO:0090090; GO:0097150; GO:0097400; GO:0098685; GO:0098839; GO:0098978; GO:0099565; GO:0120163; GO:0140537; GO:1901189; GO:1901201; GO:1902263; GO:1902339; GO:1903849; GO:2000048; GO:2000737; GO:2000811; GO:2000974; GO:2001027 animal organ regeneration [GO:0031100]; aortic valve morphogenesis [GO:0003180]; apoptotic process involved in embryonic digit morphogenesis [GO:1902263]; arterial endothelial cell differentiation [GO:0060842]; astrocyte differentiation [GO:0048708]; atrioventricular node development [GO:0003162]; atrioventricular valve morphogenesis [GO:0003181]; auditory receptor cell fate commitment [GO:0009912]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; branching morphogenesis of an epithelial tube [GO:0048754]; camera-type eye morphogenesis [GO:0048593]; cardiac atrium morphogenesis [GO:0003209]; cardiac chamber formation [GO:0003207]; cardiac epithelial to mesenchymal transition [GO:0060317]; cardiac left ventricle morphogenesis [GO:0003214]; cardiac muscle cell myoblast differentiation [GO:0060379]; cardiac muscle cell proliferation [GO:0060038]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac right atrium morphogenesis [GO:0003213]; cardiac right ventricle formation [GO:0003219]; cardiac septum morphogenesis [GO:0060411]; cardiac vascular smooth muscle cell development [GO:0060948]; cardiac ventricle morphogenesis [GO:0003208]; cell differentiation [GO:0030154]; cell differentiation in spinal cord [GO:0021515]; cell fate commitment [GO:0045165]; cell fate specification [GO:0001708]; cell migration involved in endocardial cushion formation [GO:0003273]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to hypoxia [GO:0071456]; cellular response to tumor cell [GO:0071228]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; chemical synaptic transmission, postsynaptic [GO:0099565]; cilium assembly [GO:0060271]; collecting duct development [GO:0072044]; compartment pattern specification [GO:0007386]; coronary artery morphogenesis [GO:0060982]; coronary sinus valve morphogenesis [GO:0003182]; coronary vein morphogenesis [GO:0003169]; determination of left/right symmetry [GO:0007368]; distal tubule development [GO:0072017]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic limb morphogenesis [GO:0030326]; endocardial cell differentiation [GO:0060956]; endocardial cushion development [GO:0003197]; endocardial cushion morphogenesis [GO:0003203]; endocardium development [GO:0003157]; endocardium morphogenesis [GO:0003160]; endoderm development [GO:0007492]; epidermis development [GO:0008544]; epithelial to mesenchymal transition [GO:0001837]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; forebrain development [GO:0030900]; foregut morphogenesis [GO:0007440]; gene expression [GO:0010467]; glial cell differentiation [GO:0010001]; glomerular mesangial cell development [GO:0072144]; growth involved in heart morphogenesis [GO:0003241]; hair follicle morphogenesis [GO:0031069]; heart development [GO:0007507]; heart looping [GO:0001947]; heart trabecula morphogenesis [GO:0061384]; homeostasis of number of cells within a tissue [GO:0048873]; humoral immune response [GO:0006959]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; interleukin-17-mediated signaling pathway [GO:0097400]; keratinocyte differentiation [GO:0030216]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; lung development [GO:0030324]; luteolysis [GO:0001554]; mesenchymal cell development [GO:0014031]; mitral valve formation [GO:0003192]; negative regulation of anoikis [GO:2000811]; negative regulation of biomineral tissue development [GO:0070168]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of catalytic activity [GO:0043086]; negative regulation of cell adhesion molecule production [GO:0060354]; negative regulation of cell differentiation [GO:0045596]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell proliferation involved in heart valve morphogenesis [GO:0003252]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of collagen biosynthetic process [GO:0032966]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of endothelial cell chemotaxis [GO:2001027]; negative regulation of extracellular matrix constituent secretion [GO:0003332]; negative regulation of gene expression [GO:0010629]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of inner ear auditory receptor cell differentiation [GO:0045608]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of ossification [GO:0030279]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of photoreceptor cell differentiation [GO:0046533]; negative regulation of pro-B cell differentiation [GO:2000974]; negative regulation of programmed cell death [GO:0043069]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural tube development [GO:0021915]; neuron differentiation [GO:0030182]; neuron fate commitment [GO:0048663]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; oligodendrocyte differentiation [GO:0048709]; osteoblast fate commitment [GO:0002051]; outflow tract morphogenesis [GO:0003151]; pericardium morphogenesis [GO:0003344]; positive regulation of aorta morphogenesis [GO:1903849]; positive regulation of apoptotic process [GO:0043065]; positive regulation of apoptotic process involved in morphogenesis [GO:1902339]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cardiac epithelial to mesenchymal transition [GO:0062043]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of ephrin receptor signaling pathway [GO:1901189]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of glial cell differentiation [GO:0045687]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of smooth muscle cell differentiation [GO:0051152]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription of Notch receptor target [GO:0007221]; positive regulation of viral genome replication [GO:0045070]; prostate gland epithelium morphogenesis [GO:0060740]; protein catabolic process [GO:0030163]; protein import into nucleus [GO:0006606]; pulmonary valve morphogenesis [GO:0003184]; regulation of cardioblast proliferation [GO:0003264]; regulation of cell adhesion involved in heart morphogenesis [GO:0061344]; regulation of cell migration [GO:0030334]; regulation of cell population proliferation [GO:0042127]; regulation of epithelial cell proliferation [GO:0050678]; regulation of epithelial cell proliferation involved in prostate gland development [GO:0060768]; regulation of extracellular matrix assembly [GO:1901201]; regulation of gene expression [GO:0010468]; regulation of inner ear auditory receptor cell differentiation [GO:0045607]; regulation of neurogenesis [GO:0050767]; regulation of Notch signaling pathway [GO:0008593]; regulation of somitogenesis [GO:0014807]; regulation of transcription by RNA polymerase II [GO:0006357]; response to lipopolysaccharide [GO:0032496]; response to muramyl dipeptide [GO:0032495]; secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development [GO:0060528]; skeletal muscle cell differentiation [GO:0035914]; somatic stem cell division [GO:0048103]; spermatogenesis [GO:0007283]; sprouting angiogenesis [GO:0002040]; T-helper 17 type immune response [GO:0072538]; tissue regeneration [GO:0042246]; tube formation [GO:0035148]; vasculogenesis involved in coronary vascular morphogenesis [GO:0060979]; venous blood vessel morphogenesis [GO:0048845]; venous endothelial cell differentiation [GO:0060843]; ventricular septum morphogenesis [GO:0060412]; ventricular trabecula myocardium morphogenesis [GO:0003222] acrosomal vesicle [GO:0001669]; adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell periphery [GO:0071944]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; lamellipodium [GO:0030027]; late endosome membrane [GO:0031902]; MAML1-RBP-Jkappa- ICN1 complex [GO:0002193]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; receptor complex [GO:0043235]; ruffle [GO:0001726]; Schaffer collateral - CA1 synapse [GO:0098685] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; identical protein binding [GO:0042802]; Notch binding [GO:0005112]; transcription coactivator activity [GO:0003713]; transcription regulator activator activity [GO:0140537]; transmembrane signaling receptor activity [GO:0004888] g256.t4 Q01705 34.104 1428 0.0 625.0 sp|Q01705|NOTC1_MOUSE Neurogenic locus notch homolog protein 1 OS=Mus musculus OX=10090 GN=Notch1 PE=1 SV=3 NOTC1_MOUSE reviewed Neurogenic locus notch homolog protein 1 (Notch 1) (Motch A) (mT14) (p300) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Mus musculus (Mouse) GO:0000122; GO:0000139; GO:0001554; GO:0001669; GO:0001701; GO:0001708; GO:0001726; GO:0001837; GO:0001889; GO:0001947; GO:0002040; GO:0002051; GO:0002052; GO:0002193; GO:0002437; GO:0003151; GO:0003157; GO:0003160; GO:0003162; GO:0003169; GO:0003180; GO:0003181; GO:0003182; GO:0003184; GO:0003192; GO:0003197; GO:0003198; GO:0003203; GO:0003207; GO:0003208; GO:0003209; GO:0003213; GO:0003214; GO:0003219; GO:0003222; GO:0003241; GO:0003252; GO:0003264; GO:0003273; GO:0003332; GO:0003344; GO:0003682; GO:0003713; GO:0004857; GO:0004888; GO:0005112; GO:0005509; GO:0005576; GO:0005634; GO:0005654; GO:0005737; GO:0005783; GO:0005789; GO:0005829; GO:0005856; GO:0005886; GO:0005912; GO:0006357; GO:0006606; GO:0006959; GO:0007219; GO:0007221; GO:0007283; GO:0007368; GO:0007386; GO:0007409; GO:0007411; GO:0007440; GO:0007492; GO:0007507; GO:0008284; GO:0008285; GO:0008544; GO:0008593; GO:0009912; GO:0009986; GO:0010001; GO:0010008; GO:0010467; GO:0010468; GO:0010614; GO:0010628; GO:0010629; GO:0010667; GO:0010718; GO:0010812; GO:0010832; GO:0014031; GO:0014807; GO:0016324; GO:0019899; GO:0021515; GO:0021915; GO:0030027; GO:0030154; GO:0030163; GO:0030182; GO:0030216; GO:0030279; GO:0030324; GO:0030326; GO:0030334; GO:0030335; GO:0030513; GO:0030514; GO:0030900; GO:0031069; GO:0031100; GO:0031410; GO:0031490; GO:0031902; GO:0032495; GO:0032496; GO:0032966; GO:0035116; GO:0035148; GO:0035914; GO:0035924; GO:0042127; GO:0042246; GO:0042802; GO:0043065; GO:0043069; GO:0043086; GO:0043235; GO:0045070; GO:0045165; GO:0045596; GO:0045603; GO:0045607; GO:0045608; GO:0045618; GO:0045662; GO:0045665; GO:0045668; GO:0045687; GO:0045747; GO:0045892; GO:0045893; GO:0045944; GO:0045955; GO:0046427; GO:0046533; GO:0046579; GO:0048103; GO:0048593; GO:0048663; GO:0048708; GO:0048709; GO:0048711; GO:0048715; GO:0048754; GO:0048845; GO:0048873; GO:0050678; GO:0050679; GO:0050767; GO:0050768; GO:0051152; GO:0055008; GO:0060038; GO:0060045; GO:0060253; GO:0060271; GO:0060317; GO:0060354; GO:0060379; GO:0060411; GO:0060412; GO:0060528; GO:0060740; GO:0060768; GO:0060842; GO:0060843; GO:0060948; GO:0060956; GO:0060979; GO:0060982; GO:0061344; GO:0061384; GO:0062043; GO:0070168; GO:0070374; GO:0070986; GO:0071228; GO:0071372; GO:0071456; GO:0071944; GO:0072017; GO:0072044; GO:0072144; GO:0072538; GO:0090051; GO:0090090; GO:0097150; GO:0097400; GO:0098685; GO:0098839; GO:0098978; GO:0099565; GO:0120163; GO:0140537; GO:1901189; GO:1901201; GO:1902263; GO:1902339; GO:1903849; GO:2000048; GO:2000737; GO:2000811; GO:2000974; GO:2001027 animal organ regeneration [GO:0031100]; aortic valve morphogenesis [GO:0003180]; apoptotic process involved in embryonic digit morphogenesis [GO:1902263]; arterial endothelial cell differentiation [GO:0060842]; astrocyte differentiation [GO:0048708]; atrioventricular node development [GO:0003162]; atrioventricular valve morphogenesis [GO:0003181]; auditory receptor cell fate commitment [GO:0009912]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; branching morphogenesis of an epithelial tube [GO:0048754]; camera-type eye morphogenesis [GO:0048593]; cardiac atrium morphogenesis [GO:0003209]; cardiac chamber formation [GO:0003207]; cardiac epithelial to mesenchymal transition [GO:0060317]; cardiac left ventricle morphogenesis [GO:0003214]; cardiac muscle cell myoblast differentiation [GO:0060379]; cardiac muscle cell proliferation [GO:0060038]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac right atrium morphogenesis [GO:0003213]; cardiac right ventricle formation [GO:0003219]; cardiac septum morphogenesis [GO:0060411]; cardiac vascular smooth muscle cell development [GO:0060948]; cardiac ventricle morphogenesis [GO:0003208]; cell differentiation [GO:0030154]; cell differentiation in spinal cord [GO:0021515]; cell fate commitment [GO:0045165]; cell fate specification [GO:0001708]; cell migration involved in endocardial cushion formation [GO:0003273]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to hypoxia [GO:0071456]; cellular response to tumor cell [GO:0071228]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; chemical synaptic transmission, postsynaptic [GO:0099565]; cilium assembly [GO:0060271]; collecting duct development [GO:0072044]; compartment pattern specification [GO:0007386]; coronary artery morphogenesis [GO:0060982]; coronary sinus valve morphogenesis [GO:0003182]; coronary vein morphogenesis [GO:0003169]; determination of left/right symmetry [GO:0007368]; distal tubule development [GO:0072017]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic limb morphogenesis [GO:0030326]; endocardial cell differentiation [GO:0060956]; endocardial cushion development [GO:0003197]; endocardial cushion morphogenesis [GO:0003203]; endocardium development [GO:0003157]; endocardium morphogenesis [GO:0003160]; endoderm development [GO:0007492]; epidermis development [GO:0008544]; epithelial to mesenchymal transition [GO:0001837]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; forebrain development [GO:0030900]; foregut morphogenesis [GO:0007440]; gene expression [GO:0010467]; glial cell differentiation [GO:0010001]; glomerular mesangial cell development [GO:0072144]; growth involved in heart morphogenesis [GO:0003241]; hair follicle morphogenesis [GO:0031069]; heart development [GO:0007507]; heart looping [GO:0001947]; heart trabecula morphogenesis [GO:0061384]; homeostasis of number of cells within a tissue [GO:0048873]; humoral immune response [GO:0006959]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; interleukin-17-mediated signaling pathway [GO:0097400]; keratinocyte differentiation [GO:0030216]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; lung development [GO:0030324]; luteolysis [GO:0001554]; mesenchymal cell development [GO:0014031]; mitral valve formation [GO:0003192]; negative regulation of anoikis [GO:2000811]; negative regulation of biomineral tissue development [GO:0070168]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of catalytic activity [GO:0043086]; negative regulation of cell adhesion molecule production [GO:0060354]; negative regulation of cell differentiation [GO:0045596]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell proliferation involved in heart valve morphogenesis [GO:0003252]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of collagen biosynthetic process [GO:0032966]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of endothelial cell chemotaxis [GO:2001027]; negative regulation of extracellular matrix constituent secretion [GO:0003332]; negative regulation of gene expression [GO:0010629]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of inner ear auditory receptor cell differentiation [GO:0045608]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of ossification [GO:0030279]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of photoreceptor cell differentiation [GO:0046533]; negative regulation of pro-B cell differentiation [GO:2000974]; negative regulation of programmed cell death [GO:0043069]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural tube development [GO:0021915]; neuron differentiation [GO:0030182]; neuron fate commitment [GO:0048663]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; oligodendrocyte differentiation [GO:0048709]; osteoblast fate commitment [GO:0002051]; outflow tract morphogenesis [GO:0003151]; pericardium morphogenesis [GO:0003344]; positive regulation of aorta morphogenesis [GO:1903849]; positive regulation of apoptotic process [GO:0043065]; positive regulation of apoptotic process involved in morphogenesis [GO:1902339]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cardiac epithelial to mesenchymal transition [GO:0062043]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of ephrin receptor signaling pathway [GO:1901189]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of glial cell differentiation [GO:0045687]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of smooth muscle cell differentiation [GO:0051152]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription of Notch receptor target [GO:0007221]; positive regulation of viral genome replication [GO:0045070]; prostate gland epithelium morphogenesis [GO:0060740]; protein catabolic process [GO:0030163]; protein import into nucleus [GO:0006606]; pulmonary valve morphogenesis [GO:0003184]; regulation of cardioblast proliferation [GO:0003264]; regulation of cell adhesion involved in heart morphogenesis [GO:0061344]; regulation of cell migration [GO:0030334]; regulation of cell population proliferation [GO:0042127]; regulation of epithelial cell proliferation [GO:0050678]; regulation of epithelial cell proliferation involved in prostate gland development [GO:0060768]; regulation of extracellular matrix assembly [GO:1901201]; regulation of gene expression [GO:0010468]; regulation of inner ear auditory receptor cell differentiation [GO:0045607]; regulation of neurogenesis [GO:0050767]; regulation of Notch signaling pathway [GO:0008593]; regulation of somitogenesis [GO:0014807]; regulation of transcription by RNA polymerase II [GO:0006357]; response to lipopolysaccharide [GO:0032496]; response to muramyl dipeptide [GO:0032495]; secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development [GO:0060528]; skeletal muscle cell differentiation [GO:0035914]; somatic stem cell division [GO:0048103]; spermatogenesis [GO:0007283]; sprouting angiogenesis [GO:0002040]; T-helper 17 type immune response [GO:0072538]; tissue regeneration [GO:0042246]; tube formation [GO:0035148]; vasculogenesis involved in coronary vascular morphogenesis [GO:0060979]; venous blood vessel morphogenesis [GO:0048845]; venous endothelial cell differentiation [GO:0060843]; ventricular septum morphogenesis [GO:0060412]; ventricular trabecula myocardium morphogenesis [GO:0003222] acrosomal vesicle [GO:0001669]; adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell periphery [GO:0071944]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; lamellipodium [GO:0030027]; late endosome membrane [GO:0031902]; MAML1-RBP-Jkappa- ICN1 complex [GO:0002193]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; receptor complex [GO:0043235]; ruffle [GO:0001726]; Schaffer collateral - CA1 synapse [GO:0098685] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; identical protein binding [GO:0042802]; Notch binding [GO:0005112]; transcription coactivator activity [GO:0003713]; transcription regulator activator activity [GO:0140537]; transmembrane signaling receptor activity [GO:0004888] g256.t4 Q01705 34.901 1318 8.19e-160 558.0 sp|Q01705|NOTC1_MOUSE Neurogenic locus notch homolog protein 1 OS=Mus musculus OX=10090 GN=Notch1 PE=1 SV=3 NOTC1_MOUSE reviewed Neurogenic locus notch homolog protein 1 (Notch 1) (Motch A) (mT14) (p300) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Mus musculus (Mouse) GO:0000122; GO:0000139; GO:0001554; GO:0001669; GO:0001701; GO:0001708; GO:0001726; GO:0001837; GO:0001889; GO:0001947; GO:0002040; GO:0002051; GO:0002052; GO:0002193; GO:0002437; GO:0003151; GO:0003157; GO:0003160; GO:0003162; GO:0003169; GO:0003180; GO:0003181; GO:0003182; GO:0003184; GO:0003192; GO:0003197; GO:0003198; GO:0003203; GO:0003207; GO:0003208; GO:0003209; GO:0003213; GO:0003214; GO:0003219; GO:0003222; GO:0003241; GO:0003252; GO:0003264; GO:0003273; GO:0003332; GO:0003344; GO:0003682; GO:0003713; GO:0004857; GO:0004888; GO:0005112; GO:0005509; GO:0005576; GO:0005634; GO:0005654; GO:0005737; GO:0005783; GO:0005789; GO:0005829; GO:0005856; GO:0005886; GO:0005912; GO:0006357; GO:0006606; GO:0006959; GO:0007219; GO:0007221; GO:0007283; GO:0007368; GO:0007386; GO:0007409; GO:0007411; GO:0007440; GO:0007492; GO:0007507; GO:0008284; GO:0008285; GO:0008544; GO:0008593; GO:0009912; GO:0009986; GO:0010001; GO:0010008; GO:0010467; GO:0010468; GO:0010614; GO:0010628; GO:0010629; GO:0010667; GO:0010718; GO:0010812; GO:0010832; GO:0014031; GO:0014807; GO:0016324; GO:0019899; GO:0021515; GO:0021915; GO:0030027; GO:0030154; GO:0030163; GO:0030182; GO:0030216; GO:0030279; GO:0030324; GO:0030326; GO:0030334; GO:0030335; GO:0030513; GO:0030514; GO:0030900; GO:0031069; GO:0031100; GO:0031410; GO:0031490; GO:0031902; GO:0032495; GO:0032496; GO:0032966; GO:0035116; GO:0035148; GO:0035914; GO:0035924; GO:0042127; GO:0042246; GO:0042802; GO:0043065; GO:0043069; GO:0043086; GO:0043235; GO:0045070; GO:0045165; GO:0045596; GO:0045603; GO:0045607; GO:0045608; GO:0045618; GO:0045662; GO:0045665; GO:0045668; GO:0045687; GO:0045747; GO:0045892; GO:0045893; GO:0045944; GO:0045955; GO:0046427; GO:0046533; GO:0046579; GO:0048103; GO:0048593; GO:0048663; GO:0048708; GO:0048709; GO:0048711; GO:0048715; GO:0048754; GO:0048845; GO:0048873; GO:0050678; GO:0050679; GO:0050767; GO:0050768; GO:0051152; GO:0055008; GO:0060038; GO:0060045; GO:0060253; GO:0060271; GO:0060317; GO:0060354; GO:0060379; GO:0060411; GO:0060412; GO:0060528; GO:0060740; GO:0060768; GO:0060842; GO:0060843; GO:0060948; GO:0060956; GO:0060979; GO:0060982; GO:0061344; GO:0061384; GO:0062043; GO:0070168; GO:0070374; GO:0070986; GO:0071228; GO:0071372; GO:0071456; GO:0071944; GO:0072017; GO:0072044; GO:0072144; GO:0072538; GO:0090051; GO:0090090; GO:0097150; GO:0097400; GO:0098685; GO:0098839; GO:0098978; GO:0099565; GO:0120163; GO:0140537; GO:1901189; GO:1901201; GO:1902263; GO:1902339; GO:1903849; GO:2000048; GO:2000737; GO:2000811; GO:2000974; GO:2001027 animal organ regeneration [GO:0031100]; aortic valve morphogenesis [GO:0003180]; apoptotic process involved in embryonic digit morphogenesis [GO:1902263]; arterial endothelial cell differentiation [GO:0060842]; astrocyte differentiation [GO:0048708]; atrioventricular node development [GO:0003162]; atrioventricular valve morphogenesis [GO:0003181]; auditory receptor cell fate commitment [GO:0009912]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; branching morphogenesis of an epithelial tube [GO:0048754]; camera-type eye morphogenesis [GO:0048593]; cardiac atrium morphogenesis [GO:0003209]; cardiac chamber formation [GO:0003207]; cardiac epithelial to mesenchymal transition [GO:0060317]; cardiac left ventricle morphogenesis [GO:0003214]; cardiac muscle cell myoblast differentiation [GO:0060379]; cardiac muscle cell proliferation [GO:0060038]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac right atrium morphogenesis [GO:0003213]; cardiac right ventricle formation [GO:0003219]; cardiac septum morphogenesis [GO:0060411]; cardiac vascular smooth muscle cell development [GO:0060948]; cardiac ventricle morphogenesis [GO:0003208]; cell differentiation [GO:0030154]; cell differentiation in spinal cord [GO:0021515]; cell fate commitment [GO:0045165]; cell fate specification [GO:0001708]; cell migration involved in endocardial cushion formation [GO:0003273]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to hypoxia [GO:0071456]; cellular response to tumor cell [GO:0071228]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; chemical synaptic transmission, postsynaptic [GO:0099565]; cilium assembly [GO:0060271]; collecting duct development [GO:0072044]; compartment pattern specification [GO:0007386]; coronary artery morphogenesis [GO:0060982]; coronary sinus valve morphogenesis [GO:0003182]; coronary vein morphogenesis [GO:0003169]; determination of left/right symmetry [GO:0007368]; distal tubule development [GO:0072017]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic limb morphogenesis [GO:0030326]; endocardial cell differentiation [GO:0060956]; endocardial cushion development [GO:0003197]; endocardial cushion morphogenesis [GO:0003203]; endocardium development [GO:0003157]; endocardium morphogenesis [GO:0003160]; endoderm development [GO:0007492]; epidermis development [GO:0008544]; epithelial to mesenchymal transition [GO:0001837]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; forebrain development [GO:0030900]; foregut morphogenesis [GO:0007440]; gene expression [GO:0010467]; glial cell differentiation [GO:0010001]; glomerular mesangial cell development [GO:0072144]; growth involved in heart morphogenesis [GO:0003241]; hair follicle morphogenesis [GO:0031069]; heart development [GO:0007507]; heart looping [GO:0001947]; heart trabecula morphogenesis [GO:0061384]; homeostasis of number of cells within a tissue [GO:0048873]; humoral immune response [GO:0006959]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; interleukin-17-mediated signaling pathway [GO:0097400]; keratinocyte differentiation [GO:0030216]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; lung development [GO:0030324]; luteolysis [GO:0001554]; mesenchymal cell development [GO:0014031]; mitral valve formation [GO:0003192]; negative regulation of anoikis [GO:2000811]; negative regulation of biomineral tissue development [GO:0070168]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of catalytic activity [GO:0043086]; negative regulation of cell adhesion molecule production [GO:0060354]; negative regulation of cell differentiation [GO:0045596]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell proliferation involved in heart valve morphogenesis [GO:0003252]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of collagen biosynthetic process [GO:0032966]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of endothelial cell chemotaxis [GO:2001027]; negative regulation of extracellular matrix constituent secretion [GO:0003332]; negative regulation of gene expression [GO:0010629]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of inner ear auditory receptor cell differentiation [GO:0045608]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of ossification [GO:0030279]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of photoreceptor cell differentiation [GO:0046533]; negative regulation of pro-B cell differentiation [GO:2000974]; negative regulation of programmed cell death [GO:0043069]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural tube development [GO:0021915]; neuron differentiation [GO:0030182]; neuron fate commitment [GO:0048663]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; oligodendrocyte differentiation [GO:0048709]; osteoblast fate commitment [GO:0002051]; outflow tract morphogenesis [GO:0003151]; pericardium morphogenesis [GO:0003344]; positive regulation of aorta morphogenesis [GO:1903849]; positive regulation of apoptotic process [GO:0043065]; positive regulation of apoptotic process involved in morphogenesis [GO:1902339]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cardiac epithelial to mesenchymal transition [GO:0062043]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of ephrin receptor signaling pathway [GO:1901189]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of glial cell differentiation [GO:0045687]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of smooth muscle cell differentiation [GO:0051152]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription of Notch receptor target [GO:0007221]; positive regulation of viral genome replication [GO:0045070]; prostate gland epithelium morphogenesis [GO:0060740]; protein catabolic process [GO:0030163]; protein import into nucleus [GO:0006606]; pulmonary valve morphogenesis [GO:0003184]; regulation of cardioblast proliferation [GO:0003264]; regulation of cell adhesion involved in heart morphogenesis [GO:0061344]; regulation of cell migration [GO:0030334]; regulation of cell population proliferation [GO:0042127]; regulation of epithelial cell proliferation [GO:0050678]; regulation of epithelial cell proliferation involved in prostate gland development [GO:0060768]; regulation of extracellular matrix assembly [GO:1901201]; regulation of gene expression [GO:0010468]; regulation of inner ear auditory receptor cell differentiation [GO:0045607]; regulation of neurogenesis [GO:0050767]; regulation of Notch signaling pathway [GO:0008593]; regulation of somitogenesis [GO:0014807]; regulation of transcription by RNA polymerase II [GO:0006357]; response to lipopolysaccharide [GO:0032496]; response to muramyl dipeptide [GO:0032495]; secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development [GO:0060528]; skeletal muscle cell differentiation [GO:0035914]; somatic stem cell division [GO:0048103]; spermatogenesis [GO:0007283]; sprouting angiogenesis [GO:0002040]; T-helper 17 type immune response [GO:0072538]; tissue regeneration [GO:0042246]; tube formation [GO:0035148]; vasculogenesis involved in coronary vascular morphogenesis [GO:0060979]; venous blood vessel morphogenesis [GO:0048845]; venous endothelial cell differentiation [GO:0060843]; ventricular septum morphogenesis [GO:0060412]; ventricular trabecula myocardium morphogenesis [GO:0003222] acrosomal vesicle [GO:0001669]; adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell periphery [GO:0071944]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; lamellipodium [GO:0030027]; late endosome membrane [GO:0031902]; MAML1-RBP-Jkappa- ICN1 complex [GO:0002193]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; receptor complex [GO:0043235]; ruffle [GO:0001726]; Schaffer collateral - CA1 synapse [GO:0098685] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; identical protein binding [GO:0042802]; Notch binding [GO:0005112]; transcription coactivator activity [GO:0003713]; transcription regulator activator activity [GO:0140537]; transmembrane signaling receptor activity [GO:0004888] g256.t4 Q01705 36.481 1006 2.87e-130 464.0 sp|Q01705|NOTC1_MOUSE Neurogenic locus notch homolog protein 1 OS=Mus musculus OX=10090 GN=Notch1 PE=1 SV=3 NOTC1_MOUSE reviewed Neurogenic locus notch homolog protein 1 (Notch 1) (Motch A) (mT14) (p300) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Mus musculus (Mouse) GO:0000122; GO:0000139; GO:0001554; GO:0001669; GO:0001701; GO:0001708; GO:0001726; GO:0001837; GO:0001889; GO:0001947; GO:0002040; GO:0002051; GO:0002052; GO:0002193; GO:0002437; GO:0003151; GO:0003157; GO:0003160; GO:0003162; GO:0003169; GO:0003180; GO:0003181; GO:0003182; GO:0003184; GO:0003192; GO:0003197; GO:0003198; GO:0003203; GO:0003207; GO:0003208; GO:0003209; GO:0003213; GO:0003214; GO:0003219; GO:0003222; GO:0003241; GO:0003252; GO:0003264; GO:0003273; GO:0003332; GO:0003344; GO:0003682; GO:0003713; GO:0004857; GO:0004888; GO:0005112; GO:0005509; GO:0005576; GO:0005634; GO:0005654; GO:0005737; GO:0005783; GO:0005789; GO:0005829; GO:0005856; GO:0005886; GO:0005912; GO:0006357; GO:0006606; GO:0006959; GO:0007219; GO:0007221; GO:0007283; GO:0007368; GO:0007386; GO:0007409; GO:0007411; GO:0007440; GO:0007492; GO:0007507; GO:0008284; GO:0008285; GO:0008544; GO:0008593; GO:0009912; GO:0009986; GO:0010001; GO:0010008; GO:0010467; GO:0010468; GO:0010614; GO:0010628; GO:0010629; GO:0010667; GO:0010718; GO:0010812; GO:0010832; GO:0014031; GO:0014807; GO:0016324; GO:0019899; GO:0021515; GO:0021915; GO:0030027; GO:0030154; GO:0030163; GO:0030182; GO:0030216; GO:0030279; GO:0030324; GO:0030326; GO:0030334; GO:0030335; GO:0030513; GO:0030514; GO:0030900; GO:0031069; GO:0031100; GO:0031410; GO:0031490; GO:0031902; GO:0032495; GO:0032496; GO:0032966; GO:0035116; GO:0035148; GO:0035914; GO:0035924; GO:0042127; GO:0042246; GO:0042802; GO:0043065; GO:0043069; GO:0043086; GO:0043235; GO:0045070; GO:0045165; GO:0045596; GO:0045603; GO:0045607; GO:0045608; GO:0045618; GO:0045662; GO:0045665; GO:0045668; GO:0045687; GO:0045747; GO:0045892; GO:0045893; GO:0045944; GO:0045955; GO:0046427; GO:0046533; GO:0046579; GO:0048103; GO:0048593; GO:0048663; GO:0048708; GO:0048709; GO:0048711; GO:0048715; GO:0048754; GO:0048845; GO:0048873; GO:0050678; GO:0050679; GO:0050767; GO:0050768; GO:0051152; GO:0055008; GO:0060038; GO:0060045; GO:0060253; GO:0060271; GO:0060317; GO:0060354; GO:0060379; GO:0060411; GO:0060412; GO:0060528; GO:0060740; GO:0060768; GO:0060842; GO:0060843; GO:0060948; GO:0060956; GO:0060979; GO:0060982; GO:0061344; GO:0061384; GO:0062043; GO:0070168; GO:0070374; GO:0070986; GO:0071228; GO:0071372; GO:0071456; GO:0071944; GO:0072017; GO:0072044; GO:0072144; GO:0072538; GO:0090051; GO:0090090; GO:0097150; GO:0097400; GO:0098685; GO:0098839; GO:0098978; GO:0099565; GO:0120163; GO:0140537; GO:1901189; GO:1901201; GO:1902263; GO:1902339; GO:1903849; GO:2000048; GO:2000737; GO:2000811; GO:2000974; GO:2001027 animal organ regeneration [GO:0031100]; aortic valve morphogenesis [GO:0003180]; apoptotic process involved in embryonic digit morphogenesis [GO:1902263]; arterial endothelial cell differentiation [GO:0060842]; astrocyte differentiation [GO:0048708]; atrioventricular node development [GO:0003162]; atrioventricular valve morphogenesis [GO:0003181]; auditory receptor cell fate commitment [GO:0009912]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; branching morphogenesis of an epithelial tube [GO:0048754]; camera-type eye morphogenesis [GO:0048593]; cardiac atrium morphogenesis [GO:0003209]; cardiac chamber formation [GO:0003207]; cardiac epithelial to mesenchymal transition [GO:0060317]; cardiac left ventricle morphogenesis [GO:0003214]; cardiac muscle cell myoblast differentiation [GO:0060379]; cardiac muscle cell proliferation [GO:0060038]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac right atrium morphogenesis [GO:0003213]; cardiac right ventricle formation [GO:0003219]; cardiac septum morphogenesis [GO:0060411]; cardiac vascular smooth muscle cell development [GO:0060948]; cardiac ventricle morphogenesis [GO:0003208]; cell differentiation [GO:0030154]; cell differentiation in spinal cord [GO:0021515]; cell fate commitment [GO:0045165]; cell fate specification [GO:0001708]; cell migration involved in endocardial cushion formation [GO:0003273]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to hypoxia [GO:0071456]; cellular response to tumor cell [GO:0071228]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; chemical synaptic transmission, postsynaptic [GO:0099565]; cilium assembly [GO:0060271]; collecting duct development [GO:0072044]; compartment pattern specification [GO:0007386]; coronary artery morphogenesis [GO:0060982]; coronary sinus valve morphogenesis [GO:0003182]; coronary vein morphogenesis [GO:0003169]; determination of left/right symmetry [GO:0007368]; distal tubule development [GO:0072017]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic limb morphogenesis [GO:0030326]; endocardial cell differentiation [GO:0060956]; endocardial cushion development [GO:0003197]; endocardial cushion morphogenesis [GO:0003203]; endocardium development [GO:0003157]; endocardium morphogenesis [GO:0003160]; endoderm development [GO:0007492]; epidermis development [GO:0008544]; epithelial to mesenchymal transition [GO:0001837]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; forebrain development [GO:0030900]; foregut morphogenesis [GO:0007440]; gene expression [GO:0010467]; glial cell differentiation [GO:0010001]; glomerular mesangial cell development [GO:0072144]; growth involved in heart morphogenesis [GO:0003241]; hair follicle morphogenesis [GO:0031069]; heart development [GO:0007507]; heart looping [GO:0001947]; heart trabecula morphogenesis [GO:0061384]; homeostasis of number of cells within a tissue [GO:0048873]; humoral immune response [GO:0006959]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; interleukin-17-mediated signaling pathway [GO:0097400]; keratinocyte differentiation [GO:0030216]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; lung development [GO:0030324]; luteolysis [GO:0001554]; mesenchymal cell development [GO:0014031]; mitral valve formation [GO:0003192]; negative regulation of anoikis [GO:2000811]; negative regulation of biomineral tissue development [GO:0070168]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of catalytic activity [GO:0043086]; negative regulation of cell adhesion molecule production [GO:0060354]; negative regulation of cell differentiation [GO:0045596]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell proliferation involved in heart valve morphogenesis [GO:0003252]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of collagen biosynthetic process [GO:0032966]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of endothelial cell chemotaxis [GO:2001027]; negative regulation of extracellular matrix constituent secretion [GO:0003332]; negative regulation of gene expression [GO:0010629]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of inner ear auditory receptor cell differentiation [GO:0045608]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of ossification [GO:0030279]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of photoreceptor cell differentiation [GO:0046533]; negative regulation of pro-B cell differentiation [GO:2000974]; negative regulation of programmed cell death [GO:0043069]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural tube development [GO:0021915]; neuron differentiation [GO:0030182]; neuron fate commitment [GO:0048663]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; oligodendrocyte differentiation [GO:0048709]; osteoblast fate commitment [GO:0002051]; outflow tract morphogenesis [GO:0003151]; pericardium morphogenesis [GO:0003344]; positive regulation of aorta morphogenesis [GO:1903849]; positive regulation of apoptotic process [GO:0043065]; positive regulation of apoptotic process involved in morphogenesis [GO:1902339]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cardiac epithelial to mesenchymal transition [GO:0062043]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of ephrin receptor signaling pathway [GO:1901189]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of glial cell differentiation [GO:0045687]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of smooth muscle cell differentiation [GO:0051152]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription of Notch receptor target [GO:0007221]; positive regulation of viral genome replication [GO:0045070]; prostate gland epithelium morphogenesis [GO:0060740]; protein catabolic process [GO:0030163]; protein import into nucleus [GO:0006606]; pulmonary valve morphogenesis [GO:0003184]; regulation of cardioblast proliferation [GO:0003264]; regulation of cell adhesion involved in heart morphogenesis [GO:0061344]; regulation of cell migration [GO:0030334]; regulation of cell population proliferation [GO:0042127]; regulation of epithelial cell proliferation [GO:0050678]; regulation of epithelial cell proliferation involved in prostate gland development [GO:0060768]; regulation of extracellular matrix assembly [GO:1901201]; regulation of gene expression [GO:0010468]; regulation of inner ear auditory receptor cell differentiation [GO:0045607]; regulation of neurogenesis [GO:0050767]; regulation of Notch signaling pathway [GO:0008593]; regulation of somitogenesis [GO:0014807]; regulation of transcription by RNA polymerase II [GO:0006357]; response to lipopolysaccharide [GO:0032496]; response to muramyl dipeptide [GO:0032495]; secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development [GO:0060528]; skeletal muscle cell differentiation [GO:0035914]; somatic stem cell division [GO:0048103]; spermatogenesis [GO:0007283]; sprouting angiogenesis [GO:0002040]; T-helper 17 type immune response [GO:0072538]; tissue regeneration [GO:0042246]; tube formation [GO:0035148]; vasculogenesis involved in coronary vascular morphogenesis [GO:0060979]; venous blood vessel morphogenesis [GO:0048845]; venous endothelial cell differentiation [GO:0060843]; ventricular septum morphogenesis [GO:0060412]; ventricular trabecula myocardium morphogenesis [GO:0003222] acrosomal vesicle [GO:0001669]; adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell periphery [GO:0071944]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; lamellipodium [GO:0030027]; late endosome membrane [GO:0031902]; MAML1-RBP-Jkappa- ICN1 complex [GO:0002193]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; receptor complex [GO:0043235]; ruffle [GO:0001726]; Schaffer collateral - CA1 synapse [GO:0098685] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; identical protein binding [GO:0042802]; Notch binding [GO:0005112]; transcription coactivator activity [GO:0003713]; transcription regulator activator activity [GO:0140537]; transmembrane signaling receptor activity [GO:0004888] g256.t4 Q01705 37.978 445 4.46e-59 231.0 sp|Q01705|NOTC1_MOUSE Neurogenic locus notch homolog protein 1 OS=Mus musculus OX=10090 GN=Notch1 PE=1 SV=3 NOTC1_MOUSE reviewed Neurogenic locus notch homolog protein 1 (Notch 1) (Motch A) (mT14) (p300) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Mus musculus (Mouse) GO:0000122; GO:0000139; GO:0001554; GO:0001669; GO:0001701; GO:0001708; GO:0001726; GO:0001837; GO:0001889; GO:0001947; GO:0002040; GO:0002051; GO:0002052; GO:0002193; GO:0002437; GO:0003151; GO:0003157; GO:0003160; GO:0003162; GO:0003169; GO:0003180; GO:0003181; GO:0003182; GO:0003184; GO:0003192; GO:0003197; GO:0003198; GO:0003203; GO:0003207; GO:0003208; GO:0003209; GO:0003213; GO:0003214; GO:0003219; GO:0003222; GO:0003241; GO:0003252; GO:0003264; GO:0003273; GO:0003332; GO:0003344; GO:0003682; GO:0003713; GO:0004857; GO:0004888; GO:0005112; GO:0005509; GO:0005576; GO:0005634; GO:0005654; GO:0005737; GO:0005783; GO:0005789; GO:0005829; GO:0005856; GO:0005886; GO:0005912; GO:0006357; GO:0006606; GO:0006959; GO:0007219; GO:0007221; GO:0007283; GO:0007368; GO:0007386; GO:0007409; GO:0007411; GO:0007440; GO:0007492; GO:0007507; GO:0008284; GO:0008285; GO:0008544; GO:0008593; GO:0009912; GO:0009986; GO:0010001; GO:0010008; GO:0010467; GO:0010468; GO:0010614; GO:0010628; GO:0010629; GO:0010667; GO:0010718; GO:0010812; GO:0010832; GO:0014031; GO:0014807; GO:0016324; GO:0019899; GO:0021515; GO:0021915; GO:0030027; GO:0030154; GO:0030163; GO:0030182; GO:0030216; GO:0030279; GO:0030324; GO:0030326; GO:0030334; GO:0030335; GO:0030513; GO:0030514; GO:0030900; GO:0031069; GO:0031100; GO:0031410; GO:0031490; GO:0031902; GO:0032495; GO:0032496; GO:0032966; GO:0035116; GO:0035148; GO:0035914; GO:0035924; GO:0042127; GO:0042246; GO:0042802; GO:0043065; GO:0043069; GO:0043086; GO:0043235; GO:0045070; GO:0045165; GO:0045596; GO:0045603; GO:0045607; GO:0045608; GO:0045618; GO:0045662; GO:0045665; GO:0045668; GO:0045687; GO:0045747; GO:0045892; GO:0045893; GO:0045944; GO:0045955; GO:0046427; GO:0046533; GO:0046579; GO:0048103; GO:0048593; GO:0048663; GO:0048708; GO:0048709; GO:0048711; GO:0048715; GO:0048754; GO:0048845; GO:0048873; GO:0050678; GO:0050679; GO:0050767; GO:0050768; GO:0051152; GO:0055008; GO:0060038; GO:0060045; GO:0060253; GO:0060271; GO:0060317; GO:0060354; GO:0060379; GO:0060411; GO:0060412; GO:0060528; GO:0060740; GO:0060768; GO:0060842; GO:0060843; GO:0060948; GO:0060956; GO:0060979; GO:0060982; GO:0061344; GO:0061384; GO:0062043; GO:0070168; GO:0070374; GO:0070986; GO:0071228; GO:0071372; GO:0071456; GO:0071944; GO:0072017; GO:0072044; GO:0072144; GO:0072538; GO:0090051; GO:0090090; GO:0097150; GO:0097400; GO:0098685; GO:0098839; GO:0098978; GO:0099565; GO:0120163; GO:0140537; GO:1901189; GO:1901201; GO:1902263; GO:1902339; GO:1903849; GO:2000048; GO:2000737; GO:2000811; GO:2000974; GO:2001027 animal organ regeneration [GO:0031100]; aortic valve morphogenesis [GO:0003180]; apoptotic process involved in embryonic digit morphogenesis [GO:1902263]; arterial endothelial cell differentiation [GO:0060842]; astrocyte differentiation [GO:0048708]; atrioventricular node development [GO:0003162]; atrioventricular valve morphogenesis [GO:0003181]; auditory receptor cell fate commitment [GO:0009912]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; branching morphogenesis of an epithelial tube [GO:0048754]; camera-type eye morphogenesis [GO:0048593]; cardiac atrium morphogenesis [GO:0003209]; cardiac chamber formation [GO:0003207]; cardiac epithelial to mesenchymal transition [GO:0060317]; cardiac left ventricle morphogenesis [GO:0003214]; cardiac muscle cell myoblast differentiation [GO:0060379]; cardiac muscle cell proliferation [GO:0060038]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac right atrium morphogenesis [GO:0003213]; cardiac right ventricle formation [GO:0003219]; cardiac septum morphogenesis [GO:0060411]; cardiac vascular smooth muscle cell development [GO:0060948]; cardiac ventricle morphogenesis [GO:0003208]; cell differentiation [GO:0030154]; cell differentiation in spinal cord [GO:0021515]; cell fate commitment [GO:0045165]; cell fate specification [GO:0001708]; cell migration involved in endocardial cushion formation [GO:0003273]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to hypoxia [GO:0071456]; cellular response to tumor cell [GO:0071228]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; chemical synaptic transmission, postsynaptic [GO:0099565]; cilium assembly [GO:0060271]; collecting duct development [GO:0072044]; compartment pattern specification [GO:0007386]; coronary artery morphogenesis [GO:0060982]; coronary sinus valve morphogenesis [GO:0003182]; coronary vein morphogenesis [GO:0003169]; determination of left/right symmetry [GO:0007368]; distal tubule development [GO:0072017]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic limb morphogenesis [GO:0030326]; endocardial cell differentiation [GO:0060956]; endocardial cushion development [GO:0003197]; endocardial cushion morphogenesis [GO:0003203]; endocardium development [GO:0003157]; endocardium morphogenesis [GO:0003160]; endoderm development [GO:0007492]; epidermis development [GO:0008544]; epithelial to mesenchymal transition [GO:0001837]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; forebrain development [GO:0030900]; foregut morphogenesis [GO:0007440]; gene expression [GO:0010467]; glial cell differentiation [GO:0010001]; glomerular mesangial cell development [GO:0072144]; growth involved in heart morphogenesis [GO:0003241]; hair follicle morphogenesis [GO:0031069]; heart development [GO:0007507]; heart looping [GO:0001947]; heart trabecula morphogenesis [GO:0061384]; homeostasis of number of cells within a tissue [GO:0048873]; humoral immune response [GO:0006959]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; interleukin-17-mediated signaling pathway [GO:0097400]; keratinocyte differentiation [GO:0030216]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; lung development [GO:0030324]; luteolysis [GO:0001554]; mesenchymal cell development [GO:0014031]; mitral valve formation [GO:0003192]; negative regulation of anoikis [GO:2000811]; negative regulation of biomineral tissue development [GO:0070168]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of catalytic activity [GO:0043086]; negative regulation of cell adhesion molecule production [GO:0060354]; negative regulation of cell differentiation [GO:0045596]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell proliferation involved in heart valve morphogenesis [GO:0003252]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of collagen biosynthetic process [GO:0032966]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of endothelial cell chemotaxis [GO:2001027]; negative regulation of extracellular matrix constituent secretion [GO:0003332]; negative regulation of gene expression [GO:0010629]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of inner ear auditory receptor cell differentiation [GO:0045608]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of ossification [GO:0030279]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of photoreceptor cell differentiation [GO:0046533]; negative regulation of pro-B cell differentiation [GO:2000974]; negative regulation of programmed cell death [GO:0043069]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural tube development [GO:0021915]; neuron differentiation [GO:0030182]; neuron fate commitment [GO:0048663]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; oligodendrocyte differentiation [GO:0048709]; osteoblast fate commitment [GO:0002051]; outflow tract morphogenesis [GO:0003151]; pericardium morphogenesis [GO:0003344]; positive regulation of aorta morphogenesis [GO:1903849]; positive regulation of apoptotic process [GO:0043065]; positive regulation of apoptotic process involved in morphogenesis [GO:1902339]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cardiac epithelial to mesenchymal transition [GO:0062043]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of ephrin receptor signaling pathway [GO:1901189]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of glial cell differentiation [GO:0045687]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of smooth muscle cell differentiation [GO:0051152]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription of Notch receptor target [GO:0007221]; positive regulation of viral genome replication [GO:0045070]; prostate gland epithelium morphogenesis [GO:0060740]; protein catabolic process [GO:0030163]; protein import into nucleus [GO:0006606]; pulmonary valve morphogenesis [GO:0003184]; regulation of cardioblast proliferation [GO:0003264]; regulation of cell adhesion involved in heart morphogenesis [GO:0061344]; regulation of cell migration [GO:0030334]; regulation of cell population proliferation [GO:0042127]; regulation of epithelial cell proliferation [GO:0050678]; regulation of epithelial cell proliferation involved in prostate gland development [GO:0060768]; regulation of extracellular matrix assembly [GO:1901201]; regulation of gene expression [GO:0010468]; regulation of inner ear auditory receptor cell differentiation [GO:0045607]; regulation of neurogenesis [GO:0050767]; regulation of Notch signaling pathway [GO:0008593]; regulation of somitogenesis [GO:0014807]; regulation of transcription by RNA polymerase II [GO:0006357]; response to lipopolysaccharide [GO:0032496]; response to muramyl dipeptide [GO:0032495]; secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development [GO:0060528]; skeletal muscle cell differentiation [GO:0035914]; somatic stem cell division [GO:0048103]; spermatogenesis [GO:0007283]; sprouting angiogenesis [GO:0002040]; T-helper 17 type immune response [GO:0072538]; tissue regeneration [GO:0042246]; tube formation [GO:0035148]; vasculogenesis involved in coronary vascular morphogenesis [GO:0060979]; venous blood vessel morphogenesis [GO:0048845]; venous endothelial cell differentiation [GO:0060843]; ventricular septum morphogenesis [GO:0060412]; ventricular trabecula myocardium morphogenesis [GO:0003222] acrosomal vesicle [GO:0001669]; adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell periphery [GO:0071944]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; lamellipodium [GO:0030027]; late endosome membrane [GO:0031902]; MAML1-RBP-Jkappa- ICN1 complex [GO:0002193]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; receptor complex [GO:0043235]; ruffle [GO:0001726]; Schaffer collateral - CA1 synapse [GO:0098685] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; identical protein binding [GO:0042802]; Notch binding [GO:0005112]; transcription coactivator activity [GO:0003713]; transcription regulator activator activity [GO:0140537]; transmembrane signaling receptor activity [GO:0004888] g256.t4 Q01705 42.484 153 6.2699999999999995e-24 115.0 sp|Q01705|NOTC1_MOUSE Neurogenic locus notch homolog protein 1 OS=Mus musculus OX=10090 GN=Notch1 PE=1 SV=3 NOTC1_MOUSE reviewed Neurogenic locus notch homolog protein 1 (Notch 1) (Motch A) (mT14) (p300) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Mus musculus (Mouse) GO:0000122; GO:0000139; GO:0001554; GO:0001669; GO:0001701; GO:0001708; GO:0001726; GO:0001837; GO:0001889; GO:0001947; GO:0002040; GO:0002051; GO:0002052; GO:0002193; GO:0002437; GO:0003151; GO:0003157; GO:0003160; GO:0003162; GO:0003169; GO:0003180; GO:0003181; GO:0003182; GO:0003184; GO:0003192; GO:0003197; GO:0003198; GO:0003203; GO:0003207; GO:0003208; GO:0003209; GO:0003213; GO:0003214; GO:0003219; GO:0003222; GO:0003241; GO:0003252; GO:0003264; GO:0003273; GO:0003332; GO:0003344; GO:0003682; GO:0003713; GO:0004857; GO:0004888; GO:0005112; GO:0005509; GO:0005576; GO:0005634; GO:0005654; GO:0005737; GO:0005783; GO:0005789; GO:0005829; GO:0005856; GO:0005886; GO:0005912; GO:0006357; GO:0006606; GO:0006959; GO:0007219; GO:0007221; GO:0007283; GO:0007368; GO:0007386; GO:0007409; GO:0007411; GO:0007440; GO:0007492; GO:0007507; GO:0008284; GO:0008285; GO:0008544; GO:0008593; GO:0009912; GO:0009986; GO:0010001; GO:0010008; GO:0010467; GO:0010468; GO:0010614; GO:0010628; GO:0010629; GO:0010667; GO:0010718; GO:0010812; GO:0010832; GO:0014031; GO:0014807; GO:0016324; GO:0019899; GO:0021515; GO:0021915; GO:0030027; GO:0030154; GO:0030163; GO:0030182; GO:0030216; GO:0030279; GO:0030324; GO:0030326; GO:0030334; GO:0030335; GO:0030513; GO:0030514; GO:0030900; GO:0031069; GO:0031100; GO:0031410; GO:0031490; GO:0031902; GO:0032495; GO:0032496; GO:0032966; GO:0035116; GO:0035148; GO:0035914; GO:0035924; GO:0042127; GO:0042246; GO:0042802; GO:0043065; GO:0043069; GO:0043086; GO:0043235; GO:0045070; GO:0045165; GO:0045596; GO:0045603; GO:0045607; GO:0045608; GO:0045618; GO:0045662; GO:0045665; GO:0045668; GO:0045687; GO:0045747; GO:0045892; GO:0045893; GO:0045944; GO:0045955; GO:0046427; GO:0046533; GO:0046579; GO:0048103; GO:0048593; GO:0048663; GO:0048708; GO:0048709; GO:0048711; GO:0048715; GO:0048754; GO:0048845; GO:0048873; GO:0050678; GO:0050679; GO:0050767; GO:0050768; GO:0051152; GO:0055008; GO:0060038; GO:0060045; GO:0060253; GO:0060271; GO:0060317; GO:0060354; GO:0060379; GO:0060411; GO:0060412; GO:0060528; GO:0060740; GO:0060768; GO:0060842; GO:0060843; GO:0060948; GO:0060956; GO:0060979; GO:0060982; GO:0061344; GO:0061384; GO:0062043; GO:0070168; GO:0070374; GO:0070986; GO:0071228; GO:0071372; GO:0071456; GO:0071944; GO:0072017; GO:0072044; GO:0072144; GO:0072538; GO:0090051; GO:0090090; GO:0097150; GO:0097400; GO:0098685; GO:0098839; GO:0098978; GO:0099565; GO:0120163; GO:0140537; GO:1901189; GO:1901201; GO:1902263; GO:1902339; GO:1903849; GO:2000048; GO:2000737; GO:2000811; GO:2000974; GO:2001027 animal organ regeneration [GO:0031100]; aortic valve morphogenesis [GO:0003180]; apoptotic process involved in embryonic digit morphogenesis [GO:1902263]; arterial endothelial cell differentiation [GO:0060842]; astrocyte differentiation [GO:0048708]; atrioventricular node development [GO:0003162]; atrioventricular valve morphogenesis [GO:0003181]; auditory receptor cell fate commitment [GO:0009912]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; branching morphogenesis of an epithelial tube [GO:0048754]; camera-type eye morphogenesis [GO:0048593]; cardiac atrium morphogenesis [GO:0003209]; cardiac chamber formation [GO:0003207]; cardiac epithelial to mesenchymal transition [GO:0060317]; cardiac left ventricle morphogenesis [GO:0003214]; cardiac muscle cell myoblast differentiation [GO:0060379]; cardiac muscle cell proliferation [GO:0060038]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac right atrium morphogenesis [GO:0003213]; cardiac right ventricle formation [GO:0003219]; cardiac septum morphogenesis [GO:0060411]; cardiac vascular smooth muscle cell development [GO:0060948]; cardiac ventricle morphogenesis [GO:0003208]; cell differentiation [GO:0030154]; cell differentiation in spinal cord [GO:0021515]; cell fate commitment [GO:0045165]; cell fate specification [GO:0001708]; cell migration involved in endocardial cushion formation [GO:0003273]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to hypoxia [GO:0071456]; cellular response to tumor cell [GO:0071228]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; chemical synaptic transmission, postsynaptic [GO:0099565]; cilium assembly [GO:0060271]; collecting duct development [GO:0072044]; compartment pattern specification [GO:0007386]; coronary artery morphogenesis [GO:0060982]; coronary sinus valve morphogenesis [GO:0003182]; coronary vein morphogenesis [GO:0003169]; determination of left/right symmetry [GO:0007368]; distal tubule development [GO:0072017]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic limb morphogenesis [GO:0030326]; endocardial cell differentiation [GO:0060956]; endocardial cushion development [GO:0003197]; endocardial cushion morphogenesis [GO:0003203]; endocardium development [GO:0003157]; endocardium morphogenesis [GO:0003160]; endoderm development [GO:0007492]; epidermis development [GO:0008544]; epithelial to mesenchymal transition [GO:0001837]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; forebrain development [GO:0030900]; foregut morphogenesis [GO:0007440]; gene expression [GO:0010467]; glial cell differentiation [GO:0010001]; glomerular mesangial cell development [GO:0072144]; growth involved in heart morphogenesis [GO:0003241]; hair follicle morphogenesis [GO:0031069]; heart development [GO:0007507]; heart looping [GO:0001947]; heart trabecula morphogenesis [GO:0061384]; homeostasis of number of cells within a tissue [GO:0048873]; humoral immune response [GO:0006959]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; interleukin-17-mediated signaling pathway [GO:0097400]; keratinocyte differentiation [GO:0030216]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; lung development [GO:0030324]; luteolysis [GO:0001554]; mesenchymal cell development [GO:0014031]; mitral valve formation [GO:0003192]; negative regulation of anoikis [GO:2000811]; negative regulation of biomineral tissue development [GO:0070168]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of catalytic activity [GO:0043086]; negative regulation of cell adhesion molecule production [GO:0060354]; negative regulation of cell differentiation [GO:0045596]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell proliferation involved in heart valve morphogenesis [GO:0003252]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of collagen biosynthetic process [GO:0032966]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of endothelial cell chemotaxis [GO:2001027]; negative regulation of extracellular matrix constituent secretion [GO:0003332]; negative regulation of gene expression [GO:0010629]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of inner ear auditory receptor cell differentiation [GO:0045608]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of ossification [GO:0030279]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of photoreceptor cell differentiation [GO:0046533]; negative regulation of pro-B cell differentiation [GO:2000974]; negative regulation of programmed cell death [GO:0043069]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural tube development [GO:0021915]; neuron differentiation [GO:0030182]; neuron fate commitment [GO:0048663]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; oligodendrocyte differentiation [GO:0048709]; osteoblast fate commitment [GO:0002051]; outflow tract morphogenesis [GO:0003151]; pericardium morphogenesis [GO:0003344]; positive regulation of aorta morphogenesis [GO:1903849]; positive regulation of apoptotic process [GO:0043065]; positive regulation of apoptotic process involved in morphogenesis [GO:1902339]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cardiac epithelial to mesenchymal transition [GO:0062043]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of ephrin receptor signaling pathway [GO:1901189]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of glial cell differentiation [GO:0045687]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of smooth muscle cell differentiation [GO:0051152]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription of Notch receptor target [GO:0007221]; positive regulation of viral genome replication [GO:0045070]; prostate gland epithelium morphogenesis [GO:0060740]; protein catabolic process [GO:0030163]; protein import into nucleus [GO:0006606]; pulmonary valve morphogenesis [GO:0003184]; regulation of cardioblast proliferation [GO:0003264]; regulation of cell adhesion involved in heart morphogenesis [GO:0061344]; regulation of cell migration [GO:0030334]; regulation of cell population proliferation [GO:0042127]; regulation of epithelial cell proliferation [GO:0050678]; regulation of epithelial cell proliferation involved in prostate gland development [GO:0060768]; regulation of extracellular matrix assembly [GO:1901201]; regulation of gene expression [GO:0010468]; regulation of inner ear auditory receptor cell differentiation [GO:0045607]; regulation of neurogenesis [GO:0050767]; regulation of Notch signaling pathway [GO:0008593]; regulation of somitogenesis [GO:0014807]; regulation of transcription by RNA polymerase II [GO:0006357]; response to lipopolysaccharide [GO:0032496]; response to muramyl dipeptide [GO:0032495]; secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development [GO:0060528]; skeletal muscle cell differentiation [GO:0035914]; somatic stem cell division [GO:0048103]; spermatogenesis [GO:0007283]; sprouting angiogenesis [GO:0002040]; T-helper 17 type immune response [GO:0072538]; tissue regeneration [GO:0042246]; tube formation [GO:0035148]; vasculogenesis involved in coronary vascular morphogenesis [GO:0060979]; venous blood vessel morphogenesis [GO:0048845]; venous endothelial cell differentiation [GO:0060843]; ventricular septum morphogenesis [GO:0060412]; ventricular trabecula myocardium morphogenesis [GO:0003222] acrosomal vesicle [GO:0001669]; adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell periphery [GO:0071944]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; lamellipodium [GO:0030027]; late endosome membrane [GO:0031902]; MAML1-RBP-Jkappa- ICN1 complex [GO:0002193]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; receptor complex [GO:0043235]; ruffle [GO:0001726]; Schaffer collateral - CA1 synapse [GO:0098685] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; identical protein binding [GO:0042802]; Notch binding [GO:0005112]; transcription coactivator activity [GO:0003713]; transcription regulator activator activity [GO:0140537]; transmembrane signaling receptor activity [GO:0004888] g256.t4 Q01705 41.176 153 4.08e-22 109.0 sp|Q01705|NOTC1_MOUSE Neurogenic locus notch homolog protein 1 OS=Mus musculus OX=10090 GN=Notch1 PE=1 SV=3 NOTC1_MOUSE reviewed Neurogenic locus notch homolog protein 1 (Notch 1) (Motch A) (mT14) (p300) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Mus musculus (Mouse) GO:0000122; GO:0000139; GO:0001554; GO:0001669; GO:0001701; GO:0001708; GO:0001726; GO:0001837; GO:0001889; GO:0001947; GO:0002040; GO:0002051; GO:0002052; GO:0002193; GO:0002437; GO:0003151; GO:0003157; GO:0003160; GO:0003162; GO:0003169; GO:0003180; GO:0003181; GO:0003182; GO:0003184; GO:0003192; GO:0003197; GO:0003198; GO:0003203; GO:0003207; GO:0003208; GO:0003209; GO:0003213; GO:0003214; GO:0003219; GO:0003222; GO:0003241; GO:0003252; GO:0003264; GO:0003273; GO:0003332; GO:0003344; GO:0003682; GO:0003713; GO:0004857; GO:0004888; GO:0005112; GO:0005509; GO:0005576; GO:0005634; GO:0005654; GO:0005737; GO:0005783; GO:0005789; GO:0005829; GO:0005856; GO:0005886; GO:0005912; GO:0006357; GO:0006606; GO:0006959; GO:0007219; GO:0007221; GO:0007283; GO:0007368; GO:0007386; GO:0007409; GO:0007411; GO:0007440; GO:0007492; GO:0007507; GO:0008284; GO:0008285; GO:0008544; GO:0008593; GO:0009912; GO:0009986; GO:0010001; GO:0010008; GO:0010467; GO:0010468; GO:0010614; GO:0010628; GO:0010629; GO:0010667; GO:0010718; GO:0010812; GO:0010832; GO:0014031; GO:0014807; GO:0016324; GO:0019899; GO:0021515; GO:0021915; GO:0030027; GO:0030154; GO:0030163; GO:0030182; GO:0030216; GO:0030279; GO:0030324; GO:0030326; GO:0030334; GO:0030335; GO:0030513; GO:0030514; GO:0030900; GO:0031069; GO:0031100; GO:0031410; GO:0031490; GO:0031902; GO:0032495; GO:0032496; GO:0032966; GO:0035116; GO:0035148; GO:0035914; GO:0035924; GO:0042127; GO:0042246; GO:0042802; GO:0043065; GO:0043069; GO:0043086; GO:0043235; GO:0045070; GO:0045165; GO:0045596; GO:0045603; GO:0045607; GO:0045608; GO:0045618; GO:0045662; GO:0045665; GO:0045668; GO:0045687; GO:0045747; GO:0045892; GO:0045893; GO:0045944; GO:0045955; GO:0046427; GO:0046533; GO:0046579; GO:0048103; GO:0048593; GO:0048663; GO:0048708; GO:0048709; GO:0048711; GO:0048715; GO:0048754; GO:0048845; GO:0048873; GO:0050678; GO:0050679; GO:0050767; GO:0050768; GO:0051152; GO:0055008; GO:0060038; GO:0060045; GO:0060253; GO:0060271; GO:0060317; GO:0060354; GO:0060379; GO:0060411; GO:0060412; GO:0060528; GO:0060740; GO:0060768; GO:0060842; GO:0060843; GO:0060948; GO:0060956; GO:0060979; GO:0060982; GO:0061344; GO:0061384; GO:0062043; GO:0070168; GO:0070374; GO:0070986; GO:0071228; GO:0071372; GO:0071456; GO:0071944; GO:0072017; GO:0072044; GO:0072144; GO:0072538; GO:0090051; GO:0090090; GO:0097150; GO:0097400; GO:0098685; GO:0098839; GO:0098978; GO:0099565; GO:0120163; GO:0140537; GO:1901189; GO:1901201; GO:1902263; GO:1902339; GO:1903849; GO:2000048; GO:2000737; GO:2000811; GO:2000974; GO:2001027 animal organ regeneration [GO:0031100]; aortic valve morphogenesis [GO:0003180]; apoptotic process involved in embryonic digit morphogenesis [GO:1902263]; arterial endothelial cell differentiation [GO:0060842]; astrocyte differentiation [GO:0048708]; atrioventricular node development [GO:0003162]; atrioventricular valve morphogenesis [GO:0003181]; auditory receptor cell fate commitment [GO:0009912]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; branching morphogenesis of an epithelial tube [GO:0048754]; camera-type eye morphogenesis [GO:0048593]; cardiac atrium morphogenesis [GO:0003209]; cardiac chamber formation [GO:0003207]; cardiac epithelial to mesenchymal transition [GO:0060317]; cardiac left ventricle morphogenesis [GO:0003214]; cardiac muscle cell myoblast differentiation [GO:0060379]; cardiac muscle cell proliferation [GO:0060038]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac right atrium morphogenesis [GO:0003213]; cardiac right ventricle formation [GO:0003219]; cardiac septum morphogenesis [GO:0060411]; cardiac vascular smooth muscle cell development [GO:0060948]; cardiac ventricle morphogenesis [GO:0003208]; cell differentiation [GO:0030154]; cell differentiation in spinal cord [GO:0021515]; cell fate commitment [GO:0045165]; cell fate specification [GO:0001708]; cell migration involved in endocardial cushion formation [GO:0003273]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to hypoxia [GO:0071456]; cellular response to tumor cell [GO:0071228]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; chemical synaptic transmission, postsynaptic [GO:0099565]; cilium assembly [GO:0060271]; collecting duct development [GO:0072044]; compartment pattern specification [GO:0007386]; coronary artery morphogenesis [GO:0060982]; coronary sinus valve morphogenesis [GO:0003182]; coronary vein morphogenesis [GO:0003169]; determination of left/right symmetry [GO:0007368]; distal tubule development [GO:0072017]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic limb morphogenesis [GO:0030326]; endocardial cell differentiation [GO:0060956]; endocardial cushion development [GO:0003197]; endocardial cushion morphogenesis [GO:0003203]; endocardium development [GO:0003157]; endocardium morphogenesis [GO:0003160]; endoderm development [GO:0007492]; epidermis development [GO:0008544]; epithelial to mesenchymal transition [GO:0001837]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; forebrain development [GO:0030900]; foregut morphogenesis [GO:0007440]; gene expression [GO:0010467]; glial cell differentiation [GO:0010001]; glomerular mesangial cell development [GO:0072144]; growth involved in heart morphogenesis [GO:0003241]; hair follicle morphogenesis [GO:0031069]; heart development [GO:0007507]; heart looping [GO:0001947]; heart trabecula morphogenesis [GO:0061384]; homeostasis of number of cells within a tissue [GO:0048873]; humoral immune response [GO:0006959]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; interleukin-17-mediated signaling pathway [GO:0097400]; keratinocyte differentiation [GO:0030216]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; lung development [GO:0030324]; luteolysis [GO:0001554]; mesenchymal cell development [GO:0014031]; mitral valve formation [GO:0003192]; negative regulation of anoikis [GO:2000811]; negative regulation of biomineral tissue development [GO:0070168]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of catalytic activity [GO:0043086]; negative regulation of cell adhesion molecule production [GO:0060354]; negative regulation of cell differentiation [GO:0045596]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell proliferation involved in heart valve morphogenesis [GO:0003252]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of collagen biosynthetic process [GO:0032966]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of endothelial cell chemotaxis [GO:2001027]; negative regulation of extracellular matrix constituent secretion [GO:0003332]; negative regulation of gene expression [GO:0010629]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of inner ear auditory receptor cell differentiation [GO:0045608]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of ossification [GO:0030279]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of photoreceptor cell differentiation [GO:0046533]; negative regulation of pro-B cell differentiation [GO:2000974]; negative regulation of programmed cell death [GO:0043069]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural tube development [GO:0021915]; neuron differentiation [GO:0030182]; neuron fate commitment [GO:0048663]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; oligodendrocyte differentiation [GO:0048709]; osteoblast fate commitment [GO:0002051]; outflow tract morphogenesis [GO:0003151]; pericardium morphogenesis [GO:0003344]; positive regulation of aorta morphogenesis [GO:1903849]; positive regulation of apoptotic process [GO:0043065]; positive regulation of apoptotic process involved in morphogenesis [GO:1902339]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cardiac epithelial to mesenchymal transition [GO:0062043]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of ephrin receptor signaling pathway [GO:1901189]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of glial cell differentiation [GO:0045687]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of smooth muscle cell differentiation [GO:0051152]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription of Notch receptor target [GO:0007221]; positive regulation of viral genome replication [GO:0045070]; prostate gland epithelium morphogenesis [GO:0060740]; protein catabolic process [GO:0030163]; protein import into nucleus [GO:0006606]; pulmonary valve morphogenesis [GO:0003184]; regulation of cardioblast proliferation [GO:0003264]; regulation of cell adhesion involved in heart morphogenesis [GO:0061344]; regulation of cell migration [GO:0030334]; regulation of cell population proliferation [GO:0042127]; regulation of epithelial cell proliferation [GO:0050678]; regulation of epithelial cell proliferation involved in prostate gland development [GO:0060768]; regulation of extracellular matrix assembly [GO:1901201]; regulation of gene expression [GO:0010468]; regulation of inner ear auditory receptor cell differentiation [GO:0045607]; regulation of neurogenesis [GO:0050767]; regulation of Notch signaling pathway [GO:0008593]; regulation of somitogenesis [GO:0014807]; regulation of transcription by RNA polymerase II [GO:0006357]; response to lipopolysaccharide [GO:0032496]; response to muramyl dipeptide [GO:0032495]; secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development [GO:0060528]; skeletal muscle cell differentiation [GO:0035914]; somatic stem cell division [GO:0048103]; spermatogenesis [GO:0007283]; sprouting angiogenesis [GO:0002040]; T-helper 17 type immune response [GO:0072538]; tissue regeneration [GO:0042246]; tube formation [GO:0035148]; vasculogenesis involved in coronary vascular morphogenesis [GO:0060979]; venous blood vessel morphogenesis [GO:0048845]; venous endothelial cell differentiation [GO:0060843]; ventricular septum morphogenesis [GO:0060412]; ventricular trabecula myocardium morphogenesis [GO:0003222] acrosomal vesicle [GO:0001669]; adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell periphery [GO:0071944]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; lamellipodium [GO:0030027]; late endosome membrane [GO:0031902]; MAML1-RBP-Jkappa- ICN1 complex [GO:0002193]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; receptor complex [GO:0043235]; ruffle [GO:0001726]; Schaffer collateral - CA1 synapse [GO:0098685] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; identical protein binding [GO:0042802]; Notch binding [GO:0005112]; transcription coactivator activity [GO:0003713]; transcription regulator activator activity [GO:0140537]; transmembrane signaling receptor activity [GO:0004888] g256.t4 Q01705 41.176 153 2.4600000000000003e-21 107.0 sp|Q01705|NOTC1_MOUSE Neurogenic locus notch homolog protein 1 OS=Mus musculus OX=10090 GN=Notch1 PE=1 SV=3 NOTC1_MOUSE reviewed Neurogenic locus notch homolog protein 1 (Notch 1) (Motch A) (mT14) (p300) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Mus musculus (Mouse) GO:0000122; GO:0000139; GO:0001554; GO:0001669; GO:0001701; GO:0001708; GO:0001726; GO:0001837; GO:0001889; GO:0001947; GO:0002040; GO:0002051; GO:0002052; GO:0002193; GO:0002437; GO:0003151; GO:0003157; GO:0003160; GO:0003162; GO:0003169; GO:0003180; GO:0003181; GO:0003182; GO:0003184; GO:0003192; GO:0003197; GO:0003198; GO:0003203; GO:0003207; GO:0003208; GO:0003209; GO:0003213; GO:0003214; GO:0003219; GO:0003222; GO:0003241; GO:0003252; GO:0003264; GO:0003273; GO:0003332; GO:0003344; GO:0003682; GO:0003713; GO:0004857; GO:0004888; GO:0005112; GO:0005509; GO:0005576; GO:0005634; GO:0005654; GO:0005737; GO:0005783; GO:0005789; GO:0005829; GO:0005856; GO:0005886; GO:0005912; GO:0006357; GO:0006606; GO:0006959; GO:0007219; GO:0007221; GO:0007283; GO:0007368; GO:0007386; GO:0007409; GO:0007411; GO:0007440; GO:0007492; GO:0007507; GO:0008284; GO:0008285; GO:0008544; GO:0008593; GO:0009912; GO:0009986; GO:0010001; GO:0010008; GO:0010467; GO:0010468; GO:0010614; GO:0010628; GO:0010629; GO:0010667; GO:0010718; GO:0010812; GO:0010832; GO:0014031; GO:0014807; GO:0016324; GO:0019899; GO:0021515; GO:0021915; GO:0030027; GO:0030154; GO:0030163; GO:0030182; GO:0030216; GO:0030279; GO:0030324; GO:0030326; GO:0030334; GO:0030335; GO:0030513; GO:0030514; GO:0030900; GO:0031069; GO:0031100; GO:0031410; GO:0031490; GO:0031902; GO:0032495; GO:0032496; GO:0032966; GO:0035116; GO:0035148; GO:0035914; GO:0035924; GO:0042127; GO:0042246; GO:0042802; GO:0043065; GO:0043069; GO:0043086; GO:0043235; GO:0045070; GO:0045165; GO:0045596; GO:0045603; GO:0045607; GO:0045608; GO:0045618; GO:0045662; GO:0045665; GO:0045668; GO:0045687; GO:0045747; GO:0045892; GO:0045893; GO:0045944; GO:0045955; GO:0046427; GO:0046533; GO:0046579; GO:0048103; GO:0048593; GO:0048663; GO:0048708; GO:0048709; GO:0048711; GO:0048715; GO:0048754; GO:0048845; GO:0048873; GO:0050678; GO:0050679; GO:0050767; GO:0050768; GO:0051152; GO:0055008; GO:0060038; GO:0060045; GO:0060253; GO:0060271; GO:0060317; GO:0060354; GO:0060379; GO:0060411; GO:0060412; GO:0060528; GO:0060740; GO:0060768; GO:0060842; GO:0060843; GO:0060948; GO:0060956; GO:0060979; GO:0060982; GO:0061344; GO:0061384; GO:0062043; GO:0070168; GO:0070374; GO:0070986; GO:0071228; GO:0071372; GO:0071456; GO:0071944; GO:0072017; GO:0072044; GO:0072144; GO:0072538; GO:0090051; GO:0090090; GO:0097150; GO:0097400; GO:0098685; GO:0098839; GO:0098978; GO:0099565; GO:0120163; GO:0140537; GO:1901189; GO:1901201; GO:1902263; GO:1902339; GO:1903849; GO:2000048; GO:2000737; GO:2000811; GO:2000974; GO:2001027 animal organ regeneration [GO:0031100]; aortic valve morphogenesis [GO:0003180]; apoptotic process involved in embryonic digit morphogenesis [GO:1902263]; arterial endothelial cell differentiation [GO:0060842]; astrocyte differentiation [GO:0048708]; atrioventricular node development [GO:0003162]; atrioventricular valve morphogenesis [GO:0003181]; auditory receptor cell fate commitment [GO:0009912]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; branching morphogenesis of an epithelial tube [GO:0048754]; camera-type eye morphogenesis [GO:0048593]; cardiac atrium morphogenesis [GO:0003209]; cardiac chamber formation [GO:0003207]; cardiac epithelial to mesenchymal transition [GO:0060317]; cardiac left ventricle morphogenesis [GO:0003214]; cardiac muscle cell myoblast differentiation [GO:0060379]; cardiac muscle cell proliferation [GO:0060038]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac right atrium morphogenesis [GO:0003213]; cardiac right ventricle formation [GO:0003219]; cardiac septum morphogenesis [GO:0060411]; cardiac vascular smooth muscle cell development [GO:0060948]; cardiac ventricle morphogenesis [GO:0003208]; cell differentiation [GO:0030154]; cell differentiation in spinal cord [GO:0021515]; cell fate commitment [GO:0045165]; cell fate specification [GO:0001708]; cell migration involved in endocardial cushion formation [GO:0003273]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to hypoxia [GO:0071456]; cellular response to tumor cell [GO:0071228]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; chemical synaptic transmission, postsynaptic [GO:0099565]; cilium assembly [GO:0060271]; collecting duct development [GO:0072044]; compartment pattern specification [GO:0007386]; coronary artery morphogenesis [GO:0060982]; coronary sinus valve morphogenesis [GO:0003182]; coronary vein morphogenesis [GO:0003169]; determination of left/right symmetry [GO:0007368]; distal tubule development [GO:0072017]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic limb morphogenesis [GO:0030326]; endocardial cell differentiation [GO:0060956]; endocardial cushion development [GO:0003197]; endocardial cushion morphogenesis [GO:0003203]; endocardium development [GO:0003157]; endocardium morphogenesis [GO:0003160]; endoderm development [GO:0007492]; epidermis development [GO:0008544]; epithelial to mesenchymal transition [GO:0001837]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; forebrain development [GO:0030900]; foregut morphogenesis [GO:0007440]; gene expression [GO:0010467]; glial cell differentiation [GO:0010001]; glomerular mesangial cell development [GO:0072144]; growth involved in heart morphogenesis [GO:0003241]; hair follicle morphogenesis [GO:0031069]; heart development [GO:0007507]; heart looping [GO:0001947]; heart trabecula morphogenesis [GO:0061384]; homeostasis of number of cells within a tissue [GO:0048873]; humoral immune response [GO:0006959]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; interleukin-17-mediated signaling pathway [GO:0097400]; keratinocyte differentiation [GO:0030216]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; lung development [GO:0030324]; luteolysis [GO:0001554]; mesenchymal cell development [GO:0014031]; mitral valve formation [GO:0003192]; negative regulation of anoikis [GO:2000811]; negative regulation of biomineral tissue development [GO:0070168]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of catalytic activity [GO:0043086]; negative regulation of cell adhesion molecule production [GO:0060354]; negative regulation of cell differentiation [GO:0045596]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell proliferation involved in heart valve morphogenesis [GO:0003252]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of collagen biosynthetic process [GO:0032966]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of endothelial cell chemotaxis [GO:2001027]; negative regulation of extracellular matrix constituent secretion [GO:0003332]; negative regulation of gene expression [GO:0010629]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of inner ear auditory receptor cell differentiation [GO:0045608]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of ossification [GO:0030279]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of photoreceptor cell differentiation [GO:0046533]; negative regulation of pro-B cell differentiation [GO:2000974]; negative regulation of programmed cell death [GO:0043069]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural tube development [GO:0021915]; neuron differentiation [GO:0030182]; neuron fate commitment [GO:0048663]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; oligodendrocyte differentiation [GO:0048709]; osteoblast fate commitment [GO:0002051]; outflow tract morphogenesis [GO:0003151]; pericardium morphogenesis [GO:0003344]; positive regulation of aorta morphogenesis [GO:1903849]; positive regulation of apoptotic process [GO:0043065]; positive regulation of apoptotic process involved in morphogenesis [GO:1902339]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cardiac epithelial to mesenchymal transition [GO:0062043]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of ephrin receptor signaling pathway [GO:1901189]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of glial cell differentiation [GO:0045687]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of smooth muscle cell differentiation [GO:0051152]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription of Notch receptor target [GO:0007221]; positive regulation of viral genome replication [GO:0045070]; prostate gland epithelium morphogenesis [GO:0060740]; protein catabolic process [GO:0030163]; protein import into nucleus [GO:0006606]; pulmonary valve morphogenesis [GO:0003184]; regulation of cardioblast proliferation [GO:0003264]; regulation of cell adhesion involved in heart morphogenesis [GO:0061344]; regulation of cell migration [GO:0030334]; regulation of cell population proliferation [GO:0042127]; regulation of epithelial cell proliferation [GO:0050678]; regulation of epithelial cell proliferation involved in prostate gland development [GO:0060768]; regulation of extracellular matrix assembly [GO:1901201]; regulation of gene expression [GO:0010468]; regulation of inner ear auditory receptor cell differentiation [GO:0045607]; regulation of neurogenesis [GO:0050767]; regulation of Notch signaling pathway [GO:0008593]; regulation of somitogenesis [GO:0014807]; regulation of transcription by RNA polymerase II [GO:0006357]; response to lipopolysaccharide [GO:0032496]; response to muramyl dipeptide [GO:0032495]; secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development [GO:0060528]; skeletal muscle cell differentiation [GO:0035914]; somatic stem cell division [GO:0048103]; spermatogenesis [GO:0007283]; sprouting angiogenesis [GO:0002040]; T-helper 17 type immune response [GO:0072538]; tissue regeneration [GO:0042246]; tube formation [GO:0035148]; vasculogenesis involved in coronary vascular morphogenesis [GO:0060979]; venous blood vessel morphogenesis [GO:0048845]; venous endothelial cell differentiation [GO:0060843]; ventricular septum morphogenesis [GO:0060412]; ventricular trabecula myocardium morphogenesis [GO:0003222] acrosomal vesicle [GO:0001669]; adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell periphery [GO:0071944]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; lamellipodium [GO:0030027]; late endosome membrane [GO:0031902]; MAML1-RBP-Jkappa- ICN1 complex [GO:0002193]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; receptor complex [GO:0043235]; ruffle [GO:0001726]; Schaffer collateral - CA1 synapse [GO:0098685] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; identical protein binding [GO:0042802]; Notch binding [GO:0005112]; transcription coactivator activity [GO:0003713]; transcription regulator activator activity [GO:0140537]; transmembrane signaling receptor activity [GO:0004888] g256.t5 Q01705 37.857 1437 0.0 727.0 sp|Q01705|NOTC1_MOUSE Neurogenic locus notch homolog protein 1 OS=Mus musculus OX=10090 GN=Notch1 PE=1 SV=3 NOTC1_MOUSE reviewed Neurogenic locus notch homolog protein 1 (Notch 1) (Motch A) (mT14) (p300) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Mus musculus (Mouse) GO:0000122; GO:0000139; GO:0001554; GO:0001669; GO:0001701; GO:0001708; GO:0001726; GO:0001837; GO:0001889; GO:0001947; GO:0002040; GO:0002051; GO:0002052; GO:0002193; GO:0002437; GO:0003151; GO:0003157; GO:0003160; GO:0003162; GO:0003169; GO:0003180; GO:0003181; GO:0003182; GO:0003184; GO:0003192; GO:0003197; GO:0003198; GO:0003203; GO:0003207; GO:0003208; GO:0003209; GO:0003213; GO:0003214; GO:0003219; GO:0003222; GO:0003241; GO:0003252; GO:0003264; GO:0003273; GO:0003332; GO:0003344; GO:0003682; GO:0003713; GO:0004857; GO:0004888; GO:0005112; GO:0005509; GO:0005576; GO:0005634; GO:0005654; GO:0005737; GO:0005783; GO:0005789; GO:0005829; GO:0005856; GO:0005886; GO:0005912; GO:0006357; GO:0006606; GO:0006959; GO:0007219; GO:0007221; GO:0007283; GO:0007368; GO:0007386; GO:0007409; GO:0007411; GO:0007440; GO:0007492; GO:0007507; GO:0008284; GO:0008285; GO:0008544; GO:0008593; GO:0009912; GO:0009986; GO:0010001; GO:0010008; GO:0010467; GO:0010468; GO:0010614; GO:0010628; GO:0010629; GO:0010667; GO:0010718; GO:0010812; GO:0010832; GO:0014031; GO:0014807; GO:0016324; GO:0019899; GO:0021515; GO:0021915; GO:0030027; GO:0030154; GO:0030163; GO:0030182; GO:0030216; GO:0030279; GO:0030324; GO:0030326; GO:0030334; GO:0030335; GO:0030513; GO:0030514; GO:0030900; GO:0031069; GO:0031100; GO:0031410; GO:0031490; GO:0031902; GO:0032495; GO:0032496; GO:0032966; GO:0035116; GO:0035148; GO:0035914; GO:0035924; GO:0042127; GO:0042246; GO:0042802; GO:0043065; GO:0043069; GO:0043086; GO:0043235; GO:0045070; GO:0045165; GO:0045596; GO:0045603; GO:0045607; GO:0045608; GO:0045618; GO:0045662; GO:0045665; GO:0045668; GO:0045687; GO:0045747; GO:0045892; GO:0045893; GO:0045944; GO:0045955; GO:0046427; GO:0046533; GO:0046579; GO:0048103; GO:0048593; GO:0048663; GO:0048708; GO:0048709; GO:0048711; GO:0048715; GO:0048754; GO:0048845; GO:0048873; GO:0050678; GO:0050679; GO:0050767; GO:0050768; GO:0051152; GO:0055008; GO:0060038; GO:0060045; GO:0060253; GO:0060271; GO:0060317; GO:0060354; GO:0060379; GO:0060411; GO:0060412; GO:0060528; GO:0060740; GO:0060768; GO:0060842; GO:0060843; GO:0060948; GO:0060956; GO:0060979; GO:0060982; GO:0061344; GO:0061384; GO:0062043; GO:0070168; GO:0070374; GO:0070986; GO:0071228; GO:0071372; GO:0071456; GO:0071944; GO:0072017; GO:0072044; GO:0072144; GO:0072538; GO:0090051; GO:0090090; GO:0097150; GO:0097400; GO:0098685; GO:0098839; GO:0098978; GO:0099565; GO:0120163; GO:0140537; GO:1901189; GO:1901201; GO:1902263; GO:1902339; GO:1903849; GO:2000048; GO:2000737; GO:2000811; GO:2000974; GO:2001027 animal organ regeneration [GO:0031100]; aortic valve morphogenesis [GO:0003180]; apoptotic process involved in embryonic digit morphogenesis [GO:1902263]; arterial endothelial cell differentiation [GO:0060842]; astrocyte differentiation [GO:0048708]; atrioventricular node development [GO:0003162]; atrioventricular valve morphogenesis [GO:0003181]; auditory receptor cell fate commitment [GO:0009912]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; branching morphogenesis of an epithelial tube [GO:0048754]; camera-type eye morphogenesis [GO:0048593]; cardiac atrium morphogenesis [GO:0003209]; cardiac chamber formation [GO:0003207]; cardiac epithelial to mesenchymal transition [GO:0060317]; cardiac left ventricle morphogenesis [GO:0003214]; cardiac muscle cell myoblast differentiation [GO:0060379]; cardiac muscle cell proliferation [GO:0060038]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac right atrium morphogenesis [GO:0003213]; cardiac right ventricle formation [GO:0003219]; cardiac septum morphogenesis [GO:0060411]; cardiac vascular smooth muscle cell development [GO:0060948]; cardiac ventricle morphogenesis [GO:0003208]; cell differentiation [GO:0030154]; cell differentiation in spinal cord [GO:0021515]; cell fate commitment [GO:0045165]; cell fate specification [GO:0001708]; cell migration involved in endocardial cushion formation [GO:0003273]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to hypoxia [GO:0071456]; cellular response to tumor cell [GO:0071228]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; chemical synaptic transmission, postsynaptic [GO:0099565]; cilium assembly [GO:0060271]; collecting duct development [GO:0072044]; compartment pattern specification [GO:0007386]; coronary artery morphogenesis [GO:0060982]; coronary sinus valve morphogenesis [GO:0003182]; coronary vein morphogenesis [GO:0003169]; determination of left/right symmetry [GO:0007368]; distal tubule development [GO:0072017]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic limb morphogenesis [GO:0030326]; endocardial cell differentiation [GO:0060956]; endocardial cushion development [GO:0003197]; endocardial cushion morphogenesis [GO:0003203]; endocardium development [GO:0003157]; endocardium morphogenesis [GO:0003160]; endoderm development [GO:0007492]; epidermis development [GO:0008544]; epithelial to mesenchymal transition [GO:0001837]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; forebrain development [GO:0030900]; foregut morphogenesis [GO:0007440]; gene expression [GO:0010467]; glial cell differentiation [GO:0010001]; glomerular mesangial cell development [GO:0072144]; growth involved in heart morphogenesis [GO:0003241]; hair follicle morphogenesis [GO:0031069]; heart development [GO:0007507]; heart looping [GO:0001947]; heart trabecula morphogenesis [GO:0061384]; homeostasis of number of cells within a tissue [GO:0048873]; humoral immune response [GO:0006959]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; interleukin-17-mediated signaling pathway [GO:0097400]; keratinocyte differentiation [GO:0030216]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; lung development [GO:0030324]; luteolysis [GO:0001554]; mesenchymal cell development [GO:0014031]; mitral valve formation [GO:0003192]; negative regulation of anoikis [GO:2000811]; negative regulation of biomineral tissue development [GO:0070168]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of catalytic activity [GO:0043086]; negative regulation of cell adhesion molecule production [GO:0060354]; negative regulation of cell differentiation [GO:0045596]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell proliferation involved in heart valve morphogenesis [GO:0003252]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of collagen biosynthetic process [GO:0032966]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of endothelial cell chemotaxis [GO:2001027]; negative regulation of extracellular matrix constituent secretion [GO:0003332]; negative regulation of gene expression [GO:0010629]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of inner ear auditory receptor cell differentiation [GO:0045608]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of ossification [GO:0030279]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of photoreceptor cell differentiation [GO:0046533]; negative regulation of pro-B cell differentiation [GO:2000974]; negative regulation of programmed cell death [GO:0043069]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural tube development [GO:0021915]; neuron differentiation [GO:0030182]; neuron fate commitment [GO:0048663]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; oligodendrocyte differentiation [GO:0048709]; osteoblast fate commitment [GO:0002051]; outflow tract morphogenesis [GO:0003151]; pericardium morphogenesis [GO:0003344]; positive regulation of aorta morphogenesis [GO:1903849]; positive regulation of apoptotic process [GO:0043065]; positive regulation of apoptotic process involved in morphogenesis [GO:1902339]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cardiac epithelial to mesenchymal transition [GO:0062043]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of ephrin receptor signaling pathway [GO:1901189]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of glial cell differentiation [GO:0045687]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of smooth muscle cell differentiation [GO:0051152]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription of Notch receptor target [GO:0007221]; positive regulation of viral genome replication [GO:0045070]; prostate gland epithelium morphogenesis [GO:0060740]; protein catabolic process [GO:0030163]; protein import into nucleus [GO:0006606]; pulmonary valve morphogenesis [GO:0003184]; regulation of cardioblast proliferation [GO:0003264]; regulation of cell adhesion involved in heart morphogenesis [GO:0061344]; regulation of cell migration [GO:0030334]; regulation of cell population proliferation [GO:0042127]; regulation of epithelial cell proliferation [GO:0050678]; regulation of epithelial cell proliferation involved in prostate gland development [GO:0060768]; regulation of extracellular matrix assembly [GO:1901201]; regulation of gene expression [GO:0010468]; regulation of inner ear auditory receptor cell differentiation [GO:0045607]; regulation of neurogenesis [GO:0050767]; regulation of Notch signaling pathway [GO:0008593]; regulation of somitogenesis [GO:0014807]; regulation of transcription by RNA polymerase II [GO:0006357]; response to lipopolysaccharide [GO:0032496]; response to muramyl dipeptide [GO:0032495]; secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development [GO:0060528]; skeletal muscle cell differentiation [GO:0035914]; somatic stem cell division [GO:0048103]; spermatogenesis [GO:0007283]; sprouting angiogenesis [GO:0002040]; T-helper 17 type immune response [GO:0072538]; tissue regeneration [GO:0042246]; tube formation [GO:0035148]; vasculogenesis involved in coronary vascular morphogenesis [GO:0060979]; venous blood vessel morphogenesis [GO:0048845]; venous endothelial cell differentiation [GO:0060843]; ventricular septum morphogenesis [GO:0060412]; ventricular trabecula myocardium morphogenesis [GO:0003222] acrosomal vesicle [GO:0001669]; adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell periphery [GO:0071944]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; lamellipodium [GO:0030027]; late endosome membrane [GO:0031902]; MAML1-RBP-Jkappa- ICN1 complex [GO:0002193]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; receptor complex [GO:0043235]; ruffle [GO:0001726]; Schaffer collateral - CA1 synapse [GO:0098685] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; identical protein binding [GO:0042802]; Notch binding [GO:0005112]; transcription coactivator activity [GO:0003713]; transcription regulator activator activity [GO:0140537]; transmembrane signaling receptor activity [GO:0004888] g256.t5 Q01705 35.266 1449 0.0 658.0 sp|Q01705|NOTC1_MOUSE Neurogenic locus notch homolog protein 1 OS=Mus musculus OX=10090 GN=Notch1 PE=1 SV=3 NOTC1_MOUSE reviewed Neurogenic locus notch homolog protein 1 (Notch 1) (Motch A) (mT14) (p300) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Mus musculus (Mouse) GO:0000122; GO:0000139; GO:0001554; GO:0001669; GO:0001701; GO:0001708; GO:0001726; GO:0001837; GO:0001889; GO:0001947; GO:0002040; GO:0002051; GO:0002052; GO:0002193; GO:0002437; GO:0003151; GO:0003157; GO:0003160; GO:0003162; GO:0003169; GO:0003180; GO:0003181; GO:0003182; GO:0003184; GO:0003192; GO:0003197; GO:0003198; GO:0003203; GO:0003207; GO:0003208; GO:0003209; GO:0003213; GO:0003214; GO:0003219; GO:0003222; GO:0003241; GO:0003252; GO:0003264; GO:0003273; GO:0003332; GO:0003344; GO:0003682; GO:0003713; GO:0004857; GO:0004888; GO:0005112; GO:0005509; GO:0005576; GO:0005634; GO:0005654; GO:0005737; GO:0005783; GO:0005789; GO:0005829; GO:0005856; GO:0005886; GO:0005912; GO:0006357; GO:0006606; GO:0006959; GO:0007219; GO:0007221; GO:0007283; GO:0007368; GO:0007386; GO:0007409; GO:0007411; GO:0007440; GO:0007492; GO:0007507; GO:0008284; GO:0008285; GO:0008544; GO:0008593; GO:0009912; GO:0009986; GO:0010001; GO:0010008; GO:0010467; GO:0010468; GO:0010614; GO:0010628; GO:0010629; GO:0010667; GO:0010718; GO:0010812; GO:0010832; GO:0014031; GO:0014807; GO:0016324; GO:0019899; GO:0021515; GO:0021915; GO:0030027; GO:0030154; GO:0030163; GO:0030182; GO:0030216; GO:0030279; GO:0030324; GO:0030326; GO:0030334; GO:0030335; GO:0030513; GO:0030514; GO:0030900; GO:0031069; GO:0031100; GO:0031410; GO:0031490; GO:0031902; GO:0032495; GO:0032496; GO:0032966; GO:0035116; GO:0035148; GO:0035914; GO:0035924; GO:0042127; GO:0042246; GO:0042802; GO:0043065; GO:0043069; GO:0043086; GO:0043235; GO:0045070; GO:0045165; GO:0045596; GO:0045603; GO:0045607; GO:0045608; GO:0045618; GO:0045662; GO:0045665; GO:0045668; GO:0045687; GO:0045747; GO:0045892; GO:0045893; GO:0045944; GO:0045955; GO:0046427; GO:0046533; GO:0046579; GO:0048103; GO:0048593; GO:0048663; GO:0048708; GO:0048709; GO:0048711; GO:0048715; GO:0048754; GO:0048845; GO:0048873; GO:0050678; GO:0050679; GO:0050767; GO:0050768; GO:0051152; GO:0055008; GO:0060038; GO:0060045; GO:0060253; GO:0060271; GO:0060317; GO:0060354; GO:0060379; GO:0060411; GO:0060412; GO:0060528; GO:0060740; GO:0060768; GO:0060842; GO:0060843; GO:0060948; GO:0060956; GO:0060979; GO:0060982; GO:0061344; GO:0061384; GO:0062043; GO:0070168; GO:0070374; GO:0070986; GO:0071228; GO:0071372; GO:0071456; GO:0071944; GO:0072017; GO:0072044; GO:0072144; GO:0072538; GO:0090051; GO:0090090; GO:0097150; GO:0097400; GO:0098685; GO:0098839; GO:0098978; GO:0099565; GO:0120163; GO:0140537; GO:1901189; GO:1901201; GO:1902263; GO:1902339; GO:1903849; GO:2000048; GO:2000737; GO:2000811; GO:2000974; GO:2001027 animal organ regeneration [GO:0031100]; aortic valve morphogenesis [GO:0003180]; apoptotic process involved in embryonic digit morphogenesis [GO:1902263]; arterial endothelial cell differentiation [GO:0060842]; astrocyte differentiation [GO:0048708]; atrioventricular node development [GO:0003162]; atrioventricular valve morphogenesis [GO:0003181]; auditory receptor cell fate commitment [GO:0009912]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; branching morphogenesis of an epithelial tube [GO:0048754]; camera-type eye morphogenesis [GO:0048593]; cardiac atrium morphogenesis [GO:0003209]; cardiac chamber formation [GO:0003207]; cardiac epithelial to mesenchymal transition [GO:0060317]; cardiac left ventricle morphogenesis [GO:0003214]; cardiac muscle cell myoblast differentiation [GO:0060379]; cardiac muscle cell proliferation [GO:0060038]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac right atrium morphogenesis [GO:0003213]; cardiac right ventricle formation [GO:0003219]; cardiac septum morphogenesis [GO:0060411]; cardiac vascular smooth muscle cell development [GO:0060948]; cardiac ventricle morphogenesis [GO:0003208]; cell differentiation [GO:0030154]; cell differentiation in spinal cord [GO:0021515]; cell fate commitment [GO:0045165]; cell fate specification [GO:0001708]; cell migration involved in endocardial cushion formation [GO:0003273]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to hypoxia [GO:0071456]; cellular response to tumor cell [GO:0071228]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; chemical synaptic transmission, postsynaptic [GO:0099565]; cilium assembly [GO:0060271]; collecting duct development [GO:0072044]; compartment pattern specification [GO:0007386]; coronary artery morphogenesis [GO:0060982]; coronary sinus valve morphogenesis [GO:0003182]; coronary vein morphogenesis [GO:0003169]; determination of left/right symmetry [GO:0007368]; distal tubule development [GO:0072017]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic limb morphogenesis [GO:0030326]; endocardial cell differentiation [GO:0060956]; endocardial cushion development [GO:0003197]; endocardial cushion morphogenesis [GO:0003203]; endocardium development [GO:0003157]; endocardium morphogenesis [GO:0003160]; endoderm development [GO:0007492]; epidermis development [GO:0008544]; epithelial to mesenchymal transition [GO:0001837]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; forebrain development [GO:0030900]; foregut morphogenesis [GO:0007440]; gene expression [GO:0010467]; glial cell differentiation [GO:0010001]; glomerular mesangial cell development [GO:0072144]; growth involved in heart morphogenesis [GO:0003241]; hair follicle morphogenesis [GO:0031069]; heart development [GO:0007507]; heart looping [GO:0001947]; heart trabecula morphogenesis [GO:0061384]; homeostasis of number of cells within a tissue [GO:0048873]; humoral immune response [GO:0006959]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; interleukin-17-mediated signaling pathway [GO:0097400]; keratinocyte differentiation [GO:0030216]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; lung development [GO:0030324]; luteolysis [GO:0001554]; mesenchymal cell development [GO:0014031]; mitral valve formation [GO:0003192]; negative regulation of anoikis [GO:2000811]; negative regulation of biomineral tissue development [GO:0070168]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of catalytic activity [GO:0043086]; negative regulation of cell adhesion molecule production [GO:0060354]; negative regulation of cell differentiation [GO:0045596]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell proliferation involved in heart valve morphogenesis [GO:0003252]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of collagen biosynthetic process [GO:0032966]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of endothelial cell chemotaxis [GO:2001027]; negative regulation of extracellular matrix constituent secretion [GO:0003332]; negative regulation of gene expression [GO:0010629]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of inner ear auditory receptor cell differentiation [GO:0045608]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of ossification [GO:0030279]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of photoreceptor cell differentiation [GO:0046533]; negative regulation of pro-B cell differentiation [GO:2000974]; negative regulation of programmed cell death [GO:0043069]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural tube development [GO:0021915]; neuron differentiation [GO:0030182]; neuron fate commitment [GO:0048663]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; oligodendrocyte differentiation [GO:0048709]; osteoblast fate commitment [GO:0002051]; outflow tract morphogenesis [GO:0003151]; pericardium morphogenesis [GO:0003344]; positive regulation of aorta morphogenesis [GO:1903849]; positive regulation of apoptotic process [GO:0043065]; positive regulation of apoptotic process involved in morphogenesis [GO:1902339]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cardiac epithelial to mesenchymal transition [GO:0062043]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of ephrin receptor signaling pathway [GO:1901189]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of glial cell differentiation [GO:0045687]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of smooth muscle cell differentiation [GO:0051152]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription of Notch receptor target [GO:0007221]; positive regulation of viral genome replication [GO:0045070]; prostate gland epithelium morphogenesis [GO:0060740]; protein catabolic process [GO:0030163]; protein import into nucleus [GO:0006606]; pulmonary valve morphogenesis [GO:0003184]; regulation of cardioblast proliferation [GO:0003264]; regulation of cell adhesion involved in heart morphogenesis [GO:0061344]; regulation of cell migration [GO:0030334]; regulation of cell population proliferation [GO:0042127]; regulation of epithelial cell proliferation [GO:0050678]; regulation of epithelial cell proliferation involved in prostate gland development [GO:0060768]; regulation of extracellular matrix assembly [GO:1901201]; regulation of gene expression [GO:0010468]; regulation of inner ear auditory receptor cell differentiation [GO:0045607]; regulation of neurogenesis [GO:0050767]; regulation of Notch signaling pathway [GO:0008593]; regulation of somitogenesis [GO:0014807]; regulation of transcription by RNA polymerase II [GO:0006357]; response to lipopolysaccharide [GO:0032496]; response to muramyl dipeptide [GO:0032495]; secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development [GO:0060528]; skeletal muscle cell differentiation [GO:0035914]; somatic stem cell division [GO:0048103]; spermatogenesis [GO:0007283]; sprouting angiogenesis [GO:0002040]; T-helper 17 type immune response [GO:0072538]; tissue regeneration [GO:0042246]; tube formation [GO:0035148]; vasculogenesis involved in coronary vascular morphogenesis [GO:0060979]; venous blood vessel morphogenesis [GO:0048845]; venous endothelial cell differentiation [GO:0060843]; ventricular septum morphogenesis [GO:0060412]; ventricular trabecula myocardium morphogenesis [GO:0003222] acrosomal vesicle [GO:0001669]; adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell periphery [GO:0071944]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; lamellipodium [GO:0030027]; late endosome membrane [GO:0031902]; MAML1-RBP-Jkappa- ICN1 complex [GO:0002193]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; receptor complex [GO:0043235]; ruffle [GO:0001726]; Schaffer collateral - CA1 synapse [GO:0098685] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; identical protein binding [GO:0042802]; Notch binding [GO:0005112]; transcription coactivator activity [GO:0003713]; transcription regulator activator activity [GO:0140537]; transmembrane signaling receptor activity [GO:0004888] g256.t5 Q01705 35.048 1458 0.0 652.0 sp|Q01705|NOTC1_MOUSE Neurogenic locus notch homolog protein 1 OS=Mus musculus OX=10090 GN=Notch1 PE=1 SV=3 NOTC1_MOUSE reviewed Neurogenic locus notch homolog protein 1 (Notch 1) (Motch A) (mT14) (p300) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Mus musculus (Mouse) GO:0000122; GO:0000139; GO:0001554; GO:0001669; GO:0001701; GO:0001708; GO:0001726; GO:0001837; GO:0001889; GO:0001947; GO:0002040; GO:0002051; GO:0002052; GO:0002193; GO:0002437; GO:0003151; GO:0003157; GO:0003160; GO:0003162; GO:0003169; GO:0003180; GO:0003181; GO:0003182; GO:0003184; GO:0003192; GO:0003197; GO:0003198; GO:0003203; GO:0003207; GO:0003208; GO:0003209; GO:0003213; GO:0003214; GO:0003219; GO:0003222; GO:0003241; GO:0003252; GO:0003264; GO:0003273; GO:0003332; GO:0003344; GO:0003682; GO:0003713; GO:0004857; GO:0004888; GO:0005112; GO:0005509; GO:0005576; GO:0005634; GO:0005654; GO:0005737; GO:0005783; GO:0005789; GO:0005829; GO:0005856; GO:0005886; GO:0005912; GO:0006357; GO:0006606; GO:0006959; GO:0007219; GO:0007221; GO:0007283; GO:0007368; GO:0007386; GO:0007409; GO:0007411; GO:0007440; GO:0007492; GO:0007507; GO:0008284; GO:0008285; GO:0008544; GO:0008593; GO:0009912; GO:0009986; GO:0010001; GO:0010008; GO:0010467; GO:0010468; GO:0010614; GO:0010628; GO:0010629; GO:0010667; GO:0010718; GO:0010812; GO:0010832; GO:0014031; GO:0014807; GO:0016324; GO:0019899; GO:0021515; GO:0021915; GO:0030027; GO:0030154; GO:0030163; GO:0030182; GO:0030216; GO:0030279; GO:0030324; GO:0030326; GO:0030334; GO:0030335; GO:0030513; GO:0030514; GO:0030900; GO:0031069; GO:0031100; GO:0031410; GO:0031490; GO:0031902; GO:0032495; GO:0032496; GO:0032966; GO:0035116; GO:0035148; GO:0035914; GO:0035924; GO:0042127; GO:0042246; GO:0042802; GO:0043065; GO:0043069; GO:0043086; GO:0043235; GO:0045070; GO:0045165; GO:0045596; GO:0045603; GO:0045607; GO:0045608; GO:0045618; GO:0045662; GO:0045665; GO:0045668; GO:0045687; GO:0045747; GO:0045892; GO:0045893; GO:0045944; GO:0045955; GO:0046427; GO:0046533; GO:0046579; GO:0048103; GO:0048593; GO:0048663; GO:0048708; GO:0048709; GO:0048711; GO:0048715; GO:0048754; GO:0048845; GO:0048873; GO:0050678; GO:0050679; GO:0050767; GO:0050768; GO:0051152; GO:0055008; GO:0060038; GO:0060045; GO:0060253; GO:0060271; GO:0060317; GO:0060354; GO:0060379; GO:0060411; GO:0060412; GO:0060528; GO:0060740; GO:0060768; GO:0060842; GO:0060843; GO:0060948; GO:0060956; GO:0060979; GO:0060982; GO:0061344; GO:0061384; GO:0062043; GO:0070168; GO:0070374; GO:0070986; GO:0071228; GO:0071372; GO:0071456; GO:0071944; GO:0072017; GO:0072044; GO:0072144; GO:0072538; GO:0090051; GO:0090090; GO:0097150; GO:0097400; GO:0098685; GO:0098839; GO:0098978; GO:0099565; GO:0120163; GO:0140537; GO:1901189; GO:1901201; GO:1902263; GO:1902339; GO:1903849; GO:2000048; GO:2000737; GO:2000811; GO:2000974; GO:2001027 animal organ regeneration [GO:0031100]; aortic valve morphogenesis [GO:0003180]; apoptotic process involved in embryonic digit morphogenesis [GO:1902263]; arterial endothelial cell differentiation [GO:0060842]; astrocyte differentiation [GO:0048708]; atrioventricular node development [GO:0003162]; atrioventricular valve morphogenesis [GO:0003181]; auditory receptor cell fate commitment [GO:0009912]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; branching morphogenesis of an epithelial tube [GO:0048754]; camera-type eye morphogenesis [GO:0048593]; cardiac atrium morphogenesis [GO:0003209]; cardiac chamber formation [GO:0003207]; cardiac epithelial to mesenchymal transition [GO:0060317]; cardiac left ventricle morphogenesis [GO:0003214]; cardiac muscle cell myoblast differentiation [GO:0060379]; cardiac muscle cell proliferation [GO:0060038]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac right atrium morphogenesis [GO:0003213]; cardiac right ventricle formation [GO:0003219]; cardiac septum morphogenesis [GO:0060411]; cardiac vascular smooth muscle cell development [GO:0060948]; cardiac ventricle morphogenesis [GO:0003208]; cell differentiation [GO:0030154]; cell differentiation in spinal cord [GO:0021515]; cell fate commitment [GO:0045165]; cell fate specification [GO:0001708]; cell migration involved in endocardial cushion formation [GO:0003273]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to hypoxia [GO:0071456]; cellular response to tumor cell [GO:0071228]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; chemical synaptic transmission, postsynaptic [GO:0099565]; cilium assembly [GO:0060271]; collecting duct development [GO:0072044]; compartment pattern specification [GO:0007386]; coronary artery morphogenesis [GO:0060982]; coronary sinus valve morphogenesis [GO:0003182]; coronary vein morphogenesis [GO:0003169]; determination of left/right symmetry [GO:0007368]; distal tubule development [GO:0072017]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic limb morphogenesis [GO:0030326]; endocardial cell differentiation [GO:0060956]; endocardial cushion development [GO:0003197]; endocardial cushion morphogenesis [GO:0003203]; endocardium development [GO:0003157]; endocardium morphogenesis [GO:0003160]; endoderm development [GO:0007492]; epidermis development [GO:0008544]; epithelial to mesenchymal transition [GO:0001837]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; forebrain development [GO:0030900]; foregut morphogenesis [GO:0007440]; gene expression [GO:0010467]; glial cell differentiation [GO:0010001]; glomerular mesangial cell development [GO:0072144]; growth involved in heart morphogenesis [GO:0003241]; hair follicle morphogenesis [GO:0031069]; heart development [GO:0007507]; heart looping [GO:0001947]; heart trabecula morphogenesis [GO:0061384]; homeostasis of number of cells within a tissue [GO:0048873]; humoral immune response [GO:0006959]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; interleukin-17-mediated signaling pathway [GO:0097400]; keratinocyte differentiation [GO:0030216]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; lung development [GO:0030324]; luteolysis [GO:0001554]; mesenchymal cell development [GO:0014031]; mitral valve formation [GO:0003192]; negative regulation of anoikis [GO:2000811]; negative regulation of biomineral tissue development [GO:0070168]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of catalytic activity [GO:0043086]; negative regulation of cell adhesion molecule production [GO:0060354]; negative regulation of cell differentiation [GO:0045596]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell proliferation involved in heart valve morphogenesis [GO:0003252]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of collagen biosynthetic process [GO:0032966]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of endothelial cell chemotaxis [GO:2001027]; negative regulation of extracellular matrix constituent secretion [GO:0003332]; negative regulation of gene expression [GO:0010629]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of inner ear auditory receptor cell differentiation [GO:0045608]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of ossification [GO:0030279]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of photoreceptor cell differentiation [GO:0046533]; negative regulation of pro-B cell differentiation [GO:2000974]; negative regulation of programmed cell death [GO:0043069]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural tube development [GO:0021915]; neuron differentiation [GO:0030182]; neuron fate commitment [GO:0048663]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; oligodendrocyte differentiation [GO:0048709]; osteoblast fate commitment [GO:0002051]; outflow tract morphogenesis [GO:0003151]; pericardium morphogenesis [GO:0003344]; positive regulation of aorta morphogenesis [GO:1903849]; positive regulation of apoptotic process [GO:0043065]; positive regulation of apoptotic process involved in morphogenesis [GO:1902339]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cardiac epithelial to mesenchymal transition [GO:0062043]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of ephrin receptor signaling pathway [GO:1901189]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of glial cell differentiation [GO:0045687]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of smooth muscle cell differentiation [GO:0051152]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription of Notch receptor target [GO:0007221]; positive regulation of viral genome replication [GO:0045070]; prostate gland epithelium morphogenesis [GO:0060740]; protein catabolic process [GO:0030163]; protein import into nucleus [GO:0006606]; pulmonary valve morphogenesis [GO:0003184]; regulation of cardioblast proliferation [GO:0003264]; regulation of cell adhesion involved in heart morphogenesis [GO:0061344]; regulation of cell migration [GO:0030334]; regulation of cell population proliferation [GO:0042127]; regulation of epithelial cell proliferation [GO:0050678]; regulation of epithelial cell proliferation involved in prostate gland development [GO:0060768]; regulation of extracellular matrix assembly [GO:1901201]; regulation of gene expression [GO:0010468]; regulation of inner ear auditory receptor cell differentiation [GO:0045607]; regulation of neurogenesis [GO:0050767]; regulation of Notch signaling pathway [GO:0008593]; regulation of somitogenesis [GO:0014807]; regulation of transcription by RNA polymerase II [GO:0006357]; response to lipopolysaccharide [GO:0032496]; response to muramyl dipeptide [GO:0032495]; secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development [GO:0060528]; skeletal muscle cell differentiation [GO:0035914]; somatic stem cell division [GO:0048103]; spermatogenesis [GO:0007283]; sprouting angiogenesis [GO:0002040]; T-helper 17 type immune response [GO:0072538]; tissue regeneration [GO:0042246]; tube formation [GO:0035148]; vasculogenesis involved in coronary vascular morphogenesis [GO:0060979]; venous blood vessel morphogenesis [GO:0048845]; venous endothelial cell differentiation [GO:0060843]; ventricular septum morphogenesis [GO:0060412]; ventricular trabecula myocardium morphogenesis [GO:0003222] acrosomal vesicle [GO:0001669]; adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell periphery [GO:0071944]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; lamellipodium [GO:0030027]; late endosome membrane [GO:0031902]; MAML1-RBP-Jkappa- ICN1 complex [GO:0002193]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; receptor complex [GO:0043235]; ruffle [GO:0001726]; Schaffer collateral - CA1 synapse [GO:0098685] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; identical protein binding [GO:0042802]; Notch binding [GO:0005112]; transcription coactivator activity [GO:0003713]; transcription regulator activator activity [GO:0140537]; transmembrane signaling receptor activity [GO:0004888] g256.t5 Q01705 35.724 1436 0.0 642.0 sp|Q01705|NOTC1_MOUSE Neurogenic locus notch homolog protein 1 OS=Mus musculus OX=10090 GN=Notch1 PE=1 SV=3 NOTC1_MOUSE reviewed Neurogenic locus notch homolog protein 1 (Notch 1) (Motch A) (mT14) (p300) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Mus musculus (Mouse) GO:0000122; GO:0000139; GO:0001554; GO:0001669; GO:0001701; GO:0001708; GO:0001726; GO:0001837; GO:0001889; GO:0001947; GO:0002040; GO:0002051; GO:0002052; GO:0002193; GO:0002437; GO:0003151; GO:0003157; GO:0003160; GO:0003162; GO:0003169; GO:0003180; GO:0003181; GO:0003182; GO:0003184; GO:0003192; GO:0003197; GO:0003198; GO:0003203; GO:0003207; GO:0003208; GO:0003209; GO:0003213; GO:0003214; GO:0003219; GO:0003222; GO:0003241; GO:0003252; GO:0003264; GO:0003273; GO:0003332; GO:0003344; GO:0003682; GO:0003713; GO:0004857; GO:0004888; GO:0005112; GO:0005509; GO:0005576; GO:0005634; GO:0005654; GO:0005737; GO:0005783; GO:0005789; GO:0005829; GO:0005856; GO:0005886; GO:0005912; GO:0006357; GO:0006606; GO:0006959; GO:0007219; GO:0007221; GO:0007283; GO:0007368; GO:0007386; GO:0007409; GO:0007411; GO:0007440; GO:0007492; GO:0007507; GO:0008284; GO:0008285; GO:0008544; GO:0008593; GO:0009912; GO:0009986; GO:0010001; GO:0010008; GO:0010467; GO:0010468; GO:0010614; GO:0010628; GO:0010629; GO:0010667; GO:0010718; GO:0010812; GO:0010832; GO:0014031; GO:0014807; GO:0016324; GO:0019899; GO:0021515; GO:0021915; GO:0030027; GO:0030154; GO:0030163; GO:0030182; GO:0030216; GO:0030279; GO:0030324; GO:0030326; GO:0030334; GO:0030335; GO:0030513; GO:0030514; GO:0030900; GO:0031069; GO:0031100; GO:0031410; GO:0031490; GO:0031902; GO:0032495; GO:0032496; GO:0032966; GO:0035116; GO:0035148; GO:0035914; GO:0035924; GO:0042127; GO:0042246; GO:0042802; GO:0043065; GO:0043069; GO:0043086; GO:0043235; GO:0045070; GO:0045165; GO:0045596; GO:0045603; GO:0045607; GO:0045608; GO:0045618; GO:0045662; GO:0045665; GO:0045668; GO:0045687; GO:0045747; GO:0045892; GO:0045893; GO:0045944; GO:0045955; GO:0046427; GO:0046533; GO:0046579; GO:0048103; GO:0048593; GO:0048663; GO:0048708; GO:0048709; GO:0048711; GO:0048715; GO:0048754; GO:0048845; GO:0048873; GO:0050678; GO:0050679; GO:0050767; GO:0050768; GO:0051152; GO:0055008; GO:0060038; GO:0060045; GO:0060253; GO:0060271; GO:0060317; GO:0060354; GO:0060379; GO:0060411; GO:0060412; GO:0060528; GO:0060740; GO:0060768; GO:0060842; GO:0060843; GO:0060948; GO:0060956; GO:0060979; GO:0060982; GO:0061344; GO:0061384; GO:0062043; GO:0070168; GO:0070374; GO:0070986; GO:0071228; GO:0071372; GO:0071456; GO:0071944; GO:0072017; GO:0072044; GO:0072144; GO:0072538; GO:0090051; GO:0090090; GO:0097150; GO:0097400; GO:0098685; GO:0098839; GO:0098978; GO:0099565; GO:0120163; GO:0140537; GO:1901189; GO:1901201; GO:1902263; GO:1902339; GO:1903849; GO:2000048; GO:2000737; GO:2000811; GO:2000974; GO:2001027 animal organ regeneration [GO:0031100]; aortic valve morphogenesis [GO:0003180]; apoptotic process involved in embryonic digit morphogenesis [GO:1902263]; arterial endothelial cell differentiation [GO:0060842]; astrocyte differentiation [GO:0048708]; atrioventricular node development [GO:0003162]; atrioventricular valve morphogenesis [GO:0003181]; auditory receptor cell fate commitment [GO:0009912]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; branching morphogenesis of an epithelial tube [GO:0048754]; camera-type eye morphogenesis [GO:0048593]; cardiac atrium morphogenesis [GO:0003209]; cardiac chamber formation [GO:0003207]; cardiac epithelial to mesenchymal transition [GO:0060317]; cardiac left ventricle morphogenesis [GO:0003214]; cardiac muscle cell myoblast differentiation [GO:0060379]; cardiac muscle cell proliferation [GO:0060038]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac right atrium morphogenesis [GO:0003213]; cardiac right ventricle formation [GO:0003219]; cardiac septum morphogenesis [GO:0060411]; cardiac vascular smooth muscle cell development [GO:0060948]; cardiac ventricle morphogenesis [GO:0003208]; cell differentiation [GO:0030154]; cell differentiation in spinal cord [GO:0021515]; cell fate commitment [GO:0045165]; cell fate specification [GO:0001708]; cell migration involved in endocardial cushion formation [GO:0003273]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to hypoxia [GO:0071456]; cellular response to tumor cell [GO:0071228]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; chemical synaptic transmission, postsynaptic [GO:0099565]; cilium assembly [GO:0060271]; collecting duct development [GO:0072044]; compartment pattern specification [GO:0007386]; coronary artery morphogenesis [GO:0060982]; coronary sinus valve morphogenesis [GO:0003182]; coronary vein morphogenesis [GO:0003169]; determination of left/right symmetry [GO:0007368]; distal tubule development [GO:0072017]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic limb morphogenesis [GO:0030326]; endocardial cell differentiation [GO:0060956]; endocardial cushion development [GO:0003197]; endocardial cushion morphogenesis [GO:0003203]; endocardium development [GO:0003157]; endocardium morphogenesis [GO:0003160]; endoderm development [GO:0007492]; epidermis development [GO:0008544]; epithelial to mesenchymal transition [GO:0001837]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; forebrain development [GO:0030900]; foregut morphogenesis [GO:0007440]; gene expression [GO:0010467]; glial cell differentiation [GO:0010001]; glomerular mesangial cell development [GO:0072144]; growth involved in heart morphogenesis [GO:0003241]; hair follicle morphogenesis [GO:0031069]; heart development [GO:0007507]; heart looping [GO:0001947]; heart trabecula morphogenesis [GO:0061384]; homeostasis of number of cells within a tissue [GO:0048873]; humoral immune response [GO:0006959]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; interleukin-17-mediated signaling pathway [GO:0097400]; keratinocyte differentiation [GO:0030216]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; lung development [GO:0030324]; luteolysis [GO:0001554]; mesenchymal cell development [GO:0014031]; mitral valve formation [GO:0003192]; negative regulation of anoikis [GO:2000811]; negative regulation of biomineral tissue development [GO:0070168]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of catalytic activity [GO:0043086]; negative regulation of cell adhesion molecule production [GO:0060354]; negative regulation of cell differentiation [GO:0045596]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell proliferation involved in heart valve morphogenesis [GO:0003252]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of collagen biosynthetic process [GO:0032966]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of endothelial cell chemotaxis [GO:2001027]; negative regulation of extracellular matrix constituent secretion [GO:0003332]; negative regulation of gene expression [GO:0010629]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of inner ear auditory receptor cell differentiation [GO:0045608]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of ossification [GO:0030279]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of photoreceptor cell differentiation [GO:0046533]; negative regulation of pro-B cell differentiation [GO:2000974]; negative regulation of programmed cell death [GO:0043069]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural tube development [GO:0021915]; neuron differentiation [GO:0030182]; neuron fate commitment [GO:0048663]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; oligodendrocyte differentiation [GO:0048709]; osteoblast fate commitment [GO:0002051]; outflow tract morphogenesis [GO:0003151]; pericardium morphogenesis [GO:0003344]; positive regulation of aorta morphogenesis [GO:1903849]; positive regulation of apoptotic process [GO:0043065]; positive regulation of apoptotic process involved in morphogenesis [GO:1902339]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cardiac epithelial to mesenchymal transition [GO:0062043]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of ephrin receptor signaling pathway [GO:1901189]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of glial cell differentiation [GO:0045687]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of smooth muscle cell differentiation [GO:0051152]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription of Notch receptor target [GO:0007221]; positive regulation of viral genome replication [GO:0045070]; prostate gland epithelium morphogenesis [GO:0060740]; protein catabolic process [GO:0030163]; protein import into nucleus [GO:0006606]; pulmonary valve morphogenesis [GO:0003184]; regulation of cardioblast proliferation [GO:0003264]; regulation of cell adhesion involved in heart morphogenesis [GO:0061344]; regulation of cell migration [GO:0030334]; regulation of cell population proliferation [GO:0042127]; regulation of epithelial cell proliferation [GO:0050678]; regulation of epithelial cell proliferation involved in prostate gland development [GO:0060768]; regulation of extracellular matrix assembly [GO:1901201]; regulation of gene expression [GO:0010468]; regulation of inner ear auditory receptor cell differentiation [GO:0045607]; regulation of neurogenesis [GO:0050767]; regulation of Notch signaling pathway [GO:0008593]; regulation of somitogenesis [GO:0014807]; regulation of transcription by RNA polymerase II [GO:0006357]; response to lipopolysaccharide [GO:0032496]; response to muramyl dipeptide [GO:0032495]; secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development [GO:0060528]; skeletal muscle cell differentiation [GO:0035914]; somatic stem cell division [GO:0048103]; spermatogenesis [GO:0007283]; sprouting angiogenesis [GO:0002040]; T-helper 17 type immune response [GO:0072538]; tissue regeneration [GO:0042246]; tube formation [GO:0035148]; vasculogenesis involved in coronary vascular morphogenesis [GO:0060979]; venous blood vessel morphogenesis [GO:0048845]; venous endothelial cell differentiation [GO:0060843]; ventricular septum morphogenesis [GO:0060412]; ventricular trabecula myocardium morphogenesis [GO:0003222] acrosomal vesicle [GO:0001669]; adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell periphery [GO:0071944]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; lamellipodium [GO:0030027]; late endosome membrane [GO:0031902]; MAML1-RBP-Jkappa- ICN1 complex [GO:0002193]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; receptor complex [GO:0043235]; ruffle [GO:0001726]; Schaffer collateral - CA1 synapse [GO:0098685] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; identical protein binding [GO:0042802]; Notch binding [GO:0005112]; transcription coactivator activity [GO:0003713]; transcription regulator activator activity [GO:0140537]; transmembrane signaling receptor activity [GO:0004888] g256.t5 Q01705 34.822 1433 0.0 635.0 sp|Q01705|NOTC1_MOUSE Neurogenic locus notch homolog protein 1 OS=Mus musculus OX=10090 GN=Notch1 PE=1 SV=3 NOTC1_MOUSE reviewed Neurogenic locus notch homolog protein 1 (Notch 1) (Motch A) (mT14) (p300) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Mus musculus (Mouse) GO:0000122; GO:0000139; GO:0001554; GO:0001669; GO:0001701; GO:0001708; GO:0001726; GO:0001837; GO:0001889; GO:0001947; GO:0002040; GO:0002051; GO:0002052; GO:0002193; GO:0002437; GO:0003151; GO:0003157; GO:0003160; GO:0003162; GO:0003169; GO:0003180; GO:0003181; GO:0003182; GO:0003184; GO:0003192; GO:0003197; GO:0003198; GO:0003203; GO:0003207; GO:0003208; GO:0003209; GO:0003213; GO:0003214; GO:0003219; GO:0003222; GO:0003241; GO:0003252; GO:0003264; GO:0003273; GO:0003332; GO:0003344; GO:0003682; GO:0003713; GO:0004857; GO:0004888; GO:0005112; GO:0005509; GO:0005576; GO:0005634; GO:0005654; GO:0005737; GO:0005783; GO:0005789; GO:0005829; GO:0005856; GO:0005886; GO:0005912; GO:0006357; GO:0006606; GO:0006959; GO:0007219; GO:0007221; GO:0007283; GO:0007368; GO:0007386; GO:0007409; GO:0007411; GO:0007440; GO:0007492; GO:0007507; GO:0008284; GO:0008285; GO:0008544; GO:0008593; GO:0009912; GO:0009986; GO:0010001; GO:0010008; GO:0010467; GO:0010468; GO:0010614; GO:0010628; GO:0010629; GO:0010667; GO:0010718; GO:0010812; GO:0010832; GO:0014031; GO:0014807; GO:0016324; GO:0019899; GO:0021515; GO:0021915; GO:0030027; GO:0030154; GO:0030163; GO:0030182; GO:0030216; GO:0030279; GO:0030324; GO:0030326; GO:0030334; GO:0030335; GO:0030513; GO:0030514; GO:0030900; GO:0031069; GO:0031100; GO:0031410; GO:0031490; GO:0031902; GO:0032495; GO:0032496; GO:0032966; GO:0035116; GO:0035148; GO:0035914; GO:0035924; GO:0042127; GO:0042246; GO:0042802; GO:0043065; GO:0043069; GO:0043086; GO:0043235; GO:0045070; GO:0045165; GO:0045596; GO:0045603; GO:0045607; GO:0045608; GO:0045618; GO:0045662; GO:0045665; GO:0045668; GO:0045687; GO:0045747; GO:0045892; GO:0045893; GO:0045944; GO:0045955; GO:0046427; GO:0046533; GO:0046579; GO:0048103; GO:0048593; GO:0048663; GO:0048708; GO:0048709; GO:0048711; GO:0048715; GO:0048754; GO:0048845; GO:0048873; GO:0050678; GO:0050679; GO:0050767; GO:0050768; GO:0051152; GO:0055008; GO:0060038; GO:0060045; GO:0060253; GO:0060271; GO:0060317; GO:0060354; GO:0060379; GO:0060411; GO:0060412; GO:0060528; GO:0060740; GO:0060768; GO:0060842; GO:0060843; GO:0060948; GO:0060956; GO:0060979; GO:0060982; GO:0061344; GO:0061384; GO:0062043; GO:0070168; GO:0070374; GO:0070986; GO:0071228; GO:0071372; GO:0071456; GO:0071944; GO:0072017; GO:0072044; GO:0072144; GO:0072538; GO:0090051; GO:0090090; GO:0097150; GO:0097400; GO:0098685; GO:0098839; GO:0098978; GO:0099565; GO:0120163; GO:0140537; GO:1901189; GO:1901201; GO:1902263; GO:1902339; GO:1903849; GO:2000048; GO:2000737; GO:2000811; GO:2000974; GO:2001027 animal organ regeneration [GO:0031100]; aortic valve morphogenesis [GO:0003180]; apoptotic process involved in embryonic digit morphogenesis [GO:1902263]; arterial endothelial cell differentiation [GO:0060842]; astrocyte differentiation [GO:0048708]; atrioventricular node development [GO:0003162]; atrioventricular valve morphogenesis [GO:0003181]; auditory receptor cell fate commitment [GO:0009912]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; branching morphogenesis of an epithelial tube [GO:0048754]; camera-type eye morphogenesis [GO:0048593]; cardiac atrium morphogenesis [GO:0003209]; cardiac chamber formation [GO:0003207]; cardiac epithelial to mesenchymal transition [GO:0060317]; cardiac left ventricle morphogenesis [GO:0003214]; cardiac muscle cell myoblast differentiation [GO:0060379]; cardiac muscle cell proliferation [GO:0060038]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac right atrium morphogenesis [GO:0003213]; cardiac right ventricle formation [GO:0003219]; cardiac septum morphogenesis [GO:0060411]; cardiac vascular smooth muscle cell development [GO:0060948]; cardiac ventricle morphogenesis [GO:0003208]; cell differentiation [GO:0030154]; cell differentiation in spinal cord [GO:0021515]; cell fate commitment [GO:0045165]; cell fate specification [GO:0001708]; cell migration involved in endocardial cushion formation [GO:0003273]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to hypoxia [GO:0071456]; cellular response to tumor cell [GO:0071228]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; chemical synaptic transmission, postsynaptic [GO:0099565]; cilium assembly [GO:0060271]; collecting duct development [GO:0072044]; compartment pattern specification [GO:0007386]; coronary artery morphogenesis [GO:0060982]; coronary sinus valve morphogenesis [GO:0003182]; coronary vein morphogenesis [GO:0003169]; determination of left/right symmetry [GO:0007368]; distal tubule development [GO:0072017]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic limb morphogenesis [GO:0030326]; endocardial cell differentiation [GO:0060956]; endocardial cushion development [GO:0003197]; endocardial cushion morphogenesis [GO:0003203]; endocardium development [GO:0003157]; endocardium morphogenesis [GO:0003160]; endoderm development [GO:0007492]; epidermis development [GO:0008544]; epithelial to mesenchymal transition [GO:0001837]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; forebrain development [GO:0030900]; foregut morphogenesis [GO:0007440]; gene expression [GO:0010467]; glial cell differentiation [GO:0010001]; glomerular mesangial cell development [GO:0072144]; growth involved in heart morphogenesis [GO:0003241]; hair follicle morphogenesis [GO:0031069]; heart development [GO:0007507]; heart looping [GO:0001947]; heart trabecula morphogenesis [GO:0061384]; homeostasis of number of cells within a tissue [GO:0048873]; humoral immune response [GO:0006959]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; interleukin-17-mediated signaling pathway [GO:0097400]; keratinocyte differentiation [GO:0030216]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; lung development [GO:0030324]; luteolysis [GO:0001554]; mesenchymal cell development [GO:0014031]; mitral valve formation [GO:0003192]; negative regulation of anoikis [GO:2000811]; negative regulation of biomineral tissue development [GO:0070168]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of catalytic activity [GO:0043086]; negative regulation of cell adhesion molecule production [GO:0060354]; negative regulation of cell differentiation [GO:0045596]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell proliferation involved in heart valve morphogenesis [GO:0003252]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of collagen biosynthetic process [GO:0032966]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of endothelial cell chemotaxis [GO:2001027]; negative regulation of extracellular matrix constituent secretion [GO:0003332]; negative regulation of gene expression [GO:0010629]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of inner ear auditory receptor cell differentiation [GO:0045608]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of ossification [GO:0030279]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of photoreceptor cell differentiation [GO:0046533]; negative regulation of pro-B cell differentiation [GO:2000974]; negative regulation of programmed cell death [GO:0043069]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural tube development [GO:0021915]; neuron differentiation [GO:0030182]; neuron fate commitment [GO:0048663]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; oligodendrocyte differentiation [GO:0048709]; osteoblast fate commitment [GO:0002051]; outflow tract morphogenesis [GO:0003151]; pericardium morphogenesis [GO:0003344]; positive regulation of aorta morphogenesis [GO:1903849]; positive regulation of apoptotic process [GO:0043065]; positive regulation of apoptotic process involved in morphogenesis [GO:1902339]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cardiac epithelial to mesenchymal transition [GO:0062043]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of ephrin receptor signaling pathway [GO:1901189]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of glial cell differentiation [GO:0045687]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of smooth muscle cell differentiation [GO:0051152]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription of Notch receptor target [GO:0007221]; positive regulation of viral genome replication [GO:0045070]; prostate gland epithelium morphogenesis [GO:0060740]; protein catabolic process [GO:0030163]; protein import into nucleus [GO:0006606]; pulmonary valve morphogenesis [GO:0003184]; regulation of cardioblast proliferation [GO:0003264]; regulation of cell adhesion involved in heart morphogenesis [GO:0061344]; regulation of cell migration [GO:0030334]; regulation of cell population proliferation [GO:0042127]; regulation of epithelial cell proliferation [GO:0050678]; regulation of epithelial cell proliferation involved in prostate gland development [GO:0060768]; regulation of extracellular matrix assembly [GO:1901201]; regulation of gene expression [GO:0010468]; regulation of inner ear auditory receptor cell differentiation [GO:0045607]; regulation of neurogenesis [GO:0050767]; regulation of Notch signaling pathway [GO:0008593]; regulation of somitogenesis [GO:0014807]; regulation of transcription by RNA polymerase II [GO:0006357]; response to lipopolysaccharide [GO:0032496]; response to muramyl dipeptide [GO:0032495]; secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development [GO:0060528]; skeletal muscle cell differentiation [GO:0035914]; somatic stem cell division [GO:0048103]; spermatogenesis [GO:0007283]; sprouting angiogenesis [GO:0002040]; T-helper 17 type immune response [GO:0072538]; tissue regeneration [GO:0042246]; tube formation [GO:0035148]; vasculogenesis involved in coronary vascular morphogenesis [GO:0060979]; venous blood vessel morphogenesis [GO:0048845]; venous endothelial cell differentiation [GO:0060843]; ventricular septum morphogenesis [GO:0060412]; ventricular trabecula myocardium morphogenesis [GO:0003222] acrosomal vesicle [GO:0001669]; adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell periphery [GO:0071944]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; lamellipodium [GO:0030027]; late endosome membrane [GO:0031902]; MAML1-RBP-Jkappa- ICN1 complex [GO:0002193]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; receptor complex [GO:0043235]; ruffle [GO:0001726]; Schaffer collateral - CA1 synapse [GO:0098685] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; identical protein binding [GO:0042802]; Notch binding [GO:0005112]; transcription coactivator activity [GO:0003713]; transcription regulator activator activity [GO:0140537]; transmembrane signaling receptor activity [GO:0004888] g256.t5 Q01705 34.371 1606 0.0 632.0 sp|Q01705|NOTC1_MOUSE Neurogenic locus notch homolog protein 1 OS=Mus musculus OX=10090 GN=Notch1 PE=1 SV=3 NOTC1_MOUSE reviewed Neurogenic locus notch homolog protein 1 (Notch 1) (Motch A) (mT14) (p300) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Mus musculus (Mouse) GO:0000122; GO:0000139; GO:0001554; GO:0001669; GO:0001701; GO:0001708; GO:0001726; GO:0001837; GO:0001889; GO:0001947; GO:0002040; GO:0002051; GO:0002052; GO:0002193; GO:0002437; GO:0003151; GO:0003157; GO:0003160; GO:0003162; GO:0003169; GO:0003180; GO:0003181; GO:0003182; GO:0003184; GO:0003192; GO:0003197; GO:0003198; GO:0003203; GO:0003207; GO:0003208; GO:0003209; GO:0003213; GO:0003214; GO:0003219; GO:0003222; GO:0003241; GO:0003252; GO:0003264; GO:0003273; GO:0003332; GO:0003344; GO:0003682; GO:0003713; GO:0004857; GO:0004888; GO:0005112; GO:0005509; GO:0005576; GO:0005634; GO:0005654; GO:0005737; GO:0005783; GO:0005789; GO:0005829; GO:0005856; GO:0005886; GO:0005912; GO:0006357; GO:0006606; GO:0006959; GO:0007219; GO:0007221; GO:0007283; GO:0007368; GO:0007386; GO:0007409; GO:0007411; GO:0007440; GO:0007492; GO:0007507; GO:0008284; GO:0008285; GO:0008544; GO:0008593; GO:0009912; GO:0009986; GO:0010001; GO:0010008; GO:0010467; GO:0010468; GO:0010614; GO:0010628; GO:0010629; GO:0010667; GO:0010718; GO:0010812; GO:0010832; GO:0014031; GO:0014807; GO:0016324; GO:0019899; GO:0021515; GO:0021915; GO:0030027; GO:0030154; GO:0030163; GO:0030182; GO:0030216; GO:0030279; GO:0030324; GO:0030326; GO:0030334; GO:0030335; GO:0030513; GO:0030514; GO:0030900; GO:0031069; GO:0031100; GO:0031410; GO:0031490; GO:0031902; GO:0032495; GO:0032496; GO:0032966; GO:0035116; GO:0035148; GO:0035914; GO:0035924; GO:0042127; GO:0042246; GO:0042802; GO:0043065; GO:0043069; GO:0043086; GO:0043235; GO:0045070; GO:0045165; GO:0045596; GO:0045603; GO:0045607; GO:0045608; GO:0045618; GO:0045662; GO:0045665; GO:0045668; GO:0045687; GO:0045747; GO:0045892; GO:0045893; GO:0045944; GO:0045955; GO:0046427; GO:0046533; GO:0046579; GO:0048103; GO:0048593; GO:0048663; GO:0048708; GO:0048709; GO:0048711; GO:0048715; GO:0048754; GO:0048845; GO:0048873; GO:0050678; GO:0050679; GO:0050767; GO:0050768; GO:0051152; GO:0055008; GO:0060038; GO:0060045; GO:0060253; GO:0060271; GO:0060317; GO:0060354; GO:0060379; GO:0060411; GO:0060412; GO:0060528; GO:0060740; GO:0060768; GO:0060842; GO:0060843; GO:0060948; GO:0060956; GO:0060979; GO:0060982; GO:0061344; GO:0061384; GO:0062043; GO:0070168; GO:0070374; GO:0070986; GO:0071228; GO:0071372; GO:0071456; GO:0071944; GO:0072017; GO:0072044; GO:0072144; GO:0072538; GO:0090051; GO:0090090; GO:0097150; GO:0097400; GO:0098685; GO:0098839; GO:0098978; GO:0099565; GO:0120163; GO:0140537; GO:1901189; GO:1901201; GO:1902263; GO:1902339; GO:1903849; GO:2000048; GO:2000737; GO:2000811; GO:2000974; GO:2001027 animal organ regeneration [GO:0031100]; aortic valve morphogenesis [GO:0003180]; apoptotic process involved in embryonic digit morphogenesis [GO:1902263]; arterial endothelial cell differentiation [GO:0060842]; astrocyte differentiation [GO:0048708]; atrioventricular node development [GO:0003162]; atrioventricular valve morphogenesis [GO:0003181]; auditory receptor cell fate commitment [GO:0009912]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; branching morphogenesis of an epithelial tube [GO:0048754]; camera-type eye morphogenesis [GO:0048593]; cardiac atrium morphogenesis [GO:0003209]; cardiac chamber formation [GO:0003207]; cardiac epithelial to mesenchymal transition [GO:0060317]; cardiac left ventricle morphogenesis [GO:0003214]; cardiac muscle cell myoblast differentiation [GO:0060379]; cardiac muscle cell proliferation [GO:0060038]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac right atrium morphogenesis [GO:0003213]; cardiac right ventricle formation [GO:0003219]; cardiac septum morphogenesis [GO:0060411]; cardiac vascular smooth muscle cell development [GO:0060948]; cardiac ventricle morphogenesis [GO:0003208]; cell differentiation [GO:0030154]; cell differentiation in spinal cord [GO:0021515]; cell fate commitment [GO:0045165]; cell fate specification [GO:0001708]; cell migration involved in endocardial cushion formation [GO:0003273]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to hypoxia [GO:0071456]; cellular response to tumor cell [GO:0071228]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; chemical synaptic transmission, postsynaptic [GO:0099565]; cilium assembly [GO:0060271]; collecting duct development [GO:0072044]; compartment pattern specification [GO:0007386]; coronary artery morphogenesis [GO:0060982]; coronary sinus valve morphogenesis [GO:0003182]; coronary vein morphogenesis [GO:0003169]; determination of left/right symmetry [GO:0007368]; distal tubule development [GO:0072017]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic limb morphogenesis [GO:0030326]; endocardial cell differentiation [GO:0060956]; endocardial cushion development [GO:0003197]; endocardial cushion morphogenesis [GO:0003203]; endocardium development [GO:0003157]; endocardium morphogenesis [GO:0003160]; endoderm development [GO:0007492]; epidermis development [GO:0008544]; epithelial to mesenchymal transition [GO:0001837]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; forebrain development [GO:0030900]; foregut morphogenesis [GO:0007440]; gene expression [GO:0010467]; glial cell differentiation [GO:0010001]; glomerular mesangial cell development [GO:0072144]; growth involved in heart morphogenesis [GO:0003241]; hair follicle morphogenesis [GO:0031069]; heart development [GO:0007507]; heart looping [GO:0001947]; heart trabecula morphogenesis [GO:0061384]; homeostasis of number of cells within a tissue [GO:0048873]; humoral immune response [GO:0006959]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; interleukin-17-mediated signaling pathway [GO:0097400]; keratinocyte differentiation [GO:0030216]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; lung development [GO:0030324]; luteolysis [GO:0001554]; mesenchymal cell development [GO:0014031]; mitral valve formation [GO:0003192]; negative regulation of anoikis [GO:2000811]; negative regulation of biomineral tissue development [GO:0070168]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of catalytic activity [GO:0043086]; negative regulation of cell adhesion molecule production [GO:0060354]; negative regulation of cell differentiation [GO:0045596]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell proliferation involved in heart valve morphogenesis [GO:0003252]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of collagen biosynthetic process [GO:0032966]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of endothelial cell chemotaxis [GO:2001027]; negative regulation of extracellular matrix constituent secretion [GO:0003332]; negative regulation of gene expression [GO:0010629]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of inner ear auditory receptor cell differentiation [GO:0045608]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of ossification [GO:0030279]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of photoreceptor cell differentiation [GO:0046533]; negative regulation of pro-B cell differentiation [GO:2000974]; negative regulation of programmed cell death [GO:0043069]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural tube development [GO:0021915]; neuron differentiation [GO:0030182]; neuron fate commitment [GO:0048663]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; oligodendrocyte differentiation [GO:0048709]; osteoblast fate commitment [GO:0002051]; outflow tract morphogenesis [GO:0003151]; pericardium morphogenesis [GO:0003344]; positive regulation of aorta morphogenesis [GO:1903849]; positive regulation of apoptotic process [GO:0043065]; positive regulation of apoptotic process involved in morphogenesis [GO:1902339]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cardiac epithelial to mesenchymal transition [GO:0062043]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of ephrin receptor signaling pathway [GO:1901189]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of glial cell differentiation [GO:0045687]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of smooth muscle cell differentiation [GO:0051152]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription of Notch receptor target [GO:0007221]; positive regulation of viral genome replication [GO:0045070]; prostate gland epithelium morphogenesis [GO:0060740]; protein catabolic process [GO:0030163]; protein import into nucleus [GO:0006606]; pulmonary valve morphogenesis [GO:0003184]; regulation of cardioblast proliferation [GO:0003264]; regulation of cell adhesion involved in heart morphogenesis [GO:0061344]; regulation of cell migration [GO:0030334]; regulation of cell population proliferation [GO:0042127]; regulation of epithelial cell proliferation [GO:0050678]; regulation of epithelial cell proliferation involved in prostate gland development [GO:0060768]; regulation of extracellular matrix assembly [GO:1901201]; regulation of gene expression [GO:0010468]; regulation of inner ear auditory receptor cell differentiation [GO:0045607]; regulation of neurogenesis [GO:0050767]; regulation of Notch signaling pathway [GO:0008593]; regulation of somitogenesis [GO:0014807]; regulation of transcription by RNA polymerase II [GO:0006357]; response to lipopolysaccharide [GO:0032496]; response to muramyl dipeptide [GO:0032495]; secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development [GO:0060528]; skeletal muscle cell differentiation [GO:0035914]; somatic stem cell division [GO:0048103]; spermatogenesis [GO:0007283]; sprouting angiogenesis [GO:0002040]; T-helper 17 type immune response [GO:0072538]; tissue regeneration [GO:0042246]; tube formation [GO:0035148]; vasculogenesis involved in coronary vascular morphogenesis [GO:0060979]; venous blood vessel morphogenesis [GO:0048845]; venous endothelial cell differentiation [GO:0060843]; ventricular septum morphogenesis [GO:0060412]; ventricular trabecula myocardium morphogenesis [GO:0003222] acrosomal vesicle [GO:0001669]; adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell periphery [GO:0071944]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; lamellipodium [GO:0030027]; late endosome membrane [GO:0031902]; MAML1-RBP-Jkappa- ICN1 complex [GO:0002193]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; receptor complex [GO:0043235]; ruffle [GO:0001726]; Schaffer collateral - CA1 synapse [GO:0098685] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; identical protein binding [GO:0042802]; Notch binding [GO:0005112]; transcription coactivator activity [GO:0003713]; transcription regulator activator activity [GO:0140537]; transmembrane signaling receptor activity [GO:0004888] g256.t5 Q01705 35.206 1477 0.0 623.0 sp|Q01705|NOTC1_MOUSE Neurogenic locus notch homolog protein 1 OS=Mus musculus OX=10090 GN=Notch1 PE=1 SV=3 NOTC1_MOUSE reviewed Neurogenic locus notch homolog protein 1 (Notch 1) (Motch A) (mT14) (p300) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Mus musculus (Mouse) GO:0000122; GO:0000139; GO:0001554; GO:0001669; GO:0001701; GO:0001708; GO:0001726; GO:0001837; GO:0001889; GO:0001947; GO:0002040; GO:0002051; GO:0002052; GO:0002193; GO:0002437; GO:0003151; GO:0003157; GO:0003160; GO:0003162; GO:0003169; GO:0003180; GO:0003181; GO:0003182; GO:0003184; GO:0003192; GO:0003197; GO:0003198; GO:0003203; GO:0003207; GO:0003208; GO:0003209; GO:0003213; GO:0003214; GO:0003219; GO:0003222; GO:0003241; GO:0003252; GO:0003264; GO:0003273; GO:0003332; GO:0003344; GO:0003682; GO:0003713; GO:0004857; GO:0004888; GO:0005112; GO:0005509; GO:0005576; GO:0005634; GO:0005654; GO:0005737; GO:0005783; GO:0005789; GO:0005829; GO:0005856; GO:0005886; GO:0005912; GO:0006357; GO:0006606; GO:0006959; GO:0007219; GO:0007221; GO:0007283; GO:0007368; GO:0007386; GO:0007409; GO:0007411; GO:0007440; GO:0007492; GO:0007507; GO:0008284; GO:0008285; GO:0008544; GO:0008593; GO:0009912; GO:0009986; GO:0010001; GO:0010008; GO:0010467; GO:0010468; GO:0010614; GO:0010628; GO:0010629; GO:0010667; GO:0010718; GO:0010812; GO:0010832; GO:0014031; GO:0014807; GO:0016324; GO:0019899; GO:0021515; GO:0021915; GO:0030027; GO:0030154; GO:0030163; GO:0030182; GO:0030216; GO:0030279; GO:0030324; GO:0030326; GO:0030334; GO:0030335; GO:0030513; GO:0030514; GO:0030900; GO:0031069; GO:0031100; GO:0031410; GO:0031490; GO:0031902; GO:0032495; GO:0032496; GO:0032966; GO:0035116; GO:0035148; GO:0035914; GO:0035924; GO:0042127; GO:0042246; GO:0042802; GO:0043065; GO:0043069; GO:0043086; GO:0043235; GO:0045070; GO:0045165; GO:0045596; GO:0045603; GO:0045607; GO:0045608; GO:0045618; GO:0045662; GO:0045665; GO:0045668; GO:0045687; GO:0045747; GO:0045892; GO:0045893; GO:0045944; GO:0045955; GO:0046427; GO:0046533; GO:0046579; GO:0048103; GO:0048593; GO:0048663; GO:0048708; GO:0048709; GO:0048711; GO:0048715; GO:0048754; GO:0048845; GO:0048873; GO:0050678; GO:0050679; GO:0050767; GO:0050768; GO:0051152; GO:0055008; GO:0060038; GO:0060045; GO:0060253; GO:0060271; GO:0060317; GO:0060354; GO:0060379; GO:0060411; GO:0060412; GO:0060528; GO:0060740; GO:0060768; GO:0060842; GO:0060843; GO:0060948; GO:0060956; GO:0060979; GO:0060982; GO:0061344; GO:0061384; GO:0062043; GO:0070168; GO:0070374; GO:0070986; GO:0071228; GO:0071372; GO:0071456; GO:0071944; GO:0072017; GO:0072044; GO:0072144; GO:0072538; GO:0090051; GO:0090090; GO:0097150; GO:0097400; GO:0098685; GO:0098839; GO:0098978; GO:0099565; GO:0120163; GO:0140537; GO:1901189; GO:1901201; GO:1902263; GO:1902339; GO:1903849; GO:2000048; GO:2000737; GO:2000811; GO:2000974; GO:2001027 animal organ regeneration [GO:0031100]; aortic valve morphogenesis [GO:0003180]; apoptotic process involved in embryonic digit morphogenesis [GO:1902263]; arterial endothelial cell differentiation [GO:0060842]; astrocyte differentiation [GO:0048708]; atrioventricular node development [GO:0003162]; atrioventricular valve morphogenesis [GO:0003181]; auditory receptor cell fate commitment [GO:0009912]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; branching morphogenesis of an epithelial tube [GO:0048754]; camera-type eye morphogenesis [GO:0048593]; cardiac atrium morphogenesis [GO:0003209]; cardiac chamber formation [GO:0003207]; cardiac epithelial to mesenchymal transition [GO:0060317]; cardiac left ventricle morphogenesis [GO:0003214]; cardiac muscle cell myoblast differentiation [GO:0060379]; cardiac muscle cell proliferation [GO:0060038]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac right atrium morphogenesis [GO:0003213]; cardiac right ventricle formation [GO:0003219]; cardiac septum morphogenesis [GO:0060411]; cardiac vascular smooth muscle cell development [GO:0060948]; cardiac ventricle morphogenesis [GO:0003208]; cell differentiation [GO:0030154]; cell differentiation in spinal cord [GO:0021515]; cell fate commitment [GO:0045165]; cell fate specification [GO:0001708]; cell migration involved in endocardial cushion formation [GO:0003273]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to hypoxia [GO:0071456]; cellular response to tumor cell [GO:0071228]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; chemical synaptic transmission, postsynaptic [GO:0099565]; cilium assembly [GO:0060271]; collecting duct development [GO:0072044]; compartment pattern specification [GO:0007386]; coronary artery morphogenesis [GO:0060982]; coronary sinus valve morphogenesis [GO:0003182]; coronary vein morphogenesis [GO:0003169]; determination of left/right symmetry [GO:0007368]; distal tubule development [GO:0072017]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic limb morphogenesis [GO:0030326]; endocardial cell differentiation [GO:0060956]; endocardial cushion development [GO:0003197]; endocardial cushion morphogenesis [GO:0003203]; endocardium development [GO:0003157]; endocardium morphogenesis [GO:0003160]; endoderm development [GO:0007492]; epidermis development [GO:0008544]; epithelial to mesenchymal transition [GO:0001837]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; forebrain development [GO:0030900]; foregut morphogenesis [GO:0007440]; gene expression [GO:0010467]; glial cell differentiation [GO:0010001]; glomerular mesangial cell development [GO:0072144]; growth involved in heart morphogenesis [GO:0003241]; hair follicle morphogenesis [GO:0031069]; heart development [GO:0007507]; heart looping [GO:0001947]; heart trabecula morphogenesis [GO:0061384]; homeostasis of number of cells within a tissue [GO:0048873]; humoral immune response [GO:0006959]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; interleukin-17-mediated signaling pathway [GO:0097400]; keratinocyte differentiation [GO:0030216]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; lung development [GO:0030324]; luteolysis [GO:0001554]; mesenchymal cell development [GO:0014031]; mitral valve formation [GO:0003192]; negative regulation of anoikis [GO:2000811]; negative regulation of biomineral tissue development [GO:0070168]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of catalytic activity [GO:0043086]; negative regulation of cell adhesion molecule production [GO:0060354]; negative regulation of cell differentiation [GO:0045596]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell proliferation involved in heart valve morphogenesis [GO:0003252]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of collagen biosynthetic process [GO:0032966]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of endothelial cell chemotaxis [GO:2001027]; negative regulation of extracellular matrix constituent secretion [GO:0003332]; negative regulation of gene expression [GO:0010629]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of inner ear auditory receptor cell differentiation [GO:0045608]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of ossification [GO:0030279]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of photoreceptor cell differentiation [GO:0046533]; negative regulation of pro-B cell differentiation [GO:2000974]; negative regulation of programmed cell death [GO:0043069]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural tube development [GO:0021915]; neuron differentiation [GO:0030182]; neuron fate commitment [GO:0048663]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; oligodendrocyte differentiation [GO:0048709]; osteoblast fate commitment [GO:0002051]; outflow tract morphogenesis [GO:0003151]; pericardium morphogenesis [GO:0003344]; positive regulation of aorta morphogenesis [GO:1903849]; positive regulation of apoptotic process [GO:0043065]; positive regulation of apoptotic process involved in morphogenesis [GO:1902339]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cardiac epithelial to mesenchymal transition [GO:0062043]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of ephrin receptor signaling pathway [GO:1901189]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of glial cell differentiation [GO:0045687]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of smooth muscle cell differentiation [GO:0051152]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription of Notch receptor target [GO:0007221]; positive regulation of viral genome replication [GO:0045070]; prostate gland epithelium morphogenesis [GO:0060740]; protein catabolic process [GO:0030163]; protein import into nucleus [GO:0006606]; pulmonary valve morphogenesis [GO:0003184]; regulation of cardioblast proliferation [GO:0003264]; regulation of cell adhesion involved in heart morphogenesis [GO:0061344]; regulation of cell migration [GO:0030334]; regulation of cell population proliferation [GO:0042127]; regulation of epithelial cell proliferation [GO:0050678]; regulation of epithelial cell proliferation involved in prostate gland development [GO:0060768]; regulation of extracellular matrix assembly [GO:1901201]; regulation of gene expression [GO:0010468]; regulation of inner ear auditory receptor cell differentiation [GO:0045607]; regulation of neurogenesis [GO:0050767]; regulation of Notch signaling pathway [GO:0008593]; regulation of somitogenesis [GO:0014807]; regulation of transcription by RNA polymerase II [GO:0006357]; response to lipopolysaccharide [GO:0032496]; response to muramyl dipeptide [GO:0032495]; secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development [GO:0060528]; skeletal muscle cell differentiation [GO:0035914]; somatic stem cell division [GO:0048103]; spermatogenesis [GO:0007283]; sprouting angiogenesis [GO:0002040]; T-helper 17 type immune response [GO:0072538]; tissue regeneration [GO:0042246]; tube formation [GO:0035148]; vasculogenesis involved in coronary vascular morphogenesis [GO:0060979]; venous blood vessel morphogenesis [GO:0048845]; venous endothelial cell differentiation [GO:0060843]; ventricular septum morphogenesis [GO:0060412]; ventricular trabecula myocardium morphogenesis [GO:0003222] acrosomal vesicle [GO:0001669]; adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell periphery [GO:0071944]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; lamellipodium [GO:0030027]; late endosome membrane [GO:0031902]; MAML1-RBP-Jkappa- ICN1 complex [GO:0002193]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; receptor complex [GO:0043235]; ruffle [GO:0001726]; Schaffer collateral - CA1 synapse [GO:0098685] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; identical protein binding [GO:0042802]; Notch binding [GO:0005112]; transcription coactivator activity [GO:0003713]; transcription regulator activator activity [GO:0140537]; transmembrane signaling receptor activity [GO:0004888] g256.t5 Q01705 35.03 1316 1.78e-161 563.0 sp|Q01705|NOTC1_MOUSE Neurogenic locus notch homolog protein 1 OS=Mus musculus OX=10090 GN=Notch1 PE=1 SV=3 NOTC1_MOUSE reviewed Neurogenic locus notch homolog protein 1 (Notch 1) (Motch A) (mT14) (p300) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Mus musculus (Mouse) GO:0000122; GO:0000139; GO:0001554; GO:0001669; GO:0001701; GO:0001708; GO:0001726; GO:0001837; GO:0001889; GO:0001947; GO:0002040; GO:0002051; GO:0002052; GO:0002193; GO:0002437; GO:0003151; GO:0003157; GO:0003160; GO:0003162; GO:0003169; GO:0003180; GO:0003181; GO:0003182; GO:0003184; GO:0003192; GO:0003197; GO:0003198; GO:0003203; GO:0003207; GO:0003208; GO:0003209; GO:0003213; GO:0003214; GO:0003219; GO:0003222; GO:0003241; GO:0003252; GO:0003264; GO:0003273; GO:0003332; GO:0003344; GO:0003682; GO:0003713; GO:0004857; GO:0004888; GO:0005112; GO:0005509; GO:0005576; GO:0005634; GO:0005654; GO:0005737; GO:0005783; GO:0005789; GO:0005829; GO:0005856; GO:0005886; GO:0005912; GO:0006357; GO:0006606; GO:0006959; GO:0007219; GO:0007221; GO:0007283; GO:0007368; GO:0007386; GO:0007409; GO:0007411; GO:0007440; GO:0007492; GO:0007507; GO:0008284; GO:0008285; GO:0008544; GO:0008593; GO:0009912; GO:0009986; GO:0010001; GO:0010008; GO:0010467; GO:0010468; GO:0010614; GO:0010628; GO:0010629; GO:0010667; GO:0010718; GO:0010812; GO:0010832; GO:0014031; GO:0014807; GO:0016324; GO:0019899; GO:0021515; GO:0021915; GO:0030027; GO:0030154; GO:0030163; GO:0030182; GO:0030216; GO:0030279; GO:0030324; GO:0030326; GO:0030334; GO:0030335; GO:0030513; GO:0030514; GO:0030900; GO:0031069; GO:0031100; GO:0031410; GO:0031490; GO:0031902; GO:0032495; GO:0032496; GO:0032966; GO:0035116; GO:0035148; GO:0035914; GO:0035924; GO:0042127; GO:0042246; GO:0042802; GO:0043065; GO:0043069; GO:0043086; GO:0043235; GO:0045070; GO:0045165; GO:0045596; GO:0045603; GO:0045607; GO:0045608; GO:0045618; GO:0045662; GO:0045665; GO:0045668; GO:0045687; GO:0045747; GO:0045892; GO:0045893; GO:0045944; GO:0045955; GO:0046427; GO:0046533; GO:0046579; GO:0048103; GO:0048593; GO:0048663; GO:0048708; GO:0048709; GO:0048711; GO:0048715; GO:0048754; GO:0048845; GO:0048873; GO:0050678; GO:0050679; GO:0050767; GO:0050768; GO:0051152; GO:0055008; GO:0060038; GO:0060045; GO:0060253; GO:0060271; GO:0060317; GO:0060354; GO:0060379; GO:0060411; GO:0060412; GO:0060528; GO:0060740; GO:0060768; GO:0060842; GO:0060843; GO:0060948; GO:0060956; GO:0060979; GO:0060982; GO:0061344; GO:0061384; GO:0062043; GO:0070168; GO:0070374; GO:0070986; GO:0071228; GO:0071372; GO:0071456; GO:0071944; GO:0072017; GO:0072044; GO:0072144; GO:0072538; GO:0090051; GO:0090090; GO:0097150; GO:0097400; GO:0098685; GO:0098839; GO:0098978; GO:0099565; GO:0120163; GO:0140537; GO:1901189; GO:1901201; GO:1902263; GO:1902339; GO:1903849; GO:2000048; GO:2000737; GO:2000811; GO:2000974; GO:2001027 animal organ regeneration [GO:0031100]; aortic valve morphogenesis [GO:0003180]; apoptotic process involved in embryonic digit morphogenesis [GO:1902263]; arterial endothelial cell differentiation [GO:0060842]; astrocyte differentiation [GO:0048708]; atrioventricular node development [GO:0003162]; atrioventricular valve morphogenesis [GO:0003181]; auditory receptor cell fate commitment [GO:0009912]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; branching morphogenesis of an epithelial tube [GO:0048754]; camera-type eye morphogenesis [GO:0048593]; cardiac atrium morphogenesis [GO:0003209]; cardiac chamber formation [GO:0003207]; cardiac epithelial to mesenchymal transition [GO:0060317]; cardiac left ventricle morphogenesis [GO:0003214]; cardiac muscle cell myoblast differentiation [GO:0060379]; cardiac muscle cell proliferation [GO:0060038]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac right atrium morphogenesis [GO:0003213]; cardiac right ventricle formation [GO:0003219]; cardiac septum morphogenesis [GO:0060411]; cardiac vascular smooth muscle cell development [GO:0060948]; cardiac ventricle morphogenesis [GO:0003208]; cell differentiation [GO:0030154]; cell differentiation in spinal cord [GO:0021515]; cell fate commitment [GO:0045165]; cell fate specification [GO:0001708]; cell migration involved in endocardial cushion formation [GO:0003273]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to hypoxia [GO:0071456]; cellular response to tumor cell [GO:0071228]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; chemical synaptic transmission, postsynaptic [GO:0099565]; cilium assembly [GO:0060271]; collecting duct development [GO:0072044]; compartment pattern specification [GO:0007386]; coronary artery morphogenesis [GO:0060982]; coronary sinus valve morphogenesis [GO:0003182]; coronary vein morphogenesis [GO:0003169]; determination of left/right symmetry [GO:0007368]; distal tubule development [GO:0072017]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic limb morphogenesis [GO:0030326]; endocardial cell differentiation [GO:0060956]; endocardial cushion development [GO:0003197]; endocardial cushion morphogenesis [GO:0003203]; endocardium development [GO:0003157]; endocardium morphogenesis [GO:0003160]; endoderm development [GO:0007492]; epidermis development [GO:0008544]; epithelial to mesenchymal transition [GO:0001837]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; forebrain development [GO:0030900]; foregut morphogenesis [GO:0007440]; gene expression [GO:0010467]; glial cell differentiation [GO:0010001]; glomerular mesangial cell development [GO:0072144]; growth involved in heart morphogenesis [GO:0003241]; hair follicle morphogenesis [GO:0031069]; heart development [GO:0007507]; heart looping [GO:0001947]; heart trabecula morphogenesis [GO:0061384]; homeostasis of number of cells within a tissue [GO:0048873]; humoral immune response [GO:0006959]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; interleukin-17-mediated signaling pathway [GO:0097400]; keratinocyte differentiation [GO:0030216]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; lung development [GO:0030324]; luteolysis [GO:0001554]; mesenchymal cell development [GO:0014031]; mitral valve formation [GO:0003192]; negative regulation of anoikis [GO:2000811]; negative regulation of biomineral tissue development [GO:0070168]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of catalytic activity [GO:0043086]; negative regulation of cell adhesion molecule production [GO:0060354]; negative regulation of cell differentiation [GO:0045596]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell proliferation involved in heart valve morphogenesis [GO:0003252]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of collagen biosynthetic process [GO:0032966]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of endothelial cell chemotaxis [GO:2001027]; negative regulation of extracellular matrix constituent secretion [GO:0003332]; negative regulation of gene expression [GO:0010629]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of inner ear auditory receptor cell differentiation [GO:0045608]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of ossification [GO:0030279]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of photoreceptor cell differentiation [GO:0046533]; negative regulation of pro-B cell differentiation [GO:2000974]; negative regulation of programmed cell death [GO:0043069]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural tube development [GO:0021915]; neuron differentiation [GO:0030182]; neuron fate commitment [GO:0048663]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; oligodendrocyte differentiation [GO:0048709]; osteoblast fate commitment [GO:0002051]; outflow tract morphogenesis [GO:0003151]; pericardium morphogenesis [GO:0003344]; positive regulation of aorta morphogenesis [GO:1903849]; positive regulation of apoptotic process [GO:0043065]; positive regulation of apoptotic process involved in morphogenesis [GO:1902339]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cardiac epithelial to mesenchymal transition [GO:0062043]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of ephrin receptor signaling pathway [GO:1901189]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of glial cell differentiation [GO:0045687]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of smooth muscle cell differentiation [GO:0051152]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription of Notch receptor target [GO:0007221]; positive regulation of viral genome replication [GO:0045070]; prostate gland epithelium morphogenesis [GO:0060740]; protein catabolic process [GO:0030163]; protein import into nucleus [GO:0006606]; pulmonary valve morphogenesis [GO:0003184]; regulation of cardioblast proliferation [GO:0003264]; regulation of cell adhesion involved in heart morphogenesis [GO:0061344]; regulation of cell migration [GO:0030334]; regulation of cell population proliferation [GO:0042127]; regulation of epithelial cell proliferation [GO:0050678]; regulation of epithelial cell proliferation involved in prostate gland development [GO:0060768]; regulation of extracellular matrix assembly [GO:1901201]; regulation of gene expression [GO:0010468]; regulation of inner ear auditory receptor cell differentiation [GO:0045607]; regulation of neurogenesis [GO:0050767]; regulation of Notch signaling pathway [GO:0008593]; regulation of somitogenesis [GO:0014807]; regulation of transcription by RNA polymerase II [GO:0006357]; response to lipopolysaccharide [GO:0032496]; response to muramyl dipeptide [GO:0032495]; secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development [GO:0060528]; skeletal muscle cell differentiation [GO:0035914]; somatic stem cell division [GO:0048103]; spermatogenesis [GO:0007283]; sprouting angiogenesis [GO:0002040]; T-helper 17 type immune response [GO:0072538]; tissue regeneration [GO:0042246]; tube formation [GO:0035148]; vasculogenesis involved in coronary vascular morphogenesis [GO:0060979]; venous blood vessel morphogenesis [GO:0048845]; venous endothelial cell differentiation [GO:0060843]; ventricular septum morphogenesis [GO:0060412]; ventricular trabecula myocardium morphogenesis [GO:0003222] acrosomal vesicle [GO:0001669]; adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell periphery [GO:0071944]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; lamellipodium [GO:0030027]; late endosome membrane [GO:0031902]; MAML1-RBP-Jkappa- ICN1 complex [GO:0002193]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; receptor complex [GO:0043235]; ruffle [GO:0001726]; Schaffer collateral - CA1 synapse [GO:0098685] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; identical protein binding [GO:0042802]; Notch binding [GO:0005112]; transcription coactivator activity [GO:0003713]; transcription regulator activator activity [GO:0140537]; transmembrane signaling receptor activity [GO:0004888] g256.t5 Q01705 36.265 1012 4.81e-128 457.0 sp|Q01705|NOTC1_MOUSE Neurogenic locus notch homolog protein 1 OS=Mus musculus OX=10090 GN=Notch1 PE=1 SV=3 NOTC1_MOUSE reviewed Neurogenic locus notch homolog protein 1 (Notch 1) (Motch A) (mT14) (p300) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Mus musculus (Mouse) GO:0000122; GO:0000139; GO:0001554; GO:0001669; GO:0001701; GO:0001708; GO:0001726; GO:0001837; GO:0001889; GO:0001947; GO:0002040; GO:0002051; GO:0002052; GO:0002193; GO:0002437; GO:0003151; GO:0003157; GO:0003160; GO:0003162; GO:0003169; GO:0003180; GO:0003181; GO:0003182; GO:0003184; GO:0003192; GO:0003197; GO:0003198; GO:0003203; GO:0003207; GO:0003208; GO:0003209; GO:0003213; GO:0003214; GO:0003219; GO:0003222; GO:0003241; GO:0003252; GO:0003264; GO:0003273; GO:0003332; GO:0003344; GO:0003682; GO:0003713; GO:0004857; GO:0004888; GO:0005112; GO:0005509; GO:0005576; GO:0005634; GO:0005654; GO:0005737; GO:0005783; GO:0005789; GO:0005829; GO:0005856; GO:0005886; GO:0005912; GO:0006357; GO:0006606; GO:0006959; GO:0007219; GO:0007221; GO:0007283; GO:0007368; GO:0007386; GO:0007409; GO:0007411; GO:0007440; GO:0007492; GO:0007507; GO:0008284; GO:0008285; GO:0008544; GO:0008593; GO:0009912; GO:0009986; GO:0010001; GO:0010008; GO:0010467; GO:0010468; GO:0010614; GO:0010628; GO:0010629; GO:0010667; GO:0010718; GO:0010812; GO:0010832; GO:0014031; GO:0014807; GO:0016324; GO:0019899; GO:0021515; GO:0021915; GO:0030027; GO:0030154; GO:0030163; GO:0030182; GO:0030216; GO:0030279; GO:0030324; GO:0030326; GO:0030334; GO:0030335; GO:0030513; GO:0030514; GO:0030900; GO:0031069; GO:0031100; GO:0031410; GO:0031490; GO:0031902; GO:0032495; GO:0032496; GO:0032966; GO:0035116; GO:0035148; GO:0035914; GO:0035924; GO:0042127; GO:0042246; GO:0042802; GO:0043065; GO:0043069; GO:0043086; GO:0043235; GO:0045070; GO:0045165; GO:0045596; GO:0045603; GO:0045607; GO:0045608; GO:0045618; GO:0045662; GO:0045665; GO:0045668; GO:0045687; GO:0045747; GO:0045892; GO:0045893; GO:0045944; GO:0045955; GO:0046427; GO:0046533; GO:0046579; GO:0048103; GO:0048593; GO:0048663; GO:0048708; GO:0048709; GO:0048711; GO:0048715; GO:0048754; GO:0048845; GO:0048873; GO:0050678; GO:0050679; GO:0050767; GO:0050768; GO:0051152; GO:0055008; GO:0060038; GO:0060045; GO:0060253; GO:0060271; GO:0060317; GO:0060354; GO:0060379; GO:0060411; GO:0060412; GO:0060528; GO:0060740; GO:0060768; GO:0060842; GO:0060843; GO:0060948; GO:0060956; GO:0060979; GO:0060982; GO:0061344; GO:0061384; GO:0062043; GO:0070168; GO:0070374; GO:0070986; GO:0071228; GO:0071372; GO:0071456; GO:0071944; GO:0072017; GO:0072044; GO:0072144; GO:0072538; GO:0090051; GO:0090090; GO:0097150; GO:0097400; GO:0098685; GO:0098839; GO:0098978; GO:0099565; GO:0120163; GO:0140537; GO:1901189; GO:1901201; GO:1902263; GO:1902339; GO:1903849; GO:2000048; GO:2000737; GO:2000811; GO:2000974; GO:2001027 animal organ regeneration [GO:0031100]; aortic valve morphogenesis [GO:0003180]; apoptotic process involved in embryonic digit morphogenesis [GO:1902263]; arterial endothelial cell differentiation [GO:0060842]; astrocyte differentiation [GO:0048708]; atrioventricular node development [GO:0003162]; atrioventricular valve morphogenesis [GO:0003181]; auditory receptor cell fate commitment [GO:0009912]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; branching morphogenesis of an epithelial tube [GO:0048754]; camera-type eye morphogenesis [GO:0048593]; cardiac atrium morphogenesis [GO:0003209]; cardiac chamber formation [GO:0003207]; cardiac epithelial to mesenchymal transition [GO:0060317]; cardiac left ventricle morphogenesis [GO:0003214]; cardiac muscle cell myoblast differentiation [GO:0060379]; cardiac muscle cell proliferation [GO:0060038]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac right atrium morphogenesis [GO:0003213]; cardiac right ventricle formation [GO:0003219]; cardiac septum morphogenesis [GO:0060411]; cardiac vascular smooth muscle cell development [GO:0060948]; cardiac ventricle morphogenesis [GO:0003208]; cell differentiation [GO:0030154]; cell differentiation in spinal cord [GO:0021515]; cell fate commitment [GO:0045165]; cell fate specification [GO:0001708]; cell migration involved in endocardial cushion formation [GO:0003273]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to hypoxia [GO:0071456]; cellular response to tumor cell [GO:0071228]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; chemical synaptic transmission, postsynaptic [GO:0099565]; cilium assembly [GO:0060271]; collecting duct development [GO:0072044]; compartment pattern specification [GO:0007386]; coronary artery morphogenesis [GO:0060982]; coronary sinus valve morphogenesis [GO:0003182]; coronary vein morphogenesis [GO:0003169]; determination of left/right symmetry [GO:0007368]; distal tubule development [GO:0072017]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic limb morphogenesis [GO:0030326]; endocardial cell differentiation [GO:0060956]; endocardial cushion development [GO:0003197]; endocardial cushion morphogenesis [GO:0003203]; endocardium development [GO:0003157]; endocardium morphogenesis [GO:0003160]; endoderm development [GO:0007492]; epidermis development [GO:0008544]; epithelial to mesenchymal transition [GO:0001837]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; forebrain development [GO:0030900]; foregut morphogenesis [GO:0007440]; gene expression [GO:0010467]; glial cell differentiation [GO:0010001]; glomerular mesangial cell development [GO:0072144]; growth involved in heart morphogenesis [GO:0003241]; hair follicle morphogenesis [GO:0031069]; heart development [GO:0007507]; heart looping [GO:0001947]; heart trabecula morphogenesis [GO:0061384]; homeostasis of number of cells within a tissue [GO:0048873]; humoral immune response [GO:0006959]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; interleukin-17-mediated signaling pathway [GO:0097400]; keratinocyte differentiation [GO:0030216]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; lung development [GO:0030324]; luteolysis [GO:0001554]; mesenchymal cell development [GO:0014031]; mitral valve formation [GO:0003192]; negative regulation of anoikis [GO:2000811]; negative regulation of biomineral tissue development [GO:0070168]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of catalytic activity [GO:0043086]; negative regulation of cell adhesion molecule production [GO:0060354]; negative regulation of cell differentiation [GO:0045596]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell proliferation involved in heart valve morphogenesis [GO:0003252]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of collagen biosynthetic process [GO:0032966]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of endothelial cell chemotaxis [GO:2001027]; negative regulation of extracellular matrix constituent secretion [GO:0003332]; negative regulation of gene expression [GO:0010629]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of inner ear auditory receptor cell differentiation [GO:0045608]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of ossification [GO:0030279]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of photoreceptor cell differentiation [GO:0046533]; negative regulation of pro-B cell differentiation [GO:2000974]; negative regulation of programmed cell death [GO:0043069]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural tube development [GO:0021915]; neuron differentiation [GO:0030182]; neuron fate commitment [GO:0048663]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; oligodendrocyte differentiation [GO:0048709]; osteoblast fate commitment [GO:0002051]; outflow tract morphogenesis [GO:0003151]; pericardium morphogenesis [GO:0003344]; positive regulation of aorta morphogenesis [GO:1903849]; positive regulation of apoptotic process [GO:0043065]; positive regulation of apoptotic process involved in morphogenesis [GO:1902339]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cardiac epithelial to mesenchymal transition [GO:0062043]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of ephrin receptor signaling pathway [GO:1901189]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of glial cell differentiation [GO:0045687]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of smooth muscle cell differentiation [GO:0051152]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription of Notch receptor target [GO:0007221]; positive regulation of viral genome replication [GO:0045070]; prostate gland epithelium morphogenesis [GO:0060740]; protein catabolic process [GO:0030163]; protein import into nucleus [GO:0006606]; pulmonary valve morphogenesis [GO:0003184]; regulation of cardioblast proliferation [GO:0003264]; regulation of cell adhesion involved in heart morphogenesis [GO:0061344]; regulation of cell migration [GO:0030334]; regulation of cell population proliferation [GO:0042127]; regulation of epithelial cell proliferation [GO:0050678]; regulation of epithelial cell proliferation involved in prostate gland development [GO:0060768]; regulation of extracellular matrix assembly [GO:1901201]; regulation of gene expression [GO:0010468]; regulation of inner ear auditory receptor cell differentiation [GO:0045607]; regulation of neurogenesis [GO:0050767]; regulation of Notch signaling pathway [GO:0008593]; regulation of somitogenesis [GO:0014807]; regulation of transcription by RNA polymerase II [GO:0006357]; response to lipopolysaccharide [GO:0032496]; response to muramyl dipeptide [GO:0032495]; secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development [GO:0060528]; skeletal muscle cell differentiation [GO:0035914]; somatic stem cell division [GO:0048103]; spermatogenesis [GO:0007283]; sprouting angiogenesis [GO:0002040]; T-helper 17 type immune response [GO:0072538]; tissue regeneration [GO:0042246]; tube formation [GO:0035148]; vasculogenesis involved in coronary vascular morphogenesis [GO:0060979]; venous blood vessel morphogenesis [GO:0048845]; venous endothelial cell differentiation [GO:0060843]; ventricular septum morphogenesis [GO:0060412]; ventricular trabecula myocardium morphogenesis [GO:0003222] acrosomal vesicle [GO:0001669]; adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell periphery [GO:0071944]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; lamellipodium [GO:0030027]; late endosome membrane [GO:0031902]; MAML1-RBP-Jkappa- ICN1 complex [GO:0002193]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; receptor complex [GO:0043235]; ruffle [GO:0001726]; Schaffer collateral - CA1 synapse [GO:0098685] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; identical protein binding [GO:0042802]; Notch binding [GO:0005112]; transcription coactivator activity [GO:0003713]; transcription regulator activator activity [GO:0140537]; transmembrane signaling receptor activity [GO:0004888] g256.t5 Q01705 37.978 445 4.370000000000001e-59 231.0 sp|Q01705|NOTC1_MOUSE Neurogenic locus notch homolog protein 1 OS=Mus musculus OX=10090 GN=Notch1 PE=1 SV=3 NOTC1_MOUSE reviewed Neurogenic locus notch homolog protein 1 (Notch 1) (Motch A) (mT14) (p300) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Mus musculus (Mouse) GO:0000122; GO:0000139; GO:0001554; GO:0001669; GO:0001701; GO:0001708; GO:0001726; GO:0001837; GO:0001889; GO:0001947; GO:0002040; GO:0002051; GO:0002052; GO:0002193; GO:0002437; GO:0003151; GO:0003157; GO:0003160; GO:0003162; GO:0003169; GO:0003180; GO:0003181; GO:0003182; GO:0003184; GO:0003192; GO:0003197; GO:0003198; GO:0003203; GO:0003207; GO:0003208; GO:0003209; GO:0003213; GO:0003214; GO:0003219; GO:0003222; GO:0003241; GO:0003252; GO:0003264; GO:0003273; GO:0003332; GO:0003344; GO:0003682; GO:0003713; GO:0004857; GO:0004888; GO:0005112; GO:0005509; GO:0005576; GO:0005634; GO:0005654; GO:0005737; GO:0005783; GO:0005789; GO:0005829; GO:0005856; GO:0005886; GO:0005912; GO:0006357; GO:0006606; GO:0006959; GO:0007219; GO:0007221; GO:0007283; GO:0007368; GO:0007386; GO:0007409; GO:0007411; GO:0007440; GO:0007492; GO:0007507; GO:0008284; GO:0008285; GO:0008544; GO:0008593; GO:0009912; GO:0009986; GO:0010001; GO:0010008; GO:0010467; GO:0010468; GO:0010614; GO:0010628; GO:0010629; GO:0010667; GO:0010718; GO:0010812; GO:0010832; GO:0014031; GO:0014807; GO:0016324; GO:0019899; GO:0021515; GO:0021915; GO:0030027; GO:0030154; GO:0030163; GO:0030182; GO:0030216; GO:0030279; GO:0030324; GO:0030326; GO:0030334; GO:0030335; GO:0030513; GO:0030514; GO:0030900; GO:0031069; GO:0031100; GO:0031410; GO:0031490; GO:0031902; GO:0032495; GO:0032496; GO:0032966; GO:0035116; GO:0035148; GO:0035914; GO:0035924; GO:0042127; GO:0042246; GO:0042802; GO:0043065; GO:0043069; GO:0043086; GO:0043235; GO:0045070; GO:0045165; GO:0045596; GO:0045603; GO:0045607; GO:0045608; GO:0045618; GO:0045662; GO:0045665; GO:0045668; GO:0045687; GO:0045747; GO:0045892; GO:0045893; GO:0045944; GO:0045955; GO:0046427; GO:0046533; GO:0046579; GO:0048103; GO:0048593; GO:0048663; GO:0048708; GO:0048709; GO:0048711; GO:0048715; GO:0048754; GO:0048845; GO:0048873; GO:0050678; GO:0050679; GO:0050767; GO:0050768; GO:0051152; GO:0055008; GO:0060038; GO:0060045; GO:0060253; GO:0060271; GO:0060317; GO:0060354; GO:0060379; GO:0060411; GO:0060412; GO:0060528; GO:0060740; GO:0060768; GO:0060842; GO:0060843; GO:0060948; GO:0060956; GO:0060979; GO:0060982; GO:0061344; GO:0061384; GO:0062043; GO:0070168; GO:0070374; GO:0070986; GO:0071228; GO:0071372; GO:0071456; GO:0071944; GO:0072017; GO:0072044; GO:0072144; GO:0072538; GO:0090051; GO:0090090; GO:0097150; GO:0097400; GO:0098685; GO:0098839; GO:0098978; GO:0099565; GO:0120163; GO:0140537; GO:1901189; GO:1901201; GO:1902263; GO:1902339; GO:1903849; GO:2000048; GO:2000737; GO:2000811; GO:2000974; GO:2001027 animal organ regeneration [GO:0031100]; aortic valve morphogenesis [GO:0003180]; apoptotic process involved in embryonic digit morphogenesis [GO:1902263]; arterial endothelial cell differentiation [GO:0060842]; astrocyte differentiation [GO:0048708]; atrioventricular node development [GO:0003162]; atrioventricular valve morphogenesis [GO:0003181]; auditory receptor cell fate commitment [GO:0009912]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; branching morphogenesis of an epithelial tube [GO:0048754]; camera-type eye morphogenesis [GO:0048593]; cardiac atrium morphogenesis [GO:0003209]; cardiac chamber formation [GO:0003207]; cardiac epithelial to mesenchymal transition [GO:0060317]; cardiac left ventricle morphogenesis [GO:0003214]; cardiac muscle cell myoblast differentiation [GO:0060379]; cardiac muscle cell proliferation [GO:0060038]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac right atrium morphogenesis [GO:0003213]; cardiac right ventricle formation [GO:0003219]; cardiac septum morphogenesis [GO:0060411]; cardiac vascular smooth muscle cell development [GO:0060948]; cardiac ventricle morphogenesis [GO:0003208]; cell differentiation [GO:0030154]; cell differentiation in spinal cord [GO:0021515]; cell fate commitment [GO:0045165]; cell fate specification [GO:0001708]; cell migration involved in endocardial cushion formation [GO:0003273]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to hypoxia [GO:0071456]; cellular response to tumor cell [GO:0071228]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; chemical synaptic transmission, postsynaptic [GO:0099565]; cilium assembly [GO:0060271]; collecting duct development [GO:0072044]; compartment pattern specification [GO:0007386]; coronary artery morphogenesis [GO:0060982]; coronary sinus valve morphogenesis [GO:0003182]; coronary vein morphogenesis [GO:0003169]; determination of left/right symmetry [GO:0007368]; distal tubule development [GO:0072017]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic limb morphogenesis [GO:0030326]; endocardial cell differentiation [GO:0060956]; endocardial cushion development [GO:0003197]; endocardial cushion morphogenesis [GO:0003203]; endocardium development [GO:0003157]; endocardium morphogenesis [GO:0003160]; endoderm development [GO:0007492]; epidermis development [GO:0008544]; epithelial to mesenchymal transition [GO:0001837]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; forebrain development [GO:0030900]; foregut morphogenesis [GO:0007440]; gene expression [GO:0010467]; glial cell differentiation [GO:0010001]; glomerular mesangial cell development [GO:0072144]; growth involved in heart morphogenesis [GO:0003241]; hair follicle morphogenesis [GO:0031069]; heart development [GO:0007507]; heart looping [GO:0001947]; heart trabecula morphogenesis [GO:0061384]; homeostasis of number of cells within a tissue [GO:0048873]; humoral immune response [GO:0006959]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; interleukin-17-mediated signaling pathway [GO:0097400]; keratinocyte differentiation [GO:0030216]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; lung development [GO:0030324]; luteolysis [GO:0001554]; mesenchymal cell development [GO:0014031]; mitral valve formation [GO:0003192]; negative regulation of anoikis [GO:2000811]; negative regulation of biomineral tissue development [GO:0070168]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of catalytic activity [GO:0043086]; negative regulation of cell adhesion molecule production [GO:0060354]; negative regulation of cell differentiation [GO:0045596]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell proliferation involved in heart valve morphogenesis [GO:0003252]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of collagen biosynthetic process [GO:0032966]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of endothelial cell chemotaxis [GO:2001027]; negative regulation of extracellular matrix constituent secretion [GO:0003332]; negative regulation of gene expression [GO:0010629]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of inner ear auditory receptor cell differentiation [GO:0045608]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of ossification [GO:0030279]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of photoreceptor cell differentiation [GO:0046533]; negative regulation of pro-B cell differentiation [GO:2000974]; negative regulation of programmed cell death [GO:0043069]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural tube development [GO:0021915]; neuron differentiation [GO:0030182]; neuron fate commitment [GO:0048663]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; oligodendrocyte differentiation [GO:0048709]; osteoblast fate commitment [GO:0002051]; outflow tract morphogenesis [GO:0003151]; pericardium morphogenesis [GO:0003344]; positive regulation of aorta morphogenesis [GO:1903849]; positive regulation of apoptotic process [GO:0043065]; positive regulation of apoptotic process involved in morphogenesis [GO:1902339]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cardiac epithelial to mesenchymal transition [GO:0062043]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of ephrin receptor signaling pathway [GO:1901189]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of glial cell differentiation [GO:0045687]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of smooth muscle cell differentiation [GO:0051152]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription of Notch receptor target [GO:0007221]; positive regulation of viral genome replication [GO:0045070]; prostate gland epithelium morphogenesis [GO:0060740]; protein catabolic process [GO:0030163]; protein import into nucleus [GO:0006606]; pulmonary valve morphogenesis [GO:0003184]; regulation of cardioblast proliferation [GO:0003264]; regulation of cell adhesion involved in heart morphogenesis [GO:0061344]; regulation of cell migration [GO:0030334]; regulation of cell population proliferation [GO:0042127]; regulation of epithelial cell proliferation [GO:0050678]; regulation of epithelial cell proliferation involved in prostate gland development [GO:0060768]; regulation of extracellular matrix assembly [GO:1901201]; regulation of gene expression [GO:0010468]; regulation of inner ear auditory receptor cell differentiation [GO:0045607]; regulation of neurogenesis [GO:0050767]; regulation of Notch signaling pathway [GO:0008593]; regulation of somitogenesis [GO:0014807]; regulation of transcription by RNA polymerase II [GO:0006357]; response to lipopolysaccharide [GO:0032496]; response to muramyl dipeptide [GO:0032495]; secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development [GO:0060528]; skeletal muscle cell differentiation [GO:0035914]; somatic stem cell division [GO:0048103]; spermatogenesis [GO:0007283]; sprouting angiogenesis [GO:0002040]; T-helper 17 type immune response [GO:0072538]; tissue regeneration [GO:0042246]; tube formation [GO:0035148]; vasculogenesis involved in coronary vascular morphogenesis [GO:0060979]; venous blood vessel morphogenesis [GO:0048845]; venous endothelial cell differentiation [GO:0060843]; ventricular septum morphogenesis [GO:0060412]; ventricular trabecula myocardium morphogenesis [GO:0003222] acrosomal vesicle [GO:0001669]; adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell periphery [GO:0071944]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; lamellipodium [GO:0030027]; late endosome membrane [GO:0031902]; MAML1-RBP-Jkappa- ICN1 complex [GO:0002193]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; receptor complex [GO:0043235]; ruffle [GO:0001726]; Schaffer collateral - CA1 synapse [GO:0098685] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; identical protein binding [GO:0042802]; Notch binding [GO:0005112]; transcription coactivator activity [GO:0003713]; transcription regulator activator activity [GO:0140537]; transmembrane signaling receptor activity [GO:0004888] g256.t5 Q01705 42.484 153 6.5299999999999995e-24 115.0 sp|Q01705|NOTC1_MOUSE Neurogenic locus notch homolog protein 1 OS=Mus musculus OX=10090 GN=Notch1 PE=1 SV=3 NOTC1_MOUSE reviewed Neurogenic locus notch homolog protein 1 (Notch 1) (Motch A) (mT14) (p300) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Mus musculus (Mouse) GO:0000122; GO:0000139; GO:0001554; GO:0001669; GO:0001701; GO:0001708; GO:0001726; GO:0001837; GO:0001889; GO:0001947; GO:0002040; GO:0002051; GO:0002052; GO:0002193; GO:0002437; GO:0003151; GO:0003157; GO:0003160; GO:0003162; GO:0003169; GO:0003180; GO:0003181; GO:0003182; GO:0003184; GO:0003192; GO:0003197; GO:0003198; GO:0003203; GO:0003207; GO:0003208; GO:0003209; GO:0003213; GO:0003214; GO:0003219; GO:0003222; GO:0003241; GO:0003252; GO:0003264; GO:0003273; GO:0003332; GO:0003344; GO:0003682; GO:0003713; GO:0004857; GO:0004888; GO:0005112; GO:0005509; GO:0005576; GO:0005634; GO:0005654; GO:0005737; GO:0005783; GO:0005789; GO:0005829; GO:0005856; GO:0005886; GO:0005912; GO:0006357; GO:0006606; GO:0006959; GO:0007219; GO:0007221; GO:0007283; GO:0007368; GO:0007386; GO:0007409; GO:0007411; GO:0007440; GO:0007492; GO:0007507; GO:0008284; GO:0008285; GO:0008544; GO:0008593; GO:0009912; GO:0009986; GO:0010001; GO:0010008; GO:0010467; GO:0010468; GO:0010614; GO:0010628; GO:0010629; GO:0010667; GO:0010718; GO:0010812; GO:0010832; GO:0014031; GO:0014807; GO:0016324; GO:0019899; GO:0021515; GO:0021915; GO:0030027; GO:0030154; GO:0030163; GO:0030182; GO:0030216; GO:0030279; GO:0030324; GO:0030326; GO:0030334; GO:0030335; GO:0030513; GO:0030514; GO:0030900; GO:0031069; GO:0031100; GO:0031410; GO:0031490; GO:0031902; GO:0032495; GO:0032496; GO:0032966; GO:0035116; GO:0035148; GO:0035914; GO:0035924; GO:0042127; GO:0042246; GO:0042802; GO:0043065; GO:0043069; GO:0043086; GO:0043235; GO:0045070; GO:0045165; GO:0045596; GO:0045603; GO:0045607; GO:0045608; GO:0045618; GO:0045662; GO:0045665; GO:0045668; GO:0045687; GO:0045747; GO:0045892; GO:0045893; GO:0045944; GO:0045955; GO:0046427; GO:0046533; GO:0046579; GO:0048103; GO:0048593; GO:0048663; GO:0048708; GO:0048709; GO:0048711; GO:0048715; GO:0048754; GO:0048845; GO:0048873; GO:0050678; GO:0050679; GO:0050767; GO:0050768; GO:0051152; GO:0055008; GO:0060038; GO:0060045; GO:0060253; GO:0060271; GO:0060317; GO:0060354; GO:0060379; GO:0060411; GO:0060412; GO:0060528; GO:0060740; GO:0060768; GO:0060842; GO:0060843; GO:0060948; GO:0060956; GO:0060979; GO:0060982; GO:0061344; GO:0061384; GO:0062043; GO:0070168; GO:0070374; GO:0070986; GO:0071228; GO:0071372; GO:0071456; GO:0071944; GO:0072017; GO:0072044; GO:0072144; GO:0072538; GO:0090051; GO:0090090; GO:0097150; GO:0097400; GO:0098685; GO:0098839; GO:0098978; GO:0099565; GO:0120163; GO:0140537; GO:1901189; GO:1901201; GO:1902263; GO:1902339; GO:1903849; GO:2000048; GO:2000737; GO:2000811; GO:2000974; GO:2001027 animal organ regeneration [GO:0031100]; aortic valve morphogenesis [GO:0003180]; apoptotic process involved in embryonic digit morphogenesis [GO:1902263]; arterial endothelial cell differentiation [GO:0060842]; astrocyte differentiation [GO:0048708]; atrioventricular node development [GO:0003162]; atrioventricular valve morphogenesis [GO:0003181]; auditory receptor cell fate commitment [GO:0009912]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; branching morphogenesis of an epithelial tube [GO:0048754]; camera-type eye morphogenesis [GO:0048593]; cardiac atrium morphogenesis [GO:0003209]; cardiac chamber formation [GO:0003207]; cardiac epithelial to mesenchymal transition [GO:0060317]; cardiac left ventricle morphogenesis [GO:0003214]; cardiac muscle cell myoblast differentiation [GO:0060379]; cardiac muscle cell proliferation [GO:0060038]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac right atrium morphogenesis [GO:0003213]; cardiac right ventricle formation [GO:0003219]; cardiac septum morphogenesis [GO:0060411]; cardiac vascular smooth muscle cell development [GO:0060948]; cardiac ventricle morphogenesis [GO:0003208]; cell differentiation [GO:0030154]; cell differentiation in spinal cord [GO:0021515]; cell fate commitment [GO:0045165]; cell fate specification [GO:0001708]; cell migration involved in endocardial cushion formation [GO:0003273]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to hypoxia [GO:0071456]; cellular response to tumor cell [GO:0071228]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; chemical synaptic transmission, postsynaptic [GO:0099565]; cilium assembly [GO:0060271]; collecting duct development [GO:0072044]; compartment pattern specification [GO:0007386]; coronary artery morphogenesis [GO:0060982]; coronary sinus valve morphogenesis [GO:0003182]; coronary vein morphogenesis [GO:0003169]; determination of left/right symmetry [GO:0007368]; distal tubule development [GO:0072017]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic limb morphogenesis [GO:0030326]; endocardial cell differentiation [GO:0060956]; endocardial cushion development [GO:0003197]; endocardial cushion morphogenesis [GO:0003203]; endocardium development [GO:0003157]; endocardium morphogenesis [GO:0003160]; endoderm development [GO:0007492]; epidermis development [GO:0008544]; epithelial to mesenchymal transition [GO:0001837]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; forebrain development [GO:0030900]; foregut morphogenesis [GO:0007440]; gene expression [GO:0010467]; glial cell differentiation [GO:0010001]; glomerular mesangial cell development [GO:0072144]; growth involved in heart morphogenesis [GO:0003241]; hair follicle morphogenesis [GO:0031069]; heart development [GO:0007507]; heart looping [GO:0001947]; heart trabecula morphogenesis [GO:0061384]; homeostasis of number of cells within a tissue [GO:0048873]; humoral immune response [GO:0006959]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; interleukin-17-mediated signaling pathway [GO:0097400]; keratinocyte differentiation [GO:0030216]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; lung development [GO:0030324]; luteolysis [GO:0001554]; mesenchymal cell development [GO:0014031]; mitral valve formation [GO:0003192]; negative regulation of anoikis [GO:2000811]; negative regulation of biomineral tissue development [GO:0070168]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of catalytic activity [GO:0043086]; negative regulation of cell adhesion molecule production [GO:0060354]; negative regulation of cell differentiation [GO:0045596]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell proliferation involved in heart valve morphogenesis [GO:0003252]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of collagen biosynthetic process [GO:0032966]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of endothelial cell chemotaxis [GO:2001027]; negative regulation of extracellular matrix constituent secretion [GO:0003332]; negative regulation of gene expression [GO:0010629]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of inner ear auditory receptor cell differentiation [GO:0045608]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of ossification [GO:0030279]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of photoreceptor cell differentiation [GO:0046533]; negative regulation of pro-B cell differentiation [GO:2000974]; negative regulation of programmed cell death [GO:0043069]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural tube development [GO:0021915]; neuron differentiation [GO:0030182]; neuron fate commitment [GO:0048663]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; oligodendrocyte differentiation [GO:0048709]; osteoblast fate commitment [GO:0002051]; outflow tract morphogenesis [GO:0003151]; pericardium morphogenesis [GO:0003344]; positive regulation of aorta morphogenesis [GO:1903849]; positive regulation of apoptotic process [GO:0043065]; positive regulation of apoptotic process involved in morphogenesis [GO:1902339]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cardiac epithelial to mesenchymal transition [GO:0062043]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of ephrin receptor signaling pathway [GO:1901189]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of glial cell differentiation [GO:0045687]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of smooth muscle cell differentiation [GO:0051152]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription of Notch receptor target [GO:0007221]; positive regulation of viral genome replication [GO:0045070]; prostate gland epithelium morphogenesis [GO:0060740]; protein catabolic process [GO:0030163]; protein import into nucleus [GO:0006606]; pulmonary valve morphogenesis [GO:0003184]; regulation of cardioblast proliferation [GO:0003264]; regulation of cell adhesion involved in heart morphogenesis [GO:0061344]; regulation of cell migration [GO:0030334]; regulation of cell population proliferation [GO:0042127]; regulation of epithelial cell proliferation [GO:0050678]; regulation of epithelial cell proliferation involved in prostate gland development [GO:0060768]; regulation of extracellular matrix assembly [GO:1901201]; regulation of gene expression [GO:0010468]; regulation of inner ear auditory receptor cell differentiation [GO:0045607]; regulation of neurogenesis [GO:0050767]; regulation of Notch signaling pathway [GO:0008593]; regulation of somitogenesis [GO:0014807]; regulation of transcription by RNA polymerase II [GO:0006357]; response to lipopolysaccharide [GO:0032496]; response to muramyl dipeptide [GO:0032495]; secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development [GO:0060528]; skeletal muscle cell differentiation [GO:0035914]; somatic stem cell division [GO:0048103]; spermatogenesis [GO:0007283]; sprouting angiogenesis [GO:0002040]; T-helper 17 type immune response [GO:0072538]; tissue regeneration [GO:0042246]; tube formation [GO:0035148]; vasculogenesis involved in coronary vascular morphogenesis [GO:0060979]; venous blood vessel morphogenesis [GO:0048845]; venous endothelial cell differentiation [GO:0060843]; ventricular septum morphogenesis [GO:0060412]; ventricular trabecula myocardium morphogenesis [GO:0003222] acrosomal vesicle [GO:0001669]; adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell periphery [GO:0071944]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; lamellipodium [GO:0030027]; late endosome membrane [GO:0031902]; MAML1-RBP-Jkappa- ICN1 complex [GO:0002193]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; receptor complex [GO:0043235]; ruffle [GO:0001726]; Schaffer collateral - CA1 synapse [GO:0098685] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; identical protein binding [GO:0042802]; Notch binding [GO:0005112]; transcription coactivator activity [GO:0003713]; transcription regulator activator activity [GO:0140537]; transmembrane signaling receptor activity [GO:0004888] g256.t5 Q01705 41.176 153 4.39e-22 109.0 sp|Q01705|NOTC1_MOUSE Neurogenic locus notch homolog protein 1 OS=Mus musculus OX=10090 GN=Notch1 PE=1 SV=3 NOTC1_MOUSE reviewed Neurogenic locus notch homolog protein 1 (Notch 1) (Motch A) (mT14) (p300) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Mus musculus (Mouse) GO:0000122; GO:0000139; GO:0001554; GO:0001669; GO:0001701; GO:0001708; GO:0001726; GO:0001837; GO:0001889; GO:0001947; GO:0002040; GO:0002051; GO:0002052; GO:0002193; GO:0002437; GO:0003151; GO:0003157; GO:0003160; GO:0003162; GO:0003169; GO:0003180; GO:0003181; GO:0003182; GO:0003184; GO:0003192; GO:0003197; GO:0003198; GO:0003203; GO:0003207; GO:0003208; GO:0003209; GO:0003213; GO:0003214; GO:0003219; GO:0003222; GO:0003241; GO:0003252; GO:0003264; GO:0003273; GO:0003332; GO:0003344; GO:0003682; GO:0003713; GO:0004857; GO:0004888; GO:0005112; GO:0005509; GO:0005576; GO:0005634; GO:0005654; GO:0005737; GO:0005783; GO:0005789; GO:0005829; GO:0005856; GO:0005886; GO:0005912; GO:0006357; GO:0006606; GO:0006959; GO:0007219; GO:0007221; GO:0007283; GO:0007368; GO:0007386; GO:0007409; GO:0007411; GO:0007440; GO:0007492; GO:0007507; GO:0008284; GO:0008285; GO:0008544; GO:0008593; GO:0009912; GO:0009986; GO:0010001; GO:0010008; GO:0010467; GO:0010468; GO:0010614; GO:0010628; GO:0010629; GO:0010667; GO:0010718; GO:0010812; GO:0010832; GO:0014031; GO:0014807; GO:0016324; GO:0019899; GO:0021515; GO:0021915; GO:0030027; GO:0030154; GO:0030163; GO:0030182; GO:0030216; GO:0030279; GO:0030324; GO:0030326; GO:0030334; GO:0030335; GO:0030513; GO:0030514; GO:0030900; GO:0031069; GO:0031100; GO:0031410; GO:0031490; GO:0031902; GO:0032495; GO:0032496; GO:0032966; GO:0035116; GO:0035148; GO:0035914; GO:0035924; GO:0042127; GO:0042246; GO:0042802; GO:0043065; GO:0043069; GO:0043086; GO:0043235; GO:0045070; GO:0045165; GO:0045596; GO:0045603; GO:0045607; GO:0045608; GO:0045618; GO:0045662; GO:0045665; GO:0045668; GO:0045687; GO:0045747; GO:0045892; GO:0045893; GO:0045944; GO:0045955; GO:0046427; GO:0046533; GO:0046579; GO:0048103; GO:0048593; GO:0048663; GO:0048708; GO:0048709; GO:0048711; GO:0048715; GO:0048754; GO:0048845; GO:0048873; GO:0050678; GO:0050679; GO:0050767; GO:0050768; GO:0051152; GO:0055008; GO:0060038; GO:0060045; GO:0060253; GO:0060271; GO:0060317; GO:0060354; GO:0060379; GO:0060411; GO:0060412; GO:0060528; GO:0060740; GO:0060768; GO:0060842; GO:0060843; GO:0060948; GO:0060956; GO:0060979; GO:0060982; GO:0061344; GO:0061384; GO:0062043; GO:0070168; GO:0070374; GO:0070986; GO:0071228; GO:0071372; GO:0071456; GO:0071944; GO:0072017; GO:0072044; GO:0072144; GO:0072538; GO:0090051; GO:0090090; GO:0097150; GO:0097400; GO:0098685; GO:0098839; GO:0098978; GO:0099565; GO:0120163; GO:0140537; GO:1901189; GO:1901201; GO:1902263; GO:1902339; GO:1903849; GO:2000048; GO:2000737; GO:2000811; GO:2000974; GO:2001027 animal organ regeneration [GO:0031100]; aortic valve morphogenesis [GO:0003180]; apoptotic process involved in embryonic digit morphogenesis [GO:1902263]; arterial endothelial cell differentiation [GO:0060842]; astrocyte differentiation [GO:0048708]; atrioventricular node development [GO:0003162]; atrioventricular valve morphogenesis [GO:0003181]; auditory receptor cell fate commitment [GO:0009912]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; branching morphogenesis of an epithelial tube [GO:0048754]; camera-type eye morphogenesis [GO:0048593]; cardiac atrium morphogenesis [GO:0003209]; cardiac chamber formation [GO:0003207]; cardiac epithelial to mesenchymal transition [GO:0060317]; cardiac left ventricle morphogenesis [GO:0003214]; cardiac muscle cell myoblast differentiation [GO:0060379]; cardiac muscle cell proliferation [GO:0060038]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac right atrium morphogenesis [GO:0003213]; cardiac right ventricle formation [GO:0003219]; cardiac septum morphogenesis [GO:0060411]; cardiac vascular smooth muscle cell development [GO:0060948]; cardiac ventricle morphogenesis [GO:0003208]; cell differentiation [GO:0030154]; cell differentiation in spinal cord [GO:0021515]; cell fate commitment [GO:0045165]; cell fate specification [GO:0001708]; cell migration involved in endocardial cushion formation [GO:0003273]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to hypoxia [GO:0071456]; cellular response to tumor cell [GO:0071228]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; chemical synaptic transmission, postsynaptic [GO:0099565]; cilium assembly [GO:0060271]; collecting duct development [GO:0072044]; compartment pattern specification [GO:0007386]; coronary artery morphogenesis [GO:0060982]; coronary sinus valve morphogenesis [GO:0003182]; coronary vein morphogenesis [GO:0003169]; determination of left/right symmetry [GO:0007368]; distal tubule development [GO:0072017]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic limb morphogenesis [GO:0030326]; endocardial cell differentiation [GO:0060956]; endocardial cushion development [GO:0003197]; endocardial cushion morphogenesis [GO:0003203]; endocardium development [GO:0003157]; endocardium morphogenesis [GO:0003160]; endoderm development [GO:0007492]; epidermis development [GO:0008544]; epithelial to mesenchymal transition [GO:0001837]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; forebrain development [GO:0030900]; foregut morphogenesis [GO:0007440]; gene expression [GO:0010467]; glial cell differentiation [GO:0010001]; glomerular mesangial cell development [GO:0072144]; growth involved in heart morphogenesis [GO:0003241]; hair follicle morphogenesis [GO:0031069]; heart development [GO:0007507]; heart looping [GO:0001947]; heart trabecula morphogenesis [GO:0061384]; homeostasis of number of cells within a tissue [GO:0048873]; humoral immune response [GO:0006959]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; interleukin-17-mediated signaling pathway [GO:0097400]; keratinocyte differentiation [GO:0030216]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; lung development [GO:0030324]; luteolysis [GO:0001554]; mesenchymal cell development [GO:0014031]; mitral valve formation [GO:0003192]; negative regulation of anoikis [GO:2000811]; negative regulation of biomineral tissue development [GO:0070168]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of catalytic activity [GO:0043086]; negative regulation of cell adhesion molecule production [GO:0060354]; negative regulation of cell differentiation [GO:0045596]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell proliferation involved in heart valve morphogenesis [GO:0003252]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of collagen biosynthetic process [GO:0032966]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of endothelial cell chemotaxis [GO:2001027]; negative regulation of extracellular matrix constituent secretion [GO:0003332]; negative regulation of gene expression [GO:0010629]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of inner ear auditory receptor cell differentiation [GO:0045608]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of ossification [GO:0030279]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of photoreceptor cell differentiation [GO:0046533]; negative regulation of pro-B cell differentiation [GO:2000974]; negative regulation of programmed cell death [GO:0043069]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural tube development [GO:0021915]; neuron differentiation [GO:0030182]; neuron fate commitment [GO:0048663]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; oligodendrocyte differentiation [GO:0048709]; osteoblast fate commitment [GO:0002051]; outflow tract morphogenesis [GO:0003151]; pericardium morphogenesis [GO:0003344]; positive regulation of aorta morphogenesis [GO:1903849]; positive regulation of apoptotic process [GO:0043065]; positive regulation of apoptotic process involved in morphogenesis [GO:1902339]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cardiac epithelial to mesenchymal transition [GO:0062043]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of ephrin receptor signaling pathway [GO:1901189]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of glial cell differentiation [GO:0045687]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of smooth muscle cell differentiation [GO:0051152]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription of Notch receptor target [GO:0007221]; positive regulation of viral genome replication [GO:0045070]; prostate gland epithelium morphogenesis [GO:0060740]; protein catabolic process [GO:0030163]; protein import into nucleus [GO:0006606]; pulmonary valve morphogenesis [GO:0003184]; regulation of cardioblast proliferation [GO:0003264]; regulation of cell adhesion involved in heart morphogenesis [GO:0061344]; regulation of cell migration [GO:0030334]; regulation of cell population proliferation [GO:0042127]; regulation of epithelial cell proliferation [GO:0050678]; regulation of epithelial cell proliferation involved in prostate gland development [GO:0060768]; regulation of extracellular matrix assembly [GO:1901201]; regulation of gene expression [GO:0010468]; regulation of inner ear auditory receptor cell differentiation [GO:0045607]; regulation of neurogenesis [GO:0050767]; regulation of Notch signaling pathway [GO:0008593]; regulation of somitogenesis [GO:0014807]; regulation of transcription by RNA polymerase II [GO:0006357]; response to lipopolysaccharide [GO:0032496]; response to muramyl dipeptide [GO:0032495]; secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development [GO:0060528]; skeletal muscle cell differentiation [GO:0035914]; somatic stem cell division [GO:0048103]; spermatogenesis [GO:0007283]; sprouting angiogenesis [GO:0002040]; T-helper 17 type immune response [GO:0072538]; tissue regeneration [GO:0042246]; tube formation [GO:0035148]; vasculogenesis involved in coronary vascular morphogenesis [GO:0060979]; venous blood vessel morphogenesis [GO:0048845]; venous endothelial cell differentiation [GO:0060843]; ventricular septum morphogenesis [GO:0060412]; ventricular trabecula myocardium morphogenesis [GO:0003222] acrosomal vesicle [GO:0001669]; adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell periphery [GO:0071944]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; lamellipodium [GO:0030027]; late endosome membrane [GO:0031902]; MAML1-RBP-Jkappa- ICN1 complex [GO:0002193]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; receptor complex [GO:0043235]; ruffle [GO:0001726]; Schaffer collateral - CA1 synapse [GO:0098685] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; identical protein binding [GO:0042802]; Notch binding [GO:0005112]; transcription coactivator activity [GO:0003713]; transcription regulator activator activity [GO:0140537]; transmembrane signaling receptor activity [GO:0004888] g256.t5 Q01705 41.176 153 2.4000000000000003e-21 107.0 sp|Q01705|NOTC1_MOUSE Neurogenic locus notch homolog protein 1 OS=Mus musculus OX=10090 GN=Notch1 PE=1 SV=3 NOTC1_MOUSE reviewed Neurogenic locus notch homolog protein 1 (Notch 1) (Motch A) (mT14) (p300) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Mus musculus (Mouse) GO:0000122; GO:0000139; GO:0001554; GO:0001669; GO:0001701; GO:0001708; GO:0001726; GO:0001837; GO:0001889; GO:0001947; GO:0002040; GO:0002051; GO:0002052; GO:0002193; GO:0002437; GO:0003151; GO:0003157; GO:0003160; GO:0003162; GO:0003169; GO:0003180; GO:0003181; GO:0003182; GO:0003184; GO:0003192; GO:0003197; GO:0003198; GO:0003203; GO:0003207; GO:0003208; GO:0003209; GO:0003213; GO:0003214; GO:0003219; GO:0003222; GO:0003241; GO:0003252; GO:0003264; GO:0003273; GO:0003332; GO:0003344; GO:0003682; GO:0003713; GO:0004857; GO:0004888; GO:0005112; GO:0005509; GO:0005576; GO:0005634; GO:0005654; GO:0005737; GO:0005783; GO:0005789; GO:0005829; GO:0005856; GO:0005886; GO:0005912; GO:0006357; GO:0006606; GO:0006959; GO:0007219; GO:0007221; GO:0007283; GO:0007368; GO:0007386; GO:0007409; GO:0007411; GO:0007440; GO:0007492; GO:0007507; GO:0008284; GO:0008285; GO:0008544; GO:0008593; GO:0009912; GO:0009986; GO:0010001; GO:0010008; GO:0010467; GO:0010468; GO:0010614; GO:0010628; GO:0010629; GO:0010667; GO:0010718; GO:0010812; GO:0010832; GO:0014031; GO:0014807; GO:0016324; GO:0019899; GO:0021515; GO:0021915; GO:0030027; GO:0030154; GO:0030163; GO:0030182; GO:0030216; GO:0030279; GO:0030324; GO:0030326; GO:0030334; GO:0030335; GO:0030513; GO:0030514; GO:0030900; GO:0031069; GO:0031100; GO:0031410; GO:0031490; GO:0031902; GO:0032495; GO:0032496; GO:0032966; GO:0035116; GO:0035148; GO:0035914; GO:0035924; GO:0042127; GO:0042246; GO:0042802; GO:0043065; GO:0043069; GO:0043086; GO:0043235; GO:0045070; GO:0045165; GO:0045596; GO:0045603; GO:0045607; GO:0045608; GO:0045618; GO:0045662; GO:0045665; GO:0045668; GO:0045687; GO:0045747; GO:0045892; GO:0045893; GO:0045944; GO:0045955; GO:0046427; GO:0046533; GO:0046579; GO:0048103; GO:0048593; GO:0048663; GO:0048708; GO:0048709; GO:0048711; GO:0048715; GO:0048754; GO:0048845; GO:0048873; GO:0050678; GO:0050679; GO:0050767; GO:0050768; GO:0051152; GO:0055008; GO:0060038; GO:0060045; GO:0060253; GO:0060271; GO:0060317; GO:0060354; GO:0060379; GO:0060411; GO:0060412; GO:0060528; GO:0060740; GO:0060768; GO:0060842; GO:0060843; GO:0060948; GO:0060956; GO:0060979; GO:0060982; GO:0061344; GO:0061384; GO:0062043; GO:0070168; GO:0070374; GO:0070986; GO:0071228; GO:0071372; GO:0071456; GO:0071944; GO:0072017; GO:0072044; GO:0072144; GO:0072538; GO:0090051; GO:0090090; GO:0097150; GO:0097400; GO:0098685; GO:0098839; GO:0098978; GO:0099565; GO:0120163; GO:0140537; GO:1901189; GO:1901201; GO:1902263; GO:1902339; GO:1903849; GO:2000048; GO:2000737; GO:2000811; GO:2000974; GO:2001027 animal organ regeneration [GO:0031100]; aortic valve morphogenesis [GO:0003180]; apoptotic process involved in embryonic digit morphogenesis [GO:1902263]; arterial endothelial cell differentiation [GO:0060842]; astrocyte differentiation [GO:0048708]; atrioventricular node development [GO:0003162]; atrioventricular valve morphogenesis [GO:0003181]; auditory receptor cell fate commitment [GO:0009912]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; branching morphogenesis of an epithelial tube [GO:0048754]; camera-type eye morphogenesis [GO:0048593]; cardiac atrium morphogenesis [GO:0003209]; cardiac chamber formation [GO:0003207]; cardiac epithelial to mesenchymal transition [GO:0060317]; cardiac left ventricle morphogenesis [GO:0003214]; cardiac muscle cell myoblast differentiation [GO:0060379]; cardiac muscle cell proliferation [GO:0060038]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac right atrium morphogenesis [GO:0003213]; cardiac right ventricle formation [GO:0003219]; cardiac septum morphogenesis [GO:0060411]; cardiac vascular smooth muscle cell development [GO:0060948]; cardiac ventricle morphogenesis [GO:0003208]; cell differentiation [GO:0030154]; cell differentiation in spinal cord [GO:0021515]; cell fate commitment [GO:0045165]; cell fate specification [GO:0001708]; cell migration involved in endocardial cushion formation [GO:0003273]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to hypoxia [GO:0071456]; cellular response to tumor cell [GO:0071228]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; chemical synaptic transmission, postsynaptic [GO:0099565]; cilium assembly [GO:0060271]; collecting duct development [GO:0072044]; compartment pattern specification [GO:0007386]; coronary artery morphogenesis [GO:0060982]; coronary sinus valve morphogenesis [GO:0003182]; coronary vein morphogenesis [GO:0003169]; determination of left/right symmetry [GO:0007368]; distal tubule development [GO:0072017]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic limb morphogenesis [GO:0030326]; endocardial cell differentiation [GO:0060956]; endocardial cushion development [GO:0003197]; endocardial cushion morphogenesis [GO:0003203]; endocardium development [GO:0003157]; endocardium morphogenesis [GO:0003160]; endoderm development [GO:0007492]; epidermis development [GO:0008544]; epithelial to mesenchymal transition [GO:0001837]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; forebrain development [GO:0030900]; foregut morphogenesis [GO:0007440]; gene expression [GO:0010467]; glial cell differentiation [GO:0010001]; glomerular mesangial cell development [GO:0072144]; growth involved in heart morphogenesis [GO:0003241]; hair follicle morphogenesis [GO:0031069]; heart development [GO:0007507]; heart looping [GO:0001947]; heart trabecula morphogenesis [GO:0061384]; homeostasis of number of cells within a tissue [GO:0048873]; humoral immune response [GO:0006959]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; interleukin-17-mediated signaling pathway [GO:0097400]; keratinocyte differentiation [GO:0030216]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; lung development [GO:0030324]; luteolysis [GO:0001554]; mesenchymal cell development [GO:0014031]; mitral valve formation [GO:0003192]; negative regulation of anoikis [GO:2000811]; negative regulation of biomineral tissue development [GO:0070168]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of catalytic activity [GO:0043086]; negative regulation of cell adhesion molecule production [GO:0060354]; negative regulation of cell differentiation [GO:0045596]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell proliferation involved in heart valve morphogenesis [GO:0003252]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of collagen biosynthetic process [GO:0032966]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of endothelial cell chemotaxis [GO:2001027]; negative regulation of extracellular matrix constituent secretion [GO:0003332]; negative regulation of gene expression [GO:0010629]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of inner ear auditory receptor cell differentiation [GO:0045608]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of ossification [GO:0030279]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of photoreceptor cell differentiation [GO:0046533]; negative regulation of pro-B cell differentiation [GO:2000974]; negative regulation of programmed cell death [GO:0043069]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural tube development [GO:0021915]; neuron differentiation [GO:0030182]; neuron fate commitment [GO:0048663]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; oligodendrocyte differentiation [GO:0048709]; osteoblast fate commitment [GO:0002051]; outflow tract morphogenesis [GO:0003151]; pericardium morphogenesis [GO:0003344]; positive regulation of aorta morphogenesis [GO:1903849]; positive regulation of apoptotic process [GO:0043065]; positive regulation of apoptotic process involved in morphogenesis [GO:1902339]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cardiac epithelial to mesenchymal transition [GO:0062043]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of ephrin receptor signaling pathway [GO:1901189]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of glial cell differentiation [GO:0045687]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of smooth muscle cell differentiation [GO:0051152]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription of Notch receptor target [GO:0007221]; positive regulation of viral genome replication [GO:0045070]; prostate gland epithelium morphogenesis [GO:0060740]; protein catabolic process [GO:0030163]; protein import into nucleus [GO:0006606]; pulmonary valve morphogenesis [GO:0003184]; regulation of cardioblast proliferation [GO:0003264]; regulation of cell adhesion involved in heart morphogenesis [GO:0061344]; regulation of cell migration [GO:0030334]; regulation of cell population proliferation [GO:0042127]; regulation of epithelial cell proliferation [GO:0050678]; regulation of epithelial cell proliferation involved in prostate gland development [GO:0060768]; regulation of extracellular matrix assembly [GO:1901201]; regulation of gene expression [GO:0010468]; regulation of inner ear auditory receptor cell differentiation [GO:0045607]; regulation of neurogenesis [GO:0050767]; regulation of Notch signaling pathway [GO:0008593]; regulation of somitogenesis [GO:0014807]; regulation of transcription by RNA polymerase II [GO:0006357]; response to lipopolysaccharide [GO:0032496]; response to muramyl dipeptide [GO:0032495]; secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development [GO:0060528]; skeletal muscle cell differentiation [GO:0035914]; somatic stem cell division [GO:0048103]; spermatogenesis [GO:0007283]; sprouting angiogenesis [GO:0002040]; T-helper 17 type immune response [GO:0072538]; tissue regeneration [GO:0042246]; tube formation [GO:0035148]; vasculogenesis involved in coronary vascular morphogenesis [GO:0060979]; venous blood vessel morphogenesis [GO:0048845]; venous endothelial cell differentiation [GO:0060843]; ventricular septum morphogenesis [GO:0060412]; ventricular trabecula myocardium morphogenesis [GO:0003222] acrosomal vesicle [GO:0001669]; adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell periphery [GO:0071944]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; lamellipodium [GO:0030027]; late endosome membrane [GO:0031902]; MAML1-RBP-Jkappa- ICN1 complex [GO:0002193]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; receptor complex [GO:0043235]; ruffle [GO:0001726]; Schaffer collateral - CA1 synapse [GO:0098685] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; identical protein binding [GO:0042802]; Notch binding [GO:0005112]; transcription coactivator activity [GO:0003713]; transcription regulator activator activity [GO:0140537]; transmembrane signaling receptor activity [GO:0004888] g257.t1 Q80T74 26.374 455 1.02e-42 162.0 sp|Q80T74|KLH29_MOUSE Kelch-like protein 29 OS=Mus musculus OX=10090 GN=Klhl29 PE=2 SV=3 KLH29_MOUSE reviewed Kelch-like protein 29 (Kelch repeat and BTB domain-containing protein 9) Mus musculus (Mouse) GO:0005737; GO:0031463; GO:0043161; GO:1990756 proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161] Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737] ubiquitin-like ligase-substrate adaptor activity [GO:1990756] g259.t1 Q60738 37.121 264 5.11e-43 161.0 sp|Q60738|ZNT1_MOUSE Proton-coupled zinc antiporter SLC30A1 OS=Mus musculus OX=10090 GN=Slc30a1 PE=1 SV=1 ZNT1_MOUSE reviewed Proton-coupled zinc antiporter SLC30A1 (Solute carrier family 30 member 1) (Zinc transporter 1) (ZnT-1) Mus musculus (Mouse) GO:0000139; GO:0001701; GO:0005385; GO:0005737; GO:0005783; GO:0005789; GO:0005794; GO:0005886; GO:0006829; GO:0006874; GO:0006882; GO:0010312; GO:0016020; GO:0016323; GO:0019855; GO:0030315; GO:0030425; GO:0030659; GO:0031965; GO:0042742; GO:0046872; GO:0046929; GO:0061003; GO:0062111; GO:0070509; GO:0070574; GO:0071577; GO:0071584; GO:0071585; GO:0090281; GO:0098685; GO:0098839; GO:0099092; GO:0099573; GO:0140826; GO:0140882; GO:1902897 cadmium ion transmembrane transport [GO:0070574]; calcium ion import [GO:0070509]; defense response to bacterium [GO:0042742]; detoxification of cadmium ion [GO:0071585]; detoxification of zinc ion [GO:0010312]; in utero embryonic development [GO:0001701]; intracellular calcium ion homeostasis [GO:0006874]; intracellular zinc ion homeostasis [GO:0006882]; negative regulation of calcium ion import [GO:0090281]; negative regulation of neurotransmitter secretion [GO:0046929]; negative regulation of zinc ion transmembrane import [GO:0071584]; positive regulation of dendritic spine morphogenesis [GO:0061003]; regulation of postsynaptic density protein 95 clustering [GO:1902897]; zinc export across plasma membrane [GO:0140882]; zinc ion import into organelle [GO:0062111]; zinc ion transmembrane transport [GO:0071577]; zinc ion transport [GO:0006829] basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; glutamatergic postsynaptic density [GO:0099573]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; postsynaptic density, intracellular component [GO:0099092]; Schaffer collateral - CA1 synapse [GO:0098685]; T-tubule [GO:0030315] calcium channel inhibitor activity [GO:0019855]; metal ion binding [GO:0046872]; zinc ion transmembrane transporter activity [GO:0005385]; zinc:proton antiporter activity [GO:0140826] g259.t1 Q60738 50.0 114 1.04e-25 112.0 sp|Q60738|ZNT1_MOUSE Proton-coupled zinc antiporter SLC30A1 OS=Mus musculus OX=10090 GN=Slc30a1 PE=1 SV=1 ZNT1_MOUSE reviewed Proton-coupled zinc antiporter SLC30A1 (Solute carrier family 30 member 1) (Zinc transporter 1) (ZnT-1) Mus musculus (Mouse) GO:0000139; GO:0001701; GO:0005385; GO:0005737; GO:0005783; GO:0005789; GO:0005794; GO:0005886; GO:0006829; GO:0006874; GO:0006882; GO:0010312; GO:0016020; GO:0016323; GO:0019855; GO:0030315; GO:0030425; GO:0030659; GO:0031965; GO:0042742; GO:0046872; GO:0046929; GO:0061003; GO:0062111; GO:0070509; GO:0070574; GO:0071577; GO:0071584; GO:0071585; GO:0090281; GO:0098685; GO:0098839; GO:0099092; GO:0099573; GO:0140826; GO:0140882; GO:1902897 cadmium ion transmembrane transport [GO:0070574]; calcium ion import [GO:0070509]; defense response to bacterium [GO:0042742]; detoxification of cadmium ion [GO:0071585]; detoxification of zinc ion [GO:0010312]; in utero embryonic development [GO:0001701]; intracellular calcium ion homeostasis [GO:0006874]; intracellular zinc ion homeostasis [GO:0006882]; negative regulation of calcium ion import [GO:0090281]; negative regulation of neurotransmitter secretion [GO:0046929]; negative regulation of zinc ion transmembrane import [GO:0071584]; positive regulation of dendritic spine morphogenesis [GO:0061003]; regulation of postsynaptic density protein 95 clustering [GO:1902897]; zinc export across plasma membrane [GO:0140882]; zinc ion import into organelle [GO:0062111]; zinc ion transmembrane transport [GO:0071577]; zinc ion transport [GO:0006829] basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; glutamatergic postsynaptic density [GO:0099573]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; postsynaptic density, intracellular component [GO:0099092]; Schaffer collateral - CA1 synapse [GO:0098685]; T-tubule [GO:0030315] calcium channel inhibitor activity [GO:0019855]; metal ion binding [GO:0046872]; zinc ion transmembrane transporter activity [GO:0005385]; zinc:proton antiporter activity [GO:0140826] g260.t1 Q9VBW3 40.283 283 1.48e-61 229.0 sp|Q9VBW3|CAD96_DROME Tyrosine kinase receptor Cad96Ca OS=Drosophila melanogaster OX=7227 GN=Cad96Ca PE=2 SV=2 CAD96_DROME reviewed Tyrosine kinase receptor Cad96Ca (EC 2.7.10.1) (Cadherin-96Ca) (Tyrosine kinase receptor HD-14) Drosophila melanogaster (Fruit fly) GO:0004713; GO:0004714; GO:0005509; GO:0005524; GO:0005886; GO:0006468; GO:0007030; GO:0007156; GO:0007169; GO:0016339; GO:0042060; GO:0043235; GO:0045177; GO:0045792; GO:0051897; GO:0090303 calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; Golgi organization [GO:0007030]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell size [GO:0045792]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of wound healing [GO:0090303]; protein phosphorylation [GO:0006468]; wound healing [GO:0042060] apical part of cell [GO:0045177]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; protein tyrosine kinase activity [GO:0004713]; transmembrane receptor protein tyrosine kinase activity [GO:0004714] g261.t1 P20072 51.935 310 3.37e-101 308.0 sp|P20072|ANXA7_BOVIN Annexin A7 OS=Bos taurus OX=9913 GN=ANXA7 PE=1 SV=2 g262.t1 Q29471 48.544 309 4.3200000000000003e-97 292.0 sp|Q29471|ANX13_CANLF Annexin A13 OS=Canis lupus familiaris OX=9615 GN=ANXA13 PE=1 SV=2 ANX13_CANLF reviewed Annexin A13 (Annexin XIII) (Annexin-13) (Intestine-specific annexin) (ISA) Canis lupus familiaris (Dog) (Canis familiaris) GO:0001786; GO:0005509; GO:0005544; GO:0005634; GO:0005737; GO:0005886; GO:0012506; GO:0016323; GO:0016324; GO:0042997; GO:0042998; GO:0045121; GO:0070382 negative regulation of Golgi to plasma membrane protein transport [GO:0042997]; positive regulation of Golgi to plasma membrane protein transport [GO:0042998] apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; exocytic vesicle [GO:0070382]; membrane raft [GO:0045121]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; vesicle membrane [GO:0012506] calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; phosphatidylserine binding [GO:0001786] g262.t1 Q29471 32.489 237 4.81e-31 122.0 sp|Q29471|ANX13_CANLF Annexin A13 OS=Canis lupus familiaris OX=9615 GN=ANXA13 PE=1 SV=2 ANX13_CANLF reviewed Annexin A13 (Annexin XIII) (Annexin-13) (Intestine-specific annexin) (ISA) Canis lupus familiaris (Dog) (Canis familiaris) GO:0001786; GO:0005509; GO:0005544; GO:0005634; GO:0005737; GO:0005886; GO:0012506; GO:0016323; GO:0016324; GO:0042997; GO:0042998; GO:0045121; GO:0070382 negative regulation of Golgi to plasma membrane protein transport [GO:0042997]; positive regulation of Golgi to plasma membrane protein transport [GO:0042998] apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; exocytic vesicle [GO:0070382]; membrane raft [GO:0045121]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; vesicle membrane [GO:0012506] calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; phosphatidylserine binding [GO:0001786] g262.t1 Q29471 33.562 146 2.64e-21 95.5 sp|Q29471|ANX13_CANLF Annexin A13 OS=Canis lupus familiaris OX=9615 GN=ANXA13 PE=1 SV=2 ANX13_CANLF reviewed Annexin A13 (Annexin XIII) (Annexin-13) (Intestine-specific annexin) (ISA) Canis lupus familiaris (Dog) (Canis familiaris) GO:0001786; GO:0005509; GO:0005544; GO:0005634; GO:0005737; GO:0005886; GO:0012506; GO:0016323; GO:0016324; GO:0042997; GO:0042998; GO:0045121; GO:0070382 negative regulation of Golgi to plasma membrane protein transport [GO:0042997]; positive regulation of Golgi to plasma membrane protein transport [GO:0042998] apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; exocytic vesicle [GO:0070382]; membrane raft [GO:0045121]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; vesicle membrane [GO:0012506] calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; phosphatidylserine binding [GO:0001786] g263.t1 P27216 40.984 305 4.56e-58 192.0 sp|P27216|ANX13_HUMAN Annexin A13 OS=Homo sapiens OX=9606 GN=ANXA13 PE=1 SV=3 ANX13_HUMAN reviewed Annexin A13 (Annexin XIII) (Annexin-13) (Intestine-specific annexin) (ISA) Homo sapiens (Human) GO:0001786; GO:0005509; GO:0005544; GO:0005615; GO:0005634; GO:0005654; GO:0005737; GO:0005886; GO:0012506; GO:0016020; GO:0016323; GO:0016324; GO:0030154; GO:0031410; GO:0042997; GO:0042998; GO:0045121; GO:0070062; GO:0070382; GO:1901611 cell differentiation [GO:0030154]; negative regulation of Golgi to plasma membrane protein transport [GO:0042997]; positive regulation of Golgi to plasma membrane protein transport [GO:0042998] apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; exocytic vesicle [GO:0070382]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; membrane [GO:0016020]; membrane raft [GO:0045121]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; vesicle membrane [GO:0012506] calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; phosphatidylglycerol binding [GO:1901611]; phosphatidylserine binding [GO:0001786] g265.t1 P26256 51.331 263 4.36e-84 257.0 sp|P26256|ANX12_HYDVU Annexin-B12 OS=Hydra vulgaris OX=6087 GN=ANXB12 PE=1 SV=1 g266.t1 P50995 52.614 306 1.68e-106 322.0 sp|P50995|ANX11_HUMAN Annexin A11 OS=Homo sapiens OX=9606 GN=ANXA11 PE=1 SV=1 ANX11_HUMAN reviewed Annexin A11 (56 kDa autoantigen) (Annexin XI) (Annexin-11) (Calcyclin-associated annexin 50) (CAP-50) Homo sapiens (Human) GO:0001786; GO:0003723; GO:0005509; GO:0005544; GO:0005634; GO:0005635; GO:0005654; GO:0005737; GO:0005819; GO:0005829; GO:0005886; GO:0006909; GO:0008429; GO:0012506; GO:0016020; GO:0023026; GO:0030496; GO:0031012; GO:0032506; GO:0042470; GO:0042581; GO:0042582; GO:0044548; GO:0045335; GO:0048306; GO:0051592; GO:0070062 cytokinetic process [GO:0032506]; phagocytosis [GO:0006909]; response to calcium ion [GO:0051592] azurophil granule [GO:0042582]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; melanosome [GO:0042470]; membrane [GO:0016020]; midbody [GO:0030496]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; specific granule [GO:0042581]; spindle [GO:0005819]; vesicle membrane [GO:0012506] calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; calcium-dependent protein binding [GO:0048306]; MHC class II protein complex binding [GO:0023026]; phosphatidylethanolamine binding [GO:0008429]; phosphatidylserine binding [GO:0001786]; RNA binding [GO:0003723]; S100 protein binding [GO:0044548] g266.t2 P50995 52.614 306 1.68e-106 322.0 sp|P50995|ANX11_HUMAN Annexin A11 OS=Homo sapiens OX=9606 GN=ANXA11 PE=1 SV=1 ANX11_HUMAN reviewed Annexin A11 (56 kDa autoantigen) (Annexin XI) (Annexin-11) (Calcyclin-associated annexin 50) (CAP-50) Homo sapiens (Human) GO:0001786; GO:0003723; GO:0005509; GO:0005544; GO:0005634; GO:0005635; GO:0005654; GO:0005737; GO:0005819; GO:0005829; GO:0005886; GO:0006909; GO:0008429; GO:0012506; GO:0016020; GO:0023026; GO:0030496; GO:0031012; GO:0032506; GO:0042470; GO:0042581; GO:0042582; GO:0044548; GO:0045335; GO:0048306; GO:0051592; GO:0070062 cytokinetic process [GO:0032506]; phagocytosis [GO:0006909]; response to calcium ion [GO:0051592] azurophil granule [GO:0042582]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; melanosome [GO:0042470]; membrane [GO:0016020]; midbody [GO:0030496]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; specific granule [GO:0042581]; spindle [GO:0005819]; vesicle membrane [GO:0012506] calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; calcium-dependent protein binding [GO:0048306]; MHC class II protein complex binding [GO:0023026]; phosphatidylethanolamine binding [GO:0008429]; phosphatidylserine binding [GO:0001786]; RNA binding [GO:0003723]; S100 protein binding [GO:0044548] g267.t1 O60293 31.742 838 1.67e-120 427.0 sp|O60293|ZC3H1_HUMAN Zinc finger C3H1 domain-containing protein OS=Homo sapiens OX=9606 GN=ZFC3H1 PE=1 SV=3 g268.t1 Q6AXX4 37.979 287 8.809999999999999e-48 176.0 sp|Q6AXX4|SAS10_RAT Something about silencing protein 10 OS=Rattus norvegicus OX=10116 GN=Utp3 PE=1 SV=1 SAS10_RAT reviewed Something about silencing protein 10 (Charged amino acid-rich leucine zipper 1) (Disrupter of silencing SAS10) (UTP3 homolog) Rattus norvegicus (Rat) GO:0000462; GO:0005634; GO:0005730; GO:0006325; GO:0007420; GO:0032040; GO:0042274 brain development [GO:0007420]; chromatin organization [GO:0006325]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; ribosomal small subunit biogenesis [GO:0042274] nucleolus [GO:0005730]; nucleus [GO:0005634]; small-subunit processome [GO:0032040] g269.t1 Q4V8D9 49.1 389 5.93e-131 385.0 sp|Q4V8D9|LRC34_RAT Leucine-rich repeat-containing protein 34 OS=Rattus norvegicus OX=10116 GN=Lrrc34 PE=2 SV=1 g270.t1 Q6RI86 33.405 934 2.3300000000000004e-129 426.0 sp|Q6RI86|TRPA1_RAT Transient receptor potential cation channel subfamily A member 1 OS=Rattus norvegicus OX=10116 GN=Trpa1 PE=1 SV=2 TRPA1_RAT reviewed Transient receptor potential cation channel subfamily A member 1 (Ankyrin-like with transmembrane domains protein 1) (Wasabi receptor) Rattus norvegicus (Rat) GO:0005216; GO:0005245; GO:0005262; GO:0005886; GO:0006816; GO:0006874; GO:0007166; GO:0009409; GO:0009410; GO:0014832; GO:0015267; GO:0015278; GO:0016324; GO:0019233; GO:0030424; GO:0032421; GO:0034605; GO:0035774; GO:0042542; GO:0042802; GO:0046872; GO:0048265; GO:0050955; GO:0050966; GO:0050968; GO:0050974; GO:0051289; GO:0070301; GO:0070417; GO:0070588; GO:0071240; GO:0071244; GO:0071313; GO:0097237; GO:0097553; GO:0097604; GO:0098908; GO:1903522; GO:1903793; GO:1990760 calcium ion transmembrane import into cytosol [GO:0097553]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; cell surface receptor signaling pathway [GO:0007166]; cellular response to caffeine [GO:0071313]; cellular response to carbon dioxide [GO:0071244]; cellular response to cold [GO:0070417]; cellular response to food [GO:0071240]; cellular response to heat [GO:0034605]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to toxic substance [GO:0097237]; detection of chemical stimulus involved in sensory perception of pain [GO:0050968]; detection of mechanical stimulus involved in sensory perception [GO:0050974]; detection of mechanical stimulus involved in sensory perception of pain [GO:0050966]; intracellular calcium ion homeostasis [GO:0006874]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of monoatomic anion transport [GO:1903793]; protein homotetramerization [GO:0051289]; regulation of blood circulation [GO:1903522]; regulation of neuronal action potential [GO:0098908]; response to cold [GO:0009409]; response to hydrogen peroxide [GO:0042542]; response to pain [GO:0048265]; response to xenobiotic stimulus [GO:0009410]; sensory perception of pain [GO:0019233]; thermoception [GO:0050955]; urinary bladder smooth muscle contraction [GO:0014832] apical plasma membrane [GO:0016324]; axon [GO:0030424]; plasma membrane [GO:0005886]; stereocilium bundle [GO:0032421] calcium channel activity [GO:0005262]; channel activity [GO:0015267]; identical protein binding [GO:0042802]; intracellularly gated calcium channel activity [GO:0015278]; metal ion binding [GO:0046872]; monoatomic ion channel activity [GO:0005216]; osmolarity-sensing monoatomic cation channel activity [GO:1990760]; temperature-gated cation channel activity [GO:0097604]; voltage-gated calcium channel activity [GO:0005245] g274.t1 P91119 46.47 779 0.0 671.0 sp|P91119|PDE5_CAEEL Probable 3',5'-cyclic phosphodiesterase pde-5 OS=Caenorhabditis elegans OX=6239 GN=pde-5 PE=3 SV=3 PDE5_CAEEL reviewed Probable 3',5'-cyclic phosphodiesterase pde-5 (EC 3.1.4.17) Caenorhabditis elegans GO:0004115; GO:0004118; GO:0006935; GO:0007602; GO:0007635; GO:0008340; GO:0010446; GO:0010628; GO:0010754; GO:0032528; GO:0042542; GO:0046872; GO:0047555; GO:0141162 chemosensory behavior [GO:0007635]; chemotaxis [GO:0006935]; determination of adult lifespan [GO:0008340]; microvillus organization [GO:0032528]; negative regulation of cAMP/PKA signal transduction [GO:0141162]; negative regulation of cGMP-mediated signaling [GO:0010754]; phototransduction [GO:0007602]; positive regulation of gene expression [GO:0010628]; response to alkaline pH [GO:0010446]; response to hydrogen peroxide [GO:0042542] 3',5'-cGMP-stimulated cyclic-nucleotide phosphodiesterase activity [GO:0004118]; 3',5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; 3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; metal ion binding [GO:0046872] g274.t2 P91119 44.417 824 0.0 661.0 sp|P91119|PDE5_CAEEL Probable 3',5'-cyclic phosphodiesterase pde-5 OS=Caenorhabditis elegans OX=6239 GN=pde-5 PE=3 SV=3 PDE5_CAEEL reviewed Probable 3',5'-cyclic phosphodiesterase pde-5 (EC 3.1.4.17) Caenorhabditis elegans GO:0004115; GO:0004118; GO:0006935; GO:0007602; GO:0007635; GO:0008340; GO:0010446; GO:0010628; GO:0010754; GO:0032528; GO:0042542; GO:0046872; GO:0047555; GO:0141162 chemosensory behavior [GO:0007635]; chemotaxis [GO:0006935]; determination of adult lifespan [GO:0008340]; microvillus organization [GO:0032528]; negative regulation of cAMP/PKA signal transduction [GO:0141162]; negative regulation of cGMP-mediated signaling [GO:0010754]; phototransduction [GO:0007602]; positive regulation of gene expression [GO:0010628]; response to alkaline pH [GO:0010446]; response to hydrogen peroxide [GO:0042542] 3',5'-cGMP-stimulated cyclic-nucleotide phosphodiesterase activity [GO:0004118]; 3',5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; 3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; metal ion binding [GO:0046872] g274.t3 P91119 46.242 785 0.0 674.0 sp|P91119|PDE5_CAEEL Probable 3',5'-cyclic phosphodiesterase pde-5 OS=Caenorhabditis elegans OX=6239 GN=pde-5 PE=3 SV=3 PDE5_CAEEL reviewed Probable 3',5'-cyclic phosphodiesterase pde-5 (EC 3.1.4.17) Caenorhabditis elegans GO:0004115; GO:0004118; GO:0006935; GO:0007602; GO:0007635; GO:0008340; GO:0010446; GO:0010628; GO:0010754; GO:0032528; GO:0042542; GO:0046872; GO:0047555; GO:0141162 chemosensory behavior [GO:0007635]; chemotaxis [GO:0006935]; determination of adult lifespan [GO:0008340]; microvillus organization [GO:0032528]; negative regulation of cAMP/PKA signal transduction [GO:0141162]; negative regulation of cGMP-mediated signaling [GO:0010754]; phototransduction [GO:0007602]; positive regulation of gene expression [GO:0010628]; response to alkaline pH [GO:0010446]; response to hydrogen peroxide [GO:0042542] 3',5'-cGMP-stimulated cyclic-nucleotide phosphodiesterase activity [GO:0004118]; 3',5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; 3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; metal ion binding [GO:0046872] g275.t1 Q80Y55 49.048 210 3.23e-62 211.0 sp|Q80Y55|BSDC1_MOUSE BSD domain-containing protein 1 OS=Mus musculus OX=10090 GN=Bsdc1 PE=1 SV=1 g276.t1 Q58NQ5 69.34 212 8.07e-100 319.0 sp|Q58NQ5|PLAG1_CHICK Zinc finger protein PLAG1 OS=Gallus gallus OX=9031 GN=PLAG1 PE=2 SV=1 PLAG1_CHICK reviewed Zinc finger protein PLAG1 (Pleiomorphic adenoma gene 1 protein) Gallus gallus (Chicken) GO:0000978; GO:0000981; GO:0001228; GO:0005813; GO:0005829; GO:0006355; GO:0008270; GO:0010628; GO:0010629; GO:0016607; GO:0022612; GO:0035264; GO:0035265; GO:0060252 gland morphogenesis [GO:0022612]; multicellular organism growth [GO:0035264]; negative regulation of gene expression [GO:0010629]; organ growth [GO:0035265]; positive regulation of gene expression [GO:0010628]; positive regulation of glial cell proliferation [GO:0060252]; regulation of DNA-templated transcription [GO:0006355] centrosome [GO:0005813]; cytosol [GO:0005829]; nuclear speck [GO:0016607] DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270] g278.t1 M9PE65 25.225 1447 3.21e-122 429.0 sp|M9PE65|AXO_DROME Axotactin OS=Drosophila melanogaster OX=7227 GN=axo PE=1 SV=1 AXO_DROME reviewed Axotactin Drosophila melanogaster (Fruit fly) GO:0004867; GO:0016020; GO:0019226; GO:0030424 transmission of nerve impulse [GO:0019226] axon [GO:0030424]; membrane [GO:0016020] serine-type endopeptidase inhibitor activity [GO:0004867] g278.t2 M9PE65 25.71 1338 2.8599999999999997e-113 402.0 sp|M9PE65|AXO_DROME Axotactin OS=Drosophila melanogaster OX=7227 GN=axo PE=1 SV=1 AXO_DROME reviewed Axotactin Drosophila melanogaster (Fruit fly) GO:0004867; GO:0016020; GO:0019226; GO:0030424 transmission of nerve impulse [GO:0019226] axon [GO:0030424]; membrane [GO:0016020] serine-type endopeptidase inhibitor activity [GO:0004867] g279.t1 Q94K49 27.298 359 4.3e-31 126.0 sp|Q94K49|ALP1_ARATH Protein ANTAGONIST OF LIKE HETEROCHROMATIN PROTEIN 1 OS=Arabidopsis thaliana OX=3702 GN=ALP1 PE=1 SV=1 ALP1_ARATH reviewed Protein ANTAGONIST OF LIKE HETEROCHROMATIN PROTEIN 1 (EC 3.1.-.-) Arabidopsis thaliana (Mouse-ear cress) GO:0003682; GO:0004518; GO:0005634; GO:0016787; GO:0035098; GO:0035102; GO:0040029; GO:0046872 epigenetic regulation of gene expression [GO:0040029] ESC/E(Z) complex [GO:0035098]; nucleus [GO:0005634]; PRC1 complex [GO:0035102] chromatin binding [GO:0003682]; hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]; nuclease activity [GO:0004518] g282.t1 Q9Y6N9 32.51 526 7.76e-79 260.0 sp|Q9Y6N9|USH1C_HUMAN Harmonin OS=Homo sapiens OX=9606 GN=USH1C PE=1 SV=3 USH1C_HUMAN reviewed Harmonin (Antigen NY-CO-38/NY-CO-37) (Autoimmune enteropathy-related antigen AIE-75) (Protein PDZ-73) (Renal carcinoma antigen NY-REN-3) (Usher syndrome type-1C protein) Homo sapiens (Human) GO:0000086; GO:0001750; GO:0001917; GO:0002093; GO:0002142; GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0005902; GO:0005903; GO:0005929; GO:0007605; GO:0030046; GO:0030507; GO:0032420; GO:0032426; GO:0032532; GO:0042472; GO:0042491; GO:0045177; GO:0045202; GO:0045494; GO:0046549; GO:0050953; GO:0050957; GO:0051017; GO:0060122; GO:0065003; GO:1904106; GO:1904970 actin filament bundle assembly [GO:0051017]; auditory receptor cell morphogenesis [GO:0002093]; brush border assembly [GO:1904970]; equilibrioception [GO:0050957]; G2/M transition of mitotic cell cycle [GO:0000086]; inner ear auditory receptor cell differentiation [GO:0042491]; inner ear morphogenesis [GO:0042472]; inner ear receptor cell stereocilium organization [GO:0060122]; parallel actin filament bundle assembly [GO:0030046]; photoreceptor cell maintenance [GO:0045494]; protein localization to microvillus [GO:1904106]; protein-containing complex assembly [GO:0065003]; regulation of microvillus length [GO:0032532]; retinal cone cell development [GO:0046549]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605] apical part of cell [GO:0045177]; brush border [GO:0005903]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; microvillus [GO:0005902]; photoreceptor inner segment [GO:0001917]; photoreceptor outer segment [GO:0001750]; plasma membrane [GO:0005886]; stereocilia ankle link complex [GO:0002142]; stereocilium [GO:0032420]; stereocilium tip [GO:0032426]; synapse [GO:0045202] spectrin binding [GO:0030507] g286.t1 Q8SPI2 50.725 69 6.98e-22 84.7 sp|Q8SPI2|CHCH7_MACFA Coiled-coil-helix-coiled-coil-helix domain-containing protein 7 OS=Macaca fascicularis OX=9541 GN=CHCHD7 PE=3 SV=1 g287.t1 Q6R5J2 33.263 475 7.01e-53 204.0 sp|Q6R5J2|DISP1_DANRE Protein dispatched homolog 1 OS=Danio rerio OX=7955 GN=disp1 PE=2 SV=1 DISP1_DANRE reviewed Protein dispatched homolog 1 (Protein chameleon) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0007224; GO:0007519; GO:0008015; GO:0009887; GO:0009952; GO:0016020; GO:0021984; GO:0031290; GO:0042694; GO:0048701; GO:0048839 adenohypophysis development [GO:0021984]; animal organ morphogenesis [GO:0009887]; anterior/posterior pattern specification [GO:0009952]; blood circulation [GO:0008015]; embryonic cranial skeleton morphogenesis [GO:0048701]; inner ear development [GO:0048839]; muscle cell fate specification [GO:0042694]; retinal ganglion cell axon guidance [GO:0031290]; skeletal muscle tissue development [GO:0007519]; smoothened signaling pathway [GO:0007224] membrane [GO:0016020] g287.t1 Q6R5J2 48.485 231 2.1300000000000002e-47 187.0 sp|Q6R5J2|DISP1_DANRE Protein dispatched homolog 1 OS=Danio rerio OX=7955 GN=disp1 PE=2 SV=1 DISP1_DANRE reviewed Protein dispatched homolog 1 (Protein chameleon) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0007224; GO:0007519; GO:0008015; GO:0009887; GO:0009952; GO:0016020; GO:0021984; GO:0031290; GO:0042694; GO:0048701; GO:0048839 adenohypophysis development [GO:0021984]; animal organ morphogenesis [GO:0009887]; anterior/posterior pattern specification [GO:0009952]; blood circulation [GO:0008015]; embryonic cranial skeleton morphogenesis [GO:0048701]; inner ear development [GO:0048839]; muscle cell fate specification [GO:0042694]; retinal ganglion cell axon guidance [GO:0031290]; skeletal muscle tissue development [GO:0007519]; smoothened signaling pathway [GO:0007224] membrane [GO:0016020] g287.t2 Q6R5J2 33.263 475 9.44e-53 204.0 sp|Q6R5J2|DISP1_DANRE Protein dispatched homolog 1 OS=Danio rerio OX=7955 GN=disp1 PE=2 SV=1 DISP1_DANRE reviewed Protein dispatched homolog 1 (Protein chameleon) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0007224; GO:0007519; GO:0008015; GO:0009887; GO:0009952; GO:0016020; GO:0021984; GO:0031290; GO:0042694; GO:0048701; GO:0048839 adenohypophysis development [GO:0021984]; animal organ morphogenesis [GO:0009887]; anterior/posterior pattern specification [GO:0009952]; blood circulation [GO:0008015]; embryonic cranial skeleton morphogenesis [GO:0048701]; inner ear development [GO:0048839]; muscle cell fate specification [GO:0042694]; retinal ganglion cell axon guidance [GO:0031290]; skeletal muscle tissue development [GO:0007519]; smoothened signaling pathway [GO:0007224] membrane [GO:0016020] g287.t2 Q6R5J2 48.485 231 1.8600000000000002e-47 187.0 sp|Q6R5J2|DISP1_DANRE Protein dispatched homolog 1 OS=Danio rerio OX=7955 GN=disp1 PE=2 SV=1 DISP1_DANRE reviewed Protein dispatched homolog 1 (Protein chameleon) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0007224; GO:0007519; GO:0008015; GO:0009887; GO:0009952; GO:0016020; GO:0021984; GO:0031290; GO:0042694; GO:0048701; GO:0048839 adenohypophysis development [GO:0021984]; animal organ morphogenesis [GO:0009887]; anterior/posterior pattern specification [GO:0009952]; blood circulation [GO:0008015]; embryonic cranial skeleton morphogenesis [GO:0048701]; inner ear development [GO:0048839]; muscle cell fate specification [GO:0042694]; retinal ganglion cell axon guidance [GO:0031290]; skeletal muscle tissue development [GO:0007519]; smoothened signaling pathway [GO:0007224] membrane [GO:0016020] g289.t1 Q86YS7 42.658 647 1.42e-161 504.0 sp|Q86YS7|C2CD5_HUMAN C2 domain-containing protein 5 OS=Homo sapiens OX=9606 GN=C2CD5 PE=1 SV=1 C2CD5_HUMAN reviewed C2 domain-containing protein 5 (C2 domain-containing phosphoprotein of 138 kDa) Homo sapiens (Human) GO:0005509; GO:0005544; GO:0005829; GO:0005886; GO:0005938; GO:0008286; GO:0010828; GO:0030659; GO:0031340; GO:0032587; GO:0034451; GO:0065002; GO:0072659; GO:0090314 insulin receptor signaling pathway [GO:0008286]; intracellular protein transmembrane transport [GO:0065002]; positive regulation of D-glucose transmembrane transport [GO:0010828]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of vesicle fusion [GO:0031340]; protein localization to plasma membrane [GO:0072659] cell cortex [GO:0005938]; centriolar satellite [GO:0034451]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587] calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544] g289.t1 Q86YS7 71.255 247 3.05e-120 395.0 sp|Q86YS7|C2CD5_HUMAN C2 domain-containing protein 5 OS=Homo sapiens OX=9606 GN=C2CD5 PE=1 SV=1 C2CD5_HUMAN reviewed C2 domain-containing protein 5 (C2 domain-containing phosphoprotein of 138 kDa) Homo sapiens (Human) GO:0005509; GO:0005544; GO:0005829; GO:0005886; GO:0005938; GO:0008286; GO:0010828; GO:0030659; GO:0031340; GO:0032587; GO:0034451; GO:0065002; GO:0072659; GO:0090314 insulin receptor signaling pathway [GO:0008286]; intracellular protein transmembrane transport [GO:0065002]; positive regulation of D-glucose transmembrane transport [GO:0010828]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of vesicle fusion [GO:0031340]; protein localization to plasma membrane [GO:0072659] cell cortex [GO:0005938]; centriolar satellite [GO:0034451]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587] calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544] g292.t1 Q8BYF6 48.457 551 1.85e-162 481.0 sp|Q8BYF6|SC5A8_MOUSE Sodium-coupled monocarboxylate transporter 1 OS=Mus musculus OX=10090 GN=Slc5a8 PE=1 SV=1 SC5A8_MOUSE reviewed Sodium-coupled monocarboxylate transporter 1 (Electrogenic sodium monocarboxylate cotransporter) (Solute carrier family 5 member 8) Mus musculus (Mouse) GO:0000811; GO:0005343; GO:0006814; GO:0006821; GO:0006846; GO:0006848; GO:0006915; GO:0015129; GO:0015552; GO:0015636; GO:0015705; GO:0015706; GO:0015718; GO:0015727; GO:0015730; GO:0015913; GO:0016324; GO:0031526; GO:0090416; GO:0140161; GO:2001142 acetate transport [GO:0006846]; apoptotic process [GO:0006915]; chloride transport [GO:0006821]; iodide transport [GO:0015705]; lactate transport [GO:0015727]; monocarboxylic acid transport [GO:0015718]; nicotinate transport [GO:2001142]; nitrate transmembrane transport [GO:0015706]; propanoate transmembrane transport [GO:0015730]; pyruvate transport [GO:0006848]; short-chain fatty acid transmembrane transport [GO:0015913]; sodium ion transport [GO:0006814] apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; GINS complex [GO:0000811] lactate transmembrane transporter activity [GO:0015129]; monocarboxylate:sodium symporter activity [GO:0140161]; nicotinate transmembrane transporter activity [GO:0090416]; organic acid:sodium symporter activity [GO:0005343]; propionate transmembrane transporter activity [GO:0015552]; short-chain fatty acid transmembrane transporter activity [GO:0015636] g292.t2 Q8BYF6 45.876 582 2.73e-156 466.0 sp|Q8BYF6|SC5A8_MOUSE Sodium-coupled monocarboxylate transporter 1 OS=Mus musculus OX=10090 GN=Slc5a8 PE=1 SV=1 SC5A8_MOUSE reviewed Sodium-coupled monocarboxylate transporter 1 (Electrogenic sodium monocarboxylate cotransporter) (Solute carrier family 5 member 8) Mus musculus (Mouse) GO:0000811; GO:0005343; GO:0006814; GO:0006821; GO:0006846; GO:0006848; GO:0006915; GO:0015129; GO:0015552; GO:0015636; GO:0015705; GO:0015706; GO:0015718; GO:0015727; GO:0015730; GO:0015913; GO:0016324; GO:0031526; GO:0090416; GO:0140161; GO:2001142 acetate transport [GO:0006846]; apoptotic process [GO:0006915]; chloride transport [GO:0006821]; iodide transport [GO:0015705]; lactate transport [GO:0015727]; monocarboxylic acid transport [GO:0015718]; nicotinate transport [GO:2001142]; nitrate transmembrane transport [GO:0015706]; propanoate transmembrane transport [GO:0015730]; pyruvate transport [GO:0006848]; short-chain fatty acid transmembrane transport [GO:0015913]; sodium ion transport [GO:0006814] apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; GINS complex [GO:0000811] lactate transmembrane transporter activity [GO:0015129]; monocarboxylate:sodium symporter activity [GO:0140161]; nicotinate transmembrane transporter activity [GO:0090416]; organic acid:sodium symporter activity [GO:0005343]; propionate transmembrane transporter activity [GO:0015552]; short-chain fatty acid transmembrane transporter activity [GO:0015636] g293.t1 Q8BYF6 47.482 556 2.52e-158 471.0 sp|Q8BYF6|SC5A8_MOUSE Sodium-coupled monocarboxylate transporter 1 OS=Mus musculus OX=10090 GN=Slc5a8 PE=1 SV=1 SC5A8_MOUSE reviewed Sodium-coupled monocarboxylate transporter 1 (Electrogenic sodium monocarboxylate cotransporter) (Solute carrier family 5 member 8) Mus musculus (Mouse) GO:0000811; GO:0005343; GO:0006814; GO:0006821; GO:0006846; GO:0006848; GO:0006915; GO:0015129; GO:0015552; GO:0015636; GO:0015705; GO:0015706; GO:0015718; GO:0015727; GO:0015730; GO:0015913; GO:0016324; GO:0031526; GO:0090416; GO:0140161; GO:2001142 acetate transport [GO:0006846]; apoptotic process [GO:0006915]; chloride transport [GO:0006821]; iodide transport [GO:0015705]; lactate transport [GO:0015727]; monocarboxylic acid transport [GO:0015718]; nicotinate transport [GO:2001142]; nitrate transmembrane transport [GO:0015706]; propanoate transmembrane transport [GO:0015730]; pyruvate transport [GO:0006848]; short-chain fatty acid transmembrane transport [GO:0015913]; sodium ion transport [GO:0006814] apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; GINS complex [GO:0000811] lactate transmembrane transporter activity [GO:0015129]; monocarboxylate:sodium symporter activity [GO:0140161]; nicotinate transmembrane transporter activity [GO:0090416]; organic acid:sodium symporter activity [GO:0005343]; propionate transmembrane transporter activity [GO:0015552]; short-chain fatty acid transmembrane transporter activity [GO:0015636] g294.t1 Q8BYF6 45.469 618 2.41e-171 503.0 sp|Q8BYF6|SC5A8_MOUSE Sodium-coupled monocarboxylate transporter 1 OS=Mus musculus OX=10090 GN=Slc5a8 PE=1 SV=1 SC5A8_MOUSE reviewed Sodium-coupled monocarboxylate transporter 1 (Electrogenic sodium monocarboxylate cotransporter) (Solute carrier family 5 member 8) Mus musculus (Mouse) GO:0000811; GO:0005343; GO:0006814; GO:0006821; GO:0006846; GO:0006848; GO:0006915; GO:0015129; GO:0015552; GO:0015636; GO:0015705; GO:0015706; GO:0015718; GO:0015727; GO:0015730; GO:0015913; GO:0016324; GO:0031526; GO:0090416; GO:0140161; GO:2001142 acetate transport [GO:0006846]; apoptotic process [GO:0006915]; chloride transport [GO:0006821]; iodide transport [GO:0015705]; lactate transport [GO:0015727]; monocarboxylic acid transport [GO:0015718]; nicotinate transport [GO:2001142]; nitrate transmembrane transport [GO:0015706]; propanoate transmembrane transport [GO:0015730]; pyruvate transport [GO:0006848]; short-chain fatty acid transmembrane transport [GO:0015913]; sodium ion transport [GO:0006814] apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; GINS complex [GO:0000811] lactate transmembrane transporter activity [GO:0015129]; monocarboxylate:sodium symporter activity [GO:0140161]; nicotinate transmembrane transporter activity [GO:0090416]; organic acid:sodium symporter activity [GO:0005343]; propionate transmembrane transporter activity [GO:0015552]; short-chain fatty acid transmembrane transporter activity [GO:0015636] g295.t1 Q8BYF6 45.455 594 7.4e-171 502.0 sp|Q8BYF6|SC5A8_MOUSE Sodium-coupled monocarboxylate transporter 1 OS=Mus musculus OX=10090 GN=Slc5a8 PE=1 SV=1 SC5A8_MOUSE reviewed Sodium-coupled monocarboxylate transporter 1 (Electrogenic sodium monocarboxylate cotransporter) (Solute carrier family 5 member 8) Mus musculus (Mouse) GO:0000811; GO:0005343; GO:0006814; GO:0006821; GO:0006846; GO:0006848; GO:0006915; GO:0015129; GO:0015552; GO:0015636; GO:0015705; GO:0015706; GO:0015718; GO:0015727; GO:0015730; GO:0015913; GO:0016324; GO:0031526; GO:0090416; GO:0140161; GO:2001142 acetate transport [GO:0006846]; apoptotic process [GO:0006915]; chloride transport [GO:0006821]; iodide transport [GO:0015705]; lactate transport [GO:0015727]; monocarboxylic acid transport [GO:0015718]; nicotinate transport [GO:2001142]; nitrate transmembrane transport [GO:0015706]; propanoate transmembrane transport [GO:0015730]; pyruvate transport [GO:0006848]; short-chain fatty acid transmembrane transport [GO:0015913]; sodium ion transport [GO:0006814] apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; GINS complex [GO:0000811] lactate transmembrane transporter activity [GO:0015129]; monocarboxylate:sodium symporter activity [GO:0140161]; nicotinate transmembrane transporter activity [GO:0090416]; organic acid:sodium symporter activity [GO:0005343]; propionate transmembrane transporter activity [GO:0015552]; short-chain fatty acid transmembrane transporter activity [GO:0015636] g296.t1 Q8N695 47.143 560 1.0600000000000001e-166 492.0 sp|Q8N695|SC5A8_HUMAN Sodium-coupled monocarboxylate transporter 1 OS=Homo sapiens OX=9606 GN=SLC5A8 PE=1 SV=2 SC5A8_HUMAN reviewed Sodium-coupled monocarboxylate transporter 1 (Apical iodide transporter) (Electrogenic sodium monocarboxylate cotransporter) (Sodium iodide-related cotransporter) (Solute carrier family 5 member 8) Homo sapiens (Human) GO:0000811; GO:0005343; GO:0005886; GO:0006811; GO:0006814; GO:0006821; GO:0006846; GO:0006848; GO:0006915; GO:0008028; GO:0015129; GO:0015552; GO:0015705; GO:0015706; GO:0015727; GO:0015730; GO:0016324; GO:0070062; GO:0090416; GO:0140161; GO:0160081; GO:1901847; GO:2001142 acetate transport [GO:0006846]; apoptotic process [GO:0006915]; chloride transport [GO:0006821]; iodide transport [GO:0015705]; lactate transport [GO:0015727]; monoatomic ion transport [GO:0006811]; nicotinate metabolic process [GO:1901847]; nicotinate transport [GO:2001142]; nitrate transmembrane transport [GO:0015706]; propanoate transmembrane transport [GO:0015730]; pyruvate transport [GO:0006848]; sodium ion transport [GO:0006814] apical plasma membrane [GO:0016324]; extracellular exosome [GO:0070062]; GINS complex [GO:0000811]; plasma membrane [GO:0005886] iodide channel activity [GO:0160081]; lactate transmembrane transporter activity [GO:0015129]; monocarboxylate:sodium symporter activity [GO:0140161]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; nicotinate transmembrane transporter activity [GO:0090416]; organic acid:sodium symporter activity [GO:0005343]; propionate transmembrane transporter activity [GO:0015552] g296.t2 Q8N695 44.85 602 2.1300000000000002e-163 484.0 sp|Q8N695|SC5A8_HUMAN Sodium-coupled monocarboxylate transporter 1 OS=Homo sapiens OX=9606 GN=SLC5A8 PE=1 SV=2 SC5A8_HUMAN reviewed Sodium-coupled monocarboxylate transporter 1 (Apical iodide transporter) (Electrogenic sodium monocarboxylate cotransporter) (Sodium iodide-related cotransporter) (Solute carrier family 5 member 8) Homo sapiens (Human) GO:0000811; GO:0005343; GO:0005886; GO:0006811; GO:0006814; GO:0006821; GO:0006846; GO:0006848; GO:0006915; GO:0008028; GO:0015129; GO:0015552; GO:0015705; GO:0015706; GO:0015727; GO:0015730; GO:0016324; GO:0070062; GO:0090416; GO:0140161; GO:0160081; GO:1901847; GO:2001142 acetate transport [GO:0006846]; apoptotic process [GO:0006915]; chloride transport [GO:0006821]; iodide transport [GO:0015705]; lactate transport [GO:0015727]; monoatomic ion transport [GO:0006811]; nicotinate metabolic process [GO:1901847]; nicotinate transport [GO:2001142]; nitrate transmembrane transport [GO:0015706]; propanoate transmembrane transport [GO:0015730]; pyruvate transport [GO:0006848]; sodium ion transport [GO:0006814] apical plasma membrane [GO:0016324]; extracellular exosome [GO:0070062]; GINS complex [GO:0000811]; plasma membrane [GO:0005886] iodide channel activity [GO:0160081]; lactate transmembrane transporter activity [GO:0015129]; monocarboxylate:sodium symporter activity [GO:0140161]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; nicotinate transmembrane transporter activity [GO:0090416]; organic acid:sodium symporter activity [GO:0005343]; propionate transmembrane transporter activity [GO:0015552] g299.t1 F7J220 68.728 1132 0.0 1559.0 sp|F7J220|SRCR1_PATPE Scavenger receptor cysteine-rich domain superfamily protein OS=Patiria pectinifera OX=7594 GN=SRCR1 PE=1 SV=1 g300.t1 Q8NB16 31.373 204 2.39e-23 107.0 sp|Q8NB16|MLKL_HUMAN Mixed lineage kinase domain-like protein OS=Homo sapiens OX=9606 GN=MLKL PE=1 SV=1 MLKL_HUMAN reviewed Mixed lineage kinase domain-like protein (hMLKL) Homo sapiens (Human) GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0007166; GO:0019901; GO:0030054; GO:0042802; GO:0044877; GO:0051607; GO:0070207; GO:0070266; GO:0097527; GO:0097528 cell surface receptor signaling pathway [GO:0007166]; defense response to virus [GO:0051607]; execution phase of necroptosis [GO:0097528]; necroptotic process [GO:0070266]; necroptotic signaling pathway [GO:0097527]; protein homotrimerization [GO:0070207] cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886] ATP binding [GO:0005524]; identical protein binding [GO:0042802]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877] g306.t1 P09324 62.775 454 0.0 596.0 sp|P09324|YES_CHICK Tyrosine-protein kinase Yes OS=Gallus gallus OX=9031 GN=YES1 PE=1 SV=3 g307.t1 Q7Z020 37.435 1154 0.0 677.0 sp|Q7Z020|TRPA1_DROME Transient receptor potential cation channel subfamily A member 1 OS=Drosophila melanogaster OX=7227 GN=TrpA1 PE=1 SV=4 g309.t1 Q7Z020 35.915 710 4.47e-111 367.0 sp|Q7Z020|TRPA1_DROME Transient receptor potential cation channel subfamily A member 1 OS=Drosophila melanogaster OX=7227 GN=TrpA1 PE=1 SV=4 g311.t1 Q7Z020 37.33 442 4.36e-78 274.0 sp|Q7Z020|TRPA1_DROME Transient receptor potential cation channel subfamily A member 1 OS=Drosophila melanogaster OX=7227 GN=TrpA1 PE=1 SV=4 g312.t1 Q8TDN4 45.367 313 7.04e-77 254.0 sp|Q8TDN4|CABL1_HUMAN CDK5 and ABL1 enzyme substrate 1 OS=Homo sapiens OX=9606 GN=CABLES1 PE=1 SV=2 CABL1_HUMAN reviewed CDK5 and ABL1 enzyme substrate 1 (Interactor with CDK3 1) (Ik3-1) Homo sapiens (Human) GO:0005634; GO:0005829; GO:0007399; GO:0051301; GO:0051726 cell division [GO:0051301]; nervous system development [GO:0007399]; regulation of cell cycle [GO:0051726] cytosol [GO:0005829]; nucleus [GO:0005634] g313.t1 B1H3D5 47.079 291 1.78e-81 251.0 sp|B1H3D5|ENDOU_XENTR Poly(U)-specific endoribonuclease OS=Xenopus tropicalis OX=8364 GN=endou PE=2 SV=1 g314.t1 Q86YT6 77.098 1013 0.0 1609.0 sp|Q86YT6|MIB1_HUMAN E3 ubiquitin-protein ligase MIB1 OS=Homo sapiens OX=9606 GN=MIB1 PE=1 SV=1 MIB1_HUMAN reviewed E3 ubiquitin-protein ligase MIB1 (EC 2.3.2.27) (DAPK-interacting protein 1) (DIP-1) (Mind bomb homolog 1) (RING-type E3 ubiquitin transferase MIB1) (Zinc finger ZZ type with ankyrin repeat domain protein 2) Homo sapiens (Human) GO:0001568; GO:0001701; GO:0001756; GO:0001841; GO:0001947; GO:0004842; GO:0005737; GO:0005813; GO:0005829; GO:0005886; GO:0006511; GO:0006897; GO:0007219; GO:0008270; GO:0014069; GO:0016567; GO:0021953; GO:0031410; GO:0034451; GO:0045665; GO:0045807; GO:0061630; GO:0098978 blood vessel development [GO:0001568]; central nervous system neuron differentiation [GO:0021953]; endocytosis [GO:0006897]; heart looping [GO:0001947]; in utero embryonic development [GO:0001701]; negative regulation of neuron differentiation [GO:0045665]; neural tube formation [GO:0001841]; Notch signaling pathway [GO:0007219]; positive regulation of endocytosis [GO:0045807]; protein ubiquitination [GO:0016567]; somitogenesis [GO:0001756]; ubiquitin-dependent protein catabolic process [GO:0006511] centriolar satellite [GO:0034451]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069] ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] g316.t1 Q9NXZ2 48.873 577 2.29e-176 520.0 sp|Q9NXZ2|DDX43_HUMAN Probable ATP-dependent RNA helicase DDX43 OS=Homo sapiens OX=9606 GN=DDX43 PE=1 SV=2 g317.t1 O42123 75.926 108 1.29e-58 178.0 sp|O42123|FKB1A_XENLA Peptidyl-prolyl cis-trans isomerase FKBP1A OS=Xenopus laevis OX=8355 GN=fkbp1a PE=3 SV=3 g318.t1 Q3SZX8 64.141 198 1.11e-71 219.0 sp|Q3SZX8|CCD25_BOVIN Coiled-coil domain-containing protein 25 OS=Bos taurus OX=9913 GN=CCDC25 PE=2 SV=1 g320.t1 Q05397 49.401 1002 0.0 892.0 sp|Q05397|FAK1_HUMAN Focal adhesion kinase 1 OS=Homo sapiens OX=9606 GN=PTK2 PE=1 SV=2 FAK1_HUMAN reviewed Focal adhesion kinase 1 (FADK 1) (EC 2.7.10.2) (Focal adhesion kinase-related nonkinase) (FRNK) (Protein phosphatase 1 regulatory subunit 71) (PPP1R71) (Protein-tyrosine kinase 2) (p125FAK) (pp125FAK) Homo sapiens (Human) GO:0001525; GO:0001725; GO:0001890; GO:0003007; GO:0003779; GO:0004713; GO:0004715; GO:0004725; GO:0005178; GO:0005524; GO:0005634; GO:0005813; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0005929; GO:0005938; GO:0007172; GO:0007173; GO:0007179; GO:0007229; GO:0007411; GO:0008284; GO:0008360; GO:0008432; GO:0010594; GO:0010632; GO:0010634; GO:0010718; GO:0010759; GO:0010763; GO:0016477; GO:0019901; GO:0019903; GO:0022408; GO:0030010; GO:0030155; GO:0030335; GO:0033629; GO:0033634; GO:0035995; GO:0036064; GO:0038007; GO:0038096; GO:0042127; GO:0042169; GO:0043066; GO:0045667; GO:0048010; GO:0048013; GO:0048471; GO:0048870; GO:0051493; GO:0051893; GO:0051897; GO:0060396; GO:0090303; GO:0097542; GO:0097706; GO:0120041; GO:0140677; GO:1900024; GO:2000060; GO:2000811 angiogenesis [GO:0001525]; axon guidance [GO:0007411]; cell migration [GO:0016477]; cell motility [GO:0048870]; detection of muscle stretch [GO:0035995]; ephrin receptor signaling pathway [GO:0048013]; epidermal growth factor receptor signaling pathway [GO:0007173]; establishment of cell polarity [GO:0030010]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; growth hormone receptor signaling pathway [GO:0060396]; heart morphogenesis [GO:0003007]; integrin-mediated signaling pathway [GO:0007229]; negative regulation of anoikis [GO:2000811]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell adhesion mediated by integrin [GO:0033629]; negative regulation of cell-cell adhesion [GO:0022408]; netrin-activated signaling pathway [GO:0038007]; placenta development [GO:0001890]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cell-cell adhesion mediated by integrin [GO:0033634]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of macrophage chemotaxis [GO:0010759]; positive regulation of macrophage proliferation [GO:0120041]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; positive regulation of wound healing [GO:0090303]; regulation of cell adhesion [GO:0030155]; regulation of cell population proliferation [GO:0042127]; regulation of cell shape [GO:0008360]; regulation of cytoskeleton organization [GO:0051493]; regulation of endothelial cell migration [GO:0010594]; regulation of epithelial cell migration [GO:0010632]; regulation of focal adhesion assembly [GO:0051893]; regulation of osteoblast differentiation [GO:0045667]; regulation of substrate adhesion-dependent cell spreading [GO:1900024]; signal complex assembly [GO:0007172]; transforming growth factor beta receptor signaling pathway [GO:0007179]; vascular endothelial cell response to oscillatory fluid shear stress [GO:0097706]; vascular endothelial growth factor receptor signaling pathway [GO:0048010] cell cortex [GO:0005938]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary tip [GO:0097542]; cilium [GO:0005929]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; stress fiber [GO:0001725] actin binding [GO:0003779]; ATP binding [GO:0005524]; integrin binding [GO:0005178]; JUN kinase binding [GO:0008432]; molecular function activator activity [GO:0140677]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein kinase binding [GO:0019901]; protein phosphatase binding [GO:0019903]; protein tyrosine kinase activity [GO:0004713]; protein tyrosine phosphatase activity [GO:0004725]; SH2 domain binding [GO:0042169] g320.t2 Q05397 48.723 1018 0.0 882.0 sp|Q05397|FAK1_HUMAN Focal adhesion kinase 1 OS=Homo sapiens OX=9606 GN=PTK2 PE=1 SV=2 FAK1_HUMAN reviewed Focal adhesion kinase 1 (FADK 1) (EC 2.7.10.2) (Focal adhesion kinase-related nonkinase) (FRNK) (Protein phosphatase 1 regulatory subunit 71) (PPP1R71) (Protein-tyrosine kinase 2) (p125FAK) (pp125FAK) Homo sapiens (Human) GO:0001525; GO:0001725; GO:0001890; GO:0003007; GO:0003779; GO:0004713; GO:0004715; GO:0004725; GO:0005178; GO:0005524; GO:0005634; GO:0005813; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0005929; GO:0005938; GO:0007172; GO:0007173; GO:0007179; GO:0007229; GO:0007411; GO:0008284; GO:0008360; GO:0008432; GO:0010594; GO:0010632; GO:0010634; GO:0010718; GO:0010759; GO:0010763; GO:0016477; GO:0019901; GO:0019903; GO:0022408; GO:0030010; GO:0030155; GO:0030335; GO:0033629; GO:0033634; GO:0035995; GO:0036064; GO:0038007; GO:0038096; GO:0042127; GO:0042169; GO:0043066; GO:0045667; GO:0048010; GO:0048013; GO:0048471; GO:0048870; GO:0051493; GO:0051893; GO:0051897; GO:0060396; GO:0090303; GO:0097542; GO:0097706; GO:0120041; GO:0140677; GO:1900024; GO:2000060; GO:2000811 angiogenesis [GO:0001525]; axon guidance [GO:0007411]; cell migration [GO:0016477]; cell motility [GO:0048870]; detection of muscle stretch [GO:0035995]; ephrin receptor signaling pathway [GO:0048013]; epidermal growth factor receptor signaling pathway [GO:0007173]; establishment of cell polarity [GO:0030010]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; growth hormone receptor signaling pathway [GO:0060396]; heart morphogenesis [GO:0003007]; integrin-mediated signaling pathway [GO:0007229]; negative regulation of anoikis [GO:2000811]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell adhesion mediated by integrin [GO:0033629]; negative regulation of cell-cell adhesion [GO:0022408]; netrin-activated signaling pathway [GO:0038007]; placenta development [GO:0001890]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cell-cell adhesion mediated by integrin [GO:0033634]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of macrophage chemotaxis [GO:0010759]; positive regulation of macrophage proliferation [GO:0120041]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; positive regulation of wound healing [GO:0090303]; regulation of cell adhesion [GO:0030155]; regulation of cell population proliferation [GO:0042127]; regulation of cell shape [GO:0008360]; regulation of cytoskeleton organization [GO:0051493]; regulation of endothelial cell migration [GO:0010594]; regulation of epithelial cell migration [GO:0010632]; regulation of focal adhesion assembly [GO:0051893]; regulation of osteoblast differentiation [GO:0045667]; regulation of substrate adhesion-dependent cell spreading [GO:1900024]; signal complex assembly [GO:0007172]; transforming growth factor beta receptor signaling pathway [GO:0007179]; vascular endothelial cell response to oscillatory fluid shear stress [GO:0097706]; vascular endothelial growth factor receptor signaling pathway [GO:0048010] cell cortex [GO:0005938]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary tip [GO:0097542]; cilium [GO:0005929]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; stress fiber [GO:0001725] actin binding [GO:0003779]; ATP binding [GO:0005524]; integrin binding [GO:0005178]; JUN kinase binding [GO:0008432]; molecular function activator activity [GO:0140677]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein kinase binding [GO:0019901]; protein phosphatase binding [GO:0019903]; protein tyrosine kinase activity [GO:0004713]; protein tyrosine phosphatase activity [GO:0004725]; SH2 domain binding [GO:0042169] g320.t3 Q05397 48.577 1019 0.0 885.0 sp|Q05397|FAK1_HUMAN Focal adhesion kinase 1 OS=Homo sapiens OX=9606 GN=PTK2 PE=1 SV=2 FAK1_HUMAN reviewed Focal adhesion kinase 1 (FADK 1) (EC 2.7.10.2) (Focal adhesion kinase-related nonkinase) (FRNK) (Protein phosphatase 1 regulatory subunit 71) (PPP1R71) (Protein-tyrosine kinase 2) (p125FAK) (pp125FAK) Homo sapiens (Human) GO:0001525; GO:0001725; GO:0001890; GO:0003007; GO:0003779; GO:0004713; GO:0004715; GO:0004725; GO:0005178; GO:0005524; GO:0005634; GO:0005813; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0005929; GO:0005938; GO:0007172; GO:0007173; GO:0007179; GO:0007229; GO:0007411; GO:0008284; GO:0008360; GO:0008432; GO:0010594; GO:0010632; GO:0010634; GO:0010718; GO:0010759; GO:0010763; GO:0016477; GO:0019901; GO:0019903; GO:0022408; GO:0030010; GO:0030155; GO:0030335; GO:0033629; GO:0033634; GO:0035995; GO:0036064; GO:0038007; GO:0038096; GO:0042127; GO:0042169; GO:0043066; GO:0045667; GO:0048010; GO:0048013; GO:0048471; GO:0048870; GO:0051493; GO:0051893; GO:0051897; GO:0060396; GO:0090303; GO:0097542; GO:0097706; GO:0120041; GO:0140677; GO:1900024; GO:2000060; GO:2000811 angiogenesis [GO:0001525]; axon guidance [GO:0007411]; cell migration [GO:0016477]; cell motility [GO:0048870]; detection of muscle stretch [GO:0035995]; ephrin receptor signaling pathway [GO:0048013]; epidermal growth factor receptor signaling pathway [GO:0007173]; establishment of cell polarity [GO:0030010]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; growth hormone receptor signaling pathway [GO:0060396]; heart morphogenesis [GO:0003007]; integrin-mediated signaling pathway [GO:0007229]; negative regulation of anoikis [GO:2000811]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell adhesion mediated by integrin [GO:0033629]; negative regulation of cell-cell adhesion [GO:0022408]; netrin-activated signaling pathway [GO:0038007]; placenta development [GO:0001890]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cell-cell adhesion mediated by integrin [GO:0033634]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of macrophage chemotaxis [GO:0010759]; positive regulation of macrophage proliferation [GO:0120041]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; positive regulation of wound healing [GO:0090303]; regulation of cell adhesion [GO:0030155]; regulation of cell population proliferation [GO:0042127]; regulation of cell shape [GO:0008360]; regulation of cytoskeleton organization [GO:0051493]; regulation of endothelial cell migration [GO:0010594]; regulation of epithelial cell migration [GO:0010632]; regulation of focal adhesion assembly [GO:0051893]; regulation of osteoblast differentiation [GO:0045667]; regulation of substrate adhesion-dependent cell spreading [GO:1900024]; signal complex assembly [GO:0007172]; transforming growth factor beta receptor signaling pathway [GO:0007179]; vascular endothelial cell response to oscillatory fluid shear stress [GO:0097706]; vascular endothelial growth factor receptor signaling pathway [GO:0048010] cell cortex [GO:0005938]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary tip [GO:0097542]; cilium [GO:0005929]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; stress fiber [GO:0001725] actin binding [GO:0003779]; ATP binding [GO:0005524]; integrin binding [GO:0005178]; JUN kinase binding [GO:0008432]; molecular function activator activity [GO:0140677]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein kinase binding [GO:0019901]; protein phosphatase binding [GO:0019903]; protein tyrosine kinase activity [GO:0004713]; protein tyrosine phosphatase activity [GO:0004725]; SH2 domain binding [GO:0042169] g321.t1 Q8BFW9 43.939 330 5.97e-75 256.0 sp|Q8BFW9|GTR12_MOUSE Solute carrier family 2, facilitated glucose transporter member 12 OS=Mus musculus OX=10090 GN=Slc2a12 PE=2 SV=1 g321.t1 Q8BFW9 44.138 145 4.06e-27 120.0 sp|Q8BFW9|GTR12_MOUSE Solute carrier family 2, facilitated glucose transporter member 12 OS=Mus musculus OX=10090 GN=Slc2a12 PE=2 SV=1 g325.t1 Q3ZMH1 32.584 534 1.0700000000000001e-79 265.0 sp|Q3ZMH1|SC5A8_DANRE Sodium-coupled monocarboxylate transporter 1 OS=Danio rerio OX=7955 GN=slc5a8 PE=1 SV=1 SC5A8_DANRE reviewed Sodium-coupled monocarboxylate transporter 1 (Electrogenic sodium monocarboxylate cotransporter) (zSMCTe) (Sodium solute symporter family 5 member 8 protein) (Solute carrier family 5 member 8) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005343; GO:0006814; GO:0006821; GO:0006846; GO:0006848; GO:0015355; GO:0015705; GO:0015706; GO:0015727; GO:0015730; GO:0016324; GO:0140161; GO:2001142 acetate transport [GO:0006846]; chloride transport [GO:0006821]; iodide transport [GO:0015705]; lactate transport [GO:0015727]; nicotinate transport [GO:2001142]; nitrate transmembrane transport [GO:0015706]; propanoate transmembrane transport [GO:0015730]; pyruvate transport [GO:0006848]; sodium ion transport [GO:0006814] apical plasma membrane [GO:0016324] monocarboxylate:sodium symporter activity [GO:0140161]; organic acid:sodium symporter activity [GO:0005343]; secondary active monocarboxylate transmembrane transporter activity [GO:0015355] g326.t1 A6QLU6 42.09 335 1.8500000000000002e-72 255.0 sp|A6QLU6|AGRD1_BOVIN Adhesion G-protein coupled receptor D1 OS=Bos taurus OX=9913 GN=ADGRD1 PE=2 SV=1 AGRD1_BOVIN reviewed Adhesion G-protein coupled receptor D1 (G-protein coupled receptor 133) [Cleaved into: Adhesion G-protein coupled receptor D1, N-terminal fragment (ADGRD1 N-terminal fragment); Adhesion G-protein coupled receptor D1, C-terminal fragment (ADGRD1 C-terminal fragment)] Bos taurus (Bovine) GO:0004930; GO:0005886; GO:0007166; GO:0007186; GO:0007189 adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186] plasma membrane [GO:0005886] G protein-coupled receptor activity [GO:0004930] g327.t1 Q9HAR2 33.333 363 2.21e-49 192.0 sp|Q9HAR2|AGRL3_HUMAN Adhesion G protein-coupled receptor L3 OS=Homo sapiens OX=9606 GN=ADGRL3 PE=1 SV=2 g328.t1 Q9QXY9 52.815 373 8.52e-121 357.0 sp|Q9QXY9|PEX3_MOUSE Peroxisomal biogenesis factor 3 OS=Mus musculus OX=10090 GN=Pex3 PE=1 SV=1 g337.t1 Q9VUL9 33.447 293 2.09e-31 129.0 sp|Q9VUL9|FUCTA_DROME Glycoprotein 3-alpha-L-fucosyltransferase A OS=Drosophila melanogaster OX=7227 GN=FucTA PE=1 SV=2 FUCTA_DROME reviewed Glycoprotein 3-alpha-L-fucosyltransferase A (EC 2.4.1.214) (Core alpha-(1,3)-fucosyltransferase) Drosophila melanogaster (Fruit fly) GO:0005797; GO:0006491; GO:0007399; GO:0018279; GO:0018392; GO:0032580; GO:0046920 N-glycan processing [GO:0006491]; nervous system development [GO:0007399]; protein N-linked glycosylation via asparagine [GO:0018279] Golgi cisterna membrane [GO:0032580]; Golgi medial cisterna [GO:0005797] alpha-(1->3)-fucosyltransferase activity [GO:0046920]; glycoprotein 3-alpha-L-fucosyltransferase activity [GO:0018392] g338.t1 Q9NWZ5 67.647 238 2.13e-102 311.0 sp|Q9NWZ5|UCKL1_HUMAN Uridine-cytidine kinase-like 1 OS=Homo sapiens OX=9606 GN=UCKL1 PE=1 SV=2 g339.t1 Q40082 55.172 435 3.9e-176 505.0 sp|Q40082|XYLA_HORVU Xylose isomerase OS=Hordeum vulgare OX=4513 GN=XYLA PE=1 SV=1 g341.t1 Q922Q5 64.145 304 3.58e-131 382.0 sp|Q922Q5|S35B3_MOUSE Adenosine 3'-phospho 5'-phosphosulfate transporter 2 OS=Mus musculus OX=10090 GN=Slc35b3 PE=2 SV=1 g342.t1 Q14534 60.234 342 2.45e-154 451.0 sp|Q14534|ERG1_HUMAN Squalene monooxygenase OS=Homo sapiens OX=9606 GN=SQLE PE=1 SV=3 ERG1_HUMAN reviewed Squalene monooxygenase (EC 1.14.14.17) (Squalene epoxidase) (SE) Homo sapiens (Human) GO:0004506; GO:0005783; GO:0005789; GO:0006695; GO:0016020; GO:0016126; GO:0042127; GO:0043231; GO:0071949; GO:0140042; GO:1904614 cholesterol biosynthetic process [GO:0006695]; lipid droplet formation [GO:0140042]; regulation of cell population proliferation [GO:0042127]; response to biphenyl [GO:1904614]; sterol biosynthetic process [GO:0016126] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020] FAD binding [GO:0071949]; squalene monooxygenase activity [GO:0004506] g343.t1 Q5ZHS1 83.212 548 0.0 942.0 sp|Q5ZHS1|ELP3_CHICK Elongator complex protein 3 OS=Gallus gallus OX=9031 GN=ELP3 PE=2 SV=1 ELP3_CHICK reviewed Elongator complex protein 3 (EC 2.3.1.311) (tRNA uridine(34) acetyltransferase) Gallus gallus (Chicken) GO:0000049; GO:0002098; GO:0002926; GO:0005634; GO:0005737; GO:0006357; GO:0033588; GO:0046872; GO:0051539; GO:0106261 regulation of transcription by RNA polymerase II [GO:0006357]; tRNA wobble base 5-methoxycarbonylmethyl-2-thiouridinylation [GO:0002926]; tRNA wobble uridine modification [GO:0002098] cytoplasm [GO:0005737]; elongator holoenzyme complex [GO:0033588]; nucleus [GO:0005634] 4 iron, 4 sulfur cluster binding [GO:0051539]; metal ion binding [GO:0046872]; tRNA binding [GO:0000049]; tRNA uridine(34) acetyltransferase activity [GO:0106261] g344.t1 Q9BXY4 43.86 171 6.98e-49 166.0 sp|Q9BXY4|RSPO3_HUMAN R-spondin-3 OS=Homo sapiens OX=9606 GN=RSPO3 PE=1 SV=1 RSPO3_HUMAN reviewed R-spondin-3 (Protein with TSP type-1 repeat) (hPWTSR) (Roof plate-specific spondin-3) (hRspo3) (Thrombospondin type-1 domain-containing protein 2) Homo sapiens (Human) GO:0001974; GO:0002040; GO:0005102; GO:0005109; GO:0005576; GO:0005615; GO:0008201; GO:0030177; GO:0060070; GO:0060670; GO:0090263; GO:2000052; GO:2000096 blood vessel remodeling [GO:0001974]; branching involved in labyrinthine layer morphogenesis [GO:0060670]; canonical Wnt signaling pathway [GO:0060070]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of non-canonical Wnt signaling pathway [GO:2000052]; positive regulation of Wnt signaling pathway [GO:0030177]; positive regulation of Wnt signaling pathway, planar cell polarity pathway [GO:2000096]; sprouting angiogenesis [GO:0002040] extracellular region [GO:0005576]; extracellular space [GO:0005615] frizzled binding [GO:0005109]; heparin binding [GO:0008201]; signaling receptor binding [GO:0005102] g345.t1 Q6DIV6 44.576 507 8.58e-140 416.0 sp|Q6DIV6|VIAAT_XENTR Vesicular inhibitory amino acid transporter OS=Xenopus tropicalis OX=8364 GN=slc32a1 PE=2 SV=1 VIAAT_XENTR reviewed Vesicular inhibitory amino acid transporter (GABA and glycine transporter) (Solute carrier family 32 member 1) (Vesicular GABA transporter) Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0001762; GO:0003333; GO:0005774; GO:0006836; GO:0008021; GO:0015179; GO:0015185; GO:0015187; GO:0015812; GO:0015816; GO:0030659; GO:0051939; GO:0060077; GO:0098793; GO:0140799; GO:0140800 amino acid transmembrane transport [GO:0003333]; beta-alanine transport [GO:0001762]; gamma-aminobutyric acid import [GO:0051939]; gamma-aminobutyric acid transport [GO:0015812]; glycine transport [GO:0015816]; neurotransmitter transport [GO:0006836] cytoplasmic vesicle membrane [GO:0030659]; inhibitory synapse [GO:0060077]; presynapse [GO:0098793]; synaptic vesicle [GO:0008021]; vacuolar membrane [GO:0005774] gamma-aminobutyric acid transmembrane transporter activity [GO:0015185]; gamma-aminobutyric acid:proton antiporter activity [GO:0140800]; glycine transmembrane transporter activity [GO:0015187]; glycine:proton antiporter activity [GO:0140799]; L-amino acid transmembrane transporter activity [GO:0015179] g346.t1 P34024 30.07 286 2.65e-30 118.0 sp|P34024|PLC_LISMO 1-phosphatidylinositol phosphodiesterase OS=Listeria monocytogenes serovar 1/2a (strain ATCC BAA-679 / EGD-e) OX=169963 GN=plcA PE=1 SV=1 g350.t1 Q6IR74 40.902 643 2.1199999999999999e-137 419.0 sp|Q6IR74|CTL1_XENLA Choline transporter-like protein 1 OS=Xenopus laevis OX=8355 GN=slc44a1 PE=2 SV=2 g350.t2 Q6IR74 41.721 616 5.29e-137 418.0 sp|Q6IR74|CTL1_XENLA Choline transporter-like protein 1 OS=Xenopus laevis OX=8355 GN=slc44a1 PE=2 SV=2 g351.t1 Q6UPE0 65.559 572 0.0 780.0 sp|Q6UPE0|CHDH_RAT Choline dehydrogenase, mitochondrial OS=Rattus norvegicus OX=10116 GN=Chdh PE=1 SV=1 g355.t1 P56719 40.992 383 4.75e-81 259.0 sp|P56719|OX2R_RAT Orexin receptor type 2 OS=Rattus norvegicus OX=10116 GN=Hcrtr2 PE=2 SV=1 g356.t1 P0CB88 45.0 100 1.09e-24 92.4 sp|P0CB88|NDUS5_PONPY NADH dehydrogenase [ubiquinone] iron-sulfur protein 5 OS=Pongo pygmaeus OX=9600 GN=NDUFS5 PE=3 SV=1 g358.t1 Q9BRS2 56.057 487 6.27e-171 500.0 sp|Q9BRS2|RIOK1_HUMAN Serine/threonine-protein kinase RIO1 OS=Homo sapiens OX=9606 GN=RIOK1 PE=1 SV=2 RIOK1_HUMAN reviewed Serine/threonine-protein kinase RIO1 (EC 2.7.11.1) (EC 3.6.1.-) (RIO kinase 1) Homo sapiens (Human) GO:0004674; GO:0005524; GO:0005654; GO:0005829; GO:0016887; GO:0030490; GO:0030688; GO:0034708; GO:0042274; GO:0046872; GO:0106310; GO:2000234 maturation of SSU-rRNA [GO:0030490]; positive regulation of rRNA processing [GO:2000234]; ribosomal small subunit biogenesis [GO:0042274] cytosol [GO:0005829]; methyltransferase complex [GO:0034708]; nucleoplasm [GO:0005654]; preribosome, small subunit precursor [GO:0030688] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g360.t1 Q6QNK2 41.254 303 2.8299999999999997e-61 219.0 sp|Q6QNK2|AGRD1_HUMAN Adhesion G-protein coupled receptor D1 OS=Homo sapiens OX=9606 GN=ADGRD1 PE=1 SV=1 AGRD1_HUMAN reviewed Adhesion G-protein coupled receptor D1 (G-protein coupled receptor 133) (G-protein coupled receptor PGR25) [Cleaved into: Adhesion G-protein coupled receptor D1, N-terminal fragment (ADGRD1 N-terminal fragment); Adhesion G-protein coupled receptor D1, C-terminal fragment (ADGRD1 C-terminal fragment)] Homo sapiens (Human) GO:0004930; GO:0005654; GO:0005829; GO:0005886; GO:0007166; GO:0007186; GO:0007189; GO:0014819; GO:0016020; GO:0016607 adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186]; regulation of skeletal muscle contraction [GO:0014819] cytosol [GO:0005829]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] G protein-coupled receptor activity [GO:0004930] g361.t1 O74423 27.329 161 2.8e-23 98.6 sp|O74423|ENT1_SCHPO Epsin-1 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) OX=284812 GN=ent1 PE=1 SV=2 g361.t1 O74423 27.673 159 2.94e-23 98.6 sp|O74423|ENT1_SCHPO Epsin-1 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) OX=284812 GN=ent1 PE=1 SV=2 g361.t1 O74423 27.16 162 3.1399999999999995e-23 98.6 sp|O74423|ENT1_SCHPO Epsin-1 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) OX=284812 GN=ent1 PE=1 SV=2 g362.t1 Q5E9E2 69.767 172 3.54e-78 232.0 sp|Q5E9E2|MYL9_BOVIN Myosin regulatory light polypeptide 9 OS=Bos taurus OX=9913 GN=MYL9 PE=2 SV=3 MYL9_BOVIN reviewed Myosin regulatory light polypeptide 9 (Myosin regulatory light chain 2, smooth muscle isoform) (Myosin regulatory light chain 9) Bos taurus (Bovine) GO:0005509; GO:0005737; GO:0005938; GO:0016460; GO:0031032; GO:0032036; GO:0042641; GO:0097513 actomyosin structure organization [GO:0031032] actomyosin [GO:0042641]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; myosin II complex [GO:0016460]; myosin II filament [GO:0097513] calcium ion binding [GO:0005509]; myosin heavy chain binding [GO:0032036] g363.t1 A0A0H2WHF1 35.172 290 6.24e-41 155.0 sp|A0A0H2WHF1|BPAC_BURMA Autotransporter adhesin BpaC OS=Burkholderia mallei (strain ATCC 23344) OX=243160 GN=bpaC PE=1 SV=1 g363.t1 A0A0H2WHF1 33.119 311 1.3e-36 143.0 sp|A0A0H2WHF1|BPAC_BURMA Autotransporter adhesin BpaC OS=Burkholderia mallei (strain ATCC 23344) OX=243160 GN=bpaC PE=1 SV=1 g363.t1 A0A0H2WHF1 33.444 302 1.4500000000000002e-27 116.0 sp|A0A0H2WHF1|BPAC_BURMA Autotransporter adhesin BpaC OS=Burkholderia mallei (strain ATCC 23344) OX=243160 GN=bpaC PE=1 SV=1 g366.t1 P70453 43.814 388 9.33e-105 320.0 sp|P70453|PDE7A_MOUSE High affinity 3',5'-cyclic-AMP phosphodiesterase 7A OS=Mus musculus OX=10090 GN=Pde7a PE=1 SV=2 g370.t1 Q3ZBE1 46.975 281 1.07e-87 266.0 sp|Q3ZBE1|ARMC1_BOVIN Armadillo repeat-containing protein 1 OS=Bos taurus OX=9913 GN=ARMC1 PE=2 SV=1 g371.t1 Q13347 57.407 324 1.2200000000000001e-117 344.0 sp|Q13347|EIF3I_HUMAN Eukaryotic translation initiation factor 3 subunit I OS=Homo sapiens OX=9606 GN=EIF3I PE=1 SV=1 g373.t1 B9EJV3 43.33 997 0.0 734.0 sp|B9EJV3|GRB1L_MOUSE GREB1-like protein OS=Mus musculus OX=10090 GN=Greb1l PE=2 SV=1 GRB1L_MOUSE reviewed GREB1-like protein Mus musculus (Mouse) GO:0001656; GO:0001658; GO:0001822; GO:0002009; GO:0003151; GO:0003231; GO:0016020; GO:0030539; GO:0035050; GO:0042254; GO:0048384; GO:0055007; GO:0060065; GO:0060562; GO:0061205; GO:0072177 branching involved in ureteric bud morphogenesis [GO:0001658]; cardiac muscle cell differentiation [GO:0055007]; cardiac ventricle development [GO:0003231]; embryonic heart tube development [GO:0035050]; epithelial tube morphogenesis [GO:0060562]; kidney development [GO:0001822]; male genitalia development [GO:0030539]; mesonephric duct development [GO:0072177]; metanephros development [GO:0001656]; morphogenesis of an epithelium [GO:0002009]; outflow tract morphogenesis [GO:0003151]; paramesonephric duct development [GO:0061205]; retinoic acid receptor signaling pathway [GO:0048384]; ribosome biogenesis [GO:0042254]; uterus development [GO:0060065] membrane [GO:0016020] g373.t1 B9EJV3 46.373 703 0.0 654.0 sp|B9EJV3|GRB1L_MOUSE GREB1-like protein OS=Mus musculus OX=10090 GN=Greb1l PE=2 SV=1 GRB1L_MOUSE reviewed GREB1-like protein Mus musculus (Mouse) GO:0001656; GO:0001658; GO:0001822; GO:0002009; GO:0003151; GO:0003231; GO:0016020; GO:0030539; GO:0035050; GO:0042254; GO:0048384; GO:0055007; GO:0060065; GO:0060562; GO:0061205; GO:0072177 branching involved in ureteric bud morphogenesis [GO:0001658]; cardiac muscle cell differentiation [GO:0055007]; cardiac ventricle development [GO:0003231]; embryonic heart tube development [GO:0035050]; epithelial tube morphogenesis [GO:0060562]; kidney development [GO:0001822]; male genitalia development [GO:0030539]; mesonephric duct development [GO:0072177]; metanephros development [GO:0001656]; morphogenesis of an epithelium [GO:0002009]; outflow tract morphogenesis [GO:0003151]; paramesonephric duct development [GO:0061205]; retinoic acid receptor signaling pathway [GO:0048384]; ribosome biogenesis [GO:0042254]; uterus development [GO:0060065] membrane [GO:0016020] g375.t1 P85107 63.033 211 6.94e-81 286.0 sp|P85107|TGS1_RAT Trimethylguanosine synthase OS=Rattus norvegicus OX=10116 GN=Tgs1 PE=1 SV=1 TGS1_RAT reviewed Trimethylguanosine synthase (EC 2.1.1.-) (Cap-specific guanine-N(2) methyltransferase) (Nuclear receptor coactivator 6-interacting protein) (PRIP-interacting protein with methyltransferase motif) (PIMT) (PIPMT) Rattus norvegicus (Rat) GO:0005634; GO:0005730; GO:0005737; GO:0005829; GO:0015030; GO:0036261; GO:0042308; GO:0061178; GO:0071164; GO:0071333; GO:0071398 7-methylguanosine cap hypermethylation [GO:0036261]; cellular response to fatty acid [GO:0071398]; cellular response to glucose stimulus [GO:0071333]; negative regulation of protein import into nucleus [GO:0042308]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178] Cajal body [GO:0015030]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleus [GO:0005634] RNA cap trimethylguanosine synthase activity [GO:0071164] g378.t1 Q8AWH3 68.627 102 5.87e-38 145.0 sp|Q8AWH3|SX17A_XENTR Transcription factor Sox-17-alpha OS=Xenopus tropicalis OX=8364 GN=sox17a PE=2 SV=1 g385.t1 Q5IFK1 43.59 195 1.04e-40 165.0 sp|Q5IFK1|MCPH1_MACFA Microcephalin OS=Macaca fascicularis OX=9541 GN=MCPH1 PE=2 SV=1 g385.t1 Q5IFK1 51.724 116 1.78e-22 107.0 sp|Q5IFK1|MCPH1_MACFA Microcephalin OS=Macaca fascicularis OX=9541 GN=MCPH1 PE=2 SV=1 g386.t1 Q9Y6A2 39.474 456 2.0099999999999997e-104 323.0 sp|Q9Y6A2|CP46A_HUMAN Cholesterol 24-hydroxylase OS=Homo sapiens OX=9606 GN=CYP46A1 PE=1 SV=1 g390.t1 E1BD59 25.0 312 9.31e-24 108.0 sp|E1BD59|TRI56_BOVIN E3 ubiquitin-protein ligase TRIM56 OS=Bos taurus OX=9913 GN=TRIM56 PE=2 SV=1 TRI56_BOVIN reviewed E3 ubiquitin-protein ligase TRIM56 (EC 2.3.2.27) (Tripartite motif-containing protein 56) Bos taurus (Bovine) GO:0005654; GO:0005737; GO:0006513; GO:0008270; GO:0032728; GO:0034340; GO:0045087; GO:0051607; GO:0060340; GO:0061630; GO:0070534 defense response to virus [GO:0051607]; innate immune response [GO:0045087]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of type I interferon-mediated signaling pathway [GO:0060340]; protein K63-linked ubiquitination [GO:0070534]; protein monoubiquitination [GO:0006513]; response to type I interferon [GO:0034340] cytoplasm [GO:0005737]; nucleoplasm [GO:0005654] ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] g391.t1 Q9Y6A2 38.507 335 8.26e-71 232.0 sp|Q9Y6A2|CP46A_HUMAN Cholesterol 24-hydroxylase OS=Homo sapiens OX=9606 GN=CYP46A1 PE=1 SV=1 g392.t1 Q9Y2J2 71.552 348 0.0 554.0 sp|Q9Y2J2|E41L3_HUMAN Band 4.1-like protein 3 OS=Homo sapiens OX=9606 GN=EPB41L3 PE=1 SV=2 g393.t1 Q4R4V2 64.851 202 1.5299999999999999e-83 273.0 sp|Q4R4V2|PPM1G_MACFA Protein phosphatase 1G OS=Macaca fascicularis OX=9541 GN=PPM1G PE=2 SV=1 PPM1G_MACFA reviewed Protein phosphatase 1G (EC 3.1.3.16) Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey) GO:0004722; GO:0005654; GO:0005737; GO:0016020; GO:0046872; GO:0051726 regulation of cell cycle [GO:0051726] cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleoplasm [GO:0005654] metal ion binding [GO:0046872]; protein serine/threonine phosphatase activity [GO:0004722] g393.t1 Q4R4V2 60.833 120 2.47e-38 151.0 sp|Q4R4V2|PPM1G_MACFA Protein phosphatase 1G OS=Macaca fascicularis OX=9541 GN=PPM1G PE=2 SV=1 PPM1G_MACFA reviewed Protein phosphatase 1G (EC 3.1.3.16) Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey) GO:0004722; GO:0005654; GO:0005737; GO:0016020; GO:0046872; GO:0051726 regulation of cell cycle [GO:0051726] cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleoplasm [GO:0005654] metal ion binding [GO:0046872]; protein serine/threonine phosphatase activity [GO:0004722] g393.t2 P79126 62.054 224 4.61e-84 274.0 sp|P79126|PPM1G_BOVIN Protein phosphatase 1G OS=Bos taurus OX=9913 GN=PPM1G PE=2 SV=2 g393.t2 P79126 60.833 120 1.25e-38 152.0 sp|P79126|PPM1G_BOVIN Protein phosphatase 1G OS=Bos taurus OX=9913 GN=PPM1G PE=2 SV=2 g394.t1 Q5RBH9 61.002 459 0.0 551.0 sp|Q5RBH9|NRBP_PONAB Nuclear receptor-binding protein OS=Pongo abelii OX=9601 GN=NRBP1 PE=2 SV=1 g397.t1 Q28509 29.755 326 6.02e-38 144.0 sp|Q28509|ADRB2_MACMU Beta-2 adrenergic receptor OS=Macaca mulatta OX=9544 GN=ADRB2 PE=2 SV=1 ADRB2_MACMU reviewed Beta-2 adrenergic receptor (Beta-2 adrenoreceptor) (Beta-2 adrenoceptor) Macaca mulatta (Rhesus macaque) GO:0001540; GO:0002024; GO:0002025; GO:0002028; GO:0004941; GO:0005634; GO:0005769; GO:0005794; GO:0005886; GO:0006366; GO:0006898; GO:0006939; GO:0008179; GO:0009409; GO:0010666; GO:0010667; GO:0015459; GO:0016324; GO:0030501; GO:0031649; GO:0036064; GO:0040015; GO:0042803; GO:0043235; GO:0043410; GO:0044877; GO:0045171; GO:0045453; GO:0045744; GO:0045944; GO:0045986; GO:0050873; GO:0051380; GO:0061885; GO:0071880; GO:0071881; GO:0072686; GO:0098990; GO:0098992; GO:0106134; GO:0120162; GO:0141163; GO:1901098; GO:1904504; GO:1904646 adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; adenylate cyclase-inhibiting adrenergic receptor signaling pathway [GO:0071881]; AMPA selective glutamate receptor signaling pathway [GO:0098990]; bone resorption [GO:0045453]; brown fat cell differentiation [GO:0050873]; cellular response to amyloid-beta [GO:1904646]; diet induced thermogenesis [GO:0002024]; heat generation [GO:0031649]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of G protein-coupled receptor signaling pathway [GO:0045744]; negative regulation of multicellular organism growth [GO:0040015]; negative regulation of smooth muscle contraction [GO:0045986]; norepinephrine-epinephrine-mediated vasodilation involved in regulation of systemic arterial blood pressure [GO:0002025]; positive regulation of autophagosome maturation [GO:1901098]; positive regulation of bone mineralization [GO:0030501]; positive regulation of cAMP/PKA signal transduction [GO:0141163]; positive regulation of cardiac muscle cell apoptotic process [GO:0010666]; positive regulation of cardiac muscle cell contraction [GO:0106134]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of lipophagy [GO:1904504]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of mini excitatory postsynaptic potential [GO:0061885]; positive regulation of transcription by RNA polymerase II [GO:0045944]; receptor-mediated endocytosis [GO:0006898]; regulation of sodium ion transport [GO:0002028]; response to cold [GO:0009409]; smooth muscle contraction [GO:0006939]; transcription by RNA polymerase II [GO:0006366] apical plasma membrane [GO:0016324]; ciliary basal body [GO:0036064]; early endosome [GO:0005769]; Golgi apparatus [GO:0005794]; intercellular bridge [GO:0045171]; mitotic spindle [GO:0072686]; neuronal dense core vesicle [GO:0098992]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] adenylate cyclase binding [GO:0008179]; amyloid-beta binding [GO:0001540]; beta2-adrenergic receptor activity [GO:0004941]; norepinephrine binding [GO:0051380]; potassium channel regulator activity [GO:0015459]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877] g399.t1 Q5SPP5 46.975 843 0.0 739.0 sp|Q5SPP5|EFR3B_DANRE Protein EFR3 homolog B OS=Danio rerio OX=7955 GN=efr3b PE=3 SV=2 g401.t1 Q0EEE2 35.376 865 2.0199999999999998e-150 469.0 sp|Q0EEE2|PTHD3_MOUSE Patched domain-containing protein 3 OS=Mus musculus OX=10090 GN=Ptchd3 PE=1 SV=1 PTHD3_MOUSE reviewed Patched domain-containing protein 3 (RND-type protein RNDEu-3) Mus musculus (Mouse) GO:0005783; GO:0005789; GO:0016020; GO:0097225 endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; sperm midpiece [GO:0097225] g402.t1 Q15398 37.19 242 1.94e-30 132.0 sp|Q15398|DLGP5_HUMAN Disks large-associated protein 5 OS=Homo sapiens OX=9606 GN=DLGAP5 PE=1 SV=2 g402.t2 Q15398 37.19 242 2.2e-30 132.0 sp|Q15398|DLGP5_HUMAN Disks large-associated protein 5 OS=Homo sapiens OX=9606 GN=DLGAP5 PE=1 SV=2 g404.t1 Q96RW7 39.516 124 7.33e-21 103.0 sp|Q96RW7|HMCN1_HUMAN Hemicentin-1 OS=Homo sapiens OX=9606 GN=HMCN1 PE=1 SV=2 HMCN1_HUMAN reviewed Hemicentin-1 (Fibulin-6) (FIBL-6) Homo sapiens (Human) GO:0005201; GO:0005509; GO:0005604; GO:0005737; GO:0005886; GO:0005912; GO:0005927; GO:0005938; GO:0007156; GO:0007157; GO:0007601; GO:0009617; GO:0030036; GO:0031012; GO:0032154; GO:0051301; GO:0070062; GO:0071711; GO:0098631 actin cytoskeleton organization [GO:0030036]; basement membrane organization [GO:0071711]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601] adherens junction [GO:0005912]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; muscle tendon junction [GO:0005927]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; cell adhesion mediator activity [GO:0098631]; extracellular matrix structural constituent [GO:0005201] g408.t1 D3YXG0 42.222 360 1.0700000000000001e-64 250.0 sp|D3YXG0|HMCN1_MOUSE Hemicentin-1 OS=Mus musculus OX=10090 GN=Hmcn1 PE=1 SV=1 HMCN1_MOUSE reviewed Hemicentin-1 (Fibulin-6) (FIBL-6) Mus musculus (Mouse) GO:0005509; GO:0005576; GO:0005604; GO:0005737; GO:0005886; GO:0005912; GO:0005927; GO:0005938; GO:0007156; GO:0007157; GO:0009617; GO:0030036; GO:0030054; GO:0031012; GO:0032154; GO:0051301; GO:0071711; GO:0098631 actin cytoskeleton organization [GO:0030036]; basement membrane organization [GO:0071711]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617] adherens junction [GO:0005912]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; muscle tendon junction [GO:0005927]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; cell adhesion mediator activity [GO:0098631] g408.t1 D3YXG0 41.639 305 8.72e-49 197.0 sp|D3YXG0|HMCN1_MOUSE Hemicentin-1 OS=Mus musculus OX=10090 GN=Hmcn1 PE=1 SV=1 HMCN1_MOUSE reviewed Hemicentin-1 (Fibulin-6) (FIBL-6) Mus musculus (Mouse) GO:0005509; GO:0005576; GO:0005604; GO:0005737; GO:0005886; GO:0005912; GO:0005927; GO:0005938; GO:0007156; GO:0007157; GO:0009617; GO:0030036; GO:0030054; GO:0031012; GO:0032154; GO:0051301; GO:0071711; GO:0098631 actin cytoskeleton organization [GO:0030036]; basement membrane organization [GO:0071711]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617] adherens junction [GO:0005912]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; muscle tendon junction [GO:0005927]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; cell adhesion mediator activity [GO:0098631] g408.t1 D3YXG0 43.781 201 2.33e-39 166.0 sp|D3YXG0|HMCN1_MOUSE Hemicentin-1 OS=Mus musculus OX=10090 GN=Hmcn1 PE=1 SV=1 HMCN1_MOUSE reviewed Hemicentin-1 (Fibulin-6) (FIBL-6) Mus musculus (Mouse) GO:0005509; GO:0005576; GO:0005604; GO:0005737; GO:0005886; GO:0005912; GO:0005927; GO:0005938; GO:0007156; GO:0007157; GO:0009617; GO:0030036; GO:0030054; GO:0031012; GO:0032154; GO:0051301; GO:0071711; GO:0098631 actin cytoskeleton organization [GO:0030036]; basement membrane organization [GO:0071711]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617] adherens junction [GO:0005912]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; muscle tendon junction [GO:0005927]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; cell adhesion mediator activity [GO:0098631] g410.t1 P27117 37.793 426 1.23e-90 285.0 sp|P27117|DCOR_BOVIN Ornithine decarboxylase OS=Bos taurus OX=9913 GN=ODC1 PE=2 SV=1 g411.t1 P27117 35.446 426 8.94e-78 250.0 sp|P27117|DCOR_BOVIN Ornithine decarboxylase OS=Bos taurus OX=9913 GN=ODC1 PE=2 SV=1 g422.t1 Q6R5J2 35.023 1085 0.0 588.0 sp|Q6R5J2|DISP1_DANRE Protein dispatched homolog 1 OS=Danio rerio OX=7955 GN=disp1 PE=2 SV=1 DISP1_DANRE reviewed Protein dispatched homolog 1 (Protein chameleon) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0007224; GO:0007519; GO:0008015; GO:0009887; GO:0009952; GO:0016020; GO:0021984; GO:0031290; GO:0042694; GO:0048701; GO:0048839 adenohypophysis development [GO:0021984]; animal organ morphogenesis [GO:0009887]; anterior/posterior pattern specification [GO:0009952]; blood circulation [GO:0008015]; embryonic cranial skeleton morphogenesis [GO:0048701]; inner ear development [GO:0048839]; muscle cell fate specification [GO:0042694]; retinal ganglion cell axon guidance [GO:0031290]; skeletal muscle tissue development [GO:0007519]; smoothened signaling pathway [GO:0007224] membrane [GO:0016020] g423.t1 Q5XHM7 36.502 263 1.13e-38 150.0 sp|Q5XHM7|CHSTC_XENLA Carbohydrate sulfotransferase 12 OS=Xenopus laevis OX=8355 GN=chst12 PE=2 SV=2 g425.t1 B2RC85 46.318 421 7.35e-119 379.0 sp|B2RC85|R10B2_HUMAN Radial spoke head 10 homolog B2 OS=Homo sapiens OX=9606 GN=RSPH10B2 PE=1 SV=2 R10B2_HUMAN reviewed Radial spoke head 10 homolog B2 Homo sapiens (Human) GO:0005929; GO:0005930; GO:0036126; GO:0097729 9+2 motile cilium [GO:0097729]; axoneme [GO:0005930]; cilium [GO:0005929]; sperm flagellum [GO:0036126] g427.t1 Q5M7F8 48.201 139 2.18e-43 144.0 sp|Q5M7F8|CM2CA_XENLA Ciliary microtubule inner protein 2C OS=Xenopus laevis OX=8355 GN=cimip2ca PE=2 SV=1 g444.t1 P09057 40.816 392 1.95e-101 312.0 sp|P09057|DCOR_RAT Ornithine decarboxylase OS=Rattus norvegicus OX=10116 GN=Odc1 PE=1 SV=1 DCOR_RAT reviewed Ornithine decarboxylase (ODC) (EC 4.1.1.17) Rattus norvegicus (Rat) GO:0001822; GO:0004586; GO:0005737; GO:0005829; GO:0006595; GO:0008283; GO:0008284; GO:0009446; GO:0009615; GO:0033387; GO:0042176; GO:0042803; GO:0048471 cell population proliferation [GO:0008283]; kidney development [GO:0001822]; polyamine metabolic process [GO:0006595]; positive regulation of cell population proliferation [GO:0008284]; putrescine biosynthetic process [GO:0009446]; putrescine biosynthetic process from arginine, via ornithine [GO:0033387]; regulation of protein catabolic process [GO:0042176]; response to virus [GO:0009615] cytoplasm [GO:0005737]; cytosol [GO:0005829]; perinuclear region of cytoplasm [GO:0048471] ornithine decarboxylase activity [GO:0004586]; protein homodimerization activity [GO:0042803] g445.t1 P07805 44.149 376 5.51e-107 327.0 sp|P07805|DCOR_TRYBB Ornithine decarboxylase OS=Trypanosoma brucei brucei OX=5702 PE=1 SV=2 g449.t1 Q6DRP4 36.893 412 7.03e-76 245.0 sp|Q6DRP4|CCM2_DANRE Cerebral cavernous malformations protein 2 homolog OS=Danio rerio OX=7955 GN=ccm2 PE=1 SV=1 CCM2_DANRE reviewed Cerebral cavernous malformations protein 2 homolog (Malcavernin) (Valentine) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001570; GO:0005737; GO:0007043; GO:0007507; GO:0009948; GO:0048845; GO:0060047; GO:1904018; GO:1905072 anterior/posterior axis specification [GO:0009948]; cardiac jelly development [GO:1905072]; cell-cell junction assembly [GO:0007043]; heart contraction [GO:0060047]; heart development [GO:0007507]; positive regulation of vasculature development [GO:1904018]; vasculogenesis [GO:0001570]; venous blood vessel morphogenesis [GO:0048845] cytoplasm [GO:0005737] g450.t1 Q27403 52.414 145 5.06e-43 167.0 sp|Q27403|GCM_DROME Transcription factor glial cells missing OS=Drosophila melanogaster OX=7227 GN=gcm PE=1 SV=2 GCM_DROME reviewed Transcription factor glial cells missing (Protein glide) Drosophila melanogaster (Fruit fly) GO:0000977; GO:0000978; GO:0000981; GO:0001228; GO:0003677; GO:0005634; GO:0006357; GO:0007403; GO:0007516; GO:0010001; GO:0010468; GO:0010628; GO:0021782; GO:0030182; GO:0031290; GO:0035165; GO:0035289; GO:0042063; GO:0042387; GO:0042690; GO:0045610; GO:0045687; GO:0045893; GO:0045944; GO:0048813; GO:0050764; GO:0060252; GO:0060857 dendrite morphogenesis [GO:0048813]; embryonic crystal cell differentiation [GO:0035165]; establishment of glial blood-brain barrier [GO:0060857]; glial cell development [GO:0021782]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; gliogenesis [GO:0042063]; hemocyte development [GO:0007516]; negative regulation of crystal cell differentiation [GO:0042690]; neuron differentiation [GO:0030182]; plasmatocyte differentiation [GO:0042387]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of gene expression [GO:0010628]; positive regulation of glial cell differentiation [GO:0045687]; positive regulation of glial cell proliferation [GO:0060252]; positive regulation of transcription by RNA polymerase II [GO:0045944]; posterior head segmentation [GO:0035289]; regulation of gene expression [GO:0010468]; regulation of hemocyte differentiation [GO:0045610]; regulation of phagocytosis [GO:0050764]; regulation of transcription by RNA polymerase II [GO:0006357]; retinal ganglion cell axon guidance [GO:0031290] nucleus [GO:0005634] DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977] g455.t1 Q9P2K1 45.24 1523 0.0 1285.0 sp|Q9P2K1|C2D2A_HUMAN Coiled-coil and C2 domain-containing protein 2A OS=Homo sapiens OX=9606 GN=CC2D2A PE=1 SV=3 g462.t1 Q7Z449 34.607 445 6.489999999999999e-82 267.0 sp|Q7Z449|CP2U1_HUMAN Cytochrome P450 2U1 OS=Homo sapiens OX=9606 GN=CYP2U1 PE=1 SV=1 CP2U1_HUMAN reviewed Cytochrome P450 2U1 (Long-chain fatty acid omega-monooxygenase) (EC 1.14.14.80) Homo sapiens (Human) GO:0004497; GO:0005506; GO:0005737; GO:0005743; GO:0005789; GO:0006082; GO:0006805; GO:0008202; GO:0008395; GO:0016712; GO:0020037; GO:0052869; GO:0097267; GO:0102033; GO:1903604 cytochrome metabolic process [GO:1903604]; omega-hydroxylase P450 pathway [GO:0097267]; organic acid metabolic process [GO:0006082]; steroid metabolic process [GO:0008202]; xenobiotic metabolic process [GO:0006805] cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; mitochondrial inner membrane [GO:0005743] arachidonate omega-hydroxylase activity [GO:0052869]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; long-chain fatty acid omega-hydroxylase activity [GO:0102033]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; steroid hydroxylase activity [GO:0008395] g463.t1 F1NZI4 35.691 311 7.11e-61 210.0 sp|F1NZI4|PGGHG_CHICK Protein-glucosylgalactosylhydroxylysine glucosidase OS=Gallus gallus OX=9031 GN=PGGHG PE=1 SV=3 g464.t1 A0JMP0 43.49 361 1.18e-96 305.0 sp|A0JMP0|PGGHG_DANRE Protein-glucosylgalactosylhydroxylysine glucosidase OS=Danio rerio OX=7955 GN=pgghg PE=2 SV=1 g468.t1 Q1EHB4 31.494 616 1.25e-87 288.0 sp|Q1EHB4|SC5AC_HUMAN Sodium-coupled monocarboxylate transporter 2 OS=Homo sapiens OX=9606 GN=SLC5A12 PE=1 SV=2 SC5AC_HUMAN reviewed Sodium-coupled monocarboxylate transporter 2 (Electroneutral sodium monocarboxylate cotransporter) (Low-affinity sodium-lactate cotransporter) (Solute carrier family 5 member 12) Homo sapiens (Human) GO:0005343; GO:0005654; GO:0005886; GO:0006811; GO:0006814; GO:0015129; GO:0015293; GO:0015718; GO:0016324; GO:0070062; GO:0140161 monoatomic ion transport [GO:0006811]; monocarboxylic acid transport [GO:0015718]; sodium ion transport [GO:0006814] apical plasma membrane [GO:0016324]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] lactate transmembrane transporter activity [GO:0015129]; monocarboxylate:sodium symporter activity [GO:0140161]; organic acid:sodium symporter activity [GO:0005343]; symporter activity [GO:0015293] g469.t1 Q6P4H8 61.582 177 6.56e-74 226.0 sp|Q6P4H8|ACKMT_HUMAN ATP synthase subunit C lysine N-methyltransferase OS=Homo sapiens OX=9606 GN=ATPSCKMT PE=1 SV=2 ACKMT_HUMAN reviewed ATP synthase subunit C lysine N-methyltransferase (EC 2.1.1.-) (Protein N-lysine methyltransferase FAM173B) (hFAM173B) Homo sapiens (Human) GO:0005739; GO:0016279; GO:0018022; GO:0018023; GO:0030061; GO:1904058; GO:1905273; GO:1905706 peptidyl-lysine methylation [GO:0018022]; peptidyl-lysine trimethylation [GO:0018023]; positive regulation of proton-transporting ATP synthase activity, rotational mechanism [GO:1905273]; positive regulation of sensory perception of pain [GO:1904058]; regulation of mitochondrial ATP synthesis coupled proton transport [GO:1905706] mitochondrial crista [GO:0030061]; mitochondrion [GO:0005739] protein-lysine N-methyltransferase activity [GO:0016279] g470.t1 Q3ZMH1 34.198 617 8.23e-108 340.0 sp|Q3ZMH1|SC5A8_DANRE Sodium-coupled monocarboxylate transporter 1 OS=Danio rerio OX=7955 GN=slc5a8 PE=1 SV=1 SC5A8_DANRE reviewed Sodium-coupled monocarboxylate transporter 1 (Electrogenic sodium monocarboxylate cotransporter) (zSMCTe) (Sodium solute symporter family 5 member 8 protein) (Solute carrier family 5 member 8) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005343; GO:0006814; GO:0006821; GO:0006846; GO:0006848; GO:0015355; GO:0015705; GO:0015706; GO:0015727; GO:0015730; GO:0016324; GO:0140161; GO:2001142 acetate transport [GO:0006846]; chloride transport [GO:0006821]; iodide transport [GO:0015705]; lactate transport [GO:0015727]; nicotinate transport [GO:2001142]; nitrate transmembrane transport [GO:0015706]; propanoate transmembrane transport [GO:0015730]; pyruvate transport [GO:0006848]; sodium ion transport [GO:0006814] apical plasma membrane [GO:0016324] monocarboxylate:sodium symporter activity [GO:0140161]; organic acid:sodium symporter activity [GO:0005343]; secondary active monocarboxylate transmembrane transporter activity [GO:0015355] g471.t1 Q802W4 67.606 71 2.4000000000000004e-27 106.0 sp|Q802W4|NOL10_DANRE Nucleolar protein 10 OS=Danio rerio OX=7955 GN=nol10 PE=2 SV=1 g472.t1 Q7T0Q5 54.209 594 0.0 630.0 sp|Q7T0Q5|NOL10_XENLA Nucleolar protein 10 OS=Xenopus laevis OX=8355 GN=nol10 PE=2 SV=1 g477.t1 Q05585 53.846 104 1.94e-24 108.0 sp|Q05585|MSRE_RABIT Macrophage scavenger receptor types I and II OS=Oryctolagus cuniculus OX=9986 GN=MSR1 PE=2 SV=1 g478.t1 Q9WTS8 50.0 238 3.1400000000000004e-72 237.0 sp|Q9WTS8|FCN1_RAT Ficolin-1 OS=Rattus norvegicus OX=10116 GN=Fcn1 PE=2 SV=2 FCN1_RAT reviewed Ficolin-1 (Collagen/fibrinogen domain-containing protein 1) (Ficolin-A) (Ficolin-alpha) (M-ficolin) Rattus norvegicus (Rat) GO:0001867; GO:0002752; GO:0003823; GO:0005102; GO:0005581; GO:0005615; GO:0005886; GO:0007186; GO:0030246; GO:0032757; GO:0033691; GO:0038187; GO:0046872; GO:0097367; GO:0106139 cell surface pattern recognition receptor signaling pathway [GO:0002752]; complement activation, lectin pathway [GO:0001867]; G protein-coupled receptor signaling pathway [GO:0007186]; positive regulation of interleukin-8 production [GO:0032757] collagen trimer [GO:0005581]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; symbiont cell surface [GO:0106139] antigen binding [GO:0003823]; carbohydrate binding [GO:0030246]; carbohydrate derivative binding [GO:0097367]; metal ion binding [GO:0046872]; pattern recognition receptor activity [GO:0038187]; sialic acid binding [GO:0033691]; signaling receptor binding [GO:0005102] g478.t1 Q9WTS8 52.404 208 1.78e-65 219.0 sp|Q9WTS8|FCN1_RAT Ficolin-1 OS=Rattus norvegicus OX=10116 GN=Fcn1 PE=2 SV=2 FCN1_RAT reviewed Ficolin-1 (Collagen/fibrinogen domain-containing protein 1) (Ficolin-A) (Ficolin-alpha) (M-ficolin) Rattus norvegicus (Rat) GO:0001867; GO:0002752; GO:0003823; GO:0005102; GO:0005581; GO:0005615; GO:0005886; GO:0007186; GO:0030246; GO:0032757; GO:0033691; GO:0038187; GO:0046872; GO:0097367; GO:0106139 cell surface pattern recognition receptor signaling pathway [GO:0002752]; complement activation, lectin pathway [GO:0001867]; G protein-coupled receptor signaling pathway [GO:0007186]; positive regulation of interleukin-8 production [GO:0032757] collagen trimer [GO:0005581]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; symbiont cell surface [GO:0106139] antigen binding [GO:0003823]; carbohydrate binding [GO:0030246]; carbohydrate derivative binding [GO:0097367]; metal ion binding [GO:0046872]; pattern recognition receptor activity [GO:0038187]; sialic acid binding [GO:0033691]; signaling receptor binding [GO:0005102] g479.t1 Q9DBN1 24.008 529 2.4800000000000003e-27 120.0 sp|Q9DBN1|STR6L_MOUSE Stimulated by retinoic acid gene 6 protein-like OS=Mus musculus OX=10090 GN=Stra6l PE=1 SV=1 g479.t2 Q9DBN1 24.008 529 2.4800000000000003e-27 120.0 sp|Q9DBN1|STR6L_MOUSE Stimulated by retinoic acid gene 6 protein-like OS=Mus musculus OX=10090 GN=Stra6l PE=1 SV=1 g479.t3 Q9DBN1 24.008 529 2.4800000000000003e-27 120.0 sp|Q9DBN1|STR6L_MOUSE Stimulated by retinoic acid gene 6 protein-like OS=Mus musculus OX=10090 GN=Stra6l PE=1 SV=1 g479.t4 Q9DBN1 26.48 321 3.63e-23 108.0 sp|Q9DBN1|STR6L_MOUSE Stimulated by retinoic acid gene 6 protein-like OS=Mus musculus OX=10090 GN=Stra6l PE=1 SV=1 g480.t1 Q8VDW4 66.438 146 1.0699999999999999e-67 204.0 sp|Q8VDW4|UBE2W_MOUSE Ubiquitin-conjugating enzyme E2 W OS=Mus musculus OX=10090 GN=Ube2w PE=1 SV=1 UBE2W_MOUSE reviewed Ubiquitin-conjugating enzyme E2 W (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme W) (N-terminal E2 ubiquitin-conjugating enzyme) (EC 2.3.2.25) (N-terminus-conjugating E2) (Ubiquitin carrier protein W) (Ubiquitin-protein ligase W) Mus musculus (Mouse) GO:0000209; GO:0004842; GO:0005524; GO:0005634; GO:0006281; GO:0006513; GO:0006515; GO:0031625; GO:0031669; GO:0038202; GO:0043161; GO:0061631; GO:0070979; GO:0071218; GO:0140374; GO:1904262 antiviral innate immune response [GO:0140374]; cellular response to misfolded protein [GO:0071218]; cellular response to nutrient levels [GO:0031669]; DNA repair [GO:0006281]; negative regulation of TORC1 signaling [GO:1904262]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K11-linked ubiquitination [GO:0070979]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; TORC1 signaling [GO:0038202] nucleus [GO:0005634] ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842] g481.t1 Q8K1A6 33.051 472 5.18e-69 252.0 sp|Q8K1A6|C2D1A_MOUSE Coiled-coil and C2 domain-containing protein 1A OS=Mus musculus OX=10090 GN=Cc2d1a PE=1 SV=2 C2D1A_MOUSE reviewed Coiled-coil and C2 domain-containing protein 1A (Five prime repressor element under dual repression-binding protein 1) (FRE under dual repression-binding protein 1) (Freud-1) Mus musculus (Mouse) GO:0000122; GO:0000978; GO:0000981; GO:0001227; GO:0001650; GO:0002087; GO:0005634; GO:0005813; GO:0005829; GO:0005886; GO:0006357; GO:0007032; GO:0010008; GO:0036064; GO:0043576; GO:0045202; GO:0098978; GO:0140059; GO:0150023; GO:0150052; GO:1905381 apical dendrite arborization [GO:0150023]; dendrite arborization [GO:0140059]; endosome organization [GO:0007032]; negative regulation of snRNA transcription by RNA polymerase II [GO:1905381]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of postsynapse assembly [GO:0150052]; regulation of respiratory gaseous exchange [GO:0043576]; regulation of respiratory gaseous exchange by nervous system process [GO:0002087]; regulation of transcription by RNA polymerase II [GO:0006357] centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; fibrillar center [GO:0001650]; glutamatergic synapse [GO:0098978]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; synapse [GO:0045202] DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978] g482.t1 D3ZDM7 40.361 332 1.43e-87 270.0 sp|D3ZDM7|OXDD_RAT D-aspartate oxidase OS=Rattus norvegicus OX=10116 GN=Ddo PE=1 SV=1 OXDD_RAT reviewed D-aspartate oxidase (DASOX) (DASPO) (DDO) (EC 1.4.3.1) Rattus norvegicus (Rat) GO:0005737; GO:0005777; GO:0005782; GO:0005829; GO:0006531; GO:0006533; GO:0007320; GO:0007625; GO:0008445; GO:0010646; GO:0019478; GO:0042445; GO:0050877; GO:0071949 aspartate metabolic process [GO:0006531]; D-amino acid catabolic process [GO:0019478]; grooming behavior [GO:0007625]; hormone metabolic process [GO:0042445]; insemination [GO:0007320]; L-aspartate catabolic process [GO:0006533]; nervous system process [GO:0050877]; regulation of cell communication [GO:0010646] cytoplasm [GO:0005737]; cytosol [GO:0005829]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777] D-aspartate oxidase activity [GO:0008445]; FAD binding [GO:0071949] g485.t1 Q10121 58.594 128 7.6e-40 134.0 sp|Q10121|YSD2_CAEEL RutC family protein C23G10.2 OS=Caenorhabditis elegans OX=6239 GN=C23G10.2 PE=3 SV=3 g486.t1 M3TYT0 47.882 1393 0.0 1107.0 sp|M3TYT0|ROCK2_PIG Rho-associated protein kinase 2 OS=Sus scrofa OX=9823 GN=ROCK2 PE=1 SV=1 g486.t2 M3TYT0 47.739 1393 0.0 1098.0 sp|M3TYT0|ROCK2_PIG Rho-associated protein kinase 2 OS=Sus scrofa OX=9823 GN=ROCK2 PE=1 SV=1 g486.t3 M3TYT0 47.908 1386 0.0 1105.0 sp|M3TYT0|ROCK2_PIG Rho-associated protein kinase 2 OS=Sus scrofa OX=9823 GN=ROCK2 PE=1 SV=1 g490.t1 Q8R4V0 65.275 455 0.0 602.0 sp|Q8R4V0|SGK3_RAT Serine/threonine-protein kinase Sgk3 OS=Rattus norvegicus OX=10116 GN=Sgk3 PE=1 SV=2 SGK3_RAT reviewed Serine/threonine-protein kinase Sgk3 (EC 2.7.11.1) (Cytokine-independent survival kinase) (Serum/glucocorticoid-regulated kinase 3) (Serum/glucocorticoid-regulated kinase-like) Rattus norvegicus (Rat) GO:0004674; GO:0005524; GO:0005769; GO:0015459; GO:0031410; GO:0035091; GO:0035556; GO:0055037; GO:0060090; GO:0106310; GO:2001240 intracellular signal transduction [GO:0035556]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240] cytoplasmic vesicle [GO:0031410]; early endosome [GO:0005769]; recycling endosome [GO:0055037] ATP binding [GO:0005524]; molecular adaptor activity [GO:0060090]; phosphatidylinositol binding [GO:0035091]; potassium channel regulator activity [GO:0015459]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g492.t1 Q3U095 26.477 491 7.82e-35 141.0 sp|Q3U095|NXPE2_MOUSE NXPE family member 2 OS=Mus musculus OX=10090 GN=Nxpe2 PE=2 SV=1 g494.t1 O02663 27.866 506 2.91e-53 192.0 sp|O02663|UD2B9_MACFA UDP-glucuronosyltransferase 2B9 OS=Macaca fascicularis OX=9541 GN=UGT2B9 PE=2 SV=1 g497.t1 A0JNB1 44.578 332 2.29e-90 290.0 sp|A0JNB1|ZN227_BOVIN Zinc finger protein 227 OS=Bos taurus OX=9913 GN=ZNF227 PE=2 SV=1 g497.t1 A0JNB1 43.675 332 4.82e-89 287.0 sp|A0JNB1|ZN227_BOVIN Zinc finger protein 227 OS=Bos taurus OX=9913 GN=ZNF227 PE=2 SV=1 g497.t1 A0JNB1 37.534 373 1.08e-75 251.0 sp|A0JNB1|ZN227_BOVIN Zinc finger protein 227 OS=Bos taurus OX=9913 GN=ZNF227 PE=2 SV=1 g497.t1 A0JNB1 41.637 281 1.77e-67 229.0 sp|A0JNB1|ZN227_BOVIN Zinc finger protein 227 OS=Bos taurus OX=9913 GN=ZNF227 PE=2 SV=1 g497.t1 A0JNB1 42.424 198 2.87e-42 160.0 sp|A0JNB1|ZN227_BOVIN Zinc finger protein 227 OS=Bos taurus OX=9913 GN=ZNF227 PE=2 SV=1 g497.t1 A0JNB1 41.279 172 2.4099999999999997e-34 137.0 sp|A0JNB1|ZN227_BOVIN Zinc finger protein 227 OS=Bos taurus OX=9913 GN=ZNF227 PE=2 SV=1 g499.t1 Q6NY73 46.789 109 2.57e-21 101.0 sp|Q6NY73|L3BPB_DANRE Galectin-3-binding protein B OS=Danio rerio OX=7955 GN=lgals3bpb PE=2 SV=1 g502.t1 P0C6B8 26.238 606 6.169999999999999e-42 172.0 sp|P0C6B8|SVEP1_RAT Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 OS=Rattus norvegicus OX=10116 GN=Svep1 PE=1 SV=1 SVEP1_RAT reviewed Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 Rattus norvegicus (Rat) GO:0001945; GO:0003017; GO:0003682; GO:0005178; GO:0005509; GO:0005576; GO:0005615; GO:0005634; GO:0005737; GO:0008544; GO:0010467; GO:0010572; GO:0016020; GO:0031012; GO:0031099; GO:0036303; GO:0045906; GO:0048014; GO:0098640; GO:0120193 epidermis development [GO:0008544]; gene expression [GO:0010467]; lymph circulation [GO:0003017]; lymph vessel development [GO:0001945]; lymph vessel morphogenesis [GO:0036303]; negative regulation of vasoconstriction [GO:0045906]; positive regulation of platelet activation [GO:0010572]; regeneration [GO:0031099]; Tie signaling pathway [GO:0048014]; tight junction organization [GO:0120193] cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; nucleus [GO:0005634] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; integrin binding [GO:0005178]; integrin binding involved in cell-matrix adhesion [GO:0098640] g502.t1 P0C6B8 27.682 578 7.07e-41 168.0 sp|P0C6B8|SVEP1_RAT Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 OS=Rattus norvegicus OX=10116 GN=Svep1 PE=1 SV=1 SVEP1_RAT reviewed Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 Rattus norvegicus (Rat) GO:0001945; GO:0003017; GO:0003682; GO:0005178; GO:0005509; GO:0005576; GO:0005615; GO:0005634; GO:0005737; GO:0008544; GO:0010467; GO:0010572; GO:0016020; GO:0031012; GO:0031099; GO:0036303; GO:0045906; GO:0048014; GO:0098640; GO:0120193 epidermis development [GO:0008544]; gene expression [GO:0010467]; lymph circulation [GO:0003017]; lymph vessel development [GO:0001945]; lymph vessel morphogenesis [GO:0036303]; negative regulation of vasoconstriction [GO:0045906]; positive regulation of platelet activation [GO:0010572]; regeneration [GO:0031099]; Tie signaling pathway [GO:0048014]; tight junction organization [GO:0120193] cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; nucleus [GO:0005634] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; integrin binding [GO:0005178]; integrin binding involved in cell-matrix adhesion [GO:0098640] g502.t1 P0C6B8 24.382 566 1.01e-36 155.0 sp|P0C6B8|SVEP1_RAT Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 OS=Rattus norvegicus OX=10116 GN=Svep1 PE=1 SV=1 SVEP1_RAT reviewed Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 Rattus norvegicus (Rat) GO:0001945; GO:0003017; GO:0003682; GO:0005178; GO:0005509; GO:0005576; GO:0005615; GO:0005634; GO:0005737; GO:0008544; GO:0010467; GO:0010572; GO:0016020; GO:0031012; GO:0031099; GO:0036303; GO:0045906; GO:0048014; GO:0098640; GO:0120193 epidermis development [GO:0008544]; gene expression [GO:0010467]; lymph circulation [GO:0003017]; lymph vessel development [GO:0001945]; lymph vessel morphogenesis [GO:0036303]; negative regulation of vasoconstriction [GO:0045906]; positive regulation of platelet activation [GO:0010572]; regeneration [GO:0031099]; Tie signaling pathway [GO:0048014]; tight junction organization [GO:0120193] cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; nucleus [GO:0005634] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; integrin binding [GO:0005178]; integrin binding involved in cell-matrix adhesion [GO:0098640] g502.t1 P0C6B8 25.505 643 3.21e-34 147.0 sp|P0C6B8|SVEP1_RAT Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 OS=Rattus norvegicus OX=10116 GN=Svep1 PE=1 SV=1 SVEP1_RAT reviewed Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 Rattus norvegicus (Rat) GO:0001945; GO:0003017; GO:0003682; GO:0005178; GO:0005509; GO:0005576; GO:0005615; GO:0005634; GO:0005737; GO:0008544; GO:0010467; GO:0010572; GO:0016020; GO:0031012; GO:0031099; GO:0036303; GO:0045906; GO:0048014; GO:0098640; GO:0120193 epidermis development [GO:0008544]; gene expression [GO:0010467]; lymph circulation [GO:0003017]; lymph vessel development [GO:0001945]; lymph vessel morphogenesis [GO:0036303]; negative regulation of vasoconstriction [GO:0045906]; positive regulation of platelet activation [GO:0010572]; regeneration [GO:0031099]; Tie signaling pathway [GO:0048014]; tight junction organization [GO:0120193] cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; nucleus [GO:0005634] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; integrin binding [GO:0005178]; integrin binding involved in cell-matrix adhesion [GO:0098640] g502.t1 P0C6B8 25.216 579 1.62e-32 141.0 sp|P0C6B8|SVEP1_RAT Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 OS=Rattus norvegicus OX=10116 GN=Svep1 PE=1 SV=1 SVEP1_RAT reviewed Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 Rattus norvegicus (Rat) GO:0001945; GO:0003017; GO:0003682; GO:0005178; GO:0005509; GO:0005576; GO:0005615; GO:0005634; GO:0005737; GO:0008544; GO:0010467; GO:0010572; GO:0016020; GO:0031012; GO:0031099; GO:0036303; GO:0045906; GO:0048014; GO:0098640; GO:0120193 epidermis development [GO:0008544]; gene expression [GO:0010467]; lymph circulation [GO:0003017]; lymph vessel development [GO:0001945]; lymph vessel morphogenesis [GO:0036303]; negative regulation of vasoconstriction [GO:0045906]; positive regulation of platelet activation [GO:0010572]; regeneration [GO:0031099]; Tie signaling pathway [GO:0048014]; tight junction organization [GO:0120193] cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; nucleus [GO:0005634] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; integrin binding [GO:0005178]; integrin binding involved in cell-matrix adhesion [GO:0098640] g502.t1 P0C6B8 23.734 632 3.88e-31 137.0 sp|P0C6B8|SVEP1_RAT Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 OS=Rattus norvegicus OX=10116 GN=Svep1 PE=1 SV=1 SVEP1_RAT reviewed Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 Rattus norvegicus (Rat) GO:0001945; GO:0003017; GO:0003682; GO:0005178; GO:0005509; GO:0005576; GO:0005615; GO:0005634; GO:0005737; GO:0008544; GO:0010467; GO:0010572; GO:0016020; GO:0031012; GO:0031099; GO:0036303; GO:0045906; GO:0048014; GO:0098640; GO:0120193 epidermis development [GO:0008544]; gene expression [GO:0010467]; lymph circulation [GO:0003017]; lymph vessel development [GO:0001945]; lymph vessel morphogenesis [GO:0036303]; negative regulation of vasoconstriction [GO:0045906]; positive regulation of platelet activation [GO:0010572]; regeneration [GO:0031099]; Tie signaling pathway [GO:0048014]; tight junction organization [GO:0120193] cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; nucleus [GO:0005634] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; integrin binding [GO:0005178]; integrin binding involved in cell-matrix adhesion [GO:0098640] g502.t1 P0C6B8 23.292 644 1.49e-28 128.0 sp|P0C6B8|SVEP1_RAT Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 OS=Rattus norvegicus OX=10116 GN=Svep1 PE=1 SV=1 SVEP1_RAT reviewed Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 Rattus norvegicus (Rat) GO:0001945; GO:0003017; GO:0003682; GO:0005178; GO:0005509; GO:0005576; GO:0005615; GO:0005634; GO:0005737; GO:0008544; GO:0010467; GO:0010572; GO:0016020; GO:0031012; GO:0031099; GO:0036303; GO:0045906; GO:0048014; GO:0098640; GO:0120193 epidermis development [GO:0008544]; gene expression [GO:0010467]; lymph circulation [GO:0003017]; lymph vessel development [GO:0001945]; lymph vessel morphogenesis [GO:0036303]; negative regulation of vasoconstriction [GO:0045906]; positive regulation of platelet activation [GO:0010572]; regeneration [GO:0031099]; Tie signaling pathway [GO:0048014]; tight junction organization [GO:0120193] cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; nucleus [GO:0005634] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; integrin binding [GO:0005178]; integrin binding involved in cell-matrix adhesion [GO:0098640] g502.t1 P0C6B8 24.39 615 2.46e-28 127.0 sp|P0C6B8|SVEP1_RAT Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 OS=Rattus norvegicus OX=10116 GN=Svep1 PE=1 SV=1 SVEP1_RAT reviewed Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 Rattus norvegicus (Rat) GO:0001945; GO:0003017; GO:0003682; GO:0005178; GO:0005509; GO:0005576; GO:0005615; GO:0005634; GO:0005737; GO:0008544; GO:0010467; GO:0010572; GO:0016020; GO:0031012; GO:0031099; GO:0036303; GO:0045906; GO:0048014; GO:0098640; GO:0120193 epidermis development [GO:0008544]; gene expression [GO:0010467]; lymph circulation [GO:0003017]; lymph vessel development [GO:0001945]; lymph vessel morphogenesis [GO:0036303]; negative regulation of vasoconstriction [GO:0045906]; positive regulation of platelet activation [GO:0010572]; regeneration [GO:0031099]; Tie signaling pathway [GO:0048014]; tight junction organization [GO:0120193] cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; nucleus [GO:0005634] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; integrin binding [GO:0005178]; integrin binding involved in cell-matrix adhesion [GO:0098640] g502.t1 P0C6B8 24.605 569 2.4000000000000004e-27 124.0 sp|P0C6B8|SVEP1_RAT Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 OS=Rattus norvegicus OX=10116 GN=Svep1 PE=1 SV=1 SVEP1_RAT reviewed Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 Rattus norvegicus (Rat) GO:0001945; GO:0003017; GO:0003682; GO:0005178; GO:0005509; GO:0005576; GO:0005615; GO:0005634; GO:0005737; GO:0008544; GO:0010467; GO:0010572; GO:0016020; GO:0031012; GO:0031099; GO:0036303; GO:0045906; GO:0048014; GO:0098640; GO:0120193 epidermis development [GO:0008544]; gene expression [GO:0010467]; lymph circulation [GO:0003017]; lymph vessel development [GO:0001945]; lymph vessel morphogenesis [GO:0036303]; negative regulation of vasoconstriction [GO:0045906]; positive regulation of platelet activation [GO:0010572]; regeneration [GO:0031099]; Tie signaling pathway [GO:0048014]; tight junction organization [GO:0120193] cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; nucleus [GO:0005634] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; integrin binding [GO:0005178]; integrin binding involved in cell-matrix adhesion [GO:0098640] g502.t1 P0C6B8 24.808 520 3.0200000000000003e-27 124.0 sp|P0C6B8|SVEP1_RAT Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 OS=Rattus norvegicus OX=10116 GN=Svep1 PE=1 SV=1 SVEP1_RAT reviewed Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 Rattus norvegicus (Rat) GO:0001945; GO:0003017; GO:0003682; GO:0005178; GO:0005509; GO:0005576; GO:0005615; GO:0005634; GO:0005737; GO:0008544; GO:0010467; GO:0010572; GO:0016020; GO:0031012; GO:0031099; GO:0036303; GO:0045906; GO:0048014; GO:0098640; GO:0120193 epidermis development [GO:0008544]; gene expression [GO:0010467]; lymph circulation [GO:0003017]; lymph vessel development [GO:0001945]; lymph vessel morphogenesis [GO:0036303]; negative regulation of vasoconstriction [GO:0045906]; positive regulation of platelet activation [GO:0010572]; regeneration [GO:0031099]; Tie signaling pathway [GO:0048014]; tight junction organization [GO:0120193] cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; nucleus [GO:0005634] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; integrin binding [GO:0005178]; integrin binding involved in cell-matrix adhesion [GO:0098640] g503.t1 Q63530 51.594 345 8.36e-130 378.0 sp|Q63530|PTER_RAT N-acetyltaurine hydrolase OS=Rattus norvegicus OX=10116 GN=Pter PE=2 SV=2 g509.t1 P63221 73.494 83 1.5499999999999998e-40 131.0 sp|P63221|RS21_PIG Small ribosomal subunit protein eS21 OS=Sus scrofa OX=9823 GN=RPS21 PE=1 SV=1 g510.t1 Q8C176 57.514 346 7.319999999999999e-147 445.0 sp|Q8C176|TAF2_MOUSE Transcription initiation factor TFIID subunit 2 OS=Mus musculus OX=10090 GN=Taf2 PE=2 SV=2 TAF2_MOUSE reviewed Transcription initiation factor TFIID subunit 2 (TBP-associated factor 150 kDa) (Transcription initiation factor TFIID 150 kDa subunit) (TAF(II)150) (TAFII-150) (TAFII150) Mus musculus (Mouse) GO:0000086; GO:0000976; GO:0003682; GO:0005634; GO:0005669; GO:0006282; GO:0006357; GO:0006367; GO:0033276; GO:0042789; GO:0045893; GO:0051123; GO:0060261 G2/M transition of mitotic cell cycle [GO:0000086]; mRNA transcription by RNA polymerase II [GO:0042789]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription initiation by RNA polymerase II [GO:0060261]; regulation of DNA repair [GO:0006282]; regulation of transcription by RNA polymerase II [GO:0006357]; RNA polymerase II preinitiation complex assembly [GO:0051123]; transcription initiation at RNA polymerase II promoter [GO:0006367] nucleus [GO:0005634]; transcription factor TFIID complex [GO:0005669]; transcription factor TFTC complex [GO:0033276] chromatin binding [GO:0003682]; transcription cis-regulatory region binding [GO:0000976] g510.t2 Q8C176 57.803 346 3.75e-148 448.0 sp|Q8C176|TAF2_MOUSE Transcription initiation factor TFIID subunit 2 OS=Mus musculus OX=10090 GN=Taf2 PE=2 SV=2 TAF2_MOUSE reviewed Transcription initiation factor TFIID subunit 2 (TBP-associated factor 150 kDa) (Transcription initiation factor TFIID 150 kDa subunit) (TAF(II)150) (TAFII-150) (TAFII150) Mus musculus (Mouse) GO:0000086; GO:0000976; GO:0003682; GO:0005634; GO:0005669; GO:0006282; GO:0006357; GO:0006367; GO:0033276; GO:0042789; GO:0045893; GO:0051123; GO:0060261 G2/M transition of mitotic cell cycle [GO:0000086]; mRNA transcription by RNA polymerase II [GO:0042789]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription initiation by RNA polymerase II [GO:0060261]; regulation of DNA repair [GO:0006282]; regulation of transcription by RNA polymerase II [GO:0006357]; RNA polymerase II preinitiation complex assembly [GO:0051123]; transcription initiation at RNA polymerase II promoter [GO:0006367] nucleus [GO:0005634]; transcription factor TFIID complex [GO:0005669]; transcription factor TFTC complex [GO:0033276] chromatin binding [GO:0003682]; transcription cis-regulatory region binding [GO:0000976] g511.t1 Q6P1X5 54.962 655 0.0 703.0 sp|Q6P1X5|TAF2_HUMAN Transcription initiation factor TFIID subunit 2 OS=Homo sapiens OX=9606 GN=TAF2 PE=1 SV=3 TAF2_HUMAN reviewed Transcription initiation factor TFIID subunit 2 (150 kDa cofactor of initiator function) (RNA polymerase II TBP-associated factor subunit B) (TBP-associated factor 150 kDa) (Transcription initiation factor TFIID 150 kDa subunit) (TAF(II)150) (TAFII-150) (TAFII150) Homo sapiens (Human) GO:0000086; GO:0000976; GO:0003682; GO:0005634; GO:0005654; GO:0005669; GO:0006282; GO:0006357; GO:0006367; GO:0016251; GO:0033276; GO:0042789; GO:0045893; GO:0051123; GO:0060261; GO:1901562 G2/M transition of mitotic cell cycle [GO:0000086]; mRNA transcription by RNA polymerase II [GO:0042789]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription initiation by RNA polymerase II [GO:0060261]; regulation of DNA repair [GO:0006282]; regulation of transcription by RNA polymerase II [GO:0006357]; response to paraquat [GO:1901562]; RNA polymerase II preinitiation complex assembly [GO:0051123]; transcription initiation at RNA polymerase II promoter [GO:0006367] nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor TFIID complex [GO:0005669]; transcription factor TFTC complex [GO:0033276] chromatin binding [GO:0003682]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; transcription cis-regulatory region binding [GO:0000976] g514.t1 Q99MV1 25.03 835 4.49e-49 196.0 sp|Q99MV1|TDRD1_MOUSE Tudor domain-containing protein 1 OS=Mus musculus OX=10090 GN=Tdrd1 PE=1 SV=2 TDRD1_MOUSE reviewed Tudor domain-containing protein 1 Mus musculus (Mouse) GO:0005737; GO:0005829; GO:0007281; GO:0007283; GO:0008270; GO:0030719; GO:0033391; GO:0034587; GO:0043186; GO:0045202; GO:0051321; GO:0071546; GO:0141196; GO:1990904 germ cell development [GO:0007281]; meiotic cell cycle [GO:0051321]; P granule organization [GO:0030719]; piRNA processing [GO:0034587]; spermatogenesis [GO:0007283]; transposable element silencing by piRNA-mediated DNA methylation [GO:0141196] chromatoid body [GO:0033391]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; P granule [GO:0043186]; pi-body [GO:0071546]; ribonucleoprotein complex [GO:1990904]; synapse [GO:0045202] zinc ion binding [GO:0008270] g514.t1 Q99MV1 26.185 802 4.96e-41 170.0 sp|Q99MV1|TDRD1_MOUSE Tudor domain-containing protein 1 OS=Mus musculus OX=10090 GN=Tdrd1 PE=1 SV=2 TDRD1_MOUSE reviewed Tudor domain-containing protein 1 Mus musculus (Mouse) GO:0005737; GO:0005829; GO:0007281; GO:0007283; GO:0008270; GO:0030719; GO:0033391; GO:0034587; GO:0043186; GO:0045202; GO:0051321; GO:0071546; GO:0141196; GO:1990904 germ cell development [GO:0007281]; meiotic cell cycle [GO:0051321]; P granule organization [GO:0030719]; piRNA processing [GO:0034587]; spermatogenesis [GO:0007283]; transposable element silencing by piRNA-mediated DNA methylation [GO:0141196] chromatoid body [GO:0033391]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; P granule [GO:0043186]; pi-body [GO:0071546]; ribonucleoprotein complex [GO:1990904]; synapse [GO:0045202] zinc ion binding [GO:0008270] g514.t1 Q99MV1 24.913 578 2.78e-34 148.0 sp|Q99MV1|TDRD1_MOUSE Tudor domain-containing protein 1 OS=Mus musculus OX=10090 GN=Tdrd1 PE=1 SV=2 TDRD1_MOUSE reviewed Tudor domain-containing protein 1 Mus musculus (Mouse) GO:0005737; GO:0005829; GO:0007281; GO:0007283; GO:0008270; GO:0030719; GO:0033391; GO:0034587; GO:0043186; GO:0045202; GO:0051321; GO:0071546; GO:0141196; GO:1990904 germ cell development [GO:0007281]; meiotic cell cycle [GO:0051321]; P granule organization [GO:0030719]; piRNA processing [GO:0034587]; spermatogenesis [GO:0007283]; transposable element silencing by piRNA-mediated DNA methylation [GO:0141196] chromatoid body [GO:0033391]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; P granule [GO:0043186]; pi-body [GO:0071546]; ribonucleoprotein complex [GO:1990904]; synapse [GO:0045202] zinc ion binding [GO:0008270] g514.t1 Q99MV1 26.298 597 8.510000000000001e-31 136.0 sp|Q99MV1|TDRD1_MOUSE Tudor domain-containing protein 1 OS=Mus musculus OX=10090 GN=Tdrd1 PE=1 SV=2 TDRD1_MOUSE reviewed Tudor domain-containing protein 1 Mus musculus (Mouse) GO:0005737; GO:0005829; GO:0007281; GO:0007283; GO:0008270; GO:0030719; GO:0033391; GO:0034587; GO:0043186; GO:0045202; GO:0051321; GO:0071546; GO:0141196; GO:1990904 germ cell development [GO:0007281]; meiotic cell cycle [GO:0051321]; P granule organization [GO:0030719]; piRNA processing [GO:0034587]; spermatogenesis [GO:0007283]; transposable element silencing by piRNA-mediated DNA methylation [GO:0141196] chromatoid body [GO:0033391]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; P granule [GO:0043186]; pi-body [GO:0071546]; ribonucleoprotein complex [GO:1990904]; synapse [GO:0045202] zinc ion binding [GO:0008270] g518.t1 Q99LH1 63.216 541 0.0 712.0 sp|Q99LH1|NOG2_MOUSE Nucleolar GTP-binding protein 2 OS=Mus musculus OX=10090 GN=Gnl2 PE=1 SV=2 g519.t1 Q91437 68.081 2262 0.0 3102.0 sp|Q91437|PYR1_SQUAC Multifunctional protein CAD OS=Squalus acanthias OX=7797 GN=CAD PE=2 SV=1 PYR1_SQUAC reviewed Multifunctional protein CAD (Carbamoyl phosphate synthetase 2-aspartate transcarbamylase-dihydroorotase) [Includes: Glutamine-dependent carbamoyl-phosphate synthase (EC 6.3.5.5); Glutamine amidotransferase (GATase) (GLNase) (EC 3.5.1.2); Ammonium-dependent carbamoyl phosphate synthase (CPS) (CPSase) (EC 6.3.4.16); Aspartate carbamoyltransferase (EC 2.1.3.2); Dihydroorotase (EC 3.5.2.3)] Squalus acanthias (Spiny dogfish) GO:0004070; GO:0004087; GO:0004088; GO:0004151; GO:0004359; GO:0005524; GO:0005634; GO:0005951; GO:0006207; GO:0006526; GO:0006541; GO:0008270; GO:0016597; GO:0044205 'de novo' pyrimidine nucleobase biosynthetic process [GO:0006207]; 'de novo' UMP biosynthetic process [GO:0044205]; glutamine metabolic process [GO:0006541]; L-arginine biosynthetic process [GO:0006526] carbamoyl-phosphate synthase complex [GO:0005951]; nucleus [GO:0005634] amino acid binding [GO:0016597]; aspartate carbamoyltransferase activity [GO:0004070]; ATP binding [GO:0005524]; carbamoyl-phosphate synthase (ammonia) activity [GO:0004087]; carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity [GO:0004088]; dihydroorotase activity [GO:0004151]; glutaminase activity [GO:0004359]; zinc ion binding [GO:0008270] g525.t1 O60682 76.471 85 5.85e-41 140.0 sp|O60682|MUSC_HUMAN Musculin OS=Homo sapiens OX=9606 GN=MSC PE=1 SV=2 MUSC_HUMAN reviewed Musculin (Activated B-cell factor 1) (ABF-1) (Class A basic helix-loop-helix protein 22) (bHLHa22) Homo sapiens (Human) GO:0000785; GO:0000977; GO:0000978; GO:0000981; GO:0001227; GO:0003161; GO:0003700; GO:0005634; GO:0005654; GO:0006355; GO:0006357; GO:0007519; GO:0014707; GO:0046983; GO:0060021; GO:0060539; GO:1990830; GO:1990837 branchiomeric skeletal muscle development [GO:0014707]; cardiac conduction system development [GO:0003161]; cellular response to leukemia inhibitory factor [GO:1990830]; diaphragm development [GO:0060539]; regulation of DNA-templated transcription [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; roof of mouth development [GO:0060021]; skeletal muscle tissue development [GO:0007519] chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837] g531.t1 O60941 53.8 500 2.4499999999999997e-168 497.0 sp|O60941|DTNB_HUMAN Dystrobrevin beta OS=Homo sapiens OX=9606 GN=DTNB PE=1 SV=1 DTNB_HUMAN reviewed Dystrobrevin beta (DTN-B) (Beta-dystrobrevin) Homo sapiens (Human) GO:0005634; GO:0005737; GO:0005886; GO:0008270; GO:0009925; GO:0014069; GO:0030182; GO:0030425; GO:0045202; GO:0060077; GO:0099536 neuron differentiation [GO:0030182]; synaptic signaling [GO:0099536] basal plasma membrane [GO:0009925]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; inhibitory synapse [GO:0060077]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; synapse [GO:0045202] zinc ion binding [GO:0008270] g533.t1 P84060 68.852 61 2.62e-25 101.0 sp|P84060|DTNB_RAT Dystrobrevin beta OS=Rattus norvegicus OX=10116 GN=Dtnb PE=1 SV=2 DTNB_RAT reviewed Dystrobrevin beta (DTN-B) (Beta-dystrobrevin) Rattus norvegicus (Rat) GO:0003677; GO:0005634; GO:0005737; GO:0005886; GO:0008270; GO:0009925; GO:0014069; GO:0019902; GO:0030182; GO:0030425; GO:0045202; GO:0060077; GO:0098794; GO:0098982; GO:0099536 neuron differentiation [GO:0030182]; synaptic signaling [GO:0099536] basal plasma membrane [GO:0009925]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; GABA-ergic synapse [GO:0098982]; inhibitory synapse [GO:0060077]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; synapse [GO:0045202] DNA binding [GO:0003677]; phosphatase binding [GO:0019902]; zinc ion binding [GO:0008270] g533.t2 O60941 68.852 61 3.43e-25 101.0 sp|O60941|DTNB_HUMAN Dystrobrevin beta OS=Homo sapiens OX=9606 GN=DTNB PE=1 SV=1 DTNB_HUMAN reviewed Dystrobrevin beta (DTN-B) (Beta-dystrobrevin) Homo sapiens (Human) GO:0005634; GO:0005737; GO:0005886; GO:0008270; GO:0009925; GO:0014069; GO:0030182; GO:0030425; GO:0045202; GO:0060077; GO:0099536 neuron differentiation [GO:0030182]; synaptic signaling [GO:0099536] basal plasma membrane [GO:0009925]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; inhibitory synapse [GO:0060077]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; synapse [GO:0045202] zinc ion binding [GO:0008270] g541.t1 Q9NWS1 28.2 461 1.41e-32 137.0 sp|Q9NWS1|PARI_HUMAN PCNA-interacting partner OS=Homo sapiens OX=9606 GN=PARPBP PE=1 SV=3 g542.t1 Q9NX07 34.505 313 8.38e-45 157.0 sp|Q9NX07|TSAP1_HUMAN tRNA selenocysteine 1-associated protein 1 OS=Homo sapiens OX=9606 GN=TRNAU1AP PE=1 SV=1 TSAP1_HUMAN reviewed tRNA selenocysteine 1-associated protein 1 (SECp43) (tRNA selenocysteine-associated protein 1) Homo sapiens (Human) GO:0000049; GO:0001514; GO:0003723; GO:0005634; GO:0005737 selenocysteine incorporation [GO:0001514] cytoplasm [GO:0005737]; nucleus [GO:0005634] RNA binding [GO:0003723]; tRNA binding [GO:0000049] g543.t1 Q9WTS8 48.039 204 4.23e-51 184.0 sp|Q9WTS8|FCN1_RAT Ficolin-1 OS=Rattus norvegicus OX=10116 GN=Fcn1 PE=2 SV=2 FCN1_RAT reviewed Ficolin-1 (Collagen/fibrinogen domain-containing protein 1) (Ficolin-A) (Ficolin-alpha) (M-ficolin) Rattus norvegicus (Rat) GO:0001867; GO:0002752; GO:0003823; GO:0005102; GO:0005581; GO:0005615; GO:0005886; GO:0007186; GO:0030246; GO:0032757; GO:0033691; GO:0038187; GO:0046872; GO:0097367; GO:0106139 cell surface pattern recognition receptor signaling pathway [GO:0002752]; complement activation, lectin pathway [GO:0001867]; G protein-coupled receptor signaling pathway [GO:0007186]; positive regulation of interleukin-8 production [GO:0032757] collagen trimer [GO:0005581]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; symbiont cell surface [GO:0106139] antigen binding [GO:0003823]; carbohydrate binding [GO:0030246]; carbohydrate derivative binding [GO:0097367]; metal ion binding [GO:0046872]; pattern recognition receptor activity [GO:0038187]; sialic acid binding [GO:0033691]; signaling receptor binding [GO:0005102] g543.t2 Q15485 42.657 143 8.339999999999999e-23 103.0 sp|Q15485|FCN2_HUMAN Ficolin-2 OS=Homo sapiens OX=9606 GN=FCN2 PE=1 SV=2 FCN2_HUMAN reviewed Ficolin-2 (37 kDa elastin-binding protein) (EBP-37) (Collagen/fibrinogen domain-containing protein 2) (Ficolin-B) (Ficolin-beta) (Hucolin) (L-ficolin) (Serum lectin p35) Homo sapiens (Human) GO:0001867; GO:0002752; GO:0003823; GO:0005102; GO:0005576; GO:0005581; GO:0005615; GO:0006508; GO:0008228; GO:0009897; GO:0038187; GO:0043394; GO:0043654; GO:0046872; GO:0048306; GO:0050829; GO:0050830; GO:0070062; GO:0070892; GO:0072562; GO:0097367; GO:0106139; GO:1903028; GO:1905370; GO:2001065 cell surface pattern recognition receptor signaling pathway [GO:0002752]; complement activation, lectin pathway [GO:0001867]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; opsonization [GO:0008228]; positive regulation of opsonization [GO:1903028]; proteolysis [GO:0006508]; recognition of apoptotic cell [GO:0043654] blood microparticle [GO:0072562]; collagen trimer [GO:0005581]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; serine-type endopeptidase complex [GO:1905370]; symbiont cell surface [GO:0106139] antigen binding [GO:0003823]; calcium-dependent protein binding [GO:0048306]; carbohydrate derivative binding [GO:0097367]; lipoteichoic acid immune receptor activity [GO:0070892]; mannan binding [GO:2001065]; metal ion binding [GO:0046872]; pattern recognition receptor activity [GO:0038187]; proteoglycan binding [GO:0043394]; signaling receptor binding [GO:0005102] g545.t1 Q969Y0 25.528 521 4.49e-38 152.0 sp|Q969Y0|NXPE3_HUMAN NXPE family member 3 OS=Homo sapiens OX=9606 GN=NXPE3 PE=1 SV=1 g546.t1 Q9CPS6 38.971 136 7.340000000000001e-32 116.0 sp|Q9CPS6|HINT3_MOUSE Adenosine 5'-monophosphoramidase HINT3 OS=Mus musculus OX=10090 GN=Hint3 PE=1 SV=1 g549.t1 Q5RHH4 69.903 1751 0.0 2644.0 sp|Q5RHH4|IF172_DANRE Intraflagellar transport protein 172 homolog OS=Danio rerio OX=7955 GN=ift172 PE=2 SV=1 IF172_DANRE reviewed Intraflagellar transport protein 172 homolog Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005929; GO:0005930; GO:0030992; GO:0032006; GO:0036064; GO:0042073; GO:0045494; GO:0048793; GO:0060041; GO:0060271 cilium assembly [GO:0060271]; intraciliary transport [GO:0042073]; photoreceptor cell maintenance [GO:0045494]; pronephros development [GO:0048793]; regulation of TOR signaling [GO:0032006]; retina development in camera-type eye [GO:0060041] axoneme [GO:0005930]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; intraciliary transport particle B [GO:0030992] g550.t1 O70165 53.555 211 2.05e-69 222.0 sp|O70165|FCN1_MOUSE Ficolin-1 OS=Mus musculus OX=10090 GN=Fcn1 PE=1 SV=1 FCN1_MOUSE reviewed Ficolin-1 (Collagen/fibrinogen domain-containing protein 1) (Ficolin-A) (Ficolin-alpha) (M-ficolin) Mus musculus (Mouse) GO:0001664; GO:0001867; GO:0002752; GO:0003823; GO:0005102; GO:0005581; GO:0005615; GO:0005886; GO:0007186; GO:0032757; GO:0033691; GO:0038187; GO:0042802; GO:0043394; GO:0046872; GO:0048306; GO:0070892; GO:0097367; GO:0106139; GO:1905370; GO:2001065 cell surface pattern recognition receptor signaling pathway [GO:0002752]; complement activation, lectin pathway [GO:0001867]; G protein-coupled receptor signaling pathway [GO:0007186]; positive regulation of interleukin-8 production [GO:0032757] collagen trimer [GO:0005581]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; serine-type endopeptidase complex [GO:1905370]; symbiont cell surface [GO:0106139] antigen binding [GO:0003823]; calcium-dependent protein binding [GO:0048306]; carbohydrate derivative binding [GO:0097367]; G protein-coupled receptor binding [GO:0001664]; identical protein binding [GO:0042802]; lipoteichoic acid immune receptor activity [GO:0070892]; mannan binding [GO:2001065]; metal ion binding [GO:0046872]; pattern recognition receptor activity [GO:0038187]; proteoglycan binding [GO:0043394]; sialic acid binding [GO:0033691]; signaling receptor binding [GO:0005102] g551.t1 Q49LS8 39.088 307 1.5599999999999999e-60 211.0 sp|Q49LS8|XKR6_TETNG XK-related protein 6 OS=Tetraodon nigroviridis OX=99883 GN=xkr6 PE=2 SV=1 g552.t1 Q2KIR8 64.968 314 8.359999999999999e-135 392.0 sp|Q2KIR8|TDH_BOVIN L-threonine 3-dehydrogenase, mitochondrial OS=Bos taurus OX=9913 GN=TDH PE=2 SV=1 g553.t1 Q8CFG5 25.819 519 1.43e-33 144.0 sp|Q8CFG5|CA2D3_RAT Voltage-dependent calcium channel subunit alpha-2/delta-3 OS=Rattus norvegicus OX=10116 GN=Cacna2d3 PE=1 SV=1 CA2D3_RAT reviewed Voltage-dependent calcium channel subunit alpha-2/delta-3 (Voltage-gated calcium channel subunit alpha-2/delta-3) [Cleaved into: Voltage-dependent calcium channel subunit alpha-2-3; Voltage-dependent calcium channel subunit delta-3] Rattus norvegicus (Rat) GO:0005245; GO:0005246; GO:0005891; GO:0006816; GO:0046872; GO:0048787; GO:0098982; GO:0099174; GO:1990314 calcium ion transport [GO:0006816]; cellular response to insulin-like growth factor stimulus [GO:1990314]; regulation of presynapse organization [GO:0099174] GABA-ergic synapse [GO:0098982]; presynaptic active zone membrane [GO:0048787]; voltage-gated calcium channel complex [GO:0005891] calcium channel regulator activity [GO:0005246]; metal ion binding [GO:0046872]; voltage-gated calcium channel activity [GO:0005245] g554.t1 Q80V42 43.896 385 5.02e-108 329.0 sp|Q80V42|CBPM_MOUSE Carboxypeptidase M OS=Mus musculus OX=10090 GN=Cpm PE=1 SV=2 g555.t1 Q8NCW0 30.833 240 1.38e-28 123.0 sp|Q8NCW0|KREM2_HUMAN Kremen protein 2 OS=Homo sapiens OX=9606 GN=KREMEN2 PE=1 SV=1 g558.t1 Q90632 37.968 187 1.67e-28 123.0 sp|Q90632|MOT3_CHICK Monocarboxylate transporter 3 OS=Gallus gallus OX=9031 GN=SLC16A8 PE=1 SV=3 g562.t1 A6QLU6 38.245 319 6.12e-49 194.0 sp|A6QLU6|AGRD1_BOVIN Adhesion G-protein coupled receptor D1 OS=Bos taurus OX=9913 GN=ADGRD1 PE=2 SV=1 AGRD1_BOVIN reviewed Adhesion G-protein coupled receptor D1 (G-protein coupled receptor 133) [Cleaved into: Adhesion G-protein coupled receptor D1, N-terminal fragment (ADGRD1 N-terminal fragment); Adhesion G-protein coupled receptor D1, C-terminal fragment (ADGRD1 C-terminal fragment)] Bos taurus (Bovine) GO:0004930; GO:0005886; GO:0007166; GO:0007186; GO:0007189 adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186] plasma membrane [GO:0005886] G protein-coupled receptor activity [GO:0004930] g563.t1 P90850 45.169 445 2.12e-118 357.0 sp|P90850|YCF2E_CAEEL Uncharacterized peptidase C1-like protein F26E4.3 OS=Caenorhabditis elegans OX=6239 GN=F26E4.3 PE=1 SV=3 g568.t1 Q4R4I5 31.441 229 2.28e-32 120.0 sp|Q4R4I5|LAP4A_MACFA Lysosomal-associated transmembrane protein 4A OS=Macaca fascicularis OX=9541 GN=LAPTM4A PE=2 SV=1 g569.t1 Q62725 67.832 143 9.29e-62 202.0 sp|Q62725|NFYC_RAT Nuclear transcription factor Y subunit gamma OS=Rattus norvegicus OX=10116 GN=Nfyc PE=2 SV=1 g570.t1 Q9D1F3 47.26 146 3e-45 150.0 sp|Q9D1F3|EOLA1_MOUSE Protein EOLA1 OS=Mus musculus OX=10090 GN=Eola1 PE=1 SV=1 g576.t1 Q9H841 42.522 341 3.8900000000000003e-66 218.0 sp|Q9H841|NPAL2_HUMAN NIPA-like protein 2 OS=Homo sapiens OX=9606 GN=NIPAL2 PE=1 SV=2 g577.t1 B5X9L9 46.939 147 2.17e-39 136.0 sp|B5X9L9|PXL2B_SALSA Prostamide/prostaglandin F synthase OS=Salmo salar OX=8030 GN=prxl2b PE=2 SV=1 g579.t1 Q91754 32.453 644 6.62e-122 378.0 sp|Q91754|GCKR_XENLA Glucokinase regulatory protein OS=Xenopus laevis OX=8355 GN=gckr PE=1 SV=1 GCKR_XENLA reviewed Glucokinase regulatory protein (GKRP) (Glucokinase regulator) Xenopus laevis (African clawed frog) GO:0001678; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0009750; GO:0019210; GO:0019899; GO:0030246; GO:0033132; GO:0034504; GO:0070095; GO:0141089; GO:1901135 carbohydrate derivative metabolic process [GO:1901135]; intracellular glucose homeostasis [GO:0001678]; negative regulation of glucokinase activity [GO:0033132]; protein localization to nucleus [GO:0034504]; response to fructose [GO:0009750] cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654] carbohydrate binding [GO:0030246]; enzyme binding [GO:0019899]; fructose-6-phosphate binding [GO:0070095]; glucose sensor activity [GO:0141089]; kinase inhibitor activity [GO:0019210] g580.t1 Q9V9J3 71.645 462 0.0 709.0 sp|Q9V9J3|SRC42_DROME Tyrosine-protein kinase Src42A OS=Drosophila melanogaster OX=7227 GN=Src42A PE=1 SV=1 SRC42_DROME reviewed Tyrosine-protein kinase Src42A (EC 2.7.10.2) (Tyrosine-protein kinase Src41) (Dsrc41) Drosophila melanogaster (Fruit fly) GO:0004713; GO:0004715; GO:0005102; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0007169; GO:0007391; GO:0007395; GO:0007411; GO:0007424; GO:0007435; GO:0007476; GO:0009611; GO:0016477; GO:0030154; GO:0034332; GO:0036335; GO:0042059; GO:0042742; GO:0043277; GO:0045742; GO:0045874; GO:0045886; GO:0046529; GO:0048167; GO:0048749; GO:0051017; GO:0070374; GO:0090136 actin filament bundle assembly [GO:0051017]; adherens junction organization [GO:0034332]; apoptotic cell clearance [GO:0043277]; axon guidance [GO:0007411]; cell differentiation [GO:0030154]; cell migration [GO:0016477]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; compound eye development [GO:0048749]; defense response to bacterium [GO:0042742]; dorsal closure [GO:0007391]; dorsal closure, spreading of leading edge cells [GO:0007395]; epithelial cell-cell adhesion [GO:0090136]; imaginal disc fusion, thorax closure [GO:0046529]; imaginal disc-derived wing morphogenesis [GO:0007476]; intestinal stem cell homeostasis [GO:0036335]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of synaptic assembly at neuromuscular junction [GO:0045886]; open tracheal system development [GO:0007424]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of sevenless signaling pathway [GO:0045874]; regulation of synaptic plasticity [GO:0048167]; response to wounding [GO:0009611]; salivary gland morphogenesis [GO:0007435] cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886] ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein tyrosine kinase activity [GO:0004713]; signaling receptor binding [GO:0005102] g581.t1 P56518 89.855 414 0.0 701.0 sp|P56518|HDAC1_STRPU Histone deacetylase 1 OS=Strongylocentrotus purpuratus OX=7668 GN=HDAC1 PE=2 SV=1 g582.t1 O95372 53.097 113 2.1e-34 121.0 sp|O95372|LYPA2_HUMAN Acyl-protein thioesterase 2 OS=Homo sapiens OX=9606 GN=LYPLA2 PE=1 SV=1 g584.t1 O75608 53.684 95 5.1600000000000003e-26 100.0 sp|O75608|LYPA1_HUMAN Acyl-protein thioesterase 1 OS=Homo sapiens OX=9606 GN=LYPLA1 PE=1 SV=1 LYPA1_HUMAN reviewed Acyl-protein thioesterase 1 (APT-1) (hAPT1) (EC 3.1.2.-) (Lysophospholipase 1) (Lysophospholipase I) (LPL-I) (LysoPLA I) (Palmitoyl-protein hydrolase) (EC 3.1.2.22) Homo sapiens (Human) GO:0002084; GO:0004620; GO:0004622; GO:0005654; GO:0005737; GO:0005739; GO:0005783; GO:0005829; GO:0005886; GO:0006631; GO:0008474; GO:0015908; GO:0016298; GO:0031965; GO:0042997; GO:0070062; GO:1905336 fatty acid metabolic process [GO:0006631]; fatty acid transport [GO:0015908]; negative regulation of aggrephagy [GO:1905336]; negative regulation of Golgi to plasma membrane protein transport [GO:0042997]; protein depalmitoylation [GO:0002084] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; mitochondrion [GO:0005739]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] lipase activity [GO:0016298]; palmitoyl-(protein) hydrolase activity [GO:0008474]; phosphatidylcholine lysophospholipase activity [GO:0004622]; phospholipase activity [GO:0004620] g585.t1 Q5ZLX2 73.377 308 6.31e-151 429.0 sp|Q5ZLX2|IF2A_CHICK Eukaryotic translation initiation factor 2 subunit 1 OS=Gallus gallus OX=9031 GN=EIF2S1 PE=2 SV=2 IF2A_CHICK reviewed Eukaryotic translation initiation factor 2 subunit 1 (Eukaryotic translation initiation factor 2 subunit alpha) (eIF-2-alpha) (eIF-2A) (eIF-2alpha) (eIF2-alpha) Gallus gallus (Chicken) GO:0003723; GO:0003743; GO:0005737; GO:0005829; GO:0005850; GO:0006413; GO:0010494; GO:0032057; GO:0033290; GO:0034198; GO:0034644; GO:0034976; GO:0036499; GO:0043022 cellular response to amino acid starvation [GO:0034198]; cellular response to UV [GO:0034644]; negative regulation of translational initiation in response to stress [GO:0032057]; PERK-mediated unfolded protein response [GO:0036499]; response to endoplasmic reticulum stress [GO:0034976]; translational initiation [GO:0006413] cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 2 complex [GO:0005850] ribosome binding [GO:0043022]; RNA binding [GO:0003723]; translation initiation factor activity [GO:0003743] g586.t1 Q0VCR1 44.479 317 2.74e-73 231.0 sp|Q0VCR1|RTF2_BOVIN Replication termination factor 2 OS=Bos taurus OX=9913 GN=RTF2 PE=2 SV=1 RTF2_BOVIN reviewed Replication termination factor 2 (RTF2) (Replication termination factor 2 domain-containing protein 1) Bos taurus (Bovine) GO:0003677; GO:0005634; GO:0005657; GO:0072711; GO:0097752 cellular response to hydroxyurea [GO:0072711]; regulation of DNA stability [GO:0097752] nucleus [GO:0005634]; replication fork [GO:0005657] DNA binding [GO:0003677] g587.t1 Q5F413 66.667 120 6.289999999999999e-54 191.0 sp|Q5F413|SMAP2_CHICK Stromal membrane-associated protein 2 OS=Gallus gallus OX=9031 GN=SMAP2 PE=2 SV=1 g588.t1 P80146 51.235 324 7.66e-99 302.0 sp|P80146|SEPR_THESR Extracellular serine proteinase OS=Thermus sp. (strain Rt41A) OX=32063 PE=1 SV=3 g589.t1 Q4V838 45.418 491 2.33e-95 299.0 sp|Q4V838|LTV1_XENLA Protein LTV1 homolog OS=Xenopus laevis OX=8355 GN=ltv1 PE=2 SV=1 g590.t1 Q8VCL5 38.106 433 8.619999999999999e-95 296.0 sp|Q8VCL5|S17A9_MOUSE Voltage-gated purine nucleotide uniporter SLC17A9 OS=Mus musculus OX=10090 GN=Slc17a9 PE=1 SV=3 g591.t1 Q92905 86.97 330 0.0 547.0 sp|Q92905|CSN5_HUMAN COP9 signalosome complex subunit 5 OS=Homo sapiens OX=9606 GN=COPS5 PE=1 SV=4 CSN5_HUMAN reviewed COP9 signalosome complex subunit 5 (SGN5) (Signalosome subunit 5) (EC 3.4.-.-) (Jun activation domain-binding protein 1) Homo sapiens (Human) GO:0000338; GO:0000785; GO:0003713; GO:0003743; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005852; GO:0006412; GO:0006508; GO:0008021; GO:0008180; GO:0008237; GO:0019784; GO:0019899; GO:0035718; GO:0043066; GO:0043687; GO:0045116; GO:0045944; GO:0046328; GO:0046872; GO:0048471; GO:0051091; GO:0051726; GO:0140492; GO:1903894; GO:1990182; GO:2000434 exosomal secretion [GO:1990182]; negative regulation of apoptotic process [GO:0043066]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of transcription by RNA polymerase II [GO:0045944]; post-translational protein modification [GO:0043687]; protein deneddylation [GO:0000338]; protein neddylation [GO:0045116]; proteolysis [GO:0006508]; regulation of cell cycle [GO:0051726]; regulation of IRE1-mediated unfolded protein response [GO:1903894]; regulation of JNK cascade [GO:0046328]; regulation of protein neddylation [GO:2000434]; translation [GO:0006412] chromatin [GO:0000785]; COP9 signalosome [GO:0008180]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; eukaryotic translation initiation factor 3 complex [GO:0005852]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; synaptic vesicle [GO:0008021] deNEDDylase activity [GO:0019784]; enzyme binding [GO:0019899]; macrophage migration inhibitory factor binding [GO:0035718]; metal ion binding [GO:0046872]; metal-dependent deubiquitinase activity [GO:0140492]; metallopeptidase activity [GO:0008237]; transcription coactivator activity [GO:0003713]; translation initiation factor activity [GO:0003743] g592.t1 O88419 50.216 231 5.1700000000000007e-79 253.0 sp|O88419|B4GT6_RAT Beta-1,4-galactosyltransferase 6 OS=Rattus norvegicus OX=10116 GN=B4galt6 PE=1 SV=1 B4GT6_RAT reviewed Beta-1,4-galactosyltransferase 6 (Beta-1,4-GalTase 6) (Beta4Gal-T6) (b4Gal-T6) (EC 2.4.1.-) (Glucosylceramide beta-1,4-galactosyltransferase) (EC 2.4.1.274) (Lactosylceramide synthase) (LacCer synthase) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 6) (UDP-Gal:glucosylceramide beta-1,4-galactosyltransferase) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 6) Rattus norvegicus (Rat) GO:0001572; GO:0001574; GO:0005794; GO:0005975; GO:0006688; GO:0008378; GO:0008489; GO:0021955; GO:0022010; GO:0032580; GO:0042551; GO:0046872 carbohydrate metabolic process [GO:0005975]; central nervous system myelination [GO:0022010]; central nervous system neuron axonogenesis [GO:0021955]; ganglioside biosynthetic process [GO:0001574]; glycosphingolipid biosynthetic process [GO:0006688]; lactosylceramide biosynthetic process [GO:0001572]; neuron maturation [GO:0042551] Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580] galactosyltransferase activity [GO:0008378]; metal ion binding [GO:0046872]; UDP-galactose:glucosylceramide beta-1,4-galactosyltransferase activity [GO:0008489] g594.t1 Q28FY0 51.34 485 6.02e-159 461.0 sp|Q28FY0|DAA11_XENTR Dynein axonemal assembly factor 11 OS=Xenopus tropicalis OX=8364 GN=dnaaf11 PE=2 SV=1 DAA11_XENTR reviewed Dynein axonemal assembly factor 11 (DNAAF11) (Leucine-rich repeat-containing protein 6) (Protein tilB homolog) Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0003351; GO:0005576; GO:0005737; GO:0005829; GO:0030317; GO:0031514; GO:0036158; GO:0060287; GO:0061512; GO:0070286; GO:0090660; GO:0120229; GO:0120293 axonemal dynein complex assembly [GO:0070286]; cerebrospinal fluid circulation [GO:0090660]; epithelial cilium movement involved in determination of left/right asymmetry [GO:0060287]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; flagellated sperm motility [GO:0030317]; outer dynein arm assembly [GO:0036158]; protein localization to cilium [GO:0061512]; protein localization to motile cilium [GO:0120229] cytoplasm [GO:0005737]; cytosol [GO:0005829]; dynein axonemal particle [GO:0120293]; extracellular region [GO:0005576]; motile cilium [GO:0031514] g595.t1 Q26648 83.186 113 3.99e-61 194.0 sp|Q26648|TKB1_STRPU Tektin-B1 OS=Strongylocentrotus purpuratus OX=7668 PE=1 SV=1 g596.t1 Q26648 78.049 205 3.43e-111 329.0 sp|Q26648|TKB1_STRPU Tektin-B1 OS=Strongylocentrotus purpuratus OX=7668 PE=1 SV=1 g597.t1 Q3KQ80 45.57 316 5.74e-51 176.0 sp|Q3KQ80|STPG1_XENLA O(6)-methylguanine-induced apoptosis 2 OS=Xenopus laevis OX=8355 GN=stpg1 PE=2 SV=1 g598.t1 P11157 70.223 403 0.0 548.0 sp|P11157|RIR2_MOUSE Ribonucleoside-diphosphate reductase subunit M2 OS=Mus musculus OX=10090 GN=Rrm2 PE=1 SV=1 RIR2_MOUSE reviewed Ribonucleoside-diphosphate reductase subunit M2 (EC 1.17.4.1) (Ribonucleotide reductase small chain) (Ribonucleotide reductase small subunit) Mus musculus (Mouse) GO:0004748; GO:0005635; GO:0005654; GO:0005829; GO:0005971; GO:0008199; GO:0008284; GO:0009185; GO:0009262; GO:0009263; GO:0009265; GO:0042802; GO:0042803; GO:0051290; GO:1900087 2'-deoxyribonucleotide biosynthetic process [GO:0009265]; deoxyribonucleotide biosynthetic process [GO:0009263]; deoxyribonucleotide metabolic process [GO:0009262]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; protein heterotetramerization [GO:0051290]; ribonucleoside diphosphate metabolic process [GO:0009185] cytosol [GO:0005829]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; ribonucleoside-diphosphate reductase complex [GO:0005971] ferric iron binding [GO:0008199]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor [GO:0004748] g602.t1 Q5RFV4 48.81 252 1.92e-84 258.0 sp|Q5RFV4|R1441_DANRE Probable E3 ubiquitin-protein ligase RNF144A-A OS=Danio rerio OX=7955 GN=rnf144aa PE=3 SV=1 R1441_DANRE reviewed Probable E3 ubiquitin-protein ligase RNF144A-A (EC 2.3.2.31) (RING finger protein 144A-A) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000151; GO:0005737; GO:0005794; GO:0006511; GO:0008270; GO:0016567; GO:0031090; GO:0031624; GO:0061630 protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511] cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; organelle membrane [GO:0031090]; ubiquitin ligase complex [GO:0000151] ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] g605.t1 Q0EEE2 34.045 890 4.3499999999999996e-147 464.0 sp|Q0EEE2|PTHD3_MOUSE Patched domain-containing protein 3 OS=Mus musculus OX=10090 GN=Ptchd3 PE=1 SV=1 PTHD3_MOUSE reviewed Patched domain-containing protein 3 (RND-type protein RNDEu-3) Mus musculus (Mouse) GO:0005783; GO:0005789; GO:0016020; GO:0097225 endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; sperm midpiece [GO:0097225] g606.t1 Q0P8I7 41.479 311 1.05e-78 246.0 sp|Q0P8I7|GMHD_CAMJE GDP-D-glycero-alpha-D-manno-heptose dehydrogenase OS=Campylobacter jejuni subsp. jejuni serotype O:2 (strain ATCC 700819 / NCTC 11168) OX=192222 GN=Cj1427c PE=1 SV=1 GMHD_CAMJE reviewed GDP-D-glycero-alpha-D-manno-heptose dehydrogenase (EC 1.1.98.-) Campylobacter jejuni subsp. jejuni serotype O:2 (strain ATCC 700819 / NCTC 11168) GO:0016491; GO:0019003; GO:0042802; GO:0045227; GO:0051289; GO:0070404 capsule polysaccharide biosynthetic process [GO:0045227]; protein homotetramerization [GO:0051289] GDP binding [GO:0019003]; identical protein binding [GO:0042802]; NADH binding [GO:0070404]; oxidoreductase activity [GO:0016491] g607.t1 Q3T178 64.865 222 4.19e-108 313.0 sp|Q3T178|VPS28_BOVIN Vacuolar protein sorting-associated protein 28 homolog OS=Bos taurus OX=9913 GN=VPS28 PE=2 SV=1 g608.t1 O17320 88.83 376 0.0 719.0 sp|O17320|ACT_MAGGI Actin OS=Magallana gigas OX=29159 PE=2 SV=1 g611.t1 Q9Y5K1 54.227 343 5.9300000000000005e-143 423.0 sp|Q9Y5K1|SPO11_HUMAN Meiotic recombination protein SPO11 OS=Homo sapiens OX=9606 GN=SPO11 PE=1 SV=1 g615.t1 Q5GH73 34.541 414 7.73e-64 230.0 sp|Q5GH73|XKR6_HUMAN XK-related protein 6 OS=Homo sapiens OX=9606 GN=XKR6 PE=1 SV=1 g619.t1 P21128 32.353 408 9.990000000000001e-64 213.0 sp|P21128|ENDOU_HUMAN Uridylate-specific endoribonuclease OS=Homo sapiens OX=9606 GN=ENDOU PE=1 SV=2 ENDOU_HUMAN reviewed Uridylate-specific endoribonuclease (EC 3.1.-.-) (EC 4.6.1.-) (Placental protein 11) (PP11) (Protein endoU) Homo sapiens (Human) GO:0003723; GO:0004521; GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0005886; GO:0006508; GO:0006955; GO:0007565; GO:0008083; GO:0008236; GO:0016441; GO:0016829; GO:0030145; GO:0030247; GO:0050995 female pregnancy [GO:0007565]; immune response [GO:0006955]; negative regulation of lipid catabolic process [GO:0050995]; post-transcriptional gene silencing [GO:0016441]; proteolysis [GO:0006508] cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886] growth factor activity [GO:0008083]; lyase activity [GO:0016829]; manganese ion binding [GO:0030145]; polysaccharide binding [GO:0030247]; RNA binding [GO:0003723]; RNA endonuclease activity [GO:0004521]; scavenger receptor activity [GO:0005044]; serine-type peptidase activity [GO:0008236] g620.t1 Q66I84 46.565 393 1.0999999999999999e-112 338.0 sp|Q66I84|DCC1_DANRE Sister chromatid cohesion protein DCC1 OS=Danio rerio OX=7955 GN=dscc1 PE=2 SV=1 g621.t1 Q8TB45 29.858 211 1.1799999999999999e-23 105.0 sp|Q8TB45|DPTOR_HUMAN DEP domain-containing mTOR-interacting protein OS=Homo sapiens OX=9606 GN=DEPTOR PE=1 SV=2 DPTOR_HUMAN reviewed DEP domain-containing mTOR-interacting protein (hDEPTOR) (DEP domain-containing protein 6) Homo sapiens (Human) GO:0004860; GO:0005085; GO:0005096; GO:0005765; GO:0005886; GO:0006469; GO:0007186; GO:0010508; GO:0030291; GO:0032007; GO:0035556; GO:0045792; GO:0070300; GO:1903940; GO:1904262; GO:2001236 G protein-coupled receptor signaling pathway [GO:0007186]; intracellular signal transduction [GO:0035556]; negative regulation of cell size [GO:0045792]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of TOR signaling [GO:0032007]; negative regulation of TORC1 signaling [GO:1904262]; negative regulation of TORC2 signaling [GO:1903940]; positive regulation of autophagy [GO:0010508]; regulation of extrinsic apoptotic signaling pathway [GO:2001236] lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886] GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; phosphatidic acid binding [GO:0070300]; protein kinase inhibitor activity [GO:0004860]; protein serine/threonine kinase inhibitor activity [GO:0030291] g622.t1 Q9PTU6 34.066 364 4.919999999999999e-69 225.0 sp|Q9PTU6|ENDOU_PAROL Uridylate-specific endoribonuclease OS=Paralichthys olivaceus OX=8255 GN=endou PE=2 SV=1 g623.t1 O00602 57.343 143 1.65e-51 170.0 sp|O00602|FCN1_HUMAN Ficolin-1 OS=Homo sapiens OX=9606 GN=FCN1 PE=1 SV=2 FCN1_HUMAN reviewed Ficolin-1 (Collagen/fibrinogen domain-containing protein 1) (Ficolin-A) (Ficolin-alpha) (M-ficolin) Homo sapiens (Human) GO:0001664; GO:0001867; GO:0002752; GO:0003823; GO:0005102; GO:0005576; GO:0005581; GO:0005615; GO:0005886; GO:0006508; GO:0007186; GO:0009897; GO:0030246; GO:0031012; GO:0032757; GO:0033691; GO:0034394; GO:0034774; GO:0038187; GO:0043654; GO:0046597; GO:0046872; GO:0097367; GO:0106139; GO:1903028; GO:1904813; GO:1905370 cell surface pattern recognition receptor signaling pathway [GO:0002752]; complement activation, lectin pathway [GO:0001867]; G protein-coupled receptor signaling pathway [GO:0007186]; host-mediated suppression of symbiont invasion [GO:0046597]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of opsonization [GO:1903028]; protein localization to cell surface [GO:0034394]; proteolysis [GO:0006508]; recognition of apoptotic cell [GO:0043654] collagen trimer [GO:0005581]; external side of plasma membrane [GO:0009897]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; ficolin-1-rich granule lumen [GO:1904813]; plasma membrane [GO:0005886]; secretory granule lumen [GO:0034774]; serine-type endopeptidase complex [GO:1905370]; symbiont cell surface [GO:0106139] antigen binding [GO:0003823]; carbohydrate binding [GO:0030246]; carbohydrate derivative binding [GO:0097367]; G protein-coupled receptor binding [GO:0001664]; metal ion binding [GO:0046872]; pattern recognition receptor activity [GO:0038187]; sialic acid binding [GO:0033691]; signaling receptor binding [GO:0005102] g625.t1 Q0P4P2 53.456 217 1.01e-71 234.0 sp|Q0P4P2|FBCD1_XENTR Fibrinogen C domain-containing protein 1 OS=Xenopus tropicalis OX=8364 GN=fibcd1 PE=2 SV=1 g626.t1 Q29041 65.306 147 1.12e-59 190.0 sp|Q29041|FCN2_PIG Ficolin-2 OS=Sus scrofa OX=9823 GN=FCN2 PE=1 SV=1 FCN2_PIG reviewed Ficolin-2 (Collagen/fibrinogen domain-containing protein 2) (Ficolin-B) (Ficolin-beta) (L-ficolin) Sus scrofa (Pig) GO:0001867; GO:0003823; GO:0005102; GO:0005581; GO:0005615; GO:0030246; GO:0038187; GO:0046872; GO:0070892; GO:0097367; GO:0106139 complement activation, lectin pathway [GO:0001867] collagen trimer [GO:0005581]; extracellular space [GO:0005615]; symbiont cell surface [GO:0106139] antigen binding [GO:0003823]; carbohydrate binding [GO:0030246]; carbohydrate derivative binding [GO:0097367]; lipoteichoic acid immune receptor activity [GO:0070892]; metal ion binding [GO:0046872]; pattern recognition receptor activity [GO:0038187]; signaling receptor binding [GO:0005102] g627.t1 Q6NYX8 63.636 187 2.4e-86 256.0 sp|Q6NYX8|PITH1_DANRE PITH domain-containing protein 1 OS=Danio rerio OX=7955 GN=pithd1 PE=2 SV=1 g628.t1 Q6AZN4 50.0 300 7.39e-97 289.0 sp|Q6AZN4|RM15_XENLA Large ribosomal subunit protein uL15m OS=Xenopus laevis OX=8355 GN=mrpl15 PE=2 SV=1 g633.t1 Q61313 50.943 477 4.4199999999999997e-128 385.0 sp|Q61313|AP2B_MOUSE Transcription factor AP-2-beta OS=Mus musculus OX=10090 GN=Tfap2b PE=1 SV=2 g635.t1 Q9CX11 46.715 137 2.52e-40 140.0 sp|Q9CX11|UTP23_MOUSE rRNA-processing protein UTP23 homolog OS=Mus musculus OX=10090 GN=Utp23 PE=2 SV=1 g640.t1 B5RI54 59.509 326 6.63e-128 372.0 sp|B5RI54|EIF3H_SALSA Eukaryotic translation initiation factor 3 subunit H OS=Salmo salar OX=8030 GN=eif3h PE=2 SV=1 EIF3H_SALSA reviewed Eukaryotic translation initiation factor 3 subunit H (eIF3h) (Eukaryotic translation initiation factor 3 subunit 3) (eIF-3-gamma) (eIF3 p40 subunit) Salmo salar (Atlantic salmon) GO:0001732; GO:0003743; GO:0005852; GO:0006413; GO:0008237; GO:0016282; GO:0033290 formation of cytoplasmic translation initiation complex [GO:0001732]; translational initiation [GO:0006413] eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852] metallopeptidase activity [GO:0008237]; translation initiation factor activity [GO:0003743] g642.t1 Q28DT9 38.462 208 5.06e-36 134.0 sp|Q28DT9|SPSB3_XENTR SPRY domain-containing SOCS box protein 3 OS=Xenopus tropicalis OX=8364 GN=spsb3 PE=2 SV=1 g644.t1 Q66HR2 55.159 252 3.54e-88 266.0 sp|Q66HR2|MARE1_RAT Microtubule-associated protein RP/EB family member 1 OS=Rattus norvegicus OX=10116 GN=Mapre1 PE=1 SV=3 MARE1_RAT reviewed Microtubule-associated protein RP/EB family member 1 (APC-binding protein EB1) (End-binding protein 1) (EB1) Rattus norvegicus (Rat) GO:0000132; GO:0001578; GO:0005794; GO:0005813; GO:0005815; GO:0005819; GO:0005874; GO:0005881; GO:0005925; GO:0015630; GO:0016477; GO:0030981; GO:0031110; GO:0031115; GO:0031116; GO:0031253; GO:0035371; GO:0035372; GO:0036064; GO:0042802; GO:0042995; GO:0046785; GO:0051010; GO:0051225; GO:0051233; GO:0051301; GO:0051315; GO:0071539; GO:0097431; GO:0120283; GO:1902480; GO:1902888; GO:1905515; GO:1905721; GO:1990498 attachment of mitotic spindle microtubules to kinetochore [GO:0051315]; cell division [GO:0051301]; cell migration [GO:0016477]; establishment of mitotic spindle orientation [GO:0000132]; microtubule bundle formation [GO:0001578]; microtubule polymerization [GO:0046785]; negative regulation of microtubule polymerization [GO:0031115]; non-motile cilium assembly [GO:1905515]; positive regulation of microtubule polymerization [GO:0031116]; protein localization to astral microtubule [GO:1902888]; protein localization to centrosome [GO:0071539]; protein localization to microtubule [GO:0035372]; protein localization to mitotic spindle [GO:1902480]; regulation of microtubule polymerization or depolymerization [GO:0031110]; spindle assembly [GO:0051225] cell projection [GO:0042995]; cell projection membrane [GO:0031253]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cortical microtubule cytoskeleton [GO:0030981]; cytoplasmic microtubule [GO:0005881]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; microtubule organizing center [GO:0005815]; microtubule plus-end [GO:0035371]; mitotic spindle astral microtubule end [GO:1905721]; mitotic spindle microtubule [GO:1990498]; mitotic spindle pole [GO:0097431]; spindle [GO:0005819]; spindle midzone [GO:0051233] identical protein binding [GO:0042802]; microtubule plus-end binding [GO:0051010]; protein serine/threonine kinase binding [GO:0120283] g645.t1 P62025 58.58 169 4.01e-50 182.0 sp|P62025|PHAR2_RAT Phosphatase and actin regulator 2 OS=Rattus norvegicus OX=10116 GN=Phactr2 PE=1 SV=1 g646.t1 Q3T105 61.782 348 4.05e-167 473.0 sp|Q3T105|GALE_BOVIN UDP-glucose 4-epimerase OS=Bos taurus OX=9913 GN=GALE PE=2 SV=2 g654.t1 Q7T3C7 36.585 369 1.12e-70 231.0 sp|Q7T3C7|RT4I1_DANRE NAD(P)H oxidoreductase RTN4IP1, mitochondrial OS=Danio rerio OX=7955 GN=rtn4ip1 PE=2 SV=2 RT4I1_DANRE reviewed NAD(P)H oxidoreductase RTN4IP1, mitochondrial (EC 1.6.5.-) (Reticulon-4-interacting protein 1 homolog) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000166; GO:0005739; GO:0005741; GO:0005759; GO:0006744; GO:0010842; GO:0016491; GO:0042462; GO:0050773 eye photoreceptor cell development [GO:0042462]; regulation of dendrite development [GO:0050773]; retina layer formation [GO:0010842]; ubiquinone biosynthetic process [GO:0006744] mitochondrial matrix [GO:0005759]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739] nucleotide binding [GO:0000166]; oxidoreductase activity [GO:0016491] g655.t1 P62083 78.866 194 2.03e-110 316.0 sp|P62083|RS7_RAT Small ribosomal subunit protein eS7 OS=Rattus norvegicus OX=10116 GN=Rps7 PE=1 SV=1 RS7_RAT reviewed Small ribosomal subunit protein eS7 (40S ribosomal protein S7) (S8) Rattus norvegicus (Rat) GO:0001843; GO:0003730; GO:0003735; GO:0005634; GO:0005730; GO:0005783; GO:0005813; GO:0005829; GO:0006364; GO:0006412; GO:0008266; GO:0010628; GO:0014033; GO:0019901; GO:0022626; GO:0022627; GO:0032040; GO:0032991; GO:0042274; GO:0045202; GO:0048027; GO:0050821; GO:1902255; GO:1990904; GO:1990948; GO:2000059 negative regulation of ubiquitin-dependent protein catabolic process [GO:2000059]; neural crest cell differentiation [GO:0014033]; neural tube closure [GO:0001843]; positive regulation of gene expression [GO:0010628]; positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator [GO:1902255]; protein stabilization [GO:0050821]; ribosomal small subunit biogenesis [GO:0042274]; rRNA processing [GO:0006364]; translation [GO:0006412] centrosome [GO:0005813]; cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]; endoplasmic reticulum [GO:0005783]; nucleolus [GO:0005730]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; ribonucleoprotein complex [GO:1990904]; small-subunit processome [GO:0032040]; synapse [GO:0045202] mRNA 3'-UTR binding [GO:0003730]; mRNA 5'-UTR binding [GO:0048027]; poly(U) RNA binding [GO:0008266]; protein kinase binding [GO:0019901]; structural constituent of ribosome [GO:0003735]; ubiquitin ligase inhibitor activity [GO:1990948] g656.t1 O70338 40.123 324 5.99e-63 204.0 sp|O70338|RNH1_MOUSE Ribonuclease H1 OS=Mus musculus OX=10090 GN=Rnaseh1 PE=2 SV=1 g657.t1 P83941 89.286 112 6.26e-69 205.0 sp|P83941|ELOC_RAT Elongin-C OS=Rattus norvegicus OX=10116 GN=Eloc PE=1 SV=1 ELOC_RAT reviewed Elongin-C (EloC) (Elongin 15 kDa subunit) (RNA polymerase II transcription factor SIII subunit C) (SIII p15) (Stromal membrane-associated protein SMAP1B homolog) (Transcription elongation factor B polypeptide 1) Rattus norvegicus (Rat) GO:0001222; GO:0006367; GO:0006511; GO:0016567; GO:0030674; GO:0030891; GO:0031466; GO:0032968; GO:0044877; GO:0070449; GO:0140958 positive regulation of transcription elongation by RNA polymerase II [GO:0032968]; protein ubiquitination [GO:0016567]; target-directed miRNA degradation [GO:0140958]; transcription initiation at RNA polymerase II promoter [GO:0006367]; ubiquitin-dependent protein catabolic process [GO:0006511] Cul5-RING ubiquitin ligase complex [GO:0031466]; elongin complex [GO:0070449]; VCB complex [GO:0030891] protein-containing complex binding [GO:0044877]; protein-macromolecule adaptor activity [GO:0030674]; transcription corepressor binding [GO:0001222] g658.t1 Q6AXS3 40.0 135 3.35e-26 114.0 sp|Q6AXS3|DEK_RAT Protein DEK OS=Rattus norvegicus OX=10116 GN=Dek PE=1 SV=1 DEK_RAT reviewed Protein DEK Rattus norvegicus (Rat) GO:0003677; GO:0005634; GO:0005654; GO:0006325; GO:0042393; GO:0043292; GO:0045945; GO:0110016; GO:2000779; GO:2001032 chromatin organization [GO:0006325]; positive regulation of transcription by RNA polymerase III [GO:0045945]; regulation of double-strand break repair [GO:2000779]; regulation of double-strand break repair via nonhomologous end joining [GO:2001032] B-WICH complex [GO:0110016]; contractile muscle fiber [GO:0043292]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] DNA binding [GO:0003677]; histone binding [GO:0042393] g659.t1 O08876 61.143 175 3.66e-65 220.0 sp|O08876|KLF10_RAT Krueppel-like factor 10 OS=Rattus norvegicus OX=10116 GN=Klf10 PE=2 SV=1 KLF10_RAT reviewed Krueppel-like factor 10 (Transforming growth factor-beta-inducible early growth response protein 1) (TGFB-inducible early growth response protein 1) (TIEG-1) (Zinc finger transcription factor homolog CPG20) Rattus norvegicus (Rat) GO:0000978; GO:0000981; GO:0001046; GO:0001228; GO:0005634; GO:0006355; GO:0006357; GO:0007623; GO:0008270; GO:0009267; GO:0030282; GO:0035019; GO:0042752; GO:0045672; GO:0045892; GO:0045944; GO:1990837; GO:1990859 bone mineralization [GO:0030282]; cellular response to endothelin [GO:1990859]; cellular response to starvation [GO:0009267]; circadian rhythm [GO:0007623]; negative regulation of DNA-templated transcription [GO:0045892]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of circadian rhythm [GO:0042752]; regulation of DNA-templated transcription [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; somatic stem cell population maintenance [GO:0035019] nucleus [GO:0005634] core promoter sequence-specific DNA binding [GO:0001046]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; zinc ion binding [GO:0008270] g661.t1 P27117 49.77 434 1.19e-143 422.0 sp|P27117|DCOR_BOVIN Ornithine decarboxylase OS=Bos taurus OX=9913 GN=ODC1 PE=2 SV=1 g668.t1 Q9Y3Z3 54.912 397 9.18e-145 428.0 sp|Q9Y3Z3|SAMH1_HUMAN Deoxynucleoside triphosphate triphosphohydrolase SAMHD1 OS=Homo sapiens OX=9606 GN=SAMHD1 PE=1 SV=2 g671.t1 Q14721 66.022 465 0.0 602.0 sp|Q14721|KCNB1_HUMAN Potassium voltage-gated channel subfamily B member 1 OS=Homo sapiens OX=9606 GN=KCNB1 PE=1 SV=2 g674.t1 P09324 67.778 360 0.0 520.0 sp|P09324|YES_CHICK Tyrosine-protein kinase Yes OS=Gallus gallus OX=9031 GN=YES1 PE=1 SV=3 g675.t1 Q5YLG1 49.554 448 9.3e-106 334.0 sp|Q5YLG1|GUNA_BACPU Endoglucanase A OS=Bacillus pumilus OX=1408 GN=eglA PE=1 SV=1 GUNA_BACPU reviewed Endoglucanase A (EC 3.2.1.4) (Endo-1,4-beta-glucanase A) Bacillus pumilus (Bacillus mesentericus) GO:0005576; GO:0008810; GO:0030245; GO:0030248 cellulose catabolic process [GO:0030245] extracellular region [GO:0005576] cellulase activity [GO:0008810]; cellulose binding [GO:0030248] g676.t1 Q29042 56.132 212 3.4e-75 249.0 sp|Q29042|FCN1_PIG Ficolin-1 OS=Sus scrofa OX=9823 GN=FCN1 PE=1 SV=1 FCN1_PIG reviewed Ficolin-1 (Ficolin-A) (Ficolin-alpha) Sus scrofa (Pig) GO:0001867; GO:0003823; GO:0005102; GO:0005581; GO:0005615; GO:0005886; GO:0030246; GO:0033691; GO:0038187; GO:0046872; GO:0097367; GO:0106139 complement activation, lectin pathway [GO:0001867] collagen trimer [GO:0005581]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; symbiont cell surface [GO:0106139] antigen binding [GO:0003823]; carbohydrate binding [GO:0030246]; carbohydrate derivative binding [GO:0097367]; metal ion binding [GO:0046872]; pattern recognition receptor activity [GO:0038187]; sialic acid binding [GO:0033691]; signaling receptor binding [GO:0005102] g676.t2 Q29042 56.132 212 1.32e-75 249.0 sp|Q29042|FCN1_PIG Ficolin-1 OS=Sus scrofa OX=9823 GN=FCN1 PE=1 SV=1 FCN1_PIG reviewed Ficolin-1 (Ficolin-A) (Ficolin-alpha) Sus scrofa (Pig) GO:0001867; GO:0003823; GO:0005102; GO:0005581; GO:0005615; GO:0005886; GO:0030246; GO:0033691; GO:0038187; GO:0046872; GO:0097367; GO:0106139 complement activation, lectin pathway [GO:0001867] collagen trimer [GO:0005581]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; symbiont cell surface [GO:0106139] antigen binding [GO:0003823]; carbohydrate binding [GO:0030246]; carbohydrate derivative binding [GO:0097367]; metal ion binding [GO:0046872]; pattern recognition receptor activity [GO:0038187]; sialic acid binding [GO:0033691]; signaling receptor binding [GO:0005102] g676.t3 Q29042 56.132 212 1.49e-75 249.0 sp|Q29042|FCN1_PIG Ficolin-1 OS=Sus scrofa OX=9823 GN=FCN1 PE=1 SV=1 FCN1_PIG reviewed Ficolin-1 (Ficolin-A) (Ficolin-alpha) Sus scrofa (Pig) GO:0001867; GO:0003823; GO:0005102; GO:0005581; GO:0005615; GO:0005886; GO:0030246; GO:0033691; GO:0038187; GO:0046872; GO:0097367; GO:0106139 complement activation, lectin pathway [GO:0001867] collagen trimer [GO:0005581]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; symbiont cell surface [GO:0106139] antigen binding [GO:0003823]; carbohydrate binding [GO:0030246]; carbohydrate derivative binding [GO:0097367]; metal ion binding [GO:0046872]; pattern recognition receptor activity [GO:0038187]; sialic acid binding [GO:0033691]; signaling receptor binding [GO:0005102] g676.t4 Q29042 56.132 212 1.18e-75 249.0 sp|Q29042|FCN1_PIG Ficolin-1 OS=Sus scrofa OX=9823 GN=FCN1 PE=1 SV=1 FCN1_PIG reviewed Ficolin-1 (Ficolin-A) (Ficolin-alpha) Sus scrofa (Pig) GO:0001867; GO:0003823; GO:0005102; GO:0005581; GO:0005615; GO:0005886; GO:0030246; GO:0033691; GO:0038187; GO:0046872; GO:0097367; GO:0106139 complement activation, lectin pathway [GO:0001867] collagen trimer [GO:0005581]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; symbiont cell surface [GO:0106139] antigen binding [GO:0003823]; carbohydrate binding [GO:0030246]; carbohydrate derivative binding [GO:0097367]; metal ion binding [GO:0046872]; pattern recognition receptor activity [GO:0038187]; sialic acid binding [GO:0033691]; signaling receptor binding [GO:0005102] g679.t1 Q5R5U3 44.423 511 5.5099999999999996e-152 453.0 sp|Q5R5U3|ZN271_PONAB Zinc finger protein 271 OS=Pongo abelii OX=9601 GN=ZNF271 PE=2 SV=1 g679.t1 Q5R5U3 43.006 479 2.35e-134 407.0 sp|Q5R5U3|ZN271_PONAB Zinc finger protein 271 OS=Pongo abelii OX=9601 GN=ZNF271 PE=2 SV=1 g679.t1 Q5R5U3 43.158 475 2.4200000000000003e-129 395.0 sp|Q5R5U3|ZN271_PONAB Zinc finger protein 271 OS=Pongo abelii OX=9601 GN=ZNF271 PE=2 SV=1 g679.t1 Q5R5U3 43.016 451 1.7299999999999997e-126 387.0 sp|Q5R5U3|ZN271_PONAB Zinc finger protein 271 OS=Pongo abelii OX=9601 GN=ZNF271 PE=2 SV=1 g679.t1 Q5R5U3 40.455 220 1e-44 171.0 sp|Q5R5U3|ZN271_PONAB Zinc finger protein 271 OS=Pongo abelii OX=9601 GN=ZNF271 PE=2 SV=1 g684.t1 Q32LJ2 67.568 148 2.5600000000000002e-73 221.0 sp|Q32LJ2|ARFRP_BOVIN ADP-ribosylation factor-related protein 1 OS=Bos taurus OX=9913 GN=ARFRP1 PE=2 SV=1 ARFRP_BOVIN reviewed ADP-ribosylation factor-related protein 1 (ARF-related protein 1) Bos taurus (Bovine) GO:0003924; GO:0005525; GO:0005794; GO:0006886; GO:0016020; GO:0034067; GO:0043001 Golgi to plasma membrane protein transport [GO:0043001]; intracellular protein transport [GO:0006886]; protein localization to Golgi apparatus [GO:0034067] Golgi apparatus [GO:0005794]; membrane [GO:0016020] GTP binding [GO:0005525]; GTPase activity [GO:0003924] g687.t1 Q08BJ2 55.556 180 3.4500000000000003e-56 192.0 sp|Q08BJ2|KHDR2_DANRE KH domain-containing, RNA-binding, signal transduction-associated protein 2 OS=Danio rerio OX=7955 GN=khdrbs2 PE=2 SV=1 g688.t1 Q6PL18 55.298 991 0.0 989.0 sp|Q6PL18|ATAD2_HUMAN ATPase family AAA domain-containing protein 2 OS=Homo sapiens OX=9606 GN=ATAD2 PE=1 SV=1 ATAD2_HUMAN reviewed ATPase family AAA domain-containing protein 2 (EC 3.6.1.-) (AAA nuclear coregulator cancer-associated protein) (ANCCA) Homo sapiens (Human) GO:0003682; GO:0005524; GO:0005634; GO:0005654; GO:0006334; GO:0006337; GO:0016887; GO:0042393; GO:0045815; GO:0045893; GO:0070062 nucleosome assembly [GO:0006334]; nucleosome disassembly [GO:0006337]; positive regulation of DNA-templated transcription [GO:0045893]; transcription initiation-coupled chromatin remodeling [GO:0045815] extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; chromatin binding [GO:0003682]; histone binding [GO:0042393] g690.t1 Q12768 66.695 1159 0.0 1601.0 sp|Q12768|WASC5_HUMAN WASH complex subunit 5 OS=Homo sapiens OX=9606 GN=WASHC5 PE=1 SV=1 WASC5_HUMAN reviewed WASH complex subunit 5 (Strumpellin) (WASH complex subunit strumpellin) Homo sapiens (Human) GO:0001556; GO:0005768; GO:0005769; GO:0005783; GO:0005829; GO:0007032; GO:0007040; GO:0010976; GO:0015031; GO:0016197; GO:0030041; GO:0031503; GO:0031901; GO:0034315; GO:0040038; GO:0043025; GO:0051125; GO:0071203; GO:0090306; GO:0097494; GO:0140285 actin filament polymerization [GO:0030041]; endosomal transport [GO:0016197]; endosome fission [GO:0140285]; endosome organization [GO:0007032]; lysosome organization [GO:0007040]; meiotic spindle assembly [GO:0090306]; oocyte maturation [GO:0001556]; polar body extrusion after meiotic divisions [GO:0040038]; positive regulation of neuron projection development [GO:0010976]; protein transport [GO:0015031]; protein-containing complex localization [GO:0031503]; regulation of actin nucleation [GO:0051125]; regulation of Arp2/3 complex-mediated actin nucleation [GO:0034315]; regulation of vesicle size [GO:0097494] cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; neuronal cell body [GO:0043025]; WASH complex [GO:0071203] g691.t1 J3SBP3 36.577 555 9.63e-103 350.0 sp|J3SBP3|PDE2_CROAD Venom phosphodiesterase 2 OS=Crotalus adamanteus OX=8729 PE=1 SV=1 g691.t1 J3SBP3 33.942 548 1.01e-71 261.0 sp|J3SBP3|PDE2_CROAD Venom phosphodiesterase 2 OS=Crotalus adamanteus OX=8729 PE=1 SV=1 g691.t1 J3SBP3 52.137 117 2.38e-25 117.0 sp|J3SBP3|PDE2_CROAD Venom phosphodiesterase 2 OS=Crotalus adamanteus OX=8729 PE=1 SV=1 g692.t1 A0A2D0TC04 41.317 167 7.26e-31 120.0 sp|A0A2D0TC04|PDE_NAJAT Venom phosphodiesterase OS=Naja atra OX=8656 PE=1 SV=1 PDE_NAJAT reviewed Venom phosphodiesterase (PDE) (EC 3.6.1.-) Naja atra (Chinese cobra) GO:0003676; GO:0005576; GO:0009143; GO:0043262; GO:0046872; GO:0047429; GO:0090729 nucleoside triphosphate catabolic process [GO:0009143] extracellular region [GO:0005576] ADP phosphatase activity [GO:0043262]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; nucleoside triphosphate diphosphatase activity [GO:0047429]; toxin activity [GO:0090729] g693.t1 Q9V727 49.112 169 1.2899999999999998e-42 174.0 sp|Q9V727|ASX_DROME Polycomb group protein Asx OS=Drosophila melanogaster OX=7227 GN=Asx PE=1 SV=1 ASX_DROME reviewed Polycomb group protein Asx (Protein additional sex combs) Drosophila melanogaster (Fruit fly) GO:0000785; GO:0001709; GO:0003677; GO:0003682; GO:0005634; GO:0006357; GO:0007469; GO:0007475; GO:0008270; GO:0009887; GO:0009948; GO:0010468; GO:0035186; GO:0035517; GO:0035800; GO:0040029; GO:0045498; GO:0045892; GO:0045893; GO:0045944 animal organ morphogenesis [GO:0009887]; antennal development [GO:0007469]; anterior/posterior axis specification [GO:0009948]; apposition of dorsal and ventral imaginal disc-derived wing surfaces [GO:0007475]; cell fate determination [GO:0001709]; epigenetic regulation of gene expression [GO:0040029]; negative regulation of DNA-templated transcription [GO:0045892]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; regulation of transcription by RNA polymerase II [GO:0006357]; sex comb development [GO:0045498]; syncytial blastoderm mitotic cell cycle [GO:0035186] chromatin [GO:0000785]; nucleus [GO:0005634]; PR-DUB complex [GO:0035517] chromatin binding [GO:0003682]; deubiquitinase activator activity [GO:0035800]; DNA binding [GO:0003677]; zinc ion binding [GO:0008270] g695.t1 Q3UQ28 55.113 753 0.0 863.0 sp|Q3UQ28|PXDN_MOUSE Peroxidasin homolog OS=Mus musculus OX=10090 GN=Pxdn PE=1 SV=2 PXDN_MOUSE reviewed Peroxidasin homolog (EC 1.11.2.-) [Cleaved into: PXDN active fragment] Mus musculus (Mouse) GO:0001525; GO:0001654; GO:0004601; GO:0005201; GO:0005604; GO:0005615; GO:0005783; GO:0006979; GO:0007155; GO:0009986; GO:0016684; GO:0020037; GO:0030198; GO:0030199; GO:0031012; GO:0042744; GO:0043237; GO:0046872; GO:0051260; GO:0070207; GO:0070831; GO:0071711 angiogenesis [GO:0001525]; basement membrane assembly [GO:0070831]; basement membrane organization [GO:0071711]; cell adhesion [GO:0007155]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]; eye development [GO:0001654]; hydrogen peroxide catabolic process [GO:0042744]; protein homooligomerization [GO:0051260]; protein homotrimerization [GO:0070207]; response to oxidative stress [GO:0006979] basement membrane [GO:0005604]; cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615] extracellular matrix structural constituent [GO:0005201]; heme binding [GO:0020037]; laminin-1 binding [GO:0043237]; metal ion binding [GO:0046872]; oxidoreductase activity, acting on peroxide as acceptor [GO:0016684]; peroxidase activity [GO:0004601] g695.t2 Q3UQ28 60.559 644 0.0 860.0 sp|Q3UQ28|PXDN_MOUSE Peroxidasin homolog OS=Mus musculus OX=10090 GN=Pxdn PE=1 SV=2 PXDN_MOUSE reviewed Peroxidasin homolog (EC 1.11.2.-) [Cleaved into: PXDN active fragment] Mus musculus (Mouse) GO:0001525; GO:0001654; GO:0004601; GO:0005201; GO:0005604; GO:0005615; GO:0005783; GO:0006979; GO:0007155; GO:0009986; GO:0016684; GO:0020037; GO:0030198; GO:0030199; GO:0031012; GO:0042744; GO:0043237; GO:0046872; GO:0051260; GO:0070207; GO:0070831; GO:0071711 angiogenesis [GO:0001525]; basement membrane assembly [GO:0070831]; basement membrane organization [GO:0071711]; cell adhesion [GO:0007155]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]; eye development [GO:0001654]; hydrogen peroxide catabolic process [GO:0042744]; protein homooligomerization [GO:0051260]; protein homotrimerization [GO:0070207]; response to oxidative stress [GO:0006979] basement membrane [GO:0005604]; cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615] extracellular matrix structural constituent [GO:0005201]; heme binding [GO:0020037]; laminin-1 binding [GO:0043237]; metal ion binding [GO:0046872]; oxidoreductase activity, acting on peroxide as acceptor [GO:0016684]; peroxidase activity [GO:0004601] g696.t1 Q92626 52.098 572 9.91e-180 551.0 sp|Q92626|PXDN_HUMAN Peroxidasin homolog OS=Homo sapiens OX=9606 GN=PXDN PE=1 SV=2 PXDN_HUMAN reviewed Peroxidasin homolog (EC 1.11.2.-) (Melanoma-associated antigen MG50) (Peroxidasin 1) (hsPxd01) (Vascular peroxidase 1) (p53-responsive gene 2 protein) [Cleaved into: PXDN active fragment] Homo sapiens (Human) GO:0001525; GO:0001654; GO:0004601; GO:0005152; GO:0005201; GO:0005576; GO:0005604; GO:0005615; GO:0005783; GO:0006955; GO:0006979; GO:0007155; GO:0009986; GO:0016684; GO:0020037; GO:0030198; GO:0030199; GO:0031012; GO:0042744; GO:0043237; GO:0046872; GO:0051260; GO:0070062; GO:0070207; GO:0070831; GO:0071711 angiogenesis [GO:0001525]; basement membrane assembly [GO:0070831]; basement membrane organization [GO:0071711]; cell adhesion [GO:0007155]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]; eye development [GO:0001654]; hydrogen peroxide catabolic process [GO:0042744]; immune response [GO:0006955]; protein homooligomerization [GO:0051260]; protein homotrimerization [GO:0070207]; response to oxidative stress [GO:0006979] basement membrane [GO:0005604]; cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615] extracellular matrix structural constituent [GO:0005201]; heme binding [GO:0020037]; interleukin-1 receptor antagonist activity [GO:0005152]; laminin-1 binding [GO:0043237]; metal ion binding [GO:0046872]; oxidoreductase activity, acting on peroxide as acceptor [GO:0016684]; peroxidase activity [GO:0004601] g696.t1 Q92626 33.214 280 1.7000000000000002e-32 138.0 sp|Q92626|PXDN_HUMAN Peroxidasin homolog OS=Homo sapiens OX=9606 GN=PXDN PE=1 SV=2 PXDN_HUMAN reviewed Peroxidasin homolog (EC 1.11.2.-) (Melanoma-associated antigen MG50) (Peroxidasin 1) (hsPxd01) (Vascular peroxidase 1) (p53-responsive gene 2 protein) [Cleaved into: PXDN active fragment] Homo sapiens (Human) GO:0001525; GO:0001654; GO:0004601; GO:0005152; GO:0005201; GO:0005576; GO:0005604; GO:0005615; GO:0005783; GO:0006955; GO:0006979; GO:0007155; GO:0009986; GO:0016684; GO:0020037; GO:0030198; GO:0030199; GO:0031012; GO:0042744; GO:0043237; GO:0046872; GO:0051260; GO:0070062; GO:0070207; GO:0070831; GO:0071711 angiogenesis [GO:0001525]; basement membrane assembly [GO:0070831]; basement membrane organization [GO:0071711]; cell adhesion [GO:0007155]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]; eye development [GO:0001654]; hydrogen peroxide catabolic process [GO:0042744]; immune response [GO:0006955]; protein homooligomerization [GO:0051260]; protein homotrimerization [GO:0070207]; response to oxidative stress [GO:0006979] basement membrane [GO:0005604]; cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615] extracellular matrix structural constituent [GO:0005201]; heme binding [GO:0020037]; interleukin-1 receptor antagonist activity [GO:0005152]; laminin-1 binding [GO:0043237]; metal ion binding [GO:0046872]; oxidoreductase activity, acting on peroxide as acceptor [GO:0016684]; peroxidase activity [GO:0004601] g698.t1 Q9GZR7 48.684 456 2.9e-141 449.0 sp|Q9GZR7|DDX24_HUMAN ATP-dependent RNA helicase DDX24 OS=Homo sapiens OX=9606 GN=DDX24 PE=1 SV=1 g699.t1 Q54TR1 41.042 307 7.54e-73 236.0 sp|Q54TR1|CFAD_DICDI Counting factor associated protein D OS=Dictyostelium discoideum OX=44689 GN=cfaD PE=1 SV=1 CFAD_DICDI reviewed Counting factor associated protein D Dictyostelium discoideum (Social amoeba) GO:0005576; GO:0005615; GO:0005764; GO:0006508; GO:0006955; GO:0008656; GO:0031288; GO:0031410; GO:0042742; GO:0072659; GO:0140986; GO:1903665; GO:2001235 defense response to bacterium [GO:0042742]; G protein-coupled chemorepellent receptor signaling pathway [GO:0140986]; immune response [GO:0006955]; negative regulation of asexual reproduction [GO:1903665]; positive regulation of apoptotic signaling pathway [GO:2001235]; protein localization to plasma membrane [GO:0072659]; proteolysis [GO:0006508]; sorocarp morphogenesis [GO:0031288] cytoplasmic vesicle [GO:0031410]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; lysosome [GO:0005764] cysteine-type endopeptidase activator activity involved in apoptotic process [GO:0008656] g701.t1 Q2KHT6 32.419 401 2.6199999999999997e-55 189.0 sp|Q2KHT6|FBX32_BOVIN F-box only protein 32 OS=Bos taurus OX=9913 GN=FBXO32 PE=2 SV=1 g702.t1 P84175 83.471 121 1.59e-69 208.0 sp|P84175|RS12_CHICK Small ribosomal subunit protein eS12 OS=Gallus gallus OX=9031 GN=RPS12 PE=1 SV=2 g703.t1 Q03601 32.367 207 1.01e-36 127.0 sp|Q03601|NHL1_CAEEL RING finger protein nhl-1 OS=Caenorhabditis elegans OX=6239 GN=nhl-1 PE=1 SV=2 g703.t1 Q03601 39.344 61 1.01e-36 50.8 sp|Q03601|NHL1_CAEEL RING finger protein nhl-1 OS=Caenorhabditis elegans OX=6239 GN=nhl-1 PE=1 SV=2 g703.t1 Q03601 32.53 166 1.32e-29 100.0 sp|Q03601|NHL1_CAEEL RING finger protein nhl-1 OS=Caenorhabditis elegans OX=6239 GN=nhl-1 PE=1 SV=2 g703.t1 Q03601 38.71 62 1.32e-29 52.8 sp|Q03601|NHL1_CAEEL RING finger protein nhl-1 OS=Caenorhabditis elegans OX=6239 GN=nhl-1 PE=1 SV=2 g703.t1 Q03601 30.263 228 9.93e-28 124.0 sp|Q03601|NHL1_CAEEL RING finger protein nhl-1 OS=Caenorhabditis elegans OX=6239 GN=nhl-1 PE=1 SV=2 g704.t1 P49643 58.722 407 1.24e-174 500.0 sp|P49643|PRI2_HUMAN DNA primase large subunit OS=Homo sapiens OX=9606 GN=PRIM2 PE=1 SV=2 PRI2_HUMAN reviewed DNA primase large subunit (DNA primase 58 kDa subunit) (p58) Homo sapiens (Human) GO:0003677; GO:0005654; GO:0005658; GO:0006269; GO:0006270; GO:0046872; GO:0051539; GO:0071667 DNA replication initiation [GO:0006270]; DNA replication, synthesis of primer [GO:0006269] alpha DNA polymerase:primase complex [GO:0005658]; nucleoplasm [GO:0005654] 4 iron, 4 sulfur cluster binding [GO:0051539]; DNA binding [GO:0003677]; DNA/RNA hybrid binding [GO:0071667]; metal ion binding [GO:0046872] g705.t1 Q6GQN8 50.842 297 7.049999999999999e-94 285.0 sp|Q6GQN8|MECR_DANRE Enoyl-[acyl-carrier-protein] reductase, mitochondrial OS=Danio rerio OX=7955 GN=mecr PE=2 SV=2 MECR_DANRE reviewed Enoyl-[acyl-carrier-protein] reductase, mitochondrial (EC 1.3.1.104) (2-enoyl thioester reductase) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005739; GO:0006631; GO:0006633; GO:0141148 fatty acid biosynthetic process [GO:0006633]; fatty acid metabolic process [GO:0006631] mitochondrion [GO:0005739] enoyl-[acyl-carrier-protein] reductase (NADPH) activity [GO:0141148] g706.t1 Q96MY1 53.425 292 1.37e-75 244.0 sp|Q96MY1|NOL4L_HUMAN Nucleolar protein 4-like OS=Homo sapiens OX=9606 GN=NOL4L PE=1 SV=2 g706.t2 Q96MY1 52.189 297 7.039999999999999e-74 241.0 sp|Q96MY1|NOL4L_HUMAN Nucleolar protein 4-like OS=Homo sapiens OX=9606 GN=NOL4L PE=1 SV=2 g706.t3 Q96MY1 53.425 292 9.130000000000001e-75 244.0 sp|Q96MY1|NOL4L_HUMAN Nucleolar protein 4-like OS=Homo sapiens OX=9606 GN=NOL4L PE=1 SV=2 g709.t1 O94818 44.061 261 9e-59 202.0 sp|O94818|NOL4_HUMAN Nucleolar protein 4 OS=Homo sapiens OX=9606 GN=NOL4 PE=1 SV=2 NOL4_HUMAN reviewed Nucleolar protein 4 (Nucleolar-localized protein) Homo sapiens (Human) GO:0003723; GO:0005730 nucleolus [GO:0005730] RNA binding [GO:0003723] g712.t1 Q9PTU3 62.346 162 7.2e-50 174.0 sp|Q9PTU3|XPO2_PAGMA Exportin-2 OS=Pagrus major OX=143350 GN=cse1l PE=2 SV=1 g713.t1 Q7SZC2 62.63 768 0.0 983.0 sp|Q7SZC2|XPO2_DANRE Exportin-2 OS=Danio rerio OX=7955 GN=cse1l PE=1 SV=2 XPO2_DANRE reviewed Exportin-2 (Exp2) (Chromosome segregation 1-like protein) (Importin-alpha re-exporter) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005049; GO:0005635; GO:0005829; GO:0006606; GO:0006611; GO:0007589; GO:0009925; GO:0016324; GO:0016328; GO:0031267 body fluid secretion [GO:0007589]; protein export from nucleus [GO:0006611]; protein import into nucleus [GO:0006606] apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; cytosol [GO:0005829]; lateral plasma membrane [GO:0016328]; nuclear envelope [GO:0005635] nuclear export signal receptor activity [GO:0005049]; small GTPase binding [GO:0031267] g714.t1 Q640Z6 27.734 768 1.05e-39 166.0 sp|Q640Z6|NU153_XENLA Nuclear pore complex protein Nup153 OS=Xenopus laevis OX=8355 GN=nup153 PE=1 SV=1 g720.t1 Q90655 67.059 85 4.6e-36 136.0 sp|Q90655|AKR_CHICK Homeobox protein AKR OS=Gallus gallus OX=9031 PE=2 SV=1 g721.t1 B0BN95 30.488 246 9.41e-28 115.0 sp|B0BN95|HARB1_RAT Putative nuclease HARBI1 OS=Rattus norvegicus OX=10116 GN=Harbi1 PE=2 SV=1 HARB1_RAT reviewed Putative nuclease HARBI1 (EC 3.1.-.-) (Harbinger transposase-derived nuclease) Rattus norvegicus (Rat) GO:0004518; GO:0005634; GO:0005829; GO:0005886; GO:0016787; GO:0034451; GO:0046872 centriolar satellite [GO:0034451]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886] hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]; nuclease activity [GO:0004518] g723.t1 P20794 78.571 294 3.04e-177 508.0 sp|P20794|MAK_HUMAN Serine/threonine-protein kinase MAK OS=Homo sapiens OX=9606 GN=MAK PE=1 SV=2 MAK_HUMAN reviewed Serine/threonine-protein kinase MAK (EC 2.7.11.1) (Male germ cell-associated kinase) Homo sapiens (Human) GO:0001750; GO:0001917; GO:0003713; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005813; GO:0005829; GO:0005886; GO:0005929; GO:0005930; GO:0006468; GO:0007283; GO:0030154; GO:0030496; GO:0032391; GO:0035556; GO:0036064; GO:0042073; GO:0045494; GO:0046777; GO:0046872; GO:0060271; GO:0072686; GO:0097228; GO:0097229; GO:0106310; GO:0120212; GO:1902856; GO:1905515 cell differentiation [GO:0030154]; cilium assembly [GO:0060271]; intracellular signal transduction [GO:0035556]; intraciliary transport [GO:0042073]; negative regulation of non-motile cilium assembly [GO:1902856]; non-motile cilium assembly [GO:1905515]; photoreceptor cell maintenance [GO:0045494]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; spermatogenesis [GO:0007283] axoneme [GO:0005930]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; photoreceptor connecting cilium [GO:0032391]; photoreceptor inner segment [GO:0001917]; photoreceptor outer segment [GO:0001750]; plasma membrane [GO:0005886]; sperm end piece [GO:0097229]; sperm head-tail coupling apparatus [GO:0120212]; sperm principal piece [GO:0097228] ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; transcription coactivator activity [GO:0003713] g726.t1 Q5ZIT5 67.857 196 2.8e-93 273.0 sp|Q5ZIT5|RAB10_CHICK Ras-related protein Rab-10 OS=Gallus gallus OX=9031 GN=RAB10 PE=2 SV=1 RAB10_CHICK reviewed Ras-related protein Rab-10 (EC 3.6.5.2) Gallus gallus (Chicken) GO:0003925; GO:0005525; GO:0005768; GO:0005789; GO:0005794; GO:0005802; GO:0005929; GO:0006887; GO:0006893; GO:0007409; GO:0010008; GO:0016020; GO:0016192; GO:0016197; GO:0019003; GO:0030670; GO:0030859; GO:0031489; GO:0032593; GO:0032869; GO:0043001; GO:0045200; GO:0046872; GO:0048471; GO:0055037; GO:0055038; GO:0071782; GO:0071786; GO:0072659; GO:0097051; GO:0099503; GO:1903361 axonogenesis [GO:0007409]; cellular response to insulin stimulus [GO:0032869]; endoplasmic reticulum tubular network organization [GO:0071786]; endosomal transport [GO:0016197]; establishment of neuroblast polarity [GO:0045200]; establishment of protein localization to endoplasmic reticulum membrane [GO:0097051]; exocytosis [GO:0006887]; Golgi to plasma membrane protein transport [GO:0043001]; Golgi to plasma membrane transport [GO:0006893]; polarized epithelial cell differentiation [GO:0030859]; protein localization to basolateral plasma membrane [GO:1903361]; protein localization to plasma membrane [GO:0072659]; vesicle-mediated transport [GO:0016192] cilium [GO:0005929]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum tubular network [GO:0071782]; endosome [GO:0005768]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; insulin-responsive compartment [GO:0032593]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle membrane [GO:0030670]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; secretory vesicle [GO:0099503]; trans-Golgi network [GO:0005802] G protein activity [GO:0003925]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]; myosin V binding [GO:0031489] g727.t1 Q2HJI8 46.328 177 1.09e-50 173.0 sp|Q2HJI8|RAB8B_BOVIN Ras-related protein Rab-8B OS=Bos taurus OX=9913 GN=RAB8B PE=2 SV=1 RAB8B_BOVIN reviewed Ras-related protein Rab-8B (EC 3.6.5.2) Bos taurus (Bovine) GO:0003924; GO:0003925; GO:0005525; GO:0005768; GO:0005886; GO:0006887; GO:0008021; GO:0010008; GO:0015031; GO:0019003; GO:0030140; GO:0030670; GO:0032456; GO:0045335; GO:0046872 endocytic recycling [GO:0032456]; exocytosis [GO:0006887]; protein transport [GO:0015031] endosome [GO:0005768]; endosome membrane [GO:0010008]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; synaptic vesicle [GO:0008021]; trans-Golgi network transport vesicle [GO:0030140] G protein activity [GO:0003925]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872] g728.t1 Q5R5U1 48.352 182 1.31e-58 187.0 sp|Q5R5U1|RAB10_PONAB Ras-related protein Rab-10 OS=Pongo abelii OX=9601 GN=RAB10 PE=2 SV=1 RAB10_PONAB reviewed Ras-related protein Rab-10 (EC 3.6.5.2) Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0003925; GO:0005525; GO:0005764; GO:0005768; GO:0005789; GO:0005794; GO:0005802; GO:0005886; GO:0005929; GO:0006893; GO:0007409; GO:0010008; GO:0016192; GO:0016197; GO:0019003; GO:0019882; GO:0030670; GO:0030859; GO:0031489; GO:0032593; GO:0032869; GO:0043001; GO:0045055; GO:0045200; GO:0046872; GO:0048471; GO:0055037; GO:0055038; GO:0070382; GO:0071782; GO:0071786; GO:0072659; GO:0097051; GO:1903361 antigen processing and presentation [GO:0019882]; axonogenesis [GO:0007409]; cellular response to insulin stimulus [GO:0032869]; endoplasmic reticulum tubular network organization [GO:0071786]; endosomal transport [GO:0016197]; establishment of neuroblast polarity [GO:0045200]; establishment of protein localization to endoplasmic reticulum membrane [GO:0097051]; Golgi to plasma membrane protein transport [GO:0043001]; Golgi to plasma membrane transport [GO:0006893]; polarized epithelial cell differentiation [GO:0030859]; protein localization to basolateral plasma membrane [GO:1903361]; protein localization to plasma membrane [GO:0072659]; regulated exocytosis [GO:0045055]; vesicle-mediated transport [GO:0016192] cilium [GO:0005929]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum tubular network [GO:0071782]; endosome [GO:0005768]; endosome membrane [GO:0010008]; exocytic vesicle [GO:0070382]; Golgi apparatus [GO:0005794]; insulin-responsive compartment [GO:0032593]; lysosome [GO:0005764]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; trans-Golgi network [GO:0005802] G protein activity [GO:0003925]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]; myosin V binding [GO:0031489] g733.t1 Q86Y82 48.261 230 8.56e-69 219.0 sp|Q86Y82|STX12_HUMAN Syntaxin-12 OS=Homo sapiens OX=9606 GN=STX12 PE=1 SV=1 STX12_HUMAN reviewed Syntaxin-12 Homo sapiens (Human) GO:0000045; GO:0000139; GO:0000149; GO:0000407; GO:0005484; GO:0005654; GO:0005794; GO:0006886; GO:0006906; GO:0008021; GO:0012505; GO:0030672; GO:0031201; GO:0031901; GO:0031982; GO:0032456; GO:0033344; GO:0045121; GO:0045335; GO:0048278; GO:0050821; GO:0055037; GO:0055038; GO:0098837 autophagosome assembly [GO:0000045]; cholesterol efflux [GO:0033344]; endocytic recycling [GO:0032456]; intracellular protein transport [GO:0006886]; protein stabilization [GO:0050821]; vesicle docking [GO:0048278]; vesicle fusion [GO:0006906] early endosome membrane [GO:0031901]; endomembrane system [GO:0012505]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; membrane raft [GO:0045121]; nucleoplasm [GO:0005654]; phagocytic vesicle [GO:0045335]; phagophore assembly site [GO:0000407]; postsynaptic recycling endosome [GO:0098837]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; SNARE complex [GO:0031201]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672]; vesicle [GO:0031982] SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149] g733.t2 Q86Y82 47.639 233 1.31e-69 219.0 sp|Q86Y82|STX12_HUMAN Syntaxin-12 OS=Homo sapiens OX=9606 GN=STX12 PE=1 SV=1 STX12_HUMAN reviewed Syntaxin-12 Homo sapiens (Human) GO:0000045; GO:0000139; GO:0000149; GO:0000407; GO:0005484; GO:0005654; GO:0005794; GO:0006886; GO:0006906; GO:0008021; GO:0012505; GO:0030672; GO:0031201; GO:0031901; GO:0031982; GO:0032456; GO:0033344; GO:0045121; GO:0045335; GO:0048278; GO:0050821; GO:0055037; GO:0055038; GO:0098837 autophagosome assembly [GO:0000045]; cholesterol efflux [GO:0033344]; endocytic recycling [GO:0032456]; intracellular protein transport [GO:0006886]; protein stabilization [GO:0050821]; vesicle docking [GO:0048278]; vesicle fusion [GO:0006906] early endosome membrane [GO:0031901]; endomembrane system [GO:0012505]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; membrane raft [GO:0045121]; nucleoplasm [GO:0005654]; phagocytic vesicle [GO:0045335]; phagophore assembly site [GO:0000407]; postsynaptic recycling endosome [GO:0098837]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; SNARE complex [GO:0031201]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672]; vesicle [GO:0031982] SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149] g733.t3 Q86Y82 47.639 233 2.6699999999999997e-69 219.0 sp|Q86Y82|STX12_HUMAN Syntaxin-12 OS=Homo sapiens OX=9606 GN=STX12 PE=1 SV=1 STX12_HUMAN reviewed Syntaxin-12 Homo sapiens (Human) GO:0000045; GO:0000139; GO:0000149; GO:0000407; GO:0005484; GO:0005654; GO:0005794; GO:0006886; GO:0006906; GO:0008021; GO:0012505; GO:0030672; GO:0031201; GO:0031901; GO:0031982; GO:0032456; GO:0033344; GO:0045121; GO:0045335; GO:0048278; GO:0050821; GO:0055037; GO:0055038; GO:0098837 autophagosome assembly [GO:0000045]; cholesterol efflux [GO:0033344]; endocytic recycling [GO:0032456]; intracellular protein transport [GO:0006886]; protein stabilization [GO:0050821]; vesicle docking [GO:0048278]; vesicle fusion [GO:0006906] early endosome membrane [GO:0031901]; endomembrane system [GO:0012505]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; membrane raft [GO:0045121]; nucleoplasm [GO:0005654]; phagocytic vesicle [GO:0045335]; phagophore assembly site [GO:0000407]; postsynaptic recycling endosome [GO:0098837]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; SNARE complex [GO:0031201]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672]; vesicle [GO:0031982] SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149] g739.t1 Q8NA29 34.491 403 6.02e-70 233.0 sp|Q8NA29|NLS1_HUMAN Sodium-dependent lysophosphatidylcholine symporter 1 OS=Homo sapiens OX=9606 GN=MFSD2A PE=1 SV=1 NLS1_HUMAN reviewed Sodium-dependent lysophosphatidylcholine symporter 1 (NLS1) (Sodium-dependent LPC symporter 1) (Major facilitator superfamily domain-containing protein 2A) (HsMFSD2A) (MFSD2a) Homo sapiens (Human) GO:0003406; GO:0005324; GO:0005548; GO:0005764; GO:0005789; GO:0005829; GO:0005886; GO:0006656; GO:0007420; GO:0008594; GO:0008643; GO:0009267; GO:0010867; GO:0015245; GO:0015908; GO:0015909; GO:0016020; GO:0021766; GO:0030307; GO:0031999; GO:0034379; GO:0035633; GO:0035845; GO:0036464; GO:0040014; GO:0045056; GO:0050773; GO:0050890; GO:0051977; GO:0051978; GO:0055085; GO:0060042; GO:0060856; GO:0061744; GO:0097009; GO:0140329; GO:0140348; GO:0150011; GO:0150104; GO:0150172; GO:0150175; GO:0150178; GO:1901480; GO:1990379 brain development [GO:0007420]; carbohydrate transport [GO:0008643]; cellular response to starvation [GO:0009267]; cognition [GO:0050890]; energy homeostasis [GO:0097009]; establishment of blood-brain barrier [GO:0060856]; fatty acid transport [GO:0015908]; hippocampus development [GO:0021766]; lipid transport across blood-brain barrier [GO:1990379]; long-chain fatty acid transport [GO:0015909]; lysophospholipid translocation [GO:0140329]; lysophospholipid transport [GO:0051977]; maintenance of blood-brain barrier [GO:0035633]; motor behavior [GO:0061744]; negative regulation of fatty acid beta-oxidation [GO:0031999]; phosphatidylcholine biosynthetic process [GO:0006656]; photoreceptor cell morphogenesis [GO:0008594]; photoreceptor cell outer segment organization [GO:0035845]; positive regulation of cell growth [GO:0030307]; positive regulation of triglyceride biosynthetic process [GO:0010867]; regulation of dendrite development [GO:0050773]; regulation of multicellular organism growth [GO:0040014]; regulation of neuron projection arborization [GO:0150011]; regulation of phosphatidylcholine metabolic process [GO:0150172]; regulation of phosphatidylethanolamine metabolic process [GO:0150175]; regulation of phosphatidylserine metabolic process [GO:0150178]; retina morphogenesis in camera-type eye [GO:0060042]; retinal pigment epithelium development [GO:0003406]; transcytosis [GO:0045056]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104]; very-low-density lipoprotein particle assembly [GO:0034379] cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; lysosome [GO:0005764]; membrane [GO:0016020]; plasma membrane [GO:0005886] fatty acid transmembrane transporter activity [GO:0015245]; long-chain fatty acid transmembrane transporter activity [GO:0005324]; lysophosphatidylcholine flippase activity [GO:0140348]; lysophospholipid:sodium symporter activity [GO:0051978]; oleate transmembrane transporter activity [GO:1901480]; phospholipid transporter activity [GO:0005548] g746.t1 B3EWZ9 45.592 1055 0.0 940.0 sp|B3EWZ9|HEPHL_ACRMI Hephaestin-like protein OS=Acropora millepora OX=45264 PE=1 SV=1 HEPHL_ACRMI reviewed Hephaestin-like protein (EC 1.-.-.-) Acropora millepora (Staghorn coral) (Heteropora millepora) GO:0005507; GO:0005886; GO:0006825; GO:0006826; GO:0016491 copper ion transport [GO:0006825]; iron ion transport [GO:0006826] plasma membrane [GO:0005886] copper ion binding [GO:0005507]; oxidoreductase activity [GO:0016491] g746.t1 B3EWZ9 39.915 709 1.4899999999999999e-170 533.0 sp|B3EWZ9|HEPHL_ACRMI Hephaestin-like protein OS=Acropora millepora OX=45264 PE=1 SV=1 HEPHL_ACRMI reviewed Hephaestin-like protein (EC 1.-.-.-) Acropora millepora (Staghorn coral) (Heteropora millepora) GO:0005507; GO:0005886; GO:0006825; GO:0006826; GO:0016491 copper ion transport [GO:0006825]; iron ion transport [GO:0006826] plasma membrane [GO:0005886] copper ion binding [GO:0005507]; oxidoreductase activity [GO:0016491] g746.t1 B3EWZ9 38.741 715 2.82e-150 480.0 sp|B3EWZ9|HEPHL_ACRMI Hephaestin-like protein OS=Acropora millepora OX=45264 PE=1 SV=1 HEPHL_ACRMI reviewed Hephaestin-like protein (EC 1.-.-.-) Acropora millepora (Staghorn coral) (Heteropora millepora) GO:0005507; GO:0005886; GO:0006825; GO:0006826; GO:0016491 copper ion transport [GO:0006825]; iron ion transport [GO:0006826] plasma membrane [GO:0005886] copper ion binding [GO:0005507]; oxidoreductase activity [GO:0016491] g746.t1 B3EWZ9 41.88 351 4.7500000000000004e-79 285.0 sp|B3EWZ9|HEPHL_ACRMI Hephaestin-like protein OS=Acropora millepora OX=45264 PE=1 SV=1 HEPHL_ACRMI reviewed Hephaestin-like protein (EC 1.-.-.-) Acropora millepora (Staghorn coral) (Heteropora millepora) GO:0005507; GO:0005886; GO:0006825; GO:0006826; GO:0016491 copper ion transport [GO:0006825]; iron ion transport [GO:0006826] plasma membrane [GO:0005886] copper ion binding [GO:0005507]; oxidoreductase activity [GO:0016491] g746.t1 B3EWZ9 41.808 354 8.93e-75 272.0 sp|B3EWZ9|HEPHL_ACRMI Hephaestin-like protein OS=Acropora millepora OX=45264 PE=1 SV=1 HEPHL_ACRMI reviewed Hephaestin-like protein (EC 1.-.-.-) Acropora millepora (Staghorn coral) (Heteropora millepora) GO:0005507; GO:0005886; GO:0006825; GO:0006826; GO:0016491 copper ion transport [GO:0006825]; iron ion transport [GO:0006826] plasma membrane [GO:0005886] copper ion binding [GO:0005507]; oxidoreductase activity [GO:0016491] g750.t1 B3EWZ9 45.666 1073 0.0 968.0 sp|B3EWZ9|HEPHL_ACRMI Hephaestin-like protein OS=Acropora millepora OX=45264 PE=1 SV=1 HEPHL_ACRMI reviewed Hephaestin-like protein (EC 1.-.-.-) Acropora millepora (Staghorn coral) (Heteropora millepora) GO:0005507; GO:0005886; GO:0006825; GO:0006826; GO:0016491 copper ion transport [GO:0006825]; iron ion transport [GO:0006826] plasma membrane [GO:0005886] copper ion binding [GO:0005507]; oxidoreductase activity [GO:0016491] g750.t1 B3EWZ9 40.871 712 3.7300000000000005e-179 557.0 sp|B3EWZ9|HEPHL_ACRMI Hephaestin-like protein OS=Acropora millepora OX=45264 PE=1 SV=1 HEPHL_ACRMI reviewed Hephaestin-like protein (EC 1.-.-.-) Acropora millepora (Staghorn coral) (Heteropora millepora) GO:0005507; GO:0005886; GO:0006825; GO:0006826; GO:0016491 copper ion transport [GO:0006825]; iron ion transport [GO:0006826] plasma membrane [GO:0005886] copper ion binding [GO:0005507]; oxidoreductase activity [GO:0016491] g750.t1 B3EWZ9 38.494 704 2.01e-153 489.0 sp|B3EWZ9|HEPHL_ACRMI Hephaestin-like protein OS=Acropora millepora OX=45264 PE=1 SV=1 HEPHL_ACRMI reviewed Hephaestin-like protein (EC 1.-.-.-) Acropora millepora (Staghorn coral) (Heteropora millepora) GO:0005507; GO:0005886; GO:0006825; GO:0006826; GO:0016491 copper ion transport [GO:0006825]; iron ion transport [GO:0006826] plasma membrane [GO:0005886] copper ion binding [GO:0005507]; oxidoreductase activity [GO:0016491] g750.t1 B3EWZ9 39.831 354 1.3400000000000001e-70 260.0 sp|B3EWZ9|HEPHL_ACRMI Hephaestin-like protein OS=Acropora millepora OX=45264 PE=1 SV=1 HEPHL_ACRMI reviewed Hephaestin-like protein (EC 1.-.-.-) Acropora millepora (Staghorn coral) (Heteropora millepora) GO:0005507; GO:0005886; GO:0006825; GO:0006826; GO:0016491 copper ion transport [GO:0006825]; iron ion transport [GO:0006826] plasma membrane [GO:0005886] copper ion binding [GO:0005507]; oxidoreductase activity [GO:0016491] g751.t1 Q62559 70.991 424 0.0 610.0 sp|Q62559|IFT52_MOUSE Intraflagellar transport protein 52 homolog OS=Mus musculus OX=10090 GN=Ift52 PE=1 SV=2 g754.t1 Q6UXP7 37.549 253 8.05e-49 173.0 sp|Q6UXP7|F151B_HUMAN Protein FAM151B OS=Homo sapiens OX=9606 GN=FAM151B PE=1 SV=2 g754.t2 Q6UXP7 37.549 253 6.89e-49 173.0 sp|Q6UXP7|F151B_HUMAN Protein FAM151B OS=Homo sapiens OX=9606 GN=FAM151B PE=1 SV=2 g755.t1 Q9BWJ5 82.353 85 1.97e-52 161.0 sp|Q9BWJ5|SF3B5_HUMAN Splicing factor 3B subunit 5 OS=Homo sapiens OX=9606 GN=SF3B5 PE=1 SV=1 g756.t1 P25183 55.143 350 2.07e-121 359.0 sp|P25183|RCC1_XENLA Regulator of chromosome condensation OS=Xenopus laevis OX=8355 GN=rcc1 PE=2 SV=1 g760.t1 Q8BSL4 54.615 260 1.28e-93 286.0 sp|Q8BSL4|HS3S5_MOUSE Heparan sulfate glucosamine 3-O-sulfotransferase 5 OS=Mus musculus OX=10090 GN=Hs3st5 PE=2 SV=1 g761.t1 Q0P3Z2 46.132 349 3.39e-116 343.0 sp|Q0P3Z2|PTER_DANRE N-acetyltaurine hydrolase OS=Danio rerio OX=7955 GN=pter PE=2 SV=1 PTER_DANRE reviewed N-acetyltaurine hydrolase (EC 3.1.-.-) (Phosphotriesterase-related protein) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005829; GO:0008270; GO:0019530; GO:0032098; GO:0141215 regulation of appetite [GO:0032098]; taurine metabolic process [GO:0019530] cytosol [GO:0005829] N-acetyltaurine hydrolase activity [GO:0141215]; zinc ion binding [GO:0008270] g762.t1 F1NB38 50.41 244 1.59e-79 247.0 sp|F1NB38|ECHD1_CHICK Ethylmalonyl-CoA decarboxylase OS=Gallus gallus OX=9031 GN=ECHDC1 PE=3 SV=2 g763.t1 A1L2H9 45.2 250 1.77e-71 224.0 sp|A1L2H9|RFA2B_XENLA Replication protein A 32 kDa subunit-B OS=Xenopus laevis OX=8355 GN=rpa2-b PE=2 SV=1 g764.t1 Q9QXG4 65.051 495 0.0 667.0 sp|Q9QXG4|ACSA_MOUSE Acetyl-coenzyme A synthetase, cytoplasmic OS=Mus musculus OX=10090 GN=Acss2 PE=1 SV=2 ACSA_MOUSE reviewed Acetyl-coenzyme A synthetase, cytoplasmic (EC 6.2.1.1) (Acetate--CoA ligase) (Acetyl-CoA synthetase) (ACS) (AceCS) (Acetyl-CoA synthetase 1) (AceCS1) (Acyl-CoA synthetase short-chain family member 2) (Acyl-activating enzyme) (Propionate--CoA ligase) (EC 6.2.1.17) Mus musculus (Mouse) GO:0003682; GO:0003713; GO:0003987; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006085; GO:0007616; GO:0008610; GO:0019413; GO:0019542; GO:0050218 acetate biosynthetic process [GO:0019413]; acetyl-CoA biosynthetic process [GO:0006085]; lipid biosynthetic process [GO:0008610]; long-term memory [GO:0007616]; propionate biosynthetic process [GO:0019542] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634] acetate-CoA ligase activity [GO:0003987]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; propionate-CoA ligase activity [GO:0050218]; transcription coactivator activity [GO:0003713] g766.t1 Q9VP61 55.882 170 9.119999999999999e-68 221.0 sp|Q9VP61|ACSA_DROME Acetyl-coenzyme A synthetase OS=Drosophila melanogaster OX=7227 GN=AcCoAS PE=2 SV=1 g767.t1 Q865K9 35.435 333 3.46e-64 210.0 sp|Q865K9|MPRB_PIG Membrane progestin receptor beta OS=Sus scrofa OX=9823 GN=PAQR8 PE=2 SV=1 g777.t1 Q9HCU5 31.954 435 2.73e-61 208.0 sp|Q9HCU5|SEC12_HUMAN Guanine nucleotide-exchange factor SEC12 OS=Homo sapiens OX=9606 GN=PREB PE=1 SV=2 SEC12_HUMAN reviewed Guanine nucleotide-exchange factor SEC12 (Prolactin regulatory element-binding protein) Homo sapiens (Human) GO:0003400; GO:0003677; GO:0005085; GO:0005634; GO:0005789; GO:0006888; GO:0016020; GO:0042953; GO:0048208; GO:0051020; GO:0070971 COPII vesicle coating [GO:0048208]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; lipoprotein transport [GO:0042953]; regulation of COPII vesicle coating [GO:0003400] endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; nucleus [GO:0005634] DNA binding [GO:0003677]; GTPase binding [GO:0051020]; guanyl-nucleotide exchange factor activity [GO:0005085] g778.t1 Q5PPX0 55.078 256 1.1700000000000001e-79 253.0 sp|Q5PPX0|PPR42_XENLA Protein phosphatase 1 regulatory subunit 42 OS=Xenopus laevis OX=8355 GN=ppp1r42 PE=2 SV=1 g780.t1 Q8N157 47.98 594 0.0 612.0 sp|Q8N157|AHI1_HUMAN Jouberin OS=Homo sapiens OX=9606 GN=AHI1 PE=1 SV=1 g782.t1 P17945 34.074 405 1.2e-45 172.0 sp|P17945|HGF_RAT Hepatocyte growth factor OS=Rattus norvegicus OX=10116 GN=Hgf PE=1 SV=1 HGF_RAT reviewed Hepatocyte growth factor (Hepatopoietin-A) (Scatter factor) (SF) [Cleaved into: Hepatocyte growth factor alpha chain; Hepatocyte growth factor beta chain] Rattus norvegicus (Rat) GO:0000902; GO:0001889; GO:0005102; GO:0005615; GO:0006508; GO:0008083; GO:0008284; GO:0014856; GO:0030335; GO:0031643; GO:0032715; GO:0032733; GO:0035729; GO:0042056; GO:0042802; GO:0043066; GO:0043410; GO:0044877; GO:0045766; GO:0048012; GO:0050673; GO:0050728; GO:0051450; GO:0051897; GO:0060326; GO:0060665; GO:0070572; GO:0090201; GO:0097421; GO:1900744; GO:1901299; GO:1902042; GO:2000573 cell chemotaxis [GO:0060326]; cell morphogenesis [GO:0000902]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; epithelial cell proliferation [GO:0050673]; hepatocyte growth factor receptor signaling pathway [GO:0048012]; liver development [GO:0001889]; liver regeneration [GO:0097421]; myoblast proliferation [GO:0051450]; negative regulation of apoptotic process [GO:0043066]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; negative regulation of hydrogen peroxide-mediated programmed cell death [GO:1901299]; negative regulation of inflammatory response [GO:0050728]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA biosynthetic process [GO:2000573]; positive regulation of interleukin-10 production [GO:0032733]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of myelination [GO:0031643]; positive regulation of neuron projection regeneration [GO:0070572]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; proteolysis [GO:0006508]; regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling [GO:0060665]; regulation of p38MAPK cascade [GO:1900744]; skeletal muscle cell proliferation [GO:0014856] extracellular space [GO:0005615] chemoattractant activity [GO:0042056]; growth factor activity [GO:0008083]; identical protein binding [GO:0042802]; protein-containing complex binding [GO:0044877]; signaling receptor binding [GO:0005102] g782.t1 P17945 31.579 304 4.89e-24 108.0 sp|P17945|HGF_RAT Hepatocyte growth factor OS=Rattus norvegicus OX=10116 GN=Hgf PE=1 SV=1 HGF_RAT reviewed Hepatocyte growth factor (Hepatopoietin-A) (Scatter factor) (SF) [Cleaved into: Hepatocyte growth factor alpha chain; Hepatocyte growth factor beta chain] Rattus norvegicus (Rat) GO:0000902; GO:0001889; GO:0005102; GO:0005615; GO:0006508; GO:0008083; GO:0008284; GO:0014856; GO:0030335; GO:0031643; GO:0032715; GO:0032733; GO:0035729; GO:0042056; GO:0042802; GO:0043066; GO:0043410; GO:0044877; GO:0045766; GO:0048012; GO:0050673; GO:0050728; GO:0051450; GO:0051897; GO:0060326; GO:0060665; GO:0070572; GO:0090201; GO:0097421; GO:1900744; GO:1901299; GO:1902042; GO:2000573 cell chemotaxis [GO:0060326]; cell morphogenesis [GO:0000902]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; epithelial cell proliferation [GO:0050673]; hepatocyte growth factor receptor signaling pathway [GO:0048012]; liver development [GO:0001889]; liver regeneration [GO:0097421]; myoblast proliferation [GO:0051450]; negative regulation of apoptotic process [GO:0043066]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; negative regulation of hydrogen peroxide-mediated programmed cell death [GO:1901299]; negative regulation of inflammatory response [GO:0050728]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA biosynthetic process [GO:2000573]; positive regulation of interleukin-10 production [GO:0032733]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of myelination [GO:0031643]; positive regulation of neuron projection regeneration [GO:0070572]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; proteolysis [GO:0006508]; regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling [GO:0060665]; regulation of p38MAPK cascade [GO:1900744]; skeletal muscle cell proliferation [GO:0014856] extracellular space [GO:0005615] chemoattractant activity [GO:0042056]; growth factor activity [GO:0008083]; identical protein binding [GO:0042802]; protein-containing complex binding [GO:0044877]; signaling receptor binding [GO:0005102] g783.t1 Q5RAT4 67.1 231 1.77e-121 355.0 sp|Q5RAT4|ENOF1_PONAB Mitochondrial enolase superfamily member 1 OS=Pongo abelii OX=9601 GN=ENOSF1 PE=2 SV=1 g784.t1 Q6INX4 71.318 129 2.01e-64 205.0 sp|Q6INX4|ENOF1_XENLA Mitochondrial enolase superfamily member 1 OS=Xenopus laevis OX=8355 GN=enosf1 PE=2 SV=1 g785.t1 Q9Z0T0 40.678 236 3.47e-56 185.0 sp|Q9Z0T0|TPMT_RAT Thiopurine S-methyltransferase OS=Rattus norvegicus OX=10116 GN=Tpmt PE=2 SV=1 g786.t1 Q8BGW3 87.324 71 2.8700000000000003e-37 134.0 sp|Q8BGW3|BHE23_MOUSE Class E basic helix-loop-helix protein 23 OS=Mus musculus OX=10090 GN=Bhlhe23 PE=2 SV=1 BHE23_MOUSE reviewed Class E basic helix-loop-helix protein 23 (bHLHe23) (Class B basic helix-loop-helix protein 4) (bHLHb4) Mus musculus (Mouse) GO:0000981; GO:0005634; GO:0007423; GO:0045944; GO:0046548; GO:0046671; GO:0046983; GO:0048050; GO:0061564; GO:0070888; GO:1990837 axon development [GO:0061564]; negative regulation of retinal cell programmed cell death [GO:0046671]; positive regulation of transcription by RNA polymerase II [GO:0045944]; post-embryonic eye morphogenesis [GO:0048050]; retinal rod cell development [GO:0046548]; sensory organ development [GO:0007423] nucleus [GO:0005634] DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; E-box binding [GO:0070888]; protein dimerization activity [GO:0046983]; sequence-specific double-stranded DNA binding [GO:1990837] g789.t1 Q26657 73.016 63 4.64e-23 100.0 sp|Q26657|ALX_STRPU Aristaless homeobox protein (Fragment) OS=Strongylocentrotus purpuratus OX=7668 GN=ALX PE=2 SV=2 g791.t1 Q32L77 39.785 186 3.81e-36 129.0 sp|Q32L77|CFA95_BOVIN Cilia- and flagella-associated protein 95 OS=Bos taurus OX=9913 GN=CFAP95 PE=1 SV=1 CFA95_BOVIN reviewed Cilia- and flagella-associated protein 95 Bos taurus (Bovine) GO:0005737; GO:0005879; GO:0005886; GO:0030317; GO:0036126; GO:0160111 flagellated sperm motility [GO:0030317] axonemal A tubule inner sheath [GO:0160111]; axonemal microtubule [GO:0005879]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; sperm flagellum [GO:0036126] g792.t1 Q5R602 36.052 233 2.2200000000000002e-31 120.0 sp|Q5R602|STX7_PONAB Syntaxin-7 OS=Pongo abelii OX=9601 GN=STX7 PE=2 SV=3 g792.t2 Q5R602 35.897 234 5.630000000000001e-31 119.0 sp|Q5R602|STX7_PONAB Syntaxin-7 OS=Pongo abelii OX=9601 GN=STX7 PE=2 SV=3 g793.t1 Q9GRC0 77.485 342 1.05e-171 487.0 sp|Q9GRC0|MOS_PATPE Serine/threonine-protein kinase mos OS=Patiria pectinifera OX=7594 GN=mos PE=1 SV=1 g794.t1 Q9CUU3 29.114 395 1.6e-45 185.0 sp|Q9CUU3|SYCP2_MOUSE Synaptonemal complex protein 2 OS=Mus musculus OX=10090 GN=Sycp2 PE=1 SV=2 SYCP2_MOUSE reviewed Synaptonemal complex protein 2 (SCP-2) (Synaptonemal complex lateral element protein) Mus musculus (Mouse) GO:0000779; GO:0000795; GO:0000800; GO:0003677; GO:0005654; GO:0007140; GO:0007143; GO:0009566; GO:0009887; GO:0043066; GO:0048808; GO:0051301 animal organ morphogenesis [GO:0009887]; cell division [GO:0051301]; female meiotic nuclear division [GO:0007143]; fertilization [GO:0009566]; male genitalia morphogenesis [GO:0048808]; male meiotic nuclear division [GO:0007140]; negative regulation of apoptotic process [GO:0043066] condensed chromosome, centromeric region [GO:0000779]; lateral element [GO:0000800]; nucleoplasm [GO:0005654]; synaptonemal complex [GO:0000795] DNA binding [GO:0003677] g794.t2 Q9CUU3 29.114 395 1.6e-45 185.0 sp|Q9CUU3|SYCP2_MOUSE Synaptonemal complex protein 2 OS=Mus musculus OX=10090 GN=Sycp2 PE=1 SV=2 SYCP2_MOUSE reviewed Synaptonemal complex protein 2 (SCP-2) (Synaptonemal complex lateral element protein) Mus musculus (Mouse) GO:0000779; GO:0000795; GO:0000800; GO:0003677; GO:0005654; GO:0007140; GO:0007143; GO:0009566; GO:0009887; GO:0043066; GO:0048808; GO:0051301 animal organ morphogenesis [GO:0009887]; cell division [GO:0051301]; female meiotic nuclear division [GO:0007143]; fertilization [GO:0009566]; male genitalia morphogenesis [GO:0048808]; male meiotic nuclear division [GO:0007140]; negative regulation of apoptotic process [GO:0043066] condensed chromosome, centromeric region [GO:0000779]; lateral element [GO:0000800]; nucleoplasm [GO:0005654]; synaptonemal complex [GO:0000795] DNA binding [GO:0003677] g794.t3 Q9CUU3 29.114 395 1.6e-45 185.0 sp|Q9CUU3|SYCP2_MOUSE Synaptonemal complex protein 2 OS=Mus musculus OX=10090 GN=Sycp2 PE=1 SV=2 SYCP2_MOUSE reviewed Synaptonemal complex protein 2 (SCP-2) (Synaptonemal complex lateral element protein) Mus musculus (Mouse) GO:0000779; GO:0000795; GO:0000800; GO:0003677; GO:0005654; GO:0007140; GO:0007143; GO:0009566; GO:0009887; GO:0043066; GO:0048808; GO:0051301 animal organ morphogenesis [GO:0009887]; cell division [GO:0051301]; female meiotic nuclear division [GO:0007143]; fertilization [GO:0009566]; male genitalia morphogenesis [GO:0048808]; male meiotic nuclear division [GO:0007140]; negative regulation of apoptotic process [GO:0043066] condensed chromosome, centromeric region [GO:0000779]; lateral element [GO:0000800]; nucleoplasm [GO:0005654]; synaptonemal complex [GO:0000795] DNA binding [GO:0003677] g796.t1 Q8NE09 44.8 500 2.83e-131 443.0 sp|Q8NE09|RGS22_HUMAN Regulator of G-protein signaling 22 OS=Homo sapiens OX=9606 GN=RGS22 PE=1 SV=3 RGS22_HUMAN reviewed Regulator of G-protein signaling 22 (RGS22) Homo sapiens (Human) GO:0001650; GO:0001965; GO:0005634; GO:0005737; GO:0005829; GO:0009968; GO:0015629 negative regulation of signal transduction [GO:0009968] actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; nucleus [GO:0005634] G-protein alpha-subunit binding [GO:0001965] g796.t1 Q8NE09 41.631 233 5.469999999999999e-38 160.0 sp|Q8NE09|RGS22_HUMAN Regulator of G-protein signaling 22 OS=Homo sapiens OX=9606 GN=RGS22 PE=1 SV=3 RGS22_HUMAN reviewed Regulator of G-protein signaling 22 (RGS22) Homo sapiens (Human) GO:0001650; GO:0001965; GO:0005634; GO:0005737; GO:0005829; GO:0009968; GO:0015629 negative regulation of signal transduction [GO:0009968] actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; nucleus [GO:0005634] G-protein alpha-subunit binding [GO:0001965] g797.t1 A0A2D0TC04 31.09 312 1.58e-33 134.0 sp|A0A2D0TC04|PDE_NAJAT Venom phosphodiesterase OS=Naja atra OX=8656 PE=1 SV=1 PDE_NAJAT reviewed Venom phosphodiesterase (PDE) (EC 3.6.1.-) Naja atra (Chinese cobra) GO:0003676; GO:0005576; GO:0009143; GO:0043262; GO:0046872; GO:0047429; GO:0090729 nucleoside triphosphate catabolic process [GO:0009143] extracellular region [GO:0005576] ADP phosphatase activity [GO:0043262]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; nucleoside triphosphate diphosphatase activity [GO:0047429]; toxin activity [GO:0090729] g798.t1 P15396 30.093 432 2.7999999999999996e-54 200.0 sp|P15396|ENPP3_BOVIN Ectonucleotide pyrophosphatase/phosphodiesterase family member 3 OS=Bos taurus OX=9913 GN=ENPP3 PE=1 SV=2 ENPP3_BOVIN reviewed Ectonucleotide pyrophosphatase/phosphodiesterase family member 3 (E-NPP 3) (Alkaline phosphodiesterase I) (EC 3.1.4.1) (Dinucleoside polyphosphatase) (EC 3.6.1.-) (Nucleotide diphosphatase) (Nucleotide pyrophosphatase) (NPPase) (EC 3.6.1.9) (Phosphodiesterase I beta) (PD-Ibeta) (Phosphodiesterase I/nucleotide pyrophosphatase 3) (CD antigen CD203c) Bos taurus (Bovine) GO:0002276; GO:0003676; GO:0004081; GO:0004528; GO:0005509; GO:0005524; GO:0005576; GO:0005886; GO:0006220; GO:0008270; GO:0009143; GO:0009897; GO:0016324; GO:0033007; GO:0034432; GO:0036219; GO:0036221; GO:0046034; GO:0047429; GO:0047693; GO:0047710; GO:0050728; GO:0055062; GO:0070667; GO:0106177; GO:0160049 ATP metabolic process [GO:0046034]; basophil activation involved in immune response [GO:0002276]; negative regulation of cGAS/STING signaling pathway [GO:0160049]; negative regulation of inflammatory response [GO:0050728]; negative regulation of mast cell activation involved in immune response [GO:0033007]; negative regulation of mast cell proliferation [GO:0070667]; nucleoside triphosphate catabolic process [GO:0009143]; phosphate ion homeostasis [GO:0055062]; pyrimidine nucleotide metabolic process [GO:0006220] apical plasma membrane [GO:0016324]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; plasma membrane [GO:0005886] ATP binding [GO:0005524]; ATP diphosphatase activity [GO:0047693]; bis(5'-adenosyl)-pentaphosphatase activity [GO:0034432]; bis(5'-adenosyl)-triphosphatase activity [GO:0047710]; bis(5'-nucleosyl)-tetraphosphatase (asymmetrical) activity [GO:0004081]; calcium ion binding [GO:0005509]; cyclic-GMP-AMP hydrolase activity [GO:0106177]; GTP diphosphatase activity [GO:0036219]; nucleic acid binding [GO:0003676]; nucleoside triphosphate diphosphatase activity [GO:0047429]; phosphodiesterase I activity [GO:0004528]; UTP diphosphatase activity [GO:0036221]; zinc ion binding [GO:0008270] g800.t1 O43324 42.604 169 1.49e-37 130.0 sp|O43324|MCA3_HUMAN Eukaryotic translation elongation factor 1 epsilon-1 OS=Homo sapiens OX=9606 GN=EEF1E1 PE=1 SV=1 MCA3_HUMAN reviewed Eukaryotic translation elongation factor 1 epsilon-1 (Aminoacyl tRNA synthetase complex-interacting multifunctional protein 3) (Elongation factor p18) (Multisynthase complex auxiliary component p18) Homo sapiens (Human) GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0006412; GO:0008285; GO:0017101; GO:0043065; GO:0043517; GO:1990830; GO:2000774; GO:2001235 cellular response to leukemia inhibitory factor [GO:1990830]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of apoptotic process [GO:0043065]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of cellular senescence [GO:2000774]; positive regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043517]; translation [GO:0006412] aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] g805.t1 Q15485 57.616 151 2.19e-49 174.0 sp|Q15485|FCN2_HUMAN Ficolin-2 OS=Homo sapiens OX=9606 GN=FCN2 PE=1 SV=2 FCN2_HUMAN reviewed Ficolin-2 (37 kDa elastin-binding protein) (EBP-37) (Collagen/fibrinogen domain-containing protein 2) (Ficolin-B) (Ficolin-beta) (Hucolin) (L-ficolin) (Serum lectin p35) Homo sapiens (Human) GO:0001867; GO:0002752; GO:0003823; GO:0005102; GO:0005576; GO:0005581; GO:0005615; GO:0006508; GO:0008228; GO:0009897; GO:0038187; GO:0043394; GO:0043654; GO:0046872; GO:0048306; GO:0050829; GO:0050830; GO:0070062; GO:0070892; GO:0072562; GO:0097367; GO:0106139; GO:1903028; GO:1905370; GO:2001065 cell surface pattern recognition receptor signaling pathway [GO:0002752]; complement activation, lectin pathway [GO:0001867]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; opsonization [GO:0008228]; positive regulation of opsonization [GO:1903028]; proteolysis [GO:0006508]; recognition of apoptotic cell [GO:0043654] blood microparticle [GO:0072562]; collagen trimer [GO:0005581]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; serine-type endopeptidase complex [GO:1905370]; symbiont cell surface [GO:0106139] antigen binding [GO:0003823]; calcium-dependent protein binding [GO:0048306]; carbohydrate derivative binding [GO:0097367]; lipoteichoic acid immune receptor activity [GO:0070892]; mannan binding [GO:2001065]; metal ion binding [GO:0046872]; pattern recognition receptor activity [GO:0038187]; proteoglycan binding [GO:0043394]; signaling receptor binding [GO:0005102] g806.t1 Q29041 52.752 218 2.18e-66 217.0 sp|Q29041|FCN2_PIG Ficolin-2 OS=Sus scrofa OX=9823 GN=FCN2 PE=1 SV=1 FCN2_PIG reviewed Ficolin-2 (Collagen/fibrinogen domain-containing protein 2) (Ficolin-B) (Ficolin-beta) (L-ficolin) Sus scrofa (Pig) GO:0001867; GO:0003823; GO:0005102; GO:0005581; GO:0005615; GO:0030246; GO:0038187; GO:0046872; GO:0070892; GO:0097367; GO:0106139 complement activation, lectin pathway [GO:0001867] collagen trimer [GO:0005581]; extracellular space [GO:0005615]; symbiont cell surface [GO:0106139] antigen binding [GO:0003823]; carbohydrate binding [GO:0030246]; carbohydrate derivative binding [GO:0097367]; lipoteichoic acid immune receptor activity [GO:0070892]; metal ion binding [GO:0046872]; pattern recognition receptor activity [GO:0038187]; signaling receptor binding [GO:0005102] g815.t1 Q7L1S5 28.378 296 5.7099999999999996e-24 105.0 sp|Q7L1S5|CHST9_HUMAN Carbohydrate sulfotransferase 9 OS=Homo sapiens OX=9606 GN=CHST9 PE=1 SV=2 CHST9_HUMAN reviewed Carbohydrate sulfotransferase 9 (EC 2.8.2.-) (GalNAc-4-O-sulfotransferase 2) (GalNAc-4-ST2) (GalNAc4ST-2) (N-acetylgalactosamine-4-O-sulfotransferase 2) Homo sapiens (Human) GO:0000139; GO:0001537; GO:0005576; GO:0006790; GO:0008146; GO:0016020; GO:0016051; GO:0030166; GO:0030203; GO:0042446; GO:0047756; GO:0050650 carbohydrate biosynthetic process [GO:0016051]; chondroitin sulfate proteoglycan biosynthetic process [GO:0050650]; glycosaminoglycan metabolic process [GO:0030203]; hormone biosynthetic process [GO:0042446]; proteoglycan biosynthetic process [GO:0030166]; sulfur compound metabolic process [GO:0006790] extracellular region [GO:0005576]; Golgi membrane [GO:0000139]; membrane [GO:0016020] chondroitin 4-sulfotransferase activity [GO:0047756]; dermatan 4-sulfotransferase activity [GO:0001537]; sulfotransferase activity [GO:0008146] g816.t1 Q8R3G1 56.034 348 3.65e-102 307.0 sp|Q8R3G1|PP1R8_MOUSE Nuclear inhibitor of protein phosphatase 1 OS=Mus musculus OX=10090 GN=Ppp1r8 PE=1 SV=1 PP1R8_MOUSE reviewed Nuclear inhibitor of protein phosphatase 1 (NIPP-1) (Protein phosphatase 1 regulatory inhibitor subunit 8) Mus musculus (Mouse) GO:0003677; GO:0003729; GO:0004521; GO:0004865; GO:0005654; GO:0005681; GO:0006397; GO:0008283; GO:0008380; GO:0016607; GO:0019888; GO:0140678 cell population proliferation [GO:0008283]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380] nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; spliceosomal complex [GO:0005681] DNA binding [GO:0003677]; molecular function inhibitor activity [GO:0140678]; mRNA binding [GO:0003729]; protein phosphatase regulator activity [GO:0019888]; protein serine/threonine phosphatase inhibitor activity [GO:0004865]; RNA endonuclease activity [GO:0004521] g817.t1 Q9CQN6 60.0 95 3.61e-22 86.3 sp|Q9CQN6|TM14C_MOUSE Transmembrane protein 14C OS=Mus musculus OX=10090 GN=Tmem14c PE=1 SV=1 g818.t1 Q6PAF4 35.156 256 2.0599999999999998e-55 182.0 sp|Q6PAF4|NSE1_XENLA Non-structural maintenance of chromosomes element 1 homolog OS=Xenopus laevis OX=8355 GN=nsmce1 PE=1 SV=1 g819.t1 Q5XK91 41.509 265 2.59e-58 197.0 sp|Q5XK91|FBCDB_XENLA Fibrinogen C domain-containing protein 1-B OS=Xenopus laevis OX=8355 GN=fibcd1-b PE=2 SV=1 g821.t1 Q7TN79 34.286 245 4.05e-41 155.0 sp|Q7TN79|AKA7G_MOUSE A-kinase anchor protein 7 isoform gamma OS=Mus musculus OX=10090 GN=Akap7 PE=1 SV=2 AKA7G_MOUSE reviewed A-kinase anchor protein 7 isoform gamma (AKAP-7 isoform gamma) (A-kinase anchor protein 18) (AKAP-18) (Protein kinase A-anchoring protein 7 isoform gamma) (PRKA7 isoform gamma) Mus musculus (Mouse) GO:0001508; GO:0005634; GO:0005737; GO:0005829; GO:0007178; GO:0008104; GO:0016208; GO:0016324; GO:0016328; GO:0016529; GO:0019901; GO:0019904; GO:0030315; GO:0032991; GO:0034237; GO:0050804; GO:0051018; GO:0060306; GO:0070382; GO:0071320; GO:0098686; GO:0141156; GO:1901381 action potential [GO:0001508]; cAMP/PKA signal transduction [GO:0141156]; cell surface receptor protein serine/threonine kinase signaling pathway [GO:0007178]; cellular response to cAMP [GO:0071320]; intracellular protein localization [GO:0008104]; modulation of chemical synaptic transmission [GO:0050804]; positive regulation of potassium ion transmembrane transport [GO:1901381]; regulation of membrane repolarization [GO:0060306] apical plasma membrane [GO:0016324]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; exocytic vesicle [GO:0070382]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; lateral plasma membrane [GO:0016328]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; sarcoplasmic reticulum [GO:0016529]; T-tubule [GO:0030315] AMP binding [GO:0016208]; protein domain specific binding [GO:0019904]; protein kinase A binding [GO:0051018]; protein kinase A regulatory subunit binding [GO:0034237]; protein kinase binding [GO:0019901] g822.t1 Q60675 29.855 345 3.5599999999999994e-42 160.0 sp|Q60675|LAMA2_MOUSE Laminin subunit alpha-2 OS=Mus musculus OX=10090 GN=Lama2 PE=1 SV=2 LAMA2_MOUSE reviewed Laminin subunit alpha-2 (Laminin M chain) (Laminin-12 subunit alpha) (Laminin-2 subunit alpha) (Laminin-4 subunit alpha) (Merosin heavy chain) Mus musculus (Mouse) GO:0005102; GO:0005201; GO:0005576; GO:0005604; GO:0007155; GO:0007411; GO:0009887; GO:0009888; GO:0014037; GO:0030334; GO:0031012; GO:0031594; GO:0032224; GO:0042383; GO:0043083; GO:0043197; GO:0045785; GO:0045995; GO:0051149; GO:0098637; GO:0110011; GO:2001046 animal organ morphogenesis [GO:0009887]; axon guidance [GO:0007411]; cell adhesion [GO:0007155]; positive regulation of cell adhesion [GO:0045785]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of muscle cell differentiation [GO:0051149]; positive regulation of synaptic transmission, cholinergic [GO:0032224]; regulation of basement membrane organization [GO:0110011]; regulation of cell migration [GO:0030334]; regulation of embryonic development [GO:0045995]; Schwann cell differentiation [GO:0014037]; tissue development [GO:0009888] basement membrane [GO:0005604]; dendritic spine [GO:0043197]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; neuromuscular junction [GO:0031594]; protein complex involved in cell-matrix adhesion [GO:0098637]; sarcolemma [GO:0042383]; synaptic cleft [GO:0043083] extracellular matrix structural constituent [GO:0005201]; signaling receptor binding [GO:0005102] g823.t1 Q9N2B7 37.394 353 5.63e-66 217.0 sp|Q9N2B7|5HT1B_GORGO 5-hydroxytryptamine receptor 1B OS=Gorilla gorilla gorilla OX=9595 GN=HTR1B PE=3 SV=1 5HT1B_GORGO reviewed 5-hydroxytryptamine receptor 1B (5-HT-1B) (5-HT1B) (Serotonin receptor 1B) Gorilla gorilla gorilla (Western lowland gorilla) GO:0001586; GO:0004993; GO:0005886; GO:0007187; GO:0007198; GO:0007268; GO:0014063; GO:0030425; GO:0030594; GO:0042310; GO:0045202; GO:0046849; GO:0050795; GO:0071312; GO:0071466; GO:0099589 adenylate cyclase-inhibiting serotonin receptor signaling pathway [GO:0007198]; bone remodeling [GO:0046849]; cellular response to alkaloid [GO:0071312]; cellular response to xenobiotic stimulus [GO:0071466]; chemical synaptic transmission [GO:0007268]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; negative regulation of serotonin secretion [GO:0014063]; regulation of behavior [GO:0050795]; vasoconstriction [GO:0042310] dendrite [GO:0030425]; plasma membrane [GO:0005886]; synapse [GO:0045202] G protein-coupled serotonin receptor activity [GO:0004993]; Gi/o-coupled serotonin receptor activity [GO:0001586]; neurotransmitter receptor activity [GO:0030594]; serotonin receptor activity [GO:0099589] g823.t2 Q9N2B7 38.655 357 5.42e-66 218.0 sp|Q9N2B7|5HT1B_GORGO 5-hydroxytryptamine receptor 1B OS=Gorilla gorilla gorilla OX=9595 GN=HTR1B PE=3 SV=1 5HT1B_GORGO reviewed 5-hydroxytryptamine receptor 1B (5-HT-1B) (5-HT1B) (Serotonin receptor 1B) Gorilla gorilla gorilla (Western lowland gorilla) GO:0001586; GO:0004993; GO:0005886; GO:0007187; GO:0007198; GO:0007268; GO:0014063; GO:0030425; GO:0030594; GO:0042310; GO:0045202; GO:0046849; GO:0050795; GO:0071312; GO:0071466; GO:0099589 adenylate cyclase-inhibiting serotonin receptor signaling pathway [GO:0007198]; bone remodeling [GO:0046849]; cellular response to alkaloid [GO:0071312]; cellular response to xenobiotic stimulus [GO:0071466]; chemical synaptic transmission [GO:0007268]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; negative regulation of serotonin secretion [GO:0014063]; regulation of behavior [GO:0050795]; vasoconstriction [GO:0042310] dendrite [GO:0030425]; plasma membrane [GO:0005886]; synapse [GO:0045202] G protein-coupled serotonin receptor activity [GO:0004993]; Gi/o-coupled serotonin receptor activity [GO:0001586]; neurotransmitter receptor activity [GO:0030594]; serotonin receptor activity [GO:0099589] g824.t1 P24043 36.173 2770 0.0 1620.0 sp|P24043|LAMA2_HUMAN Laminin subunit alpha-2 OS=Homo sapiens OX=9606 GN=LAMA2 PE=1 SV=4 LAMA2_HUMAN reviewed Laminin subunit alpha-2 (Laminin M chain) (Laminin-12 subunit alpha) (Laminin-2 subunit alpha) (Laminin-4 subunit alpha) (Merosin heavy chain) Homo sapiens (Human) GO:0005102; GO:0005198; GO:0005576; GO:0005604; GO:0007155; GO:0007411; GO:0007517; GO:0014037; GO:0030334; GO:0031012; GO:0031594; GO:0032224; GO:0035633; GO:0042383; GO:0043083; GO:0043197; GO:0045785; GO:0045995; GO:0051149; GO:0098637; GO:0110011; GO:2001046 axon guidance [GO:0007411]; cell adhesion [GO:0007155]; maintenance of blood-brain barrier [GO:0035633]; muscle organ development [GO:0007517]; positive regulation of cell adhesion [GO:0045785]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of muscle cell differentiation [GO:0051149]; positive regulation of synaptic transmission, cholinergic [GO:0032224]; regulation of basement membrane organization [GO:0110011]; regulation of cell migration [GO:0030334]; regulation of embryonic development [GO:0045995]; Schwann cell differentiation [GO:0014037] basement membrane [GO:0005604]; dendritic spine [GO:0043197]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; neuromuscular junction [GO:0031594]; protein complex involved in cell-matrix adhesion [GO:0098637]; sarcolemma [GO:0042383]; synaptic cleft [GO:0043083] signaling receptor binding [GO:0005102]; structural molecule activity [GO:0005198] g826.t1 Q15560 49.839 311 9.21e-99 295.0 sp|Q15560|TCEA2_HUMAN Transcription elongation factor A protein 2 OS=Homo sapiens OX=9606 GN=TCEA2 PE=1 SV=1 TCEA2_HUMAN reviewed Transcription elongation factor A protein 2 (Testis-specific S-II) (Transcription elongation factor S-II protein 2) (Transcription elongation factor TFIIS.l) Homo sapiens (Human) GO:0003677; GO:0005634; GO:0005654; GO:0005813; GO:0006354; GO:0006357; GO:0006368; GO:0008023; GO:0008270; GO:0032784; GO:0036064 DNA-templated transcription elongation [GO:0006354]; regulation of DNA-templated transcription elongation [GO:0032784]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription elongation by RNA polymerase II [GO:0006368] centrosome [GO:0005813]; ciliary basal body [GO:0036064]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription elongation factor complex [GO:0008023] DNA binding [GO:0003677]; zinc ion binding [GO:0008270] g831.t1 B4E2M5 53.543 127 1.1399999999999999e-40 140.0 sp|B4E2M5|ANR66_HUMAN Ankyrin repeat domain-containing protein 66 OS=Homo sapiens OX=9606 GN=ANKRD66 PE=1 SV=3 g832.t1 Q9Y450 54.206 214 3.26e-84 267.0 sp|Q9Y450|HBS1L_HUMAN HBS1-like protein OS=Homo sapiens OX=9606 GN=HBS1L PE=1 SV=1 HBS1L_HUMAN reviewed HBS1-like protein (EC 3.6.5.-) (ERFS) Homo sapiens (Human) GO:0003746; GO:0003924; GO:0005525; GO:0005829; GO:0006412; GO:0006417; GO:0007165; GO:0016020; GO:0022626; GO:0032790; GO:0070062; GO:0070966; GO:0072344; GO:1990533 nuclear-transcribed mRNA catabolic process, no-go decay [GO:0070966]; regulation of translation [GO:0006417]; rescue of stalled ribosome [GO:0072344]; ribosome disassembly [GO:0032790]; signal transduction [GO:0007165]; translation [GO:0006412] cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; Dom34-Hbs1 complex [GO:1990533]; extracellular exosome [GO:0070062]; membrane [GO:0016020] GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746] g833.t1 Q69ZS7 59.159 333 1.7400000000000001e-124 377.0 sp|Q69ZS7|HBS1L_MOUSE HBS1-like protein OS=Mus musculus OX=10090 GN=Hbs1l PE=1 SV=2 HBS1L_MOUSE reviewed HBS1-like protein (EC 3.6.5.-) Mus musculus (Mouse) GO:0003746; GO:0003924; GO:0005525; GO:0006412; GO:0006417; GO:0022626; GO:0032790; GO:0070966; GO:0072344; GO:1990533 nuclear-transcribed mRNA catabolic process, no-go decay [GO:0070966]; regulation of translation [GO:0006417]; rescue of stalled ribosome [GO:0072344]; ribosome disassembly [GO:0032790]; translation [GO:0006412] cytosolic ribosome [GO:0022626]; Dom34-Hbs1 complex [GO:1990533] GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746] g836.t1 Q502M6 49.11 281 3.33e-84 258.0 sp|Q502M6|ANR29_DANRE Ankyrin repeat domain-containing protein 29 OS=Danio rerio OX=7955 GN=ankrd29 PE=2 SV=1 g838.t1 P42325 77.326 172 7.2e-96 279.0 sp|P42325|NCAH_DROME Neurocalcin homolog OS=Drosophila melanogaster OX=7227 GN=Nca PE=1 SV=2 NCAH_DROME reviewed Neurocalcin homolog (DrosNCa) Drosophila melanogaster (Fruit fly) GO:0005509; GO:0009966; GO:0045938; GO:1902848 negative regulation of neuronal signal transduction [GO:1902848]; positive regulation of circadian sleep/wake cycle, sleep [GO:0045938]; regulation of signal transduction [GO:0009966] calcium ion binding [GO:0005509] g843.t1 Q00174 35.634 3042 0.0 1761.0 sp|Q00174|LAMA_DROME Laminin subunit alpha OS=Drosophila melanogaster OX=7227 GN=LanA PE=1 SV=2 LAMA_DROME reviewed Laminin subunit alpha (Laminin A chain) Drosophila melanogaster (Fruit fly) GO:0005102; GO:0005201; GO:0005604; GO:0007411; GO:0007498; GO:0007507; GO:0008021; GO:0009887; GO:0009888; GO:0030155; GO:0030334; GO:0030424; GO:0031012; GO:0033627; GO:0034446; GO:0035001; GO:0035011; GO:0036062; GO:0045886; GO:0045995; GO:0071711 animal organ morphogenesis [GO:0009887]; axon guidance [GO:0007411]; basement membrane organization [GO:0071711]; cell adhesion mediated by integrin [GO:0033627]; dorsal trunk growth, open tracheal system [GO:0035001]; heart development [GO:0007507]; melanotic encapsulation of foreign target [GO:0035011]; mesoderm development [GO:0007498]; negative regulation of synaptic assembly at neuromuscular junction [GO:0045886]; regulation of cell adhesion [GO:0030155]; regulation of cell migration [GO:0030334]; regulation of embryonic development [GO:0045995]; substrate adhesion-dependent cell spreading [GO:0034446]; tissue development [GO:0009888] axon [GO:0030424]; basement membrane [GO:0005604]; extracellular matrix [GO:0031012]; presynaptic periactive zone [GO:0036062]; synaptic vesicle [GO:0008021] extracellular matrix structural constituent [GO:0005201]; signaling receptor binding [GO:0005102] g843.t2 Q00174 35.4 3048 0.0 1737.0 sp|Q00174|LAMA_DROME Laminin subunit alpha OS=Drosophila melanogaster OX=7227 GN=LanA PE=1 SV=2 LAMA_DROME reviewed Laminin subunit alpha (Laminin A chain) Drosophila melanogaster (Fruit fly) GO:0005102; GO:0005201; GO:0005604; GO:0007411; GO:0007498; GO:0007507; GO:0008021; GO:0009887; GO:0009888; GO:0030155; GO:0030334; GO:0030424; GO:0031012; GO:0033627; GO:0034446; GO:0035001; GO:0035011; GO:0036062; GO:0045886; GO:0045995; GO:0071711 animal organ morphogenesis [GO:0009887]; axon guidance [GO:0007411]; basement membrane organization [GO:0071711]; cell adhesion mediated by integrin [GO:0033627]; dorsal trunk growth, open tracheal system [GO:0035001]; heart development [GO:0007507]; melanotic encapsulation of foreign target [GO:0035011]; mesoderm development [GO:0007498]; negative regulation of synaptic assembly at neuromuscular junction [GO:0045886]; regulation of cell adhesion [GO:0030155]; regulation of cell migration [GO:0030334]; regulation of embryonic development [GO:0045995]; substrate adhesion-dependent cell spreading [GO:0034446]; tissue development [GO:0009888] axon [GO:0030424]; basement membrane [GO:0005604]; extracellular matrix [GO:0031012]; presynaptic periactive zone [GO:0036062]; synaptic vesicle [GO:0008021] extracellular matrix structural constituent [GO:0005201]; signaling receptor binding [GO:0005102] g844.t1 Q16363 27.797 590 6.36e-54 201.0 sp|Q16363|LAMA4_HUMAN Laminin subunit alpha-4 OS=Homo sapiens OX=9606 GN=LAMA4 PE=1 SV=5 g845.t1 Q3TYL0 45.045 111 2.76e-25 106.0 sp|Q3TYL0|IQAK1_MOUSE IQ motif and ankyrin repeat domain-containing protein 1 OS=Mus musculus OX=10090 GN=Iqank1 PE=1 SV=3 g846.t1 P90850 49.077 379 3.73e-114 345.0 sp|P90850|YCF2E_CAEEL Uncharacterized peptidase C1-like protein F26E4.3 OS=Caenorhabditis elegans OX=6239 GN=F26E4.3 PE=1 SV=3 g847.t1 Q9WTS8 53.521 213 1.65e-62 217.0 sp|Q9WTS8|FCN1_RAT Ficolin-1 OS=Rattus norvegicus OX=10116 GN=Fcn1 PE=2 SV=2 FCN1_RAT reviewed Ficolin-1 (Collagen/fibrinogen domain-containing protein 1) (Ficolin-A) (Ficolin-alpha) (M-ficolin) Rattus norvegicus (Rat) GO:0001867; GO:0002752; GO:0003823; GO:0005102; GO:0005581; GO:0005615; GO:0005886; GO:0007186; GO:0030246; GO:0032757; GO:0033691; GO:0038187; GO:0046872; GO:0097367; GO:0106139 cell surface pattern recognition receptor signaling pathway [GO:0002752]; complement activation, lectin pathway [GO:0001867]; G protein-coupled receptor signaling pathway [GO:0007186]; positive regulation of interleukin-8 production [GO:0032757] collagen trimer [GO:0005581]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; symbiont cell surface [GO:0106139] antigen binding [GO:0003823]; carbohydrate binding [GO:0030246]; carbohydrate derivative binding [GO:0097367]; metal ion binding [GO:0046872]; pattern recognition receptor activity [GO:0038187]; sialic acid binding [GO:0033691]; signaling receptor binding [GO:0005102] g849.t1 Q9WTS8 53.797 158 6.22e-50 172.0 sp|Q9WTS8|FCN1_RAT Ficolin-1 OS=Rattus norvegicus OX=10116 GN=Fcn1 PE=2 SV=2 FCN1_RAT reviewed Ficolin-1 (Collagen/fibrinogen domain-containing protein 1) (Ficolin-A) (Ficolin-alpha) (M-ficolin) Rattus norvegicus (Rat) GO:0001867; GO:0002752; GO:0003823; GO:0005102; GO:0005581; GO:0005615; GO:0005886; GO:0007186; GO:0030246; GO:0032757; GO:0033691; GO:0038187; GO:0046872; GO:0097367; GO:0106139 cell surface pattern recognition receptor signaling pathway [GO:0002752]; complement activation, lectin pathway [GO:0001867]; G protein-coupled receptor signaling pathway [GO:0007186]; positive regulation of interleukin-8 production [GO:0032757] collagen trimer [GO:0005581]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; symbiont cell surface [GO:0106139] antigen binding [GO:0003823]; carbohydrate binding [GO:0030246]; carbohydrate derivative binding [GO:0097367]; metal ion binding [GO:0046872]; pattern recognition receptor activity [GO:0038187]; sialic acid binding [GO:0033691]; signaling receptor binding [GO:0005102] g850.t1 Q8N6T3 72.794 136 4.4299999999999996e-69 226.0 sp|Q8N6T3|ARFG1_HUMAN ADP-ribosylation factor GTPase-activating protein 1 OS=Homo sapiens OX=9606 GN=ARFGAP1 PE=1 SV=2 ARFG1_HUMAN reviewed ADP-ribosylation factor GTPase-activating protein 1 (ARF GAP 1) (ADP-ribosylation factor 1 GTPase-activating protein) (ARF1 GAP) (ARF1-directed GTPase-activating protein) Homo sapiens (Human) GO:0000139; GO:0005096; GO:0005829; GO:0008270; GO:0015031; GO:0016192; GO:0030100; GO:0032012; GO:0045202 protein transport [GO:0015031]; regulation of ARF protein signal transduction [GO:0032012]; regulation of endocytosis [GO:0030100]; vesicle-mediated transport [GO:0016192] cytosol [GO:0005829]; Golgi membrane [GO:0000139]; synapse [GO:0045202] GTPase activator activity [GO:0005096]; zinc ion binding [GO:0008270] g850.t1 Q8N6T3 47.863 117 8.66e-29 119.0 sp|Q8N6T3|ARFG1_HUMAN ADP-ribosylation factor GTPase-activating protein 1 OS=Homo sapiens OX=9606 GN=ARFGAP1 PE=1 SV=2 ARFG1_HUMAN reviewed ADP-ribosylation factor GTPase-activating protein 1 (ARF GAP 1) (ADP-ribosylation factor 1 GTPase-activating protein) (ARF1 GAP) (ARF1-directed GTPase-activating protein) Homo sapiens (Human) GO:0000139; GO:0005096; GO:0005829; GO:0008270; GO:0015031; GO:0016192; GO:0030100; GO:0032012; GO:0045202 protein transport [GO:0015031]; regulation of ARF protein signal transduction [GO:0032012]; regulation of endocytosis [GO:0030100]; vesicle-mediated transport [GO:0016192] cytosol [GO:0005829]; Golgi membrane [GO:0000139]; synapse [GO:0045202] GTPase activator activity [GO:0005096]; zinc ion binding [GO:0008270] g852.t1 P90850 47.465 434 4.96e-125 373.0 sp|P90850|YCF2E_CAEEL Uncharacterized peptidase C1-like protein F26E4.3 OS=Caenorhabditis elegans OX=6239 GN=F26E4.3 PE=1 SV=3 g858.t1 P16065 57.1 1007 0.0 1068.0 sp|P16065|GCY_STRPU Speract receptor OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g859.t1 Q3TIW9 42.935 184 5.73e-44 155.0 sp|Q3TIW9|ENPP7_MOUSE Ectonucleotide pyrophosphatase/phosphodiesterase family member 7 OS=Mus musculus OX=10090 GN=Enpp7 PE=1 SV=1 ENPP7_MOUSE reviewed Ectonucleotide pyrophosphatase/phosphodiesterase family member 7 (E-NPP 7) (NPP-7) (EC 3.1.4.12) (Alkaline sphingomyelin phosphodiesterase) (Intestinal alkaline sphingomyelinase) (Alk-SMase) Mus musculus (Mouse) GO:0004767; GO:0005794; GO:0005886; GO:0005902; GO:0006684; GO:0006685; GO:0008081; GO:0008156; GO:0008270; GO:0008285; GO:0044241; GO:0045797; GO:0055089; GO:1904729; GO:2000304; GO:2000755 fatty acid homeostasis [GO:0055089]; lipid digestion [GO:0044241]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of DNA replication [GO:0008156]; positive regulation of ceramide biosynthetic process [GO:2000304]; positive regulation of intestinal cholesterol absorption [GO:0045797]; positive regulation of sphingomyelin catabolic process [GO:2000755]; regulation of intestinal lipid absorption [GO:1904729]; sphingomyelin catabolic process [GO:0006685]; sphingomyelin metabolic process [GO:0006684] Golgi apparatus [GO:0005794]; microvillus [GO:0005902]; plasma membrane [GO:0005886] phosphoric diester hydrolase activity [GO:0008081]; sphingomyelin phosphodiesterase activity [GO:0004767]; zinc ion binding [GO:0008270] g860.t1 Q6UWV6 33.929 168 5.84e-25 104.0 sp|Q6UWV6|ENPP7_HUMAN Ectonucleotide pyrophosphatase/phosphodiesterase family member 7 OS=Homo sapiens OX=9606 GN=ENPP7 PE=1 SV=4 ENPP7_HUMAN reviewed Ectonucleotide pyrophosphatase/phosphodiesterase family member 7 (E-NPP 7) (NPP-7) (EC 3.1.4.12) (Alkaline sphingomyelin phosphodiesterase) (Intestinal alkaline sphingomyelinase) (Alk-SMase) Homo sapiens (Human) GO:0004767; GO:0005794; GO:0005886; GO:0005902; GO:0006684; GO:0008081; GO:0008156; GO:0008270; GO:0008285; GO:0016020; GO:0044241; GO:0045797; GO:0046479; GO:0055089; GO:1904729; GO:2000304; GO:2000755 fatty acid homeostasis [GO:0055089]; glycosphingolipid catabolic process [GO:0046479]; lipid digestion [GO:0044241]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of DNA replication [GO:0008156]; positive regulation of ceramide biosynthetic process [GO:2000304]; positive regulation of intestinal cholesterol absorption [GO:0045797]; positive regulation of sphingomyelin catabolic process [GO:2000755]; regulation of intestinal lipid absorption [GO:1904729]; sphingomyelin metabolic process [GO:0006684] Golgi apparatus [GO:0005794]; membrane [GO:0016020]; microvillus [GO:0005902]; plasma membrane [GO:0005886] phosphoric diester hydrolase activity [GO:0008081]; sphingomyelin phosphodiesterase activity [GO:0004767]; zinc ion binding [GO:0008270] g862.t1 Q6NU98 32.39 318 9.56e-46 159.0 sp|Q6NU98|PDK1B_XENLA Serine/threonine-protein kinase pdik1l-B OS=Xenopus laevis OX=8355 GN=pdik1-b PE=2 SV=1 PDK1B_XENLA reviewed Serine/threonine-protein kinase pdik1l-B (EC 2.7.11.1) Xenopus laevis (African clawed frog) GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0010972; GO:0106310; GO:0110031 negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; negative regulation of G2/MI transition of meiotic cell cycle [GO:0110031] cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g863.t1 Q80ZW0 35.039 254 3.5999999999999997e-34 132.0 sp|Q80ZW0|STK35_MOUSE Serine/threonine-protein kinase 35 OS=Mus musculus OX=10090 GN=Stk35 PE=1 SV=3 STK35_MOUSE reviewed Serine/threonine-protein kinase 35 (Serine/threonine-protein kinase 35 L1) (EC 2.7.11.1) Mus musculus (Mouse) GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0010972; GO:0016604; GO:0106310; GO:0110031 negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; negative regulation of G2/MI transition of meiotic cell cycle [GO:0110031] cytoplasm [GO:0005737]; nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g864.t1 Q80ZW0 32.0 300 1.24e-36 140.0 sp|Q80ZW0|STK35_MOUSE Serine/threonine-protein kinase 35 OS=Mus musculus OX=10090 GN=Stk35 PE=1 SV=3 STK35_MOUSE reviewed Serine/threonine-protein kinase 35 (Serine/threonine-protein kinase 35 L1) (EC 2.7.11.1) Mus musculus (Mouse) GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0010972; GO:0016604; GO:0106310; GO:0110031 negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; negative regulation of G2/MI transition of meiotic cell cycle [GO:0110031] cytoplasm [GO:0005737]; nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g865.t1 Q80ZW0 29.08 337 4.239999999999999e-34 134.0 sp|Q80ZW0|STK35_MOUSE Serine/threonine-protein kinase 35 OS=Mus musculus OX=10090 GN=Stk35 PE=1 SV=3 STK35_MOUSE reviewed Serine/threonine-protein kinase 35 (Serine/threonine-protein kinase 35 L1) (EC 2.7.11.1) Mus musculus (Mouse) GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0010972; GO:0016604; GO:0106310; GO:0110031 negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; negative regulation of G2/MI transition of meiotic cell cycle [GO:0110031] cytoplasm [GO:0005737]; nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g866.t1 Q3TIW9 37.192 406 5.43e-80 257.0 sp|Q3TIW9|ENPP7_MOUSE Ectonucleotide pyrophosphatase/phosphodiesterase family member 7 OS=Mus musculus OX=10090 GN=Enpp7 PE=1 SV=1 ENPP7_MOUSE reviewed Ectonucleotide pyrophosphatase/phosphodiesterase family member 7 (E-NPP 7) (NPP-7) (EC 3.1.4.12) (Alkaline sphingomyelin phosphodiesterase) (Intestinal alkaline sphingomyelinase) (Alk-SMase) Mus musculus (Mouse) GO:0004767; GO:0005794; GO:0005886; GO:0005902; GO:0006684; GO:0006685; GO:0008081; GO:0008156; GO:0008270; GO:0008285; GO:0044241; GO:0045797; GO:0055089; GO:1904729; GO:2000304; GO:2000755 fatty acid homeostasis [GO:0055089]; lipid digestion [GO:0044241]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of DNA replication [GO:0008156]; positive regulation of ceramide biosynthetic process [GO:2000304]; positive regulation of intestinal cholesterol absorption [GO:0045797]; positive regulation of sphingomyelin catabolic process [GO:2000755]; regulation of intestinal lipid absorption [GO:1904729]; sphingomyelin catabolic process [GO:0006685]; sphingomyelin metabolic process [GO:0006684] Golgi apparatus [GO:0005794]; microvillus [GO:0005902]; plasma membrane [GO:0005886] phosphoric diester hydrolase activity [GO:0008081]; sphingomyelin phosphodiesterase activity [GO:0004767]; zinc ion binding [GO:0008270] g867.t1 Q5EZ72 37.956 411 3.56e-87 276.0 sp|Q5EZ72|ENPP7_RAT Ectonucleotide pyrophosphatase/phosphodiesterase family member 7 OS=Rattus norvegicus OX=10116 GN=Enpp7 PE=1 SV=1 ENPP7_RAT reviewed Ectonucleotide pyrophosphatase/phosphodiesterase family member 7 (E-NPP 7) (NPP-7) (EC 3.1.4.12) (Alkaline sphingomyelin phosphodiesterase) (Intestinal alkaline sphingomyelinase) (Alk-SMase) Rattus norvegicus (Rat) GO:0004767; GO:0005794; GO:0005886; GO:0005902; GO:0006684; GO:0008081; GO:0008156; GO:0008270; GO:0008285; GO:0044241; GO:0045797; GO:0055089; GO:1904729; GO:2000304; GO:2000755 fatty acid homeostasis [GO:0055089]; lipid digestion [GO:0044241]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of DNA replication [GO:0008156]; positive regulation of ceramide biosynthetic process [GO:2000304]; positive regulation of intestinal cholesterol absorption [GO:0045797]; positive regulation of sphingomyelin catabolic process [GO:2000755]; regulation of intestinal lipid absorption [GO:1904729]; sphingomyelin metabolic process [GO:0006684] Golgi apparatus [GO:0005794]; microvillus [GO:0005902]; plasma membrane [GO:0005886] phosphoric diester hydrolase activity [GO:0008081]; sphingomyelin phosphodiesterase activity [GO:0004767]; zinc ion binding [GO:0008270] g868.t1 Q56A24 33.333 567 8.35e-93 301.0 sp|Q56A24|KLH24_RAT Kelch-like protein 24 OS=Rattus norvegicus OX=10116 GN=Klhl24 PE=1 SV=1 KLH24_RAT reviewed Kelch-like protein 24 (Kainate receptor-interacting protein for GluR6) (KRIP6) (Protein DRE1) Rattus norvegicus (Rat) GO:0005737; GO:0005912; GO:0016567; GO:0030057; GO:0030424; GO:0031463; GO:0043161; GO:0043204; GO:0045109; GO:0051865; GO:1990756 intermediate filament organization [GO:0045109]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein ubiquitination [GO:0016567] adherens junction [GO:0005912]; axon [GO:0030424]; Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; desmosome [GO:0030057]; perikaryon [GO:0043204] ubiquitin-like ligase-substrate adaptor activity [GO:1990756] g869.t1 Q3TYL0 45.604 182 4.59e-28 113.0 sp|Q3TYL0|IQAK1_MOUSE IQ motif and ankyrin repeat domain-containing protein 1 OS=Mus musculus OX=10090 GN=Iqank1 PE=1 SV=3 g869.t1 Q3TYL0 76.471 17 4.59e-28 32.7 sp|Q3TYL0|IQAK1_MOUSE IQ motif and ankyrin repeat domain-containing protein 1 OS=Mus musculus OX=10090 GN=Iqank1 PE=1 SV=3 g870.t1 Q3TYL0 47.577 227 1.6699999999999998e-68 224.0 sp|Q3TYL0|IQAK1_MOUSE IQ motif and ankyrin repeat domain-containing protein 1 OS=Mus musculus OX=10090 GN=Iqank1 PE=1 SV=3 g871.t1 Q11002 36.888 347 4.58e-61 213.0 sp|Q11002|CANA_DROME Calpain-A OS=Drosophila melanogaster OX=7227 GN=CalpA PE=1 SV=2 CANA_DROME reviewed Calpain-A (EC 3.4.22.-) (Calcium-activated neutral proteinase A) (CANP A) [Cleaved into: Calpain-A catalytic subunit] Drosophila melanogaster (Fruit fly) GO:0004198; GO:0005509; GO:0005737; GO:0005783; GO:0005794; GO:0006508; GO:0007520; GO:0008345; GO:0009953; GO:0015629; GO:0016322; GO:0016540; GO:0042335; GO:0043025; GO:0050832 cuticle development [GO:0042335]; defense response to fungus [GO:0050832]; dorsal/ventral pattern formation [GO:0009953]; larval locomotory behavior [GO:0008345]; myoblast fusion [GO:0007520]; neuron remodeling [GO:0016322]; protein autoprocessing [GO:0016540]; proteolysis [GO:0006508] actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; neuronal cell body [GO:0043025] calcium ion binding [GO:0005509]; calcium-dependent cysteine-type endopeptidase activity [GO:0004198] g872.t1 Q8R4C0 47.015 134 7.65e-35 136.0 sp|Q8R4C0|CAN5_RAT Calpain-5 OS=Rattus norvegicus OX=10116 GN=Capn5 PE=1 SV=1 g873.t1 Q6TNS2 37.027 370 6.82e-73 233.0 sp|Q6TNS2|PK1IP_DANRE p21-activated protein kinase-interacting protein 1-like OS=Danio rerio OX=7955 GN=pak1ip1 PE=2 SV=1 g874.t1 Q5FVA9 72.464 345 0.0 523.0 sp|Q5FVA9|RAE1L_XENTR mRNA export factor OS=Xenopus tropicalis OX=8364 GN=rae1 PE=2 SV=1 RAE1L_XENTR reviewed mRNA export factor (Rae1 protein homolog) (mRNA-associated protein mrnp 41) Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0000972; GO:0003723; GO:0005643; GO:0005737; GO:0006405; GO:0043130; GO:0051301; GO:0060236; GO:0097431 cell division [GO:0051301]; regulation of mitotic spindle organization [GO:0060236]; RNA export from nucleus [GO:0006405]; transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery [GO:0000972] cytoplasm [GO:0005737]; mitotic spindle pole [GO:0097431]; nuclear pore [GO:0005643] RNA binding [GO:0003723]; ubiquitin binding [GO:0043130] g878.t1 P0C928 43.594 1085 0.0 843.0 sp|P0C928|RTEL1_DANRE Regulator of telomere elongation helicase 1 OS=Danio rerio OX=7955 GN=rtel1 PE=3 SV=1 g879.t1 D4A2K4 33.526 519 3.11e-71 243.0 sp|D4A2K4|KLH21_RAT Kelch-like protein 21 OS=Rattus norvegicus OX=10116 GN=Klhl21 PE=3 SV=1 g880.t1 Q9R0R1 42.281 719 0.0 551.0 sp|Q9R0R1|TRFM_MOUSE Melanotransferrin OS=Mus musculus OX=10090 GN=Meltf PE=2 SV=1 TRFM_MOUSE reviewed Melanotransferrin (Membrane-bound transferrin-like protein p97) (MTf) (CD antigen CD228) Mus musculus (Mouse) GO:0005506; GO:0005615; GO:0005769; GO:0005886; GO:0006826; GO:0009986; GO:0010756; GO:0055037; GO:0090091; GO:0098552; GO:1900025 iron ion transport [GO:0006826]; negative regulation of substrate adhesion-dependent cell spreading [GO:1900025]; positive regulation of extracellular matrix disassembly [GO:0090091]; positive regulation of plasminogen activation [GO:0010756] cell surface [GO:0009986]; early endosome [GO:0005769]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; side of membrane [GO:0098552] iron ion binding [GO:0005506] g885.t1 Q9R0R1 42.179 716 0.0 543.0 sp|Q9R0R1|TRFM_MOUSE Melanotransferrin OS=Mus musculus OX=10090 GN=Meltf PE=2 SV=1 TRFM_MOUSE reviewed Melanotransferrin (Membrane-bound transferrin-like protein p97) (MTf) (CD antigen CD228) Mus musculus (Mouse) GO:0005506; GO:0005615; GO:0005769; GO:0005886; GO:0006826; GO:0009986; GO:0010756; GO:0055037; GO:0090091; GO:0098552; GO:1900025 iron ion transport [GO:0006826]; negative regulation of substrate adhesion-dependent cell spreading [GO:1900025]; positive regulation of extracellular matrix disassembly [GO:0090091]; positive regulation of plasminogen activation [GO:0010756] cell surface [GO:0009986]; early endosome [GO:0005769]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; side of membrane [GO:0098552] iron ion binding [GO:0005506] g885.t1 Q9R0R1 45.272 349 4.5e-92 307.0 sp|Q9R0R1|TRFM_MOUSE Melanotransferrin OS=Mus musculus OX=10090 GN=Meltf PE=2 SV=1 TRFM_MOUSE reviewed Melanotransferrin (Membrane-bound transferrin-like protein p97) (MTf) (CD antigen CD228) Mus musculus (Mouse) GO:0005506; GO:0005615; GO:0005769; GO:0005886; GO:0006826; GO:0009986; GO:0010756; GO:0055037; GO:0090091; GO:0098552; GO:1900025 iron ion transport [GO:0006826]; negative regulation of substrate adhesion-dependent cell spreading [GO:1900025]; positive regulation of extracellular matrix disassembly [GO:0090091]; positive regulation of plasminogen activation [GO:0010756] cell surface [GO:0009986]; early endosome [GO:0005769]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; side of membrane [GO:0098552] iron ion binding [GO:0005506] g896.t1 Q9VML9 34.762 210 6.479999999999999e-34 140.0 sp|Q9VML9|TRISR_DROME Trissin receptor OS=Drosophila melanogaster OX=7227 GN=TrissinR PE=2 SV=4 g899.t1 Q9VML9 37.234 188 1.66e-30 129.0 sp|Q9VML9|TRISR_DROME Trissin receptor OS=Drosophila melanogaster OX=7227 GN=TrissinR PE=2 SV=4 g901.t1 P04323 35.127 316 1.67e-56 214.0 sp|P04323|POL3_DROME Retrovirus-related Pol polyprotein from transposon 17.6 OS=Drosophila melanogaster OX=7227 GN=pol PE=4 SV=1 g904.t1 P20825 39.273 550 1.91e-103 347.0 sp|P20825|POL2_DROME Retrovirus-related Pol polyprotein from transposon 297 OS=Drosophila melanogaster OX=7227 GN=pol PE=4 SV=1 g911.t1 Q15485 60.305 131 1.55e-49 164.0 sp|Q15485|FCN2_HUMAN Ficolin-2 OS=Homo sapiens OX=9606 GN=FCN2 PE=1 SV=2 FCN2_HUMAN reviewed Ficolin-2 (37 kDa elastin-binding protein) (EBP-37) (Collagen/fibrinogen domain-containing protein 2) (Ficolin-B) (Ficolin-beta) (Hucolin) (L-ficolin) (Serum lectin p35) Homo sapiens (Human) GO:0001867; GO:0002752; GO:0003823; GO:0005102; GO:0005576; GO:0005581; GO:0005615; GO:0006508; GO:0008228; GO:0009897; GO:0038187; GO:0043394; GO:0043654; GO:0046872; GO:0048306; GO:0050829; GO:0050830; GO:0070062; GO:0070892; GO:0072562; GO:0097367; GO:0106139; GO:1903028; GO:1905370; GO:2001065 cell surface pattern recognition receptor signaling pathway [GO:0002752]; complement activation, lectin pathway [GO:0001867]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; opsonization [GO:0008228]; positive regulation of opsonization [GO:1903028]; proteolysis [GO:0006508]; recognition of apoptotic cell [GO:0043654] blood microparticle [GO:0072562]; collagen trimer [GO:0005581]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; serine-type endopeptidase complex [GO:1905370]; symbiont cell surface [GO:0106139] antigen binding [GO:0003823]; calcium-dependent protein binding [GO:0048306]; carbohydrate derivative binding [GO:0097367]; lipoteichoic acid immune receptor activity [GO:0070892]; mannan binding [GO:2001065]; metal ion binding [GO:0046872]; pattern recognition receptor activity [GO:0038187]; proteoglycan binding [GO:0043394]; signaling receptor binding [GO:0005102] g915.t1 O00602 54.918 122 3.0399999999999997e-38 137.0 sp|O00602|FCN1_HUMAN Ficolin-1 OS=Homo sapiens OX=9606 GN=FCN1 PE=1 SV=2 FCN1_HUMAN reviewed Ficolin-1 (Collagen/fibrinogen domain-containing protein 1) (Ficolin-A) (Ficolin-alpha) (M-ficolin) Homo sapiens (Human) GO:0001664; GO:0001867; GO:0002752; GO:0003823; GO:0005102; GO:0005576; GO:0005581; GO:0005615; GO:0005886; GO:0006508; GO:0007186; GO:0009897; GO:0030246; GO:0031012; GO:0032757; GO:0033691; GO:0034394; GO:0034774; GO:0038187; GO:0043654; GO:0046597; GO:0046872; GO:0097367; GO:0106139; GO:1903028; GO:1904813; GO:1905370 cell surface pattern recognition receptor signaling pathway [GO:0002752]; complement activation, lectin pathway [GO:0001867]; G protein-coupled receptor signaling pathway [GO:0007186]; host-mediated suppression of symbiont invasion [GO:0046597]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of opsonization [GO:1903028]; protein localization to cell surface [GO:0034394]; proteolysis [GO:0006508]; recognition of apoptotic cell [GO:0043654] collagen trimer [GO:0005581]; external side of plasma membrane [GO:0009897]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; ficolin-1-rich granule lumen [GO:1904813]; plasma membrane [GO:0005886]; secretory granule lumen [GO:0034774]; serine-type endopeptidase complex [GO:1905370]; symbiont cell surface [GO:0106139] antigen binding [GO:0003823]; carbohydrate binding [GO:0030246]; carbohydrate derivative binding [GO:0097367]; G protein-coupled receptor binding [GO:0001664]; metal ion binding [GO:0046872]; pattern recognition receptor activity [GO:0038187]; sialic acid binding [GO:0033691]; signaling receptor binding [GO:0005102] g920.t1 Q29041 51.748 143 9.27e-42 147.0 sp|Q29041|FCN2_PIG Ficolin-2 OS=Sus scrofa OX=9823 GN=FCN2 PE=1 SV=1 FCN2_PIG reviewed Ficolin-2 (Collagen/fibrinogen domain-containing protein 2) (Ficolin-B) (Ficolin-beta) (L-ficolin) Sus scrofa (Pig) GO:0001867; GO:0003823; GO:0005102; GO:0005581; GO:0005615; GO:0030246; GO:0038187; GO:0046872; GO:0070892; GO:0097367; GO:0106139 complement activation, lectin pathway [GO:0001867] collagen trimer [GO:0005581]; extracellular space [GO:0005615]; symbiont cell surface [GO:0106139] antigen binding [GO:0003823]; carbohydrate binding [GO:0030246]; carbohydrate derivative binding [GO:0097367]; lipoteichoic acid immune receptor activity [GO:0070892]; metal ion binding [GO:0046872]; pattern recognition receptor activity [GO:0038187]; signaling receptor binding [GO:0005102] g920.t2 Q15485 59.184 98 2.05e-33 124.0 sp|Q15485|FCN2_HUMAN Ficolin-2 OS=Homo sapiens OX=9606 GN=FCN2 PE=1 SV=2 FCN2_HUMAN reviewed Ficolin-2 (37 kDa elastin-binding protein) (EBP-37) (Collagen/fibrinogen domain-containing protein 2) (Ficolin-B) (Ficolin-beta) (Hucolin) (L-ficolin) (Serum lectin p35) Homo sapiens (Human) GO:0001867; GO:0002752; GO:0003823; GO:0005102; GO:0005576; GO:0005581; GO:0005615; GO:0006508; GO:0008228; GO:0009897; GO:0038187; GO:0043394; GO:0043654; GO:0046872; GO:0048306; GO:0050829; GO:0050830; GO:0070062; GO:0070892; GO:0072562; GO:0097367; GO:0106139; GO:1903028; GO:1905370; GO:2001065 cell surface pattern recognition receptor signaling pathway [GO:0002752]; complement activation, lectin pathway [GO:0001867]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; opsonization [GO:0008228]; positive regulation of opsonization [GO:1903028]; proteolysis [GO:0006508]; recognition of apoptotic cell [GO:0043654] blood microparticle [GO:0072562]; collagen trimer [GO:0005581]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; serine-type endopeptidase complex [GO:1905370]; symbiont cell surface [GO:0106139] antigen binding [GO:0003823]; calcium-dependent protein binding [GO:0048306]; carbohydrate derivative binding [GO:0097367]; lipoteichoic acid immune receptor activity [GO:0070892]; mannan binding [GO:2001065]; metal ion binding [GO:0046872]; pattern recognition receptor activity [GO:0038187]; proteoglycan binding [GO:0043394]; signaling receptor binding [GO:0005102] g6389.t1 Q5TC84 42.152 223 5.58e-47 169.0 sp|Q5TC84|OGRL1_HUMAN Opioid growth factor receptor-like protein 1 OS=Homo sapiens OX=9606 GN=OGFRL1 PE=1 SV=1 g6390.t1 Q5TC84 49.268 205 5.17e-62 206.0 sp|Q5TC84|OGRL1_HUMAN Opioid growth factor receptor-like protein 1 OS=Homo sapiens OX=9606 GN=OGFRL1 PE=1 SV=1 g6391.t1 P20072 39.871 311 1.67e-75 244.0 sp|P20072|ANXA7_BOVIN Annexin A7 OS=Bos taurus OX=9913 GN=ANXA7 PE=1 SV=2 g6392.t1 Q9UBS5 34.065 775 8.14e-116 376.0 sp|Q9UBS5|GABR1_HUMAN Gamma-aminobutyric acid type B receptor subunit 1 OS=Homo sapiens OX=9606 GN=GABBR1 PE=1 SV=1 GABR1_HUMAN reviewed Gamma-aminobutyric acid type B receptor subunit 1 (GABA-B receptor 1) (GABA-B-R1) (GABA-BR1) (GABABR1) (Gb1) Homo sapiens (Human) GO:0001649; GO:0004965; GO:0005615; GO:0005789; GO:0005886; GO:0007193; GO:0007214; GO:0008021; GO:0008285; GO:0014049; GO:0014053; GO:0030673; GO:0031966; GO:0032811; GO:0033602; GO:0035094; GO:0038039; GO:0042734; GO:0043025; GO:0043197; GO:0043198; GO:0045211; GO:0045471; GO:0046982; GO:0050805; GO:0051932; GO:0060124; GO:0098685; GO:0098978; GO:0098982; GO:0099579; GO:0150047; GO:0150099; GO:1902712; GO:1990430 adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; gamma-aminobutyric acid signaling pathway [GO:0007214]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of dopamine secretion [GO:0033602]; negative regulation of epinephrine secretion [GO:0032811]; negative regulation of gamma-aminobutyric acid secretion [GO:0014053]; negative regulation of synaptic transmission [GO:0050805]; neuron-glial cell signaling [GO:0150099]; osteoblast differentiation [GO:0001649]; positive regulation of glutamate secretion [GO:0014049]; positive regulation of growth hormone secretion [GO:0060124]; response to ethanol [GO:0045471]; response to nicotine [GO:0035094]; synaptic transmission, GABAergic [GO:0051932] axolemma [GO:0030673]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; endoplasmic reticulum membrane [GO:0005789]; extracellular space [GO:0005615]; G protein-coupled GABA receptor complex [GO:1902712]; G protein-coupled receptor heterodimeric complex [GO:0038039]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; mitochondrial membrane [GO:0031966]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; Schaffer collateral - CA1 synapse [GO:0098685]; synaptic vesicle [GO:0008021] extracellular matrix protein binding [GO:1990430]; G protein-coupled GABA receptor activity [GO:0004965]; G protein-coupled neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential [GO:0099579]; G protein-coupled neurotransmitter receptor activity involved in regulation of presynaptic membrane potential [GO:0150047]; protein heterodimerization activity [GO:0046982] g6393.t1 O88871 50.427 117 3.4e-21 92.0 sp|O88871|GABR2_RAT Gamma-aminobutyric acid type B receptor subunit 2 OS=Rattus norvegicus OX=10116 GN=Gabbr2 PE=1 SV=2 GABR2_RAT reviewed Gamma-aminobutyric acid type B receptor subunit 2 (GABA-B receptor 2) (GABA-B-R2) (GABA-BR2) (GABABR2) (Gb2) (G-protein coupled receptor 51) Rattus norvegicus (Rat) GO:0004965; GO:0005737; GO:0005886; GO:0007193; GO:0007214; GO:0030425; GO:0038039; GO:0042734; GO:0043005; GO:0043204; GO:0045211; GO:0046982; GO:0051932; GO:0098978; GO:0098982; GO:0150099; GO:1902710; GO:1902712 adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; gamma-aminobutyric acid signaling pathway [GO:0007214]; neuron-glial cell signaling [GO:0150099]; synaptic transmission, GABAergic [GO:0051932] cytoplasm [GO:0005737]; dendrite [GO:0030425]; G protein-coupled GABA receptor complex [GO:1902712]; G protein-coupled receptor heterodimeric complex [GO:0038039]; GABA receptor complex [GO:1902710]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; neuron projection [GO:0043005]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734] G protein-coupled GABA receptor activity [GO:0004965]; protein heterodimerization activity [GO:0046982] g6394.t1 Q9Z0U4 37.288 590 1.45e-109 353.0 sp|Q9Z0U4|GABR1_RAT Gamma-aminobutyric acid type B receptor subunit 1 OS=Rattus norvegicus OX=10116 GN=Gabbr1 PE=1 SV=2 GABR1_RAT reviewed Gamma-aminobutyric acid type B receptor subunit 1 (GABA-B receptor 1) (GABA-B-R1) (GABA-BR1) (GABABR1) (Gb1) Rattus norvegicus (Rat) GO:0001649; GO:0004965; GO:0005615; GO:0005737; GO:0005789; GO:0005886; GO:0007193; GO:0007214; GO:0008021; GO:0008285; GO:0014048; GO:0014049; GO:0014053; GO:0016020; GO:0030673; GO:0031966; GO:0032811; GO:0033602; GO:0035094; GO:0038037; GO:0038039; GO:0042734; GO:0043025; GO:0043197; GO:0043198; GO:0043204; GO:0045211; GO:0045471; GO:0046982; GO:0050805; GO:0051932; GO:0060124; GO:0097060; GO:0098685; GO:0098793; GO:0098978; GO:0098982; GO:0099579; GO:0150047; GO:0150099; GO:1902710; GO:1902712; GO:1990430 adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; gamma-aminobutyric acid signaling pathway [GO:0007214]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of dopamine secretion [GO:0033602]; negative regulation of epinephrine secretion [GO:0032811]; negative regulation of gamma-aminobutyric acid secretion [GO:0014053]; negative regulation of synaptic transmission [GO:0050805]; neuron-glial cell signaling [GO:0150099]; osteoblast differentiation [GO:0001649]; positive regulation of glutamate secretion [GO:0014049]; positive regulation of growth hormone secretion [GO:0060124]; regulation of glutamate secretion [GO:0014048]; response to ethanol [GO:0045471]; response to nicotine [GO:0035094]; synaptic transmission, GABAergic [GO:0051932] axolemma [GO:0030673]; cytoplasm [GO:0005737]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; endoplasmic reticulum membrane [GO:0005789]; extracellular space [GO:0005615]; G protein-coupled GABA receptor complex [GO:1902712]; G protein-coupled receptor dimeric complex [GO:0038037]; G protein-coupled receptor heterodimeric complex [GO:0038039]; GABA receptor complex [GO:1902710]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; mitochondrial membrane [GO:0031966]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynapse [GO:0098793]; presynaptic membrane [GO:0042734]; Schaffer collateral - CA1 synapse [GO:0098685]; synaptic membrane [GO:0097060]; synaptic vesicle [GO:0008021] extracellular matrix protein binding [GO:1990430]; G protein-coupled GABA receptor activity [GO:0004965]; G protein-coupled neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential [GO:0099579]; G protein-coupled neurotransmitter receptor activity involved in regulation of presynaptic membrane potential [GO:0150047]; protein heterodimerization activity [GO:0046982] g6395.t1 P52551 39.796 490 9.21e-84 280.0 sp|P52551|MYBB_XENLA Myb-related protein B OS=Xenopus laevis OX=8355 GN=mybl2 PE=2 SV=2 g6396.t1 Q9Y6J0 44.757 1030 0.0 825.0 sp|Q9Y6J0|CABIN_HUMAN Calcineurin-binding protein cabin-1 OS=Homo sapiens OX=9606 GN=CABIN1 PE=1 SV=1 CABIN_HUMAN reviewed Calcineurin-binding protein cabin-1 (Calcineurin inhibitor) (CAIN) Homo sapiens (Human) GO:0004864; GO:0005634; GO:0005654; GO:0005829; GO:0006334; GO:0007166; GO:0016235 cell surface receptor signaling pathway [GO:0007166]; nucleosome assembly [GO:0006334] aggresome [GO:0016235]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] protein phosphatase inhibitor activity [GO:0004864] g6397.t1 Q9Y6J0 27.82 266 4.53e-21 102.0 sp|Q9Y6J0|CABIN_HUMAN Calcineurin-binding protein cabin-1 OS=Homo sapiens OX=9606 GN=CABIN1 PE=1 SV=1 CABIN_HUMAN reviewed Calcineurin-binding protein cabin-1 (Calcineurin inhibitor) (CAIN) Homo sapiens (Human) GO:0004864; GO:0005634; GO:0005654; GO:0005829; GO:0006334; GO:0007166; GO:0016235 cell surface receptor signaling pathway [GO:0007166]; nucleosome assembly [GO:0006334] aggresome [GO:0016235]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] protein phosphatase inhibitor activity [GO:0004864] g6398.t1 Q9Y6J0 48.387 279 1.8700000000000003e-80 276.0 sp|Q9Y6J0|CABIN_HUMAN Calcineurin-binding protein cabin-1 OS=Homo sapiens OX=9606 GN=CABIN1 PE=1 SV=1 CABIN_HUMAN reviewed Calcineurin-binding protein cabin-1 (Calcineurin inhibitor) (CAIN) Homo sapiens (Human) GO:0004864; GO:0005634; GO:0005654; GO:0005829; GO:0006334; GO:0007166; GO:0016235 cell surface receptor signaling pathway [GO:0007166]; nucleosome assembly [GO:0006334] aggresome [GO:0016235]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] protein phosphatase inhibitor activity [GO:0004864] g6399.t1 Q4KM31 59.701 67 1.32e-25 105.0 sp|Q4KM31|LIMD2_RAT LIM domain-containing protein 2 OS=Rattus norvegicus OX=10116 GN=Limd2 PE=2 SV=1 g6399.t2 Q9BT23 46.296 108 1.17e-26 109.0 sp|Q9BT23|LIMD2_HUMAN LIM domain-containing protein 2 OS=Homo sapiens OX=9606 GN=LIMD2 PE=1 SV=1 LIMD2_HUMAN reviewed LIM domain-containing protein 2 Homo sapiens (Human) GO:0005654; GO:0005829; GO:0005886; GO:0015629; GO:0046872; GO:0051015; GO:0051017 actin filament bundle assembly [GO:0051017] actin cytoskeleton [GO:0015629]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] actin filament binding [GO:0051015]; metal ion binding [GO:0046872] g6399.t3 Q9BT23 46.296 108 1.6600000000000002e-26 108.0 sp|Q9BT23|LIMD2_HUMAN LIM domain-containing protein 2 OS=Homo sapiens OX=9606 GN=LIMD2 PE=1 SV=1 LIMD2_HUMAN reviewed LIM domain-containing protein 2 Homo sapiens (Human) GO:0005654; GO:0005829; GO:0005886; GO:0015629; GO:0046872; GO:0051015; GO:0051017 actin filament bundle assembly [GO:0051017] actin cytoskeleton [GO:0015629]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] actin filament binding [GO:0051015]; metal ion binding [GO:0046872] g6399.t4 Q9BT23 46.296 108 2.84e-26 108.0 sp|Q9BT23|LIMD2_HUMAN LIM domain-containing protein 2 OS=Homo sapiens OX=9606 GN=LIMD2 PE=1 SV=1 LIMD2_HUMAN reviewed LIM domain-containing protein 2 Homo sapiens (Human) GO:0005654; GO:0005829; GO:0005886; GO:0015629; GO:0046872; GO:0051015; GO:0051017 actin filament bundle assembly [GO:0051017] actin cytoskeleton [GO:0015629]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] actin filament binding [GO:0051015]; metal ion binding [GO:0046872] g6400.t1 Q9XSC1 38.411 302 1.34e-69 224.0 sp|Q9XSC1|SFRP5_BOVIN Secreted frizzled-related protein 5 OS=Bos taurus OX=9913 GN=SFRP5 PE=2 SV=1 g6401.t1 Q76KP1 40.625 192 1.1699999999999999e-52 192.0 sp|Q76KP1|B4GN4_HUMAN N-acetyl-beta-glucosaminyl-glycoprotein 4-beta-N-acetylgalactosaminyltransferase 1 OS=Homo sapiens OX=9606 GN=B4GALNT4 PE=1 SV=1 g6402.t1 Q5F4B8 27.411 394 2.32e-25 112.0 sp|Q5F4B8|S46A3_CHICK Lysosomal proton-coupled steroid conjugate and bile acid symporter SLC46A3 OS=Gallus gallus OX=9031 GN=SLC46A3 PE=2 SV=1 g6412.t1 Q7LFX5 32.39 318 2.26e-40 153.0 sp|Q7LFX5|CHSTF_HUMAN Carbohydrate sulfotransferase 15 OS=Homo sapiens OX=9606 GN=CHST15 PE=1 SV=1 CHSTF_HUMAN reviewed Carbohydrate sulfotransferase 15 (EC 2.8.2.33) (B-cell RAG-associated gene protein) (hBRAG) (N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase) (GalNAc4S-6ST) Homo sapiens (Human) GO:0000139; GO:0016020; GO:0019319; GO:0050650; GO:0050651; GO:0050656; GO:0050659 chondroitin sulfate proteoglycan biosynthetic process [GO:0050650]; dermatan sulfate proteoglycan biosynthetic process [GO:0050651]; hexose biosynthetic process [GO:0019319] Golgi membrane [GO:0000139]; membrane [GO:0016020] 3'-phosphoadenosine 5'-phosphosulfate binding [GO:0050656]; N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity [GO:0050659] g6415.t1 P70627 46.023 704 0.0 629.0 sp|P70627|FOLH1_RAT Glutamate carboxypeptidase 2 OS=Rattus norvegicus OX=10116 GN=Folh1 PE=1 SV=1 g6418.t1 Q5HYC2 41.304 414 1.1299999999999999e-90 323.0 sp|Q5HYC2|BRD10_HUMAN Uncharacterized bromodomain-containing protein 10 OS=Homo sapiens OX=9606 GN=BRD10 PE=1 SV=2 g6422.t1 Q9CXE7 46.535 202 6.65e-47 158.0 sp|Q9CXE7|TMED5_MOUSE Transmembrane emp24 domain-containing protein 5 OS=Mus musculus OX=10090 GN=Tmed5 PE=1 SV=1 g6424.t1 Q8BS90 37.949 195 3.17e-26 116.0 sp|Q8BS90|BORA_MOUSE Protein aurora borealis OS=Mus musculus OX=10090 GN=Bora PE=1 SV=1 g6427.t1 B3EWZ6 41.514 1149 0.0 825.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6427.t1 B3EWZ6 39.301 1173 0.0 751.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6427.t1 B3EWZ6 38.903 1167 0.0 731.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6427.t1 B3EWZ6 39.518 1078 0.0 711.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6427.t1 B3EWZ6 36.847 1167 0.0 676.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6427.t1 B3EWZ6 35.732 1181 0.0 656.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6427.t1 B3EWZ6 33.153 1291 1.3e-176 580.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6427.t1 B3EWZ6 32.107 1386 6.3100000000000005e-173 570.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6427.t1 B3EWZ6 35.956 1004 1.8299999999999998e-172 568.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6427.t1 B3EWZ6 29.892 1385 5.75e-147 494.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6427.t1 B3EWZ6 28.633 1390 3.19e-142 480.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6427.t1 B3EWZ6 29.603 1412 3.87e-137 465.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6427.t1 B3EWZ6 30.196 1275 2.3400000000000003e-121 418.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6427.t1 B3EWZ6 27.611 1235 4.59e-106 372.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6427.t1 B3EWZ6 38.213 526 1.6599999999999997e-95 340.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6427.t1 B3EWZ6 30.446 785 1.9400000000000002e-71 266.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6427.t1 B3EWZ6 27.302 934 1.37e-65 248.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6427.t1 B3EWZ6 31.088 579 3.9800000000000004e-56 218.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6427.t1 B3EWZ6 30.627 542 1.59e-50 200.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6427.t1 B3EWZ6 33.77 382 2.04e-36 154.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6427.t1 B3EWZ6 30.788 419 3.19e-35 150.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6428.t1 B3EWZ6 38.723 2882 0.0 1715.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6428.t1 B3EWZ6 38.5 2626 0.0 1617.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6428.t1 B3EWZ6 36.736 2880 0.0 1553.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6428.t1 B3EWZ6 35.794 2506 0.0 1322.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6428.t1 B3EWZ6 38.196 1508 0.0 916.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6428.t1 B3EWZ6 36.566 1660 0.0 876.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6428.t1 B3EWZ6 36.833 1648 0.0 875.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6428.t1 B3EWZ6 30.401 2194 0.0 820.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6428.t1 B3EWZ6 28.784 2828 0.0 804.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6428.t1 B3EWZ6 33.186 1582 0.0 670.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6428.t1 B3EWZ6 30.79 1809 0.0 657.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6428.t1 B3EWZ6 30.7 1886 0.0 654.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6428.t1 B3EWZ6 34.891 1370 0.0 650.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6428.t1 B3EWZ6 30.408 1914 0.0 644.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6428.t1 B3EWZ6 29.675 1941 2.9e-162 572.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6428.t1 B3EWZ6 30.255 1451 5.3500000000000005e-129 462.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6428.t1 B3EWZ6 29.872 1252 1.6000000000000002e-123 444.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6428.t1 B3EWZ6 31.924 1159 9.259999999999999e-119 429.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6428.t1 B3EWZ6 34.13 920 1.28e-116 422.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6428.t1 B3EWZ6 32.524 824 3.7499999999999996e-94 348.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6428.t1 B3EWZ6 35.271 516 6.5900000000000004e-80 301.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6428.t1 B3EWZ6 38.741 413 6.94e-62 241.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6428.t1 B3EWZ6 39.66 353 4.28e-61 239.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6428.t1 B3EWZ6 27.197 603 6.570000000000001e-37 159.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6428.t1 B3EWZ6 31.787 431 1.36e-32 144.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6428.t2 B3EWZ6 38.902 2604 0.0 1526.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6428.t2 B3EWZ6 36.069 2936 0.0 1523.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6428.t2 B3EWZ6 36.673 2555 0.0 1348.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6428.t2 B3EWZ6 39.078 2170 0.0 1325.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6428.t2 B3EWZ6 36.986 2382 0.0 1319.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6428.t2 B3EWZ6 36.446 1660 0.0 874.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6428.t2 B3EWZ6 36.772 1648 0.0 874.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6428.t2 B3EWZ6 28.08 3198 0.0 835.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6428.t2 B3EWZ6 29.707 2252 0.0 793.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6428.t2 B3EWZ6 30.79 1809 0.0 655.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6428.t2 B3EWZ6 30.7 1886 0.0 652.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6428.t2 B3EWZ6 34.891 1370 0.0 649.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6428.t2 B3EWZ6 30.408 1914 0.0 642.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6428.t2 B3EWZ6 31.929 1638 0.0 636.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6428.t2 B3EWZ6 29.675 1941 1.04e-161 570.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6428.t2 B3EWZ6 43.445 656 1.33e-141 491.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6428.t2 B3EWZ6 54.286 35 1.33e-141 38.1 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6428.t2 B3EWZ6 40.867 646 6.18e-129 450.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6428.t2 B3EWZ6 43.902 41 6.18e-129 36.6 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6428.t2 B3EWZ6 26.968 1639 9.180000000000001e-122 439.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6428.t2 B3EWZ6 39.394 660 5.4799999999999996e-120 433.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6428.t2 B3EWZ6 31.924 1159 2.09e-118 428.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6428.t2 B3EWZ6 34.13 920 2.05e-116 421.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6428.t2 B3EWZ6 41.296 540 1.39e-107 374.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6428.t2 B3EWZ6 52.941 34 1.39e-107 41.6 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6428.t2 B3EWZ6 34.071 678 1.25e-100 369.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6428.t2 B3EWZ6 35.853 516 9.09e-80 300.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6428.t2 B3EWZ6 31.039 770 6.72e-76 288.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6428.t2 B3EWZ6 30.159 756 5.29e-75 285.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6428.t2 B3EWZ6 29.412 765 3.35e-69 265.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6428.t2 B3EWZ6 28.837 808 4.8e-64 248.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6428.t2 B3EWZ6 31.174 741 5.79e-63 245.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6428.t2 B3EWZ6 38.741 413 9.36e-62 241.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6428.t2 B3EWZ6 39.66 353 5.53e-61 238.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6428.t2 B3EWZ6 31.57 605 5.7e-59 231.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6428.t2 B3EWZ6 37.542 301 2.5099999999999998e-52 209.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6428.t2 B3EWZ6 29.917 605 1.41e-51 207.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6428.t2 B3EWZ6 31.787 431 1.83e-32 144.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6429.t1 B3EWZ6 43.114 668 6.5e-153 493.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6429.t1 B3EWZ6 41.829 667 4.44e-138 451.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6429.t1 B3EWZ6 39.614 674 2.57e-131 431.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6429.t1 B3EWZ6 38.921 686 2.41e-125 414.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6429.t1 B3EWZ6 36.245 687 6.2e-125 412.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6429.t1 B3EWZ6 37.229 693 6.4900000000000005e-109 366.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6429.t1 B3EWZ6 34.003 697 6.06e-91 313.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6429.t1 B3EWZ6 30.92 663 4.1800000000000006e-79 279.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6429.t1 B3EWZ6 30.861 674 7.4e-77 272.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6429.t1 B3EWZ6 32.485 668 2.97e-75 268.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6429.t1 B3EWZ6 32.371 658 1.4199999999999999e-74 266.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6429.t1 B3EWZ6 30.988 668 1.89e-70 253.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6429.t1 B3EWZ6 30.33 666 1.81e-69 250.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6429.t1 B3EWZ6 29.104 670 3.9799999999999996e-69 249.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6429.t1 B3EWZ6 29.63 675 4.1099999999999995e-68 246.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6429.t1 B3EWZ6 30.713 687 8.29e-68 246.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6429.t1 B3EWZ6 29.848 660 7.52e-65 237.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6429.t1 B3EWZ6 31.118 662 4.44e-64 234.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6429.t1 B3EWZ6 30.838 668 2.52e-63 232.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6429.t1 B3EWZ6 31.34 485 2.99e-60 223.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6429.t1 B3EWZ6 27.542 541 2.97e-43 172.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6429.t1 B3EWZ6 31.712 514 4.67e-43 171.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6429.t1 B3EWZ6 31.988 322 2.5599999999999997e-40 163.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6429.t1 B3EWZ6 32.194 351 2.85e-40 163.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6429.t1 B3EWZ6 31.741 293 2.46e-31 135.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6430.t1 B3EWZ6 34.037 3223 0.0 1438.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6430.t1 B3EWZ6 30.068 3246 0.0 1149.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6430.t1 B3EWZ6 29.82 3216 0.0 1107.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6430.t1 B3EWZ6 32.068 2607 0.0 1000.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6430.t1 B3EWZ6 31.121 2667 0.0 998.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6430.t1 B3EWZ6 30.572 2378 0.0 890.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6430.t1 B3EWZ6 33.762 1632 0.0 754.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6430.t1 B3EWZ6 28.232 2522 0.0 719.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6430.t1 B3EWZ6 32.788 1650 0.0 698.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6430.t1 B3EWZ6 39.394 990 0.0 668.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6430.t1 B3EWZ6 32.471 1469 0.0 647.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6430.t1 B3EWZ6 28.658 1982 5.64e-168 592.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6430.t1 B3EWZ6 35.017 871 2.69e-123 444.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6430.t1 B3EWZ6 27.382 1501 2.3000000000000003e-117 425.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6430.t1 B3EWZ6 29.69 1226 7.89e-110 400.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6430.t1 B3EWZ6 28.329 1059 1e-65 254.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6430.t1 B3EWZ6 30.561 553 1.03e-46 191.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6430.t1 B3EWZ6 36.709 316 3.16e-38 163.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6430.t1 B3EWZ6 32.877 292 5.87e-36 155.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6430.t1 B3EWZ6 26.014 592 4.34e-35 153.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6430.t1 B3EWZ6 28.35 515 6.710000000000001e-35 152.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6430.t1 B3EWZ6 28.136 590 1.15e-34 151.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6430.t1 B3EWZ6 33.974 312 2.0100000000000002e-32 144.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6430.t1 B3EWZ6 35.714 266 5.400000000000001e-32 142.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6430.t1 B3EWZ6 33.229 319 2.74e-31 140.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6430.t1 B3EWZ6 32.103 271 2.3600000000000002e-29 134.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6430.t1 B3EWZ6 31.661 319 8.01e-29 132.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6430.t1 B3EWZ6 32.911 316 1.39e-26 125.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6430.t1 B3EWZ6 28.777 278 2.58e-21 107.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6430.t1 B3EWZ6 36.875 160 5.72e-21 106.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6430.t2 B3EWZ6 33.598 3652 0.0 1558.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6430.t2 B3EWZ6 29.381 3635 0.0 1199.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6430.t2 B3EWZ6 29.82 3216 0.0 1107.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6430.t2 B3EWZ6 32.068 2607 0.0 1000.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6430.t2 B3EWZ6 30.614 2378 0.0 889.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6430.t2 B3EWZ6 27.874 2931 0.0 791.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6430.t2 B3EWZ6 33.762 1632 0.0 754.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6430.t2 B3EWZ6 32.788 1650 0.0 697.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6430.t2 B3EWZ6 39.394 990 0.0 667.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6430.t2 B3EWZ6 29.959 1966 0.0 659.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6430.t2 B3EWZ6 32.471 1469 0.0 646.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6430.t2 B3EWZ6 28.658 1982 6.82e-168 592.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6430.t2 B3EWZ6 27.382 1501 2.28e-117 425.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6430.t2 B3EWZ6 29.69 1226 7.550000000000001e-110 400.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6430.t2 B3EWZ6 24.915 1774 6.76e-94 347.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6430.t2 B3EWZ6 28.329 1059 1.02e-65 254.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6430.t2 B3EWZ6 30.561 553 9.39e-47 191.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6430.t2 B3EWZ6 27.32 582 4.47e-38 163.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6430.t2 B3EWZ6 26.014 592 5.07e-35 152.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6430.t2 B3EWZ6 28.35 515 6.47e-35 152.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6433.t1 Q2KI24 59.144 257 1.3099999999999999e-104 311.0 sp|Q2KI24|MTHSD_BOVIN Methenyltetrahydrofolate synthase domain-containing protein OS=Bos taurus OX=9913 GN=MTHFSD PE=2 SV=1 g6434.t1 Q5ZII6 87.143 70 2.36e-40 129.0 sp|Q5ZII6|KISHA_CHICK Protein kish-A OS=Gallus gallus OX=9031 GN=TMEM167A PE=3 SV=1 g6435.t1 A1A600 38.024 334 2.19e-48 172.0 sp|A1A600|EFC4A_DANRE EF-hand calcium-binding domain-containing protein 4A OS=Danio rerio OX=7955 GN=cracr2b PE=2 SV=2 g6435.t2 A1A600 38.024 334 5.18e-48 171.0 sp|A1A600|EFC4A_DANRE EF-hand calcium-binding domain-containing protein 4A OS=Danio rerio OX=7955 GN=cracr2b PE=2 SV=2 g6435.t3 Q9BSW2 52.667 150 7.239999999999999e-48 184.0 sp|Q9BSW2|EFC4B_HUMAN EF-hand calcium-binding domain-containing protein 4B OS=Homo sapiens OX=9606 GN=CRACR2A PE=1 SV=2 EFC4B_HUMAN reviewed EF-hand calcium-binding domain-containing protein 4B (Calcium release-activated calcium channel regulator 2A) (CRAC channel regulator 2A) (Calcium release-activated channel regulator 2A) (Ras-related protein Rab-46) (EC 3.6.5.2) Homo sapiens (Human) GO:0000139; GO:0001772; GO:0002115; GO:0002250; GO:0003924; GO:0003925; GO:0005509; GO:0005525; GO:0005576; GO:0005737; GO:0005815; GO:0005886; GO:0008104; GO:0016020; GO:0016192; GO:0016197; GO:0031982; GO:0032237; GO:0032588; GO:0033093; GO:0034776; GO:0035580; GO:0045063; GO:0046330; GO:0051928 activation of store-operated calcium channel activity [GO:0032237]; adaptive immune response [GO:0002250]; endosomal transport [GO:0016197]; intracellular protein localization [GO:0008104]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of JNK cascade [GO:0046330]; response to histamine [GO:0034776]; store-operated calcium entry [GO:0002115]; T-helper 1 cell differentiation [GO:0045063]; vesicle-mediated transport [GO:0016192] cytoplasm [GO:0005737]; extracellular region [GO:0005576]; Golgi membrane [GO:0000139]; immunological synapse [GO:0001772]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; plasma membrane [GO:0005886]; specific granule lumen [GO:0035580]; trans-Golgi network membrane [GO:0032588]; vesicle [GO:0031982]; Weibel-Palade body [GO:0033093] calcium ion binding [GO:0005509]; G protein activity [GO:0003925]; GTP binding [GO:0005525]; GTPase activity [GO:0003924] g6435.t3 Q9BSW2 37.982 337 4.100000000000001e-37 152.0 sp|Q9BSW2|EFC4B_HUMAN EF-hand calcium-binding domain-containing protein 4B OS=Homo sapiens OX=9606 GN=CRACR2A PE=1 SV=2 EFC4B_HUMAN reviewed EF-hand calcium-binding domain-containing protein 4B (Calcium release-activated calcium channel regulator 2A) (CRAC channel regulator 2A) (Calcium release-activated channel regulator 2A) (Ras-related protein Rab-46) (EC 3.6.5.2) Homo sapiens (Human) GO:0000139; GO:0001772; GO:0002115; GO:0002250; GO:0003924; GO:0003925; GO:0005509; GO:0005525; GO:0005576; GO:0005737; GO:0005815; GO:0005886; GO:0008104; GO:0016020; GO:0016192; GO:0016197; GO:0031982; GO:0032237; GO:0032588; GO:0033093; GO:0034776; GO:0035580; GO:0045063; GO:0046330; GO:0051928 activation of store-operated calcium channel activity [GO:0032237]; adaptive immune response [GO:0002250]; endosomal transport [GO:0016197]; intracellular protein localization [GO:0008104]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of JNK cascade [GO:0046330]; response to histamine [GO:0034776]; store-operated calcium entry [GO:0002115]; T-helper 1 cell differentiation [GO:0045063]; vesicle-mediated transport [GO:0016192] cytoplasm [GO:0005737]; extracellular region [GO:0005576]; Golgi membrane [GO:0000139]; immunological synapse [GO:0001772]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; plasma membrane [GO:0005886]; specific granule lumen [GO:0035580]; trans-Golgi network membrane [GO:0032588]; vesicle [GO:0031982]; Weibel-Palade body [GO:0033093] calcium ion binding [GO:0005509]; G protein activity [GO:0003925]; GTP binding [GO:0005525]; GTPase activity [GO:0003924] g6436.t1 Q7ZV84 43.21 486 1.3499999999999999e-106 336.0 sp|Q7ZV84|DAAF1_DANRE Dynein axonemal assembly factor 1 OS=Danio rerio OX=7955 GN=dnaaf1 PE=2 SV=2 DAAF1_DANRE reviewed Dynein axonemal assembly factor 1 (Leucine-rich repeat-containing protein 50) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001947; GO:0003143; GO:0003146; GO:0003305; GO:0003314; GO:0005930; GO:0007283; GO:0007368; GO:0007369; GO:0035082; GO:0048793; GO:0060027; GO:0060271; GO:0061371; GO:0061524; GO:0070840 axoneme assembly [GO:0035082]; cell migration involved in heart jogging [GO:0003305]; central canal development [GO:0061524]; cilium assembly [GO:0060271]; convergent extension involved in gastrulation [GO:0060027]; determination of heart left/right asymmetry [GO:0061371]; determination of left/right symmetry [GO:0007368]; embryonic heart tube morphogenesis [GO:0003143]; gastrulation [GO:0007369]; heart jogging [GO:0003146]; heart looping [GO:0001947]; heart rudiment morphogenesis [GO:0003314]; pronephros development [GO:0048793]; spermatogenesis [GO:0007283] axoneme [GO:0005930] dynein complex binding [GO:0070840] g6440.t1 P62332 94.857 175 4.82e-124 349.0 sp|P62332|ARF6_RAT ADP-ribosylation factor 6 OS=Rattus norvegicus OX=10116 GN=Arf6 PE=1 SV=2 ARF6_RAT reviewed ADP-ribosylation factor 6 (EC 3.6.5.2) Rattus norvegicus (Rat) GO:0001726; GO:0001889; GO:0003925; GO:0005525; GO:0005737; GO:0005768; GO:0005769; GO:0005794; GO:0005829; GO:0005886; GO:0005938; GO:0006886; GO:0007399; GO:0010975; GO:0010976; GO:0016020; GO:0016192; GO:0019003; GO:0030036; GO:0030139; GO:0030154; GO:0030496; GO:0030838; GO:0030866; GO:0031527; GO:0031901; GO:0031996; GO:0032154; GO:0032456; GO:0034394; GO:0035020; GO:0035591; GO:0036010; GO:0048488; GO:0050714; GO:0051489; GO:0051549; GO:0055037; GO:0055038; GO:0060998; GO:0070382; GO:0072659; GO:0090162; GO:0090543; GO:0097178; GO:0097284; GO:0098793; GO:0098794; GO:0098978; GO:0099562; GO:0120183; GO:1902217; GO:1903078; GO:1903438; GO:1905345; GO:1905606; GO:1990090; GO:2000009; GO:2000171 actin cytoskeleton organization [GO:0030036]; cell differentiation [GO:0030154]; cellular response to nerve growth factor stimulus [GO:1990090]; cortical actin cytoskeleton organization [GO:0030866]; endocytic recycling [GO:0032456]; erythrocyte apoptotic process [GO:1902217]; establishment of epithelial cell polarity [GO:0090162]; hepatocyte apoptotic process [GO:0097284]; intracellular protein transport [GO:0006886]; liver development [GO:0001889]; maintenance of postsynaptic density structure [GO:0099562]; negative regulation of dendrite development [GO:2000171]; negative regulation of protein localization to cell surface [GO:2000009]; nervous system development [GO:0007399]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of focal adhesion disassembly [GO:0120183]; positive regulation of keratinocyte migration [GO:0051549]; positive regulation of mitotic cytokinetic process [GO:1903438]; positive regulation of neuron projection development [GO:0010976]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of protein secretion [GO:0050714]; protein localization to cell surface [GO:0034394]; protein localization to cleavage furrow [GO:1905345]; protein localization to endosome [GO:0036010]; protein localization to plasma membrane [GO:0072659]; regulation of dendritic spine development [GO:0060998]; regulation of filopodium assembly [GO:0051489]; regulation of neuron projection development [GO:0010975]; regulation of presynapse assembly [GO:1905606]; regulation of Rac protein signal transduction [GO:0035020]; ruffle assembly [GO:0097178]; synaptic vesicle endocytosis [GO:0048488]; vesicle-mediated transport [GO:0016192] cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; exocytic vesicle [GO:0070382]; filopodium membrane [GO:0031527]; Flemming body [GO:0090543]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; midbody [GO:0030496]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; presynapse [GO:0098793]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; ruffle [GO:0001726] G protein activity [GO:0003925]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; signaling adaptor activity [GO:0035591]; thioesterase binding [GO:0031996] g6441.t1 Q7T385 68.074 379 0.0 550.0 sp|Q7T385|VTC1A_DANRE V-type proton ATPase subunit C 1-A OS=Danio rerio OX=7955 GN=atp6v1c1a PE=2 SV=1 g6442.t1 Q8VDM4 74.552 892 0.0 1270.0 sp|Q8VDM4|PSMD2_MOUSE 26S proteasome non-ATPase regulatory subunit 2 OS=Mus musculus OX=10090 GN=Psmd2 PE=1 SV=1 PSMD2_MOUSE reviewed 26S proteasome non-ATPase regulatory subunit 2 (26S proteasome regulatory subunit RPN1) (26S proteasome regulatory subunit S2) (26S proteasome subunit p97) Mus musculus (Mouse) GO:0000502; GO:0005634; GO:0005838; GO:0008540; GO:0022624; GO:0030234; GO:0034515; GO:0042176; GO:0043161 proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of protein catabolic process [GO:0042176] nucleus [GO:0005634]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; proteasome regulatory particle [GO:0005838]; proteasome regulatory particle, base subcomplex [GO:0008540]; proteasome storage granule [GO:0034515] enzyme regulator activity [GO:0030234] g6443.t1 Q9Y2A7 58.452 1124 0.0 1361.0 sp|Q9Y2A7|NCKP1_HUMAN Nck-associated protein 1 OS=Homo sapiens OX=9606 GN=NCKAP1 PE=1 SV=1 NCKP1_HUMAN reviewed Nck-associated protein 1 (NAP 1) (Membrane-associated protein HEM-2) (p125Nap1) Homo sapiens (Human) GO:0000902; GO:0001701; GO:0001726; GO:0001756; GO:0001843; GO:0005829; GO:0005925; GO:0006915; GO:0007354; GO:0007417; GO:0007492; GO:0008078; GO:0010172; GO:0010592; GO:0016477; GO:0016601; GO:0030027; GO:0030031; GO:0030032; GO:0030838; GO:0030866; GO:0030950; GO:0031209; GO:0031258; GO:0031941; GO:0032880; GO:0035050; GO:0042074; GO:0045175; GO:0045176; GO:0048340; GO:0048570; GO:0048617; GO:0048812; GO:0050821; GO:0070062; GO:0098794; GO:2000601 apical protein localization [GO:0045176]; apoptotic process [GO:0006915]; basal protein localization [GO:0045175]; cell migration [GO:0016477]; cell migration involved in gastrulation [GO:0042074]; cell morphogenesis [GO:0000902]; cell projection assembly [GO:0030031]; central nervous system development [GO:0007417]; cortical actin cytoskeleton organization [GO:0030866]; embryonic body morphogenesis [GO:0010172]; embryonic foregut morphogenesis [GO:0048617]; embryonic heart tube development [GO:0035050]; endoderm development [GO:0007492]; establishment or maintenance of actin cytoskeleton polarity [GO:0030950]; in utero embryonic development [GO:0001701]; lamellipodium assembly [GO:0030032]; mesodermal cell migration [GO:0008078]; neural tube closure [GO:0001843]; neuron projection morphogenesis [GO:0048812]; notochord morphogenesis [GO:0048570]; paraxial mesoderm morphogenesis [GO:0048340]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of Arp2/3 complex-mediated actin nucleation [GO:2000601]; positive regulation of lamellipodium assembly [GO:0010592]; protein stabilization [GO:0050821]; Rac protein signal transduction [GO:0016601]; regulation of protein localization [GO:0032880]; somitogenesis [GO:0001756]; zygotic determination of anterior/posterior axis, embryo [GO:0007354] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; filamentous actin [GO:0031941]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; lamellipodium membrane [GO:0031258]; postsynapse [GO:0098794]; ruffle [GO:0001726]; SCAR complex [GO:0031209] g6445.t1 Q29RK9 69.048 168 7.51e-85 252.0 sp|Q29RK9|MOB3B_BOVIN MOB kinase activator 3B OS=Bos taurus OX=9913 GN=MOB3B PE=2 SV=1 g6446.t1 P82251 37.44 414 2.8700000000000003e-97 303.0 sp|P82251|BAT1_HUMAN b(0,+)-type amino acid transporter 1 OS=Homo sapiens OX=9606 GN=SLC7A9 PE=1 SV=1 BAT1_HUMAN reviewed b(0,+)-type amino acid transporter 1 (b(0,+)AT1) (Glycoprotein-associated amino acid transporter b0,+AT1) (Solute carrier family 7 member 9) Homo sapiens (Human) GO:0003333; GO:0005886; GO:0015175; GO:0015184; GO:0015297; GO:0015804; GO:0015811; GO:0016324; GO:0031526; GO:0042605; GO:0046982; GO:0065003; GO:0180009 amino acid transmembrane transport [GO:0003333]; L-cystine transport [GO:0015811]; neutral amino acid transport [GO:0015804]; protein-containing complex assembly [GO:0065003] apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; plasma membrane [GO:0005886] antiporter activity [GO:0015297]; broad specificity neutral L-amino acid:basic L-amino acid antiporter activity [GO:0180009]; L-cystine transmembrane transporter activity [GO:0015184]; neutral L-amino acid transmembrane transporter activity [GO:0015175]; peptide antigen binding [GO:0042605]; protein heterodimerization activity [GO:0046982] g6447.t1 Q2KI15 64.344 244 2.14e-113 342.0 sp|Q2KI15|RF1ML_BOVIN Peptide chain release factor 1-like, mitochondrial OS=Bos taurus OX=9913 GN=MTRF1L PE=2 SV=1 g6448.t1 Q6GN08 41.421 746 3.2700000000000002e-164 517.0 sp|Q6GN08|CND3L_XENLA Condensin-2 complex subunit D3-L OS=Xenopus laevis OX=8355 GN=ncapd3.L PE=1 SV=1 CND3L_XENLA reviewed Condensin-2 complex subunit D3-L Xenopus laevis (African clawed frog) GO:0000779; GO:0000796; GO:0007076; GO:0010032; GO:0031981; GO:0042393; GO:0051301 cell division [GO:0051301]; meiotic chromosome condensation [GO:0010032]; mitotic chromosome condensation [GO:0007076] condensed chromosome, centromeric region [GO:0000779]; condensin complex [GO:0000796]; nuclear lumen [GO:0031981] histone binding [GO:0042393] g6449.t1 P42695 33.624 803 1.2e-110 373.0 sp|P42695|CNDD3_HUMAN Condensin-2 complex subunit D3 OS=Homo sapiens OX=9606 GN=NCAPD3 PE=1 SV=2 CNDD3_HUMAN reviewed Condensin-2 complex subunit D3 (Non-SMC condensin II complex subunit D3) (hCAP-D3) Homo sapiens (Human) GO:0000779; GO:0000794; GO:0000796; GO:0005654; GO:0005721; GO:0007076; GO:0010032; GO:0016020; GO:0042393; GO:0051301; GO:0051984; GO:0140117; GO:1905820; GO:1905821 cell division [GO:0051301]; meiotic chromosome condensation [GO:0010032]; mitotic chromosome condensation [GO:0007076]; positive regulation of chromosome condensation [GO:1905821]; positive regulation of chromosome segregation [GO:0051984]; positive regulation of chromosome separation [GO:1905820] condensed chromosome, centromeric region [GO:0000779]; condensed nuclear chromosome [GO:0000794]; condensin complex [GO:0000796]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; pericentric heterochromatin [GO:0005721] histone binding [GO:0042393]; histone H4K20me1 reader activity [GO:0140117] g6452.t1 O08755 50.396 379 2.22e-90 286.0 sp|O08755|HNF6_MOUSE Hepatocyte nuclear factor 6 OS=Mus musculus OX=10090 GN=Onecut1 PE=1 SV=1 HNF6_MOUSE reviewed Hepatocyte nuclear factor 6 (HNF-6) (One cut domain family member 1) (One cut homeobox 1) Mus musculus (Mouse) GO:0000978; GO:0000981; GO:0001228; GO:0001889; GO:0001952; GO:0002064; GO:0003677; GO:0003682; GO:0003700; GO:0005634; GO:0005654; GO:0006006; GO:0006357; GO:0007219; GO:0007492; GO:0009653; GO:0030154; GO:0030183; GO:0030335; GO:0030512; GO:0031016; GO:0031018; GO:0045165; GO:0045944; GO:0048536; GO:0060271; GO:1990837 anatomical structure morphogenesis [GO:0009653]; B cell differentiation [GO:0030183]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; cilium assembly [GO:0060271]; endocrine pancreas development [GO:0031018]; endoderm development [GO:0007492]; epithelial cell development [GO:0002064]; glucose metabolic process [GO:0006006]; liver development [GO:0001889]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; Notch signaling pathway [GO:0007219]; pancreas development [GO:0031016]; positive regulation of cell migration [GO:0030335]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell-matrix adhesion [GO:0001952]; regulation of transcription by RNA polymerase II [GO:0006357]; spleen development [GO:0048536] nucleoplasm [GO:0005654]; nucleus [GO:0005634] chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837] g6455.t1 Q12901 38.415 164 2.74e-28 117.0 sp|Q12901|ZN155_HUMAN Zinc finger protein 155 OS=Homo sapiens OX=9606 GN=ZNF155 PE=1 SV=4 g6455.t1 Q12901 35.758 165 1.27e-21 98.6 sp|Q12901|ZN155_HUMAN Zinc finger protein 155 OS=Homo sapiens OX=9606 GN=ZNF155 PE=1 SV=4 g6455.t1 Q12901 35.152 165 1.41e-21 98.6 sp|Q12901|ZN155_HUMAN Zinc finger protein 155 OS=Homo sapiens OX=9606 GN=ZNF155 PE=1 SV=4 g6459.t1 Q805E5 30.357 280 3.45e-31 125.0 sp|Q805E5|CHSTE_DANRE Carbohydrate sulfotransferase 14 OS=Danio rerio OX=7955 GN=chst14 PE=2 SV=1 CHSTE_DANRE reviewed Carbohydrate sulfotransferase 14 (EC 2.8.2.-) (Dermatan 4-sulfotransferase 1) (D4ST-1) (zD4ST-1) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000139; GO:0001537; GO:0008146; GO:0016051; GO:0050655 carbohydrate biosynthetic process [GO:0016051]; dermatan sulfate proteoglycan metabolic process [GO:0050655] Golgi membrane [GO:0000139] dermatan 4-sulfotransferase activity [GO:0001537]; sulfotransferase activity [GO:0008146] g6460.t1 Q805E5 33.7 273 2.09e-33 131.0 sp|Q805E5|CHSTE_DANRE Carbohydrate sulfotransferase 14 OS=Danio rerio OX=7955 GN=chst14 PE=2 SV=1 CHSTE_DANRE reviewed Carbohydrate sulfotransferase 14 (EC 2.8.2.-) (Dermatan 4-sulfotransferase 1) (D4ST-1) (zD4ST-1) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000139; GO:0001537; GO:0008146; GO:0016051; GO:0050655 carbohydrate biosynthetic process [GO:0016051]; dermatan sulfate proteoglycan metabolic process [GO:0050655] Golgi membrane [GO:0000139] dermatan 4-sulfotransferase activity [GO:0001537]; sulfotransferase activity [GO:0008146] g6465.t1 Q9UJU3 29.863 365 4.3e-34 142.0 sp|Q9UJU3|ZN112_HUMAN Zinc finger protein 112 OS=Homo sapiens OX=9606 GN=ZNF112 PE=1 SV=2 g6465.t1 Q9UJU3 32.663 199 5.06e-25 114.0 sp|Q9UJU3|ZN112_HUMAN Zinc finger protein 112 OS=Homo sapiens OX=9606 GN=ZNF112 PE=1 SV=2 g6469.t1 O95628 85.106 235 1.69e-141 433.0 sp|O95628|CNOT4_HUMAN CCR4-NOT transcription complex subunit 4 OS=Homo sapiens OX=9606 GN=CNOT4 PE=1 SV=3 CNOT4_HUMAN reviewed CCR4-NOT transcription complex subunit 4 (EC 2.3.2.27) (CCR4-associated factor 4) (E3 ubiquitin-protein ligase CNOT4) (Potential transcriptional repressor NOT4Hp) (RING-type E3 ubiquitin transferase CNOT4) Homo sapiens (Human) GO:0000289; GO:0003723; GO:0004842; GO:0005634; GO:0005829; GO:0006511; GO:0008270; GO:0016567; GO:0030014; GO:0045652; GO:0051865; GO:0061630 nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; protein autoubiquitination [GO:0051865]; protein ubiquitination [GO:0016567]; regulation of megakaryocyte differentiation [GO:0045652]; ubiquitin-dependent protein catabolic process [GO:0006511] CCR4-NOT complex [GO:0030014]; cytosol [GO:0005829]; nucleus [GO:0005634] RNA binding [GO:0003723]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] g6470.t1 Q2YDS5 58.333 132 6.919999999999999e-48 166.0 sp|Q2YDS5|SCNM1_DANRE Sodium channel modifier 1 OS=Danio rerio OX=7955 GN=scnm1 PE=2 SV=1 g6471.t1 Q9Z2K9 75.728 412 0.0 667.0 sp|Q9Z2K9|IDHC_MICME Isocitrate dehydrogenase [NADP] cytoplasmic OS=Microtus mexicanus OX=79689 GN=IDH1 PE=2 SV=1 g6472.t1 Q5ZIM6 45.326 353 3.09e-41 159.0 sp|Q5ZIM6|AATF_CHICK Protein AATF OS=Gallus gallus OX=9031 GN=AATF PE=2 SV=1 g6473.t1 Q6ZT07 55.413 933 0.0 1028.0 sp|Q6ZT07|TBCD9_HUMAN TBC1 domain family member 9 OS=Homo sapiens OX=9606 GN=TBC1D9 PE=1 SV=2 g6474.t1 Q9UGM3 28.715 498 2.51e-33 139.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g6474.t1 Q9UGM3 25.636 511 2.47e-25 115.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g6475.t1 Q2VLG6 28.643 803 5.7899999999999996e-61 230.0 sp|Q2VLG6|C163A_CANLF Scavenger receptor cysteine-rich type 1 protein M130 OS=Canis lupus familiaris OX=9615 GN=CD163 PE=2 SV=1 C163A_CANLF reviewed Scavenger receptor cysteine-rich type 1 protein M130 (CD antigen CD163) [Cleaved into: Soluble CD163 (sCD163)] Canis lupus familiaris (Dog) (Canis familiaris) GO:0005576; GO:0005737; GO:0006953; GO:0009897 acute-phase response [GO:0006953] cytoplasm [GO:0005737]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576] g6476.t1 P08836 56.598 341 2.19e-146 424.0 sp|P08836|FPPS_CHICK Farnesyl pyrophosphate synthase OS=Gallus gallus OX=9031 GN=FDPS PE=1 SV=2 g6477.t1 A7MB11 49.24 855 0.0 865.0 sp|A7MB11|TGFA1_BOVIN Transforming growth factor-beta receptor-associated protein 1 OS=Bos taurus OX=9913 GN=TGFBRAP1 PE=2 SV=1 TGFA1_BOVIN reviewed Transforming growth factor-beta receptor-associated protein 1 (TGF-beta receptor-associated protein 1) (TRAP-1) (TRAP1) Bos taurus (Bovine) GO:0005737; GO:0005769; GO:0006886; GO:0006914; GO:0016020; GO:0034058 autophagy [GO:0006914]; endosomal vesicle fusion [GO:0034058]; intracellular protein transport [GO:0006886] cytoplasm [GO:0005737]; early endosome [GO:0005769]; membrane [GO:0016020] g6477.t2 A7MB11 48.304 855 0.0 840.0 sp|A7MB11|TGFA1_BOVIN Transforming growth factor-beta receptor-associated protein 1 OS=Bos taurus OX=9913 GN=TGFBRAP1 PE=2 SV=1 TGFA1_BOVIN reviewed Transforming growth factor-beta receptor-associated protein 1 (TGF-beta receptor-associated protein 1) (TRAP-1) (TRAP1) Bos taurus (Bovine) GO:0005737; GO:0005769; GO:0006886; GO:0006914; GO:0016020; GO:0034058 autophagy [GO:0006914]; endosomal vesicle fusion [GO:0034058]; intracellular protein transport [GO:0006886] cytoplasm [GO:0005737]; early endosome [GO:0005769]; membrane [GO:0016020] g6479.t1 Q15599 56.383 94 4.58e-27 114.0 sp|Q15599|NHRF2_HUMAN Na(+)/H(+) exchange regulatory cofactor NHE-RF2 OS=Homo sapiens OX=9606 GN=NHERF2 PE=1 SV=2 g6479.t1 Q15599 49.593 123 6.87e-26 110.0 sp|Q15599|NHRF2_HUMAN Na(+)/H(+) exchange regulatory cofactor NHE-RF2 OS=Homo sapiens OX=9606 GN=NHERF2 PE=1 SV=2 g6479.t2 Q15599 56.383 94 6.760000000000001e-27 114.0 sp|Q15599|NHRF2_HUMAN Na(+)/H(+) exchange regulatory cofactor NHE-RF2 OS=Homo sapiens OX=9606 GN=NHERF2 PE=1 SV=2 g6479.t2 Q15599 49.593 123 1.17e-24 108.0 sp|Q15599|NHRF2_HUMAN Na(+)/H(+) exchange regulatory cofactor NHE-RF2 OS=Homo sapiens OX=9606 GN=NHERF2 PE=1 SV=2 g6480.t1 Q4V8B8 43.99 391 5.0400000000000004e-99 310.0 sp|Q4V8B8|TYW2_RAT tRNA wybutosine-synthesizing protein 2 homolog OS=Rattus norvegicus OX=10116 GN=Trmt12 PE=2 SV=2 TYW2_RAT reviewed tRNA wybutosine-synthesizing protein 2 homolog (tRNA-yW-synthesizing protein 2) (EC 2.5.1.114) (tRNA(Phe) (4-demethylwyosine(37)-C(7)) aminocarboxypropyltransferase) Rattus norvegicus (Rat) GO:0005737; GO:0008175; GO:0030488; GO:0031591; GO:0102522 tRNA methylation [GO:0030488]; wybutosine biosynthetic process [GO:0031591] cytoplasm [GO:0005737] tRNA 4-demethylwyosine alpha-amino-alpha-carboxypropyltransferase activity [GO:0102522]; tRNA methyltransferase activity [GO:0008175] g6481.t1 O42196 68.687 99 1.13e-42 147.0 sp|O42196|DNJC5_XENLA DnaJ homolog subfamily C member 5 OS=Xenopus laevis OX=8355 GN=dnajc5 PE=2 SV=1 g6483.t1 B3EWZ6 35.208 6686 0.0 3385.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6483.t1 B3EWZ6 39.697 2441 0.0 1573.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6483.t1 B3EWZ6 36.143 2883 0.0 1543.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6483.t1 B3EWZ6 30.332 3887 0.0 1405.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6483.t1 B3EWZ6 36.648 2464 0.0 1307.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6483.t1 B3EWZ6 30.906 3213 0.0 1209.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6483.t1 B3EWZ6 30.036 3296 0.0 1204.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6483.t1 B3EWZ6 29.222 3316 0.0 1109.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6483.t1 B3EWZ6 38.538 1614 0.0 1001.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6483.t1 B3EWZ6 31.308 2600 0.0 997.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6483.t1 B3EWZ6 28.634 1816 2.17e-168 595.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6483.t1 B3EWZ6 28.612 1405 1.59e-130 470.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6483.t1 B3EWZ6 30.166 1442 4.3e-130 469.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6483.t1 B3EWZ6 28.7 1439 1.37e-113 414.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6483.t1 B3EWZ6 25.768 1692 1.96e-111 407.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6483.t1 B3EWZ6 34.792 914 5.49e-111 405.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6483.t1 B3EWZ6 25.881 1248 6.7e-86 322.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6483.t1 B3EWZ6 33.735 664 1.37e-71 275.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6483.t1 B3EWZ6 28.778 900 3.73e-70 270.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6483.t1 B3EWZ6 27.586 928 1.86e-59 234.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6483.t1 B3EWZ6 31.757 592 3.69e-55 220.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6483.t1 B3EWZ6 32.528 538 2.75e-51 207.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6483.t1 B3EWZ6 30.051 589 1.96e-45 188.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6483.t1 B3EWZ6 30.864 405 5.150000000000001e-29 134.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6483.t1 B3EWZ6 32.937 252 1.7e-22 112.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6483.t2 B3EWZ6 35.133 6706 0.0 3374.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6483.t2 B3EWZ6 39.374 2461 0.0 1566.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6483.t2 B3EWZ6 35.963 2903 0.0 1533.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6483.t2 B3EWZ6 30.332 3887 0.0 1405.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6483.t2 B3EWZ6 36.353 2484 0.0 1297.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6483.t2 B3EWZ6 30.036 3296 0.0 1204.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6483.t2 B3EWZ6 30.715 3233 0.0 1197.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6483.t2 B3EWZ6 29.222 3316 0.0 1109.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6483.t2 B3EWZ6 38.066 1634 0.0 990.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6483.t2 B3EWZ6 31.069 2620 0.0 985.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6483.t2 B3EWZ6 28.322 1836 2.27e-165 585.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6483.t2 B3EWZ6 29.405 1867 4.3300000000000006e-163 578.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6483.t2 B3EWZ6 28.612 1405 1.62e-130 470.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6483.t2 B3EWZ6 29.754 1462 7.67e-127 458.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6483.t2 B3EWZ6 28.7 1439 1.25e-113 414.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6483.t2 B3EWZ6 25.768 1692 1.87e-111 407.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6483.t2 B3EWZ6 34.792 914 5.47e-111 405.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6483.t2 B3EWZ6 25.881 1248 6.900000000000001e-86 322.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6483.t2 B3EWZ6 33.735 664 1.39e-71 275.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6483.t2 B3EWZ6 27.586 928 1.6500000000000001e-59 235.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6483.t2 B3EWZ6 31.757 592 3.6499999999999996e-55 220.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6483.t2 B3EWZ6 32.528 538 2.74e-51 207.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6483.t2 B3EWZ6 31.522 552 1.3400000000000002e-47 195.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6483.t2 B3EWZ6 30.051 589 1.79e-45 188.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6483.t2 B3EWZ6 30.864 405 5.34e-29 134.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6483.t2 B3EWZ6 32.937 252 1.71e-22 112.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6484.t1 B3EWZ5 40.19 316 5.17e-64 221.0 sp|B3EWZ5|MLRP1_ACRMI MAM and LDL-receptor class A domain-containing protein 1 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6484.t1 B3EWZ5 38.562 306 4.09e-55 196.0 sp|B3EWZ5|MLRP1_ACRMI MAM and LDL-receptor class A domain-containing protein 1 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6484.t1 B3EWZ5 40.816 294 9.92e-55 194.0 sp|B3EWZ5|MLRP1_ACRMI MAM and LDL-receptor class A domain-containing protein 1 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6484.t1 B3EWZ5 38.567 293 1.04e-54 194.0 sp|B3EWZ5|MLRP1_ACRMI MAM and LDL-receptor class A domain-containing protein 1 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6484.t1 B3EWZ5 39.057 297 6.48e-51 183.0 sp|B3EWZ5|MLRP1_ACRMI MAM and LDL-receptor class A domain-containing protein 1 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6484.t1 B3EWZ5 37.919 298 7.09e-50 181.0 sp|B3EWZ5|MLRP1_ACRMI MAM and LDL-receptor class A domain-containing protein 1 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6484.t1 B3EWZ5 37.025 316 4.32e-48 175.0 sp|B3EWZ5|MLRP1_ACRMI MAM and LDL-receptor class A domain-containing protein 1 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6484.t1 B3EWZ5 37.113 291 1.4199999999999998e-46 171.0 sp|B3EWZ5|MLRP1_ACRMI MAM and LDL-receptor class A domain-containing protein 1 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6484.t1 B3EWZ5 36.156 307 2.4099999999999998e-46 170.0 sp|B3EWZ5|MLRP1_ACRMI MAM and LDL-receptor class A domain-containing protein 1 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6484.t1 B3EWZ5 38.966 290 4.63e-45 167.0 sp|B3EWZ5|MLRP1_ACRMI MAM and LDL-receptor class A domain-containing protein 1 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6484.t1 B3EWZ5 35.764 288 6.35e-45 166.0 sp|B3EWZ5|MLRP1_ACRMI MAM and LDL-receptor class A domain-containing protein 1 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6484.t1 B3EWZ5 33.956 321 1.97e-44 165.0 sp|B3EWZ5|MLRP1_ACRMI MAM and LDL-receptor class A domain-containing protein 1 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6484.t1 B3EWZ5 34.268 321 1.3199999999999999e-42 159.0 sp|B3EWZ5|MLRP1_ACRMI MAM and LDL-receptor class A domain-containing protein 1 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6484.t1 B3EWZ5 41.748 206 1.38e-42 159.0 sp|B3EWZ5|MLRP1_ACRMI MAM and LDL-receptor class A domain-containing protein 1 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6484.t1 B3EWZ5 32.239 335 8.3e-41 154.0 sp|B3EWZ5|MLRP1_ACRMI MAM and LDL-receptor class A domain-containing protein 1 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6484.t1 B3EWZ5 35.0 320 2.09e-39 150.0 sp|B3EWZ5|MLRP1_ACRMI MAM and LDL-receptor class A domain-containing protein 1 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6484.t1 B3EWZ5 36.145 249 2.5500000000000002e-36 141.0 sp|B3EWZ5|MLRP1_ACRMI MAM and LDL-receptor class A domain-containing protein 1 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6484.t1 B3EWZ5 42.945 163 1.33e-35 139.0 sp|B3EWZ5|MLRP1_ACRMI MAM and LDL-receptor class A domain-containing protein 1 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6484.t1 B3EWZ5 29.379 354 2.05e-33 133.0 sp|B3EWZ5|MLRP1_ACRMI MAM and LDL-receptor class A domain-containing protein 1 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6484.t1 B3EWZ5 32.975 279 2.76e-33 132.0 sp|B3EWZ5|MLRP1_ACRMI MAM and LDL-receptor class A domain-containing protein 1 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6484.t1 B3EWZ5 35.433 254 3.3e-33 132.0 sp|B3EWZ5|MLRP1_ACRMI MAM and LDL-receptor class A domain-containing protein 1 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6484.t1 B3EWZ5 29.213 356 8.36e-32 128.0 sp|B3EWZ5|MLRP1_ACRMI MAM and LDL-receptor class A domain-containing protein 1 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6484.t1 B3EWZ5 30.159 378 4.68e-31 126.0 sp|B3EWZ5|MLRP1_ACRMI MAM and LDL-receptor class A domain-containing protein 1 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6484.t1 B3EWZ5 43.796 137 1.43e-26 113.0 sp|B3EWZ5|MLRP1_ACRMI MAM and LDL-receptor class A domain-containing protein 1 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6486.t1 B3EWZ6 43.509 701 5.47e-156 504.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6486.t1 B3EWZ6 40.337 771 2.39e-151 491.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6486.t1 B3EWZ6 39.972 708 1.11e-139 457.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6486.t1 B3EWZ6 38.228 756 2.0899999999999998e-139 456.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6486.t1 B3EWZ6 37.867 750 3.47e-135 444.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6486.t1 B3EWZ6 37.637 728 2.5099999999999998e-126 418.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6486.t1 B3EWZ6 37.852 745 5.8699999999999993e-126 417.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6486.t1 B3EWZ6 37.274 719 2.01e-122 407.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6486.t1 B3EWZ6 36.698 733 1.66e-117 393.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6486.t1 B3EWZ6 33.799 787 6.39e-108 365.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6486.t1 B3EWZ6 39.192 569 2.06e-105 357.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6486.t1 B3EWZ6 38.256 562 4.21e-92 318.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6486.t1 B3EWZ6 30.207 821 1.42e-87 305.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6486.t1 B3EWZ6 28.356 864 1.9699999999999998e-82 290.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6486.t1 B3EWZ6 28.905 813 2.9799999999999996e-82 290.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6486.t1 B3EWZ6 30.27 816 1.72e-78 279.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6486.t1 B3EWZ6 36.364 528 5.53e-77 274.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6486.t1 B3EWZ6 29.356 838 3.68e-76 272.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6486.t1 B3EWZ6 30.446 785 3.7999999999999996e-68 248.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6486.t1 B3EWZ6 28.164 806 2.48e-64 236.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6486.t1 B3EWZ6 31.621 623 7.88e-59 220.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6486.t1 B3EWZ6 27.731 833 1.86e-52 201.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6486.t1 B3EWZ6 38.017 363 1.64e-51 198.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6486.t1 B3EWZ6 28.827 614 1.57e-47 186.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6486.t1 B3EWZ6 30.282 568 1.84e-44 177.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6486.t1 B3EWZ6 32.961 358 1.2300000000000001e-33 143.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6486.t1 B3EWZ6 30.657 411 1.3100000000000001e-33 143.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6486.t1 B3EWZ6 28.883 367 2.55e-28 126.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6487.t1 B3EWZ6 37.562 2026 0.0 1208.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6487.t1 B3EWZ6 37.789 2035 0.0 1178.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6487.t1 B3EWZ6 34.506 2104 0.0 1026.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6487.t1 B3EWZ6 38.627 1675 0.0 1018.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6487.t1 B3EWZ6 33.072 2044 0.0 917.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6487.t1 B3EWZ6 36.772 1270 0.0 706.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6487.t1 B3EWZ6 36.127 1074 3.6999999999999997e-180 614.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6487.t1 B3EWZ6 31.178 1392 6.2e-162 558.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6487.t1 B3EWZ6 31.146 1265 1.29e-137 484.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6487.t1 B3EWZ6 28.409 1496 3.74e-137 482.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6487.t1 B3EWZ6 28.842 1477 7.45e-136 478.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6487.t1 B3EWZ6 28.63 1467 1.61e-130 462.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6487.t1 B3EWZ6 38.136 708 1.19e-123 440.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6487.t1 B3EWZ6 37.147 743 8.85e-122 434.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6487.t1 B3EWZ6 33.807 914 1.72e-115 414.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6487.t1 B3EWZ6 28.845 1463 2.07e-115 414.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6487.t1 B3EWZ6 41.262 618 1.53e-114 411.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6487.t1 B3EWZ6 28.945 919 1.36e-76 288.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6487.t1 B3EWZ6 28.427 890 4.51e-76 286.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6487.t1 B3EWZ6 28.812 892 4.23e-75 283.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6487.t1 B3EWZ6 29.385 895 1.6600000000000002e-70 268.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6487.t1 B3EWZ6 37.226 411 1.3800000000000002e-66 251.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6487.t1 B3EWZ6 47.619 21 1.3800000000000002e-66 26.6 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6487.t1 B3EWZ6 28.386 849 1.63e-66 255.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6487.t1 B3EWZ6 28.049 902 2.23e-66 254.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6487.t1 B3EWZ6 26.451 896 5.31e-61 237.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6487.t1 B3EWZ6 28.919 740 2.2999999999999998e-60 235.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6487.t1 B3EWZ6 35.225 511 3.6600000000000005e-58 228.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6487.t1 B3EWZ6 38.743 382 8.81e-53 210.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6487.t1 B3EWZ6 32.624 282 1.02e-32 144.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6487.t1 B3EWZ6 33.918 342 8.149999999999999e-30 134.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6487.t1 B3EWZ6 28.836 378 2.1600000000000002e-26 123.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6488.t1 Q90YK3 48.655 446 3.4700000000000004e-163 470.0 sp|Q90YK3|GGLO_SCYTO L-gulonolactone oxidase OS=Scyliorhinus torazame OX=75743 GN=GULO PE=2 SV=1 g6488.t2 Q90YK3 48.649 444 1.15e-161 468.0 sp|Q90YK3|GGLO_SCYTO L-gulonolactone oxidase OS=Scyliorhinus torazame OX=75743 GN=GULO PE=2 SV=1 g6489.t1 O88685 83.953 430 0.0 713.0 sp|O88685|PRS6A_MOUSE 26S proteasome regulatory subunit 6A OS=Mus musculus OX=10090 GN=Psmc3 PE=1 SV=2 g6491.t1 Q962T1 77.876 113 1.5e-63 193.0 sp|Q962T1|RL32_SPOFR Large ribosomal subunit protein eL32 OS=Spodoptera frugiperda OX=7108 GN=RpL32 PE=2 SV=1 g6492.t1 Q6FHJ7 39.86 286 1.66e-56 189.0 sp|Q6FHJ7|SFRP4_HUMAN Secreted frizzled-related protein 4 OS=Homo sapiens OX=9606 GN=SFRP4 PE=1 SV=2 SFRP4_HUMAN reviewed Secreted frizzled-related protein 4 (sFRP-4) (Frizzled protein, human endometrium) (FrpHE) Homo sapiens (Human) GO:0000122; GO:0002092; GO:0005615; GO:0005634; GO:0005737; GO:0008285; GO:0009725; GO:0009986; GO:0010628; GO:0017147; GO:0030154; GO:0030178; GO:0030510; GO:0035567; GO:0043065; GO:0045606; GO:0055062; GO:0060070; GO:0060349; GO:0090090; GO:0090263; GO:1902174; GO:2000051; GO:2000119 bone morphogenesis [GO:0060349]; canonical Wnt signaling pathway [GO:0060070]; cell differentiation [GO:0030154]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of non-canonical Wnt signaling pathway [GO:2000051]; negative regulation of sodium-dependent phosphate transport [GO:2000119]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of Wnt signaling pathway [GO:0030178]; non-canonical Wnt signaling pathway [GO:0035567]; phosphate ion homeostasis [GO:0055062]; positive regulation of apoptotic process [GO:0043065]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of epidermal cell differentiation [GO:0045606]; positive regulation of gene expression [GO:0010628]; positive regulation of keratinocyte apoptotic process [GO:1902174]; positive regulation of receptor internalization [GO:0002092]; regulation of BMP signaling pathway [GO:0030510]; response to hormone [GO:0009725] cell surface [GO:0009986]; cytoplasm [GO:0005737]; extracellular space [GO:0005615]; nucleus [GO:0005634] Wnt-protein binding [GO:0017147] g6493.t1 O35623 55.556 90 1.13e-24 93.2 sp|O35623|BET1_MOUSE BET1 homolog OS=Mus musculus OX=10090 GN=Bet1 PE=1 SV=1 g6494.t1 Q6XZF7 30.619 307 5.0899999999999995e-23 109.0 sp|Q6XZF7|DNMBP_HUMAN Dynamin-binding protein OS=Homo sapiens OX=9606 GN=DNMBP PE=1 SV=1 DNMBP_HUMAN reviewed Dynamin-binding protein (Scaffold protein Tuba) Homo sapiens (Human) GO:0005085; GO:0005654; GO:0005730; GO:0005737; GO:0005794; GO:0005795; GO:0005829; GO:0005856; GO:0005911; GO:0008360; GO:0016604; GO:0035556; GO:0045202; GO:0051056; GO:0060271; GO:0098793 cilium assembly [GO:0060271]; intracellular signal transduction [GO:0035556]; regulation of cell shape [GO:0008360]; regulation of small GTPase mediated signal transduction [GO:0051056] cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi stack [GO:0005795]; nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; presynapse [GO:0098793]; synapse [GO:0045202] guanyl-nucleotide exchange factor activity [GO:0005085] g6496.t1 E2RP94 34.454 714 1.95e-119 397.0 sp|E2RP94|DNMBP_CANLF Dynamin-binding protein OS=Canis lupus familiaris OX=9615 GN=DNMBP PE=3 SV=2 g6496.t2 E2RP94 32.886 745 6.52e-114 383.0 sp|E2RP94|DNMBP_CANLF Dynamin-binding protein OS=Canis lupus familiaris OX=9615 GN=DNMBP PE=3 SV=2 g6497.t1 Q9Z2N8 66.667 432 0.0 619.0 sp|Q9Z2N8|ACL6A_MOUSE Actin-like protein 6A OS=Mus musculus OX=10090 GN=Actl6a PE=1 SV=2 ACL6A_MOUSE reviewed Actin-like protein 6A (53 kDa BRG1-associated factor A) (Actin-related protein Baf53a) (BRG1-associated factor 53A) (BAF53A) Mus musculus (Mouse) GO:0000723; GO:0000776; GO:0000785; GO:0000786; GO:0001825; GO:0003407; GO:0003682; GO:0005634; GO:0005654; GO:0005886; GO:0006275; GO:0006281; GO:0006282; GO:0006310; GO:0006338; GO:0006355; GO:0006357; GO:0007399; GO:0008284; GO:0016363; GO:0016514; GO:0016586; GO:0021510; GO:0030071; GO:0031011; GO:0033044; GO:0035060; GO:0035267; GO:0042981; GO:0045582; GO:0045596; GO:0045597; GO:0045663; GO:0045739; GO:0045893; GO:0045995; GO:0051726; GO:0060382; GO:0070316; GO:0071564; GO:0140288; GO:1902459; GO:1904507; GO:1905168; GO:2000045; GO:2000779; GO:2000781; GO:2000819 blastocyst formation [GO:0001825]; chromatin remodeling [GO:0006338]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; negative regulation of cell differentiation [GO:0045596]; nervous system development [GO:0007399]; neural retina development [GO:0003407]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA repair [GO:0045739]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of T cell differentiation [GO:0045582]; positive regulation of telomere maintenance in response to DNA damage [GO:1904507]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of chromosome organization [GO:0033044]; regulation of DNA repair [GO:0006282]; regulation of DNA replication [GO:0006275]; regulation of DNA strand elongation [GO:0060382]; regulation of DNA-templated transcription [GO:0006355]; regulation of double-strand break repair [GO:2000779]; regulation of embryonic development [GO:0045995]; regulation of G0 to G1 transition [GO:0070316]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; regulation of nucleotide-excision repair [GO:2000819]; regulation of transcription by RNA polymerase II [GO:0006357]; spinal cord development [GO:0021510]; telomere maintenance [GO:0000723] brahma complex [GO:0035060]; chromatin [GO:0000785]; GBAF complex [GO:0140288]; Ino80 complex [GO:0031011]; kinetochore [GO:0000776]; npBAF complex [GO:0071564]; NuA4 histone acetyltransferase complex [GO:0035267]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; RSC-type complex [GO:0016586]; SWI/SNF complex [GO:0016514] chromatin binding [GO:0003682] g6498.t1 O43826 41.958 429 2.6699999999999998e-115 347.0 sp|O43826|G6PT1_HUMAN Glucose-6-phosphate exchanger SLC37A4 OS=Homo sapiens OX=9606 GN=SLC37A4 PE=1 SV=1 G6PT1_HUMAN reviewed Glucose-6-phosphate exchanger SLC37A4 (Glucose-5-phosphate transporter) (Glucose-6-phosphate translocase) (Solute carrier family 37 member 4) (Transformation-related gene 19 protein) (TRG-19) Homo sapiens (Human) GO:0005783; GO:0005789; GO:0006006; GO:0006094; GO:0015152; GO:0015760; GO:0016020; GO:0035435; GO:0042593; GO:0061513 gluconeogenesis [GO:0006094]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; glucose-6-phosphate transport [GO:0015760]; phosphate ion transmembrane transport [GO:0035435] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020] glucose 6-phosphate:phosphate antiporter activity [GO:0061513]; glucose-6-phosphate transmembrane transporter activity [GO:0015152] g6499.t1 Q9UJT9 29.834 362 2.0500000000000003e-27 122.0 sp|Q9UJT9|FBXL7_HUMAN F-box/LRR-repeat protein 7 OS=Homo sapiens OX=9606 GN=FBXL7 PE=1 SV=1 FBXL7_HUMAN reviewed F-box/LRR-repeat protein 7 (F-box and leucine-rich repeat protein 7) (F-box protein FBL6/FBL7) Homo sapiens (Human) GO:0000086; GO:0000151; GO:0000209; GO:0000278; GO:0005813; GO:0005829; GO:0006511; GO:0016567; GO:0019005; GO:0031146; GO:0051301 cell division [GO:0051301]; G2/M transition of mitotic cell cycle [GO:0000086]; mitotic cell cycle [GO:0000278]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; ubiquitin-dependent protein catabolic process [GO:0006511] centrosome [GO:0005813]; cytosol [GO:0005829]; SCF ubiquitin ligase complex [GO:0019005]; ubiquitin ligase complex [GO:0000151] g6505.t1 P59382 60.386 207 7.61e-86 255.0 sp|P59382|PXMP4_RAT Peroxisomal membrane protein 4 OS=Rattus norvegicus OX=10116 GN=Pxmp4 PE=1 SV=2 g6507.t1 Q805E5 31.186 295 3.22e-36 139.0 sp|Q805E5|CHSTE_DANRE Carbohydrate sulfotransferase 14 OS=Danio rerio OX=7955 GN=chst14 PE=2 SV=1 CHSTE_DANRE reviewed Carbohydrate sulfotransferase 14 (EC 2.8.2.-) (Dermatan 4-sulfotransferase 1) (D4ST-1) (zD4ST-1) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000139; GO:0001537; GO:0008146; GO:0016051; GO:0050655 carbohydrate biosynthetic process [GO:0016051]; dermatan sulfate proteoglycan metabolic process [GO:0050655] Golgi membrane [GO:0000139] dermatan 4-sulfotransferase activity [GO:0001537]; sulfotransferase activity [GO:0008146] g6508.t1 Q5RES5 66.667 396 0.0 522.0 sp|Q5RES5|THIM_PONAB 3-ketoacyl-CoA thiolase, mitochondrial OS=Pongo abelii OX=9601 GN=ACAA2 PE=2 SV=1 THIM_PONAB reviewed 3-ketoacyl-CoA thiolase, mitochondrial (EC 2.3.1.16) (Acetyl-CoA acetyltransferase) (EC 2.3.1.9) (Acetyl-CoA acyltransferase) (Acyl-CoA hydrolase, mitochondrial) (EC 3.1.2.-, EC 3.1.2.1, EC 3.1.2.2) (Beta-ketothiolase) (Mitochondrial 3-oxoacyl-CoA thiolase) Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0003985; GO:0003986; GO:0003988; GO:0005739; GO:0006635; GO:0047617; GO:1901029 fatty acid beta-oxidation [GO:0006635]; negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901029] mitochondrion [GO:0005739] acetyl-CoA C-acetyltransferase activity [GO:0003985]; acetyl-CoA C-acyltransferase activity [GO:0003988]; acetyl-CoA hydrolase activity [GO:0003986]; fatty acyl-CoA hydrolase activity [GO:0047617] g6518.t1 Q9QXK7 80.435 92 3.2399999999999998e-46 162.0 sp|Q9QXK7|CPSF3_MOUSE Cleavage and polyadenylation specificity factor subunit 3 OS=Mus musculus OX=10090 GN=Cpsf3 PE=1 SV=2 CPSF3_MOUSE reviewed Cleavage and polyadenylation specificity factor subunit 3 (EC 3.1.27.-) (Cleavage and polyadenylation specificity factor 73 kDa subunit) (CPSF 73 kDa subunit) (mRNA 3'-end-processing endonuclease CPSF-73) Mus musculus (Mouse) GO:0003723; GO:0004521; GO:0004534; GO:0005847; GO:0006398; GO:0031124; GO:0046872; GO:0180010; GO:1900087; GO:1990904 co-transcriptional mRNA 3'-end processing, cleavage and polyadenylation pathway [GO:0180010]; mRNA 3'-end processing [GO:0031124]; mRNA 3'-end processing by stem-loop binding and cleavage [GO:0006398]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087] mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; ribonucleoprotein complex [GO:1990904] 5'-3' RNA exonuclease activity [GO:0004534]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; RNA endonuclease activity [GO:0004521] g6519.t1 A4IGP0 43.939 198 3.6299999999999996e-54 173.0 sp|A4IGP0|HIKES_XENTR Protein Hikeshi OS=Xenopus tropicalis OX=8364 GN=hikeshi PE=2 SV=1 g6520.t1 E1BFR5 52.672 131 1.16e-40 146.0 sp|E1BFR5|GWL_BOVIN Serine/threonine-protein kinase greatwall OS=Bos taurus OX=9913 GN=MASTL PE=3 SV=1 GWL_BOVIN reviewed Serine/threonine-protein kinase greatwall (GW) (GWL) (EC 2.7.11.1) (Microtubule-associated serine/threonine-protein kinase-like) (MAST-L) Bos taurus (Bovine) GO:0000086; GO:0000278; GO:0004674; GO:0005524; GO:0005634; GO:0005813; GO:0006974; GO:0007346; GO:0015630; GO:0032154; GO:0035556; GO:0051301; GO:0051721; GO:0106310 cell division [GO:0051301]; DNA damage response [GO:0006974]; G2/M transition of mitotic cell cycle [GO:0000086]; intracellular signal transduction [GO:0035556]; mitotic cell cycle [GO:0000278]; regulation of mitotic cell cycle [GO:0007346] centrosome [GO:0005813]; cleavage furrow [GO:0032154]; microtubule cytoskeleton [GO:0015630]; nucleus [GO:0005634] ATP binding [GO:0005524]; protein phosphatase 2A binding [GO:0051721]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g6521.t1 Q6DBX4 45.373 335 1.75e-87 295.0 sp|Q6DBX4|GWL_DANRE Serine/threonine-protein kinase greatwall OS=Danio rerio OX=7955 GN=mastl PE=2 SV=1 GWL_DANRE reviewed Serine/threonine-protein kinase greatwall (GW) (GWL) (EC 2.7.11.1) (Microtubule-associated serine/threonine-protein kinase-like) (MAST-L) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000086; GO:0000278; GO:0002574; GO:0004674; GO:0005524; GO:0005634; GO:0005813; GO:0006974; GO:0007346; GO:0015630; GO:0030071; GO:0032154; GO:0035556; GO:0051301; GO:0051721; GO:0106310 cell division [GO:0051301]; DNA damage response [GO:0006974]; G2/M transition of mitotic cell cycle [GO:0000086]; intracellular signal transduction [GO:0035556]; mitotic cell cycle [GO:0000278]; regulation of mitotic cell cycle [GO:0007346]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; thrombocyte differentiation [GO:0002574] centrosome [GO:0005813]; cleavage furrow [GO:0032154]; microtubule cytoskeleton [GO:0015630]; nucleus [GO:0005634] ATP binding [GO:0005524]; protein phosphatase 2A binding [GO:0051721]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g6526.t1 E9Q3S4 62.963 270 7.06e-100 357.0 sp|E9Q3S4|M3K19_MOUSE Mitogen-activated protein kinase kinase kinase 19 OS=Mus musculus OX=10090 GN=Map3k19 PE=3 SV=1 g6531.t1 Q5ZLY5 67.1 231 2.5e-117 339.0 sp|Q5ZLY5|PKHF2_CHICK Pleckstrin homology domain-containing family F member 2 OS=Gallus gallus OX=9031 GN=PLEKHF2 PE=2 SV=1 g6531.t2 Q5ZLY5 67.1 231 2.5199999999999997e-115 334.0 sp|Q5ZLY5|PKHF2_CHICK Pleckstrin homology domain-containing family F member 2 OS=Gallus gallus OX=9031 GN=PLEKHF2 PE=2 SV=1 g6532.t1 P62282 81.132 159 1.6000000000000001e-87 255.0 sp|P62282|RS11_RAT Small ribosomal subunit protein uS17 OS=Rattus norvegicus OX=10116 GN=Rps11 PE=1 SV=3 RS11_RAT reviewed Small ribosomal subunit protein uS17 (40S ribosomal protein S11) Rattus norvegicus (Rat) GO:0001649; GO:0003735; GO:0006412; GO:0016020; GO:0019843; GO:0022626; GO:0022627; GO:0032040; GO:0042274; GO:0045202 osteoblast differentiation [GO:0001649]; ribosomal small subunit biogenesis [GO:0042274]; translation [GO:0006412] cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]; membrane [GO:0016020]; small-subunit processome [GO:0032040]; synapse [GO:0045202] rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735] g6535.t1 Q9MYM7 40.441 272 3.5100000000000005e-70 224.0 sp|Q9MYM7|B3GT1_PONPY Beta-1,3-galactosyltransferase 1 OS=Pongo pygmaeus OX=9600 GN=B3GALT1 PE=3 SV=1 g6536.t1 Q01460 52.672 262 6.859999999999999e-95 287.0 sp|Q01460|DIAC_RAT Di-N-acetylchitobiase OS=Rattus norvegicus OX=10116 GN=Ctbs PE=1 SV=1 DIAC_RAT reviewed Di-N-acetylchitobiase (EC 3.2.1.-) Rattus norvegicus (Rat) GO:0004568; GO:0005764; GO:0006032; GO:0008061; GO:0009313; GO:0016798 chitin catabolic process [GO:0006032]; oligosaccharide catabolic process [GO:0009313] lysosome [GO:0005764] chitin binding [GO:0008061]; chitinase activity [GO:0004568]; hydrolase activity, acting on glycosyl bonds [GO:0016798] g6537.t1 Q01460 51.906 341 4.3499999999999997e-126 370.0 sp|Q01460|DIAC_RAT Di-N-acetylchitobiase OS=Rattus norvegicus OX=10116 GN=Ctbs PE=1 SV=1 DIAC_RAT reviewed Di-N-acetylchitobiase (EC 3.2.1.-) Rattus norvegicus (Rat) GO:0004568; GO:0005764; GO:0006032; GO:0008061; GO:0009313; GO:0016798 chitin catabolic process [GO:0006032]; oligosaccharide catabolic process [GO:0009313] lysosome [GO:0005764] chitin binding [GO:0008061]; chitinase activity [GO:0004568]; hydrolase activity, acting on glycosyl bonds [GO:0016798] g6538.t1 Q9UGM3 28.807 1458 1.08e-121 424.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g6538.t1 Q9UGM3 29.048 1439 3.82e-121 422.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g6538.t1 Q9UGM3 28.73 1441 8.73e-121 421.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g6538.t1 Q9UGM3 28.006 1314 1.6200000000000002e-97 350.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g6538.t2 Q9UGM3 28.807 1458 9.93e-122 424.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g6538.t2 Q9UGM3 29.068 1438 4.02e-121 422.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g6538.t2 Q9UGM3 28.76 1443 6.19e-121 422.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g6538.t2 Q9UGM3 28.027 1313 1.7e-97 350.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g6540.t1 Q5RI75 46.305 203 1.17e-51 188.0 sp|Q5RI75|RASEF_MOUSE Ras and EF-hand domain-containing protein homolog OS=Mus musculus OX=10090 GN=Rasef PE=1 SV=1 RASEF_MOUSE reviewed Ras and EF-hand domain-containing protein (EC 3.6.5.2) (Ras-related protein Rab-45) Mus musculus (Mouse) GO:0003924; GO:0005525; GO:0005769; GO:0005794; GO:0005829; GO:0016192; GO:0019003; GO:0036019; GO:0042802; GO:0048471; GO:0070625 vesicle-mediated transport [GO:0016192]; zymogen granule exocytosis [GO:0070625] cytosol [GO:0005829]; early endosome [GO:0005769]; endolysosome [GO:0036019]; Golgi apparatus [GO:0005794]; perinuclear region of cytoplasm [GO:0048471] GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802] g6542.t1 Q13426 30.592 304 5.1099999999999996e-23 101.0 sp|Q13426|XRCC4_HUMAN DNA repair protein XRCC4 OS=Homo sapiens OX=9606 GN=XRCC4 PE=1 SV=2 g6544.t1 P82251 42.123 292 1.59e-69 226.0 sp|P82251|BAT1_HUMAN b(0,+)-type amino acid transporter 1 OS=Homo sapiens OX=9606 GN=SLC7A9 PE=1 SV=1 BAT1_HUMAN reviewed b(0,+)-type amino acid transporter 1 (b(0,+)AT1) (Glycoprotein-associated amino acid transporter b0,+AT1) (Solute carrier family 7 member 9) Homo sapiens (Human) GO:0003333; GO:0005886; GO:0015175; GO:0015184; GO:0015297; GO:0015804; GO:0015811; GO:0016324; GO:0031526; GO:0042605; GO:0046982; GO:0065003; GO:0180009 amino acid transmembrane transport [GO:0003333]; L-cystine transport [GO:0015811]; neutral amino acid transport [GO:0015804]; protein-containing complex assembly [GO:0065003] apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; plasma membrane [GO:0005886] antiporter activity [GO:0015297]; broad specificity neutral L-amino acid:basic L-amino acid antiporter activity [GO:0180009]; L-cystine transmembrane transporter activity [GO:0015184]; neutral L-amino acid transmembrane transporter activity [GO:0015175]; peptide antigen binding [GO:0042605]; protein heterodimerization activity [GO:0046982] g6545.t1 Q9UKF6 42.188 128 1.52e-30 118.0 sp|Q9UKF6|CPSF3_HUMAN Cleavage and polyadenylation specificity factor subunit 3 OS=Homo sapiens OX=9606 GN=CPSF3 PE=1 SV=1 CPSF3_HUMAN reviewed Cleavage and polyadenylation specificity factor subunit 3 (EC 3.1.27.-) (Cleavage and polyadenylation specificity factor 73 kDa subunit) (CPSF 73 kDa subunit) (mRNA 3'-end-processing endonuclease CPSF-73) Homo sapiens (Human) GO:0003723; GO:0004521; GO:0004534; GO:0005654; GO:0005847; GO:0006398; GO:0031124; GO:0046872; GO:0180010; GO:1900087; GO:1990904 co-transcriptional mRNA 3'-end processing, cleavage and polyadenylation pathway [GO:0180010]; mRNA 3'-end processing [GO:0031124]; mRNA 3'-end processing by stem-loop binding and cleavage [GO:0006398]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087] mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; nucleoplasm [GO:0005654]; ribonucleoprotein complex [GO:1990904] 5'-3' RNA exonuclease activity [GO:0004534]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; RNA endonuclease activity [GO:0004521] g6547.t1 Q9UKF6 70.175 684 0.0 1043.0 sp|Q9UKF6|CPSF3_HUMAN Cleavage and polyadenylation specificity factor subunit 3 OS=Homo sapiens OX=9606 GN=CPSF3 PE=1 SV=1 CPSF3_HUMAN reviewed Cleavage and polyadenylation specificity factor subunit 3 (EC 3.1.27.-) (Cleavage and polyadenylation specificity factor 73 kDa subunit) (CPSF 73 kDa subunit) (mRNA 3'-end-processing endonuclease CPSF-73) Homo sapiens (Human) GO:0003723; GO:0004521; GO:0004534; GO:0005654; GO:0005847; GO:0006398; GO:0031124; GO:0046872; GO:0180010; GO:1900087; GO:1990904 co-transcriptional mRNA 3'-end processing, cleavage and polyadenylation pathway [GO:0180010]; mRNA 3'-end processing [GO:0031124]; mRNA 3'-end processing by stem-loop binding and cleavage [GO:0006398]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087] mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; nucleoplasm [GO:0005654]; ribonucleoprotein complex [GO:1990904] 5'-3' RNA exonuclease activity [GO:0004534]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; RNA endonuclease activity [GO:0004521] g6548.t1 Q32P28 34.783 230 3.4e-33 139.0 sp|Q32P28|P3H1_HUMAN Prolyl 3-hydroxylase 1 OS=Homo sapiens OX=9606 GN=P3H1 PE=1 SV=2 P3H1_HUMAN reviewed Prolyl 3-hydroxylase 1 (EC 1.14.11.7) (Growth suppressor 1) (Leucine- and proline-enriched proteoglycan 1) (Leprecan-1) Homo sapiens (Human) GO:0005506; GO:0005634; GO:0005737; GO:0005783; GO:0005788; GO:0006457; GO:0008285; GO:0010976; GO:0016020; GO:0018126; GO:0019797; GO:0030199; GO:0030278; GO:0030308; GO:0031418; GO:0032963; GO:0032991; GO:0050708; GO:0050821; GO:0060348; GO:0070062; GO:1901874 bone development [GO:0060348]; collagen fibril organization [GO:0030199]; collagen metabolic process [GO:0032963]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of post-translational protein modification [GO:1901874]; positive regulation of neuron projection development [GO:0010976]; protein folding [GO:0006457]; protein hydroxylation [GO:0018126]; protein stabilization [GO:0050821]; regulation of ossification [GO:0030278]; regulation of protein secretion [GO:0050708] cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleus [GO:0005634]; protein-containing complex [GO:0032991] iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; procollagen-proline 3-dioxygenase activity [GO:0019797] g6549.t1 Q64375 32.231 363 4.92e-54 189.0 sp|Q64375|SC65_RAT Endoplasmic reticulum protein SC65 OS=Rattus norvegicus OX=10116 GN=P3h4 PE=2 SV=3 g6550.t1 A3KQS4 53.571 308 4.13e-111 340.0 sp|A3KQS4|MINY1_DANRE Ubiquitin carboxyl-terminal hydrolase MINDY-1 OS=Danio rerio OX=7955 GN=mindy1 PE=3 SV=1 g6551.t1 Q8K2W6 78.462 65 3.09e-33 122.0 sp|Q8K2W6|PHF13_MOUSE PHD finger protein 13 OS=Mus musculus OX=10090 GN=Phf13 PE=2 SV=2 g6553.t1 Q9C0H5 56.098 410 8.65e-166 514.0 sp|Q9C0H5|RHG39_HUMAN Rho GTPase-activating protein 39 OS=Homo sapiens OX=9606 GN=ARHGAP39 PE=1 SV=2 g6553.t2 Q9C0H5 56.098 410 8.389999999999999e-165 512.0 sp|Q9C0H5|RHG39_HUMAN Rho GTPase-activating protein 39 OS=Homo sapiens OX=9606 GN=ARHGAP39 PE=1 SV=2 g6554.t1 Q9C0H5 67.045 88 5.88e-35 139.0 sp|Q9C0H5|RHG39_HUMAN Rho GTPase-activating protein 39 OS=Homo sapiens OX=9606 GN=ARHGAP39 PE=1 SV=2 g6556.t1 Q8AVY8 47.386 306 6.82e-80 248.0 sp|Q8AVY8|DH12B_XENLA Very-long-chain 3-oxoacyl-CoA reductase-B OS=Xenopus laevis OX=8355 GN=hsd17b12-b PE=2 SV=1 g6557.t1 Q3SXM5 50.47 319 6.520000000000001e-103 308.0 sp|Q3SXM5|HSDL1_HUMAN Inactive hydroxysteroid dehydrogenase-like protein 1 OS=Homo sapiens OX=9606 GN=HSDL1 PE=1 SV=3 HSDL1_HUMAN reviewed Inactive hydroxysteroid dehydrogenase-like protein 1 (Short chain dehydrogenase/reductase family 12C member 3) Homo sapiens (Human) GO:0005739; GO:0045111 intermediate filament cytoskeleton [GO:0045111]; mitochondrion [GO:0005739] g6558.t1 Q504Y0 30.03 656 8.260000000000001e-79 268.0 sp|Q504Y0|S39AC_HUMAN Zinc transporter ZIP12 OS=Homo sapiens OX=9606 GN=SLC39A12 PE=1 SV=3 S39AC_HUMAN reviewed Zinc transporter ZIP12 (LIV-1 subfamily of ZIP zinc transporter 8) (LZT-Hs8) (Solute carrier family 39 member 12) (Zrt- and Irt-like protein 12) (ZIP-12) Homo sapiens (Human) GO:0001841; GO:0005385; GO:0005886; GO:0007165; GO:0010975; GO:0030003; GO:0031113; GO:0048471; GO:0071578; GO:0140410; GO:1903561; GO:1990138 intracellular monoatomic cation homeostasis [GO:0030003]; neural tube formation [GO:0001841]; neuron projection extension [GO:1990138]; regulation of microtubule polymerization [GO:0031113]; regulation of neuron projection development [GO:0010975]; signal transduction [GO:0007165]; zinc ion import across plasma membrane [GO:0071578] extracellular vesicle [GO:1903561]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886] monoatomic cation:bicarbonate symporter activity [GO:0140410]; zinc ion transmembrane transporter activity [GO:0005385] g6559.t1 O74423 32.164 171 5.71e-21 93.2 sp|O74423|ENT1_SCHPO Epsin-1 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) OX=284812 GN=ent1 PE=1 SV=2 g6560.t1 Q5RD73 52.299 174 2.9499999999999998e-62 194.0 sp|Q5RD73|DUS3_PONAB Dual specificity protein phosphatase 3 OS=Pongo abelii OX=9601 GN=DUSP3 PE=2 SV=1 DUS3_PONAB reviewed Dual specificity protein phosphatase 3 (EC 3.1.3.16) (EC 3.1.3.48) (Vaccinia H1-related phosphatase) (VHR) Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0004722; GO:0004725; GO:0005634; GO:0005829; GO:0008138; GO:0016311; GO:0016791; GO:0033549; GO:0045931; GO:0046329; GO:0050860; GO:0050868; GO:0051893; GO:0070373; GO:0071364 cellular response to epidermal growth factor stimulus [GO:0071364]; dephosphorylation [GO:0016311]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of JNK cascade [GO:0046329]; negative regulation of T cell activation [GO:0050868]; negative regulation of T cell receptor signaling pathway [GO:0050860]; positive regulation of mitotic cell cycle [GO:0045931]; regulation of focal adhesion assembly [GO:0051893] cytosol [GO:0005829]; nucleus [GO:0005634] MAP kinase phosphatase activity [GO:0033549]; phosphatase activity [GO:0016791]; protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138] g6561.t1 P46871 74.834 751 0.0 1016.0 sp|P46871|KRP95_STRPU Kinesin-II 95 kDa subunit OS=Strongylocentrotus purpuratus OX=7668 GN=KRP95 PE=1 SV=1 g6576.t1 Q08509 37.091 275 7.98e-40 155.0 sp|Q08509|EPS8_MOUSE Epidermal growth factor receptor kinase substrate 8 OS=Mus musculus OX=10090 GN=Eps8 PE=1 SV=2 EPS8_MOUSE reviewed Epidermal growth factor receptor kinase substrate 8 Mus musculus (Mouse) GO:0003779; GO:0005829; GO:0005886; GO:0005903; GO:0005938; GO:0007266; GO:0008344; GO:0008360; GO:0010458; GO:0014069; GO:0016601; GO:0017146; GO:0030036; GO:0030426; GO:0030832; GO:0031267; GO:0032420; GO:0032421; GO:0032426; GO:0032587; GO:0035023; GO:0036336; GO:0045202; GO:0048149; GO:0051016; GO:0051017; GO:0051764; GO:0070358; GO:0098978; GO:0099072; GO:1900029; GO:1990830 actin crosslink formation [GO:0051764]; actin cytoskeleton organization [GO:0030036]; actin filament bundle assembly [GO:0051017]; actin polymerization-dependent cell motility [GO:0070358]; adult locomotory behavior [GO:0008344]; barbed-end actin filament capping [GO:0051016]; behavioral response to ethanol [GO:0048149]; cellular response to leukemia inhibitory factor [GO:1990830]; dendritic cell migration [GO:0036336]; exit from mitosis [GO:0010458]; positive regulation of ruffle assembly [GO:1900029]; Rac protein signal transduction [GO:0016601]; regulation of actin filament length [GO:0030832]; regulation of cell shape [GO:0008360]; regulation of postsynaptic membrane neurotransmitter receptor levels [GO:0099072]; regulation of Rho protein signal transduction [GO:0035023]; Rho protein signal transduction [GO:0007266] brush border [GO:0005903]; cell cortex [GO:0005938]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; NMDA selective glutamate receptor complex [GO:0017146]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; ruffle membrane [GO:0032587]; stereocilium [GO:0032420]; stereocilium bundle [GO:0032421]; stereocilium tip [GO:0032426]; synapse [GO:0045202] actin binding [GO:0003779]; small GTPase binding [GO:0031267] g6577.t1 Q9H6S3 37.615 218 2.26e-35 136.0 sp|Q9H6S3|ES8L2_HUMAN Epidermal growth factor receptor kinase substrate 8-like protein 2 OS=Homo sapiens OX=9606 GN=EPS8L2 PE=1 SV=2 g6578.t1 Q12929 51.304 115 1.32e-25 107.0 sp|Q12929|EPS8_HUMAN Epidermal growth factor receptor kinase substrate 8 OS=Homo sapiens OX=9606 GN=EPS8 PE=1 SV=1 EPS8_HUMAN reviewed Epidermal growth factor receptor kinase substrate 8 Homo sapiens (Human) GO:0003779; GO:0005886; GO:0005903; GO:0005938; GO:0007266; GO:0008344; GO:0008360; GO:0010458; GO:0014069; GO:0016601; GO:0017146; GO:0030426; GO:0030832; GO:0031267; GO:0031982; GO:0032420; GO:0032426; GO:0032587; GO:0035023; GO:0036336; GO:0048149; GO:0051016; GO:0051017; GO:0051764; GO:0070062; GO:0070358; GO:0098978; GO:0099072; GO:1900029; GO:1990830 actin crosslink formation [GO:0051764]; actin filament bundle assembly [GO:0051017]; actin polymerization-dependent cell motility [GO:0070358]; adult locomotory behavior [GO:0008344]; barbed-end actin filament capping [GO:0051016]; behavioral response to ethanol [GO:0048149]; cellular response to leukemia inhibitory factor [GO:1990830]; dendritic cell migration [GO:0036336]; exit from mitosis [GO:0010458]; positive regulation of ruffle assembly [GO:1900029]; Rac protein signal transduction [GO:0016601]; regulation of actin filament length [GO:0030832]; regulation of cell shape [GO:0008360]; regulation of postsynaptic membrane neurotransmitter receptor levels [GO:0099072]; regulation of Rho protein signal transduction [GO:0035023]; Rho protein signal transduction [GO:0007266] brush border [GO:0005903]; cell cortex [GO:0005938]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; NMDA selective glutamate receptor complex [GO:0017146]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; ruffle membrane [GO:0032587]; stereocilium [GO:0032420]; stereocilium tip [GO:0032426]; vesicle [GO:0031982] actin binding [GO:0003779]; small GTPase binding [GO:0031267] g6585.t1 P46023 30.435 506 1.85e-55 206.0 sp|P46023|GR101_LYMST G-protein coupled receptor GRL101 OS=Lymnaea stagnalis OX=6523 PE=2 SV=1 g6587.t1 O96530 47.568 185 5.92e-41 160.0 sp|O96530|HYAL_LYTVA Hyalin (Fragment) OS=Lytechinus variegatus OX=7654 PE=2 SV=1 g6587.t1 O96530 46.237 186 3.96e-39 154.0 sp|O96530|HYAL_LYTVA Hyalin (Fragment) OS=Lytechinus variegatus OX=7654 PE=2 SV=1 g6587.t1 O96530 45.355 183 6.89e-36 145.0 sp|O96530|HYAL_LYTVA Hyalin (Fragment) OS=Lytechinus variegatus OX=7654 PE=2 SV=1 g6587.t1 O96530 46.386 166 3.48e-31 131.0 sp|O96530|HYAL_LYTVA Hyalin (Fragment) OS=Lytechinus variegatus OX=7654 PE=2 SV=1 g6590.t1 Q08E66 32.636 239 5.61e-29 127.0 sp|Q08E66|WFKN2_BOVIN WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2 OS=Bos taurus OX=9913 GN=WFIKKN2 PE=2 SV=1 g6594.t1 Q91YN5 49.023 512 7.859999999999999e-172 496.0 sp|Q91YN5|UAP1_MOUSE UDP-N-acetylhexosamine pyrophosphorylase OS=Mus musculus OX=10090 GN=Uap1 PE=1 SV=1 UAP1_MOUSE reviewed UDP-N-acetylhexosamine pyrophosphorylase (Protein-pyrophosphorylation enzyme) (EC 2.7.4.-) (UDP-N-acetylgalactosamine pyrophosphorylase) (EC 2.7.7.83) (UDP-N-acetylglucosamine pyrophosphorylase) (EC 2.7.7.23) Mus musculus (Mouse) GO:0003977; GO:0005654; GO:0005829; GO:0005886; GO:0006047; GO:0006048; GO:0030246; GO:0032481; GO:0042802; GO:0052630; GO:0140374; GO:0141090 antiviral innate immune response [GO:0140374]; positive regulation of type I interferon production [GO:0032481]; UDP-N-acetylglucosamine biosynthetic process [GO:0006048]; UDP-N-acetylglucosamine metabolic process [GO:0006047] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] carbohydrate binding [GO:0030246]; identical protein binding [GO:0042802]; protein serine pyrophosphorylase activity [GO:0141090]; UDP-N-acetylgalactosamine diphosphorylase activity [GO:0052630]; UDP-N-acetylglucosamine diphosphorylase activity [GO:0003977] g6596.t1 Q8CF97 44.811 1031 0.0 862.0 sp|Q8CF97|VCIP1_RAT Deubiquitinating protein VCPIP1 OS=Rattus norvegicus OX=10116 GN=Vcpip1 PE=1 SV=2 VCIP1_RAT reviewed Deubiquitinating protein VCPIP1 (EC 3.4.19.12) (Valosin-containing protein p97/p47 complex-interacting protein 1) (Valosin-containing protein p97/p47 complex-interacting protein p135) (VCP/p47 complex-interacting 135-kDa protein) Rattus norvegicus (Rat) GO:0004843; GO:0005634; GO:0005737; GO:0005783; GO:0005795; GO:0006508; GO:0006974; GO:0007030; GO:0016320; GO:0016567; GO:0016579; GO:0035871; GO:0045202; GO:0071108; GO:0090168; GO:0106300; GO:1905634 DNA damage response [GO:0006974]; endoplasmic reticulum membrane fusion [GO:0016320]; Golgi organization [GO:0007030]; Golgi reassembly [GO:0090168]; protein deubiquitination [GO:0016579]; protein K11-linked deubiquitination [GO:0035871]; protein K48-linked deubiquitination [GO:0071108]; protein ubiquitination [GO:0016567]; protein-DNA covalent cross-linking repair [GO:0106300]; proteolysis [GO:0006508]; regulation of protein localization to chromatin [GO:1905634] cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; Golgi stack [GO:0005795]; nucleus [GO:0005634]; synapse [GO:0045202] cysteine-type deubiquitinase activity [GO:0004843] g6598.t1 Q6N075 49.773 440 7.699999999999999e-137 404.0 sp|Q6N075|MFSD5_HUMAN Molybdate-anion transporter OS=Homo sapiens OX=9606 GN=MFSD5 PE=1 SV=2 MFSD5_HUMAN reviewed Solute carrier family 61 member 1 (Major facilitator superfamily domain-containing protein 5) (Molybdate transporter 2 homolog) (hsMOT2) (Molybdate-anion transporter) Homo sapiens (Human) GO:0005886; GO:0006811; GO:0015098; GO:0015689; GO:0016020; GO:0032094; GO:0042594 molybdate ion transport [GO:0015689]; monoatomic ion transport [GO:0006811]; response to food [GO:0032094]; response to starvation [GO:0042594] membrane [GO:0016020]; plasma membrane [GO:0005886] molybdate ion transmembrane transporter activity [GO:0015098] g6599.t1 P61314 81.373 204 1.7900000000000002e-110 317.0 sp|P61314|RL15_RAT Large ribosomal subunit protein eL15 OS=Rattus norvegicus OX=10116 GN=Rpl15 PE=1 SV=2 g6604.t1 Q9EPK2 46.951 328 8.040000000000001e-110 325.0 sp|Q9EPK2|XRP2_MOUSE Protein XRP2 OS=Mus musculus OX=10090 GN=Rp2 PE=1 SV=3 XRP2_MOUSE reviewed Protein XRP2 Mus musculus (Mouse) GO:0000287; GO:0005096; GO:0005525; GO:0005654; GO:0005737; GO:0005794; GO:0005814; GO:0005829; GO:0005886; GO:0005929; GO:0006892; GO:0015031; GO:0016604; GO:0031410; GO:0036064; GO:1990075 post-Golgi vesicle-mediated transport [GO:0006892]; protein transport [GO:0015031] centriole [GO:0005814]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; periciliary membrane compartment [GO:1990075]; plasma membrane [GO:0005886] GTP binding [GO:0005525]; GTPase activator activity [GO:0005096]; magnesium ion binding [GO:0000287] g6605.t1 Q8NCJ5 47.059 408 1.33e-103 318.0 sp|Q8NCJ5|SPRY3_HUMAN SPRY domain-containing protein 3 OS=Homo sapiens OX=9606 GN=SPRYD3 PE=1 SV=2 g6606.t1 P23358 77.301 163 4.95e-93 270.0 sp|P23358|RL12_RAT Large ribosomal subunit protein uL11 OS=Rattus norvegicus OX=10116 GN=Rpl12 PE=2 SV=1 g6607.t1 Q5ZK10 42.298 409 7.11e-85 266.0 sp|Q5ZK10|NSF1C_CHICK NSFL1 cofactor p47 OS=Gallus gallus OX=9031 GN=NSFL1C PE=2 SV=1 NSF1C_CHICK reviewed NSFL1 cofactor p47 (p97 cofactor p47) Gallus gallus (Chicken) GO:0000045; GO:0000132; GO:0005634; GO:0005795; GO:0005813; GO:0005829; GO:0007030; GO:0008289; GO:0031468; GO:0043130; GO:0043161; GO:0046604; GO:0061025; GO:1904780; GO:1990730 autophagosome assembly [GO:0000045]; establishment of mitotic spindle orientation [GO:0000132]; Golgi organization [GO:0007030]; membrane fusion [GO:0061025]; negative regulation of protein localization to centrosome [GO:1904780]; nuclear membrane reassembly [GO:0031468]; positive regulation of mitotic centrosome separation [GO:0046604]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161] centrosome [GO:0005813]; cytosol [GO:0005829]; Golgi stack [GO:0005795]; nucleus [GO:0005634]; VCP-NSFL1C complex [GO:1990730] lipid binding [GO:0008289]; ubiquitin binding [GO:0043130] g6608.t1 O70511 30.351 313 4.61e-30 128.0 sp|O70511|ANK3_RAT Ankyrin-3 OS=Rattus norvegicus OX=10116 GN=Ank3 PE=1 SV=3 ANK3_RAT reviewed Ankyrin-3 (ANK-3) (Ankyrin-G) Rattus norvegicus (Rat) GO:0000281; GO:0005200; GO:0005634; GO:0005764; GO:0005856; GO:0005886; GO:0005923; GO:0006357; GO:0007009; GO:0007165; GO:0007409; GO:0007411; GO:0007528; GO:0008089; GO:0008092; GO:0009925; GO:0009986; GO:0010628; GO:0010650; GO:0010765; GO:0010960; GO:0014069; GO:0014704; GO:0014731; GO:0016020; GO:0016323; GO:0016328; GO:0016529; GO:0017080; GO:0019228; GO:0030018; GO:0030315; GO:0030424; GO:0030425; GO:0030507; GO:0030674; GO:0030951; GO:0031594; GO:0032507; GO:0033268; GO:0033270; GO:0034112; GO:0035902; GO:0042383; GO:0043001; GO:0043005; GO:0043034; GO:0043194; GO:0043266; GO:0044325; GO:0045162; GO:0045184; GO:0045202; GO:0045211; GO:0045296; GO:0045806; GO:0045838; GO:0050808; GO:0061564; GO:0061629; GO:0071286; GO:0071709; GO:0072659; GO:0072660; GO:0090314; GO:0098794; GO:0098978; GO:0099103; GO:0099159; GO:0099612; GO:0140031; GO:1900827; GO:1901224; GO:1902260; GO:1903533; GO:1903784; GO:1904115 anterograde axonal transport [GO:0008089]; axon development [GO:0061564]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; cellular response to magnesium ion [GO:0071286]; clustering of voltage-gated sodium channels [GO:0045162]; establishment of protein localization [GO:0045184]; establishment or maintenance of microtubule cytoskeleton polarity [GO:0030951]; Golgi to plasma membrane protein transport [GO:0043001]; magnesium ion homeostasis [GO:0010960]; maintenance of protein location in cell [GO:0032507]; maintenance of protein location in plasma membrane [GO:0072660]; membrane assembly [GO:0071709]; mitotic cytokinesis [GO:0000281]; negative regulation of delayed rectifier potassium channel activity [GO:1902260]; negative regulation of endocytosis [GO:0045806]; neuromuscular junction development [GO:0007528]; neuronal action potential [GO:0019228]; plasma membrane organization [GO:0007009]; positive regulation of cell communication by electrical coupling [GO:0010650]; positive regulation of gene expression [GO:0010628]; positive regulation of homotypic cell-cell adhesion [GO:0034112]; positive regulation of membrane depolarization during cardiac muscle cell action potential [GO:1900827]; positive regulation of membrane potential [GO:0045838]; positive regulation of non-canonical NF-kappaB signal transduction [GO:1901224]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of sodium ion import across plasma membrane [GO:1903784]; positive regulation of sodium ion transport [GO:0010765]; protein localization to axon [GO:0099612]; protein localization to plasma membrane [GO:0072659]; regulation of modification of postsynaptic structure [GO:0099159]; regulation of potassium ion transport [GO:0043266]; regulation of protein targeting [GO:1903533]; regulation of transcription by RNA polymerase II [GO:0006357]; response to immobilization stress [GO:0035902]; signal transduction [GO:0007165]; synapse organization [GO:0050808] axon [GO:0030424]; axon cytoplasm [GO:1904115]; axon initial segment [GO:0043194]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; bicellular tight junction [GO:0005923]; cell surface [GO:0009986]; costamere [GO:0043034]; cytoskeleton [GO:0005856]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; intercalated disc [GO:0014704]; lateral plasma membrane [GO:0016328]; lysosome [GO:0005764]; membrane [GO:0016020]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; node of Ranvier [GO:0033268]; nucleus [GO:0005634]; paranode region of axon [GO:0033270]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; sarcoplasmic reticulum [GO:0016529]; spectrin-associated cytoskeleton [GO:0014731]; synapse [GO:0045202]; T-tubule [GO:0030315]; Z disc [GO:0030018] cadherin binding [GO:0045296]; channel activator activity [GO:0099103]; cytoskeletal protein binding [GO:0008092]; phosphorylation-dependent protein binding [GO:0140031]; protein-macromolecule adaptor activity [GO:0030674]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sodium channel regulator activity [GO:0017080]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]; transmembrane transporter binding [GO:0044325] g6608.t1 O70511 25.496 353 9.969999999999999e-23 106.0 sp|O70511|ANK3_RAT Ankyrin-3 OS=Rattus norvegicus OX=10116 GN=Ank3 PE=1 SV=3 ANK3_RAT reviewed Ankyrin-3 (ANK-3) (Ankyrin-G) Rattus norvegicus (Rat) GO:0000281; GO:0005200; GO:0005634; GO:0005764; GO:0005856; GO:0005886; GO:0005923; GO:0006357; GO:0007009; GO:0007165; GO:0007409; GO:0007411; GO:0007528; GO:0008089; GO:0008092; GO:0009925; GO:0009986; GO:0010628; GO:0010650; GO:0010765; GO:0010960; GO:0014069; GO:0014704; GO:0014731; GO:0016020; GO:0016323; GO:0016328; GO:0016529; GO:0017080; GO:0019228; GO:0030018; GO:0030315; GO:0030424; GO:0030425; GO:0030507; GO:0030674; GO:0030951; GO:0031594; GO:0032507; GO:0033268; GO:0033270; GO:0034112; GO:0035902; GO:0042383; GO:0043001; GO:0043005; GO:0043034; GO:0043194; GO:0043266; GO:0044325; GO:0045162; GO:0045184; GO:0045202; GO:0045211; GO:0045296; GO:0045806; GO:0045838; GO:0050808; GO:0061564; GO:0061629; GO:0071286; GO:0071709; GO:0072659; GO:0072660; GO:0090314; GO:0098794; GO:0098978; GO:0099103; GO:0099159; GO:0099612; GO:0140031; GO:1900827; GO:1901224; GO:1902260; GO:1903533; GO:1903784; GO:1904115 anterograde axonal transport [GO:0008089]; axon development [GO:0061564]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; cellular response to magnesium ion [GO:0071286]; clustering of voltage-gated sodium channels [GO:0045162]; establishment of protein localization [GO:0045184]; establishment or maintenance of microtubule cytoskeleton polarity [GO:0030951]; Golgi to plasma membrane protein transport [GO:0043001]; magnesium ion homeostasis [GO:0010960]; maintenance of protein location in cell [GO:0032507]; maintenance of protein location in plasma membrane [GO:0072660]; membrane assembly [GO:0071709]; mitotic cytokinesis [GO:0000281]; negative regulation of delayed rectifier potassium channel activity [GO:1902260]; negative regulation of endocytosis [GO:0045806]; neuromuscular junction development [GO:0007528]; neuronal action potential [GO:0019228]; plasma membrane organization [GO:0007009]; positive regulation of cell communication by electrical coupling [GO:0010650]; positive regulation of gene expression [GO:0010628]; positive regulation of homotypic cell-cell adhesion [GO:0034112]; positive regulation of membrane depolarization during cardiac muscle cell action potential [GO:1900827]; positive regulation of membrane potential [GO:0045838]; positive regulation of non-canonical NF-kappaB signal transduction [GO:1901224]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of sodium ion import across plasma membrane [GO:1903784]; positive regulation of sodium ion transport [GO:0010765]; protein localization to axon [GO:0099612]; protein localization to plasma membrane [GO:0072659]; regulation of modification of postsynaptic structure [GO:0099159]; regulation of potassium ion transport [GO:0043266]; regulation of protein targeting [GO:1903533]; regulation of transcription by RNA polymerase II [GO:0006357]; response to immobilization stress [GO:0035902]; signal transduction [GO:0007165]; synapse organization [GO:0050808] axon [GO:0030424]; axon cytoplasm [GO:1904115]; axon initial segment [GO:0043194]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; bicellular tight junction [GO:0005923]; cell surface [GO:0009986]; costamere [GO:0043034]; cytoskeleton [GO:0005856]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; intercalated disc [GO:0014704]; lateral plasma membrane [GO:0016328]; lysosome [GO:0005764]; membrane [GO:0016020]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; node of Ranvier [GO:0033268]; nucleus [GO:0005634]; paranode region of axon [GO:0033270]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; sarcoplasmic reticulum [GO:0016529]; spectrin-associated cytoskeleton [GO:0014731]; synapse [GO:0045202]; T-tubule [GO:0030315]; Z disc [GO:0030018] cadherin binding [GO:0045296]; channel activator activity [GO:0099103]; cytoskeletal protein binding [GO:0008092]; phosphorylation-dependent protein binding [GO:0140031]; protein-macromolecule adaptor activity [GO:0030674]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sodium channel regulator activity [GO:0017080]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]; transmembrane transporter binding [GO:0044325] g6608.t1 O70511 28.07 285 4.22e-22 104.0 sp|O70511|ANK3_RAT Ankyrin-3 OS=Rattus norvegicus OX=10116 GN=Ank3 PE=1 SV=3 ANK3_RAT reviewed Ankyrin-3 (ANK-3) (Ankyrin-G) Rattus norvegicus (Rat) GO:0000281; GO:0005200; GO:0005634; GO:0005764; GO:0005856; GO:0005886; GO:0005923; GO:0006357; GO:0007009; GO:0007165; GO:0007409; GO:0007411; GO:0007528; GO:0008089; GO:0008092; GO:0009925; GO:0009986; GO:0010628; GO:0010650; GO:0010765; GO:0010960; GO:0014069; GO:0014704; GO:0014731; GO:0016020; GO:0016323; GO:0016328; GO:0016529; GO:0017080; GO:0019228; GO:0030018; GO:0030315; GO:0030424; GO:0030425; GO:0030507; GO:0030674; GO:0030951; GO:0031594; GO:0032507; GO:0033268; GO:0033270; GO:0034112; GO:0035902; GO:0042383; GO:0043001; GO:0043005; GO:0043034; GO:0043194; GO:0043266; GO:0044325; GO:0045162; GO:0045184; GO:0045202; GO:0045211; GO:0045296; GO:0045806; GO:0045838; GO:0050808; GO:0061564; GO:0061629; GO:0071286; GO:0071709; GO:0072659; GO:0072660; GO:0090314; GO:0098794; GO:0098978; GO:0099103; GO:0099159; GO:0099612; GO:0140031; GO:1900827; GO:1901224; GO:1902260; GO:1903533; GO:1903784; GO:1904115 anterograde axonal transport [GO:0008089]; axon development [GO:0061564]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; cellular response to magnesium ion [GO:0071286]; clustering of voltage-gated sodium channels [GO:0045162]; establishment of protein localization [GO:0045184]; establishment or maintenance of microtubule cytoskeleton polarity [GO:0030951]; Golgi to plasma membrane protein transport [GO:0043001]; magnesium ion homeostasis [GO:0010960]; maintenance of protein location in cell [GO:0032507]; maintenance of protein location in plasma membrane [GO:0072660]; membrane assembly [GO:0071709]; mitotic cytokinesis [GO:0000281]; negative regulation of delayed rectifier potassium channel activity [GO:1902260]; negative regulation of endocytosis [GO:0045806]; neuromuscular junction development [GO:0007528]; neuronal action potential [GO:0019228]; plasma membrane organization [GO:0007009]; positive regulation of cell communication by electrical coupling [GO:0010650]; positive regulation of gene expression [GO:0010628]; positive regulation of homotypic cell-cell adhesion [GO:0034112]; positive regulation of membrane depolarization during cardiac muscle cell action potential [GO:1900827]; positive regulation of membrane potential [GO:0045838]; positive regulation of non-canonical NF-kappaB signal transduction [GO:1901224]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of sodium ion import across plasma membrane [GO:1903784]; positive regulation of sodium ion transport [GO:0010765]; protein localization to axon [GO:0099612]; protein localization to plasma membrane [GO:0072659]; regulation of modification of postsynaptic structure [GO:0099159]; regulation of potassium ion transport [GO:0043266]; regulation of protein targeting [GO:1903533]; regulation of transcription by RNA polymerase II [GO:0006357]; response to immobilization stress [GO:0035902]; signal transduction [GO:0007165]; synapse organization [GO:0050808] axon [GO:0030424]; axon cytoplasm [GO:1904115]; axon initial segment [GO:0043194]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; bicellular tight junction [GO:0005923]; cell surface [GO:0009986]; costamere [GO:0043034]; cytoskeleton [GO:0005856]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; intercalated disc [GO:0014704]; lateral plasma membrane [GO:0016328]; lysosome [GO:0005764]; membrane [GO:0016020]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; node of Ranvier [GO:0033268]; nucleus [GO:0005634]; paranode region of axon [GO:0033270]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; sarcoplasmic reticulum [GO:0016529]; spectrin-associated cytoskeleton [GO:0014731]; synapse [GO:0045202]; T-tubule [GO:0030315]; Z disc [GO:0030018] cadherin binding [GO:0045296]; channel activator activity [GO:0099103]; cytoskeletal protein binding [GO:0008092]; phosphorylation-dependent protein binding [GO:0140031]; protein-macromolecule adaptor activity [GO:0030674]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sodium channel regulator activity [GO:0017080]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]; transmembrane transporter binding [GO:0044325] g6608.t1 O70511 26.014 296 1.73e-21 102.0 sp|O70511|ANK3_RAT Ankyrin-3 OS=Rattus norvegicus OX=10116 GN=Ank3 PE=1 SV=3 ANK3_RAT reviewed Ankyrin-3 (ANK-3) (Ankyrin-G) Rattus norvegicus (Rat) GO:0000281; GO:0005200; GO:0005634; GO:0005764; GO:0005856; GO:0005886; GO:0005923; GO:0006357; GO:0007009; GO:0007165; GO:0007409; GO:0007411; GO:0007528; GO:0008089; GO:0008092; GO:0009925; GO:0009986; GO:0010628; GO:0010650; GO:0010765; GO:0010960; GO:0014069; GO:0014704; GO:0014731; GO:0016020; GO:0016323; GO:0016328; GO:0016529; GO:0017080; GO:0019228; GO:0030018; GO:0030315; GO:0030424; GO:0030425; GO:0030507; GO:0030674; GO:0030951; GO:0031594; GO:0032507; GO:0033268; GO:0033270; GO:0034112; GO:0035902; GO:0042383; GO:0043001; GO:0043005; GO:0043034; GO:0043194; GO:0043266; GO:0044325; GO:0045162; GO:0045184; GO:0045202; GO:0045211; GO:0045296; GO:0045806; GO:0045838; GO:0050808; GO:0061564; GO:0061629; GO:0071286; GO:0071709; GO:0072659; GO:0072660; GO:0090314; GO:0098794; GO:0098978; GO:0099103; GO:0099159; GO:0099612; GO:0140031; GO:1900827; GO:1901224; GO:1902260; GO:1903533; GO:1903784; GO:1904115 anterograde axonal transport [GO:0008089]; axon development [GO:0061564]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; cellular response to magnesium ion [GO:0071286]; clustering of voltage-gated sodium channels [GO:0045162]; establishment of protein localization [GO:0045184]; establishment or maintenance of microtubule cytoskeleton polarity [GO:0030951]; Golgi to plasma membrane protein transport [GO:0043001]; magnesium ion homeostasis [GO:0010960]; maintenance of protein location in cell [GO:0032507]; maintenance of protein location in plasma membrane [GO:0072660]; membrane assembly [GO:0071709]; mitotic cytokinesis [GO:0000281]; negative regulation of delayed rectifier potassium channel activity [GO:1902260]; negative regulation of endocytosis [GO:0045806]; neuromuscular junction development [GO:0007528]; neuronal action potential [GO:0019228]; plasma membrane organization [GO:0007009]; positive regulation of cell communication by electrical coupling [GO:0010650]; positive regulation of gene expression [GO:0010628]; positive regulation of homotypic cell-cell adhesion [GO:0034112]; positive regulation of membrane depolarization during cardiac muscle cell action potential [GO:1900827]; positive regulation of membrane potential [GO:0045838]; positive regulation of non-canonical NF-kappaB signal transduction [GO:1901224]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of sodium ion import across plasma membrane [GO:1903784]; positive regulation of sodium ion transport [GO:0010765]; protein localization to axon [GO:0099612]; protein localization to plasma membrane [GO:0072659]; regulation of modification of postsynaptic structure [GO:0099159]; regulation of potassium ion transport [GO:0043266]; regulation of protein targeting [GO:1903533]; regulation of transcription by RNA polymerase II [GO:0006357]; response to immobilization stress [GO:0035902]; signal transduction [GO:0007165]; synapse organization [GO:0050808] axon [GO:0030424]; axon cytoplasm [GO:1904115]; axon initial segment [GO:0043194]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; bicellular tight junction [GO:0005923]; cell surface [GO:0009986]; costamere [GO:0043034]; cytoskeleton [GO:0005856]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; intercalated disc [GO:0014704]; lateral plasma membrane [GO:0016328]; lysosome [GO:0005764]; membrane [GO:0016020]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; node of Ranvier [GO:0033268]; nucleus [GO:0005634]; paranode region of axon [GO:0033270]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; sarcoplasmic reticulum [GO:0016529]; spectrin-associated cytoskeleton [GO:0014731]; synapse [GO:0045202]; T-tubule [GO:0030315]; Z disc [GO:0030018] cadherin binding [GO:0045296]; channel activator activity [GO:0099103]; cytoskeletal protein binding [GO:0008092]; phosphorylation-dependent protein binding [GO:0140031]; protein-macromolecule adaptor activity [GO:0030674]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sodium channel regulator activity [GO:0017080]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]; transmembrane transporter binding [GO:0044325] g6610.t1 Q9UQB3 46.004 563 6.14e-142 462.0 sp|Q9UQB3|CTND2_HUMAN Catenin delta-2 OS=Homo sapiens OX=9606 GN=CTNND2 PE=1 SV=3 CTND2_HUMAN reviewed Catenin delta-2 (Delta-catenin) (GT24) (Neural plakophilin-related ARM-repeat protein) (NPRAP) (Neurojungin) Homo sapiens (Human) GO:0005634; GO:0005737; GO:0005886; GO:0005912; GO:0007155; GO:0007165; GO:0008013; GO:0014069; GO:0016055; GO:0030425; GO:0043204; GO:0045296; GO:0050808; GO:0060828; GO:0060997; GO:0098609 cell adhesion [GO:0007155]; cell-cell adhesion [GO:0098609]; dendritic spine morphogenesis [GO:0060997]; regulation of canonical Wnt signaling pathway [GO:0060828]; signal transduction [GO:0007165]; synapse organization [GO:0050808]; Wnt signaling pathway [GO:0016055] adherens junction [GO:0005912]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; nucleus [GO:0005634]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069] beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296] g6610.t2 Q9UQB3 48.633 512 1.0700000000000001e-144 470.0 sp|Q9UQB3|CTND2_HUMAN Catenin delta-2 OS=Homo sapiens OX=9606 GN=CTNND2 PE=1 SV=3 CTND2_HUMAN reviewed Catenin delta-2 (Delta-catenin) (GT24) (Neural plakophilin-related ARM-repeat protein) (NPRAP) (Neurojungin) Homo sapiens (Human) GO:0005634; GO:0005737; GO:0005886; GO:0005912; GO:0007155; GO:0007165; GO:0008013; GO:0014069; GO:0016055; GO:0030425; GO:0043204; GO:0045296; GO:0050808; GO:0060828; GO:0060997; GO:0098609 cell adhesion [GO:0007155]; cell-cell adhesion [GO:0098609]; dendritic spine morphogenesis [GO:0060997]; regulation of canonical Wnt signaling pathway [GO:0060828]; signal transduction [GO:0007165]; synapse organization [GO:0050808]; Wnt signaling pathway [GO:0016055] adherens junction [GO:0005912]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; nucleus [GO:0005634]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069] beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296] g6610.t3 Q9UQB3 48.633 512 8.56e-145 470.0 sp|Q9UQB3|CTND2_HUMAN Catenin delta-2 OS=Homo sapiens OX=9606 GN=CTNND2 PE=1 SV=3 CTND2_HUMAN reviewed Catenin delta-2 (Delta-catenin) (GT24) (Neural plakophilin-related ARM-repeat protein) (NPRAP) (Neurojungin) Homo sapiens (Human) GO:0005634; GO:0005737; GO:0005886; GO:0005912; GO:0007155; GO:0007165; GO:0008013; GO:0014069; GO:0016055; GO:0030425; GO:0043204; GO:0045296; GO:0050808; GO:0060828; GO:0060997; GO:0098609 cell adhesion [GO:0007155]; cell-cell adhesion [GO:0098609]; dendritic spine morphogenesis [GO:0060997]; regulation of canonical Wnt signaling pathway [GO:0060828]; signal transduction [GO:0007165]; synapse organization [GO:0050808]; Wnt signaling pathway [GO:0016055] adherens junction [GO:0005912]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; nucleus [GO:0005634]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069] beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296] g6610.t4 Q9UQB3 43.402 629 4.19e-145 470.0 sp|Q9UQB3|CTND2_HUMAN Catenin delta-2 OS=Homo sapiens OX=9606 GN=CTNND2 PE=1 SV=3 CTND2_HUMAN reviewed Catenin delta-2 (Delta-catenin) (GT24) (Neural plakophilin-related ARM-repeat protein) (NPRAP) (Neurojungin) Homo sapiens (Human) GO:0005634; GO:0005737; GO:0005886; GO:0005912; GO:0007155; GO:0007165; GO:0008013; GO:0014069; GO:0016055; GO:0030425; GO:0043204; GO:0045296; GO:0050808; GO:0060828; GO:0060997; GO:0098609 cell adhesion [GO:0007155]; cell-cell adhesion [GO:0098609]; dendritic spine morphogenesis [GO:0060997]; regulation of canonical Wnt signaling pathway [GO:0060828]; signal transduction [GO:0007165]; synapse organization [GO:0050808]; Wnt signaling pathway [GO:0016055] adherens junction [GO:0005912]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; nucleus [GO:0005634]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069] beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296] g6610.t5 Q9UQB3 48.633 512 3.26e-145 469.0 sp|Q9UQB3|CTND2_HUMAN Catenin delta-2 OS=Homo sapiens OX=9606 GN=CTNND2 PE=1 SV=3 CTND2_HUMAN reviewed Catenin delta-2 (Delta-catenin) (GT24) (Neural plakophilin-related ARM-repeat protein) (NPRAP) (Neurojungin) Homo sapiens (Human) GO:0005634; GO:0005737; GO:0005886; GO:0005912; GO:0007155; GO:0007165; GO:0008013; GO:0014069; GO:0016055; GO:0030425; GO:0043204; GO:0045296; GO:0050808; GO:0060828; GO:0060997; GO:0098609 cell adhesion [GO:0007155]; cell-cell adhesion [GO:0098609]; dendritic spine morphogenesis [GO:0060997]; regulation of canonical Wnt signaling pathway [GO:0060828]; signal transduction [GO:0007165]; synapse organization [GO:0050808]; Wnt signaling pathway [GO:0016055] adherens junction [GO:0005912]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; nucleus [GO:0005634]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069] beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296] g6611.t1 Q6DBQ8 38.164 207 7.83e-45 151.0 sp|Q6DBQ8|CPTP_DANRE Ceramide-1-phosphate transfer protein OS=Danio rerio OX=7955 GN=cptp PE=2 SV=1 CPTP_DANRE reviewed Ceramide-1-phosphate transfer protein (Glycolipid transfer protein domain-containing protein 1) (CPTP) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005543; GO:0005640; GO:0005794; GO:0005829; GO:0005886; GO:0010008; GO:0010507; GO:0032691; GO:0035627; GO:0120009; GO:1900226; GO:1902387; GO:1902388; GO:1902389 ceramide 1-phosphate transport [GO:1902389]; ceramide transport [GO:0035627]; intermembrane lipid transfer [GO:0120009]; negative regulation of autophagy [GO:0010507]; negative regulation of interleukin-1 beta production [GO:0032691]; negative regulation of NLRP3 inflammasome complex assembly [GO:1900226] cytosol [GO:0005829]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; nuclear outer membrane [GO:0005640]; plasma membrane [GO:0005886] ceramide 1-phosphate binding [GO:1902387]; ceramide 1-phosphate transfer activity [GO:1902388]; phospholipid binding [GO:0005543] g6624.t1 Q92752 45.982 224 6.22e-51 185.0 sp|Q92752|TENR_HUMAN Tenascin-R OS=Homo sapiens OX=9606 GN=TNR PE=1 SV=3 TENR_HUMAN reviewed Tenascin-R (TN-R) (Janusin) (Restrictin) Homo sapiens (Human) GO:0005576; GO:0005615; GO:0007155; GO:0007158; GO:0007399; GO:0007411; GO:0008306; GO:0009986; GO:0010977; GO:0022029; GO:0022408; GO:0030155; GO:0030198; GO:0030334; GO:0031012; GO:0035249; GO:0035641; GO:0045121; GO:0045595; GO:0048677; GO:0048692; GO:0050805; GO:0050808; GO:0050885; GO:0051968; GO:0051971; GO:0060291; GO:0072534; GO:0090733; GO:0097402; GO:0098685; GO:0098978 associative learning [GO:0008306]; axon extension involved in regeneration [GO:0048677]; axon guidance [GO:0007411]; cell adhesion [GO:0007155]; extracellular matrix organization [GO:0030198]; locomotory exploration behavior [GO:0035641]; long-term synaptic potentiation [GO:0060291]; negative regulation of axon extension involved in regeneration [GO:0048692]; negative regulation of cell-cell adhesion [GO:0022408]; negative regulation of neuron projection development [GO:0010977]; negative regulation of synaptic transmission [GO:0050805]; nervous system development [GO:0007399]; neuroblast migration [GO:0097402]; neuromuscular process controlling balance [GO:0050885]; neuron cell-cell adhesion [GO:0007158]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; positive regulation of transmission of nerve impulse [GO:0051971]; regulation of cell adhesion [GO:0030155]; regulation of cell differentiation [GO:0045595]; regulation of cell migration [GO:0030334]; synapse organization [GO:0050808]; synaptic transmission, glutamatergic [GO:0035249]; telencephalon cell migration [GO:0022029] cell surface [GO:0009986]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; glutamatergic synapse [GO:0098978]; membrane raft [GO:0045121]; perineuronal net [GO:0072534]; Schaffer collateral - CA1 synapse [GO:0098685]; tenascin complex [GO:0090733] g6628.t1 B3EWZ6 36.397 1382 0.0 769.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6628.t1 B3EWZ6 36.892 1377 0.0 765.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6628.t1 B3EWZ6 36.554 1387 0.0 700.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6628.t1 B3EWZ6 35.168 1399 0.0 685.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6628.t1 B3EWZ6 32.65 1366 0.0 625.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6628.t1 B3EWZ6 32.422 1354 2.26e-158 555.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6628.t1 B3EWZ6 30.022 1379 1.0100000000000001e-145 515.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6628.t1 B3EWZ6 30.121 1401 1.7499999999999999e-141 501.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6628.t1 B3EWZ6 28.411 1422 1.36e-125 450.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6628.t1 B3EWZ6 28.392 1275 6.5e-119 428.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6628.t1 B3EWZ6 27.581 1269 1.48e-113 410.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6628.t1 B3EWZ6 25.641 1287 1.58e-85 318.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6628.t1 B3EWZ6 30.0 820 7.459999999999999e-83 310.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6628.t1 B3EWZ6 28.692 826 9.31e-82 306.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6628.t1 B3EWZ6 29.212 825 6.27e-78 293.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6628.t1 B3EWZ6 26.675 821 4.14e-69 265.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6628.t1 B3EWZ6 26.536 814 2.96e-66 255.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6628.t1 B3EWZ6 37.467 379 8.24e-56 221.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6628.t1 B3EWZ6 37.6 375 4.2899999999999996e-54 215.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6628.t1 B3EWZ6 36.923 390 4.57e-52 208.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6628.t1 B3EWZ6 36.341 410 9.17e-47 191.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6628.t1 B3EWZ6 32.779 421 1.28e-46 190.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6628.t1 B3EWZ6 36.667 360 7.51e-45 184.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6628.t1 B3EWZ6 33.995 403 1.8e-44 183.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6628.t1 B3EWZ6 33.713 439 5.629999999999999e-42 175.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6628.t1 B3EWZ6 32.477 428 1.61e-40 170.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6628.t1 B3EWZ6 31.429 385 3.21e-40 169.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6628.t1 B3EWZ6 34.4 375 3.3199999999999997e-40 169.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6628.t1 B3EWZ6 32.84 405 6.49e-40 168.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6628.t1 B3EWZ6 31.863 408 8.35e-40 168.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6628.t1 B3EWZ6 35.088 399 9.31e-40 167.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6628.t1 B3EWZ6 31.316 380 1.0999999999999999e-38 164.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6628.t1 B3EWZ6 34.177 395 2.1500000000000003e-37 160.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6628.t1 B3EWZ6 31.776 428 7.64e-37 158.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6628.t1 B3EWZ6 32.615 371 1.86e-36 157.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6628.t1 B3EWZ6 30.854 363 1.1900000000000001e-35 154.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6628.t1 B3EWZ6 30.829 386 2.29e-34 150.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6628.t1 B3EWZ6 32.061 393 4.08e-34 149.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6628.t1 B3EWZ6 29.33 358 2.34e-33 146.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6628.t1 B3EWZ6 31.053 380 4.97e-33 145.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6628.t1 B3EWZ6 30.585 376 1.6500000000000002e-31 140.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6628.t1 B3EWZ6 29.076 368 5.17e-29 132.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6628.t1 B3EWZ6 28.325 406 3.61e-28 129.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6628.t1 B3EWZ6 28.326 466 1.06e-26 124.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6628.t1 B3EWZ6 29.777 403 1.43e-26 124.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6628.t1 B3EWZ6 28.721 383 1.69e-25 120.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6628.t1 B3EWZ6 28.856 402 3.01e-24 116.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6628.t1 B3EWZ6 29.426 401 6.15e-24 115.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g6629.t1 Q96AY4 23.148 972 1.88e-44 180.0 sp|Q96AY4|TTC28_HUMAN Tetratricopeptide repeat protein 28 OS=Homo sapiens OX=9606 GN=TTC28 PE=1 SV=4 TTC28_HUMAN reviewed Tetratricopeptide repeat protein 28 (TPR repeat protein 28) (TPR repeat-containing big gene cloned at Keio) Homo sapiens (Human) GO:0000922; GO:0005813; GO:0007346; GO:0019900; GO:0030496; GO:0051301 cell division [GO:0051301]; regulation of mitotic cell cycle [GO:0007346] centrosome [GO:0005813]; midbody [GO:0030496]; spindle pole [GO:0000922] kinase binding [GO:0019900] g6632.t1 Q99PW8 66.381 467 0.0 646.0 sp|Q99PW8|KIF17_MOUSE Kinesin-like protein KIF17 OS=Mus musculus OX=10090 GN=Kif17 PE=1 SV=1 KIF17_MOUSE reviewed Kinesin-like protein KIF17 (MmKIF17) Mus musculus (Mouse) GO:0001750; GO:0001917; GO:0003777; GO:0005524; GO:0005737; GO:0005815; GO:0005829; GO:0005871; GO:0005874; GO:0005929; GO:0005930; GO:0007017; GO:0008017; GO:0008574; GO:0015031; GO:0015630; GO:0016192; GO:0016887; GO:0030030; GO:0031503; GO:0032391; GO:0032839; GO:0036064; GO:0042073; GO:0043005; GO:0098794; GO:0098971; GO:1990075 anterograde dendritic transport of neurotransmitter receptor complex [GO:0098971]; cell projection organization [GO:0030030]; intraciliary transport [GO:0042073]; microtubule-based process [GO:0007017]; protein transport [GO:0015031]; protein-containing complex localization [GO:0031503]; vesicle-mediated transport [GO:0016192] axoneme [GO:0005930]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite cytoplasm [GO:0032839]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; microtubule organizing center [GO:0005815]; neuron projection [GO:0043005]; periciliary membrane compartment [GO:1990075]; photoreceptor connecting cilium [GO:0032391]; photoreceptor inner segment [GO:0001917]; photoreceptor outer segment [GO:0001750]; postsynapse [GO:0098794] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; plus-end-directed microtubule motor activity [GO:0008574] g6632.t1 Q99PW8 39.159 309 3.29e-45 179.0 sp|Q99PW8|KIF17_MOUSE Kinesin-like protein KIF17 OS=Mus musculus OX=10090 GN=Kif17 PE=1 SV=1 KIF17_MOUSE reviewed Kinesin-like protein KIF17 (MmKIF17) Mus musculus (Mouse) GO:0001750; GO:0001917; GO:0003777; GO:0005524; GO:0005737; GO:0005815; GO:0005829; GO:0005871; GO:0005874; GO:0005929; GO:0005930; GO:0007017; GO:0008017; GO:0008574; GO:0015031; GO:0015630; GO:0016192; GO:0016887; GO:0030030; GO:0031503; GO:0032391; GO:0032839; GO:0036064; GO:0042073; GO:0043005; GO:0098794; GO:0098971; GO:1990075 anterograde dendritic transport of neurotransmitter receptor complex [GO:0098971]; cell projection organization [GO:0030030]; intraciliary transport [GO:0042073]; microtubule-based process [GO:0007017]; protein transport [GO:0015031]; protein-containing complex localization [GO:0031503]; vesicle-mediated transport [GO:0016192] axoneme [GO:0005930]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite cytoplasm [GO:0032839]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; microtubule organizing center [GO:0005815]; neuron projection [GO:0043005]; periciliary membrane compartment [GO:1990075]; photoreceptor connecting cilium [GO:0032391]; photoreceptor inner segment [GO:0001917]; photoreceptor outer segment [GO:0001750]; postsynapse [GO:0098794] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; plus-end-directed microtubule motor activity [GO:0008574] g6634.t1 Q9MYP6 53.049 164 2.25e-59 189.0 sp|Q9MYP6|DHB14_BOVIN L-fucose dehydrogenase OS=Bos taurus OX=9913 GN=HSD17B14 PE=2 SV=1 g6635.t1 A0A8I6GJ95 42.975 242 4.64e-65 206.0 sp|A0A8I6GJ95|DHB14_RAT L-fucose dehydrogenase OS=Rattus norvegicus OX=10116 GN=Hsd17b14 PE=1 SV=1 DHB14_RAT reviewed L-fucose dehydrogenase (EC 1.1.1.122) (Hydroxysteroid 17-beta dehydrogenase 14) Rattus norvegicus (Rat) GO:0005829; GO:0042355; GO:0042802; GO:0047834 L-fucose catabolic process [GO:0042355] cytosol [GO:0005829] D-threo-aldose 1-dehydrogenase activity [GO:0047834]; identical protein binding [GO:0042802] g6636.t1 Q0VAW7 43.027 337 5.0700000000000004e-77 279.0 sp|Q0VAW7|ZN112_MOUSE Zinc finger protein 112 OS=Mus musculus OX=10090 GN=Znf112 PE=2 SV=2 ZN112_MOUSE reviewed Zinc finger protein 112 (Zfp-112) Mus musculus (Mouse) GO:0001227; GO:0005634; GO:0005654; GO:0006357; GO:0008270; GO:0043565 regulation of transcription by RNA polymerase II [GO:0006357] nucleoplasm [GO:0005654]; nucleus [GO:0005634] DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270] g6636.t1 Q0VAW7 33.253 415 3.71e-51 200.0 sp|Q0VAW7|ZN112_MOUSE Zinc finger protein 112 OS=Mus musculus OX=10090 GN=Znf112 PE=2 SV=2 ZN112_MOUSE reviewed Zinc finger protein 112 (Zfp-112) Mus musculus (Mouse) GO:0001227; GO:0005634; GO:0005654; GO:0006357; GO:0008270; GO:0043565 regulation of transcription by RNA polymerase II [GO:0006357] nucleoplasm [GO:0005654]; nucleus [GO:0005634] DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270] g6636.t1 Q0VAW7 34.831 267 1.3e-35 151.0 sp|Q0VAW7|ZN112_MOUSE Zinc finger protein 112 OS=Mus musculus OX=10090 GN=Znf112 PE=2 SV=2 ZN112_MOUSE reviewed Zinc finger protein 112 (Zfp-112) Mus musculus (Mouse) GO:0001227; GO:0005634; GO:0005654; GO:0006357; GO:0008270; GO:0043565 regulation of transcription by RNA polymerase II [GO:0006357] nucleoplasm [GO:0005654]; nucleus [GO:0005634] DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270] g6636.t1 Q0VAW7 31.164 292 6.44e-34 146.0 sp|Q0VAW7|ZN112_MOUSE Zinc finger protein 112 OS=Mus musculus OX=10090 GN=Znf112 PE=2 SV=2 ZN112_MOUSE reviewed Zinc finger protein 112 (Zfp-112) Mus musculus (Mouse) GO:0001227; GO:0005634; GO:0005654; GO:0006357; GO:0008270; GO:0043565 regulation of transcription by RNA polymerase II [GO:0006357] nucleoplasm [GO:0005654]; nucleus [GO:0005634] DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270] g6636.t1 Q0VAW7 33.333 237 5.100000000000001e-31 137.0 sp|Q0VAW7|ZN112_MOUSE Zinc finger protein 112 OS=Mus musculus OX=10090 GN=Znf112 PE=2 SV=2 ZN112_MOUSE reviewed Zinc finger protein 112 (Zfp-112) Mus musculus (Mouse) GO:0001227; GO:0005634; GO:0005654; GO:0006357; GO:0008270; GO:0043565 regulation of transcription by RNA polymerase II [GO:0006357] nucleoplasm [GO:0005654]; nucleus [GO:0005634] DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270] g6636.t1 Q0VAW7 35.789 190 1.15e-30 135.0 sp|Q0VAW7|ZN112_MOUSE Zinc finger protein 112 OS=Mus musculus OX=10090 GN=Znf112 PE=2 SV=2 ZN112_MOUSE reviewed Zinc finger protein 112 (Zfp-112) Mus musculus (Mouse) GO:0001227; GO:0005634; GO:0005654; GO:0006357; GO:0008270; GO:0043565 regulation of transcription by RNA polymerase II [GO:0006357] nucleoplasm [GO:0005654]; nucleus [GO:0005634] DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270] g6636.t1 Q0VAW7 34.177 237 3.5600000000000003e-29 130.0 sp|Q0VAW7|ZN112_MOUSE Zinc finger protein 112 OS=Mus musculus OX=10090 GN=Znf112 PE=2 SV=2 ZN112_MOUSE reviewed Zinc finger protein 112 (Zfp-112) Mus musculus (Mouse) GO:0001227; GO:0005634; GO:0005654; GO:0006357; GO:0008270; GO:0043565 regulation of transcription by RNA polymerase II [GO:0006357] nucleoplasm [GO:0005654]; nucleus [GO:0005634] DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270] g6638.t1 C8YR32 45.622 434 9.33e-118 381.0 sp|C8YR32|LOXH1_MOUSE Lipoxygenase homology domain-containing protein 1 OS=Mus musculus OX=10090 GN=Loxhd1 PE=2 SV=1 g6638.t1 C8YR32 33.333 468 4.21e-59 212.0 sp|C8YR32|LOXH1_MOUSE Lipoxygenase homology domain-containing protein 1 OS=Mus musculus OX=10090 GN=Loxhd1 PE=2 SV=1 g6638.t1 C8YR32 32.051 468 2.3799999999999997e-54 198.0 sp|C8YR32|LOXH1_MOUSE Lipoxygenase homology domain-containing protein 1 OS=Mus musculus OX=10090 GN=Loxhd1 PE=2 SV=1 g6638.t1 C8YR32 31.151 443 5.1799999999999994e-54 197.0 sp|C8YR32|LOXH1_MOUSE Lipoxygenase homology domain-containing protein 1 OS=Mus musculus OX=10090 GN=Loxhd1 PE=2 SV=1 g6638.t1 C8YR32 30.993 413 9.469999999999999e-52 191.0 sp|C8YR32|LOXH1_MOUSE Lipoxygenase homology domain-containing protein 1 OS=Mus musculus OX=10090 GN=Loxhd1 PE=2 SV=1 g6638.t1 C8YR32 31.899 395 2.82e-51 189.0 sp|C8YR32|LOXH1_MOUSE Lipoxygenase homology domain-containing protein 1 OS=Mus musculus OX=10090 GN=Loxhd1 PE=2 SV=1 g6638.t1 C8YR32 32.634 429 9.34e-51 187.0 sp|C8YR32|LOXH1_MOUSE Lipoxygenase homology domain-containing protein 1 OS=Mus musculus OX=10090 GN=Loxhd1 PE=2 SV=1 g6638.t1 C8YR32 28.906 384 9.42e-34 138.0 sp|C8YR32|LOXH1_MOUSE Lipoxygenase homology domain-containing protein 1 OS=Mus musculus OX=10090 GN=Loxhd1 PE=2 SV=1 g6638.t1 C8YR32 28.329 413 2.8099999999999998e-30 127.0 sp|C8YR32|LOXH1_MOUSE Lipoxygenase homology domain-containing protein 1 OS=Mus musculus OX=10090 GN=Loxhd1 PE=2 SV=1 g6639.t1 Q8IVV2 46.241 878 0.0 802.0 sp|Q8IVV2|LOXH1_HUMAN Lipoxygenase homology domain-containing protein 1 OS=Homo sapiens OX=9606 GN=LOXHD1 PE=2 SV=4 g6639.t1 Q8IVV2 40.138 867 2.29e-173 585.0 sp|Q8IVV2|LOXH1_HUMAN Lipoxygenase homology domain-containing protein 1 OS=Homo sapiens OX=9606 GN=LOXHD1 PE=2 SV=4 g6639.t1 Q8IVV2 34.729 1051 3.2800000000000005e-163 556.0 sp|Q8IVV2|LOXH1_HUMAN Lipoxygenase homology domain-containing protein 1 OS=Homo sapiens OX=9606 GN=LOXHD1 PE=2 SV=4 g6639.t1 Q8IVV2 34.19 1050 2.6500000000000004e-156 536.0 sp|Q8IVV2|LOXH1_HUMAN Lipoxygenase homology domain-containing protein 1 OS=Homo sapiens OX=9606 GN=LOXHD1 PE=2 SV=4 g6639.t1 Q8IVV2 34.53 947 8.54e-151 520.0 sp|Q8IVV2|LOXH1_HUMAN Lipoxygenase homology domain-containing protein 1 OS=Homo sapiens OX=9606 GN=LOXHD1 PE=2 SV=4 g6639.t1 Q8IVV2 32.091 1100 3.36e-145 503.0 sp|Q8IVV2|LOXH1_HUMAN Lipoxygenase homology domain-containing protein 1 OS=Homo sapiens OX=9606 GN=LOXHD1 PE=2 SV=4 g6639.t1 Q8IVV2 31.056 1098 4.77e-139 485.0 sp|Q8IVV2|LOXH1_HUMAN Lipoxygenase homology domain-containing protein 1 OS=Homo sapiens OX=9606 GN=LOXHD1 PE=2 SV=4 g6639.t1 Q8IVV2 31.705 1085 2.69e-133 468.0 sp|Q8IVV2|LOXH1_HUMAN Lipoxygenase homology domain-containing protein 1 OS=Homo sapiens OX=9606 GN=LOXHD1 PE=2 SV=4 g6639.t1 Q8IVV2 35.355 775 1.42e-112 403.0 sp|Q8IVV2|LOXH1_HUMAN Lipoxygenase homology domain-containing protein 1 OS=Homo sapiens OX=9606 GN=LOXHD1 PE=2 SV=4 g6639.t1 Q8IVV2 33.378 746 2.73e-107 386.0 sp|Q8IVV2|LOXH1_HUMAN Lipoxygenase homology domain-containing protein 1 OS=Homo sapiens OX=9606 GN=LOXHD1 PE=2 SV=4 g6639.t1 Q8IVV2 29.94 835 3.87e-93 341.0 sp|Q8IVV2|LOXH1_HUMAN Lipoxygenase homology domain-containing protein 1 OS=Homo sapiens OX=9606 GN=LOXHD1 PE=2 SV=4 g6639.t1 Q8IVV2 32.361 720 5.530000000000001e-85 315.0 sp|Q8IVV2|LOXH1_HUMAN Lipoxygenase homology domain-containing protein 1 OS=Homo sapiens OX=9606 GN=LOXHD1 PE=2 SV=4 g6639.t1 Q8IVV2 30.161 809 8.769999999999999e-82 304.0 sp|Q8IVV2|LOXH1_HUMAN Lipoxygenase homology domain-containing protein 1 OS=Homo sapiens OX=9606 GN=LOXHD1 PE=2 SV=4 g6639.t1 Q8IVV2 29.456 791 2.05e-76 286.0 sp|Q8IVV2|LOXH1_HUMAN Lipoxygenase homology domain-containing protein 1 OS=Homo sapiens OX=9606 GN=LOXHD1 PE=2 SV=4 g6639.t1 Q8IVV2 30.598 585 7.49e-62 239.0 sp|Q8IVV2|LOXH1_HUMAN Lipoxygenase homology domain-containing protein 1 OS=Homo sapiens OX=9606 GN=LOXHD1 PE=2 SV=4 g6639.t1 Q8IVV2 33.118 465 1.1800000000000001e-58 229.0 sp|Q8IVV2|LOXH1_HUMAN Lipoxygenase homology domain-containing protein 1 OS=Homo sapiens OX=9606 GN=LOXHD1 PE=2 SV=4 g6639.t1 Q8IVV2 32.532 541 1.62e-57 225.0 sp|Q8IVV2|LOXH1_HUMAN Lipoxygenase homology domain-containing protein 1 OS=Homo sapiens OX=9606 GN=LOXHD1 PE=2 SV=4 g6639.t1 Q8IVV2 26.41 780 9.01e-50 199.0 sp|Q8IVV2|LOXH1_HUMAN Lipoxygenase homology domain-containing protein 1 OS=Homo sapiens OX=9606 GN=LOXHD1 PE=2 SV=4 g6639.t1 Q8IVV2 29.128 436 7.56e-42 174.0 sp|Q8IVV2|LOXH1_HUMAN Lipoxygenase homology domain-containing protein 1 OS=Homo sapiens OX=9606 GN=LOXHD1 PE=2 SV=4 g6642.t1 P37198 65.816 196 6.12e-87 281.0 sp|P37198|NUP62_HUMAN Nuclear pore glycoprotein p62 OS=Homo sapiens OX=9606 GN=NUP62 PE=1 SV=3 NUP62_HUMAN reviewed Nuclear pore glycoprotein p62 (62 kDa nucleoporin) (Nucleoporin Nup62) Homo sapiens (Human) GO:0000922; GO:0003682; GO:0005543; GO:0005635; GO:0005643; GO:0005654; GO:0005737; GO:0005813; GO:0006405; GO:0006606; GO:0006913; GO:0007080; GO:0007098; GO:0007100; GO:0007166; GO:0008285; GO:0009966; GO:0017056; GO:0030159; GO:0030544; GO:0031965; GO:0042059; GO:0042169; GO:0043066; GO:0043069; GO:0043123; GO:0043130; GO:0044613; GO:0045742; GO:0045840; GO:0045893; GO:0046578; GO:0046580; GO:0046601; GO:0051028; GO:0051425; GO:0051879; GO:0060236; GO:0072686; GO:0090398; GO:0090543; GO:0098534; GO:1903438; GO:1904781; GO:1990904 cell surface receptor signaling pathway [GO:0007166]; cellular senescence [GO:0090398]; centriole assembly [GO:0098534]; centrosome cycle [GO:0007098]; mitotic centrosome separation [GO:0007100]; mitotic metaphase chromosome alignment [GO:0007080]; mRNA transport [GO:0051028]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of programmed cell death [GO:0043069]; negative regulation of Ras protein signal transduction [GO:0046580]; nucleocytoplasmic transport [GO:0006913]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of centriole replication [GO:0046601]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of mitotic cytokinetic process [GO:1903438]; positive regulation of mitotic nuclear division [GO:0045840]; positive regulation of protein localization to centrosome [GO:1904781]; protein import into nucleus [GO:0006606]; regulation of mitotic spindle organization [GO:0060236]; regulation of Ras protein signal transduction [GO:0046578]; regulation of signal transduction [GO:0009966]; RNA export from nucleus [GO:0006405] centrosome [GO:0005813]; cytoplasm [GO:0005737]; Flemming body [GO:0090543]; mitotic spindle [GO:0072686]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nuclear pore central transport channel [GO:0044613]; nucleoplasm [GO:0005654]; ribonucleoprotein complex [GO:1990904]; spindle pole [GO:0000922] chromatin binding [GO:0003682]; Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]; phospholipid binding [GO:0005543]; PTB domain binding [GO:0051425]; SH2 domain binding [GO:0042169]; signaling receptor complex adaptor activity [GO:0030159]; structural constituent of nuclear pore [GO:0017056]; ubiquitin binding [GO:0043130] g6645.t1 Q5ZIH0 72.529 597 0.0 917.0 sp|Q5ZIH0|INT11_CHICK Integrator complex subunit 11 OS=Gallus gallus OX=9031 GN=INTS11 PE=2 SV=1 INT11_CHICK reviewed Integrator complex subunit 11 (Int11) (EC 3.1.27.-) (Cleavage and polyadenylation-specific factor 3-like protein) (CPSF3-like protein) Gallus gallus (Chicken) GO:0004521; GO:0005634; GO:0005737; GO:0016180; GO:0016787; GO:0032039; GO:0034472; GO:0046872; GO:0160232; GO:0160240 RNA polymerase II transcription initiation surveillance [GO:0160240]; snRNA 3'-end processing [GO:0034472]; snRNA processing [GO:0016180] cytoplasm [GO:0005737]; INTAC complex [GO:0160232]; integrator complex [GO:0032039]; nucleus [GO:0005634] hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]; RNA endonuclease activity [GO:0004521] g6646.t1 P55265 45.455 517 5.45e-133 438.0 sp|P55265|DSRAD_HUMAN Double-stranded RNA-specific adenosine deaminase OS=Homo sapiens OX=9606 GN=ADAR PE=1 SV=4 DSRAD_HUMAN reviewed Double-stranded RNA-specific adenosine deaminase (DRADA) (EC 3.5.4.37) (136 kDa double-stranded RNA-binding protein) (p136) (Interferon-inducible protein 4) (IFI-4) (K88DSRBP) Homo sapiens (Human) GO:0001649; GO:0002244; GO:0002566; GO:0003677; GO:0003723; GO:0003725; GO:0003726; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005739; GO:0005829; GO:0006382; GO:0006396; GO:0006397; GO:0006606; GO:0006611; GO:0008251; GO:0009615; GO:0016020; GO:0016553; GO:0016556; GO:0030218; GO:0031054; GO:0035455; GO:0044387; GO:0044530; GO:0045070; GO:0045087; GO:0046872; GO:0051607; GO:0060216; GO:0060339; GO:0061484; GO:0070922; GO:0097284; GO:0098586; GO:1900369; GO:1903944 adenosine to inosine editing [GO:0006382]; base conversion or substitution editing [GO:0016553]; cellular response to virus [GO:0098586]; defense response to virus [GO:0051607]; definitive hemopoiesis [GO:0060216]; erythrocyte differentiation [GO:0030218]; hematopoietic progenitor cell differentiation [GO:0002244]; hematopoietic stem cell homeostasis [GO:0061484]; hepatocyte apoptotic process [GO:0097284]; innate immune response [GO:0045087]; mRNA modification [GO:0016556]; mRNA processing [GO:0006397]; negative regulation of hepatocyte apoptotic process [GO:1903944]; negative regulation of post-transcriptional gene silencing by regulatory ncRNA [GO:1900369]; negative regulation of protein kinase activity by regulation of protein phosphorylation [GO:0044387]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; osteoblast differentiation [GO:0001649]; positive regulation of viral genome replication [GO:0045070]; pre-miRNA processing [GO:0031054]; protein export from nucleus [GO:0006611]; protein import into nucleus [GO:0006606]; response to interferon-alpha [GO:0035455]; response to virus [GO:0009615]; RISC complex assembly [GO:0070922]; RNA processing [GO:0006396]; somatic diversification of immune receptors via somatic mutation [GO:0002566] cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; supraspliceosomal complex [GO:0044530] DNA binding [GO:0003677]; double-stranded RNA adenosine deaminase activity [GO:0003726]; double-stranded RNA binding [GO:0003725]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; tRNA-specific adenosine deaminase activity [GO:0008251] g6646.t2 P55266 47.813 343 4.3000000000000003e-88 318.0 sp|P55266|DSRAD_RAT Double-stranded RNA-specific adenosine deaminase OS=Rattus norvegicus OX=10116 GN=Adar PE=1 SV=1 DSRAD_RAT reviewed Double-stranded RNA-specific adenosine deaminase (DRADA) (EC 3.5.4.37) Rattus norvegicus (Rat) GO:0001649; GO:0001701; GO:0002244; GO:0002566; GO:0003677; GO:0003725; GO:0003726; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006382; GO:0006396; GO:0006397; GO:0006606; GO:0006611; GO:0008251; GO:0009615; GO:0016553; GO:0016607; GO:0030218; GO:0031054; GO:0035196; GO:0035455; GO:0044387; GO:0044530; GO:0045070; GO:0045071; GO:0045087; GO:0046872; GO:0051607; GO:0060216; GO:0060339; GO:0061484; GO:0070922; GO:0098586; GO:1900369; GO:1903944 adenosine to inosine editing [GO:0006382]; base conversion or substitution editing [GO:0016553]; cellular response to virus [GO:0098586]; defense response to virus [GO:0051607]; definitive hemopoiesis [GO:0060216]; erythrocyte differentiation [GO:0030218]; hematopoietic progenitor cell differentiation [GO:0002244]; hematopoietic stem cell homeostasis [GO:0061484]; in utero embryonic development [GO:0001701]; innate immune response [GO:0045087]; miRNA processing [GO:0035196]; mRNA processing [GO:0006397]; negative regulation of hepatocyte apoptotic process [GO:1903944]; negative regulation of post-transcriptional gene silencing by regulatory ncRNA [GO:1900369]; negative regulation of protein kinase activity by regulation of protein phosphorylation [GO:0044387]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; negative regulation of viral genome replication [GO:0045071]; osteoblast differentiation [GO:0001649]; positive regulation of viral genome replication [GO:0045070]; pre-miRNA processing [GO:0031054]; protein export from nucleus [GO:0006611]; protein import into nucleus [GO:0006606]; response to interferon-alpha [GO:0035455]; response to virus [GO:0009615]; RISC complex assembly [GO:0070922]; RNA processing [GO:0006396]; somatic diversification of immune receptors via somatic mutation [GO:0002566] cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; supraspliceosomal complex [GO:0044530] DNA binding [GO:0003677]; double-stranded RNA adenosine deaminase activity [GO:0003726]; double-stranded RNA binding [GO:0003725]; metal ion binding [GO:0046872]; tRNA-specific adenosine deaminase activity [GO:0008251] g6646.t2 P55266 37.356 174 2.1e-24 116.0 sp|P55266|DSRAD_RAT Double-stranded RNA-specific adenosine deaminase OS=Rattus norvegicus OX=10116 GN=Adar PE=1 SV=1 DSRAD_RAT reviewed Double-stranded RNA-specific adenosine deaminase (DRADA) (EC 3.5.4.37) Rattus norvegicus (Rat) GO:0001649; GO:0001701; GO:0002244; GO:0002566; GO:0003677; GO:0003725; GO:0003726; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006382; GO:0006396; GO:0006397; GO:0006606; GO:0006611; GO:0008251; GO:0009615; GO:0016553; GO:0016607; GO:0030218; GO:0031054; GO:0035196; GO:0035455; GO:0044387; GO:0044530; GO:0045070; GO:0045071; GO:0045087; GO:0046872; GO:0051607; GO:0060216; GO:0060339; GO:0061484; GO:0070922; GO:0098586; GO:1900369; GO:1903944 adenosine to inosine editing [GO:0006382]; base conversion or substitution editing [GO:0016553]; cellular response to virus [GO:0098586]; defense response to virus [GO:0051607]; definitive hemopoiesis [GO:0060216]; erythrocyte differentiation [GO:0030218]; hematopoietic progenitor cell differentiation [GO:0002244]; hematopoietic stem cell homeostasis [GO:0061484]; in utero embryonic development [GO:0001701]; innate immune response [GO:0045087]; miRNA processing [GO:0035196]; mRNA processing [GO:0006397]; negative regulation of hepatocyte apoptotic process [GO:1903944]; negative regulation of post-transcriptional gene silencing by regulatory ncRNA [GO:1900369]; negative regulation of protein kinase activity by regulation of protein phosphorylation [GO:0044387]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; negative regulation of viral genome replication [GO:0045071]; osteoblast differentiation [GO:0001649]; positive regulation of viral genome replication [GO:0045070]; pre-miRNA processing [GO:0031054]; protein export from nucleus [GO:0006611]; protein import into nucleus [GO:0006606]; response to interferon-alpha [GO:0035455]; response to virus [GO:0009615]; RISC complex assembly [GO:0070922]; RNA processing [GO:0006396]; somatic diversification of immune receptors via somatic mutation [GO:0002566] cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; supraspliceosomal complex [GO:0044530] DNA binding [GO:0003677]; double-stranded RNA adenosine deaminase activity [GO:0003726]; double-stranded RNA binding [GO:0003725]; metal ion binding [GO:0046872]; tRNA-specific adenosine deaminase activity [GO:0008251] g6647.t1 Q4KLQ5 42.387 486 3.86e-119 368.0 sp|Q4KLQ5|WDR76_XENLA WD repeat-containing protein 76 OS=Xenopus laevis OX=8355 GN=wdr76 PE=2 SV=1 g6647.t2 Q4KLQ5 42.387 486 4.41e-118 367.0 sp|Q4KLQ5|WDR76_XENLA WD repeat-containing protein 76 OS=Xenopus laevis OX=8355 GN=wdr76 PE=2 SV=1 g6649.t1 O46037 39.749 717 5.84e-156 498.0 sp|O46037|VINC_DROME Vinculin OS=Drosophila melanogaster OX=7227 GN=Vinc PE=1 SV=1 g6649.t1 O46037 61.453 179 8.83e-47 186.0 sp|O46037|VINC_DROME Vinculin OS=Drosophila melanogaster OX=7227 GN=Vinc PE=1 SV=1 g6651.t1 Q8WNV2 39.831 354 3.24e-51 181.0 sp|Q8WNV2|INT12_MACFA Integrator complex subunit 12 OS=Macaca fascicularis OX=9541 GN=INTS12 PE=2 SV=1 g6653.t1 Q5ZKG5 51.592 157 3.3600000000000003e-47 153.0 sp|Q5ZKG5|PPAC_CHICK Low molecular weight phosphotyrosine protein phosphatase OS=Gallus gallus OX=9031 GN=ACP1 PE=2 SV=3 g6653.t2 P81693 44.937 158 6.24e-44 145.0 sp|P81693|PPAC_PIG Low molecular weight phosphotyrosine protein phosphatase OS=Sus scrofa OX=9823 GN=ACP1 PE=1 SV=2 g6653.t3 Q5ZKG5 47.059 136 1.27e-34 120.0 sp|Q5ZKG5|PPAC_CHICK Low molecular weight phosphotyrosine protein phosphatase OS=Gallus gallus OX=9031 GN=ACP1 PE=2 SV=3 g6654.t1 Q8BQ89 76.863 255 3.03e-147 420.0 sp|Q8BQ89|LIX1L_MOUSE LIX1-like protein OS=Mus musculus OX=10090 GN=Lix1l PE=2 SV=2 g6658.t1 P61963 90.029 341 0.0 659.0 sp|P61963|DCAF7_MOUSE DDB1- and CUL4-associated factor 7 OS=Mus musculus OX=10090 GN=Dcaf7 PE=1 SV=1 g6659.t1 B3A003 46.154 117 6.5e-25 97.1 sp|B3A003|LYS3_CRAVI Lysozyme 3 OS=Crassostrea virginica OX=6565 GN=lysoz3 PE=1 SV=1 LYS3_CRAVI reviewed Lysozyme 3 (EC 3.2.1.17) (1,4-beta-N-acetylmuramidase 3) (Invertebrate-type lysozyme 3) (cv-lysozyme 3) Crassostrea virginica (Eastern oyster) GO:0003796; GO:0005576; GO:0031640; GO:0050829 defense response to Gram-negative bacterium [GO:0050829]; killing of cells of another organism [GO:0031640] extracellular region [GO:0005576] lysozyme activity [GO:0003796] g6660.t1 Q9NQZ8 37.95 361 1.1700000000000001e-75 254.0 sp|Q9NQZ8|ZNF71_HUMAN Endothelial zinc finger protein induced by tumor necrosis factor alpha OS=Homo sapiens OX=9606 GN=ZNF71 PE=1 SV=1 ZNF71_HUMAN reviewed Endothelial zinc finger protein induced by tumor necrosis factor alpha (Zinc finger protein 71) Homo sapiens (Human) GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0008270 regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270] g6660.t1 Q9NQZ8 37.179 312 7.3e-60 212.0 sp|Q9NQZ8|ZNF71_HUMAN Endothelial zinc finger protein induced by tumor necrosis factor alpha OS=Homo sapiens OX=9606 GN=ZNF71 PE=1 SV=1 ZNF71_HUMAN reviewed Endothelial zinc finger protein induced by tumor necrosis factor alpha (Zinc finger protein 71) Homo sapiens (Human) GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0008270 regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270] g6660.t1 Q9NQZ8 37.255 306 5.4100000000000004e-58 207.0 sp|Q9NQZ8|ZNF71_HUMAN Endothelial zinc finger protein induced by tumor necrosis factor alpha OS=Homo sapiens OX=9606 GN=ZNF71 PE=1 SV=1 ZNF71_HUMAN reviewed Endothelial zinc finger protein induced by tumor necrosis factor alpha (Zinc finger protein 71) Homo sapiens (Human) GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0008270 regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270] g6662.t1 Q14585 34.959 369 5.82e-65 223.0 sp|Q14585|ZN345_HUMAN Zinc finger protein 345 OS=Homo sapiens OX=9606 GN=ZNF345 PE=1 SV=1 ZN345_HUMAN reviewed Zinc finger protein 345 (Zinc finger protein HZF10) Homo sapiens (Human) GO:0000122; GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0006359; GO:0006366; GO:0006383; GO:0008270; GO:1990837 negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription by RNA polymerase III [GO:0006359]; transcription by RNA polymerase II [GO:0006366]; transcription by RNA polymerase III [GO:0006383] nucleus [GO:0005634] DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; zinc ion binding [GO:0008270] g6662.t1 Q14585 33.333 357 2.6e-59 208.0 sp|Q14585|ZN345_HUMAN Zinc finger protein 345 OS=Homo sapiens OX=9606 GN=ZNF345 PE=1 SV=1 ZN345_HUMAN reviewed Zinc finger protein 345 (Zinc finger protein HZF10) Homo sapiens (Human) GO:0000122; GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0006359; GO:0006366; GO:0006383; GO:0008270; GO:1990837 negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription by RNA polymerase III [GO:0006359]; transcription by RNA polymerase II [GO:0006366]; transcription by RNA polymerase III [GO:0006383] nucleus [GO:0005634] DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; zinc ion binding [GO:0008270] g6662.t1 Q14585 36.0 300 1.54e-51 187.0 sp|Q14585|ZN345_HUMAN Zinc finger protein 345 OS=Homo sapiens OX=9606 GN=ZNF345 PE=1 SV=1 ZN345_HUMAN reviewed Zinc finger protein 345 (Zinc finger protein HZF10) Homo sapiens (Human) GO:0000122; GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0006359; GO:0006366; GO:0006383; GO:0008270; GO:1990837 negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription by RNA polymerase III [GO:0006359]; transcription by RNA polymerase II [GO:0006366]; transcription by RNA polymerase III [GO:0006383] nucleus [GO:0005634] DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; zinc ion binding [GO:0008270] g6664.t1 A2VDN6 67.987 303 4.2e-120 384.0 sp|A2VDN6|SF3A1_BOVIN Splicing factor 3A subunit 1 OS=Bos taurus OX=9913 GN=SF3A1 PE=2 SV=1 SF3A1_BOVIN reviewed Splicing factor 3A subunit 1 Bos taurus (Bovine) GO:0000398; GO:0003723; GO:0005634; GO:0005684; GO:0005686; GO:0016607; GO:0045292; GO:0071004; GO:0071005; GO:0071013; GO:1903241 mRNA cis splicing, via spliceosome [GO:0045292]; mRNA splicing, via spliceosome [GO:0000398]; U2-type prespliceosome assembly [GO:1903241] catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; U2 snRNP [GO:0005686]; U2-type precatalytic spliceosome [GO:0071005]; U2-type prespliceosome [GO:0071004]; U2-type spliceosomal complex [GO:0005684] RNA binding [GO:0003723] g6664.t1 A2VDN6 65.839 161 4.7e-53 201.0 sp|A2VDN6|SF3A1_BOVIN Splicing factor 3A subunit 1 OS=Bos taurus OX=9913 GN=SF3A1 PE=2 SV=1 SF3A1_BOVIN reviewed Splicing factor 3A subunit 1 Bos taurus (Bovine) GO:0000398; GO:0003723; GO:0005634; GO:0005684; GO:0005686; GO:0016607; GO:0045292; GO:0071004; GO:0071005; GO:0071013; GO:1903241 mRNA cis splicing, via spliceosome [GO:0045292]; mRNA splicing, via spliceosome [GO:0000398]; U2-type prespliceosome assembly [GO:1903241] catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; U2 snRNP [GO:0005686]; U2-type precatalytic spliceosome [GO:0071005]; U2-type prespliceosome [GO:0071004]; U2-type spliceosomal complex [GO:0005684] RNA binding [GO:0003723] g6664.t1 A2VDN6 67.826 115 5.63e-41 165.0 sp|A2VDN6|SF3A1_BOVIN Splicing factor 3A subunit 1 OS=Bos taurus OX=9913 GN=SF3A1 PE=2 SV=1 SF3A1_BOVIN reviewed Splicing factor 3A subunit 1 Bos taurus (Bovine) GO:0000398; GO:0003723; GO:0005634; GO:0005684; GO:0005686; GO:0016607; GO:0045292; GO:0071004; GO:0071005; GO:0071013; GO:1903241 mRNA cis splicing, via spliceosome [GO:0045292]; mRNA splicing, via spliceosome [GO:0000398]; U2-type prespliceosome assembly [GO:1903241] catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; U2 snRNP [GO:0005686]; U2-type precatalytic spliceosome [GO:0071005]; U2-type prespliceosome [GO:0071004]; U2-type spliceosomal complex [GO:0005684] RNA binding [GO:0003723] g6666.t1 Q6P6X9 42.486 346 1.12e-76 241.0 sp|Q6P6X9|NUP35_DANRE Nucleoporin NUP35 OS=Danio rerio OX=7955 GN=nup35 PE=1 SV=1 NUP35_DANRE reviewed Nucleoporin NUP35 (35 kDa nucleoporin) (Nuclear pore complex protein Nup53) (Nucleoporin NUP53) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0003676; GO:0005543; GO:0006607; GO:0006999; GO:0017056; GO:0031965; GO:0044613; GO:0044615; GO:0051028 mRNA transport [GO:0051028]; NLS-bearing protein import into nucleus [GO:0006607]; nuclear pore organization [GO:0006999] nuclear membrane [GO:0031965]; nuclear pore central transport channel [GO:0044613]; nuclear pore nuclear basket [GO:0044615] nucleic acid binding [GO:0003676]; phospholipid binding [GO:0005543]; structural constituent of nuclear pore [GO:0017056] g6667.t1 Q9NP64 53.642 151 1.58e-50 174.0 sp|Q9NP64|ZCC17_HUMAN Zinc finger CCHC domain-containing protein 17 OS=Homo sapiens OX=9606 GN=ZCCHC17 PE=1 SV=1 ZCC17_HUMAN reviewed Zinc finger CCHC domain-containing protein 17 (Nucleolar protein of 40 kDa) (pNO40) (Pnn-interacting nucleolar protein) (Putative S1 RNA-binding domain protein) (PS1D protein) Homo sapiens (Human) GO:0003723; GO:0005730; GO:0008270; GO:0022625; GO:0042802; GO:0043489 RNA stabilization [GO:0043489] cytosolic large ribosomal subunit [GO:0022625]; nucleolus [GO:0005730] identical protein binding [GO:0042802]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270] g6667.t2 Q9NP64 53.642 151 1.35e-50 174.0 sp|Q9NP64|ZCC17_HUMAN Zinc finger CCHC domain-containing protein 17 OS=Homo sapiens OX=9606 GN=ZCCHC17 PE=1 SV=1 ZCC17_HUMAN reviewed Zinc finger CCHC domain-containing protein 17 (Nucleolar protein of 40 kDa) (pNO40) (Pnn-interacting nucleolar protein) (Putative S1 RNA-binding domain protein) (PS1D protein) Homo sapiens (Human) GO:0003723; GO:0005730; GO:0008270; GO:0022625; GO:0042802; GO:0043489 RNA stabilization [GO:0043489] cytosolic large ribosomal subunit [GO:0022625]; nucleolus [GO:0005730] identical protein binding [GO:0042802]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270] g6669.t1 Q6DG81 51.51 629 0.0 581.0 sp|Q6DG81|PLST_DANRE Plastin-3 OS=Danio rerio OX=7955 GN=pls3 PE=2 SV=1 PLST_DANRE reviewed Plastin-3 (T-plastin) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005509; GO:0005737; GO:0005884; GO:0008045; GO:0030282; GO:0032432; GO:0039019; GO:0048701; GO:0051015; GO:0051017; GO:0051639; GO:0072114 actin filament bundle assembly [GO:0051017]; actin filament network formation [GO:0051639]; bone mineralization [GO:0030282]; embryonic cranial skeleton morphogenesis [GO:0048701]; motor neuron axon guidance [GO:0008045]; pronephric nephron development [GO:0039019]; pronephros morphogenesis [GO:0072114] actin filament [GO:0005884]; actin filament bundle [GO:0032432]; cytoplasm [GO:0005737] actin filament binding [GO:0051015]; calcium ion binding [GO:0005509] g6670.t1 Q9JLC8 27.817 4206 0.0 1225.0 sp|Q9JLC8|SACS_MOUSE Sacsin OS=Mus musculus OX=10090 GN=Sacs PE=1 SV=2 g6670.t1 Q9JLC8 29.087 526 2.73e-47 193.0 sp|Q9JLC8|SACS_MOUSE Sacsin OS=Mus musculus OX=10090 GN=Sacs PE=1 SV=2 g6670.t1 Q9JLC8 30.983 468 1.83e-41 174.0 sp|Q9JLC8|SACS_MOUSE Sacsin OS=Mus musculus OX=10090 GN=Sacs PE=1 SV=2 g6671.t1 Q9JLC8 43.437 419 1.08e-91 306.0 sp|Q9JLC8|SACS_MOUSE Sacsin OS=Mus musculus OX=10090 GN=Sacs PE=1 SV=2 g6671.t1 Q9JLC8 30.941 404 8.24e-42 161.0 sp|Q9JLC8|SACS_MOUSE Sacsin OS=Mus musculus OX=10090 GN=Sacs PE=1 SV=2 g6671.t1 Q9JLC8 34.156 243 3.3499999999999996e-30 127.0 sp|Q9JLC8|SACS_MOUSE Sacsin OS=Mus musculus OX=10090 GN=Sacs PE=1 SV=2 g6673.t1 Q6PFM0 67.751 338 5.06e-170 485.0 sp|Q6PFM0|JMJD6_DANRE Bifunctional arginine demethylase and lysyl-hydroxylase JMJD6 OS=Danio rerio OX=7955 GN=jmjd6 PE=2 SV=2 JMJD6_DANRE reviewed Bifunctional arginine demethylase and lysyl-hydroxylase JMJD6 (EC 1.14.11.-) (Histone arginine demethylase JMJD6) (JmjC domain-containing protein 6) (Jumonji domain-containing protein 6) (Lysyl-hydroxylase JMJD6) (Peptide-lysine 5-dioxygenase JMJD6) (Phosphatidylserine receptor) (Protein PTDSR) (zfpsr) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0002040; GO:0003727; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006397; GO:0006909; GO:0008380; GO:0018395; GO:0030154; GO:0032452; GO:0033746; GO:0033749; GO:0046872; GO:0048024; GO:0051260; GO:0070815; GO:0106140 cell differentiation [GO:0030154]; mRNA processing [GO:0006397]; peptidyl-lysine hydroxylation to 5-hydroxy-L-lysine [GO:0018395]; phagocytosis [GO:0006909]; protein homooligomerization [GO:0051260]; regulation of mRNA splicing, via spliceosome [GO:0048024]; RNA splicing [GO:0008380]; sprouting angiogenesis [GO:0002040] cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] histone demethylase activity [GO:0032452]; histone H3R2 demethylase activity [GO:0033746]; histone H4R3 demethylase activity [GO:0033749]; metal ion binding [GO:0046872]; P-TEFb complex binding [GO:0106140]; peptidyl-lysine 5-dioxygenase activity [GO:0070815]; single-stranded RNA binding [GO:0003727] g6680.t1 P15305 36.627 587 3.75e-38 152.0 sp|P15305|DYHC_ONCMY Dynein heavy chain (Fragment) OS=Oncorhynchus mykiss OX=8022 PE=2 SV=1 g6680.t1 P15305 36.813 546 7.07e-36 145.0 sp|P15305|DYHC_ONCMY Dynein heavy chain (Fragment) OS=Oncorhynchus mykiss OX=8022 PE=2 SV=1 g6680.t1 P15305 36.426 582 1.6e-34 141.0 sp|P15305|DYHC_ONCMY Dynein heavy chain (Fragment) OS=Oncorhynchus mykiss OX=8022 PE=2 SV=1 g6682.t1 Q62381 24.267 614 2.9900000000000002e-33 144.0 sp|Q62381|TLL1_MOUSE Tolloid-like protein 1 OS=Mus musculus OX=10090 GN=Tll1 PE=1 SV=1 TLL1_MOUSE reviewed Tolloid-like protein 1 (mTll) (EC 3.4.24.-) Mus musculus (Mouse) GO:0004222; GO:0005509; GO:0005518; GO:0005615; GO:0008270; GO:0009953; GO:0016485; GO:0030154 cell differentiation [GO:0030154]; dorsal/ventral pattern formation [GO:0009953]; protein processing [GO:0016485] extracellular space [GO:0005615] calcium ion binding [GO:0005509]; collagen binding [GO:0005518]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270] g6692.t1 Q9Z1K8 42.331 489 2.56e-119 364.0 sp|Q9Z1K8|YLAT1_MOUSE Y+L amino acid transporter 1 OS=Mus musculus OX=10090 GN=Slc7a7 PE=1 SV=1 g6693.t1 P18293 42.575 963 0.0 711.0 sp|P18293|ANPRA_MOUSE Atrial natriuretic peptide receptor 1 OS=Mus musculus OX=10090 GN=Npr1 PE=1 SV=2 ANPRA_MOUSE reviewed Atrial natriuretic peptide receptor 1 (EC 4.6.1.2) (Atrial natriuretic peptide receptor type A) (ANP-A) (ANPR-A) (NPR-A) (Guanylate cyclase A) (GC-A) Mus musculus (Mouse) GO:0001653; GO:0004383; GO:0004672; GO:0005524; GO:0005525; GO:0005886; GO:0006182; GO:0007166; GO:0007168; GO:0008217; GO:0010753; GO:0016941; GO:0017046; GO:0019934; GO:0035556; GO:0042417; GO:0042562; GO:0043114; GO:0043235; GO:0048662; GO:0097746; GO:1990620 blood vessel diameter maintenance [GO:0097746]; cell surface receptor signaling pathway [GO:0007166]; cGMP biosynthetic process [GO:0006182]; cGMP-mediated signaling [GO:0019934]; dopamine metabolic process [GO:0042417]; intracellular signal transduction [GO:0035556]; negative regulation of smooth muscle cell proliferation [GO:0048662]; positive regulation of cGMP-mediated signaling [GO:0010753]; receptor guanylyl cyclase signaling pathway [GO:0007168]; regulation of blood pressure [GO:0008217]; regulation of vascular permeability [GO:0043114] ANPR-A receptor complex [GO:1990620]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] ATP binding [GO:0005524]; GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; hormone binding [GO:0042562]; natriuretic peptide receptor activity [GO:0016941]; peptide hormone binding [GO:0017046]; peptide receptor activity [GO:0001653]; protein kinase activity [GO:0004672] g6701.t1 Q15428 82.96 223 2.83e-100 311.0 sp|Q15428|SF3A2_HUMAN Splicing factor 3A subunit 2 OS=Homo sapiens OX=9606 GN=SF3A2 PE=1 SV=2 SF3A2_HUMAN reviewed Splicing factor 3A subunit 2 (SF3a66) (Spliceosome-associated protein 62) (SAP 62) Homo sapiens (Human) GO:0000245; GO:0000389; GO:0000398; GO:0003723; GO:0005634; GO:0005654; GO:0005681; GO:0005684; GO:0005686; GO:0006397; GO:0008270; GO:0010976; GO:0016607; GO:0071004; GO:0071005; GO:0071013; GO:1903241 mRNA 3'-splice site recognition [GO:0000389]; mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of neuron projection development [GO:0010976]; spliceosomal complex assembly [GO:0000245]; U2-type prespliceosome assembly [GO:1903241] catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U2 snRNP [GO:0005686]; U2-type precatalytic spliceosome [GO:0071005]; U2-type prespliceosome [GO:0071004]; U2-type spliceosomal complex [GO:0005684] RNA binding [GO:0003723]; zinc ion binding [GO:0008270] g6702.t1 Q6DCC6 44.785 163 5.5099999999999995e-42 152.0 sp|Q6DCC6|GTPB6_XENLA Putative GTP-binding protein 6 OS=Xenopus laevis OX=8355 GN=gtpbp6 PE=2 SV=1 g6703.t1 Q6DCC6 44.335 203 4.6699999999999995e-53 181.0 sp|Q6DCC6|GTPB6_XENLA Putative GTP-binding protein 6 OS=Xenopus laevis OX=8355 GN=gtpbp6 PE=2 SV=1 g6704.t1 Q96C34 41.604 536 6.21e-114 354.0 sp|Q96C34|RUND1_HUMAN RUN domain-containing protein 1 OS=Homo sapiens OX=9606 GN=RUNDC1 PE=1 SV=3 g6713.t1 P30883 98.592 426 0.0 847.0 sp|P30883|TBB4_XENLA Tubulin beta-4 chain OS=Xenopus laevis OX=8355 GN=tubb4 PE=1 SV=1 g6714.t1 P30883 90.233 430 0.0 762.0 sp|P30883|TBB4_XENLA Tubulin beta-4 chain OS=Xenopus laevis OX=8355 GN=tubb4 PE=1 SV=1 g6715.t1 Q7ZXY0 60.954 566 0.0 696.0 sp|Q7ZXY0|INO1A_XENLA Inositol-3-phosphate synthase 1-A OS=Xenopus laevis OX=8355 GN=isyna1-a PE=2 SV=1 g6719.t1 Q8WZ60 27.869 488 6.63e-43 166.0 sp|Q8WZ60|KLHL6_HUMAN Kelch-like protein 6 OS=Homo sapiens OX=9606 GN=KLHL6 PE=1 SV=3 g6720.t1 Q9UGM3 34.286 770 3.54e-98 335.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g6720.t1 Q9UGM3 34.433 758 4.34e-97 332.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g6720.t1 Q9UGM3 34.933 750 3.27e-96 330.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g6720.t1 Q9UGM3 34.031 764 3.82e-95 327.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g6720.t1 Q9UGM3 34.665 626 2.7400000000000005e-79 280.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g6720.t1 Q9UGM3 32.42 657 3.23e-67 244.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g6720.t1 Q9UGM3 28.645 775 1.94e-61 227.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g6721.t1 P46023 30.155 388 5.98e-40 160.0 sp|P46023|GR101_LYMST G-protein coupled receptor GRL101 OS=Lymnaea stagnalis OX=6523 PE=2 SV=1 g6723.t1 Q6DHJ3 39.618 419 2.62e-98 305.0 sp|Q6DHJ3|NVD_DANRE Cholesterol 7-desaturase nvd OS=Danio rerio OX=7955 GN=nvd PE=1 SV=1 NVD_DANRE reviewed Cholesterol 7-desaturase nvd (EC 1.14.19.21) (Protein neverland) (Nvd protein) (nvd-Dr) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005737; GO:0008203; GO:0016020; GO:0016491; GO:0046872; GO:0051537; GO:0170056 cholesterol metabolic process [GO:0008203] cytoplasm [GO:0005737]; membrane [GO:0016020] 2 iron, 2 sulfur cluster binding [GO:0051537]; cholesterol 7-desaturase [NAD(P)H] activity [GO:0170056]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491] g6725.t1 Q9SR22 35.165 364 9.779999999999999e-69 228.0 sp|Q9SR22|PAE5_ARATH Pectin acetylesterase 5 OS=Arabidopsis thaliana OX=3702 GN=PAE5 PE=2 SV=1 g6726.t1 Q9SR22 37.978 366 4.46e-73 241.0 sp|Q9SR22|PAE5_ARATH Pectin acetylesterase 5 OS=Arabidopsis thaliana OX=3702 GN=PAE5 PE=2 SV=1 g6729.t1 Q4R9E0 30.565 301 6.590000000000001e-27 119.0 sp|Q4R9E0|TECT3_MACFA Tectonic-3 OS=Macaca fascicularis OX=9541 GN=TCTN3 PE=2 SV=1 g6731.t1 Q8K3Q3 57.669 163 1.0299999999999999e-52 190.0 sp|Q8K3Q3|FOXN4_MOUSE Forkhead box protein N4 OS=Mus musculus OX=10090 GN=Foxn4 PE=1 SV=1 FOXN4_MOUSE reviewed Forkhead box protein N4 Mus musculus (Mouse) GO:0000981; GO:0000987; GO:0001947; GO:0003682; GO:0003700; GO:0005634; GO:0006355; GO:0008016; GO:0010842; GO:0021514; GO:0030154; GO:0035881; GO:0036302; GO:0045944; GO:0048663; GO:0060579 amacrine cell differentiation [GO:0035881]; atrioventricular canal development [GO:0036302]; cell differentiation [GO:0030154]; heart looping [GO:0001947]; neuron fate commitment [GO:0048663]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA-templated transcription [GO:0006355]; regulation of heart contraction [GO:0008016]; retina layer formation [GO:0010842]; ventral spinal cord interneuron differentiation [GO:0021514]; ventral spinal cord interneuron fate commitment [GO:0060579] nucleus [GO:0005634] chromatin binding [GO:0003682]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981] g6733.t1 Q96JC4 31.095 283 7.22e-23 102.0 sp|Q96JC4|ZN479_HUMAN Zinc finger protein 479 OS=Homo sapiens OX=9606 GN=ZNF479 PE=1 SV=1 g6734.t1 O43345 24.961 1282 3.68e-78 288.0 sp|O43345|ZN208_HUMAN Zinc finger protein 208 OS=Homo sapiens OX=9606 GN=ZNF208 PE=1 SV=2 g6734.t1 O43345 26.14 1140 1.54e-77 286.0 sp|O43345|ZN208_HUMAN Zinc finger protein 208 OS=Homo sapiens OX=9606 GN=ZNF208 PE=1 SV=2 g6734.t1 O43345 25.185 1215 2.36e-74 276.0 sp|O43345|ZN208_HUMAN Zinc finger protein 208 OS=Homo sapiens OX=9606 GN=ZNF208 PE=1 SV=2 g6734.t1 O43345 25.482 985 4.96e-69 259.0 sp|O43345|ZN208_HUMAN Zinc finger protein 208 OS=Homo sapiens OX=9606 GN=ZNF208 PE=1 SV=2 g6734.t1 O43345 24.981 1325 2.66e-68 257.0 sp|O43345|ZN208_HUMAN Zinc finger protein 208 OS=Homo sapiens OX=9606 GN=ZNF208 PE=1 SV=2 g6734.t1 O43345 25.636 1022 3.74e-64 244.0 sp|O43345|ZN208_HUMAN Zinc finger protein 208 OS=Homo sapiens OX=9606 GN=ZNF208 PE=1 SV=2 g6734.t1 O43345 36.889 225 3.7000000000000004e-35 150.0 sp|O43345|ZN208_HUMAN Zinc finger protein 208 OS=Homo sapiens OX=9606 GN=ZNF208 PE=1 SV=2 g6734.t1 O43345 34.123 211 8.59e-33 143.0 sp|O43345|ZN208_HUMAN Zinc finger protein 208 OS=Homo sapiens OX=9606 GN=ZNF208 PE=1 SV=2 g6734.t1 O43345 31.222 221 8.35e-24 114.0 sp|O43345|ZN208_HUMAN Zinc finger protein 208 OS=Homo sapiens OX=9606 GN=ZNF208 PE=1 SV=2 g6735.t1 Q6NV04 64.784 602 0.0 743.0 sp|Q6NV04|HACL2_DANRE 2-hydroxyacyl-CoA lyase 2 OS=Danio rerio OX=7955 GN=ilvbl PE=2 SV=1 HACL2_DANRE reviewed 2-hydroxyacyl-CoA lyase 2 (EC 4.1.2.-) (Acetolactate synthase-like protein) (IlvB-like protein) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000287; GO:0001561; GO:0003984; GO:0005789; GO:0005948; GO:0009097; GO:0009099; GO:0016829; GO:0030976; GO:0048701; GO:0050660 embryonic cranial skeleton morphogenesis [GO:0048701]; fatty acid alpha-oxidation [GO:0001561]; isoleucine biosynthetic process [GO:0009097]; L-valine biosynthetic process [GO:0009099] acetolactate synthase complex [GO:0005948]; endoplasmic reticulum membrane [GO:0005789] acetolactate synthase activity [GO:0003984]; flavin adenine dinucleotide binding [GO:0050660]; lyase activity [GO:0016829]; magnesium ion binding [GO:0000287]; thiamine pyrophosphate binding [GO:0030976] g6739.t1 Q6J6I6 32.85 207 2.12e-23 103.0 sp|Q6J6I6|ZN566_PANTR Zinc finger protein 566 OS=Pan troglodytes OX=9598 GN=ZNF566 PE=2 SV=1 g6740.t1 P52740 30.791 354 1.19e-44 169.0 sp|P52740|ZN132_HUMAN Zinc finger protein 132 OS=Homo sapiens OX=9606 GN=ZNF132 PE=1 SV=2 g6740.t1 P52740 39.49 157 8.71e-28 120.0 sp|P52740|ZN132_HUMAN Zinc finger protein 132 OS=Homo sapiens OX=9606 GN=ZNF132 PE=1 SV=2 g6740.t1 P52740 41.844 141 1.9700000000000002e-26 116.0 sp|P52740|ZN132_HUMAN Zinc finger protein 132 OS=Homo sapiens OX=9606 GN=ZNF132 PE=1 SV=2 g6740.t1 P52740 37.956 137 2.8399999999999998e-25 112.0 sp|P52740|ZN132_HUMAN Zinc finger protein 132 OS=Homo sapiens OX=9606 GN=ZNF132 PE=1 SV=2 g6740.t1 P52740 39.597 149 1.16e-24 110.0 sp|P52740|ZN132_HUMAN Zinc finger protein 132 OS=Homo sapiens OX=9606 GN=ZNF132 PE=1 SV=2 g6740.t1 P52740 39.568 139 1.5699999999999997e-23 107.0 sp|P52740|ZN132_HUMAN Zinc finger protein 132 OS=Homo sapiens OX=9606 GN=ZNF132 PE=1 SV=2 g6740.t1 P52740 36.62 142 3.36e-23 106.0 sp|P52740|ZN132_HUMAN Zinc finger protein 132 OS=Homo sapiens OX=9606 GN=ZNF132 PE=1 SV=2 g6741.t1 Q5RBP9 41.548 633 1.83e-160 484.0 sp|Q5RBP9|MPEG1_PONAB Macrophage-expressed gene 1 protein OS=Pongo abelii OX=9601 GN=MPEG1 PE=2 SV=1 MPEG1_PONAB reviewed Macrophage-expressed gene 1 protein (Macrophage gene 1 protein) (Mpg-1) (Perforin-2) (P-2) [Cleaved into: Macrophage-expressed gene 1 protein, processed form] Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0002250; GO:0002468; GO:0002478; GO:0022829; GO:0030670; GO:0031410; GO:0042590; GO:0042742; GO:0045335; GO:0050829; GO:0050830; GO:0061474; GO:0140367 adaptive immune response [GO:0002250]; antibacterial innate immune response [GO:0140367]; antigen processing and presentation of exogenous peptide antigen [GO:0002478]; antigen processing and presentation of exogenous peptide antigen via MHC class I [GO:0042590]; defense response to bacterium [GO:0042742]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; dendritic cell antigen processing and presentation [GO:0002468] cytoplasmic vesicle [GO:0031410]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; phagolysosome membrane [GO:0061474] wide pore channel activity [GO:0022829] g6742.t1 Q9Z0W3 41.056 1420 0.0 1059.0 sp|Q9Z0W3|NU160_MOUSE Nuclear pore complex protein Nup160 OS=Mus musculus OX=10090 GN=Nup160 PE=1 SV=2 g6765.t1 Q9WVR6 49.593 492 1.41e-134 403.0 sp|Q9WVR6|LAT2_RAT Large neutral amino acids transporter small subunit 2 OS=Rattus norvegicus OX=10116 GN=Slc7a8 PE=1 SV=1 LAT2_RAT reviewed Large neutral amino acids transporter small subunit 2 (L-type amino acid transporter 2) (Solute carrier family 7 member 8) Rattus norvegicus (Rat) GO:0003333; GO:0005886; GO:0006865; GO:0009925; GO:0015101; GO:0015171; GO:0015175; GO:0015179; GO:0015180; GO:0015187; GO:0015190; GO:0015297; GO:0015349; GO:0015804; GO:0015807; GO:0015816; GO:0015820; GO:0015827; GO:0015829; GO:0016323; GO:0016324; GO:0019534; GO:0031528; GO:0035524; GO:0042605; GO:0046982; GO:0070327; GO:0089718; GO:1903801; GO:1904273 amino acid import across plasma membrane [GO:0089718]; amino acid transmembrane transport [GO:0003333]; amino acid transport [GO:0006865]; glycine transport [GO:0015816]; L-alanine import across plasma membrane [GO:1904273]; L-amino acid transport [GO:0015807]; L-leucine import across plasma membrane [GO:1903801]; L-leucine transport [GO:0015820]; neutral amino acid transport [GO:0015804]; proline transmembrane transport [GO:0035524]; thyroid hormone transport [GO:0070327]; tryptophan transport [GO:0015827]; valine transport [GO:0015829] apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; microvillus membrane [GO:0031528]; plasma membrane [GO:0005886] amino acid transmembrane transporter activity [GO:0015171]; antiporter activity [GO:0015297]; glycine transmembrane transporter activity [GO:0015187]; L-alanine transmembrane transporter activity [GO:0015180]; L-amino acid transmembrane transporter activity [GO:0015179]; L-leucine transmembrane transporter activity [GO:0015190]; neutral L-amino acid transmembrane transporter activity [GO:0015175]; organic cation transmembrane transporter activity [GO:0015101]; peptide antigen binding [GO:0042605]; protein heterodimerization activity [GO:0046982]; thyroid hormone transmembrane transporter activity [GO:0015349]; toxin transmembrane transporter activity [GO:0019534] g6768.t1 Q63150 67.944 496 0.0 712.0 sp|Q63150|DPYS_RAT Dihydropyrimidinase OS=Rattus norvegicus OX=10116 GN=Dpys PE=1 SV=2 DPYS_RAT reviewed Dihydropyrimidinase (DHP) (DHPase) (EC 3.5.2.2) (Dihydropyrimidine amidohydrolase) (Hydantoinase) Rattus norvegicus (Rat) GO:0002058; GO:0002059; GO:0004157; GO:0005829; GO:0006208; GO:0006210; GO:0006212; GO:0006248; GO:0006249; GO:0008270; GO:0016597; GO:0019482; GO:0019860; GO:0032991; GO:0042802; GO:0046050; GO:0046074; GO:0046079; GO:0051219 beta-alanine metabolic process [GO:0019482]; CMP catabolic process [GO:0006248]; dCMP catabolic process [GO:0006249]; dTMP catabolic process [GO:0046074]; dUMP catabolic process [GO:0046079]; pyrimidine nucleobase catabolic process [GO:0006208]; thymine catabolic process [GO:0006210]; UMP catabolic process [GO:0046050]; uracil catabolic process [GO:0006212]; uracil metabolic process [GO:0019860] cytosol [GO:0005829]; protein-containing complex [GO:0032991] amino acid binding [GO:0016597]; dihydropyrimidinase activity [GO:0004157]; identical protein binding [GO:0042802]; phosphoprotein binding [GO:0051219]; thymine binding [GO:0002059]; uracil binding [GO:0002058]; zinc ion binding [GO:0008270] g6768.t2 Q63150 67.944 496 0.0 715.0 sp|Q63150|DPYS_RAT Dihydropyrimidinase OS=Rattus norvegicus OX=10116 GN=Dpys PE=1 SV=2 DPYS_RAT reviewed Dihydropyrimidinase (DHP) (DHPase) (EC 3.5.2.2) (Dihydropyrimidine amidohydrolase) (Hydantoinase) Rattus norvegicus (Rat) GO:0002058; GO:0002059; GO:0004157; GO:0005829; GO:0006208; GO:0006210; GO:0006212; GO:0006248; GO:0006249; GO:0008270; GO:0016597; GO:0019482; GO:0019860; GO:0032991; GO:0042802; GO:0046050; GO:0046074; GO:0046079; GO:0051219 beta-alanine metabolic process [GO:0019482]; CMP catabolic process [GO:0006248]; dCMP catabolic process [GO:0006249]; dTMP catabolic process [GO:0046074]; dUMP catabolic process [GO:0046079]; pyrimidine nucleobase catabolic process [GO:0006208]; thymine catabolic process [GO:0006210]; UMP catabolic process [GO:0046050]; uracil catabolic process [GO:0006212]; uracil metabolic process [GO:0019860] cytosol [GO:0005829]; protein-containing complex [GO:0032991] amino acid binding [GO:0016597]; dihydropyrimidinase activity [GO:0004157]; identical protein binding [GO:0042802]; phosphoprotein binding [GO:0051219]; thymine binding [GO:0002059]; uracil binding [GO:0002058]; zinc ion binding [GO:0008270] g6769.t1 P58059 57.647 85 2.39e-22 85.5 sp|P58059|RT21_MOUSE Small ribosomal subunit protein bS21m OS=Mus musculus OX=10090 GN=Mrps21 PE=1 SV=1 g6771.t1 P46023 30.346 781 4.47e-102 343.0 sp|P46023|GR101_LYMST G-protein coupled receptor GRL101 OS=Lymnaea stagnalis OX=6523 PE=2 SV=1 g6771.t2 Q8R5M3 29.894 378 6.09e-31 133.0 sp|Q8R5M3|LRC15_RAT Leucine-rich repeat-containing protein 15 OS=Rattus norvegicus OX=10116 GN=Lrrc15 PE=2 SV=1 LRC15_RAT reviewed Leucine-rich repeat-containing protein 15 (Leucine-rich repeat protein induced by amyloid-beta) (rLib) Rattus norvegicus (Rat) GO:0001968; GO:0004930; GO:0005518; GO:0005634; GO:0005886; GO:0007186; GO:0007200; GO:0007206; GO:0007268; GO:0007626; GO:0008066; GO:0009986; GO:0014069; GO:0016324; GO:0019233; GO:0019722; GO:0030331; GO:0030335; GO:0030425; GO:0038037; GO:0038038; GO:0043005; GO:0043025; GO:0043197; GO:0043236; GO:0043410; GO:0044293; GO:0044309; GO:0045211; GO:0046597; GO:0046813; GO:0051930; GO:0071257; GO:0098670; GO:0098685; GO:0098712; GO:0098839; GO:0098872; GO:0098978; GO:0099530; GO:0099538; GO:0140311; GO:1903077 calcium-mediated signaling [GO:0019722]; cellular response to electrical stimulus [GO:0071257]; chemical synaptic transmission [GO:0007268]; entry receptor-mediated virion attachment to host cell [GO:0098670]; G protein-coupled receptor signaling pathway [GO:0007186]; host-mediated suppression of symbiont invasion [GO:0046597]; L-glutamate import across plasma membrane [GO:0098712]; locomotory behavior [GO:0007626]; negative regulation of protein localization to plasma membrane [GO:1903077]; phospholipase C-activating G protein-coupled glutamate receptor signaling pathway [GO:0007206]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of cell migration [GO:0030335]; positive regulation of MAPK cascade [GO:0043410]; receptor-mediated virion attachment to host cell [GO:0046813]; regulation of sensory perception of pain [GO:0051930]; sensory perception of pain [GO:0019233]; synaptic signaling via neuropeptide [GO:0099538] apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; dendriole [GO:0044293]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; G protein-coupled receptor dimeric complex [GO:0038037]; G protein-coupled receptor homodimeric complex [GO:0038038]; glutamatergic synapse [GO:0098978]; neuron projection [GO:0043005]; neuron spine [GO:0044309]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic density membrane [GO:0098839]; postsynaptic membrane [GO:0045211]; Schaffer collateral - CA1 synapse [GO:0098685] collagen binding [GO:0005518]; fibronectin binding [GO:0001968]; G protein-coupled neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration [GO:0098872]; G protein-coupled receptor activity [GO:0004930]; G protein-coupled receptor activity involved in regulation of postsynaptic membrane potential [GO:0099530]; glutamate receptor activity [GO:0008066]; laminin binding [GO:0043236]; nuclear estrogen receptor binding [GO:0030331]; protein sequestering activity [GO:0140311] g6772.t1 Q6DCX5 25.676 444 8.73e-33 133.0 sp|Q6DCX5|PCFT_XENLA Proton-coupled folate transporter OS=Xenopus laevis OX=8355 GN=slc46a1 PE=2 SV=1 PCFT_XENLA reviewed Proton-coupled folate transporter (Heme carrier protein 1) (Solute carrier family 46 member 1) Xenopus laevis (African clawed frog) GO:0005542; GO:0005768; GO:0005886; GO:0010008; GO:0015293; GO:0015350; GO:0016323; GO:0016324; GO:0022857; GO:0055085 transmembrane transport [GO:0055085] apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; endosome [GO:0005768]; endosome membrane [GO:0010008]; plasma membrane [GO:0005886] folic acid binding [GO:0005542]; methotrexate transmembrane transporter activity [GO:0015350]; symporter activity [GO:0015293]; transmembrane transporter activity [GO:0022857] g6775.t1 Q9BXB4 51.548 646 0.0 614.0 sp|Q9BXB4|OSB11_HUMAN Oxysterol-binding protein-related protein 11 OS=Homo sapiens OX=9606 GN=OSBPL11 PE=1 SV=2 g6776.t1 P47941 45.13 308 1.14e-77 242.0 sp|P47941|CRKL_MOUSE Crk-like protein OS=Mus musculus OX=10090 GN=Crkl PE=1 SV=2 CRKL_MOUSE reviewed Crk-like protein Mus musculus (Mouse) GO:0001558; GO:0001568; GO:0001655; GO:0001764; GO:0001783; GO:0001784; GO:0002685; GO:0003151; GO:0005654; GO:0005737; GO:0005829; GO:0006629; GO:0007167; GO:0007283; GO:0007338; GO:0007389; GO:0007507; GO:0008284; GO:0008543; GO:0008584; GO:0009887; GO:0009952; GO:0010468; GO:0010629; GO:0016358; GO:0016477; GO:0021766; GO:0021987; GO:0030010; GO:0030971; GO:0031594; GO:0032991; GO:0033628; GO:0035022; GO:0035591; GO:0035685; GO:0038026; GO:0042802; GO:0043410; GO:0045202; GO:0048384; GO:0048538; GO:0050773; GO:0050852; GO:0060017; GO:0060326; GO:0060392; GO:0061629; GO:0070374; GO:0071466; GO:0071560; GO:0071774; GO:0086100; GO:0095500; GO:0098698; GO:0098749; GO:0098761; GO:0098890; GO:0160093; GO:1900026; GO:1903977; GO:1904393; GO:1904395; GO:1904888; GO:2000404 acetylcholine receptor signaling pathway [GO:0095500]; animal organ morphogenesis [GO:0009887]; anterior/posterior pattern specification [GO:0009952]; B cell apoptotic process [GO:0001783]; blood vessel development [GO:0001568]; cell chemotaxis [GO:0060326]; cell migration [GO:0016477]; cellular response to interleukin-7 [GO:0098761]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cellular response to xenobiotic stimulus [GO:0071466]; cerebellar neuron development [GO:0098749]; cerebral cortex development [GO:0021987]; chordate pharynx development [GO:0160093]; cranial skeletal system development [GO:1904888]; dendrite development [GO:0016358]; endothelin receptor signaling pathway [GO:0086100]; enzyme-linked receptor protein signaling pathway [GO:0007167]; establishment of cell polarity [GO:0030010]; fibroblast growth factor receptor signaling pathway [GO:0008543]; heart development [GO:0007507]; helper T cell diapedesis [GO:0035685]; hippocampus development [GO:0021766]; lipid metabolic process [GO:0006629]; male gonad development [GO:0008584]; negative regulation of gene expression [GO:0010629]; negative regulation of SMAD protein signal transduction [GO:0060392]; neuron migration [GO:0001764]; outflow tract morphogenesis [GO:0003151]; parathyroid gland development [GO:0060017]; pattern specification process [GO:0007389]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of glial cell migration [GO:1903977]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of Rac protein signal transduction [GO:0035022]; positive regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904395]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; postsynaptic specialization assembly [GO:0098698]; reelin-mediated signaling pathway [GO:0038026]; regulation of cell adhesion mediated by integrin [GO:0033628]; regulation of cell growth [GO:0001558]; regulation of dendrite development [GO:0050773]; regulation of gene expression [GO:0010468]; regulation of leukocyte migration [GO:0002685]; regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904393]; regulation of T cell migration [GO:2000404]; response to fibroblast growth factor [GO:0071774]; retinoic acid receptor signaling pathway [GO:0048384]; single fertilization [GO:0007338]; spermatogenesis [GO:0007283]; T cell receptor signaling pathway [GO:0050852]; thymus development [GO:0048538]; urogenital system development [GO:0001655] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of postsynaptic membrane [GO:0098890]; neuromuscular junction [GO:0031594]; nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991]; synapse [GO:0045202] identical protein binding [GO:0042802]; phosphotyrosine residue binding [GO:0001784]; receptor tyrosine kinase binding [GO:0030971]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; signaling adaptor activity [GO:0035591] g6777.t1 Q5XI67 45.614 171 1.13e-37 155.0 sp|Q5XI67|FBX30_RAT F-box only protein 30 OS=Rattus norvegicus OX=10116 GN=Fbxo30 PE=1 SV=1 g6777.t1 Q5XI67 47.26 146 3.86e-35 147.0 sp|Q5XI67|FBX30_RAT F-box only protein 30 OS=Rattus norvegicus OX=10116 GN=Fbxo30 PE=1 SV=1 g6777.t1 Q5XI67 47.706 109 7.37e-25 114.0 sp|Q5XI67|FBX30_RAT F-box only protein 30 OS=Rattus norvegicus OX=10116 GN=Fbxo30 PE=1 SV=1 g6778.t1 Q33E94 55.034 298 8.71e-108 343.0 sp|Q33E94|RFX4_HUMAN Transcription factor RFX4 OS=Homo sapiens OX=9606 GN=RFX4 PE=1 SV=2 RFX4_HUMAN reviewed Transcription factor RFX4 (Regulatory factor X 4) (Testis development protein NYD-SP10) Homo sapiens (Human) GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0005634; GO:0006357; GO:0021513; GO:0021537; GO:0045879; GO:0045944; GO:0060271; GO:0070613; GO:1990837 cilium assembly [GO:0060271]; negative regulation of smoothened signaling pathway [GO:0045879]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of protein processing [GO:0070613]; regulation of transcription by RNA polymerase II [GO:0006357]; spinal cord dorsal/ventral patterning [GO:0021513]; telencephalon development [GO:0021537] chromatin [GO:0000785]; nucleus [GO:0005634] DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837] g6778.t2 Q33E94 52.336 321 4.8600000000000006e-110 354.0 sp|Q33E94|RFX4_HUMAN Transcription factor RFX4 OS=Homo sapiens OX=9606 GN=RFX4 PE=1 SV=2 RFX4_HUMAN reviewed Transcription factor RFX4 (Regulatory factor X 4) (Testis development protein NYD-SP10) Homo sapiens (Human) GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0005634; GO:0006357; GO:0021513; GO:0021537; GO:0045879; GO:0045944; GO:0060271; GO:0070613; GO:1990837 cilium assembly [GO:0060271]; negative regulation of smoothened signaling pathway [GO:0045879]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of protein processing [GO:0070613]; regulation of transcription by RNA polymerase II [GO:0006357]; spinal cord dorsal/ventral patterning [GO:0021513]; telencephalon development [GO:0021537] chromatin [GO:0000785]; nucleus [GO:0005634] DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837] g6782.t1 Q33E94 66.447 152 1.1e-57 196.0 sp|Q33E94|RFX4_HUMAN Transcription factor RFX4 OS=Homo sapiens OX=9606 GN=RFX4 PE=1 SV=2 RFX4_HUMAN reviewed Transcription factor RFX4 (Regulatory factor X 4) (Testis development protein NYD-SP10) Homo sapiens (Human) GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0005634; GO:0006357; GO:0021513; GO:0021537; GO:0045879; GO:0045944; GO:0060271; GO:0070613; GO:1990837 cilium assembly [GO:0060271]; negative regulation of smoothened signaling pathway [GO:0045879]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of protein processing [GO:0070613]; regulation of transcription by RNA polymerase II [GO:0006357]; spinal cord dorsal/ventral patterning [GO:0021513]; telencephalon development [GO:0021537] chromatin [GO:0000785]; nucleus [GO:0005634] DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837] g6813.t1 P19375 59.756 82 6.1e-26 102.0 sp|P19375|H1E_STRPU Histone H1, early embryonic OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g6814.t1 P19375 59.756 82 5.03e-26 102.0 sp|P19375|H1E_STRPU Histone H1, early embryonic OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g6815.t1 P19375 59.756 82 6.380000000000001e-27 102.0 sp|P19375|H1E_STRPU Histone H1, early embryonic OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g6816.t1 P19375 59.756 82 5.03e-26 102.0 sp|P19375|H1E_STRPU Histone H1, early embryonic OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g6819.t1 Q6ZW49 44.467 497 4.12e-141 449.0 sp|Q6ZW49|PAXI1_HUMAN PAX-interacting protein 1 OS=Homo sapiens OX=9606 GN=PAXIP1 PE=1 SV=2 PAXI1_HUMAN reviewed PAX-interacting protein 1 (PAX transactivation activation domain-interacting protein) Homo sapiens (Human) GO:0001570; GO:0005634; GO:0005654; GO:0005694; GO:0006281; GO:0006310; GO:0006338; GO:0010212; GO:0016363; GO:0030330; GO:0031398; GO:0035097; GO:0043433; GO:0043542; GO:0044666; GO:0045830; GO:0048304; GO:0060261; GO:0060612; GO:0060717; GO:1902749 adipose tissue development [GO:0060612]; chorion development [GO:0060717]; chromatin remodeling [GO:0006338]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; endothelial cell migration [GO:0043542]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; positive regulation of isotype switching [GO:0045830]; positive regulation of isotype switching to IgG isotypes [GO:0048304]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of transcription initiation by RNA polymerase II [GO:0060261]; regulation of cell cycle G2/M phase transition [GO:1902749]; response to ionizing radiation [GO:0010212]; vasculogenesis [GO:0001570] chromosome [GO:0005694]; histone methyltransferase complex [GO:0035097]; MLL3/4 complex [GO:0044666]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] g6819.t1 Q6ZW49 46.667 180 1.5599999999999997e-48 190.0 sp|Q6ZW49|PAXI1_HUMAN PAX-interacting protein 1 OS=Homo sapiens OX=9606 GN=PAXIP1 PE=1 SV=2 PAXI1_HUMAN reviewed PAX-interacting protein 1 (PAX transactivation activation domain-interacting protein) Homo sapiens (Human) GO:0001570; GO:0005634; GO:0005654; GO:0005694; GO:0006281; GO:0006310; GO:0006338; GO:0010212; GO:0016363; GO:0030330; GO:0031398; GO:0035097; GO:0043433; GO:0043542; GO:0044666; GO:0045830; GO:0048304; GO:0060261; GO:0060612; GO:0060717; GO:1902749 adipose tissue development [GO:0060612]; chorion development [GO:0060717]; chromatin remodeling [GO:0006338]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; endothelial cell migration [GO:0043542]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; positive regulation of isotype switching [GO:0045830]; positive regulation of isotype switching to IgG isotypes [GO:0048304]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of transcription initiation by RNA polymerase II [GO:0060261]; regulation of cell cycle G2/M phase transition [GO:1902749]; response to ionizing radiation [GO:0010212]; vasculogenesis [GO:0001570] chromosome [GO:0005694]; histone methyltransferase complex [GO:0035097]; MLL3/4 complex [GO:0044666]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] g6820.t1 Q9NPD8 64.968 157 5.69e-75 228.0 sp|Q9NPD8|UBE2T_HUMAN Ubiquitin-conjugating enzyme E2 T OS=Homo sapiens OX=9606 GN=UBE2T PE=1 SV=1 UBE2T_HUMAN reviewed Ubiquitin-conjugating enzyme E2 T (EC 2.3.2.23) (Cell proliferation-inducing gene 50 protein) (E2 ubiquitin-conjugating enzyme T) (Ubiquitin carrier protein T) (Ubiquitin-protein ligase T) Homo sapiens (Human) GO:0000209; GO:0003682; GO:0004842; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0006281; GO:0006513; GO:0006974; GO:0031625; GO:0035519; GO:0044314; GO:0051865; GO:0061631; GO:0070534; GO:0070936; GO:0070979; GO:0085020 DNA damage response [GO:0006974]; DNA repair [GO:0006281]; protein autoubiquitination [GO:0051865]; protein K11-linked ubiquitination [GO:0070979]; protein K27-linked ubiquitination [GO:0044314]; protein K29-linked ubiquitination [GO:0035519]; protein K48-linked ubiquitination [GO:0070936]; protein K6-linked ubiquitination [GO:0085020]; protein K63-linked ubiquitination [GO:0070534]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209] nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] ATP binding [GO:0005524]; chromatin binding [GO:0003682]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842] g6821.t1 Q9NW08 80.551 1126 0.0 1857.0 sp|Q9NW08|RPC2_HUMAN DNA-directed RNA polymerase III subunit RPC2 OS=Homo sapiens OX=9606 GN=POLR3B PE=1 SV=2 RPC2_HUMAN reviewed DNA-directed RNA polymerase III subunit RPC2 (RNA polymerase III subunit C2) (EC 2.7.7.6) (C128) (DNA-directed RNA polymerase III 127.6 kDa polypeptide) (DNA-directed RNA polymerase III subunit B) Homo sapiens (Human) GO:0003677; GO:0003899; GO:0005654; GO:0005666; GO:0005737; GO:0005829; GO:0008270; GO:0032549; GO:0032728; GO:0042796; GO:0045087; GO:0045089; GO:0051607; GO:0055029; GO:0071667 defense response to virus [GO:0051607]; innate immune response [GO:0045087]; positive regulation of innate immune response [GO:0045089]; positive regulation of interferon-beta production [GO:0032728]; snRNA transcription by RNA polymerase III [GO:0042796] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear DNA-directed RNA polymerase complex [GO:0055029]; nucleoplasm [GO:0005654]; RNA polymerase III complex [GO:0005666] DNA binding [GO:0003677]; DNA-directed RNA polymerase activity [GO:0003899]; DNA/RNA hybrid binding [GO:0071667]; ribonucleoside binding [GO:0032549]; zinc ion binding [GO:0008270] g6822.t1 Q6DC77 42.384 302 1.5e-71 229.0 sp|Q6DC77|MPRGB_DANRE Membrane progestin receptor gamma-B OS=Danio rerio OX=7955 GN=paqr5b PE=2 SV=1 g6823.t1 Q9BV20 62.429 354 5.62e-143 412.0 sp|Q9BV20|MTNA_HUMAN Methylthioribose-1-phosphate isomerase OS=Homo sapiens OX=9606 GN=MRI1 PE=1 SV=1 MTNA_HUMAN reviewed Methylthioribose-1-phosphate isomerase (M1Pi) (MTR-1-P isomerase) (EC 5.3.1.23) (Mediator of RhoA-dependent invasion) (S-methyl-5-thioribose-1-phosphate isomerase) (Translation initiation factor eIF-2B subunit alpha/beta/delta-like protein) Homo sapiens (Human) GO:0001650; GO:0005654; GO:0005829; GO:0019509; GO:0042802; GO:0042995; GO:0046523 L-methionine salvage from methylthioadenosine [GO:0019509] cell projection [GO:0042995]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654] identical protein binding [GO:0042802]; S-methyl-5-thioribose-1-phosphate isomerase activity [GO:0046523] g6826.t1 Q96BK5 45.701 221 3.66e-52 179.0 sp|Q96BK5|PINX1_HUMAN PIN2/TERF1-interacting telomerase inhibitor 1 OS=Homo sapiens OX=9606 GN=PINX1 PE=1 SV=2 PINX1_HUMAN reviewed PIN2/TERF1-interacting telomerase inhibitor 1 (Liver-related putative tumor suppressor) (Pin2-interacting protein X1) (Protein 67-11-3) (TRF1-interacting protein 1) Homo sapiens (Human) GO:0000228; GO:0000776; GO:0000781; GO:0005654; GO:0005730; GO:0005739; GO:0005819; GO:0007004; GO:0007080; GO:0008285; GO:0010521; GO:0010972; GO:0031397; GO:0031647; GO:0032211; GO:0044877; GO:0070034; GO:0070198; GO:1902570; GO:1904357; GO:1904751 mitotic metaphase chromosome alignment [GO:0007080]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of telomere maintenance via telomerase [GO:0032211]; negative regulation of telomere maintenance via telomere lengthening [GO:1904357]; positive regulation of protein localization to nucleolus [GO:1904751]; protein localization to chromosome, telomeric region [GO:0070198]; protein localization to nucleolus [GO:1902570]; regulation of protein stability [GO:0031647]; telomere maintenance via telomerase [GO:0007004] chromosome, telomeric region [GO:0000781]; kinetochore [GO:0000776]; mitochondrion [GO:0005739]; nuclear chromosome [GO:0000228]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; spindle [GO:0005819] protein-containing complex binding [GO:0044877]; telomerase inhibitor activity [GO:0010521]; telomerase RNA binding [GO:0070034] g6827.t1 Q66JG5 51.078 464 3.5699999999999996e-114 345.0 sp|Q66JG5|TADA3_XENTR Transcriptional adapter 3 OS=Xenopus tropicalis OX=8364 GN=tada3 PE=2 SV=1 g6830.t1 Q96MF2 37.692 130 3.46e-23 100.0 sp|Q96MF2|STAC3_HUMAN SH3 and cysteine-rich domain-containing protein 3 OS=Homo sapiens OX=9606 GN=STAC3 PE=1 SV=1 STAC3_HUMAN reviewed SH3 and cysteine-rich domain-containing protein 3 Homo sapiens (Human) GO:0003009; GO:0005654; GO:0005829; GO:0005891; GO:0007274; GO:0008270; GO:0009898; GO:0030315; GO:0042802; GO:0045202; GO:0048741; GO:1901387; GO:1903078 neuromuscular synaptic transmission [GO:0007274]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of voltage-gated calcium channel activity [GO:1901387]; skeletal muscle contraction [GO:0003009]; skeletal muscle fiber development [GO:0048741] cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; synapse [GO:0045202]; T-tubule [GO:0030315]; voltage-gated calcium channel complex [GO:0005891] identical protein binding [GO:0042802]; zinc ion binding [GO:0008270] g6833.t1 A6NJI9 31.203 266 8.890000000000001e-35 130.0 sp|A6NJI9|LRC72_HUMAN Leucine-rich repeat-containing protein 72 OS=Homo sapiens OX=9606 GN=LRRC72 PE=1 SV=2 g6835.t1 Q07832 60.781 589 0.0 769.0 sp|Q07832|PLK1_MOUSE Serine/threonine-protein kinase PLK1 OS=Mus musculus OX=10090 GN=Plk1 PE=1 SV=2 PLK1_MOUSE reviewed Serine/threonine-protein kinase PLK1 (EC 2.7.11.21) (Polo-like kinase 1) (PLK-1) (Serine/threonine-protein kinase 13) (STPK13) Mus musculus (Mouse) GO:0000070; GO:0000086; GO:0000122; GO:0000132; GO:0000278; GO:0000281; GO:0000287; GO:0000724; GO:0000775; GO:0000776; GO:0000779; GO:0000785; GO:0000795; GO:0000922; GO:0000940; GO:0001578; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005813; GO:0005814; GO:0005819; GO:0005876; GO:0006302; GO:0006468; GO:0007052; GO:0007094; GO:0007095; GO:0007098; GO:0007346; GO:0008017; GO:0010997; GO:0015630; GO:0016321; GO:0016567; GO:0019901; GO:0030071; GO:0030496; GO:0031648; GO:0032436; GO:0032465; GO:0034451; GO:0040038; GO:0042802; GO:0043066; GO:0045143; GO:0045184; GO:0045842; GO:0045862; GO:0051081; GO:0051233; GO:0051299; GO:0070194; GO:0071168; GO:0071539; GO:0090435; GO:0097431; GO:0097681; GO:0106310; GO:1901673; GO:1903673; GO:1904776; GO:1990166; GO:2000042 centrosome cycle [GO:0007098]; centrosome separation [GO:0051299]; double-strand break repair [GO:0006302]; double-strand break repair via alternative nonhomologous end joining [GO:0097681]; double-strand break repair via homologous recombination [GO:0000724]; establishment of mitotic spindle orientation [GO:0000132]; establishment of protein localization [GO:0045184]; female meiosis chromosome segregation [GO:0016321]; G2/M transition of mitotic cell cycle [GO:0000086]; homologous chromosome segregation [GO:0045143]; microtubule bundle formation [GO:0001578]; mitotic cell cycle [GO:0000278]; mitotic cleavage furrow formation [GO:1903673]; mitotic cytokinesis [GO:0000281]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; mitotic sister chromatid segregation [GO:0000070]; mitotic spindle assembly checkpoint signaling [GO:0007094]; mitotic spindle organization [GO:0007052]; negative regulation of apoptotic process [GO:0043066]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nuclear membrane disassembly [GO:0051081]; polar body extrusion after meiotic divisions [GO:0040038]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of proteolysis [GO:0045862]; protein destabilization [GO:0031648]; protein localization to centrosome [GO:0071539]; protein localization to chromatin [GO:0071168]; protein localization to nuclear envelope [GO:0090435]; protein localization to site of double-strand break [GO:1990166]; protein phosphorylation [GO:0006468]; protein ubiquitination [GO:0016567]; regulation of cytokinesis [GO:0032465]; regulation of mitotic cell cycle [GO:0007346]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; regulation of mitotic spindle assembly [GO:1901673]; regulation of protein localization to cell cortex [GO:1904776]; synaptonemal complex disassembly [GO:0070194] centriolar satellite [GO:0034451]; centriole [GO:0005814]; centrosome [GO:0005813]; chromatin [GO:0000785]; chromosome, centromeric region [GO:0000775]; condensed chromosome, centromeric region [GO:0000779]; cytoplasm [GO:0005737]; kinetochore [GO:0000776]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; mitotic spindle pole [GO:0097431]; nucleus [GO:0005634]; outer kinetochore [GO:0000940]; spindle [GO:0005819]; spindle microtubule [GO:0005876]; spindle midzone [GO:0051233]; spindle pole [GO:0000922]; synaptonemal complex [GO:0000795] anaphase-promoting complex binding [GO:0010997]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; microtubule binding [GO:0008017]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g6837.t1 Q6EAS5 62.704 673 0.0 862.0 sp|Q6EAS5|GLGB_HORSE 1,4-alpha-glucan-branching enzyme OS=Equus caballus OX=9796 GN=GBE1 PE=1 SV=1 GLGB_HORSE reviewed 1,4-alpha-glucan-branching enzyme (EC 2.4.1.18) (Brancher enzyme) (Glycogen-branching enzyme) Equus caballus (Horse) GO:0003844; GO:0004553; GO:0005737; GO:0005829; GO:0005978; GO:0043169 glycogen biosynthetic process [GO:0005978] cytoplasm [GO:0005737]; cytosol [GO:0005829] 1,4-alpha-glucan branching enzyme activity [GO:0003844]; cation binding [GO:0043169]; hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553] g6838.t1 Q6XVN8 72.5 120 4.35e-61 186.0 sp|Q6XVN8|MLP3A_RAT Microtubule-associated protein 1 light chain 3 alpha OS=Rattus norvegicus OX=10116 GN=Map1lc3a PE=1 SV=1 MLP3A_RAT reviewed Microtubule-associated protein 1 light chain 3 alpha (Autophagy-related protein LC3 A) (Autophagy-related ubiquitin-like modifier LC3 A) (MAP1 light chain 3-like protein 1) (Microtubule-associated proteins 1A/1B light chain 3A) (MAP1A/MAP1B LC3 A) (MAP1A/MAP1B light chain 3 A) Rattus norvegicus (Rat) GO:0000045; GO:0000421; GO:0000422; GO:0000423; GO:0005543; GO:0005737; GO:0005770; GO:0005776; GO:0005829; GO:0005874; GO:0006914; GO:0006995; GO:0007254; GO:0008017; GO:0008429; GO:0009267; GO:0010040; GO:0010288; GO:0016236; GO:0031090; GO:0031625; GO:0031667; GO:0034198; GO:0038066; GO:0044754; GO:0045202; GO:0060395; GO:0070301; GO:0071280; GO:0090650; GO:0097352; GO:0098978 autophagosome assembly [GO:0000045]; autophagosome maturation [GO:0097352]; autophagy [GO:0006914]; autophagy of mitochondrion [GO:0000422]; cellular response to amino acid starvation [GO:0034198]; cellular response to copper ion [GO:0071280]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to nitrogen starvation [GO:0006995]; cellular response to oxygen-glucose deprivation [GO:0090650]; cellular response to starvation [GO:0009267]; JNK cascade [GO:0007254]; macroautophagy [GO:0016236]; mitophagy [GO:0000423]; p38MAPK cascade [GO:0038066]; response to iron(II) ion [GO:0010040]; response to lead ion [GO:0010288]; response to nutrient levels [GO:0031667]; SMAD protein signal transduction [GO:0060395] autolysosome [GO:0044754]; autophagosome [GO:0005776]; autophagosome membrane [GO:0000421]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; late endosome [GO:0005770]; microtubule [GO:0005874]; organelle membrane [GO:0031090]; synapse [GO:0045202] microtubule binding [GO:0008017]; phosphatidylethanolamine binding [GO:0008429]; phospholipid binding [GO:0005543]; ubiquitin protein ligase binding [GO:0031625] g6840.t1 Q4KMD3 62.025 158 5.600000000000001e-56 179.0 sp|Q4KMD3|U1SBP_DANRE U11/U12 small nuclear ribonucleoprotein 35 kDa protein OS=Danio rerio OX=7955 GN=snrnp35 PE=2 SV=1 g6842.t1 D2HNW6 51.62 895 0.0 775.0 sp|D2HNW6|RFX6_AILME DNA-binding protein RFX6 OS=Ailuropoda melanoleuca OX=9646 GN=RFX6 PE=3 SV=2 g6844.t1 Q9UB37 58.741 143 3.0400000000000004e-57 179.0 sp|Q9UB37|CALM2_BRALA Calmodulin-2 OS=Branchiostoma lanceolatum OX=7740 GN=CAM2 PE=2 SV=3 g6846.t1 Q9Z2G9 49.561 228 7.92e-69 217.0 sp|Q9Z2G9|HTAI2_MOUSE Protein HTATIP2 OS=Mus musculus OX=10090 GN=Htatip2 PE=1 SV=3 HTAI2_MOUSE reviewed Protein HTATIP2 Mus musculus (Mouse) GO:0004674; GO:0005737; GO:0005829; GO:0006417; GO:0016620; GO:0043068; GO:0045944; GO:0051287; GO:1901607 alpha-amino acid biosynthetic process [GO:1901607]; positive regulation of programmed cell death [GO:0043068]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of translation [GO:0006417] cytoplasm [GO:0005737]; cytosol [GO:0005829] NAD binding [GO:0051287]; oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor [GO:0016620]; protein serine/threonine kinase activity [GO:0004674] g6847.t1 Q9UPU7 35.455 990 0.0 566.0 sp|Q9UPU7|TBD2B_HUMAN TBC1 domain family member 2B OS=Homo sapiens OX=9606 GN=TBC1D2B PE=1 SV=2 g6849.t1 P79800 79.255 188 3.5999999999999997e-93 272.0 sp|P79800|RASK_MELGA GTPase KRas OS=Meleagris gallopavo OX=9103 GN=KRAS PE=1 SV=1 g6849.t2 P79800 79.255 188 3.5999999999999997e-93 272.0 sp|P79800|RASK_MELGA GTPase KRas OS=Meleagris gallopavo OX=9103 GN=KRAS PE=1 SV=1 g6850.t1 O76536 28.878 606 1.45e-35 149.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g6850.t1 O76536 27.961 608 1.1900000000000002e-31 137.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g6850.t2 O76536 28.714 700 1.1199999999999999e-38 160.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g6850.t2 O76536 28.674 694 1.5300000000000002e-37 156.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g6850.t2 O76536 26.93 557 2.8000000000000003e-27 123.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g6850.t3 O76536 27.928 777 4.11e-41 168.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g6850.t3 O76536 25.538 744 5.1500000000000005e-27 122.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g6853.t1 O88871 32.709 587 2.41e-101 332.0 sp|O88871|GABR2_RAT Gamma-aminobutyric acid type B receptor subunit 2 OS=Rattus norvegicus OX=10116 GN=Gabbr2 PE=1 SV=2 GABR2_RAT reviewed Gamma-aminobutyric acid type B receptor subunit 2 (GABA-B receptor 2) (GABA-B-R2) (GABA-BR2) (GABABR2) (Gb2) (G-protein coupled receptor 51) Rattus norvegicus (Rat) GO:0004965; GO:0005737; GO:0005886; GO:0007193; GO:0007214; GO:0030425; GO:0038039; GO:0042734; GO:0043005; GO:0043204; GO:0045211; GO:0046982; GO:0051932; GO:0098978; GO:0098982; GO:0150099; GO:1902710; GO:1902712 adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; gamma-aminobutyric acid signaling pathway [GO:0007214]; neuron-glial cell signaling [GO:0150099]; synaptic transmission, GABAergic [GO:0051932] cytoplasm [GO:0005737]; dendrite [GO:0030425]; G protein-coupled GABA receptor complex [GO:1902712]; G protein-coupled receptor heterodimeric complex [GO:0038039]; GABA receptor complex [GO:1902710]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; neuron projection [GO:0043005]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734] G protein-coupled GABA receptor activity [GO:0004965]; protein heterodimerization activity [GO:0046982] g6854.t1 Q95SX7 28.609 381 3.47e-29 125.0 sp|Q95SX7|RTBS_DROME Probable RNA-directed DNA polymerase from transposon BS OS=Drosophila melanogaster OX=7227 GN=RTase PE=2 SV=1 g6865.t1 P51648 56.25 400 1.81e-145 431.0 sp|P51648|AL3A2_HUMAN Aldehyde dehydrogenase family 3 member A2 OS=Homo sapiens OX=9606 GN=ALDH3A2 PE=1 SV=1 AL3A2_HUMAN reviewed Aldehyde dehydrogenase family 3 member A2 (EC 1.2.1.3) (EC 1.2.1.94) (Aldehyde dehydrogenase 10) (Fatty aldehyde dehydrogenase) (Microsomal aldehyde dehydrogenase) Homo sapiens (Human) GO:0004028; GO:0004029; GO:0005737; GO:0005777; GO:0005778; GO:0005789; GO:0005829; GO:0006081; GO:0006631; GO:0006714; GO:0007417; GO:0007422; GO:0008544; GO:0033306; GO:0042803; GO:0043231; GO:0046458; GO:0046577; GO:0050061; GO:0052814; GO:0120553 aldehyde metabolic process [GO:0006081]; central nervous system development [GO:0007417]; epidermis development [GO:0008544]; fatty acid metabolic process [GO:0006631]; hexadecanal metabolic process [GO:0046458]; peripheral nervous system development [GO:0007422]; phytol metabolic process [GO:0033306]; sesquiterpenoid metabolic process [GO:0006714] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777] 3-chloroallyl aldehyde dehydrogenase activity [GO:0004028]; aldehyde dehydrogenase (NAD+) activity [GO:0004029]; farnesal dehydrogenase (NAD+) activity [GO:0120553]; long-chain fatty aldehyde dehydrogenase (NAD+) activity [GO:0050061]; long-chain-alcohol oxidase activity [GO:0046577]; medium-chain fatty aldehyde dehydrogenase (NAD+) activity [GO:0052814]; protein homodimerization activity [GO:0042803] g6869.t1 P0CT40 27.864 646 1.62e-60 226.0 sp|P0CT40|TF29_SCHPO Transposon Tf2-9 polyprotein OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) OX=284812 GN=Tf2-9 PE=3 SV=1 g6909.t1 Q96MB7 36.649 191 2.7700000000000003e-27 115.0 sp|Q96MB7|HARB1_HUMAN Putative nuclease HARBI1 OS=Homo sapiens OX=9606 GN=HARBI1 PE=1 SV=1 HARB1_HUMAN reviewed Putative nuclease HARBI1 (EC 3.1.-.-) (Harbinger transposase-derived nuclease) Homo sapiens (Human) GO:0004518; GO:0005634; GO:0005829; GO:0005886; GO:0016787; GO:0034451; GO:0046872 centriolar satellite [GO:0034451]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886] hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]; nuclease activity [GO:0004518] g6936.t1 Q6AZB8 37.762 143 2.28e-28 111.0 sp|Q6AZB8|HARB1_DANRE Putative nuclease HARBI1 OS=Danio rerio OX=7955 GN=harbi1 PE=2 SV=1 HARB1_DANRE reviewed Putative nuclease HARBI1 (EC 3.1.-.-) (Harbinger transposase-derived nuclease) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0004518; GO:0005634; GO:0005737; GO:0016787; GO:0046872 cytoplasm [GO:0005737]; nucleus [GO:0005634] hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]; nuclease activity [GO:0004518] g6946.t1 Q04202 40.625 160 7.75e-32 117.0 sp|Q04202|TCB2_CAEBR Transposable element Tcb2 transposase OS=Caenorhabditis briggsae OX=6238 PE=3 SV=1 g6954.t1 Q96DM1 28.872 523 4.8099999999999994e-48 180.0 sp|Q96DM1|PGBD4_HUMAN PiggyBac transposable element-derived protein 4 OS=Homo sapiens OX=9606 GN=PGBD4 PE=1 SV=3 g6956.t1 Q17QR8 34.875 281 9.96e-51 176.0 sp|Q17QR8|HARB1_BOVIN Putative nuclease HARBI1 OS=Bos taurus OX=9913 GN=HARBI1 PE=2 SV=1 g6963.t1 Q96MB7 41.772 237 2.7899999999999998e-42 150.0 sp|Q96MB7|HARB1_HUMAN Putative nuclease HARBI1 OS=Homo sapiens OX=9606 GN=HARBI1 PE=1 SV=1 HARB1_HUMAN reviewed Putative nuclease HARBI1 (EC 3.1.-.-) (Harbinger transposase-derived nuclease) Homo sapiens (Human) GO:0004518; GO:0005634; GO:0005829; GO:0005886; GO:0016787; GO:0034451; GO:0046872 centriolar satellite [GO:0034451]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886] hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]; nuclease activity [GO:0004518] g6963.t2 Q96MB7 41.732 254 1.55e-45 162.0 sp|Q96MB7|HARB1_HUMAN Putative nuclease HARBI1 OS=Homo sapiens OX=9606 GN=HARBI1 PE=1 SV=1 HARB1_HUMAN reviewed Putative nuclease HARBI1 (EC 3.1.-.-) (Harbinger transposase-derived nuclease) Homo sapiens (Human) GO:0004518; GO:0005634; GO:0005829; GO:0005886; GO:0016787; GO:0034451; GO:0046872 centriolar satellite [GO:0034451]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886] hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]; nuclease activity [GO:0004518] g6975.t1 Q9H5L6 32.53 166 6.94e-21 97.4 sp|Q9H5L6|THAP9_HUMAN DNA transposase THAP9 OS=Homo sapiens OX=9606 GN=THAP9 PE=1 SV=2 g6985.t1 Q17QR8 34.52 281 1.02e-49 173.0 sp|Q17QR8|HARB1_BOVIN Putative nuclease HARBI1 OS=Bos taurus OX=9913 GN=HARBI1 PE=2 SV=1 g6989.t1 Q9H5L6 32.18 289 3.69e-48 177.0 sp|Q9H5L6|THAP9_HUMAN DNA transposase THAP9 OS=Homo sapiens OX=9606 GN=THAP9 PE=1 SV=2 g7022.t1 Q9H0J4 35.0 300 2.85e-34 146.0 sp|Q9H0J4|QRIC2_HUMAN Glutamine-rich protein 2 OS=Homo sapiens OX=9606 GN=QRICH2 PE=1 SV=1 QRIC2_HUMAN reviewed Glutamine-rich protein 2 Homo sapiens (Human) GO:0005737; GO:0030031; GO:0030317; GO:0031965; GO:0036126; GO:2000059 cell projection assembly [GO:0030031]; flagellated sperm motility [GO:0030317]; negative regulation of ubiquitin-dependent protein catabolic process [GO:2000059] cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; sperm flagellum [GO:0036126] g7022.t1 Q9H0J4 34.177 316 4.15e-31 136.0 sp|Q9H0J4|QRIC2_HUMAN Glutamine-rich protein 2 OS=Homo sapiens OX=9606 GN=QRICH2 PE=1 SV=1 QRIC2_HUMAN reviewed Glutamine-rich protein 2 Homo sapiens (Human) GO:0005737; GO:0030031; GO:0030317; GO:0031965; GO:0036126; GO:2000059 cell projection assembly [GO:0030031]; flagellated sperm motility [GO:0030317]; negative regulation of ubiquitin-dependent protein catabolic process [GO:2000059] cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; sperm flagellum [GO:0036126] g7022.t1 Q9H0J4 33.445 299 4.3800000000000004e-29 130.0 sp|Q9H0J4|QRIC2_HUMAN Glutamine-rich protein 2 OS=Homo sapiens OX=9606 GN=QRICH2 PE=1 SV=1 QRIC2_HUMAN reviewed Glutamine-rich protein 2 Homo sapiens (Human) GO:0005737; GO:0030031; GO:0030317; GO:0031965; GO:0036126; GO:2000059 cell projection assembly [GO:0030031]; flagellated sperm motility [GO:0030317]; negative regulation of ubiquitin-dependent protein catabolic process [GO:2000059] cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; sperm flagellum [GO:0036126] g7022.t1 Q9H0J4 31.832 333 2.64e-27 124.0 sp|Q9H0J4|QRIC2_HUMAN Glutamine-rich protein 2 OS=Homo sapiens OX=9606 GN=QRICH2 PE=1 SV=1 QRIC2_HUMAN reviewed Glutamine-rich protein 2 Homo sapiens (Human) GO:0005737; GO:0030031; GO:0030317; GO:0031965; GO:0036126; GO:2000059 cell projection assembly [GO:0030031]; flagellated sperm motility [GO:0030317]; negative regulation of ubiquitin-dependent protein catabolic process [GO:2000059] cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; sperm flagellum [GO:0036126] g7022.t1 Q9H0J4 30.154 325 1.29e-23 112.0 sp|Q9H0J4|QRIC2_HUMAN Glutamine-rich protein 2 OS=Homo sapiens OX=9606 GN=QRICH2 PE=1 SV=1 QRIC2_HUMAN reviewed Glutamine-rich protein 2 Homo sapiens (Human) GO:0005737; GO:0030031; GO:0030317; GO:0031965; GO:0036126; GO:2000059 cell projection assembly [GO:0030031]; flagellated sperm motility [GO:0030317]; negative regulation of ubiquitin-dependent protein catabolic process [GO:2000059] cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; sperm flagellum [GO:0036126] g7022.t1 Q9H0J4 31.988 322 5.0899999999999995e-23 110.0 sp|Q9H0J4|QRIC2_HUMAN Glutamine-rich protein 2 OS=Homo sapiens OX=9606 GN=QRICH2 PE=1 SV=1 QRIC2_HUMAN reviewed Glutamine-rich protein 2 Homo sapiens (Human) GO:0005737; GO:0030031; GO:0030317; GO:0031965; GO:0036126; GO:2000059 cell projection assembly [GO:0030031]; flagellated sperm motility [GO:0030317]; negative regulation of ubiquitin-dependent protein catabolic process [GO:2000059] cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; sperm flagellum [GO:0036126] g7022.t1 Q9H0J4 32.288 319 1.15e-22 108.0 sp|Q9H0J4|QRIC2_HUMAN Glutamine-rich protein 2 OS=Homo sapiens OX=9606 GN=QRICH2 PE=1 SV=1 QRIC2_HUMAN reviewed Glutamine-rich protein 2 Homo sapiens (Human) GO:0005737; GO:0030031; GO:0030317; GO:0031965; GO:0036126; GO:2000059 cell projection assembly [GO:0030031]; flagellated sperm motility [GO:0030317]; negative regulation of ubiquitin-dependent protein catabolic process [GO:2000059] cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; sperm flagellum [GO:0036126] g7022.t1 Q9H0J4 29.721 323 1.1400000000000001e-21 105.0 sp|Q9H0J4|QRIC2_HUMAN Glutamine-rich protein 2 OS=Homo sapiens OX=9606 GN=QRICH2 PE=1 SV=1 QRIC2_HUMAN reviewed Glutamine-rich protein 2 Homo sapiens (Human) GO:0005737; GO:0030031; GO:0030317; GO:0031965; GO:0036126; GO:2000059 cell projection assembly [GO:0030031]; flagellated sperm motility [GO:0030317]; negative regulation of ubiquitin-dependent protein catabolic process [GO:2000059] cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; sperm flagellum [GO:0036126] g7039.t1 Q96DM1 31.919 495 4.26e-80 266.0 sp|Q96DM1|PGBD4_HUMAN PiggyBac transposable element-derived protein 4 OS=Homo sapiens OX=9606 GN=PGBD4 PE=1 SV=3 g7057.t1 Q96DM1 37.162 148 7.489999999999999e-23 97.4 sp|Q96DM1|PGBD4_HUMAN PiggyBac transposable element-derived protein 4 OS=Homo sapiens OX=9606 GN=PGBD4 PE=1 SV=3 g7100.t1 P10394 25.208 361 1.34e-23 106.0 sp|P10394|POL4_DROME Retrovirus-related Pol polyprotein from transposon 412 OS=Drosophila melanogaster OX=7227 GN=POL PE=4 SV=1 g7101.t1 Q7LHG5 34.902 255 5.750000000000001e-32 134.0 sp|Q7LHG5|YI31B_YEAST Transposon Ty3-I Gag-Pol polyprotein OS=Saccharomyces cerevisiae (strain ATCC 204508 / S288c) OX=559292 GN=TY3B-I PE=1 SV=2 YI31B_YEAST reviewed Transposon Ty3-I Gag-Pol polyprotein (Gag3-Pol3) (Transposon Ty3-2 TYA-TYB polyprotein) [Cleaved into: Capsid protein (CA) (p24); Spacer peptide p3; Nucleocapsid protein p11 (NC); Ty3 protease (PR) (EC 3.4.23.-) (p16); Spacer peptide J; Reverse transcriptase/ribonuclease H (RT) (RT-RH) (EC 2.7.7.49) (EC 2.7.7.7) (EC 3.1.26.4) (p55); Integrase p52 (IN); Integrase p49 (IN)] Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast) GO:0003677; GO:0003723; GO:0003887; GO:0003964; GO:0004190; GO:0004523; GO:0005524; GO:0005634; GO:0005737; GO:0006310; GO:0006508; GO:0008270; GO:0015074; GO:0075523 DNA integration [GO:0015074]; DNA recombination [GO:0006310]; proteolysis [GO:0006508]; viral translational frameshifting [GO:0075523] cytoplasm [GO:0005737]; nucleus [GO:0005634] aspartic-type endopeptidase activity [GO:0004190]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; RNA binding [GO:0003723]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; zinc ion binding [GO:0008270] g7109.t1 Q8I7P9 39.326 178 1.94e-28 124.0 sp|Q8I7P9|POL5_DROME Retrovirus-related Pol polyprotein from transposon opus OS=Drosophila melanogaster OX=7227 GN=pol PE=4 SV=1 g7133.t1 Q09575 38.983 295 1.0299999999999999e-55 201.0 sp|Q09575|YRD6_CAEEL Uncharacterized protein K02A2.6 OS=Caenorhabditis elegans OX=6239 GN=K02A2.6 PE=4 SV=1 g7134.t1 P10394 41.026 156 4.93e-25 104.0 sp|P10394|POL4_DROME Retrovirus-related Pol polyprotein from transposon 412 OS=Drosophila melanogaster OX=7227 GN=POL PE=4 SV=1 g7152.t1 A0A345BJN8 30.137 219 2.22e-22 105.0 sp|A0A345BJN8|CLZ9_COCLU MFS-type transporter clz9 OS=Cochliobolus lunatus OX=5503 GN=clz9 PE=3 SV=1 g7163.t1 P49283 75.806 62 1.78e-26 107.0 sp|P49283|MVL_DROME Protein Malvolio OS=Drosophila melanogaster OX=7227 GN=Mvl PE=2 SV=2 g7187.t1 Q8N328 34.884 215 2.8500000000000002e-27 111.0 sp|Q8N328|PGBD3_HUMAN PiggyBac transposable element-derived protein 3 OS=Homo sapiens OX=9606 GN=PGBD3 PE=1 SV=3 g7193.t1 Q4JAI4 29.022 317 1.34e-23 105.0 sp|Q4JAI4|METE_SULAC Methionine synthase OS=Sulfolobus acidocaldarius (strain ATCC 33909 / DSM 639 / JCM 8929 / NBRC 15157 / NCIMB 11770) OX=330779 GN=metE PE=3 SV=1 g7199.t1 Q8BR93 39.041 146 4.53e-28 110.0 sp|Q8BR93|HARB1_MOUSE Putative nuclease HARBI1 OS=Mus musculus OX=10090 GN=Harbi1 PE=2 SV=1 g7215.t1 Q96MB7 39.004 241 1.53e-49 176.0 sp|Q96MB7|HARB1_HUMAN Putative nuclease HARBI1 OS=Homo sapiens OX=9606 GN=HARBI1 PE=1 SV=1 HARB1_HUMAN reviewed Putative nuclease HARBI1 (EC 3.1.-.-) (Harbinger transposase-derived nuclease) Homo sapiens (Human) GO:0004518; GO:0005634; GO:0005829; GO:0005886; GO:0016787; GO:0034451; GO:0046872 centriolar satellite [GO:0034451]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886] hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]; nuclease activity [GO:0004518] g7235.t1 Q9M2U3 28.016 257 2.1200000000000003e-27 113.0 sp|Q9M2U3|ALPL_ARATH Protein ALP1-like OS=Arabidopsis thaliana OX=3702 GN=At3g55350 PE=2 SV=1 g7253.t1 Q95SX7 30.1 299 1.04e-25 111.0 sp|Q95SX7|RTBS_DROME Probable RNA-directed DNA polymerase from transposon BS OS=Drosophila melanogaster OX=7227 GN=RTase PE=2 SV=1 g7255.t1 P04323 42.051 195 4.24e-36 144.0 sp|P04323|POL3_DROME Retrovirus-related Pol polyprotein from transposon 17.6 OS=Drosophila melanogaster OX=7227 GN=pol PE=4 SV=1 g7256.t1 Q7LHG5 36.702 188 1.01e-34 132.0 sp|Q7LHG5|YI31B_YEAST Transposon Ty3-I Gag-Pol polyprotein OS=Saccharomyces cerevisiae (strain ATCC 204508 / S288c) OX=559292 GN=TY3B-I PE=1 SV=2 YI31B_YEAST reviewed Transposon Ty3-I Gag-Pol polyprotein (Gag3-Pol3) (Transposon Ty3-2 TYA-TYB polyprotein) [Cleaved into: Capsid protein (CA) (p24); Spacer peptide p3; Nucleocapsid protein p11 (NC); Ty3 protease (PR) (EC 3.4.23.-) (p16); Spacer peptide J; Reverse transcriptase/ribonuclease H (RT) (RT-RH) (EC 2.7.7.49) (EC 2.7.7.7) (EC 3.1.26.4) (p55); Integrase p52 (IN); Integrase p49 (IN)] Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast) GO:0003677; GO:0003723; GO:0003887; GO:0003964; GO:0004190; GO:0004523; GO:0005524; GO:0005634; GO:0005737; GO:0006310; GO:0006508; GO:0008270; GO:0015074; GO:0075523 DNA integration [GO:0015074]; DNA recombination [GO:0006310]; proteolysis [GO:0006508]; viral translational frameshifting [GO:0075523] cytoplasm [GO:0005737]; nucleus [GO:0005634] aspartic-type endopeptidase activity [GO:0004190]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; RNA binding [GO:0003723]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; zinc ion binding [GO:0008270] g7256.t2 Q09575 31.356 236 3.82e-38 145.0 sp|Q09575|YRD6_CAEEL Uncharacterized protein K02A2.6 OS=Caenorhabditis elegans OX=6239 GN=K02A2.6 PE=4 SV=1 g7264.t1 P04323 39.095 486 3.44e-94 325.0 sp|P04323|POL3_DROME Retrovirus-related Pol polyprotein from transposon 17.6 OS=Drosophila melanogaster OX=7227 GN=pol PE=4 SV=1 g7282.t1 Q09575 35.838 173 4.57e-21 95.9 sp|Q09575|YRD6_CAEEL Uncharacterized protein K02A2.6 OS=Caenorhabditis elegans OX=6239 GN=K02A2.6 PE=4 SV=1 g7287.t1 Q9UPR0 52.955 846 0.0 857.0 sp|Q9UPR0|PLCL2_HUMAN Inactive phospholipase C-like protein 2 OS=Homo sapiens OX=9606 GN=PLCL2 PE=1 SV=2 PLCL2_HUMAN reviewed Inactive phospholipase C-like protein 2 (PLC-L(2)) (PLC-L2) (Phospholipase C-L2) (Phospholipase C-epsilon-2) (PLC-epsilon-2) Homo sapiens (Human) GO:0002322; GO:0002337; GO:0004435; GO:0005737; GO:0007214; GO:0032228; GO:0046488; GO:0048015; GO:0050811; GO:0050859; GO:0051209; GO:0070679; GO:0120163 B cell proliferation involved in immune response [GO:0002322]; B-1a B cell differentiation [GO:0002337]; gamma-aminobutyric acid signaling pathway [GO:0007214]; negative regulation of B cell receptor signaling pathway [GO:0050859]; negative regulation of cold-induced thermogenesis [GO:0120163]; phosphatidylinositol metabolic process [GO:0046488]; phosphatidylinositol-mediated signaling [GO:0048015]; regulation of synaptic transmission, GABAergic [GO:0032228]; release of sequestered calcium ion into cytosol [GO:0051209] cytoplasm [GO:0005737] GABA receptor binding [GO:0050811]; inositol 1,4,5 trisphosphate binding [GO:0070679]; phosphatidylinositol-4,5-bisphosphate phospholipase C activity [GO:0004435] g7288.t1 Q3USB7 52.8 125 1.29e-36 135.0 sp|Q3USB7|PLCL1_MOUSE Inactive phospholipase C-like protein 1 OS=Mus musculus OX=10090 GN=Plcl1 PE=1 SV=3 PLCL1_MOUSE reviewed Inactive phospholipase C-like protein 1 (PLC-L1) (Phospholipase C-related but catalytically inactive protein) (PRIP) Mus musculus (Mouse) GO:0004435; GO:0005737; GO:0007214; GO:0032228; GO:0046488; GO:0048015; GO:0050811; GO:0051209; GO:0120163 gamma-aminobutyric acid signaling pathway [GO:0007214]; negative regulation of cold-induced thermogenesis [GO:0120163]; phosphatidylinositol metabolic process [GO:0046488]; phosphatidylinositol-mediated signaling [GO:0048015]; regulation of synaptic transmission, GABAergic [GO:0032228]; release of sequestered calcium ion into cytosol [GO:0051209] cytoplasm [GO:0005737] GABA receptor binding [GO:0050811]; phosphatidylinositol-4,5-bisphosphate phospholipase C activity [GO:0004435] g7292.t1 P46023 35.115 524 4.03e-75 270.0 sp|P46023|GR101_LYMST G-protein coupled receptor GRL101 OS=Lymnaea stagnalis OX=6523 PE=2 SV=1 g7307.t1 A2AV25 45.532 235 9.06e-62 206.0 sp|A2AV25|FBCD1_MOUSE Fibrinogen C domain-containing protein 1 OS=Mus musculus OX=10090 GN=Fibcd1 PE=2 SV=1 g7309.t1 Q62910 59.706 1020 0.0 1264.0 sp|Q62910|SYNJ1_RAT Synaptojanin-1 OS=Rattus norvegicus OX=10116 GN=Synj1 PE=1 SV=3 g7310.t1 Q9HB07 55.71 359 2.4900000000000002e-132 387.0 sp|Q9HB07|MYG1_HUMAN MYG1 exonuclease OS=Homo sapiens OX=9606 GN=MYG1 PE=1 SV=4 MYG1_HUMAN reviewed MYG1 exonuclease (EC 3.1.-.-) Homo sapiens (Human) GO:0000175; GO:0000959; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005739; GO:0005759; GO:0006364; GO:0006397; GO:0035641 locomotory exploration behavior [GO:0035641]; mitochondrial RNA metabolic process [GO:0000959]; mRNA processing [GO:0006397]; rRNA processing [GO:0006364] cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] 3'-5'-RNA exonuclease activity [GO:0000175] g7311.t1 Q9UIG0 40.633 822 2.48e-142 480.0 sp|Q9UIG0|BAZ1B_HUMAN Tyrosine-protein kinase BAZ1B OS=Homo sapiens OX=9606 GN=BAZ1B PE=1 SV=2 g7311.t1 Q9UIG0 35.714 336 8.290000000000001e-43 176.0 sp|Q9UIG0|BAZ1B_HUMAN Tyrosine-protein kinase BAZ1B OS=Homo sapiens OX=9606 GN=BAZ1B PE=1 SV=2 g7312.t1 Q8BH86 28.866 582 2.7300000000000004e-59 210.0 sp|Q8BH86|GLUCM_MOUSE D-glutamate cyclase, mitochondrial OS=Mus musculus OX=10090 GN=Dglucy PE=1 SV=1 g7318.t2 O76536 41.667 168 8.3e-21 100.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g7327.t1 P46023 32.341 504 1.97e-67 253.0 sp|P46023|GR101_LYMST G-protein coupled receptor GRL101 OS=Lymnaea stagnalis OX=6523 PE=2 SV=1 g7328.t1 P46023 30.595 487 5.4000000000000005e-58 224.0 sp|P46023|GR101_LYMST G-protein coupled receptor GRL101 OS=Lymnaea stagnalis OX=6523 PE=2 SV=1 g7330.t1 P61645 39.004 241 4.16e-38 148.0 sp|P61645|SIA8D_PANTR CMP-N-acetylneuraminate-poly-alpha-2,8-sialyltransferase OS=Pan troglodytes OX=9598 GN=ST8SIA4 PE=2 SV=1 g7334.t1 Q64692 32.381 210 5.2e-27 110.0 sp|Q64692|SIA8D_MOUSE CMP-N-acetylneuraminate-poly-alpha-2,8-sialyltransferase OS=Mus musculus OX=10090 GN=St8sia4 PE=1 SV=1 SIA8D_MOUSE reviewed CMP-N-acetylneuraminate-poly-alpha-2,8-sialyltransferase (EC 2.4.3.-) (Alpha-2,8-sialyltransferase 8D) (Polysialyltransferase-1) (Sialyltransferase 8D) (SIAT8-D) (Sialyltransferase St8Sia IV) (ST8SiaIV) Mus musculus (Mouse) GO:0000139; GO:0001574; GO:0003828; GO:0005576; GO:0005794; GO:0006491; GO:0008373; GO:0009311; GO:0097503 ganglioside biosynthetic process [GO:0001574]; N-glycan processing [GO:0006491]; oligosaccharide metabolic process [GO:0009311]; sialylation [GO:0097503] extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139] alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity [GO:0003828]; sialyltransferase activity [GO:0008373] g7340.t1 Q8K4T1 33.555 301 1.9300000000000002e-47 167.0 sp|Q8K4T1|SIA8F_MOUSE Alpha-2,8-sialyltransferase 8F OS=Mus musculus OX=10090 GN=St8sia6 PE=1 SV=1 SIA8F_MOUSE reviewed Alpha-2,8-sialyltransferase 8F (EC 2.4.99.-) (Sialyltransferase 8F) (SIAT8-F) (Sialyltransferase St8Sia VI) (ST8SiaVI) Mus musculus (Mouse) GO:0000139; GO:0001574; GO:0001835; GO:0003828; GO:0006491; GO:0006493; GO:0008373; GO:0009100; GO:0009247; GO:0009311; GO:0016051 blastocyst hatching [GO:0001835]; carbohydrate biosynthetic process [GO:0016051]; ganglioside biosynthetic process [GO:0001574]; glycolipid biosynthetic process [GO:0009247]; glycoprotein metabolic process [GO:0009100]; N-glycan processing [GO:0006491]; oligosaccharide metabolic process [GO:0009311]; protein O-linked glycosylation [GO:0006493] Golgi membrane [GO:0000139] alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity [GO:0003828]; sialyltransferase activity [GO:0008373] g7345.t1 Q6ZXA0 37.091 275 6.700000000000001e-47 165.0 sp|Q6ZXA0|SIA8A_XENLA Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase OS=Xenopus laevis OX=8355 GN=st8sia1 PE=1 SV=1 g7347.t1 Q9VBW3 41.837 294 1.88e-62 231.0 sp|Q9VBW3|CAD96_DROME Tyrosine kinase receptor Cad96Ca OS=Drosophila melanogaster OX=7227 GN=Cad96Ca PE=2 SV=2 CAD96_DROME reviewed Tyrosine kinase receptor Cad96Ca (EC 2.7.10.1) (Cadherin-96Ca) (Tyrosine kinase receptor HD-14) Drosophila melanogaster (Fruit fly) GO:0004713; GO:0004714; GO:0005509; GO:0005524; GO:0005886; GO:0006468; GO:0007030; GO:0007156; GO:0007169; GO:0016339; GO:0042060; GO:0043235; GO:0045177; GO:0045792; GO:0051897; GO:0090303 calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; Golgi organization [GO:0007030]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell size [GO:0045792]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of wound healing [GO:0090303]; protein phosphorylation [GO:0006468]; wound healing [GO:0042060] apical part of cell [GO:0045177]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; protein tyrosine kinase activity [GO:0004713]; transmembrane receptor protein tyrosine kinase activity [GO:0004714] g7355.t1 Q5I2E5 43.836 292 1.32e-72 235.0 sp|Q5I2E5|FCN2_BOVIN Ficolin-2 OS=Bos taurus OX=9913 GN=FCN2 PE=2 SV=1 FCN2_BOVIN reviewed Ficolin-2 (Collagen/fibrinogen domain-containing protein 2) (Ficolin-B) (Ficolin-beta) (L-ficolin) Bos taurus (Bovine) GO:0001867; GO:0003823; GO:0005102; GO:0005581; GO:0005615; GO:0030246; GO:0038187; GO:0046872; GO:0070892; GO:0097367; GO:0106139 complement activation, lectin pathway [GO:0001867] collagen trimer [GO:0005581]; extracellular space [GO:0005615]; symbiont cell surface [GO:0106139] antigen binding [GO:0003823]; carbohydrate binding [GO:0030246]; carbohydrate derivative binding [GO:0097367]; lipoteichoic acid immune receptor activity [GO:0070892]; metal ion binding [GO:0046872]; pattern recognition receptor activity [GO:0038187]; signaling receptor binding [GO:0005102] g7356.t1 O00602 54.19 179 7.470000000000001e-58 187.0 sp|O00602|FCN1_HUMAN Ficolin-1 OS=Homo sapiens OX=9606 GN=FCN1 PE=1 SV=2 FCN1_HUMAN reviewed Ficolin-1 (Collagen/fibrinogen domain-containing protein 1) (Ficolin-A) (Ficolin-alpha) (M-ficolin) Homo sapiens (Human) GO:0001664; GO:0001867; GO:0002752; GO:0003823; GO:0005102; GO:0005576; GO:0005581; GO:0005615; GO:0005886; GO:0006508; GO:0007186; GO:0009897; GO:0030246; GO:0031012; GO:0032757; GO:0033691; GO:0034394; GO:0034774; GO:0038187; GO:0043654; GO:0046597; GO:0046872; GO:0097367; GO:0106139; GO:1903028; GO:1904813; GO:1905370 cell surface pattern recognition receptor signaling pathway [GO:0002752]; complement activation, lectin pathway [GO:0001867]; G protein-coupled receptor signaling pathway [GO:0007186]; host-mediated suppression of symbiont invasion [GO:0046597]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of opsonization [GO:1903028]; protein localization to cell surface [GO:0034394]; proteolysis [GO:0006508]; recognition of apoptotic cell [GO:0043654] collagen trimer [GO:0005581]; external side of plasma membrane [GO:0009897]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; ficolin-1-rich granule lumen [GO:1904813]; plasma membrane [GO:0005886]; secretory granule lumen [GO:0034774]; serine-type endopeptidase complex [GO:1905370]; symbiont cell surface [GO:0106139] antigen binding [GO:0003823]; carbohydrate binding [GO:0030246]; carbohydrate derivative binding [GO:0097367]; G protein-coupled receptor binding [GO:0001664]; metal ion binding [GO:0046872]; pattern recognition receptor activity [GO:0038187]; sialic acid binding [GO:0033691]; signaling receptor binding [GO:0005102] g7359.t1 P38935 54.545 781 0.0 691.0 sp|P38935|SMBP2_HUMAN DNA-binding protein SMUBP-2 OS=Homo sapiens OX=9606 GN=IGHMBP2 PE=1 SV=3 SMBP2_HUMAN reviewed DNA-binding protein SMUBP-2 (EC 3.6.4.12) (EC 3.6.4.13) (ATP-dependent helicase IGHMBP2) (Glial factor 1) (GF-1) (Immunoglobulin mu-binding protein 2) Homo sapiens (Human) GO:0000049; GO:0003677; GO:0003678; GO:0003697; GO:0003723; GO:0003727; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0008094; GO:0008186; GO:0008270; GO:0016020; GO:0016604; GO:0016887; GO:0030424; GO:0030426; GO:0032574; GO:0036121; GO:0042802; GO:0043022; GO:0043139; GO:0140296; GO:1990904 axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; growth cone [GO:0030426]; membrane [GO:0016020]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904] 5'-3' DNA helicase activity [GO:0043139]; 5'-3' RNA helicase activity [GO:0032574]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent activity, acting on DNA [GO:0008094]; ATP-dependent activity, acting on RNA [GO:0008186]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; double-stranded DNA helicase activity [GO:0036121]; general transcription initiation factor binding [GO:0140296]; identical protein binding [GO:0042802]; ribosome binding [GO:0043022]; RNA binding [GO:0003723]; single-stranded DNA binding [GO:0003697]; single-stranded RNA binding [GO:0003727]; tRNA binding [GO:0000049]; zinc ion binding [GO:0008270] g7359.t1 P38935 50.485 103 1.72e-27 124.0 sp|P38935|SMBP2_HUMAN DNA-binding protein SMUBP-2 OS=Homo sapiens OX=9606 GN=IGHMBP2 PE=1 SV=3 SMBP2_HUMAN reviewed DNA-binding protein SMUBP-2 (EC 3.6.4.12) (EC 3.6.4.13) (ATP-dependent helicase IGHMBP2) (Glial factor 1) (GF-1) (Immunoglobulin mu-binding protein 2) Homo sapiens (Human) GO:0000049; GO:0003677; GO:0003678; GO:0003697; GO:0003723; GO:0003727; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0008094; GO:0008186; GO:0008270; GO:0016020; GO:0016604; GO:0016887; GO:0030424; GO:0030426; GO:0032574; GO:0036121; GO:0042802; GO:0043022; GO:0043139; GO:0140296; GO:1990904 axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; growth cone [GO:0030426]; membrane [GO:0016020]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904] 5'-3' DNA helicase activity [GO:0043139]; 5'-3' RNA helicase activity [GO:0032574]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent activity, acting on DNA [GO:0008094]; ATP-dependent activity, acting on RNA [GO:0008186]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; double-stranded DNA helicase activity [GO:0036121]; general transcription initiation factor binding [GO:0140296]; identical protein binding [GO:0042802]; ribosome binding [GO:0043022]; RNA binding [GO:0003723]; single-stranded DNA binding [GO:0003697]; single-stranded RNA binding [GO:0003727]; tRNA binding [GO:0000049]; zinc ion binding [GO:0008270] g7360.t1 C3Z1P5 89.231 65 2.21e-40 138.0 sp|C3Z1P5|RU1C_BRAFL U1 small nuclear ribonucleoprotein C OS=Branchiostoma floridae OX=7739 GN=BRAFLDRAFT_69314 PE=3 SV=1 g7361.t1 Q9NQ94 66.667 342 9.660000000000001e-163 481.0 sp|Q9NQ94|A1CF_HUMAN APOBEC1 complementation factor OS=Homo sapiens OX=9606 GN=A1CF PE=1 SV=1 A1CF_HUMAN reviewed APOBEC1 complementation factor (APOBEC1-stimulating protein) Homo sapiens (Human) GO:0003727; GO:0003729; GO:0005634; GO:0005654; GO:0005737; GO:0005783; GO:0006397; GO:0007566; GO:0010609; GO:0016554; GO:0016556; GO:0030895; GO:0045293; GO:0050821; GO:0140767; GO:0141166; GO:2000623 chromosomal 5-methylcytosine DNA demethylation pathway [GO:0141166]; cytidine to uridine editing [GO:0016554]; embryo implantation [GO:0007566]; mRNA localization resulting in post-transcriptional regulation of gene expression [GO:0010609]; mRNA modification [GO:0016556]; mRNA processing [GO:0006397]; negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:2000623]; protein stabilization [GO:0050821] apolipoprotein B mRNA editing enzyme complex [GO:0030895]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; mRNA editing complex [GO:0045293]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] enzyme-substrate adaptor activity [GO:0140767]; mRNA binding [GO:0003729]; single-stranded RNA binding [GO:0003727] g7361.t1 Q9NQ94 55.357 112 5.1800000000000005e-27 119.0 sp|Q9NQ94|A1CF_HUMAN APOBEC1 complementation factor OS=Homo sapiens OX=9606 GN=A1CF PE=1 SV=1 A1CF_HUMAN reviewed APOBEC1 complementation factor (APOBEC1-stimulating protein) Homo sapiens (Human) GO:0003727; GO:0003729; GO:0005634; GO:0005654; GO:0005737; GO:0005783; GO:0006397; GO:0007566; GO:0010609; GO:0016554; GO:0016556; GO:0030895; GO:0045293; GO:0050821; GO:0140767; GO:0141166; GO:2000623 chromosomal 5-methylcytosine DNA demethylation pathway [GO:0141166]; cytidine to uridine editing [GO:0016554]; embryo implantation [GO:0007566]; mRNA localization resulting in post-transcriptional regulation of gene expression [GO:0010609]; mRNA modification [GO:0016556]; mRNA processing [GO:0006397]; negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:2000623]; protein stabilization [GO:0050821] apolipoprotein B mRNA editing enzyme complex [GO:0030895]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; mRNA editing complex [GO:0045293]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] enzyme-substrate adaptor activity [GO:0140767]; mRNA binding [GO:0003729]; single-stranded RNA binding [GO:0003727] g7361.t2 Q9NQ94 66.667 342 6.630000000000001e-163 481.0 sp|Q9NQ94|A1CF_HUMAN APOBEC1 complementation factor OS=Homo sapiens OX=9606 GN=A1CF PE=1 SV=1 A1CF_HUMAN reviewed APOBEC1 complementation factor (APOBEC1-stimulating protein) Homo sapiens (Human) GO:0003727; GO:0003729; GO:0005634; GO:0005654; GO:0005737; GO:0005783; GO:0006397; GO:0007566; GO:0010609; GO:0016554; GO:0016556; GO:0030895; GO:0045293; GO:0050821; GO:0140767; GO:0141166; GO:2000623 chromosomal 5-methylcytosine DNA demethylation pathway [GO:0141166]; cytidine to uridine editing [GO:0016554]; embryo implantation [GO:0007566]; mRNA localization resulting in post-transcriptional regulation of gene expression [GO:0010609]; mRNA modification [GO:0016556]; mRNA processing [GO:0006397]; negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:2000623]; protein stabilization [GO:0050821] apolipoprotein B mRNA editing enzyme complex [GO:0030895]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; mRNA editing complex [GO:0045293]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] enzyme-substrate adaptor activity [GO:0140767]; mRNA binding [GO:0003729]; single-stranded RNA binding [GO:0003727] g7362.t1 A4IH75 65.753 219 1.74e-110 318.0 sp|A4IH75|ATGA1_XENTR Autophagy-related protein 101 OS=Xenopus tropicalis OX=8364 GN=atg101 PE=2 SV=1 g7363.t1 Q9D3W1 49.853 341 2.1e-91 280.0 sp|Q9D3W1|RSP14_MOUSE Radial spoke head 14 homolog OS=Mus musculus OX=10090 GN=Rsph14 PE=1 SV=1 RSP14_MOUSE reviewed Radial spoke head 14 homolog (Rhabdoid tumor deletion region protein 1) Mus musculus (Mouse) GO:0001534; GO:0003351; GO:0005576; GO:0007618; GO:0030317; GO:0036126; GO:0097729 epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; flagellated sperm motility [GO:0030317]; mating [GO:0007618] 9+2 motile cilium [GO:0097729]; extracellular region [GO:0005576]; radial spoke [GO:0001534]; sperm flagellum [GO:0036126] g7364.t1 Q6DCX5 31.829 421 1.0699999999999998e-52 187.0 sp|Q6DCX5|PCFT_XENLA Proton-coupled folate transporter OS=Xenopus laevis OX=8355 GN=slc46a1 PE=2 SV=1 PCFT_XENLA reviewed Proton-coupled folate transporter (Heme carrier protein 1) (Solute carrier family 46 member 1) Xenopus laevis (African clawed frog) GO:0005542; GO:0005768; GO:0005886; GO:0010008; GO:0015293; GO:0015350; GO:0016323; GO:0016324; GO:0022857; GO:0055085 transmembrane transport [GO:0055085] apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; endosome [GO:0005768]; endosome membrane [GO:0010008]; plasma membrane [GO:0005886] folic acid binding [GO:0005542]; methotrexate transmembrane transporter activity [GO:0015350]; symporter activity [GO:0015293]; transmembrane transporter activity [GO:0022857] g7381.t1 Q5ZKQ7 65.455 220 9.72e-96 282.0 sp|Q5ZKQ7|GID8_CHICK Glucose-induced degradation protein 8 homolog OS=Gallus gallus OX=9031 GN=GID8 PE=2 SV=1 GID8_CHICK reviewed Glucose-induced degradation protein 8 homolog Gallus gallus (Chicken) GO:0000151; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0008284; GO:0016055; GO:0030054; GO:0042803; GO:0043161; GO:0090263 positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cell population proliferation [GO:0008284]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; Wnt signaling pathway [GO:0016055] cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151] protein homodimerization activity [GO:0042803] g7383.t1 P56489 28.082 438 7.09e-51 182.0 sp|P56489|ACM1_MACMU Muscarinic acetylcholine receptor M1 OS=Macaca mulatta OX=9544 GN=CHRM1 PE=2 SV=1 g7384.t1 Q91880 83.18 434 0.0 725.0 sp|Q91880|SUH_XENLA Suppressor of hairless protein homolog OS=Xenopus laevis OX=8355 GN=rbpj PE=1 SV=1 g7384.t2 Q91880 83.18 434 0.0 721.0 sp|Q91880|SUH_XENLA Suppressor of hairless protein homolog OS=Xenopus laevis OX=8355 GN=rbpj PE=1 SV=1 g7385.t1 P97393 36.291 755 8.380000000000001e-125 431.0 sp|P97393|RHG05_MOUSE Rho GTPase-activating protein 5 OS=Mus musculus OX=10090 GN=Arhgap5 PE=1 SV=3 g7385.t1 P97393 38.542 192 1.46e-38 162.0 sp|P97393|RHG05_MOUSE Rho GTPase-activating protein 5 OS=Mus musculus OX=10090 GN=Arhgap5 PE=1 SV=3 g7385.t2 P97393 36.291 755 1.97e-124 431.0 sp|P97393|RHG05_MOUSE Rho GTPase-activating protein 5 OS=Mus musculus OX=10090 GN=Arhgap5 PE=1 SV=3 g7385.t2 P97393 38.542 192 1.14e-38 162.0 sp|P97393|RHG05_MOUSE Rho GTPase-activating protein 5 OS=Mus musculus OX=10090 GN=Arhgap5 PE=1 SV=3 g7385.t3 P97393 36.291 755 1.06e-124 431.0 sp|P97393|RHG05_MOUSE Rho GTPase-activating protein 5 OS=Mus musculus OX=10090 GN=Arhgap5 PE=1 SV=3 g7385.t3 P97393 38.542 192 1.07e-38 162.0 sp|P97393|RHG05_MOUSE Rho GTPase-activating protein 5 OS=Mus musculus OX=10090 GN=Arhgap5 PE=1 SV=3 g7385.t4 P97393 36.291 755 3.0100000000000002e-124 431.0 sp|P97393|RHG05_MOUSE Rho GTPase-activating protein 5 OS=Mus musculus OX=10090 GN=Arhgap5 PE=1 SV=3 g7385.t4 P97393 38.542 192 1.1999999999999998e-38 162.0 sp|P97393|RHG05_MOUSE Rho GTPase-activating protein 5 OS=Mus musculus OX=10090 GN=Arhgap5 PE=1 SV=3 g7393.t1 Q9W062 60.331 242 2.45e-90 286.0 sp|Q9W062|MFAP1_DROME Microfibrillar-associated protein 1 OS=Drosophila melanogaster OX=7227 GN=Mfap1 PE=1 SV=1 MFAP1_DROME reviewed Microfibrillar-associated protein 1 (Spliceosome B complex protein MFAP1) Drosophila melanogaster (Fruit fly) GO:0000398; GO:0005684; GO:0010389; GO:0032991; GO:0071011; GO:0071013 mRNA splicing, via spliceosome [GO:0000398]; regulation of G2/M transition of mitotic cell cycle [GO:0010389] catalytic step 2 spliceosome [GO:0071013]; precatalytic spliceosome [GO:0071011]; protein-containing complex [GO:0032991]; U2-type spliceosomal complex [GO:0005684] g7394.t1 Q5RGJ5 53.43 554 0.0 595.0 sp|Q5RGJ5|C19L1_DANRE CWF19-like protein 1 OS=Danio rerio OX=7955 GN=cwf19l1 PE=2 SV=1 g7394.t2 Q5RGJ5 53.249 554 0.0 594.0 sp|Q5RGJ5|C19L1_DANRE CWF19-like protein 1 OS=Danio rerio OX=7955 GN=cwf19l1 PE=2 SV=1 g7402.t1 Q5XGZ2 47.85 721 0.0 593.0 sp|Q5XGZ2|UP44B_XENLA Ubiquitin carboxyl-terminal hydrolase 44-B OS=Xenopus laevis OX=8355 GN=usp44-b PE=2 SV=1 UP44B_XENLA reviewed Ubiquitin carboxyl-terminal hydrolase 44-B (EC 3.4.19.12) (Deubiquitinating enzyme 44-B) (Ubiquitin thioesterase 44-B) (Ubiquitin-specific-processing protease 44-B) Xenopus laevis (African clawed frog) GO:0004843; GO:0005634; GO:0005737; GO:0006508; GO:0008270; GO:0010564; GO:0016579; GO:0051301; GO:1904667 cell division [GO:0051301]; negative regulation of ubiquitin protein ligase activity [GO:1904667]; protein deubiquitination [GO:0016579]; proteolysis [GO:0006508]; regulation of cell cycle process [GO:0010564] cytoplasm [GO:0005737]; nucleus [GO:0005634] cysteine-type deubiquitinase activity [GO:0004843]; zinc ion binding [GO:0008270] g7407.t1 O75899 44.748 733 0.0 638.0 sp|O75899|GABR2_HUMAN Gamma-aminobutyric acid type B receptor subunit 2 OS=Homo sapiens OX=9606 GN=GABBR2 PE=1 SV=1 GABR2_HUMAN reviewed Gamma-aminobutyric acid type B receptor subunit 2 (GABA-B receptor 2) (GABA-B-R2) (GABA-BR2) (GABABR2) (Gb2) (G-protein coupled receptor 51) (HG20) Homo sapiens (Human) GO:0004888; GO:0004965; GO:0005737; GO:0005886; GO:0007186; GO:0007193; GO:0007194; GO:0007214; GO:0007268; GO:0038039; GO:0043005; GO:0045211; GO:0046982; GO:0051932; GO:0150099; GO:1902710; GO:1902712 adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; chemical synaptic transmission [GO:0007268]; G protein-coupled receptor signaling pathway [GO:0007186]; gamma-aminobutyric acid signaling pathway [GO:0007214]; negative regulation of adenylate cyclase activity [GO:0007194]; neuron-glial cell signaling [GO:0150099]; synaptic transmission, GABAergic [GO:0051932] cytoplasm [GO:0005737]; G protein-coupled GABA receptor complex [GO:1902712]; G protein-coupled receptor heterodimeric complex [GO:0038039]; GABA receptor complex [GO:1902710]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211] G protein-coupled GABA receptor activity [GO:0004965]; protein heterodimerization activity [GO:0046982]; transmembrane signaling receptor activity [GO:0004888] g7421.t1 A2VDP6 27.014 211 2.58e-21 96.3 sp|A2VDP6|NXPE3_BOVIN NXPE family member 3 OS=Bos taurus OX=9913 GN=NXPE3 PE=2 SV=1 g7426.t1 Q17QR8 34.694 294 2.45e-49 172.0 sp|Q17QR8|HARB1_BOVIN Putative nuclease HARBI1 OS=Bos taurus OX=9913 GN=HARBI1 PE=2 SV=1 g7428.t1 Q05004 25.054 467 6.8e-28 120.0 sp|Q05004|NXPE1_RABIT NXPE family member 1 OS=Oryctolagus cuniculus OX=9986 GN=NXPE1 PE=2 SV=1 g7429.t1 Q3MHW6 33.69 187 6.52e-22 101.0 sp|Q3MHW6|MOT1_BOVIN Monocarboxylate transporter 1 OS=Bos taurus OX=9913 GN=SLC16A1 PE=2 SV=2 MOT1_BOVIN reviewed Monocarboxylate transporter 1 (MCT 1) (Solute carrier family 16 member 1) Bos taurus (Bovine) GO:0005886; GO:0015141; GO:0015295; GO:0015650; GO:0016323; GO:0016324; GO:0035879; GO:0071422; GO:1901475 plasma membrane lactate transport [GO:0035879]; pyruvate transmembrane transport [GO:1901475]; succinate transmembrane transport [GO:0071422] apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; plasma membrane [GO:0005886] lactate:proton symporter activity [GO:0015650]; solute:proton symporter activity [GO:0015295]; succinate transmembrane transporter activity [GO:0015141] g7432.t1 P10394 26.14 329 3.0899999999999997e-24 110.0 sp|P10394|POL4_DROME Retrovirus-related Pol polyprotein from transposon 412 OS=Drosophila melanogaster OX=7227 GN=POL PE=4 SV=1 g7436.t1 P11654 41.558 1001 0.0 757.0 sp|P11654|PO210_RAT Nuclear pore membrane glycoprotein 210 OS=Rattus norvegicus OX=10116 GN=Nup210 PE=1 SV=1 g7438.t1 Q8TEM1 36.424 604 9.53e-119 401.0 sp|Q8TEM1|PO210_HUMAN Nuclear pore membrane glycoprotein 210 OS=Homo sapiens OX=9606 GN=NUP210 PE=1 SV=3 PO210_HUMAN reviewed Nuclear pore membrane glycoprotein 210 (Nuclear pore protein gp210) (Nuclear envelope pore membrane protein POM 210) (POM210) (Nucleoporin Nup210) (Pore membrane protein of 210 kDa) Homo sapiens (Human) GO:0005635; GO:0005643; GO:0005789; GO:0006913; GO:0015031; GO:0016020; GO:0031965; GO:0051028 mRNA transport [GO:0051028]; nucleocytoplasmic transport [GO:0006913]; protein transport [GO:0015031] endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643] g7441.t1 Q8BMI4 43.452 504 2.4499999999999997e-126 412.0 sp|Q8BMI4|GEN_MOUSE Flap endonuclease GEN homolog 1 OS=Mus musculus OX=10090 GN=Gen1 PE=1 SV=2 g7444.t1 Q96DM1 26.766 269 2.8299999999999997e-24 108.0 sp|Q96DM1|PGBD4_HUMAN PiggyBac transposable element-derived protein 4 OS=Homo sapiens OX=9606 GN=PGBD4 PE=1 SV=3 g7448.t1 Q15485 49.162 179 1.01e-49 164.0 sp|Q15485|FCN2_HUMAN Ficolin-2 OS=Homo sapiens OX=9606 GN=FCN2 PE=1 SV=2 FCN2_HUMAN reviewed Ficolin-2 (37 kDa elastin-binding protein) (EBP-37) (Collagen/fibrinogen domain-containing protein 2) (Ficolin-B) (Ficolin-beta) (Hucolin) (L-ficolin) (Serum lectin p35) Homo sapiens (Human) GO:0001867; GO:0002752; GO:0003823; GO:0005102; GO:0005576; GO:0005581; GO:0005615; GO:0006508; GO:0008228; GO:0009897; GO:0038187; GO:0043394; GO:0043654; GO:0046872; GO:0048306; GO:0050829; GO:0050830; GO:0070062; GO:0070892; GO:0072562; GO:0097367; GO:0106139; GO:1903028; GO:1905370; GO:2001065 cell surface pattern recognition receptor signaling pathway [GO:0002752]; complement activation, lectin pathway [GO:0001867]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; opsonization [GO:0008228]; positive regulation of opsonization [GO:1903028]; proteolysis [GO:0006508]; recognition of apoptotic cell [GO:0043654] blood microparticle [GO:0072562]; collagen trimer [GO:0005581]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; serine-type endopeptidase complex [GO:1905370]; symbiont cell surface [GO:0106139] antigen binding [GO:0003823]; calcium-dependent protein binding [GO:0048306]; carbohydrate derivative binding [GO:0097367]; lipoteichoic acid immune receptor activity [GO:0070892]; mannan binding [GO:2001065]; metal ion binding [GO:0046872]; pattern recognition receptor activity [GO:0038187]; proteoglycan binding [GO:0043394]; signaling receptor binding [GO:0005102] g7449.t1 O00602 60.403 149 2.5e-60 193.0 sp|O00602|FCN1_HUMAN Ficolin-1 OS=Homo sapiens OX=9606 GN=FCN1 PE=1 SV=2 FCN1_HUMAN reviewed Ficolin-1 (Collagen/fibrinogen domain-containing protein 1) (Ficolin-A) (Ficolin-alpha) (M-ficolin) Homo sapiens (Human) GO:0001664; GO:0001867; GO:0002752; GO:0003823; GO:0005102; GO:0005576; GO:0005581; GO:0005615; GO:0005886; GO:0006508; GO:0007186; GO:0009897; GO:0030246; GO:0031012; GO:0032757; GO:0033691; GO:0034394; GO:0034774; GO:0038187; GO:0043654; GO:0046597; GO:0046872; GO:0097367; GO:0106139; GO:1903028; GO:1904813; GO:1905370 cell surface pattern recognition receptor signaling pathway [GO:0002752]; complement activation, lectin pathway [GO:0001867]; G protein-coupled receptor signaling pathway [GO:0007186]; host-mediated suppression of symbiont invasion [GO:0046597]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of opsonization [GO:1903028]; protein localization to cell surface [GO:0034394]; proteolysis [GO:0006508]; recognition of apoptotic cell [GO:0043654] collagen trimer [GO:0005581]; external side of plasma membrane [GO:0009897]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; ficolin-1-rich granule lumen [GO:1904813]; plasma membrane [GO:0005886]; secretory granule lumen [GO:0034774]; serine-type endopeptidase complex [GO:1905370]; symbiont cell surface [GO:0106139] antigen binding [GO:0003823]; carbohydrate binding [GO:0030246]; carbohydrate derivative binding [GO:0097367]; G protein-coupled receptor binding [GO:0001664]; metal ion binding [GO:0046872]; pattern recognition receptor activity [GO:0038187]; sialic acid binding [GO:0033691]; signaling receptor binding [GO:0005102] g7450.t1 Q15485 57.277 213 3.1000000000000005e-79 248.0 sp|Q15485|FCN2_HUMAN Ficolin-2 OS=Homo sapiens OX=9606 GN=FCN2 PE=1 SV=2 FCN2_HUMAN reviewed Ficolin-2 (37 kDa elastin-binding protein) (EBP-37) (Collagen/fibrinogen domain-containing protein 2) (Ficolin-B) (Ficolin-beta) (Hucolin) (L-ficolin) (Serum lectin p35) Homo sapiens (Human) GO:0001867; GO:0002752; GO:0003823; GO:0005102; GO:0005576; GO:0005581; GO:0005615; GO:0006508; GO:0008228; GO:0009897; GO:0038187; GO:0043394; GO:0043654; GO:0046872; GO:0048306; GO:0050829; GO:0050830; GO:0070062; GO:0070892; GO:0072562; GO:0097367; GO:0106139; GO:1903028; GO:1905370; GO:2001065 cell surface pattern recognition receptor signaling pathway [GO:0002752]; complement activation, lectin pathway [GO:0001867]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; opsonization [GO:0008228]; positive regulation of opsonization [GO:1903028]; proteolysis [GO:0006508]; recognition of apoptotic cell [GO:0043654] blood microparticle [GO:0072562]; collagen trimer [GO:0005581]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; serine-type endopeptidase complex [GO:1905370]; symbiont cell surface [GO:0106139] antigen binding [GO:0003823]; calcium-dependent protein binding [GO:0048306]; carbohydrate derivative binding [GO:0097367]; lipoteichoic acid immune receptor activity [GO:0070892]; mannan binding [GO:2001065]; metal ion binding [GO:0046872]; pattern recognition receptor activity [GO:0038187]; proteoglycan binding [GO:0043394]; signaling receptor binding [GO:0005102] g7455.t1 O64411 37.194 449 1.0899999999999998e-89 286.0 sp|O64411|PAO1_MAIZE Polyamine oxidase 1 OS=Zea mays OX=4577 GN=MPAO1 PE=1 SV=1 g7456.t1 A6H603 28.266 842 5.73e-56 218.0 sp|A6H603|NWD1_MOUSE NACHT domain- and WD repeat-containing protein 1 OS=Mus musculus OX=10090 GN=Nwd1 PE=2 SV=2 g7461.t1 Q9UKZ1 66.588 422 0.0 530.0 sp|Q9UKZ1|CNO11_HUMAN CCR4-NOT transcription complex subunit 11 OS=Homo sapiens OX=9606 GN=CNOT11 PE=1 SV=1 CNO11_HUMAN reviewed CCR4-NOT transcription complex subunit 11 Homo sapiens (Human) GO:0000289; GO:0005634; GO:0005829; GO:0006417; GO:0030014; GO:0031047 nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; regulation of translation [GO:0006417]; regulatory ncRNA-mediated gene silencing [GO:0031047] CCR4-NOT complex [GO:0030014]; cytosol [GO:0005829]; nucleus [GO:0005634] g7461.t2 B0BNA9 67.225 418 0.0 535.0 sp|B0BNA9|CNO11_RAT CCR4-NOT transcription complex subunit 11 OS=Rattus norvegicus OX=10116 GN=Cnot11 PE=2 SV=1 CNO11_RAT reviewed CCR4-NOT transcription complex subunit 11 Rattus norvegicus (Rat) GO:0005634; GO:0005737; GO:0006417; GO:0030014; GO:0031047 regulation of translation [GO:0006417]; regulatory ncRNA-mediated gene silencing [GO:0031047] CCR4-NOT complex [GO:0030014]; cytoplasm [GO:0005737]; nucleus [GO:0005634] g7464.t1 Q9UHR5 58.268 127 8.63e-37 138.0 sp|Q9UHR5|S30BP_HUMAN SAP30-binding protein OS=Homo sapiens OX=9606 GN=SAP30BP PE=1 SV=1 g7466.t1 Q6NRL2 43.062 418 4.06e-120 372.0 sp|Q6NRL2|SNX33_XENLA Sorting nexin-33 OS=Xenopus laevis OX=8355 GN=snx33 PE=2 SV=1 g7468.t1 Q6P4U0 29.705 882 1.2200000000000001e-100 347.0 sp|Q6P4U0|THS7B_MOUSE Thrombospondin type-1 domain-containing protein 7B OS=Mus musculus OX=10090 GN=Thsd7b PE=2 SV=1 g7468.t1 Q6P4U0 30.325 831 4.39e-74 269.0 sp|Q6P4U0|THS7B_MOUSE Thrombospondin type-1 domain-containing protein 7B OS=Mus musculus OX=10090 GN=Thsd7b PE=2 SV=1 g7468.t1 Q6P4U0 29.044 816 1.2599999999999999e-68 253.0 sp|Q6P4U0|THS7B_MOUSE Thrombospondin type-1 domain-containing protein 7B OS=Mus musculus OX=10090 GN=Thsd7b PE=2 SV=1 g7468.t1 Q6P4U0 30.277 829 1.03e-66 247.0 sp|Q6P4U0|THS7B_MOUSE Thrombospondin type-1 domain-containing protein 7B OS=Mus musculus OX=10090 GN=Thsd7b PE=2 SV=1 g7468.t1 Q6P4U0 28.846 572 3.24e-38 158.0 sp|Q6P4U0|THS7B_MOUSE Thrombospondin type-1 domain-containing protein 7B OS=Mus musculus OX=10090 GN=Thsd7b PE=2 SV=1 g7468.t1 Q6P4U0 24.365 788 4.09e-30 132.0 sp|Q6P4U0|THS7B_MOUSE Thrombospondin type-1 domain-containing protein 7B OS=Mus musculus OX=10090 GN=Thsd7b PE=2 SV=1 g7469.t1 Q9UPZ6 29.449 635 1.3700000000000001e-64 235.0 sp|Q9UPZ6|THS7A_HUMAN Thrombospondin type-1 domain-containing protein 7A OS=Homo sapiens OX=9606 GN=THSD7A PE=1 SV=4 g7469.t1 Q9UPZ6 27.51 498 3.0999999999999997e-24 112.0 sp|Q9UPZ6|THS7A_HUMAN Thrombospondin type-1 domain-containing protein 7A OS=Homo sapiens OX=9606 GN=THSD7A PE=1 SV=4 g7469.t1 Q9UPZ6 24.729 461 5.6199999999999995e-24 111.0 sp|Q9UPZ6|THS7A_HUMAN Thrombospondin type-1 domain-containing protein 7A OS=Homo sapiens OX=9606 GN=THSD7A PE=1 SV=4 g7470.t1 O55201 54.706 170 2.99e-47 169.0 sp|O55201|SPT5H_MOUSE Transcription elongation factor SPT5 OS=Mus musculus OX=10090 GN=Supt5h PE=1 SV=1 g7471.t1 Q5R405 65.752 765 0.0 1018.0 sp|Q5R405|SPT5H_PONAB Transcription elongation factor SPT5 OS=Pongo abelii OX=9601 GN=SUPT5H PE=2 SV=1 SPT5H_PONAB reviewed Transcription elongation factor SPT5 (DRB sensitivity-inducing factor large subunit) (DSIF large subunit) Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0003729; GO:0006357; GO:0006368; GO:0032044; GO:0032784 regulation of DNA-templated transcription elongation [GO:0032784]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription elongation by RNA polymerase II [GO:0006368] DSIF complex [GO:0032044] mRNA binding [GO:0003729] g7472.t1 Q8BYK8 39.412 170 1.6e-26 121.0 sp|Q8BYK8|ZC3H6_MOUSE Zinc finger CCCH domain-containing protein 6 OS=Mus musculus OX=10090 GN=Zc3h6 PE=2 SV=2 g7476.t1 Q6PC64 44.503 191 5.78e-44 150.0 sp|Q6PC64|ELOV6_DANRE Very long chain fatty acid elongase 6 OS=Danio rerio OX=7955 GN=elovl6 PE=2 SV=1 ELOV6_DANRE reviewed Very long chain fatty acid elongase 6 (EC 2.3.1.199) (3-keto acyl-CoA synthase elovl6) (ELOVL fatty acid elongase 6) (ELOVL FA elongase 6) (Elongation of very long chain fatty acids protein 6) (Very long chain 3-ketoacyl-CoA synthase 6) (Very long chain 3-oxoacyl-CoA synthase 6) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005783; GO:0005789; GO:0006636; GO:0009922; GO:0019367; GO:0030148; GO:0030497; GO:0034625; GO:0034626; GO:0035338; GO:0042759; GO:0042761 fatty acid elongation [GO:0030497]; fatty acid elongation, monounsaturated fatty acid [GO:0034625]; fatty acid elongation, polyunsaturated fatty acid [GO:0034626]; fatty acid elongation, saturated fatty acid [GO:0019367]; long-chain fatty acid biosynthetic process [GO:0042759]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; sphingolipid biosynthetic process [GO:0030148]; unsaturated fatty acid biosynthetic process [GO:0006636]; very long-chain fatty acid biosynthetic process [GO:0042761] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789] fatty acid elongase activity [GO:0009922] g7478.t1 Q3ZCX4 40.897 379 2.06e-86 292.0 sp|Q3ZCX4|ZN568_HUMAN Zinc finger protein 568 OS=Homo sapiens OX=9606 GN=ZNF568 PE=1 SV=2 ZN568_HUMAN reviewed Zinc finger protein 568 Homo sapiens (Human) GO:0000122; GO:0000976; GO:0000978; GO:0000981; GO:0001701; GO:0005634; GO:0006357; GO:0008270; GO:0045892; GO:0060669 embryonic placenta morphogenesis [GO:0060669]; in utero embryonic development [GO:0001701]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription cis-regulatory region binding [GO:0000976]; zinc ion binding [GO:0008270] g7478.t1 Q3ZCX4 38.095 378 1.88e-81 278.0 sp|Q3ZCX4|ZN568_HUMAN Zinc finger protein 568 OS=Homo sapiens OX=9606 GN=ZNF568 PE=1 SV=2 ZN568_HUMAN reviewed Zinc finger protein 568 Homo sapiens (Human) GO:0000122; GO:0000976; GO:0000978; GO:0000981; GO:0001701; GO:0005634; GO:0006357; GO:0008270; GO:0045892; GO:0060669 embryonic placenta morphogenesis [GO:0060669]; in utero embryonic development [GO:0001701]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription cis-regulatory region binding [GO:0000976]; zinc ion binding [GO:0008270] g7478.t1 Q3ZCX4 37.647 340 1.52e-68 243.0 sp|Q3ZCX4|ZN568_HUMAN Zinc finger protein 568 OS=Homo sapiens OX=9606 GN=ZNF568 PE=1 SV=2 ZN568_HUMAN reviewed Zinc finger protein 568 Homo sapiens (Human) GO:0000122; GO:0000976; GO:0000978; GO:0000981; GO:0001701; GO:0005634; GO:0006357; GO:0008270; GO:0045892; GO:0060669 embryonic placenta morphogenesis [GO:0060669]; in utero embryonic development [GO:0001701]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription cis-regulatory region binding [GO:0000976]; zinc ion binding [GO:0008270] g7479.t1 Q90980 29.111 450 1.77e-48 189.0 sp|Q90980|CNG3_CHICK Cyclic nucleotide-gated channel rod photoreceptor subunit alpha OS=Gallus gallus OX=9031 PE=2 SV=1 CNG3_CHICK reviewed Cyclic nucleotide-gated channel rod photoreceptor subunit alpha (CNG channel 3) (CNG-3) (CNG3) Gallus gallus (Chicken) GO:0005222; GO:0005223; GO:0005886; GO:0007601; GO:0007606; GO:0017071; GO:0030552; GO:0030553; GO:0042622; GO:0098655; GO:0120200 monoatomic cation transmembrane transport [GO:0098655]; sensory perception of chemical stimulus [GO:0007606]; visual perception [GO:0007601] intracellular cyclic nucleotide activated cation channel complex [GO:0017071]; photoreceptor outer segment membrane [GO:0042622]; plasma membrane [GO:0005886]; rod photoreceptor outer segment [GO:0120200] cAMP binding [GO:0030552]; cGMP binding [GO:0030553]; intracellularly cAMP-activated cation channel activity [GO:0005222]; intracellularly cGMP-activated cation channel activity [GO:0005223] g7479.t1 Q90980 25.855 468 4.460000000000001e-43 172.0 sp|Q90980|CNG3_CHICK Cyclic nucleotide-gated channel rod photoreceptor subunit alpha OS=Gallus gallus OX=9031 PE=2 SV=1 CNG3_CHICK reviewed Cyclic nucleotide-gated channel rod photoreceptor subunit alpha (CNG channel 3) (CNG-3) (CNG3) Gallus gallus (Chicken) GO:0005222; GO:0005223; GO:0005886; GO:0007601; GO:0007606; GO:0017071; GO:0030552; GO:0030553; GO:0042622; GO:0098655; GO:0120200 monoatomic cation transmembrane transport [GO:0098655]; sensory perception of chemical stimulus [GO:0007606]; visual perception [GO:0007601] intracellular cyclic nucleotide activated cation channel complex [GO:0017071]; photoreceptor outer segment membrane [GO:0042622]; plasma membrane [GO:0005886]; rod photoreceptor outer segment [GO:0120200] cAMP binding [GO:0030552]; cGMP binding [GO:0030553]; intracellularly cAMP-activated cation channel activity [GO:0005222]; intracellularly cGMP-activated cation channel activity [GO:0005223] g7479.t1 Q90980 27.924 419 2e-37 155.0 sp|Q90980|CNG3_CHICK Cyclic nucleotide-gated channel rod photoreceptor subunit alpha OS=Gallus gallus OX=9031 PE=2 SV=1 CNG3_CHICK reviewed Cyclic nucleotide-gated channel rod photoreceptor subunit alpha (CNG channel 3) (CNG-3) (CNG3) Gallus gallus (Chicken) GO:0005222; GO:0005223; GO:0005886; GO:0007601; GO:0007606; GO:0017071; GO:0030552; GO:0030553; GO:0042622; GO:0098655; GO:0120200 monoatomic cation transmembrane transport [GO:0098655]; sensory perception of chemical stimulus [GO:0007606]; visual perception [GO:0007601] intracellular cyclic nucleotide activated cation channel complex [GO:0017071]; photoreceptor outer segment membrane [GO:0042622]; plasma membrane [GO:0005886]; rod photoreceptor outer segment [GO:0120200] cAMP binding [GO:0030552]; cGMP binding [GO:0030553]; intracellularly cAMP-activated cation channel activity [GO:0005222]; intracellularly cGMP-activated cation channel activity [GO:0005223] g7479.t1 Q90980 27.273 341 1.23e-32 140.0 sp|Q90980|CNG3_CHICK Cyclic nucleotide-gated channel rod photoreceptor subunit alpha OS=Gallus gallus OX=9031 PE=2 SV=1 CNG3_CHICK reviewed Cyclic nucleotide-gated channel rod photoreceptor subunit alpha (CNG channel 3) (CNG-3) (CNG3) Gallus gallus (Chicken) GO:0005222; GO:0005223; GO:0005886; GO:0007601; GO:0007606; GO:0017071; GO:0030552; GO:0030553; GO:0042622; GO:0098655; GO:0120200 monoatomic cation transmembrane transport [GO:0098655]; sensory perception of chemical stimulus [GO:0007606]; visual perception [GO:0007601] intracellular cyclic nucleotide activated cation channel complex [GO:0017071]; photoreceptor outer segment membrane [GO:0042622]; plasma membrane [GO:0005886]; rod photoreceptor outer segment [GO:0120200] cAMP binding [GO:0030552]; cGMP binding [GO:0030553]; intracellularly cAMP-activated cation channel activity [GO:0005222]; intracellularly cGMP-activated cation channel activity [GO:0005223] g7479.t2 Q90980 29.111 450 1.66e-48 189.0 sp|Q90980|CNG3_CHICK Cyclic nucleotide-gated channel rod photoreceptor subunit alpha OS=Gallus gallus OX=9031 PE=2 SV=1 CNG3_CHICK reviewed Cyclic nucleotide-gated channel rod photoreceptor subunit alpha (CNG channel 3) (CNG-3) (CNG3) Gallus gallus (Chicken) GO:0005222; GO:0005223; GO:0005886; GO:0007601; GO:0007606; GO:0017071; GO:0030552; GO:0030553; GO:0042622; GO:0098655; GO:0120200 monoatomic cation transmembrane transport [GO:0098655]; sensory perception of chemical stimulus [GO:0007606]; visual perception [GO:0007601] intracellular cyclic nucleotide activated cation channel complex [GO:0017071]; photoreceptor outer segment membrane [GO:0042622]; plasma membrane [GO:0005886]; rod photoreceptor outer segment [GO:0120200] cAMP binding [GO:0030552]; cGMP binding [GO:0030553]; intracellularly cAMP-activated cation channel activity [GO:0005222]; intracellularly cGMP-activated cation channel activity [GO:0005223] g7479.t2 Q90980 25.855 468 3.79e-43 172.0 sp|Q90980|CNG3_CHICK Cyclic nucleotide-gated channel rod photoreceptor subunit alpha OS=Gallus gallus OX=9031 PE=2 SV=1 CNG3_CHICK reviewed Cyclic nucleotide-gated channel rod photoreceptor subunit alpha (CNG channel 3) (CNG-3) (CNG3) Gallus gallus (Chicken) GO:0005222; GO:0005223; GO:0005886; GO:0007601; GO:0007606; GO:0017071; GO:0030552; GO:0030553; GO:0042622; GO:0098655; GO:0120200 monoatomic cation transmembrane transport [GO:0098655]; sensory perception of chemical stimulus [GO:0007606]; visual perception [GO:0007601] intracellular cyclic nucleotide activated cation channel complex [GO:0017071]; photoreceptor outer segment membrane [GO:0042622]; plasma membrane [GO:0005886]; rod photoreceptor outer segment [GO:0120200] cAMP binding [GO:0030552]; cGMP binding [GO:0030553]; intracellularly cAMP-activated cation channel activity [GO:0005222]; intracellularly cGMP-activated cation channel activity [GO:0005223] g7479.t2 Q90980 27.924 419 1.85e-37 155.0 sp|Q90980|CNG3_CHICK Cyclic nucleotide-gated channel rod photoreceptor subunit alpha OS=Gallus gallus OX=9031 PE=2 SV=1 CNG3_CHICK reviewed Cyclic nucleotide-gated channel rod photoreceptor subunit alpha (CNG channel 3) (CNG-3) (CNG3) Gallus gallus (Chicken) GO:0005222; GO:0005223; GO:0005886; GO:0007601; GO:0007606; GO:0017071; GO:0030552; GO:0030553; GO:0042622; GO:0098655; GO:0120200 monoatomic cation transmembrane transport [GO:0098655]; sensory perception of chemical stimulus [GO:0007606]; visual perception [GO:0007601] intracellular cyclic nucleotide activated cation channel complex [GO:0017071]; photoreceptor outer segment membrane [GO:0042622]; plasma membrane [GO:0005886]; rod photoreceptor outer segment [GO:0120200] cAMP binding [GO:0030552]; cGMP binding [GO:0030553]; intracellularly cAMP-activated cation channel activity [GO:0005222]; intracellularly cGMP-activated cation channel activity [GO:0005223] g7479.t2 Q90980 26.593 361 5.270000000000001e-32 138.0 sp|Q90980|CNG3_CHICK Cyclic nucleotide-gated channel rod photoreceptor subunit alpha OS=Gallus gallus OX=9031 PE=2 SV=1 CNG3_CHICK reviewed Cyclic nucleotide-gated channel rod photoreceptor subunit alpha (CNG channel 3) (CNG-3) (CNG3) Gallus gallus (Chicken) GO:0005222; GO:0005223; GO:0005886; GO:0007601; GO:0007606; GO:0017071; GO:0030552; GO:0030553; GO:0042622; GO:0098655; GO:0120200 monoatomic cation transmembrane transport [GO:0098655]; sensory perception of chemical stimulus [GO:0007606]; visual perception [GO:0007601] intracellular cyclic nucleotide activated cation channel complex [GO:0017071]; photoreceptor outer segment membrane [GO:0042622]; plasma membrane [GO:0005886]; rod photoreceptor outer segment [GO:0120200] cAMP binding [GO:0030552]; cGMP binding [GO:0030553]; intracellularly cAMP-activated cation channel activity [GO:0005222]; intracellularly cGMP-activated cation channel activity [GO:0005223] g7480.t1 Q86VH2 41.275 1318 0.0 855.0 sp|Q86VH2|KIF27_HUMAN Kinesin-like protein KIF27 OS=Homo sapiens OX=9606 GN=KIF27 PE=1 SV=1 KIF27_HUMAN reviewed Kinesin-like protein KIF27 Homo sapiens (Human) GO:0003351; GO:0003777; GO:0005524; GO:0005576; GO:0005737; GO:0005871; GO:0005874; GO:0005929; GO:0007018; GO:0008017; GO:0016887; GO:0021591; GO:0051649; GO:0060271 cilium assembly [GO:0060271]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; establishment of localization in cell [GO:0051649]; microtubule-based movement [GO:0007018]; ventricular system development [GO:0021591] cilium [GO:0005929]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; kinesin complex [GO:0005871]; microtubule [GO:0005874] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777] g7480.t2 Q86VH2 42.368 1284 0.0 872.0 sp|Q86VH2|KIF27_HUMAN Kinesin-like protein KIF27 OS=Homo sapiens OX=9606 GN=KIF27 PE=1 SV=1 KIF27_HUMAN reviewed Kinesin-like protein KIF27 Homo sapiens (Human) GO:0003351; GO:0003777; GO:0005524; GO:0005576; GO:0005737; GO:0005871; GO:0005874; GO:0005929; GO:0007018; GO:0008017; GO:0016887; GO:0021591; GO:0051649; GO:0060271 cilium assembly [GO:0060271]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; establishment of localization in cell [GO:0051649]; microtubule-based movement [GO:0007018]; ventricular system development [GO:0021591] cilium [GO:0005929]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; kinesin complex [GO:0005871]; microtubule [GO:0005874] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777] g7481.t1 Q15485 41.304 230 1.09e-38 144.0 sp|Q15485|FCN2_HUMAN Ficolin-2 OS=Homo sapiens OX=9606 GN=FCN2 PE=1 SV=2 FCN2_HUMAN reviewed Ficolin-2 (37 kDa elastin-binding protein) (EBP-37) (Collagen/fibrinogen domain-containing protein 2) (Ficolin-B) (Ficolin-beta) (Hucolin) (L-ficolin) (Serum lectin p35) Homo sapiens (Human) GO:0001867; GO:0002752; GO:0003823; GO:0005102; GO:0005576; GO:0005581; GO:0005615; GO:0006508; GO:0008228; GO:0009897; GO:0038187; GO:0043394; GO:0043654; GO:0046872; GO:0048306; GO:0050829; GO:0050830; GO:0070062; GO:0070892; GO:0072562; GO:0097367; GO:0106139; GO:1903028; GO:1905370; GO:2001065 cell surface pattern recognition receptor signaling pathway [GO:0002752]; complement activation, lectin pathway [GO:0001867]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; opsonization [GO:0008228]; positive regulation of opsonization [GO:1903028]; proteolysis [GO:0006508]; recognition of apoptotic cell [GO:0043654] blood microparticle [GO:0072562]; collagen trimer [GO:0005581]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; serine-type endopeptidase complex [GO:1905370]; symbiont cell surface [GO:0106139] antigen binding [GO:0003823]; calcium-dependent protein binding [GO:0048306]; carbohydrate derivative binding [GO:0097367]; lipoteichoic acid immune receptor activity [GO:0070892]; mannan binding [GO:2001065]; metal ion binding [GO:0046872]; pattern recognition receptor activity [GO:0038187]; proteoglycan binding [GO:0043394]; signaling receptor binding [GO:0005102] g7486.t1 Q6DHJ3 40.494 405 5.69e-91 286.0 sp|Q6DHJ3|NVD_DANRE Cholesterol 7-desaturase nvd OS=Danio rerio OX=7955 GN=nvd PE=1 SV=1 NVD_DANRE reviewed Cholesterol 7-desaturase nvd (EC 1.14.19.21) (Protein neverland) (Nvd protein) (nvd-Dr) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005737; GO:0008203; GO:0016020; GO:0016491; GO:0046872; GO:0051537; GO:0170056 cholesterol metabolic process [GO:0008203] cytoplasm [GO:0005737]; membrane [GO:0016020] 2 iron, 2 sulfur cluster binding [GO:0051537]; cholesterol 7-desaturase [NAD(P)H] activity [GO:0170056]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491] g7487.t1 Q8AVI4 66.48 537 0.0 663.0 sp|Q8AVI4|SHOC2_XENLA Leucine-rich repeat protein SHOC-2 OS=Xenopus laevis OX=8355 GN=shoc2 PE=2 SV=1 g7487.t2 Q8AVI4 62.105 570 0.0 629.0 sp|Q8AVI4|SHOC2_XENLA Leucine-rich repeat protein SHOC-2 OS=Xenopus laevis OX=8355 GN=shoc2 PE=2 SV=1 g7491.t1 Q9Y5Z4 40.506 158 1.7999999999999998e-34 124.0 sp|Q9Y5Z4|HEBP2_HUMAN Heme-binding protein 2 OS=Homo sapiens OX=9606 GN=HEBP2 PE=1 SV=1 HEBP2_HUMAN reviewed Heme-binding protein 2 (Placental protein 23) (PP23) (Protein SOUL) Homo sapiens (Human) GO:0005576; GO:0005737; GO:0005739; GO:0020037; GO:0035578; GO:0070062 azurophil granule lumen [GO:0035578]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; mitochondrion [GO:0005739] heme binding [GO:0020037] g7492.t1 Q9Y5Z4 41.772 158 1.65e-34 124.0 sp|Q9Y5Z4|HEBP2_HUMAN Heme-binding protein 2 OS=Homo sapiens OX=9606 GN=HEBP2 PE=1 SV=1 HEBP2_HUMAN reviewed Heme-binding protein 2 (Placental protein 23) (PP23) (Protein SOUL) Homo sapiens (Human) GO:0005576; GO:0005737; GO:0005739; GO:0020037; GO:0035578; GO:0070062 azurophil granule lumen [GO:0035578]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; mitochondrion [GO:0005739] heme binding [GO:0020037] g7506.t1 P42669 51.515 231 4.26e-75 234.0 sp|P42669|PURA_MOUSE Transcriptional activator protein Pur-alpha OS=Mus musculus OX=10090 GN=Pura PE=1 SV=1 PURA_MOUSE reviewed Transcriptional activator protein Pur-alpha (Purine-rich single-stranded DNA-binding protein alpha) Mus musculus (Mouse) GO:0000122; GO:0000900; GO:0000977; GO:0000981; GO:0001227; GO:0003677; GO:0003690; GO:0003691; GO:0003697; GO:0003700; GO:0005634; GO:0005737; GO:0006357; GO:0007399; GO:0008284; GO:0014069; GO:0030425; GO:0032422; GO:0043025; GO:0043433; GO:0045892; GO:0046332; GO:0046651; GO:0050673; GO:0098794; GO:0098963; GO:0098978; GO:0140297; GO:0140416 dendritic transport of messenger ribonucleoprotein complex [GO:0098963]; epithelial cell proliferation [GO:0050673]; lymphocyte proliferation [GO:0046651]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]; positive regulation of cell population proliferation [GO:0008284]; regulation of transcription by RNA polymerase II [GO:0006357] cytoplasm [GO:0005737]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069] DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription factor binding [GO:0140297]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; double-stranded DNA binding [GO:0003690]; double-stranded telomeric DNA binding [GO:0003691]; mRNA regulatory element binding translation repressor activity [GO:0000900]; purine-rich negative regulatory element binding [GO:0032422]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; single-stranded DNA binding [GO:0003697]; SMAD binding [GO:0046332]; transcription regulator inhibitor activity [GO:0140416] g7509.t1 P46023 31.286 700 9.569999999999999e-82 288.0 sp|P46023|GR101_LYMST G-protein coupled receptor GRL101 OS=Lymnaea stagnalis OX=6523 PE=2 SV=1 g7512.t1 Q9VXT2 53.165 316 1.44e-71 228.0 sp|Q9VXT2|DJC25_DROME DnaJ homolog subfamily C member 25 homolog OS=Drosophila melanogaster OX=7227 GN=CG7872 PE=2 SV=1 g7513.t1 O95479 44.072 776 0.0 674.0 sp|O95479|G6PE_HUMAN GDH/6PGL endoplasmic bifunctional protein OS=Homo sapiens OX=9606 GN=H6PD PE=1 SV=2 G6PE_HUMAN reviewed GDH/6PGL endoplasmic bifunctional protein [Includes: Hexose-6-phosphate dehydrogenase (Glucose 1-dehydrogenase) (GDH) (EC 1.1.1.47) (Glucose-6-phosphate dehydrogenase) (EC 1.1.1.363); 6-phosphogluconolactonase (6PGL) (EC 3.1.1.31)] Homo sapiens (Human) GO:0004345; GO:0005783; GO:0005788; GO:0006006; GO:0009051; GO:0016529; GO:0017057; GO:0030246; GO:0031667; GO:0047934; GO:0047935; GO:0050661; GO:0097305; GO:2000064 glucose metabolic process [GO:0006006]; pentose-phosphate shunt, oxidative branch [GO:0009051]; regulation of cortisol biosynthetic process [GO:2000064]; response to alcohol [GO:0097305]; response to nutrient levels [GO:0031667] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; sarcoplasmic reticulum [GO:0016529] 6-phosphogluconolactonase activity [GO:0017057]; carbohydrate binding [GO:0030246]; glucose 1-dehydrogenase (NAD+) activity [GO:0047934]; glucose 1-dehydrogenase (NADP+) activity [GO:0047935]; glucose-6-phosphate dehydrogenase activity [GO:0004345]; NADP binding [GO:0050661] g7514.t1 Q5PQ71 64.249 193 7.329999999999999e-89 262.0 sp|Q5PQ71|ISOC2_XENLA Isochorismatase domain-containing protein 2 OS=Xenopus laevis OX=8355 GN=isoc2 PE=2 SV=1 g7516.t1 Q6ZS17 41.259 286 2.06e-61 233.0 sp|Q6ZS17|RIPR1_HUMAN Rho family-interacting cell polarization regulator 1 OS=Homo sapiens OX=9606 GN=RIPOR1 PE=1 SV=1 RIPR1_HUMAN reviewed Rho family-interacting cell polarization regulator 1 Homo sapiens (Human) GO:0005737; GO:0005794; GO:0005829; GO:0007266; GO:0009267; GO:0009611; GO:0012506; GO:0016020; GO:0030335; GO:0031252; GO:0034067; GO:0035024; GO:0051683; GO:0070062; GO:0071889; GO:0090316; GO:1990869; GO:2001107 cellular response to chemokine [GO:1990869]; cellular response to starvation [GO:0009267]; establishment of Golgi localization [GO:0051683]; negative regulation of Rho guanyl-nucleotide exchange factor activity [GO:2001107]; negative regulation of Rho protein signal transduction [GO:0035024]; positive regulation of cell migration [GO:0030335]; positive regulation of intracellular protein transport [GO:0090316]; protein localization to Golgi apparatus [GO:0034067]; response to wounding [GO:0009611]; Rho protein signal transduction [GO:0007266] cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; vesicle membrane [GO:0012506] 14-3-3 protein binding [GO:0071889] g7516.t1 Q6ZS17 30.312 320 4.4699999999999995e-24 114.0 sp|Q6ZS17|RIPR1_HUMAN Rho family-interacting cell polarization regulator 1 OS=Homo sapiens OX=9606 GN=RIPOR1 PE=1 SV=1 RIPR1_HUMAN reviewed Rho family-interacting cell polarization regulator 1 Homo sapiens (Human) GO:0005737; GO:0005794; GO:0005829; GO:0007266; GO:0009267; GO:0009611; GO:0012506; GO:0016020; GO:0030335; GO:0031252; GO:0034067; GO:0035024; GO:0051683; GO:0070062; GO:0071889; GO:0090316; GO:1990869; GO:2001107 cellular response to chemokine [GO:1990869]; cellular response to starvation [GO:0009267]; establishment of Golgi localization [GO:0051683]; negative regulation of Rho guanyl-nucleotide exchange factor activity [GO:2001107]; negative regulation of Rho protein signal transduction [GO:0035024]; positive regulation of cell migration [GO:0030335]; positive regulation of intracellular protein transport [GO:0090316]; protein localization to Golgi apparatus [GO:0034067]; response to wounding [GO:0009611]; Rho protein signal transduction [GO:0007266] cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; vesicle membrane [GO:0012506] 14-3-3 protein binding [GO:0071889] g7517.t1 O88178 40.299 134 1.05e-21 101.0 sp|O88178|B3GT4_RAT Beta-1,3-galactosyltransferase 4 OS=Rattus norvegicus OX=10116 GN=B3galt4 PE=1 SV=1 g7518.t1 Q9MYM7 37.069 232 6.46e-43 153.0 sp|Q9MYM7|B3GT1_PONPY Beta-1,3-galactosyltransferase 1 OS=Pongo pygmaeus OX=9600 GN=B3GALT1 PE=3 SV=1 g7521.t1 P43353 59.69 258 2.46e-106 320.0 sp|P43353|AL3B1_HUMAN Aldehyde dehydrogenase family 3 member B1 OS=Homo sapiens OX=9606 GN=ALDH3B1 PE=1 SV=1 AL3B1_HUMAN reviewed Aldehyde dehydrogenase family 3 member B1 (EC 1.2.1.28) (EC 1.2.1.5) (EC 1.2.1.7) (Aldehyde dehydrogenase 7) (Long-chain fatty aldehyde dehydrogenase) (EC 1.2.1.48) (Medium-chain fatty aldehyde dehydrogenase) Homo sapiens (Human) GO:0004028; GO:0004029; GO:0004030; GO:0005737; GO:0005829; GO:0005886; GO:0006066; GO:0006068; GO:0006081; GO:0006629; GO:0006979; GO:0018477; GO:0018479; GO:0030149; GO:0030667; GO:0031982; GO:0034599; GO:0035579; GO:0046185; GO:0050061; GO:0052814; GO:0070062 alcohol metabolic process [GO:0006066]; aldehyde catabolic process [GO:0046185]; aldehyde metabolic process [GO:0006081]; cellular response to oxidative stress [GO:0034599]; ethanol catabolic process [GO:0006068]; lipid metabolic process [GO:0006629]; response to oxidative stress [GO:0006979]; sphingolipid catabolic process [GO:0030149] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; specific granule membrane [GO:0035579]; vesicle [GO:0031982] 3-chloroallyl aldehyde dehydrogenase activity [GO:0004028]; aldehyde dehydrogenase (NAD+) activity [GO:0004029]; aldehyde dehydrogenase [NAD(P)+] activity [GO:0004030]; benzaldehyde dehydrogenase (NAD+) activity [GO:0018479]; benzaldehyde dehydrogenase (NADP+) activity [GO:0018477]; long-chain fatty aldehyde dehydrogenase (NAD+) activity [GO:0050061]; medium-chain fatty aldehyde dehydrogenase (NAD+) activity [GO:0052814] g7521.t2 P43353 59.69 258 1.64e-106 321.0 sp|P43353|AL3B1_HUMAN Aldehyde dehydrogenase family 3 member B1 OS=Homo sapiens OX=9606 GN=ALDH3B1 PE=1 SV=1 AL3B1_HUMAN reviewed Aldehyde dehydrogenase family 3 member B1 (EC 1.2.1.28) (EC 1.2.1.5) (EC 1.2.1.7) (Aldehyde dehydrogenase 7) (Long-chain fatty aldehyde dehydrogenase) (EC 1.2.1.48) (Medium-chain fatty aldehyde dehydrogenase) Homo sapiens (Human) GO:0004028; GO:0004029; GO:0004030; GO:0005737; GO:0005829; GO:0005886; GO:0006066; GO:0006068; GO:0006081; GO:0006629; GO:0006979; GO:0018477; GO:0018479; GO:0030149; GO:0030667; GO:0031982; GO:0034599; GO:0035579; GO:0046185; GO:0050061; GO:0052814; GO:0070062 alcohol metabolic process [GO:0006066]; aldehyde catabolic process [GO:0046185]; aldehyde metabolic process [GO:0006081]; cellular response to oxidative stress [GO:0034599]; ethanol catabolic process [GO:0006068]; lipid metabolic process [GO:0006629]; response to oxidative stress [GO:0006979]; sphingolipid catabolic process [GO:0030149] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; specific granule membrane [GO:0035579]; vesicle [GO:0031982] 3-chloroallyl aldehyde dehydrogenase activity [GO:0004028]; aldehyde dehydrogenase (NAD+) activity [GO:0004029]; aldehyde dehydrogenase [NAD(P)+] activity [GO:0004030]; benzaldehyde dehydrogenase (NAD+) activity [GO:0018479]; benzaldehyde dehydrogenase (NADP+) activity [GO:0018477]; long-chain fatty aldehyde dehydrogenase (NAD+) activity [GO:0050061]; medium-chain fatty aldehyde dehydrogenase (NAD+) activity [GO:0052814] g7522.t1 Q9VBW3 40.663 332 2.9499999999999997e-67 239.0 sp|Q9VBW3|CAD96_DROME Tyrosine kinase receptor Cad96Ca OS=Drosophila melanogaster OX=7227 GN=Cad96Ca PE=2 SV=2 CAD96_DROME reviewed Tyrosine kinase receptor Cad96Ca (EC 2.7.10.1) (Cadherin-96Ca) (Tyrosine kinase receptor HD-14) Drosophila melanogaster (Fruit fly) GO:0004713; GO:0004714; GO:0005509; GO:0005524; GO:0005886; GO:0006468; GO:0007030; GO:0007156; GO:0007169; GO:0016339; GO:0042060; GO:0043235; GO:0045177; GO:0045792; GO:0051897; GO:0090303 calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; Golgi organization [GO:0007030]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell size [GO:0045792]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of wound healing [GO:0090303]; protein phosphorylation [GO:0006468]; wound healing [GO:0042060] apical part of cell [GO:0045177]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; protein tyrosine kinase activity [GO:0004713]; transmembrane receptor protein tyrosine kinase activity [GO:0004714] g7522.t2 Q9VBW3 40.663 332 1.4099999999999999e-67 239.0 sp|Q9VBW3|CAD96_DROME Tyrosine kinase receptor Cad96Ca OS=Drosophila melanogaster OX=7227 GN=Cad96Ca PE=2 SV=2 CAD96_DROME reviewed Tyrosine kinase receptor Cad96Ca (EC 2.7.10.1) (Cadherin-96Ca) (Tyrosine kinase receptor HD-14) Drosophila melanogaster (Fruit fly) GO:0004713; GO:0004714; GO:0005509; GO:0005524; GO:0005886; GO:0006468; GO:0007030; GO:0007156; GO:0007169; GO:0016339; GO:0042060; GO:0043235; GO:0045177; GO:0045792; GO:0051897; GO:0090303 calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; Golgi organization [GO:0007030]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell size [GO:0045792]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of wound healing [GO:0090303]; protein phosphorylation [GO:0006468]; wound healing [GO:0042060] apical part of cell [GO:0045177]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; protein tyrosine kinase activity [GO:0004713]; transmembrane receptor protein tyrosine kinase activity [GO:0004714] g7523.t1 Q569T7 42.4 250 1.43e-40 157.0 sp|Q569T7|MFS4B_XENLA Sodium-dependent glucose transporter 1 OS=Xenopus laevis OX=8355 GN=mfsd4b PE=2 SV=1 g7523.t1 Q569T7 46.923 130 4.76e-22 103.0 sp|Q569T7|MFS4B_XENLA Sodium-dependent glucose transporter 1 OS=Xenopus laevis OX=8355 GN=mfsd4b PE=2 SV=1 g7524.t1 Q9QXL2 65.152 528 0.0 681.0 sp|Q9QXL2|KI21A_MOUSE Kinesin-like protein KIF21A OS=Mus musculus OX=10090 GN=Kif21a PE=1 SV=2 g7524.t1 Q9QXL2 53.134 367 2.7299999999999998e-114 403.0 sp|Q9QXL2|KI21A_MOUSE Kinesin-like protein KIF21A OS=Mus musculus OX=10090 GN=Kif21a PE=1 SV=2 g7524.t1 Q9QXL2 44.589 462 5.44e-111 393.0 sp|Q9QXL2|KI21A_MOUSE Kinesin-like protein KIF21A OS=Mus musculus OX=10090 GN=Kif21a PE=1 SV=2 g7524.t2 Q9QXL2 65.152 528 0.0 682.0 sp|Q9QXL2|KI21A_MOUSE Kinesin-like protein KIF21A OS=Mus musculus OX=10090 GN=Kif21a PE=1 SV=2 g7524.t2 Q9QXL2 53.134 367 2.47e-114 403.0 sp|Q9QXL2|KI21A_MOUSE Kinesin-like protein KIF21A OS=Mus musculus OX=10090 GN=Kif21a PE=1 SV=2 g7524.t2 Q9QXL2 44.589 462 4.73e-111 393.0 sp|Q9QXL2|KI21A_MOUSE Kinesin-like protein KIF21A OS=Mus musculus OX=10090 GN=Kif21a PE=1 SV=2 g7525.t1 Q95LU3 43.945 289 2.8000000000000002e-70 230.0 sp|Q95LU3|FBCD1_MACFA Fibrinogen C domain-containing protein 1 OS=Macaca fascicularis OX=9541 GN=FIBCD1 PE=2 SV=1 g7526.t1 P46023 28.914 626 7.04e-48 190.0 sp|P46023|GR101_LYMST G-protein coupled receptor GRL101 OS=Lymnaea stagnalis OX=6523 PE=2 SV=1 g7526.t2 P46023 28.849 617 2.77e-46 185.0 sp|P46023|GR101_LYMST G-protein coupled receptor GRL101 OS=Lymnaea stagnalis OX=6523 PE=2 SV=1 g7527.t1 P70490 31.636 275 1.83e-33 137.0 sp|P70490|MFGM_RAT Lactadherin OS=Rattus norvegicus OX=10116 GN=Mfge8 PE=2 SV=1 MFGM_RAT reviewed Lactadherin (MFGM) (Milk fat globule-EGF factor 8) (MFG-E8) (O-acetyl GD3 ganglioside synthase) (AGS) (SED1) Rattus norvegicus (Rat) GO:0001525; GO:0001786; GO:0002080; GO:0005178; GO:0005615; GO:0006910; GO:0006911; GO:0007155; GO:0007338; GO:0008284; GO:0008429; GO:0009897; GO:0043277; GO:0043627; GO:0050766 angiogenesis [GO:0001525]; apoptotic cell clearance [GO:0043277]; cell adhesion [GO:0007155]; phagocytosis, engulfment [GO:0006911]; phagocytosis, recognition [GO:0006910]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of phagocytosis [GO:0050766]; response to estrogen [GO:0043627]; single fertilization [GO:0007338] acrosomal membrane [GO:0002080]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615] integrin binding [GO:0005178]; phosphatidylethanolamine binding [GO:0008429]; phosphatidylserine binding [GO:0001786] g7527.t1 P70490 24.257 404 4.6999999999999995e-23 106.0 sp|P70490|MFGM_RAT Lactadherin OS=Rattus norvegicus OX=10116 GN=Mfge8 PE=2 SV=1 MFGM_RAT reviewed Lactadherin (MFGM) (Milk fat globule-EGF factor 8) (MFG-E8) (O-acetyl GD3 ganglioside synthase) (AGS) (SED1) Rattus norvegicus (Rat) GO:0001525; GO:0001786; GO:0002080; GO:0005178; GO:0005615; GO:0006910; GO:0006911; GO:0007155; GO:0007338; GO:0008284; GO:0008429; GO:0009897; GO:0043277; GO:0043627; GO:0050766 angiogenesis [GO:0001525]; apoptotic cell clearance [GO:0043277]; cell adhesion [GO:0007155]; phagocytosis, engulfment [GO:0006911]; phagocytosis, recognition [GO:0006910]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of phagocytosis [GO:0050766]; response to estrogen [GO:0043627]; single fertilization [GO:0007338] acrosomal membrane [GO:0002080]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615] integrin binding [GO:0005178]; phosphatidylethanolamine binding [GO:0008429]; phosphatidylserine binding [GO:0001786] g7531.t1 O76536 30.442 634 1.0800000000000001e-27 123.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g7531.t1 O76536 30.952 630 4.39e-26 118.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g7531.t1 O76536 31.029 622 8.87e-26 117.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g7531.t1 O76536 30.929 624 5.98e-23 108.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g7531.t1 O76536 29.982 547 4.26e-22 105.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g7533.t1 B3EWZ5 31.793 541 3.0400000000000002e-56 210.0 sp|B3EWZ5|MLRP1_ACRMI MAM and LDL-receptor class A domain-containing protein 1 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g7533.t1 B3EWZ5 31.186 590 5.7e-53 200.0 sp|B3EWZ5|MLRP1_ACRMI MAM and LDL-receptor class A domain-containing protein 1 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g7533.t1 B3EWZ5 28.242 563 7.37e-48 185.0 sp|B3EWZ5|MLRP1_ACRMI MAM and LDL-receptor class A domain-containing protein 1 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g7533.t1 B3EWZ5 26.354 554 9.74e-46 179.0 sp|B3EWZ5|MLRP1_ACRMI MAM and LDL-receptor class A domain-containing protein 1 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g7533.t1 B3EWZ5 28.108 555 1.38e-44 175.0 sp|B3EWZ5|MLRP1_ACRMI MAM and LDL-receptor class A domain-containing protein 1 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g7533.t1 B3EWZ5 27.972 572 3.96e-44 174.0 sp|B3EWZ5|MLRP1_ACRMI MAM and LDL-receptor class A domain-containing protein 1 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g7533.t1 B3EWZ5 28.119 537 5.3799999999999996e-42 167.0 sp|B3EWZ5|MLRP1_ACRMI MAM and LDL-receptor class A domain-containing protein 1 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g7533.t1 B3EWZ5 29.854 479 3.49e-40 162.0 sp|B3EWZ5|MLRP1_ACRMI MAM and LDL-receptor class A domain-containing protein 1 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g7533.t1 B3EWZ5 26.75 557 2.37e-39 159.0 sp|B3EWZ5|MLRP1_ACRMI MAM and LDL-receptor class A domain-containing protein 1 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g7533.t1 B3EWZ5 26.642 548 5.23e-39 158.0 sp|B3EWZ5|MLRP1_ACRMI MAM and LDL-receptor class A domain-containing protein 1 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g7533.t1 B3EWZ5 28.419 468 3.31e-36 150.0 sp|B3EWZ5|MLRP1_ACRMI MAM and LDL-receptor class A domain-containing protein 1 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g7533.t1 B3EWZ5 28.667 450 3.46e-30 131.0 sp|B3EWZ5|MLRP1_ACRMI MAM and LDL-receptor class A domain-containing protein 1 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g7533.t1 B3EWZ5 29.299 314 4.4099999999999993e-23 108.0 sp|B3EWZ5|MLRP1_ACRMI MAM and LDL-receptor class A domain-containing protein 1 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g7534.t1 O08742 27.865 384 7.689999999999999e-23 108.0 sp|O08742|GPV_MOUSE Platelet glycoprotein V OS=Mus musculus OX=10090 GN=Gp5 PE=1 SV=1 g7534.t3 P35445 43.093 666 9.819999999999999e-104 355.0 sp|P35445|COMP_BOVIN Cartilage oligomeric matrix protein OS=Bos taurus OX=9913 GN=COMP PE=1 SV=2 COMP_BOVIN reviewed Cartilage oligomeric matrix protein (COMP) Bos taurus (Bovine) GO:0002020; GO:0002063; GO:0003417; GO:0005178; GO:0005509; GO:0005518; GO:0005576; GO:0005615; GO:0006915; GO:0006986; GO:0008201; GO:0009306; GO:0010468; GO:0014829; GO:0016485; GO:0030199; GO:0030282; GO:0030500; GO:0030509; GO:0031012; GO:0032991; GO:0035264; GO:0035988; GO:0035989; GO:0036122; GO:0043066; GO:0043395; GO:0043588; GO:0048844; GO:0050881; GO:0051260; GO:0060173; GO:0070527; GO:0090398; GO:0097084; GO:1900047; GO:1902732; GO:1990079 apoptotic process [GO:0006915]; artery morphogenesis [GO:0048844]; BMP signaling pathway [GO:0030509]; bone mineralization [GO:0030282]; cartilage homeostasis [GO:1990079]; cellular senescence [GO:0090398]; chondrocyte development [GO:0002063]; chondrocyte proliferation [GO:0035988]; collagen fibril organization [GO:0030199]; growth plate cartilage development [GO:0003417]; limb development [GO:0060173]; multicellular organism growth [GO:0035264]; musculoskeletal movement [GO:0050881]; negative regulation of apoptotic process [GO:0043066]; negative regulation of hemostasis [GO:1900047]; platelet aggregation [GO:0070527]; positive regulation of chondrocyte proliferation [GO:1902732]; protein homooligomerization [GO:0051260]; protein processing [GO:0016485]; protein secretion [GO:0009306]; regulation of bone mineralization [GO:0030500]; regulation of gene expression [GO:0010468]; response to unfolded protein [GO:0006986]; skin development [GO:0043588]; tendon development [GO:0035989]; vascular associated smooth muscle cell development [GO:0097084]; vascular associated smooth muscle contraction [GO:0014829] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; protein-containing complex [GO:0032991] BMP binding [GO:0036122]; calcium ion binding [GO:0005509]; collagen binding [GO:0005518]; heparan sulfate proteoglycan binding [GO:0043395]; heparin binding [GO:0008201]; integrin binding [GO:0005178]; protease binding [GO:0002020] g7534.t4 P35445 43.093 666 9.819999999999999e-104 355.0 sp|P35445|COMP_BOVIN Cartilage oligomeric matrix protein OS=Bos taurus OX=9913 GN=COMP PE=1 SV=2 COMP_BOVIN reviewed Cartilage oligomeric matrix protein (COMP) Bos taurus (Bovine) GO:0002020; GO:0002063; GO:0003417; GO:0005178; GO:0005509; GO:0005518; GO:0005576; GO:0005615; GO:0006915; GO:0006986; GO:0008201; GO:0009306; GO:0010468; GO:0014829; GO:0016485; GO:0030199; GO:0030282; GO:0030500; GO:0030509; GO:0031012; GO:0032991; GO:0035264; GO:0035988; GO:0035989; GO:0036122; GO:0043066; GO:0043395; GO:0043588; GO:0048844; GO:0050881; GO:0051260; GO:0060173; GO:0070527; GO:0090398; GO:0097084; GO:1900047; GO:1902732; GO:1990079 apoptotic process [GO:0006915]; artery morphogenesis [GO:0048844]; BMP signaling pathway [GO:0030509]; bone mineralization [GO:0030282]; cartilage homeostasis [GO:1990079]; cellular senescence [GO:0090398]; chondrocyte development [GO:0002063]; chondrocyte proliferation [GO:0035988]; collagen fibril organization [GO:0030199]; growth plate cartilage development [GO:0003417]; limb development [GO:0060173]; multicellular organism growth [GO:0035264]; musculoskeletal movement [GO:0050881]; negative regulation of apoptotic process [GO:0043066]; negative regulation of hemostasis [GO:1900047]; platelet aggregation [GO:0070527]; positive regulation of chondrocyte proliferation [GO:1902732]; protein homooligomerization [GO:0051260]; protein processing [GO:0016485]; protein secretion [GO:0009306]; regulation of bone mineralization [GO:0030500]; regulation of gene expression [GO:0010468]; response to unfolded protein [GO:0006986]; skin development [GO:0043588]; tendon development [GO:0035989]; vascular associated smooth muscle cell development [GO:0097084]; vascular associated smooth muscle contraction [GO:0014829] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; protein-containing complex [GO:0032991] BMP binding [GO:0036122]; calcium ion binding [GO:0005509]; collagen binding [GO:0005518]; heparan sulfate proteoglycan binding [GO:0043395]; heparin binding [GO:0008201]; integrin binding [GO:0005178]; protease binding [GO:0002020] g7535.t1 Q6P0T2 44.66 206 1.13e-48 164.0 sp|Q6P0T2|TAF8_DANRE Transcription initiation factor TFIID subunit 8 OS=Danio rerio OX=7955 GN=taf8 PE=1 SV=1 TAF8_DANRE reviewed Transcription initiation factor TFIID subunit 8 (Protein taube nuss-like) (TBP-associated factor 8) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005669; GO:0005737; GO:0006367; GO:0030154; GO:0046982 cell differentiation [GO:0030154]; transcription initiation at RNA polymerase II promoter [GO:0006367] cytoplasm [GO:0005737]; transcription factor TFIID complex [GO:0005669] protein heterodimerization activity [GO:0046982] g7537.t1 A0A061I403 56.542 214 8.44e-76 243.0 sp|A0A061I403|FICD_CRIGR Protein adenylyltransferase FICD OS=Cricetulus griseus OX=10029 GN=FICD PE=1 SV=1 FICD_CRIGR reviewed Protein adenylyltransferase FICD (EC 2.7.7.108) (AMPylator FICD) (De-AMPylase FICD) (EC 3.1.4.-) (FIC domain-containing protein) (Huntingtin-interacting protein E) Cricetulus griseus (Chinese hamster) (Cricetulus barabensis griseus) GO:0005524; GO:0005789; GO:0006986; GO:0018117; GO:0030544; GO:0034976; GO:0042803; GO:0044602; GO:0044603; GO:0051087; GO:0070733; GO:1903894 protein adenylylation [GO:0018117]; protein deadenylylation [GO:0044602]; regulation of IRE1-mediated unfolded protein response [GO:1903894]; response to endoplasmic reticulum stress [GO:0034976]; response to unfolded protein [GO:0006986] endoplasmic reticulum membrane [GO:0005789] AMPylase activity [GO:0070733]; ATP binding [GO:0005524]; Hsp70 protein binding [GO:0030544]; protein adenylylhydrolase activity [GO:0044603]; protein homodimerization activity [GO:0042803]; protein-folding chaperone binding [GO:0051087] g7538.t1 Q6DRI7 53.807 197 1.79e-57 206.0 sp|Q6DRI7|DDX51_DANRE ATP-dependent RNA helicase DDX51 OS=Danio rerio OX=7955 GN=ddx51 PE=2 SV=1 DDX51_DANRE reviewed ATP-dependent RNA helicase DDX51 (EC 3.6.4.13) (DEAD box protein 51) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005730; GO:0006364; GO:0016887 rRNA processing [GO:0006364] nucleolus [GO:0005730]; nucleus [GO:0005634] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724] g7538.t2 Q6DRI7 50.391 512 5.71e-165 498.0 sp|Q6DRI7|DDX51_DANRE ATP-dependent RNA helicase DDX51 OS=Danio rerio OX=7955 GN=ddx51 PE=2 SV=1 DDX51_DANRE reviewed ATP-dependent RNA helicase DDX51 (EC 3.6.4.13) (DEAD box protein 51) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005730; GO:0006364; GO:0016887 rRNA processing [GO:0006364] nucleolus [GO:0005730]; nucleus [GO:0005634] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724] g7538.t3 Q6DRI7 50.299 334 1.08e-106 328.0 sp|Q6DRI7|DDX51_DANRE ATP-dependent RNA helicase DDX51 OS=Danio rerio OX=7955 GN=ddx51 PE=2 SV=1 DDX51_DANRE reviewed ATP-dependent RNA helicase DDX51 (EC 3.6.4.13) (DEAD box protein 51) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005730; GO:0006364; GO:0016887 rRNA processing [GO:0006364] nucleolus [GO:0005730]; nucleus [GO:0005634] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724] g7538.t4 Q6DRI7 47.213 305 6.54e-88 278.0 sp|Q6DRI7|DDX51_DANRE ATP-dependent RNA helicase DDX51 OS=Danio rerio OX=7955 GN=ddx51 PE=2 SV=1 DDX51_DANRE reviewed ATP-dependent RNA helicase DDX51 (EC 3.6.4.13) (DEAD box protein 51) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005730; GO:0006364; GO:0016887 rRNA processing [GO:0006364] nucleolus [GO:0005730]; nucleus [GO:0005634] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724] g7539.t1 P61917 43.066 137 4.4e-34 120.0 sp|P61917|NPC2_PANTR NPC intracellular cholesterol transporter 2 OS=Pan troglodytes OX=9598 GN=NPC2 PE=1 SV=1 g7541.t1 P35448 54.808 104 1.0900000000000001e-29 132.0 sp|P35448|TSP1_XENLA Thrombospondin-1 OS=Xenopus laevis OX=8355 GN=thbs1 PE=2 SV=1 g7545.t1 Q96DM1 27.949 390 8.09e-32 134.0 sp|Q96DM1|PGBD4_HUMAN PiggyBac transposable element-derived protein 4 OS=Homo sapiens OX=9606 GN=PGBD4 PE=1 SV=3 g7547.t1 Q3B8G4 48.661 224 4.5e-63 204.0 sp|Q3B8G4|YIPF3_XENLA Protein YIPF3 OS=Xenopus laevis OX=8355 GN=yipf3 PE=2 SV=1 g7550.t1 Q8IZ41 36.842 646 1.69e-101 329.0 sp|Q8IZ41|RASEF_HUMAN Ras and EF-hand domain-containing protein OS=Homo sapiens OX=9606 GN=RASEF PE=1 SV=1 RASEF_HUMAN reviewed Ras and EF-hand domain-containing protein (EC 3.6.5.2) (Ras-related protein Rab-45) Homo sapiens (Human) GO:0003924; GO:0003925; GO:0005509; GO:0005525; GO:0005737; GO:0005769; GO:0005794; GO:0005829; GO:0016192; GO:0019003; GO:0036019; GO:0042802; GO:0048471; GO:0070625 vesicle-mediated transport [GO:0016192]; zymogen granule exocytosis [GO:0070625] cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endolysosome [GO:0036019]; Golgi apparatus [GO:0005794]; perinuclear region of cytoplasm [GO:0048471] calcium ion binding [GO:0005509]; G protein activity [GO:0003925]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802] g7550.t2 Q8IZ41 34.799 773 8.24e-117 371.0 sp|Q8IZ41|RASEF_HUMAN Ras and EF-hand domain-containing protein OS=Homo sapiens OX=9606 GN=RASEF PE=1 SV=1 RASEF_HUMAN reviewed Ras and EF-hand domain-containing protein (EC 3.6.5.2) (Ras-related protein Rab-45) Homo sapiens (Human) GO:0003924; GO:0003925; GO:0005509; GO:0005525; GO:0005737; GO:0005769; GO:0005794; GO:0005829; GO:0016192; GO:0019003; GO:0036019; GO:0042802; GO:0048471; GO:0070625 vesicle-mediated transport [GO:0016192]; zymogen granule exocytosis [GO:0070625] cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endolysosome [GO:0036019]; Golgi apparatus [GO:0005794]; perinuclear region of cytoplasm [GO:0048471] calcium ion binding [GO:0005509]; G protein activity [GO:0003925]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802] g7556.t1 A0A974CYQ5 44.668 497 5.32e-146 452.0 sp|A0A974CYQ5|RFW3S_XENLA E3 ubiquitin-protein ligase rfwd3.S OS=Xenopus laevis OX=8355 GN=rfwd3.S PE=1 SV=1 RFW3S_XENLA reviewed E3 ubiquitin-protein ligase rfwd3.S (EC 2.3.2.27) (RING finger and WD repeat domain-containing protein 3.S) Xenopus laevis (African clawed frog) GO:0005737; GO:0008270; GO:0016567; GO:0016605; GO:0036297; GO:0061630 interstrand cross-link repair [GO:0036297]; protein ubiquitination [GO:0016567] cytoplasm [GO:0005737]; PML body [GO:0016605] ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] g7557.t1 Q9Z120 65.462 249 4.14e-127 363.0 sp|Q9Z120|TRMB_MOUSE tRNA (guanine-N(7)-)-methyltransferase OS=Mus musculus OX=10090 GN=Mettl1 PE=1 SV=1 TRMB_MOUSE reviewed tRNA (guanine-N(7)-)-methyltransferase (EC 2.1.1.33) (Methyltransferase-like protein 1) (mRNA (guanine-N(7)-)-methyltransferase) (EC 2.1.1.-) (miRNA (guanine-N(7)-)-methyltransferase) (EC 2.1.1.-) (tRNA (guanine(46)-N(7))-methyltransferase) (tRNA(m7G46)-methyltransferase) Mus musculus (Mouse) GO:0000049; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0006400; GO:0008176; GO:0008298; GO:0030488; GO:0033554; GO:0034063; GO:0036265; GO:0036416; GO:0043527; GO:0051028; GO:0106004; GO:0106143; GO:0160090 cellular response to stress [GO:0033554]; intracellular mRNA localization [GO:0008298]; mRNA transport [GO:0051028]; RNA (guanine-N7)-methylation [GO:0036265]; stress granule assembly [GO:0034063]; tRNA (guanine-N7)-methylation [GO:0106004]; tRNA methylation [GO:0030488]; tRNA modification [GO:0006400]; tRNA stabilization [GO:0036416] cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; tRNA (m7G46) methyltransferase complex [GO:0106143]; tRNA methyltransferase complex [GO:0043527] internal mRNA (guanine-N7-)-methyltransferase activity [GO:0160090]; tRNA (guanine(46)-N7)-methyltransferase activity [GO:0008176]; tRNA binding [GO:0000049] g7558.t1 Q6DH23 77.778 315 0.0 518.0 sp|Q6DH23|V26BL_DANRE Vacuolar protein sorting-associated protein 26B-like OS=Danio rerio OX=7955 GN=vps26bl PE=2 SV=1 g7560.t1 Q75N73 31.624 234 4.94e-32 128.0 sp|Q75N73|S39AE_MOUSE Metal cation symporter ZIP14 OS=Mus musculus OX=10090 GN=Slc39a14 PE=1 SV=1 S39AE_MOUSE reviewed Metal cation symporter ZIP14 (Factor for adipocyte differentiation 123) (FAD-123) (Solute carrier family 39 member 14) (Zrt- and Irt-like protein 14) (ZIP-14) Mus musculus (Mouse) GO:0002062; GO:0005381; GO:0005384; GO:0005385; GO:0005765; GO:0005886; GO:0006094; GO:0006826; GO:0006829; GO:0006882; GO:0008286; GO:0010817; GO:0015086; GO:0015093; GO:0015296; GO:0016020; GO:0016323; GO:0016324; GO:0030003; GO:0031901; GO:0031902; GO:0032869; GO:0033212; GO:0034755; GO:0045745; GO:0055071; GO:0071333; GO:0071421; GO:0071577; GO:0071578; GO:0098662; GO:0098739; GO:0140410 cellular response to glucose stimulus [GO:0071333]; cellular response to insulin stimulus [GO:0032869]; chondrocyte differentiation [GO:0002062]; gluconeogenesis [GO:0006094]; import across plasma membrane [GO:0098739]; inorganic cation transmembrane transport [GO:0098662]; insulin receptor signaling pathway [GO:0008286]; intracellular monoatomic cation homeostasis [GO:0030003]; intracellular zinc ion homeostasis [GO:0006882]; iron import into cell [GO:0033212]; iron ion transmembrane transport [GO:0034755]; iron ion transport [GO:0006826]; manganese ion homeostasis [GO:0055071]; manganese ion transmembrane transport [GO:0071421]; positive regulation of G protein-coupled receptor signaling pathway [GO:0045745]; regulation of hormone levels [GO:0010817]; zinc ion import across plasma membrane [GO:0071578]; zinc ion transmembrane transport [GO:0071577]; zinc ion transport [GO:0006829] apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; early endosome membrane [GO:0031901]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; plasma membrane [GO:0005886] cadmium ion transmembrane transporter activity [GO:0015086]; ferrous iron transmembrane transporter activity [GO:0015093]; iron ion transmembrane transporter activity [GO:0005381]; manganese ion transmembrane transporter activity [GO:0005384]; monoatomic anion:monoatomic cation symporter activity [GO:0015296]; monoatomic cation:bicarbonate symporter activity [GO:0140410]; zinc ion transmembrane transporter activity [GO:0005385] g7561.t1 A5D7L5 61.667 120 2.29e-34 127.0 sp|A5D7L5|S39AE_BOVIN Metal cation symporter ZIP14 OS=Bos taurus OX=9913 GN=SLC39A14 PE=2 SV=1 S39AE_BOVIN reviewed Metal cation symporter ZIP14 (Solute carrier family 39 member 14) (Zrt- and Irt-like protein 14) (ZIP-14) Bos taurus (Bovine) GO:0005381; GO:0005384; GO:0005385; GO:0005765; GO:0005886; GO:0006882; GO:0015086; GO:0015296; GO:0016323; GO:0016324; GO:0030003; GO:0031901; GO:0031902; GO:0032869; GO:0033212; GO:0034755; GO:0045745; GO:0055071; GO:0071333; GO:0071421; GO:0071577; GO:0071578; GO:0098662; GO:0098739; GO:0140410 cellular response to glucose stimulus [GO:0071333]; cellular response to insulin stimulus [GO:0032869]; import across plasma membrane [GO:0098739]; inorganic cation transmembrane transport [GO:0098662]; intracellular monoatomic cation homeostasis [GO:0030003]; intracellular zinc ion homeostasis [GO:0006882]; iron import into cell [GO:0033212]; iron ion transmembrane transport [GO:0034755]; manganese ion homeostasis [GO:0055071]; manganese ion transmembrane transport [GO:0071421]; positive regulation of G protein-coupled receptor signaling pathway [GO:0045745]; zinc ion import across plasma membrane [GO:0071578]; zinc ion transmembrane transport [GO:0071577] apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; early endosome membrane [GO:0031901]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886] cadmium ion transmembrane transporter activity [GO:0015086]; iron ion transmembrane transporter activity [GO:0005381]; manganese ion transmembrane transporter activity [GO:0005384]; monoatomic anion:monoatomic cation symporter activity [GO:0015296]; monoatomic cation:bicarbonate symporter activity [GO:0140410]; zinc ion transmembrane transporter activity [GO:0005385] g23333.t1 Q6QNK2 40.123 162 9.07e-29 124.0 sp|Q6QNK2|AGRD1_HUMAN Adhesion G-protein coupled receptor D1 OS=Homo sapiens OX=9606 GN=ADGRD1 PE=1 SV=1 AGRD1_HUMAN reviewed Adhesion G-protein coupled receptor D1 (G-protein coupled receptor 133) (G-protein coupled receptor PGR25) [Cleaved into: Adhesion G-protein coupled receptor D1, N-terminal fragment (ADGRD1 N-terminal fragment); Adhesion G-protein coupled receptor D1, C-terminal fragment (ADGRD1 C-terminal fragment)] Homo sapiens (Human) GO:0004930; GO:0005654; GO:0005829; GO:0005886; GO:0007166; GO:0007186; GO:0007189; GO:0014819; GO:0016020; GO:0016607 adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186]; regulation of skeletal muscle contraction [GO:0014819] cytosol [GO:0005829]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] G protein-coupled receptor activity [GO:0004930] g23335.t1 Q64380 60.354 903 0.0 1164.0 sp|Q64380|SARDH_RAT Sarcosine dehydrogenase, mitochondrial OS=Rattus norvegicus OX=10116 GN=Sardh PE=1 SV=2 SARDH_RAT reviewed Sarcosine dehydrogenase, mitochondrial (SarDH) (EC 1.5.8.3) Rattus norvegicus (Rat) GO:0005542; GO:0005737; GO:0005739; GO:0005759; GO:0006545; GO:0008480; GO:0016491; GO:0035999; GO:0042426; GO:0050660; GO:1901053 choline catabolic process [GO:0042426]; glycine biosynthetic process [GO:0006545]; sarcosine catabolic process [GO:1901053]; tetrahydrofolate interconversion [GO:0035999] cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] flavin adenine dinucleotide binding [GO:0050660]; folic acid binding [GO:0005542]; oxidoreductase activity [GO:0016491]; sarcosine dehydrogenase activity [GO:0008480] g23336.t1 Q5WR10 84.259 432 0.0 758.0 sp|Q5WR10|DX39B_CANLF Spliceosome RNA helicase DDX39B OS=Canis lupus familiaris OX=9615 GN=DDX39B PE=3 SV=1 DX39B_CANLF reviewed Spliceosome RNA helicase DDX39B (EC 3.6.4.13) (56 kDa U2AF65-associated protein) (DEAD box protein UAP56) Canis lupus familiaris (Dog) (Canis familiaris) GO:0000245; GO:0000346; GO:0000398; GO:0003724; GO:0003729; GO:0005524; GO:0005681; GO:0005687; GO:0005688; GO:0005737; GO:0006406; GO:0016607; GO:0016887; GO:0017070; GO:0030621; GO:0042802; GO:0043008 mRNA export from nucleus [GO:0006406]; mRNA splicing, via spliceosome [GO:0000398]; spliceosomal complex assembly [GO:0000245] cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; spliceosomal complex [GO:0005681]; transcription export complex [GO:0000346]; U4 snRNP [GO:0005687]; U6 snRNP [GO:0005688] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent protein binding [GO:0043008]; identical protein binding [GO:0042802]; mRNA binding [GO:0003729]; RNA helicase activity [GO:0003724]; U4 snRNA binding [GO:0030621]; U6 snRNA binding [GO:0017070] g23338.t1 P07207 46.452 2170 0.0 1764.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g23338.t1 P07207 36.151 1112 0.0 644.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g23338.t1 P07207 37.6 1000 3.3199999999999996e-176 609.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g23338.t2 P07207 41.06 2019 0.0 1338.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g23338.t2 P07207 42.778 1260 0.0 943.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g23338.t2 P07207 35.943 907 4.2e-142 501.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g23339.t1 Q6U7H8 39.241 237 2.98e-54 191.0 sp|Q6U7H8|PI5L1_MOUSE Phosphatidylinositol 4-phosphate 5-kinase-like protein 1 OS=Mus musculus OX=10090 GN=Pip5kl1 PE=1 SV=1 PI5L1_MOUSE reviewed Phosphatidylinositol 4-phosphate 5-kinase-like protein 1 (PI(4)P 5-kinase-like protein 1) (PtdIns(4)P-5-kinase-like protein 1) (Phosphatidylinositol phosphate kinase homolog) (PIPKH) Mus musculus (Mouse) GO:0005524; GO:0005829; GO:0005886; GO:0010917; GO:0016308; GO:0030336; GO:0042995; GO:0043065; GO:0046854; GO:0051898 negative regulation of cell migration [GO:0030336]; negative regulation of mitochondrial membrane potential [GO:0010917]; negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051898]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; positive regulation of apoptotic process [GO:0043065] cell projection [GO:0042995]; cytosol [GO:0005829]; plasma membrane [GO:0005886] 1-phosphatidylinositol-4-phosphate 5-kinase activity [GO:0016308]; ATP binding [GO:0005524] g23340.t1 Q2KIN1 59.459 74 1.0099999999999999e-24 91.3 sp|Q2KIN1|DPM2_BOVIN Dolichol phosphate-mannose biosynthesis regulatory protein OS=Bos taurus OX=9913 GN=DPM2 PE=3 SV=3 g23342.t1 Q63433 52.459 976 0.0 889.0 sp|Q63433|PKN1_RAT Serine/threonine-protein kinase N1 OS=Rattus norvegicus OX=10116 GN=Pkn1 PE=1 SV=2 g23342.t2 A7MBL8 57.91 1005 0.0 1050.0 sp|A7MBL8|PKN2_DANRE Serine/threonine-protein kinase N2 OS=Danio rerio OX=7955 GN=pkn2 PE=2 SV=1 PKN2_DANRE reviewed Serine/threonine-protein kinase N2 (EC 2.7.11.13) (PKN gamma) (Protein kinase C-like 2) (Protein-kinase C-related kinase 2) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0004674; GO:0004697; GO:0005524; GO:0005634; GO:0005737; GO:0005856; GO:0007155; GO:0030027; GO:0030496; GO:0031267; GO:0032154; GO:0035556; GO:0051301; GO:0070161; GO:0106310 cell adhesion [GO:0007155]; cell division [GO:0051301]; intracellular signal transduction [GO:0035556] anchoring junction [GO:0070161]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; lamellipodium [GO:0030027]; midbody [GO:0030496]; nucleus [GO:0005634] ATP binding [GO:0005524]; diacylglycerol-dependent serine/threonine kinase activity [GO:0004697]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; small GTPase binding [GO:0031267] g23343.t1 Q6P7N4 42.748 393 3.8599999999999996e-95 291.0 sp|Q6P7N4|HMCES_XENTR Abasic site processing protein HMCES OS=Xenopus tropicalis OX=8364 GN=hmces PE=2 SV=1 HMCES_XENTR reviewed Abasic site processing protein HMCES (EC 4.-.-.-) (Embryonic stem cell-specific 5-hydroxymethylcytosine-binding protein) (ES cell-specific 5hmC-binding protein) (Peptidase HMCES) (EC 3.4.-.-) (SRAP domain-containing protein 1) Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0003697; GO:0005657; GO:0006508; GO:0006974; GO:0008233; GO:0045830; GO:0106300; GO:0160129 DNA damage response [GO:0006974]; positive regulation of isotype switching [GO:0045830]; protein-DNA covalent cross-linking repair [GO:0106300]; proteolysis [GO:0006508] replication fork [GO:0005657] peptidase activity [GO:0008233]; protein-DNA covalent cross-linking activity [GO:0160129]; single-stranded DNA binding [GO:0003697] g23348.t1 Q9V998 86.301 73 1.11e-40 130.0 sp|Q9V998|UBL5_DROME Ubiquitin-like protein 5 OS=Drosophila melanogaster OX=7227 GN=ubl PE=3 SV=1 g23349.t1 Q6PCJ9 58.209 268 7.589999999999999e-115 337.0 sp|Q6PCJ9|PPT2A_XENLA Lysosomal thioesterase PPT2-A OS=Xenopus laevis OX=8355 GN=ppt2-a PE=2 SV=1 g23351.t1 Q6P1M0 49.679 624 0.0 641.0 sp|Q6P1M0|S27A4_HUMAN Long-chain fatty acid transport protein 4 OS=Homo sapiens OX=9606 GN=SLC27A4 PE=1 SV=1 S27A4_HUMAN reviewed Long-chain fatty acid transport protein 4 (FATP-4) (Fatty acid transport protein 4) (Arachidonate--CoA ligase) (EC 6.2.1.15) (Long-chain-fatty-acid--CoA ligase) (EC 6.2.1.3) (Solute carrier family 27 member 4) (Very long-chain acyl-CoA synthetase 4) (ACSVL4) (EC 6.2.1.-) Homo sapiens (Human) GO:0000166; GO:0001579; GO:0001676; GO:0004467; GO:0005324; GO:0005783; GO:0005789; GO:0005886; GO:0005902; GO:0006631; GO:0007584; GO:0015245; GO:0015908; GO:0015909; GO:0016020; GO:0031526; GO:0031957; GO:0042760; GO:0043065; GO:0043588; GO:0044381; GO:0044539; GO:0046627; GO:0047676; GO:0051649; GO:0090433; GO:0090434; GO:0150104; GO:1990379 establishment of localization in cell [GO:0051649]; fatty acid metabolic process [GO:0006631]; fatty acid transport [GO:0015908]; glucose import in response to insulin stimulus [GO:0044381]; lipid transport across blood-brain barrier [GO:1990379]; long-chain fatty acid import into cell [GO:0044539]; long-chain fatty acid metabolic process [GO:0001676]; long-chain fatty acid transport [GO:0015909]; medium-chain fatty acid transport [GO:0001579]; negative regulation of insulin receptor signaling pathway [GO:0046627]; positive regulation of apoptotic process [GO:0043065]; response to nutrient [GO:0007584]; skin development [GO:0043588]; transport across blood-brain barrier [GO:0150104]; very long-chain fatty acid catabolic process [GO:0042760] brush border membrane [GO:0031526]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; microvillus [GO:0005902]; plasma membrane [GO:0005886] arachidonate-CoA ligase activity [GO:0047676]; fatty acid transmembrane transporter activity [GO:0015245]; long-chain fatty acid transmembrane transporter activity [GO:0005324]; long-chain fatty acid-CoA ligase activity [GO:0004467]; nucleotide binding [GO:0000166]; oleoyl-CoA ligase activity [GO:0090434]; palmitoyl-CoA ligase activity [GO:0090433]; very long-chain fatty acid-CoA ligase activity [GO:0031957] g23354.t1 Q6AYT0 52.381 84 3.12e-24 97.1 sp|Q6AYT0|QOR_RAT Quinone oxidoreductase OS=Rattus norvegicus OX=10116 GN=Cryz PE=2 SV=1 QOR_RAT reviewed Zeta-crystallin (NADPH:quinone reductase) (Quinone oxidoreductase) (EC 1.6.5.5) Rattus norvegicus (Rat) GO:0003730; GO:0003960; GO:0005829; GO:0008270; GO:0042178; GO:0042802; GO:0048255; GO:0051289; GO:0070402 mRNA stabilization [GO:0048255]; protein homotetramerization [GO:0051289]; xenobiotic catabolic process [GO:0042178] cytosol [GO:0005829] identical protein binding [GO:0042802]; mRNA 3'-UTR binding [GO:0003730]; NADPH binding [GO:0070402]; quinone reductase (NADPH) activity [GO:0003960]; zinc ion binding [GO:0008270] g23355.t1 Q5R4S7 61.638 232 5.379999999999999e-104 307.0 sp|Q5R4S7|QOR_PONAB Quinone oxidoreductase OS=Pongo abelii OX=9601 GN=CRYZ PE=2 SV=1 g23356.t1 Q95NM6 48.319 238 5.5199999999999997e-76 237.0 sp|Q95NM6|NUCG_CAEEL Endonuclease G, mitochondrial OS=Caenorhabditis elegans OX=6239 GN=cps-6 PE=1 SV=1 NUCG_CAEEL reviewed Endonuclease G, mitochondrial (Endo G) (EC 3.1.30.-) (Ced-3 protease suppressor 6) Caenorhabditis elegans GO:0000014; GO:0004519; GO:0004520; GO:0004521; GO:0005634; GO:0005739; GO:0005743; GO:0005758; GO:0006308; GO:0006309; GO:0006401; GO:0042803; GO:0043565; GO:0046872; GO:1990238 apoptotic DNA fragmentation [GO:0006309]; DNA catabolic process [GO:0006308]; RNA catabolic process [GO:0006401] mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; nucleus [GO:0005634] DNA endonuclease activity [GO:0004520]; double-stranded DNA endonuclease activity [GO:1990238]; endonuclease activity [GO:0004519]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; RNA endonuclease activity [GO:0004521]; sequence-specific DNA binding [GO:0043565]; single-stranded DNA endodeoxyribonuclease activity [GO:0000014] g23357.t1 O94967 63.529 170 4.23e-72 236.0 sp|O94967|WDR47_HUMAN WD repeat-containing protein 47 OS=Homo sapiens OX=9606 GN=WDR47 PE=1 SV=1 WDR47_HUMAN reviewed WD repeat-containing protein 47 (Neuronal enriched MAP-interacting protein) (Nemitin) Homo sapiens (Human) GO:0000226; GO:0005737; GO:0005874; GO:0006914; GO:0007026; GO:0008344; GO:0021801; GO:0021960; GO:0022038; GO:0030425; GO:0030426; GO:0043025; GO:0044877; GO:0061351; GO:0061744; GO:0097150; GO:0120168 adult locomotory behavior [GO:0008344]; anterior commissure morphogenesis [GO:0021960]; autophagy [GO:0006914]; cerebral cortex radial glia-guided migration [GO:0021801]; corpus callosum development [GO:0022038]; detection of hot stimulus involved in thermoception [GO:0120168]; microtubule cytoskeleton organization [GO:0000226]; motor behavior [GO:0061744]; negative regulation of microtubule depolymerization [GO:0007026]; neural precursor cell proliferation [GO:0061351]; neuronal stem cell population maintenance [GO:0097150] cytoplasm [GO:0005737]; dendrite [GO:0030425]; growth cone [GO:0030426]; microtubule [GO:0005874]; neuronal cell body [GO:0043025] protein-containing complex binding [GO:0044877] g23358.t1 O94967 42.737 475 1.2300000000000001e-88 300.0 sp|O94967|WDR47_HUMAN WD repeat-containing protein 47 OS=Homo sapiens OX=9606 GN=WDR47 PE=1 SV=1 WDR47_HUMAN reviewed WD repeat-containing protein 47 (Neuronal enriched MAP-interacting protein) (Nemitin) Homo sapiens (Human) GO:0000226; GO:0005737; GO:0005874; GO:0006914; GO:0007026; GO:0008344; GO:0021801; GO:0021960; GO:0022038; GO:0030425; GO:0030426; GO:0043025; GO:0044877; GO:0061351; GO:0061744; GO:0097150; GO:0120168 adult locomotory behavior [GO:0008344]; anterior commissure morphogenesis [GO:0021960]; autophagy [GO:0006914]; cerebral cortex radial glia-guided migration [GO:0021801]; corpus callosum development [GO:0022038]; detection of hot stimulus involved in thermoception [GO:0120168]; microtubule cytoskeleton organization [GO:0000226]; motor behavior [GO:0061744]; negative regulation of microtubule depolymerization [GO:0007026]; neural precursor cell proliferation [GO:0061351]; neuronal stem cell population maintenance [GO:0097150] cytoplasm [GO:0005737]; dendrite [GO:0030425]; growth cone [GO:0030426]; microtubule [GO:0005874]; neuronal cell body [GO:0043025] protein-containing complex binding [GO:0044877] g23358.t2 Q8CGF6 42.227 476 1.31e-89 298.0 sp|Q8CGF6|WDR47_MOUSE WD repeat-containing protein 47 OS=Mus musculus OX=10090 GN=Wdr47 PE=1 SV=2 WDR47_MOUSE reviewed WD repeat-containing protein 47 (Neuronal enriched MAP interacting protein) (Nemitin) Mus musculus (Mouse) GO:0000226; GO:0005737; GO:0005874; GO:0006914; GO:0007026; GO:0007420; GO:0007626; GO:0008344; GO:0021801; GO:0021960; GO:0021987; GO:0022038; GO:0030424; GO:0030425; GO:0030426; GO:0031175; GO:0043005; GO:0044297; GO:0044877; GO:0061351; GO:0061744; GO:0097150; GO:0120168 adult locomotory behavior [GO:0008344]; anterior commissure morphogenesis [GO:0021960]; autophagy [GO:0006914]; brain development [GO:0007420]; cerebral cortex development [GO:0021987]; cerebral cortex radial glia-guided migration [GO:0021801]; corpus callosum development [GO:0022038]; detection of hot stimulus involved in thermoception [GO:0120168]; locomotory behavior [GO:0007626]; microtubule cytoskeleton organization [GO:0000226]; motor behavior [GO:0061744]; negative regulation of microtubule depolymerization [GO:0007026]; neural precursor cell proliferation [GO:0061351]; neuron projection development [GO:0031175]; neuronal stem cell population maintenance [GO:0097150] axon [GO:0030424]; cell body [GO:0044297]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; growth cone [GO:0030426]; microtubule [GO:0005874]; neuron projection [GO:0043005] protein-containing complex binding [GO:0044877] g23359.t1 Q5R6Q2 55.357 224 1.12e-78 240.0 sp|Q5R6Q2|STX6_PONAB Syntaxin-6 OS=Pongo abelii OX=9601 GN=STX6 PE=2 SV=1 STX6_PONAB reviewed Syntaxin-6 Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0000139; GO:0005484; GO:0005654; GO:0005769; GO:0005829; GO:0006886; GO:0006906; GO:0007032; GO:0019905; GO:0031201; GO:0032456; GO:0032588; GO:0032880; GO:0042147; GO:0045335; GO:0048193; GO:0048471; GO:0055037; GO:0055038 endocytic recycling [GO:0032456]; endosome organization [GO:0007032]; Golgi vesicle transport [GO:0048193]; intracellular protein transport [GO:0006886]; regulation of protein localization [GO:0032880]; retrograde transport, endosome to Golgi [GO:0042147]; vesicle fusion [GO:0006906] cytosol [GO:0005829]; early endosome [GO:0005769]; Golgi membrane [GO:0000139]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle [GO:0045335]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; SNARE complex [GO:0031201]; trans-Golgi network membrane [GO:0032588] SNAP receptor activity [GO:0005484]; syntaxin binding [GO:0019905] g23360.t1 Q27433 72.491 269 3.74e-126 370.0 sp|Q27433|MEC2_CAEEL Mechanosensory protein 2 OS=Caenorhabditis elegans OX=6239 GN=mec-2 PE=1 SV=1 MEC2_CAEEL reviewed Mechanosensory protein 2 Caenorhabditis elegans GO:0005272; GO:0005886; GO:0006813; GO:0007638; GO:0008200; GO:0009612; GO:0015485; GO:0032589; GO:0043005; GO:0050976; GO:1905789; GO:1905792 detection of mechanical stimulus involved in sensory perception of touch [GO:0050976]; mechanosensory behavior [GO:0007638]; positive regulation of detection of mechanical stimulus involved in sensory perception of touch [GO:1905789]; positive regulation of mechanosensory behavior [GO:1905792]; potassium ion transport [GO:0006813]; response to mechanical stimulus [GO:0009612] neuron projection [GO:0043005]; neuron projection membrane [GO:0032589]; plasma membrane [GO:0005886] cholesterol binding [GO:0015485]; ion channel inhibitor activity [GO:0008200]; sodium channel activity [GO:0005272] g23363.t1 Q28J59 56.949 295 6.81e-114 335.0 sp|Q28J59|F221A_XENTR Protein FAM221A OS=Xenopus tropicalis OX=8364 GN=fam221a PE=2 SV=1 g23364.t1 Q800L1 56.466 232 3.56e-94 285.0 sp|Q800L1|SURF1_CHICK Surfeit locus protein 1 OS=Gallus gallus OX=9031 GN=SURF1 PE=3 SV=1 g23365.t1 Q9JII1 52.575 369 6.95e-93 311.0 sp|Q9JII1|INP5E_MOUSE Phosphatidylinositol polyphosphate 5-phosphatase type IV OS=Mus musculus OX=10090 GN=Inpp5e PE=1 SV=1 INP5E_MOUSE reviewed Phosphatidylinositol polyphosphate 5-phosphatase type IV (72 kDa inositol polyphosphate 5-phosphatase) (Inositol polyphosphate-5-phosphatase E) (Phosphatidylinositol 4,5-bisphosphate 5-phosphatase) (EC 3.1.3.36) (Phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase) (EC 3.1.3.86) Mus musculus (Mouse) GO:0000139; GO:0001726; GO:0004439; GO:0004445; GO:0005634; GO:0005794; GO:0005886; GO:0005929; GO:0005930; GO:0016314; GO:0017148; GO:0032580; GO:0034485; GO:0043813; GO:0046488; GO:0046856; GO:0051898; GO:0060271; GO:0106019; GO:1902140; GO:1903565 cilium assembly [GO:0060271]; negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051898]; negative regulation of protein localization to cilium [GO:1903565]; negative regulation of translation [GO:0017148]; phosphatidylinositol dephosphorylation [GO:0046856]; phosphatidylinositol metabolic process [GO:0046488]; response to inositol [GO:1902140] axoneme [GO:0005930]; cilium [GO:0005929]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ruffle [GO:0001726] inositol-polyphosphate 5-phosphatase activity [GO:0004445]; phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity [GO:0016314]; phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity [GO:0034485]; phosphatidylinositol-3,5-bisphosphate 5-phosphatase activity [GO:0043813]; phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity [GO:0004439]; phosphatidylinositol-4,5-bisphosphate phosphatase activity [GO:0106019] g23366.t1 Q4V8P4 41.611 149 1.28e-31 118.0 sp|Q4V8P4|SACA9_RAT Sperm acrosome-associated protein 9 OS=Rattus norvegicus OX=10116 GN=Spaca9 PE=1 SV=1 SACA9_RAT reviewed Sperm acrosome-associated protein 9 Rattus norvegicus (Rat) GO:0001669; GO:0005634; GO:0005737; GO:0005879; GO:0005881; GO:0005930; GO:0008017; GO:0030317; GO:0035082; GO:0036064; GO:0036126; GO:0048306; GO:0097546; GO:0160110 axoneme assembly [GO:0035082]; flagellated sperm motility [GO:0030317] acrosomal vesicle [GO:0001669]; axonemal microtubule [GO:0005879]; axonemal microtubule doublet inner sheath [GO:0160110]; axoneme [GO:0005930]; ciliary basal body [GO:0036064]; ciliary base [GO:0097546]; cytoplasm [GO:0005737]; cytoplasmic microtubule [GO:0005881]; nucleus [GO:0005634]; sperm flagellum [GO:0036126] calcium-dependent protein binding [GO:0048306]; microtubule binding [GO:0008017] g23367.t1 Q76KB1 55.449 312 2.51e-119 351.0 sp|Q76KB1|HS2ST_CHICK Heparan sulfate 2-O-sulfotransferase 1 OS=Gallus gallus OX=9031 GN=HS2ST1 PE=1 SV=1 g23368.t1 O60613 42.857 147 1.23e-24 95.9 sp|O60613|SEP15_HUMAN Selenoprotein F OS=Homo sapiens OX=9606 GN=SELENOF PE=1 SV=4 SEP15_HUMAN reviewed Selenoprotein F (15 kDa selenoprotein) Homo sapiens (Human) GO:0005788; GO:0008379; GO:0008430; GO:0016491; GO:0035092; GO:0051084 'de novo' post-translational protein folding [GO:0051084]; sperm DNA condensation [GO:0035092] endoplasmic reticulum lumen [GO:0005788] oxidoreductase activity [GO:0016491]; selenium binding [GO:0008430]; thioredoxin peroxidase activity [GO:0008379] g23369.t1 Q920Q8 38.438 653 1.42e-153 463.0 sp|Q920Q8|NS1BP_MOUSE Influenza virus NS1A-binding protein homolog OS=Mus musculus OX=10090 GN=Ivns1abp PE=1 SV=2 NS1BP_MOUSE reviewed Influenza virus NS1A-binding protein homolog (NS1-BP) (NS1-binding protein homolog) (Kelch family protein Nd1-L) (ND1-L2) (Nd1-S) Mus musculus (Mouse) GO:0005634; GO:0005737; GO:0005829; GO:0005856; GO:0006397; GO:0008380; GO:0009615; GO:0031397; GO:0031463; GO:0043161; GO:1990756; GO:2001243 mRNA processing [GO:0006397]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of protein ubiquitination [GO:0031397]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; response to virus [GO:0009615]; RNA splicing [GO:0008380] Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; nucleus [GO:0005634] ubiquitin-like ligase-substrate adaptor activity [GO:1990756] g23369.t1 Q920Q8 32.143 196 3.22e-25 115.0 sp|Q920Q8|NS1BP_MOUSE Influenza virus NS1A-binding protein homolog OS=Mus musculus OX=10090 GN=Ivns1abp PE=1 SV=2 NS1BP_MOUSE reviewed Influenza virus NS1A-binding protein homolog (NS1-BP) (NS1-binding protein homolog) (Kelch family protein Nd1-L) (ND1-L2) (Nd1-S) Mus musculus (Mouse) GO:0005634; GO:0005737; GO:0005829; GO:0005856; GO:0006397; GO:0008380; GO:0009615; GO:0031397; GO:0031463; GO:0043161; GO:1990756; GO:2001243 mRNA processing [GO:0006397]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of protein ubiquitination [GO:0031397]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; response to virus [GO:0009615]; RNA splicing [GO:0008380] Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; nucleus [GO:0005634] ubiquitin-like ligase-substrate adaptor activity [GO:1990756] g23369.t1 Q920Q8 32.039 206 3.8300000000000002e-22 105.0 sp|Q920Q8|NS1BP_MOUSE Influenza virus NS1A-binding protein homolog OS=Mus musculus OX=10090 GN=Ivns1abp PE=1 SV=2 NS1BP_MOUSE reviewed Influenza virus NS1A-binding protein homolog (NS1-BP) (NS1-binding protein homolog) (Kelch family protein Nd1-L) (ND1-L2) (Nd1-S) Mus musculus (Mouse) GO:0005634; GO:0005737; GO:0005829; GO:0005856; GO:0006397; GO:0008380; GO:0009615; GO:0031397; GO:0031463; GO:0043161; GO:1990756; GO:2001243 mRNA processing [GO:0006397]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of protein ubiquitination [GO:0031397]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; response to virus [GO:0009615]; RNA splicing [GO:0008380] Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; nucleus [GO:0005634] ubiquitin-like ligase-substrate adaptor activity [GO:1990756] g23369.t2 Q920Q8 38.438 653 5.91e-154 463.0 sp|Q920Q8|NS1BP_MOUSE Influenza virus NS1A-binding protein homolog OS=Mus musculus OX=10090 GN=Ivns1abp PE=1 SV=2 NS1BP_MOUSE reviewed Influenza virus NS1A-binding protein homolog (NS1-BP) (NS1-binding protein homolog) (Kelch family protein Nd1-L) (ND1-L2) (Nd1-S) Mus musculus (Mouse) GO:0005634; GO:0005737; GO:0005829; GO:0005856; GO:0006397; GO:0008380; GO:0009615; GO:0031397; GO:0031463; GO:0043161; GO:1990756; GO:2001243 mRNA processing [GO:0006397]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of protein ubiquitination [GO:0031397]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; response to virus [GO:0009615]; RNA splicing [GO:0008380] Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; nucleus [GO:0005634] ubiquitin-like ligase-substrate adaptor activity [GO:1990756] g23369.t2 Q920Q8 32.143 196 2.81e-25 115.0 sp|Q920Q8|NS1BP_MOUSE Influenza virus NS1A-binding protein homolog OS=Mus musculus OX=10090 GN=Ivns1abp PE=1 SV=2 NS1BP_MOUSE reviewed Influenza virus NS1A-binding protein homolog (NS1-BP) (NS1-binding protein homolog) (Kelch family protein Nd1-L) (ND1-L2) (Nd1-S) Mus musculus (Mouse) GO:0005634; GO:0005737; GO:0005829; GO:0005856; GO:0006397; GO:0008380; GO:0009615; GO:0031397; GO:0031463; GO:0043161; GO:1990756; GO:2001243 mRNA processing [GO:0006397]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of protein ubiquitination [GO:0031397]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; response to virus [GO:0009615]; RNA splicing [GO:0008380] Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; nucleus [GO:0005634] ubiquitin-like ligase-substrate adaptor activity [GO:1990756] g23369.t2 Q920Q8 32.039 206 3.56e-22 105.0 sp|Q920Q8|NS1BP_MOUSE Influenza virus NS1A-binding protein homolog OS=Mus musculus OX=10090 GN=Ivns1abp PE=1 SV=2 NS1BP_MOUSE reviewed Influenza virus NS1A-binding protein homolog (NS1-BP) (NS1-binding protein homolog) (Kelch family protein Nd1-L) (ND1-L2) (Nd1-S) Mus musculus (Mouse) GO:0005634; GO:0005737; GO:0005829; GO:0005856; GO:0006397; GO:0008380; GO:0009615; GO:0031397; GO:0031463; GO:0043161; GO:1990756; GO:2001243 mRNA processing [GO:0006397]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of protein ubiquitination [GO:0031397]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; response to virus [GO:0009615]; RNA splicing [GO:0008380] Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; nucleus [GO:0005634] ubiquitin-like ligase-substrate adaptor activity [GO:1990756] g23370.t1 Q2HWF0 36.117 479 2.33e-88 290.0 sp|Q2HWF0|FBP1L_RAT Formin-binding protein 1-like OS=Rattus norvegicus OX=10116 GN=Fnbp1l PE=1 SV=2 FBP1L_RAT reviewed Formin-binding protein 1-like (Transducer of Cdc42-dependent actin assembly protein 1) (Toca-1) Rattus norvegicus (Rat) GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0005938; GO:0006900; GO:0006914; GO:0007165; GO:0007399; GO:0008289; GO:0010324; GO:0016050; GO:0030050; GO:0030154; GO:0031410; GO:0051020; GO:0051491; GO:0060271; GO:0072583; GO:0097320 autophagy [GO:0006914]; cell differentiation [GO:0030154]; cilium assembly [GO:0060271]; clathrin-dependent endocytosis [GO:0072583]; membrane invagination [GO:0010324]; nervous system development [GO:0007399]; plasma membrane tubulation [GO:0097320]; positive regulation of filopodium assembly [GO:0051491]; signal transduction [GO:0007165]; vesicle budding from membrane [GO:0006900]; vesicle organization [GO:0016050]; vesicle transport along actin filament [GO:0030050] cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; plasma membrane [GO:0005886] GTPase binding [GO:0051020]; lipid binding [GO:0008289] g23370.t2 Q2HWF0 33.912 634 1.46e-101 323.0 sp|Q2HWF0|FBP1L_RAT Formin-binding protein 1-like OS=Rattus norvegicus OX=10116 GN=Fnbp1l PE=1 SV=2 FBP1L_RAT reviewed Formin-binding protein 1-like (Transducer of Cdc42-dependent actin assembly protein 1) (Toca-1) Rattus norvegicus (Rat) GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0005938; GO:0006900; GO:0006914; GO:0007165; GO:0007399; GO:0008289; GO:0010324; GO:0016050; GO:0030050; GO:0030154; GO:0031410; GO:0051020; GO:0051491; GO:0060271; GO:0072583; GO:0097320 autophagy [GO:0006914]; cell differentiation [GO:0030154]; cilium assembly [GO:0060271]; clathrin-dependent endocytosis [GO:0072583]; membrane invagination [GO:0010324]; nervous system development [GO:0007399]; plasma membrane tubulation [GO:0097320]; positive regulation of filopodium assembly [GO:0051491]; signal transduction [GO:0007165]; vesicle budding from membrane [GO:0006900]; vesicle organization [GO:0016050]; vesicle transport along actin filament [GO:0030050] cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; plasma membrane [GO:0005886] GTPase binding [GO:0051020]; lipid binding [GO:0008289] g23370.t3 Q6DCZ7 38.152 422 3.07e-89 289.0 sp|Q6DCZ7|FBP1L_XENLA Formin-binding protein 1-like OS=Xenopus laevis OX=8355 GN=fnbp1l PE=1 SV=1 FBP1L_XENLA reviewed Formin-binding protein 1-like (Transducer of Cdc42-dependent actin assembly protein 1) (Toca-1) Xenopus laevis (African clawed frog) GO:0005856; GO:0005886; GO:0005938; GO:0006897; GO:0006914; GO:0007165; GO:0008289; GO:0031410 autophagy [GO:0006914]; endocytosis [GO:0006897]; signal transduction [GO:0007165] cell cortex [GO:0005938]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; plasma membrane [GO:0005886] lipid binding [GO:0008289] g23371.t1 P12107 39.524 210 1.63e-43 178.0 sp|P12107|COBA1_HUMAN Collagen alpha-1(XI) chain OS=Homo sapiens OX=9606 GN=COL11A1 PE=1 SV=4 COBA1_HUMAN reviewed Collagen alpha-1(XI) chain Homo sapiens (Human) GO:0001502; GO:0002063; GO:0005201; GO:0005576; GO:0005585; GO:0005592; GO:0005788; GO:0006029; GO:0007601; GO:0007605; GO:0030020; GO:0030199; GO:0030674; GO:0031012; GO:0035987; GO:0035989; GO:0042472; GO:0046872; GO:0048704; GO:0050840; GO:0050910; GO:0055010 cartilage condensation [GO:0001502]; chondrocyte development [GO:0002063]; collagen fibril organization [GO:0030199]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; embryonic skeletal system morphogenesis [GO:0048704]; endodermal cell differentiation [GO:0035987]; inner ear morphogenesis [GO:0042472]; proteoglycan metabolic process [GO:0006029]; sensory perception of sound [GO:0007605]; tendon development [GO:0035989]; ventricular cardiac muscle tissue morphogenesis [GO:0055010]; visual perception [GO:0007601] collagen type II trimer [GO:0005585]; collagen type XI trimer [GO:0005592]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576] extracellular matrix binding [GO:0050840]; extracellular matrix structural constituent [GO:0005201]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; metal ion binding [GO:0046872]; protein-macromolecule adaptor activity [GO:0030674] g23374.t1 Q9JHB4 46.382 304 2.94e-90 278.0 sp|Q9JHB4|WDR31_MOUSE WD repeat-containing protein 31 OS=Mus musculus OX=10090 GN=Wdr31 PE=2 SV=1 g23375.t1 A9JS49 56.098 205 8.86e-78 241.0 sp|A9JS49|COQ4_XENLA Ubiquinone biosynthesis protein COQ4 homolog, mitochondrial OS=Xenopus laevis OX=8355 GN=coq4 PE=2 SV=1 g23376.t1 Q8TDX7 76.838 272 1.39e-155 438.0 sp|Q8TDX7|NEK7_HUMAN Serine/threonine-protein kinase Nek7 OS=Homo sapiens OX=9606 GN=NEK7 PE=1 SV=1 NEK7_HUMAN reviewed Serine/threonine-protein kinase Nek7 (EC 2.7.11.34) (Never in mitosis A-related kinase 7) (NimA-related protein kinase 7) Homo sapiens (Human) GO:0000922; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005815; GO:0005874; GO:0006468; GO:0007346; GO:0032206; GO:0035865; GO:0046872; GO:0051225; GO:0106310; GO:0140677; GO:1900227 cellular response to potassium ion [GO:0035865]; positive regulation of NLRP3 inflammasome complex assembly [GO:1900227]; positive regulation of telomere maintenance [GO:0032206]; protein phosphorylation [GO:0006468]; regulation of mitotic cell cycle [GO:0007346]; spindle assembly [GO:0051225] centrosome [GO:0005813]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; microtubule organizing center [GO:0005815]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle pole [GO:0000922] ATP binding [GO:0005524]; metal ion binding [GO:0046872]; molecular function activator activity [GO:0140677]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g23376.t2 Q8TDX7 67.638 309 1.7299999999999998e-147 419.0 sp|Q8TDX7|NEK7_HUMAN Serine/threonine-protein kinase Nek7 OS=Homo sapiens OX=9606 GN=NEK7 PE=1 SV=1 NEK7_HUMAN reviewed Serine/threonine-protein kinase Nek7 (EC 2.7.11.34) (Never in mitosis A-related kinase 7) (NimA-related protein kinase 7) Homo sapiens (Human) GO:0000922; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005815; GO:0005874; GO:0006468; GO:0007346; GO:0032206; GO:0035865; GO:0046872; GO:0051225; GO:0106310; GO:0140677; GO:1900227 cellular response to potassium ion [GO:0035865]; positive regulation of NLRP3 inflammasome complex assembly [GO:1900227]; positive regulation of telomere maintenance [GO:0032206]; protein phosphorylation [GO:0006468]; regulation of mitotic cell cycle [GO:0007346]; spindle assembly [GO:0051225] centrosome [GO:0005813]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; microtubule organizing center [GO:0005815]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle pole [GO:0000922] ATP binding [GO:0005524]; metal ion binding [GO:0046872]; molecular function activator activity [GO:0140677]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g23380.t1 Q95ZE9 33.663 202 4.8199999999999996e-24 101.0 sp|Q95ZE9|NELFE_DROVI Negative elongation factor E OS=Drosophila virilis OX=7244 GN=Nelf-E PE=3 SV=1 g23381.t1 P62168 73.684 190 7.910000000000001e-103 297.0 sp|P62168|NCS1_RAT Neuronal calcium sensor 1 OS=Rattus norvegicus OX=10116 GN=Ncs1 PE=1 SV=2 NCS1_RAT reviewed Neuronal calcium sensor 1 (NCS-1) (Frequenin homolog) (Frequenin-like protein) (Frequenin-like ubiquitous protein) Rattus norvegicus (Rat) GO:0000287; GO:0005245; GO:0005509; GO:0005737; GO:0005794; GO:0005829; GO:0005886; GO:0008048; GO:0008427; GO:0009966; GO:0010975; GO:0014069; GO:0019901; GO:0030424; GO:0030425; GO:0031045; GO:0044305; GO:0045921; GO:0048471; GO:0050850; GO:0098794; GO:0098978; GO:0099509; GO:0099523; GO:0099524; GO:2000300 positive regulation of calcium-mediated signaling [GO:0050850]; positive regulation of exocytosis [GO:0045921]; regulation of neuron projection development [GO:0010975]; regulation of presynaptic cytosolic calcium ion concentration [GO:0099509]; regulation of signal transduction [GO:0009966]; regulation of synaptic vesicle exocytosis [GO:2000300] axon [GO:0030424]; calyx of Held [GO:0044305]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; dense core granule [GO:0031045]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic cytosol [GO:0099524]; postsynaptic density [GO:0014069]; presynaptic cytosol [GO:0099523] calcium ion binding [GO:0005509]; calcium sensitive guanylate cyclase activator activity [GO:0008048]; calcium-dependent protein kinase inhibitor activity [GO:0008427]; magnesium ion binding [GO:0000287]; protein kinase binding [GO:0019901]; voltage-gated calcium channel activity [GO:0005245] g23382.t1 Q5M7G4 50.313 479 0.0 520.0 sp|Q5M7G4|KAD8_XENLA Adenylate kinase 8 OS=Xenopus laevis OX=8355 GN=ak8 PE=2 SV=1 g23383.t1 Q5ZMC0 60.993 141 2.4499999999999998e-54 171.0 sp|Q5ZMC0|EDF1_CHICK Endothelial differentiation-related factor 1 homolog OS=Gallus gallus OX=9031 GN=EDF1 PE=2 SV=1 g23385.t1 Q6DG03 29.528 254 1.23e-25 118.0 sp|Q6DG03|DMTF1_DANRE Cyclin-D-binding Myb-like transcription factor 1 OS=Danio rerio OX=7955 GN=dmtf1 PE=2 SV=1 DMTF1_DANRE reviewed Cyclin-D-binding Myb-like transcription factor 1 Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000978; GO:0000981; GO:0005634; GO:0006357 regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978] g23388.t1 Q6DG03 28.523 298 1.03e-25 115.0 sp|Q6DG03|DMTF1_DANRE Cyclin-D-binding Myb-like transcription factor 1 OS=Danio rerio OX=7955 GN=dmtf1 PE=2 SV=1 DMTF1_DANRE reviewed Cyclin-D-binding Myb-like transcription factor 1 Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000978; GO:0000981; GO:0005634; GO:0006357 regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978] g23390.t1 Q9H8H2 53.532 269 8.26e-91 290.0 sp|Q9H8H2|DDX31_HUMAN ATP-dependent DNA helicase DDX31 OS=Homo sapiens OX=9606 GN=DDX31 PE=1 SV=2 g23391.t1 Q6NZQ2 47.325 243 1.5200000000000001e-65 219.0 sp|Q6NZQ2|DDX31_MOUSE ATP-dependent DNA helicase DDX31 OS=Mus musculus OX=10090 GN=Ddx31 PE=2 SV=2 DDX31_MOUSE reviewed ATP-dependent DNA helicase DDX31 (EC 5.6.2.-) (DEAD box protein 31) (Probable ATP-dependent RNA helicase DDX31) (EC 3.6.4.13) Mus musculus (Mouse) GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005730; GO:0005794; GO:0016887; GO:0042254 ribosome biogenesis [GO:0042254] Golgi apparatus [GO:0005794]; nucleolus [GO:0005730]; nucleus [GO:0005634] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724] g23392.t1 Q9BZE3 52.049 244 8.6e-62 205.0 sp|Q9BZE3|BARH1_HUMAN BarH-like 1 homeobox protein OS=Homo sapiens OX=9606 GN=BARHL1 PE=1 SV=1 g23395.t1 Q5SRE5 33.426 1804 0.0 820.0 sp|Q5SRE5|NU188_HUMAN Nucleoporin NUP188 OS=Homo sapiens OX=9606 GN=NUP188 PE=1 SV=1 NU188_HUMAN reviewed Nucleoporin NUP188 (hNup188) Homo sapiens (Human) GO:0005635; GO:0005643; GO:0005829; GO:0006405; GO:0006606; GO:0006913; GO:0016020; GO:0017056; GO:0044611; GO:0051028 mRNA transport [GO:0051028]; nucleocytoplasmic transport [GO:0006913]; protein import into nucleus [GO:0006606]; RNA export from nucleus [GO:0006405] cytosol [GO:0005829]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear pore [GO:0005643]; nuclear pore inner ring [GO:0044611] structural constituent of nuclear pore [GO:0017056] g23395.t2 Q5SRE5 33.555 1803 0.0 820.0 sp|Q5SRE5|NU188_HUMAN Nucleoporin NUP188 OS=Homo sapiens OX=9606 GN=NUP188 PE=1 SV=1 NU188_HUMAN reviewed Nucleoporin NUP188 (hNup188) Homo sapiens (Human) GO:0005635; GO:0005643; GO:0005829; GO:0006405; GO:0006606; GO:0006913; GO:0016020; GO:0017056; GO:0044611; GO:0051028 mRNA transport [GO:0051028]; nucleocytoplasmic transport [GO:0006913]; protein import into nucleus [GO:0006606]; RNA export from nucleus [GO:0006405] cytosol [GO:0005829]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear pore [GO:0005643]; nuclear pore inner ring [GO:0044611] structural constituent of nuclear pore [GO:0017056] g23399.t1 P56965 55.689 167 3.79e-56 182.0 sp|P56965|DDAH1_BOVIN N(G),N(G)-dimethylarginine dimethylaminohydrolase 1 OS=Bos taurus OX=9913 GN=DDAH1 PE=1 SV=3 DDAH1_BOVIN reviewed N(G),N(G)-dimethylarginine dimethylaminohydrolase 1 (DDAH-1) (Dimethylarginine dimethylaminohydrolase 1) (EC 3.5.3.18) (DDAHI) (Dimethylargininase-1) Bos taurus (Bovine) GO:0000052; GO:0006525; GO:0006809; GO:0008270; GO:0016403; GO:0016597; GO:0017014; GO:0045429 arginine metabolic process [GO:0006525]; citrulline metabolic process [GO:0000052]; nitric oxide biosynthetic process [GO:0006809]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein nitrosylation [GO:0017014] amino acid binding [GO:0016597]; dimethylargininase activity [GO:0016403]; zinc ion binding [GO:0008270] g23400.t1 Q9QXW2 56.175 251 2.4e-75 261.0 sp|Q9QXW2|FBXW5_MOUSE F-box/WD repeat-containing protein 5 OS=Mus musculus OX=10090 GN=Fbxw5 PE=1 SV=1 FBXW5_MOUSE reviewed F-box/WD repeat-containing protein 5 (F-box and WD-40 domain-containing protein 5) Mus musculus (Mouse) GO:0005737; GO:0007088; GO:0010824; GO:0016567; GO:0019005; GO:0019901; GO:0031146; GO:0043161; GO:0080008 proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of centrosome duplication [GO:0010824]; regulation of mitotic nuclear division [GO:0007088]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146] Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; cytoplasm [GO:0005737]; SCF ubiquitin ligase complex [GO:0019005] protein kinase binding [GO:0019901] g23400.t1 Q9QXW2 54.245 212 1.55e-61 223.0 sp|Q9QXW2|FBXW5_MOUSE F-box/WD repeat-containing protein 5 OS=Mus musculus OX=10090 GN=Fbxw5 PE=1 SV=1 FBXW5_MOUSE reviewed F-box/WD repeat-containing protein 5 (F-box and WD-40 domain-containing protein 5) Mus musculus (Mouse) GO:0005737; GO:0007088; GO:0010824; GO:0016567; GO:0019005; GO:0019901; GO:0031146; GO:0043161; GO:0080008 proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of centrosome duplication [GO:0010824]; regulation of mitotic nuclear division [GO:0007088]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146] Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; cytoplasm [GO:0005737]; SCF ubiquitin ligase complex [GO:0019005] protein kinase binding [GO:0019901] g23401.t1 O77775 35.294 204 1.6499999999999999e-38 154.0 sp|O77775|NCF2_BOVIN Neutrophil cytosol factor 2 OS=Bos taurus OX=9913 GN=NCF2 PE=2 SV=1 g23401.t1 O77775 33.171 205 5.74e-35 144.0 sp|O77775|NCF2_BOVIN Neutrophil cytosol factor 2 OS=Bos taurus OX=9913 GN=NCF2 PE=2 SV=1 g23403.t1 Q5XGG2 41.837 294 8.67e-80 249.0 sp|Q5XGG2|TRUB2_XENTR Pseudouridylate synthase TRUB2, mitochondrial OS=Xenopus tropicalis OX=8364 GN=Trub2 PE=2 SV=1 g23404.t1 Q25532 56.897 116 3.4999999999999997e-25 94.7 sp|Q25532|VATG_MANSE V-type proton ATPase subunit G OS=Manduca sexta OX=7130 PE=3 SV=1 g23405.t1 Q66I24 65.012 403 0.0 575.0 sp|Q66I24|ASSY_DANRE Argininosuccinate synthase OS=Danio rerio OX=7955 GN=ass1 PE=2 SV=1 g23407.t1 Q14517 37.956 137 4.3e-27 108.0 sp|Q14517|FAT1_HUMAN Protocadherin Fat 1 OS=Homo sapiens OX=9606 GN=FAT1 PE=1 SV=2 g23411.t1 Q99104 51.759 398 9.03e-137 436.0 sp|Q99104|MYO5A_MOUSE Unconventional myosin-Va OS=Mus musculus OX=10090 GN=Myo5a PE=1 SV=2 g23419.t1 D3Z8N4 83.187 571 0.0 1000.0 sp|D3Z8N4|KLH20_RAT Kelch-like protein 20 OS=Rattus norvegicus OX=10116 GN=Klhl20 PE=3 SV=1 g23420.t1 B0S794 37.43 179 6.84e-38 136.0 sp|B0S794|ANR45_DANRE Ankyrin repeat domain-containing protein 45 OS=Danio rerio OX=7955 GN=ankrd45 PE=2 SV=1 ANR45_DANRE reviewed Ankyrin repeat domain-containing protein 45 Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005737; GO:0008283; GO:0030496; GO:0032154; GO:0090543 cell population proliferation [GO:0008283] cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; Flemming body [GO:0090543]; midbody [GO:0030496] g23422.t1 Q761V0 49.068 644 0.0 618.0 sp|Q761V0|SC6A5_MOUSE Sodium- and chloride-dependent glycine transporter 2 OS=Mus musculus OX=10090 GN=Slc6a5 PE=1 SV=1 SC6A5_MOUSE reviewed Sodium- and chloride-dependent glycine transporter 2 (GlyT-2) (GlyT2) (Solute carrier family 6 member 5) Mus musculus (Mouse) GO:0001504; GO:0005768; GO:0005886; GO:0015187; GO:0015375; GO:0015816; GO:0031045; GO:0035725; GO:0042734; GO:0046872; GO:0060012; GO:0098690; GO:0098810; GO:1903804 glycine import across plasma membrane [GO:1903804]; glycine transport [GO:0015816]; neurotransmitter reuptake [GO:0098810]; neurotransmitter uptake [GO:0001504]; sodium ion transmembrane transport [GO:0035725]; synaptic transmission, glycinergic [GO:0060012] dense core granule [GO:0031045]; endosome [GO:0005768]; glycinergic synapse [GO:0098690]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734] glycine transmembrane transporter activity [GO:0015187]; glycine:sodium symporter activity [GO:0015375]; metal ion binding [GO:0046872] g23423.t1 Q761V0 51.227 611 0.0 603.0 sp|Q761V0|SC6A5_MOUSE Sodium- and chloride-dependent glycine transporter 2 OS=Mus musculus OX=10090 GN=Slc6a5 PE=1 SV=1 SC6A5_MOUSE reviewed Sodium- and chloride-dependent glycine transporter 2 (GlyT-2) (GlyT2) (Solute carrier family 6 member 5) Mus musculus (Mouse) GO:0001504; GO:0005768; GO:0005886; GO:0015187; GO:0015375; GO:0015816; GO:0031045; GO:0035725; GO:0042734; GO:0046872; GO:0060012; GO:0098690; GO:0098810; GO:1903804 glycine import across plasma membrane [GO:1903804]; glycine transport [GO:0015816]; neurotransmitter reuptake [GO:0098810]; neurotransmitter uptake [GO:0001504]; sodium ion transmembrane transport [GO:0035725]; synaptic transmission, glycinergic [GO:0060012] dense core granule [GO:0031045]; endosome [GO:0005768]; glycinergic synapse [GO:0098690]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734] glycine transmembrane transporter activity [GO:0015187]; glycine:sodium symporter activity [GO:0015375]; metal ion binding [GO:0046872] g23424.t1 Q5XKL5 30.0 370 7.18e-55 209.0 sp|Q5XKL5|BTBD8_HUMAN BTB/POZ domain-containing protein 8 OS=Homo sapiens OX=9606 GN=BTBD8 PE=1 SV=3 BTBD8_HUMAN reviewed BTB/POZ domain-containing protein 8 (AP2-interacting clathrin-endocytosis) (APache) Homo sapiens (Human) GO:0005634; GO:0005654; GO:0016182; GO:0030122; GO:0030424; GO:0044306; GO:0048488; GO:0098850 synaptic vesicle budding from endosome [GO:0016182]; synaptic vesicle endocytosis [GO:0048488] AP-2 adaptor complex [GO:0030122]; axon [GO:0030424]; extrinsic component of synaptic vesicle membrane [GO:0098850]; neuron projection terminus [GO:0044306]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] g23425.t1 Q5ZJK0 54.896 337 9.079999999999999e-120 363.0 sp|Q5ZJK0|RGPS1_CHICK Ras-specific guanine nucleotide-releasing factor RalGPS1 OS=Gallus gallus OX=9031 GN=RALGPS1 PE=2 SV=1 g23427.t1 B0UXH6 41.085 129 4.4000000000000005e-27 108.0 sp|B0UXH6|RGPS1_DANRE Ras-specific guanine nucleotide-releasing factor RalGPS1 OS=Danio rerio OX=7955 GN=ralgps1 PE=2 SV=1 g23428.t1 Q7SXE8 79.42 345 0.0 575.0 sp|Q7SXE8|CDK9_DANRE Cyclin-dependent kinase 9 OS=Danio rerio OX=7955 GN=cdk9 PE=2 SV=1 CDK9_DANRE reviewed Cyclin-dependent kinase 9 (EC 2.7.11.22) (EC 2.7.11.23) (Cell division protein kinase 9) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0004674; GO:0004693; GO:0005524; GO:0005634; GO:0005737; GO:0006281; GO:0008283; GO:0008353; GO:0016605; GO:0030852; GO:0032968; GO:0045944; GO:0060043; GO:0061026; GO:0065003; GO:0090594; GO:0106310; GO:0120187 cardiac muscle tissue regeneration [GO:0061026]; cell population proliferation [GO:0008283]; DNA repair [GO:0006281]; inflammatory response to wounding [GO:0090594]; positive regulation of protein localization to chromatin [GO:0120187]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription elongation by RNA polymerase II [GO:0032968]; protein-containing complex assembly [GO:0065003]; regulation of cardiac muscle cell proliferation [GO:0060043]; regulation of granulocyte differentiation [GO:0030852] cytoplasm [GO:0005737]; nucleus [GO:0005634]; PML body [GO:0016605] ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353] g23436.t1 F1QGD2 36.929 241 5.2799999999999995e-48 164.0 sp|F1QGD2|ZDH24_DANRE Probable palmitoyltransferase ZDHHC24 OS=Danio rerio OX=7955 GN=zdhhc24 PE=2 SV=1 g23437.t1 Q5ZLV2 79.375 160 2.3e-94 273.0 sp|Q5ZLV2|PPIL3_CHICK Peptidyl-prolyl cis-trans isomerase-like 3 OS=Gallus gallus OX=9031 GN=PPIL3 PE=2 SV=1 PPIL3_CHICK reviewed Peptidyl-prolyl cis-trans isomerase-like 3 (PPIase) (EC 5.2.1.8) (Cyclophilin-like protein PPIL3) (Rotamase PPIL3) Gallus gallus (Chicken) GO:0003755; GO:0006457; GO:0071013 protein folding [GO:0006457] catalytic step 2 spliceosome [GO:0071013] peptidyl-prolyl cis-trans isomerase activity [GO:0003755] g23439.t1 Q4V9P0 60.92 261 2.04e-98 292.0 sp|Q4V9P0|SAMC_DANRE Mitochondrial S-adenosylmethionine carrier protein OS=Danio rerio OX=7955 GN=slc25a26 PE=2 SV=1 SAMC_DANRE reviewed Mitochondrial S-adenosylmethionine carrier protein (SAM carrier) (Solute carrier family 25 member 26) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000095; GO:0005739; GO:0005743; GO:0015805; GO:0180003; GO:1990543 mitochondrial S-adenosyl-L-methionine transmembrane transport [GO:1990543]; S-adenosyl-L-methionine transport [GO:0015805] mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739] S-adenosyl-L-methionine transmembrane transporter activity [GO:0000095]; S-adenosyl-L-methionine:S-adenosyl-L-homocysteine antiporter activity [GO:0180003] g23442.t1 Q8NFJ6 40.066 302 1.82e-69 228.0 sp|Q8NFJ6|PKR2_HUMAN Prokineticin receptor 2 OS=Homo sapiens OX=9606 GN=PROKR2 PE=1 SV=1 PKR2_HUMAN reviewed Prokineticin receptor 2 (PK-R2) (G-protein coupled receptor 73-like 1) (G-protein coupled receptor I5E) (GPR73b) (GPRg2) Homo sapiens (Human) GO:0004930; GO:0004983; GO:0005886; GO:0007186; GO:0007623; GO:0032870 cellular response to hormone stimulus [GO:0032870]; circadian rhythm [GO:0007623]; G protein-coupled receptor signaling pathway [GO:0007186] plasma membrane [GO:0005886] G protein-coupled receptor activity [GO:0004930]; neuropeptide Y receptor activity [GO:0004983] g23443.t1 O14733 60.798 426 1.04e-164 472.0 sp|O14733|MP2K7_HUMAN Dual specificity mitogen-activated protein kinase kinase 7 OS=Homo sapiens OX=9606 GN=MAP2K7 PE=1 SV=2 MP2K7_HUMAN reviewed Dual specificity mitogen-activated protein kinase kinase 7 (MAP kinase kinase 7) (MAPKK 7) (EC 2.7.12.2) (JNK-activating kinase 2) (MAPK/ERK kinase 7) (MEK 7) (Stress-activated protein kinase kinase 4) (SAPK kinase 4) (SAPKK-4) (SAPKK4) (c-Jun N-terminal kinase kinase 2) (JNK kinase 2) (JNKK 2) Homo sapiens (Human) GO:0000287; GO:0004707; GO:0004708; GO:0004713; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006915; GO:0006970; GO:0007165; GO:0007254; GO:0008545; GO:0009408; GO:0009411; GO:0009611; GO:0019899; GO:0019901; GO:0019903; GO:0032206; GO:0034612; GO:0038095; GO:0045893; GO:0046330; GO:0051403; GO:0070374; GO:0071222; GO:0071347; GO:0090398; GO:0106310; GO:0140677; GO:2000671 apoptotic process [GO:0006915]; cellular response to interleukin-1 [GO:0071347]; cellular response to lipopolysaccharide [GO:0071222]; cellular senescence [GO:0090398]; Fc-epsilon receptor signaling pathway [GO:0038095]; JNK cascade [GO:0007254]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of JNK cascade [GO:0046330]; positive regulation of telomere maintenance [GO:0032206]; regulation of motor neuron apoptotic process [GO:2000671]; response to heat [GO:0009408]; response to osmotic stress [GO:0006970]; response to tumor necrosis factor [GO:0034612]; response to UV [GO:0009411]; response to wounding [GO:0009611]; signal transduction [GO:0007165]; stress-activated MAPK cascade [GO:0051403] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634] ATP binding [GO:0005524]; enzyme binding [GO:0019899]; JUN kinase kinase activity [GO:0008545]; magnesium ion binding [GO:0000287]; MAP kinase activity [GO:0004707]; MAP kinase kinase activity [GO:0004708]; molecular function activator activity [GO:0140677]; protein kinase binding [GO:0019901]; protein phosphatase binding [GO:0019903]; protein serine kinase activity [GO:0106310]; protein tyrosine kinase activity [GO:0004713] g23444.t1 Q924L9 40.449 623 1.65e-146 441.0 sp|Q924L9|FOLC_CRIGR Folylpolyglutamate synthase, mitochondrial OS=Cricetulus griseus OX=10029 GN=FPGS PE=2 SV=1 g23444.t2 Q924L9 42.167 600 2.91e-151 452.0 sp|Q924L9|FOLC_CRIGR Folylpolyglutamate synthase, mitochondrial OS=Cricetulus griseus OX=10029 GN=FPGS PE=2 SV=1 g23447.t1 P43679 27.036 307 3.4e-21 98.6 sp|P43679|ACHB3_CHICK Neuronal acetylcholine receptor subunit beta-3 OS=Gallus gallus OX=9031 GN=CHRNB3 PE=2 SV=2 g23448.t1 P09478 26.821 302 8.049999999999999e-23 104.0 sp|P09478|ACH1_DROME Acetylcholine receptor subunit alpha-like 1 OS=Drosophila melanogaster OX=7227 GN=nAChRalpha1 PE=2 SV=2 g23449.t1 P09478 27.213 305 2.21e-22 102.0 sp|P09478|ACH1_DROME Acetylcholine receptor subunit alpha-like 1 OS=Drosophila melanogaster OX=7227 GN=nAChRalpha1 PE=2 SV=2 g23450.t1 P02708 27.027 296 1.84e-26 116.0 sp|P02708|ACHA_HUMAN Acetylcholine receptor subunit alpha OS=Homo sapiens OX=9606 GN=CHRNA1 PE=1 SV=3 ACHA_HUMAN reviewed Acetylcholine receptor subunit alpha Homo sapiens (Human) GO:0003009; GO:0005886; GO:0005892; GO:0007271; GO:0007274; GO:0007528; GO:0009986; GO:0015464; GO:0019228; GO:0022848; GO:0031594; GO:0034220; GO:0035094; GO:0042166; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0046716; GO:0048630; GO:0050881; GO:0050905; GO:0051899; GO:0070050; GO:0095500; GO:0098793; GO:0099171; GO:0099634; GO:1904315 acetylcholine receptor signaling pathway [GO:0095500]; membrane depolarization [GO:0051899]; monoatomic ion transmembrane transport [GO:0034220]; muscle cell cellular homeostasis [GO:0046716]; musculoskeletal movement [GO:0050881]; neuromuscular junction development [GO:0007528]; neuromuscular process [GO:0050905]; neuromuscular synaptic transmission [GO:0007274]; neuron cellular homeostasis [GO:0070050]; neuronal action potential [GO:0019228]; presynaptic modulation of chemical synaptic transmission [GO:0099171]; regulation of membrane potential [GO:0042391]; response to nicotine [GO:0035094]; skeletal muscle contraction [GO:0003009]; skeletal muscle tissue growth [GO:0048630]; synaptic transmission, cholinergic [GO:0007271] acetylcholine-gated channel complex [GO:0005892]; cell surface [GO:0009986]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; postsynaptic specialization membrane [GO:0099634]; presynapse [GO:0098793]; synapse [GO:0045202] acetylcholine binding [GO:0042166]; acetylcholine receptor activity [GO:0015464]; acetylcholine-gated monoatomic cation-selective channel activity [GO:0022848]; transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315] g23451.t1 P43143 24.316 329 1.82e-25 111.0 sp|P43143|ACHA6_RAT Neuronal acetylcholine receptor subunit alpha-6 OS=Rattus norvegicus OX=10116 GN=Chrna6 PE=1 SV=1 g23452.t1 P55143 45.833 96 2.2399999999999998e-23 89.7 sp|P55143|GLRX_RICCO Glutaredoxin OS=Ricinus communis OX=3988 PE=3 SV=1 g23455.t1 Q5PQ23 44.689 273 3.93e-53 187.0 sp|Q5PQ23|ODFP2_XENLA Outer dense fiber protein 2 OS=Xenopus laevis OX=8355 GN=odf2 PE=2 SV=1 g23456.t1 Q5ZKK5 43.232 495 1.22e-116 365.0 sp|Q5ZKK5|ODFP2_CHICK Outer dense fiber protein 2 OS=Gallus gallus OX=9031 GN=ODF2 PE=2 SV=1 g23457.t1 Q8VBV3 69.204 289 1.7500000000000002e-144 410.0 sp|Q8VBV3|EXOS2_MOUSE Exosome complex component RRP4 OS=Mus musculus OX=10090 GN=Exosc2 PE=1 SV=1 g23458.t1 P49696 76.276 392 0.0 654.0 sp|P49696|SYVC_TAKRU Valine--tRNA ligase OS=Takifugu rubripes OX=31033 GN=vars1 PE=3 SV=1 g23459.t1 Q04462 59.792 577 0.0 718.0 sp|Q04462|SYVC_RAT Valine--tRNA ligase OS=Rattus norvegicus OX=10116 GN=Vars1 PE=2 SV=2 g23460.t1 B2KI79 54.077 233 1.2e-87 262.0 sp|B2KI79|DOPP1_RHIFE Dolichyldiphosphatase 1 OS=Rhinolophus ferrumequinum OX=59479 GN=DOLPP1 PE=3 SV=1 g23461.t1 Q7SYK1 67.7 387 0.0 566.0 sp|Q7SYK1|TGT_DANRE Queuine tRNA-ribosyltransferase catalytic subunit 1 OS=Danio rerio OX=7955 GN=qtrt1 PE=2 SV=1 g23462.t1 Q6X4W1 36.578 339 2.66e-63 216.0 sp|Q6X4W1|NSMF_HUMAN NMDA receptor synaptonuclear signaling and neuronal migration factor OS=Homo sapiens OX=9606 GN=NSMF PE=1 SV=1 NSMF_HUMAN reviewed NMDA receptor synaptonuclear signaling and neuronal migration factor (Nasal embryonic luteinizing hormone-releasing hormone factor) (Nasal embryonic LHRH factor) Homo sapiens (Human) GO:0000791; GO:0005634; GO:0005635; GO:0005654; GO:0005737; GO:0005886; GO:0014069; GO:0016020; GO:0016363; GO:0030425; GO:0030863; GO:0031965; GO:0043005; GO:0043204; GO:0043523; GO:0045202; GO:0048168; GO:0048306; GO:0048814; GO:0071230; GO:0071257; GO:0071371; GO:0097440; GO:2001224 cellular response to amino acid stimulus [GO:0071230]; cellular response to electrical stimulus [GO:0071257]; cellular response to gonadotropin stimulus [GO:0071371]; positive regulation of neuron migration [GO:2001224]; regulation of dendrite morphogenesis [GO:0048814]; regulation of neuron apoptotic process [GO:0043523]; regulation of neuronal synaptic plasticity [GO:0048168] apical dendrite [GO:0097440]; cortical cytoskeleton [GO:0030863]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; euchromatin [GO:0000791]; membrane [GO:0016020]; neuron projection [GO:0043005]; nuclear envelope [GO:0005635]; nuclear matrix [GO:0016363]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; synapse [GO:0045202] calcium-dependent protein binding [GO:0048306] g23463.t1 O77834 67.89 218 1.8e-102 298.0 sp|O77834|PRDX6_BOVIN Peroxiredoxin-6 OS=Bos taurus OX=9913 GN=PRDX6 PE=1 SV=3 PRDX6_BOVIN reviewed Peroxiredoxin-6 (EC 1.11.1.27) (1-Cys peroxiredoxin) (1-Cys PRX) (Acidic calcium-independent phospholipase A2) (aiPLA2) (EC 3.1.1.4) (Antioxidant protein 2) (Ciliary body glutathione peroxidase) (Glutathione-dependent peroxiredoxin) (Lysophosphatidylcholine acyltransferase 5) (LPC acyltransferase 5) (LPCAT-5) (Lyso-PC acyltransferase 5) (EC 2.3.1.23) (Non-selenium glutathione peroxidase) (NSGPx) (PHGPx) Bos taurus (Bovine) GO:0000302; GO:0004601; GO:0004623; GO:0005737; GO:0005764; GO:0005829; GO:0016042; GO:0045454; GO:0047184; GO:0051920 cell redox homeostasis [GO:0045454]; lipid catabolic process [GO:0016042]; response to reactive oxygen species [GO:0000302] cytoplasm [GO:0005737]; cytosol [GO:0005829]; lysosome [GO:0005764] 1-acylglycerophosphocholine O-acyltransferase activity [GO:0047184]; peroxidase activity [GO:0004601]; peroxiredoxin activity [GO:0051920]; phospholipase A2 activity [GO:0004623] g23465.t1 Q8BQN5 40.377 265 8e-59 191.0 sp|Q8BQN5|FA78B_MOUSE Protein FAM78B OS=Mus musculus OX=10090 GN=Fam78b PE=2 SV=2 g23466.t1 P35658 29.33 433 6.16e-49 197.0 sp|P35658|NU214_HUMAN Nuclear pore complex protein Nup214 OS=Homo sapiens OX=9606 GN=NUP214 PE=1 SV=2 NU214_HUMAN reviewed Nuclear pore complex protein Nup214 (214 kDa nucleoporin) (Nucleoporin Nup214) (Protein CAN) Homo sapiens (Human) GO:0005049; GO:0005635; GO:0005643; GO:0005654; GO:0005829; GO:0006405; GO:0006406; GO:0006606; GO:0006611; GO:0006913; GO:0008139; GO:0017056; GO:0046822; GO:0051726; GO:1990876 mRNA export from nucleus [GO:0006406]; nucleocytoplasmic transport [GO:0006913]; protein export from nucleus [GO:0006611]; protein import into nucleus [GO:0006606]; regulation of cell cycle [GO:0051726]; regulation of nucleocytoplasmic transport [GO:0046822]; RNA export from nucleus [GO:0006405] cytoplasmic side of nuclear pore [GO:1990876]; cytosol [GO:0005829]; nuclear envelope [GO:0005635]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654] nuclear export signal receptor activity [GO:0005049]; nuclear localization sequence binding [GO:0008139]; structural constituent of nuclear pore [GO:0017056] g23466.t1 P35658 31.698 265 6.13e-29 131.0 sp|P35658|NU214_HUMAN Nuclear pore complex protein Nup214 OS=Homo sapiens OX=9606 GN=NUP214 PE=1 SV=2 NU214_HUMAN reviewed Nuclear pore complex protein Nup214 (214 kDa nucleoporin) (Nucleoporin Nup214) (Protein CAN) Homo sapiens (Human) GO:0005049; GO:0005635; GO:0005643; GO:0005654; GO:0005829; GO:0006405; GO:0006406; GO:0006606; GO:0006611; GO:0006913; GO:0008139; GO:0017056; GO:0046822; GO:0051726; GO:1990876 mRNA export from nucleus [GO:0006406]; nucleocytoplasmic transport [GO:0006913]; protein export from nucleus [GO:0006611]; protein import into nucleus [GO:0006606]; regulation of cell cycle [GO:0051726]; regulation of nucleocytoplasmic transport [GO:0046822]; RNA export from nucleus [GO:0006405] cytoplasmic side of nuclear pore [GO:1990876]; cytosol [GO:0005829]; nuclear envelope [GO:0005635]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654] nuclear export signal receptor activity [GO:0005049]; nuclear localization sequence binding [GO:0008139]; structural constituent of nuclear pore [GO:0017056] g23468.t1 Q6DGW9 60.396 202 1.4800000000000001e-80 240.0 sp|Q6DGW9|TMCO1_DANRE Calcium load-activated calcium channel OS=Danio rerio OX=7955 GN=tmco1 PE=2 SV=1 TMCO1_DANRE reviewed Calcium load-activated calcium channel (CLAC channel) (GEL complex subunit TMCO1) (Transmembrane and coiled-coil domain-containing protein 1) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000139; GO:0005262; GO:0005737; GO:0005783; GO:0005789; GO:0006983; GO:0032469; GO:0043022; GO:0070588; GO:0160063; GO:0160064 calcium ion transmembrane transport [GO:0070588]; endoplasmic reticulum calcium ion homeostasis [GO:0032469]; ER overload response [GO:0006983]; multi-pass transmembrane protein insertion into ER membrane [GO:0160063] cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; multi-pass translocon complex [GO:0160064] calcium channel activity [GO:0005262]; ribosome binding [GO:0043022] g23469.t1 Q5I7G2 84.242 330 0.0 521.0 sp|Q5I7G2|RXR_LYMST Retinoic acid receptor RXR OS=Lymnaea stagnalis OX=6523 GN=RXR PE=1 SV=1 RXR_LYMST reviewed Retinoic acid receptor RXR (Retinoid X receptor) (LymRXR) Lymnaea stagnalis (Great pond snail) (Helix stagnalis) GO:0003707; GO:0005634; GO:0005737; GO:0008270; GO:0016020; GO:0016918; GO:0030426; GO:0043565 cytoplasm [GO:0005737]; growth cone [GO:0030426]; membrane [GO:0016020]; nucleus [GO:0005634] nuclear steroid receptor activity [GO:0003707]; retinal binding [GO:0016918]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270] g23469.t2 Q5I7G2 70.824 425 0.0 525.0 sp|Q5I7G2|RXR_LYMST Retinoic acid receptor RXR OS=Lymnaea stagnalis OX=6523 GN=RXR PE=1 SV=1 RXR_LYMST reviewed Retinoic acid receptor RXR (Retinoid X receptor) (LymRXR) Lymnaea stagnalis (Great pond snail) (Helix stagnalis) GO:0003707; GO:0005634; GO:0005737; GO:0008270; GO:0016020; GO:0016918; GO:0030426; GO:0043565 cytoplasm [GO:0005737]; growth cone [GO:0030426]; membrane [GO:0016020]; nucleus [GO:0005634] nuclear steroid receptor activity [GO:0003707]; retinal binding [GO:0016918]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270] g23471.t1 Q9QX29 39.462 446 9.970000000000001e-86 301.0 sp|Q9QX29|TRPC5_MOUSE Short transient receptor potential channel 5 OS=Mus musculus OX=10090 GN=Trpc5 PE=1 SV=2 g23471.t1 Q9QX29 40.0 330 4.48e-69 253.0 sp|Q9QX29|TRPC5_MOUSE Short transient receptor potential channel 5 OS=Mus musculus OX=10090 GN=Trpc5 PE=1 SV=2 g23472.t1 Q9H4G4 44.218 147 5.47e-35 122.0 sp|Q9H4G4|GAPR1_HUMAN Golgi-associated plant pathogenesis-related protein 1 OS=Homo sapiens OX=9606 GN=GLIPR2 PE=1 SV=3 GAPR1_HUMAN reviewed Golgi-associated plant pathogenesis-related protein 1 (GAPR-1) (Golgi-associated PR-1 protein) (Glioma pathogenesis-related protein 2) (GliPR 2) Homo sapiens (Human) GO:0000139; GO:0005615; GO:0010634; GO:0010718; GO:0042803; GO:0070062; GO:0070374 positive regulation of epithelial cell migration [GO:0010634]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of ERK1 and ERK2 cascade [GO:0070374] extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; Golgi membrane [GO:0000139] protein homodimerization activity [GO:0042803] g23473.t1 Q9H4G4 44.667 150 5.85e-37 134.0 sp|Q9H4G4|GAPR1_HUMAN Golgi-associated plant pathogenesis-related protein 1 OS=Homo sapiens OX=9606 GN=GLIPR2 PE=1 SV=3 GAPR1_HUMAN reviewed Golgi-associated plant pathogenesis-related protein 1 (GAPR-1) (Golgi-associated PR-1 protein) (Glioma pathogenesis-related protein 2) (GliPR 2) Homo sapiens (Human) GO:0000139; GO:0005615; GO:0010634; GO:0010718; GO:0042803; GO:0070062; GO:0070374 positive regulation of epithelial cell migration [GO:0010634]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of ERK1 and ERK2 cascade [GO:0070374] extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; Golgi membrane [GO:0000139] protein homodimerization activity [GO:0042803] g23473.t1 Q9H4G4 38.849 139 6.03e-26 105.0 sp|Q9H4G4|GAPR1_HUMAN Golgi-associated plant pathogenesis-related protein 1 OS=Homo sapiens OX=9606 GN=GLIPR2 PE=1 SV=3 GAPR1_HUMAN reviewed Golgi-associated plant pathogenesis-related protein 1 (GAPR-1) (Golgi-associated PR-1 protein) (Glioma pathogenesis-related protein 2) (GliPR 2) Homo sapiens (Human) GO:0000139; GO:0005615; GO:0010634; GO:0010718; GO:0042803; GO:0070062; GO:0070374 positive regulation of epithelial cell migration [GO:0010634]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of ERK1 and ERK2 cascade [GO:0070374] extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; Golgi membrane [GO:0000139] protein homodimerization activity [GO:0042803] g23474.t1 Q9H4G4 50.0 148 4.02e-39 143.0 sp|Q9H4G4|GAPR1_HUMAN Golgi-associated plant pathogenesis-related protein 1 OS=Homo sapiens OX=9606 GN=GLIPR2 PE=1 SV=3 GAPR1_HUMAN reviewed Golgi-associated plant pathogenesis-related protein 1 (GAPR-1) (Golgi-associated PR-1 protein) (Glioma pathogenesis-related protein 2) (GliPR 2) Homo sapiens (Human) GO:0000139; GO:0005615; GO:0010634; GO:0010718; GO:0042803; GO:0070062; GO:0070374 positive regulation of epithelial cell migration [GO:0010634]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of ERK1 and ERK2 cascade [GO:0070374] extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; Golgi membrane [GO:0000139] protein homodimerization activity [GO:0042803] g23474.t1 Q9H4G4 47.973 148 2.4600000000000003e-37 138.0 sp|Q9H4G4|GAPR1_HUMAN Golgi-associated plant pathogenesis-related protein 1 OS=Homo sapiens OX=9606 GN=GLIPR2 PE=1 SV=3 GAPR1_HUMAN reviewed Golgi-associated plant pathogenesis-related protein 1 (GAPR-1) (Golgi-associated PR-1 protein) (Glioma pathogenesis-related protein 2) (GliPR 2) Homo sapiens (Human) GO:0000139; GO:0005615; GO:0010634; GO:0010718; GO:0042803; GO:0070062; GO:0070374 positive regulation of epithelial cell migration [GO:0010634]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of ERK1 and ERK2 cascade [GO:0070374] extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; Golgi membrane [GO:0000139] protein homodimerization activity [GO:0042803] g23474.t1 Q9H4G4 42.466 146 4.43e-29 115.0 sp|Q9H4G4|GAPR1_HUMAN Golgi-associated plant pathogenesis-related protein 1 OS=Homo sapiens OX=9606 GN=GLIPR2 PE=1 SV=3 GAPR1_HUMAN reviewed Golgi-associated plant pathogenesis-related protein 1 (GAPR-1) (Golgi-associated PR-1 protein) (Glioma pathogenesis-related protein 2) (GliPR 2) Homo sapiens (Human) GO:0000139; GO:0005615; GO:0010634; GO:0010718; GO:0042803; GO:0070062; GO:0070374 positive regulation of epithelial cell migration [GO:0010634]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of ERK1 and ERK2 cascade [GO:0070374] extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; Golgi membrane [GO:0000139] protein homodimerization activity [GO:0042803] g23476.t1 P41823 43.273 275 6.18e-61 207.0 sp|P41823|SY65_APLCA Synaptotagmin-1 OS=Aplysia californica OX=6500 GN=SYT1 PE=1 SV=2 g23477.t1 Q9H4G4 32.414 145 2.08e-21 87.8 sp|Q9H4G4|GAPR1_HUMAN Golgi-associated plant pathogenesis-related protein 1 OS=Homo sapiens OX=9606 GN=GLIPR2 PE=1 SV=3 GAPR1_HUMAN reviewed Golgi-associated plant pathogenesis-related protein 1 (GAPR-1) (Golgi-associated PR-1 protein) (Glioma pathogenesis-related protein 2) (GliPR 2) Homo sapiens (Human) GO:0000139; GO:0005615; GO:0010634; GO:0010718; GO:0042803; GO:0070062; GO:0070374 positive regulation of epithelial cell migration [GO:0010634]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of ERK1 and ERK2 cascade [GO:0070374] extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; Golgi membrane [GO:0000139] protein homodimerization activity [GO:0042803] g23478.t1 P46379 28.682 387 2.76e-33 142.0 sp|P46379|BAG6_HUMAN Large proline-rich protein BAG6 OS=Homo sapiens OX=9606 GN=BAG6 PE=1 SV=2 BAG6_HUMAN reviewed Large proline-rich protein BAG6 (BAG family molecular chaperone regulator 6) (BCL2-associated athanogene 6) (BAG-6) (HLA-B-associated transcript 3) (Protein G3) (Protein Scythe) Homo sapiens (Human) GO:0001822; GO:0002429; GO:0005102; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006325; GO:0006511; GO:0006620; GO:0006915; GO:0007130; GO:0007283; GO:0007420; GO:0010498; GO:0016020; GO:0018393; GO:0030101; GO:0030154; GO:0030324; GO:0030544; GO:0031593; GO:0031625; GO:0031647; GO:0032435; GO:0036503; GO:0036506; GO:0042771; GO:0042802; GO:0043022; GO:0043066; GO:0043161; GO:0045861; GO:0045995; GO:0048018; GO:0050821; GO:0051132; GO:0051787; GO:0060090; GO:0061857; GO:0070059; GO:0070062; GO:0070628; GO:0071816; GO:0071818; GO:0140597; GO:0140677; GO:1904294; GO:1990381 apoptotic process [GO:0006915]; brain development [GO:0007420]; cell differentiation [GO:0030154]; chromatin organization [GO:0006325]; endoplasmic reticulum stress-induced pre-emptive quality control [GO:0061857]; ERAD pathway [GO:0036503]; immune response-activating cell surface receptor signaling pathway [GO:0002429]; internal peptidyl-lysine acetylation [GO:0018393]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; kidney development [GO:0001822]; lung development [GO:0030324]; maintenance of unfolded protein [GO:0036506]; natural killer cell activation [GO:0030101]; negative regulation of apoptotic process [GO:0043066]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of proteolysis [GO:0045861]; NK T cell activation [GO:0051132]; positive regulation of ERAD pathway [GO:1904294]; post-translational protein targeting to endoplasmic reticulum membrane [GO:0006620]; proteasomal protein catabolic process [GO:0010498]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein stabilization [GO:0050821]; regulation of embryonic development [GO:0045995]; regulation of protein stability [GO:0031647]; spermatogenesis [GO:0007283]; synaptonemal complex assembly [GO:0007130]; tail-anchored membrane protein insertion into ER membrane [GO:0071816]; ubiquitin-dependent protein catabolic process [GO:0006511] BAT3 complex [GO:0071818]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] Hsp70 protein binding [GO:0030544]; identical protein binding [GO:0042802]; misfolded protein binding [GO:0051787]; molecular adaptor activity [GO:0060090]; molecular function activator activity [GO:0140677]; polyubiquitin modification-dependent protein binding [GO:0031593]; proteasome binding [GO:0070628]; protein carrier chaperone [GO:0140597]; receptor ligand activity [GO:0048018]; ribosome binding [GO:0043022]; signaling receptor binding [GO:0005102]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-specific protease binding [GO:1990381] g23479.t1 P46379 43.094 181 8.77e-27 112.0 sp|P46379|BAG6_HUMAN Large proline-rich protein BAG6 OS=Homo sapiens OX=9606 GN=BAG6 PE=1 SV=2 BAG6_HUMAN reviewed Large proline-rich protein BAG6 (BAG family molecular chaperone regulator 6) (BCL2-associated athanogene 6) (BAG-6) (HLA-B-associated transcript 3) (Protein G3) (Protein Scythe) Homo sapiens (Human) GO:0001822; GO:0002429; GO:0005102; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006325; GO:0006511; GO:0006620; GO:0006915; GO:0007130; GO:0007283; GO:0007420; GO:0010498; GO:0016020; GO:0018393; GO:0030101; GO:0030154; GO:0030324; GO:0030544; GO:0031593; GO:0031625; GO:0031647; GO:0032435; GO:0036503; GO:0036506; GO:0042771; GO:0042802; GO:0043022; GO:0043066; GO:0043161; GO:0045861; GO:0045995; GO:0048018; GO:0050821; GO:0051132; GO:0051787; GO:0060090; GO:0061857; GO:0070059; GO:0070062; GO:0070628; GO:0071816; GO:0071818; GO:0140597; GO:0140677; GO:1904294; GO:1990381 apoptotic process [GO:0006915]; brain development [GO:0007420]; cell differentiation [GO:0030154]; chromatin organization [GO:0006325]; endoplasmic reticulum stress-induced pre-emptive quality control [GO:0061857]; ERAD pathway [GO:0036503]; immune response-activating cell surface receptor signaling pathway [GO:0002429]; internal peptidyl-lysine acetylation [GO:0018393]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; kidney development [GO:0001822]; lung development [GO:0030324]; maintenance of unfolded protein [GO:0036506]; natural killer cell activation [GO:0030101]; negative regulation of apoptotic process [GO:0043066]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of proteolysis [GO:0045861]; NK T cell activation [GO:0051132]; positive regulation of ERAD pathway [GO:1904294]; post-translational protein targeting to endoplasmic reticulum membrane [GO:0006620]; proteasomal protein catabolic process [GO:0010498]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein stabilization [GO:0050821]; regulation of embryonic development [GO:0045995]; regulation of protein stability [GO:0031647]; spermatogenesis [GO:0007283]; synaptonemal complex assembly [GO:0007130]; tail-anchored membrane protein insertion into ER membrane [GO:0071816]; ubiquitin-dependent protein catabolic process [GO:0006511] BAT3 complex [GO:0071818]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] Hsp70 protein binding [GO:0030544]; identical protein binding [GO:0042802]; misfolded protein binding [GO:0051787]; molecular adaptor activity [GO:0060090]; molecular function activator activity [GO:0140677]; polyubiquitin modification-dependent protein binding [GO:0031593]; proteasome binding [GO:0070628]; protein carrier chaperone [GO:0140597]; receptor ligand activity [GO:0048018]; ribosome binding [GO:0043022]; signaling receptor binding [GO:0005102]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-specific protease binding [GO:1990381] g23479.t2 P46379 43.575 179 4.410000000000001e-27 113.0 sp|P46379|BAG6_HUMAN Large proline-rich protein BAG6 OS=Homo sapiens OX=9606 GN=BAG6 PE=1 SV=2 BAG6_HUMAN reviewed Large proline-rich protein BAG6 (BAG family molecular chaperone regulator 6) (BCL2-associated athanogene 6) (BAG-6) (HLA-B-associated transcript 3) (Protein G3) (Protein Scythe) Homo sapiens (Human) GO:0001822; GO:0002429; GO:0005102; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006325; GO:0006511; GO:0006620; GO:0006915; GO:0007130; GO:0007283; GO:0007420; GO:0010498; GO:0016020; GO:0018393; GO:0030101; GO:0030154; GO:0030324; GO:0030544; GO:0031593; GO:0031625; GO:0031647; GO:0032435; GO:0036503; GO:0036506; GO:0042771; GO:0042802; GO:0043022; GO:0043066; GO:0043161; GO:0045861; GO:0045995; GO:0048018; GO:0050821; GO:0051132; GO:0051787; GO:0060090; GO:0061857; GO:0070059; GO:0070062; GO:0070628; GO:0071816; GO:0071818; GO:0140597; GO:0140677; GO:1904294; GO:1990381 apoptotic process [GO:0006915]; brain development [GO:0007420]; cell differentiation [GO:0030154]; chromatin organization [GO:0006325]; endoplasmic reticulum stress-induced pre-emptive quality control [GO:0061857]; ERAD pathway [GO:0036503]; immune response-activating cell surface receptor signaling pathway [GO:0002429]; internal peptidyl-lysine acetylation [GO:0018393]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; kidney development [GO:0001822]; lung development [GO:0030324]; maintenance of unfolded protein [GO:0036506]; natural killer cell activation [GO:0030101]; negative regulation of apoptotic process [GO:0043066]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of proteolysis [GO:0045861]; NK T cell activation [GO:0051132]; positive regulation of ERAD pathway [GO:1904294]; post-translational protein targeting to endoplasmic reticulum membrane [GO:0006620]; proteasomal protein catabolic process [GO:0010498]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein stabilization [GO:0050821]; regulation of embryonic development [GO:0045995]; regulation of protein stability [GO:0031647]; spermatogenesis [GO:0007283]; synaptonemal complex assembly [GO:0007130]; tail-anchored membrane protein insertion into ER membrane [GO:0071816]; ubiquitin-dependent protein catabolic process [GO:0006511] BAT3 complex [GO:0071818]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] Hsp70 protein binding [GO:0030544]; identical protein binding [GO:0042802]; misfolded protein binding [GO:0051787]; molecular adaptor activity [GO:0060090]; molecular function activator activity [GO:0140677]; polyubiquitin modification-dependent protein binding [GO:0031593]; proteasome binding [GO:0070628]; protein carrier chaperone [GO:0140597]; receptor ligand activity [GO:0048018]; ribosome binding [GO:0043022]; signaling receptor binding [GO:0005102]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-specific protease binding [GO:1990381] g23480.t1 Q0VCQ4 55.618 178 1.62e-65 207.0 sp|Q0VCQ4|RRFM_BOVIN Ribosome-recycling factor, mitochondrial OS=Bos taurus OX=9913 GN=MRRF PE=2 SV=1 g23481.t1 Q7Z7A1 26.306 1110 2.28e-66 253.0 sp|Q7Z7A1|CNTRL_HUMAN Centriolin OS=Homo sapiens OX=9606 GN=CNTRL PE=1 SV=2 CNTRL_HUMAN reviewed Centriolin (Centrosomal protein 1) (Centrosomal protein of 110 kDa) (Cep110) Homo sapiens (Human) GO:0001822; GO:0003281; GO:0005794; GO:0005813; GO:0005814; GO:0005815; GO:0005829; GO:0005886; GO:0016020; GO:0034451; GO:0035904; GO:0036064; GO:0048471; GO:0051301; GO:0060976; GO:0090543; GO:0090619; GO:0097431; GO:0120103 aorta development [GO:0035904]; cell division [GO:0051301]; coronary vasculature development [GO:0060976]; kidney development [GO:0001822]; ventricular septum development [GO:0003281] centriolar satellite [GO:0034451]; centriolar subdistal appendage [GO:0120103]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytosol [GO:0005829]; Flemming body [GO:0090543]; Golgi apparatus [GO:0005794]; meiotic spindle pole [GO:0090619]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; mitotic spindle pole [GO:0097431]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886] g23483.t1 A2AL36 38.977 567 4.920000000000001e-97 333.0 sp|A2AL36|CNTRL_MOUSE Centriolin OS=Mus musculus OX=10090 GN=Cntrl PE=1 SV=2 CNTRL_MOUSE reviewed Centriolin (Centrosomal protein 1) (Centrosomal protein of 110 kDa) (Cep110) Mus musculus (Mouse) GO:0001822; GO:0003279; GO:0003281; GO:0005794; GO:0005813; GO:0005829; GO:0005886; GO:0034451; GO:0035904; GO:0036064; GO:0048132; GO:0048471; GO:0060976; GO:0072687; GO:0090543; GO:0090619; GO:0097431; GO:0120103 aorta development [GO:0035904]; cardiac septum development [GO:0003279]; coronary vasculature development [GO:0060976]; female germ-line stem cell asymmetric division [GO:0048132]; kidney development [GO:0001822]; ventricular septum development [GO:0003281] centriolar satellite [GO:0034451]; centriolar subdistal appendage [GO:0120103]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytosol [GO:0005829]; Flemming body [GO:0090543]; Golgi apparatus [GO:0005794]; meiotic spindle [GO:0072687]; meiotic spindle pole [GO:0090619]; mitotic spindle pole [GO:0097431]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886] g23485.t1 Q99943 38.095 252 1.8299999999999998e-46 160.0 sp|Q99943|PLCA_HUMAN 1-acyl-sn-glycerol-3-phosphate acyltransferase alpha OS=Homo sapiens OX=9606 GN=AGPAT1 PE=1 SV=2 PLCA_HUMAN reviewed 1-acyl-sn-glycerol-3-phosphate acyltransferase alpha (EC 2.3.1.51) (1-acylglycerol-3-phosphate O-acyltransferase 1) (1-AGP acyltransferase 1) (1-AGPAT 1) (Lysophosphatidic acid acyltransferase alpha) (LPAAT-alpha) (Protein G15) Homo sapiens (Human) GO:0001819; GO:0001961; GO:0003841; GO:0005783; GO:0005789; GO:0006644; GO:0006654; GO:0016020; GO:0016024 CDP-diacylglycerol biosynthetic process [GO:0016024]; phosphatidic acid biosynthetic process [GO:0006654]; phospholipid metabolic process [GO:0006644]; positive regulation of cytokine production [GO:0001819]; positive regulation of cytokine-mediated signaling pathway [GO:0001961] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020] 1-acylglycerol-3-phosphate O-acyltransferase activity [GO:0003841] g23486.t1 Q9JHA8 27.546 766 7.95e-64 238.0 sp|Q9JHA8|VWA7_MOUSE von Willebrand factor A domain-containing protein 7 OS=Mus musculus OX=10090 GN=Vwa7 PE=2 SV=1 g23488.t1 Q9JHA8 29.339 726 1.03e-65 238.0 sp|Q9JHA8|VWA7_MOUSE von Willebrand factor A domain-containing protein 7 OS=Mus musculus OX=10090 GN=Vwa7 PE=2 SV=1 g23489.t1 Q96RW7 29.752 242 1.42e-23 111.0 sp|Q96RW7|HMCN1_HUMAN Hemicentin-1 OS=Homo sapiens OX=9606 GN=HMCN1 PE=1 SV=2 HMCN1_HUMAN reviewed Hemicentin-1 (Fibulin-6) (FIBL-6) Homo sapiens (Human) GO:0005201; GO:0005509; GO:0005604; GO:0005737; GO:0005886; GO:0005912; GO:0005927; GO:0005938; GO:0007156; GO:0007157; GO:0007601; GO:0009617; GO:0030036; GO:0031012; GO:0032154; GO:0051301; GO:0070062; GO:0071711; GO:0098631 actin cytoskeleton organization [GO:0030036]; basement membrane organization [GO:0071711]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601] adherens junction [GO:0005912]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; muscle tendon junction [GO:0005927]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; cell adhesion mediator activity [GO:0098631]; extracellular matrix structural constituent [GO:0005201] g23491.t1 P51688 59.919 494 0.0 642.0 sp|P51688|SPHM_HUMAN N-sulphoglucosamine sulphohydrolase OS=Homo sapiens OX=9606 GN=SGSH PE=1 SV=1 SPHM_HUMAN reviewed N-sulphoglucosamine sulphohydrolase (EC 3.10.1.1) (Sulfoglucosamine sulfamidase) (Sulphamidase) Homo sapiens (Human) GO:0005764; GO:0006027; GO:0008340; GO:0008484; GO:0016250; GO:0030200; GO:0043202; GO:0046872; GO:0061744; GO:0070062 determination of adult lifespan [GO:0008340]; glycosaminoglycan catabolic process [GO:0006027]; heparan sulfate proteoglycan catabolic process [GO:0030200]; motor behavior [GO:0061744] extracellular exosome [GO:0070062]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764] metal ion binding [GO:0046872]; N-sulfoglucosamine sulfohydrolase activity [GO:0016250]; sulfuric ester hydrolase activity [GO:0008484] g23492.t1 A7RWC9 71.978 182 4.6e-93 273.0 sp|A7RWC9|ITPA_NEMVE Inosine triphosphate pyrophosphatase OS=Nematostella vectensis OX=45351 GN=v1g163483 PE=3 SV=1 ITPA_NEMVE reviewed Inosine triphosphate pyrophosphatase (ITPase) (Inosine triphosphatase) (EC 3.6.1.66) (Non-canonical purine NTP pyrophosphatase) (Non-standard purine NTP pyrophosphatase) (Nucleoside-triphosphate diphosphatase) (Nucleoside-triphosphate pyrophosphatase) (NTPase) (XTP/dITP diphosphatase) Nematostella vectensis (Starlet sea anemone) GO:0000166; GO:0005737; GO:0009117; GO:0009143; GO:0009204; GO:0035870; GO:0036220; GO:0036222; GO:0046872; GO:0047429 deoxyribonucleoside triphosphate catabolic process [GO:0009204]; nucleoside triphosphate catabolic process [GO:0009143]; nucleotide metabolic process [GO:0009117] cytoplasm [GO:0005737] dITP diphosphatase activity [GO:0035870]; ITP diphosphatase activity [GO:0036220]; metal ion binding [GO:0046872]; nucleoside triphosphate diphosphatase activity [GO:0047429]; nucleotide binding [GO:0000166]; XTP diphosphatase activity [GO:0036222] g23493.t1 Q9NZL6 37.281 743 1.94e-125 395.0 sp|Q9NZL6|RGL1_HUMAN Ral guanine nucleotide dissociation stimulator-like 1 OS=Homo sapiens OX=9606 GN=RGL1 PE=1 SV=1 g23494.t1 Q9Z0E6 30.623 369 4.52e-35 145.0 sp|Q9Z0E6|GBP2_MOUSE Guanylate-binding protein 2 OS=Mus musculus OX=10090 GN=Gbp2 PE=1 SV=1 g23494.t2 Q9Z0E6 30.623 369 4.37e-35 145.0 sp|Q9Z0E6|GBP2_MOUSE Guanylate-binding protein 2 OS=Mus musculus OX=10090 GN=Gbp2 PE=1 SV=1 g23496.t1 Q15477 58.065 992 0.0 1126.0 sp|Q15477|SKI2_HUMAN Superkiller complex protein 2 OS=Homo sapiens OX=9606 GN=SKIC2 PE=1 SV=3 g23496.t1 Q15477 47.594 187 5.879999999999999e-38 159.0 sp|Q15477|SKI2_HUMAN Superkiller complex protein 2 OS=Homo sapiens OX=9606 GN=SKIC2 PE=1 SV=3 g23497.t1 Q28FE4 76.023 171 1.02e-98 285.0 sp|Q28FE4|MORN5_XENTR MORN repeat-containing protein 5 OS=Xenopus tropicalis OX=8364 GN=morn5 PE=2 SV=1 g23498.t1 Q8VCC1 29.832 238 8.379999999999999e-24 100.0 sp|Q8VCC1|PGDH_MOUSE 15-hydroxyprostaglandin dehydrogenase [NAD(+)] OS=Mus musculus OX=10090 GN=Hpgd PE=1 SV=1 g23501.t1 Q05192 56.471 85 1.09e-26 120.0 sp|Q05192|FTF1B_DROME Nuclear hormone receptor FTZ-F1 beta OS=Drosophila melanogaster OX=7227 GN=Hr39 PE=1 SV=3 FTF1B_DROME reviewed Nuclear hormone receptor FTZ-F1 beta (Nuclear hormone receptor HR39) (dHR39) (Nuclear receptor subfamily 5 group B member 1) Drosophila melanogaster (Fruit fly) GO:0000978; GO:0004879; GO:0005634; GO:0006355; GO:0008270; GO:0035211 regulation of DNA-templated transcription [GO:0006355]; spermathecum morphogenesis [GO:0035211] nucleus [GO:0005634] nuclear receptor activity [GO:0004879]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270] g23502.t1 Q4V869 46.809 235 6.31e-70 220.0 sp|Q4V869|ACBD6_XENLA Acyl-CoA-binding domain-containing protein 6 OS=Xenopus laevis OX=8355 GN=acbd6 PE=2 SV=1 g23504.t1 Q58DL5 33.621 580 3.35e-78 271.0 sp|Q58DL5|BCAR3_BOVIN Breast cancer anti-estrogen resistance protein 3 homolog OS=Bos taurus OX=9913 GN=BCAR3 PE=2 SV=2 BCAR3_BOVIN reviewed Breast cancer anti-estrogen resistance protein 3 homolog Bos taurus (Bovine) GO:0001784; GO:0005085; GO:0005737; GO:0005925; GO:0007173; GO:0007264; GO:0008284; GO:0008286; GO:0016020; GO:0043410; GO:0043547; GO:0086100 endothelin receptor signaling pathway [GO:0086100]; epidermal growth factor receptor signaling pathway [GO:0007173]; insulin receptor signaling pathway [GO:0008286]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of GTPase activity [GO:0043547]; positive regulation of MAPK cascade [GO:0043410]; small GTPase-mediated signal transduction [GO:0007264] cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; membrane [GO:0016020] guanyl-nucleotide exchange factor activity [GO:0005085]; phosphotyrosine residue binding [GO:0001784] g23507.t1 Q761V0 41.909 618 8.68e-155 467.0 sp|Q761V0|SC6A5_MOUSE Sodium- and chloride-dependent glycine transporter 2 OS=Mus musculus OX=10090 GN=Slc6a5 PE=1 SV=1 SC6A5_MOUSE reviewed Sodium- and chloride-dependent glycine transporter 2 (GlyT-2) (GlyT2) (Solute carrier family 6 member 5) Mus musculus (Mouse) GO:0001504; GO:0005768; GO:0005886; GO:0015187; GO:0015375; GO:0015816; GO:0031045; GO:0035725; GO:0042734; GO:0046872; GO:0060012; GO:0098690; GO:0098810; GO:1903804 glycine import across plasma membrane [GO:1903804]; glycine transport [GO:0015816]; neurotransmitter reuptake [GO:0098810]; neurotransmitter uptake [GO:0001504]; sodium ion transmembrane transport [GO:0035725]; synaptic transmission, glycinergic [GO:0060012] dense core granule [GO:0031045]; endosome [GO:0005768]; glycinergic synapse [GO:0098690]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734] glycine transmembrane transporter activity [GO:0015187]; glycine:sodium symporter activity [GO:0015375]; metal ion binding [GO:0046872] g23509.t1 Q00685 27.029 1639 1.15e-146 498.0 sp|Q00685|CO3_LETCA Complement C3 (Fragment) OS=Lethenteron camtschaticum OX=980415 GN=C3 PE=2 SV=1 g23510.t1 Q28717 52.492 301 3.2e-117 343.0 sp|Q28717|PTPA_RABIT Serine/threonine-protein phosphatase 2A activator OS=Oryctolagus cuniculus OX=9986 GN=PTPA PE=1 SV=1 PTPA_RABIT reviewed Serine/threonine-protein phosphatase 2A activator (EC 5.2.1.8) (PP2A, subunit B', PR53 isoform) (Phosphotyrosyl phosphatase activator) (PTPA) (Serine/threonine-protein phosphatase 2A regulatory subunit 4) (Serine/threonine-protein phosphatase 2A regulatory subunit B') Oryctolagus cuniculus (Rabbit) GO:0000159; GO:0003755; GO:0005524; GO:0005634; GO:0005737; GO:0007052; GO:0008160; GO:0019888; GO:0042803; GO:0046872; GO:0051721; GO:1904949 mitotic spindle organization [GO:0007052] ATPase complex [GO:1904949]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; protein phosphatase type 2A complex [GO:0000159] ATP binding [GO:0005524]; metal ion binding [GO:0046872]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; protein homodimerization activity [GO:0042803]; protein phosphatase 2A binding [GO:0051721]; protein phosphatase regulator activity [GO:0019888]; protein tyrosine phosphatase activator activity [GO:0008160] g23511.t1 P47934 54.262 610 0.0 657.0 sp|P47934|CACP_MOUSE Carnitine O-acetyltransferase OS=Mus musculus OX=10090 GN=Crat PE=1 SV=3 CACP_MOUSE reviewed Carnitine O-acetyltransferase (Carnitine acetylase) (EC 2.3.1.137) (EC 2.3.1.7) (Carnitine acetyltransferase) (CAT) (CrAT) Mus musculus (Mouse) GO:0003997; GO:0004092; GO:0005739; GO:0005743; GO:0005777; GO:0005783; GO:0006631; GO:0008458; GO:0019254; GO:0033540; GO:0046459; GO:0051791 carnitine metabolic process, CoA-linked [GO:0019254]; fatty acid beta-oxidation using acyl-CoA oxidase [GO:0033540]; fatty acid metabolic process [GO:0006631]; medium-chain fatty acid metabolic process [GO:0051791]; short-chain fatty acid metabolic process [GO:0046459] endoplasmic reticulum [GO:0005783]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; peroxisome [GO:0005777] acyl-CoA oxidase activity [GO:0003997]; carnitine O-acetyltransferase activity [GO:0004092]; carnitine O-octanoyltransferase activity [GO:0008458] g23512.t1 Q7TSV3 60.101 198 2.54e-78 237.0 sp|Q7TSV3|ZMY19_RAT Zinc finger MYND domain-containing protein 19 OS=Rattus norvegicus OX=10116 GN=Zmynd19 PE=2 SV=1 g23513.t1 P41234 46.412 2536 0.0 2078.0 sp|P41234|ABCA2_MOUSE ATP-binding cassette sub-family A member 2 OS=Mus musculus OX=10090 GN=Abca2 PE=1 SV=4 g23513.t2 P41234 46.53 2536 0.0 2089.0 sp|P41234|ABCA2_MOUSE ATP-binding cassette sub-family A member 2 OS=Mus musculus OX=10090 GN=Abca2 PE=1 SV=4 g23517.t1 D3ZWZ9 62.762 239 6.950000000000001e-109 327.0 sp|D3ZWZ9|GP107_RAT Protein GPR107 OS=Rattus norvegicus OX=10116 GN=Gpr107 PE=1 SV=1 g23520.t1 Q7T0U6 51.44 486 6.93e-172 494.0 sp|Q7T0U6|SCM1B_XENLA Mitochondrial adenyl nucleotide antiporter SLC25A24-B OS=Xenopus laevis OX=8355 GN=slc25a24-b PE=2 SV=1 SCM1B_XENLA reviewed Mitochondrial adenyl nucleotide antiporter SLC25A24-B (Small calcium-binding mitochondrial carrier protein 1-B) (SCaMC-1-A) (Solute carrier family 25 member 24-B) Xenopus laevis (African clawed frog) GO:0000295; GO:0005347; GO:0005509; GO:0005739; GO:0005743; GO:0015866; GO:0015867; GO:0016020; GO:0051503; GO:0071277; GO:0140987; GO:0140988; GO:1990544 adenine nucleotide transport [GO:0051503]; ADP transport [GO:0015866]; ATP transport [GO:0015867]; cellular response to calcium ion [GO:0071277]; mitochondrial ATP transmembrane transport [GO:1990544] membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739] adenine nucleotide transmembrane transporter activity [GO:0000295]; ADP:phosphate antiporter activity [GO:0140988]; ATP transmembrane transporter activity [GO:0005347]; ATP:phosphate antiporter activity [GO:0140987]; calcium ion binding [GO:0005509] g23520.t2 Q7T0U6 54.095 464 3.73e-178 509.0 sp|Q7T0U6|SCM1B_XENLA Mitochondrial adenyl nucleotide antiporter SLC25A24-B OS=Xenopus laevis OX=8355 GN=slc25a24-b PE=2 SV=1 SCM1B_XENLA reviewed Mitochondrial adenyl nucleotide antiporter SLC25A24-B (Small calcium-binding mitochondrial carrier protein 1-B) (SCaMC-1-A) (Solute carrier family 25 member 24-B) Xenopus laevis (African clawed frog) GO:0000295; GO:0005347; GO:0005509; GO:0005739; GO:0005743; GO:0015866; GO:0015867; GO:0016020; GO:0051503; GO:0071277; GO:0140987; GO:0140988; GO:1990544 adenine nucleotide transport [GO:0051503]; ADP transport [GO:0015866]; ATP transport [GO:0015867]; cellular response to calcium ion [GO:0071277]; mitochondrial ATP transmembrane transport [GO:1990544] membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739] adenine nucleotide transmembrane transporter activity [GO:0000295]; ADP:phosphate antiporter activity [GO:0140988]; ATP transmembrane transporter activity [GO:0005347]; ATP:phosphate antiporter activity [GO:0140987]; calcium ion binding [GO:0005509] g23522.t1 Q27433 77.992 259 3.12e-133 390.0 sp|Q27433|MEC2_CAEEL Mechanosensory protein 2 OS=Caenorhabditis elegans OX=6239 GN=mec-2 PE=1 SV=1 MEC2_CAEEL reviewed Mechanosensory protein 2 Caenorhabditis elegans GO:0005272; GO:0005886; GO:0006813; GO:0007638; GO:0008200; GO:0009612; GO:0015485; GO:0032589; GO:0043005; GO:0050976; GO:1905789; GO:1905792 detection of mechanical stimulus involved in sensory perception of touch [GO:0050976]; mechanosensory behavior [GO:0007638]; positive regulation of detection of mechanical stimulus involved in sensory perception of touch [GO:1905789]; positive regulation of mechanosensory behavior [GO:1905792]; potassium ion transport [GO:0006813]; response to mechanical stimulus [GO:0009612] neuron projection [GO:0043005]; neuron projection membrane [GO:0032589]; plasma membrane [GO:0005886] cholesterol binding [GO:0015485]; ion channel inhibitor activity [GO:0008200]; sodium channel activity [GO:0005272] g23523.t1 Q5E9D6 36.481 233 1.04e-51 171.0 sp|Q5E9D6|HDHD3_BOVIN Haloacid dehalogenase-like hydrolase domain-containing protein 3 OS=Bos taurus OX=9913 GN=HDHD3 PE=2 SV=1 g23524.t1 Q64739 59.677 186 5.48e-39 163.0 sp|Q64739|COBA2_MOUSE Collagen alpha-2(XI) chain OS=Mus musculus OX=10090 GN=Col11a2 PE=2 SV=3 g23525.t1 P12107 48.927 233 2.88e-71 249.0 sp|P12107|COBA1_HUMAN Collagen alpha-1(XI) chain OS=Homo sapiens OX=9606 GN=COL11A1 PE=1 SV=4 COBA1_HUMAN reviewed Collagen alpha-1(XI) chain Homo sapiens (Human) GO:0001502; GO:0002063; GO:0005201; GO:0005576; GO:0005585; GO:0005592; GO:0005788; GO:0006029; GO:0007601; GO:0007605; GO:0030020; GO:0030199; GO:0030674; GO:0031012; GO:0035987; GO:0035989; GO:0042472; GO:0046872; GO:0048704; GO:0050840; GO:0050910; GO:0055010 cartilage condensation [GO:0001502]; chondrocyte development [GO:0002063]; collagen fibril organization [GO:0030199]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; embryonic skeletal system morphogenesis [GO:0048704]; endodermal cell differentiation [GO:0035987]; inner ear morphogenesis [GO:0042472]; proteoglycan metabolic process [GO:0006029]; sensory perception of sound [GO:0007605]; tendon development [GO:0035989]; ventricular cardiac muscle tissue morphogenesis [GO:0055010]; visual perception [GO:0007601] collagen type II trimer [GO:0005585]; collagen type XI trimer [GO:0005592]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576] extracellular matrix binding [GO:0050840]; extracellular matrix structural constituent [GO:0005201]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; metal ion binding [GO:0046872]; protein-macromolecule adaptor activity [GO:0030674] g23526.t1 Q9TTF0 45.476 420 5.67e-104 317.0 sp|Q9TTF0|NR2E3_BOVIN Photoreceptor-specific nuclear receptor OS=Bos taurus OX=9913 GN=NR2E3 PE=1 SV=2 g23527.t1 Q810W9 58.621 87 2.6699999999999998e-24 107.0 sp|Q810W9|WHRN_RAT Whirlin OS=Rattus norvegicus OX=10116 GN=Whrn PE=1 SV=1 WHRN_RAT reviewed Whirlin (CASK-interacting protein CIP98) Rattus norvegicus (Rat) GO:0001895; GO:0001917; GO:0002141; GO:0002142; GO:0005737; GO:0005884; GO:0005886; GO:0005929; GO:0007605; GO:0010628; GO:0019904; GO:0021694; GO:0030426; GO:0032391; GO:0032420; GO:0032421; GO:0032426; GO:0036064; GO:0042802; GO:0043005; GO:0043025; GO:0043198; GO:0044303; GO:0045184; GO:0048471; GO:0050910; GO:0050953; GO:0051649; GO:0060088; GO:0060122; GO:0097440; GO:0098793; GO:0098794; GO:1990075; GO:1990227; GO:1990696 auditory receptor cell stereocilium organization [GO:0060088]; cerebellar Purkinje cell layer formation [GO:0021694]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; establishment of localization in cell [GO:0051649]; establishment of protein localization [GO:0045184]; inner ear receptor cell stereocilium organization [GO:0060122]; paranodal junction maintenance [GO:1990227]; positive regulation of gene expression [GO:0010628]; retina homeostasis [GO:0001895]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605] actin filament [GO:0005884]; apical dendrite [GO:0097440]; axon collateral [GO:0044303]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; dendritic shaft [GO:0043198]; growth cone [GO:0030426]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; periciliary membrane compartment [GO:1990075]; perinuclear region of cytoplasm [GO:0048471]; photoreceptor connecting cilium [GO:0032391]; photoreceptor inner segment [GO:0001917]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; presynapse [GO:0098793]; stereocilia ankle link [GO:0002141]; stereocilia ankle link complex [GO:0002142]; stereocilium [GO:0032420]; stereocilium bundle [GO:0032421]; stereocilium tip [GO:0032426]; USH2 complex [GO:1990696] identical protein binding [GO:0042802]; protein domain specific binding [GO:0019904] g23529.t1 Q80VW5 51.603 312 3.04e-97 315.0 sp|Q80VW5|WHRN_MOUSE Whirlin OS=Mus musculus OX=10090 GN=Whrn PE=1 SV=3 g23529.t2 Q80VW5 51.603 312 9.15e-97 315.0 sp|Q80VW5|WHRN_MOUSE Whirlin OS=Mus musculus OX=10090 GN=Whrn PE=1 SV=3 g23530.t1 Q80VW5 36.898 187 1.11e-26 110.0 sp|Q80VW5|WHRN_MOUSE Whirlin OS=Mus musculus OX=10090 GN=Whrn PE=1 SV=3 g23534.t1 P10620 54.225 142 7.159999999999999e-48 155.0 sp|P10620|MGST1_HUMAN Microsomal glutathione S-transferase 1 OS=Homo sapiens OX=9606 GN=MGST1 PE=1 SV=1 MGST1_HUMAN reviewed Microsomal glutathione S-transferase 1 (Microsomal GST-1) (EC 2.5.1.18) (Microsomal GST-I) Homo sapiens (Human) GO:0004364; GO:0004602; GO:0005739; GO:0005741; GO:0005778; GO:0005783; GO:0005789; GO:0005886; GO:0016020; GO:0034635; GO:0035577; GO:0071449 cellular response to lipid hydroperoxide [GO:0071449]; glutathione transport [GO:0034635] azurophil granule membrane [GO:0035577]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; peroxisomal membrane [GO:0005778]; plasma membrane [GO:0005886] glutathione peroxidase activity [GO:0004602]; glutathione transferase activity [GO:0004364] g23537.t1 Q9ESK9 25.838 1014 2.53e-57 221.0 sp|Q9ESK9|RBCC1_MOUSE RB1-inducible coiled-coil protein 1 OS=Mus musculus OX=10090 GN=Rb1cc1 PE=1 SV=3 RBCC1_MOUSE reviewed RB1-inducible coiled-coil protein 1 (Coiled-coil-forming protein 1) (FAK family kinase-interacting protein of 200 kDa) (FIP200) (LaXp180) Mus musculus (Mouse) GO:0000045; GO:0000407; GO:0000421; GO:0000422; GO:0000425; GO:0001889; GO:0005634; GO:0005737; GO:0005764; GO:0005829; GO:0006914; GO:0007507; GO:0008285; GO:0010508; GO:0019901; GO:0031965; GO:0034045; GO:0034517; GO:0034727; GO:0043066; GO:0043495; GO:0045087; GO:0045793; GO:0046330; GO:0051607; GO:0060090; GO:0061709; GO:0061723; GO:1990316; GO:2001237 autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; autophagy of mitochondrion [GO:0000422]; defense response to virus [GO:0051607]; glycophagy [GO:0061723]; heart development [GO:0007507]; innate immune response [GO:0045087]; liver development [GO:0001889]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; pexophagy [GO:0000425]; piecemeal microautophagy of the nucleus [GO:0034727]; positive regulation of autophagy [GO:0010508]; positive regulation of cell size [GO:0045793]; positive regulation of JNK cascade [GO:0046330]; reticulophagy [GO:0061709]; ribophagy [GO:0034517] Atg1/ULK1 kinase complex [GO:1990316]; autophagosome membrane [GO:0000421]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; lysosome [GO:0005764]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; phagophore assembly site [GO:0000407]; phagophore assembly site membrane [GO:0034045] molecular adaptor activity [GO:0060090]; protein kinase binding [GO:0019901]; protein-membrane adaptor activity [GO:0043495] g23537.t1 Q9ESK9 36.918 279 8.139999999999999e-38 158.0 sp|Q9ESK9|RBCC1_MOUSE RB1-inducible coiled-coil protein 1 OS=Mus musculus OX=10090 GN=Rb1cc1 PE=1 SV=3 RBCC1_MOUSE reviewed RB1-inducible coiled-coil protein 1 (Coiled-coil-forming protein 1) (FAK family kinase-interacting protein of 200 kDa) (FIP200) (LaXp180) Mus musculus (Mouse) GO:0000045; GO:0000407; GO:0000421; GO:0000422; GO:0000425; GO:0001889; GO:0005634; GO:0005737; GO:0005764; GO:0005829; GO:0006914; GO:0007507; GO:0008285; GO:0010508; GO:0019901; GO:0031965; GO:0034045; GO:0034517; GO:0034727; GO:0043066; GO:0043495; GO:0045087; GO:0045793; GO:0046330; GO:0051607; GO:0060090; GO:0061709; GO:0061723; GO:1990316; GO:2001237 autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; autophagy of mitochondrion [GO:0000422]; defense response to virus [GO:0051607]; glycophagy [GO:0061723]; heart development [GO:0007507]; innate immune response [GO:0045087]; liver development [GO:0001889]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; pexophagy [GO:0000425]; piecemeal microautophagy of the nucleus [GO:0034727]; positive regulation of autophagy [GO:0010508]; positive regulation of cell size [GO:0045793]; positive regulation of JNK cascade [GO:0046330]; reticulophagy [GO:0061709]; ribophagy [GO:0034517] Atg1/ULK1 kinase complex [GO:1990316]; autophagosome membrane [GO:0000421]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; lysosome [GO:0005764]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; phagophore assembly site [GO:0000407]; phagophore assembly site membrane [GO:0034045] molecular adaptor activity [GO:0060090]; protein kinase binding [GO:0019901]; protein-membrane adaptor activity [GO:0043495] g23538.t1 Q8TDY2 43.094 181 1.25e-43 159.0 sp|Q8TDY2|RBCC1_HUMAN RB1-inducible coiled-coil protein 1 OS=Homo sapiens OX=9606 GN=RB1CC1 PE=1 SV=3 g23540.t1 Q9H7Z7 44.444 261 6.31e-69 225.0 sp|Q9H7Z7|PGES2_HUMAN Prostaglandin E synthase 2 OS=Homo sapiens OX=9606 GN=PTGES2 PE=1 SV=1 PGES2_HUMAN reviewed Prostaglandin E synthase 2 (EC 5.3.99.3) (Membrane-associated prostaglandin E synthase-2) (mPGE synthase-2) (Microsomal prostaglandin E synthase 2) (mPGES-2) (Prostaglandin-H(2) E-isomerase) [Cleaved into: Prostaglandin E synthase 2 truncated form] Homo sapiens (Human) GO:0000139; GO:0003677; GO:0005576; GO:0005634; GO:0005739; GO:0005829; GO:0006629; GO:0016829; GO:0019371; GO:0020037; GO:0035578; GO:0036134; GO:0043295; GO:0045893; GO:0046457; GO:0046903; GO:0048471; GO:0050220 cyclooxygenase pathway [GO:0019371]; lipid metabolic process [GO:0006629]; positive regulation of DNA-templated transcription [GO:0045893]; prostanoid biosynthetic process [GO:0046457]; secretion [GO:0046903] azurophil granule lumen [GO:0035578]; cytosol [GO:0005829]; extracellular region [GO:0005576]; Golgi membrane [GO:0000139]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471] 12-hydroxyheptadecatrienoic acid synthase activity [GO:0036134]; DNA binding [GO:0003677]; glutathione binding [GO:0043295]; heme binding [GO:0020037]; lyase activity [GO:0016829]; prostaglandin-E synthase activity [GO:0050220] g23544.t1 Q8R4K8 35.924 1055 0.0 605.0 sp|Q8R4K8|PAPP1_MOUSE Pappalysin-1 OS=Mus musculus OX=10090 GN=Pappa PE=2 SV=2 PAPP1_MOUSE reviewed Pappalysin-1 (EC 3.4.24.79) (Insulin-like growth factor-dependent IGF-binding protein 4 protease) (IGF-dependent IGFBP-4 protease) (IGFBP-4ase) (Pregnancy-associated plasma protein A) (PAPP-A) Mus musculus (Mouse) GO:0004175; GO:0004222; GO:0005576; GO:0005615; GO:0006508; GO:0007166; GO:0008237; GO:0030163; GO:0046872; GO:0071548 cell surface receptor signaling pathway [GO:0007166]; protein catabolic process [GO:0030163]; proteolysis [GO:0006508]; response to dexamethasone [GO:0071548] extracellular region [GO:0005576]; extracellular space [GO:0005615] endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237] g23544.t1 Q8R4K8 35.097 359 4.34e-62 198.0 sp|Q8R4K8|PAPP1_MOUSE Pappalysin-1 OS=Mus musculus OX=10090 GN=Pappa PE=2 SV=2 PAPP1_MOUSE reviewed Pappalysin-1 (EC 3.4.24.79) (Insulin-like growth factor-dependent IGF-binding protein 4 protease) (IGF-dependent IGFBP-4 protease) (IGFBP-4ase) (Pregnancy-associated plasma protein A) (PAPP-A) Mus musculus (Mouse) GO:0004175; GO:0004222; GO:0005576; GO:0005615; GO:0006508; GO:0007166; GO:0008237; GO:0030163; GO:0046872; GO:0071548 cell surface receptor signaling pathway [GO:0007166]; protein catabolic process [GO:0030163]; proteolysis [GO:0006508]; response to dexamethasone [GO:0071548] extracellular region [GO:0005576]; extracellular space [GO:0005615] endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237] g23544.t1 Q8R4K8 40.449 89 4.34e-62 64.7 sp|Q8R4K8|PAPP1_MOUSE Pappalysin-1 OS=Mus musculus OX=10090 GN=Pappa PE=2 SV=2 PAPP1_MOUSE reviewed Pappalysin-1 (EC 3.4.24.79) (Insulin-like growth factor-dependent IGF-binding protein 4 protease) (IGF-dependent IGFBP-4 protease) (IGFBP-4ase) (Pregnancy-associated plasma protein A) (PAPP-A) Mus musculus (Mouse) GO:0004175; GO:0004222; GO:0005576; GO:0005615; GO:0006508; GO:0007166; GO:0008237; GO:0030163; GO:0046872; GO:0071548 cell surface receptor signaling pathway [GO:0007166]; protein catabolic process [GO:0030163]; proteolysis [GO:0006508]; response to dexamethasone [GO:0071548] extracellular region [GO:0005576]; extracellular space [GO:0005615] endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237] g23545.t1 Q9D6J3 68.0 175 6.37e-70 226.0 sp|Q9D6J3|YJU2_MOUSE Splicing factor YJU2 OS=Mus musculus OX=10090 GN=Yju2 PE=1 SV=1 g23545.t2 Q9D6J3 68.0 175 4.6900000000000003e-70 226.0 sp|Q9D6J3|YJU2_MOUSE Splicing factor YJU2 OS=Mus musculus OX=10090 GN=Yju2 PE=1 SV=1 g23546.t1 P70195 61.786 280 4.21e-117 339.0 sp|P70195|PSB7_MOUSE Proteasome subunit beta type-7 OS=Mus musculus OX=10090 GN=Psmb7 PE=1 SV=1 g23548.t1 Q80ZF0 36.704 722 3.789999999999999e-68 258.0 sp|Q80ZF0|CORA1_RAT Collagen alpha-1(XXVII) chain OS=Rattus norvegicus OX=10116 GN=Col27a1 PE=2 SV=1 g23548.t1 Q80ZF0 38.571 350 9.65e-24 113.0 sp|Q80ZF0|CORA1_RAT Collagen alpha-1(XXVII) chain OS=Rattus norvegicus OX=10116 GN=Col27a1 PE=2 SV=1 g23548.t1 Q80ZF0 39.935 308 3.67e-22 108.0 sp|Q80ZF0|CORA1_RAT Collagen alpha-1(XXVII) chain OS=Rattus norvegicus OX=10116 GN=Col27a1 PE=2 SV=1 g23548.t1 Q80ZF0 36.885 366 6.110000000000001e-21 104.0 sp|Q80ZF0|CORA1_RAT Collagen alpha-1(XXVII) chain OS=Rattus norvegicus OX=10116 GN=Col27a1 PE=2 SV=1 g23550.t1 Q5T8I3 46.045 354 2.37e-81 254.0 sp|Q5T8I3|EEIG2_HUMAN EEIG family member 2 OS=Homo sapiens OX=9606 GN=EEIG2 PE=1 SV=2 g23551.t1 Q9D0T2 38.86 193 9.22e-40 144.0 sp|Q9D0T2|DUS12_MOUSE Dual specificity protein phosphatase 12 OS=Mus musculus OX=10090 GN=Dusp12 PE=2 SV=1 DUS12_MOUSE reviewed Dual specificity protein phosphatase 12 (EC 3.1.3.16) (EC 3.1.3.48) (Dual specificity phosphatase T-DSP4) (Dual specificity phosphatase VH1) Mus musculus (Mouse) GO:0004721; GO:0004722; GO:0004725; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0008138; GO:0008270; GO:0016791; GO:0019900 cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] kinase binding [GO:0019900]; phosphatase activity [GO:0016791]; phosphoprotein phosphatase activity [GO:0004721]; protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; zinc ion binding [GO:0008270] g23552.t1 Q8NHH1 42.083 240 3.72e-49 183.0 sp|Q8NHH1|TTL11_HUMAN Tubulin polyglutamylase TTLL11 OS=Homo sapiens OX=9606 GN=TTLL11 PE=1 SV=3 g23552.t1 Q8NHH1 49.451 91 1.2e-30 95.1 sp|Q8NHH1|TTL11_HUMAN Tubulin polyglutamylase TTLL11 OS=Homo sapiens OX=9606 GN=TTLL11 PE=1 SV=3 g23552.t1 Q8NHH1 44.444 81 1.2e-30 61.2 sp|Q8NHH1|TTL11_HUMAN Tubulin polyglutamylase TTLL11 OS=Homo sapiens OX=9606 GN=TTLL11 PE=1 SV=3 g23554.t1 Q8CHT3 37.538 333 7.28e-56 201.0 sp|Q8CHT3|INT5_MOUSE Integrator complex subunit 5 OS=Mus musculus OX=10090 GN=Ints5 PE=2 SV=1 g23555.t1 Q8CHT3 41.652 581 7.43e-123 389.0 sp|Q8CHT3|INT5_MOUSE Integrator complex subunit 5 OS=Mus musculus OX=10090 GN=Ints5 PE=2 SV=1 g23558.t1 P41367 76.804 388 0.0 643.0 sp|P41367|ACADM_PIG Medium-chain specific acyl-CoA dehydrogenase, mitochondrial OS=Sus scrofa OX=9823 GN=ACADM PE=1 SV=3 g23559.t1 Q9BYN0 68.224 107 5.530000000000001e-47 152.0 sp|Q9BYN0|SRXN1_HUMAN Sulfiredoxin-1 OS=Homo sapiens OX=9606 GN=SRXN1 PE=1 SV=2 SRXN1_HUMAN reviewed Sulfiredoxin-1 (EC 1.8.98.2) Homo sapiens (Human) GO:0005524; GO:0005737; GO:0005789; GO:0005829; GO:0006979; GO:0016667; GO:0032542; GO:0034599 cellular response to oxidative stress [GO:0034599]; response to oxidative stress [GO:0006979] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789] ATP binding [GO:0005524]; oxidoreductase activity, acting on a sulfur group of donors [GO:0016667]; sulfiredoxin activity [GO:0032542] g23560.t1 Q62381 27.292 469 2.5500000000000002e-26 121.0 sp|Q62381|TLL1_MOUSE Tolloid-like protein 1 OS=Mus musculus OX=10090 GN=Tll1 PE=1 SV=1 TLL1_MOUSE reviewed Tolloid-like protein 1 (mTll) (EC 3.4.24.-) Mus musculus (Mouse) GO:0004222; GO:0005509; GO:0005518; GO:0005615; GO:0008270; GO:0009953; GO:0016485; GO:0030154 cell differentiation [GO:0030154]; dorsal/ventral pattern formation [GO:0009953]; protein processing [GO:0016485] extracellular space [GO:0005615] calcium ion binding [GO:0005509]; collagen binding [GO:0005518]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270] g23561.t1 Q9P2N4 29.757 699 6.28e-66 252.0 sp|Q9P2N4|ATS9_HUMAN A disintegrin and metalloproteinase with thrombospondin motifs 9 OS=Homo sapiens OX=9606 GN=ADAMTS9 PE=1 SV=4 ATS9_HUMAN reviewed A disintegrin and metalloproteinase with thrombospondin motifs 9 (ADAM-TS 9) (ADAM-TS9) (ADAMTS-9) (EC 3.4.24.-) Homo sapiens (Human) GO:0002088; GO:0003179; GO:0003229; GO:0004222; GO:0005615; GO:0005783; GO:0006508; GO:0008237; GO:0008270; GO:0009617; GO:0009986; GO:0010596; GO:0015031; GO:0016192; GO:0030198; GO:0030318; GO:0031012; GO:0035909; GO:0045636; GO:0048593; GO:0061303; GO:0090673; GO:1903671 aorta morphogenesis [GO:0035909]; camera-type eye morphogenesis [GO:0048593]; cornea development in camera-type eye [GO:0061303]; endothelial cell-matrix adhesion [GO:0090673]; extracellular matrix organization [GO:0030198]; heart valve morphogenesis [GO:0003179]; lens development in camera-type eye [GO:0002088]; melanocyte differentiation [GO:0030318]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of sprouting angiogenesis [GO:1903671]; positive regulation of melanocyte differentiation [GO:0045636]; protein transport [GO:0015031]; proteolysis [GO:0006508]; response to bacterium [GO:0009617]; ventricular cardiac muscle tissue development [GO:0003229]; vesicle-mediated transport [GO:0016192] cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615] metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; zinc ion binding [GO:0008270] g23561.t1 Q9P2N4 24.457 875 1.3999999999999999e-45 185.0 sp|Q9P2N4|ATS9_HUMAN A disintegrin and metalloproteinase with thrombospondin motifs 9 OS=Homo sapiens OX=9606 GN=ADAMTS9 PE=1 SV=4 ATS9_HUMAN reviewed A disintegrin and metalloproteinase with thrombospondin motifs 9 (ADAM-TS 9) (ADAM-TS9) (ADAMTS-9) (EC 3.4.24.-) Homo sapiens (Human) GO:0002088; GO:0003179; GO:0003229; GO:0004222; GO:0005615; GO:0005783; GO:0006508; GO:0008237; GO:0008270; GO:0009617; GO:0009986; GO:0010596; GO:0015031; GO:0016192; GO:0030198; GO:0030318; GO:0031012; GO:0035909; GO:0045636; GO:0048593; GO:0061303; GO:0090673; GO:1903671 aorta morphogenesis [GO:0035909]; camera-type eye morphogenesis [GO:0048593]; cornea development in camera-type eye [GO:0061303]; endothelial cell-matrix adhesion [GO:0090673]; extracellular matrix organization [GO:0030198]; heart valve morphogenesis [GO:0003179]; lens development in camera-type eye [GO:0002088]; melanocyte differentiation [GO:0030318]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of sprouting angiogenesis [GO:1903671]; positive regulation of melanocyte differentiation [GO:0045636]; protein transport [GO:0015031]; proteolysis [GO:0006508]; response to bacterium [GO:0009617]; ventricular cardiac muscle tissue development [GO:0003229]; vesicle-mediated transport [GO:0016192] cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615] metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; zinc ion binding [GO:0008270] g23561.t1 Q9P2N4 27.017 533 8.33e-39 163.0 sp|Q9P2N4|ATS9_HUMAN A disintegrin and metalloproteinase with thrombospondin motifs 9 OS=Homo sapiens OX=9606 GN=ADAMTS9 PE=1 SV=4 ATS9_HUMAN reviewed A disintegrin and metalloproteinase with thrombospondin motifs 9 (ADAM-TS 9) (ADAM-TS9) (ADAMTS-9) (EC 3.4.24.-) Homo sapiens (Human) GO:0002088; GO:0003179; GO:0003229; GO:0004222; GO:0005615; GO:0005783; GO:0006508; GO:0008237; GO:0008270; GO:0009617; GO:0009986; GO:0010596; GO:0015031; GO:0016192; GO:0030198; GO:0030318; GO:0031012; GO:0035909; GO:0045636; GO:0048593; GO:0061303; GO:0090673; GO:1903671 aorta morphogenesis [GO:0035909]; camera-type eye morphogenesis [GO:0048593]; cornea development in camera-type eye [GO:0061303]; endothelial cell-matrix adhesion [GO:0090673]; extracellular matrix organization [GO:0030198]; heart valve morphogenesis [GO:0003179]; lens development in camera-type eye [GO:0002088]; melanocyte differentiation [GO:0030318]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of sprouting angiogenesis [GO:1903671]; positive regulation of melanocyte differentiation [GO:0045636]; protein transport [GO:0015031]; proteolysis [GO:0006508]; response to bacterium [GO:0009617]; ventricular cardiac muscle tissue development [GO:0003229]; vesicle-mediated transport [GO:0016192] cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615] metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; zinc ion binding [GO:0008270] g23561.t1 Q9P2N4 26.884 491 1e-36 156.0 sp|Q9P2N4|ATS9_HUMAN A disintegrin and metalloproteinase with thrombospondin motifs 9 OS=Homo sapiens OX=9606 GN=ADAMTS9 PE=1 SV=4 ATS9_HUMAN reviewed A disintegrin and metalloproteinase with thrombospondin motifs 9 (ADAM-TS 9) (ADAM-TS9) (ADAMTS-9) (EC 3.4.24.-) Homo sapiens (Human) GO:0002088; GO:0003179; GO:0003229; GO:0004222; GO:0005615; GO:0005783; GO:0006508; GO:0008237; GO:0008270; GO:0009617; GO:0009986; GO:0010596; GO:0015031; GO:0016192; GO:0030198; GO:0030318; GO:0031012; GO:0035909; GO:0045636; GO:0048593; GO:0061303; GO:0090673; GO:1903671 aorta morphogenesis [GO:0035909]; camera-type eye morphogenesis [GO:0048593]; cornea development in camera-type eye [GO:0061303]; endothelial cell-matrix adhesion [GO:0090673]; extracellular matrix organization [GO:0030198]; heart valve morphogenesis [GO:0003179]; lens development in camera-type eye [GO:0002088]; melanocyte differentiation [GO:0030318]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of sprouting angiogenesis [GO:1903671]; positive regulation of melanocyte differentiation [GO:0045636]; protein transport [GO:0015031]; proteolysis [GO:0006508]; response to bacterium [GO:0009617]; ventricular cardiac muscle tissue development [GO:0003229]; vesicle-mediated transport [GO:0016192] cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615] metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; zinc ion binding [GO:0008270] g23561.t1 Q9P2N4 25.503 596 1.8600000000000002e-31 139.0 sp|Q9P2N4|ATS9_HUMAN A disintegrin and metalloproteinase with thrombospondin motifs 9 OS=Homo sapiens OX=9606 GN=ADAMTS9 PE=1 SV=4 ATS9_HUMAN reviewed A disintegrin and metalloproteinase with thrombospondin motifs 9 (ADAM-TS 9) (ADAM-TS9) (ADAMTS-9) (EC 3.4.24.-) Homo sapiens (Human) GO:0002088; GO:0003179; GO:0003229; GO:0004222; GO:0005615; GO:0005783; GO:0006508; GO:0008237; GO:0008270; GO:0009617; GO:0009986; GO:0010596; GO:0015031; GO:0016192; GO:0030198; GO:0030318; GO:0031012; GO:0035909; GO:0045636; GO:0048593; GO:0061303; GO:0090673; GO:1903671 aorta morphogenesis [GO:0035909]; camera-type eye morphogenesis [GO:0048593]; cornea development in camera-type eye [GO:0061303]; endothelial cell-matrix adhesion [GO:0090673]; extracellular matrix organization [GO:0030198]; heart valve morphogenesis [GO:0003179]; lens development in camera-type eye [GO:0002088]; melanocyte differentiation [GO:0030318]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of sprouting angiogenesis [GO:1903671]; positive regulation of melanocyte differentiation [GO:0045636]; protein transport [GO:0015031]; proteolysis [GO:0006508]; response to bacterium [GO:0009617]; ventricular cardiac muscle tissue development [GO:0003229]; vesicle-mediated transport [GO:0016192] cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615] metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; zinc ion binding [GO:0008270] g23561.t1 Q9P2N4 30.547 311 1.65e-24 116.0 sp|Q9P2N4|ATS9_HUMAN A disintegrin and metalloproteinase with thrombospondin motifs 9 OS=Homo sapiens OX=9606 GN=ADAMTS9 PE=1 SV=4 ATS9_HUMAN reviewed A disintegrin and metalloproteinase with thrombospondin motifs 9 (ADAM-TS 9) (ADAM-TS9) (ADAMTS-9) (EC 3.4.24.-) Homo sapiens (Human) GO:0002088; GO:0003179; GO:0003229; GO:0004222; GO:0005615; GO:0005783; GO:0006508; GO:0008237; GO:0008270; GO:0009617; GO:0009986; GO:0010596; GO:0015031; GO:0016192; GO:0030198; GO:0030318; GO:0031012; GO:0035909; GO:0045636; GO:0048593; GO:0061303; GO:0090673; GO:1903671 aorta morphogenesis [GO:0035909]; camera-type eye morphogenesis [GO:0048593]; cornea development in camera-type eye [GO:0061303]; endothelial cell-matrix adhesion [GO:0090673]; extracellular matrix organization [GO:0030198]; heart valve morphogenesis [GO:0003179]; lens development in camera-type eye [GO:0002088]; melanocyte differentiation [GO:0030318]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of sprouting angiogenesis [GO:1903671]; positive regulation of melanocyte differentiation [GO:0045636]; protein transport [GO:0015031]; proteolysis [GO:0006508]; response to bacterium [GO:0009617]; ventricular cardiac muscle tissue development [GO:0003229]; vesicle-mediated transport [GO:0016192] cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615] metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; zinc ion binding [GO:0008270] g23562.t1 Q921Y2 62.57 179 2.41e-86 254.0 sp|Q921Y2|IMP3_MOUSE U3 small nucleolar ribonucleoprotein protein IMP3 OS=Mus musculus OX=10090 GN=Imp3 PE=2 SV=1 g23564.t1 Q9EPT5 32.23 453 2.77e-54 196.0 sp|Q9EPT5|SO2A1_MOUSE Solute carrier organic anion transporter family member 2A1 OS=Mus musculus OX=10090 GN=Slco2a1 PE=1 SV=2 SO2A1_MOUSE reviewed Solute carrier organic anion transporter family member 2A1 (SLCO2A1) (OATP2A1) (PHOAR2) (Prostaglandin transporter) (PGT) (Solute carrier family 21 member 2) (SLC21A2) Mus musculus (Mouse) GO:0005764; GO:0005886; GO:0009925; GO:0015132; GO:0015347; GO:0015732; GO:0016323; GO:0043252 prostaglandin transport [GO:0015732]; sodium-independent organic anion transport [GO:0043252] basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; lysosome [GO:0005764]; plasma membrane [GO:0005886] prostaglandin transmembrane transporter activity [GO:0015132]; sodium-independent organic anion transmembrane transporter activity [GO:0015347] g23565.t1 Q9R0Y5 65.957 188 9.94e-82 264.0 sp|Q9R0Y5|KAD1_MOUSE Adenylate kinase isoenzyme 1 OS=Mus musculus OX=10090 GN=Ak1 PE=1 SV=1 KAD1_MOUSE reviewed Adenylate kinase isoenzyme 1 (AK 1) (EC 2.7.4.3) (EC 2.7.4.4) (EC 2.7.4.6) (ATP-AMP transphosphorylase 1) (ATP:AMP phosphotransferase) (Adenylate monophosphate kinase) (Myokinase) Mus musculus (Mouse) GO:0001520; GO:0004017; GO:0004550; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0006172; GO:0009142; GO:0010828; GO:0030017; GO:0036126; GO:0046033; GO:0046034; GO:0046103; GO:0047506; GO:0048471; GO:2000045 ADP biosynthetic process [GO:0006172]; AMP metabolic process [GO:0046033]; ATP metabolic process [GO:0046034]; inosine biosynthetic process [GO:0046103]; nucleoside triphosphate biosynthetic process [GO:0009142]; positive regulation of D-glucose transmembrane transport [GO:0010828]; regulation of G1/S transition of mitotic cell cycle [GO:2000045] cytoplasm [GO:0005737]; cytosol [GO:0005829]; outer dense fiber [GO:0001520]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; sarcomere [GO:0030017]; sperm flagellum [GO:0036126] AMP kinase activity [GO:0004017]; ATP binding [GO:0005524]; dAMP kinase activity [GO:0047506]; nucleoside diphosphate kinase activity [GO:0004550] g23565.t1 Q9R0Y5 34.211 190 1.35e-31 125.0 sp|Q9R0Y5|KAD1_MOUSE Adenylate kinase isoenzyme 1 OS=Mus musculus OX=10090 GN=Ak1 PE=1 SV=1 KAD1_MOUSE reviewed Adenylate kinase isoenzyme 1 (AK 1) (EC 2.7.4.3) (EC 2.7.4.4) (EC 2.7.4.6) (ATP-AMP transphosphorylase 1) (ATP:AMP phosphotransferase) (Adenylate monophosphate kinase) (Myokinase) Mus musculus (Mouse) GO:0001520; GO:0004017; GO:0004550; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0006172; GO:0009142; GO:0010828; GO:0030017; GO:0036126; GO:0046033; GO:0046034; GO:0046103; GO:0047506; GO:0048471; GO:2000045 ADP biosynthetic process [GO:0006172]; AMP metabolic process [GO:0046033]; ATP metabolic process [GO:0046034]; inosine biosynthetic process [GO:0046103]; nucleoside triphosphate biosynthetic process [GO:0009142]; positive regulation of D-glucose transmembrane transport [GO:0010828]; regulation of G1/S transition of mitotic cell cycle [GO:2000045] cytoplasm [GO:0005737]; cytosol [GO:0005829]; outer dense fiber [GO:0001520]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; sarcomere [GO:0030017]; sperm flagellum [GO:0036126] AMP kinase activity [GO:0004017]; ATP binding [GO:0005524]; dAMP kinase activity [GO:0047506]; nucleoside diphosphate kinase activity [GO:0004550] g23565.t1 Q9R0Y5 34.146 164 2.76e-25 107.0 sp|Q9R0Y5|KAD1_MOUSE Adenylate kinase isoenzyme 1 OS=Mus musculus OX=10090 GN=Ak1 PE=1 SV=1 KAD1_MOUSE reviewed Adenylate kinase isoenzyme 1 (AK 1) (EC 2.7.4.3) (EC 2.7.4.4) (EC 2.7.4.6) (ATP-AMP transphosphorylase 1) (ATP:AMP phosphotransferase) (Adenylate monophosphate kinase) (Myokinase) Mus musculus (Mouse) GO:0001520; GO:0004017; GO:0004550; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0006172; GO:0009142; GO:0010828; GO:0030017; GO:0036126; GO:0046033; GO:0046034; GO:0046103; GO:0047506; GO:0048471; GO:2000045 ADP biosynthetic process [GO:0006172]; AMP metabolic process [GO:0046033]; ATP metabolic process [GO:0046034]; inosine biosynthetic process [GO:0046103]; nucleoside triphosphate biosynthetic process [GO:0009142]; positive regulation of D-glucose transmembrane transport [GO:0010828]; regulation of G1/S transition of mitotic cell cycle [GO:2000045] cytoplasm [GO:0005737]; cytosol [GO:0005829]; outer dense fiber [GO:0001520]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; sarcomere [GO:0030017]; sperm flagellum [GO:0036126] AMP kinase activity [GO:0004017]; ATP binding [GO:0005524]; dAMP kinase activity [GO:0047506]; nucleoside diphosphate kinase activity [GO:0004550] g23567.t1 Q5TJG6 76.761 142 5.74e-69 253.0 sp|Q5TJG6|BRD2_CANLF Bromodomain-containing protein 2 OS=Canis lupus familiaris OX=9615 GN=BRD2 PE=3 SV=1 g23567.t1 Q5TJG6 68.702 131 1.12e-51 200.0 sp|Q5TJG6|BRD2_CANLF Bromodomain-containing protein 2 OS=Canis lupus familiaris OX=9615 GN=BRD2 PE=3 SV=1 g23567.t1 Q5TJG6 80.992 121 1.45e-44 178.0 sp|Q5TJG6|BRD2_CANLF Bromodomain-containing protein 2 OS=Canis lupus familiaris OX=9615 GN=BRD2 PE=3 SV=1 g23567.t1 Q5TJG6 48.696 115 2.6e-25 117.0 sp|Q5TJG6|BRD2_CANLF Bromodomain-containing protein 2 OS=Canis lupus familiaris OX=9615 GN=BRD2 PE=3 SV=1 g23567.t1 Q5TJG6 43.966 116 4.1899999999999995e-23 110.0 sp|Q5TJG6|BRD2_CANLF Bromodomain-containing protein 2 OS=Canis lupus familiaris OX=9615 GN=BRD2 PE=3 SV=1 g23567.t2 Q5TJG6 76.761 142 5.73e-69 253.0 sp|Q5TJG6|BRD2_CANLF Bromodomain-containing protein 2 OS=Canis lupus familiaris OX=9615 GN=BRD2 PE=3 SV=1 g23567.t2 Q5TJG6 68.702 131 1.09e-51 200.0 sp|Q5TJG6|BRD2_CANLF Bromodomain-containing protein 2 OS=Canis lupus familiaris OX=9615 GN=BRD2 PE=3 SV=1 g23567.t2 Q5TJG6 80.992 121 1.38e-44 178.0 sp|Q5TJG6|BRD2_CANLF Bromodomain-containing protein 2 OS=Canis lupus familiaris OX=9615 GN=BRD2 PE=3 SV=1 g23567.t2 Q5TJG6 48.696 115 2.49e-25 117.0 sp|Q5TJG6|BRD2_CANLF Bromodomain-containing protein 2 OS=Canis lupus familiaris OX=9615 GN=BRD2 PE=3 SV=1 g23567.t2 Q5TJG6 43.966 116 4.1799999999999995e-23 110.0 sp|Q5TJG6|BRD2_CANLF Bromodomain-containing protein 2 OS=Canis lupus familiaris OX=9615 GN=BRD2 PE=3 SV=1 g23568.t1 Q8R3D1 51.515 396 1.53e-139 406.0 sp|Q8R3D1|TBC13_MOUSE TBC1 domain family member 13 OS=Mus musculus OX=10090 GN=Tbc1d13 PE=1 SV=1 g23571.t1 A2AWA9 59.219 461 2.1200000000000003e-167 520.0 sp|A2AWA9|RBGP1_MOUSE Rab GTPase-activating protein 1 OS=Mus musculus OX=10090 GN=Rabgap1 PE=1 SV=1 RBGP1_MOUSE reviewed Rab GTPase-activating protein 1 (GAP and centrosome-associated protein) (Rab6 GTPase-activating protein GAPCenA) Mus musculus (Mouse) GO:0005096; GO:0005813; GO:0005829; GO:0031267 centrosome [GO:0005813]; cytosol [GO:0005829] GTPase activator activity [GO:0005096]; small GTPase binding [GO:0031267] g23571.t1 A2AWA9 42.157 408 2.7300000000000002e-73 265.0 sp|A2AWA9|RBGP1_MOUSE Rab GTPase-activating protein 1 OS=Mus musculus OX=10090 GN=Rabgap1 PE=1 SV=1 RBGP1_MOUSE reviewed Rab GTPase-activating protein 1 (GAP and centrosome-associated protein) (Rab6 GTPase-activating protein GAPCenA) Mus musculus (Mouse) GO:0005096; GO:0005813; GO:0005829; GO:0031267 centrosome [GO:0005813]; cytosol [GO:0005829] GTPase activator activity [GO:0005096]; small GTPase binding [GO:0031267] g23574.t1 Q5ZJA4 48.288 584 9.61e-169 496.0 sp|Q5ZJA4|ARP5_CHICK Actin-related protein 5 OS=Gallus gallus OX=9031 GN=ACTR5 PE=2 SV=1 g23575.t1 B1H116 65.441 272 1.9100000000000003e-124 358.0 sp|B1H116|UCK2_XENTR Uridine-cytidine kinase 2 OS=Xenopus tropicalis OX=8364 GN=uck2 PE=2 SV=1 g23577.t1 Q5RE52 40.393 458 1.3500000000000001e-99 318.0 sp|Q5RE52|APC5_PONAB Anaphase-promoting complex subunit 5 OS=Pongo abelii OX=9601 GN=ANAPC5 PE=2 SV=1 APC5_PONAB reviewed Anaphase-promoting complex subunit 5 (APC5) (Cyclosome subunit 5) Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0005634; GO:0005680; GO:0005819; GO:0019903; GO:0031145; GO:0045842; GO:0051301; GO:0070936; GO:0070979; GO:0141198 anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell division [GO:0051301]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; protein branched polyubiquitination [GO:0141198]; protein K11-linked ubiquitination [GO:0070979]; protein K48-linked ubiquitination [GO:0070936] anaphase-promoting complex [GO:0005680]; nucleus [GO:0005634]; spindle [GO:0005819] protein phosphatase binding [GO:0019903] g23578.t1 P15104 67.039 358 0.0 541.0 sp|P15104|GLNA_HUMAN Glutamine synthetase OS=Homo sapiens OX=9606 GN=GLUL PE=1 SV=4 GLNA_HUMAN reviewed Glutamine synthetase (GS) (EC 6.3.1.2) (Glutamate--ammonia ligase) (Palmitoyltransferase GLUL) (EC 2.3.1.225) Homo sapiens (Human) GO:0001525; GO:0004356; GO:0005524; GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0005886; GO:0006538; GO:0006542; GO:0008283; GO:0009267; GO:0009749; GO:0010594; GO:0018345; GO:0019706; GO:0042254; GO:0042802; GO:0044297; GO:0045648; GO:0046872; GO:0070062; GO:0097275; GO:0097386; GO:1903670; GO:1904749 angiogenesis [GO:0001525]; cell population proliferation [GO:0008283]; cellular response to starvation [GO:0009267]; glutamine biosynthetic process [GO:0006542]; intracellular ammonium homeostasis [GO:0097275]; L-glutamate catabolic process [GO:0006538]; positive regulation of erythrocyte differentiation [GO:0045648]; protein palmitoylation [GO:0018345]; regulation of endothelial cell migration [GO:0010594]; regulation of protein localization to nucleolus [GO:1904749]; regulation of sprouting angiogenesis [GO:1903670]; response to glucose [GO:0009749]; ribosome biogenesis [GO:0042254] cell body [GO:0044297]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; glial cell projection [GO:0097386]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886] ATP binding [GO:0005524]; glutamine synthetase activity [GO:0004356]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein-cysteine S-palmitoyltransferase activity [GO:0019706] g23579.t1 P57771 55.285 123 2.9e-40 147.0 sp|P57771|RGS8_HUMAN Regulator of G-protein signaling 8 OS=Homo sapiens OX=9606 GN=RGS8 PE=1 SV=1 RGS8_HUMAN reviewed Regulator of G-protein signaling 8 (RGS8) Homo sapiens (Human) GO:0003924; GO:0005096; GO:0005634; GO:0005886; GO:0007186; GO:0007213; GO:0009898; GO:0009968; GO:0030425; GO:0032809; GO:0043204; GO:0043547; GO:0045202; GO:0060159 G protein-coupled acetylcholine receptor signaling pathway [GO:0007213]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of signal transduction [GO:0009968]; positive regulation of GTPase activity [GO:0043547]; regulation of dopamine receptor signaling pathway [GO:0060159] cytoplasmic side of plasma membrane [GO:0009898]; dendrite [GO:0030425]; neuronal cell body membrane [GO:0032809]; nucleus [GO:0005634]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; synapse [GO:0045202] GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924] g23585.t1 Q27746 70.588 493 0.0 734.0 sp|Q27746|DNMT1_PARLI DNA (cytosine-5)-methyltransferase PliMCI OS=Paracentrotus lividus OX=7656 GN=DNMT PE=2 SV=1 DNMT1_PARLI reviewed DNA (cytosine-5)-methyltransferase PliMCI (EC 2.1.1.37) (DNA methyltransferase PliMCI) (DNA MTase PliMCI) (M.PliMCI) (Dnmt1) (MCMT) Paracentrotus lividus (Common sea urchin) GO:0000792; GO:0003677; GO:0003682; GO:0003886; GO:0005634; GO:0006346; GO:0008270; GO:0032259; GO:0044027; GO:0140254; GO:0140258; GO:0141119 chromosomal DNA methylation maintenance following DNA replication [GO:0141119]; DNA methylation-dependent constitutive heterochromatin formation [GO:0006346]; methylation [GO:0032259]; negative regulation of gene expression via chromosomal CpG island methylation [GO:0044027] heterochromatin [GO:0000792]; nucleus [GO:0005634] chromatin binding [GO:0003682]; DNA (cytosine-5-)-methyltransferase activity [GO:0003886]; DNA binding [GO:0003677]; histone H3K14ub reader activity [GO:0140258]; histone H3K18ub reader activity [GO:0140254]; zinc ion binding [GO:0008270] g23586.t1 Q9NSG2 30.814 860 3.08e-119 385.0 sp|Q9NSG2|FIRRM_HUMAN FIGNL1-interacting regulator of recombination and mitosis OS=Homo sapiens OX=9606 GN=FIRRM PE=1 SV=1 g23587.t1 P62287 30.344 1048 2.53e-106 369.0 sp|P62287|ASPM_COLGU Abnormal spindle-like microcephaly-associated protein homolog OS=Colobus guereza OX=33548 GN=ASPM PE=3 SV=1 g23587.t1 P62287 25.618 769 1.23e-38 161.0 sp|P62287|ASPM_COLGU Abnormal spindle-like microcephaly-associated protein homolog OS=Colobus guereza OX=33548 GN=ASPM PE=3 SV=1 g23587.t1 P62287 25.119 840 8.12e-38 158.0 sp|P62287|ASPM_COLGU Abnormal spindle-like microcephaly-associated protein homolog OS=Colobus guereza OX=33548 GN=ASPM PE=3 SV=1 g23587.t1 P62287 28.222 613 1.47e-34 148.0 sp|P62287|ASPM_COLGU Abnormal spindle-like microcephaly-associated protein homolog OS=Colobus guereza OX=33548 GN=ASPM PE=3 SV=1 g23587.t1 P62287 25.401 811 1.15e-32 142.0 sp|P62287|ASPM_COLGU Abnormal spindle-like microcephaly-associated protein homolog OS=Colobus guereza OX=33548 GN=ASPM PE=3 SV=1 g23587.t1 P62287 25.776 838 7.54e-32 139.0 sp|P62287|ASPM_COLGU Abnormal spindle-like microcephaly-associated protein homolog OS=Colobus guereza OX=33548 GN=ASPM PE=3 SV=1 g23587.t1 P62287 26.123 601 3.78e-27 124.0 sp|P62287|ASPM_COLGU Abnormal spindle-like microcephaly-associated protein homolog OS=Colobus guereza OX=33548 GN=ASPM PE=3 SV=1 g23587.t1 P62287 27.332 611 6.63e-24 113.0 sp|P62287|ASPM_COLGU Abnormal spindle-like microcephaly-associated protein homolog OS=Colobus guereza OX=33548 GN=ASPM PE=3 SV=1 g23590.t1 P53792 69.565 69 4.91e-28 107.0 sp|P53792|SC5A2_RAT Sodium/glucose cotransporter 2 OS=Rattus norvegicus OX=10116 GN=Slc5a2 PE=1 SV=1 g23591.t1 Q8R415 46.099 141 7.360000000000001e-32 120.0 sp|Q8R415|PKR2_RAT Prokineticin receptor 2 OS=Rattus norvegicus OX=10116 GN=Prokr2 PE=2 SV=2 PKR2_RAT reviewed Prokineticin receptor 2 (PK-R2) (G-protein coupled receptor 73-like 1) (G-protein coupled receptor I5E) Rattus norvegicus (Rat) GO:0004930; GO:0004983; GO:0005886; GO:0007186; GO:0007623; GO:0032870 cellular response to hormone stimulus [GO:0032870]; circadian rhythm [GO:0007623]; G protein-coupled receptor signaling pathway [GO:0007186] plasma membrane [GO:0005886] G protein-coupled receptor activity [GO:0004930]; neuropeptide Y receptor activity [GO:0004983] g23592.t1 Q9DBQ9 31.222 221 5.21e-26 111.0 sp|Q9DBQ9|SWT1_MOUSE Transcriptional protein SWT1 OS=Mus musculus OX=10090 GN=Swt1 PE=2 SV=3 g23593.t1 Q9DBQ9 30.565 301 1.19e-24 114.0 sp|Q9DBQ9|SWT1_MOUSE Transcriptional protein SWT1 OS=Mus musculus OX=10090 GN=Swt1 PE=2 SV=3 g23593.t1 Q9DBQ9 30.942 223 1.72e-22 107.0 sp|Q9DBQ9|SWT1_MOUSE Transcriptional protein SWT1 OS=Mus musculus OX=10090 GN=Swt1 PE=2 SV=3 g23595.t1 Q5T280 65.217 69 2.08e-22 91.3 sp|Q5T280|SPOUT_HUMAN 28S rRNA (uridine-N(3))-methyltransferase OS=Homo sapiens OX=9606 GN=SPOUT1 PE=1 SV=3 SPOUT_HUMAN reviewed 28S rRNA (uridine-N(3))-methyltransferase (EC 2.1.1.-) (Centromere protein 32) (CENP-32) (Kinetochore-associated protein) (Methyltransferase C9orf114) (Ribosomal RNA methyltransferase SPOUT1) (SPOUT domain-containing methyltransferase 1) Homo sapiens (Human) GO:0000776; GO:0003723; GO:0008168; GO:0008173; GO:0010608; GO:0031616; GO:0035196; GO:0035198; GO:0051301; GO:0051661; GO:0070042; GO:0070475; GO:0072686; GO:1904047 cell division [GO:0051301]; maintenance of centrosome location [GO:0051661]; miRNA processing [GO:0035196]; post-transcriptional regulation of gene expression [GO:0010608]; rRNA base methylation [GO:0070475] kinetochore [GO:0000776]; mitotic spindle [GO:0072686]; spindle pole centrosome [GO:0031616] methyltransferase activity [GO:0008168]; miRNA binding [GO:0035198]; RNA binding [GO:0003723]; RNA methyltransferase activity [GO:0008173]; rRNA (uridine-N3-)-methyltransferase activity [GO:0070042]; S-adenosyl-L-methionine binding [GO:1904047] g23596.t1 Q2UVX4 29.824 1700 0.0 592.0 sp|Q2UVX4|CO3_BOVIN Complement C3 OS=Bos taurus OX=9913 GN=C3 PE=1 SV=2 CO3_BOVIN reviewed Complement C3 [Cleaved into: Complement C3 beta chain; Complement C3 alpha chain; C3a anaphylatoxin; C3-beta-c (C3bc); Acylation stimulating protein (ASP) (C3adesArg); Complement C3b (Complement C3b-alpha' chain); Complement C3c alpha' chain fragment 1; Complement C3dg fragment; Complement C3g fragment; Complement C3d fragment; Complement C3f fragment; Complement C3c alpha' chain fragment 2] Bos taurus (Bovine) GO:0001798; GO:0001867; GO:0001934; GO:0001970; GO:0002430; GO:0003823; GO:0004866; GO:0005601; GO:0005615; GO:0006631; GO:0006954; GO:0006956; GO:0006957; GO:0006958; GO:0008228; GO:0009617; GO:0009986; GO:0010575; GO:0010828; GO:0010866; GO:0010884; GO:0016322; GO:0031715; GO:0035846; GO:0042113; GO:0045745; GO:0045766; GO:0048018; GO:0048260; GO:0060100; GO:0097242; GO:0097278; GO:0106139; GO:0150062; GO:0150064; GO:0160257; GO:2000427 amyloid-beta clearance [GO:0097242]; B cell activation [GO:0042113]; complement activation [GO:0006956]; complement activation, alternative pathway [GO:0006957]; complement activation, classical pathway [GO:0006958]; complement activation, GZMK pathway [GO:0160257]; complement activation, lectin pathway [GO:0001867]; complement receptor mediated signaling pathway [GO:0002430]; complement-dependent cytotoxicity [GO:0097278]; complement-mediated synapse pruning [GO:0150062]; fatty acid metabolic process [GO:0006631]; inflammatory response [GO:0006954]; neuron remodeling [GO:0016322]; opsonization [GO:0008228]; oviduct epithelium development [GO:0035846]; positive regulation of activation of membrane attack complex [GO:0001970]; positive regulation of angiogenesis [GO:0045766]; positive regulation of apoptotic cell clearance [GO:2000427]; positive regulation of D-glucose transmembrane transport [GO:0010828]; positive regulation of G protein-coupled receptor signaling pathway [GO:0045745]; positive regulation of lipid storage [GO:0010884]; positive regulation of phagocytosis, engulfment [GO:0060100]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of receptor-mediated endocytosis [GO:0048260]; positive regulation of type IIa hypersensitivity [GO:0001798]; positive regulation of vascular endothelial growth factor production [GO:0010575]; regulation of triglyceride biosynthetic process [GO:0010866]; response to bacterium [GO:0009617]; vertebrate eye-specific patterning [GO:0150064] cell surface [GO:0009986]; classical-complement-pathway C3/C5 convertase complex [GO:0005601]; extracellular space [GO:0005615]; symbiont cell surface [GO:0106139] antigen binding [GO:0003823]; C5L2 anaphylatoxin chemotactic receptor binding [GO:0031715]; endopeptidase inhibitor activity [GO:0004866]; receptor ligand activity [GO:0048018] g23598.t1 Q3YEC7 60.938 320 9.72e-94 304.0 sp|Q3YEC7|RABL6_HUMAN Rab-like protein 6 OS=Homo sapiens OX=9606 GN=RABL6 PE=1 SV=2 RABL6_HUMAN reviewed Rab-like protein 6 (EC 3.6.5.2) (GTP-binding protein Parf) (Partner of ARF) (Rab-like protein 1) (RBEL1) Homo sapiens (Human) GO:0003925; GO:0005525; GO:0005634; GO:0005737; GO:0005813; GO:0005829; GO:0034451; GO:0036064 centriolar satellite [GO:0034451]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634] G protein activity [GO:0003925]; GTP binding [GO:0005525] g23603.t1 P48508 36.466 266 3.51e-55 182.0 sp|P48508|GSH0_RAT Glutamate--cysteine ligase regulatory subunit OS=Rattus norvegicus OX=10116 GN=Gclm PE=1 SV=1 g23604.t1 P26640 52.284 985 0.0 1053.0 sp|P26640|SYVC_HUMAN Valine--tRNA ligase OS=Homo sapiens OX=9606 GN=VARS1 PE=1 SV=4 SYVC_HUMAN reviewed Valine--tRNA ligase (EC 6.1.1.9) (Protein G7a) (Valyl-tRNA synthetase) (ValRS) Homo sapiens (Human) GO:0002161; GO:0004832; GO:0005524; GO:0005783; GO:0005829; GO:0006418; GO:0006438; GO:0097225; GO:0097228; GO:0097229 tRNA aminoacylation for protein translation [GO:0006418]; valyl-tRNA aminoacylation [GO:0006438] cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; sperm end piece [GO:0097229]; sperm midpiece [GO:0097225]; sperm principal piece [GO:0097228] aminoacyl-tRNA deacylase activity [GO:0002161]; ATP binding [GO:0005524]; valine-tRNA ligase activity [GO:0004832] g23605.t1 Q99941 36.722 482 1.19e-65 232.0 sp|Q99941|ATF6B_HUMAN Cyclic AMP-dependent transcription factor ATF-6 beta OS=Homo sapiens OX=9606 GN=ATF6B PE=1 SV=2 ATF6B_HUMAN reviewed Cyclic AMP-dependent transcription factor ATF-6 beta (cAMP-dependent transcription factor ATF-6 beta) (Activating transcription factor 6 beta) (ATF6-beta) (Protein G13) (cAMP response element-binding protein-related protein) (Creb-rp) (cAMP-responsive element-binding protein-like 1) [Cleaved into: Processed cyclic AMP-dependent transcription factor ATF-6 beta] Homo sapiens (Human) GO:0000139; GO:0000785; GO:0000976; GO:0000981; GO:0003700; GO:0005634; GO:0005654; GO:0005730; GO:0005789; GO:0005794; GO:0005829; GO:0006357; GO:0007165; GO:0030968; GO:0032993; GO:0034976; GO:0036500; GO:0045944; GO:0090575; GO:1903892; GO:1990837 ATF6-mediated unfolded protein response [GO:0036500]; endoplasmic reticulum unfolded protein response [GO:0030968]; negative regulation of ATF6-mediated unfolded protein response [GO:1903892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; response to endoplasmic reticulum stress [GO:0034976]; signal transduction [GO:0007165] chromatin [GO:0000785]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-DNA complex [GO:0032993]; RNA polymerase II transcription regulator complex [GO:0090575] DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976] g23606.t1 Q5ZIR1 57.025 363 6.02e-143 412.0 sp|Q5ZIR1|SHLB1_CHICK Endophilin-B1 OS=Gallus gallus OX=9031 GN=SH3GLB1 PE=2 SV=1 SHLB1_CHICK reviewed Endophilin-B1 (SH3 domain-containing GRB2-like protein B1) Gallus gallus (Chicken) GO:0000139; GO:0005741; GO:0006915; GO:0008289; GO:0016020; GO:0061024 apoptotic process [GO:0006915]; membrane organization [GO:0061024] Golgi membrane [GO:0000139]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741] lipid binding [GO:0008289] g23606.t2 Q5ZIR1 55.172 377 9.419999999999999e-140 405.0 sp|Q5ZIR1|SHLB1_CHICK Endophilin-B1 OS=Gallus gallus OX=9031 GN=SH3GLB1 PE=2 SV=1 SHLB1_CHICK reviewed Endophilin-B1 (SH3 domain-containing GRB2-like protein B1) Gallus gallus (Chicken) GO:0000139; GO:0005741; GO:0006915; GO:0008289; GO:0016020; GO:0061024 apoptotic process [GO:0006915]; membrane organization [GO:0061024] Golgi membrane [GO:0000139]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741] lipid binding [GO:0008289] g23610.t1 P49253 31.078 473 3.65e-74 248.0 sp|P49253|AOF_ONCMY Amine oxidase [flavin-containing] OS=Oncorhynchus mykiss OX=8022 GN=mao PE=2 SV=2 g23610.t2 P49253 31.078 473 3.2499999999999997e-74 248.0 sp|P49253|AOF_ONCMY Amine oxidase [flavin-containing] OS=Oncorhynchus mykiss OX=8022 GN=mao PE=2 SV=2 g23611.t1 Q8C1F5 39.871 464 1.83e-111 362.0 sp|Q8C1F5|TTC16_MOUSE Tetratricopeptide repeat protein 16 OS=Mus musculus OX=10090 GN=Ttc16 PE=2 SV=1 g23611.t2 Q8C1F5 39.871 464 1.46e-111 362.0 sp|Q8C1F5|TTC16_MOUSE Tetratricopeptide repeat protein 16 OS=Mus musculus OX=10090 GN=Ttc16 PE=2 SV=1 g23614.t1 P81076 48.872 133 1.7800000000000002e-35 122.0 sp|P81076|AIF1_PIG Allograft inflammatory factor 1 OS=Sus scrofa OX=9823 GN=AIF1 PE=1 SV=1 g23616.t1 Q16832 61.111 342 1.1300000000000001e-129 413.0 sp|Q16832|DDR2_HUMAN Discoidin domain-containing receptor 2 OS=Homo sapiens OX=9606 GN=DDR2 PE=1 SV=2 DDR2_HUMAN reviewed Discoidin domain-containing receptor 2 (Discoidin domain receptor 2) (EC 2.7.10.1) (CD167 antigen-like family member B) (Discoidin domain-containing receptor tyrosine kinase 2) (Neurotrophic tyrosine kinase, receptor-related 3) (Receptor protein-tyrosine kinase TKT) (Tyrosine-protein kinase TYRO10) (CD antigen CD167b) Homo sapiens (Human) GO:0001503; GO:0003416; GO:0004714; GO:0005518; GO:0005524; GO:0005886; GO:0005925; GO:0007155; GO:0007165; GO:0007169; GO:0010715; GO:0010763; GO:0010976; GO:0015629; GO:0016324; GO:0018108; GO:0030199; GO:0030500; GO:0031214; GO:0032967; GO:0034103; GO:0035988; GO:0035994; GO:0038062; GO:0038063; GO:0043066; GO:0043235; GO:0045669; GO:0045860; GO:0046777; GO:0048146; GO:0051091; GO:0051897; GO:0070374; GO:0071456; GO:0071560; GO:0090091; GO:0090303; GO:1900087; GO:1901299; GO:1904385; GO:1904707; GO:1904754; GO:1904899; GO:2000491 biomineral tissue development [GO:0031214]; cell adhesion [GO:0007155]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; cellular response to angiotensin [GO:1904385]; cellular response to hypoxia [GO:0071456]; cellular response to transforming growth factor beta stimulus [GO:0071560]; chondrocyte proliferation [GO:0035988]; collagen fibril organization [GO:0030199]; collagen-activated tyrosine kinase receptor signaling pathway [GO:0038063]; endochondral bone growth [GO:0003416]; negative regulation of apoptotic process [GO:0043066]; negative regulation of hydrogen peroxide-mediated programmed cell death [GO:1901299]; ossification [GO:0001503]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of collagen biosynthetic process [GO:0032967]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of extracellular matrix disassembly [GO:0090091]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of hepatic stellate cell activation [GO:2000491]; positive regulation of hepatic stellate cell proliferation [GO:1904899]; positive regulation of neuron projection development [GO:0010976]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of vascular associated smooth muscle cell migration [GO:1904754]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; positive regulation of wound healing [GO:0090303]; protein autophosphorylation [GO:0046777]; regulation of bone mineralization [GO:0030500]; regulation of extracellular matrix disassembly [GO:0010715]; regulation of tissue remodeling [GO:0034103]; response to muscle stretch [GO:0035994]; signal transduction [GO:0007165] actin cytoskeleton [GO:0015629]; apical plasma membrane [GO:0016324]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] ATP binding [GO:0005524]; collagen binding [GO:0005518]; protein tyrosine kinase collagen receptor activity [GO:0038062]; transmembrane receptor protein tyrosine kinase activity [GO:0004714] g23616.t1 Q16832 34.165 401 2.0099999999999997e-61 227.0 sp|Q16832|DDR2_HUMAN Discoidin domain-containing receptor 2 OS=Homo sapiens OX=9606 GN=DDR2 PE=1 SV=2 DDR2_HUMAN reviewed Discoidin domain-containing receptor 2 (Discoidin domain receptor 2) (EC 2.7.10.1) (CD167 antigen-like family member B) (Discoidin domain-containing receptor tyrosine kinase 2) (Neurotrophic tyrosine kinase, receptor-related 3) (Receptor protein-tyrosine kinase TKT) (Tyrosine-protein kinase TYRO10) (CD antigen CD167b) Homo sapiens (Human) GO:0001503; GO:0003416; GO:0004714; GO:0005518; GO:0005524; GO:0005886; GO:0005925; GO:0007155; GO:0007165; GO:0007169; GO:0010715; GO:0010763; GO:0010976; GO:0015629; GO:0016324; GO:0018108; GO:0030199; GO:0030500; GO:0031214; GO:0032967; GO:0034103; GO:0035988; GO:0035994; GO:0038062; GO:0038063; GO:0043066; GO:0043235; GO:0045669; GO:0045860; GO:0046777; GO:0048146; GO:0051091; GO:0051897; GO:0070374; GO:0071456; GO:0071560; GO:0090091; GO:0090303; GO:1900087; GO:1901299; GO:1904385; GO:1904707; GO:1904754; GO:1904899; GO:2000491 biomineral tissue development [GO:0031214]; cell adhesion [GO:0007155]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; cellular response to angiotensin [GO:1904385]; cellular response to hypoxia [GO:0071456]; cellular response to transforming growth factor beta stimulus [GO:0071560]; chondrocyte proliferation [GO:0035988]; collagen fibril organization [GO:0030199]; collagen-activated tyrosine kinase receptor signaling pathway [GO:0038063]; endochondral bone growth [GO:0003416]; negative regulation of apoptotic process [GO:0043066]; negative regulation of hydrogen peroxide-mediated programmed cell death [GO:1901299]; ossification [GO:0001503]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of collagen biosynthetic process [GO:0032967]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of extracellular matrix disassembly [GO:0090091]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of hepatic stellate cell activation [GO:2000491]; positive regulation of hepatic stellate cell proliferation [GO:1904899]; positive regulation of neuron projection development [GO:0010976]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of vascular associated smooth muscle cell migration [GO:1904754]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; positive regulation of wound healing [GO:0090303]; protein autophosphorylation [GO:0046777]; regulation of bone mineralization [GO:0030500]; regulation of extracellular matrix disassembly [GO:0010715]; regulation of tissue remodeling [GO:0034103]; response to muscle stretch [GO:0035994]; signal transduction [GO:0007165] actin cytoskeleton [GO:0015629]; apical plasma membrane [GO:0016324]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] ATP binding [GO:0005524]; collagen binding [GO:0005518]; protein tyrosine kinase collagen receptor activity [GO:0038062]; transmembrane receptor protein tyrosine kinase activity [GO:0004714] g23618.t1 B2RZF9 47.594 187 1.53e-49 171.0 sp|B2RZF9|ATAT_XENTR Alpha-tubulin N-acetyltransferase 1 OS=Xenopus tropicalis OX=8364 GN=atat1 PE=2 SV=1 g23619.t1 Q5RA07 56.504 492 0.0 567.0 sp|Q5RA07|GNL1_PONAB Guanine nucleotide-binding protein-like 1 OS=Pongo abelii OX=9601 GN=GNL1 PE=2 SV=1 g23620.t1 Q9Y345 41.374 597 1.34e-146 447.0 sp|Q9Y345|SC6A5_HUMAN Sodium- and chloride-dependent glycine transporter 2 OS=Homo sapiens OX=9606 GN=SLC6A5 PE=1 SV=3 SC6A5_HUMAN reviewed Sodium- and chloride-dependent glycine transporter 2 (GlyT-2) (GlyT2) (Solute carrier family 6 member 5) Homo sapiens (Human) GO:0005768; GO:0005886; GO:0006836; GO:0007268; GO:0015375; GO:0016020; GO:0031045; GO:0035725; GO:0045202; GO:0046872; GO:0060012; GO:1903804 chemical synaptic transmission [GO:0007268]; glycine import across plasma membrane [GO:1903804]; neurotransmitter transport [GO:0006836]; sodium ion transmembrane transport [GO:0035725]; synaptic transmission, glycinergic [GO:0060012] dense core granule [GO:0031045]; endosome [GO:0005768]; membrane [GO:0016020]; plasma membrane [GO:0005886]; synapse [GO:0045202] glycine:sodium symporter activity [GO:0015375]; metal ion binding [GO:0046872] g23622.t1 Q13148 50.73 274 8.46e-90 278.0 sp|Q13148|TADBP_HUMAN TAR DNA-binding protein 43 OS=Homo sapiens OX=9606 GN=TARDBP PE=1 SV=1 g23623.t1 Q3U0J8 29.865 519 5.31e-60 228.0 sp|Q3U0J8|TBD2B_MOUSE TBC1 domain family member 2B OS=Mus musculus OX=10090 GN=Tbc1d2b PE=1 SV=2 g23625.t1 Q9Y5Z4 39.13 161 4.3700000000000004e-32 118.0 sp|Q9Y5Z4|HEBP2_HUMAN Heme-binding protein 2 OS=Homo sapiens OX=9606 GN=HEBP2 PE=1 SV=1 HEBP2_HUMAN reviewed Heme-binding protein 2 (Placental protein 23) (PP23) (Protein SOUL) Homo sapiens (Human) GO:0005576; GO:0005737; GO:0005739; GO:0020037; GO:0035578; GO:0070062 azurophil granule lumen [GO:0035578]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; mitochondrion [GO:0005739] heme binding [GO:0020037] g23626.t1 Q9Y5Z4 41.791 134 3.08e-29 109.0 sp|Q9Y5Z4|HEBP2_HUMAN Heme-binding protein 2 OS=Homo sapiens OX=9606 GN=HEBP2 PE=1 SV=1 HEBP2_HUMAN reviewed Heme-binding protein 2 (Placental protein 23) (PP23) (Protein SOUL) Homo sapiens (Human) GO:0005576; GO:0005737; GO:0005739; GO:0020037; GO:0035578; GO:0070062 azurophil granule lumen [GO:0035578]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; mitochondrion [GO:0005739] heme binding [GO:0020037] g23630.t1 Q06AT3 62.865 342 4.2300000000000006e-157 447.0 sp|Q06AT3|UCHL5_PIG Ubiquitin carboxyl-terminal hydrolase isozyme L5 OS=Sus scrofa OX=9823 GN=UCHL5 PE=2 SV=1 g23631.t1 O61491 72.684 421 0.0 517.0 sp|O61491|FLOT1_DROME Flotillin-1 OS=Drosophila melanogaster OX=7227 GN=Flo1 PE=2 SV=1 g23632.t1 Q8TB37 68.441 263 4.6099999999999997e-128 372.0 sp|Q8TB37|NUBPL_HUMAN Iron-sulfur cluster transfer protein NUBPL OS=Homo sapiens OX=9606 GN=NUBPL PE=1 SV=3 NUBPL_HUMAN reviewed Iron-sulfur cluster transfer protein NUBPL (IND1 homolog) (Nucleotide-binding protein-like) (huInd1) Homo sapiens (Human) GO:0005524; GO:0005739; GO:0005759; GO:0005886; GO:0007005; GO:0016226; GO:0032981; GO:0046872; GO:0051539; GO:0140663 iron-sulfur cluster assembly [GO:0016226]; mitochondrial respiratory chain complex I assembly [GO:0032981]; mitochondrion organization [GO:0007005] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886] 4 iron, 4 sulfur cluster binding [GO:0051539]; ATP binding [GO:0005524]; ATP-dependent FeS chaperone activity [GO:0140663]; metal ion binding [GO:0046872] g23633.t1 P17702 57.143 133 1.2600000000000001e-37 129.0 sp|P17702|RL28_RAT Large ribosomal subunit protein eL28 OS=Rattus norvegicus OX=10116 GN=Rpl28 PE=1 SV=4 g23638.t1 Q9NTG1 28.571 329 7.509999999999999e-24 107.0 sp|Q9NTG1|PKDRE_HUMAN Polycystin family receptor for egg jelly OS=Homo sapiens OX=9606 GN=PKDREJ PE=1 SV=2 g23639.t1 Q7TN88 41.667 540 2.57e-103 348.0 sp|Q7TN88|PK1L2_MOUSE Polycystin-1-like protein 2 OS=Mus musculus OX=10090 GN=Pkd1l2 PE=2 SV=1 PK1L2_MOUSE reviewed Polycystin-1-like protein 2 (Polycystin-1L2) (PC1-like 2 protein) (Polycystic kidney disease protein 1-like 2) Mus musculus (Mouse) GO:0001965; GO:0005262; GO:0005509; GO:0016020; GO:0030246; GO:0050982 detection of mechanical stimulus [GO:0050982] membrane [GO:0016020] calcium channel activity [GO:0005262]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; G-protein alpha-subunit binding [GO:0001965] g23641.t1 Q7TN88 30.786 458 6.270000000000001e-47 176.0 sp|Q7TN88|PK1L2_MOUSE Polycystin-1-like protein 2 OS=Mus musculus OX=10090 GN=Pkd1l2 PE=2 SV=1 PK1L2_MOUSE reviewed Polycystin-1-like protein 2 (Polycystin-1L2) (PC1-like 2 protein) (Polycystic kidney disease protein 1-like 2) Mus musculus (Mouse) GO:0001965; GO:0005262; GO:0005509; GO:0016020; GO:0030246; GO:0050982 detection of mechanical stimulus [GO:0050982] membrane [GO:0016020] calcium channel activity [GO:0005262]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; G-protein alpha-subunit binding [GO:0001965] g23641.t1 Q7TN88 53.571 28 6.270000000000001e-47 33.9 sp|Q7TN88|PK1L2_MOUSE Polycystin-1-like protein 2 OS=Mus musculus OX=10090 GN=Pkd1l2 PE=2 SV=1 PK1L2_MOUSE reviewed Polycystin-1-like protein 2 (Polycystin-1L2) (PC1-like 2 protein) (Polycystic kidney disease protein 1-like 2) Mus musculus (Mouse) GO:0001965; GO:0005262; GO:0005509; GO:0016020; GO:0030246; GO:0050982 detection of mechanical stimulus [GO:0050982] membrane [GO:0016020] calcium channel activity [GO:0005262]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; G-protein alpha-subunit binding [GO:0001965] g23643.t1 Q6DF96 46.445 422 3.64e-127 377.0 sp|Q6DF96|QTRT2_XENLA Queuine tRNA-ribosyltransferase accessory subunit 2 OS=Xenopus laevis OX=8355 GN=qtrt2 PE=2 SV=1 QTRT2_XENLA reviewed Queuine tRNA-ribosyltransferase accessory subunit 2 (Queuine tRNA-ribosyltransferase domain-containing protein 1) Xenopus laevis (African clawed frog) GO:0005737; GO:0005739; GO:0005741; GO:0006400; GO:0008479; GO:0042803; GO:0046872; GO:0046982; GO:0140767 tRNA modification [GO:0006400] cytoplasm [GO:0005737]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739] enzyme-substrate adaptor activity [GO:0140767]; metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; tRNA-guanosine(34) queuine transglycosylase activity [GO:0008479] g23643.t2 Q6DF96 46.445 422 3.4e-127 377.0 sp|Q6DF96|QTRT2_XENLA Queuine tRNA-ribosyltransferase accessory subunit 2 OS=Xenopus laevis OX=8355 GN=qtrt2 PE=2 SV=1 QTRT2_XENLA reviewed Queuine tRNA-ribosyltransferase accessory subunit 2 (Queuine tRNA-ribosyltransferase domain-containing protein 1) Xenopus laevis (African clawed frog) GO:0005737; GO:0005739; GO:0005741; GO:0006400; GO:0008479; GO:0042803; GO:0046872; GO:0046982; GO:0140767 tRNA modification [GO:0006400] cytoplasm [GO:0005737]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739] enzyme-substrate adaptor activity [GO:0140767]; metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; tRNA-guanosine(34) queuine transglycosylase activity [GO:0008479] g23644.t1 Q0VCN1 34.185 313 1.12e-41 149.0 sp|Q0VCN1|NMRL1_BOVIN NmrA-like family domain-containing protein 1 OS=Bos taurus OX=9913 GN=NMRAL1 PE=2 SV=1 g23645.t1 Q5PQQ4 54.035 285 8.53e-101 300.0 sp|Q5PQQ4|PIGC_RAT Phosphatidylinositol N-acetylglucosaminyltransferase subunit C OS=Rattus norvegicus OX=10116 GN=Pigc PE=2 SV=1 g23646.t1 Q0VFN8 47.146 473 5.62e-111 352.0 sp|Q0VFN8|CF157_XENTR Cilia- and flagella-associated protein 157 OS=Xenopus tropicalis OX=8364 GN=cfap157 PE=2 SV=1 g23648.t1 A1A619 58.696 92 1.9399999999999997e-34 127.0 sp|A1A619|OCAD1_XENLA OCIA domain-containing protein 1 OS=Xenopus laevis OX=8355 GN=ociad1 PE=2 SV=3 g23649.t1 Q9P1Z9 32.082 932 8.63e-115 404.0 sp|Q9P1Z9|CC180_HUMAN Coiled-coil domain-containing protein 180 OS=Homo sapiens OX=9606 GN=CCDC180 PE=1 SV=3 g23649.t1 Q9P1Z9 33.675 585 2.98e-97 350.0 sp|Q9P1Z9|CC180_HUMAN Coiled-coil domain-containing protein 180 OS=Homo sapiens OX=9606 GN=CCDC180 PE=1 SV=3 g23651.t1 Q9JMB8 26.915 483 1.6200000000000002e-36 149.0 sp|Q9JMB8|CNTN6_MOUSE Contactin-6 OS=Mus musculus OX=10090 GN=Cntn6 PE=1 SV=2 CNTN6_MOUSE reviewed Contactin-6 (Neural recognition molecule NB-3) (mNB-3) Mus musculus (Mouse) GO:0005886; GO:0007156; GO:0007219; GO:0007411; GO:0030424; GO:0042734; GO:0045202; GO:0045747; GO:0050808; GO:0070593; GO:0098552; GO:0098632; GO:0098688; GO:0098793 axon guidance [GO:0007411]; dendrite self-avoidance [GO:0070593]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; Notch signaling pathway [GO:0007219]; positive regulation of Notch signaling pathway [GO:0045747]; synapse organization [GO:0050808] axon [GO:0030424]; parallel fiber to Purkinje cell synapse [GO:0098688]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; presynaptic membrane [GO:0042734]; side of membrane [GO:0098552]; synapse [GO:0045202] cell-cell adhesion mediator activity [GO:0098632] g23652.t1 O89026 26.575 508 4.46e-31 132.0 sp|O89026|ROBO1_MOUSE Roundabout homolog 1 OS=Mus musculus OX=10090 GN=Robo1 PE=1 SV=1 ROBO1_MOUSE reviewed Roundabout homolog 1 Mus musculus (Mouse) GO:0001822; GO:0002042; GO:0003129; GO:0003148; GO:0003180; GO:0003184; GO:0003272; GO:0003281; GO:0005737; GO:0005829; GO:0005886; GO:0005929; GO:0007156; GO:0007411; GO:0007507; GO:0008046; GO:0008285; GO:0009986; GO:0010628; GO:0010629; GO:0016199; GO:0021836; GO:0021891; GO:0030275; GO:0030336; GO:0030424; GO:0030425; GO:0030673; GO:0030949; GO:0033116; GO:0033600; GO:0035025; GO:0035385; GO:0035904; GO:0042802; GO:0043025; GO:0043410; GO:0045747; GO:0048814; GO:0050772; GO:0050925; GO:0051964; GO:0060412; GO:0060763; GO:0060976; GO:0070100; GO:1900748; GO:1990138 aorta development [GO:0035904]; aortic valve morphogenesis [GO:0003180]; axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; cell migration involved in sprouting angiogenesis [GO:0002042]; chemorepulsion involved in postnatal olfactory bulb interneuron migration [GO:0021836]; coronary vasculature development [GO:0060976]; endocardial cushion formation [GO:0003272]; heart development [GO:0007507]; heart induction [GO:0003129]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; kidney development [GO:0001822]; mammary duct terminal end bud growth [GO:0060763]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of chemokine-mediated signaling pathway [GO:0070100]; negative regulation of gene expression [GO:0010629]; negative regulation of mammary gland epithelial cell proliferation [GO:0033600]; negative regulation of negative chemotaxis [GO:0050925]; negative regulation of synapse assembly [GO:0051964]; neuron projection extension [GO:1990138]; olfactory bulb interneuron development [GO:0021891]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of axonogenesis [GO:0050772]; positive regulation of gene expression [GO:0010628]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of Rho protein signal transduction [GO:0035025]; positive regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030949]; positive regulation of vascular endothelial growth factor signaling pathway [GO:1900748]; pulmonary valve morphogenesis [GO:0003184]; regulation of dendrite morphogenesis [GO:0048814]; Roundabout signaling pathway [GO:0035385]; ventricular septum development [GO:0003281]; ventricular septum morphogenesis [GO:0060412] axolemma [GO:0030673]; axon [GO:0030424]; cell surface [GO:0009986]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886] axon guidance receptor activity [GO:0008046]; identical protein binding [GO:0042802]; LRR domain binding [GO:0030275] g23652.t1 O89026 31.489 235 1.85e-27 120.0 sp|O89026|ROBO1_MOUSE Roundabout homolog 1 OS=Mus musculus OX=10090 GN=Robo1 PE=1 SV=1 ROBO1_MOUSE reviewed Roundabout homolog 1 Mus musculus (Mouse) GO:0001822; GO:0002042; GO:0003129; GO:0003148; GO:0003180; GO:0003184; GO:0003272; GO:0003281; GO:0005737; GO:0005829; GO:0005886; GO:0005929; GO:0007156; GO:0007411; GO:0007507; GO:0008046; GO:0008285; GO:0009986; GO:0010628; GO:0010629; GO:0016199; GO:0021836; GO:0021891; GO:0030275; GO:0030336; GO:0030424; GO:0030425; GO:0030673; GO:0030949; GO:0033116; GO:0033600; GO:0035025; GO:0035385; GO:0035904; GO:0042802; GO:0043025; GO:0043410; GO:0045747; GO:0048814; GO:0050772; GO:0050925; GO:0051964; GO:0060412; GO:0060763; GO:0060976; GO:0070100; GO:1900748; GO:1990138 aorta development [GO:0035904]; aortic valve morphogenesis [GO:0003180]; axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; cell migration involved in sprouting angiogenesis [GO:0002042]; chemorepulsion involved in postnatal olfactory bulb interneuron migration [GO:0021836]; coronary vasculature development [GO:0060976]; endocardial cushion formation [GO:0003272]; heart development [GO:0007507]; heart induction [GO:0003129]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; kidney development [GO:0001822]; mammary duct terminal end bud growth [GO:0060763]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of chemokine-mediated signaling pathway [GO:0070100]; negative regulation of gene expression [GO:0010629]; negative regulation of mammary gland epithelial cell proliferation [GO:0033600]; negative regulation of negative chemotaxis [GO:0050925]; negative regulation of synapse assembly [GO:0051964]; neuron projection extension [GO:1990138]; olfactory bulb interneuron development [GO:0021891]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of axonogenesis [GO:0050772]; positive regulation of gene expression [GO:0010628]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of Rho protein signal transduction [GO:0035025]; positive regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030949]; positive regulation of vascular endothelial growth factor signaling pathway [GO:1900748]; pulmonary valve morphogenesis [GO:0003184]; regulation of dendrite morphogenesis [GO:0048814]; Roundabout signaling pathway [GO:0035385]; ventricular septum development [GO:0003281]; ventricular septum morphogenesis [GO:0060412] axolemma [GO:0030673]; axon [GO:0030424]; cell surface [GO:0009986]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886] axon guidance receptor activity [GO:0008046]; identical protein binding [GO:0042802]; LRR domain binding [GO:0030275] g23652.t1 O89026 27.073 410 8.78e-22 103.0 sp|O89026|ROBO1_MOUSE Roundabout homolog 1 OS=Mus musculus OX=10090 GN=Robo1 PE=1 SV=1 ROBO1_MOUSE reviewed Roundabout homolog 1 Mus musculus (Mouse) GO:0001822; GO:0002042; GO:0003129; GO:0003148; GO:0003180; GO:0003184; GO:0003272; GO:0003281; GO:0005737; GO:0005829; GO:0005886; GO:0005929; GO:0007156; GO:0007411; GO:0007507; GO:0008046; GO:0008285; GO:0009986; GO:0010628; GO:0010629; GO:0016199; GO:0021836; GO:0021891; GO:0030275; GO:0030336; GO:0030424; GO:0030425; GO:0030673; GO:0030949; GO:0033116; GO:0033600; GO:0035025; GO:0035385; GO:0035904; GO:0042802; GO:0043025; GO:0043410; GO:0045747; GO:0048814; GO:0050772; GO:0050925; GO:0051964; GO:0060412; GO:0060763; GO:0060976; GO:0070100; GO:1900748; GO:1990138 aorta development [GO:0035904]; aortic valve morphogenesis [GO:0003180]; axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; cell migration involved in sprouting angiogenesis [GO:0002042]; chemorepulsion involved in postnatal olfactory bulb interneuron migration [GO:0021836]; coronary vasculature development [GO:0060976]; endocardial cushion formation [GO:0003272]; heart development [GO:0007507]; heart induction [GO:0003129]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; kidney development [GO:0001822]; mammary duct terminal end bud growth [GO:0060763]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of chemokine-mediated signaling pathway [GO:0070100]; negative regulation of gene expression [GO:0010629]; negative regulation of mammary gland epithelial cell proliferation [GO:0033600]; negative regulation of negative chemotaxis [GO:0050925]; negative regulation of synapse assembly [GO:0051964]; neuron projection extension [GO:1990138]; olfactory bulb interneuron development [GO:0021891]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of axonogenesis [GO:0050772]; positive regulation of gene expression [GO:0010628]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of Rho protein signal transduction [GO:0035025]; positive regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030949]; positive regulation of vascular endothelial growth factor signaling pathway [GO:1900748]; pulmonary valve morphogenesis [GO:0003184]; regulation of dendrite morphogenesis [GO:0048814]; Roundabout signaling pathway [GO:0035385]; ventricular septum development [GO:0003281]; ventricular septum morphogenesis [GO:0060412] axolemma [GO:0030673]; axon [GO:0030424]; cell surface [GO:0009986]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886] axon guidance receptor activity [GO:0008046]; identical protein binding [GO:0042802]; LRR domain binding [GO:0030275] g23653.t1 Q26626 80.097 829 0.0 1239.0 sp|Q26626|KIFA3_STRPU Kinesin-associated protein 3 OS=Strongylocentrotus purpuratus OX=7668 GN=KAP115 PE=1 SV=1 g23655.t1 Q3SWX2 48.248 371 1.3699999999999999e-120 360.0 sp|Q3SWX2|ACOT9_BOVIN Acyl-coenzyme A thioesterase 9, mitochondrial OS=Bos taurus OX=9913 GN=ACOT9 PE=2 SV=1 ACOT9_BOVIN reviewed Acyl-coenzyme A thioesterase 9, mitochondrial (Acyl-CoA thioesterase 9) (EC 3.1.2.-) (EC 3.1.2.2) (Acyl-CoA thioester hydrolase 9) Bos taurus (Bovine) GO:0001676; GO:0005739; GO:0005743; GO:0005759; GO:0006637; GO:0046459; GO:0047617; GO:0052689 acyl-CoA metabolic process [GO:0006637]; long-chain fatty acid metabolic process [GO:0001676]; short-chain fatty acid metabolic process [GO:0046459] mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] carboxylic ester hydrolase activity [GO:0052689]; fatty acyl-CoA hydrolase activity [GO:0047617] g23656.t1 Q6NWX7 53.456 217 2.3e-82 248.0 sp|Q6NWX7|NTM1A_DANRE N-terminal Xaa-Pro-Lys N-methyltransferase 1 OS=Danio rerio OX=7955 GN=ntmt1 PE=2 SV=1 NTM1A_DANRE reviewed N-terminal Xaa-Pro-Lys N-methyltransferase 1 (EC 2.1.1.244) (Alpha N-terminal protein methyltransferase 1A) (Methyltransferase-like protein 11A) (X-Pro-Lys N-terminal protein methyltransferase 1A) (NTM1A) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005634; GO:0005737; GO:0007051; GO:0007059; GO:0008276; GO:0018013; GO:0018016; GO:0035572; GO:0035573; GO:0042054; GO:0071885 chromosome segregation [GO:0007059]; N-terminal peptidyl-glycine methylation [GO:0018013]; N-terminal peptidyl-proline dimethylation [GO:0018016]; N-terminal peptidyl-serine dimethylation [GO:0035572]; N-terminal peptidyl-serine trimethylation [GO:0035573]; spindle organization [GO:0007051] cytoplasm [GO:0005737]; nucleus [GO:0005634] histone methyltransferase activity [GO:0042054]; N-terminal protein N-methyltransferase activity [GO:0071885]; protein methyltransferase activity [GO:0008276] g23657.t1 P61765 61.345 595 0.0 758.0 sp|P61765|STXB1_RAT Syntaxin-binding protein 1 OS=Rattus norvegicus OX=10116 GN=Stxbp1 PE=1 SV=1 STXB1_RAT reviewed Syntaxin-binding protein 1 (N-Sec1) (Protein unc-18 homolog 1) (Unc18-1) (Protein unc-18 homolog A) (Unc-18A) (p67) (rbSec1) Rattus norvegicus (Rat) GO:0000149; GO:0002576; GO:0003006; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0006886; GO:0006887; GO:0006904; GO:0007269; GO:0007274; GO:0007412; GO:0010807; GO:0010808; GO:0016082; GO:0016188; GO:0017075; GO:0019901; GO:0019904; GO:0019905; GO:0030141; GO:0030424; GO:0031091; GO:0031333; GO:0031338; GO:0031340; GO:0032229; GO:0032355; GO:0032991; GO:0035493; GO:0035544; GO:0042802; GO:0043195; GO:0043274; GO:0043306; GO:0043524; GO:0045335; GO:0045921; GO:0045956; GO:0048471; GO:0050821; GO:0051402; GO:0051649; GO:0060090; GO:0060292; GO:0061670; GO:0070527; GO:0071346; GO:0072659; GO:0098688; GO:0098793; GO:0098794; GO:0098831; GO:0098888; GO:0098978; GO:0099523; GO:0099525; GO:0106022; GO:1903296; GO:2000367 axon target recognition [GO:0007412]; cellular response to type II interferon [GO:0071346]; developmental process involved in reproduction [GO:0003006]; establishment of localization in cell [GO:0051649]; evoked neurotransmitter secretion [GO:0061670]; exocytosis [GO:0006887]; intracellular protein transport [GO:0006886]; long-term synaptic depression [GO:0060292]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of protein-containing complex assembly [GO:0031333]; negative regulation of SNARE complex assembly [GO:0035544]; negative regulation of synaptic transmission, GABAergic [GO:0032229]; neuromuscular synaptic transmission [GO:0007274]; neuron apoptotic process [GO:0051402]; neurotransmitter secretion [GO:0007269]; platelet aggregation [GO:0070527]; platelet degranulation [GO:0002576]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; positive regulation of exocytosis [GO:0045921]; positive regulation of glutamate secretion, neurotransmission [GO:1903296]; positive regulation of mast cell degranulation [GO:0043306]; positive regulation of synaptic vesicle priming [GO:0010808]; positive regulation of vesicle docking [GO:0106022]; positive regulation of vesicle fusion [GO:0031340]; presynaptic dense core vesicle exocytosis [GO:0099525]; protein localization to plasma membrane [GO:0072659]; protein stabilization [GO:0050821]; regulation of acrosomal vesicle exocytosis [GO:2000367]; regulation of synaptic vesicle priming [GO:0010807]; regulation of vesicle fusion [GO:0031338]; response to estradiol [GO:0032355]; SNARE complex assembly [GO:0035493]; synaptic vesicle maturation [GO:0016188]; synaptic vesicle priming [GO:0016082]; vesicle docking involved in exocytosis [GO:0006904] axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of presynaptic membrane [GO:0098888]; glutamatergic synapse [GO:0098978]; nucleoplasm [GO:0005654]; parallel fiber to Purkinje cell synapse [GO:0098688]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; platelet alpha granule [GO:0031091]; postsynapse [GO:0098794]; presynapse [GO:0098793]; presynaptic active zone cytoplasmic component [GO:0098831]; presynaptic cytosol [GO:0099523]; protein-containing complex [GO:0032991]; secretory granule [GO:0030141]; terminal bouton [GO:0043195] identical protein binding [GO:0042802]; molecular adaptor activity [GO:0060090]; phospholipase binding [GO:0043274]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905]; syntaxin-1 binding [GO:0017075] g23658.t1 A9YUB5 63.636 110 1.18e-44 143.0 sp|A9YUB5|URM1_CAPHI Ubiquitin-related modifier 1 OS=Capra hircus OX=9925 GN=URM1 PE=3 SV=1 g23659.t1 Q03958 49.524 105 6.5000000000000005e-31 110.0 sp|Q03958|PFD6_MOUSE Prefoldin subunit 6 OS=Mus musculus OX=10090 GN=Pfdn6 PE=1 SV=1 g23660.t1 Q8NE28 25.816 643 8.390000000000001e-49 185.0 sp|Q8NE28|STKL1_HUMAN Serine/threonine kinase-like domain-containing protein STKLD1 OS=Homo sapiens OX=9606 GN=STKLD1 PE=1 SV=5 g23661.t1 P98068 31.445 353 1.8600000000000002e-37 146.0 sp|P98068|SPAN_STRPU Protein SpAN OS=Strongylocentrotus purpuratus OX=7668 GN=SPAN PE=2 SV=1 g23662.t1 P42674 29.455 404 3.05e-37 147.0 sp|P42674|BP10_PARLI Blastula protease 10 OS=Paracentrotus lividus OX=7656 GN=BP10 PE=2 SV=1 g23663.t1 Q6PAR5 41.108 776 9.730000000000001e-161 520.0 sp|Q6PAR5|GAPD1_MOUSE GTPase-activating protein and VPS9 domain-containing protein 1 OS=Mus musculus OX=10090 GN=Gapvd1 PE=1 SV=2 GAPD1_MOUSE reviewed GTPase-activating protein and VPS9 domain-containing protein 1 (GAPex-5) (Rab5-activating protein 6) Mus musculus (Mouse) GO:0005085; GO:0005096; GO:0005768; GO:0005829; GO:0005886; GO:0006897; GO:0030139; GO:0031267; GO:0032794; GO:0051223 endocytosis [GO:0006897]; regulation of protein transport [GO:0051223] cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; plasma membrane [GO:0005886] GTPase activating protein binding [GO:0032794]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; small GTPase binding [GO:0031267] g23664.t1 A5D794 48.918 462 7.33e-130 413.0 sp|A5D794|GAPD1_BOVIN GTPase-activating protein and VPS9 domain-containing protein 1 OS=Bos taurus OX=9913 GN=GAPVD1 PE=2 SV=1 GAPD1_BOVIN reviewed GTPase-activating protein and VPS9 domain-containing protein 1 Bos taurus (Bovine) GO:0005085; GO:0005096; GO:0005768; GO:0005829; GO:0006897; GO:0016020; GO:0030139; GO:0031267; GO:0032794; GO:0051223 endocytosis [GO:0006897]; regulation of protein transport [GO:0051223] cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; membrane [GO:0016020] GTPase activating protein binding [GO:0032794]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; small GTPase binding [GO:0031267] g23667.t1 Q710E6 49.796 245 4.88e-66 228.0 sp|Q710E6|SUCO_RAT SUN domain-containing ossification factor OS=Rattus norvegicus OX=10116 GN=Suco PE=2 SV=1 g23668.t1 Q9UBS9 59.434 106 5.49e-23 108.0 sp|Q9UBS9|SUCO_HUMAN SUN domain-containing ossification factor OS=Homo sapiens OX=9606 GN=SUCO PE=1 SV=1 SUCO_HUMAN reviewed SUN domain-containing ossification factor (Membrane protein CH1) (Protein osteopotentia homolog) (SUN-like protein 1) Homo sapiens (Human) GO:0001503; GO:0005737; GO:0005791; GO:0016020; GO:0030867; GO:0032967; GO:0045669; GO:0046850 ossification [GO:0001503]; positive regulation of collagen biosynthetic process [GO:0032967]; positive regulation of osteoblast differentiation [GO:0045669]; regulation of bone remodeling [GO:0046850] cytoplasm [GO:0005737]; membrane [GO:0016020]; rough endoplasmic reticulum [GO:0005791]; rough endoplasmic reticulum membrane [GO:0030867] g23671.t1 Q54MC6 25.856 263 5.8200000000000005e-21 98.6 sp|Q54MC6|LRLA_DICDI Latrophilin receptor-like protein A OS=Dictyostelium discoideum OX=44689 GN=lrlA PE=3 SV=1 g23672.t1 A1DWM3 28.08 349 2.0000000000000002e-29 127.0 sp|A1DWM3|MFSD6_PIG Major facilitator superfamily domain-containing protein 6 OS=Sus scrofa OX=9823 GN=MFSD6 PE=2 SV=1 g23673.t1 Q8CBH5 22.833 600 9.520000000000001e-27 119.0 sp|Q8CBH5|MFSD6_MOUSE Major facilitator superfamily domain-containing protein 6 OS=Mus musculus OX=10090 GN=Mfsd6 PE=1 SV=1 g23674.t1 A0P8Z4 44.619 446 7.080000000000001e-124 372.0 sp|A0P8Z4|NR6A1_PIG Nuclear receptor subfamily 6 group A member 1 OS=Sus scrofa OX=9823 GN=NR6A1 PE=1 SV=2 NR6A1_PIG reviewed Nuclear receptor subfamily 6 group A member 1 (Germ cell nuclear factor) (GCNF) Sus scrofa (Pig) GO:0000785; GO:0004879; GO:0005634; GO:0006357; GO:0007283; GO:0008270; GO:0030154; GO:0034056; GO:2000741 cell differentiation [GO:0030154]; positive regulation of mesenchymal stem cell differentiation [GO:2000741]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283] chromatin [GO:0000785]; nucleus [GO:0005634] estrogen response element binding [GO:0034056]; nuclear receptor activity [GO:0004879]; zinc ion binding [GO:0008270] g23675.t1 O00482 48.462 520 1.57e-152 449.0 sp|O00482|NR5A2_HUMAN Nuclear receptor subfamily 5 group A member 2 OS=Homo sapiens OX=9606 GN=NR5A2 PE=1 SV=2 NR5A2_HUMAN reviewed Nuclear receptor subfamily 5 group A member 2 (Alpha-1-fetoprotein transcription factor) (B1-binding factor) (hB1F) (CYP7A promoter-binding factor) (Hepatocytic transcription factor) (Liver receptor homolog 1) (LRH-1) Homo sapiens (Human) GO:0000785; GO:0000976; GO:0000978; GO:0000981; GO:0001221; GO:0001228; GO:0001545; GO:0001826; GO:0002669; GO:0003677; GO:0003682; GO:0003700; GO:0004879; GO:0005543; GO:0005634; GO:0005654; GO:0005737; GO:0006338; GO:0006355; GO:0006357; GO:0007283; GO:0008206; GO:0008270; GO:0009755; GO:0009792; GO:0009888; GO:0022008; GO:0031017; GO:0031948; GO:0032331; GO:0035019; GO:0040016; GO:0042102; GO:0042592; GO:0042632; GO:0043565; GO:0045070; GO:0045893; GO:0045944; GO:0050728; GO:0050870; GO:0051216; GO:0060009; GO:0061113; GO:0090425; GO:0090575; GO:0097720; GO:0140001; GO:0141064; GO:1990830; GO:1990837; GO:2000738; GO:2001051 acinar cell differentiation [GO:0090425]; bile acid metabolic process [GO:0008206]; calcineurin-mediated signaling [GO:0097720]; cartilage development [GO:0051216]; cellular response to leukemia inhibitory factor [GO:1990830]; cholesterol homeostasis [GO:0042632]; chromatin remodeling [GO:0006338]; embryo development ending in birth or egg hatching [GO:0009792]; embryonic cleavage [GO:0040016]; exocrine pancreas development [GO:0031017]; homeostatic process [GO:0042592]; hormone-mediated signaling pathway [GO:0009755]; inner cell mass cell differentiation [GO:0001826]; morula formation [GO:0140001]; negative regulation of chondrocyte differentiation [GO:0032331]; negative regulation of inflammatory response [GO:0050728]; neurogenesis [GO:0022008]; pancreas morphogenesis [GO:0061113]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of glucocorticoid biosynthetic process [GO:0031948]; positive regulation of stem cell differentiation [GO:2000738]; positive regulation of T cell activation [GO:0050870]; positive regulation of T cell anergy [GO:0002669]; positive regulation of T cell proliferation [GO:0042102]; positive regulation of tendon cell differentiation [GO:2001051]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of viral genome replication [GO:0045070]; primary ovarian follicle growth [GO:0001545]; regulation of DNA-templated transcription [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; Sertoli cell development [GO:0060009]; somatic stem cell population maintenance [GO:0035019]; spermatogenesis [GO:0007283]; tissue development [GO:0009888]; zygotic genome activation [GO:0141064] chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575] chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; nuclear receptor activity [GO:0004879]; phospholipid binding [GO:0005543]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]; transcription coregulator binding [GO:0001221]; zinc ion binding [GO:0008270] g23676.t1 Q3T168 45.291 223 2.25e-54 178.0 sp|Q3T168|CYBP_BOVIN Calcyclin-binding protein OS=Bos taurus OX=9913 GN=CACYBP PE=2 SV=1 CYBP_BOVIN reviewed Calcyclin-binding protein (CacyBP) Bos taurus (Bovine) GO:0005634; GO:0005737; GO:0007507; GO:0015631; GO:0030877; GO:0031625; GO:0044548 heart development [GO:0007507] beta-catenin destruction complex [GO:0030877]; cytoplasm [GO:0005737]; nucleus [GO:0005634] S100 protein binding [GO:0044548]; tubulin binding [GO:0015631]; ubiquitin protein ligase binding [GO:0031625] g23677.t1 Q03443 29.607 331 1.4700000000000002e-32 126.0 sp|Q03443|CRJ1B_TRICY Crystallin J1B OS=Tripedalia cystophora OX=6141 PE=1 SV=1 g23681.t1 Q5JSZ5 42.727 220 3.36e-33 144.0 sp|Q5JSZ5|PRC2B_HUMAN Protein PRRC2B OS=Homo sapiens OX=9606 GN=PRRC2B PE=1 SV=2 PRC2B_HUMAN reviewed Protein PRRC2B (HLA-B-associated transcript 2-like 1) (Proline-rich coiled-coil protein 2B) Homo sapiens (Human) GO:0003723; GO:0030154 cell differentiation [GO:0030154] RNA binding [GO:0003723] g23683.t1 Q7Z7L7 41.489 564 6.04e-121 377.0 sp|Q7Z7L7|ZER1_HUMAN Protein zer-1 homolog OS=Homo sapiens OX=9606 GN=ZER1 PE=1 SV=1 ZER1_HUMAN reviewed Protein zer-1 homolog (Hzyg) (Zyg-11 homolog B-like protein) (Zyg11b-like protein) Homo sapiens (Human) GO:0006515; GO:0031462; GO:0032436 positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515] Cul2-RING ubiquitin ligase complex [GO:0031462] g23684.t1 C9J069 40.0 250 2.41e-44 179.0 sp|C9J069|AJM1_HUMAN Apical junction component 1 homolog OS=Homo sapiens OX=9606 GN=AJM1 PE=1 SV=1 AJM1_HUMAN reviewed Apical junction component 1 homolog Homo sapiens (Human) GO:0005886; GO:0005912; GO:0005929; GO:0016324; GO:0043296; GO:0045216 cell-cell junction organization [GO:0045216] adherens junction [GO:0005912]; apical junction complex [GO:0043296]; apical plasma membrane [GO:0016324]; cilium [GO:0005929]; plasma membrane [GO:0005886] g23686.t1 Q7TSK7 35.714 392 8.87e-72 251.0 sp|Q7TSK7|ATL2_MOUSE ADAMTS-like protein 2 OS=Mus musculus OX=10090 GN=Adamtsl2 PE=1 SV=1 g23687.t1 Q86TH1 28.324 346 1.88e-36 146.0 sp|Q86TH1|ATL2_HUMAN ADAMTS-like protein 2 OS=Homo sapiens OX=9606 GN=ADAMTSL2 PE=1 SV=1 ATL2_HUMAN reviewed ADAMTS-like protein 2 (ADAMTSL-2) Homo sapiens (Human) GO:0005576; GO:0030198; GO:0030512; GO:0031012; GO:0050436; GO:0060481 extracellular matrix organization [GO:0030198]; lobar bronchus epithelium development [GO:0060481]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512] extracellular matrix [GO:0031012]; extracellular region [GO:0005576] microfibril binding [GO:0050436] g23689.t1 Q5XI68 68.75 112 3.12e-53 168.0 sp|Q5XI68|NC2B_RAT Protein Dr1 OS=Rattus norvegicus OX=10116 GN=Dr1 PE=2 SV=1 NC2B_RAT reviewed Protein Dr1 (Down-regulator of transcription 1) (Negative cofactor 2-beta) (NC2-beta) (TATA-binding protein-associated phosphoprotein) Rattus norvegicus (Rat) GO:0000122; GO:0003677; GO:0005634; GO:0005654; GO:0006355; GO:0006357; GO:0016251; GO:0017025; GO:0017054; GO:0045995; GO:0046982; GO:0051123; GO:0051302; GO:0051726; GO:0090575; GO:0140672 negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of cell cycle [GO:0051726]; regulation of cell division [GO:0051302]; regulation of DNA-templated transcription [GO:0006355]; regulation of embryonic development [GO:0045995]; regulation of transcription by RNA polymerase II [GO:0006357]; RNA polymerase II preinitiation complex assembly [GO:0051123] ATAC complex [GO:0140672]; negative cofactor 2 complex [GO:0017054]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575] DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; TBP-class protein binding [GO:0017025] g23690.t1 Q8BRM2 52.593 135 1.39e-37 144.0 sp|Q8BRM2|GORAB_MOUSE RAB6-interacting golgin OS=Mus musculus OX=10090 GN=Gorab PE=1 SV=1 GORAB_MOUSE reviewed RAB6-interacting golgin (N-terminal kinase-like-binding protein 1) (NTKL-BP1) (NTKL-binding protein 1) (mNTKL-BP1) (SCY1-like 1-binding protein 1) (SCYL1-BP1) (SCYL1-binding protein 1) Mus musculus (Mouse) GO:0005654; GO:0005730; GO:0005737; GO:0005794; GO:0005829; GO:0031069; GO:0045880; GO:1905515 hair follicle morphogenesis [GO:0031069]; non-motile cilium assembly [GO:1905515]; positive regulation of smoothened signaling pathway [GO:0045880] cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654] g23691.t1 Q641F8 52.041 196 2.06e-67 214.0 sp|Q641F8|TYW3_XENLA tRNA wybutosine-synthesizing protein 3 homolog OS=Xenopus laevis OX=8355 GN=tyw3 PE=2 SV=1 g23692.t1 Q15058 55.793 656 0.0 707.0 sp|Q15058|KIF14_HUMAN Kinesin-like protein KIF14 OS=Homo sapiens OX=9606 GN=KIF14 PE=1 SV=1 g23695.t1 Q05437 49.153 118 6.760000000000001e-29 77.0 sp|Q05437|PRRX1_CHICK Paired mesoderm homeobox protein 1 OS=Gallus gallus OX=9031 GN=PRRX1 PE=1 SV=2 PRRX1_CHICK reviewed Paired mesoderm homeobox protein 1 (GMHOX) (Homeobox protein MHOX) (Paired-related homeobox protein 1) (PRX-1) Gallus gallus (Chicken) GO:0000978; GO:0000981; GO:0001227; GO:0001228; GO:0002053; GO:0005634; GO:0005654; GO:0005829; GO:0006357; GO:0007224; GO:0010463; GO:0016251; GO:0030326; GO:0042472; GO:0042474; GO:0045880; GO:0048664; GO:0048701; GO:0048844; GO:0051216; GO:0060021; GO:0061629; GO:0070570; GO:0071837; GO:0072089; GO:0097150; GO:2000648 artery morphogenesis [GO:0048844]; cartilage development [GO:0051216]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic limb morphogenesis [GO:0030326]; inner ear morphogenesis [GO:0042472]; mesenchymal cell proliferation [GO:0010463]; middle ear morphogenesis [GO:0042474]; neuron fate determination [GO:0048664]; neuronal stem cell population maintenance [GO:0097150]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of smoothened signaling pathway [GO:0045880]; positive regulation of stem cell proliferation [GO:2000648]; regulation of neuron projection regeneration [GO:0070570]; regulation of transcription by RNA polymerase II [GO:0006357]; roof of mouth development [GO:0060021]; smoothened signaling pathway [GO:0007224]; stem cell proliferation [GO:0072089] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; HMG box domain binding [GO:0071837]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629] g23695.t1 Q05437 48.485 66 6.760000000000001e-29 60.1 sp|Q05437|PRRX1_CHICK Paired mesoderm homeobox protein 1 OS=Gallus gallus OX=9031 GN=PRRX1 PE=1 SV=2 PRRX1_CHICK reviewed Paired mesoderm homeobox protein 1 (GMHOX) (Homeobox protein MHOX) (Paired-related homeobox protein 1) (PRX-1) Gallus gallus (Chicken) GO:0000978; GO:0000981; GO:0001227; GO:0001228; GO:0002053; GO:0005634; GO:0005654; GO:0005829; GO:0006357; GO:0007224; GO:0010463; GO:0016251; GO:0030326; GO:0042472; GO:0042474; GO:0045880; GO:0048664; GO:0048701; GO:0048844; GO:0051216; GO:0060021; GO:0061629; GO:0070570; GO:0071837; GO:0072089; GO:0097150; GO:2000648 artery morphogenesis [GO:0048844]; cartilage development [GO:0051216]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic limb morphogenesis [GO:0030326]; inner ear morphogenesis [GO:0042472]; mesenchymal cell proliferation [GO:0010463]; middle ear morphogenesis [GO:0042474]; neuron fate determination [GO:0048664]; neuronal stem cell population maintenance [GO:0097150]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of smoothened signaling pathway [GO:0045880]; positive regulation of stem cell proliferation [GO:2000648]; regulation of neuron projection regeneration [GO:0070570]; regulation of transcription by RNA polymerase II [GO:0006357]; roof of mouth development [GO:0060021]; smoothened signaling pathway [GO:0007224]; stem cell proliferation [GO:0072089] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; HMG box domain binding [GO:0071837]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629] g23695.t1 Q05437 50.0 26 6.760000000000001e-29 32.0 sp|Q05437|PRRX1_CHICK Paired mesoderm homeobox protein 1 OS=Gallus gallus OX=9031 GN=PRRX1 PE=1 SV=2 PRRX1_CHICK reviewed Paired mesoderm homeobox protein 1 (GMHOX) (Homeobox protein MHOX) (Paired-related homeobox protein 1) (PRX-1) Gallus gallus (Chicken) GO:0000978; GO:0000981; GO:0001227; GO:0001228; GO:0002053; GO:0005634; GO:0005654; GO:0005829; GO:0006357; GO:0007224; GO:0010463; GO:0016251; GO:0030326; GO:0042472; GO:0042474; GO:0045880; GO:0048664; GO:0048701; GO:0048844; GO:0051216; GO:0060021; GO:0061629; GO:0070570; GO:0071837; GO:0072089; GO:0097150; GO:2000648 artery morphogenesis [GO:0048844]; cartilage development [GO:0051216]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic limb morphogenesis [GO:0030326]; inner ear morphogenesis [GO:0042472]; mesenchymal cell proliferation [GO:0010463]; middle ear morphogenesis [GO:0042474]; neuron fate determination [GO:0048664]; neuronal stem cell population maintenance [GO:0097150]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of smoothened signaling pathway [GO:0045880]; positive regulation of stem cell proliferation [GO:2000648]; regulation of neuron projection regeneration [GO:0070570]; regulation of transcription by RNA polymerase II [GO:0006357]; roof of mouth development [GO:0060021]; smoothened signaling pathway [GO:0007224]; stem cell proliferation [GO:0072089] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; HMG box domain binding [GO:0071837]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629] g23696.t1 E9QAT4 51.204 457 1.8299999999999998e-137 479.0 sp|E9QAT4|SC16A_MOUSE Protein transport protein Sec16A OS=Mus musculus OX=10090 GN=Sec16a PE=1 SV=1 g23696.t2 E9QAT4 51.204 457 1.9899999999999999e-137 479.0 sp|E9QAT4|SC16A_MOUSE Protein transport protein Sec16A OS=Mus musculus OX=10090 GN=Sec16a PE=1 SV=1 g23696.t3 E9QAT4 51.204 457 2.21e-137 479.0 sp|E9QAT4|SC16A_MOUSE Protein transport protein Sec16A OS=Mus musculus OX=10090 GN=Sec16a PE=1 SV=1 g23698.t1 Q9Y5Q8 35.983 478 5.01e-94 300.0 sp|Q9Y5Q8|TF3C5_HUMAN General transcription factor 3C polypeptide 5 OS=Homo sapiens OX=9606 GN=GTF3C5 PE=1 SV=2 TF3C5_HUMAN reviewed General transcription factor 3C polypeptide 5 (TF3C-epsilon) (Transcription factor IIIC 63 kDa subunit) (TFIIIC 63 kDa subunit) (TFIIIC63) (Transcription factor IIIC subunit epsilon) Homo sapiens (Human) GO:0000127; GO:0000995; GO:0003677; GO:0005654; GO:0006383; GO:0006384; GO:0035914; GO:0042791; GO:0042797 5S class rRNA transcription by RNA polymerase III [GO:0042791]; skeletal muscle cell differentiation [GO:0035914]; transcription by RNA polymerase III [GO:0006383]; transcription initiation at RNA polymerase III promoter [GO:0006384]; tRNA transcription by RNA polymerase III [GO:0042797] nucleoplasm [GO:0005654]; transcription factor TFIIIC complex [GO:0000127] DNA binding [GO:0003677]; RNA polymerase III general transcription initiation factor activity [GO:0000995] g23699.t1 O35657 40.164 122 4.3399999999999995e-24 98.2 sp|O35657|NEUR1_MOUSE Sialidase-1 OS=Mus musculus OX=10090 GN=Neu1 PE=1 SV=1 NEUR1_MOUSE reviewed Sialidase-1 (EC 3.2.1.18) (G9 sialidase) (Lysosomal sialidase) (N-acetyl-alpha-neuraminidase 1) Mus musculus (Mouse) GO:0004308; GO:0005737; GO:0005764; GO:0005765; GO:0005886; GO:0006689; GO:0009313; GO:0009986; GO:0010976; GO:0016020; GO:0016997; GO:0030054; GO:0031410; GO:0043202; GO:2000291 ganglioside catabolic process [GO:0006689]; oligosaccharide catabolic process [GO:0009313]; positive regulation of neuron projection development [GO:0010976]; regulation of myoblast proliferation [GO:2000291] cell junction [GO:0030054]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; plasma membrane [GO:0005886] alpha-sialidase activity [GO:0016997]; exo-alpha-sialidase activity [GO:0004308] g23700.t1 Q5RAF4 55.844 231 1.72e-80 250.0 sp|Q5RAF4|NEUR1_PONAB Sialidase-1 OS=Pongo abelii OX=9601 GN=NEU1 PE=2 SV=1 NEUR1_PONAB reviewed Sialidase-1 (EC 3.2.1.18) (Acetylneuraminyl hydrolase) (Lysosomal sialidase) (N-acetyl-alpha-neuraminidase 1) Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0004308; GO:0005764; GO:0005765; GO:0005886; GO:0006689; GO:0009313; GO:0031410; GO:0043202 ganglioside catabolic process [GO:0006689]; oligosaccharide catabolic process [GO:0009313] cytoplasmic vesicle [GO:0031410]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; plasma membrane [GO:0005886] exo-alpha-sialidase activity [GO:0004308] g23701.t1 Q6KAU4 32.982 285 6.66e-33 125.0 sp|Q6KAU4|MB12B_MOUSE Multivesicular body subunit 12B OS=Mus musculus OX=10090 GN=Mvb12b PE=1 SV=2 MB12B_MOUSE reviewed Multivesicular body subunit 12B (ESCRT-I complex subunit MVB12B) (Protein FAM125B) Mus musculus (Mouse) GO:0000813; GO:0005634; GO:0005769; GO:0005770; GO:0005829; GO:0005886; GO:0008289; GO:0015031; GO:0019075; GO:0031902; GO:0031982; GO:0042058; GO:0046755 protein transport [GO:0015031]; regulation of epidermal growth factor receptor signaling pathway [GO:0042058]; viral budding [GO:0046755]; virus maturation [GO:0019075] cytosol [GO:0005829]; early endosome [GO:0005769]; ESCRT I complex [GO:0000813]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; vesicle [GO:0031982] lipid binding [GO:0008289] g23705.t1 P60027 61.745 447 0.0 563.0 sp|P60027|TF2H4_PANTR General transcription factor IIH subunit 4 OS=Pan troglodytes OX=9598 GN=GTF2H4 PE=3 SV=1 g23708.t1 Q5UR46 36.316 190 4.2e-22 100.0 sp|Q5UR46|YR571_MIMIV Uncharacterized protein R571 OS=Acanthamoeba polyphaga mimivirus OX=212035 GN=MIMI_R571 PE=3 SV=1 g23709.t1 Q5VVW2 46.735 490 5.67e-136 429.0 sp|Q5VVW2|GARL3_HUMAN GTPase-activating Rap/Ran-GAP domain-like protein 3 OS=Homo sapiens OX=9606 GN=GARNL3 PE=1 SV=2 g23709.t2 Q5VVW2 46.83 489 8.569999999999999e-138 433.0 sp|Q5VVW2|GARL3_HUMAN GTPase-activating Rap/Ran-GAP domain-like protein 3 OS=Homo sapiens OX=9606 GN=GARNL3 PE=1 SV=2 g23710.t1 Q5ZJY3 68.611 360 2.94e-169 498.0 sp|Q5ZJY3|GARL3_CHICK GTPase-activating Rap/Ran-GAP domain-like protein 3 OS=Gallus gallus OX=9031 GN=GARNL3 PE=2 SV=1 g23713.t1 Q8C159 26.652 454 1.7200000000000002e-31 133.0 sp|Q8C159|TTC22_MOUSE Tetratricopeptide repeat protein 22 OS=Mus musculus OX=10090 GN=Ttc22 PE=2 SV=1 g23714.t1 Q5TAA0 27.511 458 1.74e-27 122.0 sp|Q5TAA0|TTC22_HUMAN Tetratricopeptide repeat protein 22 OS=Homo sapiens OX=9606 GN=TTC22 PE=1 SV=1 g23716.t2 Q8C159 25.885 452 2.62e-29 127.0 sp|Q8C159|TTC22_MOUSE Tetratricopeptide repeat protein 22 OS=Mus musculus OX=10090 GN=Ttc22 PE=2 SV=1 g23722.t1 Q91398 92.574 202 4.72e-131 370.0 sp|Q91398|CSK2B_DANRE Casein kinase II subunit beta OS=Danio rerio OX=7955 GN=csnk2b PE=2 SV=1 g23723.t1 Q13526 60.123 163 1.34e-60 187.0 sp|Q13526|PIN1_HUMAN Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 OS=Homo sapiens OX=9606 GN=PIN1 PE=1 SV=1 PIN1_HUMAN reviewed Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 (EC 5.2.1.8) (Peptidyl-prolyl cis-trans isomerase Pin1) (PPIase Pin1) (Rotamase Pin1) Homo sapiens (Human) GO:0000413; GO:0001666; GO:0001934; GO:0003755; GO:0003774; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006626; GO:0007088; GO:0007266; GO:0008013; GO:0010468; GO:0016607; GO:0016859; GO:0030182; GO:0030496; GO:0030512; GO:0031434; GO:0031647; GO:0031648; GO:0032465; GO:0032794; GO:0036064; GO:0042177; GO:0045944; GO:0048156; GO:0050808; GO:0050815; GO:0050816; GO:0050821; GO:0051219; GO:0060392; GO:0070373; GO:0071456; GO:0090263; GO:0098978; GO:0099524; GO:1900180; GO:1902430; GO:1903444; GO:1990757; GO:2000146 cellular response to hypoxia [GO:0071456]; negative regulation of amyloid-beta formation [GO:1902430]; negative regulation of brown fat cell differentiation [GO:1903444]; negative regulation of cell motility [GO:2000146]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of SMAD protein signal transduction [GO:0060392]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; neuron differentiation [GO:0030182]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein destabilization [GO:0031648]; protein peptidyl-prolyl isomerization [GO:0000413]; protein stabilization [GO:0050821]; protein targeting to mitochondrion [GO:0006626]; regulation of cytokinesis [GO:0032465]; regulation of gene expression [GO:0010468]; regulation of mitotic nuclear division [GO:0007088]; regulation of protein localization to nucleus [GO:1900180]; regulation of protein stability [GO:0031647]; response to hypoxia [GO:0001666]; Rho protein signal transduction [GO:0007266]; synapse organization [GO:0050808] ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; midbody [GO:0030496]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynaptic cytosol [GO:0099524] beta-catenin binding [GO:0008013]; cis-trans isomerase activity [GO:0016859]; cytoskeletal motor activity [GO:0003774]; GTPase activating protein binding [GO:0032794]; mitogen-activated protein kinase kinase binding [GO:0031434]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; phosphoprotein binding [GO:0051219]; phosphoserine residue binding [GO:0050815]; phosphothreonine residue binding [GO:0050816]; tau protein binding [GO:0048156]; ubiquitin ligase activator activity [GO:1990757] g23724.t1 Q96CN4 46.832 726 0.0 605.0 sp|Q96CN4|EVI5L_HUMAN EVI5-like protein OS=Homo sapiens OX=9606 GN=EVI5L PE=1 SV=1 EVI5L_HUMAN reviewed EVI5-like protein (Ecotropic viral integration site 5-like protein) Homo sapiens (Human) GO:0005096; GO:0031267; GO:0043547; GO:1902018 negative regulation of cilium assembly [GO:1902018]; positive regulation of GTPase activity [GO:0043547] GTPase activator activity [GO:0005096]; small GTPase binding [GO:0031267] g23724.t2 Q96CN4 45.053 748 0.0 597.0 sp|Q96CN4|EVI5L_HUMAN EVI5-like protein OS=Homo sapiens OX=9606 GN=EVI5L PE=1 SV=1 EVI5L_HUMAN reviewed EVI5-like protein (Ecotropic viral integration site 5-like protein) Homo sapiens (Human) GO:0005096; GO:0031267; GO:0043547; GO:1902018 negative regulation of cilium assembly [GO:1902018]; positive regulation of GTPase activity [GO:0043547] GTPase activator activity [GO:0005096]; small GTPase binding [GO:0031267] g23725.t1 P19615 35.686 1275 0.0 701.0 sp|P19615|MYP_STRPU Major yolk protein OS=Strongylocentrotus purpuratus OX=7668 PE=1 SV=2 g23726.t1 Q6UWE0 36.849 730 3.6899999999999997e-119 377.0 sp|Q6UWE0|LRSM1_HUMAN E3 ubiquitin-protein ligase LRSAM1 OS=Homo sapiens OX=9606 GN=LRSAM1 PE=1 SV=1 LRSM1_HUMAN reviewed E3 ubiquitin-protein ligase LRSAM1 (EC 2.3.2.27) (Leucine-rich repeat and sterile alpha motif-containing protein 1) (RING-type E3 ubiquitin transferase LRSAM1) (Tsg101-associated ligase) (hTAL) Homo sapiens (Human) GO:0000209; GO:0004842; GO:0005737; GO:0005829; GO:0006914; GO:0008270; GO:0016020; GO:0030163; GO:0045806; GO:0046755; GO:0051865; GO:0061630; GO:0070086; GO:1904417; GO:2000786 autophagy [GO:0006914]; negative regulation of endocytosis [GO:0045806]; positive regulation of autophagosome assembly [GO:2000786]; positive regulation of xenophagy [GO:1904417]; protein autoubiquitination [GO:0051865]; protein catabolic process [GO:0030163]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent endocytosis [GO:0070086]; viral budding [GO:0046755] cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020] ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] g23727.t1 Q6DRC4 55.102 294 1.5500000000000001e-99 296.0 sp|Q6DRC4|EIF3G_DANRE Eukaryotic translation initiation factor 3 subunit G OS=Danio rerio OX=7955 GN=eif3g PE=1 SV=1 EIF3G_DANRE reviewed Eukaryotic translation initiation factor 3 subunit G (eIF3g) (Eukaryotic translation initiation factor 3 RNA-binding subunit) (eIF-3 RNA-binding subunit) (Eukaryotic translation initiation factor 3 subunit 4) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001732; GO:0003723; GO:0003743; GO:0005852; GO:0006413; GO:0016282; GO:0033290 formation of cytoplasmic translation initiation complex [GO:0001732]; translational initiation [GO:0006413] eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852] RNA binding [GO:0003723]; translation initiation factor activity [GO:0003743] g23736.t1 Q9H7T0 30.597 402 2.54e-51 197.0 sp|Q9H7T0|CTSRB_HUMAN Cation channel sperm-associated auxiliary subunit beta OS=Homo sapiens OX=9606 GN=CATSPERB PE=1 SV=2 g23738.t1 O57590 71.642 268 9.92e-111 323.0 sp|O57590|SURF4_TAKRU Surfeit locus protein 4 OS=Takifugu rubripes OX=31033 GN=surf4 PE=3 SV=1 g23739.t1 B2GUY0 52.252 666 0.0 657.0 sp|B2GUY0|MA1B1_RAT Endoplasmic reticulum mannosyl-oligosaccharide 1,2-alpha-mannosidase OS=Rattus norvegicus OX=10116 GN=Man1b1 PE=2 SV=2 MA1B1_RAT reviewed Endoplasmic reticulum mannosyl-oligosaccharide 1,2-alpha-mannosidase (EC 3.2.1.113) (ER alpha-1,2-mannosidase) (ER mannosidase 1) (ERMan1) (Mannosidase alpha class 1B member 1) Rattus norvegicus (Rat) GO:0004571; GO:0005509; GO:0005783; GO:0005789; GO:0005975; GO:0016020; GO:0031410; GO:0036503; GO:0044322 carbohydrate metabolic process [GO:0005975]; ERAD pathway [GO:0036503] cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum quality control compartment [GO:0044322]; membrane [GO:0016020] calcium ion binding [GO:0005509]; mannosyl-oligosaccharide 1,2-alpha-mannosidase activity [GO:0004571] g23740.t1 Q9H4F1 45.098 255 6.32e-71 227.0 sp|Q9H4F1|SIA7D_HUMAN Alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1,3-N-acetyl-galactosaminide alpha-2,6-sialyltransferase OS=Homo sapiens OX=9606 GN=ST6GALNAC4 PE=1 SV=2 g23741.t1 Q9CXY9 63.603 272 2.45e-130 379.0 sp|Q9CXY9|GPI8_MOUSE GPI-anchor transamidase OS=Mus musculus OX=10090 GN=Pigk PE=1 SV=2 g23743.t1 P55866 38.764 178 2.3700000000000003e-27 112.0 sp|P55866|CASP3_XENLA Caspase-3 OS=Xenopus laevis OX=8355 GN=casp3 PE=2 SV=1 g23745.t1 Q5TJE1 40.594 202 2.79e-43 166.0 sp|Q5TJE1|DAXX_CANLF Death domain-associated protein 6 OS=Canis lupus familiaris OX=9615 GN=DAXX PE=3 SV=1 g23746.t1 Q9UER7 38.61 259 1.1999999999999998e-38 158.0 sp|Q9UER7|DAXX_HUMAN Death domain-associated protein 6 OS=Homo sapiens OX=9606 GN=DAXX PE=1 SV=2 DAXX_HUMAN reviewed Death domain-associated protein 6 (Daxx) (hDaxx) (ETS1-associated protein 1) (EAP1) (Fas death domain-associated protein) Homo sapiens (Human) GO:0000775; GO:0002039; GO:0003713; GO:0003714; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0006334; GO:0006338; GO:0006355; GO:0007254; GO:0008625; GO:0010468; GO:0010629; GO:0016604; GO:0016605; GO:0019899; GO:0019901; GO:0030295; GO:0030521; GO:0031072; GO:0031396; GO:0031625; GO:0034605; GO:0034620; GO:0036480; GO:0042393; GO:0042803; GO:0042981; GO:0045892; GO:0050681; GO:0061629; GO:0071276; GO:0071280; GO:0072738; GO:0140416; GO:0140693; GO:1903936 androgen receptor signaling pathway [GO:0030521]; cellular response to cadmium ion [GO:0071276]; cellular response to copper ion [GO:0071280]; cellular response to diamide [GO:0072738]; cellular response to heat [GO:0034605]; cellular response to sodium arsenite [GO:1903936]; cellular response to unfolded protein [GO:0034620]; chromatin remodeling [GO:0006338]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; JNK cascade [GO:0007254]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of gene expression [GO:0010629]; neuron intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0036480]; nucleosome assembly [GO:0006334]; regulation of apoptotic process [GO:0042981]; regulation of DNA-templated transcription [GO:0006355]; regulation of gene expression [GO:0010468]; regulation of protein ubiquitination [GO:0031396] chromosome, centromeric region [GO:0000775]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605] enzyme binding [GO:0019899]; heat shock protein binding [GO:0031072]; histone binding [GO:0042393]; molecular condensate scaffold activity [GO:0140693]; nuclear androgen receptor binding [GO:0050681]; p53 binding [GO:0002039]; protein homodimerization activity [GO:0042803]; protein kinase activator activity [GO:0030295]; protein kinase binding [GO:0019901]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; transcription regulator inhibitor activity [GO:0140416]; ubiquitin protein ligase binding [GO:0031625] g23747.t1 A4II29 68.889 90 3.48e-39 129.0 sp|A4II29|NRARP_XENTR Notch-regulated ankyrin repeat-containing protein OS=Xenopus tropicalis OX=8364 GN=nrarp PE=3 SV=1 g23748.t1 Q0IIB1 53.333 285 7.6e-102 302.0 sp|Q0IIB1|PHYD1_BOVIN Phytanoyl-CoA dioxygenase domain-containing protein 1 OS=Bos taurus OX=9913 GN=PHYHD1 PE=2 SV=1 g23749.t1 P53413 57.312 253 3.72e-91 282.0 sp|P53413|LMX1B_CHICK LIM/homeobox protein LMX-1.2 OS=Gallus gallus OX=9031 GN=LMX1B PE=2 SV=2 g23752.t1 Q9D994 45.161 279 1.62e-79 247.0 sp|Q9D994|WDR38_MOUSE WD repeat-containing protein 38 OS=Mus musculus OX=10090 GN=Wdr38 PE=2 SV=1 g23753.t1 O35127 51.961 102 1.41e-34 119.0 sp|O35127|C10_MOUSE Protein C10 OS=Mus musculus OX=10090 GN=Grcc10 PE=1 SV=1 g23756.t1 Q95NU5 38.762 307 9.780000000000001e-72 229.0 sp|Q95NU5|TORS_CAEEL Torsin-like protein OS=Caenorhabditis elegans OX=6239 GN=ooc-5 PE=1 SV=1 TORS_CAEEL reviewed Torsin-like protein (Abnormal oocyte formation protein 5) Caenorhabditis elegans GO:0000922; GO:0005524; GO:0005783; GO:0005788; GO:0005818; GO:0005819; GO:0005886; GO:0016887; GO:0048471; GO:0071218 cellular response to misfolded protein [GO:0071218] aster [GO:0005818]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; spindle [GO:0005819]; spindle pole [GO:0000922] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887] g23757.t1 E9Q309 33.813 556 4.66e-60 235.0 sp|E9Q309|CE350_MOUSE Centrosome-associated protein 350 OS=Mus musculus OX=10090 GN=Cep350 PE=1 SV=1 g23757.t1 E9Q309 35.294 340 5.46e-35 152.0 sp|E9Q309|CE350_MOUSE Centrosome-associated protein 350 OS=Mus musculus OX=10090 GN=Cep350 PE=1 SV=1 g23758.t1 Q8N1B4 62.865 684 0.0 949.0 sp|Q8N1B4|VPS52_HUMAN Vacuolar protein sorting-associated protein 52 homolog OS=Homo sapiens OX=9606 GN=VPS52 PE=1 SV=1 VPS52_HUMAN reviewed Vacuolar protein sorting-associated protein 52 homolog (SAC2 suppressor of actin mutations 2-like protein) Homo sapiens (Human) GO:0000938; GO:0005794; GO:0005829; GO:0006605; GO:0006896; GO:0007041; GO:0010008; GO:0010668; GO:0015031; GO:0016020; GO:0019905; GO:0032456; GO:0032588; GO:0042147; GO:0048471; GO:0048611; GO:0055037; GO:0090119; GO:0098793; GO:0098794; GO:1990745 ectodermal cell differentiation [GO:0010668]; embryonic ectodermal digestive tract development [GO:0048611]; endocytic recycling [GO:0032456]; Golgi to vacuole transport [GO:0006896]; lysosomal transport [GO:0007041]; protein targeting [GO:0006605]; protein transport [GO:0015031]; retrograde transport, endosome to Golgi [GO:0042147]; vesicle-mediated cholesterol transport [GO:0090119] cytosol [GO:0005829]; EARP complex [GO:1990745]; endosome membrane [GO:0010008]; GARP complex [GO:0000938]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; postsynapse [GO:0098794]; presynapse [GO:0098793]; recycling endosome [GO:0055037]; trans-Golgi network membrane [GO:0032588] syntaxin binding [GO:0019905] g23759.t1 Q8ISP0 86.26 131 1.14e-83 245.0 sp|Q8ISP0|RS18_BRABE Small ribosomal subunit protein uS13 OS=Branchiostoma belcheri OX=7741 GN=RPS18 PE=2 SV=1 g23760.t1 Q6DCP1 55.396 278 1.8e-96 299.0 sp|Q6DCP1|FXRD1_XENLA FAD-dependent oxidoreductase domain-containing protein 1 OS=Xenopus laevis OX=8355 GN=foxred1 PE=2 SV=1 g23761.t1 Q5EA45 54.07 172 2.0600000000000002e-47 165.0 sp|Q5EA45|FXRD1_BOVIN FAD-dependent oxidoreductase domain-containing protein 1 OS=Bos taurus OX=9913 GN=FOXRED1 PE=2 SV=1 g23762.t1 Q7M370 39.574 235 5.95e-39 145.0 sp|Q7M370|AAAD_RABIT Arylacetamide deacetylase OS=Oryctolagus cuniculus OX=9986 GN=AADAC PE=1 SV=1 AAAD_RABIT reviewed Arylacetamide deacetylase (EC 3.1.1.3) (50 kDa microsomal esterase/N-deacetylase) Oryctolagus cuniculus (Rabbit) GO:0004806; GO:0005789; GO:0006629; GO:0019213 lipid metabolic process [GO:0006629] endoplasmic reticulum membrane [GO:0005789] deacetylase activity [GO:0019213]; triacylglycerol lipase activity [GO:0004806] g23765.t1 Q6AX44 48.768 203 5.3099999999999995e-55 187.0 sp|Q6AX44|FBCDA_XENLA Fibrinogen C domain-containing protein 1-A OS=Xenopus laevis OX=8355 GN=fibcd1-a PE=2 SV=1 g23767.t1 Q2T9J0 32.67 603 9.579999999999999e-81 268.0 sp|Q2T9J0|TYSD1_HUMAN Peroxisomal leader peptide-processing protease OS=Homo sapiens OX=9606 GN=TYSND1 PE=1 SV=3 TYSD1_HUMAN reviewed Peroxisomal leader peptide-processing protease (EC 3.4.21.-) (Trypsin domain-containing protein 1) [Cleaved into: Peroxisomal leader peptide-processing protease, 15 kDa form; Peroxisomal leader peptide-processing protease, 45 kDa form] Homo sapiens (Human) GO:0002020; GO:0004252; GO:0005777; GO:0005782; GO:0005829; GO:0006508; GO:0016020; GO:0016485; GO:0031998; GO:0042802 protein processing [GO:0016485]; proteolysis [GO:0006508]; regulation of fatty acid beta-oxidation [GO:0031998] cytosol [GO:0005829]; membrane [GO:0016020]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777] identical protein binding [GO:0042802]; protease binding [GO:0002020]; serine-type endopeptidase activity [GO:0004252] g23768.t1 Q8N531 37.671 438 1.64e-69 236.0 sp|Q8N531|FBXL6_HUMAN F-box/LRR-repeat protein 6 OS=Homo sapiens OX=9606 GN=FBXL6 PE=1 SV=2 g23769.t1 A0A087WRI3 40.664 241 3.44e-52 174.0 sp|A0A087WRI3|CFA77_MOUSE Cilia- and flagella-associated protein 77 OS=Mus musculus OX=10090 GN=Cfap77 PE=1 SV=1 CFA77_MOUSE reviewed Cilia- and flagella-associated protein 77 Mus musculus (Mouse) GO:0005879; GO:0005929; GO:0005930; GO:0030317; GO:0036126; GO:0160112 flagellated sperm motility [GO:0030317] axonemal B tubule inner sheath [GO:0160112]; axonemal microtubule [GO:0005879]; axoneme [GO:0005930]; cilium [GO:0005929]; sperm flagellum [GO:0036126] g23770.t1 O13076 28.571 336 1.94e-31 125.0 sp|O13076|AA2BR_CHICK Adenosine receptor A2b OS=Gallus gallus OX=9031 GN=ADORA2B PE=2 SV=1 g23774.t1 C3KJF2 47.573 103 1.04e-22 94.0 sp|C3KJF2|SWI5_ANOFI DNA repair protein SWI5 homolog OS=Anoplopoma fimbria OX=229290 GN=swi5 PE=2 SV=1 g23776.t1 A7MBH5 39.06 553 2.02e-101 322.0 sp|A7MBH5|ODAD3_BOVIN Outer dynein arm-docking complex subunit 3 OS=Bos taurus OX=9913 GN=ODAD3 PE=1 SV=1 ODAD3_BOVIN reviewed Outer dynein arm-docking complex subunit 3 (Coiled-coil domain-containing protein 151) Bos taurus (Bovine) GO:0003341; GO:0005814; GO:0005929; GO:0005930; GO:0035253; GO:0036064; GO:0036158; GO:0097542; GO:0120228; GO:1902017 cilium movement [GO:0003341]; outer dynein arm assembly [GO:0036158]; regulation of cilium assembly [GO:1902017] axoneme [GO:0005930]; centriole [GO:0005814]; ciliary basal body [GO:0036064]; ciliary rootlet [GO:0035253]; ciliary tip [GO:0097542]; cilium [GO:0005929]; outer dynein arm docking complex [GO:0120228] g23779.t1 Q5NU32 28.512 484 1.08e-49 180.0 sp|Q5NU32|AOFA_HORSE Amine oxidase [flavin-containing] A OS=Equus caballus OX=9796 GN=MAOA PE=2 SV=1 AOFA_HORSE reviewed Amine oxidase [flavin-containing] A (EC 1.4.3.21) (EC 1.4.3.4) (Monoamine oxidase type A) (MAO-A) Equus caballus (Horse) GO:0005739; GO:0005741; GO:0006584; GO:0008131; GO:0050660; GO:0097621 catecholamine metabolic process [GO:0006584] mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739] flavin adenine dinucleotide binding [GO:0050660]; monoamine oxidase activity [GO:0097621]; primary methylamine oxidase activity [GO:0008131] g23780.t1 P29348 50.0 346 1.94e-124 366.0 sp|P29348|GNAT3_RAT Guanine nucleotide-binding protein G(t) subunit alpha-3 OS=Rattus norvegicus OX=10116 GN=Gnat3 PE=1 SV=3 GNAT3_RAT reviewed Guanine nucleotide-binding protein G(t) subunit alpha-3 (Gustducin alpha-3 chain) Rattus norvegicus (Rat) GO:0001664; GO:0001669; GO:0003924; GO:0005525; GO:0005737; GO:0005834; GO:0005886; GO:0005930; GO:0007186; GO:0007188; GO:0007603; GO:0016324; GO:0031683; GO:0032991; GO:0035094; GO:0046872; GO:0050908; GO:0050909; GO:0050913; GO:0050916; GO:0050917 adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; detection of light stimulus involved in visual perception [GO:0050908]; G protein-coupled receptor signaling pathway [GO:0007186]; phototransduction, visible light [GO:0007603]; response to nicotine [GO:0035094]; sensory perception of bitter taste [GO:0050913]; sensory perception of sweet taste [GO:0050916]; sensory perception of taste [GO:0050909]; sensory perception of umami taste [GO:0050917] acrosomal vesicle [GO:0001669]; apical plasma membrane [GO:0016324]; axoneme [GO:0005930]; cytoplasm [GO:0005737]; heterotrimeric G-protein complex [GO:0005834]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] G protein-coupled receptor binding [GO:0001664]; G-protein beta/gamma-subunit complex binding [GO:0031683]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872] g23782.t1 Q68F67 46.035 454 5.8e-135 423.0 sp|Q68F67|DEN1A_XENLA DENN domain-containing protein 1A OS=Xenopus laevis OX=8355 GN=dennd1a PE=2 SV=1 g23782.t2 Q68F67 46.739 460 4.77e-137 429.0 sp|Q68F67|DEN1A_XENLA DENN domain-containing protein 1A OS=Xenopus laevis OX=8355 GN=dennd1a PE=2 SV=1 g23783.t1 Q5VUE5 53.947 76 3e-22 90.9 sp|Q5VUE5|CA053_HUMAN Uncharacterized protein C1orf53 OS=Homo sapiens OX=9606 GN=C1orf53 PE=1 SV=1 g23785.t1 Q5T1B0 32.845 1023 3.7600000000000004e-163 513.0 sp|Q5T1B0|AXDN1_HUMAN Axonemal dynein light chain domain-containing protein 1 OS=Homo sapiens OX=9606 GN=AXDND1 PE=1 SV=1 AXDN1_HUMAN reviewed Axonemal dynein light chain domain-containing protein 1 Homo sapiens (Human) GO:0005737; GO:0005829; GO:0005929; GO:0007283; GO:0036064; GO:1905198 manchette assembly [GO:1905198]; spermatogenesis [GO:0007283] ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829] g23787.t1 Q6GQB9 59.923 781 0.0 900.0 sp|Q6GQB9|EDEM3_XENLA ER degradation-enhancing alpha-mannosidase-like protein 3 OS=Xenopus laevis OX=8355 GN=edem3 PE=2 SV=2 EDEM3_XENLA reviewed ER degradation-enhancing alpha-mannosidase-like protein 3 (EC 3.2.1.113) (Alpha-1,2-mannosidase EDEM3) Xenopus laevis (African clawed frog) GO:0004571; GO:0005509; GO:0005783; GO:0005788; GO:0005975; GO:0016020; GO:0030968; GO:0044322; GO:0097466; GO:1904380 carbohydrate metabolic process [GO:0005975]; endoplasmic reticulum mannose trimming [GO:1904380]; endoplasmic reticulum unfolded protein response [GO:0030968]; ubiquitin-dependent glycoprotein ERAD pathway [GO:0097466] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum quality control compartment [GO:0044322]; membrane [GO:0016020] calcium ion binding [GO:0005509]; mannosyl-oligosaccharide 1,2-alpha-mannosidase activity [GO:0004571] g23789.t1 Q8R3W5 35.971 139 2.33e-21 90.5 sp|Q8R3W5|SEN15_MOUSE tRNA-splicing endonuclease subunit Sen15 OS=Mus musculus OX=10090 GN=Tsen15 PE=1 SV=1 g23790.t1 Q3TRM4 48.358 1340 0.0 1148.0 sp|Q3TRM4|PLPL6_MOUSE Patatin-like phospholipase domain-containing protein 6 OS=Mus musculus OX=10090 GN=Pnpla6 PE=1 SV=2 PLPL6_MOUSE reviewed Patatin-like phospholipase domain-containing protein 6 (Neuropathy target esterase) (EC 3.1.1.5) Mus musculus (Mouse) GO:0001525; GO:0004622; GO:0005783; GO:0005789; GO:0005829; GO:0009887; GO:0016020; GO:0016042; GO:0046470; GO:0052689 angiogenesis [GO:0001525]; animal organ morphogenesis [GO:0009887]; lipid catabolic process [GO:0016042]; phosphatidylcholine metabolic process [GO:0046470] cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020] carboxylic ester hydrolase activity [GO:0052689]; phosphatidylcholine lysophospholipase activity [GO:0004622] g23790.t2 Q3TRM4 48.72 1328 0.0 1146.0 sp|Q3TRM4|PLPL6_MOUSE Patatin-like phospholipase domain-containing protein 6 OS=Mus musculus OX=10090 GN=Pnpla6 PE=1 SV=2 PLPL6_MOUSE reviewed Patatin-like phospholipase domain-containing protein 6 (Neuropathy target esterase) (EC 3.1.1.5) Mus musculus (Mouse) GO:0001525; GO:0004622; GO:0005783; GO:0005789; GO:0005829; GO:0009887; GO:0016020; GO:0016042; GO:0046470; GO:0052689 angiogenesis [GO:0001525]; animal organ morphogenesis [GO:0009887]; lipid catabolic process [GO:0016042]; phosphatidylcholine metabolic process [GO:0046470] cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020] carboxylic ester hydrolase activity [GO:0052689]; phosphatidylcholine lysophospholipase activity [GO:0004622] g23790.t3 Q3TRM4 47.897 1355 0.0 1138.0 sp|Q3TRM4|PLPL6_MOUSE Patatin-like phospholipase domain-containing protein 6 OS=Mus musculus OX=10090 GN=Pnpla6 PE=1 SV=2 PLPL6_MOUSE reviewed Patatin-like phospholipase domain-containing protein 6 (Neuropathy target esterase) (EC 3.1.1.5) Mus musculus (Mouse) GO:0001525; GO:0004622; GO:0005783; GO:0005789; GO:0005829; GO:0009887; GO:0016020; GO:0016042; GO:0046470; GO:0052689 angiogenesis [GO:0001525]; animal organ morphogenesis [GO:0009887]; lipid catabolic process [GO:0016042]; phosphatidylcholine metabolic process [GO:0046470] cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020] carboxylic ester hydrolase activity [GO:0052689]; phosphatidylcholine lysophospholipase activity [GO:0004622] g23790.t4 Q3TRM4 47.897 1355 0.0 1138.0 sp|Q3TRM4|PLPL6_MOUSE Patatin-like phospholipase domain-containing protein 6 OS=Mus musculus OX=10090 GN=Pnpla6 PE=1 SV=2 PLPL6_MOUSE reviewed Patatin-like phospholipase domain-containing protein 6 (Neuropathy target esterase) (EC 3.1.1.5) Mus musculus (Mouse) GO:0001525; GO:0004622; GO:0005783; GO:0005789; GO:0005829; GO:0009887; GO:0016020; GO:0016042; GO:0046470; GO:0052689 angiogenesis [GO:0001525]; animal organ morphogenesis [GO:0009887]; lipid catabolic process [GO:0016042]; phosphatidylcholine metabolic process [GO:0046470] cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020] carboxylic ester hydrolase activity [GO:0052689]; phosphatidylcholine lysophospholipase activity [GO:0004622] g23791.t1 Q3TQI7 53.846 273 2.11e-78 243.0 sp|Q3TQI7|TLS1_MOUSE Splicing factor C9orf78 homolog OS=Mus musculus OX=10090 PE=1 SV=2 g23793.t1 O75899 30.172 696 3.76e-95 320.0 sp|O75899|GABR2_HUMAN Gamma-aminobutyric acid type B receptor subunit 2 OS=Homo sapiens OX=9606 GN=GABBR2 PE=1 SV=1 GABR2_HUMAN reviewed Gamma-aminobutyric acid type B receptor subunit 2 (GABA-B receptor 2) (GABA-B-R2) (GABA-BR2) (GABABR2) (Gb2) (G-protein coupled receptor 51) (HG20) Homo sapiens (Human) GO:0004888; GO:0004965; GO:0005737; GO:0005886; GO:0007186; GO:0007193; GO:0007194; GO:0007214; GO:0007268; GO:0038039; GO:0043005; GO:0045211; GO:0046982; GO:0051932; GO:0150099; GO:1902710; GO:1902712 adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; chemical synaptic transmission [GO:0007268]; G protein-coupled receptor signaling pathway [GO:0007186]; gamma-aminobutyric acid signaling pathway [GO:0007214]; negative regulation of adenylate cyclase activity [GO:0007194]; neuron-glial cell signaling [GO:0150099]; synaptic transmission, GABAergic [GO:0051932] cytoplasm [GO:0005737]; G protein-coupled GABA receptor complex [GO:1902712]; G protein-coupled receptor heterodimeric complex [GO:0038039]; GABA receptor complex [GO:1902710]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211] G protein-coupled GABA receptor activity [GO:0004965]; protein heterodimerization activity [GO:0046982]; transmembrane signaling receptor activity [GO:0004888] g23797.t1 Q6PFP6 55.664 512 0.0 572.0 sp|Q6PFP6|NDOR1_DANRE NADPH-dependent diflavin oxidoreductase 1 OS=Danio rerio OX=7955 GN=ndor1 PE=2 SV=1 NDOR1_DANRE reviewed NADPH-dependent diflavin oxidoreductase 1 (EC 1.18.1.-) (NADPH-dependent FMN and FAD-containing oxidoreductase) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005634; GO:0005829; GO:0009055; GO:0010181; GO:0016226; GO:0016491; GO:0016653; GO:0048471; GO:0050660; GO:0050661; GO:0160246 iron-sulfur cluster assembly [GO:0016226] cytosol [GO:0005829]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471] electron transfer activity [GO:0009055]; flavin adenine dinucleotide binding [GO:0050660]; FMN binding [GO:0010181]; NADP binding [GO:0050661]; NADPH-iron-sulfur [2Fe-2S] protein oxidoreductase activity [GO:0160246]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on NAD(P)H, heme protein as acceptor [GO:0016653] g23800.t1 Q9Z0S2 47.945 146 9.38e-28 110.0 sp|Q9Z0S2|LHX2_MOUSE LIM/homeobox protein Lhx2 OS=Mus musculus OX=10090 GN=Lhx2 PE=1 SV=1 LHX2_MOUSE reviewed LIM/homeobox protein Lhx2 (Homeobox protein LH-2) (LIM homeobox protein 2) Mus musculus (Mouse) GO:0000977; GO:0000978; GO:0000981; GO:0001228; GO:0001843; GO:0001942; GO:0003682; GO:0005634; GO:0005654; GO:0006357; GO:0007399; GO:0007411; GO:0007420; GO:0007498; GO:0009953; GO:0021537; GO:0021772; GO:0021978; GO:0021987; GO:0022008; GO:0030182; GO:0043565; GO:0045199; GO:0045814; GO:0045893; GO:0045944; GO:0046872; GO:0048646; GO:0048675; GO:0050768; GO:0060041; GO:2000179 anatomical structure formation involved in morphogenesis [GO:0048646]; axon extension [GO:0048675]; axon guidance [GO:0007411]; brain development [GO:0007420]; cerebral cortex development [GO:0021987]; dorsal/ventral pattern formation [GO:0009953]; hair follicle development [GO:0001942]; maintenance of epithelial cell apical/basal polarity [GO:0045199]; mesoderm development [GO:0007498]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of neurogenesis [GO:0050768]; nervous system development [GO:0007399]; neural tube closure [GO:0001843]; neurogenesis [GO:0022008]; neuron differentiation [GO:0030182]; olfactory bulb development [GO:0021772]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; retina development in camera-type eye [GO:0060041]; telencephalon development [GO:0021537]; telencephalon regionalization [GO:0021978] nucleoplasm [GO:0005654]; nucleus [GO:0005634] chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565] g23801.t1 Q1LWV4 61.475 122 1.41e-38 143.0 sp|Q1LWV4|LHX9_DANRE LIM/homeobox protein Lhx9 OS=Danio rerio OX=7955 GN=lhx9 PE=2 SV=1 LHX9_DANRE reviewed LIM/homeobox protein Lhx9 (LIM homeobox protein 9) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000977; GO:0000981; GO:0005634; GO:0006357; GO:0021794; GO:0030182; GO:0045892; GO:0046872; GO:0048665; GO:0097380 dorsal spinal cord interneuron anterior axon guidance [GO:0097380]; negative regulation of DNA-templated transcription [GO:0045892]; neuron differentiation [GO:0030182]; neuron fate specification [GO:0048665]; regulation of transcription by RNA polymerase II [GO:0006357]; thalamus development [GO:0021794] nucleus [GO:0005634] DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977] g23802.t1 Q5TM62 53.731 134 2.51e-44 151.0 sp|Q5TM62|RT18B_MACMU Small ribosomal subunit protein mS40 OS=Macaca mulatta OX=9544 GN=MRPS18B PE=3 SV=1 g23804.t1 Q6GLQ4 45.455 143 2.85e-30 132.0 sp|Q6GLQ4|PP1RA_XENLA Serine/threonine-protein phosphatase 1 regulatory subunit 10 OS=Xenopus laevis OX=8355 GN=ppp1r10 PE=2 SV=1 g23804.t2 Q6GLQ4 45.455 143 2.64e-30 132.0 sp|Q6GLQ4|PP1RA_XENLA Serine/threonine-protein phosphatase 1 regulatory subunit 10 OS=Xenopus laevis OX=8355 GN=ppp1r10 PE=2 SV=1 g23805.t1 A1IH00 37.546 823 7.17e-116 384.0 sp|A1IH00|GOGA2_DANRE Golgin subfamily A member 2 OS=Danio rerio OX=7955 GN=golga2 PE=2 SV=1 GOGA2_DANRE reviewed Golgin subfamily A member 2 (Golgin A2) (cis-Golgi matrix protein GM130) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000137; GO:0000922; GO:0001966; GO:0005801; GO:0005874; GO:0007030; GO:0007420; GO:0007519; GO:0015031; GO:0032580; GO:0033116; GO:0051301 brain development [GO:0007420]; cell division [GO:0051301]; Golgi organization [GO:0007030]; protein transport [GO:0015031]; skeletal muscle tissue development [GO:0007519]; thigmotaxis [GO:0001966] cis-Golgi network [GO:0005801]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi cis cisterna [GO:0000137]; Golgi cisterna membrane [GO:0032580]; microtubule [GO:0005874]; spindle pole [GO:0000922] g23806.t1 Q32Q86 56.549 481 0.0 612.0 sp|Q32Q86|CRY1_RAT Cryptochrome-1 OS=Rattus norvegicus OX=10116 GN=Cry1 PE=1 SV=1 CRY1_RAT reviewed Cryptochrome-1 Rattus norvegicus (Rat) GO:0000122; GO:0003677; GO:0003690; GO:0005634; GO:0005737; GO:0005739; GO:0006094; GO:0006111; GO:0007623; GO:0009416; GO:0009881; GO:0014823; GO:0016922; GO:0019900; GO:0019901; GO:0019902; GO:0019915; GO:0031397; GO:0031398; GO:0032868; GO:0032922; GO:0033762; GO:0042593; GO:0042752; GO:0042754; GO:0042770; GO:0042826; GO:0043153; GO:0045721; GO:0045722; GO:0045744; GO:0045892; GO:0070888; GO:0071949; GO:0140297; GO:2000001; GO:2000323; GO:2000850 circadian regulation of gene expression [GO:0032922]; circadian rhythm [GO:0007623]; entrainment of circadian clock by photoperiod [GO:0043153]; gluconeogenesis [GO:0006094]; glucose homeostasis [GO:0042593]; lipid storage [GO:0019915]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of G protein-coupled receptor signaling pathway [GO:0045744]; negative regulation of glucocorticoid secretion [GO:2000850]; negative regulation of gluconeogenesis [GO:0045721]; negative regulation of nuclear receptor-mediated glucocorticoid signaling pathway [GO:2000323]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of gluconeogenesis [GO:0045722]; positive regulation of protein ubiquitination [GO:0031398]; regulation of circadian rhythm [GO:0042752]; regulation of DNA damage checkpoint [GO:2000001]; regulation of gluconeogenesis [GO:0006111]; response to activity [GO:0014823]; response to glucagon [GO:0033762]; response to insulin [GO:0032868]; response to light stimulus [GO:0009416]; signal transduction in response to DNA damage [GO:0042770] cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleus [GO:0005634] DNA binding [GO:0003677]; DNA-binding transcription factor binding [GO:0140297]; double-stranded DNA binding [GO:0003690]; E-box binding [GO:0070888]; FAD binding [GO:0071949]; histone deacetylase binding [GO:0042826]; kinase binding [GO:0019900]; nuclear receptor binding [GO:0016922]; phosphatase binding [GO:0019902]; photoreceptor activity [GO:0009881]; protein kinase binding [GO:0019901] g23813.t1 Q7ZVB2 58.678 484 0.0 580.0 sp|Q7ZVB2|A9A1A_DANRE 4-trimethylaminobutyraldehyde dehydrogenase A OS=Danio rerio OX=7955 GN=aldh9a1a PE=2 SV=1 g23814.t1 Q6XLQ7 33.476 233 2.43e-30 119.0 sp|Q6XLQ7|CALU_RABIT Calumenin OS=Oryctolagus cuniculus OX=9986 GN=CALU PE=1 SV=2 g23816.t1 Q6AXY7 71.875 192 3.87e-81 261.0 sp|Q6AXY7|PR38B_RAT Pre-mRNA-splicing factor 38B OS=Rattus norvegicus OX=10116 GN=Prpf38b PE=1 SV=1 g23816.t2 Q80SY5 63.981 211 2.56e-72 238.0 sp|Q80SY5|PR38B_MOUSE Pre-mRNA-splicing factor 38B OS=Mus musculus OX=10090 GN=Prpf38b PE=1 SV=1 g23817.t1 Q9D3A8 66.507 209 2.64e-82 273.0 sp|Q9D3A8|CAPON_MOUSE Carboxyl-terminal PDZ ligand of neuronal nitric oxide synthase protein OS=Mus musculus OX=10090 GN=Nos1ap PE=1 SV=3 CAPON_MOUSE reviewed Carboxyl-terminal PDZ ligand of neuronal nitric oxide synthase protein (C-terminal PDZ ligand of neuronal nitric oxide synthase protein) (Nitric oxide synthase 1 adaptor protein) Mus musculus (Mouse) GO:0002020; GO:0002102; GO:0003062; GO:0005634; GO:0005739; GO:0005829; GO:0030018; GO:0030165; GO:0030175; GO:0031434; GO:0031965; GO:0033017; GO:0035591; GO:0050998; GO:0060307; GO:0098793; GO:0098794; GO:0098974; GO:0098978 postsynaptic actin cytoskeleton organization [GO:0098974]; regulation of heart rate by chemical signal [GO:0003062]; regulation of ventricular cardiac muscle cell membrane repolarization [GO:0060307] cytosol [GO:0005829]; filopodium [GO:0030175]; glutamatergic synapse [GO:0098978]; mitochondrion [GO:0005739]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; podosome [GO:0002102]; postsynapse [GO:0098794]; presynapse [GO:0098793]; sarcoplasmic reticulum membrane [GO:0033017]; Z disc [GO:0030018] mitogen-activated protein kinase kinase binding [GO:0031434]; nitric-oxide synthase binding [GO:0050998]; PDZ domain binding [GO:0030165]; protease binding [GO:0002020]; signaling adaptor activity [GO:0035591] g23819.t1 B3EWY9 31.752 548 6.18e-62 235.0 sp|B3EWY9|MLP_ACRMI Mucin-like protein (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g23819.t1 B3EWY9 32.836 335 1.27e-26 122.0 sp|B3EWY9|MLP_ACRMI Mucin-like protein (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g23819.t1 B3EWY9 35.231 281 1.6700000000000001e-22 108.0 sp|B3EWY9|MLP_ACRMI Mucin-like protein (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g23820.t1 Q8HZ57 33.022 536 6.36e-60 220.0 sp|Q8HZ57|CCHCR_PANPA Coiled-coil alpha-helical rod protein 1 OS=Pan paniscus OX=9597 GN=CCHCR1 PE=3 SV=1 g23821.t1 Q5RF15 48.571 420 1.1700000000000001e-130 392.0 sp|Q5RF15|TNI3K_PONAB Serine/threonine-protein kinase TNNI3K OS=Pongo abelii OX=9601 GN=TNNI3K PE=2 SV=3 TNI3K_PONAB reviewed Serine/threonine-protein kinase TNNI3K (EC 2.7.11.1) (TNNI3-interacting kinase) Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0046872; GO:0106310 cytoplasm [GO:0005737]; nucleus [GO:0005634] ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g23822.t1 Q0VA36 32.308 325 1.55e-55 191.0 sp|Q0VA36|ODR4_XENTR Protein odr-4 homolog OS=Xenopus tropicalis OX=8364 GN=odr4 PE=2 SV=2 g23823.t1 B0S5D5 37.063 286 4.4899999999999995e-52 175.0 sp|B0S5D5|ZD12A_DANRE Palmitoyltransferase ZDHHC12-A OS=Danio rerio OX=7955 GN=zdhhc12a PE=3 SV=1 ZD12A_DANRE reviewed Palmitoyltransferase ZDHHC12-A (EC 2.3.1.225) (Zinc finger DHHC domain-containing protein 12-A) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000139; GO:0005783; GO:0005789; GO:0005794; GO:0006612; GO:0018230; GO:0019706; GO:1900226 negative regulation of NLRP3 inflammasome complex assembly [GO:1900226]; peptidyl-L-cysteine S-palmitoylation [GO:0018230]; protein targeting to membrane [GO:0006612] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139] protein-cysteine S-palmitoyltransferase activity [GO:0019706] g23828.t1 Q9DAW6 64.158 505 0.0 656.0 sp|Q9DAW6|PRP4_MOUSE U4/U6 small nuclear ribonucleoprotein Prp4 OS=Mus musculus OX=10090 GN=Prpf4 PE=1 SV=1 g23829.t1 Q566U4 39.932 293 1.28e-69 221.0 sp|Q566U4|KFA_DANRE Kynurenine formamidase OS=Danio rerio OX=7955 GN=afmid PE=2 SV=2 g23830.t1 G1TFM5 90.547 201 1.05e-136 384.0 sp|G1TFM5|RS5_RABIT Small ribosomal subunit protein uS7 OS=Oryctolagus cuniculus OX=9986 GN=RPS5 PE=1 SV=1 g23831.t1 Q9D6I7 39.175 388 1.04e-103 317.0 sp|Q9D6I7|DIK1A_MOUSE Divergent protein kinase domain 1A OS=Mus musculus OX=10090 GN=Dipk1a PE=2 SV=1 g23834.t1 P21329 25.788 539 2.58e-33 140.0 sp|P21329|RTJK_DROFU RNA-directed DNA polymerase from mobile element jockey OS=Drosophila funebris OX=7221 GN=jockey\pol PE=1 SV=1 g23836.t1 P25109 28.8 250 9.440000000000001e-29 118.0 sp|P25109|ACHB_RAT Acetylcholine receptor subunit beta OS=Rattus norvegicus OX=10116 GN=Chrnb1 PE=2 SV=1 ACHB_RAT reviewed Acetylcholine receptor subunit beta Rattus norvegicus (Rat) GO:0001941; GO:0003009; GO:0005886; GO:0005892; GO:0006812; GO:0006936; GO:0007165; GO:0007271; GO:0007274; GO:0015267; GO:0015276; GO:0015464; GO:0022848; GO:0031594; GO:0034220; GO:0035095; GO:0042166; GO:0042391; GO:0043005; GO:0045202; GO:0050877; GO:0051899; GO:0055001; GO:0095500; GO:0099634; GO:1904315 acetylcholine receptor signaling pathway [GO:0095500]; behavioral response to nicotine [GO:0035095]; membrane depolarization [GO:0051899]; monoatomic cation transport [GO:0006812]; monoatomic ion transmembrane transport [GO:0034220]; muscle cell development [GO:0055001]; muscle contraction [GO:0006936]; nervous system process [GO:0050877]; neuromuscular synaptic transmission [GO:0007274]; postsynaptic membrane organization [GO:0001941]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]; skeletal muscle contraction [GO:0003009]; synaptic transmission, cholinergic [GO:0007271] acetylcholine-gated channel complex [GO:0005892]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic specialization membrane [GO:0099634]; synapse [GO:0045202] acetylcholine binding [GO:0042166]; acetylcholine receptor activity [GO:0015464]; acetylcholine-gated monoatomic cation-selective channel activity [GO:0022848]; channel activity [GO:0015267]; ligand-gated monoatomic ion channel activity [GO:0015276]; transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315] g23837.t1 O15431 54.483 145 2.4899999999999997e-54 174.0 sp|O15431|COPT1_HUMAN High affinity copper uptake protein 1 OS=Homo sapiens OX=9606 GN=SLC31A1 PE=1 SV=1 COPT1_HUMAN reviewed High affinity copper uptake protein 1 (Copper transporter 1) (hCTR1) (Solute carrier family 31 member 1) [Cleaved into: Truncated CTR1 form] Homo sapiens (Human) GO:0001525; GO:0005375; GO:0005507; GO:0005886; GO:0006825; GO:0006878; GO:0014704; GO:0015080; GO:0015677; GO:0015679; GO:0016323; GO:0016324; GO:0031901; GO:0031902; GO:0036324; GO:0042802; GO:0042908; GO:0042910; GO:0051259; GO:0051649; GO:0055038; GO:1902601 angiogenesis [GO:0001525]; copper ion import [GO:0015677]; copper ion transport [GO:0006825]; establishment of localization in cell [GO:0051649]; intracellular copper ion homeostasis [GO:0006878]; plasma membrane copper ion transport [GO:0015679]; protein complex oligomerization [GO:0051259]; silver ion transmembrane transport [GO:1902601]; vascular endothelial growth factor receptor-2 signaling pathway [GO:0036324]; xenobiotic transport [GO:0042908] apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; early endosome membrane [GO:0031901]; intercalated disc [GO:0014704]; late endosome membrane [GO:0031902]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038] copper ion binding [GO:0005507]; copper ion transmembrane transporter activity [GO:0005375]; identical protein binding [GO:0042802]; silver ion transmembrane transporter activity [GO:0015080]; xenobiotic transmembrane transporter activity [GO:0042910] g23840.t1 Q8WU76 34.739 498 8.3e-73 244.0 sp|Q8WU76|SCFD2_HUMAN Sec1 family domain-containing protein 2 OS=Homo sapiens OX=9606 GN=SCFD2 PE=1 SV=2 g23841.t1 Q8WU76 51.88 133 8.03e-40 145.0 sp|Q8WU76|SCFD2_HUMAN Sec1 family domain-containing protein 2 OS=Homo sapiens OX=9606 GN=SCFD2 PE=1 SV=2 g23842.t1 Q01105 72.081 197 3.3e-100 298.0 sp|Q01105|SET_HUMAN Protein SET OS=Homo sapiens OX=9606 GN=SET PE=1 SV=3 SET_HUMAN reviewed Protein SET (HLA-DR-associated protein II) (Inhibitor of granzyme A-activated DNase) (IGAAD) (PHAPII) (Phosphatase 2A inhibitor I2PP2A) (I-2PP2A) (Template-activating factor I) (TAF-I) Homo sapiens (Human) GO:0000785; GO:0003677; GO:0003682; GO:0004864; GO:0005634; GO:0005654; GO:0005737; GO:0005783; GO:0005811; GO:0005829; GO:0006260; GO:0006334; GO:0006337; GO:0019888; GO:0032991; GO:0042393; GO:0043524; GO:0045892; GO:0048471 DNA replication [GO:0006260]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of neuron apoptotic process [GO:0043524]; nucleosome assembly [GO:0006334]; nucleosome disassembly [GO:0006337] chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; lipid droplet [GO:0005811]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991] chromatin binding [GO:0003682]; DNA binding [GO:0003677]; histone binding [GO:0042393]; protein phosphatase inhibitor activity [GO:0004864]; protein phosphatase regulator activity [GO:0019888] g23843.t1 Q8K211 36.296 135 1.71e-24 96.7 sp|Q8K211|COPT1_MOUSE High affinity copper uptake protein 1 OS=Mus musculus OX=10090 GN=Slc31a1 PE=1 SV=1 COPT1_MOUSE reviewed High affinity copper uptake protein 1 (Copper transporter 1) (CTR1) (Solute carrier family 31 member 1) [Cleaved into: Truncated CTR1 form] Mus musculus (Mouse) GO:0001525; GO:0005375; GO:0005507; GO:0005770; GO:0005886; GO:0006825; GO:0006878; GO:0014704; GO:0015080; GO:0015677; GO:0015679; GO:0016323; GO:0016324; GO:0031901; GO:0031902; GO:0036324; GO:0042802; GO:0042908; GO:0042910; GO:0043025; GO:0051259; GO:0055037; GO:0055038; GO:0055085; GO:0072719; GO:0098705; GO:1902601 angiogenesis [GO:0001525]; cellular response to cisplatin [GO:0072719]; copper ion import [GO:0015677]; copper ion import across plasma membrane [GO:0098705]; copper ion transport [GO:0006825]; intracellular copper ion homeostasis [GO:0006878]; plasma membrane copper ion transport [GO:0015679]; protein complex oligomerization [GO:0051259]; silver ion transmembrane transport [GO:1902601]; transmembrane transport [GO:0055085]; vascular endothelial growth factor receptor-2 signaling pathway [GO:0036324]; xenobiotic transport [GO:0042908] apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; early endosome membrane [GO:0031901]; intercalated disc [GO:0014704]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038] copper ion binding [GO:0005507]; copper ion transmembrane transporter activity [GO:0005375]; identical protein binding [GO:0042802]; silver ion transmembrane transporter activity [GO:0015080]; xenobiotic transmembrane transporter activity [GO:0042910] g23844.t1 P28175 31.118 331 4.45e-31 133.0 sp|P28175|CFC_TACTR Clotting factor C OS=Tachypleus tridentatus OX=6853 PE=1 SV=1 g23845.t1 Q9MYM7 40.086 232 1.21e-49 174.0 sp|Q9MYM7|B3GT1_PONPY Beta-1,3-galactosyltransferase 1 OS=Pongo pygmaeus OX=9600 GN=B3GALT1 PE=3 SV=1 g23847.t1 Q5T1M5 53.604 222 9.47e-67 227.0 sp|Q5T1M5|FKB15_HUMAN FK506-binding protein 15 OS=Homo sapiens OX=9606 GN=FKBP15 PE=1 SV=2 FKB15_HUMAN reviewed FK506-binding protein 15 (FKBP-15) (133 kDa FK506-binding protein) (133 kDa FKBP) (FKBP-133) (WASP- and FKBP-like protein) (WAFL) Homo sapiens (Human) GO:0003755; GO:0003779; GO:0005769; GO:0006897; GO:0015629; GO:0016020; GO:0030426 endocytosis [GO:0006897] actin cytoskeleton [GO:0015629]; early endosome [GO:0005769]; growth cone [GO:0030426]; membrane [GO:0016020] actin binding [GO:0003779]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755] g23849.t1 Q5T1M5 38.051 431 4.8e-71 258.0 sp|Q5T1M5|FKB15_HUMAN FK506-binding protein 15 OS=Homo sapiens OX=9606 GN=FKBP15 PE=1 SV=2 FKB15_HUMAN reviewed FK506-binding protein 15 (FKBP-15) (133 kDa FK506-binding protein) (133 kDa FKBP) (FKBP-133) (WASP- and FKBP-like protein) (WAFL) Homo sapiens (Human) GO:0003755; GO:0003779; GO:0005769; GO:0006897; GO:0015629; GO:0016020; GO:0030426 endocytosis [GO:0006897] actin cytoskeleton [GO:0015629]; early endosome [GO:0005769]; growth cone [GO:0030426]; membrane [GO:0016020] actin binding [GO:0003779]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755] g23853.t1 Q9R1A8 76.981 265 6.48e-148 434.0 sp|Q9R1A8|COP1_MOUSE E3 ubiquitin-protein ligase COP1 OS=Mus musculus OX=10090 GN=Cop1 PE=1 SV=2 COP1_MOUSE reviewed E3 ubiquitin-protein ligase COP1 (EC 2.3.2.27) (Constitutive photomorphogenesis protein 1 homolog) (mCOP1) (RING finger and WD repeat domain protein 2) (RING-type E3 ubiquitin transferase RFWD2) Mus musculus (Mouse) GO:0000139; GO:0008270; GO:0010212; GO:0016567; GO:0016607; GO:0031464; GO:0032436; GO:0043161; GO:0061630 positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; response to ionizing radiation [GO:0010212] Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]; Golgi membrane [GO:0000139]; nuclear speck [GO:0016607] ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] g23854.t1 Q9R1A8 52.924 342 6.5e-111 343.0 sp|Q9R1A8|COP1_MOUSE E3 ubiquitin-protein ligase COP1 OS=Mus musculus OX=10090 GN=Cop1 PE=1 SV=2 COP1_MOUSE reviewed E3 ubiquitin-protein ligase COP1 (EC 2.3.2.27) (Constitutive photomorphogenesis protein 1 homolog) (mCOP1) (RING finger and WD repeat domain protein 2) (RING-type E3 ubiquitin transferase RFWD2) Mus musculus (Mouse) GO:0000139; GO:0008270; GO:0010212; GO:0016567; GO:0016607; GO:0031464; GO:0032436; GO:0043161; GO:0061630 positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; response to ionizing radiation [GO:0010212] Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]; Golgi membrane [GO:0000139]; nuclear speck [GO:0016607] ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] g23855.t1 Q8C8N2 78.351 97 3.38e-47 162.0 sp|Q8C8N2|SCAI_MOUSE Protein SCAI OS=Mus musculus OX=10090 GN=Scai PE=1 SV=2 SCAI_MOUSE reviewed Protein SCAI (Suppressor of cancer cell invasion protein) Mus musculus (Mouse) GO:0003714; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0030336; GO:0031965; GO:0035024 DNA-templated transcription [GO:0006351]; negative regulation of cell migration [GO:0030336]; negative regulation of Rho protein signal transduction [GO:0035024] cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] transcription corepressor activity [GO:0003714] g23856.t1 Q8C8N2 50.483 414 6.629999999999999e-137 409.0 sp|Q8C8N2|SCAI_MOUSE Protein SCAI OS=Mus musculus OX=10090 GN=Scai PE=1 SV=2 SCAI_MOUSE reviewed Protein SCAI (Suppressor of cancer cell invasion protein) Mus musculus (Mouse) GO:0003714; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0030336; GO:0031965; GO:0035024 DNA-templated transcription [GO:0006351]; negative regulation of cell migration [GO:0030336]; negative regulation of Rho protein signal transduction [GO:0035024] cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] transcription corepressor activity [GO:0003714] g23857.t1 Q60HH9 65.465 333 6.190000000000001e-166 468.0 sp|Q60HH9|HEM2_MACFA Delta-aminolevulinic acid dehydratase OS=Macaca fascicularis OX=9541 GN=ALAD PE=2 SV=2 g23859.t1 Q09711 71.892 185 2.24e-91 268.0 sp|Q09711|NCS1_SCHPO Calcium-binding protein NCS-1 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) OX=284812 GN=ncs1 PE=1 SV=2 NCS1_SCHPO reviewed Calcium-binding protein NCS-1 Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast) GO:0005509; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0009966; GO:0016020; GO:0019722; GO:0030435; GO:0032588; GO:0046854; GO:0098744; GO:1905949 calcium-mediated signaling [GO:0019722]; negative regulation of calcium ion import across plasma membrane [GO:1905949]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; regulation of signal transduction [GO:0009966]; sporulation resulting in formation of a cellular spore [GO:0030435] cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; trans-Golgi network membrane [GO:0032588] 1-phosphatidylinositol 4-kinase activator activity [GO:0098744]; calcium ion binding [GO:0005509] g23861.t1 Q91614 72.973 111 2.06e-53 169.0 sp|Q91614|NCS1_XENLA Neuronal calcium sensor 1 OS=Xenopus laevis OX=8355 GN=ncs1 PE=2 SV=2 g23862.t1 Q91614 74.312 109 3.98e-53 168.0 sp|Q91614|NCS1_XENLA Neuronal calcium sensor 1 OS=Xenopus laevis OX=8355 GN=ncs1 PE=2 SV=2 g23863.t1 Q2WGJ8 29.858 211 3.29e-25 101.0 sp|Q2WGJ8|TM249_HUMAN Cation channel sperm-associated auxiliary subunit TMEM249 OS=Homo sapiens OX=9606 GN=TMEM249 PE=1 SV=1 CTSRQ_HUMAN reviewed Cation channel sperm-associated auxiliary subunit theta (Cation channel sperm-associated auxiliary subunit TMEM249) (Catsper channel auxiliary subunit theta) (Transmembrane protein 249) Homo sapiens (Human) GO:0036128; GO:0097228 CatSper complex [GO:0036128]; sperm principal piece [GO:0097228] g23864.t1 Q91175 28.71 310 8.240000000000001e-27 113.0 sp|Q91175|ADA1A_ORYLA Alpha-1A adrenergic receptor OS=Oryzias latipes OX=8090 GN=adra1a PE=3 SV=1 ADA1A_ORYLA reviewed Alpha-1A adrenergic receptor (Alpha-1A adrenoreceptor) (Alpha-1A adrenoceptor) (MAR1) Oryzias latipes (Japanese rice fish) (Japanese killifish) GO:0004937; GO:0005886; GO:0007200; GO:0007204; GO:0007267; GO:0010613; GO:0043410; GO:0071880 adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; cell-cell signaling [GO:0007267]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of MAPK cascade [GO:0043410] plasma membrane [GO:0005886] alpha1-adrenergic receptor activity [GO:0004937] g23865.t1 Q02395 43.973 589 2.66e-157 470.0 sp|Q02395|MTF2_MOUSE Metal-response element-binding transcription factor 2 OS=Mus musculus OX=10090 GN=Mtf2 PE=1 SV=2 MTF2_MOUSE reviewed Metal-response element-binding transcription factor 2 (Metal regulatory transcription factor 2) (Metal-response element DNA-binding protein M96) (Polycomb-like protein 2) (mPCl2) (Zinc-regulated factor 1) (ZiRF1) Mus musculus (Mouse) GO:0000977; GO:0001222; GO:0003677; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0007379; GO:0008270; GO:0019827; GO:0040029; GO:0045814; GO:0048863; GO:0140003; GO:1990830 cellular response to leukemia inhibitory factor [GO:1990830]; epigenetic regulation of gene expression [GO:0040029]; negative regulation of gene expression, epigenetic [GO:0045814]; segment specification [GO:0007379]; stem cell differentiation [GO:0048863]; stem cell population maintenance [GO:0019827] cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] chromatin binding [GO:0003682]; DNA binding [GO:0003677]; histone H3K36me3 reader activity [GO:0140003]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; transcription corepressor binding [GO:0001222]; zinc ion binding [GO:0008270] g23866.t1 Q9V6X7 45.918 392 9.32e-113 338.0 sp|Q9V6X7|OFUT1_DROME GDP-fucose protein O-fucosyltransferase 1 OS=Drosophila melanogaster OX=7227 GN=O-fut1 PE=1 SV=1 OFUT1_DROME reviewed GDP-fucose protein O-fucosyltransferase 1 (EC 2.4.1.221) (Neurotic protein) (Peptide-O-fucosyltransferase 1) (O-FucT-1) Drosophila melanogaster (Fruit fly) GO:0005112; GO:0005783; GO:0005788; GO:0006004; GO:0007219; GO:0036066; GO:0045165; GO:0045747; GO:0045807; GO:0046922 cell fate commitment [GO:0045165]; fucose metabolic process [GO:0006004]; Notch signaling pathway [GO:0007219]; positive regulation of endocytosis [GO:0045807]; positive regulation of Notch signaling pathway [GO:0045747]; protein O-linked glycosylation via fucose [GO:0036066] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788] Notch binding [GO:0005112]; peptide-O-fucosyltransferase activity [GO:0046922] g23868.t1 Q7ZYH1 44.595 518 3.6e-148 438.0 sp|Q7ZYH1|SIN1_XENLA Target of rapamycin complex 2 subunit MAPKAP1 OS=Xenopus laevis OX=8355 GN=mapkap1 PE=2 SV=1 SIN1_XENLA reviewed Target of rapamycin complex 2 subunit MAPKAP1 (TORC2 subunit MAPKAP1) (Mitogen-activated protein kinase 2-associated protein 1) (Stress-activated map kinase-interacting protein 1) (SAPK-interacting protein 1) Xenopus laevis (African clawed frog) GO:0000139; GO:0005546; GO:0005547; GO:0005634; GO:0005737; GO:0005741; GO:0005764; GO:0005765; GO:0005769; GO:0005770; GO:0005783; GO:0005789; GO:0005886; GO:0031901; GO:0031902; GO:0031932; GO:0038203; GO:0048471; GO:0140767 TORC2 signaling [GO:0038203] cytoplasm [GO:0005737]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; mitochondrial outer membrane [GO:0005741]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; TORC2 complex [GO:0031932] enzyme-substrate adaptor activity [GO:0140767]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546] g23869.t1 P40426 54.767 451 7.01e-114 343.0 sp|P40426|PBX3_HUMAN Pre-B-cell leukemia transcription factor 3 OS=Homo sapiens OX=9606 GN=PBX3 PE=1 SV=1 PBX3_HUMAN reviewed Pre-B-cell leukemia transcription factor 3 (Homeobox protein PBX3) Homo sapiens (Human) GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0001654; GO:0002087; GO:0005634; GO:0005667; GO:0007387; GO:0007388; GO:0007420; GO:0007585; GO:0008344; GO:0009887; GO:0021516; GO:0048568; GO:0048666 adult locomotory behavior [GO:0008344]; animal organ morphogenesis [GO:0009887]; anterior compartment pattern formation [GO:0007387]; brain development [GO:0007420]; dorsal spinal cord development [GO:0021516]; embryonic organ development [GO:0048568]; eye development [GO:0001654]; neuron development [GO:0048666]; posterior compartment specification [GO:0007388]; regulation of respiratory gaseous exchange by nervous system process [GO:0002087]; respiratory gaseous exchange by respiratory system [GO:0007585] chromatin [GO:0000785]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667] DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978] g23876.t1 Q8BY89 47.526 667 3.62e-174 516.0 sp|Q8BY89|CTL2_MOUSE Choline transporter-like protein 2 OS=Mus musculus OX=10090 GN=Slc44a2 PE=1 SV=2 CTL2_MOUSE reviewed Choline transporter-like protein 2 (Solute carrier family 44 member 2) Mus musculus (Mouse) GO:0005739; GO:0005741; GO:0005886; GO:0015220; GO:0015297; GO:0015871; GO:0016020; GO:0022857; GO:0034228; GO:0034229; GO:0055085 choline transport [GO:0015871]; ethanolamine transport [GO:0034229]; transmembrane transport [GO:0055085] membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886] antiporter activity [GO:0015297]; choline transmembrane transporter activity [GO:0015220]; ethanolamine transmembrane transporter activity [GO:0034228]; transmembrane transporter activity [GO:0022857] g23877.t1 Q6IP59 43.733 750 0.0 555.0 sp|Q6IP59|CTL2_XENLA Choline transporter-like protein 2 OS=Xenopus laevis OX=8355 GN=slc44a2 PE=2 SV=1 g23878.t1 Q7SXP0 63.256 215 1.66e-87 259.0 sp|Q7SXP0|S22BB_DANRE Vesicle-trafficking protein SEC22b-B OS=Danio rerio OX=7955 GN=sec22bb PE=2 SV=1 g23879.t1 A7SBN6 42.615 413 1.81e-83 272.0 sp|A7SBN6|ZGPAT_NEMVE Zinc finger CCCH-type with G patch domain-containing protein OS=Nematostella vectensis OX=45351 GN=v1g244155 PE=3 SV=1 g23881.t1 Q9LGZ2 30.353 425 8.03e-39 149.0 sp|Q9LGZ2|LCYD1_ORYSJ Putative L-cysteine desulfhydrase 1 OS=Oryza sativa subsp. japonica OX=39947 GN=Os01g0290100 PE=2 SV=1 g23882.t1 Q63285 32.944 428 1.01e-60 206.0 sp|Q63285|UHMK1_RAT Serine/threonine-protein kinase Kist OS=Rattus norvegicus OX=10116 GN=Uhmk1 PE=1 SV=1 UHMK1_RAT reviewed Serine/threonine-protein kinase Kist (EC 2.7.11.1) (Kinase interacting with stathmin) (PAM COOH-terminal interactor protein 2) (P-CIP2) (U2AF homology motif kinase 1) Rattus norvegicus (Rat) GO:0003723; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0018105; GO:0019899; GO:0030424; GO:0031175; GO:0032839; GO:0043021; GO:0045948; GO:0046825; GO:0051726; GO:0071598; GO:0106310; GO:1990935 neuron projection development [GO:0031175]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of translational initiation [GO:0045948]; regulation of cell cycle [GO:0051726]; regulation of protein export from nucleus [GO:0046825] axon [GO:0030424]; cytoplasm [GO:0005737]; dendrite cytoplasm [GO:0032839]; neuronal ribonucleoprotein granule [GO:0071598]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] ATP binding [GO:0005524]; enzyme binding [GO:0019899]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; ribonucleoprotein complex binding [GO:0043021]; RNA binding [GO:0003723]; splicing factor binding [GO:1990935] g23883.t1 Q8T3X9 73.984 123 4.08e-64 194.0 sp|Q8T3X9|ISCA1_DROME Iron-sulfur cluster assembly 1 homolog, mitochondrial OS=Drosophila melanogaster OX=7227 GN=MagR PE=1 SV=1 g23885.t1 Q99943 45.833 240 2.06e-59 193.0 sp|Q99943|PLCA_HUMAN 1-acyl-sn-glycerol-3-phosphate acyltransferase alpha OS=Homo sapiens OX=9606 GN=AGPAT1 PE=1 SV=2 PLCA_HUMAN reviewed 1-acyl-sn-glycerol-3-phosphate acyltransferase alpha (EC 2.3.1.51) (1-acylglycerol-3-phosphate O-acyltransferase 1) (1-AGP acyltransferase 1) (1-AGPAT 1) (Lysophosphatidic acid acyltransferase alpha) (LPAAT-alpha) (Protein G15) Homo sapiens (Human) GO:0001819; GO:0001961; GO:0003841; GO:0005783; GO:0005789; GO:0006644; GO:0006654; GO:0016020; GO:0016024 CDP-diacylglycerol biosynthetic process [GO:0016024]; phosphatidic acid biosynthetic process [GO:0006654]; phospholipid metabolic process [GO:0006644]; positive regulation of cytokine production [GO:0001819]; positive regulation of cytokine-mediated signaling pathway [GO:0001961] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020] 1-acylglycerol-3-phosphate O-acyltransferase activity [GO:0003841] g23886.t1 Q5R478 68.66 418 0.0 577.0 sp|Q5R478|AP3M1_PONAB AP-3 complex subunit mu-1 OS=Pongo abelii OX=9601 GN=AP3M1 PE=2 SV=1 g23887.t1 O35161 31.538 891 7.79e-129 432.0 sp|O35161|CELR1_MOUSE Cadherin EGF LAG seven-pass G-type receptor 1 OS=Mus musculus OX=10090 GN=Celsr1 PE=1 SV=3 CELR1_MOUSE reviewed Cadherin EGF LAG seven-pass G-type receptor 1 Mus musculus (Mouse) GO:0001736; GO:0001764; GO:0001843; GO:0001942; GO:0004930; GO:0005509; GO:0005654; GO:0005886; GO:0005912; GO:0007156; GO:0007166; GO:0007266; GO:0007409; GO:0007626; GO:0009952; GO:0016020; GO:0032956; GO:0042060; GO:0042249; GO:0042472; GO:0044331; GO:0045176; GO:0048105; GO:0060488; GO:0060489; GO:0060490; GO:0090251; GO:0097475 anterior/posterior pattern specification [GO:0009952]; apical protein localization [GO:0045176]; axonogenesis [GO:0007409]; cell surface receptor signaling pathway [GO:0007166]; cell-cell adhesion mediated by cadherin [GO:0044331]; establishment of body hair planar orientation [GO:0048105]; establishment of planar polarity [GO:0001736]; establishment of planar polarity of embryonic epithelium [GO:0042249]; hair follicle development [GO:0001942]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; inner ear morphogenesis [GO:0042472]; lateral sprouting involved in lung morphogenesis [GO:0060490]; locomotory behavior [GO:0007626]; motor neuron migration [GO:0097475]; neural tube closure [GO:0001843]; neuron migration [GO:0001764]; orthogonal dichotomous subdivision of terminal units involved in lung branching morphogenesis [GO:0060488]; planar dichotomous subdivision of terminal units involved in lung branching morphogenesis [GO:0060489]; protein localization involved in establishment of planar polarity [GO:0090251]; regulation of actin cytoskeleton organization [GO:0032956]; Rho protein signal transduction [GO:0007266]; wound healing [GO:0042060] adherens junction [GO:0005912]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; G protein-coupled receptor activity [GO:0004930] g23887.t1 O35161 25.104 482 1.16e-21 105.0 sp|O35161|CELR1_MOUSE Cadherin EGF LAG seven-pass G-type receptor 1 OS=Mus musculus OX=10090 GN=Celsr1 PE=1 SV=3 CELR1_MOUSE reviewed Cadherin EGF LAG seven-pass G-type receptor 1 Mus musculus (Mouse) GO:0001736; GO:0001764; GO:0001843; GO:0001942; GO:0004930; GO:0005509; GO:0005654; GO:0005886; GO:0005912; GO:0007156; GO:0007166; GO:0007266; GO:0007409; GO:0007626; GO:0009952; GO:0016020; GO:0032956; GO:0042060; GO:0042249; GO:0042472; GO:0044331; GO:0045176; GO:0048105; GO:0060488; GO:0060489; GO:0060490; GO:0090251; GO:0097475 anterior/posterior pattern specification [GO:0009952]; apical protein localization [GO:0045176]; axonogenesis [GO:0007409]; cell surface receptor signaling pathway [GO:0007166]; cell-cell adhesion mediated by cadherin [GO:0044331]; establishment of body hair planar orientation [GO:0048105]; establishment of planar polarity [GO:0001736]; establishment of planar polarity of embryonic epithelium [GO:0042249]; hair follicle development [GO:0001942]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; inner ear morphogenesis [GO:0042472]; lateral sprouting involved in lung morphogenesis [GO:0060490]; locomotory behavior [GO:0007626]; motor neuron migration [GO:0097475]; neural tube closure [GO:0001843]; neuron migration [GO:0001764]; orthogonal dichotomous subdivision of terminal units involved in lung branching morphogenesis [GO:0060488]; planar dichotomous subdivision of terminal units involved in lung branching morphogenesis [GO:0060489]; protein localization involved in establishment of planar polarity [GO:0090251]; regulation of actin cytoskeleton organization [GO:0032956]; Rho protein signal transduction [GO:0007266]; wound healing [GO:0042060] adherens junction [GO:0005912]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; G protein-coupled receptor activity [GO:0004930] g23889.t1 Q22328 28.571 560 3.44e-58 216.0 sp|Q22328|LEV9_CAEEL Protein lev-9 OS=Caenorhabditis elegans OX=6239 GN=lev-9 PE=1 SV=3 g23889.t1 Q22328 27.912 455 5.52e-33 140.0 sp|Q22328|LEV9_CAEEL Protein lev-9 OS=Caenorhabditis elegans OX=6239 GN=lev-9 PE=1 SV=3 g23892.t1 Q8NF86 30.576 278 3.07e-31 127.0 sp|Q8NF86|PRS33_HUMAN Serine protease 33 OS=Homo sapiens OX=9606 GN=PRSS33 PE=1 SV=3 g23893.t1 Q80T79 26.365 531 2.65e-26 122.0 sp|Q80T79|CSMD3_MOUSE CUB and sushi domain-containing protein 3 OS=Mus musculus OX=10090 GN=Csmd3 PE=1 SV=3 CSMD3_MOUSE reviewed CUB and sushi domain-containing protein 3 (CUB and sushi multiple domains protein 3) Mus musculus (Mouse) GO:0005886; GO:0050773 regulation of dendrite development [GO:0050773] plasma membrane [GO:0005886] g23893.t1 Q80T79 26.276 529 4.68e-25 117.0 sp|Q80T79|CSMD3_MOUSE CUB and sushi domain-containing protein 3 OS=Mus musculus OX=10090 GN=Csmd3 PE=1 SV=3 CSMD3_MOUSE reviewed CUB and sushi domain-containing protein 3 (CUB and sushi multiple domains protein 3) Mus musculus (Mouse) GO:0005886; GO:0050773 regulation of dendrite development [GO:0050773] plasma membrane [GO:0005886] g23897.t1 Q3SYW2 30.631 444 2.0399999999999998e-48 185.0 sp|Q3SYW2|CO2_BOVIN Complement C2 OS=Bos taurus OX=9913 GN=C2 PE=2 SV=1 CO2_BOVIN reviewed Complement C2 (C3/C5 convertase) [Cleaved into: Complement C2a; Serine protease complement C2b (EC 3.4.21.43)] Bos taurus (Bovine) GO:0001867; GO:0004252; GO:0005601; GO:0006508; GO:0006956; GO:0006958; GO:0009617; GO:0009986; GO:0046872; GO:0106139; GO:0160257 complement activation [GO:0006956]; complement activation, classical pathway [GO:0006958]; complement activation, GZMK pathway [GO:0160257]; complement activation, lectin pathway [GO:0001867]; proteolysis [GO:0006508]; response to bacterium [GO:0009617] cell surface [GO:0009986]; classical-complement-pathway C3/C5 convertase complex [GO:0005601]; symbiont cell surface [GO:0106139] metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252] g23904.t1 Q3SYW2 27.284 777 3.8e-60 223.0 sp|Q3SYW2|CO2_BOVIN Complement C2 OS=Bos taurus OX=9913 GN=C2 PE=2 SV=1 CO2_BOVIN reviewed Complement C2 (C3/C5 convertase) [Cleaved into: Complement C2a; Serine protease complement C2b (EC 3.4.21.43)] Bos taurus (Bovine) GO:0001867; GO:0004252; GO:0005601; GO:0006508; GO:0006956; GO:0006958; GO:0009617; GO:0009986; GO:0046872; GO:0106139; GO:0160257 complement activation [GO:0006956]; complement activation, classical pathway [GO:0006958]; complement activation, GZMK pathway [GO:0160257]; complement activation, lectin pathway [GO:0001867]; proteolysis [GO:0006508]; response to bacterium [GO:0009617] cell surface [GO:0009986]; classical-complement-pathway C3/C5 convertase complex [GO:0005601]; symbiont cell surface [GO:0106139] metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252] g23905.t1 P09926 54.098 122 8.88e-37 133.0 sp|P09926|SURF2_MOUSE Surfeit locus protein 2 OS=Mus musculus OX=10090 GN=Surf2 PE=1 SV=1 g23907.t1 A0A1D3PCM3 56.55 313 7.660000000000001e-122 369.0 sp|A0A1D3PCM3|SST_EMEND Serine O-succinyltransferase OS=Emericella nidulans OX=162425 GN=CysA PE=1 SV=1 g23908.t1 Q8BZQ7 45.788 819 0.0 679.0 sp|Q8BZQ7|ANC2_MOUSE Anaphase-promoting complex subunit 2 OS=Mus musculus OX=10090 GN=Anapc2 PE=1 SV=2 ANC2_MOUSE reviewed Anaphase-promoting complex subunit 2 (APC2) (Cyclosome subunit 2) Mus musculus (Mouse) GO:0005680; GO:0007091; GO:0007399; GO:0010629; GO:0030154; GO:0031145; GO:0031625; GO:0031915; GO:0045773; GO:0050775; GO:0051301; GO:0070936; GO:0070979; GO:0090129; GO:0141198 anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell differentiation [GO:0030154]; cell division [GO:0051301]; metaphase/anaphase transition of mitotic cell cycle [GO:0007091]; negative regulation of gene expression [GO:0010629]; nervous system development [GO:0007399]; positive regulation of axon extension [GO:0045773]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of synapse maturation [GO:0090129]; positive regulation of synaptic plasticity [GO:0031915]; protein branched polyubiquitination [GO:0141198]; protein K11-linked ubiquitination [GO:0070979]; protein K48-linked ubiquitination [GO:0070936] anaphase-promoting complex [GO:0005680] ubiquitin protein ligase binding [GO:0031625] g23910.t1 Q29361 78.689 122 2.92e-28 103.0 sp|Q29361|RL35_PIG Large ribosomal subunit protein uL29 OS=Sus scrofa OX=9823 GN=RPL35 PE=1 SV=3 g23917.t1 P20825 35.429 350 2.18e-58 213.0 sp|P20825|POL2_DROME Retrovirus-related Pol polyprotein from transposon 297 OS=Drosophila melanogaster OX=7227 GN=pol PE=4 SV=1 g23927.t1 Q7LHG5 34.694 147 1.5100000000000002e-21 93.2 sp|Q7LHG5|YI31B_YEAST Transposon Ty3-I Gag-Pol polyprotein OS=Saccharomyces cerevisiae (strain ATCC 204508 / S288c) OX=559292 GN=TY3B-I PE=1 SV=2 YI31B_YEAST reviewed Transposon Ty3-I Gag-Pol polyprotein (Gag3-Pol3) (Transposon Ty3-2 TYA-TYB polyprotein) [Cleaved into: Capsid protein (CA) (p24); Spacer peptide p3; Nucleocapsid protein p11 (NC); Ty3 protease (PR) (EC 3.4.23.-) (p16); Spacer peptide J; Reverse transcriptase/ribonuclease H (RT) (RT-RH) (EC 2.7.7.49) (EC 2.7.7.7) (EC 3.1.26.4) (p55); Integrase p52 (IN); Integrase p49 (IN)] Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast) GO:0003677; GO:0003723; GO:0003887; GO:0003964; GO:0004190; GO:0004523; GO:0005524; GO:0005634; GO:0005737; GO:0006310; GO:0006508; GO:0008270; GO:0015074; GO:0075523 DNA integration [GO:0015074]; DNA recombination [GO:0006310]; proteolysis [GO:0006508]; viral translational frameshifting [GO:0075523] cytoplasm [GO:0005737]; nucleus [GO:0005634] aspartic-type endopeptidase activity [GO:0004190]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; RNA binding [GO:0003723]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; zinc ion binding [GO:0008270] g23928.t1 P0C090 69.168 493 0.0 696.0 sp|P0C090|RC3H2_MOUSE Roquin-2 OS=Mus musculus OX=10090 GN=Rc3h2 PE=1 SV=1 RC3H2_MOUSE reviewed Roquin-2 (EC 2.3.2.27) (Membrane-associated nucleic acid-binding protein) (RING finger and CCCH-type zinc finger domain-containing protein 2) (RING-type E3 ubiquitin transferase Roquin-2) Mus musculus (Mouse) GO:0000209; GO:0000288; GO:0000932; GO:0001782; GO:0003677; GO:0003725; GO:0003729; GO:0006511; GO:0008270; GO:0009791; GO:0009986; GO:0010468; GO:0010494; GO:0010608; GO:0016020; GO:0035264; GO:0035613; GO:0042098; GO:0043029; GO:0048286; GO:0048535; GO:0048536; GO:0050852; GO:0060173; GO:0061470; GO:0061630; GO:1901224; GO:2000320; GO:2000628 B cell homeostasis [GO:0001782]; limb development [GO:0060173]; lung alveolus development [GO:0048286]; lymph node development [GO:0048535]; multicellular organism growth [GO:0035264]; negative regulation of T-helper 17 cell differentiation [GO:2000320]; nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:0000288]; positive regulation of non-canonical NF-kappaB signal transduction [GO:1901224]; post-embryonic development [GO:0009791]; post-transcriptional regulation of gene expression [GO:0010608]; protein polyubiquitination [GO:0000209]; regulation of gene expression [GO:0010468]; regulation of miRNA metabolic process [GO:2000628]; spleen development [GO:0048536]; T cell homeostasis [GO:0043029]; T cell proliferation [GO:0042098]; T cell receptor signaling pathway [GO:0050852]; T follicular helper cell differentiation [GO:0061470]; ubiquitin-dependent protein catabolic process [GO:0006511] cell surface [GO:0009986]; cytoplasmic stress granule [GO:0010494]; membrane [GO:0016020]; P-body [GO:0000932] DNA binding [GO:0003677]; double-stranded RNA binding [GO:0003725]; mRNA binding [GO:0003729]; RNA stem-loop binding [GO:0035613]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] g23928.t2 P0C090 69.168 493 0.0 697.0 sp|P0C090|RC3H2_MOUSE Roquin-2 OS=Mus musculus OX=10090 GN=Rc3h2 PE=1 SV=1 RC3H2_MOUSE reviewed Roquin-2 (EC 2.3.2.27) (Membrane-associated nucleic acid-binding protein) (RING finger and CCCH-type zinc finger domain-containing protein 2) (RING-type E3 ubiquitin transferase Roquin-2) Mus musculus (Mouse) GO:0000209; GO:0000288; GO:0000932; GO:0001782; GO:0003677; GO:0003725; GO:0003729; GO:0006511; GO:0008270; GO:0009791; GO:0009986; GO:0010468; GO:0010494; GO:0010608; GO:0016020; GO:0035264; GO:0035613; GO:0042098; GO:0043029; GO:0048286; GO:0048535; GO:0048536; GO:0050852; GO:0060173; GO:0061470; GO:0061630; GO:1901224; GO:2000320; GO:2000628 B cell homeostasis [GO:0001782]; limb development [GO:0060173]; lung alveolus development [GO:0048286]; lymph node development [GO:0048535]; multicellular organism growth [GO:0035264]; negative regulation of T-helper 17 cell differentiation [GO:2000320]; nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:0000288]; positive regulation of non-canonical NF-kappaB signal transduction [GO:1901224]; post-embryonic development [GO:0009791]; post-transcriptional regulation of gene expression [GO:0010608]; protein polyubiquitination [GO:0000209]; regulation of gene expression [GO:0010468]; regulation of miRNA metabolic process [GO:2000628]; spleen development [GO:0048536]; T cell homeostasis [GO:0043029]; T cell proliferation [GO:0042098]; T cell receptor signaling pathway [GO:0050852]; T follicular helper cell differentiation [GO:0061470]; ubiquitin-dependent protein catabolic process [GO:0006511] cell surface [GO:0009986]; cytoplasmic stress granule [GO:0010494]; membrane [GO:0016020]; P-body [GO:0000932] DNA binding [GO:0003677]; double-stranded RNA binding [GO:0003725]; mRNA binding [GO:0003729]; RNA stem-loop binding [GO:0035613]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] g23929.t1 O02751 29.524 315 6.91e-28 120.0 sp|O02751|CFDP2_BOVIN Craniofacial development protein 2 OS=Bos taurus OX=9913 GN=CFDP2 PE=1 SV=2 g23933.t1 Q8IYK4 48.744 199 1.9899999999999998e-61 204.0 sp|Q8IYK4|GT252_HUMAN Procollagen galactosyltransferase 2 OS=Homo sapiens OX=9606 GN=COLGALT2 PE=1 SV=1 GT252_HUMAN reviewed Procollagen galactosyltransferase 2 (EC 2.4.1.50) (Collagen beta(1-O)galactosyltransferase 2) (ColGalT 2) (Glycosyltransferase 25 family member 2) (Hydroxylysine galactosyltransferase 2) Homo sapiens (Human) GO:0005788; GO:0030199; GO:0050211 collagen fibril organization [GO:0030199] endoplasmic reticulum lumen [GO:0005788] procollagen galactosyltransferase activity [GO:0050211] g23934.t1 A7MB73 52.174 253 1.04e-97 305.0 sp|A7MB73|GT253_BOVIN Probable inactive glycosyltransferase 25 family member 3 OS=Bos taurus OX=9913 GN=CERCAM PE=2 SV=1 g23936.t1 Q6PFL0 47.386 306 6.48e-79 245.0 sp|Q6PFL0|MED27_DANRE Mediator of RNA polymerase II transcription subunit 27 OS=Danio rerio OX=7955 GN=med27 PE=2 SV=1 g23939.t1 Q16401 32.821 521 3.25e-87 281.0 sp|Q16401|PSMD5_HUMAN 26S proteasome non-ATPase regulatory subunit 5 OS=Homo sapiens OX=9606 GN=PSMD5 PE=1 SV=3 g23944.t1 H2N4I1 38.171 503 1.17e-92 303.0 sp|H2N4I1|QSOX1_PONAB Sulfhydryl oxidase 1 OS=Pongo abelii OX=9601 GN=QSOX1 PE=3 SV=2 g23944.t2 H2N4I1 36.944 517 1.96e-91 300.0 sp|H2N4I1|QSOX1_PONAB Sulfhydryl oxidase 1 OS=Pongo abelii OX=9601 GN=QSOX1 PE=3 SV=2 g23945.t1 Q498M4 92.429 317 0.0 607.0 sp|Q498M4|WDR5_RAT WD repeat-containing protein 5 OS=Rattus norvegicus OX=10116 GN=Wdr5 PE=1 SV=1 WDR5_RAT reviewed WD repeat-containing protein 5 Rattus norvegicus (Rat) GO:0000122; GO:0000123; GO:0001501; GO:0005634; GO:0005654; GO:0006355; GO:0006357; GO:0031175; GO:0035097; GO:0042393; GO:0042800; GO:0044545; GO:0044665; GO:0044666; GO:0045722; GO:0045815; GO:0045995; GO:0048188; GO:0051302; GO:0051726; GO:0071339; GO:0140004; GO:0140109; GO:0140672 negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron projection development [GO:0031175]; positive regulation of gluconeogenesis [GO:0045722]; regulation of cell cycle [GO:0051726]; regulation of cell division [GO:0051302]; regulation of DNA-templated transcription [GO:0006355]; regulation of embryonic development [GO:0045995]; regulation of transcription by RNA polymerase II [GO:0006357]; skeletal system development [GO:0001501]; transcription initiation-coupled chromatin remodeling [GO:0045815] ATAC complex [GO:0140672]; histone acetyltransferase complex [GO:0000123]; histone methyltransferase complex [GO:0035097]; MLL1 complex [GO:0071339]; MLL1/2 complex [GO:0044665]; MLL3/4 complex [GO:0044666]; NSL complex [GO:0044545]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Set1C/COMPASS complex [GO:0048188] histone binding [GO:0042393]; histone H3K4 methyltransferase activity [GO:0042800]; histone H3K4me1 reader activity [GO:0140109]; histone H3Q5ser reader activity [GO:0140004] g23955.t1 P53412 49.239 394 1.7500000000000003e-117 350.0 sp|P53412|LHX3_CHICK LIM/homeobox protein Lhx3 OS=Gallus gallus OX=9031 GN=LHX3 PE=2 SV=1 g23956.t2 Q95SX7 31.579 266 6.299999999999999e-23 107.0 sp|Q95SX7|RTBS_DROME Probable RNA-directed DNA polymerase from transposon BS OS=Drosophila melanogaster OX=7227 GN=RTase PE=2 SV=1 g23957.t1 Q6DJ06 62.238 143 1.41e-58 183.0 sp|Q6DJ06|LMO42_XENTR LIM domain transcription factor LMO4.2 OS=Xenopus tropicalis OX=8364 GN=lmo4.2 PE=2 SV=1 g23960.t1 Q92805 30.659 349 4.1700000000000003e-32 136.0 sp|Q92805|GOGA1_HUMAN Golgin subfamily A member 1 OS=Homo sapiens OX=9606 GN=GOLGA1 PE=1 SV=3 GOGA1_HUMAN reviewed Golgin subfamily A member 1 (Golgin-97) Homo sapiens (Human) GO:0000139; GO:0001669; GO:0005794; GO:0005802; GO:0005829; GO:0048471; GO:0070633; GO:0140104 transepithelial transport [GO:0070633] acrosomal vesicle [GO:0001669]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; perinuclear region of cytoplasm [GO:0048471]; trans-Golgi network [GO:0005802] molecular carrier activity [GO:0140104] g23963.t1 Q38931 49.0 100 2.9199999999999997e-23 96.7 sp|Q38931|FKB62_ARATH Peptidyl-prolyl cis-trans isomerase FKBP62 OS=Arabidopsis thaliana OX=3702 GN=FKBP62 PE=1 SV=2 FKB62_ARATH reviewed Peptidyl-prolyl cis-trans isomerase FKBP62 (PPIase FKBP62) (EC 5.2.1.8) (70 kDa peptidyl-prolyl isomerase) (FK506-binding protein 62) (AtFKBP62) (Immunophilin FKBP62) (Peptidylprolyl isomerase ROF1) (Protein ROTAMASE FKBP 1) (Rotamase) Arabidopsis thaliana (Mouse-ear cress) GO:0003755; GO:0005516; GO:0005634; GO:0005737; GO:0005829; GO:0006970; GO:0009408; GO:0009611; GO:0009644; GO:0009845; GO:0032266; GO:0070370; GO:0071944; GO:0080025 cellular heat acclimation [GO:0070370]; response to heat [GO:0009408]; response to high light intensity [GO:0009644]; response to osmotic stress [GO:0006970]; response to wounding [GO:0009611]; seed germination [GO:0009845] cell periphery [GO:0071944]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634] calmodulin binding [GO:0005516]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-3-phosphate binding [GO:0032266] g23964.t1 Q19UN5 31.194 561 2.9499999999999997e-52 208.0 sp|Q19UN5|CK5P2_PANTR CDK5 regulatory subunit-associated protein 2 OS=Pan troglodytes OX=9598 GN=CDK5RAP2 PE=2 SV=1 CK5P2_PANTR reviewed CDK5 regulatory subunit-associated protein 2 Pan troglodytes (Chimpanzee) GO:0000132; GO:0000226; GO:0000242; GO:0000922; GO:0000976; GO:0001578; GO:0005516; GO:0005737; GO:0005794; GO:0005813; GO:0005874; GO:0007059; GO:0007098; GO:0007099; GO:0007420; GO:0008017; GO:0022008; GO:0031023; GO:0035371; GO:0043015; GO:0045893; GO:0046600; GO:0048471; GO:0090266; GO:0097431 brain development [GO:0007420]; centriole replication [GO:0007099]; centrosome cycle [GO:0007098]; chromosome segregation [GO:0007059]; establishment of mitotic spindle orientation [GO:0000132]; microtubule bundle formation [GO:0001578]; microtubule cytoskeleton organization [GO:0000226]; microtubule organizing center organization [GO:0031023]; negative regulation of centriole replication [GO:0046600]; neurogenesis [GO:0022008]; positive regulation of DNA-templated transcription [GO:0045893]; regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090266] centrosome [GO:0005813]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; microtubule [GO:0005874]; microtubule plus-end [GO:0035371]; mitotic spindle pole [GO:0097431]; pericentriolar material [GO:0000242]; perinuclear region of cytoplasm [GO:0048471]; spindle pole [GO:0000922] calmodulin binding [GO:0005516]; gamma-tubulin binding [GO:0043015]; microtubule binding [GO:0008017]; transcription cis-regulatory region binding [GO:0000976] g23964.t2 Q19UN5 31.25 560 4.54e-52 207.0 sp|Q19UN5|CK5P2_PANTR CDK5 regulatory subunit-associated protein 2 OS=Pan troglodytes OX=9598 GN=CDK5RAP2 PE=2 SV=1 CK5P2_PANTR reviewed CDK5 regulatory subunit-associated protein 2 Pan troglodytes (Chimpanzee) GO:0000132; GO:0000226; GO:0000242; GO:0000922; GO:0000976; GO:0001578; GO:0005516; GO:0005737; GO:0005794; GO:0005813; GO:0005874; GO:0007059; GO:0007098; GO:0007099; GO:0007420; GO:0008017; GO:0022008; GO:0031023; GO:0035371; GO:0043015; GO:0045893; GO:0046600; GO:0048471; GO:0090266; GO:0097431 brain development [GO:0007420]; centriole replication [GO:0007099]; centrosome cycle [GO:0007098]; chromosome segregation [GO:0007059]; establishment of mitotic spindle orientation [GO:0000132]; microtubule bundle formation [GO:0001578]; microtubule cytoskeleton organization [GO:0000226]; microtubule organizing center organization [GO:0031023]; negative regulation of centriole replication [GO:0046600]; neurogenesis [GO:0022008]; positive regulation of DNA-templated transcription [GO:0045893]; regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090266] centrosome [GO:0005813]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; microtubule [GO:0005874]; microtubule plus-end [GO:0035371]; mitotic spindle pole [GO:0097431]; pericentriolar material [GO:0000242]; perinuclear region of cytoplasm [GO:0048471]; spindle pole [GO:0000922] calmodulin binding [GO:0005516]; gamma-tubulin binding [GO:0043015]; microtubule binding [GO:0008017]; transcription cis-regulatory region binding [GO:0000976] g23965.t1 P0CG30 40.909 198 9.7e-49 162.0 sp|P0CG30|GSTT2_HUMAN Glutathione S-transferase theta-2B OS=Homo sapiens OX=9606 GN=GSTT2B PE=1 SV=1 GSTT2_HUMAN reviewed Glutathione S-transferase theta-2B (EC 2.5.1.18) (Glutathione S-transferase theta-2) (GST class-theta-2) Homo sapiens (Human) GO:0004364; GO:0005737; GO:0005829; GO:0006749; GO:0070062 glutathione metabolic process [GO:0006749] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062] glutathione transferase activity [GO:0004364] g23973.t1 Q5R5W2 53.333 270 1.79e-94 295.0 sp|Q5R5W2|TADBP_PONAB TAR DNA-binding protein 43 OS=Pongo abelii OX=9601 GN=TARDBP PE=2 SV=1 TADBP_PONAB reviewed TAR DNA-binding protein 43 (TDP-43) Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0000785; GO:0003690; GO:0003723; GO:0005730; GO:0005739; GO:0006397; GO:0008380; GO:0010468; GO:0016607; GO:0031647; GO:0042752 mRNA processing [GO:0006397]; regulation of circadian rhythm [GO:0042752]; regulation of gene expression [GO:0010468]; regulation of protein stability [GO:0031647]; RNA splicing [GO:0008380] chromatin [GO:0000785]; mitochondrion [GO:0005739]; nuclear speck [GO:0016607]; nucleolus [GO:0005730] double-stranded DNA binding [GO:0003690]; RNA binding [GO:0003723] g23974.t1 O75063 57.434 343 4.44e-149 434.0 sp|O75063|XYLK_HUMAN Glycosaminoglycan xylosylkinase OS=Homo sapiens OX=9606 GN=FAM20B PE=1 SV=1 XYLK_HUMAN reviewed Glycosaminoglycan xylosylkinase (EC 2.7.1.-) (Xylose kinase) Homo sapiens (Human) GO:0000139; GO:0005524; GO:0005654; GO:0005794; GO:0016301; GO:0016773; GO:0030166; GO:0046872; GO:1902729 negative regulation of proteoglycan biosynthetic process [GO:1902729]; proteoglycan biosynthetic process [GO:0030166] Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; nucleoplasm [GO:0005654] ATP binding [GO:0005524]; kinase activity [GO:0016301]; metal ion binding [GO:0046872]; phosphotransferase activity, alcohol group as acceptor [GO:0016773] g23980.t1 Q99L04 51.22 328 7.34e-114 335.0 sp|Q99L04|DHRS1_MOUSE Dehydrogenase/reductase SDR family member 1 OS=Mus musculus OX=10090 GN=Dhrs1 PE=1 SV=1 g23981.t1 Q8BSN3 27.29 513 2.21e-32 135.0 sp|Q8BSN3|ODAD3_MOUSE Outer dynein arm-docking complex subunit 3 OS=Mus musculus OX=10090 GN=ODAD3 PE=2 SV=2 ODAD3_MOUSE reviewed Outer dynein arm-docking complex subunit 3 (Coiled-coil domain-containing protein 151) Mus musculus (Mouse) GO:0000902; GO:0003341; GO:0005576; GO:0005814; GO:0005929; GO:0005930; GO:0007283; GO:0007338; GO:0007368; GO:0007507; GO:0030317; GO:0035253; GO:0035264; GO:0036064; GO:0036126; GO:0036158; GO:0044782; GO:0048872; GO:0060287; GO:0061371; GO:0072520; GO:0090660; GO:0097542; GO:0120228; GO:1902017 cell morphogenesis [GO:0000902]; cerebrospinal fluid circulation [GO:0090660]; cilium movement [GO:0003341]; cilium organization [GO:0044782]; determination of heart left/right asymmetry [GO:0061371]; determination of left/right symmetry [GO:0007368]; epithelial cilium movement involved in determination of left/right asymmetry [GO:0060287]; flagellated sperm motility [GO:0030317]; heart development [GO:0007507]; homeostasis of number of cells [GO:0048872]; multicellular organism growth [GO:0035264]; outer dynein arm assembly [GO:0036158]; regulation of cilium assembly [GO:1902017]; seminiferous tubule development [GO:0072520]; single fertilization [GO:0007338]; spermatogenesis [GO:0007283] axoneme [GO:0005930]; centriole [GO:0005814]; ciliary basal body [GO:0036064]; ciliary rootlet [GO:0035253]; ciliary tip [GO:0097542]; cilium [GO:0005929]; extracellular region [GO:0005576]; outer dynein arm docking complex [GO:0120228]; sperm flagellum [GO:0036126] g23981.t2 Q8BSN3 27.539 512 3.44e-33 137.0 sp|Q8BSN3|ODAD3_MOUSE Outer dynein arm-docking complex subunit 3 OS=Mus musculus OX=10090 GN=ODAD3 PE=2 SV=2 ODAD3_MOUSE reviewed Outer dynein arm-docking complex subunit 3 (Coiled-coil domain-containing protein 151) Mus musculus (Mouse) GO:0000902; GO:0003341; GO:0005576; GO:0005814; GO:0005929; GO:0005930; GO:0007283; GO:0007338; GO:0007368; GO:0007507; GO:0030317; GO:0035253; GO:0035264; GO:0036064; GO:0036126; GO:0036158; GO:0044782; GO:0048872; GO:0060287; GO:0061371; GO:0072520; GO:0090660; GO:0097542; GO:0120228; GO:1902017 cell morphogenesis [GO:0000902]; cerebrospinal fluid circulation [GO:0090660]; cilium movement [GO:0003341]; cilium organization [GO:0044782]; determination of heart left/right asymmetry [GO:0061371]; determination of left/right symmetry [GO:0007368]; epithelial cilium movement involved in determination of left/right asymmetry [GO:0060287]; flagellated sperm motility [GO:0030317]; heart development [GO:0007507]; homeostasis of number of cells [GO:0048872]; multicellular organism growth [GO:0035264]; outer dynein arm assembly [GO:0036158]; regulation of cilium assembly [GO:1902017]; seminiferous tubule development [GO:0072520]; single fertilization [GO:0007338]; spermatogenesis [GO:0007283] axoneme [GO:0005930]; centriole [GO:0005814]; ciliary basal body [GO:0036064]; ciliary rootlet [GO:0035253]; ciliary tip [GO:0097542]; cilium [GO:0005929]; extracellular region [GO:0005576]; outer dynein arm docking complex [GO:0120228]; sperm flagellum [GO:0036126] g23982.t1 Q8BP86 33.254 421 7.729999999999999e-61 234.0 sp|Q8BP86|SNPC4_MOUSE snRNA-activating protein complex subunit 4 OS=Mus musculus OX=10090 GN=Snapc4 PE=1 SV=2 g23985.t1 P21575 72.513 764 0.0 1120.0 sp|P21575|DYN1_RAT Dynamin-1 OS=Rattus norvegicus OX=10116 GN=Dnm1 PE=1 SV=2 g23985.t2 P21575 70.893 773 0.0 1106.0 sp|P21575|DYN1_RAT Dynamin-1 OS=Rattus norvegicus OX=10116 GN=Dnm1 PE=1 SV=2 g23986.t1 Q91VS7 46.479 142 7.37e-40 134.0 sp|Q91VS7|MGST1_MOUSE Microsomal glutathione S-transferase 1 OS=Mus musculus OX=10090 GN=Mgst1 PE=1 SV=3 MGST1_MOUSE reviewed Microsomal glutathione S-transferase 1 (Microsomal GST-1) (EC 2.5.1.18) (Microsomal GST-I) Mus musculus (Mouse) GO:0004364; GO:0004602; GO:0005739; GO:0005741; GO:0005743; GO:0005778; GO:0005783; GO:0005789; GO:0006749; GO:0009410; GO:0016020; GO:0032496; GO:0034635; GO:0042802; GO:0043295; GO:0045177; GO:0071449 cellular response to lipid hydroperoxide [GO:0071449]; glutathione metabolic process [GO:0006749]; glutathione transport [GO:0034635]; response to lipopolysaccharide [GO:0032496]; response to xenobiotic stimulus [GO:0009410] apical part of cell [GO:0045177]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; peroxisomal membrane [GO:0005778] glutathione binding [GO:0043295]; glutathione peroxidase activity [GO:0004602]; glutathione transferase activity [GO:0004364]; identical protein binding [GO:0042802] g23987.t1 P08011 49.296 142 1.61e-44 146.0 sp|P08011|MGST1_RAT Microsomal glutathione S-transferase 1 OS=Rattus norvegicus OX=10116 GN=Mgst1 PE=1 SV=3 MGST1_RAT reviewed Microsomal glutathione S-transferase 1 (Microsomal GST-1) (EC 2.5.1.18) (Microsomal GST-I) Rattus norvegicus (Rat) GO:0004364; GO:0004602; GO:0005739; GO:0005741; GO:0005778; GO:0005783; GO:0005789; GO:0006749; GO:0009410; GO:0016020; GO:0032496; GO:0033327; GO:0034635; GO:0042802; GO:0043295; GO:0045177; GO:0071449 cellular response to lipid hydroperoxide [GO:0071449]; glutathione metabolic process [GO:0006749]; glutathione transport [GO:0034635]; Leydig cell differentiation [GO:0033327]; response to lipopolysaccharide [GO:0032496]; response to xenobiotic stimulus [GO:0009410] apical part of cell [GO:0045177]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; peroxisomal membrane [GO:0005778] glutathione binding [GO:0043295]; glutathione peroxidase activity [GO:0004602]; glutathione transferase activity [GO:0004364]; identical protein binding [GO:0042802] g23993.t1 Q80VJ4 35.838 173 1.63e-25 105.0 sp|Q80VJ4|GPCP1_RAT Glycerophosphocholine phosphodiesterase GPCPD1 OS=Rattus norvegicus OX=10116 GN=Gpcpd1 PE=1 SV=1 g23994.t1 Q8BYK4 36.0 300 1.1899999999999999e-45 159.0 sp|Q8BYK4|RDH12_MOUSE Retinol dehydrogenase 12 OS=Mus musculus OX=10090 GN=Rdh12 PE=2 SV=1 RDH12_MOUSE reviewed Retinol dehydrogenase 12 (EC 1.1.1.300) Mus musculus (Mouse) GO:0001917; GO:0004745; GO:0007601; GO:0042572; GO:0052650; GO:0102354; GO:0110095 cellular detoxification of aldehyde [GO:0110095]; retinol metabolic process [GO:0042572]; visual perception [GO:0007601] photoreceptor inner segment [GO:0001917] 11-cis-retinol dehydrogenase (NADP+) activity [GO:0102354]; all-trans-retinol dehydrogenase (NAD+) activity [GO:0004745]; all-trans-retinol dehydrogenase (NADP+) activity [GO:0052650] g23995.t1 P02469 29.115 972 2.06e-88 325.0 sp|P02469|LAMB1_MOUSE Laminin subunit beta-1 OS=Mus musculus OX=10090 GN=Lamb1 PE=1 SV=3 LAMB1_MOUSE reviewed Laminin subunit beta-1 (Laminin B1 chain) (Laminin-1 subunit beta) (Laminin-10 subunit beta) (Laminin-12 subunit beta) (Laminin-2 subunit beta) (Laminin-6 subunit beta) (Laminin-8 subunit beta) Mus musculus (Mouse) GO:0005178; GO:0005201; GO:0005576; GO:0005604; GO:0005606; GO:0005607; GO:0005615; GO:0005634; GO:0007162; GO:0007411; GO:0007566; GO:0007611; GO:0009887; GO:0009888; GO:0016477; GO:0019899; GO:0021812; GO:0030335; GO:0031012; GO:0031175; GO:0034446; GO:0035987; GO:0042476; GO:0043208; GO:0043256; GO:0043257; GO:0043259; GO:0045785; GO:0048018; GO:0048471; GO:0051149; GO:0070831; GO:0098637; GO:0110011; GO:1904395; GO:2001046 animal organ morphogenesis [GO:0009887]; axon guidance [GO:0007411]; basement membrane assembly [GO:0070831]; cell migration [GO:0016477]; embryo implantation [GO:0007566]; endodermal cell differentiation [GO:0035987]; learning or memory [GO:0007611]; negative regulation of cell adhesion [GO:0007162]; neuron projection development [GO:0031175]; neuronal-glial interaction involved in cerebral cortex radial glia guided migration [GO:0021812]; odontogenesis [GO:0042476]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cell migration [GO:0030335]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of muscle cell differentiation [GO:0051149]; positive regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904395]; regulation of basement membrane organization [GO:0110011]; substrate adhesion-dependent cell spreading [GO:0034446]; tissue development [GO:0009888] basement membrane [GO:0005604]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; laminin complex [GO:0043256]; laminin-1 complex [GO:0005606]; laminin-10 complex [GO:0043259]; laminin-2 complex [GO:0005607]; laminin-8 complex [GO:0043257]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein complex involved in cell-matrix adhesion [GO:0098637] enzyme binding [GO:0019899]; extracellular matrix structural constituent [GO:0005201]; glycosphingolipid binding [GO:0043208]; integrin binding [GO:0005178]; receptor ligand activity [GO:0048018] g23996.t1 Q0P5M8 56.738 423 2.35e-152 445.0 sp|Q0P5M8|MPPA_BOVIN Mitochondrial-processing peptidase subunit alpha OS=Bos taurus OX=9913 GN=PMPCA PE=2 SV=1 MPPA_BOVIN reviewed Mitochondrial-processing peptidase subunit alpha (Alpha-MPP) (Inactive zinc metalloprotease alpha) Bos taurus (Bovine) GO:0004222; GO:0005739; GO:0005743; GO:0005759; GO:0006627; GO:0016485; GO:0046872 protein processing [GO:0016485]; protein processing involved in protein targeting to mitochondrion [GO:0006627] mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222] g23997.t1 P02469 29.95 995 4.6e-112 400.0 sp|P02469|LAMB1_MOUSE Laminin subunit beta-1 OS=Mus musculus OX=10090 GN=Lamb1 PE=1 SV=3 LAMB1_MOUSE reviewed Laminin subunit beta-1 (Laminin B1 chain) (Laminin-1 subunit beta) (Laminin-10 subunit beta) (Laminin-12 subunit beta) (Laminin-2 subunit beta) (Laminin-6 subunit beta) (Laminin-8 subunit beta) Mus musculus (Mouse) GO:0005178; GO:0005201; GO:0005576; GO:0005604; GO:0005606; GO:0005607; GO:0005615; GO:0005634; GO:0007162; GO:0007411; GO:0007566; GO:0007611; GO:0009887; GO:0009888; GO:0016477; GO:0019899; GO:0021812; GO:0030335; GO:0031012; GO:0031175; GO:0034446; GO:0035987; GO:0042476; GO:0043208; GO:0043256; GO:0043257; GO:0043259; GO:0045785; GO:0048018; GO:0048471; GO:0051149; GO:0070831; GO:0098637; GO:0110011; GO:1904395; GO:2001046 animal organ morphogenesis [GO:0009887]; axon guidance [GO:0007411]; basement membrane assembly [GO:0070831]; cell migration [GO:0016477]; embryo implantation [GO:0007566]; endodermal cell differentiation [GO:0035987]; learning or memory [GO:0007611]; negative regulation of cell adhesion [GO:0007162]; neuron projection development [GO:0031175]; neuronal-glial interaction involved in cerebral cortex radial glia guided migration [GO:0021812]; odontogenesis [GO:0042476]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cell migration [GO:0030335]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of muscle cell differentiation [GO:0051149]; positive regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904395]; regulation of basement membrane organization [GO:0110011]; substrate adhesion-dependent cell spreading [GO:0034446]; tissue development [GO:0009888] basement membrane [GO:0005604]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; laminin complex [GO:0043256]; laminin-1 complex [GO:0005606]; laminin-10 complex [GO:0043259]; laminin-2 complex [GO:0005607]; laminin-8 complex [GO:0043257]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein complex involved in cell-matrix adhesion [GO:0098637] enzyme binding [GO:0019899]; extracellular matrix structural constituent [GO:0005201]; glycosphingolipid binding [GO:0043208]; integrin binding [GO:0005178]; receptor ligand activity [GO:0048018] g23997.t1 P02469 29.843 573 9.800000000000001e-59 229.0 sp|P02469|LAMB1_MOUSE Laminin subunit beta-1 OS=Mus musculus OX=10090 GN=Lamb1 PE=1 SV=3 LAMB1_MOUSE reviewed Laminin subunit beta-1 (Laminin B1 chain) (Laminin-1 subunit beta) (Laminin-10 subunit beta) (Laminin-12 subunit beta) (Laminin-2 subunit beta) (Laminin-6 subunit beta) (Laminin-8 subunit beta) Mus musculus (Mouse) GO:0005178; GO:0005201; GO:0005576; GO:0005604; GO:0005606; GO:0005607; GO:0005615; GO:0005634; GO:0007162; GO:0007411; GO:0007566; GO:0007611; GO:0009887; GO:0009888; GO:0016477; GO:0019899; GO:0021812; GO:0030335; GO:0031012; GO:0031175; GO:0034446; GO:0035987; GO:0042476; GO:0043208; GO:0043256; GO:0043257; GO:0043259; GO:0045785; GO:0048018; GO:0048471; GO:0051149; GO:0070831; GO:0098637; GO:0110011; GO:1904395; GO:2001046 animal organ morphogenesis [GO:0009887]; axon guidance [GO:0007411]; basement membrane assembly [GO:0070831]; cell migration [GO:0016477]; embryo implantation [GO:0007566]; endodermal cell differentiation [GO:0035987]; learning or memory [GO:0007611]; negative regulation of cell adhesion [GO:0007162]; neuron projection development [GO:0031175]; neuronal-glial interaction involved in cerebral cortex radial glia guided migration [GO:0021812]; odontogenesis [GO:0042476]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cell migration [GO:0030335]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of muscle cell differentiation [GO:0051149]; positive regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904395]; regulation of basement membrane organization [GO:0110011]; substrate adhesion-dependent cell spreading [GO:0034446]; tissue development [GO:0009888] basement membrane [GO:0005604]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; laminin complex [GO:0043256]; laminin-1 complex [GO:0005606]; laminin-10 complex [GO:0043259]; laminin-2 complex [GO:0005607]; laminin-8 complex [GO:0043257]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein complex involved in cell-matrix adhesion [GO:0098637] enzyme binding [GO:0019899]; extracellular matrix structural constituent [GO:0005201]; glycosphingolipid binding [GO:0043208]; integrin binding [GO:0005178]; receptor ligand activity [GO:0048018] g23997.t1 P02469 35.271 258 7.449999999999999e-30 134.0 sp|P02469|LAMB1_MOUSE Laminin subunit beta-1 OS=Mus musculus OX=10090 GN=Lamb1 PE=1 SV=3 LAMB1_MOUSE reviewed Laminin subunit beta-1 (Laminin B1 chain) (Laminin-1 subunit beta) (Laminin-10 subunit beta) (Laminin-12 subunit beta) (Laminin-2 subunit beta) (Laminin-6 subunit beta) (Laminin-8 subunit beta) Mus musculus (Mouse) GO:0005178; GO:0005201; GO:0005576; GO:0005604; GO:0005606; GO:0005607; GO:0005615; GO:0005634; GO:0007162; GO:0007411; GO:0007566; GO:0007611; GO:0009887; GO:0009888; GO:0016477; GO:0019899; GO:0021812; GO:0030335; GO:0031012; GO:0031175; GO:0034446; GO:0035987; GO:0042476; GO:0043208; GO:0043256; GO:0043257; GO:0043259; GO:0045785; GO:0048018; GO:0048471; GO:0051149; GO:0070831; GO:0098637; GO:0110011; GO:1904395; GO:2001046 animal organ morphogenesis [GO:0009887]; axon guidance [GO:0007411]; basement membrane assembly [GO:0070831]; cell migration [GO:0016477]; embryo implantation [GO:0007566]; endodermal cell differentiation [GO:0035987]; learning or memory [GO:0007611]; negative regulation of cell adhesion [GO:0007162]; neuron projection development [GO:0031175]; neuronal-glial interaction involved in cerebral cortex radial glia guided migration [GO:0021812]; odontogenesis [GO:0042476]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cell migration [GO:0030335]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of muscle cell differentiation [GO:0051149]; positive regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904395]; regulation of basement membrane organization [GO:0110011]; substrate adhesion-dependent cell spreading [GO:0034446]; tissue development [GO:0009888] basement membrane [GO:0005604]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; laminin complex [GO:0043256]; laminin-1 complex [GO:0005606]; laminin-10 complex [GO:0043259]; laminin-2 complex [GO:0005607]; laminin-8 complex [GO:0043257]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein complex involved in cell-matrix adhesion [GO:0098637] enzyme binding [GO:0019899]; extracellular matrix structural constituent [GO:0005201]; glycosphingolipid binding [GO:0043208]; integrin binding [GO:0005178]; receptor ligand activity [GO:0048018] g23997.t1 P02469 35.0 320 2.2100000000000002e-29 132.0 sp|P02469|LAMB1_MOUSE Laminin subunit beta-1 OS=Mus musculus OX=10090 GN=Lamb1 PE=1 SV=3 LAMB1_MOUSE reviewed Laminin subunit beta-1 (Laminin B1 chain) (Laminin-1 subunit beta) (Laminin-10 subunit beta) (Laminin-12 subunit beta) (Laminin-2 subunit beta) (Laminin-6 subunit beta) (Laminin-8 subunit beta) Mus musculus (Mouse) GO:0005178; GO:0005201; GO:0005576; GO:0005604; GO:0005606; GO:0005607; GO:0005615; GO:0005634; GO:0007162; GO:0007411; GO:0007566; GO:0007611; GO:0009887; GO:0009888; GO:0016477; GO:0019899; GO:0021812; GO:0030335; GO:0031012; GO:0031175; GO:0034446; GO:0035987; GO:0042476; GO:0043208; GO:0043256; GO:0043257; GO:0043259; GO:0045785; GO:0048018; GO:0048471; GO:0051149; GO:0070831; GO:0098637; GO:0110011; GO:1904395; GO:2001046 animal organ morphogenesis [GO:0009887]; axon guidance [GO:0007411]; basement membrane assembly [GO:0070831]; cell migration [GO:0016477]; embryo implantation [GO:0007566]; endodermal cell differentiation [GO:0035987]; learning or memory [GO:0007611]; negative regulation of cell adhesion [GO:0007162]; neuron projection development [GO:0031175]; neuronal-glial interaction involved in cerebral cortex radial glia guided migration [GO:0021812]; odontogenesis [GO:0042476]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cell migration [GO:0030335]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of muscle cell differentiation [GO:0051149]; positive regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904395]; regulation of basement membrane organization [GO:0110011]; substrate adhesion-dependent cell spreading [GO:0034446]; tissue development [GO:0009888] basement membrane [GO:0005604]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; laminin complex [GO:0043256]; laminin-1 complex [GO:0005606]; laminin-10 complex [GO:0043259]; laminin-2 complex [GO:0005607]; laminin-8 complex [GO:0043257]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein complex involved in cell-matrix adhesion [GO:0098637] enzyme binding [GO:0019899]; extracellular matrix structural constituent [GO:0005201]; glycosphingolipid binding [GO:0043208]; integrin binding [GO:0005178]; receptor ligand activity [GO:0048018] g23997.t1 P02469 26.265 514 1.08e-28 130.0 sp|P02469|LAMB1_MOUSE Laminin subunit beta-1 OS=Mus musculus OX=10090 GN=Lamb1 PE=1 SV=3 LAMB1_MOUSE reviewed Laminin subunit beta-1 (Laminin B1 chain) (Laminin-1 subunit beta) (Laminin-10 subunit beta) (Laminin-12 subunit beta) (Laminin-2 subunit beta) (Laminin-6 subunit beta) (Laminin-8 subunit beta) Mus musculus (Mouse) GO:0005178; GO:0005201; GO:0005576; GO:0005604; GO:0005606; GO:0005607; GO:0005615; GO:0005634; GO:0007162; GO:0007411; GO:0007566; GO:0007611; GO:0009887; GO:0009888; GO:0016477; GO:0019899; GO:0021812; GO:0030335; GO:0031012; GO:0031175; GO:0034446; GO:0035987; GO:0042476; GO:0043208; GO:0043256; GO:0043257; GO:0043259; GO:0045785; GO:0048018; GO:0048471; GO:0051149; GO:0070831; GO:0098637; GO:0110011; GO:1904395; GO:2001046 animal organ morphogenesis [GO:0009887]; axon guidance [GO:0007411]; basement membrane assembly [GO:0070831]; cell migration [GO:0016477]; embryo implantation [GO:0007566]; endodermal cell differentiation [GO:0035987]; learning or memory [GO:0007611]; negative regulation of cell adhesion [GO:0007162]; neuron projection development [GO:0031175]; neuronal-glial interaction involved in cerebral cortex radial glia guided migration [GO:0021812]; odontogenesis [GO:0042476]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cell migration [GO:0030335]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of muscle cell differentiation [GO:0051149]; positive regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904395]; regulation of basement membrane organization [GO:0110011]; substrate adhesion-dependent cell spreading [GO:0034446]; tissue development [GO:0009888] basement membrane [GO:0005604]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; laminin complex [GO:0043256]; laminin-1 complex [GO:0005606]; laminin-10 complex [GO:0043259]; laminin-2 complex [GO:0005607]; laminin-8 complex [GO:0043257]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein complex involved in cell-matrix adhesion [GO:0098637] enzyme binding [GO:0019899]; extracellular matrix structural constituent [GO:0005201]; glycosphingolipid binding [GO:0043208]; integrin binding [GO:0005178]; receptor ligand activity [GO:0048018] g23997.t2 P07942 29.633 1009 8.31e-113 402.0 sp|P07942|LAMB1_HUMAN Laminin subunit beta-1 OS=Homo sapiens OX=9606 GN=LAMB1 PE=1 SV=2 LAMB1_HUMAN reviewed Laminin subunit beta-1 (Laminin B1 chain) (Laminin-1 subunit beta) (Laminin-10 subunit beta) (Laminin-12 subunit beta) (Laminin-2 subunit beta) (Laminin-6 subunit beta) (Laminin-8 subunit beta) Homo sapiens (Human) GO:0005178; GO:0005198; GO:0005201; GO:0005576; GO:0005604; GO:0005606; GO:0005607; GO:0005615; GO:0005634; GO:0005788; GO:0007155; GO:0007162; GO:0007165; GO:0007566; GO:0019899; GO:0021812; GO:0030155; GO:0030334; GO:0030335; GO:0031012; GO:0031175; GO:0034446; GO:0035987; GO:0042476; GO:0043208; GO:0043257; GO:0043259; GO:0045785; GO:0045995; GO:0048471; GO:0050679; GO:0051149; GO:0070062; GO:0098637; GO:0110011; GO:2001046 cell adhesion [GO:0007155]; embryo implantation [GO:0007566]; endodermal cell differentiation [GO:0035987]; negative regulation of cell adhesion [GO:0007162]; neuron projection development [GO:0031175]; neuronal-glial interaction involved in cerebral cortex radial glia guided migration [GO:0021812]; odontogenesis [GO:0042476]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cell migration [GO:0030335]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of muscle cell differentiation [GO:0051149]; regulation of basement membrane organization [GO:0110011]; regulation of cell adhesion [GO:0030155]; regulation of cell migration [GO:0030334]; regulation of embryonic development [GO:0045995]; signal transduction [GO:0007165]; substrate adhesion-dependent cell spreading [GO:0034446] basement membrane [GO:0005604]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; laminin-1 complex [GO:0005606]; laminin-10 complex [GO:0043259]; laminin-2 complex [GO:0005607]; laminin-8 complex [GO:0043257]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein complex involved in cell-matrix adhesion [GO:0098637] enzyme binding [GO:0019899]; extracellular matrix structural constituent [GO:0005201]; glycosphingolipid binding [GO:0043208]; integrin binding [GO:0005178]; structural molecule activity [GO:0005198] g23997.t2 P07942 30.035 566 1.3099999999999999e-61 238.0 sp|P07942|LAMB1_HUMAN Laminin subunit beta-1 OS=Homo sapiens OX=9606 GN=LAMB1 PE=1 SV=2 LAMB1_HUMAN reviewed Laminin subunit beta-1 (Laminin B1 chain) (Laminin-1 subunit beta) (Laminin-10 subunit beta) (Laminin-12 subunit beta) (Laminin-2 subunit beta) (Laminin-6 subunit beta) (Laminin-8 subunit beta) Homo sapiens (Human) GO:0005178; GO:0005198; GO:0005201; GO:0005576; GO:0005604; GO:0005606; GO:0005607; GO:0005615; GO:0005634; GO:0005788; GO:0007155; GO:0007162; GO:0007165; GO:0007566; GO:0019899; GO:0021812; GO:0030155; GO:0030334; GO:0030335; GO:0031012; GO:0031175; GO:0034446; GO:0035987; GO:0042476; GO:0043208; GO:0043257; GO:0043259; GO:0045785; GO:0045995; GO:0048471; GO:0050679; GO:0051149; GO:0070062; GO:0098637; GO:0110011; GO:2001046 cell adhesion [GO:0007155]; embryo implantation [GO:0007566]; endodermal cell differentiation [GO:0035987]; negative regulation of cell adhesion [GO:0007162]; neuron projection development [GO:0031175]; neuronal-glial interaction involved in cerebral cortex radial glia guided migration [GO:0021812]; odontogenesis [GO:0042476]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cell migration [GO:0030335]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of muscle cell differentiation [GO:0051149]; regulation of basement membrane organization [GO:0110011]; regulation of cell adhesion [GO:0030155]; regulation of cell migration [GO:0030334]; regulation of embryonic development [GO:0045995]; signal transduction [GO:0007165]; substrate adhesion-dependent cell spreading [GO:0034446] basement membrane [GO:0005604]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; laminin-1 complex [GO:0005606]; laminin-10 complex [GO:0043259]; laminin-2 complex [GO:0005607]; laminin-8 complex [GO:0043257]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein complex involved in cell-matrix adhesion [GO:0098637] enzyme binding [GO:0019899]; extracellular matrix structural constituent [GO:0005201]; glycosphingolipid binding [GO:0043208]; integrin binding [GO:0005178]; structural molecule activity [GO:0005198] g23997.t2 P07942 36.434 258 6.74e-32 141.0 sp|P07942|LAMB1_HUMAN Laminin subunit beta-1 OS=Homo sapiens OX=9606 GN=LAMB1 PE=1 SV=2 LAMB1_HUMAN reviewed Laminin subunit beta-1 (Laminin B1 chain) (Laminin-1 subunit beta) (Laminin-10 subunit beta) (Laminin-12 subunit beta) (Laminin-2 subunit beta) (Laminin-6 subunit beta) (Laminin-8 subunit beta) Homo sapiens (Human) GO:0005178; GO:0005198; GO:0005201; GO:0005576; GO:0005604; GO:0005606; GO:0005607; GO:0005615; GO:0005634; GO:0005788; GO:0007155; GO:0007162; GO:0007165; GO:0007566; GO:0019899; GO:0021812; GO:0030155; GO:0030334; GO:0030335; GO:0031012; GO:0031175; GO:0034446; GO:0035987; GO:0042476; GO:0043208; GO:0043257; GO:0043259; GO:0045785; GO:0045995; GO:0048471; GO:0050679; GO:0051149; GO:0070062; GO:0098637; GO:0110011; GO:2001046 cell adhesion [GO:0007155]; embryo implantation [GO:0007566]; endodermal cell differentiation [GO:0035987]; negative regulation of cell adhesion [GO:0007162]; neuron projection development [GO:0031175]; neuronal-glial interaction involved in cerebral cortex radial glia guided migration [GO:0021812]; odontogenesis [GO:0042476]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cell migration [GO:0030335]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of muscle cell differentiation [GO:0051149]; regulation of basement membrane organization [GO:0110011]; regulation of cell adhesion [GO:0030155]; regulation of cell migration [GO:0030334]; regulation of embryonic development [GO:0045995]; signal transduction [GO:0007165]; substrate adhesion-dependent cell spreading [GO:0034446] basement membrane [GO:0005604]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; laminin-1 complex [GO:0005606]; laminin-10 complex [GO:0043259]; laminin-2 complex [GO:0005607]; laminin-8 complex [GO:0043257]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein complex involved in cell-matrix adhesion [GO:0098637] enzyme binding [GO:0019899]; extracellular matrix structural constituent [GO:0005201]; glycosphingolipid binding [GO:0043208]; integrin binding [GO:0005178]; structural molecule activity [GO:0005198] g23997.t2 P07942 27.894 527 3.5200000000000003e-29 132.0 sp|P07942|LAMB1_HUMAN Laminin subunit beta-1 OS=Homo sapiens OX=9606 GN=LAMB1 PE=1 SV=2 LAMB1_HUMAN reviewed Laminin subunit beta-1 (Laminin B1 chain) (Laminin-1 subunit beta) (Laminin-10 subunit beta) (Laminin-12 subunit beta) (Laminin-2 subunit beta) (Laminin-6 subunit beta) (Laminin-8 subunit beta) Homo sapiens (Human) GO:0005178; GO:0005198; GO:0005201; GO:0005576; GO:0005604; GO:0005606; GO:0005607; GO:0005615; GO:0005634; GO:0005788; GO:0007155; GO:0007162; GO:0007165; GO:0007566; GO:0019899; GO:0021812; GO:0030155; GO:0030334; GO:0030335; GO:0031012; GO:0031175; GO:0034446; GO:0035987; GO:0042476; GO:0043208; GO:0043257; GO:0043259; GO:0045785; GO:0045995; GO:0048471; GO:0050679; GO:0051149; GO:0070062; GO:0098637; GO:0110011; GO:2001046 cell adhesion [GO:0007155]; embryo implantation [GO:0007566]; endodermal cell differentiation [GO:0035987]; negative regulation of cell adhesion [GO:0007162]; neuron projection development [GO:0031175]; neuronal-glial interaction involved in cerebral cortex radial glia guided migration [GO:0021812]; odontogenesis [GO:0042476]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cell migration [GO:0030335]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of muscle cell differentiation [GO:0051149]; regulation of basement membrane organization [GO:0110011]; regulation of cell adhesion [GO:0030155]; regulation of cell migration [GO:0030334]; regulation of embryonic development [GO:0045995]; signal transduction [GO:0007165]; substrate adhesion-dependent cell spreading [GO:0034446] basement membrane [GO:0005604]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; laminin-1 complex [GO:0005606]; laminin-10 complex [GO:0043259]; laminin-2 complex [GO:0005607]; laminin-8 complex [GO:0043257]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein complex involved in cell-matrix adhesion [GO:0098637] enzyme binding [GO:0019899]; extracellular matrix structural constituent [GO:0005201]; glycosphingolipid binding [GO:0043208]; integrin binding [GO:0005178]; structural molecule activity [GO:0005198] g23999.t1 Q68FK8 56.454 1162 0.0 1293.0 sp|Q68FK8|DHX9_XENLA ATP-dependent RNA helicase A protein OS=Xenopus laevis OX=8355 GN=dhx9 PE=2 SV=1 DHX9_XENLA reviewed ATP-dependent RNA helicase A protein (EC 3.6.4.13) (DEAH box protein 9) (Nuclear DNA helicase II) (NDH II) Xenopus laevis (African clawed frog) GO:0000380; GO:0000978; GO:0003677; GO:0003678; GO:0003688; GO:0003690; GO:0003697; GO:0003713; GO:0003723; GO:0003724; GO:0003725; GO:0003727; GO:0003729; GO:0005524; GO:0005634; GO:0005654; GO:0005726; GO:0005730; GO:0005737; GO:0005813; GO:0006260; GO:0006325; GO:0006353; GO:0015629; GO:0016442; GO:0016604; GO:0016887; GO:0017111; GO:0031490; GO:0033679; GO:0034458; GO:0035195; GO:0035613; GO:0036464; GO:0043022; GO:0043138; GO:0045142; GO:0045739; GO:0045740; GO:0045944; GO:0046833; GO:0046872; GO:0047429; GO:0048146; GO:0050684; GO:0051028; GO:0051092; GO:0061676; GO:0070063; GO:0070578; GO:0070922; GO:0070937; GO:0097165; GO:0140640; GO:1905172; GO:1990518; GO:1990825; GO:1990841; GO:1990904; GO:2000765; GO:2000767 alternative mRNA splicing, via spliceosome [GO:0000380]; chromatin organization [GO:0006325]; DNA replication [GO:0006260]; DNA-templated transcription termination [GO:0006353]; miRNA-mediated post-transcriptional gene silencing [GO:0035195]; mRNA transport [GO:0051028]; positive regulation of cytoplasmic translation [GO:2000767]; positive regulation of DNA repair [GO:0045739]; positive regulation of DNA replication [GO:0045740]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of RNA export from nucleus [GO:0046833]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cytoplasmic translation [GO:2000765]; regulation of mRNA processing [GO:0050684]; RISC complex assembly [GO:0070922] actin cytoskeleton [GO:0015629]; centrosome [GO:0005813]; CRD-mediated mRNA stability complex [GO:0070937]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; nuclear body [GO:0016604]; nuclear stress granule [GO:0097165]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perichromatin fibrils [GO:0005726]; ribonucleoprotein complex [GO:1990904]; RISC complex [GO:0016442]; RISC-loading complex [GO:0070578] 3'-5' DNA helicase activity [GO:0043138]; 3'-5' DNA/RNA helicase activity [GO:0033679]; 3'-5' RNA helicase activity [GO:0034458]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; catalytic activity, acting on a nucleic acid [GO:0140640]; chromatin DNA binding [GO:0031490]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; DNA replication origin binding [GO:0003688]; double-stranded DNA binding [GO:0003690]; double-stranded RNA binding [GO:0003725]; importin-alpha family protein binding [GO:0061676]; metal ion binding [GO:0046872]; mRNA binding [GO:0003729]; nucleoside triphosphate diphosphatase activity [GO:0047429]; promoter-specific chromatin binding [GO:1990841]; ribonucleoside triphosphate phosphatase activity [GO:0017111]; ribosome binding [GO:0043022]; RISC complex binding [GO:1905172]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; RNA polymerase binding [GO:0070063]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA stem-loop binding [GO:0035613]; sequence-specific mRNA binding [GO:1990825]; single-stranded 3'-5' DNA helicase activity [GO:1990518]; single-stranded DNA binding [GO:0003697]; single-stranded RNA binding [GO:0003727]; transcription coactivator activity [GO:0003713]; triplex DNA binding [GO:0045142] g24000.t1 A0JP86 42.83 1590 0.0 1295.0 sp|A0JP86|LAMC1_XENTR Laminin subunit gamma-1 OS=Xenopus tropicalis OX=8364 GN=lamc1 PE=2 SV=1 g24002.t1 Q9UBS5 44.894 470 7.21e-122 386.0 sp|Q9UBS5|GABR1_HUMAN Gamma-aminobutyric acid type B receptor subunit 1 OS=Homo sapiens OX=9606 GN=GABBR1 PE=1 SV=1 GABR1_HUMAN reviewed Gamma-aminobutyric acid type B receptor subunit 1 (GABA-B receptor 1) (GABA-B-R1) (GABA-BR1) (GABABR1) (Gb1) Homo sapiens (Human) GO:0001649; GO:0004965; GO:0005615; GO:0005789; GO:0005886; GO:0007193; GO:0007214; GO:0008021; GO:0008285; GO:0014049; GO:0014053; GO:0030673; GO:0031966; GO:0032811; GO:0033602; GO:0035094; GO:0038039; GO:0042734; GO:0043025; GO:0043197; GO:0043198; GO:0045211; GO:0045471; GO:0046982; GO:0050805; GO:0051932; GO:0060124; GO:0098685; GO:0098978; GO:0098982; GO:0099579; GO:0150047; GO:0150099; GO:1902712; GO:1990430 adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; gamma-aminobutyric acid signaling pathway [GO:0007214]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of dopamine secretion [GO:0033602]; negative regulation of epinephrine secretion [GO:0032811]; negative regulation of gamma-aminobutyric acid secretion [GO:0014053]; negative regulation of synaptic transmission [GO:0050805]; neuron-glial cell signaling [GO:0150099]; osteoblast differentiation [GO:0001649]; positive regulation of glutamate secretion [GO:0014049]; positive regulation of growth hormone secretion [GO:0060124]; response to ethanol [GO:0045471]; response to nicotine [GO:0035094]; synaptic transmission, GABAergic [GO:0051932] axolemma [GO:0030673]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; endoplasmic reticulum membrane [GO:0005789]; extracellular space [GO:0005615]; G protein-coupled GABA receptor complex [GO:1902712]; G protein-coupled receptor heterodimeric complex [GO:0038039]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; mitochondrial membrane [GO:0031966]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; Schaffer collateral - CA1 synapse [GO:0098685]; synaptic vesicle [GO:0008021] extracellular matrix protein binding [GO:1990430]; G protein-coupled GABA receptor activity [GO:0004965]; G protein-coupled neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential [GO:0099579]; G protein-coupled neurotransmitter receptor activity involved in regulation of presynaptic membrane potential [GO:0150047]; protein heterodimerization activity [GO:0046982] g24004.t1 Q9Z0U4 67.961 103 2.02e-44 160.0 sp|Q9Z0U4|GABR1_RAT Gamma-aminobutyric acid type B receptor subunit 1 OS=Rattus norvegicus OX=10116 GN=Gabbr1 PE=1 SV=2 GABR1_RAT reviewed Gamma-aminobutyric acid type B receptor subunit 1 (GABA-B receptor 1) (GABA-B-R1) (GABA-BR1) (GABABR1) (Gb1) Rattus norvegicus (Rat) GO:0001649; GO:0004965; GO:0005615; GO:0005737; GO:0005789; GO:0005886; GO:0007193; GO:0007214; GO:0008021; GO:0008285; GO:0014048; GO:0014049; GO:0014053; GO:0016020; GO:0030673; GO:0031966; GO:0032811; GO:0033602; GO:0035094; GO:0038037; GO:0038039; GO:0042734; GO:0043025; GO:0043197; GO:0043198; GO:0043204; GO:0045211; GO:0045471; GO:0046982; GO:0050805; GO:0051932; GO:0060124; GO:0097060; GO:0098685; GO:0098793; GO:0098978; GO:0098982; GO:0099579; GO:0150047; GO:0150099; GO:1902710; GO:1902712; GO:1990430 adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; gamma-aminobutyric acid signaling pathway [GO:0007214]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of dopamine secretion [GO:0033602]; negative regulation of epinephrine secretion [GO:0032811]; negative regulation of gamma-aminobutyric acid secretion [GO:0014053]; negative regulation of synaptic transmission [GO:0050805]; neuron-glial cell signaling [GO:0150099]; osteoblast differentiation [GO:0001649]; positive regulation of glutamate secretion [GO:0014049]; positive regulation of growth hormone secretion [GO:0060124]; regulation of glutamate secretion [GO:0014048]; response to ethanol [GO:0045471]; response to nicotine [GO:0035094]; synaptic transmission, GABAergic [GO:0051932] axolemma [GO:0030673]; cytoplasm [GO:0005737]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; endoplasmic reticulum membrane [GO:0005789]; extracellular space [GO:0005615]; G protein-coupled GABA receptor complex [GO:1902712]; G protein-coupled receptor dimeric complex [GO:0038037]; G protein-coupled receptor heterodimeric complex [GO:0038039]; GABA receptor complex [GO:1902710]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; mitochondrial membrane [GO:0031966]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynapse [GO:0098793]; presynaptic membrane [GO:0042734]; Schaffer collateral - CA1 synapse [GO:0098685]; synaptic membrane [GO:0097060]; synaptic vesicle [GO:0008021] extracellular matrix protein binding [GO:1990430]; G protein-coupled GABA receptor activity [GO:0004965]; G protein-coupled neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential [GO:0099579]; G protein-coupled neurotransmitter receptor activity involved in regulation of presynaptic membrane potential [GO:0150047]; protein heterodimerization activity [GO:0046982] g24004.t2 Q9WV18 72.5 80 1.01e-34 130.0 sp|Q9WV18|GABR1_MOUSE Gamma-aminobutyric acid type B receptor subunit 1 OS=Mus musculus OX=10090 GN=Gabbr1 PE=1 SV=1 GABR1_MOUSE reviewed Gamma-aminobutyric acid type B receptor subunit 1 (GABA-B receptor 1) (GABA-B-R1) (GABA-BR1) (GABABR1) (Gb1) Mus musculus (Mouse) GO:0001649; GO:0004965; GO:0005615; GO:0005737; GO:0005789; GO:0005886; GO:0007193; GO:0007214; GO:0008021; GO:0008285; GO:0014048; GO:0014049; GO:0014053; GO:0016020; GO:0030673; GO:0031966; GO:0032811; GO:0033602; GO:0035094; GO:0038037; GO:0038039; GO:0042734; GO:0043025; GO:0043197; GO:0043198; GO:0045211; GO:0045471; GO:0046982; GO:0050805; GO:0051932; GO:0060124; GO:0097060; GO:0098685; GO:0098793; GO:0098978; GO:0098982; GO:0099579; GO:0150047; GO:0150099; GO:1902710; GO:1902712; GO:1990430 adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; gamma-aminobutyric acid signaling pathway [GO:0007214]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of dopamine secretion [GO:0033602]; negative regulation of epinephrine secretion [GO:0032811]; negative regulation of gamma-aminobutyric acid secretion [GO:0014053]; negative regulation of synaptic transmission [GO:0050805]; neuron-glial cell signaling [GO:0150099]; osteoblast differentiation [GO:0001649]; positive regulation of glutamate secretion [GO:0014049]; positive regulation of growth hormone secretion [GO:0060124]; regulation of glutamate secretion [GO:0014048]; response to ethanol [GO:0045471]; response to nicotine [GO:0035094]; synaptic transmission, GABAergic [GO:0051932] axolemma [GO:0030673]; cytoplasm [GO:0005737]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; endoplasmic reticulum membrane [GO:0005789]; extracellular space [GO:0005615]; G protein-coupled GABA receptor complex [GO:1902712]; G protein-coupled receptor dimeric complex [GO:0038037]; G protein-coupled receptor heterodimeric complex [GO:0038039]; GABA receptor complex [GO:1902710]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; mitochondrial membrane [GO:0031966]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynapse [GO:0098793]; presynaptic membrane [GO:0042734]; Schaffer collateral - CA1 synapse [GO:0098685]; synaptic membrane [GO:0097060]; synaptic vesicle [GO:0008021] extracellular matrix protein binding [GO:1990430]; G protein-coupled GABA receptor activity [GO:0004965]; G protein-coupled neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential [GO:0099579]; G protein-coupled neurotransmitter receptor activity involved in regulation of presynaptic membrane potential [GO:0150047]; protein heterodimerization activity [GO:0046982] g24007.t1 Q5RF97 44.314 255 4.14e-65 216.0 sp|Q5RF97|BCD1_PONAB Box C/D snoRNA protein 1 OS=Pongo abelii OX=9601 GN=ZNHIT6 PE=2 SV=1 g24008.t1 Q5QJE6 50.0 178 2.24e-49 181.0 sp|Q5QJE6|TDIF2_HUMAN Deoxynucleotidyltransferase terminal-interacting protein 2 OS=Homo sapiens OX=9606 GN=DNTTIP2 PE=1 SV=2 TDIF2_HUMAN reviewed Deoxynucleotidyltransferase terminal-interacting protein 2 (Estrogen receptor-binding protein) (LPTS-interacting protein 2) (LPTS-RP2) (Terminal deoxynucleotidyltransferase-interacting factor 2) (TdIF2) (TdT-interacting factor 2) Homo sapiens (Human) GO:0003723; GO:0005654; GO:0005694; GO:0005730; GO:0006396; GO:0032040; GO:0042274 ribosomal small subunit biogenesis [GO:0042274]; RNA processing [GO:0006396] chromosome [GO:0005694]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; small-subunit processome [GO:0032040] RNA binding [GO:0003723] g24009.t1 A6QNM7 48.588 673 0.0 620.0 sp|A6QNM7|UBP33_BOVIN Ubiquitin carboxyl-terminal hydrolase 33 OS=Bos taurus OX=9913 GN=USP33 PE=2 SV=1 UBP33_BOVIN reviewed Ubiquitin carboxyl-terminal hydrolase 33 (EC 3.4.19.12) (Deubiquitinating enzyme 33) (Ubiquitin thioesterase 33) (Ubiquitin-specific-processing protease 33) Bos taurus (Bovine) GO:0004197; GO:0004843; GO:0005813; GO:0006508; GO:0006897; GO:0007399; GO:0007411; GO:0008270; GO:0008277; GO:0016477; GO:0016579; GO:0048471; GO:0051298; GO:0070536; GO:0071108 axon guidance [GO:0007411]; cell migration [GO:0016477]; centrosome duplication [GO:0051298]; endocytosis [GO:0006897]; nervous system development [GO:0007399]; protein deubiquitination [GO:0016579]; protein K48-linked deubiquitination [GO:0071108]; protein K63-linked deubiquitination [GO:0070536]; proteolysis [GO:0006508]; regulation of G protein-coupled receptor signaling pathway [GO:0008277] centrosome [GO:0005813]; perinuclear region of cytoplasm [GO:0048471] cysteine-type deubiquitinase activity [GO:0004843]; cysteine-type endopeptidase activity [GO:0004197]; zinc ion binding [GO:0008270] g24010.t1 Q8C6M1 41.121 214 6.48e-50 177.0 sp|Q8C6M1|UBP20_MOUSE Ubiquitin carboxyl-terminal hydrolase 20 OS=Mus musculus OX=10090 GN=Usp20 PE=1 SV=1 UBP20_MOUSE reviewed Ubiquitin carboxyl-terminal hydrolase 20 (EC 3.4.19.12) (Deubiquitinating enzyme 20) (Ubiquitin thioesterase 20) (Ubiquitin-specific-processing protease 20) (VHL-interacting deubiquitinating enzyme 2) Mus musculus (Mouse) GO:0001664; GO:0004197; GO:0004843; GO:0005783; GO:0005813; GO:0006508; GO:0006897; GO:0007249; GO:0007399; GO:0008270; GO:0008277; GO:0010508; GO:0016579; GO:0043124; GO:0048471; GO:0070536; GO:0071108; GO:0140374 antiviral innate immune response [GO:0140374]; canonical NF-kappaB signal transduction [GO:0007249]; endocytosis [GO:0006897]; negative regulation of canonical NF-kappaB signal transduction [GO:0043124]; nervous system development [GO:0007399]; positive regulation of autophagy [GO:0010508]; protein deubiquitination [GO:0016579]; protein K48-linked deubiquitination [GO:0071108]; protein K63-linked deubiquitination [GO:0070536]; proteolysis [GO:0006508]; regulation of G protein-coupled receptor signaling pathway [GO:0008277] centrosome [GO:0005813]; endoplasmic reticulum [GO:0005783]; perinuclear region of cytoplasm [GO:0048471] cysteine-type deubiquitinase activity [GO:0004843]; cysteine-type endopeptidase activity [GO:0004197]; G protein-coupled receptor binding [GO:0001664]; zinc ion binding [GO:0008270] g24011.t1 P35061 86.139 101 1.8e-60 185.0 sp|P35061|H2A_ACRFO Histone H2A OS=Acropora formosa OX=126732 PE=3 SV=2 g24018.t1 P00520 66.499 397 0.0 553.0 sp|P00520|ABL1_MOUSE Tyrosine-protein kinase ABL1 OS=Mus musculus OX=10090 GN=Abl1 PE=1 SV=3 g24021.t1 A2AJ77 52.922 308 1.45e-115 341.0 sp|A2AJ77|PRD12_MOUSE PR domain zinc finger protein 12 OS=Mus musculus OX=10090 GN=Prdm12 PE=2 SV=1 PRD12_MOUSE reviewed PR domain zinc finger protein 12 (PR domain-containing protein 12) Mus musculus (Mouse) GO:0000122; GO:0000981; GO:0001227; GO:0001228; GO:0003677; GO:0005634; GO:0005654; GO:0008270; GO:0010468; GO:0019233; GO:0022008; GO:0031175; GO:0048665; GO:0050965; GO:0140713; GO:1990226 detection of temperature stimulus involved in sensory perception of pain [GO:0050965]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neurogenesis [GO:0022008]; neuron fate specification [GO:0048665]; neuron projection development [GO:0031175]; regulation of gene expression [GO:0010468]; sensory perception of pain [GO:0019233] nucleoplasm [GO:0005654]; nucleus [GO:0005634] DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; histone chaperone activity [GO:0140713]; histone methyltransferase binding [GO:1990226]; zinc ion binding [GO:0008270] g24022.t1 H3ZPL1 30.653 398 3.3e-47 171.0 sp|H3ZPL1|ARAT1_THELN Aromatic-amino-acid aminotransferase 1 OS=Thermococcus litoralis (strain ATCC 51850 / DSM 5473 / JCM 8560 / NS-C) OX=523849 GN=OCC_04335 PE=1 SV=1 g24024.t1 Q9W539 79.545 88 3.0299999999999997e-45 171.0 sp|Q9W539|HR4_DROME Hormone receptor 4 OS=Drosophila melanogaster OX=7227 GN=Hr4 PE=1 SV=4 HR4_DROME reviewed Hormone receptor 4 (dHR4) (Nuclear receptor subfamily 6 group A member 2) Drosophila melanogaster (Fruit fly) GO:0000785; GO:0004879; GO:0005634; GO:0005737; GO:0006357; GO:0008270; GO:0034056; GO:0040018; GO:0048638; GO:0071456; GO:0106023; GO:0120143 cellular response to hypoxia [GO:0071456]; negative regulation of ecdysone receptor signaling pathway [GO:0120143]; positive regulation of multicellular organism growth [GO:0040018]; regulation of developmental growth [GO:0048638]; regulation of pupariation [GO:0106023]; regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleus [GO:0005634] estrogen response element binding [GO:0034056]; nuclear receptor activity [GO:0004879]; zinc ion binding [GO:0008270] g24028.t1 Q1LVF3 46.356 494 4.21e-121 392.0 sp|Q1LVF3|SMG7_DANRE Nonsense-mediated mRNA decay factor SMG7 OS=Danio rerio OX=7955 GN=smg7 PE=2 SV=2 SMG7_DANRE reviewed Nonsense-mediated mRNA decay factor SMG7 (SMG-7 homolog) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000184; GO:0005697; GO:0005737; GO:0042162; GO:0043009; GO:0070034 chordate embryonic development [GO:0043009]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184] cytoplasm [GO:0005737]; telomerase holoenzyme complex [GO:0005697] telomerase RNA binding [GO:0070034]; telomeric DNA binding [GO:0042162] g24029.t1 Q28CY9 52.744 656 0.0 602.0 sp|Q28CY9|XPR1_XENTR Xenotropic and polytropic retrovirus receptor 1 homolog OS=Xenopus tropicalis OX=8364 GN=xpr1 PE=2 SV=1 g24031.t1 Q640L5 30.221 1403 1.07e-113 398.0 sp|Q640L5|CCD18_MOUSE Coiled-coil domain-containing protein 18 OS=Mus musculus OX=10090 GN=Ccdc18 PE=1 SV=1 g24032.t1 Q26481 75.338 296 1.26e-160 452.0 sp|Q26481|RL5_STYCL Large ribosomal subunit protein uL18 OS=Styela clava OX=7725 GN=RPL5 PE=3 SV=3 g24033.t1 Q8IZE3 40.089 449 4.71e-91 305.0 sp|Q8IZE3|PACE1_HUMAN Protein-associating with the carboxyl-terminal domain of ezrin OS=Homo sapiens OX=9606 GN=SCYL3 PE=1 SV=3 PACE1_HUMAN reviewed Protein-associating with the carboxyl-terminal domain of ezrin (Ezrin-binding protein PACE-1) (SCY1-like protein 3) Homo sapiens (Human) GO:0000139; GO:0005524; GO:0005737; GO:0005783; GO:0005794; GO:0005829; GO:0006954; GO:0008104; GO:0016477; GO:0021522; GO:0030027; GO:0042802; GO:0048666 cell migration [GO:0016477]; inflammatory response [GO:0006954]; intracellular protein localization [GO:0008104]; neuron development [GO:0048666]; spinal cord motor neuron differentiation [GO:0021522] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; lamellipodium [GO:0030027] ATP binding [GO:0005524]; identical protein binding [GO:0042802] g24034.t1 Q96I24 35.865 474 3.1500000000000005e-70 241.0 sp|Q96I24|FUBP3_HUMAN Far upstream element-binding protein 3 OS=Homo sapiens OX=9606 GN=FUBP3 PE=1 SV=2 FUBP3_HUMAN reviewed Far upstream element-binding protein 3 (FUSE-binding protein 3) Homo sapiens (Human) GO:0003697; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0005737; GO:0005840; GO:0006351; GO:0006357; GO:0008298; GO:0010628; GO:0016020; GO:0043025; GO:0043198; GO:0045893; GO:0045944 DNA-templated transcription [GO:0006351]; intracellular mRNA localization [GO:0008298]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357] cytoplasm [GO:0005737]; dendritic shaft [GO:0043198]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribosome [GO:0005840] mRNA binding [GO:0003729]; RNA binding [GO:0003723]; single-stranded DNA binding [GO:0003697] g24034.t2 Q96I24 35.865 474 3.22e-70 241.0 sp|Q96I24|FUBP3_HUMAN Far upstream element-binding protein 3 OS=Homo sapiens OX=9606 GN=FUBP3 PE=1 SV=2 FUBP3_HUMAN reviewed Far upstream element-binding protein 3 (FUSE-binding protein 3) Homo sapiens (Human) GO:0003697; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0005737; GO:0005840; GO:0006351; GO:0006357; GO:0008298; GO:0010628; GO:0016020; GO:0043025; GO:0043198; GO:0045893; GO:0045944 DNA-templated transcription [GO:0006351]; intracellular mRNA localization [GO:0008298]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357] cytoplasm [GO:0005737]; dendritic shaft [GO:0043198]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribosome [GO:0005840] mRNA binding [GO:0003729]; RNA binding [GO:0003723]; single-stranded DNA binding [GO:0003697] g24035.t1 Q3ZCC3 32.367 207 9.15e-29 115.0 sp|Q3ZCC3|TRAF6_BOVIN TNF receptor-associated factor 6 OS=Bos taurus OX=9913 GN=TRAF6 PE=2 SV=1 TRAF6_BOVIN reviewed TNF receptor-associated factor 6 (EC 2.3.2.27) (E3 ubiquitin-protein ligase TRAF6) (RING-type E3 ubiquitin transferase TRAF6) Bos taurus (Bovine) GO:0000045; GO:0000122; GO:0001503; GO:0001701; GO:0001843; GO:0002637; GO:0002726; GO:0002753; GO:0004842; GO:0005164; GO:0005634; GO:0005737; GO:0005811; GO:0005829; GO:0005938; GO:0006974; GO:0007249; GO:0008270; GO:0009299; GO:0009898; GO:0019886; GO:0023035; GO:0030316; GO:0031624; GO:0031663; GO:0031666; GO:0032481; GO:0032735; GO:0032743; GO:0032755; GO:0033209; GO:0034142; GO:0034450; GO:0035591; GO:0035631; GO:0038061; GO:0038172; GO:0038173; GO:0042088; GO:0042102; GO:0042475; GO:0042742; GO:0042802; GO:0042826; GO:0042981; GO:0043011; GO:0043122; GO:0043123; GO:0043124; GO:0043422; GO:0045087; GO:0045453; GO:0045672; GO:0045944; GO:0046330; GO:0048471; GO:0050852; GO:0051092; GO:0051865; GO:0061630; GO:0070498; GO:0070534; GO:0070936; GO:0097400; GO:0098696; GO:0098978; GO:0140374; GO:0141198; GO:1904996 antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; antiviral innate immune response [GO:0140374]; autophagosome assembly [GO:0000045]; bone resorption [GO:0045453]; canonical NF-kappaB signal transduction [GO:0007249]; CD40 signaling pathway [GO:0023035]; cytoplasmic pattern recognition receptor signaling pathway [GO:0002753]; defense response to bacterium [GO:0042742]; DNA damage response [GO:0006974]; in utero embryonic development [GO:0001701]; innate immune response [GO:0045087]; interleukin-1-mediated signaling pathway [GO:0070498]; interleukin-17-mediated signaling pathway [GO:0097400]; interleukin-17A-mediated signaling pathway [GO:0038173]; interleukin-33-mediated signaling pathway [GO:0038172]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; mRNA transcription [GO:0009299]; myeloid dendritic cell differentiation [GO:0043011]; negative regulation of canonical NF-kappaB signal transduction [GO:0043124]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural tube closure [GO:0001843]; non-canonical NF-kappaB signal transduction [GO:0038061]; odontogenesis of dentin-containing tooth [GO:0042475]; ossification [GO:0001503]; osteoclast differentiation [GO:0030316]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of JNK cascade [GO:0046330]; positive regulation of leukocyte adhesion to vascular endothelial cell [GO:1904996]; positive regulation of lipopolysaccharide-mediated signaling pathway [GO:0031666]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of T cell cytokine production [GO:0002726]; positive regulation of T cell proliferation [GO:0042102]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of type I interferon production [GO:0032481]; protein autoubiquitination [GO:0051865]; protein branched polyubiquitination [GO:0141198]; protein K48-linked ubiquitination [GO:0070936]; protein K63-linked ubiquitination [GO:0070534]; regulation of apoptotic process [GO:0042981]; regulation of canonical NF-kappaB signal transduction [GO:0043122]; regulation of immunoglobulin production [GO:0002637]; regulation of neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0098696]; T cell receptor signaling pathway [GO:0050852]; T-helper 1 type immune response [GO:0042088]; toll-like receptor 4 signaling pathway [GO:0034142]; tumor necrosis factor-mediated signaling pathway [GO:0033209] CD40 receptor complex [GO:0035631]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; lipid droplet [GO:0005811]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471] histone deacetylase binding [GO:0042826]; identical protein binding [GO:0042802]; protein kinase B binding [GO:0043422]; signaling adaptor activity [GO:0035591]; tumor necrosis factor receptor binding [GO:0005164]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; ubiquitin-ubiquitin ligase activity [GO:0034450]; zinc ion binding [GO:0008270] g24037.t1 P39429 59.77 174 1.57e-78 245.0 sp|P39429|TRAF2_MOUSE TNF receptor-associated factor 2 OS=Mus musculus OX=10090 GN=Traf2 PE=1 SV=1 TRAF2_MOUSE reviewed TNF receptor-associated factor 2 (EC 2.3.2.27) (E3 ubiquitin-protein ligase TRAF2) (RING-type E3 ubiquitin transferase TRAF2) Mus musculus (Mouse) GO:0000151; GO:0002637; GO:0002726; GO:0002947; GO:0004842; GO:0005164; GO:0005174; GO:0005737; GO:0005829; GO:0005938; GO:0006915; GO:0007165; GO:0008270; GO:0009898; GO:0012506; GO:0019899; GO:0019901; GO:0019903; GO:0023035; GO:0030163; GO:0030674; GO:0031435; GO:0031625; GO:0031996; GO:0032743; GO:0032991; GO:0033209; GO:0034351; GO:0035591; GO:0035631; GO:0038061; GO:0038202; GO:0038203; GO:0042110; GO:0042802; GO:0042981; GO:0043066; GO:0043120; GO:0043123; GO:0043254; GO:0043507; GO:0044877; GO:0045087; GO:0045121; GO:0046328; GO:0046625; GO:0048255; GO:0051092; GO:0051865; GO:0061630; GO:0065003; GO:0070534; GO:0071732; GO:0097057; GO:0097300; GO:0097400; GO:0160162; GO:1903265; GO:1905669; GO:1905670; GO:1990604; GO:2001238 apoptotic process [GO:0006915]; CD27 signaling pathway [GO:0160162]; CD40 signaling pathway [GO:0023035]; cellular response to nitric oxide [GO:0071732]; innate immune response [GO:0045087]; interleukin-17-mediated signaling pathway [GO:0097400]; mRNA stabilization [GO:0048255]; negative regulation of apoptotic process [GO:0043066]; negative regulation of glial cell apoptotic process [GO:0034351]; non-canonical NF-kappaB signal transduction [GO:0038061]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of T cell cytokine production [GO:0002726]; positive regulation of tumor necrosis factor-mediated signaling pathway [GO:1903265]; programmed necrotic cell death [GO:0097300]; protein autoubiquitination [GO:0051865]; protein catabolic process [GO:0030163]; protein K63-linked ubiquitination [GO:0070534]; protein-containing complex assembly [GO:0065003]; regulation of apoptotic process [GO:0042981]; regulation of immunoglobulin production [GO:0002637]; regulation of JNK cascade [GO:0046328]; regulation of protein-containing complex assembly [GO:0043254]; signal transduction [GO:0007165]; T cell activation [GO:0042110]; TORC1 complex assembly [GO:1905669]; TORC1 signaling [GO:0038202]; TORC2 complex disassembly [GO:1905670]; TORC2 signaling [GO:0038203]; tumor necrosis factor-mediated signaling pathway [GO:0033209] CD40 receptor complex [GO:0035631]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; IRE1-TRAF2-ASK1 complex [GO:1990604]; membrane raft [GO:0045121]; protein-containing complex [GO:0032991]; TRAF2-GSTP1 complex [GO:0097057]; tumor necrosis factor receptor superfamily complex [GO:0002947]; ubiquitin ligase complex [GO:0000151]; vesicle membrane [GO:0012506] CD40 receptor binding [GO:0005174]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; mitogen-activated protein kinase kinase kinase binding [GO:0031435]; protein kinase binding [GO:0019901]; protein phosphatase binding [GO:0019903]; protein-containing complex binding [GO:0044877]; protein-macromolecule adaptor activity [GO:0030674]; signaling adaptor activity [GO:0035591]; sphingolipid binding [GO:0046625]; thioesterase binding [GO:0031996]; tumor necrosis factor binding [GO:0043120]; tumor necrosis factor receptor binding [GO:0005164]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] g24038.t1 P53611 71.386 332 1.33e-180 504.0 sp|P53611|PGTB2_HUMAN Geranylgeranyl transferase type-2 subunit beta OS=Homo sapiens OX=9606 GN=RABGGTB PE=1 SV=2 PGTB2_HUMAN reviewed Geranylgeranyl transferase type-2 subunit beta (EC 2.5.1.60) (Geranylgeranyl transferase type II subunit beta) (GGTase-II-beta) (Rab geranyl-geranyltransferase subunit beta) (Rab GG transferase beta) (Rab GGTase beta) (Rab geranylgeranyltransferase subunit beta) (Type II protein geranyl-geranyltransferase subunit beta) Homo sapiens (Human) GO:0004663; GO:0005829; GO:0005886; GO:0005968; GO:0006888; GO:0007601; GO:0008270; GO:0018344; GO:0031267; GO:0036211 endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; protein geranylgeranylation [GO:0018344]; protein modification process [GO:0036211]; visual perception [GO:0007601] cytosol [GO:0005829]; plasma membrane [GO:0005886]; Rab-protein geranylgeranyltransferase complex [GO:0005968] Rab geranylgeranyltransferase activity [GO:0004663]; small GTPase binding [GO:0031267]; zinc ion binding [GO:0008270] g24039.t1 Q6KAQ7 43.86 456 8.83e-98 333.0 sp|Q6KAQ7|ZZZ3_MOUSE ZZ-type zinc finger-containing protein 3 OS=Mus musculus OX=10090 GN=Zzz3 PE=1 SV=2 ZZZ3_MOUSE reviewed ZZ-type zinc finger-containing protein 3 Mus musculus (Mouse) GO:0003677; GO:0005654; GO:0005730; GO:0006325; GO:0006355; GO:0006357; GO:0008270; GO:0042393; GO:0045995; GO:0051302; GO:0051726; GO:0072686; GO:0140672 chromatin organization [GO:0006325]; regulation of cell cycle [GO:0051726]; regulation of cell division [GO:0051302]; regulation of DNA-templated transcription [GO:0006355]; regulation of embryonic development [GO:0045995]; regulation of transcription by RNA polymerase II [GO:0006357] ATAC complex [GO:0140672]; mitotic spindle [GO:0072686]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654] DNA binding [GO:0003677]; histone binding [GO:0042393]; zinc ion binding [GO:0008270] g24039.t2 Q6KAQ7 43.668 458 5.07e-97 330.0 sp|Q6KAQ7|ZZZ3_MOUSE ZZ-type zinc finger-containing protein 3 OS=Mus musculus OX=10090 GN=Zzz3 PE=1 SV=2 ZZZ3_MOUSE reviewed ZZ-type zinc finger-containing protein 3 Mus musculus (Mouse) GO:0003677; GO:0005654; GO:0005730; GO:0006325; GO:0006355; GO:0006357; GO:0008270; GO:0042393; GO:0045995; GO:0051302; GO:0051726; GO:0072686; GO:0140672 chromatin organization [GO:0006325]; regulation of cell cycle [GO:0051726]; regulation of cell division [GO:0051302]; regulation of DNA-templated transcription [GO:0006355]; regulation of embryonic development [GO:0045995]; regulation of transcription by RNA polymerase II [GO:0006357] ATAC complex [GO:0140672]; mitotic spindle [GO:0072686]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654] DNA binding [GO:0003677]; histone binding [GO:0042393]; zinc ion binding [GO:0008270] g24042.t1 Q9HCS7 69.519 853 0.0 1163.0 sp|Q9HCS7|SYF1_HUMAN Pre-mRNA-splicing factor SYF1 OS=Homo sapiens OX=9606 GN=XAB2 PE=1 SV=2 SYF1_HUMAN reviewed Pre-mRNA-splicing factor SYF1 (Protein HCNP) (XPA-binding protein 2) Homo sapiens (Human) GO:0000349; GO:0000398; GO:0000974; GO:0001824; GO:0005634; GO:0005654; GO:0006283; GO:0006351; GO:0016020; GO:0021987; GO:0071007; GO:0071013; GO:0071014 blastocyst development [GO:0001824]; cerebral cortex development [GO:0021987]; DNA-templated transcription [GO:0006351]; generation of catalytic spliceosome for first transesterification step [GO:0000349]; mRNA splicing, via spliceosome [GO:0000398]; transcription-coupled nucleotide-excision repair [GO:0006283] catalytic step 2 spliceosome [GO:0071013]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; post-mRNA release spliceosomal complex [GO:0071014]; Prp19 complex [GO:0000974]; U2-type catalytic step 2 spliceosome [GO:0071007] g24043.t1 P81274 56.094 640 0.0 672.0 sp|P81274|GPSM2_HUMAN G-protein-signaling modulator 2 OS=Homo sapiens OX=9606 GN=GPSM2 PE=1 SV=3 GPSM2_HUMAN reviewed G-protein-signaling modulator 2 (Mosaic protein LGN) Homo sapiens (Human) GO:0000132; GO:0000166; GO:0001965; GO:0005092; GO:0005737; GO:0005813; GO:0005829; GO:0005938; GO:0007052; GO:0007186; GO:0009642; GO:0014069; GO:0016328; GO:0019904; GO:0032991; GO:0042802; GO:0051301; GO:0051661; GO:0060236; GO:0070840; GO:0097431; GO:0097575; GO:0099645; GO:0099738; GO:1904778; GO:1905832 cell division [GO:0051301]; establishment of mitotic spindle orientation [GO:0000132]; G protein-coupled receptor signaling pathway [GO:0007186]; maintenance of centrosome location [GO:0051661]; mitotic spindle organization [GO:0007052]; neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0099645]; positive regulation of protein localization to cell cortex [GO:1904778]; positive regulation of spindle assembly [GO:1905832]; regulation of mitotic spindle organization [GO:0060236]; response to light intensity [GO:0009642] cell cortex [GO:0005938]; cell cortex region [GO:0099738]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; lateral cell cortex [GO:0097575]; lateral plasma membrane [GO:0016328]; mitotic spindle pole [GO:0097431]; postsynaptic density [GO:0014069]; protein-containing complex [GO:0032991] dynein complex binding [GO:0070840]; G-protein alpha-subunit binding [GO:0001965]; GDP-dissociation inhibitor activity [GO:0005092]; identical protein binding [GO:0042802]; nucleotide binding [GO:0000166]; protein domain specific binding [GO:0019904] g24045.t1 P97443 27.425 299 8.060000000000001e-32 131.0 sp|P97443|SMYD1_MOUSE Histone-lysine N-methyltransferase Smyd1 OS=Mus musculus OX=10090 GN=Smyd1 PE=1 SV=3 SMYD1_MOUSE reviewed Histone-lysine N-methyltransferase Smyd1 (EC 2.1.1.354) (CD8b-opposite) (SET and MYND domain-containing protein 1) (Zinc finger protein BOP) (m-BOP) Mus musculus (Mouse) GO:0003677; GO:0003714; GO:0005634; GO:0005654; GO:0005737; GO:0006338; GO:0007507; GO:0008270; GO:0010831; GO:0032259; GO:0035914; GO:0045663; GO:0045892; GO:0140999 chromatin remodeling [GO:0006338]; heart development [GO:0007507]; methylation [GO:0032259]; negative regulation of DNA-templated transcription [GO:0045892]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of myotube differentiation [GO:0010831]; skeletal muscle cell differentiation [GO:0035914] cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] DNA binding [GO:0003677]; histone H3K4 trimethyltransferase activity [GO:0140999]; transcription corepressor activity [GO:0003714]; zinc ion binding [GO:0008270] g24046.t1 O57592 78.333 240 2.3600000000000002e-132 378.0 sp|O57592|RL7A_TAKRU Large ribosomal subunit protein eL8 OS=Takifugu rubripes OX=31033 GN=rpl7a PE=3 SV=3 g24047.t1 A5WUL3 66.917 133 3.21e-60 187.0 sp|A5WUL3|MED22_DANRE Mediator of RNA polymerase II transcription subunit 22 OS=Danio rerio OX=7955 GN=med22 PE=2 SV=1 g24048.t1 Q8NE71 69.47 547 0.0 675.0 sp|Q8NE71|ABCF1_HUMAN ATP-binding cassette sub-family F member 1 OS=Homo sapiens OX=9606 GN=ABCF1 PE=1 SV=2 ABCF1_HUMAN reviewed ATP-binding cassette sub-family F member 1 (ATP-binding cassette 50) (TNF-alpha-stimulated ABC protein) Homo sapiens (Human) GO:0003723; GO:0005524; GO:0005635; GO:0005654; GO:0005737; GO:0005829; GO:0006412; GO:0006413; GO:0006954; GO:0008135; GO:0008494; GO:0016020; GO:0016887; GO:0043022; GO:0045727 inflammatory response [GO:0006954]; positive regulation of translation [GO:0045727]; translation [GO:0006412]; translational initiation [GO:0006413] cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ribosome binding [GO:0043022]; RNA binding [GO:0003723]; translation activator activity [GO:0008494]; translation factor activity, RNA binding [GO:0008135] g24051.t1 Q6MFY5 42.241 116 9.21e-25 94.0 sp|Q6MFY5|RPA12_RAT DNA-directed RNA polymerase I subunit RPA12 OS=Rattus norvegicus OX=10116 GN=Polr1h PE=3 SV=1 g24052.t1 Q7YR39 69.59 878 0.0 1198.0 sp|Q7YR39|DHX16_PANTR Pre-mRNA-splicing factor ATP-dependent RNA helicase DHX16 OS=Pan troglodytes OX=9598 GN=DHX16 PE=3 SV=1 g24053.t1 O43805 66.972 109 2.04e-47 151.0 sp|O43805|SSNA1_HUMAN Microtubule nucleation factor SSNA1 OS=Homo sapiens OX=9606 GN=SSNA1 PE=1 SV=2 SSNA1_HUMAN reviewed Microtubule nucleation factor SSNA1 (Nuclear autoantigen of 14 kDa) (Sjoegren syndrome nuclear autoantigen 1) Homo sapiens (Human) GO:0000226; GO:0005634; GO:0005813; GO:0005814; GO:0005829; GO:0005886; GO:0005930; GO:0007020; GO:0007224; GO:0007409; GO:0008017; GO:0030424; GO:0030496; GO:0036064; GO:0042073; GO:0042802; GO:0043113; GO:0048675; GO:0051301; GO:0099512; GO:0140060 axon arborization [GO:0140060]; axon extension [GO:0048675]; axonogenesis [GO:0007409]; cell division [GO:0051301]; intraciliary transport [GO:0042073]; microtubule cytoskeleton organization [GO:0000226]; microtubule nucleation [GO:0007020]; receptor clustering [GO:0043113]; smoothened signaling pathway [GO:0007224] axon [GO:0030424]; axoneme [GO:0005930]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytosol [GO:0005829]; midbody [GO:0030496]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; supramolecular fiber [GO:0099512] identical protein binding [GO:0042802]; microtubule binding [GO:0008017] g24058.t1 Q3KRD0 55.357 504 0.0 596.0 sp|Q3KRD0|SYDM_RAT Aspartate--tRNA ligase, mitochondrial OS=Rattus norvegicus OX=10116 GN=Dars2 PE=1 SV=1 SYDM_RAT reviewed Aspartate--tRNA ligase, mitochondrial (EC 6.1.1.12) (Aspartyl-tRNA synthetase) (AspRS) Rattus norvegicus (Rat) GO:0003676; GO:0004815; GO:0005524; GO:0005654; GO:0005739; GO:0005759; GO:0006422; GO:0031966; GO:0042803; GO:0043039; GO:0050560; GO:0070145 aspartyl-tRNA aminoacylation [GO:0006422]; mitochondrial asparaginyl-tRNA aminoacylation [GO:0070145]; tRNA aminoacylation [GO:0043039] mitochondrial matrix [GO:0005759]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654] aspartate-tRNA ligase activity [GO:0004815]; aspartate-tRNA(Asn) ligase activity [GO:0050560]; ATP binding [GO:0005524]; nucleic acid binding [GO:0003676]; protein homodimerization activity [GO:0042803] g24063.t1 P29054 76.568 303 5.58e-165 464.0 sp|P29054|TF2B_XENLA Transcription initiation factor IIB OS=Xenopus laevis OX=8355 GN=gtf2b PE=2 SV=1 g24064.t1 Q9BQ50 39.13 207 1.1e-33 123.0 sp|Q9BQ50|TREX2_HUMAN Three prime repair exonuclease 2 OS=Homo sapiens OX=9606 GN=TREX2 PE=1 SV=2 TREX2_HUMAN reviewed Three prime repair exonuclease 2 (EC 3.1.11.2) (3'-5' exonuclease TREX2) Homo sapiens (Human) GO:0000287; GO:0003677; GO:0005634; GO:0005737; GO:0006259; GO:0006281; GO:0006308; GO:0008296; GO:0008311; GO:0042803; GO:0060090 DNA catabolic process [GO:0006308]; DNA metabolic process [GO:0006259]; DNA repair [GO:0006281] cytoplasm [GO:0005737]; nucleus [GO:0005634] 3'-5'-DNA exonuclease activity [GO:0008296]; DNA binding [GO:0003677]; double-stranded DNA 3'-5' DNA exonuclease activity [GO:0008311]; magnesium ion binding [GO:0000287]; molecular adaptor activity [GO:0060090]; protein homodimerization activity [GO:0042803] g24065.t1 Q9R1A9 39.914 233 1.12e-53 176.0 sp|Q9R1A9|TREX2_MOUSE Three prime repair exonuclease 2 OS=Mus musculus OX=10090 GN=Trex2 PE=1 SV=1 g24066.t1 P16086 63.12 2481 0.0 3128.0 sp|P16086|SPTN1_RAT Spectrin alpha chain, non-erythrocytic 1 OS=Rattus norvegicus OX=10116 GN=Sptan1 PE=1 SV=2 SPTN1_RAT reviewed Spectrin alpha chain, non-erythrocytic 1 (Alpha-II spectrin) (Fodrin alpha chain) Rattus norvegicus (Rat) GO:0005509; GO:0005516; GO:0005829; GO:0005886; GO:0005916; GO:0008091; GO:0015630; GO:0016020; GO:0016328; GO:0030018; GO:0030036; GO:0030054; GO:0030507; GO:0030863; GO:0030864; GO:0032437; GO:0032991; GO:0033010; GO:0033270; GO:0042995; GO:0044877; GO:0051015; GO:0051693; GO:0098794; GO:0098978 actin cytoskeleton organization [GO:0030036]; actin filament capping [GO:0051693] cell junction [GO:0030054]; cell projection [GO:0042995]; cortical actin cytoskeleton [GO:0030864]; cortical cytoskeleton [GO:0030863]; cuticular plate [GO:0032437]; cytosol [GO:0005829]; fascia adherens [GO:0005916]; glutamatergic synapse [GO:0098978]; lateral plasma membrane [GO:0016328]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; paranodal junction [GO:0033010]; paranode region of axon [GO:0033270]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; protein-containing complex [GO:0032991]; spectrin [GO:0008091]; Z disc [GO:0030018] actin filament binding [GO:0051015]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; protein-containing complex binding [GO:0044877]; spectrin binding [GO:0030507] g24066.t1 P16086 26.834 995 7.37e-99 361.0 sp|P16086|SPTN1_RAT Spectrin alpha chain, non-erythrocytic 1 OS=Rattus norvegicus OX=10116 GN=Sptan1 PE=1 SV=2 SPTN1_RAT reviewed Spectrin alpha chain, non-erythrocytic 1 (Alpha-II spectrin) (Fodrin alpha chain) Rattus norvegicus (Rat) GO:0005509; GO:0005516; GO:0005829; GO:0005886; GO:0005916; GO:0008091; GO:0015630; GO:0016020; GO:0016328; GO:0030018; GO:0030036; GO:0030054; GO:0030507; GO:0030863; GO:0030864; GO:0032437; GO:0032991; GO:0033010; GO:0033270; GO:0042995; GO:0044877; GO:0051015; GO:0051693; GO:0098794; GO:0098978 actin cytoskeleton organization [GO:0030036]; actin filament capping [GO:0051693] cell junction [GO:0030054]; cell projection [GO:0042995]; cortical actin cytoskeleton [GO:0030864]; cortical cytoskeleton [GO:0030863]; cuticular plate [GO:0032437]; cytosol [GO:0005829]; fascia adherens [GO:0005916]; glutamatergic synapse [GO:0098978]; lateral plasma membrane [GO:0016328]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; paranodal junction [GO:0033010]; paranode region of axon [GO:0033270]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; protein-containing complex [GO:0032991]; spectrin [GO:0008091]; Z disc [GO:0030018] actin filament binding [GO:0051015]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; protein-containing complex binding [GO:0044877]; spectrin binding [GO:0030507] g24067.t1 A8E5W8 38.514 296 1.58e-60 198.0 sp|A8E5W8|CMI2B_XENTR Ciliary microtubule inner protein 2B OS=Xenopus tropicalis OX=8364 GN=cimip2b PE=2 SV=1 g24069.t1 Q9EPE9 60.881 1181 0.0 1320.0 sp|Q9EPE9|AT131_MOUSE Endoplasmic reticulum transmembrane helix translocase OS=Mus musculus OX=10090 GN=Atp13a1 PE=1 SV=2 AT131_MOUSE reviewed Endoplasmic reticulum transmembrane helix translocase (EC 7.4.2.-) (Endoplasmic reticulum P5A-ATPase) Mus musculus (Mouse) GO:0005524; GO:0005789; GO:0006874; GO:0015031; GO:0015662; GO:0016887; GO:0019829; GO:0046872; GO:0055085; GO:0140567; GO:0140569 extraction of mislocalized protein from ER membrane [GO:0140569]; intracellular calcium ion homeostasis [GO:0006874]; protein transport [GO:0015031]; transmembrane transport [GO:0055085] endoplasmic reticulum membrane [GO:0005789] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled monoatomic cation transmembrane transporter activity [GO:0019829]; membrane protein dislocase activity [GO:0140567]; metal ion binding [GO:0046872]; P-type ion transporter activity [GO:0015662] g24070.t1 Q9BSY4 40.0 90 4.58e-25 95.5 sp|Q9BSY4|CHCH5_HUMAN Coiled-coil-helix-coiled-coil-helix domain-containing protein 5 OS=Homo sapiens OX=9606 GN=CHCHD5 PE=1 SV=1 g24071.t1 Q61555 35.118 971 2.56e-103 378.0 sp|Q61555|FBN2_MOUSE Fibrillin-2 OS=Mus musculus OX=10090 GN=Fbn2 PE=1 SV=2 FBN2_MOUSE reviewed Fibrillin-2 [Cleaved into: Placensin] Mus musculus (Mouse) GO:0001527; GO:0001890; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0005615; GO:0006006; GO:0030326; GO:0030501; GO:0031012; GO:0035108; GO:0035583; GO:0042593; GO:0043010; GO:0045669; GO:0048048; GO:0060346; GO:1901163 bone trabecula formation [GO:0060346]; camera-type eye development [GO:0043010]; embryonic eye morphogenesis [GO:0048048]; embryonic limb morphogenesis [GO:0030326]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; limb morphogenesis [GO:0035108]; placenta development [GO:0001890]; positive regulation of bone mineralization [GO:0030501]; positive regulation of osteoblast differentiation [GO:0045669]; regulation of trophoblast cell migration [GO:1901163]; sequestering of TGFbeta in extracellular matrix [GO:0035583] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; microfibril [GO:0001527] calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; hormone activity [GO:0005179] g24071.t1 Q61555 30.095 1266 1.04e-93 346.0 sp|Q61555|FBN2_MOUSE Fibrillin-2 OS=Mus musculus OX=10090 GN=Fbn2 PE=1 SV=2 FBN2_MOUSE reviewed Fibrillin-2 [Cleaved into: Placensin] Mus musculus (Mouse) GO:0001527; GO:0001890; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0005615; GO:0006006; GO:0030326; GO:0030501; GO:0031012; GO:0035108; GO:0035583; GO:0042593; GO:0043010; GO:0045669; GO:0048048; GO:0060346; GO:1901163 bone trabecula formation [GO:0060346]; camera-type eye development [GO:0043010]; embryonic eye morphogenesis [GO:0048048]; embryonic limb morphogenesis [GO:0030326]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; limb morphogenesis [GO:0035108]; placenta development [GO:0001890]; positive regulation of bone mineralization [GO:0030501]; positive regulation of osteoblast differentiation [GO:0045669]; regulation of trophoblast cell migration [GO:1901163]; sequestering of TGFbeta in extracellular matrix [GO:0035583] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; microfibril [GO:0001527] calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; hormone activity [GO:0005179] g24071.t1 Q61555 30.702 1267 2.55e-91 338.0 sp|Q61555|FBN2_MOUSE Fibrillin-2 OS=Mus musculus OX=10090 GN=Fbn2 PE=1 SV=2 FBN2_MOUSE reviewed Fibrillin-2 [Cleaved into: Placensin] Mus musculus (Mouse) GO:0001527; GO:0001890; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0005615; GO:0006006; GO:0030326; GO:0030501; GO:0031012; GO:0035108; GO:0035583; GO:0042593; GO:0043010; GO:0045669; GO:0048048; GO:0060346; GO:1901163 bone trabecula formation [GO:0060346]; camera-type eye development [GO:0043010]; embryonic eye morphogenesis [GO:0048048]; embryonic limb morphogenesis [GO:0030326]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; limb morphogenesis [GO:0035108]; placenta development [GO:0001890]; positive regulation of bone mineralization [GO:0030501]; positive regulation of osteoblast differentiation [GO:0045669]; regulation of trophoblast cell migration [GO:1901163]; sequestering of TGFbeta in extracellular matrix [GO:0035583] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; microfibril [GO:0001527] calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; hormone activity [GO:0005179] g24071.t1 Q61555 30.276 1123 3.89e-88 328.0 sp|Q61555|FBN2_MOUSE Fibrillin-2 OS=Mus musculus OX=10090 GN=Fbn2 PE=1 SV=2 FBN2_MOUSE reviewed Fibrillin-2 [Cleaved into: Placensin] Mus musculus (Mouse) GO:0001527; GO:0001890; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0005615; GO:0006006; GO:0030326; GO:0030501; GO:0031012; GO:0035108; GO:0035583; GO:0042593; GO:0043010; GO:0045669; GO:0048048; GO:0060346; GO:1901163 bone trabecula formation [GO:0060346]; camera-type eye development [GO:0043010]; embryonic eye morphogenesis [GO:0048048]; embryonic limb morphogenesis [GO:0030326]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; limb morphogenesis [GO:0035108]; placenta development [GO:0001890]; positive regulation of bone mineralization [GO:0030501]; positive regulation of osteoblast differentiation [GO:0045669]; regulation of trophoblast cell migration [GO:1901163]; sequestering of TGFbeta in extracellular matrix [GO:0035583] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; microfibril [GO:0001527] calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; hormone activity [GO:0005179] g24071.t1 Q61555 32.136 1002 5.5e-84 314.0 sp|Q61555|FBN2_MOUSE Fibrillin-2 OS=Mus musculus OX=10090 GN=Fbn2 PE=1 SV=2 FBN2_MOUSE reviewed Fibrillin-2 [Cleaved into: Placensin] Mus musculus (Mouse) GO:0001527; GO:0001890; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0005615; GO:0006006; GO:0030326; GO:0030501; GO:0031012; GO:0035108; GO:0035583; GO:0042593; GO:0043010; GO:0045669; GO:0048048; GO:0060346; GO:1901163 bone trabecula formation [GO:0060346]; camera-type eye development [GO:0043010]; embryonic eye morphogenesis [GO:0048048]; embryonic limb morphogenesis [GO:0030326]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; limb morphogenesis [GO:0035108]; placenta development [GO:0001890]; positive regulation of bone mineralization [GO:0030501]; positive regulation of osteoblast differentiation [GO:0045669]; regulation of trophoblast cell migration [GO:1901163]; sequestering of TGFbeta in extracellular matrix [GO:0035583] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; microfibril [GO:0001527] calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; hormone activity [GO:0005179] g24071.t1 Q61555 32.02 990 1.74e-78 296.0 sp|Q61555|FBN2_MOUSE Fibrillin-2 OS=Mus musculus OX=10090 GN=Fbn2 PE=1 SV=2 FBN2_MOUSE reviewed Fibrillin-2 [Cleaved into: Placensin] Mus musculus (Mouse) GO:0001527; GO:0001890; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0005615; GO:0006006; GO:0030326; GO:0030501; GO:0031012; GO:0035108; GO:0035583; GO:0042593; GO:0043010; GO:0045669; GO:0048048; GO:0060346; GO:1901163 bone trabecula formation [GO:0060346]; camera-type eye development [GO:0043010]; embryonic eye morphogenesis [GO:0048048]; embryonic limb morphogenesis [GO:0030326]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; limb morphogenesis [GO:0035108]; placenta development [GO:0001890]; positive regulation of bone mineralization [GO:0030501]; positive regulation of osteoblast differentiation [GO:0045669]; regulation of trophoblast cell migration [GO:1901163]; sequestering of TGFbeta in extracellular matrix [GO:0035583] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; microfibril [GO:0001527] calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; hormone activity [GO:0005179] g24071.t1 Q61555 31.799 956 2.88e-78 295.0 sp|Q61555|FBN2_MOUSE Fibrillin-2 OS=Mus musculus OX=10090 GN=Fbn2 PE=1 SV=2 FBN2_MOUSE reviewed Fibrillin-2 [Cleaved into: Placensin] Mus musculus (Mouse) GO:0001527; GO:0001890; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0005615; GO:0006006; GO:0030326; GO:0030501; GO:0031012; GO:0035108; GO:0035583; GO:0042593; GO:0043010; GO:0045669; GO:0048048; GO:0060346; GO:1901163 bone trabecula formation [GO:0060346]; camera-type eye development [GO:0043010]; embryonic eye morphogenesis [GO:0048048]; embryonic limb morphogenesis [GO:0030326]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; limb morphogenesis [GO:0035108]; placenta development [GO:0001890]; positive regulation of bone mineralization [GO:0030501]; positive regulation of osteoblast differentiation [GO:0045669]; regulation of trophoblast cell migration [GO:1901163]; sequestering of TGFbeta in extracellular matrix [GO:0035583] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; microfibril [GO:0001527] calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; hormone activity [GO:0005179] g24071.t1 Q61555 32.35 915 6.41e-77 291.0 sp|Q61555|FBN2_MOUSE Fibrillin-2 OS=Mus musculus OX=10090 GN=Fbn2 PE=1 SV=2 FBN2_MOUSE reviewed Fibrillin-2 [Cleaved into: Placensin] Mus musculus (Mouse) GO:0001527; GO:0001890; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0005615; GO:0006006; GO:0030326; GO:0030501; GO:0031012; GO:0035108; GO:0035583; GO:0042593; GO:0043010; GO:0045669; GO:0048048; GO:0060346; GO:1901163 bone trabecula formation [GO:0060346]; camera-type eye development [GO:0043010]; embryonic eye morphogenesis [GO:0048048]; embryonic limb morphogenesis [GO:0030326]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; limb morphogenesis [GO:0035108]; placenta development [GO:0001890]; positive regulation of bone mineralization [GO:0030501]; positive regulation of osteoblast differentiation [GO:0045669]; regulation of trophoblast cell migration [GO:1901163]; sequestering of TGFbeta in extracellular matrix [GO:0035583] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; microfibril [GO:0001527] calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; hormone activity [GO:0005179] g24071.t1 Q61555 30.681 867 4.1299999999999996e-61 239.0 sp|Q61555|FBN2_MOUSE Fibrillin-2 OS=Mus musculus OX=10090 GN=Fbn2 PE=1 SV=2 FBN2_MOUSE reviewed Fibrillin-2 [Cleaved into: Placensin] Mus musculus (Mouse) GO:0001527; GO:0001890; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0005615; GO:0006006; GO:0030326; GO:0030501; GO:0031012; GO:0035108; GO:0035583; GO:0042593; GO:0043010; GO:0045669; GO:0048048; GO:0060346; GO:1901163 bone trabecula formation [GO:0060346]; camera-type eye development [GO:0043010]; embryonic eye morphogenesis [GO:0048048]; embryonic limb morphogenesis [GO:0030326]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; limb morphogenesis [GO:0035108]; placenta development [GO:0001890]; positive regulation of bone mineralization [GO:0030501]; positive regulation of osteoblast differentiation [GO:0045669]; regulation of trophoblast cell migration [GO:1901163]; sequestering of TGFbeta in extracellular matrix [GO:0035583] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; microfibril [GO:0001527] calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; hormone activity [GO:0005179] g24071.t1 Q61555 33.333 501 2.57e-50 203.0 sp|Q61555|FBN2_MOUSE Fibrillin-2 OS=Mus musculus OX=10090 GN=Fbn2 PE=1 SV=2 FBN2_MOUSE reviewed Fibrillin-2 [Cleaved into: Placensin] Mus musculus (Mouse) GO:0001527; GO:0001890; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0005615; GO:0006006; GO:0030326; GO:0030501; GO:0031012; GO:0035108; GO:0035583; GO:0042593; GO:0043010; GO:0045669; GO:0048048; GO:0060346; GO:1901163 bone trabecula formation [GO:0060346]; camera-type eye development [GO:0043010]; embryonic eye morphogenesis [GO:0048048]; embryonic limb morphogenesis [GO:0030326]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; limb morphogenesis [GO:0035108]; placenta development [GO:0001890]; positive regulation of bone mineralization [GO:0030501]; positive regulation of osteoblast differentiation [GO:0045669]; regulation of trophoblast cell migration [GO:1901163]; sequestering of TGFbeta in extracellular matrix [GO:0035583] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; microfibril [GO:0001527] calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; hormone activity [GO:0005179] g24080.t1 Q91YU8 46.847 444 6.93e-129 386.0 sp|Q91YU8|SSF1_MOUSE Suppressor of SWI4 1 homolog OS=Mus musculus OX=10090 GN=Ppan PE=1 SV=2 g24081.t1 Q90593 85.714 609 0.0 959.0 sp|Q90593|BIP_CHICK Endoplasmic reticulum chaperone BiP OS=Gallus gallus OX=9031 GN=HSPA5 PE=1 SV=1 BIP_CHICK reviewed Endoplasmic reticulum chaperone BiP (EC 3.6.4.10) (78 kDa glucose-regulated protein) (GRP-78) (Binding-immunoglobulin protein) (BiP) (Heat shock protein 70 family protein 5) (HSP70 family protein 5) (Heat shock protein family A member 5) (Immunoglobulin heavy chain-binding protein) Gallus gallus (Chicken) GO:0005524; GO:0005634; GO:0005737; GO:0005739; GO:0005788; GO:0005789; GO:0005793; GO:0005829; GO:0005886; GO:0006413; GO:0006983; GO:0008180; GO:0009986; GO:0016020; GO:0016887; GO:0019904; GO:0021589; GO:0021680; GO:0030291; GO:0030335; GO:0030496; GO:0030512; GO:0030968; GO:0031072; GO:0031204; GO:0031333; GO:0031398; GO:0031625; GO:0034663; GO:0035437; GO:0036498; GO:0036499; GO:0036503; GO:0042026; GO:0042149; GO:0042470; GO:0043022; GO:0043066; GO:0044183; GO:0051787; GO:0071353; GO:0140662; GO:1903895; GO:1903898 cellular response to glucose starvation [GO:0042149]; cellular response to interleukin-4 [GO:0071353]; cerebellar Purkinje cell layer development [GO:0021680]; cerebellum structural organization [GO:0021589]; endoplasmic reticulum unfolded protein response [GO:0030968]; ER overload response [GO:0006983]; ERAD pathway [GO:0036503]; IRE1-mediated unfolded protein response [GO:0036498]; maintenance of protein localization in endoplasmic reticulum [GO:0035437]; negative regulation of apoptotic process [GO:0043066]; negative regulation of IRE1-mediated unfolded protein response [GO:1903895]; negative regulation of PERK-mediated unfolded protein response [GO:1903898]; negative regulation of protein-containing complex assembly [GO:0031333]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; PERK-mediated unfolded protein response [GO:0036499]; positive regulation of cell migration [GO:0030335]; positive regulation of protein ubiquitination [GO:0031398]; post-translational protein targeting to membrane, translocation [GO:0031204]; protein refolding [GO:0042026]; translational initiation [GO:0006413] cell surface [GO:0009986]; COP9 signalosome [GO:0008180]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; melanosome [GO:0042470]; membrane [GO:0016020]; midbody [GO:0030496]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent protein folding chaperone [GO:0140662]; heat shock protein binding [GO:0031072]; misfolded protein binding [GO:0051787]; protein domain specific binding [GO:0019904]; protein folding chaperone [GO:0044183]; protein serine/threonine kinase inhibitor activity [GO:0030291]; ribosome binding [GO:0043022]; ubiquitin protein ligase binding [GO:0031625] g24083.t1 Q9CWR2 32.135 445 6.920000000000001e-66 223.0 sp|Q9CWR2|SMYD3_MOUSE Histone-lysine N-methyltransferase SMYD3 OS=Mus musculus OX=10090 GN=Smyd3 PE=2 SV=1 SMYD3_MOUSE reviewed Histone-lysine N-methyltransferase SMYD3 (EC 2.1.1.354) (SET and MYND domain-containing protein 3) (Zinc finger MYND domain-containing protein 1) Mus musculus (Mouse) GO:0000978; GO:0000993; GO:0001162; GO:0005634; GO:0005654; GO:0005829; GO:0006334; GO:0008270; GO:0014904; GO:0032259; GO:0045184; GO:0045944; GO:0071549; GO:0140939; GO:0140954; GO:0140999 cellular response to dexamethasone stimulus [GO:0071549]; establishment of protein localization [GO:0045184]; methylation [GO:0032259]; myotube cell development [GO:0014904]; nucleosome assembly [GO:0006334]; positive regulation of transcription by RNA polymerase II [GO:0045944] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] histone H3K36 dimethyltransferase activity [GO:0140954]; histone H3K4 trimethyltransferase activity [GO:0140999]; histone H4 methyltransferase activity [GO:0140939]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II complex binding [GO:0000993]; RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding [GO:0001162]; zinc ion binding [GO:0008270] g24085.t1 P12821 46.493 613 0.0 580.0 sp|P12821|ACE_HUMAN Angiotensin-converting enzyme OS=Homo sapiens OX=9606 GN=ACE PE=1 SV=1 ACE_HUMAN reviewed Angiotensin-converting enzyme (ACE) (EC 3.4.15.1) (Dipeptidyl carboxypeptidase I) (Kininase II) (CD antigen CD143) [Cleaved into: Angiotensin-converting enzyme, soluble form] Homo sapiens (Human) GO:0001822; GO:0001974; GO:0002003; GO:0002019; GO:0002446; GO:0002474; GO:0003081; GO:0003084; GO:0003779; GO:0004175; GO:0004181; GO:0004222; GO:0005516; GO:0005576; GO:0005615; GO:0005764; GO:0005768; GO:0005886; GO:0006508; GO:0007283; GO:0008217; GO:0008233; GO:0008237; GO:0008238; GO:0008240; GO:0008241; GO:0008270; GO:0008584; GO:0009897; GO:0010608; GO:0010629; GO:0010814; GO:0010815; GO:0014910; GO:0019229; GO:0031404; GO:0031434; GO:0031711; GO:0032943; GO:0038166; GO:0042445; GO:0042447; GO:0043171; GO:0048167; GO:0050435; GO:0050482; GO:0051019; GO:0060047; GO:0060177; GO:0060218; GO:0070062; GO:0070573; GO:0071838; GO:0086091; GO:0097746; GO:1902033; GO:1903597 amyloid-beta metabolic process [GO:0050435]; angiotensin maturation [GO:0002003]; angiotensin-activated signaling pathway [GO:0038166]; antigen processing and presentation of peptide antigen via MHC class I [GO:0002474]; arachidonate secretion [GO:0050482]; blood vessel diameter maintenance [GO:0097746]; blood vessel remodeling [GO:0001974]; bradykinin catabolic process [GO:0010815]; cell proliferation in bone marrow [GO:0071838]; heart contraction [GO:0060047]; hematopoietic stem cell differentiation [GO:0060218]; hormone catabolic process [GO:0042447]; hormone metabolic process [GO:0042445]; kidney development [GO:0001822]; male gonad development [GO:0008584]; mononuclear cell proliferation [GO:0032943]; negative regulation of gap junction assembly [GO:1903597]; negative regulation of gene expression [GO:0010629]; neutrophil mediated immunity [GO:0002446]; peptide catabolic process [GO:0043171]; positive regulation of systemic arterial blood pressure [GO:0003084]; post-transcriptional regulation of gene expression [GO:0010608]; proteolysis [GO:0006508]; regulation of angiotensin metabolic process [GO:0060177]; regulation of blood pressure [GO:0008217]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of hematopoietic stem cell proliferation [GO:1902033]; regulation of renal output by angiotensin [GO:0002019]; regulation of smooth muscle cell migration [GO:0014910]; regulation of synaptic plasticity [GO:0048167]; regulation of systemic arterial blood pressure by renin-angiotensin [GO:0003081]; regulation of vasoconstriction [GO:0019229]; spermatogenesis [GO:0007283]; substance P catabolic process [GO:0010814] endosome [GO:0005768]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; lysosome [GO:0005764]; plasma membrane [GO:0005886] actin binding [GO:0003779]; bradykinin receptor binding [GO:0031711]; calmodulin binding [GO:0005516]; chloride ion binding [GO:0031404]; endopeptidase activity [GO:0004175]; exopeptidase activity [GO:0008238]; metallocarboxypeptidase activity [GO:0004181]; metallodipeptidase activity [GO:0070573]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; mitogen-activated protein kinase binding [GO:0051019]; mitogen-activated protein kinase kinase binding [GO:0031434]; peptidase activity [GO:0008233]; peptidyl-dipeptidase activity [GO:0008241]; tripeptidyl-peptidase activity [GO:0008240]; zinc ion binding [GO:0008270] g24085.t1 P12821 43.898 590 2.5100000000000002e-173 531.0 sp|P12821|ACE_HUMAN Angiotensin-converting enzyme OS=Homo sapiens OX=9606 GN=ACE PE=1 SV=1 ACE_HUMAN reviewed Angiotensin-converting enzyme (ACE) (EC 3.4.15.1) (Dipeptidyl carboxypeptidase I) (Kininase II) (CD antigen CD143) [Cleaved into: Angiotensin-converting enzyme, soluble form] Homo sapiens (Human) GO:0001822; GO:0001974; GO:0002003; GO:0002019; GO:0002446; GO:0002474; GO:0003081; GO:0003084; GO:0003779; GO:0004175; GO:0004181; GO:0004222; GO:0005516; GO:0005576; GO:0005615; GO:0005764; GO:0005768; GO:0005886; GO:0006508; GO:0007283; GO:0008217; GO:0008233; GO:0008237; GO:0008238; GO:0008240; GO:0008241; GO:0008270; GO:0008584; GO:0009897; GO:0010608; GO:0010629; GO:0010814; GO:0010815; GO:0014910; GO:0019229; GO:0031404; GO:0031434; GO:0031711; GO:0032943; GO:0038166; GO:0042445; GO:0042447; GO:0043171; GO:0048167; GO:0050435; GO:0050482; GO:0051019; GO:0060047; GO:0060177; GO:0060218; GO:0070062; GO:0070573; GO:0071838; GO:0086091; GO:0097746; GO:1902033; GO:1903597 amyloid-beta metabolic process [GO:0050435]; angiotensin maturation [GO:0002003]; angiotensin-activated signaling pathway [GO:0038166]; antigen processing and presentation of peptide antigen via MHC class I [GO:0002474]; arachidonate secretion [GO:0050482]; blood vessel diameter maintenance [GO:0097746]; blood vessel remodeling [GO:0001974]; bradykinin catabolic process [GO:0010815]; cell proliferation in bone marrow [GO:0071838]; heart contraction [GO:0060047]; hematopoietic stem cell differentiation [GO:0060218]; hormone catabolic process [GO:0042447]; hormone metabolic process [GO:0042445]; kidney development [GO:0001822]; male gonad development [GO:0008584]; mononuclear cell proliferation [GO:0032943]; negative regulation of gap junction assembly [GO:1903597]; negative regulation of gene expression [GO:0010629]; neutrophil mediated immunity [GO:0002446]; peptide catabolic process [GO:0043171]; positive regulation of systemic arterial blood pressure [GO:0003084]; post-transcriptional regulation of gene expression [GO:0010608]; proteolysis [GO:0006508]; regulation of angiotensin metabolic process [GO:0060177]; regulation of blood pressure [GO:0008217]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of hematopoietic stem cell proliferation [GO:1902033]; regulation of renal output by angiotensin [GO:0002019]; regulation of smooth muscle cell migration [GO:0014910]; regulation of synaptic plasticity [GO:0048167]; regulation of systemic arterial blood pressure by renin-angiotensin [GO:0003081]; regulation of vasoconstriction [GO:0019229]; spermatogenesis [GO:0007283]; substance P catabolic process [GO:0010814] endosome [GO:0005768]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; lysosome [GO:0005764]; plasma membrane [GO:0005886] actin binding [GO:0003779]; bradykinin receptor binding [GO:0031711]; calmodulin binding [GO:0005516]; chloride ion binding [GO:0031404]; endopeptidase activity [GO:0004175]; exopeptidase activity [GO:0008238]; metallocarboxypeptidase activity [GO:0004181]; metallodipeptidase activity [GO:0070573]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; mitogen-activated protein kinase binding [GO:0051019]; mitogen-activated protein kinase kinase binding [GO:0031434]; peptidase activity [GO:0008233]; peptidyl-dipeptidase activity [GO:0008241]; tripeptidyl-peptidase activity [GO:0008240]; zinc ion binding [GO:0008270] g24086.t1 Q92990 36.977 311 1.5799999999999998e-67 234.0 sp|Q92990|GLMN_HUMAN Glomulin OS=Homo sapiens OX=9606 GN=GLMN PE=1 SV=2 GLMN_HUMAN reviewed Glomulin (FK506-binding protein-associated protein) (FAP) (FKBP-associated protein) Homo sapiens (Human) GO:0001570; GO:0001819; GO:0001843; GO:0005102; GO:0005171; GO:0005737; GO:0007166; GO:0008285; GO:0031461; GO:0031462; GO:0031463; GO:0031464; GO:0031625; GO:0032434; GO:0032743; GO:0040029; GO:0042130; GO:0042327; GO:0042692; GO:0055105 cell surface receptor signaling pathway [GO:0007166]; epigenetic regulation of gene expression [GO:0040029]; muscle cell differentiation [GO:0042692]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of T cell proliferation [GO:0042130]; neural tube closure [GO:0001843]; positive regulation of cytokine production [GO:0001819]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of phosphorylation [GO:0042327]; regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032434]; vasculogenesis [GO:0001570] Cul2-RING ubiquitin ligase complex [GO:0031462]; Cul3-RING ubiquitin ligase complex [GO:0031463]; Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]; cullin-RING ubiquitin ligase complex [GO:0031461]; cytoplasm [GO:0005737] hepatocyte growth factor receptor binding [GO:0005171]; signaling receptor binding [GO:0005102]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase inhibitor activity [GO:0055105] g24087.t1 P12821 47.126 609 0.0 600.0 sp|P12821|ACE_HUMAN Angiotensin-converting enzyme OS=Homo sapiens OX=9606 GN=ACE PE=1 SV=1 ACE_HUMAN reviewed Angiotensin-converting enzyme (ACE) (EC 3.4.15.1) (Dipeptidyl carboxypeptidase I) (Kininase II) (CD antigen CD143) [Cleaved into: Angiotensin-converting enzyme, soluble form] Homo sapiens (Human) GO:0001822; GO:0001974; GO:0002003; GO:0002019; GO:0002446; GO:0002474; GO:0003081; GO:0003084; GO:0003779; GO:0004175; GO:0004181; GO:0004222; GO:0005516; GO:0005576; GO:0005615; GO:0005764; GO:0005768; GO:0005886; GO:0006508; GO:0007283; GO:0008217; GO:0008233; GO:0008237; GO:0008238; GO:0008240; GO:0008241; GO:0008270; GO:0008584; GO:0009897; GO:0010608; GO:0010629; GO:0010814; GO:0010815; GO:0014910; GO:0019229; GO:0031404; GO:0031434; GO:0031711; GO:0032943; GO:0038166; GO:0042445; GO:0042447; GO:0043171; GO:0048167; GO:0050435; GO:0050482; GO:0051019; GO:0060047; GO:0060177; GO:0060218; GO:0070062; GO:0070573; GO:0071838; GO:0086091; GO:0097746; GO:1902033; GO:1903597 amyloid-beta metabolic process [GO:0050435]; angiotensin maturation [GO:0002003]; angiotensin-activated signaling pathway [GO:0038166]; antigen processing and presentation of peptide antigen via MHC class I [GO:0002474]; arachidonate secretion [GO:0050482]; blood vessel diameter maintenance [GO:0097746]; blood vessel remodeling [GO:0001974]; bradykinin catabolic process [GO:0010815]; cell proliferation in bone marrow [GO:0071838]; heart contraction [GO:0060047]; hematopoietic stem cell differentiation [GO:0060218]; hormone catabolic process [GO:0042447]; hormone metabolic process [GO:0042445]; kidney development [GO:0001822]; male gonad development [GO:0008584]; mononuclear cell proliferation [GO:0032943]; negative regulation of gap junction assembly [GO:1903597]; negative regulation of gene expression [GO:0010629]; neutrophil mediated immunity [GO:0002446]; peptide catabolic process [GO:0043171]; positive regulation of systemic arterial blood pressure [GO:0003084]; post-transcriptional regulation of gene expression [GO:0010608]; proteolysis [GO:0006508]; regulation of angiotensin metabolic process [GO:0060177]; regulation of blood pressure [GO:0008217]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of hematopoietic stem cell proliferation [GO:1902033]; regulation of renal output by angiotensin [GO:0002019]; regulation of smooth muscle cell migration [GO:0014910]; regulation of synaptic plasticity [GO:0048167]; regulation of systemic arterial blood pressure by renin-angiotensin [GO:0003081]; regulation of vasoconstriction [GO:0019229]; spermatogenesis [GO:0007283]; substance P catabolic process [GO:0010814] endosome [GO:0005768]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; lysosome [GO:0005764]; plasma membrane [GO:0005886] actin binding [GO:0003779]; bradykinin receptor binding [GO:0031711]; calmodulin binding [GO:0005516]; chloride ion binding [GO:0031404]; endopeptidase activity [GO:0004175]; exopeptidase activity [GO:0008238]; metallocarboxypeptidase activity [GO:0004181]; metallodipeptidase activity [GO:0070573]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; mitogen-activated protein kinase binding [GO:0051019]; mitogen-activated protein kinase kinase binding [GO:0031434]; peptidase activity [GO:0008233]; peptidyl-dipeptidase activity [GO:0008241]; tripeptidyl-peptidase activity [GO:0008240]; zinc ion binding [GO:0008270] g24087.t1 P12821 42.833 593 2.7299999999999997e-170 523.0 sp|P12821|ACE_HUMAN Angiotensin-converting enzyme OS=Homo sapiens OX=9606 GN=ACE PE=1 SV=1 ACE_HUMAN reviewed Angiotensin-converting enzyme (ACE) (EC 3.4.15.1) (Dipeptidyl carboxypeptidase I) (Kininase II) (CD antigen CD143) [Cleaved into: Angiotensin-converting enzyme, soluble form] Homo sapiens (Human) GO:0001822; GO:0001974; GO:0002003; GO:0002019; GO:0002446; GO:0002474; GO:0003081; GO:0003084; GO:0003779; GO:0004175; GO:0004181; GO:0004222; GO:0005516; GO:0005576; GO:0005615; GO:0005764; GO:0005768; GO:0005886; GO:0006508; GO:0007283; GO:0008217; GO:0008233; GO:0008237; GO:0008238; GO:0008240; GO:0008241; GO:0008270; GO:0008584; GO:0009897; GO:0010608; GO:0010629; GO:0010814; GO:0010815; GO:0014910; GO:0019229; GO:0031404; GO:0031434; GO:0031711; GO:0032943; GO:0038166; GO:0042445; GO:0042447; GO:0043171; GO:0048167; GO:0050435; GO:0050482; GO:0051019; GO:0060047; GO:0060177; GO:0060218; GO:0070062; GO:0070573; GO:0071838; GO:0086091; GO:0097746; GO:1902033; GO:1903597 amyloid-beta metabolic process [GO:0050435]; angiotensin maturation [GO:0002003]; angiotensin-activated signaling pathway [GO:0038166]; antigen processing and presentation of peptide antigen via MHC class I [GO:0002474]; arachidonate secretion [GO:0050482]; blood vessel diameter maintenance [GO:0097746]; blood vessel remodeling [GO:0001974]; bradykinin catabolic process [GO:0010815]; cell proliferation in bone marrow [GO:0071838]; heart contraction [GO:0060047]; hematopoietic stem cell differentiation [GO:0060218]; hormone catabolic process [GO:0042447]; hormone metabolic process [GO:0042445]; kidney development [GO:0001822]; male gonad development [GO:0008584]; mononuclear cell proliferation [GO:0032943]; negative regulation of gap junction assembly [GO:1903597]; negative regulation of gene expression [GO:0010629]; neutrophil mediated immunity [GO:0002446]; peptide catabolic process [GO:0043171]; positive regulation of systemic arterial blood pressure [GO:0003084]; post-transcriptional regulation of gene expression [GO:0010608]; proteolysis [GO:0006508]; regulation of angiotensin metabolic process [GO:0060177]; regulation of blood pressure [GO:0008217]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of hematopoietic stem cell proliferation [GO:1902033]; regulation of renal output by angiotensin [GO:0002019]; regulation of smooth muscle cell migration [GO:0014910]; regulation of synaptic plasticity [GO:0048167]; regulation of systemic arterial blood pressure by renin-angiotensin [GO:0003081]; regulation of vasoconstriction [GO:0019229]; spermatogenesis [GO:0007283]; substance P catabolic process [GO:0010814] endosome [GO:0005768]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; lysosome [GO:0005764]; plasma membrane [GO:0005886] actin binding [GO:0003779]; bradykinin receptor binding [GO:0031711]; calmodulin binding [GO:0005516]; chloride ion binding [GO:0031404]; endopeptidase activity [GO:0004175]; exopeptidase activity [GO:0008238]; metallocarboxypeptidase activity [GO:0004181]; metallodipeptidase activity [GO:0070573]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; mitogen-activated protein kinase binding [GO:0051019]; mitogen-activated protein kinase kinase binding [GO:0031434]; peptidase activity [GO:0008233]; peptidyl-dipeptidase activity [GO:0008241]; tripeptidyl-peptidase activity [GO:0008240]; zinc ion binding [GO:0008270] g24088.t1 P09172 40.067 594 7e-130 396.0 sp|P09172|DOPO_HUMAN Dopamine beta-hydroxylase OS=Homo sapiens OX=9606 GN=DBH PE=1 SV=3 DOPO_HUMAN reviewed Dopamine beta-hydroxylase (EC 1.14.17.1) (Dopamine beta-monooxygenase) [Cleaved into: Soluble dopamine beta-hydroxylase] Homo sapiens (Human) GO:0001974; GO:0001975; GO:0002443; GO:0003824; GO:0004500; GO:0005507; GO:0005576; GO:0005615; GO:0005737; GO:0005783; GO:0006589; GO:0007268; GO:0007613; GO:0007626; GO:0008542; GO:0016020; GO:0030658; GO:0030667; GO:0031418; GO:0034451; GO:0034466; GO:0034774; GO:0042309; GO:0042310; GO:0042420; GO:0042421; GO:0042584; GO:0042593; GO:0042596; GO:0042711; GO:0045202; GO:0045907; GO:0048149; GO:0048265; GO:0050900; GO:0120162; GO:1904705; GO:1905562; GO:2001236 behavioral response to ethanol [GO:0048149]; blood vessel remodeling [GO:0001974]; chemical synaptic transmission [GO:0007268]; dopamine catabolic process [GO:0042420]; fear response [GO:0042596]; glucose homeostasis [GO:0042593]; homoiothermy [GO:0042309]; leukocyte mediated immunity [GO:0002443]; leukocyte migration [GO:0050900]; locomotory behavior [GO:0007626]; maternal behavior [GO:0042711]; memory [GO:0007613]; norepinephrine biosynthetic process [GO:0042421]; octopamine biosynthetic process [GO:0006589]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of vasoconstriction [GO:0045907]; regulation of extrinsic apoptotic signaling pathway [GO:2001236]; regulation of vascular associated smooth muscle cell proliferation [GO:1904705]; regulation of vascular endothelial cell proliferation [GO:1905562]; response to amphetamine [GO:0001975]; response to pain [GO:0048265]; vasoconstriction [GO:0042310]; visual learning [GO:0008542] centriolar satellite [GO:0034451]; chromaffin granule lumen [GO:0034466]; chromaffin granule membrane [GO:0042584]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; secretory granule lumen [GO:0034774]; secretory granule membrane [GO:0030667]; synapse [GO:0045202]; transport vesicle membrane [GO:0030658] catalytic activity [GO:0003824]; copper ion binding [GO:0005507]; dopamine beta-monooxygenase activity [GO:0004500]; L-ascorbic acid binding [GO:0031418] g24089.t1 Q62904 48.75 320 8.15e-109 323.0 sp|Q62904|DHB7_RAT 3-keto-steroid reductase/17-beta-hydroxysteroid dehydrogenase 7 OS=Rattus norvegicus OX=10116 GN=Hsd17b7 PE=1 SV=1 DHB7_RAT reviewed 3-keto-steroid reductase/17-beta-hydroxysteroid dehydrogenase 7 (17-beta-hydroxysteroid dehydrogenase 7) (17-beta-HSD 7) (3-keto-steroid reductase) (EC 1.1.1.270) (Dihydrotestosterone oxidoreductase) (EC 1.1.1.210) (Estradiol 17-beta-dehydrogenase 7) (EC 1.1.1.62) (PRL receptor-associated protein) (PRAP) Rattus norvegicus (Rat) GO:0000253; GO:0004303; GO:0005148; GO:0005783; GO:0005789; GO:0006695; GO:0006703; GO:0007399; GO:0007420; GO:0008209; GO:0009410; GO:0021766; GO:0030154; GO:0032355; GO:0033489; GO:0033490; GO:0036197; GO:0047024; GO:0048568; GO:0048706; GO:0060135; GO:1990637 androgen metabolic process [GO:0008209]; brain development [GO:0007420]; cell differentiation [GO:0030154]; cholesterol biosynthetic process [GO:0006695]; cholesterol biosynthetic process via desmosterol [GO:0033489]; cholesterol biosynthetic process via lathosterol [GO:0033490]; embryonic organ development [GO:0048568]; embryonic skeletal system development [GO:0048706]; estrogen biosynthetic process [GO:0006703]; hippocampus development [GO:0021766]; maternal process involved in female pregnancy [GO:0060135]; nervous system development [GO:0007399]; response to estradiol [GO:0032355]; response to prolactin [GO:1990637]; response to xenobiotic stimulus [GO:0009410]; zymosterol biosynthetic process [GO:0036197] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789] 3-beta-hydroxysteroid 3-dehydrogenase (NADP+) activity [GO:0000253]; 5-alpha-androstane-3-beta,17-beta-diol dehydrogenase (NADP+) activity [GO:0047024]; estradiol 17-beta-dehydrogenase [NAD(P)+] activity [GO:0004303]; prolactin receptor binding [GO:0005148] g24090.t1 Q9ER41 28.148 270 3.3e-21 98.6 sp|Q9ER41|TOR1B_MOUSE Torsin-1B OS=Mus musculus OX=10090 GN=Tor1b PE=1 SV=2 TOR1B_MOUSE reviewed Torsin-1B (Torsin ATPase-1B) (EC 3.6.4.-) (Torsin family 1 member B) Mus musculus (Mouse) GO:0005524; GO:0005635; GO:0005737; GO:0005783; GO:0005788; GO:0007029; GO:0016887; GO:0019894; GO:0031965; GO:0034504; GO:0042802; GO:0071763 endoplasmic reticulum organization [GO:0007029]; nuclear membrane organization [GO:0071763]; protein localization to nucleus [GO:0034504] cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; identical protein binding [GO:0042802]; kinesin binding [GO:0019894] g24091.t1 Q96AY4 26.871 294 9.08e-24 114.0 sp|Q96AY4|TTC28_HUMAN Tetratricopeptide repeat protein 28 OS=Homo sapiens OX=9606 GN=TTC28 PE=1 SV=4 TTC28_HUMAN reviewed Tetratricopeptide repeat protein 28 (TPR repeat protein 28) (TPR repeat-containing big gene cloned at Keio) Homo sapiens (Human) GO:0000922; GO:0005813; GO:0007346; GO:0019900; GO:0030496; GO:0051301 cell division [GO:0051301]; regulation of mitotic cell cycle [GO:0007346] centrosome [GO:0005813]; midbody [GO:0030496]; spindle pole [GO:0000922] kinase binding [GO:0019900] g24091.t1 Q96AY4 30.932 236 2.38e-21 106.0 sp|Q96AY4|TTC28_HUMAN Tetratricopeptide repeat protein 28 OS=Homo sapiens OX=9606 GN=TTC28 PE=1 SV=4 TTC28_HUMAN reviewed Tetratricopeptide repeat protein 28 (TPR repeat protein 28) (TPR repeat-containing big gene cloned at Keio) Homo sapiens (Human) GO:0000922; GO:0005813; GO:0007346; GO:0019900; GO:0030496; GO:0051301 cell division [GO:0051301]; regulation of mitotic cell cycle [GO:0007346] centrosome [GO:0005813]; midbody [GO:0030496]; spindle pole [GO:0000922] kinase binding [GO:0019900] g24092.t1 Q9Y399 64.039 203 2.2999999999999998e-92 277.0 sp|Q9Y399|RT02_HUMAN Small ribosomal subunit protein uS2m OS=Homo sapiens OX=9606 GN=MRPS2 PE=1 SV=1 RT02_HUMAN reviewed Small ribosomal subunit protein uS2m (28S ribosomal protein S2, mitochondrial) (MRP-S2) (S2mt) Homo sapiens (Human) GO:0003735; GO:0005739; GO:0005743; GO:0005759; GO:0005763; GO:0032543; GO:0061668 mitochondrial ribosome assembly [GO:0061668]; mitochondrial translation [GO:0032543] mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial small ribosomal subunit [GO:0005763]; mitochondrion [GO:0005739] structural constituent of ribosome [GO:0003735] g24095.t1 Q1EHB3 34.122 296 2.6600000000000003e-43 165.0 sp|Q1EHB3|ATS7_RAT A disintegrin and metalloproteinase with thrombospondin motifs 7 OS=Rattus norvegicus OX=10116 GN=Adamts7 PE=1 SV=1 ATS7_RAT reviewed A disintegrin and metalloproteinase with thrombospondin motifs 7 (ADAM-TS 7) (ADAM-TS7) (ADAMTS-7) (EC 3.4.24.-) Rattus norvegicus (Rat) GO:0001503; GO:0002062; GO:0004222; GO:0006029; GO:0006508; GO:0008237; GO:0009986; GO:0030198; GO:0030199; GO:0031012; GO:0032331; GO:0043931; GO:0046872; GO:0051603; GO:0071347; GO:0071356; GO:0071773 cellular response to BMP stimulus [GO:0071773]; cellular response to interleukin-1 [GO:0071347]; cellular response to tumor necrosis factor [GO:0071356]; chondrocyte differentiation [GO:0002062]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]; negative regulation of chondrocyte differentiation [GO:0032331]; ossification [GO:0001503]; ossification involved in bone maturation [GO:0043931]; proteoglycan metabolic process [GO:0006029]; proteolysis [GO:0006508]; proteolysis involved in protein catabolic process [GO:0051603] cell surface [GO:0009986]; extracellular matrix [GO:0031012] metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237] g24097.t1 Q14DL3 44.66 206 4.6499999999999994e-52 194.0 sp|Q14DL3|LRIQ3_MOUSE Leucine-rich repeat and IQ domain-containing protein 3 OS=Mus musculus OX=10090 GN=Lrriq3 PE=2 SV=1 g24098.t1 O15527 39.678 373 1.13e-80 253.0 sp|O15527|OGG1_HUMAN N-glycosylase/DNA lyase OS=Homo sapiens OX=9606 GN=OGG1 PE=1 SV=2 g24101.t1 Q64620 82.667 300 0.0 528.0 sp|Q64620|PPP6_RAT Serine/threonine-protein phosphatase 6 catalytic subunit OS=Rattus norvegicus OX=10116 GN=Ppp6c PE=2 SV=2 g24102.t1 Q64620 89.542 306 0.0 587.0 sp|Q64620|PPP6_RAT Serine/threonine-protein phosphatase 6 catalytic subunit OS=Rattus norvegicus OX=10116 GN=Ppp6c PE=2 SV=2 g24103.t1 P10155 50.279 537 0.0 546.0 sp|P10155|RO60_HUMAN RNA-binding protein RO60 OS=Homo sapiens OX=9606 GN=RO60 PE=1 SV=2 RO60_HUMAN reviewed RNA-binding protein RO60 (60 kDa SS-A/Ro ribonucleoprotein) (60 kDa Ro protein) (60 kDa ribonucleoprotein Ro) (RoRNP) (Ro 60 kDa autoantigen) (Ro60 autoantigen) (Sjoegren syndrome antigen A2) (Sjoegren syndrome type A antigen) (SS-A) (TROVE domain family member 2) Homo sapiens (Human) GO:0002520; GO:0003723; GO:0005654; GO:0005829; GO:0005929; GO:0006383; GO:0007224; GO:0009411; GO:0010468; GO:0016604; GO:0030620; GO:0035457; GO:0046872; GO:0060271; GO:1990904 cellular response to interferon-alpha [GO:0035457]; cilium assembly [GO:0060271]; immune system development [GO:0002520]; regulation of gene expression [GO:0010468]; response to UV [GO:0009411]; smoothened signaling pathway [GO:0007224]; transcription by RNA polymerase III [GO:0006383] cilium [GO:0005929]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; ribonucleoprotein complex [GO:1990904] metal ion binding [GO:0046872]; RNA binding [GO:0003723]; U2 snRNA binding [GO:0030620] g24104.t1 Q8JZM7 66.481 540 0.0 593.0 sp|Q8JZM7|CDC73_MOUSE Parafibromin OS=Mus musculus OX=10090 GN=Cdc73 PE=1 SV=1 CDC73_MOUSE reviewed Parafibromin (Cell division cycle protein 73 homolog) (Hyperparathyroidism 2 protein homolog) Mus musculus (Mouse) GO:0000122; GO:0000993; GO:0001558; GO:0001711; GO:0005634; GO:0005654; GO:0005829; GO:0006357; GO:0006368; GO:0008285; GO:0016055; GO:0016593; GO:0019827; GO:0030177; GO:0031124; GO:0031442; GO:0031648; GO:0032968; GO:0043066; GO:0045638; GO:0045944; GO:0048147; GO:0050680; GO:0071222; GO:1902808; GO:2000134 cellular response to lipopolysaccharide [GO:0071222]; endodermal cell fate commitment [GO:0001711]; mRNA 3'-end processing [GO:0031124]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of myeloid cell differentiation [GO:0045638]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell cycle G1/S phase transition [GO:1902808]; positive regulation of mRNA 3'-end processing [GO:0031442]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription elongation by RNA polymerase II [GO:0032968]; positive regulation of Wnt signaling pathway [GO:0030177]; protein destabilization [GO:0031648]; regulation of cell growth [GO:0001558]; regulation of transcription by RNA polymerase II [GO:0006357]; stem cell population maintenance [GO:0019827]; transcription elongation by RNA polymerase II [GO:0006368]; Wnt signaling pathway [GO:0016055] Cdc73/Paf1 complex [GO:0016593]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] RNA polymerase II complex binding [GO:0000993] g24105.t1 Q5VCS6 27.96 397 3.51e-30 134.0 sp|Q5VCS6|TDRD5_MOUSE Tudor domain-containing protein 5 OS=Mus musculus OX=10090 GN=Tdrd5 PE=1 SV=3 TDRD5_MOUSE reviewed Tudor domain-containing protein 5 Mus musculus (Mouse) GO:0007286; GO:0030719; GO:0033391; GO:0045202; GO:0071546; GO:0141196 P granule organization [GO:0030719]; spermatid development [GO:0007286]; transposable element silencing by piRNA-mediated DNA methylation [GO:0141196] chromatoid body [GO:0033391]; pi-body [GO:0071546]; synapse [GO:0045202] g24106.t1 Q9PUB8 57.558 344 2.91e-105 321.0 sp|Q9PUB8|S39A7_DANRE Zinc transporter Slc39a7 OS=Danio rerio OX=7955 GN=slc39a7 PE=2 SV=2 S39A7_DANRE reviewed Zinc transporter Slc39a7 (Histidine-rich membrane protein Ke4) (Solute carrier family 39 member 7) (Zrt-, Irt-like protein 7) (ZIP7) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005385; GO:0005789; GO:0005794; GO:0006829; GO:0006882; GO:0030183; GO:0071577; GO:0098773; GO:0110075 B cell differentiation [GO:0030183]; intracellular zinc ion homeostasis [GO:0006882]; regulation of ferroptosis [GO:0110075]; skin epidermis development [GO:0098773]; zinc ion transmembrane transport [GO:0071577]; zinc ion transport [GO:0006829] endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794] zinc ion transmembrane transporter activity [GO:0005385] g24107.t1 Q92574 45.312 320 8.51e-80 266.0 sp|Q92574|TSC1_HUMAN Hamartin OS=Homo sapiens OX=9606 GN=TSC1 PE=1 SV=2 TSC1_HUMAN reviewed Hamartin (Tuberous sclerosis 1 protein) Homo sapiens (Human) GO:0001822; GO:0001843; GO:0001952; GO:0002250; GO:0005634; GO:0005737; GO:0005765; GO:0005811; GO:0005829; GO:0005886; GO:0005938; GO:0006813; GO:0007160; GO:0008283; GO:0008285; GO:0008306; GO:0008344; GO:0009267; GO:0014069; GO:0016020; GO:0016242; GO:0021766; GO:0021987; GO:0030027; GO:0030030; GO:0030544; GO:0032007; GO:0032780; GO:0032868; GO:0032991; GO:0033596; GO:0035869; GO:0036064; GO:0036294; GO:0042030; GO:0042552; GO:0043379; GO:0044183; GO:0045792; GO:0046323; GO:0048471; GO:0050808; GO:0050821; GO:0051087; GO:0051492; GO:0051726; GO:0051879; GO:0051894; GO:0055007; GO:0090630; GO:0101031; GO:1904262 activation of GTPase activity [GO:0090630]; adaptive immune response [GO:0002250]; adult locomotory behavior [GO:0008344]; associative learning [GO:0008306]; cardiac muscle cell differentiation [GO:0055007]; cell population proliferation [GO:0008283]; cell projection organization [GO:0030030]; cell-matrix adhesion [GO:0007160]; cellular response to decreased oxygen levels [GO:0036294]; cellular response to starvation [GO:0009267]; cerebral cortex development [GO:0021987]; D-glucose import [GO:0046323]; hippocampus development [GO:0021766]; kidney development [GO:0001822]; memory T cell differentiation [GO:0043379]; myelination [GO:0042552]; negative regulation of ATP-dependent activity [GO:0032780]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell size [GO:0045792]; negative regulation of macroautophagy [GO:0016242]; negative regulation of TOR signaling [GO:0032007]; negative regulation of TORC1 signaling [GO:1904262]; neural tube closure [GO:0001843]; positive regulation of focal adhesion assembly [GO:0051894]; potassium ion transport [GO:0006813]; protein stabilization [GO:0050821]; regulation of cell cycle [GO:0051726]; regulation of cell-matrix adhesion [GO:0001952]; regulation of stress fiber assembly [GO:0051492]; response to insulin [GO:0032868]; synapse organization [GO:0050808] cell cortex [GO:0005938]; ciliary basal body [GO:0036064]; ciliary transition zone [GO:0035869]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; lamellipodium [GO:0030027]; lipid droplet [GO:0005811]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; protein folding chaperone complex [GO:0101031]; protein-containing complex [GO:0032991]; TSC1-TSC2 complex [GO:0033596] ATPase inhibitor activity [GO:0042030]; Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]; protein folding chaperone [GO:0044183]; protein-folding chaperone binding [GO:0051087] g24109.t1 Q9Z136 36.76 321 1.94e-42 167.0 sp|Q9Z136|TSC1_RAT Hamartin OS=Rattus norvegicus OX=10116 GN=Tsc1 PE=1 SV=1 g24110.t1 Q5R8Z8 90.233 215 6.479999999999999e-147 410.0 sp|Q5R8Z8|RAB14_PONAB Ras-related protein Rab-14 OS=Pongo abelii OX=9601 GN=RAB14 PE=2 SV=3 RAB14_PONAB reviewed Ras-related protein Rab-14 (EC 3.6.5.2) Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0000139; GO:0003924; GO:0003925; GO:0005525; GO:0005802; GO:0005829; GO:0006895; GO:0008543; GO:0015031; GO:0019003; GO:0031901; GO:0032456; GO:0032880; GO:0042742; GO:0045335; GO:0045995; GO:0046872; GO:0055037; GO:0090382 defense response to bacterium [GO:0042742]; endocytic recycling [GO:0032456]; fibroblast growth factor receptor signaling pathway [GO:0008543]; Golgi to endosome transport [GO:0006895]; phagosome maturation [GO:0090382]; protein transport [GO:0015031]; regulation of embryonic development [GO:0045995]; regulation of protein localization [GO:0032880] cytosol [GO:0005829]; early endosome membrane [GO:0031901]; Golgi membrane [GO:0000139]; phagocytic vesicle [GO:0045335]; recycling endosome [GO:0055037]; trans-Golgi network [GO:0005802] G protein activity [GO:0003925]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872] g24111.t1 Q4V7B5 28.389 391 2.5200000000000003e-37 145.0 sp|Q4V7B5|TEKL1_RAT Tektin-like protein 1 OS=Rattus norvegicus OX=10116 GN=Tektl1 PE=1 SV=1 g24113.t1 P35054 27.566 341 2.33e-21 103.0 sp|P35054|TGBR3_PIG Transforming growth factor beta receptor type 3 OS=Sus scrofa OX=9823 GN=TGFBR3 PE=2 SV=1 g24114.t1 O00311 42.491 546 5.05e-121 372.0 sp|O00311|CDC7_HUMAN Cell division cycle 7-related protein kinase OS=Homo sapiens OX=9606 GN=CDC7 PE=1 SV=1 CDC7_HUMAN reviewed Cell division cycle 7-related protein kinase (CDC7-related kinase) (HsCdc7) (huCdc7) (EC 2.7.11.1) Homo sapiens (Human) GO:0000082; GO:0000727; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0007165; GO:0008284; GO:0010571; GO:0010971; GO:0016301; GO:0044770; GO:0045171; GO:0046872; GO:0051301; GO:0072686; GO:0106310 cell cycle phase transition [GO:0044770]; cell division [GO:0051301]; double-strand break repair via break-induced replication [GO:0000727]; G1/S transition of mitotic cell cycle [GO:0000082]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of nuclear cell cycle DNA replication [GO:0010571]; signal transduction [GO:0007165] cytoplasm [GO:0005737]; intercellular bridge [GO:0045171]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] ATP binding [GO:0005524]; kinase activity [GO:0016301]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g24115.t1 O15213 55.804 448 9.01e-174 509.0 sp|O15213|WDR46_HUMAN WD repeat-containing protein 46 OS=Homo sapiens OX=9606 GN=WDR46 PE=1 SV=3 WDR46_HUMAN reviewed WD repeat-containing protein 46 (WD repeat-containing protein BING4) Homo sapiens (Human) GO:0000462; GO:0003723; GO:0005654; GO:0005730; GO:0032040; GO:0042274 maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; ribosomal small subunit biogenesis [GO:0042274] nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; small-subunit processome [GO:0032040] RNA binding [GO:0003723] g24116.t1 Q9D818 38.265 196 3.02e-25 110.0 sp|Q9D818|SAPC2_MOUSE Suppressor APC domain-containing protein 2 OS=Mus musculus OX=10090 GN=Sapcd2 PE=1 SV=1 SAPC2_MOUSE reviewed Suppressor APC domain-containing protein 2 (Protein Ang) Mus musculus (Mouse) GO:0000132; GO:0005654; GO:0005730; GO:0005829; GO:0005923; GO:0008284; GO:0016324; GO:0043296; GO:0045179; GO:0090175; GO:0098725; GO:1904777 establishment of mitotic spindle orientation [GO:0000132]; negative regulation of protein localization to cell cortex [GO:1904777]; positive regulation of cell population proliferation [GO:0008284]; regulation of establishment of planar polarity [GO:0090175]; symmetric cell division [GO:0098725] apical cortex [GO:0045179]; apical junction complex [GO:0043296]; apical plasma membrane [GO:0016324]; bicellular tight junction [GO:0005923]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654] g24116.t2 Q9D818 40.306 196 2.0099999999999997e-30 125.0 sp|Q9D818|SAPC2_MOUSE Suppressor APC domain-containing protein 2 OS=Mus musculus OX=10090 GN=Sapcd2 PE=1 SV=1 SAPC2_MOUSE reviewed Suppressor APC domain-containing protein 2 (Protein Ang) Mus musculus (Mouse) GO:0000132; GO:0005654; GO:0005730; GO:0005829; GO:0005923; GO:0008284; GO:0016324; GO:0043296; GO:0045179; GO:0090175; GO:0098725; GO:1904777 establishment of mitotic spindle orientation [GO:0000132]; negative regulation of protein localization to cell cortex [GO:1904777]; positive regulation of cell population proliferation [GO:0008284]; regulation of establishment of planar polarity [GO:0090175]; symmetric cell division [GO:0098725] apical cortex [GO:0045179]; apical junction complex [GO:0043296]; apical plasma membrane [GO:0016324]; bicellular tight junction [GO:0005923]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654] g24117.t1 Q8BK03 38.269 439 2.0600000000000002e-71 242.0 sp|Q8BK03|MIGA2_MOUSE Mitoguardin 2 OS=Mus musculus OX=10090 GN=Miga2 PE=1 SV=1 MIGA2_MOUSE reviewed Mitoguardin 2 (Protein FAM73B) Mus musculus (Mouse) GO:0005741; GO:0005886; GO:0008053; GO:0042803; GO:0046982; GO:0060348 bone development [GO:0060348]; mitochondrial fusion [GO:0008053] mitochondrial outer membrane [GO:0005741]; plasma membrane [GO:0005886] protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803] g24119.t1 Q8C4Y3 46.774 186 1.4200000000000001e-44 158.0 sp|Q8C4Y3|NELFB_MOUSE Negative elongation factor B OS=Mus musculus OX=10090 GN=Nelfb PE=1 SV=2 NELFB_MOUSE reviewed Negative elongation factor B (NELF-B) (Cofactor of BRCA1) Mus musculus (Mouse) GO:0003723; GO:0005634; GO:0005654; GO:0005737; GO:0005741; GO:0005829; GO:0008283; GO:0032021; GO:0034244; GO:0048863; GO:2000737 cell population proliferation [GO:0008283]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of transcription elongation by RNA polymerase II [GO:0034244]; stem cell differentiation [GO:0048863] cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial outer membrane [GO:0005741]; NELF complex [GO:0032021]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] RNA binding [GO:0003723] g24120.t1 Q8WX92 55.615 374 5.92e-122 367.0 sp|Q8WX92|NELFB_HUMAN Negative elongation factor B OS=Homo sapiens OX=9606 GN=NELFB PE=1 SV=1 NELFB_HUMAN reviewed Negative elongation factor B (NELF-B) (Cofactor of BRCA1) Homo sapiens (Human) GO:0003723; GO:0005634; GO:0005654; GO:0005737; GO:0008283; GO:0032021; GO:0034244; GO:0048863; GO:2000737 cell population proliferation [GO:0008283]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of transcription elongation by RNA polymerase II [GO:0034244]; stem cell differentiation [GO:0048863] cytoplasm [GO:0005737]; NELF complex [GO:0032021]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] RNA binding [GO:0003723] g24121.t1 Q27433 74.721 269 3.09e-127 375.0 sp|Q27433|MEC2_CAEEL Mechanosensory protein 2 OS=Caenorhabditis elegans OX=6239 GN=mec-2 PE=1 SV=1 MEC2_CAEEL reviewed Mechanosensory protein 2 Caenorhabditis elegans GO:0005272; GO:0005886; GO:0006813; GO:0007638; GO:0008200; GO:0009612; GO:0015485; GO:0032589; GO:0043005; GO:0050976; GO:1905789; GO:1905792 detection of mechanical stimulus involved in sensory perception of touch [GO:0050976]; mechanosensory behavior [GO:0007638]; positive regulation of detection of mechanical stimulus involved in sensory perception of touch [GO:1905789]; positive regulation of mechanosensory behavior [GO:1905792]; potassium ion transport [GO:0006813]; response to mechanical stimulus [GO:0009612] neuron projection [GO:0043005]; neuron projection membrane [GO:0032589]; plasma membrane [GO:0005886] cholesterol binding [GO:0015485]; ion channel inhibitor activity [GO:0008200]; sodium channel activity [GO:0005272] g24121.t2 Q27433 74.632 272 3.03e-127 375.0 sp|Q27433|MEC2_CAEEL Mechanosensory protein 2 OS=Caenorhabditis elegans OX=6239 GN=mec-2 PE=1 SV=1 MEC2_CAEEL reviewed Mechanosensory protein 2 Caenorhabditis elegans GO:0005272; GO:0005886; GO:0006813; GO:0007638; GO:0008200; GO:0009612; GO:0015485; GO:0032589; GO:0043005; GO:0050976; GO:1905789; GO:1905792 detection of mechanical stimulus involved in sensory perception of touch [GO:0050976]; mechanosensory behavior [GO:0007638]; positive regulation of detection of mechanical stimulus involved in sensory perception of touch [GO:1905789]; positive regulation of mechanosensory behavior [GO:1905792]; potassium ion transport [GO:0006813]; response to mechanical stimulus [GO:0009612] neuron projection [GO:0043005]; neuron projection membrane [GO:0032589]; plasma membrane [GO:0005886] cholesterol binding [GO:0015485]; ion channel inhibitor activity [GO:0008200]; sodium channel activity [GO:0005272] g24123.t1 A0A348HAX6 29.768 776 3.8e-86 307.0 sp|A0A348HAX6|PHIA_FUNX7 Highly reducing polyketide synthase phiA OS=Fungal sp. (strain ATCC 74256) OX=1729595 GN=phiA PE=1 SV=1 g24125.t1 Q55E72 30.881 1237 1.46e-159 531.0 sp|Q55E72|PKS1_DICDI Probable polyketide synthase 1 OS=Dictyostelium discoideum OX=44689 GN=stlA PE=1 SV=1 PKS1_DICDI reviewed Probable polyketide synthase 1 (dipks1) [Includes: Polyketide synthase stlA (EC 2.3.1.-); Chalcone synthase stlA (EC 2.3.1.74) (Steely1)] Dictyostelium discoideum (Social amoeba) GO:0004312; GO:0004315; GO:0006633; GO:0007165; GO:0009813; GO:0010628; GO:0010629; GO:0016210; GO:0016491; GO:0019505; GO:0030639; GO:0031149; GO:0031152; GO:0043327; GO:0044671; GO:0048837; GO:0106070 aggregation involved in sorocarp development [GO:0031152]; chemotaxis to cAMP [GO:0043327]; fatty acid biosynthetic process [GO:0006633]; flavonoid biosynthetic process [GO:0009813]; negative regulation of gene expression [GO:0010629]; polyketide biosynthetic process [GO:0030639]; positive regulation of gene expression [GO:0010628]; regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0106070]; resorcinol metabolic process [GO:0019505]; signal transduction [GO:0007165]; sorocarp sorus development [GO:0048837]; sorocarp spore cell differentiation [GO:0044671]; sorocarp stalk cell differentiation [GO:0031149] 3-oxoacyl-[acyl-carrier-protein] synthase activity [GO:0004315]; fatty acid synthase activity [GO:0004312]; naringenin-chalcone synthase activity [GO:0016210]; oxidoreductase activity [GO:0016491] g24126.t1 E9Q236 48.343 1328 0.0 1203.0 sp|E9Q236|MRP4_MOUSE ATP-binding cassette sub-family C member 4 OS=Mus musculus OX=10090 GN=Abcc4 PE=1 SV=1 g24127.t1 P37892 51.942 206 1.57e-65 213.0 sp|P37892|CBPE_LOPAM Carboxypeptidase E OS=Lophius americanus OX=8073 GN=cpe PE=2 SV=1 g24128.t1 Q00493 48.663 187 3.7499999999999997e-54 183.0 sp|Q00493|CBPE_MOUSE Carboxypeptidase E OS=Mus musculus OX=10090 GN=Cpe PE=1 SV=2 g24129.t1 B5XF11 45.694 418 4.0500000000000005e-129 383.0 sp|B5XF11|KDM8_SALSA Lysine-specific demethylase 8 OS=Salmo salar OX=8030 GN=kdm8 PE=2 SV=1 g24129.t2 B5XF11 44.977 438 1.76e-130 385.0 sp|B5XF11|KDM8_SALSA Lysine-specific demethylase 8 OS=Salmo salar OX=8030 GN=kdm8 PE=2 SV=1 g24130.t1 Q9UHF1 30.088 339 3.26e-31 122.0 sp|Q9UHF1|EGFL7_HUMAN Epidermal growth factor-like protein 7 OS=Homo sapiens OX=9606 GN=EGFL7 PE=1 SV=3 EGFL7_HUMAN reviewed Epidermal growth factor-like protein 7 (EGF-like protein 7) (Multiple epidermal growth factor-like domains protein 7) (Multiple EGF-like domains protein 7) (NOTCH4-like protein) (Vascular endothelial statin) (VE-statin) (Zneu1) Homo sapiens (Human) GO:0001525; GO:0001568; GO:0001570; GO:0001938; GO:0005102; GO:0005509; GO:0005576; GO:0007155; GO:0009986; GO:0031012; GO:0045746 angiogenesis [GO:0001525]; blood vessel development [GO:0001568]; cell adhesion [GO:0007155]; negative regulation of Notch signaling pathway [GO:0045746]; positive regulation of endothelial cell proliferation [GO:0001938]; vasculogenesis [GO:0001570] cell surface [GO:0009986]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576] calcium ion binding [GO:0005509]; signaling receptor binding [GO:0005102] g24130.t2 A5A8Y8 32.984 191 2.53e-27 112.0 sp|A5A8Y8|EGFL8_PIG Epidermal growth factor-like protein 8 OS=Sus scrofa OX=9823 GN=EGFL8 PE=3 SV=1 g24131.t1 P10040 33.671 2076 0.0 921.0 sp|P10040|CRB_DROME Protein crumbs OS=Drosophila melanogaster OX=7227 GN=crb PE=1 SV=3 CRB_DROME reviewed Protein crumbs (95F) Drosophila melanogaster (Fruit fly) GO:0001745; GO:0003383; GO:0005080; GO:0005112; GO:0005509; GO:0005634; GO:0005819; GO:0005886; GO:0007163; GO:0007391; GO:0007424; GO:0007435; GO:0007443; GO:0016028; GO:0016324; GO:0016327; GO:0016332; GO:0016334; GO:0030507; GO:0032391; GO:0032435; GO:0032880; GO:0033157; GO:0033583; GO:0034332; GO:0035002; GO:0035003; GO:0035088; GO:0035090; GO:0035239; GO:0035332; GO:0042051; GO:0042052; GO:0045176; GO:0045186; GO:0045218; GO:0045494; GO:0045570; GO:0045746; GO:0046621; GO:0046664; GO:0046665; GO:0048190; GO:0050821; GO:0051301; GO:0051642; GO:0060438; GO:0061024; GO:0061336; GO:0061541; GO:0098813; GO:0106036 adherens junction organization [GO:0034332]; amnioserosa maintenance [GO:0046665]; apical constriction [GO:0003383]; apical protein localization [GO:0045176]; assembly of apicomedial cortex actomyosin [GO:0106036]; cell division [GO:0051301]; cell morphogenesis involved in Malpighian tubule morphogenesis [GO:0061336]; centrosome localization [GO:0051642]; compound eye morphogenesis [GO:0001745]; compound eye photoreceptor development [GO:0042051]; dorsal closure [GO:0007391]; dorsal closure, amnioserosa morphology change [GO:0046664]; establishment or maintenance of apical/basal cell polarity [GO:0035088]; establishment or maintenance of cell polarity [GO:0007163]; establishment or maintenance of polarity of embryonic epithelium [GO:0016332]; establishment or maintenance of polarity of follicular epithelium [GO:0016334]; liquid clearance, open tracheal system [GO:0035002]; maintenance of apical/basal cell polarity [GO:0035090]; Malpighian tubule morphogenesis [GO:0007443]; membrane organization [GO:0061024]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of organ growth [GO:0046621]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; nuclear chromosome segregation [GO:0098813]; open tracheal system development [GO:0007424]; photoreceptor cell maintenance [GO:0045494]; positive regulation of hippo signaling [GO:0035332]; protein stabilization [GO:0050821]; regulation of imaginal disc growth [GO:0045570]; regulation of intracellular protein transport [GO:0033157]; regulation of protein localization [GO:0032880]; rhabdomere development [GO:0042052]; rhabdomere morphogenesis [GO:0061541]; salivary gland morphogenesis [GO:0007435]; trachea development [GO:0060438]; tube morphogenesis [GO:0035239]; wing disc dorsal/ventral pattern formation [GO:0048190]; zonula adherens assembly [GO:0045186]; zonula adherens maintenance [GO:0045218] apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; nucleus [GO:0005634]; photoreceptor connecting cilium [GO:0032391]; plasma membrane [GO:0005886]; rhabdomere [GO:0016028]; rhabdomere membrane [GO:0033583]; spindle [GO:0005819]; subapical complex [GO:0035003] calcium ion binding [GO:0005509]; Notch binding [GO:0005112]; protein kinase C binding [GO:0005080]; spectrin binding [GO:0030507] g24131.t1 P10040 34.398 532 5.86e-63 243.0 sp|P10040|CRB_DROME Protein crumbs OS=Drosophila melanogaster OX=7227 GN=crb PE=1 SV=3 CRB_DROME reviewed Protein crumbs (95F) Drosophila melanogaster (Fruit fly) GO:0001745; GO:0003383; GO:0005080; GO:0005112; GO:0005509; GO:0005634; GO:0005819; GO:0005886; GO:0007163; GO:0007391; GO:0007424; GO:0007435; GO:0007443; GO:0016028; GO:0016324; GO:0016327; GO:0016332; GO:0016334; GO:0030507; GO:0032391; GO:0032435; GO:0032880; GO:0033157; GO:0033583; GO:0034332; GO:0035002; GO:0035003; GO:0035088; GO:0035090; GO:0035239; GO:0035332; GO:0042051; GO:0042052; GO:0045176; GO:0045186; GO:0045218; GO:0045494; GO:0045570; GO:0045746; GO:0046621; GO:0046664; GO:0046665; GO:0048190; GO:0050821; GO:0051301; GO:0051642; GO:0060438; GO:0061024; GO:0061336; GO:0061541; GO:0098813; GO:0106036 adherens junction organization [GO:0034332]; amnioserosa maintenance [GO:0046665]; apical constriction [GO:0003383]; apical protein localization [GO:0045176]; assembly of apicomedial cortex actomyosin [GO:0106036]; cell division [GO:0051301]; cell morphogenesis involved in Malpighian tubule morphogenesis [GO:0061336]; centrosome localization [GO:0051642]; compound eye morphogenesis [GO:0001745]; compound eye photoreceptor development [GO:0042051]; dorsal closure [GO:0007391]; dorsal closure, amnioserosa morphology change [GO:0046664]; establishment or maintenance of apical/basal cell polarity [GO:0035088]; establishment or maintenance of cell polarity [GO:0007163]; establishment or maintenance of polarity of embryonic epithelium [GO:0016332]; establishment or maintenance of polarity of follicular epithelium [GO:0016334]; liquid clearance, open tracheal system [GO:0035002]; maintenance of apical/basal cell polarity [GO:0035090]; Malpighian tubule morphogenesis [GO:0007443]; membrane organization [GO:0061024]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of organ growth [GO:0046621]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; nuclear chromosome segregation [GO:0098813]; open tracheal system development [GO:0007424]; photoreceptor cell maintenance [GO:0045494]; positive regulation of hippo signaling [GO:0035332]; protein stabilization [GO:0050821]; regulation of imaginal disc growth [GO:0045570]; regulation of intracellular protein transport [GO:0033157]; regulation of protein localization [GO:0032880]; rhabdomere development [GO:0042052]; rhabdomere morphogenesis [GO:0061541]; salivary gland morphogenesis [GO:0007435]; trachea development [GO:0060438]; tube morphogenesis [GO:0035239]; wing disc dorsal/ventral pattern formation [GO:0048190]; zonula adherens assembly [GO:0045186]; zonula adherens maintenance [GO:0045218] apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; nucleus [GO:0005634]; photoreceptor connecting cilium [GO:0032391]; plasma membrane [GO:0005886]; rhabdomere [GO:0016028]; rhabdomere membrane [GO:0033583]; spindle [GO:0005819]; subapical complex [GO:0035003] calcium ion binding [GO:0005509]; Notch binding [GO:0005112]; protein kinase C binding [GO:0005080]; spectrin binding [GO:0030507] g24131.t1 P10040 30.981 581 3.27e-60 234.0 sp|P10040|CRB_DROME Protein crumbs OS=Drosophila melanogaster OX=7227 GN=crb PE=1 SV=3 CRB_DROME reviewed Protein crumbs (95F) Drosophila melanogaster (Fruit fly) GO:0001745; GO:0003383; GO:0005080; GO:0005112; GO:0005509; GO:0005634; GO:0005819; GO:0005886; GO:0007163; GO:0007391; GO:0007424; GO:0007435; GO:0007443; GO:0016028; GO:0016324; GO:0016327; GO:0016332; GO:0016334; GO:0030507; GO:0032391; GO:0032435; GO:0032880; GO:0033157; GO:0033583; GO:0034332; GO:0035002; GO:0035003; GO:0035088; GO:0035090; GO:0035239; GO:0035332; GO:0042051; GO:0042052; GO:0045176; GO:0045186; GO:0045218; GO:0045494; GO:0045570; GO:0045746; GO:0046621; GO:0046664; GO:0046665; GO:0048190; GO:0050821; GO:0051301; GO:0051642; GO:0060438; GO:0061024; GO:0061336; GO:0061541; GO:0098813; GO:0106036 adherens junction organization [GO:0034332]; amnioserosa maintenance [GO:0046665]; apical constriction [GO:0003383]; apical protein localization [GO:0045176]; assembly of apicomedial cortex actomyosin [GO:0106036]; cell division [GO:0051301]; cell morphogenesis involved in Malpighian tubule morphogenesis [GO:0061336]; centrosome localization [GO:0051642]; compound eye morphogenesis [GO:0001745]; compound eye photoreceptor development [GO:0042051]; dorsal closure [GO:0007391]; dorsal closure, amnioserosa morphology change [GO:0046664]; establishment or maintenance of apical/basal cell polarity [GO:0035088]; establishment or maintenance of cell polarity [GO:0007163]; establishment or maintenance of polarity of embryonic epithelium [GO:0016332]; establishment or maintenance of polarity of follicular epithelium [GO:0016334]; liquid clearance, open tracheal system [GO:0035002]; maintenance of apical/basal cell polarity [GO:0035090]; Malpighian tubule morphogenesis [GO:0007443]; membrane organization [GO:0061024]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of organ growth [GO:0046621]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; nuclear chromosome segregation [GO:0098813]; open tracheal system development [GO:0007424]; photoreceptor cell maintenance [GO:0045494]; positive regulation of hippo signaling [GO:0035332]; protein stabilization [GO:0050821]; regulation of imaginal disc growth [GO:0045570]; regulation of intracellular protein transport [GO:0033157]; regulation of protein localization [GO:0032880]; rhabdomere development [GO:0042052]; rhabdomere morphogenesis [GO:0061541]; salivary gland morphogenesis [GO:0007435]; trachea development [GO:0060438]; tube morphogenesis [GO:0035239]; wing disc dorsal/ventral pattern formation [GO:0048190]; zonula adherens assembly [GO:0045186]; zonula adherens maintenance [GO:0045218] apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; nucleus [GO:0005634]; photoreceptor connecting cilium [GO:0032391]; plasma membrane [GO:0005886]; rhabdomere [GO:0016028]; rhabdomere membrane [GO:0033583]; spindle [GO:0005819]; subapical complex [GO:0035003] calcium ion binding [GO:0005509]; Notch binding [GO:0005112]; protein kinase C binding [GO:0005080]; spectrin binding [GO:0030507] g24131.t1 P10040 39.196 398 3.54e-55 218.0 sp|P10040|CRB_DROME Protein crumbs OS=Drosophila melanogaster OX=7227 GN=crb PE=1 SV=3 CRB_DROME reviewed Protein crumbs (95F) Drosophila melanogaster (Fruit fly) GO:0001745; GO:0003383; GO:0005080; GO:0005112; GO:0005509; GO:0005634; GO:0005819; GO:0005886; GO:0007163; GO:0007391; GO:0007424; GO:0007435; GO:0007443; GO:0016028; GO:0016324; GO:0016327; GO:0016332; GO:0016334; GO:0030507; GO:0032391; GO:0032435; GO:0032880; GO:0033157; GO:0033583; GO:0034332; GO:0035002; GO:0035003; GO:0035088; GO:0035090; GO:0035239; GO:0035332; GO:0042051; GO:0042052; GO:0045176; GO:0045186; GO:0045218; GO:0045494; GO:0045570; GO:0045746; GO:0046621; GO:0046664; GO:0046665; GO:0048190; GO:0050821; GO:0051301; GO:0051642; GO:0060438; GO:0061024; GO:0061336; GO:0061541; GO:0098813; GO:0106036 adherens junction organization [GO:0034332]; amnioserosa maintenance [GO:0046665]; apical constriction [GO:0003383]; apical protein localization [GO:0045176]; assembly of apicomedial cortex actomyosin [GO:0106036]; cell division [GO:0051301]; cell morphogenesis involved in Malpighian tubule morphogenesis [GO:0061336]; centrosome localization [GO:0051642]; compound eye morphogenesis [GO:0001745]; compound eye photoreceptor development [GO:0042051]; dorsal closure [GO:0007391]; dorsal closure, amnioserosa morphology change [GO:0046664]; establishment or maintenance of apical/basal cell polarity [GO:0035088]; establishment or maintenance of cell polarity [GO:0007163]; establishment or maintenance of polarity of embryonic epithelium [GO:0016332]; establishment or maintenance of polarity of follicular epithelium [GO:0016334]; liquid clearance, open tracheal system [GO:0035002]; maintenance of apical/basal cell polarity [GO:0035090]; Malpighian tubule morphogenesis [GO:0007443]; membrane organization [GO:0061024]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of organ growth [GO:0046621]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; nuclear chromosome segregation [GO:0098813]; open tracheal system development [GO:0007424]; photoreceptor cell maintenance [GO:0045494]; positive regulation of hippo signaling [GO:0035332]; protein stabilization [GO:0050821]; regulation of imaginal disc growth [GO:0045570]; regulation of intracellular protein transport [GO:0033157]; regulation of protein localization [GO:0032880]; rhabdomere development [GO:0042052]; rhabdomere morphogenesis [GO:0061541]; salivary gland morphogenesis [GO:0007435]; trachea development [GO:0060438]; tube morphogenesis [GO:0035239]; wing disc dorsal/ventral pattern formation [GO:0048190]; zonula adherens assembly [GO:0045186]; zonula adherens maintenance [GO:0045218] apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; nucleus [GO:0005634]; photoreceptor connecting cilium [GO:0032391]; plasma membrane [GO:0005886]; rhabdomere [GO:0016028]; rhabdomere membrane [GO:0033583]; spindle [GO:0005819]; subapical complex [GO:0035003] calcium ion binding [GO:0005509]; Notch binding [GO:0005112]; protein kinase C binding [GO:0005080]; spectrin binding [GO:0030507] g24131.t1 P10040 32.917 480 2.47e-47 192.0 sp|P10040|CRB_DROME Protein crumbs OS=Drosophila melanogaster OX=7227 GN=crb PE=1 SV=3 CRB_DROME reviewed Protein crumbs (95F) Drosophila melanogaster (Fruit fly) GO:0001745; GO:0003383; GO:0005080; GO:0005112; GO:0005509; GO:0005634; GO:0005819; GO:0005886; GO:0007163; GO:0007391; GO:0007424; GO:0007435; GO:0007443; GO:0016028; GO:0016324; GO:0016327; GO:0016332; GO:0016334; GO:0030507; GO:0032391; GO:0032435; GO:0032880; GO:0033157; GO:0033583; GO:0034332; GO:0035002; GO:0035003; GO:0035088; GO:0035090; GO:0035239; GO:0035332; GO:0042051; GO:0042052; GO:0045176; GO:0045186; GO:0045218; GO:0045494; GO:0045570; GO:0045746; GO:0046621; GO:0046664; GO:0046665; GO:0048190; GO:0050821; GO:0051301; GO:0051642; GO:0060438; GO:0061024; GO:0061336; GO:0061541; GO:0098813; GO:0106036 adherens junction organization [GO:0034332]; amnioserosa maintenance [GO:0046665]; apical constriction [GO:0003383]; apical protein localization [GO:0045176]; assembly of apicomedial cortex actomyosin [GO:0106036]; cell division [GO:0051301]; cell morphogenesis involved in Malpighian tubule morphogenesis [GO:0061336]; centrosome localization [GO:0051642]; compound eye morphogenesis [GO:0001745]; compound eye photoreceptor development [GO:0042051]; dorsal closure [GO:0007391]; dorsal closure, amnioserosa morphology change [GO:0046664]; establishment or maintenance of apical/basal cell polarity [GO:0035088]; establishment or maintenance of cell polarity [GO:0007163]; establishment or maintenance of polarity of embryonic epithelium [GO:0016332]; establishment or maintenance of polarity of follicular epithelium [GO:0016334]; liquid clearance, open tracheal system [GO:0035002]; maintenance of apical/basal cell polarity [GO:0035090]; Malpighian tubule morphogenesis [GO:0007443]; membrane organization [GO:0061024]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of organ growth [GO:0046621]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; nuclear chromosome segregation [GO:0098813]; open tracheal system development [GO:0007424]; photoreceptor cell maintenance [GO:0045494]; positive regulation of hippo signaling [GO:0035332]; protein stabilization [GO:0050821]; regulation of imaginal disc growth [GO:0045570]; regulation of intracellular protein transport [GO:0033157]; regulation of protein localization [GO:0032880]; rhabdomere development [GO:0042052]; rhabdomere morphogenesis [GO:0061541]; salivary gland morphogenesis [GO:0007435]; trachea development [GO:0060438]; tube morphogenesis [GO:0035239]; wing disc dorsal/ventral pattern formation [GO:0048190]; zonula adherens assembly [GO:0045186]; zonula adherens maintenance [GO:0045218] apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; nucleus [GO:0005634]; photoreceptor connecting cilium [GO:0032391]; plasma membrane [GO:0005886]; rhabdomere [GO:0016028]; rhabdomere membrane [GO:0033583]; spindle [GO:0005819]; subapical complex [GO:0035003] calcium ion binding [GO:0005509]; Notch binding [GO:0005112]; protein kinase C binding [GO:0005080]; spectrin binding [GO:0030507] g24131.t1 P10040 36.877 301 2.59e-29 132.0 sp|P10040|CRB_DROME Protein crumbs OS=Drosophila melanogaster OX=7227 GN=crb PE=1 SV=3 CRB_DROME reviewed Protein crumbs (95F) Drosophila melanogaster (Fruit fly) GO:0001745; GO:0003383; GO:0005080; GO:0005112; GO:0005509; GO:0005634; GO:0005819; GO:0005886; GO:0007163; GO:0007391; GO:0007424; GO:0007435; GO:0007443; GO:0016028; GO:0016324; GO:0016327; GO:0016332; GO:0016334; GO:0030507; GO:0032391; GO:0032435; GO:0032880; GO:0033157; GO:0033583; GO:0034332; GO:0035002; GO:0035003; GO:0035088; GO:0035090; GO:0035239; GO:0035332; GO:0042051; GO:0042052; GO:0045176; GO:0045186; GO:0045218; GO:0045494; GO:0045570; GO:0045746; GO:0046621; GO:0046664; GO:0046665; GO:0048190; GO:0050821; GO:0051301; GO:0051642; GO:0060438; GO:0061024; GO:0061336; GO:0061541; GO:0098813; GO:0106036 adherens junction organization [GO:0034332]; amnioserosa maintenance [GO:0046665]; apical constriction [GO:0003383]; apical protein localization [GO:0045176]; assembly of apicomedial cortex actomyosin [GO:0106036]; cell division [GO:0051301]; cell morphogenesis involved in Malpighian tubule morphogenesis [GO:0061336]; centrosome localization [GO:0051642]; compound eye morphogenesis [GO:0001745]; compound eye photoreceptor development [GO:0042051]; dorsal closure [GO:0007391]; dorsal closure, amnioserosa morphology change [GO:0046664]; establishment or maintenance of apical/basal cell polarity [GO:0035088]; establishment or maintenance of cell polarity [GO:0007163]; establishment or maintenance of polarity of embryonic epithelium [GO:0016332]; establishment or maintenance of polarity of follicular epithelium [GO:0016334]; liquid clearance, open tracheal system [GO:0035002]; maintenance of apical/basal cell polarity [GO:0035090]; Malpighian tubule morphogenesis [GO:0007443]; membrane organization [GO:0061024]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of organ growth [GO:0046621]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; nuclear chromosome segregation [GO:0098813]; open tracheal system development [GO:0007424]; photoreceptor cell maintenance [GO:0045494]; positive regulation of hippo signaling [GO:0035332]; protein stabilization [GO:0050821]; regulation of imaginal disc growth [GO:0045570]; regulation of intracellular protein transport [GO:0033157]; regulation of protein localization [GO:0032880]; rhabdomere development [GO:0042052]; rhabdomere morphogenesis [GO:0061541]; salivary gland morphogenesis [GO:0007435]; trachea development [GO:0060438]; tube morphogenesis [GO:0035239]; wing disc dorsal/ventral pattern formation [GO:0048190]; zonula adherens assembly [GO:0045186]; zonula adherens maintenance [GO:0045218] apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; nucleus [GO:0005634]; photoreceptor connecting cilium [GO:0032391]; plasma membrane [GO:0005886]; rhabdomere [GO:0016028]; rhabdomere membrane [GO:0033583]; spindle [GO:0005819]; subapical complex [GO:0035003] calcium ion binding [GO:0005509]; Notch binding [GO:0005112]; protein kinase C binding [GO:0005080]; spectrin binding [GO:0030507] g24131.t1 P10040 30.522 249 6.86e-22 108.0 sp|P10040|CRB_DROME Protein crumbs OS=Drosophila melanogaster OX=7227 GN=crb PE=1 SV=3 CRB_DROME reviewed Protein crumbs (95F) Drosophila melanogaster (Fruit fly) GO:0001745; GO:0003383; GO:0005080; GO:0005112; GO:0005509; GO:0005634; GO:0005819; GO:0005886; GO:0007163; GO:0007391; GO:0007424; GO:0007435; GO:0007443; GO:0016028; GO:0016324; GO:0016327; GO:0016332; GO:0016334; GO:0030507; GO:0032391; GO:0032435; GO:0032880; GO:0033157; GO:0033583; GO:0034332; GO:0035002; GO:0035003; GO:0035088; GO:0035090; GO:0035239; GO:0035332; GO:0042051; GO:0042052; GO:0045176; GO:0045186; GO:0045218; GO:0045494; GO:0045570; GO:0045746; GO:0046621; GO:0046664; GO:0046665; GO:0048190; GO:0050821; GO:0051301; GO:0051642; GO:0060438; GO:0061024; GO:0061336; GO:0061541; GO:0098813; GO:0106036 adherens junction organization [GO:0034332]; amnioserosa maintenance [GO:0046665]; apical constriction [GO:0003383]; apical protein localization [GO:0045176]; assembly of apicomedial cortex actomyosin [GO:0106036]; cell division [GO:0051301]; cell morphogenesis involved in Malpighian tubule morphogenesis [GO:0061336]; centrosome localization [GO:0051642]; compound eye morphogenesis [GO:0001745]; compound eye photoreceptor development [GO:0042051]; dorsal closure [GO:0007391]; dorsal closure, amnioserosa morphology change [GO:0046664]; establishment or maintenance of apical/basal cell polarity [GO:0035088]; establishment or maintenance of cell polarity [GO:0007163]; establishment or maintenance of polarity of embryonic epithelium [GO:0016332]; establishment or maintenance of polarity of follicular epithelium [GO:0016334]; liquid clearance, open tracheal system [GO:0035002]; maintenance of apical/basal cell polarity [GO:0035090]; Malpighian tubule morphogenesis [GO:0007443]; membrane organization [GO:0061024]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of organ growth [GO:0046621]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; nuclear chromosome segregation [GO:0098813]; open tracheal system development [GO:0007424]; photoreceptor cell maintenance [GO:0045494]; positive regulation of hippo signaling [GO:0035332]; protein stabilization [GO:0050821]; regulation of imaginal disc growth [GO:0045570]; regulation of intracellular protein transport [GO:0033157]; regulation of protein localization [GO:0032880]; rhabdomere development [GO:0042052]; rhabdomere morphogenesis [GO:0061541]; salivary gland morphogenesis [GO:0007435]; trachea development [GO:0060438]; tube morphogenesis [GO:0035239]; wing disc dorsal/ventral pattern formation [GO:0048190]; zonula adherens assembly [GO:0045186]; zonula adherens maintenance [GO:0045218] apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; nucleus [GO:0005634]; photoreceptor connecting cilium [GO:0032391]; plasma membrane [GO:0005886]; rhabdomere [GO:0016028]; rhabdomere membrane [GO:0033583]; spindle [GO:0005819]; subapical complex [GO:0035003] calcium ion binding [GO:0005509]; Notch binding [GO:0005112]; protein kinase C binding [GO:0005080]; spectrin binding [GO:0030507] g24131.t2 P10040 33.382 2067 0.0 896.0 sp|P10040|CRB_DROME Protein crumbs OS=Drosophila melanogaster OX=7227 GN=crb PE=1 SV=3 CRB_DROME reviewed Protein crumbs (95F) Drosophila melanogaster (Fruit fly) GO:0001745; GO:0003383; GO:0005080; GO:0005112; GO:0005509; GO:0005634; GO:0005819; GO:0005886; GO:0007163; GO:0007391; GO:0007424; GO:0007435; GO:0007443; GO:0016028; GO:0016324; GO:0016327; GO:0016332; GO:0016334; GO:0030507; GO:0032391; GO:0032435; GO:0032880; GO:0033157; GO:0033583; GO:0034332; GO:0035002; GO:0035003; GO:0035088; GO:0035090; GO:0035239; GO:0035332; GO:0042051; GO:0042052; GO:0045176; GO:0045186; GO:0045218; GO:0045494; GO:0045570; GO:0045746; GO:0046621; GO:0046664; GO:0046665; GO:0048190; GO:0050821; GO:0051301; GO:0051642; GO:0060438; GO:0061024; GO:0061336; GO:0061541; GO:0098813; GO:0106036 adherens junction organization [GO:0034332]; amnioserosa maintenance [GO:0046665]; apical constriction [GO:0003383]; apical protein localization [GO:0045176]; assembly of apicomedial cortex actomyosin [GO:0106036]; cell division [GO:0051301]; cell morphogenesis involved in Malpighian tubule morphogenesis [GO:0061336]; centrosome localization [GO:0051642]; compound eye morphogenesis [GO:0001745]; compound eye photoreceptor development [GO:0042051]; dorsal closure [GO:0007391]; dorsal closure, amnioserosa morphology change [GO:0046664]; establishment or maintenance of apical/basal cell polarity [GO:0035088]; establishment or maintenance of cell polarity [GO:0007163]; establishment or maintenance of polarity of embryonic epithelium [GO:0016332]; establishment or maintenance of polarity of follicular epithelium [GO:0016334]; liquid clearance, open tracheal system [GO:0035002]; maintenance of apical/basal cell polarity [GO:0035090]; Malpighian tubule morphogenesis [GO:0007443]; membrane organization [GO:0061024]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of organ growth [GO:0046621]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; nuclear chromosome segregation [GO:0098813]; open tracheal system development [GO:0007424]; photoreceptor cell maintenance [GO:0045494]; positive regulation of hippo signaling [GO:0035332]; protein stabilization [GO:0050821]; regulation of imaginal disc growth [GO:0045570]; regulation of intracellular protein transport [GO:0033157]; regulation of protein localization [GO:0032880]; rhabdomere development [GO:0042052]; rhabdomere morphogenesis [GO:0061541]; salivary gland morphogenesis [GO:0007435]; trachea development [GO:0060438]; tube morphogenesis [GO:0035239]; wing disc dorsal/ventral pattern formation [GO:0048190]; zonula adherens assembly [GO:0045186]; zonula adherens maintenance [GO:0045218] apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; nucleus [GO:0005634]; photoreceptor connecting cilium [GO:0032391]; plasma membrane [GO:0005886]; rhabdomere [GO:0016028]; rhabdomere membrane [GO:0033583]; spindle [GO:0005819]; subapical complex [GO:0035003] calcium ion binding [GO:0005509]; Notch binding [GO:0005112]; protein kinase C binding [GO:0005080]; spectrin binding [GO:0030507] g24131.t2 P10040 33.183 663 4.06e-67 257.0 sp|P10040|CRB_DROME Protein crumbs OS=Drosophila melanogaster OX=7227 GN=crb PE=1 SV=3 CRB_DROME reviewed Protein crumbs (95F) Drosophila melanogaster (Fruit fly) GO:0001745; GO:0003383; GO:0005080; GO:0005112; GO:0005509; GO:0005634; GO:0005819; GO:0005886; GO:0007163; GO:0007391; GO:0007424; GO:0007435; GO:0007443; GO:0016028; GO:0016324; GO:0016327; GO:0016332; GO:0016334; GO:0030507; GO:0032391; GO:0032435; GO:0032880; GO:0033157; GO:0033583; GO:0034332; GO:0035002; GO:0035003; GO:0035088; GO:0035090; GO:0035239; GO:0035332; GO:0042051; GO:0042052; GO:0045176; GO:0045186; GO:0045218; GO:0045494; GO:0045570; GO:0045746; GO:0046621; GO:0046664; GO:0046665; GO:0048190; GO:0050821; GO:0051301; GO:0051642; GO:0060438; GO:0061024; GO:0061336; GO:0061541; GO:0098813; GO:0106036 adherens junction organization [GO:0034332]; amnioserosa maintenance [GO:0046665]; apical constriction [GO:0003383]; apical protein localization [GO:0045176]; assembly of apicomedial cortex actomyosin [GO:0106036]; cell division [GO:0051301]; cell morphogenesis involved in Malpighian tubule morphogenesis [GO:0061336]; centrosome localization [GO:0051642]; compound eye morphogenesis [GO:0001745]; compound eye photoreceptor development [GO:0042051]; dorsal closure [GO:0007391]; dorsal closure, amnioserosa morphology change [GO:0046664]; establishment or maintenance of apical/basal cell polarity [GO:0035088]; establishment or maintenance of cell polarity [GO:0007163]; establishment or maintenance of polarity of embryonic epithelium [GO:0016332]; establishment or maintenance of polarity of follicular epithelium [GO:0016334]; liquid clearance, open tracheal system [GO:0035002]; maintenance of apical/basal cell polarity [GO:0035090]; Malpighian tubule morphogenesis [GO:0007443]; membrane organization [GO:0061024]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of organ growth [GO:0046621]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; nuclear chromosome segregation [GO:0098813]; open tracheal system development [GO:0007424]; photoreceptor cell maintenance [GO:0045494]; positive regulation of hippo signaling [GO:0035332]; protein stabilization [GO:0050821]; regulation of imaginal disc growth [GO:0045570]; regulation of intracellular protein transport [GO:0033157]; regulation of protein localization [GO:0032880]; rhabdomere development [GO:0042052]; rhabdomere morphogenesis [GO:0061541]; salivary gland morphogenesis [GO:0007435]; trachea development [GO:0060438]; tube morphogenesis [GO:0035239]; wing disc dorsal/ventral pattern formation [GO:0048190]; zonula adherens assembly [GO:0045186]; zonula adherens maintenance [GO:0045218] apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; nucleus [GO:0005634]; photoreceptor connecting cilium [GO:0032391]; plasma membrane [GO:0005886]; rhabdomere [GO:0016028]; rhabdomere membrane [GO:0033583]; spindle [GO:0005819]; subapical complex [GO:0035003] calcium ion binding [GO:0005509]; Notch binding [GO:0005112]; protein kinase C binding [GO:0005080]; spectrin binding [GO:0030507] g24131.t2 P10040 28.52 831 3.8900000000000003e-66 253.0 sp|P10040|CRB_DROME Protein crumbs OS=Drosophila melanogaster OX=7227 GN=crb PE=1 SV=3 CRB_DROME reviewed Protein crumbs (95F) Drosophila melanogaster (Fruit fly) GO:0001745; GO:0003383; GO:0005080; GO:0005112; GO:0005509; GO:0005634; GO:0005819; GO:0005886; GO:0007163; GO:0007391; GO:0007424; GO:0007435; GO:0007443; GO:0016028; GO:0016324; GO:0016327; GO:0016332; GO:0016334; GO:0030507; GO:0032391; GO:0032435; GO:0032880; GO:0033157; GO:0033583; GO:0034332; GO:0035002; GO:0035003; GO:0035088; GO:0035090; GO:0035239; GO:0035332; GO:0042051; GO:0042052; GO:0045176; GO:0045186; GO:0045218; GO:0045494; GO:0045570; GO:0045746; GO:0046621; GO:0046664; GO:0046665; GO:0048190; GO:0050821; GO:0051301; GO:0051642; GO:0060438; GO:0061024; GO:0061336; GO:0061541; GO:0098813; GO:0106036 adherens junction organization [GO:0034332]; amnioserosa maintenance [GO:0046665]; apical constriction [GO:0003383]; apical protein localization [GO:0045176]; assembly of apicomedial cortex actomyosin [GO:0106036]; cell division [GO:0051301]; cell morphogenesis involved in Malpighian tubule morphogenesis [GO:0061336]; centrosome localization [GO:0051642]; compound eye morphogenesis [GO:0001745]; compound eye photoreceptor development [GO:0042051]; dorsal closure [GO:0007391]; dorsal closure, amnioserosa morphology change [GO:0046664]; establishment or maintenance of apical/basal cell polarity [GO:0035088]; establishment or maintenance of cell polarity [GO:0007163]; establishment or maintenance of polarity of embryonic epithelium [GO:0016332]; establishment or maintenance of polarity of follicular epithelium [GO:0016334]; liquid clearance, open tracheal system [GO:0035002]; maintenance of apical/basal cell polarity [GO:0035090]; Malpighian tubule morphogenesis [GO:0007443]; membrane organization [GO:0061024]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of organ growth [GO:0046621]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; nuclear chromosome segregation [GO:0098813]; open tracheal system development [GO:0007424]; photoreceptor cell maintenance [GO:0045494]; positive regulation of hippo signaling [GO:0035332]; protein stabilization [GO:0050821]; regulation of imaginal disc growth [GO:0045570]; regulation of intracellular protein transport [GO:0033157]; regulation of protein localization [GO:0032880]; rhabdomere development [GO:0042052]; rhabdomere morphogenesis [GO:0061541]; salivary gland morphogenesis [GO:0007435]; trachea development [GO:0060438]; tube morphogenesis [GO:0035239]; wing disc dorsal/ventral pattern formation [GO:0048190]; zonula adherens assembly [GO:0045186]; zonula adherens maintenance [GO:0045218] apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; nucleus [GO:0005634]; photoreceptor connecting cilium [GO:0032391]; plasma membrane [GO:0005886]; rhabdomere [GO:0016028]; rhabdomere membrane [GO:0033583]; spindle [GO:0005819]; subapical complex [GO:0035003] calcium ion binding [GO:0005509]; Notch binding [GO:0005112]; protein kinase C binding [GO:0005080]; spectrin binding [GO:0030507] g24131.t2 P10040 38.601 386 3.38e-48 194.0 sp|P10040|CRB_DROME Protein crumbs OS=Drosophila melanogaster OX=7227 GN=crb PE=1 SV=3 CRB_DROME reviewed Protein crumbs (95F) Drosophila melanogaster (Fruit fly) GO:0001745; GO:0003383; GO:0005080; GO:0005112; GO:0005509; GO:0005634; GO:0005819; GO:0005886; GO:0007163; GO:0007391; GO:0007424; GO:0007435; GO:0007443; GO:0016028; GO:0016324; GO:0016327; GO:0016332; GO:0016334; GO:0030507; GO:0032391; GO:0032435; GO:0032880; GO:0033157; GO:0033583; GO:0034332; GO:0035002; GO:0035003; GO:0035088; GO:0035090; GO:0035239; GO:0035332; GO:0042051; GO:0042052; GO:0045176; GO:0045186; GO:0045218; GO:0045494; GO:0045570; GO:0045746; GO:0046621; GO:0046664; GO:0046665; GO:0048190; GO:0050821; GO:0051301; GO:0051642; GO:0060438; GO:0061024; GO:0061336; GO:0061541; GO:0098813; GO:0106036 adherens junction organization [GO:0034332]; amnioserosa maintenance [GO:0046665]; apical constriction [GO:0003383]; apical protein localization [GO:0045176]; assembly of apicomedial cortex actomyosin [GO:0106036]; cell division [GO:0051301]; cell morphogenesis involved in Malpighian tubule morphogenesis [GO:0061336]; centrosome localization [GO:0051642]; compound eye morphogenesis [GO:0001745]; compound eye photoreceptor development [GO:0042051]; dorsal closure [GO:0007391]; dorsal closure, amnioserosa morphology change [GO:0046664]; establishment or maintenance of apical/basal cell polarity [GO:0035088]; establishment or maintenance of cell polarity [GO:0007163]; establishment or maintenance of polarity of embryonic epithelium [GO:0016332]; establishment or maintenance of polarity of follicular epithelium [GO:0016334]; liquid clearance, open tracheal system [GO:0035002]; maintenance of apical/basal cell polarity [GO:0035090]; Malpighian tubule morphogenesis [GO:0007443]; membrane organization [GO:0061024]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of organ growth [GO:0046621]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; nuclear chromosome segregation [GO:0098813]; open tracheal system development [GO:0007424]; photoreceptor cell maintenance [GO:0045494]; positive regulation of hippo signaling [GO:0035332]; protein stabilization [GO:0050821]; regulation of imaginal disc growth [GO:0045570]; regulation of intracellular protein transport [GO:0033157]; regulation of protein localization [GO:0032880]; rhabdomere development [GO:0042052]; rhabdomere morphogenesis [GO:0061541]; salivary gland morphogenesis [GO:0007435]; trachea development [GO:0060438]; tube morphogenesis [GO:0035239]; wing disc dorsal/ventral pattern formation [GO:0048190]; zonula adherens assembly [GO:0045186]; zonula adherens maintenance [GO:0045218] apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; nucleus [GO:0005634]; photoreceptor connecting cilium [GO:0032391]; plasma membrane [GO:0005886]; rhabdomere [GO:0016028]; rhabdomere membrane [GO:0033583]; spindle [GO:0005819]; subapical complex [GO:0035003] calcium ion binding [GO:0005509]; Notch binding [GO:0005112]; protein kinase C binding [GO:0005080]; spectrin binding [GO:0030507] g24131.t2 P10040 31.746 504 2.0600000000000002e-47 192.0 sp|P10040|CRB_DROME Protein crumbs OS=Drosophila melanogaster OX=7227 GN=crb PE=1 SV=3 CRB_DROME reviewed Protein crumbs (95F) Drosophila melanogaster (Fruit fly) GO:0001745; GO:0003383; GO:0005080; GO:0005112; GO:0005509; GO:0005634; GO:0005819; GO:0005886; GO:0007163; GO:0007391; GO:0007424; GO:0007435; GO:0007443; GO:0016028; GO:0016324; GO:0016327; GO:0016332; GO:0016334; GO:0030507; GO:0032391; GO:0032435; GO:0032880; GO:0033157; GO:0033583; GO:0034332; GO:0035002; GO:0035003; GO:0035088; GO:0035090; GO:0035239; GO:0035332; GO:0042051; GO:0042052; GO:0045176; GO:0045186; GO:0045218; GO:0045494; GO:0045570; GO:0045746; GO:0046621; GO:0046664; GO:0046665; GO:0048190; GO:0050821; GO:0051301; GO:0051642; GO:0060438; GO:0061024; GO:0061336; GO:0061541; GO:0098813; GO:0106036 adherens junction organization [GO:0034332]; amnioserosa maintenance [GO:0046665]; apical constriction [GO:0003383]; apical protein localization [GO:0045176]; assembly of apicomedial cortex actomyosin [GO:0106036]; cell division [GO:0051301]; cell morphogenesis involved in Malpighian tubule morphogenesis [GO:0061336]; centrosome localization [GO:0051642]; compound eye morphogenesis [GO:0001745]; compound eye photoreceptor development [GO:0042051]; dorsal closure [GO:0007391]; dorsal closure, amnioserosa morphology change [GO:0046664]; establishment or maintenance of apical/basal cell polarity [GO:0035088]; establishment or maintenance of cell polarity [GO:0007163]; establishment or maintenance of polarity of embryonic epithelium [GO:0016332]; establishment or maintenance of polarity of follicular epithelium [GO:0016334]; liquid clearance, open tracheal system [GO:0035002]; maintenance of apical/basal cell polarity [GO:0035090]; Malpighian tubule morphogenesis [GO:0007443]; membrane organization [GO:0061024]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of organ growth [GO:0046621]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; nuclear chromosome segregation [GO:0098813]; open tracheal system development [GO:0007424]; photoreceptor cell maintenance [GO:0045494]; positive regulation of hippo signaling [GO:0035332]; protein stabilization [GO:0050821]; regulation of imaginal disc growth [GO:0045570]; regulation of intracellular protein transport [GO:0033157]; regulation of protein localization [GO:0032880]; rhabdomere development [GO:0042052]; rhabdomere morphogenesis [GO:0061541]; salivary gland morphogenesis [GO:0007435]; trachea development [GO:0060438]; tube morphogenesis [GO:0035239]; wing disc dorsal/ventral pattern formation [GO:0048190]; zonula adherens assembly [GO:0045186]; zonula adherens maintenance [GO:0045218] apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; nucleus [GO:0005634]; photoreceptor connecting cilium [GO:0032391]; plasma membrane [GO:0005886]; rhabdomere [GO:0016028]; rhabdomere membrane [GO:0033583]; spindle [GO:0005819]; subapical complex [GO:0035003] calcium ion binding [GO:0005509]; Notch binding [GO:0005112]; protein kinase C binding [GO:0005080]; spectrin binding [GO:0030507] g24131.t2 P10040 33.493 418 7.99e-46 187.0 sp|P10040|CRB_DROME Protein crumbs OS=Drosophila melanogaster OX=7227 GN=crb PE=1 SV=3 CRB_DROME reviewed Protein crumbs (95F) Drosophila melanogaster (Fruit fly) GO:0001745; GO:0003383; GO:0005080; GO:0005112; GO:0005509; GO:0005634; GO:0005819; GO:0005886; GO:0007163; GO:0007391; GO:0007424; GO:0007435; GO:0007443; GO:0016028; GO:0016324; GO:0016327; GO:0016332; GO:0016334; GO:0030507; GO:0032391; GO:0032435; GO:0032880; GO:0033157; GO:0033583; GO:0034332; GO:0035002; GO:0035003; GO:0035088; GO:0035090; GO:0035239; GO:0035332; GO:0042051; GO:0042052; GO:0045176; GO:0045186; GO:0045218; GO:0045494; GO:0045570; GO:0045746; GO:0046621; GO:0046664; GO:0046665; GO:0048190; GO:0050821; GO:0051301; GO:0051642; GO:0060438; GO:0061024; GO:0061336; GO:0061541; GO:0098813; GO:0106036 adherens junction organization [GO:0034332]; amnioserosa maintenance [GO:0046665]; apical constriction [GO:0003383]; apical protein localization [GO:0045176]; assembly of apicomedial cortex actomyosin [GO:0106036]; cell division [GO:0051301]; cell morphogenesis involved in Malpighian tubule morphogenesis [GO:0061336]; centrosome localization [GO:0051642]; compound eye morphogenesis [GO:0001745]; compound eye photoreceptor development [GO:0042051]; dorsal closure [GO:0007391]; dorsal closure, amnioserosa morphology change [GO:0046664]; establishment or maintenance of apical/basal cell polarity [GO:0035088]; establishment or maintenance of cell polarity [GO:0007163]; establishment or maintenance of polarity of embryonic epithelium [GO:0016332]; establishment or maintenance of polarity of follicular epithelium [GO:0016334]; liquid clearance, open tracheal system [GO:0035002]; maintenance of apical/basal cell polarity [GO:0035090]; Malpighian tubule morphogenesis [GO:0007443]; membrane organization [GO:0061024]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of organ growth [GO:0046621]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; nuclear chromosome segregation [GO:0098813]; open tracheal system development [GO:0007424]; photoreceptor cell maintenance [GO:0045494]; positive regulation of hippo signaling [GO:0035332]; protein stabilization [GO:0050821]; regulation of imaginal disc growth [GO:0045570]; regulation of intracellular protein transport [GO:0033157]; regulation of protein localization [GO:0032880]; rhabdomere development [GO:0042052]; rhabdomere morphogenesis [GO:0061541]; salivary gland morphogenesis [GO:0007435]; trachea development [GO:0060438]; tube morphogenesis [GO:0035239]; wing disc dorsal/ventral pattern formation [GO:0048190]; zonula adherens assembly [GO:0045186]; zonula adherens maintenance [GO:0045218] apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; nucleus [GO:0005634]; photoreceptor connecting cilium [GO:0032391]; plasma membrane [GO:0005886]; rhabdomere [GO:0016028]; rhabdomere membrane [GO:0033583]; spindle [GO:0005819]; subapical complex [GO:0035003] calcium ion binding [GO:0005509]; Notch binding [GO:0005112]; protein kinase C binding [GO:0005080]; spectrin binding [GO:0030507] g24131.t2 P10040 35.294 340 2.4e-41 172.0 sp|P10040|CRB_DROME Protein crumbs OS=Drosophila melanogaster OX=7227 GN=crb PE=1 SV=3 CRB_DROME reviewed Protein crumbs (95F) Drosophila melanogaster (Fruit fly) GO:0001745; GO:0003383; GO:0005080; GO:0005112; GO:0005509; GO:0005634; GO:0005819; GO:0005886; GO:0007163; GO:0007391; GO:0007424; GO:0007435; GO:0007443; GO:0016028; GO:0016324; GO:0016327; GO:0016332; GO:0016334; GO:0030507; GO:0032391; GO:0032435; GO:0032880; GO:0033157; GO:0033583; GO:0034332; GO:0035002; GO:0035003; GO:0035088; GO:0035090; GO:0035239; GO:0035332; GO:0042051; GO:0042052; GO:0045176; GO:0045186; GO:0045218; GO:0045494; GO:0045570; GO:0045746; GO:0046621; GO:0046664; GO:0046665; GO:0048190; GO:0050821; GO:0051301; GO:0051642; GO:0060438; GO:0061024; GO:0061336; GO:0061541; GO:0098813; GO:0106036 adherens junction organization [GO:0034332]; amnioserosa maintenance [GO:0046665]; apical constriction [GO:0003383]; apical protein localization [GO:0045176]; assembly of apicomedial cortex actomyosin [GO:0106036]; cell division [GO:0051301]; cell morphogenesis involved in Malpighian tubule morphogenesis [GO:0061336]; centrosome localization [GO:0051642]; compound eye morphogenesis [GO:0001745]; compound eye photoreceptor development [GO:0042051]; dorsal closure [GO:0007391]; dorsal closure, amnioserosa morphology change [GO:0046664]; establishment or maintenance of apical/basal cell polarity [GO:0035088]; establishment or maintenance of cell polarity [GO:0007163]; establishment or maintenance of polarity of embryonic epithelium [GO:0016332]; establishment or maintenance of polarity of follicular epithelium [GO:0016334]; liquid clearance, open tracheal system [GO:0035002]; maintenance of apical/basal cell polarity [GO:0035090]; Malpighian tubule morphogenesis [GO:0007443]; membrane organization [GO:0061024]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of organ growth [GO:0046621]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; nuclear chromosome segregation [GO:0098813]; open tracheal system development [GO:0007424]; photoreceptor cell maintenance [GO:0045494]; positive regulation of hippo signaling [GO:0035332]; protein stabilization [GO:0050821]; regulation of imaginal disc growth [GO:0045570]; regulation of intracellular protein transport [GO:0033157]; regulation of protein localization [GO:0032880]; rhabdomere development [GO:0042052]; rhabdomere morphogenesis [GO:0061541]; salivary gland morphogenesis [GO:0007435]; trachea development [GO:0060438]; tube morphogenesis [GO:0035239]; wing disc dorsal/ventral pattern formation [GO:0048190]; zonula adherens assembly [GO:0045186]; zonula adherens maintenance [GO:0045218] apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; nucleus [GO:0005634]; photoreceptor connecting cilium [GO:0032391]; plasma membrane [GO:0005886]; rhabdomere [GO:0016028]; rhabdomere membrane [GO:0033583]; spindle [GO:0005819]; subapical complex [GO:0035003] calcium ion binding [GO:0005509]; Notch binding [GO:0005112]; protein kinase C binding [GO:0005080]; spectrin binding [GO:0030507] g24131.t2 P10040 35.135 333 5.64e-39 164.0 sp|P10040|CRB_DROME Protein crumbs OS=Drosophila melanogaster OX=7227 GN=crb PE=1 SV=3 CRB_DROME reviewed Protein crumbs (95F) Drosophila melanogaster (Fruit fly) GO:0001745; GO:0003383; GO:0005080; GO:0005112; GO:0005509; GO:0005634; GO:0005819; GO:0005886; GO:0007163; GO:0007391; GO:0007424; GO:0007435; GO:0007443; GO:0016028; GO:0016324; GO:0016327; GO:0016332; GO:0016334; GO:0030507; GO:0032391; GO:0032435; GO:0032880; GO:0033157; GO:0033583; GO:0034332; GO:0035002; GO:0035003; GO:0035088; GO:0035090; GO:0035239; GO:0035332; GO:0042051; GO:0042052; GO:0045176; GO:0045186; GO:0045218; GO:0045494; GO:0045570; GO:0045746; GO:0046621; GO:0046664; GO:0046665; GO:0048190; GO:0050821; GO:0051301; GO:0051642; GO:0060438; GO:0061024; GO:0061336; GO:0061541; GO:0098813; GO:0106036 adherens junction organization [GO:0034332]; amnioserosa maintenance [GO:0046665]; apical constriction [GO:0003383]; apical protein localization [GO:0045176]; assembly of apicomedial cortex actomyosin [GO:0106036]; cell division [GO:0051301]; cell morphogenesis involved in Malpighian tubule morphogenesis [GO:0061336]; centrosome localization [GO:0051642]; compound eye morphogenesis [GO:0001745]; compound eye photoreceptor development [GO:0042051]; dorsal closure [GO:0007391]; dorsal closure, amnioserosa morphology change [GO:0046664]; establishment or maintenance of apical/basal cell polarity [GO:0035088]; establishment or maintenance of cell polarity [GO:0007163]; establishment or maintenance of polarity of embryonic epithelium [GO:0016332]; establishment or maintenance of polarity of follicular epithelium [GO:0016334]; liquid clearance, open tracheal system [GO:0035002]; maintenance of apical/basal cell polarity [GO:0035090]; Malpighian tubule morphogenesis [GO:0007443]; membrane organization [GO:0061024]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of organ growth [GO:0046621]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; nuclear chromosome segregation [GO:0098813]; open tracheal system development [GO:0007424]; photoreceptor cell maintenance [GO:0045494]; positive regulation of hippo signaling [GO:0035332]; protein stabilization [GO:0050821]; regulation of imaginal disc growth [GO:0045570]; regulation of intracellular protein transport [GO:0033157]; regulation of protein localization [GO:0032880]; rhabdomere development [GO:0042052]; rhabdomere morphogenesis [GO:0061541]; salivary gland morphogenesis [GO:0007435]; trachea development [GO:0060438]; tube morphogenesis [GO:0035239]; wing disc dorsal/ventral pattern formation [GO:0048190]; zonula adherens assembly [GO:0045186]; zonula adherens maintenance [GO:0045218] apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; nucleus [GO:0005634]; photoreceptor connecting cilium [GO:0032391]; plasma membrane [GO:0005886]; rhabdomere [GO:0016028]; rhabdomere membrane [GO:0033583]; spindle [GO:0005819]; subapical complex [GO:0035003] calcium ion binding [GO:0005509]; Notch binding [GO:0005112]; protein kinase C binding [GO:0005080]; spectrin binding [GO:0030507] g24131.t2 P10040 36.306 314 3.26e-33 145.0 sp|P10040|CRB_DROME Protein crumbs OS=Drosophila melanogaster OX=7227 GN=crb PE=1 SV=3 CRB_DROME reviewed Protein crumbs (95F) Drosophila melanogaster (Fruit fly) GO:0001745; GO:0003383; GO:0005080; GO:0005112; GO:0005509; GO:0005634; GO:0005819; GO:0005886; GO:0007163; GO:0007391; GO:0007424; GO:0007435; GO:0007443; GO:0016028; GO:0016324; GO:0016327; GO:0016332; GO:0016334; GO:0030507; GO:0032391; GO:0032435; GO:0032880; GO:0033157; GO:0033583; GO:0034332; GO:0035002; GO:0035003; GO:0035088; GO:0035090; GO:0035239; GO:0035332; GO:0042051; GO:0042052; GO:0045176; GO:0045186; GO:0045218; GO:0045494; GO:0045570; GO:0045746; GO:0046621; GO:0046664; GO:0046665; GO:0048190; GO:0050821; GO:0051301; GO:0051642; GO:0060438; GO:0061024; GO:0061336; GO:0061541; GO:0098813; GO:0106036 adherens junction organization [GO:0034332]; amnioserosa maintenance [GO:0046665]; apical constriction [GO:0003383]; apical protein localization [GO:0045176]; assembly of apicomedial cortex actomyosin [GO:0106036]; cell division [GO:0051301]; cell morphogenesis involved in Malpighian tubule morphogenesis [GO:0061336]; centrosome localization [GO:0051642]; compound eye morphogenesis [GO:0001745]; compound eye photoreceptor development [GO:0042051]; dorsal closure [GO:0007391]; dorsal closure, amnioserosa morphology change [GO:0046664]; establishment or maintenance of apical/basal cell polarity [GO:0035088]; establishment or maintenance of cell polarity [GO:0007163]; establishment or maintenance of polarity of embryonic epithelium [GO:0016332]; establishment or maintenance of polarity of follicular epithelium [GO:0016334]; liquid clearance, open tracheal system [GO:0035002]; maintenance of apical/basal cell polarity [GO:0035090]; Malpighian tubule morphogenesis [GO:0007443]; membrane organization [GO:0061024]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of organ growth [GO:0046621]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; nuclear chromosome segregation [GO:0098813]; open tracheal system development [GO:0007424]; photoreceptor cell maintenance [GO:0045494]; positive regulation of hippo signaling [GO:0035332]; protein stabilization [GO:0050821]; regulation of imaginal disc growth [GO:0045570]; regulation of intracellular protein transport [GO:0033157]; regulation of protein localization [GO:0032880]; rhabdomere development [GO:0042052]; rhabdomere morphogenesis [GO:0061541]; salivary gland morphogenesis [GO:0007435]; trachea development [GO:0060438]; tube morphogenesis [GO:0035239]; wing disc dorsal/ventral pattern formation [GO:0048190]; zonula adherens assembly [GO:0045186]; zonula adherens maintenance [GO:0045218] apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; nucleus [GO:0005634]; photoreceptor connecting cilium [GO:0032391]; plasma membrane [GO:0005886]; rhabdomere [GO:0016028]; rhabdomere membrane [GO:0033583]; spindle [GO:0005819]; subapical complex [GO:0035003] calcium ion binding [GO:0005509]; Notch binding [GO:0005112]; protein kinase C binding [GO:0005080]; spectrin binding [GO:0030507] g24131.t2 P10040 33.138 341 4.45e-33 145.0 sp|P10040|CRB_DROME Protein crumbs OS=Drosophila melanogaster OX=7227 GN=crb PE=1 SV=3 CRB_DROME reviewed Protein crumbs (95F) Drosophila melanogaster (Fruit fly) GO:0001745; GO:0003383; GO:0005080; GO:0005112; GO:0005509; GO:0005634; GO:0005819; GO:0005886; GO:0007163; GO:0007391; GO:0007424; GO:0007435; GO:0007443; GO:0016028; GO:0016324; GO:0016327; GO:0016332; GO:0016334; GO:0030507; GO:0032391; GO:0032435; GO:0032880; GO:0033157; GO:0033583; GO:0034332; GO:0035002; GO:0035003; GO:0035088; GO:0035090; GO:0035239; GO:0035332; GO:0042051; GO:0042052; GO:0045176; GO:0045186; GO:0045218; GO:0045494; GO:0045570; GO:0045746; GO:0046621; GO:0046664; GO:0046665; GO:0048190; GO:0050821; GO:0051301; GO:0051642; GO:0060438; GO:0061024; GO:0061336; GO:0061541; GO:0098813; GO:0106036 adherens junction organization [GO:0034332]; amnioserosa maintenance [GO:0046665]; apical constriction [GO:0003383]; apical protein localization [GO:0045176]; assembly of apicomedial cortex actomyosin [GO:0106036]; cell division [GO:0051301]; cell morphogenesis involved in Malpighian tubule morphogenesis [GO:0061336]; centrosome localization [GO:0051642]; compound eye morphogenesis [GO:0001745]; compound eye photoreceptor development [GO:0042051]; dorsal closure [GO:0007391]; dorsal closure, amnioserosa morphology change [GO:0046664]; establishment or maintenance of apical/basal cell polarity [GO:0035088]; establishment or maintenance of cell polarity [GO:0007163]; establishment or maintenance of polarity of embryonic epithelium [GO:0016332]; establishment or maintenance of polarity of follicular epithelium [GO:0016334]; liquid clearance, open tracheal system [GO:0035002]; maintenance of apical/basal cell polarity [GO:0035090]; Malpighian tubule morphogenesis [GO:0007443]; membrane organization [GO:0061024]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of organ growth [GO:0046621]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; nuclear chromosome segregation [GO:0098813]; open tracheal system development [GO:0007424]; photoreceptor cell maintenance [GO:0045494]; positive regulation of hippo signaling [GO:0035332]; protein stabilization [GO:0050821]; regulation of imaginal disc growth [GO:0045570]; regulation of intracellular protein transport [GO:0033157]; regulation of protein localization [GO:0032880]; rhabdomere development [GO:0042052]; rhabdomere morphogenesis [GO:0061541]; salivary gland morphogenesis [GO:0007435]; trachea development [GO:0060438]; tube morphogenesis [GO:0035239]; wing disc dorsal/ventral pattern formation [GO:0048190]; zonula adherens assembly [GO:0045186]; zonula adherens maintenance [GO:0045218] apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; nucleus [GO:0005634]; photoreceptor connecting cilium [GO:0032391]; plasma membrane [GO:0005886]; rhabdomere [GO:0016028]; rhabdomere membrane [GO:0033583]; spindle [GO:0005819]; subapical complex [GO:0035003] calcium ion binding [GO:0005509]; Notch binding [GO:0005112]; protein kinase C binding [GO:0005080]; spectrin binding [GO:0030507] g24131.t2 P10040 36.877 301 3.29e-29 132.0 sp|P10040|CRB_DROME Protein crumbs OS=Drosophila melanogaster OX=7227 GN=crb PE=1 SV=3 CRB_DROME reviewed Protein crumbs (95F) Drosophila melanogaster (Fruit fly) GO:0001745; GO:0003383; GO:0005080; GO:0005112; GO:0005509; GO:0005634; GO:0005819; GO:0005886; GO:0007163; GO:0007391; GO:0007424; GO:0007435; GO:0007443; GO:0016028; GO:0016324; GO:0016327; GO:0016332; GO:0016334; GO:0030507; GO:0032391; GO:0032435; GO:0032880; GO:0033157; GO:0033583; GO:0034332; GO:0035002; GO:0035003; GO:0035088; GO:0035090; GO:0035239; GO:0035332; GO:0042051; GO:0042052; GO:0045176; GO:0045186; GO:0045218; GO:0045494; GO:0045570; GO:0045746; GO:0046621; GO:0046664; GO:0046665; GO:0048190; GO:0050821; GO:0051301; GO:0051642; GO:0060438; GO:0061024; GO:0061336; GO:0061541; GO:0098813; GO:0106036 adherens junction organization [GO:0034332]; amnioserosa maintenance [GO:0046665]; apical constriction [GO:0003383]; apical protein localization [GO:0045176]; assembly of apicomedial cortex actomyosin [GO:0106036]; cell division [GO:0051301]; cell morphogenesis involved in Malpighian tubule morphogenesis [GO:0061336]; centrosome localization [GO:0051642]; compound eye morphogenesis [GO:0001745]; compound eye photoreceptor development [GO:0042051]; dorsal closure [GO:0007391]; dorsal closure, amnioserosa morphology change [GO:0046664]; establishment or maintenance of apical/basal cell polarity [GO:0035088]; establishment or maintenance of cell polarity [GO:0007163]; establishment or maintenance of polarity of embryonic epithelium [GO:0016332]; establishment or maintenance of polarity of follicular epithelium [GO:0016334]; liquid clearance, open tracheal system [GO:0035002]; maintenance of apical/basal cell polarity [GO:0035090]; Malpighian tubule morphogenesis [GO:0007443]; membrane organization [GO:0061024]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of organ growth [GO:0046621]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; nuclear chromosome segregation [GO:0098813]; open tracheal system development [GO:0007424]; photoreceptor cell maintenance [GO:0045494]; positive regulation of hippo signaling [GO:0035332]; protein stabilization [GO:0050821]; regulation of imaginal disc growth [GO:0045570]; regulation of intracellular protein transport [GO:0033157]; regulation of protein localization [GO:0032880]; rhabdomere development [GO:0042052]; rhabdomere morphogenesis [GO:0061541]; salivary gland morphogenesis [GO:0007435]; trachea development [GO:0060438]; tube morphogenesis [GO:0035239]; wing disc dorsal/ventral pattern formation [GO:0048190]; zonula adherens assembly [GO:0045186]; zonula adherens maintenance [GO:0045218] apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; nucleus [GO:0005634]; photoreceptor connecting cilium [GO:0032391]; plasma membrane [GO:0005886]; rhabdomere [GO:0016028]; rhabdomere membrane [GO:0033583]; spindle [GO:0005819]; subapical complex [GO:0035003] calcium ion binding [GO:0005509]; Notch binding [GO:0005112]; protein kinase C binding [GO:0005080]; spectrin binding [GO:0030507] g24131.t2 P10040 31.278 227 8.91e-22 108.0 sp|P10040|CRB_DROME Protein crumbs OS=Drosophila melanogaster OX=7227 GN=crb PE=1 SV=3 CRB_DROME reviewed Protein crumbs (95F) Drosophila melanogaster (Fruit fly) GO:0001745; GO:0003383; GO:0005080; GO:0005112; GO:0005509; GO:0005634; GO:0005819; GO:0005886; GO:0007163; GO:0007391; GO:0007424; GO:0007435; GO:0007443; GO:0016028; GO:0016324; GO:0016327; GO:0016332; GO:0016334; GO:0030507; GO:0032391; GO:0032435; GO:0032880; GO:0033157; GO:0033583; GO:0034332; GO:0035002; GO:0035003; GO:0035088; GO:0035090; GO:0035239; GO:0035332; GO:0042051; GO:0042052; GO:0045176; GO:0045186; GO:0045218; GO:0045494; GO:0045570; GO:0045746; GO:0046621; GO:0046664; GO:0046665; GO:0048190; GO:0050821; GO:0051301; GO:0051642; GO:0060438; GO:0061024; GO:0061336; GO:0061541; GO:0098813; GO:0106036 adherens junction organization [GO:0034332]; amnioserosa maintenance [GO:0046665]; apical constriction [GO:0003383]; apical protein localization [GO:0045176]; assembly of apicomedial cortex actomyosin [GO:0106036]; cell division [GO:0051301]; cell morphogenesis involved in Malpighian tubule morphogenesis [GO:0061336]; centrosome localization [GO:0051642]; compound eye morphogenesis [GO:0001745]; compound eye photoreceptor development [GO:0042051]; dorsal closure [GO:0007391]; dorsal closure, amnioserosa morphology change [GO:0046664]; establishment or maintenance of apical/basal cell polarity [GO:0035088]; establishment or maintenance of cell polarity [GO:0007163]; establishment or maintenance of polarity of embryonic epithelium [GO:0016332]; establishment or maintenance of polarity of follicular epithelium [GO:0016334]; liquid clearance, open tracheal system [GO:0035002]; maintenance of apical/basal cell polarity [GO:0035090]; Malpighian tubule morphogenesis [GO:0007443]; membrane organization [GO:0061024]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of organ growth [GO:0046621]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; nuclear chromosome segregation [GO:0098813]; open tracheal system development [GO:0007424]; photoreceptor cell maintenance [GO:0045494]; positive regulation of hippo signaling [GO:0035332]; protein stabilization [GO:0050821]; regulation of imaginal disc growth [GO:0045570]; regulation of intracellular protein transport [GO:0033157]; regulation of protein localization [GO:0032880]; rhabdomere development [GO:0042052]; rhabdomere morphogenesis [GO:0061541]; salivary gland morphogenesis [GO:0007435]; trachea development [GO:0060438]; tube morphogenesis [GO:0035239]; wing disc dorsal/ventral pattern formation [GO:0048190]; zonula adherens assembly [GO:0045186]; zonula adherens maintenance [GO:0045218] apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; nucleus [GO:0005634]; photoreceptor connecting cilium [GO:0032391]; plasma membrane [GO:0005886]; rhabdomere [GO:0016028]; rhabdomere membrane [GO:0033583]; spindle [GO:0005819]; subapical complex [GO:0035003] calcium ion binding [GO:0005509]; Notch binding [GO:0005112]; protein kinase C binding [GO:0005080]; spectrin binding [GO:0030507] g24131.t3 P10040 32.7 2052 0.0 865.0 sp|P10040|CRB_DROME Protein crumbs OS=Drosophila melanogaster OX=7227 GN=crb PE=1 SV=3 CRB_DROME reviewed Protein crumbs (95F) Drosophila melanogaster (Fruit fly) GO:0001745; GO:0003383; GO:0005080; GO:0005112; GO:0005509; GO:0005634; GO:0005819; GO:0005886; GO:0007163; GO:0007391; GO:0007424; GO:0007435; GO:0007443; GO:0016028; GO:0016324; GO:0016327; GO:0016332; GO:0016334; GO:0030507; GO:0032391; GO:0032435; GO:0032880; GO:0033157; GO:0033583; GO:0034332; GO:0035002; GO:0035003; GO:0035088; GO:0035090; GO:0035239; GO:0035332; GO:0042051; GO:0042052; GO:0045176; GO:0045186; GO:0045218; GO:0045494; GO:0045570; GO:0045746; GO:0046621; GO:0046664; GO:0046665; GO:0048190; GO:0050821; GO:0051301; GO:0051642; GO:0060438; GO:0061024; GO:0061336; GO:0061541; GO:0098813; GO:0106036 adherens junction organization [GO:0034332]; amnioserosa maintenance [GO:0046665]; apical constriction [GO:0003383]; apical protein localization [GO:0045176]; assembly of apicomedial cortex actomyosin [GO:0106036]; cell division [GO:0051301]; cell morphogenesis involved in Malpighian tubule morphogenesis [GO:0061336]; centrosome localization [GO:0051642]; compound eye morphogenesis [GO:0001745]; compound eye photoreceptor development [GO:0042051]; dorsal closure [GO:0007391]; dorsal closure, amnioserosa morphology change [GO:0046664]; establishment or maintenance of apical/basal cell polarity [GO:0035088]; establishment or maintenance of cell polarity [GO:0007163]; establishment or maintenance of polarity of embryonic epithelium [GO:0016332]; establishment or maintenance of polarity of follicular epithelium [GO:0016334]; liquid clearance, open tracheal system [GO:0035002]; maintenance of apical/basal cell polarity [GO:0035090]; Malpighian tubule morphogenesis [GO:0007443]; membrane organization [GO:0061024]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of organ growth [GO:0046621]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; nuclear chromosome segregation [GO:0098813]; open tracheal system development [GO:0007424]; photoreceptor cell maintenance [GO:0045494]; positive regulation of hippo signaling [GO:0035332]; protein stabilization [GO:0050821]; regulation of imaginal disc growth [GO:0045570]; regulation of intracellular protein transport [GO:0033157]; regulation of protein localization [GO:0032880]; rhabdomere development [GO:0042052]; rhabdomere morphogenesis [GO:0061541]; salivary gland morphogenesis [GO:0007435]; trachea development [GO:0060438]; tube morphogenesis [GO:0035239]; wing disc dorsal/ventral pattern formation [GO:0048190]; zonula adherens assembly [GO:0045186]; zonula adherens maintenance [GO:0045218] apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; nucleus [GO:0005634]; photoreceptor connecting cilium [GO:0032391]; plasma membrane [GO:0005886]; rhabdomere [GO:0016028]; rhabdomere membrane [GO:0033583]; spindle [GO:0005819]; subapical complex [GO:0035003] calcium ion binding [GO:0005509]; Notch binding [GO:0005112]; protein kinase C binding [GO:0005080]; spectrin binding [GO:0030507] g24131.t3 P10040 33.183 663 4.45e-67 256.0 sp|P10040|CRB_DROME Protein crumbs OS=Drosophila melanogaster OX=7227 GN=crb PE=1 SV=3 CRB_DROME reviewed Protein crumbs (95F) Drosophila melanogaster (Fruit fly) GO:0001745; GO:0003383; GO:0005080; GO:0005112; GO:0005509; GO:0005634; GO:0005819; GO:0005886; GO:0007163; GO:0007391; GO:0007424; GO:0007435; GO:0007443; GO:0016028; GO:0016324; GO:0016327; GO:0016332; GO:0016334; GO:0030507; GO:0032391; GO:0032435; GO:0032880; GO:0033157; GO:0033583; GO:0034332; GO:0035002; GO:0035003; GO:0035088; GO:0035090; GO:0035239; GO:0035332; GO:0042051; GO:0042052; GO:0045176; GO:0045186; GO:0045218; GO:0045494; GO:0045570; GO:0045746; GO:0046621; GO:0046664; GO:0046665; GO:0048190; GO:0050821; GO:0051301; GO:0051642; GO:0060438; GO:0061024; GO:0061336; GO:0061541; GO:0098813; GO:0106036 adherens junction organization [GO:0034332]; amnioserosa maintenance [GO:0046665]; apical constriction [GO:0003383]; apical protein localization [GO:0045176]; assembly of apicomedial cortex actomyosin [GO:0106036]; cell division [GO:0051301]; cell morphogenesis involved in Malpighian tubule morphogenesis [GO:0061336]; centrosome localization [GO:0051642]; compound eye morphogenesis [GO:0001745]; compound eye photoreceptor development [GO:0042051]; dorsal closure [GO:0007391]; dorsal closure, amnioserosa morphology change [GO:0046664]; establishment or maintenance of apical/basal cell polarity [GO:0035088]; establishment or maintenance of cell polarity [GO:0007163]; establishment or maintenance of polarity of embryonic epithelium [GO:0016332]; establishment or maintenance of polarity of follicular epithelium [GO:0016334]; liquid clearance, open tracheal system [GO:0035002]; maintenance of apical/basal cell polarity [GO:0035090]; Malpighian tubule morphogenesis [GO:0007443]; membrane organization [GO:0061024]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of organ growth [GO:0046621]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; nuclear chromosome segregation [GO:0098813]; open tracheal system development [GO:0007424]; photoreceptor cell maintenance [GO:0045494]; positive regulation of hippo signaling [GO:0035332]; protein stabilization [GO:0050821]; regulation of imaginal disc growth [GO:0045570]; regulation of intracellular protein transport [GO:0033157]; regulation of protein localization [GO:0032880]; rhabdomere development [GO:0042052]; rhabdomere morphogenesis [GO:0061541]; salivary gland morphogenesis [GO:0007435]; trachea development [GO:0060438]; tube morphogenesis [GO:0035239]; wing disc dorsal/ventral pattern formation [GO:0048190]; zonula adherens assembly [GO:0045186]; zonula adherens maintenance [GO:0045218] apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; nucleus [GO:0005634]; photoreceptor connecting cilium [GO:0032391]; plasma membrane [GO:0005886]; rhabdomere [GO:0016028]; rhabdomere membrane [GO:0033583]; spindle [GO:0005819]; subapical complex [GO:0035003] calcium ion binding [GO:0005509]; Notch binding [GO:0005112]; protein kinase C binding [GO:0005080]; spectrin binding [GO:0030507] g24131.t3 P10040 28.52 831 4.22e-66 253.0 sp|P10040|CRB_DROME Protein crumbs OS=Drosophila melanogaster OX=7227 GN=crb PE=1 SV=3 CRB_DROME reviewed Protein crumbs (95F) Drosophila melanogaster (Fruit fly) GO:0001745; GO:0003383; GO:0005080; GO:0005112; GO:0005509; GO:0005634; GO:0005819; GO:0005886; GO:0007163; GO:0007391; GO:0007424; GO:0007435; GO:0007443; GO:0016028; GO:0016324; GO:0016327; GO:0016332; GO:0016334; GO:0030507; GO:0032391; GO:0032435; GO:0032880; GO:0033157; GO:0033583; GO:0034332; GO:0035002; GO:0035003; GO:0035088; GO:0035090; GO:0035239; GO:0035332; GO:0042051; GO:0042052; GO:0045176; GO:0045186; GO:0045218; GO:0045494; GO:0045570; GO:0045746; GO:0046621; GO:0046664; GO:0046665; GO:0048190; GO:0050821; GO:0051301; GO:0051642; GO:0060438; GO:0061024; GO:0061336; GO:0061541; GO:0098813; GO:0106036 adherens junction organization [GO:0034332]; amnioserosa maintenance [GO:0046665]; apical constriction [GO:0003383]; apical protein localization [GO:0045176]; assembly of apicomedial cortex actomyosin [GO:0106036]; cell division [GO:0051301]; cell morphogenesis involved in Malpighian tubule morphogenesis [GO:0061336]; centrosome localization [GO:0051642]; compound eye morphogenesis [GO:0001745]; compound eye photoreceptor development [GO:0042051]; dorsal closure [GO:0007391]; dorsal closure, amnioserosa morphology change [GO:0046664]; establishment or maintenance of apical/basal cell polarity [GO:0035088]; establishment or maintenance of cell polarity [GO:0007163]; establishment or maintenance of polarity of embryonic epithelium [GO:0016332]; establishment or maintenance of polarity of follicular epithelium [GO:0016334]; liquid clearance, open tracheal system [GO:0035002]; maintenance of apical/basal cell polarity [GO:0035090]; Malpighian tubule morphogenesis [GO:0007443]; membrane organization [GO:0061024]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of organ growth [GO:0046621]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; nuclear chromosome segregation [GO:0098813]; open tracheal system development [GO:0007424]; photoreceptor cell maintenance [GO:0045494]; positive regulation of hippo signaling [GO:0035332]; protein stabilization [GO:0050821]; regulation of imaginal disc growth [GO:0045570]; regulation of intracellular protein transport [GO:0033157]; regulation of protein localization [GO:0032880]; rhabdomere development [GO:0042052]; rhabdomere morphogenesis [GO:0061541]; salivary gland morphogenesis [GO:0007435]; trachea development [GO:0060438]; tube morphogenesis [GO:0035239]; wing disc dorsal/ventral pattern formation [GO:0048190]; zonula adherens assembly [GO:0045186]; zonula adherens maintenance [GO:0045218] apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; nucleus [GO:0005634]; photoreceptor connecting cilium [GO:0032391]; plasma membrane [GO:0005886]; rhabdomere [GO:0016028]; rhabdomere membrane [GO:0033583]; spindle [GO:0005819]; subapical complex [GO:0035003] calcium ion binding [GO:0005509]; Notch binding [GO:0005112]; protein kinase C binding [GO:0005080]; spectrin binding [GO:0030507] g24131.t3 P10040 38.601 386 3.0799999999999996e-48 195.0 sp|P10040|CRB_DROME Protein crumbs OS=Drosophila melanogaster OX=7227 GN=crb PE=1 SV=3 CRB_DROME reviewed Protein crumbs (95F) Drosophila melanogaster (Fruit fly) GO:0001745; GO:0003383; GO:0005080; GO:0005112; GO:0005509; GO:0005634; GO:0005819; GO:0005886; GO:0007163; GO:0007391; GO:0007424; GO:0007435; GO:0007443; GO:0016028; GO:0016324; GO:0016327; GO:0016332; GO:0016334; GO:0030507; GO:0032391; GO:0032435; GO:0032880; GO:0033157; GO:0033583; GO:0034332; GO:0035002; GO:0035003; GO:0035088; GO:0035090; GO:0035239; GO:0035332; GO:0042051; GO:0042052; GO:0045176; GO:0045186; GO:0045218; GO:0045494; GO:0045570; GO:0045746; GO:0046621; GO:0046664; GO:0046665; GO:0048190; GO:0050821; GO:0051301; GO:0051642; GO:0060438; GO:0061024; GO:0061336; GO:0061541; GO:0098813; GO:0106036 adherens junction organization [GO:0034332]; amnioserosa maintenance [GO:0046665]; apical constriction [GO:0003383]; apical protein localization [GO:0045176]; assembly of apicomedial cortex actomyosin [GO:0106036]; cell division [GO:0051301]; cell morphogenesis involved in Malpighian tubule morphogenesis [GO:0061336]; centrosome localization [GO:0051642]; compound eye morphogenesis [GO:0001745]; compound eye photoreceptor development [GO:0042051]; dorsal closure [GO:0007391]; dorsal closure, amnioserosa morphology change [GO:0046664]; establishment or maintenance of apical/basal cell polarity [GO:0035088]; establishment or maintenance of cell polarity [GO:0007163]; establishment or maintenance of polarity of embryonic epithelium [GO:0016332]; establishment or maintenance of polarity of follicular epithelium [GO:0016334]; liquid clearance, open tracheal system [GO:0035002]; maintenance of apical/basal cell polarity [GO:0035090]; Malpighian tubule morphogenesis [GO:0007443]; membrane organization [GO:0061024]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of organ growth [GO:0046621]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; nuclear chromosome segregation [GO:0098813]; open tracheal system development [GO:0007424]; photoreceptor cell maintenance [GO:0045494]; positive regulation of hippo signaling [GO:0035332]; protein stabilization [GO:0050821]; regulation of imaginal disc growth [GO:0045570]; regulation of intracellular protein transport [GO:0033157]; regulation of protein localization [GO:0032880]; rhabdomere development [GO:0042052]; rhabdomere morphogenesis [GO:0061541]; salivary gland morphogenesis [GO:0007435]; trachea development [GO:0060438]; tube morphogenesis [GO:0035239]; wing disc dorsal/ventral pattern formation [GO:0048190]; zonula adherens assembly [GO:0045186]; zonula adherens maintenance [GO:0045218] apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; nucleus [GO:0005634]; photoreceptor connecting cilium [GO:0032391]; plasma membrane [GO:0005886]; rhabdomere [GO:0016028]; rhabdomere membrane [GO:0033583]; spindle [GO:0005819]; subapical complex [GO:0035003] calcium ion binding [GO:0005509]; Notch binding [GO:0005112]; protein kinase C binding [GO:0005080]; spectrin binding [GO:0030507] g24131.t3 P10040 31.746 504 2.0600000000000002e-47 192.0 sp|P10040|CRB_DROME Protein crumbs OS=Drosophila melanogaster OX=7227 GN=crb PE=1 SV=3 CRB_DROME reviewed Protein crumbs (95F) Drosophila melanogaster (Fruit fly) GO:0001745; GO:0003383; GO:0005080; GO:0005112; GO:0005509; GO:0005634; GO:0005819; GO:0005886; GO:0007163; GO:0007391; GO:0007424; GO:0007435; GO:0007443; GO:0016028; GO:0016324; GO:0016327; GO:0016332; GO:0016334; GO:0030507; GO:0032391; GO:0032435; GO:0032880; GO:0033157; GO:0033583; GO:0034332; GO:0035002; GO:0035003; GO:0035088; GO:0035090; GO:0035239; GO:0035332; GO:0042051; GO:0042052; GO:0045176; GO:0045186; GO:0045218; GO:0045494; GO:0045570; GO:0045746; GO:0046621; GO:0046664; GO:0046665; GO:0048190; GO:0050821; GO:0051301; GO:0051642; GO:0060438; GO:0061024; GO:0061336; GO:0061541; GO:0098813; GO:0106036 adherens junction organization [GO:0034332]; amnioserosa maintenance [GO:0046665]; apical constriction [GO:0003383]; apical protein localization [GO:0045176]; assembly of apicomedial cortex actomyosin [GO:0106036]; cell division [GO:0051301]; cell morphogenesis involved in Malpighian tubule morphogenesis [GO:0061336]; centrosome localization [GO:0051642]; compound eye morphogenesis [GO:0001745]; compound eye photoreceptor development [GO:0042051]; dorsal closure [GO:0007391]; dorsal closure, amnioserosa morphology change [GO:0046664]; establishment or maintenance of apical/basal cell polarity [GO:0035088]; establishment or maintenance of cell polarity [GO:0007163]; establishment or maintenance of polarity of embryonic epithelium [GO:0016332]; establishment or maintenance of polarity of follicular epithelium [GO:0016334]; liquid clearance, open tracheal system [GO:0035002]; maintenance of apical/basal cell polarity [GO:0035090]; Malpighian tubule morphogenesis [GO:0007443]; membrane organization [GO:0061024]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of organ growth [GO:0046621]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; nuclear chromosome segregation [GO:0098813]; open tracheal system development [GO:0007424]; photoreceptor cell maintenance [GO:0045494]; positive regulation of hippo signaling [GO:0035332]; protein stabilization [GO:0050821]; regulation of imaginal disc growth [GO:0045570]; regulation of intracellular protein transport [GO:0033157]; regulation of protein localization [GO:0032880]; rhabdomere development [GO:0042052]; rhabdomere morphogenesis [GO:0061541]; salivary gland morphogenesis [GO:0007435]; trachea development [GO:0060438]; tube morphogenesis [GO:0035239]; wing disc dorsal/ventral pattern formation [GO:0048190]; zonula adherens assembly [GO:0045186]; zonula adherens maintenance [GO:0045218] apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; nucleus [GO:0005634]; photoreceptor connecting cilium [GO:0032391]; plasma membrane [GO:0005886]; rhabdomere [GO:0016028]; rhabdomere membrane [GO:0033583]; spindle [GO:0005819]; subapical complex [GO:0035003] calcium ion binding [GO:0005509]; Notch binding [GO:0005112]; protein kinase C binding [GO:0005080]; spectrin binding [GO:0030507] g24131.t3 P10040 33.493 418 7.93e-46 187.0 sp|P10040|CRB_DROME Protein crumbs OS=Drosophila melanogaster OX=7227 GN=crb PE=1 SV=3 CRB_DROME reviewed Protein crumbs (95F) Drosophila melanogaster (Fruit fly) GO:0001745; GO:0003383; GO:0005080; GO:0005112; GO:0005509; GO:0005634; GO:0005819; GO:0005886; GO:0007163; GO:0007391; GO:0007424; GO:0007435; GO:0007443; GO:0016028; GO:0016324; GO:0016327; GO:0016332; GO:0016334; GO:0030507; GO:0032391; GO:0032435; GO:0032880; GO:0033157; GO:0033583; GO:0034332; GO:0035002; GO:0035003; GO:0035088; GO:0035090; GO:0035239; GO:0035332; GO:0042051; GO:0042052; GO:0045176; GO:0045186; GO:0045218; GO:0045494; GO:0045570; GO:0045746; GO:0046621; GO:0046664; GO:0046665; GO:0048190; GO:0050821; GO:0051301; GO:0051642; GO:0060438; GO:0061024; GO:0061336; GO:0061541; GO:0098813; GO:0106036 adherens junction organization [GO:0034332]; amnioserosa maintenance [GO:0046665]; apical constriction [GO:0003383]; apical protein localization [GO:0045176]; assembly of apicomedial cortex actomyosin [GO:0106036]; cell division [GO:0051301]; cell morphogenesis involved in Malpighian tubule morphogenesis [GO:0061336]; centrosome localization [GO:0051642]; compound eye morphogenesis [GO:0001745]; compound eye photoreceptor development [GO:0042051]; dorsal closure [GO:0007391]; dorsal closure, amnioserosa morphology change [GO:0046664]; establishment or maintenance of apical/basal cell polarity [GO:0035088]; establishment or maintenance of cell polarity [GO:0007163]; establishment or maintenance of polarity of embryonic epithelium [GO:0016332]; establishment or maintenance of polarity of follicular epithelium [GO:0016334]; liquid clearance, open tracheal system [GO:0035002]; maintenance of apical/basal cell polarity [GO:0035090]; Malpighian tubule morphogenesis [GO:0007443]; membrane organization [GO:0061024]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of organ growth [GO:0046621]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; nuclear chromosome segregation [GO:0098813]; open tracheal system development [GO:0007424]; photoreceptor cell maintenance [GO:0045494]; positive regulation of hippo signaling [GO:0035332]; protein stabilization [GO:0050821]; regulation of imaginal disc growth [GO:0045570]; regulation of intracellular protein transport [GO:0033157]; regulation of protein localization [GO:0032880]; rhabdomere development [GO:0042052]; rhabdomere morphogenesis [GO:0061541]; salivary gland morphogenesis [GO:0007435]; trachea development [GO:0060438]; tube morphogenesis [GO:0035239]; wing disc dorsal/ventral pattern formation [GO:0048190]; zonula adherens assembly [GO:0045186]; zonula adherens maintenance [GO:0045218] apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; nucleus [GO:0005634]; photoreceptor connecting cilium [GO:0032391]; plasma membrane [GO:0005886]; rhabdomere [GO:0016028]; rhabdomere membrane [GO:0033583]; spindle [GO:0005819]; subapical complex [GO:0035003] calcium ion binding [GO:0005509]; Notch binding [GO:0005112]; protein kinase C binding [GO:0005080]; spectrin binding [GO:0030507] g24131.t3 P10040 35.294 340 1.96e-41 172.0 sp|P10040|CRB_DROME Protein crumbs OS=Drosophila melanogaster OX=7227 GN=crb PE=1 SV=3 CRB_DROME reviewed Protein crumbs (95F) Drosophila melanogaster (Fruit fly) GO:0001745; GO:0003383; GO:0005080; GO:0005112; GO:0005509; GO:0005634; GO:0005819; GO:0005886; GO:0007163; GO:0007391; GO:0007424; GO:0007435; GO:0007443; GO:0016028; GO:0016324; GO:0016327; GO:0016332; GO:0016334; GO:0030507; GO:0032391; GO:0032435; GO:0032880; GO:0033157; GO:0033583; GO:0034332; GO:0035002; GO:0035003; GO:0035088; GO:0035090; GO:0035239; GO:0035332; GO:0042051; GO:0042052; GO:0045176; GO:0045186; GO:0045218; GO:0045494; GO:0045570; GO:0045746; GO:0046621; GO:0046664; GO:0046665; GO:0048190; GO:0050821; GO:0051301; GO:0051642; GO:0060438; GO:0061024; GO:0061336; GO:0061541; GO:0098813; GO:0106036 adherens junction organization [GO:0034332]; amnioserosa maintenance [GO:0046665]; apical constriction [GO:0003383]; apical protein localization [GO:0045176]; assembly of apicomedial cortex actomyosin [GO:0106036]; cell division [GO:0051301]; cell morphogenesis involved in Malpighian tubule morphogenesis [GO:0061336]; centrosome localization [GO:0051642]; compound eye morphogenesis [GO:0001745]; compound eye photoreceptor development [GO:0042051]; dorsal closure [GO:0007391]; dorsal closure, amnioserosa morphology change [GO:0046664]; establishment or maintenance of apical/basal cell polarity [GO:0035088]; establishment or maintenance of cell polarity [GO:0007163]; establishment or maintenance of polarity of embryonic epithelium [GO:0016332]; establishment or maintenance of polarity of follicular epithelium [GO:0016334]; liquid clearance, open tracheal system [GO:0035002]; maintenance of apical/basal cell polarity [GO:0035090]; Malpighian tubule morphogenesis [GO:0007443]; membrane organization [GO:0061024]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of organ growth [GO:0046621]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; nuclear chromosome segregation [GO:0098813]; open tracheal system development [GO:0007424]; photoreceptor cell maintenance [GO:0045494]; positive regulation of hippo signaling [GO:0035332]; protein stabilization [GO:0050821]; regulation of imaginal disc growth [GO:0045570]; regulation of intracellular protein transport [GO:0033157]; regulation of protein localization [GO:0032880]; rhabdomere development [GO:0042052]; rhabdomere morphogenesis [GO:0061541]; salivary gland morphogenesis [GO:0007435]; trachea development [GO:0060438]; tube morphogenesis [GO:0035239]; wing disc dorsal/ventral pattern formation [GO:0048190]; zonula adherens assembly [GO:0045186]; zonula adherens maintenance [GO:0045218] apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; nucleus [GO:0005634]; photoreceptor connecting cilium [GO:0032391]; plasma membrane [GO:0005886]; rhabdomere [GO:0016028]; rhabdomere membrane [GO:0033583]; spindle [GO:0005819]; subapical complex [GO:0035003] calcium ion binding [GO:0005509]; Notch binding [GO:0005112]; protein kinase C binding [GO:0005080]; spectrin binding [GO:0030507] g24131.t3 P10040 35.135 333 5.33e-39 164.0 sp|P10040|CRB_DROME Protein crumbs OS=Drosophila melanogaster OX=7227 GN=crb PE=1 SV=3 CRB_DROME reviewed Protein crumbs (95F) Drosophila melanogaster (Fruit fly) GO:0001745; GO:0003383; GO:0005080; GO:0005112; GO:0005509; GO:0005634; GO:0005819; GO:0005886; GO:0007163; GO:0007391; GO:0007424; GO:0007435; GO:0007443; GO:0016028; GO:0016324; GO:0016327; GO:0016332; GO:0016334; GO:0030507; GO:0032391; GO:0032435; GO:0032880; GO:0033157; GO:0033583; GO:0034332; GO:0035002; GO:0035003; GO:0035088; GO:0035090; GO:0035239; GO:0035332; GO:0042051; GO:0042052; GO:0045176; GO:0045186; GO:0045218; GO:0045494; GO:0045570; GO:0045746; GO:0046621; GO:0046664; GO:0046665; GO:0048190; GO:0050821; GO:0051301; GO:0051642; GO:0060438; GO:0061024; GO:0061336; GO:0061541; GO:0098813; GO:0106036 adherens junction organization [GO:0034332]; amnioserosa maintenance [GO:0046665]; apical constriction [GO:0003383]; apical protein localization [GO:0045176]; assembly of apicomedial cortex actomyosin [GO:0106036]; cell division [GO:0051301]; cell morphogenesis involved in Malpighian tubule morphogenesis [GO:0061336]; centrosome localization [GO:0051642]; compound eye morphogenesis [GO:0001745]; compound eye photoreceptor development [GO:0042051]; dorsal closure [GO:0007391]; dorsal closure, amnioserosa morphology change [GO:0046664]; establishment or maintenance of apical/basal cell polarity [GO:0035088]; establishment or maintenance of cell polarity [GO:0007163]; establishment or maintenance of polarity of embryonic epithelium [GO:0016332]; establishment or maintenance of polarity of follicular epithelium [GO:0016334]; liquid clearance, open tracheal system [GO:0035002]; maintenance of apical/basal cell polarity [GO:0035090]; Malpighian tubule morphogenesis [GO:0007443]; membrane organization [GO:0061024]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of organ growth [GO:0046621]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; nuclear chromosome segregation [GO:0098813]; open tracheal system development [GO:0007424]; photoreceptor cell maintenance [GO:0045494]; positive regulation of hippo signaling [GO:0035332]; protein stabilization [GO:0050821]; regulation of imaginal disc growth [GO:0045570]; regulation of intracellular protein transport [GO:0033157]; regulation of protein localization [GO:0032880]; rhabdomere development [GO:0042052]; rhabdomere morphogenesis [GO:0061541]; salivary gland morphogenesis [GO:0007435]; trachea development [GO:0060438]; tube morphogenesis [GO:0035239]; wing disc dorsal/ventral pattern formation [GO:0048190]; zonula adherens assembly [GO:0045186]; zonula adherens maintenance [GO:0045218] apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; nucleus [GO:0005634]; photoreceptor connecting cilium [GO:0032391]; plasma membrane [GO:0005886]; rhabdomere [GO:0016028]; rhabdomere membrane [GO:0033583]; spindle [GO:0005819]; subapical complex [GO:0035003] calcium ion binding [GO:0005509]; Notch binding [GO:0005112]; protein kinase C binding [GO:0005080]; spectrin binding [GO:0030507] g24131.t3 P10040 36.306 314 2.7900000000000002e-33 145.0 sp|P10040|CRB_DROME Protein crumbs OS=Drosophila melanogaster OX=7227 GN=crb PE=1 SV=3 CRB_DROME reviewed Protein crumbs (95F) Drosophila melanogaster (Fruit fly) GO:0001745; GO:0003383; GO:0005080; GO:0005112; GO:0005509; GO:0005634; GO:0005819; GO:0005886; GO:0007163; GO:0007391; GO:0007424; GO:0007435; GO:0007443; GO:0016028; GO:0016324; GO:0016327; GO:0016332; GO:0016334; GO:0030507; GO:0032391; GO:0032435; GO:0032880; GO:0033157; GO:0033583; GO:0034332; GO:0035002; GO:0035003; GO:0035088; GO:0035090; GO:0035239; GO:0035332; GO:0042051; GO:0042052; GO:0045176; GO:0045186; GO:0045218; GO:0045494; GO:0045570; GO:0045746; GO:0046621; GO:0046664; GO:0046665; GO:0048190; GO:0050821; GO:0051301; GO:0051642; GO:0060438; GO:0061024; GO:0061336; GO:0061541; GO:0098813; GO:0106036 adherens junction organization [GO:0034332]; amnioserosa maintenance [GO:0046665]; apical constriction [GO:0003383]; apical protein localization [GO:0045176]; assembly of apicomedial cortex actomyosin [GO:0106036]; cell division [GO:0051301]; cell morphogenesis involved in Malpighian tubule morphogenesis [GO:0061336]; centrosome localization [GO:0051642]; compound eye morphogenesis [GO:0001745]; compound eye photoreceptor development [GO:0042051]; dorsal closure [GO:0007391]; dorsal closure, amnioserosa morphology change [GO:0046664]; establishment or maintenance of apical/basal cell polarity [GO:0035088]; establishment or maintenance of cell polarity [GO:0007163]; establishment or maintenance of polarity of embryonic epithelium [GO:0016332]; establishment or maintenance of polarity of follicular epithelium [GO:0016334]; liquid clearance, open tracheal system [GO:0035002]; maintenance of apical/basal cell polarity [GO:0035090]; Malpighian tubule morphogenesis [GO:0007443]; membrane organization [GO:0061024]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of organ growth [GO:0046621]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; nuclear chromosome segregation [GO:0098813]; open tracheal system development [GO:0007424]; photoreceptor cell maintenance [GO:0045494]; positive regulation of hippo signaling [GO:0035332]; protein stabilization [GO:0050821]; regulation of imaginal disc growth [GO:0045570]; regulation of intracellular protein transport [GO:0033157]; regulation of protein localization [GO:0032880]; rhabdomere development [GO:0042052]; rhabdomere morphogenesis [GO:0061541]; salivary gland morphogenesis [GO:0007435]; trachea development [GO:0060438]; tube morphogenesis [GO:0035239]; wing disc dorsal/ventral pattern formation [GO:0048190]; zonula adherens assembly [GO:0045186]; zonula adherens maintenance [GO:0045218] apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; nucleus [GO:0005634]; photoreceptor connecting cilium [GO:0032391]; plasma membrane [GO:0005886]; rhabdomere [GO:0016028]; rhabdomere membrane [GO:0033583]; spindle [GO:0005819]; subapical complex [GO:0035003] calcium ion binding [GO:0005509]; Notch binding [GO:0005112]; protein kinase C binding [GO:0005080]; spectrin binding [GO:0030507] g24131.t3 P10040 33.138 341 4.07e-33 145.0 sp|P10040|CRB_DROME Protein crumbs OS=Drosophila melanogaster OX=7227 GN=crb PE=1 SV=3 CRB_DROME reviewed Protein crumbs (95F) Drosophila melanogaster (Fruit fly) GO:0001745; GO:0003383; GO:0005080; GO:0005112; GO:0005509; GO:0005634; GO:0005819; GO:0005886; GO:0007163; GO:0007391; GO:0007424; GO:0007435; GO:0007443; GO:0016028; GO:0016324; GO:0016327; GO:0016332; GO:0016334; GO:0030507; GO:0032391; GO:0032435; GO:0032880; GO:0033157; GO:0033583; GO:0034332; GO:0035002; GO:0035003; GO:0035088; GO:0035090; GO:0035239; GO:0035332; GO:0042051; GO:0042052; GO:0045176; GO:0045186; GO:0045218; GO:0045494; GO:0045570; GO:0045746; GO:0046621; GO:0046664; GO:0046665; GO:0048190; GO:0050821; GO:0051301; GO:0051642; GO:0060438; GO:0061024; GO:0061336; GO:0061541; GO:0098813; GO:0106036 adherens junction organization [GO:0034332]; amnioserosa maintenance [GO:0046665]; apical constriction [GO:0003383]; apical protein localization [GO:0045176]; assembly of apicomedial cortex actomyosin [GO:0106036]; cell division [GO:0051301]; cell morphogenesis involved in Malpighian tubule morphogenesis [GO:0061336]; centrosome localization [GO:0051642]; compound eye morphogenesis [GO:0001745]; compound eye photoreceptor development [GO:0042051]; dorsal closure [GO:0007391]; dorsal closure, amnioserosa morphology change [GO:0046664]; establishment or maintenance of apical/basal cell polarity [GO:0035088]; establishment or maintenance of cell polarity [GO:0007163]; establishment or maintenance of polarity of embryonic epithelium [GO:0016332]; establishment or maintenance of polarity of follicular epithelium [GO:0016334]; liquid clearance, open tracheal system [GO:0035002]; maintenance of apical/basal cell polarity [GO:0035090]; Malpighian tubule morphogenesis [GO:0007443]; membrane organization [GO:0061024]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of organ growth [GO:0046621]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; nuclear chromosome segregation [GO:0098813]; open tracheal system development [GO:0007424]; photoreceptor cell maintenance [GO:0045494]; positive regulation of hippo signaling [GO:0035332]; protein stabilization [GO:0050821]; regulation of imaginal disc growth [GO:0045570]; regulation of intracellular protein transport [GO:0033157]; regulation of protein localization [GO:0032880]; rhabdomere development [GO:0042052]; rhabdomere morphogenesis [GO:0061541]; salivary gland morphogenesis [GO:0007435]; trachea development [GO:0060438]; tube morphogenesis [GO:0035239]; wing disc dorsal/ventral pattern formation [GO:0048190]; zonula adherens assembly [GO:0045186]; zonula adherens maintenance [GO:0045218] apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; nucleus [GO:0005634]; photoreceptor connecting cilium [GO:0032391]; plasma membrane [GO:0005886]; rhabdomere [GO:0016028]; rhabdomere membrane [GO:0033583]; spindle [GO:0005819]; subapical complex [GO:0035003] calcium ion binding [GO:0005509]; Notch binding [GO:0005112]; protein kinase C binding [GO:0005080]; spectrin binding [GO:0030507] g24131.t3 P10040 36.877 301 2.61e-29 132.0 sp|P10040|CRB_DROME Protein crumbs OS=Drosophila melanogaster OX=7227 GN=crb PE=1 SV=3 CRB_DROME reviewed Protein crumbs (95F) Drosophila melanogaster (Fruit fly) GO:0001745; GO:0003383; GO:0005080; GO:0005112; GO:0005509; GO:0005634; GO:0005819; GO:0005886; GO:0007163; GO:0007391; GO:0007424; GO:0007435; GO:0007443; GO:0016028; GO:0016324; GO:0016327; GO:0016332; GO:0016334; GO:0030507; GO:0032391; GO:0032435; GO:0032880; GO:0033157; GO:0033583; GO:0034332; GO:0035002; GO:0035003; GO:0035088; GO:0035090; GO:0035239; GO:0035332; GO:0042051; GO:0042052; GO:0045176; GO:0045186; GO:0045218; GO:0045494; GO:0045570; GO:0045746; GO:0046621; GO:0046664; GO:0046665; GO:0048190; GO:0050821; GO:0051301; GO:0051642; GO:0060438; GO:0061024; GO:0061336; GO:0061541; GO:0098813; GO:0106036 adherens junction organization [GO:0034332]; amnioserosa maintenance [GO:0046665]; apical constriction [GO:0003383]; apical protein localization [GO:0045176]; assembly of apicomedial cortex actomyosin [GO:0106036]; cell division [GO:0051301]; cell morphogenesis involved in Malpighian tubule morphogenesis [GO:0061336]; centrosome localization [GO:0051642]; compound eye morphogenesis [GO:0001745]; compound eye photoreceptor development [GO:0042051]; dorsal closure [GO:0007391]; dorsal closure, amnioserosa morphology change [GO:0046664]; establishment or maintenance of apical/basal cell polarity [GO:0035088]; establishment or maintenance of cell polarity [GO:0007163]; establishment or maintenance of polarity of embryonic epithelium [GO:0016332]; establishment or maintenance of polarity of follicular epithelium [GO:0016334]; liquid clearance, open tracheal system [GO:0035002]; maintenance of apical/basal cell polarity [GO:0035090]; Malpighian tubule morphogenesis [GO:0007443]; membrane organization [GO:0061024]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of organ growth [GO:0046621]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; nuclear chromosome segregation [GO:0098813]; open tracheal system development [GO:0007424]; photoreceptor cell maintenance [GO:0045494]; positive regulation of hippo signaling [GO:0035332]; protein stabilization [GO:0050821]; regulation of imaginal disc growth [GO:0045570]; regulation of intracellular protein transport [GO:0033157]; regulation of protein localization [GO:0032880]; rhabdomere development [GO:0042052]; rhabdomere morphogenesis [GO:0061541]; salivary gland morphogenesis [GO:0007435]; trachea development [GO:0060438]; tube morphogenesis [GO:0035239]; wing disc dorsal/ventral pattern formation [GO:0048190]; zonula adherens assembly [GO:0045186]; zonula adherens maintenance [GO:0045218] apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; nucleus [GO:0005634]; photoreceptor connecting cilium [GO:0032391]; plasma membrane [GO:0005886]; rhabdomere [GO:0016028]; rhabdomere membrane [GO:0033583]; spindle [GO:0005819]; subapical complex [GO:0035003] calcium ion binding [GO:0005509]; Notch binding [GO:0005112]; protein kinase C binding [GO:0005080]; spectrin binding [GO:0030507] g24131.t3 P10040 30.522 249 8.46e-22 108.0 sp|P10040|CRB_DROME Protein crumbs OS=Drosophila melanogaster OX=7227 GN=crb PE=1 SV=3 CRB_DROME reviewed Protein crumbs (95F) Drosophila melanogaster (Fruit fly) GO:0001745; GO:0003383; GO:0005080; GO:0005112; GO:0005509; GO:0005634; GO:0005819; GO:0005886; GO:0007163; GO:0007391; GO:0007424; GO:0007435; GO:0007443; GO:0016028; GO:0016324; GO:0016327; GO:0016332; GO:0016334; GO:0030507; GO:0032391; GO:0032435; GO:0032880; GO:0033157; GO:0033583; GO:0034332; GO:0035002; GO:0035003; GO:0035088; GO:0035090; GO:0035239; GO:0035332; GO:0042051; GO:0042052; GO:0045176; GO:0045186; GO:0045218; GO:0045494; GO:0045570; GO:0045746; GO:0046621; GO:0046664; GO:0046665; GO:0048190; GO:0050821; GO:0051301; GO:0051642; GO:0060438; GO:0061024; GO:0061336; GO:0061541; GO:0098813; GO:0106036 adherens junction organization [GO:0034332]; amnioserosa maintenance [GO:0046665]; apical constriction [GO:0003383]; apical protein localization [GO:0045176]; assembly of apicomedial cortex actomyosin [GO:0106036]; cell division [GO:0051301]; cell morphogenesis involved in Malpighian tubule morphogenesis [GO:0061336]; centrosome localization [GO:0051642]; compound eye morphogenesis [GO:0001745]; compound eye photoreceptor development [GO:0042051]; dorsal closure [GO:0007391]; dorsal closure, amnioserosa morphology change [GO:0046664]; establishment or maintenance of apical/basal cell polarity [GO:0035088]; establishment or maintenance of cell polarity [GO:0007163]; establishment or maintenance of polarity of embryonic epithelium [GO:0016332]; establishment or maintenance of polarity of follicular epithelium [GO:0016334]; liquid clearance, open tracheal system [GO:0035002]; maintenance of apical/basal cell polarity [GO:0035090]; Malpighian tubule morphogenesis [GO:0007443]; membrane organization [GO:0061024]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of organ growth [GO:0046621]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; nuclear chromosome segregation [GO:0098813]; open tracheal system development [GO:0007424]; photoreceptor cell maintenance [GO:0045494]; positive regulation of hippo signaling [GO:0035332]; protein stabilization [GO:0050821]; regulation of imaginal disc growth [GO:0045570]; regulation of intracellular protein transport [GO:0033157]; regulation of protein localization [GO:0032880]; rhabdomere development [GO:0042052]; rhabdomere morphogenesis [GO:0061541]; salivary gland morphogenesis [GO:0007435]; trachea development [GO:0060438]; tube morphogenesis [GO:0035239]; wing disc dorsal/ventral pattern formation [GO:0048190]; zonula adherens assembly [GO:0045186]; zonula adherens maintenance [GO:0045218] apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; nucleus [GO:0005634]; photoreceptor connecting cilium [GO:0032391]; plasma membrane [GO:0005886]; rhabdomere [GO:0016028]; rhabdomere membrane [GO:0033583]; spindle [GO:0005819]; subapical complex [GO:0035003] calcium ion binding [GO:0005509]; Notch binding [GO:0005112]; protein kinase C binding [GO:0005080]; spectrin binding [GO:0030507] g24133.t1 Q96DM1 37.548 522 4.09e-96 308.0 sp|Q96DM1|PGBD4_HUMAN PiggyBac transposable element-derived protein 4 OS=Homo sapiens OX=9606 GN=PGBD4 PE=1 SV=3 g24134.t1 Q96DM1 40.636 283 5.899999999999999e-54 187.0 sp|Q96DM1|PGBD4_HUMAN PiggyBac transposable element-derived protein 4 OS=Homo sapiens OX=9606 GN=PGBD4 PE=1 SV=3 g24134.t2 Q96DM1 36.782 522 4.43e-94 302.0 sp|Q96DM1|PGBD4_HUMAN PiggyBac transposable element-derived protein 4 OS=Homo sapiens OX=9606 GN=PGBD4 PE=1 SV=3 g24135.t1 Q3UHC7 47.682 604 1.6e-174 557.0 sp|Q3UHC7|DAB2P_MOUSE Disabled homolog 2-interacting protein OS=Mus musculus OX=10090 GN=Dab2ip PE=1 SV=1 DAB2P_MOUSE reviewed Disabled homolog 2-interacting protein (DAB2-interacting protein) (ASK-interacting protein 1) (DOC-2/DAB-2 interactive protein) Mus musculus (Mouse) GO:0000122; GO:0001525; GO:0005096; GO:0005123; GO:0005737; GO:0005886; GO:0006954; GO:0006986; GO:0008285; GO:0008625; GO:0010596; GO:0010633; GO:0010719; GO:0010976; GO:0016020; GO:0016525; GO:0017124; GO:0019900; GO:0019901; GO:0021814; GO:0021819; GO:0030139; GO:0030163; GO:0030308; GO:0030424; GO:0030425; GO:0030948; GO:0031334; GO:0031434; GO:0031435; GO:0032266; GO:0032809; GO:0033209; GO:0034144; GO:0034260; GO:0035148; GO:0035556; GO:0035591; GO:0035924; GO:0036312; GO:0036324; GO:0042059; GO:0042177; GO:0042802; GO:0042803; GO:0043025; GO:0043065; GO:0043087; GO:0043122; GO:0043123; GO:0043124; GO:0043184; GO:0043254; GO:0043409; GO:0043410; GO:0043539; GO:0043548; GO:0044300; GO:0044301; GO:0044877; GO:0045087; GO:0045732; GO:0045892; GO:0045944; GO:0046330; GO:0046580; GO:0048147; GO:0048812; GO:0050679; GO:0050680; GO:0051721; GO:0051726; GO:0051898; GO:0070059; GO:0070273; GO:0070317; GO:0070373; GO:0071222; GO:0071347; GO:0071356; GO:0071364; GO:0071889; GO:0090090; GO:0090129; GO:0140042; GO:1900006; GO:1900744; GO:1900747; GO:1901223; GO:1901800; GO:1902531; GO:1990032; GO:1990597; GO:2001224; GO:2001235 angiogenesis [GO:0001525]; cell motility involved in cerebral cortex radial glia guided migration [GO:0021814]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to interleukin-1 [GO:0071347]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; intracellular signal transduction [GO:0035556]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; layer formation in cerebral cortex [GO:0021819]; lipid droplet formation [GO:0140042]; negative regulation of angiogenesis [GO:0016525]; negative regulation of canonical NF-kappaB signal transduction [GO:0043124]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of epithelial cell migration [GO:0010633]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of G0 to G1 transition [GO:0070317]; negative regulation of GTPase activity [GO:0034260]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of non-canonical NF-kappaB signal transduction [GO:1901223]; negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051898]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of Ras protein signal transduction [GO:0046580]; negative regulation of toll-like receptor 4 signaling pathway [GO:0034144]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030948]; negative regulation of vascular endothelial growth factor signaling pathway [GO:1900747]; neuron projection morphogenesis [GO:0048812]; positive regulation of apoptotic process [GO:0043065]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of dendrite development [GO:1900006]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of JNK cascade [GO:0046330]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of neuron migration [GO:2001224]; positive regulation of neuron projection development [GO:0010976]; positive regulation of proteasomal protein catabolic process [GO:1901800]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein-containing complex assembly [GO:0031334]; positive regulation of synapse maturation [GO:0090129]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein catabolic process [GO:0030163]; regulation of canonical NF-kappaB signal transduction [GO:0043122]; regulation of cell cycle [GO:0051726]; regulation of GTPase activity [GO:0043087]; regulation of intracellular signal transduction [GO:1902531]; regulation of p38MAPK cascade [GO:1900744]; regulation of protein-containing complex assembly [GO:0043254]; response to unfolded protein [GO:0006986]; tube formation [GO:0035148]; tumor necrosis factor-mediated signaling pathway [GO:0033209]; vascular endothelial growth factor receptor-2 signaling pathway [GO:0036324] AIP1-IRE1 complex [GO:1990597]; axon [GO:0030424]; cerebellar mossy fiber [GO:0044300]; climbing fiber [GO:0044301]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; endocytic vesicle [GO:0030139]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; neuronal cell body membrane [GO:0032809]; parallel fiber [GO:1990032]; plasma membrane [GO:0005886] 14-3-3 protein binding [GO:0071889]; death receptor binding [GO:0005123]; GTPase activator activity [GO:0005096]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; mitogen-activated protein kinase kinase binding [GO:0031434]; mitogen-activated protein kinase kinase kinase binding [GO:0031435]; phosphatidylinositol 3-kinase binding [GO:0043548]; phosphatidylinositol 3-kinase regulatory subunit binding [GO:0036312]; phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol-4-phosphate binding [GO:0070273]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein phosphatase 2A binding [GO:0051721]; protein serine/threonine kinase activator activity [GO:0043539]; protein-containing complex binding [GO:0044877]; SH3 domain binding [GO:0017124]; signaling adaptor activity [GO:0035591]; vascular endothelial growth factor receptor 2 binding [GO:0043184] g24135.t2 Q5VWQ8 47.011 619 2.3999999999999998e-172 551.0 sp|Q5VWQ8|DAB2P_HUMAN Disabled homolog 2-interacting protein OS=Homo sapiens OX=9606 GN=DAB2IP PE=1 SV=2 DAB2P_HUMAN reviewed Disabled homolog 2-interacting protein (DAB2 interaction protein) (DAB2-interacting protein) (ASK-interacting protein 1) (AIP-1) (DOC-2/DAB-2 interactive protein) Homo sapiens (Human) GO:0000122; GO:0001525; GO:0005096; GO:0005123; GO:0005737; GO:0005829; GO:0005886; GO:0006954; GO:0008285; GO:0008625; GO:0010596; GO:0010633; GO:0010719; GO:0010976; GO:0016020; GO:0016525; GO:0017124; GO:0019900; GO:0019901; GO:0021814; GO:0021819; GO:0030139; GO:0030163; GO:0030424; GO:0030425; GO:0030948; GO:0031334; GO:0031434; GO:0031435; GO:0032266; GO:0032809; GO:0033209; GO:0034144; GO:0034260; GO:0034620; GO:0035148; GO:0035556; GO:0035591; GO:0035924; GO:0036312; GO:0036324; GO:0042059; GO:0042177; GO:0042802; GO:0042803; GO:0043025; GO:0043065; GO:0043087; GO:0043122; GO:0043123; GO:0043124; GO:0043184; GO:0043254; GO:0043409; GO:0043410; GO:0043539; GO:0043548; GO:0044300; GO:0044301; GO:0044877; GO:0045087; GO:0045296; GO:0045732; GO:0045892; GO:0045944; GO:0046330; GO:0046580; GO:0048147; GO:0048812; GO:0050680; GO:0051721; GO:0051726; GO:0051898; GO:0070059; GO:0070273; GO:0070317; GO:0070373; GO:0071222; GO:0071347; GO:0071356; GO:0071364; GO:0071889; GO:0072577; GO:0090090; GO:0090129; GO:0140042; GO:1900006; GO:1900744; GO:1900747; GO:1901223; GO:1901800; GO:1902531; GO:1903896; GO:1990032; GO:1990597; GO:2001224; GO:2001235 angiogenesis [GO:0001525]; cell motility involved in cerebral cortex radial glia guided migration [GO:0021814]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to interleukin-1 [GO:0071347]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to unfolded protein [GO:0034620]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; endothelial cell apoptotic process [GO:0072577]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; intracellular signal transduction [GO:0035556]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; layer formation in cerebral cortex [GO:0021819]; lipid droplet formation [GO:0140042]; negative regulation of angiogenesis [GO:0016525]; negative regulation of canonical NF-kappaB signal transduction [GO:0043124]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of epithelial cell migration [GO:0010633]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of G0 to G1 transition [GO:0070317]; negative regulation of GTPase activity [GO:0034260]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of non-canonical NF-kappaB signal transduction [GO:1901223]; negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051898]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of Ras protein signal transduction [GO:0046580]; negative regulation of toll-like receptor 4 signaling pathway [GO:0034144]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030948]; negative regulation of vascular endothelial growth factor signaling pathway [GO:1900747]; neuron projection morphogenesis [GO:0048812]; positive regulation of apoptotic process [GO:0043065]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of dendrite development [GO:1900006]; positive regulation of IRE1-mediated unfolded protein response [GO:1903896]; positive regulation of JNK cascade [GO:0046330]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of neuron migration [GO:2001224]; positive regulation of neuron projection development [GO:0010976]; positive regulation of proteasomal protein catabolic process [GO:1901800]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein-containing complex assembly [GO:0031334]; positive regulation of synapse maturation [GO:0090129]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein catabolic process [GO:0030163]; regulation of canonical NF-kappaB signal transduction [GO:0043122]; regulation of cell cycle [GO:0051726]; regulation of GTPase activity [GO:0043087]; regulation of intracellular signal transduction [GO:1902531]; regulation of p38MAPK cascade [GO:1900744]; regulation of protein-containing complex assembly [GO:0043254]; tube formation [GO:0035148]; tumor necrosis factor-mediated signaling pathway [GO:0033209]; vascular endothelial growth factor receptor-2 signaling pathway [GO:0036324] AIP1-IRE1 complex [GO:1990597]; axon [GO:0030424]; cerebellar mossy fiber [GO:0044300]; climbing fiber [GO:0044301]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; endocytic vesicle [GO:0030139]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; neuronal cell body membrane [GO:0032809]; parallel fiber [GO:1990032]; plasma membrane [GO:0005886] 14-3-3 protein binding [GO:0071889]; cadherin binding [GO:0045296]; death receptor binding [GO:0005123]; GTPase activator activity [GO:0005096]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; mitogen-activated protein kinase kinase binding [GO:0031434]; mitogen-activated protein kinase kinase kinase binding [GO:0031435]; phosphatidylinositol 3-kinase binding [GO:0043548]; phosphatidylinositol 3-kinase regulatory subunit binding [GO:0036312]; phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol-4-phosphate binding [GO:0070273]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein phosphatase 2A binding [GO:0051721]; protein serine/threonine kinase activator activity [GO:0043539]; protein-containing complex binding [GO:0044877]; SH3 domain binding [GO:0017124]; signaling adaptor activity [GO:0035591]; vascular endothelial growth factor receptor 2 binding [GO:0043184] g24142.t1 Q75WF2 50.606 330 2.38e-112 333.0 sp|Q75WF2|DNA2_ACAPL Plancitoxin-1 OS=Acanthaster planci OX=133434 PE=1 SV=1 g24143.t1 P48039 27.331 311 2.1e-21 96.7 sp|P48039|MTR1A_HUMAN Melatonin receptor type 1A OS=Homo sapiens OX=9606 GN=MTNR1A PE=1 SV=1 MTR1A_HUMAN reviewed Melatonin receptor type 1A (Mel-1A-R) (Mel1a receptor) Homo sapiens (Human) GO:0004930; GO:0005886; GO:0007186; GO:0007187; GO:0007193; GO:0007617; GO:0007623; GO:0008502; GO:0042562; GO:0043235 adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; circadian rhythm [GO:0007623]; G protein-coupled receptor signaling pathway [GO:0007186]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; mating behavior [GO:0007617] plasma membrane [GO:0005886]; receptor complex [GO:0043235] G protein-coupled receptor activity [GO:0004930]; hormone binding [GO:0042562]; melatonin receptor activity [GO:0008502] g24144.t1 P59083 52.632 114 7.5e-36 123.0 sp|P59083|PHP14_PIG 14 kDa phosphohistidine phosphatase OS=Sus scrofa OX=9823 GN=PHPT1 PE=1 SV=2 g24145.t1 Q5BIM1 37.726 554 2.66e-118 368.0 sp|Q5BIM1|TRI45_BOVIN E3 ubiquitin-protein ligase TRIM45 OS=Bos taurus OX=9913 GN=TRIM45 PE=2 SV=1 g24147.t1 Q9Z148 48.338 782 0.0 767.0 sp|Q9Z148|EHMT2_MOUSE Histone-lysine N-methyltransferase EHMT2 OS=Mus musculus OX=10090 GN=Ehmt2 PE=1 SV=2 g24148.t1 Q02485 43.777 1647 0.0 1229.0 sp|Q02485|CAC1S_RAT Voltage-dependent L-type calcium channel subunit alpha-1S OS=Rattus norvegicus OX=10116 GN=Cacna1s PE=1 SV=2 g24148.t2 O35505 45.316 1580 0.0 1222.0 sp|O35505|CAC1C_CAVPO Voltage-dependent L-type calcium channel subunit alpha-1C OS=Cavia porcellus OX=10141 GN=CACNA1C PE=1 SV=2 g24148.t3 Q02485 43.534 1647 0.0 1222.0 sp|Q02485|CAC1S_RAT Voltage-dependent L-type calcium channel subunit alpha-1S OS=Rattus norvegicus OX=10116 GN=Cacna1s PE=1 SV=2 g24148.t4 O35505 45.316 1580 0.0 1222.0 sp|O35505|CAC1C_CAVPO Voltage-dependent L-type calcium channel subunit alpha-1C OS=Cavia porcellus OX=10141 GN=CACNA1C PE=1 SV=2 g24148.t5 C9D7C2 59.546 1498 0.0 1624.0 sp|C9D7C2|CAC1A_APIME Voltage-dependent calcium channel type A subunit alpha-1 OS=Apis mellifera OX=7460 GN=CAC PE=2 SV=1 CAC1A_APIME reviewed Voltage-dependent calcium channel type A subunit alpha-1 (Cacophony protein) Apis mellifera (Honeybee) GO:0005509; GO:0005891; GO:0007268; GO:0008331; GO:0009581; GO:0009582; GO:0016322; GO:0016323; GO:0016324; GO:0019722; GO:0042045; GO:0045202; GO:0050906; GO:0098703 calcium ion import across plasma membrane [GO:0098703]; calcium-mediated signaling [GO:0019722]; chemical synaptic transmission [GO:0007268]; detection of abiotic stimulus [GO:0009582]; detection of external stimulus [GO:0009581]; detection of stimulus involved in sensory perception [GO:0050906]; epithelial fluid transport [GO:0042045]; neuron remodeling [GO:0016322] apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; synapse [GO:0045202]; voltage-gated calcium channel complex [GO:0005891] calcium ion binding [GO:0005509]; high voltage-gated calcium channel activity [GO:0008331] g24148.t6 Q02485 42.637 1691 0.0 1207.0 sp|Q02485|CAC1S_RAT Voltage-dependent L-type calcium channel subunit alpha-1S OS=Rattus norvegicus OX=10116 GN=Cacna1s PE=1 SV=2 g24148.t7 O35505 44.465 1617 0.0 1205.0 sp|O35505|CAC1C_CAVPO Voltage-dependent L-type calcium channel subunit alpha-1C OS=Cavia porcellus OX=10141 GN=CACNA1C PE=1 SV=2 g24148.t8 O35505 45.253 1580 0.0 1215.0 sp|O35505|CAC1C_CAVPO Voltage-dependent L-type calcium channel subunit alpha-1C OS=Cavia porcellus OX=10141 GN=CACNA1C PE=1 SV=2 g24151.t1 Q96RW7 33.042 4343 0.0 2138.0 sp|Q96RW7|HMCN1_HUMAN Hemicentin-1 OS=Homo sapiens OX=9606 GN=HMCN1 PE=1 SV=2 HMCN1_HUMAN reviewed Hemicentin-1 (Fibulin-6) (FIBL-6) Homo sapiens (Human) GO:0005201; GO:0005509; GO:0005604; GO:0005737; GO:0005886; GO:0005912; GO:0005927; GO:0005938; GO:0007156; GO:0007157; GO:0007601; GO:0009617; GO:0030036; GO:0031012; GO:0032154; GO:0051301; GO:0070062; GO:0071711; GO:0098631 actin cytoskeleton organization [GO:0030036]; basement membrane organization [GO:0071711]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601] adherens junction [GO:0005912]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; muscle tendon junction [GO:0005927]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; cell adhesion mediator activity [GO:0098631]; extracellular matrix structural constituent [GO:0005201] g24151.t1 Q96RW7 33.776 3618 0.0 1821.0 sp|Q96RW7|HMCN1_HUMAN Hemicentin-1 OS=Homo sapiens OX=9606 GN=HMCN1 PE=1 SV=2 HMCN1_HUMAN reviewed Hemicentin-1 (Fibulin-6) (FIBL-6) Homo sapiens (Human) GO:0005201; GO:0005509; GO:0005604; GO:0005737; GO:0005886; GO:0005912; GO:0005927; GO:0005938; GO:0007156; GO:0007157; GO:0007601; GO:0009617; GO:0030036; GO:0031012; GO:0032154; GO:0051301; GO:0070062; GO:0071711; GO:0098631 actin cytoskeleton organization [GO:0030036]; basement membrane organization [GO:0071711]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601] adherens junction [GO:0005912]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; muscle tendon junction [GO:0005927]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; cell adhesion mediator activity [GO:0098631]; extracellular matrix structural constituent [GO:0005201] g24151.t1 Q96RW7 31.668 1301 2.88e-152 541.0 sp|Q96RW7|HMCN1_HUMAN Hemicentin-1 OS=Homo sapiens OX=9606 GN=HMCN1 PE=1 SV=2 HMCN1_HUMAN reviewed Hemicentin-1 (Fibulin-6) (FIBL-6) Homo sapiens (Human) GO:0005201; GO:0005509; GO:0005604; GO:0005737; GO:0005886; GO:0005912; GO:0005927; GO:0005938; GO:0007156; GO:0007157; GO:0007601; GO:0009617; GO:0030036; GO:0031012; GO:0032154; GO:0051301; GO:0070062; GO:0071711; GO:0098631 actin cytoskeleton organization [GO:0030036]; basement membrane organization [GO:0071711]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601] adherens junction [GO:0005912]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; muscle tendon junction [GO:0005927]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; cell adhesion mediator activity [GO:0098631]; extracellular matrix structural constituent [GO:0005201] g24151.t2 D3YXG0 34.099 4352 0.0 2275.0 sp|D3YXG0|HMCN1_MOUSE Hemicentin-1 OS=Mus musculus OX=10090 GN=Hmcn1 PE=1 SV=1 HMCN1_MOUSE reviewed Hemicentin-1 (Fibulin-6) (FIBL-6) Mus musculus (Mouse) GO:0005509; GO:0005576; GO:0005604; GO:0005737; GO:0005886; GO:0005912; GO:0005927; GO:0005938; GO:0007156; GO:0007157; GO:0009617; GO:0030036; GO:0030054; GO:0031012; GO:0032154; GO:0051301; GO:0071711; GO:0098631 actin cytoskeleton organization [GO:0030036]; basement membrane organization [GO:0071711]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617] adherens junction [GO:0005912]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; muscle tendon junction [GO:0005927]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; cell adhesion mediator activity [GO:0098631] g24151.t2 D3YXG0 33.785 3614 0.0 1833.0 sp|D3YXG0|HMCN1_MOUSE Hemicentin-1 OS=Mus musculus OX=10090 GN=Hmcn1 PE=1 SV=1 HMCN1_MOUSE reviewed Hemicentin-1 (Fibulin-6) (FIBL-6) Mus musculus (Mouse) GO:0005509; GO:0005576; GO:0005604; GO:0005737; GO:0005886; GO:0005912; GO:0005927; GO:0005938; GO:0007156; GO:0007157; GO:0009617; GO:0030036; GO:0030054; GO:0031012; GO:0032154; GO:0051301; GO:0071711; GO:0098631 actin cytoskeleton organization [GO:0030036]; basement membrane organization [GO:0071711]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617] adherens junction [GO:0005912]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; muscle tendon junction [GO:0005927]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; cell adhesion mediator activity [GO:0098631] g24151.t2 D3YXG0 31.058 1333 9.620000000000001e-155 549.0 sp|D3YXG0|HMCN1_MOUSE Hemicentin-1 OS=Mus musculus OX=10090 GN=Hmcn1 PE=1 SV=1 HMCN1_MOUSE reviewed Hemicentin-1 (Fibulin-6) (FIBL-6) Mus musculus (Mouse) GO:0005509; GO:0005576; GO:0005604; GO:0005737; GO:0005886; GO:0005912; GO:0005927; GO:0005938; GO:0007156; GO:0007157; GO:0009617; GO:0030036; GO:0030054; GO:0031012; GO:0032154; GO:0051301; GO:0071711; GO:0098631 actin cytoskeleton organization [GO:0030036]; basement membrane organization [GO:0071711]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617] adherens junction [GO:0005912]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; muscle tendon junction [GO:0005927]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; cell adhesion mediator activity [GO:0098631] g24152.t1 Q5RA37 50.595 168 6.32e-44 172.0 sp|Q5RA37|RPAP2_PONAB Putative RNA polymerase II subunit B1 CTD phosphatase RPAP2 OS=Pongo abelii OX=9601 GN=RPAP2 PE=2 SV=1 RPAP2_PONAB reviewed Putative RNA polymerase II subunit B1 CTD phosphatase RPAP2 (EC 3.1.3.16) (RNA polymerase II-associated protein 2) Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0004722; GO:0005634; GO:0005737; GO:0008270; GO:0008420; GO:0009301; GO:0036499; GO:0043175; GO:0097550 PERK-mediated unfolded protein response [GO:0036499]; snRNA transcription [GO:0009301] cytoplasm [GO:0005737]; nucleus [GO:0005634]; transcription preinitiation complex [GO:0097550] protein serine/threonine phosphatase activity [GO:0004722]; RNA polymerase core enzyme binding [GO:0043175]; RNA polymerase II CTD heptapeptide repeat phosphatase activity [GO:0008420]; zinc ion binding [GO:0008270] g24153.t1 Q07120 68.122 229 8.150000000000001e-103 315.0 sp|Q07120|GFI1_RAT Zinc finger protein Gfi-1 OS=Rattus norvegicus OX=10116 GN=Gfi1 PE=1 SV=1 g24154.t1 B3EWZ3 42.38 479 3.9499999999999996e-74 277.0 sp|B3EWZ3|CADN_ACRMI Coadhesin (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g24154.t1 B3EWZ3 43.51 416 8.33e-71 266.0 sp|B3EWZ3|CADN_ACRMI Coadhesin (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g24154.t1 B3EWZ3 45.0 360 2.98e-63 242.0 sp|B3EWZ3|CADN_ACRMI Coadhesin (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g24157.t1 A0A1D5NSM8 46.108 167 1.13e-36 151.0 sp|A0A1D5NSM8|SVEP1_DANRE Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 OS=Danio rerio OX=7955 GN=svep1 PE=1 SV=1 SVEP1_DANRE reviewed Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 (Polydom) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001945; GO:0005509; GO:0005576; GO:0005634; GO:0005737; GO:0008544; GO:0009913; GO:0016020; GO:0016477; GO:0036303; GO:0090136 cell migration [GO:0016477]; epidermal cell differentiation [GO:0009913]; epidermis development [GO:0008544]; epithelial cell-cell adhesion [GO:0090136]; lymph vessel development [GO:0001945]; lymph vessel morphogenesis [GO:0036303] cytoplasm [GO:0005737]; extracellular region [GO:0005576]; membrane [GO:0016020]; nucleus [GO:0005634] calcium ion binding [GO:0005509] g24157.t1 A0A1D5NSM8 43.836 146 4.5099999999999995e-28 124.0 sp|A0A1D5NSM8|SVEP1_DANRE Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 OS=Danio rerio OX=7955 GN=svep1 PE=1 SV=1 SVEP1_DANRE reviewed Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 (Polydom) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001945; GO:0005509; GO:0005576; GO:0005634; GO:0005737; GO:0008544; GO:0009913; GO:0016020; GO:0016477; GO:0036303; GO:0090136 cell migration [GO:0016477]; epidermal cell differentiation [GO:0009913]; epidermis development [GO:0008544]; epithelial cell-cell adhesion [GO:0090136]; lymph vessel development [GO:0001945]; lymph vessel morphogenesis [GO:0036303] cytoplasm [GO:0005737]; extracellular region [GO:0005576]; membrane [GO:0016020]; nucleus [GO:0005634] calcium ion binding [GO:0005509] g24157.t1 A0A1D5NSM8 43.066 137 1.95e-21 103.0 sp|A0A1D5NSM8|SVEP1_DANRE Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 OS=Danio rerio OX=7955 GN=svep1 PE=1 SV=1 SVEP1_DANRE reviewed Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 (Polydom) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001945; GO:0005509; GO:0005576; GO:0005634; GO:0005737; GO:0008544; GO:0009913; GO:0016020; GO:0016477; GO:0036303; GO:0090136 cell migration [GO:0016477]; epidermal cell differentiation [GO:0009913]; epidermis development [GO:0008544]; epithelial cell-cell adhesion [GO:0090136]; lymph vessel development [GO:0001945]; lymph vessel morphogenesis [GO:0036303] cytoplasm [GO:0005737]; extracellular region [GO:0005576]; membrane [GO:0016020]; nucleus [GO:0005634] calcium ion binding [GO:0005509] g24158.t1 P10079 46.279 739 0.0 585.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g24158.t1 P10079 45.742 728 0.0 579.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g24158.t1 P10079 47.112 658 4.44e-168 531.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g24159.t1 Q14517 31.222 221 8.200000000000001e-27 114.0 sp|Q14517|FAT1_HUMAN Protocadherin Fat 1 OS=Homo sapiens OX=9606 GN=FAT1 PE=1 SV=2 g24159.t2 Q14517 31.004 229 4.08e-27 115.0 sp|Q14517|FAT1_HUMAN Protocadherin Fat 1 OS=Homo sapiens OX=9606 GN=FAT1 PE=1 SV=2 g24160.t1 P06603 99.537 432 0.0 871.0 sp|P06603|TBA1_DROME Tubulin alpha-1 chain OS=Drosophila melanogaster OX=7227 GN=alphaTub84B PE=1 SV=1 TBA1_DROME reviewed Tubulin alpha-1 chain (EC 3.6.5.-) Drosophila melanogaster (Fruit fly) GO:0000226; GO:0000235; GO:0000278; GO:0005200; GO:0005525; GO:0005634; GO:0005737; GO:0005813; GO:0005819; GO:0005874; GO:0016787; GO:0032418; GO:0046872; GO:0048471 lysosome localization [GO:0032418]; microtubule cytoskeleton organization [GO:0000226]; mitotic cell cycle [GO:0000278] astral microtubule [GO:0000235]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; spindle [GO:0005819] GTP binding [GO:0005525]; hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]; structural constituent of cytoskeleton [GO:0005200] g24161.t1 Q5R4W3 66.667 120 2.2599999999999997e-54 173.0 sp|Q5R4W3|DPOE3_PONAB DNA polymerase epsilon subunit 3 OS=Pongo abelii OX=9601 GN=POLE3 PE=2 SV=1 g24163.t1 Q13905 61.598 388 1.98e-145 466.0 sp|Q13905|RPGF1_HUMAN Rap guanine nucleotide exchange factor 1 OS=Homo sapiens OX=9606 GN=RAPGEF1 PE=1 SV=3 g24164.t1 Q6P338 63.47 219 5.479999999999999e-81 244.0 sp|Q6P338|STEEP_XENTR STING ER exit protein OS=Xenopus tropicalis OX=8364 GN=steep1 PE=2 SV=1 g24166.t1 Q9NRR4 51.991 427 5.1000000000000007e-132 433.0 sp|Q9NRR4|RNC_HUMAN Ribonuclease 3 OS=Homo sapiens OX=9606 GN=DROSHA PE=1 SV=2 g24167.t1 Q9NRR4 61.923 520 0.0 677.0 sp|Q9NRR4|RNC_HUMAN Ribonuclease 3 OS=Homo sapiens OX=9606 GN=DROSHA PE=1 SV=2 g24170.t1 Q9VJJ7 37.143 455 2.05e-83 295.0 sp|Q9VJJ7|TRPG_DROME Transient receptor potential-gamma protein OS=Drosophila melanogaster OX=7227 GN=Trpgamma PE=1 SV=2 TRPG_DROME reviewed Transient receptor potential-gamma protein (TRPgamma) (Transient receptor potential cation channel gamma) Drosophila melanogaster (Fruit fly) GO:0005261; GO:0005262; GO:0005886; GO:0006812; GO:0006816; GO:0007628; GO:0008381; GO:0009416; GO:0015279; GO:0016028; GO:0033583; GO:0034703; GO:0043025; GO:0050884; GO:0050908; GO:0051480; GO:0070588; GO:0070679; GO:1990635 adult walking behavior [GO:0007628]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; detection of light stimulus involved in visual perception [GO:0050908]; monoatomic cation transport [GO:0006812]; neuromuscular process controlling posture [GO:0050884]; regulation of cytosolic calcium ion concentration [GO:0051480]; response to light stimulus [GO:0009416] cation channel complex [GO:0034703]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; proximal dendrite [GO:1990635]; rhabdomere [GO:0016028]; rhabdomere membrane [GO:0033583] calcium channel activity [GO:0005262]; inositol 1,4,5 trisphosphate binding [GO:0070679]; mechanosensitive monoatomic ion channel activity [GO:0008381]; monoatomic cation channel activity [GO:0005261]; store-operated calcium channel activity [GO:0015279] g24170.t1 Q9VJJ7 39.873 316 1.18e-46 185.0 sp|Q9VJJ7|TRPG_DROME Transient receptor potential-gamma protein OS=Drosophila melanogaster OX=7227 GN=Trpgamma PE=1 SV=2 TRPG_DROME reviewed Transient receptor potential-gamma protein (TRPgamma) (Transient receptor potential cation channel gamma) Drosophila melanogaster (Fruit fly) GO:0005261; GO:0005262; GO:0005886; GO:0006812; GO:0006816; GO:0007628; GO:0008381; GO:0009416; GO:0015279; GO:0016028; GO:0033583; GO:0034703; GO:0043025; GO:0050884; GO:0050908; GO:0051480; GO:0070588; GO:0070679; GO:1990635 adult walking behavior [GO:0007628]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; detection of light stimulus involved in visual perception [GO:0050908]; monoatomic cation transport [GO:0006812]; neuromuscular process controlling posture [GO:0050884]; regulation of cytosolic calcium ion concentration [GO:0051480]; response to light stimulus [GO:0009416] cation channel complex [GO:0034703]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; proximal dendrite [GO:1990635]; rhabdomere [GO:0016028]; rhabdomere membrane [GO:0033583] calcium channel activity [GO:0005262]; inositol 1,4,5 trisphosphate binding [GO:0070679]; mechanosensitive monoatomic ion channel activity [GO:0008381]; monoatomic cation channel activity [GO:0005261]; store-operated calcium channel activity [GO:0015279] g13533.t1 Q0P593 65.783 415 0.0 567.0 sp|Q0P593|DAW1_BOVIN Dynein assembly factor with WD repeat domains 1 OS=Bos taurus OX=9913 GN=DAW1 PE=2 SV=1 DAW1_BOVIN reviewed Dynein assembly factor with WD repeat domains 1 (Outer row dynein assembly protein 16 homolog) (WD repeat-containing protein 69) Bos taurus (Bovine) GO:0000209; GO:0005929; GO:0007368; GO:0007507; GO:0019005; GO:0036064; GO:0036158; GO:0042073; GO:1990756 determination of left/right symmetry [GO:0007368]; heart development [GO:0007507]; intraciliary transport [GO:0042073]; outer dynein arm assembly [GO:0036158]; protein polyubiquitination [GO:0000209] ciliary basal body [GO:0036064]; cilium [GO:0005929]; SCF ubiquitin ligase complex [GO:0019005] ubiquitin-like ligase-substrate adaptor activity [GO:1990756] g13534.t1 Q6PBU5 54.407 329 1.28e-135 392.0 sp|Q6PBU5|GRT1A_DANRE Growth hormone-regulated TBC protein 1-A OS=Danio rerio OX=7955 GN=grtp1a PE=2 SV=1 g13535.t1 Q5XI81 55.037 407 1.7299999999999998e-150 453.0 sp|Q5XI81|FXR1_RAT RNA-binding protein FXR1 OS=Rattus norvegicus OX=10116 GN=Fxr1 PE=1 SV=1 FXR1_RAT reviewed RNA-binding protein FXR1 (FMR1 autosomal homolog 1) Rattus norvegicus (Rat) GO:0002151; GO:0002183; GO:0003723; GO:0003729; GO:0003730; GO:0005634; GO:0005635; GO:0005737; GO:0005829; GO:0005840; GO:0007286; GO:0007517; GO:0010494; GO:0010608; GO:0017148; GO:0021542; GO:0030424; GO:0030425; GO:0032720; GO:0033592; GO:0035025; GO:0035770; GO:0035925; GO:0036464; GO:0042803; GO:0043005; GO:0043021; GO:0043034; GO:0043197; GO:0043232; GO:0043488; GO:0045182; GO:0045187; GO:0045727; GO:0046982; GO:0048170; GO:0048471; GO:0048513; GO:0050728; GO:0050767; GO:0051028; GO:0051292; GO:0051664; GO:0051966; GO:0060538; GO:0061157; GO:0098793; GO:0098794; GO:0098978; GO:0099577; GO:0140693; GO:0140694; GO:1900272; GO:1902373; GO:2000637 animal organ development [GO:0048513]; cytoplasmic translational initiation [GO:0002183]; dentate gyrus development [GO:0021542]; membraneless organelle assembly [GO:0140694]; mRNA destabilization [GO:0061157]; mRNA transport [GO:0051028]; muscle organ development [GO:0007517]; negative regulation of inflammatory response [GO:0050728]; negative regulation of long-term synaptic potentiation [GO:1900272]; negative regulation of mRNA catabolic process [GO:1902373]; negative regulation of translation [GO:0017148]; negative regulation of tumor necrosis factor production [GO:0032720]; nuclear pore complex assembly [GO:0051292]; nuclear pore localization [GO:0051664]; positive regulation of long-term neuronal synaptic plasticity [GO:0048170]; positive regulation of miRNA-mediated gene silencing [GO:2000637]; positive regulation of Rho protein signal transduction [GO:0035025]; positive regulation of translation [GO:0045727]; post-transcriptional regulation of gene expression [GO:0010608]; regulation of circadian sleep/wake cycle, sleep [GO:0045187]; regulation of mRNA stability [GO:0043488]; regulation of neurogenesis [GO:0050767]; regulation of synaptic transmission, glutamatergic [GO:0051966]; regulation of translation at presynapse, modulating synaptic transmission [GO:0099577]; skeletal muscle organ development [GO:0060538]; spermatid development [GO:0007286] axon [GO:0030424]; costamere [GO:0043034]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; intracellular membraneless organelle [GO:0043232]; neuron projection [GO:0043005]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; postsynapse [GO:0098794]; presynapse [GO:0098793]; ribonucleoprotein granule [GO:0035770]; ribosome [GO:0005840] G-quadruplex RNA binding [GO:0002151]; molecular condensate scaffold activity [GO:0140693]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; mRNA 3'-UTR binding [GO:0003730]; mRNA binding [GO:0003729]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; ribonucleoprotein complex binding [GO:0043021]; RNA binding [GO:0003723]; RNA strand annealing activity [GO:0033592]; translation regulator activity [GO:0045182] g13536.t1 P13984 45.42 262 1.37e-75 233.0 sp|P13984|T2FB_HUMAN General transcription factor IIF subunit 2 OS=Homo sapiens OX=9606 GN=GTF2F2 PE=1 SV=2 T2FB_HUMAN reviewed General transcription factor IIF subunit 2 (General transcription factor IIF 30 kDa subunit) (Transcription initiation factor IIF subunit beta) (TFIIF-beta) (Transcription initiation factor RAP30) Homo sapiens (Human) GO:0003677; GO:0005634; GO:0005654; GO:0005674; GO:0006366; GO:0006367; GO:0006368; GO:0015630; GO:0016251; GO:0045944 positive regulation of transcription by RNA polymerase II [GO:0045944]; transcription by RNA polymerase II [GO:0006366]; transcription elongation by RNA polymerase II [GO:0006368]; transcription initiation at RNA polymerase II promoter [GO:0006367] microtubule cytoskeleton [GO:0015630]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor TFIIF complex [GO:0005674] DNA binding [GO:0003677]; RNA polymerase II general transcription initiation factor activity [GO:0016251] g13538.t1 Q0VD51 49.045 314 4.07e-92 285.0 sp|Q0VD51|RNF13_BOVIN E3 ubiquitin-protein ligase RNF13 OS=Bos taurus OX=9913 GN=RNF13 PE=2 SV=1 RNF13_BOVIN reviewed E3 ubiquitin-protein ligase RNF13 (EC 2.3.2.27) (RING finger protein 13) Bos taurus (Bovine) GO:0004842; GO:0005637; GO:0005654; GO:0005737; GO:0005765; GO:0005783; GO:0005789; GO:0005829; GO:0006511; GO:0008270; GO:0008432; GO:0031902; GO:0046330; GO:0051865; GO:0061630 positive regulation of JNK cascade [GO:0046330]; protein autoubiquitination [GO:0051865]; ubiquitin-dependent protein catabolic process [GO:0006511] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; nuclear inner membrane [GO:0005637]; nucleoplasm [GO:0005654] JUN kinase binding [GO:0008432]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] g13538.t2 Q5RCV8 55.944 143 1.6099999999999998e-45 166.0 sp|Q5RCV8|RNF13_PONAB E3 ubiquitin-protein ligase RNF13 OS=Pongo abelii OX=9601 GN=RNF13 PE=2 SV=1 RNF13_PONAB reviewed E3 ubiquitin-protein ligase RNF13 (EC 2.3.2.27) (RING finger protein 13) Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0004842; GO:0005637; GO:0005654; GO:0005765; GO:0005783; GO:0005789; GO:0005829; GO:0008270; GO:0008432; GO:0031902; GO:0046330; GO:0051865; GO:0061630 positive regulation of JNK cascade [GO:0046330]; protein autoubiquitination [GO:0051865] cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; nuclear inner membrane [GO:0005637]; nucleoplasm [GO:0005654] JUN kinase binding [GO:0008432]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] g13538.t2 Q5RCV8 41.237 194 1.2400000000000001e-33 134.0 sp|Q5RCV8|RNF13_PONAB E3 ubiquitin-protein ligase RNF13 OS=Pongo abelii OX=9601 GN=RNF13 PE=2 SV=1 RNF13_PONAB reviewed E3 ubiquitin-protein ligase RNF13 (EC 2.3.2.27) (RING finger protein 13) Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0004842; GO:0005637; GO:0005654; GO:0005765; GO:0005783; GO:0005789; GO:0005829; GO:0008270; GO:0008432; GO:0031902; GO:0046330; GO:0051865; GO:0061630 positive regulation of JNK cascade [GO:0046330]; protein autoubiquitination [GO:0051865] cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; nuclear inner membrane [GO:0005637]; nucleoplasm [GO:0005654] JUN kinase binding [GO:0008432]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] g13539.t1 A0A0B4K7J2 27.65 651 2.6e-62 241.0 sp|A0A0B4K7J2|RBP2_DROME E3 SUMO-protein ligase RanBP2 OS=Drosophila melanogaster OX=7227 GN=Nup358 PE=1 SV=1 RBP2_DROME reviewed E3 SUMO-protein ligase RanBP2 (EC 2.3.2.-) (358 kDa nucleoporin) (Nuclear pore complex protein Nup358) Drosophila melanogaster (Fruit fly) GO:0005642; GO:0005643; GO:0005737; GO:0006406; GO:0006606; GO:0006607; GO:0007281; GO:0007419; GO:0008270; GO:0010628; GO:0019789; GO:0030674; GO:0035626; GO:0051292; GO:1900182 germ cell development [GO:0007281]; juvenile hormone mediated signaling pathway [GO:0035626]; mRNA export from nucleus [GO:0006406]; NLS-bearing protein import into nucleus [GO:0006607]; nuclear pore complex assembly [GO:0051292]; positive regulation of gene expression [GO:0010628]; positive regulation of protein localization to nucleus [GO:1900182]; protein import into nucleus [GO:0006606]; ventral cord development [GO:0007419] annulate lamellae [GO:0005642]; cytoplasm [GO:0005737]; nuclear pore [GO:0005643] protein-macromolecule adaptor activity [GO:0030674]; SUMO transferase activity [GO:0019789]; zinc ion binding [GO:0008270] g13539.t1 A0A0B4K7J2 46.154 143 8.139999999999999e-30 134.0 sp|A0A0B4K7J2|RBP2_DROME E3 SUMO-protein ligase RanBP2 OS=Drosophila melanogaster OX=7227 GN=Nup358 PE=1 SV=1 RBP2_DROME reviewed E3 SUMO-protein ligase RanBP2 (EC 2.3.2.-) (358 kDa nucleoporin) (Nuclear pore complex protein Nup358) Drosophila melanogaster (Fruit fly) GO:0005642; GO:0005643; GO:0005737; GO:0006406; GO:0006606; GO:0006607; GO:0007281; GO:0007419; GO:0008270; GO:0010628; GO:0019789; GO:0030674; GO:0035626; GO:0051292; GO:1900182 germ cell development [GO:0007281]; juvenile hormone mediated signaling pathway [GO:0035626]; mRNA export from nucleus [GO:0006406]; NLS-bearing protein import into nucleus [GO:0006607]; nuclear pore complex assembly [GO:0051292]; positive regulation of gene expression [GO:0010628]; positive regulation of protein localization to nucleus [GO:1900182]; protein import into nucleus [GO:0006606]; ventral cord development [GO:0007419] annulate lamellae [GO:0005642]; cytoplasm [GO:0005737]; nuclear pore [GO:0005643] protein-macromolecule adaptor activity [GO:0030674]; SUMO transferase activity [GO:0019789]; zinc ion binding [GO:0008270] g13539.t1 A0A0B4K7J2 38.217 157 2.5100000000000002e-29 132.0 sp|A0A0B4K7J2|RBP2_DROME E3 SUMO-protein ligase RanBP2 OS=Drosophila melanogaster OX=7227 GN=Nup358 PE=1 SV=1 RBP2_DROME reviewed E3 SUMO-protein ligase RanBP2 (EC 2.3.2.-) (358 kDa nucleoporin) (Nuclear pore complex protein Nup358) Drosophila melanogaster (Fruit fly) GO:0005642; GO:0005643; GO:0005737; GO:0006406; GO:0006606; GO:0006607; GO:0007281; GO:0007419; GO:0008270; GO:0010628; GO:0019789; GO:0030674; GO:0035626; GO:0051292; GO:1900182 germ cell development [GO:0007281]; juvenile hormone mediated signaling pathway [GO:0035626]; mRNA export from nucleus [GO:0006406]; NLS-bearing protein import into nucleus [GO:0006607]; nuclear pore complex assembly [GO:0051292]; positive regulation of gene expression [GO:0010628]; positive regulation of protein localization to nucleus [GO:1900182]; protein import into nucleus [GO:0006606]; ventral cord development [GO:0007419] annulate lamellae [GO:0005642]; cytoplasm [GO:0005737]; nuclear pore [GO:0005643] protein-macromolecule adaptor activity [GO:0030674]; SUMO transferase activity [GO:0019789]; zinc ion binding [GO:0008270] g13539.t1 A0A0B4K7J2 45.522 134 5.4000000000000005e-27 125.0 sp|A0A0B4K7J2|RBP2_DROME E3 SUMO-protein ligase RanBP2 OS=Drosophila melanogaster OX=7227 GN=Nup358 PE=1 SV=1 RBP2_DROME reviewed E3 SUMO-protein ligase RanBP2 (EC 2.3.2.-) (358 kDa nucleoporin) (Nuclear pore complex protein Nup358) Drosophila melanogaster (Fruit fly) GO:0005642; GO:0005643; GO:0005737; GO:0006406; GO:0006606; GO:0006607; GO:0007281; GO:0007419; GO:0008270; GO:0010628; GO:0019789; GO:0030674; GO:0035626; GO:0051292; GO:1900182 germ cell development [GO:0007281]; juvenile hormone mediated signaling pathway [GO:0035626]; mRNA export from nucleus [GO:0006406]; NLS-bearing protein import into nucleus [GO:0006607]; nuclear pore complex assembly [GO:0051292]; positive regulation of gene expression [GO:0010628]; positive regulation of protein localization to nucleus [GO:1900182]; protein import into nucleus [GO:0006606]; ventral cord development [GO:0007419] annulate lamellae [GO:0005642]; cytoplasm [GO:0005737]; nuclear pore [GO:0005643] protein-macromolecule adaptor activity [GO:0030674]; SUMO transferase activity [GO:0019789]; zinc ion binding [GO:0008270] g13539.t1 A0A0B4K7J2 40.0 155 6.95e-27 124.0 sp|A0A0B4K7J2|RBP2_DROME E3 SUMO-protein ligase RanBP2 OS=Drosophila melanogaster OX=7227 GN=Nup358 PE=1 SV=1 RBP2_DROME reviewed E3 SUMO-protein ligase RanBP2 (EC 2.3.2.-) (358 kDa nucleoporin) (Nuclear pore complex protein Nup358) Drosophila melanogaster (Fruit fly) GO:0005642; GO:0005643; GO:0005737; GO:0006406; GO:0006606; GO:0006607; GO:0007281; GO:0007419; GO:0008270; GO:0010628; GO:0019789; GO:0030674; GO:0035626; GO:0051292; GO:1900182 germ cell development [GO:0007281]; juvenile hormone mediated signaling pathway [GO:0035626]; mRNA export from nucleus [GO:0006406]; NLS-bearing protein import into nucleus [GO:0006607]; nuclear pore complex assembly [GO:0051292]; positive regulation of gene expression [GO:0010628]; positive regulation of protein localization to nucleus [GO:1900182]; protein import into nucleus [GO:0006606]; ventral cord development [GO:0007419] annulate lamellae [GO:0005642]; cytoplasm [GO:0005737]; nuclear pore [GO:0005643] protein-macromolecule adaptor activity [GO:0030674]; SUMO transferase activity [GO:0019789]; zinc ion binding [GO:0008270] g13539.t1 A0A0B4K7J2 39.394 132 1.37e-24 117.0 sp|A0A0B4K7J2|RBP2_DROME E3 SUMO-protein ligase RanBP2 OS=Drosophila melanogaster OX=7227 GN=Nup358 PE=1 SV=1 RBP2_DROME reviewed E3 SUMO-protein ligase RanBP2 (EC 2.3.2.-) (358 kDa nucleoporin) (Nuclear pore complex protein Nup358) Drosophila melanogaster (Fruit fly) GO:0005642; GO:0005643; GO:0005737; GO:0006406; GO:0006606; GO:0006607; GO:0007281; GO:0007419; GO:0008270; GO:0010628; GO:0019789; GO:0030674; GO:0035626; GO:0051292; GO:1900182 germ cell development [GO:0007281]; juvenile hormone mediated signaling pathway [GO:0035626]; mRNA export from nucleus [GO:0006406]; NLS-bearing protein import into nucleus [GO:0006607]; nuclear pore complex assembly [GO:0051292]; positive regulation of gene expression [GO:0010628]; positive regulation of protein localization to nucleus [GO:1900182]; protein import into nucleus [GO:0006606]; ventral cord development [GO:0007419] annulate lamellae [GO:0005642]; cytoplasm [GO:0005737]; nuclear pore [GO:0005643] protein-macromolecule adaptor activity [GO:0030674]; SUMO transferase activity [GO:0019789]; zinc ion binding [GO:0008270] g13539.t1 A0A0B4K7J2 35.256 156 1.87e-24 116.0 sp|A0A0B4K7J2|RBP2_DROME E3 SUMO-protein ligase RanBP2 OS=Drosophila melanogaster OX=7227 GN=Nup358 PE=1 SV=1 RBP2_DROME reviewed E3 SUMO-protein ligase RanBP2 (EC 2.3.2.-) (358 kDa nucleoporin) (Nuclear pore complex protein Nup358) Drosophila melanogaster (Fruit fly) GO:0005642; GO:0005643; GO:0005737; GO:0006406; GO:0006606; GO:0006607; GO:0007281; GO:0007419; GO:0008270; GO:0010628; GO:0019789; GO:0030674; GO:0035626; GO:0051292; GO:1900182 germ cell development [GO:0007281]; juvenile hormone mediated signaling pathway [GO:0035626]; mRNA export from nucleus [GO:0006406]; NLS-bearing protein import into nucleus [GO:0006607]; nuclear pore complex assembly [GO:0051292]; positive regulation of gene expression [GO:0010628]; positive regulation of protein localization to nucleus [GO:1900182]; protein import into nucleus [GO:0006606]; ventral cord development [GO:0007419] annulate lamellae [GO:0005642]; cytoplasm [GO:0005737]; nuclear pore [GO:0005643] protein-macromolecule adaptor activity [GO:0030674]; SUMO transferase activity [GO:0019789]; zinc ion binding [GO:0008270] g13539.t1 A0A0B4K7J2 40.876 137 2.05e-24 116.0 sp|A0A0B4K7J2|RBP2_DROME E3 SUMO-protein ligase RanBP2 OS=Drosophila melanogaster OX=7227 GN=Nup358 PE=1 SV=1 RBP2_DROME reviewed E3 SUMO-protein ligase RanBP2 (EC 2.3.2.-) (358 kDa nucleoporin) (Nuclear pore complex protein Nup358) Drosophila melanogaster (Fruit fly) GO:0005642; GO:0005643; GO:0005737; GO:0006406; GO:0006606; GO:0006607; GO:0007281; GO:0007419; GO:0008270; GO:0010628; GO:0019789; GO:0030674; GO:0035626; GO:0051292; GO:1900182 germ cell development [GO:0007281]; juvenile hormone mediated signaling pathway [GO:0035626]; mRNA export from nucleus [GO:0006406]; NLS-bearing protein import into nucleus [GO:0006607]; nuclear pore complex assembly [GO:0051292]; positive regulation of gene expression [GO:0010628]; positive regulation of protein localization to nucleus [GO:1900182]; protein import into nucleus [GO:0006606]; ventral cord development [GO:0007419] annulate lamellae [GO:0005642]; cytoplasm [GO:0005737]; nuclear pore [GO:0005643] protein-macromolecule adaptor activity [GO:0030674]; SUMO transferase activity [GO:0019789]; zinc ion binding [GO:0008270] g13539.t1 A0A0B4K7J2 42.748 131 4.26e-21 105.0 sp|A0A0B4K7J2|RBP2_DROME E3 SUMO-protein ligase RanBP2 OS=Drosophila melanogaster OX=7227 GN=Nup358 PE=1 SV=1 RBP2_DROME reviewed E3 SUMO-protein ligase RanBP2 (EC 2.3.2.-) (358 kDa nucleoporin) (Nuclear pore complex protein Nup358) Drosophila melanogaster (Fruit fly) GO:0005642; GO:0005643; GO:0005737; GO:0006406; GO:0006606; GO:0006607; GO:0007281; GO:0007419; GO:0008270; GO:0010628; GO:0019789; GO:0030674; GO:0035626; GO:0051292; GO:1900182 germ cell development [GO:0007281]; juvenile hormone mediated signaling pathway [GO:0035626]; mRNA export from nucleus [GO:0006406]; NLS-bearing protein import into nucleus [GO:0006607]; nuclear pore complex assembly [GO:0051292]; positive regulation of gene expression [GO:0010628]; positive regulation of protein localization to nucleus [GO:1900182]; protein import into nucleus [GO:0006606]; ventral cord development [GO:0007419] annulate lamellae [GO:0005642]; cytoplasm [GO:0005737]; nuclear pore [GO:0005643] protein-macromolecule adaptor activity [GO:0030674]; SUMO transferase activity [GO:0019789]; zinc ion binding [GO:0008270] g13540.t1 P49792 30.876 719 1.55e-82 294.0 sp|P49792|RBP2_HUMAN E3 SUMO-protein ligase RanBP2 OS=Homo sapiens OX=9606 GN=RANBP2 PE=1 SV=2 RBP2_HUMAN reviewed E3 SUMO-protein ligase RanBP2 (EC 2.3.2.-) (358 kDa nucleoporin) (Nuclear pore complex protein Nup358) (Nucleoporin Nup358) (Ran-binding protein 2) (RanBP2) (p270) Homo sapiens (Human) GO:0000122; GO:0001678; GO:0001975; GO:0003723; GO:0005634; GO:0005635; GO:0005642; GO:0005643; GO:0005654; GO:0005737; GO:0005829; GO:0006111; GO:0006457; GO:0006607; GO:0006913; GO:0008270; GO:0016020; GO:0016925; GO:0019209; GO:0019789; GO:0030674; GO:0031267; GO:0031965; GO:0042405; GO:0044614; GO:0044615; GO:0044877; GO:0051028; GO:0051168; GO:0051642; GO:0061665; GO:0106068; GO:1990723 centrosome localization [GO:0051642]; intracellular glucose homeostasis [GO:0001678]; mRNA transport [GO:0051028]; negative regulation of transcription by RNA polymerase II [GO:0000122]; NLS-bearing protein import into nucleus [GO:0006607]; nuclear export [GO:0051168]; nucleocytoplasmic transport [GO:0006913]; protein folding [GO:0006457]; protein sumoylation [GO:0016925]; regulation of gluconeogenesis [GO:0006111]; response to amphetamine [GO:0001975] annulate lamellae [GO:0005642]; cytoplasm [GO:0005737]; cytoplasmic periphery of the nuclear pore complex [GO:1990723]; cytosol [GO:0005829]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear inclusion body [GO:0042405]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nuclear pore cytoplasmic filaments [GO:0044614]; nuclear pore nuclear basket [GO:0044615]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SUMO ligase complex [GO:0106068] kinase activator activity [GO:0019209]; protein-containing complex binding [GO:0044877]; protein-macromolecule adaptor activity [GO:0030674]; RNA binding [GO:0003723]; small GTPase binding [GO:0031267]; SUMO ligase activity [GO:0061665]; SUMO transferase activity [GO:0019789]; zinc ion binding [GO:0008270] g13543.t1 Q8BX90 40.881 976 0.0 687.0 sp|Q8BX90|FND3A_MOUSE Fibronectin type-III domain-containing protein 3A OS=Mus musculus OX=10090 GN=Fndc3a PE=1 SV=3 FND3A_MOUSE reviewed Fibronectin type-III domain-containing protein 3A Mus musculus (Mouse) GO:0000139; GO:0001669; GO:0005737; GO:0005794; GO:0005829; GO:0007286; GO:0009566; GO:0012506; GO:0016020; GO:0031410; GO:0060009; GO:0098609 cell-cell adhesion [GO:0098609]; fertilization [GO:0009566]; Sertoli cell development [GO:0060009]; spermatid development [GO:0007286] acrosomal vesicle [GO:0001669]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; vesicle membrane [GO:0012506] g13546.t1 Q8BLN6 53.279 244 1.9999999999999997e-68 261.0 sp|Q8BLN6|UNC80_MOUSE Protein unc-80 homolog OS=Mus musculus OX=10090 GN=Unc80 PE=1 SV=3 UNC80_MOUSE reviewed Protein unc-80 homolog (mUNC-80) Mus musculus (Mouse) GO:0005261; GO:0005886; GO:0030424; GO:0030425; GO:0034703; GO:0034706; GO:0055080 monoatomic cation homeostasis [GO:0055080] axon [GO:0030424]; cation channel complex [GO:0034703]; dendrite [GO:0030425]; plasma membrane [GO:0005886]; sodium channel complex [GO:0034706] monoatomic cation channel activity [GO:0005261] g13546.t1 Q8BLN6 38.141 312 6.660000000000001e-59 230.0 sp|Q8BLN6|UNC80_MOUSE Protein unc-80 homolog OS=Mus musculus OX=10090 GN=Unc80 PE=1 SV=3 UNC80_MOUSE reviewed Protein unc-80 homolog (mUNC-80) Mus musculus (Mouse) GO:0005261; GO:0005886; GO:0030424; GO:0030425; GO:0034703; GO:0034706; GO:0055080 monoatomic cation homeostasis [GO:0055080] axon [GO:0030424]; cation channel complex [GO:0034703]; dendrite [GO:0030425]; plasma membrane [GO:0005886]; sodium channel complex [GO:0034706] monoatomic cation channel activity [GO:0005261] g13546.t1 Q8BLN6 53.623 207 1.77e-52 209.0 sp|Q8BLN6|UNC80_MOUSE Protein unc-80 homolog OS=Mus musculus OX=10090 GN=Unc80 PE=1 SV=3 UNC80_MOUSE reviewed Protein unc-80 homolog (mUNC-80) Mus musculus (Mouse) GO:0005261; GO:0005886; GO:0030424; GO:0030425; GO:0034703; GO:0034706; GO:0055080 monoatomic cation homeostasis [GO:0055080] axon [GO:0030424]; cation channel complex [GO:0034703]; dendrite [GO:0030425]; plasma membrane [GO:0005886]; sodium channel complex [GO:0034706] monoatomic cation channel activity [GO:0005261] g13546.t1 Q8BLN6 40.889 225 2.36e-42 176.0 sp|Q8BLN6|UNC80_MOUSE Protein unc-80 homolog OS=Mus musculus OX=10090 GN=Unc80 PE=1 SV=3 UNC80_MOUSE reviewed Protein unc-80 homolog (mUNC-80) Mus musculus (Mouse) GO:0005261; GO:0005886; GO:0030424; GO:0030425; GO:0034703; GO:0034706; GO:0055080 monoatomic cation homeostasis [GO:0055080] axon [GO:0030424]; cation channel complex [GO:0034703]; dendrite [GO:0030425]; plasma membrane [GO:0005886]; sodium channel complex [GO:0034706] monoatomic cation channel activity [GO:0005261] g13546.t2 Q8BLN6 36.771 446 1.72e-80 301.0 sp|Q8BLN6|UNC80_MOUSE Protein unc-80 homolog OS=Mus musculus OX=10090 GN=Unc80 PE=1 SV=3 UNC80_MOUSE reviewed Protein unc-80 homolog (mUNC-80) Mus musculus (Mouse) GO:0005261; GO:0005886; GO:0030424; GO:0030425; GO:0034703; GO:0034706; GO:0055080 monoatomic cation homeostasis [GO:0055080] axon [GO:0030424]; cation channel complex [GO:0034703]; dendrite [GO:0030425]; plasma membrane [GO:0005886]; sodium channel complex [GO:0034706] monoatomic cation channel activity [GO:0005261] g13546.t2 Q8BLN6 53.279 244 2.2099999999999998e-68 261.0 sp|Q8BLN6|UNC80_MOUSE Protein unc-80 homolog OS=Mus musculus OX=10090 GN=Unc80 PE=1 SV=3 UNC80_MOUSE reviewed Protein unc-80 homolog (mUNC-80) Mus musculus (Mouse) GO:0005261; GO:0005886; GO:0030424; GO:0030425; GO:0034703; GO:0034706; GO:0055080 monoatomic cation homeostasis [GO:0055080] axon [GO:0030424]; cation channel complex [GO:0034703]; dendrite [GO:0030425]; plasma membrane [GO:0005886]; sodium channel complex [GO:0034706] monoatomic cation channel activity [GO:0005261] g13546.t2 Q8BLN6 53.623 207 1.5299999999999999e-52 209.0 sp|Q8BLN6|UNC80_MOUSE Protein unc-80 homolog OS=Mus musculus OX=10090 GN=Unc80 PE=1 SV=3 UNC80_MOUSE reviewed Protein unc-80 homolog (mUNC-80) Mus musculus (Mouse) GO:0005261; GO:0005886; GO:0030424; GO:0030425; GO:0034703; GO:0034706; GO:0055080 monoatomic cation homeostasis [GO:0055080] axon [GO:0030424]; cation channel complex [GO:0034703]; dendrite [GO:0030425]; plasma membrane [GO:0005886]; sodium channel complex [GO:0034706] monoatomic cation channel activity [GO:0005261] g13546.t2 Q8BLN6 40.889 225 2.26e-42 176.0 sp|Q8BLN6|UNC80_MOUSE Protein unc-80 homolog OS=Mus musculus OX=10090 GN=Unc80 PE=1 SV=3 UNC80_MOUSE reviewed Protein unc-80 homolog (mUNC-80) Mus musculus (Mouse) GO:0005261; GO:0005886; GO:0030424; GO:0030425; GO:0034703; GO:0034706; GO:0055080 monoatomic cation homeostasis [GO:0055080] axon [GO:0030424]; cation channel complex [GO:0034703]; dendrite [GO:0030425]; plasma membrane [GO:0005886]; sodium channel complex [GO:0034706] monoatomic cation channel activity [GO:0005261] g13546.t3 Q8BLN6 39.551 1560 0.0 1079.0 sp|Q8BLN6|UNC80_MOUSE Protein unc-80 homolog OS=Mus musculus OX=10090 GN=Unc80 PE=1 SV=3 UNC80_MOUSE reviewed Protein unc-80 homolog (mUNC-80) Mus musculus (Mouse) GO:0005261; GO:0005886; GO:0030424; GO:0030425; GO:0034703; GO:0034706; GO:0055080 monoatomic cation homeostasis [GO:0055080] axon [GO:0030424]; cation channel complex [GO:0034703]; dendrite [GO:0030425]; plasma membrane [GO:0005886]; sodium channel complex [GO:0034706] monoatomic cation channel activity [GO:0005261] g13546.t3 Q8BLN6 53.279 244 4.86e-68 261.0 sp|Q8BLN6|UNC80_MOUSE Protein unc-80 homolog OS=Mus musculus OX=10090 GN=Unc80 PE=1 SV=3 UNC80_MOUSE reviewed Protein unc-80 homolog (mUNC-80) Mus musculus (Mouse) GO:0005261; GO:0005886; GO:0030424; GO:0030425; GO:0034703; GO:0034706; GO:0055080 monoatomic cation homeostasis [GO:0055080] axon [GO:0030424]; cation channel complex [GO:0034703]; dendrite [GO:0030425]; plasma membrane [GO:0005886]; sodium channel complex [GO:0034706] monoatomic cation channel activity [GO:0005261] g13546.t3 Q8BLN6 53.623 207 4.67e-52 209.0 sp|Q8BLN6|UNC80_MOUSE Protein unc-80 homolog OS=Mus musculus OX=10090 GN=Unc80 PE=1 SV=3 UNC80_MOUSE reviewed Protein unc-80 homolog (mUNC-80) Mus musculus (Mouse) GO:0005261; GO:0005886; GO:0030424; GO:0030425; GO:0034703; GO:0034706; GO:0055080 monoatomic cation homeostasis [GO:0055080] axon [GO:0030424]; cation channel complex [GO:0034703]; dendrite [GO:0030425]; plasma membrane [GO:0005886]; sodium channel complex [GO:0034706] monoatomic cation channel activity [GO:0005261] g13546.t3 Q8BLN6 40.889 225 8.229999999999999e-42 175.0 sp|Q8BLN6|UNC80_MOUSE Protein unc-80 homolog OS=Mus musculus OX=10090 GN=Unc80 PE=1 SV=3 UNC80_MOUSE reviewed Protein unc-80 homolog (mUNC-80) Mus musculus (Mouse) GO:0005261; GO:0005886; GO:0030424; GO:0030425; GO:0034703; GO:0034706; GO:0055080 monoatomic cation homeostasis [GO:0055080] axon [GO:0030424]; cation channel complex [GO:0034703]; dendrite [GO:0030425]; plasma membrane [GO:0005886]; sodium channel complex [GO:0034706] monoatomic cation channel activity [GO:0005261] g13546.t4 Q8BLN6 36.771 446 1.67e-80 301.0 sp|Q8BLN6|UNC80_MOUSE Protein unc-80 homolog OS=Mus musculus OX=10090 GN=Unc80 PE=1 SV=3 UNC80_MOUSE reviewed Protein unc-80 homolog (mUNC-80) Mus musculus (Mouse) GO:0005261; GO:0005886; GO:0030424; GO:0030425; GO:0034703; GO:0034706; GO:0055080 monoatomic cation homeostasis [GO:0055080] axon [GO:0030424]; cation channel complex [GO:0034703]; dendrite [GO:0030425]; plasma membrane [GO:0005886]; sodium channel complex [GO:0034706] monoatomic cation channel activity [GO:0005261] g13546.t4 Q8BLN6 53.279 244 2.25e-68 261.0 sp|Q8BLN6|UNC80_MOUSE Protein unc-80 homolog OS=Mus musculus OX=10090 GN=Unc80 PE=1 SV=3 UNC80_MOUSE reviewed Protein unc-80 homolog (mUNC-80) Mus musculus (Mouse) GO:0005261; GO:0005886; GO:0030424; GO:0030425; GO:0034703; GO:0034706; GO:0055080 monoatomic cation homeostasis [GO:0055080] axon [GO:0030424]; cation channel complex [GO:0034703]; dendrite [GO:0030425]; plasma membrane [GO:0005886]; sodium channel complex [GO:0034706] monoatomic cation channel activity [GO:0005261] g13546.t4 Q8BLN6 53.623 207 1.52e-52 209.0 sp|Q8BLN6|UNC80_MOUSE Protein unc-80 homolog OS=Mus musculus OX=10090 GN=Unc80 PE=1 SV=3 UNC80_MOUSE reviewed Protein unc-80 homolog (mUNC-80) Mus musculus (Mouse) GO:0005261; GO:0005886; GO:0030424; GO:0030425; GO:0034703; GO:0034706; GO:0055080 monoatomic cation homeostasis [GO:0055080] axon [GO:0030424]; cation channel complex [GO:0034703]; dendrite [GO:0030425]; plasma membrane [GO:0005886]; sodium channel complex [GO:0034706] monoatomic cation channel activity [GO:0005261] g13546.t4 Q8BLN6 40.889 225 2.3899999999999998e-42 176.0 sp|Q8BLN6|UNC80_MOUSE Protein unc-80 homolog OS=Mus musculus OX=10090 GN=Unc80 PE=1 SV=3 UNC80_MOUSE reviewed Protein unc-80 homolog (mUNC-80) Mus musculus (Mouse) GO:0005261; GO:0005886; GO:0030424; GO:0030425; GO:0034703; GO:0034706; GO:0055080 monoatomic cation homeostasis [GO:0055080] axon [GO:0030424]; cation channel complex [GO:0034703]; dendrite [GO:0030425]; plasma membrane [GO:0005886]; sodium channel complex [GO:0034706] monoatomic cation channel activity [GO:0005261] g13546.t5 Q8N2C7 40.536 1231 0.0 850.0 sp|Q8N2C7|UNC80_HUMAN Protein unc-80 homolog OS=Homo sapiens OX=9606 GN=UNC80 PE=1 SV=2 g13546.t6 Q8N2C7 39.199 1273 0.0 833.0 sp|Q8N2C7|UNC80_HUMAN Protein unc-80 homolog OS=Homo sapiens OX=9606 GN=UNC80 PE=1 SV=2 g13547.t1 P49585 59.871 309 7.5e-118 348.0 sp|P49585|PCY1A_HUMAN Choline-phosphate cytidylyltransferase A OS=Homo sapiens OX=9606 GN=PCYT1A PE=1 SV=2 PCY1A_HUMAN reviewed Choline-phosphate cytidylyltransferase A (EC 2.7.7.15) (CCT-alpha) (CTP:phosphocholine cytidylyltransferase A) (CCT A) (CT A) (Phosphorylcholine transferase A) Homo sapiens (Human) GO:0004105; GO:0005516; GO:0005634; GO:0005635; GO:0005783; GO:0005789; GO:0005829; GO:0006656; GO:0006657; GO:0031210; GO:0042100; GO:0042587; GO:0042802; GO:0042803; GO:0045190; GO:0140678 B cell proliferation [GO:0042100]; CDP-choline pathway [GO:0006657]; isotype switching [GO:0045190]; phosphatidylcholine biosynthetic process [GO:0006656] cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; glycogen granule [GO:0042587]; nuclear envelope [GO:0005635]; nucleus [GO:0005634] calmodulin binding [GO:0005516]; choline-phosphate cytidylyltransferase activity [GO:0004105]; identical protein binding [GO:0042802]; molecular function inhibitor activity [GO:0140678]; phosphatidylcholine binding [GO:0031210]; protein homodimerization activity [GO:0042803] g13548.t1 O42115 42.739 241 9.359999999999999e-34 132.0 sp|O42115|ARX_DANRE Aristaless-related homeobox protein OS=Danio rerio OX=7955 GN=arx PE=2 SV=1 g13549.t1 P09884 50.0 302 4.17e-85 283.0 sp|P09884|DPOLA_HUMAN DNA polymerase alpha catalytic subunit OS=Homo sapiens OX=9606 GN=POLA1 PE=1 SV=2 DPOLA_HUMAN reviewed DNA polymerase alpha catalytic subunit (EC 2.7.7.7) (DNA polymerase alpha catalytic subunit p180) Homo sapiens (Human) GO:0000166; GO:0000731; GO:0000785; GO:0003677; GO:0003682; GO:0003688; GO:0003697; GO:0003887; GO:0005634; GO:0005635; GO:0005654; GO:0005658; GO:0005730; GO:0005829; GO:0006260; GO:0006269; GO:0006270; GO:0006271; GO:0006272; GO:0006273; GO:0006281; GO:0006303; GO:0008270; GO:0016363; GO:0019901; GO:0032479; GO:1902975 DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA replication initiation [GO:0006270]; DNA replication, synthesis of primer [GO:0006269]; DNA strand elongation involved in DNA replication [GO:0006271]; DNA synthesis involved in DNA repair [GO:0000731]; double-strand break repair via nonhomologous end joining [GO:0006303]; lagging strand elongation [GO:0006273]; leading strand elongation [GO:0006272]; mitotic DNA replication initiation [GO:1902975]; regulation of type I interferon production [GO:0032479] alpha DNA polymerase:primase complex [GO:0005658]; chromatin [GO:0000785]; cytosol [GO:0005829]; nuclear envelope [GO:0005635]; nuclear matrix [GO:0016363]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA replication origin binding [GO:0003688]; DNA-directed DNA polymerase activity [GO:0003887]; nucleotide binding [GO:0000166]; protein kinase binding [GO:0019901]; single-stranded DNA binding [GO:0003697]; zinc ion binding [GO:0008270] g13550.t1 Q9DE46 64.457 709 0.0 887.0 sp|Q9DE46|DPOLA_XENLA DNA polymerase alpha catalytic subunit OS=Xenopus laevis OX=8355 GN=pola1 PE=1 SV=1 DPOLA_XENLA reviewed DNA polymerase alpha catalytic subunit (EC 2.7.7.7) (DNA polymerase alpha catalytic subunit p180) Xenopus laevis (African clawed frog) GO:0000166; GO:0000785; GO:0003677; GO:0003682; GO:0003688; GO:0003697; GO:0003887; GO:0005634; GO:0005635; GO:0005654; GO:0005658; GO:0005730; GO:0006260; GO:0006269; GO:0006270; GO:0006271; GO:0006272; GO:0006273; GO:0006303; GO:0008270; GO:0016363; GO:1902975 DNA replication [GO:0006260]; DNA replication initiation [GO:0006270]; DNA replication, synthesis of primer [GO:0006269]; DNA strand elongation involved in DNA replication [GO:0006271]; double-strand break repair via nonhomologous end joining [GO:0006303]; lagging strand elongation [GO:0006273]; leading strand elongation [GO:0006272]; mitotic DNA replication initiation [GO:1902975] alpha DNA polymerase:primase complex [GO:0005658]; chromatin [GO:0000785]; nuclear envelope [GO:0005635]; nuclear matrix [GO:0016363]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA replication origin binding [GO:0003688]; DNA-directed DNA polymerase activity [GO:0003887]; nucleotide binding [GO:0000166]; single-stranded DNA binding [GO:0003697]; zinc ion binding [GO:0008270] g13551.t1 P33609 37.288 472 2.76e-47 179.0 sp|P33609|DPOLA_MOUSE DNA polymerase alpha catalytic subunit OS=Mus musculus OX=10090 GN=Pola1 PE=1 SV=2 DPOLA_MOUSE reviewed DNA polymerase alpha catalytic subunit (EC 2.7.7.7) (DNA polymerase alpha catalytic subunit p180) Mus musculus (Mouse) GO:0000166; GO:0000731; GO:0000785; GO:0003677; GO:0003682; GO:0003688; GO:0003690; GO:0003697; GO:0003887; GO:0005634; GO:0005635; GO:0005654; GO:0005658; GO:0005730; GO:0005829; GO:0006260; GO:0006269; GO:0006270; GO:0006271; GO:0006272; GO:0006273; GO:0006281; GO:0006303; GO:0008270; GO:0016363; GO:0017076; GO:0019103; GO:0019901; GO:0032479; GO:0071897; GO:1902975 DNA biosynthetic process [GO:0071897]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA replication initiation [GO:0006270]; DNA replication, synthesis of primer [GO:0006269]; DNA strand elongation involved in DNA replication [GO:0006271]; DNA synthesis involved in DNA repair [GO:0000731]; double-strand break repair via nonhomologous end joining [GO:0006303]; lagging strand elongation [GO:0006273]; leading strand elongation [GO:0006272]; mitotic DNA replication initiation [GO:1902975]; regulation of type I interferon production [GO:0032479] alpha DNA polymerase:primase complex [GO:0005658]; chromatin [GO:0000785]; cytosol [GO:0005829]; nuclear envelope [GO:0005635]; nuclear matrix [GO:0016363]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA replication origin binding [GO:0003688]; DNA-directed DNA polymerase activity [GO:0003887]; double-stranded DNA binding [GO:0003690]; nucleotide binding [GO:0000166]; protein kinase binding [GO:0019901]; purine nucleotide binding [GO:0017076]; pyrimidine nucleotide binding [GO:0019103]; single-stranded DNA binding [GO:0003697]; zinc ion binding [GO:0008270] g13552.t1 Q9D0P0 60.87 184 3.1e-71 218.0 sp|Q9D0P0|EBPL_MOUSE Emopamil-binding protein-like OS=Mus musculus OX=10090 GN=Ebpl PE=2 SV=1 g13554.t1 P22717 54.207 618 0.0 625.0 sp|P22717|GCYB2_RAT Guanylate cyclase soluble subunit beta-2 OS=Rattus norvegicus OX=10116 GN=Gucy1b2 PE=2 SV=1 GCYB2_RAT reviewed Guanylate cyclase soluble subunit beta-2 (GCS-beta-2) (EC 4.6.1.2) Rattus norvegicus (Rat) GO:0004383; GO:0005525; GO:0005829; GO:0008074; GO:0019934; GO:0020037; GO:0046872; GO:0070026; GO:0070482 cGMP-mediated signaling [GO:0019934]; response to oxygen levels [GO:0070482] cytosol [GO:0005829]; guanylate cyclase complex, soluble [GO:0008074] GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; nitric oxide binding [GO:0070026] g13556.t1 P55205 51.709 234 8.71e-73 250.0 sp|P55205|GUC2G_RAT Guanylate cyclase 2G OS=Rattus norvegicus OX=10116 GN=Gucy2g PE=2 SV=2 g13557.t1 Q503Y7 84.375 96 1.5000000000000002e-56 176.0 sp|Q503Y7|PIN4_DANRE Peptidyl-prolyl cis-trans isomerase NIMA-interacting 4 OS=Danio rerio OX=7955 GN=pin4 PE=2 SV=1 g13558.t1 Q5R863 40.217 276 8.89e-47 166.0 sp|Q5R863|GPAM1_PONAB GPALPP motifs-containing protein 1 OS=Pongo abelii OX=9601 GN=GPALPP1 PE=2 SV=1 g13559.t1 Q5FWM8 36.693 387 4.34e-81 259.0 sp|Q5FWM8|GP180_XENLA Integral membrane protein GPR180 OS=Xenopus laevis OX=8355 GN=gpr180 PE=2 SV=1 g13564.t1 S8FIE4 37.153 288 2.44e-49 179.0 sp|S8FIE4|LAC1_FOMSC Laccase-1 OS=Fomitopsis schrenkii OX=2126942 GN=LCC1 PE=1 SV=1 g13566.t1 E7F7V7 25.466 322 4.7e-21 95.9 sp|E7F7V7|GAL2B_DANRE Galanin receptor 2b OS=Danio rerio OX=7955 GN=galr2b PE=2 SV=1 g13576.t1 Q5W041 48.718 156 8.600000000000001e-43 163.0 sp|Q5W041|ARMC3_HUMAN Armadillo repeat-containing protein 3 OS=Homo sapiens OX=9606 GN=ARMC3 PE=1 SV=2 ARMC3_HUMAN reviewed Armadillo repeat-containing protein 3 (Beta-catenin-like protein) (Cancer/testis antigen 81) (CT81) (KU-CT-1) Homo sapiens (Human) GO:0007286; GO:0030317; GO:0034517; GO:0070062 flagellated sperm motility [GO:0030317]; ribophagy [GO:0034517]; spermatid development [GO:0007286] extracellular exosome [GO:0070062] g13576.t1 Q5W041 44.792 192 2.61e-32 132.0 sp|Q5W041|ARMC3_HUMAN Armadillo repeat-containing protein 3 OS=Homo sapiens OX=9606 GN=ARMC3 PE=1 SV=2 ARMC3_HUMAN reviewed Armadillo repeat-containing protein 3 (Beta-catenin-like protein) (Cancer/testis antigen 81) (CT81) (KU-CT-1) Homo sapiens (Human) GO:0007286; GO:0030317; GO:0034517; GO:0070062 flagellated sperm motility [GO:0030317]; ribophagy [GO:0034517]; spermatid development [GO:0007286] extracellular exosome [GO:0070062] g13577.t1 Q5W041 54.522 387 3.11e-116 362.0 sp|Q5W041|ARMC3_HUMAN Armadillo repeat-containing protein 3 OS=Homo sapiens OX=9606 GN=ARMC3 PE=1 SV=2 ARMC3_HUMAN reviewed Armadillo repeat-containing protein 3 (Beta-catenin-like protein) (Cancer/testis antigen 81) (CT81) (KU-CT-1) Homo sapiens (Human) GO:0007286; GO:0030317; GO:0034517; GO:0070062 flagellated sperm motility [GO:0030317]; ribophagy [GO:0034517]; spermatid development [GO:0007286] extracellular exosome [GO:0070062] g13578.t1 Q5R885 69.923 389 0.0 582.0 sp|Q5R885|UXS1_PONAB UDP-glucuronic acid decarboxylase 1 OS=Pongo abelii OX=9601 GN=UXS1 PE=2 SV=1 UXS1_PONAB reviewed UDP-glucuronic acid decarboxylase 1 (EC 4.1.1.35) (UDP-glucuronate decarboxylase 1) (UGD) (UXS-1) Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0000139; GO:0005789; GO:0006024; GO:0032580; GO:0033320; GO:0042732; GO:0048040; GO:0070403 D-xylose metabolic process [GO:0042732]; glycosaminoglycan biosynthetic process [GO:0006024]; UDP-D-xylose biosynthetic process [GO:0033320] endoplasmic reticulum membrane [GO:0005789]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139] NAD+ binding [GO:0070403]; UDP-glucuronate decarboxylase activity [GO:0048040] g13580.t1 Q96DM1 30.612 294 1.76e-31 129.0 sp|Q96DM1|PGBD4_HUMAN PiggyBac transposable element-derived protein 4 OS=Homo sapiens OX=9606 GN=PGBD4 PE=1 SV=3 g13581.t1 G3GXG9 27.494 411 2.54e-31 134.0 sp|G3GXG9|PEX1_CRIGR Peroxisomal ATPase PEX1 OS=Cricetulus griseus OX=10029 GN=PEX1 PE=3 SV=2 g13581.t1 G3GXG9 52.174 23 2.54e-31 24.3 sp|G3GXG9|PEX1_CRIGR Peroxisomal ATPase PEX1 OS=Cricetulus griseus OX=10029 GN=PEX1 PE=3 SV=2 g13582.t1 G3GXG9 63.574 291 3.04e-97 322.0 sp|G3GXG9|PEX1_CRIGR Peroxisomal ATPase PEX1 OS=Cricetulus griseus OX=10029 GN=PEX1 PE=3 SV=2 g13583.t1 Q32LC1 31.863 204 1.19e-25 107.0 sp|Q32LC1|RPP38_BOVIN Ribonuclease P protein subunit p38 OS=Bos taurus OX=9913 GN=RPP38 PE=2 SV=2 g13584.t1 Q5HZP1 39.583 288 2.29e-61 200.0 sp|Q5HZP1|RNH2B_XENLA Ribonuclease H2 subunit B OS=Xenopus laevis OX=8355 GN=rnaseh2b PE=2 SV=1 g13588.t1 B5FXE5 41.888 339 7.46e-89 275.0 sp|B5FXE5|FSP1_TAEGU Ferroptosis suppressor protein 1 OS=Taeniopygia guttata OX=59729 GN=AIFM2 PE=2 SV=1 FSP1_TAEGU reviewed Ferroptosis suppressor protein 1 (FSP1) (EC 1.6.5.-) (Apoptosis-inducing factor homologous mitochondrion-associated inducer of death) (AMID) (p53-responsive gene 3 protein) Taeniopygia guttata (Zebra finch) (Poephila guttata) GO:0004174; GO:0005634; GO:0005811; GO:0005886; GO:0008637; GO:0016655; GO:0031966; GO:0042373; GO:0043065; GO:0050660 apoptotic mitochondrial changes [GO:0008637]; positive regulation of apoptotic process [GO:0043065]; vitamin K metabolic process [GO:0042373] lipid droplet [GO:0005811]; mitochondrial membrane [GO:0031966]; nucleus [GO:0005634]; plasma membrane [GO:0005886] electron-transferring-flavoprotein dehydrogenase activity [GO:0004174]; flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor [GO:0016655] g13589.t1 B5FXE5 39.823 339 4.51e-81 255.0 sp|B5FXE5|FSP1_TAEGU Ferroptosis suppressor protein 1 OS=Taeniopygia guttata OX=59729 GN=AIFM2 PE=2 SV=1 FSP1_TAEGU reviewed Ferroptosis suppressor protein 1 (FSP1) (EC 1.6.5.-) (Apoptosis-inducing factor homologous mitochondrion-associated inducer of death) (AMID) (p53-responsive gene 3 protein) Taeniopygia guttata (Zebra finch) (Poephila guttata) GO:0004174; GO:0005634; GO:0005811; GO:0005886; GO:0008637; GO:0016655; GO:0031966; GO:0042373; GO:0043065; GO:0050660 apoptotic mitochondrial changes [GO:0008637]; positive regulation of apoptotic process [GO:0043065]; vitamin K metabolic process [GO:0042373] lipid droplet [GO:0005811]; mitochondrial membrane [GO:0031966]; nucleus [GO:0005634]; plasma membrane [GO:0005886] electron-transferring-flavoprotein dehydrogenase activity [GO:0004174]; flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor [GO:0016655] g13590.t1 P08045 32.852 277 3.8800000000000005e-32 134.0 sp|P08045|XFIN_XENLA Zinc finger protein Xfin OS=Xenopus laevis OX=8355 PE=1 SV=1 g13590.t1 P08045 26.335 281 4.58e-21 100.0 sp|P08045|XFIN_XENLA Zinc finger protein Xfin OS=Xenopus laevis OX=8355 PE=1 SV=1 g13592.t1 Q4R877 41.386 505 7.3e-120 365.0 sp|Q4R877|S19A3_MACFA Thiamine transporter 2 OS=Macaca fascicularis OX=9541 GN=SLC19A3 PE=2 SV=1 g13593.t1 Q8C0J2 41.176 612 1.97e-147 441.0 sp|Q8C0J2|A16L1_MOUSE Autophagy-related protein 16-1 OS=Mus musculus OX=10090 GN=Atg16l1 PE=1 SV=1 A16L1_MOUSE reviewed Autophagy-related protein 16-1 (APG16-like 1) Mus musculus (Mouse) GO:0000045; GO:0000421; GO:0005737; GO:0005776; GO:0005829; GO:0005930; GO:0010508; GO:0015031; GO:0016236; GO:0016237; GO:0021766; GO:0022038; GO:0030424; GO:0034045; GO:0034274; GO:0034497; GO:0036020; GO:0039689; GO:0042802; GO:0043495; GO:0045202; GO:0051020; GO:0051607; GO:0097225; GO:0098792; GO:0098930; GO:0098978; GO:0120095; GO:0140059; GO:1903860 autophagosome assembly [GO:0000045]; axonal transport [GO:0098930]; corpus callosum development [GO:0022038]; defense response to virus [GO:0051607]; dendrite arborization [GO:0140059]; hippocampus development [GO:0021766]; macroautophagy [GO:0016236]; microautophagy [GO:0016237]; negative regulation of dendrite extension [GO:1903860]; negative stranded viral RNA replication [GO:0039689]; positive regulation of autophagy [GO:0010508]; protein localization to phagophore assembly site [GO:0034497]; protein transport [GO:0015031]; xenophagy [GO:0098792] Atg12-Atg5-Atg16 complex [GO:0034274]; autophagosome [GO:0005776]; autophagosome membrane [GO:0000421]; axon [GO:0030424]; axoneme [GO:0005930]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endolysosome membrane [GO:0036020]; glutamatergic synapse [GO:0098978]; phagophore assembly site membrane [GO:0034045]; sperm midpiece [GO:0097225]; synapse [GO:0045202]; vacuole-isolation membrane contact site [GO:0120095] GTPase binding [GO:0051020]; identical protein binding [GO:0042802]; protein-membrane adaptor activity [GO:0043495] g13594.t1 Q9H4G4 42.857 154 2.87e-31 122.0 sp|Q9H4G4|GAPR1_HUMAN Golgi-associated plant pathogenesis-related protein 1 OS=Homo sapiens OX=9606 GN=GLIPR2 PE=1 SV=3 GAPR1_HUMAN reviewed Golgi-associated plant pathogenesis-related protein 1 (GAPR-1) (Golgi-associated PR-1 protein) (Glioma pathogenesis-related protein 2) (GliPR 2) Homo sapiens (Human) GO:0000139; GO:0005615; GO:0010634; GO:0010718; GO:0042803; GO:0070062; GO:0070374 positive regulation of epithelial cell migration [GO:0010634]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of ERK1 and ERK2 cascade [GO:0070374] extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; Golgi membrane [GO:0000139] protein homodimerization activity [GO:0042803] g13594.t1 Q9H4G4 36.364 154 1.0499999999999999e-23 100.0 sp|Q9H4G4|GAPR1_HUMAN Golgi-associated plant pathogenesis-related protein 1 OS=Homo sapiens OX=9606 GN=GLIPR2 PE=1 SV=3 GAPR1_HUMAN reviewed Golgi-associated plant pathogenesis-related protein 1 (GAPR-1) (Golgi-associated PR-1 protein) (Glioma pathogenesis-related protein 2) (GliPR 2) Homo sapiens (Human) GO:0000139; GO:0005615; GO:0010634; GO:0010718; GO:0042803; GO:0070062; GO:0070374 positive regulation of epithelial cell migration [GO:0010634]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of ERK1 and ERK2 cascade [GO:0070374] extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; Golgi membrane [GO:0000139] protein homodimerization activity [GO:0042803] g13596.t1 Q4G0X4 56.757 111 1.0900000000000001e-36 128.0 sp|Q4G0X4|KCD21_HUMAN BTB/POZ domain-containing protein KCTD21 OS=Homo sapiens OX=9606 GN=KCTD21 PE=1 SV=1 KCD21_HUMAN reviewed BTB/POZ domain-containing protein KCTD21 (KCASH2 protein) (Potassium channel tetramerization domain-containing protein 21) Homo sapiens (Human) GO:0006511; GO:0016567; GO:0042802; GO:0042826; GO:0045879; GO:0051260; GO:0097602 negative regulation of smoothened signaling pathway [GO:0045879]; protein homooligomerization [GO:0051260]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511] cullin family protein binding [GO:0097602]; histone deacetylase binding [GO:0042826]; identical protein binding [GO:0042802] g13597.t1 Q6DG99 39.512 205 4.12e-35 127.0 sp|Q6DG99|KCTD6_DANRE BTB/POZ domain-containing protein KCTD6 OS=Danio rerio OX=7955 GN=kctd6 PE=2 SV=1 g13598.t1 Q3URF8 60.0 95 3.7200000000000003e-31 118.0 sp|Q3URF8|KCD21_MOUSE BTB/POZ domain-containing protein KCTD21 OS=Mus musculus OX=10090 GN=Kctd21 PE=1 SV=1 g13599.t1 Q3URF8 55.263 114 4.65e-34 125.0 sp|Q3URF8|KCD21_MOUSE BTB/POZ domain-containing protein KCTD21 OS=Mus musculus OX=10090 GN=Kctd21 PE=1 SV=1 g13600.t1 Q8NC69 66.99 103 1.4e-32 120.0 sp|Q8NC69|KCTD6_HUMAN BTB/POZ domain-containing protein KCTD6 OS=Homo sapiens OX=9606 GN=KCTD6 PE=1 SV=2 KCTD6_HUMAN reviewed BTB/POZ domain-containing protein KCTD6 (KCASH3 protein) (Potassium channel tetramerization domain-containing protein 6) Homo sapiens (Human) GO:0005829; GO:0006511; GO:0016567; GO:0030506; GO:0031430; GO:0042802; GO:0045879; GO:0051260; GO:0097602 negative regulation of smoothened signaling pathway [GO:0045879]; protein homooligomerization [GO:0051260]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511] cytosol [GO:0005829]; M band [GO:0031430] ankyrin binding [GO:0030506]; cullin family protein binding [GO:0097602]; identical protein binding [GO:0042802] g13601.t1 Q6DG99 53.535 99 5.19e-26 104.0 sp|Q6DG99|KCTD6_DANRE BTB/POZ domain-containing protein KCTD6 OS=Danio rerio OX=7955 GN=kctd6 PE=2 SV=1 g13602.t1 Q3URF8 49.007 151 1.3700000000000001e-36 132.0 sp|Q3URF8|KCD21_MOUSE BTB/POZ domain-containing protein KCTD21 OS=Mus musculus OX=10090 GN=Kctd21 PE=1 SV=1 g13603.t1 Q6DG99 62.376 101 8.520000000000001e-37 132.0 sp|Q6DG99|KCTD6_DANRE BTB/POZ domain-containing protein KCTD6 OS=Danio rerio OX=7955 GN=kctd6 PE=2 SV=1 g13604.t1 Q3URF8 54.955 111 9.43e-34 125.0 sp|Q3URF8|KCD21_MOUSE BTB/POZ domain-containing protein KCTD21 OS=Mus musculus OX=10090 GN=Kctd21 PE=1 SV=1 g13604.t1 Q3URF8 54.054 111 1.66e-33 124.0 sp|Q3URF8|KCD21_MOUSE BTB/POZ domain-containing protein KCTD21 OS=Mus musculus OX=10090 GN=Kctd21 PE=1 SV=1 g13605.t1 Q5PRC1 42.786 201 3.72e-55 176.0 sp|Q5PRC1|LHPL6_DANRE LHFPL tetraspan subfamily member 6 protein OS=Danio rerio OX=7955 GN=lhfpl6 PE=2 SV=1 g13606.t1 Q8N2R8 30.476 210 1.26e-26 109.0 sp|Q8N2R8|FA43A_HUMAN Protein FAM43A OS=Homo sapiens OX=9606 GN=FAM43A PE=1 SV=2 g13615.t1 A0JC51 49.819 552 3.31e-135 405.0 sp|A0JC51|ZIC4_XENLA Zinc finger protein ZIC 4 OS=Xenopus laevis OX=8355 GN=zic4 PE=2 SV=1 g13619.t1 P27393 46.733 704 7.130000000000001e-129 432.0 sp|P27393|CO4A2_ASCSU Collagen alpha-2(IV) chain OS=Ascaris suum OX=6253 PE=2 SV=1 g13620.t1 Q5UQ13 40.184 326 3.06e-23 110.0 sp|Q5UQ13|COLL2_MIMIV Collagen-like protein 2 OS=Acanthamoeba polyphaga mimivirus OX=212035 GN=MIMI_R196 PE=4 SV=1 g13622.t1 P27393 47.554 736 7.06e-132 431.0 sp|P27393|CO4A2_ASCSU Collagen alpha-2(IV) chain OS=Ascaris suum OX=6253 PE=2 SV=1 g13623.t1 Q5ZKU1 70.656 259 1.4399999999999998e-140 398.0 sp|Q5ZKU1|DCNL1_CHICK DCN1-like protein 1 OS=Gallus gallus OX=9031 GN=DCUN1D1 PE=2 SV=1 g13625.t1 Q8BHC7 44.828 290 1.03e-72 233.0 sp|Q8BHC7|RHBL4_MOUSE Rhomboid-related protein 4 OS=Mus musculus OX=10090 GN=Rhbdd1 PE=1 SV=1 RHBL4_MOUSE reviewed Rhomboid-related protein 4 (RRP4) (EC 3.4.21.105) (Rhomboid domain-containing protein 1) (mRHBDD1) (Rhomboid-like protein 4) Mus musculus (Mouse) GO:0004175; GO:0004252; GO:0005783; GO:0005789; GO:0006915; GO:0008233; GO:0010954; GO:0031293; GO:0031966; GO:0033619; GO:0034620; GO:0034644; GO:0036503; GO:0043066; GO:0043687; GO:0044322; GO:0045732; GO:0048515; GO:0051047; GO:1904211 apoptotic process [GO:0006915]; cellular response to unfolded protein [GO:0034620]; cellular response to UV [GO:0034644]; ERAD pathway [GO:0036503]; membrane protein intracellular domain proteolysis [GO:0031293]; membrane protein proteolysis [GO:0033619]; membrane protein proteolysis involved in retrograde protein transport, ER to cytosol [GO:1904211]; negative regulation of apoptotic process [GO:0043066]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein processing [GO:0010954]; positive regulation of secretion [GO:0051047]; post-translational protein modification [GO:0043687]; spermatid differentiation [GO:0048515] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum quality control compartment [GO:0044322]; mitochondrial membrane [GO:0031966] endopeptidase activity [GO:0004175]; peptidase activity [GO:0008233]; serine-type endopeptidase activity [GO:0004252] g13626.t1 Q6PHY8 56.818 132 9.76e-51 165.0 sp|Q6PHY8|SELTB_DANRE Thioredoxin reductase-like selenoprotein T1b OS=Danio rerio OX=7955 GN=selenot1b PE=2 SV=3 g13629.t1 O15440 54.409 601 0.0 647.0 sp|O15440|MRP5_HUMAN ATP-binding cassette sub-family C member 5 OS=Homo sapiens OX=9606 GN=ABCC5 PE=1 SV=2 MRP5_HUMAN reviewed ATP-binding cassette sub-family C member 5 (EC 7.6.2.-) (EC 7.6.2.2) (Multi-specific organic anion transporter C) (MOAT-C) (Multidrug resistance-associated protein 5) (SMRP) (pABC11) Homo sapiens (Human) GO:0005524; GO:0005796; GO:0005886; GO:0006805; GO:0006855; GO:0008514; GO:0008559; GO:0010008; GO:0015216; GO:0015232; GO:0015562; GO:0015865; GO:0016020; GO:0016323; GO:0016324; GO:0016887; GO:0022884; GO:0030213; GO:0034634; GO:0034775; GO:0035351; GO:0042626; GO:0042908; GO:0042910; GO:0043225; GO:0055085; GO:0070730; GO:0070731; GO:0098838; GO:0140115; GO:0140359; GO:0150104; GO:1901264; GO:1901505; GO:1990961 cAMP transport [GO:0070730]; carbohydrate derivative transport [GO:1901264]; cGMP transport [GO:0070731]; export across plasma membrane [GO:0140115]; folate transmembrane transport [GO:0098838]; glutathione transmembrane transport [GO:0034775]; heme transmembrane transport [GO:0035351]; hyaluronan biosynthetic process [GO:0030213]; purine nucleotide transport [GO:0015865]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104]; xenobiotic detoxification by transmembrane export across the plasma membrane [GO:1990961]; xenobiotic metabolic process [GO:0006805]; xenobiotic transmembrane transport [GO:0006855]; xenobiotic transport [GO:0042908] apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; endosome membrane [GO:0010008]; Golgi lumen [GO:0005796]; membrane [GO:0016020]; plasma membrane [GO:0005886] ABC-type transporter activity [GO:0140359]; ABC-type xenobiotic transporter activity [GO:0008559]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled inorganic anion transmembrane transporter activity [GO:0043225]; ATPase-coupled transmembrane transporter activity [GO:0042626]; carbohydrate derivative transmembrane transporter activity [GO:1901505]; efflux transmembrane transporter activity [GO:0015562]; glutathione transmembrane transporter activity [GO:0034634]; heme transmembrane transporter activity [GO:0015232]; macromolecule transmembrane transporter activity [GO:0022884]; organic anion transmembrane transporter activity [GO:0008514]; purine nucleotide transmembrane transporter activity [GO:0015216]; xenobiotic transmembrane transporter activity [GO:0042910] g13629.t1 O15440 40.346 694 5.42e-142 477.0 sp|O15440|MRP5_HUMAN ATP-binding cassette sub-family C member 5 OS=Homo sapiens OX=9606 GN=ABCC5 PE=1 SV=2 MRP5_HUMAN reviewed ATP-binding cassette sub-family C member 5 (EC 7.6.2.-) (EC 7.6.2.2) (Multi-specific organic anion transporter C) (MOAT-C) (Multidrug resistance-associated protein 5) (SMRP) (pABC11) Homo sapiens (Human) GO:0005524; GO:0005796; GO:0005886; GO:0006805; GO:0006855; GO:0008514; GO:0008559; GO:0010008; GO:0015216; GO:0015232; GO:0015562; GO:0015865; GO:0016020; GO:0016323; GO:0016324; GO:0016887; GO:0022884; GO:0030213; GO:0034634; GO:0034775; GO:0035351; GO:0042626; GO:0042908; GO:0042910; GO:0043225; GO:0055085; GO:0070730; GO:0070731; GO:0098838; GO:0140115; GO:0140359; GO:0150104; GO:1901264; GO:1901505; GO:1990961 cAMP transport [GO:0070730]; carbohydrate derivative transport [GO:1901264]; cGMP transport [GO:0070731]; export across plasma membrane [GO:0140115]; folate transmembrane transport [GO:0098838]; glutathione transmembrane transport [GO:0034775]; heme transmembrane transport [GO:0035351]; hyaluronan biosynthetic process [GO:0030213]; purine nucleotide transport [GO:0015865]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104]; xenobiotic detoxification by transmembrane export across the plasma membrane [GO:1990961]; xenobiotic metabolic process [GO:0006805]; xenobiotic transmembrane transport [GO:0006855]; xenobiotic transport [GO:0042908] apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; endosome membrane [GO:0010008]; Golgi lumen [GO:0005796]; membrane [GO:0016020]; plasma membrane [GO:0005886] ABC-type transporter activity [GO:0140359]; ABC-type xenobiotic transporter activity [GO:0008559]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled inorganic anion transmembrane transporter activity [GO:0043225]; ATPase-coupled transmembrane transporter activity [GO:0042626]; carbohydrate derivative transmembrane transporter activity [GO:1901505]; efflux transmembrane transporter activity [GO:0015562]; glutathione transmembrane transporter activity [GO:0034634]; heme transmembrane transporter activity [GO:0015232]; macromolecule transmembrane transporter activity [GO:0022884]; organic anion transmembrane transporter activity [GO:0008514]; purine nucleotide transmembrane transporter activity [GO:0015216]; xenobiotic transmembrane transporter activity [GO:0042910] g13635.t1 A0A0B6VQ48 36.396 283 9.8e-39 148.0 sp|A0A0B6VQ48|PAR1_ROSHC Phenylacetaldehyde reductase OS=Rosa hybrid cultivar OX=128735 GN=PAR PE=1 SV=1 g13640.t1 Q86YW9 54.604 619 0.0 598.0 sp|Q86YW9|MD12L_HUMAN Mediator of RNA polymerase II transcription subunit 12-like protein OS=Homo sapiens OX=9606 GN=MED12L PE=1 SV=2 MD12L_HUMAN reviewed Mediator of RNA polymerase II transcription subunit 12-like protein (Mediator complex subunit 12-like protein) (Thyroid hormone receptor-associated-like protein) (Trinucleotide repeat-containing gene 11 protein-like) Homo sapiens (Human) GO:0003713; GO:0008013; GO:0016592; GO:0045944 positive regulation of transcription by RNA polymerase II [GO:0045944] mediator complex [GO:0016592] beta-catenin binding [GO:0008013]; transcription coactivator activity [GO:0003713] g13640.t2 Q86YW9 54.604 619 0.0 599.0 sp|Q86YW9|MD12L_HUMAN Mediator of RNA polymerase II transcription subunit 12-like protein OS=Homo sapiens OX=9606 GN=MED12L PE=1 SV=2 MD12L_HUMAN reviewed Mediator of RNA polymerase II transcription subunit 12-like protein (Mediator complex subunit 12-like protein) (Thyroid hormone receptor-associated-like protein) (Trinucleotide repeat-containing gene 11 protein-like) Homo sapiens (Human) GO:0003713; GO:0008013; GO:0016592; GO:0045944 positive regulation of transcription by RNA polymerase II [GO:0045944] mediator complex [GO:0016592] beta-catenin binding [GO:0008013]; transcription coactivator activity [GO:0003713] g13642.t1 Q2QCI8 48.559 1180 0.0 1018.0 sp|Q2QCI8|MED12_DANRE Mediator of RNA polymerase II transcription subunit 12 OS=Danio rerio OX=7955 GN=med12 PE=2 SV=1 MED12_DANRE reviewed Mediator of RNA polymerase II transcription subunit 12 (Mediator complex subunit 12) (Protein kohtalo) (Protein motionless) (Thyroid hormone receptor-associated protein complex 230 kDa component) (Trap230) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001822; GO:0002761; GO:0003700; GO:0003713; GO:0007492; GO:0007507; GO:0008013; GO:0014032; GO:0016592; GO:0021591; GO:0021654; GO:0021954; GO:0021982; GO:0021986; GO:0030182; GO:0030900; GO:0030901; GO:0035118; GO:0043583; GO:0045893; GO:0045944; GO:0048702; GO:0048703; GO:0050935; GO:0140585; GO:0140587 central nervous system neuron development [GO:0021954]; ear development [GO:0043583]; embryonic neurocranium morphogenesis [GO:0048702]; embryonic pectoral fin morphogenesis [GO:0035118]; embryonic viscerocranium morphogenesis [GO:0048703]; endoderm development [GO:0007492]; forebrain development [GO:0030900]; habenula development [GO:0021986]; heart development [GO:0007507]; iridophore differentiation [GO:0050935]; kidney development [GO:0001822]; midbrain development [GO:0030901]; neural crest cell development [GO:0014032]; neuron differentiation [GO:0030182]; pineal gland development [GO:0021982]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of myeloid leukocyte differentiation [GO:0002761]; rhombomere boundary formation [GO:0021654]; ventricular system development [GO:0021591] mediator complex [GO:0016592] beta-catenin binding [GO:0008013]; chromatin loop anchoring activity [GO:0140587]; DNA-binding transcription factor activity [GO:0003700]; promoter-enhancer loop anchoring activity [GO:0140585]; transcription coactivator activity [GO:0003713] g13643.t1 Q90YI3 56.075 535 0.0 621.0 sp|Q90YI3|SYMM_TAKRU Methionine--tRNA ligase, mitochondrial OS=Takifugu rubripes OX=31033 GN=mars2 PE=3 SV=1 g13644.t1 P62783 100.0 82 2.27e-53 165.0 sp|P62783|H4_STRPU Histone H4 OS=Strongylocentrotus purpuratus OX=7668 PE=3 SV=2 g13645.t1 P69079 100.0 136 1.54e-95 274.0 sp|P69079|H3_STRDR Histone H3, embryonic OS=Strongylocentrotus droebachiensis OX=7671 PE=2 SV=2 g13646.t1 B2RPY5 43.017 179 6.68e-46 162.0 sp|B2RPY5|GP161_MOUSE G-protein coupled receptor 161 OS=Mus musculus OX=10090 GN=Gpr161 PE=1 SV=1 GP161_MOUSE reviewed G-protein coupled receptor 161 Mus musculus (Mouse) GO:0004930; GO:0005929; GO:0007186; GO:0007189; GO:0055037; GO:0060170; GO:1901621 adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning [GO:1901621] ciliary membrane [GO:0060170]; cilium [GO:0005929]; recycling endosome [GO:0055037] G protein-coupled receptor activity [GO:0004930] g13647.t1 P02269 100.0 95 8.930000000000001e-64 193.0 sp|P02269|H2A_ASTRU Histone H2A OS=Asterias rubens OX=7604 PE=1 SV=2 g13648.t1 P02286 100.0 91 7.17e-62 188.0 sp|P02286|H2B_ASTRU Histone H2B, gonadal OS=Asterias rubens OX=7604 PE=1 SV=2 g13650.t1 P02286 100.0 91 7.17e-62 188.0 sp|P02286|H2B_ASTRU Histone H2B, gonadal OS=Asterias rubens OX=7604 PE=1 SV=2 g13651.t1 P02269 100.0 95 8.930000000000001e-64 193.0 sp|P02269|H2A_ASTRU Histone H2A OS=Asterias rubens OX=7604 PE=1 SV=2 g13653.t1 Q33E94 38.499 413 3.26e-87 295.0 sp|Q33E94|RFX4_HUMAN Transcription factor RFX4 OS=Homo sapiens OX=9606 GN=RFX4 PE=1 SV=2 RFX4_HUMAN reviewed Transcription factor RFX4 (Regulatory factor X 4) (Testis development protein NYD-SP10) Homo sapiens (Human) GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0005634; GO:0006357; GO:0021513; GO:0021537; GO:0045879; GO:0045944; GO:0060271; GO:0070613; GO:1990837 cilium assembly [GO:0060271]; negative regulation of smoothened signaling pathway [GO:0045879]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of protein processing [GO:0070613]; regulation of transcription by RNA polymerase II [GO:0006357]; spinal cord dorsal/ventral patterning [GO:0021513]; telencephalon development [GO:0021537] chromatin [GO:0000785]; nucleus [GO:0005634] DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837] g13654.t1 Q27312 33.077 260 2.2299999999999998e-45 159.0 sp|Q27312|NADA_APLKU ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase OS=Aplysia kurodai OX=6501 PE=1 SV=1 NADA_APLKU reviewed ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase (EC 3.2.2.-) (EC 3.2.2.6) (2'-phospho-ADP-ribosyl cyclase) (2'-phospho-ADP-ribosyl cyclase/2'-phospho-cyclic-ADP-ribose transferase) (EC 2.4.99.20) (2'-phospho-cyclic-ADP-ribose transferase) (ADP-ribosyl cyclase) (ADPRC) (ADRC) (NAD glycohydrolase) (NAD(+) nucleosidase) (NADase) Aplysia kurodai (Kuroda's sea hare) GO:0005886; GO:0007338; GO:0016740; GO:0016849; GO:0031410; GO:0061809 single fertilization [GO:0007338] cytoplasmic vesicle [GO:0031410]; plasma membrane [GO:0005886] NAD+ nucleosidase activity, cyclic ADP-ribose generating [GO:0061809]; phosphorus-oxygen lyase activity [GO:0016849]; transferase activity [GO:0016740] g13655.t1 Q08BL9 35.563 568 5.0799999999999996e-95 313.0 sp|Q08BL9|KL24A_DANRE Kelch-like protein 24a OS=Danio rerio OX=7955 GN=klhl24a PE=2 SV=1 KL24A_DANRE reviewed Kelch-like protein 24a (Kelch-like family member 24a) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005737; GO:0005912; GO:0007507; GO:0030057; GO:0030424; GO:0031463; GO:0043161; GO:0043204; GO:1990756 heart development [GO:0007507]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161] adherens junction [GO:0005912]; axon [GO:0030424]; Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; desmosome [GO:0030057]; perikaryon [GO:0043204] ubiquitin-like ligase-substrate adaptor activity [GO:1990756] g13658.t1 Q96JB2 51.079 834 0.0 767.0 sp|Q96JB2|COG3_HUMAN Conserved oligomeric Golgi complex subunit 3 OS=Homo sapiens OX=9606 GN=COG3 PE=1 SV=3 g13659.t1 Q5XJY4 48.901 364 8.05e-111 331.0 sp|Q5XJY4|PARL_MOUSE Presenilin-associated rhomboid-like protein, mitochondrial OS=Mus musculus OX=10090 GN=Parl PE=1 SV=1 PARL_MOUSE reviewed Presenilin-associated rhomboid-like protein, mitochondrial (EC 3.4.21.105) (Mitochondrial intramembrane-cleaving protease PARL) [Cleaved into: P-beta (Pbeta)] Mus musculus (Mouse) GO:0004175; GO:0004252; GO:0005634; GO:0005739; GO:0005743; GO:0006465; GO:0006508; GO:0008053; GO:0010821; GO:0016485; GO:0030162; GO:0033619; GO:0090201; GO:1901524; GO:1903214; GO:2000377; GO:2001243 membrane protein proteolysis [GO:0033619]; mitochondrial fusion [GO:0008053]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; protein processing [GO:0016485]; proteolysis [GO:0006508]; regulation of mitochondrion organization [GO:0010821]; regulation of mitophagy [GO:1901524]; regulation of protein targeting to mitochondrion [GO:1903214]; regulation of proteolysis [GO:0030162]; regulation of reactive oxygen species metabolic process [GO:2000377]; signal peptide processing [GO:0006465] mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nucleus [GO:0005634] endopeptidase activity [GO:0004175]; serine-type endopeptidase activity [GO:0004252] g13660.t1 O35594 62.609 115 7.56e-40 140.0 sp|O35594|IFT81_MOUSE Intraflagellar transport protein 81 homolog OS=Mus musculus OX=10090 GN=Ift81 PE=1 SV=4 IFT81_MOUSE reviewed Intraflagellar transport protein 81 homolog (Carnitine deficiency-associated protein expressed in ventricle 1) (CDV-1) Mus musculus (Mouse) GO:0005737; GO:0005813; GO:0005814; GO:0005929; GO:0007283; GO:0008589; GO:0015631; GO:0030992; GO:0035720; GO:0035735; GO:0036064; GO:0042073; GO:0060271; GO:0097225; GO:0097228; GO:0120316 cilium assembly [GO:0060271]; intraciliary anterograde transport [GO:0035720]; intraciliary transport [GO:0042073]; intraciliary transport involved in cilium assembly [GO:0035735]; regulation of smoothened signaling pathway [GO:0008589]; sperm flagellum assembly [GO:0120316]; spermatogenesis [GO:0007283] centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; intraciliary transport particle B [GO:0030992]; sperm midpiece [GO:0097225]; sperm principal piece [GO:0097228] tubulin binding [GO:0015631] g13660.t1 O35594 68.966 29 7.56e-40 43.1 sp|O35594|IFT81_MOUSE Intraflagellar transport protein 81 homolog OS=Mus musculus OX=10090 GN=Ift81 PE=1 SV=4 IFT81_MOUSE reviewed Intraflagellar transport protein 81 homolog (Carnitine deficiency-associated protein expressed in ventricle 1) (CDV-1) Mus musculus (Mouse) GO:0005737; GO:0005813; GO:0005814; GO:0005929; GO:0007283; GO:0008589; GO:0015631; GO:0030992; GO:0035720; GO:0035735; GO:0036064; GO:0042073; GO:0060271; GO:0097225; GO:0097228; GO:0120316 cilium assembly [GO:0060271]; intraciliary anterograde transport [GO:0035720]; intraciliary transport [GO:0042073]; intraciliary transport involved in cilium assembly [GO:0035735]; regulation of smoothened signaling pathway [GO:0008589]; sperm flagellum assembly [GO:0120316]; spermatogenesis [GO:0007283] centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; intraciliary transport particle B [GO:0030992]; sperm midpiece [GO:0097225]; sperm principal piece [GO:0097228] tubulin binding [GO:0015631] g13661.t1 P83829 60.381 472 0.0 559.0 sp|P83829|IFT81_RAT Intraflagellar transport protein 81 homolog OS=Rattus norvegicus OX=10116 GN=Ift81 PE=2 SV=1 IFT81_RAT reviewed Intraflagellar transport protein 81 homolog (Carnitine deficiency-associated protein expressed in ventricle 1) (CDV-1) Rattus norvegicus (Rat) GO:0005737; GO:0005813; GO:0005814; GO:0005929; GO:0007283; GO:0008589; GO:0015631; GO:0030992; GO:0035735; GO:0036064; GO:0042073; GO:0060271; GO:0097225; GO:0097228; GO:0120316 cilium assembly [GO:0060271]; intraciliary transport [GO:0042073]; intraciliary transport involved in cilium assembly [GO:0035735]; regulation of smoothened signaling pathway [GO:0008589]; sperm flagellum assembly [GO:0120316]; spermatogenesis [GO:0007283] centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; intraciliary transport particle B [GO:0030992]; sperm midpiece [GO:0097225]; sperm principal piece [GO:0097228] tubulin binding [GO:0015631] g13666.t1 Q3UHB1 47.251 491 3.57e-164 479.0 sp|Q3UHB1|NT5D3_MOUSE 5'-nucleotidase domain-containing protein 3 OS=Mus musculus OX=10090 GN=Nt5dc3 PE=1 SV=1 g13667.t1 B0R0T1 58.094 1878 0.0 2079.0 sp|B0R0T1|VWA8_DANRE von Willebrand factor A domain-containing protein 8 OS=Danio rerio OX=7955 GN=vwa8 PE=3 SV=1 VWA8_DANRE reviewed von Willebrand factor A domain-containing protein 8 Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005524; GO:0005737; GO:0005739; GO:0016887; GO:0030903 notochord development [GO:0030903] cytoplasm [GO:0005737]; mitochondrion [GO:0005739] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887] g13681.t1 Q9JLA3 53.119 1491 0.0 1501.0 sp|Q9JLA3|UGGG1_RAT UDP-glucose:glycoprotein glucosyltransferase 1 OS=Rattus norvegicus OX=10116 GN=Uggt1 PE=1 SV=2 UGGG1_RAT reviewed UDP-glucose:glycoprotein glucosyltransferase 1 (UGT1) (rUGT1) (EC 2.4.1.-) (UDP--Glc:glycoprotein glucosyltransferase) (UDP-glucose ceramide glucosyltransferase-like 1) Rattus norvegicus (Rat) GO:0003980; GO:0005783; GO:0005788; GO:0005793; GO:0006457; GO:0009306; GO:0018279; GO:0032991; GO:0051082; GO:0051084 'de novo' post-translational protein folding [GO:0051084]; protein folding [GO:0006457]; protein N-linked glycosylation via asparagine [GO:0018279]; protein secretion [GO:0009306] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; protein-containing complex [GO:0032991] UDP-glucose:glycoprotein glucosyltransferase activity [GO:0003980]; unfolded protein binding [GO:0051082] g13681.t2 Q9JLA3 53.146 1494 0.0 1492.0 sp|Q9JLA3|UGGG1_RAT UDP-glucose:glycoprotein glucosyltransferase 1 OS=Rattus norvegicus OX=10116 GN=Uggt1 PE=1 SV=2 UGGG1_RAT reviewed UDP-glucose:glycoprotein glucosyltransferase 1 (UGT1) (rUGT1) (EC 2.4.1.-) (UDP--Glc:glycoprotein glucosyltransferase) (UDP-glucose ceramide glucosyltransferase-like 1) Rattus norvegicus (Rat) GO:0003980; GO:0005783; GO:0005788; GO:0005793; GO:0006457; GO:0009306; GO:0018279; GO:0032991; GO:0051082; GO:0051084 'de novo' post-translational protein folding [GO:0051084]; protein folding [GO:0006457]; protein N-linked glycosylation via asparagine [GO:0018279]; protein secretion [GO:0009306] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; protein-containing complex [GO:0032991] UDP-glucose:glycoprotein glucosyltransferase activity [GO:0003980]; unfolded protein binding [GO:0051082] g13686.t1 Q96T23 59.0 100 1.9500000000000002e-26 121.0 sp|Q96T23|RSF1_HUMAN Remodeling and spacing factor 1 OS=Homo sapiens OX=9606 GN=RSF1 PE=1 SV=2 RSF1_HUMAN reviewed Remodeling and spacing factor 1 (Rsf-1) (HBV pX-associated protein 8) (Hepatitis B virus X-associated protein) (p325 subunit of RSF chromatin-remodeling complex) Homo sapiens (Human) GO:0005634; GO:0005654; GO:0006325; GO:0006334; GO:0006338; GO:0006352; GO:0006355; GO:0008270; GO:0031213; GO:0042393; GO:0043392; GO:0045892; GO:0045893; GO:0050434; GO:0140751 chromatin organization [GO:0006325]; chromatin remodeling [GO:0006338]; DNA-templated transcription initiation [GO:0006352]; negative regulation of DNA binding [GO:0043392]; negative regulation of DNA-templated transcription [GO:0045892]; nucleosome assembly [GO:0006334]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of viral transcription [GO:0050434]; regulation of DNA-templated transcription [GO:0006355] nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RSF complex [GO:0031213] histone binding [GO:0042393]; histone octamer slider activity [GO:0140751]; zinc ion binding [GO:0008270] g13687.t1 Q96T23 45.078 193 4.38e-46 166.0 sp|Q96T23|RSF1_HUMAN Remodeling and spacing factor 1 OS=Homo sapiens OX=9606 GN=RSF1 PE=1 SV=2 RSF1_HUMAN reviewed Remodeling and spacing factor 1 (Rsf-1) (HBV pX-associated protein 8) (Hepatitis B virus X-associated protein) (p325 subunit of RSF chromatin-remodeling complex) Homo sapiens (Human) GO:0005634; GO:0005654; GO:0006325; GO:0006334; GO:0006338; GO:0006352; GO:0006355; GO:0008270; GO:0031213; GO:0042393; GO:0043392; GO:0045892; GO:0045893; GO:0050434; GO:0140751 chromatin organization [GO:0006325]; chromatin remodeling [GO:0006338]; DNA-templated transcription initiation [GO:0006352]; negative regulation of DNA binding [GO:0043392]; negative regulation of DNA-templated transcription [GO:0045892]; nucleosome assembly [GO:0006334]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of viral transcription [GO:0050434]; regulation of DNA-templated transcription [GO:0006355] nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RSF complex [GO:0031213] histone binding [GO:0042393]; histone octamer slider activity [GO:0140751]; zinc ion binding [GO:0008270] g13688.t1 Q9R0Q9 47.154 246 3.3699999999999997e-82 249.0 sp|Q9R0Q9|MPU1_MOUSE Mannose-P-dolichol utilization defect 1 protein OS=Mus musculus OX=10090 GN=Mpdu1 PE=1 SV=1 g13689.t1 O46043 33.333 324 6.73e-38 157.0 sp|O46043|PARG_DROME Poly(ADP-ribose) glycohydrolase OS=Drosophila melanogaster OX=7227 GN=Parg PE=1 SV=3 g13691.t1 Q8BH01 51.608 684 0.0 607.0 sp|Q8BH01|TMCO3_MOUSE Transmembrane and coiled-coil domain-containing protein 3 OS=Mus musculus OX=10090 GN=Tmco3 PE=2 SV=1 g13692.t1 Q5JVF3 66.834 398 0.0 557.0 sp|Q5JVF3|PCID2_HUMAN PCI domain-containing protein 2 OS=Homo sapiens OX=9606 GN=PCID2 PE=1 SV=2 PCID2_HUMAN reviewed PCI domain-containing protein 2 (CSN12-like protein) Homo sapiens (Human) GO:0000973; GO:0003690; GO:0003723; GO:0005634; GO:0005737; GO:0006368; GO:0015031; GO:0016973; GO:0044615; GO:0045579; GO:0045814; GO:0048536; GO:0070390; GO:1905457 negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of lymphoid progenitor cell differentiation [GO:1905457]; poly(A)+ mRNA export from nucleus [GO:0016973]; positive regulation of B cell differentiation [GO:0045579]; post-transcriptional tethering of RNA polymerase II gene DNA at nuclear periphery [GO:0000973]; protein transport [GO:0015031]; spleen development [GO:0048536]; transcription elongation by RNA polymerase II [GO:0006368] cytoplasm [GO:0005737]; nuclear pore nuclear basket [GO:0044615]; nucleus [GO:0005634]; transcription export complex 2 [GO:0070390] double-stranded DNA binding [GO:0003690]; RNA binding [GO:0003723] g13693.t1 Q2T9X3 59.694 196 9.539999999999999e-81 241.0 sp|Q2T9X3|SPRY7_BOVIN SPRY domain-containing protein 7 OS=Bos taurus OX=9913 GN=SPRYD7 PE=2 SV=1 g13694.t1 Q2KIU2 48.592 142 4.8399999999999995e-42 141.0 sp|Q2KIU2|PMVK_BOVIN Phosphomevalonate kinase OS=Bos taurus OX=9913 GN=PMVK PE=2 SV=3 g13695.t1 O57460 34.815 540 8.07e-86 295.0 sp|O57460|TLL1_DANRE Dorsal-ventral patterning tolloid-like protein 1 OS=Danio rerio OX=7955 GN=tll1 PE=2 SV=1 TLL1_DANRE reviewed Dorsal-ventral patterning tolloid-like protein 1 (EC 3.4.24.-) (Mini fin protein) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001568; GO:0001707; GO:0001885; GO:0004222; GO:0005509; GO:0005576; GO:0005615; GO:0006508; GO:0008233; GO:0008237; GO:0008270; GO:0009953; GO:0016485; GO:0030513; GO:0035124; GO:0035162; GO:0036342; GO:0048264 blood vessel development [GO:0001568]; determination of ventral identity [GO:0048264]; dorsal/ventral pattern formation [GO:0009953]; embryonic caudal fin morphogenesis [GO:0035124]; embryonic hemopoiesis [GO:0035162]; endothelial cell development [GO:0001885]; mesoderm formation [GO:0001707]; positive regulation of BMP signaling pathway [GO:0030513]; post-anal tail morphogenesis [GO:0036342]; protein processing [GO:0016485]; proteolysis [GO:0006508] extracellular region [GO:0005576]; extracellular space [GO:0005615] calcium ion binding [GO:0005509]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; peptidase activity [GO:0008233]; zinc ion binding [GO:0008270] g13699.t1 O57382 29.503 322 3.7499999999999998e-34 134.0 sp|O57382|TLL2_XENLA Tolloid-like protein 2 OS=Xenopus laevis OX=8355 GN=tll2 PE=2 SV=1 g13699.t1 O57382 32.423 293 4.1499999999999996e-30 123.0 sp|O57382|TLL2_XENLA Tolloid-like protein 2 OS=Xenopus laevis OX=8355 GN=tll2 PE=2 SV=1 g13699.t1 O57382 29.596 223 8.399999999999999e-23 101.0 sp|O57382|TLL2_XENLA Tolloid-like protein 2 OS=Xenopus laevis OX=8355 GN=tll2 PE=2 SV=1 g13700.t1 Q05C16 45.49 255 9.22e-53 194.0 sp|Q05C16|LRC63_HUMAN Leucine-rich repeat-containing protein 63 OS=Homo sapiens OX=9606 GN=LRRC63 PE=1 SV=3 g13702.t1 Q7M370 37.569 181 5.86e-29 115.0 sp|Q7M370|AAAD_RABIT Arylacetamide deacetylase OS=Oryctolagus cuniculus OX=9986 GN=AADAC PE=1 SV=1 AAAD_RABIT reviewed Arylacetamide deacetylase (EC 3.1.1.3) (50 kDa microsomal esterase/N-deacetylase) Oryctolagus cuniculus (Rabbit) GO:0004806; GO:0005789; GO:0006629; GO:0019213 lipid metabolic process [GO:0006629] endoplasmic reticulum membrane [GO:0005789] deacetylase activity [GO:0019213]; triacylglycerol lipase activity [GO:0004806] g13703.t1 Q7M370 33.174 419 3.15e-53 186.0 sp|Q7M370|AAAD_RABIT Arylacetamide deacetylase OS=Oryctolagus cuniculus OX=9986 GN=AADAC PE=1 SV=1 AAAD_RABIT reviewed Arylacetamide deacetylase (EC 3.1.1.3) (50 kDa microsomal esterase/N-deacetylase) Oryctolagus cuniculus (Rabbit) GO:0004806; GO:0005789; GO:0006629; GO:0019213 lipid metabolic process [GO:0006629] endoplasmic reticulum membrane [GO:0005789] deacetylase activity [GO:0019213]; triacylglycerol lipase activity [GO:0004806] g13704.t1 Q6PIU2 37.245 392 6.21e-67 221.0 sp|Q6PIU2|NCEH1_HUMAN Neutral cholesterol ester hydrolase 1 OS=Homo sapiens OX=9606 GN=NCEH1 PE=1 SV=3 NCEH1_HUMAN reviewed Neutral cholesterol ester hydrolase 1 (NCEH) (EC 3.1.1.-) (Acetylalkylglycerol acetylhydrolase) (2-acetyl MAGE hydrolase) (EC 3.1.1.71) (Arylacetamide deacetylase-like 1) Homo sapiens (Human) GO:0004771; GO:0005789; GO:0005886; GO:0006805; GO:0016020; GO:0016042; GO:0017171; GO:0034383; GO:0042301; GO:0046485; GO:0047378 ether lipid metabolic process [GO:0046485]; lipid catabolic process [GO:0016042]; low-density lipoprotein particle clearance [GO:0034383]; xenobiotic metabolic process [GO:0006805] endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; plasma membrane [GO:0005886] acetylalkylglycerol acetylhydrolase activity [GO:0047378]; phosphate ion binding [GO:0042301]; serine hydrolase activity [GO:0017171]; sterol ester esterase activity [GO:0004771] g13705.t1 Q6PIU2 38.832 394 7.91e-73 236.0 sp|Q6PIU2|NCEH1_HUMAN Neutral cholesterol ester hydrolase 1 OS=Homo sapiens OX=9606 GN=NCEH1 PE=1 SV=3 NCEH1_HUMAN reviewed Neutral cholesterol ester hydrolase 1 (NCEH) (EC 3.1.1.-) (Acetylalkylglycerol acetylhydrolase) (2-acetyl MAGE hydrolase) (EC 3.1.1.71) (Arylacetamide deacetylase-like 1) Homo sapiens (Human) GO:0004771; GO:0005789; GO:0005886; GO:0006805; GO:0016020; GO:0016042; GO:0017171; GO:0034383; GO:0042301; GO:0046485; GO:0047378 ether lipid metabolic process [GO:0046485]; lipid catabolic process [GO:0016042]; low-density lipoprotein particle clearance [GO:0034383]; xenobiotic metabolic process [GO:0006805] endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; plasma membrane [GO:0005886] acetylalkylglycerol acetylhydrolase activity [GO:0047378]; phosphate ion binding [GO:0042301]; serine hydrolase activity [GO:0017171]; sterol ester esterase activity [GO:0004771] g13706.t1 Q0P5B7 40.437 366 4.73e-76 244.0 sp|Q0P5B7|AAAD_BOVIN Arylacetamide deacetylase OS=Bos taurus OX=9913 GN=AADAC PE=2 SV=1 AAAD_BOVIN reviewed Arylacetamide deacetylase (EC 3.1.1.3) Bos taurus (Bovine) GO:0004806; GO:0005789; GO:0006629; GO:0010898; GO:0017171 lipid metabolic process [GO:0006629]; positive regulation of triglyceride catabolic process [GO:0010898] endoplasmic reticulum membrane [GO:0005789] serine hydrolase activity [GO:0017171]; triacylglycerol lipase activity [GO:0004806] g13707.t1 Q7ZUV7 71.014 138 1.3800000000000001e-58 225.0 sp|Q7ZUV7|EMSY_DANRE BRCA2-interacting transcriptional repressor EMSY OS=Danio rerio OX=7955 GN=emsy PE=2 SV=1 g13709.t1 A5PK71 65.471 223 2.44e-92 273.0 sp|A5PK71|PACRG_BOVIN Parkin coregulated gene protein OS=Bos taurus OX=9913 GN=PACRG PE=1 SV=1 PACRG_BOVIN reviewed Parkin coregulated gene protein Bos taurus (Bovine) GO:0001664; GO:0002177; GO:0003779; GO:0005829; GO:0005879; GO:0007286; GO:0008104; GO:0030317; GO:0030544; GO:0031625; GO:0031982; GO:0043005; GO:0043014; GO:0044297; GO:0048487; GO:0051879; GO:0097225; GO:0097386; GO:0160112 flagellated sperm motility [GO:0030317]; intracellular protein localization [GO:0008104]; spermatid development [GO:0007286] axonemal B tubule inner sheath [GO:0160112]; axonemal microtubule [GO:0005879]; cell body [GO:0044297]; cytosol [GO:0005829]; glial cell projection [GO:0097386]; manchette [GO:0002177]; neuron projection [GO:0043005]; sperm midpiece [GO:0097225]; vesicle [GO:0031982] actin binding [GO:0003779]; alpha-tubulin binding [GO:0043014]; beta-tubulin binding [GO:0048487]; G protein-coupled receptor binding [GO:0001664]; Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]; ubiquitin protein ligase binding [GO:0031625] g13711.t1 Q5I0S8 45.383 379 2.84e-101 310.0 sp|Q5I0S8|ILEU_XENTR Leukocyte elastase inhibitor OS=Xenopus tropicalis OX=8364 GN=serpinb1 PE=2 SV=1 g13712.t1 Q52L45 44.01 384 3.36e-102 310.0 sp|Q52L45|ILEU_XENLA Leukocyte elastase inhibitor OS=Xenopus laevis OX=8355 GN=serpinb1 PE=2 SV=1 g13714.t1 Q52L45 43.49 384 7.11e-102 310.0 sp|Q52L45|ILEU_XENLA Leukocyte elastase inhibitor OS=Xenopus laevis OX=8355 GN=serpinb1 PE=2 SV=1 g13715.t1 Q52L45 43.455 382 1.55e-103 313.0 sp|Q52L45|ILEU_XENLA Leukocyte elastase inhibitor OS=Xenopus laevis OX=8355 GN=serpinb1 PE=2 SV=1 g13717.t1 P46023 35.043 468 5.25e-66 249.0 sp|P46023|GR101_LYMST G-protein coupled receptor GRL101 OS=Lymnaea stagnalis OX=6523 PE=2 SV=1 g13719.t1 P29144 56.718 1243 0.0 1399.0 sp|P29144|TPP2_HUMAN Tripeptidyl-peptidase 2 OS=Homo sapiens OX=9606 GN=TPP2 PE=1 SV=4 TPP2_HUMAN reviewed Tripeptidyl-peptidase 2 (TPP-2) (EC 3.4.14.10) (Tripeptidyl aminopeptidase) (Tripeptidyl-peptidase II) (TPP-II) Homo sapiens (Human) GO:0000209; GO:0004175; GO:0004177; GO:0004252; GO:0005654; GO:0005737; GO:0005829; GO:0006508; GO:0008240; GO:0016604; GO:0042802; GO:0080144 intracellular amino acid homeostasis [GO:0080144]; protein polyubiquitination [GO:0000209]; proteolysis [GO:0006508] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654] aminopeptidase activity [GO:0004177]; endopeptidase activity [GO:0004175]; identical protein binding [GO:0042802]; serine-type endopeptidase activity [GO:0004252]; tripeptidyl-peptidase activity [GO:0008240] g13719.t2 P29144 55.81 1265 0.0 1394.0 sp|P29144|TPP2_HUMAN Tripeptidyl-peptidase 2 OS=Homo sapiens OX=9606 GN=TPP2 PE=1 SV=4 TPP2_HUMAN reviewed Tripeptidyl-peptidase 2 (TPP-2) (EC 3.4.14.10) (Tripeptidyl aminopeptidase) (Tripeptidyl-peptidase II) (TPP-II) Homo sapiens (Human) GO:0000209; GO:0004175; GO:0004177; GO:0004252; GO:0005654; GO:0005737; GO:0005829; GO:0006508; GO:0008240; GO:0016604; GO:0042802; GO:0080144 intracellular amino acid homeostasis [GO:0080144]; protein polyubiquitination [GO:0000209]; proteolysis [GO:0006508] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654] aminopeptidase activity [GO:0004177]; endopeptidase activity [GO:0004175]; identical protein binding [GO:0042802]; serine-type endopeptidase activity [GO:0004252]; tripeptidyl-peptidase activity [GO:0008240] g13720.t1 Q08639 57.568 370 1.0400000000000001e-109 335.0 sp|Q08639|TFDP1_MOUSE Transcription factor Dp-1 OS=Mus musculus OX=10090 GN=Tfdp1 PE=1 SV=1 g13721.t1 Q27968 42.405 474 6.42e-111 339.0 sp|Q27968|DNJC3_BOVIN DnaJ homolog subfamily C member 3 OS=Bos taurus OX=9913 GN=DNAJC3 PE=1 SV=1 DNJC3_BOVIN reviewed DnaJ homolog subfamily C member 3 (Interferon-induced, double-stranded RNA-activated protein kinase inhibitor) (Protein kinase inhibitor of 58 kDa) (Protein kinase inhibitor p58) Bos taurus (Bovine) GO:0004860; GO:0005783; GO:0005829; GO:0006986; GO:0019901; GO:0034975; GO:0036494; GO:0051087; GO:0051787; GO:0070417; GO:1903912 cellular response to cold [GO:0070417]; negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation [GO:1903912]; positive regulation of translation initiation in response to endoplasmic reticulum stress [GO:0036494]; protein folding in endoplasmic reticulum [GO:0034975]; response to unfolded protein [GO:0006986] cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783] misfolded protein binding [GO:0051787]; protein kinase binding [GO:0019901]; protein kinase inhibitor activity [GO:0004860]; protein-folding chaperone binding [GO:0051087] g13725.t1 O00222 30.898 479 1.95e-63 234.0 sp|O00222|GRM8_HUMAN Metabotropic glutamate receptor 8 OS=Homo sapiens OX=9606 GN=GRM8 PE=1 SV=2 GRM8_HUMAN reviewed Metabotropic glutamate receptor 8 (mGluR8) Homo sapiens (Human) GO:0001642; GO:0004930; GO:0005886; GO:0007193; GO:0007196; GO:0007216; GO:0007601; GO:0008066; GO:0051966 adenylate cyclase-inhibiting G protein-coupled glutamate receptor signaling pathway [GO:0007196]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; regulation of synaptic transmission, glutamatergic [GO:0051966]; visual perception [GO:0007601] plasma membrane [GO:0005886] G protein-coupled receptor activity [GO:0004930]; glutamate receptor activity [GO:0008066]; group III metabotropic glutamate receptor activity [GO:0001642] g13729.t1 Q5RAL3 35.829 374 5.48e-61 217.0 sp|Q5RAL3|GRM3_PONAB Metabotropic glutamate receptor 3 OS=Pongo abelii OX=9601 GN=GRM3 PE=2 SV=1 g13730.t1 Q0P3X8 46.465 99 5.39e-28 100.0 sp|Q0P3X8|LTOR4_DANRE Ragulator complex protein LAMTOR4 OS=Danio rerio OX=7955 GN=lamtor4 PE=3 SV=1 LTOR4_DANRE reviewed Ragulator complex protein LAMTOR4 (Late endosomal/lysosomal adaptor and MAPK and MTOR activator 4) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005764; GO:0005765; GO:0008361; GO:0032008; GO:0061462; GO:0071230; GO:0071986; GO:1904263 cellular response to amino acid stimulus [GO:0071230]; positive regulation of TOR signaling [GO:0032008]; positive regulation of TORC1 signaling [GO:1904263]; protein localization to lysosome [GO:0061462]; regulation of cell size [GO:0008361] lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; Ragulator complex [GO:0071986] g13731.t1 E7F240 34.503 342 7.809999999999999e-48 180.0 sp|E7F240|TPC14_DANRE Trafficking protein particle complex subunit 14 OS=Danio rerio OX=7955 GN=trappc14 PE=3 SV=1 g13732.t1 Q640M6 37.367 562 3.19e-121 375.0 sp|Q640M6|GDPD5_MOUSE Glycerophosphodiester phosphodiesterase domain-containing protein 5 OS=Mus musculus OX=10090 GN=Gdpd5 PE=1 SV=1 GDPD5_MOUSE reviewed Glycerophosphodiester phosphodiesterase domain-containing protein 5 (Glycerophosphocholine phosphodiesterase GDPD5) (EC 3.1.4.2) (Glycerophosphodiester phosphodiesterase 2) (Phosphoinositide phospholipase C GDPD5) (EC 3.1.4.11) Mus musculus (Mouse) GO:0004435; GO:0005789; GO:0005886; GO:0006629; GO:0008889; GO:0016020; GO:0021522; GO:0021895; GO:0030424; GO:0030426; GO:0031175; GO:0043025; GO:0045666; GO:0045746; GO:0045787; GO:0047389; GO:0048505; GO:0097038 cerebral cortex neuron differentiation [GO:0021895]; lipid metabolic process [GO:0006629]; negative regulation of Notch signaling pathway [GO:0045746]; neuron projection development [GO:0031175]; positive regulation of cell cycle [GO:0045787]; positive regulation of neuron differentiation [GO:0045666]; regulation of timing of cell differentiation [GO:0048505]; spinal cord motor neuron differentiation [GO:0021522] axon [GO:0030424]; endoplasmic reticulum membrane [GO:0005789]; growth cone [GO:0030426]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; perinuclear endoplasmic reticulum [GO:0097038]; plasma membrane [GO:0005886] glycerophosphocholine phosphodiesterase activity [GO:0047389]; glycerophosphodiester phosphodiesterase activity [GO:0008889]; phosphatidylinositol-4,5-bisphosphate phospholipase C activity [GO:0004435] g13733.t1 O43639 43.766 393 1.2700000000000002e-103 314.0 sp|O43639|NCK2_HUMAN Cytoplasmic protein NCK2 OS=Homo sapiens OX=9606 GN=NCK2 PE=1 SV=2 NCK2_HUMAN reviewed Cytoplasmic protein NCK2 (Growth factor receptor-bound protein 4) (NCK adaptor protein 2) (Nck-2) (SH2/SH3 adaptor protein NCK-beta) Homo sapiens (Human) GO:0000122; GO:0001771; GO:0001784; GO:0005737; GO:0005783; GO:0005829; GO:0007015; GO:0007165; GO:0007172; GO:0007173; GO:0008093; GO:0008285; GO:0012506; GO:0014069; GO:0016477; GO:0030032; GO:0030159; GO:0030838; GO:0030971; GO:0035591; GO:0036491; GO:0036493; GO:0042102; GO:0042110; GO:0044877; GO:0045944; GO:0048013; GO:0060996; GO:0097110; GO:1902237; GO:1903898 actin filament organization [GO:0007015]; cell migration [GO:0016477]; dendritic spine development [GO:0060996]; ephrin receptor signaling pathway [GO:0048013]; epidermal growth factor receptor signaling pathway [GO:0007173]; immunological synapse formation [GO:0001771]; lamellipodium assembly [GO:0030032]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of PERK-mediated unfolded protein response [GO:1903898]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902237]; positive regulation of T cell proliferation [GO:0042102]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of translation in response to endoplasmic reticulum stress [GO:0036493]; regulation of translation initiation in response to endoplasmic reticulum stress [GO:0036491]; signal complex assembly [GO:0007172]; signal transduction [GO:0007165]; T cell activation [GO:0042110] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; postsynaptic density [GO:0014069]; vesicle membrane [GO:0012506] cytoskeletal anchor activity [GO:0008093]; phosphotyrosine residue binding [GO:0001784]; protein-containing complex binding [GO:0044877]; receptor tyrosine kinase binding [GO:0030971]; scaffold protein binding [GO:0097110]; signaling adaptor activity [GO:0035591]; signaling receptor complex adaptor activity [GO:0030159] g13735.t1 Q8BHR2 36.061 330 3.75e-46 176.0 sp|Q8BHR2|ENOX1_MOUSE Ecto-NOX disulfide-thiol exchanger 1 OS=Mus musculus OX=10090 GN=Enox1 PE=2 SV=1 g13737.t1 Q8AYS7 29.118 340 4.3999999999999995e-42 159.0 sp|Q8AYS7|CENPI_CHICK Centromere protein I OS=Gallus gallus OX=9031 GN=CENPI PE=1 SV=1 g13738.t1 Q8AYS7 33.681 383 4.51e-69 237.0 sp|Q8AYS7|CENPI_CHICK Centromere protein I OS=Gallus gallus OX=9031 GN=CENPI PE=1 SV=1 g13739.t1 Q0D4Z6 26.562 576 1.41e-41 162.0 sp|Q0D4Z6|GH38_ORYSJ Indole-3-acetic acid-amido synthetase GH3.8 OS=Oryza sativa subsp. japonica OX=39947 GN=GH3.8 PE=1 SV=1 GH38_ORYSJ reviewed Indole-3-acetic acid-amido synthetase GH3.8 (EC 6.3.2.-) (Auxin-responsive GH3-like protein 8) (OsGH3-8) (OsMGH3) Oryza sativa subsp. japonica (Rice) GO:0005737; GO:0006952; GO:0009555; GO:0009851; GO:0010279; GO:0016208; GO:0016881; GO:0140964; GO:1900424 auxin biosynthetic process [GO:0009851]; defense response [GO:0006952]; intracellular auxin homeostasis [GO:0140964]; pollen development [GO:0009555]; regulation of defense response to bacterium [GO:1900424] cytoplasm [GO:0005737] acid-amino acid ligase activity [GO:0016881]; AMP binding [GO:0016208]; indole-3-acetic acid amido synthetase activity [GO:0010279] g13740.t1 O22190 27.21 577 6.61e-48 181.0 sp|O22190|GH33_ARATH Indole-3-acetic acid-amido synthetase GH3.3 OS=Arabidopsis thaliana OX=3702 GN=GH3.3 PE=1 SV=1 g13744.t1 Q13042 56.55 458 0.0 531.0 sp|Q13042|CDC16_HUMAN Cell division cycle protein 16 homolog OS=Homo sapiens OX=9606 GN=CDC16 PE=1 SV=2 g13746.t1 O35817 44.366 142 2.35e-39 143.0 sp|O35817|AKA14_RAT A-kinase anchor protein 14 OS=Rattus norvegicus OX=10116 GN=Akap14 PE=2 SV=1 g13747.t1 Q8BG19 46.25 320 6.96e-95 299.0 sp|Q8BG19|TMTC4_MOUSE Protein O-mannosyl-transferase TMTC4 OS=Mus musculus OX=10090 GN=Tmtc4 PE=2 SV=1 TMTC4_MOUSE reviewed Protein O-mannosyl-transferase TMTC4 (EC 2.4.1.109) (Transmembrane O-mannosyltransferase targeting cadherins 4) (Transmembrane and tetratricopeptide repeat-containing 4) Mus musculus (Mouse) GO:0000030; GO:0004169; GO:0005783; GO:0007605; GO:0016020; GO:0030968; GO:0032470; GO:0035269; GO:0051117; GO:1905584 endoplasmic reticulum unfolded protein response [GO:0030968]; outer hair cell apoptotic process [GO:1905584]; positive regulation of endoplasmic reticulum calcium ion concentration [GO:0032470]; protein O-linked glycosylation via mannose [GO:0035269]; sensory perception of sound [GO:0007605] endoplasmic reticulum [GO:0005783]; membrane [GO:0016020] ATPase binding [GO:0051117]; dolichyl-phosphate-mannose-protein mannosyltransferase activity [GO:0004169]; mannosyltransferase activity [GO:0000030] g13747.t2 Q8BG19 47.188 320 4.12e-97 305.0 sp|Q8BG19|TMTC4_MOUSE Protein O-mannosyl-transferase TMTC4 OS=Mus musculus OX=10090 GN=Tmtc4 PE=2 SV=1 TMTC4_MOUSE reviewed Protein O-mannosyl-transferase TMTC4 (EC 2.4.1.109) (Transmembrane O-mannosyltransferase targeting cadherins 4) (Transmembrane and tetratricopeptide repeat-containing 4) Mus musculus (Mouse) GO:0000030; GO:0004169; GO:0005783; GO:0007605; GO:0016020; GO:0030968; GO:0032470; GO:0035269; GO:0051117; GO:1905584 endoplasmic reticulum unfolded protein response [GO:0030968]; outer hair cell apoptotic process [GO:1905584]; positive regulation of endoplasmic reticulum calcium ion concentration [GO:0032470]; protein O-linked glycosylation via mannose [GO:0035269]; sensory perception of sound [GO:0007605] endoplasmic reticulum [GO:0005783]; membrane [GO:0016020] ATPase binding [GO:0051117]; dolichyl-phosphate-mannose-protein mannosyltransferase activity [GO:0004169]; mannosyltransferase activity [GO:0000030] g13747.t3 Q8BG19 44.345 336 2.01e-91 291.0 sp|Q8BG19|TMTC4_MOUSE Protein O-mannosyl-transferase TMTC4 OS=Mus musculus OX=10090 GN=Tmtc4 PE=2 SV=1 TMTC4_MOUSE reviewed Protein O-mannosyl-transferase TMTC4 (EC 2.4.1.109) (Transmembrane O-mannosyltransferase targeting cadherins 4) (Transmembrane and tetratricopeptide repeat-containing 4) Mus musculus (Mouse) GO:0000030; GO:0004169; GO:0005783; GO:0007605; GO:0016020; GO:0030968; GO:0032470; GO:0035269; GO:0051117; GO:1905584 endoplasmic reticulum unfolded protein response [GO:0030968]; outer hair cell apoptotic process [GO:1905584]; positive regulation of endoplasmic reticulum calcium ion concentration [GO:0032470]; protein O-linked glycosylation via mannose [GO:0035269]; sensory perception of sound [GO:0007605] endoplasmic reticulum [GO:0005783]; membrane [GO:0016020] ATPase binding [GO:0051117]; dolichyl-phosphate-mannose-protein mannosyltransferase activity [GO:0004169]; mannosyltransferase activity [GO:0000030] g13748.t1 Q8BG19 49.33 373 2.9e-88 288.0 sp|Q8BG19|TMTC4_MOUSE Protein O-mannosyl-transferase TMTC4 OS=Mus musculus OX=10090 GN=Tmtc4 PE=2 SV=1 TMTC4_MOUSE reviewed Protein O-mannosyl-transferase TMTC4 (EC 2.4.1.109) (Transmembrane O-mannosyltransferase targeting cadherins 4) (Transmembrane and tetratricopeptide repeat-containing 4) Mus musculus (Mouse) GO:0000030; GO:0004169; GO:0005783; GO:0007605; GO:0016020; GO:0030968; GO:0032470; GO:0035269; GO:0051117; GO:1905584 endoplasmic reticulum unfolded protein response [GO:0030968]; outer hair cell apoptotic process [GO:1905584]; positive regulation of endoplasmic reticulum calcium ion concentration [GO:0032470]; protein O-linked glycosylation via mannose [GO:0035269]; sensory perception of sound [GO:0007605] endoplasmic reticulum [GO:0005783]; membrane [GO:0016020] ATPase binding [GO:0051117]; dolichyl-phosphate-mannose-protein mannosyltransferase activity [GO:0004169]; mannosyltransferase activity [GO:0000030] g13749.t1 Q6NU05 34.756 164 7.72e-33 119.0 sp|Q6NU05|HEBP1_XENLA Heme-binding protein 1 OS=Xenopus laevis OX=8355 GN=hebp1 PE=2 SV=1 g13750.t1 Q70VZ7 50.301 332 2.83e-113 335.0 sp|Q70VZ7|MOGT1_BOVIN 2-acylglycerol O-acyltransferase 1 OS=Bos taurus OX=9913 GN=MOGAT1 PE=2 SV=1 MOGT1_BOVIN reviewed 2-acylglycerol O-acyltransferase 1 (EC 2.3.1.22) (Acyl CoA:monoacylglycerol acyltransferase 1) (MGAT1) (Monoacylglycerol O-acyltransferase 1) Bos taurus (Bovine) GO:0003846; GO:0004144; GO:0005789; GO:0006071; GO:0006651; GO:0019432 diacylglycerol biosynthetic process [GO:0006651]; glycerol metabolic process [GO:0006071]; triglyceride biosynthetic process [GO:0019432] endoplasmic reticulum membrane [GO:0005789] 2-acylglycerol O-acyltransferase activity [GO:0003846]; diacylglycerol O-acyltransferase activity [GO:0004144] g13751.t1 Q70VZ7 51.36 331 4.22e-113 334.0 sp|Q70VZ7|MOGT1_BOVIN 2-acylglycerol O-acyltransferase 1 OS=Bos taurus OX=9913 GN=MOGAT1 PE=2 SV=1 MOGT1_BOVIN reviewed 2-acylglycerol O-acyltransferase 1 (EC 2.3.1.22) (Acyl CoA:monoacylglycerol acyltransferase 1) (MGAT1) (Monoacylglycerol O-acyltransferase 1) Bos taurus (Bovine) GO:0003846; GO:0004144; GO:0005789; GO:0006071; GO:0006651; GO:0019432 diacylglycerol biosynthetic process [GO:0006651]; glycerol metabolic process [GO:0006071]; triglyceride biosynthetic process [GO:0019432] endoplasmic reticulum membrane [GO:0005789] 2-acylglycerol O-acyltransferase activity [GO:0003846]; diacylglycerol O-acyltransferase activity [GO:0004144] g13752.t1 Q70VZ7 50.0 338 6.4300000000000005e-118 347.0 sp|Q70VZ7|MOGT1_BOVIN 2-acylglycerol O-acyltransferase 1 OS=Bos taurus OX=9913 GN=MOGAT1 PE=2 SV=1 MOGT1_BOVIN reviewed 2-acylglycerol O-acyltransferase 1 (EC 2.3.1.22) (Acyl CoA:monoacylglycerol acyltransferase 1) (MGAT1) (Monoacylglycerol O-acyltransferase 1) Bos taurus (Bovine) GO:0003846; GO:0004144; GO:0005789; GO:0006071; GO:0006651; GO:0019432 diacylglycerol biosynthetic process [GO:0006651]; glycerol metabolic process [GO:0006071]; triglyceride biosynthetic process [GO:0019432] endoplasmic reticulum membrane [GO:0005789] 2-acylglycerol O-acyltransferase activity [GO:0003846]; diacylglycerol O-acyltransferase activity [GO:0004144] g13754.t1 Q80W94 52.402 229 1.23e-71 224.0 sp|Q80W94|MOGT2_MOUSE 2-acylglycerol O-acyltransferase 2 OS=Mus musculus OX=10090 GN=Mogat2 PE=1 SV=1 MOGT2_MOUSE reviewed 2-acylglycerol O-acyltransferase 2 (EC 2.3.1.20) (EC 2.3.1.22) (Acyl-CoA:monoacylglycerol acyltransferase 2) (MGAT2) (Diacylglycerol acyltransferase 2-like protein 5) (Monoacylglycerol O-acyltransferase 1-like) (Monoacylglycerol O-acyltransferase 2) Mus musculus (Mouse) GO:0003846; GO:0004144; GO:0005783; GO:0005789; GO:0006071; GO:0006629; GO:0006640; GO:0006651; GO:0016407; GO:0019432; GO:0046462; GO:0050892; GO:1990578 diacylglycerol biosynthetic process [GO:0006651]; glycerol metabolic process [GO:0006071]; intestinal absorption [GO:0050892]; lipid metabolic process [GO:0006629]; monoacylglycerol biosynthetic process [GO:0006640]; monoacylglycerol metabolic process [GO:0046462]; triglyceride biosynthetic process [GO:0019432] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; perinuclear endoplasmic reticulum membrane [GO:1990578] 2-acylglycerol O-acyltransferase activity [GO:0003846]; acetyltransferase activity [GO:0016407]; diacylglycerol O-acyltransferase activity [GO:0004144] g13755.t1 Q8VC51 47.786 429 3.4800000000000003e-129 390.0 sp|Q8VC51|TCAB1_MOUSE Telomerase Cajal body protein 1 OS=Mus musculus OX=10090 GN=Wrap53 PE=1 SV=1 g13756.t1 Q3SZI0 53.477 417 3.1700000000000004e-154 451.0 sp|Q3SZI0|MPI_BOVIN Mannose-6-phosphate isomerase OS=Bos taurus OX=9913 GN=MPI PE=2 SV=3 g13757.t1 O97580 69.734 413 0.0 612.0 sp|O97580|SUCB1_PIG Succinate--CoA ligase [ADP-forming] subunit beta, mitochondrial (Fragment) OS=Sus scrofa OX=9823 GN=SUCLA2 PE=2 SV=1 g13758.t1 Q9Y5P8 40.684 263 7.68e-51 179.0 sp|Q9Y5P8|P2R3B_HUMAN Serine/threonine-protein phosphatase 2A regulatory subunit B'' subunit beta OS=Homo sapiens OX=9606 GN=PPP2R3B PE=1 SV=2 g13762.t1 Q06190 68.293 246 9.82e-118 369.0 sp|Q06190|P2R3A_HUMAN Serine/threonine-protein phosphatase 2A regulatory subunit B'' subunit alpha OS=Homo sapiens OX=9606 GN=PPP2R3A PE=1 SV=1 P2R3A_HUMAN reviewed Serine/threonine-protein phosphatase 2A regulatory subunit B'' subunit alpha (PP2A subunit B isoform PR72/PR130) (PP2A subunit B isoform R3 isoform) (PP2A subunit B isoforms B''-PR72/PR130) (PP2A subunit B isoforms B72/B130) (Serine/threonine-protein phosphatase 2A 72/130 kDa regulatory subunit B) Homo sapiens (Human) GO:0000159; GO:0001754; GO:0001756; GO:0005509; GO:0006470; GO:0007525; GO:0019888; GO:0030674; GO:0045732; GO:0060828; GO:0061053; GO:0090090; GO:0090249; GO:0090263 eye photoreceptor cell differentiation [GO:0001754]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of protein catabolic process [GO:0045732]; protein dephosphorylation [GO:0006470]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of cell migration involved in somitogenic axis elongation [GO:0090249]; somatic muscle development [GO:0007525]; somite development [GO:0061053]; somitogenesis [GO:0001756] protein phosphatase type 2A complex [GO:0000159] calcium ion binding [GO:0005509]; protein phosphatase regulator activity [GO:0019888]; protein-macromolecule adaptor activity [GO:0030674] g13765.t1 A0A1D5NVS8 55.319 94 6.22e-33 124.0 sp|A0A1D5NVS8|MSL2_CHICK E3 ubiquitin-protein ligase MSL2 OS=Gallus gallus OX=9031 GN=MSL2 PE=3 SV=1 g13766.t1 Q2TBR0 75.908 523 0.0 808.0 sp|Q2TBR0|PCCB_BOVIN Propionyl-CoA carboxylase beta chain, mitochondrial OS=Bos taurus OX=9913 GN=PCCB PE=2 SV=1 g13768.t1 Q5XIA0 25.501 549 5.25e-32 137.0 sp|Q5XIA0|DZI1L_RAT Cilium assembly protein DZIP1L OS=Rattus norvegicus OX=10116 GN=Dzip1l PE=1 SV=1 DZI1L_RAT reviewed Cilium assembly protein DZIP1L (DAZ-interacting zinc finger protein 1-like) Rattus norvegicus (Rat) GO:0005654; GO:0005737; GO:0005814; GO:0005829; GO:0005929; GO:0005930; GO:0007224; GO:0008270; GO:0015630; GO:0021532; GO:0032880; GO:0033504; GO:0036064; GO:0045171; GO:0060271; GO:0061512; GO:0072686; GO:1905349 ciliary transition zone assembly [GO:1905349]; cilium assembly [GO:0060271]; floor plate development [GO:0033504]; neural tube patterning [GO:0021532]; protein localization to cilium [GO:0061512]; regulation of protein localization [GO:0032880]; smoothened signaling pathway [GO:0007224] axoneme [GO:0005930]; centriole [GO:0005814]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intercellular bridge [GO:0045171]; microtubule cytoskeleton [GO:0015630]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654] zinc ion binding [GO:0008270] g13768.t2 Q5XIA0 29.201 363 1.3e-29 130.0 sp|Q5XIA0|DZI1L_RAT Cilium assembly protein DZIP1L OS=Rattus norvegicus OX=10116 GN=Dzip1l PE=1 SV=1 DZI1L_RAT reviewed Cilium assembly protein DZIP1L (DAZ-interacting zinc finger protein 1-like) Rattus norvegicus (Rat) GO:0005654; GO:0005737; GO:0005814; GO:0005829; GO:0005929; GO:0005930; GO:0007224; GO:0008270; GO:0015630; GO:0021532; GO:0032880; GO:0033504; GO:0036064; GO:0045171; GO:0060271; GO:0061512; GO:0072686; GO:1905349 ciliary transition zone assembly [GO:1905349]; cilium assembly [GO:0060271]; floor plate development [GO:0033504]; neural tube patterning [GO:0021532]; protein localization to cilium [GO:0061512]; regulation of protein localization [GO:0032880]; smoothened signaling pathway [GO:0007224] axoneme [GO:0005930]; centriole [GO:0005814]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intercellular bridge [GO:0045171]; microtubule cytoskeleton [GO:0015630]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654] zinc ion binding [GO:0008270] g13768.t3 Q5XIA0 29.201 363 2.3000000000000002e-29 129.0 sp|Q5XIA0|DZI1L_RAT Cilium assembly protein DZIP1L OS=Rattus norvegicus OX=10116 GN=Dzip1l PE=1 SV=1 DZI1L_RAT reviewed Cilium assembly protein DZIP1L (DAZ-interacting zinc finger protein 1-like) Rattus norvegicus (Rat) GO:0005654; GO:0005737; GO:0005814; GO:0005829; GO:0005929; GO:0005930; GO:0007224; GO:0008270; GO:0015630; GO:0021532; GO:0032880; GO:0033504; GO:0036064; GO:0045171; GO:0060271; GO:0061512; GO:0072686; GO:1905349 ciliary transition zone assembly [GO:1905349]; cilium assembly [GO:0060271]; floor plate development [GO:0033504]; neural tube patterning [GO:0021532]; protein localization to cilium [GO:0061512]; regulation of protein localization [GO:0032880]; smoothened signaling pathway [GO:0007224] axoneme [GO:0005930]; centriole [GO:0005814]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intercellular bridge [GO:0045171]; microtubule cytoskeleton [GO:0015630]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654] zinc ion binding [GO:0008270] g13769.t1 Q8BQ48 37.879 330 1.45e-40 169.0 sp|Q8BQ48|CE295_MOUSE Centrosomal protein of 295 kDa OS=Mus musculus OX=10090 GN=Cep295 PE=1 SV=3 CE295_MOUSE reviewed Centrosomal protein of 295 kDa Mus musculus (Mouse) GO:0005737; GO:0005813; GO:0005814; GO:0005829; GO:0005856; GO:0007099; GO:0008017; GO:0010825; GO:0030030; GO:0046599; GO:1901985; GO:1903724; GO:1904951; GO:1990498 cell projection organization [GO:0030030]; centriole replication [GO:0007099]; positive regulation of centriole elongation [GO:1903724]; positive regulation of centrosome duplication [GO:0010825]; positive regulation of establishment of protein localization [GO:1904951]; positive regulation of protein acetylation [GO:1901985]; regulation of centriole replication [GO:0046599] centriole [GO:0005814]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; mitotic spindle microtubule [GO:1990498] microtubule binding [GO:0008017] g13770.t1 P56560 50.391 512 3.33e-158 462.0 sp|P56560|AOFB_BOVIN Amine oxidase [flavin-containing] B OS=Bos taurus OX=9913 GN=MAOB PE=1 SV=4 AOFB_BOVIN reviewed Amine oxidase [flavin-containing] B (EC 1.4.3.21) (EC 1.4.3.4) (Monoamine oxidase type B) (MAO-B) Bos taurus (Bovine) GO:0005739; GO:0005741; GO:0008131; GO:0050660; GO:0097621 mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739] flavin adenine dinucleotide binding [GO:0050660]; monoamine oxidase activity [GO:0097621]; primary methylamine oxidase activity [GO:0008131] g13770.t2 Q8BW75 47.948 536 8.99e-154 451.0 sp|Q8BW75|AOFB_MOUSE Amine oxidase [flavin-containing] B OS=Mus musculus OX=10090 GN=Maob PE=1 SV=4 AOFB_MOUSE reviewed Amine oxidase [flavin-containing] B (EC 1.4.3.21) (EC 1.4.3.4) (Monoamine oxidase type B) (MAO-B) Mus musculus (Mouse) GO:0005739; GO:0005741; GO:0005743; GO:0008131; GO:0014063; GO:0019607; GO:0030425; GO:0042802; GO:0043025; GO:0045964; GO:0048545; GO:0050660; GO:0097621 negative regulation of serotonin secretion [GO:0014063]; phenylethylamine catabolic process [GO:0019607]; positive regulation of dopamine metabolic process [GO:0045964]; response to steroid hormone [GO:0048545] dendrite [GO:0030425]; mitochondrial inner membrane [GO:0005743]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025] flavin adenine dinucleotide binding [GO:0050660]; identical protein binding [GO:0042802]; monoamine oxidase activity [GO:0097621]; primary methylamine oxidase activity [GO:0008131] g13770.t3 Q8BW75 47.793 521 2.1e-146 432.0 sp|Q8BW75|AOFB_MOUSE Amine oxidase [flavin-containing] B OS=Mus musculus OX=10090 GN=Maob PE=1 SV=4 AOFB_MOUSE reviewed Amine oxidase [flavin-containing] B (EC 1.4.3.21) (EC 1.4.3.4) (Monoamine oxidase type B) (MAO-B) Mus musculus (Mouse) GO:0005739; GO:0005741; GO:0005743; GO:0008131; GO:0014063; GO:0019607; GO:0030425; GO:0042802; GO:0043025; GO:0045964; GO:0048545; GO:0050660; GO:0097621 negative regulation of serotonin secretion [GO:0014063]; phenylethylamine catabolic process [GO:0019607]; positive regulation of dopamine metabolic process [GO:0045964]; response to steroid hormone [GO:0048545] dendrite [GO:0030425]; mitochondrial inner membrane [GO:0005743]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025] flavin adenine dinucleotide binding [GO:0050660]; identical protein binding [GO:0042802]; monoamine oxidase activity [GO:0097621]; primary methylamine oxidase activity [GO:0008131] g13771.t1 P28715 47.812 320 3.97e-80 291.0 sp|P28715|ERCC5_HUMAN DNA excision repair protein ERCC-5 OS=Homo sapiens OX=9606 GN=ERCC5 PE=1 SV=3 ERCC5_HUMAN reviewed DNA excision repair protein ERCC-5 (EC 3.1.-.-) (DNA repair protein complementing XP-G cells) (XPG) (Xeroderma pigmentosum group G-complementing protein) Homo sapiens (Human) GO:0000109; GO:0000405; GO:0000724; GO:0000993; GO:0003684; GO:0003690; GO:0003697; GO:0004519; GO:0004520; GO:0005634; GO:0005654; GO:0005694; GO:0006283; GO:0006285; GO:0006289; GO:0008047; GO:0009411; GO:0010225; GO:0016788; GO:0032991; GO:0042803; GO:0043066; GO:0044877; GO:0046872 base-excision repair, AP site formation [GO:0006285]; double-strand break repair via homologous recombination [GO:0000724]; negative regulation of apoptotic process [GO:0043066]; nucleotide-excision repair [GO:0006289]; response to UV [GO:0009411]; response to UV-C [GO:0010225]; transcription-coupled nucleotide-excision repair [GO:0006283] chromosome [GO:0005694]; nucleoplasm [GO:0005654]; nucleotide-excision repair complex [GO:0000109]; nucleus [GO:0005634]; protein-containing complex [GO:0032991] bubble DNA binding [GO:0000405]; damaged DNA binding [GO:0003684]; DNA endonuclease activity [GO:0004520]; double-stranded DNA binding [GO:0003690]; endonuclease activity [GO:0004519]; enzyme activator activity [GO:0008047]; hydrolase activity, acting on ester bonds [GO:0016788]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; RNA polymerase II complex binding [GO:0000993]; single-stranded DNA binding [GO:0003697] g13771.t1 P28715 46.0 300 1.28e-68 256.0 sp|P28715|ERCC5_HUMAN DNA excision repair protein ERCC-5 OS=Homo sapiens OX=9606 GN=ERCC5 PE=1 SV=3 ERCC5_HUMAN reviewed DNA excision repair protein ERCC-5 (EC 3.1.-.-) (DNA repair protein complementing XP-G cells) (XPG) (Xeroderma pigmentosum group G-complementing protein) Homo sapiens (Human) GO:0000109; GO:0000405; GO:0000724; GO:0000993; GO:0003684; GO:0003690; GO:0003697; GO:0004519; GO:0004520; GO:0005634; GO:0005654; GO:0005694; GO:0006283; GO:0006285; GO:0006289; GO:0008047; GO:0009411; GO:0010225; GO:0016788; GO:0032991; GO:0042803; GO:0043066; GO:0044877; GO:0046872 base-excision repair, AP site formation [GO:0006285]; double-strand break repair via homologous recombination [GO:0000724]; negative regulation of apoptotic process [GO:0043066]; nucleotide-excision repair [GO:0006289]; response to UV [GO:0009411]; response to UV-C [GO:0010225]; transcription-coupled nucleotide-excision repair [GO:0006283] chromosome [GO:0005694]; nucleoplasm [GO:0005654]; nucleotide-excision repair complex [GO:0000109]; nucleus [GO:0005634]; protein-containing complex [GO:0032991] bubble DNA binding [GO:0000405]; damaged DNA binding [GO:0003684]; DNA endonuclease activity [GO:0004520]; double-stranded DNA binding [GO:0003690]; endonuclease activity [GO:0004519]; enzyme activator activity [GO:0008047]; hydrolase activity, acting on ester bonds [GO:0016788]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; RNA polymerase II complex binding [GO:0000993]; single-stranded DNA binding [GO:0003697] g13772.t1 O60832 74.005 427 0.0 634.0 sp|O60832|DKC1_HUMAN H/ACA ribonucleoprotein complex subunit DKC1 OS=Homo sapiens OX=9606 GN=DKC1 PE=1 SV=3 DKC1_HUMAN reviewed H/ACA ribonucleoprotein complex subunit DKC1 (EC 5.4.99.-) (CBF5 homolog) (Dyskerin) (Nopp140-associated protein of 57 kDa) (Nucleolar protein NAP57) (Nucleolar protein family A member 4) (snoRNP protein DKC1) Homo sapiens (Human) GO:0000455; GO:0000495; GO:0001650; GO:0003720; GO:0003723; GO:0005634; GO:0005654; GO:0005697; GO:0005730; GO:0005737; GO:0006364; GO:0006396; GO:0007004; GO:0009982; GO:0031118; GO:0031120; GO:0031429; GO:0032212; GO:0034513; GO:0070034; GO:0072589; GO:0090661; GO:0090666; GO:0090669; GO:1904867; GO:1904872; GO:1904874; GO:1905323; GO:1990481 box H/ACA sno(s)RNA 3'-end processing [GO:0000495]; enzyme-directed rRNA pseudouridine synthesis [GO:0000455]; mRNA pseudouridine synthesis [GO:1990481]; positive regulation of telomerase RNA localization to Cajal body [GO:1904874]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein localization to Cajal body [GO:1904867]; regulation of telomerase RNA localization to Cajal body [GO:1904872]; RNA processing [GO:0006396]; rRNA processing [GO:0006364]; rRNA pseudouridine synthesis [GO:0031118]; scaRNA localization to Cajal body [GO:0090666]; snRNA pseudouridine synthesis [GO:0031120]; telomerase holoenzyme complex assembly [GO:1905323]; telomerase RNA stabilization [GO:0090669]; telomere maintenance via telomerase [GO:0007004] box H/ACA scaRNP complex [GO:0072589]; box H/ACA snoRNP complex [GO:0031429]; box H/ACA telomerase RNP complex [GO:0090661]; cytoplasm [GO:0005737]; fibrillar center [GO:0001650]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; telomerase holoenzyme complex [GO:0005697] box H/ACA snoRNA binding [GO:0034513]; pseudouridine synthase activity [GO:0009982]; RNA binding [GO:0003723]; telomerase activity [GO:0003720]; telomerase RNA binding [GO:0070034] g13774.t1 P29241 35.521 259 1.62e-42 150.0 sp|P29241|NADA_APLCA ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase OS=Aplysia californica OX=6500 PE=1 SV=1 g13779.t1 Q5F418 71.394 818 0.0 1152.0 sp|Q5F418|PSMD1_CHICK 26S proteasome non-ATPase regulatory subunit 1 OS=Gallus gallus OX=9031 GN=PSMD1 PE=2 SV=1 g13780.t1 A2VDR8 48.379 771 0.0 705.0 sp|A2VDR8|COG7_BOVIN Conserved oligomeric Golgi complex subunit 7 OS=Bos taurus OX=9913 GN=COG7 PE=2 SV=1 g13781.t1 P81134 35.977 353 8.97e-62 204.0 sp|P81134|RENR_BOVIN Renin receptor OS=Bos taurus OX=9913 GN=ATP6AP2 PE=1 SV=2 RENR_BOVIN reviewed Renin receptor (ATPase H(+)-transporting lysosomal accessory protein 2) (ATPase H(+)-transporting lysosomal-interacting protein 2) (Renin/prorenin receptor) (Vacuolar ATP synthase membrane sector-associated protein M8-9) (V-ATPase M8.9 subunit) [Cleaved into: Renin receptor extracellular fragment; Renin receptor cytoplasmic fragment] Bos taurus (Bovine) GO:0000220; GO:0000421; GO:0005765; GO:0005789; GO:0007042; GO:0009897; GO:0010008; GO:0030177; GO:0030424; GO:0030665; GO:0030672; GO:0032591; GO:0038023; GO:0045851; GO:0090263; GO:1902600 lysosomal lumen acidification [GO:0007042]; pH reduction [GO:0045851]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of Wnt signaling pathway [GO:0030177]; proton transmembrane transport [GO:1902600] autophagosome membrane [GO:0000421]; axon [GO:0030424]; clathrin-coated vesicle membrane [GO:0030665]; dendritic spine membrane [GO:0032591]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; external side of plasma membrane [GO:0009897]; lysosomal membrane [GO:0005765]; synaptic vesicle membrane [GO:0030672]; vacuolar proton-transporting V-type ATPase, V0 domain [GO:0000220] signaling receptor activity [GO:0038023] g13784.t1 Q8CGN4 43.878 294 2.9200000000000003e-64 241.0 sp|Q8CGN4|BCOR_MOUSE BCL-6 corepressor OS=Mus musculus OX=10090 GN=Bcor PE=1 SV=2 BCOR_MOUSE reviewed BCL-6 corepressor (BCoR) Mus musculus (Mouse) GO:0000122; GO:0000976; GO:0000977; GO:0001835; GO:0003714; GO:0004842; GO:0005634; GO:0005654; GO:0006338; GO:0007507; GO:0030502; GO:0031072; GO:0042476; GO:0042826; GO:0045892; GO:0060021; GO:0065001; GO:0070171; GO:0140261; GO:0140297 blastocyst hatching [GO:0001835]; chromatin remodeling [GO:0006338]; heart development [GO:0007507]; negative regulation of bone mineralization [GO:0030502]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of tooth mineralization [GO:0070171]; negative regulation of transcription by RNA polymerase II [GO:0000122]; odontogenesis [GO:0042476]; roof of mouth development [GO:0060021]; specification of axis polarity [GO:0065001] BCOR complex [GO:0140261]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] DNA-binding transcription factor binding [GO:0140297]; heat shock protein binding [GO:0031072]; histone deacetylase binding [GO:0042826]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; transcription cis-regulatory region binding [GO:0000976]; transcription corepressor activity [GO:0003714]; ubiquitin-protein transferase activity [GO:0004842] g13785.t1 Q9QYM0 50.056 893 0.0 839.0 sp|Q9QYM0|MRP5_RAT ATP-binding cassette sub-family C member 5 OS=Rattus norvegicus OX=10116 GN=Abcc5 PE=2 SV=2 MRP5_RAT reviewed ATP-binding cassette sub-family C member 5 (EC 7.6.2.-) (EC 7.6.2.2) (Multidrug resistance-associated protein 5) Rattus norvegicus (Rat) GO:0005524; GO:0005796; GO:0005886; GO:0008559; GO:0010008; GO:0015216; GO:0015232; GO:0015562; GO:0015865; GO:0016020; GO:0016323; GO:0016324; GO:0016887; GO:0022884; GO:0030213; GO:0032496; GO:0032868; GO:0034634; GO:0034775; GO:0035351; GO:0042626; GO:0042908; GO:0042910; GO:0048471; GO:0055085; GO:0070730; GO:0070731; GO:0098838; GO:0140115; GO:0140359; GO:1901505 cAMP transport [GO:0070730]; cGMP transport [GO:0070731]; export across plasma membrane [GO:0140115]; folate transmembrane transport [GO:0098838]; glutathione transmembrane transport [GO:0034775]; heme transmembrane transport [GO:0035351]; hyaluronan biosynthetic process [GO:0030213]; purine nucleotide transport [GO:0015865]; response to insulin [GO:0032868]; response to lipopolysaccharide [GO:0032496]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908] apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; endosome membrane [GO:0010008]; Golgi lumen [GO:0005796]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886] ABC-type transporter activity [GO:0140359]; ABC-type xenobiotic transporter activity [GO:0008559]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; carbohydrate derivative transmembrane transporter activity [GO:1901505]; efflux transmembrane transporter activity [GO:0015562]; glutathione transmembrane transporter activity [GO:0034634]; heme transmembrane transporter activity [GO:0015232]; macromolecule transmembrane transporter activity [GO:0022884]; purine nucleotide transmembrane transporter activity [GO:0015216]; xenobiotic transmembrane transporter activity [GO:0042910] g13785.t1 Q9QYM0 31.852 405 2.8400000000000003e-47 189.0 sp|Q9QYM0|MRP5_RAT ATP-binding cassette sub-family C member 5 OS=Rattus norvegicus OX=10116 GN=Abcc5 PE=2 SV=2 MRP5_RAT reviewed ATP-binding cassette sub-family C member 5 (EC 7.6.2.-) (EC 7.6.2.2) (Multidrug resistance-associated protein 5) Rattus norvegicus (Rat) GO:0005524; GO:0005796; GO:0005886; GO:0008559; GO:0010008; GO:0015216; GO:0015232; GO:0015562; GO:0015865; GO:0016020; GO:0016323; GO:0016324; GO:0016887; GO:0022884; GO:0030213; GO:0032496; GO:0032868; GO:0034634; GO:0034775; GO:0035351; GO:0042626; GO:0042908; GO:0042910; GO:0048471; GO:0055085; GO:0070730; GO:0070731; GO:0098838; GO:0140115; GO:0140359; GO:1901505 cAMP transport [GO:0070730]; cGMP transport [GO:0070731]; export across plasma membrane [GO:0140115]; folate transmembrane transport [GO:0098838]; glutathione transmembrane transport [GO:0034775]; heme transmembrane transport [GO:0035351]; hyaluronan biosynthetic process [GO:0030213]; purine nucleotide transport [GO:0015865]; response to insulin [GO:0032868]; response to lipopolysaccharide [GO:0032496]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908] apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; endosome membrane [GO:0010008]; Golgi lumen [GO:0005796]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886] ABC-type transporter activity [GO:0140359]; ABC-type xenobiotic transporter activity [GO:0008559]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; carbohydrate derivative transmembrane transporter activity [GO:1901505]; efflux transmembrane transporter activity [GO:0015562]; glutathione transmembrane transporter activity [GO:0034634]; heme transmembrane transporter activity [GO:0015232]; macromolecule transmembrane transporter activity [GO:0022884]; purine nucleotide transmembrane transporter activity [GO:0015216]; xenobiotic transmembrane transporter activity [GO:0042910] g13786.t1 Q92581 50.151 662 0.0 544.0 sp|Q92581|SL9A6_HUMAN Sodium/hydrogen exchanger 6 OS=Homo sapiens OX=9606 GN=SLC9A6 PE=1 SV=3 SL9A6_HUMAN reviewed Sodium/hydrogen exchanger 6 (Na(+)/H(+) exchanger 6) (NHE-6) (Solute carrier family 9 member 6) Homo sapiens (Human) GO:0005789; GO:0005886; GO:0006811; GO:0015385; GO:0015386; GO:0030010; GO:0031901; GO:0031902; GO:0042802; GO:0048675; GO:0048812; GO:0051453; GO:0055037; GO:0055038; GO:0071805; GO:0097484; GO:0098719 axon extension [GO:0048675]; dendrite extension [GO:0097484]; establishment of cell polarity [GO:0030010]; monoatomic ion transport [GO:0006811]; neuron projection morphogenesis [GO:0048812]; potassium ion transmembrane transport [GO:0071805]; regulation of intracellular pH [GO:0051453]; sodium ion import across plasma membrane [GO:0098719] early endosome membrane [GO:0031901]; endoplasmic reticulum membrane [GO:0005789]; late endosome membrane [GO:0031902]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038] identical protein binding [GO:0042802]; potassium:proton antiporter activity [GO:0015386]; sodium:proton antiporter activity [GO:0015385] g13788.t1 Q9H6R0 59.969 642 0.0 802.0 sp|Q9H6R0|DHX33_HUMAN ATP-dependent RNA helicase DHX33 OS=Homo sapiens OX=9606 GN=DHX33 PE=1 SV=2 DHX33_HUMAN reviewed ATP-dependent RNA helicase DHX33 (EC 3.6.4.13) (DEAH box protein 33) Homo sapiens (Human) GO:0000182; GO:0003723; GO:0003724; GO:0003725; GO:0003729; GO:0004386; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006413; GO:0016887; GO:0032481; GO:0043023; GO:0043410; GO:0045943; GO:0051092; GO:0072559; GO:0140297; GO:1900227 positive regulation of MAPK cascade [GO:0043410]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of NLRP3 inflammasome complex assembly [GO:1900227]; positive regulation of transcription by RNA polymerase I [GO:0045943]; positive regulation of type I interferon production [GO:0032481]; translational initiation [GO:0006413] cytoplasm [GO:0005737]; NLRP3 inflammasome complex [GO:0072559]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA-binding transcription factor binding [GO:0140297]; double-stranded RNA binding [GO:0003725]; helicase activity [GO:0004386]; mRNA binding [GO:0003729]; rDNA binding [GO:0000182]; ribosomal large subunit binding [GO:0043023]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724] g13789.t1 Q28044 28.873 284 5.1200000000000004e-27 113.0 sp|Q28044|ADRB2_BOVIN Beta-2 adrenergic receptor OS=Bos taurus OX=9913 GN=ADRB2 PE=2 SV=2 ADRB2_BOVIN reviewed Beta-2 adrenergic receptor (Beta-2 adrenoreceptor) (Beta-2 adrenoceptor) Bos taurus (Bovine) GO:0001540; GO:0002024; GO:0002025; GO:0002028; GO:0004941; GO:0005634; GO:0005769; GO:0005794; GO:0005886; GO:0006366; GO:0006898; GO:0006939; GO:0008179; GO:0009409; GO:0010666; GO:0010667; GO:0015459; GO:0016324; GO:0030501; GO:0031649; GO:0036064; GO:0040015; GO:0042803; GO:0043235; GO:0043410; GO:0044877; GO:0045171; GO:0045453; GO:0045744; GO:0045944; GO:0045986; GO:0050873; GO:0051380; GO:0061885; GO:0071880; GO:0071881; GO:0072686; GO:0098990; GO:0098992; GO:0106134; GO:0120162; GO:0141163; GO:1901098; GO:1904504; GO:1904646 adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; adenylate cyclase-inhibiting adrenergic receptor signaling pathway [GO:0071881]; AMPA selective glutamate receptor signaling pathway [GO:0098990]; bone resorption [GO:0045453]; brown fat cell differentiation [GO:0050873]; cellular response to amyloid-beta [GO:1904646]; diet induced thermogenesis [GO:0002024]; heat generation [GO:0031649]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of G protein-coupled receptor signaling pathway [GO:0045744]; negative regulation of multicellular organism growth [GO:0040015]; negative regulation of smooth muscle contraction [GO:0045986]; norepinephrine-epinephrine-mediated vasodilation involved in regulation of systemic arterial blood pressure [GO:0002025]; positive regulation of autophagosome maturation [GO:1901098]; positive regulation of bone mineralization [GO:0030501]; positive regulation of cAMP/PKA signal transduction [GO:0141163]; positive regulation of cardiac muscle cell apoptotic process [GO:0010666]; positive regulation of cardiac muscle cell contraction [GO:0106134]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of lipophagy [GO:1904504]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of mini excitatory postsynaptic potential [GO:0061885]; positive regulation of transcription by RNA polymerase II [GO:0045944]; receptor-mediated endocytosis [GO:0006898]; regulation of sodium ion transport [GO:0002028]; response to cold [GO:0009409]; smooth muscle contraction [GO:0006939]; transcription by RNA polymerase II [GO:0006366] apical plasma membrane [GO:0016324]; ciliary basal body [GO:0036064]; early endosome [GO:0005769]; Golgi apparatus [GO:0005794]; intercellular bridge [GO:0045171]; mitotic spindle [GO:0072686]; neuronal dense core vesicle [GO:0098992]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] adenylate cyclase binding [GO:0008179]; amyloid-beta binding [GO:0001540]; beta2-adrenergic receptor activity [GO:0004941]; norepinephrine binding [GO:0051380]; potassium channel regulator activity [GO:0015459]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877] g13790.t1 O75795 36.127 537 4.5e-96 305.0 sp|O75795|UDB17_HUMAN UDP-glucuronosyltransferase 2B17 OS=Homo sapiens OX=9606 GN=UGT2B17 PE=1 SV=1 UDB17_HUMAN reviewed UDP-glucuronosyltransferase 2B17 (UDPGT 2B17) (UGT2B17) (EC 2.4.1.17) (C19-steroid-specific UDP-glucuronosyltransferase) (C19-steroid-specific UDPGT) Homo sapiens (Human) GO:0005789; GO:0006805; GO:0008202; GO:0008210; GO:0015020; GO:0016020 estrogen metabolic process [GO:0008210]; steroid metabolic process [GO:0008202]; xenobiotic metabolic process [GO:0006805] endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020] glucuronosyltransferase activity [GO:0015020] g13791.t1 Q16880 36.456 395 5.75e-81 265.0 sp|Q16880|CGT_HUMAN 2-hydroxyacylsphingosine 1-beta-galactosyltransferase OS=Homo sapiens OX=9606 GN=UGT8 PE=1 SV=2 CGT_HUMAN reviewed 2-hydroxyacylsphingosine 1-beta-galactosyltransferase (EC 2.4.1.47) (Ceramide UDP-galactosyltransferase) (Cerebroside synthase) (UDP-galactose-ceramide galactosyltransferase) Homo sapiens (Human) GO:0002175; GO:0003851; GO:0005783; GO:0005789; GO:0006682; GO:0006688; GO:0007010; GO:0007417; GO:0007422; GO:0008489; GO:0030913; GO:0035902; GO:0048812; GO:0098553 central nervous system development [GO:0007417]; cytoskeleton organization [GO:0007010]; galactosylceramide biosynthetic process [GO:0006682]; glycosphingolipid biosynthetic process [GO:0006688]; neuron projection morphogenesis [GO:0048812]; paranodal junction assembly [GO:0030913]; peripheral nervous system development [GO:0007422]; protein localization to paranode region of axon [GO:0002175]; response to immobilization stress [GO:0035902] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; lumenal side of endoplasmic reticulum membrane [GO:0098553] N-acylsphingosine galactosyltransferase activity [GO:0003851]; UDP-galactose:glucosylceramide beta-1,4-galactosyltransferase activity [GO:0008489] g13792.t1 O75795 26.936 297 8.46e-22 99.4 sp|O75795|UDB17_HUMAN UDP-glucuronosyltransferase 2B17 OS=Homo sapiens OX=9606 GN=UGT2B17 PE=1 SV=1 UDB17_HUMAN reviewed UDP-glucuronosyltransferase 2B17 (UDPGT 2B17) (UGT2B17) (EC 2.4.1.17) (C19-steroid-specific UDP-glucuronosyltransferase) (C19-steroid-specific UDPGT) Homo sapiens (Human) GO:0005789; GO:0006805; GO:0008202; GO:0008210; GO:0015020; GO:0016020 estrogen metabolic process [GO:0008210]; steroid metabolic process [GO:0008202]; xenobiotic metabolic process [GO:0006805] endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020] glucuronosyltransferase activity [GO:0015020] g13793.t1 O75795 27.869 305 1.3900000000000001e-21 98.6 sp|O75795|UDB17_HUMAN UDP-glucuronosyltransferase 2B17 OS=Homo sapiens OX=9606 GN=UGT2B17 PE=1 SV=1 UDB17_HUMAN reviewed UDP-glucuronosyltransferase 2B17 (UDPGT 2B17) (UGT2B17) (EC 2.4.1.17) (C19-steroid-specific UDP-glucuronosyltransferase) (C19-steroid-specific UDPGT) Homo sapiens (Human) GO:0005789; GO:0006805; GO:0008202; GO:0008210; GO:0015020; GO:0016020 estrogen metabolic process [GO:0008210]; steroid metabolic process [GO:0008202]; xenobiotic metabolic process [GO:0006805] endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020] glucuronosyltransferase activity [GO:0015020] g13794.t1 P36514 42.119 387 9.61e-103 316.0 sp|P36514|UD2C1_RABIT UDP-glucuronosyltransferase 2C1 (Fragment) OS=Oryctolagus cuniculus OX=9986 GN=UGT2C1 PE=2 SV=1 g13796.t1 P54855 35.835 533 4.72e-94 303.0 sp|P54855|UDB15_HUMAN UDP-glucuronosyltransferase 2B15 OS=Homo sapiens OX=9606 GN=UGT2B15 PE=1 SV=3 UDB15_HUMAN reviewed UDP-glucuronosyltransferase 2B15 (UDPGT 2B15) (UGT2B15) (EC 2.4.1.17) (HLUG4) (UDP-glucuronosyltransferase 2B8) (UDPGT 2B8) (UDPGTh-3) Homo sapiens (Human) GO:0005789; GO:0006805; GO:0008202; GO:0008210; GO:0015020 estrogen metabolic process [GO:0008210]; steroid metabolic process [GO:0008202]; xenobiotic metabolic process [GO:0006805] endoplasmic reticulum membrane [GO:0005789] glucuronosyltransferase activity [GO:0015020] g13798.t1 A4FUB0 25.0 392 2.67e-25 113.0 sp|A4FUB0|CE034_BOVIN Uncharacterized protein C5orf34 homolog OS=Bos taurus OX=9913 PE=2 SV=1 g13799.t1 Q6AYM1 36.943 157 1.34e-28 116.0 sp|Q6AYM1|CE034_RAT Uncharacterized protein C5orf34 homolog OS=Rattus norvegicus OX=10116 PE=2 SV=1 g13800.t1 Q92622 40.994 161 1.0600000000000002e-27 118.0 sp|Q92622|RUBIC_HUMAN Run domain Beclin-1-interacting and cysteine-rich domain-containing protein OS=Homo sapiens OX=9606 GN=RUBCN PE=1 SV=4 RUBIC_HUMAN reviewed Run domain Beclin-1-interacting and cysteine-rich domain-containing protein (Rubicon) (Beclin-1 associated RUN domain containing protein) (Baron) Homo sapiens (Human) GO:0002376; GO:0005654; GO:0005764; GO:0005769; GO:0005770; GO:0005829; GO:0006909; GO:0006914; GO:0010507; GO:0045806; GO:0051898; GO:0071985; GO:0141039; GO:1901097; GO:1901981 autophagy [GO:0006914]; immune system process [GO:0002376]; multivesicular body sorting pathway [GO:0071985]; negative regulation of autophagosome maturation [GO:1901097]; negative regulation of autophagy [GO:0010507]; negative regulation of endocytosis [GO:0045806]; negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051898]; phagocytosis [GO:0006909] cytosol [GO:0005829]; early endosome [GO:0005769]; late endosome [GO:0005770]; lysosome [GO:0005764]; nucleoplasm [GO:0005654] phosphatidylinositol 3-kinase inhibitor activity [GO:0141039]; phosphatidylinositol phosphate binding [GO:1901981] g13801.t1 Q80U62 53.005 366 1.3600000000000001e-133 410.0 sp|Q80U62|RUBIC_MOUSE Run domain Beclin-1-interacting and cysteine-rich domain-containing protein OS=Mus musculus OX=10090 GN=Rubcn PE=1 SV=2 RUBIC_MOUSE reviewed Run domain Beclin-1-interacting and cysteine-rich domain-containing protein (Rubicon) Mus musculus (Mouse) GO:0002376; GO:0005654; GO:0005764; GO:0005769; GO:0005770; GO:0005829; GO:0006897; GO:0006914; GO:0010507; GO:0045806; GO:0051898; GO:0141039; GO:1901097; GO:1901981 autophagy [GO:0006914]; endocytosis [GO:0006897]; immune system process [GO:0002376]; negative regulation of autophagosome maturation [GO:1901097]; negative regulation of autophagy [GO:0010507]; negative regulation of endocytosis [GO:0045806]; negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051898] cytosol [GO:0005829]; early endosome [GO:0005769]; late endosome [GO:0005770]; lysosome [GO:0005764]; nucleoplasm [GO:0005654] phosphatidylinositol 3-kinase inhibitor activity [GO:0141039]; phosphatidylinositol phosphate binding [GO:1901981] g13801.t2 Q92622 46.429 532 2.58e-138 428.0 sp|Q92622|RUBIC_HUMAN Run domain Beclin-1-interacting and cysteine-rich domain-containing protein OS=Homo sapiens OX=9606 GN=RUBCN PE=1 SV=4 RUBIC_HUMAN reviewed Run domain Beclin-1-interacting and cysteine-rich domain-containing protein (Rubicon) (Beclin-1 associated RUN domain containing protein) (Baron) Homo sapiens (Human) GO:0002376; GO:0005654; GO:0005764; GO:0005769; GO:0005770; GO:0005829; GO:0006909; GO:0006914; GO:0010507; GO:0045806; GO:0051898; GO:0071985; GO:0141039; GO:1901097; GO:1901981 autophagy [GO:0006914]; immune system process [GO:0002376]; multivesicular body sorting pathway [GO:0071985]; negative regulation of autophagosome maturation [GO:1901097]; negative regulation of autophagy [GO:0010507]; negative regulation of endocytosis [GO:0045806]; negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051898]; phagocytosis [GO:0006909] cytosol [GO:0005829]; early endosome [GO:0005769]; late endosome [GO:0005770]; lysosome [GO:0005764]; nucleoplasm [GO:0005654] phosphatidylinositol 3-kinase inhibitor activity [GO:0141039]; phosphatidylinositol phosphate binding [GO:1901981] g13804.t1 Q64104 70.732 82 1.06e-31 128.0 sp|Q64104|NR2E1_MOUSE Nuclear receptor subfamily 2 group E member 1 OS=Mus musculus OX=10090 GN=Nr2e1 PE=1 SV=1 NR2E1_MOUSE reviewed Nuclear receptor subfamily 2 group E member 1 (Nuclear receptor TLX) (Protein tailless homolog) (Tll) (mTll) Mus musculus (Mouse) GO:0000122; GO:0000978; GO:0001227; GO:0001228; GO:0001662; GO:0002118; GO:0004879; GO:0005634; GO:0005654; GO:0007420; GO:0007601; GO:0008270; GO:0008284; GO:0008347; GO:0019899; GO:0021542; GO:0021764; GO:0021772; GO:0021819; GO:0021872; GO:0021895; GO:0021960; GO:0021987; GO:0030154; GO:0030198; GO:0035019; GO:0035176; GO:0042826; GO:0043010; GO:0043066; GO:0045165; GO:0045665; GO:0045766; GO:0045787; GO:0048712; GO:0048814; GO:0060041; GO:0060164; GO:0060291; GO:0090049; GO:1990837; GO:2000178; GO:2000179; GO:2000648 aggressive behavior [GO:0002118]; amygdala development [GO:0021764]; anterior commissure morphogenesis [GO:0021960]; behavioral fear response [GO:0001662]; brain development [GO:0007420]; camera-type eye development [GO:0043010]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; cerebral cortex development [GO:0021987]; cerebral cortex neuron differentiation [GO:0021895]; dentate gyrus development [GO:0021542]; extracellular matrix organization [GO:0030198]; forebrain generation of neurons [GO:0021872]; glial cell migration [GO:0008347]; layer formation in cerebral cortex [GO:0021819]; long-term synaptic potentiation [GO:0060291]; negative regulation of apoptotic process [GO:0043066]; negative regulation of astrocyte differentiation [GO:0048712]; negative regulation of neural precursor cell proliferation [GO:2000178]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of transcription by RNA polymerase II [GO:0000122]; olfactory bulb development [GO:0021772]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell cycle [GO:0045787]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of stem cell proliferation [GO:2000648]; regulation of cell migration involved in sprouting angiogenesis [GO:0090049]; regulation of dendrite morphogenesis [GO:0048814]; regulation of timing of neuron differentiation [GO:0060164]; retina development in camera-type eye [GO:0060041]; social behavior [GO:0035176]; somatic stem cell population maintenance [GO:0035019]; visual perception [GO:0007601] nucleoplasm [GO:0005654]; nucleus [GO:0005634] DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; enzyme binding [GO:0019899]; histone deacetylase binding [GO:0042826]; nuclear receptor activity [GO:0004879]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; zinc ion binding [GO:0008270] g13804.t1 Q64104 34.135 208 6.9e-26 112.0 sp|Q64104|NR2E1_MOUSE Nuclear receptor subfamily 2 group E member 1 OS=Mus musculus OX=10090 GN=Nr2e1 PE=1 SV=1 NR2E1_MOUSE reviewed Nuclear receptor subfamily 2 group E member 1 (Nuclear receptor TLX) (Protein tailless homolog) (Tll) (mTll) Mus musculus (Mouse) GO:0000122; GO:0000978; GO:0001227; GO:0001228; GO:0001662; GO:0002118; GO:0004879; GO:0005634; GO:0005654; GO:0007420; GO:0007601; GO:0008270; GO:0008284; GO:0008347; GO:0019899; GO:0021542; GO:0021764; GO:0021772; GO:0021819; GO:0021872; GO:0021895; GO:0021960; GO:0021987; GO:0030154; GO:0030198; GO:0035019; GO:0035176; GO:0042826; GO:0043010; GO:0043066; GO:0045165; GO:0045665; GO:0045766; GO:0045787; GO:0048712; GO:0048814; GO:0060041; GO:0060164; GO:0060291; GO:0090049; GO:1990837; GO:2000178; GO:2000179; GO:2000648 aggressive behavior [GO:0002118]; amygdala development [GO:0021764]; anterior commissure morphogenesis [GO:0021960]; behavioral fear response [GO:0001662]; brain development [GO:0007420]; camera-type eye development [GO:0043010]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; cerebral cortex development [GO:0021987]; cerebral cortex neuron differentiation [GO:0021895]; dentate gyrus development [GO:0021542]; extracellular matrix organization [GO:0030198]; forebrain generation of neurons [GO:0021872]; glial cell migration [GO:0008347]; layer formation in cerebral cortex [GO:0021819]; long-term synaptic potentiation [GO:0060291]; negative regulation of apoptotic process [GO:0043066]; negative regulation of astrocyte differentiation [GO:0048712]; negative regulation of neural precursor cell proliferation [GO:2000178]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of transcription by RNA polymerase II [GO:0000122]; olfactory bulb development [GO:0021772]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell cycle [GO:0045787]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of stem cell proliferation [GO:2000648]; regulation of cell migration involved in sprouting angiogenesis [GO:0090049]; regulation of dendrite morphogenesis [GO:0048814]; regulation of timing of neuron differentiation [GO:0060164]; retina development in camera-type eye [GO:0060041]; social behavior [GO:0035176]; somatic stem cell population maintenance [GO:0035019]; visual perception [GO:0007601] nucleoplasm [GO:0005654]; nucleus [GO:0005634] DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; enzyme binding [GO:0019899]; histone deacetylase binding [GO:0042826]; nuclear receptor activity [GO:0004879]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; zinc ion binding [GO:0008270] g13805.t1 Q6GQ34 38.211 246 3.81e-51 181.0 sp|Q6GQ34|F124A_XENLA Protein FAM124A OS=Xenopus laevis OX=8355 GN=fam124a PE=2 SV=1 g13806.t1 A9UL78 50.303 165 5.46e-51 163.0 sp|A9UL78|CEP19_XENTR Centrosomal protein of 19 kDa OS=Xenopus tropicalis OX=8364 GN=cep19 PE=2 SV=1 g13807.t1 Q0V9T8 53.795 303 1e-107 333.0 sp|Q0V9T8|BIVM_XENTR Basic immunoglobulin-like variable motif-containing protein OS=Xenopus tropicalis OX=8364 GN=bivm PE=2 SV=1 g13808.t1 Q8K1C7 25.678 553 8.99e-43 163.0 sp|Q8K1C7|MOT14_MOUSE Monocarboxylate transporter 14 OS=Mus musculus OX=10090 GN=Slc16a14 PE=2 SV=1 g13811.t1 Q05004 27.292 469 7.52e-39 152.0 sp|Q05004|NXPE1_RABIT NXPE family member 1 OS=Oryctolagus cuniculus OX=9986 GN=NXPE1 PE=2 SV=1 g13815.t1 E7F7V7 26.28 293 2.84e-22 99.4 sp|E7F7V7|GAL2B_DANRE Galanin receptor 2b OS=Danio rerio OX=7955 GN=galr2b PE=2 SV=1 g13819.t1 Q8N137 32.927 492 1.09e-44 177.0 sp|Q8N137|CNTRB_HUMAN Centrobin OS=Homo sapiens OX=9606 GN=CNTROB PE=1 SV=1 CNTRB_HUMAN reviewed Centrobin (Centrosomal BRCA2-interacting protein) (LYST-interacting protein 8) Homo sapiens (Human) GO:0005813; GO:0005814; GO:0005829; GO:0007099; GO:0019904; GO:0036064; GO:0051299; GO:1902017; GO:1902410 centriole replication [GO:0007099]; centrosome separation [GO:0051299]; mitotic cytokinetic process [GO:1902410]; regulation of cilium assembly [GO:1902017] centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytosol [GO:0005829] protein domain specific binding [GO:0019904] g13820.t1 Q64707 55.45 211 1.12e-75 252.0 sp|Q64707|U2AFL_MOUSE U2 small nuclear ribonucleoprotein auxiliary factor 35 kDa subunit-related protein 2-like OS=Mus musculus OX=10090 GN=Zrsr2-ps1 PE=1 SV=1 U2AFL_MOUSE reviewed U2 small nuclear ribonucleoprotein auxiliary factor 35 kDa subunit-related protein 2-like (CCCH type zinc finger, RNA-binding motif and serine/arginine rich protein 1) (SP2) (U2 small nuclear ribonucleoprotein auxiliary factor 35 kDa subunit-related protein 1) (U2(RNU2) small nuclear RNA auxiliary factor 1-like 1) Mus musculus (Mouse) GO:0000398; GO:0005681; GO:0005689; GO:0008270; GO:0030628; GO:0042802; GO:0089701 mRNA splicing, via spliceosome [GO:0000398] spliceosomal complex [GO:0005681]; U12-type spliceosomal complex [GO:0005689]; U2AF complex [GO:0089701] identical protein binding [GO:0042802]; pre-mRNA 3'-splice site binding [GO:0030628]; zinc ion binding [GO:0008270] g13823.t1 Q14644 50.24 834 0.0 836.0 sp|Q14644|RASA3_HUMAN Ras GTPase-activating protein 3 OS=Homo sapiens OX=9606 GN=RASA3 PE=1 SV=3 RASA3_HUMAN reviewed Ras GTPase-activating protein 3 (GAP1(IP4BP)) (Ins P4-binding protein) Homo sapiens (Human) GO:0005096; GO:0005246; GO:0005829; GO:0007165; GO:0008270; GO:0009898; GO:0030168; GO:0035556; GO:0046580; GO:1902531 intracellular signal transduction [GO:0035556]; negative regulation of Ras protein signal transduction [GO:0046580]; platelet activation [GO:0030168]; regulation of intracellular signal transduction [GO:1902531]; signal transduction [GO:0007165] cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829] calcium channel regulator activity [GO:0005246]; GTPase activator activity [GO:0005096]; zinc ion binding [GO:0008270] g13826.t1 Q708S6 31.398 379 6.4e-61 208.0 sp|Q708S6|ASI1C_DANRE Acid-sensing ion channel 1C OS=Danio rerio OX=7955 GN=asic1c PE=1 SV=1 ASI1C_DANRE reviewed Acid-sensing ion channel 1C (ASIC1-C) (Acid-sensing ion channel 1.3-C) (Amiloride-sensitive cation channel 2-C, neuronal-C) (ZASIC1.3) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005261; GO:0005886; GO:0007269; GO:0015280; GO:0030425; GO:0035725; GO:0045211; GO:0071467; GO:0098793; GO:0098978; GO:0160128 cellular response to pH [GO:0071467]; neurotransmitter secretion [GO:0007269]; sodium ion transmembrane transport [GO:0035725] dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynapse [GO:0098793] ligand-gated sodium channel activity [GO:0015280]; monoatomic cation channel activity [GO:0005261]; pH-gated monoatomic ion channel activity [GO:0160128] g13827.t1 Q9IAK4 22.334 497 1.2600000000000002e-31 132.0 sp|Q9IAK4|NOE1_CHICK Noelin OS=Gallus gallus OX=9031 GN=OLFM1 PE=1 SV=1 NOE1_CHICK reviewed Noelin (Neuronal olfactomedin-related ER localized protein) (Olfactomedin-1) (Pancortin) Gallus gallus (Chicken) GO:0003190; GO:0005615; GO:0005783; GO:0007165; GO:0010628; GO:0010629; GO:0010718; GO:0023041; GO:0030424; GO:0030516; GO:0043025; GO:0043065; GO:0043204; GO:0044295; GO:0045202; GO:0060317 atrioventricular valve formation [GO:0003190]; cardiac epithelial to mesenchymal transition [GO:0060317]; negative regulation of gene expression [GO:0010629]; neuronal signal transduction [GO:0023041]; positive regulation of apoptotic process [GO:0043065]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of gene expression [GO:0010628]; regulation of axon extension [GO:0030516]; signal transduction [GO:0007165] axon [GO:0030424]; axonal growth cone [GO:0044295]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; synapse [GO:0045202] g13828.t1 Q9IAK4 23.944 497 4.72e-35 140.0 sp|Q9IAK4|NOE1_CHICK Noelin OS=Gallus gallus OX=9031 GN=OLFM1 PE=1 SV=1 NOE1_CHICK reviewed Noelin (Neuronal olfactomedin-related ER localized protein) (Olfactomedin-1) (Pancortin) Gallus gallus (Chicken) GO:0003190; GO:0005615; GO:0005783; GO:0007165; GO:0010628; GO:0010629; GO:0010718; GO:0023041; GO:0030424; GO:0030516; GO:0043025; GO:0043065; GO:0043204; GO:0044295; GO:0045202; GO:0060317 atrioventricular valve formation [GO:0003190]; cardiac epithelial to mesenchymal transition [GO:0060317]; negative regulation of gene expression [GO:0010629]; neuronal signal transduction [GO:0023041]; positive regulation of apoptotic process [GO:0043065]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of gene expression [GO:0010628]; regulation of axon extension [GO:0030516]; signal transduction [GO:0007165] axon [GO:0030424]; axonal growth cone [GO:0044295]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; synapse [GO:0045202] g13837.t1 Q09575 33.475 236 7.9e-37 145.0 sp|Q09575|YRD6_CAEEL Uncharacterized protein K02A2.6 OS=Caenorhabditis elegans OX=6239 GN=K02A2.6 PE=4 SV=1 g13838.t1 Q09575 32.509 283 1.6499999999999998e-42 169.0 sp|Q09575|YRD6_CAEEL Uncharacterized protein K02A2.6 OS=Caenorhabditis elegans OX=6239 GN=K02A2.6 PE=4 SV=1 g13840.t1 Q9HAR2 30.316 475 1.9600000000000002e-56 211.0 sp|Q9HAR2|AGRL3_HUMAN Adhesion G protein-coupled receptor L3 OS=Homo sapiens OX=9606 GN=ADGRL3 PE=1 SV=2 g13843.t1 Q969Y0 27.354 446 8.76e-28 120.0 sp|Q969Y0|NXPE3_HUMAN NXPE family member 3 OS=Homo sapiens OX=9606 GN=NXPE3 PE=1 SV=1 g13847.t1 Q7JQ32 41.176 238 6.979999999999999e-55 207.0 sp|Q7JQ32|GC76C_DROME Receptor-type guanylate cyclase Gyc76C OS=Drosophila melanogaster OX=7227 GN=Gyc76C PE=1 SV=1 GC76C_DROME reviewed Receptor-type guanylate cyclase Gyc76C (EC 4.6.1.2) (DrGC-1) Drosophila melanogaster (Fruit fly) GO:0001653; GO:0004383; GO:0005524; GO:0005525; GO:0005886; GO:0006182; GO:0007168; GO:0007411; GO:0007428; GO:0007435; GO:0007526; GO:0008045; GO:0009651; GO:0016199; GO:0030198; GO:0030215; GO:0030510; GO:0035556; GO:0038023; GO:0046872; GO:0050830 axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; cGMP biosynthetic process [GO:0006182]; defense response to Gram-positive bacterium [GO:0050830]; extracellular matrix organization [GO:0030198]; intracellular signal transduction [GO:0035556]; larval somatic muscle development [GO:0007526]; motor neuron axon guidance [GO:0008045]; primary branching, open tracheal system [GO:0007428]; receptor guanylyl cyclase signaling pathway [GO:0007168]; regulation of BMP signaling pathway [GO:0030510]; response to salt stress [GO:0009651]; salivary gland morphogenesis [GO:0007435] plasma membrane [GO:0005886] ATP binding [GO:0005524]; GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; metal ion binding [GO:0046872]; peptide receptor activity [GO:0001653]; semaphorin receptor binding [GO:0030215]; signaling receptor activity [GO:0038023] g13849.t1 O15042 52.231 605 2.89e-172 519.0 sp|O15042|SR140_HUMAN U2 snRNP-associated SURP motif-containing protein OS=Homo sapiens OX=9606 GN=U2SURP PE=1 SV=2 g13850.t1 Q8WVM7 57.803 974 0.0 1079.0 sp|Q8WVM7|STAG1_HUMAN Cohesin subunit SA-1 OS=Homo sapiens OX=9606 GN=STAG1 PE=1 SV=3 STAG1_HUMAN reviewed Cohesin subunit SA-1 (SCC3 homolog 1) (Stromal antigen 1) Homo sapiens (Human) GO:0000775; GO:0000785; GO:0003682; GO:0005634; GO:0005654; GO:0005694; GO:0005829; GO:0005929; GO:0007062; GO:0008278; GO:0016363; GO:0016604; GO:0030892; GO:0034087; GO:0051301; GO:0090307; GO:0097431 cell division [GO:0051301]; establishment of mitotic sister chromatid cohesion [GO:0034087]; mitotic spindle assembly [GO:0090307]; sister chromatid cohesion [GO:0007062] chromatin [GO:0000785]; chromosome [GO:0005694]; chromosome, centromeric region [GO:0000775]; cilium [GO:0005929]; cohesin complex [GO:0008278]; cytosol [GO:0005829]; mitotic cohesin complex [GO:0030892]; mitotic spindle pole [GO:0097431]; nuclear body [GO:0016604]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] chromatin binding [GO:0003682] g13850.t2 Q8WVM7 57.846 975 0.0 1078.0 sp|Q8WVM7|STAG1_HUMAN Cohesin subunit SA-1 OS=Homo sapiens OX=9606 GN=STAG1 PE=1 SV=3 STAG1_HUMAN reviewed Cohesin subunit SA-1 (SCC3 homolog 1) (Stromal antigen 1) Homo sapiens (Human) GO:0000775; GO:0000785; GO:0003682; GO:0005634; GO:0005654; GO:0005694; GO:0005829; GO:0005929; GO:0007062; GO:0008278; GO:0016363; GO:0016604; GO:0030892; GO:0034087; GO:0051301; GO:0090307; GO:0097431 cell division [GO:0051301]; establishment of mitotic sister chromatid cohesion [GO:0034087]; mitotic spindle assembly [GO:0090307]; sister chromatid cohesion [GO:0007062] chromatin [GO:0000785]; chromosome [GO:0005694]; chromosome, centromeric region [GO:0000775]; cilium [GO:0005929]; cohesin complex [GO:0008278]; cytosol [GO:0005829]; mitotic cohesin complex [GO:0030892]; mitotic spindle pole [GO:0097431]; nuclear body [GO:0016604]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] chromatin binding [GO:0003682] g13852.t1 O15440 43.216 877 0.0 677.0 sp|O15440|MRP5_HUMAN ATP-binding cassette sub-family C member 5 OS=Homo sapiens OX=9606 GN=ABCC5 PE=1 SV=2 MRP5_HUMAN reviewed ATP-binding cassette sub-family C member 5 (EC 7.6.2.-) (EC 7.6.2.2) (Multi-specific organic anion transporter C) (MOAT-C) (Multidrug resistance-associated protein 5) (SMRP) (pABC11) Homo sapiens (Human) GO:0005524; GO:0005796; GO:0005886; GO:0006805; GO:0006855; GO:0008514; GO:0008559; GO:0010008; GO:0015216; GO:0015232; GO:0015562; GO:0015865; GO:0016020; GO:0016323; GO:0016324; GO:0016887; GO:0022884; GO:0030213; GO:0034634; GO:0034775; GO:0035351; GO:0042626; GO:0042908; GO:0042910; GO:0043225; GO:0055085; GO:0070730; GO:0070731; GO:0098838; GO:0140115; GO:0140359; GO:0150104; GO:1901264; GO:1901505; GO:1990961 cAMP transport [GO:0070730]; carbohydrate derivative transport [GO:1901264]; cGMP transport [GO:0070731]; export across plasma membrane [GO:0140115]; folate transmembrane transport [GO:0098838]; glutathione transmembrane transport [GO:0034775]; heme transmembrane transport [GO:0035351]; hyaluronan biosynthetic process [GO:0030213]; purine nucleotide transport [GO:0015865]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104]; xenobiotic detoxification by transmembrane export across the plasma membrane [GO:1990961]; xenobiotic metabolic process [GO:0006805]; xenobiotic transmembrane transport [GO:0006855]; xenobiotic transport [GO:0042908] apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; endosome membrane [GO:0010008]; Golgi lumen [GO:0005796]; membrane [GO:0016020]; plasma membrane [GO:0005886] ABC-type transporter activity [GO:0140359]; ABC-type xenobiotic transporter activity [GO:0008559]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled inorganic anion transmembrane transporter activity [GO:0043225]; ATPase-coupled transmembrane transporter activity [GO:0042626]; carbohydrate derivative transmembrane transporter activity [GO:1901505]; efflux transmembrane transporter activity [GO:0015562]; glutathione transmembrane transporter activity [GO:0034634]; heme transmembrane transporter activity [GO:0015232]; macromolecule transmembrane transporter activity [GO:0022884]; organic anion transmembrane transporter activity [GO:0008514]; purine nucleotide transmembrane transporter activity [GO:0015216]; xenobiotic transmembrane transporter activity [GO:0042910] g13854.t1 Q9R1X5 35.294 204 5.91e-28 118.0 sp|Q9R1X5|MRP5_MOUSE ATP-binding cassette sub-family C member 5 OS=Mus musculus OX=10090 GN=Abcc5 PE=1 SV=2 MRP5_MOUSE reviewed ATP-binding cassette sub-family C member 5 (EC 7.6.2.-) (EC 7.6.2.2) (Multi-specific organic anion transporter C) (MOAT-C) (Multidrug resistance-associated protein 5) (SMRP) Mus musculus (Mouse) GO:0005524; GO:0005796; GO:0005886; GO:0008559; GO:0010008; GO:0015216; GO:0015232; GO:0015562; GO:0015865; GO:0016020; GO:0016323; GO:0016324; GO:0016887; GO:0030213; GO:0034634; GO:0034775; GO:0035351; GO:0042908; GO:0042910; GO:0048471; GO:0055085; GO:0070730; GO:0070731; GO:0098838; GO:0140115; GO:0140359 cAMP transport [GO:0070730]; cGMP transport [GO:0070731]; export across plasma membrane [GO:0140115]; folate transmembrane transport [GO:0098838]; glutathione transmembrane transport [GO:0034775]; heme transmembrane transport [GO:0035351]; hyaluronan biosynthetic process [GO:0030213]; purine nucleotide transport [GO:0015865]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908] apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; endosome membrane [GO:0010008]; Golgi lumen [GO:0005796]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886] ABC-type transporter activity [GO:0140359]; ABC-type xenobiotic transporter activity [GO:0008559]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; efflux transmembrane transporter activity [GO:0015562]; glutathione transmembrane transporter activity [GO:0034634]; heme transmembrane transporter activity [GO:0015232]; purine nucleotide transmembrane transporter activity [GO:0015216]; xenobiotic transmembrane transporter activity [GO:0042910] g13855.t1 O15440 45.89 292 2.9600000000000003e-80 266.0 sp|O15440|MRP5_HUMAN ATP-binding cassette sub-family C member 5 OS=Homo sapiens OX=9606 GN=ABCC5 PE=1 SV=2 MRP5_HUMAN reviewed ATP-binding cassette sub-family C member 5 (EC 7.6.2.-) (EC 7.6.2.2) (Multi-specific organic anion transporter C) (MOAT-C) (Multidrug resistance-associated protein 5) (SMRP) (pABC11) Homo sapiens (Human) GO:0005524; GO:0005796; GO:0005886; GO:0006805; GO:0006855; GO:0008514; GO:0008559; GO:0010008; GO:0015216; GO:0015232; GO:0015562; GO:0015865; GO:0016020; GO:0016323; GO:0016324; GO:0016887; GO:0022884; GO:0030213; GO:0034634; GO:0034775; GO:0035351; GO:0042626; GO:0042908; GO:0042910; GO:0043225; GO:0055085; GO:0070730; GO:0070731; GO:0098838; GO:0140115; GO:0140359; GO:0150104; GO:1901264; GO:1901505; GO:1990961 cAMP transport [GO:0070730]; carbohydrate derivative transport [GO:1901264]; cGMP transport [GO:0070731]; export across plasma membrane [GO:0140115]; folate transmembrane transport [GO:0098838]; glutathione transmembrane transport [GO:0034775]; heme transmembrane transport [GO:0035351]; hyaluronan biosynthetic process [GO:0030213]; purine nucleotide transport [GO:0015865]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104]; xenobiotic detoxification by transmembrane export across the plasma membrane [GO:1990961]; xenobiotic metabolic process [GO:0006805]; xenobiotic transmembrane transport [GO:0006855]; xenobiotic transport [GO:0042908] apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; endosome membrane [GO:0010008]; Golgi lumen [GO:0005796]; membrane [GO:0016020]; plasma membrane [GO:0005886] ABC-type transporter activity [GO:0140359]; ABC-type xenobiotic transporter activity [GO:0008559]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled inorganic anion transmembrane transporter activity [GO:0043225]; ATPase-coupled transmembrane transporter activity [GO:0042626]; carbohydrate derivative transmembrane transporter activity [GO:1901505]; efflux transmembrane transporter activity [GO:0015562]; glutathione transmembrane transporter activity [GO:0034634]; heme transmembrane transporter activity [GO:0015232]; macromolecule transmembrane transporter activity [GO:0022884]; organic anion transmembrane transporter activity [GO:0008514]; purine nucleotide transmembrane transporter activity [GO:0015216]; xenobiotic transmembrane transporter activity [GO:0042910] g13856.t1 O15440 44.444 144 1.72e-32 125.0 sp|O15440|MRP5_HUMAN ATP-binding cassette sub-family C member 5 OS=Homo sapiens OX=9606 GN=ABCC5 PE=1 SV=2 MRP5_HUMAN reviewed ATP-binding cassette sub-family C member 5 (EC 7.6.2.-) (EC 7.6.2.2) (Multi-specific organic anion transporter C) (MOAT-C) (Multidrug resistance-associated protein 5) (SMRP) (pABC11) Homo sapiens (Human) GO:0005524; GO:0005796; GO:0005886; GO:0006805; GO:0006855; GO:0008514; GO:0008559; GO:0010008; GO:0015216; GO:0015232; GO:0015562; GO:0015865; GO:0016020; GO:0016323; GO:0016324; GO:0016887; GO:0022884; GO:0030213; GO:0034634; GO:0034775; GO:0035351; GO:0042626; GO:0042908; GO:0042910; GO:0043225; GO:0055085; GO:0070730; GO:0070731; GO:0098838; GO:0140115; GO:0140359; GO:0150104; GO:1901264; GO:1901505; GO:1990961 cAMP transport [GO:0070730]; carbohydrate derivative transport [GO:1901264]; cGMP transport [GO:0070731]; export across plasma membrane [GO:0140115]; folate transmembrane transport [GO:0098838]; glutathione transmembrane transport [GO:0034775]; heme transmembrane transport [GO:0035351]; hyaluronan biosynthetic process [GO:0030213]; purine nucleotide transport [GO:0015865]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104]; xenobiotic detoxification by transmembrane export across the plasma membrane [GO:1990961]; xenobiotic metabolic process [GO:0006805]; xenobiotic transmembrane transport [GO:0006855]; xenobiotic transport [GO:0042908] apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; endosome membrane [GO:0010008]; Golgi lumen [GO:0005796]; membrane [GO:0016020]; plasma membrane [GO:0005886] ABC-type transporter activity [GO:0140359]; ABC-type xenobiotic transporter activity [GO:0008559]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled inorganic anion transmembrane transporter activity [GO:0043225]; ATPase-coupled transmembrane transporter activity [GO:0042626]; carbohydrate derivative transmembrane transporter activity [GO:1901505]; efflux transmembrane transporter activity [GO:0015562]; glutathione transmembrane transporter activity [GO:0034634]; heme transmembrane transporter activity [GO:0015232]; macromolecule transmembrane transporter activity [GO:0022884]; organic anion transmembrane transporter activity [GO:0008514]; purine nucleotide transmembrane transporter activity [GO:0015216]; xenobiotic transmembrane transporter activity [GO:0042910] g13857.t1 O15440 36.715 828 2.7099999999999995e-138 447.0 sp|O15440|MRP5_HUMAN ATP-binding cassette sub-family C member 5 OS=Homo sapiens OX=9606 GN=ABCC5 PE=1 SV=2 MRP5_HUMAN reviewed ATP-binding cassette sub-family C member 5 (EC 7.6.2.-) (EC 7.6.2.2) (Multi-specific organic anion transporter C) (MOAT-C) (Multidrug resistance-associated protein 5) (SMRP) (pABC11) Homo sapiens (Human) GO:0005524; GO:0005796; GO:0005886; GO:0006805; GO:0006855; GO:0008514; GO:0008559; GO:0010008; GO:0015216; GO:0015232; GO:0015562; GO:0015865; GO:0016020; GO:0016323; GO:0016324; GO:0016887; GO:0022884; GO:0030213; GO:0034634; GO:0034775; GO:0035351; GO:0042626; GO:0042908; GO:0042910; GO:0043225; GO:0055085; GO:0070730; GO:0070731; GO:0098838; GO:0140115; GO:0140359; GO:0150104; GO:1901264; GO:1901505; GO:1990961 cAMP transport [GO:0070730]; carbohydrate derivative transport [GO:1901264]; cGMP transport [GO:0070731]; export across plasma membrane [GO:0140115]; folate transmembrane transport [GO:0098838]; glutathione transmembrane transport [GO:0034775]; heme transmembrane transport [GO:0035351]; hyaluronan biosynthetic process [GO:0030213]; purine nucleotide transport [GO:0015865]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104]; xenobiotic detoxification by transmembrane export across the plasma membrane [GO:1990961]; xenobiotic metabolic process [GO:0006805]; xenobiotic transmembrane transport [GO:0006855]; xenobiotic transport [GO:0042908] apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; endosome membrane [GO:0010008]; Golgi lumen [GO:0005796]; membrane [GO:0016020]; plasma membrane [GO:0005886] ABC-type transporter activity [GO:0140359]; ABC-type xenobiotic transporter activity [GO:0008559]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled inorganic anion transmembrane transporter activity [GO:0043225]; ATPase-coupled transmembrane transporter activity [GO:0042626]; carbohydrate derivative transmembrane transporter activity [GO:1901505]; efflux transmembrane transporter activity [GO:0015562]; glutathione transmembrane transporter activity [GO:0034634]; heme transmembrane transporter activity [GO:0015232]; macromolecule transmembrane transporter activity [GO:0022884]; organic anion transmembrane transporter activity [GO:0008514]; purine nucleotide transmembrane transporter activity [GO:0015216]; xenobiotic transmembrane transporter activity [GO:0042910] g13858.t1 Q8BKC5 55.128 390 1.16e-154 467.0 sp|Q8BKC5|IPO5_MOUSE Importin-5 OS=Mus musculus OX=10090 GN=Ipo5 PE=1 SV=3 IPO5_MOUSE reviewed Importin-5 (Imp5) (Importin subunit beta-3) (Karyopherin beta-3) (Ran-binding protein 5) (RanBP5) Mus musculus (Mouse) GO:0002753; GO:0005634; GO:0005654; GO:0005737; GO:0005794; GO:0005829; GO:0006606; GO:0006607; GO:0006610; GO:0008139; GO:0031267; GO:0031965; GO:0042307; GO:0061608; GO:0071230 cellular response to amino acid stimulus [GO:0071230]; cytoplasmic pattern recognition receptor signaling pathway [GO:0002753]; NLS-bearing protein import into nucleus [GO:0006607]; positive regulation of protein import into nucleus [GO:0042307]; protein import into nucleus [GO:0006606]; ribosomal protein import into nucleus [GO:0006610] cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] nuclear import signal receptor activity [GO:0061608]; nuclear localization sequence binding [GO:0008139]; small GTPase binding [GO:0031267] g13859.t1 Q8BKC5 70.739 352 0.0 538.0 sp|Q8BKC5|IPO5_MOUSE Importin-5 OS=Mus musculus OX=10090 GN=Ipo5 PE=1 SV=3 IPO5_MOUSE reviewed Importin-5 (Imp5) (Importin subunit beta-3) (Karyopherin beta-3) (Ran-binding protein 5) (RanBP5) Mus musculus (Mouse) GO:0002753; GO:0005634; GO:0005654; GO:0005737; GO:0005794; GO:0005829; GO:0006606; GO:0006607; GO:0006610; GO:0008139; GO:0031267; GO:0031965; GO:0042307; GO:0061608; GO:0071230 cellular response to amino acid stimulus [GO:0071230]; cytoplasmic pattern recognition receptor signaling pathway [GO:0002753]; NLS-bearing protein import into nucleus [GO:0006607]; positive regulation of protein import into nucleus [GO:0042307]; protein import into nucleus [GO:0006606]; ribosomal protein import into nucleus [GO:0006610] cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] nuclear import signal receptor activity [GO:0061608]; nuclear localization sequence binding [GO:0008139]; small GTPase binding [GO:0031267] g13860.t1 Q8BKC5 49.485 291 8.26e-86 282.0 sp|Q8BKC5|IPO5_MOUSE Importin-5 OS=Mus musculus OX=10090 GN=Ipo5 PE=1 SV=3 IPO5_MOUSE reviewed Importin-5 (Imp5) (Importin subunit beta-3) (Karyopherin beta-3) (Ran-binding protein 5) (RanBP5) Mus musculus (Mouse) GO:0002753; GO:0005634; GO:0005654; GO:0005737; GO:0005794; GO:0005829; GO:0006606; GO:0006607; GO:0006610; GO:0008139; GO:0031267; GO:0031965; GO:0042307; GO:0061608; GO:0071230 cellular response to amino acid stimulus [GO:0071230]; cytoplasmic pattern recognition receptor signaling pathway [GO:0002753]; NLS-bearing protein import into nucleus [GO:0006607]; positive regulation of protein import into nucleus [GO:0042307]; protein import into nucleus [GO:0006606]; ribosomal protein import into nucleus [GO:0006610] cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] nuclear import signal receptor activity [GO:0061608]; nuclear localization sequence binding [GO:0008139]; small GTPase binding [GO:0031267] g13862.t1 P51784 37.342 158 3.59e-29 120.0 sp|P51784|UBP11_HUMAN Ubiquitin carboxyl-terminal hydrolase 11 OS=Homo sapiens OX=9606 GN=USP11 PE=1 SV=3 UBP11_HUMAN reviewed Ubiquitin carboxyl-terminal hydrolase 11 (EC 3.4.19.12) (Deubiquitinating enzyme 11) (Ubiquitin thioesterase 11) (Ubiquitin-specific-processing protease 11) Homo sapiens (Human) GO:0001222; GO:0004197; GO:0004843; GO:0005634; GO:0005654; GO:0005694; GO:0005829; GO:0006508; GO:0016579 protein deubiquitination [GO:0016579]; proteolysis [GO:0006508] chromosome [GO:0005694]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cysteine-type deubiquitinase activity [GO:0004843]; cysteine-type endopeptidase activity [GO:0004197]; transcription corepressor binding [GO:0001222] g13866.t1 Q5M9Q1 82.075 106 7.689999999999999e-52 179.0 sp|Q5M9Q1|NKAPL_HUMAN NKAP-like protein OS=Homo sapiens OX=9606 GN=NKAPL PE=1 SV=3 NKAPL_HUMAN reviewed NKAP-like protein Homo sapiens (Human) GO:0003682; GO:0005634; GO:0007283; GO:0010468; GO:0030154 cell differentiation [GO:0030154]; regulation of gene expression [GO:0010468]; spermatogenesis [GO:0007283] nucleus [GO:0005634] chromatin binding [GO:0003682] g13868.t1 Q9Z2W1 66.983 421 7.26e-172 493.0 sp|Q9Z2W1|STK25_MOUSE Serine/threonine-protein kinase 25 OS=Mus musculus OX=10090 GN=Stk25 PE=1 SV=2 STK25_MOUSE reviewed Serine/threonine-protein kinase 25 (EC 2.7.11.1) (Ste20-like kinase) (Sterile 20/oxidant stress-response kinase 1) (SOK-1) (Ste20/oxidant stress response kinase 1) Mus musculus (Mouse) GO:0000139; GO:0004674; GO:0005524; GO:0005737; GO:0005794; GO:0007163; GO:0032874; GO:0034599; GO:0035556; GO:0036481; GO:0042803; GO:0046872; GO:0050772; GO:0051645; GO:0051683; GO:0090168; GO:0090443; GO:0106310 cellular response to oxidative stress [GO:0034599]; establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Golgi localization [GO:0051645]; Golgi reassembly [GO:0090168]; intracellular signal transduction [GO:0035556]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; positive regulation of axonogenesis [GO:0050772]; positive regulation of stress-activated MAPK cascade [GO:0032874] cytoplasm [GO:0005737]; FAR/SIN/STRIPAK complex [GO:0090443]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139] ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g13870.t1 Q6P2D8 43.151 292 1.52e-49 191.0 sp|Q6P2D8|XRRA1_HUMAN X-ray radiation resistance-associated protein 1 OS=Homo sapiens OX=9606 GN=XRRA1 PE=1 SV=2 XRRA1_HUMAN reviewed X-ray radiation resistance-associated protein 1 Homo sapiens (Human) GO:0005634; GO:0005654; GO:0005737; GO:0010165; GO:0016604 response to X-ray [GO:0010165] cytoplasm [GO:0005737]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] g13870.t1 Q6P2D8 30.964 394 3.3700000000000004e-27 122.0 sp|Q6P2D8|XRRA1_HUMAN X-ray radiation resistance-associated protein 1 OS=Homo sapiens OX=9606 GN=XRRA1 PE=1 SV=2 XRRA1_HUMAN reviewed X-ray radiation resistance-associated protein 1 Homo sapiens (Human) GO:0005634; GO:0005654; GO:0005737; GO:0010165; GO:0016604 response to X-ray [GO:0010165] cytoplasm [GO:0005737]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] g13873.t1 Q78YY6 70.238 84 5.57e-39 130.0 sp|Q78YY6|DJC15_MOUSE DnaJ homolog subfamily C member 15 OS=Mus musculus OX=10090 GN=Dnajc15 PE=1 SV=1 DJC15_MOUSE reviewed DnaJ homolog subfamily C member 15 Mus musculus (Mouse) GO:0001405; GO:0001671; GO:0005739; GO:0005743; GO:0009267; GO:0019216; GO:0030150; GO:0031333; GO:1902957 cellular response to starvation [GO:0009267]; negative regulation of mitochondrial electron transport, NADH to ubiquinone [GO:1902957]; negative regulation of protein-containing complex assembly [GO:0031333]; protein import into mitochondrial matrix [GO:0030150]; regulation of lipid metabolic process [GO:0019216] mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; PAM complex, Tim23 associated import motor [GO:0001405] ATPase activator activity [GO:0001671] g13875.t1 Q8C0L6 27.751 418 4.1600000000000005e-31 129.0 sp|Q8C0L6|PAOX_MOUSE Peroxisomal N(1)-acetyl-spermine/spermidine oxidase OS=Mus musculus OX=10090 GN=Paox PE=1 SV=3 PAOX_MOUSE reviewed Peroxisomal N(1)-acetyl-spermine/spermidine oxidase (EC 1.5.3.13) (Polyamine oxidase) Mus musculus (Mouse) GO:0005737; GO:0005782; GO:0006598; GO:0009446; GO:0009447; GO:0046203; GO:0046208; GO:0046592; GO:0052903; GO:1901307 polyamine catabolic process [GO:0006598]; positive regulation of spermidine biosynthetic process [GO:1901307]; putrescine biosynthetic process [GO:0009446]; putrescine catabolic process [GO:0009447]; spermidine catabolic process [GO:0046203]; spermine catabolic process [GO:0046208] cytoplasm [GO:0005737]; peroxisomal matrix [GO:0005782] N(1)-acetylpolyamine oxidase (3-acetamidopropanal-forming) activity [GO:0052903]; polyamine oxidase activity [GO:0046592] g13879.t1 O62761 32.294 545 2.6e-86 282.0 sp|O62761|CHLE_PANTT Cholinesterase OS=Panthera tigris tigris OX=74535 GN=BCHE PE=2 SV=1 g13881.t1 Q9R0Y1 35.714 182 2.8000000000000003e-31 122.0 sp|Q9R0Y1|ASIC5_MOUSE Bile acid-sensitive ion channel OS=Mus musculus OX=10090 GN=Asic5 PE=1 SV=1 g13882.t1 Q62962 35.897 234 2.76e-44 159.0 sp|Q62962|ASIC2_RAT Acid-sensing ion channel 2 OS=Rattus norvegicus OX=10116 GN=Asic2 PE=1 SV=1 ASIC2_RAT reviewed Acid-sensing ion channel 2 (ASIC2) (Amiloride-sensitive brain sodium channel) (Amiloride-sensitive brain sodium channel 2) (Amiloride-sensitive cation channel 1, neuronal) (Amiloride-sensitive cation channel neuronal 1) (Brain sodium channel 1) (BNC1) (BNaC1) (Mammalian degenerin homolog) (MDEG) Rattus norvegicus (Rat) GO:0003026; GO:0005216; GO:0005261; GO:0005886; GO:0006812; GO:0006814; GO:0007602; GO:0007605; GO:0009612; GO:0010447; GO:0015280; GO:0016020; GO:0019229; GO:0022839; GO:0034220; GO:0034765; GO:0035418; GO:0035725; GO:0042391; GO:0043005; GO:0043025; GO:0043066; GO:0043197; GO:0045202; GO:0050915; GO:0050974; GO:0051649; GO:0051965; GO:0071466; GO:0071468; GO:0098839; GO:0150052; GO:0160125 cellular response to acidic pH [GO:0071468]; cellular response to xenobiotic stimulus [GO:0071466]; detection of mechanical stimulus involved in sensory perception [GO:0050974]; establishment of localization in cell [GO:0051649]; monoatomic cation transport [GO:0006812]; monoatomic ion transmembrane transport [GO:0034220]; negative regulation of apoptotic process [GO:0043066]; phototransduction [GO:0007602]; positive regulation of synapse assembly [GO:0051965]; protein localization to synapse [GO:0035418]; regulation of membrane potential [GO:0042391]; regulation of monoatomic ion transmembrane transport [GO:0034765]; regulation of postsynapse assembly [GO:0150052]; regulation of systemic arterial blood pressure by aortic arch baroreceptor feedback [GO:0003026]; regulation of vasoconstriction [GO:0019229]; response to acidic pH [GO:0010447]; response to mechanical stimulus [GO:0009612]; sensory perception of sound [GO:0007605]; sensory perception of sour taste [GO:0050915]; sodium ion transmembrane transport [GO:0035725]; sodium ion transport [GO:0006814] dendritic spine [GO:0043197]; membrane [GO:0016020]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; synapse [GO:0045202] ligand-gated sodium channel activity [GO:0015280]; monoatomic cation channel activity [GO:0005261]; monoatomic ion channel activity [GO:0005216]; monoatomic ion-gated channel activity [GO:0022839]; pH-gated sodium channel activity [GO:0160125] g13882.t2 Q62962 36.287 237 2.7e-44 159.0 sp|Q62962|ASIC2_RAT Acid-sensing ion channel 2 OS=Rattus norvegicus OX=10116 GN=Asic2 PE=1 SV=1 ASIC2_RAT reviewed Acid-sensing ion channel 2 (ASIC2) (Amiloride-sensitive brain sodium channel) (Amiloride-sensitive brain sodium channel 2) (Amiloride-sensitive cation channel 1, neuronal) (Amiloride-sensitive cation channel neuronal 1) (Brain sodium channel 1) (BNC1) (BNaC1) (Mammalian degenerin homolog) (MDEG) Rattus norvegicus (Rat) GO:0003026; GO:0005216; GO:0005261; GO:0005886; GO:0006812; GO:0006814; GO:0007602; GO:0007605; GO:0009612; GO:0010447; GO:0015280; GO:0016020; GO:0019229; GO:0022839; GO:0034220; GO:0034765; GO:0035418; GO:0035725; GO:0042391; GO:0043005; GO:0043025; GO:0043066; GO:0043197; GO:0045202; GO:0050915; GO:0050974; GO:0051649; GO:0051965; GO:0071466; GO:0071468; GO:0098839; GO:0150052; GO:0160125 cellular response to acidic pH [GO:0071468]; cellular response to xenobiotic stimulus [GO:0071466]; detection of mechanical stimulus involved in sensory perception [GO:0050974]; establishment of localization in cell [GO:0051649]; monoatomic cation transport [GO:0006812]; monoatomic ion transmembrane transport [GO:0034220]; negative regulation of apoptotic process [GO:0043066]; phototransduction [GO:0007602]; positive regulation of synapse assembly [GO:0051965]; protein localization to synapse [GO:0035418]; regulation of membrane potential [GO:0042391]; regulation of monoatomic ion transmembrane transport [GO:0034765]; regulation of postsynapse assembly [GO:0150052]; regulation of systemic arterial blood pressure by aortic arch baroreceptor feedback [GO:0003026]; regulation of vasoconstriction [GO:0019229]; response to acidic pH [GO:0010447]; response to mechanical stimulus [GO:0009612]; sensory perception of sound [GO:0007605]; sensory perception of sour taste [GO:0050915]; sodium ion transmembrane transport [GO:0035725]; sodium ion transport [GO:0006814] dendritic spine [GO:0043197]; membrane [GO:0016020]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; synapse [GO:0045202] ligand-gated sodium channel activity [GO:0015280]; monoatomic cation channel activity [GO:0005261]; monoatomic ion channel activity [GO:0005216]; monoatomic ion-gated channel activity [GO:0022839]; pH-gated sodium channel activity [GO:0160125] g13882.t3 Q62962 35.714 252 9.82e-46 164.0 sp|Q62962|ASIC2_RAT Acid-sensing ion channel 2 OS=Rattus norvegicus OX=10116 GN=Asic2 PE=1 SV=1 ASIC2_RAT reviewed Acid-sensing ion channel 2 (ASIC2) (Amiloride-sensitive brain sodium channel) (Amiloride-sensitive brain sodium channel 2) (Amiloride-sensitive cation channel 1, neuronal) (Amiloride-sensitive cation channel neuronal 1) (Brain sodium channel 1) (BNC1) (BNaC1) (Mammalian degenerin homolog) (MDEG) Rattus norvegicus (Rat) GO:0003026; GO:0005216; GO:0005261; GO:0005886; GO:0006812; GO:0006814; GO:0007602; GO:0007605; GO:0009612; GO:0010447; GO:0015280; GO:0016020; GO:0019229; GO:0022839; GO:0034220; GO:0034765; GO:0035418; GO:0035725; GO:0042391; GO:0043005; GO:0043025; GO:0043066; GO:0043197; GO:0045202; GO:0050915; GO:0050974; GO:0051649; GO:0051965; GO:0071466; GO:0071468; GO:0098839; GO:0150052; GO:0160125 cellular response to acidic pH [GO:0071468]; cellular response to xenobiotic stimulus [GO:0071466]; detection of mechanical stimulus involved in sensory perception [GO:0050974]; establishment of localization in cell [GO:0051649]; monoatomic cation transport [GO:0006812]; monoatomic ion transmembrane transport [GO:0034220]; negative regulation of apoptotic process [GO:0043066]; phototransduction [GO:0007602]; positive regulation of synapse assembly [GO:0051965]; protein localization to synapse [GO:0035418]; regulation of membrane potential [GO:0042391]; regulation of monoatomic ion transmembrane transport [GO:0034765]; regulation of postsynapse assembly [GO:0150052]; regulation of systemic arterial blood pressure by aortic arch baroreceptor feedback [GO:0003026]; regulation of vasoconstriction [GO:0019229]; response to acidic pH [GO:0010447]; response to mechanical stimulus [GO:0009612]; sensory perception of sound [GO:0007605]; sensory perception of sour taste [GO:0050915]; sodium ion transmembrane transport [GO:0035725]; sodium ion transport [GO:0006814] dendritic spine [GO:0043197]; membrane [GO:0016020]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; synapse [GO:0045202] ligand-gated sodium channel activity [GO:0015280]; monoatomic cation channel activity [GO:0005261]; monoatomic ion channel activity [GO:0005216]; monoatomic ion-gated channel activity [GO:0022839]; pH-gated sodium channel activity [GO:0160125] g13883.t1 Q708S6 35.385 455 6.92e-84 283.0 sp|Q708S6|ASI1C_DANRE Acid-sensing ion channel 1C OS=Danio rerio OX=7955 GN=asic1c PE=1 SV=1 ASI1C_DANRE reviewed Acid-sensing ion channel 1C (ASIC1-C) (Acid-sensing ion channel 1.3-C) (Amiloride-sensitive cation channel 2-C, neuronal-C) (ZASIC1.3) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005261; GO:0005886; GO:0007269; GO:0015280; GO:0030425; GO:0035725; GO:0045211; GO:0071467; GO:0098793; GO:0098978; GO:0160128 cellular response to pH [GO:0071467]; neurotransmitter secretion [GO:0007269]; sodium ion transmembrane transport [GO:0035725] dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynapse [GO:0098793] ligand-gated sodium channel activity [GO:0015280]; monoatomic cation channel activity [GO:0005261]; pH-gated monoatomic ion channel activity [GO:0160128] g13883.t1 Q708S6 34.725 455 4.56e-83 281.0 sp|Q708S6|ASI1C_DANRE Acid-sensing ion channel 1C OS=Danio rerio OX=7955 GN=asic1c PE=1 SV=1 ASI1C_DANRE reviewed Acid-sensing ion channel 1C (ASIC1-C) (Acid-sensing ion channel 1.3-C) (Amiloride-sensitive cation channel 2-C, neuronal-C) (ZASIC1.3) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005261; GO:0005886; GO:0007269; GO:0015280; GO:0030425; GO:0035725; GO:0045211; GO:0071467; GO:0098793; GO:0098978; GO:0160128 cellular response to pH [GO:0071467]; neurotransmitter secretion [GO:0007269]; sodium ion transmembrane transport [GO:0035725] dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynapse [GO:0098793] ligand-gated sodium channel activity [GO:0015280]; monoatomic cation channel activity [GO:0005261]; pH-gated monoatomic ion channel activity [GO:0160128] g13886.t1 P55926 35.611 483 1.25e-89 286.0 sp|P55926|ASIC1_RAT Acid-sensing ion channel 1 OS=Rattus norvegicus OX=10116 GN=Asic1 PE=1 SV=1 g13887.t1 Q62962 36.111 324 1.08e-59 204.0 sp|Q62962|ASIC2_RAT Acid-sensing ion channel 2 OS=Rattus norvegicus OX=10116 GN=Asic2 PE=1 SV=1 ASIC2_RAT reviewed Acid-sensing ion channel 2 (ASIC2) (Amiloride-sensitive brain sodium channel) (Amiloride-sensitive brain sodium channel 2) (Amiloride-sensitive cation channel 1, neuronal) (Amiloride-sensitive cation channel neuronal 1) (Brain sodium channel 1) (BNC1) (BNaC1) (Mammalian degenerin homolog) (MDEG) Rattus norvegicus (Rat) GO:0003026; GO:0005216; GO:0005261; GO:0005886; GO:0006812; GO:0006814; GO:0007602; GO:0007605; GO:0009612; GO:0010447; GO:0015280; GO:0016020; GO:0019229; GO:0022839; GO:0034220; GO:0034765; GO:0035418; GO:0035725; GO:0042391; GO:0043005; GO:0043025; GO:0043066; GO:0043197; GO:0045202; GO:0050915; GO:0050974; GO:0051649; GO:0051965; GO:0071466; GO:0071468; GO:0098839; GO:0150052; GO:0160125 cellular response to acidic pH [GO:0071468]; cellular response to xenobiotic stimulus [GO:0071466]; detection of mechanical stimulus involved in sensory perception [GO:0050974]; establishment of localization in cell [GO:0051649]; monoatomic cation transport [GO:0006812]; monoatomic ion transmembrane transport [GO:0034220]; negative regulation of apoptotic process [GO:0043066]; phototransduction [GO:0007602]; positive regulation of synapse assembly [GO:0051965]; protein localization to synapse [GO:0035418]; regulation of membrane potential [GO:0042391]; regulation of monoatomic ion transmembrane transport [GO:0034765]; regulation of postsynapse assembly [GO:0150052]; regulation of systemic arterial blood pressure by aortic arch baroreceptor feedback [GO:0003026]; regulation of vasoconstriction [GO:0019229]; response to acidic pH [GO:0010447]; response to mechanical stimulus [GO:0009612]; sensory perception of sound [GO:0007605]; sensory perception of sour taste [GO:0050915]; sodium ion transmembrane transport [GO:0035725]; sodium ion transport [GO:0006814] dendritic spine [GO:0043197]; membrane [GO:0016020]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; synapse [GO:0045202] ligand-gated sodium channel activity [GO:0015280]; monoatomic cation channel activity [GO:0005261]; monoatomic ion channel activity [GO:0005216]; monoatomic ion-gated channel activity [GO:0022839]; pH-gated sodium channel activity [GO:0160125] g13892.t1 Q3SZJ4 53.846 325 1.32e-109 325.0 sp|Q3SZJ4|PTGR1_BOVIN Prostaglandin reductase 1 OS=Bos taurus OX=9913 GN=PTGR1 PE=2 SV=1 PTGR1_BOVIN reviewed Prostaglandin reductase 1 (PRG-1) (15-oxoprostaglandin 13-reductase) (EC 1.3.1.48) (Dithiolethione-inducible gene 1 protein) (D3T-inducible gene 1 protein) (DIG-1) (Leukotriene B4 12-hydroxydehydrogenase) (NAD(P)H-dependent alkenal/one oxidoreductase) (EC 1.3.1.74) Bos taurus (Bovine) GO:0005737; GO:0006693; GO:0035798; GO:0036102; GO:0036185; GO:0047522; GO:0097257; GO:2001302 leukotriene B4 metabolic process [GO:0036102]; lipoxin A4 metabolic process [GO:2001302]; prostaglandin metabolic process [GO:0006693] cytoplasm [GO:0005737] 13-lipoxin reductase activity [GO:0036185]; 15-oxoprostaglandin 13-reductase [NAD(P)+] activity [GO:0047522]; 2-alkenal reductase (NADPH) activity [GO:0035798]; leukotriene B4 12-hydroxy dehydrogenase activity [GO:0097257] g13895.t1 Q3SZJ4 53.538 325 2.65e-109 324.0 sp|Q3SZJ4|PTGR1_BOVIN Prostaglandin reductase 1 OS=Bos taurus OX=9913 GN=PTGR1 PE=2 SV=1 PTGR1_BOVIN reviewed Prostaglandin reductase 1 (PRG-1) (15-oxoprostaglandin 13-reductase) (EC 1.3.1.48) (Dithiolethione-inducible gene 1 protein) (D3T-inducible gene 1 protein) (DIG-1) (Leukotriene B4 12-hydroxydehydrogenase) (NAD(P)H-dependent alkenal/one oxidoreductase) (EC 1.3.1.74) Bos taurus (Bovine) GO:0005737; GO:0006693; GO:0035798; GO:0036102; GO:0036185; GO:0047522; GO:0097257; GO:2001302 leukotriene B4 metabolic process [GO:0036102]; lipoxin A4 metabolic process [GO:2001302]; prostaglandin metabolic process [GO:0006693] cytoplasm [GO:0005737] 13-lipoxin reductase activity [GO:0036185]; 15-oxoprostaglandin 13-reductase [NAD(P)+] activity [GO:0047522]; 2-alkenal reductase (NADPH) activity [GO:0035798]; leukotriene B4 12-hydroxy dehydrogenase activity [GO:0097257] g13898.t1 Q3SZJ4 53.846 325 3.65e-110 326.0 sp|Q3SZJ4|PTGR1_BOVIN Prostaglandin reductase 1 OS=Bos taurus OX=9913 GN=PTGR1 PE=2 SV=1 PTGR1_BOVIN reviewed Prostaglandin reductase 1 (PRG-1) (15-oxoprostaglandin 13-reductase) (EC 1.3.1.48) (Dithiolethione-inducible gene 1 protein) (D3T-inducible gene 1 protein) (DIG-1) (Leukotriene B4 12-hydroxydehydrogenase) (NAD(P)H-dependent alkenal/one oxidoreductase) (EC 1.3.1.74) Bos taurus (Bovine) GO:0005737; GO:0006693; GO:0035798; GO:0036102; GO:0036185; GO:0047522; GO:0097257; GO:2001302 leukotriene B4 metabolic process [GO:0036102]; lipoxin A4 metabolic process [GO:2001302]; prostaglandin metabolic process [GO:0006693] cytoplasm [GO:0005737] 13-lipoxin reductase activity [GO:0036185]; 15-oxoprostaglandin 13-reductase [NAD(P)+] activity [GO:0047522]; 2-alkenal reductase (NADPH) activity [GO:0035798]; leukotriene B4 12-hydroxy dehydrogenase activity [GO:0097257] g13899.t1 Q3SZJ4 53.846 325 5.28e-106 316.0 sp|Q3SZJ4|PTGR1_BOVIN Prostaglandin reductase 1 OS=Bos taurus OX=9913 GN=PTGR1 PE=2 SV=1 PTGR1_BOVIN reviewed Prostaglandin reductase 1 (PRG-1) (15-oxoprostaglandin 13-reductase) (EC 1.3.1.48) (Dithiolethione-inducible gene 1 protein) (D3T-inducible gene 1 protein) (DIG-1) (Leukotriene B4 12-hydroxydehydrogenase) (NAD(P)H-dependent alkenal/one oxidoreductase) (EC 1.3.1.74) Bos taurus (Bovine) GO:0005737; GO:0006693; GO:0035798; GO:0036102; GO:0036185; GO:0047522; GO:0097257; GO:2001302 leukotriene B4 metabolic process [GO:0036102]; lipoxin A4 metabolic process [GO:2001302]; prostaglandin metabolic process [GO:0006693] cytoplasm [GO:0005737] 13-lipoxin reductase activity [GO:0036185]; 15-oxoprostaglandin 13-reductase [NAD(P)+] activity [GO:0047522]; 2-alkenal reductase (NADPH) activity [GO:0035798]; leukotriene B4 12-hydroxy dehydrogenase activity [GO:0097257] g13900.t1 F1QNX7 50.0 168 2.12e-37 149.0 sp|F1QNX7|REN3B_DANRE Regulator of nonsense transcripts 3B OS=Danio rerio OX=7955 GN=upf3b PE=2 SV=1 g13901.t1 Q96RQ3 59.881 673 0.0 815.0 sp|Q96RQ3|MCCA_HUMAN Methylcrotonoyl-CoA carboxylase subunit alpha, mitochondrial OS=Homo sapiens OX=9606 GN=MCCC1 PE=1 SV=3 MCCA_HUMAN reviewed Methylcrotonoyl-CoA carboxylase subunit alpha, mitochondrial (MCCase subunit alpha) (EC 6.4.1.4) (3-methylcrotonyl-CoA carboxylase 1) (3-methylcrotonyl-CoA carboxylase biotin-containing subunit) (3-methylcrotonyl-CoA:carbon dioxide ligase subunit alpha) Homo sapiens (Human) GO:0004075; GO:0004485; GO:0005524; GO:0005739; GO:0005759; GO:0005829; GO:0006552; GO:0006768; GO:0009083; GO:0009374; GO:0046872; GO:1905202 biotin metabolic process [GO:0006768]; branched-chain amino acid catabolic process [GO:0009083]; L-leucine catabolic process [GO:0006552] cytosol [GO:0005829]; methylcrotonoyl-CoA carboxylase complex [GO:1905202]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] ATP binding [GO:0005524]; biotin binding [GO:0009374]; biotin carboxylase activity [GO:0004075]; metal ion binding [GO:0046872]; methylcrotonoyl-CoA carboxylase activity [GO:0004485] g13902.t1 A8MYZ0 32.0 425 1.77e-55 195.0 sp|A8MYZ0|MIY4B_HUMAN Inactive ubiquitin carboxyl-terminal hydrolase MINDY-4B OS=Homo sapiens OX=9606 GN=MINDY4B PE=3 SV=3 g13903.t1 Q3SZJ4 54.012 324 9.740000000000001e-110 325.0 sp|Q3SZJ4|PTGR1_BOVIN Prostaglandin reductase 1 OS=Bos taurus OX=9913 GN=PTGR1 PE=2 SV=1 PTGR1_BOVIN reviewed Prostaglandin reductase 1 (PRG-1) (15-oxoprostaglandin 13-reductase) (EC 1.3.1.48) (Dithiolethione-inducible gene 1 protein) (D3T-inducible gene 1 protein) (DIG-1) (Leukotriene B4 12-hydroxydehydrogenase) (NAD(P)H-dependent alkenal/one oxidoreductase) (EC 1.3.1.74) Bos taurus (Bovine) GO:0005737; GO:0006693; GO:0035798; GO:0036102; GO:0036185; GO:0047522; GO:0097257; GO:2001302 leukotriene B4 metabolic process [GO:0036102]; lipoxin A4 metabolic process [GO:2001302]; prostaglandin metabolic process [GO:0006693] cytoplasm [GO:0005737] 13-lipoxin reductase activity [GO:0036185]; 15-oxoprostaglandin 13-reductase [NAD(P)+] activity [GO:0047522]; 2-alkenal reductase (NADPH) activity [GO:0035798]; leukotriene B4 12-hydroxy dehydrogenase activity [GO:0097257] g13905.t1 P35504 29.848 526 4.6600000000000005e-59 208.0 sp|P35504|UD15_HUMAN UDP-glucuronosyltransferase 1A5 OS=Homo sapiens OX=9606 GN=UGT1A5 PE=1 SV=1 UD15_HUMAN reviewed UDP-glucuronosyltransferase 1A5 (UGT1A5) (EC 2.4.1.17) (UDP-glucuronosyltransferase 1-5) (UDPGT 1-5) (UGT1*5) (UGT1-05) (UGT1.5) (UDP-glucuronosyltransferase 1-E) (UGT-1E) (UGT1E) Homo sapiens (Human) GO:0005783; GO:0005789; GO:0008202; GO:0015020; GO:0019899; GO:0042803; GO:0046982 steroid metabolic process [GO:0008202] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789] enzyme binding [GO:0019899]; glucuronosyltransferase activity [GO:0015020]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803] g13910.t1 Q90600 41.509 477 2.43e-92 305.0 sp|Q90600|RB_CHICK Retinoblastoma-associated protein OS=Gallus gallus OX=9031 GN=RB1 PE=1 SV=1 g13911.t1 P06400 31.707 205 7.65e-24 101.0 sp|P06400|RB_HUMAN Retinoblastoma-associated protein OS=Homo sapiens OX=9606 GN=RB1 PE=1 SV=2 RB_HUMAN reviewed Retinoblastoma-associated protein (p105-Rb) (p110-RB1) (pRb) (Rb) (pp110) Homo sapiens (Human) GO:0000082; GO:0000122; GO:0000785; GO:0000977; GO:0001894; GO:0002062; GO:0003180; GO:0003714; GO:0005634; GO:0005654; GO:0005737; GO:0005819; GO:0005829; GO:0006338; GO:0006355; GO:0006366; GO:0006469; GO:0007224; GO:0007265; GO:0007283; GO:0007346; GO:0010629; GO:0014009; GO:0016514; GO:0016605; GO:0019900; GO:0030154; GO:0030308; GO:0031134; GO:0031175; GO:0031507; GO:0031625; GO:0032869; GO:0034088; GO:0034349; GO:0035189; GO:0035914; GO:0042551; GO:0042802; GO:0043353; GO:0043550; GO:0045445; GO:0045651; GO:0045786; GO:0045842; GO:0045879; GO:0045892; GO:0045944; GO:0048565; GO:0048667; GO:0050673; GO:0050680; GO:0050728; GO:0051146; GO:0051219; GO:0051276; GO:0051301; GO:0051402; GO:0051726; GO:0060090; GO:0060253; GO:0061629; GO:0061676; GO:0061793; GO:0071459; GO:0071466; GO:0097284; GO:0097718; GO:0120163; GO:0140297; GO:1903055; GO:1903944; GO:1904028; GO:1904761; GO:2000134; GO:2000679; GO:2001234 aortic valve morphogenesis [GO:0003180]; cell differentiation [GO:0030154]; cell division [GO:0051301]; cell morphogenesis involved in neuron differentiation [GO:0048667]; cellular response to insulin stimulus [GO:0032869]; cellular response to xenobiotic stimulus [GO:0071466]; chondrocyte differentiation [GO:0002062]; chromatin remodeling [GO:0006338]; chromosome organization [GO:0051276]; digestive tract development [GO:0048565]; enucleate erythrocyte differentiation [GO:0043353]; epithelial cell proliferation [GO:0050673]; G1/S transition of mitotic cell cycle [GO:0000082]; glial cell apoptotic process [GO:0034349]; glial cell proliferation [GO:0014009]; hepatocyte apoptotic process [GO:0097284]; heterochromatin formation [GO:0031507]; maintenance of mitotic sister chromatid cohesion [GO:0034088]; myoblast differentiation [GO:0045445]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell growth [GO:0030308]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of gene expression [GO:0010629]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of hepatocyte apoptotic process [GO:1903944]; negative regulation of inflammatory response [GO:0050728]; negative regulation of myofibroblast differentiation [GO:1904761]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of smoothened signaling pathway [GO:0045879]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron apoptotic process [GO:0051402]; neuron maturation [GO:0042551]; neuron projection development [GO:0031175]; positive regulation of collagen fibril organization [GO:1904028]; positive regulation of extracellular matrix organization [GO:1903055]; positive regulation of macrophage differentiation [GO:0045651]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription regulatory region DNA binding [GO:2000679]; protein localization to chromosome, centromeric region [GO:0071459]; Ras protein signal transduction [GO:0007265]; regulation of cell cycle [GO:0051726]; regulation of DNA-templated transcription [GO:0006355]; regulation of lipid kinase activity [GO:0043550]; regulation of mitotic cell cycle [GO:0007346]; sister chromatid biorientation [GO:0031134]; skeletal muscle cell differentiation [GO:0035914]; smoothened signaling pathway [GO:0007224]; spermatogenesis [GO:0007283]; striated muscle cell differentiation [GO:0051146]; tissue homeostasis [GO:0001894]; transcription by RNA polymerase II [GO:0006366] chromatin [GO:0000785]; chromatin lock complex [GO:0061793]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; Rb-E2F complex [GO:0035189]; spindle [GO:0005819]; SWI/SNF complex [GO:0016514] disordered domain specific binding [GO:0097718]; DNA-binding transcription factor binding [GO:0140297]; identical protein binding [GO:0042802]; importin-alpha family protein binding [GO:0061676]; kinase binding [GO:0019900]; molecular adaptor activity [GO:0060090]; phosphoprotein binding [GO:0051219]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription corepressor activity [GO:0003714]; ubiquitin protein ligase binding [GO:0031625] g13913.t1 Q6P5L7 61.429 140 4.42e-28 110.0 sp|Q6P5L7|ARGLA_DANRE Arginine and glutamate-rich protein 1-A OS=Danio rerio OX=7955 GN=arglu1a PE=2 SV=1 g13915.t1 Q5ZIV5 58.462 130 2.1499999999999997e-42 142.0 sp|Q5ZIV5|PDC10_CHICK Programmed cell death protein 10 OS=Gallus gallus OX=9031 GN=PDCD10 PE=2 SV=1 PDC10_CHICK reviewed Programmed cell death protein 10 Gallus gallus (Chicken) GO:0000139; GO:0001525; GO:0005829; GO:0005886; GO:0008284; GO:0010628; GO:0010629; GO:0019901; GO:0030335; GO:0032874; GO:0036481; GO:0042803; GO:0043066; GO:0044319; GO:0045747; GO:0050821; GO:0051683; GO:0090051; GO:0090168; GO:0090316; GO:0090443; GO:1903588; GO:1990830 angiogenesis [GO:0001525]; cellular response to leukemia inhibitory factor [GO:1990830]; establishment of Golgi localization [GO:0051683]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; negative regulation of apoptotic process [GO:0043066]; negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis [GO:1903588]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of gene expression [GO:0010629]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein stabilization [GO:0050821]; wound healing, spreading of cells [GO:0044319] cytosol [GO:0005829]; FAR/SIN/STRIPAK complex [GO:0090443]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886] protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901] g13916.t1 Q6PCM2 48.878 980 0.0 857.0 sp|Q6PCM2|INT6_MOUSE Integrator complex subunit 6 OS=Mus musculus OX=10090 GN=Ints6 PE=1 SV=1 g13916.t2 Q9UL03 51.856 943 0.0 884.0 sp|Q9UL03|INT6_HUMAN Integrator complex subunit 6 OS=Homo sapiens OX=9606 GN=INTS6 PE=1 SV=1 g13918.t1 Q3T0I5 60.331 121 7.43e-47 152.0 sp|Q3T0I5|FIS1_BOVIN Mitochondrial fission 1 protein OS=Bos taurus OX=9913 GN=FIS1 PE=2 SV=1 g13920.t1 Q96RE9 56.364 110 2.56e-35 140.0 sp|Q96RE9|ZN300_HUMAN Zinc finger protein 300 OS=Homo sapiens OX=9606 GN=ZNF300 PE=1 SV=1 ZN300_HUMAN reviewed Zinc finger protein 300 Homo sapiens (Human) GO:0000978; GO:0000981; GO:0001228; GO:0005634; GO:0005654; GO:0005730; GO:0006357; GO:0008270; GO:0016604; GO:0043565; GO:0045944 positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357] nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270] g13920.t1 Q96RE9 54.545 110 2.2900000000000002e-33 135.0 sp|Q96RE9|ZN300_HUMAN Zinc finger protein 300 OS=Homo sapiens OX=9606 GN=ZNF300 PE=1 SV=1 ZN300_HUMAN reviewed Zinc finger protein 300 Homo sapiens (Human) GO:0000978; GO:0000981; GO:0001228; GO:0005634; GO:0005654; GO:0005730; GO:0006357; GO:0008270; GO:0016604; GO:0043565; GO:0045944 positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357] nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270] g13920.t1 Q96RE9 51.818 110 1.8900000000000002e-32 132.0 sp|Q96RE9|ZN300_HUMAN Zinc finger protein 300 OS=Homo sapiens OX=9606 GN=ZNF300 PE=1 SV=1 ZN300_HUMAN reviewed Zinc finger protein 300 Homo sapiens (Human) GO:0000978; GO:0000981; GO:0001228; GO:0005634; GO:0005654; GO:0005730; GO:0006357; GO:0008270; GO:0016604; GO:0043565; GO:0045944 positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357] nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270] g13920.t1 Q96RE9 51.818 110 2.5e-32 132.0 sp|Q96RE9|ZN300_HUMAN Zinc finger protein 300 OS=Homo sapiens OX=9606 GN=ZNF300 PE=1 SV=1 ZN300_HUMAN reviewed Zinc finger protein 300 Homo sapiens (Human) GO:0000978; GO:0000981; GO:0001228; GO:0005634; GO:0005654; GO:0005730; GO:0006357; GO:0008270; GO:0016604; GO:0043565; GO:0045944 positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357] nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270] g13920.t1 Q96RE9 51.818 110 2.5300000000000003e-32 132.0 sp|Q96RE9|ZN300_HUMAN Zinc finger protein 300 OS=Homo sapiens OX=9606 GN=ZNF300 PE=1 SV=1 ZN300_HUMAN reviewed Zinc finger protein 300 Homo sapiens (Human) GO:0000978; GO:0000981; GO:0001228; GO:0005634; GO:0005654; GO:0005730; GO:0006357; GO:0008270; GO:0016604; GO:0043565; GO:0045944 positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357] nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270] g13920.t1 Q96RE9 46.774 124 7.23e-32 130.0 sp|Q96RE9|ZN300_HUMAN Zinc finger protein 300 OS=Homo sapiens OX=9606 GN=ZNF300 PE=1 SV=1 ZN300_HUMAN reviewed Zinc finger protein 300 Homo sapiens (Human) GO:0000978; GO:0000981; GO:0001228; GO:0005634; GO:0005654; GO:0005730; GO:0006357; GO:0008270; GO:0016604; GO:0043565; GO:0045944 positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357] nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270] g13920.t1 Q96RE9 50.909 110 5.9e-31 128.0 sp|Q96RE9|ZN300_HUMAN Zinc finger protein 300 OS=Homo sapiens OX=9606 GN=ZNF300 PE=1 SV=1 ZN300_HUMAN reviewed Zinc finger protein 300 Homo sapiens (Human) GO:0000978; GO:0000981; GO:0001228; GO:0005634; GO:0005654; GO:0005730; GO:0006357; GO:0008270; GO:0016604; GO:0043565; GO:0045944 positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357] nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270] g13920.t1 Q96RE9 50.0 110 1.63e-30 126.0 sp|Q96RE9|ZN300_HUMAN Zinc finger protein 300 OS=Homo sapiens OX=9606 GN=ZNF300 PE=1 SV=1 ZN300_HUMAN reviewed Zinc finger protein 300 Homo sapiens (Human) GO:0000978; GO:0000981; GO:0001228; GO:0005634; GO:0005654; GO:0005730; GO:0006357; GO:0008270; GO:0016604; GO:0043565; GO:0045944 positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357] nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270] g13920.t1 Q96RE9 44.118 136 9.26e-29 121.0 sp|Q96RE9|ZN300_HUMAN Zinc finger protein 300 OS=Homo sapiens OX=9606 GN=ZNF300 PE=1 SV=1 ZN300_HUMAN reviewed Zinc finger protein 300 Homo sapiens (Human) GO:0000978; GO:0000981; GO:0001228; GO:0005634; GO:0005654; GO:0005730; GO:0006357; GO:0008270; GO:0016604; GO:0043565; GO:0045944 positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357] nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270] g13920.t1 Q96RE9 42.188 128 1.3e-24 109.0 sp|Q96RE9|ZN300_HUMAN Zinc finger protein 300 OS=Homo sapiens OX=9606 GN=ZNF300 PE=1 SV=1 ZN300_HUMAN reviewed Zinc finger protein 300 Homo sapiens (Human) GO:0000978; GO:0000981; GO:0001228; GO:0005634; GO:0005654; GO:0005730; GO:0006357; GO:0008270; GO:0016604; GO:0043565; GO:0045944 positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357] nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270] g13921.t1 P24928 73.51 151 4.88e-49 186.0 sp|P24928|RPB1_HUMAN DNA-directed RNA polymerase II subunit RPB1 OS=Homo sapiens OX=9606 GN=POLR2A PE=1 SV=2 RPB1_HUMAN reviewed DNA-directed RNA polymerase II subunit RPB1 (RNA polymerase II subunit B1) (EC 2.7.7.6) (3'-5' exoribonuclease) (EC 3.1.13.-) (DNA-directed RNA polymerase II subunit A) (DNA-directed RNA polymerase III largest subunit) (RNA-directed RNA polymerase II subunit RPB1) (EC 2.7.7.48) Homo sapiens (Human) GO:0000287; GO:0003677; GO:0003723; GO:0003899; GO:0003968; GO:0005634; GO:0005654; GO:0005665; GO:0005694; GO:0005737; GO:0006353; GO:0006355; GO:0006366; GO:0006368; GO:0008270; GO:0016787; GO:0019900; GO:0031625; GO:0033120; GO:0042789; GO:0050436; GO:1990841 DNA-templated transcription termination [GO:0006353]; mRNA transcription by RNA polymerase II [GO:0042789]; positive regulation of RNA splicing [GO:0033120]; regulation of DNA-templated transcription [GO:0006355]; transcription by RNA polymerase II [GO:0006366]; transcription elongation by RNA polymerase II [GO:0006368] chromosome [GO:0005694]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II, core complex [GO:0005665] DNA binding [GO:0003677]; DNA-directed RNA polymerase activity [GO:0003899]; hydrolase activity [GO:0016787]; kinase binding [GO:0019900]; magnesium ion binding [GO:0000287]; microfibril binding [GO:0050436]; promoter-specific chromatin binding [GO:1990841]; RNA binding [GO:0003723]; RNA-directed RNA polymerase activity [GO:0003968]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270] g13922.t1 P08775 79.008 1391 0.0 2365.0 sp|P08775|RPB1_MOUSE DNA-directed RNA polymerase II subunit RPB1 OS=Mus musculus OX=10090 GN=Polr2a PE=1 SV=3 g13925.t1 Q8BYM5 52.427 103 8.34e-25 103.0 sp|Q8BYM5|NLGN3_MOUSE Neuroligin-3 OS=Mus musculus OX=10090 GN=Nlgn3 PE=1 SV=2 NLGN3_MOUSE reviewed Neuroligin-3 (Gliotactin homolog) Mus musculus (Mouse) GO:0002087; GO:0005886; GO:0006898; GO:0007158; GO:0007268; GO:0007416; GO:0007612; GO:0008542; GO:0009986; GO:0030139; GO:0030425; GO:0030534; GO:0035176; GO:0038023; GO:0042043; GO:0042745; GO:0043025; GO:0045202; GO:0045211; GO:0048488; GO:0048675; GO:0048709; GO:0050804; GO:0050808; GO:0050839; GO:0051965; GO:0051966; GO:0051968; GO:0060024; GO:0060076; GO:0060077; GO:0060079; GO:0060080; GO:0060134; GO:0060291; GO:0060999; GO:0061001; GO:0061002; GO:0071625; GO:0090394; GO:0097104; GO:0097105; GO:0097110; GO:0097151; GO:0098631; GO:0098698; GO:0098793; GO:0098978; GO:0098982; GO:0099634; GO:1900271; GO:1900451; GO:1902474; GO:2000310; GO:2000311; GO:2000331; GO:2000463; GO:2000809; GO:2000969 adult behavior [GO:0030534]; axon extension [GO:0048675]; chemical synaptic transmission [GO:0007268]; circadian sleep/wake cycle [GO:0042745]; excitatory postsynaptic potential [GO:0060079]; inhibitory postsynaptic potential [GO:0060080]; learning [GO:0007612]; long-term synaptic potentiation [GO:0060291]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of dendritic spine morphogenesis [GO:0061002]; negative regulation of excitatory postsynaptic potential [GO:0090394]; neuron cell-cell adhesion [GO:0007158]; oligodendrocyte differentiation [GO:0048709]; positive regulation of AMPA receptor activity [GO:2000969]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of glutamate receptor signaling pathway [GO:1900451]; positive regulation of inhibitory postsynaptic potential [GO:0097151]; positive regulation of protein localization to synapse [GO:1902474]; positive regulation of synapse assembly [GO:0051965]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; positive regulation of synaptic vesicle clustering [GO:2000809]; postsynaptic membrane assembly [GO:0097104]; postsynaptic specialization assembly [GO:0098698]; prepulse inhibition [GO:0060134]; presynaptic membrane assembly [GO:0097105]; receptor-mediated endocytosis [GO:0006898]; regulation of AMPA receptor activity [GO:2000311]; regulation of dendritic spine morphogenesis [GO:0061001]; regulation of long-term synaptic potentiation [GO:1900271]; regulation of NMDA receptor activity [GO:2000310]; regulation of respiratory gaseous exchange by nervous system process [GO:0002087]; regulation of synaptic transmission, glutamatergic [GO:0051966]; regulation of terminal button organization [GO:2000331]; rhythmic synaptic transmission [GO:0060024]; social behavior [GO:0035176]; synapse assembly [GO:0007416]; synapse organization [GO:0050808]; synaptic vesicle endocytosis [GO:0048488]; visual learning [GO:0008542]; vocalization behavior [GO:0071625] cell surface [GO:0009986]; dendrite [GO:0030425]; endocytic vesicle [GO:0030139]; excitatory synapse [GO:0060076]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; inhibitory synapse [GO:0060077]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; postsynaptic specialization membrane [GO:0099634]; presynapse [GO:0098793]; synapse [GO:0045202] cell adhesion mediator activity [GO:0098631]; cell adhesion molecule binding [GO:0050839]; neurexin family protein binding [GO:0042043]; scaffold protein binding [GO:0097110]; signaling receptor activity [GO:0038023] g13926.t1 Q8N0W4 39.721 574 1.5999999999999999e-114 367.0 sp|Q8N0W4|NLGNX_HUMAN Neuroligin-4, X-linked OS=Homo sapiens OX=9606 GN=NLGN4X PE=1 SV=1 NLGNX_HUMAN reviewed Neuroligin-4, X-linked (Neuroligin X) (HNLX) Homo sapiens (Human) GO:0003360; GO:0005886; GO:0007158; GO:0007416; GO:0007612; GO:0009986; GO:0016020; GO:0021549; GO:0030182; GO:0030425; GO:0030534; GO:0031404; GO:0035176; GO:0035265; GO:0042043; GO:0042803; GO:0045202; GO:0045216; GO:0050804; GO:0050808; GO:0050839; GO:0051963; GO:0060076; GO:0071625; GO:0090394; GO:0097105; GO:0097110; GO:0098631; GO:0098839; GO:0098978; GO:0098982; GO:0098983; GO:0098985; GO:0099054; GO:0099634 adult behavior [GO:0030534]; brainstem development [GO:0003360]; cell-cell junction organization [GO:0045216]; cerebellum development [GO:0021549]; learning [GO:0007612]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of excitatory postsynaptic potential [GO:0090394]; neuron cell-cell adhesion [GO:0007158]; neuron differentiation [GO:0030182]; organ growth [GO:0035265]; presynapse assembly [GO:0099054]; presynaptic membrane assembly [GO:0097105]; regulation of synapse assembly [GO:0051963]; social behavior [GO:0035176]; synapse assembly [GO:0007416]; synapse organization [GO:0050808]; vocalization behavior [GO:0071625] asymmetric, glutamatergic, excitatory synapse [GO:0098985]; cell surface [GO:0009986]; dendrite [GO:0030425]; excitatory synapse [GO:0060076]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; postsynaptic specialization membrane [GO:0099634]; symmetric, GABA-ergic, inhibitory synapse [GO:0098983]; synapse [GO:0045202] cell adhesion mediator activity [GO:0098631]; cell adhesion molecule binding [GO:0050839]; chloride ion binding [GO:0031404]; neurexin family protein binding [GO:0042043]; protein homodimerization activity [GO:0042803]; scaffold protein binding [GO:0097110] g13928.t1 Q8BX05 49.63 135 1.15e-28 112.0 sp|Q8BX05|GLPK5_MOUSE Glycerol kinase 5 OS=Mus musculus OX=10090 GN=Gk5 PE=1 SV=2 GLPK5_MOUSE reviewed Glycerol kinase 5 (GK 5) (Glycerokinase 5) (EC 2.7.1.30) (ATP:glycerol 3-phosphotransferase 5) Mus musculus (Mouse) GO:0004370; GO:0005524; GO:0005737; GO:0005739; GO:0006071; GO:0006641; GO:0019563; GO:0046167 glycerol catabolic process [GO:0019563]; glycerol metabolic process [GO:0006071]; glycerol-3-phosphate biosynthetic process [GO:0046167]; triglyceride metabolic process [GO:0006641] cytoplasm [GO:0005737]; mitochondrion [GO:0005739] ATP binding [GO:0005524]; glycerol kinase activity [GO:0004370] g13929.t1 Q6GP95 50.0 336 8.02e-124 367.0 sp|Q6GP95|GLPK5_XENLA Glycerol kinase 5 OS=Xenopus laevis OX=8355 GN=gk5 PE=2 SV=1 GLPK5_XENLA reviewed Glycerol kinase 5 (GK 5) (Glycerokinase 5) (EC 2.7.1.30) (ATP:glycerol 3-phosphotransferase 5) Xenopus laevis (African clawed frog) GO:0004370; GO:0005524; GO:0005737; GO:0005739; GO:0006071; GO:0006641; GO:0019563; GO:0046167 glycerol catabolic process [GO:0019563]; glycerol metabolic process [GO:0006071]; glycerol-3-phosphate biosynthetic process [GO:0046167]; triglyceride metabolic process [GO:0006641] cytoplasm [GO:0005737]; mitochondrion [GO:0005739] ATP binding [GO:0005524]; glycerol kinase activity [GO:0004370] g13931.t1 P49129 27.251 422 1.32e-25 112.0 sp|P49129|LAMP1_CRIGR Lysosome-associated membrane glycoprotein 1 OS=Cricetulus griseus OX=10029 GN=LAMP1 PE=2 SV=1 g13932.t1 Q8R2X8 35.75 400 1.25e-48 172.0 sp|Q8R2X8|GO45_MOUSE Golgin-45 OS=Mus musculus OX=10090 GN=Blzf1 PE=1 SV=2 GO45_MOUSE reviewed Golgin-45 (Basic leucine zipper nuclear factor 1) Mus musculus (Mouse) GO:0000139; GO:0005634; GO:0005654; GO:0005794; GO:0007030; GO:0019899; GO:0031625; GO:0043001 Golgi organization [GO:0007030]; Golgi to plasma membrane protein transport [GO:0043001] Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] enzyme binding [GO:0019899]; ubiquitin protein ligase binding [GO:0031625] g13933.t1 Q7ZWA3 60.0 85 2.1399999999999997e-23 104.0 sp|Q7ZWA3|RBMX_DANRE RNA-binding motif protein, X chromosome OS=Danio rerio OX=7955 GN=rbmx PE=2 SV=1 RBMX_DANRE reviewed RNA-binding motif protein, X chromosome (Heterogeneous nuclear ribonucleoprotein G) (hnRNP G) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000381; GO:0000398; GO:0000791; GO:0000978; GO:0003682; GO:0003723; GO:0003729; GO:0005634; GO:0006366; GO:0006509; GO:0017069; GO:0044530; GO:0045944; GO:0048025; GO:0048026; GO:0051260; GO:0070062; GO:0071013; GO:0071347 cellular response to interleukin-1 [GO:0071347]; membrane protein ectodomain proteolysis [GO:0006509]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein homooligomerization [GO:0051260]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; transcription by RNA polymerase II [GO:0006366] catalytic step 2 spliceosome [GO:0071013]; euchromatin [GO:0000791]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; supraspliceosomal complex [GO:0044530] chromatin binding [GO:0003682]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; snRNA binding [GO:0017069] g13933.t2 Q7ZWA3 60.0 85 2.9099999999999996e-23 105.0 sp|Q7ZWA3|RBMX_DANRE RNA-binding motif protein, X chromosome OS=Danio rerio OX=7955 GN=rbmx PE=2 SV=1 RBMX_DANRE reviewed RNA-binding motif protein, X chromosome (Heterogeneous nuclear ribonucleoprotein G) (hnRNP G) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000381; GO:0000398; GO:0000791; GO:0000978; GO:0003682; GO:0003723; GO:0003729; GO:0005634; GO:0006366; GO:0006509; GO:0017069; GO:0044530; GO:0045944; GO:0048025; GO:0048026; GO:0051260; GO:0070062; GO:0071013; GO:0071347 cellular response to interleukin-1 [GO:0071347]; membrane protein ectodomain proteolysis [GO:0006509]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein homooligomerization [GO:0051260]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; transcription by RNA polymerase II [GO:0006366] catalytic step 2 spliceosome [GO:0071013]; euchromatin [GO:0000791]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; supraspliceosomal complex [GO:0044530] chromatin binding [GO:0003682]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; snRNA binding [GO:0017069] g13933.t3 Q7ZWA3 60.0 85 5.0899999999999995e-23 104.0 sp|Q7ZWA3|RBMX_DANRE RNA-binding motif protein, X chromosome OS=Danio rerio OX=7955 GN=rbmx PE=2 SV=1 RBMX_DANRE reviewed RNA-binding motif protein, X chromosome (Heterogeneous nuclear ribonucleoprotein G) (hnRNP G) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000381; GO:0000398; GO:0000791; GO:0000978; GO:0003682; GO:0003723; GO:0003729; GO:0005634; GO:0006366; GO:0006509; GO:0017069; GO:0044530; GO:0045944; GO:0048025; GO:0048026; GO:0051260; GO:0070062; GO:0071013; GO:0071347 cellular response to interleukin-1 [GO:0071347]; membrane protein ectodomain proteolysis [GO:0006509]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein homooligomerization [GO:0051260]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; transcription by RNA polymerase II [GO:0006366] catalytic step 2 spliceosome [GO:0071013]; euchromatin [GO:0000791]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; supraspliceosomal complex [GO:0044530] chromatin binding [GO:0003682]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; snRNA binding [GO:0017069] g13934.t1 Q4KLA0 66.279 258 1.18e-133 382.0 sp|Q4KLA0|CCNC_XENLA Cyclin-C OS=Xenopus laevis OX=8355 GN=ccnc PE=2 SV=1 g13935.t1 Q9VJ31 38.854 314 8.89e-65 210.0 sp|Q9VJ31|BHMT_DROME Betaine-homocysteine S-methyltransferase OS=Drosophila melanogaster OX=7227 GN=Bhmt PE=2 SV=1 g13936.t1 Q8CCH2 48.333 300 2.39e-93 284.0 sp|Q8CCH2|NHLC3_MOUSE NHL repeat-containing protein 3 OS=Mus musculus OX=10090 GN=Nhlrc3 PE=1 SV=1 g13937.t1 H2QII6 48.993 149 6.07e-35 150.0 sp|H2QII6|RBP2_PANTR E3 SUMO-protein ligase RanBP2 OS=Pan troglodytes OX=9598 GN=RANBP2 PE=1 SV=1 g13937.t1 H2QII6 42.593 162 1.17e-31 139.0 sp|H2QII6|RBP2_PANTR E3 SUMO-protein ligase RanBP2 OS=Pan troglodytes OX=9598 GN=RANBP2 PE=1 SV=1 g13937.t1 H2QII6 34.884 258 2.4e-31 138.0 sp|H2QII6|RBP2_PANTR E3 SUMO-protein ligase RanBP2 OS=Pan troglodytes OX=9598 GN=RANBP2 PE=1 SV=1 g13937.t1 H2QII6 50.735 136 5.630000000000001e-31 137.0 sp|H2QII6|RBP2_PANTR E3 SUMO-protein ligase RanBP2 OS=Pan troglodytes OX=9598 GN=RANBP2 PE=1 SV=1 g13937.t2 H2QII6 45.946 148 1.1100000000000001e-31 139.0 sp|H2QII6|RBP2_PANTR E3 SUMO-protein ligase RanBP2 OS=Pan troglodytes OX=9598 GN=RANBP2 PE=1 SV=1 g13937.t2 H2QII6 33.852 257 7.13e-29 130.0 sp|H2QII6|RBP2_PANTR E3 SUMO-protein ligase RanBP2 OS=Pan troglodytes OX=9598 GN=RANBP2 PE=1 SV=1 g13937.t2 H2QII6 40.373 161 1.02e-28 129.0 sp|H2QII6|RBP2_PANTR E3 SUMO-protein ligase RanBP2 OS=Pan troglodytes OX=9598 GN=RANBP2 PE=1 SV=1 g13937.t2 H2QII6 47.407 135 1.3e-27 126.0 sp|H2QII6|RBP2_PANTR E3 SUMO-protein ligase RanBP2 OS=Pan troglodytes OX=9598 GN=RANBP2 PE=1 SV=1 g13937.t3 H2QII6 45.946 148 1.16e-31 139.0 sp|H2QII6|RBP2_PANTR E3 SUMO-protein ligase RanBP2 OS=Pan troglodytes OX=9598 GN=RANBP2 PE=1 SV=1 g13937.t3 H2QII6 33.852 257 7.440000000000001e-29 130.0 sp|H2QII6|RBP2_PANTR E3 SUMO-protein ligase RanBP2 OS=Pan troglodytes OX=9598 GN=RANBP2 PE=1 SV=1 g13937.t3 H2QII6 40.373 161 1.06e-28 129.0 sp|H2QII6|RBP2_PANTR E3 SUMO-protein ligase RanBP2 OS=Pan troglodytes OX=9598 GN=RANBP2 PE=1 SV=1 g13937.t3 H2QII6 47.407 135 1.3600000000000002e-27 126.0 sp|H2QII6|RBP2_PANTR E3 SUMO-protein ligase RanBP2 OS=Pan troglodytes OX=9598 GN=RANBP2 PE=1 SV=1 g13939.t1 P48820 55.446 101 8.17e-26 117.0 sp|P48820|RBP2_BOVIN E3 SUMO-protein ligase RanBP2 (Fragment) OS=Bos taurus OX=9913 GN=RANBP2 PE=2 SV=2 RBP2_BOVIN reviewed E3 SUMO-protein ligase RanBP2 (EC 2.3.2.-) (358 kDa nucleoporin) (Nuclear pore complex protein Nup358) (Nucleoporin Nup358) (Ran-binding protein 2) (RanBP2) (p270) Bos taurus (Bovine) GO:0003723; GO:0003755; GO:0005635; GO:0005642; GO:0005643; GO:0005737; GO:0006457; GO:0015031; GO:0016018; GO:0016740; GO:0016925; GO:0031965; GO:0042405; GO:0044615; GO:0051028 mRNA transport [GO:0051028]; protein folding [GO:0006457]; protein sumoylation [GO:0016925]; protein transport [GO:0015031] annulate lamellae [GO:0005642]; cytoplasm [GO:0005737]; nuclear envelope [GO:0005635]; nuclear inclusion body [GO:0042405]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nuclear pore nuclear basket [GO:0044615] cyclosporin A binding [GO:0016018]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; RNA binding [GO:0003723]; transferase activity [GO:0016740] g13940.t1 H2QII6 40.777 206 1.72e-38 159.0 sp|H2QII6|RBP2_PANTR E3 SUMO-protein ligase RanBP2 OS=Pan troglodytes OX=9598 GN=RANBP2 PE=1 SV=1 g13940.t1 H2QII6 51.128 133 3.79e-36 151.0 sp|H2QII6|RBP2_PANTR E3 SUMO-protein ligase RanBP2 OS=Pan troglodytes OX=9598 GN=RANBP2 PE=1 SV=1 g13940.t1 H2QII6 51.128 133 3.79e-36 151.0 sp|H2QII6|RBP2_PANTR E3 SUMO-protein ligase RanBP2 OS=Pan troglodytes OX=9598 GN=RANBP2 PE=1 SV=1 g13940.t1 H2QII6 50.0 140 8.8e-36 150.0 sp|H2QII6|RBP2_PANTR E3 SUMO-protein ligase RanBP2 OS=Pan troglodytes OX=9598 GN=RANBP2 PE=1 SV=1 g13940.t1 H2QII6 43.82 178 8.96e-36 150.0 sp|H2QII6|RBP2_PANTR E3 SUMO-protein ligase RanBP2 OS=Pan troglodytes OX=9598 GN=RANBP2 PE=1 SV=1 g13940.t1 H2QII6 43.82 178 8.96e-36 150.0 sp|H2QII6|RBP2_PANTR E3 SUMO-protein ligase RanBP2 OS=Pan troglodytes OX=9598 GN=RANBP2 PE=1 SV=1 g13940.t1 H2QII6 47.727 132 1.5800000000000002e-31 137.0 sp|H2QII6|RBP2_PANTR E3 SUMO-protein ligase RanBP2 OS=Pan troglodytes OX=9598 GN=RANBP2 PE=1 SV=1 g13940.t1 H2QII6 47.727 132 1.5800000000000002e-31 137.0 sp|H2QII6|RBP2_PANTR E3 SUMO-protein ligase RanBP2 OS=Pan troglodytes OX=9598 GN=RANBP2 PE=1 SV=1 g13940.t1 H2QII6 52.747 91 3.6300000000000003e-22 107.0 sp|H2QII6|RBP2_PANTR E3 SUMO-protein ligase RanBP2 OS=Pan troglodytes OX=9598 GN=RANBP2 PE=1 SV=1 g13940.t1 H2QII6 48.98 98 3.0900000000000003e-21 103.0 sp|H2QII6|RBP2_PANTR E3 SUMO-protein ligase RanBP2 OS=Pan troglodytes OX=9598 GN=RANBP2 PE=1 SV=1 g13942.t1 P0DJD0 33.238 349 1.2599999999999999e-42 174.0 sp|P0DJD0|RGPD1_HUMAN RANBP2-like and GRIP domain-containing protein 1 OS=Homo sapiens OX=9606 GN=RGPD1 PE=2 SV=1 g13942.t1 P0DJD0 54.198 131 8.92e-39 162.0 sp|P0DJD0|RGPD1_HUMAN RANBP2-like and GRIP domain-containing protein 1 OS=Homo sapiens OX=9606 GN=RGPD1 PE=2 SV=1 g13942.t1 P0DJD0 54.4 125 2.21e-36 154.0 sp|P0DJD0|RGPD1_HUMAN RANBP2-like and GRIP domain-containing protein 1 OS=Homo sapiens OX=9606 GN=RGPD1 PE=2 SV=1 g13942.t1 P0DJD0 38.306 248 9.16e-36 152.0 sp|P0DJD0|RGPD1_HUMAN RANBP2-like and GRIP domain-containing protein 1 OS=Homo sapiens OX=9606 GN=RGPD1 PE=2 SV=1 g13942.t1 P0DJD0 48.837 129 5.12e-33 143.0 sp|P0DJD0|RGPD1_HUMAN RANBP2-like and GRIP domain-containing protein 1 OS=Homo sapiens OX=9606 GN=RGPD1 PE=2 SV=1 g13942.t1 P0DJD0 50.0 126 7.26e-33 142.0 sp|P0DJD0|RGPD1_HUMAN RANBP2-like and GRIP domain-containing protein 1 OS=Homo sapiens OX=9606 GN=RGPD1 PE=2 SV=1 g13943.t1 P0DJD0 36.73 422 1.6899999999999997e-67 258.0 sp|P0DJD0|RGPD1_HUMAN RANBP2-like and GRIP domain-containing protein 1 OS=Homo sapiens OX=9606 GN=RGPD1 PE=2 SV=1 g13943.t1 P0DJD0 36.73 422 1.95e-67 257.0 sp|P0DJD0|RGPD1_HUMAN RANBP2-like and GRIP domain-containing protein 1 OS=Homo sapiens OX=9606 GN=RGPD1 PE=2 SV=1 g13943.t1 P0DJD0 48.193 166 2.96e-37 159.0 sp|P0DJD0|RGPD1_HUMAN RANBP2-like and GRIP domain-containing protein 1 OS=Homo sapiens OX=9606 GN=RGPD1 PE=2 SV=1 g13943.t1 P0DJD0 43.125 160 7.26e-36 154.0 sp|P0DJD0|RGPD1_HUMAN RANBP2-like and GRIP domain-containing protein 1 OS=Homo sapiens OX=9606 GN=RGPD1 PE=2 SV=1 g13943.t1 P0DJD0 47.305 167 2.07e-35 152.0 sp|P0DJD0|RGPD1_HUMAN RANBP2-like and GRIP domain-containing protein 1 OS=Homo sapiens OX=9606 GN=RGPD1 PE=2 SV=1 g13943.t1 P0DJD0 49.254 134 1.38e-34 150.0 sp|P0DJD0|RGPD1_HUMAN RANBP2-like and GRIP domain-containing protein 1 OS=Homo sapiens OX=9606 GN=RGPD1 PE=2 SV=1 g13943.t1 P0DJD0 38.075 239 7.27e-34 147.0 sp|P0DJD0|RGPD1_HUMAN RANBP2-like and GRIP domain-containing protein 1 OS=Homo sapiens OX=9606 GN=RGPD1 PE=2 SV=1 g13943.t1 P0DJD0 37.657 239 2.9e-33 145.0 sp|P0DJD0|RGPD1_HUMAN RANBP2-like and GRIP domain-containing protein 1 OS=Homo sapiens OX=9606 GN=RGPD1 PE=2 SV=1 g13943.t1 P0DJD0 48.837 129 2.4300000000000002e-32 142.0 sp|P0DJD0|RGPD1_HUMAN RANBP2-like and GRIP domain-containing protein 1 OS=Homo sapiens OX=9606 GN=RGPD1 PE=2 SV=1 g13943.t1 P0DJD0 48.837 129 2.4300000000000002e-32 142.0 sp|P0DJD0|RGPD1_HUMAN RANBP2-like and GRIP domain-containing protein 1 OS=Homo sapiens OX=9606 GN=RGPD1 PE=2 SV=1 g13944.t1 Q9ERU9 54.331 127 3.16e-38 154.0 sp|Q9ERU9|RBP2_MOUSE E3 SUMO-protein ligase RanBP2 OS=Mus musculus OX=10090 GN=Ranbp2 PE=1 SV=2 RBP2_MOUSE reviewed E3 SUMO-protein ligase RanBP2 (EC 2.3.2.-) (Ran-binding protein 2) (RanBP2) Mus musculus (Mouse) GO:0001975; GO:0002224; GO:0002753; GO:0003723; GO:0003755; GO:0005634; GO:0005635; GO:0005642; GO:0005643; GO:0005654; GO:0005737; GO:0005829; GO:0006111; GO:0006457; GO:0006607; GO:0006913; GO:0008270; GO:0016925; GO:0019209; GO:0019789; GO:0031267; GO:0031965; GO:0042405; GO:0044614; GO:0044615; GO:0044877; GO:0045824; GO:0046832; GO:0051028; GO:0051168; GO:0051642; GO:0061665; GO:0106068; GO:1990723 centrosome localization [GO:0051642]; cytoplasmic pattern recognition receptor signaling pathway [GO:0002753]; mRNA transport [GO:0051028]; negative regulation of innate immune response [GO:0045824]; negative regulation of RNA export from nucleus [GO:0046832]; NLS-bearing protein import into nucleus [GO:0006607]; nuclear export [GO:0051168]; nucleocytoplasmic transport [GO:0006913]; protein folding [GO:0006457]; protein sumoylation [GO:0016925]; regulation of gluconeogenesis [GO:0006111]; response to amphetamine [GO:0001975]; toll-like receptor signaling pathway [GO:0002224] annulate lamellae [GO:0005642]; cytoplasm [GO:0005737]; cytoplasmic periphery of the nuclear pore complex [GO:1990723]; cytosol [GO:0005829]; nuclear envelope [GO:0005635]; nuclear inclusion body [GO:0042405]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nuclear pore cytoplasmic filaments [GO:0044614]; nuclear pore nuclear basket [GO:0044615]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SUMO ligase complex [GO:0106068] kinase activator activity [GO:0019209]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; small GTPase binding [GO:0031267]; SUMO ligase activity [GO:0061665]; SUMO transferase activity [GO:0019789]; zinc ion binding [GO:0008270] g13944.t1 Q9ERU9 54.93 142 3.5e-37 151.0 sp|Q9ERU9|RBP2_MOUSE E3 SUMO-protein ligase RanBP2 OS=Mus musculus OX=10090 GN=Ranbp2 PE=1 SV=2 RBP2_MOUSE reviewed E3 SUMO-protein ligase RanBP2 (EC 2.3.2.-) (Ran-binding protein 2) (RanBP2) Mus musculus (Mouse) GO:0001975; GO:0002224; GO:0002753; GO:0003723; GO:0003755; GO:0005634; GO:0005635; GO:0005642; GO:0005643; GO:0005654; GO:0005737; GO:0005829; GO:0006111; GO:0006457; GO:0006607; GO:0006913; GO:0008270; GO:0016925; GO:0019209; GO:0019789; GO:0031267; GO:0031965; GO:0042405; GO:0044614; GO:0044615; GO:0044877; GO:0045824; GO:0046832; GO:0051028; GO:0051168; GO:0051642; GO:0061665; GO:0106068; GO:1990723 centrosome localization [GO:0051642]; cytoplasmic pattern recognition receptor signaling pathway [GO:0002753]; mRNA transport [GO:0051028]; negative regulation of innate immune response [GO:0045824]; negative regulation of RNA export from nucleus [GO:0046832]; NLS-bearing protein import into nucleus [GO:0006607]; nuclear export [GO:0051168]; nucleocytoplasmic transport [GO:0006913]; protein folding [GO:0006457]; protein sumoylation [GO:0016925]; regulation of gluconeogenesis [GO:0006111]; response to amphetamine [GO:0001975]; toll-like receptor signaling pathway [GO:0002224] annulate lamellae [GO:0005642]; cytoplasm [GO:0005737]; cytoplasmic periphery of the nuclear pore complex [GO:1990723]; cytosol [GO:0005829]; nuclear envelope [GO:0005635]; nuclear inclusion body [GO:0042405]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nuclear pore cytoplasmic filaments [GO:0044614]; nuclear pore nuclear basket [GO:0044615]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SUMO ligase complex [GO:0106068] kinase activator activity [GO:0019209]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; small GTPase binding [GO:0031267]; SUMO ligase activity [GO:0061665]; SUMO transferase activity [GO:0019789]; zinc ion binding [GO:0008270] g13944.t1 Q9ERU9 48.0 150 1.3500000000000002e-32 137.0 sp|Q9ERU9|RBP2_MOUSE E3 SUMO-protein ligase RanBP2 OS=Mus musculus OX=10090 GN=Ranbp2 PE=1 SV=2 RBP2_MOUSE reviewed E3 SUMO-protein ligase RanBP2 (EC 2.3.2.-) (Ran-binding protein 2) (RanBP2) Mus musculus (Mouse) GO:0001975; GO:0002224; GO:0002753; GO:0003723; GO:0003755; GO:0005634; GO:0005635; GO:0005642; GO:0005643; GO:0005654; GO:0005737; GO:0005829; GO:0006111; GO:0006457; GO:0006607; GO:0006913; GO:0008270; GO:0016925; GO:0019209; GO:0019789; GO:0031267; GO:0031965; GO:0042405; GO:0044614; GO:0044615; GO:0044877; GO:0045824; GO:0046832; GO:0051028; GO:0051168; GO:0051642; GO:0061665; GO:0106068; GO:1990723 centrosome localization [GO:0051642]; cytoplasmic pattern recognition receptor signaling pathway [GO:0002753]; mRNA transport [GO:0051028]; negative regulation of innate immune response [GO:0045824]; negative regulation of RNA export from nucleus [GO:0046832]; NLS-bearing protein import into nucleus [GO:0006607]; nuclear export [GO:0051168]; nucleocytoplasmic transport [GO:0006913]; protein folding [GO:0006457]; protein sumoylation [GO:0016925]; regulation of gluconeogenesis [GO:0006111]; response to amphetamine [GO:0001975]; toll-like receptor signaling pathway [GO:0002224] annulate lamellae [GO:0005642]; cytoplasm [GO:0005737]; cytoplasmic periphery of the nuclear pore complex [GO:1990723]; cytosol [GO:0005829]; nuclear envelope [GO:0005635]; nuclear inclusion body [GO:0042405]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nuclear pore cytoplasmic filaments [GO:0044614]; nuclear pore nuclear basket [GO:0044615]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SUMO ligase complex [GO:0106068] kinase activator activity [GO:0019209]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; small GTPase binding [GO:0031267]; SUMO ligase activity [GO:0061665]; SUMO transferase activity [GO:0019789]; zinc ion binding [GO:0008270] g13944.t1 Q9ERU9 40.659 182 1.7200000000000002e-31 134.0 sp|Q9ERU9|RBP2_MOUSE E3 SUMO-protein ligase RanBP2 OS=Mus musculus OX=10090 GN=Ranbp2 PE=1 SV=2 RBP2_MOUSE reviewed E3 SUMO-protein ligase RanBP2 (EC 2.3.2.-) (Ran-binding protein 2) (RanBP2) Mus musculus (Mouse) GO:0001975; GO:0002224; GO:0002753; GO:0003723; GO:0003755; GO:0005634; GO:0005635; GO:0005642; GO:0005643; GO:0005654; GO:0005737; GO:0005829; GO:0006111; GO:0006457; GO:0006607; GO:0006913; GO:0008270; GO:0016925; GO:0019209; GO:0019789; GO:0031267; GO:0031965; GO:0042405; GO:0044614; GO:0044615; GO:0044877; GO:0045824; GO:0046832; GO:0051028; GO:0051168; GO:0051642; GO:0061665; GO:0106068; GO:1990723 centrosome localization [GO:0051642]; cytoplasmic pattern recognition receptor signaling pathway [GO:0002753]; mRNA transport [GO:0051028]; negative regulation of innate immune response [GO:0045824]; negative regulation of RNA export from nucleus [GO:0046832]; NLS-bearing protein import into nucleus [GO:0006607]; nuclear export [GO:0051168]; nucleocytoplasmic transport [GO:0006913]; protein folding [GO:0006457]; protein sumoylation [GO:0016925]; regulation of gluconeogenesis [GO:0006111]; response to amphetamine [GO:0001975]; toll-like receptor signaling pathway [GO:0002224] annulate lamellae [GO:0005642]; cytoplasm [GO:0005737]; cytoplasmic periphery of the nuclear pore complex [GO:1990723]; cytosol [GO:0005829]; nuclear envelope [GO:0005635]; nuclear inclusion body [GO:0042405]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nuclear pore cytoplasmic filaments [GO:0044614]; nuclear pore nuclear basket [GO:0044615]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SUMO ligase complex [GO:0106068] kinase activator activity [GO:0019209]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; small GTPase binding [GO:0031267]; SUMO ligase activity [GO:0061665]; SUMO transferase activity [GO:0019789]; zinc ion binding [GO:0008270] g13945.t1 Q9BRZ2 29.344 259 2.49e-26 119.0 sp|Q9BRZ2|TRI56_HUMAN E3 ubiquitin-protein ligase TRIM56 OS=Homo sapiens OX=9606 GN=TRIM56 PE=1 SV=3 g13946.t1 P78333 35.0 320 1.5000000000000002e-56 202.0 sp|P78333|GPC5_HUMAN Glypican-5 OS=Homo sapiens OX=9606 GN=GPC5 PE=1 SV=1 GPC5_HUMAN reviewed Glypican-5 [Cleaved into: Secreted glypican-5] Homo sapiens (Human) GO:0005576; GO:0005796; GO:0005886; GO:0009986; GO:0016020; GO:0016477; GO:0043202; GO:0090263; GO:0098552; GO:1905475 cell migration [GO:0016477]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; regulation of protein localization to membrane [GO:1905475] cell surface [GO:0009986]; extracellular region [GO:0005576]; Golgi lumen [GO:0005796]; lysosomal lumen [GO:0043202]; membrane [GO:0016020]; plasma membrane [GO:0005886]; side of membrane [GO:0098552] g13948.t1 O95819 63.566 387 1.63e-162 515.0 sp|O95819|M4K4_HUMAN Mitogen-activated protein kinase kinase kinase kinase 4 OS=Homo sapiens OX=9606 GN=MAP4K4 PE=1 SV=2 g13948.t1 O95819 77.946 331 1e-148 478.0 sp|O95819|M4K4_HUMAN Mitogen-activated protein kinase kinase kinase kinase 4 OS=Homo sapiens OX=9606 GN=MAP4K4 PE=1 SV=2 g13948.t2 O95819 63.566 387 3.51e-162 515.0 sp|O95819|M4K4_HUMAN Mitogen-activated protein kinase kinase kinase kinase 4 OS=Homo sapiens OX=9606 GN=MAP4K4 PE=1 SV=2 g13948.t2 O95819 77.946 331 2.34e-148 478.0 sp|O95819|M4K4_HUMAN Mitogen-activated protein kinase kinase kinase kinase 4 OS=Homo sapiens OX=9606 GN=MAP4K4 PE=1 SV=2 g13948.t3 O95819 63.566 387 2.34e-162 514.0 sp|O95819|M4K4_HUMAN Mitogen-activated protein kinase kinase kinase kinase 4 OS=Homo sapiens OX=9606 GN=MAP4K4 PE=1 SV=2 g13948.t3 O95819 77.946 331 1.13e-148 478.0 sp|O95819|M4K4_HUMAN Mitogen-activated protein kinase kinase kinase kinase 4 OS=Homo sapiens OX=9606 GN=MAP4K4 PE=1 SV=2 g13951.t1 P53356 43.988 657 9.98e-172 514.0 sp|P53356|HTK16_HYDVU Tyrosine-protein kinase HTK16 OS=Hydra vulgaris OX=6087 GN=HTK16 PE=2 SV=1 g13956.t1 Q9HAR2 29.797 443 1.6399999999999999e-40 166.0 sp|Q9HAR2|AGRL3_HUMAN Adhesion G protein-coupled receptor L3 OS=Homo sapiens OX=9606 GN=ADGRL3 PE=1 SV=2 g13957.t1 P48059 69.536 302 2.9099999999999997e-146 418.0 sp|P48059|LIMS1_HUMAN LIM and senescent cell antigen-like-containing domain protein 1 OS=Homo sapiens OX=9606 GN=LIMS1 PE=1 SV=4 LIMS1_HUMAN reviewed LIM and senescent cell antigen-like-containing domain protein 1 (Particularly interesting new Cys-His protein 1) (PINCH-1) (Renal carcinoma antigen NY-REN-48) Homo sapiens (Human) GO:0003779; GO:0005737; GO:0005829; GO:0005886; GO:0005911; GO:0005925; GO:0007160; GO:0008270; GO:0019901; GO:0033209; GO:0043123; GO:0045216; GO:0045892; GO:0048471; GO:0071560; GO:0098609; GO:1900026; GO:2001046 cell-cell adhesion [GO:0098609]; cell-cell junction organization [GO:0045216]; cell-matrix adhesion [GO:0007160]; cellular response to transforming growth factor beta stimulus [GO:0071560]; negative regulation of DNA-templated transcription [GO:0045892]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; tumor necrosis factor-mediated signaling pathway [GO:0033209] cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886] actin binding [GO:0003779]; protein kinase binding [GO:0019901]; zinc ion binding [GO:0008270] g13958.t1 P07768 46.057 317 1.65e-84 282.0 sp|P07768|SUIS_RABIT Sucrase-isomaltase, intestinal OS=Oryctolagus cuniculus OX=9986 GN=SI PE=1 SV=3 g13958.t1 P07768 43.252 326 3.41e-80 270.0 sp|P07768|SUIS_RABIT Sucrase-isomaltase, intestinal OS=Oryctolagus cuniculus OX=9986 GN=SI PE=1 SV=3 g13958.t2 P07768 47.634 317 2.57e-91 302.0 sp|P07768|SUIS_RABIT Sucrase-isomaltase, intestinal OS=Oryctolagus cuniculus OX=9986 GN=SI PE=1 SV=3 g13958.t2 P07768 42.553 329 1.37e-80 271.0 sp|P07768|SUIS_RABIT Sucrase-isomaltase, intestinal OS=Oryctolagus cuniculus OX=9986 GN=SI PE=1 SV=3 g13959.t1 P14410 49.383 567 3.12e-162 509.0 sp|P14410|SUIS_HUMAN Sucrase-isomaltase, intestinal OS=Homo sapiens OX=9606 GN=SI PE=1 SV=6 SUIS_HUMAN reviewed Sucrase-isomaltase, intestinal [Cleaved into: Sucrase (EC 3.2.1.48); Isomaltase (EC 3.2.1.10)] Homo sapiens (Human) GO:0004558; GO:0004574; GO:0004575; GO:0005794; GO:0005886; GO:0005903; GO:0005987; GO:0016324; GO:0030246; GO:0044245; GO:0070062 polysaccharide digestion [GO:0044245]; sucrose catabolic process [GO:0005987] apical plasma membrane [GO:0016324]; brush border [GO:0005903]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; plasma membrane [GO:0005886] alpha-1,4-glucosidase activity [GO:0004558]; carbohydrate binding [GO:0030246]; oligo-1,6-glucosidase activity [GO:0004574]; sucrose alpha-glucosidase activity [GO:0004575] g13959.t1 P14410 43.438 541 1.7999999999999999e-128 416.0 sp|P14410|SUIS_HUMAN Sucrase-isomaltase, intestinal OS=Homo sapiens OX=9606 GN=SI PE=1 SV=6 SUIS_HUMAN reviewed Sucrase-isomaltase, intestinal [Cleaved into: Sucrase (EC 3.2.1.48); Isomaltase (EC 3.2.1.10)] Homo sapiens (Human) GO:0004558; GO:0004574; GO:0004575; GO:0005794; GO:0005886; GO:0005903; GO:0005987; GO:0016324; GO:0030246; GO:0044245; GO:0070062 polysaccharide digestion [GO:0044245]; sucrose catabolic process [GO:0005987] apical plasma membrane [GO:0016324]; brush border [GO:0005903]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; plasma membrane [GO:0005886] alpha-1,4-glucosidase activity [GO:0004558]; carbohydrate binding [GO:0030246]; oligo-1,6-glucosidase activity [GO:0004574]; sucrose alpha-glucosidase activity [GO:0004575] g13960.t1 P07768 35.816 913 3.71e-173 553.0 sp|P07768|SUIS_RABIT Sucrase-isomaltase, intestinal OS=Oryctolagus cuniculus OX=9986 GN=SI PE=1 SV=3 g13960.t1 P07768 33.023 860 8.73e-136 451.0 sp|P07768|SUIS_RABIT Sucrase-isomaltase, intestinal OS=Oryctolagus cuniculus OX=9986 GN=SI PE=1 SV=3 g13962.t1 P41247 41.057 246 8.49e-63 205.0 sp|P41247|PLPL4_HUMAN Patatin-like phospholipase domain-containing protein 4 OS=Homo sapiens OX=9606 GN=PNPLA4 PE=1 SV=3 PLPL4_HUMAN reviewed Patatin-like phospholipase domain-containing protein 4 (EC 3.1.1.3) (Calcium-independent phospholipase A2-eta) (iPLA2-eta) (EC 3.1.1.4) (Protein GS2) Homo sapiens (Human) GO:0004623; GO:0004806; GO:0005737; GO:0005739; GO:0005811; GO:0005829; GO:0016020; GO:0016411; GO:0019433; GO:0047376; GO:0050253; GO:0051264; GO:0051265; GO:0055088 lipid homeostasis [GO:0055088]; triglyceride catabolic process [GO:0019433] cytoplasm [GO:0005737]; cytosol [GO:0005829]; lipid droplet [GO:0005811]; membrane [GO:0016020]; mitochondrion [GO:0005739] acylglycerol O-acyltransferase activity [GO:0016411]; all-trans-retinyl-palmitate hydrolase, all-trans-retinol forming activity [GO:0047376]; diolein transacylation activity [GO:0051265]; mono-olein transacylation activity [GO:0051264]; phospholipase A2 activity [GO:0004623]; retinyl-palmitate esterase activity [GO:0050253]; triacylglycerol lipase activity [GO:0004806] g13963.t1 Q6PFS7 69.375 320 4.97e-147 419.0 sp|Q6PFS7|ATG3_DANRE Ubiquitin-like-conjugating enzyme ATG3 OS=Danio rerio OX=7955 GN=atg3 PE=2 SV=1 ATG3_DANRE reviewed Ubiquitin-like-conjugating enzyme ATG3 (EC 2.3.2.-) (Autophagy-related protein 3) (APG3-like) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000045; GO:0000407; GO:0000422; GO:0005829; GO:0006914; GO:0015031; GO:0019776; GO:0019777; GO:0043653; GO:0044804; GO:0061723; GO:0141046 autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; autophagy of mitochondrion [GO:0000422]; glycophagy [GO:0061723]; mitochondrial fragmentation involved in apoptotic process [GO:0043653]; nucleophagy [GO:0044804]; protein transport [GO:0015031] cytosol [GO:0005829]; phagophore assembly site [GO:0000407] Atg12 transferase activity [GO:0019777]; Atg8-family conjugating enzyme activity [GO:0141046]; Atg8-family ligase activity [GO:0019776] g13964.t1 P49407 57.045 440 3.36e-151 441.0 sp|P49407|ARRB1_HUMAN Beta-arrestin-1 OS=Homo sapiens OX=9606 GN=ARRB1 PE=1 SV=2 ARRB1_HUMAN reviewed Beta-arrestin-1 (Arrestin beta-1) (Non-visual arrestin-2) Homo sapiens (Human) GO:0000139; GO:0000785; GO:0001664; GO:0001678; GO:0001934; GO:0002029; GO:0002031; GO:0002092; GO:0003713; GO:0004857; GO:0005096; GO:0005159; GO:0005634; GO:0005654; GO:0005737; GO:0005765; GO:0005829; GO:0005886; GO:0005905; GO:0006357; GO:0006511; GO:0007166; GO:0007600; GO:0010613; GO:0015031; GO:0016567; GO:0016604; GO:0030659; GO:0030666; GO:0031143; GO:0031397; GO:0031410; GO:0031625; GO:0031701; GO:0032088; GO:0032715; GO:0032717; GO:0035025; GO:0043149; GO:0043161; GO:0045746; GO:0045944; GO:0060090; GO:0070374; GO:1990763 cell surface receptor signaling pathway [GO:0007166]; desensitization of G protein-coupled receptor signaling pathway [GO:0002029]; G protein-coupled receptor internalization [GO:0002031]; intracellular glucose homeostasis [GO:0001678]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of interleukin-8 production [GO:0032717]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of protein ubiquitination [GO:0031397]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of receptor internalization [GO:0002092]; positive regulation of Rho protein signal transduction [GO:0035025]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein transport [GO:0015031]; protein ubiquitination [GO:0016567]; regulation of transcription by RNA polymerase II [GO:0006357]; sensory perception [GO:0007600]; stress fiber assembly [GO:0043149]; ubiquitin-dependent protein catabolic process [GO:0006511] chromatin [GO:0000785]; clathrin-coated pit [GO:0005905]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; endocytic vesicle membrane [GO:0030666]; Golgi membrane [GO:0000139]; lysosomal membrane [GO:0005765]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; pseudopodium [GO:0031143] angiotensin receptor binding [GO:0031701]; arrestin family protein binding [GO:1990763]; enzyme inhibitor activity [GO:0004857]; G protein-coupled receptor binding [GO:0001664]; GTPase activator activity [GO:0005096]; insulin-like growth factor receptor binding [GO:0005159]; molecular adaptor activity [GO:0060090]; transcription coactivator activity [GO:0003713]; ubiquitin protein ligase binding [GO:0031625] g13964.t2 P49407 56.979 437 1.21e-149 435.0 sp|P49407|ARRB1_HUMAN Beta-arrestin-1 OS=Homo sapiens OX=9606 GN=ARRB1 PE=1 SV=2 ARRB1_HUMAN reviewed Beta-arrestin-1 (Arrestin beta-1) (Non-visual arrestin-2) Homo sapiens (Human) GO:0000139; GO:0000785; GO:0001664; GO:0001678; GO:0001934; GO:0002029; GO:0002031; GO:0002092; GO:0003713; GO:0004857; GO:0005096; GO:0005159; GO:0005634; GO:0005654; GO:0005737; GO:0005765; GO:0005829; GO:0005886; GO:0005905; GO:0006357; GO:0006511; GO:0007166; GO:0007600; GO:0010613; GO:0015031; GO:0016567; GO:0016604; GO:0030659; GO:0030666; GO:0031143; GO:0031397; GO:0031410; GO:0031625; GO:0031701; GO:0032088; GO:0032715; GO:0032717; GO:0035025; GO:0043149; GO:0043161; GO:0045746; GO:0045944; GO:0060090; GO:0070374; GO:1990763 cell surface receptor signaling pathway [GO:0007166]; desensitization of G protein-coupled receptor signaling pathway [GO:0002029]; G protein-coupled receptor internalization [GO:0002031]; intracellular glucose homeostasis [GO:0001678]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of interleukin-8 production [GO:0032717]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of protein ubiquitination [GO:0031397]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of receptor internalization [GO:0002092]; positive regulation of Rho protein signal transduction [GO:0035025]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein transport [GO:0015031]; protein ubiquitination [GO:0016567]; regulation of transcription by RNA polymerase II [GO:0006357]; sensory perception [GO:0007600]; stress fiber assembly [GO:0043149]; ubiquitin-dependent protein catabolic process [GO:0006511] chromatin [GO:0000785]; clathrin-coated pit [GO:0005905]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; endocytic vesicle membrane [GO:0030666]; Golgi membrane [GO:0000139]; lysosomal membrane [GO:0005765]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; pseudopodium [GO:0031143] angiotensin receptor binding [GO:0031701]; arrestin family protein binding [GO:1990763]; enzyme inhibitor activity [GO:0004857]; G protein-coupled receptor binding [GO:0001664]; GTPase activator activity [GO:0005096]; insulin-like growth factor receptor binding [GO:0005159]; molecular adaptor activity [GO:0060090]; transcription coactivator activity [GO:0003713]; ubiquitin protein ligase binding [GO:0031625] g13966.t1 Q5F3U0 37.634 279 4.210000000000001e-43 174.0 sp|Q5F3U0|SP130_CHICK Histone deacetylase complex subunit SAP130 OS=Gallus gallus OX=9031 GN=SAP130 PE=2 SV=1 g13967.t1 Q68EW7 52.941 102 5.6400000000000004e-33 114.0 sp|Q68EW7|MED11_XENLA Mediator of RNA polymerase II transcription subunit 11 OS=Xenopus laevis OX=8355 GN=med11 PE=3 SV=1 g13969.t1 Q2I6J1 37.876 932 0.0 583.0 sp|Q2I6J1|SHP2A_DANRE Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2A OS=Danio rerio OX=7955 GN=inppl1a PE=2 SV=2 SHP2A_DANRE reviewed Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2A (EC 3.1.3.86) (Inositol polyphosphate phosphatase-like protein 1A) (INPPL1-A) (SH2 domain-containing inositol 5'-phosphatase 2A) (SH2 domain-containing inositol phosphatase 2A) (SHIP-2A) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0002376; GO:0003779; GO:0004445; GO:0005634; GO:0005829; GO:0005856; GO:0007155; GO:0016020; GO:0016607; GO:0030027; GO:0030175; GO:0030509; GO:0034485; GO:0040037; GO:0043569; GO:0046856; GO:0050776; GO:0090024 BMP signaling pathway [GO:0030509]; cell adhesion [GO:0007155]; immune system process [GO:0002376]; negative regulation of fibroblast growth factor receptor signaling pathway [GO:0040037]; negative regulation of insulin-like growth factor receptor signaling pathway [GO:0043569]; negative regulation of neutrophil chemotaxis [GO:0090024]; phosphatidylinositol dephosphorylation [GO:0046856]; regulation of immune response [GO:0050776] cytoskeleton [GO:0005856]; cytosol [GO:0005829]; filopodium [GO:0030175]; lamellipodium [GO:0030027]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleus [GO:0005634] actin binding [GO:0003779]; inositol-polyphosphate 5-phosphatase activity [GO:0004445]; phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity [GO:0034485] g13970.t1 P48818 60.925 627 0.0 763.0 sp|P48818|ACADV_BOVIN Very long-chain specific acyl-CoA dehydrogenase, mitochondrial OS=Bos taurus OX=9913 GN=ACADVL PE=2 SV=3 ACADV_BOVIN reviewed Very long-chain specific acyl-CoA dehydrogenase, mitochondrial (VLCAD) (EC 1.3.8.9) (Long-chain specific acyl-CoA dehydrogenase, mitochondrial) (EC 1.3.8.8) Bos taurus (Bovine) GO:0000062; GO:0003995; GO:0005743; GO:0017099; GO:0033539; GO:0042802; GO:0050660 fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539] mitochondrial inner membrane [GO:0005743] acyl-CoA dehydrogenase activity [GO:0003995]; fatty-acyl-CoA binding [GO:0000062]; flavin adenine dinucleotide binding [GO:0050660]; identical protein binding [GO:0042802]; very-long-chain fatty acyl-CoA dehydrogenase activity [GO:0017099] g13971.t1 O55043 40.973 637 1.9e-149 449.0 sp|O55043|ARHG7_RAT Rho guanine nucleotide exchange factor 7 OS=Rattus norvegicus OX=10116 GN=Arhgef7 PE=1 SV=1 ARHG7_RAT reviewed Rho guanine nucleotide exchange factor 7 (Beta-Pix) (PAK-interacting exchange factor beta) Rattus norvegicus (Rat) GO:0000322; GO:0001726; GO:0002244; GO:0005085; GO:0005737; GO:0005813; GO:0005829; GO:0005886; GO:0005925; GO:0005938; GO:0007030; GO:0007264; GO:0007266; GO:0019901; GO:0030027; GO:0030032; GO:0030426; GO:0032991; GO:0043005; GO:0043008; GO:0043015; GO:0043025; GO:0043065; GO:0043615; GO:0060124; GO:0097431; GO:0098794; GO:0098974; GO:0098982; GO:0099140; GO:1905833 astrocyte cell migration [GO:0043615]; Golgi organization [GO:0007030]; hematopoietic progenitor cell differentiation [GO:0002244]; lamellipodium assembly [GO:0030032]; negative regulation of microtubule nucleation [GO:1905833]; positive regulation of apoptotic process [GO:0043065]; positive regulation of growth hormone secretion [GO:0060124]; postsynaptic actin cytoskeleton organization [GO:0098974]; presynaptic actin cytoskeleton organization [GO:0099140]; Rho protein signal transduction [GO:0007266]; small GTPase-mediated signal transduction [GO:0007264] cell cortex [GO:0005938]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; GABA-ergic synapse [GO:0098982]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; mitotic spindle pole [GO:0097431]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; protein-containing complex [GO:0032991]; ruffle [GO:0001726]; storage vacuole [GO:0000322] ATP-dependent protein binding [GO:0043008]; gamma-tubulin binding [GO:0043015]; guanyl-nucleotide exchange factor activity [GO:0005085]; protein kinase binding [GO:0019901] g13971.t2 Q9ES28 38.825 698 7.26e-146 448.0 sp|Q9ES28|ARHG7_MOUSE Rho guanine nucleotide exchange factor 7 OS=Mus musculus OX=10090 GN=Arhgef7 PE=1 SV=2 g13971.t3 O55043 40.072 554 2.7600000000000004e-116 362.0 sp|O55043|ARHG7_RAT Rho guanine nucleotide exchange factor 7 OS=Rattus norvegicus OX=10116 GN=Arhgef7 PE=1 SV=1 ARHG7_RAT reviewed Rho guanine nucleotide exchange factor 7 (Beta-Pix) (PAK-interacting exchange factor beta) Rattus norvegicus (Rat) GO:0000322; GO:0001726; GO:0002244; GO:0005085; GO:0005737; GO:0005813; GO:0005829; GO:0005886; GO:0005925; GO:0005938; GO:0007030; GO:0007264; GO:0007266; GO:0019901; GO:0030027; GO:0030032; GO:0030426; GO:0032991; GO:0043005; GO:0043008; GO:0043015; GO:0043025; GO:0043065; GO:0043615; GO:0060124; GO:0097431; GO:0098794; GO:0098974; GO:0098982; GO:0099140; GO:1905833 astrocyte cell migration [GO:0043615]; Golgi organization [GO:0007030]; hematopoietic progenitor cell differentiation [GO:0002244]; lamellipodium assembly [GO:0030032]; negative regulation of microtubule nucleation [GO:1905833]; positive regulation of apoptotic process [GO:0043065]; positive regulation of growth hormone secretion [GO:0060124]; postsynaptic actin cytoskeleton organization [GO:0098974]; presynaptic actin cytoskeleton organization [GO:0099140]; Rho protein signal transduction [GO:0007266]; small GTPase-mediated signal transduction [GO:0007264] cell cortex [GO:0005938]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; GABA-ergic synapse [GO:0098982]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; mitotic spindle pole [GO:0097431]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; protein-containing complex [GO:0032991]; ruffle [GO:0001726]; storage vacuole [GO:0000322] ATP-dependent protein binding [GO:0043008]; gamma-tubulin binding [GO:0043015]; guanyl-nucleotide exchange factor activity [GO:0005085]; protein kinase binding [GO:0019901] g13972.t1 P70170 37.157 1604 0.0 951.0 sp|P70170|ABCC9_MOUSE ATP-binding cassette sub-family C member 9 OS=Mus musculus OX=10090 GN=Abcc9 PE=1 SV=2 g13972.t2 P70170 36.347 1604 0.0 919.0 sp|P70170|ABCC9_MOUSE ATP-binding cassette sub-family C member 9 OS=Mus musculus OX=10090 GN=Abcc9 PE=1 SV=2 g13974.t1 A0A0R4IBK5 30.0 1110 2.5199999999999997e-115 419.0 sp|A0A0R4IBK5|R213A_DANRE E3 ubiquitin-protein ligase rnf213-alpha OS=Danio rerio OX=7955 GN=rnf213a PE=3 SV=1 R213A_DANRE reviewed E3 ubiquitin-protein ligase rnf213-alpha (EC 2.3.2.27) (EC 3.6.4.-) (E3 ubiquitin-lipopolysaccharide ligase rnf213-alpha) (EC 2.3.2.-) (Mysterin-A) (Mysterin-alpha) (RING finger protein 213-A) (RING finger protein 213-alpha) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0002040; GO:0002376; GO:0004842; GO:0005524; GO:0005730; GO:0005811; GO:0005829; GO:0006511; GO:0008015; GO:0008270; GO:0016887; GO:0019216; GO:0042742; GO:0045765; GO:0061630; GO:0070534; GO:0098792; GO:0120323; GO:0140042; GO:2000051 blood circulation [GO:0008015]; defense response to bacterium [GO:0042742]; immune system process [GO:0002376]; lipid droplet formation [GO:0140042]; lipid ubiquitination [GO:0120323]; negative regulation of non-canonical Wnt signaling pathway [GO:2000051]; protein K63-linked ubiquitination [GO:0070534]; regulation of angiogenesis [GO:0045765]; regulation of lipid metabolic process [GO:0019216]; sprouting angiogenesis [GO:0002040]; ubiquitin-dependent protein catabolic process [GO:0006511]; xenophagy [GO:0098792] cytosol [GO:0005829]; lipid droplet [GO:0005811]; nucleolus [GO:0005730] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] g13982.t1 F4IF36 42.561 531 1.84e-121 412.0 sp|F4IF36|FGT1_ARATH Protein FORGETTER 1 OS=Arabidopsis thaliana OX=3702 GN=FGT1 PE=1 SV=1 FGT1_ARATH reviewed Protein FORGETTER 1 (Protein EMBRYO DEFECTIVE 1135) Arabidopsis thaliana (Mouse-ear cress) GO:0005634; GO:0006338; GO:0006355; GO:0008270; GO:0009408; GO:0010286; GO:0031490; GO:0040029; GO:0042393; GO:1900036; GO:1990841 chromatin remodeling [GO:0006338]; epigenetic regulation of gene expression [GO:0040029]; heat acclimation [GO:0010286]; positive regulation of cellular response to heat [GO:1900036]; regulation of DNA-templated transcription [GO:0006355]; response to heat [GO:0009408] nucleus [GO:0005634] chromatin DNA binding [GO:0031490]; histone binding [GO:0042393]; promoter-specific chromatin binding [GO:1990841]; zinc ion binding [GO:0008270] g13982.t1 F4IF36 41.25 480 5.13e-97 343.0 sp|F4IF36|FGT1_ARATH Protein FORGETTER 1 OS=Arabidopsis thaliana OX=3702 GN=FGT1 PE=1 SV=1 FGT1_ARATH reviewed Protein FORGETTER 1 (Protein EMBRYO DEFECTIVE 1135) Arabidopsis thaliana (Mouse-ear cress) GO:0005634; GO:0006338; GO:0006355; GO:0008270; GO:0009408; GO:0010286; GO:0031490; GO:0040029; GO:0042393; GO:1900036; GO:1990841 chromatin remodeling [GO:0006338]; epigenetic regulation of gene expression [GO:0040029]; heat acclimation [GO:0010286]; positive regulation of cellular response to heat [GO:1900036]; regulation of DNA-templated transcription [GO:0006355]; response to heat [GO:0009408] nucleus [GO:0005634] chromatin DNA binding [GO:0031490]; histone binding [GO:0042393]; promoter-specific chromatin binding [GO:1990841]; zinc ion binding [GO:0008270] g13984.t1 Q61165 47.669 472 1.06e-119 380.0 sp|Q61165|SL9A1_MOUSE Sodium/hydrogen exchanger 1 OS=Mus musculus OX=10090 GN=Slc9a1 PE=1 SV=1 SL9A1_MOUSE reviewed Sodium/hydrogen exchanger 1 (Na(+)/H(+) exchanger 1) (NHE-1) (Solute carrier family 9 member 1) Mus musculus (Mouse) GO:0002026; GO:0005516; GO:0005543; GO:0005654; GO:0005737; GO:0005739; GO:0005886; GO:0006814; GO:0006883; GO:0006885; GO:0009986; GO:0010447; GO:0010613; GO:0010882; GO:0014704; GO:0015385; GO:0015386; GO:0016020; GO:0016323; GO:0016324; GO:0030214; GO:0030307; GO:0030315; GO:0030346; GO:0032869; GO:0035794; GO:0035994; GO:0036376; GO:0042383; GO:0042802; GO:0043065; GO:0043066; GO:0045121; GO:0045760; GO:0045944; GO:0048306; GO:0048471; GO:0051259; GO:0051453; GO:0055007; GO:0070417; GO:0070886; GO:0071236; GO:0071257; GO:0071456; GO:0071468; GO:0071805; GO:0071872; GO:0086003; GO:0086092; GO:0090533; GO:0098719; GO:0098735; GO:1902533; GO:1902600; GO:1990351 cardiac muscle cell contraction [GO:0086003]; cardiac muscle cell differentiation [GO:0055007]; cellular response to acidic pH [GO:0071468]; cellular response to antibiotic [GO:0071236]; cellular response to cold [GO:0070417]; cellular response to electrical stimulus [GO:0071257]; cellular response to epinephrine stimulus [GO:0071872]; cellular response to hypoxia [GO:0071456]; cellular response to insulin stimulus [GO:0032869]; hyaluronan catabolic process [GO:0030214]; intracellular sodium ion homeostasis [GO:0006883]; negative regulation of apoptotic process [GO:0043066]; positive regulation of action potential [GO:0045760]; positive regulation of apoptotic process [GO:0043065]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of cell growth [GO:0030307]; positive regulation of intracellular signal transduction [GO:1902533]; positive regulation of mitochondrial membrane permeability [GO:0035794]; positive regulation of the force of heart contraction [GO:0098735]; positive regulation of transcription by RNA polymerase II [GO:0045944]; potassium ion transmembrane transport [GO:0071805]; protein complex oligomerization [GO:0051259]; proton transmembrane transport [GO:1902600]; regulation of cardiac muscle contraction by calcium ion signaling [GO:0010882]; regulation of intracellular pH [GO:0051453]; regulation of pH [GO:0006885]; regulation of the force of heart contraction [GO:0002026]; regulation of the force of heart contraction by cardiac conduction [GO:0086092]; response to acidic pH [GO:0010447]; response to muscle stretch [GO:0035994]; sodium ion export across plasma membrane [GO:0036376]; sodium ion import across plasma membrane [GO:0098719]; sodium ion transport [GO:0006814] apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cation-transporting ATPase complex [GO:0090533]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; intercalated disc [GO:0014704]; membrane [GO:0016020]; membrane raft [GO:0045121]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; T-tubule [GO:0030315]; transporter complex [GO:1990351] calcium-dependent protein binding [GO:0048306]; calmodulin binding [GO:0005516]; identical protein binding [GO:0042802]; phospholipid binding [GO:0005543]; potassium:proton antiporter activity [GO:0015386]; protein phosphatase 2B binding [GO:0030346]; sodium:proton antiporter activity [GO:0015385] g13984.t2 P48764 44.618 511 3.08e-116 372.0 sp|P48764|SL9A3_HUMAN Sodium/hydrogen exchanger 3 OS=Homo sapiens OX=9606 GN=SLC9A3 PE=1 SV=2 SL9A3_HUMAN reviewed Sodium/hydrogen exchanger 3 (Na(+)/H(+) exchanger 3) (NHE-3) (Solute carrier family 9 member 3) Homo sapiens (Human) GO:0005769; GO:0005886; GO:0005903; GO:0006811; GO:0009986; GO:0015385; GO:0015386; GO:0016324; GO:0030165; GO:0031526; GO:0031901; GO:0035091; GO:0042802; GO:0051453; GO:0055038; GO:0070062; GO:0071805; GO:0098719 monoatomic ion transport [GO:0006811]; potassium ion transmembrane transport [GO:0071805]; regulation of intracellular pH [GO:0051453]; sodium ion import across plasma membrane [GO:0098719] apical plasma membrane [GO:0016324]; brush border [GO:0005903]; brush border membrane [GO:0031526]; cell surface [GO:0009986]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; extracellular exosome [GO:0070062]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038] identical protein binding [GO:0042802]; PDZ domain binding [GO:0030165]; phosphatidylinositol binding [GO:0035091]; potassium:proton antiporter activity [GO:0015386]; sodium:proton antiporter activity [GO:0015385] g13987.t1 Q8BGC3 30.618 356 1.16e-21 100.0 sp|Q8BGC3|MOT12_MOUSE Monocarboxylate transporter 12 OS=Mus musculus OX=10090 GN=Slc16a12 PE=1 SV=1 g13988.t1 Q9VIH7 34.725 527 2.53e-93 301.0 sp|Q9VIH7|SKY_DROME GTPase-activating protein skywalker OS=Drosophila melanogaster OX=7227 GN=sky PE=1 SV=2 g13991.t1 P41732 39.548 177 2.24e-34 124.0 sp|P41732|TSN7_HUMAN Tetraspanin-7 OS=Homo sapiens OX=9606 GN=TSPAN7 PE=1 SV=2 TSN7_HUMAN reviewed Tetraspanin-7 (Tspan-7) (Cell surface glycoprotein A15) (Membrane component chromosome X surface marker 1) (T-cell acute lymphoblastic leukemia-associated antigen 1) (TALLA-1) (Transmembrane 4 superfamily member 2) (CD antigen CD231) Homo sapiens (Human) GO:0005886 plasma membrane [GO:0005886] g13992.t1 Q5F4B3 39.011 364 7.629999999999999e-92 285.0 sp|Q5F4B3|TMLH_CHICK Trimethyllysine dioxygenase, mitochondrial OS=Gallus gallus OX=9031 GN=TMLHE PE=2 SV=1 TMLH_CHICK reviewed Trimethyllysine dioxygenase, mitochondrial (EC 1.14.11.8) (Epsilon-trimethyllysine 2-oxoglutarate dioxygenase) (TML hydroxylase) (TML-alpha-ketoglutarate dioxygenase) (TML dioxygenase) (TMLD) Gallus gallus (Chicken) GO:0005506; GO:0005739; GO:0005759; GO:0045329; GO:0050353 carnitine biosynthetic process [GO:0045329] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] iron ion binding [GO:0005506]; trimethyllysine dioxygenase activity [GO:0050353] g13993.t1 Q96N46 40.568 387 9.429999999999999e-76 272.0 sp|Q96N46|TTC14_HUMAN Tetratricopeptide repeat protein 14 OS=Homo sapiens OX=9606 GN=TTC14 PE=1 SV=1 g13994.t1 P41116 84.921 252 2.57e-160 447.0 sp|P41116|RL8_XENLA Large ribosomal subunit protein uL2 OS=Xenopus laevis OX=8355 GN=rpl8 PE=2 SV=3 g13995.t1 Q9NYQ6 35.294 340 4.53e-40 164.0 sp|Q9NYQ6|CELR1_HUMAN Cadherin EGF LAG seven-pass G-type receptor 1 OS=Homo sapiens OX=9606 GN=CELSR1 PE=1 SV=1 CELR1_HUMAN reviewed Cadherin EGF LAG seven-pass G-type receptor 1 (Cadherin family member 9) (Flamingo homolog 2) (hFmi2) Homo sapiens (Human) GO:0001736; GO:0001764; GO:0001843; GO:0004930; GO:0005509; GO:0005654; GO:0005886; GO:0005912; GO:0007156; GO:0007266; GO:0007409; GO:0007417; GO:0016020; GO:0032956; GO:0042249; GO:0044331; GO:0045176; GO:0048105; GO:0060071; GO:0060488; GO:0060489; GO:0060490; GO:0090251 apical protein localization [GO:0045176]; axonogenesis [GO:0007409]; cell-cell adhesion mediated by cadherin [GO:0044331]; central nervous system development [GO:0007417]; establishment of body hair planar orientation [GO:0048105]; establishment of planar polarity [GO:0001736]; establishment of planar polarity of embryonic epithelium [GO:0042249]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; lateral sprouting involved in lung morphogenesis [GO:0060490]; neural tube closure [GO:0001843]; neuron migration [GO:0001764]; orthogonal dichotomous subdivision of terminal units involved in lung branching morphogenesis [GO:0060488]; planar dichotomous subdivision of terminal units involved in lung branching morphogenesis [GO:0060489]; protein localization involved in establishment of planar polarity [GO:0090251]; regulation of actin cytoskeleton organization [GO:0032956]; Rho protein signal transduction [GO:0007266]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071] adherens junction [GO:0005912]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; G protein-coupled receptor activity [GO:0004930] g13998.t1 P30715 28.966 290 9.34e-29 115.0 sp|P30715|AT1B1_RHIMB Sodium/potassium-transporting ATPase subunit beta-1 OS=Rhinella marina OX=8386 PE=2 SV=1 g13999.t1 P51165 33.929 280 9.66e-46 159.0 sp|P51165|AT1B1_ANGAN Sodium/potassium-transporting ATPase subunit beta-1 OS=Anguilla anguilla OX=7936 GN=atp1b1 PE=2 SV=1 g14001.t1 E9PUQ8 68.791 612 0.0 835.0 sp|E9PUQ8|DGKD_MOUSE Diacylglycerol kinase delta OS=Mus musculus OX=10090 GN=Dgkd PE=1 SV=1 DGKD_MOUSE reviewed Diacylglycerol kinase delta (DAG kinase delta) (EC 2.7.1.107) Mus musculus (Mouse) GO:0004143; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0005905; GO:0006654; GO:0006897; GO:0007200; GO:0008270; GO:0015031; GO:0019900; GO:0031410; GO:0035556; GO:0042802; GO:0042803; GO:0045742; GO:0046339; GO:0046340; GO:0046834; GO:0046982; GO:0160195; GO:2000370 diacylglycerol catabolic process [GO:0046340]; diacylglycerol metabolic process [GO:0046339]; endocytosis [GO:0006897]; intracellular signal transduction [GO:0035556]; lipid phosphorylation [GO:0046834]; negative regulation of phospholipase C/protein kinase C signal transduction [GO:0160195]; phosphatidic acid biosynthetic process [GO:0006654]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of clathrin-dependent endocytosis [GO:2000370]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; protein transport [GO:0015031] clathrin-coated pit [GO:0005905]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; plasma membrane [GO:0005886] ATP binding [GO:0005524]; ATP-dependent diacylglycerol kinase activity [GO:0004143]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; zinc ion binding [GO:0008270] g14001.t1 E9PUQ8 82.39 159 6.81e-83 282.0 sp|E9PUQ8|DGKD_MOUSE Diacylglycerol kinase delta OS=Mus musculus OX=10090 GN=Dgkd PE=1 SV=1 DGKD_MOUSE reviewed Diacylglycerol kinase delta (DAG kinase delta) (EC 2.7.1.107) Mus musculus (Mouse) GO:0004143; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0005905; GO:0006654; GO:0006897; GO:0007200; GO:0008270; GO:0015031; GO:0019900; GO:0031410; GO:0035556; GO:0042802; GO:0042803; GO:0045742; GO:0046339; GO:0046340; GO:0046834; GO:0046982; GO:0160195; GO:2000370 diacylglycerol catabolic process [GO:0046340]; diacylglycerol metabolic process [GO:0046339]; endocytosis [GO:0006897]; intracellular signal transduction [GO:0035556]; lipid phosphorylation [GO:0046834]; negative regulation of phospholipase C/protein kinase C signal transduction [GO:0160195]; phosphatidic acid biosynthetic process [GO:0006654]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of clathrin-dependent endocytosis [GO:2000370]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; protein transport [GO:0015031] clathrin-coated pit [GO:0005905]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; plasma membrane [GO:0005886] ATP binding [GO:0005524]; ATP-dependent diacylglycerol kinase activity [GO:0004143]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; zinc ion binding [GO:0008270] g14001.t1 E9PUQ8 70.833 24 6.81e-83 49.7 sp|E9PUQ8|DGKD_MOUSE Diacylglycerol kinase delta OS=Mus musculus OX=10090 GN=Dgkd PE=1 SV=1 DGKD_MOUSE reviewed Diacylglycerol kinase delta (DAG kinase delta) (EC 2.7.1.107) Mus musculus (Mouse) GO:0004143; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0005905; GO:0006654; GO:0006897; GO:0007200; GO:0008270; GO:0015031; GO:0019900; GO:0031410; GO:0035556; GO:0042802; GO:0042803; GO:0045742; GO:0046339; GO:0046340; GO:0046834; GO:0046982; GO:0160195; GO:2000370 diacylglycerol catabolic process [GO:0046340]; diacylglycerol metabolic process [GO:0046339]; endocytosis [GO:0006897]; intracellular signal transduction [GO:0035556]; lipid phosphorylation [GO:0046834]; negative regulation of phospholipase C/protein kinase C signal transduction [GO:0160195]; phosphatidic acid biosynthetic process [GO:0006654]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of clathrin-dependent endocytosis [GO:2000370]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; protein transport [GO:0015031] clathrin-coated pit [GO:0005905]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; plasma membrane [GO:0005886] ATP binding [GO:0005524]; ATP-dependent diacylglycerol kinase activity [GO:0004143]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; zinc ion binding [GO:0008270] g14003.t1 E9PUQ8 33.096 281 9.67e-34 134.0 sp|E9PUQ8|DGKD_MOUSE Diacylglycerol kinase delta OS=Mus musculus OX=10090 GN=Dgkd PE=1 SV=1 DGKD_MOUSE reviewed Diacylglycerol kinase delta (DAG kinase delta) (EC 2.7.1.107) Mus musculus (Mouse) GO:0004143; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0005905; GO:0006654; GO:0006897; GO:0007200; GO:0008270; GO:0015031; GO:0019900; GO:0031410; GO:0035556; GO:0042802; GO:0042803; GO:0045742; GO:0046339; GO:0046340; GO:0046834; GO:0046982; GO:0160195; GO:2000370 diacylglycerol catabolic process [GO:0046340]; diacylglycerol metabolic process [GO:0046339]; endocytosis [GO:0006897]; intracellular signal transduction [GO:0035556]; lipid phosphorylation [GO:0046834]; negative regulation of phospholipase C/protein kinase C signal transduction [GO:0160195]; phosphatidic acid biosynthetic process [GO:0006654]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of clathrin-dependent endocytosis [GO:2000370]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; protein transport [GO:0015031] clathrin-coated pit [GO:0005905]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; plasma membrane [GO:0005886] ATP binding [GO:0005524]; ATP-dependent diacylglycerol kinase activity [GO:0004143]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; zinc ion binding [GO:0008270] g14004.t1 Q27ID4 27.833 503 2.3e-54 204.0 sp|Q27ID4|TERT_BOVIN Telomerase reverse transcriptase OS=Bos taurus OX=9913 GN=TERT PE=3 SV=2 TERT_BOVIN reviewed Telomerase reverse transcriptase (EC 2.7.7.49) (Telomerase catalytic subunit) Bos taurus (Bovine) GO:0000333; GO:0000781; GO:0003720; GO:0005697; GO:0005730; GO:0005739; GO:0007004; GO:0016605; GO:0042162; GO:0046872; GO:0070034 telomere maintenance via telomerase [GO:0007004] chromosome, telomeric region [GO:0000781]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; PML body [GO:0016605]; telomerase catalytic core complex [GO:0000333]; telomerase holoenzyme complex [GO:0005697] metal ion binding [GO:0046872]; telomerase activity [GO:0003720]; telomerase RNA binding [GO:0070034]; telomeric DNA binding [GO:0042162] g14004.t2 Q27ID4 27.451 510 6.569999999999999e-52 197.0 sp|Q27ID4|TERT_BOVIN Telomerase reverse transcriptase OS=Bos taurus OX=9913 GN=TERT PE=3 SV=2 TERT_BOVIN reviewed Telomerase reverse transcriptase (EC 2.7.7.49) (Telomerase catalytic subunit) Bos taurus (Bovine) GO:0000333; GO:0000781; GO:0003720; GO:0005697; GO:0005730; GO:0005739; GO:0007004; GO:0016605; GO:0042162; GO:0046872; GO:0070034 telomere maintenance via telomerase [GO:0007004] chromosome, telomeric region [GO:0000781]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; PML body [GO:0016605]; telomerase catalytic core complex [GO:0000333]; telomerase holoenzyme complex [GO:0005697] metal ion binding [GO:0046872]; telomerase activity [GO:0003720]; telomerase RNA binding [GO:0070034]; telomeric DNA binding [GO:0042162] g14006.t1 O14746 31.111 315 1.61e-43 161.0 sp|O14746|TERT_HUMAN Telomerase reverse transcriptase OS=Homo sapiens OX=9606 GN=TERT PE=1 SV=1 TERT_HUMAN reviewed Telomerase reverse transcriptase (EC 2.7.7.49) (HEST2) (Telomerase catalytic subunit) (Telomerase-associated protein 2) (TP2) Homo sapiens (Human) GO:0000049; GO:0000333; GO:0000722; GO:0000723; GO:0000781; GO:0000783; GO:0001172; GO:0001223; GO:0003677; GO:0003720; GO:0003723; GO:0003964; GO:0003968; GO:0005634; GO:0005654; GO:0005697; GO:0005730; GO:0005829; GO:0005886; GO:0006278; GO:0006606; GO:0007004; GO:0007005; GO:0007507; GO:0016605; GO:0016607; GO:0022616; GO:0030177; GO:0030422; GO:0031379; GO:0031647; GO:0042162; GO:0042635; GO:0042645; GO:0042802; GO:0042803; GO:0043524; GO:0045766; GO:0046326; GO:0046686; GO:0046872; GO:0051087; GO:0070034; GO:0070200; GO:0071456; GO:0071897; GO:0090399; GO:0098680; GO:0140745; GO:1900087; GO:1902895; GO:1903620; GO:1904707; GO:1904751; GO:1904754; GO:1990572; GO:2000352; GO:2000648; GO:2000773; GO:2001240 cellular response to hypoxia [GO:0071456]; DNA biosynthetic process [GO:0071897]; DNA strand elongation [GO:0022616]; establishment of protein localization to telomere [GO:0070200]; heart development [GO:0007507]; mitochondrion organization [GO:0007005]; negative regulation of cellular senescence [GO:2000773]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; negative regulation of neuron apoptotic process [GO:0043524]; positive regulation of angiogenesis [GO:0045766]; positive regulation of D-glucose import [GO:0046326]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of hair cycle [GO:0042635]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of protein localization to nucleolus [GO:1904751]; positive regulation of stem cell proliferation [GO:2000648]; positive regulation of transdifferentiation [GO:1903620]; positive regulation of vascular associated smooth muscle cell migration [GO:1904754]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; positive regulation of Wnt signaling pathway [GO:0030177]; protein import into nucleus [GO:0006606]; regulation of protein stability [GO:0031647]; replicative senescence [GO:0090399]; response to cadmium ion [GO:0046686]; RNA-templated DNA biosynthetic process [GO:0006278]; RNA-templated transcription [GO:0001172]; siRNA processing [GO:0030422]; siRNA transcription [GO:0140745]; telomere maintenance [GO:0000723]; telomere maintenance via recombination [GO:0000722]; telomere maintenance via telomerase [GO:0007004] chromosome, telomeric region [GO:0000781]; cytosol [GO:0005829]; mitochondrial nucleoid [GO:0042645]; nuclear speck [GO:0016607]; nuclear telomere cap complex [GO:0000783]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; PML body [GO:0016605]; RNA-directed RNA polymerase complex [GO:0031379]; telomerase catalytic core complex [GO:0000333]; telomerase holoenzyme complex [GO:0005697]; TERT-RMRP complex [GO:1990572] DNA binding [GO:0003677]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; protein-folding chaperone binding [GO:0051087]; RNA binding [GO:0003723]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-directed RNA polymerase activity [GO:0003968]; telomerase activity [GO:0003720]; telomerase RNA binding [GO:0070034]; telomeric DNA binding [GO:0042162]; template-free RNA nucleotidyltransferase [GO:0098680]; transcription coactivator binding [GO:0001223]; tRNA binding [GO:0000049] g14007.t1 Q9Y6X6 38.409 1182 0.0 813.0 sp|Q9Y6X6|MYO16_HUMAN Unconventional myosin-XVI OS=Homo sapiens OX=9606 GN=MYO16 PE=1 SV=3 MYO16_HUMAN reviewed Unconventional myosin-XVI (Neuronal tyrosine-phosphorylated phosphoinositide-3-kinase adapter 3) (Unconventional myosin-16) Homo sapiens (Human) GO:0003774; GO:0005524; GO:0005654; GO:0005737; GO:0005886; GO:0008285; GO:0016459; GO:0019903; GO:0021549; GO:0043491; GO:0048471; GO:0048812; GO:0051015; GO:2000134 cerebellum development [GO:0021549]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; neuron projection morphogenesis [GO:0048812]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491] cytoplasm [GO:0005737]; myosin complex [GO:0016459]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886] actin filament binding [GO:0051015]; ATP binding [GO:0005524]; cytoskeletal motor activity [GO:0003774]; protein phosphatase binding [GO:0019903] g14008.t1 Q8JFP1 71.707 410 0.0 569.0 sp|Q8JFP1|IF4A2_CHICK Eukaryotic initiation factor 4A-II OS=Gallus gallus OX=9031 GN=EIF4A2 PE=2 SV=1 g14009.t1 Q99J62 63.415 287 1.84e-130 377.0 sp|Q99J62|RFC4_MOUSE Replication factor C subunit 4 OS=Mus musculus OX=10090 GN=Rfc4 PE=1 SV=1 g14011.t1 Q5RJQ0 29.213 356 3.9e-40 151.0 sp|Q5RJQ0|CHST1_RAT Carbohydrate sulfotransferase 1 OS=Rattus norvegicus OX=10116 GN=Chst1 PE=2 SV=1 CHST1_RAT reviewed Carbohydrate sulfotransferase 1 (Galactose/N-acetylglucosamine/N-acetylglucosamine 6-O-sulfotransferase 1) (GST-1) (Keratan sulfate Gal-6 sulfotransferase) (KS6ST) (KSGal6ST) (KSST) (EC 2.8.2.21) Rattus norvegicus (Rat) GO:0000139; GO:0001517; GO:0006012; GO:0006044; GO:0006790; GO:0006954; GO:0008146; GO:0018146; GO:0042339; GO:0045130 galactose metabolic process [GO:0006012]; inflammatory response [GO:0006954]; keratan sulfate proteoglycan biosynthetic process [GO:0018146]; keratan sulfate proteoglycan metabolic process [GO:0042339]; N-acetylglucosamine metabolic process [GO:0006044]; sulfur compound metabolic process [GO:0006790] Golgi membrane [GO:0000139] keratan sulfotransferase activity [GO:0045130]; N-acetylglucosamine 6-O-sulfotransferase activity [GO:0001517]; sulfotransferase activity [GO:0008146] g14012.t1 Q5RF43 73.181 481 0.0 720.0 sp|Q5RF43|DDX3Y_PONAB ATP-dependent RNA helicase DDX3Y OS=Pongo abelii OX=9601 GN=DDX3Y PE=2 SV=1 DDX3Y_PONAB reviewed ATP-dependent RNA helicase DDX3Y (EC 3.6.4.13) (DEAD box protein 3, Y-chromosomal) Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0003677; GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005737; GO:0016887 cytoplasm [GO:0005737]; nucleus [GO:0005634] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724] g14012.t2 Q5RF43 72.485 487 0.0 716.0 sp|Q5RF43|DDX3Y_PONAB ATP-dependent RNA helicase DDX3Y OS=Pongo abelii OX=9601 GN=DDX3Y PE=2 SV=1 DDX3Y_PONAB reviewed ATP-dependent RNA helicase DDX3Y (EC 3.6.4.13) (DEAD box protein 3, Y-chromosomal) Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0003677; GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005737; GO:0016887 cytoplasm [GO:0005737]; nucleus [GO:0005634] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724] g14012.t3 Q5RF43 73.181 481 0.0 720.0 sp|Q5RF43|DDX3Y_PONAB ATP-dependent RNA helicase DDX3Y OS=Pongo abelii OX=9601 GN=DDX3Y PE=2 SV=1 DDX3Y_PONAB reviewed ATP-dependent RNA helicase DDX3Y (EC 3.6.4.13) (DEAD box protein 3, Y-chromosomal) Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0003677; GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005737; GO:0016887 cytoplasm [GO:0005737]; nucleus [GO:0005634] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724] g14015.t1 Q96RP9 66.3 727 0.0 971.0 sp|Q96RP9|EFGM_HUMAN Elongation factor G, mitochondrial OS=Homo sapiens OX=9606 GN=GFM1 PE=1 SV=2 EFGM_HUMAN reviewed Elongation factor G, mitochondrial (EF-Gmt) (EC 3.6.5.-) (Elongation factor G 1, mitochondrial) (mEF-G 1) (Elongation factor G1) (hEFG1) Homo sapiens (Human) GO:0003723; GO:0003746; GO:0003924; GO:0005525; GO:0005739; GO:0005759; GO:0070125 mitochondrial translational elongation [GO:0070125] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] GTP binding [GO:0005525]; GTPase activity [GO:0003924]; RNA binding [GO:0003723]; translation elongation factor activity [GO:0003746] g14017.t1 F4IF36 46.667 450 1.91e-120 399.0 sp|F4IF36|FGT1_ARATH Protein FORGETTER 1 OS=Arabidopsis thaliana OX=3702 GN=FGT1 PE=1 SV=1 FGT1_ARATH reviewed Protein FORGETTER 1 (Protein EMBRYO DEFECTIVE 1135) Arabidopsis thaliana (Mouse-ear cress) GO:0005634; GO:0006338; GO:0006355; GO:0008270; GO:0009408; GO:0010286; GO:0031490; GO:0040029; GO:0042393; GO:1900036; GO:1990841 chromatin remodeling [GO:0006338]; epigenetic regulation of gene expression [GO:0040029]; heat acclimation [GO:0010286]; positive regulation of cellular response to heat [GO:1900036]; regulation of DNA-templated transcription [GO:0006355]; response to heat [GO:0009408] nucleus [GO:0005634] chromatin DNA binding [GO:0031490]; histone binding [GO:0042393]; promoter-specific chromatin binding [GO:1990841]; zinc ion binding [GO:0008270] g14017.t1 F4IF36 48.788 330 1.51e-83 296.0 sp|F4IF36|FGT1_ARATH Protein FORGETTER 1 OS=Arabidopsis thaliana OX=3702 GN=FGT1 PE=1 SV=1 FGT1_ARATH reviewed Protein FORGETTER 1 (Protein EMBRYO DEFECTIVE 1135) Arabidopsis thaliana (Mouse-ear cress) GO:0005634; GO:0006338; GO:0006355; GO:0008270; GO:0009408; GO:0010286; GO:0031490; GO:0040029; GO:0042393; GO:1900036; GO:1990841 chromatin remodeling [GO:0006338]; epigenetic regulation of gene expression [GO:0040029]; heat acclimation [GO:0010286]; positive regulation of cellular response to heat [GO:1900036]; regulation of DNA-templated transcription [GO:0006355]; response to heat [GO:0009408] nucleus [GO:0005634] chromatin DNA binding [GO:0031490]; histone binding [GO:0042393]; promoter-specific chromatin binding [GO:1990841]; zinc ion binding [GO:0008270] g14033.t1 P15622 41.129 248 7.999999999999999e-61 209.0 sp|P15622|ZN250_HUMAN Zinc finger protein 250 OS=Homo sapiens OX=9606 GN=ZNF250 PE=1 SV=3 ZN250_HUMAN reviewed Zinc finger protein 250 (Zinc finger protein 647) Homo sapiens (Human) GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0008270; GO:0042802; GO:1990837 regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; zinc ion binding [GO:0008270] g14033.t1 P15622 38.153 249 3.5e-52 186.0 sp|P15622|ZN250_HUMAN Zinc finger protein 250 OS=Homo sapiens OX=9606 GN=ZNF250 PE=1 SV=3 ZN250_HUMAN reviewed Zinc finger protein 250 (Zinc finger protein 647) Homo sapiens (Human) GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0008270; GO:0042802; GO:1990837 regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; zinc ion binding [GO:0008270] g14033.t1 P15622 34.375 256 5.6e-51 183.0 sp|P15622|ZN250_HUMAN Zinc finger protein 250 OS=Homo sapiens OX=9606 GN=ZNF250 PE=1 SV=3 ZN250_HUMAN reviewed Zinc finger protein 250 (Zinc finger protein 647) Homo sapiens (Human) GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0008270; GO:0042802; GO:1990837 regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; zinc ion binding [GO:0008270] g14033.t1 P15622 35.772 246 1.84e-48 176.0 sp|P15622|ZN250_HUMAN Zinc finger protein 250 OS=Homo sapiens OX=9606 GN=ZNF250 PE=1 SV=3 ZN250_HUMAN reviewed Zinc finger protein 250 (Zinc finger protein 647) Homo sapiens (Human) GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0008270; GO:0042802; GO:1990837 regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; zinc ion binding [GO:0008270] g14033.t1 P15622 32.271 251 1.8699999999999998e-45 168.0 sp|P15622|ZN250_HUMAN Zinc finger protein 250 OS=Homo sapiens OX=9606 GN=ZNF250 PE=1 SV=3 ZN250_HUMAN reviewed Zinc finger protein 250 (Zinc finger protein 647) Homo sapiens (Human) GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0008270; GO:0042802; GO:1990837 regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; zinc ion binding [GO:0008270] g14034.t1 Q8TD23 43.191 257 4.0600000000000004e-57 196.0 sp|Q8TD23|ZN675_HUMAN Zinc finger protein 675 OS=Homo sapiens OX=9606 GN=ZNF675 PE=1 SV=3 ZN675_HUMAN reviewed Zinc finger protein 675 (TRAF6-binding zinc finger protein) (TRAF6-inhibitory zinc finger protein) Homo sapiens (Human) GO:0000122; GO:0000978; GO:0000981; GO:0001960; GO:0003677; GO:0005634; GO:0006355; GO:0008270; GO:0010804; GO:0031625; GO:0043124; GO:0045453; GO:0045671; GO:0046329; GO:0048471; GO:2000660 bone resorption [GO:0045453]; negative regulation of canonical NF-kappaB signal transduction [GO:0043124]; negative regulation of cytokine-mediated signaling pathway [GO:0001960]; negative regulation of interleukin-1-mediated signaling pathway [GO:2000660]; negative regulation of JNK cascade [GO:0046329]; negative regulation of osteoclast differentiation [GO:0045671]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of tumor necrosis factor-mediated signaling pathway [GO:0010804]; regulation of DNA-templated transcription [GO:0006355] nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471] DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270] g14034.t1 Q8TD23 41.525 236 8.869999999999999e-48 171.0 sp|Q8TD23|ZN675_HUMAN Zinc finger protein 675 OS=Homo sapiens OX=9606 GN=ZNF675 PE=1 SV=3 ZN675_HUMAN reviewed Zinc finger protein 675 (TRAF6-binding zinc finger protein) (TRAF6-inhibitory zinc finger protein) Homo sapiens (Human) GO:0000122; GO:0000978; GO:0000981; GO:0001960; GO:0003677; GO:0005634; GO:0006355; GO:0008270; GO:0010804; GO:0031625; GO:0043124; GO:0045453; GO:0045671; GO:0046329; GO:0048471; GO:2000660 bone resorption [GO:0045453]; negative regulation of canonical NF-kappaB signal transduction [GO:0043124]; negative regulation of cytokine-mediated signaling pathway [GO:0001960]; negative regulation of interleukin-1-mediated signaling pathway [GO:2000660]; negative regulation of JNK cascade [GO:0046329]; negative regulation of osteoclast differentiation [GO:0045671]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of tumor necrosis factor-mediated signaling pathway [GO:0010804]; regulation of DNA-templated transcription [GO:0006355] nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471] DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270] g14034.t1 Q8TD23 36.957 276 4.28e-42 156.0 sp|Q8TD23|ZN675_HUMAN Zinc finger protein 675 OS=Homo sapiens OX=9606 GN=ZNF675 PE=1 SV=3 ZN675_HUMAN reviewed Zinc finger protein 675 (TRAF6-binding zinc finger protein) (TRAF6-inhibitory zinc finger protein) Homo sapiens (Human) GO:0000122; GO:0000978; GO:0000981; GO:0001960; GO:0003677; GO:0005634; GO:0006355; GO:0008270; GO:0010804; GO:0031625; GO:0043124; GO:0045453; GO:0045671; GO:0046329; GO:0048471; GO:2000660 bone resorption [GO:0045453]; negative regulation of canonical NF-kappaB signal transduction [GO:0043124]; negative regulation of cytokine-mediated signaling pathway [GO:0001960]; negative regulation of interleukin-1-mediated signaling pathway [GO:2000660]; negative regulation of JNK cascade [GO:0046329]; negative regulation of osteoclast differentiation [GO:0045671]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of tumor necrosis factor-mediated signaling pathway [GO:0010804]; regulation of DNA-templated transcription [GO:0006355] nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471] DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270] g14034.t1 Q8TD23 37.354 257 4.11e-39 147.0 sp|Q8TD23|ZN675_HUMAN Zinc finger protein 675 OS=Homo sapiens OX=9606 GN=ZNF675 PE=1 SV=3 ZN675_HUMAN reviewed Zinc finger protein 675 (TRAF6-binding zinc finger protein) (TRAF6-inhibitory zinc finger protein) Homo sapiens (Human) GO:0000122; GO:0000978; GO:0000981; GO:0001960; GO:0003677; GO:0005634; GO:0006355; GO:0008270; GO:0010804; GO:0031625; GO:0043124; GO:0045453; GO:0045671; GO:0046329; GO:0048471; GO:2000660 bone resorption [GO:0045453]; negative regulation of canonical NF-kappaB signal transduction [GO:0043124]; negative regulation of cytokine-mediated signaling pathway [GO:0001960]; negative regulation of interleukin-1-mediated signaling pathway [GO:2000660]; negative regulation of JNK cascade [GO:0046329]; negative regulation of osteoclast differentiation [GO:0045671]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of tumor necrosis factor-mediated signaling pathway [GO:0010804]; regulation of DNA-templated transcription [GO:0006355] nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471] DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270] g14036.t1 Q96LI9 49.735 189 6.81e-70 221.0 sp|Q96LI9|CX058_HUMAN Uncharacterized protein CXorf58 OS=Homo sapiens OX=9606 GN=CXorf58 PE=1 SV=2 g14037.t1 Q66HB3 65.517 638 0.0 923.0 sp|Q66HB3|IFT80_RAT Intraflagellar transport protein 80 homolog OS=Rattus norvegicus OX=10116 GN=Ift80 PE=2 SV=1 IFT80_RAT reviewed Intraflagellar transport protein 80 homolog (WD repeat-containing protein 56) Rattus norvegicus (Rat) GO:0001501; GO:0001503; GO:0001649; GO:0001958; GO:0002062; GO:0003417; GO:0003418; GO:0005813; GO:0005929; GO:0005930; GO:0006915; GO:0007163; GO:0007224; GO:0007249; GO:0008283; GO:0008543; GO:0009888; GO:0010467; GO:0010498; GO:0010839; GO:0016567; GO:0021510; GO:0030316; GO:0030992; GO:0033687; GO:0035264; GO:0035567; GO:0035630; GO:0036064; GO:0042476; GO:0043491; GO:0043616; GO:0044691; GO:0044782; GO:0048863; GO:0050821; GO:0051216; GO:0060173; GO:0060271; GO:0060348; GO:0060349; GO:0061975; GO:0071895; GO:0072089; GO:0097500; GO:0097731; GO:1902140; GO:1905515; GO:1990079; GO:2000051 apoptotic process [GO:0006915]; articular cartilage development [GO:0061975]; bone development [GO:0060348]; bone mineralization involved in bone maturation [GO:0035630]; bone morphogenesis [GO:0060349]; canonical NF-kappaB signal transduction [GO:0007249]; cartilage development [GO:0051216]; cartilage homeostasis [GO:1990079]; cell population proliferation [GO:0008283]; chondrocyte differentiation [GO:0002062]; cilium assembly [GO:0060271]; cilium organization [GO:0044782]; endochondral ossification [GO:0001958]; establishment or maintenance of cell polarity [GO:0007163]; fibroblast growth factor receptor signaling pathway [GO:0008543]; gene expression [GO:0010467]; growth plate cartilage chondrocyte differentiation [GO:0003418]; growth plate cartilage development [GO:0003417]; keratinocyte proliferation [GO:0043616]; limb development [GO:0060173]; multicellular organism growth [GO:0035264]; negative regulation of keratinocyte proliferation [GO:0010839]; negative regulation of non-canonical Wnt signaling pathway [GO:2000051]; non-canonical Wnt signaling pathway [GO:0035567]; non-motile cilium assembly [GO:1905515]; odontoblast differentiation [GO:0071895]; odontogenesis [GO:0042476]; ossification [GO:0001503]; osteoblast differentiation [GO:0001649]; osteoblast proliferation [GO:0033687]; osteoclast differentiation [GO:0030316]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; proteasomal protein catabolic process [GO:0010498]; protein stabilization [GO:0050821]; protein ubiquitination [GO:0016567]; receptor localization to non-motile cilium [GO:0097500]; response to inositol [GO:1902140]; skeletal system development [GO:0001501]; smoothened signaling pathway [GO:0007224]; spinal cord development [GO:0021510]; stem cell differentiation [GO:0048863]; stem cell proliferation [GO:0072089]; tissue development [GO:0009888]; tooth eruption [GO:0044691] 9+0 non-motile cilium [GO:0097731]; axoneme [GO:0005930]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; intraciliary transport particle B [GO:0030992] g14038.t1 Q66HB3 64.198 81 6.67e-31 116.0 sp|Q66HB3|IFT80_RAT Intraflagellar transport protein 80 homolog OS=Rattus norvegicus OX=10116 GN=Ift80 PE=2 SV=1 IFT80_RAT reviewed Intraflagellar transport protein 80 homolog (WD repeat-containing protein 56) Rattus norvegicus (Rat) GO:0001501; GO:0001503; GO:0001649; GO:0001958; GO:0002062; GO:0003417; GO:0003418; GO:0005813; GO:0005929; GO:0005930; GO:0006915; GO:0007163; GO:0007224; GO:0007249; GO:0008283; GO:0008543; GO:0009888; GO:0010467; GO:0010498; GO:0010839; GO:0016567; GO:0021510; GO:0030316; GO:0030992; GO:0033687; GO:0035264; GO:0035567; GO:0035630; GO:0036064; GO:0042476; GO:0043491; GO:0043616; GO:0044691; GO:0044782; GO:0048863; GO:0050821; GO:0051216; GO:0060173; GO:0060271; GO:0060348; GO:0060349; GO:0061975; GO:0071895; GO:0072089; GO:0097500; GO:0097731; GO:1902140; GO:1905515; GO:1990079; GO:2000051 apoptotic process [GO:0006915]; articular cartilage development [GO:0061975]; bone development [GO:0060348]; bone mineralization involved in bone maturation [GO:0035630]; bone morphogenesis [GO:0060349]; canonical NF-kappaB signal transduction [GO:0007249]; cartilage development [GO:0051216]; cartilage homeostasis [GO:1990079]; cell population proliferation [GO:0008283]; chondrocyte differentiation [GO:0002062]; cilium assembly [GO:0060271]; cilium organization [GO:0044782]; endochondral ossification [GO:0001958]; establishment or maintenance of cell polarity [GO:0007163]; fibroblast growth factor receptor signaling pathway [GO:0008543]; gene expression [GO:0010467]; growth plate cartilage chondrocyte differentiation [GO:0003418]; growth plate cartilage development [GO:0003417]; keratinocyte proliferation [GO:0043616]; limb development [GO:0060173]; multicellular organism growth [GO:0035264]; negative regulation of keratinocyte proliferation [GO:0010839]; negative regulation of non-canonical Wnt signaling pathway [GO:2000051]; non-canonical Wnt signaling pathway [GO:0035567]; non-motile cilium assembly [GO:1905515]; odontoblast differentiation [GO:0071895]; odontogenesis [GO:0042476]; ossification [GO:0001503]; osteoblast differentiation [GO:0001649]; osteoblast proliferation [GO:0033687]; osteoclast differentiation [GO:0030316]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; proteasomal protein catabolic process [GO:0010498]; protein stabilization [GO:0050821]; protein ubiquitination [GO:0016567]; receptor localization to non-motile cilium [GO:0097500]; response to inositol [GO:1902140]; skeletal system development [GO:0001501]; smoothened signaling pathway [GO:0007224]; spinal cord development [GO:0021510]; stem cell differentiation [GO:0048863]; stem cell proliferation [GO:0072089]; tissue development [GO:0009888]; tooth eruption [GO:0044691] 9+0 non-motile cilium [GO:0097731]; axoneme [GO:0005930]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; intraciliary transport particle B [GO:0030992] g14039.t3 Q9JKP5 38.682 349 4.1699999999999996e-46 167.0 sp|Q9JKP5|MBNL1_MOUSE Muscleblind-like protein 1 OS=Mus musculus OX=10090 GN=Mbnl1 PE=1 SV=1 MBNL1_MOUSE reviewed Muscleblind-like protein 1 (Triplet-expansion RNA-binding protein) Mus musculus (Mouse) GO:0000380; GO:0000381; GO:0001069; GO:0001701; GO:0003723; GO:0003725; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006376; GO:0007399; GO:0007519; GO:0008270; GO:0008380; GO:0010494; GO:0030326; GO:0043484; GO:0045445 alternative mRNA splicing, via spliceosome [GO:0000380]; embryonic limb morphogenesis [GO:0030326]; in utero embryonic development [GO:0001701]; mRNA splice site recognition [GO:0006376]; myoblast differentiation [GO:0045445]; nervous system development [GO:0007399]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of RNA splicing [GO:0043484]; RNA splicing [GO:0008380]; skeletal muscle tissue development [GO:0007519] cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] double-stranded RNA binding [GO:0003725]; regulatory region RNA binding [GO:0001069]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270] g14039.t4 Q5ZKW9 46.602 309 2.37e-80 252.0 sp|Q5ZKW9|MBNL1_CHICK Muscleblind-like protein 1 OS=Gallus gallus OX=9031 GN=MBNL1 PE=2 SV=1 g14039.t5 Q6Q2B2 41.132 265 1.25e-46 163.0 sp|Q6Q2B2|MBN2A_TAKRU Muscleblind-like protein 2a OS=Takifugu rubripes OX=31033 GN=mbnl2a PE=2 SV=1 g14041.t1 Q9Y2G3 50.576 1042 0.0 1003.0 sp|Q9Y2G3|AT11B_HUMAN Phospholipid-transporting ATPase IF OS=Homo sapiens OX=9606 GN=ATP11B PE=1 SV=2 g14048.t1 Q8CHG3 34.707 752 3.55e-97 352.0 sp|Q8CHG3|GCC2_MOUSE GRIP and coiled-coil domain-containing protein 2 OS=Mus musculus OX=10090 GN=Gcc2 PE=1 SV=3 g14050.t1 Q7ZY11 50.334 598 0.0 561.0 sp|Q7ZY11|EIF2A_XENLA Eukaryotic translation initiation factor 2A OS=Xenopus laevis OX=8355 GN=eif2a PE=2 SV=2 g14051.t1 Q6INS5 45.143 175 5.08e-34 142.0 sp|Q6INS5|RN168_XENLA E3 ubiquitin-protein ligase rnf168 OS=Xenopus laevis OX=8355 GN=rnf168 PE=2 SV=1 RN168_XENLA reviewed E3 ubiquitin-protein ligase rnf168 (EC 2.3.2.27) (RING finger protein 168) (RING-type E3 ubiquitin transferase rnf168) Xenopus laevis (African clawed frog) GO:0000151; GO:0003682; GO:0004842; GO:0005634; GO:0006302; GO:0006511; GO:0006974; GO:0008270; GO:0010212; GO:0016567; GO:0031491; GO:0034244; GO:0035861; GO:0042393; GO:0043130; GO:0045190; GO:0045739; GO:0061630; GO:0070530; GO:0070534; GO:0140861 DNA damage response [GO:0006974]; DNA repair-dependent chromatin remodeling [GO:0140861]; double-strand break repair [GO:0006302]; isotype switching [GO:0045190]; negative regulation of transcription elongation by RNA polymerase II [GO:0034244]; positive regulation of DNA repair [GO:0045739]; protein K63-linked ubiquitination [GO:0070534]; protein ubiquitination [GO:0016567]; response to ionizing radiation [GO:0010212]; ubiquitin-dependent protein catabolic process [GO:0006511] nucleus [GO:0005634]; site of double-strand break [GO:0035861]; ubiquitin ligase complex [GO:0000151] chromatin binding [GO:0003682]; histone binding [GO:0042393]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; nucleosome binding [GO:0031491]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] g14052.t1 Q58HI1 34.826 603 1.7400000000000002e-80 283.0 sp|Q58HI1|PELP1_XENLA Proline-, glutamic acid- and leucine-rich protein 1 OS=Xenopus laevis OX=8355 GN=pelp1 PE=1 SV=1 PELP1_XENLA reviewed Proline-, glutamic acid- and leucine-rich protein 1 (Modulator of non-genomic activity of estrogen receptor) Xenopus laevis (African clawed frog) GO:0000791; GO:0003682; GO:0005634; GO:0005737; GO:0006364; GO:0045944; GO:0071339; GO:0071391 cellular response to estrogen stimulus [GO:0071391]; positive regulation of transcription by RNA polymerase II [GO:0045944]; rRNA processing [GO:0006364] cytoplasm [GO:0005737]; euchromatin [GO:0000791]; MLL1 complex [GO:0071339]; nucleus [GO:0005634] chromatin binding [GO:0003682] g14055.t1 Q8NFF2 58.955 134 3.1000000000000004e-37 140.0 sp|Q8NFF2|NCKX4_HUMAN Sodium/potassium/calcium exchanger 4 OS=Homo sapiens OX=9606 GN=SLC24A4 PE=1 SV=2 NCKX4_HUMAN reviewed Sodium/potassium/calcium exchanger 4 (Na(+)/K(+)/Ca(2+)-exchange protein 4) (Solute carrier family 24 member 4) Homo sapiens (Human) GO:0005262; GO:0005516; GO:0005737; GO:0005886; GO:0006811; GO:0006874; GO:0007602; GO:0007608; GO:0008273; GO:0008277; GO:0009644; GO:0010628; GO:0015293; GO:0016020; GO:0016324; GO:0021630; GO:0031982; GO:0035725; GO:0036368; GO:0042756; GO:0048306; GO:0050849; GO:0050911; GO:0055074; GO:0070166; GO:0070588; GO:0071486; GO:0071805; GO:0086009; GO:0097186; GO:0098703; GO:0120199; GO:1903998; GO:1990034; GO:1990680; GO:1990834 amelogenesis [GO:0097186]; calcium ion export across plasma membrane [GO:1990034]; calcium ion homeostasis [GO:0055074]; calcium ion import across plasma membrane [GO:0098703]; calcium ion transmembrane transport [GO:0070588]; cellular response to high light intensity [GO:0071486]; cone photoresponse recovery [GO:0036368]; detection of chemical stimulus involved in sensory perception of smell [GO:0050911]; drinking behavior [GO:0042756]; enamel mineralization [GO:0070166]; intracellular calcium ion homeostasis [GO:0006874]; membrane repolarization [GO:0086009]; monoatomic ion transport [GO:0006811]; negative regulation of calcium-mediated signaling [GO:0050849]; olfactory nerve maturation [GO:0021630]; phototransduction [GO:0007602]; positive regulation of gene expression [GO:0010628]; potassium ion transmembrane transport [GO:0071805]; regulation of eating behavior [GO:1903998]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; response to high light intensity [GO:0009644]; response to melanocyte-stimulating hormone [GO:1990680]; response to odorant [GO:1990834]; sensory perception of smell [GO:0007608]; sodium ion transmembrane transport [GO:0035725] apical plasma membrane [GO:0016324]; cone photoreceptor outer segment [GO:0120199]; cytoplasm [GO:0005737]; membrane [GO:0016020]; plasma membrane [GO:0005886]; vesicle [GO:0031982] calcium channel activity [GO:0005262]; calcium, potassium:sodium antiporter activity [GO:0008273]; calcium-dependent protein binding [GO:0048306]; calmodulin binding [GO:0005516]; symporter activity [GO:0015293] g14056.t1 Q8CGQ8 36.139 202 4.9000000000000005e-33 132.0 sp|Q8CGQ8|NCKX4_MOUSE Sodium/potassium/calcium exchanger 4 OS=Mus musculus OX=10090 GN=Slc24a4 PE=1 SV=2 NCKX4_MOUSE reviewed Sodium/potassium/calcium exchanger 4 (Na(+)/K(+)/Ca(2+)-exchange protein 4) (Solute carrier family 24 member 4) Mus musculus (Mouse) GO:0005262; GO:0005432; GO:0005516; GO:0005737; GO:0005886; GO:0006874; GO:0007602; GO:0007608; GO:0008273; GO:0008277; GO:0010628; GO:0015293; GO:0016020; GO:0016324; GO:0021630; GO:0031982; GO:0035725; GO:0036368; GO:0042756; GO:0048306; GO:0050849; GO:0050911; GO:0055074; GO:0070588; GO:0071486; GO:0071805; GO:0086009; GO:0097186; GO:0098703; GO:0120199; GO:1903998; GO:1990034; GO:1990680; GO:1990834 amelogenesis [GO:0097186]; calcium ion export across plasma membrane [GO:1990034]; calcium ion homeostasis [GO:0055074]; calcium ion import across plasma membrane [GO:0098703]; calcium ion transmembrane transport [GO:0070588]; cellular response to high light intensity [GO:0071486]; cone photoresponse recovery [GO:0036368]; detection of chemical stimulus involved in sensory perception of smell [GO:0050911]; drinking behavior [GO:0042756]; intracellular calcium ion homeostasis [GO:0006874]; membrane repolarization [GO:0086009]; negative regulation of calcium-mediated signaling [GO:0050849]; olfactory nerve maturation [GO:0021630]; phototransduction [GO:0007602]; positive regulation of gene expression [GO:0010628]; potassium ion transmembrane transport [GO:0071805]; regulation of eating behavior [GO:1903998]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; response to melanocyte-stimulating hormone [GO:1990680]; response to odorant [GO:1990834]; sensory perception of smell [GO:0007608]; sodium ion transmembrane transport [GO:0035725] apical plasma membrane [GO:0016324]; cone photoreceptor outer segment [GO:0120199]; cytoplasm [GO:0005737]; membrane [GO:0016020]; plasma membrane [GO:0005886]; vesicle [GO:0031982] calcium channel activity [GO:0005262]; calcium, potassium:sodium antiporter activity [GO:0008273]; calcium-dependent protein binding [GO:0048306]; calcium:sodium antiporter activity [GO:0005432]; calmodulin binding [GO:0005516]; symporter activity [GO:0015293] g14057.t1 O15266 50.211 237 4.54e-64 210.0 sp|O15266|SHOX_HUMAN Short stature homeobox protein OS=Homo sapiens OX=9606 GN=SHOX PE=1 SV=1 SHOX_HUMAN reviewed Short stature homeobox protein (Pseudoautosomal homeobox-containing osteogenic protein) (Short stature homeobox-containing protein) Homo sapiens (Human) GO:0000785; GO:0000981; GO:0001228; GO:0001501; GO:0005634; GO:0005654; GO:0006357; GO:0043565; GO:0045944; GO:1990837 positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; skeletal system development [GO:0001501] chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837] g14058.t1 A4K526 55.856 111 4.9099999999999994e-34 117.0 sp|A4K526|TM256_BUFGR Transmembrane protein 256 homolog OS=Bufo gargarizans OX=30331 PE=3 SV=1 g14061.t1 Q12908 35.227 264 1.8700000000000001e-35 137.0 sp|Q12908|NTCP2_HUMAN Ileal sodium/bile acid cotransporter OS=Homo sapiens OX=9606 GN=SLC10A2 PE=1 SV=2 NTCP2_HUMAN reviewed Ileal sodium/bile acid cotransporter (Apical sodium-dependent bile acid transporter) (ASBT) (Ileal Na(+)/bile acid cotransporter) (Ileal sodium-dependent bile acid transporter) (IBAT) (ISBT) (Na(+)-dependent ileal bile acid transporter) (Sodium/taurocholate cotransporting polypeptide, ileal) (Solute carrier family 10 member 2) Homo sapiens (Human) GO:0005886; GO:0005902; GO:0008508; GO:0009617; GO:0015721; GO:0016324 bile acid and bile salt transport [GO:0015721]; response to bacterium [GO:0009617] apical plasma membrane [GO:0016324]; microvillus [GO:0005902]; plasma membrane [GO:0005886] bile acid:sodium symporter activity [GO:0008508] g14068.t1 Q6DCG9 50.276 181 1.41e-49 169.0 sp|Q6DCG9|S35A5_XENLA UDP-sugar transporter protein SLC35A5 OS=Xenopus laevis OX=8355 GN=slc35a5 PE=2 SV=1 g14069.t1 P97292 47.727 132 5.29e-34 129.0 sp|P97292|HRH2_MOUSE Histamine H2 receptor OS=Mus musculus OX=10090 GN=Hrh2 PE=2 SV=2 HRH2_MOUSE reviewed Histamine H2 receptor (H2R) (HH2R) (Gastric receptor I) Mus musculus (Mouse) GO:0001696; GO:0001697; GO:0001698; GO:0003382; GO:0004969; GO:0005886; GO:0007187; GO:0007268; GO:0007613; GO:0008542; GO:0030425; GO:0030594; GO:0045202; GO:0045907; GO:0048167; GO:0048565; GO:0048732; GO:1900139; GO:1901363 chemical synaptic transmission [GO:0007268]; digestive tract development [GO:0048565]; epithelial cell morphogenesis [GO:0003382]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; gastric acid secretion [GO:0001696]; gastrin-induced gastric acid secretion [GO:0001698]; gland development [GO:0048732]; histamine-induced gastric acid secretion [GO:0001697]; memory [GO:0007613]; negative regulation of arachidonate secretion [GO:1900139]; positive regulation of vasoconstriction [GO:0045907]; regulation of synaptic plasticity [GO:0048167]; visual learning [GO:0008542] dendrite [GO:0030425]; plasma membrane [GO:0005886]; synapse [GO:0045202] heterocyclic compound binding [GO:1901363]; histamine receptor activity [GO:0004969]; neurotransmitter receptor activity [GO:0030594] g14076.t1 A0A0B6VQ48 41.026 273 4.53e-45 161.0 sp|A0A0B6VQ48|PAR1_ROSHC Phenylacetaldehyde reductase OS=Rosa hybrid cultivar OX=128735 GN=PAR PE=1 SV=1 g14076.t2 A0A0B6VQ48 41.026 273 2.95e-45 162.0 sp|A0A0B6VQ48|PAR1_ROSHC Phenylacetaldehyde reductase OS=Rosa hybrid cultivar OX=128735 GN=PAR PE=1 SV=1 g14077.t1 Q3ZBG9 61.883 223 1.33e-93 281.0 sp|Q3ZBG9|PLS2_BOVIN Phospholipid scramblase 2 OS=Bos taurus OX=9913 GN=PLSCR2 PE=2 SV=1 g14079.t1 Q3SZI7 62.124 631 0.0 786.0 sp|Q3SZI7|COG6_BOVIN Conserved oligomeric Golgi complex subunit 6 OS=Bos taurus OX=9913 GN=COG6 PE=2 SV=1 g14080.t1 Q3B752 59.135 208 1.16e-89 265.0 sp|Q3B752|KTHY_DANRE Thymidylate kinase OS=Danio rerio OX=7955 GN=dtymk PE=2 SV=1 g14081.t1 Q6PZ02 54.66 397 3.09e-154 444.0 sp|Q6PZ02|ATG4B_CHICK Cysteine protease ATG4B OS=Gallus gallus OX=9031 GN=ATG4B PE=2 SV=1 ATG4B_CHICK reviewed Cysteine protease ATG4B (EC 3.4.22.-) (Autophagy-related cysteine endopeptidase 2B) (Autophagin-2B) (cAut2B) (Autophagy-related protein 4 homolog B) Gallus gallus (Chicken) GO:0000045; GO:0000423; GO:0004197; GO:0005737; GO:0005739; GO:0005776; GO:0005783; GO:0005829; GO:0006914; GO:0015031; GO:0016237; GO:0016485; GO:0019786; GO:0031173; GO:0031410; GO:0034727; GO:0035973 aggrephagy [GO:0035973]; autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; microautophagy [GO:0016237]; mitophagy [GO:0000423]; otolith mineralization completed early in development [GO:0031173]; piecemeal microautophagy of the nucleus [GO:0034727]; protein processing [GO:0016485]; protein transport [GO:0015031] autophagosome [GO:0005776]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; mitochondrion [GO:0005739] cysteine-type endopeptidase activity [GO:0004197]; protein-phosphatidylethanolamide deconjugating activity [GO:0019786] g14082.t1 Q29R99 60.185 216 6.47e-93 275.0 sp|Q29R99|LIPT2_DANRE Octanoyl-[acyl-carrier-protein]:protein N-octanoyltransferase LIPT2, mitochondrial OS=Danio rerio OX=7955 GN=lipt2 PE=2 SV=1 LIPT2_DANRE reviewed Octanoyl-[acyl-carrier-protein]:protein N-octanoyltransferase LIPT2, mitochondrial (Lipoate-protein ligase B) (Lipoyl/octanoyl transferase) (Lipoyltransferase 2) (EC 2.3.1.181) (Octanoyl-[acyl-carrier-protein]-protein N-octanoyltransferase) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005739; GO:0009249; GO:0016874; GO:0033819; GO:2000376 positive regulation of oxygen metabolic process [GO:2000376]; protein lipoylation [GO:0009249] mitochondrion [GO:0005739] ligase activity [GO:0016874]; lipoyl(octanoyl) transferase activity [GO:0033819] g14084.t1 Q96HW7 46.535 404 1.4699999999999999e-108 344.0 sp|Q96HW7|INT4_HUMAN Integrator complex subunit 4 OS=Homo sapiens OX=9606 GN=INTS4 PE=1 SV=2 INT4_HUMAN reviewed Integrator complex subunit 4 (Int4) Homo sapiens (Human) GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0016180; GO:0030674; GO:0032039; GO:0034243; GO:0160232; GO:0160240 regulation of transcription elongation by RNA polymerase II [GO:0034243]; RNA polymerase II transcription initiation surveillance [GO:0160240]; snRNA processing [GO:0016180] cytoplasm [GO:0005737]; INTAC complex [GO:0160232]; integrator complex [GO:0032039]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] protein-macromolecule adaptor activity [GO:0030674] g14085.t1 Q68F70 43.627 557 2.96e-144 443.0 sp|Q68F70|INT4_XENLA Integrator complex subunit 4 OS=Xenopus laevis OX=8355 GN=ints4 PE=2 SV=1 g14086.t1 Q5I0R4 54.651 258 8.97e-100 295.0 sp|Q5I0R4|CF300_XENTR Cilia- and flagella-associated protein 300 OS=Xenopus tropicalis OX=8364 GN=cfap300 PE=2 SV=1 g14087.t1 Q4V8D1 34.898 490 8.34e-87 280.0 sp|Q4V8D1|CP2U1_RAT Cytochrome P450 2U1 OS=Rattus norvegicus OX=10116 GN=Cyp2u1 PE=1 SV=1 CP2U1_RAT reviewed Cytochrome P450 2U1 (Long-chain fatty acid omega-monooxygenase) (EC 1.14.14.80) Rattus norvegicus (Rat) GO:0005506; GO:0005737; GO:0005743; GO:0005789; GO:0006082; GO:0006805; GO:0008202; GO:0008395; GO:0016712; GO:0020037; GO:0052869; GO:0097267; GO:0102033 omega-hydroxylase P450 pathway [GO:0097267]; organic acid metabolic process [GO:0006082]; steroid metabolic process [GO:0008202]; xenobiotic metabolic process [GO:0006805] cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; mitochondrial inner membrane [GO:0005743] arachidonate omega-hydroxylase activity [GO:0052869]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; long-chain fatty acid omega-hydroxylase activity [GO:0102033]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; steroid hydroxylase activity [GO:0008395] g14090.t1 Q7ZTL7 67.633 414 0.0 536.0 sp|Q7ZTL7|BCS1_XENLA Mitochondrial chaperone BCS1 OS=Xenopus laevis OX=8355 GN=bcs1l PE=2 SV=1 g14092.t1 O15484 53.333 210 3.18e-77 247.0 sp|O15484|CAN5_HUMAN Calpain-5 OS=Homo sapiens OX=9606 GN=CAPN5 PE=1 SV=2 CAN5_HUMAN reviewed Calpain-5 (EC 3.4.22.-) (Calpain htra-3) (New calpain 3) (nCL-3) Homo sapiens (Human) GO:0004198; GO:0005737; GO:0005925; GO:0006508; GO:0007165; GO:0009986; GO:0045202; GO:0070062 proteolysis [GO:0006508]; signal transduction [GO:0007165] cell surface [GO:0009986]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; synapse [GO:0045202] calcium-dependent cysteine-type endopeptidase activity [GO:0004198] g14093.t1 O15484 43.029 416 8.62e-118 360.0 sp|O15484|CAN5_HUMAN Calpain-5 OS=Homo sapiens OX=9606 GN=CAPN5 PE=1 SV=2 CAN5_HUMAN reviewed Calpain-5 (EC 3.4.22.-) (Calpain htra-3) (New calpain 3) (nCL-3) Homo sapiens (Human) GO:0004198; GO:0005737; GO:0005925; GO:0006508; GO:0007165; GO:0009986; GO:0045202; GO:0070062 proteolysis [GO:0006508]; signal transduction [GO:0007165] cell surface [GO:0009986]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; synapse [GO:0045202] calcium-dependent cysteine-type endopeptidase activity [GO:0004198] g14094.t1 Q9CZR2 28.879 651 1.12e-66 237.0 sp|Q9CZR2|NALD2_MOUSE N-acetylated-alpha-linked acidic dipeptidase 2 OS=Mus musculus OX=10090 GN=Naalad2 PE=1 SV=2 NALD2_MOUSE reviewed N-acetylated-alpha-linked acidic dipeptidase 2 (EC 3.4.17.21) (Glutamate carboxypeptidase III) (GCPIII) (N-acetylaspartylglutamate peptidase II) (NAAG-peptidase II) (N-acetylated-alpha-linked acidic dipeptidase II) (NAALADase II) Mus musculus (Mouse) GO:0004180; GO:0004181; GO:0005886; GO:0006508; GO:0008233; GO:0016020; GO:0016805; GO:0046872; GO:0050129 proteolysis [GO:0006508] membrane [GO:0016020]; plasma membrane [GO:0005886] carboxypeptidase activity [GO:0004180]; dipeptidase activity [GO:0016805]; metal ion binding [GO:0046872]; metallocarboxypeptidase activity [GO:0004181]; N-formylglutamate deformylase activity [GO:0050129]; peptidase activity [GO:0008233] g14095.t1 O43257 63.816 152 1.02e-56 177.0 sp|O43257|ZNHI1_HUMAN Zinc finger HIT domain-containing protein 1 OS=Homo sapiens OX=9606 GN=ZNHIT1 PE=1 SV=1 ZNHI1_HUMAN reviewed Zinc finger HIT domain-containing protein 1 (Cyclin-G1-binding protein 1) (Zinc finger protein subfamily 4A member 1) (p18 Hamlet) Homo sapiens (Human) GO:0000122; GO:0000786; GO:0000812; GO:0003015; GO:0005634; GO:0005654; GO:0006338; GO:0006355; GO:0008270; GO:0031491; GO:0036335; GO:0042129; GO:0042393; GO:0042692; GO:0042826; GO:0043517; GO:0045815; GO:0055074; GO:0060261; GO:0061484; GO:0070317; GO:1905458 calcium ion homeostasis [GO:0055074]; chromatin remodeling [GO:0006338]; heart process [GO:0003015]; hematopoietic stem cell homeostasis [GO:0061484]; intestinal stem cell homeostasis [GO:0036335]; muscle cell differentiation [GO:0042692]; negative regulation of G0 to G1 transition [GO:0070317]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043517]; positive regulation of lymphoid progenitor cell differentiation [GO:1905458]; positive regulation of transcription initiation by RNA polymerase II [GO:0060261]; regulation of DNA-templated transcription [GO:0006355]; regulation of T cell proliferation [GO:0042129]; transcription initiation-coupled chromatin remodeling [GO:0045815] nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634]; Swr1 complex [GO:0000812] histone binding [GO:0042393]; histone deacetylase binding [GO:0042826]; nucleosome binding [GO:0031491]; zinc ion binding [GO:0008270] g14096.t1 Q8VZP1 53.478 230 8.03e-78 237.0 sp|Q8VZP1|GPP2_ARATH (DL)-glycerol-3-phosphatase 2 OS=Arabidopsis thaliana OX=3702 GN=GPP2 PE=1 SV=1 GPP2_ARATH reviewed (DL)-glycerol-3-phosphatase 2 (EC 3.1.3.21) (Glycerol-1-phosphatase 2) (Haloacid dehalogenase-like hydrolase domain-containing protein GPP2) Arabidopsis thaliana (Mouse-ear cress) GO:0000121; GO:0005739; GO:0005829; GO:0006114; GO:0016311; GO:0043136; GO:0046872; GO:0050308 dephosphorylation [GO:0016311]; glycerol biosynthetic process [GO:0006114] cytosol [GO:0005829]; mitochondrion [GO:0005739] metal ion binding [GO:0046872]; sn-glycerol 1-phosphatase activity [GO:0000121]; sn-glycerol 3-phosphatase activity [GO:0043136]; sugar-phosphatase activity [GO:0050308] g14097.t1 Q9H8V3 43.488 883 0.0 656.0 sp|Q9H8V3|ECT2_HUMAN Protein ECT2 OS=Homo sapiens OX=9606 GN=ECT2 PE=1 SV=4 g14098.t1 H2LBU8 43.511 262 2.08e-51 185.0 sp|H2LBU8|YAP1_ORYLA Transcriptional coactivator YAP1 OS=Oryzias latipes OX=8090 GN=yap1 PE=1 SV=2 YAP1_ORYLA reviewed Transcriptional coactivator YAP1 (Yes-associated protein 1) (Protein hirame) (Protein yorkie homolog) (Yes-associated protein YAP65 homolog) Oryzias latipes (Japanese rice fish) (Japanese killifish) GO:0003713; GO:0003714; GO:0005634; GO:0005737; GO:0005886; GO:0005911; GO:0005923; GO:0035329; GO:0045944 hippo signaling [GO:0035329]; positive regulation of transcription by RNA polymerase II [GO:0045944] bicellular tight junction [GO:0005923]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886] transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714] g14098.t1 H2LBU8 47.552 143 1.2000000000000001e-29 125.0 sp|H2LBU8|YAP1_ORYLA Transcriptional coactivator YAP1 OS=Oryzias latipes OX=8090 GN=yap1 PE=1 SV=2 YAP1_ORYLA reviewed Transcriptional coactivator YAP1 (Yes-associated protein 1) (Protein hirame) (Protein yorkie homolog) (Yes-associated protein YAP65 homolog) Oryzias latipes (Japanese rice fish) (Japanese killifish) GO:0003713; GO:0003714; GO:0005634; GO:0005737; GO:0005886; GO:0005911; GO:0005923; GO:0035329; GO:0045944 hippo signaling [GO:0035329]; positive regulation of transcription by RNA polymerase II [GO:0045944] bicellular tight junction [GO:0005923]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886] transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714] g14098.t2 H2LBU8 45.749 247 1.8399999999999998e-54 193.0 sp|H2LBU8|YAP1_ORYLA Transcriptional coactivator YAP1 OS=Oryzias latipes OX=8090 GN=yap1 PE=1 SV=2 YAP1_ORYLA reviewed Transcriptional coactivator YAP1 (Yes-associated protein 1) (Protein hirame) (Protein yorkie homolog) (Yes-associated protein YAP65 homolog) Oryzias latipes (Japanese rice fish) (Japanese killifish) GO:0003713; GO:0003714; GO:0005634; GO:0005737; GO:0005886; GO:0005911; GO:0005923; GO:0035329; GO:0045944 hippo signaling [GO:0035329]; positive regulation of transcription by RNA polymerase II [GO:0045944] bicellular tight junction [GO:0005923]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886] transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714] g14098.t2 H2LBU8 47.552 143 1.1500000000000001e-29 125.0 sp|H2LBU8|YAP1_ORYLA Transcriptional coactivator YAP1 OS=Oryzias latipes OX=8090 GN=yap1 PE=1 SV=2 YAP1_ORYLA reviewed Transcriptional coactivator YAP1 (Yes-associated protein 1) (Protein hirame) (Protein yorkie homolog) (Yes-associated protein YAP65 homolog) Oryzias latipes (Japanese rice fish) (Japanese killifish) GO:0003713; GO:0003714; GO:0005634; GO:0005737; GO:0005886; GO:0005911; GO:0005923; GO:0035329; GO:0045944 hippo signaling [GO:0035329]; positive regulation of transcription by RNA polymerase II [GO:0045944] bicellular tight junction [GO:0005923]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886] transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714] g14101.t1 P0CB05 32.632 570 2.46e-58 215.0 sp|P0CB05|CEP63_CHICK Centrosomal protein of 63 kDa OS=Gallus gallus OX=9031 GN=CEP63 PE=2 SV=1 g14102.t1 P02286 100.0 91 7.17e-62 188.0 sp|P02286|H2B_ASTRU Histone H2B, gonadal OS=Asterias rubens OX=7604 PE=1 SV=2 g14103.t1 P02269 98.947 95 2.4e-63 192.0 sp|P02269|H2A_ASTRU Histone H2A OS=Asterias rubens OX=7604 PE=1 SV=2 g14105.t1 Q06807 46.392 291 5.64e-82 273.0 sp|Q06807|TIE2_BOVIN Angiopoietin-1 receptor OS=Bos taurus OX=9913 GN=TEK PE=2 SV=1 TIE2_BOVIN reviewed Angiopoietin-1 receptor (EC 2.7.10.1) (Endothelial tyrosine kinase) (Tyrosine kinase with Ig and EGF homology domains-2) (Tyrosine-protein kinase receptor TIE-2) (CD antigen CD202b) Bos taurus (Bovine) GO:0001525; GO:0001935; GO:0001936; GO:0002040; GO:0004714; GO:0005524; GO:0005576; GO:0005856; GO:0005886; GO:0005925; GO:0007169; GO:0007507; GO:0010595; GO:0016525; GO:0030097; GO:0032878; GO:0034446; GO:0043235; GO:0043410; GO:0045766; GO:0048014; GO:0051894; GO:0051897; GO:0060347; GO:0070374; GO:1902533; GO:2000352 angiogenesis [GO:0001525]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; endothelial cell proliferation [GO:0001935]; heart development [GO:0007507]; heart trabecula formation [GO:0060347]; hemopoiesis [GO:0030097]; negative regulation of angiogenesis [GO:0016525]; negative regulation of endothelial cell apoptotic process [GO:2000352]; positive regulation of angiogenesis [GO:0045766]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of intracellular signal transduction [GO:1902533]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; regulation of endothelial cell proliferation [GO:0001936]; regulation of establishment or maintenance of cell polarity [GO:0032878]; sprouting angiogenesis [GO:0002040]; substrate adhesion-dependent cell spreading [GO:0034446]; Tie signaling pathway [GO:0048014] cytoskeleton [GO:0005856]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] ATP binding [GO:0005524]; transmembrane receptor protein tyrosine kinase activity [GO:0004714] g14106.t1 O88572 34.091 264 7.75e-39 157.0 sp|O88572|LRP6_MOUSE Low-density lipoprotein receptor-related protein 6 OS=Mus musculus OX=10090 GN=Lrp6 PE=1 SV=1 LRP6_MOUSE reviewed Low-density lipoprotein receptor-related protein 6 (LRP-6) Mus musculus (Mouse) GO:0001702; GO:0001756; GO:0001843; GO:0001947; GO:0002053; GO:0003344; GO:0003401; GO:0005041; GO:0005102; GO:0005109; GO:0005769; GO:0005783; GO:0005886; GO:0006355; GO:0007204; GO:0007268; GO:0007399; GO:0008078; GO:0009880; GO:0009950; GO:0009952; GO:0009986; GO:0010976; GO:0014029; GO:0014033; GO:0015026; GO:0016020; GO:0016055; GO:0017147; GO:0019210; GO:0019534; GO:0021587; GO:0021794; GO:0021795; GO:0021861; GO:0021872; GO:0021915; GO:0021943; GO:0021987; GO:0030291; GO:0030326; GO:0030900; GO:0030901; GO:0030917; GO:0031410; GO:0034185; GO:0034392; GO:0035108; GO:0035115; GO:0035116; GO:0035261; GO:0036342; GO:0042074; GO:0042127; GO:0042475; GO:0042733; GO:0042802; GO:0042803; GO:0042813; GO:0043025; GO:0043065; GO:0045121; GO:0045202; GO:0045599; GO:0045778; GO:0045780; GO:0045787; GO:0045893; GO:0045944; GO:0046849; GO:0048596; GO:0048699; GO:0048705; GO:0050680; GO:0051593; GO:0060021; GO:0060026; GO:0060042; GO:0060059; GO:0060070; GO:0060284; GO:0060325; GO:0060444; GO:0060535; GO:0060596; GO:0060603; GO:0060856; GO:0071397; GO:0071542; GO:0072659; GO:0090009; GO:0090118; GO:0090245; GO:0098609; GO:0110135; GO:1990851; GO:1990909; GO:1990963; GO:2000051 anterior/posterior pattern specification [GO:0009952]; axis elongation [GO:0003401]; axis elongation involved in somitogenesis [GO:0090245]; bone remodeling [GO:0046849]; branching involved in mammary gland duct morphogenesis [GO:0060444]; canonical Wnt signaling pathway [GO:0060070]; cell migration involved in gastrulation [GO:0042074]; cell-cell adhesion [GO:0098609]; cellular response to cholesterol [GO:0071397]; cerebellum morphogenesis [GO:0021587]; cerebral cortex cell migration [GO:0021795]; cerebral cortex development [GO:0021987]; chemical synaptic transmission [GO:0007268]; convergent extension [GO:0060026]; dopaminergic neuron differentiation [GO:0071542]; dorsal/ventral axis specification [GO:0009950]; embryonic camera-type eye morphogenesis [GO:0048596]; embryonic digit morphogenesis [GO:0042733]; embryonic forelimb morphogenesis [GO:0035115]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic limb morphogenesis [GO:0030326]; embryonic pattern specification [GO:0009880]; embryonic retina morphogenesis in camera-type eye [GO:0060059]; establishment of blood-brain barrier [GO:0060856]; establishment of blood-retinal barrier [GO:1990963]; external genitalia morphogenesis [GO:0035261]; face morphogenesis [GO:0060325]; forebrain development [GO:0030900]; forebrain generation of neurons [GO:0021872]; forebrain radial glial cell differentiation [GO:0021861]; formation of radial glial scaffolds [GO:0021943]; gastrulation with mouth forming second [GO:0001702]; generation of neurons [GO:0048699]; heart looping [GO:0001947]; limb morphogenesis [GO:0035108]; mammary gland duct morphogenesis [GO:0060603]; mammary placode formation [GO:0060596]; mesodermal cell migration [GO:0008078]; midbrain development [GO:0030901]; midbrain-hindbrain boundary development [GO:0030917]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of non-canonical Wnt signaling pathway [GO:2000051]; negative regulation of smooth muscle cell apoptotic process [GO:0034392]; nervous system development [GO:0007399]; neural crest cell differentiation [GO:0014033]; neural crest formation [GO:0014029]; neural tube closure [GO:0001843]; neural tube development [GO:0021915]; Norrin signaling pathway [GO:0110135]; odontogenesis of dentin-containing tooth [GO:0042475]; pericardium morphogenesis [GO:0003344]; positive regulation of apoptotic process [GO:0043065]; positive regulation of bone resorption [GO:0045780]; positive regulation of cell cycle [GO:0045787]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of neuron projection development [GO:0010976]; positive regulation of ossification [GO:0045778]; positive regulation of transcription by RNA polymerase II [GO:0045944]; post-anal tail morphogenesis [GO:0036342]; primitive streak formation [GO:0090009]; protein localization to plasma membrane [GO:0072659]; receptor-mediated endocytosis involved in cholesterol transport [GO:0090118]; regulation of cell development [GO:0060284]; regulation of cell population proliferation [GO:0042127]; regulation of DNA-templated transcription [GO:0006355]; response to folic acid [GO:0051593]; retina morphogenesis in camera-type eye [GO:0060042]; roof of mouth development [GO:0060021]; skeletal system morphogenesis [GO:0048705]; somitogenesis [GO:0001756]; thalamus development [GO:0021794]; trachea cartilage morphogenesis [GO:0060535]; Wnt signaling pathway [GO:0016055] cell surface [GO:0009986]; cytoplasmic vesicle [GO:0031410]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; membrane [GO:0016020]; membrane raft [GO:0045121]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; synapse [GO:0045202]; Wnt signalosome [GO:1990909]; Wnt-Frizzled-LRP5/6 complex [GO:1990851] apolipoprotein binding [GO:0034185]; coreceptor activity [GO:0015026]; frizzled binding [GO:0005109]; identical protein binding [GO:0042802]; kinase inhibitor activity [GO:0019210]; low-density lipoprotein particle receptor activity [GO:0005041]; protein homodimerization activity [GO:0042803]; protein serine/threonine kinase inhibitor activity [GO:0030291]; signaling receptor binding [GO:0005102]; toxin transmembrane transporter activity [GO:0019534]; Wnt receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147] g14106.t1 O88572 39.336 211 1.15e-34 144.0 sp|O88572|LRP6_MOUSE Low-density lipoprotein receptor-related protein 6 OS=Mus musculus OX=10090 GN=Lrp6 PE=1 SV=1 LRP6_MOUSE reviewed Low-density lipoprotein receptor-related protein 6 (LRP-6) Mus musculus (Mouse) GO:0001702; GO:0001756; GO:0001843; GO:0001947; GO:0002053; GO:0003344; GO:0003401; GO:0005041; GO:0005102; GO:0005109; GO:0005769; GO:0005783; GO:0005886; GO:0006355; GO:0007204; GO:0007268; GO:0007399; GO:0008078; GO:0009880; GO:0009950; GO:0009952; GO:0009986; GO:0010976; GO:0014029; GO:0014033; GO:0015026; GO:0016020; GO:0016055; GO:0017147; GO:0019210; GO:0019534; GO:0021587; GO:0021794; GO:0021795; GO:0021861; GO:0021872; GO:0021915; GO:0021943; GO:0021987; GO:0030291; GO:0030326; GO:0030900; GO:0030901; GO:0030917; GO:0031410; GO:0034185; GO:0034392; GO:0035108; GO:0035115; GO:0035116; GO:0035261; GO:0036342; GO:0042074; GO:0042127; GO:0042475; GO:0042733; GO:0042802; GO:0042803; GO:0042813; GO:0043025; GO:0043065; GO:0045121; GO:0045202; GO:0045599; GO:0045778; GO:0045780; GO:0045787; GO:0045893; GO:0045944; GO:0046849; GO:0048596; GO:0048699; GO:0048705; GO:0050680; GO:0051593; GO:0060021; GO:0060026; GO:0060042; GO:0060059; GO:0060070; GO:0060284; GO:0060325; GO:0060444; GO:0060535; GO:0060596; GO:0060603; GO:0060856; GO:0071397; GO:0071542; GO:0072659; GO:0090009; GO:0090118; GO:0090245; GO:0098609; GO:0110135; GO:1990851; GO:1990909; GO:1990963; GO:2000051 anterior/posterior pattern specification [GO:0009952]; axis elongation [GO:0003401]; axis elongation involved in somitogenesis [GO:0090245]; bone remodeling [GO:0046849]; branching involved in mammary gland duct morphogenesis [GO:0060444]; canonical Wnt signaling pathway [GO:0060070]; cell migration involved in gastrulation [GO:0042074]; cell-cell adhesion [GO:0098609]; cellular response to cholesterol [GO:0071397]; cerebellum morphogenesis [GO:0021587]; cerebral cortex cell migration [GO:0021795]; cerebral cortex development [GO:0021987]; chemical synaptic transmission [GO:0007268]; convergent extension [GO:0060026]; dopaminergic neuron differentiation [GO:0071542]; dorsal/ventral axis specification [GO:0009950]; embryonic camera-type eye morphogenesis [GO:0048596]; embryonic digit morphogenesis [GO:0042733]; embryonic forelimb morphogenesis [GO:0035115]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic limb morphogenesis [GO:0030326]; embryonic pattern specification [GO:0009880]; embryonic retina morphogenesis in camera-type eye [GO:0060059]; establishment of blood-brain barrier [GO:0060856]; establishment of blood-retinal barrier [GO:1990963]; external genitalia morphogenesis [GO:0035261]; face morphogenesis [GO:0060325]; forebrain development [GO:0030900]; forebrain generation of neurons [GO:0021872]; forebrain radial glial cell differentiation [GO:0021861]; formation of radial glial scaffolds [GO:0021943]; gastrulation with mouth forming second [GO:0001702]; generation of neurons [GO:0048699]; heart looping [GO:0001947]; limb morphogenesis [GO:0035108]; mammary gland duct morphogenesis [GO:0060603]; mammary placode formation [GO:0060596]; mesodermal cell migration [GO:0008078]; midbrain development [GO:0030901]; midbrain-hindbrain boundary development [GO:0030917]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of non-canonical Wnt signaling pathway [GO:2000051]; negative regulation of smooth muscle cell apoptotic process [GO:0034392]; nervous system development [GO:0007399]; neural crest cell differentiation [GO:0014033]; neural crest formation [GO:0014029]; neural tube closure [GO:0001843]; neural tube development [GO:0021915]; Norrin signaling pathway [GO:0110135]; odontogenesis of dentin-containing tooth [GO:0042475]; pericardium morphogenesis [GO:0003344]; positive regulation of apoptotic process [GO:0043065]; positive regulation of bone resorption [GO:0045780]; positive regulation of cell cycle [GO:0045787]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of neuron projection development [GO:0010976]; positive regulation of ossification [GO:0045778]; positive regulation of transcription by RNA polymerase II [GO:0045944]; post-anal tail morphogenesis [GO:0036342]; primitive streak formation [GO:0090009]; protein localization to plasma membrane [GO:0072659]; receptor-mediated endocytosis involved in cholesterol transport [GO:0090118]; regulation of cell development [GO:0060284]; regulation of cell population proliferation [GO:0042127]; regulation of DNA-templated transcription [GO:0006355]; response to folic acid [GO:0051593]; retina morphogenesis in camera-type eye [GO:0060042]; roof of mouth development [GO:0060021]; skeletal system morphogenesis [GO:0048705]; somitogenesis [GO:0001756]; thalamus development [GO:0021794]; trachea cartilage morphogenesis [GO:0060535]; Wnt signaling pathway [GO:0016055] cell surface [GO:0009986]; cytoplasmic vesicle [GO:0031410]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; membrane [GO:0016020]; membrane raft [GO:0045121]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; synapse [GO:0045202]; Wnt signalosome [GO:1990909]; Wnt-Frizzled-LRP5/6 complex [GO:1990851] apolipoprotein binding [GO:0034185]; coreceptor activity [GO:0015026]; frizzled binding [GO:0005109]; identical protein binding [GO:0042802]; kinase inhibitor activity [GO:0019210]; low-density lipoprotein particle receptor activity [GO:0005041]; protein homodimerization activity [GO:0042803]; protein serine/threonine kinase inhibitor activity [GO:0030291]; signaling receptor binding [GO:0005102]; toxin transmembrane transporter activity [GO:0019534]; Wnt receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147] g14106.t1 O88572 37.879 198 1.62e-29 129.0 sp|O88572|LRP6_MOUSE Low-density lipoprotein receptor-related protein 6 OS=Mus musculus OX=10090 GN=Lrp6 PE=1 SV=1 LRP6_MOUSE reviewed Low-density lipoprotein receptor-related protein 6 (LRP-6) Mus musculus (Mouse) GO:0001702; GO:0001756; GO:0001843; GO:0001947; GO:0002053; GO:0003344; GO:0003401; GO:0005041; GO:0005102; GO:0005109; GO:0005769; GO:0005783; GO:0005886; GO:0006355; GO:0007204; GO:0007268; GO:0007399; GO:0008078; GO:0009880; GO:0009950; GO:0009952; GO:0009986; GO:0010976; GO:0014029; GO:0014033; GO:0015026; GO:0016020; GO:0016055; GO:0017147; GO:0019210; GO:0019534; GO:0021587; GO:0021794; GO:0021795; GO:0021861; GO:0021872; GO:0021915; GO:0021943; GO:0021987; GO:0030291; GO:0030326; GO:0030900; GO:0030901; GO:0030917; GO:0031410; GO:0034185; GO:0034392; GO:0035108; GO:0035115; GO:0035116; GO:0035261; GO:0036342; GO:0042074; GO:0042127; GO:0042475; GO:0042733; GO:0042802; GO:0042803; GO:0042813; GO:0043025; GO:0043065; GO:0045121; GO:0045202; GO:0045599; GO:0045778; GO:0045780; GO:0045787; GO:0045893; GO:0045944; GO:0046849; GO:0048596; GO:0048699; GO:0048705; GO:0050680; GO:0051593; GO:0060021; GO:0060026; GO:0060042; GO:0060059; GO:0060070; GO:0060284; GO:0060325; GO:0060444; GO:0060535; GO:0060596; GO:0060603; GO:0060856; GO:0071397; GO:0071542; GO:0072659; GO:0090009; GO:0090118; GO:0090245; GO:0098609; GO:0110135; GO:1990851; GO:1990909; GO:1990963; GO:2000051 anterior/posterior pattern specification [GO:0009952]; axis elongation [GO:0003401]; axis elongation involved in somitogenesis [GO:0090245]; bone remodeling [GO:0046849]; branching involved in mammary gland duct morphogenesis [GO:0060444]; canonical Wnt signaling pathway [GO:0060070]; cell migration involved in gastrulation [GO:0042074]; cell-cell adhesion [GO:0098609]; cellular response to cholesterol [GO:0071397]; cerebellum morphogenesis [GO:0021587]; cerebral cortex cell migration [GO:0021795]; cerebral cortex development [GO:0021987]; chemical synaptic transmission [GO:0007268]; convergent extension [GO:0060026]; dopaminergic neuron differentiation [GO:0071542]; dorsal/ventral axis specification [GO:0009950]; embryonic camera-type eye morphogenesis [GO:0048596]; embryonic digit morphogenesis [GO:0042733]; embryonic forelimb morphogenesis [GO:0035115]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic limb morphogenesis [GO:0030326]; embryonic pattern specification [GO:0009880]; embryonic retina morphogenesis in camera-type eye [GO:0060059]; establishment of blood-brain barrier [GO:0060856]; establishment of blood-retinal barrier [GO:1990963]; external genitalia morphogenesis [GO:0035261]; face morphogenesis [GO:0060325]; forebrain development [GO:0030900]; forebrain generation of neurons [GO:0021872]; forebrain radial glial cell differentiation [GO:0021861]; formation of radial glial scaffolds [GO:0021943]; gastrulation with mouth forming second [GO:0001702]; generation of neurons [GO:0048699]; heart looping [GO:0001947]; limb morphogenesis [GO:0035108]; mammary gland duct morphogenesis [GO:0060603]; mammary placode formation [GO:0060596]; mesodermal cell migration [GO:0008078]; midbrain development [GO:0030901]; midbrain-hindbrain boundary development [GO:0030917]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of non-canonical Wnt signaling pathway [GO:2000051]; negative regulation of smooth muscle cell apoptotic process [GO:0034392]; nervous system development [GO:0007399]; neural crest cell differentiation [GO:0014033]; neural crest formation [GO:0014029]; neural tube closure [GO:0001843]; neural tube development [GO:0021915]; Norrin signaling pathway [GO:0110135]; odontogenesis of dentin-containing tooth [GO:0042475]; pericardium morphogenesis [GO:0003344]; positive regulation of apoptotic process [GO:0043065]; positive regulation of bone resorption [GO:0045780]; positive regulation of cell cycle [GO:0045787]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of neuron projection development [GO:0010976]; positive regulation of ossification [GO:0045778]; positive regulation of transcription by RNA polymerase II [GO:0045944]; post-anal tail morphogenesis [GO:0036342]; primitive streak formation [GO:0090009]; protein localization to plasma membrane [GO:0072659]; receptor-mediated endocytosis involved in cholesterol transport [GO:0090118]; regulation of cell development [GO:0060284]; regulation of cell population proliferation [GO:0042127]; regulation of DNA-templated transcription [GO:0006355]; response to folic acid [GO:0051593]; retina morphogenesis in camera-type eye [GO:0060042]; roof of mouth development [GO:0060021]; skeletal system morphogenesis [GO:0048705]; somitogenesis [GO:0001756]; thalamus development [GO:0021794]; trachea cartilage morphogenesis [GO:0060535]; Wnt signaling pathway [GO:0016055] cell surface [GO:0009986]; cytoplasmic vesicle [GO:0031410]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; membrane [GO:0016020]; membrane raft [GO:0045121]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; synapse [GO:0045202]; Wnt signalosome [GO:1990909]; Wnt-Frizzled-LRP5/6 complex [GO:1990851] apolipoprotein binding [GO:0034185]; coreceptor activity [GO:0015026]; frizzled binding [GO:0005109]; identical protein binding [GO:0042802]; kinase inhibitor activity [GO:0019210]; low-density lipoprotein particle receptor activity [GO:0005041]; protein homodimerization activity [GO:0042803]; protein serine/threonine kinase inhibitor activity [GO:0030291]; signaling receptor binding [GO:0005102]; toxin transmembrane transporter activity [GO:0019534]; Wnt receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147] g14106.t1 O88572 28.159 277 1.7699999999999998e-24 113.0 sp|O88572|LRP6_MOUSE Low-density lipoprotein receptor-related protein 6 OS=Mus musculus OX=10090 GN=Lrp6 PE=1 SV=1 LRP6_MOUSE reviewed Low-density lipoprotein receptor-related protein 6 (LRP-6) Mus musculus (Mouse) GO:0001702; GO:0001756; GO:0001843; GO:0001947; GO:0002053; GO:0003344; GO:0003401; GO:0005041; GO:0005102; GO:0005109; GO:0005769; GO:0005783; GO:0005886; GO:0006355; GO:0007204; GO:0007268; GO:0007399; GO:0008078; GO:0009880; GO:0009950; GO:0009952; GO:0009986; GO:0010976; GO:0014029; GO:0014033; GO:0015026; GO:0016020; GO:0016055; GO:0017147; GO:0019210; GO:0019534; GO:0021587; GO:0021794; GO:0021795; GO:0021861; GO:0021872; GO:0021915; GO:0021943; GO:0021987; GO:0030291; GO:0030326; GO:0030900; GO:0030901; GO:0030917; GO:0031410; GO:0034185; GO:0034392; GO:0035108; GO:0035115; GO:0035116; GO:0035261; GO:0036342; GO:0042074; GO:0042127; GO:0042475; GO:0042733; GO:0042802; GO:0042803; GO:0042813; GO:0043025; GO:0043065; GO:0045121; GO:0045202; GO:0045599; GO:0045778; GO:0045780; GO:0045787; GO:0045893; GO:0045944; GO:0046849; GO:0048596; GO:0048699; GO:0048705; GO:0050680; GO:0051593; GO:0060021; GO:0060026; GO:0060042; GO:0060059; GO:0060070; GO:0060284; GO:0060325; GO:0060444; GO:0060535; GO:0060596; GO:0060603; GO:0060856; GO:0071397; GO:0071542; GO:0072659; GO:0090009; GO:0090118; GO:0090245; GO:0098609; GO:0110135; GO:1990851; GO:1990909; GO:1990963; GO:2000051 anterior/posterior pattern specification [GO:0009952]; axis elongation [GO:0003401]; axis elongation involved in somitogenesis [GO:0090245]; bone remodeling [GO:0046849]; branching involved in mammary gland duct morphogenesis [GO:0060444]; canonical Wnt signaling pathway [GO:0060070]; cell migration involved in gastrulation [GO:0042074]; cell-cell adhesion [GO:0098609]; cellular response to cholesterol [GO:0071397]; cerebellum morphogenesis [GO:0021587]; cerebral cortex cell migration [GO:0021795]; cerebral cortex development [GO:0021987]; chemical synaptic transmission [GO:0007268]; convergent extension [GO:0060026]; dopaminergic neuron differentiation [GO:0071542]; dorsal/ventral axis specification [GO:0009950]; embryonic camera-type eye morphogenesis [GO:0048596]; embryonic digit morphogenesis [GO:0042733]; embryonic forelimb morphogenesis [GO:0035115]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic limb morphogenesis [GO:0030326]; embryonic pattern specification [GO:0009880]; embryonic retina morphogenesis in camera-type eye [GO:0060059]; establishment of blood-brain barrier [GO:0060856]; establishment of blood-retinal barrier [GO:1990963]; external genitalia morphogenesis [GO:0035261]; face morphogenesis [GO:0060325]; forebrain development [GO:0030900]; forebrain generation of neurons [GO:0021872]; forebrain radial glial cell differentiation [GO:0021861]; formation of radial glial scaffolds [GO:0021943]; gastrulation with mouth forming second [GO:0001702]; generation of neurons [GO:0048699]; heart looping [GO:0001947]; limb morphogenesis [GO:0035108]; mammary gland duct morphogenesis [GO:0060603]; mammary placode formation [GO:0060596]; mesodermal cell migration [GO:0008078]; midbrain development [GO:0030901]; midbrain-hindbrain boundary development [GO:0030917]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of non-canonical Wnt signaling pathway [GO:2000051]; negative regulation of smooth muscle cell apoptotic process [GO:0034392]; nervous system development [GO:0007399]; neural crest cell differentiation [GO:0014033]; neural crest formation [GO:0014029]; neural tube closure [GO:0001843]; neural tube development [GO:0021915]; Norrin signaling pathway [GO:0110135]; odontogenesis of dentin-containing tooth [GO:0042475]; pericardium morphogenesis [GO:0003344]; positive regulation of apoptotic process [GO:0043065]; positive regulation of bone resorption [GO:0045780]; positive regulation of cell cycle [GO:0045787]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of neuron projection development [GO:0010976]; positive regulation of ossification [GO:0045778]; positive regulation of transcription by RNA polymerase II [GO:0045944]; post-anal tail morphogenesis [GO:0036342]; primitive streak formation [GO:0090009]; protein localization to plasma membrane [GO:0072659]; receptor-mediated endocytosis involved in cholesterol transport [GO:0090118]; regulation of cell development [GO:0060284]; regulation of cell population proliferation [GO:0042127]; regulation of DNA-templated transcription [GO:0006355]; response to folic acid [GO:0051593]; retina morphogenesis in camera-type eye [GO:0060042]; roof of mouth development [GO:0060021]; skeletal system morphogenesis [GO:0048705]; somitogenesis [GO:0001756]; thalamus development [GO:0021794]; trachea cartilage morphogenesis [GO:0060535]; Wnt signaling pathway [GO:0016055] cell surface [GO:0009986]; cytoplasmic vesicle [GO:0031410]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; membrane [GO:0016020]; membrane raft [GO:0045121]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; synapse [GO:0045202]; Wnt signalosome [GO:1990909]; Wnt-Frizzled-LRP5/6 complex [GO:1990851] apolipoprotein binding [GO:0034185]; coreceptor activity [GO:0015026]; frizzled binding [GO:0005109]; identical protein binding [GO:0042802]; kinase inhibitor activity [GO:0019210]; low-density lipoprotein particle receptor activity [GO:0005041]; protein homodimerization activity [GO:0042803]; protein serine/threonine kinase inhibitor activity [GO:0030291]; signaling receptor binding [GO:0005102]; toxin transmembrane transporter activity [GO:0019534]; Wnt receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147] g14108.t1 Q62829 68.165 534 0.0 686.0 sp|Q62829|PAK3_RAT Serine/threonine-protein kinase PAK 3 OS=Rattus norvegicus OX=10116 GN=Pak3 PE=1 SV=1 g14110.t1 Q27312 33.852 257 1.53e-46 162.0 sp|Q27312|NADA_APLKU ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase OS=Aplysia kurodai OX=6501 PE=1 SV=1 NADA_APLKU reviewed ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase (EC 3.2.2.-) (EC 3.2.2.6) (2'-phospho-ADP-ribosyl cyclase) (2'-phospho-ADP-ribosyl cyclase/2'-phospho-cyclic-ADP-ribose transferase) (EC 2.4.99.20) (2'-phospho-cyclic-ADP-ribose transferase) (ADP-ribosyl cyclase) (ADPRC) (ADRC) (NAD glycohydrolase) (NAD(+) nucleosidase) (NADase) Aplysia kurodai (Kuroda's sea hare) GO:0005886; GO:0007338; GO:0016740; GO:0016849; GO:0031410; GO:0061809 single fertilization [GO:0007338] cytoplasmic vesicle [GO:0031410]; plasma membrane [GO:0005886] NAD+ nucleosidase activity, cyclic ADP-ribose generating [GO:0061809]; phosphorus-oxygen lyase activity [GO:0016849]; transferase activity [GO:0016740] g14111.t1 P70691 30.769 338 2.4899999999999997e-48 180.0 sp|P70691|UD12_MOUSE UDP-glucuronosyltransferase 1-2 OS=Mus musculus OX=10090 GN=Ugt1a2 PE=1 SV=1 g14112.t1 P46023 39.64 111 1.7100000000000003e-21 94.4 sp|P46023|GR101_LYMST G-protein coupled receptor GRL101 OS=Lymnaea stagnalis OX=6523 PE=2 SV=1 g14116.t1 Q7Z407 28.037 321 1.23e-22 110.0 sp|Q7Z407|CSMD3_HUMAN CUB and sushi domain-containing protein 3 OS=Homo sapiens OX=9606 GN=CSMD3 PE=1 SV=3 CSMD3_HUMAN reviewed CUB and sushi domain-containing protein 3 (CUB and sushi multiple domains protein 3) Homo sapiens (Human) GO:0005886; GO:0050773 regulation of dendrite development [GO:0050773] plasma membrane [GO:0005886] g14117.t1 F1P065 53.471 533 0.0 587.0 sp|F1P065|FARP1_CHICK FERM, ARHGEF and pleckstrin domain-containing protein 1 OS=Gallus gallus OX=9031 GN=FARP1 PE=1 SV=2 g14117.t2 F1P065 52.39 544 0.0 578.0 sp|F1P065|FARP1_CHICK FERM, ARHGEF and pleckstrin domain-containing protein 1 OS=Gallus gallus OX=9031 GN=FARP1 PE=1 SV=2 g14118.t1 F1LYQ8 48.429 382 6.55e-98 343.0 sp|F1LYQ8|FARP1_RAT FERM, ARHGEF and pleckstrin domain-containing protein 1 OS=Rattus norvegicus OX=10116 GN=Farp1 PE=1 SV=2 FARP1_RAT reviewed FERM, ARHGEF and pleckstrin domain-containing protein 1 (FERM, RhoGEF and pleckstrin domain-containing protein 1) Rattus norvegicus (Rat) GO:0005085; GO:0005829; GO:0007167; GO:0007416; GO:0008092; GO:0009898; GO:0016601; GO:0030175; GO:0030425; GO:0031267; GO:0043197; GO:0048813; GO:0098890; GO:0098942; GO:0098974; GO:0098978; GO:1904395; GO:1905606 dendrite morphogenesis [GO:0048813]; enzyme-linked receptor protein signaling pathway [GO:0007167]; positive regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904395]; postsynaptic actin cytoskeleton organization [GO:0098974]; Rac protein signal transduction [GO:0016601]; regulation of presynapse assembly [GO:1905606]; retrograde trans-synaptic signaling by trans-synaptic protein complex [GO:0098942]; synapse assembly [GO:0007416] cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; extrinsic component of postsynaptic membrane [GO:0098890]; filopodium [GO:0030175]; glutamatergic synapse [GO:0098978] cytoskeletal protein binding [GO:0008092]; guanyl-nucleotide exchange factor activity [GO:0005085]; small GTPase binding [GO:0031267] g14118.t2 F1LYQ8 48.421 380 4.94e-98 343.0 sp|F1LYQ8|FARP1_RAT FERM, ARHGEF and pleckstrin domain-containing protein 1 OS=Rattus norvegicus OX=10116 GN=Farp1 PE=1 SV=2 FARP1_RAT reviewed FERM, ARHGEF and pleckstrin domain-containing protein 1 (FERM, RhoGEF and pleckstrin domain-containing protein 1) Rattus norvegicus (Rat) GO:0005085; GO:0005829; GO:0007167; GO:0007416; GO:0008092; GO:0009898; GO:0016601; GO:0030175; GO:0030425; GO:0031267; GO:0043197; GO:0048813; GO:0098890; GO:0098942; GO:0098974; GO:0098978; GO:1904395; GO:1905606 dendrite morphogenesis [GO:0048813]; enzyme-linked receptor protein signaling pathway [GO:0007167]; positive regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904395]; postsynaptic actin cytoskeleton organization [GO:0098974]; Rac protein signal transduction [GO:0016601]; regulation of presynapse assembly [GO:1905606]; retrograde trans-synaptic signaling by trans-synaptic protein complex [GO:0098942]; synapse assembly [GO:0007416] cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; extrinsic component of postsynaptic membrane [GO:0098890]; filopodium [GO:0030175]; glutamatergic synapse [GO:0098978] cytoskeletal protein binding [GO:0008092]; guanyl-nucleotide exchange factor activity [GO:0005085]; small GTPase binding [GO:0031267] g14119.t1 Q9D8Z1 45.278 360 1.78e-87 271.0 sp|Q9D8Z1|ASCC1_MOUSE Activating signal cointegrator 1 complex subunit 1 OS=Mus musculus OX=10090 GN=Ascc1 PE=1 SV=1 g14128.t1 Q8R3L0 43.0 100 2.17e-25 95.5 sp|Q8R3L0|MMGT2_MOUSE Membrane magnesium transporter 2 OS=Mus musculus OX=10090 GN=Mmgt2 PE=2 SV=1 MMGT2_MOUSE reviewed Membrane magnesium transporter 2 Mus musculus (Mouse) GO:0000139; GO:0005375; GO:0005384; GO:0005769; GO:0005794; GO:0005886; GO:0006812; GO:0006824; GO:0006825; GO:0006828; GO:0015087; GO:0015095; GO:0015099; GO:0015675; GO:0015693; GO:0022890; GO:0031901; GO:0072546 cobalt ion transport [GO:0006824]; copper ion transport [GO:0006825]; magnesium ion transport [GO:0015693]; manganese ion transport [GO:0006828]; monoatomic cation transport [GO:0006812]; nickel cation transport [GO:0015675] early endosome [GO:0005769]; early endosome membrane [GO:0031901]; EMC complex [GO:0072546]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886] cobalt ion transmembrane transporter activity [GO:0015087]; copper ion transmembrane transporter activity [GO:0005375]; inorganic cation transmembrane transporter activity [GO:0022890]; magnesium ion transmembrane transporter activity [GO:0015095]; manganese ion transmembrane transporter activity [GO:0005384]; nickel cation transmembrane transporter activity [GO:0015099] g14129.t1 Q5PQM9 65.772 298 4.06e-138 394.0 sp|Q5PQM9|KMCP1_RAT Kidney mitochondrial carrier protein 1 OS=Rattus norvegicus OX=10116 GN=Slc25a30 PE=2 SV=1 KMCP1_RAT reviewed Kidney mitochondrial carrier protein 1 (Solute carrier family 25 member 30) Rattus norvegicus (Rat) GO:0005452; GO:0005739; GO:0005743; GO:0015698; GO:0022857 inorganic anion transport [GO:0015698] mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739] solute:inorganic anion antiporter activity [GO:0005452]; transmembrane transporter activity [GO:0022857] g14130.t1 Q8BZ20 37.701 435 1.87e-73 263.0 sp|Q8BZ20|PAR12_MOUSE Protein mono-ADP-ribosyltransferase PARP12 OS=Mus musculus OX=10090 GN=Parp12 PE=1 SV=3 PAR12_MOUSE reviewed Protein mono-ADP-ribosyltransferase PARP12 (EC 2.4.2.-) (ADP-ribosyltransferase diphtheria toxin-like 12) (ARTD12) (Poly [ADP-ribose] polymerase 12) (PARP-12) (Zinc finger CCCH domain-containing protein 1) Mus musculus (Mouse) GO:0003950; GO:0005634; GO:0005802; GO:0008270; GO:0010494; GO:0016779; GO:0044331; GO:0070213; GO:0070633; GO:0140803; GO:0140806; GO:1990404 cell-cell adhesion mediated by cadherin [GO:0044331]; protein auto-ADP-ribosylation [GO:0070213]; transepithelial transport [GO:0070633] cytoplasmic stress granule [GO:0010494]; nucleus [GO:0005634]; trans-Golgi network [GO:0005802] NAD+ poly-ADP-ribosyltransferase activity [GO:0003950]; NAD+-protein mono-ADP-ribosyltransferase activity [GO:1990404]; NAD+-protein-aspartate ADP-ribosyltransferase activity [GO:0140806]; NAD+-protein-cysteine ADP-ribosyltransferase activity [GO:0140803]; nucleotidyltransferase activity [GO:0016779]; zinc ion binding [GO:0008270] g14131.t1 Q9H0J9 37.158 366 7.42e-51 195.0 sp|Q9H0J9|PAR12_HUMAN Protein mono-ADP-ribosyltransferase PARP12 OS=Homo sapiens OX=9606 GN=PARP12 PE=1 SV=1 g14132.t1 Q96II8 54.661 236 3.26e-87 281.0 sp|Q96II8|LRCH3_HUMAN DISP complex protein LRCH3 OS=Homo sapiens OX=9606 GN=LRCH3 PE=1 SV=2 g14132.t2 P41737 52.5 200 5.05e-56 187.0 sp|P41737|LRCH1_FELCA Leucine-rich repeat and calponin homology domain-containing protein 1 (Fragment) OS=Felis catus OX=9685 PE=2 SV=2 g14132.t3 Q96II8 48.161 299 4.6200000000000004e-88 295.0 sp|Q96II8|LRCH3_HUMAN DISP complex protein LRCH3 OS=Homo sapiens OX=9606 GN=LRCH3 PE=1 SV=2 g14132.t3 Q96II8 68.675 83 1.4e-26 119.0 sp|Q96II8|LRCH3_HUMAN DISP complex protein LRCH3 OS=Homo sapiens OX=9606 GN=LRCH3 PE=1 SV=2 g14132.t4 P41737 52.5 200 1.1699999999999999e-55 187.0 sp|P41737|LRCH1_FELCA Leucine-rich repeat and calponin homology domain-containing protein 1 (Fragment) OS=Felis catus OX=9685 PE=2 SV=2 g14133.t1 Q2T9V2 42.895 373 3.0700000000000004e-85 269.0 sp|Q2T9V2|DRC9_BOVIN Dynein regulatory complex protein 9 OS=Bos taurus OX=9913 GN=IQCG PE=2 SV=1 g14134.t1 P49180 60.0 110 8.75e-47 149.0 sp|P49180|RL35A_CAEEL Large ribosomal subunit protein eL33 OS=Caenorhabditis elegans OX=6239 GN=rpl-35A PE=1 SV=3 g14136.t1 S8FIE4 31.277 470 1.46e-41 161.0 sp|S8FIE4|LAC1_FOMSC Laccase-1 OS=Fomitopsis schrenkii OX=2126942 GN=LCC1 PE=1 SV=1 g14137.t1 Q02079 35.473 296 1.7499999999999998e-42 164.0 sp|Q02079|LAC3_THACU Laccase-3 OS=Thanatephorus cucumeris OX=107832 GN=LCC3 PE=2 SV=1 g14138.t1 Q6PBM8 47.753 178 3.77e-45 150.0 sp|Q6PBM8|RBM18_DANRE Probable RNA-binding protein 18 OS=Danio rerio OX=7955 GN=rbm18 PE=2 SV=1 g14146.t1 P22303 45.085 590 1.53e-175 515.0 sp|P22303|ACES_HUMAN Acetylcholinesterase OS=Homo sapiens OX=9606 GN=ACHE PE=1 SV=1 ACES_HUMAN reviewed Acetylcholinesterase (AChE) (EC 3.1.1.7) Homo sapiens (Human) GO:0001507; GO:0001540; GO:0001919; GO:0002076; GO:0003990; GO:0004104; GO:0005518; GO:0005576; GO:0005604; GO:0005615; GO:0005634; GO:0005794; GO:0005886; GO:0006581; GO:0007155; GO:0007399; GO:0007416; GO:0009986; GO:0016020; GO:0016787; GO:0017171; GO:0031594; GO:0031623; GO:0032223; GO:0042166; GO:0042803; GO:0042982; GO:0043083; GO:0043236; GO:0045202; GO:0048471; GO:0050714; GO:0060041; GO:0095500; GO:0098552; GO:0120162 acetylcholine catabolic process [GO:0006581]; acetylcholine catabolic process in synaptic cleft [GO:0001507]; acetylcholine receptor signaling pathway [GO:0095500]; amyloid precursor protein metabolic process [GO:0042982]; cell adhesion [GO:0007155]; negative regulation of synaptic transmission, cholinergic [GO:0032223]; nervous system development [GO:0007399]; osteoblast development [GO:0002076]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of protein secretion [GO:0050714]; receptor internalization [GO:0031623]; regulation of receptor recycling [GO:0001919]; retina development in camera-type eye [GO:0060041]; synapse assembly [GO:0007416] basement membrane [GO:0005604]; cell surface [GO:0009986]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; neuromuscular junction [GO:0031594]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; side of membrane [GO:0098552]; synapse [GO:0045202]; synaptic cleft [GO:0043083] acetylcholine binding [GO:0042166]; acetylcholinesterase activity [GO:0003990]; amyloid-beta binding [GO:0001540]; cholinesterase activity [GO:0004104]; collagen binding [GO:0005518]; hydrolase activity [GO:0016787]; laminin binding [GO:0043236]; protein homodimerization activity [GO:0042803]; serine hydrolase activity [GO:0017171] g14182.t1 Q8NEA4 48.066 181 1.84e-59 187.0 sp|Q8NEA4|FBX36_HUMAN F-box only protein 36 OS=Homo sapiens OX=9606 GN=FBXO36 PE=1 SV=2 g14183.t1 O70546 63.353 513 0.0 648.0 sp|O70546|KDM6A_MOUSE Lysine-specific demethylase 6A OS=Mus musculus OX=10090 GN=Kdm6a PE=1 SV=2 KDM6A_MOUSE reviewed Lysine-specific demethylase 6A (EC 1.14.11.68) (Histone demethylase UTX) (Ubiquitously transcribed TPR protein on the X chromosome) (Ubiquitously transcribed X chromosome tetratricopeptide repeat protein) ([histone H3]-trimethyl-L-lysine(27) demethylase 6A) Mus musculus (Mouse) GO:0000978; GO:0001701; GO:0001843; GO:0003007; GO:0003016; GO:0005634; GO:0005654; GO:0006338; GO:0007507; GO:0010468; GO:0010628; GO:0021915; GO:0031490; GO:0032525; GO:0035097; GO:0035264; GO:0042802; GO:0044666; GO:0045793; GO:0045944; GO:0046872; GO:0048333; GO:0048568; GO:0048570; GO:0071305; GO:0071456; GO:0071558; GO:0071560; GO:0072359; GO:1903298; GO:1904385; GO:1990859 cellular response to angiotensin [GO:1904385]; cellular response to endothelin [GO:1990859]; cellular response to hypoxia [GO:0071456]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cellular response to vitamin D [GO:0071305]; chromatin remodeling [GO:0006338]; circulatory system development [GO:0072359]; embryonic organ development [GO:0048568]; heart development [GO:0007507]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; mesodermal cell differentiation [GO:0048333]; multicellular organism growth [GO:0035264]; negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway [GO:1903298]; neural tube closure [GO:0001843]; neural tube development [GO:0021915]; notochord morphogenesis [GO:0048570]; positive regulation of cell size [GO:0045793]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; respiratory system process [GO:0003016]; somite rostral/caudal axis specification [GO:0032525] histone methyltransferase complex [GO:0035097]; MLL3/4 complex [GO:0044666]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] chromatin DNA binding [GO:0031490]; histone H3K27me2/H3K27me3 demethylase activity [GO:0071558]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978] g14183.t1 O70546 68.657 268 2.82e-110 385.0 sp|O70546|KDM6A_MOUSE Lysine-specific demethylase 6A OS=Mus musculus OX=10090 GN=Kdm6a PE=1 SV=2 KDM6A_MOUSE reviewed Lysine-specific demethylase 6A (EC 1.14.11.68) (Histone demethylase UTX) (Ubiquitously transcribed TPR protein on the X chromosome) (Ubiquitously transcribed X chromosome tetratricopeptide repeat protein) ([histone H3]-trimethyl-L-lysine(27) demethylase 6A) Mus musculus (Mouse) GO:0000978; GO:0001701; GO:0001843; GO:0003007; GO:0003016; GO:0005634; GO:0005654; GO:0006338; GO:0007507; GO:0010468; GO:0010628; GO:0021915; GO:0031490; GO:0032525; GO:0035097; GO:0035264; GO:0042802; GO:0044666; GO:0045793; GO:0045944; GO:0046872; GO:0048333; GO:0048568; GO:0048570; GO:0071305; GO:0071456; GO:0071558; GO:0071560; GO:0072359; GO:1903298; GO:1904385; GO:1990859 cellular response to angiotensin [GO:1904385]; cellular response to endothelin [GO:1990859]; cellular response to hypoxia [GO:0071456]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cellular response to vitamin D [GO:0071305]; chromatin remodeling [GO:0006338]; circulatory system development [GO:0072359]; embryonic organ development [GO:0048568]; heart development [GO:0007507]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; mesodermal cell differentiation [GO:0048333]; multicellular organism growth [GO:0035264]; negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway [GO:1903298]; neural tube closure [GO:0001843]; neural tube development [GO:0021915]; notochord morphogenesis [GO:0048570]; positive regulation of cell size [GO:0045793]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; respiratory system process [GO:0003016]; somite rostral/caudal axis specification [GO:0032525] histone methyltransferase complex [GO:0035097]; MLL3/4 complex [GO:0044666]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] chromatin DNA binding [GO:0031490]; histone H3K27me2/H3K27me3 demethylase activity [GO:0071558]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978] g14184.t1 O15550 49.593 123 1.98e-28 111.0 sp|O15550|KDM6A_HUMAN Lysine-specific demethylase 6A OS=Homo sapiens OX=9606 GN=KDM6A PE=1 SV=2 KDM6A_HUMAN reviewed Lysine-specific demethylase 6A (EC 1.14.11.68) (Histone demethylase UTX) (Ubiquitously-transcribed TPR protein on the X chromosome) (Ubiquitously-transcribed X chromosome tetratricopeptide repeat protein) ([histone H3]-trimethyl-L-lysine(27) demethylase 6A) Homo sapiens (Human) GO:0000978; GO:0005634; GO:0005654; GO:0006338; GO:0007507; GO:0010468; GO:0031490; GO:0032452; GO:0035097; GO:0044666; GO:0046872; GO:0071558 chromatin remodeling [GO:0006338]; heart development [GO:0007507]; regulation of gene expression [GO:0010468] histone methyltransferase complex [GO:0035097]; MLL3/4 complex [GO:0044666]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] chromatin DNA binding [GO:0031490]; histone demethylase activity [GO:0032452]; histone H3K27me2/H3K27me3 demethylase activity [GO:0071558]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978] g14185.t1 Q9JLB5 36.364 462 3.24e-98 306.0 sp|Q9JLB5|ACH10_RAT Neuronal acetylcholine receptor subunit alpha-10 OS=Rattus norvegicus OX=10116 GN=Chrna10 PE=1 SV=1 ACH10_RAT reviewed Neuronal acetylcholine receptor subunit alpha-10 (Nicotinic acetylcholine receptor subunit alpha-10) (NACHR alpha-10) Rattus norvegicus (Rat) GO:0005231; GO:0005262; GO:0005886; GO:0005892; GO:0007204; GO:0007268; GO:0007271; GO:0010996; GO:0022848; GO:0022850; GO:0030424; GO:0034220; GO:0034703; GO:0042391; GO:0042472; GO:0043005; GO:0043204; GO:0045202; GO:0050910; GO:0051899; GO:0070373; GO:0098878; GO:0098981; GO:0099634; GO:1902495; GO:1904315 chemical synaptic transmission [GO:0007268]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; inner ear morphogenesis [GO:0042472]; membrane depolarization [GO:0051899]; monoatomic ion transmembrane transport [GO:0034220]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; regulation of membrane potential [GO:0042391]; response to auditory stimulus [GO:0010996]; synaptic transmission, cholinergic [GO:0007271] acetylcholine-gated channel complex [GO:0005892]; axon [GO:0030424]; cation channel complex [GO:0034703]; cholinergic synapse [GO:0098981]; neuron projection [GO:0043005]; neurotransmitter receptor complex [GO:0098878]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic specialization membrane [GO:0099634]; synapse [GO:0045202]; transmembrane transporter complex [GO:1902495] acetylcholine-gated monoatomic cation-selective channel activity [GO:0022848]; calcium channel activity [GO:0005262]; excitatory extracellular ligand-gated monoatomic ion channel activity [GO:0005231]; serotonin-gated monoatomic cation channel activity [GO:0022850]; transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315] g14186.t1 Q8NFW1 40.323 186 1.02e-31 134.0 sp|Q8NFW1|COMA1_HUMAN Collagen alpha-1(XXII) chain OS=Homo sapiens OX=9606 GN=COL22A1 PE=1 SV=2 g14187.t1 Q95JI2 26.272 727 1.0899999999999999e-69 248.0 sp|Q95JI2|CTSRD_MACFA Cation channel sperm-associated auxiliary subunit delta OS=Macaca fascicularis OX=9541 GN=CATSPERD PE=2 SV=2 g14188.t1 Q5RF14 51.802 666 0.0 718.0 sp|Q5RF14|MIPEP_PONAB Mitochondrial intermediate peptidase OS=Pongo abelii OX=9601 GN=MIPEP PE=2 SV=1 g14189.t1 Q7M370 33.652 419 2.45e-47 169.0 sp|Q7M370|AAAD_RABIT Arylacetamide deacetylase OS=Oryctolagus cuniculus OX=9986 GN=AADAC PE=1 SV=1 AAAD_RABIT reviewed Arylacetamide deacetylase (EC 3.1.1.3) (50 kDa microsomal esterase/N-deacetylase) Oryctolagus cuniculus (Rabbit) GO:0004806; GO:0005789; GO:0006629; GO:0019213 lipid metabolic process [GO:0006629] endoplasmic reticulum membrane [GO:0005789] deacetylase activity [GO:0019213]; triacylglycerol lipase activity [GO:0004806] g14190.t1 Q1JQE6 33.99 406 7.24e-49 174.0 sp|Q1JQE6|NCEH1_BOVIN Neutral cholesterol ester hydrolase 1 OS=Bos taurus OX=9913 GN=NCEH1 PE=2 SV=2 NCEH1_BOVIN reviewed Neutral cholesterol ester hydrolase 1 (NCEH) (EC 3.1.1.-) (Acetylalkylglycerol acetylhydrolase) (2-acetyl MAGE hydrolase) (EC 3.1.1.71) (Arylacetamide deacetylase-like 1) Bos taurus (Bovine) GO:0005886; GO:0016042; GO:0017171; GO:0046485; GO:0047378 ether lipid metabolic process [GO:0046485]; lipid catabolic process [GO:0016042] plasma membrane [GO:0005886] acetylalkylglycerol acetylhydrolase activity [GO:0047378]; serine hydrolase activity [GO:0017171] g14191.t1 Q7M370 35.572 402 4.37e-49 174.0 sp|Q7M370|AAAD_RABIT Arylacetamide deacetylase OS=Oryctolagus cuniculus OX=9986 GN=AADAC PE=1 SV=1 AAAD_RABIT reviewed Arylacetamide deacetylase (EC 3.1.1.3) (50 kDa microsomal esterase/N-deacetylase) Oryctolagus cuniculus (Rabbit) GO:0004806; GO:0005789; GO:0006629; GO:0019213 lipid metabolic process [GO:0006629] endoplasmic reticulum membrane [GO:0005789] deacetylase activity [GO:0019213]; triacylglycerol lipase activity [GO:0004806] g14193.t1 Q8NDN9 59.888 536 0.0 639.0 sp|Q8NDN9|RCBT1_HUMAN RCC1 and BTB domain-containing protein 1 OS=Homo sapiens OX=9606 GN=RCBTB1 PE=1 SV=1 RCBT1_HUMAN reviewed RCC1 and BTB domain-containing protein 1 (Chronic lymphocytic leukemia deletion region gene 7 protein) (CLL deletion region gene 7 protein) (Regulator of chromosome condensation and BTB domain-containing protein 1) Homo sapiens (Human) GO:0005634; GO:0005737; GO:0006325 chromatin organization [GO:0006325] cytoplasm [GO:0005737]; nucleus [GO:0005634] g14195.t1 P41740 29.444 360 6.489999999999999e-38 151.0 sp|P41740|ANPRC_RAT Atrial natriuretic peptide receptor 3 OS=Rattus norvegicus OX=10116 GN=Npr3 PE=2 SV=1 ANPRC_RAT reviewed Atrial natriuretic peptide receptor 3 (Atrial natriuretic peptide clearance receptor) (Atrial natriuretic peptide receptor type C) (ANP-C) (ANPR-C) (NPR-C) Rattus norvegicus (Rat) GO:0001501; GO:0001525; GO:0001974; GO:0002158; GO:0002931; GO:0005886; GO:0006182; GO:0007165; GO:0007193; GO:0007200; GO:0007218; GO:0008217; GO:0008528; GO:0016941; GO:0017046; GO:0031404; GO:0032991; GO:0033688; GO:0035810; GO:0042277; GO:0042311; GO:0042562; GO:0042802; GO:0042803; GO:0048662; GO:0090187; GO:0120163; GO:0140319; GO:1901082 adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; angiogenesis [GO:0001525]; blood vessel remodeling [GO:0001974]; cGMP biosynthetic process [GO:0006182]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of smooth muscle cell proliferation [GO:0048662]; neuropeptide signaling pathway [GO:0007218]; osteoclast proliferation [GO:0002158]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of pancreatic juice secretion [GO:0090187]; positive regulation of relaxation of smooth muscle [GO:1901082]; positive regulation of urine volume [GO:0035810]; regulation of blood pressure [GO:0008217]; regulation of osteoblast proliferation [GO:0033688]; response to ischemia [GO:0002931]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; vasodilation [GO:0042311] plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] chloride ion binding [GO:0031404]; G protein-coupled peptide receptor activity [GO:0008528]; hormone binding [GO:0042562]; identical protein binding [GO:0042802]; natriuretic peptide receptor activity [GO:0016941]; peptide binding [GO:0042277]; peptide hormone binding [GO:0017046]; protein homodimerization activity [GO:0042803]; receptor decoy activity [GO:0140319] g14196.t1 B0BN95 30.488 246 4.46e-26 112.0 sp|B0BN95|HARB1_RAT Putative nuclease HARBI1 OS=Rattus norvegicus OX=10116 GN=Harbi1 PE=2 SV=1 HARB1_RAT reviewed Putative nuclease HARBI1 (EC 3.1.-.-) (Harbinger transposase-derived nuclease) Rattus norvegicus (Rat) GO:0004518; GO:0005634; GO:0005829; GO:0005886; GO:0016787; GO:0034451; GO:0046872 centriolar satellite [GO:0034451]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886] hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]; nuclease activity [GO:0004518] g14197.t1 P46197 50.53 566 0.0 551.0 sp|P46197|ANPRB_BOVIN Atrial natriuretic peptide receptor 2 OS=Bos taurus OX=9913 GN=NPR2 PE=2 SV=1 g14197.t2 P20594 51.693 561 0.0 553.0 sp|P20594|ANPRB_HUMAN Atrial natriuretic peptide receptor 2 OS=Homo sapiens OX=9606 GN=NPR2 PE=1 SV=1 ANPRB_HUMAN reviewed Atrial natriuretic peptide receptor 2 (EC 4.6.1.2) (Atrial natriuretic peptide receptor type B) (ANP-B) (ANPR-B) (NPR-B) (Guanylate cyclase B) (GC-B) Homo sapiens (Human) GO:0000165; GO:0001549; GO:0001570; GO:0001945; GO:0001958; GO:0001964; GO:0001974; GO:0002062; GO:0003417; GO:0004383; GO:0004672; GO:0005524; GO:0005525; GO:0005634; GO:0005737; GO:0005886; GO:0005929; GO:0006182; GO:0007033; GO:0007168; GO:0007173; GO:0007268; GO:0007283; GO:0007605; GO:0008217; GO:0016941; GO:0017046; GO:0019228; GO:0021647; GO:0030540; GO:0034699; GO:0035108; GO:0035112; GO:0035264; GO:0035483; GO:0035988; GO:0036342; GO:0042562; GO:0042802; GO:0043005; GO:0045202; GO:0048546; GO:0048668; GO:0048745; GO:0050872; GO:0051276; GO:0051402; GO:0051447; GO:0060385; GO:0060466; GO:0061042; GO:0061939; GO:0071321; GO:0071774; GO:0097011; GO:0097194; GO:0098868; GO:1900194; GO:1901653; GO:1902074; GO:1903537 activation of meiosis involved in egg activation [GO:0060466]; axonogenesis involved in innervation [GO:0060385]; blood vessel remodeling [GO:0001974]; bone growth [GO:0098868]; c-di-GMP signaling [GO:0061939]; cellular response to cGMP [GO:0071321]; cellular response to granulocyte macrophage colony-stimulating factor stimulus [GO:0097011]; cellular response to peptide [GO:1901653]; cGMP biosynthetic process [GO:0006182]; chemical synaptic transmission [GO:0007268]; chondrocyte differentiation [GO:0002062]; chondrocyte proliferation [GO:0035988]; chromosome organization [GO:0051276]; collateral sprouting [GO:0048668]; cumulus cell differentiation [GO:0001549]; digestive tract morphogenesis [GO:0048546]; endochondral ossification [GO:0001958]; epidermal growth factor receptor signaling pathway [GO:0007173]; execution phase of apoptosis [GO:0097194]; female genitalia development [GO:0030540]; gastric emptying [GO:0035483]; genitalia morphogenesis [GO:0035112]; growth plate cartilage development [GO:0003417]; limb morphogenesis [GO:0035108]; lymph vessel development [GO:0001945]; MAPK cascade [GO:0000165]; meiotic cell cycle process involved in oocyte maturation [GO:1903537]; multicellular organism growth [GO:0035264]; negative regulation of meiotic cell cycle [GO:0051447]; negative regulation of oocyte maturation [GO:1900194]; neuron apoptotic process [GO:0051402]; neuronal action potential [GO:0019228]; post-anal tail morphogenesis [GO:0036342]; receptor guanylyl cyclase signaling pathway [GO:0007168]; regulation of blood pressure [GO:0008217]; response to fibroblast growth factor [GO:0071774]; response to luteinizing hormone [GO:0034699]; response to salt [GO:1902074]; sensory perception of sound [GO:0007605]; smooth muscle tissue development [GO:0048745]; spermatogenesis [GO:0007283]; startle response [GO:0001964]; vacuole organization [GO:0007033]; vascular wound healing [GO:0061042]; vasculogenesis [GO:0001570]; vestibulocochlear nerve maturation [GO:0021647]; white fat cell differentiation [GO:0050872] cilium [GO:0005929]; cytoplasm [GO:0005737]; neuron projection [GO:0043005]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; synapse [GO:0045202] ATP binding [GO:0005524]; GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; hormone binding [GO:0042562]; identical protein binding [GO:0042802]; natriuretic peptide receptor activity [GO:0016941]; peptide hormone binding [GO:0017046]; protein kinase activity [GO:0004672] g14197.t3 P20594 51.693 561 0.0 553.0 sp|P20594|ANPRB_HUMAN Atrial natriuretic peptide receptor 2 OS=Homo sapiens OX=9606 GN=NPR2 PE=1 SV=1 ANPRB_HUMAN reviewed Atrial natriuretic peptide receptor 2 (EC 4.6.1.2) (Atrial natriuretic peptide receptor type B) (ANP-B) (ANPR-B) (NPR-B) (Guanylate cyclase B) (GC-B) Homo sapiens (Human) GO:0000165; GO:0001549; GO:0001570; GO:0001945; GO:0001958; GO:0001964; GO:0001974; GO:0002062; GO:0003417; GO:0004383; GO:0004672; GO:0005524; GO:0005525; GO:0005634; GO:0005737; GO:0005886; GO:0005929; GO:0006182; GO:0007033; GO:0007168; GO:0007173; GO:0007268; GO:0007283; GO:0007605; GO:0008217; GO:0016941; GO:0017046; GO:0019228; GO:0021647; GO:0030540; GO:0034699; GO:0035108; GO:0035112; GO:0035264; GO:0035483; GO:0035988; GO:0036342; GO:0042562; GO:0042802; GO:0043005; GO:0045202; GO:0048546; GO:0048668; GO:0048745; GO:0050872; GO:0051276; GO:0051402; GO:0051447; GO:0060385; GO:0060466; GO:0061042; GO:0061939; GO:0071321; GO:0071774; GO:0097011; GO:0097194; GO:0098868; GO:1900194; GO:1901653; GO:1902074; GO:1903537 activation of meiosis involved in egg activation [GO:0060466]; axonogenesis involved in innervation [GO:0060385]; blood vessel remodeling [GO:0001974]; bone growth [GO:0098868]; c-di-GMP signaling [GO:0061939]; cellular response to cGMP [GO:0071321]; cellular response to granulocyte macrophage colony-stimulating factor stimulus [GO:0097011]; cellular response to peptide [GO:1901653]; cGMP biosynthetic process [GO:0006182]; chemical synaptic transmission [GO:0007268]; chondrocyte differentiation [GO:0002062]; chondrocyte proliferation [GO:0035988]; chromosome organization [GO:0051276]; collateral sprouting [GO:0048668]; cumulus cell differentiation [GO:0001549]; digestive tract morphogenesis [GO:0048546]; endochondral ossification [GO:0001958]; epidermal growth factor receptor signaling pathway [GO:0007173]; execution phase of apoptosis [GO:0097194]; female genitalia development [GO:0030540]; gastric emptying [GO:0035483]; genitalia morphogenesis [GO:0035112]; growth plate cartilage development [GO:0003417]; limb morphogenesis [GO:0035108]; lymph vessel development [GO:0001945]; MAPK cascade [GO:0000165]; meiotic cell cycle process involved in oocyte maturation [GO:1903537]; multicellular organism growth [GO:0035264]; negative regulation of meiotic cell cycle [GO:0051447]; negative regulation of oocyte maturation [GO:1900194]; neuron apoptotic process [GO:0051402]; neuronal action potential [GO:0019228]; post-anal tail morphogenesis [GO:0036342]; receptor guanylyl cyclase signaling pathway [GO:0007168]; regulation of blood pressure [GO:0008217]; response to fibroblast growth factor [GO:0071774]; response to luteinizing hormone [GO:0034699]; response to salt [GO:1902074]; sensory perception of sound [GO:0007605]; smooth muscle tissue development [GO:0048745]; spermatogenesis [GO:0007283]; startle response [GO:0001964]; vacuole organization [GO:0007033]; vascular wound healing [GO:0061042]; vasculogenesis [GO:0001570]; vestibulocochlear nerve maturation [GO:0021647]; white fat cell differentiation [GO:0050872] cilium [GO:0005929]; cytoplasm [GO:0005737]; neuron projection [GO:0043005]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; synapse [GO:0045202] ATP binding [GO:0005524]; GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; hormone binding [GO:0042562]; identical protein binding [GO:0042802]; natriuretic peptide receptor activity [GO:0016941]; peptide hormone binding [GO:0017046]; protein kinase activity [GO:0004672] g14199.t1 O62763 42.978 591 8.17e-146 440.0 sp|O62763|ACES_FELCA Acetylcholinesterase OS=Felis catus OX=9685 GN=ACHE PE=3 SV=1 g14199.t2 P21836 37.995 379 9.040000000000001e-70 239.0 sp|P21836|ACES_MOUSE Acetylcholinesterase OS=Mus musculus OX=10090 GN=Ache PE=1 SV=1 ACES_MOUSE reviewed Acetylcholinesterase (AChE) (EC 3.1.1.7) Mus musculus (Mouse) GO:0001919; GO:0002076; GO:0003990; GO:0004104; GO:0005518; GO:0005576; GO:0005604; GO:0005615; GO:0005635; GO:0005788; GO:0005794; GO:0005886; GO:0006581; GO:0007155; GO:0007416; GO:0008291; GO:0009986; GO:0016020; GO:0016787; GO:0017171; GO:0019695; GO:0030424; GO:0030425; GO:0031594; GO:0031623; GO:0032868; GO:0042166; GO:0042734; GO:0042802; GO:0042803; GO:0043025; GO:0043083; GO:0043236; GO:0045121; GO:0045202; GO:0045211; GO:0048471; GO:0050772; GO:0050775; GO:0060041; GO:0095500; GO:0098552; GO:0120162 acetylcholine catabolic process [GO:0006581]; acetylcholine metabolic process [GO:0008291]; acetylcholine receptor signaling pathway [GO:0095500]; cell adhesion [GO:0007155]; choline metabolic process [GO:0019695]; osteoblast development [GO:0002076]; positive regulation of axonogenesis [GO:0050772]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of dendrite morphogenesis [GO:0050775]; receptor internalization [GO:0031623]; regulation of receptor recycling [GO:0001919]; response to insulin [GO:0032868]; retina development in camera-type eye [GO:0060041]; synapse assembly [GO:0007416] axon [GO:0030424]; basement membrane [GO:0005604]; cell surface [GO:0009986]; dendrite [GO:0030425]; endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; membrane raft [GO:0045121]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; nuclear envelope [GO:0005635]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; side of membrane [GO:0098552]; synapse [GO:0045202]; synaptic cleft [GO:0043083] acetylcholine binding [GO:0042166]; acetylcholinesterase activity [GO:0003990]; cholinesterase activity [GO:0004104]; collagen binding [GO:0005518]; hydrolase activity [GO:0016787]; identical protein binding [GO:0042802]; laminin binding [GO:0043236]; protein homodimerization activity [GO:0042803]; serine hydrolase activity [GO:0017171] g14199.t2 P21836 51.456 103 6.37e-22 103.0 sp|P21836|ACES_MOUSE Acetylcholinesterase OS=Mus musculus OX=10090 GN=Ache PE=1 SV=1 ACES_MOUSE reviewed Acetylcholinesterase (AChE) (EC 3.1.1.7) Mus musculus (Mouse) GO:0001919; GO:0002076; GO:0003990; GO:0004104; GO:0005518; GO:0005576; GO:0005604; GO:0005615; GO:0005635; GO:0005788; GO:0005794; GO:0005886; GO:0006581; GO:0007155; GO:0007416; GO:0008291; GO:0009986; GO:0016020; GO:0016787; GO:0017171; GO:0019695; GO:0030424; GO:0030425; GO:0031594; GO:0031623; GO:0032868; GO:0042166; GO:0042734; GO:0042802; GO:0042803; GO:0043025; GO:0043083; GO:0043236; GO:0045121; GO:0045202; GO:0045211; GO:0048471; GO:0050772; GO:0050775; GO:0060041; GO:0095500; GO:0098552; GO:0120162 acetylcholine catabolic process [GO:0006581]; acetylcholine metabolic process [GO:0008291]; acetylcholine receptor signaling pathway [GO:0095500]; cell adhesion [GO:0007155]; choline metabolic process [GO:0019695]; osteoblast development [GO:0002076]; positive regulation of axonogenesis [GO:0050772]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of dendrite morphogenesis [GO:0050775]; receptor internalization [GO:0031623]; regulation of receptor recycling [GO:0001919]; response to insulin [GO:0032868]; retina development in camera-type eye [GO:0060041]; synapse assembly [GO:0007416] axon [GO:0030424]; basement membrane [GO:0005604]; cell surface [GO:0009986]; dendrite [GO:0030425]; endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; membrane raft [GO:0045121]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; nuclear envelope [GO:0005635]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; side of membrane [GO:0098552]; synapse [GO:0045202]; synaptic cleft [GO:0043083] acetylcholine binding [GO:0042166]; acetylcholinesterase activity [GO:0003990]; cholinesterase activity [GO:0004104]; collagen binding [GO:0005518]; hydrolase activity [GO:0016787]; identical protein binding [GO:0042802]; laminin binding [GO:0043236]; protein homodimerization activity [GO:0042803]; serine hydrolase activity [GO:0017171] g14206.t1 Q5R988 64.674 184 1.02e-71 218.0 sp|Q5R988|RAP2A_PONAB Ras-related protein Rap-2a OS=Pongo abelii OX=9601 GN=RAP2A PE=2 SV=2 RAP2A_PONAB reviewed Ras-related protein Rap-2a (EC 3.6.5.2) Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0000287; GO:0003924; GO:0003925; GO:0005525; GO:0005794; GO:0005829; GO:0008104; GO:0019003; GO:0030036; GO:0030335; GO:0030336; GO:0030496; GO:0031258; GO:0032486; GO:0036019; GO:0045184; GO:0046328; GO:0048814; GO:0051963; GO:0055038; GO:0098685; GO:0099072; GO:1903698 actin cytoskeleton organization [GO:0030036]; establishment of protein localization [GO:0045184]; intracellular protein localization [GO:0008104]; negative regulation of cell migration [GO:0030336]; positive regulation of cell migration [GO:0030335]; positive regulation of microvillus assembly [GO:1903698]; Rap protein signal transduction [GO:0032486]; regulation of dendrite morphogenesis [GO:0048814]; regulation of JNK cascade [GO:0046328]; regulation of postsynaptic membrane neurotransmitter receptor levels [GO:0099072]; regulation of synapse assembly [GO:0051963] cytosol [GO:0005829]; endolysosome [GO:0036019]; Golgi apparatus [GO:0005794]; lamellipodium membrane [GO:0031258]; midbody [GO:0030496]; recycling endosome membrane [GO:0055038]; Schaffer collateral - CA1 synapse [GO:0098685] G protein activity [GO:0003925]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; magnesium ion binding [GO:0000287] g14207.t1 O60244 45.448 1483 0.0 1160.0 sp|O60244|MED14_HUMAN Mediator of RNA polymerase II transcription subunit 14 OS=Homo sapiens OX=9606 GN=MED14 PE=1 SV=2 MED14_HUMAN reviewed Mediator of RNA polymerase II transcription subunit 14 (Activator-recruited cofactor 150 kDa component) (ARC150) (Cofactor required for Sp1 transcriptional activation subunit 2) (CRSP complex subunit 2) (Mediator complex subunit 14) (RGR1 homolog) (hRGR1) (Thyroid hormone receptor-associated protein complex 170 kDa component) (Trap170) (Transcriptional coactivator CRSP150) (Vitamin D3 receptor-interacting protein complex 150 kDa component) (DRIP150) Homo sapiens (Human) GO:0003712; GO:0003713; GO:0005634; GO:0005654; GO:0006357; GO:0016020; GO:0016592; GO:0032968; GO:0035019; GO:0042809; GO:0045893; GO:0045944; GO:0051123; GO:0060261; GO:0070847 positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription elongation by RNA polymerase II [GO:0032968]; positive regulation of transcription initiation by RNA polymerase II [GO:0060261]; regulation of transcription by RNA polymerase II [GO:0006357]; RNA polymerase II preinitiation complex assembly [GO:0051123]; somatic stem cell population maintenance [GO:0035019] core mediator complex [GO:0070847]; mediator complex [GO:0016592]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] nuclear vitamin D receptor binding [GO:0042809]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712] g14208.t1 Q6NZK5 39.08 174 1.41e-21 103.0 sp|Q6NZK5|K1328_MOUSE Protein hinderin OS=Mus musculus OX=10090 GN=Kiaa1328 PE=1 SV=2 g14209.t1 Q9VUL9 39.247 186 1.08e-35 135.0 sp|Q9VUL9|FUCTA_DROME Glycoprotein 3-alpha-L-fucosyltransferase A OS=Drosophila melanogaster OX=7227 GN=FucTA PE=1 SV=2 FUCTA_DROME reviewed Glycoprotein 3-alpha-L-fucosyltransferase A (EC 2.4.1.214) (Core alpha-(1,3)-fucosyltransferase) Drosophila melanogaster (Fruit fly) GO:0005797; GO:0006491; GO:0007399; GO:0018279; GO:0018392; GO:0032580; GO:0046920 N-glycan processing [GO:0006491]; nervous system development [GO:0007399]; protein N-linked glycosylation via asparagine [GO:0018279] Golgi cisterna membrane [GO:0032580]; Golgi medial cisterna [GO:0005797] alpha-(1->3)-fucosyltransferase activity [GO:0046920]; glycoprotein 3-alpha-L-fucosyltransferase activity [GO:0018392] g14211.t1 Q7ZX53 36.14 487 8.310000000000001e-80 259.0 sp|Q7ZX53|S22FL_XENLA Solute carrier family 22 member 15-like OS=Xenopus laevis OX=8355 GN=slc22a15b PE=2 SV=1 g14212.t1 Q7ZX53 34.36 422 7.42e-70 231.0 sp|Q7ZX53|S22FL_XENLA Solute carrier family 22 member 15-like OS=Xenopus laevis OX=8355 GN=slc22a15b PE=2 SV=1 g14213.t1 Q8WW35 61.864 118 4.650000000000001e-43 141.0 sp|Q8WW35|DYT2B_HUMAN Dynein light chain Tctex-type protein 2B OS=Homo sapiens OX=9606 GN=DYNLT2B PE=1 SV=2 DYT2B_HUMAN reviewed Dynein light chain Tctex-type protein 2B (Tctex1 domain-containing protein 2) Homo sapiens (Human) GO:0005737; GO:0005868; GO:0005929; GO:0007018; GO:0035721; GO:0045505; GO:0060271; GO:0120293; GO:1902017; GO:1905799 cilium assembly [GO:0060271]; intraciliary retrograde transport [GO:0035721]; microtubule-based movement [GO:0007018]; regulation of cilium assembly [GO:1902017]; regulation of intraciliary retrograde transport [GO:1905799] cilium [GO:0005929]; cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; dynein axonemal particle [GO:0120293] dynein intermediate chain binding [GO:0045505] g14215.t1 O15068 39.443 1113 0.0 716.0 sp|O15068|MCF2L_HUMAN Guanine nucleotide exchange factor DBS OS=Homo sapiens OX=9606 GN=MCF2L PE=1 SV=2 g14215.t2 O15068 39.764 1104 0.0 723.0 sp|O15068|MCF2L_HUMAN Guanine nucleotide exchange factor DBS OS=Homo sapiens OX=9606 GN=MCF2L PE=1 SV=2 g14215.t3 O15068 39.729 1105 0.0 719.0 sp|O15068|MCF2L_HUMAN Guanine nucleotide exchange factor DBS OS=Homo sapiens OX=9606 GN=MCF2L PE=1 SV=2 g14215.t4 O15068 44.336 512 1.21e-111 361.0 sp|O15068|MCF2L_HUMAN Guanine nucleotide exchange factor DBS OS=Homo sapiens OX=9606 GN=MCF2L PE=1 SV=2 g14215.t5 Q63406 39.623 1113 0.0 716.0 sp|Q63406|MCF2L_RAT Guanine nucleotide exchange factor DBS OS=Rattus norvegicus OX=10116 GN=Mcf2l PE=1 SV=3 MCF2L_RAT reviewed Guanine nucleotide exchange factor DBS (DBL's big sister) (MCF2-transforming sequence-like protein) (OST oncogene) Rattus norvegicus (Rat) GO:0005085; GO:0005545; GO:0005737; GO:0007266; GO:0012505; GO:0016020; GO:0030027; GO:0031234; GO:0035025; GO:0035091; GO:0035556; GO:0045944 intracellular signal transduction [GO:0035556]; positive regulation of Rho protein signal transduction [GO:0035025]; positive regulation of transcription by RNA polymerase II [GO:0045944]; Rho protein signal transduction [GO:0007266] cytoplasm [GO:0005737]; endomembrane system [GO:0012505]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; lamellipodium [GO:0030027]; membrane [GO:0016020] 1-phosphatidylinositol binding [GO:0005545]; guanyl-nucleotide exchange factor activity [GO:0005085]; phosphatidylinositol binding [GO:0035091] g14217.t1 Q9VCA2 33.627 568 7.580000000000001e-72 242.0 sp|Q9VCA2|ORCT_DROME Organic cation transporter protein OS=Drosophila melanogaster OX=7227 GN=Orct PE=1 SV=1 g14218.t1 Q8BHN0 49.167 360 3.34e-118 349.0 sp|Q8BHN0|PPM1L_MOUSE Protein phosphatase 1L OS=Mus musculus OX=10090 GN=Ppm1l PE=1 SV=1 PPM1L_MOUSE reviewed Protein phosphatase 1L (EC 3.1.3.16) (Protein phosphatase 1-like) (Protein phosphatase 2C isoform epsilon) (PP2C-epsilon) Mus musculus (Mouse) GO:0000165; GO:0004722; GO:0007165; GO:0007178; GO:0016020; GO:0046872 cell surface receptor protein serine/threonine kinase signaling pathway [GO:0007178]; MAPK cascade [GO:0000165]; signal transduction [GO:0007165] membrane [GO:0016020] metal ion binding [GO:0046872]; protein serine/threonine phosphatase activity [GO:0004722] g14219.t1 P32007 80.205 293 2.7199999999999997e-159 448.0 sp|P32007|ADT3_BOVIN ADP/ATP translocase 3 OS=Bos taurus OX=9913 GN=SLC25A6 PE=1 SV=3 ADT3_BOVIN reviewed ADP/ATP translocase 3 (ADP,ATP carrier protein 3) (ADP,ATP carrier protein, isoform T2) (ANT 2) (Adenine nucleotide translocator 3) (ANT 3) (Solute carrier family 25 member 6) [Cleaved into: ADP/ATP translocase 3, N-terminally processed] Bos taurus (Bovine) GO:0005471; GO:0005743; GO:0006915; GO:0016020; GO:0140021; GO:1901029; GO:1990544 apoptotic process [GO:0006915]; mitochondrial ADP transmembrane transport [GO:0140021]; mitochondrial ATP transmembrane transport [GO:1990544]; negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901029] membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743] ATP:ADP antiporter activity [GO:0005471] g14220.t1 Q5R9E1 65.938 320 3.43e-145 415.0 sp|Q5R9E1|HMGCL_PONAB Hydroxymethylglutaryl-CoA lyase, mitochondrial OS=Pongo abelii OX=9601 GN=HMGCL PE=2 SV=1 HMGCL_PONAB reviewed Hydroxymethylglutaryl-CoA lyase, mitochondrial (HL) (HMG-CoA lyase) (EC 4.1.3.4) (3-hydroxy-3-methylglutarate-CoA lyase) Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0004419; GO:0005759; GO:0005777; GO:0006552; GO:0046872; GO:0046951 ketone body biosynthetic process [GO:0046951]; L-leucine catabolic process [GO:0006552] mitochondrial matrix [GO:0005759]; peroxisome [GO:0005777] hydroxymethylglutaryl-CoA lyase activity [GO:0004419]; metal ion binding [GO:0046872] g14221.t1 P51817 63.303 327 8.92e-161 457.0 sp|P51817|PRKX_HUMAN cAMP-dependent protein kinase catalytic subunit PRKX OS=Homo sapiens OX=9606 GN=PRKX PE=1 SV=1 PRKX_HUMAN reviewed cAMP-dependent protein kinase catalytic subunit PRKX (PrKX) (Protein kinase X) (Protein kinase X-linked) (Serine/threonine-protein kinase PRKX) (EC 2.7.11.1) (Protein kinase PKX1) Homo sapiens (Human) GO:0001525; GO:0001935; GO:0004691; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005952; GO:0007155; GO:0007189; GO:0018105; GO:0030099; GO:0030155; GO:0030334; GO:0031589; GO:0043542; GO:0046777; GO:0060562; GO:0060993; GO:0106310; GO:2000696 adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; angiogenesis [GO:0001525]; cell adhesion [GO:0007155]; cell-substrate adhesion [GO:0031589]; endothelial cell migration [GO:0043542]; endothelial cell proliferation [GO:0001935]; epithelial tube morphogenesis [GO:0060562]; kidney morphogenesis [GO:0060993]; myeloid cell differentiation [GO:0030099]; peptidyl-serine phosphorylation [GO:0018105]; protein autophosphorylation [GO:0046777]; regulation of cell adhesion [GO:0030155]; regulation of cell migration [GO:0030334]; regulation of epithelial cell differentiation involved in kidney development [GO:2000696] cAMP-dependent protein kinase complex [GO:0005952]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]; protein serine kinase activity [GO:0106310] g14222.t1 Q9DC37 59.804 102 4.3000000000000005e-37 133.0 sp|Q9DC37|MFSD1_MOUSE Lysosomal dipeptide transporter MFSD1 OS=Mus musculus OX=10090 GN=Mfsd1 PE=1 SV=1 MFSD1_MOUSE reviewed Lysosomal dipeptide transporter MFSD1 (Major facilitator superfamily domain-containing protein 1) Mus musculus (Mouse) GO:0005764; GO:0005765; GO:0042803; GO:0050821; GO:0061462; GO:0141204; GO:0160178 dipeptide transmembrane transport from lysosomal lumen to cytosol [GO:0141204]; protein localization to lysosome [GO:0061462]; protein stabilization [GO:0050821] lysosomal membrane [GO:0005765]; lysosome [GO:0005764] dipeptide uniporter activity [GO:0160178]; protein homodimerization activity [GO:0042803] g14223.t1 Q1JQC1 55.0 280 6.42e-101 308.0 sp|Q1JQC1|MFSD1_BOVIN Lysosomal dipeptide transporter MFSD1 OS=Bos taurus OX=9913 GN=MFSD1 PE=2 SV=1 MFSD1_BOVIN reviewed Lysosomal dipeptide transporter MFSD1 (Major facilitator superfamily domain-containing protein 1) Bos taurus (Bovine) GO:0005764; GO:0005765; GO:0042803; GO:0050821; GO:0061462; GO:0141204; GO:0160178 dipeptide transmembrane transport from lysosomal lumen to cytosol [GO:0141204]; protein localization to lysosome [GO:0061462]; protein stabilization [GO:0050821] lysosomal membrane [GO:0005765]; lysosome [GO:0005764] dipeptide uniporter activity [GO:0160178]; protein homodimerization activity [GO:0042803] g14224.t1 Q6DHU8 50.769 195 3.9699999999999995e-55 183.0 sp|Q6DHU8|TOPK_DANRE Lymphokine-activated killer T-cell-originated protein kinase homolog OS=Danio rerio OX=7955 GN=pbk PE=2 SV=1 TOPK_DANRE reviewed Lymphokine-activated killer T-cell-originated protein kinase homolog (EC 2.7.12.2) (PDZ-binding kinase) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0004674; GO:0004708; GO:0004713; GO:0005524; GO:0051403; GO:0106310 stress-activated MAPK cascade [GO:0051403] ATP binding [GO:0005524]; MAP kinase kinase activity [GO:0004708]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713] g14226.t1 Q32LD1 49.704 169 4.7099999999999996e-42 142.0 sp|Q32LD1|BAP18_BOVIN BPTF-associated chromatin complex component 1 OS=Bos taurus OX=9913 GN=BACC1 PE=2 SV=1 g14227.t1 A0A286QZ36 62.105 190 9.9e-86 254.0 sp|A0A286QZ36|RAC1_STIJA Ras-related protein Rac1 OS=Stichopus japonicus OX=307972 GN=RAC1 PE=2 SV=1 g14228.t1 P23352 29.002 631 7.02e-78 265.0 sp|P23352|KALM_HUMAN Anosmin-1 OS=Homo sapiens OX=9606 GN=ANOS1 PE=1 SV=3 KALM_HUMAN reviewed Anosmin-1 (Adhesion molecule-like X-linked) (Kallmann syndrome protein) Homo sapiens (Human) GO:0004867; GO:0005201; GO:0005576; GO:0005615; GO:0005886; GO:0006935; GO:0007155; GO:0007411; GO:0008201; GO:0009986; GO:0030182; GO:0031012 axon guidance [GO:0007411]; cell adhesion [GO:0007155]; chemotaxis [GO:0006935]; neuron differentiation [GO:0030182] cell surface [GO:0009986]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886] extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; serine-type endopeptidase inhibitor activity [GO:0004867] g14228.t2 P23352 29.241 619 8.4e-80 270.0 sp|P23352|KALM_HUMAN Anosmin-1 OS=Homo sapiens OX=9606 GN=ANOS1 PE=1 SV=3 KALM_HUMAN reviewed Anosmin-1 (Adhesion molecule-like X-linked) (Kallmann syndrome protein) Homo sapiens (Human) GO:0004867; GO:0005201; GO:0005576; GO:0005615; GO:0005886; GO:0006935; GO:0007155; GO:0007411; GO:0008201; GO:0009986; GO:0030182; GO:0031012 axon guidance [GO:0007411]; cell adhesion [GO:0007155]; chemotaxis [GO:0006935]; neuron differentiation [GO:0030182] cell surface [GO:0009986]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886] extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; serine-type endopeptidase inhibitor activity [GO:0004867] g14229.t1 Q8C0W1 36.382 973 5.64e-178 549.0 sp|Q8C0W1|ANMY1_MOUSE Ankyrin repeat and MYND domain-containing protein 1 OS=Mus musculus OX=10090 GN=Ankmy1 PE=1 SV=1 g14230.t1 Q0MVN8 44.848 330 4.56e-92 280.0 sp|Q0MVN8|QOR_PIG Quinone oxidoreductase OS=Sus scrofa OX=9823 GN=CRYZ PE=2 SV=1 g14231.t1 Q9UBF6 91.86 86 8.55e-55 169.0 sp|Q9UBF6|RBX2_HUMAN RING-box protein 2 OS=Homo sapiens OX=9606 GN=RNF7 PE=1 SV=1 g14232.t1 Q8BHJ5 81.907 514 0.0 845.0 sp|Q8BHJ5|TBL1R_MOUSE F-box-like/WD repeat-containing protein TBL1XR1 OS=Mus musculus OX=10090 GN=Tbl1xr1 PE=1 SV=1 TBL1R_MOUSE reviewed F-box-like/WD repeat-containing protein TBL1XR1 (Nuclear receptor corepressor/HDAC3 complex subunit TBLR1) (TBL1-related protein 1) (Transducin beta-like 1X-related protein 1) Mus musculus (Mouse) GO:0000118; GO:0000122; GO:0000976; GO:0001835; GO:0002021; GO:0003677; GO:0003714; GO:0005634; GO:0005654; GO:0006325; GO:0006357; GO:0008013; GO:0010468; GO:0016042; GO:0017053; GO:0035264; GO:0042393; GO:0043161; GO:0045892; GO:0045893; GO:0045944; GO:0050872; GO:0060612; GO:0060613; GO:0072686; GO:0090207; GO:0090263 adipose tissue development [GO:0060612]; blastocyst hatching [GO:0001835]; chromatin organization [GO:0006325]; fat pad development [GO:0060613]; lipid catabolic process [GO:0016042]; multicellular organism growth [GO:0035264]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of gene expression [GO:0010468]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of triglyceride metabolic process [GO:0090207]; response to dietary excess [GO:0002021]; white fat cell differentiation [GO:0050872] histone deacetylase complex [GO:0000118]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053] beta-catenin binding [GO:0008013]; DNA binding [GO:0003677]; histone binding [GO:0042393]; transcription cis-regulatory region binding [GO:0000976]; transcription corepressor activity [GO:0003714] g14234.t1 Q9QXL8 58.602 372 5.91e-166 473.0 sp|Q9QXL8|NDK7_MOUSE Nucleoside diphosphate kinase homolog 7 OS=Mus musculus OX=10090 GN=Nme7 PE=1 SV=2 NDK7_MOUSE reviewed Nucleoside diphosphate kinase 7 (NDK7) (NDP kinase 7) (Nm23-M7) (Putative 3'-5'-DNA exonuclease NDK7) (EC 3.1.11.-) (Serine protein kinase NME7) (EC 2.7.11.1) Mus musculus (Mouse) GO:0000931; GO:0003351; GO:0004550; GO:0004672; GO:0005524; GO:0005576; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005819; GO:0005829; GO:0005879; GO:0005886; GO:0005929; GO:0006183; GO:0006228; GO:0006241; GO:0006308; GO:0007368; GO:0007420; GO:0008296; GO:0010968; GO:0030317; GO:0036064; GO:0036126; GO:0042073; GO:0043113; GO:0046872; GO:0060271; GO:0060972; GO:0160111; GO:1990830 brain development [GO:0007420]; cellular response to leukemia inhibitory factor [GO:1990830]; cilium assembly [GO:0060271]; CTP biosynthetic process [GO:0006241]; determination of left/right symmetry [GO:0007368]; DNA catabolic process [GO:0006308]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; flagellated sperm motility [GO:0030317]; GTP biosynthetic process [GO:0006183]; intraciliary transport [GO:0042073]; left/right pattern formation [GO:0060972]; receptor clustering [GO:0043113]; regulation of microtubule nucleation [GO:0010968]; UTP biosynthetic process [GO:0006228] axonemal A tubule inner sheath [GO:0160111]; axonemal microtubule [GO:0005879]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; gamma-tubulin ring complex [GO:0000931]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; sperm flagellum [GO:0036126]; spindle [GO:0005819] 3'-5'-DNA exonuclease activity [GO:0008296]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; nucleoside diphosphate kinase activity [GO:0004550]; protein kinase activity [GO:0004672] g14235.t1 Q56UJ5 54.515 299 2.86e-110 330.0 sp|Q56UJ5|H6S1A_DANRE Heparan-sulfate 6-O-sulfotransferase 1-A OS=Danio rerio OX=7955 GN=hs6st1a PE=2 SV=2 H6S1A_DANRE reviewed Heparan-sulfate 6-O-sulfotransferase 1-A (HS 6-OST-1A) (HS6ST-1) (EC 2.8.2.-) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0015012; GO:0016020; GO:0017095 heparan sulfate proteoglycan biosynthetic process [GO:0015012] membrane [GO:0016020] heparan sulfate 6-sulfotransferase activity [GO:0017095] g14237.t1 B1H2T2 44.16 351 2.9200000000000002e-99 304.0 sp|B1H2T2|DIK2A_XENTR Divergent protein kinase domain 2A OS=Xenopus tropicalis OX=8364 GN=dipk2a PE=2 SV=1 g14238.t1 Q8BIK4 58.642 486 0.0 579.0 sp|Q8BIK4|DOCK9_MOUSE Dedicator of cytokinesis protein 9 OS=Mus musculus OX=10090 GN=Dock9 PE=1 SV=2 DOCK9_MOUSE reviewed Dedicator of cytokinesis protein 9 (Cdc42 guanine nucleotide exchange factor zizimin-1) (Zizimin-1) Mus musculus (Mouse) GO:0005085; GO:0007264; GO:0012505; GO:0031267; GO:0035023; GO:0043547 positive regulation of GTPase activity [GO:0043547]; regulation of Rho protein signal transduction [GO:0035023]; small GTPase-mediated signal transduction [GO:0007264] endomembrane system [GO:0012505] guanyl-nucleotide exchange factor activity [GO:0005085]; small GTPase binding [GO:0031267] g14239.t1 Q9BZ29 47.627 1201 0.0 1014.0 sp|Q9BZ29|DOCK9_HUMAN Dedicator of cytokinesis protein 9 OS=Homo sapiens OX=9606 GN=DOCK9 PE=1 SV=2 DOCK9_HUMAN reviewed Dedicator of cytokinesis protein 9 (Cdc42 guanine nucleotide exchange factor zizimin-1) (Zizimin-1) Homo sapiens (Human) GO:0005085; GO:0005829; GO:0007264; GO:0012505; GO:0016020; GO:0035023; GO:0043547; GO:0045296 positive regulation of GTPase activity [GO:0043547]; regulation of Rho protein signal transduction [GO:0035023]; small GTPase-mediated signal transduction [GO:0007264] cytosol [GO:0005829]; endomembrane system [GO:0012505]; membrane [GO:0016020] cadherin binding [GO:0045296]; guanyl-nucleotide exchange factor activity [GO:0005085] g14239.t1 Q9BZ29 37.748 302 3.27e-52 207.0 sp|Q9BZ29|DOCK9_HUMAN Dedicator of cytokinesis protein 9 OS=Homo sapiens OX=9606 GN=DOCK9 PE=1 SV=2 DOCK9_HUMAN reviewed Dedicator of cytokinesis protein 9 (Cdc42 guanine nucleotide exchange factor zizimin-1) (Zizimin-1) Homo sapiens (Human) GO:0005085; GO:0005829; GO:0007264; GO:0012505; GO:0016020; GO:0035023; GO:0043547; GO:0045296 positive regulation of GTPase activity [GO:0043547]; regulation of Rho protein signal transduction [GO:0035023]; small GTPase-mediated signal transduction [GO:0007264] cytosol [GO:0005829]; endomembrane system [GO:0012505]; membrane [GO:0016020] cadherin binding [GO:0045296]; guanyl-nucleotide exchange factor activity [GO:0005085] g14239.t2 Q9BZ29 47.456 1199 0.0 1010.0 sp|Q9BZ29|DOCK9_HUMAN Dedicator of cytokinesis protein 9 OS=Homo sapiens OX=9606 GN=DOCK9 PE=1 SV=2 DOCK9_HUMAN reviewed Dedicator of cytokinesis protein 9 (Cdc42 guanine nucleotide exchange factor zizimin-1) (Zizimin-1) Homo sapiens (Human) GO:0005085; GO:0005829; GO:0007264; GO:0012505; GO:0016020; GO:0035023; GO:0043547; GO:0045296 positive regulation of GTPase activity [GO:0043547]; regulation of Rho protein signal transduction [GO:0035023]; small GTPase-mediated signal transduction [GO:0007264] cytosol [GO:0005829]; endomembrane system [GO:0012505]; membrane [GO:0016020] cadherin binding [GO:0045296]; guanyl-nucleotide exchange factor activity [GO:0005085] g14239.t2 Q9BZ29 37.748 302 3.41e-52 207.0 sp|Q9BZ29|DOCK9_HUMAN Dedicator of cytokinesis protein 9 OS=Homo sapiens OX=9606 GN=DOCK9 PE=1 SV=2 DOCK9_HUMAN reviewed Dedicator of cytokinesis protein 9 (Cdc42 guanine nucleotide exchange factor zizimin-1) (Zizimin-1) Homo sapiens (Human) GO:0005085; GO:0005829; GO:0007264; GO:0012505; GO:0016020; GO:0035023; GO:0043547; GO:0045296 positive regulation of GTPase activity [GO:0043547]; regulation of Rho protein signal transduction [GO:0035023]; small GTPase-mediated signal transduction [GO:0007264] cytosol [GO:0005829]; endomembrane system [GO:0012505]; membrane [GO:0016020] cadherin binding [GO:0045296]; guanyl-nucleotide exchange factor activity [GO:0005085] g14239.t3 Q9BZ29 47.273 1210 0.0 1011.0 sp|Q9BZ29|DOCK9_HUMAN Dedicator of cytokinesis protein 9 OS=Homo sapiens OX=9606 GN=DOCK9 PE=1 SV=2 DOCK9_HUMAN reviewed Dedicator of cytokinesis protein 9 (Cdc42 guanine nucleotide exchange factor zizimin-1) (Zizimin-1) Homo sapiens (Human) GO:0005085; GO:0005829; GO:0007264; GO:0012505; GO:0016020; GO:0035023; GO:0043547; GO:0045296 positive regulation of GTPase activity [GO:0043547]; regulation of Rho protein signal transduction [GO:0035023]; small GTPase-mediated signal transduction [GO:0007264] cytosol [GO:0005829]; endomembrane system [GO:0012505]; membrane [GO:0016020] cadherin binding [GO:0045296]; guanyl-nucleotide exchange factor activity [GO:0005085] g14239.t3 Q9BZ29 37.748 302 2.8599999999999996e-52 207.0 sp|Q9BZ29|DOCK9_HUMAN Dedicator of cytokinesis protein 9 OS=Homo sapiens OX=9606 GN=DOCK9 PE=1 SV=2 DOCK9_HUMAN reviewed Dedicator of cytokinesis protein 9 (Cdc42 guanine nucleotide exchange factor zizimin-1) (Zizimin-1) Homo sapiens (Human) GO:0005085; GO:0005829; GO:0007264; GO:0012505; GO:0016020; GO:0035023; GO:0043547; GO:0045296 positive regulation of GTPase activity [GO:0043547]; regulation of Rho protein signal transduction [GO:0035023]; small GTPase-mediated signal transduction [GO:0007264] cytosol [GO:0005829]; endomembrane system [GO:0012505]; membrane [GO:0016020] cadherin binding [GO:0045296]; guanyl-nucleotide exchange factor activity [GO:0005085] g14241.t1 Q63486 90.397 302 0.0 570.0 sp|Q63486|RRAGA_RAT Ras-related GTP-binding protein A OS=Rattus norvegicus OX=10116 GN=Rraga PE=1 SV=1 RRAGA_RAT reviewed Ras-related GTP-binding protein A (Rag A) (RagA) (EC 3.6.5.-) Rattus norvegicus (Rat) GO:0000045; GO:0002181; GO:0003924; GO:0005525; GO:0005634; GO:0005654; GO:0005737; GO:0005764; GO:0005765; GO:0006915; GO:0008104; GO:0009267; GO:0010507; GO:0031625; GO:0031669; GO:0032008; GO:0033209; GO:0034198; GO:0035556; GO:0038202; GO:0042593; GO:0042803; GO:0043200; GO:0043495; GO:0045947; GO:0045948; GO:0046982; GO:0051219; GO:0061431; GO:0061462; GO:0071230; GO:0072657; GO:1903432; GO:1904263; GO:1990130; GO:1990131; GO:1990877 apoptotic process [GO:0006915]; autophagosome assembly [GO:0000045]; cellular response to amino acid starvation [GO:0034198]; cellular response to amino acid stimulus [GO:0071230]; cellular response to methionine [GO:0061431]; cellular response to nutrient levels [GO:0031669]; cellular response to starvation [GO:0009267]; cytoplasmic translation [GO:0002181]; glucose homeostasis [GO:0042593]; intracellular protein localization [GO:0008104]; intracellular signal transduction [GO:0035556]; negative regulation of autophagy [GO:0010507]; negative regulation of translational initiation [GO:0045947]; positive regulation of TOR signaling [GO:0032008]; positive regulation of TORC1 signaling [GO:1904263]; positive regulation of translational initiation [GO:0045948]; protein localization to lysosome [GO:0061462]; protein localization to membrane [GO:0072657]; regulation of TORC1 signaling [GO:1903432]; response to amino acid [GO:0043200]; TORC1 signaling [GO:0038202]; tumor necrosis factor-mediated signaling pathway [GO:0033209] cytoplasm [GO:0005737]; FNIP-folliculin RagC/D GAP [GO:1990877]; GATOR1 complex [GO:1990130]; Gtr1-Gtr2 GTPase complex [GO:1990131]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] GTP binding [GO:0005525]; GTPase activity [GO:0003924]; phosphoprotein binding [GO:0051219]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; protein-membrane adaptor activity [GO:0043495]; ubiquitin protein ligase binding [GO:0031625] g14242.t1 Q9R087 48.228 508 5.02e-166 486.0 sp|Q9R087|GPC6_MOUSE Glypican-6 OS=Mus musculus OX=10090 GN=Gpc6 PE=1 SV=1 g14244.t1 Q6P2X9 32.524 206 1.43e-24 108.0 sp|Q6P2X9|MOT12_XENTR Monocarboxylate transporter 12 OS=Xenopus tropicalis OX=8364 GN=slc16a12 PE=2 SV=1 g14245.t1 P57788 36.757 185 1.1799999999999999e-23 105.0 sp|P57788|MOT4_CHICK Monocarboxylate transporter 4 OS=Gallus gallus OX=9031 GN=SLC16A3 PE=2 SV=2 g14247.t1 O18334 86.058 208 1.67e-129 366.0 sp|O18334|RAB6_DROME Ras-related protein Rab6 OS=Drosophila melanogaster OX=7227 GN=Rab6 PE=1 SV=1 RAB6_DROME reviewed Ras-related protein Rab6 (Protein warthog) Drosophila melanogaster (Fruit fly) GO:0000139; GO:0001745; GO:0001881; GO:0003779; GO:0003924; GO:0005525; GO:0005764; GO:0005776; GO:0005794; GO:0005829; GO:0006886; GO:0006887; GO:0006890; GO:0006891; GO:0007293; GO:0007411; GO:0007602; GO:0008103; GO:0012505; GO:0016192; GO:0031410; GO:0032482; GO:0042147; GO:0043025; GO:0043204; GO:0045202; GO:0045451; GO:0045467; GO:0060078; GO:0140450 axon guidance [GO:0007411]; compound eye morphogenesis [GO:0001745]; exocytosis [GO:0006887]; germarium-derived egg chamber formation [GO:0007293]; intra-Golgi vesicle-mediated transport [GO:0006891]; intracellular protein transport [GO:0006886]; oocyte microtubule cytoskeleton polarization [GO:0008103]; phototransduction [GO:0007602]; pole plasm oskar mRNA localization [GO:0045451]; protein targeting to Golgi apparatus [GO:0140450]; R7 cell development [GO:0045467]; Rab protein signal transduction [GO:0032482]; receptor recycling [GO:0001881]; regulation of postsynaptic membrane potential [GO:0060078]; retrograde transport, endosome to Golgi [GO:0042147]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; vesicle-mediated transport [GO:0016192] autophagosome [GO:0005776]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; lysosome [GO:0005764]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; synapse [GO:0045202] actin binding [GO:0003779]; GTP binding [GO:0005525]; GTPase activity [GO:0003924] g14247.t2 Q5RAV6 85.646 209 4.9900000000000004e-130 369.0 sp|Q5RAV6|RAB6A_PONAB Ras-related protein Rab-6A OS=Pongo abelii OX=9601 GN=RAB6A PE=2 SV=3 RAB6A_PONAB reviewed Ras-related protein Rab-6A (Rab-6) (EC 3.6.5.2) Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0000139; GO:0002080; GO:0003924; GO:0003925; GO:0005525; GO:0005794; GO:0006890; GO:0015031; GO:0034067; GO:0036064; GO:0046872 protein localization to Golgi apparatus [GO:0034067]; protein transport [GO:0015031]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890] acrosomal membrane [GO:0002080]; ciliary basal body [GO:0036064]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139] G protein activity [GO:0003925]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872] g14249.t1 O60488 47.692 715 0.0 637.0 sp|O60488|ACSL4_HUMAN Long-chain-fatty-acid--CoA ligase 4 OS=Homo sapiens OX=9606 GN=ACSL4 PE=1 SV=2 ACSL4_HUMAN reviewed Long-chain-fatty-acid--CoA ligase 4 (EC 6.2.1.3) (Arachidonate--CoA ligase) (EC 6.2.1.15) (Long-chain acyl-CoA synthetase 4) (LACS 4) Homo sapiens (Human) GO:0001676; GO:0004467; GO:0005524; GO:0005737; GO:0005739; GO:0005741; GO:0005778; GO:0005783; GO:0005789; GO:0005811; GO:0005886; GO:0006629; GO:0006631; GO:0006636; GO:0008610; GO:0016020; GO:0030182; GO:0030307; GO:0031957; GO:0032024; GO:0032307; GO:0035336; GO:0035338; GO:0036109; GO:0042759; GO:0044233; GO:0047676; GO:0060136; GO:0070062; GO:0090433; GO:0160020 alpha-linolenic acid metabolic process [GO:0036109]; embryonic process involved in female pregnancy [GO:0060136]; fatty acid metabolic process [GO:0006631]; lipid biosynthetic process [GO:0008610]; lipid metabolic process [GO:0006629]; long-chain fatty acid biosynthetic process [GO:0042759]; long-chain fatty acid metabolic process [GO:0001676]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; long-chain fatty-acyl-CoA metabolic process [GO:0035336]; negative regulation of prostaglandin secretion [GO:0032307]; neuron differentiation [GO:0030182]; positive regulation of cell growth [GO:0030307]; positive regulation of ferroptosis [GO:0160020]; positive regulation of insulin secretion [GO:0032024]; unsaturated fatty acid biosynthetic process [GO:0006636] cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; lipid droplet [GO:0005811]; membrane [GO:0016020]; mitochondria-associated endoplasmic reticulum membrane contact site [GO:0044233]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; peroxisomal membrane [GO:0005778]; plasma membrane [GO:0005886] arachidonate-CoA ligase activity [GO:0047676]; ATP binding [GO:0005524]; long-chain fatty acid-CoA ligase activity [GO:0004467]; palmitoyl-CoA ligase activity [GO:0090433]; very long-chain fatty acid-CoA ligase activity [GO:0031957] g14250.t1 Q567G2 31.148 366 2.73e-35 134.0 sp|Q567G2|WDR73_DANRE Integrator complex assembly factor WDR73 OS=Danio rerio OX=7955 GN=wdr73 PE=2 SV=1 WDR73_DANRE reviewed Integrator complex assembly factor WDR73 (WD repeat-containing protein 73) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000922; GO:0005737; GO:0021549; GO:0021702; GO:0030674; GO:0030901; GO:0031122; GO:0032154 cerebellar Purkinje cell differentiation [GO:0021702]; cerebellum development [GO:0021549]; cytoplasmic microtubule organization [GO:0031122]; midbrain development [GO:0030901] cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; spindle pole [GO:0000922] protein-macromolecule adaptor activity [GO:0030674] g14251.t1 Q96PF2 35.424 271 1.91e-40 147.0 sp|Q96PF2|TSSK2_HUMAN Testis-specific serine/threonine-protein kinase 2 OS=Homo sapiens OX=9606 GN=TSSK2 PE=1 SV=2 TSSK2_HUMAN reviewed Testis-specific serine/threonine-protein kinase 2 (TSK-2) (TSK2) (TSSK-2) (Testis-specific kinase 2) (EC 2.7.11.1) (DiGeorge syndrome protein G) (DGS-G) (Serine/threonine-protein kinase 22B) Homo sapiens (Human) GO:0000287; GO:0001669; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005814; GO:0006468; GO:0007286; GO:0044877; GO:0046777; GO:0106310 protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; spermatid development [GO:0007286] acrosomal vesicle [GO:0001669]; centriole [GO:0005814]; cytoplasm [GO:0005737]; nucleus [GO:0005634] ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein-containing complex binding [GO:0044877] g14252.t1 Q0P5B9 48.087 183 1.6e-50 164.0 sp|Q0P5B9|ANR39_BOVIN Ankyrin repeat domain-containing protein 39 OS=Bos taurus OX=9913 GN=ANKRD39 PE=2 SV=1 g14254.t1 Q7T1N4 35.338 266 5.44e-33 130.0 sp|Q7T1N4|ASIC1_OPSTA Acid-sensing ion channel 1 OS=Opsanus tau OX=8068 GN=asic1 PE=1 SV=1 ASIC1_OPSTA reviewed Acid-sensing ion channel 1 (ASIC1) Opsanus tau (Oyster toadfish) (Gadus tau) GO:0005886; GO:0015280; GO:0030425; GO:0035725; GO:0045211; GO:0071467; GO:0160128 cellular response to pH [GO:0071467]; sodium ion transmembrane transport [GO:0035725] dendrite [GO:0030425]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211] ligand-gated sodium channel activity [GO:0015280]; pH-gated monoatomic ion channel activity [GO:0160128] g14259.t1 Q708S6 31.911 492 8.74e-60 208.0 sp|Q708S6|ASI1C_DANRE Acid-sensing ion channel 1C OS=Danio rerio OX=7955 GN=asic1c PE=1 SV=1 ASI1C_DANRE reviewed Acid-sensing ion channel 1C (ASIC1-C) (Acid-sensing ion channel 1.3-C) (Amiloride-sensitive cation channel 2-C, neuronal-C) (ZASIC1.3) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005261; GO:0005886; GO:0007269; GO:0015280; GO:0030425; GO:0035725; GO:0045211; GO:0071467; GO:0098793; GO:0098978; GO:0160128 cellular response to pH [GO:0071467]; neurotransmitter secretion [GO:0007269]; sodium ion transmembrane transport [GO:0035725] dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynapse [GO:0098793] ligand-gated sodium channel activity [GO:0015280]; monoatomic cation channel activity [GO:0005261]; pH-gated monoatomic ion channel activity [GO:0160128] g14260.t1 Q7T1N4 31.544 447 2.82e-59 206.0 sp|Q7T1N4|ASIC1_OPSTA Acid-sensing ion channel 1 OS=Opsanus tau OX=8068 GN=asic1 PE=1 SV=1 ASIC1_OPSTA reviewed Acid-sensing ion channel 1 (ASIC1) Opsanus tau (Oyster toadfish) (Gadus tau) GO:0005886; GO:0015280; GO:0030425; GO:0035725; GO:0045211; GO:0071467; GO:0160128 cellular response to pH [GO:0071467]; sodium ion transmembrane transport [GO:0035725] dendrite [GO:0030425]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211] ligand-gated sodium channel activity [GO:0015280]; pH-gated monoatomic ion channel activity [GO:0160128] g14261.t1 Q708S4 32.819 454 6.9000000000000005e-56 198.0 sp|Q708S4|ASI4A_DANRE Acid-sensing ion channel 4-A OS=Danio rerio OX=7955 GN=asic4a PE=1 SV=1 ASI4A_DANRE reviewed Acid-sensing ion channel 4-A (ASIC4-A) (Acid-sensing ion channel 4.1) (Amiloride-sensitive cation channel 4-A) (ZASIC4.1) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005248; GO:0005261; GO:0005886; GO:0015280; GO:0035725; GO:0045177 sodium ion transmembrane transport [GO:0035725] apical part of cell [GO:0045177]; plasma membrane [GO:0005886] ligand-gated sodium channel activity [GO:0015280]; monoatomic cation channel activity [GO:0005261]; voltage-gated sodium channel activity [GO:0005248] g14262.t1 Q7M757 56.983 179 7.72e-69 214.0 sp|Q7M757|BRC3L_MOUSE Lys-63-specific deubiquitinase BRCC36-like OS=Mus musculus OX=10090 GN=Brcc3dc PE=2 SV=1 BRC3L_MOUSE reviewed Lys-63-specific deubiquitinase BRCC36-like (EC 3.4.19.-) (BRCA1/BRCA2-containing complex subunit 3-like) Mus musculus (Mouse) GO:0000152; GO:0004843; GO:0005634; GO:0005654; GO:0005737; GO:0006302; GO:0006508; GO:0007095; GO:0008237; GO:0010212; GO:0031593; GO:0044546; GO:0045739; GO:0046872; GO:0061578; GO:0070531; GO:0070536; GO:0070552; GO:0071479; GO:0140492; GO:0140861; GO:1900227 cellular response to ionizing radiation [GO:0071479]; DNA repair-dependent chromatin remodeling [GO:0140861]; double-strand break repair [GO:0006302]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; NLRP3 inflammasome complex assembly [GO:0044546]; positive regulation of DNA repair [GO:0045739]; positive regulation of NLRP3 inflammasome complex assembly [GO:1900227]; protein K63-linked deubiquitination [GO:0070536]; proteolysis [GO:0006508]; response to ionizing radiation [GO:0010212] BRCA1-A complex [GO:0070531]; BRISC complex [GO:0070552]; cytoplasm [GO:0005737]; nuclear ubiquitin ligase complex [GO:0000152]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cysteine-type deubiquitinase activity [GO:0004843]; K63-linked deubiquitinase activity [GO:0061578]; metal ion binding [GO:0046872]; metal-dependent deubiquitinase activity [GO:0140492]; metallopeptidase activity [GO:0008237]; polyubiquitin modification-dependent protein binding [GO:0031593] g14263.t1 B5X8M4 74.667 75 2.3e-34 120.0 sp|B5X8M4|BRCC3_SALSA Lys-63-specific deubiquitinase BRCC36 OS=Salmo salar OX=8030 GN=brcc3 PE=2 SV=1 BRCC3_SALSA reviewed Lys-63-specific deubiquitinase BRCC36 (EC 3.4.19.-) (BRCA1-A complex subunit BRCC36) (BRCA1/BRCA2-containing complex subunit 3) (BRCA1/BRCA2-containing complex subunit 36) (BRISC complex subunit BRCC36) Salmo salar (Atlantic salmon) GO:0000922; GO:0004843; GO:0005634; GO:0005737; GO:0006302; GO:0006508; GO:0007095; GO:0008237; GO:0010212; GO:0031593; GO:0045739; GO:0046872; GO:0051301; GO:0070531; GO:0070536; GO:0070552; GO:0140492; GO:0140861; GO:1900227 cell division [GO:0051301]; DNA repair-dependent chromatin remodeling [GO:0140861]; double-strand break repair [GO:0006302]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; positive regulation of DNA repair [GO:0045739]; positive regulation of NLRP3 inflammasome complex assembly [GO:1900227]; protein K63-linked deubiquitination [GO:0070536]; proteolysis [GO:0006508]; response to ionizing radiation [GO:0010212] BRCA1-A complex [GO:0070531]; BRISC complex [GO:0070552]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; spindle pole [GO:0000922] cysteine-type deubiquitinase activity [GO:0004843]; metal ion binding [GO:0046872]; metal-dependent deubiquitinase activity [GO:0140492]; metallopeptidase activity [GO:0008237]; polyubiquitin modification-dependent protein binding [GO:0031593] g14264.t1 Q86X83 59.596 198 7.58e-78 234.0 sp|Q86X83|COMD2_HUMAN COMM domain-containing protein 2 OS=Homo sapiens OX=9606 GN=COMMD2 PE=1 SV=2 g14268.t1 A6BMK7 41.243 354 7.280000000000001e-80 254.0 sp|A6BMK7|NEUR1_BOVIN Sialidase-1 OS=Bos taurus OX=9913 GN=NEU1 PE=2 SV=2 NEUR1_BOVIN reviewed Sialidase-1 (EC 3.2.1.18) (Acetylneuraminyl hydrolase) (Lysosomal sialidase) (N-acetyl-alpha-neuraminidase 1) Bos taurus (Bovine) GO:0004308; GO:0005737; GO:0005764; GO:0005765; GO:0005886; GO:0006689; GO:0009313; GO:0016020; GO:0030054; GO:0031410; GO:0043202 ganglioside catabolic process [GO:0006689]; oligosaccharide catabolic process [GO:0009313] cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; plasma membrane [GO:0005886] exo-alpha-sialidase activity [GO:0004308] g14273.t1 P97872 36.538 468 2.32e-75 249.0 sp|P97872|FMO5_MOUSE Flavin-containing monooxygenase 5 OS=Mus musculus OX=10090 GN=Fmo5 PE=1 SV=4 FMO5_MOUSE reviewed Flavin-containing monooxygenase 5 (FMO 5) (Dimethylaniline monooxygenase [N-oxide-forming] 5) (EC 1.14.13.8) (Dimethylaniline oxidase 5) (Hepatic flavin-containing monooxygenase 5) (NADPH oxidase) (EC 1.6.3.1) Mus musculus (Mouse) GO:0004497; GO:0004499; GO:0005783; GO:0005789; GO:0005829; GO:0006629; GO:0006805; GO:0016174; GO:0050660; GO:0050661; GO:0090181 lipid metabolic process [GO:0006629]; regulation of cholesterol metabolic process [GO:0090181]; xenobiotic metabolic process [GO:0006805] cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789] flavin adenine dinucleotide binding [GO:0050660]; monooxygenase activity [GO:0004497]; N,N-dimethylaniline monooxygenase activity [GO:0004499]; NAD(P)H oxidase H2O2-forming activity [GO:0016174]; NADP binding [GO:0050661] g14274.t1 Q9Y376 61.818 220 1.61e-80 247.0 sp|Q9Y376|CAB39_HUMAN Calcium-binding protein 39 OS=Homo sapiens OX=9606 GN=CAB39 PE=1 SV=1 g14275.t1 P91891 78.723 94 1.13e-45 152.0 sp|P91891|MO25_DROME Protein Mo25 OS=Drosophila melanogaster OX=7227 GN=Mo25 PE=2 SV=2 g14276.t1 Q01887 43.939 132 3.9600000000000003e-32 123.0 sp|Q01887|RYK_MOUSE Tyrosine-protein kinase RYK OS=Mus musculus OX=10090 GN=Ryk PE=1 SV=2 RYK_MOUSE reviewed Tyrosine-protein kinase RYK (EC 2.7.10.1) (Kinase VIK) (Met-related kinase) (NYK-R) Mus musculus (Mouse) GO:0004713; GO:0004888; GO:0005109; GO:0005524; GO:0005634; GO:0005737; GO:0005886; GO:0007169; GO:0007409; GO:0007411; GO:0010976; GO:0016020; GO:0016055; GO:0017147; GO:0022038; GO:0030182; GO:0031175; GO:0036518; GO:0042813; GO:0043235; GO:0043410; GO:0048705; GO:0048787; GO:0048843; GO:0050919; GO:0051897; GO:0060071; GO:0061643; GO:0071679; GO:0098839; GO:0098978; GO:1904935; GO:1904948 axon guidance [GO:0007411]; axonogenesis [GO:0007409]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; chemorepulsion of axon [GO:0061643]; chemorepulsion of dopaminergic neuron axon [GO:0036518]; commissural neuron axon guidance [GO:0071679]; corpus callosum development [GO:0022038]; midbrain dopaminergic neuron differentiation [GO:1904948]; negative chemotaxis [GO:0050919]; negative regulation of axon extension involved in axon guidance [GO:0048843]; neuron differentiation [GO:0030182]; neuron projection development [GO:0031175]; positive regulation of cell proliferation in midbrain [GO:1904935]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of neuron projection development [GO:0010976]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; skeletal system morphogenesis [GO:0048705]; Wnt signaling pathway [GO:0016055]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071] cytoplasm [GO:0005737]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; presynaptic active zone membrane [GO:0048787]; receptor complex [GO:0043235] ATP binding [GO:0005524]; frizzled binding [GO:0005109]; protein tyrosine kinase activity [GO:0004713]; transmembrane signaling receptor activity [GO:0004888]; Wnt receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147] g14277.t1 Q01887 60.068 293 2.2999999999999998e-126 379.0 sp|Q01887|RYK_MOUSE Tyrosine-protein kinase RYK OS=Mus musculus OX=10090 GN=Ryk PE=1 SV=2 RYK_MOUSE reviewed Tyrosine-protein kinase RYK (EC 2.7.10.1) (Kinase VIK) (Met-related kinase) (NYK-R) Mus musculus (Mouse) GO:0004713; GO:0004888; GO:0005109; GO:0005524; GO:0005634; GO:0005737; GO:0005886; GO:0007169; GO:0007409; GO:0007411; GO:0010976; GO:0016020; GO:0016055; GO:0017147; GO:0022038; GO:0030182; GO:0031175; GO:0036518; GO:0042813; GO:0043235; GO:0043410; GO:0048705; GO:0048787; GO:0048843; GO:0050919; GO:0051897; GO:0060071; GO:0061643; GO:0071679; GO:0098839; GO:0098978; GO:1904935; GO:1904948 axon guidance [GO:0007411]; axonogenesis [GO:0007409]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; chemorepulsion of axon [GO:0061643]; chemorepulsion of dopaminergic neuron axon [GO:0036518]; commissural neuron axon guidance [GO:0071679]; corpus callosum development [GO:0022038]; midbrain dopaminergic neuron differentiation [GO:1904948]; negative chemotaxis [GO:0050919]; negative regulation of axon extension involved in axon guidance [GO:0048843]; neuron differentiation [GO:0030182]; neuron projection development [GO:0031175]; positive regulation of cell proliferation in midbrain [GO:1904935]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of neuron projection development [GO:0010976]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; skeletal system morphogenesis [GO:0048705]; Wnt signaling pathway [GO:0016055]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071] cytoplasm [GO:0005737]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; presynaptic active zone membrane [GO:0048787]; receptor complex [GO:0043235] ATP binding [GO:0005524]; frizzled binding [GO:0005109]; protein tyrosine kinase activity [GO:0004713]; transmembrane signaling receptor activity [GO:0004888]; Wnt receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147] g14278.t1 Q6AYT4 46.231 199 1.4700000000000001e-21 94.7 sp|Q6AYT4|PBIR1_RAT P2R1A-PPP2R2A-interacting phosphatase regulator 1 OS=Rattus norvegicus OX=10116 GN=Pabir1 PE=1 SV=1 PBIR1_RAT reviewed P2R1A-PPP2R2A-interacting phosphatase regulator 1 (PABIR family member 1) Rattus norvegicus (Rat) GO:0004864; GO:0004865; GO:0005634; GO:0005654; GO:0005737; GO:0016604; GO:0030307; GO:0032436; GO:0044818; GO:0051721 mitotic G2/M transition checkpoint [GO:0044818]; positive regulation of cell growth [GO:0030307]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436] cytoplasm [GO:0005737]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] protein phosphatase 2A binding [GO:0051721]; protein phosphatase inhibitor activity [GO:0004864]; protein serine/threonine phosphatase inhibitor activity [GO:0004865] g14280.t1 P47791 59.657 466 0.0 532.0 sp|P47791|GSHR_MOUSE Glutathione reductase, mitochondrial OS=Mus musculus OX=10090 GN=Gsr PE=1 SV=3 g14281.t1 Q5RDQ3 52.069 290 2.6e-97 291.0 sp|Q5RDQ3|AMERL_PONAB AMMECR1-like protein OS=Pongo abelii OX=9601 GN=AMMECR1L PE=2 SV=1 g14282.t1 P35521 43.836 146 1.8200000000000001e-31 118.0 sp|P35521|ICLN_CANLF Methylosome subunit pICln OS=Canis lupus familiaris OX=9615 GN=CLNS1A PE=1 SV=1 g14284.t1 Q5U3C3 54.676 139 7.2e-51 167.0 sp|Q5U3C3|TM164_HUMAN Transmembrane protein 164 OS=Homo sapiens OX=9606 GN=TMEM164 PE=1 SV=1 g14285.t1 Q7ZXB1 78.245 547 0.0 872.0 sp|Q7ZXB1|MCM7B_XENLA DNA replication licensing factor mcm7-B OS=Xenopus laevis OX=8355 GN=mcm7-b PE=1 SV=1 MCM7B_XENLA reviewed DNA replication licensing factor mcm7-B (EC 3.6.4.12) (CDC47 homolog B) (CDC47-2p) (Minichromosome maintenance protein 7-B) (xMCM7-B) Xenopus laevis (African clawed frog) GO:0000727; GO:0000785; GO:0003697; GO:0005524; GO:0005634; GO:0006270; GO:0006271; GO:0008270; GO:0016887; GO:0017116; GO:0030174; GO:0042555; GO:0071162 DNA replication initiation [GO:0006270]; DNA strand elongation involved in DNA replication [GO:0006271]; double-strand break repair via break-induced replication [GO:0000727]; regulation of DNA-templated DNA replication initiation [GO:0030174] chromatin [GO:0000785]; CMG complex [GO:0071162]; MCM complex [GO:0042555]; nucleus [GO:0005634] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; single-stranded DNA binding [GO:0003697]; single-stranded DNA helicase activity [GO:0017116]; zinc ion binding [GO:0008270] g14287.t1 Q3ZBH9 60.465 86 1.66e-30 115.0 sp|Q3ZBH9|MCM7_BOVIN DNA replication licensing factor MCM7 OS=Bos taurus OX=9913 GN=MCM7 PE=2 SV=1 MCM7_BOVIN reviewed DNA replication licensing factor MCM7 (EC 3.6.4.12) Bos taurus (Bovine) GO:0000727; GO:0003678; GO:0003697; GO:0005524; GO:0005634; GO:0006260; GO:0006270; GO:0006271; GO:0006974; GO:0008283; GO:0016887; GO:0042325; GO:0042555; GO:0071162 cell population proliferation [GO:0008283]; DNA damage response [GO:0006974]; DNA replication [GO:0006260]; DNA replication initiation [GO:0006270]; DNA strand elongation involved in DNA replication [GO:0006271]; double-strand break repair via break-induced replication [GO:0000727]; regulation of phosphorylation [GO:0042325] CMG complex [GO:0071162]; MCM complex [GO:0042555]; nucleus [GO:0005634] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA helicase activity [GO:0003678]; single-stranded DNA binding [GO:0003697] g14288.t1 O14936 73.881 938 0.0 1418.0 sp|O14936|CSKP_HUMAN Peripheral plasma membrane protein CASK OS=Homo sapiens OX=9606 GN=CASK PE=1 SV=3 g14288.t2 O14936 73.959 937 0.0 1423.0 sp|O14936|CSKP_HUMAN Peripheral plasma membrane protein CASK OS=Homo sapiens OX=9606 GN=CASK PE=1 SV=3 g14289.t1 Q6XQG9 32.362 309 2.2e-37 142.0 sp|Q6XQG9|G3ST2_PIG Galactose-3-O-sulfotransferase 2 OS=Sus scrofa OX=9823 GN=GAL3ST2 PE=2 SV=1 g14291.t1 Q9N126 39.286 280 4.19e-46 160.0 sp|Q9N126|RDH8_BOVIN Retinol dehydrogenase 8 OS=Bos taurus OX=9913 GN=RDH8 PE=1 SV=1 g14292.t1 Q9QXE5 38.178 461 2.5299999999999998e-95 303.0 sp|Q9QXE5|TSSP_MOUSE Thymus-specific serine protease OS=Mus musculus OX=10090 GN=Prss16 PE=2 SV=1 g14293.t1 Q561X3 43.21 243 7.91e-51 169.0 sp|Q561X3|MED4_DANRE Mediator of RNA polymerase II transcription subunit 4 OS=Danio rerio OX=7955 GN=med4 PE=2 SV=1 g14294.t1 O60573 67.857 224 7.28e-108 313.0 sp|O60573|IF4E2_HUMAN Eukaryotic translation initiation factor 4E type 2 OS=Homo sapiens OX=9606 GN=EIF4E2 PE=1 SV=1 IF4E2_HUMAN reviewed Eukaryotic translation initiation factor 4E type 2 (eIF-4E type 2) (eIF4E type 2) (Eukaryotic translation initiation factor 4E homologous protein) (Eukaryotic translation initiation factor 4E-like 3) (eIF4E-like protein 4E-LP) (mRNA cap-binding protein 4EHP) (h4EHP) (mRNA cap-binding protein type 3) Homo sapiens (Human) GO:0000339; GO:0000340; GO:0000932; GO:0003723; GO:0003743; GO:0005737; GO:0005829; GO:0006413; GO:0008135; GO:0016281; GO:0017148; GO:0031625; GO:0035278; GO:0045947; GO:0060339; GO:0072344; GO:0098808 miRNA-mediated gene silencing by inhibition of translation [GO:0035278]; negative regulation of translation [GO:0017148]; negative regulation of translational initiation [GO:0045947]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; rescue of stalled ribosome [GO:0072344]; translational initiation [GO:0006413] cytoplasm [GO:0005737]; cytosol [GO:0005829]; eukaryotic translation initiation factor 4F complex [GO:0016281]; P-body [GO:0000932] mRNA cap binding [GO:0098808]; RNA 7-methylguanosine cap binding [GO:0000340]; RNA binding [GO:0003723]; RNA cap binding [GO:0000339]; translation factor activity, RNA binding [GO:0008135]; translation initiation factor activity [GO:0003743]; ubiquitin protein ligase binding [GO:0031625] g14296.t1 Q6QBQ4 36.715 207 3.53e-29 114.0 sp|Q6QBQ4|PLS3_RAT Phospholipid scramblase 3 OS=Rattus norvegicus OX=10116 GN=Plscr3 PE=1 SV=1 PLS3_RAT reviewed Phospholipid scramblase 3 (PL scramblase 3) (Ca(2+)-dependent phospholipid scramblase 3) Rattus norvegicus (Rat) GO:0000287; GO:0005509; GO:0005634; GO:0005739; GO:0005743; GO:0005829; GO:0005886; GO:0006915; GO:0007006; GO:0017121; GO:0017124; GO:0017128; GO:0032791; GO:0042593; GO:0042632; GO:0042981; GO:0045340; GO:0048306; GO:0071222; GO:0090199 apoptotic process [GO:0006915]; cellular response to lipopolysaccharide [GO:0071222]; cholesterol homeostasis [GO:0042632]; glucose homeostasis [GO:0042593]; mitochondrial membrane organization [GO:0007006]; plasma membrane phospholipid scrambling [GO:0017121]; regulation of apoptotic process [GO:0042981]; regulation of release of cytochrome c from mitochondria [GO:0090199] cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; calcium-dependent protein binding [GO:0048306]; lead ion binding [GO:0032791]; magnesium ion binding [GO:0000287]; mercury ion binding [GO:0045340]; phospholipid scramblase activity [GO:0017128]; SH3 domain binding [GO:0017124] g14309.t1 Q2TBI2 51.299 154 2.27e-45 160.0 sp|Q2TBI2|THAP4_BOVIN Peroxynitrite isomerase THAP4 OS=Bos taurus OX=9913 GN=THAP4 PE=2 SV=2 THAP4_BOVIN reviewed Peroxynitrite isomerase THAP4 (EC 5.99.-.-) (Ferric nitrobindin) (Nb(III)) (THAP domain-containing protein 4) Bos taurus (Bovine) GO:0003677; GO:0005634; GO:0005737; GO:0006570; GO:0008270; GO:0042126; GO:0062213; GO:0070026 nitrate metabolic process [GO:0042126]; tyrosine metabolic process [GO:0006570] cytoplasm [GO:0005737]; nucleus [GO:0005634] DNA binding [GO:0003677]; nitric oxide binding [GO:0070026]; peroxynitrite isomerase activity [GO:0062213]; zinc ion binding [GO:0008270] g14310.t1 O73787 51.995 802 0.0 772.0 sp|O73787|GCP3_XENLA Gamma-tubulin complex component 3 homolog OS=Xenopus laevis OX=8355 GN=tubgcp3 PE=1 SV=1 g14310.t2 O73787 51.87 802 0.0 774.0 sp|O73787|GCP3_XENLA Gamma-tubulin complex component 3 homolog OS=Xenopus laevis OX=8355 GN=tubgcp3 PE=1 SV=1 g14311.t1 P58854 49.02 102 4.5400000000000003e-26 104.0 sp|P58854|GCP3_MOUSE Gamma-tubulin complex component 3 OS=Mus musculus OX=10090 GN=Tubgcp3 PE=1 SV=2 g14315.t1 Q0J290 33.446 296 7.04e-42 154.0 sp|Q0J290|PAO7_ORYSJ Polyamine oxidase 7 OS=Oryza sativa subsp. japonica OX=39947 GN=PAO7 PE=1 SV=1 PAO7_ORYSJ reviewed Polyamine oxidase 7 (OsPAO7) (EC 1.5.3.-) Oryza sativa subsp. japonica (Rice) GO:0006598; GO:0046203; GO:0046208; GO:0046592; GO:0048046; GO:0050660; GO:0052901; GO:0052903; GO:1903602; GO:1990534 polyamine catabolic process [GO:0006598]; spermidine catabolic process [GO:0046203]; spermine catabolic process [GO:0046208]; thermospermine catabolic process [GO:1903602] apoplast [GO:0048046] flavin adenine dinucleotide binding [GO:0050660]; N(1)-acetylpolyamine oxidase (3-acetamidopropanal-forming) activity [GO:0052903]; polyamine oxidase activity [GO:0046592]; spermine oxidase activity [GO:0052901]; thermospermine oxidase activity [GO:1990534] g14316.t1 P50532 51.736 1210 0.0 1058.0 sp|P50532|SMC4_XENLA Structural maintenance of chromosomes protein 4 OS=Xenopus laevis OX=8355 GN=smc4 PE=1 SV=1 g14317.t1 B0XK69 47.468 158 1.6e-44 147.0 sp|B0XK69|SDHF2_CULQU Succinate dehydrogenase assembly factor 2, mitochondrial OS=Culex quinquefasciatus OX=7176 GN=CPIJ019830 PE=3 SV=1 g14318.t1 A6QP05 55.346 318 1.51e-123 360.0 sp|A6QP05|DHR12_BOVIN Dehydrogenase/reductase SDR family member 12 OS=Bos taurus OX=9913 GN=DHRS12 PE=2 SV=1 g14319.t1 P32007 80.205 293 2.7199999999999997e-159 448.0 sp|P32007|ADT3_BOVIN ADP/ATP translocase 3 OS=Bos taurus OX=9913 GN=SLC25A6 PE=1 SV=3 ADT3_BOVIN reviewed ADP/ATP translocase 3 (ADP,ATP carrier protein 3) (ADP,ATP carrier protein, isoform T2) (ANT 2) (Adenine nucleotide translocator 3) (ANT 3) (Solute carrier family 25 member 6) [Cleaved into: ADP/ATP translocase 3, N-terminally processed] Bos taurus (Bovine) GO:0005471; GO:0005743; GO:0006915; GO:0016020; GO:0140021; GO:1901029; GO:1990544 apoptotic process [GO:0006915]; mitochondrial ADP transmembrane transport [GO:0140021]; mitochondrial ATP transmembrane transport [GO:1990544]; negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901029] membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743] ATP:ADP antiporter activity [GO:0005471] g14324.t1 Q9BXJ3 43.972 141 7.99e-22 100.0 sp|Q9BXJ3|C1QT4_HUMAN Complement C1q tumor necrosis factor-related protein 4 OS=Homo sapiens OX=9606 GN=C1QTNF4 PE=1 SV=2 C1QT4_HUMAN reviewed Complement C1q tumor necrosis factor-related protein 4 (C1q/TNF-related protein 4) Homo sapiens (Human) GO:0002023; GO:0005125; GO:0005615; GO:0010467; GO:0032755; GO:0032760; GO:0070105; GO:0097696; GO:1901224 cell surface receptor signaling pathway via STAT [GO:0097696]; gene expression [GO:0010467]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-6-mediated signaling pathway [GO:0070105]; positive regulation of non-canonical NF-kappaB signal transduction [GO:1901224]; positive regulation of tumor necrosis factor production [GO:0032760]; reduction of food intake in response to dietary excess [GO:0002023] extracellular space [GO:0005615] cytokine activity [GO:0005125] g14326.t1 P13280 48.507 134 7.41e-38 130.0 sp|P13280|GLYG_RABIT Glycogenin-1 OS=Oryctolagus cuniculus OX=9986 GN=GYG1 PE=1 SV=3 g14326.t1 P13280 70.968 31 7.41e-38 47.0 sp|P13280|GLYG_RABIT Glycogenin-1 OS=Oryctolagus cuniculus OX=9986 GN=GYG1 PE=1 SV=3 g14327.t1 Q7Z5U6 35.061 328 6.44e-58 194.0 sp|Q7Z5U6|WDR53_HUMAN WD repeat-containing protein 53 OS=Homo sapiens OX=9606 GN=WDR53 PE=1 SV=1 g14328.t1 F1M3J4 66.169 201 4.56e-87 283.0 sp|F1M3J4|MRP4_RAT ATP-binding cassette subfamily C member 4 OS=Rattus norvegicus OX=10116 GN=Abcc4 PE=1 SV=3 MRP4_RAT reviewed ATP-binding cassette subfamily C member 4 (EC 7.6.2.-) (EC 7.6.2.2) (EC 7.6.2.3) (Multidrug resistance-associated protein 4) Rattus norvegicus (Rat) GO:0001409; GO:0005524; GO:0005730; GO:0005794; GO:0005886; GO:0006568; GO:0008559; GO:0009410; GO:0015132; GO:0015143; GO:0015216; GO:0015431; GO:0015432; GO:0015562; GO:0015721; GO:0015732; GO:0015747; GO:0016020; GO:0016323; GO:0016324; GO:0016887; GO:0022857; GO:0031088; GO:0032310; GO:0034275; GO:0034634; GO:0042626; GO:0042910; GO:0048661; GO:0055085; GO:0060271; GO:0070730; GO:0071716; GO:0098591; GO:0140115; GO:0140359; GO:1904772 bile acid and bile salt transport [GO:0015721]; cAMP transport [GO:0070730]; cilium assembly [GO:0060271]; export across plasma membrane [GO:0140115]; kynurenic acid metabolic process [GO:0034275]; L-tryptophan metabolic process [GO:0006568]; leukotriene transport [GO:0071716]; positive regulation of smooth muscle cell proliferation [GO:0048661]; prostaglandin secretion [GO:0032310]; prostaglandin transport [GO:0015732]; response to tetrachloromethane [GO:1904772]; response to xenobiotic stimulus [GO:0009410]; transmembrane transport [GO:0055085]; urate transport [GO:0015747] apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; external side of apical plasma membrane [GO:0098591]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; platelet dense granule membrane [GO:0031088] ABC-type bile acid transporter activity [GO:0015432]; ABC-type glutathione S-conjugate transporter activity [GO:0015431]; ABC-type transporter activity [GO:0140359]; ABC-type xenobiotic transporter activity [GO:0008559]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; efflux transmembrane transporter activity [GO:0015562]; glutathione transmembrane transporter activity [GO:0034634]; guanine nucleotide transmembrane transporter activity [GO:0001409]; prostaglandin transmembrane transporter activity [GO:0015132]; purine nucleotide transmembrane transporter activity [GO:0015216]; transmembrane transporter activity [GO:0022857]; urate transmembrane transporter activity [GO:0015143]; xenobiotic transmembrane transporter activity [GO:0042910] g14329.t1 E9Q236 43.443 1098 0.0 875.0 sp|E9Q236|MRP4_MOUSE ATP-binding cassette sub-family C member 4 OS=Mus musculus OX=10090 GN=Abcc4 PE=1 SV=1 g14332.t1 A4IF63 27.595 790 4.43e-94 312.0 sp|A4IF63|TRIM2_BOVIN Tripartite motif-containing protein 2 OS=Bos taurus OX=9913 GN=TRIM2 PE=2 SV=1 TRIM2_BOVIN reviewed Tripartite motif-containing protein 2 (EC 2.3.2.27) (E3 ubiquitin-protein ligase TRIM2) (RING-type E3 ubiquitin transferase TRIM2) Bos taurus (Bovine) GO:0000209; GO:0004842; GO:0005737; GO:0008270; GO:0043161; GO:0043523; GO:0061630 proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; regulation of neuron apoptotic process [GO:0043523] cytoplasm [GO:0005737] ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] g14337.t1 Q17LW0 60.923 1538 0.0 1812.0 sp|Q17LW0|MYO7A_AEDAE Myosin-VIIa OS=Aedes aegypti OX=7159 GN=ck PE=3 SV=1 MYO7A_AEDAE reviewed Myosin-VIIa (Protein crinkled) Aedes aegypti (Yellowfever mosquito) (Culex aegypti) GO:0000146; GO:0003779; GO:0005524; GO:0005737; GO:0005902; GO:0007605; GO:0008407; GO:0016461; GO:0030048; GO:0032027; GO:0035317; GO:0045177; GO:0048800; GO:0071944 actin filament-based movement [GO:0030048]; antennal morphogenesis [GO:0048800]; chaeta morphogenesis [GO:0008407]; imaginal disc-derived wing hair organization [GO:0035317]; sensory perception of sound [GO:0007605] apical part of cell [GO:0045177]; cell periphery [GO:0071944]; cytoplasm [GO:0005737]; microvillus [GO:0005902]; unconventional myosin complex [GO:0016461] actin binding [GO:0003779]; ATP binding [GO:0005524]; microfilament motor activity [GO:0000146]; myosin light chain binding [GO:0032027] g14337.t1 Q17LW0 50.226 221 2.6e-60 234.0 sp|Q17LW0|MYO7A_AEDAE Myosin-VIIa OS=Aedes aegypti OX=7159 GN=ck PE=3 SV=1 MYO7A_AEDAE reviewed Myosin-VIIa (Protein crinkled) Aedes aegypti (Yellowfever mosquito) (Culex aegypti) GO:0000146; GO:0003779; GO:0005524; GO:0005737; GO:0005902; GO:0007605; GO:0008407; GO:0016461; GO:0030048; GO:0032027; GO:0035317; GO:0045177; GO:0048800; GO:0071944 actin filament-based movement [GO:0030048]; antennal morphogenesis [GO:0048800]; chaeta morphogenesis [GO:0008407]; imaginal disc-derived wing hair organization [GO:0035317]; sensory perception of sound [GO:0007605] apical part of cell [GO:0045177]; cell periphery [GO:0071944]; cytoplasm [GO:0005737]; microvillus [GO:0005902]; unconventional myosin complex [GO:0016461] actin binding [GO:0003779]; ATP binding [GO:0005524]; microfilament motor activity [GO:0000146]; myosin light chain binding [GO:0032027] g14339.t1 Q6DDL7 49.224 451 6.9e-149 436.0 sp|Q6DDL7|UN93A_XENLA Protein unc-93 homolog A OS=Xenopus laevis OX=8355 GN=unc93a PE=2 SV=1 g14340.t1 Q9I3S3 62.62 313 7.75e-140 402.0 sp|Q9I3S3|GBUA_PSEAE Guanidinobutyrase OS=Pseudomonas aeruginosa (strain ATCC 15692 / DSM 22644 / CIP 104116 / JCM 14847 / LMG 12228 / 1C / PRS 101 / PAO1) OX=208964 GN=gbuA PE=1 SV=1 g14342.t1 Q9NUN7 39.231 260 4.83e-58 191.0 sp|Q9NUN7|ACER3_HUMAN Alkaline ceramidase 3 OS=Homo sapiens OX=9606 GN=ACER3 PE=1 SV=3 ACER3_HUMAN reviewed Alkaline ceramidase 3 (AlkCDase 3) (Alkaline CDase 3) (EC 3.5.1.-) (EC 3.5.1.23) (Alkaline dihydroceramidase SB89) (Alkaline phytoceramidase) (aPHC) Homo sapiens (Human) GO:0000139; GO:0005509; GO:0005789; GO:0006954; GO:0008270; GO:0008284; GO:0016020; GO:0017040; GO:0042552; GO:0043067; GO:0046512; GO:0046514; GO:0071602 ceramide catabolic process [GO:0046514]; inflammatory response [GO:0006954]; myelination [GO:0042552]; phytosphingosine biosynthetic process [GO:0071602]; positive regulation of cell population proliferation [GO:0008284]; regulation of programmed cell death [GO:0043067]; sphingosine biosynthetic process [GO:0046512] endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; membrane [GO:0016020] calcium ion binding [GO:0005509]; N-acylsphingosine amidohydrolase activity [GO:0017040]; zinc ion binding [GO:0008270] g14345.t1 Q9QXX8 45.283 106 2.7e-25 113.0 sp|Q9QXX8|NUFP1_MOUSE FMR1-interacting protein NUFIP1 OS=Mus musculus OX=10090 GN=Nufip1 PE=1 SV=1 NUFP1_MOUSE reviewed FMR1-interacting protein NUFIP1 (Nuclear FMRP-interacting protein 1) Mus musculus (Mouse) GO:0000492; GO:0001650; GO:0003723; GO:0005634; GO:0005654; GO:0005726; GO:0005730; GO:0008023; GO:0008270; GO:0016363; GO:0030515; GO:0030674; GO:0032991; GO:0042802; GO:0045202; GO:0045944; GO:0048786; GO:0051117; GO:0070761 box C/D snoRNP assembly [GO:0000492]; positive regulation of transcription by RNA polymerase II [GO:0045944] fibrillar center [GO:0001650]; nuclear matrix [GO:0016363]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perichromatin fibrils [GO:0005726]; pre-snoRNP complex [GO:0070761]; presynaptic active zone [GO:0048786]; protein-containing complex [GO:0032991]; synapse [GO:0045202]; transcription elongation factor complex [GO:0008023] ATPase binding [GO:0051117]; identical protein binding [GO:0042802]; protein-macromolecule adaptor activity [GO:0030674]; RNA binding [GO:0003723]; snoRNA binding [GO:0030515]; zinc ion binding [GO:0008270] g14346.t1 B7P877 75.694 144 3.38e-81 239.0 sp|B7P877|NCBP2_IXOSC Nuclear cap-binding protein subunit 2 OS=Ixodes scapularis OX=6945 GN=Cbp20 PE=3 SV=1 g14349.t1 Q15700 53.333 885 0.0 775.0 sp|Q15700|DLG2_HUMAN Disks large homolog 2 OS=Homo sapiens OX=9606 GN=DLG2 PE=1 SV=3 g14355.t1 Q7Z449 39.069 494 4.76e-119 363.0 sp|Q7Z449|CP2U1_HUMAN Cytochrome P450 2U1 OS=Homo sapiens OX=9606 GN=CYP2U1 PE=1 SV=1 CP2U1_HUMAN reviewed Cytochrome P450 2U1 (Long-chain fatty acid omega-monooxygenase) (EC 1.14.14.80) Homo sapiens (Human) GO:0004497; GO:0005506; GO:0005737; GO:0005743; GO:0005789; GO:0006082; GO:0006805; GO:0008202; GO:0008395; GO:0016712; GO:0020037; GO:0052869; GO:0097267; GO:0102033; GO:1903604 cytochrome metabolic process [GO:1903604]; omega-hydroxylase P450 pathway [GO:0097267]; organic acid metabolic process [GO:0006082]; steroid metabolic process [GO:0008202]; xenobiotic metabolic process [GO:0006805] cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; mitochondrial inner membrane [GO:0005743] arachidonate omega-hydroxylase activity [GO:0052869]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; long-chain fatty acid omega-hydroxylase activity [GO:0102033]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; steroid hydroxylase activity [GO:0008395] g14356.t1 Q2KMM2 65.714 140 1.87e-66 201.0 sp|Q2KMM2|TPPC1_RAT Trafficking protein particle complex subunit 1 OS=Rattus norvegicus OX=10116 GN=Trappc1 PE=2 SV=1 g14357.t1 Q8BTM8 27.816 870 2.3300000000000002e-64 239.0 sp|Q8BTM8|FLNA_MOUSE Filamin-A OS=Mus musculus OX=10090 GN=Flna PE=1 SV=5 FLNA_MOUSE reviewed Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Alpha-filamin) (Endothelial actin-binding protein) (Filamin-1) (Non-muscle filamin) Mus musculus (Mouse) GO:0001525; GO:0001664; GO:0001837; GO:0001974; GO:0002102; GO:0003007; GO:0003779; GO:0005080; GO:0005634; GO:0005730; GO:0005737; GO:0005802; GO:0005829; GO:0005884; GO:0005886; GO:0005903; GO:0005911; GO:0005938; GO:0007195; GO:0007597; GO:0010572; GO:0010977; GO:0015459; GO:0015629; GO:0016479; GO:0019900; GO:0021943; GO:0030018; GO:0030036; GO:0030334; GO:0030426; GO:0030863; GO:0031267; GO:0031523; GO:0032231; GO:0032233; GO:0032432; GO:0034394; GO:0034988; GO:0035855; GO:0042177; GO:0042307; GO:0042789; GO:0042803; GO:0043025; GO:0043066; GO:0043113; GO:0043123; GO:0043198; GO:0043204; GO:0043433; GO:0044295; GO:0044319; GO:0044325; GO:0044877; GO:0045022; GO:0045184; GO:0045216; GO:0046332; GO:0048471; GO:0048680; GO:0050808; GO:0050821; GO:0051015; GO:0051020; GO:0051209; GO:0051764; GO:0060271; GO:0071526; GO:0072659; GO:0090307; GO:0097368; GO:0097440; GO:0098794; GO:0098978; GO:0140297; GO:0140311; GO:1900026; GO:1901381; GO:1902396; GO:1905000; GO:1905031; GO:1990779; GO:2000179; GO:2001046; GO:2001224 actin crosslink formation [GO:0051764]; actin cytoskeleton organization [GO:0030036]; adenylate cyclase-inhibiting dopamine receptor signaling pathway [GO:0007195]; angiogenesis [GO:0001525]; blood coagulation, intrinsic pathway [GO:0007597]; blood vessel remodeling [GO:0001974]; cell-cell junction organization [GO:0045216]; cilium assembly [GO:0060271]; early endosome to late endosome transport [GO:0045022]; epithelial to mesenchymal transition [GO:0001837]; establishment of protein localization [GO:0045184]; establishment of Sertoli cell barrier [GO:0097368]; formation of radial glial scaffolds [GO:0021943]; heart morphogenesis [GO:0003007]; megakaryocyte development [GO:0035855]; mitotic spindle assembly [GO:0090307]; mRNA transcription by RNA polymerase II [GO:0042789]; negative regulation of apoptotic process [GO:0043066]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of neuron projection development [GO:0010977]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of transcription by RNA polymerase I [GO:0016479]; positive regulation of actin filament bundle assembly [GO:0032233]; positive regulation of axon regeneration [GO:0048680]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of neuron migration [GO:2001224]; positive regulation of platelet activation [GO:0010572]; positive regulation of potassium ion transmembrane transport [GO:1901381]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; protein localization to bicellular tight junction [GO:1902396]; protein localization to cell surface [GO:0034394]; protein localization to plasma membrane [GO:0072659]; protein stabilization [GO:0050821]; receptor clustering [GO:0043113]; regulation of actin filament bundle assembly [GO:0032231]; regulation of cell migration [GO:0030334]; regulation of membrane repolarization during atrial cardiac muscle cell action potential [GO:1905000]; regulation of membrane repolarization during cardiac muscle cell action potential [GO:1905031]; release of sequestered calcium ion into cytosol [GO:0051209]; semaphorin-plexin signaling pathway [GO:0071526]; synapse organization [GO:0050808]; wound healing, spreading of cells [GO:0044319] actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; actin filament bundle [GO:0032432]; apical dendrite [GO:0097440]; axonal growth cone [GO:0044295]; brush border [GO:0005903]; cell cortex [GO:0005938]; cell-cell junction [GO:0005911]; cortical cytoskeleton [GO:0030863]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic shaft [GO:0043198]; glutamatergic synapse [GO:0098978]; glycoprotein Ib-IX-V complex [GO:1990779]; growth cone [GO:0030426]; Myb complex [GO:0031523]; neuronal cell body [GO:0043025]; nucleolus [GO:0005730]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; podosome [GO:0002102]; postsynapse [GO:0098794]; trans-Golgi network [GO:0005802]; Z disc [GO:0030018] actin binding [GO:0003779]; actin filament binding [GO:0051015]; DNA-binding transcription factor binding [GO:0140297]; Fc-gamma receptor I complex binding [GO:0034988]; G protein-coupled receptor binding [GO:0001664]; GTPase binding [GO:0051020]; kinase binding [GO:0019900]; potassium channel regulator activity [GO:0015459]; protein homodimerization activity [GO:0042803]; protein kinase C binding [GO:0005080]; protein sequestering activity [GO:0140311]; protein-containing complex binding [GO:0044877]; SMAD binding [GO:0046332]; small GTPase binding [GO:0031267]; transmembrane transporter binding [GO:0044325] g14357.t1 Q8BTM8 27.333 450 2.3300000000000002e-29 130.0 sp|Q8BTM8|FLNA_MOUSE Filamin-A OS=Mus musculus OX=10090 GN=Flna PE=1 SV=5 FLNA_MOUSE reviewed Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Alpha-filamin) (Endothelial actin-binding protein) (Filamin-1) (Non-muscle filamin) Mus musculus (Mouse) GO:0001525; GO:0001664; GO:0001837; GO:0001974; GO:0002102; GO:0003007; GO:0003779; GO:0005080; GO:0005634; GO:0005730; GO:0005737; GO:0005802; GO:0005829; GO:0005884; GO:0005886; GO:0005903; GO:0005911; GO:0005938; GO:0007195; GO:0007597; GO:0010572; GO:0010977; GO:0015459; GO:0015629; GO:0016479; GO:0019900; GO:0021943; GO:0030018; GO:0030036; GO:0030334; GO:0030426; GO:0030863; GO:0031267; GO:0031523; GO:0032231; GO:0032233; GO:0032432; GO:0034394; GO:0034988; GO:0035855; GO:0042177; GO:0042307; GO:0042789; GO:0042803; GO:0043025; GO:0043066; GO:0043113; GO:0043123; GO:0043198; GO:0043204; GO:0043433; GO:0044295; GO:0044319; GO:0044325; GO:0044877; GO:0045022; GO:0045184; GO:0045216; GO:0046332; GO:0048471; GO:0048680; GO:0050808; GO:0050821; GO:0051015; GO:0051020; GO:0051209; GO:0051764; GO:0060271; GO:0071526; GO:0072659; GO:0090307; GO:0097368; GO:0097440; GO:0098794; GO:0098978; GO:0140297; GO:0140311; GO:1900026; GO:1901381; GO:1902396; GO:1905000; GO:1905031; GO:1990779; GO:2000179; GO:2001046; GO:2001224 actin crosslink formation [GO:0051764]; actin cytoskeleton organization [GO:0030036]; adenylate cyclase-inhibiting dopamine receptor signaling pathway [GO:0007195]; angiogenesis [GO:0001525]; blood coagulation, intrinsic pathway [GO:0007597]; blood vessel remodeling [GO:0001974]; cell-cell junction organization [GO:0045216]; cilium assembly [GO:0060271]; early endosome to late endosome transport [GO:0045022]; epithelial to mesenchymal transition [GO:0001837]; establishment of protein localization [GO:0045184]; establishment of Sertoli cell barrier [GO:0097368]; formation of radial glial scaffolds [GO:0021943]; heart morphogenesis [GO:0003007]; megakaryocyte development [GO:0035855]; mitotic spindle assembly [GO:0090307]; mRNA transcription by RNA polymerase II [GO:0042789]; negative regulation of apoptotic process [GO:0043066]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of neuron projection development [GO:0010977]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of transcription by RNA polymerase I [GO:0016479]; positive regulation of actin filament bundle assembly [GO:0032233]; positive regulation of axon regeneration [GO:0048680]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of neuron migration [GO:2001224]; positive regulation of platelet activation [GO:0010572]; positive regulation of potassium ion transmembrane transport [GO:1901381]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; protein localization to bicellular tight junction [GO:1902396]; protein localization to cell surface [GO:0034394]; protein localization to plasma membrane [GO:0072659]; protein stabilization [GO:0050821]; receptor clustering [GO:0043113]; regulation of actin filament bundle assembly [GO:0032231]; regulation of cell migration [GO:0030334]; regulation of membrane repolarization during atrial cardiac muscle cell action potential [GO:1905000]; regulation of membrane repolarization during cardiac muscle cell action potential [GO:1905031]; release of sequestered calcium ion into cytosol [GO:0051209]; semaphorin-plexin signaling pathway [GO:0071526]; synapse organization [GO:0050808]; wound healing, spreading of cells [GO:0044319] actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; actin filament bundle [GO:0032432]; apical dendrite [GO:0097440]; axonal growth cone [GO:0044295]; brush border [GO:0005903]; cell cortex [GO:0005938]; cell-cell junction [GO:0005911]; cortical cytoskeleton [GO:0030863]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic shaft [GO:0043198]; glutamatergic synapse [GO:0098978]; glycoprotein Ib-IX-V complex [GO:1990779]; growth cone [GO:0030426]; Myb complex [GO:0031523]; neuronal cell body [GO:0043025]; nucleolus [GO:0005730]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; podosome [GO:0002102]; postsynapse [GO:0098794]; trans-Golgi network [GO:0005802]; Z disc [GO:0030018] actin binding [GO:0003779]; actin filament binding [GO:0051015]; DNA-binding transcription factor binding [GO:0140297]; Fc-gamma receptor I complex binding [GO:0034988]; G protein-coupled receptor binding [GO:0001664]; GTPase binding [GO:0051020]; kinase binding [GO:0019900]; potassium channel regulator activity [GO:0015459]; protein homodimerization activity [GO:0042803]; protein kinase C binding [GO:0005080]; protein sequestering activity [GO:0140311]; protein-containing complex binding [GO:0044877]; SMAD binding [GO:0046332]; small GTPase binding [GO:0031267]; transmembrane transporter binding [GO:0044325] g14357.t1 Q8BTM8 26.186 527 5.84e-29 129.0 sp|Q8BTM8|FLNA_MOUSE Filamin-A OS=Mus musculus OX=10090 GN=Flna PE=1 SV=5 FLNA_MOUSE reviewed Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Alpha-filamin) (Endothelial actin-binding protein) (Filamin-1) (Non-muscle filamin) Mus musculus (Mouse) GO:0001525; GO:0001664; GO:0001837; GO:0001974; GO:0002102; GO:0003007; GO:0003779; GO:0005080; GO:0005634; GO:0005730; GO:0005737; GO:0005802; GO:0005829; GO:0005884; GO:0005886; GO:0005903; GO:0005911; GO:0005938; GO:0007195; GO:0007597; GO:0010572; GO:0010977; GO:0015459; GO:0015629; GO:0016479; GO:0019900; GO:0021943; GO:0030018; GO:0030036; GO:0030334; GO:0030426; GO:0030863; GO:0031267; GO:0031523; GO:0032231; GO:0032233; GO:0032432; GO:0034394; GO:0034988; GO:0035855; GO:0042177; GO:0042307; GO:0042789; GO:0042803; GO:0043025; GO:0043066; GO:0043113; GO:0043123; GO:0043198; GO:0043204; GO:0043433; GO:0044295; GO:0044319; GO:0044325; GO:0044877; GO:0045022; GO:0045184; GO:0045216; GO:0046332; GO:0048471; GO:0048680; GO:0050808; GO:0050821; GO:0051015; GO:0051020; GO:0051209; GO:0051764; GO:0060271; GO:0071526; GO:0072659; GO:0090307; GO:0097368; GO:0097440; GO:0098794; GO:0098978; GO:0140297; GO:0140311; GO:1900026; GO:1901381; GO:1902396; GO:1905000; GO:1905031; GO:1990779; GO:2000179; GO:2001046; GO:2001224 actin crosslink formation [GO:0051764]; actin cytoskeleton organization [GO:0030036]; adenylate cyclase-inhibiting dopamine receptor signaling pathway [GO:0007195]; angiogenesis [GO:0001525]; blood coagulation, intrinsic pathway [GO:0007597]; blood vessel remodeling [GO:0001974]; cell-cell junction organization [GO:0045216]; cilium assembly [GO:0060271]; early endosome to late endosome transport [GO:0045022]; epithelial to mesenchymal transition [GO:0001837]; establishment of protein localization [GO:0045184]; establishment of Sertoli cell barrier [GO:0097368]; formation of radial glial scaffolds [GO:0021943]; heart morphogenesis [GO:0003007]; megakaryocyte development [GO:0035855]; mitotic spindle assembly [GO:0090307]; mRNA transcription by RNA polymerase II [GO:0042789]; negative regulation of apoptotic process [GO:0043066]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of neuron projection development [GO:0010977]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of transcription by RNA polymerase I [GO:0016479]; positive regulation of actin filament bundle assembly [GO:0032233]; positive regulation of axon regeneration [GO:0048680]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of neuron migration [GO:2001224]; positive regulation of platelet activation [GO:0010572]; positive regulation of potassium ion transmembrane transport [GO:1901381]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; protein localization to bicellular tight junction [GO:1902396]; protein localization to cell surface [GO:0034394]; protein localization to plasma membrane [GO:0072659]; protein stabilization [GO:0050821]; receptor clustering [GO:0043113]; regulation of actin filament bundle assembly [GO:0032231]; regulation of cell migration [GO:0030334]; regulation of membrane repolarization during atrial cardiac muscle cell action potential [GO:1905000]; regulation of membrane repolarization during cardiac muscle cell action potential [GO:1905031]; release of sequestered calcium ion into cytosol [GO:0051209]; semaphorin-plexin signaling pathway [GO:0071526]; synapse organization [GO:0050808]; wound healing, spreading of cells [GO:0044319] actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; actin filament bundle [GO:0032432]; apical dendrite [GO:0097440]; axonal growth cone [GO:0044295]; brush border [GO:0005903]; cell cortex [GO:0005938]; cell-cell junction [GO:0005911]; cortical cytoskeleton [GO:0030863]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic shaft [GO:0043198]; glutamatergic synapse [GO:0098978]; glycoprotein Ib-IX-V complex [GO:1990779]; growth cone [GO:0030426]; Myb complex [GO:0031523]; neuronal cell body [GO:0043025]; nucleolus [GO:0005730]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; podosome [GO:0002102]; postsynapse [GO:0098794]; trans-Golgi network [GO:0005802]; Z disc [GO:0030018] actin binding [GO:0003779]; actin filament binding [GO:0051015]; DNA-binding transcription factor binding [GO:0140297]; Fc-gamma receptor I complex binding [GO:0034988]; G protein-coupled receptor binding [GO:0001664]; GTPase binding [GO:0051020]; kinase binding [GO:0019900]; potassium channel regulator activity [GO:0015459]; protein homodimerization activity [GO:0042803]; protein kinase C binding [GO:0005080]; protein sequestering activity [GO:0140311]; protein-containing complex binding [GO:0044877]; SMAD binding [GO:0046332]; small GTPase binding [GO:0031267]; transmembrane transporter binding [GO:0044325] g14357.t1 Q8BTM8 25.904 498 6.2100000000000006e-27 122.0 sp|Q8BTM8|FLNA_MOUSE Filamin-A OS=Mus musculus OX=10090 GN=Flna PE=1 SV=5 FLNA_MOUSE reviewed Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Alpha-filamin) (Endothelial actin-binding protein) (Filamin-1) (Non-muscle filamin) Mus musculus (Mouse) GO:0001525; GO:0001664; GO:0001837; GO:0001974; GO:0002102; GO:0003007; GO:0003779; GO:0005080; GO:0005634; GO:0005730; GO:0005737; GO:0005802; GO:0005829; GO:0005884; GO:0005886; GO:0005903; GO:0005911; GO:0005938; GO:0007195; GO:0007597; GO:0010572; GO:0010977; GO:0015459; GO:0015629; GO:0016479; GO:0019900; GO:0021943; GO:0030018; GO:0030036; GO:0030334; GO:0030426; GO:0030863; GO:0031267; GO:0031523; GO:0032231; GO:0032233; GO:0032432; GO:0034394; GO:0034988; GO:0035855; GO:0042177; GO:0042307; GO:0042789; GO:0042803; GO:0043025; GO:0043066; GO:0043113; GO:0043123; GO:0043198; GO:0043204; GO:0043433; GO:0044295; GO:0044319; GO:0044325; GO:0044877; GO:0045022; GO:0045184; GO:0045216; GO:0046332; GO:0048471; GO:0048680; GO:0050808; GO:0050821; GO:0051015; GO:0051020; GO:0051209; GO:0051764; GO:0060271; GO:0071526; GO:0072659; GO:0090307; GO:0097368; GO:0097440; GO:0098794; GO:0098978; GO:0140297; GO:0140311; GO:1900026; GO:1901381; GO:1902396; GO:1905000; GO:1905031; GO:1990779; GO:2000179; GO:2001046; GO:2001224 actin crosslink formation [GO:0051764]; actin cytoskeleton organization [GO:0030036]; adenylate cyclase-inhibiting dopamine receptor signaling pathway [GO:0007195]; angiogenesis [GO:0001525]; blood coagulation, intrinsic pathway [GO:0007597]; blood vessel remodeling [GO:0001974]; cell-cell junction organization [GO:0045216]; cilium assembly [GO:0060271]; early endosome to late endosome transport [GO:0045022]; epithelial to mesenchymal transition [GO:0001837]; establishment of protein localization [GO:0045184]; establishment of Sertoli cell barrier [GO:0097368]; formation of radial glial scaffolds [GO:0021943]; heart morphogenesis [GO:0003007]; megakaryocyte development [GO:0035855]; mitotic spindle assembly [GO:0090307]; mRNA transcription by RNA polymerase II [GO:0042789]; negative regulation of apoptotic process [GO:0043066]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of neuron projection development [GO:0010977]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of transcription by RNA polymerase I [GO:0016479]; positive regulation of actin filament bundle assembly [GO:0032233]; positive regulation of axon regeneration [GO:0048680]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of neuron migration [GO:2001224]; positive regulation of platelet activation [GO:0010572]; positive regulation of potassium ion transmembrane transport [GO:1901381]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; protein localization to bicellular tight junction [GO:1902396]; protein localization to cell surface [GO:0034394]; protein localization to plasma membrane [GO:0072659]; protein stabilization [GO:0050821]; receptor clustering [GO:0043113]; regulation of actin filament bundle assembly [GO:0032231]; regulation of cell migration [GO:0030334]; regulation of membrane repolarization during atrial cardiac muscle cell action potential [GO:1905000]; regulation of membrane repolarization during cardiac muscle cell action potential [GO:1905031]; release of sequestered calcium ion into cytosol [GO:0051209]; semaphorin-plexin signaling pathway [GO:0071526]; synapse organization [GO:0050808]; wound healing, spreading of cells [GO:0044319] actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; actin filament bundle [GO:0032432]; apical dendrite [GO:0097440]; axonal growth cone [GO:0044295]; brush border [GO:0005903]; cell cortex [GO:0005938]; cell-cell junction [GO:0005911]; cortical cytoskeleton [GO:0030863]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic shaft [GO:0043198]; glutamatergic synapse [GO:0098978]; glycoprotein Ib-IX-V complex [GO:1990779]; growth cone [GO:0030426]; Myb complex [GO:0031523]; neuronal cell body [GO:0043025]; nucleolus [GO:0005730]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; podosome [GO:0002102]; postsynapse [GO:0098794]; trans-Golgi network [GO:0005802]; Z disc [GO:0030018] actin binding [GO:0003779]; actin filament binding [GO:0051015]; DNA-binding transcription factor binding [GO:0140297]; Fc-gamma receptor I complex binding [GO:0034988]; G protein-coupled receptor binding [GO:0001664]; GTPase binding [GO:0051020]; kinase binding [GO:0019900]; potassium channel regulator activity [GO:0015459]; protein homodimerization activity [GO:0042803]; protein kinase C binding [GO:0005080]; protein sequestering activity [GO:0140311]; protein-containing complex binding [GO:0044877]; SMAD binding [GO:0046332]; small GTPase binding [GO:0031267]; transmembrane transporter binding [GO:0044325] g14357.t1 Q8BTM8 24.396 455 1.68e-26 121.0 sp|Q8BTM8|FLNA_MOUSE Filamin-A OS=Mus musculus OX=10090 GN=Flna PE=1 SV=5 FLNA_MOUSE reviewed Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Alpha-filamin) (Endothelial actin-binding protein) (Filamin-1) (Non-muscle filamin) Mus musculus (Mouse) GO:0001525; GO:0001664; GO:0001837; GO:0001974; GO:0002102; GO:0003007; GO:0003779; GO:0005080; GO:0005634; GO:0005730; GO:0005737; GO:0005802; GO:0005829; GO:0005884; GO:0005886; GO:0005903; GO:0005911; GO:0005938; GO:0007195; GO:0007597; GO:0010572; GO:0010977; GO:0015459; GO:0015629; GO:0016479; GO:0019900; GO:0021943; GO:0030018; GO:0030036; GO:0030334; GO:0030426; GO:0030863; GO:0031267; GO:0031523; GO:0032231; GO:0032233; GO:0032432; GO:0034394; GO:0034988; GO:0035855; GO:0042177; GO:0042307; GO:0042789; GO:0042803; GO:0043025; GO:0043066; GO:0043113; GO:0043123; GO:0043198; GO:0043204; GO:0043433; GO:0044295; GO:0044319; GO:0044325; GO:0044877; GO:0045022; GO:0045184; GO:0045216; GO:0046332; GO:0048471; GO:0048680; GO:0050808; GO:0050821; GO:0051015; GO:0051020; GO:0051209; GO:0051764; GO:0060271; GO:0071526; GO:0072659; GO:0090307; GO:0097368; GO:0097440; GO:0098794; GO:0098978; GO:0140297; GO:0140311; GO:1900026; GO:1901381; GO:1902396; GO:1905000; GO:1905031; GO:1990779; GO:2000179; GO:2001046; GO:2001224 actin crosslink formation [GO:0051764]; actin cytoskeleton organization [GO:0030036]; adenylate cyclase-inhibiting dopamine receptor signaling pathway [GO:0007195]; angiogenesis [GO:0001525]; blood coagulation, intrinsic pathway [GO:0007597]; blood vessel remodeling [GO:0001974]; cell-cell junction organization [GO:0045216]; cilium assembly [GO:0060271]; early endosome to late endosome transport [GO:0045022]; epithelial to mesenchymal transition [GO:0001837]; establishment of protein localization [GO:0045184]; establishment of Sertoli cell barrier [GO:0097368]; formation of radial glial scaffolds [GO:0021943]; heart morphogenesis [GO:0003007]; megakaryocyte development [GO:0035855]; mitotic spindle assembly [GO:0090307]; mRNA transcription by RNA polymerase II [GO:0042789]; negative regulation of apoptotic process [GO:0043066]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of neuron projection development [GO:0010977]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of transcription by RNA polymerase I [GO:0016479]; positive regulation of actin filament bundle assembly [GO:0032233]; positive regulation of axon regeneration [GO:0048680]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of neuron migration [GO:2001224]; positive regulation of platelet activation [GO:0010572]; positive regulation of potassium ion transmembrane transport [GO:1901381]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; protein localization to bicellular tight junction [GO:1902396]; protein localization to cell surface [GO:0034394]; protein localization to plasma membrane [GO:0072659]; protein stabilization [GO:0050821]; receptor clustering [GO:0043113]; regulation of actin filament bundle assembly [GO:0032231]; regulation of cell migration [GO:0030334]; regulation of membrane repolarization during atrial cardiac muscle cell action potential [GO:1905000]; regulation of membrane repolarization during cardiac muscle cell action potential [GO:1905031]; release of sequestered calcium ion into cytosol [GO:0051209]; semaphorin-plexin signaling pathway [GO:0071526]; synapse organization [GO:0050808]; wound healing, spreading of cells [GO:0044319] actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; actin filament bundle [GO:0032432]; apical dendrite [GO:0097440]; axonal growth cone [GO:0044295]; brush border [GO:0005903]; cell cortex [GO:0005938]; cell-cell junction [GO:0005911]; cortical cytoskeleton [GO:0030863]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic shaft [GO:0043198]; glutamatergic synapse [GO:0098978]; glycoprotein Ib-IX-V complex [GO:1990779]; growth cone [GO:0030426]; Myb complex [GO:0031523]; neuronal cell body [GO:0043025]; nucleolus [GO:0005730]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; podosome [GO:0002102]; postsynapse [GO:0098794]; trans-Golgi network [GO:0005802]; Z disc [GO:0030018] actin binding [GO:0003779]; actin filament binding [GO:0051015]; DNA-binding transcription factor binding [GO:0140297]; Fc-gamma receptor I complex binding [GO:0034988]; G protein-coupled receptor binding [GO:0001664]; GTPase binding [GO:0051020]; kinase binding [GO:0019900]; potassium channel regulator activity [GO:0015459]; protein homodimerization activity [GO:0042803]; protein kinase C binding [GO:0005080]; protein sequestering activity [GO:0140311]; protein-containing complex binding [GO:0044877]; SMAD binding [GO:0046332]; small GTPase binding [GO:0031267]; transmembrane transporter binding [GO:0044325] g14357.t1 Q8BTM8 23.651 482 5.889999999999999e-23 109.0 sp|Q8BTM8|FLNA_MOUSE Filamin-A OS=Mus musculus OX=10090 GN=Flna PE=1 SV=5 FLNA_MOUSE reviewed Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Alpha-filamin) (Endothelial actin-binding protein) (Filamin-1) (Non-muscle filamin) Mus musculus (Mouse) GO:0001525; GO:0001664; GO:0001837; GO:0001974; GO:0002102; GO:0003007; GO:0003779; GO:0005080; GO:0005634; GO:0005730; GO:0005737; GO:0005802; GO:0005829; GO:0005884; GO:0005886; GO:0005903; GO:0005911; GO:0005938; GO:0007195; GO:0007597; GO:0010572; GO:0010977; GO:0015459; GO:0015629; GO:0016479; GO:0019900; GO:0021943; GO:0030018; GO:0030036; GO:0030334; GO:0030426; GO:0030863; GO:0031267; GO:0031523; GO:0032231; GO:0032233; GO:0032432; GO:0034394; GO:0034988; GO:0035855; GO:0042177; GO:0042307; GO:0042789; GO:0042803; GO:0043025; GO:0043066; GO:0043113; GO:0043123; GO:0043198; GO:0043204; GO:0043433; GO:0044295; GO:0044319; GO:0044325; GO:0044877; GO:0045022; GO:0045184; GO:0045216; GO:0046332; GO:0048471; GO:0048680; GO:0050808; GO:0050821; GO:0051015; GO:0051020; GO:0051209; GO:0051764; GO:0060271; GO:0071526; GO:0072659; GO:0090307; GO:0097368; GO:0097440; GO:0098794; GO:0098978; GO:0140297; GO:0140311; GO:1900026; GO:1901381; GO:1902396; GO:1905000; GO:1905031; GO:1990779; GO:2000179; GO:2001046; GO:2001224 actin crosslink formation [GO:0051764]; actin cytoskeleton organization [GO:0030036]; adenylate cyclase-inhibiting dopamine receptor signaling pathway [GO:0007195]; angiogenesis [GO:0001525]; blood coagulation, intrinsic pathway [GO:0007597]; blood vessel remodeling [GO:0001974]; cell-cell junction organization [GO:0045216]; cilium assembly [GO:0060271]; early endosome to late endosome transport [GO:0045022]; epithelial to mesenchymal transition [GO:0001837]; establishment of protein localization [GO:0045184]; establishment of Sertoli cell barrier [GO:0097368]; formation of radial glial scaffolds [GO:0021943]; heart morphogenesis [GO:0003007]; megakaryocyte development [GO:0035855]; mitotic spindle assembly [GO:0090307]; mRNA transcription by RNA polymerase II [GO:0042789]; negative regulation of apoptotic process [GO:0043066]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of neuron projection development [GO:0010977]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of transcription by RNA polymerase I [GO:0016479]; positive regulation of actin filament bundle assembly [GO:0032233]; positive regulation of axon regeneration [GO:0048680]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of neuron migration [GO:2001224]; positive regulation of platelet activation [GO:0010572]; positive regulation of potassium ion transmembrane transport [GO:1901381]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; protein localization to bicellular tight junction [GO:1902396]; protein localization to cell surface [GO:0034394]; protein localization to plasma membrane [GO:0072659]; protein stabilization [GO:0050821]; receptor clustering [GO:0043113]; regulation of actin filament bundle assembly [GO:0032231]; regulation of cell migration [GO:0030334]; regulation of membrane repolarization during atrial cardiac muscle cell action potential [GO:1905000]; regulation of membrane repolarization during cardiac muscle cell action potential [GO:1905031]; release of sequestered calcium ion into cytosol [GO:0051209]; semaphorin-plexin signaling pathway [GO:0071526]; synapse organization [GO:0050808]; wound healing, spreading of cells [GO:0044319] actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; actin filament bundle [GO:0032432]; apical dendrite [GO:0097440]; axonal growth cone [GO:0044295]; brush border [GO:0005903]; cell cortex [GO:0005938]; cell-cell junction [GO:0005911]; cortical cytoskeleton [GO:0030863]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic shaft [GO:0043198]; glutamatergic synapse [GO:0098978]; glycoprotein Ib-IX-V complex [GO:1990779]; growth cone [GO:0030426]; Myb complex [GO:0031523]; neuronal cell body [GO:0043025]; nucleolus [GO:0005730]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; podosome [GO:0002102]; postsynapse [GO:0098794]; trans-Golgi network [GO:0005802]; Z disc [GO:0030018] actin binding [GO:0003779]; actin filament binding [GO:0051015]; DNA-binding transcription factor binding [GO:0140297]; Fc-gamma receptor I complex binding [GO:0034988]; G protein-coupled receptor binding [GO:0001664]; GTPase binding [GO:0051020]; kinase binding [GO:0019900]; potassium channel regulator activity [GO:0015459]; protein homodimerization activity [GO:0042803]; protein kinase C binding [GO:0005080]; protein sequestering activity [GO:0140311]; protein-containing complex binding [GO:0044877]; SMAD binding [GO:0046332]; small GTPase binding [GO:0031267]; transmembrane transporter binding [GO:0044325] g14357.t2 Q9VEN1 43.111 225 1.6e-41 170.0 sp|Q9VEN1|FLNA_DROME Filamin-A OS=Drosophila melanogaster OX=7227 GN=cher PE=1 SV=2 FLNA_DROME reviewed Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Filamin-1) (Filamin1) Drosophila melanogaster (Fruit fly) GO:0000278; GO:0003779; GO:0005829; GO:0005886; GO:0007301; GO:0007616; GO:0008045; GO:0008104; GO:0008302; GO:0008340; GO:0015629; GO:0030018; GO:0030708; GO:0030725; GO:0035182; GO:0035183; GO:0035204; GO:0035324; GO:0045179; GO:0045214; GO:0048149; GO:0051015; GO:0051495; GO:0051764; GO:0110069 actin crosslink formation [GO:0051764]; behavioral response to ethanol [GO:0048149]; determination of adult lifespan [GO:0008340]; female germline ring canal formation [GO:0007301]; female germline ring canal formation, actin assembly [GO:0008302]; germarium-derived female germ-line cyst encapsulation [GO:0030708]; germline ring canal formation [GO:0030725]; intracellular protein localization [GO:0008104]; long-term memory [GO:0007616]; mitotic cell cycle [GO:0000278]; motor neuron axon guidance [GO:0008045]; negative regulation of lamellocyte differentiation [GO:0035204]; positive regulation of cytoskeleton organization [GO:0051495]; sarcomere organization [GO:0045214]; syncytial embryo cellularization [GO:0110069] actin cytoskeleton [GO:0015629]; apical cortex [GO:0045179]; cytosol [GO:0005829]; female germline ring canal [GO:0035324]; female germline ring canal inner rim [GO:0035183]; female germline ring canal outer rim [GO:0035182]; plasma membrane [GO:0005886]; Z disc [GO:0030018] actin binding [GO:0003779]; actin filament binding [GO:0051015] g14357.t2 Q9VEN1 28.529 333 4.08e-27 123.0 sp|Q9VEN1|FLNA_DROME Filamin-A OS=Drosophila melanogaster OX=7227 GN=cher PE=1 SV=2 FLNA_DROME reviewed Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Filamin-1) (Filamin1) Drosophila melanogaster (Fruit fly) GO:0000278; GO:0003779; GO:0005829; GO:0005886; GO:0007301; GO:0007616; GO:0008045; GO:0008104; GO:0008302; GO:0008340; GO:0015629; GO:0030018; GO:0030708; GO:0030725; GO:0035182; GO:0035183; GO:0035204; GO:0035324; GO:0045179; GO:0045214; GO:0048149; GO:0051015; GO:0051495; GO:0051764; GO:0110069 actin crosslink formation [GO:0051764]; behavioral response to ethanol [GO:0048149]; determination of adult lifespan [GO:0008340]; female germline ring canal formation [GO:0007301]; female germline ring canal formation, actin assembly [GO:0008302]; germarium-derived female germ-line cyst encapsulation [GO:0030708]; germline ring canal formation [GO:0030725]; intracellular protein localization [GO:0008104]; long-term memory [GO:0007616]; mitotic cell cycle [GO:0000278]; motor neuron axon guidance [GO:0008045]; negative regulation of lamellocyte differentiation [GO:0035204]; positive regulation of cytoskeleton organization [GO:0051495]; sarcomere organization [GO:0045214]; syncytial embryo cellularization [GO:0110069] actin cytoskeleton [GO:0015629]; apical cortex [GO:0045179]; cytosol [GO:0005829]; female germline ring canal [GO:0035324]; female germline ring canal inner rim [GO:0035183]; female germline ring canal outer rim [GO:0035182]; plasma membrane [GO:0005886]; Z disc [GO:0030018] actin binding [GO:0003779]; actin filament binding [GO:0051015] g14358.t1 Q9VEN1 38.583 127 5.53e-23 97.4 sp|Q9VEN1|FLNA_DROME Filamin-A OS=Drosophila melanogaster OX=7227 GN=cher PE=1 SV=2 FLNA_DROME reviewed Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Filamin-1) (Filamin1) Drosophila melanogaster (Fruit fly) GO:0000278; GO:0003779; GO:0005829; GO:0005886; GO:0007301; GO:0007616; GO:0008045; GO:0008104; GO:0008302; GO:0008340; GO:0015629; GO:0030018; GO:0030708; GO:0030725; GO:0035182; GO:0035183; GO:0035204; GO:0035324; GO:0045179; GO:0045214; GO:0048149; GO:0051015; GO:0051495; GO:0051764; GO:0110069 actin crosslink formation [GO:0051764]; behavioral response to ethanol [GO:0048149]; determination of adult lifespan [GO:0008340]; female germline ring canal formation [GO:0007301]; female germline ring canal formation, actin assembly [GO:0008302]; germarium-derived female germ-line cyst encapsulation [GO:0030708]; germline ring canal formation [GO:0030725]; intracellular protein localization [GO:0008104]; long-term memory [GO:0007616]; mitotic cell cycle [GO:0000278]; motor neuron axon guidance [GO:0008045]; negative regulation of lamellocyte differentiation [GO:0035204]; positive regulation of cytoskeleton organization [GO:0051495]; sarcomere organization [GO:0045214]; syncytial embryo cellularization [GO:0110069] actin cytoskeleton [GO:0015629]; apical cortex [GO:0045179]; cytosol [GO:0005829]; female germline ring canal [GO:0035324]; female germline ring canal inner rim [GO:0035183]; female germline ring canal outer rim [GO:0035182]; plasma membrane [GO:0005886]; Z disc [GO:0030018] actin binding [GO:0003779]; actin filament binding [GO:0051015] g14358.t1 Q9VEN1 41.085 129 6.09e-22 94.4 sp|Q9VEN1|FLNA_DROME Filamin-A OS=Drosophila melanogaster OX=7227 GN=cher PE=1 SV=2 FLNA_DROME reviewed Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Filamin-1) (Filamin1) Drosophila melanogaster (Fruit fly) GO:0000278; GO:0003779; GO:0005829; GO:0005886; GO:0007301; GO:0007616; GO:0008045; GO:0008104; GO:0008302; GO:0008340; GO:0015629; GO:0030018; GO:0030708; GO:0030725; GO:0035182; GO:0035183; GO:0035204; GO:0035324; GO:0045179; GO:0045214; GO:0048149; GO:0051015; GO:0051495; GO:0051764; GO:0110069 actin crosslink formation [GO:0051764]; behavioral response to ethanol [GO:0048149]; determination of adult lifespan [GO:0008340]; female germline ring canal formation [GO:0007301]; female germline ring canal formation, actin assembly [GO:0008302]; germarium-derived female germ-line cyst encapsulation [GO:0030708]; germline ring canal formation [GO:0030725]; intracellular protein localization [GO:0008104]; long-term memory [GO:0007616]; mitotic cell cycle [GO:0000278]; motor neuron axon guidance [GO:0008045]; negative regulation of lamellocyte differentiation [GO:0035204]; positive regulation of cytoskeleton organization [GO:0051495]; sarcomere organization [GO:0045214]; syncytial embryo cellularization [GO:0110069] actin cytoskeleton [GO:0015629]; apical cortex [GO:0045179]; cytosol [GO:0005829]; female germline ring canal [GO:0035324]; female germline ring canal inner rim [GO:0035183]; female germline ring canal outer rim [GO:0035182]; plasma membrane [GO:0005886]; Z disc [GO:0030018] actin binding [GO:0003779]; actin filament binding [GO:0051015] g14359.t1 Q17LW0 55.786 1011 0.0 994.0 sp|Q17LW0|MYO7A_AEDAE Myosin-VIIa OS=Aedes aegypti OX=7159 GN=ck PE=3 SV=1 MYO7A_AEDAE reviewed Myosin-VIIa (Protein crinkled) Aedes aegypti (Yellowfever mosquito) (Culex aegypti) GO:0000146; GO:0003779; GO:0005524; GO:0005737; GO:0005902; GO:0007605; GO:0008407; GO:0016461; GO:0030048; GO:0032027; GO:0035317; GO:0045177; GO:0048800; GO:0071944 actin filament-based movement [GO:0030048]; antennal morphogenesis [GO:0048800]; chaeta morphogenesis [GO:0008407]; imaginal disc-derived wing hair organization [GO:0035317]; sensory perception of sound [GO:0007605] apical part of cell [GO:0045177]; cell periphery [GO:0071944]; cytoplasm [GO:0005737]; microvillus [GO:0005902]; unconventional myosin complex [GO:0016461] actin binding [GO:0003779]; ATP binding [GO:0005524]; microfilament motor activity [GO:0000146]; myosin light chain binding [GO:0032027] g14359.t2 Q17LW0 60.926 1533 0.0 1758.0 sp|Q17LW0|MYO7A_AEDAE Myosin-VIIa OS=Aedes aegypti OX=7159 GN=ck PE=3 SV=1 MYO7A_AEDAE reviewed Myosin-VIIa (Protein crinkled) Aedes aegypti (Yellowfever mosquito) (Culex aegypti) GO:0000146; GO:0003779; GO:0005524; GO:0005737; GO:0005902; GO:0007605; GO:0008407; GO:0016461; GO:0030048; GO:0032027; GO:0035317; GO:0045177; GO:0048800; GO:0071944 actin filament-based movement [GO:0030048]; antennal morphogenesis [GO:0048800]; chaeta morphogenesis [GO:0008407]; imaginal disc-derived wing hair organization [GO:0035317]; sensory perception of sound [GO:0007605] apical part of cell [GO:0045177]; cell periphery [GO:0071944]; cytoplasm [GO:0005737]; microvillus [GO:0005902]; unconventional myosin complex [GO:0016461] actin binding [GO:0003779]; ATP binding [GO:0005524]; microfilament motor activity [GO:0000146]; myosin light chain binding [GO:0032027] g14360.t1 P97479 64.456 588 0.0 808.0 sp|P97479|MYO7A_MOUSE Unconventional myosin-VIIa OS=Mus musculus OX=10090 GN=Myo7a PE=1 SV=2 MYO7A_MOUSE reviewed Unconventional myosin-VIIa Mus musculus (Mouse) GO:0000146; GO:0001750; GO:0001845; GO:0001917; GO:0003774; GO:0003779; GO:0005516; GO:0005524; GO:0005737; GO:0005765; GO:0005829; GO:0005902; GO:0005938; GO:0006886; GO:0006897; GO:0006909; GO:0007015; GO:0007040; GO:0007423; GO:0007600; GO:0007601; GO:0007605; GO:0008104; GO:0015629; GO:0016020; GO:0016324; GO:0016459; GO:0019904; GO:0030030; GO:0030048; GO:0030507; GO:0031477; GO:0032391; GO:0032420; GO:0042470; GO:0042472; GO:0042490; GO:0042491; GO:0042802; GO:0043531; GO:0044877; GO:0045202; GO:0048839; GO:0050953; GO:0050957; GO:0051015; GO:0051875; GO:0051904; GO:0060088; GO:0060113; GO:0060122; GO:0090102; GO:0120044; GO:1990435 actin filament organization [GO:0007015]; actin filament-based movement [GO:0030048]; auditory receptor cell stereocilium organization [GO:0060088]; cell projection organization [GO:0030030]; cochlea development [GO:0090102]; endocytosis [GO:0006897]; equilibrioception [GO:0050957]; inner ear auditory receptor cell differentiation [GO:0042491]; inner ear development [GO:0048839]; inner ear morphogenesis [GO:0042472]; inner ear receptor cell differentiation [GO:0060113]; inner ear receptor cell stereocilium organization [GO:0060122]; intracellular protein localization [GO:0008104]; intracellular protein transport [GO:0006886]; lysosome organization [GO:0007040]; mechanoreceptor differentiation [GO:0042490]; phagocytosis [GO:0006909]; phagolysosome assembly [GO:0001845]; pigment granule localization [GO:0051875]; pigment granule transport [GO:0051904]; sensory organ development [GO:0007423]; sensory perception [GO:0007600]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601] actin cytoskeleton [GO:0015629]; apical plasma membrane [GO:0016324]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; lysosomal membrane [GO:0005765]; melanosome [GO:0042470]; membrane [GO:0016020]; microvillus [GO:0005902]; myosin complex [GO:0016459]; myosin VII complex [GO:0031477]; photoreceptor connecting cilium [GO:0032391]; photoreceptor inner segment [GO:0001917]; photoreceptor outer segment [GO:0001750]; stereocilium [GO:0032420]; stereocilium base [GO:0120044]; synapse [GO:0045202]; upper tip-link density [GO:1990435] actin binding [GO:0003779]; actin filament binding [GO:0051015]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; cytoskeletal motor activity [GO:0003774]; identical protein binding [GO:0042802]; microfilament motor activity [GO:0000146]; protein domain specific binding [GO:0019904]; protein-containing complex binding [GO:0044877]; spectrin binding [GO:0030507] g14361.t1 Q16594 61.719 128 7.609999999999999e-61 195.0 sp|Q16594|TAF9_HUMAN Transcription initiation factor TFIID subunit 9 OS=Homo sapiens OX=9606 GN=TAF9 PE=1 SV=1 TAF9_HUMAN reviewed Transcription initiation factor TFIID subunit 9 (RNA polymerase II TBP-associated factor subunit G) (STAF31/32) (Transcription initiation factor TFIID 31 kDa subunit) (TAFII-31) (TAFII31) (Transcription initiation factor TFIID 32 kDa subunit) (TAFII-32) (TAFII32) Homo sapiens (Human) GO:0000124; GO:0000492; GO:0000976; GO:0002039; GO:0003677; GO:0003713; GO:0005634; GO:0005654; GO:0005669; GO:0006282; GO:0006338; GO:0006355; GO:0006357; GO:0006974; GO:0016251; GO:0032435; GO:0033276; GO:0042789; GO:0043066; GO:0043484; GO:0045893; GO:0045944; GO:0046982; GO:0050821; GO:0051117; GO:0051123; GO:0060261; GO:0060760; GO:0070555; GO:0070742; GO:0070761; GO:0071339; GO:0140297; GO:1902166 box C/D snoRNP assembly [GO:0000492]; chromatin remodeling [GO:0006338]; DNA damage response [GO:0006974]; mRNA transcription by RNA polymerase II [GO:0042789]; negative regulation of apoptotic process [GO:0043066]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:1902166]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of response to cytokine stimulus [GO:0060760]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription initiation by RNA polymerase II [GO:0060261]; protein stabilization [GO:0050821]; regulation of DNA repair [GO:0006282]; regulation of DNA-templated transcription [GO:0006355]; regulation of RNA splicing [GO:0043484]; regulation of transcription by RNA polymerase II [GO:0006357]; response to interleukin-1 [GO:0070555]; RNA polymerase II preinitiation complex assembly [GO:0051123] MLL1 complex [GO:0071339]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pre-snoRNP complex [GO:0070761]; SAGA complex [GO:0000124]; transcription factor TFIID complex [GO:0005669]; transcription factor TFTC complex [GO:0033276] ATPase binding [GO:0051117]; C2H2 zinc finger domain binding [GO:0070742]; DNA binding [GO:0003677]; DNA-binding transcription factor binding [GO:0140297]; p53 binding [GO:0002039]; protein heterodimerization activity [GO:0046982]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; transcription cis-regulatory region binding [GO:0000976]; transcription coactivator activity [GO:0003713] g14362.t1 Q9EP97 38.462 208 6.79e-36 147.0 sp|Q9EP97|SENP3_MOUSE Sentrin-specific protease 3 OS=Mus musculus OX=10090 GN=Senp3 PE=1 SV=1 SENP3_MOUSE reviewed Sentrin-specific protease 3 (EC 3.4.22.-) (SUMO-1-specific protease 3) (Sentrin/SUMO-specific protease SENP3) (Smt3-specific isopeptidase 1) (Smt3ip1) Mus musculus (Mouse) GO:0004843; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006508; GO:0008234; GO:0016604; GO:0016926; GO:0016929; GO:0071339; GO:2000042 negative regulation of double-strand break repair via homologous recombination [GO:2000042]; protein desumoylation [GO:0016926]; proteolysis [GO:0006508] cytoplasm [GO:0005737]; MLL1 complex [GO:0071339]; nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cysteine-type deubiquitinase activity [GO:0004843]; cysteine-type peptidase activity [GO:0008234]; deSUMOylase activity [GO:0016929] g14363.t1 Q6GPF3 78.609 762 0.0 1233.0 sp|Q6GPF3|CUL3B_XENLA Cullin-3-B OS=Xenopus laevis OX=8355 GN=cul3b PE=1 SV=1 CUL3B_XENLA reviewed Cullin-3-B (CUL-3-B) Xenopus laevis (African clawed frog) GO:0000209; GO:0000922; GO:0005634; GO:0005737; GO:0005813; GO:0005827; GO:0006513; GO:0006888; GO:0006915; GO:0006950; GO:0007080; GO:0007229; GO:0010468; GO:0016477; GO:0016567; GO:0017145; GO:0031463; GO:0031625; GO:0035024; GO:0040016; GO:0043149; GO:0043161; GO:0045842; GO:0048208; GO:0072686; GO:0080090; GO:1901992 apoptotic process [GO:0006915]; cell migration [GO:0016477]; COPII vesicle coating [GO:0048208]; embryonic cleavage [GO:0040016]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; integrin-mediated signaling pathway [GO:0007229]; mitotic metaphase chromosome alignment [GO:0007080]; negative regulation of Rho protein signal transduction [GO:0035024]; positive regulation of mitotic cell cycle phase transition [GO:1901992]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of gene expression [GO:0010468]; regulation of primary metabolic process [GO:0080090]; response to stress [GO:0006950]; stem cell division [GO:0017145]; stress fiber assembly [GO:0043149] centrosome [GO:0005813]; Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]; polar microtubule [GO:0005827]; spindle pole [GO:0000922] ubiquitin protein ligase binding [GO:0031625] g14365.t1 B4F6W9 62.873 905 0.0 1182.0 sp|B4F6W9|TRIPC_XENTR E3 ubiquitin-protein ligase TRIP12 OS=Xenopus tropicalis OX=8364 GN=trip12 PE=2 SV=1 TRIPC_XENTR reviewed E3 ubiquitin-protein ligase TRIP12 (EC 2.3.2.26) (HECT-type E3 ubiquitin transferase TRIP12) (Thyroid receptor-interacting protein 12) (TR-interacting protein 12) (TRIP-12) Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0000209; GO:0005654; GO:0006281; GO:0006511; GO:0008270; GO:0033696; GO:0045995; GO:0061630; GO:0140861 DNA repair [GO:0006281]; DNA repair-dependent chromatin remodeling [GO:0140861]; heterochromatin boundary formation [GO:0033696]; protein polyubiquitination [GO:0000209]; regulation of embryonic development [GO:0045995]; ubiquitin-dependent protein catabolic process [GO:0006511] nucleoplasm [GO:0005654] ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] g14365.t1 B4F6W9 67.711 734 0.0 922.0 sp|B4F6W9|TRIPC_XENTR E3 ubiquitin-protein ligase TRIP12 OS=Xenopus tropicalis OX=8364 GN=trip12 PE=2 SV=1 TRIPC_XENTR reviewed E3 ubiquitin-protein ligase TRIP12 (EC 2.3.2.26) (HECT-type E3 ubiquitin transferase TRIP12) (Thyroid receptor-interacting protein 12) (TR-interacting protein 12) (TRIP-12) Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0000209; GO:0005654; GO:0006281; GO:0006511; GO:0008270; GO:0033696; GO:0045995; GO:0061630; GO:0140861 DNA repair [GO:0006281]; DNA repair-dependent chromatin remodeling [GO:0140861]; heterochromatin boundary formation [GO:0033696]; protein polyubiquitination [GO:0000209]; regulation of embryonic development [GO:0045995]; ubiquitin-dependent protein catabolic process [GO:0006511] nucleoplasm [GO:0005654] ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] g14366.t1 Q8VDR7 55.49 337 3.84e-139 402.0 sp|Q8VDR7|TGDS_MOUSE dTDP-D-glucose 4,6-dehydratase OS=Mus musculus OX=10090 GN=Tgds PE=2 SV=2 TGDS_MOUSE reviewed UDP-D-glucose 4,6-dehydratase (EC 4.2.1.76) (dTDP-D-glucose 4,6-dehydratase) Mus musculus (Mouse) GO:0005783; GO:0005794; GO:0006024; GO:0008460; GO:0009225; GO:0050377 glycosaminoglycan biosynthetic process [GO:0006024]; nucleotide-sugar metabolic process [GO:0009225] endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794] dTDP-glucose 4,6-dehydratase activity [GO:0008460]; UDP-glucose 4,6-dehydratase activity [GO:0050377] g14368.t1 Q9NR80 53.591 362 1.5200000000000002e-116 389.0 sp|Q9NR80|ARHG4_HUMAN Rho guanine nucleotide exchange factor 4 OS=Homo sapiens OX=9606 GN=ARHGEF4 PE=1 SV=3 ARHG4_HUMAN reviewed Rho guanine nucleotide exchange factor 4 (APC-stimulated guanine nucleotide exchange factor 1) (Asef) (Asef1) Homo sapiens (Human) GO:0005085; GO:0005829; GO:0019904; GO:0030032; GO:0032587; GO:0035556; GO:0046847; GO:0051056 filopodium assembly [GO:0046847]; intracellular signal transduction [GO:0035556]; lamellipodium assembly [GO:0030032]; regulation of small GTPase mediated signal transduction [GO:0051056] cytosol [GO:0005829]; ruffle membrane [GO:0032587] guanyl-nucleotide exchange factor activity [GO:0005085]; protein domain specific binding [GO:0019904] g14368.t2 Q9NR80 53.591 362 2.46e-116 389.0 sp|Q9NR80|ARHG4_HUMAN Rho guanine nucleotide exchange factor 4 OS=Homo sapiens OX=9606 GN=ARHGEF4 PE=1 SV=3 ARHG4_HUMAN reviewed Rho guanine nucleotide exchange factor 4 (APC-stimulated guanine nucleotide exchange factor 1) (Asef) (Asef1) Homo sapiens (Human) GO:0005085; GO:0005829; GO:0019904; GO:0030032; GO:0032587; GO:0035556; GO:0046847; GO:0051056 filopodium assembly [GO:0046847]; intracellular signal transduction [GO:0035556]; lamellipodium assembly [GO:0030032]; regulation of small GTPase mediated signal transduction [GO:0051056] cytosol [GO:0005829]; ruffle membrane [GO:0032587] guanyl-nucleotide exchange factor activity [GO:0005085]; protein domain specific binding [GO:0019904] g14371.t1 Q91857 56.107 524 0.0 560.0 sp|Q91857|TAF6_XENLA Transcription initiation factor TFIID subunit 6 OS=Xenopus laevis OX=8355 GN=taf6 PE=2 SV=3 g14372.t1 Q4VCS5 39.706 272 4.03e-38 158.0 sp|Q4VCS5|AMOT_HUMAN Angiomotin OS=Homo sapiens OX=9606 GN=AMOT PE=1 SV=1 AMOT_HUMAN reviewed Angiomotin Homo sapiens (Human) GO:0000122; GO:0001525; GO:0001570; GO:0001701; GO:0001702; GO:0001725; GO:0001726; GO:0003365; GO:0005737; GO:0005829; GO:0005884; GO:0005886; GO:0005923; GO:0006935; GO:0007043; GO:0008104; GO:0009897; GO:0009986; GO:0014069; GO:0016020; GO:0016525; GO:0030027; GO:0030036; GO:0030139; GO:0030334; GO:0031410; GO:0035329; GO:0038023; GO:0040019; GO:0042074; GO:0043116; GO:0043532; GO:0043534; GO:0043536; GO:0045793; GO:0051056; GO:0051496; GO:0098978; GO:1905274 actin cytoskeleton organization [GO:0030036]; angiogenesis [GO:0001525]; blood vessel endothelial cell migration [GO:0043534]; cell migration involved in gastrulation [GO:0042074]; cell-cell junction assembly [GO:0007043]; chemotaxis [GO:0006935]; establishment of cell polarity involved in ameboidal cell migration [GO:0003365]; gastrulation with mouth forming second [GO:0001702]; hippo signaling [GO:0035329]; in utero embryonic development [GO:0001701]; intracellular protein localization [GO:0008104]; negative regulation of angiogenesis [GO:0016525]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of vascular permeability [GO:0043116]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of cell size [GO:0045793]; positive regulation of embryonic development [GO:0040019]; positive regulation of stress fiber assembly [GO:0051496]; regulation of cell migration [GO:0030334]; regulation of modification of postsynaptic actin cytoskeleton [GO:1905274]; regulation of small GTPase mediated signal transduction [GO:0051056]; vasculogenesis [GO:0001570] actin filament [GO:0005884]; bicellular tight junction [GO:0005923]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; external side of plasma membrane [GO:0009897]; glutamatergic synapse [GO:0098978]; lamellipodium [GO:0030027]; membrane [GO:0016020]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; ruffle [GO:0001726]; stress fiber [GO:0001725] angiostatin binding [GO:0043532]; signaling receptor activity [GO:0038023] g14373.t1 F4HYF3 41.019 373 3.08e-88 276.0 sp|F4HYF3|DCYD1_ARATH Bifunctional D-cysteine desulfhydrase/1-aminocyclopropane-1-carboxylate deaminase, mitochondrial OS=Arabidopsis thaliana OX=3702 GN=DCD PE=1 SV=1 DCYD1_ARATH reviewed Bifunctional D-cysteine desulfhydrase/1-aminocyclopropane-1-carboxylate deaminase, mitochondrial (EC 3.5.99.7) (EC 4.4.1.15) (1-aminocyclopropane-1-carboxylic acid deaminase 1) (AtACD1) (AtD-CDes1) (D-CDes1) (D-CDES) Arabidopsis thaliana (Mouse-ear cress) GO:0005634; GO:0005739; GO:0005829; GO:0009507; GO:0009693; GO:0016787; GO:0019148; GO:0019447; GO:0050897; GO:1990170 D-cysteine catabolic process [GO:0019447]; ethylene biosynthetic process [GO:0009693]; stress response to cadmium ion [GO:1990170] chloroplast [GO:0009507]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634] cobalt ion binding [GO:0050897]; D-cysteine desulfhydrase activity [GO:0019148]; hydrolase activity [GO:0016787] g14374.t1 Q6ZHE5 44.66 206 8.74e-38 138.0 sp|Q6ZHE5|DCYD1_ORYSJ D-cysteine desulfhydrase 1, mitochondrial OS=Oryza sativa subsp. japonica OX=39947 GN=DCD1 PE=1 SV=2 DCYD1_ORYSJ reviewed D-cysteine desulfhydrase 1, mitochondrial (OsDCD1) (EC 4.4.1.15) (OsD-CDes1) (D-CDes1) Oryza sativa subsp. japonica (Rice) GO:0005739; GO:0019148; GO:0042802; GO:0042803 mitochondrion [GO:0005739] D-cysteine desulfhydrase activity [GO:0019148]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803] g14375.t1 F4HYF3 49.425 87 1.2199999999999999e-24 99.0 sp|F4HYF3|DCYD1_ARATH Bifunctional D-cysteine desulfhydrase/1-aminocyclopropane-1-carboxylate deaminase, mitochondrial OS=Arabidopsis thaliana OX=3702 GN=DCD PE=1 SV=1 DCYD1_ARATH reviewed Bifunctional D-cysteine desulfhydrase/1-aminocyclopropane-1-carboxylate deaminase, mitochondrial (EC 3.5.99.7) (EC 4.4.1.15) (1-aminocyclopropane-1-carboxylic acid deaminase 1) (AtACD1) (AtD-CDes1) (D-CDes1) (D-CDES) Arabidopsis thaliana (Mouse-ear cress) GO:0005634; GO:0005739; GO:0005829; GO:0009507; GO:0009693; GO:0016787; GO:0019148; GO:0019447; GO:0050897; GO:1990170 D-cysteine catabolic process [GO:0019447]; ethylene biosynthetic process [GO:0009693]; stress response to cadmium ion [GO:1990170] chloroplast [GO:0009507]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634] cobalt ion binding [GO:0050897]; D-cysteine desulfhydrase activity [GO:0019148]; hydrolase activity [GO:0016787] g14376.t1 Q6NUB2 66.234 231 5.99e-53 173.0 sp|Q6NUB2|CW15A_XENLA Protein CWC15 homolog A OS=Xenopus laevis OX=8355 GN=cwc15-a PE=2 SV=1 g14377.t1 Q54U75 23.934 305 3.4e-26 111.0 sp|Q54U75|CRLA_DICDI Cyclic AMP receptor-like protein A OS=Dictyostelium discoideum OX=44689 GN=crlA PE=2 SV=1 CRLA_DICDI reviewed Cyclic AMP receptor-like protein A Dictyostelium discoideum (Social amoeba) GO:0001646; GO:0004930; GO:0005886; GO:0007165; GO:0007189; GO:0030308; GO:0030435 adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; negative regulation of cell growth [GO:0030308]; signal transduction [GO:0007165]; sporulation resulting in formation of a cellular spore [GO:0030435] plasma membrane [GO:0005886] cAMP receptor activity [GO:0001646]; G protein-coupled receptor activity [GO:0004930] g14378.t1 Q1T769 33.155 187 1.74e-25 102.0 sp|Q1T769|MIS12_CHICK Protein MIS12 homolog OS=Gallus gallus OX=9031 GN=MIS12 PE=2 SV=1 g14381.t1 Q8NFT8 32.53 415 1.13e-59 211.0 sp|Q8NFT8|DNER_HUMAN Delta and Notch-like epidermal growth factor-related receptor OS=Homo sapiens OX=9606 GN=DNER PE=1 SV=1 DNER_HUMAN reviewed Delta and Notch-like epidermal growth factor-related receptor Homo sapiens (Human) GO:0001764; GO:0004888; GO:0005112; GO:0005509; GO:0005769; GO:0005886; GO:0006897; GO:0007219; GO:0007220; GO:0007416; GO:0007417; GO:0010001; GO:0030276; GO:0030425; GO:0043025; GO:0048741 central nervous system development [GO:0007417]; endocytosis [GO:0006897]; glial cell differentiation [GO:0010001]; neuron migration [GO:0001764]; Notch receptor processing [GO:0007220]; Notch signaling pathway [GO:0007219]; skeletal muscle fiber development [GO:0048741]; synapse assembly [GO:0007416] dendrite [GO:0030425]; early endosome [GO:0005769]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; clathrin binding [GO:0030276]; Notch binding [GO:0005112]; transmembrane signaling receptor activity [GO:0004888] g14381.t1 Q8NFT8 40.65 246 9.77e-47 176.0 sp|Q8NFT8|DNER_HUMAN Delta and Notch-like epidermal growth factor-related receptor OS=Homo sapiens OX=9606 GN=DNER PE=1 SV=1 DNER_HUMAN reviewed Delta and Notch-like epidermal growth factor-related receptor Homo sapiens (Human) GO:0001764; GO:0004888; GO:0005112; GO:0005509; GO:0005769; GO:0005886; GO:0006897; GO:0007219; GO:0007220; GO:0007416; GO:0007417; GO:0010001; GO:0030276; GO:0030425; GO:0043025; GO:0048741 central nervous system development [GO:0007417]; endocytosis [GO:0006897]; glial cell differentiation [GO:0010001]; neuron migration [GO:0001764]; Notch receptor processing [GO:0007220]; Notch signaling pathway [GO:0007219]; skeletal muscle fiber development [GO:0048741]; synapse assembly [GO:0007416] dendrite [GO:0030425]; early endosome [GO:0005769]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; clathrin binding [GO:0030276]; Notch binding [GO:0005112]; transmembrane signaling receptor activity [GO:0004888] g14382.t1 B0BNE5 68.327 281 8.68e-151 427.0 sp|B0BNE5|ESTD_RAT S-formylglutathione hydrolase OS=Rattus norvegicus OX=10116 GN=Esd PE=2 SV=1 ESTD_RAT reviewed S-formylglutathione hydrolase (FGH) (EC 3.1.2.12) (Esterase D) Rattus norvegicus (Rat) GO:0005829; GO:0016788; GO:0018738; GO:0031410; GO:0042802; GO:0046294; GO:0052689 formaldehyde catabolic process [GO:0046294] cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829] carboxylic ester hydrolase activity [GO:0052689]; hydrolase activity, acting on ester bonds [GO:0016788]; identical protein binding [GO:0042802]; S-formylglutathione hydrolase activity [GO:0018738] g14384.t1 P05165 61.657 712 0.0 899.0 sp|P05165|PCCA_HUMAN Propionyl-CoA carboxylase alpha chain, mitochondrial OS=Homo sapiens OX=9606 GN=PCCA PE=1 SV=4 PCCA_HUMAN reviewed Propionyl-CoA carboxylase alpha chain, mitochondrial (PCCase subunit alpha) (EC 6.4.1.3) (Propanoyl-CoA:carbon dioxide ligase subunit alpha) Homo sapiens (Human) GO:0004658; GO:0005524; GO:0005739; GO:0005759; GO:0005829; GO:0006631; GO:0009081; GO:0009374; GO:0019626; GO:0019899; GO:0046872; GO:1902494 branched-chain amino acid metabolic process [GO:0009081]; fatty acid metabolic process [GO:0006631]; short-chain fatty acid catabolic process [GO:0019626] catalytic complex [GO:1902494]; cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] ATP binding [GO:0005524]; biotin binding [GO:0009374]; enzyme binding [GO:0019899]; metal ion binding [GO:0046872]; propionyl-CoA carboxylase activity [GO:0004658] g14385.t1 Q93008 69.167 2400 0.0 3260.0 sp|Q93008|USP9X_HUMAN Ubiquitin carboxyl-terminal hydrolase 9X OS=Homo sapiens OX=9606 GN=USP9X PE=1 SV=4 USP9X_HUMAN reviewed Ubiquitin carboxyl-terminal hydrolase 9X (EC 3.4.19.12) (Deubiquitinating enzyme FAF-X) (Fat facets in mammals) (hFAM) (Fat facets protein-related, X-linked) (Ubiquitin thioesterase FAF-X) (Ubiquitin-specific protease 9, X chromosome) (Ubiquitin-specific-processing protease FAF-X) Homo sapiens (Human) GO:0000122; GO:0001764; GO:0004197; GO:0004843; GO:0005634; GO:0005737; GO:0005813; GO:0005829; GO:0005929; GO:0005930; GO:0006307; GO:0007059; GO:0007179; GO:0007292; GO:0008104; GO:0008234; GO:0016020; GO:0016477; GO:0016562; GO:0016567; GO:0016579; GO:0030426; GO:0030509; GO:0031647; GO:0032092; GO:0032435; GO:0035520; GO:0042752; GO:0048511; GO:0048675; GO:0050821; GO:0051301; GO:0060271; GO:0061578; GO:0061824; GO:0070410; GO:0070536; GO:0071947; GO:0101005; GO:0140313; GO:0180017; GO:1904515; GO:1990000; GO:1990380 amyloid fibril formation [GO:1990000]; axon extension [GO:0048675]; BMP signaling pathway [GO:0030509]; cell division [GO:0051301]; cell migration [GO:0016477]; chromosome segregation [GO:0007059]; cilium assembly [GO:0060271]; cytosolic ciliogenesis [GO:0061824]; DNA alkylation repair [GO:0006307]; female gamete generation [GO:0007292]; intracellular protein localization [GO:0008104]; monoubiquitinated protein deubiquitination [GO:0035520]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron migration [GO:0001764]; positive regulation of protein binding [GO:0032092]; positive regulation of TORC2 signaling [GO:1904515]; protein deubiquitination [GO:0016579]; protein deubiquitination involved in ubiquitin-dependent protein catabolic process [GO:0071947]; protein import into peroxisome matrix, receptor recycling [GO:0016562]; protein K63-linked deubiquitination [GO:0070536]; protein stabilization [GO:0050821]; protein ubiquitination [GO:0016567]; regulation of circadian rhythm [GO:0042752]; regulation of protein stability [GO:0031647]; rhythmic process [GO:0048511]; transforming growth factor beta receptor signaling pathway [GO:0007179] axoneme [GO:0005930]; centrosome [GO:0005813]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; growth cone [GO:0030426]; membrane [GO:0016020]; nucleus [GO:0005634] co-SMAD binding [GO:0070410]; cysteine-type deubiquitinase activity [GO:0004843]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]; deubiquitinase activity [GO:0101005]; K11-linked deubiquitinase activity [GO:0180017]; K48-linked deubiquitinase activity [GO:1990380]; K63-linked deubiquitinase activity [GO:0061578]; molecular sequestering activity [GO:0140313] g14388.t1 Q02338 40.816 196 4.97e-49 166.0 sp|Q02338|BDH_HUMAN D-beta-hydroxybutyrate dehydrogenase, mitochondrial OS=Homo sapiens OX=9606 GN=BDH1 PE=1 SV=3 g14389.t1 Q96J65 31.673 281 1.3e-34 137.0 sp|Q96J65|MRP9_HUMAN ATP-binding cassette sub-family C member 12 OS=Homo sapiens OX=9606 GN=ABCC12 PE=1 SV=3 g14390.t1 Q9R1X5 44.742 1122 0.0 881.0 sp|Q9R1X5|MRP5_MOUSE ATP-binding cassette sub-family C member 5 OS=Mus musculus OX=10090 GN=Abcc5 PE=1 SV=2 MRP5_MOUSE reviewed ATP-binding cassette sub-family C member 5 (EC 7.6.2.-) (EC 7.6.2.2) (Multi-specific organic anion transporter C) (MOAT-C) (Multidrug resistance-associated protein 5) (SMRP) Mus musculus (Mouse) GO:0005524; GO:0005796; GO:0005886; GO:0008559; GO:0010008; GO:0015216; GO:0015232; GO:0015562; GO:0015865; GO:0016020; GO:0016323; GO:0016324; GO:0016887; GO:0030213; GO:0034634; GO:0034775; GO:0035351; GO:0042908; GO:0042910; GO:0048471; GO:0055085; GO:0070730; GO:0070731; GO:0098838; GO:0140115; GO:0140359 cAMP transport [GO:0070730]; cGMP transport [GO:0070731]; export across plasma membrane [GO:0140115]; folate transmembrane transport [GO:0098838]; glutathione transmembrane transport [GO:0034775]; heme transmembrane transport [GO:0035351]; hyaluronan biosynthetic process [GO:0030213]; purine nucleotide transport [GO:0015865]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908] apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; endosome membrane [GO:0010008]; Golgi lumen [GO:0005796]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886] ABC-type transporter activity [GO:0140359]; ABC-type xenobiotic transporter activity [GO:0008559]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; efflux transmembrane transporter activity [GO:0015562]; glutathione transmembrane transporter activity [GO:0034634]; heme transmembrane transporter activity [GO:0015232]; purine nucleotide transmembrane transporter activity [GO:0015216]; xenobiotic transmembrane transporter activity [GO:0042910] g14390.t2 Q9R1X5 47.042 1065 0.0 920.0 sp|Q9R1X5|MRP5_MOUSE ATP-binding cassette sub-family C member 5 OS=Mus musculus OX=10090 GN=Abcc5 PE=1 SV=2 MRP5_MOUSE reviewed ATP-binding cassette sub-family C member 5 (EC 7.6.2.-) (EC 7.6.2.2) (Multi-specific organic anion transporter C) (MOAT-C) (Multidrug resistance-associated protein 5) (SMRP) Mus musculus (Mouse) GO:0005524; GO:0005796; GO:0005886; GO:0008559; GO:0010008; GO:0015216; GO:0015232; GO:0015562; GO:0015865; GO:0016020; GO:0016323; GO:0016324; GO:0016887; GO:0030213; GO:0034634; GO:0034775; GO:0035351; GO:0042908; GO:0042910; GO:0048471; GO:0055085; GO:0070730; GO:0070731; GO:0098838; GO:0140115; GO:0140359 cAMP transport [GO:0070730]; cGMP transport [GO:0070731]; export across plasma membrane [GO:0140115]; folate transmembrane transport [GO:0098838]; glutathione transmembrane transport [GO:0034775]; heme transmembrane transport [GO:0035351]; hyaluronan biosynthetic process [GO:0030213]; purine nucleotide transport [GO:0015865]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908] apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; endosome membrane [GO:0010008]; Golgi lumen [GO:0005796]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886] ABC-type transporter activity [GO:0140359]; ABC-type xenobiotic transporter activity [GO:0008559]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; efflux transmembrane transporter activity [GO:0015562]; glutathione transmembrane transporter activity [GO:0034634]; heme transmembrane transporter activity [GO:0015232]; purine nucleotide transmembrane transporter activity [GO:0015216]; xenobiotic transmembrane transporter activity [GO:0042910] g14393.t1 P56377 83.439 157 2.2299999999999998e-95 275.0 sp|P56377|AP1S2_HUMAN AP-1 complex subunit sigma-2 OS=Homo sapiens OX=9606 GN=AP1S2 PE=1 SV=1 AP1S2_HUMAN reviewed AP-1 complex subunit sigma-2 (Adaptor protein complex AP-1 subunit sigma-1B) (Adaptor-related protein complex 1 subunit sigma-1B) (Clathrin assembly protein complex 1 sigma-1B small chain) (Golgi adaptor HA1/AP1 adaptin sigma-1B subunit) (Sigma 1B subunit of AP-1 clathrin) (Sigma-adaptin 1B) (Sigma1B-adaptin) Homo sapiens (Human) GO:0000139; GO:0005765; GO:0005769; GO:0005794; GO:0005829; GO:0005905; GO:0006886; GO:0016192; GO:0030119; GO:0030121; GO:0030659; GO:0032588; GO:0035615; GO:0060155; GO:1903232 intracellular protein transport [GO:0006886]; melanosome assembly [GO:1903232]; platelet dense granule organization [GO:0060155]; vesicle-mediated transport [GO:0016192] AP-1 adaptor complex [GO:0030121]; AP-type membrane coat adaptor complex [GO:0030119]; clathrin-coated pit [GO:0005905]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; early endosome [GO:0005769]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; lysosomal membrane [GO:0005765]; trans-Golgi network membrane [GO:0032588] clathrin adaptor activity [GO:0035615] g14395.t1 P55863 54.849 299 2.33e-78 244.0 sp|P55863|SOX3A_XENLA Transcription factor Sox-3-A OS=Xenopus laevis OX=8355 GN=sox3-a PE=1 SV=1 g14396.t1 Q04892 69.014 142 3.87e-46 157.0 sp|Q04892|SOX14_MOUSE Transcription factor SOX-14 OS=Mus musculus OX=10090 GN=Sox14 PE=2 SV=2 SOX14_MOUSE reviewed Transcription factor SOX-14 Mus musculus (Mouse) GO:0000122; GO:0000978; GO:0000981; GO:0001228; GO:0003682; GO:0005634; GO:0005667; GO:0007420; GO:0007601; GO:0009649; GO:0030182; GO:0043565; GO:0045892; GO:0045944; GO:1990837; GO:2001222 brain development [GO:0007420]; entrainment of circadian clock [GO:0009649]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron differentiation [GO:0030182]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of neuron migration [GO:2001222]; visual perception [GO:0007601] nucleus [GO:0005634]; transcription regulator complex [GO:0005667] chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837] g14398.t1 Q0V9R4 53.539 777 0.0 778.0 sp|Q0V9R4|CCD39_XENTR Coiled-coil domain-containing protein 39 OS=Xenopus tropicalis OX=8364 GN=ccdc39 PE=2 SV=1 g14400.t1 O35344 70.793 517 0.0 723.0 sp|O35344|IMA4_MOUSE Importin subunit alpha-4 OS=Mus musculus OX=10090 GN=Kpna3 PE=1 SV=1 g14404.t1 Q32TF8 55.989 743 0.0 862.0 sp|Q32TF8|EFHC2_DANRE EF-hand domain-containing family member C2 OS=Danio rerio OX=7955 GN=efhc2 PE=2 SV=2 g14407.t1 Q9VCA2 36.585 451 1.3200000000000001e-77 256.0 sp|Q9VCA2|ORCT_DROME Organic cation transporter protein OS=Drosophila melanogaster OX=7227 GN=Orct PE=1 SV=1 g14409.t1 O70497 41.35 237 1.09e-51 177.0 sp|O70497|FCN2_MOUSE Ficolin-2 OS=Mus musculus OX=10090 GN=Fcn2 PE=2 SV=2 g14411.t1 Q8SQC1 37.531 405 9.889999999999999e-89 285.0 sp|Q8SQC1|SCRB1_PIG Scavenger receptor class B member 1 OS=Sus scrofa OX=9823 GN=SCARB1 PE=2 SV=1 g14412.t1 P81908 46.207 580 0.0 533.0 sp|P81908|CHLE_HORSE Cholinesterase OS=Equus caballus OX=9796 GN=BCHE PE=1 SV=1 g14414.t1 Q28J82 42.857 364 4.04e-108 323.0 sp|Q28J82|W11B2_XENTR Protein Wnt-11b-2 OS=Xenopus tropicalis OX=8364 GN=wnt11b-2 PE=2 SV=1 W11B2_XENTR reviewed Protein Wnt-11b-2 Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0005109; GO:0005125; GO:0005576; GO:0005615; GO:0007369; GO:0030182; GO:0045165; GO:0060070 canonical Wnt signaling pathway [GO:0060070]; cell fate commitment [GO:0045165]; gastrulation [GO:0007369]; neuron differentiation [GO:0030182] extracellular region [GO:0005576]; extracellular space [GO:0005615] cytokine activity [GO:0005125]; frizzled binding [GO:0005109] g14415.t1 Q9BXA6 42.966 263 4.79e-64 209.0 sp|Q9BXA6|TSSK6_HUMAN Testis-specific serine/threonine-protein kinase 6 OS=Homo sapiens OX=9606 GN=TSSK6 PE=1 SV=1 g14416.t1 Q8K245 39.224 464 1.99e-97 312.0 sp|Q8K245|UVRAG_MOUSE UV radiation resistance-associated protein OS=Mus musculus OX=10090 GN=Uvrag PE=1 SV=2 UVRAG_MOUSE reviewed UV radiation resistance-associated protein Mus musculus (Mouse) GO:0000149; GO:0000323; GO:0000421; GO:0000775; GO:0005764; GO:0005768; GO:0005769; GO:0005770; GO:0005783; GO:0005813; GO:0006281; GO:0006890; GO:0006914; GO:0007051; GO:0007059; GO:0007098; GO:0010506; GO:0017124; GO:0030496; GO:0032465; GO:0032801; GO:0032991; GO:0035032; GO:0035493; GO:0036092; GO:0045335; GO:0046718; GO:0051684; GO:0070418; GO:0097352; GO:0097680 autophagosome maturation [GO:0097352]; autophagy [GO:0006914]; centrosome cycle [GO:0007098]; chromosome segregation [GO:0007059]; DNA repair [GO:0006281]; double-strand break repair via classical nonhomologous end joining [GO:0097680]; maintenance of Golgi location [GO:0051684]; phosphatidylinositol-3-phosphate biosynthetic process [GO:0036092]; receptor catabolic process [GO:0032801]; regulation of autophagy [GO:0010506]; regulation of cytokinesis [GO:0032465]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; SNARE complex assembly [GO:0035493]; spindle organization [GO:0007051]; symbiont entry into host cell [GO:0046718] autophagosome membrane [GO:0000421]; centrosome [GO:0005813]; chromosome, centromeric region [GO:0000775]; DNA-dependent protein kinase complex [GO:0070418]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; late endosome [GO:0005770]; lysosome [GO:0005764]; lytic vacuole [GO:0000323]; midbody [GO:0030496]; phagocytic vesicle [GO:0045335]; phosphatidylinositol 3-kinase complex, class III [GO:0035032]; protein-containing complex [GO:0032991] SH3 domain binding [GO:0017124]; SNARE binding [GO:0000149] g14418.t1 Q5XGI5 65.789 304 3.61e-151 429.0 sp|Q5XGI5|WDR83_XENTR WD repeat domain-containing protein 83 OS=Xenopus tropicalis OX=8364 GN=wdr83 PE=2 SV=1 g14422.t1 Q96P53 58.145 399 0.0 524.0 sp|Q96P53|WDFY2_HUMAN WD repeat and FYVE domain-containing protein 2 OS=Homo sapiens OX=9606 GN=WDFY2 PE=1 SV=2 WDFY2_HUMAN reviewed WD repeat and FYVE domain-containing protein 2 (Propeller-FYVE protein) (Prof) (WD40- and FYVE domain-containing protein 2) (Zinc finger FYVE domain-containing protein 22) Homo sapiens (Human) GO:0001934; GO:0005769; GO:0008270; GO:0031982; GO:0045600 positive regulation of fat cell differentiation [GO:0045600]; positive regulation of protein phosphorylation [GO:0001934] early endosome [GO:0005769]; vesicle [GO:0031982] zinc ion binding [GO:0008270] g14423.t1 Q8VEL0 51.185 211 2.5700000000000003e-64 201.0 sp|Q8VEL0|MSPD1_MOUSE Motile sperm domain-containing protein 1 OS=Mus musculus OX=10090 GN=Mospd1 PE=1 SV=1 MSPD1_MOUSE reviewed Motile sperm domain-containing protein 1 Mus musculus (Mouse) GO:0000122; GO:0000139; GO:0005634; GO:0005737; GO:0005789; GO:0030154; GO:0045944; GO:0048471 cell differentiation [GO:0030154]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944] cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471] g14424.t1 Q8WTR4 33.792 509 5.11e-86 281.0 sp|Q8WTR4|GDPD5_HUMAN Glycerophosphodiester phosphodiesterase domain-containing protein 5 OS=Homo sapiens OX=9606 GN=GDPD5 PE=1 SV=2 GDPD5_HUMAN reviewed Glycerophosphodiester phosphodiesterase domain-containing protein 5 (Glycerophosphocholine phosphodiesterase GDPD5) (EC 3.1.4.2) (Glycerophosphodiester phosphodiesterase 2) (Phosphoinositide phospholipase C GDPD5) (EC 3.1.4.11) Homo sapiens (Human) GO:0004435; GO:0005886; GO:0006629; GO:0007399; GO:0008889; GO:0012505; GO:0030426; GO:0045666; GO:0047389; GO:0048471 lipid metabolic process [GO:0006629]; nervous system development [GO:0007399]; positive regulation of neuron differentiation [GO:0045666] endomembrane system [GO:0012505]; growth cone [GO:0030426]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886] glycerophosphocholine phosphodiesterase activity [GO:0047389]; glycerophosphodiester phosphodiesterase activity [GO:0008889]; phosphatidylinositol-4,5-bisphosphate phospholipase C activity [GO:0004435] g14425.t1 O08726 26.22 328 1.0099999999999999e-23 104.0 sp|O08726|GALR2_RAT Galanin receptor type 2 OS=Rattus norvegicus OX=10116 GN=Galr2 PE=2 SV=1 g14426.t1 Q9CX98 36.34 388 6.51e-66 223.0 sp|Q9CX98|CP2U1_MOUSE Cytochrome P450 2U1 OS=Mus musculus OX=10090 GN=Cyp2u1 PE=2 SV=2 CP2U1_MOUSE reviewed Cytochrome P450 2U1 (Long-chain fatty acid omega-monooxygenase) (EC 1.14.14.80) Mus musculus (Mouse) GO:0005506; GO:0005737; GO:0005743; GO:0005789; GO:0006082; GO:0006805; GO:0008202; GO:0008395; GO:0016712; GO:0020037; GO:0052869; GO:0097267; GO:0102033 omega-hydroxylase P450 pathway [GO:0097267]; organic acid metabolic process [GO:0006082]; steroid metabolic process [GO:0008202]; xenobiotic metabolic process [GO:0006805] cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; mitochondrial inner membrane [GO:0005743] arachidonate omega-hydroxylase activity [GO:0052869]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; long-chain fatty acid omega-hydroxylase activity [GO:0102033]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; steroid hydroxylase activity [GO:0008395] g14428.t1 P12938 45.148 237 7.529999999999999e-55 186.0 sp|P12938|CP2D3_RAT Cytochrome P450 2D3 OS=Rattus norvegicus OX=10116 GN=Cyp2d3 PE=2 SV=2 g14435.t1 Q5SDA5 40.807 1066 0.0 706.0 sp|Q5SDA5|GUC2F_MOUSE Retinal guanylyl cyclase 2 OS=Mus musculus OX=10090 GN=Gucy2f PE=1 SV=1 GUC2F_MOUSE reviewed Retinal guanylyl cyclase 2 (EC 4.6.1.2) (Guanylate cyclase 2F) Mus musculus (Mouse) GO:0001653; GO:0004383; GO:0004672; GO:0005524; GO:0005525; GO:0005886; GO:0006182; GO:0007168; GO:0019934; GO:0042802; GO:0044877; GO:0050908; GO:0120200 cGMP biosynthetic process [GO:0006182]; cGMP-mediated signaling [GO:0019934]; detection of light stimulus involved in visual perception [GO:0050908]; receptor guanylyl cyclase signaling pathway [GO:0007168] plasma membrane [GO:0005886]; rod photoreceptor outer segment [GO:0120200] ATP binding [GO:0005524]; GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; identical protein binding [GO:0042802]; peptide receptor activity [GO:0001653]; protein kinase activity [GO:0004672]; protein-containing complex binding [GO:0044877] g14440.t1 Q7SZS2 50.575 348 8.26e-133 385.0 sp|Q7SZS2|PTER_XENLA N-acetyltaurine hydrolase OS=Xenopus laevis OX=8355 GN=pter PE=2 SV=1 g14443.t1 Q12719 31.157 536 1.8400000000000002e-57 206.0 sp|Q12719|LAC4_TRAVE Laccase-4 OS=Trametes versicolor OX=5325 GN=LCC4 PE=3 SV=1 g14444.t1 Q6WN34 32.832 399 3.1399999999999995e-61 209.0 sp|Q6WN34|CRDL2_HUMAN Chordin-like protein 2 OS=Homo sapiens OX=9606 GN=CHRDL2 PE=1 SV=1 CRDL2_HUMAN reviewed Chordin-like protein 2 (Breast tumor novel factor 1) (BNF-1) (Chordin-related protein 2) Homo sapiens (Human) GO:0001503; GO:0005615; GO:0005737; GO:0030154; GO:0030514; GO:0036122; GO:0051216 cartilage development [GO:0051216]; cell differentiation [GO:0030154]; negative regulation of BMP signaling pathway [GO:0030514]; ossification [GO:0001503] cytoplasm [GO:0005737]; extracellular space [GO:0005615] BMP binding [GO:0036122] g14445.t1 Q5ZK28 41.748 206 9.49e-43 160.0 sp|Q5ZK28|DPOD3_CHICK DNA polymerase delta subunit 3 OS=Gallus gallus OX=9031 GN=POLD3 PE=1 SV=2 DPOD3_CHICK reviewed DNA polymerase delta subunit 3 (DNA polymerase delta subunit p66) Gallus gallus (Chicken) GO:0005654; GO:0005737; GO:0006260; GO:0006281; GO:0043625; GO:0071897 DNA biosynthetic process [GO:0071897]; DNA repair [GO:0006281]; DNA replication [GO:0006260] cytoplasm [GO:0005737]; delta DNA polymerase complex [GO:0043625]; nucleoplasm [GO:0005654] g14446.t1 A4K526 51.887 106 5.850000000000001e-31 109.0 sp|A4K526|TM256_BUFGR Transmembrane protein 256 homolog OS=Bufo gargarizans OX=30331 PE=3 SV=1 g14447.t1 Q9Y388 70.213 141 7.05e-69 220.0 sp|Q9Y388|RBMX2_HUMAN RNA-binding motif protein, X-linked 2 OS=Homo sapiens OX=9606 GN=RBMX2 PE=1 SV=2 RBMX2_HUMAN reviewed RNA-binding motif protein, X-linked 2 Homo sapiens (Human) GO:0000398; GO:0003723; GO:0005634; GO:0005654; GO:0005681; GO:0005686; GO:0005730; GO:0005783; GO:0031965; GO:0071005; GO:0071011; GO:1903241 mRNA splicing, via spliceosome [GO:0000398]; U2-type prespliceosome assembly [GO:1903241] endoplasmic reticulum [GO:0005783]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; spliceosomal complex [GO:0005681]; U2 snRNP [GO:0005686]; U2-type precatalytic spliceosome [GO:0071005] RNA binding [GO:0003723] g14449.t1 Q6C4G1 40.331 181 3.5699999999999997e-23 93.6 sp|Q6C4G1|TCTP_YARLI Translationally-controlled tumor protein homolog OS=Yarrowia lipolytica (strain CLIB 122 / E 150) OX=284591 GN=YALI0E27071g PE=3 SV=1 g14450.t1 Q5T200 41.358 162 2.96e-26 122.0 sp|Q5T200|ZC3HD_HUMAN Zinc finger CCCH domain-containing protein 13 OS=Homo sapiens OX=9606 GN=ZC3H13 PE=1 SV=1 ZC3HD_HUMAN reviewed Zinc finger CCCH domain-containing protein 13 Homo sapiens (Human) GO:0003723; GO:0005634; GO:0005654; GO:0006397; GO:0008270; GO:0008380; GO:0016607; GO:0036396; GO:2000036 mRNA processing [GO:0006397]; regulation of stem cell population maintenance [GO:2000036]; RNA splicing [GO:0008380] nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA N6-methyladenosine methyltransferase complex [GO:0036396] RNA binding [GO:0003723]; zinc ion binding [GO:0008270] g14451.t1 Q2TA45 71.171 111 3.41e-49 185.0 sp|Q2TA45|AGFG1_BOVIN Arf-GAP domain and FG repeat-containing protein 1 OS=Bos taurus OX=9913 GN=AGFG1 PE=2 SV=1 AGFG1_BOVIN reviewed Arf-GAP domain and FG repeat-containing protein 1 (HIV-1 Rev-binding protein homolog) (Nucleoporin-like protein RIP) Bos taurus (Bovine) GO:0001675; GO:0003677; GO:0005096; GO:0005634; GO:0005737; GO:0007289; GO:0008270; GO:0031410; GO:0045109 acrosome assembly [GO:0001675]; intermediate filament organization [GO:0045109]; spermatid nucleus differentiation [GO:0007289] cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; nucleus [GO:0005634] DNA binding [GO:0003677]; GTPase activator activity [GO:0005096]; zinc ion binding [GO:0008270] g14452.t1 Q8BUZ3 29.032 372 1.18e-55 203.0 sp|Q8BUZ3|TIGD4_MOUSE Tigger transposable element-derived protein 4 OS=Mus musculus OX=10090 GN=Tigd4 PE=2 SV=1 g14456.t1 Q09426 29.485 485 3.15e-59 208.0 sp|Q09426|CGT_RAT 2-hydroxyacylsphingosine 1-beta-galactosyltransferase OS=Rattus norvegicus OX=10116 GN=Ugt8 PE=1 SV=1 CGT_RAT reviewed 2-hydroxyacylsphingosine 1-beta-galactosyltransferase (EC 2.4.1.47) (Ceramide UDP-galactosyltransferase) (CGalT) (Cerebroside synthase) (UDP-galactose-ceramide galactosyltransferase) Rattus norvegicus (Rat) GO:0002175; GO:0003851; GO:0005783; GO:0006682; GO:0006688; GO:0007010; GO:0008489; GO:0016020; GO:0030913; GO:0035902; GO:0042552; GO:0048812 cytoskeleton organization [GO:0007010]; galactosylceramide biosynthetic process [GO:0006682]; glycosphingolipid biosynthetic process [GO:0006688]; myelination [GO:0042552]; neuron projection morphogenesis [GO:0048812]; paranodal junction assembly [GO:0030913]; protein localization to paranode region of axon [GO:0002175]; response to immobilization stress [GO:0035902] endoplasmic reticulum [GO:0005783]; membrane [GO:0016020] N-acylsphingosine galactosyltransferase activity [GO:0003851]; UDP-galactose:glucosylceramide beta-1,4-galactosyltransferase activity [GO:0008489] g14458.t1 Q9VCA2 33.81 559 1.45e-89 290.0 sp|Q9VCA2|ORCT_DROME Organic cation transporter protein OS=Drosophila melanogaster OX=7227 GN=Orct PE=1 SV=1 g14459.t1 Q9WTW5 27.66 564 3.6300000000000003e-47 176.0 sp|Q9WTW5|S22A3_MOUSE Solute carrier family 22 member 3 OS=Mus musculus OX=10090 GN=Slc22a3 PE=1 SV=1 S22A3_MOUSE reviewed Solute carrier family 22 member 3 (Organic cation transporter 3) (OCT3) Mus musculus (Mouse) GO:0005326; GO:0005330; GO:0005640; GO:0005886; GO:0006836; GO:0006837; GO:0008504; GO:0008514; GO:0012505; GO:0015101; GO:0015606; GO:0015651; GO:0015695; GO:0015697; GO:0015711; GO:0015718; GO:0015844; GO:0015848; GO:0015850; GO:0015872; GO:0015874; GO:0016323; GO:0016324; GO:0019534; GO:0022857; GO:0031966; GO:0032098; GO:0042908; GO:0043025; GO:0048241; GO:0051608; GO:0051610; GO:0051615; GO:0051620; GO:0051625; GO:0090494; GO:0098793; GO:1990748 cellular detoxification [GO:1990748]; dopamine transport [GO:0015872]; dopamine uptake [GO:0090494]; epinephrine transport [GO:0048241]; epinephrine uptake [GO:0051625]; histamine transport [GO:0051608]; histamine uptake [GO:0051615]; monoamine transport [GO:0015844]; monocarboxylic acid transport [GO:0015718]; neurotransmitter transport [GO:0006836]; norepinephrine transport [GO:0015874]; norepinephrine uptake [GO:0051620]; organic anion transport [GO:0015711]; organic cation transport [GO:0015695]; organic hydroxy compound transport [GO:0015850]; quaternary ammonium group transport [GO:0015697]; regulation of appetite [GO:0032098]; serotonin transport [GO:0006837]; serotonin uptake [GO:0051610]; spermidine transport [GO:0015848]; xenobiotic transport [GO:0042908] apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; endomembrane system [GO:0012505]; mitochondrial membrane [GO:0031966]; neuronal cell body [GO:0043025]; nuclear outer membrane [GO:0005640]; plasma membrane [GO:0005886]; presynapse [GO:0098793] dopamine:sodium symporter activity [GO:0005330]; monoamine transmembrane transporter activity [GO:0008504]; neurotransmitter transmembrane transporter activity [GO:0005326]; organic anion transmembrane transporter activity [GO:0008514]; organic cation transmembrane transporter activity [GO:0015101]; quaternary ammonium group transmembrane transporter activity [GO:0015651]; spermidine transmembrane transporter activity [GO:0015606]; toxin transmembrane transporter activity [GO:0019534]; transmembrane transporter activity [GO:0022857] g14460.t1 Q9VCA2 30.0 550 2.53e-63 219.0 sp|Q9VCA2|ORCT_DROME Organic cation transporter protein OS=Drosophila melanogaster OX=7227 GN=Orct PE=1 SV=1 g14461.t1 D2YVK5 34.868 152 3.69e-22 89.7 sp|D2YVK5|LECM_NOTSC C-type lectin mannose-binding isoform OS=Notechis scutatus scutatus OX=70142 PE=2 SV=1 g14462.t1 D2YVH7 34.591 159 1.67e-23 93.6 sp|D2YVH7|LECM_OXYSU C-type lectin mannose-binding isoform OS=Oxyuranus scutellatus OX=8668 PE=1 SV=1 g14463.t1 O95470 50.203 492 0.0 521.0 sp|O95470|SGPL1_HUMAN Sphingosine-1-phosphate lyase 1 OS=Homo sapiens OX=9606 GN=SGPL1 PE=1 SV=3 SGPL1_HUMAN reviewed Sphingosine-1-phosphate lyase 1 (S1PL) (SP-lyase 1) (SPL 1) (hSPL) (EC 4.1.2.27) (Sphingosine-1-phosphate aldolase) Homo sapiens (Human) GO:0001553; GO:0001570; GO:0001822; GO:0005783; GO:0005789; GO:0006631; GO:0006672; GO:0007283; GO:0008117; GO:0008209; GO:0008210; GO:0009791; GO:0010761; GO:0030097; GO:0030149; GO:0030170; GO:0033327; GO:0040014; GO:0048008; GO:0048705; GO:0060021; GO:0060325; GO:0097190 androgen metabolic process [GO:0008209]; apoptotic signaling pathway [GO:0097190]; ceramide metabolic process [GO:0006672]; estrogen metabolic process [GO:0008210]; face morphogenesis [GO:0060325]; fatty acid metabolic process [GO:0006631]; fibroblast migration [GO:0010761]; hemopoiesis [GO:0030097]; kidney development [GO:0001822]; Leydig cell differentiation [GO:0033327]; luteinization [GO:0001553]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; post-embryonic development [GO:0009791]; regulation of multicellular organism growth [GO:0040014]; roof of mouth development [GO:0060021]; skeletal system morphogenesis [GO:0048705]; spermatogenesis [GO:0007283]; sphingolipid catabolic process [GO:0030149]; vasculogenesis [GO:0001570] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789] pyridoxal phosphate binding [GO:0030170]; sphinganine-1-phosphate aldolase activity [GO:0008117] g14463.t2 O95470 47.593 540 0.0 535.0 sp|O95470|SGPL1_HUMAN Sphingosine-1-phosphate lyase 1 OS=Homo sapiens OX=9606 GN=SGPL1 PE=1 SV=3 SGPL1_HUMAN reviewed Sphingosine-1-phosphate lyase 1 (S1PL) (SP-lyase 1) (SPL 1) (hSPL) (EC 4.1.2.27) (Sphingosine-1-phosphate aldolase) Homo sapiens (Human) GO:0001553; GO:0001570; GO:0001822; GO:0005783; GO:0005789; GO:0006631; GO:0006672; GO:0007283; GO:0008117; GO:0008209; GO:0008210; GO:0009791; GO:0010761; GO:0030097; GO:0030149; GO:0030170; GO:0033327; GO:0040014; GO:0048008; GO:0048705; GO:0060021; GO:0060325; GO:0097190 androgen metabolic process [GO:0008209]; apoptotic signaling pathway [GO:0097190]; ceramide metabolic process [GO:0006672]; estrogen metabolic process [GO:0008210]; face morphogenesis [GO:0060325]; fatty acid metabolic process [GO:0006631]; fibroblast migration [GO:0010761]; hemopoiesis [GO:0030097]; kidney development [GO:0001822]; Leydig cell differentiation [GO:0033327]; luteinization [GO:0001553]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; post-embryonic development [GO:0009791]; regulation of multicellular organism growth [GO:0040014]; roof of mouth development [GO:0060021]; skeletal system morphogenesis [GO:0048705]; spermatogenesis [GO:0007283]; sphingolipid catabolic process [GO:0030149]; vasculogenesis [GO:0001570] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789] pyridoxal phosphate binding [GO:0030170]; sphinganine-1-phosphate aldolase activity [GO:0008117] g14465.t1 Q8VI56 34.251 908 9.87e-143 498.0 sp|Q8VI56|LRP4_MOUSE Low-density lipoprotein receptor-related protein 4 OS=Mus musculus OX=10090 GN=Lrp4 PE=1 SV=3 LRP4_MOUSE reviewed Low-density lipoprotein receptor-related protein 4 (LRP-4) (LDLR dan) Mus musculus (Mouse) GO:0001822; GO:0001942; GO:0005509; GO:0005886; GO:0006897; GO:0007167; GO:0008104; GO:0009953; GO:0009954; GO:0009986; GO:0014069; GO:0015026; GO:0016055; GO:0030279; GO:0030326; GO:0030425; GO:0030971; GO:0031594; GO:0034185; GO:0035022; GO:0042475; GO:0042733; GO:0042803; GO:0043025; GO:0043113; GO:0044853; GO:0045202; GO:0048699; GO:0048813; GO:0050771; GO:0050808; GO:0051124; GO:0060173; GO:0071340; GO:0090090; GO:0097060; GO:0097104; GO:0097105; GO:0097110; GO:0150052; GO:0150094; GO:1901631; GO:1904395 amyloid-beta clearance by cellular catabolic process [GO:0150094]; dendrite morphogenesis [GO:0048813]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; embryonic limb morphogenesis [GO:0030326]; endocytosis [GO:0006897]; enzyme-linked receptor protein signaling pathway [GO:0007167]; generation of neurons [GO:0048699]; hair follicle development [GO:0001942]; intracellular protein localization [GO:0008104]; kidney development [GO:0001822]; limb development [GO:0060173]; negative regulation of axonogenesis [GO:0050771]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of ossification [GO:0030279]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of presynaptic membrane organization [GO:1901631]; positive regulation of Rac protein signal transduction [GO:0035022]; positive regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904395]; postsynaptic membrane assembly [GO:0097104]; presynaptic membrane assembly [GO:0097105]; proximal/distal pattern formation [GO:0009954]; receptor clustering [GO:0043113]; regulation of postsynapse assembly [GO:0150052]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; synapse organization [GO:0050808]; synaptic assembly at neuromuscular junction [GO:0051124]; Wnt signaling pathway [GO:0016055] cell surface [GO:0009986]; dendrite [GO:0030425]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic density [GO:0014069]; synapse [GO:0045202]; synaptic membrane [GO:0097060] apolipoprotein binding [GO:0034185]; calcium ion binding [GO:0005509]; coreceptor activity [GO:0015026]; protein homodimerization activity [GO:0042803]; receptor tyrosine kinase binding [GO:0030971]; scaffold protein binding [GO:0097110] g14465.t1 Q8VI56 32.034 949 1.13e-130 461.0 sp|Q8VI56|LRP4_MOUSE Low-density lipoprotein receptor-related protein 4 OS=Mus musculus OX=10090 GN=Lrp4 PE=1 SV=3 LRP4_MOUSE reviewed Low-density lipoprotein receptor-related protein 4 (LRP-4) (LDLR dan) Mus musculus (Mouse) GO:0001822; GO:0001942; GO:0005509; GO:0005886; GO:0006897; GO:0007167; GO:0008104; GO:0009953; GO:0009954; GO:0009986; GO:0014069; GO:0015026; GO:0016055; GO:0030279; GO:0030326; GO:0030425; GO:0030971; GO:0031594; GO:0034185; GO:0035022; GO:0042475; GO:0042733; GO:0042803; GO:0043025; GO:0043113; GO:0044853; GO:0045202; GO:0048699; GO:0048813; GO:0050771; GO:0050808; GO:0051124; GO:0060173; GO:0071340; GO:0090090; GO:0097060; GO:0097104; GO:0097105; GO:0097110; GO:0150052; GO:0150094; GO:1901631; GO:1904395 amyloid-beta clearance by cellular catabolic process [GO:0150094]; dendrite morphogenesis [GO:0048813]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; embryonic limb morphogenesis [GO:0030326]; endocytosis [GO:0006897]; enzyme-linked receptor protein signaling pathway [GO:0007167]; generation of neurons [GO:0048699]; hair follicle development [GO:0001942]; intracellular protein localization [GO:0008104]; kidney development [GO:0001822]; limb development [GO:0060173]; negative regulation of axonogenesis [GO:0050771]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of ossification [GO:0030279]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of presynaptic membrane organization [GO:1901631]; positive regulation of Rac protein signal transduction [GO:0035022]; positive regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904395]; postsynaptic membrane assembly [GO:0097104]; presynaptic membrane assembly [GO:0097105]; proximal/distal pattern formation [GO:0009954]; receptor clustering [GO:0043113]; regulation of postsynapse assembly [GO:0150052]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; synapse organization [GO:0050808]; synaptic assembly at neuromuscular junction [GO:0051124]; Wnt signaling pathway [GO:0016055] cell surface [GO:0009986]; dendrite [GO:0030425]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic density [GO:0014069]; synapse [GO:0045202]; synaptic membrane [GO:0097060] apolipoprotein binding [GO:0034185]; calcium ion binding [GO:0005509]; coreceptor activity [GO:0015026]; protein homodimerization activity [GO:0042803]; receptor tyrosine kinase binding [GO:0030971]; scaffold protein binding [GO:0097110] g14465.t1 Q8VI56 33.184 669 1.52e-98 359.0 sp|Q8VI56|LRP4_MOUSE Low-density lipoprotein receptor-related protein 4 OS=Mus musculus OX=10090 GN=Lrp4 PE=1 SV=3 LRP4_MOUSE reviewed Low-density lipoprotein receptor-related protein 4 (LRP-4) (LDLR dan) Mus musculus (Mouse) GO:0001822; GO:0001942; GO:0005509; GO:0005886; GO:0006897; GO:0007167; GO:0008104; GO:0009953; GO:0009954; GO:0009986; GO:0014069; GO:0015026; GO:0016055; GO:0030279; GO:0030326; GO:0030425; GO:0030971; GO:0031594; GO:0034185; GO:0035022; GO:0042475; GO:0042733; GO:0042803; GO:0043025; GO:0043113; GO:0044853; GO:0045202; GO:0048699; GO:0048813; GO:0050771; GO:0050808; GO:0051124; GO:0060173; GO:0071340; GO:0090090; GO:0097060; GO:0097104; GO:0097105; GO:0097110; GO:0150052; GO:0150094; GO:1901631; GO:1904395 amyloid-beta clearance by cellular catabolic process [GO:0150094]; dendrite morphogenesis [GO:0048813]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; embryonic limb morphogenesis [GO:0030326]; endocytosis [GO:0006897]; enzyme-linked receptor protein signaling pathway [GO:0007167]; generation of neurons [GO:0048699]; hair follicle development [GO:0001942]; intracellular protein localization [GO:0008104]; kidney development [GO:0001822]; limb development [GO:0060173]; negative regulation of axonogenesis [GO:0050771]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of ossification [GO:0030279]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of presynaptic membrane organization [GO:1901631]; positive regulation of Rac protein signal transduction [GO:0035022]; positive regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904395]; postsynaptic membrane assembly [GO:0097104]; presynaptic membrane assembly [GO:0097105]; proximal/distal pattern formation [GO:0009954]; receptor clustering [GO:0043113]; regulation of postsynapse assembly [GO:0150052]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; synapse organization [GO:0050808]; synaptic assembly at neuromuscular junction [GO:0051124]; Wnt signaling pathway [GO:0016055] cell surface [GO:0009986]; dendrite [GO:0030425]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic density [GO:0014069]; synapse [GO:0045202]; synaptic membrane [GO:0097060] apolipoprotein binding [GO:0034185]; calcium ion binding [GO:0005509]; coreceptor activity [GO:0015026]; protein homodimerization activity [GO:0042803]; receptor tyrosine kinase binding [GO:0030971]; scaffold protein binding [GO:0097110] g14465.t1 Q8VI56 35.556 270 2.01e-35 153.0 sp|Q8VI56|LRP4_MOUSE Low-density lipoprotein receptor-related protein 4 OS=Mus musculus OX=10090 GN=Lrp4 PE=1 SV=3 LRP4_MOUSE reviewed Low-density lipoprotein receptor-related protein 4 (LRP-4) (LDLR dan) Mus musculus (Mouse) GO:0001822; GO:0001942; GO:0005509; GO:0005886; GO:0006897; GO:0007167; GO:0008104; GO:0009953; GO:0009954; GO:0009986; GO:0014069; GO:0015026; GO:0016055; GO:0030279; GO:0030326; GO:0030425; GO:0030971; GO:0031594; GO:0034185; GO:0035022; GO:0042475; GO:0042733; GO:0042803; GO:0043025; GO:0043113; GO:0044853; GO:0045202; GO:0048699; GO:0048813; GO:0050771; GO:0050808; GO:0051124; GO:0060173; GO:0071340; GO:0090090; GO:0097060; GO:0097104; GO:0097105; GO:0097110; GO:0150052; GO:0150094; GO:1901631; GO:1904395 amyloid-beta clearance by cellular catabolic process [GO:0150094]; dendrite morphogenesis [GO:0048813]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; embryonic limb morphogenesis [GO:0030326]; endocytosis [GO:0006897]; enzyme-linked receptor protein signaling pathway [GO:0007167]; generation of neurons [GO:0048699]; hair follicle development [GO:0001942]; intracellular protein localization [GO:0008104]; kidney development [GO:0001822]; limb development [GO:0060173]; negative regulation of axonogenesis [GO:0050771]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of ossification [GO:0030279]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of presynaptic membrane organization [GO:1901631]; positive regulation of Rac protein signal transduction [GO:0035022]; positive regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904395]; postsynaptic membrane assembly [GO:0097104]; presynaptic membrane assembly [GO:0097105]; proximal/distal pattern formation [GO:0009954]; receptor clustering [GO:0043113]; regulation of postsynapse assembly [GO:0150052]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; synapse organization [GO:0050808]; synaptic assembly at neuromuscular junction [GO:0051124]; Wnt signaling pathway [GO:0016055] cell surface [GO:0009986]; dendrite [GO:0030425]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic density [GO:0014069]; synapse [GO:0045202]; synaptic membrane [GO:0097060] apolipoprotein binding [GO:0034185]; calcium ion binding [GO:0005509]; coreceptor activity [GO:0015026]; protein homodimerization activity [GO:0042803]; receptor tyrosine kinase binding [GO:0030971]; scaffold protein binding [GO:0097110] g14470.t1 P39963 56.537 283 2.0200000000000002e-103 316.0 sp|P39963|CCNB3_CHICK G2/mitotic-specific cyclin-B3 OS=Gallus gallus OX=9031 GN=CCNB3 PE=2 SV=1 g14471.t1 Q8C1D8 55.333 300 8.22e-98 325.0 sp|Q8C1D8|IWS1_MOUSE Protein IWS1 homolog OS=Mus musculus OX=10090 GN=Iws1 PE=1 SV=1 IWS1_MOUSE reviewed Protein IWS1 homolog (IWS1-like protein) Mus musculus (Mouse) GO:0001701; GO:0005634; GO:0005654; GO:0006338; GO:0006397; GO:0008380; GO:0010467; GO:0010793; GO:0016973; GO:0050684; GO:0140673 chromatin remodeling [GO:0006338]; gene expression [GO:0010467]; in utero embryonic development [GO:0001701]; mRNA processing [GO:0006397]; poly(A)+ mRNA export from nucleus [GO:0016973]; regulation of mRNA export from nucleus [GO:0010793]; regulation of mRNA processing [GO:0050684]; RNA splicing [GO:0008380]; transcription elongation-coupled chromatin remodeling [GO:0140673] nucleoplasm [GO:0005654]; nucleus [GO:0005634] g14472.t1 Q5REY7 54.088 318 6.5300000000000005e-99 311.0 sp|Q5REY7|UBXN7_PONAB UBX domain-containing protein 7 OS=Pongo abelii OX=9601 GN=UBXN7 PE=2 SV=2 UBXN7_PONAB reviewed UBX domain-containing protein 7 Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0005654; GO:0031625; GO:0034098; GO:0043130; GO:0043161; GO:0061629 proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161] nucleoplasm [GO:0005654]; VCP-NPL4-UFD1 AAA ATPase complex [GO:0034098] RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625] g14472.t1 Q5REY7 64.474 76 4.91e-25 112.0 sp|Q5REY7|UBXN7_PONAB UBX domain-containing protein 7 OS=Pongo abelii OX=9601 GN=UBXN7 PE=2 SV=2 UBXN7_PONAB reviewed UBX domain-containing protein 7 Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0005654; GO:0031625; GO:0034098; GO:0043130; GO:0043161; GO:0061629 proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161] nucleoplasm [GO:0005654]; VCP-NPL4-UFD1 AAA ATPase complex [GO:0034098] RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625] g14473.t1 Q8BGC9 34.921 189 1.03e-31 119.0 sp|Q8BGC9|CREG2_MOUSE Protein CREG2 OS=Mus musculus OX=10090 GN=Creg2 PE=1 SV=1 g14475.t1 Q8WPD0 37.063 143 1.63e-22 92.0 sp|Q8WPD0|LECG_PATPE Alpha-N-acetylgalactosamine-specific lectin OS=Patiria pectinifera OX=7594 PE=1 SV=1 g14476.t1 Q9NP71 37.681 207 6.74e-30 132.0 sp|Q9NP71|MLXPL_HUMAN Carbohydrate-responsive element-binding protein OS=Homo sapiens OX=9606 GN=MLXIPL PE=1 SV=1 MLXPL_HUMAN reviewed Carbohydrate-responsive element-binding protein (ChREBP) (Class D basic helix-loop-helix protein 14) (bHLHd14) (MLX interactor) (MLX-interacting protein-like) (WS basic-helix-loop-helix leucine zipper protein) (WS-bHLH) (Williams-Beuren syndrome chromosomal region 14 protein) Homo sapiens (Human) GO:0000432; GO:0000785; GO:0000978; GO:0000981; GO:0001216; GO:0001227; GO:0001228; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0005667; GO:0005737; GO:0005829; GO:0006355; GO:0006357; GO:0008284; GO:0008610; GO:0009653; GO:0010255; GO:0035538; GO:0035774; GO:0042593; GO:0045723; GO:0045821; GO:0045892; GO:0045893; GO:0045944; GO:0046889; GO:0046982; GO:0055089; GO:0061629; GO:0070328; GO:0090324; GO:0097009; GO:0140297; GO:1901797 anatomical structure morphogenesis [GO:0009653]; energy homeostasis [GO:0097009]; fatty acid homeostasis [GO:0055089]; glucose homeostasis [GO:0042593]; glucose mediated signaling pathway [GO:0010255]; lipid biosynthetic process [GO:0008610]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of oxidative phosphorylation [GO:0090324]; negative regulation of signal transduction by p53 class mediator [GO:1901797]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of fatty acid biosynthetic process [GO:0045723]; positive regulation of glycolytic process [GO:0045821]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of lipid biosynthetic process [GO:0046889]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter by glucose [GO:0000432]; regulation of DNA-templated transcription [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; triglyceride homeostasis [GO:0070328] chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667] carbohydrate response element binding [GO:0035538]; DNA binding [GO:0003677]; DNA-binding transcription activator activity [GO:0001216]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription factor binding [GO:0140297]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; protein heterodimerization activity [GO:0046982]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629] g14477.t1 A2A432 72.343 734 0.0 1052.0 sp|A2A432|CUL4B_MOUSE Cullin-4B OS=Mus musculus OX=10090 GN=Cul4b PE=1 SV=1 CUL4B_MOUSE reviewed Cullin-4B (CUL-4B) Mus musculus (Mouse) GO:0000209; GO:0003684; GO:0005634; GO:0005654; GO:0005829; GO:0006511; GO:0006974; GO:0010467; GO:0010498; GO:0016567; GO:0031175; GO:0031464; GO:0031465; GO:0031625; GO:0034644; GO:0042254; GO:0045732; GO:0048708; GO:0070914; GO:0080008; GO:1900087 astrocyte differentiation [GO:0048708]; cellular response to UV [GO:0034644]; DNA damage response [GO:0006974]; gene expression [GO:0010467]; neuron projection development [GO:0031175]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of protein catabolic process [GO:0045732]; proteasomal protein catabolic process [GO:0010498]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; ribosome biogenesis [GO:0042254]; ubiquitin-dependent protein catabolic process [GO:0006511]; UV-damage excision repair [GO:0070914] Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]; Cul4B-RING E3 ubiquitin ligase complex [GO:0031465]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] damaged DNA binding [GO:0003684]; ubiquitin protein ligase binding [GO:0031625] g14478.t1 P0C2W1 72.727 220 3.95e-115 334.0 sp|P0C2W1|FBSP1_HUMAN F-box/SPRY domain-containing protein 1 OS=Homo sapiens OX=9606 GN=FBXO45 PE=1 SV=1 FBSP1_HUMAN reviewed F-box/SPRY domain-containing protein 1 (F-box only protein 45) (hFbxo45) Homo sapiens (Human) GO:0001764; GO:0005576; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0006511; GO:0006974; GO:0014069; GO:0016567; GO:0019005; GO:0021799; GO:0021800; GO:0021957; GO:0021960; GO:0042734; GO:0043161; GO:0045202; GO:0045211; GO:0060386; GO:0070936; GO:0098978; GO:0099523; GO:0099524; GO:1990756; GO:2000300 anterior commissure morphogenesis [GO:0021960]; cerebral cortex radially oriented cell migration [GO:0021799]; cerebral cortex tangential migration [GO:0021800]; corticospinal tract morphogenesis [GO:0021957]; DNA damage response [GO:0006974]; neuron migration [GO:0001764]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K48-linked ubiquitination [GO:0070936]; protein ubiquitination [GO:0016567]; regulation of synaptic vesicle exocytosis [GO:2000300]; synapse assembly involved in innervation [GO:0060386]; ubiquitin-dependent protein catabolic process [GO:0006511] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; postsynaptic cytosol [GO:0099524]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; presynaptic cytosol [GO:0099523]; presynaptic membrane [GO:0042734]; SCF ubiquitin ligase complex [GO:0019005]; synapse [GO:0045202] ubiquitin-like ligase-substrate adaptor activity [GO:1990756] g14481.t1 O88545 70.13 308 4.8199999999999994e-152 431.0 sp|O88545|CSN6_MOUSE COP9 signalosome complex subunit 6 OS=Mus musculus OX=10090 GN=Cops6 PE=1 SV=1 g14482.t1 Q62623 51.581 506 2.7899999999999997e-176 509.0 sp|Q62623|CDC20_RAT Cell division cycle protein 20 homolog OS=Rattus norvegicus OX=10116 GN=Cdc20 PE=1 SV=2 CDC20_RAT reviewed Cell division cycle protein 20 homolog (p55CDC) Rattus norvegicus (Rat) GO:0000086; GO:0000776; GO:0000922; GO:0005654; GO:0005680; GO:0005813; GO:0005829; GO:0007064; GO:0008284; GO:0010997; GO:0016567; GO:0016579; GO:0031145; GO:0031146; GO:0031915; GO:0032991; GO:0033597; GO:0040020; GO:0042826; GO:0044784; GO:0045842; GO:0048471; GO:0050773; GO:0051301; GO:0090129; GO:0090307; GO:1904146; GO:1904668; GO:1905786; GO:1990756; GO:1990757; GO:1990949 anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell division [GO:0051301]; G2/M transition of mitotic cell cycle [GO:0000086]; metaphase/anaphase transition of cell cycle [GO:0044784]; metaphase/anaphase transition of meiosis I [GO:1990949]; mitotic sister chromatid cohesion [GO:0007064]; mitotic spindle assembly [GO:0090307]; positive regulation of anaphase-promoting complex-dependent catabolic process [GO:1905786]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of meiotic cell cycle process involved in oocyte maturation [GO:1904146]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; positive regulation of synapse maturation [GO:0090129]; positive regulation of synaptic plasticity [GO:0031915]; positive regulation of ubiquitin protein ligase activity [GO:1904668]; protein deubiquitination [GO:0016579]; protein ubiquitination [GO:0016567]; regulation of dendrite development [GO:0050773]; regulation of meiotic nuclear division [GO:0040020]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146] anaphase-promoting complex [GO:0005680]; centrosome [GO:0005813]; cytosol [GO:0005829]; kinetochore [GO:0000776]; mitotic checkpoint complex [GO:0033597]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; spindle pole [GO:0000922] anaphase-promoting complex binding [GO:0010997]; histone deacetylase binding [GO:0042826]; ubiquitin ligase activator activity [GO:1990757]; ubiquitin-like ligase-substrate adaptor activity [GO:1990756] g14483.t1 Q9D099 40.149 269 2.5300000000000003e-56 184.0 sp|Q9D099|ACER3_MOUSE Alkaline ceramidase 3 OS=Mus musculus OX=10090 GN=Acer3 PE=1 SV=1 ACER3_MOUSE reviewed Alkaline ceramidase 3 (AlkCDase 3) (Alkaline CDase 3) (EC 3.5.1.-) (EC 3.5.1.23) (Alkaline phytoceramidase) (aPHC) Mus musculus (Mouse) GO:0000139; GO:0005509; GO:0005789; GO:0006954; GO:0008270; GO:0008284; GO:0016020; GO:0017040; GO:0042552; GO:0043067; GO:0046512; GO:0046514; GO:0071602 ceramide catabolic process [GO:0046514]; inflammatory response [GO:0006954]; myelination [GO:0042552]; phytosphingosine biosynthetic process [GO:0071602]; positive regulation of cell population proliferation [GO:0008284]; regulation of programmed cell death [GO:0043067]; sphingosine biosynthetic process [GO:0046512] endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; membrane [GO:0016020] calcium ion binding [GO:0005509]; N-acylsphingosine amidohydrolase activity [GO:0017040]; zinc ion binding [GO:0008270] g14484.t1 Q9D099 61.111 90 1.1100000000000001e-32 117.0 sp|Q9D099|ACER3_MOUSE Alkaline ceramidase 3 OS=Mus musculus OX=10090 GN=Acer3 PE=1 SV=1 ACER3_MOUSE reviewed Alkaline ceramidase 3 (AlkCDase 3) (Alkaline CDase 3) (EC 3.5.1.-) (EC 3.5.1.23) (Alkaline phytoceramidase) (aPHC) Mus musculus (Mouse) GO:0000139; GO:0005509; GO:0005789; GO:0006954; GO:0008270; GO:0008284; GO:0016020; GO:0017040; GO:0042552; GO:0043067; GO:0046512; GO:0046514; GO:0071602 ceramide catabolic process [GO:0046514]; inflammatory response [GO:0006954]; myelination [GO:0042552]; phytosphingosine biosynthetic process [GO:0071602]; positive regulation of cell population proliferation [GO:0008284]; regulation of programmed cell death [GO:0043067]; sphingosine biosynthetic process [GO:0046512] endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; membrane [GO:0016020] calcium ion binding [GO:0005509]; N-acylsphingosine amidohydrolase activity [GO:0017040]; zinc ion binding [GO:0008270] g14485.t1 Q9D099 38.728 173 1.8700000000000002e-26 103.0 sp|Q9D099|ACER3_MOUSE Alkaline ceramidase 3 OS=Mus musculus OX=10090 GN=Acer3 PE=1 SV=1 ACER3_MOUSE reviewed Alkaline ceramidase 3 (AlkCDase 3) (Alkaline CDase 3) (EC 3.5.1.-) (EC 3.5.1.23) (Alkaline phytoceramidase) (aPHC) Mus musculus (Mouse) GO:0000139; GO:0005509; GO:0005789; GO:0006954; GO:0008270; GO:0008284; GO:0016020; GO:0017040; GO:0042552; GO:0043067; GO:0046512; GO:0046514; GO:0071602 ceramide catabolic process [GO:0046514]; inflammatory response [GO:0006954]; myelination [GO:0042552]; phytosphingosine biosynthetic process [GO:0071602]; positive regulation of cell population proliferation [GO:0008284]; regulation of programmed cell death [GO:0043067]; sphingosine biosynthetic process [GO:0046512] endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; membrane [GO:0016020] calcium ion binding [GO:0005509]; N-acylsphingosine amidohydrolase activity [GO:0017040]; zinc ion binding [GO:0008270] g14486.t1 Q9DB72 31.227 269 3.03e-33 133.0 sp|Q9DB72|BTBDH_MOUSE BTB/POZ domain-containing protein 17 OS=Mus musculus OX=10090 GN=Btbd17 PE=1 SV=1 g14487.t1 Q66HG5 69.397 647 0.0 919.0 sp|Q66HG5|TM9S2_RAT Transmembrane 9 superfamily member 2 OS=Rattus norvegicus OX=10116 GN=Tm9sf2 PE=2 SV=1 TM9S2_RAT reviewed Transmembrane 9 superfamily member 2 Rattus norvegicus (Rat) GO:0005794; GO:0005815; GO:0006672; GO:0006688; GO:0010008; GO:0010908; GO:0016020; GO:0072657 ceramide metabolic process [GO:0006672]; glycosphingolipid biosynthetic process [GO:0006688]; protein localization to membrane [GO:0072657]; regulation of heparan sulfate proteoglycan biosynthetic process [GO:0010908] endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; microtubule organizing center [GO:0005815] g14488.t1 Q66HG5 63.848 473 0.0 609.0 sp|Q66HG5|TM9S2_RAT Transmembrane 9 superfamily member 2 OS=Rattus norvegicus OX=10116 GN=Tm9sf2 PE=2 SV=1 TM9S2_RAT reviewed Transmembrane 9 superfamily member 2 Rattus norvegicus (Rat) GO:0005794; GO:0005815; GO:0006672; GO:0006688; GO:0010008; GO:0010908; GO:0016020; GO:0072657 ceramide metabolic process [GO:0006672]; glycosphingolipid biosynthetic process [GO:0006688]; protein localization to membrane [GO:0072657]; regulation of heparan sulfate proteoglycan biosynthetic process [GO:0010908] endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; microtubule organizing center [GO:0005815] g11558.t1 Q8K268 62.179 624 0.0 796.0 sp|Q8K268|ABCF3_MOUSE ATP-binding cassette sub-family F member 3 OS=Mus musculus OX=10090 GN=Abcf3 PE=1 SV=1 g11560.t1 O75529 43.993 591 1.07e-166 490.0 sp|O75529|TAF5L_HUMAN TAF5-like RNA polymerase II p300/CBP-associated factor-associated factor 65 kDa subunit 5L OS=Homo sapiens OX=9606 GN=TAF5L PE=1 SV=1 g11563.t1 Q9UGM3 35.727 557 6.9e-84 291.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g11563.t1 Q9UGM3 35.211 568 1.62e-83 290.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g11563.t1 Q9UGM3 35.993 539 1.8e-83 290.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g11563.t1 Q9UGM3 34.867 565 1.2899999999999999e-82 288.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g11563.t1 Q9UGM3 35.135 555 7.66e-82 285.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g11563.t1 Q9UGM3 35.112 581 9.709999999999999e-82 285.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g11563.t1 Q9UGM3 35.81 525 9.78e-78 273.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g11563.t1 Q9UGM3 31.961 413 3.6100000000000003e-37 152.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g11563.t1 Q9UGM3 50.0 114 5.5200000000000005e-22 105.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g11564.t1 Q5RDX1 25.641 507 8.690000000000001e-26 116.0 sp|Q5RDX1|Z585A_PONAB Zinc finger protein 585A OS=Pongo abelii OX=9601 GN=ZNF585A PE=2 SV=1 g11564.t1 Q5RDX1 24.266 511 2.47e-22 105.0 sp|Q5RDX1|Z585A_PONAB Zinc finger protein 585A OS=Pongo abelii OX=9601 GN=ZNF585A PE=2 SV=1 g11565.t1 P43646 46.309 149 4.81e-37 129.0 sp|P43646|CATR_TETST Caltractin (Fragment) OS=Tetraselmis striata OX=3165 PE=2 SV=1 g11567.t1 Q3SX07 50.688 436 2.61e-151 441.0 sp|Q3SX07|PUS3_BOVIN tRNA pseudouridine(38/39) synthase OS=Bos taurus OX=9913 GN=PUS3 PE=2 SV=1 PUS3_BOVIN reviewed tRNA pseudouridine(38/39) synthase (EC 5.4.99.45) (tRNA pseudouridine synthase 3) (tRNA pseudouridylate synthase 3) (tRNA-uridine isomerase 3) Bos taurus (Bovine) GO:0003723; GO:0005634; GO:0005737; GO:0009982; GO:0031119; GO:0160154; GO:1990481 mRNA pseudouridine synthesis [GO:1990481]; tRNA pseudouridine synthesis [GO:0031119] cytoplasm [GO:0005737]; nucleus [GO:0005634] pseudouridine synthase activity [GO:0009982]; RNA binding [GO:0003723]; tRNA pseudouridine(38/39) synthase activity [GO:0160154] g11568.t1 Q6AY20 44.309 246 9.53e-53 176.0 sp|Q6AY20|MPRD_RAT Cation-dependent mannose-6-phosphate receptor OS=Rattus norvegicus OX=10116 GN=M6pr PE=1 SV=1 MPRD_RAT reviewed Cation-dependent mannose-6-phosphate receptor (CD Man-6-P receptor) (CD-MPR) Rattus norvegicus (Rat) GO:0005765; GO:0005768; GO:0005770; GO:0005802; GO:0006622; GO:0007041; GO:0019904; GO:0033299; GO:0048471; GO:1905394 lysosomal transport [GO:0007041]; protein targeting to lysosome [GO:0006622]; secretion of lysosomal enzymes [GO:0033299] endosome [GO:0005768]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; perinuclear region of cytoplasm [GO:0048471]; trans-Golgi network [GO:0005802] protein domain specific binding [GO:0019904]; retromer complex binding [GO:1905394] g11571.t1 A6NNF4 39.482 309 6.03e-54 194.0 sp|A6NNF4|ZN726_HUMAN Zinc finger protein 726 OS=Homo sapiens OX=9606 GN=ZNF726 PE=1 SV=5 g11571.t1 A6NNF4 34.341 364 1.1999999999999999e-46 174.0 sp|A6NNF4|ZN726_HUMAN Zinc finger protein 726 OS=Homo sapiens OX=9606 GN=ZNF726 PE=1 SV=5 g11571.t1 A6NNF4 37.066 259 4.8200000000000005e-32 132.0 sp|A6NNF4|ZN726_HUMAN Zinc finger protein 726 OS=Homo sapiens OX=9606 GN=ZNF726 PE=1 SV=5 g11571.t2 Q9UJW7 38.797 482 3.18e-101 333.0 sp|Q9UJW7|ZN229_HUMAN Zinc finger protein 229 OS=Homo sapiens OX=9606 GN=ZNF229 PE=1 SV=4 g11571.t2 Q9UJW7 34.584 373 1.22e-64 233.0 sp|Q9UJW7|ZN229_HUMAN Zinc finger protein 229 OS=Homo sapiens OX=9606 GN=ZNF229 PE=1 SV=4 g11571.t2 Q9UJW7 35.027 374 4.0199999999999994e-61 224.0 sp|Q9UJW7|ZN229_HUMAN Zinc finger protein 229 OS=Homo sapiens OX=9606 GN=ZNF229 PE=1 SV=4 g11571.t2 Q9UJW7 35.514 321 5.21e-55 206.0 sp|Q9UJW7|ZN229_HUMAN Zinc finger protein 229 OS=Homo sapiens OX=9606 GN=ZNF229 PE=1 SV=4 g11571.t2 Q9UJW7 33.463 257 8.74e-40 161.0 sp|Q9UJW7|ZN229_HUMAN Zinc finger protein 229 OS=Homo sapiens OX=9606 GN=ZNF229 PE=1 SV=4 g11571.t2 Q9UJW7 28.425 292 6.14e-33 140.0 sp|Q9UJW7|ZN229_HUMAN Zinc finger protein 229 OS=Homo sapiens OX=9606 GN=ZNF229 PE=1 SV=4 g11572.t1 Q14692 66.667 438 7.11e-165 531.0 sp|Q14692|BMS1_HUMAN Ribosome biogenesis protein BMS1 homolog OS=Homo sapiens OX=9606 GN=BMS1 PE=1 SV=1 BMS1_HUMAN reviewed Ribosome biogenesis protein BMS1 homolog (EC 3.6.5.-) (Ribosome assembly protein BMS1 homolog) Homo sapiens (Human) GO:0000462; GO:0000479; GO:0003723; GO:0003924; GO:0005524; GO:0005525; GO:0005654; GO:0005694; GO:0005730; GO:0032040; GO:0034511; GO:0042274 endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000479]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; ribosomal small subunit biogenesis [GO:0042274] chromosome [GO:0005694]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; small-subunit processome [GO:0032040] ATP binding [GO:0005524]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; RNA binding [GO:0003723]; U3 snoRNA binding [GO:0034511] g11572.t1 Q14692 65.464 388 3.4400000000000004e-163 526.0 sp|Q14692|BMS1_HUMAN Ribosome biogenesis protein BMS1 homolog OS=Homo sapiens OX=9606 GN=BMS1 PE=1 SV=1 BMS1_HUMAN reviewed Ribosome biogenesis protein BMS1 homolog (EC 3.6.5.-) (Ribosome assembly protein BMS1 homolog) Homo sapiens (Human) GO:0000462; GO:0000479; GO:0003723; GO:0003924; GO:0005524; GO:0005525; GO:0005654; GO:0005694; GO:0005730; GO:0032040; GO:0034511; GO:0042274 endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000479]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; ribosomal small subunit biogenesis [GO:0042274] chromosome [GO:0005694]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; small-subunit processome [GO:0032040] ATP binding [GO:0005524]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; RNA binding [GO:0003723]; U3 snoRNA binding [GO:0034511] g11572.t1 Q14692 50.725 138 2.5500000000000003e-27 124.0 sp|Q14692|BMS1_HUMAN Ribosome biogenesis protein BMS1 homolog OS=Homo sapiens OX=9606 GN=BMS1 PE=1 SV=1 BMS1_HUMAN reviewed Ribosome biogenesis protein BMS1 homolog (EC 3.6.5.-) (Ribosome assembly protein BMS1 homolog) Homo sapiens (Human) GO:0000462; GO:0000479; GO:0003723; GO:0003924; GO:0005524; GO:0005525; GO:0005654; GO:0005694; GO:0005730; GO:0032040; GO:0034511; GO:0042274 endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000479]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; ribosomal small subunit biogenesis [GO:0042274] chromosome [GO:0005694]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; small-subunit processome [GO:0032040] ATP binding [GO:0005524]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; RNA binding [GO:0003723]; U3 snoRNA binding [GO:0034511] g11573.t1 Q4V7W5 42.667 150 3.46e-26 114.0 sp|Q4V7W5|PHC2_XENLA Polyhomeotic-like protein 2 OS=Xenopus laevis OX=8355 GN=phc2 PE=2 SV=1 g11573.t1 Q4V7W5 67.647 68 1.7599999999999998e-24 109.0 sp|Q4V7W5|PHC2_XENLA Polyhomeotic-like protein 2 OS=Xenopus laevis OX=8355 GN=phc2 PE=2 SV=1 g11573.t2 Q8IXK0 45.39 141 3.41e-28 125.0 sp|Q8IXK0|PHC2_HUMAN Polyhomeotic-like protein 2 OS=Homo sapiens OX=9606 GN=PHC2 PE=1 SV=1 g11573.t2 Q8IXK0 69.118 68 1.74e-23 110.0 sp|Q8IXK0|PHC2_HUMAN Polyhomeotic-like protein 2 OS=Homo sapiens OX=9606 GN=PHC2 PE=1 SV=1 g11575.t1 Q08DT6 45.545 202 9.069999999999999e-46 157.0 sp|Q08DT6|RM47_BOVIN Large ribosomal subunit protein uL29m OS=Bos taurus OX=9913 GN=MRPL47 PE=2 SV=1 g11576.t1 O09012 52.519 655 0.0 599.0 sp|O09012|PEX5_MOUSE Peroxisomal targeting signal 1 receptor OS=Mus musculus OX=10090 GN=Pex5 PE=1 SV=2 g11576.t2 O09012 51.543 648 0.0 560.0 sp|O09012|PEX5_MOUSE Peroxisomal targeting signal 1 receptor OS=Mus musculus OX=10090 GN=Pex5 PE=1 SV=2 g11577.t1 O55057 85.417 144 1.23e-91 265.0 sp|O55057|PDE6D_MOUSE Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit delta OS=Mus musculus OX=10090 GN=Pde6d PE=1 SV=1 g11578.t1 Q9CQH3 46.575 146 1.1300000000000001e-43 146.0 sp|Q9CQH3|NDUB5_MOUSE NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 5, mitochondrial OS=Mus musculus OX=10090 GN=Ndufb5 PE=1 SV=1 g11581.t1 P50429 45.328 503 2.6e-138 410.0 sp|P50429|ARSB_MOUSE Arylsulfatase B OS=Mus musculus OX=10090 GN=Arsb PE=1 SV=3 ARSB_MOUSE reviewed Arylsulfatase B (ASB) (EC 3.1.6.12) (N-acetylgalactosamine-4-sulfatase) (G4S) Mus musculus (Mouse) GO:0003943; GO:0004065; GO:0005764; GO:0006914; GO:0007584; GO:0008484; GO:0009268; GO:0009986; GO:0010632; GO:0010976; GO:0030207; GO:0030209; GO:0043627; GO:0043890; GO:0046872; GO:0051597; GO:0061580; GO:0097065 anterior head development [GO:0097065]; autophagy [GO:0006914]; chondroitin sulfate proteoglycan catabolic process [GO:0030207]; colon epithelial cell migration [GO:0061580]; dermatan sulfate proteoglycan catabolic process [GO:0030209]; positive regulation of neuron projection development [GO:0010976]; regulation of epithelial cell migration [GO:0010632]; response to estrogen [GO:0043627]; response to methylmercury [GO:0051597]; response to nutrient [GO:0007584]; response to pH [GO:0009268] cell surface [GO:0009986]; lysosome [GO:0005764] arylsulfatase activity [GO:0004065]; metal ion binding [GO:0046872]; N-acetylgalactosamine-4-sulfatase activity [GO:0003943]; N-acetylgalactosamine-6-sulfatase activity [GO:0043890]; sulfuric ester hydrolase activity [GO:0008484] g11582.t1 Q9R1Q2 64.901 302 2.9499999999999996e-138 412.0 sp|Q9R1Q2|CCNL1_RAT Cyclin-L1 OS=Rattus norvegicus OX=10116 GN=Ccnl1 PE=1 SV=1 g11582.t2 Q5RD50 70.0 120 3.87e-61 188.0 sp|Q5RD50|CCNL1_PONAB Cyclin-L1 OS=Pongo abelii OX=9601 GN=CCNL1 PE=3 SV=1 g11583.t1 Q5U4Z8 45.139 144 7.46e-40 135.0 sp|Q5U4Z8|RM20_XENLA Large ribosomal subunit protein bL20m OS=Xenopus laevis OX=8355 GN=mrpl20 PE=2 SV=1 g11584.t1 Q9EQK7 50.0 286 2.48e-95 285.0 sp|Q9EQK7|ICMT_MOUSE Protein-S-isoprenylcysteine O-methyltransferase OS=Mus musculus OX=10090 GN=Icmt PE=2 SV=2 ICMT_MOUSE reviewed Protein-S-isoprenylcysteine O-methyltransferase (EC 2.1.1.100) (Isoprenylcysteine carboxylmethyltransferase) (Prenylated protein carboxyl methyltransferase) (PPMT) (Prenylcysteine carboxyl methyltransferase) (pcCMT) Mus musculus (Mouse) GO:0001701; GO:0001889; GO:0004671; GO:0005783; GO:0005789; GO:0006998; GO:0008104; GO:0008140; GO:0008284; GO:0008340; GO:0030282; GO:0031929; GO:0032259; GO:0032880; GO:0035264; GO:0046498; GO:0046499; GO:0046578; GO:0050905; GO:0051604; GO:0080120; GO:2000772 bone mineralization [GO:0030282]; CAAX-box protein maturation [GO:0080120]; determination of adult lifespan [GO:0008340]; in utero embryonic development [GO:0001701]; intracellular protein localization [GO:0008104]; liver development [GO:0001889]; methylation [GO:0032259]; multicellular organism growth [GO:0035264]; neuromuscular process [GO:0050905]; nuclear envelope organization [GO:0006998]; positive regulation of cell population proliferation [GO:0008284]; protein maturation [GO:0051604]; regulation of cellular senescence [GO:2000772]; regulation of protein localization [GO:0032880]; regulation of Ras protein signal transduction [GO:0046578]; S-adenosylhomocysteine metabolic process [GO:0046498]; S-adenosylmethioninamine metabolic process [GO:0046499]; TOR signaling [GO:0031929] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789] cAMP response element binding protein binding [GO:0008140]; protein C-terminal S-isoprenylcysteine carboxyl O-methyltransferase activity [GO:0004671] g11585.t1 P46471 90.553 434 0.0 763.0 sp|P46471|PRS7_MOUSE 26S proteasome regulatory subunit 7 OS=Mus musculus OX=10090 GN=Psmc2 PE=1 SV=5 g11586.t1 A0LJ16 42.029 276 6.15e-70 220.0 sp|A0LJ16|PHNXL_SYNFM Phosphonoacetaldehyde hydrolase-like protein OS=Syntrophobacter fumaroxidans (strain DSM 10017 / MPOB) OX=335543 GN=phnX2 PE=3 SV=1 g11587.t1 Q9NZN8 55.708 438 4.07e-151 448.0 sp|Q9NZN8|CNOT2_HUMAN CCR4-NOT transcription complex subunit 2 OS=Homo sapiens OX=9606 GN=CNOT2 PE=1 SV=1 g11588.t1 P55115 34.783 368 5.38e-62 214.0 sp|P55115|NAS15_CAEEL Zinc metalloproteinase nas-15 OS=Caenorhabditis elegans OX=6239 GN=nas-15 PE=2 SV=2 g11589.t1 O53532 32.686 309 6.6e-45 160.0 sp|O53532|Y2258_MYCTU S-adenosylmethionine-dependent methyltransferase Rv2258c OS=Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv) OX=83332 GN=Rv2258c PE=1 SV=1 g11592.t1 P0AC33 72.109 294 3.66e-158 455.0 sp|P0AC33|FUMA_ECOLI Fumarate hydratase class I, aerobic OS=Escherichia coli (strain K12) OX=83333 GN=fumA PE=1 SV=2 FUMA_ECOLI reviewed Fumarate hydratase class I, aerobic (EC 4.2.1.2) (Fumarase A) (Oxaloacetate keto--enol-isomerase) (OAAKE isomerase) (Oxaloacetate tautomerase) (EC 5.3.2.2) Escherichia coli (strain K12) GO:0004333; GO:0005829; GO:0006099; GO:0042802; GO:0042803; GO:0046872; GO:0050163; GO:0051539 tricarboxylic acid cycle [GO:0006099] cytosol [GO:0005829] 4 iron, 4 sulfur cluster binding [GO:0051539]; fumarate hydratase activity [GO:0004333]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; oxaloacetate tautomerase activity [GO:0050163]; protein homodimerization activity [GO:0042803] g11593.t1 P0AC33 57.277 213 1.36e-75 242.0 sp|P0AC33|FUMA_ECOLI Fumarate hydratase class I, aerobic OS=Escherichia coli (strain K12) OX=83333 GN=fumA PE=1 SV=2 FUMA_ECOLI reviewed Fumarate hydratase class I, aerobic (EC 4.2.1.2) (Fumarase A) (Oxaloacetate keto--enol-isomerase) (OAAKE isomerase) (Oxaloacetate tautomerase) (EC 5.3.2.2) Escherichia coli (strain K12) GO:0004333; GO:0005829; GO:0006099; GO:0042802; GO:0042803; GO:0046872; GO:0050163; GO:0051539 tricarboxylic acid cycle [GO:0006099] cytosol [GO:0005829] 4 iron, 4 sulfur cluster binding [GO:0051539]; fumarate hydratase activity [GO:0004333]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; oxaloacetate tautomerase activity [GO:0050163]; protein homodimerization activity [GO:0042803] g11595.t1 I6V1W0 37.461 323 5.84e-70 239.0 sp|I6V1W0|BMBL_DANRE Protein brambleberry OS=Danio rerio OX=7955 GN=bmb PE=2 SV=1 g11595.t2 I6V1W0 37.461 323 6.24e-70 239.0 sp|I6V1W0|BMBL_DANRE Protein brambleberry OS=Danio rerio OX=7955 GN=bmb PE=2 SV=1 g11599.t1 A4IGL7 34.296 277 5.2e-38 145.0 sp|A4IGL7|PXDN_XENTR Peroxidasin OS=Xenopus tropicalis OX=8364 GN=pxdn PE=2 SV=1 PXDN_XENTR reviewed Peroxidasin (EC 1.11.2.-) [Cleaved into: PXDN active fragment] Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0001525; GO:0004601; GO:0005604; GO:0005783; GO:0006979; GO:0007155; GO:0009986; GO:0016684; GO:0020037; GO:0031012; GO:0042744; GO:0046872; GO:0051260; GO:0070207; GO:0070831; GO:0071711 angiogenesis [GO:0001525]; basement membrane assembly [GO:0070831]; basement membrane organization [GO:0071711]; cell adhesion [GO:0007155]; hydrogen peroxide catabolic process [GO:0042744]; protein homooligomerization [GO:0051260]; protein homotrimerization [GO:0070207]; response to oxidative stress [GO:0006979] basement membrane [GO:0005604]; cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; extracellular matrix [GO:0031012] heme binding [GO:0020037]; metal ion binding [GO:0046872]; oxidoreductase activity, acting on peroxide as acceptor [GO:0016684]; peroxidase activity [GO:0004601] g11600.t1 Q8R481 27.523 218 1.88e-22 72.8 sp|Q8R481|PERL_MESAU Lactoperoxidase OS=Mesocricetus auratus OX=10036 GN=LPO PE=1 SV=1 PERL_MESAU reviewed Lactoperoxidase (LPO) (EC 1.11.1.7) (Lacrimal gland peroxidase) Mesocricetus auratus (Golden hamster) GO:0001580; GO:0004601; GO:0005615; GO:0005737; GO:0006979; GO:0016323; GO:0020037; GO:0036393; GO:0042742; GO:0046872; GO:0140825 defense response to bacterium [GO:0042742]; detection of chemical stimulus involved in sensory perception of bitter taste [GO:0001580]; response to oxidative stress [GO:0006979] basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; extracellular space [GO:0005615] heme binding [GO:0020037]; lactoperoxidase activity [GO:0140825]; metal ion binding [GO:0046872]; peroxidase activity [GO:0004601]; thiocyanate peroxidase activity [GO:0036393] g11600.t1 Q8R481 62.5 40 1.88e-22 55.1 sp|Q8R481|PERL_MESAU Lactoperoxidase OS=Mesocricetus auratus OX=10036 GN=LPO PE=1 SV=1 PERL_MESAU reviewed Lactoperoxidase (LPO) (EC 1.11.1.7) (Lacrimal gland peroxidase) Mesocricetus auratus (Golden hamster) GO:0001580; GO:0004601; GO:0005615; GO:0005737; GO:0006979; GO:0016323; GO:0020037; GO:0036393; GO:0042742; GO:0046872; GO:0140825 defense response to bacterium [GO:0042742]; detection of chemical stimulus involved in sensory perception of bitter taste [GO:0001580]; response to oxidative stress [GO:0006979] basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; extracellular space [GO:0005615] heme binding [GO:0020037]; lactoperoxidase activity [GO:0140825]; metal ion binding [GO:0046872]; peroxidase activity [GO:0004601]; thiocyanate peroxidase activity [GO:0036393] g11602.t1 Q9YHY6 39.474 912 0.0 608.0 sp|Q9YHY6|CND1_XENLA Condensin complex subunit 1 OS=Xenopus laevis OX=8355 GN=ncapd2 PE=1 SV=1 g11603.t1 Q9YHY6 50.909 385 8.2e-121 387.0 sp|Q9YHY6|CND1_XENLA Condensin complex subunit 1 OS=Xenopus laevis OX=8355 GN=ncapd2 PE=1 SV=1 g11605.t1 P91685 38.745 733 7.72e-174 526.0 sp|P91685|GRM_DROME Metabotropic glutamate receptor OS=Drosophila melanogaster OX=7227 GN=mGluR PE=1 SV=2 GRM_DROME reviewed Metabotropic glutamate receptor (DmGluRA) Drosophila melanogaster (Fruit fly) GO:0001641; GO:0004930; GO:0005886; GO:0007216; GO:0007528; GO:0007612; GO:0007614; GO:0007616; GO:0008049; GO:0008066; GO:0015485; GO:0016020; GO:0016595; GO:0038038; GO:0045121; GO:0051966; GO:0072553 G protein-coupled glutamate receptor signaling pathway [GO:0007216]; learning [GO:0007612]; long-term memory [GO:0007616]; male courtship behavior [GO:0008049]; neuromuscular junction development [GO:0007528]; regulation of synaptic transmission, glutamatergic [GO:0051966]; short-term memory [GO:0007614]; terminal button organization [GO:0072553] G protein-coupled receptor homodimeric complex [GO:0038038]; membrane [GO:0016020]; membrane raft [GO:0045121]; plasma membrane [GO:0005886] cholesterol binding [GO:0015485]; G protein-coupled receptor activity [GO:0004930]; glutamate binding [GO:0016595]; glutamate receptor activity [GO:0008066]; group II metabotropic glutamate receptor activity [GO:0001641] g11606.t1 Q9Z1Z6 60.63 127 1.6299999999999999e-52 173.0 sp|Q9Z1Z6|ILKAP_RAT Integrin-linked kinase-associated serine/threonine phosphatase 2C OS=Rattus norvegicus OX=10116 GN=Ilkap PE=2 SV=1 g11607.t1 Q9H0C8 57.714 175 7.07e-68 214.0 sp|Q9H0C8|ILKAP_HUMAN Integrin-linked kinase-associated serine/threonine phosphatase 2C OS=Homo sapiens OX=9606 GN=ILKAP PE=1 SV=1 g11607.t2 Q9H0C8 55.758 165 1.5e-59 194.0 sp|Q9H0C8|ILKAP_HUMAN Integrin-linked kinase-associated serine/threonine phosphatase 2C OS=Homo sapiens OX=9606 GN=ILKAP PE=1 SV=1 g11608.t1 P13701 77.647 85 1.06e-38 129.0 sp|P13701|SYB_TETCF Synaptobrevin OS=Tetronarce californica OX=7787 PE=2 SV=1 g11609.t1 Q14D04 45.683 278 5.940000000000001e-70 246.0 sp|Q14D04|MELT_HUMAN Ventricular zone-expressed PH domain-containing protein homolog 1 OS=Homo sapiens OX=9606 GN=VEPH1 PE=1 SV=1 g11609.t2 Q14D04 46.043 278 1.5400000000000002e-70 248.0 sp|Q14D04|MELT_HUMAN Ventricular zone-expressed PH domain-containing protein homolog 1 OS=Homo sapiens OX=9606 GN=VEPH1 PE=1 SV=1 g11610.t1 A2BID5 63.725 204 1.55e-82 265.0 sp|A2BID5|MELT_DANRE Ventricular zone-expressed PH domain-containing protein OS=Danio rerio OX=7955 GN=veph PE=2 SV=1 g11611.t1 Q5M888 43.066 411 3.82e-112 339.0 sp|Q5M888|CG025_RAT UPF0415 protein C7orf25 homolog OS=Rattus norvegicus OX=10116 PE=2 SV=1 g11612.t1 Q6NYE2 51.762 369 2.59e-120 360.0 sp|Q6NYE2|RCC2_DANRE Protein RCC2 homolog OS=Danio rerio OX=7955 GN=rcc2 PE=2 SV=1 RCC2_DANRE reviewed Protein RCC2 homolog Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000775; GO:0001755; GO:0005730; GO:0005819; GO:0005886; GO:0016020; GO:0030496; GO:0031267; GO:0051301; GO:0051987; GO:0072356 cell division [GO:0051301]; chromosome passenger complex localization to kinetochore [GO:0072356]; neural crest cell migration [GO:0001755]; positive regulation of attachment of spindle microtubules to kinetochore [GO:0051987] chromosome, centromeric region [GO:0000775]; membrane [GO:0016020]; midbody [GO:0030496]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; spindle [GO:0005819] small GTPase binding [GO:0031267] g11614.t1 A1A5X5 48.897 272 1.95e-70 223.0 sp|A1A5X5|ADIPL_DANRE Adipolin OS=Danio rerio OX=7955 GN=c1qtnf12 PE=2 SV=1 ADIPL_DANRE reviewed Adipolin (Adipose-derived insulin-sensitizing factor) (Complement C1q tumor necrosis factor-related protein 12) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005179; GO:0005576; GO:0005615; GO:0046324 regulation of D-glucose import [GO:0046324] extracellular region [GO:0005576]; extracellular space [GO:0005615] hormone activity [GO:0005179] g11617.t1 Q60855 33.898 295 2.75e-39 157.0 sp|Q60855|RIPK1_MOUSE Receptor-interacting serine/threonine-protein kinase 1 OS=Mus musculus OX=10090 GN=Ripk1 PE=1 SV=1 RIPK1_MOUSE reviewed Receptor-interacting serine/threonine-protein kinase 1 (EC 2.7.11.1) (Cell death protein RIP) (Receptor-interacting protein 1) (RIP-1) Mus musculus (Mouse) GO:0001934; GO:0004672; GO:0004674; GO:0004706; GO:0005123; GO:0005524; GO:0005737; GO:0005739; GO:0006915; GO:0006954; GO:0006979; GO:0007249; GO:0008625; GO:0010628; GO:0030163; GO:0031264; GO:0031625; GO:0032757; GO:0032760; GO:0032991; GO:0033209; GO:0034612; GO:0035556; GO:0035591; GO:0036289; GO:0042327; GO:0042802; GO:0042803; GO:0043065; GO:0043066; GO:0043068; GO:0043123; GO:0043124; GO:0043235; GO:0043410; GO:0043525; GO:0044877; GO:0045651; GO:0045944; GO:0046330; GO:0046777; GO:0050729; GO:0051092; GO:0060545; GO:0060546; GO:0062100; GO:0070105; GO:0070231; GO:0070266; GO:0070301; GO:0070513; GO:0071356; GO:0071363; GO:0097191; GO:0097300; GO:0097342; GO:0097343; GO:0097527; GO:0106310; GO:1900119; GO:1901026; GO:1901224; GO:1903265; GO:1903800; GO:1990000; GO:2000377; GO:2001237; GO:2001238; GO:2001240 amyloid fibril formation [GO:1990000]; apoptotic process [GO:0006915]; canonical NF-kappaB signal transduction [GO:0007249]; cellular response to growth factor stimulus [GO:0071363]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to tumor necrosis factor [GO:0071356]; extrinsic apoptotic signaling pathway [GO:0097191]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; inflammatory response [GO:0006954]; intracellular signal transduction [GO:0035556]; necroptotic process [GO:0070266]; necroptotic signaling pathway [GO:0097527]; negative regulation of apoptotic process [GO:0043066]; negative regulation of canonical NF-kappaB signal transduction [GO:0043124]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; negative regulation of necroptotic process [GO:0060546]; peptidyl-serine autophosphorylation [GO:0036289]; positive regulation of apoptotic process [GO:0043065]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of execution phase of apoptosis [GO:1900119]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; positive regulation of gene expression [GO:0010628]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interleukin-6-mediated signaling pathway [GO:0070105]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of JNK cascade [GO:0046330]; positive regulation of macrophage differentiation [GO:0045651]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of miRNA processing [GO:1903800]; positive regulation of necroptotic process [GO:0060545]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of non-canonical NF-kappaB signal transduction [GO:1901224]; positive regulation of phosphorylation [GO:0042327]; positive regulation of programmed cell death [GO:0043068]; positive regulation of programmed necrotic cell death [GO:0062100]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]; positive regulation of tumor necrosis factor-mediated signaling pathway [GO:1903265]; programmed necrotic cell death [GO:0097300]; protein autophosphorylation [GO:0046777]; protein catabolic process [GO:0030163]; regulation of reactive oxygen species metabolic process [GO:2000377]; response to oxidative stress [GO:0006979]; response to tumor necrosis factor [GO:0034612]; ripoptosome assembly [GO:0097343]; ripoptosome assembly involved in necroptotic process [GO:1901026]; T cell apoptotic process [GO:0070231]; tumor necrosis factor-mediated signaling pathway [GO:0033209] cytoplasm [GO:0005737]; death-inducing signaling complex [GO:0031264]; mitochondrion [GO:0005739]; protein-containing complex [GO:0032991]; receptor complex [GO:0043235]; ripoptosome [GO:0097342] ATP binding [GO:0005524]; death domain binding [GO:0070513]; death receptor binding [GO:0005123]; identical protein binding [GO:0042802]; JUN kinase kinase kinase activity [GO:0004706]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein-containing complex binding [GO:0044877]; signaling adaptor activity [GO:0035591]; ubiquitin protein ligase binding [GO:0031625] g11618.t1 P52569 30.294 647 4.73e-67 236.0 sp|P52569|CTR2_HUMAN Cationic amino acid transporter 2 OS=Homo sapiens OX=9606 GN=SLC7A2 PE=1 SV=2 CTR2_HUMAN reviewed Cationic amino acid transporter 2 (CAT-2) (CAT2) (Low affinity cationic amino acid transporter 2) (Solute carrier family 7 member 2) Homo sapiens (Human) GO:0000064; GO:0005886; GO:0006865; GO:0015171; GO:0015174; GO:0015179; GO:0015189; GO:0015807; GO:0030054; GO:0061459; GO:0089718; GO:0097638; GO:0150104; GO:1902475; GO:1903352; GO:1903826 amino acid import across plasma membrane [GO:0089718]; amino acid transport [GO:0006865]; L-alpha-amino acid transmembrane transport [GO:1902475]; L-amino acid transport [GO:0015807]; L-arginine import across plasma membrane [GO:0097638]; L-arginine transmembrane transport [GO:1903826]; L-ornithine transmembrane transport [GO:1903352]; transport across blood-brain barrier [GO:0150104] cell junction [GO:0030054]; plasma membrane [GO:0005886] amino acid transmembrane transporter activity [GO:0015171]; basic amino acid transmembrane transporter activity [GO:0015174]; L-amino acid transmembrane transporter activity [GO:0015179]; L-arginine transmembrane transporter activity [GO:0061459]; L-lysine transmembrane transporter activity [GO:0015189]; L-ornithine transmembrane transporter activity [GO:0000064] g11619.t1 B3TP03 42.833 586 5.1400000000000006e-129 398.0 sp|B3TP03|CTR2_CHICK Cationic amino acid transporter 2 OS=Gallus gallus OX=9031 GN=SLC7A2 PE=2 SV=1 CTR2_CHICK reviewed Cationic amino acid transporter 2 (CAT-2) (CAT2) (cCAT-2) (Low affinity cationic amino acid transporter 2) (Solute carrier family 7 member 2) Gallus gallus (Chicken) GO:0000064; GO:0005737; GO:0005794; GO:0005886; GO:0015189; GO:0031410; GO:0061459; GO:0097638; GO:0097639; GO:1903352 L-arginine import across plasma membrane [GO:0097638]; L-lysine import across plasma membrane [GO:0097639]; L-ornithine transmembrane transport [GO:1903352] cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; Golgi apparatus [GO:0005794]; plasma membrane [GO:0005886] L-arginine transmembrane transporter activity [GO:0061459]; L-lysine transmembrane transporter activity [GO:0015189]; L-ornithine transmembrane transporter activity [GO:0000064] g11621.t1 Q03112 52.691 353 1.56e-123 390.0 sp|Q03112|MECOM_HUMAN Histone-lysine N-methyltransferase MECOM OS=Homo sapiens OX=9606 GN=MECOM PE=1 SV=3 MECOM_HUMAN reviewed Histone-lysine N-methyltransferase MECOM (EC 2.1.1.367) (Ecotropic virus integration site 1 protein homolog) (EVI-1) (MDS1 and EVI1 complex locus protein) (Myelodysplasia syndrome 1 protein) (Myelodysplasia syndrome-associated protein 1) Homo sapiens (Human) GO:0000978; GO:0001228; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0005829; GO:0006357; GO:0006915; GO:0008270; GO:0016607; GO:0032259; GO:0042803; GO:0043069; GO:0045892; GO:0045893; GO:0046329; GO:0046974; GO:0051604; GO:0051726; GO:0070828; GO:0071425; GO:0140938; GO:0140948 apoptotic process [GO:0006915]; hematopoietic stem cell proliferation [GO:0071425]; heterochromatin organization [GO:0070828]; methylation [GO:0032259]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of JNK cascade [GO:0046329]; negative regulation of programmed cell death [GO:0043069]; positive regulation of DNA-templated transcription [GO:0045893]; protein maturation [GO:0051604]; regulation of cell cycle [GO:0051726]; regulation of transcription by RNA polymerase II [GO:0006357] cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; histone H3 methyltransferase activity [GO:0140938]; histone H3K9 methyltransferase activity [GO:0046974]; histone H3K9 monomethyltransferase activity [GO:0140948]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270] g11623.t1 Q9HAZ2 49.18 244 3.83e-60 216.0 sp|Q9HAZ2|PRD16_HUMAN Histone-lysine N-methyltransferase PRDM16 OS=Homo sapiens OX=9606 GN=PRDM16 PE=1 SV=3 g11624.t1 P41743 74.708 257 5.38e-136 398.0 sp|P41743|KPCI_HUMAN Protein kinase C iota type OS=Homo sapiens OX=9606 GN=PRKCI PE=1 SV=2 KPCI_HUMAN reviewed Protein kinase C iota type (EC 2.7.11.13) (Atypical protein kinase C-lambda/iota) (PRKC-lambda/iota) (aPKC-lambda/iota) (nPKC-iota) Homo sapiens (Human) GO:0000139; GO:0004672; GO:0004674; GO:0004697; GO:0004699; GO:0005524; GO:0005543; GO:0005634; GO:0005654; GO:0005768; GO:0005829; GO:0005886; GO:0005903; GO:0005923; GO:0005929; GO:0006468; GO:0006612; GO:0007010; GO:0007015; GO:0008270; GO:0010976; GO:0015630; GO:0016192; GO:0016324; GO:0016477; GO:0030010; GO:0031252; GO:0032869; GO:0034351; GO:0035089; GO:0035556; GO:0042462; GO:0043066; GO:0043220; GO:0043524; GO:0045171; GO:0045197; GO:0045216; GO:0045747; GO:0046326; GO:0046903; GO:0048194; GO:0051092; GO:0060252; GO:0061024; GO:0062197; GO:0070062; GO:0070160; GO:0070555; GO:0072659; GO:0098685; GO:0098978; GO:0099072; GO:0106310; GO:0120157; GO:1903078; GO:2000353 actin filament organization [GO:0007015]; cell migration [GO:0016477]; cell-cell junction organization [GO:0045216]; cellular response to chemical stress [GO:0062197]; cellular response to insulin stimulus [GO:0032869]; cytoskeleton organization [GO:0007010]; establishment of apical/basal cell polarity [GO:0035089]; establishment of cell polarity [GO:0030010]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; eye photoreceptor cell development [GO:0042462]; Golgi vesicle budding [GO:0048194]; intracellular signal transduction [GO:0035556]; membrane organization [GO:0061024]; negative regulation of apoptotic process [GO:0043066]; negative regulation of glial cell apoptotic process [GO:0034351]; negative regulation of neuron apoptotic process [GO:0043524]; positive regulation of D-glucose import [GO:0046326]; positive regulation of endothelial cell apoptotic process [GO:2000353]; positive regulation of glial cell proliferation [GO:0060252]; positive regulation of neuron projection development [GO:0010976]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of protein localization to plasma membrane [GO:1903078]; protein localization to plasma membrane [GO:0072659]; protein phosphorylation [GO:0006468]; protein targeting to membrane [GO:0006612]; regulation of postsynaptic membrane neurotransmitter receptor levels [GO:0099072]; response to interleukin-1 [GO:0070555]; secretion [GO:0046903]; vesicle-mediated transport [GO:0016192] apical plasma membrane [GO:0016324]; bicellular tight junction [GO:0005923]; brush border [GO:0005903]; cell leading edge [GO:0031252]; cilium [GO:0005929]; cytosol [GO:0005829]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; intercellular bridge [GO:0045171]; microtubule cytoskeleton [GO:0015630]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PAR polarity complex [GO:0120157]; plasma membrane [GO:0005886]; Schaffer collateral - CA1 synapse [GO:0098685]; Schmidt-Lanterman incisure [GO:0043220]; tight junction [GO:0070160] ATP binding [GO:0005524]; diacylglycerol-dependent serine/threonine kinase activity [GO:0004697]; diacylglycerol-dependent, calcium-independent serine/threonine kinase activity [GO:0004699]; phospholipid binding [GO:0005543]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; zinc ion binding [GO:0008270] g11625.t1 P41743 54.777 314 3.78e-107 327.0 sp|P41743|KPCI_HUMAN Protein kinase C iota type OS=Homo sapiens OX=9606 GN=PRKCI PE=1 SV=2 KPCI_HUMAN reviewed Protein kinase C iota type (EC 2.7.11.13) (Atypical protein kinase C-lambda/iota) (PRKC-lambda/iota) (aPKC-lambda/iota) (nPKC-iota) Homo sapiens (Human) GO:0000139; GO:0004672; GO:0004674; GO:0004697; GO:0004699; GO:0005524; GO:0005543; GO:0005634; GO:0005654; GO:0005768; GO:0005829; GO:0005886; GO:0005903; GO:0005923; GO:0005929; GO:0006468; GO:0006612; GO:0007010; GO:0007015; GO:0008270; GO:0010976; GO:0015630; GO:0016192; GO:0016324; GO:0016477; GO:0030010; GO:0031252; GO:0032869; GO:0034351; GO:0035089; GO:0035556; GO:0042462; GO:0043066; GO:0043220; GO:0043524; GO:0045171; GO:0045197; GO:0045216; GO:0045747; GO:0046326; GO:0046903; GO:0048194; GO:0051092; GO:0060252; GO:0061024; GO:0062197; GO:0070062; GO:0070160; GO:0070555; GO:0072659; GO:0098685; GO:0098978; GO:0099072; GO:0106310; GO:0120157; GO:1903078; GO:2000353 actin filament organization [GO:0007015]; cell migration [GO:0016477]; cell-cell junction organization [GO:0045216]; cellular response to chemical stress [GO:0062197]; cellular response to insulin stimulus [GO:0032869]; cytoskeleton organization [GO:0007010]; establishment of apical/basal cell polarity [GO:0035089]; establishment of cell polarity [GO:0030010]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; eye photoreceptor cell development [GO:0042462]; Golgi vesicle budding [GO:0048194]; intracellular signal transduction [GO:0035556]; membrane organization [GO:0061024]; negative regulation of apoptotic process [GO:0043066]; negative regulation of glial cell apoptotic process [GO:0034351]; negative regulation of neuron apoptotic process [GO:0043524]; positive regulation of D-glucose import [GO:0046326]; positive regulation of endothelial cell apoptotic process [GO:2000353]; positive regulation of glial cell proliferation [GO:0060252]; positive regulation of neuron projection development [GO:0010976]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of protein localization to plasma membrane [GO:1903078]; protein localization to plasma membrane [GO:0072659]; protein phosphorylation [GO:0006468]; protein targeting to membrane [GO:0006612]; regulation of postsynaptic membrane neurotransmitter receptor levels [GO:0099072]; response to interleukin-1 [GO:0070555]; secretion [GO:0046903]; vesicle-mediated transport [GO:0016192] apical plasma membrane [GO:0016324]; bicellular tight junction [GO:0005923]; brush border [GO:0005903]; cell leading edge [GO:0031252]; cilium [GO:0005929]; cytosol [GO:0005829]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; intercellular bridge [GO:0045171]; microtubule cytoskeleton [GO:0015630]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PAR polarity complex [GO:0120157]; plasma membrane [GO:0005886]; Schaffer collateral - CA1 synapse [GO:0098685]; Schmidt-Lanterman incisure [GO:0043220]; tight junction [GO:0070160] ATP binding [GO:0005524]; diacylglycerol-dependent serine/threonine kinase activity [GO:0004697]; diacylglycerol-dependent, calcium-independent serine/threonine kinase activity [GO:0004699]; phospholipid binding [GO:0005543]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; zinc ion binding [GO:0008270] g11628.t1 Q5BKC9 37.185 476 7.47e-89 305.0 sp|Q5BKC9|NGEF_RAT Ephexin-1 OS=Rattus norvegicus OX=10116 GN=Ngef PE=1 SV=2 NGEF_RAT reviewed Ephexin-1 (Eph-interacting exchange protein) (Neuronal guanine nucleotide exchange factor) Rattus norvegicus (Rat) GO:0005085; GO:0005737; GO:0007399; GO:0016020; GO:0030154; GO:0030426; GO:0032956; GO:0043087; GO:0046875; GO:0048013; GO:0061002; GO:0098794; GO:0098978; GO:1905806 cell differentiation [GO:0030154]; ephrin receptor signaling pathway [GO:0048013]; negative regulation of dendritic spine morphogenesis [GO:0061002]; nervous system development [GO:0007399]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of GTPase activity [GO:0043087]; regulation of synapse pruning [GO:1905806] cytoplasm [GO:0005737]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; membrane [GO:0016020]; postsynapse [GO:0098794] ephrin receptor binding [GO:0046875]; guanyl-nucleotide exchange factor activity [GO:0005085] g11631.t1 Q99N34 38.024 334 2.1799999999999998e-67 218.0 sp|Q99N34|DFFB_RAT DNA fragmentation factor subunit beta OS=Rattus norvegicus OX=10116 GN=Dffb PE=1 SV=1 g11632.t1 Q12756 58.492 1101 0.0 1208.0 sp|Q12756|KIF1A_HUMAN Kinesin-like protein KIF1A OS=Homo sapiens OX=9606 GN=KIF1A PE=1 SV=2 KIF1A_HUMAN reviewed Kinesin-like protein KIF1A (EC 5.6.1.3) (Axonal transporter of synaptic vesicles) (Microtubule-based motor KIF1A) (Unc-104- and KIF1A-related protein) (hUnc-104) Homo sapiens (Human) GO:0003774; GO:0005524; GO:0005737; GO:0005871; GO:0005874; GO:0008017; GO:0008089; GO:0008574; GO:0016192; GO:0016887; GO:0030424; GO:0030425; GO:0042802; GO:0045202; GO:0046872; GO:0048471; GO:0060998; GO:0061001; GO:0098992; GO:0099012; GO:0099519; GO:1904115; GO:1990048; GO:1990049 anterograde axonal transport [GO:0008089]; anterograde neuronal dense core vesicle transport [GO:1990048]; dense core granule cytoskeletal transport [GO:0099519]; regulation of dendritic spine development [GO:0060998]; regulation of dendritic spine morphogenesis [GO:0061001]; retrograde neuronal dense core vesicle transport [GO:1990049]; vesicle-mediated transport [GO:0016192] axon [GO:0030424]; axon cytoplasm [GO:1904115]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; neuronal dense core vesicle [GO:0098992]; neuronal dense core vesicle membrane [GO:0099012]; perinuclear region of cytoplasm [GO:0048471]; synapse [GO:0045202] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; cytoskeletal motor activity [GO:0003774]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; microtubule binding [GO:0008017]; plus-end-directed microtubule motor activity [GO:0008574] g11632.t1 Q12756 78.868 265 7.73e-125 435.0 sp|Q12756|KIF1A_HUMAN Kinesin-like protein KIF1A OS=Homo sapiens OX=9606 GN=KIF1A PE=1 SV=2 KIF1A_HUMAN reviewed Kinesin-like protein KIF1A (EC 5.6.1.3) (Axonal transporter of synaptic vesicles) (Microtubule-based motor KIF1A) (Unc-104- and KIF1A-related protein) (hUnc-104) Homo sapiens (Human) GO:0003774; GO:0005524; GO:0005737; GO:0005871; GO:0005874; GO:0008017; GO:0008089; GO:0008574; GO:0016192; GO:0016887; GO:0030424; GO:0030425; GO:0042802; GO:0045202; GO:0046872; GO:0048471; GO:0060998; GO:0061001; GO:0098992; GO:0099012; GO:0099519; GO:1904115; GO:1990048; GO:1990049 anterograde axonal transport [GO:0008089]; anterograde neuronal dense core vesicle transport [GO:1990048]; dense core granule cytoskeletal transport [GO:0099519]; regulation of dendritic spine development [GO:0060998]; regulation of dendritic spine morphogenesis [GO:0061001]; retrograde neuronal dense core vesicle transport [GO:1990049]; vesicle-mediated transport [GO:0016192] axon [GO:0030424]; axon cytoplasm [GO:1904115]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; neuronal dense core vesicle [GO:0098992]; neuronal dense core vesicle membrane [GO:0099012]; perinuclear region of cytoplasm [GO:0048471]; synapse [GO:0045202] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; cytoskeletal motor activity [GO:0003774]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; microtubule binding [GO:0008017]; plus-end-directed microtubule motor activity [GO:0008574] g11632.t1 Q12756 67.442 129 6.35e-41 170.0 sp|Q12756|KIF1A_HUMAN Kinesin-like protein KIF1A OS=Homo sapiens OX=9606 GN=KIF1A PE=1 SV=2 KIF1A_HUMAN reviewed Kinesin-like protein KIF1A (EC 5.6.1.3) (Axonal transporter of synaptic vesicles) (Microtubule-based motor KIF1A) (Unc-104- and KIF1A-related protein) (hUnc-104) Homo sapiens (Human) GO:0003774; GO:0005524; GO:0005737; GO:0005871; GO:0005874; GO:0008017; GO:0008089; GO:0008574; GO:0016192; GO:0016887; GO:0030424; GO:0030425; GO:0042802; GO:0045202; GO:0046872; GO:0048471; GO:0060998; GO:0061001; GO:0098992; GO:0099012; GO:0099519; GO:1904115; GO:1990048; GO:1990049 anterograde axonal transport [GO:0008089]; anterograde neuronal dense core vesicle transport [GO:1990048]; dense core granule cytoskeletal transport [GO:0099519]; regulation of dendritic spine development [GO:0060998]; regulation of dendritic spine morphogenesis [GO:0061001]; retrograde neuronal dense core vesicle transport [GO:1990049]; vesicle-mediated transport [GO:0016192] axon [GO:0030424]; axon cytoplasm [GO:1904115]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; neuronal dense core vesicle [GO:0098992]; neuronal dense core vesicle membrane [GO:0099012]; perinuclear region of cytoplasm [GO:0048471]; synapse [GO:0045202] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; cytoskeletal motor activity [GO:0003774]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; microtubule binding [GO:0008017]; plus-end-directed microtubule motor activity [GO:0008574] g11641.t1 Q4KWZ7 46.817 487 1.4900000000000002e-124 417.0 sp|Q4KWZ7|REV1_CHICK DNA repair protein REV1 OS=Gallus gallus OX=9031 GN=REV1 PE=2 SV=1 REV1_CHICK reviewed Translesion synthesis protein REV1 (Molecular adapter protein REV1) (Rev1-like terminal deoxycytidyl transferase) (Reversionless protein 1 homolog) (REV1 homolog) (Template-dependent deoxycytidyl transferase REV1) (EC 2.7.7.-) Gallus gallus (Chicken) GO:0002206; GO:0003677; GO:0003684; GO:0003887; GO:0005654; GO:0006302; GO:0016446; GO:0017125; GO:0019985; GO:0042276; GO:0046872; GO:0070987 double-strand break repair [GO:0006302]; error-free translesion synthesis [GO:0070987]; error-prone translesion synthesis [GO:0042276]; gene conversion of immunoglobulin genes [GO:0002206]; somatic hypermutation of immunoglobulin genes [GO:0016446]; translesion synthesis [GO:0019985] nucleoplasm [GO:0005654] damaged DNA binding [GO:0003684]; deoxycytidyl transferase activity [GO:0017125]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; metal ion binding [GO:0046872] g11641.t1 Q4KWZ7 52.941 170 3.65e-32 140.0 sp|Q4KWZ7|REV1_CHICK DNA repair protein REV1 OS=Gallus gallus OX=9031 GN=REV1 PE=2 SV=1 REV1_CHICK reviewed Translesion synthesis protein REV1 (Molecular adapter protein REV1) (Rev1-like terminal deoxycytidyl transferase) (Reversionless protein 1 homolog) (REV1 homolog) (Template-dependent deoxycytidyl transferase REV1) (EC 2.7.7.-) Gallus gallus (Chicken) GO:0002206; GO:0003677; GO:0003684; GO:0003887; GO:0005654; GO:0006302; GO:0016446; GO:0017125; GO:0019985; GO:0042276; GO:0046872; GO:0070987 double-strand break repair [GO:0006302]; error-free translesion synthesis [GO:0070987]; error-prone translesion synthesis [GO:0042276]; gene conversion of immunoglobulin genes [GO:0002206]; somatic hypermutation of immunoglobulin genes [GO:0016446]; translesion synthesis [GO:0019985] nucleoplasm [GO:0005654] damaged DNA binding [GO:0003684]; deoxycytidyl transferase activity [GO:0017125]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; metal ion binding [GO:0046872] g11641.t1 Q4KWZ7 41.667 180 6.3399999999999995e-28 126.0 sp|Q4KWZ7|REV1_CHICK DNA repair protein REV1 OS=Gallus gallus OX=9031 GN=REV1 PE=2 SV=1 REV1_CHICK reviewed Translesion synthesis protein REV1 (Molecular adapter protein REV1) (Rev1-like terminal deoxycytidyl transferase) (Reversionless protein 1 homolog) (REV1 homolog) (Template-dependent deoxycytidyl transferase REV1) (EC 2.7.7.-) Gallus gallus (Chicken) GO:0002206; GO:0003677; GO:0003684; GO:0003887; GO:0005654; GO:0006302; GO:0016446; GO:0017125; GO:0019985; GO:0042276; GO:0046872; GO:0070987 double-strand break repair [GO:0006302]; error-free translesion synthesis [GO:0070987]; error-prone translesion synthesis [GO:0042276]; gene conversion of immunoglobulin genes [GO:0002206]; somatic hypermutation of immunoglobulin genes [GO:0016446]; translesion synthesis [GO:0019985] nucleoplasm [GO:0005654] damaged DNA binding [GO:0003684]; deoxycytidyl transferase activity [GO:0017125]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; metal ion binding [GO:0046872] g11641.t2 Q4KWZ7 48.305 472 2.0899999999999998e-128 427.0 sp|Q4KWZ7|REV1_CHICK DNA repair protein REV1 OS=Gallus gallus OX=9031 GN=REV1 PE=2 SV=1 REV1_CHICK reviewed Translesion synthesis protein REV1 (Molecular adapter protein REV1) (Rev1-like terminal deoxycytidyl transferase) (Reversionless protein 1 homolog) (REV1 homolog) (Template-dependent deoxycytidyl transferase REV1) (EC 2.7.7.-) Gallus gallus (Chicken) GO:0002206; GO:0003677; GO:0003684; GO:0003887; GO:0005654; GO:0006302; GO:0016446; GO:0017125; GO:0019985; GO:0042276; GO:0046872; GO:0070987 double-strand break repair [GO:0006302]; error-free translesion synthesis [GO:0070987]; error-prone translesion synthesis [GO:0042276]; gene conversion of immunoglobulin genes [GO:0002206]; somatic hypermutation of immunoglobulin genes [GO:0016446]; translesion synthesis [GO:0019985] nucleoplasm [GO:0005654] damaged DNA binding [GO:0003684]; deoxycytidyl transferase activity [GO:0017125]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; metal ion binding [GO:0046872] g11641.t2 Q4KWZ7 52.941 170 3.52e-32 140.0 sp|Q4KWZ7|REV1_CHICK DNA repair protein REV1 OS=Gallus gallus OX=9031 GN=REV1 PE=2 SV=1 REV1_CHICK reviewed Translesion synthesis protein REV1 (Molecular adapter protein REV1) (Rev1-like terminal deoxycytidyl transferase) (Reversionless protein 1 homolog) (REV1 homolog) (Template-dependent deoxycytidyl transferase REV1) (EC 2.7.7.-) Gallus gallus (Chicken) GO:0002206; GO:0003677; GO:0003684; GO:0003887; GO:0005654; GO:0006302; GO:0016446; GO:0017125; GO:0019985; GO:0042276; GO:0046872; GO:0070987 double-strand break repair [GO:0006302]; error-free translesion synthesis [GO:0070987]; error-prone translesion synthesis [GO:0042276]; gene conversion of immunoglobulin genes [GO:0002206]; somatic hypermutation of immunoglobulin genes [GO:0016446]; translesion synthesis [GO:0019985] nucleoplasm [GO:0005654] damaged DNA binding [GO:0003684]; deoxycytidyl transferase activity [GO:0017125]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; metal ion binding [GO:0046872] g11641.t2 Q4KWZ7 41.667 180 5.77e-28 126.0 sp|Q4KWZ7|REV1_CHICK DNA repair protein REV1 OS=Gallus gallus OX=9031 GN=REV1 PE=2 SV=1 REV1_CHICK reviewed Translesion synthesis protein REV1 (Molecular adapter protein REV1) (Rev1-like terminal deoxycytidyl transferase) (Reversionless protein 1 homolog) (REV1 homolog) (Template-dependent deoxycytidyl transferase REV1) (EC 2.7.7.-) Gallus gallus (Chicken) GO:0002206; GO:0003677; GO:0003684; GO:0003887; GO:0005654; GO:0006302; GO:0016446; GO:0017125; GO:0019985; GO:0042276; GO:0046872; GO:0070987 double-strand break repair [GO:0006302]; error-free translesion synthesis [GO:0070987]; error-prone translesion synthesis [GO:0042276]; gene conversion of immunoglobulin genes [GO:0002206]; somatic hypermutation of immunoglobulin genes [GO:0016446]; translesion synthesis [GO:0019985] nucleoplasm [GO:0005654] damaged DNA binding [GO:0003684]; deoxycytidyl transferase activity [GO:0017125]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; metal ion binding [GO:0046872] g11642.t1 P58195 50.207 241 2.88e-73 229.0 sp|P58195|PLS1_RAT Phospholipid scramblase 1 OS=Rattus norvegicus OX=10116 GN=Plscr1 PE=1 SV=1 PLS1_RAT reviewed Phospholipid scramblase 1 (PL scramblase 1) (Ca(2+)-dependent phospholipid scramblase 1) (Mg(2+)-dependent nuclease) (EC 3.1.-.-) Rattus norvegicus (Rat) GO:0000287; GO:0001228; GO:0001618; GO:0003677; GO:0004518; GO:0005154; GO:0005509; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005794; GO:0005829; GO:0005886; GO:0006659; GO:0006915; GO:0006953; GO:0006955; GO:0008270; GO:0010288; GO:0010628; GO:0015914; GO:0016787; GO:0017121; GO:0017124; GO:0017128; GO:0019899; GO:0030099; GO:0032791; GO:0033003; GO:0035455; GO:0035456; GO:0042609; GO:0043065; GO:0045071; GO:0045089; GO:0045121; GO:0045340; GO:0045944; GO:0048471; GO:0050765; GO:0051607; GO:0060368; GO:0070782; GO:0071222; GO:0071345; GO:0097193; GO:1902231; GO:1905820; GO:2000373 acute-phase response [GO:0006953]; apoptotic process [GO:0006915]; cellular response to cytokine stimulus [GO:0071345]; cellular response to lipopolysaccharide [GO:0071222]; defense response to virus [GO:0051607]; immune response [GO:0006955]; intrinsic apoptotic signaling pathway [GO:0097193]; myeloid cell differentiation [GO:0030099]; negative regulation of phagocytosis [GO:0050765]; negative regulation of viral genome replication [GO:0045071]; phosphatidylserine biosynthetic process [GO:0006659]; phosphatidylserine exposure on apoptotic cell surface [GO:0070782]; phospholipid transport [GO:0015914]; plasma membrane phospholipid scrambling [GO:0017121]; positive regulation of apoptotic process [GO:0043065]; positive regulation of chromosome separation [GO:1905820]; positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity [GO:2000373]; positive regulation of gene expression [GO:0010628]; positive regulation of innate immune response [GO:0045089]; positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage [GO:1902231]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of Fc receptor mediated stimulatory signaling pathway [GO:0060368]; regulation of mast cell activation [GO:0033003]; response to interferon-alpha [GO:0035455]; response to interferon-beta [GO:0035456]; response to lead ion [GO:0010288] cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; membrane raft [GO:0045121]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; CD4 receptor binding [GO:0042609]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; enzyme binding [GO:0019899]; epidermal growth factor receptor binding [GO:0005154]; hydrolase activity [GO:0016787]; lead ion binding [GO:0032791]; magnesium ion binding [GO:0000287]; mercury ion binding [GO:0045340]; nuclease activity [GO:0004518]; phospholipid scramblase activity [GO:0017128]; SH3 domain binding [GO:0017124]; virus receptor activity [GO:0001618]; zinc ion binding [GO:0008270] g11644.t1 Q3ZBG9 43.878 294 3.16e-75 235.0 sp|Q3ZBG9|PLS2_BOVIN Phospholipid scramblase 2 OS=Bos taurus OX=9913 GN=PLSCR2 PE=2 SV=1 g11647.t1 Q3ZBG9 55.242 248 1.5599999999999999e-83 258.0 sp|Q3ZBG9|PLS2_BOVIN Phospholipid scramblase 2 OS=Bos taurus OX=9913 GN=PLSCR2 PE=2 SV=1 g11648.t1 Q9BXM7 38.514 444 3.98e-83 276.0 sp|Q9BXM7|PINK1_HUMAN Serine/threonine-protein kinase PINK1, mitochondrial OS=Homo sapiens OX=9606 GN=PINK1 PE=1 SV=1 g11649.t1 Q9ES00 49.164 1076 0.0 1051.0 sp|Q9ES00|UBE4B_MOUSE Ubiquitin conjugation factor E4 B OS=Mus musculus OX=10090 GN=Ube4b PE=1 SV=3 UBE4B_MOUSE reviewed Ubiquitin conjugation factor E4 B (EC 2.3.2.27) (RING-type E3 ubiquitin transferase E4 B) (Ubiquitin fusion degradation protein 2) Mus musculus (Mouse) GO:0000151; GO:0000209; GO:0003222; GO:0005524; GO:0005634; GO:0005737; GO:0006457; GO:0006511; GO:0006513; GO:0008626; GO:0009411; GO:0016567; GO:0019899; GO:0030163; GO:0031175; GO:0034450; GO:0034976; GO:0036503; GO:0043161; GO:0051082; GO:0051117; GO:0051865; GO:0061630 ERAD pathway [GO:0036503]; granzyme-mediated apoptotic signaling pathway [GO:0008626]; neuron projection development [GO:0031175]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein catabolic process [GO:0030163]; protein folding [GO:0006457]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; response to endoplasmic reticulum stress [GO:0034976]; response to UV [GO:0009411]; ubiquitin-dependent protein catabolic process [GO:0006511]; ventricular trabecula myocardium morphogenesis [GO:0003222] cytoplasm [GO:0005737]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151] ATP binding [GO:0005524]; ATPase binding [GO:0051117]; enzyme binding [GO:0019899]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-ubiquitin ligase activity [GO:0034450]; unfolded protein binding [GO:0051082] g11650.t1 Q95327 47.232 849 0.0 792.0 sp|Q95327|MANBA_CAPHI Beta-mannosidase OS=Capra hircus OX=9925 GN=MANBA PE=1 SV=1 MANBA_CAPHI reviewed Beta-mannosidase (EC 3.2.1.25) (Lysosomal beta A mannosidase) (Mannanase) (Mannase) Capra hircus (Goat) GO:0004567; GO:0005764; GO:0005975; GO:0006516 carbohydrate metabolic process [GO:0005975]; glycoprotein catabolic process [GO:0006516] lysosome [GO:0005764] beta-mannosidase activity [GO:0004567] g11651.t1 Q5F464 64.807 233 3.7199999999999996e-108 336.0 sp|Q5F464|LPP_CHICK Lipoma-preferred partner homolog OS=Gallus gallus OX=9031 GN=LPP PE=2 SV=1 LPP_CHICK reviewed Lipoma-preferred partner homolog Gallus gallus (Chicken) GO:0001725; GO:0005634; GO:0005737; GO:0005925; GO:0046872; GO:0098609 cell-cell adhesion [GO:0098609] cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; nucleus [GO:0005634]; stress fiber [GO:0001725] metal ion binding [GO:0046872] g11651.t2 Q5F464 64.807 233 5.3e-108 336.0 sp|Q5F464|LPP_CHICK Lipoma-preferred partner homolog OS=Gallus gallus OX=9031 GN=LPP PE=2 SV=1 LPP_CHICK reviewed Lipoma-preferred partner homolog Gallus gallus (Chicken) GO:0001725; GO:0005634; GO:0005737; GO:0005925; GO:0046872; GO:0098609 cell-cell adhesion [GO:0098609] cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; nucleus [GO:0005634]; stress fiber [GO:0001725] metal ion binding [GO:0046872] g11651.t3 Q5F464 64.807 233 1.04e-108 337.0 sp|Q5F464|LPP_CHICK Lipoma-preferred partner homolog OS=Gallus gallus OX=9031 GN=LPP PE=2 SV=1 LPP_CHICK reviewed Lipoma-preferred partner homolog Gallus gallus (Chicken) GO:0001725; GO:0005634; GO:0005737; GO:0005925; GO:0046872; GO:0098609 cell-cell adhesion [GO:0098609] cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; nucleus [GO:0005634]; stress fiber [GO:0001725] metal ion binding [GO:0046872] g11651.t4 Q5F464 64.807 233 3.9600000000000004e-109 338.0 sp|Q5F464|LPP_CHICK Lipoma-preferred partner homolog OS=Gallus gallus OX=9031 GN=LPP PE=2 SV=1 LPP_CHICK reviewed Lipoma-preferred partner homolog Gallus gallus (Chicken) GO:0001725; GO:0005634; GO:0005737; GO:0005925; GO:0046872; GO:0098609 cell-cell adhesion [GO:0098609] cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; nucleus [GO:0005634]; stress fiber [GO:0001725] metal ion binding [GO:0046872] g11652.t1 Q9Y2W3 39.161 286 2.4999999999999996e-52 193.0 sp|Q9Y2W3|S45A1_HUMAN Proton-associated sugar transporter A OS=Homo sapiens OX=9606 GN=SLC45A1 PE=1 SV=6 S45A1_HUMAN reviewed Proton-associated sugar transporter A (PAST-A) (Deleted in neuroblastoma 5 protein) (DNb-5) (Solute carrier family 45 member 1) Homo sapiens (Human) GO:0005356; GO:0008506; GO:0015517; GO:0015757; GO:0016020; GO:1904659 D-glucose transmembrane transport [GO:1904659]; galactose transmembrane transport [GO:0015757] membrane [GO:0016020] D-glucose:proton symporter activity [GO:0005356]; galactose:proton symporter activity [GO:0015517]; sucrose:proton symporter activity [GO:0008506] g11652.t1 Q9Y2W3 54.037 161 9.54e-39 154.0 sp|Q9Y2W3|S45A1_HUMAN Proton-associated sugar transporter A OS=Homo sapiens OX=9606 GN=SLC45A1 PE=1 SV=6 S45A1_HUMAN reviewed Proton-associated sugar transporter A (PAST-A) (Deleted in neuroblastoma 5 protein) (DNb-5) (Solute carrier family 45 member 1) Homo sapiens (Human) GO:0005356; GO:0008506; GO:0015517; GO:0015757; GO:0016020; GO:1904659 D-glucose transmembrane transport [GO:1904659]; galactose transmembrane transport [GO:0015757] membrane [GO:0016020] D-glucose:proton symporter activity [GO:0005356]; galactose:proton symporter activity [GO:0015517]; sucrose:proton symporter activity [GO:0008506] g11654.t1 P58355 34.574 564 3.55e-100 318.0 sp|P58355|S45A2_MOUSE Membrane-associated transporter protein OS=Mus musculus OX=10090 GN=Slc45a2 PE=1 SV=1 S45A2_MOUSE reviewed Membrane-associated transporter protein (Melanoma antigen AIM1) (Protein AIM-1) (Protein underwhite) (Solute carrier family 45 member 2) Mus musculus (Mouse) GO:0005356; GO:0006583; GO:0007601; GO:0008506; GO:0015770; GO:0016020; GO:0033162; GO:0035752; GO:0048066 developmental pigmentation [GO:0048066]; lysosomal lumen pH elevation [GO:0035752]; melanin biosynthetic process from tyrosine [GO:0006583]; sucrose transport [GO:0015770]; visual perception [GO:0007601] melanosome membrane [GO:0033162]; membrane [GO:0016020] D-glucose:proton symporter activity [GO:0005356]; sucrose:proton symporter activity [GO:0008506] g11655.t1 O60683 45.483 321 2.12e-75 236.0 sp|O60683|PEX10_HUMAN Peroxisome biogenesis factor 10 OS=Homo sapiens OX=9606 GN=PEX10 PE=1 SV=1 g11657.t1 Q5F499 65.015 686 0.0 923.0 sp|Q5F499|OPA1_CHICK Dynamin-like GTPase OPA1, mitochondrial OS=Gallus gallus OX=9031 GN=OPA1 PE=2 SV=1 OPA1_CHICK reviewed Dynamin-like GTPase OPA1, mitochondrial (EC 3.6.5.5) (Optic atrophy protein 1 homolog) [Cleaved into: Dynamin-like GTPase OPA1, long form (L-OPA1); Dynamin-like GTPase OPA1, short form (S-OPA1)] Gallus gallus (Chicken) GO:0003924; GO:0005525; GO:0005737; GO:0005743; GO:0005758; GO:0005874; GO:0006915; GO:0008017; GO:0008053; GO:0016559; GO:0031966; GO:0032740; GO:0046039; GO:0046872; GO:0070300; GO:0097749; GO:0140523; GO:0180020; GO:1901612; GO:1990627; GO:2000330 apoptotic process [GO:0006915]; GTP metabolic process [GO:0046039]; membrane tubulation [GO:0097749]; mitochondrial fusion [GO:0008053]; mitochondrial inner membrane fusion [GO:1990627]; peroxisome fission [GO:0016559]; positive regulation of interleukin-17 production [GO:0032740]; positive regulation of T-helper 17 cell lineage commitment [GO:2000330] cytoplasm [GO:0005737]; microtubule [GO:0005874]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrial membrane [GO:0031966] cardiolipin binding [GO:1901612]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; GTPase-dependent fusogenic activity [GO:0140523]; membrane bending activity [GO:0180020]; metal ion binding [GO:0046872]; microtubule binding [GO:0008017]; phosphatidic acid binding [GO:0070300] g11659.t1 Q6IRB2 70.4 125 2.08e-53 182.0 sp|Q6IRB2|HES1A_XENLA Transcription factor HES-1-A OS=Xenopus laevis OX=8355 GN=hes1-a PE=1 SV=1 HES1A_XENLA reviewed Transcription factor HES-1-A (Hairy and enhancer of split 1-A) (Protein hairy-1) (Xhairy-1) (Xhairy1) (Xlh1) Xenopus laevis (African clawed frog) GO:0000122; GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0007219; GO:0009952; GO:0043425; GO:0043565; GO:0045665; GO:0045892; GO:0046982; GO:0048635; GO:0050767 anterior/posterior pattern specification [GO:0009952]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of muscle organ development [GO:0048635]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of transcription by RNA polymerase II [GO:0000122]; Notch signaling pathway [GO:0007219]; regulation of neurogenesis [GO:0050767]; regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] bHLH transcription factor binding [GO:0043425]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein heterodimerization activity [GO:0046982]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565] g11662.t1 Q8AVU4 58.955 134 4.06e-46 159.0 sp|Q8AVU4|HES1B_XENLA Transcription factor HES-1-B OS=Xenopus laevis OX=8355 GN=hes1-b PE=2 SV=1 g11663.t1 Q4V8C3 42.049 654 1.41e-176 530.0 sp|Q4V8C3|EMAL1_RAT Echinoderm microtubule-associated protein-like 1 OS=Rattus norvegicus OX=10116 GN=Eml1 PE=1 SV=2 EMAL1_RAT reviewed Echinoderm microtubule-associated protein-like 1 (EMAP-1) Rattus norvegicus (Rat) GO:0000226; GO:0002244; GO:0005829; GO:0005874; GO:0007052; GO:0007405; GO:0007420; GO:0008017; GO:0015630; GO:0015631; GO:0048471; GO:0097431; GO:1990023 brain development [GO:0007420]; hematopoietic progenitor cell differentiation [GO:0002244]; microtubule cytoskeleton organization [GO:0000226]; mitotic spindle organization [GO:0007052]; neuroblast proliferation [GO:0007405] cytosol [GO:0005829]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; mitotic spindle midzone [GO:1990023]; mitotic spindle pole [GO:0097431]; perinuclear region of cytoplasm [GO:0048471] microtubule binding [GO:0008017]; tubulin binding [GO:0015631] g11664.t1 O88809 33.333 246 3.69e-30 123.0 sp|O88809|DCX_MOUSE Neuronal migration protein doublecortin OS=Mus musculus OX=10090 GN=Dcx PE=1 SV=1 DCX_MOUSE reviewed Neuronal migration protein doublecortin (Doublin) (Lissencephalin-X) (Lis-X) Mus musculus (Mouse) GO:0001764; GO:0005737; GO:0005829; GO:0005874; GO:0007420; GO:0008017; GO:0019901; GO:0021766; GO:0021819; GO:0021860; GO:0021952; GO:0030424; GO:0030425; GO:0030426; GO:0035082; GO:0035556; GO:0043005; GO:0043025; GO:0045807; GO:0048672; GO:0048675; GO:0048813; GO:0060041; GO:0098793; GO:0098978; GO:0098982; GO:0150052 axon extension [GO:0048675]; axoneme assembly [GO:0035082]; brain development [GO:0007420]; central nervous system projection neuron axonogenesis [GO:0021952]; dendrite morphogenesis [GO:0048813]; hippocampus development [GO:0021766]; intracellular signal transduction [GO:0035556]; layer formation in cerebral cortex [GO:0021819]; neuron migration [GO:0001764]; positive regulation of collateral sprouting [GO:0048672]; positive regulation of endocytosis [GO:0045807]; pyramidal neuron development [GO:0021860]; regulation of postsynapse assembly [GO:0150052]; retina development in camera-type eye [GO:0060041] axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; microtubule [GO:0005874]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; presynapse [GO:0098793] microtubule binding [GO:0008017]; protein kinase binding [GO:0019901] g11665.t1 Q15427 92.891 211 1.8e-131 386.0 sp|Q15427|SF3B4_HUMAN Splicing factor 3B subunit 4 OS=Homo sapiens OX=9606 GN=SF3B4 PE=1 SV=1 SF3B4_HUMAN reviewed Splicing factor 3B subunit 4 (Pre-mRNA-splicing factor SF3b 49 kDa subunit) (Spliceosome-associated protein 49) (SAP 49) Homo sapiens (Human) GO:0000375; GO:0000398; GO:0003723; GO:0005634; GO:0005654; GO:0005681; GO:0005684; GO:0005686; GO:0005689; GO:0006397; GO:0008380; GO:0071005; GO:0071011; GO:1903241; GO:1990935 mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; RNA splicing [GO:0008380]; RNA splicing, via transesterification reactions [GO:0000375]; U2-type prespliceosome assembly [GO:1903241] nucleoplasm [GO:0005654]; nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; spliceosomal complex [GO:0005681]; U12-type spliceosomal complex [GO:0005689]; U2 snRNP [GO:0005686]; U2-type precatalytic spliceosome [GO:0071005]; U2-type spliceosomal complex [GO:0005684] RNA binding [GO:0003723]; splicing factor binding [GO:1990935] g11666.t1 Q96T58 53.506 271 8.099999999999999e-91 328.0 sp|Q96T58|MINT_HUMAN Msx2-interacting protein OS=Homo sapiens OX=9606 GN=SPEN PE=1 SV=1 MINT_HUMAN reviewed Msx2-interacting protein (SMART/HDAC1-associated repressor protein) (SPEN homolog) Homo sapiens (Human) GO:0000122; GO:0003677; GO:0003714; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0006357; GO:0007219; GO:0017053; GO:0031048; GO:0045892; GO:0050769; GO:0060816; GO:0061629; GO:0070062 negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; Notch signaling pathway [GO:0007219]; positive regulation of neurogenesis [GO:0050769]; random inactivation of X chromosome [GO:0060816]; regulation of transcription by RNA polymerase II [GO:0006357]; regulatory ncRNA-mediated heterochromatin formation [GO:0031048] extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053] DNA binding [GO:0003677]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription corepressor activity [GO:0003714] g11666.t1 Q96T58 48.81 168 4.55e-35 150.0 sp|Q96T58|MINT_HUMAN Msx2-interacting protein OS=Homo sapiens OX=9606 GN=SPEN PE=1 SV=1 MINT_HUMAN reviewed Msx2-interacting protein (SMART/HDAC1-associated repressor protein) (SPEN homolog) Homo sapiens (Human) GO:0000122; GO:0003677; GO:0003714; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0006357; GO:0007219; GO:0017053; GO:0031048; GO:0045892; GO:0050769; GO:0060816; GO:0061629; GO:0070062 negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; Notch signaling pathway [GO:0007219]; positive regulation of neurogenesis [GO:0050769]; random inactivation of X chromosome [GO:0060816]; regulation of transcription by RNA polymerase II [GO:0006357]; regulatory ncRNA-mediated heterochromatin formation [GO:0031048] extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053] DNA binding [GO:0003677]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription corepressor activity [GO:0003714] g11670.t1 Q96T58 57.292 192 2.57e-59 222.0 sp|Q96T58|MINT_HUMAN Msx2-interacting protein OS=Homo sapiens OX=9606 GN=SPEN PE=1 SV=1 MINT_HUMAN reviewed Msx2-interacting protein (SMART/HDAC1-associated repressor protein) (SPEN homolog) Homo sapiens (Human) GO:0000122; GO:0003677; GO:0003714; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0006357; GO:0007219; GO:0017053; GO:0031048; GO:0045892; GO:0050769; GO:0060816; GO:0061629; GO:0070062 negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; Notch signaling pathway [GO:0007219]; positive regulation of neurogenesis [GO:0050769]; random inactivation of X chromosome [GO:0060816]; regulation of transcription by RNA polymerase II [GO:0006357]; regulatory ncRNA-mediated heterochromatin formation [GO:0031048] extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053] DNA binding [GO:0003677]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription corepressor activity [GO:0003714] g11675.t1 A2ALS5 53.052 426 2.42e-152 462.0 sp|A2ALS5|RPGP1_MOUSE Rap1 GTPase-activating protein 1 OS=Mus musculus OX=10090 GN=Rap1gap PE=1 SV=2 RPGP1_MOUSE reviewed Rap1 GTPase-activating protein 1 (Rap1GAP) (Rap1GAP1) (ARPP-90) Mus musculus (Mouse) GO:0000139; GO:0005096; GO:0005737; GO:0005769; GO:0005829; GO:0016020; GO:0022409; GO:0030424; GO:0030425; GO:0031267; GO:0042803; GO:0043025; GO:0045665; GO:0050766; GO:0051056; GO:1903697; GO:1904442; GO:1990792 cellular response to glial cell derived neurotrophic factor [GO:1990792]; negative regulation of microvillus assembly [GO:1903697]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of thyroid gland epithelial cell proliferation [GO:1904442]; positive regulation of cell-cell adhesion [GO:0022409]; positive regulation of phagocytosis [GO:0050766]; regulation of small GTPase mediated signal transduction [GO:0051056] axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; early endosome [GO:0005769]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; neuronal cell body [GO:0043025] GTPase activator activity [GO:0005096]; protein homodimerization activity [GO:0042803]; small GTPase binding [GO:0031267] g11699.t1 Q9P2J3 41.87 246 5.0699999999999995e-67 223.0 sp|Q9P2J3|KLHL9_HUMAN Kelch-like protein 9 OS=Homo sapiens OX=9606 GN=KLHL9 PE=1 SV=2 KLHL9_HUMAN reviewed Kelch-like protein 9 Homo sapiens (Human) GO:0005829; GO:0016567; GO:0030496; GO:0031463; GO:0032465; GO:0051301; GO:0097602 cell division [GO:0051301]; protein ubiquitination [GO:0016567]; regulation of cytokinesis [GO:0032465] Cul3-RING ubiquitin ligase complex [GO:0031463]; cytosol [GO:0005829]; midbody [GO:0030496] cullin family protein binding [GO:0097602] g11702.t1 Q9D287 60.0 195 9.46e-81 246.0 sp|Q9D287|SPF27_MOUSE Pre-mRNA-splicing factor SPF27 OS=Mus musculus OX=10090 GN=Bcas2 PE=1 SV=1 SPF27_MOUSE reviewed Pre-mRNA-splicing factor SPF27 (Breast carcinoma-amplified sequence 2 homolog) (DNA amplified in mammary carcinoma 1 protein) Mus musculus (Mouse) GO:0000380; GO:0000398; GO:0000974; GO:0001541; GO:0005634; GO:0005662; GO:0005681; GO:0005730; GO:0005813; GO:0007611; GO:0016358; GO:0016607; GO:0021542; GO:0030163; GO:0048477; GO:0048599; GO:0048813; GO:0051225; GO:0071007; GO:0071013; GO:0097061 alternative mRNA splicing, via spliceosome [GO:0000380]; dendrite development [GO:0016358]; dendrite morphogenesis [GO:0048813]; dendritic spine organization [GO:0097061]; dentate gyrus development [GO:0021542]; learning or memory [GO:0007611]; mRNA splicing, via spliceosome [GO:0000398]; oocyte development [GO:0048599]; oogenesis [GO:0048477]; ovarian follicle development [GO:0001541]; protein catabolic process [GO:0030163]; spindle assembly [GO:0051225] catalytic step 2 spliceosome [GO:0071013]; centrosome [GO:0005813]; DNA replication factor A complex [GO:0005662]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleus [GO:0005634]; Prp19 complex [GO:0000974]; spliceosomal complex [GO:0005681]; U2-type catalytic step 2 spliceosome [GO:0071007] g11703.t1 Q645J3 58.095 210 6.95e-85 254.0 sp|Q645J3|SGMR1_TARGR Sigma non-opioid intracellular receptor 1 OS=Taricha granulosa OX=8321 GN=SIGMAR1 PE=2 SV=1 g11706.t1 Q9W436 34.375 736 2.58e-144 447.0 sp|Q9W436|NEP_DROME Neprilysin-1 OS=Drosophila melanogaster OX=7227 GN=Nep1 PE=2 SV=2 NEP_DROME reviewed Neprilysin-1 (EC 3.4.24.11) Drosophila melanogaster (Fruit fly) GO:0004222; GO:0005886; GO:0006508; GO:0008237; GO:0016020; GO:0046872 proteolysis [GO:0006508] membrane [GO:0016020]; plasma membrane [GO:0005886] metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237] g11708.t1 Q6DCE8 45.522 134 4.9e-45 110.0 sp|Q6DCE8|CTR2_XENLA Cationic amino acid transporter 2 OS=Xenopus laevis OX=8355 GN=slc7a2 PE=2 SV=1 g11708.t1 Q6DCE8 60.317 63 4.9e-45 92.0 sp|Q6DCE8|CTR2_XENLA Cationic amino acid transporter 2 OS=Xenopus laevis OX=8355 GN=slc7a2 PE=2 SV=1 g11709.t1 P30823 36.059 269 2.62e-29 119.0 sp|P30823|CTR1_RAT High affinity cationic amino acid transporter 1 OS=Rattus norvegicus OX=10116 GN=Slc7a1 PE=2 SV=1 CTR1_RAT reviewed High affinity cationic amino acid transporter 1 (CAT-1) (CAT1) (Ecotropic retroviral leukemia receptor) (Ecotropic retrovirus receptor) (EcoR) (Solute carrier family 7 member 1) (System Y+ basic amino acid transporter) Rattus norvegicus (Rat) GO:0000064; GO:0001618; GO:0005290; GO:0005886; GO:0009925; GO:0015171; GO:0015174; GO:0015189; GO:0015802; GO:0015807; GO:0015819; GO:0015822; GO:0016323; GO:0016324; GO:0032006; GO:0032991; GO:0042102; GO:0061459; GO:0089718; GO:0097638; GO:1903352; GO:1903810; GO:1903826 amino acid import across plasma membrane [GO:0089718]; basic amino acid transport [GO:0015802]; L-amino acid transport [GO:0015807]; L-arginine import across plasma membrane [GO:0097638]; L-arginine transmembrane transport [GO:1903826]; L-histidine import across plasma membrane [GO:1903810]; L-ornithine transmembrane transport [GO:1903352]; lysine transport [GO:0015819]; ornithine transport [GO:0015822]; positive regulation of T cell proliferation [GO:0042102]; regulation of TOR signaling [GO:0032006] apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] amino acid transmembrane transporter activity [GO:0015171]; basic amino acid transmembrane transporter activity [GO:0015174]; L-arginine transmembrane transporter activity [GO:0061459]; L-histidine transmembrane transporter activity [GO:0005290]; L-lysine transmembrane transporter activity [GO:0015189]; L-ornithine transmembrane transporter activity [GO:0000064]; virus receptor activity [GO:0001618] g11715.t1 Q8IYB7 41.146 384 1.47e-77 259.0 sp|Q8IYB7|DI3L2_HUMAN DIS3-like exonuclease 2 OS=Homo sapiens OX=9606 GN=DIS3L2 PE=1 SV=4 DI3L2_HUMAN reviewed DIS3-like exonuclease 2 (hDIS3L2) (EC 3.1.13.-) Homo sapiens (Human) GO:0000175; GO:0000278; GO:0000287; GO:0000932; GO:0000956; GO:0004540; GO:0005737; GO:0006402; GO:0008266; GO:0008285; GO:0010587; GO:0019827; GO:0051301; GO:0051306; GO:1990074 cell division [GO:0051301]; miRNA catabolic process [GO:0010587]; mitotic cell cycle [GO:0000278]; mitotic sister chromatid separation [GO:0051306]; mRNA catabolic process [GO:0006402]; negative regulation of cell population proliferation [GO:0008285]; nuclear-transcribed mRNA catabolic process [GO:0000956]; polyuridylation-dependent mRNA catabolic process [GO:1990074]; stem cell population maintenance [GO:0019827] cytoplasm [GO:0005737]; P-body [GO:0000932] 3'-5'-RNA exonuclease activity [GO:0000175]; magnesium ion binding [GO:0000287]; poly(U) RNA binding [GO:0008266]; RNA nuclease activity [GO:0004540] g11716.t1 Q0V9R3 49.011 455 9.56e-142 428.0 sp|Q0V9R3|DI3L2_XENTR DIS3-like exonuclease 2 OS=Xenopus tropicalis OX=8364 GN=dis3l2 PE=2 SV=2 g11722.t1 Q8CI75 55.222 632 0.0 724.0 sp|Q8CI75|DI3L2_MOUSE DIS3-like exonuclease 2 OS=Mus musculus OX=10090 GN=Dis3l2 PE=1 SV=1 DI3L2_MOUSE reviewed DIS3-like exonuclease 2 (EC 3.1.13.-) Mus musculus (Mouse) GO:0000175; GO:0000278; GO:0000287; GO:0000932; GO:0000956; GO:0004540; GO:0005737; GO:0005829; GO:0006402; GO:0008266; GO:0008285; GO:0010587; GO:0019827; GO:0051301; GO:0051306; GO:1990074 cell division [GO:0051301]; miRNA catabolic process [GO:0010587]; mitotic cell cycle [GO:0000278]; mitotic sister chromatid separation [GO:0051306]; mRNA catabolic process [GO:0006402]; negative regulation of cell population proliferation [GO:0008285]; nuclear-transcribed mRNA catabolic process [GO:0000956]; polyuridylation-dependent mRNA catabolic process [GO:1990074]; stem cell population maintenance [GO:0019827] cytoplasm [GO:0005737]; cytosol [GO:0005829]; P-body [GO:0000932] 3'-5'-RNA exonuclease activity [GO:0000175]; magnesium ion binding [GO:0000287]; poly(U) RNA binding [GO:0008266]; RNA nuclease activity [GO:0004540] g11723.t1 P32138 48.159 679 0.0 670.0 sp|P32138|SQASE_ECOLI Sulfoquinovosidase OS=Escherichia coli (strain K12) OX=83333 GN=yihQ PE=1 SV=3 SQASE_ECOLI reviewed Sulfoquinovosidase (SQase) (EC 3.2.1.199) Escherichia coli (strain K12) GO:0004553; GO:0005975; GO:0030246; GO:0061720; GO:1990929 6-sulfoquinovose(1-) catabolic process to glycerone phosphate and 3-sulfolactaldehyde [GO:0061720]; carbohydrate metabolic process [GO:0005975] carbohydrate binding [GO:0030246]; hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]; sulfoquinovosidase activity [GO:1990929] g11724.t1 Q9WU20 65.412 425 0.0 586.0 sp|Q9WU20|MTHR_MOUSE Methylenetetrahydrofolate reductase (NADPH) OS=Mus musculus OX=10090 GN=Mthfr PE=1 SV=2 MTHR_MOUSE reviewed Methylenetetrahydrofolate reductase (NADPH) (EC 1.5.1.53) Mus musculus (Mouse) GO:0001843; GO:0004489; GO:0005829; GO:0006555; GO:0009086; GO:0035999; GO:0044877; GO:0046653; GO:0050660; GO:0050661; GO:0050667; GO:0070828; GO:0071949; GO:0072341; GO:0106313 heterochromatin organization [GO:0070828]; homocysteine metabolic process [GO:0050667]; methionine biosynthetic process [GO:0009086]; methionine metabolic process [GO:0006555]; neural tube closure [GO:0001843]; tetrahydrofolate interconversion [GO:0035999]; tetrahydrofolate metabolic process [GO:0046653] cytosol [GO:0005829] FAD binding [GO:0071949]; flavin adenine dinucleotide binding [GO:0050660]; methylenetetrahydrofolate reductase (NADPH) activity [GO:0106313]; methylenetetrahydrofolate reductase [NAD(P)H] activity [GO:0004489]; modified amino acid binding [GO:0072341]; NADP binding [GO:0050661]; protein-containing complex binding [GO:0044877] g11726.t1 A1A4J8 61.364 220 5.64e-97 291.0 sp|A1A4J8|SCO1_BOVIN Protein SCO1 homolog, mitochondrial OS=Bos taurus OX=9913 GN=SCO1 PE=2 SV=1 g11727.t1 Q4FZX7 49.393 247 5.1700000000000005e-73 227.0 sp|Q4FZX7|SRPRB_RAT Signal recognition particle receptor subunit beta OS=Rattus norvegicus OX=10116 GN=Srprb PE=2 SV=1 g11730.t1 O05389 32.941 340 1.0799999999999999e-54 188.0 sp|O05389|YRBE_BACSU Uncharacterized oxidoreductase YrbE OS=Bacillus subtilis (strain 168) OX=224308 GN=yrbE PE=3 SV=2 g11733.t1 O05389 33.333 342 3.81e-59 197.0 sp|O05389|YRBE_BACSU Uncharacterized oxidoreductase YrbE OS=Bacillus subtilis (strain 168) OX=224308 GN=yrbE PE=3 SV=2 g11734.t1 P56389 65.625 64 2.4799999999999997e-23 89.7 sp|P56389|CDD_MOUSE Cytidine deaminase OS=Mus musculus OX=10090 GN=Cda PE=1 SV=2 CDD_MOUSE reviewed Cytidine deaminase (EC 3.5.4.5) (Cytidine aminohydrolase) Mus musculus (Mouse) GO:0001882; GO:0004126; GO:0005829; GO:0006248; GO:0006249; GO:0008270; GO:0019239; GO:0042802; GO:0042803; GO:0044206; GO:0071217 cellular response to external biotic stimulus [GO:0071217]; CMP catabolic process [GO:0006248]; dCMP catabolic process [GO:0006249]; UMP salvage [GO:0044206] cytosol [GO:0005829] cytidine deaminase activity [GO:0004126]; deaminase activity [GO:0019239]; identical protein binding [GO:0042802]; nucleoside binding [GO:0001882]; protein homodimerization activity [GO:0042803]; zinc ion binding [GO:0008270] g11735.t1 P15428 33.333 249 2.91e-47 161.0 sp|P15428|PGDH_HUMAN 15-hydroxyprostaglandin dehydrogenase [NAD(+)] OS=Homo sapiens OX=9606 GN=HPGD PE=1 SV=1 PGDH_HUMAN reviewed 15-hydroxyprostaglandin dehydrogenase [NAD(+)] (15-PGDH) (EC 1.1.1.141) (Eicosanoid/docosanoid dehydrogenase [NAD(+)]) (EC 1.1.1.-, EC 1.1.1.232) (Prostaglandin dehydrogenase 1) (Short chain dehydrogenase/reductase family 36C member 1) Homo sapiens (Human) GO:0001822; GO:0004957; GO:0005654; GO:0005737; GO:0005829; GO:0006693; GO:0007179; GO:0007565; GO:0007567; GO:0016323; GO:0016404; GO:0016616; GO:0019372; GO:0030728; GO:0032355; GO:0032496; GO:0042802; GO:0043065; GO:0045471; GO:0045786; GO:0047034; GO:0051287; GO:0070062; GO:0070403; GO:0070493; GO:0097070; GO:1904707; GO:1905828 ductus arteriosus closure [GO:0097070]; female pregnancy [GO:0007565]; kidney development [GO:0001822]; lipoxygenase pathway [GO:0019372]; negative regulation of cell cycle [GO:0045786]; ovulation [GO:0030728]; parturition [GO:0007567]; positive regulation of apoptotic process [GO:0043065]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; prostaglandin metabolic process [GO:0006693]; regulation of prostaglandin catabolic process [GO:1905828]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to lipopolysaccharide [GO:0032496]; thrombin-activated receptor signaling pathway [GO:0070493]; transforming growth factor beta receptor signaling pathway [GO:0007179] basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654] 15-hydroxyicosatetraenoate dehydrogenase activity [GO:0047034]; 15-hydroxyprostaglandin dehydrogenase (NAD+) activity [GO:0016404]; identical protein binding [GO:0042802]; NAD binding [GO:0051287]; NAD+ binding [GO:0070403]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]; prostaglandin E receptor activity [GO:0004957] g11736.t1 Q80V31 50.611 409 1.5800000000000003e-123 383.0 sp|Q80V31|CE104_MOUSE Centrosomal protein of 104 kDa OS=Mus musculus OX=10090 GN=Cep104 PE=1 SV=1 g11736.t2 O60308 50.605 413 1.43e-123 382.0 sp|O60308|CE104_HUMAN Centrosomal protein of 104 kDa OS=Homo sapiens OX=9606 GN=CEP104 PE=1 SV=1 CE104_HUMAN reviewed Centrosomal protein of 104 kDa (Cep104) Homo sapiens (Human) GO:0000922; GO:0005813; GO:0005814; GO:0005929 centriole [GO:0005814]; centrosome [GO:0005813]; cilium [GO:0005929]; spindle pole [GO:0000922] g11738.t1 D3Z8X7 47.328 131 2.51e-35 137.0 sp|D3Z8X7|CE104_RAT Centrosomal protein of 104 kDa OS=Rattus norvegicus OX=10116 GN=Cep104 PE=2 SV=3 g11743.t1 Q8TAQ5 52.569 253 3.75e-87 278.0 sp|Q8TAQ5|ZN420_HUMAN Zinc finger protein 420 OS=Homo sapiens OX=9606 GN=ZNF420 PE=1 SV=1 g11743.t1 Q8TAQ5 51.21 248 8.289999999999999e-82 264.0 sp|Q8TAQ5|ZN420_HUMAN Zinc finger protein 420 OS=Homo sapiens OX=9606 GN=ZNF420 PE=1 SV=1 g11743.t1 Q8TAQ5 49.802 253 8.44e-78 253.0 sp|Q8TAQ5|ZN420_HUMAN Zinc finger protein 420 OS=Homo sapiens OX=9606 GN=ZNF420 PE=1 SV=1 g11743.t1 Q8TAQ5 47.308 260 6.2e-77 251.0 sp|Q8TAQ5|ZN420_HUMAN Zinc finger protein 420 OS=Homo sapiens OX=9606 GN=ZNF420 PE=1 SV=1 g11743.t1 Q8TAQ5 47.984 248 2e-76 249.0 sp|Q8TAQ5|ZN420_HUMAN Zinc finger protein 420 OS=Homo sapiens OX=9606 GN=ZNF420 PE=1 SV=1 g11743.t1 Q8TAQ5 48.221 253 1.36e-75 247.0 sp|Q8TAQ5|ZN420_HUMAN Zinc finger protein 420 OS=Homo sapiens OX=9606 GN=ZNF420 PE=1 SV=1 g11743.t1 Q8TAQ5 47.41 251 3.33e-75 246.0 sp|Q8TAQ5|ZN420_HUMAN Zinc finger protein 420 OS=Homo sapiens OX=9606 GN=ZNF420 PE=1 SV=1 g11743.t1 Q8TAQ5 46.538 260 8.97e-74 243.0 sp|Q8TAQ5|ZN420_HUMAN Zinc finger protein 420 OS=Homo sapiens OX=9606 GN=ZNF420 PE=1 SV=1 g11743.t1 Q8TAQ5 45.0 260 9.56e-74 243.0 sp|Q8TAQ5|ZN420_HUMAN Zinc finger protein 420 OS=Homo sapiens OX=9606 GN=ZNF420 PE=1 SV=1 g11743.t1 Q8TAQ5 50.0 234 2.34e-73 241.0 sp|Q8TAQ5|ZN420_HUMAN Zinc finger protein 420 OS=Homo sapiens OX=9606 GN=ZNF420 PE=1 SV=1 g11743.t1 Q8TAQ5 45.85 253 3.59e-73 241.0 sp|Q8TAQ5|ZN420_HUMAN Zinc finger protein 420 OS=Homo sapiens OX=9606 GN=ZNF420 PE=1 SV=1 g11743.t1 Q8TAQ5 47.082 257 7.04e-73 240.0 sp|Q8TAQ5|ZN420_HUMAN Zinc finger protein 420 OS=Homo sapiens OX=9606 GN=ZNF420 PE=1 SV=1 g11744.t1 B0DOB4 33.009 821 4.79e-113 380.0 sp|B0DOB4|NPHP4_XENLA Nephrocystin-4 OS=Xenopus laevis OX=8355 GN=nphp4 PE=2 SV=1 g11744.t2 B0DOB4 32.488 828 1.34e-110 375.0 sp|B0DOB4|NPHP4_XENLA Nephrocystin-4 OS=Xenopus laevis OX=8355 GN=nphp4 PE=2 SV=1 g11745.t1 B0DOB4 46.711 608 4.6500000000000004e-179 547.0 sp|B0DOB4|NPHP4_XENLA Nephrocystin-4 OS=Xenopus laevis OX=8355 GN=nphp4 PE=2 SV=1 g11747.t1 Q8N3Y7 45.018 271 7.64e-80 248.0 sp|Q8N3Y7|RDHE2_HUMAN Epidermal retinol dehydrogenase 2 OS=Homo sapiens OX=9606 GN=SDR16C5 PE=1 SV=2 RDHE2_HUMAN reviewed Epidermal retinol dehydrogenase 2 (EPHD-2) (RDH-E2) (EC 1.1.1.105) (Retinal short-chain dehydrogenase reductase 2) (retSDR2) (Short-chain dehydrogenase/reductase family 16C member 5) Homo sapiens (Human) GO:0000122; GO:0000785; GO:0003714; GO:0004745; GO:0005634; GO:0005789; GO:0005811; GO:0017053; GO:0042572; GO:0042574; GO:0043616; GO:0045814; GO:0061629; GO:0140297 keratinocyte proliferation [GO:0043616]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of transcription by RNA polymerase II [GO:0000122]; retinal metabolic process [GO:0042574]; retinol metabolic process [GO:0042572] chromatin [GO:0000785]; endoplasmic reticulum membrane [GO:0005789]; lipid droplet [GO:0005811]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053] all-trans-retinol dehydrogenase (NAD+) activity [GO:0004745]; DNA-binding transcription factor binding [GO:0140297]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription corepressor activity [GO:0003714] g11751.t1 P49275 38.258 264 4.08e-43 150.0 sp|P49275|DERF3_DERFA Mite allergen Der f 3 OS=Dermatophagoides farinae OX=6954 GN=DERF3 PE=1 SV=2 g11752.t1 P70059 40.769 260 3.18e-52 173.0 sp|P70059|TRY2_XENLA Trypsin OS=Xenopus laevis OX=8355 PE=2 SV=1 g11756.t1 P46197 57.391 230 3.93e-72 255.0 sp|P46197|ANPRB_BOVIN Atrial natriuretic peptide receptor 2 OS=Bos taurus OX=9913 GN=NPR2 PE=2 SV=1 g11777.t1 Q3B7T6 68.067 238 3.5199999999999996e-119 343.0 sp|Q3B7T6|CNEP1_RAT CTD nuclear envelope phosphatase 1 OS=Rattus norvegicus OX=10116 GN=Ctdnep1 PE=2 SV=2 CNEP1_RAT reviewed CTD nuclear envelope phosphatase 1 (EC 3.1.3.16) (Serine/threonine-protein phosphatase dullard) Rattus norvegicus (Rat) GO:0004721; GO:0004722; GO:0005634; GO:0005635; GO:0005737; GO:0005789; GO:0005811; GO:0006998; GO:0007276; GO:0007498; GO:0010867; GO:0031965; GO:0034504; GO:0071595; GO:0090263 gamete generation [GO:0007276]; mesoderm development [GO:0007498]; nuclear envelope organization [GO:0006998]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of triglyceride biosynthetic process [GO:0010867]; protein localization to nucleus [GO:0034504] cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; lipid droplet [GO:0005811]; Nem1-Spo7 phosphatase complex [GO:0071595]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nucleus [GO:0005634] phosphoprotein phosphatase activity [GO:0004721]; protein serine/threonine phosphatase activity [GO:0004722] g11781.t1 O95619 77.57 214 1.4899999999999999e-115 334.0 sp|O95619|YETS4_HUMAN YEATS domain-containing protein 4 OS=Homo sapiens OX=9606 GN=YEATS4 PE=1 SV=1 YETS4_HUMAN reviewed YEATS domain-containing protein 4 (Glioma-amplified sequence 41) (Gas41) (NuMA-binding protein 1) (NuBI-1) (NuBI1) Homo sapiens (Human) GO:0000278; GO:0000786; GO:0005200; GO:0005634; GO:0005654; GO:0006338; GO:0006355; GO:0006357; GO:0016363; GO:0031965; GO:0035267; GO:0042393; GO:0042981; GO:0045893; GO:0051726; GO:0140044; GO:0140119; GO:1905168; GO:2000779 chromatin remodeling [GO:0006338]; mitotic cell cycle [GO:0000278]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of DNA-templated transcription [GO:0006355]; regulation of double-strand break repair [GO:2000779]; regulation of transcription by RNA polymerase II [GO:0006357] NuA4 histone acetyltransferase complex [GO:0035267]; nuclear matrix [GO:0016363]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634] histone binding [GO:0042393]; histone H3K18ac reader activity [GO:0140044]; histone H3K27ac reader activity [GO:0140119]; structural constituent of cytoskeleton [GO:0005200] g11782.t1 O54697 34.827 692 5e-114 363.0 sp|O54697|NALDL_RAT Aminopeptidase NAALADL1 OS=Rattus norvegicus OX=10116 GN=Naaladl1 PE=1 SV=1 g11785.t1 Q95JN5 46.964 560 2.24e-154 476.0 sp|Q95JN5|AT133_MACFA Polyamine-transporting ATPase 13A3 OS=Macaca fascicularis OX=9541 GN=ATP13A3 PE=2 SV=3 AT133_MACFA reviewed Polyamine-transporting ATPase 13A3 (ATPase family homolog up-regulated in senescence cells 1) (Putrescine transporting ATPase) (EC 7.6.2.16) Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey) GO:0005524; GO:0006874; GO:0015594; GO:0015662; GO:0016887; GO:0019829; GO:0031901; GO:0031902; GO:0046872; GO:0055038; GO:0140358 intracellular calcium ion homeostasis [GO:0006874] early endosome membrane [GO:0031901]; late endosome membrane [GO:0031902]; recycling endosome membrane [GO:0055038] ABC-type putrescine transporter activity [GO:0015594]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled monoatomic cation transmembrane transporter activity [GO:0019829]; metal ion binding [GO:0046872]; P-type ion transporter activity [GO:0015662]; P-type transmembrane transporter activity [GO:0140358] g11786.t1 Q95JN5 43.664 584 8.65e-155 478.0 sp|Q95JN5|AT133_MACFA Polyamine-transporting ATPase 13A3 OS=Macaca fascicularis OX=9541 GN=ATP13A3 PE=2 SV=3 AT133_MACFA reviewed Polyamine-transporting ATPase 13A3 (ATPase family homolog up-regulated in senescence cells 1) (Putrescine transporting ATPase) (EC 7.6.2.16) Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey) GO:0005524; GO:0006874; GO:0015594; GO:0015662; GO:0016887; GO:0019829; GO:0031901; GO:0031902; GO:0046872; GO:0055038; GO:0140358 intracellular calcium ion homeostasis [GO:0006874] early endosome membrane [GO:0031901]; late endosome membrane [GO:0031902]; recycling endosome membrane [GO:0055038] ABC-type putrescine transporter activity [GO:0015594]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled monoatomic cation transmembrane transporter activity [GO:0019829]; metal ion binding [GO:0046872]; P-type ion transporter activity [GO:0015662]; P-type transmembrane transporter activity [GO:0140358] g11786.t2 Q95JN5 43.174 586 1.77e-155 480.0 sp|Q95JN5|AT133_MACFA Polyamine-transporting ATPase 13A3 OS=Macaca fascicularis OX=9541 GN=ATP13A3 PE=2 SV=3 AT133_MACFA reviewed Polyamine-transporting ATPase 13A3 (ATPase family homolog up-regulated in senescence cells 1) (Putrescine transporting ATPase) (EC 7.6.2.16) Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey) GO:0005524; GO:0006874; GO:0015594; GO:0015662; GO:0016887; GO:0019829; GO:0031901; GO:0031902; GO:0046872; GO:0055038; GO:0140358 intracellular calcium ion homeostasis [GO:0006874] early endosome membrane [GO:0031901]; late endosome membrane [GO:0031902]; recycling endosome membrane [GO:0055038] ABC-type putrescine transporter activity [GO:0015594]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled monoatomic cation transmembrane transporter activity [GO:0019829]; metal ion binding [GO:0046872]; P-type ion transporter activity [GO:0015662]; P-type transmembrane transporter activity [GO:0140358] g11787.t1 Q95JN5 45.255 1138 0.0 924.0 sp|Q95JN5|AT133_MACFA Polyamine-transporting ATPase 13A3 OS=Macaca fascicularis OX=9541 GN=ATP13A3 PE=2 SV=3 AT133_MACFA reviewed Polyamine-transporting ATPase 13A3 (ATPase family homolog up-regulated in senescence cells 1) (Putrescine transporting ATPase) (EC 7.6.2.16) Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey) GO:0005524; GO:0006874; GO:0015594; GO:0015662; GO:0016887; GO:0019829; GO:0031901; GO:0031902; GO:0046872; GO:0055038; GO:0140358 intracellular calcium ion homeostasis [GO:0006874] early endosome membrane [GO:0031901]; late endosome membrane [GO:0031902]; recycling endosome membrane [GO:0055038] ABC-type putrescine transporter activity [GO:0015594]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled monoatomic cation transmembrane transporter activity [GO:0019829]; metal ion binding [GO:0046872]; P-type ion transporter activity [GO:0015662]; P-type transmembrane transporter activity [GO:0140358] g11787.t2 Q95JN5 44.979 1165 0.0 933.0 sp|Q95JN5|AT133_MACFA Polyamine-transporting ATPase 13A3 OS=Macaca fascicularis OX=9541 GN=ATP13A3 PE=2 SV=3 AT133_MACFA reviewed Polyamine-transporting ATPase 13A3 (ATPase family homolog up-regulated in senescence cells 1) (Putrescine transporting ATPase) (EC 7.6.2.16) Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey) GO:0005524; GO:0006874; GO:0015594; GO:0015662; GO:0016887; GO:0019829; GO:0031901; GO:0031902; GO:0046872; GO:0055038; GO:0140358 intracellular calcium ion homeostasis [GO:0006874] early endosome membrane [GO:0031901]; late endosome membrane [GO:0031902]; recycling endosome membrane [GO:0055038] ABC-type putrescine transporter activity [GO:0015594]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled monoatomic cation transmembrane transporter activity [GO:0019829]; metal ion binding [GO:0046872]; P-type ion transporter activity [GO:0015662]; P-type transmembrane transporter activity [GO:0140358] g11788.t1 Q5RDY1 42.763 304 2.03e-76 239.0 sp|Q5RDY1|NPL_PONAB N-acetylneuraminate lyase OS=Pongo abelii OX=9601 GN=NPL PE=2 SV=1 NPL_PONAB reviewed N-acetylneuraminate lyase (NALase) (EC 4.1.3.3) (N-acetylneuraminate pyruvate-lyase) (N-acetylneuraminic acid aldolase) (Sialate lyase) (Sialate-pyruvate lyase) (Sialic acid aldolase) (Sialic acid lyase) Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0005737; GO:0005975; GO:0008747; GO:0019262 carbohydrate metabolic process [GO:0005975]; N-acetylneuraminate catabolic process [GO:0019262] cytoplasm [GO:0005737] N-acetylneuraminate lyase activity [GO:0008747] g11789.t1 Q58CP2 49.442 269 2.05e-87 268.0 sp|Q58CP2|SUMF2_BOVIN Inactive C-alpha-formylglycine-generating enzyme 2 OS=Bos taurus OX=9913 GN=SUMF2 PE=2 SV=1 g11789.t2 Q58CP2 49.814 269 3.68e-85 263.0 sp|Q58CP2|SUMF2_BOVIN Inactive C-alpha-formylglycine-generating enzyme 2 OS=Bos taurus OX=9913 GN=SUMF2 PE=2 SV=1 g11791.t1 Q0VGW6 49.4 917 0.0 795.0 sp|Q0VGW6|S12A9_XENLA Solute carrier family 12 member 9 OS=Xenopus laevis OX=8355 GN=slc12a9 PE=2 SV=1 g11796.t1 O14039 46.269 134 1.1800000000000001e-32 122.0 sp|O14039|RCM1_SCHPO 25S rRNA (cytosine-C(5))-methyltransferase rcm1 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) OX=284812 GN=rcm1 PE=3 SV=3 g11798.t1 Q9H0R3 61.111 162 2.03e-75 228.0 sp|Q9H0R3|TM222_HUMAN Transmembrane protein 222 OS=Homo sapiens OX=9606 GN=TMEM222 PE=1 SV=2 TM222_HUMAN reviewed Transmembrane protein 222 Homo sapiens (Human) GO:0016020; GO:0030425 dendrite [GO:0030425]; membrane [GO:0016020] g11799.t1 Q642G4 43.049 223 3.08e-44 159.0 sp|Q642G4|PEX14_RAT Peroxisomal membrane protein PEX14 OS=Rattus norvegicus OX=10116 GN=Pex14 PE=1 SV=1 PEX14_RAT reviewed Peroxisomal membrane protein PEX14 (PTS1 receptor-docking protein) (Peroxin-14) (Peroxisomal membrane anchor protein PEX14) Rattus norvegicus (Rat) GO:0001650; GO:0003714; GO:0005102; GO:0005777; GO:0005778; GO:0007031; GO:0008017; GO:0008320; GO:0016558; GO:0016560; GO:0016561; GO:0016562; GO:0030674; GO:0032991; GO:0034453; GO:0034614; GO:0036250; GO:0042802; GO:0043335; GO:0044721; GO:0045892; GO:0048487; GO:0065003; GO:1990429 cellular response to reactive oxygen species [GO:0034614]; microtubule anchoring [GO:0034453]; negative regulation of DNA-templated transcription [GO:0045892]; peroxisome organization [GO:0007031]; peroxisome transport along microtubule [GO:0036250]; protein import into peroxisome matrix [GO:0016558]; protein import into peroxisome matrix, docking [GO:0016560]; protein import into peroxisome matrix, receptor recycling [GO:0016562]; protein import into peroxisome matrix, substrate release [GO:0044721]; protein import into peroxisome matrix, translocation [GO:0016561]; protein unfolding [GO:0043335]; protein-containing complex assembly [GO:0065003] fibrillar center [GO:0001650]; peroxisomal importomer complex [GO:1990429]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; protein-containing complex [GO:0032991] beta-tubulin binding [GO:0048487]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; protein transmembrane transporter activity [GO:0008320]; protein-macromolecule adaptor activity [GO:0030674]; signaling receptor binding [GO:0005102]; transcription corepressor activity [GO:0003714] g11805.t1 A7RL75 59.538 173 3.8000000000000003e-57 181.0 sp|A7RL75|TTC36_NEMVE Tetratricopeptide repeat protein 36 homolog OS=Nematostella vectensis OX=45351 GN=ttc36 PE=3 SV=1 g11807.t1 Q9JHG1 51.2 125 3.84e-39 130.0 sp|Q9JHG1|PIGP_MOUSE Phosphatidylinositol N-acetylglucosaminyltransferase subunit P OS=Mus musculus OX=10090 GN=Pigp PE=2 SV=1 g11808.t1 Q5ZMP6 85.185 432 0.0 777.0 sp|Q5ZMP6|AP2M1_CHICK AP-2 complex subunit mu OS=Gallus gallus OX=9031 GN=AP2M1 PE=2 SV=1 g11809.t1 Q9JJP2 44.565 276 5.61e-66 232.0 sp|Q9JJP2|P73_MOUSE Tumor protein p73 OS=Mus musculus OX=10090 GN=Tp73 PE=1 SV=1 g11809.t2 Q9JJP2 44.928 276 3.4600000000000003e-66 231.0 sp|Q9JJP2|P73_MOUSE Tumor protein p73 OS=Mus musculus OX=10090 GN=Tp73 PE=1 SV=1 g11810.t1 Q9QYS2 27.629 894 5.91e-90 307.0 sp|Q9QYS2|GRM3_MOUSE Metabotropic glutamate receptor 3 OS=Mus musculus OX=10090 GN=Grm3 PE=1 SV=1 GRM3_MOUSE reviewed Metabotropic glutamate receptor 3 (mGluR3) Mus musculus (Mouse) GO:0001641; GO:0005246; GO:0005886; GO:0007193; GO:0007216; GO:0010467; GO:0014069; GO:0019233; GO:0030424; GO:0033554; GO:0035249; GO:0042734; GO:0043005; GO:0043197; GO:0045211; GO:0048786; GO:0050804; GO:0051930; GO:0051966; GO:0097110; GO:0097449; GO:0098978; GO:0099170 adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; cellular response to stress [GO:0033554]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; gene expression [GO:0010467]; modulation of chemical synaptic transmission [GO:0050804]; postsynaptic modulation of chemical synaptic transmission [GO:0099170]; regulation of sensory perception of pain [GO:0051930]; regulation of synaptic transmission, glutamatergic [GO:0051966]; sensory perception of pain [GO:0019233]; synaptic transmission, glutamatergic [GO:0035249] astrocyte projection [GO:0097449]; axon [GO:0030424]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; presynaptic active zone [GO:0048786]; presynaptic membrane [GO:0042734] calcium channel regulator activity [GO:0005246]; group II metabotropic glutamate receptor activity [GO:0001641]; scaffold protein binding [GO:0097110] g11811.t1 Q9VGH7 52.48 383 3.0399999999999997e-89 302.0 sp|Q9VGH7|CLCN2_DROME Chloride channel protein 2 OS=Drosophila melanogaster OX=7227 GN=ClC-a PE=2 SV=3 g11812.t1 P51788 46.453 437 3.3299999999999997e-91 298.0 sp|P51788|CLCN2_HUMAN Chloride channel protein 2 OS=Homo sapiens OX=9606 GN=CLCN2 PE=1 SV=2 CLCN2_HUMAN reviewed Chloride channel protein 2 (ClC-2) Homo sapiens (Human) GO:0005247; GO:0005886; GO:0006821; GO:0006911; GO:0016323; GO:0017081; GO:0030322; GO:0030324; GO:0032347; GO:0032591; GO:0034707; GO:0043194; GO:0043204; GO:0043209; GO:0048714; GO:0060041; GO:0060075; GO:0060689; GO:0071476; GO:0072320; GO:0090425; GO:0097450; GO:0098902 acinar cell differentiation [GO:0090425]; cell differentiation involved in salivary gland development [GO:0060689]; cellular hypotonic response [GO:0071476]; chloride transport [GO:0006821]; lung development [GO:0030324]; phagocytosis, engulfment [GO:0006911]; positive regulation of oligodendrocyte differentiation [GO:0048714]; regulation of aldosterone biosynthetic process [GO:0032347]; regulation of membrane depolarization during action potential [GO:0098902]; regulation of resting membrane potential [GO:0060075]; retina development in camera-type eye [GO:0060041]; stabilization of membrane potential [GO:0030322] astrocyte end-foot [GO:0097450]; axon initial segment [GO:0043194]; basolateral plasma membrane [GO:0016323]; chloride channel complex [GO:0034707]; dendritic spine membrane [GO:0032591]; myelin sheath [GO:0043209]; perikaryon [GO:0043204]; plasma membrane [GO:0005886] chloride channel regulator activity [GO:0017081]; voltage-gated chloride channel activity [GO:0005247]; volume-sensitive chloride channel activity [GO:0072320] g11812.t2 P51788 47.17 424 8.6e-94 304.0 sp|P51788|CLCN2_HUMAN Chloride channel protein 2 OS=Homo sapiens OX=9606 GN=CLCN2 PE=1 SV=2 CLCN2_HUMAN reviewed Chloride channel protein 2 (ClC-2) Homo sapiens (Human) GO:0005247; GO:0005886; GO:0006821; GO:0006911; GO:0016323; GO:0017081; GO:0030322; GO:0030324; GO:0032347; GO:0032591; GO:0034707; GO:0043194; GO:0043204; GO:0043209; GO:0048714; GO:0060041; GO:0060075; GO:0060689; GO:0071476; GO:0072320; GO:0090425; GO:0097450; GO:0098902 acinar cell differentiation [GO:0090425]; cell differentiation involved in salivary gland development [GO:0060689]; cellular hypotonic response [GO:0071476]; chloride transport [GO:0006821]; lung development [GO:0030324]; phagocytosis, engulfment [GO:0006911]; positive regulation of oligodendrocyte differentiation [GO:0048714]; regulation of aldosterone biosynthetic process [GO:0032347]; regulation of membrane depolarization during action potential [GO:0098902]; regulation of resting membrane potential [GO:0060075]; retina development in camera-type eye [GO:0060041]; stabilization of membrane potential [GO:0030322] astrocyte end-foot [GO:0097450]; axon initial segment [GO:0043194]; basolateral plasma membrane [GO:0016323]; chloride channel complex [GO:0034707]; dendritic spine membrane [GO:0032591]; myelin sheath [GO:0043209]; perikaryon [GO:0043204]; plasma membrane [GO:0005886] chloride channel regulator activity [GO:0017081]; voltage-gated chloride channel activity [GO:0005247]; volume-sensitive chloride channel activity [GO:0072320] g11813.t1 P31424 27.033 836 4.62e-66 244.0 sp|P31424|GRM5_RAT Metabotropic glutamate receptor 5 OS=Rattus norvegicus OX=10116 GN=Grm5 PE=1 SV=2 GRM5_RAT reviewed Metabotropic glutamate receptor 5 (mGluR5) Rattus norvegicus (Rat) GO:0001639; GO:0001640; GO:0001659; GO:0001975; GO:0002029; GO:0004930; GO:0005516; GO:0005637; GO:0005737; GO:0005886; GO:0006355; GO:0006468; GO:0007200; GO:0007204; GO:0007206; GO:0007216; GO:0007268; GO:0007611; GO:0007612; GO:0007626; GO:0008066; GO:0008306; GO:0030165; GO:0030296; GO:0030425; GO:0031687; GO:0033603; GO:0035106; GO:0036228; GO:0042802; GO:0043005; GO:0043025; GO:0043197; GO:0043198; GO:0043278; GO:0043410; GO:0044309; GO:0045211; GO:0045471; GO:0046677; GO:0048015; GO:0048169; GO:0048170; GO:0050804; GO:0050808; GO:0050850; GO:0050890; GO:0051412; GO:0051966; GO:0061002; GO:0062036; GO:0090394; GO:0097449; GO:0098685; GO:0098839; GO:0098978; GO:0099530; GO:0099583; GO:1900039; GO:1900452; GO:1904058; GO:1904646; GO:1990708; GO:1990782; GO:2000179 associative learning [GO:0008306]; cellular response to amyloid-beta [GO:1904646]; chemical synaptic transmission [GO:0007268]; cognition [GO:0050890]; conditioned place preference [GO:1990708]; desensitization of G protein-coupled receptor signaling pathway [GO:0002029]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; learning [GO:0007612]; learning or memory [GO:0007611]; locomotory behavior [GO:0007626]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of dendritic spine morphogenesis [GO:0061002]; negative regulation of excitatory postsynaptic potential [GO:0090394]; operant conditioning [GO:0035106]; phosphatidylinositol-mediated signaling [GO:0048015]; phospholipase C-activating G protein-coupled glutamate receptor signaling pathway [GO:0007206]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of calcium-mediated signaling [GO:0050850]; positive regulation of cellular response to hypoxia [GO:1900039]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of dopamine secretion [GO:0033603]; positive regulation of long-term neuronal synaptic plasticity [GO:0048170]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of sensory perception of pain [GO:1904058]; protein localization to nuclear inner membrane [GO:0036228]; protein phosphorylation [GO:0006468]; regulation of DNA-templated transcription [GO:0006355]; regulation of long-term neuronal synaptic plasticity [GO:0048169]; regulation of long-term synaptic depression [GO:1900452]; regulation of synaptic transmission, glutamatergic [GO:0051966]; response to amphetamine [GO:0001975]; response to antibiotic [GO:0046677]; response to corticosterone [GO:0051412]; response to ethanol [GO:0045471]; response to morphine [GO:0043278]; sensory perception of hot stimulus [GO:0062036]; synapse organization [GO:0050808]; temperature homeostasis [GO:0001659] astrocyte projection [GO:0097449]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; neuron projection [GO:0043005]; neuron spine [GO:0044309]; neuronal cell body [GO:0043025]; nuclear inner membrane [GO:0005637]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; postsynaptic membrane [GO:0045211]; Schaffer collateral - CA1 synapse [GO:0098685] A2A adenosine receptor binding [GO:0031687]; adenylate cyclase inhibiting G protein-coupled glutamate receptor activity [GO:0001640]; calmodulin binding [GO:0005516]; G protein-coupled receptor activity [GO:0004930]; G protein-coupled receptor activity involved in regulation of postsynaptic membrane potential [GO:0099530]; glutamate receptor activity [GO:0008066]; identical protein binding [GO:0042802]; neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration [GO:0099583]; PDZ domain binding [GO:0030165]; PLC activating G protein-coupled glutamate receptor activity [GO:0001639]; protein tyrosine kinase activator activity [GO:0030296]; protein tyrosine kinase binding [GO:1990782] g11814.t1 Q68ED2 28.367 839 2.03e-75 268.0 sp|Q68ED2|GRM7_MOUSE Metabotropic glutamate receptor 7 OS=Mus musculus OX=10090 GN=Grm7 PE=1 SV=1 GRM7_MOUSE reviewed Metabotropic glutamate receptor 7 (mGluR7) Mus musculus (Mouse) GO:0001640; GO:0001642; GO:0001661; GO:0001662; GO:0005245; GO:0005246; GO:0005509; GO:0005516; GO:0005886; GO:0005938; GO:0007193; GO:0007196; GO:0007216; GO:0007268; GO:0007605; GO:0007613; GO:0007614; GO:0008066; GO:0008306; GO:0009986; GO:0010855; GO:0014050; GO:0016020; GO:0016595; GO:0019226; GO:0030165; GO:0030424; GO:0030425; GO:0030534; GO:0032279; GO:0032991; GO:0033555; GO:0042734; GO:0042802; GO:0043025; GO:0043195; GO:0043198; GO:0043235; GO:0043524; GO:0043679; GO:0045211; GO:0046983; GO:0048306; GO:0048786; GO:0048787; GO:0050877; GO:0051966; GO:0061564; GO:0070905; GO:0098978; GO:0098982; GO:0099171 adenylate cyclase-inhibiting G protein-coupled glutamate receptor signaling pathway [GO:0007196]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; adult behavior [GO:0030534]; associative learning [GO:0008306]; axon development [GO:0061564]; behavioral fear response [GO:0001662]; chemical synaptic transmission [GO:0007268]; conditioned taste aversion [GO:0001661]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; memory [GO:0007613]; multicellular organismal response to stress [GO:0033555]; negative regulation of glutamate secretion [GO:0014050]; negative regulation of neuron apoptotic process [GO:0043524]; nervous system process [GO:0050877]; presynaptic modulation of chemical synaptic transmission [GO:0099171]; regulation of synaptic transmission, glutamatergic [GO:0051966]; sensory perception of sound [GO:0007605]; short-term memory [GO:0007614]; transmission of nerve impulse [GO:0019226] asymmetric synapse [GO:0032279]; axon [GO:0030424]; axon terminus [GO:0043679]; cell cortex [GO:0005938]; cell surface [GO:0009986]; dendrite [GO:0030425]; dendritic shaft [GO:0043198]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic active zone [GO:0048786]; presynaptic active zone membrane [GO:0048787]; presynaptic membrane [GO:0042734]; protein-containing complex [GO:0032991]; receptor complex [GO:0043235]; terminal bouton [GO:0043195] adenylate cyclase inhibiting G protein-coupled glutamate receptor activity [GO:0001640]; adenylate cyclase inhibitor activity [GO:0010855]; calcium channel regulator activity [GO:0005246]; calcium ion binding [GO:0005509]; calcium-dependent protein binding [GO:0048306]; calmodulin binding [GO:0005516]; glutamate binding [GO:0016595]; glutamate receptor activity [GO:0008066]; group III metabotropic glutamate receptor activity [GO:0001642]; identical protein binding [GO:0042802]; PDZ domain binding [GO:0030165]; protein dimerization activity [GO:0046983]; serine binding [GO:0070905]; voltage-gated calcium channel activity [GO:0005245] g11815.t1 P35400 32.329 365 1.1499999999999999e-48 180.0 sp|P35400|GRM7_RAT Metabotropic glutamate receptor 7 OS=Rattus norvegicus OX=10116 GN=Grm7 PE=1 SV=1 GRM7_RAT reviewed Metabotropic glutamate receptor 7 (mGluR7) Rattus norvegicus (Rat) GO:0001640; GO:0001642; GO:0001661; GO:0001662; GO:0005245; GO:0005246; GO:0005509; GO:0005516; GO:0005886; GO:0005938; GO:0007193; GO:0007196; GO:0007216; GO:0007268; GO:0007605; GO:0007611; GO:0007613; GO:0007614; GO:0008066; GO:0008306; GO:0009986; GO:0010855; GO:0014050; GO:0016020; GO:0016595; GO:0019226; GO:0030165; GO:0030424; GO:0030425; GO:0030534; GO:0032279; GO:0032991; GO:0033555; GO:0042734; GO:0042802; GO:0043025; GO:0043195; GO:0043198; GO:0043235; GO:0043524; GO:0043679; GO:0045211; GO:0046983; GO:0048306; GO:0048786; GO:0048787; GO:0050877; GO:0051966; GO:0061564; GO:0070905; GO:0098978; GO:0098982; GO:0099171 adenylate cyclase-inhibiting G protein-coupled glutamate receptor signaling pathway [GO:0007196]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; adult behavior [GO:0030534]; associative learning [GO:0008306]; axon development [GO:0061564]; behavioral fear response [GO:0001662]; chemical synaptic transmission [GO:0007268]; conditioned taste aversion [GO:0001661]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; learning or memory [GO:0007611]; memory [GO:0007613]; multicellular organismal response to stress [GO:0033555]; negative regulation of glutamate secretion [GO:0014050]; negative regulation of neuron apoptotic process [GO:0043524]; nervous system process [GO:0050877]; presynaptic modulation of chemical synaptic transmission [GO:0099171]; regulation of synaptic transmission, glutamatergic [GO:0051966]; sensory perception of sound [GO:0007605]; short-term memory [GO:0007614]; transmission of nerve impulse [GO:0019226] asymmetric synapse [GO:0032279]; axon [GO:0030424]; axon terminus [GO:0043679]; cell cortex [GO:0005938]; cell surface [GO:0009986]; dendrite [GO:0030425]; dendritic shaft [GO:0043198]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic active zone [GO:0048786]; presynaptic active zone membrane [GO:0048787]; presynaptic membrane [GO:0042734]; protein-containing complex [GO:0032991]; receptor complex [GO:0043235]; terminal bouton [GO:0043195] adenylate cyclase inhibiting G protein-coupled glutamate receptor activity [GO:0001640]; adenylate cyclase inhibitor activity [GO:0010855]; calcium channel regulator activity [GO:0005246]; calcium ion binding [GO:0005509]; calcium-dependent protein binding [GO:0048306]; calmodulin binding [GO:0005516]; glutamate binding [GO:0016595]; glutamate receptor activity [GO:0008066]; group III metabotropic glutamate receptor activity [GO:0001642]; identical protein binding [GO:0042802]; PDZ domain binding [GO:0030165]; protein dimerization activity [GO:0046983]; serine binding [GO:0070905]; voltage-gated calcium channel activity [GO:0005245] g11816.t1 P41594 30.039 516 4.3100000000000003e-57 217.0 sp|P41594|GRM5_HUMAN Metabotropic glutamate receptor 5 OS=Homo sapiens OX=9606 GN=GRM5 PE=1 SV=2 GRM5_HUMAN reviewed Metabotropic glutamate receptor 5 (mGluR5) Homo sapiens (Human) GO:0001640; GO:0001659; GO:0001975; GO:0002029; GO:0004930; GO:0005637; GO:0005737; GO:0005886; GO:0006355; GO:0007204; GO:0007206; GO:0007216; GO:0007268; GO:0007611; GO:0007626; GO:0008066; GO:0030296; GO:0030425; GO:0031687; GO:0033603; GO:0035106; GO:0036228; GO:0042802; GO:0043025; GO:0043197; GO:0043198; GO:0043278; GO:0043410; GO:0045471; GO:0046677; GO:0048170; GO:0050808; GO:0050850; GO:0050890; GO:0051412; GO:0051966; GO:0061002; GO:0062036; GO:0090394; GO:0097449; GO:0098685; GO:0098839; GO:0098978; GO:0099530; GO:0099583; GO:1900039; GO:1900452; GO:1904058; GO:1904646; GO:1990708; GO:1990782; GO:2000179 cellular response to amyloid-beta [GO:1904646]; chemical synaptic transmission [GO:0007268]; cognition [GO:0050890]; conditioned place preference [GO:1990708]; desensitization of G protein-coupled receptor signaling pathway [GO:0002029]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; learning or memory [GO:0007611]; locomotory behavior [GO:0007626]; negative regulation of dendritic spine morphogenesis [GO:0061002]; negative regulation of excitatory postsynaptic potential [GO:0090394]; operant conditioning [GO:0035106]; phospholipase C-activating G protein-coupled glutamate receptor signaling pathway [GO:0007206]; positive regulation of calcium-mediated signaling [GO:0050850]; positive regulation of cellular response to hypoxia [GO:1900039]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of dopamine secretion [GO:0033603]; positive regulation of long-term neuronal synaptic plasticity [GO:0048170]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of sensory perception of pain [GO:1904058]; protein localization to nuclear inner membrane [GO:0036228]; regulation of DNA-templated transcription [GO:0006355]; regulation of long-term synaptic depression [GO:1900452]; regulation of synaptic transmission, glutamatergic [GO:0051966]; response to amphetamine [GO:0001975]; response to antibiotic [GO:0046677]; response to corticosterone [GO:0051412]; response to ethanol [GO:0045471]; response to morphine [GO:0043278]; sensory perception of hot stimulus [GO:0062036]; synapse organization [GO:0050808]; temperature homeostasis [GO:0001659] astrocyte projection [GO:0097449]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; neuronal cell body [GO:0043025]; nuclear inner membrane [GO:0005637]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; Schaffer collateral - CA1 synapse [GO:0098685] A2A adenosine receptor binding [GO:0031687]; adenylate cyclase inhibiting G protein-coupled glutamate receptor activity [GO:0001640]; G protein-coupled receptor activity [GO:0004930]; G protein-coupled receptor activity involved in regulation of postsynaptic membrane potential [GO:0099530]; glutamate receptor activity [GO:0008066]; identical protein binding [GO:0042802]; neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration [GO:0099583]; protein tyrosine kinase activator activity [GO:0030296]; protein tyrosine kinase binding [GO:1990782] g11816.t1 P41594 24.571 350 2.4199999999999998e-23 110.0 sp|P41594|GRM5_HUMAN Metabotropic glutamate receptor 5 OS=Homo sapiens OX=9606 GN=GRM5 PE=1 SV=2 GRM5_HUMAN reviewed Metabotropic glutamate receptor 5 (mGluR5) Homo sapiens (Human) GO:0001640; GO:0001659; GO:0001975; GO:0002029; GO:0004930; GO:0005637; GO:0005737; GO:0005886; GO:0006355; GO:0007204; GO:0007206; GO:0007216; GO:0007268; GO:0007611; GO:0007626; GO:0008066; GO:0030296; GO:0030425; GO:0031687; GO:0033603; GO:0035106; GO:0036228; GO:0042802; GO:0043025; GO:0043197; GO:0043198; GO:0043278; GO:0043410; GO:0045471; GO:0046677; GO:0048170; GO:0050808; GO:0050850; GO:0050890; GO:0051412; GO:0051966; GO:0061002; GO:0062036; GO:0090394; GO:0097449; GO:0098685; GO:0098839; GO:0098978; GO:0099530; GO:0099583; GO:1900039; GO:1900452; GO:1904058; GO:1904646; GO:1990708; GO:1990782; GO:2000179 cellular response to amyloid-beta [GO:1904646]; chemical synaptic transmission [GO:0007268]; cognition [GO:0050890]; conditioned place preference [GO:1990708]; desensitization of G protein-coupled receptor signaling pathway [GO:0002029]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; learning or memory [GO:0007611]; locomotory behavior [GO:0007626]; negative regulation of dendritic spine morphogenesis [GO:0061002]; negative regulation of excitatory postsynaptic potential [GO:0090394]; operant conditioning [GO:0035106]; phospholipase C-activating G protein-coupled glutamate receptor signaling pathway [GO:0007206]; positive regulation of calcium-mediated signaling [GO:0050850]; positive regulation of cellular response to hypoxia [GO:1900039]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of dopamine secretion [GO:0033603]; positive regulation of long-term neuronal synaptic plasticity [GO:0048170]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of sensory perception of pain [GO:1904058]; protein localization to nuclear inner membrane [GO:0036228]; regulation of DNA-templated transcription [GO:0006355]; regulation of long-term synaptic depression [GO:1900452]; regulation of synaptic transmission, glutamatergic [GO:0051966]; response to amphetamine [GO:0001975]; response to antibiotic [GO:0046677]; response to corticosterone [GO:0051412]; response to ethanol [GO:0045471]; response to morphine [GO:0043278]; sensory perception of hot stimulus [GO:0062036]; synapse organization [GO:0050808]; temperature homeostasis [GO:0001659] astrocyte projection [GO:0097449]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; neuronal cell body [GO:0043025]; nuclear inner membrane [GO:0005637]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; Schaffer collateral - CA1 synapse [GO:0098685] A2A adenosine receptor binding [GO:0031687]; adenylate cyclase inhibiting G protein-coupled glutamate receptor activity [GO:0001640]; G protein-coupled receptor activity [GO:0004930]; G protein-coupled receptor activity involved in regulation of postsynaptic membrane potential [GO:0099530]; glutamate receptor activity [GO:0008066]; identical protein binding [GO:0042802]; neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration [GO:0099583]; protein tyrosine kinase activator activity [GO:0030296]; protein tyrosine kinase binding [GO:1990782] g11817.t1 O62714 32.576 264 1.8600000000000002e-29 121.0 sp|O62714|CASR_PIG Extracellular calcium-sensing receptor OS=Sus scrofa OX=9823 GN=CASR PE=2 SV=3 g11825.t1 Q5BJQ6 61.574 432 0.0 576.0 sp|Q5BJQ6|CSTF1_RAT Cleavage stimulation factor subunit 1 OS=Rattus norvegicus OX=10116 GN=Cstf1 PE=2 SV=1 g11827.t1 O53532 38.053 339 1.3500000000000001e-58 196.0 sp|O53532|Y2258_MYCTU S-adenosylmethionine-dependent methyltransferase Rv2258c OS=Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv) OX=83332 GN=Rv2258c PE=1 SV=1 g11828.t1 Q3UY96 38.684 1246 0.0 790.0 sp|Q3UY96|CFA74_MOUSE Cilia- and flagella-associated protein 74 OS=Mus musculus OX=10090 GN=Cfap74 PE=2 SV=3 g11828.t1 Q3UY96 33.428 353 1.84e-46 188.0 sp|Q3UY96|CFA74_MOUSE Cilia- and flagella-associated protein 74 OS=Mus musculus OX=10090 GN=Cfap74 PE=2 SV=3 g11829.t1 Q9WV70 49.671 608 0.0 561.0 sp|Q9WV70|NOC2L_MOUSE Nucleolar complex protein 2 homolog OS=Mus musculus OX=10090 GN=Noc2l PE=1 SV=2 NOC2L_MOUSE reviewed Nucleolar complex protein 2 homolog (Protein NOC2 homolog) (NOC2-like protein) (Novel INHAT repressor) Mus musculus (Mouse) GO:0000122; GO:0000786; GO:0002039; GO:0002903; GO:0003682; GO:0003714; GO:0005634; GO:0005654; GO:0005694; GO:0005730; GO:0005829; GO:0006915; GO:0030690; GO:0030691; GO:0031491; GO:0034644; GO:0042273; GO:0042393; GO:0140297; GO:2001243 apoptotic process [GO:0006915]; cellular response to UV [GO:0034644]; negative regulation of B cell apoptotic process [GO:0002903]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of transcription by RNA polymerase II [GO:0000122]; ribosomal large subunit biogenesis [GO:0042273] chromosome [GO:0005694]; cytosol [GO:0005829]; Noc1p-Noc2p complex [GO:0030690]; Noc2p-Noc3p complex [GO:0030691]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634] chromatin binding [GO:0003682]; DNA-binding transcription factor binding [GO:0140297]; histone binding [GO:0042393]; nucleosome binding [GO:0031491]; p53 binding [GO:0002039]; transcription corepressor activity [GO:0003714] g11830.t1 Q96NU1 68.571 70 1.4799999999999999e-24 111.0 sp|Q96NU1|SAM11_HUMAN Sterile alpha motif domain-containing protein 11 OS=Homo sapiens OX=9606 GN=SAMD11 PE=1 SV=3 g11833.t1 Q8WMN1 42.463 471 2.98e-113 347.0 sp|Q8WMN1|GTR5_SHEEP Solute carrier family 2, facilitated glucose transporter member 5 OS=Ovis aries OX=9940 GN=SLC2A5 PE=2 SV=1 g11834.t1 P17809 48.522 406 2.1400000000000002e-105 325.0 sp|P17809|GTR1_MOUSE Solute carrier family 2, facilitated glucose transporter member 1 OS=Mus musculus OX=10090 GN=Slc2a1 PE=1 SV=4 GTR1_MOUSE reviewed Solute carrier family 2, facilitated glucose transporter member 1 (Glucose transporter type 1, erythrocyte/brain) (GLUT-1) (GT1) Mus musculus (Mouse) GO:0000139; GO:0001666; GO:0001917; GO:0001939; GO:0005324; GO:0005737; GO:0005829; GO:0005886; GO:0005901; GO:0005911; GO:0007417; GO:0007565; GO:0014704; GO:0015150; GO:0015911; GO:0016020; GO:0016323; GO:0016324; GO:0019900; GO:0021987; GO:0030018; GO:0030496; GO:0030864; GO:0031982; GO:0032868; GO:0033300; GO:0042149; GO:0042383; GO:0042802; GO:0042908; GO:0042910; GO:0045121; GO:0045202; GO:0045494; GO:0046323; GO:0055056; GO:0065003; GO:0070837; GO:0071260; GO:0071474; GO:0098708; GO:0098793; GO:0150104; GO:1904016; GO:1904659; GO:1990350 cellular hyperosmotic response [GO:0071474]; cellular response to glucose starvation [GO:0042149]; cellular response to mechanical stimulus [GO:0071260]; central nervous system development [GO:0007417]; cerebral cortex development [GO:0021987]; D-glucose import [GO:0046323]; D-glucose import across plasma membrane [GO:0098708]; D-glucose transmembrane transport [GO:1904659]; dehydroascorbic acid transport [GO:0070837]; female pregnancy [GO:0007565]; long-chain fatty acid import across plasma membrane [GO:0015911]; photoreceptor cell maintenance [GO:0045494]; protein-containing complex assembly [GO:0065003]; response to hypoxia [GO:0001666]; response to insulin [GO:0032868]; response to Thyroglobulin triiodothyronine [GO:1904016]; transport across blood-brain barrier [GO:0150104]; xenobiotic transport [GO:0042908] apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; caveola [GO:0005901]; cell-cell junction [GO:0005911]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; female pronucleus [GO:0001939]; glucose transporter complex [GO:1990350]; Golgi membrane [GO:0000139]; intercalated disc [GO:0014704]; membrane [GO:0016020]; membrane raft [GO:0045121]; midbody [GO:0030496]; photoreceptor inner segment [GO:0001917]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; sarcolemma [GO:0042383]; synapse [GO:0045202]; vesicle [GO:0031982]; Z disc [GO:0030018] D-glucose transmembrane transporter activity [GO:0055056]; dehydroascorbic acid transmembrane transporter activity [GO:0033300]; fucose transmembrane transporter activity [GO:0015150]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; long-chain fatty acid transmembrane transporter activity [GO:0005324]; xenobiotic transmembrane transporter activity [GO:0042910] g11839.t1 Q08013 72.376 181 2.3200000000000002e-88 259.0 sp|Q08013|SSRG_RAT Translocon-associated protein subunit gamma OS=Rattus norvegicus OX=10116 GN=Ssr3 PE=1 SV=2 g11840.t1 Q12873 64.973 1102 0.0 1355.0 sp|Q12873|CHD3_HUMAN Chromodomain-helicase-DNA-binding protein 3 OS=Homo sapiens OX=9606 GN=CHD3 PE=1 SV=3 CHD3_HUMAN reviewed ATP-dependent chromatin remodeler CHD3 (EC 3.6.4.-) (Chromo domain-containing protein 3) (CHD-3) (Mi-2 autoantigen 240 kDa protein) (Mi2-alpha) (Zinc finger helicase-like) (hZFH) Homo sapiens (Human) GO:0000122; GO:0000785; GO:0000976; GO:0003677; GO:0003682; GO:0003723; GO:0004386; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005813; GO:0006338; GO:0006355; GO:0007051; GO:0007098; GO:0008270; GO:0016581; GO:0016605; GO:0016887; GO:0034451; GO:0042393; GO:0042659; GO:0045892; GO:0045893; GO:0140658; GO:2000736 centrosome cycle [GO:0007098]; chromatin remodeling [GO:0006338]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of DNA-templated transcription [GO:0045893]; regulation of cell fate specification [GO:0042659]; regulation of DNA-templated transcription [GO:0006355]; regulation of stem cell differentiation [GO:2000736]; spindle organization [GO:0007051] centriolar satellite [GO:0034451]; centrosome [GO:0005813]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; NuRD complex [GO:0016581]; PML body [GO:0016605] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent chromatin remodeler activity [GO:0140658]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; helicase activity [GO:0004386]; histone binding [GO:0042393]; RNA binding [GO:0003723]; transcription cis-regulatory region binding [GO:0000976]; zinc ion binding [GO:0008270] g11840.t2 Q12873 63.782 1121 0.0 1358.0 sp|Q12873|CHD3_HUMAN Chromodomain-helicase-DNA-binding protein 3 OS=Homo sapiens OX=9606 GN=CHD3 PE=1 SV=3 CHD3_HUMAN reviewed ATP-dependent chromatin remodeler CHD3 (EC 3.6.4.-) (Chromo domain-containing protein 3) (CHD-3) (Mi-2 autoantigen 240 kDa protein) (Mi2-alpha) (Zinc finger helicase-like) (hZFH) Homo sapiens (Human) GO:0000122; GO:0000785; GO:0000976; GO:0003677; GO:0003682; GO:0003723; GO:0004386; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005813; GO:0006338; GO:0006355; GO:0007051; GO:0007098; GO:0008270; GO:0016581; GO:0016605; GO:0016887; GO:0034451; GO:0042393; GO:0042659; GO:0045892; GO:0045893; GO:0140658; GO:2000736 centrosome cycle [GO:0007098]; chromatin remodeling [GO:0006338]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of DNA-templated transcription [GO:0045893]; regulation of cell fate specification [GO:0042659]; regulation of DNA-templated transcription [GO:0006355]; regulation of stem cell differentiation [GO:2000736]; spindle organization [GO:0007051] centriolar satellite [GO:0034451]; centrosome [GO:0005813]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; NuRD complex [GO:0016581]; PML body [GO:0016605] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent chromatin remodeler activity [GO:0140658]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; helicase activity [GO:0004386]; histone binding [GO:0042393]; RNA binding [GO:0003723]; transcription cis-regulatory region binding [GO:0000976]; zinc ion binding [GO:0008270] g11841.t1 O97159 84.967 153 1.17e-83 287.0 sp|O97159|CHDM_DROME Chromodomain-helicase-DNA-binding protein Mi-2 homolog OS=Drosophila melanogaster OX=7227 GN=Mi-2 PE=1 SV=2 g11841.t1 O97159 62.222 90 4.67e-25 114.0 sp|O97159|CHDM_DROME Chromodomain-helicase-DNA-binding protein Mi-2 homolog OS=Drosophila melanogaster OX=7227 GN=Mi-2 PE=1 SV=2 g11843.t1 Q5ZJD3 46.707 167 3.18e-36 135.0 sp|Q5ZJD3|LSG1_CHICK Large subunit GTPase 1 homolog OS=Gallus gallus OX=9031 GN=LSG1 PE=2 SV=1 LSG1_CHICK reviewed Large subunit GTPase 1 homolog (EC 3.6.5.-) Gallus gallus (Chicken) GO:0000054; GO:0003924; GO:0005525; GO:0005783; GO:0005829; GO:0015030; GO:0015031; GO:0051168 nuclear export [GO:0051168]; protein transport [GO:0015031]; ribosomal subunit export from nucleus [GO:0000054] Cajal body [GO:0015030]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783] GTP binding [GO:0005525]; GTPase activity [GO:0003924] g11844.t1 Q6NY89 60.92 261 4.05e-99 316.0 sp|Q6NY89|LSG1_DANRE Large subunit GTPase 1 homolog OS=Danio rerio OX=7955 GN=lsg1 PE=2 SV=1 LSG1_DANRE reviewed Large subunit GTPase 1 homolog (EC 3.6.5.-) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000054; GO:0003924; GO:0005525; GO:0005783; GO:0005829; GO:0015030; GO:0015031; GO:0051168 nuclear export [GO:0051168]; protein transport [GO:0015031]; ribosomal subunit export from nucleus [GO:0000054] Cajal body [GO:0015030]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783] GTP binding [GO:0005525]; GTPase activity [GO:0003924] g11844.t1 Q6NY89 64.8 125 3.2999999999999997e-46 175.0 sp|Q6NY89|LSG1_DANRE Large subunit GTPase 1 homolog OS=Danio rerio OX=7955 GN=lsg1 PE=2 SV=1 LSG1_DANRE reviewed Large subunit GTPase 1 homolog (EC 3.6.5.-) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000054; GO:0003924; GO:0005525; GO:0005783; GO:0005829; GO:0015030; GO:0015031; GO:0051168 nuclear export [GO:0051168]; protein transport [GO:0015031]; ribosomal subunit export from nucleus [GO:0000054] Cajal body [GO:0015030]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783] GTP binding [GO:0005525]; GTPase activity [GO:0003924] g11845.t1 Q09621 33.744 406 2.1099999999999998e-69 230.0 sp|Q09621|LACT2_CAEEL Beta-lactamase domain-containing protein 2 OS=Caenorhabditis elegans OX=6239 GN=lact-2 PE=4 SV=1 g11846.t1 Q91V01 35.189 449 1.24e-86 277.0 sp|Q91V01|MBOA5_MOUSE Lysophospholipid acyltransferase 5 OS=Mus musculus OX=10090 GN=Lpcat3 PE=1 SV=1 MBOA5_MOUSE reviewed Lysophospholipid acyltransferase 5 (LPLAT 5) (EC 2.3.1.-) (1-acylglycerophosphocholine O-acyltransferase) (EC 2.3.1.23) (1-acylglycerophosphoethanolamine O-acyltransferase) (EC 2.3.1.n7) (1-acylglycerophosphoserine O-acyltransferase) (EC 2.3.1.n6) (Lysophosphatidylcholine acyltransferase) (LPCAT) (Lyso-PC acyltransferase) (Lysophosphatidylcholine acyltransferase 3) (Lyso-PC acyltransferase 3) (mLPCAT3) (Lysophosphatidylethanolamine acyltransferase) (LPEAT) (Lyso-PE acyltransferase) (Lysophosphatidylserine acyltransferase) (LPSAT) (Lyso-PS acyltransferase) (Membrane-bound O-acyltransferase domain-containing protein 5) (O-acyltransferase domain-containing protein 5) Mus musculus (Mouse) GO:0005789; GO:0006656; GO:0016020; GO:0030258; GO:0034378; GO:0034379; GO:0036150; GO:0036151; GO:0036152; GO:0036335; GO:0045540; GO:0045797; GO:0047184; GO:0050728; GO:0071617; GO:0090158; GO:0097006; GO:0106262; GO:0106263; GO:1903573; GO:1905885 chylomicron assembly [GO:0034378]; endoplasmic reticulum membrane organization [GO:0090158]; intestinal stem cell homeostasis [GO:0036335]; lipid modification [GO:0030258]; negative regulation of inflammatory response [GO:0050728]; negative regulation of response to endoplasmic reticulum stress [GO:1903573]; phosphatidylcholine acyl-chain remodeling [GO:0036151]; phosphatidylcholine biosynthetic process [GO:0006656]; phosphatidylethanolamine acyl-chain remodeling [GO:0036152]; phosphatidylserine acyl-chain remodeling [GO:0036150]; positive regulation of intestinal cholesterol absorption [GO:0045797]; positive regulation of triglyceride transport [GO:1905885]; regulation of cholesterol biosynthetic process [GO:0045540]; regulation of plasma lipoprotein particle levels [GO:0097006]; very-low-density lipoprotein particle assembly [GO:0034379] endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020] 1-acylglycerophosphocholine O-acyltransferase activity [GO:0047184]; 1-acylglycerophosphoethanolamine O-acyltransferase activity [GO:0106262]; 1-acylglycerophosphoserine O-acyltransferase activity [GO:0106263]; lysophospholipid acyltransferase activity [GO:0071617] g11847.t1 Q95ZS2 58.088 136 5.04e-48 167.0 sp|Q95ZS2|TDC1_CAEEL Tyrosine decarboxylase OS=Caenorhabditis elegans OX=6239 GN=tdc-1 PE=2 SV=1 g11848.t1 Q95ZS2 56.198 242 3.14e-96 300.0 sp|Q95ZS2|TDC1_CAEEL Tyrosine decarboxylase OS=Caenorhabditis elegans OX=6239 GN=tdc-1 PE=2 SV=1 g11849.t1 O43156 38.406 1117 0.0 656.0 sp|O43156|TTI1_HUMAN TELO2-interacting protein 1 homolog OS=Homo sapiens OX=9606 GN=TTI1 PE=1 SV=3 TTI1_HUMAN reviewed TELO2-interacting protein 1 homolog (Protein SMG10) Homo sapiens (Human) GO:0005634; GO:0005737; GO:0019900; GO:0031931; GO:0031932; GO:0032006; GO:0050821; GO:0110078; GO:0140777; GO:2000003 positive regulation of DNA damage checkpoint [GO:2000003]; protein stabilization [GO:0050821]; regulation of TOR signaling [GO:0032006] cytoplasm [GO:0005737]; nucleus [GO:0005634]; TORC1 complex [GO:0031931]; TORC2 complex [GO:0031932]; TTT Hsp90 cochaperone complex [GO:0110078] kinase binding [GO:0019900]; protein-containing complex stabilizing activity [GO:0140777] g11850.t1 Q5ZJX0 37.113 291 8.539999999999999e-42 149.0 sp|Q5ZJX0|LAAT1_CHICK Lysosomal amino acid transporter 1 homolog OS=Gallus gallus OX=9031 GN=SLC66A1 PE=2 SV=1 g11852.t1 Q6NZJ6 40.905 1039 8.569999999999999e-172 569.0 sp|Q6NZJ6|IF4G1_MOUSE Eukaryotic translation initiation factor 4 gamma 1 OS=Mus musculus OX=10090 GN=Eif4g1 PE=1 SV=1 IF4G1_MOUSE reviewed Eukaryotic translation initiation factor 4 gamma 1 (eIF-4-gamma 1) (eIF-4G 1) (eIF-4G1) Mus musculus (Mouse) GO:0001662; GO:0003729; GO:0003743; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005840; GO:0006412; GO:0006413; GO:0006446; GO:0008135; GO:0008190; GO:0010494; GO:0010507; GO:0016281; GO:0030307; GO:0031669; GO:0035278; GO:0036493; GO:0045666; GO:0051247; GO:0097009; GO:0098794; GO:1900087; GO:1904377; GO:1905537; GO:1905606 behavioral fear response [GO:0001662]; cellular response to nutrient levels [GO:0031669]; energy homeostasis [GO:0097009]; miRNA-mediated gene silencing by inhibition of translation [GO:0035278]; negative regulation of autophagy [GO:0010507]; positive regulation of cell growth [GO:0030307]; positive regulation of eukaryotic translation initiation factor 4F complex assembly [GO:1905537]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of protein localization to cell periphery [GO:1904377]; positive regulation of protein metabolic process [GO:0051247]; positive regulation of translation in response to endoplasmic reticulum stress [GO:0036493]; regulation of presynapse assembly [GO:1905606]; regulation of translational initiation [GO:0006446]; translation [GO:0006412]; translational initiation [GO:0006413] cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; eukaryotic translation initiation factor 4F complex [GO:0016281]; nucleus [GO:0005634]; postsynapse [GO:0098794]; ribosome [GO:0005840] ATP binding [GO:0005524]; eukaryotic initiation factor 4E binding [GO:0008190]; mRNA binding [GO:0003729]; translation factor activity, RNA binding [GO:0008135]; translation initiation factor activity [GO:0003743] g11852.t2 Q6NZJ6 40.905 1039 8.429999999999999e-172 569.0 sp|Q6NZJ6|IF4G1_MOUSE Eukaryotic translation initiation factor 4 gamma 1 OS=Mus musculus OX=10090 GN=Eif4g1 PE=1 SV=1 IF4G1_MOUSE reviewed Eukaryotic translation initiation factor 4 gamma 1 (eIF-4-gamma 1) (eIF-4G 1) (eIF-4G1) Mus musculus (Mouse) GO:0001662; GO:0003729; GO:0003743; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005840; GO:0006412; GO:0006413; GO:0006446; GO:0008135; GO:0008190; GO:0010494; GO:0010507; GO:0016281; GO:0030307; GO:0031669; GO:0035278; GO:0036493; GO:0045666; GO:0051247; GO:0097009; GO:0098794; GO:1900087; GO:1904377; GO:1905537; GO:1905606 behavioral fear response [GO:0001662]; cellular response to nutrient levels [GO:0031669]; energy homeostasis [GO:0097009]; miRNA-mediated gene silencing by inhibition of translation [GO:0035278]; negative regulation of autophagy [GO:0010507]; positive regulation of cell growth [GO:0030307]; positive regulation of eukaryotic translation initiation factor 4F complex assembly [GO:1905537]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of protein localization to cell periphery [GO:1904377]; positive regulation of protein metabolic process [GO:0051247]; positive regulation of translation in response to endoplasmic reticulum stress [GO:0036493]; regulation of presynapse assembly [GO:1905606]; regulation of translational initiation [GO:0006446]; translation [GO:0006412]; translational initiation [GO:0006413] cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; eukaryotic translation initiation factor 4F complex [GO:0016281]; nucleus [GO:0005634]; postsynapse [GO:0098794]; ribosome [GO:0005840] ATP binding [GO:0005524]; eukaryotic initiation factor 4E binding [GO:0008190]; mRNA binding [GO:0003729]; translation factor activity, RNA binding [GO:0008135]; translation initiation factor activity [GO:0003743] g11856.t1 Q923V4 36.187 257 5.35e-49 167.0 sp|Q923V4|FBX6_RAT F-box only protein 6 OS=Rattus norvegicus OX=10116 GN=Fbxo6 PE=1 SV=1 g11857.t1 P49660 28.698 338 2.71e-23 104.0 sp|P49660|SSR4_MOUSE Somatostatin receptor type 4 OS=Mus musculus OX=10090 GN=Sstr4 PE=1 SV=2 g11859.t1 Q9NQ86 31.316 760 3.8800000000000004e-110 355.0 sp|Q9NQ86|TRI36_HUMAN E3 ubiquitin-protein ligase TRIM36 OS=Homo sapiens OX=9606 GN=TRIM36 PE=1 SV=2 TRI36_HUMAN reviewed E3 ubiquitin-protein ligase TRIM36 (EC 2.3.2.27) (RING finger protein 98) (RING-type E3 ubiquitin transferase TRIM36) (Tripartite motif-containing protein 36) (Zinc-binding protein Rbcc728) Homo sapiens (Human) GO:0000281; GO:0001669; GO:0004842; GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0007051; GO:0007340; GO:0008270; GO:0043014; GO:0051726; GO:0061630; GO:0070507 acrosome reaction [GO:0007340]; mitotic cytokinesis [GO:0000281]; regulation of cell cycle [GO:0051726]; regulation of microtubule cytoskeleton organization [GO:0070507]; spindle organization [GO:0007051] acrosomal vesicle [GO:0001669]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; plasma membrane [GO:0005886] alpha-tubulin binding [GO:0043014]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] g11861.t1 Q8BZ20 30.648 633 3.1599999999999996e-82 280.0 sp|Q8BZ20|PAR12_MOUSE Protein mono-ADP-ribosyltransferase PARP12 OS=Mus musculus OX=10090 GN=Parp12 PE=1 SV=3 PAR12_MOUSE reviewed Protein mono-ADP-ribosyltransferase PARP12 (EC 2.4.2.-) (ADP-ribosyltransferase diphtheria toxin-like 12) (ARTD12) (Poly [ADP-ribose] polymerase 12) (PARP-12) (Zinc finger CCCH domain-containing protein 1) Mus musculus (Mouse) GO:0003950; GO:0005634; GO:0005802; GO:0008270; GO:0010494; GO:0016779; GO:0044331; GO:0070213; GO:0070633; GO:0140803; GO:0140806; GO:1990404 cell-cell adhesion mediated by cadherin [GO:0044331]; protein auto-ADP-ribosylation [GO:0070213]; transepithelial transport [GO:0070633] cytoplasmic stress granule [GO:0010494]; nucleus [GO:0005634]; trans-Golgi network [GO:0005802] NAD+ poly-ADP-ribosyltransferase activity [GO:0003950]; NAD+-protein mono-ADP-ribosyltransferase activity [GO:1990404]; NAD+-protein-aspartate ADP-ribosyltransferase activity [GO:0140806]; NAD+-protein-cysteine ADP-ribosyltransferase activity [GO:0140803]; nucleotidyltransferase activity [GO:0016779]; zinc ion binding [GO:0008270] g11862.t1 Q6NYS8 70.426 399 0.0 595.0 sp|Q6NYS8|OST48_DANRE Dolichyl-diphosphooligosaccharide--protein glycosyltransferase 48 kDa subunit OS=Danio rerio OX=7955 GN=ddost PE=2 SV=2 g11864.t1 Q8VCC1 38.735 253 5.46e-53 176.0 sp|Q8VCC1|PGDH_MOUSE 15-hydroxyprostaglandin dehydrogenase [NAD(+)] OS=Mus musculus OX=10090 GN=Hpgd PE=1 SV=1 g11866.t1 Q5R630 72.727 110 3.4299999999999997e-53 171.0 sp|Q5R630|NECP1_PONAB Adaptin ear-binding coat-associated protein 1 OS=Pongo abelii OX=9601 GN=NECAP1 PE=2 SV=1 g11867.t1 Q3T0W4 53.455 275 2.21e-84 261.0 sp|Q3T0W4|PP1R7_BOVIN Protein phosphatase 1 regulatory subunit 7 OS=Bos taurus OX=9913 GN=PPP1R7 PE=1 SV=1 PP1R7_BOVIN reviewed Protein phosphatase 1 regulatory subunit 7 (Protein phosphatase 1 regulatory subunit 22) Bos taurus (Bovine) GO:0005634 nucleus [GO:0005634] g11868.t1 P49915 62.281 684 0.0 821.0 sp|P49915|GUAA_HUMAN GMP synthase [glutamine-hydrolyzing] OS=Homo sapiens OX=9606 GN=GMPS PE=1 SV=1 GUAA_HUMAN reviewed GMP synthase [glutamine-hydrolyzing] (EC 6.3.5.2) (GMP synthetase) (Glutamine amidotransferase) Homo sapiens (Human) GO:0003921; GO:0003922; GO:0005524; GO:0005829; GO:0006177; GO:0009113; GO:0009168 GMP biosynthetic process [GO:0006177]; purine nucleobase biosynthetic process [GO:0009113]; purine ribonucleoside monophosphate biosynthetic process [GO:0009168] cytosol [GO:0005829] ATP binding [GO:0005524]; GMP synthase (glutamine-hydrolyzing) activity [GO:0003922]; GMP synthase activity [GO:0003921] g11873.t1 Q5ZL00 39.343 1004 0.0 659.0 sp|Q5ZL00|EMC1_CHICK ER membrane protein complex subunit 1 OS=Gallus gallus OX=9031 GN=EMC1 PE=2 SV=1 EMC1_CHICK reviewed ER membrane protein complex subunit 1 Gallus gallus (Chicken) GO:0005789; GO:0016020; GO:0045050; GO:0071816; GO:0072546 protein insertion into ER membrane by stop-transfer membrane-anchor sequence [GO:0045050]; tail-anchored membrane protein insertion into ER membrane [GO:0071816] EMC complex [GO:0072546]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020] g11875.t1 A4Q9F3 51.671 389 8.86e-119 379.0 sp|A4Q9F3|TTL10_MOUSE Protein polyglycylase TTLL10 OS=Mus musculus OX=10090 GN=Ttll10 PE=1 SV=1 TTL10_MOUSE reviewed Protein polyglycylase TTLL10 (EC 6.3.2.-) (Tubulin--tyrosine ligase-like protein 10) Mus musculus (Mouse) GO:0005524; GO:0005874; GO:0005929; GO:0005930; GO:0015630; GO:0018094; GO:0046872; GO:0070735; GO:0070737 protein polyglycylation [GO:0018094] axoneme [GO:0005930]; cilium [GO:0005929]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630] ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein-glycine ligase activity [GO:0070735]; protein-glycine ligase activity, elongating [GO:0070737] g11876.t1 Q90687 49.877 405 6.79e-117 356.0 sp|Q90687|PTN11_CHICK Tyrosine-protein phosphatase non-receptor type 11 OS=Gallus gallus OX=9031 GN=PTPN11 PE=2 SV=1 PTN11_CHICK reviewed Tyrosine-protein phosphatase non-receptor type 11 (EC 3.1.3.48) (SH-PTP2) (cSH-PTP2) Gallus gallus (Chicken) GO:0004725; GO:0004726; GO:0005634; GO:0005737; GO:0030971; GO:0032331; GO:0038127; GO:0045778; GO:0050839; GO:0070374; GO:0071364 cellular response to epidermal growth factor stimulus [GO:0071364]; ERBB signaling pathway [GO:0038127]; negative regulation of chondrocyte differentiation [GO:0032331]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of ossification [GO:0045778] cytoplasm [GO:0005737]; nucleus [GO:0005634] cell adhesion molecule binding [GO:0050839]; non-membrane spanning protein tyrosine phosphatase activity [GO:0004726]; protein tyrosine phosphatase activity [GO:0004725]; receptor tyrosine kinase binding [GO:0030971] g11877.t1 Q06124 77.143 175 1.9e-91 280.0 sp|Q06124|PTN11_HUMAN Tyrosine-protein phosphatase non-receptor type 11 OS=Homo sapiens OX=9606 GN=PTPN11 PE=1 SV=3 PTN11_HUMAN reviewed Tyrosine-protein phosphatase non-receptor type 11 (EC 3.1.3.48) (Protein-tyrosine phosphatase 1D) (PTP-1D) (Protein-tyrosine phosphatase 2C) (PTP-2C) (SH-PTP2) (SHP-2) (Shp2) (SH-PTP3) Homo sapiens (Human) GO:0000077; GO:0001784; GO:0004721; GO:0004725; GO:0004726; GO:0005158; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0005925; GO:0006641; GO:0007173; GO:0007229; GO:0007409; GO:0007420; GO:0007507; GO:0008543; GO:0009755; GO:0019221; GO:0019901; GO:0021697; GO:0030159; GO:0030220; GO:0030971; GO:0031295; GO:0031666; GO:0032331; GO:0032480; GO:0032528; GO:0032728; GO:0032760; GO:0032991; GO:0033629; GO:0035264; GO:0035265; GO:0035335; GO:0035855; GO:0036302; GO:0038127; GO:0042130; GO:0042311; GO:0042445; GO:0042593; GO:0043254; GO:0045296; GO:0045778; GO:0045931; GO:0046326; GO:0046628; GO:0046676; GO:0046825; GO:0046887; GO:0048008; GO:0048011; GO:0048013; GO:0048806; GO:0048839; GO:0048873; GO:0050839; GO:0050860; GO:0050868; GO:0051428; GO:0051463; GO:0051897; GO:0060020; GO:0060090; GO:0060125; GO:0060325; GO:0060338; GO:0061582; GO:0070374; GO:0071260; GO:0071364; GO:1902533; GO:1902564; GO:1990782 atrioventricular canal development [GO:0036302]; axonogenesis [GO:0007409]; Bergmann glial cell differentiation [GO:0060020]; brain development [GO:0007420]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to mechanical stimulus [GO:0071260]; cerebellar cortex formation [GO:0021697]; cytokine-mediated signaling pathway [GO:0019221]; DNA damage checkpoint signaling [GO:0000077]; ephrin receptor signaling pathway [GO:0048013]; epidermal growth factor receptor signaling pathway [GO:0007173]; ERBB signaling pathway [GO:0038127]; face morphogenesis [GO:0060325]; fibroblast growth factor receptor signaling pathway [GO:0008543]; genitalia development [GO:0048806]; glucose homeostasis [GO:0042593]; heart development [GO:0007507]; homeostasis of number of cells within a tissue [GO:0048873]; hormone metabolic process [GO:0042445]; hormone-mediated signaling pathway [GO:0009755]; inner ear development [GO:0048839]; integrin-mediated signaling pathway [GO:0007229]; intestinal epithelial cell migration [GO:0061582]; megakaryocyte development [GO:0035855]; microvillus organization [GO:0032528]; multicellular organism growth [GO:0035264]; negative regulation of cell adhesion mediated by integrin [GO:0033629]; negative regulation of chondrocyte differentiation [GO:0032331]; negative regulation of cortisol secretion [GO:0051463]; negative regulation of growth hormone secretion [GO:0060125]; negative regulation of insulin secretion [GO:0046676]; negative regulation of neutrophil activation [GO:1902564]; negative regulation of T cell activation [GO:0050868]; negative regulation of T cell proliferation [GO:0042130]; negative regulation of T cell receptor signaling pathway [GO:0050860]; negative regulation of type I interferon production [GO:0032480]; neurotrophin TRK receptor signaling pathway [GO:0048011]; organ growth [GO:0035265]; peptidyl-tyrosine dephosphorylation [GO:0035335]; platelet formation [GO:0030220]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of D-glucose import [GO:0046326]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of hormone secretion [GO:0046887]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of intracellular signal transduction [GO:1902533]; positive regulation of lipopolysaccharide-mediated signaling pathway [GO:0031666]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of ossification [GO:0045778]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of tumor necrosis factor production [GO:0032760]; regulation of protein export from nucleus [GO:0046825]; regulation of protein-containing complex assembly [GO:0043254]; regulation of type I interferon-mediated signaling pathway [GO:0060338]; T cell costimulation [GO:0031295]; triglyceride metabolic process [GO:0006641]; vasodilation [GO:0042311] cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991] cadherin binding [GO:0045296]; cell adhesion molecule binding [GO:0050839]; insulin receptor binding [GO:0005158]; molecular adaptor activity [GO:0060090]; non-membrane spanning protein tyrosine phosphatase activity [GO:0004726]; peptide hormone receptor binding [GO:0051428]; phosphoprotein phosphatase activity [GO:0004721]; phosphotyrosine residue binding [GO:0001784]; protein kinase binding [GO:0019901]; protein tyrosine kinase binding [GO:1990782]; protein tyrosine phosphatase activity [GO:0004725]; receptor tyrosine kinase binding [GO:0030971]; signaling receptor complex adaptor activity [GO:0030159] g11879.t1 O00411 34.314 612 1.82e-113 384.0 sp|O00411|RPOM_HUMAN DNA-directed RNA polymerase, mitochondrial OS=Homo sapiens OX=9606 GN=POLRMT PE=1 SV=2 RPOM_HUMAN reviewed DNA-directed RNA polymerase, mitochondrial (MtRPOL) (EC 2.7.7.6) Homo sapiens (Human) GO:0000175; GO:0001018; GO:0003723; GO:0003899; GO:0005739; GO:0005759; GO:0006264; GO:0006390; GO:0006391; GO:0032991; GO:0034245; GO:0042645; GO:0043565 mitochondrial DNA replication [GO:0006264]; mitochondrial transcription [GO:0006390]; transcription initiation at mitochondrial promoter [GO:0006391] mitochondrial DNA-directed RNA polymerase complex [GO:0034245]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; protein-containing complex [GO:0032991] 3'-5'-RNA exonuclease activity [GO:0000175]; DNA-directed RNA polymerase activity [GO:0003899]; mitochondrial promoter sequence-specific DNA binding [GO:0001018]; RNA binding [GO:0003723]; sequence-specific DNA binding [GO:0043565] g11879.t1 O00411 62.097 124 1.3799999999999999e-30 119.0 sp|O00411|RPOM_HUMAN DNA-directed RNA polymerase, mitochondrial OS=Homo sapiens OX=9606 GN=POLRMT PE=1 SV=2 RPOM_HUMAN reviewed DNA-directed RNA polymerase, mitochondrial (MtRPOL) (EC 2.7.7.6) Homo sapiens (Human) GO:0000175; GO:0001018; GO:0003723; GO:0003899; GO:0005739; GO:0005759; GO:0006264; GO:0006390; GO:0006391; GO:0032991; GO:0034245; GO:0042645; GO:0043565 mitochondrial DNA replication [GO:0006264]; mitochondrial transcription [GO:0006390]; transcription initiation at mitochondrial promoter [GO:0006391] mitochondrial DNA-directed RNA polymerase complex [GO:0034245]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; protein-containing complex [GO:0032991] 3'-5'-RNA exonuclease activity [GO:0000175]; DNA-directed RNA polymerase activity [GO:0003899]; mitochondrial promoter sequence-specific DNA binding [GO:0001018]; RNA binding [GO:0003723]; sequence-specific DNA binding [GO:0043565] g11879.t1 O00411 72.727 22 1.3799999999999999e-30 37.7 sp|O00411|RPOM_HUMAN DNA-directed RNA polymerase, mitochondrial OS=Homo sapiens OX=9606 GN=POLRMT PE=1 SV=2 RPOM_HUMAN reviewed DNA-directed RNA polymerase, mitochondrial (MtRPOL) (EC 2.7.7.6) Homo sapiens (Human) GO:0000175; GO:0001018; GO:0003723; GO:0003899; GO:0005739; GO:0005759; GO:0006264; GO:0006390; GO:0006391; GO:0032991; GO:0034245; GO:0042645; GO:0043565 mitochondrial DNA replication [GO:0006264]; mitochondrial transcription [GO:0006390]; transcription initiation at mitochondrial promoter [GO:0006391] mitochondrial DNA-directed RNA polymerase complex [GO:0034245]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; protein-containing complex [GO:0032991] 3'-5'-RNA exonuclease activity [GO:0000175]; DNA-directed RNA polymerase activity [GO:0003899]; mitochondrial promoter sequence-specific DNA binding [GO:0001018]; RNA binding [GO:0003723]; sequence-specific DNA binding [GO:0043565] g11880.t1 Q8BKF1 47.917 144 5.52e-42 152.0 sp|Q8BKF1|RPOM_MOUSE DNA-directed RNA polymerase, mitochondrial OS=Mus musculus OX=10090 GN=Polrmt PE=1 SV=1 g11881.t1 Q9UPW0 57.416 209 1.97e-63 220.0 sp|Q9UPW0|FOXJ3_HUMAN Forkhead box protein J3 OS=Homo sapiens OX=9606 GN=FOXJ3 PE=1 SV=2 FOXJ3_HUMAN reviewed Forkhead box protein J3 Homo sapiens (Human) GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0005634; GO:0006357; GO:0007141; GO:0007283; GO:0030154; GO:0043565; GO:0045944; GO:1990837 cell differentiation [GO:0030154]; male meiosis I [GO:0007141]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283] chromatin [GO:0000785]; nucleus [GO:0005634] DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837] g11882.t1 Q5TGY1 46.838 506 4.02e-133 411.0 sp|Q5TGY1|TMCO4_HUMAN Transmembrane and coiled-coil domain-containing protein 4 OS=Homo sapiens OX=9606 GN=TMCO4 PE=1 SV=1 g11884.t1 P79385 33.803 213 3.1499999999999995e-23 101.0 sp|P79385|MFGM_PIG Lactadherin OS=Sus scrofa OX=9823 GN=MFGE8 PE=1 SV=2 g11888.t1 Q55EX9 31.9 279 1.6500000000000002e-31 120.0 sp|Q55EX9|Y8948_DICDI Putative methyltransferase DDB_G0268948 OS=Dictyostelium discoideum OX=44689 GN=DDB_G0268948 PE=1 SV=2 g11889.t1 Q55EX9 26.277 274 4.3799999999999995e-25 103.0 sp|Q55EX9|Y8948_DICDI Putative methyltransferase DDB_G0268948 OS=Dictyostelium discoideum OX=44689 GN=DDB_G0268948 PE=1 SV=2 g11894.t1 Q8IZF0 53.793 1305 0.0 1324.0 sp|Q8IZF0|NALCN_HUMAN Sodium leak channel NALCN OS=Homo sapiens OX=9606 GN=NALCN PE=1 SV=1 NALCN_HUMAN reviewed Sodium leak channel NALCN (CanIon) (Sodium leak channel non-selective protein) (Voltage gated channel-like protein 1) Homo sapiens (Human) GO:0005248; GO:0005261; GO:0005272; GO:0005886; GO:0022840; GO:0032224; GO:0032230; GO:0034220; GO:0034702; GO:0035725; GO:0060075; GO:0070588; GO:0071805 calcium ion transmembrane transport [GO:0070588]; monoatomic ion transmembrane transport [GO:0034220]; positive regulation of synaptic transmission, cholinergic [GO:0032224]; positive regulation of synaptic transmission, GABAergic [GO:0032230]; potassium ion transmembrane transport [GO:0071805]; regulation of resting membrane potential [GO:0060075]; sodium ion transmembrane transport [GO:0035725] monoatomic ion channel complex [GO:0034702]; plasma membrane [GO:0005886] leak channel activity [GO:0022840]; monoatomic cation channel activity [GO:0005261]; sodium channel activity [GO:0005272]; voltage-gated sodium channel activity [GO:0005248] g11894.t2 Q8BXR5 51.817 1789 0.0 1676.0 sp|Q8BXR5|NALCN_MOUSE Sodium leak channel NALCN OS=Mus musculus OX=10090 GN=Nalcn PE=1 SV=2 NALCN_MOUSE reviewed Sodium leak channel NALCN (Sodium leak channel non-selective protein) (Voltage gated channel-like protein 1) Mus musculus (Mouse) GO:0005248; GO:0005261; GO:0005886; GO:0022840; GO:0032224; GO:0032230; GO:0034702; GO:0035725; GO:0060075; GO:0070588; GO:0071805 calcium ion transmembrane transport [GO:0070588]; positive regulation of synaptic transmission, cholinergic [GO:0032224]; positive regulation of synaptic transmission, GABAergic [GO:0032230]; potassium ion transmembrane transport [GO:0071805]; regulation of resting membrane potential [GO:0060075]; sodium ion transmembrane transport [GO:0035725] monoatomic ion channel complex [GO:0034702]; plasma membrane [GO:0005886] leak channel activity [GO:0022840]; monoatomic cation channel activity [GO:0005261]; voltage-gated sodium channel activity [GO:0005248] g11894.t3 Q8IZF0 53.027 1784 0.0 1750.0 sp|Q8IZF0|NALCN_HUMAN Sodium leak channel NALCN OS=Homo sapiens OX=9606 GN=NALCN PE=1 SV=1 NALCN_HUMAN reviewed Sodium leak channel NALCN (CanIon) (Sodium leak channel non-selective protein) (Voltage gated channel-like protein 1) Homo sapiens (Human) GO:0005248; GO:0005261; GO:0005272; GO:0005886; GO:0022840; GO:0032224; GO:0032230; GO:0034220; GO:0034702; GO:0035725; GO:0060075; GO:0070588; GO:0071805 calcium ion transmembrane transport [GO:0070588]; monoatomic ion transmembrane transport [GO:0034220]; positive regulation of synaptic transmission, cholinergic [GO:0032224]; positive regulation of synaptic transmission, GABAergic [GO:0032230]; potassium ion transmembrane transport [GO:0071805]; regulation of resting membrane potential [GO:0060075]; sodium ion transmembrane transport [GO:0035725] monoatomic ion channel complex [GO:0034702]; plasma membrane [GO:0005886] leak channel activity [GO:0022840]; monoatomic cation channel activity [GO:0005261]; sodium channel activity [GO:0005272]; voltage-gated sodium channel activity [GO:0005248] g11894.t4 Q8IZF0 53.146 1780 0.0 1758.0 sp|Q8IZF0|NALCN_HUMAN Sodium leak channel NALCN OS=Homo sapiens OX=9606 GN=NALCN PE=1 SV=1 NALCN_HUMAN reviewed Sodium leak channel NALCN (CanIon) (Sodium leak channel non-selective protein) (Voltage gated channel-like protein 1) Homo sapiens (Human) GO:0005248; GO:0005261; GO:0005272; GO:0005886; GO:0022840; GO:0032224; GO:0032230; GO:0034220; GO:0034702; GO:0035725; GO:0060075; GO:0070588; GO:0071805 calcium ion transmembrane transport [GO:0070588]; monoatomic ion transmembrane transport [GO:0034220]; positive regulation of synaptic transmission, cholinergic [GO:0032224]; positive regulation of synaptic transmission, GABAergic [GO:0032230]; potassium ion transmembrane transport [GO:0071805]; regulation of resting membrane potential [GO:0060075]; sodium ion transmembrane transport [GO:0035725] monoatomic ion channel complex [GO:0034702]; plasma membrane [GO:0005886] leak channel activity [GO:0022840]; monoatomic cation channel activity [GO:0005261]; sodium channel activity [GO:0005272]; voltage-gated sodium channel activity [GO:0005248] g11894.t5 Q8IZF0 52.971 1784 0.0 1760.0 sp|Q8IZF0|NALCN_HUMAN Sodium leak channel NALCN OS=Homo sapiens OX=9606 GN=NALCN PE=1 SV=1 NALCN_HUMAN reviewed Sodium leak channel NALCN (CanIon) (Sodium leak channel non-selective protein) (Voltage gated channel-like protein 1) Homo sapiens (Human) GO:0005248; GO:0005261; GO:0005272; GO:0005886; GO:0022840; GO:0032224; GO:0032230; GO:0034220; GO:0034702; GO:0035725; GO:0060075; GO:0070588; GO:0071805 calcium ion transmembrane transport [GO:0070588]; monoatomic ion transmembrane transport [GO:0034220]; positive regulation of synaptic transmission, cholinergic [GO:0032224]; positive regulation of synaptic transmission, GABAergic [GO:0032230]; potassium ion transmembrane transport [GO:0071805]; regulation of resting membrane potential [GO:0060075]; sodium ion transmembrane transport [GO:0035725] monoatomic ion channel complex [GO:0034702]; plasma membrane [GO:0005886] leak channel activity [GO:0022840]; monoatomic cation channel activity [GO:0005261]; sodium channel activity [GO:0005272]; voltage-gated sodium channel activity [GO:0005248] g11894.t6 Q8BXR5 53.27 1789 0.0 1751.0 sp|Q8BXR5|NALCN_MOUSE Sodium leak channel NALCN OS=Mus musculus OX=10090 GN=Nalcn PE=1 SV=2 NALCN_MOUSE reviewed Sodium leak channel NALCN (Sodium leak channel non-selective protein) (Voltage gated channel-like protein 1) Mus musculus (Mouse) GO:0005248; GO:0005261; GO:0005886; GO:0022840; GO:0032224; GO:0032230; GO:0034702; GO:0035725; GO:0060075; GO:0070588; GO:0071805 calcium ion transmembrane transport [GO:0070588]; positive regulation of synaptic transmission, cholinergic [GO:0032224]; positive regulation of synaptic transmission, GABAergic [GO:0032230]; potassium ion transmembrane transport [GO:0071805]; regulation of resting membrane potential [GO:0060075]; sodium ion transmembrane transport [GO:0035725] monoatomic ion channel complex [GO:0034702]; plasma membrane [GO:0005886] leak channel activity [GO:0022840]; monoatomic cation channel activity [GO:0005261]; voltage-gated sodium channel activity [GO:0005248] g11895.t1 Q8CBC7 72.945 292 2.14e-143 410.0 sp|Q8CBC7|TRM7_MOUSE tRNA (cytidine(32)/guanosine(34)-2'-O)-methyltransferase OS=Mus musculus OX=10090 GN=Ftsj1 PE=1 SV=1 g11896.t1 P08472 34.177 395 1.15e-56 214.0 sp|P08472|M130_STRPU Mesenchyme-specific cell surface glycoprotein OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=2 g11896.t1 P08472 34.794 388 7.42e-55 209.0 sp|P08472|M130_STRPU Mesenchyme-specific cell surface glycoprotein OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=2 g11896.t2 P08472 34.177 395 9.770000000000001e-57 214.0 sp|P08472|M130_STRPU Mesenchyme-specific cell surface glycoprotein OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=2 g11896.t2 P08472 35.44 364 9.279999999999999e-54 205.0 sp|P08472|M130_STRPU Mesenchyme-specific cell surface glycoprotein OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=2 g11898.t1 Q05961 29.393 313 1.42e-31 127.0 sp|Q05961|OAS1A_RAT 2'-5'-oligoadenylate synthase 1A OS=Rattus norvegicus OX=10116 GN=Oas1a PE=2 SV=1 OAS1A_RAT reviewed 2'-5'-oligoadenylate synthase 1A ((2-5')oligo(A) synthase 1A) (2-5A synthase 1A) (EC 2.7.7.84) Rattus norvegicus (Rat) GO:0001730; GO:0003725; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005783; GO:0005829; GO:0005840; GO:0006006; GO:0009615; GO:0016020; GO:0032728; GO:0032760; GO:0034138; GO:0034142; GO:0035457; GO:0035458; GO:0042593; GO:0043129; GO:0045071; GO:0046872; GO:0051259; GO:0051607; GO:0060337; GO:0060339; GO:0070106; GO:0071360; GO:0071639; GO:0071659; GO:0140374; GO:1901857; GO:2000342 antiviral innate immune response [GO:0140374]; cellular response to exogenous dsRNA [GO:0071360]; cellular response to interferon-alpha [GO:0035457]; cellular response to interferon-beta [GO:0035458]; defense response to virus [GO:0051607]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; interleukin-27-mediated signaling pathway [GO:0070106]; negative regulation of chemokine (C-X-C motif) ligand 2 production [GO:2000342]; negative regulation of IP-10 production [GO:0071659]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; negative regulation of viral genome replication [GO:0045071]; positive regulation of cellular respiration [GO:1901857]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of monocyte chemotactic protein-1 production [GO:0071639]; positive regulation of tumor necrosis factor production [GO:0032760]; protein complex oligomerization [GO:0051259]; response to virus [GO:0009615]; surfactant homeostasis [GO:0043129]; toll-like receptor 3 signaling pathway [GO:0034138]; toll-like receptor 4 signaling pathway [GO:0034142]; type I interferon-mediated signaling pathway [GO:0060337] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribosome [GO:0005840] 2'-5'-oligoadenylate synthetase activity [GO:0001730]; ATP binding [GO:0005524]; double-stranded RNA binding [GO:0003725]; metal ion binding [GO:0046872] g11899.t1 Q8VI93 25.963 701 4.680000000000001e-43 171.0 sp|Q8VI93|OAS3_MOUSE 2'-5'-oligoadenylate synthase 3 OS=Mus musculus OX=10090 GN=Oas3 PE=1 SV=1 OAS3_MOUSE reviewed 2'-5'-oligoadenylate synthase 3 ((2-5')oligo(A) synthase 3) (2-5A synthase 3) (EC 2.7.7.84) (2',5'-oligoadenylate synthetase-like 10) Mus musculus (Mouse) GO:0001730; GO:0003725; GO:0005524; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0009615; GO:0016020; GO:0032728; GO:0032760; GO:0035395; GO:0039529; GO:0039530; GO:0042742; GO:0045071; GO:0046872; GO:0051607; GO:0060337; GO:0060339; GO:0070106; GO:0071360; GO:0071639; GO:0071650; GO:0071659; GO:0140374; GO:2000342 antiviral innate immune response [GO:0140374]; cellular response to exogenous dsRNA [GO:0071360]; defense response to bacterium [GO:0042742]; defense response to virus [GO:0051607]; interleukin-27-mediated signaling pathway [GO:0070106]; MDA-5 signaling pathway [GO:0039530]; negative regulation of chemokine (C-C motif) ligand 5 production [GO:0071650]; negative regulation of chemokine (C-X-C motif) ligand 2 production [GO:2000342]; negative regulation of chemokine (C-X-C motif) ligand 9 production [GO:0035395]; negative regulation of IP-10 production [GO:0071659]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; negative regulation of viral genome replication [GO:0045071]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of monocyte chemotactic protein-1 production [GO:0071639]; positive regulation of tumor necrosis factor production [GO:0032760]; response to virus [GO:0009615]; RIG-I signaling pathway [GO:0039529]; type I interferon-mediated signaling pathway [GO:0060337] cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] 2'-5'-oligoadenylate synthetase activity [GO:0001730]; ATP binding [GO:0005524]; double-stranded RNA binding [GO:0003725]; metal ion binding [GO:0046872] g11900.t1 Q5BKD0 30.164 305 1.17e-24 106.0 sp|Q5BKD0|OAS1B_RAT Inactive 2'-5'-oligoadenylate synthase 1B OS=Rattus norvegicus OX=10116 GN=Oas1b PE=2 SV=1 g11901.t1 Q09621 36.165 412 1.4100000000000001e-73 241.0 sp|Q09621|LACT2_CAEEL Beta-lactamase domain-containing protein 2 OS=Caenorhabditis elegans OX=6239 GN=lact-2 PE=4 SV=1 g11902.t1 Q09621 37.44 414 3.5600000000000005e-79 256.0 sp|Q09621|LACT2_CAEEL Beta-lactamase domain-containing protein 2 OS=Caenorhabditis elegans OX=6239 GN=lact-2 PE=4 SV=1 g11903.t1 Q09621 36.675 409 2.45e-75 246.0 sp|Q09621|LACT2_CAEEL Beta-lactamase domain-containing protein 2 OS=Caenorhabditis elegans OX=6239 GN=lact-2 PE=4 SV=1 g11905.t1 B1AJZ9 25.072 690 3.54e-53 208.0 sp|B1AJZ9|FHAD1_HUMAN Forkhead-associated domain-containing protein 1 OS=Homo sapiens OX=9606 GN=FHAD1 PE=1 SV=2 FHAD1_HUMAN reviewed Forkhead-associated domain-containing protein 1 (FHA domain-containing protein 1) Homo sapiens (Human) GO:0036126 sperm flagellum [GO:0036126] g11905.t2 B1AJZ9 25.802 686 6.13e-55 214.0 sp|B1AJZ9|FHAD1_HUMAN Forkhead-associated domain-containing protein 1 OS=Homo sapiens OX=9606 GN=FHAD1 PE=1 SV=2 FHAD1_HUMAN reviewed Forkhead-associated domain-containing protein 1 (FHA domain-containing protein 1) Homo sapiens (Human) GO:0036126 sperm flagellum [GO:0036126] g11905.t3 B1AJZ9 24.441 716 2.08e-51 202.0 sp|B1AJZ9|FHAD1_HUMAN Forkhead-associated domain-containing protein 1 OS=Homo sapiens OX=9606 GN=FHAD1 PE=1 SV=2 FHAD1_HUMAN reviewed Forkhead-associated domain-containing protein 1 (FHA domain-containing protein 1) Homo sapiens (Human) GO:0036126 sperm flagellum [GO:0036126] g11906.t1 Q99497 63.388 183 9.95e-76 228.0 sp|Q99497|PARK7_HUMAN Parkinson disease protein 7 OS=Homo sapiens OX=9606 GN=PARK7 PE=1 SV=2 PARK7_HUMAN reviewed Parkinson disease protein 7 (Maillard deglycase) (Oncogene DJ1) (Parkinsonism-associated deglycase) (Protein DJ-1) (DJ-1) (Protein/nucleic acid deglycase DJ-1) (EC 3.1.2.-, EC 3.5.1.-, EC 3.5.1.124) Homo sapiens (Human) GO:0000785; GO:0002866; GO:0003713; GO:0003729; GO:0005102; GO:0005507; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005758; GO:0005759; GO:0005783; GO:0005814; GO:0005829; GO:0005886; GO:0005912; GO:0006281; GO:0006508; GO:0006914; GO:0006954; GO:0006979; GO:0007005; GO:0007265; GO:0007338; GO:0008021; GO:0008047; GO:0008233; GO:0008344; GO:0009438; GO:0010273; GO:0010628; GO:0010629; GO:0016532; GO:0016605; GO:0016684; GO:0019249; GO:0019430; GO:0019826; GO:0019899; GO:0019900; GO:0019955; GO:0030073; GO:0030091; GO:0030414; GO:0030424; GO:0030521; GO:0030546; GO:0031334; GO:0031397; GO:0032435; GO:0032757; GO:0033234; GO:0034599; GO:0036470; GO:0036471; GO:0036478; GO:0036524; GO:0042593; GO:0042743; GO:0042802; GO:0042803; GO:0043523; GO:0043524; GO:0044297; GO:0044388; GO:0044390; GO:0045121; GO:0045296; GO:0045340; GO:0045944; GO:0046295; GO:0046826; GO:0048471; GO:0050681; GO:0050727; GO:0050787; GO:0050821; GO:0051583; GO:0051881; GO:0051897; GO:0051899; GO:0051920; GO:0055105; GO:0060081; GO:0060765; GO:0061691; GO:0061727; GO:0070062; GO:0070301; GO:0070994; GO:0097110; GO:0097225; GO:0106044; GO:0106045; GO:0106046; GO:0110095; GO:0140041; GO:0140297; GO:1900182; GO:1900242; GO:1902176; GO:1902177; GO:1902236; GO:1902903; GO:1902958; GO:1903073; GO:1903094; GO:1903122; GO:1903135; GO:1903136; GO:1903181; GO:1903189; GO:1903197; GO:1903376; GO:1903377; GO:1903384; GO:1903427; GO:1903428; GO:1903599; GO:1903751; GO:1905259; GO:1990381; GO:1990422; GO:2000379; GO:2001237 adult locomotory behavior [GO:0008344]; androgen receptor signaling pathway [GO:0030521]; autophagy [GO:0006914]; cellular detoxification of aldehyde [GO:0110095]; cellular detoxification of methylglyoxal [GO:0140041]; cellular response to glyoxal [GO:0036471]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to oxidative stress [GO:0034599]; detection of oxidative stress [GO:0070994]; detoxification of copper ion [GO:0010273]; detoxification of hydrogen peroxide [GO:0061691]; detoxification of mercury ion [GO:0050787]; DNA repair [GO:0006281]; dopamine uptake involved in synaptic transmission [GO:0051583]; glucose homeostasis [GO:0042593]; glycolate biosynthetic process [GO:0046295]; glyoxal metabolic process [GO:1903189]; guanine deglycation [GO:0106044]; guanine deglycation, glyoxal removal [GO:0106046]; guanine deglycation, methylglyoxal removal [GO:0106045]; hydrogen peroxide metabolic process [GO:0042743]; inflammatory response [GO:0006954]; insulin secretion [GO:0030073]; lactate biosynthetic process [GO:0019249]; membrane depolarization [GO:0051899]; membrane hyperpolarization [GO:0060081]; methylglyoxal catabolic process to lactate [GO:0061727]; methylglyoxal metabolic process [GO:0009438]; mitochondrion organization [GO:0007005]; negative regulation of death-inducing signaling complex assembly [GO:1903073]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of gene expression [GO:0010629]; negative regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway [GO:1903384]; negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:1903751]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of nitrosative stress-induced intrinsic apoptotic signaling pathway [GO:1905259]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway [GO:1903377]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of protein export from nucleus [GO:0046826]; negative regulation of protein K48-linked deubiquitination [GO:1903094]; negative regulation of protein sumoylation [GO:0033234]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of reactive oxygen species biosynthetic process [GO:1903427]; negative regulation of TRAIL-activated apoptotic signaling pathway [GO:1903122]; positive regulation of acute inflammatory response to antigenic stimulus [GO:0002866]; positive regulation of autophagy of mitochondrion [GO:1903599]; positive regulation of dopamine biosynthetic process [GO:1903181]; positive regulation of gene expression [GO:0010628]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of L-dopa biosynthetic process [GO:1903197]; positive regulation of mitochondrial electron transport, NADH to ubiquinone [GO:1902958]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of protein-containing complex assembly [GO:0031334]; positive regulation of reactive oxygen species biosynthetic process [GO:1903428]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein repair [GO:0030091]; protein stabilization [GO:0050821]; proteolysis [GO:0006508]; Ras protein signal transduction [GO:0007265]; regulation of androgen receptor signaling pathway [GO:0060765]; regulation of inflammatory response [GO:0050727]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of neuron apoptotic process [GO:0043523]; regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway [GO:1903376]; regulation of supramolecular fiber organization [GO:1902903]; regulation of synaptic vesicle endocytosis [GO:1900242]; removal of superoxide radicals [GO:0019430]; response to oxidative stress [GO:0006979]; single fertilization [GO:0007338] adherens junction [GO:0005912]; axon [GO:0030424]; cell body [GO:0044297]; centriole [GO:0005814]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; membrane raft [GO:0045121]; mitochondrial intermembrane space [GO:0005758]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; PML body [GO:0016605]; sperm midpiece [GO:0097225]; synaptic vesicle [GO:0008021] cadherin binding [GO:0045296]; copper ion binding [GO:0005507]; cupric ion binding [GO:1903135]; cuprous ion binding [GO:1903136]; cytokine binding [GO:0019955]; DNA-binding transcription factor binding [GO:0140297]; enzyme activator activity [GO:0008047]; enzyme binding [GO:0019899]; glyoxalase (glycolic acid-forming) activity [GO:1990422]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; L-dopa decarboxylase activator activity [GO:0036478]; mercury ion binding [GO:0045340]; mRNA binding [GO:0003729]; nuclear androgen receptor binding [GO:0050681]; oxidoreductase activity, acting on peroxide as acceptor [GO:0016684]; oxygen sensor activity [GO:0019826]; peptidase activity [GO:0008233]; peptidase inhibitor activity [GO:0030414]; peroxiredoxin activity [GO:0051920]; protein deglycase activity [GO:0036524]; protein homodimerization activity [GO:0042803]; scaffold protein binding [GO:0097110]; signaling receptor activator activity [GO:0030546]; signaling receptor binding [GO:0005102]; small protein activating enzyme binding [GO:0044388]; superoxide dismutase copper chaperone activity [GO:0016532]; transcription coactivator activity [GO:0003713]; tyrosine 3-monooxygenase activator activity [GO:0036470]; ubiquitin-like protein conjugating enzyme binding [GO:0044390]; ubiquitin-protein transferase inhibitor activity [GO:0055105]; ubiquitin-specific protease binding [GO:1990381] g11907.t1 A1Z6E0 65.108 278 5.94e-135 385.0 sp|A1Z6E0|GUS_DROME Protein gustavus OS=Drosophila melanogaster OX=7227 GN=gus PE=1 SV=2 GUS_DROME reviewed Protein gustavus Drosophila melanogaster (Fruit fly) GO:0005634; GO:0005737; GO:0005938; GO:0007281; GO:0007314; GO:0007315; GO:0007472; GO:0008104; GO:0008354; GO:0019005; GO:0031466; GO:0035017; GO:0035556; GO:0043161; GO:0045495; GO:0045732; GO:0046843; GO:0048471; GO:0070449 cuticle pattern formation [GO:0035017]; dorsal appendage formation [GO:0046843]; germ cell development [GO:0007281]; germ cell migration [GO:0008354]; intracellular protein localization [GO:0008104]; intracellular signal transduction [GO:0035556]; oocyte anterior/posterior axis specification [GO:0007314]; pole plasm assembly [GO:0007315]; positive regulation of protein catabolic process [GO:0045732]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; wing disc morphogenesis [GO:0007472] cell cortex [GO:0005938]; Cul5-RING ubiquitin ligase complex [GO:0031466]; cytoplasm [GO:0005737]; elongin complex [GO:0070449]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; pole plasm [GO:0045495]; SCF ubiquitin ligase complex [GO:0019005] g11908.t1 P40757 58.505 388 2.8699999999999996e-146 429.0 sp|P40757|ALN_AQUCT Allantoinase, mitochondrial OS=Aquarana catesbeiana OX=8400 GN=ALN PE=1 SV=1 g11909.t1 Q5FVC7 45.35 785 0.0 672.0 sp|Q5FVC7|ACAP2_RAT Arf-GAP with coiled-coil, ANK repeat and PH domain-containing protein 2 OS=Rattus norvegicus OX=10116 GN=Acap2 PE=1 SV=1 ACAP2_RAT reviewed Arf-GAP with coiled-coil, ANK repeat and PH domain-containing protein 2 (Centaurin-beta-2) (Cnt-b2) Rattus norvegicus (Rat) GO:0001726; GO:0005096; GO:0005886; GO:0008270; GO:0010008; GO:0030029; GO:0031267; GO:0032456; GO:0080025; GO:1990090 actin filament-based process [GO:0030029]; cellular response to nerve growth factor stimulus [GO:1990090]; endocytic recycling [GO:0032456] endosome membrane [GO:0010008]; plasma membrane [GO:0005886]; ruffle [GO:0001726] GTPase activator activity [GO:0005096]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; small GTPase binding [GO:0031267]; zinc ion binding [GO:0008270] g11909.t2 Q6IVG4 44.913 806 0.0 672.0 sp|Q6IVG4|ACAP2_RABIT Arf-GAP with coiled-coil, ANK repeat and PH domain-containing protein 2 OS=Oryctolagus cuniculus OX=9986 GN=ACAP2 PE=2 SV=1 g11910.t1 Q9WUA2 56.098 615 0.0 664.0 sp|Q9WUA2|SYFB_MOUSE Phenylalanine--tRNA ligase beta subunit OS=Mus musculus OX=10090 GN=Farsb PE=1 SV=2 g11910.t2 Q9WUA2 56.441 590 0.0 639.0 sp|Q9WUA2|SYFB_MOUSE Phenylalanine--tRNA ligase beta subunit OS=Mus musculus OX=10090 GN=Farsb PE=1 SV=2 g11911.t1 O94827 32.846 615 6.67e-89 309.0 sp|O94827|PKHG5_HUMAN Pleckstrin homology domain-containing family G member 5 OS=Homo sapiens OX=9606 GN=PLEKHG5 PE=1 SV=4 g11911.t2 Q66T02 32.67 704 4.99e-94 325.0 sp|Q66T02|PKHG5_MOUSE Pleckstrin homology domain-containing family G member 5 OS=Mus musculus OX=10090 GN=Plekhg5 PE=1 SV=1 PKHG5_MOUSE reviewed Pleckstrin homology domain-containing family G member 5 (PH domain-containing family G member 5) (Synectin-binding RhoA exchange factor) (SYX) Mus musculus (Mouse) GO:0005085; GO:0005737; GO:0005886; GO:0005911; GO:0007266; GO:0030027; GO:0030139; GO:0030424; GO:0035767; GO:0043542; GO:0048471; GO:0098793; GO:0140251 endothelial cell chemotaxis [GO:0035767]; endothelial cell migration [GO:0043542]; regulation protein catabolic process at presynapse [GO:0140251]; Rho protein signal transduction [GO:0007266] axon [GO:0030424]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; endocytic vesicle [GO:0030139]; lamellipodium [GO:0030027]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; presynapse [GO:0098793] guanyl-nucleotide exchange factor activity [GO:0005085] g11911.t3 Q66T02 32.578 706 1.28e-93 324.0 sp|Q66T02|PKHG5_MOUSE Pleckstrin homology domain-containing family G member 5 OS=Mus musculus OX=10090 GN=Plekhg5 PE=1 SV=1 PKHG5_MOUSE reviewed Pleckstrin homology domain-containing family G member 5 (PH domain-containing family G member 5) (Synectin-binding RhoA exchange factor) (SYX) Mus musculus (Mouse) GO:0005085; GO:0005737; GO:0005886; GO:0005911; GO:0007266; GO:0030027; GO:0030139; GO:0030424; GO:0035767; GO:0043542; GO:0048471; GO:0098793; GO:0140251 endothelial cell chemotaxis [GO:0035767]; endothelial cell migration [GO:0043542]; regulation protein catabolic process at presynapse [GO:0140251]; Rho protein signal transduction [GO:0007266] axon [GO:0030424]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; endocytic vesicle [GO:0030139]; lamellipodium [GO:0030027]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; presynapse [GO:0098793] guanyl-nucleotide exchange factor activity [GO:0005085] g11912.t1 P56705 65.116 344 3.68e-170 481.0 sp|P56705|WNT4_HUMAN Protein Wnt-4 OS=Homo sapiens OX=9606 GN=WNT4 PE=1 SV=4 WNT4_HUMAN reviewed Protein Wnt-4 Homo sapiens (Human) GO:0001658; GO:0001822; GO:0001837; GO:0001838; GO:0001889; GO:0003714; GO:0005109; GO:0005125; GO:0005576; GO:0005615; GO:0005737; GO:0005788; GO:0005796; GO:0005886; GO:0008543; GO:0008584; GO:0008585; GO:0009267; GO:0009986; GO:0010629; GO:0010894; GO:0022407; GO:0030182; GO:0030237; GO:0030325; GO:0030336; GO:0030501; GO:0030666; GO:0031012; GO:0032349; GO:0032967; GO:0033080; GO:0035567; GO:0040037; GO:0042445; GO:0043410; GO:0045165; GO:0045596; GO:0045669; GO:0045836; GO:0045892; GO:0045893; GO:0046580; GO:0048018; GO:0048599; GO:0051145; GO:0051496; GO:0051894; GO:0060008; GO:0060070; GO:0060126; GO:0060129; GO:0060231; GO:0060748; GO:0061045; GO:0061180; GO:0061184; GO:0061205; GO:0061369; GO:0070062; GO:0071560; GO:0072033; GO:0072034; GO:0072162; GO:0072174; GO:0072273; GO:0097190; GO:0140013; GO:1904238; GO:2000019; GO:2000066; GO:2000180; GO:2000225; GO:2001234 adrenal gland development [GO:0030325]; apoptotic signaling pathway [GO:0097190]; branching involved in ureteric bud morphogenesis [GO:0001658]; canonical Wnt signaling pathway [GO:0060070]; cell fate commitment [GO:0045165]; cellular response to starvation [GO:0009267]; cellular response to transforming growth factor beta stimulus [GO:0071560]; embryonic epithelial tube formation [GO:0001838]; epithelial to mesenchymal transition [GO:0001837]; female gonad development [GO:0008585]; female sex determination [GO:0030237]; fibroblast growth factor receptor signaling pathway [GO:0008543]; hormone metabolic process [GO:0042445]; immature T cell proliferation in thymus [GO:0033080]; kidney development [GO:0001822]; liver development [GO:0001889]; male gonad development [GO:0008584]; mammary gland epithelium development [GO:0061180]; meiotic nuclear division [GO:0140013]; mesenchymal to epithelial transition [GO:0060231]; metanephric mesenchymal cell differentiation [GO:0072162]; metanephric nephron morphogenesis [GO:0072273]; metanephric tubule formation [GO:0072174]; negative regulation of androgen biosynthetic process [GO:2000180]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of cell differentiation [GO:0045596]; negative regulation of cell migration [GO:0030336]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of fibroblast growth factor receptor signaling pathway [GO:0040037]; negative regulation of gene expression [GO:0010629]; negative regulation of male gonad development [GO:2000019]; negative regulation of Ras protein signal transduction [GO:0046580]; negative regulation of steroid biosynthetic process [GO:0010894]; negative regulation of testicular blood vessel morphogenesis [GO:0061369]; negative regulation of testosterone biosynthetic process [GO:2000225]; negative regulation of wound healing [GO:0061045]; neuron differentiation [GO:0030182]; non-canonical Wnt signaling pathway [GO:0035567]; oocyte development [GO:0048599]; paramesonephric duct development [GO:0061205]; pericyte cell differentiation [GO:1904238]; positive regulation of aldosterone biosynthetic process [GO:0032349]; positive regulation of bone mineralization [GO:0030501]; positive regulation of collagen biosynthetic process [GO:0032967]; positive regulation of cortisol biosynthetic process [GO:2000066]; positive regulation of dermatome development [GO:0061184]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of meiotic nuclear division [GO:0045836]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of stress fiber assembly [GO:0051496]; regulation of cell-cell adhesion [GO:0022407]; renal vesicle formation [GO:0072033]; renal vesicle induction [GO:0072034]; Sertoli cell differentiation [GO:0060008]; smooth muscle cell differentiation [GO:0051145]; somatotropin secreting cell differentiation [GO:0060126]; tertiary branching involved in mammary gland duct morphogenesis [GO:0060748]; thyroid-stimulating hormone-secreting cell differentiation [GO:0060129] cell surface [GO:0009986]; cytoplasm [GO:0005737]; endocytic vesicle membrane [GO:0030666]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; plasma membrane [GO:0005886] cytokine activity [GO:0005125]; frizzled binding [GO:0005109]; receptor ligand activity [GO:0048018]; transcription corepressor activity [GO:0003714] g11917.t1 O88281 40.054 1478 0.0 1010.0 sp|O88281|MEGF6_RAT Multiple epidermal growth factor-like domains protein 6 OS=Rattus norvegicus OX=10116 GN=Megf6 PE=1 SV=1 g11917.t1 O88281 36.019 633 4.780000000000001e-109 336.0 sp|O88281|MEGF6_RAT Multiple epidermal growth factor-like domains protein 6 OS=Rattus norvegicus OX=10116 GN=Megf6 PE=1 SV=1 g11917.t1 O88281 42.975 121 4.780000000000001e-109 84.0 sp|O88281|MEGF6_RAT Multiple epidermal growth factor-like domains protein 6 OS=Rattus norvegicus OX=10116 GN=Megf6 PE=1 SV=1 g11918.t1 Q6IR42 41.304 184 1.04e-40 163.0 sp|Q6IR42|ZCPW1_MOUSE Zinc finger CW-type PWWP domain protein 1 OS=Mus musculus OX=10090 GN=Zcwpw1 PE=1 SV=2 ZCPW1_MOUSE reviewed Zinc finger CW-type PWWP domain protein 1 Mus musculus (Mouse) GO:0001741; GO:0005634; GO:0007127; GO:0007129; GO:0007283; GO:0008270; GO:0030154; GO:0040029; GO:0045911; GO:0140002; GO:0140003; GO:0140566; GO:1990918; GO:2000781 cell differentiation [GO:0030154]; double-strand break repair involved in meiotic recombination [GO:1990918]; epigenetic regulation of gene expression [GO:0040029]; homologous chromosome pairing at meiosis [GO:0007129]; meiosis I [GO:0007127]; positive regulation of DNA recombination [GO:0045911]; positive regulation of double-strand break repair [GO:2000781]; spermatogenesis [GO:0007283] nucleus [GO:0005634]; XY body [GO:0001741] histone H3K36me3 reader activity [GO:0140003]; histone H3K4me3 reader activity [GO:0140002]; histone reader activity [GO:0140566]; zinc ion binding [GO:0008270] g11920.t1 Q9P2S5 60.793 454 0.0 599.0 sp|Q9P2S5|WRP73_HUMAN WD repeat-containing protein WRAP73 OS=Homo sapiens OX=9606 GN=WRAP73 PE=1 SV=1 WRP73_HUMAN reviewed WD repeat-containing protein WRAP73 (WD repeat-containing protein 8) (WD repeat-containing protein antisense to TP73 gene) Homo sapiens (Human) GO:0005737; GO:0005813; GO:0005814; GO:0005815; GO:0030030; GO:0034451; GO:0036064; GO:0090307; GO:1902857; GO:1990810; GO:1990811 cell projection organization [GO:0030030]; microtubule anchoring at mitotic spindle pole body [GO:1990810]; mitotic spindle assembly [GO:0090307]; positive regulation of non-motile cilium assembly [GO:1902857] centriolar satellite [GO:0034451]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; MWP complex [GO:1990811] g11922.t1 Q5RC70 53.887 566 0.0 573.0 sp|Q5RC70|DJC11_PONAB DnaJ homolog subfamily C member 11 OS=Pongo abelii OX=9601 GN=DNAJC11 PE=2 SV=1 DJC11_PONAB reviewed DnaJ homolog subfamily C member 11 Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0001401; GO:0016607; GO:0042407; GO:0061617 cristae formation [GO:0042407] MICOS complex [GO:0061617]; nuclear speck [GO:0016607]; SAM complex [GO:0001401] g11934.t1 P41594 30.473 804 9.34e-106 357.0 sp|P41594|GRM5_HUMAN Metabotropic glutamate receptor 5 OS=Homo sapiens OX=9606 GN=GRM5 PE=1 SV=2 GRM5_HUMAN reviewed Metabotropic glutamate receptor 5 (mGluR5) Homo sapiens (Human) GO:0001640; GO:0001659; GO:0001975; GO:0002029; GO:0004930; GO:0005637; GO:0005737; GO:0005886; GO:0006355; GO:0007204; GO:0007206; GO:0007216; GO:0007268; GO:0007611; GO:0007626; GO:0008066; GO:0030296; GO:0030425; GO:0031687; GO:0033603; GO:0035106; GO:0036228; GO:0042802; GO:0043025; GO:0043197; GO:0043198; GO:0043278; GO:0043410; GO:0045471; GO:0046677; GO:0048170; GO:0050808; GO:0050850; GO:0050890; GO:0051412; GO:0051966; GO:0061002; GO:0062036; GO:0090394; GO:0097449; GO:0098685; GO:0098839; GO:0098978; GO:0099530; GO:0099583; GO:1900039; GO:1900452; GO:1904058; GO:1904646; GO:1990708; GO:1990782; GO:2000179 cellular response to amyloid-beta [GO:1904646]; chemical synaptic transmission [GO:0007268]; cognition [GO:0050890]; conditioned place preference [GO:1990708]; desensitization of G protein-coupled receptor signaling pathway [GO:0002029]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; learning or memory [GO:0007611]; locomotory behavior [GO:0007626]; negative regulation of dendritic spine morphogenesis [GO:0061002]; negative regulation of excitatory postsynaptic potential [GO:0090394]; operant conditioning [GO:0035106]; phospholipase C-activating G protein-coupled glutamate receptor signaling pathway [GO:0007206]; positive regulation of calcium-mediated signaling [GO:0050850]; positive regulation of cellular response to hypoxia [GO:1900039]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of dopamine secretion [GO:0033603]; positive regulation of long-term neuronal synaptic plasticity [GO:0048170]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of sensory perception of pain [GO:1904058]; protein localization to nuclear inner membrane [GO:0036228]; regulation of DNA-templated transcription [GO:0006355]; regulation of long-term synaptic depression [GO:1900452]; regulation of synaptic transmission, glutamatergic [GO:0051966]; response to amphetamine [GO:0001975]; response to antibiotic [GO:0046677]; response to corticosterone [GO:0051412]; response to ethanol [GO:0045471]; response to morphine [GO:0043278]; sensory perception of hot stimulus [GO:0062036]; synapse organization [GO:0050808]; temperature homeostasis [GO:0001659] astrocyte projection [GO:0097449]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; neuronal cell body [GO:0043025]; nuclear inner membrane [GO:0005637]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; Schaffer collateral - CA1 synapse [GO:0098685] A2A adenosine receptor binding [GO:0031687]; adenylate cyclase inhibiting G protein-coupled glutamate receptor activity [GO:0001640]; G protein-coupled receptor activity [GO:0004930]; G protein-coupled receptor activity involved in regulation of postsynaptic membrane potential [GO:0099530]; glutamate receptor activity [GO:0008066]; identical protein binding [GO:0042802]; neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration [GO:0099583]; protein tyrosine kinase activator activity [GO:0030296]; protein tyrosine kinase binding [GO:1990782] g11935.t1 Q16YG0 70.157 191 9.3e-74 222.0 sp|Q16YG0|CDC42_AEDAE Cdc42 homolog OS=Aedes aegypti OX=7159 GN=Cdc42 PE=3 SV=1 g11936.t1 Q84TH5 48.77 244 2.61e-70 245.0 sp|Q84TH5|AB25G_ARATH ABC transporter G family member 25 OS=Arabidopsis thaliana OX=3702 GN=ABCG25 PE=1 SV=1 g11936.t1 Q84TH5 28.105 306 2.1599999999999998e-30 131.0 sp|Q84TH5|AB25G_ARATH ABC transporter G family member 25 OS=Arabidopsis thaliana OX=3702 GN=ABCG25 PE=1 SV=1 g11937.t1 Q6P8M1 65.87 293 5.85e-154 435.0 sp|Q6P8M1|TATD1_MOUSE Deoxyribonuclease TATDN1 OS=Mus musculus OX=10090 GN=Tatdn1 PE=1 SV=1 g11939.t1 Q5T0B9 52.683 205 8.65e-72 237.0 sp|Q5T0B9|ZN362_HUMAN Zinc finger protein 362 OS=Homo sapiens OX=9606 GN=ZNF362 PE=1 SV=1 g11940.t1 P08472 36.883 385 5.21e-59 221.0 sp|P08472|M130_STRPU Mesenchyme-specific cell surface glycoprotein OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=2 g11940.t1 P08472 33.333 384 2.49e-51 198.0 sp|P08472|M130_STRPU Mesenchyme-specific cell surface glycoprotein OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=2 g11942.t1 Q8CBC7 72.945 292 3.3e-139 400.0 sp|Q8CBC7|TRM7_MOUSE tRNA (cytidine(32)/guanosine(34)-2'-O)-methyltransferase OS=Mus musculus OX=10090 GN=Ftsj1 PE=1 SV=1 g11944.t1 P52209 78.468 483 0.0 783.0 sp|P52209|6PGD_HUMAN 6-phosphogluconate dehydrogenase, decarboxylating OS=Homo sapiens OX=9606 GN=PGD PE=1 SV=3 6PGD_HUMAN reviewed 6-phosphogluconate dehydrogenase, decarboxylating (EC 1.1.1.44) Homo sapiens (Human) GO:0004616; GO:0005634; GO:0005829; GO:0006098; GO:0009051; GO:0019322; GO:0019521; GO:0030246; GO:0031406; GO:0050661; GO:0070062 D-gluconate metabolic process [GO:0019521]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634] carbohydrate binding [GO:0030246]; carboxylic acid binding [GO:0031406]; NADP binding [GO:0050661]; phosphogluconate dehydrogenase (decarboxylating) activity [GO:0004616] g11945.t1 A2VDS1 60.526 418 6.38e-174 497.0 sp|A2VDS1|SCLY_BOVIN Selenocysteine lyase OS=Bos taurus OX=9913 GN=SCLY PE=2 SV=1 g11946.t1 Q3ZBV2 64.354 418 0.0 594.0 sp|Q3ZBV2|DD19A_BOVIN ATP-dependent RNA helicase DDX19A OS=Bos taurus OX=9913 GN=DDX19A PE=2 SV=1 DD19A_BOVIN reviewed ATP-dependent RNA helicase DDX19A (EC 3.6.4.13) (DEAD box protein 19A) Bos taurus (Bovine) GO:0003724; GO:0003729; GO:0005524; GO:0005634; GO:0005654; GO:0010494; GO:0016887; GO:0016973 poly(A)+ mRNA export from nucleus [GO:0016973] cytoplasmic stress granule [GO:0010494]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; mRNA binding [GO:0003729]; RNA helicase activity [GO:0003724] g11947.t1 P09487 49.4 500 2.95e-158 464.0 sp|P09487|PPBT_BOVIN Alkaline phosphatase, tissue-nonspecific isozyme OS=Bos taurus OX=9913 GN=ALPL PE=1 SV=2 PPBT_BOVIN reviewed Alkaline phosphatase, tissue-nonspecific isozyme (AP-TNAP) (TNAP) (TNSALP) (EC 3.1.3.1) (Alkaline phosphatase liver/bone/kidney isozyme) (Phosphoamidase) (Phosphocreatine phosphatase) (EC 3.9.1.1) Bos taurus (Bovine) GO:0004035; GO:0004427; GO:0005509; GO:0005758; GO:0005886; GO:0016462; GO:0016887; GO:0030282; GO:0031214; GO:0031966; GO:0033883; GO:0043262; GO:0050187; GO:0052732; GO:0065010; GO:0098552; GO:0120162 biomineral tissue development [GO:0031214]; bone mineralization [GO:0030282]; positive regulation of cold-induced thermogenesis [GO:0120162] extracellular membrane-bounded organelle [GO:0065010]; mitochondrial intermembrane space [GO:0005758]; mitochondrial membrane [GO:0031966]; plasma membrane [GO:0005886]; side of membrane [GO:0098552] ADP phosphatase activity [GO:0043262]; alkaline phosphatase activity [GO:0004035]; ATP hydrolysis activity [GO:0016887]; calcium ion binding [GO:0005509]; inorganic diphosphate phosphatase activity [GO:0004427]; phosphoamidase activity [GO:0050187]; phosphoethanolamine phosphatase activity [GO:0052732]; pyridoxal phosphatase activity [GO:0033883]; pyrophosphatase activity [GO:0016462] g11948.t1 P83456 50.951 473 9.93e-161 469.0 sp|P83456|PPB_GADMO Alkaline phosphatase OS=Gadus morhua OX=8049 PE=1 SV=1 g11949.t1 P07478 44.503 191 5.0399999999999995e-42 146.0 sp|P07478|TRY2_HUMAN Trypsin-2 OS=Homo sapiens OX=9606 GN=PRSS2 PE=1 SV=1 TRY2_HUMAN reviewed Trypsin-2 (EC 3.4.21.4) (Anionic trypsinogen) (Serine protease 2) (Trypsin II) Homo sapiens (Human) GO:0004222; GO:0004252; GO:0005509; GO:0005576; GO:0005615; GO:0006508; GO:0007586; GO:0008236; GO:0019730; GO:0022617; GO:0030307; GO:0030574; GO:0031012; GO:0035578; GO:0045785 antimicrobial humoral response [GO:0019730]; collagen catabolic process [GO:0030574]; digestion [GO:0007586]; extracellular matrix disassembly [GO:0022617]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cell growth [GO:0030307]; proteolysis [GO:0006508] azurophil granule lumen [GO:0035578]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615] calcium ion binding [GO:0005509]; metalloendopeptidase activity [GO:0004222]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236] g11950.t1 Q8NHM4 44.13 247 1.96e-52 174.0 sp|Q8NHM4|TRY6_HUMAN Putative trypsin-6 OS=Homo sapiens OX=9606 GN=PRSS3P2 PE=5 SV=2 g11951.t1 P07478 45.175 228 7.43e-63 200.0 sp|P07478|TRY2_HUMAN Trypsin-2 OS=Homo sapiens OX=9606 GN=PRSS2 PE=1 SV=1 TRY2_HUMAN reviewed Trypsin-2 (EC 3.4.21.4) (Anionic trypsinogen) (Serine protease 2) (Trypsin II) Homo sapiens (Human) GO:0004222; GO:0004252; GO:0005509; GO:0005576; GO:0005615; GO:0006508; GO:0007586; GO:0008236; GO:0019730; GO:0022617; GO:0030307; GO:0030574; GO:0031012; GO:0035578; GO:0045785 antimicrobial humoral response [GO:0019730]; collagen catabolic process [GO:0030574]; digestion [GO:0007586]; extracellular matrix disassembly [GO:0022617]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cell growth [GO:0030307]; proteolysis [GO:0006508] azurophil granule lumen [GO:0035578]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615] calcium ion binding [GO:0005509]; metalloendopeptidase activity [GO:0004222]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236] g11952.t1 Q86UV5 43.446 267 1.74e-44 163.0 sp|Q86UV5|UBP48_HUMAN Ubiquitin carboxyl-terminal hydrolase 48 OS=Homo sapiens OX=9606 GN=USP48 PE=1 SV=1 g11953.t1 A0A0R4IB93 51.579 760 0.0 789.0 sp|A0A0R4IB93|UBP48_DANRE Ubiquitin carboxyl-terminal hydrolase 48 OS=Danio rerio OX=7955 GN=usp48 PE=3 SV=1 UBP48_DANRE reviewed Ubiquitin carboxyl-terminal hydrolase 48 (EC 3.4.19.12) (Ubiquitin specific peptidase 48) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001966; GO:0004197; GO:0004843; GO:0005634; GO:0005829; GO:0006508; GO:0010975; GO:0010996; GO:0016579; GO:0031647; GO:1904888 cranial skeletal system development [GO:1904888]; protein deubiquitination [GO:0016579]; proteolysis [GO:0006508]; regulation of neuron projection development [GO:0010975]; regulation of protein stability [GO:0031647]; response to auditory stimulus [GO:0010996]; thigmotaxis [GO:0001966] cytosol [GO:0005829]; nucleus [GO:0005634] cysteine-type deubiquitinase activity [GO:0004843]; cysteine-type endopeptidase activity [GO:0004197] g11954.t1 Q07943 35.032 157 1.2e-26 105.0 sp|Q07943|VDP_BOMMO Vitellin-degrading protease OS=Bombyx mori OX=7091 PE=1 SV=1 g11955.t1 P39675 39.516 248 1.46e-47 162.0 sp|P39675|DERP3_DERPT Mite allergen Der p 3 OS=Dermatophagoides pteronyssinus OX=6956 GN=DERP3 PE=1 SV=1 g11957.t1 Q08AW4 50.638 235 4.4900000000000004e-79 271.0 sp|Q08AW4|PKHM3_XENLA Pleckstrin homology domain-containing family M member 3 OS=Xenopus laevis OX=8355 GN=plekhm3 PE=2 SV=1 g11957.t2 Q08AW4 50.638 235 2.4e-79 272.0 sp|Q08AW4|PKHM3_XENLA Pleckstrin homology domain-containing family M member 3 OS=Xenopus laevis OX=8355 GN=plekhm3 PE=2 SV=1 g11961.t1 Q9I7F7 44.248 452 1.9199999999999999e-112 362.0 sp|Q9I7F7|ACKL_DROME Activated Cdc42 kinase-like OS=Drosophila melanogaster OX=7227 GN=Ack-like PE=1 SV=3 ACKL_DROME reviewed Activated Cdc42 kinase-like (EC 2.7.10.2) (Tyrosine-protein kinase PR2) Drosophila melanogaster (Fruit fly) GO:0004713; GO:0004715; GO:0005524; GO:0005886; GO:0006468; GO:0008258; GO:0031034; GO:0046664 dorsal closure, amnioserosa morphology change [GO:0046664]; head involution [GO:0008258]; myosin filament assembly [GO:0031034]; protein phosphorylation [GO:0006468] plasma membrane [GO:0005886] ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein tyrosine kinase activity [GO:0004713] g11962.t1 Q5T2D3 42.773 339 1.17e-85 269.0 sp|Q5T2D3|OTUD3_HUMAN OTU domain-containing protein 3 OS=Homo sapiens OX=9606 GN=OTUD3 PE=1 SV=1 OTUD3_HUMAN reviewed OTU domain-containing protein 3 (EC 3.4.19.12) Homo sapiens (Human) GO:0004843; GO:0005634; GO:0005737; GO:0005829; GO:0006508; GO:0016579; GO:0031669; GO:0035871; GO:0044313; GO:0050821; GO:0051898; GO:0071108; GO:1990167 cellular response to nutrient levels [GO:0031669]; negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051898]; protein deubiquitination [GO:0016579]; protein K11-linked deubiquitination [GO:0035871]; protein K27-linked deubiquitination [GO:1990167]; protein K48-linked deubiquitination [GO:0071108]; protein K6-linked deubiquitination [GO:0044313]; protein stabilization [GO:0050821]; proteolysis [GO:0006508] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634] cysteine-type deubiquitinase activity [GO:0004843] g11965.t1 Q96C19 67.785 149 2.13e-57 183.0 sp|Q96C19|EFHD2_HUMAN EF-hand domain-containing protein D2 OS=Homo sapiens OX=9606 GN=EFHD2 PE=1 SV=1 g11966.t1 Q6DG32 60.738 298 1.3600000000000001e-117 345.0 sp|Q6DG32|S2536_DANRE Solute carrier family 25 member 36-A OS=Danio rerio OX=7955 GN=slc25a36a PE=2 SV=1 g11967.t1 Q0IHQ9 33.945 436 5.1799999999999995e-52 189.0 sp|Q0IHQ9|PXYP1_XENTR 2-phosphoxylose phosphatase 1 OS=Xenopus tropicalis OX=8364 GN=pxylp1 PE=2 SV=1 g11968.t1 F1R520 40.756 979 0.0 625.0 sp|F1R520|CSTN1_DANRE Calsyntenin-1 OS=Danio rerio OX=7955 GN=clstn1 PE=1 SV=1 CSTN1_DANRE reviewed Calsyntenin-1 Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000139; GO:0005509; GO:0005789; GO:0007156; GO:0009986; GO:0030424; GO:0030951; GO:0032456; GO:0045211; GO:0048670; GO:0050806; GO:0051965; GO:0098930; GO:0140060 axon arborization [GO:0140060]; axonal transport [GO:0098930]; endocytic recycling [GO:0032456]; establishment or maintenance of microtubule cytoskeleton polarity [GO:0030951]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; positive regulation of synapse assembly [GO:0051965]; positive regulation of synaptic transmission [GO:0050806]; regulation of collateral sprouting [GO:0048670] axon [GO:0030424]; cell surface [GO:0009986]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; postsynaptic membrane [GO:0045211] calcium ion binding [GO:0005509] g11968.t2 F1R520 41.092 971 0.0 633.0 sp|F1R520|CSTN1_DANRE Calsyntenin-1 OS=Danio rerio OX=7955 GN=clstn1 PE=1 SV=1 CSTN1_DANRE reviewed Calsyntenin-1 Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000139; GO:0005509; GO:0005789; GO:0007156; GO:0009986; GO:0030424; GO:0030951; GO:0032456; GO:0045211; GO:0048670; GO:0050806; GO:0051965; GO:0098930; GO:0140060 axon arborization [GO:0140060]; axonal transport [GO:0098930]; endocytic recycling [GO:0032456]; establishment or maintenance of microtubule cytoskeleton polarity [GO:0030951]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; positive regulation of synapse assembly [GO:0051965]; positive regulation of synaptic transmission [GO:0050806]; regulation of collateral sprouting [GO:0048670] axon [GO:0030424]; cell surface [GO:0009986]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; postsynaptic membrane [GO:0045211] calcium ion binding [GO:0005509] g11969.t1 Q8WZA0 70.0 180 1.35e-60 190.0 sp|Q8WZA0|LZIC_HUMAN Protein LZIC OS=Homo sapiens OX=9606 GN=LZIC PE=1 SV=1 g11972.t1 A1A4J7 38.8 250 9.370000000000001e-47 169.0 sp|A1A4J7|SMG8_BOVIN Nonsense-mediated mRNA decay factor SMG8 OS=Bos taurus OX=9913 GN=SMG8 PE=2 SV=2 g11973.t1 A1A4J7 41.342 462 1.69e-91 301.0 sp|A1A4J7|SMG8_BOVIN Nonsense-mediated mRNA decay factor SMG8 OS=Bos taurus OX=9913 GN=SMG8 PE=2 SV=2 g11974.t1 O75038 53.222 419 1.13e-128 446.0 sp|O75038|PLCH2_HUMAN 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase eta-2 OS=Homo sapiens OX=9606 GN=PLCH2 PE=1 SV=3 PLCH2_HUMAN reviewed 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase eta-2 (EC 3.1.4.11) (Phosphoinositide phospholipase C-eta-2) (Phosphoinositide phospholipase C-like 4) (PLC-L4) (Phospholipase C-like protein 4) (Phospholipase C-eta-2) (PLC-eta2) Homo sapiens (Human) GO:0004435; GO:0005509; GO:0005737; GO:0005886; GO:0007200; GO:0016042; GO:0046488; GO:0048015; GO:0051209 lipid catabolic process [GO:0016042]; phosphatidylinositol metabolic process [GO:0046488]; phosphatidylinositol-mediated signaling [GO:0048015]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; release of sequestered calcium ion into cytosol [GO:0051209] cytoplasm [GO:0005737]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; phosphatidylinositol-4,5-bisphosphate phospholipase C activity [GO:0004435] g11974.t1 O75038 54.275 269 1.04e-86 318.0 sp|O75038|PLCH2_HUMAN 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase eta-2 OS=Homo sapiens OX=9606 GN=PLCH2 PE=1 SV=3 PLCH2_HUMAN reviewed 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase eta-2 (EC 3.1.4.11) (Phosphoinositide phospholipase C-eta-2) (Phosphoinositide phospholipase C-like 4) (PLC-L4) (Phospholipase C-like protein 4) (Phospholipase C-eta-2) (PLC-eta2) Homo sapiens (Human) GO:0004435; GO:0005509; GO:0005737; GO:0005886; GO:0007200; GO:0016042; GO:0046488; GO:0048015; GO:0051209 lipid catabolic process [GO:0016042]; phosphatidylinositol metabolic process [GO:0046488]; phosphatidylinositol-mediated signaling [GO:0048015]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; release of sequestered calcium ion into cytosol [GO:0051209] cytoplasm [GO:0005737]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; phosphatidylinositol-4,5-bisphosphate phospholipase C activity [GO:0004435] g11975.t1 A9UMS3 71.429 301 5.81e-120 349.0 sp|A9UMS3|PHB2_XENTR Prohibitin-2 OS=Xenopus tropicalis OX=8364 GN=phb2 PE=2 SV=1 g11976.t1 Q8C811 62.681 276 2.28e-117 351.0 sp|Q8C811|S35E2_MOUSE Solute carrier family 35 member E2A OS=Mus musculus OX=10090 GN=Slc35e2a PE=2 SV=1 g11977.t1 Q8CJF7 35.314 1178 0.0 645.0 sp|Q8CJF7|ELYS_MOUSE Protein ELYS OS=Mus musculus OX=10090 GN=Ahctf1 PE=1 SV=1 ELYS_MOUSE reviewed Protein ELYS (Embryonic large molecule derived from yolk sac) (Protein MEL-28) (Putative AT-hook-containing transcription factor 1) Mus musculus (Mouse) GO:0000776; GO:0000785; GO:0003677; GO:0005634; GO:0005635; GO:0005643; GO:0005654; GO:0005737; GO:0006913; GO:0015031; GO:0016363; GO:0016604; GO:0030097; GO:0031080; GO:0031965; GO:0032465; GO:0051028; GO:0051292; GO:0051301 cell division [GO:0051301]; hemopoiesis [GO:0030097]; mRNA transport [GO:0051028]; nuclear pore complex assembly [GO:0051292]; nucleocytoplasmic transport [GO:0006913]; protein transport [GO:0015031]; regulation of cytokinesis [GO:0032465] chromatin [GO:0000785]; cytoplasm [GO:0005737]; kinetochore [GO:0000776]; nuclear body [GO:0016604]; nuclear envelope [GO:0005635]; nuclear matrix [GO:0016363]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nuclear pore outer ring [GO:0031080]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] DNA binding [GO:0003677] g11977.t2 Q8CJF7 35.314 1178 0.0 645.0 sp|Q8CJF7|ELYS_MOUSE Protein ELYS OS=Mus musculus OX=10090 GN=Ahctf1 PE=1 SV=1 ELYS_MOUSE reviewed Protein ELYS (Embryonic large molecule derived from yolk sac) (Protein MEL-28) (Putative AT-hook-containing transcription factor 1) Mus musculus (Mouse) GO:0000776; GO:0000785; GO:0003677; GO:0005634; GO:0005635; GO:0005643; GO:0005654; GO:0005737; GO:0006913; GO:0015031; GO:0016363; GO:0016604; GO:0030097; GO:0031080; GO:0031965; GO:0032465; GO:0051028; GO:0051292; GO:0051301 cell division [GO:0051301]; hemopoiesis [GO:0030097]; mRNA transport [GO:0051028]; nuclear pore complex assembly [GO:0051292]; nucleocytoplasmic transport [GO:0006913]; protein transport [GO:0015031]; regulation of cytokinesis [GO:0032465] chromatin [GO:0000785]; cytoplasm [GO:0005737]; kinetochore [GO:0000776]; nuclear body [GO:0016604]; nuclear envelope [GO:0005635]; nuclear matrix [GO:0016363]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nuclear pore outer ring [GO:0031080]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] DNA binding [GO:0003677] g11978.t1 P55006 40.0 305 3.63e-62 204.0 sp|P55006|RDH7_RAT Retinol dehydrogenase 7 OS=Rattus norvegicus OX=10116 GN=Rdh7 PE=1 SV=1 g11981.t1 P58058 58.158 380 1.7200000000000002e-144 421.0 sp|P58058|NADK_MOUSE NAD kinase OS=Mus musculus OX=10090 GN=Nadk PE=1 SV=2 g11981.t2 P58058 58.158 380 4.95e-144 423.0 sp|P58058|NADK_MOUSE NAD kinase OS=Mus musculus OX=10090 GN=Nadk PE=1 SV=2 g11986.t1 O35125 60.63 254 1.6299999999999999e-106 318.0 sp|O35125|LRC23_MOUSE Leucine-rich repeat-containing protein 23 OS=Mus musculus OX=10090 GN=Lrrc23 PE=1 SV=1 LRC23_MOUSE reviewed Leucine-rich repeat-containing protein 23 (Leucine-rich protein B7) Mus musculus (Mouse) GO:0005737; GO:0005829; GO:0030317; GO:0036126; GO:0062177 flagellated sperm motility [GO:0030317]; radial spoke assembly [GO:0062177] cytoplasm [GO:0005737]; cytosol [GO:0005829]; sperm flagellum [GO:0036126] g11988.t1 Q9CWL2 72.781 169 1.45e-76 279.0 sp|Q9CWL2|CASZ1_MOUSE Zinc finger protein castor homolog 1 OS=Mus musculus OX=10090 GN=Casz1 PE=1 SV=3 CASZ1_MOUSE reviewed Zinc finger protein castor homolog 1 (Castor-related protein) Mus musculus (Mouse) GO:0000785; GO:0000977; GO:0000981; GO:0001228; GO:0005634; GO:0005654; GO:0005829; GO:0008270; GO:0045596; GO:0045664; GO:0045665; GO:0045893; GO:0045944; GO:0060040; GO:0060223; GO:0060226; GO:1902870 negative regulation of amacrine cell differentiation [GO:1902870]; negative regulation of cell differentiation [GO:0045596]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of retinal cone cell fate commitment [GO:0060226]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of neuron differentiation [GO:0045664]; retinal bipolar neuron differentiation [GO:0060040]; retinal rod cell fate commitment [GO:0060223] chromatin [GO:0000785]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; zinc ion binding [GO:0008270] g11988.t1 Q9CWL2 56.098 164 6.9000000000000005e-56 216.0 sp|Q9CWL2|CASZ1_MOUSE Zinc finger protein castor homolog 1 OS=Mus musculus OX=10090 GN=Casz1 PE=1 SV=3 CASZ1_MOUSE reviewed Zinc finger protein castor homolog 1 (Castor-related protein) Mus musculus (Mouse) GO:0000785; GO:0000977; GO:0000981; GO:0001228; GO:0005634; GO:0005654; GO:0005829; GO:0008270; GO:0045596; GO:0045664; GO:0045665; GO:0045893; GO:0045944; GO:0060040; GO:0060223; GO:0060226; GO:1902870 negative regulation of amacrine cell differentiation [GO:1902870]; negative regulation of cell differentiation [GO:0045596]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of retinal cone cell fate commitment [GO:0060226]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of neuron differentiation [GO:0045664]; retinal bipolar neuron differentiation [GO:0060040]; retinal rod cell fate commitment [GO:0060223] chromatin [GO:0000785]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; zinc ion binding [GO:0008270] g11988.t1 Q9CWL2 34.375 192 2.75e-22 107.0 sp|Q9CWL2|CASZ1_MOUSE Zinc finger protein castor homolog 1 OS=Mus musculus OX=10090 GN=Casz1 PE=1 SV=3 CASZ1_MOUSE reviewed Zinc finger protein castor homolog 1 (Castor-related protein) Mus musculus (Mouse) GO:0000785; GO:0000977; GO:0000981; GO:0001228; GO:0005634; GO:0005654; GO:0005829; GO:0008270; GO:0045596; GO:0045664; GO:0045665; GO:0045893; GO:0045944; GO:0060040; GO:0060223; GO:0060226; GO:1902870 negative regulation of amacrine cell differentiation [GO:1902870]; negative regulation of cell differentiation [GO:0045596]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of retinal cone cell fate commitment [GO:0060226]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of neuron differentiation [GO:0045664]; retinal bipolar neuron differentiation [GO:0060040]; retinal rod cell fate commitment [GO:0060223] chromatin [GO:0000785]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; zinc ion binding [GO:0008270] g11988.t1 Q9CWL2 33.333 156 1.3100000000000002e-21 105.0 sp|Q9CWL2|CASZ1_MOUSE Zinc finger protein castor homolog 1 OS=Mus musculus OX=10090 GN=Casz1 PE=1 SV=3 CASZ1_MOUSE reviewed Zinc finger protein castor homolog 1 (Castor-related protein) Mus musculus (Mouse) GO:0000785; GO:0000977; GO:0000981; GO:0001228; GO:0005634; GO:0005654; GO:0005829; GO:0008270; GO:0045596; GO:0045664; GO:0045665; GO:0045893; GO:0045944; GO:0060040; GO:0060223; GO:0060226; GO:1902870 negative regulation of amacrine cell differentiation [GO:1902870]; negative regulation of cell differentiation [GO:0045596]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of retinal cone cell fate commitment [GO:0060226]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of neuron differentiation [GO:0045664]; retinal bipolar neuron differentiation [GO:0060040]; retinal rod cell fate commitment [GO:0060223] chromatin [GO:0000785]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; zinc ion binding [GO:0008270] g11988.t2 Q86V15 72.781 169 7.01e-77 280.0 sp|Q86V15|CASZ1_HUMAN Zinc finger protein castor homolog 1 OS=Homo sapiens OX=9606 GN=CASZ1 PE=1 SV=4 CASZ1_HUMAN reviewed Zinc finger protein castor homolog 1 (Castor-related protein) (Putative survival-related protein) (Zinc finger protein 693) Homo sapiens (Human) GO:0000785; GO:0000977; GO:0000981; GO:0001228; GO:0005634; GO:0005654; GO:0005829; GO:0008270; GO:0045664; GO:0045893; GO:0045944 positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of neuron differentiation [GO:0045664] chromatin [GO:0000785]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; zinc ion binding [GO:0008270] g11988.t2 Q86V15 56.098 164 6.769999999999999e-55 212.0 sp|Q86V15|CASZ1_HUMAN Zinc finger protein castor homolog 1 OS=Homo sapiens OX=9606 GN=CASZ1 PE=1 SV=4 CASZ1_HUMAN reviewed Zinc finger protein castor homolog 1 (Castor-related protein) (Putative survival-related protein) (Zinc finger protein 693) Homo sapiens (Human) GO:0000785; GO:0000977; GO:0000981; GO:0001228; GO:0005634; GO:0005654; GO:0005829; GO:0008270; GO:0045664; GO:0045893; GO:0045944 positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of neuron differentiation [GO:0045664] chromatin [GO:0000785]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; zinc ion binding [GO:0008270] g11988.t2 Q86V15 34.375 192 2.45e-22 108.0 sp|Q86V15|CASZ1_HUMAN Zinc finger protein castor homolog 1 OS=Homo sapiens OX=9606 GN=CASZ1 PE=1 SV=4 CASZ1_HUMAN reviewed Zinc finger protein castor homolog 1 (Castor-related protein) (Putative survival-related protein) (Zinc finger protein 693) Homo sapiens (Human) GO:0000785; GO:0000977; GO:0000981; GO:0001228; GO:0005634; GO:0005654; GO:0005829; GO:0008270; GO:0045664; GO:0045893; GO:0045944 positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of neuron differentiation [GO:0045664] chromatin [GO:0000785]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; zinc ion binding [GO:0008270] g11988.t2 Q86V15 33.333 156 3.83e-21 103.0 sp|Q86V15|CASZ1_HUMAN Zinc finger protein castor homolog 1 OS=Homo sapiens OX=9606 GN=CASZ1 PE=1 SV=4 CASZ1_HUMAN reviewed Zinc finger protein castor homolog 1 (Castor-related protein) (Putative survival-related protein) (Zinc finger protein 693) Homo sapiens (Human) GO:0000785; GO:0000977; GO:0000981; GO:0001228; GO:0005634; GO:0005654; GO:0005829; GO:0008270; GO:0045664; GO:0045893; GO:0045944 positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of neuron differentiation [GO:0045664] chromatin [GO:0000785]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; zinc ion binding [GO:0008270] g11990.t1 D3ZFW5 49.275 138 1.9599999999999998e-46 150.0 sp|D3ZFW5|TM107_RAT Transmembrane protein 107 OS=Rattus norvegicus OX=10116 GN=Tmem107 PE=3 SV=1 g11990.t2 D3ZFW5 48.305 118 3.23e-37 127.0 sp|D3ZFW5|TM107_RAT Transmembrane protein 107 OS=Rattus norvegicus OX=10116 GN=Tmem107 PE=3 SV=1 g11991.t1 Q5R664 74.155 917 0.0 1468.0 sp|Q5R664|COPB2_PONAB Coatomer subunit beta' OS=Pongo abelii OX=9601 GN=COPB2 PE=2 SV=1 g11993.t1 O88470 82.143 56 1.44e-25 102.0 sp|O88470|FOXL2_MOUSE Forkhead box protein L2 OS=Mus musculus OX=10090 GN=Foxl2 PE=1 SV=2 FOXL2_MOUSE reviewed Forkhead box protein L2 (Pituitary forkhead factor) (P-Frk) Mus musculus (Mouse) GO:0000122; GO:0000978; GO:0000981; GO:0001228; GO:0001541; GO:0002074; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0006309; GO:0006357; GO:0007338; GO:0008585; GO:0009653; GO:0010629; GO:0019101; GO:0030154; GO:0030331; GO:0031624; GO:0033686; GO:0043028; GO:0043065; GO:0044752; GO:0045892; GO:0045944; GO:0046881; GO:0048048; GO:0060014; GO:0060065; GO:0090543; GO:1990837 anatomical structure morphogenesis [GO:0009653]; apoptotic DNA fragmentation [GO:0006309]; cell differentiation [GO:0030154]; embryonic eye morphogenesis [GO:0048048]; extraocular skeletal muscle development [GO:0002074]; female gonad development [GO:0008585]; female somatic sex determination [GO:0019101]; granulosa cell differentiation [GO:0060014]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; ovarian follicle development [GO:0001541]; positive regulation of apoptotic process [GO:0043065]; positive regulation of follicle-stimulating hormone secretion [GO:0046881]; positive regulation of luteinizing hormone secretion [GO:0033686]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; response to human chorionic gonadotropin [GO:0044752]; single fertilization [GO:0007338]; uterus development [GO:0060065] Flemming body [GO:0090543]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cysteine-type endopeptidase regulator activity involved in apoptotic process [GO:0043028]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; nuclear estrogen receptor binding [GO:0030331]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; ubiquitin conjugating enzyme binding [GO:0031624] g11994.t1 Q8AXN9 41.714 525 2.6500000000000002e-129 390.0 sp|Q8AXN9|RPE65_CYNPY Retinoid isomerohydrolase OS=Cynops pyrrhogaster OX=8330 GN=RPE65 PE=2 SV=3 RPE65_CYNPY reviewed Retinoid isomerohydrolase (EC 3.1.1.64) (All-trans-retinyl-palmitate hydrolase) (Lutein isomerase) (Meso-zeaxanthin isomerase) (EC 5.3.3.22) (Retinal pigment epithelium-specific 65 kDa protein) (Retinol isomerase) Cynops pyrrhogaster (Japanese fire-bellied newt) (Molge pyrrhogaster) GO:0001523; GO:0001786; GO:0003834; GO:0005789; GO:0005886; GO:0007601; GO:0016020; GO:0016853; GO:0031210; GO:0042574; GO:0046872; GO:0050251; GO:0052884; GO:0052885; GO:1901612; GO:1901827 retinal metabolic process [GO:0042574]; retinoid metabolic process [GO:0001523]; visual perception [GO:0007601]; zeaxanthin biosynthetic process [GO:1901827] endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; plasma membrane [GO:0005886] all-trans-retinyl-ester hydrolase, 11-cis retinol forming activity [GO:0052885]; all-trans-retinyl-palmitate hydrolase, 11-cis retinol forming activity [GO:0052884]; beta-carotene 15,15'-dioxygenase activity [GO:0003834]; cardiolipin binding [GO:1901612]; isomerase activity [GO:0016853]; metal ion binding [GO:0046872]; phosphatidylcholine binding [GO:0031210]; phosphatidylserine binding [GO:0001786]; retinol isomerase activity [GO:0050251] g11995.t1 Q96MB7 35.547 256 3.7499999999999996e-48 167.0 sp|Q96MB7|HARB1_HUMAN Putative nuclease HARBI1 OS=Homo sapiens OX=9606 GN=HARBI1 PE=1 SV=1 HARB1_HUMAN reviewed Putative nuclease HARBI1 (EC 3.1.-.-) (Harbinger transposase-derived nuclease) Homo sapiens (Human) GO:0004518; GO:0005634; GO:0005829; GO:0005886; GO:0016787; GO:0034451; GO:0046872 centriolar satellite [GO:0034451]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886] hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]; nuclease activity [GO:0004518] g11997.t1 Q8R4B8 27.164 335 3.82e-22 107.0 sp|Q8R4B8|NLRP3_MOUSE NACHT, LRR and PYD domains-containing protein 3 OS=Mus musculus OX=10090 GN=Nlrp3 PE=1 SV=1 NLRP3_MOUSE reviewed NACHT, LRR and PYD domains-containing protein 3 (EC 3.6.4.-) (Cold autoinflammatory syndrome 1 protein homolog) (Cryopyrin) (Mast cell maturation-associated-inducible protein 1) (PYRIN-containing APAF1-like protein 1) Mus musculus (Mouse) GO:0000139; GO:0002221; GO:0002526; GO:0002674; GO:0002720; GO:0002830; GO:0005524; GO:0005576; GO:0005634; GO:0005737; GO:0005739; GO:0005783; GO:0005815; GO:0005829; GO:0006954; GO:0007231; GO:0009306; GO:0009595; GO:0016020; GO:0016887; GO:0030674; GO:0031021; GO:0032691; GO:0032731; GO:0032736; GO:0032741; GO:0032753; GO:0032754; GO:0035591; GO:0035655; GO:0042802; GO:0043531; GO:0043565; GO:0044546; GO:0045087; GO:0045471; GO:0045630; GO:0045944; GO:0050727; GO:0050728; GO:0050729; GO:0050830; GO:0051260; GO:0051604; GO:0051607; GO:0060090; GO:0061702; GO:0070269; GO:0070273; GO:0070498; GO:0071222; GO:0071224; GO:0072559; GO:0098586; GO:0140297; GO:0140299; GO:0140608; GO:0140693; GO:1900227; GO:1901223; GO:1901224; GO:1901981; GO:2000321; GO:2000553 acute inflammatory response [GO:0002526]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to peptidoglycan [GO:0071224]; cellular response to virus [GO:0098586]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; detection of biotic stimulus [GO:0009595]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; interleukin-1-mediated signaling pathway [GO:0070498]; interleukin-18-mediated signaling pathway [GO:0035655]; negative regulation of acute inflammatory response [GO:0002674]; negative regulation of inflammatory response [GO:0050728]; negative regulation of interleukin-1 beta production [GO:0032691]; negative regulation of non-canonical NF-kappaB signal transduction [GO:1901223]; NLRP3 inflammasome complex assembly [GO:0044546]; osmosensory signaling pathway [GO:0007231]; pattern recognition receptor signaling pathway [GO:0002221]; positive regulation of cytokine production involved in immune response [GO:0002720]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of interleukin-13 production [GO:0032736]; positive regulation of interleukin-18 production [GO:0032741]; positive regulation of interleukin-4 production [GO:0032753]; positive regulation of interleukin-5 production [GO:0032754]; positive regulation of NLRP3 inflammasome complex assembly [GO:1900227]; positive regulation of non-canonical NF-kappaB signal transduction [GO:1901224]; positive regulation of T-helper 17 cell differentiation [GO:2000321]; positive regulation of T-helper 2 cell cytokine production [GO:2000553]; positive regulation of T-helper 2 cell differentiation [GO:0045630]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of type 2 immune response [GO:0002830]; protein homooligomerization [GO:0051260]; protein maturation [GO:0051604]; protein secretion [GO:0009306]; pyroptotic inflammatory response [GO:0070269]; regulation of inflammatory response [GO:0050727]; response to ethanol [GO:0045471] canonical inflammasome complex [GO:0061702]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; Golgi membrane [GO:0000139]; interphase microtubule organizing center [GO:0031021]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; mitochondrion [GO:0005739]; NLRP3 inflammasome complex [GO:0072559]; nucleus [GO:0005634] ADP binding [GO:0043531]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; cysteine-type endopeptidase activator activity [GO:0140608]; DNA-binding transcription factor binding [GO:0140297]; identical protein binding [GO:0042802]; molecular adaptor activity [GO:0060090]; molecular condensate scaffold activity [GO:0140693]; molecular sensor activity [GO:0140299]; phosphatidylinositol phosphate binding [GO:1901981]; phosphatidylinositol-4-phosphate binding [GO:0070273]; protein-macromolecule adaptor activity [GO:0030674]; sequence-specific DNA binding [GO:0043565]; signaling adaptor activity [GO:0035591] g11999.t1 C6EUD4 57.883 444 0.0 526.0 sp|C6EUD4|APSCT_FASHE Succinyl-CoA:acetate/propanoyl-CoA:succinate CoA transferase OS=Fasciola hepatica OX=6192 PE=1 SV=1 g12000.t1 Q9W436 38.953 688 4.23e-175 526.0 sp|Q9W436|NEP_DROME Neprilysin-1 OS=Drosophila melanogaster OX=7227 GN=Nep1 PE=2 SV=2 NEP_DROME reviewed Neprilysin-1 (EC 3.4.24.11) Drosophila melanogaster (Fruit fly) GO:0004222; GO:0005886; GO:0006508; GO:0008237; GO:0016020; GO:0046872 proteolysis [GO:0006508] membrane [GO:0016020]; plasma membrane [GO:0005886] metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237] g12001.t1 Q9W436 38.372 688 3.42e-173 521.0 sp|Q9W436|NEP_DROME Neprilysin-1 OS=Drosophila melanogaster OX=7227 GN=Nep1 PE=2 SV=2 NEP_DROME reviewed Neprilysin-1 (EC 3.4.24.11) Drosophila melanogaster (Fruit fly) GO:0004222; GO:0005886; GO:0006508; GO:0008237; GO:0016020; GO:0046872 proteolysis [GO:0006508] membrane [GO:0016020]; plasma membrane [GO:0005886] metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237] g12002.t1 Q9W436 35.376 718 1.57e-158 484.0 sp|Q9W436|NEP_DROME Neprilysin-1 OS=Drosophila melanogaster OX=7227 GN=Nep1 PE=2 SV=2 NEP_DROME reviewed Neprilysin-1 (EC 3.4.24.11) Drosophila melanogaster (Fruit fly) GO:0004222; GO:0005886; GO:0006508; GO:0008237; GO:0016020; GO:0046872 proteolysis [GO:0006508] membrane [GO:0016020]; plasma membrane [GO:0005886] metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237] g12002.t2 Q9W436 35.361 707 1.4499999999999999e-152 468.0 sp|Q9W436|NEP_DROME Neprilysin-1 OS=Drosophila melanogaster OX=7227 GN=Nep1 PE=2 SV=2 NEP_DROME reviewed Neprilysin-1 (EC 3.4.24.11) Drosophila melanogaster (Fruit fly) GO:0004222; GO:0005886; GO:0006508; GO:0008237; GO:0016020; GO:0046872 proteolysis [GO:0006508] membrane [GO:0016020]; plasma membrane [GO:0005886] metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237] g12004.t1 Q9W436 36.994 692 1.19e-155 476.0 sp|Q9W436|NEP_DROME Neprilysin-1 OS=Drosophila melanogaster OX=7227 GN=Nep1 PE=2 SV=2 NEP_DROME reviewed Neprilysin-1 (EC 3.4.24.11) Drosophila melanogaster (Fruit fly) GO:0004222; GO:0005886; GO:0006508; GO:0008237; GO:0016020; GO:0046872 proteolysis [GO:0006508] membrane [GO:0016020]; plasma membrane [GO:0005886] metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237] g12005.t1 Q9W436 46.056 393 1.11e-129 396.0 sp|Q9W436|NEP_DROME Neprilysin-1 OS=Drosophila melanogaster OX=7227 GN=Nep1 PE=2 SV=2 NEP_DROME reviewed Neprilysin-1 (EC 3.4.24.11) Drosophila melanogaster (Fruit fly) GO:0004222; GO:0005886; GO:0006508; GO:0008237; GO:0016020; GO:0046872 proteolysis [GO:0006508] membrane [GO:0016020]; plasma membrane [GO:0005886] metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237] g12006.t1 Q9W436 39.109 202 3.07e-40 139.0 sp|Q9W436|NEP_DROME Neprilysin-1 OS=Drosophila melanogaster OX=7227 GN=Nep1 PE=2 SV=2 NEP_DROME reviewed Neprilysin-1 (EC 3.4.24.11) Drosophila melanogaster (Fruit fly) GO:0004222; GO:0005886; GO:0006508; GO:0008237; GO:0016020; GO:0046872 proteolysis [GO:0006508] membrane [GO:0016020]; plasma membrane [GO:0005886] metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237] g12006.t1 Q9W436 39.286 56 3.07e-40 48.9 sp|Q9W436|NEP_DROME Neprilysin-1 OS=Drosophila melanogaster OX=7227 GN=Nep1 PE=2 SV=2 NEP_DROME reviewed Neprilysin-1 (EC 3.4.24.11) Drosophila melanogaster (Fruit fly) GO:0004222; GO:0005886; GO:0006508; GO:0008237; GO:0016020; GO:0046872 proteolysis [GO:0006508] membrane [GO:0016020]; plasma membrane [GO:0005886] metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237] g12007.t1 Q6Y7W6 45.507 345 1.5e-36 151.0 sp|Q6Y7W6|GGYF2_HUMAN GRB10-interacting GYF protein 2 OS=Homo sapiens OX=9606 GN=GIGYF2 PE=1 SV=1 GGYF2_HUMAN reviewed GRB10-interacting GYF protein 2 (PERQ amino acid-rich with GYF domain-containing protein 2) (Trinucleotide repeat-containing gene 15 protein) Homo sapiens (Human) GO:0003723; GO:0005768; GO:0005783; GO:0005794; GO:0005829; GO:0007631; GO:0008344; GO:0009791; GO:0010494; GO:0016020; GO:0016441; GO:0017148; GO:0021522; GO:0031571; GO:0031982; GO:0032991; GO:0035264; GO:0043204; GO:0045296; GO:0045947; GO:0048009; GO:0048873; GO:0050881; GO:0050885; GO:0060090; GO:0060339; GO:0061157; GO:0070064; GO:0072344; GO:1990635 adult locomotory behavior [GO:0008344]; feeding behavior [GO:0007631]; homeostasis of number of cells within a tissue [GO:0048873]; insulin-like growth factor receptor signaling pathway [GO:0048009]; mitotic G1 DNA damage checkpoint signaling [GO:0031571]; mRNA destabilization [GO:0061157]; multicellular organism growth [GO:0035264]; musculoskeletal movement [GO:0050881]; negative regulation of translation [GO:0017148]; negative regulation of translational initiation [GO:0045947]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; neuromuscular process controlling balance [GO:0050885]; post-embryonic development [GO:0009791]; post-transcriptional gene silencing [GO:0016441]; rescue of stalled ribosome [GO:0072344]; spinal cord motor neuron differentiation [GO:0021522] cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; perikaryon [GO:0043204]; protein-containing complex [GO:0032991]; proximal dendrite [GO:1990635]; vesicle [GO:0031982] cadherin binding [GO:0045296]; molecular adaptor activity [GO:0060090]; proline-rich region binding [GO:0070064]; RNA binding [GO:0003723] g12008.t1 Q5U236 34.568 324 1.87e-40 164.0 sp|Q5U236|GGYF2_XENLA GRB10-interacting GYF protein 2 OS=Xenopus laevis OX=8355 GN=gigyf2 PE=2 SV=1 g12008.t2 Q5U236 34.154 325 9.19e-41 166.0 sp|Q5U236|GGYF2_XENLA GRB10-interacting GYF protein 2 OS=Xenopus laevis OX=8355 GN=gigyf2 PE=2 SV=1 g12008.t3 Q6Y7W6 40.0 225 1.66e-31 136.0 sp|Q6Y7W6|GGYF2_HUMAN GRB10-interacting GYF protein 2 OS=Homo sapiens OX=9606 GN=GIGYF2 PE=1 SV=1 GGYF2_HUMAN reviewed GRB10-interacting GYF protein 2 (PERQ amino acid-rich with GYF domain-containing protein 2) (Trinucleotide repeat-containing gene 15 protein) Homo sapiens (Human) GO:0003723; GO:0005768; GO:0005783; GO:0005794; GO:0005829; GO:0007631; GO:0008344; GO:0009791; GO:0010494; GO:0016020; GO:0016441; GO:0017148; GO:0021522; GO:0031571; GO:0031982; GO:0032991; GO:0035264; GO:0043204; GO:0045296; GO:0045947; GO:0048009; GO:0048873; GO:0050881; GO:0050885; GO:0060090; GO:0060339; GO:0061157; GO:0070064; GO:0072344; GO:1990635 adult locomotory behavior [GO:0008344]; feeding behavior [GO:0007631]; homeostasis of number of cells within a tissue [GO:0048873]; insulin-like growth factor receptor signaling pathway [GO:0048009]; mitotic G1 DNA damage checkpoint signaling [GO:0031571]; mRNA destabilization [GO:0061157]; multicellular organism growth [GO:0035264]; musculoskeletal movement [GO:0050881]; negative regulation of translation [GO:0017148]; negative regulation of translational initiation [GO:0045947]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; neuromuscular process controlling balance [GO:0050885]; post-embryonic development [GO:0009791]; post-transcriptional gene silencing [GO:0016441]; rescue of stalled ribosome [GO:0072344]; spinal cord motor neuron differentiation [GO:0021522] cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; perikaryon [GO:0043204]; protein-containing complex [GO:0032991]; proximal dendrite [GO:1990635]; vesicle [GO:0031982] cadherin binding [GO:0045296]; molecular adaptor activity [GO:0060090]; proline-rich region binding [GO:0070064]; RNA binding [GO:0003723] g12015.t1 A1KXI1 41.509 159 5.03e-27 107.0 sp|A1KXI1|BLOT3_BLOTA Trypsin Blo t 3 OS=Blomia tropicalis OX=40697 PE=1 SV=1 g12017.t1 P20231 31.174 247 1.05e-28 113.0 sp|P20231|TRYB2_HUMAN Tryptase beta-2 OS=Homo sapiens OX=9606 GN=TPSB2 PE=1 SV=3 TRYB2_HUMAN reviewed Tryptase beta-2 (Tryptase-2) (EC 3.4.21.59) (Tryptase II) Homo sapiens (Human) GO:0004252; GO:0005615; GO:0006508; GO:0008236; GO:0031012 proteolysis [GO:0006508] extracellular matrix [GO:0031012]; extracellular space [GO:0005615] serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236] g12018.t1 Q91WI7 45.946 444 1.92e-119 358.0 sp|Q91WI7|ITFG2_MOUSE KICSTOR complex protein ITFG2 OS=Mus musculus OX=10090 GN=Itfg2 PE=2 SV=1 g12024.t1 Q09143 27.013 385 2.9e-32 132.0 sp|Q09143|CTR1_MOUSE High affinity cationic amino acid transporter 1 OS=Mus musculus OX=10090 GN=Slc7a1 PE=1 SV=1 CTR1_MOUSE reviewed High affinity cationic amino acid transporter 1 (CAT-1) (CAT1) (Ecotropic retroviral leukemia receptor) (Ecotropic retrovirus receptor) (ERR) (EcoR) (Solute carrier family 7 member 1) (System Y+ basic amino acid transporter) Mus musculus (Mouse) GO:0000064; GO:0001618; GO:0005290; GO:0005886; GO:0009925; GO:0015171; GO:0015174; GO:0015189; GO:0015807; GO:0015819; GO:0015822; GO:0016020; GO:0016323; GO:0016324; GO:0032006; GO:0032991; GO:0042102; GO:0061459; GO:0089718; GO:0097638; GO:1903352; GO:1903810; GO:1903826 amino acid import across plasma membrane [GO:0089718]; L-amino acid transport [GO:0015807]; L-arginine import across plasma membrane [GO:0097638]; L-arginine transmembrane transport [GO:1903826]; L-histidine import across plasma membrane [GO:1903810]; L-ornithine transmembrane transport [GO:1903352]; lysine transport [GO:0015819]; ornithine transport [GO:0015822]; positive regulation of T cell proliferation [GO:0042102]; regulation of TOR signaling [GO:0032006] apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; membrane [GO:0016020]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] amino acid transmembrane transporter activity [GO:0015171]; basic amino acid transmembrane transporter activity [GO:0015174]; L-arginine transmembrane transporter activity [GO:0061459]; L-histidine transmembrane transporter activity [GO:0005290]; L-lysine transmembrane transporter activity [GO:0015189]; L-ornithine transmembrane transporter activity [GO:0000064]; virus receptor activity [GO:0001618] g12026.t1 Q8TBB6 57.599 658 0.0 686.0 sp|Q8TBB6|S7A14_HUMAN Solute carrier family 7 member 14 OS=Homo sapiens OX=9606 GN=SLC7A14 PE=1 SV=3 S7A14_HUMAN reviewed Solute carrier family 7 member 14 (Gamma-aminobutyric acid transporter SLC7A14) Homo sapiens (Human) GO:0005654; GO:0005765; GO:0005829; GO:0005886; GO:0006865; GO:0015171; GO:0015185; GO:0051939 amino acid transport [GO:0006865]; gamma-aminobutyric acid import [GO:0051939] cytosol [GO:0005829]; lysosomal membrane [GO:0005765]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] amino acid transmembrane transporter activity [GO:0015171]; gamma-aminobutyric acid transmembrane transporter activity [GO:0015185] g12027.t1 Q1JQ91 81.481 135 1.24e-64 196.0 sp|Q1JQ91|RPB4_BOVIN DNA-directed RNA polymerase II subunit RPB4 OS=Bos taurus OX=9913 GN=POLR2D PE=1 SV=1 g12028.t1 Q7SYJ9 50.917 218 8.3e-62 196.0 sp|Q7SYJ9|SPAG7_DANRE Sperm-associated antigen 7 homolog OS=Danio rerio OX=7955 GN=spag7 PE=1 SV=1 g12029.t1 A0A1L7U3D7 29.451 455 3.14e-44 168.0 sp|A0A1L7U3D7|FPY1_FUSMA Highly reducing polyketide synthase 40 OS=Fusarium mangiferae OX=192010 GN=FPY1 PE=2 SV=1 g12030.t1 P96202 44.33 97 8.92e-21 89.0 sp|P96202|PPSC_MYCTU Phenolphthiocerol/phthiocerol polyketide synthase subunit C OS=Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv) OX=83332 GN=ppsC PE=1 SV=2 g12032.t1 Q55E72 30.425 1318 2.7900000000000003e-160 541.0 sp|Q55E72|PKS1_DICDI Probable polyketide synthase 1 OS=Dictyostelium discoideum OX=44689 GN=stlA PE=1 SV=1 PKS1_DICDI reviewed Probable polyketide synthase 1 (dipks1) [Includes: Polyketide synthase stlA (EC 2.3.1.-); Chalcone synthase stlA (EC 2.3.1.74) (Steely1)] Dictyostelium discoideum (Social amoeba) GO:0004312; GO:0004315; GO:0006633; GO:0007165; GO:0009813; GO:0010628; GO:0010629; GO:0016210; GO:0016491; GO:0019505; GO:0030639; GO:0031149; GO:0031152; GO:0043327; GO:0044671; GO:0048837; GO:0106070 aggregation involved in sorocarp development [GO:0031152]; chemotaxis to cAMP [GO:0043327]; fatty acid biosynthetic process [GO:0006633]; flavonoid biosynthetic process [GO:0009813]; negative regulation of gene expression [GO:0010629]; polyketide biosynthetic process [GO:0030639]; positive regulation of gene expression [GO:0010628]; regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0106070]; resorcinol metabolic process [GO:0019505]; signal transduction [GO:0007165]; sorocarp sorus development [GO:0048837]; sorocarp spore cell differentiation [GO:0044671]; sorocarp stalk cell differentiation [GO:0031149] 3-oxoacyl-[acyl-carrier-protein] synthase activity [GO:0004315]; fatty acid synthase activity [GO:0004312]; naringenin-chalcone synthase activity [GO:0016210]; oxidoreductase activity [GO:0016491] g12036.t1 Q66JG1 44.529 393 2.0300000000000002e-103 319.0 sp|Q66JG1|DDB2_XENTR DNA damage-binding protein 2 OS=Xenopus tropicalis OX=8364 GN=ddb2 PE=2 SV=1 g12037.t1 P54714 65.726 248 3.0900000000000004e-124 356.0 sp|P54714|TPIS_CANLF Triosephosphate isomerase OS=Canis lupus familiaris OX=9615 GN=TPI1 PE=1 SV=3 g12038.t1 Q8N357 56.267 375 1.6599999999999998e-126 372.0 sp|Q8N357|S35F6_HUMAN Solute carrier family 35 member F6 OS=Homo sapiens OX=9606 GN=SLC35F6 PE=1 SV=1 S35F6_HUMAN reviewed Solute carrier family 35 member F6 (ANT2-binding protein) (ANT2BP) (Transport and Golgi organization 9 homolog) Homo sapiens (Human) GO:0005654; GO:0005739; GO:0005765; GO:0005829; GO:0008284; GO:0016020; GO:0022857; GO:0070062; GO:1901029 negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901029]; positive regulation of cell population proliferation [GO:0008284] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654] transmembrane transporter activity [GO:0022857] g12039.t1 A5PJ65 66.154 195 4.34e-91 268.0 sp|A5PJ65|RER1_BOVIN Protein RER1 OS=Bos taurus OX=9913 GN=RER1 PE=2 SV=2 g12039.t2 A5PJ65 69.189 185 2.84e-93 273.0 sp|A5PJ65|RER1_BOVIN Protein RER1 OS=Bos taurus OX=9913 GN=RER1 PE=2 SV=2 g12040.t1 P51913 77.546 432 0.0 702.0 sp|P51913|ENOA_CHICK Alpha-enolase OS=Gallus gallus OX=9031 GN=ENO1 PE=2 SV=2 g12045.t1 Q6NR09 45.192 104 1.1e-23 99.0 sp|Q6NR09|EGRAP_DROME EGFR adapter protein OS=Drosophila melanogaster OX=7227 GN=Egfrap PE=1 SV=1 EGRAP_DROME reviewed EGFR adapter protein Drosophila melanogaster (Fruit fly) GO:0005925; GO:0030971; GO:0042059; GO:0045179 negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059] apical cortex [GO:0045179]; focal adhesion [GO:0005925] receptor tyrosine kinase binding [GO:0030971] g12046.t1 Q8JZW5 42.857 126 5.9e-23 105.0 sp|Q8JZW5|SH2D5_MOUSE SH2 domain-containing protein 5 OS=Mus musculus OX=10090 GN=Sh2d5 PE=1 SV=3 g12048.t1 P42336 61.181 474 0.0 595.0 sp|P42336|PK3CA_HUMAN Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform OS=Homo sapiens OX=9606 GN=PIK3CA PE=1 SV=2 PK3CA_HUMAN reviewed Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (PI3-kinase subunit alpha) (PI3K-alpha) (PI3Kalpha) (PtdIns-3-kinase subunit alpha) (EC 2.7.1.137) (EC 2.7.1.153) (Phosphatidylinositol 4,5-bisphosphate 3-kinase 110 kDa catalytic subunit alpha) (PtdIns-3-kinase subunit p110-alpha) (p110alpha) (Phosphoinositide 3-kinase alpha) (Phosphoinositide-3-kinase catalytic alpha polypeptide) (Serine/threonine protein kinase PIK3CA) (EC 2.7.11.1) Homo sapiens (Human) GO:0001525; GO:0001889; GO:0001944; GO:0004674; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0005942; GO:0005943; GO:0005944; GO:0006006; GO:0006909; GO:0007173; GO:0008286; GO:0010592; GO:0010629; GO:0014704; GO:0014823; GO:0014870; GO:0016242; GO:0016303; GO:0016477; GO:0030027; GO:0030036; GO:0030168; GO:0030295; GO:0030835; GO:0032008; GO:0032869; GO:0035005; GO:0035994; GO:0036092; GO:0038084; GO:0038203; GO:0040014; GO:0043201; GO:0043276; GO:0043457; GO:0043491; GO:0043524; GO:0043542; GO:0043560; GO:0046854; GO:0046934; GO:0048009; GO:0048015; GO:0048471; GO:0048661; GO:0050852; GO:0051897; GO:0055119; GO:0060048; GO:0060612; GO:0071333; GO:0071464; GO:0071548; GO:0086003; GO:0097009; GO:0106310; GO:0110053; GO:0141068; GO:1903544; GO:1905477; GO:2000270; GO:2000811 actin cytoskeleton organization [GO:0030036]; adipose tissue development [GO:0060612]; angiogenesis [GO:0001525]; anoikis [GO:0043276]; autosome genomic imprinting [GO:0141068]; cardiac muscle cell contraction [GO:0086003]; cardiac muscle contraction [GO:0060048]; cell migration [GO:0016477]; cellular response to glucose stimulus [GO:0071333]; cellular response to hydrostatic pressure [GO:0071464]; cellular response to insulin stimulus [GO:0032869]; endothelial cell migration [GO:0043542]; energy homeostasis [GO:0097009]; epidermal growth factor receptor signaling pathway [GO:0007173]; glucose metabolic process [GO:0006006]; insulin receptor signaling pathway [GO:0008286]; insulin-like growth factor receptor signaling pathway [GO:0048009]; liver development [GO:0001889]; negative regulation of actin filament depolymerization [GO:0030835]; negative regulation of anoikis [GO:2000811]; negative regulation of fibroblast apoptotic process [GO:2000270]; negative regulation of gene expression [GO:0010629]; negative regulation of macroautophagy [GO:0016242]; negative regulation of neuron apoptotic process [GO:0043524]; phagocytosis [GO:0006909]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; phosphatidylinositol-3-phosphate biosynthetic process [GO:0036092]; phosphatidylinositol-mediated signaling [GO:0048015]; platelet activation [GO:0030168]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of protein localization to membrane [GO:1905477]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of TOR signaling [GO:0032008]; regulation of actin filament organization [GO:0110053]; regulation of cellular respiration [GO:0043457]; regulation of multicellular organism growth [GO:0040014]; relaxation of cardiac muscle [GO:0055119]; response to activity [GO:0014823]; response to butyrate [GO:1903544]; response to dexamethasone [GO:0071548]; response to L-leucine [GO:0043201]; response to muscle inactivity [GO:0014870]; response to muscle stretch [GO:0035994]; T cell receptor signaling pathway [GO:0050852]; TORC2 signaling [GO:0038203]; vascular endothelial growth factor signaling pathway [GO:0038084]; vasculature development [GO:0001944] cytoplasm [GO:0005737]; cytosol [GO:0005829]; intercalated disc [GO:0014704]; lamellipodium [GO:0030027]; perinuclear region of cytoplasm [GO:0048471]; phosphatidylinositol 3-kinase complex [GO:0005942]; phosphatidylinositol 3-kinase complex, class IA [GO:0005943]; phosphatidylinositol 3-kinase complex, class IB [GO:0005944]; plasma membrane [GO:0005886] 1-phosphatidylinositol-3-kinase activity [GO:0016303]; 1-phosphatidylinositol-4,5-bisphosphate 3-kinase activity [GO:0046934]; 1-phosphatidylinositol-4-phosphate 3-kinase activity [GO:0035005]; ATP binding [GO:0005524]; insulin receptor substrate binding [GO:0043560]; protein kinase activator activity [GO:0030295]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g12049.t1 A0A0G2K344 63.333 540 0.0 679.0 sp|A0A0G2K344|PK3CA_RAT Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform OS=Rattus norvegicus OX=10116 GN=Pik3ca PE=1 SV=1 PK3CA_RAT reviewed Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (PI3-kinase subunit alpha) (PI3K-alpha) (PI3Kalpha) (PtdIns-3-kinase subunit alpha) (EC 2.7.1.137) (EC 2.7.1.153) (Phosphatidylinositol 4,5-bisphosphate 3-kinase 110 kDa catalytic subunit alpha) (PtdIns-3-kinase subunit p110-alpha) (p110alpha) (Phosphoinositide-3-kinase catalytic alpha polypeptide) (Serine/threonine protein kinase PIK3CA) (EC 2.7.11.1) Rattus norvegicus (Rat) GO:0001525; GO:0001889; GO:0004674; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0005942; GO:0005943; GO:0005944; GO:0006006; GO:0006909; GO:0008286; GO:0010468; GO:0010629; GO:0014704; GO:0014823; GO:0014870; GO:0016303; GO:0016477; GO:0030027; GO:0030036; GO:0030295; GO:0030835; GO:0032869; GO:0035005; GO:0035994; GO:0036092; GO:0038084; GO:0040014; GO:0043201; GO:0043457; GO:0043491; GO:0043524; GO:0043560; GO:0046854; GO:0046934; GO:0048009; GO:0048015; GO:0048661; GO:0051897; GO:0055119; GO:0060612; GO:0071333; GO:0071464; GO:0071548; GO:0086003; GO:0097009; GO:0106310; GO:0110053; GO:0141068; GO:1903544; GO:1905477; GO:2000270; GO:2000811 actin cytoskeleton organization [GO:0030036]; adipose tissue development [GO:0060612]; angiogenesis [GO:0001525]; autosome genomic imprinting [GO:0141068]; cardiac muscle cell contraction [GO:0086003]; cell migration [GO:0016477]; cellular response to glucose stimulus [GO:0071333]; cellular response to hydrostatic pressure [GO:0071464]; cellular response to insulin stimulus [GO:0032869]; energy homeostasis [GO:0097009]; glucose metabolic process [GO:0006006]; insulin receptor signaling pathway [GO:0008286]; insulin-like growth factor receptor signaling pathway [GO:0048009]; liver development [GO:0001889]; negative regulation of actin filament depolymerization [GO:0030835]; negative regulation of anoikis [GO:2000811]; negative regulation of fibroblast apoptotic process [GO:2000270]; negative regulation of gene expression [GO:0010629]; negative regulation of neuron apoptotic process [GO:0043524]; phagocytosis [GO:0006909]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; phosphatidylinositol-3-phosphate biosynthetic process [GO:0036092]; phosphatidylinositol-mediated signaling [GO:0048015]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of protein localization to membrane [GO:1905477]; positive regulation of smooth muscle cell proliferation [GO:0048661]; regulation of actin filament organization [GO:0110053]; regulation of cellular respiration [GO:0043457]; regulation of gene expression [GO:0010468]; regulation of multicellular organism growth [GO:0040014]; relaxation of cardiac muscle [GO:0055119]; response to activity [GO:0014823]; response to butyrate [GO:1903544]; response to dexamethasone [GO:0071548]; response to L-leucine [GO:0043201]; response to muscle inactivity [GO:0014870]; response to muscle stretch [GO:0035994]; vascular endothelial growth factor signaling pathway [GO:0038084] cytoplasm [GO:0005737]; cytosol [GO:0005829]; intercalated disc [GO:0014704]; lamellipodium [GO:0030027]; phosphatidylinositol 3-kinase complex [GO:0005942]; phosphatidylinositol 3-kinase complex, class IA [GO:0005943]; phosphatidylinositol 3-kinase complex, class IB [GO:0005944]; plasma membrane [GO:0005886] 1-phosphatidylinositol-3-kinase activity [GO:0016303]; 1-phosphatidylinositol-4,5-bisphosphate 3-kinase activity [GO:0046934]; 1-phosphatidylinositol-4-phosphate 3-kinase activity [GO:0035005]; ATP binding [GO:0005524]; insulin receptor substrate binding [GO:0043560]; protein kinase activator activity [GO:0030295]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g12050.t1 Q91845 43.103 1044 0.0 797.0 sp|Q91845|EPA4A_XENLA Ephrin type-A receptor 4-A OS=Xenopus laevis OX=8355 GN=epha4-a PE=2 SV=1 g12051.t1 Q5JXC2 37.766 188 3.79e-30 125.0 sp|Q5JXC2|MIIP_HUMAN Migration and invasion-inhibitory protein OS=Homo sapiens OX=9606 GN=MIIP PE=1 SV=3 MIIP_HUMAN reviewed Migration and invasion-inhibitory protein (IGFBP2-binding protein) (Invasion-inhibitory protein 45) (IIp45) Homo sapiens (Human) GO:0010972; GO:0030336 negative regulation of cell migration [GO:0030336]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972] g12052.t1 Q3U4G3 43.96 298 2.0099999999999998e-82 266.0 sp|Q3U4G3|XXLT1_MOUSE Xyloside xylosyltransferase 1 OS=Mus musculus OX=10090 GN=Xxylt1 PE=1 SV=2 XXLT1_MOUSE reviewed Xyloside xylosyltransferase 1 (EC 2.4.2.62) (UDP-xylose:alpha-xyloside alpha-1,3-xylosyltransferase) Mus musculus (Mouse) GO:0000287; GO:0005789; GO:0016266; GO:0030145; GO:0035252; GO:0140560; GO:0180059 protein O-linked glycosylation via glucose [GO:0180059]; protein O-linked glycosylation via N-acetyl-galactosamine [GO:0016266] endoplasmic reticulum membrane [GO:0005789] magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; UDP-xylosyltransferase activity [GO:0035252]; xylosyl alpha-1,3-xylosyltransferase activity [GO:0140560] g12053.t1 Q60692 62.174 230 2.8699999999999998e-95 281.0 sp|Q60692|PSB6_MOUSE Proteasome subunit beta type-6 OS=Mus musculus OX=10090 GN=Psmb6 PE=1 SV=3 PSB6_MOUSE reviewed Proteasome subunit beta type-6 (EC 3.4.25.1) (Low molecular mass protein 19) (Macropain delta chain) (Multicatalytic endopeptidase complex delta chain) (Proteasome delta chain) (Proteasome subunit Y) (Proteasome subunit beta-1) (beta-1) Mus musculus (Mouse) GO:0000502; GO:0004175; GO:0004298; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0005839; GO:0019774; GO:0043161 proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161] cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; proteasome core complex [GO:0005839]; proteasome core complex, beta-subunit complex [GO:0019774] endopeptidase activity [GO:0004175]; threonine-type endopeptidase activity [GO:0004298] g12054.t1 C9JN71 31.25 336 9.97e-29 125.0 sp|C9JN71|ZN878_HUMAN Zinc finger protein 878 OS=Homo sapiens OX=9606 GN=ZNF878 PE=1 SV=2 g12056.t1 Q5ZIJ9 31.133 803 2.2e-95 319.0 sp|Q5ZIJ9|MIB2_CHICK E3 ubiquitin-protein ligase MIB2 OS=Gallus gallus OX=9031 GN=MIB2 PE=2 SV=1 g12057.t1 Q5ZIJ9 32.36 445 1.78e-55 207.0 sp|Q5ZIJ9|MIB2_CHICK E3 ubiquitin-protein ligase MIB2 OS=Gallus gallus OX=9031 GN=MIB2 PE=2 SV=1 g12057.t1 Q5ZIJ9 48.214 168 1.42e-38 156.0 sp|Q5ZIJ9|MIB2_CHICK E3 ubiquitin-protein ligase MIB2 OS=Gallus gallus OX=9031 GN=MIB2 PE=2 SV=1 g12058.t1 Q8K0Z9 26.571 350 6.68e-33 139.0 sp|Q8K0Z9|GP153_MOUSE Probable G-protein coupled receptor 153 OS=Mus musculus OX=10090 GN=Gpr153 PE=2 SV=2 g12061.t1 Q9BWF2 33.579 271 1.25e-28 116.0 sp|Q9BWF2|TRAIP_HUMAN E3 ubiquitin-protein ligase TRAIP OS=Homo sapiens OX=9606 GN=TRAIP PE=1 SV=1 TRAIP_HUMAN reviewed E3 ubiquitin-protein ligase TRAIP (EC 2.3.2.27) (RING finger protein 206) (TRAF-interacting protein) Homo sapiens (Human) GO:0004842; GO:0005634; GO:0005654; GO:0005730; GO:0006915; GO:0006974; GO:0007165; GO:0008270; GO:0010804; GO:0016567; GO:0031297; GO:0032688; GO:0042802; GO:0048471; GO:0061630; GO:0090734; GO:0106300 apoptotic process [GO:0006915]; DNA damage response [GO:0006974]; negative regulation of interferon-beta production [GO:0032688]; negative regulation of tumor necrosis factor-mediated signaling pathway [GO:0010804]; protein ubiquitination [GO:0016567]; protein-DNA covalent cross-linking repair [GO:0106300]; replication fork processing [GO:0031297]; signal transduction [GO:0007165] nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; site of DNA damage [GO:0090734] identical protein binding [GO:0042802]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] g12063.t1 Q64674 63.604 283 1.1999999999999999e-119 347.0 sp|Q64674|SPEE_MOUSE Spermidine synthase OS=Mus musculus OX=10090 GN=Srm PE=1 SV=1 g12065.t1 Q07929 32.597 181 8.38e-21 93.2 sp|Q07929|SP63_STRPU 63 kDa sperm flagellar membrane protein OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g12069.t1 O00400 58.984 512 0.0 571.0 sp|O00400|ACATN_HUMAN Acetyl-coenzyme A transporter 1 OS=Homo sapiens OX=9606 GN=SLC33A1 PE=1 SV=1 ACATN_HUMAN reviewed Acetyl-coenzyme A transporter 1 (AT-1) (Acetyl-CoA transporter 1) (Solute carrier family 33 member 1) Homo sapiens (Human) GO:0000139; GO:0005789; GO:0005886; GO:0008521; GO:0016020; GO:0035348; GO:0042803; GO:0055085 acetyl-CoA transmembrane transport [GO:0035348]; transmembrane transport [GO:0055085] endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; plasma membrane [GO:0005886] acetyl-CoA transmembrane transporter activity [GO:0008521]; protein homodimerization activity [GO:0042803] g12071.t1 P29787 40.329 243 7.8e-49 165.0 sp|P29787|TRY5_AEDAE Trypsin 5G1 OS=Aedes aegypti OX=7159 GN=AAEL013712 PE=2 SV=2 g12076.t1 Q8WPA2 29.329 283 3.64e-24 104.0 sp|Q8WPA2|AR_BOMMO Allatostatin-A receptor OS=Bombyx mori OX=7091 GN=AR PE=2 SV=1 g12077.t1 Q6P073 62.846 253 1.03e-102 301.0 sp|Q6P073|UB2J2_MOUSE Ubiquitin-conjugating enzyme E2 J2 OS=Mus musculus OX=10090 GN=Ube2j2 PE=1 SV=1 UB2J2_MOUSE reviewed Ubiquitin-conjugating enzyme E2 J2 (EC 2.3.2.23) (Non-canonical ubiquitin-conjugating enzyme 2) (NCUBE-2) Mus musculus (Mouse) GO:0000151; GO:0000209; GO:0005524; GO:0005634; GO:0005783; GO:0005789; GO:0006511; GO:0006986; GO:0031625; GO:0036503; GO:0061631; GO:0085020 ERAD pathway [GO:0036503]; protein K6-linked ubiquitination [GO:0085020]; protein polyubiquitination [GO:0000209]; response to unfolded protein [GO:0006986]; ubiquitin-dependent protein catabolic process [GO:0006511] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151] ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin protein ligase binding [GO:0031625] g12081.t1 Q4T2X8 76.536 179 4.4199999999999995e-108 309.0 sp|Q4T2X8|NIP7_TETNG 60S ribosome subunit biogenesis protein NIP7 homolog OS=Tetraodon nigroviridis OX=99883 GN=nip7 PE=3 SV=1 g12082.t1 Q14AT5 53.905 781 0.0 827.0 sp|Q14AT5|ANO7_MOUSE Anoctamin-7 OS=Mus musculus OX=10090 GN=Ano7 PE=1 SV=2 g12082.t2 Q14AT5 54.688 768 0.0 835.0 sp|Q14AT5|ANO7_MOUSE Anoctamin-7 OS=Mus musculus OX=10090 GN=Ano7 PE=1 SV=2 g12083.t1 Q8VDJ3 55.219 1255 0.0 1379.0 sp|Q8VDJ3|VIGLN_MOUSE Vigilin OS=Mus musculus OX=10090 GN=Hdlbp PE=1 SV=1 g12090.t1 O57472 35.567 970 0.0 588.0 sp|O57472|CHRD_DANRE Chordin OS=Danio rerio OX=7955 GN=chd PE=2 SV=1 CHRD_DANRE reviewed Chordin (Protein chordino) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001756; GO:0001947; GO:0003143; GO:0005615; GO:0007368; GO:0009948; GO:0009953; GO:0010159; GO:0030510; GO:0030514; GO:0035143; GO:0035162; GO:0036122; GO:0043049; GO:0048264; GO:0060030; GO:0061371; GO:0070121 anterior/posterior axis specification [GO:0009948]; caudal fin morphogenesis [GO:0035143]; determination of heart left/right asymmetry [GO:0061371]; determination of left/right symmetry [GO:0007368]; determination of ventral identity [GO:0048264]; dorsal convergence [GO:0060030]; dorsal/ventral pattern formation [GO:0009953]; embryonic heart tube morphogenesis [GO:0003143]; embryonic hemopoiesis [GO:0035162]; heart looping [GO:0001947]; Kupffer's vesicle development [GO:0070121]; negative regulation of BMP signaling pathway [GO:0030514]; otic placode formation [GO:0043049]; regulation of BMP signaling pathway [GO:0030510]; somitogenesis [GO:0001756]; specification of animal organ position [GO:0010159] extracellular space [GO:0005615] BMP binding [GO:0036122] g12091.t1 P46197 47.656 256 4.22e-66 239.0 sp|P46197|ANPRB_BOVIN Atrial natriuretic peptide receptor 2 OS=Bos taurus OX=9913 GN=NPR2 PE=2 SV=1 g12092.t1 O16118 49.751 402 1.84e-128 378.0 sp|O16118|GNAS_HOMAM Guanine nucleotide-binding protein G(s) subunit alpha OS=Homarus americanus OX=6706 PE=2 SV=1 g12095.t1 Q3TUL7 28.545 536 2.9199999999999997e-52 189.0 sp|Q3TUL7|DCA17_MOUSE DDB1- and CUL4-associated factor 17 OS=Mus musculus OX=10090 GN=Dcaf17 PE=2 SV=1 g12100.t1 O00154 48.299 294 2.04e-89 275.0 sp|O00154|BACH_HUMAN Cytosolic acyl coenzyme A thioester hydrolase OS=Homo sapiens OX=9606 GN=ACOT7 PE=1 SV=3 BACH_HUMAN reviewed Cytosolic acyl coenzyme A thioester hydrolase (EC 3.1.2.2) (Acyl-CoA thioesterase 7) (Brain acyl-CoA hydrolase) (BACH) (hBACH) (CTE-IIa) (CTE-II) (Long chain acyl-CoA thioester hydrolase) Homo sapiens (Human) GO:0000062; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0006637; GO:0009062; GO:0015937; GO:0036042; GO:0036114; GO:0036116; GO:0042803; GO:0051792; GO:0052689; GO:0052816; GO:0070062; GO:1900535 acyl-CoA metabolic process [GO:0006637]; coenzyme A biosynthetic process [GO:0015937]; fatty acid catabolic process [GO:0009062]; long-chain fatty-acyl-CoA catabolic process [GO:0036116]; medium-chain fatty acid biosynthetic process [GO:0051792]; medium-chain fatty-acyl-CoA catabolic process [GO:0036114]; palmitic acid biosynthetic process [GO:1900535] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654] carboxylic ester hydrolase activity [GO:0052689]; fatty-acyl-CoA binding [GO:0000062]; long-chain fatty acyl-CoA binding [GO:0036042]; long-chain fatty acyl-CoA hydrolase activity [GO:0052816]; protein homodimerization activity [GO:0042803] g12104.t1 Q5FWS6 57.709 227 7.04e-88 282.0 sp|Q5FWS6|KAZRN_RAT Kazrin OS=Rattus norvegicus OX=10116 GN=Kazn PE=2 SV=2 g12106.t1 O60290 25.621 523 4.81e-43 170.0 sp|O60290|ZN862_HUMAN Zinc finger protein 862 OS=Homo sapiens OX=9606 GN=ZNF862 PE=1 SV=2 g12107.t1 Q69ZS8 57.391 115 1.7e-34 140.0 sp|Q69ZS8|KAZRN_MOUSE Kazrin OS=Mus musculus OX=10090 GN=Kazn PE=1 SV=2 KAZRN_MOUSE reviewed Kazrin Mus musculus (Mouse) GO:0001533; GO:0005654; GO:0005829; GO:0005856; GO:0016607; GO:0030057; GO:0031424 keratinization [GO:0031424] cornified envelope [GO:0001533]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; desmosome [GO:0030057]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654] g12108.t1 O54967 54.241 507 1.96e-166 528.0 sp|O54967|ACK1_MOUSE Activated CDC42 kinase 1 OS=Mus musculus OX=10090 GN=Tnk2 PE=1 SV=2 ACK1_MOUSE reviewed Activated CDC42 kinase 1 (ACK-1) (EC 2.7.10.2) (EC 2.7.11.1) (Non-receptor protein tyrosine kinase Ack) (Tyrosine kinase non-receptor protein 2) Mus musculus (Mouse) GO:0004674; GO:0004712; GO:0004713; GO:0004715; GO:0005154; GO:0005524; GO:0005634; GO:0005737; GO:0005768; GO:0005886; GO:0005905; GO:0005912; GO:0006897; GO:0007165; GO:0007286; GO:0016310; GO:0030136; GO:0030424; GO:0030425; GO:0030426; GO:0030659; GO:0031625; GO:0042802; GO:0043025; GO:0046872; GO:0050699; GO:0070436; GO:0097268; GO:0099523; GO:0099524; GO:0106310; GO:2000369 endocytosis [GO:0006897]; phosphorylation [GO:0016310]; regulation of clathrin-dependent endocytosis [GO:2000369]; signal transduction [GO:0007165]; spermatid development [GO:0007286] adherens junction [GO:0005912]; axon [GO:0030424]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; cytoophidium [GO:0097268]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; dendrite [GO:0030425]; endosome [GO:0005768]; Grb2-EGFR complex [GO:0070436]; growth cone [GO:0030426]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic cytosol [GO:0099524]; presynaptic cytosol [GO:0099523] ATP binding [GO:0005524]; epidermal growth factor receptor binding [GO:0005154]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; ubiquitin protein ligase binding [GO:0031625]; WW domain binding [GO:0050699] g12112.t1 Q05025 78.144 334 1.32e-177 498.0 sp|Q05025|G3P_COTJA Glyceraldehyde-3-phosphate dehydrogenase OS=Coturnix japonica OX=93934 GN=GAPDH PE=2 SV=2 G3P_COTJA reviewed Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) (EC 1.2.1.12) (Peptidyl-cysteine S-nitrosylase GAPDH) (EC 2.6.99.-) Coturnix japonica (Japanese quail) (Coturnix coturnix japonica) GO:0000226; GO:0004365; GO:0005634; GO:0005737; GO:0005811; GO:0005829; GO:0005886; GO:0006006; GO:0006096; GO:0008017; GO:0015630; GO:0017148; GO:0019828; GO:0031965; GO:0032481; GO:0035605; GO:0035606; GO:0042802; GO:0043123; GO:0050661; GO:0050821; GO:0050832; GO:0051287; GO:0051402; GO:0051873; GO:0061844; GO:0071346; GO:0097452; GO:0097718; GO:1990904 antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; cellular response to type II interferon [GO:0071346]; defense response to fungus [GO:0050832]; glucose metabolic process [GO:0006006]; glycolytic process [GO:0006096]; killing by host of symbiont cells [GO:0051873]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of translation [GO:0017148]; neuron apoptotic process [GO:0051402]; peptidyl-cysteine S-trans-nitrosylation [GO:0035606]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of type I interferon production [GO:0032481]; protein stabilization [GO:0050821] cytoplasm [GO:0005737]; cytosol [GO:0005829]; GAIT complex [GO:0097452]; lipid droplet [GO:0005811]; microtubule cytoskeleton [GO:0015630]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ribonucleoprotein complex [GO:1990904] aspartic-type endopeptidase inhibitor activity [GO:0019828]; disordered domain specific binding [GO:0097718]; glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity [GO:0004365]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; NAD binding [GO:0051287]; NADP binding [GO:0050661]; peptidyl-cysteine S-nitrosylase activity [GO:0035605] g12114.t1 A2BIG9 73.77 61 6.759999999999999e-28 99.4 sp|A2BIG9|NAA38_DANRE N-alpha-acetyltransferase 38, NatC auxiliary subunit OS=Danio rerio OX=7955 GN=naa38 PE=3 SV=1 g12115.t1 Q567I9 67.925 212 2.99e-105 305.0 sp|Q567I9|CB5D1_DANRE Cytochrome b5 domain-containing protein 1 OS=Danio rerio OX=7955 GN=cyb5d1 PE=2 SV=1 g12116.t1 Q8K4P0 64.835 546 0.0 733.0 sp|Q8K4P0|WDR33_MOUSE pre-mRNA 3' end processing protein WDR33 OS=Mus musculus OX=10090 GN=Wdr33 PE=1 SV=1 g12117.t1 Q9NP77 69.792 192 5.94e-93 272.0 sp|Q9NP77|SSU72_HUMAN RNA polymerase II subunit A C-terminal domain phosphatase SSU72 OS=Homo sapiens OX=9606 GN=SSU72 PE=1 SV=1 SSU72_HUMAN reviewed RNA polymerase II subunit A C-terminal domain phosphatase SSU72 (CTD phosphatase SSU72) (EC 3.1.3.16) Homo sapiens (Human) GO:0005654; GO:0005829; GO:0005847; GO:0006369; GO:0008420; GO:0180010 co-transcriptional mRNA 3'-end processing, cleavage and polyadenylation pathway [GO:0180010]; termination of RNA polymerase II transcription [GO:0006369] cytosol [GO:0005829]; mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; nucleoplasm [GO:0005654] RNA polymerase II CTD heptapeptide repeat phosphatase activity [GO:0008420] g12119.t1 Q96WV6 40.741 405 7.049999999999999e-30 125.0 sp|Q96WV6|YHU2_SCHPO Uncharacterized threonine-rich GPI-anchored glycoprotein PJ4664.02 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) OX=284812 GN=SPBPJ4664.02 PE=3 SV=1 g12119.t1 Q96WV6 41.519 395 9.5e-30 125.0 sp|Q96WV6|YHU2_SCHPO Uncharacterized threonine-rich GPI-anchored glycoprotein PJ4664.02 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) OX=284812 GN=SPBPJ4664.02 PE=3 SV=1 g12119.t1 Q96WV6 40.933 386 5.1e-29 123.0 sp|Q96WV6|YHU2_SCHPO Uncharacterized threonine-rich GPI-anchored glycoprotein PJ4664.02 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) OX=284812 GN=SPBPJ4664.02 PE=3 SV=1 g12119.t1 Q96WV6 39.951 408 6.94e-29 122.0 sp|Q96WV6|YHU2_SCHPO Uncharacterized threonine-rich GPI-anchored glycoprotein PJ4664.02 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) OX=284812 GN=SPBPJ4664.02 PE=3 SV=1 g12119.t1 Q96WV6 41.71 386 1.05e-28 122.0 sp|Q96WV6|YHU2_SCHPO Uncharacterized threonine-rich GPI-anchored glycoprotein PJ4664.02 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) OX=284812 GN=SPBPJ4664.02 PE=3 SV=1 g12119.t1 Q96WV6 39.614 414 2.73e-28 121.0 sp|Q96WV6|YHU2_SCHPO Uncharacterized threonine-rich GPI-anchored glycoprotein PJ4664.02 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) OX=284812 GN=SPBPJ4664.02 PE=3 SV=1 g12119.t1 Q96WV6 39.558 407 3.05e-28 120.0 sp|Q96WV6|YHU2_SCHPO Uncharacterized threonine-rich GPI-anchored glycoprotein PJ4664.02 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) OX=284812 GN=SPBPJ4664.02 PE=3 SV=1 g12119.t1 Q96WV6 40.338 414 3.42e-28 120.0 sp|Q96WV6|YHU2_SCHPO Uncharacterized threonine-rich GPI-anchored glycoprotein PJ4664.02 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) OX=284812 GN=SPBPJ4664.02 PE=3 SV=1 g12119.t1 Q96WV6 41.266 395 5.44e-28 120.0 sp|Q96WV6|YHU2_SCHPO Uncharacterized threonine-rich GPI-anchored glycoprotein PJ4664.02 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) OX=284812 GN=SPBPJ4664.02 PE=3 SV=1 g12119.t1 Q96WV6 40.447 403 6.26e-28 120.0 sp|Q96WV6|YHU2_SCHPO Uncharacterized threonine-rich GPI-anchored glycoprotein PJ4664.02 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) OX=284812 GN=SPBPJ4664.02 PE=3 SV=1 g12119.t1 Q96WV6 41.162 396 1.0400000000000002e-27 119.0 sp|Q96WV6|YHU2_SCHPO Uncharacterized threonine-rich GPI-anchored glycoprotein PJ4664.02 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) OX=284812 GN=SPBPJ4664.02 PE=3 SV=1 g12119.t1 Q96WV6 39.857 419 1.21e-27 119.0 sp|Q96WV6|YHU2_SCHPO Uncharacterized threonine-rich GPI-anchored glycoprotein PJ4664.02 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) OX=284812 GN=SPBPJ4664.02 PE=3 SV=1 g12119.t1 Q96WV6 39.25 400 2.7700000000000003e-27 118.0 sp|Q96WV6|YHU2_SCHPO Uncharacterized threonine-rich GPI-anchored glycoprotein PJ4664.02 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) OX=284812 GN=SPBPJ4664.02 PE=3 SV=1 g12119.t1 Q96WV6 40.506 395 3.0200000000000003e-27 118.0 sp|Q96WV6|YHU2_SCHPO Uncharacterized threonine-rich GPI-anchored glycoprotein PJ4664.02 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) OX=284812 GN=SPBPJ4664.02 PE=3 SV=1 g12119.t1 Q96WV6 39.036 415 3.1600000000000003e-27 117.0 sp|Q96WV6|YHU2_SCHPO Uncharacterized threonine-rich GPI-anchored glycoprotein PJ4664.02 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) OX=284812 GN=SPBPJ4664.02 PE=3 SV=1 g12119.t1 Q96WV6 39.13 414 3.31e-27 117.0 sp|Q96WV6|YHU2_SCHPO Uncharacterized threonine-rich GPI-anchored glycoprotein PJ4664.02 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) OX=284812 GN=SPBPJ4664.02 PE=3 SV=1 g12119.t1 Q96WV6 40.657 396 5.47e-27 117.0 sp|Q96WV6|YHU2_SCHPO Uncharacterized threonine-rich GPI-anchored glycoprotein PJ4664.02 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) OX=284812 GN=SPBPJ4664.02 PE=3 SV=1 g12119.t1 Q96WV6 39.706 408 5.520000000000001e-27 117.0 sp|Q96WV6|YHU2_SCHPO Uncharacterized threonine-rich GPI-anchored glycoprotein PJ4664.02 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) OX=284812 GN=SPBPJ4664.02 PE=3 SV=1 g12119.t1 Q96WV6 40.299 402 7.57e-27 116.0 sp|Q96WV6|YHU2_SCHPO Uncharacterized threonine-rich GPI-anchored glycoprotein PJ4664.02 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) OX=284812 GN=SPBPJ4664.02 PE=3 SV=1 g12119.t1 Q96WV6 39.698 398 1.17e-26 116.0 sp|Q96WV6|YHU2_SCHPO Uncharacterized threonine-rich GPI-anchored glycoprotein PJ4664.02 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) OX=284812 GN=SPBPJ4664.02 PE=3 SV=1 g12119.t1 Q96WV6 40.682 381 1.92e-26 115.0 sp|Q96WV6|YHU2_SCHPO Uncharacterized threonine-rich GPI-anchored glycoprotein PJ4664.02 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) OX=284812 GN=SPBPJ4664.02 PE=3 SV=1 g12119.t1 Q96WV6 39.803 407 1.99e-26 115.0 sp|Q96WV6|YHU2_SCHPO Uncharacterized threonine-rich GPI-anchored glycoprotein PJ4664.02 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) OX=284812 GN=SPBPJ4664.02 PE=3 SV=1 g12119.t1 Q96WV6 40.199 403 2.3700000000000002e-26 115.0 sp|Q96WV6|YHU2_SCHPO Uncharacterized threonine-rich GPI-anchored glycoprotein PJ4664.02 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) OX=284812 GN=SPBPJ4664.02 PE=3 SV=1 g12119.t1 Q96WV6 41.071 392 3.1300000000000003e-26 115.0 sp|Q96WV6|YHU2_SCHPO Uncharacterized threonine-rich GPI-anchored glycoprotein PJ4664.02 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) OX=284812 GN=SPBPJ4664.02 PE=3 SV=1 g12119.t1 Q96WV6 39.216 408 3.16e-26 115.0 sp|Q96WV6|YHU2_SCHPO Uncharacterized threonine-rich GPI-anchored glycoprotein PJ4664.02 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) OX=284812 GN=SPBPJ4664.02 PE=3 SV=1 g12119.t1 Q96WV6 40.769 390 4.3400000000000003e-26 114.0 sp|Q96WV6|YHU2_SCHPO Uncharacterized threonine-rich GPI-anchored glycoprotein PJ4664.02 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) OX=284812 GN=SPBPJ4664.02 PE=3 SV=1 g12119.t1 Q96WV6 40.506 395 4.9400000000000004e-26 114.0 sp|Q96WV6|YHU2_SCHPO Uncharacterized threonine-rich GPI-anchored glycoprotein PJ4664.02 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) OX=284812 GN=SPBPJ4664.02 PE=3 SV=1 g12119.t1 Q96WV6 40.152 396 4.9400000000000004e-26 114.0 sp|Q96WV6|YHU2_SCHPO Uncharacterized threonine-rich GPI-anchored glycoprotein PJ4664.02 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) OX=284812 GN=SPBPJ4664.02 PE=3 SV=1 g12119.t1 Q96WV6 39.048 420 9.810000000000001e-26 113.0 sp|Q96WV6|YHU2_SCHPO Uncharacterized threonine-rich GPI-anchored glycoprotein PJ4664.02 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) OX=284812 GN=SPBPJ4664.02 PE=3 SV=1 g12119.t1 Q96WV6 39.95 403 9.810000000000001e-26 113.0 sp|Q96WV6|YHU2_SCHPO Uncharacterized threonine-rich GPI-anchored glycoprotein PJ4664.02 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) OX=284812 GN=SPBPJ4664.02 PE=3 SV=1 g12119.t1 Q96WV6 40.909 396 2.74e-25 112.0 sp|Q96WV6|YHU2_SCHPO Uncharacterized threonine-rich GPI-anchored glycoprotein PJ4664.02 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) OX=284812 GN=SPBPJ4664.02 PE=3 SV=1 g12119.t1 Q96WV6 40.415 386 2.74e-25 112.0 sp|Q96WV6|YHU2_SCHPO Uncharacterized threonine-rich GPI-anchored glycoprotein PJ4664.02 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) OX=284812 GN=SPBPJ4664.02 PE=3 SV=1 g12119.t1 Q96WV6 40.404 396 3.27e-25 112.0 sp|Q96WV6|YHU2_SCHPO Uncharacterized threonine-rich GPI-anchored glycoprotein PJ4664.02 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) OX=284812 GN=SPBPJ4664.02 PE=3 SV=1 g12119.t1 Q96WV6 41.582 392 3.62e-25 111.0 sp|Q96WV6|YHU2_SCHPO Uncharacterized threonine-rich GPI-anchored glycoprotein PJ4664.02 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) OX=284812 GN=SPBPJ4664.02 PE=3 SV=1 g12119.t1 Q96WV6 39.95 403 7.53e-25 110.0 sp|Q96WV6|YHU2_SCHPO Uncharacterized threonine-rich GPI-anchored glycoprotein PJ4664.02 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) OX=284812 GN=SPBPJ4664.02 PE=3 SV=1 g12119.t1 Q96WV6 39.898 391 1.09e-24 110.0 sp|Q96WV6|YHU2_SCHPO Uncharacterized threonine-rich GPI-anchored glycoprotein PJ4664.02 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) OX=284812 GN=SPBPJ4664.02 PE=3 SV=1 g12119.t1 Q96WV6 39.899 396 1.23e-24 110.0 sp|Q96WV6|YHU2_SCHPO Uncharacterized threonine-rich GPI-anchored glycoprotein PJ4664.02 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) OX=284812 GN=SPBPJ4664.02 PE=3 SV=1 g12119.t1 Q96WV6 39.216 408 1.3999999999999999e-24 110.0 sp|Q96WV6|YHU2_SCHPO Uncharacterized threonine-rich GPI-anchored glycoprotein PJ4664.02 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) OX=284812 GN=SPBPJ4664.02 PE=3 SV=1 g12119.t1 Q96WV6 39.95 398 1.85e-24 109.0 sp|Q96WV6|YHU2_SCHPO Uncharacterized threonine-rich GPI-anchored glycoprotein PJ4664.02 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) OX=284812 GN=SPBPJ4664.02 PE=3 SV=1 g12119.t1 Q96WV6 40.299 402 2.0299999999999998e-24 109.0 sp|Q96WV6|YHU2_SCHPO Uncharacterized threonine-rich GPI-anchored glycoprotein PJ4664.02 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) OX=284812 GN=SPBPJ4664.02 PE=3 SV=1 g12119.t1 Q96WV6 39.075 389 2.5499999999999998e-24 109.0 sp|Q96WV6|YHU2_SCHPO Uncharacterized threonine-rich GPI-anchored glycoprotein PJ4664.02 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) OX=284812 GN=SPBPJ4664.02 PE=3 SV=1 g12119.t1 Q96WV6 40.299 402 2.65e-24 109.0 sp|Q96WV6|YHU2_SCHPO Uncharacterized threonine-rich GPI-anchored glycoprotein PJ4664.02 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) OX=284812 GN=SPBPJ4664.02 PE=3 SV=1 g12119.t1 Q96WV6 39.646 396 3.0699999999999998e-24 108.0 sp|Q96WV6|YHU2_SCHPO Uncharacterized threonine-rich GPI-anchored glycoprotein PJ4664.02 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) OX=284812 GN=SPBPJ4664.02 PE=3 SV=1 g12119.t1 Q96WV6 40.104 384 3.2199999999999997e-24 108.0 sp|Q96WV6|YHU2_SCHPO Uncharacterized threonine-rich GPI-anchored glycoprotein PJ4664.02 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) OX=284812 GN=SPBPJ4664.02 PE=3 SV=1 g12119.t1 Q96WV6 40.31 387 3.34e-24 108.0 sp|Q96WV6|YHU2_SCHPO Uncharacterized threonine-rich GPI-anchored glycoprotein PJ4664.02 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) OX=284812 GN=SPBPJ4664.02 PE=3 SV=1 g12119.t1 Q96WV6 39.37 381 4.87e-24 108.0 sp|Q96WV6|YHU2_SCHPO Uncharacterized threonine-rich GPI-anchored glycoprotein PJ4664.02 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) OX=284812 GN=SPBPJ4664.02 PE=3 SV=1 g12119.t1 Q96WV6 39.899 396 8.33e-24 107.0 sp|Q96WV6|YHU2_SCHPO Uncharacterized threonine-rich GPI-anchored glycoprotein PJ4664.02 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) OX=284812 GN=SPBPJ4664.02 PE=3 SV=1 g12119.t1 Q96WV6 37.585 439 8.33e-24 107.0 sp|Q96WV6|YHU2_SCHPO Uncharacterized threonine-rich GPI-anchored glycoprotein PJ4664.02 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) OX=284812 GN=SPBPJ4664.02 PE=3 SV=1 g12119.t1 Q96WV6 40.157 381 9.92e-24 107.0 sp|Q96WV6|YHU2_SCHPO Uncharacterized threonine-rich GPI-anchored glycoprotein PJ4664.02 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) OX=284812 GN=SPBPJ4664.02 PE=3 SV=1 g12119.t1 Q96WV6 38.263 426 1e-23 107.0 sp|Q96WV6|YHU2_SCHPO Uncharacterized threonine-rich GPI-anchored glycoprotein PJ4664.02 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) OX=284812 GN=SPBPJ4664.02 PE=3 SV=1 g12119.t1 Q96WV6 38.903 401 1.49e-23 107.0 sp|Q96WV6|YHU2_SCHPO Uncharacterized threonine-rich GPI-anchored glycoprotein PJ4664.02 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) OX=284812 GN=SPBPJ4664.02 PE=3 SV=1 g12119.t1 Q96WV6 39.378 386 1.55e-23 107.0 sp|Q96WV6|YHU2_SCHPO Uncharacterized threonine-rich GPI-anchored glycoprotein PJ4664.02 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) OX=284812 GN=SPBPJ4664.02 PE=3 SV=1 g12119.t1 Q96WV6 40.674 386 1.86e-23 106.0 sp|Q96WV6|YHU2_SCHPO Uncharacterized threonine-rich GPI-anchored glycoprotein PJ4664.02 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) OX=284812 GN=SPBPJ4664.02 PE=3 SV=1 g12119.t1 Q96WV6 39.277 415 2.7899999999999997e-23 106.0 sp|Q96WV6|YHU2_SCHPO Uncharacterized threonine-rich GPI-anchored glycoprotein PJ4664.02 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) OX=284812 GN=SPBPJ4664.02 PE=3 SV=1 g12119.t1 Q96WV6 40.674 386 3.75e-23 105.0 sp|Q96WV6|YHU2_SCHPO Uncharacterized threonine-rich GPI-anchored glycoprotein PJ4664.02 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) OX=284812 GN=SPBPJ4664.02 PE=3 SV=1 g12119.t1 Q96WV6 38.821 407 3.9199999999999995e-23 105.0 sp|Q96WV6|YHU2_SCHPO Uncharacterized threonine-rich GPI-anchored glycoprotein PJ4664.02 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) OX=284812 GN=SPBPJ4664.02 PE=3 SV=1 g12119.t1 Q96WV6 40.164 366 6.879999999999999e-23 105.0 sp|Q96WV6|YHU2_SCHPO Uncharacterized threonine-rich GPI-anchored glycoprotein PJ4664.02 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) OX=284812 GN=SPBPJ4664.02 PE=3 SV=1 g12119.t1 Q96WV6 39.655 406 6.879999999999999e-23 105.0 sp|Q96WV6|YHU2_SCHPO Uncharacterized threonine-rich GPI-anchored glycoprotein PJ4664.02 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) OX=284812 GN=SPBPJ4664.02 PE=3 SV=1 g12119.t1 Q96WV6 39.604 404 1.17e-22 104.0 sp|Q96WV6|YHU2_SCHPO Uncharacterized threonine-rich GPI-anchored glycoprotein PJ4664.02 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) OX=284812 GN=SPBPJ4664.02 PE=3 SV=1 g12119.t1 Q96WV6 38.614 404 1.29e-22 104.0 sp|Q96WV6|YHU2_SCHPO Uncharacterized threonine-rich GPI-anchored glycoprotein PJ4664.02 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) OX=284812 GN=SPBPJ4664.02 PE=3 SV=1 g12119.t1 Q96WV6 38.313 415 1.9300000000000001e-22 103.0 sp|Q96WV6|YHU2_SCHPO Uncharacterized threonine-rich GPI-anchored glycoprotein PJ4664.02 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) OX=284812 GN=SPBPJ4664.02 PE=3 SV=1 g12119.t1 Q96WV6 38.725 408 2.34e-22 103.0 sp|Q96WV6|YHU2_SCHPO Uncharacterized threonine-rich GPI-anchored glycoprotein PJ4664.02 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) OX=284812 GN=SPBPJ4664.02 PE=3 SV=1 g12119.t1 Q96WV6 38.118 425 2.74e-22 103.0 sp|Q96WV6|YHU2_SCHPO Uncharacterized threonine-rich GPI-anchored glycoprotein PJ4664.02 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) OX=284812 GN=SPBPJ4664.02 PE=3 SV=1 g12119.t1 Q96WV6 38.406 414 4.37e-22 102.0 sp|Q96WV6|YHU2_SCHPO Uncharacterized threonine-rich GPI-anchored glycoprotein PJ4664.02 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) OX=284812 GN=SPBPJ4664.02 PE=3 SV=1 g12119.t1 Q96WV6 38.342 386 6.8e-22 102.0 sp|Q96WV6|YHU2_SCHPO Uncharacterized threonine-rich GPI-anchored glycoprotein PJ4664.02 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) OX=284812 GN=SPBPJ4664.02 PE=3 SV=1 g12119.t1 Q96WV6 37.559 426 1.19e-21 101.0 sp|Q96WV6|YHU2_SCHPO Uncharacterized threonine-rich GPI-anchored glycoprotein PJ4664.02 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) OX=284812 GN=SPBPJ4664.02 PE=3 SV=1 g12119.t1 Q96WV6 37.887 388 2.0500000000000003e-21 100.0 sp|Q96WV6|YHU2_SCHPO Uncharacterized threonine-rich GPI-anchored glycoprotein PJ4664.02 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) OX=284812 GN=SPBPJ4664.02 PE=3 SV=1 g12119.t1 Q96WV6 39.378 386 2.7e-21 100.0 sp|Q96WV6|YHU2_SCHPO Uncharacterized threonine-rich GPI-anchored glycoprotein PJ4664.02 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) OX=284812 GN=SPBPJ4664.02 PE=3 SV=1 g12119.t1 Q96WV6 39.216 408 4.3000000000000006e-21 99.8 sp|Q96WV6|YHU2_SCHPO Uncharacterized threonine-rich GPI-anchored glycoprotein PJ4664.02 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) OX=284812 GN=SPBPJ4664.02 PE=3 SV=1 g12119.t1 Q96WV6 38.734 395 6.21e-21 99.0 sp|Q96WV6|YHU2_SCHPO Uncharacterized threonine-rich GPI-anchored glycoprotein PJ4664.02 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) OX=284812 GN=SPBPJ4664.02 PE=3 SV=1 g12119.t1 Q96WV6 38.636 396 7.95e-21 99.0 sp|Q96WV6|YHU2_SCHPO Uncharacterized threonine-rich GPI-anchored glycoprotein PJ4664.02 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) OX=284812 GN=SPBPJ4664.02 PE=3 SV=1 g12121.t1 Q96WV6 41.748 309 3.38e-23 103.0 sp|Q96WV6|YHU2_SCHPO Uncharacterized threonine-rich GPI-anchored glycoprotein PJ4664.02 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) OX=284812 GN=SPBPJ4664.02 PE=3 SV=1 g12121.t1 Q96WV6 41.042 307 8.749999999999999e-23 102.0 sp|Q96WV6|YHU2_SCHPO Uncharacterized threonine-rich GPI-anchored glycoprotein PJ4664.02 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) OX=284812 GN=SPBPJ4664.02 PE=3 SV=1 g12121.t1 Q96WV6 39.766 342 4.1200000000000003e-22 100.0 sp|Q96WV6|YHU2_SCHPO Uncharacterized threonine-rich GPI-anchored glycoprotein PJ4664.02 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) OX=284812 GN=SPBPJ4664.02 PE=3 SV=1 g12121.t1 Q96WV6 41.509 318 5.84e-22 100.0 sp|Q96WV6|YHU2_SCHPO Uncharacterized threonine-rich GPI-anchored glycoprotein PJ4664.02 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) OX=284812 GN=SPBPJ4664.02 PE=3 SV=1 g12121.t1 Q96WV6 40.303 330 6.23e-22 100.0 sp|Q96WV6|YHU2_SCHPO Uncharacterized threonine-rich GPI-anchored glycoprotein PJ4664.02 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) OX=284812 GN=SPBPJ4664.02 PE=3 SV=1 g12121.t1 Q96WV6 42.069 290 7.74e-22 99.8 sp|Q96WV6|YHU2_SCHPO Uncharacterized threonine-rich GPI-anchored glycoprotein PJ4664.02 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) OX=284812 GN=SPBPJ4664.02 PE=3 SV=1 g12121.t1 Q96WV6 41.121 321 9.51e-22 99.4 sp|Q96WV6|YHU2_SCHPO Uncharacterized threonine-rich GPI-anchored glycoprotein PJ4664.02 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) OX=284812 GN=SPBPJ4664.02 PE=3 SV=1 g12121.t1 Q96WV6 40.0 330 1.02e-21 99.4 sp|Q96WV6|YHU2_SCHPO Uncharacterized threonine-rich GPI-anchored glycoprotein PJ4664.02 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) OX=284812 GN=SPBPJ4664.02 PE=3 SV=1 g12121.t1 Q96WV6 40.752 319 1.1200000000000002e-21 99.4 sp|Q96WV6|YHU2_SCHPO Uncharacterized threonine-rich GPI-anchored glycoprotein PJ4664.02 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) OX=284812 GN=SPBPJ4664.02 PE=3 SV=1 g12121.t1 Q96WV6 42.395 309 1.7e-21 98.6 sp|Q96WV6|YHU2_SCHPO Uncharacterized threonine-rich GPI-anchored glycoprotein PJ4664.02 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) OX=284812 GN=SPBPJ4664.02 PE=3 SV=1 g12121.t1 Q96WV6 40.549 328 1.89e-21 98.6 sp|Q96WV6|YHU2_SCHPO Uncharacterized threonine-rich GPI-anchored glycoprotein PJ4664.02 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) OX=284812 GN=SPBPJ4664.02 PE=3 SV=1 g12121.t1 Q96WV6 42.006 319 2.13e-21 98.6 sp|Q96WV6|YHU2_SCHPO Uncharacterized threonine-rich GPI-anchored glycoprotein PJ4664.02 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) OX=284812 GN=SPBPJ4664.02 PE=3 SV=1 g12121.t1 Q96WV6 41.824 318 2.2500000000000002e-21 98.6 sp|Q96WV6|YHU2_SCHPO Uncharacterized threonine-rich GPI-anchored glycoprotein PJ4664.02 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) OX=284812 GN=SPBPJ4664.02 PE=3 SV=1 g12121.t1 Q96WV6 40.752 319 2.36e-21 98.2 sp|Q96WV6|YHU2_SCHPO Uncharacterized threonine-rich GPI-anchored glycoprotein PJ4664.02 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) OX=284812 GN=SPBPJ4664.02 PE=3 SV=1 g12121.t1 Q96WV6 40.566 318 2.57e-21 98.2 sp|Q96WV6|YHU2_SCHPO Uncharacterized threonine-rich GPI-anchored glycoprotein PJ4664.02 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) OX=284812 GN=SPBPJ4664.02 PE=3 SV=1 g12121.t1 Q96WV6 39.879 331 3.600000000000001e-21 97.8 sp|Q96WV6|YHU2_SCHPO Uncharacterized threonine-rich GPI-anchored glycoprotein PJ4664.02 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) OX=284812 GN=SPBPJ4664.02 PE=3 SV=1 g12121.t1 Q96WV6 39.474 342 3.7400000000000005e-21 97.8 sp|Q96WV6|YHU2_SCHPO Uncharacterized threonine-rich GPI-anchored glycoprotein PJ4664.02 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) OX=284812 GN=SPBPJ4664.02 PE=3 SV=1 g12121.t1 Q96WV6 40.81 321 3.8100000000000004e-21 97.8 sp|Q96WV6|YHU2_SCHPO Uncharacterized threonine-rich GPI-anchored glycoprotein PJ4664.02 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) OX=284812 GN=SPBPJ4664.02 PE=3 SV=1 g12121.t1 Q96WV6 40.881 318 3.9200000000000006e-21 97.8 sp|Q96WV6|YHU2_SCHPO Uncharacterized threonine-rich GPI-anchored glycoprotein PJ4664.02 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) OX=284812 GN=SPBPJ4664.02 PE=3 SV=1 g12121.t1 Q96WV6 39.697 330 4.1100000000000006e-21 97.8 sp|Q96WV6|YHU2_SCHPO Uncharacterized threonine-rich GPI-anchored glycoprotein PJ4664.02 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) OX=284812 GN=SPBPJ4664.02 PE=3 SV=1 g12121.t1 Q96WV6 40.0 330 5.4400000000000005e-21 97.4 sp|Q96WV6|YHU2_SCHPO Uncharacterized threonine-rich GPI-anchored glycoprotein PJ4664.02 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) OX=284812 GN=SPBPJ4664.02 PE=3 SV=1 g12121.t1 Q96WV6 40.181 331 5.600000000000001e-21 97.4 sp|Q96WV6|YHU2_SCHPO Uncharacterized threonine-rich GPI-anchored glycoprotein PJ4664.02 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) OX=284812 GN=SPBPJ4664.02 PE=3 SV=1 g12121.t1 Q96WV6 41.748 309 6.6900000000000006e-21 97.1 sp|Q96WV6|YHU2_SCHPO Uncharacterized threonine-rich GPI-anchored glycoprotein PJ4664.02 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) OX=284812 GN=SPBPJ4664.02 PE=3 SV=1 g12121.t1 Q96WV6 42.038 314 7.080000000000001e-21 97.1 sp|Q96WV6|YHU2_SCHPO Uncharacterized threonine-rich GPI-anchored glycoprotein PJ4664.02 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) OX=284812 GN=SPBPJ4664.02 PE=3 SV=1 g12121.t1 Q96WV6 40.058 342 9.030000000000001e-21 96.7 sp|Q96WV6|YHU2_SCHPO Uncharacterized threonine-rich GPI-anchored glycoprotein PJ4664.02 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) OX=284812 GN=SPBPJ4664.02 PE=3 SV=1 g12125.t1 Q68CQ7 46.241 266 5.29e-75 239.0 sp|Q68CQ7|GL8D1_HUMAN Glycosyltransferase 8 domain-containing protein 1 OS=Homo sapiens OX=9606 GN=GLT8D1 PE=1 SV=2 GL8D1_HUMAN reviewed Glycosyltransferase 8 domain-containing protein 1 (EC 2.4.1.-) Homo sapiens (Human) GO:0005794; GO:0008194; GO:0016020 Golgi apparatus [GO:0005794]; membrane [GO:0016020] UDP-glycosyltransferase activity [GO:0008194] g12127.t1 B0FWK4 64.045 89 2.05e-36 122.0 sp|B0FWK4|SPCS1_PIG Signal peptidase complex subunit 1 OS=Sus scrofa OX=9823 GN=SPCS1 PE=3 SV=1 g12129.t1 P60517 93.966 116 1.15e-76 225.0 sp|P60517|GBRAP_RAT Gamma-aminobutyric acid receptor-associated protein OS=Rattus norvegicus OX=10116 GN=Gabarap PE=1 SV=1 GBRAP_RAT reviewed Gamma-aminobutyric acid receptor-associated protein (GABA(A) receptor-associated protein) Rattus norvegicus (Rat) GO:0000045; GO:0000139; GO:0000226; GO:0000421; GO:0000423; GO:0005764; GO:0005776; GO:0005790; GO:0005794; GO:0005874; GO:0005875; GO:0005886; GO:0005930; GO:0006995; GO:0008017; GO:0008429; GO:0008625; GO:0015031; GO:0015629; GO:0031410; GO:0031625; GO:0032436; GO:0035020; GO:0044297; GO:0048471; GO:0048487; GO:0050811; GO:0097225; GO:0097352; GO:0098696; GO:0098982; GO:0099091; GO:1902524 autophagosome assembly [GO:0000045]; autophagosome maturation [GO:0097352]; cellular response to nitrogen starvation [GO:0006995]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; microtubule cytoskeleton organization [GO:0000226]; mitophagy [GO:0000423]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein K48-linked ubiquitination [GO:1902524]; protein transport [GO:0015031]; regulation of neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0098696]; regulation of Rac protein signal transduction [GO:0035020] actin cytoskeleton [GO:0015629]; autophagosome [GO:0005776]; autophagosome membrane [GO:0000421]; axoneme [GO:0005930]; cell body [GO:0044297]; cytoplasmic vesicle [GO:0031410]; GABA-ergic synapse [GO:0098982]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; lysosome [GO:0005764]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic specialization, intracellular component [GO:0099091]; smooth endoplasmic reticulum [GO:0005790]; sperm midpiece [GO:0097225] beta-tubulin binding [GO:0048487]; GABA receptor binding [GO:0050811]; microtubule binding [GO:0008017]; phosphatidylethanolamine binding [GO:0008429]; ubiquitin protein ligase binding [GO:0031625] g12137.t1 P46087 73.13 361 1.8600000000000003e-179 536.0 sp|P46087|NOP2_HUMAN 28S rRNA (cytosine(4447)-C(5))-methyltransferase OS=Homo sapiens OX=9606 GN=NOP2 PE=1 SV=2 NOP2_HUMAN reviewed 28S rRNA (cytosine(4447)-C(5))-methyltransferase (EC 2.1.1.-) (Nucleolar protein 1) (Nucleolar protein 2 homolog) (Proliferating-cell nucleolar antigen p120) (Proliferation-associated nucleolar protein p120) Homo sapiens (Human) GO:0000027; GO:0000470; GO:0003723; GO:0005634; GO:0005654; GO:0005730; GO:0006364; GO:0008284; GO:0009383; GO:0042273; GO:0070475; GO:1901796 maturation of LSU-rRNA [GO:0000470]; positive regulation of cell population proliferation [GO:0008284]; regulation of signal transduction by p53 class mediator [GO:1901796]; ribosomal large subunit assembly [GO:0000027]; ribosomal large subunit biogenesis [GO:0042273]; rRNA base methylation [GO:0070475]; rRNA processing [GO:0006364] nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] RNA binding [GO:0003723]; rRNA (cytosine-C5-)-methyltransferase activity [GO:0009383] g12138.t1 Q505F5 39.792 578 2.47e-87 284.0 sp|Q505F5|LRC47_MOUSE Leucine-rich repeat-containing protein 47 OS=Mus musculus OX=10090 GN=Lrrc47 PE=1 SV=1 g12141.t1 D4A1X2 40.729 933 0.0 643.0 sp|D4A1X2|EXOSX_RAT Exosome complex component 10 OS=Rattus norvegicus OX=10116 GN=Exosc10 PE=1 SV=2 EXOSX_RAT reviewed Exosome complex component 10 (EC 3.1.13.-) Rattus norvegicus (Rat) GO:0000166; GO:0000175; GO:0000176; GO:0000178; GO:0000184; GO:0000460; GO:0000467; GO:0000791; GO:0000956; GO:0003727; GO:0004532; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0006281; GO:0006396; GO:0006401; GO:0032040; GO:0032211; GO:0042274; GO:0046872; GO:0060816; GO:0070034; GO:0071028; GO:0071034; GO:0071035; GO:0071036; GO:0071037; GO:0071038; GO:0071039; GO:0071040; GO:0071044; GO:0071051; GO:1904872; GO:1905746 CUT catabolic process [GO:0071034]; DNA repair [GO:0006281]; exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000467]; histone mRNA catabolic process [GO:0071044]; maturation of 5.8S rRNA [GO:0000460]; negative regulation of telomere maintenance via telomerase [GO:0032211]; nuclear mRNA surveillance [GO:0071028]; nuclear polyadenylation-dependent antisense transcript catabolic process [GO:0071040]; nuclear polyadenylation-dependent CUT catabolic process [GO:0071039]; nuclear polyadenylation-dependent rRNA catabolic process [GO:0071035]; nuclear polyadenylation-dependent snoRNA catabolic process [GO:0071036]; nuclear polyadenylation-dependent snRNA catabolic process [GO:0071037]; nuclear-transcribed mRNA catabolic process [GO:0000956]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; poly(A)-dependent snoRNA 3'-end processing [GO:0071051]; positive regulation of mRNA cis splicing, via spliceosome [GO:1905746]; random inactivation of X chromosome [GO:0060816]; regulation of telomerase RNA localization to Cajal body [GO:1904872]; ribosomal small subunit biogenesis [GO:0042274]; RNA catabolic process [GO:0006401]; RNA processing [GO:0006396]; TRAMP-dependent tRNA surveillance pathway [GO:0071038] cytoplasm [GO:0005737]; cytosol [GO:0005829]; euchromatin [GO:0000791]; exosome (RNase complex) [GO:0000178]; nuclear exosome (RNase complex) [GO:0000176]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; small-subunit processome [GO:0032040] 3'-5'-RNA exonuclease activity [GO:0000175]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]; RNA exonuclease activity [GO:0004532]; single-stranded RNA binding [GO:0003727]; telomerase RNA binding [GO:0070034] g12142.t1 P38166 33.493 209 3.1500000000000004e-32 120.0 sp|P38166|SFT2_YEAST Protein transport protein SFT2 OS=Saccharomyces cerevisiae (strain ATCC 204508 / S288c) OX=559292 GN=SFT2 PE=1 SV=1 g12145.t1 Q6KAR6 24.848 656 6.62e-48 184.0 sp|Q6KAR6|EXOC3_MOUSE Exocyst complex component 3 OS=Mus musculus OX=10090 GN=Exoc3 PE=1 SV=2 EXOC3_MOUSE reviewed Exocyst complex component 3 (Exocyst complex component Sec6) Mus musculus (Mouse) GO:0000145; GO:0000149; GO:0000281; GO:0005794; GO:0006887; GO:0006904; GO:0015031; GO:0030426; GO:0030496; GO:0030667; GO:0042734; GO:0048471; GO:0051601; GO:0090148; GO:0090522 exocyst localization [GO:0051601]; exocytosis [GO:0006887]; membrane fission [GO:0090148]; mitotic cytokinesis [GO:0000281]; protein transport [GO:0015031]; vesicle docking involved in exocytosis [GO:0006904]; vesicle tethering involved in exocytosis [GO:0090522] exocyst [GO:0000145]; Golgi apparatus [GO:0005794]; growth cone [GO:0030426]; midbody [GO:0030496]; perinuclear region of cytoplasm [GO:0048471]; presynaptic membrane [GO:0042734]; secretory granule membrane [GO:0030667] SNARE binding [GO:0000149] g12145.t2 Q6KAR6 24.848 656 3.14e-48 184.0 sp|Q6KAR6|EXOC3_MOUSE Exocyst complex component 3 OS=Mus musculus OX=10090 GN=Exoc3 PE=1 SV=2 EXOC3_MOUSE reviewed Exocyst complex component 3 (Exocyst complex component Sec6) Mus musculus (Mouse) GO:0000145; GO:0000149; GO:0000281; GO:0005794; GO:0006887; GO:0006904; GO:0015031; GO:0030426; GO:0030496; GO:0030667; GO:0042734; GO:0048471; GO:0051601; GO:0090148; GO:0090522 exocyst localization [GO:0051601]; exocytosis [GO:0006887]; membrane fission [GO:0090148]; mitotic cytokinesis [GO:0000281]; protein transport [GO:0015031]; vesicle docking involved in exocytosis [GO:0006904]; vesicle tethering involved in exocytosis [GO:0090522] exocyst [GO:0000145]; Golgi apparatus [GO:0005794]; growth cone [GO:0030426]; midbody [GO:0030496]; perinuclear region of cytoplasm [GO:0048471]; presynaptic membrane [GO:0042734]; secretory granule membrane [GO:0030667] SNARE binding [GO:0000149] g12146.t1 Q5T089 51.087 276 3.04e-87 281.0 sp|Q5T089|MORN1_HUMAN MORN repeat-containing protein 1 OS=Homo sapiens OX=9606 GN=MORN1 PE=1 SV=2 g12146.t2 Q5T089 51.087 276 1.97e-86 281.0 sp|Q5T089|MORN1_HUMAN MORN repeat-containing protein 1 OS=Homo sapiens OX=9606 GN=MORN1 PE=1 SV=2 g12147.t1 Q7ZUC2 35.323 201 1.7200000000000001e-29 115.0 sp|Q7ZUC2|CAB45_DANRE 45 kDa calcium-binding protein OS=Danio rerio OX=7955 GN=sdf4 PE=2 SV=1 CAB45_DANRE reviewed 45 kDa calcium-binding protein (Cab45) (Stromal cell-derived factor 4) (SDF-4) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0002040; GO:0005509; GO:0005783; GO:0005796; GO:0017156 calcium-ion regulated exocytosis [GO:0017156]; sprouting angiogenesis [GO:0002040] endoplasmic reticulum [GO:0005783]; Golgi lumen [GO:0005796] calcium ion binding [GO:0005509] g12148.t1 Q5BKL9 46.154 130 7.93e-32 118.0 sp|Q5BKL9|CAB45_XENTR 45 kDa calcium-binding protein OS=Xenopus tropicalis OX=8364 GN=sdf4 PE=2 SV=1 g12149.t1 Q91Z92 49.492 295 1.13e-107 320.0 sp|Q91Z92|B3GT6_MOUSE Beta-1,3-galactosyltransferase 6 OS=Mus musculus OX=10090 GN=B3galt6 PE=2 SV=1 B3GT6_MOUSE reviewed Beta-1,3-galactosyltransferase 6 (Beta-1,3-GalTase 6) (Beta3Gal-T6) (Beta3GalT6) (EC 2.4.1.134) (GAG GalTII) (Galactosyltransferase II) (Galactosylxylosylprotein 3-beta-galactosyltransferase) (UDP-Gal:betaGal beta 1,3-galactosyltransferase polypeptide 6) Mus musculus (Mouse) GO:0000139; GO:0005794; GO:0005797; GO:0006024; GO:0006493; GO:0015012; GO:0030166; GO:0032580; GO:0035250; GO:0047220; GO:0050650; GO:0050651 chondroitin sulfate proteoglycan biosynthetic process [GO:0050650]; dermatan sulfate proteoglycan biosynthetic process [GO:0050651]; glycosaminoglycan biosynthetic process [GO:0006024]; heparan sulfate proteoglycan biosynthetic process [GO:0015012]; protein O-linked glycosylation [GO:0006493]; proteoglycan biosynthetic process [GO:0030166] Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi medial cisterna [GO:0005797]; Golgi membrane [GO:0000139] galactosylxylosylprotein 3-beta-galactosyltransferase activity [GO:0047220]; UDP-galactosyltransferase activity [GO:0035250] g12150.t1 Q91Z92 52.431 288 2.82e-107 319.0 sp|Q91Z92|B3GT6_MOUSE Beta-1,3-galactosyltransferase 6 OS=Mus musculus OX=10090 GN=B3galt6 PE=2 SV=1 B3GT6_MOUSE reviewed Beta-1,3-galactosyltransferase 6 (Beta-1,3-GalTase 6) (Beta3Gal-T6) (Beta3GalT6) (EC 2.4.1.134) (GAG GalTII) (Galactosyltransferase II) (Galactosylxylosylprotein 3-beta-galactosyltransferase) (UDP-Gal:betaGal beta 1,3-galactosyltransferase polypeptide 6) Mus musculus (Mouse) GO:0000139; GO:0005794; GO:0005797; GO:0006024; GO:0006493; GO:0015012; GO:0030166; GO:0032580; GO:0035250; GO:0047220; GO:0050650; GO:0050651 chondroitin sulfate proteoglycan biosynthetic process [GO:0050650]; dermatan sulfate proteoglycan biosynthetic process [GO:0050651]; glycosaminoglycan biosynthetic process [GO:0006024]; heparan sulfate proteoglycan biosynthetic process [GO:0015012]; protein O-linked glycosylation [GO:0006493]; proteoglycan biosynthetic process [GO:0030166] Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi medial cisterna [GO:0005797]; Golgi membrane [GO:0000139] galactosylxylosylprotein 3-beta-galactosyltransferase activity [GO:0047220]; UDP-galactosyltransferase activity [GO:0035250] g12153.t1 Q5FVM7 32.996 791 2.93e-130 409.0 sp|Q5FVM7|DJC16_RAT DnaJ homolog subfamily C member 16 OS=Rattus norvegicus OX=10116 GN=Dnajc16 PE=2 SV=1 DJC16_RAT reviewed DnaJ homolog subfamily C member 16 (Endoplasmic reticulum DNA J domain-containing protein 8) (ER-resident protein ERdj8) (ERdj8) Rattus norvegicus (Rat) GO:0005789; GO:0016243 regulation of autophagosome size [GO:0016243] endoplasmic reticulum membrane [GO:0005789] g12154.t1 A3KQ55 37.842 658 5.180000000000001e-109 350.0 sp|A3KQ55|MEPCE_DANRE 7SK snRNA methylphosphate capping enzyme OS=Danio rerio OX=7955 GN=mepce PE=3 SV=2 MEPCE_DANRE reviewed 7SK snRNA methylphosphate capping enzyme (MePCE) (EC 2.1.1.-) (Bicoid-interacting protein 3 homolog) (Bin3 homolog) (zBCDIN3) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001510; GO:0005634; GO:0008171; GO:0008173; GO:0008757; GO:0016073; GO:0017069; GO:0040031; GO:1904871; GO:1905382; GO:1990276; GO:1990904 positive regulation of protein localization to Cajal body [GO:1904871]; positive regulation of snRNA transcription by RNA polymerase II [GO:1905382]; RNA methylation [GO:0001510]; snRNA metabolic process [GO:0016073]; snRNA modification [GO:0040031] nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904] O-methyltransferase activity [GO:0008171]; RNA 5'-gamma-phosphate methyltransferase activity [GO:1990276]; RNA methyltransferase activity [GO:0008173]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]; snRNA binding [GO:0017069] g12155.t1 P32822 33.333 231 1.81e-26 106.0 sp|P32822|TRYB_RAT Trypsin V-B OS=Rattus norvegicus OX=10116 PE=2 SV=1 g12158.t1 P09487 50.361 415 8.12e-128 382.0 sp|P09487|PPBT_BOVIN Alkaline phosphatase, tissue-nonspecific isozyme OS=Bos taurus OX=9913 GN=ALPL PE=1 SV=2 PPBT_BOVIN reviewed Alkaline phosphatase, tissue-nonspecific isozyme (AP-TNAP) (TNAP) (TNSALP) (EC 3.1.3.1) (Alkaline phosphatase liver/bone/kidney isozyme) (Phosphoamidase) (Phosphocreatine phosphatase) (EC 3.9.1.1) Bos taurus (Bovine) GO:0004035; GO:0004427; GO:0005509; GO:0005758; GO:0005886; GO:0016462; GO:0016887; GO:0030282; GO:0031214; GO:0031966; GO:0033883; GO:0043262; GO:0050187; GO:0052732; GO:0065010; GO:0098552; GO:0120162 biomineral tissue development [GO:0031214]; bone mineralization [GO:0030282]; positive regulation of cold-induced thermogenesis [GO:0120162] extracellular membrane-bounded organelle [GO:0065010]; mitochondrial intermembrane space [GO:0005758]; mitochondrial membrane [GO:0031966]; plasma membrane [GO:0005886]; side of membrane [GO:0098552] ADP phosphatase activity [GO:0043262]; alkaline phosphatase activity [GO:0004035]; ATP hydrolysis activity [GO:0016887]; calcium ion binding [GO:0005509]; inorganic diphosphate phosphatase activity [GO:0004427]; phosphoamidase activity [GO:0050187]; phosphoethanolamine phosphatase activity [GO:0052732]; pyridoxal phosphatase activity [GO:0033883]; pyrophosphatase activity [GO:0016462] g12159.t1 P09487 50.497 503 6.5500000000000004e-164 478.0 sp|P09487|PPBT_BOVIN Alkaline phosphatase, tissue-nonspecific isozyme OS=Bos taurus OX=9913 GN=ALPL PE=1 SV=2 PPBT_BOVIN reviewed Alkaline phosphatase, tissue-nonspecific isozyme (AP-TNAP) (TNAP) (TNSALP) (EC 3.1.3.1) (Alkaline phosphatase liver/bone/kidney isozyme) (Phosphoamidase) (Phosphocreatine phosphatase) (EC 3.9.1.1) Bos taurus (Bovine) GO:0004035; GO:0004427; GO:0005509; GO:0005758; GO:0005886; GO:0016462; GO:0016887; GO:0030282; GO:0031214; GO:0031966; GO:0033883; GO:0043262; GO:0050187; GO:0052732; GO:0065010; GO:0098552; GO:0120162 biomineral tissue development [GO:0031214]; bone mineralization [GO:0030282]; positive regulation of cold-induced thermogenesis [GO:0120162] extracellular membrane-bounded organelle [GO:0065010]; mitochondrial intermembrane space [GO:0005758]; mitochondrial membrane [GO:0031966]; plasma membrane [GO:0005886]; side of membrane [GO:0098552] ADP phosphatase activity [GO:0043262]; alkaline phosphatase activity [GO:0004035]; ATP hydrolysis activity [GO:0016887]; calcium ion binding [GO:0005509]; inorganic diphosphate phosphatase activity [GO:0004427]; phosphoamidase activity [GO:0050187]; phosphoethanolamine phosphatase activity [GO:0052732]; pyridoxal phosphatase activity [GO:0033883]; pyrophosphatase activity [GO:0016462] g12160.t1 P83456 50.844 474 1.5e-166 484.0 sp|P83456|PPB_GADMO Alkaline phosphatase OS=Gadus morhua OX=8049 PE=1 SV=1 g12167.t1 Q5EA33 54.194 155 2.3e-49 167.0 sp|Q5EA33|ANR49_BOVIN Ankyrin repeat domain-containing protein 49 OS=Bos taurus OX=9913 GN=ANKRD49 PE=2 SV=1 g12170.t1 Q8CHN8 37.746 710 7.36e-133 412.0 sp|Q8CHN8|MASP1_RAT Mannan-binding lectin serine protease 1 OS=Rattus norvegicus OX=10116 GN=Masp1 PE=1 SV=2 MASP1_RAT reviewed Mannan-binding lectin serine protease 1 (EC 3.4.21.-) (Complement-activating component of Ra-reactive factor) (Mannose-binding lectin-associated serine protease 1) (MASP-1) (Mannose-binding protein-associated serine protease) (Ra-reactive factor serine protease p100) (RaRF) (Serine protease 5) [Cleaved into: Mannan-binding lectin serine protease 1 heavy chain; Mannan-binding lectin serine protease 1 light chain] Rattus norvegicus (Rat) GO:0001867; GO:0001905; GO:0004252; GO:0005509; GO:0005615; GO:0005654; GO:0005829; GO:0006956; GO:0006957; GO:0008228; GO:0008233; GO:0031638; GO:0031640; GO:0042802; GO:0042803; GO:0045916; GO:0048306; GO:0051604; GO:0106139 activation of membrane attack complex [GO:0001905]; complement activation [GO:0006956]; complement activation, alternative pathway [GO:0006957]; complement activation, lectin pathway [GO:0001867]; killing of cells of another organism [GO:0031640]; negative regulation of complement activation [GO:0045916]; opsonization [GO:0008228]; protein maturation [GO:0051604]; zymogen activation [GO:0031638] cytosol [GO:0005829]; extracellular space [GO:0005615]; nucleoplasm [GO:0005654]; symbiont cell surface [GO:0106139] calcium ion binding [GO:0005509]; calcium-dependent protein binding [GO:0048306]; identical protein binding [GO:0042802]; peptidase activity [GO:0008233]; protein homodimerization activity [GO:0042803]; serine-type endopeptidase activity [GO:0004252] g12171.t1 P98064 36.662 731 5.11e-152 461.0 sp|P98064|MASP1_MOUSE Mannan-binding lectin serine protease 1 OS=Mus musculus OX=10090 GN=Masp1 PE=1 SV=2 g12172.t1 Q8CHN8 35.646 735 5.09e-149 453.0 sp|Q8CHN8|MASP1_RAT Mannan-binding lectin serine protease 1 OS=Rattus norvegicus OX=10116 GN=Masp1 PE=1 SV=2 MASP1_RAT reviewed Mannan-binding lectin serine protease 1 (EC 3.4.21.-) (Complement-activating component of Ra-reactive factor) (Mannose-binding lectin-associated serine protease 1) (MASP-1) (Mannose-binding protein-associated serine protease) (Ra-reactive factor serine protease p100) (RaRF) (Serine protease 5) [Cleaved into: Mannan-binding lectin serine protease 1 heavy chain; Mannan-binding lectin serine protease 1 light chain] Rattus norvegicus (Rat) GO:0001867; GO:0001905; GO:0004252; GO:0005509; GO:0005615; GO:0005654; GO:0005829; GO:0006956; GO:0006957; GO:0008228; GO:0008233; GO:0031638; GO:0031640; GO:0042802; GO:0042803; GO:0045916; GO:0048306; GO:0051604; GO:0106139 activation of membrane attack complex [GO:0001905]; complement activation [GO:0006956]; complement activation, alternative pathway [GO:0006957]; complement activation, lectin pathway [GO:0001867]; killing of cells of another organism [GO:0031640]; negative regulation of complement activation [GO:0045916]; opsonization [GO:0008228]; protein maturation [GO:0051604]; zymogen activation [GO:0031638] cytosol [GO:0005829]; extracellular space [GO:0005615]; nucleoplasm [GO:0005654]; symbiont cell surface [GO:0106139] calcium ion binding [GO:0005509]; calcium-dependent protein binding [GO:0048306]; identical protein binding [GO:0042802]; peptidase activity [GO:0008233]; protein homodimerization activity [GO:0042803]; serine-type endopeptidase activity [GO:0004252] g12175.t1 P98064 37.047 718 4.3099999999999996e-152 461.0 sp|P98064|MASP1_MOUSE Mannan-binding lectin serine protease 1 OS=Mus musculus OX=10090 GN=Masp1 PE=1 SV=2 g12177.t1 Q32KI9 52.555 274 6.599999999999999e-94 293.0 sp|Q32KI9|ARSI_MOUSE Arylsulfatase I OS=Mus musculus OX=10090 GN=Arsi PE=2 SV=1 g12181.t1 J9SQF3 35.06 1255 0.0 633.0 sp|J9SQF3|TRPM3_MOUSE Transient receptor potential cation channel subfamily M member 3 OS=Mus musculus OX=10090 GN=Trpm3 PE=1 SV=1 TRPM3_MOUSE reviewed Transient receptor potential cation channel subfamily M member 3 Mus musculus (Mouse) GO:0005262; GO:0005385; GO:0005516; GO:0005546; GO:0005886; GO:0006812; GO:0006814; GO:0031683; GO:0051289; GO:0070588; GO:0071577; GO:0097603 calcium ion transmembrane transport [GO:0070588]; monoatomic cation transport [GO:0006812]; protein homotetramerization [GO:0051289]; sodium ion transport [GO:0006814]; zinc ion transmembrane transport [GO:0071577] plasma membrane [GO:0005886] calcium channel activity [GO:0005262]; calmodulin binding [GO:0005516]; G-protein beta/gamma-subunit complex binding [GO:0031683]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; temperature-gated ion channel activity [GO:0097603]; zinc ion transmembrane transporter activity [GO:0005385] g12182.t1 A8DYE2 38.78 508 1.72e-98 331.0 sp|A8DYE2|TRPCG_DROME Transient receptor potential cation channel trpm OS=Drosophila melanogaster OX=7227 GN=Trpm PE=1 SV=1 TRPCG_DROME reviewed Transient receptor potential cation channel trpm (Transient receptor potential cation channel, subfamily M ortholog) Drosophila melanogaster (Fruit fly) GO:0005261; GO:0005385; GO:0005886; GO:0006882; GO:0010960; GO:0022890; GO:0030001; GO:0034703; GO:0051262; GO:0097682; GO:0098655 intracellular zinc ion homeostasis [GO:0006882]; magnesium ion homeostasis [GO:0010960]; metal ion transport [GO:0030001]; monoatomic cation transmembrane transport [GO:0098655]; protein tetramerization [GO:0051262] cation channel complex [GO:0034703]; plasma membrane [GO:0005886] inorganic cation transmembrane transporter activity [GO:0022890]; intracellularly phosphatidylinositol-3,5-bisphosphate-gated monatomic cation channel activity [GO:0097682]; monoatomic cation channel activity [GO:0005261]; zinc ion transmembrane transporter activity [GO:0005385] g12183.t1 Q2WEA5 33.657 618 4.8500000000000004e-88 303.0 sp|Q2WEA5|TRPM1_RAT Transient receptor potential cation channel subfamily M member 1 OS=Rattus norvegicus OX=10116 GN=Trpm1 PE=2 SV=2 TRPM1_RAT reviewed Transient receptor potential cation channel subfamily M member 1 (Melastatin-1) Rattus norvegicus (Rat) GO:0005216; GO:0005261; GO:0005262; GO:0005783; GO:0005789; GO:0005886; GO:0006816; GO:0007165; GO:0007216; GO:0007601; GO:0008104; GO:0008324; GO:0030424; GO:0030425; GO:0035841; GO:0046548; GO:0051262; GO:0051286; GO:0071482; GO:0098655; GO:0098703 calcium ion import across plasma membrane [GO:0098703]; calcium ion transport [GO:0006816]; cellular response to light stimulus [GO:0071482]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; intracellular protein localization [GO:0008104]; monoatomic cation transmembrane transport [GO:0098655]; protein tetramerization [GO:0051262]; retinal rod cell development [GO:0046548]; signal transduction [GO:0007165]; visual perception [GO:0007601] axon [GO:0030424]; cell tip [GO:0051286]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; new growing cell tip [GO:0035841]; plasma membrane [GO:0005886] calcium channel activity [GO:0005262]; monoatomic cation channel activity [GO:0005261]; monoatomic cation transmembrane transporter activity [GO:0008324]; monoatomic ion channel activity [GO:0005216] g12190.t1 P56399 55.164 852 0.0 902.0 sp|P56399|UBP5_MOUSE Ubiquitin carboxyl-terminal hydrolase 5 OS=Mus musculus OX=10090 GN=Usp5 PE=1 SV=1 g12192.t1 Q95JN5 44.226 1169 0.0 920.0 sp|Q95JN5|AT133_MACFA Polyamine-transporting ATPase 13A3 OS=Macaca fascicularis OX=9541 GN=ATP13A3 PE=2 SV=3 AT133_MACFA reviewed Polyamine-transporting ATPase 13A3 (ATPase family homolog up-regulated in senescence cells 1) (Putrescine transporting ATPase) (EC 7.6.2.16) Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey) GO:0005524; GO:0006874; GO:0015594; GO:0015662; GO:0016887; GO:0019829; GO:0031901; GO:0031902; GO:0046872; GO:0055038; GO:0140358 intracellular calcium ion homeostasis [GO:0006874] early endosome membrane [GO:0031901]; late endosome membrane [GO:0031902]; recycling endosome membrane [GO:0055038] ABC-type putrescine transporter activity [GO:0015594]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled monoatomic cation transmembrane transporter activity [GO:0019829]; metal ion binding [GO:0046872]; P-type ion transporter activity [GO:0015662]; P-type transmembrane transporter activity [GO:0140358] g12193.t1 Q8C3Q9 30.932 472 4.15e-55 191.0 sp|Q8C3Q9|CASP9_MOUSE Caspase-9 OS=Mus musculus OX=10090 GN=Casp9 PE=1 SV=1 CASP9_MOUSE reviewed Caspase-9 (CASP-9) (EC 3.4.22.62) (Apoptotic protease Mch-6) (Apoptotic protease-activating factor 3) (APAF-3) (ICE-like apoptotic protease 6) (ICE-LAP6) [Cleaved into: Caspase-9 subunit p35; Caspase-9 subunit p10] Mus musculus (Mouse) GO:0001666; GO:0001822; GO:0002931; GO:0004197; GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0006915; GO:0006974; GO:0008233; GO:0008234; GO:0008303; GO:0008630; GO:0009411; GO:0016485; GO:0019901; GO:0032025; GO:0032355; GO:0032496; GO:0032991; GO:0034349; GO:0034644; GO:0042770; GO:0042802; GO:0043065; GO:0043293; GO:0043525; GO:0045471; GO:0051604; GO:0070059; GO:0071549; GO:0071680; GO:0071887; GO:0072347; GO:0097193; GO:1900119 apoptotic process [GO:0006915]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to UV [GO:0034644]; DNA damage response [GO:0006974]; glial cell apoptotic process [GO:0034349]; intrinsic apoptotic signaling pathway [GO:0097193]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; kidney development [GO:0001822]; leukocyte apoptotic process [GO:0071887]; positive regulation of apoptotic process [GO:0043065]; positive regulation of execution phase of apoptosis [GO:1900119]; positive regulation of neuron apoptotic process [GO:0043525]; protein maturation [GO:0051604]; protein processing [GO:0016485]; response to anesthetic [GO:0072347]; response to cobalt ion [GO:0032025]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to hypoxia [GO:0001666]; response to indole-3-methanol [GO:0071680]; response to ischemia [GO:0002931]; response to lipopolysaccharide [GO:0032496]; response to UV [GO:0009411]; signal transduction in response to DNA damage [GO:0042770] apoptosome [GO:0043293]; caspase complex [GO:0008303]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; protein-containing complex [GO:0032991] cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]; identical protein binding [GO:0042802]; peptidase activity [GO:0008233]; protein kinase binding [GO:0019901] g12195.t1 Q8C3Q9 32.577 485 1.6499999999999997e-67 225.0 sp|Q8C3Q9|CASP9_MOUSE Caspase-9 OS=Mus musculus OX=10090 GN=Casp9 PE=1 SV=1 CASP9_MOUSE reviewed Caspase-9 (CASP-9) (EC 3.4.22.62) (Apoptotic protease Mch-6) (Apoptotic protease-activating factor 3) (APAF-3) (ICE-like apoptotic protease 6) (ICE-LAP6) [Cleaved into: Caspase-9 subunit p35; Caspase-9 subunit p10] Mus musculus (Mouse) GO:0001666; GO:0001822; GO:0002931; GO:0004197; GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0006915; GO:0006974; GO:0008233; GO:0008234; GO:0008303; GO:0008630; GO:0009411; GO:0016485; GO:0019901; GO:0032025; GO:0032355; GO:0032496; GO:0032991; GO:0034349; GO:0034644; GO:0042770; GO:0042802; GO:0043065; GO:0043293; GO:0043525; GO:0045471; GO:0051604; GO:0070059; GO:0071549; GO:0071680; GO:0071887; GO:0072347; GO:0097193; GO:1900119 apoptotic process [GO:0006915]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to UV [GO:0034644]; DNA damage response [GO:0006974]; glial cell apoptotic process [GO:0034349]; intrinsic apoptotic signaling pathway [GO:0097193]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; kidney development [GO:0001822]; leukocyte apoptotic process [GO:0071887]; positive regulation of apoptotic process [GO:0043065]; positive regulation of execution phase of apoptosis [GO:1900119]; positive regulation of neuron apoptotic process [GO:0043525]; protein maturation [GO:0051604]; protein processing [GO:0016485]; response to anesthetic [GO:0072347]; response to cobalt ion [GO:0032025]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to hypoxia [GO:0001666]; response to indole-3-methanol [GO:0071680]; response to ischemia [GO:0002931]; response to lipopolysaccharide [GO:0032496]; response to UV [GO:0009411]; signal transduction in response to DNA damage [GO:0042770] apoptosome [GO:0043293]; caspase complex [GO:0008303]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; protein-containing complex [GO:0032991] cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]; identical protein binding [GO:0042802]; peptidase activity [GO:0008233]; protein kinase binding [GO:0019901] g12196.t1 P17343 86.804 341 0.0 598.0 sp|P17343|GBB1_CAEEL Guanine nucleotide-binding protein subunit beta-1 OS=Caenorhabditis elegans OX=6239 GN=gpb-1 PE=1 SV=2 g12197.t1 P24802 50.423 710 0.0 717.0 sp|P24802|PLOD1_CHICK Procollagen-lysine,2-oxoglutarate 5-dioxygenase 1 OS=Gallus gallus OX=9031 GN=PLOD1 PE=1 SV=1 g12198.t1 P0C6S8 29.545 396 1.7e-21 102.0 sp|P0C6S8|LIGO3_HUMAN Leucine-rich repeat and immunoglobulin-like domain-containing nogo receptor-interacting protein 3 OS=Homo sapiens OX=9606 GN=LINGO3 PE=1 SV=1 g12205.t1 B2RQR8 48.454 679 0.0 723.0 sp|B2RQR8|ECE2_MOUSE Endothelin-converting enzyme 2 OS=Mus musculus OX=10090 GN=Ece2 PE=1 SV=1 ECE2_MOUSE reviewed Endothelin-converting enzyme 2 (ECE-2) (EC 3.4.24.71) Mus musculus (Mouse) GO:0000139; GO:0004222; GO:0016486; GO:0030658; GO:0046872 peptide hormone processing [GO:0016486] Golgi membrane [GO:0000139]; transport vesicle membrane [GO:0030658] metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222] g12209.t1 D3YXG0 41.04 173 6.260000000000001e-26 119.0 sp|D3YXG0|HMCN1_MOUSE Hemicentin-1 OS=Mus musculus OX=10090 GN=Hmcn1 PE=1 SV=1 HMCN1_MOUSE reviewed Hemicentin-1 (Fibulin-6) (FIBL-6) Mus musculus (Mouse) GO:0005509; GO:0005576; GO:0005604; GO:0005737; GO:0005886; GO:0005912; GO:0005927; GO:0005938; GO:0007156; GO:0007157; GO:0009617; GO:0030036; GO:0030054; GO:0031012; GO:0032154; GO:0051301; GO:0071711; GO:0098631 actin cytoskeleton organization [GO:0030036]; basement membrane organization [GO:0071711]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617] adherens junction [GO:0005912]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; muscle tendon junction [GO:0005927]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; cell adhesion mediator activity [GO:0098631] g12209.t1 D3YXG0 39.306 173 4.8299999999999995e-23 110.0 sp|D3YXG0|HMCN1_MOUSE Hemicentin-1 OS=Mus musculus OX=10090 GN=Hmcn1 PE=1 SV=1 HMCN1_MOUSE reviewed Hemicentin-1 (Fibulin-6) (FIBL-6) Mus musculus (Mouse) GO:0005509; GO:0005576; GO:0005604; GO:0005737; GO:0005886; GO:0005912; GO:0005927; GO:0005938; GO:0007156; GO:0007157; GO:0009617; GO:0030036; GO:0030054; GO:0031012; GO:0032154; GO:0051301; GO:0071711; GO:0098631 actin cytoskeleton organization [GO:0030036]; basement membrane organization [GO:0071711]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617] adherens junction [GO:0005912]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; muscle tendon junction [GO:0005927]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; cell adhesion mediator activity [GO:0098631] g12210.t1 D3YXG0 37.553 237 4.08e-30 131.0 sp|D3YXG0|HMCN1_MOUSE Hemicentin-1 OS=Mus musculus OX=10090 GN=Hmcn1 PE=1 SV=1 HMCN1_MOUSE reviewed Hemicentin-1 (Fibulin-6) (FIBL-6) Mus musculus (Mouse) GO:0005509; GO:0005576; GO:0005604; GO:0005737; GO:0005886; GO:0005912; GO:0005927; GO:0005938; GO:0007156; GO:0007157; GO:0009617; GO:0030036; GO:0030054; GO:0031012; GO:0032154; GO:0051301; GO:0071711; GO:0098631 actin cytoskeleton organization [GO:0030036]; basement membrane organization [GO:0071711]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617] adherens junction [GO:0005912]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; muscle tendon junction [GO:0005927]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; cell adhesion mediator activity [GO:0098631] g12210.t1 D3YXG0 40.217 184 2.21e-25 116.0 sp|D3YXG0|HMCN1_MOUSE Hemicentin-1 OS=Mus musculus OX=10090 GN=Hmcn1 PE=1 SV=1 HMCN1_MOUSE reviewed Hemicentin-1 (Fibulin-6) (FIBL-6) Mus musculus (Mouse) GO:0005509; GO:0005576; GO:0005604; GO:0005737; GO:0005886; GO:0005912; GO:0005927; GO:0005938; GO:0007156; GO:0007157; GO:0009617; GO:0030036; GO:0030054; GO:0031012; GO:0032154; GO:0051301; GO:0071711; GO:0098631 actin cytoskeleton organization [GO:0030036]; basement membrane organization [GO:0071711]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617] adherens junction [GO:0005912]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; muscle tendon junction [GO:0005927]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; cell adhesion mediator activity [GO:0098631] g12210.t1 D3YXG0 37.895 190 5.63e-24 112.0 sp|D3YXG0|HMCN1_MOUSE Hemicentin-1 OS=Mus musculus OX=10090 GN=Hmcn1 PE=1 SV=1 HMCN1_MOUSE reviewed Hemicentin-1 (Fibulin-6) (FIBL-6) Mus musculus (Mouse) GO:0005509; GO:0005576; GO:0005604; GO:0005737; GO:0005886; GO:0005912; GO:0005927; GO:0005938; GO:0007156; GO:0007157; GO:0009617; GO:0030036; GO:0030054; GO:0031012; GO:0032154; GO:0051301; GO:0071711; GO:0098631 actin cytoskeleton organization [GO:0030036]; basement membrane organization [GO:0071711]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617] adherens junction [GO:0005912]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; muscle tendon junction [GO:0005927]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; cell adhesion mediator activity [GO:0098631] g12210.t1 D3YXG0 39.306 173 2.33e-22 107.0 sp|D3YXG0|HMCN1_MOUSE Hemicentin-1 OS=Mus musculus OX=10090 GN=Hmcn1 PE=1 SV=1 HMCN1_MOUSE reviewed Hemicentin-1 (Fibulin-6) (FIBL-6) Mus musculus (Mouse) GO:0005509; GO:0005576; GO:0005604; GO:0005737; GO:0005886; GO:0005912; GO:0005927; GO:0005938; GO:0007156; GO:0007157; GO:0009617; GO:0030036; GO:0030054; GO:0031012; GO:0032154; GO:0051301; GO:0071711; GO:0098631 actin cytoskeleton organization [GO:0030036]; basement membrane organization [GO:0071711]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617] adherens junction [GO:0005912]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; muscle tendon junction [GO:0005927]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; cell adhesion mediator activity [GO:0098631] g12213.t1 G5ECS8 27.862 725 2.28e-43 178.0 sp|G5ECS8|ADT1_CAEEL A disintegrin and metalloproteinase with thrombospondin motifs adt-1 OS=Caenorhabditis elegans OX=6239 GN=adt-1 PE=2 SV=1 g12213.t1 G5ECS8 29.037 675 1.49e-42 175.0 sp|G5ECS8|ADT1_CAEEL A disintegrin and metalloproteinase with thrombospondin motifs adt-1 OS=Caenorhabditis elegans OX=6239 GN=adt-1 PE=2 SV=1 g12213.t1 G5ECS8 27.057 547 2.5800000000000002e-26 122.0 sp|G5ECS8|ADT1_CAEEL A disintegrin and metalloproteinase with thrombospondin motifs adt-1 OS=Caenorhabditis elegans OX=6239 GN=adt-1 PE=2 SV=1 g12213.t1 G5ECS8 28.406 433 1.1799999999999999e-25 120.0 sp|G5ECS8|ADT1_CAEEL A disintegrin and metalloproteinase with thrombospondin motifs adt-1 OS=Caenorhabditis elegans OX=6239 GN=adt-1 PE=2 SV=1 g12213.t1 G5ECS8 27.968 379 2.8000000000000004e-21 105.0 sp|G5ECS8|ADT1_CAEEL A disintegrin and metalloproteinase with thrombospondin motifs adt-1 OS=Caenorhabditis elegans OX=6239 GN=adt-1 PE=2 SV=1 g12217.t1 B9U3F2 50.402 373 2.49e-97 341.0 sp|B9U3F2|DISP3_CHICK Protein dispatched homolog 3 OS=Gallus gallus OX=9031 GN=DISP3 PE=1 SV=1 DISP3_CHICK reviewed Protein dispatched homolog 3 (Patched domain-containing protein 2) (Thyroid hormone receptor up-regulated protein 1) (TRUP1) Gallus gallus (Chicken) GO:0005737; GO:0005783; GO:0005789; GO:0008203; GO:0009725; GO:0016020; GO:0030154; GO:0030659; GO:0031965; GO:0042632; GO:0045665; GO:0045834; GO:2000179 cell differentiation [GO:0030154]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; negative regulation of neuron differentiation [GO:0045665]; positive regulation of lipid metabolic process [GO:0045834]; positive regulation of neural precursor cell proliferation [GO:2000179]; response to hormone [GO:0009725] cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; nuclear membrane [GO:0031965] g12217.t1 B9U3F2 38.815 523 4.73e-59 226.0 sp|B9U3F2|DISP3_CHICK Protein dispatched homolog 3 OS=Gallus gallus OX=9031 GN=DISP3 PE=1 SV=1 DISP3_CHICK reviewed Protein dispatched homolog 3 (Patched domain-containing protein 2) (Thyroid hormone receptor up-regulated protein 1) (TRUP1) Gallus gallus (Chicken) GO:0005737; GO:0005783; GO:0005789; GO:0008203; GO:0009725; GO:0016020; GO:0030154; GO:0030659; GO:0031965; GO:0042632; GO:0045665; GO:0045834; GO:2000179 cell differentiation [GO:0030154]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; negative regulation of neuron differentiation [GO:0045665]; positive regulation of lipid metabolic process [GO:0045834]; positive regulation of neural precursor cell proliferation [GO:2000179]; response to hormone [GO:0009725] cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; nuclear membrane [GO:0031965] g12218.t1 Q9TUG2 50.689 363 2.04e-107 344.0 sp|Q9TUG2|SKI_HORSE Ski oncogene OS=Equus caballus OX=9796 GN=SKI PE=2 SV=1 g12218.t1 Q9TUG2 51.515 132 5.36e-27 120.0 sp|Q9TUG2|SKI_HORSE Ski oncogene OS=Equus caballus OX=9796 GN=SKI PE=2 SV=1 g12219.t1 Q8C033 40.596 872 0.0 638.0 sp|Q8C033|ARHGA_MOUSE Rho guanine nucleotide exchange factor 10 OS=Mus musculus OX=10090 GN=Arhgef10 PE=1 SV=2 ARHGA_MOUSE reviewed Rho guanine nucleotide exchange factor 10 Mus musculus (Mouse) GO:0005085; GO:0005737; GO:0005813; GO:0019894; GO:0022011; GO:0030036; GO:0035025; GO:0051298; GO:0051496; GO:0090307 actin cytoskeleton organization [GO:0030036]; centrosome duplication [GO:0051298]; mitotic spindle assembly [GO:0090307]; myelination in peripheral nervous system [GO:0022011]; positive regulation of Rho protein signal transduction [GO:0035025]; positive regulation of stress fiber assembly [GO:0051496] centrosome [GO:0005813]; cytoplasm [GO:0005737] guanyl-nucleotide exchange factor activity [GO:0005085]; kinesin binding [GO:0019894] g12219.t2 Q8C033 40.596 872 0.0 639.0 sp|Q8C033|ARHGA_MOUSE Rho guanine nucleotide exchange factor 10 OS=Mus musculus OX=10090 GN=Arhgef10 PE=1 SV=2 ARHGA_MOUSE reviewed Rho guanine nucleotide exchange factor 10 Mus musculus (Mouse) GO:0005085; GO:0005737; GO:0005813; GO:0019894; GO:0022011; GO:0030036; GO:0035025; GO:0051298; GO:0051496; GO:0090307 actin cytoskeleton organization [GO:0030036]; centrosome duplication [GO:0051298]; mitotic spindle assembly [GO:0090307]; myelination in peripheral nervous system [GO:0022011]; positive regulation of Rho protein signal transduction [GO:0035025]; positive regulation of stress fiber assembly [GO:0051496] centrosome [GO:0005813]; cytoplasm [GO:0005737] guanyl-nucleotide exchange factor activity [GO:0005085]; kinesin binding [GO:0019894] g12220.t1 Q5XI32 80.597 268 9.41e-164 457.0 sp|Q5XI32|CAPZB_RAT F-actin-capping protein subunit beta OS=Rattus norvegicus OX=10116 GN=Capzb PE=1 SV=1 CAPZB_RAT reviewed F-actin-capping protein subunit beta (CapZ beta) Rattus norvegicus (Rat) GO:0000902; GO:0003779; GO:0005903; GO:0007010; GO:0008154; GO:0008290; GO:0010591; GO:0014069; GO:0014704; GO:0016020; GO:0022604; GO:0030018; GO:0030027; GO:0030030; GO:0030032; GO:0030863; GO:0031115; GO:0031175; GO:0032279; GO:0043025; GO:0043197; GO:0048487; GO:0051015; GO:0051016; GO:0051490; GO:0055001; GO:0061827; GO:0071203; GO:0090036; GO:0098685; GO:0098686; GO:0120212 actin polymerization or depolymerization [GO:0008154]; barbed-end actin filament capping [GO:0051016]; cell morphogenesis [GO:0000902]; cell projection organization [GO:0030030]; cytoskeleton organization [GO:0007010]; lamellipodium assembly [GO:0030032]; muscle cell development [GO:0055001]; negative regulation of filopodium assembly [GO:0051490]; negative regulation of microtubule polymerization [GO:0031115]; neuron projection development [GO:0031175]; regulation of cell morphogenesis [GO:0022604]; regulation of lamellipodium assembly [GO:0010591]; regulation of protein kinase C signaling [GO:0090036] asymmetric synapse [GO:0032279]; brush border [GO:0005903]; cortical cytoskeleton [GO:0030863]; dendritic spine [GO:0043197]; F-actin capping protein complex [GO:0008290]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; intercalated disc [GO:0014704]; lamellipodium [GO:0030027]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; postsynaptic density [GO:0014069]; Schaffer collateral - CA1 synapse [GO:0098685]; sperm head [GO:0061827]; sperm head-tail coupling apparatus [GO:0120212]; WASH complex [GO:0071203]; Z disc [GO:0030018] actin binding [GO:0003779]; actin filament binding [GO:0051015]; beta-tubulin binding [GO:0048487] g12221.t1 P97386 65.426 188 6.73e-79 266.0 sp|P97386|DNLI3_MOUSE DNA ligase 3 OS=Mus musculus OX=10090 GN=Lig3 PE=1 SV=2 DNLI3_MOUSE reviewed DNA ligase 3 (EC 6.5.1.1) (DNA ligase III) (Polydeoxyribonucleotide synthase [ATP] 3) Mus musculus (Mouse) GO:0000794; GO:0000795; GO:0003677; GO:0003909; GO:0003910; GO:0005524; GO:0005634; GO:0005654; GO:0005739; GO:0006273; GO:0006284; GO:0006302; GO:0006303; GO:0006310; GO:0007005; GO:0008270; GO:0043504; GO:0045910; GO:0051301; GO:0070421; GO:0071897; GO:0090298; GO:0097681 base-excision repair [GO:0006284]; cell division [GO:0051301]; DNA biosynthetic process [GO:0071897]; DNA recombination [GO:0006310]; double-strand break repair [GO:0006302]; double-strand break repair via alternative nonhomologous end joining [GO:0097681]; double-strand break repair via nonhomologous end joining [GO:0006303]; lagging strand elongation [GO:0006273]; mitochondrial DNA repair [GO:0043504]; mitochondrion organization [GO:0007005]; negative regulation of DNA recombination [GO:0045910]; negative regulation of mitochondrial DNA replication [GO:0090298] condensed nuclear chromosome [GO:0000794]; DNA ligase III-XRCC1 complex [GO:0070421]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; synaptonemal complex [GO:0000795] ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA ligase (ATP) activity [GO:0003910]; DNA ligase activity [GO:0003909]; zinc ion binding [GO:0008270] g12222.t1 P49916 76.842 95 1.49e-48 156.0 sp|P49916|DNLI3_HUMAN DNA ligase 3 OS=Homo sapiens OX=9606 GN=LIG3 PE=1 SV=2 DNLI3_HUMAN reviewed DNA ligase 3 (EC 6.5.1.1) (DNA ligase III) (Polydeoxyribonucleotide synthase [ATP] 3) Homo sapiens (Human) GO:0000724; GO:0003677; GO:0003909; GO:0003910; GO:0005524; GO:0005634; GO:0005654; GO:0005739; GO:0005759; GO:0006273; GO:0006284; GO:0006287; GO:0006302; GO:0007005; GO:0008270; GO:0043504; GO:0051301; GO:0070421; GO:0071897; GO:0090298; GO:0097681 base-excision repair [GO:0006284]; base-excision repair, gap-filling [GO:0006287]; cell division [GO:0051301]; DNA biosynthetic process [GO:0071897]; double-strand break repair [GO:0006302]; double-strand break repair via alternative nonhomologous end joining [GO:0097681]; double-strand break repair via homologous recombination [GO:0000724]; lagging strand elongation [GO:0006273]; mitochondrial DNA repair [GO:0043504]; mitochondrion organization [GO:0007005]; negative regulation of mitochondrial DNA replication [GO:0090298] DNA ligase III-XRCC1 complex [GO:0070421]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA ligase (ATP) activity [GO:0003910]; DNA ligase activity [GO:0003909]; zinc ion binding [GO:0008270] g12222.t1 P49916 67.742 31 1.49e-48 55.8 sp|P49916|DNLI3_HUMAN DNA ligase 3 OS=Homo sapiens OX=9606 GN=LIG3 PE=1 SV=2 DNLI3_HUMAN reviewed DNA ligase 3 (EC 6.5.1.1) (DNA ligase III) (Polydeoxyribonucleotide synthase [ATP] 3) Homo sapiens (Human) GO:0000724; GO:0003677; GO:0003909; GO:0003910; GO:0005524; GO:0005634; GO:0005654; GO:0005739; GO:0005759; GO:0006273; GO:0006284; GO:0006287; GO:0006302; GO:0007005; GO:0008270; GO:0043504; GO:0051301; GO:0070421; GO:0071897; GO:0090298; GO:0097681 base-excision repair [GO:0006284]; base-excision repair, gap-filling [GO:0006287]; cell division [GO:0051301]; DNA biosynthetic process [GO:0071897]; double-strand break repair [GO:0006302]; double-strand break repair via alternative nonhomologous end joining [GO:0097681]; double-strand break repair via homologous recombination [GO:0000724]; lagging strand elongation [GO:0006273]; mitochondrial DNA repair [GO:0043504]; mitochondrion organization [GO:0007005]; negative regulation of mitochondrial DNA replication [GO:0090298] DNA ligase III-XRCC1 complex [GO:0070421]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA ligase (ATP) activity [GO:0003910]; DNA ligase activity [GO:0003909]; zinc ion binding [GO:0008270] g12223.t1 P49916 51.22 328 2.92e-85 255.0 sp|P49916|DNLI3_HUMAN DNA ligase 3 OS=Homo sapiens OX=9606 GN=LIG3 PE=1 SV=2 DNLI3_HUMAN reviewed DNA ligase 3 (EC 6.5.1.1) (DNA ligase III) (Polydeoxyribonucleotide synthase [ATP] 3) Homo sapiens (Human) GO:0000724; GO:0003677; GO:0003909; GO:0003910; GO:0005524; GO:0005634; GO:0005654; GO:0005739; GO:0005759; GO:0006273; GO:0006284; GO:0006287; GO:0006302; GO:0007005; GO:0008270; GO:0043504; GO:0051301; GO:0070421; GO:0071897; GO:0090298; GO:0097681 base-excision repair [GO:0006284]; base-excision repair, gap-filling [GO:0006287]; cell division [GO:0051301]; DNA biosynthetic process [GO:0071897]; double-strand break repair [GO:0006302]; double-strand break repair via alternative nonhomologous end joining [GO:0097681]; double-strand break repair via homologous recombination [GO:0000724]; lagging strand elongation [GO:0006273]; mitochondrial DNA repair [GO:0043504]; mitochondrion organization [GO:0007005]; negative regulation of mitochondrial DNA replication [GO:0090298] DNA ligase III-XRCC1 complex [GO:0070421]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA ligase (ATP) activity [GO:0003910]; DNA ligase activity [GO:0003909]; zinc ion binding [GO:0008270] g12223.t1 P49916 61.905 63 2.92e-85 82.8 sp|P49916|DNLI3_HUMAN DNA ligase 3 OS=Homo sapiens OX=9606 GN=LIG3 PE=1 SV=2 DNLI3_HUMAN reviewed DNA ligase 3 (EC 6.5.1.1) (DNA ligase III) (Polydeoxyribonucleotide synthase [ATP] 3) Homo sapiens (Human) GO:0000724; GO:0003677; GO:0003909; GO:0003910; GO:0005524; GO:0005634; GO:0005654; GO:0005739; GO:0005759; GO:0006273; GO:0006284; GO:0006287; GO:0006302; GO:0007005; GO:0008270; GO:0043504; GO:0051301; GO:0070421; GO:0071897; GO:0090298; GO:0097681 base-excision repair [GO:0006284]; base-excision repair, gap-filling [GO:0006287]; cell division [GO:0051301]; DNA biosynthetic process [GO:0071897]; double-strand break repair [GO:0006302]; double-strand break repair via alternative nonhomologous end joining [GO:0097681]; double-strand break repair via homologous recombination [GO:0000724]; lagging strand elongation [GO:0006273]; mitochondrial DNA repair [GO:0043504]; mitochondrion organization [GO:0007005]; negative regulation of mitochondrial DNA replication [GO:0090298] DNA ligase III-XRCC1 complex [GO:0070421]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA ligase (ATP) activity [GO:0003910]; DNA ligase activity [GO:0003909]; zinc ion binding [GO:0008270] g12226.t1 Q9MYM7 37.109 256 6.140000000000001e-47 169.0 sp|Q9MYM7|B3GT1_PONPY Beta-1,3-galactosyltransferase 1 OS=Pongo pygmaeus OX=9600 GN=B3GALT1 PE=3 SV=1 g12228.t1 Q62901 64.43 298 9.74e-114 359.0 sp|Q62901|RERE_RAT Arginine-glutamic acid dipeptide repeats protein OS=Rattus norvegicus OX=10116 GN=Rere PE=1 SV=2 RERE_RAT reviewed Arginine-glutamic acid dipeptide repeats protein (Atrophin-1-related protein) Rattus norvegicus (Rat) GO:0000118; GO:0003682; GO:0003713; GO:0003714; GO:0005634; GO:0005654; GO:0006338; GO:0008270; GO:0016604; GO:0016605; GO:0021549; GO:0021691; GO:0021930; GO:0021942; GO:0043565; GO:0048755; GO:0048813 branching morphogenesis of a nerve [GO:0048755]; cerebellar granule cell precursor proliferation [GO:0021930]; cerebellar Purkinje cell layer maturation [GO:0021691]; cerebellum development [GO:0021549]; chromatin remodeling [GO:0006338]; dendrite morphogenesis [GO:0048813]; radial glia guided migration of Purkinje cell [GO:0021942] histone deacetylase complex [GO:0000118]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605] chromatin binding [GO:0003682]; sequence-specific DNA binding [GO:0043565]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; zinc ion binding [GO:0008270] g12228.t1 Q62901 83.333 42 9.74e-114 75.9 sp|Q62901|RERE_RAT Arginine-glutamic acid dipeptide repeats protein OS=Rattus norvegicus OX=10116 GN=Rere PE=1 SV=2 RERE_RAT reviewed Arginine-glutamic acid dipeptide repeats protein (Atrophin-1-related protein) Rattus norvegicus (Rat) GO:0000118; GO:0003682; GO:0003713; GO:0003714; GO:0005634; GO:0005654; GO:0006338; GO:0008270; GO:0016604; GO:0016605; GO:0021549; GO:0021691; GO:0021930; GO:0021942; GO:0043565; GO:0048755; GO:0048813 branching morphogenesis of a nerve [GO:0048755]; cerebellar granule cell precursor proliferation [GO:0021930]; cerebellar Purkinje cell layer maturation [GO:0021691]; cerebellum development [GO:0021549]; chromatin remodeling [GO:0006338]; dendrite morphogenesis [GO:0048813]; radial glia guided migration of Purkinje cell [GO:0021942] histone deacetylase complex [GO:0000118]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605] chromatin binding [GO:0003682]; sequence-specific DNA binding [GO:0043565]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; zinc ion binding [GO:0008270] g12230.t1 G3M4F8 28.06 335 3.49e-30 123.0 sp|G3M4F8|OCTB2_CHISP Octopamine receptor beta-2R OS=Chilo suppressalis OX=168631 GN=OA2B2 PE=2 SV=1 OCTB2_CHISP reviewed Octopamine receptor beta-2R (CsOA2B2) Chilo suppressalis (Asiatic rice borer moth) GO:0004989; GO:0005886; GO:0007189; GO:0008226; GO:0016020; GO:0043410; GO:0071418; GO:0071880; GO:0071927; GO:0071928 adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cellular response to amine stimulus [GO:0071418]; octopamine signaling pathway [GO:0071927]; positive regulation of MAPK cascade [GO:0043410]; tyramine signaling pathway [GO:0071928] membrane [GO:0016020]; plasma membrane [GO:0005886] octopamine receptor activity [GO:0004989]; tyramine receptor activity [GO:0008226] g12231.t1 P97292 29.492 295 7.5299999999999995e-28 116.0 sp|P97292|HRH2_MOUSE Histamine H2 receptor OS=Mus musculus OX=10090 GN=Hrh2 PE=2 SV=2 HRH2_MOUSE reviewed Histamine H2 receptor (H2R) (HH2R) (Gastric receptor I) Mus musculus (Mouse) GO:0001696; GO:0001697; GO:0001698; GO:0003382; GO:0004969; GO:0005886; GO:0007187; GO:0007268; GO:0007613; GO:0008542; GO:0030425; GO:0030594; GO:0045202; GO:0045907; GO:0048167; GO:0048565; GO:0048732; GO:1900139; GO:1901363 chemical synaptic transmission [GO:0007268]; digestive tract development [GO:0048565]; epithelial cell morphogenesis [GO:0003382]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; gastric acid secretion [GO:0001696]; gastrin-induced gastric acid secretion [GO:0001698]; gland development [GO:0048732]; histamine-induced gastric acid secretion [GO:0001697]; memory [GO:0007613]; negative regulation of arachidonate secretion [GO:1900139]; positive regulation of vasoconstriction [GO:0045907]; regulation of synaptic plasticity [GO:0048167]; visual learning [GO:0008542] dendrite [GO:0030425]; plasma membrane [GO:0005886]; synapse [GO:0045202] heterocyclic compound binding [GO:1901363]; histamine receptor activity [GO:0004969]; neurotransmitter receptor activity [GO:0030594] g12232.t1 P30680 35.455 330 8.5e-37 139.0 sp|P30680|SSR2_RAT Somatostatin receptor type 2 OS=Rattus norvegicus OX=10116 GN=Sstr2 PE=1 SV=1 g12233.t1 Q8BGC3 29.14 477 6.95e-41 155.0 sp|Q8BGC3|MOT12_MOUSE Monocarboxylate transporter 12 OS=Mus musculus OX=10090 GN=Slc16a12 PE=1 SV=1 g12234.t1 Q95JN5 49.376 1122 0.0 977.0 sp|Q95JN5|AT133_MACFA Polyamine-transporting ATPase 13A3 OS=Macaca fascicularis OX=9541 GN=ATP13A3 PE=2 SV=3 AT133_MACFA reviewed Polyamine-transporting ATPase 13A3 (ATPase family homolog up-regulated in senescence cells 1) (Putrescine transporting ATPase) (EC 7.6.2.16) Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey) GO:0005524; GO:0006874; GO:0015594; GO:0015662; GO:0016887; GO:0019829; GO:0031901; GO:0031902; GO:0046872; GO:0055038; GO:0140358 intracellular calcium ion homeostasis [GO:0006874] early endosome membrane [GO:0031901]; late endosome membrane [GO:0031902]; recycling endosome membrane [GO:0055038] ABC-type putrescine transporter activity [GO:0015594]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled monoatomic cation transmembrane transporter activity [GO:0019829]; metal ion binding [GO:0046872]; P-type ion transporter activity [GO:0015662]; P-type transmembrane transporter activity [GO:0140358] g12238.t1 C0HM36 43.636 220 1.52e-60 199.0 sp|C0HM36|LEC1_ECHLU Echinolectin 1 OS=Echinometra lucunter OX=105361 PE=1 SV=1 g12241.t1 Q90VV1 47.2 125 3.41e-26 110.0 sp|Q90VV1|HES4B_XENLA Transcription factor HES-4-B OS=Xenopus laevis OX=8355 GN=hes4-b PE=1 SV=1 HES4B_XENLA reviewed Transcription factor HES-4-B (Hairy and enhancer of split 4-B) (Protein hairy-2) (Xhairy2) (Protein hairy-2a) (Xhairy2b) Xenopus laevis (African clawed frog) GO:0000122; GO:0000978; GO:0000981; GO:0002088; GO:0005634; GO:0006357; GO:0007219; GO:0007517; GO:0009952; GO:0014029; GO:0021501; GO:0033504; GO:0043066; GO:0043565; GO:0045892; GO:0046982; GO:0048642; GO:0050767 anterior/posterior pattern specification [GO:0009952]; floor plate development [GO:0033504]; lens development in camera-type eye [GO:0002088]; muscle organ development [GO:0007517]; negative regulation of apoptotic process [GO:0043066]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of skeletal muscle tissue development [GO:0048642]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural crest formation [GO:0014029]; Notch signaling pathway [GO:0007219]; prechordal plate formation [GO:0021501]; regulation of neurogenesis [GO:0050767]; regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein heterodimerization activity [GO:0046982]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565] g12242.t1 Q04666 46.4 125 1.99e-30 118.0 sp|Q04666|HES1_RAT Transcription factor HES-1 OS=Rattus norvegicus OX=10116 GN=Hes1 PE=1 SV=1 HES1_RAT reviewed Transcription factor HES-1 (Hairy and enhancer of split 1) (Hairy-like protein) (RHL) Rattus norvegicus (Rat) GO:0000122; GO:0000785; GO:0000981; GO:0001217; GO:0001222; GO:0001227; GO:0001701; GO:0001709; GO:0001889; GO:0002085; GO:0003143; GO:0003151; GO:0003266; GO:0003281; GO:0003310; GO:0003677; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006357; GO:0007155; GO:0007219; GO:0007224; GO:0007389; GO:0008284; GO:0008432; GO:0009615; GO:0009952; GO:0010628; GO:0010629; GO:0010977; GO:0016363; GO:0016477; GO:0021537; GO:0021555; GO:0021557; GO:0021558; GO:0021575; GO:0021861; GO:0021870; GO:0021915; GO:0021953; GO:0021983; GO:0021984; GO:0030182; GO:0030324; GO:0030509; GO:0030513; GO:0030901; GO:0031016; GO:0032991; GO:0035019; GO:0035315; GO:0035881; GO:0035909; GO:0035910; GO:0042098; GO:0042102; GO:0042491; GO:0042531; GO:0042802; GO:0042803; GO:0042826; GO:0043254; GO:0043279; GO:0043388; GO:0043398; GO:0043565; GO:0044877; GO:0045165; GO:0045596; GO:0045598; GO:0045608; GO:0045664; GO:0045665; GO:0045687; GO:0045747; GO:0045892; GO:0045893; GO:0045944; GO:0045977; GO:0046331; GO:0046425; GO:0046427; GO:0048469; GO:0048505; GO:0048538; GO:0048667; GO:0048711; GO:0048715; GO:0048844; GO:0050678; GO:0050767; GO:0050768; GO:0051087; GO:0060122; GO:0060164; GO:0060253; GO:0060412; GO:0060675; GO:0060716; GO:0061009; GO:0061101; GO:0061102; GO:0061106; GO:0061309; GO:0061626; GO:0061629; GO:0065003; GO:0070888; GO:0071347; GO:0071356; GO:0071398; GO:0071820; GO:0072012; GO:0072049; GO:0072050; GO:0072141; GO:0072282; GO:0090102; GO:0090162; GO:0090281; GO:0097066; GO:0097084; GO:0097150; GO:1902870; GO:1904010; GO:1905934; GO:1990090; GO:1990837; GO:2000227; GO:2000737; GO:2000974; GO:2000978; GO:2000981 adenohypophysis development [GO:0021984]; amacrine cell differentiation [GO:0035881]; anterior/posterior pattern specification [GO:0009952]; aorta morphogenesis [GO:0035909]; artery morphogenesis [GO:0048844]; ascending aorta morphogenesis [GO:0035910]; BMP signaling pathway [GO:0030509]; Cajal-Retzius cell differentiation [GO:0021870]; cardiac neural crest cell development involved in outflow tract morphogenesis [GO:0061309]; cell adhesion [GO:0007155]; cell fate commitment [GO:0045165]; cell fate determination [GO:0001709]; cell maturation [GO:0048469]; cell migration [GO:0016477]; cell morphogenesis involved in neuron differentiation [GO:0048667]; cellular response to fatty acid [GO:0071398]; cellular response to interleukin-1 [GO:0071347]; cellular response to nerve growth factor stimulus [GO:1990090]; cellular response to tumor necrosis factor [GO:0071356]; central nervous system neuron differentiation [GO:0021953]; cochlea development [GO:0090102]; comma-shaped body morphogenesis [GO:0072049]; common bile duct development [GO:0061009]; embryonic heart tube morphogenesis [GO:0003143]; establishment of epithelial cell polarity [GO:0090162]; forebrain radial glial cell differentiation [GO:0021861]; glomerulus vasculature development [GO:0072012]; hair cell differentiation [GO:0035315]; hindbrain morphogenesis [GO:0021575]; in utero embryonic development [GO:0001701]; inhibition of neuroepithelial cell differentiation [GO:0002085]; inner ear auditory receptor cell differentiation [GO:0042491]; inner ear receptor cell stereocilium organization [GO:0060122]; labyrinthine layer blood vessel development [GO:0060716]; lateral inhibition [GO:0046331]; liver development [GO:0001889]; lung development [GO:0030324]; metanephric nephron tubule morphogenesis [GO:0072282]; midbrain development [GO:0030901]; midbrain-hindbrain boundary morphogenesis [GO:0021555]; negative regulation of amacrine cell differentiation [GO:1902870]; negative regulation of calcium ion import [GO:0090281]; negative regulation of cell differentiation [GO:0045596]; negative regulation of cell fate determination [GO:1905934]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of forebrain neuron differentiation [GO:2000978]; negative regulation of gene expression [GO:0010629]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of inner ear auditory receptor cell differentiation [GO:0045608]; negative regulation of inner ear receptor cell differentiation [GO:2000981]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of neuron projection development [GO:0010977]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of pancreatic A cell differentiation [GO:2000227]; negative regulation of pro-B cell differentiation [GO:2000974]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of stomach neuroendocrine cell differentiation [GO:0061106]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural tube development [GO:0021915]; neuroendocrine cell differentiation [GO:0061101]; neuron differentiation [GO:0030182]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; oculomotor nerve development [GO:0021557]; outflow tract morphogenesis [GO:0003151]; pancreas development [GO:0031016]; pancreatic A cell differentiation [GO:0003310]; pattern specification process [GO:0007389]; pharyngeal arch artery morphogenesis [GO:0061626]; pituitary gland development [GO:0021983]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA binding [GO:0043388]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of gene expression [GO:0010628]; positive regulation of glial cell differentiation [GO:0045687]; positive regulation of mitotic cell cycle, embryonic [GO:0045977]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of T cell proliferation [GO:0042102]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; protein-containing complex assembly [GO:0065003]; regulation of epithelial cell proliferation [GO:0050678]; regulation of fat cell differentiation [GO:0045598]; regulation of neurogenesis [GO:0050767]; regulation of neuron differentiation [GO:0045664]; regulation of protein-containing complex assembly [GO:0043254]; regulation of receptor signaling pathway via JAK-STAT [GO:0046425]; regulation of secondary heart field cardioblast proliferation [GO:0003266]; regulation of timing of cell differentiation [GO:0048505]; regulation of timing of neuron differentiation [GO:0060164]; regulation of transcription by RNA polymerase II [GO:0006357]; renal interstitial fibroblast development [GO:0072141]; response to alkaloid [GO:0043279]; response to Aroclor 1254 [GO:1904010]; response to thyroid hormone [GO:0097066]; response to virus [GO:0009615]; S-shaped body morphogenesis [GO:0072050]; smoothened signaling pathway [GO:0007224]; somatic stem cell population maintenance [GO:0035019]; stomach neuroendocrine cell differentiation [GO:0061102]; T cell proliferation [GO:0042098]; telencephalon development [GO:0021537]; thymus development [GO:0048538]; trochlear nerve development [GO:0021558]; ureteric bud morphogenesis [GO:0060675]; vascular associated smooth muscle cell development [GO:0097084]; ventricular septum development [GO:0003281]; ventricular septum morphogenesis [GO:0060412] chromatin [GO:0000785]; cytoplasm [GO:0005737]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991] chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity [GO:0001217]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; E-box binding [GO:0070888]; histone deacetylase binding [GO:0042826]; HLH domain binding [GO:0043398]; identical protein binding [GO:0042802]; JUN kinase binding [GO:0008432]; N-box binding [GO:0071820]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; protein-folding chaperone binding [GO:0051087]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription corepressor binding [GO:0001222] g12243.t1 Q5ZIJ9 47.433 974 0.0 879.0 sp|Q5ZIJ9|MIB2_CHICK E3 ubiquitin-protein ligase MIB2 OS=Gallus gallus OX=9031 GN=MIB2 PE=2 SV=1 g12243.t2 Q5ZIJ9 47.433 974 0.0 879.0 sp|Q5ZIJ9|MIB2_CHICK E3 ubiquitin-protein ligase MIB2 OS=Gallus gallus OX=9031 GN=MIB2 PE=2 SV=1 g12244.t1 Q55EX9 33.333 261 8.82e-41 145.0 sp|Q55EX9|Y8948_DICDI Putative methyltransferase DDB_G0268948 OS=Dictyostelium discoideum OX=44689 GN=DDB_G0268948 PE=1 SV=2 g12244.t2 Q55EX9 33.721 258 1.5499999999999998e-40 144.0 sp|Q55EX9|Y8948_DICDI Putative methyltransferase DDB_G0268948 OS=Dictyostelium discoideum OX=44689 GN=DDB_G0268948 PE=1 SV=2 g12245.t1 P31696 33.129 326 2.56e-44 165.0 sp|P31696|AGRIN_CHICK Agrin OS=Gallus gallus OX=9031 GN=AGRN PE=1 SV=3 g12245.t1 P31696 32.889 225 3.94e-22 100.0 sp|P31696|AGRIN_CHICK Agrin OS=Gallus gallus OX=9031 GN=AGRN PE=1 SV=3 g12246.t1 P25304 34.479 1018 1.16e-147 503.0 sp|P25304|AGRIN_RAT Agrin OS=Rattus norvegicus OX=10116 GN=Agrn PE=1 SV=2 AGRIN_RAT reviewed Agrin [Cleaved into: Agrin N-terminal 110 kDa subunit; Agrin C-terminal 110 kDa subunit; Agrin C-terminal 90 kDa fragment (C90); Agrin C-terminal 22 kDa fragment (C22)] Rattus norvegicus (Rat) GO:0002162; GO:0005509; GO:0005576; GO:0005604; GO:0005615; GO:0007009; GO:0007167; GO:0007268; GO:0007416; GO:0007528; GO:0007623; GO:0009986; GO:0015031; GO:0030154; GO:0030548; GO:0031012; GO:0033691; GO:0035022; GO:0035374; GO:0036122; GO:0042030; GO:0042383; GO:0043113; GO:0043395; GO:0044295; GO:0044325; GO:0045202; GO:0045887; GO:0045944; GO:0046847; GO:0048018; GO:0050431; GO:0050807; GO:0055117; GO:0060025; GO:0070507; GO:0071340; GO:0086036; GO:0098978; GO:0099645; GO:0141110; GO:1902667; GO:1903277; GO:1904395; GO:2000673 cell differentiation [GO:0030154]; chemical synaptic transmission [GO:0007268]; circadian rhythm [GO:0007623]; enzyme-linked receptor protein signaling pathway [GO:0007167]; filopodium assembly [GO:0046847]; negative regulation of sodium ion export across plasma membrane [GO:1903277]; neuromuscular junction development [GO:0007528]; neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0099645]; plasma membrane organization [GO:0007009]; positive regulation of motor neuron apoptotic process [GO:2000673]; positive regulation of Rac protein signal transduction [GO:0035022]; positive regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904395]; positive regulation of synaptic assembly at neuromuscular junction [GO:0045887]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein transport [GO:0015031]; receptor clustering [GO:0043113]; regulation of axon guidance [GO:1902667]; regulation of cardiac muscle cell membrane potential [GO:0086036]; regulation of cardiac muscle contraction [GO:0055117]; regulation of microtubule cytoskeleton organization [GO:0070507]; regulation of synapse organization [GO:0050807]; regulation of synaptic activity [GO:0060025]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; synapse assembly [GO:0007416] axonal growth cone [GO:0044295]; basement membrane [GO:0005604]; cell surface [GO:0009986]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; glutamatergic synapse [GO:0098978]; sarcolemma [GO:0042383]; synapse [GO:0045202] acetylcholine receptor regulator activity [GO:0030548]; ATPase inhibitor activity [GO:0042030]; BMP binding [GO:0036122]; calcium ion binding [GO:0005509]; chondroitin sulfate binding [GO:0035374]; dystroglycan binding [GO:0002162]; heparan sulfate proteoglycan binding [GO:0043395]; receptor ligand activity [GO:0048018]; sialic acid binding [GO:0033691]; transforming growth factor beta binding [GO:0050431]; transmembrane transporter binding [GO:0044325]; transporter inhibitor activity [GO:0141110] g12246.t1 P25304 40.049 407 9.36e-82 303.0 sp|P25304|AGRIN_RAT Agrin OS=Rattus norvegicus OX=10116 GN=Agrn PE=1 SV=2 AGRIN_RAT reviewed Agrin [Cleaved into: Agrin N-terminal 110 kDa subunit; Agrin C-terminal 110 kDa subunit; Agrin C-terminal 90 kDa fragment (C90); Agrin C-terminal 22 kDa fragment (C22)] Rattus norvegicus (Rat) GO:0002162; GO:0005509; GO:0005576; GO:0005604; GO:0005615; GO:0007009; GO:0007167; GO:0007268; GO:0007416; GO:0007528; GO:0007623; GO:0009986; GO:0015031; GO:0030154; GO:0030548; GO:0031012; GO:0033691; GO:0035022; GO:0035374; GO:0036122; GO:0042030; GO:0042383; GO:0043113; GO:0043395; GO:0044295; GO:0044325; GO:0045202; GO:0045887; GO:0045944; GO:0046847; GO:0048018; GO:0050431; GO:0050807; GO:0055117; GO:0060025; GO:0070507; GO:0071340; GO:0086036; GO:0098978; GO:0099645; GO:0141110; GO:1902667; GO:1903277; GO:1904395; GO:2000673 cell differentiation [GO:0030154]; chemical synaptic transmission [GO:0007268]; circadian rhythm [GO:0007623]; enzyme-linked receptor protein signaling pathway [GO:0007167]; filopodium assembly [GO:0046847]; negative regulation of sodium ion export across plasma membrane [GO:1903277]; neuromuscular junction development [GO:0007528]; neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0099645]; plasma membrane organization [GO:0007009]; positive regulation of motor neuron apoptotic process [GO:2000673]; positive regulation of Rac protein signal transduction [GO:0035022]; positive regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904395]; positive regulation of synaptic assembly at neuromuscular junction [GO:0045887]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein transport [GO:0015031]; receptor clustering [GO:0043113]; regulation of axon guidance [GO:1902667]; regulation of cardiac muscle cell membrane potential [GO:0086036]; regulation of cardiac muscle contraction [GO:0055117]; regulation of microtubule cytoskeleton organization [GO:0070507]; regulation of synapse organization [GO:0050807]; regulation of synaptic activity [GO:0060025]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; synapse assembly [GO:0007416] axonal growth cone [GO:0044295]; basement membrane [GO:0005604]; cell surface [GO:0009986]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; glutamatergic synapse [GO:0098978]; sarcolemma [GO:0042383]; synapse [GO:0045202] acetylcholine receptor regulator activity [GO:0030548]; ATPase inhibitor activity [GO:0042030]; BMP binding [GO:0036122]; calcium ion binding [GO:0005509]; chondroitin sulfate binding [GO:0035374]; dystroglycan binding [GO:0002162]; heparan sulfate proteoglycan binding [GO:0043395]; receptor ligand activity [GO:0048018]; sialic acid binding [GO:0033691]; transforming growth factor beta binding [GO:0050431]; transmembrane transporter binding [GO:0044325]; transporter inhibitor activity [GO:0141110] g12249.t1 P13732 82.653 98 3.16e-40 134.0 sp|P13732|RL22_TRIGR Large ribosomal subunit protein eL22 OS=Tripneustes gratilla OX=7673 GN=RPL22 PE=2 SV=1 g12250.t1 Q5ZKY4 63.78 254 1.35e-111 324.0 sp|Q5ZKY4|ING4_CHICK Inhibitor of growth protein 4 OS=Gallus gallus OX=9031 GN=ING4 PE=2 SV=1 ING4_CHICK reviewed Inhibitor of growth protein 4 (p29ING4) Gallus gallus (Chicken) GO:0005634; GO:0006355; GO:0008270; GO:0043065; GO:0140889 DNA replication-dependent chromatin disassembly [GO:0140889]; positive regulation of apoptotic process [GO:0043065]; regulation of DNA-templated transcription [GO:0006355] nucleus [GO:0005634] zinc ion binding [GO:0008270] g12251.t1 A1L0Y2 47.231 307 6.54e-79 264.0 sp|A1L0Y2|NEUL4_XENTR Neuralized-like protein 4 OS=Xenopus tropicalis OX=8364 GN=neurl4 PE=2 SV=1 g12251.t1 A1L0Y2 41.237 291 5.3299999999999996e-61 213.0 sp|A1L0Y2|NEUL4_XENTR Neuralized-like protein 4 OS=Xenopus tropicalis OX=8364 GN=neurl4 PE=2 SV=1 g12251.t1 A1L0Y2 38.408 289 4.5800000000000006e-58 204.0 sp|A1L0Y2|NEUL4_XENTR Neuralized-like protein 4 OS=Xenopus tropicalis OX=8364 GN=neurl4 PE=2 SV=1 g12251.t1 A1L0Y2 36.271 295 1.0199999999999999e-48 177.0 sp|A1L0Y2|NEUL4_XENTR Neuralized-like protein 4 OS=Xenopus tropicalis OX=8364 GN=neurl4 PE=2 SV=1 g12251.t1 A1L0Y2 37.423 163 3.79e-30 123.0 sp|A1L0Y2|NEUL4_XENTR Neuralized-like protein 4 OS=Xenopus tropicalis OX=8364 GN=neurl4 PE=2 SV=1 g12251.t1 A1L0Y2 28.808 302 2.76e-24 106.0 sp|A1L0Y2|NEUL4_XENTR Neuralized-like protein 4 OS=Xenopus tropicalis OX=8364 GN=neurl4 PE=2 SV=1 g12252.t1 A1L0Y2 43.57 1182 0.0 892.0 sp|A1L0Y2|NEUL4_XENTR Neuralized-like protein 4 OS=Xenopus tropicalis OX=8364 GN=neurl4 PE=2 SV=1 g12252.t1 A1L0Y2 32.878 952 1.72e-145 476.0 sp|A1L0Y2|NEUL4_XENTR Neuralized-like protein 4 OS=Xenopus tropicalis OX=8364 GN=neurl4 PE=2 SV=1 g12252.t1 A1L0Y2 28.457 622 1.11e-62 238.0 sp|A1L0Y2|NEUL4_XENTR Neuralized-like protein 4 OS=Xenopus tropicalis OX=8364 GN=neurl4 PE=2 SV=1 g12252.t1 A1L0Y2 40.491 163 7.28e-35 149.0 sp|A1L0Y2|NEUL4_XENTR Neuralized-like protein 4 OS=Xenopus tropicalis OX=8364 GN=neurl4 PE=2 SV=1 g12252.t1 A1L0Y2 36.585 164 1.4500000000000002e-21 105.0 sp|A1L0Y2|NEUL4_XENTR Neuralized-like protein 4 OS=Xenopus tropicalis OX=8364 GN=neurl4 PE=2 SV=1 g12256.t1 Q8NCX0 31.288 326 3.45e-25 112.0 sp|Q8NCX0|CC150_HUMAN Coiled-coil domain-containing protein 150 OS=Homo sapiens OX=9606 GN=CCDC150 PE=1 SV=2 g12260.t1 Q8IZH2 46.835 1027 0.0 858.0 sp|Q8IZH2|XRN1_HUMAN 5'-3' exoribonuclease 1 OS=Homo sapiens OX=9606 GN=XRN1 PE=1 SV=1 XRN1_HUMAN reviewed 5'-3' exoribonuclease 1 (EC 3.1.13.-) (Strand-exchange protein 1 homolog) Homo sapiens (Human) GO:0000932; GO:0000956; GO:0002151; GO:0003723; GO:0004534; GO:0005634; GO:0005829; GO:0005886; GO:0016020; GO:0016075; GO:0017148; GO:0030425; GO:0032211; GO:0033574; GO:0043025; GO:0051880; GO:0070034; GO:0071028; GO:0071044; GO:0071409; GO:1905795 cellular response to cycloheximide [GO:0071409]; cellular response to puromycin [GO:1905795]; histone mRNA catabolic process [GO:0071044]; negative regulation of telomere maintenance via telomerase [GO:0032211]; negative regulation of translation [GO:0017148]; nuclear mRNA surveillance [GO:0071028]; nuclear-transcribed mRNA catabolic process [GO:0000956]; response to testosterone [GO:0033574]; rRNA catabolic process [GO:0016075] cytosol [GO:0005829]; dendrite [GO:0030425]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; P-body [GO:0000932]; plasma membrane [GO:0005886] 5'-3' RNA exonuclease activity [GO:0004534]; G-quadruplex DNA binding [GO:0051880]; G-quadruplex RNA binding [GO:0002151]; RNA binding [GO:0003723]; telomerase RNA binding [GO:0070034] g12261.t1 P97789 87.097 93 2.7799999999999997e-52 178.0 sp|P97789|XRN1_MOUSE 5'-3' exoribonuclease 1 OS=Mus musculus OX=10090 GN=Xrn1 PE=1 SV=1 XRN1_MOUSE reviewed 5'-3' exoribonuclease 1 (mXRN1) (EC 3.1.13.-) (Protein Dhm2) (Strand-exchange protein 1 homolog) Mus musculus (Mouse) GO:0000723; GO:0000932; GO:0000956; GO:0002151; GO:0003723; GO:0004534; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0006396; GO:0016075; GO:0017148; GO:0030425; GO:0043025; GO:0051321; GO:0051880; GO:0070034; GO:0071028; GO:0071044 histone mRNA catabolic process [GO:0071044]; meiotic cell cycle [GO:0051321]; negative regulation of translation [GO:0017148]; nuclear mRNA surveillance [GO:0071028]; nuclear-transcribed mRNA catabolic process [GO:0000956]; RNA processing [GO:0006396]; rRNA catabolic process [GO:0016075]; telomere maintenance [GO:0000723] cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; P-body [GO:0000932]; plasma membrane [GO:0005886] 5'-3' RNA exonuclease activity [GO:0004534]; G-quadruplex DNA binding [GO:0051880]; G-quadruplex RNA binding [GO:0002151]; RNA binding [GO:0003723]; telomerase RNA binding [GO:0070034] g12263.t1 Q32KY3 40.385 208 1.24e-32 123.0 sp|Q32KY3|MLF1_BOVIN Myeloid leukemia factor 1 OS=Bos taurus OX=9913 GN=MLF1 PE=2 SV=1 MLF1_BOVIN reviewed Myeloid leukemia factor 1 (Myelodysplasia-myeloid leukemia factor 1) Bos taurus (Bovine) GO:0002318; GO:0003677; GO:0005634; GO:0005737; GO:0005929; GO:0006351; GO:0006355; GO:0036064; GO:1902806 DNA-templated transcription [GO:0006351]; myeloid progenitor cell differentiation [GO:0002318]; regulation of cell cycle G1/S phase transition [GO:1902806]; regulation of DNA-templated transcription [GO:0006355] ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; nucleus [GO:0005634] DNA binding [GO:0003677] g12264.t1 Q91V01 37.783 442 9.44e-105 324.0 sp|Q91V01|MBOA5_MOUSE Lysophospholipid acyltransferase 5 OS=Mus musculus OX=10090 GN=Lpcat3 PE=1 SV=1 MBOA5_MOUSE reviewed Lysophospholipid acyltransferase 5 (LPLAT 5) (EC 2.3.1.-) (1-acylglycerophosphocholine O-acyltransferase) (EC 2.3.1.23) (1-acylglycerophosphoethanolamine O-acyltransferase) (EC 2.3.1.n7) (1-acylglycerophosphoserine O-acyltransferase) (EC 2.3.1.n6) (Lysophosphatidylcholine acyltransferase) (LPCAT) (Lyso-PC acyltransferase) (Lysophosphatidylcholine acyltransferase 3) (Lyso-PC acyltransferase 3) (mLPCAT3) (Lysophosphatidylethanolamine acyltransferase) (LPEAT) (Lyso-PE acyltransferase) (Lysophosphatidylserine acyltransferase) (LPSAT) (Lyso-PS acyltransferase) (Membrane-bound O-acyltransferase domain-containing protein 5) (O-acyltransferase domain-containing protein 5) Mus musculus (Mouse) GO:0005789; GO:0006656; GO:0016020; GO:0030258; GO:0034378; GO:0034379; GO:0036150; GO:0036151; GO:0036152; GO:0036335; GO:0045540; GO:0045797; GO:0047184; GO:0050728; GO:0071617; GO:0090158; GO:0097006; GO:0106262; GO:0106263; GO:1903573; GO:1905885 chylomicron assembly [GO:0034378]; endoplasmic reticulum membrane organization [GO:0090158]; intestinal stem cell homeostasis [GO:0036335]; lipid modification [GO:0030258]; negative regulation of inflammatory response [GO:0050728]; negative regulation of response to endoplasmic reticulum stress [GO:1903573]; phosphatidylcholine acyl-chain remodeling [GO:0036151]; phosphatidylcholine biosynthetic process [GO:0006656]; phosphatidylethanolamine acyl-chain remodeling [GO:0036152]; phosphatidylserine acyl-chain remodeling [GO:0036150]; positive regulation of intestinal cholesterol absorption [GO:0045797]; positive regulation of triglyceride transport [GO:1905885]; regulation of cholesterol biosynthetic process [GO:0045540]; regulation of plasma lipoprotein particle levels [GO:0097006]; very-low-density lipoprotein particle assembly [GO:0034379] endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020] 1-acylglycerophosphocholine O-acyltransferase activity [GO:0047184]; 1-acylglycerophosphoethanolamine O-acyltransferase activity [GO:0106262]; 1-acylglycerophosphoserine O-acyltransferase activity [GO:0106263]; lysophospholipid acyltransferase activity [GO:0071617] g12271.t1 Q9W436 34.398 689 1.22e-137 429.0 sp|Q9W436|NEP_DROME Neprilysin-1 OS=Drosophila melanogaster OX=7227 GN=Nep1 PE=2 SV=2 NEP_DROME reviewed Neprilysin-1 (EC 3.4.24.11) Drosophila melanogaster (Fruit fly) GO:0004222; GO:0005886; GO:0006508; GO:0008237; GO:0016020; GO:0046872 proteolysis [GO:0006508] membrane [GO:0016020]; plasma membrane [GO:0005886] metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237] g12273.t1 Q8T062 38.623 523 4.1399999999999995e-128 402.0 sp|Q8T062|NEP4_DROME Neprilysin-4 OS=Drosophila melanogaster OX=7227 GN=Nep4 PE=1 SV=1 NEP4_DROME reviewed Neprilysin-4 (EC 3.4.24.11) Drosophila melanogaster (Fruit fly) GO:0004175; GO:0004222; GO:0005615; GO:0005886; GO:0006508; GO:0008237; GO:0016020; GO:0016485; GO:0016529; GO:0046872 protein processing [GO:0016485]; proteolysis [GO:0006508] extracellular space [GO:0005615]; membrane [GO:0016020]; plasma membrane [GO:0005886]; sarcoplasmic reticulum [GO:0016529] endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237] g12274.t1 P54131 35.586 503 4.33e-84 273.0 sp|P54131|ACHA7_BOVIN Neuronal acetylcholine receptor subunit alpha-7 OS=Bos taurus OX=9913 GN=CHRNA7 PE=1 SV=1 ACHA7_BOVIN reviewed Neuronal acetylcholine receptor subunit alpha-7 (nAChR7) (Nicotinic acetylcholine receptor subunit alpha-7) Bos taurus (Bovine) GO:0001540; GO:0001666; GO:0005886; GO:0005892; GO:0006816; GO:0006874; GO:0007165; GO:0007268; GO:0007271; GO:0008284; GO:0015464; GO:0015643; GO:0017081; GO:0022848; GO:0030425; GO:0032720; GO:0034220; GO:0035094; GO:0042166; GO:0042391; GO:0042803; GO:0043005; GO:0043410; GO:0045202; GO:0045211; GO:0045766; GO:0046872; GO:0050890; GO:1900016 calcium ion transport [GO:0006816]; chemical synaptic transmission [GO:0007268]; cognition [GO:0050890]; intracellular calcium ion homeostasis [GO:0006874]; monoatomic ion transmembrane transport [GO:0034220]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of tumor necrosis factor production [GO:0032720]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of MAPK cascade [GO:0043410]; regulation of membrane potential [GO:0042391]; response to hypoxia [GO:0001666]; response to nicotine [GO:0035094]; signal transduction [GO:0007165]; synaptic transmission, cholinergic [GO:0007271] acetylcholine-gated channel complex [GO:0005892]; dendrite [GO:0030425]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202] acetylcholine binding [GO:0042166]; acetylcholine receptor activity [GO:0015464]; acetylcholine-gated monoatomic cation-selective channel activity [GO:0022848]; amyloid-beta binding [GO:0001540]; chloride channel regulator activity [GO:0017081]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; toxic substance binding [GO:0015643] g12276.t1 Q5R762 50.342 292 3.95e-84 257.0 sp|Q5R762|CSN7A_PONAB COP9 signalosome complex subunit 7a OS=Pongo abelii OX=9601 GN=COPS7A PE=2 SV=1 g12277.t1 Q9NRZ9 47.759 848 0.0 736.0 sp|Q9NRZ9|HELLS_HUMAN Lymphoid-specific helicase OS=Homo sapiens OX=9606 GN=HELLS PE=1 SV=1 HELLS_HUMAN reviewed Lymphoid-specific helicase (LSH) (EC 3.6.4.-) (Proliferation-associated SNF2-like protein) (SWI/SNF2-related matrix-associated actin-dependent regulator of chromatin subfamily A member 6) (SMARCA6) Homo sapiens (Human) GO:0000724; GO:0000775; GO:0001655; GO:0001822; GO:0003682; GO:0004386; GO:0005524; GO:0005634; GO:0005721; GO:0006302; GO:0006346; GO:0006915; GO:0016787; GO:0031508; GO:0035861; GO:0044027; GO:0046651; GO:0051301; GO:0140463; GO:0140658; GO:0141119; GO:1990830; GO:2001243 apoptotic process [GO:0006915]; cell division [GO:0051301]; cellular response to leukemia inhibitory factor [GO:1990830]; chromosomal DNA methylation maintenance following DNA replication [GO:0141119]; DNA methylation-dependent constitutive heterochromatin formation [GO:0006346]; double-strand break repair [GO:0006302]; double-strand break repair via homologous recombination [GO:0000724]; kidney development [GO:0001822]; lymphocyte proliferation [GO:0046651]; negative regulation of gene expression via chromosomal CpG island methylation [GO:0044027]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; pericentric heterochromatin formation [GO:0031508]; urogenital system development [GO:0001655] chromosome, centromeric region [GO:0000775]; nucleus [GO:0005634]; pericentric heterochromatin [GO:0005721]; site of double-strand break [GO:0035861] ATP binding [GO:0005524]; ATP-dependent chromatin remodeler activity [GO:0140658]; chromatin binding [GO:0003682]; chromatin-protein adaptor activity [GO:0140463]; helicase activity [GO:0004386]; hydrolase activity [GO:0016787] g12278.t1 Q5SWT3 55.254 295 1.4200000000000002e-109 322.0 sp|Q5SWT3|S2535_MOUSE Solute carrier family 25 member 35 OS=Mus musculus OX=10090 GN=Slc25a35 PE=1 SV=2 g12279.t1 P41146 32.292 288 7.21e-22 98.6 sp|P41146|OPRX_HUMAN Nociceptin receptor OS=Homo sapiens OX=9606 GN=OPRL1 PE=1 SV=1 OPRX_HUMAN reviewed Nociceptin receptor (Kappa-type 3 opioid receptor) (KOR-3) (Orphanin FQ receptor) Homo sapiens (Human) GO:0001626; GO:0004930; GO:0005886; GO:0007193; GO:0007200; GO:0007218; GO:0007270; GO:0007600; GO:0019233; GO:0019722; GO:0031410; GO:0042923; GO:0043005; GO:0097060 adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; calcium-mediated signaling [GO:0019722]; neuron-neuron synaptic transmission [GO:0007270]; neuropeptide signaling pathway [GO:0007218]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; sensory perception [GO:0007600]; sensory perception of pain [GO:0019233] cytoplasmic vesicle [GO:0031410]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; synaptic membrane [GO:0097060] G protein-coupled receptor activity [GO:0004930]; neuropeptide binding [GO:0042923]; nociceptin receptor activity [GO:0001626] g12286.t1 Q6GQ53 48.322 149 4.9e-41 142.0 sp|Q6GQ53|PUSL1_XENLA tRNA pseudouridine synthase-like 1 OS=Xenopus laevis OX=8355 GN=pusl1 PE=2 SV=1 g12288.t1 Q5ZLD3 30.392 612 1.0999999999999999e-89 295.0 sp|Q5ZLD3|KLH13_CHICK Kelch-like protein 13 OS=Gallus gallus OX=9031 GN=KLHL13 PE=2 SV=1 g12289.t1 Q05793 37.53 413 4.6499999999999994e-61 232.0 sp|Q05793|PGBM_MOUSE Basement membrane-specific heparan sulfate proteoglycan core protein OS=Mus musculus OX=10090 GN=Hspg2 PE=1 SV=1 PGBM_MOUSE reviewed Basement membrane-specific heparan sulfate proteoglycan core protein (HSPG) (Perlecan) [Cleaved into: Endorepellin; LG3 peptide] Mus musculus (Mouse) GO:0001525; GO:0001938; GO:0001958; GO:0002020; GO:0002062; GO:0002162; GO:0005509; GO:0005576; GO:0005604; GO:0005796; GO:0006898; GO:0007162; GO:0007224; GO:0007420; GO:0008104; GO:0008285; GO:0009887; GO:0009888; GO:0030198; GO:0031012; GO:0032223; GO:0035418; GO:0043524; GO:0048704; GO:0048738; GO:0060090; GO:0060351; GO:0070052; GO:1905907 angiogenesis [GO:0001525]; animal organ morphogenesis [GO:0009887]; brain development [GO:0007420]; cardiac muscle tissue development [GO:0048738]; cartilage development involved in endochondral bone morphogenesis [GO:0060351]; chondrocyte differentiation [GO:0002062]; embryonic skeletal system morphogenesis [GO:0048704]; endochondral ossification [GO:0001958]; extracellular matrix organization [GO:0030198]; intracellular protein localization [GO:0008104]; negative regulation of amyloid fibril formation [GO:1905907]; negative regulation of cell adhesion [GO:0007162]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of synaptic transmission, cholinergic [GO:0032223]; positive regulation of endothelial cell proliferation [GO:0001938]; protein localization to synapse [GO:0035418]; receptor-mediated endocytosis [GO:0006898]; smoothened signaling pathway [GO:0007224]; tissue development [GO:0009888] basement membrane [GO:0005604]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; Golgi lumen [GO:0005796] calcium ion binding [GO:0005509]; collagen V binding [GO:0070052]; dystroglycan binding [GO:0002162]; molecular adaptor activity [GO:0060090]; protease binding [GO:0002020] g12290.t1 Q05793 43.019 616 1.08e-156 502.0 sp|Q05793|PGBM_MOUSE Basement membrane-specific heparan sulfate proteoglycan core protein OS=Mus musculus OX=10090 GN=Hspg2 PE=1 SV=1 PGBM_MOUSE reviewed Basement membrane-specific heparan sulfate proteoglycan core protein (HSPG) (Perlecan) [Cleaved into: Endorepellin; LG3 peptide] Mus musculus (Mouse) GO:0001525; GO:0001938; GO:0001958; GO:0002020; GO:0002062; GO:0002162; GO:0005509; GO:0005576; GO:0005604; GO:0005796; GO:0006898; GO:0007162; GO:0007224; GO:0007420; GO:0008104; GO:0008285; GO:0009887; GO:0009888; GO:0030198; GO:0031012; GO:0032223; GO:0035418; GO:0043524; GO:0048704; GO:0048738; GO:0060090; GO:0060351; GO:0070052; GO:1905907 angiogenesis [GO:0001525]; animal organ morphogenesis [GO:0009887]; brain development [GO:0007420]; cardiac muscle tissue development [GO:0048738]; cartilage development involved in endochondral bone morphogenesis [GO:0060351]; chondrocyte differentiation [GO:0002062]; embryonic skeletal system morphogenesis [GO:0048704]; endochondral ossification [GO:0001958]; extracellular matrix organization [GO:0030198]; intracellular protein localization [GO:0008104]; negative regulation of amyloid fibril formation [GO:1905907]; negative regulation of cell adhesion [GO:0007162]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of synaptic transmission, cholinergic [GO:0032223]; positive regulation of endothelial cell proliferation [GO:0001938]; protein localization to synapse [GO:0035418]; receptor-mediated endocytosis [GO:0006898]; smoothened signaling pathway [GO:0007224]; tissue development [GO:0009888] basement membrane [GO:0005604]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; Golgi lumen [GO:0005796] calcium ion binding [GO:0005509]; collagen V binding [GO:0070052]; dystroglycan binding [GO:0002162]; molecular adaptor activity [GO:0060090]; protease binding [GO:0002020] g12290.t1 Q05793 43.621 580 5.59e-143 462.0 sp|Q05793|PGBM_MOUSE Basement membrane-specific heparan sulfate proteoglycan core protein OS=Mus musculus OX=10090 GN=Hspg2 PE=1 SV=1 PGBM_MOUSE reviewed Basement membrane-specific heparan sulfate proteoglycan core protein (HSPG) (Perlecan) [Cleaved into: Endorepellin; LG3 peptide] Mus musculus (Mouse) GO:0001525; GO:0001938; GO:0001958; GO:0002020; GO:0002062; GO:0002162; GO:0005509; GO:0005576; GO:0005604; GO:0005796; GO:0006898; GO:0007162; GO:0007224; GO:0007420; GO:0008104; GO:0008285; GO:0009887; GO:0009888; GO:0030198; GO:0031012; GO:0032223; GO:0035418; GO:0043524; GO:0048704; GO:0048738; GO:0060090; GO:0060351; GO:0070052; GO:1905907 angiogenesis [GO:0001525]; animal organ morphogenesis [GO:0009887]; brain development [GO:0007420]; cardiac muscle tissue development [GO:0048738]; cartilage development involved in endochondral bone morphogenesis [GO:0060351]; chondrocyte differentiation [GO:0002062]; embryonic skeletal system morphogenesis [GO:0048704]; endochondral ossification [GO:0001958]; extracellular matrix organization [GO:0030198]; intracellular protein localization [GO:0008104]; negative regulation of amyloid fibril formation [GO:1905907]; negative regulation of cell adhesion [GO:0007162]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of synaptic transmission, cholinergic [GO:0032223]; positive regulation of endothelial cell proliferation [GO:0001938]; protein localization to synapse [GO:0035418]; receptor-mediated endocytosis [GO:0006898]; smoothened signaling pathway [GO:0007224]; tissue development [GO:0009888] basement membrane [GO:0005604]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; Golgi lumen [GO:0005796] calcium ion binding [GO:0005509]; collagen V binding [GO:0070052]; dystroglycan binding [GO:0002162]; molecular adaptor activity [GO:0060090]; protease binding [GO:0002020] g12290.t1 Q05793 35.57 447 1.31e-74 264.0 sp|Q05793|PGBM_MOUSE Basement membrane-specific heparan sulfate proteoglycan core protein OS=Mus musculus OX=10090 GN=Hspg2 PE=1 SV=1 PGBM_MOUSE reviewed Basement membrane-specific heparan sulfate proteoglycan core protein (HSPG) (Perlecan) [Cleaved into: Endorepellin; LG3 peptide] Mus musculus (Mouse) GO:0001525; GO:0001938; GO:0001958; GO:0002020; GO:0002062; GO:0002162; GO:0005509; GO:0005576; GO:0005604; GO:0005796; GO:0006898; GO:0007162; GO:0007224; GO:0007420; GO:0008104; GO:0008285; GO:0009887; GO:0009888; GO:0030198; GO:0031012; GO:0032223; GO:0035418; GO:0043524; GO:0048704; GO:0048738; GO:0060090; GO:0060351; GO:0070052; GO:1905907 angiogenesis [GO:0001525]; animal organ morphogenesis [GO:0009887]; brain development [GO:0007420]; cardiac muscle tissue development [GO:0048738]; cartilage development involved in endochondral bone morphogenesis [GO:0060351]; chondrocyte differentiation [GO:0002062]; embryonic skeletal system morphogenesis [GO:0048704]; endochondral ossification [GO:0001958]; extracellular matrix organization [GO:0030198]; intracellular protein localization [GO:0008104]; negative regulation of amyloid fibril formation [GO:1905907]; negative regulation of cell adhesion [GO:0007162]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of synaptic transmission, cholinergic [GO:0032223]; positive regulation of endothelial cell proliferation [GO:0001938]; protein localization to synapse [GO:0035418]; receptor-mediated endocytosis [GO:0006898]; smoothened signaling pathway [GO:0007224]; tissue development [GO:0009888] basement membrane [GO:0005604]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; Golgi lumen [GO:0005796] calcium ion binding [GO:0005509]; collagen V binding [GO:0070052]; dystroglycan binding [GO:0002162]; molecular adaptor activity [GO:0060090]; protease binding [GO:0002020] g12290.t1 Q05793 47.126 174 1.71e-35 147.0 sp|Q05793|PGBM_MOUSE Basement membrane-specific heparan sulfate proteoglycan core protein OS=Mus musculus OX=10090 GN=Hspg2 PE=1 SV=1 PGBM_MOUSE reviewed Basement membrane-specific heparan sulfate proteoglycan core protein (HSPG) (Perlecan) [Cleaved into: Endorepellin; LG3 peptide] Mus musculus (Mouse) GO:0001525; GO:0001938; GO:0001958; GO:0002020; GO:0002062; GO:0002162; GO:0005509; GO:0005576; GO:0005604; GO:0005796; GO:0006898; GO:0007162; GO:0007224; GO:0007420; GO:0008104; GO:0008285; GO:0009887; GO:0009888; GO:0030198; GO:0031012; GO:0032223; GO:0035418; GO:0043524; GO:0048704; GO:0048738; GO:0060090; GO:0060351; GO:0070052; GO:1905907 angiogenesis [GO:0001525]; animal organ morphogenesis [GO:0009887]; brain development [GO:0007420]; cardiac muscle tissue development [GO:0048738]; cartilage development involved in endochondral bone morphogenesis [GO:0060351]; chondrocyte differentiation [GO:0002062]; embryonic skeletal system morphogenesis [GO:0048704]; endochondral ossification [GO:0001958]; extracellular matrix organization [GO:0030198]; intracellular protein localization [GO:0008104]; negative regulation of amyloid fibril formation [GO:1905907]; negative regulation of cell adhesion [GO:0007162]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of synaptic transmission, cholinergic [GO:0032223]; positive regulation of endothelial cell proliferation [GO:0001938]; protein localization to synapse [GO:0035418]; receptor-mediated endocytosis [GO:0006898]; smoothened signaling pathway [GO:0007224]; tissue development [GO:0009888] basement membrane [GO:0005604]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; Golgi lumen [GO:0005796] calcium ion binding [GO:0005509]; collagen V binding [GO:0070052]; dystroglycan binding [GO:0002162]; molecular adaptor activity [GO:0060090]; protease binding [GO:0002020] g12291.t1 P98160 31.996 1894 0.0 905.0 sp|P98160|PGBM_HUMAN Basement membrane-specific heparan sulfate proteoglycan core protein OS=Homo sapiens OX=9606 GN=HSPG2 PE=1 SV=4 PGBM_HUMAN reviewed Basement membrane-specific heparan sulfate proteoglycan core protein (HSPG) (Perlecan) (PLC) [Cleaved into: Endorepellin; LG3 peptide] Homo sapiens (Human) GO:0001525; GO:0001540; GO:0001666; GO:0001938; GO:0005509; GO:0005576; GO:0005604; GO:0005615; GO:0005796; GO:0005886; GO:0005925; GO:0006629; GO:0006898; GO:0006954; GO:0007162; GO:0007224; GO:0007420; GO:0007566; GO:0008285; GO:0009410; GO:0016525; GO:0030021; GO:0030154; GO:0031012; GO:0031100; GO:0031594; GO:0032223; GO:0035418; GO:0043005; GO:0043202; GO:0050750; GO:0060090; GO:0070052; GO:0070062; GO:0072359; GO:0098797 angiogenesis [GO:0001525]; animal organ regeneration [GO:0031100]; brain development [GO:0007420]; cell differentiation [GO:0030154]; circulatory system development [GO:0072359]; embryo implantation [GO:0007566]; inflammatory response [GO:0006954]; lipid metabolic process [GO:0006629]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell adhesion [GO:0007162]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of synaptic transmission, cholinergic [GO:0032223]; positive regulation of endothelial cell proliferation [GO:0001938]; protein localization to synapse [GO:0035418]; receptor-mediated endocytosis [GO:0006898]; response to hypoxia [GO:0001666]; response to xenobiotic stimulus [GO:0009410]; smoothened signaling pathway [GO:0007224] basement membrane [GO:0005604]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; Golgi lumen [GO:0005796]; lysosomal lumen [GO:0043202]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; plasma membrane protein complex [GO:0098797] amyloid-beta binding [GO:0001540]; calcium ion binding [GO:0005509]; collagen V binding [GO:0070052]; extracellular matrix structural constituent conferring compression resistance [GO:0030021]; low-density lipoprotein particle receptor binding [GO:0050750]; molecular adaptor activity [GO:0060090] g12291.t1 P98160 30.79 1507 0.0 633.0 sp|P98160|PGBM_HUMAN Basement membrane-specific heparan sulfate proteoglycan core protein OS=Homo sapiens OX=9606 GN=HSPG2 PE=1 SV=4 PGBM_HUMAN reviewed Basement membrane-specific heparan sulfate proteoglycan core protein (HSPG) (Perlecan) (PLC) [Cleaved into: Endorepellin; LG3 peptide] Homo sapiens (Human) GO:0001525; GO:0001540; GO:0001666; GO:0001938; GO:0005509; GO:0005576; GO:0005604; GO:0005615; GO:0005796; GO:0005886; GO:0005925; GO:0006629; GO:0006898; GO:0006954; GO:0007162; GO:0007224; GO:0007420; GO:0007566; GO:0008285; GO:0009410; GO:0016525; GO:0030021; GO:0030154; GO:0031012; GO:0031100; GO:0031594; GO:0032223; GO:0035418; GO:0043005; GO:0043202; GO:0050750; GO:0060090; GO:0070052; GO:0070062; GO:0072359; GO:0098797 angiogenesis [GO:0001525]; animal organ regeneration [GO:0031100]; brain development [GO:0007420]; cell differentiation [GO:0030154]; circulatory system development [GO:0072359]; embryo implantation [GO:0007566]; inflammatory response [GO:0006954]; lipid metabolic process [GO:0006629]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell adhesion [GO:0007162]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of synaptic transmission, cholinergic [GO:0032223]; positive regulation of endothelial cell proliferation [GO:0001938]; protein localization to synapse [GO:0035418]; receptor-mediated endocytosis [GO:0006898]; response to hypoxia [GO:0001666]; response to xenobiotic stimulus [GO:0009410]; smoothened signaling pathway [GO:0007224] basement membrane [GO:0005604]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; Golgi lumen [GO:0005796]; lysosomal lumen [GO:0043202]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; plasma membrane protein complex [GO:0098797] amyloid-beta binding [GO:0001540]; calcium ion binding [GO:0005509]; collagen V binding [GO:0070052]; extracellular matrix structural constituent conferring compression resistance [GO:0030021]; low-density lipoprotein particle receptor binding [GO:0050750]; molecular adaptor activity [GO:0060090] g12291.t1 P98160 26.773 1128 1.51e-93 344.0 sp|P98160|PGBM_HUMAN Basement membrane-specific heparan sulfate proteoglycan core protein OS=Homo sapiens OX=9606 GN=HSPG2 PE=1 SV=4 PGBM_HUMAN reviewed Basement membrane-specific heparan sulfate proteoglycan core protein (HSPG) (Perlecan) (PLC) [Cleaved into: Endorepellin; LG3 peptide] Homo sapiens (Human) GO:0001525; GO:0001540; GO:0001666; GO:0001938; GO:0005509; GO:0005576; GO:0005604; GO:0005615; GO:0005796; GO:0005886; GO:0005925; GO:0006629; GO:0006898; GO:0006954; GO:0007162; GO:0007224; GO:0007420; GO:0007566; GO:0008285; GO:0009410; GO:0016525; GO:0030021; GO:0030154; GO:0031012; GO:0031100; GO:0031594; GO:0032223; GO:0035418; GO:0043005; GO:0043202; GO:0050750; GO:0060090; GO:0070052; GO:0070062; GO:0072359; GO:0098797 angiogenesis [GO:0001525]; animal organ regeneration [GO:0031100]; brain development [GO:0007420]; cell differentiation [GO:0030154]; circulatory system development [GO:0072359]; embryo implantation [GO:0007566]; inflammatory response [GO:0006954]; lipid metabolic process [GO:0006629]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell adhesion [GO:0007162]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of synaptic transmission, cholinergic [GO:0032223]; positive regulation of endothelial cell proliferation [GO:0001938]; protein localization to synapse [GO:0035418]; receptor-mediated endocytosis [GO:0006898]; response to hypoxia [GO:0001666]; response to xenobiotic stimulus [GO:0009410]; smoothened signaling pathway [GO:0007224] basement membrane [GO:0005604]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; Golgi lumen [GO:0005796]; lysosomal lumen [GO:0043202]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; plasma membrane protein complex [GO:0098797] amyloid-beta binding [GO:0001540]; calcium ion binding [GO:0005509]; collagen V binding [GO:0070052]; extracellular matrix structural constituent conferring compression resistance [GO:0030021]; low-density lipoprotein particle receptor binding [GO:0050750]; molecular adaptor activity [GO:0060090] g12291.t1 P98160 26.394 1076 1.0600000000000001e-85 318.0 sp|P98160|PGBM_HUMAN Basement membrane-specific heparan sulfate proteoglycan core protein OS=Homo sapiens OX=9606 GN=HSPG2 PE=1 SV=4 PGBM_HUMAN reviewed Basement membrane-specific heparan sulfate proteoglycan core protein (HSPG) (Perlecan) (PLC) [Cleaved into: Endorepellin; LG3 peptide] Homo sapiens (Human) GO:0001525; GO:0001540; GO:0001666; GO:0001938; GO:0005509; GO:0005576; GO:0005604; GO:0005615; GO:0005796; GO:0005886; GO:0005925; GO:0006629; GO:0006898; GO:0006954; GO:0007162; GO:0007224; GO:0007420; GO:0007566; GO:0008285; GO:0009410; GO:0016525; GO:0030021; GO:0030154; GO:0031012; GO:0031100; GO:0031594; GO:0032223; GO:0035418; GO:0043005; GO:0043202; GO:0050750; GO:0060090; GO:0070052; GO:0070062; GO:0072359; GO:0098797 angiogenesis [GO:0001525]; animal organ regeneration [GO:0031100]; brain development [GO:0007420]; cell differentiation [GO:0030154]; circulatory system development [GO:0072359]; embryo implantation [GO:0007566]; inflammatory response [GO:0006954]; lipid metabolic process [GO:0006629]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell adhesion [GO:0007162]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of synaptic transmission, cholinergic [GO:0032223]; positive regulation of endothelial cell proliferation [GO:0001938]; protein localization to synapse [GO:0035418]; receptor-mediated endocytosis [GO:0006898]; response to hypoxia [GO:0001666]; response to xenobiotic stimulus [GO:0009410]; smoothened signaling pathway [GO:0007224] basement membrane [GO:0005604]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; Golgi lumen [GO:0005796]; lysosomal lumen [GO:0043202]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; plasma membrane protein complex [GO:0098797] amyloid-beta binding [GO:0001540]; calcium ion binding [GO:0005509]; collagen V binding [GO:0070052]; extracellular matrix structural constituent conferring compression resistance [GO:0030021]; low-density lipoprotein particle receptor binding [GO:0050750]; molecular adaptor activity [GO:0060090] g12291.t1 P98160 25.03 843 2.73e-66 254.0 sp|P98160|PGBM_HUMAN Basement membrane-specific heparan sulfate proteoglycan core protein OS=Homo sapiens OX=9606 GN=HSPG2 PE=1 SV=4 PGBM_HUMAN reviewed Basement membrane-specific heparan sulfate proteoglycan core protein (HSPG) (Perlecan) (PLC) [Cleaved into: Endorepellin; LG3 peptide] Homo sapiens (Human) GO:0001525; GO:0001540; GO:0001666; GO:0001938; GO:0005509; GO:0005576; GO:0005604; GO:0005615; GO:0005796; GO:0005886; GO:0005925; GO:0006629; GO:0006898; GO:0006954; GO:0007162; GO:0007224; GO:0007420; GO:0007566; GO:0008285; GO:0009410; GO:0016525; GO:0030021; GO:0030154; GO:0031012; GO:0031100; GO:0031594; GO:0032223; GO:0035418; GO:0043005; GO:0043202; GO:0050750; GO:0060090; GO:0070052; GO:0070062; GO:0072359; GO:0098797 angiogenesis [GO:0001525]; animal organ regeneration [GO:0031100]; brain development [GO:0007420]; cell differentiation [GO:0030154]; circulatory system development [GO:0072359]; embryo implantation [GO:0007566]; inflammatory response [GO:0006954]; lipid metabolic process [GO:0006629]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell adhesion [GO:0007162]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of synaptic transmission, cholinergic [GO:0032223]; positive regulation of endothelial cell proliferation [GO:0001938]; protein localization to synapse [GO:0035418]; receptor-mediated endocytosis [GO:0006898]; response to hypoxia [GO:0001666]; response to xenobiotic stimulus [GO:0009410]; smoothened signaling pathway [GO:0007224] basement membrane [GO:0005604]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; Golgi lumen [GO:0005796]; lysosomal lumen [GO:0043202]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; plasma membrane protein complex [GO:0098797] amyloid-beta binding [GO:0001540]; calcium ion binding [GO:0005509]; collagen V binding [GO:0070052]; extracellular matrix structural constituent conferring compression resistance [GO:0030021]; low-density lipoprotein particle receptor binding [GO:0050750]; molecular adaptor activity [GO:0060090] g12291.t1 P98160 33.239 352 5.13e-46 188.0 sp|P98160|PGBM_HUMAN Basement membrane-specific heparan sulfate proteoglycan core protein OS=Homo sapiens OX=9606 GN=HSPG2 PE=1 SV=4 PGBM_HUMAN reviewed Basement membrane-specific heparan sulfate proteoglycan core protein (HSPG) (Perlecan) (PLC) [Cleaved into: Endorepellin; LG3 peptide] Homo sapiens (Human) GO:0001525; GO:0001540; GO:0001666; GO:0001938; GO:0005509; GO:0005576; GO:0005604; GO:0005615; GO:0005796; GO:0005886; GO:0005925; GO:0006629; GO:0006898; GO:0006954; GO:0007162; GO:0007224; GO:0007420; GO:0007566; GO:0008285; GO:0009410; GO:0016525; GO:0030021; GO:0030154; GO:0031012; GO:0031100; GO:0031594; GO:0032223; GO:0035418; GO:0043005; GO:0043202; GO:0050750; GO:0060090; GO:0070052; GO:0070062; GO:0072359; GO:0098797 angiogenesis [GO:0001525]; animal organ regeneration [GO:0031100]; brain development [GO:0007420]; cell differentiation [GO:0030154]; circulatory system development [GO:0072359]; embryo implantation [GO:0007566]; inflammatory response [GO:0006954]; lipid metabolic process [GO:0006629]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell adhesion [GO:0007162]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of synaptic transmission, cholinergic [GO:0032223]; positive regulation of endothelial cell proliferation [GO:0001938]; protein localization to synapse [GO:0035418]; receptor-mediated endocytosis [GO:0006898]; response to hypoxia [GO:0001666]; response to xenobiotic stimulus [GO:0009410]; smoothened signaling pathway [GO:0007224] basement membrane [GO:0005604]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; Golgi lumen [GO:0005796]; lysosomal lumen [GO:0043202]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; plasma membrane protein complex [GO:0098797] amyloid-beta binding [GO:0001540]; calcium ion binding [GO:0005509]; collagen V binding [GO:0070052]; extracellular matrix structural constituent conferring compression resistance [GO:0030021]; low-density lipoprotein particle receptor binding [GO:0050750]; molecular adaptor activity [GO:0060090] g12291.t1 P98160 35.922 309 6.41e-42 174.0 sp|P98160|PGBM_HUMAN Basement membrane-specific heparan sulfate proteoglycan core protein OS=Homo sapiens OX=9606 GN=HSPG2 PE=1 SV=4 PGBM_HUMAN reviewed Basement membrane-specific heparan sulfate proteoglycan core protein (HSPG) (Perlecan) (PLC) [Cleaved into: Endorepellin; LG3 peptide] Homo sapiens (Human) GO:0001525; GO:0001540; GO:0001666; GO:0001938; GO:0005509; GO:0005576; GO:0005604; GO:0005615; GO:0005796; GO:0005886; GO:0005925; GO:0006629; GO:0006898; GO:0006954; GO:0007162; GO:0007224; GO:0007420; GO:0007566; GO:0008285; GO:0009410; GO:0016525; GO:0030021; GO:0030154; GO:0031012; GO:0031100; GO:0031594; GO:0032223; GO:0035418; GO:0043005; GO:0043202; GO:0050750; GO:0060090; GO:0070052; GO:0070062; GO:0072359; GO:0098797 angiogenesis [GO:0001525]; animal organ regeneration [GO:0031100]; brain development [GO:0007420]; cell differentiation [GO:0030154]; circulatory system development [GO:0072359]; embryo implantation [GO:0007566]; inflammatory response [GO:0006954]; lipid metabolic process [GO:0006629]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell adhesion [GO:0007162]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of synaptic transmission, cholinergic [GO:0032223]; positive regulation of endothelial cell proliferation [GO:0001938]; protein localization to synapse [GO:0035418]; receptor-mediated endocytosis [GO:0006898]; response to hypoxia [GO:0001666]; response to xenobiotic stimulus [GO:0009410]; smoothened signaling pathway [GO:0007224] basement membrane [GO:0005604]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; Golgi lumen [GO:0005796]; lysosomal lumen [GO:0043202]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; plasma membrane protein complex [GO:0098797] amyloid-beta binding [GO:0001540]; calcium ion binding [GO:0005509]; collagen V binding [GO:0070052]; extracellular matrix structural constituent conferring compression resistance [GO:0030021]; low-density lipoprotein particle receptor binding [GO:0050750]; molecular adaptor activity [GO:0060090] g12291.t2 P98160 32.337 1874 0.0 919.0 sp|P98160|PGBM_HUMAN Basement membrane-specific heparan sulfate proteoglycan core protein OS=Homo sapiens OX=9606 GN=HSPG2 PE=1 SV=4 PGBM_HUMAN reviewed Basement membrane-specific heparan sulfate proteoglycan core protein (HSPG) (Perlecan) (PLC) [Cleaved into: Endorepellin; LG3 peptide] Homo sapiens (Human) GO:0001525; GO:0001540; GO:0001666; GO:0001938; GO:0005509; GO:0005576; GO:0005604; GO:0005615; GO:0005796; GO:0005886; GO:0005925; GO:0006629; GO:0006898; GO:0006954; GO:0007162; GO:0007224; GO:0007420; GO:0007566; GO:0008285; GO:0009410; GO:0016525; GO:0030021; GO:0030154; GO:0031012; GO:0031100; GO:0031594; GO:0032223; GO:0035418; GO:0043005; GO:0043202; GO:0050750; GO:0060090; GO:0070052; GO:0070062; GO:0072359; GO:0098797 angiogenesis [GO:0001525]; animal organ regeneration [GO:0031100]; brain development [GO:0007420]; cell differentiation [GO:0030154]; circulatory system development [GO:0072359]; embryo implantation [GO:0007566]; inflammatory response [GO:0006954]; lipid metabolic process [GO:0006629]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell adhesion [GO:0007162]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of synaptic transmission, cholinergic [GO:0032223]; positive regulation of endothelial cell proliferation [GO:0001938]; protein localization to synapse [GO:0035418]; receptor-mediated endocytosis [GO:0006898]; response to hypoxia [GO:0001666]; response to xenobiotic stimulus [GO:0009410]; smoothened signaling pathway [GO:0007224] basement membrane [GO:0005604]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; Golgi lumen [GO:0005796]; lysosomal lumen [GO:0043202]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; plasma membrane protein complex [GO:0098797] amyloid-beta binding [GO:0001540]; calcium ion binding [GO:0005509]; collagen V binding [GO:0070052]; extracellular matrix structural constituent conferring compression resistance [GO:0030021]; low-density lipoprotein particle receptor binding [GO:0050750]; molecular adaptor activity [GO:0060090] g12291.t2 P98160 30.79 1507 0.0 635.0 sp|P98160|PGBM_HUMAN Basement membrane-specific heparan sulfate proteoglycan core protein OS=Homo sapiens OX=9606 GN=HSPG2 PE=1 SV=4 PGBM_HUMAN reviewed Basement membrane-specific heparan sulfate proteoglycan core protein (HSPG) (Perlecan) (PLC) [Cleaved into: Endorepellin; LG3 peptide] Homo sapiens (Human) GO:0001525; GO:0001540; GO:0001666; GO:0001938; GO:0005509; GO:0005576; GO:0005604; GO:0005615; GO:0005796; GO:0005886; GO:0005925; GO:0006629; GO:0006898; GO:0006954; GO:0007162; GO:0007224; GO:0007420; GO:0007566; GO:0008285; GO:0009410; GO:0016525; GO:0030021; GO:0030154; GO:0031012; GO:0031100; GO:0031594; GO:0032223; GO:0035418; GO:0043005; GO:0043202; GO:0050750; GO:0060090; GO:0070052; GO:0070062; GO:0072359; GO:0098797 angiogenesis [GO:0001525]; animal organ regeneration [GO:0031100]; brain development [GO:0007420]; cell differentiation [GO:0030154]; circulatory system development [GO:0072359]; embryo implantation [GO:0007566]; inflammatory response [GO:0006954]; lipid metabolic process [GO:0006629]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell adhesion [GO:0007162]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of synaptic transmission, cholinergic [GO:0032223]; positive regulation of endothelial cell proliferation [GO:0001938]; protein localization to synapse [GO:0035418]; receptor-mediated endocytosis [GO:0006898]; response to hypoxia [GO:0001666]; response to xenobiotic stimulus [GO:0009410]; smoothened signaling pathway [GO:0007224] basement membrane [GO:0005604]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; Golgi lumen [GO:0005796]; lysosomal lumen [GO:0043202]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; plasma membrane protein complex [GO:0098797] amyloid-beta binding [GO:0001540]; calcium ion binding [GO:0005509]; collagen V binding [GO:0070052]; extracellular matrix structural constituent conferring compression resistance [GO:0030021]; low-density lipoprotein particle receptor binding [GO:0050750]; molecular adaptor activity [GO:0060090] g12291.t2 P98160 26.773 1128 5.14e-94 345.0 sp|P98160|PGBM_HUMAN Basement membrane-specific heparan sulfate proteoglycan core protein OS=Homo sapiens OX=9606 GN=HSPG2 PE=1 SV=4 PGBM_HUMAN reviewed Basement membrane-specific heparan sulfate proteoglycan core protein (HSPG) (Perlecan) (PLC) [Cleaved into: Endorepellin; LG3 peptide] Homo sapiens (Human) GO:0001525; GO:0001540; GO:0001666; GO:0001938; GO:0005509; GO:0005576; GO:0005604; GO:0005615; GO:0005796; GO:0005886; GO:0005925; GO:0006629; GO:0006898; GO:0006954; GO:0007162; GO:0007224; GO:0007420; GO:0007566; GO:0008285; GO:0009410; GO:0016525; GO:0030021; GO:0030154; GO:0031012; GO:0031100; GO:0031594; GO:0032223; GO:0035418; GO:0043005; GO:0043202; GO:0050750; GO:0060090; GO:0070052; GO:0070062; GO:0072359; GO:0098797 angiogenesis [GO:0001525]; animal organ regeneration [GO:0031100]; brain development [GO:0007420]; cell differentiation [GO:0030154]; circulatory system development [GO:0072359]; embryo implantation [GO:0007566]; inflammatory response [GO:0006954]; lipid metabolic process [GO:0006629]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell adhesion [GO:0007162]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of synaptic transmission, cholinergic [GO:0032223]; positive regulation of endothelial cell proliferation [GO:0001938]; protein localization to synapse [GO:0035418]; receptor-mediated endocytosis [GO:0006898]; response to hypoxia [GO:0001666]; response to xenobiotic stimulus [GO:0009410]; smoothened signaling pathway [GO:0007224] basement membrane [GO:0005604]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; Golgi lumen [GO:0005796]; lysosomal lumen [GO:0043202]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; plasma membrane protein complex [GO:0098797] amyloid-beta binding [GO:0001540]; calcium ion binding [GO:0005509]; collagen V binding [GO:0070052]; extracellular matrix structural constituent conferring compression resistance [GO:0030021]; low-density lipoprotein particle receptor binding [GO:0050750]; molecular adaptor activity [GO:0060090] g12291.t2 P98160 26.394 1076 4.2500000000000004e-86 320.0 sp|P98160|PGBM_HUMAN Basement membrane-specific heparan sulfate proteoglycan core protein OS=Homo sapiens OX=9606 GN=HSPG2 PE=1 SV=4 PGBM_HUMAN reviewed Basement membrane-specific heparan sulfate proteoglycan core protein (HSPG) (Perlecan) (PLC) [Cleaved into: Endorepellin; LG3 peptide] Homo sapiens (Human) GO:0001525; GO:0001540; GO:0001666; GO:0001938; GO:0005509; GO:0005576; GO:0005604; GO:0005615; GO:0005796; GO:0005886; GO:0005925; GO:0006629; GO:0006898; GO:0006954; GO:0007162; GO:0007224; GO:0007420; GO:0007566; GO:0008285; GO:0009410; GO:0016525; GO:0030021; GO:0030154; GO:0031012; GO:0031100; GO:0031594; GO:0032223; GO:0035418; GO:0043005; GO:0043202; GO:0050750; GO:0060090; GO:0070052; GO:0070062; GO:0072359; GO:0098797 angiogenesis [GO:0001525]; animal organ regeneration [GO:0031100]; brain development [GO:0007420]; cell differentiation [GO:0030154]; circulatory system development [GO:0072359]; embryo implantation [GO:0007566]; inflammatory response [GO:0006954]; lipid metabolic process [GO:0006629]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell adhesion [GO:0007162]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of synaptic transmission, cholinergic [GO:0032223]; positive regulation of endothelial cell proliferation [GO:0001938]; protein localization to synapse [GO:0035418]; receptor-mediated endocytosis [GO:0006898]; response to hypoxia [GO:0001666]; response to xenobiotic stimulus [GO:0009410]; smoothened signaling pathway [GO:0007224] basement membrane [GO:0005604]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; Golgi lumen [GO:0005796]; lysosomal lumen [GO:0043202]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; plasma membrane protein complex [GO:0098797] amyloid-beta binding [GO:0001540]; calcium ion binding [GO:0005509]; collagen V binding [GO:0070052]; extracellular matrix structural constituent conferring compression resistance [GO:0030021]; low-density lipoprotein particle receptor binding [GO:0050750]; molecular adaptor activity [GO:0060090] g12291.t2 P98160 24.971 853 1.3e-66 256.0 sp|P98160|PGBM_HUMAN Basement membrane-specific heparan sulfate proteoglycan core protein OS=Homo sapiens OX=9606 GN=HSPG2 PE=1 SV=4 PGBM_HUMAN reviewed Basement membrane-specific heparan sulfate proteoglycan core protein (HSPG) (Perlecan) (PLC) [Cleaved into: Endorepellin; LG3 peptide] Homo sapiens (Human) GO:0001525; GO:0001540; GO:0001666; GO:0001938; GO:0005509; GO:0005576; GO:0005604; GO:0005615; GO:0005796; GO:0005886; GO:0005925; GO:0006629; GO:0006898; GO:0006954; GO:0007162; GO:0007224; GO:0007420; GO:0007566; GO:0008285; GO:0009410; GO:0016525; GO:0030021; GO:0030154; GO:0031012; GO:0031100; GO:0031594; GO:0032223; GO:0035418; GO:0043005; GO:0043202; GO:0050750; GO:0060090; GO:0070052; GO:0070062; GO:0072359; GO:0098797 angiogenesis [GO:0001525]; animal organ regeneration [GO:0031100]; brain development [GO:0007420]; cell differentiation [GO:0030154]; circulatory system development [GO:0072359]; embryo implantation [GO:0007566]; inflammatory response [GO:0006954]; lipid metabolic process [GO:0006629]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell adhesion [GO:0007162]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of synaptic transmission, cholinergic [GO:0032223]; positive regulation of endothelial cell proliferation [GO:0001938]; protein localization to synapse [GO:0035418]; receptor-mediated endocytosis [GO:0006898]; response to hypoxia [GO:0001666]; response to xenobiotic stimulus [GO:0009410]; smoothened signaling pathway [GO:0007224] basement membrane [GO:0005604]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; Golgi lumen [GO:0005796]; lysosomal lumen [GO:0043202]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; plasma membrane protein complex [GO:0098797] amyloid-beta binding [GO:0001540]; calcium ion binding [GO:0005509]; collagen V binding [GO:0070052]; extracellular matrix structural constituent conferring compression resistance [GO:0030021]; low-density lipoprotein particle receptor binding [GO:0050750]; molecular adaptor activity [GO:0060090] g12291.t2 P98160 33.239 352 3.89e-46 188.0 sp|P98160|PGBM_HUMAN Basement membrane-specific heparan sulfate proteoglycan core protein OS=Homo sapiens OX=9606 GN=HSPG2 PE=1 SV=4 PGBM_HUMAN reviewed Basement membrane-specific heparan sulfate proteoglycan core protein (HSPG) (Perlecan) (PLC) [Cleaved into: Endorepellin; LG3 peptide] Homo sapiens (Human) GO:0001525; GO:0001540; GO:0001666; GO:0001938; GO:0005509; GO:0005576; GO:0005604; GO:0005615; GO:0005796; GO:0005886; GO:0005925; GO:0006629; GO:0006898; GO:0006954; GO:0007162; GO:0007224; GO:0007420; GO:0007566; GO:0008285; GO:0009410; GO:0016525; GO:0030021; GO:0030154; GO:0031012; GO:0031100; GO:0031594; GO:0032223; GO:0035418; GO:0043005; GO:0043202; GO:0050750; GO:0060090; GO:0070052; GO:0070062; GO:0072359; GO:0098797 angiogenesis [GO:0001525]; animal organ regeneration [GO:0031100]; brain development [GO:0007420]; cell differentiation [GO:0030154]; circulatory system development [GO:0072359]; embryo implantation [GO:0007566]; inflammatory response [GO:0006954]; lipid metabolic process [GO:0006629]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell adhesion [GO:0007162]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of synaptic transmission, cholinergic [GO:0032223]; positive regulation of endothelial cell proliferation [GO:0001938]; protein localization to synapse [GO:0035418]; receptor-mediated endocytosis [GO:0006898]; response to hypoxia [GO:0001666]; response to xenobiotic stimulus [GO:0009410]; smoothened signaling pathway [GO:0007224] basement membrane [GO:0005604]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; Golgi lumen [GO:0005796]; lysosomal lumen [GO:0043202]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; plasma membrane protein complex [GO:0098797] amyloid-beta binding [GO:0001540]; calcium ion binding [GO:0005509]; collagen V binding [GO:0070052]; extracellular matrix structural constituent conferring compression resistance [GO:0030021]; low-density lipoprotein particle receptor binding [GO:0050750]; molecular adaptor activity [GO:0060090] g12291.t2 P98160 35.922 309 4.659999999999999e-42 175.0 sp|P98160|PGBM_HUMAN Basement membrane-specific heparan sulfate proteoglycan core protein OS=Homo sapiens OX=9606 GN=HSPG2 PE=1 SV=4 PGBM_HUMAN reviewed Basement membrane-specific heparan sulfate proteoglycan core protein (HSPG) (Perlecan) (PLC) [Cleaved into: Endorepellin; LG3 peptide] Homo sapiens (Human) GO:0001525; GO:0001540; GO:0001666; GO:0001938; GO:0005509; GO:0005576; GO:0005604; GO:0005615; GO:0005796; GO:0005886; GO:0005925; GO:0006629; GO:0006898; GO:0006954; GO:0007162; GO:0007224; GO:0007420; GO:0007566; GO:0008285; GO:0009410; GO:0016525; GO:0030021; GO:0030154; GO:0031012; GO:0031100; GO:0031594; GO:0032223; GO:0035418; GO:0043005; GO:0043202; GO:0050750; GO:0060090; GO:0070052; GO:0070062; GO:0072359; GO:0098797 angiogenesis [GO:0001525]; animal organ regeneration [GO:0031100]; brain development [GO:0007420]; cell differentiation [GO:0030154]; circulatory system development [GO:0072359]; embryo implantation [GO:0007566]; inflammatory response [GO:0006954]; lipid metabolic process [GO:0006629]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell adhesion [GO:0007162]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of synaptic transmission, cholinergic [GO:0032223]; positive regulation of endothelial cell proliferation [GO:0001938]; protein localization to synapse [GO:0035418]; receptor-mediated endocytosis [GO:0006898]; response to hypoxia [GO:0001666]; response to xenobiotic stimulus [GO:0009410]; smoothened signaling pathway [GO:0007224] basement membrane [GO:0005604]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; Golgi lumen [GO:0005796]; lysosomal lumen [GO:0043202]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; plasma membrane protein complex [GO:0098797] amyloid-beta binding [GO:0001540]; calcium ion binding [GO:0005509]; collagen V binding [GO:0070052]; extracellular matrix structural constituent conferring compression resistance [GO:0030021]; low-density lipoprotein particle receptor binding [GO:0050750]; molecular adaptor activity [GO:0060090] g12295.t1 Q05961 31.159 276 6.88e-24 103.0 sp|Q05961|OAS1A_RAT 2'-5'-oligoadenylate synthase 1A OS=Rattus norvegicus OX=10116 GN=Oas1a PE=2 SV=1 OAS1A_RAT reviewed 2'-5'-oligoadenylate synthase 1A ((2-5')oligo(A) synthase 1A) (2-5A synthase 1A) (EC 2.7.7.84) Rattus norvegicus (Rat) GO:0001730; GO:0003725; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005783; GO:0005829; GO:0005840; GO:0006006; GO:0009615; GO:0016020; GO:0032728; GO:0032760; GO:0034138; GO:0034142; GO:0035457; GO:0035458; GO:0042593; GO:0043129; GO:0045071; GO:0046872; GO:0051259; GO:0051607; GO:0060337; GO:0060339; GO:0070106; GO:0071360; GO:0071639; GO:0071659; GO:0140374; GO:1901857; GO:2000342 antiviral innate immune response [GO:0140374]; cellular response to exogenous dsRNA [GO:0071360]; cellular response to interferon-alpha [GO:0035457]; cellular response to interferon-beta [GO:0035458]; defense response to virus [GO:0051607]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; interleukin-27-mediated signaling pathway [GO:0070106]; negative regulation of chemokine (C-X-C motif) ligand 2 production [GO:2000342]; negative regulation of IP-10 production [GO:0071659]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; negative regulation of viral genome replication [GO:0045071]; positive regulation of cellular respiration [GO:1901857]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of monocyte chemotactic protein-1 production [GO:0071639]; positive regulation of tumor necrosis factor production [GO:0032760]; protein complex oligomerization [GO:0051259]; response to virus [GO:0009615]; surfactant homeostasis [GO:0043129]; toll-like receptor 3 signaling pathway [GO:0034138]; toll-like receptor 4 signaling pathway [GO:0034142]; type I interferon-mediated signaling pathway [GO:0060337] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribosome [GO:0005840] 2'-5'-oligoadenylate synthetase activity [GO:0001730]; ATP binding [GO:0005524]; double-stranded RNA binding [GO:0003725]; metal ion binding [GO:0046872] g12297.t1 Q2TBV5 57.881 387 1.66e-169 483.0 sp|Q2TBV5|TF2H2_BOVIN General transcription factor IIH subunit 2 OS=Bos taurus OX=9913 GN=GTF2H2 PE=2 SV=1 g12298.t1 B1WAP7 72.403 308 5.109999999999999e-134 415.0 sp|B1WAP7|DVL3_XENTR Segment polarity protein dishevelled homolog DVL-3 OS=Xenopus tropicalis OX=8364 GN=dvl3 PE=2 SV=1 g12298.t1 B1WAP7 70.423 142 5.390000000000001e-56 207.0 sp|B1WAP7|DVL3_XENTR Segment polarity protein dishevelled homolog DVL-3 OS=Xenopus tropicalis OX=8364 GN=dvl3 PE=2 SV=1 g12298.t2 B1WAP7 72.403 308 5.109999999999999e-134 415.0 sp|B1WAP7|DVL3_XENTR Segment polarity protein dishevelled homolog DVL-3 OS=Xenopus tropicalis OX=8364 GN=dvl3 PE=2 SV=1 g12298.t2 B1WAP7 70.423 142 5.390000000000001e-56 207.0 sp|B1WAP7|DVL3_XENTR Segment polarity protein dishevelled homolog DVL-3 OS=Xenopus tropicalis OX=8364 GN=dvl3 PE=2 SV=1 g12298.t3 B1WAP7 72.403 308 2.7e-134 415.0 sp|B1WAP7|DVL3_XENTR Segment polarity protein dishevelled homolog DVL-3 OS=Xenopus tropicalis OX=8364 GN=dvl3 PE=2 SV=1 g12298.t3 B1WAP7 69.079 152 1.54e-58 214.0 sp|B1WAP7|DVL3_XENTR Segment polarity protein dishevelled homolog DVL-3 OS=Xenopus tropicalis OX=8364 GN=dvl3 PE=2 SV=1 g12299.t1 Q8NA47 33.141 519 2.83e-69 236.0 sp|Q8NA47|CCD63_HUMAN Coiled-coil domain-containing protein 63 OS=Homo sapiens OX=9606 GN=CCDC63 PE=1 SV=1 g12300.t1 Q02978 68.581 296 1.61e-148 421.0 sp|Q02978|M2OM_HUMAN Mitochondrial 2-oxoglutarate/malate carrier protein OS=Homo sapiens OX=9606 GN=SLC25A11 PE=1 SV=3 M2OM_HUMAN reviewed Mitochondrial 2-oxoglutarate/malate carrier protein (Alpha-oxoglutarate carrier) (OGCP) (Solute carrier family 25 member 11) (SLC25A11) Homo sapiens (Human) GO:0003723; GO:0005634; GO:0005739; GO:0005743; GO:0005886; GO:0006094; GO:0006869; GO:0015367; GO:0022857; GO:0043490 gluconeogenesis [GO:0006094]; lipid transport [GO:0006869]; malate-aspartate shuttle [GO:0043490] mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886] oxoglutarate:malate antiporter activity [GO:0015367]; RNA binding [GO:0003723]; transmembrane transporter activity [GO:0022857] g12302.t1 Q8K4C0 39.059 489 1.5499999999999997e-126 382.0 sp|Q8K4C0|FMO5_RAT Flavin-containing monooxygenase 5 OS=Rattus norvegicus OX=10116 GN=Fmo5 PE=1 SV=3 FMO5_RAT reviewed Flavin-containing monooxygenase 5 (FMO 5) (Dimethylaniline monooxygenase [N-oxide-forming] 5) (EC 1.14.13.8) (Dimethylaniline oxidase 5) (Hepatic flavin-containing monooxygenase 5) (NADPH oxidase) (EC 1.6.3.1) Rattus norvegicus (Rat) GO:0004497; GO:0004499; GO:0005783; GO:0005789; GO:0005829; GO:0006629; GO:0006805; GO:0016174; GO:0050660; GO:0050661; GO:0090181 lipid metabolic process [GO:0006629]; regulation of cholesterol metabolic process [GO:0090181]; xenobiotic metabolic process [GO:0006805] cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789] flavin adenine dinucleotide binding [GO:0050660]; monooxygenase activity [GO:0004497]; N,N-dimethylaniline monooxygenase activity [GO:0004499]; NAD(P)H oxidase H2O2-forming activity [GO:0016174]; NADP binding [GO:0050661] g12303.t1 A0A0L1JG62 38.244 672 5.81e-133 436.0 sp|A0A0L1JG62|RSTN3_ASPN3 Highly reducing polyketide synthase rstn3 OS=Aspergillus nomiae NRRL (strain ATCC 15546 / NRRL 13137 / CBS 260.88 / M93) OX=1509407 GN=rstn3 PE=3 SV=1 g12304.t1 S3D9F1 26.981 1464 2.9000000000000003e-99 356.0 sp|S3D9F1|GLOL_GLAL2 Highly reducing polyketide synthase gloL OS=Glarea lozoyensis (strain ATCC 20868 / MF5171) OX=1116229 GN=gloL PE=1 SV=1 g12305.t1 G3J453 28.044 271 3.72e-23 101.0 sp|G3J453|CM3B_CORMM Highly reducing polyketide synthase cm3B OS=Cordyceps militaris (strain CM01) OX=983644 GN=cm3B PE=1 SV=1 g12306.t1 Q8JG30 29.304 273 3.71e-39 142.0 sp|Q8JG30|ST1B1_CHICK Sulfotransferase 1B1 OS=Gallus gallus OX=9031 GN=SULT1B1 PE=1 SV=1 g12307.t1 Q7M456 38.158 228 9.070000000000001e-47 158.0 sp|Q7M456|RNOY_MAGGI Ribonuclease Oy OS=Magallana gigas OX=29159 PE=1 SV=1 g12311.t1 Q5RDA9 35.556 405 1.01e-65 230.0 sp|Q5RDA9|FBX42_PONAB F-box only protein 42 OS=Pongo abelii OX=9601 GN=FBXO42 PE=2 SV=1 g12312.t1 A2A825 46.341 246 2.73e-80 246.0 sp|A2A825|CPLN2_MOUSE Ciliogenesis and planar polarity effector 2 OS=Mus musculus OX=10090 GN=Cplane2 PE=1 SV=1 CPLN2_MOUSE reviewed Ciliogenesis and planar polarity effector 2 (REM2- and Rab-like small GTPase 1) Mus musculus (Mouse) GO:0003274; GO:0003924; GO:0005525; GO:0005814; GO:0006887; GO:0007224; GO:0008104; GO:0008589; GO:0015031; GO:0016485; GO:0017157; GO:0031338; GO:0035082; GO:0035869; GO:0036064; GO:0060173; GO:0060271; GO:0097546; GO:1904888 axoneme assembly [GO:0035082]; cilium assembly [GO:0060271]; cranial skeletal system development [GO:1904888]; endocardial cushion fusion [GO:0003274]; exocytosis [GO:0006887]; intracellular protein localization [GO:0008104]; limb development [GO:0060173]; protein processing [GO:0016485]; protein transport [GO:0015031]; regulation of exocytosis [GO:0017157]; regulation of smoothened signaling pathway [GO:0008589]; regulation of vesicle fusion [GO:0031338]; smoothened signaling pathway [GO:0007224] centriole [GO:0005814]; ciliary basal body [GO:0036064]; ciliary base [GO:0097546]; ciliary transition zone [GO:0035869] GTP binding [GO:0005525]; GTPase activity [GO:0003924] g12313.t1 P84850 56.057 487 0.0 536.0 sp|P84850|D2HDH_RAT D-2-hydroxyglutarate dehydrogenase, mitochondrial OS=Rattus norvegicus OX=10116 GN=D2hgdh PE=1 SV=1 D2HDH_RAT reviewed D-2-hydroxyglutarate dehydrogenase, mitochondrial (EC 1.1.99.39) Rattus norvegicus (Rat) GO:0005739; GO:0006089; GO:0006108; GO:0008270; GO:0010042; GO:0010043; GO:0032025; GO:0051990; GO:0071949; GO:1901275 lactate metabolic process [GO:0006089]; malate metabolic process [GO:0006108]; response to cobalt ion [GO:0032025]; response to manganese ion [GO:0010042]; response to zinc ion [GO:0010043]; tartrate metabolic process [GO:1901275] mitochondrion [GO:0005739] (R)-2-hydroxyglutarate dehydrogenase activity [GO:0051990]; FAD binding [GO:0071949]; zinc ion binding [GO:0008270] g12314.t1 Q6NZ13 50.962 104 9.79e-33 117.0 sp|Q6NZ13|NBL1_DANRE Neuroblastoma suppressor of tumorigenicity 1 OS=Danio rerio OX=7955 GN=nbl1 PE=2 SV=1 g12316.t1 Q2KIP7 51.724 203 1.34e-69 214.0 sp|Q2KIP7|MD2L2_BOVIN Mitotic spindle assembly checkpoint protein MAD2B OS=Bos taurus OX=9913 GN=MAD2L2 PE=2 SV=1 MD2L2_BOVIN reviewed Mitotic spindle assembly checkpoint protein MAD2B (Mitotic arrest deficient 2-like protein 2) (MAD2-like protein 2) Bos taurus (Bovine) GO:0001558; GO:0005634; GO:0005737; GO:0005819; GO:0006281; GO:0006302; GO:0008432; GO:0010717; GO:0016035; GO:0033138; GO:0042177; GO:0042772; GO:0045893; GO:0051301; GO:1904667 cell division [GO:0051301]; DNA damage response, signal transduction resulting in transcription [GO:0042772]; DNA repair [GO:0006281]; double-strand break repair [GO:0006302]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of ubiquitin protein ligase activity [GO:1904667]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; regulation of cell growth [GO:0001558]; regulation of epithelial to mesenchymal transition [GO:0010717] cytoplasm [GO:0005737]; nucleus [GO:0005634]; spindle [GO:0005819]; zeta DNA polymerase complex [GO:0016035] JUN kinase binding [GO:0008432] g12317.t1 Q8H1F7 36.061 330 3.43e-50 172.0 sp|Q8H1F7|IPK_ARATH Isopentenyl phosphate kinase OS=Arabidopsis thaliana OX=3702 GN=IPK PE=1 SV=1 g12323.t2 Q9Y5Z9 62.174 230 5.91e-91 274.0 sp|Q9Y5Z9|UBIA1_HUMAN UbiA prenyltransferase domain-containing protein 1 OS=Homo sapiens OX=9606 GN=UBIAD1 PE=1 SV=1 g12328.t1 Q8BTI9 44.3 1079 0.0 879.0 sp|Q8BTI9|PK3CB_MOUSE Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform OS=Mus musculus OX=10090 GN=Pik3cb PE=1 SV=2 PK3CB_MOUSE reviewed Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform (PI3-kinase subunit beta) (PI3K-beta) (PI3Kbeta) (PtdIns-3-kinase subunit beta) (EC 2.7.1.153) (Phosphatidylinositol 4,5-bisphosphate 3-kinase 110 kDa catalytic subunit beta) (PtdIns-3-kinase subunit p110-beta) (p110beta) (Serine/threonine protein kinase PIK3CB) (EC 2.7.11.1) Mus musculus (Mouse) GO:0001935; GO:0001952; GO:0002931; GO:0003376; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0005886; GO:0005942; GO:0005943; GO:0006874; GO:0006897; GO:0006914; GO:0007156; GO:0010595; GO:0010628; GO:0016303; GO:0016477; GO:0030168; GO:0030496; GO:0031526; GO:0033031; GO:0035005; GO:0035022; GO:0036092; GO:0040016; GO:0042267; GO:0043409; GO:0043491; GO:0043560; GO:0045429; GO:0046854; GO:0046934; GO:0048015; GO:0051898; GO:0060055; GO:0106310; GO:1900747; GO:1903298; GO:1903671 angiogenesis involved in wound healing [GO:0060055]; autophagy [GO:0006914]; cell migration [GO:0016477]; embryonic cleavage [GO:0040016]; endocytosis [GO:0006897]; endothelial cell proliferation [GO:0001935]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; intracellular calcium ion homeostasis [GO:0006874]; natural killer cell mediated cytotoxicity [GO:0042267]; negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway [GO:1903298]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051898]; negative regulation of sprouting angiogenesis [GO:1903671]; negative regulation of vascular endothelial growth factor signaling pathway [GO:1900747]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; phosphatidylinositol-3-phosphate biosynthetic process [GO:0036092]; phosphatidylinositol-mediated signaling [GO:0048015]; platelet activation [GO:0030168]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of gene expression [GO:0010628]; positive regulation of neutrophil apoptotic process [GO:0033031]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of Rac protein signal transduction [GO:0035022]; regulation of cell-matrix adhesion [GO:0001952]; response to ischemia [GO:0002931]; sphingosine-1-phosphate receptor signaling pathway [GO:0003376] brush border membrane [GO:0031526]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; midbody [GO:0030496]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; phosphatidylinositol 3-kinase complex [GO:0005942]; phosphatidylinositol 3-kinase complex, class IA [GO:0005943]; plasma membrane [GO:0005886] 1-phosphatidylinositol-3-kinase activity [GO:0016303]; 1-phosphatidylinositol-4,5-bisphosphate 3-kinase activity [GO:0046934]; 1-phosphatidylinositol-4-phosphate 3-kinase activity [GO:0035005]; ATP binding [GO:0005524]; insulin receptor substrate binding [GO:0043560]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g12329.t1 Q96DM1 24.101 556 2.5300000000000003e-32 136.0 sp|Q96DM1|PGBD4_HUMAN PiggyBac transposable element-derived protein 4 OS=Homo sapiens OX=9606 GN=PGBD4 PE=1 SV=3 g12330.t1 P31029 55.325 385 1.17e-149 433.0 sp|P31029|AGT1_CALJA Alanine--glyoxylate aminotransferase OS=Callithrix jacchus OX=9483 GN=AGXT PE=2 SV=1 g12331.t1 Q5ZIJ9 32.716 810 1.64e-120 387.0 sp|Q5ZIJ9|MIB2_CHICK E3 ubiquitin-protein ligase MIB2 OS=Gallus gallus OX=9031 GN=MIB2 PE=2 SV=1 g12332.t1 Q80SY4 32.066 789 3.5200000000000004e-117 378.0 sp|Q80SY4|MIB1_MOUSE E3 ubiquitin-protein ligase MIB1 OS=Mus musculus OX=10090 GN=Mib1 PE=1 SV=1 MIB1_MOUSE reviewed E3 ubiquitin-protein ligase MIB1 (EC 2.3.2.27) (DAPK-interacting protein 1) (DIP-1) (Mind bomb homolog 1) (RING-type E3 ubiquitin transferase MIB1) Mus musculus (Mouse) GO:0001568; GO:0001701; GO:0001756; GO:0001841; GO:0001947; GO:0005737; GO:0005813; GO:0005886; GO:0006511; GO:0006897; GO:0007219; GO:0007507; GO:0008270; GO:0014069; GO:0016567; GO:0031410; GO:0034451; GO:0045665; GO:0045807; GO:0061630; GO:0098978 blood vessel development [GO:0001568]; endocytosis [GO:0006897]; heart development [GO:0007507]; heart looping [GO:0001947]; in utero embryonic development [GO:0001701]; negative regulation of neuron differentiation [GO:0045665]; neural tube formation [GO:0001841]; Notch signaling pathway [GO:0007219]; positive regulation of endocytosis [GO:0045807]; protein ubiquitination [GO:0016567]; somitogenesis [GO:0001756]; ubiquitin-dependent protein catabolic process [GO:0006511] centriolar satellite [GO:0034451]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069] ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] g12335.t1 Q6ZXD2 32.588 313 3.91e-45 161.0 sp|Q6ZXD2|SIA8A_BOVIN Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase OS=Bos taurus OX=9913 GN=ST8SIA1 PE=2 SV=1 g12337.t1 Q9I7S6 58.011 362 5.93e-142 449.0 sp|Q9I7S6|PDE9A_DROME High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A OS=Drosophila melanogaster OX=7227 GN=Pde9 PE=2 SV=2 g12339.t1 O35454 55.215 163 1.1e-40 149.0 sp|O35454|CLCN6_MOUSE H(+)/Cl(-) exchange transporter 6 OS=Mus musculus OX=10090 GN=Clcn6 PE=1 SV=1 CLCN6_MOUSE reviewed H(+)/Cl(-) exchange transporter 6 (Chloride channel protein 6) (ClC-6) (Chloride transport protein 6) Mus musculus (Mouse) GO:0005247; GO:0005524; GO:0006821; GO:0009612; GO:0015297; GO:0031902 chloride transport [GO:0006821]; response to mechanical stimulus [GO:0009612] late endosome membrane [GO:0031902] antiporter activity [GO:0015297]; ATP binding [GO:0005524]; voltage-gated chloride channel activity [GO:0005247] g12340.t1 Q9TT16 58.075 644 0.0 659.0 sp|Q9TT16|CLCN6_RABIT H(+)/Cl(-) exchange transporter 6 OS=Oryctolagus cuniculus OX=9986 GN=CLCN6 PE=2 SV=1 g12344.t1 Q6ZSM3 26.799 403 1.65e-27 119.0 sp|Q6ZSM3|MOT12_HUMAN Monocarboxylate transporter 12 OS=Homo sapiens OX=9606 GN=SLC16A12 PE=1 SV=3 MOT12_HUMAN reviewed Monocarboxylate transporter 12 (MCT 12) (Creatine transporter 2) (CRT2) (Solute carrier family 16 member 12) Homo sapiens (Human) GO:0005308; GO:0005886; GO:0015292; GO:0015881; GO:0016323; GO:0022857; GO:0046449; GO:0150104 creatine transmembrane transport [GO:0015881]; creatinine metabolic process [GO:0046449]; transport across blood-brain barrier [GO:0150104] basolateral plasma membrane [GO:0016323]; plasma membrane [GO:0005886] creatine transmembrane transporter activity [GO:0005308]; transmembrane transporter activity [GO:0022857]; uniporter activity [GO:0015292] g12347.t1 P20397 33.038 339 1.45e-41 164.0 sp|P20397|NUCL_XENLA Nucleolin OS=Xenopus laevis OX=8355 GN=ncl PE=2 SV=3 g12348.t1 Q9H0C1 52.071 338 6.17e-119 352.0 sp|Q9H0C1|ZMY12_HUMAN Zinc finger MYND domain-containing protein 12 OS=Homo sapiens OX=9606 GN=ZMYND12 PE=1 SV=3 ZMY12_HUMAN reviewed Zinc finger MYND domain-containing protein 12 Homo sapiens (Human) GO:0007288; GO:0008270; GO:0030317; GO:0036126 flagellated sperm motility [GO:0030317]; sperm axoneme assembly [GO:0007288] sperm flagellum [GO:0036126] zinc ion binding [GO:0008270] g12349.t1 P29274 29.674 337 3.99e-30 122.0 sp|P29274|AA2AR_HUMAN Adenosine receptor A2a OS=Homo sapiens OX=9606 GN=ADORA2A PE=1 SV=2 AA2AR_HUMAN reviewed Adenosine receptor A2a Homo sapiens (Human) GO:0001609; GO:0001963; GO:0001973; GO:0001975; GO:0005516; GO:0005882; GO:0005886; GO:0006355; GO:0006909; GO:0006915; GO:0006954; GO:0006968; GO:0007188; GO:0007189; GO:0007200; GO:0007267; GO:0007271; GO:0007417; GO:0007596; GO:0007600; GO:0007626; GO:0008015; GO:0008285; GO:0008289; GO:0009410; GO:0014049; GO:0014057; GO:0014061; GO:0014074; GO:0016020; GO:0019899; GO:0030425; GO:0030673; GO:0031000; GO:0031802; GO:0032230; GO:0032279; GO:0035249; GO:0035810; GO:0042311; GO:0042734; GO:0042755; GO:0042802; GO:0043025; GO:0043116; GO:0043524; GO:0044877; GO:0045211; GO:0045938; GO:0046636; GO:0048143; GO:0048786; GO:0048812; GO:0050714; GO:0050728; GO:0051393; GO:0051881; GO:0051899; GO:0051924; GO:0051968; GO:0060079; GO:0060080; GO:0060134; GO:0070374; GO:0097190; GO:0098978; GO:0099171; GO:1900273; GO:2001235 adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; apoptotic process [GO:0006915]; apoptotic signaling pathway [GO:0097190]; astrocyte activation [GO:0048143]; blood circulation [GO:0008015]; blood coagulation [GO:0007596]; cell-cell signaling [GO:0007267]; cellular defense response [GO:0006968]; central nervous system development [GO:0007417]; eating behavior [GO:0042755]; excitatory postsynaptic potential [GO:0060079]; G protein-coupled adenosine receptor signaling pathway [GO:0001973]; inflammatory response [GO:0006954]; inhibitory postsynaptic potential [GO:0060080]; locomotory behavior [GO:0007626]; membrane depolarization [GO:0051899]; negative regulation of alpha-beta T cell activation [GO:0046636]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of inflammatory response [GO:0050728]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of vascular permeability [GO:0043116]; neuron projection morphogenesis [GO:0048812]; phagocytosis [GO:0006909]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of acetylcholine secretion, neurotransmission [GO:0014057]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of circadian sleep/wake cycle, sleep [GO:0045938]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of glutamate secretion [GO:0014049]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of protein secretion [GO:0050714]; positive regulation of synaptic transmission, GABAergic [GO:0032230]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; positive regulation of urine volume [GO:0035810]; prepulse inhibition [GO:0060134]; presynaptic modulation of chemical synaptic transmission [GO:0099171]; regulation of calcium ion transport [GO:0051924]; regulation of DNA-templated transcription [GO:0006355]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of norepinephrine secretion [GO:0014061]; response to amphetamine [GO:0001975]; response to caffeine [GO:0031000]; response to purine-containing compound [GO:0014074]; response to xenobiotic stimulus [GO:0009410]; sensory perception [GO:0007600]; synaptic transmission, cholinergic [GO:0007271]; synaptic transmission, dopaminergic [GO:0001963]; synaptic transmission, glutamatergic [GO:0035249]; vasodilation [GO:0042311] asymmetric synapse [GO:0032279]; axolemma [GO:0030673]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; intermediate filament [GO:0005882]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic active zone [GO:0048786]; presynaptic membrane [GO:0042734] alpha-actinin binding [GO:0051393]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; G protein-coupled adenosine receptor activity [GO:0001609]; identical protein binding [GO:0042802]; lipid binding [GO:0008289]; protein-containing complex binding [GO:0044877]; type 5 metabotropic glutamate receptor binding [GO:0031802] g12350.t1 P21912 78.125 256 8.74e-158 443.0 sp|P21912|SDHB_HUMAN Succinate dehydrogenase [ubiquinone] iron-sulfur subunit, mitochondrial OS=Homo sapiens OX=9606 GN=SDHB PE=1 SV=3 SDHB_HUMAN reviewed Succinate dehydrogenase [ubiquinone] iron-sulfur subunit, mitochondrial (EC 1.3.5.1) (Iron-sulfur subunit of complex II) (Ip) (Malate dehydrogenase [quinone] iron-sulfur subunit) (EC 1.1.5.-) Homo sapiens (Human) GO:0005654; GO:0005739; GO:0005743; GO:0005759; GO:0005886; GO:0006099; GO:0006105; GO:0006121; GO:0008177; GO:0009055; GO:0009060; GO:0022904; GO:0031966; GO:0042776; GO:0045273; GO:0046872; GO:0048039; GO:0051537; GO:0051538; GO:0051539 aerobic respiration [GO:0009060]; mitochondrial electron transport, succinate to ubiquinone [GO:0006121]; proton motive force-driven mitochondrial ATP synthesis [GO:0042776]; respiratory electron transport chain [GO:0022904]; succinate metabolic process [GO:0006105]; tricarboxylic acid cycle [GO:0006099] mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; respiratory chain complex II (succinate dehydrogenase) [GO:0045273] 2 iron, 2 sulfur cluster binding [GO:0051537]; 3 iron, 4 sulfur cluster binding [GO:0051538]; 4 iron, 4 sulfur cluster binding [GO:0051539]; electron transfer activity [GO:0009055]; metal ion binding [GO:0046872]; succinate dehydrogenase (quinone) activity [GO:0008177]; ubiquinone binding [GO:0048039] g12351.t1 Q5THJ4 38.538 301 6.32e-47 171.0 sp|Q5THJ4|VP13D_HUMAN Intermembrane lipid transfer protein VPS13D OS=Homo sapiens OX=9606 GN=VPS13D PE=1 SV=2 VP13D_HUMAN reviewed Intermembrane lipid transfer protein VPS13D (Vacuolar protein sorting-associated protein 13D) Homo sapiens (Human) GO:0005739; GO:0006623; GO:0006869; GO:0007005; GO:0045053; GO:0070062; GO:1901526 lipid transport [GO:0006869]; mitochondrion organization [GO:0007005]; positive regulation of mitophagy [GO:1901526]; protein retention in Golgi apparatus [GO:0045053]; protein targeting to vacuole [GO:0006623] extracellular exosome [GO:0070062]; mitochondrion [GO:0005739] g12352.t1 Q5THJ4 39.92 1989 0.0 1303.0 sp|Q5THJ4|VP13D_HUMAN Intermembrane lipid transfer protein VPS13D OS=Homo sapiens OX=9606 GN=VPS13D PE=1 SV=2 VP13D_HUMAN reviewed Intermembrane lipid transfer protein VPS13D (Vacuolar protein sorting-associated protein 13D) Homo sapiens (Human) GO:0005739; GO:0006623; GO:0006869; GO:0007005; GO:0045053; GO:0070062; GO:1901526 lipid transport [GO:0006869]; mitochondrion organization [GO:0007005]; positive regulation of mitophagy [GO:1901526]; protein retention in Golgi apparatus [GO:0045053]; protein targeting to vacuole [GO:0006623] extracellular exosome [GO:0070062]; mitochondrion [GO:0005739] g12352.t1 Q5THJ4 38.427 445 1e-62 243.0 sp|Q5THJ4|VP13D_HUMAN Intermembrane lipid transfer protein VPS13D OS=Homo sapiens OX=9606 GN=VPS13D PE=1 SV=2 VP13D_HUMAN reviewed Intermembrane lipid transfer protein VPS13D (Vacuolar protein sorting-associated protein 13D) Homo sapiens (Human) GO:0005739; GO:0006623; GO:0006869; GO:0007005; GO:0045053; GO:0070062; GO:1901526 lipid transport [GO:0006869]; mitochondrion organization [GO:0007005]; positive regulation of mitophagy [GO:1901526]; protein retention in Golgi apparatus [GO:0045053]; protein targeting to vacuole [GO:0006623] extracellular exosome [GO:0070062]; mitochondrion [GO:0005739] g12354.t1 Q5THJ4 36.852 1099 0.0 659.0 sp|Q5THJ4|VP13D_HUMAN Intermembrane lipid transfer protein VPS13D OS=Homo sapiens OX=9606 GN=VPS13D PE=1 SV=2 VP13D_HUMAN reviewed Intermembrane lipid transfer protein VPS13D (Vacuolar protein sorting-associated protein 13D) Homo sapiens (Human) GO:0005739; GO:0006623; GO:0006869; GO:0007005; GO:0045053; GO:0070062; GO:1901526 lipid transport [GO:0006869]; mitochondrion organization [GO:0007005]; positive regulation of mitophagy [GO:1901526]; protein retention in Golgi apparatus [GO:0045053]; protein targeting to vacuole [GO:0006623] extracellular exosome [GO:0070062]; mitochondrion [GO:0005739] g12355.t1 Q0E908 30.233 430 2.75e-60 226.0 sp|Q0E908|HIL_DROME Hillarin OS=Drosophila melanogaster OX=7227 GN=Hil PE=1 SV=1 HIL_DROME reviewed Hillarin (D-Hillarin) (D-hil) Drosophila melanogaster (Fruit fly) GO:0005737; GO:0005938; GO:0032154; GO:0046872 cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737] metal ion binding [GO:0046872] g12363.t1 Q6NVR9 73.77 61 2.8e-22 65.9 sp|Q6NVR9|ATAD3_XENTR ATPase family AAA domain-containing protein 3 OS=Xenopus tropicalis OX=8364 GN=atad3 PE=2 SV=1 g12363.t1 Q6NVR9 75.0 40 2.8e-22 59.7 sp|Q6NVR9|ATAD3_XENTR ATPase family AAA domain-containing protein 3 OS=Xenopus tropicalis OX=8364 GN=atad3 PE=2 SV=1 g12364.t1 Q58E76 67.813 407 0.0 564.0 sp|Q58E76|ATD3A_XENLA ATPase family AAA domain-containing protein 3-A OS=Xenopus laevis OX=8355 GN=atad3-a PE=2 SV=1 ATD3A_XENLA reviewed ATPase family AAA domain-containing protein 3-A (EC 3.6.1.-) Xenopus laevis (African clawed frog) GO:0005524; GO:0005739; GO:0005743; GO:0007005; GO:0008270; GO:0016887; GO:0030291; GO:0042645; GO:1903898 mitochondrion organization [GO:0007005]; negative regulation of PERK-mediated unfolded protein response [GO:1903898] mitochondrial inner membrane [GO:0005743]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; protein serine/threonine kinase inhibitor activity [GO:0030291]; zinc ion binding [GO:0008270] g12365.t1 Q9SAL0 54.545 264 3.31e-97 296.0 sp|Q9SAL0|RGLG4_ARATH E3 ubiquitin-protein ligase RGLG4 OS=Arabidopsis thaliana OX=3702 GN=RGLG4 PE=1 SV=1 g12365.t2 Q9SAL0 54.167 264 1.96e-94 289.0 sp|Q9SAL0|RGLG4_ARATH E3 ubiquitin-protein ligase RGLG4 OS=Arabidopsis thaliana OX=3702 GN=RGLG4 PE=1 SV=1 g12366.t1 Q9N0C5 48.848 217 8.32e-75 235.0 sp|Q9N0C5|KITM_MACFA Thymidine kinase 2, mitochondrial OS=Macaca fascicularis OX=9541 GN=TK2 PE=2 SV=1 g12367.t1 B1AK53 46.037 328 2.71e-86 282.0 sp|B1AK53|ESPN_HUMAN Espin OS=Homo sapiens OX=9606 GN=ESPN PE=1 SV=1 ESPN_HUMAN reviewed Espin (Autosomal recessive deafness type 36 protein) (Ectoplasmic specialization protein) Homo sapiens (Human) GO:0005737; GO:0005902; GO:0005903; GO:0007605; GO:0017124; GO:0030034; GO:0031941; GO:0032420; GO:0032426; GO:0051015; GO:0051017 actin filament bundle assembly [GO:0051017]; microvillar actin bundle assembly [GO:0030034]; sensory perception of sound [GO:0007605] brush border [GO:0005903]; cytoplasm [GO:0005737]; filamentous actin [GO:0031941]; microvillus [GO:0005902]; stereocilium [GO:0032420]; stereocilium tip [GO:0032426] actin filament binding [GO:0051015]; SH3 domain binding [GO:0017124] g12370.t1 Q12962 75.0 116 2.55e-58 183.0 sp|Q12962|TAF10_HUMAN Transcription initiation factor TFIID subunit 10 OS=Homo sapiens OX=9606 GN=TAF10 PE=1 SV=1 TAF10_HUMAN reviewed Transcription initiation factor TFIID subunit 10 (STAF28) (Transcription initiation factor TFIID 30 kDa subunit) (TAF(II)30) (TAFII-30) (TAFII30) Homo sapiens (Human) GO:0000082; GO:0000124; GO:0001673; GO:0001756; GO:0001892; GO:0003677; GO:0005634; GO:0005654; GO:0005669; GO:0005737; GO:0006282; GO:0006338; GO:0006352; GO:0006355; GO:0006357; GO:0006366; GO:0006367; GO:0006915; GO:0016251; GO:0019899; GO:0030331; GO:0033276; GO:0035264; GO:0036285; GO:0042789; GO:0042802; GO:0043484; GO:0045893; GO:0048371; GO:0048471; GO:0051123; GO:0060173; GO:0060261; GO:0070063; GO:0070365; GO:0097550; GO:1905069; GO:1990841 allantois development [GO:1905069]; apoptotic process [GO:0006915]; chromatin remodeling [GO:0006338]; DNA-templated transcription initiation [GO:0006352]; embryonic placenta development [GO:0001892]; G1/S transition of mitotic cell cycle [GO:0000082]; hepatocyte differentiation [GO:0070365]; lateral mesodermal cell differentiation [GO:0048371]; limb development [GO:0060173]; mRNA transcription by RNA polymerase II [GO:0042789]; multicellular organism growth [GO:0035264]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription initiation by RNA polymerase II [GO:0060261]; regulation of DNA repair [GO:0006282]; regulation of DNA-templated transcription [GO:0006355]; regulation of RNA splicing [GO:0043484]; regulation of transcription by RNA polymerase II [GO:0006357]; RNA polymerase II preinitiation complex assembly [GO:0051123]; SAGA complex assembly [GO:0036285]; somitogenesis [GO:0001756]; transcription by RNA polymerase II [GO:0006366]; transcription initiation at RNA polymerase II promoter [GO:0006367] cytoplasm [GO:0005737]; male germ cell nucleus [GO:0001673]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; SAGA complex [GO:0000124]; transcription factor TFIID complex [GO:0005669]; transcription factor TFTC complex [GO:0033276]; transcription preinitiation complex [GO:0097550] DNA binding [GO:0003677]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; nuclear estrogen receptor binding [GO:0030331]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase binding [GO:0070063]; RNA polymerase II general transcription initiation factor activity [GO:0016251] g12371.t1 Q9CXW2 49.66 294 2.1700000000000001e-103 311.0 sp|Q9CXW2|RT22_MOUSE Small ribosomal subunit protein mS22 OS=Mus musculus OX=10090 GN=Mrps22 PE=1 SV=1 g12376.t1 Q23236 35.961 203 2.4400000000000003e-31 117.0 sp|Q23236|NDX3_CAEEL Nudix hydrolase 3 OS=Caenorhabditis elegans OX=6239 GN=ndx-3 PE=3 SV=2 g12377.t1 Q6TDP4 63.492 63 1.1200000000000002e-21 90.1 sp|Q6TDP4|KLH17_HUMAN Kelch-like protein 17 OS=Homo sapiens OX=9606 GN=KLHL17 PE=1 SV=1 g12378.t1 Q8K430 61.585 492 0.0 613.0 sp|Q8K430|KLH17_RAT Kelch-like protein 17 OS=Rattus norvegicus OX=10116 GN=Klhl17 PE=1 SV=1 KLH17_RAT reviewed Kelch-like protein 17 (Actinfilin) Rattus norvegicus (Rat) GO:0005737; GO:0014069; GO:0015629; GO:0016567; GO:0030036; GO:0031208; GO:0031463; GO:0032839; GO:0043025; GO:0043161; GO:0051015; GO:0060090; GO:0098794; GO:0098978; GO:0140252; GO:1990756 actin cytoskeleton organization [GO:0030036]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation protein catabolic process at postsynapse [GO:0140252] actin cytoskeleton [GO:0015629]; Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; dendrite cytoplasm [GO:0032839]; glutamatergic synapse [GO:0098978]; neuronal cell body [GO:0043025]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069] actin filament binding [GO:0051015]; molecular adaptor activity [GO:0060090]; POZ domain binding [GO:0031208]; ubiquitin-like ligase-substrate adaptor activity [GO:1990756] g12378.t1 Q8K430 50.267 187 3.3e-43 166.0 sp|Q8K430|KLH17_RAT Kelch-like protein 17 OS=Rattus norvegicus OX=10116 GN=Klhl17 PE=1 SV=1 KLH17_RAT reviewed Kelch-like protein 17 (Actinfilin) Rattus norvegicus (Rat) GO:0005737; GO:0014069; GO:0015629; GO:0016567; GO:0030036; GO:0031208; GO:0031463; GO:0032839; GO:0043025; GO:0043161; GO:0051015; GO:0060090; GO:0098794; GO:0098978; GO:0140252; GO:1990756 actin cytoskeleton organization [GO:0030036]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation protein catabolic process at postsynapse [GO:0140252] actin cytoskeleton [GO:0015629]; Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; dendrite cytoplasm [GO:0032839]; glutamatergic synapse [GO:0098978]; neuronal cell body [GO:0043025]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069] actin filament binding [GO:0051015]; molecular adaptor activity [GO:0060090]; POZ domain binding [GO:0031208]; ubiquitin-like ligase-substrate adaptor activity [GO:1990756] g12379.t1 Q5U247 46.2 671 0.0 589.0 sp|Q5U247|EXOC8_XENLA Exocyst complex component 8 OS=Xenopus laevis OX=8355 GN=exoc8 PE=2 SV=1 g12381.t1 Q7SY23 56.278 446 0.0 563.0 sp|Q7SY23|AL4A1_DANRE Delta-1-pyrroline-5-carboxylate dehydrogenase, mitochondrial OS=Danio rerio OX=7955 GN=aldh4a1 PE=2 SV=1 g12383.t1 Q9Y6Y1 43.191 257 7.69e-41 160.0 sp|Q9Y6Y1|CMTA1_HUMAN Calmodulin-binding transcription activator 1 OS=Homo sapiens OX=9606 GN=CAMTA1 PE=1 SV=4 CMTA1_HUMAN reviewed Calmodulin-binding transcription activator 1 Homo sapiens (Human) GO:0003690; GO:0003712; GO:0005634; GO:0005737; GO:0006357; GO:0043565; GO:0045944; GO:0050885; GO:0070886 neuromuscular process controlling balance [GO:0050885]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357] cytoplasm [GO:0005737]; nucleus [GO:0005634] double-stranded DNA binding [GO:0003690]; sequence-specific DNA binding [GO:0043565]; transcription coregulator activity [GO:0003712] g12384.t1 A2A891 49.378 241 5.27e-61 231.0 sp|A2A891|CMTA1_MOUSE Calmodulin-binding transcription activator 1 OS=Mus musculus OX=10090 GN=Camta1 PE=2 SV=1 CMTA1_MOUSE reviewed Calmodulin-binding transcription activator 1 Mus musculus (Mouse) GO:0003690; GO:0003712; GO:0005634; GO:0005737; GO:0006357; GO:0043565; GO:0045944; GO:0050885; GO:0070886 neuromuscular process controlling balance [GO:0050885]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357] cytoplasm [GO:0005737]; nucleus [GO:0005634] double-stranded DNA binding [GO:0003690]; sequence-specific DNA binding [GO:0043565]; transcription coregulator activity [GO:0003712] g12384.t1 A2A891 47.706 218 8.529999999999999e-54 209.0 sp|A2A891|CMTA1_MOUSE Calmodulin-binding transcription activator 1 OS=Mus musculus OX=10090 GN=Camta1 PE=2 SV=1 CMTA1_MOUSE reviewed Calmodulin-binding transcription activator 1 Mus musculus (Mouse) GO:0003690; GO:0003712; GO:0005634; GO:0005737; GO:0006357; GO:0043565; GO:0045944; GO:0050885; GO:0070886 neuromuscular process controlling balance [GO:0050885]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357] cytoplasm [GO:0005737]; nucleus [GO:0005634] double-stranded DNA binding [GO:0003690]; sequence-specific DNA binding [GO:0043565]; transcription coregulator activity [GO:0003712] g12385.t1 Q5PQ76 64.407 177 1.88e-81 243.0 sp|Q5PQ76|CA050_XENLA Uncharacterized protein C1orf50 homolog OS=Xenopus laevis OX=8355 PE=2 SV=1 g12397.t1 Q5R629 54.134 641 0.0 640.0 sp|Q5R629|ARMC9_PONAB LisH domain-containing protein ARMC9 OS=Pongo abelii OX=9601 GN=ARMC9 PE=2 SV=1 ARMC9_PONAB reviewed LisH domain-containing protein ARMC9 Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0005814; GO:0005929; GO:0036064; GO:0045880; GO:0060271; GO:0097542 cilium assembly [GO:0060271]; positive regulation of smoothened signaling pathway [GO:0045880] centriole [GO:0005814]; ciliary basal body [GO:0036064]; ciliary tip [GO:0097542]; cilium [GO:0005929] g12397.t2 Q5R629 54.134 641 0.0 640.0 sp|Q5R629|ARMC9_PONAB LisH domain-containing protein ARMC9 OS=Pongo abelii OX=9601 GN=ARMC9 PE=2 SV=1 ARMC9_PONAB reviewed LisH domain-containing protein ARMC9 Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0005814; GO:0005929; GO:0036064; GO:0045880; GO:0060271; GO:0097542 cilium assembly [GO:0060271]; positive regulation of smoothened signaling pathway [GO:0045880] centriole [GO:0005814]; ciliary basal body [GO:0036064]; ciliary tip [GO:0097542]; cilium [GO:0005929] g12398.t1 O43447 79.33 179 3.47e-103 296.0 sp|O43447|PPIH_HUMAN Peptidyl-prolyl cis-trans isomerase H OS=Homo sapiens OX=9606 GN=PPIH PE=1 SV=1 PPIH_HUMAN reviewed Peptidyl-prolyl cis-trans isomerase H (PPIase H) (EC 5.2.1.8) (Rotamase H) (Small nuclear ribonucleoprotein particle-specific cyclophilin H) (CypH) (U-snRNP-associated cyclophilin SnuCyp-20) (USA-CYP) Homo sapiens (Human) GO:0000398; GO:0003755; GO:0005654; GO:0005681; GO:0005737; GO:0005829; GO:0006457; GO:0016018; GO:0016607; GO:0043021; GO:0045070; GO:0046540; GO:0065003; GO:0071001 mRNA splicing, via spliceosome [GO:0000398]; positive regulation of viral genome replication [GO:0045070]; protein folding [GO:0006457]; protein-containing complex assembly [GO:0065003] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; spliceosomal complex [GO:0005681]; U4/U6 snRNP [GO:0071001]; U4/U6 x U5 tri-snRNP complex [GO:0046540] cyclosporin A binding [GO:0016018]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; ribonucleoprotein complex binding [GO:0043021] g12399.t1 P41824 68.142 113 6.959999999999999e-46 157.0 sp|P41824|YBOXH_APLCA Y-box factor homolog OS=Aplysia californica OX=6500 PE=2 SV=1 g12400.t1 P10160 67.974 153 1.92e-77 229.0 sp|P10160|IF5A1_RABIT Eukaryotic translation initiation factor 5A-1 OS=Oryctolagus cuniculus OX=9986 GN=EIF5A PE=1 SV=2 g12401.t1 P10160 57.718 149 8.02e-63 193.0 sp|P10160|IF5A1_RABIT Eukaryotic translation initiation factor 5A-1 OS=Oryctolagus cuniculus OX=9986 GN=EIF5A PE=1 SV=2 g12402.t1 Q9BUP0 39.548 177 8.15e-32 119.0 sp|Q9BUP0|EFHD1_HUMAN EF-hand domain-containing protein D1 OS=Homo sapiens OX=9606 GN=EFHD1 PE=1 SV=1 g12405.t1 Q92685 61.425 407 1.65e-147 429.0 sp|Q92685|ALG3_HUMAN Dol-P-Man:Man(5)GlcNAc(2)-PP-Dol alpha-1,3-mannosyltransferase OS=Homo sapiens OX=9606 GN=ALG3 PE=1 SV=1 ALG3_HUMAN reviewed Dol-P-Man:Man(5)GlcNAc(2)-PP-Dol alpha-1,3-mannosyltransferase (EC 2.4.1.258) (Asparagine-linked glycosylation protein 3 homolog) (Dol-P-Man-dependent alpha(1-3)-mannosyltransferase) (Dolichyl-P-Man:Man(5)GlcNAc(2)-PP-dolichyl mannosyltransferase) (Dolichyl-phosphate-mannose--glycolipid alpha-mannosyltransferase) (Not56-like protein) Homo sapiens (Human) GO:0000033; GO:0005783; GO:0005789; GO:0006487; GO:0006488; GO:0052925; GO:0098553 dolichol-linked oligosaccharide biosynthetic process [GO:0006488]; protein N-linked glycosylation [GO:0006487] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; lumenal side of endoplasmic reticulum membrane [GO:0098553] alpha-1,3-mannosyltransferase activity [GO:0000033]; dol-P-Man:Man(5)GlcNAc(2)-PP-Dol alpha-1,3-mannosyltransferase activity [GO:0052925] g12407.t1 A9Z1V5 42.412 481 1.88e-106 361.0 sp|A9Z1V5|VW5B1_MOUSE von Willebrand factor A domain-containing protein 5B1 OS=Mus musculus OX=10090 GN=Vwa5b1 PE=2 SV=1 g12411.t1 Q80TQ5 44.118 442 1.66e-117 390.0 sp|Q80TQ5|PKHM2_MOUSE Pleckstrin homology domain-containing family M member 2 OS=Mus musculus OX=10090 GN=Plekhm2 PE=1 SV=2 g12411.t1 Q80TQ5 44.72 161 3.02e-37 155.0 sp|Q80TQ5|PKHM2_MOUSE Pleckstrin homology domain-containing family M member 2 OS=Mus musculus OX=10090 GN=Plekhm2 PE=1 SV=2 g12412.t1 Q13029 39.85 133 9e-24 111.0 sp|Q13029|PRDM2_HUMAN PR domain zinc finger protein 2 OS=Homo sapiens OX=9606 GN=PRDM2 PE=1 SV=3 PRDM2_HUMAN reviewed PR domain zinc finger protein 2 (EC 2.1.1.355) (GATA-3-binding protein G3B) (Lysine N-methyltransferase 8) (MTB-ZF) (MTE-binding protein) (PR domain-containing protein 2) (Retinoblastoma protein-interacting zinc finger protein) (Zinc finger protein RIZ) Homo sapiens (Human) GO:0000122; GO:0000977; GO:0000981; GO:0001227; GO:0001228; GO:0003700; GO:0005634; GO:0005654; GO:0005794; GO:0006355; GO:0006357; GO:0008270; GO:0008340; GO:0032259; GO:0043565; GO:0045944; GO:0140949 determination of adult lifespan [GO:0008340]; methylation [GO:0032259]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA-templated transcription [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357] Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; histone H3K9 trimethyltransferase activity [GO:0140949]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270] g12413.t1 Q13029 32.682 358 7.25e-40 164.0 sp|Q13029|PRDM2_HUMAN PR domain zinc finger protein 2 OS=Homo sapiens OX=9606 GN=PRDM2 PE=1 SV=3 PRDM2_HUMAN reviewed PR domain zinc finger protein 2 (EC 2.1.1.355) (GATA-3-binding protein G3B) (Lysine N-methyltransferase 8) (MTB-ZF) (MTE-binding protein) (PR domain-containing protein 2) (Retinoblastoma protein-interacting zinc finger protein) (Zinc finger protein RIZ) Homo sapiens (Human) GO:0000122; GO:0000977; GO:0000981; GO:0001227; GO:0001228; GO:0003700; GO:0005634; GO:0005654; GO:0005794; GO:0006355; GO:0006357; GO:0008270; GO:0008340; GO:0032259; GO:0043565; GO:0045944; GO:0140949 determination of adult lifespan [GO:0008340]; methylation [GO:0032259]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA-templated transcription [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357] Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; histone H3K9 trimethyltransferase activity [GO:0140949]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270] g12416.t1 P21127 75.959 391 0.0 646.0 sp|P21127|CD11B_HUMAN Cyclin-dependent kinase 11B OS=Homo sapiens OX=9606 GN=CDK11B PE=1 SV=4 CD11B_HUMAN reviewed Cyclin-dependent kinase 11B (EC 2.7.11.22) (EC 2.7.11.23) (Cell division cycle 2-like protein kinase 1) (CLK-1) (Cell division protein kinase 11B) (Galactosyltransferase-associated protein kinase p58/GTA) (PITSLRE serine/threonine-protein kinase CDC2L1) (p58 CLK-1) Homo sapiens (Human) GO:0000278; GO:0000307; GO:0001558; GO:0003723; GO:0004672; GO:0004674; GO:0004693; GO:0005524; GO:0005634; GO:0005737; GO:0006355; GO:0006468; GO:0006915; GO:0042981; GO:0043484; GO:0046605; GO:0050684; GO:0051726; GO:0071962; GO:0106310 apoptotic process [GO:0006915]; mitotic cell cycle [GO:0000278]; mitotic sister chromatid cohesion, centromeric [GO:0071962]; protein phosphorylation [GO:0006468]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of cell growth [GO:0001558]; regulation of centrosome cycle [GO:0046605]; regulation of DNA-templated transcription [GO:0006355]; regulation of mRNA processing [GO:0050684]; regulation of RNA splicing [GO:0043484] cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; nucleus [GO:0005634] ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; RNA binding [GO:0003723] g12417.t1 Q5T0D9 35.814 215 3.47e-46 160.0 sp|Q5T0D9|TPRGL_HUMAN Tumor protein p63-regulated gene 1-like protein OS=Homo sapiens OX=9606 GN=TPRG1L PE=1 SV=1 g12424.t1 Q8BLQ7 37.793 598 6.5e-114 357.0 sp|Q8BLQ7|CTR4_MOUSE Cationic amino acid transporter 4 OS=Mus musculus OX=10090 GN=Slc7a4 PE=1 SV=1 g12425.t1 P24392 43.003 293 4.17e-76 238.0 sp|P24392|PEX2_RAT Peroxisome biogenesis factor 2 OS=Rattus norvegicus OX=10116 GN=Pex2 PE=2 SV=1 g12426.t1 Q8CJ40 40.547 2121 0.0 1164.0 sp|Q8CJ40|CROCC_MOUSE Rootletin OS=Mus musculus OX=10090 GN=Crocc PE=1 SV=2 CROCC_MOUSE reviewed Rootletin (Ciliary rootlet coiled-coil protein) Mus musculus (Mouse) GO:0001917; GO:0003779; GO:0005198; GO:0005200; GO:0005813; GO:0005814; GO:0005829; GO:0005886; GO:0007098; GO:0008104; GO:0010457; GO:0010669; GO:0015629; GO:0019894; GO:0032053; GO:0035253; GO:0036064; GO:0045494; GO:0045724; GO:0051656; GO:0097729; GO:0120219; GO:1903566 centriole-centriole cohesion [GO:0010457]; centrosome cycle [GO:0007098]; ciliary basal body organization [GO:0032053]; epithelial structure maintenance [GO:0010669]; establishment of organelle localization [GO:0051656]; intracellular protein localization [GO:0008104]; photoreceptor cell maintenance [GO:0045494]; positive regulation of cilium assembly [GO:0045724]; positive regulation of protein localization to cilium [GO:1903566] 9+2 motile cilium [GO:0097729]; actin cytoskeleton [GO:0015629]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary rootlet [GO:0035253]; cytosol [GO:0005829]; photoreceptor inner segment [GO:0001917]; plasma membrane [GO:0005886]; subapical part of cell [GO:0120219] actin binding [GO:0003779]; kinesin binding [GO:0019894]; structural constituent of cytoskeleton [GO:0005200]; structural molecule activity [GO:0005198] g12427.t1 Q8BLQ7 41.475 610 1.38e-117 367.0 sp|Q8BLQ7|CTR4_MOUSE Cationic amino acid transporter 4 OS=Mus musculus OX=10090 GN=Slc7a4 PE=1 SV=1 g12430.t1 Q9V477 25.774 807 6.5199999999999996e-52 199.0 sp|Q9V477|TOLL8_DROME Toll-like receptor Tollo OS=Drosophila melanogaster OX=7227 GN=Tollo PE=1 SV=1 TOLL8_DROME reviewed Toll-like receptor Tollo (Toll-like receptor 8) Drosophila melanogaster (Fruit fly) GO:0003401; GO:0005886; GO:0007165; GO:0010559; GO:0016324; GO:0045087; GO:0048018; GO:0048935; GO:0060026 axis elongation [GO:0003401]; convergent extension [GO:0060026]; innate immune response [GO:0045087]; peripheral nervous system neuron development [GO:0048935]; regulation of glycoprotein biosynthetic process [GO:0010559]; signal transduction [GO:0007165] apical plasma membrane [GO:0016324]; plasma membrane [GO:0005886] receptor ligand activity [GO:0048018] g12431.t1 Q5R4Q3 50.0 120 1.57e-29 121.0 sp|Q5R4Q3|SEC62_PONAB Translocation protein SEC62 OS=Pongo abelii OX=9601 GN=SEC62 PE=2 SV=1 g12431.t1 Q5R4Q3 60.204 98 1.05e-26 113.0 sp|Q5R4Q3|SEC62_PONAB Translocation protein SEC62 OS=Pongo abelii OX=9601 GN=SEC62 PE=2 SV=1 g12432.t1 F1QR43 55.192 520 0.0 595.0 sp|F1QR43|GLCEB_DANRE D-glucuronyl C5-epimerase B OS=Danio rerio OX=7955 GN=glceb PE=1 SV=1 GLCEB_DANRE reviewed D-glucuronyl C5-epimerase B (EC 5.1.3.17) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000139; GO:0005794; GO:0015012; GO:0030210; GO:0042802; GO:0046872; GO:0047464 heparan sulfate proteoglycan biosynthetic process [GO:0015012]; heparin proteoglycan biosynthetic process [GO:0030210] Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139] heparosan-N-sulfate-glucuronate 5-epimerase activity [GO:0047464]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872] g21603.t1 Q9D8S9 58.586 99 7.08e-36 123.0 sp|Q9D8S9|BOLA1_MOUSE BolA-like protein 1 OS=Mus musculus OX=10090 GN=Bola1 PE=1 SV=1 g21604.t1 O15072 39.196 796 0.0 576.0 sp|O15072|ATS3_HUMAN A disintegrin and metalloproteinase with thrombospondin motifs 3 OS=Homo sapiens OX=9606 GN=ADAMTS3 PE=1 SV=4 ATS3_HUMAN reviewed A disintegrin and metalloproteinase with thrombospondin motifs 3 (ADAM-TS 3) (ADAM-TS3) (ADAMTS-3) (EC 3.4.24.-) (Procollagen II N-proteinase) (PC II-NP) (Procollagen II amino propeptide-processing enzyme) Homo sapiens (Human) GO:0001701; GO:0004175; GO:0004222; GO:0005576; GO:0005615; GO:0006508; GO:0008201; GO:0008270; GO:0010573; GO:0016485; GO:0030198; GO:0030199; GO:0030574; GO:0031012; GO:0032964; GO:0070062; GO:0097435; GO:1900748 collagen biosynthetic process [GO:0032964]; collagen catabolic process [GO:0030574]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]; in utero embryonic development [GO:0001701]; positive regulation of vascular endothelial growth factor signaling pathway [GO:1900748]; protein processing [GO:0016485]; proteolysis [GO:0006508]; supramolecular fiber organization [GO:0097435]; vascular endothelial growth factor production [GO:0010573] extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615] endopeptidase activity [GO:0004175]; heparin binding [GO:0008201]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270] g21604.t1 O15072 37.748 151 1.02e-22 109.0 sp|O15072|ATS3_HUMAN A disintegrin and metalloproteinase with thrombospondin motifs 3 OS=Homo sapiens OX=9606 GN=ADAMTS3 PE=1 SV=4 ATS3_HUMAN reviewed A disintegrin and metalloproteinase with thrombospondin motifs 3 (ADAM-TS 3) (ADAM-TS3) (ADAMTS-3) (EC 3.4.24.-) (Procollagen II N-proteinase) (PC II-NP) (Procollagen II amino propeptide-processing enzyme) Homo sapiens (Human) GO:0001701; GO:0004175; GO:0004222; GO:0005576; GO:0005615; GO:0006508; GO:0008201; GO:0008270; GO:0010573; GO:0016485; GO:0030198; GO:0030199; GO:0030574; GO:0031012; GO:0032964; GO:0070062; GO:0097435; GO:1900748 collagen biosynthetic process [GO:0032964]; collagen catabolic process [GO:0030574]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]; in utero embryonic development [GO:0001701]; positive regulation of vascular endothelial growth factor signaling pathway [GO:1900748]; protein processing [GO:0016485]; proteolysis [GO:0006508]; supramolecular fiber organization [GO:0097435]; vascular endothelial growth factor production [GO:0010573] extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615] endopeptidase activity [GO:0004175]; heparin binding [GO:0008201]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270] g21608.t1 Q8MPM1 54.57 372 7.32e-131 382.0 sp|Q8MPM1|GELS2_LUMTE Gelsolin-like protein 2 OS=Lumbricus terrestris OX=6398 GN=gelsolin PE=1 SV=1 g21609.t1 Q8MPM1 55.372 363 1.57e-142 410.0 sp|Q8MPM1|GELS2_LUMTE Gelsolin-like protein 2 OS=Lumbricus terrestris OX=6398 GN=gelsolin PE=1 SV=1 g21610.t1 Q8MPM1 49.866 373 2.46e-127 373.0 sp|Q8MPM1|GELS2_LUMTE Gelsolin-like protein 2 OS=Lumbricus terrestris OX=6398 GN=gelsolin PE=1 SV=1 g21611.t1 Q86YA3 48.913 828 0.0 729.0 sp|Q86YA3|ZGRF1_HUMAN 5'-3' DNA helicase ZGRF1 OS=Homo sapiens OX=9606 GN=ZGRF1 PE=1 SV=3 ZGRF1_HUMAN reviewed 5'-3' DNA helicase ZGRF1 (EC 5.6.2.3) (GRF-type zinc finger domain-containing protein 1) Homo sapiens (Human) GO:0000725; GO:0005524; GO:0005634; GO:0006302; GO:0008270; GO:0016787; GO:0035861; GO:0043139 double-strand break repair [GO:0006302]; recombinational repair [GO:0000725] nucleus [GO:0005634]; site of double-strand break [GO:0035861] 5'-3' DNA helicase activity [GO:0043139]; ATP binding [GO:0005524]; hydrolase activity [GO:0016787]; zinc ion binding [GO:0008270] g21612.t1 D3UW23 43.715 883 0.0 738.0 sp|D3UW23|AMPE_BITRH Glutamyl aminopeptidase OS=Bitis rhinoceros OX=715877 PE=1 SV=1 g21613.t1 Q9U637 61.024 254 4.62e-83 257.0 sp|Q9U637|PITX_BRABE Pituitary homeobox x OS=Branchiostoma belcheri OX=7741 GN=Ptx PE=2 SV=1 g21614.t1 Q9U637 69.058 223 5.14e-92 283.0 sp|Q9U637|PITX_BRABE Pituitary homeobox x OS=Branchiostoma belcheri OX=7741 GN=Ptx PE=2 SV=1 g21614.t2 Q9U637 69.058 223 5.1e-93 282.0 sp|Q9U637|PITX_BRABE Pituitary homeobox x OS=Branchiostoma belcheri OX=7741 GN=Ptx PE=2 SV=1 g21617.t1 Q9U637 63.934 183 4.8599999999999994e-61 195.0 sp|Q9U637|PITX_BRABE Pituitary homeobox x OS=Branchiostoma belcheri OX=7741 GN=Ptx PE=2 SV=1 g21618.t2 Q9W751 63.75 80 5.0499999999999995e-25 103.0 sp|Q9W751|PITX1_XENLA Pituitary homeobox 1 OS=Xenopus laevis OX=8355 GN=pitx1 PE=2 SV=1 g21620.t1 Q566X8 75.591 127 1.57e-53 186.0 sp|Q566X8|DMX1B_DANRE Diencephalon/mesencephalon homeobox protein 1-B OS=Danio rerio OX=7955 GN=dmbx1b PE=2 SV=1 DMX1B_DANRE reviewed Diencephalon/mesencephalon homeobox protein 1-B Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000977; GO:0000981; GO:0005634; GO:0006357; GO:0007346; GO:0030901; GO:0050767; GO:0051726; GO:0060041; GO:0061074 midbrain development [GO:0030901]; regulation of cell cycle [GO:0051726]; regulation of mitotic cell cycle [GO:0007346]; regulation of neural retina development [GO:0061074]; regulation of neurogenesis [GO:0050767]; regulation of transcription by RNA polymerase II [GO:0006357]; retina development in camera-type eye [GO:0060041] nucleus [GO:0005634] DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977] g21623.t1 Q566X8 63.866 119 4.7599999999999996e-45 155.0 sp|Q566X8|DMX1B_DANRE Diencephalon/mesencephalon homeobox protein 1-B OS=Danio rerio OX=7955 GN=dmbx1b PE=2 SV=1 DMX1B_DANRE reviewed Diencephalon/mesencephalon homeobox protein 1-B Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000977; GO:0000981; GO:0005634; GO:0006357; GO:0007346; GO:0030901; GO:0050767; GO:0051726; GO:0060041; GO:0061074 midbrain development [GO:0030901]; regulation of cell cycle [GO:0051726]; regulation of mitotic cell cycle [GO:0007346]; regulation of neural retina development [GO:0061074]; regulation of neurogenesis [GO:0050767]; regulation of transcription by RNA polymerase II [GO:0006357]; retina development in camera-type eye [GO:0060041] nucleus [GO:0005634] DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977] g21624.t1 P82808 68.759 685 0.0 986.0 sp|P82808|GFPT1_RAT Glutamine--fructose-6-phosphate aminotransferase [isomerizing] 1 OS=Rattus norvegicus OX=10116 GN=Gfpt1 PE=1 SV=3 GFPT1_RAT reviewed Glutamine--fructose-6-phosphate aminotransferase [isomerizing] 1 (EC 2.6.1.16) (D-fructose-6-phosphate amidotransferase 1) (Glutamine:fructose-6-phosphate amidotransferase 1) (GFAT 1) (GFAT1) (Hexosephosphate aminotransferase 1) Rattus norvegicus (Rat) GO:0004360; GO:0006002; GO:0006042; GO:0006047; GO:0006048; GO:0006487; GO:0009744; GO:0016597; GO:0030246; GO:0032868; GO:0032869; GO:0032922; GO:0042802; GO:0045719; GO:0097367 cellular response to insulin stimulus [GO:0032869]; circadian regulation of gene expression [GO:0032922]; fructose 6-phosphate metabolic process [GO:0006002]; glucosamine biosynthetic process [GO:0006042]; negative regulation of glycogen biosynthetic process [GO:0045719]; protein N-linked glycosylation [GO:0006487]; response to insulin [GO:0032868]; response to sucrose [GO:0009744]; UDP-N-acetylglucosamine biosynthetic process [GO:0006048]; UDP-N-acetylglucosamine metabolic process [GO:0006047] amino acid binding [GO:0016597]; carbohydrate binding [GO:0030246]; carbohydrate derivative binding [GO:0097367]; glutamine-fructose-6-phosphate transaminase (isomerizing) activity [GO:0004360]; identical protein binding [GO:0042802] g21625.t1 Q71U00 84.049 163 1.13e-79 236.0 sp|Q71U00|SKP1_XENLA S-phase kinase-associated protein 1 OS=Xenopus laevis OX=8355 GN=skp1 PE=1 SV=3 g21631.t1 Q3UPL0 54.348 92 5.42e-24 102.0 sp|Q3UPL0|SC31A_MOUSE Protein transport protein Sec31A OS=Mus musculus OX=10090 GN=Sec31a PE=1 SV=2 g21631.t2 Q3UPL0 35.455 220 3e-25 106.0 sp|Q3UPL0|SC31A_MOUSE Protein transport protein Sec31A OS=Mus musculus OX=10090 GN=Sec31a PE=1 SV=2 g21632.t1 Q3UPL0 51.861 833 0.0 871.0 sp|Q3UPL0|SC31A_MOUSE Protein transport protein Sec31A OS=Mus musculus OX=10090 GN=Sec31a PE=1 SV=2 g21633.t1 Q6NTS3 55.882 170 2.1399999999999998e-67 206.0 sp|Q6NTS3|RT24A_XENLA Small ribosomal subunit protein uS3mA OS=Xenopus laevis OX=8355 GN=mrps24-a PE=2 SV=1 g21634.t1 P34714 37.054 224 9.37e-44 152.0 sp|P34714|SPRC_CAEEL SPARC OS=Caenorhabditis elegans OX=6239 GN=ost-1 PE=1 SV=1 g21635.t1 P30975 34.014 294 4.0199999999999994e-46 170.0 sp|P30975|TLR2_DROME Tachykinin-like peptides receptor 99D OS=Drosophila melanogaster OX=7227 GN=TkR99D PE=2 SV=2 g21636.t1 P18163 50.153 652 0.0 665.0 sp|P18163|ACSL1_RAT Long-chain-fatty-acid--CoA ligase 1 OS=Rattus norvegicus OX=10116 GN=Acsl1 PE=1 SV=1 g21637.t1 Q92038 61.486 296 2.92e-132 383.0 sp|Q92038|ACOD_CYPCA Acyl-CoA desaturase OS=Cyprinus carpio OX=7962 PE=2 SV=2 g21638.t1 Q92038 58.176 318 2.0300000000000002e-133 386.0 sp|Q92038|ACOD_CYPCA Acyl-CoA desaturase OS=Cyprinus carpio OX=7962 PE=2 SV=2 g21639.t1 O54750 30.12 415 6.750000000000001e-59 202.0 sp|O54750|CP2J6_MOUSE Cytochrome P450 2J6 OS=Mus musculus OX=10090 GN=Cyp2j6 PE=2 SV=2 g21639.t2 Q9QXF7 33.122 474 1.18e-78 257.0 sp|Q9QXF7|CP2J4_RAT Cytochrome P450 2J4 OS=Rattus norvegicus OX=10116 GN=CYP2J4 PE=1 SV=1 g21641.t1 O73853 35.927 437 2.42e-96 304.0 sp|O73853|CP17A_ICTPU Steroid 17-alpha-hydroxylase/17,20 lyase OS=Ictalurus punctatus OX=7998 GN=cyp17a1 PE=2 SV=1 g21642.t1 O73853 36.547 446 7.590000000000001e-100 313.0 sp|O73853|CP17A_ICTPU Steroid 17-alpha-hydroxylase/17,20 lyase OS=Ictalurus punctatus OX=7998 GN=cyp17a1 PE=2 SV=1 g21645.t1 Q9DCG6 48.966 290 1.97e-94 284.0 sp|Q9DCG6|PBLD1_MOUSE Phenazine biosynthesis-like domain-containing protein 1 OS=Mus musculus OX=10090 GN=Pbld1 PE=1 SV=2 g21646.t1 B1H2N3 51.23 447 1.4600000000000001e-148 435.0 sp|B1H2N3|MICU1_XENTR Calcium uptake protein 1, mitochondrial OS=Xenopus tropicalis OX=8364 GN=micu1 PE=2 SV=2 MICU1_XENTR reviewed Calcium uptake protein 1, mitochondrial (Calcium-binding atopy-related autoantigen 1 homolog) Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0005509; GO:0005743; GO:0005758; GO:0006851; GO:0031966; GO:0036444; GO:0046982; GO:0051560; GO:0051561; GO:0061891; GO:0070509; GO:1903852; GO:1990246 calcium import into the mitochondrion [GO:0036444]; calcium ion import [GO:0070509]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrial calcium ion transmembrane transport [GO:0006851]; positive regulation of cristae formation [GO:1903852]; positive regulation of mitochondrial calcium ion concentration [GO:0051561] mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrial membrane [GO:0031966]; uniplex complex [GO:1990246] calcium ion binding [GO:0005509]; calcium ion sensor activity [GO:0061891]; protein heterodimerization activity [GO:0046982] g21649.t1 Q3UMR5 54.483 290 3.26e-105 314.0 sp|Q3UMR5|MCU_MOUSE Calcium uniporter protein, mitochondrial OS=Mus musculus OX=10090 GN=Mcu PE=1 SV=2 g21650.t1 Q9JID6 47.923 626 0.0 610.0 sp|Q9JID6|ACSL1_CAVPO Long-chain-fatty-acid--CoA ligase 1 OS=Cavia porcellus OX=10141 GN=ACSL1 PE=2 SV=1 g21652.t1 P53992 55.411 767 0.0 847.0 sp|P53992|SC24C_HUMAN Protein transport protein Sec24C OS=Homo sapiens OX=9606 GN=SEC24C PE=1 SV=3 SC24C_HUMAN reviewed Protein transport protein Sec24C (SEC24-related protein C) Homo sapiens (Human) GO:0000149; GO:0001701; GO:0005789; GO:0005829; GO:0006886; GO:0006888; GO:0008270; GO:0012507; GO:0030127; GO:0070971; GO:0090110 COPII-coated vesicle cargo loading [GO:0090110]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; in utero embryonic development [GO:0001701]; intracellular protein transport [GO:0006886] COPII vesicle coat [GO:0030127]; cytosol [GO:0005829]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; ER to Golgi transport vesicle membrane [GO:0012507] SNARE binding [GO:0000149]; zinc ion binding [GO:0008270] g21653.t1 H1AFJ5 32.881 295 1.34e-41 163.0 sp|H1AFJ5|SCNNA_NEOFS Epithelial sodium channel subunit alpha OS=Neoceratodus forsteri OX=7892 GN=scnn1a PE=1 SV=1 SCNNA_NEOFS reviewed Epithelial sodium channel subunit alpha (Alpha-ENaC) (Epithelial Na(+) channel subunit alpha) (Alpha-NaCH) (Amiloride-sensitive sodium channel subunit alpha) (Nonvoltage-gated sodium channel 1 subunit alpha) (SCNEA) Neoceratodus forsteri (Australian lungfish) (Ceratodus forsteri) GO:0001669; GO:0005737; GO:0015280; GO:0016324; GO:0031514; GO:0034706; GO:0035725 sodium ion transmembrane transport [GO:0035725] acrosomal vesicle [GO:0001669]; apical plasma membrane [GO:0016324]; cytoplasm [GO:0005737]; motile cilium [GO:0031514]; sodium channel complex [GO:0034706] ligand-gated sodium channel activity [GO:0015280] g21653.t2 H1AFJ5 32.881 295 2.45e-41 163.0 sp|H1AFJ5|SCNNA_NEOFS Epithelial sodium channel subunit alpha OS=Neoceratodus forsteri OX=7892 GN=scnn1a PE=1 SV=1 SCNNA_NEOFS reviewed Epithelial sodium channel subunit alpha (Alpha-ENaC) (Epithelial Na(+) channel subunit alpha) (Alpha-NaCH) (Amiloride-sensitive sodium channel subunit alpha) (Nonvoltage-gated sodium channel 1 subunit alpha) (SCNEA) Neoceratodus forsteri (Australian lungfish) (Ceratodus forsteri) GO:0001669; GO:0005737; GO:0015280; GO:0016324; GO:0031514; GO:0034706; GO:0035725 sodium ion transmembrane transport [GO:0035725] acrosomal vesicle [GO:0001669]; apical plasma membrane [GO:0016324]; cytoplasm [GO:0005737]; motile cilium [GO:0031514]; sodium channel complex [GO:0034706] ligand-gated sodium channel activity [GO:0015280] g21654.t1 Q96J42 50.435 115 1.65e-24 105.0 sp|Q96J42|TXD15_HUMAN Thioredoxin domain-containing protein 15 OS=Homo sapiens OX=9606 GN=TXNDC15 PE=1 SV=1 g21655.t1 Q5ZJR8 52.344 256 8.44e-84 256.0 sp|Q5ZJR8|ELOV6_CHICK Very long chain fatty acid elongase 6 OS=Gallus gallus OX=9031 GN=ELOVL6 PE=2 SV=1 ELOV6_CHICK reviewed Very long chain fatty acid elongase 6 (EC 2.3.1.199) (3-keto acyl-CoA synthase ELOVL6) (ELOVL fatty acid elongase 6) (ELOVL FA elongase 6) (Elongation of very long chain fatty acids protein 6) (Very long chain 3-ketoacyl-CoA synthase 6) (Very long chain 3-oxoacyl-CoA synthase 6) Gallus gallus (Chicken) GO:0005783; GO:0005789; GO:0006636; GO:0009922; GO:0019367; GO:0034625; GO:0035338; GO:0042759; GO:0042761 fatty acid elongation, monounsaturated fatty acid [GO:0034625]; fatty acid elongation, saturated fatty acid [GO:0019367]; long-chain fatty acid biosynthetic process [GO:0042759]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; unsaturated fatty acid biosynthetic process [GO:0006636]; very long-chain fatty acid biosynthetic process [GO:0042761] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789] fatty acid elongase activity [GO:0009922] g21656.t1 Q6PC64 46.718 259 4.95e-74 231.0 sp|Q6PC64|ELOV6_DANRE Very long chain fatty acid elongase 6 OS=Danio rerio OX=7955 GN=elovl6 PE=2 SV=1 ELOV6_DANRE reviewed Very long chain fatty acid elongase 6 (EC 2.3.1.199) (3-keto acyl-CoA synthase elovl6) (ELOVL fatty acid elongase 6) (ELOVL FA elongase 6) (Elongation of very long chain fatty acids protein 6) (Very long chain 3-ketoacyl-CoA synthase 6) (Very long chain 3-oxoacyl-CoA synthase 6) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005783; GO:0005789; GO:0006636; GO:0009922; GO:0019367; GO:0030148; GO:0030497; GO:0034625; GO:0034626; GO:0035338; GO:0042759; GO:0042761 fatty acid elongation [GO:0030497]; fatty acid elongation, monounsaturated fatty acid [GO:0034625]; fatty acid elongation, polyunsaturated fatty acid [GO:0034626]; fatty acid elongation, saturated fatty acid [GO:0019367]; long-chain fatty acid biosynthetic process [GO:0042759]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; sphingolipid biosynthetic process [GO:0030148]; unsaturated fatty acid biosynthetic process [GO:0006636]; very long-chain fatty acid biosynthetic process [GO:0042761] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789] fatty acid elongase activity [GO:0009922] g21657.t1 Q9VV87 44.097 288 2.4699999999999998e-68 218.0 sp|Q9VV87|ELOV6_DROME Very long chain fatty acid elongase 6 OS=Drosophila melanogaster OX=7227 GN=Baldspot PE=1 SV=2 ELOV6_DROME reviewed Very long chain fatty acid elongase 6 (ELOVL6) (EC 2.3.1.199) (Elongation of very long chain fatty acids protein 6) (Neighbor of abl) (Very-long-chain 3-oxoacyl-CoA synthase) Drosophila melanogaster (Fruit fly) GO:0005741; GO:0005789; GO:0009922; GO:0019367; GO:0030148; GO:0030497; GO:0034625; GO:0034626; GO:0042759; GO:0042761 fatty acid elongation [GO:0030497]; fatty acid elongation, monounsaturated fatty acid [GO:0034625]; fatty acid elongation, polyunsaturated fatty acid [GO:0034626]; fatty acid elongation, saturated fatty acid [GO:0019367]; long-chain fatty acid biosynthetic process [GO:0042759]; sphingolipid biosynthetic process [GO:0030148]; very long-chain fatty acid biosynthetic process [GO:0042761] endoplasmic reticulum membrane [GO:0005789]; mitochondrial outer membrane [GO:0005741] fatty acid elongase activity [GO:0009922] g21658.t1 Q9NYP7 33.333 207 5.46e-24 99.8 sp|Q9NYP7|ELOV5_HUMAN Very long chain fatty acid elongase 5 OS=Homo sapiens OX=9606 GN=ELOVL5 PE=1 SV=1 ELOV5_HUMAN reviewed Very long chain fatty acid elongase 5 (EC 2.3.1.199) (3-keto acyl-CoA synthase ELOVL5) (ELOVL fatty acid elongase 5) (ELOVL FA elongase 5) (Elongation of very long chain fatty acids protein 5) (Fatty acid elongase 1) (hELO1) (Very long chain 3-ketoacyl-CoA synthase 5) (Very long chain 3-oxoacyl-CoA synthase 5) Homo sapiens (Human) GO:0005783; GO:0005789; GO:0006636; GO:0009922; GO:0016020; GO:0019367; GO:0030148; GO:0030425; GO:0034625; GO:0034626; GO:0035338; GO:0036109; GO:0042759; GO:0042761; GO:0043025; GO:0043651; GO:0045723; GO:0097447 alpha-linolenic acid metabolic process [GO:0036109]; fatty acid elongation, monounsaturated fatty acid [GO:0034625]; fatty acid elongation, polyunsaturated fatty acid [GO:0034626]; fatty acid elongation, saturated fatty acid [GO:0019367]; linoleic acid metabolic process [GO:0043651]; long-chain fatty acid biosynthetic process [GO:0042759]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; positive regulation of fatty acid biosynthetic process [GO:0045723]; sphingolipid biosynthetic process [GO:0030148]; unsaturated fatty acid biosynthetic process [GO:0006636]; very long-chain fatty acid biosynthetic process [GO:0042761] dendrite [GO:0030425]; dendritic tree [GO:0097447]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; neuronal cell body [GO:0043025] fatty acid elongase activity [GO:0009922] g21659.t1 C0HM36 40.367 218 2.49e-38 139.0 sp|C0HM36|LEC1_ECHLU Echinolectin 1 OS=Echinometra lucunter OX=105361 PE=1 SV=1 g21661.t1 Q5XH39 71.196 184 1.0399999999999999e-95 285.0 sp|Q5XH39|MARH8_XENLA E3 ubiquitin-protein ligase MARCHF8 OS=Xenopus laevis OX=8355 GN=marchf8 PE=2 SV=2 MARH8_XENLA reviewed E3 ubiquitin-protein ligase MARCHF8 (EC 2.3.2.27) (Membrane-associated RING finger protein 8) (Membrane-associated RING-CH protein VIII) (MARCH-VIII) (RING-type E3 ubiquitin transferase MARCHF8) Xenopus laevis (African clawed frog) GO:0000209; GO:0002495; GO:0004842; GO:0005737; GO:0005764; GO:0005765; GO:0005768; GO:0006955; GO:0008270; GO:0031901; GO:0031902; GO:0042287; GO:0061630 antigen processing and presentation of peptide antigen via MHC class II [GO:0002495]; immune response [GO:0006955]; protein polyubiquitination [GO:0000209] cytoplasm [GO:0005737]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764] MHC protein binding [GO:0042287]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] g21662.t1 Q5F2N2 49.762 420 1.66e-145 430.0 sp|Q5F2N2|OFUT4_ORYLA GDP-fucose protein O-fucosyltransferase 4 OS=Oryzias latipes OX=8090 GN=fut11 PE=2 SV=1 OFUT4_ORYLA reviewed GDP-fucose protein O-fucosyltransferase 4 (EC 2.4.1.221) (Fucosyltransferase XI) (Fuc-TXI) (FucT-XI) (Galactoside 3-L-fucosyltransferase 11) (Fucosyltransferase 11) Oryzias latipes (Japanese rice fish) (Japanese killifish) GO:0000139; GO:0005783; GO:0005789; GO:0046920; GO:0046922; GO:0050714 positive regulation of protein secretion [GO:0050714] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139] alpha-(1->3)-fucosyltransferase activity [GO:0046920]; peptide-O-fucosyltransferase activity [GO:0046922] g21663.t1 A5PLN7 29.421 639 5.11e-43 170.0 sp|A5PLN7|F149A_HUMAN Protein FAM149A OS=Homo sapiens OX=9606 GN=FAM149A PE=1 SV=2 F149A_HUMAN reviewed Protein FAM149A Homo sapiens (Human) g21665.t1 Q91X20 53.537 523 0.0 560.0 sp|Q91X20|ASH2L_MOUSE Set1/Ash2 histone methyltransferase complex subunit ASH2 OS=Mus musculus OX=10090 GN=Ash2l PE=1 SV=1 ASH2L_MOUSE reviewed Set1/Ash2 histone methyltransferase complex subunit ASH2 (ASH2-like protein) Mus musculus (Mouse) GO:0000791; GO:0000976; GO:0005634; GO:0005654; GO:0006974; GO:0008013; GO:0008270; GO:0008284; GO:0035097; GO:0043627; GO:0044665; GO:0044666; GO:0045815; GO:0045944; GO:0048188; GO:0071339 DNA damage response [GO:0006974]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of transcription by RNA polymerase II [GO:0045944]; response to estrogen [GO:0043627]; transcription initiation-coupled chromatin remodeling [GO:0045815] euchromatin [GO:0000791]; histone methyltransferase complex [GO:0035097]; MLL1 complex [GO:0071339]; MLL1/2 complex [GO:0044665]; MLL3/4 complex [GO:0044666]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Set1C/COMPASS complex [GO:0048188] beta-catenin binding [GO:0008013]; transcription cis-regulatory region binding [GO:0000976]; zinc ion binding [GO:0008270] g21666.t1 Q2M2I8 61.517 356 9.670000000000001e-144 466.0 sp|Q2M2I8|AAK1_HUMAN AP2-associated protein kinase 1 OS=Homo sapiens OX=9606 GN=AAK1 PE=1 SV=3 AAK1_HUMAN reviewed AP2-associated protein kinase 1 (EC 2.7.11.1) (Adaptor-associated kinase 1) Homo sapiens (Human) GO:0004674; GO:0005112; GO:0005524; GO:0005829; GO:0005886; GO:0005905; GO:0006468; GO:0030136; GO:0031252; GO:0032880; GO:0035612; GO:0043195; GO:0045747; GO:0050821; GO:0061024; GO:0098793; GO:0106310; GO:0140238; GO:2000369 membrane organization [GO:0061024]; positive regulation of Notch signaling pathway [GO:0045747]; presynaptic endocytosis [GO:0140238]; protein phosphorylation [GO:0006468]; protein stabilization [GO:0050821]; regulation of clathrin-dependent endocytosis [GO:2000369]; regulation of protein localization [GO:0032880] cell leading edge [GO:0031252]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; terminal bouton [GO:0043195] AP-2 adaptor complex binding [GO:0035612]; ATP binding [GO:0005524]; Notch binding [GO:0005112]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g21667.t1 P56966 65.292 291 7.7e-146 415.0 sp|P56966|GGPPS_BOVIN Geranylgeranyl pyrophosphate synthase OS=Bos taurus OX=9913 GN=GGPS1 PE=1 SV=2 g21668.t1 Q5XGC0 41.538 260 1.67e-57 190.0 sp|Q5XGC0|FXL15_XENTR F-box/LRR-repeat protein 15 OS=Xenopus tropicalis OX=8364 GN=fbxl15 PE=2 SV=1 g21669.t1 Q8CDG1 46.01 802 0.0 746.0 sp|Q8CDG1|PIWL2_MOUSE Piwi-like protein 2 OS=Mus musculus OX=10090 GN=Piwil2 PE=1 SV=2 PIWL2_MOUSE reviewed Piwi-like protein 2 (EC 3.1.26.-) Mus musculus (Mouse) GO:0003729; GO:0004521; GO:0005634; GO:0005737; GO:0005829; GO:0007283; GO:0010370; GO:0016787; GO:0030718; GO:0031047; GO:0033391; GO:0034584; GO:0034587; GO:0042754; GO:0043186; GO:0046872; GO:0048477; GO:0048511; GO:0051321; GO:0060903; GO:0071546; GO:0097433; GO:0140965; GO:0140991; GO:0141005; GO:0141006; GO:0141008; GO:0141196; GO:1990923; GO:2000767 germ-line stem cell population maintenance [GO:0030718]; meiotic cell cycle [GO:0051321]; negative regulation of circadian rhythm [GO:0042754]; oogenesis [GO:0048477]; piRNA processing [GO:0034587]; piRNA-mediated gene silencing by mRNA destabilization [GO:0140991]; positive regulation of cytoplasmic translation [GO:2000767]; positive regulation of meiosis I [GO:0060903]; regulatory ncRNA-mediated gene silencing [GO:0031047]; rhythmic process [GO:0048511]; secondary piRNA processing [GO:0140965]; spermatogenesis [GO:0007283]; transposable element silencing by heterochromatin formation [GO:0141005]; transposable element silencing by mRNA destabilization [GO:0141008]; transposable element silencing by piRNA-mediated DNA methylation [GO:0141196]; transposable element silencing by piRNA-mediated heterochromatin formation [GO:0141006] chromatoid body [GO:0033391]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dense body [GO:0097433]; nucleus [GO:0005634]; P granule [GO:0043186]; perinucleolar chromocenter [GO:0010370]; PET complex [GO:1990923]; pi-body [GO:0071546] hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]; mRNA binding [GO:0003729]; piRNA binding [GO:0034584]; RNA endonuclease activity [GO:0004521] g21670.t1 Q9M7Q7 61.069 131 7.54e-49 160.0 sp|Q9M7Q7|PCNA1_ARATH Proliferating cellular nuclear antigen 1 OS=Arabidopsis thaliana OX=3702 GN=PCNA PE=1 SV=2 g21671.t1 Q9M7Q7 54.098 122 2.8e-44 148.0 sp|Q9M7Q7|PCNA1_ARATH Proliferating cellular nuclear antigen 1 OS=Arabidopsis thaliana OX=3702 GN=PCNA PE=1 SV=2 g21673.t1 Q8N264 37.861 346 6.51e-68 233.0 sp|Q8N264|RHG24_HUMAN Rho GTPase-activating protein 24 OS=Homo sapiens OX=9606 GN=ARHGAP24 PE=1 SV=2 g21675.t1 P92208 76.816 358 0.0 585.0 sp|P92208|JNK_DROME Stress-activated protein kinase JNK OS=Drosophila melanogaster OX=7227 GN=bsk PE=1 SV=1 JNK_DROME reviewed Stress-activated protein kinase JNK (dJNK) (EC 2.7.11.24) (Protein basket) Drosophila melanogaster (Fruit fly) GO:0004672; GO:0004674; GO:0004705; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006979; GO:0007254; GO:0007391; GO:0007395; GO:0007411; GO:0007616; GO:0008284; GO:0009408; GO:0010508; GO:0010628; GO:0016319; GO:0019731; GO:0030424; GO:0030425; GO:0030707; GO:0033209; GO:0034599; GO:0034614; GO:0035006; GO:0035313; GO:0042060; GO:0043065; GO:0043068; GO:0043652; GO:0046529; GO:0046843; GO:0046844; GO:0048010; GO:0048615; GO:0048666; GO:0048674; GO:0048675; GO:0048803; GO:0048812; GO:0050829; GO:0061057; GO:0071243; GO:0071276; GO:0071907; GO:0071963; GO:0106310; GO:0140255; GO:1903688; GO:1903689; GO:1904801 antibacterial humoral response [GO:0019731]; axon extension [GO:0048675]; axon guidance [GO:0007411]; cellular response to arsenic-containing substance [GO:0071243]; cellular response to cadmium ion [GO:0071276]; cellular response to oxidative stress [GO:0034599]; cellular response to reactive oxygen species [GO:0034614]; chorion micropyle formation [GO:0046844]; collateral sprouting of injured axon [GO:0048674]; defense response to Gram-negative bacterium [GO:0050829]; determination of digestive tract left/right asymmetry [GO:0071907]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal closure, spreading of leading edge cells [GO:0007395]; embryonic anterior midgut (ectodermal) morphogenesis [GO:0048615]; engulfment of apoptotic cell [GO:0043652]; establishment or maintenance of cell polarity regulating cell shape [GO:0071963]; follicle cell of egg chamber development [GO:0030707]; imaginal disc fusion, thorax closure [GO:0046529]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; JNK cascade [GO:0007254]; long-term memory [GO:0007616]; melanization defense response [GO:0035006]; mushroom body development [GO:0016319]; neuron development [GO:0048666]; neuron projection morphogenesis [GO:0048812]; peptidoglycan recognition protein signaling pathway [GO:0061057]; positive regulation of apoptotic process [GO:0043065]; positive regulation of autophagy [GO:0010508]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron remodeling [GO:1904801]; positive regulation of programmed cell death [GO:0043068]; regulation of cellular response to phosphate starvation [GO:0140255]; regulation of wound healing, spreading of epidermal cells [GO:1903689]; response to heat [GO:0009408]; response to oxidative stress [GO:0006979]; tumor necrosis factor-mediated signaling pathway [GO:0033209]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]; wound healing [GO:0042060]; wound healing, spreading of epidermal cells [GO:0035313] axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] ATP binding [GO:0005524]; JUN kinase activity [GO:0004705]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g21676.t1 Q8N264 51.553 322 8.45e-95 311.0 sp|Q8N264|RHG24_HUMAN Rho GTPase-activating protein 24 OS=Homo sapiens OX=9606 GN=ARHGAP24 PE=1 SV=2 g21677.t1 Q12923 46.45 338 8.6e-77 287.0 sp|Q12923|PTN13_HUMAN Tyrosine-protein phosphatase non-receptor type 13 OS=Homo sapiens OX=9606 GN=PTPN13 PE=1 SV=2 g21677.t1 Q12923 38.947 190 1.63e-28 129.0 sp|Q12923|PTN13_HUMAN Tyrosine-protein phosphatase non-receptor type 13 OS=Homo sapiens OX=9606 GN=PTPN13 PE=1 SV=2 g21677.t1 Q12923 59.551 89 2.45e-25 119.0 sp|Q12923|PTN13_HUMAN Tyrosine-protein phosphatase non-receptor type 13 OS=Homo sapiens OX=9606 GN=PTPN13 PE=1 SV=2 g21677.t1 Q12923 66.216 74 6.7700000000000004e-21 104.0 sp|Q12923|PTN13_HUMAN Tyrosine-protein phosphatase non-receptor type 13 OS=Homo sapiens OX=9606 GN=PTPN13 PE=1 SV=2 g21677.t2 Q12923 46.45 338 1.82e-76 286.0 sp|Q12923|PTN13_HUMAN Tyrosine-protein phosphatase non-receptor type 13 OS=Homo sapiens OX=9606 GN=PTPN13 PE=1 SV=2 g21677.t2 Q12923 38.947 190 1.6900000000000001e-29 132.0 sp|Q12923|PTN13_HUMAN Tyrosine-protein phosphatase non-receptor type 13 OS=Homo sapiens OX=9606 GN=PTPN13 PE=1 SV=2 g21677.t2 Q12923 59.551 89 2.81e-25 119.0 sp|Q12923|PTN13_HUMAN Tyrosine-protein phosphatase non-receptor type 13 OS=Homo sapiens OX=9606 GN=PTPN13 PE=1 SV=2 g21677.t2 Q12923 66.216 74 6.7600000000000005e-21 104.0 sp|Q12923|PTN13_HUMAN Tyrosine-protein phosphatase non-receptor type 13 OS=Homo sapiens OX=9606 GN=PTPN13 PE=1 SV=2 g21678.t1 Q12923 46.104 308 1.32e-82 306.0 sp|Q12923|PTN13_HUMAN Tyrosine-protein phosphatase non-receptor type 13 OS=Homo sapiens OX=9606 GN=PTPN13 PE=1 SV=2 g21678.t2 Q12923 46.104 308 1.77e-82 305.0 sp|Q12923|PTN13_HUMAN Tyrosine-protein phosphatase non-receptor type 13 OS=Homo sapiens OX=9606 GN=PTPN13 PE=1 SV=2 g21679.t1 Q8SY96 69.082 207 3.75e-106 313.0 sp|Q8SY96|NFU1_DROME NFU1 iron-sulfur cluster scaffold homolog, mitochondrial OS=Drosophila melanogaster OX=7227 GN=CG32500 PE=2 SV=1 g21680.t1 B6LS00 64.13 92 2.08e-41 134.0 sp|B6LS00|U728_BRAFL UPF0728 protein OS=Branchiostoma floridae OX=7739 GN=BRAFLDRAFT_270831 PE=3 SV=1 g21681.t1 Q924A0 43.277 476 4.2599999999999995e-68 232.0 sp|Q924A0|TF7L2_MOUSE Transcription factor 7-like 2 OS=Mus musculus OX=10090 GN=Tcf7l2 PE=1 SV=2 g21681.t2 Q924A0 56.126 253 7e-64 222.0 sp|Q924A0|TF7L2_MOUSE Transcription factor 7-like 2 OS=Mus musculus OX=10090 GN=Tcf7l2 PE=1 SV=2 g21682.t1 Q503W7 60.108 371 1.17e-158 452.0 sp|Q503W7|ATD1B_DANRE Outer mitochondrial transmembrane helix translocase OS=Danio rerio OX=7955 GN=atad1b PE=2 SV=2 g21684.t1 O54857 55.714 350 5.31e-122 362.0 sp|O54857|PTEN_RAT Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN OS=Rattus norvegicus OX=10116 GN=Pten PE=1 SV=1 PTEN_RAT reviewed Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN (EC 3.1.3.16) (EC 3.1.3.48) (EC 3.1.3.67) (Inositol polyphosphate 3-phosphatase) (EC 3.1.3.-) (Phosphatase and tensin homolog) Rattus norvegicus (Rat) GO:0001525; GO:0001649; GO:0002902; GO:0004438; GO:0004721; GO:0004722; GO:0004725; GO:0005161; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0006915; GO:0007056; GO:0007270; GO:0007416; GO:0007417; GO:0007507; GO:0007584; GO:0007611; GO:0007613; GO:0007626; GO:0008013; GO:0008138; GO:0008284; GO:0008285; GO:0009410; GO:0009749; GO:0009898; GO:0010043; GO:0010467; GO:0010628; GO:0010666; GO:0010719; GO:0010975; GO:0010977; GO:0010997; GO:0014069; GO:0014823; GO:0016314; GO:0016324; GO:0016477; GO:0016605; GO:0019899; GO:0019901; GO:0021542; GO:0021955; GO:0030165; GO:0030336; GO:0030351; GO:0030534; GO:0030889; GO:0031175; GO:0031642; GO:0031647; GO:0032228; GO:0032286; GO:0032355; GO:0032535; GO:0032755; GO:0032760; GO:0032869; GO:0033198; GO:0033555; GO:0035176; GO:0035255; GO:0035749; GO:0036294; GO:0042130; GO:0042711; GO:0042802; GO:0042995; GO:0043005; GO:0043065; GO:0043066; GO:0043197; GO:0043220; GO:0043491; GO:0043542; GO:0044320; GO:0045211; GO:0045471; GO:0045475; GO:0045666; GO:0045668; GO:0045786; GO:0045792; GO:0045944; GO:0046621; GO:0046685; GO:0046856; GO:0048008; GO:0048679; GO:0048681; GO:0048738; GO:0048853; GO:0048854; GO:0048870; GO:0050680; GO:0050765; GO:0050771; GO:0050821; GO:0051548; GO:0051717; GO:0051726; GO:0051800; GO:0051895; GO:0051896; GO:0051898; GO:0052866; GO:0060024; GO:0060044; GO:0060074; GO:0060134; GO:0060179; GO:0060291; GO:0060292; GO:0060341; GO:0060368; GO:0060736; GO:0060766; GO:0060997; GO:0061002; GO:0070374; GO:0071257; GO:0071361; GO:0071456; GO:0071545; GO:0072709; GO:0090071; GO:0090394; GO:0097105; GO:0097107; GO:0099524; GO:0140678; GO:1900425; GO:1902533; GO:1902807; GO:1903690; GO:1903860; GO:1904262; GO:1904706; GO:1905235; GO:1990090; GO:1990314; GO:1990381; GO:1990757; GO:1990782; GO:2000060; GO:2000109; GO:2000134; GO:2000463; GO:2000773; GO:2000808; GO:2001235 adult behavior [GO:0030534]; angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; brain morphogenesis [GO:0048854]; cardiac muscle tissue development [GO:0048738]; cell migration [GO:0016477]; cell motility [GO:0048870]; cellular response to decreased oxygen levels [GO:0036294]; cellular response to electrical stimulus [GO:0071257]; cellular response to ethanol [GO:0071361]; cellular response to hypoxia [GO:0071456]; cellular response to insulin stimulus [GO:0032869]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to leptin stimulus [GO:0044320]; cellular response to nerve growth factor stimulus [GO:1990090]; cellular response to sorbitol [GO:0072709]; central nervous system development [GO:0007417]; central nervous system myelin maintenance [GO:0032286]; central nervous system neuron axonogenesis [GO:0021955]; dendritic spine morphogenesis [GO:0060997]; dentate gyrus development [GO:0021542]; endothelial cell migration [GO:0043542]; forebrain morphogenesis [GO:0048853]; gene expression [GO:0010467]; heart development [GO:0007507]; inositol phosphate catabolic process [GO:0071545]; learning or memory [GO:0007611]; locomotor rhythm [GO:0045475]; locomotory behavior [GO:0007626]; long-term synaptic depression [GO:0060292]; long-term synaptic potentiation [GO:0060291]; male mating behavior [GO:0060179]; maternal behavior [GO:0042711]; memory [GO:0007613]; multicellular organismal response to stress [GO:0033555]; negative regulation of androgen receptor signaling pathway [GO:0060766]; negative regulation of apoptotic process [GO:0043066]; negative regulation of axon regeneration [GO:0048681]; negative regulation of axonogenesis [GO:0050771]; negative regulation of B cell proliferation [GO:0030889]; negative regulation of cardiac muscle cell proliferation [GO:0060044]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell cycle G1/S phase transition [GO:1902807]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell size [GO:0045792]; negative regulation of cellular senescence [GO:2000773]; negative regulation of defense response to bacterium [GO:1900425]; negative regulation of dendrite extension [GO:1903860]; negative regulation of dendritic spine morphogenesis [GO:0061002]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of excitatory postsynaptic potential [GO:0090394]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of keratinocyte migration [GO:0051548]; negative regulation of myelination [GO:0031642]; negative regulation of neuron projection development [GO:0010977]; negative regulation of organ growth [GO:0046621]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of phagocytosis [GO:0050765]; negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051898]; negative regulation of ribosome biogenesis [GO:0090071]; negative regulation of synaptic vesicle clustering [GO:2000808]; negative regulation of T cell proliferation [GO:0042130]; negative regulation of TORC1 signaling [GO:1904262]; negative regulation of vascular associated smooth muscle cell proliferation [GO:1904706]; negative regulation of wound healing, spreading of epidermal cells [GO:1903690]; neuron projection development [GO:0031175]; neuron-neuron synaptic transmission [GO:0007270]; osteoblast differentiation [GO:0001649]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; phosphatidylinositol dephosphorylation [GO:0046856]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of apoptotic process [GO:0043065]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of cardiac muscle cell apoptotic process [GO:0010666]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of gene expression [GO:0010628]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of intracellular signal transduction [GO:1902533]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; postsynaptic density assembly [GO:0097107]; prepulse inhibition [GO:0060134]; presynaptic membrane assembly [GO:0097105]; prostate gland growth [GO:0060736]; protein stabilization [GO:0050821]; regulation of axon regeneration [GO:0048679]; regulation of B cell apoptotic process [GO:0002902]; regulation of cell cycle [GO:0051726]; regulation of cellular component size [GO:0032535]; regulation of cellular localization [GO:0060341]; regulation of Fc receptor mediated stimulatory signaling pathway [GO:0060368]; regulation of macrophage apoptotic process [GO:2000109]; regulation of neuron projection development [GO:0010975]; regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051896]; regulation of protein stability [GO:0031647]; regulation of synaptic transmission, GABAergic [GO:0032228]; response to activity [GO:0014823]; response to arsenic-containing substance [GO:0046685]; response to ATP [GO:0033198]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to glucose [GO:0009749]; response to nutrient [GO:0007584]; response to quercetin [GO:1905235]; response to xenobiotic stimulus [GO:0009410]; response to zinc ion [GO:0010043]; rhythmic synaptic transmission [GO:0060024]; social behavior [GO:0035176]; spindle assembly involved in female meiosis [GO:0007056]; synapse assembly [GO:0007416]; synapse maturation [GO:0060074] apical plasma membrane [GO:0016324]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; myelin sheath adaxonal region [GO:0035749]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; PML body [GO:0016605]; postsynaptic cytosol [GO:0099524]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; Schmidt-Lanterman incisure [GO:0043220] anaphase-promoting complex binding [GO:0010997]; beta-catenin binding [GO:0008013]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; inositol-1,3,4,5,6-pentakisphosphate 3-phosphatase activity [GO:0030351]; inositol-1,3,4,5-tetrakisphosphate 3-phosphatase activity [GO:0051717]; ionotropic glutamate receptor binding [GO:0035255]; molecular function inhibitor activity [GO:0140678]; PDZ domain binding [GO:0030165]; phosphatidylinositol phosphate phosphatase activity [GO:0052866]; phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity [GO:0016314]; phosphatidylinositol-3,4-bisphosphate 3-phosphatase activity [GO:0051800]; phosphatidylinositol-3-phosphate phosphatase activity [GO:0004438]; phosphoprotein phosphatase activity [GO:0004721]; platelet-derived growth factor receptor binding [GO:0005161]; protein kinase binding [GO:0019901]; protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine kinase binding [GO:1990782]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; ubiquitin ligase activator activity [GO:1990757]; ubiquitin-specific protease binding [GO:1990381] g21685.t1 O54857 55.949 395 1.24e-151 437.0 sp|O54857|PTEN_RAT Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN OS=Rattus norvegicus OX=10116 GN=Pten PE=1 SV=1 PTEN_RAT reviewed Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN (EC 3.1.3.16) (EC 3.1.3.48) (EC 3.1.3.67) (Inositol polyphosphate 3-phosphatase) (EC 3.1.3.-) (Phosphatase and tensin homolog) Rattus norvegicus (Rat) GO:0001525; GO:0001649; GO:0002902; GO:0004438; GO:0004721; GO:0004722; GO:0004725; GO:0005161; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0006915; GO:0007056; GO:0007270; GO:0007416; GO:0007417; GO:0007507; GO:0007584; GO:0007611; GO:0007613; GO:0007626; GO:0008013; GO:0008138; GO:0008284; GO:0008285; GO:0009410; GO:0009749; GO:0009898; GO:0010043; GO:0010467; GO:0010628; GO:0010666; GO:0010719; GO:0010975; GO:0010977; GO:0010997; GO:0014069; GO:0014823; GO:0016314; GO:0016324; GO:0016477; GO:0016605; GO:0019899; GO:0019901; GO:0021542; GO:0021955; GO:0030165; GO:0030336; GO:0030351; GO:0030534; GO:0030889; GO:0031175; GO:0031642; GO:0031647; GO:0032228; GO:0032286; GO:0032355; GO:0032535; GO:0032755; GO:0032760; GO:0032869; GO:0033198; GO:0033555; GO:0035176; GO:0035255; GO:0035749; GO:0036294; GO:0042130; GO:0042711; GO:0042802; GO:0042995; GO:0043005; GO:0043065; GO:0043066; GO:0043197; GO:0043220; GO:0043491; GO:0043542; GO:0044320; GO:0045211; GO:0045471; GO:0045475; GO:0045666; GO:0045668; GO:0045786; GO:0045792; GO:0045944; GO:0046621; GO:0046685; GO:0046856; GO:0048008; GO:0048679; GO:0048681; GO:0048738; GO:0048853; GO:0048854; GO:0048870; GO:0050680; GO:0050765; GO:0050771; GO:0050821; GO:0051548; GO:0051717; GO:0051726; GO:0051800; GO:0051895; GO:0051896; GO:0051898; GO:0052866; GO:0060024; GO:0060044; GO:0060074; GO:0060134; GO:0060179; GO:0060291; GO:0060292; GO:0060341; GO:0060368; GO:0060736; GO:0060766; GO:0060997; GO:0061002; GO:0070374; GO:0071257; GO:0071361; GO:0071456; GO:0071545; GO:0072709; GO:0090071; GO:0090394; GO:0097105; GO:0097107; GO:0099524; GO:0140678; GO:1900425; GO:1902533; GO:1902807; GO:1903690; GO:1903860; GO:1904262; GO:1904706; GO:1905235; GO:1990090; GO:1990314; GO:1990381; GO:1990757; GO:1990782; GO:2000060; GO:2000109; GO:2000134; GO:2000463; GO:2000773; GO:2000808; GO:2001235 adult behavior [GO:0030534]; angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; brain morphogenesis [GO:0048854]; cardiac muscle tissue development [GO:0048738]; cell migration [GO:0016477]; cell motility [GO:0048870]; cellular response to decreased oxygen levels [GO:0036294]; cellular response to electrical stimulus [GO:0071257]; cellular response to ethanol [GO:0071361]; cellular response to hypoxia [GO:0071456]; cellular response to insulin stimulus [GO:0032869]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to leptin stimulus [GO:0044320]; cellular response to nerve growth factor stimulus [GO:1990090]; cellular response to sorbitol [GO:0072709]; central nervous system development [GO:0007417]; central nervous system myelin maintenance [GO:0032286]; central nervous system neuron axonogenesis [GO:0021955]; dendritic spine morphogenesis [GO:0060997]; dentate gyrus development [GO:0021542]; endothelial cell migration [GO:0043542]; forebrain morphogenesis [GO:0048853]; gene expression [GO:0010467]; heart development [GO:0007507]; inositol phosphate catabolic process [GO:0071545]; learning or memory [GO:0007611]; locomotor rhythm [GO:0045475]; locomotory behavior [GO:0007626]; long-term synaptic depression [GO:0060292]; long-term synaptic potentiation [GO:0060291]; male mating behavior [GO:0060179]; maternal behavior [GO:0042711]; memory [GO:0007613]; multicellular organismal response to stress [GO:0033555]; negative regulation of androgen receptor signaling pathway [GO:0060766]; negative regulation of apoptotic process [GO:0043066]; negative regulation of axon regeneration [GO:0048681]; negative regulation of axonogenesis [GO:0050771]; negative regulation of B cell proliferation [GO:0030889]; negative regulation of cardiac muscle cell proliferation [GO:0060044]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell cycle G1/S phase transition [GO:1902807]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell size [GO:0045792]; negative regulation of cellular senescence [GO:2000773]; negative regulation of defense response to bacterium [GO:1900425]; negative regulation of dendrite extension [GO:1903860]; negative regulation of dendritic spine morphogenesis [GO:0061002]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of excitatory postsynaptic potential [GO:0090394]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of keratinocyte migration [GO:0051548]; negative regulation of myelination [GO:0031642]; negative regulation of neuron projection development [GO:0010977]; negative regulation of organ growth [GO:0046621]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of phagocytosis [GO:0050765]; negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051898]; negative regulation of ribosome biogenesis [GO:0090071]; negative regulation of synaptic vesicle clustering [GO:2000808]; negative regulation of T cell proliferation [GO:0042130]; negative regulation of TORC1 signaling [GO:1904262]; negative regulation of vascular associated smooth muscle cell proliferation [GO:1904706]; negative regulation of wound healing, spreading of epidermal cells [GO:1903690]; neuron projection development [GO:0031175]; neuron-neuron synaptic transmission [GO:0007270]; osteoblast differentiation [GO:0001649]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; phosphatidylinositol dephosphorylation [GO:0046856]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of apoptotic process [GO:0043065]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of cardiac muscle cell apoptotic process [GO:0010666]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of gene expression [GO:0010628]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of intracellular signal transduction [GO:1902533]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; postsynaptic density assembly [GO:0097107]; prepulse inhibition [GO:0060134]; presynaptic membrane assembly [GO:0097105]; prostate gland growth [GO:0060736]; protein stabilization [GO:0050821]; regulation of axon regeneration [GO:0048679]; regulation of B cell apoptotic process [GO:0002902]; regulation of cell cycle [GO:0051726]; regulation of cellular component size [GO:0032535]; regulation of cellular localization [GO:0060341]; regulation of Fc receptor mediated stimulatory signaling pathway [GO:0060368]; regulation of macrophage apoptotic process [GO:2000109]; regulation of neuron projection development [GO:0010975]; regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051896]; regulation of protein stability [GO:0031647]; regulation of synaptic transmission, GABAergic [GO:0032228]; response to activity [GO:0014823]; response to arsenic-containing substance [GO:0046685]; response to ATP [GO:0033198]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to glucose [GO:0009749]; response to nutrient [GO:0007584]; response to quercetin [GO:1905235]; response to xenobiotic stimulus [GO:0009410]; response to zinc ion [GO:0010043]; rhythmic synaptic transmission [GO:0060024]; social behavior [GO:0035176]; spindle assembly involved in female meiosis [GO:0007056]; synapse assembly [GO:0007416]; synapse maturation [GO:0060074] apical plasma membrane [GO:0016324]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; myelin sheath adaxonal region [GO:0035749]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; PML body [GO:0016605]; postsynaptic cytosol [GO:0099524]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; Schmidt-Lanterman incisure [GO:0043220] anaphase-promoting complex binding [GO:0010997]; beta-catenin binding [GO:0008013]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; inositol-1,3,4,5,6-pentakisphosphate 3-phosphatase activity [GO:0030351]; inositol-1,3,4,5-tetrakisphosphate 3-phosphatase activity [GO:0051717]; ionotropic glutamate receptor binding [GO:0035255]; molecular function inhibitor activity [GO:0140678]; PDZ domain binding [GO:0030165]; phosphatidylinositol phosphate phosphatase activity [GO:0052866]; phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity [GO:0016314]; phosphatidylinositol-3,4-bisphosphate 3-phosphatase activity [GO:0051800]; phosphatidylinositol-3-phosphate phosphatase activity [GO:0004438]; phosphoprotein phosphatase activity [GO:0004721]; platelet-derived growth factor receptor binding [GO:0005161]; protein kinase binding [GO:0019901]; protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine kinase binding [GO:1990782]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; ubiquitin ligase activator activity [GO:1990757]; ubiquitin-specific protease binding [GO:1990381] g21686.t1 F1LZF0 58.559 111 7.379999999999999e-34 125.0 sp|F1LZF0|KLHL2_RAT Kelch-like protein 2 OS=Rattus norvegicus OX=10116 GN=Klhl2 PE=1 SV=3 g21687.t1 F1LZF0 66.667 393 0.0 565.0 sp|F1LZF0|KLHL2_RAT Kelch-like protein 2 OS=Rattus norvegicus OX=10116 GN=Klhl2 PE=1 SV=3 g21687.t1 F1LZF0 43.902 123 1.4199999999999999e-25 112.0 sp|F1LZF0|KLHL2_RAT Kelch-like protein 2 OS=Rattus norvegicus OX=10116 GN=Klhl2 PE=1 SV=3 g21690.t1 Q5PPZ9 38.058 515 1.23e-100 318.0 sp|Q5PPZ9|GDS1B_XENLA Rap1 GTPase-GDP dissociation stimulator 1-B OS=Xenopus laevis OX=8355 GN=rap1gds1-b PE=2 SV=1 g21690.t2 Q5PPZ9 38.901 455 2.82e-91 291.0 sp|Q5PPZ9|GDS1B_XENLA Rap1 GTPase-GDP dissociation stimulator 1-B OS=Xenopus laevis OX=8355 GN=rap1gds1-b PE=2 SV=1 g21692.t1 Q6TCH7 45.907 281 1.3e-85 263.0 sp|Q6TCH7|PAQR3_HUMAN Progestin and adipoQ receptor family member 3 OS=Homo sapiens OX=9606 GN=PAQR3 PE=1 SV=2 PAQR3_HUMAN reviewed Progestin and adipoQ receptor family member 3 (Progestin and adipoQ receptor family member III) (Raf kinase trapping to Golgi) (RKTG) Homo sapiens (Human) GO:0000139; GO:0001933; GO:0005794; GO:0010977; GO:0032436; GO:0033137; GO:0034067; GO:0035359; GO:0043407; GO:0043495; GO:0045542; GO:1990756; GO:2000640 negative regulation of MAP kinase activity [GO:0043407]; negative regulation of neuron projection development [GO:0010977]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; negative regulation of peroxisome proliferator activated receptor signaling pathway [GO:0035359]; negative regulation of protein phosphorylation [GO:0001933]; positive regulation of cholesterol biosynthetic process [GO:0045542]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of SREBP signaling pathway [GO:2000640]; protein localization to Golgi apparatus [GO:0034067] Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139] protein-membrane adaptor activity [GO:0043495]; ubiquitin-like ligase-substrate adaptor activity [GO:1990756] g21694.t1 Q9WU19 45.38 368 1.91e-92 283.0 sp|Q9WU19|HAOX1_MOUSE 2-Hydroxyacid oxidase 1 OS=Mus musculus OX=10090 GN=Hao1 PE=1 SV=1 HAOX1_MOUSE reviewed 2-Hydroxyacid oxidase 1 (HAOX1) (EC 1.1.3.15) (Glycolate oxidase) (GOX) (Glyoxylate oxidase) (EC 1.2.3.5) Mus musculus (Mouse) GO:0001561; GO:0003973; GO:0005777; GO:0005782; GO:0006545; GO:0006979; GO:0010181; GO:0046296; GO:0047969 fatty acid alpha-oxidation [GO:0001561]; glycine biosynthetic process [GO:0006545]; glycolate catabolic process [GO:0046296]; response to oxidative stress [GO:0006979] peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777] (S)-2-hydroxy-acid oxidase activity [GO:0003973]; FMN binding [GO:0010181]; glyoxylate oxidase activity [GO:0047969] g21695.t1 B0BNF9 44.475 362 3.43e-90 278.0 sp|B0BNF9|HAOX1_RAT 2-Hydroxyacid oxidase 1 OS=Rattus norvegicus OX=10116 GN=Hao1 PE=1 SV=1 HAOX1_RAT reviewed 2-Hydroxyacid oxidase 1 (HAOX1) (EC 1.1.3.15) (Glycolate oxidase) (GOX) (Glyoxylate oxidase) (EC 1.2.3.5) Rattus norvegicus (Rat) GO:0001561; GO:0003973; GO:0005777; GO:0005782; GO:0006545; GO:0006979; GO:0010181; GO:0046296; GO:0047969 fatty acid alpha-oxidation [GO:0001561]; glycine biosynthetic process [GO:0006545]; glycolate catabolic process [GO:0046296]; response to oxidative stress [GO:0006979] peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777] (S)-2-hydroxy-acid oxidase activity [GO:0003973]; FMN binding [GO:0010181]; glyoxylate oxidase activity [GO:0047969] g21696.t1 B0BNF9 47.802 364 7.77e-107 321.0 sp|B0BNF9|HAOX1_RAT 2-Hydroxyacid oxidase 1 OS=Rattus norvegicus OX=10116 GN=Hao1 PE=1 SV=1 HAOX1_RAT reviewed 2-Hydroxyacid oxidase 1 (HAOX1) (EC 1.1.3.15) (Glycolate oxidase) (GOX) (Glyoxylate oxidase) (EC 1.2.3.5) Rattus norvegicus (Rat) GO:0001561; GO:0003973; GO:0005777; GO:0005782; GO:0006545; GO:0006979; GO:0010181; GO:0046296; GO:0047969 fatty acid alpha-oxidation [GO:0001561]; glycine biosynthetic process [GO:0006545]; glycolate catabolic process [GO:0046296]; response to oxidative stress [GO:0006979] peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777] (S)-2-hydroxy-acid oxidase activity [GO:0003973]; FMN binding [GO:0010181]; glyoxylate oxidase activity [GO:0047969] g21698.t1 Q9QUR2 48.498 466 9.16e-153 445.0 sp|Q9QUR2|DCTN4_RAT Dynactin subunit 4 OS=Rattus norvegicus OX=10116 GN=Dctn4 PE=1 SV=1 DCTN4_RAT reviewed Dynactin subunit 4 (Dynactin subunit p62) Rattus norvegicus (Rat) GO:0000776; GO:0000922; GO:0001725; GO:0005813; GO:0005868; GO:0005869; GO:0005925; GO:0005938; GO:0030017 cell cortex [GO:0005938]; centrosome [GO:0005813]; cytoplasmic dynein complex [GO:0005868]; dynactin complex [GO:0005869]; focal adhesion [GO:0005925]; kinetochore [GO:0000776]; sarcomere [GO:0030017]; spindle pole [GO:0000922]; stress fiber [GO:0001725] g21701.t1 G5E8K5 55.536 560 0.0 664.0 sp|G5E8K5|ANK3_MOUSE Ankyrin-3 OS=Mus musculus OX=10090 GN=Ank3 PE=1 SV=1 ANK3_MOUSE reviewed Ankyrin-3 (ANK-3) (Ankyrin-G) Mus musculus (Mouse) GO:0000281; GO:0005200; GO:0005737; GO:0005764; GO:0005886; GO:0007009; GO:0007165; GO:0007409; GO:0007411; GO:0007528; GO:0008089; GO:0008092; GO:0009925; GO:0009986; GO:0010628; GO:0010650; GO:0010765; GO:0010960; GO:0014069; GO:0014704; GO:0014731; GO:0016020; GO:0016323; GO:0016328; GO:0016529; GO:0017080; GO:0019228; GO:0030018; GO:0030315; GO:0030424; GO:0030425; GO:0030507; GO:0030674; GO:0030951; GO:0031594; GO:0032507; GO:0033268; GO:0033270; GO:0034112; GO:0042383; GO:0043001; GO:0043034; GO:0043194; GO:0043266; GO:0044325; GO:0045162; GO:0045184; GO:0045202; GO:0045211; GO:0045296; GO:0045760; GO:0045806; GO:0045838; GO:0050808; GO:0061564; GO:0071286; GO:0071709; GO:0072659; GO:0072660; GO:0090314; GO:0098794; GO:0098978; GO:0099103; GO:0099159; GO:0099612; GO:0140031; GO:1900827; GO:1901224; GO:1902260; GO:1903533; GO:1903784; GO:1904115 anterograde axonal transport [GO:0008089]; axon development [GO:0061564]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; cellular response to magnesium ion [GO:0071286]; clustering of voltage-gated sodium channels [GO:0045162]; establishment of protein localization [GO:0045184]; establishment or maintenance of microtubule cytoskeleton polarity [GO:0030951]; Golgi to plasma membrane protein transport [GO:0043001]; magnesium ion homeostasis [GO:0010960]; maintenance of protein location in cell [GO:0032507]; maintenance of protein location in plasma membrane [GO:0072660]; membrane assembly [GO:0071709]; mitotic cytokinesis [GO:0000281]; negative regulation of delayed rectifier potassium channel activity [GO:1902260]; negative regulation of endocytosis [GO:0045806]; neuromuscular junction development [GO:0007528]; neuronal action potential [GO:0019228]; plasma membrane organization [GO:0007009]; positive regulation of action potential [GO:0045760]; positive regulation of cell communication by electrical coupling [GO:0010650]; positive regulation of gene expression [GO:0010628]; positive regulation of homotypic cell-cell adhesion [GO:0034112]; positive regulation of membrane depolarization during cardiac muscle cell action potential [GO:1900827]; positive regulation of membrane potential [GO:0045838]; positive regulation of non-canonical NF-kappaB signal transduction [GO:1901224]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of sodium ion import across plasma membrane [GO:1903784]; positive regulation of sodium ion transport [GO:0010765]; protein localization to axon [GO:0099612]; protein localization to plasma membrane [GO:0072659]; regulation of modification of postsynaptic structure [GO:0099159]; regulation of potassium ion transport [GO:0043266]; regulation of protein targeting [GO:1903533]; signal transduction [GO:0007165]; synapse organization [GO:0050808] axon [GO:0030424]; axon cytoplasm [GO:1904115]; axon initial segment [GO:0043194]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; costamere [GO:0043034]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; intercalated disc [GO:0014704]; lateral plasma membrane [GO:0016328]; lysosome [GO:0005764]; membrane [GO:0016020]; neuromuscular junction [GO:0031594]; node of Ranvier [GO:0033268]; paranode region of axon [GO:0033270]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; sarcoplasmic reticulum [GO:0016529]; spectrin-associated cytoskeleton [GO:0014731]; synapse [GO:0045202]; T-tubule [GO:0030315]; Z disc [GO:0030018] cadherin binding [GO:0045296]; channel activator activity [GO:0099103]; cytoskeletal protein binding [GO:0008092]; phosphorylation-dependent protein binding [GO:0140031]; protein-macromolecule adaptor activity [GO:0030674]; sodium channel regulator activity [GO:0017080]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]; transmembrane transporter binding [GO:0044325] g21703.t1 Q12955 67.015 861 0.0 1137.0 sp|Q12955|ANK3_HUMAN Ankyrin-3 OS=Homo sapiens OX=9606 GN=ANK3 PE=1 SV=3 g21703.t2 Q12955 66.094 873 0.0 1129.0 sp|Q12955|ANK3_HUMAN Ankyrin-3 OS=Homo sapiens OX=9606 GN=ANK3 PE=1 SV=3 g21711.t1 P54985 76.829 164 1.89e-90 263.0 sp|P54985|PPIA_BLAGE Peptidyl-prolyl cis-trans isomerase OS=Blattella germanica OX=6973 GN=CYPA PE=2 SV=1 g21712.t1 P54985 73.171 164 2.18e-88 258.0 sp|P54985|PPIA_BLAGE Peptidyl-prolyl cis-trans isomerase OS=Blattella germanica OX=6973 GN=CYPA PE=2 SV=1 g21713.t1 Q8TDM6 34.563 732 1.75e-107 387.0 sp|Q8TDM6|DLG5_HUMAN Disks large homolog 5 OS=Homo sapiens OX=9606 GN=DLG5 PE=1 SV=4 g21713.t1 Q8TDM6 38.676 574 1.2399999999999999e-89 329.0 sp|Q8TDM6|DLG5_HUMAN Disks large homolog 5 OS=Homo sapiens OX=9606 GN=DLG5 PE=1 SV=4 g21720.t1 Q805E5 28.992 238 1.81e-22 100.0 sp|Q805E5|CHSTE_DANRE Carbohydrate sulfotransferase 14 OS=Danio rerio OX=7955 GN=chst14 PE=2 SV=1 CHSTE_DANRE reviewed Carbohydrate sulfotransferase 14 (EC 2.8.2.-) (Dermatan 4-sulfotransferase 1) (D4ST-1) (zD4ST-1) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000139; GO:0001537; GO:0008146; GO:0016051; GO:0050655 carbohydrate biosynthetic process [GO:0016051]; dermatan sulfate proteoglycan metabolic process [GO:0050655] Golgi membrane [GO:0000139] dermatan 4-sulfotransferase activity [GO:0001537]; sulfotransferase activity [GO:0008146] g21721.t1 O70209 39.264 326 1.5799999999999998e-67 226.0 sp|O70209|PDLI3_MOUSE PDZ and LIM domain protein 3 OS=Mus musculus OX=10090 GN=Pdlim3 PE=1 SV=1 g21721.t2 O70209 39.264 326 2.58e-67 228.0 sp|O70209|PDLI3_MOUSE PDZ and LIM domain protein 3 OS=Mus musculus OX=10090 GN=Pdlim3 PE=1 SV=1 g21721.t3 O70209 39.264 326 3.11e-67 228.0 sp|O70209|PDLI3_MOUSE PDZ and LIM domain protein 3 OS=Mus musculus OX=10090 GN=Pdlim3 PE=1 SV=1 g21726.t1 Q68F72 31.095 402 4.4599999999999994e-48 180.0 sp|Q68F72|S15A4_XENLA Solute carrier family 15 member 4 OS=Xenopus laevis OX=8355 GN=slc15a4 PE=2 SV=1 S15A4_XENLA reviewed Solute carrier family 15 member 4 Xenopus laevis (African clawed frog) GO:0005290; GO:0005765; GO:0015031; GO:0015333; GO:0015647; GO:0015835; GO:0016020; GO:0031901; GO:0033023; GO:0034157; GO:0034161; GO:0034165; GO:0036020; GO:0045087; GO:0045089; GO:0048302; GO:0070424; GO:0070430; GO:0070434; GO:0071916; GO:0140206 dipeptide import across plasma membrane [GO:0140206]; innate immune response [GO:0045087]; mast cell homeostasis [GO:0033023]; peptidoglycan transport [GO:0015835]; positive regulation of innate immune response [GO:0045089]; positive regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway [GO:0070430]; positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway [GO:0070434]; positive regulation of toll-like receptor 7 signaling pathway [GO:0034157]; positive regulation of toll-like receptor 8 signaling pathway [GO:0034161]; positive regulation of toll-like receptor 9 signaling pathway [GO:0034165]; protein transport [GO:0015031]; regulation of isotype switching to IgG isotypes [GO:0048302]; regulation of nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway [GO:0070424] early endosome membrane [GO:0031901]; endolysosome membrane [GO:0036020]; lysosomal membrane [GO:0005765]; membrane [GO:0016020] dipeptide transmembrane transporter activity [GO:0071916]; L-histidine transmembrane transporter activity [GO:0005290]; peptide:proton symporter activity [GO:0015333]; peptidoglycan transmembrane transporter activity [GO:0015647] g21730.t1 Q9EQD2 35.547 256 2.5799999999999997e-38 141.0 sp|Q9EQD2|NPFF2_RAT Neuropeptide FF receptor 2 OS=Rattus norvegicus OX=10116 GN=Npffr2 PE=2 SV=1 g21731.t1 P06766 67.262 336 1.46e-159 452.0 sp|P06766|DPOLB_RAT DNA polymerase beta OS=Rattus norvegicus OX=10116 GN=Polb PE=1 SV=4 DPOLB_RAT reviewed DNA polymerase beta (EC 2.7.7.7) (5'-deoxyribose-phosphate lyase) (5'-dRP lyase) (EC 4.2.99.-) (AP lyase) (EC 4.2.99.18) Rattus norvegicus (Rat) GO:0001701; GO:0003677; GO:0003684; GO:0003887; GO:0005634; GO:0005737; GO:0005874; GO:0005876; GO:0006260; GO:0006284; GO:0006287; GO:0006290; GO:0006303; GO:0006915; GO:0006954; GO:0006974; GO:0007435; GO:0008017; GO:0008630; GO:0010332; GO:0016445; GO:0016446; GO:0016829; GO:0019899; GO:0032991; GO:0045471; GO:0046872; GO:0048535; GO:0048536; GO:0048872; GO:0051402; GO:0051575; GO:0055093; GO:0071707; GO:0140078 apoptotic process [GO:0006915]; base-excision repair [GO:0006284]; base-excision repair, gap-filling [GO:0006287]; DNA damage response [GO:0006974]; DNA replication [GO:0006260]; double-strand break repair via nonhomologous end joining [GO:0006303]; homeostasis of number of cells [GO:0048872]; immunoglobulin heavy chain V-D-J recombination [GO:0071707]; in utero embryonic development [GO:0001701]; inflammatory response [GO:0006954]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; lymph node development [GO:0048535]; neuron apoptotic process [GO:0051402]; pyrimidine dimer repair [GO:0006290]; response to ethanol [GO:0045471]; response to gamma radiation [GO:0010332]; response to hyperoxia [GO:0055093]; salivary gland morphogenesis [GO:0007435]; somatic diversification of immunoglobulins [GO:0016445]; somatic hypermutation of immunoglobulin genes [GO:0016446]; spleen development [GO:0048536] cytoplasm [GO:0005737]; microtubule [GO:0005874]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; spindle microtubule [GO:0005876] 5'-deoxyribose-5-phosphate lyase activity [GO:0051575]; class I DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0140078]; damaged DNA binding [GO:0003684]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; enzyme binding [GO:0019899]; lyase activity [GO:0016829]; metal ion binding [GO:0046872]; microtubule binding [GO:0008017] g21732.t1 Q3T0T7 69.744 195 5.7e-100 290.0 sp|Q3T0T7|SAR1B_BOVIN Small COPII coat GTPase SAR1B OS=Bos taurus OX=9913 GN=SAR1B PE=2 SV=1 SAR1B_BOVIN reviewed Small COPII coat GTPase SAR1B (EC 3.6.5.2) Bos taurus (Bovine) GO:0003400; GO:0003924; GO:0003925; GO:0005525; GO:0005765; GO:0005789; GO:0005829; GO:0006886; GO:0006888; GO:0016050; GO:0030127; GO:0032368; GO:0032580; GO:0042953; GO:0046872; GO:0048208; GO:0055088; GO:0061024; GO:0070971; GO:0090110; GO:0140353; GO:0140785; GO:1904262; GO:1990253 cellular response to leucine starvation [GO:1990253]; COPII vesicle coating [GO:0048208]; COPII-coated vesicle cargo loading [GO:0090110]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886]; lipid export from cell [GO:0140353]; lipid homeostasis [GO:0055088]; lipoprotein transport [GO:0042953]; membrane organization [GO:0061024]; negative regulation of TORC1 signaling [GO:1904262]; regulation of COPII vesicle coating [GO:0003400]; regulation of lipid transport [GO:0032368]; vesicle organization [GO:0016050] COPII vesicle coat [GO:0030127]; cytosol [GO:0005829]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; Golgi cisterna membrane [GO:0032580]; lysosomal membrane [GO:0005765] amino acid sensor activity [GO:0140785]; G protein activity [GO:0003925]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872] g21733.t1 O95487 54.297 256 9.01e-83 290.0 sp|O95487|SC24B_HUMAN Protein transport protein Sec24B OS=Homo sapiens OX=9606 GN=SEC24B PE=1 SV=2 SC24B_HUMAN reviewed Protein transport protein Sec24B (SEC24-related protein B) Homo sapiens (Human) GO:0000149; GO:0001843; GO:0003151; GO:0005789; GO:0005829; GO:0006886; GO:0006888; GO:0008270; GO:0012507; GO:0021747; GO:0030127; GO:0035909; GO:0060088; GO:0060463; GO:0060982; GO:0061156; GO:0070971; GO:0090110; GO:0090178; GO:1901301 aorta morphogenesis [GO:0035909]; auditory receptor cell stereocilium organization [GO:0060088]; cochlear nucleus development [GO:0021747]; COPII-coated vesicle cargo loading [GO:0090110]; coronary artery morphogenesis [GO:0060982]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886]; lung lobe morphogenesis [GO:0060463]; neural tube closure [GO:0001843]; outflow tract morphogenesis [GO:0003151]; pulmonary artery morphogenesis [GO:0061156]; regulation of cargo loading into COPII-coated vesicle [GO:1901301]; regulation of establishment of planar polarity involved in neural tube closure [GO:0090178] COPII vesicle coat [GO:0030127]; cytosol [GO:0005829]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; ER to Golgi transport vesicle membrane [GO:0012507] SNARE binding [GO:0000149]; zinc ion binding [GO:0008270] g21734.t1 O95487 58.647 532 0.0 650.0 sp|O95487|SC24B_HUMAN Protein transport protein Sec24B OS=Homo sapiens OX=9606 GN=SEC24B PE=1 SV=2 SC24B_HUMAN reviewed Protein transport protein Sec24B (SEC24-related protein B) Homo sapiens (Human) GO:0000149; GO:0001843; GO:0003151; GO:0005789; GO:0005829; GO:0006886; GO:0006888; GO:0008270; GO:0012507; GO:0021747; GO:0030127; GO:0035909; GO:0060088; GO:0060463; GO:0060982; GO:0061156; GO:0070971; GO:0090110; GO:0090178; GO:1901301 aorta morphogenesis [GO:0035909]; auditory receptor cell stereocilium organization [GO:0060088]; cochlear nucleus development [GO:0021747]; COPII-coated vesicle cargo loading [GO:0090110]; coronary artery morphogenesis [GO:0060982]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886]; lung lobe morphogenesis [GO:0060463]; neural tube closure [GO:0001843]; outflow tract morphogenesis [GO:0003151]; pulmonary artery morphogenesis [GO:0061156]; regulation of cargo loading into COPII-coated vesicle [GO:1901301]; regulation of establishment of planar polarity involved in neural tube closure [GO:0090178] COPII vesicle coat [GO:0030127]; cytosol [GO:0005829]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; ER to Golgi transport vesicle membrane [GO:0012507] SNARE binding [GO:0000149]; zinc ion binding [GO:0008270] g21736.t1 O46658 39.332 389 9.61e-84 266.0 sp|O46658|CP2DP_PIG Vitamin D(3) 25-hydroxylase OS=Sus scrofa OX=9823 GN=CYP2D25 PE=1 SV=3 g21737.t1 Q9VW71 23.429 1400 1.84e-33 147.0 sp|Q9VW71|FAT2_DROME Fat-like cadherin-related tumor suppressor homolog OS=Drosophila melanogaster OX=7227 GN=kug PE=2 SV=3 FAT2_DROME reviewed Fat-like cadherin-related tumor suppressor homolog (Protein kugelei) Drosophila melanogaster (Fruit fly) GO:0005509; GO:0005886; GO:0005912; GO:0005925; GO:0007156; GO:0007295; GO:0007424; GO:0007431; GO:0007440; GO:0007442; GO:0009925; GO:0016339; GO:0030950; GO:0031254; GO:0042247; GO:0044331; GO:0044877; GO:0045089; GO:0048477; GO:0050829; GO:0050839; GO:0051491; GO:0060269; GO:0098858; GO:1902463 calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell-cell adhesion mediated by cadherin [GO:0044331]; centripetally migrating follicle cell migration [GO:0060269]; defense response to Gram-negative bacterium [GO:0050829]; establishment of planar polarity of follicular epithelium [GO:0042247]; establishment or maintenance of actin cytoskeleton polarity [GO:0030950]; foregut morphogenesis [GO:0007440]; growth of a germarium-derived egg chamber [GO:0007295]; hindgut morphogenesis [GO:0007442]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; oogenesis [GO:0048477]; open tracheal system development [GO:0007424]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of innate immune response [GO:0045089]; protein localization to cell leading edge [GO:1902463]; salivary gland development [GO:0007431] actin-based cell projection [GO:0098858]; adherens junction [GO:0005912]; basal plasma membrane [GO:0009925]; cell trailing edge [GO:0031254]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; protein-containing complex binding [GO:0044877] g21738.t1 Q7LGC8 27.826 345 1.09e-31 128.0 sp|Q7LGC8|CHST3_HUMAN Carbohydrate sulfotransferase 3 OS=Homo sapiens OX=9606 GN=CHST3 PE=1 SV=3 CHST3_HUMAN reviewed Carbohydrate sulfotransferase 3 (EC 2.8.2.17) (EC 2.8.2.21) (Chondroitin 6-O-sulfotransferase 1) (C6ST-1) (Chondroitin 6-sulfotransferase) (C6ST) (Galactose/N-acetylglucosamine/N-acetylglucosamine 6-O-sulfotransferase 0) (GST-0) Homo sapiens (Human) GO:0000139; GO:0001517; GO:0005975; GO:0006044; GO:0006790; GO:0008459; GO:0018146; GO:0043029; GO:0045130; GO:0050650 carbohydrate metabolic process [GO:0005975]; chondroitin sulfate proteoglycan biosynthetic process [GO:0050650]; keratan sulfate proteoglycan biosynthetic process [GO:0018146]; N-acetylglucosamine metabolic process [GO:0006044]; sulfur compound metabolic process [GO:0006790]; T cell homeostasis [GO:0043029] Golgi membrane [GO:0000139] chondroitin 6-sulfotransferase activity [GO:0008459]; keratan sulfotransferase activity [GO:0045130]; N-acetylglucosamine 6-O-sulfotransferase activity [GO:0001517] g21739.t1 P25867 91.156 147 1.02e-88 258.0 sp|P25867|UBCD1_DROME Ubiquitin-conjugating enzyme E2-17 kDa OS=Drosophila melanogaster OX=7227 GN=eff PE=1 SV=1 g21740.t1 Q6P2X9 27.045 440 1.77e-36 144.0 sp|Q6P2X9|MOT12_XENTR Monocarboxylate transporter 12 OS=Xenopus tropicalis OX=8364 GN=slc16a12 PE=2 SV=1 g21741.t1 Q8BGC3 29.31 232 8.52e-32 134.0 sp|Q8BGC3|MOT12_MOUSE Monocarboxylate transporter 12 OS=Mus musculus OX=10090 GN=Slc16a12 PE=1 SV=1 g21741.t2 Q8BGC3 29.31 232 8.23e-32 134.0 sp|Q8BGC3|MOT12_MOUSE Monocarboxylate transporter 12 OS=Mus musculus OX=10090 GN=Slc16a12 PE=1 SV=1 g21745.t1 Q28GB8 28.977 352 7.63e-37 143.0 sp|Q28GB8|NODAL_XENTR Nodal homolog OS=Xenopus tropicalis OX=8364 GN=nodal PE=2 SV=1 NODAL_XENTR reviewed Nodal homolog (Nodal-related protein 1) Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0003401; GO:0005125; GO:0005615; GO:0007368; GO:0007507; GO:0008083; GO:0048320; GO:0055110 axial mesoderm formation [GO:0048320]; axis elongation [GO:0003401]; determination of left/right symmetry [GO:0007368]; heart development [GO:0007507]; involution involved in gastrulation with mouth forming second [GO:0055110] extracellular space [GO:0005615] cytokine activity [GO:0005125]; growth factor activity [GO:0008083] g21746.t1 Q920G9 52.36 445 3.64e-162 472.0 sp|Q920G9|GMCL1_MOUSE Germ cell-less protein-like 1 OS=Mus musculus OX=10090 GN=Gmcl1 PE=1 SV=2 g21747.t1 Q96M20 27.126 247 6.1900000000000006e-21 99.4 sp|Q96M20|CNBD2_HUMAN Cyclic nucleotide-binding domain-containing protein 2 OS=Homo sapiens OX=9606 GN=CNBD2 PE=1 SV=2 g21749.t1 Q7Z5K2 42.19 685 2.02e-111 376.0 sp|Q7Z5K2|WAPL_HUMAN Wings apart-like protein homolog OS=Homo sapiens OX=9606 GN=WAPL PE=1 SV=1 WAPL_HUMAN reviewed Wings apart-like protein homolog (Friend of EBNA2 protein) (WAPL cohesin release factor) Homo sapiens (Human) GO:0000070; GO:0000775; GO:0000785; GO:0005634; GO:0005654; GO:0005694; GO:0005737; GO:0005829; GO:0008156; GO:0035562; GO:0045171; GO:0045875; GO:0051301; GO:0071168; GO:0072686; GO:0140083 cell division [GO:0051301]; mitotic sister chromatid segregation [GO:0000070]; negative regulation of chromatin binding [GO:0035562]; negative regulation of DNA replication [GO:0008156]; negative regulation of sister chromatid cohesion [GO:0045875]; protein localization to chromatin [GO:0071168] chromatin [GO:0000785]; chromosome [GO:0005694]; chromosome, centromeric region [GO:0000775]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intercellular bridge [GO:0045171]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] ATP-dependent protein-DNA unloader activity [GO:0140083] g21751.t1 Q99NH0 65.753 730 0.0 822.0 sp|Q99NH0|ANR17_MOUSE Ankyrin repeat domain-containing protein 17 OS=Mus musculus OX=10090 GN=Ankrd17 PE=1 SV=2 g21751.t1 Q99NH0 37.784 352 3.46e-53 206.0 sp|Q99NH0|ANR17_MOUSE Ankyrin repeat domain-containing protein 17 OS=Mus musculus OX=10090 GN=Ankrd17 PE=1 SV=2 g21751.t1 Q99NH0 34.961 389 8.799999999999999e-48 189.0 sp|Q99NH0|ANR17_MOUSE Ankyrin repeat domain-containing protein 17 OS=Mus musculus OX=10090 GN=Ankrd17 PE=1 SV=2 g21751.t1 Q99NH0 34.153 366 2.32e-40 166.0 sp|Q99NH0|ANR17_MOUSE Ankyrin repeat domain-containing protein 17 OS=Mus musculus OX=10090 GN=Ankrd17 PE=1 SV=2 g21751.t1 Q99NH0 35.106 376 1.91e-35 150.0 sp|Q99NH0|ANR17_MOUSE Ankyrin repeat domain-containing protein 17 OS=Mus musculus OX=10090 GN=Ankrd17 PE=1 SV=2 g21751.t1 Q99NH0 37.023 262 7.470000000000001e-31 135.0 sp|Q99NH0|ANR17_MOUSE Ankyrin repeat domain-containing protein 17 OS=Mus musculus OX=10090 GN=Ankrd17 PE=1 SV=2 g21751.t2 O75179 72.926 639 0.0 842.0 sp|O75179|ANR17_HUMAN Ankyrin repeat domain-containing protein 17 OS=Homo sapiens OX=9606 GN=ANKRD17 PE=1 SV=3 ANR17_HUMAN reviewed Ankyrin repeat domain-containing protein 17 (Gene trap ankyrin repeat protein) (Serologically defined breast cancer antigen NY-BR-16) Homo sapiens (Human) GO:0000785; GO:0003682; GO:0003723; GO:0005634; GO:0005654; GO:0005737; GO:0006275; GO:0016020; GO:0031965; GO:0042742; GO:0043123; GO:0045087; GO:0045787; GO:1900087; GO:1900245; GO:1900246 defense response to bacterium [GO:0042742]; innate immune response [GO:0045087]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of cell cycle [GO:0045787]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of MDA-5 signaling pathway [GO:1900245]; positive regulation of RIG-I signaling pathway [GO:1900246]; regulation of DNA replication [GO:0006275] chromatin [GO:0000785]; cytoplasm [GO:0005737]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] chromatin binding [GO:0003682]; RNA binding [GO:0003723] g21751.t2 O75179 37.401 377 2.7499999999999997e-54 209.0 sp|O75179|ANR17_HUMAN Ankyrin repeat domain-containing protein 17 OS=Homo sapiens OX=9606 GN=ANKRD17 PE=1 SV=3 ANR17_HUMAN reviewed Ankyrin repeat domain-containing protein 17 (Gene trap ankyrin repeat protein) (Serologically defined breast cancer antigen NY-BR-16) Homo sapiens (Human) GO:0000785; GO:0003682; GO:0003723; GO:0005634; GO:0005654; GO:0005737; GO:0006275; GO:0016020; GO:0031965; GO:0042742; GO:0043123; GO:0045087; GO:0045787; GO:1900087; GO:1900245; GO:1900246 defense response to bacterium [GO:0042742]; innate immune response [GO:0045087]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of cell cycle [GO:0045787]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of MDA-5 signaling pathway [GO:1900245]; positive regulation of RIG-I signaling pathway [GO:1900246]; regulation of DNA replication [GO:0006275] chromatin [GO:0000785]; cytoplasm [GO:0005737]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] chromatin binding [GO:0003682]; RNA binding [GO:0003723] g21751.t2 O75179 36.461 373 3.36e-49 194.0 sp|O75179|ANR17_HUMAN Ankyrin repeat domain-containing protein 17 OS=Homo sapiens OX=9606 GN=ANKRD17 PE=1 SV=3 ANR17_HUMAN reviewed Ankyrin repeat domain-containing protein 17 (Gene trap ankyrin repeat protein) (Serologically defined breast cancer antigen NY-BR-16) Homo sapiens (Human) GO:0000785; GO:0003682; GO:0003723; GO:0005634; GO:0005654; GO:0005737; GO:0006275; GO:0016020; GO:0031965; GO:0042742; GO:0043123; GO:0045087; GO:0045787; GO:1900087; GO:1900245; GO:1900246 defense response to bacterium [GO:0042742]; innate immune response [GO:0045087]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of cell cycle [GO:0045787]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of MDA-5 signaling pathway [GO:1900245]; positive regulation of RIG-I signaling pathway [GO:1900246]; regulation of DNA replication [GO:0006275] chromatin [GO:0000785]; cytoplasm [GO:0005737]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] chromatin binding [GO:0003682]; RNA binding [GO:0003723] g21751.t2 O75179 33.88 366 5.7e-40 164.0 sp|O75179|ANR17_HUMAN Ankyrin repeat domain-containing protein 17 OS=Homo sapiens OX=9606 GN=ANKRD17 PE=1 SV=3 ANR17_HUMAN reviewed Ankyrin repeat domain-containing protein 17 (Gene trap ankyrin repeat protein) (Serologically defined breast cancer antigen NY-BR-16) Homo sapiens (Human) GO:0000785; GO:0003682; GO:0003723; GO:0005634; GO:0005654; GO:0005737; GO:0006275; GO:0016020; GO:0031965; GO:0042742; GO:0043123; GO:0045087; GO:0045787; GO:1900087; GO:1900245; GO:1900246 defense response to bacterium [GO:0042742]; innate immune response [GO:0045087]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of cell cycle [GO:0045787]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of MDA-5 signaling pathway [GO:1900245]; positive regulation of RIG-I signaling pathway [GO:1900246]; regulation of DNA replication [GO:0006275] chromatin [GO:0000785]; cytoplasm [GO:0005737]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] chromatin binding [GO:0003682]; RNA binding [GO:0003723] g21751.t2 O75179 35.106 376 3.82e-36 152.0 sp|O75179|ANR17_HUMAN Ankyrin repeat domain-containing protein 17 OS=Homo sapiens OX=9606 GN=ANKRD17 PE=1 SV=3 ANR17_HUMAN reviewed Ankyrin repeat domain-containing protein 17 (Gene trap ankyrin repeat protein) (Serologically defined breast cancer antigen NY-BR-16) Homo sapiens (Human) GO:0000785; GO:0003682; GO:0003723; GO:0005634; GO:0005654; GO:0005737; GO:0006275; GO:0016020; GO:0031965; GO:0042742; GO:0043123; GO:0045087; GO:0045787; GO:1900087; GO:1900245; GO:1900246 defense response to bacterium [GO:0042742]; innate immune response [GO:0045087]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of cell cycle [GO:0045787]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of MDA-5 signaling pathway [GO:1900245]; positive regulation of RIG-I signaling pathway [GO:1900246]; regulation of DNA replication [GO:0006275] chromatin [GO:0000785]; cytoplasm [GO:0005737]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] chromatin binding [GO:0003682]; RNA binding [GO:0003723] g21751.t2 O75179 37.023 262 7.380000000000001e-31 135.0 sp|O75179|ANR17_HUMAN Ankyrin repeat domain-containing protein 17 OS=Homo sapiens OX=9606 GN=ANKRD17 PE=1 SV=3 ANR17_HUMAN reviewed Ankyrin repeat domain-containing protein 17 (Gene trap ankyrin repeat protein) (Serologically defined breast cancer antigen NY-BR-16) Homo sapiens (Human) GO:0000785; GO:0003682; GO:0003723; GO:0005634; GO:0005654; GO:0005737; GO:0006275; GO:0016020; GO:0031965; GO:0042742; GO:0043123; GO:0045087; GO:0045787; GO:1900087; GO:1900245; GO:1900246 defense response to bacterium [GO:0042742]; innate immune response [GO:0045087]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of cell cycle [GO:0045787]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of MDA-5 signaling pathway [GO:1900245]; positive regulation of RIG-I signaling pathway [GO:1900246]; regulation of DNA replication [GO:0006275] chromatin [GO:0000785]; cytoplasm [GO:0005737]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] chromatin binding [GO:0003682]; RNA binding [GO:0003723] g21753.t1 O75179 85.588 340 0.0 609.0 sp|O75179|ANR17_HUMAN Ankyrin repeat domain-containing protein 17 OS=Homo sapiens OX=9606 GN=ANKRD17 PE=1 SV=3 ANR17_HUMAN reviewed Ankyrin repeat domain-containing protein 17 (Gene trap ankyrin repeat protein) (Serologically defined breast cancer antigen NY-BR-16) Homo sapiens (Human) GO:0000785; GO:0003682; GO:0003723; GO:0005634; GO:0005654; GO:0005737; GO:0006275; GO:0016020; GO:0031965; GO:0042742; GO:0043123; GO:0045087; GO:0045787; GO:1900087; GO:1900245; GO:1900246 defense response to bacterium [GO:0042742]; innate immune response [GO:0045087]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of cell cycle [GO:0045787]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of MDA-5 signaling pathway [GO:1900245]; positive regulation of RIG-I signaling pathway [GO:1900246]; regulation of DNA replication [GO:0006275] chromatin [GO:0000785]; cytoplasm [GO:0005737]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] chromatin binding [GO:0003682]; RNA binding [GO:0003723] g21753.t1 O75179 34.421 337 1.57e-42 174.0 sp|O75179|ANR17_HUMAN Ankyrin repeat domain-containing protein 17 OS=Homo sapiens OX=9606 GN=ANKRD17 PE=1 SV=3 ANR17_HUMAN reviewed Ankyrin repeat domain-containing protein 17 (Gene trap ankyrin repeat protein) (Serologically defined breast cancer antigen NY-BR-16) Homo sapiens (Human) GO:0000785; GO:0003682; GO:0003723; GO:0005634; GO:0005654; GO:0005737; GO:0006275; GO:0016020; GO:0031965; GO:0042742; GO:0043123; GO:0045087; GO:0045787; GO:1900087; GO:1900245; GO:1900246 defense response to bacterium [GO:0042742]; innate immune response [GO:0045087]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of cell cycle [GO:0045787]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of MDA-5 signaling pathway [GO:1900245]; positive regulation of RIG-I signaling pathway [GO:1900246]; regulation of DNA replication [GO:0006275] chromatin [GO:0000785]; cytoplasm [GO:0005737]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] chromatin binding [GO:0003682]; RNA binding [GO:0003723] g21753.t1 O75179 32.537 335 7.76e-40 165.0 sp|O75179|ANR17_HUMAN Ankyrin repeat domain-containing protein 17 OS=Homo sapiens OX=9606 GN=ANKRD17 PE=1 SV=3 ANR17_HUMAN reviewed Ankyrin repeat domain-containing protein 17 (Gene trap ankyrin repeat protein) (Serologically defined breast cancer antigen NY-BR-16) Homo sapiens (Human) GO:0000785; GO:0003682; GO:0003723; GO:0005634; GO:0005654; GO:0005737; GO:0006275; GO:0016020; GO:0031965; GO:0042742; GO:0043123; GO:0045087; GO:0045787; GO:1900087; GO:1900245; GO:1900246 defense response to bacterium [GO:0042742]; innate immune response [GO:0045087]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of cell cycle [GO:0045787]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of MDA-5 signaling pathway [GO:1900245]; positive regulation of RIG-I signaling pathway [GO:1900246]; regulation of DNA replication [GO:0006275] chromatin [GO:0000785]; cytoplasm [GO:0005737]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] chromatin binding [GO:0003682]; RNA binding [GO:0003723] g21753.t1 O75179 35.836 293 1.02e-34 148.0 sp|O75179|ANR17_HUMAN Ankyrin repeat domain-containing protein 17 OS=Homo sapiens OX=9606 GN=ANKRD17 PE=1 SV=3 ANR17_HUMAN reviewed Ankyrin repeat domain-containing protein 17 (Gene trap ankyrin repeat protein) (Serologically defined breast cancer antigen NY-BR-16) Homo sapiens (Human) GO:0000785; GO:0003682; GO:0003723; GO:0005634; GO:0005654; GO:0005737; GO:0006275; GO:0016020; GO:0031965; GO:0042742; GO:0043123; GO:0045087; GO:0045787; GO:1900087; GO:1900245; GO:1900246 defense response to bacterium [GO:0042742]; innate immune response [GO:0045087]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of cell cycle [GO:0045787]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of MDA-5 signaling pathway [GO:1900245]; positive regulation of RIG-I signaling pathway [GO:1900246]; regulation of DNA replication [GO:0006275] chromatin [GO:0000785]; cytoplasm [GO:0005737]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] chromatin binding [GO:0003682]; RNA binding [GO:0003723] g21753.t1 O75179 42.915 247 3.02e-32 140.0 sp|O75179|ANR17_HUMAN Ankyrin repeat domain-containing protein 17 OS=Homo sapiens OX=9606 GN=ANKRD17 PE=1 SV=3 ANR17_HUMAN reviewed Ankyrin repeat domain-containing protein 17 (Gene trap ankyrin repeat protein) (Serologically defined breast cancer antigen NY-BR-16) Homo sapiens (Human) GO:0000785; GO:0003682; GO:0003723; GO:0005634; GO:0005654; GO:0005737; GO:0006275; GO:0016020; GO:0031965; GO:0042742; GO:0043123; GO:0045087; GO:0045787; GO:1900087; GO:1900245; GO:1900246 defense response to bacterium [GO:0042742]; innate immune response [GO:0045087]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of cell cycle [GO:0045787]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of MDA-5 signaling pathway [GO:1900245]; positive regulation of RIG-I signaling pathway [GO:1900246]; regulation of DNA replication [GO:0006275] chromatin [GO:0000785]; cytoplasm [GO:0005737]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] chromatin binding [GO:0003682]; RNA binding [GO:0003723] g21753.t1 O75179 35.833 240 4.27e-31 137.0 sp|O75179|ANR17_HUMAN Ankyrin repeat domain-containing protein 17 OS=Homo sapiens OX=9606 GN=ANKRD17 PE=1 SV=3 ANR17_HUMAN reviewed Ankyrin repeat domain-containing protein 17 (Gene trap ankyrin repeat protein) (Serologically defined breast cancer antigen NY-BR-16) Homo sapiens (Human) GO:0000785; GO:0003682; GO:0003723; GO:0005634; GO:0005654; GO:0005737; GO:0006275; GO:0016020; GO:0031965; GO:0042742; GO:0043123; GO:0045087; GO:0045787; GO:1900087; GO:1900245; GO:1900246 defense response to bacterium [GO:0042742]; innate immune response [GO:0045087]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of cell cycle [GO:0045787]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of MDA-5 signaling pathway [GO:1900245]; positive regulation of RIG-I signaling pathway [GO:1900246]; regulation of DNA replication [GO:0006275] chromatin [GO:0000785]; cytoplasm [GO:0005737]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] chromatin binding [GO:0003682]; RNA binding [GO:0003723] g21753.t1 O75179 37.321 209 2.84e-28 127.0 sp|O75179|ANR17_HUMAN Ankyrin repeat domain-containing protein 17 OS=Homo sapiens OX=9606 GN=ANKRD17 PE=1 SV=3 ANR17_HUMAN reviewed Ankyrin repeat domain-containing protein 17 (Gene trap ankyrin repeat protein) (Serologically defined breast cancer antigen NY-BR-16) Homo sapiens (Human) GO:0000785; GO:0003682; GO:0003723; GO:0005634; GO:0005654; GO:0005737; GO:0006275; GO:0016020; GO:0031965; GO:0042742; GO:0043123; GO:0045087; GO:0045787; GO:1900087; GO:1900245; GO:1900246 defense response to bacterium [GO:0042742]; innate immune response [GO:0045087]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of cell cycle [GO:0045787]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of MDA-5 signaling pathway [GO:1900245]; positive regulation of RIG-I signaling pathway [GO:1900246]; regulation of DNA replication [GO:0006275] chromatin [GO:0000785]; cytoplasm [GO:0005737]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] chromatin binding [GO:0003682]; RNA binding [GO:0003723] g21753.t2 O75179 85.588 340 0.0 610.0 sp|O75179|ANR17_HUMAN Ankyrin repeat domain-containing protein 17 OS=Homo sapiens OX=9606 GN=ANKRD17 PE=1 SV=3 ANR17_HUMAN reviewed Ankyrin repeat domain-containing protein 17 (Gene trap ankyrin repeat protein) (Serologically defined breast cancer antigen NY-BR-16) Homo sapiens (Human) GO:0000785; GO:0003682; GO:0003723; GO:0005634; GO:0005654; GO:0005737; GO:0006275; GO:0016020; GO:0031965; GO:0042742; GO:0043123; GO:0045087; GO:0045787; GO:1900087; GO:1900245; GO:1900246 defense response to bacterium [GO:0042742]; innate immune response [GO:0045087]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of cell cycle [GO:0045787]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of MDA-5 signaling pathway [GO:1900245]; positive regulation of RIG-I signaling pathway [GO:1900246]; regulation of DNA replication [GO:0006275] chromatin [GO:0000785]; cytoplasm [GO:0005737]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] chromatin binding [GO:0003682]; RNA binding [GO:0003723] g21753.t2 O75179 34.421 337 9.96e-43 174.0 sp|O75179|ANR17_HUMAN Ankyrin repeat domain-containing protein 17 OS=Homo sapiens OX=9606 GN=ANKRD17 PE=1 SV=3 ANR17_HUMAN reviewed Ankyrin repeat domain-containing protein 17 (Gene trap ankyrin repeat protein) (Serologically defined breast cancer antigen NY-BR-16) Homo sapiens (Human) GO:0000785; GO:0003682; GO:0003723; GO:0005634; GO:0005654; GO:0005737; GO:0006275; GO:0016020; GO:0031965; GO:0042742; GO:0043123; GO:0045087; GO:0045787; GO:1900087; GO:1900245; GO:1900246 defense response to bacterium [GO:0042742]; innate immune response [GO:0045087]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of cell cycle [GO:0045787]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of MDA-5 signaling pathway [GO:1900245]; positive regulation of RIG-I signaling pathway [GO:1900246]; regulation of DNA replication [GO:0006275] chromatin [GO:0000785]; cytoplasm [GO:0005737]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] chromatin binding [GO:0003682]; RNA binding [GO:0003723] g21753.t2 O75179 32.537 335 5.299999999999999e-40 166.0 sp|O75179|ANR17_HUMAN Ankyrin repeat domain-containing protein 17 OS=Homo sapiens OX=9606 GN=ANKRD17 PE=1 SV=3 ANR17_HUMAN reviewed Ankyrin repeat domain-containing protein 17 (Gene trap ankyrin repeat protein) (Serologically defined breast cancer antigen NY-BR-16) Homo sapiens (Human) GO:0000785; GO:0003682; GO:0003723; GO:0005634; GO:0005654; GO:0005737; GO:0006275; GO:0016020; GO:0031965; GO:0042742; GO:0043123; GO:0045087; GO:0045787; GO:1900087; GO:1900245; GO:1900246 defense response to bacterium [GO:0042742]; innate immune response [GO:0045087]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of cell cycle [GO:0045787]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of MDA-5 signaling pathway [GO:1900245]; positive regulation of RIG-I signaling pathway [GO:1900246]; regulation of DNA replication [GO:0006275] chromatin [GO:0000785]; cytoplasm [GO:0005737]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] chromatin binding [GO:0003682]; RNA binding [GO:0003723] g21753.t2 O75179 45.228 241 9.58e-40 164.0 sp|O75179|ANR17_HUMAN Ankyrin repeat domain-containing protein 17 OS=Homo sapiens OX=9606 GN=ANKRD17 PE=1 SV=3 ANR17_HUMAN reviewed Ankyrin repeat domain-containing protein 17 (Gene trap ankyrin repeat protein) (Serologically defined breast cancer antigen NY-BR-16) Homo sapiens (Human) GO:0000785; GO:0003682; GO:0003723; GO:0005634; GO:0005654; GO:0005737; GO:0006275; GO:0016020; GO:0031965; GO:0042742; GO:0043123; GO:0045087; GO:0045787; GO:1900087; GO:1900245; GO:1900246 defense response to bacterium [GO:0042742]; innate immune response [GO:0045087]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of cell cycle [GO:0045787]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of MDA-5 signaling pathway [GO:1900245]; positive regulation of RIG-I signaling pathway [GO:1900246]; regulation of DNA replication [GO:0006275] chromatin [GO:0000785]; cytoplasm [GO:0005737]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] chromatin binding [GO:0003682]; RNA binding [GO:0003723] g21753.t2 O75179 35.836 293 8.070000000000001e-35 149.0 sp|O75179|ANR17_HUMAN Ankyrin repeat domain-containing protein 17 OS=Homo sapiens OX=9606 GN=ANKRD17 PE=1 SV=3 ANR17_HUMAN reviewed Ankyrin repeat domain-containing protein 17 (Gene trap ankyrin repeat protein) (Serologically defined breast cancer antigen NY-BR-16) Homo sapiens (Human) GO:0000785; GO:0003682; GO:0003723; GO:0005634; GO:0005654; GO:0005737; GO:0006275; GO:0016020; GO:0031965; GO:0042742; GO:0043123; GO:0045087; GO:0045787; GO:1900087; GO:1900245; GO:1900246 defense response to bacterium [GO:0042742]; innate immune response [GO:0045087]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of cell cycle [GO:0045787]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of MDA-5 signaling pathway [GO:1900245]; positive regulation of RIG-I signaling pathway [GO:1900246]; regulation of DNA replication [GO:0006275] chromatin [GO:0000785]; cytoplasm [GO:0005737]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] chromatin binding [GO:0003682]; RNA binding [GO:0003723] g21753.t2 O75179 35.833 240 3.5500000000000004e-31 137.0 sp|O75179|ANR17_HUMAN Ankyrin repeat domain-containing protein 17 OS=Homo sapiens OX=9606 GN=ANKRD17 PE=1 SV=3 ANR17_HUMAN reviewed Ankyrin repeat domain-containing protein 17 (Gene trap ankyrin repeat protein) (Serologically defined breast cancer antigen NY-BR-16) Homo sapiens (Human) GO:0000785; GO:0003682; GO:0003723; GO:0005634; GO:0005654; GO:0005737; GO:0006275; GO:0016020; GO:0031965; GO:0042742; GO:0043123; GO:0045087; GO:0045787; GO:1900087; GO:1900245; GO:1900246 defense response to bacterium [GO:0042742]; innate immune response [GO:0045087]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of cell cycle [GO:0045787]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of MDA-5 signaling pathway [GO:1900245]; positive regulation of RIG-I signaling pathway [GO:1900246]; regulation of DNA replication [GO:0006275] chromatin [GO:0000785]; cytoplasm [GO:0005737]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] chromatin binding [GO:0003682]; RNA binding [GO:0003723] g21753.t2 O75179 37.321 209 2.34e-28 127.0 sp|O75179|ANR17_HUMAN Ankyrin repeat domain-containing protein 17 OS=Homo sapiens OX=9606 GN=ANKRD17 PE=1 SV=3 ANR17_HUMAN reviewed Ankyrin repeat domain-containing protein 17 (Gene trap ankyrin repeat protein) (Serologically defined breast cancer antigen NY-BR-16) Homo sapiens (Human) GO:0000785; GO:0003682; GO:0003723; GO:0005634; GO:0005654; GO:0005737; GO:0006275; GO:0016020; GO:0031965; GO:0042742; GO:0043123; GO:0045087; GO:0045787; GO:1900087; GO:1900245; GO:1900246 defense response to bacterium [GO:0042742]; innate immune response [GO:0045087]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of cell cycle [GO:0045787]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of MDA-5 signaling pathway [GO:1900245]; positive regulation of RIG-I signaling pathway [GO:1900246]; regulation of DNA replication [GO:0006275] chromatin [GO:0000785]; cytoplasm [GO:0005737]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] chromatin binding [GO:0003682]; RNA binding [GO:0003723] g21756.t1 O14802 73.016 1386 0.0 2100.0 sp|O14802|RPC1_HUMAN DNA-directed RNA polymerase III subunit RPC1 OS=Homo sapiens OX=9606 GN=POLR3A PE=1 SV=2 RPC1_HUMAN reviewed DNA-directed RNA polymerase III subunit RPC1 (RNA polymerase III subunit C1) (EC 2.7.7.6) (DNA-directed RNA polymerase III largest subunit) (DNA-directed RNA polymerase III subunit A) (RNA polymerase III 155 kDa subunit) (RPC155) (RNA polymerase III subunit C160) Homo sapiens (Human) GO:0000287; GO:0003677; GO:0003682; GO:0003899; GO:0005634; GO:0005654; GO:0005666; GO:0005737; GO:0005829; GO:0006351; GO:0008270; GO:0016020; GO:0032728; GO:0042797; GO:0045087; GO:0051607; GO:0071667 defense response to virus [GO:0051607]; DNA-templated transcription [GO:0006351]; innate immune response [GO:0045087]; positive regulation of interferon-beta production [GO:0032728]; tRNA transcription by RNA polymerase III [GO:0042797] cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase III complex [GO:0005666] chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-directed RNA polymerase activity [GO:0003899]; DNA/RNA hybrid binding [GO:0071667]; magnesium ion binding [GO:0000287]; zinc ion binding [GO:0008270] g21757.t1 O75899 30.323 742 4.14e-103 342.0 sp|O75899|GABR2_HUMAN Gamma-aminobutyric acid type B receptor subunit 2 OS=Homo sapiens OX=9606 GN=GABBR2 PE=1 SV=1 GABR2_HUMAN reviewed Gamma-aminobutyric acid type B receptor subunit 2 (GABA-B receptor 2) (GABA-B-R2) (GABA-BR2) (GABABR2) (Gb2) (G-protein coupled receptor 51) (HG20) Homo sapiens (Human) GO:0004888; GO:0004965; GO:0005737; GO:0005886; GO:0007186; GO:0007193; GO:0007194; GO:0007214; GO:0007268; GO:0038039; GO:0043005; GO:0045211; GO:0046982; GO:0051932; GO:0150099; GO:1902710; GO:1902712 adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; chemical synaptic transmission [GO:0007268]; G protein-coupled receptor signaling pathway [GO:0007186]; gamma-aminobutyric acid signaling pathway [GO:0007214]; negative regulation of adenylate cyclase activity [GO:0007194]; neuron-glial cell signaling [GO:0150099]; synaptic transmission, GABAergic [GO:0051932] cytoplasm [GO:0005737]; G protein-coupled GABA receptor complex [GO:1902712]; G protein-coupled receptor heterodimeric complex [GO:0038039]; GABA receptor complex [GO:1902710]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211] G protein-coupled GABA receptor activity [GO:0004965]; protein heterodimerization activity [GO:0046982]; transmembrane signaling receptor activity [GO:0004888] g21759.t1 O75899 31.718 681 6.44e-100 334.0 sp|O75899|GABR2_HUMAN Gamma-aminobutyric acid type B receptor subunit 2 OS=Homo sapiens OX=9606 GN=GABBR2 PE=1 SV=1 GABR2_HUMAN reviewed Gamma-aminobutyric acid type B receptor subunit 2 (GABA-B receptor 2) (GABA-B-R2) (GABA-BR2) (GABABR2) (Gb2) (G-protein coupled receptor 51) (HG20) Homo sapiens (Human) GO:0004888; GO:0004965; GO:0005737; GO:0005886; GO:0007186; GO:0007193; GO:0007194; GO:0007214; GO:0007268; GO:0038039; GO:0043005; GO:0045211; GO:0046982; GO:0051932; GO:0150099; GO:1902710; GO:1902712 adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; chemical synaptic transmission [GO:0007268]; G protein-coupled receptor signaling pathway [GO:0007186]; gamma-aminobutyric acid signaling pathway [GO:0007214]; negative regulation of adenylate cyclase activity [GO:0007194]; neuron-glial cell signaling [GO:0150099]; synaptic transmission, GABAergic [GO:0051932] cytoplasm [GO:0005737]; G protein-coupled GABA receptor complex [GO:1902712]; G protein-coupled receptor heterodimeric complex [GO:0038039]; GABA receptor complex [GO:1902710]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211] G protein-coupled GABA receptor activity [GO:0004965]; protein heterodimerization activity [GO:0046982]; transmembrane signaling receptor activity [GO:0004888] g21760.t1 P81004 65.299 268 6.83e-125 359.0 sp|P81004|VDAC2_XENLA Non-selective voltage-gated ion channel VDAC2 OS=Xenopus laevis OX=8355 GN=vdac2 PE=1 SV=1 g21763.t1 Q95266 67.683 164 7.95e-80 248.0 sp|Q95266|KCC2D_PIG Calcium/calmodulin-dependent protein kinase type II subunit delta OS=Sus scrofa OX=9823 GN=CAMK2D PE=2 SV=1 KCC2D_PIG reviewed Calcium/calmodulin-dependent protein kinase type II subunit delta (CaM kinase II subunit delta) (CaMK-II subunit delta) (EC 2.7.11.17) Sus scrofa (Pig) GO:0004683; GO:0005516; GO:0005524; GO:0005737; GO:0006468; GO:0010613; GO:0014069; GO:0033017; GO:0042383; GO:0043005; GO:0048168; GO:0060341; GO:0106310; GO:1903076 positive regulation of cardiac muscle hypertrophy [GO:0010613]; protein phosphorylation [GO:0006468]; regulation of cellular localization [GO:0060341]; regulation of neuronal synaptic plasticity [GO:0048168]; regulation of protein localization to plasma membrane [GO:1903076] cytoplasm [GO:0005737]; neuron projection [GO:0043005]; postsynaptic density [GO:0014069]; sarcolemma [GO:0042383]; sarcoplasmic reticulum membrane [GO:0033017] ATP binding [GO:0005524]; calcium/calmodulin-dependent protein kinase activity [GO:0004683]; calmodulin binding [GO:0005516]; protein serine kinase activity [GO:0106310] g21764.t1 Q00168 84.762 315 0.0 570.0 sp|Q00168|KCC2A_DROME Calcium/calmodulin-dependent protein kinase type II alpha chain OS=Drosophila melanogaster OX=7227 GN=CaMKII PE=1 SV=1 g21765.t1 Q08BC4 41.77 565 1.1699999999999998e-128 391.0 sp|Q08BC4|STPG2_DANRE Sperm-tail PG-rich repeat-containing protein 2 OS=Danio rerio OX=7955 GN=stpg2 PE=2 SV=1 g21766.t1 C5IAW9 42.892 408 3.27e-101 343.0 sp|C5IAW9|UN5BB_XENLA Netrin receptor UNC5B-b OS=Xenopus laevis OX=8355 GN=unc5b-b PE=1 SV=1 UN5BB_XENLA reviewed Netrin receptor UNC5B-b (Protein unc-5 homolog-b) (Unc-5-like protein B) Xenopus laevis (African clawed frog) GO:0005042; GO:0005886; GO:0033564 anterior/posterior axon guidance [GO:0033564] plasma membrane [GO:0005886] netrin receptor activity [GO:0005042] g21766.t1 C5IAW9 47.785 316 5.5399999999999996e-92 318.0 sp|C5IAW9|UN5BB_XENLA Netrin receptor UNC5B-b OS=Xenopus laevis OX=8355 GN=unc5b-b PE=1 SV=1 UN5BB_XENLA reviewed Netrin receptor UNC5B-b (Protein unc-5 homolog-b) (Unc-5-like protein B) Xenopus laevis (African clawed frog) GO:0005042; GO:0005886; GO:0033564 anterior/posterior axon guidance [GO:0033564] plasma membrane [GO:0005886] netrin receptor activity [GO:0005042] g21768.t1 P51030 52.326 344 7.87e-105 315.0 sp|P51030|WNT8C_CHICK Protein Wnt-8c OS=Gallus gallus OX=9031 GN=WNT8C PE=2 SV=1 g21769.t1 Q86XQ3 33.609 363 2.1e-64 214.0 sp|Q86XQ3|CTSR3_HUMAN Cation channel sperm-associated protein 3 OS=Homo sapiens OX=9606 GN=CATSPER3 PE=1 SV=1 CTSR3_HUMAN reviewed Cation channel sperm-associated protein 3 (CatSper3) (Ca(v)-like protein) (One-repeat calcium channel-like protein) Homo sapiens (Human) GO:0001669; GO:0005245; GO:0005783; GO:0005886; GO:0006814; GO:0030317; GO:0036128; GO:0048240; GO:0051649; GO:0097225; GO:0097228 establishment of localization in cell [GO:0051649]; flagellated sperm motility [GO:0030317]; sodium ion transport [GO:0006814]; sperm capacitation [GO:0048240] acrosomal vesicle [GO:0001669]; CatSper complex [GO:0036128]; endoplasmic reticulum [GO:0005783]; plasma membrane [GO:0005886]; sperm midpiece [GO:0097225]; sperm principal piece [GO:0097228] voltage-gated calcium channel activity [GO:0005245] g21770.t1 Q9JMK0 40.645 310 6.09e-73 234.0 sp|Q9JMK0|B4GT5_MOUSE Beta-1,4-galactosyltransferase 5 OS=Mus musculus OX=10090 GN=B4galt5 PE=1 SV=2 B4GT5_MOUSE reviewed Beta-1,4-galactosyltransferase 5 (Beta-1,4-GalTase 5) (Beta4Gal-T5) (b4Gal-T5) (EC 2.4.1.-) (Beta-1,4-GalT II) (Glucosylceramide beta-1,4-galactosyltransferase) (EC 2.4.1.274) (Lactosylceramide synthase) (LacCer synthase) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 5) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 5) Mus musculus (Mouse) GO:0001574; GO:0003945; GO:0005794; GO:0005975; GO:0008489; GO:0009101; GO:0021955; GO:0022010; GO:0030311; GO:0031647; GO:0032580; GO:0040019; GO:0042551; GO:0046872 carbohydrate metabolic process [GO:0005975]; central nervous system myelination [GO:0022010]; central nervous system neuron axonogenesis [GO:0021955]; ganglioside biosynthetic process [GO:0001574]; glycoprotein biosynthetic process [GO:0009101]; neuron maturation [GO:0042551]; poly-N-acetyllactosamine biosynthetic process [GO:0030311]; positive regulation of embryonic development [GO:0040019]; regulation of protein stability [GO:0031647] Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580] metal ion binding [GO:0046872]; N-acetyllactosamine synthase activity [GO:0003945]; UDP-galactose:glucosylceramide beta-1,4-galactosyltransferase activity [GO:0008489] g21775.t1 Q5UQ13 39.706 340 4.94e-28 119.0 sp|Q5UQ13|COLL2_MIMIV Collagen-like protein 2 OS=Acanthamoeba polyphaga mimivirus OX=212035 GN=MIMI_R196 PE=4 SV=1 g21775.t1 Q5UQ13 43.043 230 1.11e-27 118.0 sp|Q5UQ13|COLL2_MIMIV Collagen-like protein 2 OS=Acanthamoeba polyphaga mimivirus OX=212035 GN=MIMI_R196 PE=4 SV=1 g21775.t1 Q5UQ13 39.222 334 7.200000000000001e-27 115.0 sp|Q5UQ13|COLL2_MIMIV Collagen-like protein 2 OS=Acanthamoeba polyphaga mimivirus OX=212035 GN=MIMI_R196 PE=4 SV=1 g21775.t1 Q5UQ13 42.562 242 3.79e-25 110.0 sp|Q5UQ13|COLL2_MIMIV Collagen-like protein 2 OS=Acanthamoeba polyphaga mimivirus OX=212035 GN=MIMI_R196 PE=4 SV=1 g21775.t1 Q5UQ13 37.027 370 6.11e-25 110.0 sp|Q5UQ13|COLL2_MIMIV Collagen-like protein 2 OS=Acanthamoeba polyphaga mimivirus OX=212035 GN=MIMI_R196 PE=4 SV=1 g21775.t1 Q5UQ13 39.692 325 1.39e-24 108.0 sp|Q5UQ13|COLL2_MIMIV Collagen-like protein 2 OS=Acanthamoeba polyphaga mimivirus OX=212035 GN=MIMI_R196 PE=4 SV=1 g21775.t1 Q5UQ13 41.2 250 6.17e-24 107.0 sp|Q5UQ13|COLL2_MIMIV Collagen-like protein 2 OS=Acanthamoeba polyphaga mimivirus OX=212035 GN=MIMI_R196 PE=4 SV=1 g21775.t1 Q5UQ13 43.318 217 8.189999999999999e-23 103.0 sp|Q5UQ13|COLL2_MIMIV Collagen-like protein 2 OS=Acanthamoeba polyphaga mimivirus OX=212035 GN=MIMI_R196 PE=4 SV=1 g21775.t1 Q5UQ13 39.63 270 2.66e-22 102.0 sp|Q5UQ13|COLL2_MIMIV Collagen-like protein 2 OS=Acanthamoeba polyphaga mimivirus OX=212035 GN=MIMI_R196 PE=4 SV=1 g21775.t1 Q5UQ13 37.687 268 1.97e-21 99.8 sp|Q5UQ13|COLL2_MIMIV Collagen-like protein 2 OS=Acanthamoeba polyphaga mimivirus OX=212035 GN=MIMI_R196 PE=4 SV=1 g21778.t1 Q08209 78.099 484 0.0 790.0 sp|Q08209|PP2BA_HUMAN Protein phosphatase 3 catalytic subunit alpha OS=Homo sapiens OX=9606 GN=PPP3CA PE=1 SV=1 PP2BA_HUMAN reviewed Protein phosphatase 3 catalytic subunit alpha (EC 3.1.3.16) (CAM-PRP catalytic subunit) (Calcineurin A alpha) (Calmodulin-dependent calcineurin A subunit alpha isoform) (CNA alpha) (Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform) Homo sapiens (Human) GO:0000082; GO:0004722; GO:0005509; GO:0005516; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0005886; GO:0005955; GO:0006470; GO:0006606; GO:0006816; GO:0008287; GO:0008544; GO:0010628; GO:0010629; GO:0014883; GO:0014898; GO:0016311; GO:0019897; GO:0019899; GO:0023057; GO:0030018; GO:0030216; GO:0030335; GO:0033173; GO:0033192; GO:0033555; GO:0042060; GO:0042104; GO:0042110; GO:0042383; GO:0043197; GO:0043403; GO:0045669; GO:0045672; GO:0045785; GO:0045807; GO:0045944; GO:0046878; GO:0046983; GO:0048741; GO:0048813; GO:0050774; GO:0050804; GO:0051117; GO:0051592; GO:0060079; GO:0061006; GO:0070262; GO:0070886; GO:0090193; GO:0097205; GO:0097720; GO:0098685; GO:0098978; GO:0099170; GO:0110062; GO:1903235; GO:1903244; GO:1905205; GO:1905665; GO:1905949 calcineurin-mediated signaling [GO:0097720]; calcineurin-NFAT signaling cascade [GO:0033173]; calcium ion transport [GO:0006816]; cardiac muscle hypertrophy in response to stress [GO:0014898]; dendrite morphogenesis [GO:0048813]; dephosphorylation [GO:0016311]; epidermis development [GO:0008544]; excitatory postsynaptic potential [GO:0060079]; G1/S transition of mitotic cell cycle [GO:0000082]; keratinocyte differentiation [GO:0030216]; modulation of chemical synaptic transmission [GO:0050804]; multicellular organismal response to stress [GO:0033555]; negative regulation of angiotensin-activated signaling pathway [GO:0110062]; negative regulation of calcium ion import across plasma membrane [GO:1905949]; negative regulation of dendrite morphogenesis [GO:0050774]; negative regulation of gene expression [GO:0010629]; negative regulation of signaling [GO:0023057]; peptidyl-serine dephosphorylation [GO:0070262]; positive regulation of activated T cell proliferation [GO:0042104]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886]; positive regulation of calcium ion import across plasma membrane [GO:1905665]; positive regulation of calcium ion-dependent exocytosis of neurotransmitter [GO:1903235]; positive regulation of cardiac muscle hypertrophy in response to stress [GO:1903244]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cell migration [GO:0030335]; positive regulation of connective tissue replacement [GO:1905205]; positive regulation of endocytosis [GO:0045807]; positive regulation of gene expression [GO:0010628]; positive regulation of glomerulus development [GO:0090193]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of saliva secretion [GO:0046878]; positive regulation of transcription by RNA polymerase II [GO:0045944]; postsynaptic modulation of chemical synaptic transmission [GO:0099170]; protein dephosphorylation [GO:0006470]; protein import into nucleus [GO:0006606]; regulation of cell proliferation involved in kidney morphogenesis [GO:0061006]; renal filtration [GO:0097205]; response to calcium ion [GO:0051592]; skeletal muscle fiber development [GO:0048741]; skeletal muscle tissue regeneration [GO:0043403]; T cell activation [GO:0042110]; transition between fast and slow fiber [GO:0014883]; wound healing [GO:0042060] calcineurin complex [GO:0005955]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; extrinsic component of plasma membrane [GO:0019897]; glutamatergic synapse [GO:0098978]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; protein serine/threonine phosphatase complex [GO:0008287]; sarcolemma [GO:0042383]; Schaffer collateral - CA1 synapse [GO:0098685]; Z disc [GO:0030018] ATPase binding [GO:0051117]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; calmodulin-dependent protein phosphatase activity [GO:0033192]; enzyme binding [GO:0019899]; protein dimerization activity [GO:0046983]; protein serine/threonine phosphatase activity [GO:0004722] g21778.t2 Q08209 77.033 492 0.0 799.0 sp|Q08209|PP2BA_HUMAN Protein phosphatase 3 catalytic subunit alpha OS=Homo sapiens OX=9606 GN=PPP3CA PE=1 SV=1 PP2BA_HUMAN reviewed Protein phosphatase 3 catalytic subunit alpha (EC 3.1.3.16) (CAM-PRP catalytic subunit) (Calcineurin A alpha) (Calmodulin-dependent calcineurin A subunit alpha isoform) (CNA alpha) (Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform) Homo sapiens (Human) GO:0000082; GO:0004722; GO:0005509; GO:0005516; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0005886; GO:0005955; GO:0006470; GO:0006606; GO:0006816; GO:0008287; GO:0008544; GO:0010628; GO:0010629; GO:0014883; GO:0014898; GO:0016311; GO:0019897; GO:0019899; GO:0023057; GO:0030018; GO:0030216; GO:0030335; GO:0033173; GO:0033192; GO:0033555; GO:0042060; GO:0042104; GO:0042110; GO:0042383; GO:0043197; GO:0043403; GO:0045669; GO:0045672; GO:0045785; GO:0045807; GO:0045944; GO:0046878; GO:0046983; GO:0048741; GO:0048813; GO:0050774; GO:0050804; GO:0051117; GO:0051592; GO:0060079; GO:0061006; GO:0070262; GO:0070886; GO:0090193; GO:0097205; GO:0097720; GO:0098685; GO:0098978; GO:0099170; GO:0110062; GO:1903235; GO:1903244; GO:1905205; GO:1905665; GO:1905949 calcineurin-mediated signaling [GO:0097720]; calcineurin-NFAT signaling cascade [GO:0033173]; calcium ion transport [GO:0006816]; cardiac muscle hypertrophy in response to stress [GO:0014898]; dendrite morphogenesis [GO:0048813]; dephosphorylation [GO:0016311]; epidermis development [GO:0008544]; excitatory postsynaptic potential [GO:0060079]; G1/S transition of mitotic cell cycle [GO:0000082]; keratinocyte differentiation [GO:0030216]; modulation of chemical synaptic transmission [GO:0050804]; multicellular organismal response to stress [GO:0033555]; negative regulation of angiotensin-activated signaling pathway [GO:0110062]; negative regulation of calcium ion import across plasma membrane [GO:1905949]; negative regulation of dendrite morphogenesis [GO:0050774]; negative regulation of gene expression [GO:0010629]; negative regulation of signaling [GO:0023057]; peptidyl-serine dephosphorylation [GO:0070262]; positive regulation of activated T cell proliferation [GO:0042104]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886]; positive regulation of calcium ion import across plasma membrane [GO:1905665]; positive regulation of calcium ion-dependent exocytosis of neurotransmitter [GO:1903235]; positive regulation of cardiac muscle hypertrophy in response to stress [GO:1903244]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cell migration [GO:0030335]; positive regulation of connective tissue replacement [GO:1905205]; positive regulation of endocytosis [GO:0045807]; positive regulation of gene expression [GO:0010628]; positive regulation of glomerulus development [GO:0090193]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of saliva secretion [GO:0046878]; positive regulation of transcription by RNA polymerase II [GO:0045944]; postsynaptic modulation of chemical synaptic transmission [GO:0099170]; protein dephosphorylation [GO:0006470]; protein import into nucleus [GO:0006606]; regulation of cell proliferation involved in kidney morphogenesis [GO:0061006]; renal filtration [GO:0097205]; response to calcium ion [GO:0051592]; skeletal muscle fiber development [GO:0048741]; skeletal muscle tissue regeneration [GO:0043403]; T cell activation [GO:0042110]; transition between fast and slow fiber [GO:0014883]; wound healing [GO:0042060] calcineurin complex [GO:0005955]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; extrinsic component of plasma membrane [GO:0019897]; glutamatergic synapse [GO:0098978]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; protein serine/threonine phosphatase complex [GO:0008287]; sarcolemma [GO:0042383]; Schaffer collateral - CA1 synapse [GO:0098685]; Z disc [GO:0030018] ATPase binding [GO:0051117]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; calmodulin-dependent protein phosphatase activity [GO:0033192]; enzyme binding [GO:0019899]; protein dimerization activity [GO:0046983]; protein serine/threonine phosphatase activity [GO:0004722] g21780.t1 Q5U4T7 57.143 448 6.44e-135 436.0 sp|Q5U4T7|BIC1B_XENLA Protein bicaudal C homolog 1-B OS=Xenopus laevis OX=8355 GN=bicc1-b PE=2 SV=1 g21780.t1 Q5U4T7 47.321 224 4.88e-36 152.0 sp|Q5U4T7|BIC1B_XENLA Protein bicaudal C homolog 1-B OS=Xenopus laevis OX=8355 GN=bicc1-b PE=2 SV=1 g21781.t1 Q6TH47 51.282 195 3.1100000000000003e-66 221.0 sp|Q6TH47|STBPA_DANRE STAM-binding protein-like A OS=Danio rerio OX=7955 GN=stambpa PE=2 SV=3 g21781.t1 Q6TH47 52.212 113 5.66e-29 121.0 sp|Q6TH47|STBPA_DANRE STAM-binding protein-like A OS=Danio rerio OX=7955 GN=stambpa PE=2 SV=3 g21782.t1 G9JJU2 52.066 121 4.6199999999999997e-39 134.0 sp|G9JJU2|GPX_PROCL Glutathione peroxidase OS=Procambarus clarkii OX=6728 GN=GPx PE=2 SV=1 g21783.t1 Q4AEH5 34.555 191 7.2799999999999995e-34 123.0 sp|Q4AEH5|GPX3_HYLLA Glutathione peroxidase 3 OS=Hylobates lar OX=9580 GN=GPX3 PE=2 SV=2 g21787.t1 Q6DGQ8 67.476 206 5.2e-93 274.0 sp|Q6DGQ8|NDK5_DANRE Nucleoside diphosphate kinase homolog 5 OS=Danio rerio OX=7955 GN=nme5 PE=2 SV=2 NDK5_DANRE reviewed Nucleoside diphosphate kinase 5 (NDK5) (Putative 3'-5'-DNA exonuclease NDK5) (EC 3.1.11.-) (Radial spoke head protein 23 homolog) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0003341; GO:0005929; GO:0006183; GO:0006228; GO:0006241; GO:0006308; GO:0008296; GO:1902176 cilium movement [GO:0003341]; CTP biosynthetic process [GO:0006241]; DNA catabolic process [GO:0006308]; GTP biosynthetic process [GO:0006183]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; UTP biosynthetic process [GO:0006228] cilium [GO:0005929] 3'-5'-DNA exonuclease activity [GO:0008296] g21788.t1 Q9R110 33.058 484 1.21e-70 251.0 sp|Q9R110|UD2A3_CAVPO UDP-glucuronosyltransferase 2A3 OS=Cavia porcellus OX=10141 GN=UGT2A3 PE=2 SV=1 g21788.t1 Q9R110 31.906 467 1.5299999999999998e-67 242.0 sp|Q9R110|UD2A3_CAVPO UDP-glucuronosyltransferase 2A3 OS=Cavia porcellus OX=10141 GN=UGT2A3 PE=2 SV=1 g21788.t1 Q9R110 30.303 528 5.0700000000000005e-65 234.0 sp|Q9R110|UD2A3_CAVPO UDP-glucuronosyltransferase 2A3 OS=Cavia porcellus OX=10141 GN=UGT2A3 PE=2 SV=1 g21788.t1 Q9R110 29.24 513 1.1599999999999999e-54 204.0 sp|Q9R110|UD2A3_CAVPO UDP-glucuronosyltransferase 2A3 OS=Cavia porcellus OX=10141 GN=UGT2A3 PE=2 SV=1 g21789.t1 O88278 27.862 725 2.37e-65 243.0 sp|O88278|CELR3_RAT Cadherin EGF LAG seven-pass G-type receptor 3 OS=Rattus norvegicus OX=10116 GN=Celsr3 PE=1 SV=1 CELR3_RAT reviewed Cadherin EGF LAG seven-pass G-type receptor 3 (Multiple epidermal growth factor-like domains protein 2) (Multiple EGF-like domains protein 2) Rattus norvegicus (Rat) GO:0004930; GO:0005509; GO:0005886; GO:0005912; GO:0007156; GO:0007409; GO:0007413; GO:0032880; GO:0036514; GO:0036515; GO:0044331; GO:0048787; GO:0060071; GO:0060271; GO:0097475; GO:0098839; GO:0098978 axonal fasciculation [GO:0007413]; axonogenesis [GO:0007409]; cell-cell adhesion mediated by cadherin [GO:0044331]; cilium assembly [GO:0060271]; dopaminergic neuron axon guidance [GO:0036514]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; motor neuron migration [GO:0097475]; regulation of protein localization [GO:0032880]; serotonergic neuron axon guidance [GO:0036515]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071] adherens junction [GO:0005912]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; presynaptic active zone membrane [GO:0048787] calcium ion binding [GO:0005509]; G protein-coupled receptor activity [GO:0004930] g21789.t1 O88278 27.807 766 5.64e-57 218.0 sp|O88278|CELR3_RAT Cadherin EGF LAG seven-pass G-type receptor 3 OS=Rattus norvegicus OX=10116 GN=Celsr3 PE=1 SV=1 CELR3_RAT reviewed Cadherin EGF LAG seven-pass G-type receptor 3 (Multiple epidermal growth factor-like domains protein 2) (Multiple EGF-like domains protein 2) Rattus norvegicus (Rat) GO:0004930; GO:0005509; GO:0005886; GO:0005912; GO:0007156; GO:0007409; GO:0007413; GO:0032880; GO:0036514; GO:0036515; GO:0044331; GO:0048787; GO:0060071; GO:0060271; GO:0097475; GO:0098839; GO:0098978 axonal fasciculation [GO:0007413]; axonogenesis [GO:0007409]; cell-cell adhesion mediated by cadherin [GO:0044331]; cilium assembly [GO:0060271]; dopaminergic neuron axon guidance [GO:0036514]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; motor neuron migration [GO:0097475]; regulation of protein localization [GO:0032880]; serotonergic neuron axon guidance [GO:0036515]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071] adherens junction [GO:0005912]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; presynaptic active zone membrane [GO:0048787] calcium ion binding [GO:0005509]; G protein-coupled receptor activity [GO:0004930] g21789.t1 O88278 28.375 363 2.9999999999999994e-23 110.0 sp|O88278|CELR3_RAT Cadherin EGF LAG seven-pass G-type receptor 3 OS=Rattus norvegicus OX=10116 GN=Celsr3 PE=1 SV=1 CELR3_RAT reviewed Cadherin EGF LAG seven-pass G-type receptor 3 (Multiple epidermal growth factor-like domains protein 2) (Multiple EGF-like domains protein 2) Rattus norvegicus (Rat) GO:0004930; GO:0005509; GO:0005886; GO:0005912; GO:0007156; GO:0007409; GO:0007413; GO:0032880; GO:0036514; GO:0036515; GO:0044331; GO:0048787; GO:0060071; GO:0060271; GO:0097475; GO:0098839; GO:0098978 axonal fasciculation [GO:0007413]; axonogenesis [GO:0007409]; cell-cell adhesion mediated by cadherin [GO:0044331]; cilium assembly [GO:0060271]; dopaminergic neuron axon guidance [GO:0036514]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; motor neuron migration [GO:0097475]; regulation of protein localization [GO:0032880]; serotonergic neuron axon guidance [GO:0036515]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071] adherens junction [GO:0005912]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; presynaptic active zone membrane [GO:0048787] calcium ion binding [GO:0005509]; G protein-coupled receptor activity [GO:0004930] g21790.t1 Q9H251 28.538 862 4.46e-65 242.0 sp|Q9H251|CAD23_HUMAN Cadherin-23 OS=Homo sapiens OX=9606 GN=CDH23 PE=1 SV=2 g21790.t1 Q9H251 27.586 522 3.97e-27 123.0 sp|Q9H251|CAD23_HUMAN Cadherin-23 OS=Homo sapiens OX=9606 GN=CDH23 PE=1 SV=2 g21790.t1 Q9H251 29.065 492 1.1399999999999999e-23 112.0 sp|Q9H251|CAD23_HUMAN Cadherin-23 OS=Homo sapiens OX=9606 GN=CDH23 PE=1 SV=2 g21790.t1 Q9H251 28.339 554 1.6400000000000002e-21 105.0 sp|Q9H251|CAD23_HUMAN Cadherin-23 OS=Homo sapiens OX=9606 GN=CDH23 PE=1 SV=2 g21792.t1 P20072 58.621 290 2.72e-111 332.0 sp|P20072|ANXA7_BOVIN Annexin A7 OS=Bos taurus OX=9913 GN=ANXA7 PE=1 SV=2 g21794.t1 P36898 53.737 495 3.49e-180 518.0 sp|P36898|BMR1B_MOUSE Bone morphogenetic protein receptor type-1B OS=Mus musculus OX=10090 GN=Bmpr1b PE=1 SV=1 g21795.t1 P48463 94.822 309 0.0 623.0 sp|P48463|PP2AA_CHICK Serine/threonine-protein phosphatase 2A catalytic subunit alpha isoform OS=Gallus gallus OX=9031 GN=PPP2CA PE=2 SV=1 g21796.t1 P63245 80.769 312 0.0 540.0 sp|P63245|RACK1_RAT Small ribosomal subunit protein RACK1 OS=Rattus norvegicus OX=10116 GN=Rack1 PE=1 SV=3 g21797.t1 Q28DX1 71.672 293 1.03e-149 426.0 sp|Q28DX1|ERLN1_XENTR Erlin-1 OS=Xenopus tropicalis OX=8364 GN=erlin1 PE=2 SV=1 g21798.t1 Q17QJ5 43.333 270 2.66e-49 168.0 sp|Q17QJ5|TSN5_BOVIN Tetraspanin-5 OS=Bos taurus OX=9913 GN=TSPAN5 PE=1 SV=1 g21799.t1 Q9UBI4 36.261 353 2.85e-59 202.0 sp|Q9UBI4|STML1_HUMAN Stomatin-like protein 1 OS=Homo sapiens OX=9606 GN=STOML1 PE=1 SV=1 g21800.t1 P00367 74.659 513 0.0 847.0 sp|P00367|DHE3_HUMAN Glutamate dehydrogenase 1, mitochondrial OS=Homo sapiens OX=9606 GN=GLUD1 PE=1 SV=2 DHE3_HUMAN reviewed Glutamate dehydrogenase 1, mitochondrial (GDH 1) (EC 1.4.1.3) Homo sapiens (Human) GO:0004352; GO:0004353; GO:0004354; GO:0005524; GO:0005525; GO:0005737; GO:0005739; GO:0005759; GO:0005783; GO:0006537; GO:0006538; GO:0006541; GO:0021762; GO:0032024; GO:0042803; GO:0043531; GO:0070403; GO:0070728; GO:0072350 glutamate biosynthetic process [GO:0006537]; glutamine metabolic process [GO:0006541]; L-glutamate catabolic process [GO:0006538]; positive regulation of insulin secretion [GO:0032024]; substantia nigra development [GO:0021762]; tricarboxylic acid metabolic process [GO:0072350] cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] ADP binding [GO:0043531]; ATP binding [GO:0005524]; glutamate dehydrogenase (NAD+) activity [GO:0004352]; glutamate dehydrogenase (NADP+) activity [GO:0004354]; glutamate dehydrogenase [NAD(P)+] activity [GO:0004353]; GTP binding [GO:0005525]; L-leucine binding [GO:0070728]; NAD+ binding [GO:0070403]; protein homodimerization activity [GO:0042803] g21801.t1 Q9P278 39.645 507 6.17e-87 310.0 sp|Q9P278|FNIP2_HUMAN Folliculin-interacting protein 2 OS=Homo sapiens OX=9606 GN=FNIP2 PE=1 SV=2 FNIP2_HUMAN reviewed Folliculin-interacting protein 2 (FNIP1-like protein) (O6-methylguanine-induced apoptosis 1 protein) Homo sapiens (Human) GO:0000122; GO:0005737; GO:0005765; GO:0005829; GO:0008630; GO:0031334; GO:0034451; GO:0042030; GO:0051087; GO:1904263; GO:1990877 intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of protein-containing complex assembly [GO:0031334]; positive regulation of TORC1 signaling [GO:1904263] centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; FNIP-folliculin RagC/D GAP [GO:1990877]; lysosomal membrane [GO:0005765] ATPase inhibitor activity [GO:0042030]; protein-folding chaperone binding [GO:0051087] g21801.t1 Q9P278 44.509 173 6.86e-30 132.0 sp|Q9P278|FNIP2_HUMAN Folliculin-interacting protein 2 OS=Homo sapiens OX=9606 GN=FNIP2 PE=1 SV=2 FNIP2_HUMAN reviewed Folliculin-interacting protein 2 (FNIP1-like protein) (O6-methylguanine-induced apoptosis 1 protein) Homo sapiens (Human) GO:0000122; GO:0005737; GO:0005765; GO:0005829; GO:0008630; GO:0031334; GO:0034451; GO:0042030; GO:0051087; GO:1904263; GO:1990877 intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of protein-containing complex assembly [GO:0031334]; positive regulation of TORC1 signaling [GO:1904263] centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; FNIP-folliculin RagC/D GAP [GO:1990877]; lysosomal membrane [GO:0005765] ATPase inhibitor activity [GO:0042030]; protein-folding chaperone binding [GO:0051087] g21803.t1 Q9ULJ6 74.725 91 4.25e-40 145.0 sp|Q9ULJ6|ZMIZ1_HUMAN Zinc finger MIZ domain-containing protein 1 OS=Homo sapiens OX=9606 GN=ZMIZ1 PE=1 SV=3 g21805.t1 Q9ULJ6 62.893 477 1.26e-175 547.0 sp|Q9ULJ6|ZMIZ1_HUMAN Zinc finger MIZ domain-containing protein 1 OS=Homo sapiens OX=9606 GN=ZMIZ1 PE=1 SV=3 g21807.t1 Q569Z5 66.272 845 0.0 1028.0 sp|Q569Z5|DDX46_MOUSE Probable ATP-dependent RNA helicase DDX46 OS=Mus musculus OX=10090 GN=Ddx46 PE=1 SV=2 DDX46_MOUSE reviewed Probable ATP-dependent RNA helicase DDX46 (EC 3.6.4.13) (DEAD box protein 46) Mus musculus (Mouse) GO:0000398; GO:0001650; GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005684; GO:0015030; GO:0016607; GO:0016887; GO:1903241 mRNA splicing, via spliceosome [GO:0000398]; U2-type prespliceosome assembly [GO:1903241] Cajal body [GO:0015030]; fibrillar center [GO:0001650]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; U2-type spliceosomal complex [GO:0005684] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724] g21810.t1 Q561R0 38.411 151 2.53e-29 111.0 sp|Q561R0|MZB1_RAT Marginal zone B- and B1-cell-specific protein OS=Rattus norvegicus OX=10116 GN=Mzb1 PE=2 SV=1 MZB1_RAT reviewed Marginal zone B- and B1-cell-specific protein (Plasma cell-induced resident endoplasmic reticulum protein) (Plasma cell-induced resident ER protein) (pERp1) (Proapoptotic caspase adapter protein) Rattus norvegicus (Rat) GO:0002639; GO:0005576; GO:0005737; GO:0005788; GO:0008284; GO:0030888; GO:0033622; GO:0034663; GO:0042127; GO:0046626 integrin activation [GO:0033622]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of immunoglobulin production [GO:0002639]; regulation of B cell proliferation [GO:0030888]; regulation of cell population proliferation [GO:0042127]; regulation of insulin receptor signaling pathway [GO:0046626] cytoplasm [GO:0005737]; endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576] g21811.t1 Q5VYX0 42.188 384 7.500000000000001e-109 326.0 sp|Q5VYX0|RNLS_HUMAN Renalase OS=Homo sapiens OX=9606 GN=RNLS PE=1 SV=1 RNLS_HUMAN reviewed Renalase (EC 1.6.3.5) (Monoamine oxidase-C) (MAO-C) Homo sapiens (Human) GO:0002931; GO:0005576; GO:0005615; GO:0010459; GO:0016651; GO:0045776; GO:0051379; GO:0070404; GO:0071869; GO:0071871; GO:0097621; GO:1902074 negative regulation of blood pressure [GO:0045776]; negative regulation of heart rate [GO:0010459]; response to catecholamine [GO:0071869]; response to epinephrine [GO:0071871]; response to ischemia [GO:0002931]; response to salt [GO:1902074] extracellular region [GO:0005576]; extracellular space [GO:0005615] epinephrine binding [GO:0051379]; monoamine oxidase activity [GO:0097621]; NADH binding [GO:0070404]; oxidoreductase activity, acting on NAD(P)H [GO:0016651] g21813.t1 Q5XHC1 54.305 302 1.52e-97 292.0 sp|Q5XHC1|CFA96_XENLA Cilia-and flagella-associated protein 96 OS=Xenopus laevis OX=8355 GN=cfap96.L PE=2 SV=1 g21814.t1 Q8TCA0 36.025 161 1.6300000000000001e-21 89.7 sp|Q8TCA0|LRC20_HUMAN Leucine-rich repeat-containing protein 20 OS=Homo sapiens OX=9606 GN=LRRC20 PE=1 SV=1 g21815.t1 Q8CH18 57.596 441 5.29e-151 486.0 sp|Q8CH18|CCAR1_MOUSE Cell division cycle and apoptosis regulator protein 1 OS=Mus musculus OX=10090 GN=Ccar1 PE=1 SV=1 g21815.t1 Q8CH18 32.794 247 4.1200000000000004e-27 123.0 sp|Q8CH18|CCAR1_MOUSE Cell division cycle and apoptosis regulator protein 1 OS=Mus musculus OX=10090 GN=Ccar1 PE=1 SV=1 g21815.t1 Q8CH18 73.418 79 3.22e-26 120.0 sp|Q8CH18|CCAR1_MOUSE Cell division cycle and apoptosis regulator protein 1 OS=Mus musculus OX=10090 GN=Ccar1 PE=1 SV=1 g21815.t2 Q8CH18 57.014 442 4.4999999999999997e-150 483.0 sp|Q8CH18|CCAR1_MOUSE Cell division cycle and apoptosis regulator protein 1 OS=Mus musculus OX=10090 GN=Ccar1 PE=1 SV=1 g21815.t2 Q8CH18 32.794 247 3.91e-27 124.0 sp|Q8CH18|CCAR1_MOUSE Cell division cycle and apoptosis regulator protein 1 OS=Mus musculus OX=10090 GN=Ccar1 PE=1 SV=1 g21815.t2 Q8CH18 73.418 79 3.08e-26 120.0 sp|Q8CH18|CCAR1_MOUSE Cell division cycle and apoptosis regulator protein 1 OS=Mus musculus OX=10090 GN=Ccar1 PE=1 SV=1 g21819.t1 Q54G14 34.921 189 4.1800000000000003e-22 78.6 sp|Q54G14|Y0266_DICDI Uncharacterized protein DDB_G0290685 OS=Dictyostelium discoideum OX=44689 GN=DDB_G0290685 PE=2 SV=2 g21819.t1 Q54G14 36.264 91 4.1800000000000003e-22 48.5 sp|Q54G14|Y0266_DICDI Uncharacterized protein DDB_G0290685 OS=Dictyostelium discoideum OX=44689 GN=DDB_G0290685 PE=2 SV=2 g21819.t1 Q54G14 34.826 201 1.49e-21 83.2 sp|Q54G14|Y0266_DICDI Uncharacterized protein DDB_G0290685 OS=Dictyostelium discoideum OX=44689 GN=DDB_G0290685 PE=2 SV=2 g21819.t1 Q54G14 32.258 93 1.49e-21 41.6 sp|Q54G14|Y0266_DICDI Uncharacterized protein DDB_G0290685 OS=Dictyostelium discoideum OX=44689 GN=DDB_G0290685 PE=2 SV=2 g21821.t1 Q68VK5 43.145 248 2.3999999999999997e-46 163.0 sp|Q68VK5|TSN5_RAT Tetraspanin-5 OS=Rattus norvegicus OX=10116 GN=Tspan5 PE=2 SV=2 g21821.t2 Q68VK5 43.621 243 1.09e-46 162.0 sp|Q68VK5|TSN5_RAT Tetraspanin-5 OS=Rattus norvegicus OX=10116 GN=Tspan5 PE=2 SV=2 g21822.t1 Q6Q473 31.148 915 3.65e-111 369.0 sp|Q6Q473|CLA4A_MOUSE Calcium-activated chloride channel regulator 4A OS=Mus musculus OX=10090 GN=Clca4a PE=1 SV=2 CLA4A_MOUSE reviewed Calcium-activated chloride channel regulator 4A (EC 3.4.-.-) (Calcium-activated chloride channel regulator 6) (mClca6) [Cleaved into: Calcium-activated chloride channel regulator 4A, 110 kDa form; Calcium-activated chloride channel regulator 4A, 30 kDa form] Mus musculus (Mouse) GO:0005229; GO:0005254; GO:0005576; GO:0005886; GO:0006508; GO:0006821; GO:0008237; GO:0015276; GO:0016324; GO:0046872 chloride transport [GO:0006821]; proteolysis [GO:0006508] apical plasma membrane [GO:0016324]; extracellular region [GO:0005576]; plasma membrane [GO:0005886] chloride channel activity [GO:0005254]; intracellularly calcium-gated chloride channel activity [GO:0005229]; ligand-gated monoatomic ion channel activity [GO:0015276]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237] g21823.t1 Q9D7Z6 34.479 844 3.1e-137 434.0 sp|Q9D7Z6|CLCA1_MOUSE Calcium-activated chloride channel regulator 1 OS=Mus musculus OX=10090 GN=Clca1 PE=1 SV=2 CLCA1_MOUSE reviewed Calcium-activated chloride channel regulator 1 (EC 3.4.-.-) (Calcium-activated chloride channel family member 3) (mCLCA3) (Protein gob-5) Mus musculus (Mouse) GO:0005229; GO:0005254; GO:0005576; GO:0005886; GO:0005902; GO:0006508; GO:0006816; GO:0006821; GO:0008237; GO:0016020; GO:0030141; GO:0042589; GO:0046872; GO:0071456 calcium ion transport [GO:0006816]; cellular response to hypoxia [GO:0071456]; chloride transport [GO:0006821]; proteolysis [GO:0006508] extracellular region [GO:0005576]; membrane [GO:0016020]; microvillus [GO:0005902]; plasma membrane [GO:0005886]; secretory granule [GO:0030141]; zymogen granule membrane [GO:0042589] chloride channel activity [GO:0005254]; intracellularly calcium-gated chloride channel activity [GO:0005229]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237] g21824.t1 A8K7I4 35.938 832 1.51e-137 439.0 sp|A8K7I4|CLCA1_HUMAN Calcium-activated chloride channel regulator 1 OS=Homo sapiens OX=9606 GN=CLCA1 PE=1 SV=3 CLCA1_HUMAN reviewed Calcium-activated chloride channel regulator 1 (EC 3.4.-.-) (Calcium-activated chloride channel family member 1) (hCLCA1) (Calcium-activated chloride channel protein 1) (CaCC-1) (hCaCC-1) Homo sapiens (Human) GO:0004222; GO:0005229; GO:0005254; GO:0005576; GO:0005886; GO:0005902; GO:0006508; GO:0006816; GO:0034220; GO:0042589; GO:0046872; GO:0071456 calcium ion transport [GO:0006816]; cellular response to hypoxia [GO:0071456]; monoatomic ion transmembrane transport [GO:0034220]; proteolysis [GO:0006508] extracellular region [GO:0005576]; microvillus [GO:0005902]; plasma membrane [GO:0005886]; zymogen granule membrane [GO:0042589] chloride channel activity [GO:0005254]; intracellularly calcium-gated chloride channel activity [GO:0005229]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222] g21825.t1 Q6Q473 32.609 966 4.41e-142 451.0 sp|Q6Q473|CLA4A_MOUSE Calcium-activated chloride channel regulator 4A OS=Mus musculus OX=10090 GN=Clca4a PE=1 SV=2 CLA4A_MOUSE reviewed Calcium-activated chloride channel regulator 4A (EC 3.4.-.-) (Calcium-activated chloride channel regulator 6) (mClca6) [Cleaved into: Calcium-activated chloride channel regulator 4A, 110 kDa form; Calcium-activated chloride channel regulator 4A, 30 kDa form] Mus musculus (Mouse) GO:0005229; GO:0005254; GO:0005576; GO:0005886; GO:0006508; GO:0006821; GO:0008237; GO:0015276; GO:0016324; GO:0046872 chloride transport [GO:0006821]; proteolysis [GO:0006508] apical plasma membrane [GO:0016324]; extracellular region [GO:0005576]; plasma membrane [GO:0005886] chloride channel activity [GO:0005254]; intracellularly calcium-gated chloride channel activity [GO:0005229]; ligand-gated monoatomic ion channel activity [GO:0015276]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237] g21827.t1 Q9D7Z6 31.591 899 7.95e-105 354.0 sp|Q9D7Z6|CLCA1_MOUSE Calcium-activated chloride channel regulator 1 OS=Mus musculus OX=10090 GN=Clca1 PE=1 SV=2 CLCA1_MOUSE reviewed Calcium-activated chloride channel regulator 1 (EC 3.4.-.-) (Calcium-activated chloride channel family member 3) (mCLCA3) (Protein gob-5) Mus musculus (Mouse) GO:0005229; GO:0005254; GO:0005576; GO:0005886; GO:0005902; GO:0006508; GO:0006816; GO:0006821; GO:0008237; GO:0016020; GO:0030141; GO:0042589; GO:0046872; GO:0071456 calcium ion transport [GO:0006816]; cellular response to hypoxia [GO:0071456]; chloride transport [GO:0006821]; proteolysis [GO:0006508] extracellular region [GO:0005576]; membrane [GO:0016020]; microvillus [GO:0005902]; plasma membrane [GO:0005886]; secretory granule [GO:0030141]; zymogen granule membrane [GO:0042589] chloride channel activity [GO:0005254]; intracellularly calcium-gated chloride channel activity [GO:0005229]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237] g21830.t1 B2RVL6 72.826 184 4.56e-93 279.0 sp|B2RVL6|ZCH24_MOUSE Zinc finger CCHC domain-containing protein 24 OS=Mus musculus OX=10090 GN=Zcchc24 PE=1 SV=1 g21837.t1 Q6PAV2 48.365 581 1.2600000000000001e-179 538.0 sp|Q6PAV2|HERC4_MOUSE Probable E3 ubiquitin-protein ligase HERC4 OS=Mus musculus OX=10090 GN=Herc4 PE=1 SV=2 HERC4_MOUSE reviewed Probable E3 ubiquitin-protein ligase HERC4 (EC 2.3.2.26) (HECT domain and RCC1-like domain-containing protein 4) (HECT-type E3 ubiquitin transferase HERC4) Mus musculus (Mouse) GO:0001650; GO:0004842; GO:0005737; GO:0005829; GO:0006511; GO:0007283; GO:0016567; GO:0030154; GO:0045879; GO:0061630 cell differentiation [GO:0030154]; negative regulation of smoothened signaling pathway [GO:0045879]; protein ubiquitination [GO:0016567]; spermatogenesis [GO:0007283]; ubiquitin-dependent protein catabolic process [GO:0006511] cytoplasm [GO:0005737]; cytosol [GO:0005829]; fibrillar center [GO:0001650] ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842] g21837.t2 Q5PQN1 45.562 676 0.0 576.0 sp|Q5PQN1|HERC4_RAT Probable E3 ubiquitin-protein ligase HERC4 OS=Rattus norvegicus OX=10116 GN=Herc4 PE=2 SV=1 HERC4_RAT reviewed Probable E3 ubiquitin-protein ligase HERC4 (EC 2.3.2.26) (HECT domain and RCC1-like domain-containing protein 4) (HECT-type E3 ubiquitin transferase HERC4) Rattus norvegicus (Rat) GO:0001650; GO:0005737; GO:0005829; GO:0006511; GO:0007283; GO:0016567; GO:0030154; GO:0045879; GO:0061630 cell differentiation [GO:0030154]; negative regulation of smoothened signaling pathway [GO:0045879]; protein ubiquitination [GO:0016567]; spermatogenesis [GO:0007283]; ubiquitin-dependent protein catabolic process [GO:0006511] cytoplasm [GO:0005737]; cytosol [GO:0005829]; fibrillar center [GO:0001650] ubiquitin protein ligase activity [GO:0061630] g21847.t1 Q5PQN1 49.198 374 1.73e-103 335.0 sp|Q5PQN1|HERC4_RAT Probable E3 ubiquitin-protein ligase HERC4 OS=Rattus norvegicus OX=10116 GN=Herc4 PE=2 SV=1 HERC4_RAT reviewed Probable E3 ubiquitin-protein ligase HERC4 (EC 2.3.2.26) (HECT domain and RCC1-like domain-containing protein 4) (HECT-type E3 ubiquitin transferase HERC4) Rattus norvegicus (Rat) GO:0001650; GO:0005737; GO:0005829; GO:0006511; GO:0007283; GO:0016567; GO:0030154; GO:0045879; GO:0061630 cell differentiation [GO:0030154]; negative regulation of smoothened signaling pathway [GO:0045879]; protein ubiquitination [GO:0016567]; spermatogenesis [GO:0007283]; ubiquitin-dependent protein catabolic process [GO:0006511] cytoplasm [GO:0005737]; cytosol [GO:0005829]; fibrillar center [GO:0001650] ubiquitin protein ligase activity [GO:0061630] g21847.t1 Q5PQN1 26.766 269 3.0700000000000002e-21 101.0 sp|Q5PQN1|HERC4_RAT Probable E3 ubiquitin-protein ligase HERC4 OS=Rattus norvegicus OX=10116 GN=Herc4 PE=2 SV=1 HERC4_RAT reviewed Probable E3 ubiquitin-protein ligase HERC4 (EC 2.3.2.26) (HECT domain and RCC1-like domain-containing protein 4) (HECT-type E3 ubiquitin transferase HERC4) Rattus norvegicus (Rat) GO:0001650; GO:0005737; GO:0005829; GO:0006511; GO:0007283; GO:0016567; GO:0030154; GO:0045879; GO:0061630 cell differentiation [GO:0030154]; negative regulation of smoothened signaling pathway [GO:0045879]; protein ubiquitination [GO:0016567]; spermatogenesis [GO:0007283]; ubiquitin-dependent protein catabolic process [GO:0006511] cytoplasm [GO:0005737]; cytosol [GO:0005829]; fibrillar center [GO:0001650] ubiquitin protein ligase activity [GO:0061630] g21849.t1 Q5ZKA5 57.812 192 2.32e-72 225.0 sp|Q5ZKA5|MTDC_CHICK Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial OS=Gallus gallus OX=9031 GN=MTHFD2 PE=2 SV=1 g21850.t1 Q8BWU8 57.077 431 1.27e-169 489.0 sp|Q8BWU8|AT2L1_MOUSE Ethanolamine-phosphate phospho-lyase OS=Mus musculus OX=10090 GN=Etnppl PE=2 SV=1 g21851.t1 Q86XX4 44.963 3921 0.0 3386.0 sp|Q86XX4|FRAS1_HUMAN Extracellular matrix organizing protein FRAS1 OS=Homo sapiens OX=9606 GN=FRAS1 PE=1 SV=2 g21851.t1 Q86XX4 28.485 990 3.84e-102 374.0 sp|Q86XX4|FRAS1_HUMAN Extracellular matrix organizing protein FRAS1 OS=Homo sapiens OX=9606 GN=FRAS1 PE=1 SV=2 g21851.t1 Q86XX4 29.118 1020 2.2600000000000002e-97 358.0 sp|Q86XX4|FRAS1_HUMAN Extracellular matrix organizing protein FRAS1 OS=Homo sapiens OX=9606 GN=FRAS1 PE=1 SV=2 g21852.t1 Q5R5H1 70.876 388 0.0 546.0 sp|Q5R5H1|METK2_PONAB S-adenosylmethionine synthase isoform type-2 OS=Pongo abelii OX=9601 GN=MAT2A PE=2 SV=1 METK2_PONAB reviewed S-adenosylmethionine synthase isoform type-2 (AdoMet synthase 2) (EC 2.5.1.6) (Methionine adenosyltransferase 2) (MAT 2) Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0004478; GO:0005524; GO:0006556; GO:0006730; GO:0031503; GO:0034198; GO:0034214; GO:0038202; GO:0042802; GO:0046872; GO:0048269; GO:0051291; GO:0061431; GO:0061462; GO:1904262; GO:1904263; GO:1990830 cellular response to amino acid starvation [GO:0034198]; cellular response to leukemia inhibitory factor [GO:1990830]; cellular response to methionine [GO:0061431]; negative regulation of TORC1 signaling [GO:1904262]; one-carbon metabolic process [GO:0006730]; positive regulation of TORC1 signaling [GO:1904263]; protein heterooligomerization [GO:0051291]; protein hexamerization [GO:0034214]; protein localization to lysosome [GO:0061462]; protein-containing complex localization [GO:0031503]; S-adenosylmethionine biosynthetic process [GO:0006556]; TORC1 signaling [GO:0038202] methionine adenosyltransferase complex [GO:0048269] ATP binding [GO:0005524]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; methionine adenosyltransferase activity [GO:0004478] g21853.t1 O00124 35.897 195 8.38e-22 95.1 sp|O00124|UBXN8_HUMAN UBX domain-containing protein 8 OS=Homo sapiens OX=9606 GN=UBXN8 PE=1 SV=2 UBXN8_HUMAN reviewed UBX domain-containing protein 8 (Reproduction 8 protein) (Rep-8 protein) (UBX domain-containing protein 6) Homo sapiens (Human) GO:0000151; GO:0005654; GO:0005730; GO:0005783; GO:0005789; GO:0007338; GO:0030674; GO:0036503; GO:0043130 ERAD pathway [GO:0036503]; single fertilization [GO:0007338] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; ubiquitin ligase complex [GO:0000151] protein-macromolecule adaptor activity [GO:0030674]; ubiquitin binding [GO:0043130] g21854.t1 Q8BPB0 83.645 214 2.0899999999999998e-140 394.0 sp|Q8BPB0|MOB1B_MOUSE MOB kinase activator 1B OS=Mus musculus OX=10090 GN=Mob1b PE=1 SV=3 g21855.t1 Q62417 46.196 184 9.04e-39 155.0 sp|Q62417|SRBS1_MOUSE Sorbin and SH3 domain-containing protein 1 OS=Mus musculus OX=10090 GN=Sorbs1 PE=1 SV=2 g21868.t1 Q18PE0 32.828 198 2.4e-26 118.0 sp|Q18PE0|DOK7_MOUSE Protein Dok-7 OS=Mus musculus OX=10090 GN=Dok7 PE=1 SV=1 DOK7_MOUSE reviewed Protein Dok-7 (Downstream of tyrosine kinase 7) Mus musculus (Mouse) GO:0005654; GO:0005739; GO:0007167; GO:0007528; GO:0019901; GO:0031594; GO:0035022; GO:0035091; GO:0035591; GO:0043113; GO:0045211; GO:0061098 enzyme-linked receptor protein signaling pathway [GO:0007167]; neuromuscular junction development [GO:0007528]; positive regulation of protein tyrosine kinase activity [GO:0061098]; positive regulation of Rac protein signal transduction [GO:0035022]; receptor clustering [GO:0043113] mitochondrion [GO:0005739]; neuromuscular junction [GO:0031594]; nucleoplasm [GO:0005654]; postsynaptic membrane [GO:0045211] phosphatidylinositol binding [GO:0035091]; protein kinase binding [GO:0019901]; signaling adaptor activity [GO:0035591] g21869.t1 A1L2T6 34.463 177 2.96e-25 114.0 sp|A1L2T6|ZCHC7_XENLA Zinc finger CCHC domain-containing protein 7 OS=Xenopus laevis OX=8355 GN=zcchc7 PE=2 SV=2 g21870.t1 Q53GS9 71.762 471 0.0 680.0 sp|Q53GS9|UBP39_HUMAN Ubiquitin carboxyl-terminal hydrolase 39 OS=Homo sapiens OX=9606 GN=USP39 PE=1 SV=2 UBP39_HUMAN reviewed Ubiquitin carboxyl-terminal hydrolase 39 (EC 3.4.19.12) (SAD1 homolog) (U4/U6.U5 tri-snRNP-associated 65 kDa protein) Homo sapiens (Human) GO:0000245; GO:0000398; GO:0005634; GO:0005654; GO:0005681; GO:0006397; GO:0008270; GO:0008380; GO:0016579; GO:0016787; GO:0046540; GO:0051301 cell division [GO:0051301]; mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; protein deubiquitination [GO:0016579]; RNA splicing [GO:0008380]; spliceosomal complex assembly [GO:0000245] nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U4/U6 x U5 tri-snRNP complex [GO:0046540] hydrolase activity [GO:0016787]; zinc ion binding [GO:0008270] g21876.t1 D3Z3C6 40.201 199 1.0900000000000001e-29 119.0 sp|D3Z3C6|ZFAN4_MOUSE AN1-type zinc finger protein 4 OS=Mus musculus OX=10090 GN=Zfand4 PE=1 SV=2 g21877.t1 D3Z3C6 70.297 202 7.17e-91 288.0 sp|D3Z3C6|ZFAN4_MOUSE AN1-type zinc finger protein 4 OS=Mus musculus OX=10090 GN=Zfand4 PE=1 SV=2 g21878.t1 Q8AVY8 40.385 312 1.58e-72 229.0 sp|Q8AVY8|DH12B_XENLA Very-long-chain 3-oxoacyl-CoA reductase-B OS=Xenopus laevis OX=8355 GN=hsd17b12-b PE=2 SV=1 g21879.t1 Q86UD5 54.088 477 7.57e-155 460.0 sp|Q86UD5|SL9B2_HUMAN Sodium/hydrogen exchanger 9B2 OS=Homo sapiens OX=9606 GN=SLC9B2 PE=1 SV=2 SL9B2_HUMAN reviewed Sodium/hydrogen exchanger 9B2 (Na(+)/H(+) exchanger NHA2) (Na(+)/H(+) exchanger-like domain-containing protein 2) (NHE domain-containing protein 2) (Sodium/hydrogen exchanger-like domain-containing protein 2) (Solute carrier family 9 subfamily B member 2) Homo sapiens (Human) GO:0005739; GO:0005743; GO:0005886; GO:0006814; GO:0010348; GO:0010351; GO:0015385; GO:0016323; GO:0016324; GO:0030317; GO:0030672; GO:0031966; GO:0034220; GO:0042802; GO:0055037; GO:0055038; GO:0055078; GO:0061178; GO:0072583; GO:0097228; GO:0098662; GO:2001206 clathrin-dependent endocytosis [GO:0072583]; flagellated sperm motility [GO:0030317]; inorganic cation transmembrane transport [GO:0098662]; lithium ion transport [GO:0010351]; monoatomic ion transmembrane transport [GO:0034220]; positive regulation of osteoclast development [GO:2001206]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]; sodium ion homeostasis [GO:0055078]; sodium ion transport [GO:0006814] apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; sperm principal piece [GO:0097228]; synaptic vesicle membrane [GO:0030672] identical protein binding [GO:0042802]; lithium:proton antiporter activity [GO:0010348]; sodium:proton antiporter activity [GO:0015385] g21880.t1 Q86UD5 42.759 580 1.54e-93 302.0 sp|Q86UD5|SL9B2_HUMAN Sodium/hydrogen exchanger 9B2 OS=Homo sapiens OX=9606 GN=SLC9B2 PE=1 SV=2 SL9B2_HUMAN reviewed Sodium/hydrogen exchanger 9B2 (Na(+)/H(+) exchanger NHA2) (Na(+)/H(+) exchanger-like domain-containing protein 2) (NHE domain-containing protein 2) (Sodium/hydrogen exchanger-like domain-containing protein 2) (Solute carrier family 9 subfamily B member 2) Homo sapiens (Human) GO:0005739; GO:0005743; GO:0005886; GO:0006814; GO:0010348; GO:0010351; GO:0015385; GO:0016323; GO:0016324; GO:0030317; GO:0030672; GO:0031966; GO:0034220; GO:0042802; GO:0055037; GO:0055038; GO:0055078; GO:0061178; GO:0072583; GO:0097228; GO:0098662; GO:2001206 clathrin-dependent endocytosis [GO:0072583]; flagellated sperm motility [GO:0030317]; inorganic cation transmembrane transport [GO:0098662]; lithium ion transport [GO:0010351]; monoatomic ion transmembrane transport [GO:0034220]; positive regulation of osteoclast development [GO:2001206]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]; sodium ion homeostasis [GO:0055078]; sodium ion transport [GO:0006814] apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; sperm principal piece [GO:0097228]; synaptic vesicle membrane [GO:0030672] identical protein binding [GO:0042802]; lithium:proton antiporter activity [GO:0010348]; sodium:proton antiporter activity [GO:0015385] g21884.t1 Q6NZ22 60.194 412 6.159999999999999e-178 509.0 sp|Q6NZ22|MET14_DANRE N(6)-adenosine-methyltransferase non-catalytic subunit METTL14 OS=Danio rerio OX=7955 GN=mettl14 PE=2 SV=1 g21890.t1 Q8R4C2 46.912 599 1.33e-162 481.0 sp|Q8R4C2|RUFY2_MOUSE RUN and FYVE domain-containing protein 2 OS=Mus musculus OX=10090 GN=Rufy2 PE=1 SV=2 g21891.t1 A6X942 38.76 258 1.8799999999999997e-40 155.0 sp|A6X942|SH24B_MOUSE SH2 domain-containing protein 4B OS=Mus musculus OX=10090 GN=Sh2d4b PE=2 SV=1 g21892.t1 Q5R754 72.313 307 1.1399999999999999e-172 503.0 sp|Q5R754|CDKL2_PONAB Cyclin-dependent kinase-like 2 OS=Pongo abelii OX=9601 GN=CDKL2 PE=2 SV=1 CDKL2_PONAB reviewed Cyclin-dependent kinase-like 2 (EC 2.7.11.22) Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0004693; GO:0005524; GO:0005634; GO:0005737; GO:0106310 cytoplasm [GO:0005737]; nucleus [GO:0005634] ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; protein serine kinase activity [GO:0106310] g21896.t1 P97379 68.889 135 3.84e-57 201.0 sp|P97379|G3BP2_MOUSE Ras GTPase-activating protein-binding protein 2 OS=Mus musculus OX=10090 GN=G3bp2 PE=1 SV=2 g21896.t1 P97379 58.889 90 1.7699999999999998e-23 107.0 sp|P97379|G3BP2_MOUSE Ras GTPase-activating protein-binding protein 2 OS=Mus musculus OX=10090 GN=G3bp2 PE=1 SV=2 g21897.t1 Q8TB73 38.989 554 4.53e-133 404.0 sp|Q8TB73|NDNF_HUMAN Protein NDNF OS=Homo sapiens OX=9606 GN=NDNF PE=1 SV=2 NDNF_HUMAN reviewed Protein NDNF (Neuron-derived neurotrophic factor) Homo sapiens (Human) GO:0001525; GO:0001764; GO:0002931; GO:0005539; GO:0005576; GO:0005615; GO:0007263; GO:0008201; GO:0010811; GO:0010976; GO:0021828; GO:0030198; GO:0031012; GO:0043524; GO:0044344; GO:0061042; GO:0071456; GO:2000352 angiogenesis [GO:0001525]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to hypoxia [GO:0071456]; extracellular matrix organization [GO:0030198]; gonadotrophin-releasing hormone neuronal migration to the hypothalamus [GO:0021828]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of neuron apoptotic process [GO:0043524]; neuron migration [GO:0001764]; nitric oxide mediated signal transduction [GO:0007263]; positive regulation of cell-substrate adhesion [GO:0010811]; positive regulation of neuron projection development [GO:0010976]; response to ischemia [GO:0002931]; vascular wound healing [GO:0061042] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615] glycosaminoglycan binding [GO:0005539]; heparin binding [GO:0008201] g21900.t1 O14718 24.746 295 4.91e-30 119.0 sp|O14718|OPSX_HUMAN Visual pigment-like receptor peropsin OS=Homo sapiens OX=9606 GN=RRH PE=1 SV=1 g21901.t1 Q5RBN8 53.67 436 1.97e-127 392.0 sp|Q5RBN8|LIN54_PONAB Protein lin-54 homolog OS=Pongo abelii OX=9601 GN=LIN54 PE=2 SV=1 LIN54_PONAB reviewed Protein lin-54 homolog Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0003677; GO:0005634; GO:0006355; GO:0046872 regulation of DNA-templated transcription [GO:0006355] nucleus [GO:0005634] DNA binding [GO:0003677]; metal ion binding [GO:0046872] g21901.t2 Q5RBN8 53.061 441 3.98e-124 383.0 sp|Q5RBN8|LIN54_PONAB Protein lin-54 homolog OS=Pongo abelii OX=9601 GN=LIN54 PE=2 SV=1 LIN54_PONAB reviewed Protein lin-54 homolog Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0003677; GO:0005634; GO:0006355; GO:0046872 regulation of DNA-templated transcription [GO:0006355] nucleus [GO:0005634] DNA binding [GO:0003677]; metal ion binding [GO:0046872] g21902.t1 Q5R648 76.485 404 0.0 651.0 sp|Q5R648|CSN4_PONAB COP9 signalosome complex subunit 4 OS=Pongo abelii OX=9601 GN=COPS4 PE=2 SV=1 g21903.t1 P07602 24.949 493 1.34e-39 159.0 sp|P07602|SAP_HUMAN Prosaposin OS=Homo sapiens OX=9606 GN=PSAP PE=1 SV=2 SAP_HUMAN reviewed Prosaposin (Proactivator polypeptide) [Cleaved into: Saposin-A (Protein A); Saposin-B-Val; Saposin-B (Cerebroside sulfate activator) (CSAct) (Dispersin) (Sphingolipid activator protein 1) (SAP-1) (Sulfatide/GM1 activator); Saposin-C (A1 activator) (Co-beta-glucosidase) (Glucosylceramidase activator) (Sphingolipid activator protein 2) (SAP-2); Saposin-D (Component C) (Protein C)] Homo sapiens (Human) GO:0002020; GO:0005543; GO:0005576; GO:0005615; GO:0005764; GO:0005765; GO:0005770; GO:0005886; GO:0006665; GO:0007041; GO:0007193; GO:0008047; GO:0010467; GO:0010506; GO:0019216; GO:0035577; GO:0042802; GO:0042803; GO:0043202; GO:0060736; GO:0060742; GO:0070062; GO:0097110; GO:1905572; GO:1905573; GO:1905574; GO:1905575; GO:1905576; GO:1905577 adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; epithelial cell differentiation involved in prostate gland development [GO:0060742]; ganglioside GM1 transport to membrane [GO:1905572]; gene expression [GO:0010467]; lysosomal transport [GO:0007041]; prostate gland growth [GO:0060736]; regulation of autophagy [GO:0010506]; regulation of lipid metabolic process [GO:0019216]; sphingolipid metabolic process [GO:0006665] azurophil granule membrane [GO:0035577]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; late endosome [GO:0005770]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; plasma membrane [GO:0005886] enzyme activator activity [GO:0008047]; ganglioside GM1 binding [GO:1905573]; ganglioside GM2 binding [GO:1905574]; ganglioside GM3 binding [GO:1905575]; ganglioside GP1c binding [GO:1905577]; ganglioside GT1b binding [GO:1905576]; identical protein binding [GO:0042802]; phospholipid binding [GO:0005543]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; scaffold protein binding [GO:0097110] g21903.t1 P07602 25.858 437 4.37e-31 133.0 sp|P07602|SAP_HUMAN Prosaposin OS=Homo sapiens OX=9606 GN=PSAP PE=1 SV=2 SAP_HUMAN reviewed Prosaposin (Proactivator polypeptide) [Cleaved into: Saposin-A (Protein A); Saposin-B-Val; Saposin-B (Cerebroside sulfate activator) (CSAct) (Dispersin) (Sphingolipid activator protein 1) (SAP-1) (Sulfatide/GM1 activator); Saposin-C (A1 activator) (Co-beta-glucosidase) (Glucosylceramidase activator) (Sphingolipid activator protein 2) (SAP-2); Saposin-D (Component C) (Protein C)] Homo sapiens (Human) GO:0002020; GO:0005543; GO:0005576; GO:0005615; GO:0005764; GO:0005765; GO:0005770; GO:0005886; GO:0006665; GO:0007041; GO:0007193; GO:0008047; GO:0010467; GO:0010506; GO:0019216; GO:0035577; GO:0042802; GO:0042803; GO:0043202; GO:0060736; GO:0060742; GO:0070062; GO:0097110; GO:1905572; GO:1905573; GO:1905574; GO:1905575; GO:1905576; GO:1905577 adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; epithelial cell differentiation involved in prostate gland development [GO:0060742]; ganglioside GM1 transport to membrane [GO:1905572]; gene expression [GO:0010467]; lysosomal transport [GO:0007041]; prostate gland growth [GO:0060736]; regulation of autophagy [GO:0010506]; regulation of lipid metabolic process [GO:0019216]; sphingolipid metabolic process [GO:0006665] azurophil granule membrane [GO:0035577]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; late endosome [GO:0005770]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; plasma membrane [GO:0005886] enzyme activator activity [GO:0008047]; ganglioside GM1 binding [GO:1905573]; ganglioside GM2 binding [GO:1905574]; ganglioside GM3 binding [GO:1905575]; ganglioside GP1c binding [GO:1905577]; ganglioside GT1b binding [GO:1905576]; identical protein binding [GO:0042802]; phospholipid binding [GO:0005543]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; scaffold protein binding [GO:0097110] g21903.t1 P07602 24.008 479 1.6699999999999999e-25 116.0 sp|P07602|SAP_HUMAN Prosaposin OS=Homo sapiens OX=9606 GN=PSAP PE=1 SV=2 SAP_HUMAN reviewed Prosaposin (Proactivator polypeptide) [Cleaved into: Saposin-A (Protein A); Saposin-B-Val; Saposin-B (Cerebroside sulfate activator) (CSAct) (Dispersin) (Sphingolipid activator protein 1) (SAP-1) (Sulfatide/GM1 activator); Saposin-C (A1 activator) (Co-beta-glucosidase) (Glucosylceramidase activator) (Sphingolipid activator protein 2) (SAP-2); Saposin-D (Component C) (Protein C)] Homo sapiens (Human) GO:0002020; GO:0005543; GO:0005576; GO:0005615; GO:0005764; GO:0005765; GO:0005770; GO:0005886; GO:0006665; GO:0007041; GO:0007193; GO:0008047; GO:0010467; GO:0010506; GO:0019216; GO:0035577; GO:0042802; GO:0042803; GO:0043202; GO:0060736; GO:0060742; GO:0070062; GO:0097110; GO:1905572; GO:1905573; GO:1905574; GO:1905575; GO:1905576; GO:1905577 adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; epithelial cell differentiation involved in prostate gland development [GO:0060742]; ganglioside GM1 transport to membrane [GO:1905572]; gene expression [GO:0010467]; lysosomal transport [GO:0007041]; prostate gland growth [GO:0060736]; regulation of autophagy [GO:0010506]; regulation of lipid metabolic process [GO:0019216]; sphingolipid metabolic process [GO:0006665] azurophil granule membrane [GO:0035577]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; late endosome [GO:0005770]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; plasma membrane [GO:0005886] enzyme activator activity [GO:0008047]; ganglioside GM1 binding [GO:1905573]; ganglioside GM2 binding [GO:1905574]; ganglioside GM3 binding [GO:1905575]; ganglioside GP1c binding [GO:1905577]; ganglioside GT1b binding [GO:1905576]; identical protein binding [GO:0042802]; phospholipid binding [GO:0005543]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; scaffold protein binding [GO:0097110] g21903.t1 P07602 24.204 471 3.7999999999999995e-24 112.0 sp|P07602|SAP_HUMAN Prosaposin OS=Homo sapiens OX=9606 GN=PSAP PE=1 SV=2 SAP_HUMAN reviewed Prosaposin (Proactivator polypeptide) [Cleaved into: Saposin-A (Protein A); Saposin-B-Val; Saposin-B (Cerebroside sulfate activator) (CSAct) (Dispersin) (Sphingolipid activator protein 1) (SAP-1) (Sulfatide/GM1 activator); Saposin-C (A1 activator) (Co-beta-glucosidase) (Glucosylceramidase activator) (Sphingolipid activator protein 2) (SAP-2); Saposin-D (Component C) (Protein C)] Homo sapiens (Human) GO:0002020; GO:0005543; GO:0005576; GO:0005615; GO:0005764; GO:0005765; GO:0005770; GO:0005886; GO:0006665; GO:0007041; GO:0007193; GO:0008047; GO:0010467; GO:0010506; GO:0019216; GO:0035577; GO:0042802; GO:0042803; GO:0043202; GO:0060736; GO:0060742; GO:0070062; GO:0097110; GO:1905572; GO:1905573; GO:1905574; GO:1905575; GO:1905576; GO:1905577 adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; epithelial cell differentiation involved in prostate gland development [GO:0060742]; ganglioside GM1 transport to membrane [GO:1905572]; gene expression [GO:0010467]; lysosomal transport [GO:0007041]; prostate gland growth [GO:0060736]; regulation of autophagy [GO:0010506]; regulation of lipid metabolic process [GO:0019216]; sphingolipid metabolic process [GO:0006665] azurophil granule membrane [GO:0035577]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; late endosome [GO:0005770]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; plasma membrane [GO:0005886] enzyme activator activity [GO:0008047]; ganglioside GM1 binding [GO:1905573]; ganglioside GM2 binding [GO:1905574]; ganglioside GM3 binding [GO:1905575]; ganglioside GP1c binding [GO:1905577]; ganglioside GT1b binding [GO:1905576]; identical protein binding [GO:0042802]; phospholipid binding [GO:0005543]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; scaffold protein binding [GO:0097110] g21909.t1 G4WMX4 38.182 220 2.8899999999999995e-42 150.0 sp|G4WMX4|RYAR_TRICA RYamide receptor OS=Tribolium castaneum OX=7070 GN=RYa-R PE=2 SV=1 g21914.t1 P50749 41.935 124 5.310000000000001e-29 117.0 sp|P50749|RASF2_HUMAN Ras association domain-containing protein 2 OS=Homo sapiens OX=9606 GN=RASSF2 PE=1 SV=1 RASF2_HUMAN reviewed Ras association domain-containing protein 2 Homo sapiens (Human) GO:0000776; GO:0001501; GO:0001503; GO:0004672; GO:0005634; GO:0005654; GO:0005737; GO:0005794; GO:0005829; GO:0005886; GO:0007165; GO:0007173; GO:0007249; GO:0031954; GO:0032991; GO:0033137; GO:0043065; GO:0045667; GO:0045670; GO:0045860; GO:0046330; GO:0046849; GO:0048872; GO:0050821; GO:1901222; GO:1901223 bone remodeling [GO:0046849]; canonical NF-kappaB signal transduction [GO:0007249]; epidermal growth factor receptor signaling pathway [GO:0007173]; homeostasis of number of cells [GO:0048872]; negative regulation of non-canonical NF-kappaB signal transduction [GO:1901223]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; ossification [GO:0001503]; positive regulation of apoptotic process [GO:0043065]; positive regulation of JNK cascade [GO:0046330]; positive regulation of protein autophosphorylation [GO:0031954]; positive regulation of protein kinase activity [GO:0045860]; protein stabilization [GO:0050821]; regulation of non-canonical NF-kappaB signal transduction [GO:1901222]; regulation of osteoblast differentiation [GO:0045667]; regulation of osteoclast differentiation [GO:0045670]; signal transduction [GO:0007165]; skeletal system development [GO:0001501] cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; kinetochore [GO:0000776]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] protein kinase activity [GO:0004672] g21915.t1 Q8BL06 58.311 367 4.39e-143 472.0 sp|Q8BL06|UBP54_MOUSE Ubiquitin carboxyl-terminal hydrolase 54 OS=Mus musculus OX=10090 GN=Usp54 PE=1 SV=2 g21915.t2 Q8BL06 58.311 367 4.5e-143 472.0 sp|Q8BL06|UBP54_MOUSE Ubiquitin carboxyl-terminal hydrolase 54 OS=Mus musculus OX=10090 GN=Usp54 PE=1 SV=2 g21918.t1 Q9VJ79 55.956 722 0.0 847.0 sp|Q9VJ79|PDE11_DROME Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11 OS=Drosophila melanogaster OX=7227 GN=Pde11 PE=1 SV=4 g21918.t2 Q9VJ79 57.831 249 1.09e-84 286.0 sp|Q9VJ79|PDE11_DROME Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11 OS=Drosophila melanogaster OX=7227 GN=Pde11 PE=1 SV=4 g21918.t2 Q9VJ79 35.079 191 4.9100000000000004e-26 115.0 sp|Q9VJ79|PDE11_DROME Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11 OS=Drosophila melanogaster OX=7227 GN=Pde11 PE=1 SV=4 g21931.t1 P40630 31.799 239 1.0800000000000001e-31 120.0 sp|P40630|TFAM_MOUSE Transcription factor A, mitochondrial OS=Mus musculus OX=10090 GN=Tfam PE=1 SV=2 TFAM_MOUSE reviewed Transcription factor A, mitochondrial (mtTFA) (Testis-specific high mobility group protein) (TS-HMG) Mus musculus (Mouse) GO:0001018; GO:0001223; GO:0001666; GO:0003682; GO:0005634; GO:0005739; GO:0005759; GO:0006390; GO:0006391; GO:0007584; GO:0031072; GO:0032991; GO:0033108; GO:0034246; GO:0042645; GO:0043565 mitochondrial respiratory chain complex assembly [GO:0033108]; mitochondrial transcription [GO:0006390]; response to hypoxia [GO:0001666]; response to nutrient [GO:0007584]; transcription initiation at mitochondrial promoter [GO:0006391] mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; protein-containing complex [GO:0032991] chromatin binding [GO:0003682]; heat shock protein binding [GO:0031072]; mitochondrial promoter sequence-specific DNA binding [GO:0001018]; mitochondrial transcription factor activity [GO:0034246]; sequence-specific DNA binding [GO:0043565]; transcription coactivator binding [GO:0001223] g21932.t1 Q805E5 33.333 270 5.28e-39 144.0 sp|Q805E5|CHSTE_DANRE Carbohydrate sulfotransferase 14 OS=Danio rerio OX=7955 GN=chst14 PE=2 SV=1 CHSTE_DANRE reviewed Carbohydrate sulfotransferase 14 (EC 2.8.2.-) (Dermatan 4-sulfotransferase 1) (D4ST-1) (zD4ST-1) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000139; GO:0001537; GO:0008146; GO:0016051; GO:0050655 carbohydrate biosynthetic process [GO:0016051]; dermatan sulfate proteoglycan metabolic process [GO:0050655] Golgi membrane [GO:0000139] dermatan 4-sulfotransferase activity [GO:0001537]; sulfotransferase activity [GO:0008146] g21933.t1 Q14BI2 30.303 495 4.04e-60 227.0 sp|Q14BI2|GRM2_MOUSE Metabotropic glutamate receptor 2 OS=Mus musculus OX=10090 GN=Grm2 PE=1 SV=2 g21933.t1 Q14BI2 27.027 740 2.37e-51 200.0 sp|Q14BI2|GRM2_MOUSE Metabotropic glutamate receptor 2 OS=Mus musculus OX=10090 GN=Grm2 PE=1 SV=2 g21935.t1 Q1ZZH0 31.667 240 1.6900000000000001e-29 129.0 sp|Q1ZZH0|GRM4_MACFA Metabotropic glutamate receptor 4 OS=Macaca fascicularis OX=9541 GN=GRM4 PE=2 SV=1 g21936.t1 Q5RDQ8 36.181 199 4.17e-27 122.0 sp|Q5RDQ8|GRM7_PONAB Metabotropic glutamate receptor 7 OS=Pongo abelii OX=9601 GN=GRM7 PE=2 SV=1 GRM7_PONAB reviewed Metabotropic glutamate receptor 7 (mGluR7) Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0001642; GO:0005886; GO:0007196; GO:0008066; GO:0046983; GO:0061564 adenylate cyclase-inhibiting G protein-coupled glutamate receptor signaling pathway [GO:0007196]; axon development [GO:0061564] plasma membrane [GO:0005886] glutamate receptor activity [GO:0008066]; group III metabotropic glutamate receptor activity [GO:0001642]; protein dimerization activity [GO:0046983] g21941.t1 P04323 33.413 419 4.42e-69 250.0 sp|P04323|POL3_DROME Retrovirus-related Pol polyprotein from transposon 17.6 OS=Drosophila melanogaster OX=7227 GN=pol PE=4 SV=1 g21947.t1 O94907 38.251 183 1.8700000000000002e-21 96.3 sp|O94907|DKK1_HUMAN Dickkopf-related protein 1 OS=Homo sapiens OX=9606 GN=DKK1 PE=1 SV=1 g21953.t1 P20072 57.263 358 6.49e-144 426.0 sp|P20072|ANXA7_BOVIN Annexin A7 OS=Bos taurus OX=9913 GN=ANXA7 PE=1 SV=2 g21965.t1 Q96AJ9 56.701 194 7.6e-73 223.0 sp|Q96AJ9|VTI1A_HUMAN Vesicle transport through interaction with t-SNAREs homolog 1A OS=Homo sapiens OX=9606 GN=VTI1A PE=1 SV=2 VTI1A_HUMAN reviewed Vesicle transport through interaction with t-SNAREs homolog 1A (Vesicle transport v-SNARE protein Vti1-like 2) (Vti1-rp2) Homo sapiens (Human) GO:0000139; GO:0000149; GO:0005484; GO:0005768; GO:0005776; GO:0005789; GO:0005794; GO:0005829; GO:0006886; GO:0006888; GO:0006891; GO:0006896; GO:0006914; GO:0008021; GO:0012507; GO:0016236; GO:0030136; GO:0031201; GO:0031902; GO:0032456; GO:0032588; GO:0042147; GO:0043025; GO:0044306; GO:0048280; GO:0048471; GO:0050882 autophagy [GO:0006914]; endocytic recycling [GO:0032456]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi to vacuole transport [GO:0006896]; intra-Golgi vesicle-mediated transport [GO:0006891]; intracellular protein transport [GO:0006886]; macroautophagy [GO:0016236]; retrograde transport, endosome to Golgi [GO:0042147]; vesicle fusion with Golgi apparatus [GO:0048280]; voluntary musculoskeletal movement [GO:0050882] autophagosome [GO:0005776]; clathrin-coated vesicle [GO:0030136]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; ER to Golgi transport vesicle membrane [GO:0012507]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; late endosome membrane [GO:0031902]; neuron projection terminus [GO:0044306]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; SNARE complex [GO:0031201]; synaptic vesicle [GO:0008021]; trans-Golgi network membrane [GO:0032588] SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149] g21966.t1 A0A1D8PDZ1 58.182 110 1.44e-38 129.0 sp|A0A1D8PDZ1|RL34B_CANAL Large ribosomal subunit protein eL34 OS=Candida albicans (strain SC5314 / ATCC MYA-2876) OX=237561 GN=RPL34B PE=1 SV=1 g21969.t1 P22444 55.455 110 1.6299999999999999e-34 136.0 sp|P22444|BMP3_BOVIN Bone morphogenetic protein 3 OS=Bos taurus OX=9913 GN=BMP3 PE=1 SV=2 g21971.t1 O95393 32.361 377 8.300000000000001e-56 194.0 sp|O95393|BMP10_HUMAN Bone morphogenetic protein 10 OS=Homo sapiens OX=9606 GN=BMP10 PE=1 SV=1 BMP10_HUMAN reviewed Bone morphogenetic protein 10 (BMP-10) Homo sapiens (Human) GO:0001822; GO:0005125; GO:0005179; GO:0005576; GO:0005615; GO:0005737; GO:0007155; GO:0007512; GO:0008083; GO:0009986; GO:0010596; GO:0010613; GO:0010614; GO:0010628; GO:0030018; GO:0030308; GO:0030336; GO:0030509; GO:0031433; GO:0032924; GO:0033612; GO:0045214; GO:0045893; GO:0055009; GO:0055010; GO:0055015; GO:0055117; GO:0060038; GO:0060045; GO:0060298; GO:0060347; GO:0060391; GO:0061036; GO:1903242; GO:2000138 activin receptor signaling pathway [GO:0032924]; adult heart development [GO:0007512]; atrial cardiac muscle tissue morphogenesis [GO:0055009]; BMP signaling pathway [GO:0030509]; cardiac muscle cell proliferation [GO:0060038]; cell adhesion [GO:0007155]; heart trabecula formation [GO:0060347]; kidney development [GO:0001822]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of cell growth [GO:0030308]; negative regulation of cell migration [GO:0030336]; negative regulation of endothelial cell migration [GO:0010596]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of cartilage development [GO:0061036]; positive regulation of cell proliferation involved in heart morphogenesis [GO:2000138]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of gene expression [GO:0010628]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of SMAD protein signal transduction [GO:0060391]; regulation of cardiac muscle contraction [GO:0055117]; regulation of cardiac muscle hypertrophy in response to stress [GO:1903242]; sarcomere organization [GO:0045214]; ventricular cardiac muscle cell development [GO:0055015]; ventricular cardiac muscle tissue morphogenesis [GO:0055010] cell surface [GO:0009986]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Z disc [GO:0030018] cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; hormone activity [GO:0005179]; receptor serine/threonine kinase binding [GO:0033612]; telethonin binding [GO:0031433] g21973.t1 Q32PL8 41.711 187 4.74e-33 132.0 sp|Q32PL8|PRIPO_DANRE DNA-directed primase/polymerase protein OS=Danio rerio OX=7955 GN=primpol PE=2 SV=2 PRIPO_DANRE reviewed DNA-directed primase/polymerase protein (EC 2.7.7.102) (EC 2.7.7.7) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000428; GO:0003682; GO:0003887; GO:0003899; GO:0005634; GO:0005657; GO:0005759; GO:0006264; GO:0008270; GO:0009411; GO:0019985; GO:0030145; GO:0031297; GO:0042276; GO:0043504; GO:0062176 error-prone translesion synthesis [GO:0042276]; mitochondrial DNA repair [GO:0043504]; mitochondrial DNA replication [GO:0006264]; R-loop processing [GO:0062176]; replication fork processing [GO:0031297]; response to UV [GO:0009411]; translesion synthesis [GO:0019985] DNA-directed RNA polymerase complex [GO:0000428]; mitochondrial matrix [GO:0005759]; nucleus [GO:0005634]; replication fork [GO:0005657] chromatin binding [GO:0003682]; DNA-directed DNA polymerase activity [GO:0003887]; DNA-directed RNA polymerase activity [GO:0003899]; manganese ion binding [GO:0030145]; zinc ion binding [GO:0008270] g21979.t1 Q7L4P6 43.089 123 5.31e-23 100.0 sp|Q7L4P6|BEND5_HUMAN BEN domain-containing protein 5 OS=Homo sapiens OX=9606 GN=BEND5 PE=1 SV=1 BEND5_HUMAN reviewed BEN domain-containing protein 5 Homo sapiens (Human) GO:0003677; GO:0005794; GO:0045892 negative regulation of DNA-templated transcription [GO:0045892] Golgi apparatus [GO:0005794] DNA binding [GO:0003677] g21995.t1 O73853 36.384 437 1.32e-97 307.0 sp|O73853|CP17A_ICTPU Steroid 17-alpha-hydroxylase/17,20 lyase OS=Ictalurus punctatus OX=7998 GN=cyp17a1 PE=2 SV=1 g21997.t1 Q09575 30.667 300 8.989999999999999e-28 119.0 sp|Q09575|YRD6_CAEEL Uncharacterized protein K02A2.6 OS=Caenorhabditis elegans OX=6239 GN=K02A2.6 PE=4 SV=1 g22009.t1 Q6ZXA0 38.938 226 2.4800000000000003e-43 152.0 sp|Q6ZXA0|SIA8A_XENLA Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase OS=Xenopus laevis OX=8355 GN=st8sia1 PE=1 SV=1 g22013.t1 Q64689 34.516 310 5.849999999999999e-45 163.0 sp|Q64689|SIA8C_MOUSE Alpha-N-acetylneuraminate alpha-2,8-sialyltransferase ST8SIA3 OS=Mus musculus OX=10090 GN=St8sia3 PE=1 SV=2 SIA8C_MOUSE reviewed Alpha-N-acetylneuraminate alpha-2,8-sialyltransferase ST8SIA3 (EC 2.4.3.-) (Alpha-2,8-sialyltransferase 8C) (Alpha-2,8-sialyltransferase III) (Ganglioside GD3 synthase ST8SIA3) (EC 2.4.3.8) (ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 3) (Sia alpha 2,3Gal beta 1,4GlcNAc alpha 2,8-sialyltransferase) (Sialyltransferase 8C) (SIAT8-C) (Sialyltransferase St8Sia III) (ST8SiaIII) Mus musculus (Mouse) GO:0000139; GO:0001574; GO:0003828; GO:0006491; GO:0008373; GO:0009100; GO:0009311; GO:0042802; GO:0097503 ganglioside biosynthetic process [GO:0001574]; glycoprotein metabolic process [GO:0009100]; N-glycan processing [GO:0006491]; oligosaccharide metabolic process [GO:0009311]; sialylation [GO:0097503] Golgi membrane [GO:0000139] alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity [GO:0003828]; identical protein binding [GO:0042802]; sialyltransferase activity [GO:0008373] g22020.t1 P09534 42.857 119 8.76e-35 127.0 sp|P09534|DVR1_XENLA Protein DVR-1 OS=Xenopus laevis OX=8355 GN=dvr1 PE=1 SV=1 g22022.t1 P14272 38.909 275 4.97e-44 164.0 sp|P14272|KLKB1_RAT Plasma kallikrein OS=Rattus norvegicus OX=10116 GN=Klkb1 PE=1 SV=1 KLKB1_RAT reviewed Plasma kallikrein (EC 3.4.21.34) (Fletcher factor) (Kininogenin) (Plasma prekallikrein) [Cleaved into: Plasma kallikrein heavy chain; Plasma kallikrein light chain] Rattus norvegicus (Rat) GO:0004252; GO:0005615; GO:0006954; GO:0007596; GO:0008236; GO:0031639; GO:0042730; GO:0051919; GO:0097421 blood coagulation [GO:0007596]; fibrinolysis [GO:0042730]; inflammatory response [GO:0006954]; liver regeneration [GO:0097421]; plasminogen activation [GO:0031639]; positive regulation of fibrinolysis [GO:0051919] extracellular space [GO:0005615] serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236] g22023.t1 G3V801 37.367 281 2.36e-43 166.0 sp|G3V801|NETR_RAT Neurotrypsin OS=Rattus norvegicus OX=10116 GN=Prss12 PE=1 SV=1 NETR_RAT reviewed Neurotrypsin (EC 3.4.21.-) (Serine protease 12) Rattus norvegicus (Rat) GO:0004252; GO:0005886; GO:0006508; GO:0006887; GO:0008233; GO:0030424; GO:0030425; GO:0031410; GO:0031638; GO:0043083; GO:0043195; GO:0045202; GO:0098685; GO:0098793; GO:0098978 exocytosis [GO:0006887]; proteolysis [GO:0006508]; zymogen activation [GO:0031638] axon [GO:0030424]; cytoplasmic vesicle [GO:0031410]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; Schaffer collateral - CA1 synapse [GO:0098685]; synapse [GO:0045202]; synaptic cleft [GO:0043083]; terminal bouton [GO:0043195] peptidase activity [GO:0008233]; serine-type endopeptidase activity [GO:0004252] g22024.t1 Q5ZJB4 40.63 635 6.890000000000001e-163 493.0 sp|Q5ZJB4|IKKA_CHICK Inhibitor of nuclear factor kappa-B kinase subunit alpha OS=Gallus gallus OX=9031 GN=CHUK PE=2 SV=1 IKKA_CHICK reviewed Inhibitor of nuclear factor kappa-B kinase subunit alpha (I kappa-B kinase alpha) (IKK-A) (IKK-alpha) (IkBKA) (IkappaB kinase) (EC 2.7.11.10) (Conserved helix-loop-helix ubiquitous kinase) (Nuclear factor NF-kappa-B inhibitor kinase alpha) (NFKBIKA) Gallus gallus (Chicken) GO:0002224; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0008384; GO:0008385; GO:0033209; GO:0042803; GO:0043123; GO:0045944; GO:0046982; GO:0071356 cellular response to tumor necrosis factor [GO:0071356]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of transcription by RNA polymerase II [GO:0045944]; toll-like receptor signaling pathway [GO:0002224]; tumor necrosis factor-mediated signaling pathway [GO:0033209] cytoplasm [GO:0005737]; cytosol [GO:0005829]; IkappaB kinase complex [GO:0008385]; nucleus [GO:0005634] ATP binding [GO:0005524]; IkappaB kinase activity [GO:0008384]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; protein serine/threonine kinase activity [GO:0004674] g22025.t1 Q86X67 39.13 345 2e-80 253.0 sp|Q86X67|NUD13_HUMAN NAD(P)H pyrophosphatase NUDT13, mitochondrial OS=Homo sapiens OX=9606 GN=NUDT13 PE=1 SV=3 NUD13_HUMAN reviewed NAD(P)H pyrophosphatase NUDT13, mitochondrial (EC 3.6.1.22) (Nucleoside diphosphate-linked moiety X motif 13) (Nudix motif 13) (Protein KiSS-16) Homo sapiens (Human) GO:0000210; GO:0005739; GO:0005759; GO:0010943; GO:0015949; GO:0016462; GO:0035529; GO:0046872 nucleobase-containing small molecule interconversion [GO:0015949] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] metal ion binding [GO:0046872]; NAD+ diphosphatase activity [GO:0000210]; NADH pyrophosphatase activity [GO:0035529]; NADPH pyrophosphatase activity [GO:0010943]; pyrophosphatase activity [GO:0016462] g22026.t1 Q96LI5 59.594 542 0.0 626.0 sp|Q96LI5|CNO6L_HUMAN CCR4-NOT transcription complex subunit 6-like OS=Homo sapiens OX=9606 GN=CNOT6L PE=1 SV=2 CNO6L_HUMAN reviewed CCR4-NOT transcription complex subunit 6-like (EC 3.1.13.4) (Carbon catabolite repressor protein 4 homolog B) Homo sapiens (Human) GO:0000175; GO:0000289; GO:0004535; GO:0005634; GO:0005737; GO:0005829; GO:0006397; GO:0006417; GO:0008284; GO:0010606; GO:0030014; GO:0031047; GO:0046872 mRNA processing [GO:0006397]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cytoplasmic mRNA processing body assembly [GO:0010606]; regulation of translation [GO:0006417]; regulatory ncRNA-mediated gene silencing [GO:0031047] CCR4-NOT complex [GO:0030014]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634] 3'-5'-RNA exonuclease activity [GO:0000175]; metal ion binding [GO:0046872]; poly(A)-specific ribonuclease activity [GO:0004535] g22027.t1 Q9BYD6 33.061 245 6.68e-39 144.0 sp|Q9BYD6|RM01_HUMAN Large ribosomal subunit protein uL1m OS=Homo sapiens OX=9606 GN=MRPL1 PE=1 SV=2 g22028.t1 Q9UKB3 45.078 193 1.8800000000000001e-47 156.0 sp|Q9UKB3|DJC12_HUMAN DnaJ homolog subfamily C member 12 OS=Homo sapiens OX=9606 GN=DNAJC12 PE=1 SV=1 g22030.t1 A0A0G2JZ79 65.549 328 4.35e-153 450.0 sp|A0A0G2JZ79|SIR1_RAT NAD-dependent protein deacetylase sirtuin-1 OS=Rattus norvegicus OX=10116 GN=Sirt1 PE=3 SV=2 SIR1_RAT reviewed NAD-dependent protein deacetylase sirtuin-1 (EC 2.3.1.286) (NAD-dependent protein deacylase sirtuin-1) (EC 2.3.1.-) [Cleaved into: SirtT1 75 kDa fragment (75SirT1)] Rattus norvegicus (Rat) GO:0000012; GO:0000122; GO:0000183; GO:0000720; GO:0000731; GO:0000781; GO:0000785; GO:0000791; GO:0000792; GO:0000978; GO:0001525; GO:0001542; GO:0001650; GO:0001678; GO:0001938; GO:0002039; GO:0002821; GO:0003713; GO:0003714; GO:0004407; GO:0004857; GO:0005634; GO:0005635; GO:0005637; GO:0005654; GO:0005677; GO:0005730; GO:0005737; GO:0005739; GO:0005829; GO:0006094; GO:0006325; GO:0006642; GO:0006974; GO:0006979; GO:0007005; GO:0007179; GO:0007283; GO:0007346; GO:0007517; GO:0007623; GO:0008047; GO:0008284; GO:0008630; GO:0009267; GO:0010046; GO:0010460; GO:0010628; GO:0010629; GO:0010659; GO:0010667; GO:0010824; GO:0010868; GO:0010875; GO:0010883; GO:0010898; GO:0010906; GO:0010918; GO:0010976; GO:0014858; GO:0016239; GO:0016567; GO:0016605; GO:0016922; GO:0017136; GO:0019213; GO:0019432; GO:0019899; GO:0019904; GO:0030225; GO:0030424; GO:0030426; GO:0030512; GO:0030968; GO:0031393; GO:0031507; GO:0031509; GO:0031648; GO:0031667; GO:0032007; GO:0032041; GO:0032436; GO:0032720; GO:0032868; GO:0032922; GO:0032991; GO:0033210; GO:0033553; GO:0033558; GO:0034391; GO:0034979; GO:0035098; GO:0035329; GO:0035331; GO:0035356; GO:0035358; GO:0035774; GO:0042127; GO:0042149; GO:0042220; GO:0042311; GO:0042393; GO:0042542; GO:0042595; GO:0042632; GO:0042771; GO:0042802; GO:0042981; GO:0043065; GO:0043066; GO:0043124; GO:0043161; GO:0043398; GO:0043422; GO:0043425; GO:0043518; GO:0043524; GO:0043536; GO:0044321; GO:0045348; GO:0045471; GO:0045599; GO:0045722; GO:0045739; GO:0045766; GO:0045786; GO:0045892; GO:0045944; GO:0046015; GO:0046628; GO:0046872; GO:0046969; GO:0046970; GO:0050872; GO:0051019; GO:0051152; GO:0051315; GO:0051402; GO:0051658; GO:0051897; GO:0051898; GO:0055089; GO:0060125; GO:0060766; GO:0060907; GO:0061051; GO:0061773; GO:0070301; GO:0070403; GO:0070857; GO:0070914; GO:0071236; GO:0071303; GO:0071356; GO:0071456; GO:0071479; GO:0072331; GO:0072350; GO:0089720; GO:0090335; GO:0090400; GO:0097009; GO:0097193; GO:0106230; GO:0106231; GO:0140297; GO:0140416; GO:0140861; GO:0140937; GO:0141050; GO:0141208; GO:0160012; GO:1900181; GO:1901797; GO:1902166; GO:1902176; GO:1902237; GO:1902424; GO:1902617; GO:1903427; GO:1904178; GO:1904179; GO:1904373; GO:1904638; GO:1904639; GO:1904644; GO:1904646; GO:1904648; GO:1904710; GO:1990254; GO:1990830; GO:1990841; GO:2000111; GO:2000270; GO:2000614; GO:2000655; GO:2000773; GO:2000774; GO:2000781; GO:2001171 angiogenesis [GO:0001525]; attachment of mitotic spindle microtubules to kinetochore [GO:0051315]; behavioral response to starvation [GO:0042595]; cardiac muscle cell apoptotic process [GO:0010659]; cellular response to amyloid-beta [GO:1904646]; cellular response to antibiotic [GO:0071236]; cellular response to curcumin [GO:1904644]; cellular response to glucose starvation [GO:0042149]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to hypoxia [GO:0071456]; cellular response to ionizing radiation [GO:0071479]; cellular response to leukemia inhibitory factor [GO:1990830]; cellular response to resveratrol [GO:1904639]; cellular response to rotenone [GO:1904648]; cellular response to starvation [GO:0009267]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to vitamin B3 [GO:0071303]; cholesterol homeostasis [GO:0042632]; chromatin organization [GO:0006325]; circadian regulation of gene expression [GO:0032922]; circadian rhythm [GO:0007623]; DNA damage response [GO:0006974]; DNA repair-dependent chromatin remodeling [GO:0140861]; DNA synthesis involved in DNA repair [GO:0000731]; endoplasmic reticulum unfolded protein response [GO:0030968]; energy homeostasis [GO:0097009]; fatty acid homeostasis [GO:0055089]; gluconeogenesis [GO:0006094]; heterochromatin formation [GO:0031507]; hippo signaling [GO:0035329]; intracellular glucose homeostasis [GO:0001678]; intracellular triglyceride homeostasis [GO:0035356]; intrinsic apoptotic signaling pathway [GO:0097193]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; leptin-mediated signaling pathway [GO:0033210]; macrophage differentiation [GO:0030225]; maintenance of nucleus location [GO:0051658]; mitochondrion organization [GO:0007005]; muscle organ development [GO:0007517]; negative regulation of adipose tissue development [GO:1904178]; negative regulation of androgen receptor signaling pathway [GO:0060766]; negative regulation of apoptotic process [GO:0043066]; negative regulation of attachment of mitotic spindle microtubules to kinetochore [GO:1902424]; negative regulation of canonical NF-kappaB signal transduction [GO:0043124]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of cell cycle [GO:0045786]; negative regulation of cellular response to testosterone stimulus [GO:2000655]; negative regulation of cellular senescence [GO:2000773]; negative regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043518]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of fibroblast apoptotic process [GO:2000270]; negative regulation of gene expression [GO:0010629]; negative regulation of growth hormone secretion [GO:0060125]; negative regulation of hippo signaling [GO:0035331]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:1902166]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051898]; negative regulation of prostaglandin biosynthetic process [GO:0031393]; negative regulation of protein localization to nucleus [GO:1900181]; negative regulation of reactive oxygen species biosynthetic process [GO:1903427]; negative regulation of signal transduction by p53 class mediator [GO:1901797]; negative regulation of TOR signaling [GO:0032007]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; negative regulation of triglyceride biosynthetic process [GO:0010868]; negative regulation of tumor necrosis factor production [GO:0032720]; neuron apoptotic process [GO:0051402]; ovulation from ovarian follicle [GO:0001542]; positive regulation of adaptive immune response [GO:0002821]; positive regulation of adipose tissue development [GO:1904179]; positive regulation of angiogenesis [GO:0045766]; positive regulation of apoptotic process [GO:0043065]; positive regulation of ATP biosynthetic process [GO:2001171]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of cell growth involved in cardiac muscle cell development [GO:0061051]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cellular senescence [GO:2000774]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of DNA repair [GO:0045739]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902237]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of gene expression [GO:0010628]; positive regulation of gluconeogenesis [GO:0045722]; positive regulation of granulosa cell apoptotic process [GO:1904710]; positive regulation of heart rate [GO:0010460]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of macroautophagy [GO:0016239]; positive regulation of macrophage apoptotic process [GO:2000111]; positive regulation of macrophage cytokine production [GO:0060907]; positive regulation of MHC class II biosynthetic process [GO:0045348]; positive regulation of mitochondrial membrane potential [GO:0010918]; positive regulation of neuron projection development [GO:0010976]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of skeletal muscle cell proliferation [GO:0014858]; positive regulation of smooth muscle cell differentiation [GO:0051152]; positive regulation of thyroid-stimulating hormone secretion [GO:2000614]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of triglyceride catabolic process [GO:0010898]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein depropionylation [GO:0106230]; protein destabilization [GO:0031648]; protein ubiquitination [GO:0016567]; pyrimidine dimer repair by nucleotide-excision repair [GO:0000720]; rDNA heterochromatin formation [GO:0000183]; regulation of apoptotic process [GO:0042981]; regulation of bile acid biosynthetic process [GO:0070857]; regulation of brown fat cell differentiation [GO:0090335]; regulation of cell population proliferation [GO:0042127]; regulation of centrosome duplication [GO:0010824]; regulation of glucose metabolic process [GO:0010906]; regulation of lipid storage [GO:0010883]; regulation of mitotic cell cycle [GO:0007346]; regulation of peroxisome proliferator activated receptor signaling pathway [GO:0035358]; regulation of smooth muscle cell apoptotic process [GO:0034391]; regulation of transcription by glucose [GO:0046015]; response to cocaine [GO:0042220]; response to ethanol [GO:0045471]; response to fluoride [GO:1902617]; response to hydrogen peroxide [GO:0042542]; response to insulin [GO:0032868]; response to kainic acid [GO:1904373]; response to leptin [GO:0044321]; response to mycotoxin [GO:0010046]; response to nutrient levels [GO:0031667]; response to oxidative stress [GO:0006979]; response to resveratrol [GO:1904638]; signal transduction by p53 class mediator [GO:0072331]; single strand break repair [GO:0000012]; spermatogenesis [GO:0007283]; stress-induced premature senescence [GO:0090400]; subtelomeric heterochromatin formation [GO:0031509]; transforming growth factor beta receptor signaling pathway [GO:0007179]; tricarboxylic acid metabolic process [GO:0072350]; triglyceride biosynthetic process [GO:0019432]; triglyceride mobilization [GO:0006642]; UV-damage excision repair [GO:0070914]; vasodilation [GO:0042311]; white fat cell differentiation [GO:0050872] axon [GO:0030424]; chromatin [GO:0000785]; chromatin silencing complex [GO:0005677]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; eNoSc complex [GO:0061773]; ESC/E(Z) complex [GO:0035098]; euchromatin [GO:0000791]; fibrillar center [GO:0001650]; growth cone [GO:0030426]; heterochromatin [GO:0000792]; mitochondrion [GO:0005739]; nuclear envelope [GO:0005635]; nuclear inner membrane [GO:0005637]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; protein-containing complex [GO:0032991]; rDNA heterochromatin [GO:0033553] bHLH transcription factor binding [GO:0043425]; caspase binding [GO:0089720]; deacetylase activity [GO:0019213]; DNA-binding transcription factor binding [GO:0140297]; enzyme activator activity [GO:0008047]; enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; histone binding [GO:0042393]; histone deacetylase activity [GO:0004407]; histone deacetylase activity, NAD-dependent [GO:0017136]; histone decrotonylase activity, NAD-dependent [GO:0160012]; histone H3K deacetylase activity [GO:0141050]; histone H3K14 deacetylase activity, NAD-dependent [GO:0032041]; histone H3K9 deacetylase activity, NAD-dependent [GO:0046969]; histone H4K12 deacetylase activity, hydrolytic mechanism [GO:0140937]; histone H4K16 deacetylase activity, NAD-dependent [GO:0046970]; HLH domain binding [GO:0043398]; identical protein binding [GO:0042802]; keratin filament binding [GO:1990254]; metal ion binding [GO:0046872]; mitogen-activated protein kinase binding [GO:0051019]; NAD+ binding [GO:0070403]; NAD-dependent protein lysine deacetylase activity [GO:0034979]; NAD-dependent protein lysine delactylase activity [GO:0141208]; NAD-dependent protein-lysine depropionylase activity [GO:0106231]; nuclear receptor binding [GO:0016922]; p53 binding [GO:0002039]; promoter-specific chromatin binding [GO:1990841]; protein domain specific binding [GO:0019904]; protein kinase B binding [GO:0043422]; protein lysine deacetylase activity [GO:0033558]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; transcription regulator inhibitor activity [GO:0140416] g22033.t1 P51958 74.074 297 2.55e-164 461.0 sp|P51958|CDK1_CARAU Cyclin-dependent kinase 1 OS=Carassius auratus OX=7957 GN=cdk1 PE=1 SV=1 g22034.t1 Q5XI01 38.71 186 1.67e-30 121.0 sp|Q5XI01|LARP7_RAT La-related protein 7 OS=Rattus norvegicus OX=10116 GN=Larp7 PE=1 SV=2 LARP7_RAT reviewed La-related protein 7 (La ribonucleoprotein domain family member 7) Rattus norvegicus (Rat) GO:0000122; GO:0000494; GO:0003723; GO:0005634; GO:0005654; GO:0005829; GO:0006397; GO:0007283; GO:0008380; GO:0017070; GO:0030154; GO:0032897; GO:0036093; GO:0048024; GO:0097322; GO:0120259; GO:1900087; GO:1904871; GO:1905382; GO:1990438; GO:1990904 box C/D sno(s)RNA 3'-end processing [GO:0000494]; cell differentiation [GO:0030154]; germ cell proliferation [GO:0036093]; mRNA processing [GO:0006397]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of viral transcription [GO:0032897]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of protein localization to Cajal body [GO:1904871]; positive regulation of snRNA transcription by RNA polymerase II [GO:1905382]; regulation of mRNA splicing, via spliceosome [GO:0048024]; RNA splicing [GO:0008380]; spermatogenesis [GO:0007283]; U6 2'-O-snRNA methylation [GO:1990438] 7SK snRNP [GO:0120259]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904] 7SK snRNA binding [GO:0097322]; RNA binding [GO:0003723]; U6 snRNA binding [GO:0017070] g22035.t1 Q4G0J3 43.503 177 5.11e-45 163.0 sp|Q4G0J3|LARP7_HUMAN La-related protein 7 OS=Homo sapiens OX=9606 GN=LARP7 PE=1 SV=1 LARP7_HUMAN reviewed La-related protein 7 (La ribonucleoprotein domain family member 7) (hLARP7) (P-TEFb-interaction protein for 7SK stability) (PIP7S) Homo sapiens (Human) GO:0000122; GO:0000494; GO:0003723; GO:0005634; GO:0005654; GO:0005829; GO:0006397; GO:0007283; GO:0008380; GO:0017070; GO:0030154; GO:0032897; GO:0034244; GO:0048024; GO:0097322; GO:0120259; GO:1904871; GO:1905382; GO:1990438; GO:1990904 box C/D sno(s)RNA 3'-end processing [GO:0000494]; cell differentiation [GO:0030154]; mRNA processing [GO:0006397]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription elongation by RNA polymerase II [GO:0034244]; negative regulation of viral transcription [GO:0032897]; positive regulation of protein localization to Cajal body [GO:1904871]; positive regulation of snRNA transcription by RNA polymerase II [GO:1905382]; regulation of mRNA splicing, via spliceosome [GO:0048024]; RNA splicing [GO:0008380]; spermatogenesis [GO:0007283]; U6 2'-O-snRNA methylation [GO:1990438] 7SK snRNP [GO:0120259]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904] 7SK snRNA binding [GO:0097322]; RNA binding [GO:0003723]; U6 snRNA binding [GO:0017070] g22037.t1 Q9Z1Z0 52.306 954 0.0 893.0 sp|Q9Z1Z0|USO1_MOUSE General vesicular transport factor p115 OS=Mus musculus OX=10090 GN=Uso1 PE=1 SV=2 USO1_MOUSE reviewed General vesicular transport factor p115 (Protein USO1 homolog) (Transcytosis-associated protein) (TAP) (Vesicle-docking protein) Mus musculus (Mouse) GO:0000139; GO:0001650; GO:0005783; GO:0005794; GO:0005795; GO:0005829; GO:0006886; GO:0006888; GO:0007030; GO:0007264; GO:0012507; GO:0032252; GO:0045056; GO:0048211; GO:0048280; GO:0048471; GO:0061025; GO:1900076 endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; Golgi vesicle docking [GO:0048211]; intracellular protein transport [GO:0006886]; membrane fusion [GO:0061025]; regulation of cellular response to insulin stimulus [GO:1900076]; secretory granule localization [GO:0032252]; small GTPase-mediated signal transduction [GO:0007264]; transcytosis [GO:0045056]; vesicle fusion with Golgi apparatus [GO:0048280] cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; ER to Golgi transport vesicle membrane [GO:0012507]; fibrillar center [GO:0001650]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; perinuclear region of cytoplasm [GO:0048471] g22040.t1 O77460 57.785 289 1.57e-115 340.0 sp|O77460|IPYR_DROME Inorganic pyrophosphatase OS=Drosophila melanogaster OX=7227 GN=Nurf-38 PE=1 SV=3 g22041.t1 O95858 39.544 263 4.24e-63 203.0 sp|O95858|TSN15_HUMAN Tetraspanin-15 OS=Homo sapiens OX=9606 GN=TSPAN15 PE=1 SV=1 TSN15_HUMAN reviewed Tetraspanin-15 (Tspan-15) (Tetraspan NET-7) (Transmembrane 4 superfamily member 15) Homo sapiens (Human) GO:0005788; GO:0005829; GO:0005886; GO:0009986; GO:0016604; GO:0019899; GO:0030054; GO:0031902; GO:0045746; GO:0051043; GO:0051604; GO:0072659; GO:0097197 negative regulation of Notch signaling pathway [GO:0045746]; protein localization to plasma membrane [GO:0072659]; protein maturation [GO:0051604]; regulation of membrane protein ectodomain proteolysis [GO:0051043] cell junction [GO:0030054]; cell surface [GO:0009986]; cytosol [GO:0005829]; endoplasmic reticulum lumen [GO:0005788]; late endosome membrane [GO:0031902]; nuclear body [GO:0016604]; plasma membrane [GO:0005886]; tetraspanin-enriched microdomain [GO:0097197] enzyme binding [GO:0019899] g22044.t1 Q28GW8 43.878 686 0.0 554.0 sp|Q28GW8|MELK_XENTR Maternal embryonic leucine zipper kinase OS=Xenopus tropicalis OX=8364 GN=melk PE=2 SV=1 MELK_XENTR reviewed Maternal embryonic leucine zipper kinase (EC 2.7.11.1) Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0004674; GO:0004715; GO:0005509; GO:0005524; GO:0005737; GO:0005886; GO:0005938; GO:0006915; GO:0008016; GO:0008283; GO:0008289; GO:0030097; GO:0035556; GO:0043065; GO:0046777; GO:0048821; GO:0061351; GO:0106310 apoptotic process [GO:0006915]; cell population proliferation [GO:0008283]; erythrocyte development [GO:0048821]; hemopoiesis [GO:0030097]; intracellular signal transduction [GO:0035556]; neural precursor cell proliferation [GO:0061351]; positive regulation of apoptotic process [GO:0043065]; protein autophosphorylation [GO:0046777]; regulation of heart contraction [GO:0008016] cell cortex [GO:0005938]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886] ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; lipid binding [GO:0008289]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g22045.t1 P32114 76.8 125 3.2e-58 207.0 sp|P32114|PAX2_MOUSE Paired box protein Pax-2 OS=Mus musculus OX=10090 GN=Pax2 PE=1 SV=2 PAX2_MOUSE reviewed Paired box protein Pax-2 Mus musculus (Mouse) GO:0000122; GO:0000976; GO:0000978; GO:0000981; GO:0000987; GO:0001655; GO:0001656; GO:0001657; GO:0001658; GO:0001709; GO:0001822; GO:0001823; GO:0001843; GO:0002072; GO:0003337; GO:0003406; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0005667; GO:0005815; GO:0006357; GO:0007399; GO:0007417; GO:0007423; GO:0007501; GO:0008284; GO:0010001; GO:0021554; GO:0021631; GO:0021633; GO:0021650; GO:0031016; GO:0032991; GO:0032993; GO:0034451; GO:0035566; GO:0035799; GO:0039003; GO:0042472; GO:0042981; GO:0043010; GO:0043066; GO:0043067; GO:0043069; GO:0045892; GO:0045893; GO:0045944; GO:0048793; GO:0048854; GO:0048863; GO:0050679; GO:0060231; GO:0061205; GO:0061360; GO:0070742; GO:0071260; GO:0071300; GO:0071333; GO:0071542; GO:0072075; GO:0072108; GO:0072162; GO:0072164; GO:0072172; GO:0072177; GO:0072179; GO:0072189; GO:0072197; GO:0072205; GO:0072207; GO:0072221; GO:0072289; GO:0072300; GO:0072305; GO:0072307; GO:0090102; GO:0090103; GO:0090190; GO:1900212; GO:1900215; GO:1900218; GO:1990837; GO:2000378; GO:2000594; GO:2000597 brain morphogenesis [GO:0048854]; branching involved in ureteric bud morphogenesis [GO:0001658]; camera-type eye development [GO:0043010]; cell fate determination [GO:0001709]; cellular response to glucose stimulus [GO:0071333]; cellular response to mechanical stimulus [GO:0071260]; cellular response to retinoic acid [GO:0071300]; central nervous system development [GO:0007417]; cochlea development [GO:0090102]; cochlea morphogenesis [GO:0090103]; dopaminergic neuron differentiation [GO:0071542]; glial cell differentiation [GO:0010001]; inner ear morphogenesis [GO:0042472]; kidney development [GO:0001822]; mesenchymal to epithelial transition [GO:0060231]; mesenchymal to epithelial transition involved in metanephros morphogenesis [GO:0003337]; mesodermal cell fate specification [GO:0007501]; mesonephric duct development [GO:0072177]; mesonephric tubule development [GO:0072164]; mesonephric tubule formation [GO:0072172]; mesonephros development [GO:0001823]; metanephric collecting duct development [GO:0072205]; metanephric distal convoluted tubule development [GO:0072221]; metanephric epithelium development [GO:0072207]; metanephric mesenchymal cell differentiation [GO:0072162]; metanephric mesenchyme development [GO:0072075]; metanephric nephron tubule formation [GO:0072289]; metanephros development [GO:0001656]; negative regulation of apoptotic process [GO:0043066]; negative regulation of apoptotic process involved in metanephric collecting duct development [GO:1900215]; negative regulation of apoptotic process involved in metanephric nephron tubule development [GO:1900218]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis [GO:0072305]; negative regulation of mesenchymal cell apoptotic process involved in metanephros development [GO:1900212]; negative regulation of programmed cell death [GO:0043069]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nephric duct formation [GO:0072179]; nervous system development [GO:0007399]; neural tube closure [GO:0001843]; optic chiasma development [GO:0061360]; optic cup morphogenesis involved in camera-type eye development [GO:0002072]; optic nerve development [GO:0021554]; optic nerve morphogenesis [GO:0021631]; optic nerve structural organization [GO:0021633]; pancreas development [GO:0031016]; paramesonephric duct development [GO:0061205]; positive regulation of branching involved in ureteric bud morphogenesis [GO:0090190]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis [GO:0072108]; positive regulation of metanephric DCT cell differentiation [GO:2000594]; positive regulation of metanephric glomerulus development [GO:0072300]; positive regulation of optic nerve formation [GO:2000597]; positive regulation of transcription by RNA polymerase II [GO:0045944]; pronephric field specification [GO:0039003]; pronephros development [GO:0048793]; regulation of apoptotic process [GO:0042981]; regulation of metanephric nephron tubule epithelial cell differentiation [GO:0072307]; regulation of metanephros size [GO:0035566]; regulation of programmed cell death [GO:0043067]; regulation of transcription by RNA polymerase II [GO:0006357]; retinal pigment epithelium development [GO:0003406]; sensory organ development [GO:0007423]; stem cell differentiation [GO:0048863]; ureter development [GO:0072189]; ureter maturation [GO:0035799]; ureter morphogenesis [GO:0072197]; ureteric bud development [GO:0001657]; urogenital system development [GO:0001655]; vestibulocochlear nerve formation [GO:0021650] centriolar satellite [GO:0034451]; microtubule organizing center [GO:0005815]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; protein-DNA complex [GO:0032993]; transcription regulator complex [GO:0005667] C2H2 zinc finger domain binding [GO:0070742]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976] g22046.t1 P32114 83.696 92 3.53e-47 158.0 sp|P32114|PAX2_MOUSE Paired box protein Pax-2 OS=Mus musculus OX=10090 GN=Pax2 PE=1 SV=2 PAX2_MOUSE reviewed Paired box protein Pax-2 Mus musculus (Mouse) GO:0000122; GO:0000976; GO:0000978; GO:0000981; GO:0000987; GO:0001655; GO:0001656; GO:0001657; GO:0001658; GO:0001709; GO:0001822; GO:0001823; GO:0001843; GO:0002072; GO:0003337; GO:0003406; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0005667; GO:0005815; GO:0006357; GO:0007399; GO:0007417; GO:0007423; GO:0007501; GO:0008284; GO:0010001; GO:0021554; GO:0021631; GO:0021633; GO:0021650; GO:0031016; GO:0032991; GO:0032993; GO:0034451; GO:0035566; GO:0035799; GO:0039003; GO:0042472; GO:0042981; GO:0043010; GO:0043066; GO:0043067; GO:0043069; GO:0045892; GO:0045893; GO:0045944; GO:0048793; GO:0048854; GO:0048863; GO:0050679; GO:0060231; GO:0061205; GO:0061360; GO:0070742; GO:0071260; GO:0071300; GO:0071333; GO:0071542; GO:0072075; GO:0072108; GO:0072162; GO:0072164; GO:0072172; GO:0072177; GO:0072179; GO:0072189; GO:0072197; GO:0072205; GO:0072207; GO:0072221; GO:0072289; GO:0072300; GO:0072305; GO:0072307; GO:0090102; GO:0090103; GO:0090190; GO:1900212; GO:1900215; GO:1900218; GO:1990837; GO:2000378; GO:2000594; GO:2000597 brain morphogenesis [GO:0048854]; branching involved in ureteric bud morphogenesis [GO:0001658]; camera-type eye development [GO:0043010]; cell fate determination [GO:0001709]; cellular response to glucose stimulus [GO:0071333]; cellular response to mechanical stimulus [GO:0071260]; cellular response to retinoic acid [GO:0071300]; central nervous system development [GO:0007417]; cochlea development [GO:0090102]; cochlea morphogenesis [GO:0090103]; dopaminergic neuron differentiation [GO:0071542]; glial cell differentiation [GO:0010001]; inner ear morphogenesis [GO:0042472]; kidney development [GO:0001822]; mesenchymal to epithelial transition [GO:0060231]; mesenchymal to epithelial transition involved in metanephros morphogenesis [GO:0003337]; mesodermal cell fate specification [GO:0007501]; mesonephric duct development [GO:0072177]; mesonephric tubule development [GO:0072164]; mesonephric tubule formation [GO:0072172]; mesonephros development [GO:0001823]; metanephric collecting duct development [GO:0072205]; metanephric distal convoluted tubule development [GO:0072221]; metanephric epithelium development [GO:0072207]; metanephric mesenchymal cell differentiation [GO:0072162]; metanephric mesenchyme development [GO:0072075]; metanephric nephron tubule formation [GO:0072289]; metanephros development [GO:0001656]; negative regulation of apoptotic process [GO:0043066]; negative regulation of apoptotic process involved in metanephric collecting duct development [GO:1900215]; negative regulation of apoptotic process involved in metanephric nephron tubule development [GO:1900218]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis [GO:0072305]; negative regulation of mesenchymal cell apoptotic process involved in metanephros development [GO:1900212]; negative regulation of programmed cell death [GO:0043069]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nephric duct formation [GO:0072179]; nervous system development [GO:0007399]; neural tube closure [GO:0001843]; optic chiasma development [GO:0061360]; optic cup morphogenesis involved in camera-type eye development [GO:0002072]; optic nerve development [GO:0021554]; optic nerve morphogenesis [GO:0021631]; optic nerve structural organization [GO:0021633]; pancreas development [GO:0031016]; paramesonephric duct development [GO:0061205]; positive regulation of branching involved in ureteric bud morphogenesis [GO:0090190]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis [GO:0072108]; positive regulation of metanephric DCT cell differentiation [GO:2000594]; positive regulation of metanephric glomerulus development [GO:0072300]; positive regulation of optic nerve formation [GO:2000597]; positive regulation of transcription by RNA polymerase II [GO:0045944]; pronephric field specification [GO:0039003]; pronephros development [GO:0048793]; regulation of apoptotic process [GO:0042981]; regulation of metanephric nephron tubule epithelial cell differentiation [GO:0072307]; regulation of metanephros size [GO:0035566]; regulation of programmed cell death [GO:0043067]; regulation of transcription by RNA polymerase II [GO:0006357]; retinal pigment epithelium development [GO:0003406]; sensory organ development [GO:0007423]; stem cell differentiation [GO:0048863]; ureter development [GO:0072189]; ureter maturation [GO:0035799]; ureter morphogenesis [GO:0072197]; ureteric bud development [GO:0001657]; urogenital system development [GO:0001655]; vestibulocochlear nerve formation [GO:0021650] centriolar satellite [GO:0034451]; microtubule organizing center [GO:0005815]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; protein-DNA complex [GO:0032993]; transcription regulator complex [GO:0005667] C2H2 zinc finger domain binding [GO:0070742]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976] g22047.t1 O57682 30.402 398 2.95e-25 111.0 sp|O57682|PAX2B_XENLA Paired box protein Pax-2-B OS=Xenopus laevis OX=8355 GN=pax2-b PE=2 SV=2 g22047.t2 O57682 30.303 396 3.96e-25 108.0 sp|O57682|PAX2B_XENLA Paired box protein Pax-2-B OS=Xenopus laevis OX=8355 GN=pax2-b PE=2 SV=2 g22048.t1 Q9H6X2 42.657 286 4.6e-63 218.0 sp|Q9H6X2|ANTR1_HUMAN Anthrax toxin receptor 1 OS=Homo sapiens OX=9606 GN=ANTXR1 PE=1 SV=2 g22049.t1 Q5U239 37.41 417 4.59e-83 274.0 sp|Q5U239|TM145_XENLA Transmembrane protein 145 OS=Xenopus laevis OX=8355 GN=tmem145 PE=2 SV=1 g22050.t1 Q5PQ44 79.06 234 6.72e-127 361.0 sp|Q5PQ44|CF299_XENLA Cilia- and flagella-associated protein 299 OS=Xenopus laevis OX=8355 GN=cfap299 PE=2 SV=1 g22054.t1 Q9N126 45.756 271 3.3800000000000004e-70 222.0 sp|Q9N126|RDH8_BOVIN Retinol dehydrogenase 8 OS=Bos taurus OX=9913 GN=RDH8 PE=1 SV=1 g22055.t1 Q9N126 43.911 271 6.669999999999999e-68 216.0 sp|Q9N126|RDH8_BOVIN Retinol dehydrogenase 8 OS=Bos taurus OX=9913 GN=RDH8 PE=1 SV=1 g22057.t1 Q3MHI8 41.837 196 2.08e-44 156.0 sp|Q3MHI8|TM10A_BOVIN tRNA methyltransferase 10 homolog A OS=Bos taurus OX=9913 GN=TRMT10A PE=2 SV=1 TM10A_BOVIN reviewed tRNA methyltransferase 10 homolog A (EC 2.1.1.221) (RNA (guanine-9-)-methyltransferase domain-containing protein 2) (tRNA (guanine(9)-N(1))-methyltransferase TRMT10A) Bos taurus (Bovine) GO:0000049; GO:0002939; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0030488; GO:0052905 tRNA methylation [GO:0030488]; tRNA N1-guanine methylation [GO:0002939] cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] tRNA (guanosine(9)-N1)-methyltransferase activity [GO:0052905]; tRNA binding [GO:0000049] g22058.t2 Q7TSD4 32.824 262 8.849999999999999e-23 102.0 sp|Q7TSD4|TBATA_MOUSE Protein TBATA OS=Mus musculus OX=10090 GN=Tbata PE=1 SV=2 g22060.t1 P00516 65.579 674 0.0 877.0 sp|P00516|KGP1_BOVIN cGMP-dependent protein kinase 1 OS=Bos taurus OX=9913 GN=PRKG1 PE=1 SV=2 g22061.t1 Q556Y8 36.216 185 9.09e-31 125.0 sp|Q556Y8|DUSPR_DICDI Probable rhodanese domain-containing dual specificity protein phosphatase OS=Dictyostelium discoideum OX=44689 GN=DDB_G0273199 PE=3 SV=1 DUSPR_DICDI reviewed Probable rhodanese domain-containing dual specificity protein phosphatase (EC 3.1.3.16) (EC 3.1.3.48) Dictyostelium discoideum (Social amoeba) GO:0004721; GO:0004722; GO:0005737; GO:0007165; GO:0008330; GO:0017017; GO:0030587; GO:0033550; GO:0043409; GO:0072718 negative regulation of MAPK cascade [GO:0043409]; response to cisplatin [GO:0072718]; signal transduction [GO:0007165]; sorocarp development [GO:0030587] cytoplasm [GO:0005737] MAP kinase tyrosine phosphatase activity [GO:0033550]; MAP kinase tyrosine/serine/threonine phosphatase activity [GO:0017017]; phosphoprotein phosphatase activity [GO:0004721]; protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine/threonine phosphatase activity [GO:0008330] g22064.t1 Q9NQV8 67.606 71 1.08e-25 102.0 sp|Q9NQV8|PRDM8_HUMAN PR domain zinc finger protein 8 OS=Homo sapiens OX=9606 GN=PRDM8 PE=1 SV=3 g22066.t1 O88917 28.935 432 2.53e-44 171.0 sp|O88917|AGRL1_RAT Adhesion G protein-coupled receptor L1 OS=Rattus norvegicus OX=10116 GN=Adgrl1 PE=1 SV=1 AGRL1_RAT reviewed Adhesion G protein-coupled receptor L1 (Calcium-independent alpha-latrotoxin receptor 1) (CIRL-1) (Latrophilin-1) Rattus norvegicus (Rat) GO:0004930; GO:0005886; GO:0007166; GO:0007186; GO:0015643; GO:0016524; GO:0030246; GO:0030424; GO:0030426; GO:0042734; GO:0043005; GO:0045202; GO:0050839; GO:0051965; GO:0098978 cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186]; positive regulation of synapse assembly [GO:0051965] axon [GO:0030424]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; synapse [GO:0045202] carbohydrate binding [GO:0030246]; cell adhesion molecule binding [GO:0050839]; G protein-coupled receptor activity [GO:0004930]; latrotoxin receptor activity [GO:0016524]; toxic substance binding [GO:0015643] g22067.t1 C9ZN16 26.936 594 2.24e-34 147.0 sp|C9ZN16|FAZ1_TRYB9 Flagellar attachment zone protein 1 OS=Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) OX=679716 GN=TbgDal_IV3690 PE=3 SV=1 g22070.t1 Q96DM1 26.782 463 1.89e-38 153.0 sp|Q96DM1|PGBD4_HUMAN PiggyBac transposable element-derived protein 4 OS=Homo sapiens OX=9606 GN=PGBD4 PE=1 SV=3 g22074.t1 Q3UDW8 41.008 595 5.81e-151 454.0 sp|Q3UDW8|HGNAT_MOUSE Heparan-alpha-glucosaminide N-acetyltransferase OS=Mus musculus OX=10090 GN=Hgsnat PE=1 SV=2 HGNAT_MOUSE reviewed Heparan-alpha-glucosaminide N-acetyltransferase (EC 2.3.1.78) (Transmembrane protein 76) Mus musculus (Mouse) GO:0005765; GO:0007041; GO:0015019; GO:0016746; GO:0030200; GO:0043202; GO:0051259 heparan sulfate proteoglycan catabolic process [GO:0030200]; lysosomal transport [GO:0007041]; protein complex oligomerization [GO:0051259] lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765] acyltransferase activity [GO:0016746]; heparan-alpha-glucosaminide N-acetyltransferase activity [GO:0015019] g22075.t1 Q9D1P2 76.019 417 0.0 679.0 sp|Q9D1P2|KAT8_MOUSE Histone acetyltransferase KAT8 OS=Mus musculus OX=10090 GN=Kat8 PE=1 SV=1 KAT8_MOUSE reviewed Histone acetyltransferase KAT8 (EC 2.3.1.48) (Lysine acetyltransferase 8) (MOZ, YBF2/SAS3, SAS2 and TIP60 protein 1) (MYST-1) (Males-absent on the first protein homolog) (mMof) (Protein acetyltransferase KAT8) (EC 2.3.1.-) (Protein propionyltransferase KAT8) (EC 2.3.1.-) Mus musculus (Mouse) GO:0000123; GO:0000776; GO:0001837; GO:0003713; GO:0005634; GO:0005654; GO:0005694; GO:0005739; GO:0008270; GO:0009048; GO:0010485; GO:0010506; GO:0010718; GO:0010719; GO:0016363; GO:0016407; GO:0019899; GO:0022008; GO:0030099; GO:0032480; GO:0032481; GO:0035166; GO:0035267; GO:0043995; GO:0043996; GO:0044545; GO:0045815; GO:0045892; GO:0045893; GO:0046972; GO:0048477; GO:0050684; GO:0060261; GO:0061629; GO:0061733; GO:0061920; GO:0071339; GO:0072487; GO:0140694; GO:1902726; GO:1903108; GO:1990841 dosage compensation by inactivation of X chromosome [GO:0009048]; epithelial to mesenchymal transition [GO:0001837]; membraneless organelle assembly [GO:0140694]; myeloid cell differentiation [GO:0030099]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of type I interferon production [GO:0032480]; neurogenesis [GO:0022008]; oogenesis [GO:0048477]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of skeletal muscle satellite cell differentiation [GO:1902726]; positive regulation of transcription initiation by RNA polymerase II [GO:0060261]; positive regulation of type I interferon production [GO:0032481]; post-embryonic hemopoiesis [GO:0035166]; regulation of autophagy [GO:0010506]; regulation of mitochondrial transcription [GO:1903108]; regulation of mRNA processing [GO:0050684]; transcription initiation-coupled chromatin remodeling [GO:0045815] chromosome [GO:0005694]; histone acetyltransferase complex [GO:0000123]; kinetochore [GO:0000776]; mitochondrion [GO:0005739]; MLL1 complex [GO:0071339]; MSL complex [GO:0072487]; NSL complex [GO:0044545]; NuA4 histone acetyltransferase complex [GO:0035267]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] acetyltransferase activity [GO:0016407]; enzyme binding [GO:0019899]; histone H4 acetyltransferase activity [GO:0010485]; histone H4K16 acetyltransferase activity [GO:0046972]; histone H4K5 acetyltransferase activity [GO:0043995]; histone H4K8 acetyltransferase activity [GO:0043996]; promoter-specific chromatin binding [GO:1990841]; protein propionyltransferase activity [GO:0061920]; protein-lysine-acetyltransferase activity [GO:0061733]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription coactivator activity [GO:0003713]; zinc ion binding [GO:0008270] g22076.t1 Q5RCN6 52.017 471 7.56e-171 494.0 sp|Q5RCN6|CP4V2_PONAB Cytochrome P450 4V2 OS=Pongo abelii OX=9601 GN=CYP4V2 PE=2 SV=1 CP4V2_PONAB reviewed Cytochrome P450 4V2 (Docosahexaenoic acid omega-hydroxylase CYP4V2) (EC 1.14.14.79) (Long-chain fatty acid omega-monooxygenase) (EC 1.14.14.80) Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0005506; GO:0005789; GO:0010430; GO:0020037; GO:0102033 fatty acid omega-oxidation [GO:0010430] endoplasmic reticulum membrane [GO:0005789] heme binding [GO:0020037]; iron ion binding [GO:0005506]; long-chain fatty acid omega-hydroxylase activity [GO:0102033] g22077.t1 Q5ZM16 77.419 310 0.0 543.0 sp|Q5ZM16|RBM22_CHICK Pre-mRNA-splicing factor RBM22 OS=Gallus gallus OX=9031 GN=RBM22 PE=2 SV=1 RBM22_CHICK reviewed Pre-mRNA-splicing factor RBM22 (RNA-binding motif protein 22) Gallus gallus (Chicken) GO:0000974; GO:0005634; GO:0005737; GO:0008270; GO:0017070; GO:0033120; GO:0036002; GO:0045292; GO:0071006; GO:0071007; GO:0071466 cellular response to xenobiotic stimulus [GO:0071466]; mRNA cis splicing, via spliceosome [GO:0045292]; positive regulation of RNA splicing [GO:0033120] cytoplasm [GO:0005737]; nucleus [GO:0005634]; Prp19 complex [GO:0000974]; U2-type catalytic step 1 spliceosome [GO:0071006]; U2-type catalytic step 2 spliceosome [GO:0071007] pre-mRNA binding [GO:0036002]; U6 snRNA binding [GO:0017070]; zinc ion binding [GO:0008270] g22078.t1 P31943 58.537 82 3.03e-22 95.9 sp|P31943|HNRH1_HUMAN Heterogeneous nuclear ribonucleoprotein H OS=Homo sapiens OX=9606 GN=HNRNPH1 PE=1 SV=4 HNRH1_HUMAN reviewed Heterogeneous nuclear ribonucleoprotein H (hnRNP H) [Cleaved into: Heterogeneous nuclear ribonucleoprotein H, N-terminally processed] Homo sapiens (Human) GO:0000398; GO:0003723; GO:0005634; GO:0005654; GO:0005829; GO:0006396; GO:0008266; GO:0016020; GO:0042802; GO:0043484; GO:0071013; GO:1990904 mRNA splicing, via spliceosome [GO:0000398]; regulation of RNA splicing [GO:0043484]; RNA processing [GO:0006396] catalytic step 2 spliceosome [GO:0071013]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904] identical protein binding [GO:0042802]; poly(U) RNA binding [GO:0008266]; RNA binding [GO:0003723] g22079.t1 Q5E9J1 52.632 209 5.5300000000000004e-70 224.0 sp|Q5E9J1|HNRPF_BOVIN Heterogeneous nuclear ribonucleoprotein F OS=Bos taurus OX=9913 GN=HNRNPF PE=2 SV=3 g22080.t1 P98191 55.087 403 7.04e-157 456.0 sp|P98191|CDS1_MOUSE Phosphatidate cytidylyltransferase 1 OS=Mus musculus OX=10090 GN=Cds1 PE=1 SV=2 CDS1_MOUSE reviewed Phosphatidate cytidylyltransferase 1 (EC 2.7.7.41) (CDP-DAG synthase 1) (CDP-DG synthase 1) (CDP-diacylglycerol synthase 1) (CDS 1) (CDP-diglyceride pyrophosphorylase 1) (CDP-diglyceride synthase 1) (CTP:phosphatidate cytidylyltransferase 1) Mus musculus (Mouse) GO:0004605; GO:0005783; GO:0005789; GO:0006661; GO:0016020; GO:0016024; GO:0045600; GO:0140042 CDP-diacylglycerol biosynthetic process [GO:0016024]; lipid droplet formation [GO:0140042]; phosphatidylinositol biosynthetic process [GO:0006661]; positive regulation of fat cell differentiation [GO:0045600] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020] phosphatidate cytidylyltransferase activity [GO:0004605] g22081.t1 Q9EPR2 39.062 128 4.5599999999999994e-23 92.8 sp|Q9EPR2|PG12A_MOUSE Group XIIA secretory phospholipase A2 OS=Mus musculus OX=10090 GN=Pla2g12a PE=1 SV=2 g22083.t1 Q9DA37 69.547 243 2.34e-124 365.0 sp|Q9DA37|SAMD8_MOUSE Sphingomyelin synthase-related protein 1 OS=Mus musculus OX=10090 GN=Samd8 PE=1 SV=1 SAMD8_MOUSE reviewed Sphingomyelin synthase-related protein 1 (SMSr) (EC 2.7.8.-) (Ceramide phosphoethanolamine synthase) (CPE synthase) (Phosphatidylethanolamine Phospholipase C) (PE-PLC) (EC 3.1.4.62) (Sterile alpha motif domain-containing protein 8) (SAM domain-containing protein 8) Mus musculus (Mouse) GO:0000139; GO:0002950; GO:0005783; GO:0005789; GO:0005829; GO:0005886; GO:0006686; GO:0016020; GO:0033188; GO:0046513; GO:0047493; GO:1905373; GO:2000303 ceramide biosynthetic process [GO:0046513]; ceramide phosphoethanolamine biosynthetic process [GO:1905373]; regulation of ceramide biosynthetic process [GO:2000303]; sphingomyelin biosynthetic process [GO:0006686] cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; plasma membrane [GO:0005886] ceramide cholinephosphotransferase activity [GO:0047493]; ceramide phosphoethanolamine synthase activity [GO:0002950]; sphingomyelin synthase activity [GO:0033188] g22084.t1 Q96LT4 49.27 274 6.41e-90 279.0 sp|Q96LT4|SAMD8_HUMAN Sphingomyelin synthase-related protein 1 OS=Homo sapiens OX=9606 GN=SAMD8 PE=1 SV=2 SAMD8_HUMAN reviewed Sphingomyelin synthase-related protein 1 (SMSr) (EC 2.7.8.-) (Ceramide phosphoethanolamine synthase) (CPE synthase) (Phosphatidylethanolamine Phospholipase C) (PE-PLC) (EC 3.1.4.62) (Sterile alpha motif domain-containing protein 8) (SAM domain-containing protein 8) Homo sapiens (Human) GO:0000139; GO:0005783; GO:0005789; GO:0005829; GO:0005886; GO:0006686; GO:0016020; GO:0033188; GO:0046513; GO:0047493; GO:2000303 ceramide biosynthetic process [GO:0046513]; regulation of ceramide biosynthetic process [GO:2000303]; sphingomyelin biosynthetic process [GO:0006686] cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; plasma membrane [GO:0005886] ceramide cholinephosphotransferase activity [GO:0047493]; sphingomyelin synthase activity [GO:0033188] g22085.t1 P12007 70.096 418 0.0 607.0 sp|P12007|IVD_RAT Isovaleryl-CoA dehydrogenase, mitochondrial OS=Rattus norvegicus OX=10116 GN=Ivd PE=1 SV=2 g22086.t1 O73888 34.951 206 4.31e-30 113.0 sp|O73888|HPGDS_CHICK Hematopoietic prostaglandin D synthase OS=Gallus gallus OX=9031 GN=HPGDS PE=1 SV=3 g22090.t1 E7FAM5 21.006 676 2.22e-22 106.0 sp|E7FAM5|LIN41_DANRE E3 ubiquitin-protein ligase TRIM71 OS=Danio rerio OX=7955 GN=trim71 PE=1 SV=1 LIN41_DANRE reviewed E3 ubiquitin-protein ligase TRIM71 (EC 2.3.2.27) (Protein lin-41 homolog) (RING-type E3 ubiquitin transferase TRIM71) (Tripartite motif-containing protein 71) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000082; GO:0000209; GO:0000932; GO:0004842; GO:0008270; GO:0008543; GO:0021915; GO:0035198; GO:0035278; GO:0043161; GO:0051865; GO:0061630; GO:0072089; GO:2000177 fibroblast growth factor receptor signaling pathway [GO:0008543]; G1/S transition of mitotic cell cycle [GO:0000082]; miRNA-mediated gene silencing by inhibition of translation [GO:0035278]; neural tube development [GO:0021915]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein polyubiquitination [GO:0000209]; regulation of neural precursor cell proliferation [GO:2000177]; stem cell proliferation [GO:0072089] P-body [GO:0000932] miRNA binding [GO:0035198]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] g22091.t1 P46428 36.946 203 1.6600000000000001e-37 132.0 sp|P46428|GST_ANOGA Glutathione S-transferase OS=Anopheles gambiae OX=7165 GN=GstS1 PE=2 SV=4 g22093.t1 O02751 31.076 251 5.94e-28 122.0 sp|O02751|CFDP2_BOVIN Craniofacial development protein 2 OS=Bos taurus OX=9913 GN=CFDP2 PE=1 SV=2 g22094.t1 O16116 53.012 83 5.63e-22 88.2 sp|O16116|GST3_CAEEL Glutathione S-transferase 3 OS=Caenorhabditis elegans OX=6239 GN=gst-3 PE=2 SV=1 g22096.t1 Q94B65 34.483 319 3.09e-34 131.0 sp|Q94B65|UTR7_ARATH UDP-galactose/UDP-glucose transporter 7 OS=Arabidopsis thaliana OX=3702 GN=UTR7 PE=1 SV=1 UTR7_ARATH reviewed UDP-galactose/UDP-glucose transporter 7 (AtUTr7) Arabidopsis thaliana (Mouse-ear cress) GO:0000139; GO:0005459; GO:0005460; GO:0005794; GO:0015297; GO:0015786; GO:0048527; GO:0055085; GO:0072334; GO:0080147 lateral root development [GO:0048527]; root hair cell development [GO:0080147]; transmembrane transport [GO:0055085]; UDP-galactose transmembrane transport [GO:0072334]; UDP-glucose transmembrane transport [GO:0015786] Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139] antiporter activity [GO:0015297]; UDP-galactose transmembrane transporter activity [GO:0005459]; UDP-glucose transmembrane transporter activity [GO:0005460] g22098.t1 O09159 47.59 996 0.0 897.0 sp|O09159|MA2B1_MOUSE Lysosomal alpha-mannosidase OS=Mus musculus OX=10090 GN=Man2b1 PE=1 SV=4 g22101.t1 P59723 57.994 319 2.94e-133 385.0 sp|P59723|HIF1N_DANRE Hypoxia-inducible factor 1-alpha inhibitor OS=Danio rerio OX=7955 GN=hif1an PE=2 SV=2 HIF1N_DANRE reviewed Hypoxia-inducible factor 1-alpha inhibitor (EC 1.14.11.30) (EC 1.14.11.n4) (Hypoxia-inducible factor asparagine hydroxylase) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005634; GO:0005737; GO:0008198; GO:0008270; GO:0030947; GO:0031406; GO:0036139; GO:0036140; GO:0042803; GO:0045746; GO:0048471; GO:0062101; GO:1901343 negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of vasculature development [GO:1901343]; regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030947] cytoplasm [GO:0005737]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471] [protein]-asparagine 3-dioxygenase activity [GO:0036140]; carboxylic acid binding [GO:0031406]; ferrous iron binding [GO:0008198]; peptidyl-aspartic acid 3-dioxygenase activity [GO:0062101]; peptidyl-histidine dioxygenase activity [GO:0036139]; protein homodimerization activity [GO:0042803]; zinc ion binding [GO:0008270] g22102.t1 Q99PF4 31.807 2817 0.0 917.0 sp|Q99PF4|CAD23_MOUSE Cadherin-23 OS=Mus musculus OX=10090 GN=Cdh23 PE=1 SV=2 CAD23_MOUSE reviewed Cadherin-23 (Otocadherin) Mus musculus (Mouse) GO:0001917; GO:0005509; GO:0005813; GO:0005886; GO:0006816; GO:0007155; GO:0007156; GO:0007605; GO:0007626; GO:0008013; GO:0016339; GO:0016342; GO:0016477; GO:0031175; GO:0032420; GO:0032426; GO:0042472; GO:0042491; GO:0045177; GO:0045202; GO:0045296; GO:0045494; GO:0048839; GO:0050953; GO:0050957; GO:0051480; GO:0060088; GO:0060091; GO:0060122; GO:0090102; GO:0098683; GO:0098684; GO:0098742 auditory receptor cell stereocilium organization [GO:0060088]; calcium ion transport [GO:0006816]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; cochlea development [GO:0090102]; equilibrioception [GO:0050957]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; inner ear auditory receptor cell differentiation [GO:0042491]; inner ear development [GO:0048839]; inner ear morphogenesis [GO:0042472]; inner ear receptor cell stereocilium organization [GO:0060122]; locomotory behavior [GO:0007626]; neuron projection development [GO:0031175]; photoreceptor cell maintenance [GO:0045494]; regulation of cytosolic calcium ion concentration [GO:0051480]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605] apical part of cell [GO:0045177]; catenin complex [GO:0016342]; centrosome [GO:0005813]; cochlear hair cell ribbon synapse [GO:0098683]; kinocilium [GO:0060091]; photoreceptor inner segment [GO:0001917]; photoreceptor ribbon synapse [GO:0098684]; plasma membrane [GO:0005886]; stereocilium [GO:0032420]; stereocilium tip [GO:0032426]; synapse [GO:0045202] beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509] g22102.t1 Q99PF4 27.619 3074 0.0 697.0 sp|Q99PF4|CAD23_MOUSE Cadherin-23 OS=Mus musculus OX=10090 GN=Cdh23 PE=1 SV=2 CAD23_MOUSE reviewed Cadherin-23 (Otocadherin) Mus musculus (Mouse) GO:0001917; GO:0005509; GO:0005813; GO:0005886; GO:0006816; GO:0007155; GO:0007156; GO:0007605; GO:0007626; GO:0008013; GO:0016339; GO:0016342; GO:0016477; GO:0031175; GO:0032420; GO:0032426; GO:0042472; GO:0042491; GO:0045177; GO:0045202; GO:0045296; GO:0045494; GO:0048839; GO:0050953; GO:0050957; GO:0051480; GO:0060088; GO:0060091; GO:0060122; GO:0090102; GO:0098683; GO:0098684; GO:0098742 auditory receptor cell stereocilium organization [GO:0060088]; calcium ion transport [GO:0006816]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; cochlea development [GO:0090102]; equilibrioception [GO:0050957]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; inner ear auditory receptor cell differentiation [GO:0042491]; inner ear development [GO:0048839]; inner ear morphogenesis [GO:0042472]; inner ear receptor cell stereocilium organization [GO:0060122]; locomotory behavior [GO:0007626]; neuron projection development [GO:0031175]; photoreceptor cell maintenance [GO:0045494]; regulation of cytosolic calcium ion concentration [GO:0051480]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605] apical part of cell [GO:0045177]; catenin complex [GO:0016342]; centrosome [GO:0005813]; cochlear hair cell ribbon synapse [GO:0098683]; kinocilium [GO:0060091]; photoreceptor inner segment [GO:0001917]; photoreceptor ribbon synapse [GO:0098684]; plasma membrane [GO:0005886]; stereocilium [GO:0032420]; stereocilium tip [GO:0032426]; synapse [GO:0045202] beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509] g22102.t1 Q99PF4 29.199 2959 0.0 657.0 sp|Q99PF4|CAD23_MOUSE Cadherin-23 OS=Mus musculus OX=10090 GN=Cdh23 PE=1 SV=2 CAD23_MOUSE reviewed Cadherin-23 (Otocadherin) Mus musculus (Mouse) GO:0001917; GO:0005509; GO:0005813; GO:0005886; GO:0006816; GO:0007155; GO:0007156; GO:0007605; GO:0007626; GO:0008013; GO:0016339; GO:0016342; GO:0016477; GO:0031175; GO:0032420; GO:0032426; GO:0042472; GO:0042491; GO:0045177; GO:0045202; GO:0045296; GO:0045494; GO:0048839; GO:0050953; GO:0050957; GO:0051480; GO:0060088; GO:0060091; GO:0060122; GO:0090102; GO:0098683; GO:0098684; GO:0098742 auditory receptor cell stereocilium organization [GO:0060088]; calcium ion transport [GO:0006816]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; cochlea development [GO:0090102]; equilibrioception [GO:0050957]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; inner ear auditory receptor cell differentiation [GO:0042491]; inner ear development [GO:0048839]; inner ear morphogenesis [GO:0042472]; inner ear receptor cell stereocilium organization [GO:0060122]; locomotory behavior [GO:0007626]; neuron projection development [GO:0031175]; photoreceptor cell maintenance [GO:0045494]; regulation of cytosolic calcium ion concentration [GO:0051480]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605] apical part of cell [GO:0045177]; catenin complex [GO:0016342]; centrosome [GO:0005813]; cochlear hair cell ribbon synapse [GO:0098683]; kinocilium [GO:0060091]; photoreceptor inner segment [GO:0001917]; photoreceptor ribbon synapse [GO:0098684]; plasma membrane [GO:0005886]; stereocilium [GO:0032420]; stereocilium tip [GO:0032426]; synapse [GO:0045202] beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509] g22102.t1 Q99PF4 28.917 2687 4.39e-151 536.0 sp|Q99PF4|CAD23_MOUSE Cadherin-23 OS=Mus musculus OX=10090 GN=Cdh23 PE=1 SV=2 CAD23_MOUSE reviewed Cadherin-23 (Otocadherin) Mus musculus (Mouse) GO:0001917; GO:0005509; GO:0005813; GO:0005886; GO:0006816; GO:0007155; GO:0007156; GO:0007605; GO:0007626; GO:0008013; GO:0016339; GO:0016342; GO:0016477; GO:0031175; GO:0032420; GO:0032426; GO:0042472; GO:0042491; GO:0045177; GO:0045202; GO:0045296; GO:0045494; GO:0048839; GO:0050953; GO:0050957; GO:0051480; GO:0060088; GO:0060091; GO:0060122; GO:0090102; GO:0098683; GO:0098684; GO:0098742 auditory receptor cell stereocilium organization [GO:0060088]; calcium ion transport [GO:0006816]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; cochlea development [GO:0090102]; equilibrioception [GO:0050957]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; inner ear auditory receptor cell differentiation [GO:0042491]; inner ear development [GO:0048839]; inner ear morphogenesis [GO:0042472]; inner ear receptor cell stereocilium organization [GO:0060122]; locomotory behavior [GO:0007626]; neuron projection development [GO:0031175]; photoreceptor cell maintenance [GO:0045494]; regulation of cytosolic calcium ion concentration [GO:0051480]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605] apical part of cell [GO:0045177]; catenin complex [GO:0016342]; centrosome [GO:0005813]; cochlear hair cell ribbon synapse [GO:0098683]; kinocilium [GO:0060091]; photoreceptor inner segment [GO:0001917]; photoreceptor ribbon synapse [GO:0098684]; plasma membrane [GO:0005886]; stereocilium [GO:0032420]; stereocilium tip [GO:0032426]; synapse [GO:0045202] beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509] g22102.t1 Q99PF4 27.836 1904 1.25e-114 416.0 sp|Q99PF4|CAD23_MOUSE Cadherin-23 OS=Mus musculus OX=10090 GN=Cdh23 PE=1 SV=2 CAD23_MOUSE reviewed Cadherin-23 (Otocadherin) Mus musculus (Mouse) GO:0001917; GO:0005509; GO:0005813; GO:0005886; GO:0006816; GO:0007155; GO:0007156; GO:0007605; GO:0007626; GO:0008013; GO:0016339; GO:0016342; GO:0016477; GO:0031175; GO:0032420; GO:0032426; GO:0042472; GO:0042491; GO:0045177; GO:0045202; GO:0045296; GO:0045494; GO:0048839; GO:0050953; GO:0050957; GO:0051480; GO:0060088; GO:0060091; GO:0060122; GO:0090102; GO:0098683; GO:0098684; GO:0098742 auditory receptor cell stereocilium organization [GO:0060088]; calcium ion transport [GO:0006816]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; cochlea development [GO:0090102]; equilibrioception [GO:0050957]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; inner ear auditory receptor cell differentiation [GO:0042491]; inner ear development [GO:0048839]; inner ear morphogenesis [GO:0042472]; inner ear receptor cell stereocilium organization [GO:0060122]; locomotory behavior [GO:0007626]; neuron projection development [GO:0031175]; photoreceptor cell maintenance [GO:0045494]; regulation of cytosolic calcium ion concentration [GO:0051480]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605] apical part of cell [GO:0045177]; catenin complex [GO:0016342]; centrosome [GO:0005813]; cochlear hair cell ribbon synapse [GO:0098683]; kinocilium [GO:0060091]; photoreceptor inner segment [GO:0001917]; photoreceptor ribbon synapse [GO:0098684]; plasma membrane [GO:0005886]; stereocilium [GO:0032420]; stereocilium tip [GO:0032426]; synapse [GO:0045202] beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509] g22102.t1 Q99PF4 28.824 1471 2.92e-101 372.0 sp|Q99PF4|CAD23_MOUSE Cadherin-23 OS=Mus musculus OX=10090 GN=Cdh23 PE=1 SV=2 CAD23_MOUSE reviewed Cadherin-23 (Otocadherin) Mus musculus (Mouse) GO:0001917; GO:0005509; GO:0005813; GO:0005886; GO:0006816; GO:0007155; GO:0007156; GO:0007605; GO:0007626; GO:0008013; GO:0016339; GO:0016342; GO:0016477; GO:0031175; GO:0032420; GO:0032426; GO:0042472; GO:0042491; GO:0045177; GO:0045202; GO:0045296; GO:0045494; GO:0048839; GO:0050953; GO:0050957; GO:0051480; GO:0060088; GO:0060091; GO:0060122; GO:0090102; GO:0098683; GO:0098684; GO:0098742 auditory receptor cell stereocilium organization [GO:0060088]; calcium ion transport [GO:0006816]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; cochlea development [GO:0090102]; equilibrioception [GO:0050957]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; inner ear auditory receptor cell differentiation [GO:0042491]; inner ear development [GO:0048839]; inner ear morphogenesis [GO:0042472]; inner ear receptor cell stereocilium organization [GO:0060122]; locomotory behavior [GO:0007626]; neuron projection development [GO:0031175]; photoreceptor cell maintenance [GO:0045494]; regulation of cytosolic calcium ion concentration [GO:0051480]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605] apical part of cell [GO:0045177]; catenin complex [GO:0016342]; centrosome [GO:0005813]; cochlear hair cell ribbon synapse [GO:0098683]; kinocilium [GO:0060091]; photoreceptor inner segment [GO:0001917]; photoreceptor ribbon synapse [GO:0098684]; plasma membrane [GO:0005886]; stereocilium [GO:0032420]; stereocilium tip [GO:0032426]; synapse [GO:0045202] beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509] g22102.t2 Q99PF4 31.807 2817 0.0 917.0 sp|Q99PF4|CAD23_MOUSE Cadherin-23 OS=Mus musculus OX=10090 GN=Cdh23 PE=1 SV=2 CAD23_MOUSE reviewed Cadherin-23 (Otocadherin) Mus musculus (Mouse) GO:0001917; GO:0005509; GO:0005813; GO:0005886; GO:0006816; GO:0007155; GO:0007156; GO:0007605; GO:0007626; GO:0008013; GO:0016339; GO:0016342; GO:0016477; GO:0031175; GO:0032420; GO:0032426; GO:0042472; GO:0042491; GO:0045177; GO:0045202; GO:0045296; GO:0045494; GO:0048839; GO:0050953; GO:0050957; GO:0051480; GO:0060088; GO:0060091; GO:0060122; GO:0090102; GO:0098683; GO:0098684; GO:0098742 auditory receptor cell stereocilium organization [GO:0060088]; calcium ion transport [GO:0006816]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; cochlea development [GO:0090102]; equilibrioception [GO:0050957]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; inner ear auditory receptor cell differentiation [GO:0042491]; inner ear development [GO:0048839]; inner ear morphogenesis [GO:0042472]; inner ear receptor cell stereocilium organization [GO:0060122]; locomotory behavior [GO:0007626]; neuron projection development [GO:0031175]; photoreceptor cell maintenance [GO:0045494]; regulation of cytosolic calcium ion concentration [GO:0051480]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605] apical part of cell [GO:0045177]; catenin complex [GO:0016342]; centrosome [GO:0005813]; cochlear hair cell ribbon synapse [GO:0098683]; kinocilium [GO:0060091]; photoreceptor inner segment [GO:0001917]; photoreceptor ribbon synapse [GO:0098684]; plasma membrane [GO:0005886]; stereocilium [GO:0032420]; stereocilium tip [GO:0032426]; synapse [GO:0045202] beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509] g22102.t2 Q99PF4 27.619 3074 0.0 697.0 sp|Q99PF4|CAD23_MOUSE Cadherin-23 OS=Mus musculus OX=10090 GN=Cdh23 PE=1 SV=2 CAD23_MOUSE reviewed Cadherin-23 (Otocadherin) Mus musculus (Mouse) GO:0001917; GO:0005509; GO:0005813; GO:0005886; GO:0006816; GO:0007155; GO:0007156; GO:0007605; GO:0007626; GO:0008013; GO:0016339; GO:0016342; GO:0016477; GO:0031175; GO:0032420; GO:0032426; GO:0042472; GO:0042491; GO:0045177; GO:0045202; GO:0045296; GO:0045494; GO:0048839; GO:0050953; GO:0050957; GO:0051480; GO:0060088; GO:0060091; GO:0060122; GO:0090102; GO:0098683; GO:0098684; GO:0098742 auditory receptor cell stereocilium organization [GO:0060088]; calcium ion transport [GO:0006816]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; cochlea development [GO:0090102]; equilibrioception [GO:0050957]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; inner ear auditory receptor cell differentiation [GO:0042491]; inner ear development [GO:0048839]; inner ear morphogenesis [GO:0042472]; inner ear receptor cell stereocilium organization [GO:0060122]; locomotory behavior [GO:0007626]; neuron projection development [GO:0031175]; photoreceptor cell maintenance [GO:0045494]; regulation of cytosolic calcium ion concentration [GO:0051480]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605] apical part of cell [GO:0045177]; catenin complex [GO:0016342]; centrosome [GO:0005813]; cochlear hair cell ribbon synapse [GO:0098683]; kinocilium [GO:0060091]; photoreceptor inner segment [GO:0001917]; photoreceptor ribbon synapse [GO:0098684]; plasma membrane [GO:0005886]; stereocilium [GO:0032420]; stereocilium tip [GO:0032426]; synapse [GO:0045202] beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509] g22102.t2 Q99PF4 29.199 2959 0.0 657.0 sp|Q99PF4|CAD23_MOUSE Cadherin-23 OS=Mus musculus OX=10090 GN=Cdh23 PE=1 SV=2 CAD23_MOUSE reviewed Cadherin-23 (Otocadherin) Mus musculus (Mouse) GO:0001917; GO:0005509; GO:0005813; GO:0005886; GO:0006816; GO:0007155; GO:0007156; GO:0007605; GO:0007626; GO:0008013; GO:0016339; GO:0016342; GO:0016477; GO:0031175; GO:0032420; GO:0032426; GO:0042472; GO:0042491; GO:0045177; GO:0045202; GO:0045296; GO:0045494; GO:0048839; GO:0050953; GO:0050957; GO:0051480; GO:0060088; GO:0060091; GO:0060122; GO:0090102; GO:0098683; GO:0098684; GO:0098742 auditory receptor cell stereocilium organization [GO:0060088]; calcium ion transport [GO:0006816]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; cochlea development [GO:0090102]; equilibrioception [GO:0050957]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; inner ear auditory receptor cell differentiation [GO:0042491]; inner ear development [GO:0048839]; inner ear morphogenesis [GO:0042472]; inner ear receptor cell stereocilium organization [GO:0060122]; locomotory behavior [GO:0007626]; neuron projection development [GO:0031175]; photoreceptor cell maintenance [GO:0045494]; regulation of cytosolic calcium ion concentration [GO:0051480]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605] apical part of cell [GO:0045177]; catenin complex [GO:0016342]; centrosome [GO:0005813]; cochlear hair cell ribbon synapse [GO:0098683]; kinocilium [GO:0060091]; photoreceptor inner segment [GO:0001917]; photoreceptor ribbon synapse [GO:0098684]; plasma membrane [GO:0005886]; stereocilium [GO:0032420]; stereocilium tip [GO:0032426]; synapse [GO:0045202] beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509] g22102.t2 Q99PF4 28.917 2687 4.51e-151 536.0 sp|Q99PF4|CAD23_MOUSE Cadherin-23 OS=Mus musculus OX=10090 GN=Cdh23 PE=1 SV=2 CAD23_MOUSE reviewed Cadherin-23 (Otocadherin) Mus musculus (Mouse) GO:0001917; GO:0005509; GO:0005813; GO:0005886; GO:0006816; GO:0007155; GO:0007156; GO:0007605; GO:0007626; GO:0008013; GO:0016339; GO:0016342; GO:0016477; GO:0031175; GO:0032420; GO:0032426; GO:0042472; GO:0042491; GO:0045177; GO:0045202; GO:0045296; GO:0045494; GO:0048839; GO:0050953; GO:0050957; GO:0051480; GO:0060088; GO:0060091; GO:0060122; GO:0090102; GO:0098683; GO:0098684; GO:0098742 auditory receptor cell stereocilium organization [GO:0060088]; calcium ion transport [GO:0006816]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; cochlea development [GO:0090102]; equilibrioception [GO:0050957]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; inner ear auditory receptor cell differentiation [GO:0042491]; inner ear development [GO:0048839]; inner ear morphogenesis [GO:0042472]; inner ear receptor cell stereocilium organization [GO:0060122]; locomotory behavior [GO:0007626]; neuron projection development [GO:0031175]; photoreceptor cell maintenance [GO:0045494]; regulation of cytosolic calcium ion concentration [GO:0051480]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605] apical part of cell [GO:0045177]; catenin complex [GO:0016342]; centrosome [GO:0005813]; cochlear hair cell ribbon synapse [GO:0098683]; kinocilium [GO:0060091]; photoreceptor inner segment [GO:0001917]; photoreceptor ribbon synapse [GO:0098684]; plasma membrane [GO:0005886]; stereocilium [GO:0032420]; stereocilium tip [GO:0032426]; synapse [GO:0045202] beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509] g22102.t2 Q99PF4 27.836 1904 1.28e-114 416.0 sp|Q99PF4|CAD23_MOUSE Cadherin-23 OS=Mus musculus OX=10090 GN=Cdh23 PE=1 SV=2 CAD23_MOUSE reviewed Cadherin-23 (Otocadherin) Mus musculus (Mouse) GO:0001917; GO:0005509; GO:0005813; GO:0005886; GO:0006816; GO:0007155; GO:0007156; GO:0007605; GO:0007626; GO:0008013; GO:0016339; GO:0016342; GO:0016477; GO:0031175; GO:0032420; GO:0032426; GO:0042472; GO:0042491; GO:0045177; GO:0045202; GO:0045296; GO:0045494; GO:0048839; GO:0050953; GO:0050957; GO:0051480; GO:0060088; GO:0060091; GO:0060122; GO:0090102; GO:0098683; GO:0098684; GO:0098742 auditory receptor cell stereocilium organization [GO:0060088]; calcium ion transport [GO:0006816]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; cochlea development [GO:0090102]; equilibrioception [GO:0050957]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; inner ear auditory receptor cell differentiation [GO:0042491]; inner ear development [GO:0048839]; inner ear morphogenesis [GO:0042472]; inner ear receptor cell stereocilium organization [GO:0060122]; locomotory behavior [GO:0007626]; neuron projection development [GO:0031175]; photoreceptor cell maintenance [GO:0045494]; regulation of cytosolic calcium ion concentration [GO:0051480]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605] apical part of cell [GO:0045177]; catenin complex [GO:0016342]; centrosome [GO:0005813]; cochlear hair cell ribbon synapse [GO:0098683]; kinocilium [GO:0060091]; photoreceptor inner segment [GO:0001917]; photoreceptor ribbon synapse [GO:0098684]; plasma membrane [GO:0005886]; stereocilium [GO:0032420]; stereocilium tip [GO:0032426]; synapse [GO:0045202] beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509] g22102.t2 Q99PF4 28.824 1471 2.98e-101 372.0 sp|Q99PF4|CAD23_MOUSE Cadherin-23 OS=Mus musculus OX=10090 GN=Cdh23 PE=1 SV=2 CAD23_MOUSE reviewed Cadherin-23 (Otocadherin) Mus musculus (Mouse) GO:0001917; GO:0005509; GO:0005813; GO:0005886; GO:0006816; GO:0007155; GO:0007156; GO:0007605; GO:0007626; GO:0008013; GO:0016339; GO:0016342; GO:0016477; GO:0031175; GO:0032420; GO:0032426; GO:0042472; GO:0042491; GO:0045177; GO:0045202; GO:0045296; GO:0045494; GO:0048839; GO:0050953; GO:0050957; GO:0051480; GO:0060088; GO:0060091; GO:0060122; GO:0090102; GO:0098683; GO:0098684; GO:0098742 auditory receptor cell stereocilium organization [GO:0060088]; calcium ion transport [GO:0006816]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; cochlea development [GO:0090102]; equilibrioception [GO:0050957]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; inner ear auditory receptor cell differentiation [GO:0042491]; inner ear development [GO:0048839]; inner ear morphogenesis [GO:0042472]; inner ear receptor cell stereocilium organization [GO:0060122]; locomotory behavior [GO:0007626]; neuron projection development [GO:0031175]; photoreceptor cell maintenance [GO:0045494]; regulation of cytosolic calcium ion concentration [GO:0051480]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605] apical part of cell [GO:0045177]; catenin complex [GO:0016342]; centrosome [GO:0005813]; cochlear hair cell ribbon synapse [GO:0098683]; kinocilium [GO:0060091]; photoreceptor inner segment [GO:0001917]; photoreceptor ribbon synapse [GO:0098684]; plasma membrane [GO:0005886]; stereocilium [GO:0032420]; stereocilium tip [GO:0032426]; synapse [GO:0045202] beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509] g22102.t3 Q99PF4 31.807 2817 0.0 917.0 sp|Q99PF4|CAD23_MOUSE Cadherin-23 OS=Mus musculus OX=10090 GN=Cdh23 PE=1 SV=2 CAD23_MOUSE reviewed Cadherin-23 (Otocadherin) Mus musculus (Mouse) GO:0001917; GO:0005509; GO:0005813; GO:0005886; GO:0006816; GO:0007155; GO:0007156; GO:0007605; GO:0007626; GO:0008013; GO:0016339; GO:0016342; GO:0016477; GO:0031175; GO:0032420; GO:0032426; GO:0042472; GO:0042491; GO:0045177; GO:0045202; GO:0045296; GO:0045494; GO:0048839; GO:0050953; GO:0050957; GO:0051480; GO:0060088; GO:0060091; GO:0060122; GO:0090102; GO:0098683; GO:0098684; GO:0098742 auditory receptor cell stereocilium organization [GO:0060088]; calcium ion transport [GO:0006816]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; cochlea development [GO:0090102]; equilibrioception [GO:0050957]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; inner ear auditory receptor cell differentiation [GO:0042491]; inner ear development [GO:0048839]; inner ear morphogenesis [GO:0042472]; inner ear receptor cell stereocilium organization [GO:0060122]; locomotory behavior [GO:0007626]; neuron projection development [GO:0031175]; photoreceptor cell maintenance [GO:0045494]; regulation of cytosolic calcium ion concentration [GO:0051480]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605] apical part of cell [GO:0045177]; catenin complex [GO:0016342]; centrosome [GO:0005813]; cochlear hair cell ribbon synapse [GO:0098683]; kinocilium [GO:0060091]; photoreceptor inner segment [GO:0001917]; photoreceptor ribbon synapse [GO:0098684]; plasma membrane [GO:0005886]; stereocilium [GO:0032420]; stereocilium tip [GO:0032426]; synapse [GO:0045202] beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509] g22102.t3 Q99PF4 27.619 3074 0.0 697.0 sp|Q99PF4|CAD23_MOUSE Cadherin-23 OS=Mus musculus OX=10090 GN=Cdh23 PE=1 SV=2 CAD23_MOUSE reviewed Cadherin-23 (Otocadherin) Mus musculus (Mouse) GO:0001917; GO:0005509; GO:0005813; GO:0005886; GO:0006816; GO:0007155; GO:0007156; GO:0007605; GO:0007626; GO:0008013; GO:0016339; GO:0016342; GO:0016477; GO:0031175; GO:0032420; GO:0032426; GO:0042472; GO:0042491; GO:0045177; GO:0045202; GO:0045296; GO:0045494; GO:0048839; GO:0050953; GO:0050957; GO:0051480; GO:0060088; GO:0060091; GO:0060122; GO:0090102; GO:0098683; GO:0098684; GO:0098742 auditory receptor cell stereocilium organization [GO:0060088]; calcium ion transport [GO:0006816]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; cochlea development [GO:0090102]; equilibrioception [GO:0050957]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; inner ear auditory receptor cell differentiation [GO:0042491]; inner ear development [GO:0048839]; inner ear morphogenesis [GO:0042472]; inner ear receptor cell stereocilium organization [GO:0060122]; locomotory behavior [GO:0007626]; neuron projection development [GO:0031175]; photoreceptor cell maintenance [GO:0045494]; regulation of cytosolic calcium ion concentration [GO:0051480]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605] apical part of cell [GO:0045177]; catenin complex [GO:0016342]; centrosome [GO:0005813]; cochlear hair cell ribbon synapse [GO:0098683]; kinocilium [GO:0060091]; photoreceptor inner segment [GO:0001917]; photoreceptor ribbon synapse [GO:0098684]; plasma membrane [GO:0005886]; stereocilium [GO:0032420]; stereocilium tip [GO:0032426]; synapse [GO:0045202] beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509] g22102.t3 Q99PF4 29.199 2959 0.0 657.0 sp|Q99PF4|CAD23_MOUSE Cadherin-23 OS=Mus musculus OX=10090 GN=Cdh23 PE=1 SV=2 CAD23_MOUSE reviewed Cadherin-23 (Otocadherin) Mus musculus (Mouse) GO:0001917; GO:0005509; GO:0005813; GO:0005886; GO:0006816; GO:0007155; GO:0007156; GO:0007605; GO:0007626; GO:0008013; GO:0016339; GO:0016342; GO:0016477; GO:0031175; GO:0032420; GO:0032426; GO:0042472; GO:0042491; GO:0045177; GO:0045202; GO:0045296; GO:0045494; GO:0048839; GO:0050953; GO:0050957; GO:0051480; GO:0060088; GO:0060091; GO:0060122; GO:0090102; GO:0098683; GO:0098684; GO:0098742 auditory receptor cell stereocilium organization [GO:0060088]; calcium ion transport [GO:0006816]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; cochlea development [GO:0090102]; equilibrioception [GO:0050957]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; inner ear auditory receptor cell differentiation [GO:0042491]; inner ear development [GO:0048839]; inner ear morphogenesis [GO:0042472]; inner ear receptor cell stereocilium organization [GO:0060122]; locomotory behavior [GO:0007626]; neuron projection development [GO:0031175]; photoreceptor cell maintenance [GO:0045494]; regulation of cytosolic calcium ion concentration [GO:0051480]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605] apical part of cell [GO:0045177]; catenin complex [GO:0016342]; centrosome [GO:0005813]; cochlear hair cell ribbon synapse [GO:0098683]; kinocilium [GO:0060091]; photoreceptor inner segment [GO:0001917]; photoreceptor ribbon synapse [GO:0098684]; plasma membrane [GO:0005886]; stereocilium [GO:0032420]; stereocilium tip [GO:0032426]; synapse [GO:0045202] beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509] g22102.t3 Q99PF4 28.917 2687 4.49e-151 536.0 sp|Q99PF4|CAD23_MOUSE Cadherin-23 OS=Mus musculus OX=10090 GN=Cdh23 PE=1 SV=2 CAD23_MOUSE reviewed Cadherin-23 (Otocadherin) Mus musculus (Mouse) GO:0001917; GO:0005509; GO:0005813; GO:0005886; GO:0006816; GO:0007155; GO:0007156; GO:0007605; GO:0007626; GO:0008013; GO:0016339; GO:0016342; GO:0016477; GO:0031175; GO:0032420; GO:0032426; GO:0042472; GO:0042491; GO:0045177; GO:0045202; GO:0045296; GO:0045494; GO:0048839; GO:0050953; GO:0050957; GO:0051480; GO:0060088; GO:0060091; GO:0060122; GO:0090102; GO:0098683; GO:0098684; GO:0098742 auditory receptor cell stereocilium organization [GO:0060088]; calcium ion transport [GO:0006816]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; cochlea development [GO:0090102]; equilibrioception [GO:0050957]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; inner ear auditory receptor cell differentiation [GO:0042491]; inner ear development [GO:0048839]; inner ear morphogenesis [GO:0042472]; inner ear receptor cell stereocilium organization [GO:0060122]; locomotory behavior [GO:0007626]; neuron projection development [GO:0031175]; photoreceptor cell maintenance [GO:0045494]; regulation of cytosolic calcium ion concentration [GO:0051480]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605] apical part of cell [GO:0045177]; catenin complex [GO:0016342]; centrosome [GO:0005813]; cochlear hair cell ribbon synapse [GO:0098683]; kinocilium [GO:0060091]; photoreceptor inner segment [GO:0001917]; photoreceptor ribbon synapse [GO:0098684]; plasma membrane [GO:0005886]; stereocilium [GO:0032420]; stereocilium tip [GO:0032426]; synapse [GO:0045202] beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509] g22102.t3 Q99PF4 27.836 1904 1.27e-114 416.0 sp|Q99PF4|CAD23_MOUSE Cadherin-23 OS=Mus musculus OX=10090 GN=Cdh23 PE=1 SV=2 CAD23_MOUSE reviewed Cadherin-23 (Otocadherin) Mus musculus (Mouse) GO:0001917; GO:0005509; GO:0005813; GO:0005886; GO:0006816; GO:0007155; GO:0007156; GO:0007605; GO:0007626; GO:0008013; GO:0016339; GO:0016342; GO:0016477; GO:0031175; GO:0032420; GO:0032426; GO:0042472; GO:0042491; GO:0045177; GO:0045202; GO:0045296; GO:0045494; GO:0048839; GO:0050953; GO:0050957; GO:0051480; GO:0060088; GO:0060091; GO:0060122; GO:0090102; GO:0098683; GO:0098684; GO:0098742 auditory receptor cell stereocilium organization [GO:0060088]; calcium ion transport [GO:0006816]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; cochlea development [GO:0090102]; equilibrioception [GO:0050957]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; inner ear auditory receptor cell differentiation [GO:0042491]; inner ear development [GO:0048839]; inner ear morphogenesis [GO:0042472]; inner ear receptor cell stereocilium organization [GO:0060122]; locomotory behavior [GO:0007626]; neuron projection development [GO:0031175]; photoreceptor cell maintenance [GO:0045494]; regulation of cytosolic calcium ion concentration [GO:0051480]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605] apical part of cell [GO:0045177]; catenin complex [GO:0016342]; centrosome [GO:0005813]; cochlear hair cell ribbon synapse [GO:0098683]; kinocilium [GO:0060091]; photoreceptor inner segment [GO:0001917]; photoreceptor ribbon synapse [GO:0098684]; plasma membrane [GO:0005886]; stereocilium [GO:0032420]; stereocilium tip [GO:0032426]; synapse [GO:0045202] beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509] g22102.t3 Q99PF4 28.824 1471 2.97e-101 372.0 sp|Q99PF4|CAD23_MOUSE Cadherin-23 OS=Mus musculus OX=10090 GN=Cdh23 PE=1 SV=2 CAD23_MOUSE reviewed Cadherin-23 (Otocadherin) Mus musculus (Mouse) GO:0001917; GO:0005509; GO:0005813; GO:0005886; GO:0006816; GO:0007155; GO:0007156; GO:0007605; GO:0007626; GO:0008013; GO:0016339; GO:0016342; GO:0016477; GO:0031175; GO:0032420; GO:0032426; GO:0042472; GO:0042491; GO:0045177; GO:0045202; GO:0045296; GO:0045494; GO:0048839; GO:0050953; GO:0050957; GO:0051480; GO:0060088; GO:0060091; GO:0060122; GO:0090102; GO:0098683; GO:0098684; GO:0098742 auditory receptor cell stereocilium organization [GO:0060088]; calcium ion transport [GO:0006816]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; cochlea development [GO:0090102]; equilibrioception [GO:0050957]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; inner ear auditory receptor cell differentiation [GO:0042491]; inner ear development [GO:0048839]; inner ear morphogenesis [GO:0042472]; inner ear receptor cell stereocilium organization [GO:0060122]; locomotory behavior [GO:0007626]; neuron projection development [GO:0031175]; photoreceptor cell maintenance [GO:0045494]; regulation of cytosolic calcium ion concentration [GO:0051480]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605] apical part of cell [GO:0045177]; catenin complex [GO:0016342]; centrosome [GO:0005813]; cochlear hair cell ribbon synapse [GO:0098683]; kinocilium [GO:0060091]; photoreceptor inner segment [GO:0001917]; photoreceptor ribbon synapse [GO:0098684]; plasma membrane [GO:0005886]; stereocilium [GO:0032420]; stereocilium tip [GO:0032426]; synapse [GO:0045202] beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509] g22103.t1 P49013 37.917 240 3.71e-28 123.0 sp|P49013|FBP3_STRPU Fibropellin-3 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF3 PE=1 SV=1 g22105.t1 Q9QYI4 41.565 409 1.53e-87 273.0 sp|Q9QYI4|DJB12_MOUSE DnaJ homolog subfamily B member 12 OS=Mus musculus OX=10090 GN=Dnajb12 PE=1 SV=2 g22106.t1 P38571 49.866 373 3.9199999999999994e-126 375.0 sp|P38571|LICH_HUMAN Lysosomal acid lipase/cholesteryl ester hydrolase OS=Homo sapiens OX=9606 GN=LIPA PE=1 SV=2 LICH_HUMAN reviewed Lysosomal acid lipase/cholesteryl ester hydrolase (Acid cholesteryl ester hydrolase) (LAL) (EC 3.1.1.13) (Cholesteryl esterase) (Diacylglycerol lipase) (Lipase A) (Sterol esterase) (Triacylglycerol ester hydrolase) (Triacylglycerol lipase) Homo sapiens (Human) GO:0000278; GO:0000902; GO:0001650; GO:0001935; GO:0002021; GO:0002244; GO:0002526; GO:0002536; GO:0004771; GO:0005654; GO:0005764; GO:0005829; GO:0006006; GO:0006096; GO:0006631; GO:0006641; GO:0006695; GO:0006754; GO:0006776; GO:0006897; GO:0007005; GO:0007040; GO:0007264; GO:0008333; GO:0008340; GO:0009409; GO:0009410; GO:0010467; GO:0010878; GO:0016042; GO:0016125; GO:0016298; GO:0030099; GO:0030217; GO:0030324; GO:0030421; GO:0031929; GO:0033028; GO:0033189; GO:0033344; GO:0034383; GO:0035726; GO:0042098; GO:0042159; GO:0043202; GO:0048536; GO:0048539; GO:0048771; GO:0048873; GO:0050862; GO:0051881; GO:0055088; GO:0060612; GO:0060837; GO:0061519; GO:0070231; GO:0070341; GO:0071830; GO:0071838; GO:0072576; GO:0140354; GO:0140962; GO:1901355; GO:1903409; GO:1990845 acute inflammatory response [GO:0002526]; adaptive thermogenesis [GO:1990845]; adipose tissue development [GO:0060612]; ATP biosynthetic process [GO:0006754]; blood vessel endothelial cell differentiation [GO:0060837]; bone marrow development [GO:0048539]; cell morphogenesis [GO:0000902]; cell proliferation in bone marrow [GO:0071838]; cholesterol biosynthetic process [GO:0006695]; cholesterol efflux [GO:0033344]; cholesterol storage [GO:0010878]; common myeloid progenitor cell proliferation [GO:0035726]; defecation [GO:0030421]; determination of adult lifespan [GO:0008340]; endocytosis [GO:0006897]; endosome to lysosome transport [GO:0008333]; endothelial cell proliferation [GO:0001935]; fat cell proliferation [GO:0070341]; fatty acid metabolic process [GO:0006631]; gene expression [GO:0010467]; glucose metabolic process [GO:0006006]; glycolytic process [GO:0006096]; hematopoietic progenitor cell differentiation [GO:0002244]; homeostasis of number of cells within a tissue [GO:0048873]; lipid catabolic process [GO:0016042]; lipid homeostasis [GO:0055088]; lipid import into cell [GO:0140354]; lipoprotein catabolic process [GO:0042159]; liver morphogenesis [GO:0072576]; low-density lipoprotein particle clearance [GO:0034383]; lung development [GO:0030324]; lysosome organization [GO:0007040]; macrophage homeostasis [GO:0061519]; mitochondrion organization [GO:0007005]; mitotic cell cycle [GO:0000278]; multicellular organismal-level chemical homeostasis [GO:0140962]; myeloid cell apoptotic process [GO:0033028]; myeloid cell differentiation [GO:0030099]; positive regulation of T cell receptor signaling pathway [GO:0050862]; reactive oxygen species biosynthetic process [GO:1903409]; regulation of mitochondrial membrane potential [GO:0051881]; respiratory burst involved in inflammatory response [GO:0002536]; response to cold [GO:0009409]; response to dietary excess [GO:0002021]; response to rapamycin [GO:1901355]; response to vitamin A [GO:0033189]; response to xenobiotic stimulus [GO:0009410]; small GTPase-mediated signal transduction [GO:0007264]; spleen development [GO:0048536]; sterol metabolic process [GO:0016125]; T cell apoptotic process [GO:0070231]; T cell differentiation [GO:0030217]; T cell proliferation [GO:0042098]; tissue remodeling [GO:0048771]; TOR signaling [GO:0031929]; triglyceride metabolic process [GO:0006641]; triglyceride-rich lipoprotein particle clearance [GO:0071830]; vitamin A metabolic process [GO:0006776] cytosol [GO:0005829]; fibrillar center [GO:0001650]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764]; nucleoplasm [GO:0005654] lipase activity [GO:0016298]; sterol ester esterase activity [GO:0004771] g22107.t1 P08991 100.0 103 3.35e-69 207.0 sp|P08991|H2AV_STRPU Histone H2A.V (Fragment) OS=Strongylocentrotus purpuratus OX=7668 GN=H2A.F/Z PE=1 SV=1 g22108.t1 Q8VD50 36.585 164 8.69e-22 91.7 sp|Q8VD50|DDT4L_RAT DNA damage-inducible transcript 4-like protein OS=Rattus norvegicus OX=10116 GN=Ddit4l PE=2 SV=1 g22109.t1 Q6N021 61.749 183 2.8599999999999997e-67 247.0 sp|Q6N021|TET2_HUMAN Methylcytosine dioxygenase TET2 OS=Homo sapiens OX=9606 GN=TET2 PE=1 SV=3 TET2_HUMAN reviewed Methylcytosine dioxygenase TET2 (EC 1.14.11.80) Homo sapiens (Human) GO:0002521; GO:0003677; GO:0005634; GO:0005654; GO:0005694; GO:0006493; GO:0008198; GO:0008270; GO:0030099; GO:0044029; GO:0045944; GO:0070579 leukocyte differentiation [GO:0002521]; myeloid cell differentiation [GO:0030099]; positive regulation of gene expression via chromosomal CpG island demethylation [GO:0044029]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein O-linked glycosylation [GO:0006493] chromosome [GO:0005694]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] DNA 5-methylcytosine dioxygenase activity [GO:0070579]; DNA binding [GO:0003677]; ferrous iron binding [GO:0008198]; zinc ion binding [GO:0008270] g22109.t1 Q6N021 39.614 207 3.26e-25 117.0 sp|Q6N021|TET2_HUMAN Methylcytosine dioxygenase TET2 OS=Homo sapiens OX=9606 GN=TET2 PE=1 SV=3 TET2_HUMAN reviewed Methylcytosine dioxygenase TET2 (EC 1.14.11.80) Homo sapiens (Human) GO:0002521; GO:0003677; GO:0005634; GO:0005654; GO:0005694; GO:0006493; GO:0008198; GO:0008270; GO:0030099; GO:0044029; GO:0045944; GO:0070579 leukocyte differentiation [GO:0002521]; myeloid cell differentiation [GO:0030099]; positive regulation of gene expression via chromosomal CpG island demethylation [GO:0044029]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein O-linked glycosylation [GO:0006493] chromosome [GO:0005694]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] DNA 5-methylcytosine dioxygenase activity [GO:0070579]; DNA binding [GO:0003677]; ferrous iron binding [GO:0008198]; zinc ion binding [GO:0008270] g22114.t1 Q9D9B4 52.632 228 2.71e-78 239.0 sp|Q9D9B4|LRMDA_MOUSE Leucine-rich melanocyte differentiation-associated protein OS=Mus musculus OX=10090 GN=Lrmda PE=1 SV=1 g22115.t1 P09481 32.287 446 2.63e-75 248.0 sp|P09481|ACHA3_CHICK Neuronal acetylcholine receptor subunit alpha-3 OS=Gallus gallus OX=9031 GN=CHRNA3 PE=1 SV=2 g22117.t1 P79100 34.395 314 5.4e-45 179.0 sp|P79100|TRPC4_BOVIN Short transient receptor potential channel 4 OS=Bos taurus OX=9913 GN=TRPC4 PE=2 SV=2 TRPC4_BOVIN reviewed Short transient receptor potential channel 4 (TrpC4) (Capacitative calcium entry channel 1) (CCE1) Bos taurus (Bovine) GO:0005886; GO:0015279; GO:0034703; GO:0046872; GO:0051480; GO:0070588; GO:0070679 calcium ion transmembrane transport [GO:0070588]; regulation of cytosolic calcium ion concentration [GO:0051480] cation channel complex [GO:0034703]; plasma membrane [GO:0005886] inositol 1,4,5 trisphosphate binding [GO:0070679]; metal ion binding [GO:0046872]; store-operated calcium channel activity [GO:0015279] g22117.t1 P79100 28.297 364 3.02e-34 145.0 sp|P79100|TRPC4_BOVIN Short transient receptor potential channel 4 OS=Bos taurus OX=9913 GN=TRPC4 PE=2 SV=2 TRPC4_BOVIN reviewed Short transient receptor potential channel 4 (TrpC4) (Capacitative calcium entry channel 1) (CCE1) Bos taurus (Bovine) GO:0005886; GO:0015279; GO:0034703; GO:0046872; GO:0051480; GO:0070588; GO:0070679 calcium ion transmembrane transport [GO:0070588]; regulation of cytosolic calcium ion concentration [GO:0051480] cation channel complex [GO:0034703]; plasma membrane [GO:0005886] inositol 1,4,5 trisphosphate binding [GO:0070679]; metal ion binding [GO:0046872]; store-operated calcium channel activity [GO:0015279] g22118.t1 Q9MYW0 24.425 913 1.47e-59 226.0 sp|Q9MYW0|TRPC6_BOVIN Short transient receptor potential channel 6 OS=Bos taurus OX=9913 GN=TRPC6 PE=2 SV=2 g22119.t1 O62852 27.436 780 1.91e-69 256.0 sp|O62852|TRPC5_RABIT Short transient receptor potential channel 5 OS=Oryctolagus cuniculus OX=9986 GN=TRPC5 PE=2 SV=1 g22123.t1 Q99NF1 40.577 520 3.15e-130 395.0 sp|Q99NF1|BCDO2_MOUSE Carotenoid-cleaving dioxygenase, mitochondrial OS=Mus musculus OX=10090 GN=Bco2 PE=1 SV=1 BCDO2_MOUSE reviewed Carotenoid-cleaving dioxygenase, mitochondrial (EC 1.13.11.-) (EC 1.13.11.71) (B-diox-II) (Beta,beta-carotene 9',10'-oxygenase) (Beta-carotene dioxygenase 2) Mus musculus (Mouse) GO:0003834; GO:0005739; GO:0010436; GO:0010437; GO:0016116; GO:0016119; GO:0016121; GO:0016122; GO:0016124; GO:0016702; GO:0042573; GO:0042574; GO:0046872; GO:0051881; GO:0062172; GO:0102076; GO:1901176; GO:1901826; GO:2000377 carotene catabolic process [GO:0016121]; carotene metabolic process [GO:0016119]; carotenoid metabolic process [GO:0016116]; lutein catabolic process [GO:0062172]; lycopene catabolic process [GO:1901176]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of reactive oxygen species metabolic process [GO:2000377]; retinal metabolic process [GO:0042574]; retinoic acid metabolic process [GO:0042573]; xanthophyll catabolic process [GO:0016124]; xanthophyll metabolic process [GO:0016122]; zeaxanthin catabolic process [GO:1901826] mitochondrion [GO:0005739] 9,10 (9', 10')-carotenoid-cleaving dioxygenase activity [GO:0010437]; beta,beta-carotene-9',10'-cleaving oxygenase activity [GO:0102076]; beta-carotene 15,15'-dioxygenase activity [GO:0003834]; carotenoid dioxygenase activity [GO:0010436]; metal ion binding [GO:0046872]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen [GO:0016702] g22124.t1 Q16836 64.856 313 1.3000000000000001e-122 357.0 sp|Q16836|HCDH_HUMAN Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial OS=Homo sapiens OX=9606 GN=HADH PE=1 SV=3 g22125.t1 Q6ZYL4 61.765 68 9.13e-28 97.8 sp|Q6ZYL4|TF2H5_HUMAN General transcription factor IIH subunit 5 OS=Homo sapiens OX=9606 GN=GTF2H5 PE=1 SV=1 TF2H5_HUMAN reviewed General transcription factor IIH subunit 5 (General transcription factor IIH polypeptide 5) (TFB5 ortholog) (TFIIH basal transcription factor complex TTD-A subunit) (TFIIH subunit p8) Homo sapiens (Human) GO:0000439; GO:0000462; GO:0005654; GO:0005669; GO:0005675; GO:0005730; GO:0005737; GO:0006289; GO:0006294; GO:0006362; GO:0006366; GO:0006367; GO:0071480 cellular response to gamma radiation [GO:0071480]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; nucleotide-excision repair [GO:0006289]; nucleotide-excision repair, preincision complex assembly [GO:0006294]; transcription by RNA polymerase II [GO:0006366]; transcription elongation by RNA polymerase I [GO:0006362]; transcription initiation at RNA polymerase II promoter [GO:0006367] cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; transcription factor TFIID complex [GO:0005669]; transcription factor TFIIH core complex [GO:0000439]; transcription factor TFIIH holo complex [GO:0005675] g22129.t1 Q9WVC5 26.549 791 1.67e-49 194.0 sp|Q9WVC5|TRPC7_MOUSE Short transient receptor potential channel 7 OS=Mus musculus OX=10090 GN=Trpc7 PE=2 SV=1 TRPC7_MOUSE reviewed Short transient receptor potential channel 7 (TrpC7) (Transient receptor protein 7) (TRP-7) (mTRP7) Mus musculus (Mouse) GO:0005262; GO:0005635; GO:0005886; GO:0006816; GO:0006828; GO:0007338; GO:0015279; GO:0016020; GO:0034703; GO:0048471; GO:0051480; GO:0070588; GO:0070679 calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; manganese ion transport [GO:0006828]; regulation of cytosolic calcium ion concentration [GO:0051480]; single fertilization [GO:0007338] cation channel complex [GO:0034703]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886] calcium channel activity [GO:0005262]; inositol 1,4,5 trisphosphate binding [GO:0070679]; store-operated calcium channel activity [GO:0015279] g22130.t1 Q99NF1 42.717 508 5.5000000000000005e-133 406.0 sp|Q99NF1|BCDO2_MOUSE Carotenoid-cleaving dioxygenase, mitochondrial OS=Mus musculus OX=10090 GN=Bco2 PE=1 SV=1 BCDO2_MOUSE reviewed Carotenoid-cleaving dioxygenase, mitochondrial (EC 1.13.11.-) (EC 1.13.11.71) (B-diox-II) (Beta,beta-carotene 9',10'-oxygenase) (Beta-carotene dioxygenase 2) Mus musculus (Mouse) GO:0003834; GO:0005739; GO:0010436; GO:0010437; GO:0016116; GO:0016119; GO:0016121; GO:0016122; GO:0016124; GO:0016702; GO:0042573; GO:0042574; GO:0046872; GO:0051881; GO:0062172; GO:0102076; GO:1901176; GO:1901826; GO:2000377 carotene catabolic process [GO:0016121]; carotene metabolic process [GO:0016119]; carotenoid metabolic process [GO:0016116]; lutein catabolic process [GO:0062172]; lycopene catabolic process [GO:1901176]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of reactive oxygen species metabolic process [GO:2000377]; retinal metabolic process [GO:0042574]; retinoic acid metabolic process [GO:0042573]; xanthophyll catabolic process [GO:0016124]; xanthophyll metabolic process [GO:0016122]; zeaxanthin catabolic process [GO:1901826] mitochondrion [GO:0005739] 9,10 (9', 10')-carotenoid-cleaving dioxygenase activity [GO:0010437]; beta,beta-carotene-9',10'-cleaving oxygenase activity [GO:0102076]; beta-carotene 15,15'-dioxygenase activity [GO:0003834]; carotenoid dioxygenase activity [GO:0010436]; metal ion binding [GO:0046872]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen [GO:0016702] g22132.t1 Q5TKR9 68.051 313 1.78e-136 472.0 sp|Q5TKR9|KAT6A_RAT Histone acetyltransferase KAT6A OS=Rattus norvegicus OX=10116 GN=Kat6a PE=1 SV=2 KAT6A_RAT reviewed Histone acetyltransferase KAT6A (EC 2.3.1.48) (MOZ, YBF2/SAS3, SAS2 and TIP60 protein 3) (MYST-3) (Monocytic leukemia zinc finger homolog) (Monocytic leukemia zinc finger protein) (MOZ) Rattus norvegicus (Rat) GO:0000785; GO:0000786; GO:0003007; GO:0003677; GO:0003682; GO:0003712; GO:0003713; GO:0004402; GO:0005634; GO:0005730; GO:0005829; GO:0006334; GO:0006355; GO:0006357; GO:0006473; GO:0008270; GO:0010484; GO:0010628; GO:0016605; GO:0016607; GO:0030099; GO:0035019; GO:0035162; GO:0035909; GO:0036408; GO:0043992; GO:0043995; GO:0043996; GO:0043997; GO:0045892; GO:0045893; GO:0046972; GO:0060325; GO:0070776; GO:0090398; GO:0140297 aorta morphogenesis [GO:0035909]; cellular senescence [GO:0090398]; embryonic hemopoiesis [GO:0035162]; face morphogenesis [GO:0060325]; heart morphogenesis [GO:0003007]; myeloid cell differentiation [GO:0030099]; negative regulation of DNA-templated transcription [GO:0045892]; nucleosome assembly [GO:0006334]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of gene expression [GO:0010628]; protein acetylation [GO:0006473]; regulation of DNA-templated transcription [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; somatic stem cell population maintenance [GO:0035019] chromatin [GO:0000785]; cytosol [GO:0005829]; MOZ/MORF histone acetyltransferase complex [GO:0070776]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleosome [GO:0000786]; nucleus [GO:0005634]; PML body [GO:0016605] chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription factor binding [GO:0140297]; histone acetyltransferase activity [GO:0004402]; histone H3 acetyltransferase activity [GO:0010484]; histone H3K14 acetyltransferase activity [GO:0036408]; histone H3K9 acetyltransferase activity [GO:0043992]; histone H4K12 acetyltransferase activity [GO:0043997]; histone H4K16 acetyltransferase activity [GO:0046972]; histone H4K5 acetyltransferase activity [GO:0043995]; histone H4K8 acetyltransferase activity [GO:0043996]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; zinc ion binding [GO:0008270] g22132.t1 Q5TKR9 40.885 384 1.0799999999999999e-61 238.0 sp|Q5TKR9|KAT6A_RAT Histone acetyltransferase KAT6A OS=Rattus norvegicus OX=10116 GN=Kat6a PE=1 SV=2 KAT6A_RAT reviewed Histone acetyltransferase KAT6A (EC 2.3.1.48) (MOZ, YBF2/SAS3, SAS2 and TIP60 protein 3) (MYST-3) (Monocytic leukemia zinc finger homolog) (Monocytic leukemia zinc finger protein) (MOZ) Rattus norvegicus (Rat) GO:0000785; GO:0000786; GO:0003007; GO:0003677; GO:0003682; GO:0003712; GO:0003713; GO:0004402; GO:0005634; GO:0005730; GO:0005829; GO:0006334; GO:0006355; GO:0006357; GO:0006473; GO:0008270; GO:0010484; GO:0010628; GO:0016605; GO:0016607; GO:0030099; GO:0035019; GO:0035162; GO:0035909; GO:0036408; GO:0043992; GO:0043995; GO:0043996; GO:0043997; GO:0045892; GO:0045893; GO:0046972; GO:0060325; GO:0070776; GO:0090398; GO:0140297 aorta morphogenesis [GO:0035909]; cellular senescence [GO:0090398]; embryonic hemopoiesis [GO:0035162]; face morphogenesis [GO:0060325]; heart morphogenesis [GO:0003007]; myeloid cell differentiation [GO:0030099]; negative regulation of DNA-templated transcription [GO:0045892]; nucleosome assembly [GO:0006334]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of gene expression [GO:0010628]; protein acetylation [GO:0006473]; regulation of DNA-templated transcription [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; somatic stem cell population maintenance [GO:0035019] chromatin [GO:0000785]; cytosol [GO:0005829]; MOZ/MORF histone acetyltransferase complex [GO:0070776]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleosome [GO:0000786]; nucleus [GO:0005634]; PML body [GO:0016605] chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription factor binding [GO:0140297]; histone acetyltransferase activity [GO:0004402]; histone H3 acetyltransferase activity [GO:0010484]; histone H3K14 acetyltransferase activity [GO:0036408]; histone H3K9 acetyltransferase activity [GO:0043992]; histone H4K12 acetyltransferase activity [GO:0043997]; histone H4K16 acetyltransferase activity [GO:0046972]; histone H4K5 acetyltransferase activity [GO:0043995]; histone H4K8 acetyltransferase activity [GO:0043996]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; zinc ion binding [GO:0008270] g22132.t2 Q8BZ21 68.051 313 1.8999999999999998e-136 472.0 sp|Q8BZ21|KAT6A_MOUSE Histone acetyltransferase KAT6A OS=Mus musculus OX=10090 GN=Kat6a PE=1 SV=2 g22132.t2 Q8BZ21 40.104 384 1.24e-59 231.0 sp|Q8BZ21|KAT6A_MOUSE Histone acetyltransferase KAT6A OS=Mus musculus OX=10090 GN=Kat6a PE=1 SV=2 g22132.t3 Q8WYB5 67.485 326 4.61e-135 469.0 sp|Q8WYB5|KAT6B_HUMAN Histone acetyltransferase KAT6B OS=Homo sapiens OX=9606 GN=KAT6B PE=1 SV=3 KAT6B_HUMAN reviewed Histone acetyltransferase KAT6B (EC 2.3.1.48) (Histone acetyltransferase MOZ2) (MOZ, YBF2/SAS3, SAS2 and TIP60 protein 4) (MYST-4) (Monocytic leukemia zinc finger protein-related factor) Homo sapiens (Human) GO:0000785; GO:0000786; GO:0003677; GO:0003682; GO:0003712; GO:0003713; GO:0004402; GO:0005634; GO:0005654; GO:0006334; GO:0006355; GO:0006357; GO:0008270; GO:0010484; GO:0036408; GO:0044877; GO:0045892; GO:0045893; GO:0045944; GO:0050793; GO:0061733; GO:0070776; GO:1903706 negative regulation of DNA-templated transcription [GO:0045892]; nucleosome assembly [GO:0006334]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of developmental process [GO:0050793]; regulation of DNA-templated transcription [GO:0006355]; regulation of hemopoiesis [GO:1903706]; regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; MOZ/MORF histone acetyltransferase complex [GO:0070776]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634] chromatin binding [GO:0003682]; DNA binding [GO:0003677]; histone acetyltransferase activity [GO:0004402]; histone H3 acetyltransferase activity [GO:0010484]; histone H3K14 acetyltransferase activity [GO:0036408]; protein-containing complex binding [GO:0044877]; protein-lysine-acetyltransferase activity [GO:0061733]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; zinc ion binding [GO:0008270] g22132.t3 Q8WYB5 41.449 345 1.91e-57 224.0 sp|Q8WYB5|KAT6B_HUMAN Histone acetyltransferase KAT6B OS=Homo sapiens OX=9606 GN=KAT6B PE=1 SV=3 KAT6B_HUMAN reviewed Histone acetyltransferase KAT6B (EC 2.3.1.48) (Histone acetyltransferase MOZ2) (MOZ, YBF2/SAS3, SAS2 and TIP60 protein 4) (MYST-4) (Monocytic leukemia zinc finger protein-related factor) Homo sapiens (Human) GO:0000785; GO:0000786; GO:0003677; GO:0003682; GO:0003712; GO:0003713; GO:0004402; GO:0005634; GO:0005654; GO:0006334; GO:0006355; GO:0006357; GO:0008270; GO:0010484; GO:0036408; GO:0044877; GO:0045892; GO:0045893; GO:0045944; GO:0050793; GO:0061733; GO:0070776; GO:1903706 negative regulation of DNA-templated transcription [GO:0045892]; nucleosome assembly [GO:0006334]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of developmental process [GO:0050793]; regulation of DNA-templated transcription [GO:0006355]; regulation of hemopoiesis [GO:1903706]; regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; MOZ/MORF histone acetyltransferase complex [GO:0070776]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634] chromatin binding [GO:0003682]; DNA binding [GO:0003677]; histone acetyltransferase activity [GO:0004402]; histone H3 acetyltransferase activity [GO:0010484]; histone H3K14 acetyltransferase activity [GO:0036408]; protein-containing complex binding [GO:0044877]; protein-lysine-acetyltransferase activity [GO:0061733]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; zinc ion binding [GO:0008270] g22133.t1 P55264 54.42 362 9.03e-122 357.0 sp|P55264|ADK_MOUSE Adenosine kinase OS=Mus musculus OX=10090 GN=Adk PE=1 SV=2 g22133.t2 O49923 51.026 341 2.76e-121 355.0 sp|O49923|ADK_PHYPA Adenosine kinase OS=Physcomitrium patens OX=3218 GN=ADK PE=2 SV=1 g22134.t1 Q9Z210 34.118 255 2.2199999999999998e-42 148.0 sp|Q9Z210|PX11B_MOUSE Peroxisomal membrane protein 11B OS=Mus musculus OX=10090 GN=Pex11b PE=1 SV=1 g22135.t1 Q5R792 57.554 278 1.72e-116 338.0 sp|Q5R792|ATG5_PONAB Autophagy protein 5 OS=Pongo abelii OX=9601 GN=ATG5 PE=2 SV=1 ATG5_PONAB reviewed Autophagy protein 5 (APG5-like) Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0000045; GO:0000422; GO:0001974; GO:0002718; GO:0005776; GO:0005930; GO:0006325; GO:0006914; GO:0006995; GO:0009410; GO:0009620; GO:0010659; GO:0010667; GO:0016567; GO:0019776; GO:0019883; GO:0030424; GO:0031397; GO:0032480; GO:0034045; GO:0034274; GO:0034727; GO:0035973; GO:0039689; GO:0042311; GO:0044233; GO:0045060; GO:0045087; GO:0045824; GO:0048840; GO:0050687; GO:0050765; GO:0051279; GO:0051607; GO:0055015; GO:0060047; GO:0061908; GO:0070254; GO:0070257; GO:0071500; GO:0098685; GO:0098794; GO:0098930; GO:0098978; GO:0099072; GO:0099170; GO:1901096; GO:1902017; GO:1904093; GO:1904973; GO:2000377 aggrephagy [GO:0035973]; antigen processing and presentation of endogenous antigen [GO:0019883]; autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; autophagy of mitochondrion [GO:0000422]; axonal transport [GO:0098930]; blood vessel remodeling [GO:0001974]; cardiac muscle cell apoptotic process [GO:0010659]; cellular response to nitrogen starvation [GO:0006995]; cellular response to nitrosative stress [GO:0071500]; chromatin organization [GO:0006325]; defense response to virus [GO:0051607]; heart contraction [GO:0060047]; innate immune response [GO:0045087]; mucus secretion [GO:0070254]; negative regulation of autophagic cell death [GO:1904093]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of defense response to virus [GO:0050687]; negative regulation of innate immune response [GO:0045824]; negative regulation of phagocytosis [GO:0050765]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of type I interferon production [GO:0032480]; negative stranded viral RNA replication [GO:0039689]; negative thymic T cell selection [GO:0045060]; otolith development [GO:0048840]; piecemeal microautophagy of the nucleus [GO:0034727]; positive regulation of mucus secretion [GO:0070257]; positive regulation of viral translation [GO:1904973]; postsynaptic modulation of chemical synaptic transmission [GO:0099170]; protein ubiquitination [GO:0016567]; regulation of autophagosome maturation [GO:1901096]; regulation of cilium assembly [GO:1902017]; regulation of cytokine production involved in immune response [GO:0002718]; regulation of postsynaptic membrane neurotransmitter receptor levels [GO:0099072]; regulation of reactive oxygen species metabolic process [GO:2000377]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; response to fungus [GO:0009620]; response to xenobiotic stimulus [GO:0009410]; vasodilation [GO:0042311]; ventricular cardiac muscle cell development [GO:0055015] Atg12-Atg5-Atg16 complex [GO:0034274]; autophagosome [GO:0005776]; axon [GO:0030424]; axoneme [GO:0005930]; glutamatergic synapse [GO:0098978]; mitochondria-associated endoplasmic reticulum membrane contact site [GO:0044233]; phagophore [GO:0061908]; phagophore assembly site membrane [GO:0034045]; postsynapse [GO:0098794]; Schaffer collateral - CA1 synapse [GO:0098685] Atg8-family ligase activity [GO:0019776] g22136.t1 Q5L1E5 30.245 367 5.680000000000001e-35 136.0 sp|Q5L1E5|MTNK_GEOKA Methylthioribose kinase OS=Geobacillus kaustophilus (strain HTA426) OX=235909 GN=mtnK PE=3 SV=1 g22137.t1 Q6P161 47.368 95 3.26e-24 94.0 sp|Q6P161|RM54_HUMAN Large ribosomal subunit protein mL54 OS=Homo sapiens OX=9606 GN=MRPL54 PE=1 SV=1 RM54_HUMAN reviewed Large ribosomal subunit protein mL54 (39S ribosomal protein L54, mitochondrial) (L54mt) (MRP-L54) Homo sapiens (Human) GO:0003723; GO:0003735; GO:0005739; GO:0005743; GO:0005762; GO:0032543 mitochondrial translation [GO:0032543] mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739] RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735] g22138.t1 Q07590 40.323 558 4.25e-115 372.0 sp|Q07590|SAV_SULAC Protein SAV OS=Sulfolobus acidocaldarius (strain ATCC 33909 / DSM 639 / JCM 8929 / NBRC 15157 / NCIMB 11770) OX=330779 GN=sav PE=3 SV=2 g22138.t1 Q07590 38.721 297 3.35e-41 166.0 sp|Q07590|SAV_SULAC Protein SAV OS=Sulfolobus acidocaldarius (strain ATCC 33909 / DSM 639 / JCM 8929 / NBRC 15157 / NCIMB 11770) OX=330779 GN=sav PE=3 SV=2 g22139.t1 Q6DIR8 37.94 796 1.43e-178 538.0 sp|Q6DIR8|PALD_XENTR Paladin OS=Xenopus tropicalis OX=8364 GN=pald1 PE=2 SV=1 g22141.t1 Q5RFS2 69.108 314 2.06e-157 452.0 sp|Q5RFS2|CSN3_PONAB COP9 signalosome complex subunit 3 OS=Pongo abelii OX=9601 GN=COPS3 PE=2 SV=1 g22142.t1 Q8N5R6 27.833 406 9.89e-35 147.0 sp|Q8N5R6|CCD33_HUMAN Coiled-coil domain-containing protein 33 OS=Homo sapiens OX=9606 GN=CCDC33 PE=1 SV=3 CCD33_HUMAN reviewed Coiled-coil domain-containing protein 33 (Cancer/testis antigen 61) (CT61) Homo sapiens (Human) GO:0005777 peroxisome [GO:0005777] g22144.t1 O42606 62.353 85 4.24e-28 107.0 sp|O42606|NGN1_DANRE Neurogenin-1 OS=Danio rerio OX=7955 GN=neurog1 PE=2 SV=1 NGN1_DANRE reviewed Neurogenin-1 (NGN-1) (Neurogenic differentiation factor 3) (NeuroD3) (Neurogenin-related protein 1) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000981; GO:0003682; GO:0005634; GO:0007399; GO:0007413; GO:0007422; GO:0007423; GO:0021516; GO:0021575; GO:0021772; GO:0021884; GO:0021986; GO:0030900; GO:0031103; GO:0045666; GO:0045944; GO:0046983; GO:0048699; GO:0048884; GO:0048909; GO:0048918; GO:0048935; GO:0050768; GO:0051091; GO:0061564; GO:0070888; GO:0071698 anterior lateral line nerve development [GO:0048909]; axon development [GO:0061564]; axon regeneration [GO:0031103]; axonal fasciculation [GO:0007413]; dorsal spinal cord development [GO:0021516]; forebrain development [GO:0030900]; forebrain neuron development [GO:0021884]; generation of neurons [GO:0048699]; habenula development [GO:0021986]; hindbrain morphogenesis [GO:0021575]; negative regulation of neurogenesis [GO:0050768]; nervous system development [GO:0007399]; neuromast development [GO:0048884]; olfactory bulb development [GO:0021772]; olfactory placode development [GO:0071698]; peripheral nervous system development [GO:0007422]; peripheral nervous system neuron development [GO:0048935]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of transcription by RNA polymerase II [GO:0045944]; posterior lateral line nerve development [GO:0048918]; sensory organ development [GO:0007423] nucleus [GO:0005634] chromatin binding [GO:0003682]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; E-box binding [GO:0070888]; protein dimerization activity [GO:0046983] g22149.t1 Q13257 55.67 194 8.749999999999999e-69 212.0 sp|Q13257|MD2L1_HUMAN Mitotic spindle assembly checkpoint protein MAD2A OS=Homo sapiens OX=9606 GN=MAD2L1 PE=1 SV=1 g22152.t1 Q55G11 50.0 686 0.0 624.0 sp|Q55G11|NCSEB_DICDI Neutral ceramidase B OS=Dictyostelium discoideum OX=44689 GN=dcd2B PE=3 SV=1 g22153.t1 Q5RAG8 51.402 535 0.0 540.0 sp|Q5RAG8|P4HA1_PONAB Prolyl 4-hydroxylase subunit alpha-1 OS=Pongo abelii OX=9601 GN=P4HA1 PE=2 SV=1 g22153.t2 Q5RAG8 49.819 552 0.0 529.0 sp|Q5RAG8|P4HA1_PONAB Prolyl 4-hydroxylase subunit alpha-1 OS=Pongo abelii OX=9601 GN=P4HA1 PE=2 SV=1 g22154.t1 Q9H0I2 39.394 297 3.1699999999999997e-46 162.0 sp|Q9H0I2|ENKD1_HUMAN Enkurin domain-containing protein 1 OS=Homo sapiens OX=9606 GN=ENKD1 PE=1 SV=1 g22155.t1 A8NIX5 51.754 114 2.99e-32 124.0 sp|A8NIX5|CB081_BOVIN Uncharacterized protein C2orf81 homolog OS=Bos taurus OX=9913 PE=2 SV=2 g22157.t1 Q9CX98 28.384 458 1.28e-57 203.0 sp|Q9CX98|CP2U1_MOUSE Cytochrome P450 2U1 OS=Mus musculus OX=10090 GN=Cyp2u1 PE=2 SV=2 CP2U1_MOUSE reviewed Cytochrome P450 2U1 (Long-chain fatty acid omega-monooxygenase) (EC 1.14.14.80) Mus musculus (Mouse) GO:0005506; GO:0005737; GO:0005743; GO:0005789; GO:0006082; GO:0006805; GO:0008202; GO:0008395; GO:0016712; GO:0020037; GO:0052869; GO:0097267; GO:0102033 omega-hydroxylase P450 pathway [GO:0097267]; organic acid metabolic process [GO:0006082]; steroid metabolic process [GO:0008202]; xenobiotic metabolic process [GO:0006805] cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; mitochondrial inner membrane [GO:0005743] arachidonate omega-hydroxylase activity [GO:0052869]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; long-chain fatty acid omega-hydroxylase activity [GO:0102033]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; steroid hydroxylase activity [GO:0008395] g22158.t1 Q99542 38.494 478 1.5199999999999999e-89 286.0 sp|Q99542|MMP19_HUMAN Matrix metalloproteinase-19 OS=Homo sapiens OX=9606 GN=MMP19 PE=1 SV=1 MMP19_HUMAN reviewed Matrix metalloproteinase-19 (MMP-19) (EC 3.4.24.-) (Matrix metalloproteinase RASI) (Matrix metalloproteinase-18) (MMP-18) Homo sapiens (Human) GO:0001525; GO:0001541; GO:0001542; GO:0001554; GO:0004222; GO:0004252; GO:0005576; GO:0005615; GO:0006508; GO:0008270; GO:0009725; GO:0022617; GO:0030154; GO:0030198; GO:0030574; GO:0031012; GO:0051591 angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; collagen catabolic process [GO:0030574]; extracellular matrix disassembly [GO:0022617]; extracellular matrix organization [GO:0030198]; luteolysis [GO:0001554]; ovarian follicle development [GO:0001541]; ovulation from ovarian follicle [GO:0001542]; proteolysis [GO:0006508]; response to cAMP [GO:0051591]; response to hormone [GO:0009725] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615] metalloendopeptidase activity [GO:0004222]; serine-type endopeptidase activity [GO:0004252]; zinc ion binding [GO:0008270] g22159.t1 Q99PW6 35.095 473 2.28e-77 257.0 sp|Q99PW6|MMP24_RAT Matrix metalloproteinase-24 OS=Rattus norvegicus OX=10116 GN=Mmp24 PE=1 SV=1 MMP24_RAT reviewed Matrix metalloproteinase-24 (MMP-24) (EC 3.4.24.-) (Membrane-type matrix metalloproteinase 5) (MT-MMP 5) (MTMMP5) (Membrane-type-5 matrix metalloproteinase) (MT5-MMP) (MT5MMP) [Cleaved into: Processed matrix metalloproteinase-24] Rattus norvegicus (Rat) GO:0004222; GO:0005615; GO:0005886; GO:0006508; GO:0008233; GO:0008270; GO:0010001; GO:0030198; GO:0030574; GO:0031012; GO:0032588; GO:0044331; GO:0045296; GO:0050965; GO:0097150; GO:0098742 cell-cell adhesion mediated by cadherin [GO:0044331]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; collagen catabolic process [GO:0030574]; detection of temperature stimulus involved in sensory perception of pain [GO:0050965]; extracellular matrix organization [GO:0030198]; glial cell differentiation [GO:0010001]; neuronal stem cell population maintenance [GO:0097150]; proteolysis [GO:0006508] extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; trans-Golgi network membrane [GO:0032588] cadherin binding [GO:0045296]; metalloendopeptidase activity [GO:0004222]; peptidase activity [GO:0008233]; zinc ion binding [GO:0008270] g22160.t1 Q99542 37.347 490 4.06e-87 280.0 sp|Q99542|MMP19_HUMAN Matrix metalloproteinase-19 OS=Homo sapiens OX=9606 GN=MMP19 PE=1 SV=1 MMP19_HUMAN reviewed Matrix metalloproteinase-19 (MMP-19) (EC 3.4.24.-) (Matrix metalloproteinase RASI) (Matrix metalloproteinase-18) (MMP-18) Homo sapiens (Human) GO:0001525; GO:0001541; GO:0001542; GO:0001554; GO:0004222; GO:0004252; GO:0005576; GO:0005615; GO:0006508; GO:0008270; GO:0009725; GO:0022617; GO:0030154; GO:0030198; GO:0030574; GO:0031012; GO:0051591 angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; collagen catabolic process [GO:0030574]; extracellular matrix disassembly [GO:0022617]; extracellular matrix organization [GO:0030198]; luteolysis [GO:0001554]; ovarian follicle development [GO:0001541]; ovulation from ovarian follicle [GO:0001542]; proteolysis [GO:0006508]; response to cAMP [GO:0051591]; response to hormone [GO:0009725] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615] metalloendopeptidase activity [GO:0004222]; serine-type endopeptidase activity [GO:0004252]; zinc ion binding [GO:0008270] g22161.t1 P91953 39.858 424 3.5e-83 272.0 sp|P91953|HE_HEMPU 50 kDa hatching enzyme OS=Hemicentrotus pulcherrimus OX=7650 PE=1 SV=1 g22163.t1 Q0ZM14 32.201 1354 4.3600000000000004e-144 496.0 sp|Q0ZM14|PCD15_CHICK Protocadherin-15 OS=Gallus gallus OX=9031 GN=Pcdh15 PE=1 SV=1 PCD15_CHICK reviewed Protocadherin-15 Gallus gallus (Chicken) GO:0001750; GO:0005509; GO:0005886; GO:0007155; GO:0007156; GO:0007605; GO:0032420; GO:0048839; GO:0050839; GO:0050953; GO:0050957 cell adhesion [GO:0007155]; equilibrioception [GO:0050957]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; inner ear development [GO:0048839]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605] photoreceptor outer segment [GO:0001750]; plasma membrane [GO:0005886]; stereocilium [GO:0032420] calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839] g22163.t1 Q0ZM14 25.0 804 6e-22 108.0 sp|Q0ZM14|PCD15_CHICK Protocadherin-15 OS=Gallus gallus OX=9031 GN=Pcdh15 PE=1 SV=1 PCD15_CHICK reviewed Protocadherin-15 Gallus gallus (Chicken) GO:0001750; GO:0005509; GO:0005886; GO:0007155; GO:0007156; GO:0007605; GO:0032420; GO:0048839; GO:0050839; GO:0050953; GO:0050957 cell adhesion [GO:0007155]; equilibrioception [GO:0050957]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; inner ear development [GO:0048839]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605] photoreceptor outer segment [GO:0001750]; plasma membrane [GO:0005886]; stereocilium [GO:0032420] calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839] g22163.t2 Q0ZM14 32.201 1354 2.7000000000000003e-144 496.0 sp|Q0ZM14|PCD15_CHICK Protocadherin-15 OS=Gallus gallus OX=9031 GN=Pcdh15 PE=1 SV=1 PCD15_CHICK reviewed Protocadherin-15 Gallus gallus (Chicken) GO:0001750; GO:0005509; GO:0005886; GO:0007155; GO:0007156; GO:0007605; GO:0032420; GO:0048839; GO:0050839; GO:0050953; GO:0050957 cell adhesion [GO:0007155]; equilibrioception [GO:0050957]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; inner ear development [GO:0048839]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605] photoreceptor outer segment [GO:0001750]; plasma membrane [GO:0005886]; stereocilium [GO:0032420] calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839] g22163.t2 Q0ZM14 25.0 804 5.26e-22 108.0 sp|Q0ZM14|PCD15_CHICK Protocadherin-15 OS=Gallus gallus OX=9031 GN=Pcdh15 PE=1 SV=1 PCD15_CHICK reviewed Protocadherin-15 Gallus gallus (Chicken) GO:0001750; GO:0005509; GO:0005886; GO:0007155; GO:0007156; GO:0007605; GO:0032420; GO:0048839; GO:0050839; GO:0050953; GO:0050957 cell adhesion [GO:0007155]; equilibrioception [GO:0050957]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; inner ear development [GO:0048839]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605] photoreceptor outer segment [GO:0001750]; plasma membrane [GO:0005886]; stereocilium [GO:0032420] calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839] g22163.t3 Q0ZM14 32.201 1354 2.3000000000000003e-144 496.0 sp|Q0ZM14|PCD15_CHICK Protocadherin-15 OS=Gallus gallus OX=9031 GN=Pcdh15 PE=1 SV=1 PCD15_CHICK reviewed Protocadherin-15 Gallus gallus (Chicken) GO:0001750; GO:0005509; GO:0005886; GO:0007155; GO:0007156; GO:0007605; GO:0032420; GO:0048839; GO:0050839; GO:0050953; GO:0050957 cell adhesion [GO:0007155]; equilibrioception [GO:0050957]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; inner ear development [GO:0048839]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605] photoreceptor outer segment [GO:0001750]; plasma membrane [GO:0005886]; stereocilium [GO:0032420] calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839] g22163.t3 Q0ZM14 25.0 804 5.49e-22 108.0 sp|Q0ZM14|PCD15_CHICK Protocadherin-15 OS=Gallus gallus OX=9031 GN=Pcdh15 PE=1 SV=1 PCD15_CHICK reviewed Protocadherin-15 Gallus gallus (Chicken) GO:0001750; GO:0005509; GO:0005886; GO:0007155; GO:0007156; GO:0007605; GO:0032420; GO:0048839; GO:0050839; GO:0050953; GO:0050957 cell adhesion [GO:0007155]; equilibrioception [GO:0050957]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; inner ear development [GO:0048839]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605] photoreceptor outer segment [GO:0001750]; plasma membrane [GO:0005886]; stereocilium [GO:0032420] calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839] g22163.t4 Q0ZM14 32.201 1354 2.4400000000000003e-144 496.0 sp|Q0ZM14|PCD15_CHICK Protocadherin-15 OS=Gallus gallus OX=9031 GN=Pcdh15 PE=1 SV=1 PCD15_CHICK reviewed Protocadherin-15 Gallus gallus (Chicken) GO:0001750; GO:0005509; GO:0005886; GO:0007155; GO:0007156; GO:0007605; GO:0032420; GO:0048839; GO:0050839; GO:0050953; GO:0050957 cell adhesion [GO:0007155]; equilibrioception [GO:0050957]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; inner ear development [GO:0048839]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605] photoreceptor outer segment [GO:0001750]; plasma membrane [GO:0005886]; stereocilium [GO:0032420] calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839] g22163.t4 Q0ZM14 25.0 804 6.22e-22 108.0 sp|Q0ZM14|PCD15_CHICK Protocadherin-15 OS=Gallus gallus OX=9031 GN=Pcdh15 PE=1 SV=1 PCD15_CHICK reviewed Protocadherin-15 Gallus gallus (Chicken) GO:0001750; GO:0005509; GO:0005886; GO:0007155; GO:0007156; GO:0007605; GO:0032420; GO:0048839; GO:0050839; GO:0050953; GO:0050957 cell adhesion [GO:0007155]; equilibrioception [GO:0050957]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; inner ear development [GO:0048839]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605] photoreceptor outer segment [GO:0001750]; plasma membrane [GO:0005886]; stereocilium [GO:0032420] calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839] g22164.t1 Q9UBQ7 53.667 300 4.15e-105 313.0 sp|Q9UBQ7|GRHPR_HUMAN Glyoxylate reductase/hydroxypyruvate reductase OS=Homo sapiens OX=9606 GN=GRHPR PE=1 SV=1 GRHPR_HUMAN reviewed Glyoxylate reductase/hydroxypyruvate reductase (EC 1.1.1.79) (EC 1.1.1.81) Homo sapiens (Human) GO:0005737; GO:0005739; GO:0005782; GO:0005829; GO:0008465; GO:0016618; GO:0019752; GO:0030267; GO:0031406; GO:0042803; GO:0043648; GO:0046487; GO:0051287; GO:0070062; GO:0070402; GO:0120509; GO:1902494 carboxylic acid metabolic process [GO:0019752]; dicarboxylic acid metabolic process [GO:0043648]; glyoxylate metabolic process [GO:0046487] catalytic complex [GO:1902494]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; mitochondrion [GO:0005739]; peroxisomal matrix [GO:0005782] carboxylic acid binding [GO:0031406]; glyoxylate reductase (NADPH) activity [GO:0030267]; hydroxypyruvate reductase (NADH) activity [GO:0008465]; hydroxypyruvate reductase (NADPH) activity [GO:0120509]; hydroxypyruvate reductase [NAD(P)H] activity [GO:0016618]; NAD binding [GO:0051287]; NADPH binding [GO:0070402]; protein homodimerization activity [GO:0042803] g22164.t2 Q9UBQ7 53.667 300 4.15e-105 313.0 sp|Q9UBQ7|GRHPR_HUMAN Glyoxylate reductase/hydroxypyruvate reductase OS=Homo sapiens OX=9606 GN=GRHPR PE=1 SV=1 GRHPR_HUMAN reviewed Glyoxylate reductase/hydroxypyruvate reductase (EC 1.1.1.79) (EC 1.1.1.81) Homo sapiens (Human) GO:0005737; GO:0005739; GO:0005782; GO:0005829; GO:0008465; GO:0016618; GO:0019752; GO:0030267; GO:0031406; GO:0042803; GO:0043648; GO:0046487; GO:0051287; GO:0070062; GO:0070402; GO:0120509; GO:1902494 carboxylic acid metabolic process [GO:0019752]; dicarboxylic acid metabolic process [GO:0043648]; glyoxylate metabolic process [GO:0046487] catalytic complex [GO:1902494]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; mitochondrion [GO:0005739]; peroxisomal matrix [GO:0005782] carboxylic acid binding [GO:0031406]; glyoxylate reductase (NADPH) activity [GO:0030267]; hydroxypyruvate reductase (NADH) activity [GO:0008465]; hydroxypyruvate reductase (NADPH) activity [GO:0120509]; hydroxypyruvate reductase [NAD(P)H] activity [GO:0016618]; NAD binding [GO:0051287]; NADPH binding [GO:0070402]; protein homodimerization activity [GO:0042803] g22165.t1 Q9UBQ7 66.316 95 1.92e-39 136.0 sp|Q9UBQ7|GRHPR_HUMAN Glyoxylate reductase/hydroxypyruvate reductase OS=Homo sapiens OX=9606 GN=GRHPR PE=1 SV=1 GRHPR_HUMAN reviewed Glyoxylate reductase/hydroxypyruvate reductase (EC 1.1.1.79) (EC 1.1.1.81) Homo sapiens (Human) GO:0005737; GO:0005739; GO:0005782; GO:0005829; GO:0008465; GO:0016618; GO:0019752; GO:0030267; GO:0031406; GO:0042803; GO:0043648; GO:0046487; GO:0051287; GO:0070062; GO:0070402; GO:0120509; GO:1902494 carboxylic acid metabolic process [GO:0019752]; dicarboxylic acid metabolic process [GO:0043648]; glyoxylate metabolic process [GO:0046487] catalytic complex [GO:1902494]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; mitochondrion [GO:0005739]; peroxisomal matrix [GO:0005782] carboxylic acid binding [GO:0031406]; glyoxylate reductase (NADPH) activity [GO:0030267]; hydroxypyruvate reductase (NADH) activity [GO:0008465]; hydroxypyruvate reductase (NADPH) activity [GO:0120509]; hydroxypyruvate reductase [NAD(P)H] activity [GO:0016618]; NAD binding [GO:0051287]; NADPH binding [GO:0070402]; protein homodimerization activity [GO:0042803] g22165.t2 Q9UBQ7 53.279 122 8.839999999999999e-34 122.0 sp|Q9UBQ7|GRHPR_HUMAN Glyoxylate reductase/hydroxypyruvate reductase OS=Homo sapiens OX=9606 GN=GRHPR PE=1 SV=1 GRHPR_HUMAN reviewed Glyoxylate reductase/hydroxypyruvate reductase (EC 1.1.1.79) (EC 1.1.1.81) Homo sapiens (Human) GO:0005737; GO:0005739; GO:0005782; GO:0005829; GO:0008465; GO:0016618; GO:0019752; GO:0030267; GO:0031406; GO:0042803; GO:0043648; GO:0046487; GO:0051287; GO:0070062; GO:0070402; GO:0120509; GO:1902494 carboxylic acid metabolic process [GO:0019752]; dicarboxylic acid metabolic process [GO:0043648]; glyoxylate metabolic process [GO:0046487] catalytic complex [GO:1902494]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; mitochondrion [GO:0005739]; peroxisomal matrix [GO:0005782] carboxylic acid binding [GO:0031406]; glyoxylate reductase (NADPH) activity [GO:0030267]; hydroxypyruvate reductase (NADH) activity [GO:0008465]; hydroxypyruvate reductase (NADPH) activity [GO:0120509]; hydroxypyruvate reductase [NAD(P)H] activity [GO:0016618]; NAD binding [GO:0051287]; NADPH binding [GO:0070402]; protein homodimerization activity [GO:0042803] g22166.t1 Q9UBQ7 56.18 178 7.06e-64 204.0 sp|Q9UBQ7|GRHPR_HUMAN Glyoxylate reductase/hydroxypyruvate reductase OS=Homo sapiens OX=9606 GN=GRHPR PE=1 SV=1 GRHPR_HUMAN reviewed Glyoxylate reductase/hydroxypyruvate reductase (EC 1.1.1.79) (EC 1.1.1.81) Homo sapiens (Human) GO:0005737; GO:0005739; GO:0005782; GO:0005829; GO:0008465; GO:0016618; GO:0019752; GO:0030267; GO:0031406; GO:0042803; GO:0043648; GO:0046487; GO:0051287; GO:0070062; GO:0070402; GO:0120509; GO:1902494 carboxylic acid metabolic process [GO:0019752]; dicarboxylic acid metabolic process [GO:0043648]; glyoxylate metabolic process [GO:0046487] catalytic complex [GO:1902494]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; mitochondrion [GO:0005739]; peroxisomal matrix [GO:0005782] carboxylic acid binding [GO:0031406]; glyoxylate reductase (NADPH) activity [GO:0030267]; hydroxypyruvate reductase (NADH) activity [GO:0008465]; hydroxypyruvate reductase (NADPH) activity [GO:0120509]; hydroxypyruvate reductase [NAD(P)H] activity [GO:0016618]; NAD binding [GO:0051287]; NADPH binding [GO:0070402]; protein homodimerization activity [GO:0042803] g22167.t1 Q9UBQ7 61.682 321 1.25e-142 409.0 sp|Q9UBQ7|GRHPR_HUMAN Glyoxylate reductase/hydroxypyruvate reductase OS=Homo sapiens OX=9606 GN=GRHPR PE=1 SV=1 GRHPR_HUMAN reviewed Glyoxylate reductase/hydroxypyruvate reductase (EC 1.1.1.79) (EC 1.1.1.81) Homo sapiens (Human) GO:0005737; GO:0005739; GO:0005782; GO:0005829; GO:0008465; GO:0016618; GO:0019752; GO:0030267; GO:0031406; GO:0042803; GO:0043648; GO:0046487; GO:0051287; GO:0070062; GO:0070402; GO:0120509; GO:1902494 carboxylic acid metabolic process [GO:0019752]; dicarboxylic acid metabolic process [GO:0043648]; glyoxylate metabolic process [GO:0046487] catalytic complex [GO:1902494]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; mitochondrion [GO:0005739]; peroxisomal matrix [GO:0005782] carboxylic acid binding [GO:0031406]; glyoxylate reductase (NADPH) activity [GO:0030267]; hydroxypyruvate reductase (NADH) activity [GO:0008465]; hydroxypyruvate reductase (NADPH) activity [GO:0120509]; hydroxypyruvate reductase [NAD(P)H] activity [GO:0016618]; NAD binding [GO:0051287]; NADPH binding [GO:0070402]; protein homodimerization activity [GO:0042803] g22168.t1 Q3T0P5 51.362 257 8.76e-85 261.0 sp|Q3T0P5|CASP6_BOVIN Caspase-6 OS=Bos taurus OX=9913 GN=CASP6 PE=2 SV=1 CASP6_BOVIN reviewed Caspase-6 (CASP-6) (EC 3.4.22.59) [Cleaved into: Caspase-6 subunit p18; Caspase-6 subunit p11] Bos taurus (Bovine) GO:0002218; GO:0004197; GO:0005634; GO:0005737; GO:0006915; GO:0016540; GO:0043065; GO:0043525; GO:0060545; GO:0070269; GO:0072332; GO:0097284 activation of innate immune response [GO:0002218]; apoptotic process [GO:0006915]; hepatocyte apoptotic process [GO:0097284]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; positive regulation of apoptotic process [GO:0043065]; positive regulation of necroptotic process [GO:0060545]; positive regulation of neuron apoptotic process [GO:0043525]; protein autoprocessing [GO:0016540]; pyroptotic inflammatory response [GO:0070269] cytoplasm [GO:0005737]; nucleus [GO:0005634] cysteine-type endopeptidase activity [GO:0004197] g22169.t1 Q5R4J5 32.234 273 2.49e-38 149.0 sp|Q5R4J5|SYT1_PONAB Synaptotagmin-1 OS=Pongo abelii OX=9601 GN=SYT1 PE=2 SV=1 SYT1_PONAB reviewed Synaptotagmin-1 (Synaptotagmin I) (SytI) Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0000149; GO:0001786; GO:0005509; GO:0005544; GO:0005886; GO:0030154; GO:0030276; GO:0030424; GO:0030669; GO:0030672; GO:0031045; GO:0042584; GO:0048488; GO:0048791; GO:1903235; GO:1903861 calcium ion-regulated exocytosis of neurotransmitter [GO:0048791]; cell differentiation [GO:0030154]; positive regulation of calcium ion-dependent exocytosis of neurotransmitter [GO:1903235]; positive regulation of dendrite extension [GO:1903861]; synaptic vesicle endocytosis [GO:0048488] axon [GO:0030424]; chromaffin granule membrane [GO:0042584]; clathrin-coated endocytic vesicle membrane [GO:0030669]; dense core granule [GO:0031045]; plasma membrane [GO:0005886]; synaptic vesicle membrane [GO:0030672] calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; clathrin binding [GO:0030276]; phosphatidylserine binding [GO:0001786]; SNARE binding [GO:0000149] g22170.t1 P25867 76.027 146 1.6900000000000002e-70 211.0 sp|P25867|UBCD1_DROME Ubiquitin-conjugating enzyme E2-17 kDa OS=Drosophila melanogaster OX=7227 GN=eff PE=1 SV=1 g22171.t1 C1C524 47.727 132 7.02e-38 128.0 sp|C1C524|CISD2_AQUCT CDGSH iron-sulfur domain-containing protein 2 OS=Aquarana catesbeiana OX=8400 GN=cisd2 PE=2 SV=1 g22171.t2 Q6AZG1 38.217 157 1.09e-31 113.0 sp|Q6AZG1|CID2B_XENLA CDGSH iron-sulfur domain-containing protein 2B OS=Xenopus laevis OX=8355 GN=cisd2-b PE=2 SV=1 g22172.t1 Q5RC04 58.368 478 0.0 590.0 sp|Q5RC04|RGF1B_PONAB Ras-GEF domain-containing family member 1B OS=Pongo abelii OX=9601 GN=RASGEF1B PE=2 SV=2 g22172.t2 Q5RC04 62.1 438 0.0 585.0 sp|Q5RC04|RGF1B_PONAB Ras-GEF domain-containing family member 1B OS=Pongo abelii OX=9601 GN=RASGEF1B PE=2 SV=2 g22174.t1 Q02874 60.227 352 9.75e-142 410.0 sp|Q02874|H2AY_RAT Core histone macro-H2A.1 OS=Rattus norvegicus OX=10116 GN=Macroh2a1 PE=1 SV=5 g22177.t1 P18426 39.024 205 1.14e-37 132.0 sp|P18426|SCR11_NOTSL S-crystallin SL11 OS=Nototodarus sloanii OX=215440 PE=2 SV=1 g22178.t1 O42387 77.863 131 3.16e-59 182.0 sp|O42387|RS24_TAKRU Small ribosomal subunit protein eS24 OS=Takifugu rubripes OX=31033 GN=rps24 PE=3 SV=1 g22179.t1 P18426 38.756 209 8.52e-41 140.0 sp|P18426|SCR11_NOTSL S-crystallin SL11 OS=Nototodarus sloanii OX=215440 PE=2 SV=1 g22185.t1 Q9N2A7 36.478 159 2.75e-25 113.0 sp|Q9N2A7|ACM2_PANTR Muscarinic acetylcholine receptor M2 (Fragment) OS=Pan troglodytes OX=9598 GN=CHRM2 PE=3 SV=1 g22188.t1 O73853 29.474 475 3.06e-50 183.0 sp|O73853|CP17A_ICTPU Steroid 17-alpha-hydroxylase/17,20 lyase OS=Ictalurus punctatus OX=7998 GN=cyp17a1 PE=2 SV=1 g22189.t1 Q95328 29.787 423 7.83e-51 185.0 sp|Q95328|CP17A_HORSE Steroid 17-alpha-hydroxylase/17,20 lyase OS=Equus caballus OX=9796 GN=CYP17A1 PE=2 SV=1 CP17A_HORSE reviewed Steroid 17-alpha-hydroxylase/17,20 lyase (EC 1.14.14.19) (17-alpha-hydroxyprogesterone aldolase) (EC 1.14.14.32) (CYPXVII) (Cytochrome P450 17A1) (Cytochrome P450-C17) (Cytochrome P450c17) (Steroid 17-alpha-monooxygenase) Equus caballus (Horse) GO:0004508; GO:0005506; GO:0005789; GO:0006704; GO:0008202; GO:0016829; GO:0020037; GO:0042446; GO:0042448 glucocorticoid biosynthetic process [GO:0006704]; hormone biosynthetic process [GO:0042446]; progesterone metabolic process [GO:0042448]; steroid metabolic process [GO:0008202] endoplasmic reticulum membrane [GO:0005789] heme binding [GO:0020037]; iron ion binding [GO:0005506]; lyase activity [GO:0016829]; steroid 17-alpha-monooxygenase activity [GO:0004508] g22190.t1 Q8N475 34.675 323 5.31e-61 210.0 sp|Q8N475|FSTL5_HUMAN Follistatin-related protein 5 OS=Homo sapiens OX=9606 GN=FSTL5 PE=1 SV=2 g22192.t1 Q9BXU1 22.177 992 2.07e-32 140.0 sp|Q9BXU1|STK31_HUMAN Serine/threonine-protein kinase 31 OS=Homo sapiens OX=9606 GN=STK31 PE=1 SV=2 g22194.t1 Q5ZKY0 38.202 178 8.419999999999999e-24 101.0 sp|Q5ZKY0|TM175_CHICK Endosomal/lysosomal proton channel TMEM175 OS=Gallus gallus OX=9031 GN=TMEM175 PE=2 SV=2 TM175_CHICK reviewed Endosomal/lysosomal proton channel TMEM175 (Potassium channel TMEM175) (Transmembrane protein 175) Gallus gallus (Chicken) GO:0005267; GO:0005764; GO:0005765; GO:0005768; GO:0010008; GO:0015252; GO:0022841; GO:0035751; GO:0035752; GO:0050544; GO:0070050; GO:0071805; GO:0090385; GO:1902600 lysosomal lumen pH elevation [GO:0035752]; neuron cellular homeostasis [GO:0070050]; phagosome-lysosome fusion [GO:0090385]; potassium ion transmembrane transport [GO:0071805]; proton transmembrane transport [GO:1902600]; regulation of lysosomal lumen pH [GO:0035751] endosome [GO:0005768]; endosome membrane [GO:0010008]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764] arachidonate binding [GO:0050544]; potassium channel activity [GO:0005267]; potassium ion leak channel activity [GO:0022841]; proton channel activity [GO:0015252] g22195.t1 Q13976 53.723 685 0.0 701.0 sp|Q13976|KGP1_HUMAN cGMP-dependent protein kinase 1 OS=Homo sapiens OX=9606 GN=PRKG1 PE=1 SV=3 KGP1_HUMAN reviewed cGMP-dependent protein kinase 1 (cGK 1) (cGK1) (EC 2.7.11.12) (cGMP-dependent protein kinase I) (cGKI) Homo sapiens (Human) GO:0001669; GO:0001764; GO:0004672; GO:0004692; GO:0005246; GO:0005524; GO:0005654; GO:0005737; GO:0005794; GO:0005829; GO:0005886; GO:0007165; GO:0007204; GO:0007286; GO:0010920; GO:0014050; GO:0016358; GO:0019934; GO:0021549; GO:0030553; GO:0030900; GO:0042383; GO:0042753; GO:0042802; GO:0043114; GO:0048273; GO:0048668; GO:0060087; GO:0061049; GO:0090331; GO:0098868; GO:0106310; GO:1904706; GO:1904753; GO:2000224 bone growth [GO:0098868]; cell growth involved in cardiac muscle cell development [GO:0061049]; cerebellum development [GO:0021549]; cGMP-mediated signaling [GO:0019934]; collateral sprouting [GO:0048668]; dendrite development [GO:0016358]; forebrain development [GO:0030900]; negative regulation of glutamate secretion [GO:0014050]; negative regulation of inositol phosphate biosynthetic process [GO:0010920]; negative regulation of platelet aggregation [GO:0090331]; negative regulation of vascular associated smooth muscle cell migration [GO:1904753]; negative regulation of vascular associated smooth muscle cell proliferation [GO:1904706]; neuron migration [GO:0001764]; positive regulation of circadian rhythm [GO:0042753]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; regulation of testosterone biosynthetic process [GO:2000224]; regulation of vascular permeability [GO:0043114]; relaxation of vascular associated smooth muscle [GO:0060087]; signal transduction [GO:0007165]; spermatid development [GO:0007286] acrosomal vesicle [GO:0001669]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383] ATP binding [GO:0005524]; calcium channel regulator activity [GO:0005246]; cGMP binding [GO:0030553]; cGMP-dependent protein kinase activity [GO:0004692]; identical protein binding [GO:0042802]; mitogen-activated protein kinase p38 binding [GO:0048273]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310] g22195.t2 Q13976 55.09 668 0.0 707.0 sp|Q13976|KGP1_HUMAN cGMP-dependent protein kinase 1 OS=Homo sapiens OX=9606 GN=PRKG1 PE=1 SV=3 KGP1_HUMAN reviewed cGMP-dependent protein kinase 1 (cGK 1) (cGK1) (EC 2.7.11.12) (cGMP-dependent protein kinase I) (cGKI) Homo sapiens (Human) GO:0001669; GO:0001764; GO:0004672; GO:0004692; GO:0005246; GO:0005524; GO:0005654; GO:0005737; GO:0005794; GO:0005829; GO:0005886; GO:0007165; GO:0007204; GO:0007286; GO:0010920; GO:0014050; GO:0016358; GO:0019934; GO:0021549; GO:0030553; GO:0030900; GO:0042383; GO:0042753; GO:0042802; GO:0043114; GO:0048273; GO:0048668; GO:0060087; GO:0061049; GO:0090331; GO:0098868; GO:0106310; GO:1904706; GO:1904753; GO:2000224 bone growth [GO:0098868]; cell growth involved in cardiac muscle cell development [GO:0061049]; cerebellum development [GO:0021549]; cGMP-mediated signaling [GO:0019934]; collateral sprouting [GO:0048668]; dendrite development [GO:0016358]; forebrain development [GO:0030900]; negative regulation of glutamate secretion [GO:0014050]; negative regulation of inositol phosphate biosynthetic process [GO:0010920]; negative regulation of platelet aggregation [GO:0090331]; negative regulation of vascular associated smooth muscle cell migration [GO:1904753]; negative regulation of vascular associated smooth muscle cell proliferation [GO:1904706]; neuron migration [GO:0001764]; positive regulation of circadian rhythm [GO:0042753]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; regulation of testosterone biosynthetic process [GO:2000224]; regulation of vascular permeability [GO:0043114]; relaxation of vascular associated smooth muscle [GO:0060087]; signal transduction [GO:0007165]; spermatid development [GO:0007286] acrosomal vesicle [GO:0001669]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383] ATP binding [GO:0005524]; calcium channel regulator activity [GO:0005246]; cGMP binding [GO:0030553]; cGMP-dependent protein kinase activity [GO:0004692]; identical protein binding [GO:0042802]; mitogen-activated protein kinase p38 binding [GO:0048273]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310] g22196.t1 A4II15 41.558 154 2.8299999999999996e-42 143.0 sp|A4II15|TMA16_XENTR Translation machinery-associated protein 16 OS=Xenopus tropicalis OX=8364 GN=tma16 PE=2 SV=1 g22198.t1 Q14191 43.298 843 0.0 707.0 sp|Q14191|WRN_HUMAN Bifunctional 3'-5' exonuclease/ATP-dependent helicase WRN OS=Homo sapiens OX=9606 GN=WRN PE=1 SV=2 WRN_HUMAN reviewed Bifunctional 3'-5' exonuclease/ATP-dependent helicase WRN (DNA helicase, RecQ-like type 3) (RecQ protein-like 2) (Werner syndrome protein) [Includes: 3'-5' exonuclease (EC 3.1.-.-); ATP-dependent helicase (EC 5.6.2.4) (DNA 3'-5' helicase WRN)] Homo sapiens (Human) GO:0000287; GO:0000400; GO:0000403; GO:0000405; GO:0000723; GO:0000724; GO:0000731; GO:0000781; GO:0003677; GO:0003678; GO:0004527; GO:0005524; GO:0005634; GO:0005654; GO:0005657; GO:0005694; GO:0005730; GO:0005737; GO:0005813; GO:0006259; GO:0006260; GO:0006284; GO:0006298; GO:0006302; GO:0006974; GO:0006979; GO:0008340; GO:0008408; GO:0009267; GO:0009378; GO:0010225; GO:0016607; GO:0016887; GO:0030145; GO:0031297; GO:0032201; GO:0032392; GO:0032405; GO:0040009; GO:0042803; GO:0043138; GO:0044877; GO:0051345; GO:0051880; GO:0061749; GO:0061820; GO:0061821; GO:0061849; GO:0070337; GO:0071480; GO:0090398; GO:0090399; GO:0090656; GO:0098530; GO:1902570; GO:1905773 base-excision repair [GO:0006284]; cellular response to gamma radiation [GO:0071480]; cellular response to starvation [GO:0009267]; cellular senescence [GO:0090398]; determination of adult lifespan [GO:0008340]; DNA damage response [GO:0006974]; DNA geometric change [GO:0032392]; DNA metabolic process [GO:0006259]; DNA replication [GO:0006260]; DNA synthesis involved in DNA repair [GO:0000731]; double-strand break repair [GO:0006302]; double-strand break repair via homologous recombination [GO:0000724]; mismatch repair [GO:0006298]; positive regulation of hydrolase activity [GO:0051345]; positive regulation of strand invasion [GO:0098530]; protein localization to nucleolus [GO:1902570]; regulation of growth rate [GO:0040009]; replication fork processing [GO:0031297]; replicative senescence [GO:0090399]; response to oxidative stress [GO:0006979]; response to UV-C [GO:0010225]; t-circle formation [GO:0090656]; telomere maintenance [GO:0000723]; telomere maintenance via semi-conservative replication [GO:0032201]; telomeric D-loop disassembly [GO:0061820] centrosome [GO:0005813]; chromosome [GO:0005694]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; replication fork [GO:0005657] 3'-5' DNA helicase activity [GO:0043138]; 3'-5' exonuclease activity [GO:0008408]; 3'-flap-structured DNA binding [GO:0070337]; 8-hydroxy-2'-deoxyguanosine DNA binding [GO:1905773]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; bubble DNA binding [GO:0000405]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; exonuclease activity [GO:0004527]; forked DNA-dependent helicase activity [GO:0061749]; four-way junction DNA binding [GO:0000400]; four-way junction helicase activity [GO:0009378]; G-quadruplex DNA binding [GO:0051880]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; MutLalpha complex binding [GO:0032405]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; telomeric D-loop binding [GO:0061821]; telomeric G-quadruplex DNA binding [GO:0061849]; Y-form DNA binding [GO:0000403] g22199.t1 Q2PFD7 50.233 430 1.8199999999999998e-134 435.0 sp|Q2PFD7|PSD3_MOUSE PH and SEC7 domain-containing protein 3 OS=Mus musculus OX=10090 GN=Psd3 PE=1 SV=2 PSD3_MOUSE reviewed PH and SEC7 domain-containing protein 3 (Exchange factor for ADP-ribosylation factor guanine nucleotide factor 6 D) (Exchange factor for ARF6 D) (Pleckstrin homology and SEC7 domain-containing protein 3) Mus musculus (Mouse) GO:0005085; GO:0014069; GO:0016020; GO:0032011; GO:0032012; GO:0032587; GO:0098794; GO:0098978 ARF protein signal transduction [GO:0032011]; regulation of ARF protein signal transduction [GO:0032012] glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; ruffle membrane [GO:0032587] guanyl-nucleotide exchange factor activity [GO:0005085] g22199.t2 Q2PFD7 52.195 410 2.22e-138 445.0 sp|Q2PFD7|PSD3_MOUSE PH and SEC7 domain-containing protein 3 OS=Mus musculus OX=10090 GN=Psd3 PE=1 SV=2 PSD3_MOUSE reviewed PH and SEC7 domain-containing protein 3 (Exchange factor for ADP-ribosylation factor guanine nucleotide factor 6 D) (Exchange factor for ARF6 D) (Pleckstrin homology and SEC7 domain-containing protein 3) Mus musculus (Mouse) GO:0005085; GO:0014069; GO:0016020; GO:0032011; GO:0032012; GO:0032587; GO:0098794; GO:0098978 ARF protein signal transduction [GO:0032011]; regulation of ARF protein signal transduction [GO:0032012] glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; ruffle membrane [GO:0032587] guanyl-nucleotide exchange factor activity [GO:0005085] g22204.t2 Q12791 56.851 1124 0.0 1192.0 sp|Q12791|KCMA1_HUMAN Calcium-activated potassium channel subunit alpha-1 OS=Homo sapiens OX=9606 GN=KCNMA1 PE=1 SV=2 g22204.t3 Q12791 59.306 1037 0.0 1158.0 sp|Q12791|KCMA1_HUMAN Calcium-activated potassium channel subunit alpha-1 OS=Homo sapiens OX=9606 GN=KCNMA1 PE=1 SV=2 g22204.t4 Q12791 58.12 1053 0.0 1145.0 sp|Q12791|KCMA1_HUMAN Calcium-activated potassium channel subunit alpha-1 OS=Homo sapiens OX=9606 GN=KCNMA1 PE=1 SV=2 g22204.t5 Q12791 56.917 1077 0.0 1136.0 sp|Q12791|KCMA1_HUMAN Calcium-activated potassium channel subunit alpha-1 OS=Homo sapiens OX=9606 GN=KCNMA1 PE=1 SV=2 g22204.t6 Q90ZC7 65.963 379 7.500000000000001e-156 481.0 sp|Q90ZC7|KCMA1_XENLA Calcium-activated potassium channel subunit alpha-1 OS=Xenopus laevis OX=8355 GN=kcnma1 PE=2 SV=1 KCMA1_XENLA reviewed Calcium-activated potassium channel subunit alpha-1 (BK channel) (BKCA alpha) (Calcium-activated potassium channel, subfamily M subunit alpha-1) (K(VCA)alpha) (KCa1.1) (Maxi K channel) (MaxiK) (Slo-alpha) (Slo1) (Slowpoke homolog) (Slo homolog) (xSlo) Xenopus laevis (African clawed frog) GO:0034702; GO:0045211; GO:0046872; GO:0060072; GO:0071805 potassium ion transmembrane transport [GO:0071805] monoatomic ion channel complex [GO:0034702]; postsynaptic membrane [GO:0045211] large conductance calcium-activated potassium channel activity [GO:0060072]; metal ion binding [GO:0046872] g22207.t1 Q5ZIM5 69.231 364 0.0 543.0 sp|Q5ZIM5|MAP1_CHICK Methionine aminopeptidase 1 OS=Gallus gallus OX=9031 GN=METAP1 PE=2 SV=1 MAP1_CHICK reviewed Methionine aminopeptidase 1 (MAP 1) (MetAP 1) (EC 3.4.11.18) (Peptidase M 1) Gallus gallus (Chicken) GO:0004239; GO:0005829; GO:0006508; GO:0008270; GO:0070006 proteolysis [GO:0006508] cytosol [GO:0005829] initiator methionyl aminopeptidase activity [GO:0004239]; metalloaminopeptidase activity [GO:0070006]; zinc ion binding [GO:0008270] g22208.t1 Q3ZC42 62.881 361 1.62e-161 459.0 sp|Q3ZC42|ADHX_BOVIN Alcohol dehydrogenase class-3 OS=Bos taurus OX=9913 GN=ADH5 PE=2 SV=1 ADHX_BOVIN reviewed Alcohol dehydrogenase class-3 (EC 1.1.1.1) (Alcohol dehydrogenase 5) (Alcohol dehydrogenase class-III) (Glutathione-dependent formaldehyde dehydrogenase) (FALDH) (FDH) (GSH-FDH) (EC 1.1.1.-) (S-(hydroxymethyl)glutathione dehydrogenase) (EC 1.1.1.284) Bos taurus (Bovine) GO:0001523; GO:0003016; GO:0004022; GO:0005504; GO:0005739; GO:0005829; GO:0008270; GO:0010430; GO:0018467; GO:0032496; GO:0042802; GO:0045777; GO:0046294; GO:0051409; GO:0051775; GO:0051903; GO:0080007; GO:0106321; GO:0106322 fatty acid omega-oxidation [GO:0010430]; formaldehyde catabolic process [GO:0046294]; positive regulation of blood pressure [GO:0045777]; respiratory system process [GO:0003016]; response to lipopolysaccharide [GO:0032496]; response to nitrosative stress [GO:0051409]; response to redox state [GO:0051775]; retinoid metabolic process [GO:0001523] cytosol [GO:0005829]; mitochondrion [GO:0005739] alcohol dehydrogenase (NAD+) activity [GO:0004022]; fatty acid binding [GO:0005504]; formaldehyde dehydrogenase (NAD+) activity [GO:0018467]; identical protein binding [GO:0042802]; S-(hydroxymethyl)glutathione dehydrogenase (NAD+) activity [GO:0106322]; S-(hydroxymethyl)glutathione dehydrogenase (NADP+) activity [GO:0106321]; S-(hydroxymethyl)glutathione dehydrogenase [NAD(P)+] activity [GO:0051903]; S-nitrosoglutathione reductase (NADH) activity [GO:0080007]; zinc ion binding [GO:0008270] g22210.t1 Q99NI4 46.93 228 4.16e-63 214.0 sp|Q99NI4|IPMK_RAT Inositol polyphosphate multikinase OS=Rattus norvegicus OX=10116 GN=Ipmk PE=1 SV=1 IPMK_RAT reviewed Inositol polyphosphate multikinase (EC 2.7.1.140) (EC 2.7.1.151) (EC 2.7.1.153) (Inositol 1,3,4,6-tetrakisphosphate 5-kinase) Rattus norvegicus (Rat) GO:0000823; GO:0000824; GO:0000825; GO:0001841; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0008440; GO:0032957; GO:0032958; GO:0036064; GO:0046488; GO:0046872; GO:0046934; GO:0047326; GO:0051765; GO:0070266; GO:0097243 inositol phosphate biosynthetic process [GO:0032958]; inositol trisphosphate metabolic process [GO:0032957]; necroptotic process [GO:0070266]; neural tube formation [GO:0001841]; phosphatidylinositol metabolic process [GO:0046488] ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] 1-phosphatidylinositol-4,5-bisphosphate 3-kinase activity [GO:0046934]; ATP binding [GO:0005524]; flavonoid binding [GO:0097243]; inositol tetrakisphosphate kinase activity [GO:0051765]; inositol-1,3,4,5-tetrakisphosphate 6-kinase activity [GO:0000825]; inositol-1,3,4,6-tetrakisphosphate 5-kinase activity [GO:0047326]; inositol-1,4,5,6-tetrakisphosphate 3-kinase activity [GO:0000824]; inositol-1,4,5-trisphosphate 3-kinase activity [GO:0008440]; inositol-1,4,5-trisphosphate 6-kinase activity [GO:0000823]; metal ion binding [GO:0046872] g22211.t1 Q9NR30 51.439 556 4.01e-178 531.0 sp|Q9NR30|DDX21_HUMAN Nucleolar RNA helicase 2 OS=Homo sapiens OX=9606 GN=DDX21 PE=1 SV=5 DDX21_HUMAN reviewed Nucleolar RNA helicase 2 (EC 3.6.4.13) (DEAD box protein 21) (Gu-alpha) (Nucleolar RNA helicase Gu) (Nucleolar RNA helicase II) (RH II/Gu) Homo sapiens (Human) GO:0001649; GO:0002735; GO:0003723; GO:0003724; GO:0003725; GO:0003729; GO:0005524; GO:0005654; GO:0005694; GO:0005730; GO:0005739; GO:0005829; GO:0006338; GO:0006364; GO:0006366; GO:0016020; GO:0016479; GO:0016887; GO:0019843; GO:0030515; GO:0035198; GO:0042802; GO:0043123; GO:0043330; GO:0045087; GO:0045943; GO:0045944; GO:0045945; GO:0051607; GO:0062176; GO:0097322; GO:0110016; GO:0140870 chromatin remodeling [GO:0006338]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; negative regulation of transcription by RNA polymerase I [GO:0016479]; osteoblast differentiation [GO:0001649]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of myeloid dendritic cell cytokine production [GO:0002735]; positive regulation of transcription by RNA polymerase I [GO:0045943]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription by RNA polymerase III [GO:0045945]; R-loop processing [GO:0062176]; response to exogenous dsRNA [GO:0043330]; rRNA processing [GO:0006364]; transcription by RNA polymerase II [GO:0006366] B-WICH complex [GO:0110016]; chromosome [GO:0005694]; cytosol [GO:0005829]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654] 7SK snRNA binding [GO:0097322]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; double-stranded RNA binding [GO:0003725]; identical protein binding [GO:0042802]; miRNA binding [GO:0035198]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; RNA polymerase inhibitor activity [GO:0140870]; rRNA binding [GO:0019843]; snoRNA binding [GO:0030515] g22212.t1 P14316 57.5 120 4.9600000000000005e-43 157.0 sp|P14316|IRF2_HUMAN Interferon regulatory factor 2 OS=Homo sapiens OX=9606 GN=IRF2 PE=1 SV=2 IRF2_HUMAN reviewed Interferon regulatory factor 2 (IRF-2) Homo sapiens (Human) GO:0000122; GO:0000785; GO:0000977; GO:0000978; GO:0000981; GO:0001228; GO:0002376; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0005829; GO:0005925; GO:0006355; GO:0006357; GO:0008283; GO:0032480; GO:0034138; GO:0043565; GO:0045944; GO:0051607; GO:1990837 cell population proliferation [GO:0008283]; defense response to virus [GO:0051607]; immune system process [GO:0002376]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of type I interferon production [GO:0032480]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA-templated transcription [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; toll-like receptor 3 signaling pathway [GO:0034138] chromatin [GO:0000785]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837] g22214.t1 Q66KB9 61.667 120 4.4700000000000005e-35 122.0 sp|Q66KB9|BL1S2_XENTR Biogenesis of lysosome-related organelles complex 1 subunit 2 OS=Xenopus tropicalis OX=8364 GN=bloc1s2 PE=2 SV=1 g22215.t1 Q7ZVE0 69.565 92 5.93e-39 137.0 sp|Q7ZVE0|GAR1_DANRE H/ACA ribonucleoprotein complex subunit 1 OS=Danio rerio OX=7955 GN=gar1 PE=2 SV=1 g22217.t1 P25931 38.506 348 5.2800000000000006e-73 238.0 sp|P25931|RYAR_DROME RYamide receptor OS=Drosophila melanogaster OX=7227 GN=RYa-R PE=2 SV=2 g22219.t1 G3V9H8 61.111 252 1.65e-89 311.0 sp|G3V9H8|RET_RAT Proto-oncogene tyrosine-protein kinase receptor Ret OS=Rattus norvegicus OX=10116 GN=Ret PE=1 SV=1 RET_RAT reviewed Proto-oncogene tyrosine-protein kinase receptor Ret (EC 2.7.10.1) [Cleaved into: Soluble RET kinase fragment; Extracellular cell-membrane anchored RET cadherin 120 kDa fragment] Rattus norvegicus (Rat) GO:0000165; GO:0001657; GO:0001755; GO:0001838; GO:0004714; GO:0005509; GO:0005524; GO:0005769; GO:0005886; GO:0007156; GO:0007158; GO:0007169; GO:0007399; GO:0009410; GO:0010008; GO:0010628; GO:0010976; GO:0014042; GO:0030155; GO:0030182; GO:0030335; GO:0030424; GO:0030425; GO:0033619; GO:0033630; GO:0035799; GO:0035860; GO:0042551; GO:0043025; GO:0043235; GO:0043410; GO:0045793; GO:0045893; GO:0048265; GO:0048484; GO:0050770; GO:0051897; GO:0060041; GO:0060384; GO:0061146; GO:0071300; GO:0072300; GO:0098797; GO:0160144; GO:1904894; GO:2001241 cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; cellular response to retinoic acid [GO:0071300]; embryonic epithelial tube formation [GO:0001838]; enteric nervous system development [GO:0048484]; GDF15-GFRAL signaling pathway [GO:0160144]; glial cell-derived neurotrophic factor receptor signaling pathway [GO:0035860]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; innervation [GO:0060384]; MAPK cascade [GO:0000165]; membrane protein proteolysis [GO:0033619]; nervous system development [GO:0007399]; neural crest cell migration [GO:0001755]; neuron cell-cell adhesion [GO:0007158]; neuron differentiation [GO:0030182]; neuron maturation [GO:0042551]; Peyer's patch morphogenesis [GO:0061146]; positive regulation of cell adhesion mediated by integrin [GO:0033630]; positive regulation of cell migration [GO:0030335]; positive regulation of cell size [GO:0045793]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001241]; positive regulation of gene expression [GO:0010628]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of metanephric glomerulus development [GO:0072300]; positive regulation of neuron maturation [GO:0014042]; positive regulation of neuron projection development [GO:0010976]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of receptor signaling pathway via STAT [GO:1904894]; regulation of axonogenesis [GO:0050770]; regulation of cell adhesion [GO:0030155]; response to pain [GO:0048265]; response to xenobiotic stimulus [GO:0009410]; retina development in camera-type eye [GO:0060041]; ureter maturation [GO:0035799]; ureteric bud development [GO:0001657] axon [GO:0030424]; dendrite [GO:0030425]; early endosome [GO:0005769]; endosome membrane [GO:0010008]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; plasma membrane protein complex [GO:0098797]; receptor complex [GO:0043235] ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; transmembrane receptor protein tyrosine kinase activity [GO:0004714] g22220.t1 Q9MYM7 49.635 274 1.19e-96 296.0 sp|Q9MYM7|B3GT1_PONPY Beta-1,3-galactosyltransferase 1 OS=Pongo pygmaeus OX=9600 GN=B3GALT1 PE=3 SV=1 g22221.t1 Q9MYM7 47.183 284 8.059999999999999e-91 281.0 sp|Q9MYM7|B3GT1_PONPY Beta-1,3-galactosyltransferase 1 OS=Pongo pygmaeus OX=9600 GN=B3GALT1 PE=3 SV=1 g22223.t1 Q99068 28.852 305 2.0500000000000002e-26 111.0 sp|Q99068|AMRP_RAT Alpha-2-macroglobulin receptor-associated protein OS=Rattus norvegicus OX=10116 GN=Lrpap1 PE=1 SV=2 g22226.t1 Q9QYP1 33.04 681 4.02e-109 378.0 sp|Q9QYP1|LRP4_RAT Low-density lipoprotein receptor-related protein 4 OS=Rattus norvegicus OX=10116 GN=Lrp4 PE=1 SV=2 LRP4_RAT reviewed Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7) Rattus norvegicus (Rat) GO:0001822; GO:0001942; GO:0005509; GO:0005886; GO:0006897; GO:0007167; GO:0008104; GO:0009953; GO:0009954; GO:0009986; GO:0014069; GO:0015026; GO:0016055; GO:0016601; GO:0030279; GO:0030326; GO:0030425; GO:0030971; GO:0031594; GO:0034185; GO:0035022; GO:0042475; GO:0042733; GO:0042803; GO:0043025; GO:0043113; GO:0044853; GO:0045202; GO:0048699; GO:0048813; GO:0050771; GO:0050808; GO:0051124; GO:0060173; GO:0071340; GO:0090090; GO:0097060; GO:0097104; GO:0097105; GO:0097110; GO:0150052; GO:0150094; GO:1901631; GO:1904395 amyloid-beta clearance by cellular catabolic process [GO:0150094]; dendrite morphogenesis [GO:0048813]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; embryonic limb morphogenesis [GO:0030326]; endocytosis [GO:0006897]; enzyme-linked receptor protein signaling pathway [GO:0007167]; generation of neurons [GO:0048699]; hair follicle development [GO:0001942]; intracellular protein localization [GO:0008104]; kidney development [GO:0001822]; limb development [GO:0060173]; negative regulation of axonogenesis [GO:0050771]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of ossification [GO:0030279]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of presynaptic membrane organization [GO:1901631]; positive regulation of Rac protein signal transduction [GO:0035022]; positive regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904395]; postsynaptic membrane assembly [GO:0097104]; presynaptic membrane assembly [GO:0097105]; proximal/distal pattern formation [GO:0009954]; Rac protein signal transduction [GO:0016601]; receptor clustering [GO:0043113]; regulation of postsynapse assembly [GO:0150052]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; synapse organization [GO:0050808]; synaptic assembly at neuromuscular junction [GO:0051124]; Wnt signaling pathway [GO:0016055] cell surface [GO:0009986]; dendrite [GO:0030425]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic density [GO:0014069]; synapse [GO:0045202]; synaptic membrane [GO:0097060] apolipoprotein binding [GO:0034185]; calcium ion binding [GO:0005509]; coreceptor activity [GO:0015026]; protein homodimerization activity [GO:0042803]; receptor tyrosine kinase binding [GO:0030971]; scaffold protein binding [GO:0097110] g22226.t1 Q9QYP1 28.0 650 3.37e-78 285.0 sp|Q9QYP1|LRP4_RAT Low-density lipoprotein receptor-related protein 4 OS=Rattus norvegicus OX=10116 GN=Lrp4 PE=1 SV=2 LRP4_RAT reviewed Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7) Rattus norvegicus (Rat) GO:0001822; GO:0001942; GO:0005509; GO:0005886; GO:0006897; GO:0007167; GO:0008104; GO:0009953; GO:0009954; GO:0009986; GO:0014069; GO:0015026; GO:0016055; GO:0016601; GO:0030279; GO:0030326; GO:0030425; GO:0030971; GO:0031594; GO:0034185; GO:0035022; GO:0042475; GO:0042733; GO:0042803; GO:0043025; GO:0043113; GO:0044853; GO:0045202; GO:0048699; GO:0048813; GO:0050771; GO:0050808; GO:0051124; GO:0060173; GO:0071340; GO:0090090; GO:0097060; GO:0097104; GO:0097105; GO:0097110; GO:0150052; GO:0150094; GO:1901631; GO:1904395 amyloid-beta clearance by cellular catabolic process [GO:0150094]; dendrite morphogenesis [GO:0048813]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; embryonic limb morphogenesis [GO:0030326]; endocytosis [GO:0006897]; enzyme-linked receptor protein signaling pathway [GO:0007167]; generation of neurons [GO:0048699]; hair follicle development [GO:0001942]; intracellular protein localization [GO:0008104]; kidney development [GO:0001822]; limb development [GO:0060173]; negative regulation of axonogenesis [GO:0050771]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of ossification [GO:0030279]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of presynaptic membrane organization [GO:1901631]; positive regulation of Rac protein signal transduction [GO:0035022]; positive regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904395]; postsynaptic membrane assembly [GO:0097104]; presynaptic membrane assembly [GO:0097105]; proximal/distal pattern formation [GO:0009954]; Rac protein signal transduction [GO:0016601]; receptor clustering [GO:0043113]; regulation of postsynapse assembly [GO:0150052]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; synapse organization [GO:0050808]; synaptic assembly at neuromuscular junction [GO:0051124]; Wnt signaling pathway [GO:0016055] cell surface [GO:0009986]; dendrite [GO:0030425]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic density [GO:0014069]; synapse [GO:0045202]; synaptic membrane [GO:0097060] apolipoprotein binding [GO:0034185]; calcium ion binding [GO:0005509]; coreceptor activity [GO:0015026]; protein homodimerization activity [GO:0042803]; receptor tyrosine kinase binding [GO:0030971]; scaffold protein binding [GO:0097110] g22226.t1 Q9QYP1 29.107 560 2.67e-71 264.0 sp|Q9QYP1|LRP4_RAT Low-density lipoprotein receptor-related protein 4 OS=Rattus norvegicus OX=10116 GN=Lrp4 PE=1 SV=2 LRP4_RAT reviewed Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7) Rattus norvegicus (Rat) GO:0001822; GO:0001942; GO:0005509; GO:0005886; GO:0006897; GO:0007167; GO:0008104; GO:0009953; GO:0009954; GO:0009986; GO:0014069; GO:0015026; GO:0016055; GO:0016601; GO:0030279; GO:0030326; GO:0030425; GO:0030971; GO:0031594; GO:0034185; GO:0035022; GO:0042475; GO:0042733; GO:0042803; GO:0043025; GO:0043113; GO:0044853; GO:0045202; GO:0048699; GO:0048813; GO:0050771; GO:0050808; GO:0051124; GO:0060173; GO:0071340; GO:0090090; GO:0097060; GO:0097104; GO:0097105; GO:0097110; GO:0150052; GO:0150094; GO:1901631; GO:1904395 amyloid-beta clearance by cellular catabolic process [GO:0150094]; dendrite morphogenesis [GO:0048813]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; embryonic limb morphogenesis [GO:0030326]; endocytosis [GO:0006897]; enzyme-linked receptor protein signaling pathway [GO:0007167]; generation of neurons [GO:0048699]; hair follicle development [GO:0001942]; intracellular protein localization [GO:0008104]; kidney development [GO:0001822]; limb development [GO:0060173]; negative regulation of axonogenesis [GO:0050771]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of ossification [GO:0030279]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of presynaptic membrane organization [GO:1901631]; positive regulation of Rac protein signal transduction [GO:0035022]; positive regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904395]; postsynaptic membrane assembly [GO:0097104]; presynaptic membrane assembly [GO:0097105]; proximal/distal pattern formation [GO:0009954]; Rac protein signal transduction [GO:0016601]; receptor clustering [GO:0043113]; regulation of postsynapse assembly [GO:0150052]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; synapse organization [GO:0050808]; synaptic assembly at neuromuscular junction [GO:0051124]; Wnt signaling pathway [GO:0016055] cell surface [GO:0009986]; dendrite [GO:0030425]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic density [GO:0014069]; synapse [GO:0045202]; synaptic membrane [GO:0097060] apolipoprotein binding [GO:0034185]; calcium ion binding [GO:0005509]; coreceptor activity [GO:0015026]; protein homodimerization activity [GO:0042803]; receptor tyrosine kinase binding [GO:0030971]; scaffold protein binding [GO:0097110] g22226.t1 Q9QYP1 30.872 298 3.54e-34 146.0 sp|Q9QYP1|LRP4_RAT Low-density lipoprotein receptor-related protein 4 OS=Rattus norvegicus OX=10116 GN=Lrp4 PE=1 SV=2 LRP4_RAT reviewed Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7) Rattus norvegicus (Rat) GO:0001822; GO:0001942; GO:0005509; GO:0005886; GO:0006897; GO:0007167; GO:0008104; GO:0009953; GO:0009954; GO:0009986; GO:0014069; GO:0015026; GO:0016055; GO:0016601; GO:0030279; GO:0030326; GO:0030425; GO:0030971; GO:0031594; GO:0034185; GO:0035022; GO:0042475; GO:0042733; GO:0042803; GO:0043025; GO:0043113; GO:0044853; GO:0045202; GO:0048699; GO:0048813; GO:0050771; GO:0050808; GO:0051124; GO:0060173; GO:0071340; GO:0090090; GO:0097060; GO:0097104; GO:0097105; GO:0097110; GO:0150052; GO:0150094; GO:1901631; GO:1904395 amyloid-beta clearance by cellular catabolic process [GO:0150094]; dendrite morphogenesis [GO:0048813]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; embryonic limb morphogenesis [GO:0030326]; endocytosis [GO:0006897]; enzyme-linked receptor protein signaling pathway [GO:0007167]; generation of neurons [GO:0048699]; hair follicle development [GO:0001942]; intracellular protein localization [GO:0008104]; kidney development [GO:0001822]; limb development [GO:0060173]; negative regulation of axonogenesis [GO:0050771]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of ossification [GO:0030279]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of presynaptic membrane organization [GO:1901631]; positive regulation of Rac protein signal transduction [GO:0035022]; positive regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904395]; postsynaptic membrane assembly [GO:0097104]; presynaptic membrane assembly [GO:0097105]; proximal/distal pattern formation [GO:0009954]; Rac protein signal transduction [GO:0016601]; receptor clustering [GO:0043113]; regulation of postsynapse assembly [GO:0150052]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; synapse organization [GO:0050808]; synaptic assembly at neuromuscular junction [GO:0051124]; Wnt signaling pathway [GO:0016055] cell surface [GO:0009986]; dendrite [GO:0030425]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic density [GO:0014069]; synapse [GO:0045202]; synaptic membrane [GO:0097060] apolipoprotein binding [GO:0034185]; calcium ion binding [GO:0005509]; coreceptor activity [GO:0015026]; protein homodimerization activity [GO:0042803]; receptor tyrosine kinase binding [GO:0030971]; scaffold protein binding [GO:0097110] g22227.t1 Q5D016 57.724 123 4.84e-44 143.0 sp|Q5D016|PFD1_DANRE Prefoldin subunit 1 OS=Danio rerio OX=7955 GN=pfdn1 PE=2 SV=1 g22228.t1 Q6IVV8 54.144 748 0.0 766.0 sp|Q6IVV8|PKD2_DANRE Polycystin-2 OS=Danio rerio OX=7955 GN=pkd2 PE=1 SV=1 PKD2_DANRE reviewed Polycystin-2 (Curly up) (Cup) (Polycystic kidney disease 2 protein homolog) (Transient receptor potential cation channel subfamily P member 2) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001822; GO:0001946; GO:0001947; GO:0003143; GO:0003146; GO:0003171; GO:0003173; GO:0005102; GO:0005245; GO:0005248; GO:0005261; GO:0005262; GO:0005267; GO:0005509; GO:0005783; GO:0005886; GO:0005929; GO:0007166; GO:0007368; GO:0007507; GO:0009953; GO:0010882; GO:0015271; GO:0016020; GO:0016323; GO:0016324; GO:0016328; GO:0030017; GO:0030659; GO:0032965; GO:0033017; GO:0034703; GO:0042383; GO:0048793; GO:0050982; GO:0051209; GO:0051262; GO:0051284; GO:0051290; GO:0051371; GO:0060271; GO:0060972; GO:0061371; GO:0065003; GO:0070121; GO:0070588; GO:0071277; GO:0071805; GO:0072019; GO:0072114; GO:0097704; GO:0098662 atrioventricular valve development [GO:0003171]; calcium ion transmembrane transport [GO:0070588]; cell surface receptor signaling pathway [GO:0007166]; cellular response to calcium ion [GO:0071277]; cellular response to oscillatory fluid shear stress [GO:0097704]; cilium assembly [GO:0060271]; detection of mechanical stimulus [GO:0050982]; determination of heart left/right asymmetry [GO:0061371]; determination of left/right symmetry [GO:0007368]; dorsal/ventral pattern formation [GO:0009953]; embryonic heart tube morphogenesis [GO:0003143]; heart development [GO:0007507]; heart jogging [GO:0003146]; heart looping [GO:0001947]; inorganic cation transmembrane transport [GO:0098662]; kidney development [GO:0001822]; Kupffer's vesicle development [GO:0070121]; left/right pattern formation [GO:0060972]; lymphangiogenesis [GO:0001946]; positive regulation of sequestering of calcium ion [GO:0051284]; potassium ion transmembrane transport [GO:0071805]; pronephros development [GO:0048793]; pronephros morphogenesis [GO:0072114]; protein heterotetramerization [GO:0051290]; protein tetramerization [GO:0051262]; protein-containing complex assembly [GO:0065003]; proximal convoluted tubule development [GO:0072019]; regulation of cardiac muscle contraction by calcium ion signaling [GO:0010882]; regulation of collagen biosynthetic process [GO:0032965]; release of sequestered calcium ion into cytosol [GO:0051209]; ventriculo bulbo valve development [GO:0003173] apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cation channel complex [GO:0034703]; cilium [GO:0005929]; cytoplasmic vesicle membrane [GO:0030659]; endoplasmic reticulum [GO:0005783]; lateral plasma membrane [GO:0016328]; membrane [GO:0016020]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; sarcomere [GO:0030017]; sarcoplasmic reticulum membrane [GO:0033017] calcium channel activity [GO:0005262]; calcium ion binding [GO:0005509]; monoatomic cation channel activity [GO:0005261]; muscle alpha-actinin binding [GO:0051371]; outward rectifier potassium channel activity [GO:0015271]; potassium channel activity [GO:0005267]; signaling receptor binding [GO:0005102]; voltage-gated calcium channel activity [GO:0005245]; voltage-gated sodium channel activity [GO:0005248] g22229.t1 B2RQL2 38.621 145 2.26e-28 113.0 sp|B2RQL2|STOX1_MOUSE Storkhead-box protein 1 OS=Mus musculus OX=10090 GN=Stox1 PE=1 SV=1 STOX1_MOUSE reviewed Storkhead-box protein 1 Mus musculus (Mouse) GO:0000977; GO:0001650; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005938; GO:0006357; GO:0007346; GO:0010468; GO:0010628; GO:0010629; GO:0010821; GO:0010971; GO:0045787; GO:0048839; GO:0051301; GO:0051881; GO:0051897; GO:0071500; GO:1900087; GO:1901858; GO:1902882; GO:1904120 cell division [GO:0051301]; cellular response to nitrosative stress [GO:0071500]; inner ear development [GO:0048839]; negative regulation of gene expression [GO:0010629]; positive regulation of cell cycle [GO:0045787]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of gene expression [GO:0010628]; positive regulation of otic vesicle morphogenesis [GO:1904120]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; regulation of gene expression [GO:0010468]; regulation of mitochondrial DNA metabolic process [GO:1901858]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of mitochondrion organization [GO:0010821]; regulation of mitotic cell cycle [GO:0007346]; regulation of response to oxidative stress [GO:1902882]; regulation of transcription by RNA polymerase II [GO:0006357] cell cortex [GO:0005938]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977] g22234.t1 O62471 33.99 203 3.4e-25 105.0 sp|O62471|QUI1_CAEEL Protein qui-1 OS=Caenorhabditis elegans OX=6239 GN=qui-1 PE=1 SV=2 g22234.t2 O62471 38.356 146 2.89e-25 107.0 sp|O62471|QUI1_CAEEL Protein qui-1 OS=Caenorhabditis elegans OX=6239 GN=qui-1 PE=1 SV=2 g22235.t1 A6H603 24.823 1269 3.8e-74 275.0 sp|A6H603|NWD1_MOUSE NACHT domain- and WD repeat-containing protein 1 OS=Mus musculus OX=10090 GN=Nwd1 PE=2 SV=2 g22237.t1 Q07175 47.773 741 0.0 666.0 sp|Q07175|VKGC_BOVIN Vitamin K-dependent gamma-carboxylase OS=Bos taurus OX=9913 GN=GGCX PE=1 SV=1 g22243.t1 Q7ZWN6 29.961 514 1.41e-26 116.0 sp|Q7ZWN6|Z703A_XENLA Zinc finger protein 703-A OS=Xenopus laevis OX=8355 GN=znf703-a PE=2 SV=2 Z703A_XENLA reviewed Zinc finger protein 703-A Xenopus laevis (African clawed frog) GO:0005634; GO:0005737; GO:0008270; GO:0016363; GO:0017015; GO:0030335; GO:0034111; GO:0034333; GO:0045892; GO:0051726; GO:0060828 adherens junction assembly [GO:0034333]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of homotypic cell-cell adhesion [GO:0034111]; positive regulation of cell migration [GO:0030335]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of cell cycle [GO:0051726]; regulation of transforming growth factor beta receptor signaling pathway [GO:0017015] cytoplasm [GO:0005737]; nuclear matrix [GO:0016363]; nucleus [GO:0005634] zinc ion binding [GO:0008270] g22248.t1 Q6DFZ1 50.625 1600 0.0 1334.0 sp|Q6DFZ1|GBF1_MOUSE Golgi-specific brefeldin A-resistance guanine nucleotide exchange factor 1 OS=Mus musculus OX=10090 GN=Gbf1 PE=1 SV=1 GBF1_MOUSE reviewed Golgi-specific brefeldin A-resistance guanine nucleotide exchange factor 1 (BFA-resistant GEF 1) Mus musculus (Mouse) GO:0000139; GO:0002263; GO:0005085; GO:0005547; GO:0005777; GO:0005788; GO:0005793; GO:0005794; GO:0005795; GO:0005801; GO:0005802; GO:0005811; GO:0005829; GO:0006890; GO:0006895; GO:0007030; GO:0007346; GO:0015031; GO:0030593; GO:0031252; GO:0032012; GO:0034067; GO:0042147; GO:0048205; GO:0061162; GO:0070973; GO:0080025; GO:0090166; GO:0097111; GO:0098586; GO:1903409; GO:1903420; GO:2000008 cell activation involved in immune response [GO:0002263]; cellular response to virus [GO:0098586]; COPI coating of Golgi vesicle [GO:0048205]; endoplasmic reticulum-Golgi intermediate compartment organization [GO:0097111]; establishment of monopolar cell polarity [GO:0061162]; Golgi disassembly [GO:0090166]; Golgi organization [GO:0007030]; Golgi to endosome transport [GO:0006895]; neutrophil chemotaxis [GO:0030593]; protein localization to endoplasmic reticulum exit site [GO:0070973]; protein localization to endoplasmic reticulum tubular network [GO:1903420]; protein localization to Golgi apparatus [GO:0034067]; protein transport [GO:0015031]; reactive oxygen species biosynthetic process [GO:1903409]; regulation of ARF protein signal transduction [GO:0032012]; regulation of mitotic cell cycle [GO:0007346]; regulation of protein localization to cell surface [GO:2000008]; retrograde transport, endosome to Golgi [GO:0042147]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890] cell leading edge [GO:0031252]; cis-Golgi network [GO:0005801]; cytosol [GO:0005829]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; lipid droplet [GO:0005811]; peroxisome [GO:0005777]; trans-Golgi network [GO:0005802] guanyl-nucleotide exchange factor activity [GO:0005085]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025] g22248.t1 Q6DFZ1 74.429 219 8.41e-95 345.0 sp|Q6DFZ1|GBF1_MOUSE Golgi-specific brefeldin A-resistance guanine nucleotide exchange factor 1 OS=Mus musculus OX=10090 GN=Gbf1 PE=1 SV=1 GBF1_MOUSE reviewed Golgi-specific brefeldin A-resistance guanine nucleotide exchange factor 1 (BFA-resistant GEF 1) Mus musculus (Mouse) GO:0000139; GO:0002263; GO:0005085; GO:0005547; GO:0005777; GO:0005788; GO:0005793; GO:0005794; GO:0005795; GO:0005801; GO:0005802; GO:0005811; GO:0005829; GO:0006890; GO:0006895; GO:0007030; GO:0007346; GO:0015031; GO:0030593; GO:0031252; GO:0032012; GO:0034067; GO:0042147; GO:0048205; GO:0061162; GO:0070973; GO:0080025; GO:0090166; GO:0097111; GO:0098586; GO:1903409; GO:1903420; GO:2000008 cell activation involved in immune response [GO:0002263]; cellular response to virus [GO:0098586]; COPI coating of Golgi vesicle [GO:0048205]; endoplasmic reticulum-Golgi intermediate compartment organization [GO:0097111]; establishment of monopolar cell polarity [GO:0061162]; Golgi disassembly [GO:0090166]; Golgi organization [GO:0007030]; Golgi to endosome transport [GO:0006895]; neutrophil chemotaxis [GO:0030593]; protein localization to endoplasmic reticulum exit site [GO:0070973]; protein localization to endoplasmic reticulum tubular network [GO:1903420]; protein localization to Golgi apparatus [GO:0034067]; protein transport [GO:0015031]; reactive oxygen species biosynthetic process [GO:1903409]; regulation of ARF protein signal transduction [GO:0032012]; regulation of mitotic cell cycle [GO:0007346]; regulation of protein localization to cell surface [GO:2000008]; retrograde transport, endosome to Golgi [GO:0042147]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890] cell leading edge [GO:0031252]; cis-Golgi network [GO:0005801]; cytosol [GO:0005829]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; lipid droplet [GO:0005811]; peroxisome [GO:0005777]; trans-Golgi network [GO:0005802] guanyl-nucleotide exchange factor activity [GO:0005085]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025] g22250.t1 P27012 36.792 212 3.22e-43 147.0 sp|P27012|SCRY4_ENTDO S-crystallin 4 OS=Enteroctopus dofleini OX=267067 PE=2 SV=1 g22252.t1 O73888 42.857 203 2.1e-45 152.0 sp|O73888|HPGDS_CHICK Hematopoietic prostaglandin D synthase OS=Gallus gallus OX=9031 GN=HPGDS PE=1 SV=3 g22253.t1 A0JNB1 45.337 386 4.49e-115 362.0 sp|A0JNB1|ZN227_BOVIN Zinc finger protein 227 OS=Bos taurus OX=9913 GN=ZNF227 PE=2 SV=1 g22253.t1 A0JNB1 37.991 458 1.22e-97 316.0 sp|A0JNB1|ZN227_BOVIN Zinc finger protein 227 OS=Bos taurus OX=9913 GN=ZNF227 PE=2 SV=1 g22253.t1 A0JNB1 42.782 381 1.87e-96 313.0 sp|A0JNB1|ZN227_BOVIN Zinc finger protein 227 OS=Bos taurus OX=9913 GN=ZNF227 PE=2 SV=1 g22253.t1 A0JNB1 36.641 393 8.47e-75 255.0 sp|A0JNB1|ZN227_BOVIN Zinc finger protein 227 OS=Bos taurus OX=9913 GN=ZNF227 PE=2 SV=1 g22253.t1 A0JNB1 41.852 270 5.92e-61 218.0 sp|A0JNB1|ZN227_BOVIN Zinc finger protein 227 OS=Bos taurus OX=9913 GN=ZNF227 PE=2 SV=1 g22254.t1 Q5R4G0 51.489 235 7.94e-87 271.0 sp|Q5R4G0|SGPL1_PONAB Sphingosine-1-phosphate lyase 1 OS=Pongo abelii OX=9601 GN=SGPL1 PE=2 SV=1 g22255.t1 Q8CHN6 47.312 279 1.28e-76 247.0 sp|Q8CHN6|SGPL1_RAT Sphingosine-1-phosphate lyase 1 OS=Rattus norvegicus OX=10116 GN=Sgpl1 PE=2 SV=1 SGPL1_RAT reviewed Sphingosine-1-phosphate lyase 1 (S1PL) (SP-lyase 1) (SPL) (SPL 1) (EC 4.1.2.27) (Sphingosine-1-phosphate aldolase) Rattus norvegicus (Rat) GO:0001553; GO:0001570; GO:0001822; GO:0005783; GO:0005789; GO:0006631; GO:0006672; GO:0007283; GO:0008117; GO:0008209; GO:0008210; GO:0008585; GO:0009791; GO:0010761; GO:0030097; GO:0030149; GO:0030170; GO:0033327; GO:0040014; GO:0048008; GO:0048705; GO:0060021; GO:0060325; GO:0097190 androgen metabolic process [GO:0008209]; apoptotic signaling pathway [GO:0097190]; ceramide metabolic process [GO:0006672]; estrogen metabolic process [GO:0008210]; face morphogenesis [GO:0060325]; fatty acid metabolic process [GO:0006631]; female gonad development [GO:0008585]; fibroblast migration [GO:0010761]; hemopoiesis [GO:0030097]; kidney development [GO:0001822]; Leydig cell differentiation [GO:0033327]; luteinization [GO:0001553]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; post-embryonic development [GO:0009791]; regulation of multicellular organism growth [GO:0040014]; roof of mouth development [GO:0060021]; skeletal system morphogenesis [GO:0048705]; spermatogenesis [GO:0007283]; sphingolipid catabolic process [GO:0030149]; vasculogenesis [GO:0001570] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789] pyridoxal phosphate binding [GO:0030170]; sphinganine-1-phosphate aldolase activity [GO:0008117] g22256.t1 Q8JI28 59.731 817 0.0 952.0 sp|Q8JI28|TLL1_XENLA Tolloid-like protein 1 OS=Xenopus laevis OX=8355 GN=tll1 PE=1 SV=1 g22256.t1 Q8JI28 34.206 535 5.09e-85 297.0 sp|Q8JI28|TLL1_XENLA Tolloid-like protein 1 OS=Xenopus laevis OX=8355 GN=tll1 PE=1 SV=1 g22256.t1 Q8JI28 34.383 381 1.08e-66 245.0 sp|Q8JI28|TLL1_XENLA Tolloid-like protein 1 OS=Xenopus laevis OX=8355 GN=tll1 PE=1 SV=1 g22256.t1 Q8JI28 36.889 225 4.0699999999999997e-41 167.0 sp|Q8JI28|TLL1_XENLA Tolloid-like protein 1 OS=Xenopus laevis OX=8355 GN=tll1 PE=1 SV=1 g22257.t1 O57382 48.673 113 2.88e-32 123.0 sp|O57382|TLL2_XENLA Tolloid-like protein 2 OS=Xenopus laevis OX=8355 GN=tll2 PE=2 SV=1 g22259.t1 P80646 37.872 235 1.2e-35 133.0 sp|P80646|CTRB_GADMO Chymotrypsin B OS=Gadus morhua OX=8049 PE=1 SV=1 g22260.t1 P04813 37.121 264 1.28e-45 159.0 sp|P04813|CTR2_CANLF Chymotrypsinogen 2 OS=Canis lupus familiaris OX=9615 GN=CTRB1 PE=2 SV=1 g22261.t1 Q5G271 35.922 206 9.28e-32 129.0 sp|Q5G271|NETR_PANTR Neurotrypsin OS=Pan troglodytes OX=9598 GN=PRSS12 PE=3 SV=1 NETR_PANTR reviewed Neurotrypsin (EC 3.4.21.-) (Serine protease 12) Pan troglodytes (Chimpanzee) GO:0004252; GO:0005886; GO:0006508; GO:0006887; GO:0030424; GO:0030425; GO:0043083; GO:0043195; GO:0098978 exocytosis [GO:0006887]; proteolysis [GO:0006508] axon [GO:0030424]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; synaptic cleft [GO:0043083]; terminal bouton [GO:0043195] serine-type endopeptidase activity [GO:0004252] g22262.t1 C0HKA1 92.857 140 1.3700000000000003e-79 235.0 sp|C0HKA1|RS14B_DROME Small ribosomal subunit protein uS11B OS=Drosophila melanogaster OX=7227 GN=RpS14b PE=2 SV=1 RS14B_DROME reviewed Small ribosomal subunit protein uS11B (40S ribosomal protein S14b) Drosophila melanogaster (Fruit fly) GO:0000028; GO:0002181; GO:0003735; GO:0006412; GO:0022626; GO:0022627 cytoplasmic translation [GO:0002181]; ribosomal small subunit assembly [GO:0000028]; translation [GO:0006412] cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627] structural constituent of ribosome [GO:0003735] g22263.t1 Q3UHH1 60.895 514 0.0 600.0 sp|Q3UHH1|ZSWM8_MOUSE Zinc finger SWIM domain-containing protein 8 OS=Mus musculus OX=10090 GN=Zswim8 PE=1 SV=1 ZSWM8_MOUSE reviewed Zinc finger SWIM domain-containing protein 8 Mus musculus (Mouse) GO:0005829; GO:0006515; GO:0008270; GO:0016567; GO:0031461; GO:0031462; GO:0031463; GO:0043161; GO:0060337; GO:0140958; GO:1990756; GO:2000627 positive regulation of miRNA catabolic process [GO:2000627]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; protein ubiquitination [GO:0016567]; target-directed miRNA degradation [GO:0140958]; type I interferon-mediated signaling pathway [GO:0060337] Cul2-RING ubiquitin ligase complex [GO:0031462]; Cul3-RING ubiquitin ligase complex [GO:0031463]; cullin-RING ubiquitin ligase complex [GO:0031461]; cytosol [GO:0005829] ubiquitin-like ligase-substrate adaptor activity [GO:1990756]; zinc ion binding [GO:0008270] g22263.t1 Q3UHH1 43.354 316 1.14e-57 222.0 sp|Q3UHH1|ZSWM8_MOUSE Zinc finger SWIM domain-containing protein 8 OS=Mus musculus OX=10090 GN=Zswim8 PE=1 SV=1 ZSWM8_MOUSE reviewed Zinc finger SWIM domain-containing protein 8 Mus musculus (Mouse) GO:0005829; GO:0006515; GO:0008270; GO:0016567; GO:0031461; GO:0031462; GO:0031463; GO:0043161; GO:0060337; GO:0140958; GO:1990756; GO:2000627 positive regulation of miRNA catabolic process [GO:2000627]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; protein ubiquitination [GO:0016567]; target-directed miRNA degradation [GO:0140958]; type I interferon-mediated signaling pathway [GO:0060337] Cul2-RING ubiquitin ligase complex [GO:0031462]; Cul3-RING ubiquitin ligase complex [GO:0031463]; cullin-RING ubiquitin ligase complex [GO:0031461]; cytosol [GO:0005829] ubiquitin-like ligase-substrate adaptor activity [GO:1990756]; zinc ion binding [GO:0008270] g22264.t1 A7E305 66.942 242 4.69e-94 322.0 sp|A7E305|ZSWM8_BOVIN Zinc finger SWIM domain-containing protein 8 OS=Bos taurus OX=9913 GN=ZSWIM8 PE=2 SV=1 ZSWM8_BOVIN reviewed Zinc finger SWIM domain-containing protein 8 Bos taurus (Bovine) GO:0005829; GO:0008270; GO:0016567; GO:0031462; GO:0031463; GO:0043161; GO:1990756; GO:2000627 positive regulation of miRNA catabolic process [GO:2000627]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567] Cul2-RING ubiquitin ligase complex [GO:0031462]; Cul3-RING ubiquitin ligase complex [GO:0031463]; cytosol [GO:0005829] ubiquitin-like ligase-substrate adaptor activity [GO:1990756]; zinc ion binding [GO:0008270] g22266.t1 Q5G265 36.757 555 1.11e-87 307.0 sp|Q5G265|NETR_SAGLB Neurotrypsin OS=Saguinus labiatus OX=78454 GN=PRSS12 PE=3 SV=1 NETR_SAGLB reviewed Neurotrypsin (EC 3.4.21.-) (Serine protease 12) Saguinus labiatus (Red-chested mustached tamarin) GO:0004252; GO:0005576; GO:0005886; GO:0006508; GO:0006887; GO:0030424; GO:0098793; GO:0098978 exocytosis [GO:0006887]; proteolysis [GO:0006508] axon [GO:0030424]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; presynapse [GO:0098793] serine-type endopeptidase activity [GO:0004252] g22266.t1 Q5G265 37.716 289 2.91e-42 171.0 sp|Q5G265|NETR_SAGLB Neurotrypsin OS=Saguinus labiatus OX=78454 GN=PRSS12 PE=3 SV=1 NETR_SAGLB reviewed Neurotrypsin (EC 3.4.21.-) (Serine protease 12) Saguinus labiatus (Red-chested mustached tamarin) GO:0004252; GO:0005576; GO:0005886; GO:0006508; GO:0006887; GO:0030424; GO:0098793; GO:0098978 exocytosis [GO:0006887]; proteolysis [GO:0006508] axon [GO:0030424]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; presynapse [GO:0098793] serine-type endopeptidase activity [GO:0004252] g22268.t1 Q8VC74 47.49 259 1.3900000000000001e-77 244.0 sp|Q8VC74|COX18_MOUSE Cytochrome c oxidase assembly protein COX18, mitochondrial OS=Mus musculus OX=10090 GN=Cox18 PE=1 SV=5 g22272.t1 A6NNA5 73.626 91 8.19e-40 142.0 sp|A6NNA5|DRGX_HUMAN Dorsal root ganglia homeobox protein OS=Homo sapiens OX=9606 GN=DRGX PE=1 SV=1 DRGX_HUMAN reviewed Dorsal root ganglia homeobox protein (Paired-related homeobox protein-like 1) Homo sapiens (Human) GO:0000785; GO:0000977; GO:0000981; GO:0001764; GO:0005634; GO:0006357; GO:0007411; GO:0009593; GO:0016048; GO:0021516; GO:0021559; GO:0048666; GO:0050954; GO:1990837 axon guidance [GO:0007411]; detection of chemical stimulus [GO:0009593]; detection of temperature stimulus [GO:0016048]; dorsal spinal cord development [GO:0021516]; neuron development [GO:0048666]; neuron migration [GO:0001764]; regulation of transcription by RNA polymerase II [GO:0006357]; sensory perception of mechanical stimulus [GO:0050954]; trigeminal nerve development [GO:0021559] chromatin [GO:0000785]; nucleus [GO:0005634] DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837] g22274.t1 Q9HD45 80.357 56 1.53e-26 105.0 sp|Q9HD45|TM9S3_HUMAN Transmembrane 9 superfamily member 3 OS=Homo sapiens OX=9606 GN=TM9SF3 PE=1 SV=2 g22275.t1 Q9HD45 78.525 461 0.0 707.0 sp|Q9HD45|TM9S3_HUMAN Transmembrane 9 superfamily member 3 OS=Homo sapiens OX=9606 GN=TM9SF3 PE=1 SV=2 g22278.t1 P37892 48.984 443 2.6799999999999997e-134 397.0 sp|P37892|CBPE_LOPAM Carboxypeptidase E OS=Lophius americanus OX=8073 GN=cpe PE=2 SV=1 g22279.t1 Q8TDX6 45.806 465 1.4399999999999998e-146 439.0 sp|Q8TDX6|CGAT1_HUMAN Chondroitin sulfate N-acetylgalactosaminyltransferase 1 OS=Homo sapiens OX=9606 GN=CSGALNACT1 PE=1 SV=2 g22281.t1 Q9H3K2 51.351 259 2.36e-62 202.0 sp|Q9H3K2|GHITM_HUMAN Growth hormone-inducible transmembrane protein OS=Homo sapiens OX=9606 GN=GHITM PE=1 SV=2 GHITM_HUMAN reviewed Growth hormone-inducible transmembrane protein (Dermal papilla-derived protein 2) (Mitochondrial morphology and cristae structure 1) (MICS1) (Transmembrane BAX inhibitor motif-containing protein 5) Homo sapiens (Human) GO:0005262; GO:0005739; GO:0005743; GO:0005789; GO:0006816; GO:0006851; GO:0006915; GO:0007007; GO:0015369; GO:0031966; GO:0070062; GO:0090201; GO:0099093; GO:0140141; GO:1905448 apoptotic process [GO:0006915]; calcium export from the mitochondrion [GO:0099093]; calcium ion transport [GO:0006816]; inner mitochondrial membrane organization [GO:0007007]; mitochondrial calcium ion transmembrane transport [GO:0006851]; mitochondrial potassium ion transmembrane transport [GO:0140141]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; positive regulation of mitochondrial ATP synthesis coupled electron transport [GO:1905448] endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739] calcium channel activity [GO:0005262]; calcium:proton antiporter activity [GO:0015369] g22283.t1 Q4R1I4 41.121 107 1.14e-22 95.9 sp|Q4R1I4|OPN4_BRABE Melanopsin OS=Branchiostoma belcheri OX=7741 GN=OPN4 PE=1 SV=1 OPN4_BRABE reviewed Melanopsin (Opsin-4) (amphi-MOP) Branchiostoma belcheri (Amphioxus) GO:0005886; GO:0007186; GO:0007601; GO:0007602; GO:0008020; GO:0016020 G protein-coupled receptor signaling pathway [GO:0007186]; phototransduction [GO:0007602]; visual perception [GO:0007601] membrane [GO:0016020]; plasma membrane [GO:0005886] G protein-coupled photoreceptor activity [GO:0008020] g22287.t1 P83337 37.158 366 3.2100000000000002e-77 248.0 sp|P83337|OFUT1_CRIGR GDP-fucose protein O-fucosyltransferase 1 OS=Cricetulus griseus OX=10029 GN=POFUT1 PE=1 SV=2 OFUT1_CRIGR reviewed GDP-fucose protein O-fucosyltransferase 1 (EC 2.4.1.221) (Peptide-O-fucosyltransferase 1) (O-FucT-1) Cricetulus griseus (Chinese hamster) (Cricetulus barabensis griseus) GO:0001525; GO:0001756; GO:0005789; GO:0006004; GO:0007219; GO:0007399; GO:0007507; GO:0008593; GO:0009101; GO:0016740; GO:0016757; GO:0046922 angiogenesis [GO:0001525]; fucose metabolic process [GO:0006004]; glycoprotein biosynthetic process [GO:0009101]; heart development [GO:0007507]; nervous system development [GO:0007399]; Notch signaling pathway [GO:0007219]; regulation of Notch signaling pathway [GO:0008593]; somitogenesis [GO:0001756] endoplasmic reticulum membrane [GO:0005789] glycosyltransferase activity [GO:0016757]; peptide-O-fucosyltransferase activity [GO:0046922]; transferase activity [GO:0016740] g22288.t1 Q8TCT9 61.475 366 1.3400000000000001e-161 462.0 sp|Q8TCT9|SPP_HUMAN Signal peptide peptidase OS=Homo sapiens OX=9606 GN=HM13 PE=1 SV=1 SPP_HUMAN reviewed Signal peptide peptidase (EC 3.4.23.-) (Intramembrane protease 1) (IMP-1) (IMPAS-1) (hIMP1) (Minor histocompatibility antigen H13) (Presenilin-like protein 3) (Signal peptide peptidase-like 1) Homo sapiens (Human) GO:0001701; GO:0005783; GO:0005789; GO:0005791; GO:0005886; GO:0006465; GO:0008233; GO:0009986; GO:0016020; GO:0031625; GO:0033619; GO:0034599; GO:0036513; GO:0042500; GO:0042803; GO:0098553; GO:0098554; GO:1904211 cellular response to oxidative stress [GO:0034599]; in utero embryonic development [GO:0001701]; membrane protein proteolysis [GO:0033619]; membrane protein proteolysis involved in retrograde protein transport, ER to cytosol [GO:1904211]; signal peptide processing [GO:0006465] cell surface [GO:0009986]; cytoplasmic side of endoplasmic reticulum membrane [GO:0098554]; Derlin-1 retrotranslocation complex [GO:0036513]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; lumenal side of endoplasmic reticulum membrane [GO:0098553]; membrane [GO:0016020]; plasma membrane [GO:0005886]; rough endoplasmic reticulum [GO:0005791] aspartic endopeptidase activity, intramembrane cleaving [GO:0042500]; peptidase activity [GO:0008233]; protein homodimerization activity [GO:0042803]; ubiquitin protein ligase binding [GO:0031625] g22290.t1 P42839 28.748 647 1.01e-61 225.0 sp|P42839|VNX1_YEAST Low affinity vacuolar monovalent cation/H(+) antiporter OS=Saccharomyces cerevisiae (strain ATCC 204508 / S288c) OX=559292 GN=VNX1 PE=1 SV=1 g22292.t1 Q6TH22 55.838 394 5.53e-140 410.0 sp|Q6TH22|DDI2_DANRE Protein DDI1 homolog 2 OS=Danio rerio OX=7955 GN=ddi2 PE=2 SV=1 g22293.t1 O15973 39.527 296 1.3599999999999999e-67 226.0 sp|O15973|OPSD1_MIZYE Rhodopsin, GQ-coupled OS=Mizuhopecten yessoensis OX=6573 GN=SCOP1 PE=1 SV=1 g22293.t2 O15973 38.614 303 4.5100000000000005e-65 221.0 sp|O15973|OPSD1_MIZYE Rhodopsin, GQ-coupled OS=Mizuhopecten yessoensis OX=6573 GN=SCOP1 PE=1 SV=1 g22293.t3 O15973 39.527 296 1.29e-67 227.0 sp|O15973|OPSD1_MIZYE Rhodopsin, GQ-coupled OS=Mizuhopecten yessoensis OX=6573 GN=SCOP1 PE=1 SV=1 g22294.t1 Q7T2P6 48.81 168 3.41e-50 164.0 sp|Q7T2P6|TIM23_DANRE Mitochondrial import inner membrane translocase subunit Tim23 OS=Danio rerio OX=7955 GN=timm23 PE=2 SV=1 TIM23_DANRE reviewed Mitochondrial import inner membrane translocase subunit Tim23 Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005744; GO:0006886; GO:0008320; GO:0015450; GO:0016020; GO:0030150; GO:0042719; GO:0045039 intracellular protein transport [GO:0006886]; protein import into mitochondrial matrix [GO:0030150]; protein insertion into mitochondrial inner membrane [GO:0045039] membrane [GO:0016020]; mitochondrial intermembrane space chaperone complex [GO:0042719]; TIM23 mitochondrial import inner membrane translocase complex [GO:0005744] protein transmembrane transporter activity [GO:0008320]; protein-transporting ATPase activity [GO:0015450] g22295.t1 O02776 50.091 549 0.0 565.0 sp|O02776|PARG_BOVIN Poly(ADP-ribose) glycohydrolase OS=Bos taurus OX=9913 GN=PARG PE=1 SV=1 g22296.t1 A0A0R4IVV0 29.672 883 1.6500000000000002e-109 360.0 sp|A0A0R4IVV0|MTP_DANRE Microsomal triglyceride transfer protein large subunit OS=Danio rerio OX=7955 GN=mttp PE=1 SV=1 MTP_DANRE reviewed Microsomal triglyceride transfer protein large subunit Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001579; GO:0002040; GO:0005319; GO:0005548; GO:0005783; GO:0005794; GO:0006629; GO:0006869; GO:0007586; GO:0008289; GO:0009306; GO:0015909; GO:0016323; GO:0034377; GO:0042157; GO:0042158; GO:0042632; GO:0042953; GO:0120013; GO:1904121 cholesterol homeostasis [GO:0042632]; digestion [GO:0007586]; lipid metabolic process [GO:0006629]; lipid transport [GO:0006869]; lipoprotein biosynthetic process [GO:0042158]; lipoprotein metabolic process [GO:0042157]; lipoprotein transport [GO:0042953]; long-chain fatty acid transport [GO:0015909]; medium-chain fatty acid transport [GO:0001579]; plasma lipoprotein particle assembly [GO:0034377]; protein secretion [GO:0009306]; sprouting angiogenesis [GO:0002040] basolateral plasma membrane [GO:0016323]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794] lipid binding [GO:0008289]; lipid transfer activity [GO:0120013]; lipid transporter activity [GO:0005319]; phosphatidylethanolamine transfer activity [GO:1904121]; phospholipid transporter activity [GO:0005548] g22300.t1 Q8N328 30.315 508 1.36e-69 239.0 sp|Q8N328|PGBD3_HUMAN PiggyBac transposable element-derived protein 3 OS=Homo sapiens OX=9606 GN=PGBD3 PE=1 SV=3 g22302.t1 C3ZQF9 43.251 363 1.3e-77 247.0 sp|C3ZQF9|QRFPR_BRAFL QRFP-like peptide receptor OS=Branchiostoma floridae OX=7739 GN=QRFPR PE=3 SV=1 g22308.t1 Q27128 73.0 600 0.0 928.0 sp|Q27128|PAPSS_URECA Bifunctional 3'-phosphoadenosine 5'-phosphosulfate synthase OS=Urechis caupo OX=6431 PE=1 SV=1 PAPSS_URECA reviewed Bifunctional 3'-phosphoadenosine 5'-phosphosulfate synthase (PAPS synthase) (PAPS synthetase) (PAPSS) (Sulfurylase kinase) (SK) [Includes: Sulfate adenylyltransferase (EC 2.7.7.4) (ATP-sulfurylase) (Sulfate adenylate transferase) (SAT); Adenylyl-sulfate kinase (EC 2.7.1.25) (3'-phosphoadenosine-5'-phosphosulfate synthase) (APS kinase) (Adenosine-5'-phosphosulfate 3'-phosphotransferase) (Adenylylsulfate 3'-phosphotransferase)] Urechis caupo (Innkeeper worm) (Spoonworm) GO:0000103; GO:0004020; GO:0004781; GO:0005524; GO:0016779; GO:0050428 3'-phosphoadenosine 5'-phosphosulfate biosynthetic process [GO:0050428]; sulfate assimilation [GO:0000103] adenylylsulfate kinase activity [GO:0004020]; ATP binding [GO:0005524]; nucleotidyltransferase activity [GO:0016779]; sulfate adenylyltransferase (ATP) activity [GO:0004781] g22308.t2 Q27128 73.0 600 0.0 926.0 sp|Q27128|PAPSS_URECA Bifunctional 3'-phosphoadenosine 5'-phosphosulfate synthase OS=Urechis caupo OX=6431 PE=1 SV=1 PAPSS_URECA reviewed Bifunctional 3'-phosphoadenosine 5'-phosphosulfate synthase (PAPS synthase) (PAPS synthetase) (PAPSS) (Sulfurylase kinase) (SK) [Includes: Sulfate adenylyltransferase (EC 2.7.7.4) (ATP-sulfurylase) (Sulfate adenylate transferase) (SAT); Adenylyl-sulfate kinase (EC 2.7.1.25) (3'-phosphoadenosine-5'-phosphosulfate synthase) (APS kinase) (Adenosine-5'-phosphosulfate 3'-phosphotransferase) (Adenylylsulfate 3'-phosphotransferase)] Urechis caupo (Innkeeper worm) (Spoonworm) GO:0000103; GO:0004020; GO:0004781; GO:0005524; GO:0016779; GO:0050428 3'-phosphoadenosine 5'-phosphosulfate biosynthetic process [GO:0050428]; sulfate assimilation [GO:0000103] adenylylsulfate kinase activity [GO:0004020]; ATP binding [GO:0005524]; nucleotidyltransferase activity [GO:0016779]; sulfate adenylyltransferase (ATP) activity [GO:0004781] g22309.t1 Q9UNW1 27.119 472 3.1699999999999997e-38 149.0 sp|Q9UNW1|MINP1_HUMAN Multiple inositol polyphosphate phosphatase 1 OS=Homo sapiens OX=9606 GN=MINPP1 PE=1 SV=1 g22310.t1 Q6GPV5 50.307 163 2.88e-47 153.0 sp|Q6GPV5|RN181_XENLA E3 ubiquitin-protein ligase RNF181 OS=Xenopus laevis OX=8355 GN=rnf181 PE=2 SV=1 g22312.t1 O14718 36.278 317 6.11e-66 214.0 sp|O14718|OPSX_HUMAN Visual pigment-like receptor peropsin OS=Homo sapiens OX=9606 GN=RRH PE=1 SV=1 g22313.t1 Q6VNB8 65.734 143 1.67e-65 230.0 sp|Q6VNB8|WDFY3_MOUSE WD repeat and FYVE domain-containing protein 3 OS=Mus musculus OX=10090 GN=Wdfy3 PE=1 SV=1 WDFY3_MOUSE reviewed WD repeat and FYVE domain-containing protein 3 (Beach domain, WD repeat and FYVE domain-containing protein 1) (BWF1) Mus musculus (Mouse) GO:0000421; GO:0003831; GO:0005545; GO:0005635; GO:0005654; GO:0005730; GO:0005737; GO:0005776; GO:0005829; GO:0005886; GO:0008270; GO:0016020; GO:0016234; GO:0016605; GO:0030424; GO:0035973; GO:0043204 aggrephagy [GO:0035973] autophagosome [GO:0005776]; autophagosome membrane [GO:0000421]; axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; inclusion body [GO:0016234]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; PML body [GO:0016605] 1-phosphatidylinositol binding [GO:0005545]; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity [GO:0003831]; zinc ion binding [GO:0008270] g22314.t1 Q6VNB8 54.955 111 4.16e-35 130.0 sp|Q6VNB8|WDFY3_MOUSE WD repeat and FYVE domain-containing protein 3 OS=Mus musculus OX=10090 GN=Wdfy3 PE=1 SV=1 WDFY3_MOUSE reviewed WD repeat and FYVE domain-containing protein 3 (Beach domain, WD repeat and FYVE domain-containing protein 1) (BWF1) Mus musculus (Mouse) GO:0000421; GO:0003831; GO:0005545; GO:0005635; GO:0005654; GO:0005730; GO:0005737; GO:0005776; GO:0005829; GO:0005886; GO:0008270; GO:0016020; GO:0016234; GO:0016605; GO:0030424; GO:0035973; GO:0043204 aggrephagy [GO:0035973] autophagosome [GO:0005776]; autophagosome membrane [GO:0000421]; axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; inclusion body [GO:0016234]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; PML body [GO:0016605] 1-phosphatidylinositol binding [GO:0005545]; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity [GO:0003831]; zinc ion binding [GO:0008270] g22315.t1 Q8IZQ1 51.451 2861 0.0 2632.0 sp|Q8IZQ1|WDFY3_HUMAN WD repeat and FYVE domain-containing protein 3 OS=Homo sapiens OX=9606 GN=WDFY3 PE=1 SV=2 WDFY3_HUMAN reviewed WD repeat and FYVE domain-containing protein 3 (Autophagy-linked FYVE protein) (Alfy) Homo sapiens (Human) GO:0000421; GO:0005545; GO:0005635; GO:0005654; GO:0005730; GO:0005737; GO:0005776; GO:0005829; GO:0005886; GO:0008270; GO:0016020; GO:0016234; GO:0016605; GO:0030424; GO:0031965; GO:0035973; GO:0043204 aggrephagy [GO:0035973] autophagosome [GO:0005776]; autophagosome membrane [GO:0000421]; axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; inclusion body [GO:0016234]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; PML body [GO:0016605] 1-phosphatidylinositol binding [GO:0005545]; zinc ion binding [GO:0008270] g22316.t1 Q8IZQ1 58.952 229 1.1900000000000001e-77 258.0 sp|Q8IZQ1|WDFY3_HUMAN WD repeat and FYVE domain-containing protein 3 OS=Homo sapiens OX=9606 GN=WDFY3 PE=1 SV=2 WDFY3_HUMAN reviewed WD repeat and FYVE domain-containing protein 3 (Autophagy-linked FYVE protein) (Alfy) Homo sapiens (Human) GO:0000421; GO:0005545; GO:0005635; GO:0005654; GO:0005730; GO:0005737; GO:0005776; GO:0005829; GO:0005886; GO:0008270; GO:0016020; GO:0016234; GO:0016605; GO:0030424; GO:0031965; GO:0035973; GO:0043204 aggrephagy [GO:0035973] autophagosome [GO:0005776]; autophagosome membrane [GO:0000421]; axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; inclusion body [GO:0016234]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; PML body [GO:0016605] 1-phosphatidylinositol binding [GO:0005545]; zinc ion binding [GO:0008270] g22318.t1 Q5F2L1 49.59 244 2.3e-72 232.0 sp|Q5F2L1|OFUT3_RAT GDP-fucose protein O-fucosyltransferase 3 OS=Rattus norvegicus OX=10116 GN=Fut10 PE=2 SV=1 OFUT3_RAT reviewed GDP-fucose protein O-fucosyltransferase 3 (EC 2.4.1.221) (Alpha-(1,3)-fucosyltransferase 10) (EC 2.4.1.-) (Fucosyltransferase X) (Fuc-TX) (FucT-X) (Galactoside 3-L-fucosyltransferase 10) (Fucosyltransferase 10) Rattus norvegicus (Rat) GO:0000139; GO:0005654; GO:0005783; GO:0005789; GO:0005794; GO:0006491; GO:0008417; GO:0021799; GO:0036445; GO:0046920; GO:0046922; GO:0050714; GO:0097150; GO:0097402 cerebral cortex radially oriented cell migration [GO:0021799]; N-glycan processing [GO:0006491]; neuroblast migration [GO:0097402]; neuronal stem cell division [GO:0036445]; neuronal stem cell population maintenance [GO:0097150]; positive regulation of protein secretion [GO:0050714] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; nucleoplasm [GO:0005654] alpha-(1->3)-fucosyltransferase activity [GO:0046920]; fucosyltransferase activity [GO:0008417]; peptide-O-fucosyltransferase activity [GO:0046922] g22319.t1 Q8AWB5 52.795 161 9.48e-56 186.0 sp|Q8AWB5|OFUT3_CHICK GDP-fucose protein O-fucosyltransferase 3 OS=Gallus gallus OX=9031 GN=FUT10 PE=2 SV=2 g22320.t1 P16260 51.014 296 8.28e-102 304.0 sp|P16260|GDC_HUMAN Solute carrier family 25 member 16 OS=Homo sapiens OX=9606 GN=SLC25A16 PE=1 SV=3 g22321.t1 Q16204 60.599 401 8.579999999999999e-95 296.0 sp|Q16204|CCDC6_HUMAN Coiled-coil domain-containing protein 6 OS=Homo sapiens OX=9606 GN=CCDC6 PE=1 SV=2 CCDC6_HUMAN reviewed Coiled-coil domain-containing protein 6 (Papillary thyroid carcinoma-encoded protein) (Protein H4) Homo sapiens (Human) GO:0005200; GO:0005829; GO:0005856; GO:0017124; GO:0042802 cytoskeleton [GO:0005856]; cytosol [GO:0005829] identical protein binding [GO:0042802]; SH3 domain binding [GO:0017124]; structural constituent of cytoskeleton [GO:0005200] g22321.t2 Q16204 62.148 391 1.18e-95 297.0 sp|Q16204|CCDC6_HUMAN Coiled-coil domain-containing protein 6 OS=Homo sapiens OX=9606 GN=CCDC6 PE=1 SV=2 CCDC6_HUMAN reviewed Coiled-coil domain-containing protein 6 (Papillary thyroid carcinoma-encoded protein) (Protein H4) Homo sapiens (Human) GO:0005200; GO:0005829; GO:0005856; GO:0017124; GO:0042802 cytoskeleton [GO:0005856]; cytosol [GO:0005829] identical protein binding [GO:0042802]; SH3 domain binding [GO:0017124]; structural constituent of cytoskeleton [GO:0005200] g22321.t3 Q16204 61.381 391 7.759999999999999e-95 295.0 sp|Q16204|CCDC6_HUMAN Coiled-coil domain-containing protein 6 OS=Homo sapiens OX=9606 GN=CCDC6 PE=1 SV=2 CCDC6_HUMAN reviewed Coiled-coil domain-containing protein 6 (Papillary thyroid carcinoma-encoded protein) (Protein H4) Homo sapiens (Human) GO:0005200; GO:0005829; GO:0005856; GO:0017124; GO:0042802 cytoskeleton [GO:0005856]; cytosol [GO:0005829] identical protein binding [GO:0042802]; SH3 domain binding [GO:0017124]; structural constituent of cytoskeleton [GO:0005200] g22322.t1 A6K136 53.378 296 2.8299999999999996e-104 313.0 sp|A6K136|PPM1K_RAT Protein phosphatase Mn(2+)-dependent 1K OS=Rattus norvegicus OX=10116 GN=Ppm1k PE=1 SV=1 PPM1K_RAT reviewed Protein phosphatase Mn(2+)-dependent 1K (EC 3.1.3.16) (Branched-chain alpha-ketoacid dehydrogenase phosphatase) (BCKDH) (BDP) (Protein phosphatase 2C family member) ([3-methyl-2-oxobutanoate dehydrogenase (2-methylpropanoyl-transferring)]-phosphatase) (EC 3.1.3.52) Rattus norvegicus (Rat) GO:0004722; GO:0005739; GO:0005759; GO:0009083; GO:0030145; GO:0047385; GO:1902108 branched-chain amino acid catabolic process [GO:0009083]; regulation of mitochondrial membrane permeability involved in apoptotic process [GO:1902108] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] [3-methyl-2-oxobutanoate dehydrogenase (lipoamide)]-phosphatase activity [GO:0047385]; manganese ion binding [GO:0030145]; protein serine/threonine phosphatase activity [GO:0004722] g22325.t1 P48597 58.824 187 3.82e-83 249.0 sp|P48597|IF4E_XENLA Eukaryotic translation initiation factor 4E OS=Xenopus laevis OX=8355 GN=eif4e PE=1 SV=1 g22327.t1 Q5MB13 52.269 639 0.0 620.0 sp|Q5MB13|ABCG2_MACMU Broad substrate specificity ATP-binding cassette transporter ABCG2 OS=Macaca mulatta OX=9544 GN=ABCG2 PE=2 SV=1 ABCG2_MACMU reviewed Broad substrate specificity ATP-binding cassette transporter ABCG2 (EC 7.6.2.2) (ATP-binding cassette sub-family G member 2) (Urate exporter) (CD antigen CD338) Macaca mulatta (Rhesus macaque) GO:0005524; GO:0005886; GO:0006869; GO:0008559; GO:0015143; GO:0015225; GO:0015562; GO:0015878; GO:0016324; GO:0016887; GO:0031526; GO:0031966; GO:0032217; GO:0032218; GO:0042626; GO:0045121; GO:0046983; GO:0055085; GO:0097744 biotin transport [GO:0015878]; lipid transport [GO:0006869]; renal urate salt excretion [GO:0097744]; riboflavin transport [GO:0032218]; transmembrane transport [GO:0055085] apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; membrane raft [GO:0045121]; mitochondrial membrane [GO:0031966]; plasma membrane [GO:0005886] ABC-type xenobiotic transporter activity [GO:0008559]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; biotin transmembrane transporter activity [GO:0015225]; efflux transmembrane transporter activity [GO:0015562]; protein dimerization activity [GO:0046983]; riboflavin transmembrane transporter activity [GO:0032217]; urate transmembrane transporter activity [GO:0015143] g22328.t1 Q9UNQ0 50.553 633 0.0 612.0 sp|Q9UNQ0|ABCG2_HUMAN Broad substrate specificity ATP-binding cassette transporter ABCG2 OS=Homo sapiens OX=9606 GN=ABCG2 PE=1 SV=3 ABCG2_HUMAN reviewed Broad substrate specificity ATP-binding cassette transporter ABCG2 (EC 7.6.2.2) (ATP-binding cassette sub-family G member 2) (Breast cancer resistance protein) (CDw338) (Mitoxantrone resistance-associated protein) (Placenta-specific ATP-binding cassette transporter) (Urate exporter) (CD antigen CD338) Homo sapiens (Human) GO:0005524; GO:0005654; GO:0005886; GO:0008514; GO:0008559; GO:0015143; GO:0015225; GO:0015562; GO:0015711; GO:0015878; GO:0016324; GO:0016887; GO:0030148; GO:0031526; GO:0031966; GO:0032217; GO:0032218; GO:0042626; GO:0042802; GO:0042803; GO:0042910; GO:0045121; GO:0046415; GO:0046624; GO:0055085; GO:0070633; GO:0097744; GO:0098591; GO:0140115; GO:0150104; GO:1990748; GO:1990962 biotin transport [GO:0015878]; cellular detoxification [GO:1990748]; export across plasma membrane [GO:0140115]; organic anion transport [GO:0015711]; renal urate salt excretion [GO:0097744]; riboflavin transport [GO:0032218]; sphingolipid biosynthetic process [GO:0030148]; transepithelial transport [GO:0070633]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104]; urate metabolic process [GO:0046415]; xenobiotic transport across blood-brain barrier [GO:1990962] apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; external side of apical plasma membrane [GO:0098591]; membrane raft [GO:0045121]; mitochondrial membrane [GO:0031966]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] ABC-type xenobiotic transporter activity [GO:0008559]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; biotin transmembrane transporter activity [GO:0015225]; efflux transmembrane transporter activity [GO:0015562]; identical protein binding [GO:0042802]; organic anion transmembrane transporter activity [GO:0008514]; protein homodimerization activity [GO:0042803]; riboflavin transmembrane transporter activity [GO:0032217]; sphingolipid transporter activity [GO:0046624]; urate transmembrane transporter activity [GO:0015143]; xenobiotic transmembrane transporter activity [GO:0042910] g22328.t2 Q5MB13 49.247 664 0.0 613.0 sp|Q5MB13|ABCG2_MACMU Broad substrate specificity ATP-binding cassette transporter ABCG2 OS=Macaca mulatta OX=9544 GN=ABCG2 PE=2 SV=1 ABCG2_MACMU reviewed Broad substrate specificity ATP-binding cassette transporter ABCG2 (EC 7.6.2.2) (ATP-binding cassette sub-family G member 2) (Urate exporter) (CD antigen CD338) Macaca mulatta (Rhesus macaque) GO:0005524; GO:0005886; GO:0006869; GO:0008559; GO:0015143; GO:0015225; GO:0015562; GO:0015878; GO:0016324; GO:0016887; GO:0031526; GO:0031966; GO:0032217; GO:0032218; GO:0042626; GO:0045121; GO:0046983; GO:0055085; GO:0097744 biotin transport [GO:0015878]; lipid transport [GO:0006869]; renal urate salt excretion [GO:0097744]; riboflavin transport [GO:0032218]; transmembrane transport [GO:0055085] apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; membrane raft [GO:0045121]; mitochondrial membrane [GO:0031966]; plasma membrane [GO:0005886] ABC-type xenobiotic transporter activity [GO:0008559]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; biotin transmembrane transporter activity [GO:0015225]; efflux transmembrane transporter activity [GO:0015562]; protein dimerization activity [GO:0046983]; riboflavin transmembrane transporter activity [GO:0032217]; urate transmembrane transporter activity [GO:0015143] g22329.t1 Q4GZT4 53.846 325 2.12e-119 363.0 sp|Q4GZT4|ABCG2_BOVIN Broad substrate specificity ATP-binding cassette transporter ABCG2 OS=Bos taurus OX=9913 GN=ABCG2 PE=3 SV=2 ABCG2_BOVIN reviewed Broad substrate specificity ATP-binding cassette transporter ABCG2 (EC 7.6.2.2) (ATP-binding cassette sub-family G member 2) (Urate exporter) (CD antigen CD338) Bos taurus (Bovine) GO:0005524; GO:0005886; GO:0006869; GO:0008559; GO:0015143; GO:0015225; GO:0015562; GO:0015878; GO:0016324; GO:0016887; GO:0031526; GO:0031966; GO:0032217; GO:0032218; GO:0042626; GO:0045121; GO:0055085; GO:0097744 biotin transport [GO:0015878]; lipid transport [GO:0006869]; renal urate salt excretion [GO:0097744]; riboflavin transport [GO:0032218]; transmembrane transport [GO:0055085] apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; membrane raft [GO:0045121]; mitochondrial membrane [GO:0031966]; plasma membrane [GO:0005886] ABC-type xenobiotic transporter activity [GO:0008559]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; biotin transmembrane transporter activity [GO:0015225]; efflux transmembrane transporter activity [GO:0015562]; riboflavin transmembrane transporter activity [GO:0032217]; urate transmembrane transporter activity [GO:0015143] g22330.t1 Q5MB13 43.411 258 3.82e-60 204.0 sp|Q5MB13|ABCG2_MACMU Broad substrate specificity ATP-binding cassette transporter ABCG2 OS=Macaca mulatta OX=9544 GN=ABCG2 PE=2 SV=1 ABCG2_MACMU reviewed Broad substrate specificity ATP-binding cassette transporter ABCG2 (EC 7.6.2.2) (ATP-binding cassette sub-family G member 2) (Urate exporter) (CD antigen CD338) Macaca mulatta (Rhesus macaque) GO:0005524; GO:0005886; GO:0006869; GO:0008559; GO:0015143; GO:0015225; GO:0015562; GO:0015878; GO:0016324; GO:0016887; GO:0031526; GO:0031966; GO:0032217; GO:0032218; GO:0042626; GO:0045121; GO:0046983; GO:0055085; GO:0097744 biotin transport [GO:0015878]; lipid transport [GO:0006869]; renal urate salt excretion [GO:0097744]; riboflavin transport [GO:0032218]; transmembrane transport [GO:0055085] apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; membrane raft [GO:0045121]; mitochondrial membrane [GO:0031966]; plasma membrane [GO:0005886] ABC-type xenobiotic transporter activity [GO:0008559]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; biotin transmembrane transporter activity [GO:0015225]; efflux transmembrane transporter activity [GO:0015562]; protein dimerization activity [GO:0046983]; riboflavin transmembrane transporter activity [GO:0032217]; urate transmembrane transporter activity [GO:0015143] g22331.t1 Q9V3L1 49.362 705 0.0 697.0 sp|Q9V3L1|NDST_DROME Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase OS=Drosophila melanogaster OX=7227 GN=sfl PE=1 SV=1 NDST_DROME reviewed Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase (EC 2.8.2.8) (Glucosaminyl N-deacetylase/N-sulfotransferase) (Sulfateless) [Includes: Heparan sulfate N-deacetylase (EC 3.-.-.-); Heparan sulfate N-sulfotransferase (EC 2.8.2.-)] Drosophila melanogaster (Fruit fly) GO:0000137; GO:0000139; GO:0005783; GO:0005794; GO:0006024; GO:0006790; GO:0007283; GO:0007367; GO:0007427; GO:0007474; GO:0007509; GO:0008543; GO:0008587; GO:0015012; GO:0015016; GO:0016055; GO:0019213; GO:0030210; GO:0045570; GO:0102140 epithelial cell migration, open tracheal system [GO:0007427]; fibroblast growth factor receptor signaling pathway [GO:0008543]; glycosaminoglycan biosynthetic process [GO:0006024]; heparan sulfate proteoglycan biosynthetic process [GO:0015012]; heparin proteoglycan biosynthetic process [GO:0030210]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing vein specification [GO:0007474]; mesoderm migration involved in gastrulation [GO:0007509]; regulation of imaginal disc growth [GO:0045570]; segment polarity determination [GO:0007367]; spermatogenesis [GO:0007283]; sulfur compound metabolic process [GO:0006790]; Wnt signaling pathway [GO:0016055] endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi cis cisterna [GO:0000137]; Golgi membrane [GO:0000139] deacetylase activity [GO:0019213]; heparan sulfate N-deacetylase activity [GO:0102140]; heparan sulfate N-sulfotransferase activity [GO:0015016] g22335.t1 Q9EQW8 47.867 211 1.42e-62 201.0 sp|Q9EQW8|NDST4_MOUSE Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 4 OS=Mus musculus OX=10090 GN=Ndst4 PE=2 SV=2 NDST4_MOUSE reviewed Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 4 (EC 2.8.2.8) (Glucosaminyl N-deacetylase/N-sulfotransferase 4) (NDST-4) (N-heparan sulfate sulfotransferase 4) (N-HSST 4) [Includes: Heparan sulfate N-deacetylase 4 (EC 3.-.-.-); Heparan sulfate N-sulfotransferase 4 (EC 2.8.2.-)] Mus musculus (Mouse) GO:0000139; GO:0005794; GO:0008146; GO:0015012; GO:0015016; GO:0019213; GO:0030210; GO:0050119 heparan sulfate proteoglycan biosynthetic process [GO:0015012]; heparin proteoglycan biosynthetic process [GO:0030210] Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139] deacetylase activity [GO:0019213]; heparan sulfate N-sulfotransferase activity [GO:0015016]; N-acetylglucosamine deacetylase activity [GO:0050119]; sulfotransferase activity [GO:0008146] g22335.t1 Q9EQW8 78.125 32 1.42e-62 60.5 sp|Q9EQW8|NDST4_MOUSE Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 4 OS=Mus musculus OX=10090 GN=Ndst4 PE=2 SV=2 NDST4_MOUSE reviewed Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 4 (EC 2.8.2.8) (Glucosaminyl N-deacetylase/N-sulfotransferase 4) (NDST-4) (N-heparan sulfate sulfotransferase 4) (N-HSST 4) [Includes: Heparan sulfate N-deacetylase 4 (EC 3.-.-.-); Heparan sulfate N-sulfotransferase 4 (EC 2.8.2.-)] Mus musculus (Mouse) GO:0000139; GO:0005794; GO:0008146; GO:0015012; GO:0015016; GO:0019213; GO:0030210; GO:0050119 heparan sulfate proteoglycan biosynthetic process [GO:0015012]; heparin proteoglycan biosynthetic process [GO:0030210] Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139] deacetylase activity [GO:0019213]; heparan sulfate N-sulfotransferase activity [GO:0015016]; N-acetylglucosamine deacetylase activity [GO:0050119]; sulfotransferase activity [GO:0008146] g22336.t1 Q02353 52.279 373 1.18e-138 419.0 sp|Q02353|NDST1_RAT Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1 OS=Rattus norvegicus OX=10116 GN=Ndst1 PE=1 SV=1 NDST1_RAT reviewed Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1 (Glucosaminyl N-deacetylase/N-sulfotransferase 1) (NDST-1) (Golgi heparan sulfate N-deacetylase/N-sulfotransferase) (N-heparan sulfate sulfotransferase 1) (N-HSST) (N-HSST 1) ([Heparan sulfate]-glucosamine N-sulfotransferase 1) (HSNST 1) [Includes: Heparan sulfate N-deacetylase 1 (EC 3.5.1.-); Heparan sulfate N-sulfotransferase 1 (EC 2.8.2.8)] Rattus norvegicus (Rat) GO:0000139; GO:0000271; GO:0003279; GO:0005794; GO:0006954; GO:0007507; GO:0007585; GO:0008146; GO:0008283; GO:0008543; GO:0009887; GO:0015012; GO:0015016; GO:0019213; GO:0030203; GO:0030210; GO:0030900; GO:0030901; GO:0032588; GO:0035904; GO:0043410; GO:0045880; GO:0048702; GO:0048703; GO:0050119; GO:0060976; GO:0102140 animal organ morphogenesis [GO:0009887]; aorta development [GO:0035904]; cardiac septum development [GO:0003279]; cell population proliferation [GO:0008283]; coronary vasculature development [GO:0060976]; embryonic neurocranium morphogenesis [GO:0048702]; embryonic viscerocranium morphogenesis [GO:0048703]; fibroblast growth factor receptor signaling pathway [GO:0008543]; forebrain development [GO:0030900]; glycosaminoglycan metabolic process [GO:0030203]; heart development [GO:0007507]; heparan sulfate proteoglycan biosynthetic process [GO:0015012]; heparin proteoglycan biosynthetic process [GO:0030210]; inflammatory response [GO:0006954]; midbrain development [GO:0030901]; polysaccharide biosynthetic process [GO:0000271]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of smoothened signaling pathway [GO:0045880]; respiratory gaseous exchange by respiratory system [GO:0007585] Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; trans-Golgi network membrane [GO:0032588] deacetylase activity [GO:0019213]; heparan sulfate N-deacetylase activity [GO:0102140]; heparan sulfate N-sulfotransferase activity [GO:0015016]; N-acetylglucosamine deacetylase activity [GO:0050119]; sulfotransferase activity [GO:0008146] g22337.t1 P16581 30.462 325 5.4800000000000004e-27 120.0 sp|P16581|LYAM2_HUMAN E-selectin OS=Homo sapiens OX=9606 GN=SELE PE=1 SV=1 LYAM2_HUMAN reviewed E-selectin (CD62 antigen-like family member E) (Endothelial leukocyte adhesion molecule 1) (ELAM-1) (Leukocyte-endothelial cell adhesion molecule 2) (LECAM2) (CD antigen CD62E) Homo sapiens (Human) GO:0002092; GO:0002523; GO:0002687; GO:0004888; GO:0005615; GO:0005886; GO:0005901; GO:0005905; GO:0006954; GO:0007157; GO:0007159; GO:0007200; GO:0009897; GO:0019722; GO:0030029; GO:0030863; GO:0032496; GO:0033691; GO:0034097; GO:0034612; GO:0043274; GO:0045121; GO:0046872; GO:0048471; GO:0050727; GO:0050901; GO:0070492; GO:0070555; GO:1903238 actin filament-based process [GO:0030029]; calcium-mediated signaling [GO:0019722]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; inflammatory response [GO:0006954]; leukocyte cell-cell adhesion [GO:0007159]; leukocyte migration involved in inflammatory response [GO:0002523]; leukocyte tethering or rolling [GO:0050901]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of leukocyte migration [GO:0002687]; positive regulation of leukocyte tethering or rolling [GO:1903238]; positive regulation of receptor internalization [GO:0002092]; regulation of inflammatory response [GO:0050727]; response to cytokine [GO:0034097]; response to interleukin-1 [GO:0070555]; response to lipopolysaccharide [GO:0032496]; response to tumor necrosis factor [GO:0034612] caveola [GO:0005901]; clathrin-coated pit [GO:0005905]; cortical cytoskeleton [GO:0030863]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; membrane raft [GO:0045121]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886] metal ion binding [GO:0046872]; oligosaccharide binding [GO:0070492]; phospholipase binding [GO:0043274]; sialic acid binding [GO:0033691]; transmembrane signaling receptor activity [GO:0004888] g22337.t1 P16581 29.48 346 7.229999999999999e-23 107.0 sp|P16581|LYAM2_HUMAN E-selectin OS=Homo sapiens OX=9606 GN=SELE PE=1 SV=1 LYAM2_HUMAN reviewed E-selectin (CD62 antigen-like family member E) (Endothelial leukocyte adhesion molecule 1) (ELAM-1) (Leukocyte-endothelial cell adhesion molecule 2) (LECAM2) (CD antigen CD62E) Homo sapiens (Human) GO:0002092; GO:0002523; GO:0002687; GO:0004888; GO:0005615; GO:0005886; GO:0005901; GO:0005905; GO:0006954; GO:0007157; GO:0007159; GO:0007200; GO:0009897; GO:0019722; GO:0030029; GO:0030863; GO:0032496; GO:0033691; GO:0034097; GO:0034612; GO:0043274; GO:0045121; GO:0046872; GO:0048471; GO:0050727; GO:0050901; GO:0070492; GO:0070555; GO:1903238 actin filament-based process [GO:0030029]; calcium-mediated signaling [GO:0019722]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; inflammatory response [GO:0006954]; leukocyte cell-cell adhesion [GO:0007159]; leukocyte migration involved in inflammatory response [GO:0002523]; leukocyte tethering or rolling [GO:0050901]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of leukocyte migration [GO:0002687]; positive regulation of leukocyte tethering or rolling [GO:1903238]; positive regulation of receptor internalization [GO:0002092]; regulation of inflammatory response [GO:0050727]; response to cytokine [GO:0034097]; response to interleukin-1 [GO:0070555]; response to lipopolysaccharide [GO:0032496]; response to tumor necrosis factor [GO:0034612] caveola [GO:0005901]; clathrin-coated pit [GO:0005905]; cortical cytoskeleton [GO:0030863]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; membrane raft [GO:0045121]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886] metal ion binding [GO:0046872]; oligosaccharide binding [GO:0070492]; phospholipase binding [GO:0043274]; sialic acid binding [GO:0033691]; transmembrane signaling receptor activity [GO:0004888] g22338.t1 A0A1D5NSM8 30.189 1007 8.77e-116 407.0 sp|A0A1D5NSM8|SVEP1_DANRE Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 OS=Danio rerio OX=7955 GN=svep1 PE=1 SV=1 SVEP1_DANRE reviewed Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 (Polydom) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001945; GO:0005509; GO:0005576; GO:0005634; GO:0005737; GO:0008544; GO:0009913; GO:0016020; GO:0016477; GO:0036303; GO:0090136 cell migration [GO:0016477]; epidermal cell differentiation [GO:0009913]; epidermis development [GO:0008544]; epithelial cell-cell adhesion [GO:0090136]; lymph vessel development [GO:0001945]; lymph vessel morphogenesis [GO:0036303] cytoplasm [GO:0005737]; extracellular region [GO:0005576]; membrane [GO:0016020]; nucleus [GO:0005634] calcium ion binding [GO:0005509] g22339.t1 P10079 47.917 384 2.81e-101 351.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g22339.t1 P10079 46.096 397 3.41e-96 337.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g22339.t1 P10079 44.361 399 2.77e-94 331.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g22339.t1 P10079 40.732 437 9.83e-94 330.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g22339.t1 P10079 38.197 466 5.76e-91 322.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g22339.t1 P10079 42.166 434 3.6e-90 320.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g22339.t1 P10079 41.855 399 2.32e-87 311.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g22339.t1 P10079 41.604 399 2.91e-87 311.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g22340.t1 Q9Y4G8 48.445 1061 0.0 952.0 sp|Q9Y4G8|RPGF2_HUMAN Rap guanine nucleotide exchange factor 2 OS=Homo sapiens OX=9606 GN=RAPGEF2 PE=1 SV=1 g22340.t2 Q9Y4G8 48.445 1061 0.0 951.0 sp|Q9Y4G8|RPGF2_HUMAN Rap guanine nucleotide exchange factor 2 OS=Homo sapiens OX=9606 GN=RAPGEF2 PE=1 SV=1 g22342.t1 Q9DDT2 26.543 486 2.4800000000000002e-26 119.0 sp|Q9DDT2|BCAP_CHICK Phosphoinositide 3-kinase adapter protein 1 OS=Gallus gallus OX=9031 GN=PIK3AP1 PE=1 SV=1 g22342.t2 Q9DDT2 26.543 486 2.51e-26 119.0 sp|Q9DDT2|BCAP_CHICK Phosphoinositide 3-kinase adapter protein 1 OS=Gallus gallus OX=9031 GN=PIK3AP1 PE=1 SV=1 g22343.t1 Q9CZP0 44.286 210 6.88e-56 180.0 sp|Q9CZP0|UFSP1_MOUSE Ufm1-specific protease 1 OS=Mus musculus OX=10090 GN=Ufsp1 PE=1 SV=1 g22348.t1 Q920Q6 40.957 188 1.6100000000000001e-35 136.0 sp|Q920Q6|MSI2H_MOUSE RNA-binding protein Musashi homolog 2 OS=Mus musculus OX=10090 GN=Msi2 PE=1 SV=1 g22349.t1 F1NPQ2 35.798 257 8.12e-43 159.0 sp|F1NPQ2|MINP1_CHICK Multiple inositol polyphosphate phosphatase 1 OS=Gallus gallus OX=9031 GN=MINPP1 PE=1 SV=3 MINP1_CHICK reviewed Multiple inositol polyphosphate phosphatase 1 (EC 3.1.3.62) (2,3-bisphosphoglycerate 3-phosphatase) (2,3-BPG phosphatase) (EC 3.1.3.80) (Band 17) (Histidine phosphatase of the endoplasmic reticulum 1) (HiPER1) Gallus gallus (Chicken) GO:0003993; GO:0004446; GO:0005615; GO:0005788; GO:0005886; GO:0008707; GO:0016158; GO:0016312; GO:0030003; GO:0030351; GO:0030352; GO:0034417; GO:0046030; GO:0052745; GO:0052827 intracellular monoatomic cation homeostasis [GO:0030003] endoplasmic reticulum lumen [GO:0005788]; extracellular space [GO:0005615]; plasma membrane [GO:0005886] acid phosphatase activity [GO:0003993]; bisphosphoglycerate 3-phosphatase activity [GO:0034417]; inositol bisphosphate phosphatase activity [GO:0016312]; inositol hexakisphosphate 3-phosphatase activity [GO:0016158]; inositol hexakisphosphate 4-phosphatase activity [GO:0008707]; inositol hexakisphosphate phosphatase activity [GO:0004446]; inositol pentakisphosphate phosphatase activity [GO:0052827]; inositol phosphate phosphatase activity [GO:0052745]; inositol trisphosphate phosphatase activity [GO:0046030]; inositol-1,3,4,5,6-pentakisphosphate 3-phosphatase activity [GO:0030351]; inositol-1,4,5,6-tetrakisphosphate 6-phosphatase activity [GO:0030352] g22350.t1 Q8HYW0 38.384 297 1.81e-40 164.0 sp|Q8HYW0|FA13A_BOVIN Protein FAM13A OS=Bos taurus OX=9913 GN=FAM13A PE=2 SV=1 g22350.t2 O94988 38.318 214 7.769999999999999e-40 164.0 sp|O94988|FA13A_HUMAN Protein FAM13A OS=Homo sapiens OX=9606 GN=FAM13A PE=1 SV=2 g22350.t2 O94988 35.69 297 1.07e-32 141.0 sp|O94988|FA13A_HUMAN Protein FAM13A OS=Homo sapiens OX=9606 GN=FAM13A PE=1 SV=2 g22350.t3 Q8HYW0 38.384 297 1.53e-40 164.0 sp|Q8HYW0|FA13A_BOVIN Protein FAM13A OS=Bos taurus OX=9913 GN=FAM13A PE=2 SV=1 g22352.t1 Q86SS6 31.746 315 3.06e-33 134.0 sp|Q86SS6|SYT9_HUMAN Synaptotagmin-9 OS=Homo sapiens OX=9606 GN=SYT9 PE=1 SV=1 SYT9_HUMAN reviewed Synaptotagmin-9 (Synaptotagmin IX) (SytIX) Homo sapiens (Human) GO:0000149; GO:0001786; GO:0005544; GO:0005546; GO:0005886; GO:0007268; GO:0016192; GO:0017158; GO:0030669; GO:0030672; GO:0031045; GO:0031340; GO:0042802; GO:0046872; GO:0061891; GO:0070382; GO:0098686; GO:0099502 calcium-dependent activation of synaptic vesicle fusion [GO:0099502]; chemical synaptic transmission [GO:0007268]; positive regulation of vesicle fusion [GO:0031340]; regulation of calcium ion-dependent exocytosis [GO:0017158]; vesicle-mediated transport [GO:0016192] clathrin-coated endocytic vesicle membrane [GO:0030669]; dense core granule [GO:0031045]; exocytic vesicle [GO:0070382]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; plasma membrane [GO:0005886]; synaptic vesicle membrane [GO:0030672] calcium ion sensor activity [GO:0061891]; calcium-dependent phospholipid binding [GO:0005544]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphatidylserine binding [GO:0001786]; SNARE binding [GO:0000149] g22353.t1 Q9BQS2 50.329 304 3.83e-95 296.0 sp|Q9BQS2|SYT15_HUMAN Synaptotagmin-15 OS=Homo sapiens OX=9606 GN=SYT15 PE=1 SV=3 SYT15_HUMAN reviewed Synaptotagmin-15 (Chr10Syt) (Synaptotagmin XV) (SytXV) Homo sapiens (Human) GO:0000149; GO:0005544; GO:0005886; GO:0016192; GO:0017158; GO:0061891; GO:0070382 regulation of calcium ion-dependent exocytosis [GO:0017158]; vesicle-mediated transport [GO:0016192] exocytic vesicle [GO:0070382]; plasma membrane [GO:0005886] calcium ion sensor activity [GO:0061891]; calcium-dependent phospholipid binding [GO:0005544]; SNARE binding [GO:0000149] g22354.t1 O75899 30.803 685 1.25e-94 320.0 sp|O75899|GABR2_HUMAN Gamma-aminobutyric acid type B receptor subunit 2 OS=Homo sapiens OX=9606 GN=GABBR2 PE=1 SV=1 GABR2_HUMAN reviewed Gamma-aminobutyric acid type B receptor subunit 2 (GABA-B receptor 2) (GABA-B-R2) (GABA-BR2) (GABABR2) (Gb2) (G-protein coupled receptor 51) (HG20) Homo sapiens (Human) GO:0004888; GO:0004965; GO:0005737; GO:0005886; GO:0007186; GO:0007193; GO:0007194; GO:0007214; GO:0007268; GO:0038039; GO:0043005; GO:0045211; GO:0046982; GO:0051932; GO:0150099; GO:1902710; GO:1902712 adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; chemical synaptic transmission [GO:0007268]; G protein-coupled receptor signaling pathway [GO:0007186]; gamma-aminobutyric acid signaling pathway [GO:0007214]; negative regulation of adenylate cyclase activity [GO:0007194]; neuron-glial cell signaling [GO:0150099]; synaptic transmission, GABAergic [GO:0051932] cytoplasm [GO:0005737]; G protein-coupled GABA receptor complex [GO:1902712]; G protein-coupled receptor heterodimeric complex [GO:0038039]; GABA receptor complex [GO:1902710]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211] G protein-coupled GABA receptor activity [GO:0004965]; protein heterodimerization activity [GO:0046982]; transmembrane signaling receptor activity [GO:0004888] g22355.t1 Q80T41 28.386 694 1.29e-79 277.0 sp|Q80T41|GABR2_MOUSE Gamma-aminobutyric acid type B receptor subunit 2 OS=Mus musculus OX=10090 GN=Gabbr2 PE=1 SV=2 GABR2_MOUSE reviewed Gamma-aminobutyric acid type B receptor subunit 2 (GABA-B receptor 2) (GABA-B-R2) (GABA-BR2) (GABABR2) (Gb2) (G-protein coupled receptor 51) Mus musculus (Mouse) GO:0004965; GO:0005737; GO:0005886; GO:0007193; GO:0007214; GO:0038039; GO:0042734; GO:0043005; GO:0045211; GO:0046982; GO:0051932; GO:0098978; GO:0098982; GO:0150099; GO:1902710; GO:1902712 adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; gamma-aminobutyric acid signaling pathway [GO:0007214]; neuron-glial cell signaling [GO:0150099]; synaptic transmission, GABAergic [GO:0051932] cytoplasm [GO:0005737]; G protein-coupled GABA receptor complex [GO:1902712]; G protein-coupled receptor heterodimeric complex [GO:0038039]; GABA receptor complex [GO:1902710]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734] G protein-coupled GABA receptor activity [GO:0004965]; protein heterodimerization activity [GO:0046982] g22357.t1 P30975 36.639 363 1.6600000000000002e-70 233.0 sp|P30975|TLR2_DROME Tachykinin-like peptides receptor 99D OS=Drosophila melanogaster OX=7227 GN=TkR99D PE=2 SV=2 g22359.t1 P30975 39.394 330 8.27e-62 210.0 sp|P30975|TLR2_DROME Tachykinin-like peptides receptor 99D OS=Drosophila melanogaster OX=7227 GN=TkR99D PE=2 SV=2 g22360.t1 Q5REH2 48.454 388 4.51e-117 350.0 sp|Q5REH2|ZDHC6_PONAB Palmitoyltransferase ZDHHC6 OS=Pongo abelii OX=9601 GN=ZDHHC6 PE=3 SV=1 ZDHC6_PONAB reviewed Palmitoyltransferase ZDHHC6 (EC 2.3.1.225) (Stearoyltransferase ZDHHC6) (EC 2.3.1.-) (Zinc finger DHHC domain-containing protein 6) (DHHC-6) Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0005783; GO:0005789; GO:0016409; GO:0019706; GO:0035556; GO:0140439 intracellular signal transduction [GO:0035556] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789] palmitoyltransferase activity [GO:0016409]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]; protein-cysteine S-stearoyltransferase activity [GO:0140439] g22365.t1 P80174 49.375 160 1.96e-43 146.0 sp|P80174|SODC_CARCR Superoxide dismutase [Cu-Zn] OS=Caretta caretta OX=8467 PE=1 SV=2 g22366.t1 Q03059 52.181 596 0.0 601.0 sp|Q03059|CLAT_MOUSE Choline O-acetyltransferase OS=Mus musculus OX=10090 GN=Chat PE=2 SV=2 g22367.t1 Q08C75 61.702 470 0.0 596.0 sp|Q08C75|VACHA_DANRE Probable vesicular acetylcholine transporter-A OS=Danio rerio OX=7955 GN=slc18a3a PE=2 SV=1 g22371.t1 Q9QXF7 39.122 501 1.61e-98 309.0 sp|Q9QXF7|CP2J4_RAT Cytochrome P450 2J4 OS=Rattus norvegicus OX=10116 GN=CYP2J4 PE=1 SV=1 g22372.t1 Q9QXF7 40.2 500 5.5300000000000004e-124 374.0 sp|Q9QXF7|CP2J4_RAT Cytochrome P450 2J4 OS=Rattus norvegicus OX=10116 GN=CYP2J4 PE=1 SV=1 g22373.t1 Q9N126 36.111 288 6.15e-47 162.0 sp|Q9N126|RDH8_BOVIN Retinol dehydrogenase 8 OS=Bos taurus OX=9913 GN=RDH8 PE=1 SV=1 g22374.t1 Q9N126 38.776 294 5.840000000000001e-59 194.0 sp|Q9N126|RDH8_BOVIN Retinol dehydrogenase 8 OS=Bos taurus OX=9913 GN=RDH8 PE=1 SV=1 g22375.t1 Q9N126 35.125 279 3.83e-44 155.0 sp|Q9N126|RDH8_BOVIN Retinol dehydrogenase 8 OS=Bos taurus OX=9913 GN=RDH8 PE=1 SV=1 g22376.t1 Q02218 70.203 839 0.0 1271.0 sp|Q02218|ODO1_HUMAN 2-oxoglutarate dehydrogenase complex component E1 OS=Homo sapiens OX=9606 GN=OGDH PE=1 SV=3 ODO1_HUMAN reviewed 2-oxoglutarate dehydrogenase complex component E1 (E1o) (HsOGDH) (OGDC-E1) (OGDH-E1) (EC 1.2.4.2) (2-oxoglutarate dehydrogenase, mitochondrial) (Alpha-ketoglutarate dehydrogenase) (Alpha-KGDH-E1) (Thiamine diphosphate (ThDP)-dependent 2-oxoglutarate dehydrogenase) Homo sapiens (Human) GO:0004591; GO:0005634; GO:0005739; GO:0005759; GO:0006091; GO:0006096; GO:0006099; GO:0006103; GO:0006104; GO:0021695; GO:0021756; GO:0021766; GO:0021794; GO:0021860; GO:0022028; GO:0030976; GO:0031072; GO:0031966; GO:0045252; GO:0046872; GO:0051087; GO:0061034; GO:0120551 2-oxoglutarate decarboxylation to succinyl-CoA [GO:0120551]; 2-oxoglutarate metabolic process [GO:0006103]; cerebellar cortex development [GO:0021695]; generation of precursor metabolites and energy [GO:0006091]; glycolytic process [GO:0006096]; hippocampus development [GO:0021766]; olfactory bulb mitral cell layer development [GO:0061034]; pyramidal neuron development [GO:0021860]; striatum development [GO:0021756]; succinyl-CoA metabolic process [GO:0006104]; tangential migration from the subventricular zone to the olfactory bulb [GO:0022028]; thalamus development [GO:0021794]; tricarboxylic acid cycle [GO:0006099] mitochondrial matrix [GO:0005759]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; oxoglutarate dehydrogenase complex [GO:0045252] heat shock protein binding [GO:0031072]; metal ion binding [GO:0046872]; oxoglutarate dehydrogenase (succinyl-transferring) activity [GO:0004591]; protein-folding chaperone binding [GO:0051087]; thiamine pyrophosphate binding [GO:0030976] g22376.t2 Q02218 70.155 841 0.0 1274.0 sp|Q02218|ODO1_HUMAN 2-oxoglutarate dehydrogenase complex component E1 OS=Homo sapiens OX=9606 GN=OGDH PE=1 SV=3 ODO1_HUMAN reviewed 2-oxoglutarate dehydrogenase complex component E1 (E1o) (HsOGDH) (OGDC-E1) (OGDH-E1) (EC 1.2.4.2) (2-oxoglutarate dehydrogenase, mitochondrial) (Alpha-ketoglutarate dehydrogenase) (Alpha-KGDH-E1) (Thiamine diphosphate (ThDP)-dependent 2-oxoglutarate dehydrogenase) Homo sapiens (Human) GO:0004591; GO:0005634; GO:0005739; GO:0005759; GO:0006091; GO:0006096; GO:0006099; GO:0006103; GO:0006104; GO:0021695; GO:0021756; GO:0021766; GO:0021794; GO:0021860; GO:0022028; GO:0030976; GO:0031072; GO:0031966; GO:0045252; GO:0046872; GO:0051087; GO:0061034; GO:0120551 2-oxoglutarate decarboxylation to succinyl-CoA [GO:0120551]; 2-oxoglutarate metabolic process [GO:0006103]; cerebellar cortex development [GO:0021695]; generation of precursor metabolites and energy [GO:0006091]; glycolytic process [GO:0006096]; hippocampus development [GO:0021766]; olfactory bulb mitral cell layer development [GO:0061034]; pyramidal neuron development [GO:0021860]; striatum development [GO:0021756]; succinyl-CoA metabolic process [GO:0006104]; tangential migration from the subventricular zone to the olfactory bulb [GO:0022028]; thalamus development [GO:0021794]; tricarboxylic acid cycle [GO:0006099] mitochondrial matrix [GO:0005759]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; oxoglutarate dehydrogenase complex [GO:0045252] heat shock protein binding [GO:0031072]; metal ion binding [GO:0046872]; oxoglutarate dehydrogenase (succinyl-transferring) activity [GO:0004591]; protein-folding chaperone binding [GO:0051087]; thiamine pyrophosphate binding [GO:0030976] g22376.t3 Q148N0 68.345 417 0.0 578.0 sp|Q148N0|ODO1_BOVIN 2-oxoglutarate dehydrogenase complex component E1 OS=Bos taurus OX=9913 GN=OGDH PE=1 SV=1 g22376.t4 Q60597 55.462 119 6.14e-32 123.0 sp|Q60597|ODO1_MOUSE 2-oxoglutarate dehydrogenase complex component E1 OS=Mus musculus OX=10090 GN=Ogdh PE=1 SV=3 g22378.t1 Q68F72 36.154 520 1.18e-85 279.0 sp|Q68F72|S15A4_XENLA Solute carrier family 15 member 4 OS=Xenopus laevis OX=8355 GN=slc15a4 PE=2 SV=1 S15A4_XENLA reviewed Solute carrier family 15 member 4 Xenopus laevis (African clawed frog) GO:0005290; GO:0005765; GO:0015031; GO:0015333; GO:0015647; GO:0015835; GO:0016020; GO:0031901; GO:0033023; GO:0034157; GO:0034161; GO:0034165; GO:0036020; GO:0045087; GO:0045089; GO:0048302; GO:0070424; GO:0070430; GO:0070434; GO:0071916; GO:0140206 dipeptide import across plasma membrane [GO:0140206]; innate immune response [GO:0045087]; mast cell homeostasis [GO:0033023]; peptidoglycan transport [GO:0015835]; positive regulation of innate immune response [GO:0045089]; positive regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway [GO:0070430]; positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway [GO:0070434]; positive regulation of toll-like receptor 7 signaling pathway [GO:0034157]; positive regulation of toll-like receptor 8 signaling pathway [GO:0034161]; positive regulation of toll-like receptor 9 signaling pathway [GO:0034165]; protein transport [GO:0015031]; regulation of isotype switching to IgG isotypes [GO:0048302]; regulation of nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway [GO:0070424] early endosome membrane [GO:0031901]; endolysosome membrane [GO:0036020]; lysosomal membrane [GO:0005765]; membrane [GO:0016020] dipeptide transmembrane transporter activity [GO:0071916]; L-histidine transmembrane transporter activity [GO:0005290]; peptide:proton symporter activity [GO:0015333]; peptidoglycan transmembrane transporter activity [GO:0015647] g22379.t1 Q9HA92 47.397 365 2.9200000000000004e-110 333.0 sp|Q9HA92|RSAD1_HUMAN Radical S-adenosyl methionine domain-containing protein 1, mitochondrial OS=Homo sapiens OX=9606 GN=RSAD1 PE=1 SV=2 g22380.t1 Q6F3J0 55.621 338 2.47e-109 367.0 sp|Q6F3J0|NFKB1_CANLF Nuclear factor NF-kappa-B p105 subunit OS=Canis lupus familiaris OX=9615 GN=NFKB1 PE=2 SV=2 NFKB1_CANLF reviewed Nuclear factor NF-kappa-B p105 subunit (Nuclear factor of kappa light polypeptide gene enhancer in B-cells 1) [Cleaved into: Nuclear factor NF-kappa-B p50 subunit] Canis lupus familiaris (Dog) (Canis familiaris) GO:0000122; GO:0000976; GO:0003700; GO:0005634; GO:0005737; GO:0007165; GO:0032991; GO:0042802; GO:0045893; GO:0071222; GO:0071356 cellular response to lipopolysaccharide [GO:0071222]; cellular response to tumor necrosis factor [GO:0071356]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of DNA-templated transcription [GO:0045893]; signal transduction [GO:0007165] cytoplasm [GO:0005737]; nucleus [GO:0005634]; protein-containing complex [GO:0032991] DNA-binding transcription factor activity [GO:0003700]; identical protein binding [GO:0042802]; transcription cis-regulatory region binding [GO:0000976] g22380.t1 Q6F3J0 34.504 484 1.6e-58 222.0 sp|Q6F3J0|NFKB1_CANLF Nuclear factor NF-kappa-B p105 subunit OS=Canis lupus familiaris OX=9615 GN=NFKB1 PE=2 SV=2 NFKB1_CANLF reviewed Nuclear factor NF-kappa-B p105 subunit (Nuclear factor of kappa light polypeptide gene enhancer in B-cells 1) [Cleaved into: Nuclear factor NF-kappa-B p50 subunit] Canis lupus familiaris (Dog) (Canis familiaris) GO:0000122; GO:0000976; GO:0003700; GO:0005634; GO:0005737; GO:0007165; GO:0032991; GO:0042802; GO:0045893; GO:0071222; GO:0071356 cellular response to lipopolysaccharide [GO:0071222]; cellular response to tumor necrosis factor [GO:0071356]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of DNA-templated transcription [GO:0045893]; signal transduction [GO:0007165] cytoplasm [GO:0005737]; nucleus [GO:0005634]; protein-containing complex [GO:0032991] DNA-binding transcription factor activity [GO:0003700]; identical protein binding [GO:0042802]; transcription cis-regulatory region binding [GO:0000976] g22380.t2 Q6F3J0 55.621 338 4.1600000000000003e-110 367.0 sp|Q6F3J0|NFKB1_CANLF Nuclear factor NF-kappa-B p105 subunit OS=Canis lupus familiaris OX=9615 GN=NFKB1 PE=2 SV=2 NFKB1_CANLF reviewed Nuclear factor NF-kappa-B p105 subunit (Nuclear factor of kappa light polypeptide gene enhancer in B-cells 1) [Cleaved into: Nuclear factor NF-kappa-B p50 subunit] Canis lupus familiaris (Dog) (Canis familiaris) GO:0000122; GO:0000976; GO:0003700; GO:0005634; GO:0005737; GO:0007165; GO:0032991; GO:0042802; GO:0045893; GO:0071222; GO:0071356 cellular response to lipopolysaccharide [GO:0071222]; cellular response to tumor necrosis factor [GO:0071356]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of DNA-templated transcription [GO:0045893]; signal transduction [GO:0007165] cytoplasm [GO:0005737]; nucleus [GO:0005634]; protein-containing complex [GO:0032991] DNA-binding transcription factor activity [GO:0003700]; identical protein binding [GO:0042802]; transcription cis-regulatory region binding [GO:0000976] g22380.t2 Q6F3J0 34.504 484 1.1800000000000001e-58 222.0 sp|Q6F3J0|NFKB1_CANLF Nuclear factor NF-kappa-B p105 subunit OS=Canis lupus familiaris OX=9615 GN=NFKB1 PE=2 SV=2 NFKB1_CANLF reviewed Nuclear factor NF-kappa-B p105 subunit (Nuclear factor of kappa light polypeptide gene enhancer in B-cells 1) [Cleaved into: Nuclear factor NF-kappa-B p50 subunit] Canis lupus familiaris (Dog) (Canis familiaris) GO:0000122; GO:0000976; GO:0003700; GO:0005634; GO:0005737; GO:0007165; GO:0032991; GO:0042802; GO:0045893; GO:0071222; GO:0071356 cellular response to lipopolysaccharide [GO:0071222]; cellular response to tumor necrosis factor [GO:0071356]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of DNA-templated transcription [GO:0045893]; signal transduction [GO:0007165] cytoplasm [GO:0005737]; nucleus [GO:0005634]; protein-containing complex [GO:0032991] DNA-binding transcription factor activity [GO:0003700]; identical protein binding [GO:0042802]; transcription cis-regulatory region binding [GO:0000976] g15552.t1 Q9N0P9 57.875 273 1.93e-112 330.0 sp|Q9N0P9|PIM1_BOVIN Serine/threonine-protein kinase pim-1 OS=Bos taurus OX=9913 GN=PIM1 PE=2 SV=1 g15563.t1 P05423 37.407 270 8.56e-36 135.0 sp|P05423|RPC4_HUMAN DNA-directed RNA polymerase III subunit RPC4 OS=Homo sapiens OX=9606 GN=POLR3D PE=1 SV=2 RPC4_HUMAN reviewed DNA-directed RNA polymerase III subunit RPC4 (RNA polymerase III subunit C4) (DNA-directed RNA polymerase III subunit D) (Protein BN51) (RNA polymerase III 47 kDa subunit) (RPC53 homolog) Homo sapiens (Human) GO:0003677; GO:0003682; GO:0005654; GO:0005666; GO:0005829; GO:0032728; GO:0042797; GO:0045087; GO:0045089; GO:0051607 defense response to virus [GO:0051607]; innate immune response [GO:0045087]; positive regulation of innate immune response [GO:0045089]; positive regulation of interferon-beta production [GO:0032728]; tRNA transcription by RNA polymerase III [GO:0042797] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; RNA polymerase III complex [GO:0005666] chromatin binding [GO:0003682]; DNA binding [GO:0003677] g15565.t1 P35520 48.097 289 9.2e-83 263.0 sp|P35520|CBS_HUMAN Cystathionine beta-synthase OS=Homo sapiens OX=9606 GN=CBS PE=1 SV=2 CBS_HUMAN reviewed Cystathionine beta-synthase (EC 4.2.1.22) (Beta-thionase) (Serine sulfhydrase) Homo sapiens (Human) GO:0001958; GO:0001974; GO:0004122; GO:0005634; GO:0005737; GO:0005829; GO:0006535; GO:0006563; GO:0006565; GO:0006801; GO:0010749; GO:0019343; GO:0019344; GO:0019346; GO:0019448; GO:0019825; GO:0019899; GO:0020037; GO:0021587; GO:0030170; GO:0031625; GO:0042262; GO:0042802; GO:0042803; GO:0043066; GO:0043418; GO:0046328; GO:0046872; GO:0050421; GO:0050667; GO:0051593; GO:0060135; GO:0060351; GO:0070025; GO:0070026; GO:0070814; GO:0071456; GO:0072341; GO:0097746; GO:1904047 blood vessel diameter maintenance [GO:0097746]; blood vessel remodeling [GO:0001974]; cartilage development involved in endochondral bone morphogenesis [GO:0060351]; cellular response to hypoxia [GO:0071456]; cerebellum morphogenesis [GO:0021587]; cysteine biosynthetic process [GO:0019344]; cysteine biosynthetic process from serine [GO:0006535]; cysteine biosynthetic process via cystathionine [GO:0019343]; DNA protection [GO:0042262]; endochondral ossification [GO:0001958]; homocysteine catabolic process [GO:0043418]; homocysteine metabolic process [GO:0050667]; hydrogen sulfide biosynthetic process [GO:0070814]; L-cysteine catabolic process [GO:0019448]; L-serine catabolic process [GO:0006565]; L-serine metabolic process [GO:0006563]; maternal process involved in female pregnancy [GO:0060135]; negative regulation of apoptotic process [GO:0043066]; regulation of JNK cascade [GO:0046328]; regulation of nitric oxide mediated signal transduction [GO:0010749]; response to folic acid [GO:0051593]; superoxide metabolic process [GO:0006801]; transsulfuration [GO:0019346] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634] carbon monoxide binding [GO:0070025]; cystathionine beta-synthase activity [GO:0004122]; enzyme binding [GO:0019899]; heme binding [GO:0020037]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; modified amino acid binding [GO:0072341]; nitric oxide binding [GO:0070026]; nitrite reductase (NO-forming) activity [GO:0050421]; oxygen binding [GO:0019825]; protein homodimerization activity [GO:0042803]; pyridoxal phosphate binding [GO:0030170]; S-adenosyl-L-methionine binding [GO:1904047]; ubiquitin protein ligase binding [GO:0031625] g15571.t1 Q9HCN4 74.113 282 1.53e-150 434.0 sp|Q9HCN4|GPN1_HUMAN GPN-loop GTPase 1 OS=Homo sapiens OX=9606 GN=GPN1 PE=1 SV=1 g15573.t1 Q9CQT2 48.571 140 6.370000000000001e-32 121.0 sp|Q9CQT2|RBM7_MOUSE RNA-binding protein 7 OS=Mus musculus OX=10090 GN=Rbm7 PE=1 SV=1 RBM7_MOUSE reviewed RNA-binding protein 7 (RNA-binding motif protein 7) Mus musculus (Mouse) GO:0000381; GO:0003723; GO:0003727; GO:0005634; GO:0005654; GO:0016076; GO:0017069; GO:0051321; GO:0071889; GO:0097157 meiotic cell cycle [GO:0051321]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; snRNA catabolic process [GO:0016076] nucleoplasm [GO:0005654]; nucleus [GO:0005634] 14-3-3 protein binding [GO:0071889]; pre-mRNA intronic binding [GO:0097157]; RNA binding [GO:0003723]; single-stranded RNA binding [GO:0003727]; snRNA binding [GO:0017069] g15574.t1 Q8NDA2 26.074 978 6.979999999999999e-52 206.0 sp|Q8NDA2|HMCN2_HUMAN Hemicentin-2 OS=Homo sapiens OX=9606 GN=HMCN2 PE=1 SV=4 g15574.t1 Q8NDA2 26.102 885 4.1399999999999995e-45 184.0 sp|Q8NDA2|HMCN2_HUMAN Hemicentin-2 OS=Homo sapiens OX=9606 GN=HMCN2 PE=1 SV=4 g15574.t1 Q8NDA2 25.788 857 2.5900000000000003e-43 178.0 sp|Q8NDA2|HMCN2_HUMAN Hemicentin-2 OS=Homo sapiens OX=9606 GN=HMCN2 PE=1 SV=4 g15574.t1 Q8NDA2 25.196 893 2.8299999999999996e-42 174.0 sp|Q8NDA2|HMCN2_HUMAN Hemicentin-2 OS=Homo sapiens OX=9606 GN=HMCN2 PE=1 SV=4 g15574.t1 Q8NDA2 26.948 616 1.99e-41 172.0 sp|Q8NDA2|HMCN2_HUMAN Hemicentin-2 OS=Homo sapiens OX=9606 GN=HMCN2 PE=1 SV=4 g15574.t1 Q8NDA2 24.81 919 1.01e-40 169.0 sp|Q8NDA2|HMCN2_HUMAN Hemicentin-2 OS=Homo sapiens OX=9606 GN=HMCN2 PE=1 SV=4 g15574.t1 Q8NDA2 22.732 937 1.3700000000000001e-36 156.0 sp|Q8NDA2|HMCN2_HUMAN Hemicentin-2 OS=Homo sapiens OX=9606 GN=HMCN2 PE=1 SV=4 g15574.t1 Q8NDA2 24.481 915 1.2e-34 149.0 sp|Q8NDA2|HMCN2_HUMAN Hemicentin-2 OS=Homo sapiens OX=9606 GN=HMCN2 PE=1 SV=4 g15574.t1 Q8NDA2 22.065 920 9.06e-30 134.0 sp|Q8NDA2|HMCN2_HUMAN Hemicentin-2 OS=Homo sapiens OX=9606 GN=HMCN2 PE=1 SV=4 g15574.t1 Q8NDA2 21.665 937 5.51e-28 127.0 sp|Q8NDA2|HMCN2_HUMAN Hemicentin-2 OS=Homo sapiens OX=9606 GN=HMCN2 PE=1 SV=4 g15574.t2 Q8NDA2 26.074 978 7.179999999999999e-52 206.0 sp|Q8NDA2|HMCN2_HUMAN Hemicentin-2 OS=Homo sapiens OX=9606 GN=HMCN2 PE=1 SV=4 g15574.t2 Q8NDA2 26.102 885 4.2399999999999995e-45 184.0 sp|Q8NDA2|HMCN2_HUMAN Hemicentin-2 OS=Homo sapiens OX=9606 GN=HMCN2 PE=1 SV=4 g15574.t2 Q8NDA2 25.788 857 2.65e-43 178.0 sp|Q8NDA2|HMCN2_HUMAN Hemicentin-2 OS=Homo sapiens OX=9606 GN=HMCN2 PE=1 SV=4 g15574.t2 Q8NDA2 25.196 893 2.8899999999999995e-42 174.0 sp|Q8NDA2|HMCN2_HUMAN Hemicentin-2 OS=Homo sapiens OX=9606 GN=HMCN2 PE=1 SV=4 g15574.t2 Q8NDA2 26.948 616 2.03e-41 172.0 sp|Q8NDA2|HMCN2_HUMAN Hemicentin-2 OS=Homo sapiens OX=9606 GN=HMCN2 PE=1 SV=4 g15574.t2 Q8NDA2 24.81 919 1.0299999999999999e-40 169.0 sp|Q8NDA2|HMCN2_HUMAN Hemicentin-2 OS=Homo sapiens OX=9606 GN=HMCN2 PE=1 SV=4 g15574.t2 Q8NDA2 22.732 937 1.4e-36 156.0 sp|Q8NDA2|HMCN2_HUMAN Hemicentin-2 OS=Homo sapiens OX=9606 GN=HMCN2 PE=1 SV=4 g15574.t2 Q8NDA2 24.481 915 1.23e-34 149.0 sp|Q8NDA2|HMCN2_HUMAN Hemicentin-2 OS=Homo sapiens OX=9606 GN=HMCN2 PE=1 SV=4 g15574.t2 Q8NDA2 22.065 920 9.22e-30 134.0 sp|Q8NDA2|HMCN2_HUMAN Hemicentin-2 OS=Homo sapiens OX=9606 GN=HMCN2 PE=1 SV=4 g15574.t2 Q8NDA2 21.665 937 5.61e-28 127.0 sp|Q8NDA2|HMCN2_HUMAN Hemicentin-2 OS=Homo sapiens OX=9606 GN=HMCN2 PE=1 SV=4 g15575.t1 Q80Y83 41.176 442 1.03e-77 271.0 sp|Q80Y83|DIXC1_MOUSE Dixin OS=Mus musculus OX=10090 GN=Dixdc1 PE=1 SV=1 g15575.t1 Q80Y83 51.333 150 1.45e-35 148.0 sp|Q80Y83|DIXC1_MOUSE Dixin OS=Mus musculus OX=10090 GN=Dixdc1 PE=1 SV=1 g15575.t2 Q80Y83 41.002 439 8.16e-78 270.0 sp|Q80Y83|DIXC1_MOUSE Dixin OS=Mus musculus OX=10090 GN=Dixdc1 PE=1 SV=1 g15575.t2 Q80Y83 51.333 150 1.37e-35 148.0 sp|Q80Y83|DIXC1_MOUSE Dixin OS=Mus musculus OX=10090 GN=Dixdc1 PE=1 SV=1 g15577.t1 Q9VBW3 47.267 311 6.27e-87 295.0 sp|Q9VBW3|CAD96_DROME Tyrosine kinase receptor Cad96Ca OS=Drosophila melanogaster OX=7227 GN=Cad96Ca PE=2 SV=2 CAD96_DROME reviewed Tyrosine kinase receptor Cad96Ca (EC 2.7.10.1) (Cadherin-96Ca) (Tyrosine kinase receptor HD-14) Drosophila melanogaster (Fruit fly) GO:0004713; GO:0004714; GO:0005509; GO:0005524; GO:0005886; GO:0006468; GO:0007030; GO:0007156; GO:0007169; GO:0016339; GO:0042060; GO:0043235; GO:0045177; GO:0045792; GO:0051897; GO:0090303 calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; Golgi organization [GO:0007030]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell size [GO:0045792]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of wound healing [GO:0090303]; protein phosphorylation [GO:0006468]; wound healing [GO:0042060] apical part of cell [GO:0045177]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; protein tyrosine kinase activity [GO:0004713]; transmembrane receptor protein tyrosine kinase activity [GO:0004714] g15579.t1 Q03164 75.814 215 5.89e-109 347.0 sp|Q03164|KMT2A_HUMAN Histone-lysine N-methyltransferase 2A OS=Homo sapiens OX=9606 GN=KMT2A PE=1 SV=5 KMT2A_HUMAN reviewed Histone-lysine N-methyltransferase 2A (Lysine N-methyltransferase 2A) (EC 2.1.1.364) (ALL-1) (CXXC-type zinc finger protein 7) (Cysteine methyltransferase KMT2A) (EC 2.1.1.-) (Myeloid/lymphoid or mixed-lineage leukemia) (Myeloid/lymphoid or mixed-lineage leukemia protein 1) (Trithorax-like protein) (Zinc finger protein HRX) [Cleaved into: MLL cleavage product N320 (N-terminal cleavage product of 320 kDa) (p320); MLL cleavage product C180 (C-terminal cleavage product of 180 kDa) (p180)] Homo sapiens (Human) GO:0003680; GO:0003682; GO:0005634; GO:0005654; GO:0005829; GO:0006915; GO:0008270; GO:0008542; GO:0009791; GO:0009952; GO:0032259; GO:0032922; GO:0035097; GO:0035162; GO:0035640; GO:0035864; GO:0042800; GO:0042802; GO:0042803; GO:0045064; GO:0045322; GO:0045815; GO:0045893; GO:0045944; GO:0048144; GO:0048147; GO:0048172; GO:0048536; GO:0048873; GO:0051899; GO:0060216; GO:0065003; GO:0071339; GO:0071560; GO:0090310; GO:0106363; GO:0140945; GO:0140999 anterior/posterior pattern specification [GO:0009952]; apoptotic process [GO:0006915]; cellular response to transforming growth factor beta stimulus [GO:0071560]; circadian regulation of gene expression [GO:0032922]; definitive hemopoiesis [GO:0060216]; embryonic hemopoiesis [GO:0035162]; exploration behavior [GO:0035640]; fibroblast proliferation [GO:0048144]; homeostasis of number of cells within a tissue [GO:0048873]; membrane depolarization [GO:0051899]; methylation [GO:0032259]; negative regulation of DNA methylation-dependent heterochromatin formation [GO:0090310]; negative regulation of fibroblast proliferation [GO:0048147]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; post-embryonic development [GO:0009791]; protein-containing complex assembly [GO:0065003]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; response to potassium ion [GO:0035864]; spleen development [GO:0048536]; T-helper 2 cell differentiation [GO:0045064]; transcription initiation-coupled chromatin remodeling [GO:0045815]; visual learning [GO:0008542] cytosol [GO:0005829]; histone methyltransferase complex [GO:0035097]; MLL1 complex [GO:0071339]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] chromatin binding [GO:0003682]; histone H3K4 methyltransferase activity [GO:0042800]; histone H3K4 monomethyltransferase activity [GO:0140945]; histone H3K4 trimethyltransferase activity [GO:0140999]; identical protein binding [GO:0042802]; minor groove of adenine-thymine-rich DNA binding [GO:0003680]; protein homodimerization activity [GO:0042803]; protein-cysteine methyltransferase activity [GO:0106363]; unmethylated CpG binding [GO:0045322]; zinc ion binding [GO:0008270] g15580.t1 Q03164 61.481 270 1.21e-100 370.0 sp|Q03164|KMT2A_HUMAN Histone-lysine N-methyltransferase 2A OS=Homo sapiens OX=9606 GN=KMT2A PE=1 SV=5 KMT2A_HUMAN reviewed Histone-lysine N-methyltransferase 2A (Lysine N-methyltransferase 2A) (EC 2.1.1.364) (ALL-1) (CXXC-type zinc finger protein 7) (Cysteine methyltransferase KMT2A) (EC 2.1.1.-) (Myeloid/lymphoid or mixed-lineage leukemia) (Myeloid/lymphoid or mixed-lineage leukemia protein 1) (Trithorax-like protein) (Zinc finger protein HRX) [Cleaved into: MLL cleavage product N320 (N-terminal cleavage product of 320 kDa) (p320); MLL cleavage product C180 (C-terminal cleavage product of 180 kDa) (p180)] Homo sapiens (Human) GO:0003680; GO:0003682; GO:0005634; GO:0005654; GO:0005829; GO:0006915; GO:0008270; GO:0008542; GO:0009791; GO:0009952; GO:0032259; GO:0032922; GO:0035097; GO:0035162; GO:0035640; GO:0035864; GO:0042800; GO:0042802; GO:0042803; GO:0045064; GO:0045322; GO:0045815; GO:0045893; GO:0045944; GO:0048144; GO:0048147; GO:0048172; GO:0048536; GO:0048873; GO:0051899; GO:0060216; GO:0065003; GO:0071339; GO:0071560; GO:0090310; GO:0106363; GO:0140945; GO:0140999 anterior/posterior pattern specification [GO:0009952]; apoptotic process [GO:0006915]; cellular response to transforming growth factor beta stimulus [GO:0071560]; circadian regulation of gene expression [GO:0032922]; definitive hemopoiesis [GO:0060216]; embryonic hemopoiesis [GO:0035162]; exploration behavior [GO:0035640]; fibroblast proliferation [GO:0048144]; homeostasis of number of cells within a tissue [GO:0048873]; membrane depolarization [GO:0051899]; methylation [GO:0032259]; negative regulation of DNA methylation-dependent heterochromatin formation [GO:0090310]; negative regulation of fibroblast proliferation [GO:0048147]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; post-embryonic development [GO:0009791]; protein-containing complex assembly [GO:0065003]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; response to potassium ion [GO:0035864]; spleen development [GO:0048536]; T-helper 2 cell differentiation [GO:0045064]; transcription initiation-coupled chromatin remodeling [GO:0045815]; visual learning [GO:0008542] cytosol [GO:0005829]; histone methyltransferase complex [GO:0035097]; MLL1 complex [GO:0071339]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] chromatin binding [GO:0003682]; histone H3K4 methyltransferase activity [GO:0042800]; histone H3K4 monomethyltransferase activity [GO:0140945]; histone H3K4 trimethyltransferase activity [GO:0140999]; identical protein binding [GO:0042802]; minor groove of adenine-thymine-rich DNA binding [GO:0003680]; protein homodimerization activity [GO:0042803]; protein-cysteine methyltransferase activity [GO:0106363]; unmethylated CpG binding [GO:0045322]; zinc ion binding [GO:0008270] g15580.t1 Q03164 43.396 424 1.18e-96 357.0 sp|Q03164|KMT2A_HUMAN Histone-lysine N-methyltransferase 2A OS=Homo sapiens OX=9606 GN=KMT2A PE=1 SV=5 KMT2A_HUMAN reviewed Histone-lysine N-methyltransferase 2A (Lysine N-methyltransferase 2A) (EC 2.1.1.364) (ALL-1) (CXXC-type zinc finger protein 7) (Cysteine methyltransferase KMT2A) (EC 2.1.1.-) (Myeloid/lymphoid or mixed-lineage leukemia) (Myeloid/lymphoid or mixed-lineage leukemia protein 1) (Trithorax-like protein) (Zinc finger protein HRX) [Cleaved into: MLL cleavage product N320 (N-terminal cleavage product of 320 kDa) (p320); MLL cleavage product C180 (C-terminal cleavage product of 180 kDa) (p180)] Homo sapiens (Human) GO:0003680; GO:0003682; GO:0005634; GO:0005654; GO:0005829; GO:0006915; GO:0008270; GO:0008542; GO:0009791; GO:0009952; GO:0032259; GO:0032922; GO:0035097; GO:0035162; GO:0035640; GO:0035864; GO:0042800; GO:0042802; GO:0042803; GO:0045064; GO:0045322; GO:0045815; GO:0045893; GO:0045944; GO:0048144; GO:0048147; GO:0048172; GO:0048536; GO:0048873; GO:0051899; GO:0060216; GO:0065003; GO:0071339; GO:0071560; GO:0090310; GO:0106363; GO:0140945; GO:0140999 anterior/posterior pattern specification [GO:0009952]; apoptotic process [GO:0006915]; cellular response to transforming growth factor beta stimulus [GO:0071560]; circadian regulation of gene expression [GO:0032922]; definitive hemopoiesis [GO:0060216]; embryonic hemopoiesis [GO:0035162]; exploration behavior [GO:0035640]; fibroblast proliferation [GO:0048144]; homeostasis of number of cells within a tissue [GO:0048873]; membrane depolarization [GO:0051899]; methylation [GO:0032259]; negative regulation of DNA methylation-dependent heterochromatin formation [GO:0090310]; negative regulation of fibroblast proliferation [GO:0048147]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; post-embryonic development [GO:0009791]; protein-containing complex assembly [GO:0065003]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; response to potassium ion [GO:0035864]; spleen development [GO:0048536]; T-helper 2 cell differentiation [GO:0045064]; transcription initiation-coupled chromatin remodeling [GO:0045815]; visual learning [GO:0008542] cytosol [GO:0005829]; histone methyltransferase complex [GO:0035097]; MLL1 complex [GO:0071339]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] chromatin binding [GO:0003682]; histone H3K4 methyltransferase activity [GO:0042800]; histone H3K4 monomethyltransferase activity [GO:0140945]; histone H3K4 trimethyltransferase activity [GO:0140999]; identical protein binding [GO:0042802]; minor groove of adenine-thymine-rich DNA binding [GO:0003680]; protein homodimerization activity [GO:0042803]; protein-cysteine methyltransferase activity [GO:0106363]; unmethylated CpG binding [GO:0045322]; zinc ion binding [GO:0008270] g15587.t1 Q9VBW3 47.774 337 7.46e-91 311.0 sp|Q9VBW3|CAD96_DROME Tyrosine kinase receptor Cad96Ca OS=Drosophila melanogaster OX=7227 GN=Cad96Ca PE=2 SV=2 CAD96_DROME reviewed Tyrosine kinase receptor Cad96Ca (EC 2.7.10.1) (Cadherin-96Ca) (Tyrosine kinase receptor HD-14) Drosophila melanogaster (Fruit fly) GO:0004713; GO:0004714; GO:0005509; GO:0005524; GO:0005886; GO:0006468; GO:0007030; GO:0007156; GO:0007169; GO:0016339; GO:0042060; GO:0043235; GO:0045177; GO:0045792; GO:0051897; GO:0090303 calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; Golgi organization [GO:0007030]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell size [GO:0045792]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of wound healing [GO:0090303]; protein phosphorylation [GO:0006468]; wound healing [GO:0042060] apical part of cell [GO:0045177]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; protein tyrosine kinase activity [GO:0004713]; transmembrane receptor protein tyrosine kinase activity [GO:0004714] g15587.t1 Q9VBW3 49.296 284 4.58e-87 301.0 sp|Q9VBW3|CAD96_DROME Tyrosine kinase receptor Cad96Ca OS=Drosophila melanogaster OX=7227 GN=Cad96Ca PE=2 SV=2 CAD96_DROME reviewed Tyrosine kinase receptor Cad96Ca (EC 2.7.10.1) (Cadherin-96Ca) (Tyrosine kinase receptor HD-14) Drosophila melanogaster (Fruit fly) GO:0004713; GO:0004714; GO:0005509; GO:0005524; GO:0005886; GO:0006468; GO:0007030; GO:0007156; GO:0007169; GO:0016339; GO:0042060; GO:0043235; GO:0045177; GO:0045792; GO:0051897; GO:0090303 calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; Golgi organization [GO:0007030]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell size [GO:0045792]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of wound healing [GO:0090303]; protein phosphorylation [GO:0006468]; wound healing [GO:0042060] apical part of cell [GO:0045177]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; protein tyrosine kinase activity [GO:0004713]; transmembrane receptor protein tyrosine kinase activity [GO:0004714] g15588.t1 Q9VBW3 49.084 273 1.38e-81 274.0 sp|Q9VBW3|CAD96_DROME Tyrosine kinase receptor Cad96Ca OS=Drosophila melanogaster OX=7227 GN=Cad96Ca PE=2 SV=2 CAD96_DROME reviewed Tyrosine kinase receptor Cad96Ca (EC 2.7.10.1) (Cadherin-96Ca) (Tyrosine kinase receptor HD-14) Drosophila melanogaster (Fruit fly) GO:0004713; GO:0004714; GO:0005509; GO:0005524; GO:0005886; GO:0006468; GO:0007030; GO:0007156; GO:0007169; GO:0016339; GO:0042060; GO:0043235; GO:0045177; GO:0045792; GO:0051897; GO:0090303 calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; Golgi organization [GO:0007030]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell size [GO:0045792]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of wound healing [GO:0090303]; protein phosphorylation [GO:0006468]; wound healing [GO:0042060] apical part of cell [GO:0045177]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; protein tyrosine kinase activity [GO:0004713]; transmembrane receptor protein tyrosine kinase activity [GO:0004714] g15590.t1 Q9VBW3 47.297 296 1.07e-78 281.0 sp|Q9VBW3|CAD96_DROME Tyrosine kinase receptor Cad96Ca OS=Drosophila melanogaster OX=7227 GN=Cad96Ca PE=2 SV=2 CAD96_DROME reviewed Tyrosine kinase receptor Cad96Ca (EC 2.7.10.1) (Cadherin-96Ca) (Tyrosine kinase receptor HD-14) Drosophila melanogaster (Fruit fly) GO:0004713; GO:0004714; GO:0005509; GO:0005524; GO:0005886; GO:0006468; GO:0007030; GO:0007156; GO:0007169; GO:0016339; GO:0042060; GO:0043235; GO:0045177; GO:0045792; GO:0051897; GO:0090303 calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; Golgi organization [GO:0007030]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell size [GO:0045792]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of wound healing [GO:0090303]; protein phosphorylation [GO:0006468]; wound healing [GO:0042060] apical part of cell [GO:0045177]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; protein tyrosine kinase activity [GO:0004713]; transmembrane receptor protein tyrosine kinase activity [GO:0004714] g15590.t1 Q9VBW3 63.953 86 1.0500000000000001e-29 131.0 sp|Q9VBW3|CAD96_DROME Tyrosine kinase receptor Cad96Ca OS=Drosophila melanogaster OX=7227 GN=Cad96Ca PE=2 SV=2 CAD96_DROME reviewed Tyrosine kinase receptor Cad96Ca (EC 2.7.10.1) (Cadherin-96Ca) (Tyrosine kinase receptor HD-14) Drosophila melanogaster (Fruit fly) GO:0004713; GO:0004714; GO:0005509; GO:0005524; GO:0005886; GO:0006468; GO:0007030; GO:0007156; GO:0007169; GO:0016339; GO:0042060; GO:0043235; GO:0045177; GO:0045792; GO:0051897; GO:0090303 calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; Golgi organization [GO:0007030]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell size [GO:0045792]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of wound healing [GO:0090303]; protein phosphorylation [GO:0006468]; wound healing [GO:0042060] apical part of cell [GO:0045177]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; protein tyrosine kinase activity [GO:0004713]; transmembrane receptor protein tyrosine kinase activity [GO:0004714] g15593.t1 Q8K0F1 50.949 685 0.0 638.0 sp|Q8K0F1|TBC23_MOUSE TBC1 domain family member 23 OS=Mus musculus OX=10090 GN=Tbc1d23 PE=1 SV=1 TBC23_MOUSE reviewed TBC1 domain family member 23 Mus musculus (Mouse) GO:0005794; GO:0005802; GO:0005829; GO:0007420; GO:0016192; GO:0031175; GO:0031410; GO:0032680; GO:0032755; GO:0042147; GO:0050727; GO:0099041; GO:1990403 brain development [GO:0007420]; embryonic brain development [GO:1990403]; neuron projection development [GO:0031175]; positive regulation of interleukin-6 production [GO:0032755]; regulation of inflammatory response [GO:0050727]; regulation of tumor necrosis factor production [GO:0032680]; retrograde transport, endosome to Golgi [GO:0042147]; vesicle tethering to Golgi [GO:0099041]; vesicle-mediated transport [GO:0016192] cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; trans-Golgi network [GO:0005802] g15594.t1 P22682 67.089 395 0.0 588.0 sp|P22682|CBL_MOUSE E3 ubiquitin-protein ligase CBL OS=Mus musculus OX=10090 GN=Cbl PE=1 SV=3 CBL_MOUSE reviewed E3 ubiquitin-protein ligase CBL (EC 2.3.2.27) (Casitas B-lineage lymphoma proto-oncogene) (Proto-oncogene c-Cbl) (RING-type E3 ubiquitin transferase CBL) (Signal transduction protein CBL) Mus musculus (Mouse) GO:0000209; GO:0001784; GO:0005509; GO:0005794; GO:0005829; GO:0005886; GO:0005925; GO:0005929; GO:0006468; GO:0006511; GO:0006513; GO:0006974; GO:0007165; GO:0007166; GO:0008270; GO:0008584; GO:0010332; GO:0014823; GO:0016567; GO:0016600; GO:0017124; GO:0019901; GO:0030424; GO:0030426; GO:0030971; GO:0032487; GO:0033574; GO:0036120; GO:0036312; GO:0042059; GO:0042594; GO:0043066; GO:0043303; GO:0045121; GO:0045453; GO:0045471; GO:0046875; GO:0048260; GO:0048471; GO:0050821; GO:0050860; GO:0050868; GO:0051865; GO:0051897; GO:0061630; GO:0070086; GO:0070534; GO:0071456; GO:1990090; GO:1990782; GO:2000583 bone resorption [GO:0045453]; cell surface receptor signaling pathway [GO:0007166]; cellular response to hypoxia [GO:0071456]; cellular response to nerve growth factor stimulus [GO:1990090]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; DNA damage response [GO:0006974]; male gonad development [GO:0008584]; mast cell degranulation [GO:0043303]; negative regulation of apoptotic process [GO:0043066]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of T cell activation [GO:0050868]; negative regulation of T cell receptor signaling pathway [GO:0050860]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of receptor-mediated endocytosis [GO:0048260]; protein autoubiquitination [GO:0051865]; protein K63-linked ubiquitination [GO:0070534]; protein monoubiquitination [GO:0006513]; protein phosphorylation [GO:0006468]; protein polyubiquitination [GO:0000209]; protein stabilization [GO:0050821]; protein ubiquitination [GO:0016567]; regulation of platelet-derived growth factor receptor-alpha signaling pathway [GO:2000583]; regulation of Rap protein signal transduction [GO:0032487]; response to activity [GO:0014823]; response to ethanol [GO:0045471]; response to gamma radiation [GO:0010332]; response to starvation [GO:0042594]; response to testosterone [GO:0033574]; signal transduction [GO:0007165]; ubiquitin-dependent endocytosis [GO:0070086]; ubiquitin-dependent protein catabolic process [GO:0006511] axon [GO:0030424]; cilium [GO:0005929]; cytosol [GO:0005829]; flotillin complex [GO:0016600]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; growth cone [GO:0030426]; membrane raft [GO:0045121]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; ephrin receptor binding [GO:0046875]; phosphatidylinositol 3-kinase regulatory subunit binding [GO:0036312]; phosphotyrosine residue binding [GO:0001784]; protein kinase binding [GO:0019901]; protein tyrosine kinase binding [GO:1990782]; receptor tyrosine kinase binding [GO:0030971]; SH3 domain binding [GO:0017124]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] g15594.t2 P22682 67.089 395 0.0 589.0 sp|P22682|CBL_MOUSE E3 ubiquitin-protein ligase CBL OS=Mus musculus OX=10090 GN=Cbl PE=1 SV=3 CBL_MOUSE reviewed E3 ubiquitin-protein ligase CBL (EC 2.3.2.27) (Casitas B-lineage lymphoma proto-oncogene) (Proto-oncogene c-Cbl) (RING-type E3 ubiquitin transferase CBL) (Signal transduction protein CBL) Mus musculus (Mouse) GO:0000209; GO:0001784; GO:0005509; GO:0005794; GO:0005829; GO:0005886; GO:0005925; GO:0005929; GO:0006468; GO:0006511; GO:0006513; GO:0006974; GO:0007165; GO:0007166; GO:0008270; GO:0008584; GO:0010332; GO:0014823; GO:0016567; GO:0016600; GO:0017124; GO:0019901; GO:0030424; GO:0030426; GO:0030971; GO:0032487; GO:0033574; GO:0036120; GO:0036312; GO:0042059; GO:0042594; GO:0043066; GO:0043303; GO:0045121; GO:0045453; GO:0045471; GO:0046875; GO:0048260; GO:0048471; GO:0050821; GO:0050860; GO:0050868; GO:0051865; GO:0051897; GO:0061630; GO:0070086; GO:0070534; GO:0071456; GO:1990090; GO:1990782; GO:2000583 bone resorption [GO:0045453]; cell surface receptor signaling pathway [GO:0007166]; cellular response to hypoxia [GO:0071456]; cellular response to nerve growth factor stimulus [GO:1990090]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; DNA damage response [GO:0006974]; male gonad development [GO:0008584]; mast cell degranulation [GO:0043303]; negative regulation of apoptotic process [GO:0043066]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of T cell activation [GO:0050868]; negative regulation of T cell receptor signaling pathway [GO:0050860]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of receptor-mediated endocytosis [GO:0048260]; protein autoubiquitination [GO:0051865]; protein K63-linked ubiquitination [GO:0070534]; protein monoubiquitination [GO:0006513]; protein phosphorylation [GO:0006468]; protein polyubiquitination [GO:0000209]; protein stabilization [GO:0050821]; protein ubiquitination [GO:0016567]; regulation of platelet-derived growth factor receptor-alpha signaling pathway [GO:2000583]; regulation of Rap protein signal transduction [GO:0032487]; response to activity [GO:0014823]; response to ethanol [GO:0045471]; response to gamma radiation [GO:0010332]; response to starvation [GO:0042594]; response to testosterone [GO:0033574]; signal transduction [GO:0007165]; ubiquitin-dependent endocytosis [GO:0070086]; ubiquitin-dependent protein catabolic process [GO:0006511] axon [GO:0030424]; cilium [GO:0005929]; cytosol [GO:0005829]; flotillin complex [GO:0016600]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; growth cone [GO:0030426]; membrane raft [GO:0045121]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; ephrin receptor binding [GO:0046875]; phosphatidylinositol 3-kinase regulatory subunit binding [GO:0036312]; phosphotyrosine residue binding [GO:0001784]; protein kinase binding [GO:0019901]; protein tyrosine kinase binding [GO:1990782]; receptor tyrosine kinase binding [GO:0030971]; SH3 domain binding [GO:0017124]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] g15595.t1 Q08DJ7 41.379 377 6.53e-95 290.0 sp|Q08DJ7|AAR2_BOVIN Protein AAR2 homolog OS=Bos taurus OX=9913 GN=AAR2 PE=2 SV=1 g15596.t1 Q5XGG3 36.308 325 8.73e-61 200.0 sp|Q5XGG3|PIHD2_XENTR PIH1 domain-containing protein 2 OS=Xenopus tropicalis OX=8364 GN=pih1d2 PE=2 SV=1 g15597.t1 Q80TR1 36.246 309 3.5e-49 189.0 sp|Q80TR1|AGRL1_MOUSE Adhesion G protein-coupled receptor L1 OS=Mus musculus OX=10090 GN=Adgrl1 PE=1 SV=2 AGRL1_MOUSE reviewed Adhesion G protein-coupled receptor L1 (Calcium-independent alpha-latrotoxin receptor 1) (CIRL-1) (Latrophilin-1) (Lectomedin-2) Mus musculus (Mouse) GO:0004930; GO:0005886; GO:0007166; GO:0007186; GO:0015643; GO:0016524; GO:0030246; GO:0030424; GO:0030426; GO:0042734; GO:0043005; GO:0045202; GO:0050839; GO:0051965; GO:0098978 cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186]; positive regulation of synapse assembly [GO:0051965] axon [GO:0030424]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; synapse [GO:0045202] carbohydrate binding [GO:0030246]; cell adhesion molecule binding [GO:0050839]; G protein-coupled receptor activity [GO:0004930]; latrotoxin receptor activity [GO:0016524]; toxic substance binding [GO:0015643] g15598.t1 Q923G2 82.781 151 3.99e-88 256.0 sp|Q923G2|RPAB3_MOUSE DNA-directed RNA polymerases I, II, and III subunit RPABC3 OS=Mus musculus OX=10090 GN=Polr2h PE=1 SV=3 g15598.t2 Q923G2 73.099 171 2.36e-83 245.0 sp|Q923G2|RPAB3_MOUSE DNA-directed RNA polymerases I, II, and III subunit RPABC3 OS=Mus musculus OX=10090 GN=Polr2h PE=1 SV=3 g15601.t1 O54853 55.962 520 7.27e-175 530.0 sp|O54853|KCNH6_RAT Voltage-gated inwardly rectifying potassium channel KCNH6 OS=Rattus norvegicus OX=10116 GN=Kcnh6 PE=1 SV=1 KCNH6_RAT reviewed Voltage-gated inwardly rectifying potassium channel KCNH6 (Ether-a-go-go-related gene potassium channel 2) (ERG-2) (Eag-related protein 2) (Ether-a-go-go-related protein 2) (Potassium voltage-gated channel subfamily H member 6) (Voltage-gated potassium channel subunit Kv11.2) Rattus norvegicus (Rat) GO:0005242; GO:0005249; GO:0005267; GO:0005886; GO:0006813; GO:0034702; GO:0044877; GO:0060307; GO:0071805; GO:0086013; GO:0086091 membrane repolarization during cardiac muscle cell action potential [GO:0086013]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of ventricular cardiac muscle cell membrane repolarization [GO:0060307] monoatomic ion channel complex [GO:0034702]; plasma membrane [GO:0005886] inward rectifier potassium channel activity [GO:0005242]; potassium channel activity [GO:0005267]; protein-containing complex binding [GO:0044877]; voltage-gated potassium channel activity [GO:0005249] g15604.t1 Q8BGG7 42.081 644 7.79e-166 491.0 sp|Q8BGG7|UBS3B_MOUSE Ubiquitin-associated and SH3 domain-containing protein B OS=Mus musculus OX=10090 GN=Ubash3b PE=1 SV=1 UBS3B_MOUSE reviewed Ubiquitin-associated and SH3 domain-containing protein B (EC 3.1.3.48) (Cbl-interacting protein p70) (Suppressor of T-cell receptor signaling 1) (STS-1) (T-cell ubiquitin ligand 2) (TULA-2) (Tyrosine-protein phosphatase STS1/TULA2) Mus musculus (Mouse) GO:0004725; GO:0005634; GO:0005737; GO:0009968; GO:0030168; GO:0031625; GO:0038063; GO:0038065; GO:0042802; GO:0045670; GO:0045671; GO:0045779; GO:0051219; GO:0051279; GO:0070527; GO:0090331 collagen-activated signaling pathway [GO:0038065]; collagen-activated tyrosine kinase receptor signaling pathway [GO:0038063]; negative regulation of bone resorption [GO:0045779]; negative regulation of osteoclast differentiation [GO:0045671]; negative regulation of platelet aggregation [GO:0090331]; negative regulation of signal transduction [GO:0009968]; platelet activation [GO:0030168]; platelet aggregation [GO:0070527]; regulation of osteoclast differentiation [GO:0045670]; regulation of release of sequestered calcium ion into cytosol [GO:0051279] cytoplasm [GO:0005737]; nucleus [GO:0005634] identical protein binding [GO:0042802]; phosphoprotein binding [GO:0051219]; protein tyrosine phosphatase activity [GO:0004725]; ubiquitin protein ligase binding [GO:0031625] g15607.t1 O75310 26.536 358 4.77e-28 118.0 sp|O75310|UDB11_HUMAN UDP-glucuronosyltransferase 2B11 OS=Homo sapiens OX=9606 GN=UGT2B11 PE=1 SV=1 g15608.t1 Q6K1J1 42.169 166 2.2300000000000002e-37 137.0 sp|Q6K1J1|UDB31_CANLF UDP-glucuronosyltransferase 2B31 OS=Canis lupus familiaris OX=9615 GN=UGT2B31 PE=1 SV=1 g15609.t1 O75310 33.463 514 5.5199999999999995e-89 287.0 sp|O75310|UDB11_HUMAN UDP-glucuronosyltransferase 2B11 OS=Homo sapiens OX=9606 GN=UGT2B11 PE=1 SV=1 g15610.t1 O77649 33.792 509 3.75e-92 295.0 sp|O77649|UDB20_MACFA UDP-glucuronosyltransferase 2B20 OS=Macaca fascicularis OX=9541 GN=UGT2B20 PE=1 SV=1 g15612.t1 P40855 33.462 260 7.35e-38 140.0 sp|P40855|PEX19_HUMAN Peroxisomal biogenesis factor 19 OS=Homo sapiens OX=9606 GN=PEX19 PE=1 SV=1 PEX19_HUMAN reviewed Peroxisomal biogenesis factor 19 (33 kDa housekeeping protein) (Peroxin-19) (Peroxisomal farnesylated protein) Homo sapiens (Human) GO:0005634; GO:0005654; GO:0005737; GO:0005777; GO:0005778; GO:0005829; GO:0006457; GO:0006625; GO:0007031; GO:0016020; GO:0016557; GO:0016559; GO:0031526; GO:0032991; GO:0033328; GO:0036105; GO:0045046; GO:0050821; GO:0051117; GO:0072663; GO:0140597; GO:1900131 establishment of protein localization to peroxisome [GO:0072663]; negative regulation of lipid binding [GO:1900131]; peroxisome fission [GO:0016559]; peroxisome membrane biogenesis [GO:0016557]; peroxisome organization [GO:0007031]; protein folding [GO:0006457]; protein import into peroxisome membrane [GO:0045046]; protein stabilization [GO:0050821]; protein targeting to peroxisome [GO:0006625] brush border membrane [GO:0031526]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; protein-containing complex [GO:0032991] ATPase binding [GO:0051117]; peroxisome membrane class-1 targeting sequence binding [GO:0036105]; peroxisome membrane targeting sequence binding [GO:0033328]; protein carrier chaperone [GO:0140597] g15613.t1 Q5ZIJ0 37.768 654 7.18e-75 253.0 sp|Q5ZIJ0|BUD13_CHICK BUD13 homolog OS=Gallus gallus OX=9031 GN=BUD13 PE=2 SV=1 g15614.t1 Q6P4S6 49.364 707 6.37e-161 523.0 sp|Q6P4S6|SIK3_MOUSE Serine/threonine-protein kinase SIK3 OS=Mus musculus OX=10090 GN=Sik3 PE=1 SV=4 SIK3_MOUSE reviewed Serine/threonine-protein kinase SIK3 (EC 2.7.11.1) (Salt-inducible kinase 3) (SIK-3) (Serine/threonine-protein kinase QSK) Mus musculus (Mouse) GO:0000226; GO:0000287; GO:0001958; GO:0004674; GO:0005524; GO:0005737; GO:0006468; GO:0032880; GO:0035108; GO:0035264; GO:0035556; GO:0048705; GO:0050321; GO:0060351; GO:0106310; GO:1904263; GO:1904515 cartilage development involved in endochondral bone morphogenesis [GO:0060351]; endochondral ossification [GO:0001958]; intracellular signal transduction [GO:0035556]; limb morphogenesis [GO:0035108]; microtubule cytoskeleton organization [GO:0000226]; multicellular organism growth [GO:0035264]; positive regulation of TORC1 signaling [GO:1904263]; positive regulation of TORC2 signaling [GO:1904515]; protein phosphorylation [GO:0006468]; regulation of protein localization [GO:0032880]; skeletal system morphogenesis [GO:0048705] cytoplasm [GO:0005737] ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; tau-protein kinase activity [GO:0050321] g15614.t2 Q6P4S6 49.646 707 2.31e-164 532.0 sp|Q6P4S6|SIK3_MOUSE Serine/threonine-protein kinase SIK3 OS=Mus musculus OX=10090 GN=Sik3 PE=1 SV=4 SIK3_MOUSE reviewed Serine/threonine-protein kinase SIK3 (EC 2.7.11.1) (Salt-inducible kinase 3) (SIK-3) (Serine/threonine-protein kinase QSK) Mus musculus (Mouse) GO:0000226; GO:0000287; GO:0001958; GO:0004674; GO:0005524; GO:0005737; GO:0006468; GO:0032880; GO:0035108; GO:0035264; GO:0035556; GO:0048705; GO:0050321; GO:0060351; GO:0106310; GO:1904263; GO:1904515 cartilage development involved in endochondral bone morphogenesis [GO:0060351]; endochondral ossification [GO:0001958]; intracellular signal transduction [GO:0035556]; limb morphogenesis [GO:0035108]; microtubule cytoskeleton organization [GO:0000226]; multicellular organism growth [GO:0035264]; positive regulation of TORC1 signaling [GO:1904263]; positive regulation of TORC2 signaling [GO:1904515]; protein phosphorylation [GO:0006468]; regulation of protein localization [GO:0032880]; skeletal system morphogenesis [GO:0048705] cytoplasm [GO:0005737] ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; tau-protein kinase activity [GO:0050321] g15619.t1 Q5BJX1 43.636 110 1.49e-29 107.0 sp|Q5BJX1|RM41_RAT Large ribosomal subunit protein mL41 OS=Rattus norvegicus OX=10116 GN=Mrpl41 PE=1 SV=1 g15620.t1 Q9H0K1 59.844 513 0.0 588.0 sp|Q9H0K1|SIK2_HUMAN Serine/threonine-protein kinase SIK2 OS=Homo sapiens OX=9606 GN=SIK2 PE=1 SV=1 SIK2_HUMAN reviewed Serine/threonine-protein kinase SIK2 (EC 2.7.11.1) (Qin-induced kinase) (Salt-inducible kinase 2) (SIK-2) (Serine/threonine-protein kinase SNF1-like kinase 2) Homo sapiens (Human) GO:0000287; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005789; GO:0006468; GO:0035556; GO:0046626; GO:0046777; GO:0106310 intracellular signal transduction [GO:0035556]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of insulin receptor signaling pathway [GO:0046626] cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; nucleus [GO:0005634] ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g15623.t1 Q6K1J1 44.928 207 4.37e-61 204.0 sp|Q6K1J1|UDB31_CANLF UDP-glucuronosyltransferase 2B31 OS=Canis lupus familiaris OX=9615 GN=UGT2B31 PE=1 SV=1 g15624.t1 Q32NT4 51.692 325 5.81e-95 290.0 sp|Q32NT4|LRC58_XENLA Leucine-rich repeat-containing protein 58 OS=Xenopus laevis OX=8355 GN=lrrc58 PE=2 SV=1 g15626.t1 Q12841 42.52 254 2.07e-63 206.0 sp|Q12841|FSTL1_HUMAN Follistatin-related protein 1 OS=Homo sapiens OX=9606 GN=FSTL1 PE=1 SV=1 g15630.t1 Q8TAA9 56.923 260 1.39e-95 298.0 sp|Q8TAA9|VANG1_HUMAN Vang-like protein 1 OS=Homo sapiens OX=9606 GN=VANGL1 PE=1 SV=1 VANG1_HUMAN reviewed Vang-like protein 1 (Loop-tail protein 2 homolog) (LPP2) (Strabismus 2) (Van Gogh-like protein 1) Homo sapiens (Human) GO:0005576; GO:0005886; GO:0016328; GO:0043473; GO:0060071; GO:0120197 mucociliary clearance [GO:0120197]; pigmentation [GO:0043473]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071] extracellular region [GO:0005576]; lateral plasma membrane [GO:0016328]; plasma membrane [GO:0005886] g15633.t1 Q4G078 37.895 190 4.31e-39 146.0 sp|Q4G078|MTEF4_RAT Transcription termination factor 4, mitochondrial OS=Rattus norvegicus OX=10116 GN=Mterf4 PE=2 SV=1 g15634.t1 Q9YH85 40.377 265 2.82e-43 166.0 sp|Q9YH85|TECTA_CHICK Alpha-tectorin OS=Gallus gallus OX=9031 GN=TECTA PE=1 SV=1 g15635.t1 Q4G078 37.368 190 2.42e-38 142.0 sp|Q4G078|MTEF4_RAT Transcription termination factor 4, mitochondrial OS=Rattus norvegicus OX=10116 GN=Mterf4 PE=2 SV=1 g15636.t1 Q9YH85 40.377 265 2.82e-43 166.0 sp|Q9YH85|TECTA_CHICK Alpha-tectorin OS=Gallus gallus OX=9031 GN=TECTA PE=1 SV=1 g15637.t1 Q4G078 37.368 190 2.4499999999999997e-38 142.0 sp|Q4G078|MTEF4_RAT Transcription termination factor 4, mitochondrial OS=Rattus norvegicus OX=10116 GN=Mterf4 PE=2 SV=1 g15638.t1 Q8JZM8 31.011 445 9.170000000000001e-32 137.0 sp|Q8JZM8|MUC4_MOUSE Mucin-4 OS=Mus musculus OX=10090 GN=Muc4 PE=2 SV=2 MUC4_MOUSE reviewed Mucin-4 (MUC-4) (Ascites sialoglycoprotein) (ASGP) (Pancreatic adenocarcinoma mucin) (Testis mucin) [Cleaved into: Mucin-4 alpha chain (Ascites sialoglycoprotein 1) (ASGP-1); Mucin-4 beta chain (Ascites sialoglycoprotein 2) (ASGP-2)] Mus musculus (Mouse) GO:0001953; GO:0002244; GO:0002853; GO:0005176; GO:0005615; GO:0007160; GO:0016324; GO:0022408; GO:0030277; GO:0031012; GO:0031528; GO:0032991; GO:0043066; GO:0044877 cell-matrix adhesion [GO:0007160]; hematopoietic progenitor cell differentiation [GO:0002244]; maintenance of gastrointestinal epithelium [GO:0030277]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell-cell adhesion [GO:0022408]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of T cell mediated cytotoxicity directed against tumor cell target [GO:0002853] apical plasma membrane [GO:0016324]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; microvillus membrane [GO:0031528]; protein-containing complex [GO:0032991] ErbB-2 class receptor binding [GO:0005176]; protein-containing complex binding [GO:0044877] g15640.t1 P35555 31.992 472 1.65e-44 182.0 sp|P35555|FBN1_HUMAN Fibrillin-1 OS=Homo sapiens OX=9606 GN=FBN1 PE=1 SV=4 FBN1_HUMAN reviewed Fibrillin-1 [Cleaved into: Asprosin] Homo sapiens (Human) GO:0001501; GO:0001527; GO:0001656; GO:0005178; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0005604; GO:0005615; GO:0005788; GO:0006006; GO:0007507; GO:0008201; GO:0010467; GO:0030023; GO:0031012; GO:0033627; GO:0035582; GO:0035583; GO:0042593; GO:0042802; GO:0043010; GO:0044877; GO:0045671; GO:0048048; GO:0048050; GO:0048286; GO:0071560; GO:1990314; GO:2001205 camera-type eye development [GO:0043010]; cell adhesion mediated by integrin [GO:0033627]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to transforming growth factor beta stimulus [GO:0071560]; embryonic eye morphogenesis [GO:0048048]; gene expression [GO:0010467]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; heart development [GO:0007507]; lung alveolus development [GO:0048286]; metanephros development [GO:0001656]; negative regulation of osteoclast development [GO:2001205]; negative regulation of osteoclast differentiation [GO:0045671]; post-embryonic eye morphogenesis [GO:0048050]; sequestering of BMP in extracellular matrix [GO:0035582]; sequestering of TGFbeta in extracellular matrix [GO:0035583]; skeletal system development [GO:0001501] basement membrane [GO:0005604]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; microfibril [GO:0001527] calcium ion binding [GO:0005509]; extracellular matrix constituent conferring elasticity [GO:0030023]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; hormone activity [GO:0005179]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; protein-containing complex binding [GO:0044877] g15640.t1 P35555 36.919 409 7.29e-44 180.0 sp|P35555|FBN1_HUMAN Fibrillin-1 OS=Homo sapiens OX=9606 GN=FBN1 PE=1 SV=4 FBN1_HUMAN reviewed Fibrillin-1 [Cleaved into: Asprosin] Homo sapiens (Human) GO:0001501; GO:0001527; GO:0001656; GO:0005178; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0005604; GO:0005615; GO:0005788; GO:0006006; GO:0007507; GO:0008201; GO:0010467; GO:0030023; GO:0031012; GO:0033627; GO:0035582; GO:0035583; GO:0042593; GO:0042802; GO:0043010; GO:0044877; GO:0045671; GO:0048048; GO:0048050; GO:0048286; GO:0071560; GO:1990314; GO:2001205 camera-type eye development [GO:0043010]; cell adhesion mediated by integrin [GO:0033627]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to transforming growth factor beta stimulus [GO:0071560]; embryonic eye morphogenesis [GO:0048048]; gene expression [GO:0010467]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; heart development [GO:0007507]; lung alveolus development [GO:0048286]; metanephros development [GO:0001656]; negative regulation of osteoclast development [GO:2001205]; negative regulation of osteoclast differentiation [GO:0045671]; post-embryonic eye morphogenesis [GO:0048050]; sequestering of BMP in extracellular matrix [GO:0035582]; sequestering of TGFbeta in extracellular matrix [GO:0035583]; skeletal system development [GO:0001501] basement membrane [GO:0005604]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; microfibril [GO:0001527] calcium ion binding [GO:0005509]; extracellular matrix constituent conferring elasticity [GO:0030023]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; hormone activity [GO:0005179]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; protein-containing complex binding [GO:0044877] g15640.t1 P35555 32.553 470 5.79e-39 164.0 sp|P35555|FBN1_HUMAN Fibrillin-1 OS=Homo sapiens OX=9606 GN=FBN1 PE=1 SV=4 FBN1_HUMAN reviewed Fibrillin-1 [Cleaved into: Asprosin] Homo sapiens (Human) GO:0001501; GO:0001527; GO:0001656; GO:0005178; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0005604; GO:0005615; GO:0005788; GO:0006006; GO:0007507; GO:0008201; GO:0010467; GO:0030023; GO:0031012; GO:0033627; GO:0035582; GO:0035583; GO:0042593; GO:0042802; GO:0043010; GO:0044877; GO:0045671; GO:0048048; GO:0048050; GO:0048286; GO:0071560; GO:1990314; GO:2001205 camera-type eye development [GO:0043010]; cell adhesion mediated by integrin [GO:0033627]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to transforming growth factor beta stimulus [GO:0071560]; embryonic eye morphogenesis [GO:0048048]; gene expression [GO:0010467]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; heart development [GO:0007507]; lung alveolus development [GO:0048286]; metanephros development [GO:0001656]; negative regulation of osteoclast development [GO:2001205]; negative regulation of osteoclast differentiation [GO:0045671]; post-embryonic eye morphogenesis [GO:0048050]; sequestering of BMP in extracellular matrix [GO:0035582]; sequestering of TGFbeta in extracellular matrix [GO:0035583]; skeletal system development [GO:0001501] basement membrane [GO:0005604]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; microfibril [GO:0001527] calcium ion binding [GO:0005509]; extracellular matrix constituent conferring elasticity [GO:0030023]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; hormone activity [GO:0005179]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; protein-containing complex binding [GO:0044877] g15640.t1 P35555 29.791 574 3.14e-35 152.0 sp|P35555|FBN1_HUMAN Fibrillin-1 OS=Homo sapiens OX=9606 GN=FBN1 PE=1 SV=4 FBN1_HUMAN reviewed Fibrillin-1 [Cleaved into: Asprosin] Homo sapiens (Human) GO:0001501; GO:0001527; GO:0001656; GO:0005178; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0005604; GO:0005615; GO:0005788; GO:0006006; GO:0007507; GO:0008201; GO:0010467; GO:0030023; GO:0031012; GO:0033627; GO:0035582; GO:0035583; GO:0042593; GO:0042802; GO:0043010; GO:0044877; GO:0045671; GO:0048048; GO:0048050; GO:0048286; GO:0071560; GO:1990314; GO:2001205 camera-type eye development [GO:0043010]; cell adhesion mediated by integrin [GO:0033627]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to transforming growth factor beta stimulus [GO:0071560]; embryonic eye morphogenesis [GO:0048048]; gene expression [GO:0010467]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; heart development [GO:0007507]; lung alveolus development [GO:0048286]; metanephros development [GO:0001656]; negative regulation of osteoclast development [GO:2001205]; negative regulation of osteoclast differentiation [GO:0045671]; post-embryonic eye morphogenesis [GO:0048050]; sequestering of BMP in extracellular matrix [GO:0035582]; sequestering of TGFbeta in extracellular matrix [GO:0035583]; skeletal system development [GO:0001501] basement membrane [GO:0005604]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; microfibril [GO:0001527] calcium ion binding [GO:0005509]; extracellular matrix constituent conferring elasticity [GO:0030023]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; hormone activity [GO:0005179]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; protein-containing complex binding [GO:0044877] g15640.t1 P35555 31.204 548 2.88e-31 139.0 sp|P35555|FBN1_HUMAN Fibrillin-1 OS=Homo sapiens OX=9606 GN=FBN1 PE=1 SV=4 FBN1_HUMAN reviewed Fibrillin-1 [Cleaved into: Asprosin] Homo sapiens (Human) GO:0001501; GO:0001527; GO:0001656; GO:0005178; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0005604; GO:0005615; GO:0005788; GO:0006006; GO:0007507; GO:0008201; GO:0010467; GO:0030023; GO:0031012; GO:0033627; GO:0035582; GO:0035583; GO:0042593; GO:0042802; GO:0043010; GO:0044877; GO:0045671; GO:0048048; GO:0048050; GO:0048286; GO:0071560; GO:1990314; GO:2001205 camera-type eye development [GO:0043010]; cell adhesion mediated by integrin [GO:0033627]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to transforming growth factor beta stimulus [GO:0071560]; embryonic eye morphogenesis [GO:0048048]; gene expression [GO:0010467]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; heart development [GO:0007507]; lung alveolus development [GO:0048286]; metanephros development [GO:0001656]; negative regulation of osteoclast development [GO:2001205]; negative regulation of osteoclast differentiation [GO:0045671]; post-embryonic eye morphogenesis [GO:0048050]; sequestering of BMP in extracellular matrix [GO:0035582]; sequestering of TGFbeta in extracellular matrix [GO:0035583]; skeletal system development [GO:0001501] basement membrane [GO:0005604]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; microfibril [GO:0001527] calcium ion binding [GO:0005509]; extracellular matrix constituent conferring elasticity [GO:0030023]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; hormone activity [GO:0005179]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; protein-containing complex binding [GO:0044877] g15640.t1 P35555 35.161 310 3.29e-29 132.0 sp|P35555|FBN1_HUMAN Fibrillin-1 OS=Homo sapiens OX=9606 GN=FBN1 PE=1 SV=4 FBN1_HUMAN reviewed Fibrillin-1 [Cleaved into: Asprosin] Homo sapiens (Human) GO:0001501; GO:0001527; GO:0001656; GO:0005178; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0005604; GO:0005615; GO:0005788; GO:0006006; GO:0007507; GO:0008201; GO:0010467; GO:0030023; GO:0031012; GO:0033627; GO:0035582; GO:0035583; GO:0042593; GO:0042802; GO:0043010; GO:0044877; GO:0045671; GO:0048048; GO:0048050; GO:0048286; GO:0071560; GO:1990314; GO:2001205 camera-type eye development [GO:0043010]; cell adhesion mediated by integrin [GO:0033627]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to transforming growth factor beta stimulus [GO:0071560]; embryonic eye morphogenesis [GO:0048048]; gene expression [GO:0010467]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; heart development [GO:0007507]; lung alveolus development [GO:0048286]; metanephros development [GO:0001656]; negative regulation of osteoclast development [GO:2001205]; negative regulation of osteoclast differentiation [GO:0045671]; post-embryonic eye morphogenesis [GO:0048050]; sequestering of BMP in extracellular matrix [GO:0035582]; sequestering of TGFbeta in extracellular matrix [GO:0035583]; skeletal system development [GO:0001501] basement membrane [GO:0005604]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; microfibril [GO:0001527] calcium ion binding [GO:0005509]; extracellular matrix constituent conferring elasticity [GO:0030023]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; hormone activity [GO:0005179]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; protein-containing complex binding [GO:0044877] g15640.t1 P35555 29.118 601 5.37e-29 131.0 sp|P35555|FBN1_HUMAN Fibrillin-1 OS=Homo sapiens OX=9606 GN=FBN1 PE=1 SV=4 FBN1_HUMAN reviewed Fibrillin-1 [Cleaved into: Asprosin] Homo sapiens (Human) GO:0001501; GO:0001527; GO:0001656; GO:0005178; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0005604; GO:0005615; GO:0005788; GO:0006006; GO:0007507; GO:0008201; GO:0010467; GO:0030023; GO:0031012; GO:0033627; GO:0035582; GO:0035583; GO:0042593; GO:0042802; GO:0043010; GO:0044877; GO:0045671; GO:0048048; GO:0048050; GO:0048286; GO:0071560; GO:1990314; GO:2001205 camera-type eye development [GO:0043010]; cell adhesion mediated by integrin [GO:0033627]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to transforming growth factor beta stimulus [GO:0071560]; embryonic eye morphogenesis [GO:0048048]; gene expression [GO:0010467]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; heart development [GO:0007507]; lung alveolus development [GO:0048286]; metanephros development [GO:0001656]; negative regulation of osteoclast development [GO:2001205]; negative regulation of osteoclast differentiation [GO:0045671]; post-embryonic eye morphogenesis [GO:0048050]; sequestering of BMP in extracellular matrix [GO:0035582]; sequestering of TGFbeta in extracellular matrix [GO:0035583]; skeletal system development [GO:0001501] basement membrane [GO:0005604]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; microfibril [GO:0001527] calcium ion binding [GO:0005509]; extracellular matrix constituent conferring elasticity [GO:0030023]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; hormone activity [GO:0005179]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; protein-containing complex binding [GO:0044877] g15640.t1 P35555 27.193 684 9.35e-29 130.0 sp|P35555|FBN1_HUMAN Fibrillin-1 OS=Homo sapiens OX=9606 GN=FBN1 PE=1 SV=4 FBN1_HUMAN reviewed Fibrillin-1 [Cleaved into: Asprosin] Homo sapiens (Human) GO:0001501; GO:0001527; GO:0001656; GO:0005178; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0005604; GO:0005615; GO:0005788; GO:0006006; GO:0007507; GO:0008201; GO:0010467; GO:0030023; GO:0031012; GO:0033627; GO:0035582; GO:0035583; GO:0042593; GO:0042802; GO:0043010; GO:0044877; GO:0045671; GO:0048048; GO:0048050; GO:0048286; GO:0071560; GO:1990314; GO:2001205 camera-type eye development [GO:0043010]; cell adhesion mediated by integrin [GO:0033627]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to transforming growth factor beta stimulus [GO:0071560]; embryonic eye morphogenesis [GO:0048048]; gene expression [GO:0010467]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; heart development [GO:0007507]; lung alveolus development [GO:0048286]; metanephros development [GO:0001656]; negative regulation of osteoclast development [GO:2001205]; negative regulation of osteoclast differentiation [GO:0045671]; post-embryonic eye morphogenesis [GO:0048050]; sequestering of BMP in extracellular matrix [GO:0035582]; sequestering of TGFbeta in extracellular matrix [GO:0035583]; skeletal system development [GO:0001501] basement membrane [GO:0005604]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; microfibril [GO:0001527] calcium ion binding [GO:0005509]; extracellular matrix constituent conferring elasticity [GO:0030023]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; hormone activity [GO:0005179]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; protein-containing complex binding [GO:0044877] g15640.t1 P35555 29.754 568 1.85e-27 126.0 sp|P35555|FBN1_HUMAN Fibrillin-1 OS=Homo sapiens OX=9606 GN=FBN1 PE=1 SV=4 FBN1_HUMAN reviewed Fibrillin-1 [Cleaved into: Asprosin] Homo sapiens (Human) GO:0001501; GO:0001527; GO:0001656; GO:0005178; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0005604; GO:0005615; GO:0005788; GO:0006006; GO:0007507; GO:0008201; GO:0010467; GO:0030023; GO:0031012; GO:0033627; GO:0035582; GO:0035583; GO:0042593; GO:0042802; GO:0043010; GO:0044877; GO:0045671; GO:0048048; GO:0048050; GO:0048286; GO:0071560; GO:1990314; GO:2001205 camera-type eye development [GO:0043010]; cell adhesion mediated by integrin [GO:0033627]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to transforming growth factor beta stimulus [GO:0071560]; embryonic eye morphogenesis [GO:0048048]; gene expression [GO:0010467]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; heart development [GO:0007507]; lung alveolus development [GO:0048286]; metanephros development [GO:0001656]; negative regulation of osteoclast development [GO:2001205]; negative regulation of osteoclast differentiation [GO:0045671]; post-embryonic eye morphogenesis [GO:0048050]; sequestering of BMP in extracellular matrix [GO:0035582]; sequestering of TGFbeta in extracellular matrix [GO:0035583]; skeletal system development [GO:0001501] basement membrane [GO:0005604]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; microfibril [GO:0001527] calcium ion binding [GO:0005509]; extracellular matrix constituent conferring elasticity [GO:0030023]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; hormone activity [GO:0005179]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; protein-containing complex binding [GO:0044877] g15640.t1 P35555 32.558 387 9.67e-26 120.0 sp|P35555|FBN1_HUMAN Fibrillin-1 OS=Homo sapiens OX=9606 GN=FBN1 PE=1 SV=4 FBN1_HUMAN reviewed Fibrillin-1 [Cleaved into: Asprosin] Homo sapiens (Human) GO:0001501; GO:0001527; GO:0001656; GO:0005178; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0005604; GO:0005615; GO:0005788; GO:0006006; GO:0007507; GO:0008201; GO:0010467; GO:0030023; GO:0031012; GO:0033627; GO:0035582; GO:0035583; GO:0042593; GO:0042802; GO:0043010; GO:0044877; GO:0045671; GO:0048048; GO:0048050; GO:0048286; GO:0071560; GO:1990314; GO:2001205 camera-type eye development [GO:0043010]; cell adhesion mediated by integrin [GO:0033627]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to transforming growth factor beta stimulus [GO:0071560]; embryonic eye morphogenesis [GO:0048048]; gene expression [GO:0010467]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; heart development [GO:0007507]; lung alveolus development [GO:0048286]; metanephros development [GO:0001656]; negative regulation of osteoclast development [GO:2001205]; negative regulation of osteoclast differentiation [GO:0045671]; post-embryonic eye morphogenesis [GO:0048050]; sequestering of BMP in extracellular matrix [GO:0035582]; sequestering of TGFbeta in extracellular matrix [GO:0035583]; skeletal system development [GO:0001501] basement membrane [GO:0005604]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; microfibril [GO:0001527] calcium ion binding [GO:0005509]; extracellular matrix constituent conferring elasticity [GO:0030023]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; hormone activity [GO:0005179]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; protein-containing complex binding [GO:0044877] g15640.t1 P35555 30.0 500 1.74e-25 120.0 sp|P35555|FBN1_HUMAN Fibrillin-1 OS=Homo sapiens OX=9606 GN=FBN1 PE=1 SV=4 FBN1_HUMAN reviewed Fibrillin-1 [Cleaved into: Asprosin] Homo sapiens (Human) GO:0001501; GO:0001527; GO:0001656; GO:0005178; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0005604; GO:0005615; GO:0005788; GO:0006006; GO:0007507; GO:0008201; GO:0010467; GO:0030023; GO:0031012; GO:0033627; GO:0035582; GO:0035583; GO:0042593; GO:0042802; GO:0043010; GO:0044877; GO:0045671; GO:0048048; GO:0048050; GO:0048286; GO:0071560; GO:1990314; GO:2001205 camera-type eye development [GO:0043010]; cell adhesion mediated by integrin [GO:0033627]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to transforming growth factor beta stimulus [GO:0071560]; embryonic eye morphogenesis [GO:0048048]; gene expression [GO:0010467]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; heart development [GO:0007507]; lung alveolus development [GO:0048286]; metanephros development [GO:0001656]; negative regulation of osteoclast development [GO:2001205]; negative regulation of osteoclast differentiation [GO:0045671]; post-embryonic eye morphogenesis [GO:0048050]; sequestering of BMP in extracellular matrix [GO:0035582]; sequestering of TGFbeta in extracellular matrix [GO:0035583]; skeletal system development [GO:0001501] basement membrane [GO:0005604]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; microfibril [GO:0001527] calcium ion binding [GO:0005509]; extracellular matrix constituent conferring elasticity [GO:0030023]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; hormone activity [GO:0005179]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; protein-containing complex binding [GO:0044877] g15640.t1 P35555 30.682 440 8.209999999999999e-24 114.0 sp|P35555|FBN1_HUMAN Fibrillin-1 OS=Homo sapiens OX=9606 GN=FBN1 PE=1 SV=4 FBN1_HUMAN reviewed Fibrillin-1 [Cleaved into: Asprosin] Homo sapiens (Human) GO:0001501; GO:0001527; GO:0001656; GO:0005178; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0005604; GO:0005615; GO:0005788; GO:0006006; GO:0007507; GO:0008201; GO:0010467; GO:0030023; GO:0031012; GO:0033627; GO:0035582; GO:0035583; GO:0042593; GO:0042802; GO:0043010; GO:0044877; GO:0045671; GO:0048048; GO:0048050; GO:0048286; GO:0071560; GO:1990314; GO:2001205 camera-type eye development [GO:0043010]; cell adhesion mediated by integrin [GO:0033627]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to transforming growth factor beta stimulus [GO:0071560]; embryonic eye morphogenesis [GO:0048048]; gene expression [GO:0010467]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; heart development [GO:0007507]; lung alveolus development [GO:0048286]; metanephros development [GO:0001656]; negative regulation of osteoclast development [GO:2001205]; negative regulation of osteoclast differentiation [GO:0045671]; post-embryonic eye morphogenesis [GO:0048050]; sequestering of BMP in extracellular matrix [GO:0035582]; sequestering of TGFbeta in extracellular matrix [GO:0035583]; skeletal system development [GO:0001501] basement membrane [GO:0005604]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; microfibril [GO:0001527] calcium ion binding [GO:0005509]; extracellular matrix constituent conferring elasticity [GO:0030023]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; hormone activity [GO:0005179]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; protein-containing complex binding [GO:0044877] g15640.t1 P35555 29.151 518 5.7500000000000005e-21 105.0 sp|P35555|FBN1_HUMAN Fibrillin-1 OS=Homo sapiens OX=9606 GN=FBN1 PE=1 SV=4 FBN1_HUMAN reviewed Fibrillin-1 [Cleaved into: Asprosin] Homo sapiens (Human) GO:0001501; GO:0001527; GO:0001656; GO:0005178; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0005604; GO:0005615; GO:0005788; GO:0006006; GO:0007507; GO:0008201; GO:0010467; GO:0030023; GO:0031012; GO:0033627; GO:0035582; GO:0035583; GO:0042593; GO:0042802; GO:0043010; GO:0044877; GO:0045671; GO:0048048; GO:0048050; GO:0048286; GO:0071560; GO:1990314; GO:2001205 camera-type eye development [GO:0043010]; cell adhesion mediated by integrin [GO:0033627]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to transforming growth factor beta stimulus [GO:0071560]; embryonic eye morphogenesis [GO:0048048]; gene expression [GO:0010467]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; heart development [GO:0007507]; lung alveolus development [GO:0048286]; metanephros development [GO:0001656]; negative regulation of osteoclast development [GO:2001205]; negative regulation of osteoclast differentiation [GO:0045671]; post-embryonic eye morphogenesis [GO:0048050]; sequestering of BMP in extracellular matrix [GO:0035582]; sequestering of TGFbeta in extracellular matrix [GO:0035583]; skeletal system development [GO:0001501] basement membrane [GO:0005604]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; microfibril [GO:0001527] calcium ion binding [GO:0005509]; extracellular matrix constituent conferring elasticity [GO:0030023]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; hormone activity [GO:0005179]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; protein-containing complex binding [GO:0044877] g15640.t2 P35555 32.12 467 2.07e-44 182.0 sp|P35555|FBN1_HUMAN Fibrillin-1 OS=Homo sapiens OX=9606 GN=FBN1 PE=1 SV=4 FBN1_HUMAN reviewed Fibrillin-1 [Cleaved into: Asprosin] Homo sapiens (Human) GO:0001501; GO:0001527; GO:0001656; GO:0005178; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0005604; GO:0005615; GO:0005788; GO:0006006; GO:0007507; GO:0008201; GO:0010467; GO:0030023; GO:0031012; GO:0033627; GO:0035582; GO:0035583; GO:0042593; GO:0042802; GO:0043010; GO:0044877; GO:0045671; GO:0048048; GO:0048050; GO:0048286; GO:0071560; GO:1990314; GO:2001205 camera-type eye development [GO:0043010]; cell adhesion mediated by integrin [GO:0033627]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to transforming growth factor beta stimulus [GO:0071560]; embryonic eye morphogenesis [GO:0048048]; gene expression [GO:0010467]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; heart development [GO:0007507]; lung alveolus development [GO:0048286]; metanephros development [GO:0001656]; negative regulation of osteoclast development [GO:2001205]; negative regulation of osteoclast differentiation [GO:0045671]; post-embryonic eye morphogenesis [GO:0048050]; sequestering of BMP in extracellular matrix [GO:0035582]; sequestering of TGFbeta in extracellular matrix [GO:0035583]; skeletal system development [GO:0001501] basement membrane [GO:0005604]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; microfibril [GO:0001527] calcium ion binding [GO:0005509]; extracellular matrix constituent conferring elasticity [GO:0030023]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; hormone activity [GO:0005179]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; protein-containing complex binding [GO:0044877] g15640.t2 P35555 36.919 409 8.98e-44 180.0 sp|P35555|FBN1_HUMAN Fibrillin-1 OS=Homo sapiens OX=9606 GN=FBN1 PE=1 SV=4 FBN1_HUMAN reviewed Fibrillin-1 [Cleaved into: Asprosin] Homo sapiens (Human) GO:0001501; GO:0001527; GO:0001656; GO:0005178; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0005604; GO:0005615; GO:0005788; GO:0006006; GO:0007507; GO:0008201; GO:0010467; GO:0030023; GO:0031012; GO:0033627; GO:0035582; GO:0035583; GO:0042593; GO:0042802; GO:0043010; GO:0044877; GO:0045671; GO:0048048; GO:0048050; GO:0048286; GO:0071560; GO:1990314; GO:2001205 camera-type eye development [GO:0043010]; cell adhesion mediated by integrin [GO:0033627]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to transforming growth factor beta stimulus [GO:0071560]; embryonic eye morphogenesis [GO:0048048]; gene expression [GO:0010467]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; heart development [GO:0007507]; lung alveolus development [GO:0048286]; metanephros development [GO:0001656]; negative regulation of osteoclast development [GO:2001205]; negative regulation of osteoclast differentiation [GO:0045671]; post-embryonic eye morphogenesis [GO:0048050]; sequestering of BMP in extracellular matrix [GO:0035582]; sequestering of TGFbeta in extracellular matrix [GO:0035583]; skeletal system development [GO:0001501] basement membrane [GO:0005604]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; microfibril [GO:0001527] calcium ion binding [GO:0005509]; extracellular matrix constituent conferring elasticity [GO:0030023]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; hormone activity [GO:0005179]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; protein-containing complex binding [GO:0044877] g15640.t2 P35555 32.553 470 8.57e-39 163.0 sp|P35555|FBN1_HUMAN Fibrillin-1 OS=Homo sapiens OX=9606 GN=FBN1 PE=1 SV=4 FBN1_HUMAN reviewed Fibrillin-1 [Cleaved into: Asprosin] Homo sapiens (Human) GO:0001501; GO:0001527; GO:0001656; GO:0005178; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0005604; GO:0005615; GO:0005788; GO:0006006; GO:0007507; GO:0008201; GO:0010467; GO:0030023; GO:0031012; GO:0033627; GO:0035582; GO:0035583; GO:0042593; GO:0042802; GO:0043010; GO:0044877; GO:0045671; GO:0048048; GO:0048050; GO:0048286; GO:0071560; GO:1990314; GO:2001205 camera-type eye development [GO:0043010]; cell adhesion mediated by integrin [GO:0033627]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to transforming growth factor beta stimulus [GO:0071560]; embryonic eye morphogenesis [GO:0048048]; gene expression [GO:0010467]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; heart development [GO:0007507]; lung alveolus development [GO:0048286]; metanephros development [GO:0001656]; negative regulation of osteoclast development [GO:2001205]; negative regulation of osteoclast differentiation [GO:0045671]; post-embryonic eye morphogenesis [GO:0048050]; sequestering of BMP in extracellular matrix [GO:0035582]; sequestering of TGFbeta in extracellular matrix [GO:0035583]; skeletal system development [GO:0001501] basement membrane [GO:0005604]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; microfibril [GO:0001527] calcium ion binding [GO:0005509]; extracellular matrix constituent conferring elasticity [GO:0030023]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; hormone activity [GO:0005179]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; protein-containing complex binding [GO:0044877] g15640.t2 P35555 29.791 574 4.99e-35 151.0 sp|P35555|FBN1_HUMAN Fibrillin-1 OS=Homo sapiens OX=9606 GN=FBN1 PE=1 SV=4 FBN1_HUMAN reviewed Fibrillin-1 [Cleaved into: Asprosin] Homo sapiens (Human) GO:0001501; GO:0001527; GO:0001656; GO:0005178; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0005604; GO:0005615; GO:0005788; GO:0006006; GO:0007507; GO:0008201; GO:0010467; GO:0030023; GO:0031012; GO:0033627; GO:0035582; GO:0035583; GO:0042593; GO:0042802; GO:0043010; GO:0044877; GO:0045671; GO:0048048; GO:0048050; GO:0048286; GO:0071560; GO:1990314; GO:2001205 camera-type eye development [GO:0043010]; cell adhesion mediated by integrin [GO:0033627]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to transforming growth factor beta stimulus [GO:0071560]; embryonic eye morphogenesis [GO:0048048]; gene expression [GO:0010467]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; heart development [GO:0007507]; lung alveolus development [GO:0048286]; metanephros development [GO:0001656]; negative regulation of osteoclast development [GO:2001205]; negative regulation of osteoclast differentiation [GO:0045671]; post-embryonic eye morphogenesis [GO:0048050]; sequestering of BMP in extracellular matrix [GO:0035582]; sequestering of TGFbeta in extracellular matrix [GO:0035583]; skeletal system development [GO:0001501] basement membrane [GO:0005604]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; microfibril [GO:0001527] calcium ion binding [GO:0005509]; extracellular matrix constituent conferring elasticity [GO:0030023]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; hormone activity [GO:0005179]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; protein-containing complex binding [GO:0044877] g15640.t2 P35555 31.204 548 3.99e-31 138.0 sp|P35555|FBN1_HUMAN Fibrillin-1 OS=Homo sapiens OX=9606 GN=FBN1 PE=1 SV=4 FBN1_HUMAN reviewed Fibrillin-1 [Cleaved into: Asprosin] Homo sapiens (Human) GO:0001501; GO:0001527; GO:0001656; GO:0005178; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0005604; GO:0005615; GO:0005788; GO:0006006; GO:0007507; GO:0008201; GO:0010467; GO:0030023; GO:0031012; GO:0033627; GO:0035582; GO:0035583; GO:0042593; GO:0042802; GO:0043010; GO:0044877; GO:0045671; GO:0048048; GO:0048050; GO:0048286; GO:0071560; GO:1990314; GO:2001205 camera-type eye development [GO:0043010]; cell adhesion mediated by integrin [GO:0033627]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to transforming growth factor beta stimulus [GO:0071560]; embryonic eye morphogenesis [GO:0048048]; gene expression [GO:0010467]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; heart development [GO:0007507]; lung alveolus development [GO:0048286]; metanephros development [GO:0001656]; negative regulation of osteoclast development [GO:2001205]; negative regulation of osteoclast differentiation [GO:0045671]; post-embryonic eye morphogenesis [GO:0048050]; sequestering of BMP in extracellular matrix [GO:0035582]; sequestering of TGFbeta in extracellular matrix [GO:0035583]; skeletal system development [GO:0001501] basement membrane [GO:0005604]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; microfibril [GO:0001527] calcium ion binding [GO:0005509]; extracellular matrix constituent conferring elasticity [GO:0030023]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; hormone activity [GO:0005179]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; protein-containing complex binding [GO:0044877] g15640.t2 P35555 35.161 310 4.13e-29 132.0 sp|P35555|FBN1_HUMAN Fibrillin-1 OS=Homo sapiens OX=9606 GN=FBN1 PE=1 SV=4 FBN1_HUMAN reviewed Fibrillin-1 [Cleaved into: Asprosin] Homo sapiens (Human) GO:0001501; GO:0001527; GO:0001656; GO:0005178; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0005604; GO:0005615; GO:0005788; GO:0006006; GO:0007507; GO:0008201; GO:0010467; GO:0030023; GO:0031012; GO:0033627; GO:0035582; GO:0035583; GO:0042593; GO:0042802; GO:0043010; GO:0044877; GO:0045671; GO:0048048; GO:0048050; GO:0048286; GO:0071560; GO:1990314; GO:2001205 camera-type eye development [GO:0043010]; cell adhesion mediated by integrin [GO:0033627]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to transforming growth factor beta stimulus [GO:0071560]; embryonic eye morphogenesis [GO:0048048]; gene expression [GO:0010467]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; heart development [GO:0007507]; lung alveolus development [GO:0048286]; metanephros development [GO:0001656]; negative regulation of osteoclast development [GO:2001205]; negative regulation of osteoclast differentiation [GO:0045671]; post-embryonic eye morphogenesis [GO:0048050]; sequestering of BMP in extracellular matrix [GO:0035582]; sequestering of TGFbeta in extracellular matrix [GO:0035583]; skeletal system development [GO:0001501] basement membrane [GO:0005604]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; microfibril [GO:0001527] calcium ion binding [GO:0005509]; extracellular matrix constituent conferring elasticity [GO:0030023]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; hormone activity [GO:0005179]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; protein-containing complex binding [GO:0044877] g15640.t2 P35555 29.118 601 7.320000000000001e-29 131.0 sp|P35555|FBN1_HUMAN Fibrillin-1 OS=Homo sapiens OX=9606 GN=FBN1 PE=1 SV=4 FBN1_HUMAN reviewed Fibrillin-1 [Cleaved into: Asprosin] Homo sapiens (Human) GO:0001501; GO:0001527; GO:0001656; GO:0005178; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0005604; GO:0005615; GO:0005788; GO:0006006; GO:0007507; GO:0008201; GO:0010467; GO:0030023; GO:0031012; GO:0033627; GO:0035582; GO:0035583; GO:0042593; GO:0042802; GO:0043010; GO:0044877; GO:0045671; GO:0048048; GO:0048050; GO:0048286; GO:0071560; GO:1990314; GO:2001205 camera-type eye development [GO:0043010]; cell adhesion mediated by integrin [GO:0033627]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to transforming growth factor beta stimulus [GO:0071560]; embryonic eye morphogenesis [GO:0048048]; gene expression [GO:0010467]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; heart development [GO:0007507]; lung alveolus development [GO:0048286]; metanephros development [GO:0001656]; negative regulation of osteoclast development [GO:2001205]; negative regulation of osteoclast differentiation [GO:0045671]; post-embryonic eye morphogenesis [GO:0048050]; sequestering of BMP in extracellular matrix [GO:0035582]; sequestering of TGFbeta in extracellular matrix [GO:0035583]; skeletal system development [GO:0001501] basement membrane [GO:0005604]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; microfibril [GO:0001527] calcium ion binding [GO:0005509]; extracellular matrix constituent conferring elasticity [GO:0030023]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; hormone activity [GO:0005179]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; protein-containing complex binding [GO:0044877] g15640.t2 P35555 27.193 684 1.1199999999999999e-28 130.0 sp|P35555|FBN1_HUMAN Fibrillin-1 OS=Homo sapiens OX=9606 GN=FBN1 PE=1 SV=4 FBN1_HUMAN reviewed Fibrillin-1 [Cleaved into: Asprosin] Homo sapiens (Human) GO:0001501; GO:0001527; GO:0001656; GO:0005178; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0005604; GO:0005615; GO:0005788; GO:0006006; GO:0007507; GO:0008201; GO:0010467; GO:0030023; GO:0031012; GO:0033627; GO:0035582; GO:0035583; GO:0042593; GO:0042802; GO:0043010; GO:0044877; GO:0045671; GO:0048048; GO:0048050; GO:0048286; GO:0071560; GO:1990314; GO:2001205 camera-type eye development [GO:0043010]; cell adhesion mediated by integrin [GO:0033627]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to transforming growth factor beta stimulus [GO:0071560]; embryonic eye morphogenesis [GO:0048048]; gene expression [GO:0010467]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; heart development [GO:0007507]; lung alveolus development [GO:0048286]; metanephros development [GO:0001656]; negative regulation of osteoclast development [GO:2001205]; negative regulation of osteoclast differentiation [GO:0045671]; post-embryonic eye morphogenesis [GO:0048050]; sequestering of BMP in extracellular matrix [GO:0035582]; sequestering of TGFbeta in extracellular matrix [GO:0035583]; skeletal system development [GO:0001501] basement membrane [GO:0005604]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; microfibril [GO:0001527] calcium ion binding [GO:0005509]; extracellular matrix constituent conferring elasticity [GO:0030023]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; hormone activity [GO:0005179]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; protein-containing complex binding [GO:0044877] g15640.t2 P35555 29.754 568 2.3300000000000004e-27 126.0 sp|P35555|FBN1_HUMAN Fibrillin-1 OS=Homo sapiens OX=9606 GN=FBN1 PE=1 SV=4 FBN1_HUMAN reviewed Fibrillin-1 [Cleaved into: Asprosin] Homo sapiens (Human) GO:0001501; GO:0001527; GO:0001656; GO:0005178; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0005604; GO:0005615; GO:0005788; GO:0006006; GO:0007507; GO:0008201; GO:0010467; GO:0030023; GO:0031012; GO:0033627; GO:0035582; GO:0035583; GO:0042593; GO:0042802; GO:0043010; GO:0044877; GO:0045671; GO:0048048; GO:0048050; GO:0048286; GO:0071560; GO:1990314; GO:2001205 camera-type eye development [GO:0043010]; cell adhesion mediated by integrin [GO:0033627]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to transforming growth factor beta stimulus [GO:0071560]; embryonic eye morphogenesis [GO:0048048]; gene expression [GO:0010467]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; heart development [GO:0007507]; lung alveolus development [GO:0048286]; metanephros development [GO:0001656]; negative regulation of osteoclast development [GO:2001205]; negative regulation of osteoclast differentiation [GO:0045671]; post-embryonic eye morphogenesis [GO:0048050]; sequestering of BMP in extracellular matrix [GO:0035582]; sequestering of TGFbeta in extracellular matrix [GO:0035583]; skeletal system development [GO:0001501] basement membrane [GO:0005604]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; microfibril [GO:0001527] calcium ion binding [GO:0005509]; extracellular matrix constituent conferring elasticity [GO:0030023]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; hormone activity [GO:0005179]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; protein-containing complex binding [GO:0044877] g15640.t2 P35555 32.558 387 1.12e-25 120.0 sp|P35555|FBN1_HUMAN Fibrillin-1 OS=Homo sapiens OX=9606 GN=FBN1 PE=1 SV=4 FBN1_HUMAN reviewed Fibrillin-1 [Cleaved into: Asprosin] Homo sapiens (Human) GO:0001501; GO:0001527; GO:0001656; GO:0005178; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0005604; GO:0005615; GO:0005788; GO:0006006; GO:0007507; GO:0008201; GO:0010467; GO:0030023; GO:0031012; GO:0033627; GO:0035582; GO:0035583; GO:0042593; GO:0042802; GO:0043010; GO:0044877; GO:0045671; GO:0048048; GO:0048050; GO:0048286; GO:0071560; GO:1990314; GO:2001205 camera-type eye development [GO:0043010]; cell adhesion mediated by integrin [GO:0033627]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to transforming growth factor beta stimulus [GO:0071560]; embryonic eye morphogenesis [GO:0048048]; gene expression [GO:0010467]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; heart development [GO:0007507]; lung alveolus development [GO:0048286]; metanephros development [GO:0001656]; negative regulation of osteoclast development [GO:2001205]; negative regulation of osteoclast differentiation [GO:0045671]; post-embryonic eye morphogenesis [GO:0048050]; sequestering of BMP in extracellular matrix [GO:0035582]; sequestering of TGFbeta in extracellular matrix [GO:0035583]; skeletal system development [GO:0001501] basement membrane [GO:0005604]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; microfibril [GO:0001527] calcium ion binding [GO:0005509]; extracellular matrix constituent conferring elasticity [GO:0030023]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; hormone activity [GO:0005179]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; protein-containing complex binding [GO:0044877] g15640.t2 P35555 30.0 500 1.93e-25 119.0 sp|P35555|FBN1_HUMAN Fibrillin-1 OS=Homo sapiens OX=9606 GN=FBN1 PE=1 SV=4 FBN1_HUMAN reviewed Fibrillin-1 [Cleaved into: Asprosin] Homo sapiens (Human) GO:0001501; GO:0001527; GO:0001656; GO:0005178; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0005604; GO:0005615; GO:0005788; GO:0006006; GO:0007507; GO:0008201; GO:0010467; GO:0030023; GO:0031012; GO:0033627; GO:0035582; GO:0035583; GO:0042593; GO:0042802; GO:0043010; GO:0044877; GO:0045671; GO:0048048; GO:0048050; GO:0048286; GO:0071560; GO:1990314; GO:2001205 camera-type eye development [GO:0043010]; cell adhesion mediated by integrin [GO:0033627]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to transforming growth factor beta stimulus [GO:0071560]; embryonic eye morphogenesis [GO:0048048]; gene expression [GO:0010467]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; heart development [GO:0007507]; lung alveolus development [GO:0048286]; metanephros development [GO:0001656]; negative regulation of osteoclast development [GO:2001205]; negative regulation of osteoclast differentiation [GO:0045671]; post-embryonic eye morphogenesis [GO:0048050]; sequestering of BMP in extracellular matrix [GO:0035582]; sequestering of TGFbeta in extracellular matrix [GO:0035583]; skeletal system development [GO:0001501] basement membrane [GO:0005604]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; microfibril [GO:0001527] calcium ion binding [GO:0005509]; extracellular matrix constituent conferring elasticity [GO:0030023]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; hormone activity [GO:0005179]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; protein-containing complex binding [GO:0044877] g15640.t2 P35555 26.056 1136 1.4699999999999999e-24 117.0 sp|P35555|FBN1_HUMAN Fibrillin-1 OS=Homo sapiens OX=9606 GN=FBN1 PE=1 SV=4 FBN1_HUMAN reviewed Fibrillin-1 [Cleaved into: Asprosin] Homo sapiens (Human) GO:0001501; GO:0001527; GO:0001656; GO:0005178; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0005604; GO:0005615; GO:0005788; GO:0006006; GO:0007507; GO:0008201; GO:0010467; GO:0030023; GO:0031012; GO:0033627; GO:0035582; GO:0035583; GO:0042593; GO:0042802; GO:0043010; GO:0044877; GO:0045671; GO:0048048; GO:0048050; GO:0048286; GO:0071560; GO:1990314; GO:2001205 camera-type eye development [GO:0043010]; cell adhesion mediated by integrin [GO:0033627]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to transforming growth factor beta stimulus [GO:0071560]; embryonic eye morphogenesis [GO:0048048]; gene expression [GO:0010467]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; heart development [GO:0007507]; lung alveolus development [GO:0048286]; metanephros development [GO:0001656]; negative regulation of osteoclast development [GO:2001205]; negative regulation of osteoclast differentiation [GO:0045671]; post-embryonic eye morphogenesis [GO:0048050]; sequestering of BMP in extracellular matrix [GO:0035582]; sequestering of TGFbeta in extracellular matrix [GO:0035583]; skeletal system development [GO:0001501] basement membrane [GO:0005604]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; microfibril [GO:0001527] calcium ion binding [GO:0005509]; extracellular matrix constituent conferring elasticity [GO:0030023]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; hormone activity [GO:0005179]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; protein-containing complex binding [GO:0044877] g15640.t2 P35555 29.175 497 7.14e-21 104.0 sp|P35555|FBN1_HUMAN Fibrillin-1 OS=Homo sapiens OX=9606 GN=FBN1 PE=1 SV=4 FBN1_HUMAN reviewed Fibrillin-1 [Cleaved into: Asprosin] Homo sapiens (Human) GO:0001501; GO:0001527; GO:0001656; GO:0005178; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0005604; GO:0005615; GO:0005788; GO:0006006; GO:0007507; GO:0008201; GO:0010467; GO:0030023; GO:0031012; GO:0033627; GO:0035582; GO:0035583; GO:0042593; GO:0042802; GO:0043010; GO:0044877; GO:0045671; GO:0048048; GO:0048050; GO:0048286; GO:0071560; GO:1990314; GO:2001205 camera-type eye development [GO:0043010]; cell adhesion mediated by integrin [GO:0033627]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to transforming growth factor beta stimulus [GO:0071560]; embryonic eye morphogenesis [GO:0048048]; gene expression [GO:0010467]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; heart development [GO:0007507]; lung alveolus development [GO:0048286]; metanephros development [GO:0001656]; negative regulation of osteoclast development [GO:2001205]; negative regulation of osteoclast differentiation [GO:0045671]; post-embryonic eye morphogenesis [GO:0048050]; sequestering of BMP in extracellular matrix [GO:0035582]; sequestering of TGFbeta in extracellular matrix [GO:0035583]; skeletal system development [GO:0001501] basement membrane [GO:0005604]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; microfibril [GO:0001527] calcium ion binding [GO:0005509]; extracellular matrix constituent conferring elasticity [GO:0030023]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; hormone activity [GO:0005179]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; protein-containing complex binding [GO:0044877] g15646.t1 Q5RFH0 55.67 97 2.87e-34 117.0 sp|Q5RFH0|ATP5L_PONAB ATP synthase F(0) complex subunit g, mitochondrial OS=Pongo abelii OX=9601 GN=ATP5MG PE=3 SV=1 g15647.t1 Q9HBU1 78.351 97 4.52e-40 140.0 sp|Q9HBU1|BARX1_HUMAN Homeobox protein BarH-like 1 OS=Homo sapiens OX=9606 GN=BARX1 PE=1 SV=2 g15650.t1 A2VDQ7 47.607 397 2.9700000000000002e-123 380.0 sp|A2VDQ7|ZN420_BOVIN Zinc finger protein 420 OS=Bos taurus OX=9913 GN=ZNF420 PE=2 SV=1 g15650.t1 A2VDQ7 47.487 398 2.57e-121 375.0 sp|A2VDQ7|ZN420_BOVIN Zinc finger protein 420 OS=Bos taurus OX=9913 GN=ZNF420 PE=2 SV=1 g15650.t1 A2VDQ7 47.028 387 7.36e-115 359.0 sp|A2VDQ7|ZN420_BOVIN Zinc finger protein 420 OS=Bos taurus OX=9913 GN=ZNF420 PE=2 SV=1 g15650.t1 A2VDQ7 44.709 378 1.48e-113 355.0 sp|A2VDQ7|ZN420_BOVIN Zinc finger protein 420 OS=Bos taurus OX=9913 GN=ZNF420 PE=2 SV=1 g15650.t1 A2VDQ7 44.697 396 2.35e-113 355.0 sp|A2VDQ7|ZN420_BOVIN Zinc finger protein 420 OS=Bos taurus OX=9913 GN=ZNF420 PE=2 SV=1 g15650.t1 A2VDQ7 46.316 380 7.52e-113 353.0 sp|A2VDQ7|ZN420_BOVIN Zinc finger protein 420 OS=Bos taurus OX=9913 GN=ZNF420 PE=2 SV=1 g15650.t1 A2VDQ7 45.915 355 1.0900000000000001e-103 330.0 sp|A2VDQ7|ZN420_BOVIN Zinc finger protein 420 OS=Bos taurus OX=9913 GN=ZNF420 PE=2 SV=1 g15650.t1 A2VDQ7 42.294 279 7.339999999999999e-69 238.0 sp|A2VDQ7|ZN420_BOVIN Zinc finger protein 420 OS=Bos taurus OX=9913 GN=ZNF420 PE=2 SV=1 g15651.t1 A5PKG6 42.268 1067 0.0 853.0 sp|A5PKG6|UBE4A_BOVIN Ubiquitin conjugation factor E4 A OS=Bos taurus OX=9913 GN=UBE4A PE=2 SV=1 g15652.t1 Q8T674 35.049 719 1.38e-130 405.0 sp|Q8T674|ABCGK_DICDI ABC transporter G family member 20 OS=Dictyostelium discoideum OX=44689 GN=abcG20 PE=3 SV=1 g15653.t1 A2AJ76 30.314 541 4.22e-44 177.0 sp|A2AJ76|HMCN2_MOUSE Hemicentin-2 OS=Mus musculus OX=10090 GN=Hmcn2 PE=1 SV=1 HMCN2_MOUSE reviewed Hemicentin-2 Mus musculus (Mouse) GO:0005509; GO:0005576; GO:0005604; GO:0005886; GO:0005938; GO:0007156; GO:0008046; GO:0030054; GO:0030424; GO:0031012; GO:0032154; GO:0043025; GO:0050808 homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; synapse organization [GO:0050808] axon [GO:0030424]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886] axon guidance receptor activity [GO:0008046]; calcium ion binding [GO:0005509] g15653.t1 A2AJ76 27.007 548 2.5100000000000002e-43 174.0 sp|A2AJ76|HMCN2_MOUSE Hemicentin-2 OS=Mus musculus OX=10090 GN=Hmcn2 PE=1 SV=1 HMCN2_MOUSE reviewed Hemicentin-2 Mus musculus (Mouse) GO:0005509; GO:0005576; GO:0005604; GO:0005886; GO:0005938; GO:0007156; GO:0008046; GO:0030054; GO:0030424; GO:0031012; GO:0032154; GO:0043025; GO:0050808 homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; synapse organization [GO:0050808] axon [GO:0030424]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886] axon guidance receptor activity [GO:0008046]; calcium ion binding [GO:0005509] g15653.t1 A2AJ76 27.971 547 1.18e-42 172.0 sp|A2AJ76|HMCN2_MOUSE Hemicentin-2 OS=Mus musculus OX=10090 GN=Hmcn2 PE=1 SV=1 HMCN2_MOUSE reviewed Hemicentin-2 Mus musculus (Mouse) GO:0005509; GO:0005576; GO:0005604; GO:0005886; GO:0005938; GO:0007156; GO:0008046; GO:0030054; GO:0030424; GO:0031012; GO:0032154; GO:0043025; GO:0050808 homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; synapse organization [GO:0050808] axon [GO:0030424]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886] axon guidance receptor activity [GO:0008046]; calcium ion binding [GO:0005509] g15653.t1 A2AJ76 26.889 569 2e-38 159.0 sp|A2AJ76|HMCN2_MOUSE Hemicentin-2 OS=Mus musculus OX=10090 GN=Hmcn2 PE=1 SV=1 HMCN2_MOUSE reviewed Hemicentin-2 Mus musculus (Mouse) GO:0005509; GO:0005576; GO:0005604; GO:0005886; GO:0005938; GO:0007156; GO:0008046; GO:0030054; GO:0030424; GO:0031012; GO:0032154; GO:0043025; GO:0050808 homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; synapse organization [GO:0050808] axon [GO:0030424]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886] axon guidance receptor activity [GO:0008046]; calcium ion binding [GO:0005509] g15653.t1 A2AJ76 25.744 571 2.09e-38 159.0 sp|A2AJ76|HMCN2_MOUSE Hemicentin-2 OS=Mus musculus OX=10090 GN=Hmcn2 PE=1 SV=1 HMCN2_MOUSE reviewed Hemicentin-2 Mus musculus (Mouse) GO:0005509; GO:0005576; GO:0005604; GO:0005886; GO:0005938; GO:0007156; GO:0008046; GO:0030054; GO:0030424; GO:0031012; GO:0032154; GO:0043025; GO:0050808 homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; synapse organization [GO:0050808] axon [GO:0030424]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886] axon guidance receptor activity [GO:0008046]; calcium ion binding [GO:0005509] g15653.t1 A2AJ76 24.386 570 7.45e-38 157.0 sp|A2AJ76|HMCN2_MOUSE Hemicentin-2 OS=Mus musculus OX=10090 GN=Hmcn2 PE=1 SV=1 HMCN2_MOUSE reviewed Hemicentin-2 Mus musculus (Mouse) GO:0005509; GO:0005576; GO:0005604; GO:0005886; GO:0005938; GO:0007156; GO:0008046; GO:0030054; GO:0030424; GO:0031012; GO:0032154; GO:0043025; GO:0050808 homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; synapse organization [GO:0050808] axon [GO:0030424]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886] axon guidance receptor activity [GO:0008046]; calcium ion binding [GO:0005509] g15653.t1 A2AJ76 25.637 589 1.2600000000000001e-37 156.0 sp|A2AJ76|HMCN2_MOUSE Hemicentin-2 OS=Mus musculus OX=10090 GN=Hmcn2 PE=1 SV=1 HMCN2_MOUSE reviewed Hemicentin-2 Mus musculus (Mouse) GO:0005509; GO:0005576; GO:0005604; GO:0005886; GO:0005938; GO:0007156; GO:0008046; GO:0030054; GO:0030424; GO:0031012; GO:0032154; GO:0043025; GO:0050808 homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; synapse organization [GO:0050808] axon [GO:0030424]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886] axon guidance receptor activity [GO:0008046]; calcium ion binding [GO:0005509] g15653.t1 A2AJ76 25.723 657 1.44e-37 156.0 sp|A2AJ76|HMCN2_MOUSE Hemicentin-2 OS=Mus musculus OX=10090 GN=Hmcn2 PE=1 SV=1 HMCN2_MOUSE reviewed Hemicentin-2 Mus musculus (Mouse) GO:0005509; GO:0005576; GO:0005604; GO:0005886; GO:0005938; GO:0007156; GO:0008046; GO:0030054; GO:0030424; GO:0031012; GO:0032154; GO:0043025; GO:0050808 homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; synapse organization [GO:0050808] axon [GO:0030424]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886] axon guidance receptor activity [GO:0008046]; calcium ion binding [GO:0005509] g15653.t1 A2AJ76 24.459 601 3.12e-36 152.0 sp|A2AJ76|HMCN2_MOUSE Hemicentin-2 OS=Mus musculus OX=10090 GN=Hmcn2 PE=1 SV=1 HMCN2_MOUSE reviewed Hemicentin-2 Mus musculus (Mouse) GO:0005509; GO:0005576; GO:0005604; GO:0005886; GO:0005938; GO:0007156; GO:0008046; GO:0030054; GO:0030424; GO:0031012; GO:0032154; GO:0043025; GO:0050808 homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; synapse organization [GO:0050808] axon [GO:0030424]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886] axon guidance receptor activity [GO:0008046]; calcium ion binding [GO:0005509] g15653.t1 A2AJ76 24.407 590 7.25e-35 148.0 sp|A2AJ76|HMCN2_MOUSE Hemicentin-2 OS=Mus musculus OX=10090 GN=Hmcn2 PE=1 SV=1 HMCN2_MOUSE reviewed Hemicentin-2 Mus musculus (Mouse) GO:0005509; GO:0005576; GO:0005604; GO:0005886; GO:0005938; GO:0007156; GO:0008046; GO:0030054; GO:0030424; GO:0031012; GO:0032154; GO:0043025; GO:0050808 homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; synapse organization [GO:0050808] axon [GO:0030424]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886] axon guidance receptor activity [GO:0008046]; calcium ion binding [GO:0005509] g15653.t1 A2AJ76 26.316 532 2.89e-34 146.0 sp|A2AJ76|HMCN2_MOUSE Hemicentin-2 OS=Mus musculus OX=10090 GN=Hmcn2 PE=1 SV=1 HMCN2_MOUSE reviewed Hemicentin-2 Mus musculus (Mouse) GO:0005509; GO:0005576; GO:0005604; GO:0005886; GO:0005938; GO:0007156; GO:0008046; GO:0030054; GO:0030424; GO:0031012; GO:0032154; GO:0043025; GO:0050808 homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; synapse organization [GO:0050808] axon [GO:0030424]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886] axon guidance receptor activity [GO:0008046]; calcium ion binding [GO:0005509] g15653.t1 A2AJ76 26.817 578 1.4000000000000001e-33 144.0 sp|A2AJ76|HMCN2_MOUSE Hemicentin-2 OS=Mus musculus OX=10090 GN=Hmcn2 PE=1 SV=1 HMCN2_MOUSE reviewed Hemicentin-2 Mus musculus (Mouse) GO:0005509; GO:0005576; GO:0005604; GO:0005886; GO:0005938; GO:0007156; GO:0008046; GO:0030054; GO:0030424; GO:0031012; GO:0032154; GO:0043025; GO:0050808 homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; synapse organization [GO:0050808] axon [GO:0030424]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886] axon guidance receptor activity [GO:0008046]; calcium ion binding [GO:0005509] g15653.t1 A2AJ76 25.191 524 9.46e-33 141.0 sp|A2AJ76|HMCN2_MOUSE Hemicentin-2 OS=Mus musculus OX=10090 GN=Hmcn2 PE=1 SV=1 HMCN2_MOUSE reviewed Hemicentin-2 Mus musculus (Mouse) GO:0005509; GO:0005576; GO:0005604; GO:0005886; GO:0005938; GO:0007156; GO:0008046; GO:0030054; GO:0030424; GO:0031012; GO:0032154; GO:0043025; GO:0050808 homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; synapse organization [GO:0050808] axon [GO:0030424]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886] axon guidance receptor activity [GO:0008046]; calcium ion binding [GO:0005509] g15653.t1 A2AJ76 25.651 538 7.66e-30 132.0 sp|A2AJ76|HMCN2_MOUSE Hemicentin-2 OS=Mus musculus OX=10090 GN=Hmcn2 PE=1 SV=1 HMCN2_MOUSE reviewed Hemicentin-2 Mus musculus (Mouse) GO:0005509; GO:0005576; GO:0005604; GO:0005886; GO:0005938; GO:0007156; GO:0008046; GO:0030054; GO:0030424; GO:0031012; GO:0032154; GO:0043025; GO:0050808 homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; synapse organization [GO:0050808] axon [GO:0030424]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886] axon guidance receptor activity [GO:0008046]; calcium ion binding [GO:0005509] g15653.t1 A2AJ76 22.085 566 6.33e-28 125.0 sp|A2AJ76|HMCN2_MOUSE Hemicentin-2 OS=Mus musculus OX=10090 GN=Hmcn2 PE=1 SV=1 HMCN2_MOUSE reviewed Hemicentin-2 Mus musculus (Mouse) GO:0005509; GO:0005576; GO:0005604; GO:0005886; GO:0005938; GO:0007156; GO:0008046; GO:0030054; GO:0030424; GO:0031012; GO:0032154; GO:0043025; GO:0050808 homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; synapse organization [GO:0050808] axon [GO:0030424]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886] axon guidance receptor activity [GO:0008046]; calcium ion binding [GO:0005509] g15653.t1 A2AJ76 26.087 414 7.32e-24 112.0 sp|A2AJ76|HMCN2_MOUSE Hemicentin-2 OS=Mus musculus OX=10090 GN=Hmcn2 PE=1 SV=1 HMCN2_MOUSE reviewed Hemicentin-2 Mus musculus (Mouse) GO:0005509; GO:0005576; GO:0005604; GO:0005886; GO:0005938; GO:0007156; GO:0008046; GO:0030054; GO:0030424; GO:0031012; GO:0032154; GO:0043025; GO:0050808 homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; synapse organization [GO:0050808] axon [GO:0030424]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886] axon guidance receptor activity [GO:0008046]; calcium ion binding [GO:0005509] g15654.t1 Q9TZH6 69.892 93 1.1e-46 150.0 sp|Q9TZH6|PHS_CAEEL Putative pterin-4-alpha-carbinolamine dehydratase OS=Caenorhabditis elegans OX=6239 GN=pcbd-1 PE=3 SV=3 g15655.t1 O95490 23.482 741 2.03e-25 117.0 sp|O95490|AGRL2_HUMAN Adhesion G protein-coupled receptor L2 OS=Homo sapiens OX=9606 GN=ADGRL2 PE=1 SV=2 g15657.t1 Q60HE6 48.261 460 2.52e-150 452.0 sp|Q60HE6|MRE11_MACFA Double-strand break repair protein MRE11 OS=Macaca fascicularis OX=9541 GN=MRE11 PE=2 SV=1 g15670.t1 Q9VBW3 48.089 314 5.11e-93 297.0 sp|Q9VBW3|CAD96_DROME Tyrosine kinase receptor Cad96Ca OS=Drosophila melanogaster OX=7227 GN=Cad96Ca PE=2 SV=2 CAD96_DROME reviewed Tyrosine kinase receptor Cad96Ca (EC 2.7.10.1) (Cadherin-96Ca) (Tyrosine kinase receptor HD-14) Drosophila melanogaster (Fruit fly) GO:0004713; GO:0004714; GO:0005509; GO:0005524; GO:0005886; GO:0006468; GO:0007030; GO:0007156; GO:0007169; GO:0016339; GO:0042060; GO:0043235; GO:0045177; GO:0045792; GO:0051897; GO:0090303 calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; Golgi organization [GO:0007030]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell size [GO:0045792]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of wound healing [GO:0090303]; protein phosphorylation [GO:0006468]; wound healing [GO:0042060] apical part of cell [GO:0045177]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; protein tyrosine kinase activity [GO:0004713]; transmembrane receptor protein tyrosine kinase activity [GO:0004714] g15674.t1 O75899 36.677 319 2.2799999999999997e-52 197.0 sp|O75899|GABR2_HUMAN Gamma-aminobutyric acid type B receptor subunit 2 OS=Homo sapiens OX=9606 GN=GABBR2 PE=1 SV=1 GABR2_HUMAN reviewed Gamma-aminobutyric acid type B receptor subunit 2 (GABA-B receptor 2) (GABA-B-R2) (GABA-BR2) (GABABR2) (Gb2) (G-protein coupled receptor 51) (HG20) Homo sapiens (Human) GO:0004888; GO:0004965; GO:0005737; GO:0005886; GO:0007186; GO:0007193; GO:0007194; GO:0007214; GO:0007268; GO:0038039; GO:0043005; GO:0045211; GO:0046982; GO:0051932; GO:0150099; GO:1902710; GO:1902712 adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; chemical synaptic transmission [GO:0007268]; G protein-coupled receptor signaling pathway [GO:0007186]; gamma-aminobutyric acid signaling pathway [GO:0007214]; negative regulation of adenylate cyclase activity [GO:0007194]; neuron-glial cell signaling [GO:0150099]; synaptic transmission, GABAergic [GO:0051932] cytoplasm [GO:0005737]; G protein-coupled GABA receptor complex [GO:1902712]; G protein-coupled receptor heterodimeric complex [GO:0038039]; GABA receptor complex [GO:1902710]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211] G protein-coupled GABA receptor activity [GO:0004965]; protein heterodimerization activity [GO:0046982]; transmembrane signaling receptor activity [GO:0004888] g15675.t1 Q6PBI5 73.256 86 8.18e-38 129.0 sp|Q6PBI5|RS25_DANRE Small ribosomal subunit protein eS25 OS=Danio rerio OX=7955 GN=rps25 PE=1 SV=1 g15676.t1 Q96MT7 39.875 1116 0.0 674.0 sp|Q96MT7|CFA44_HUMAN Cilia- and flagella-associated protein 44 OS=Homo sapiens OX=9606 GN=CFAP44 PE=1 SV=2 CFA44_HUMAN reviewed Cilia- and flagella-associated protein 44 (WD repeat-containing protein 52) Homo sapiens (Human) GO:0000226; GO:0000902; GO:0006997; GO:0007288; GO:0008233; GO:0031514 cell morphogenesis [GO:0000902]; microtubule cytoskeleton organization [GO:0000226]; nucleus organization [GO:0006997]; sperm axoneme assembly [GO:0007288] motile cilium [GO:0031514] peptidase activity [GO:0008233] g15676.t1 Q96MT7 52.692 520 7.86e-180 600.0 sp|Q96MT7|CFA44_HUMAN Cilia- and flagella-associated protein 44 OS=Homo sapiens OX=9606 GN=CFAP44 PE=1 SV=2 CFA44_HUMAN reviewed Cilia- and flagella-associated protein 44 (WD repeat-containing protein 52) Homo sapiens (Human) GO:0000226; GO:0000902; GO:0006997; GO:0007288; GO:0008233; GO:0031514 cell morphogenesis [GO:0000902]; microtubule cytoskeleton organization [GO:0000226]; nucleus organization [GO:0006997]; sperm axoneme assembly [GO:0007288] motile cilium [GO:0031514] peptidase activity [GO:0008233] g15678.t1 Q61070 54.459 314 5.85e-98 295.0 sp|Q61070|EI24_MOUSE Etoposide-induced protein 2.4 OS=Mus musculus OX=10090 GN=Ei24 PE=1 SV=3 EI24_MOUSE reviewed Etoposide-induced protein 2.4 (p53-induced gene 8 protein) Mus musculus (Mouse) GO:0005783; GO:0005789; GO:0005794; GO:0005829; GO:0006914; GO:0008630; GO:0009410; GO:0016236; GO:0030308; GO:0031965; GO:0042308; GO:0050885; GO:0061676; GO:0071494; GO:2001244 autophagy [GO:0006914]; cellular response to UV-C [GO:0071494]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; macroautophagy [GO:0016236]; negative regulation of cell growth [GO:0030308]; negative regulation of protein import into nucleus [GO:0042308]; neuromuscular process controlling balance [GO:0050885]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; response to xenobiotic stimulus [GO:0009410] cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; nuclear membrane [GO:0031965] importin-alpha family protein binding [GO:0061676] g15679.t1 Q9Y2M2 35.667 300 1.68e-52 183.0 sp|Q9Y2M2|SSUH2_HUMAN Protein SSUH2 homolog OS=Homo sapiens OX=9606 GN=SSUH2 PE=1 SV=2 g15683.t1 Q7ZUW2 60.901 555 0.0 679.0 sp|Q7ZUW2|HYOU1_DANRE Hypoxia up-regulated protein 1 OS=Danio rerio OX=7955 GN=hyou1 PE=2 SV=1 HYOU1_DANRE reviewed Hypoxia up-regulated protein 1 Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000774; GO:0005524; GO:0005788; GO:0006950; GO:0034663; GO:0140662; GO:1903298 negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway [GO:1903298]; response to stress [GO:0006950] endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum lumen [GO:0005788] adenyl-nucleotide exchange factor activity [GO:0000774]; ATP binding [GO:0005524]; ATP-dependent protein folding chaperone [GO:0140662] g15684.t1 Q9QXF7 37.029 478 9.4e-101 314.0 sp|Q9QXF7|CP2J4_RAT Cytochrome P450 2J4 OS=Rattus norvegicus OX=10116 GN=CYP2J4 PE=1 SV=1 g15685.t1 Q4V8D1 35.853 463 1.54e-88 283.0 sp|Q4V8D1|CP2U1_RAT Cytochrome P450 2U1 OS=Rattus norvegicus OX=10116 GN=Cyp2u1 PE=1 SV=1 CP2U1_RAT reviewed Cytochrome P450 2U1 (Long-chain fatty acid omega-monooxygenase) (EC 1.14.14.80) Rattus norvegicus (Rat) GO:0005506; GO:0005737; GO:0005743; GO:0005789; GO:0006082; GO:0006805; GO:0008202; GO:0008395; GO:0016712; GO:0020037; GO:0052869; GO:0097267; GO:0102033 omega-hydroxylase P450 pathway [GO:0097267]; organic acid metabolic process [GO:0006082]; steroid metabolic process [GO:0008202]; xenobiotic metabolic process [GO:0006805] cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; mitochondrial inner membrane [GO:0005743] arachidonate omega-hydroxylase activity [GO:0052869]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; long-chain fatty acid omega-hydroxylase activity [GO:0102033]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; steroid hydroxylase activity [GO:0008395] g15687.t1 Q9Z2F6 30.859 256 4.81e-24 104.0 sp|Q9Z2F6|BCL3_MOUSE B-cell lymphoma 3 protein homolog OS=Mus musculus OX=10090 GN=Bcl3 PE=1 SV=2 BCL3_MOUSE reviewed B-cell lymphoma 3 protein homolog (BCL-3) Mus musculus (Mouse) GO:0002268; GO:0002315; GO:0002455; GO:0002467; GO:0003713; GO:0003714; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006606; GO:0006974; GO:0007249; GO:0009615; GO:0010225; GO:0019730; GO:0030198; GO:0030330; GO:0030496; GO:0030674; GO:0032717; GO:0032720; GO:0032729; GO:0032733; GO:0032991; GO:0032996; GO:0033257; GO:0036064; GO:0042088; GO:0042742; GO:0042771; GO:0042826; GO:0042832; GO:0042981; GO:0043066; GO:0045064; GO:0045727; GO:0045892; GO:0045893; GO:0045944; GO:0046426; GO:0048471; GO:0048536; GO:0140297; GO:1901222 antimicrobial humoral response [GO:0019730]; canonical NF-kappaB signal transduction [GO:0007249]; defense response to bacterium [GO:0042742]; defense response to protozoan [GO:0042832]; DNA damage response [GO:0006974]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; extracellular matrix organization [GO:0030198]; follicular dendritic cell differentiation [GO:0002268]; germinal center formation [GO:0002467]; humoral immune response mediated by circulating immunoglobulin [GO:0002455]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; marginal zone B cell differentiation [GO:0002315]; negative regulation of apoptotic process [GO:0043066]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of interleukin-8 production [GO:0032717]; negative regulation of receptor signaling pathway via JAK-STAT [GO:0046426]; negative regulation of tumor necrosis factor production [GO:0032720]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of interleukin-10 production [GO:0032733]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of translation [GO:0045727]; positive regulation of type II interferon production [GO:0032729]; protein import into nucleus [GO:0006606]; regulation of apoptotic process [GO:0042981]; regulation of non-canonical NF-kappaB signal transduction [GO:1901222]; response to UV-C [GO:0010225]; response to virus [GO:0009615]; spleen development [GO:0048536]; T-helper 1 type immune response [GO:0042088]; T-helper 2 cell differentiation [GO:0045064] Bcl3-Bcl10 complex [GO:0032996]; Bcl3/NF-kappaB2 complex [GO:0033257]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; midbody [GO:0030496]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991] DNA-binding transcription factor binding [GO:0140297]; histone deacetylase binding [GO:0042826]; protein-macromolecule adaptor activity [GO:0030674]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714] g15689.t1 Q63665 52.874 348 2.8e-102 306.0 sp|Q63665|USF2_RAT Upstream stimulatory factor 2 OS=Rattus norvegicus OX=10116 GN=Usf2 PE=1 SV=2 g15691.t1 O57429 39.691 388 9.68e-81 270.0 sp|O57429|UBP2_CHICK Ubiquitin carboxyl-terminal hydrolase 2 OS=Gallus gallus OX=9031 GN=USP2 PE=2 SV=1 g15691.t2 O57429 44.898 343 3.68e-90 295.0 sp|O57429|UBP2_CHICK Ubiquitin carboxyl-terminal hydrolase 2 OS=Gallus gallus OX=9031 GN=USP2 PE=2 SV=1 g15695.t1 O75636 43.216 199 2.11e-40 146.0 sp|O75636|FCN3_HUMAN Ficolin-3 OS=Homo sapiens OX=9606 GN=FCN3 PE=1 SV=2 FCN3_HUMAN reviewed Ficolin-3 (Collagen/fibrinogen domain-containing lectin 3 p35) (Collagen/fibrinogen domain-containing protein 3) (H-ficolin) (Hakata antigen) Homo sapiens (Human) GO:0001867; GO:0002752; GO:0003823; GO:0005102; GO:0005576; GO:0005581; GO:0005615; GO:0006508; GO:0006956; GO:0009897; GO:0030246; GO:0038187; GO:0043654; GO:0046597; GO:0046872; GO:0051607; GO:0072562; GO:0097367; GO:0106139; GO:1902679; GO:1903028; GO:1905370 cell surface pattern recognition receptor signaling pathway [GO:0002752]; complement activation [GO:0006956]; complement activation, lectin pathway [GO:0001867]; defense response to virus [GO:0051607]; host-mediated suppression of symbiont invasion [GO:0046597]; negative regulation of RNA biosynthetic process [GO:1902679]; positive regulation of opsonization [GO:1903028]; proteolysis [GO:0006508]; recognition of apoptotic cell [GO:0043654] blood microparticle [GO:0072562]; collagen trimer [GO:0005581]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; serine-type endopeptidase complex [GO:1905370]; symbiont cell surface [GO:0106139] antigen binding [GO:0003823]; carbohydrate binding [GO:0030246]; carbohydrate derivative binding [GO:0097367]; metal ion binding [GO:0046872]; pattern recognition receptor activity [GO:0038187]; signaling receptor binding [GO:0005102] g15696.t1 Q9NZN5 48.485 198 3.93e-44 167.0 sp|Q9NZN5|ARHGC_HUMAN Rho guanine nucleotide exchange factor 12 OS=Homo sapiens OX=9606 GN=ARHGEF12 PE=1 SV=1 ARHGC_HUMAN reviewed Rho guanine nucleotide exchange factor 12 (Leukemia-associated RhoGEF) Homo sapiens (Human) GO:0001664; GO:0005085; GO:0005096; GO:0005737; GO:0005829; GO:0007186; GO:0007266; GO:0016020; GO:0051056; GO:0070062; GO:0160221 G protein-coupled receptor signaling pathway [GO:0007186]; regulation of small GTPase mediated signal transduction [GO:0051056]; Rho protein signal transduction [GO:0007266]; Rho-activating G protein-coupled receptor signaling pathway [GO:0160221] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020] G protein-coupled receptor binding [GO:0001664]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085] g15697.t1 Q9NZN5 50.524 382 7.11e-101 360.0 sp|Q9NZN5|ARHGC_HUMAN Rho guanine nucleotide exchange factor 12 OS=Homo sapiens OX=9606 GN=ARHGEF12 PE=1 SV=1 ARHGC_HUMAN reviewed Rho guanine nucleotide exchange factor 12 (Leukemia-associated RhoGEF) Homo sapiens (Human) GO:0001664; GO:0005085; GO:0005096; GO:0005737; GO:0005829; GO:0007186; GO:0007266; GO:0016020; GO:0051056; GO:0070062; GO:0160221 G protein-coupled receptor signaling pathway [GO:0007186]; regulation of small GTPase mediated signal transduction [GO:0051056]; Rho protein signal transduction [GO:0007266]; Rho-activating G protein-coupled receptor signaling pathway [GO:0160221] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020] G protein-coupled receptor binding [GO:0001664]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085] g15697.t1 Q9NZN5 31.466 232 8.74e-22 107.0 sp|Q9NZN5|ARHGC_HUMAN Rho guanine nucleotide exchange factor 12 OS=Homo sapiens OX=9606 GN=ARHGEF12 PE=1 SV=1 ARHGC_HUMAN reviewed Rho guanine nucleotide exchange factor 12 (Leukemia-associated RhoGEF) Homo sapiens (Human) GO:0001664; GO:0005085; GO:0005096; GO:0005737; GO:0005829; GO:0007186; GO:0007266; GO:0016020; GO:0051056; GO:0070062; GO:0160221 G protein-coupled receptor signaling pathway [GO:0007186]; regulation of small GTPase mediated signal transduction [GO:0051056]; Rho protein signal transduction [GO:0007266]; Rho-activating G protein-coupled receptor signaling pathway [GO:0160221] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020] G protein-coupled receptor binding [GO:0001664]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085] g15697.t2 Q9NZN5 50.524 382 6.18e-101 361.0 sp|Q9NZN5|ARHGC_HUMAN Rho guanine nucleotide exchange factor 12 OS=Homo sapiens OX=9606 GN=ARHGEF12 PE=1 SV=1 ARHGC_HUMAN reviewed Rho guanine nucleotide exchange factor 12 (Leukemia-associated RhoGEF) Homo sapiens (Human) GO:0001664; GO:0005085; GO:0005096; GO:0005737; GO:0005829; GO:0007186; GO:0007266; GO:0016020; GO:0051056; GO:0070062; GO:0160221 G protein-coupled receptor signaling pathway [GO:0007186]; regulation of small GTPase mediated signal transduction [GO:0051056]; Rho protein signal transduction [GO:0007266]; Rho-activating G protein-coupled receptor signaling pathway [GO:0160221] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020] G protein-coupled receptor binding [GO:0001664]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085] g15697.t2 Q9NZN5 31.466 232 8.4e-22 107.0 sp|Q9NZN5|ARHGC_HUMAN Rho guanine nucleotide exchange factor 12 OS=Homo sapiens OX=9606 GN=ARHGEF12 PE=1 SV=1 ARHGC_HUMAN reviewed Rho guanine nucleotide exchange factor 12 (Leukemia-associated RhoGEF) Homo sapiens (Human) GO:0001664; GO:0005085; GO:0005096; GO:0005737; GO:0005829; GO:0007186; GO:0007266; GO:0016020; GO:0051056; GO:0070062; GO:0160221 G protein-coupled receptor signaling pathway [GO:0007186]; regulation of small GTPase mediated signal transduction [GO:0051056]; Rho protein signal transduction [GO:0007266]; Rho-activating G protein-coupled receptor signaling pathway [GO:0160221] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020] G protein-coupled receptor binding [GO:0001664]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085] g15697.t3 Q9NZN5 50.524 382 5.74e-101 361.0 sp|Q9NZN5|ARHGC_HUMAN Rho guanine nucleotide exchange factor 12 OS=Homo sapiens OX=9606 GN=ARHGEF12 PE=1 SV=1 ARHGC_HUMAN reviewed Rho guanine nucleotide exchange factor 12 (Leukemia-associated RhoGEF) Homo sapiens (Human) GO:0001664; GO:0005085; GO:0005096; GO:0005737; GO:0005829; GO:0007186; GO:0007266; GO:0016020; GO:0051056; GO:0070062; GO:0160221 G protein-coupled receptor signaling pathway [GO:0007186]; regulation of small GTPase mediated signal transduction [GO:0051056]; Rho protein signal transduction [GO:0007266]; Rho-activating G protein-coupled receptor signaling pathway [GO:0160221] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020] G protein-coupled receptor binding [GO:0001664]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085] g15697.t3 Q9NZN5 31.466 232 7.89e-22 107.0 sp|Q9NZN5|ARHGC_HUMAN Rho guanine nucleotide exchange factor 12 OS=Homo sapiens OX=9606 GN=ARHGEF12 PE=1 SV=1 ARHGC_HUMAN reviewed Rho guanine nucleotide exchange factor 12 (Leukemia-associated RhoGEF) Homo sapiens (Human) GO:0001664; GO:0005085; GO:0005096; GO:0005737; GO:0005829; GO:0007186; GO:0007266; GO:0016020; GO:0051056; GO:0070062; GO:0160221 G protein-coupled receptor signaling pathway [GO:0007186]; regulation of small GTPase mediated signal transduction [GO:0051056]; Rho protein signal transduction [GO:0007266]; Rho-activating G protein-coupled receptor signaling pathway [GO:0160221] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020] G protein-coupled receptor binding [GO:0001664]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085] g15698.t1 Q75Q39 50.749 534 3e-176 513.0 sp|Q75Q39|TOM70_RAT Mitochondrial import receptor subunit TOM70 OS=Rattus norvegicus OX=10116 GN=Tomm70 PE=1 SV=1 TOM70_RAT reviewed Mitochondrial import receptor subunit TOM70 (Mitochondrial precursor proteins import receptor) (Translocase of outer membrane 70 kDa subunit) (Translocase of outer mitochondrial membrane protein 70) Rattus norvegicus (Rat) GO:0002218; GO:0002230; GO:0005739; GO:0005741; GO:0006626; GO:0009299; GO:0030150; GO:0030674; GO:0030943; GO:0031966; GO:0032728; GO:0042981; GO:0045039; GO:0060090; GO:0061052; GO:0097068; GO:0098586; GO:0140374; GO:1903955 activation of innate immune response [GO:0002218]; antiviral innate immune response [GO:0140374]; cellular response to virus [GO:0098586]; mRNA transcription [GO:0009299]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of protein targeting to mitochondrion [GO:1903955]; protein import into mitochondrial matrix [GO:0030150]; protein insertion into mitochondrial inner membrane [GO:0045039]; protein targeting to mitochondrion [GO:0006626]; regulation of apoptotic process [GO:0042981]; response to thyroxine [GO:0097068] mitochondrial membrane [GO:0031966]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739] mitochondrion targeting sequence binding [GO:0030943]; molecular adaptor activity [GO:0060090]; protein-macromolecule adaptor activity [GO:0030674] g15699.t1 Q9NYG2 36.33 267 2.9900000000000002e-33 126.0 sp|Q9NYG2|ZDHC3_HUMAN Palmitoyltransferase ZDHHC3 OS=Homo sapiens OX=9606 GN=ZDHHC3 PE=1 SV=2 g15710.t1 Q90268 73.282 131 6.700000000000001e-56 192.0 sp|Q90268|PAX2A_DANRE Paired box protein Pax-2a OS=Danio rerio OX=7955 GN=pax2a PE=2 SV=2 g15710.t2 Q90268 73.282 131 6.43e-56 192.0 sp|Q90268|PAX2A_DANRE Paired box protein Pax-2a OS=Danio rerio OX=7955 GN=pax2a PE=2 SV=2 g15712.t1 Q9VBW3 44.371 302 5.68e-88 299.0 sp|Q9VBW3|CAD96_DROME Tyrosine kinase receptor Cad96Ca OS=Drosophila melanogaster OX=7227 GN=Cad96Ca PE=2 SV=2 CAD96_DROME reviewed Tyrosine kinase receptor Cad96Ca (EC 2.7.10.1) (Cadherin-96Ca) (Tyrosine kinase receptor HD-14) Drosophila melanogaster (Fruit fly) GO:0004713; GO:0004714; GO:0005509; GO:0005524; GO:0005886; GO:0006468; GO:0007030; GO:0007156; GO:0007169; GO:0016339; GO:0042060; GO:0043235; GO:0045177; GO:0045792; GO:0051897; GO:0090303 calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; Golgi organization [GO:0007030]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell size [GO:0045792]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of wound healing [GO:0090303]; protein phosphorylation [GO:0006468]; wound healing [GO:0042060] apical part of cell [GO:0045177]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; protein tyrosine kinase activity [GO:0004713]; transmembrane receptor protein tyrosine kinase activity [GO:0004714] g15713.t1 Q6P825 53.684 285 9.11e-112 331.0 sp|Q6P825|TOM40_XENTR Mitochondrial import receptor subunit TOM40 homolog OS=Xenopus tropicalis OX=8364 GN=tomm40 PE=2 SV=1 g15714.t1 Q62384 50.63 397 5.25e-138 405.0 sp|Q62384|ZPR1_MOUSE Zinc finger protein ZPR1 OS=Mus musculus OX=10090 GN=Zpr1 PE=1 SV=1 g15714.t1 Q62384 35.829 187 3.55e-28 118.0 sp|Q62384|ZPR1_MOUSE Zinc finger protein ZPR1 OS=Mus musculus OX=10090 GN=Zpr1 PE=1 SV=1 g15714.t1 Q62384 30.303 165 8.1e-22 100.0 sp|Q62384|ZPR1_MOUSE Zinc finger protein ZPR1 OS=Mus musculus OX=10090 GN=Zpr1 PE=1 SV=1 g15716.t1 O05527 44.207 328 3.58e-78 250.0 sp|O05527|PHB_DELAC Poly(3-hydroxybutyrate) depolymerase OS=Delftia acidovorans OX=80866 GN=phaZCac PE=1 SV=1 g15718.t1 Q5RC33 35.644 404 9.099999999999999e-61 216.0 sp|Q5RC33|ASTRC_PONAB Protein Aster-C OS=Pongo abelii OX=9601 GN=GRAMD1C PE=2 SV=1 g15718.t2 Q5RC33 35.644 404 6.52e-61 216.0 sp|Q5RC33|ASTRC_PONAB Protein Aster-C OS=Pongo abelii OX=9601 GN=GRAMD1C PE=2 SV=1 g15721.t1 A7MBP4 73.023 215 7.950000000000001e-117 342.0 sp|A7MBP4|IFT46_DANRE Intraflagellar transport protein 46 homolog OS=Danio rerio OX=7955 GN=ift46 PE=2 SV=2 IFT46_DANRE reviewed Intraflagellar transport protein 46 homolog Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005815; GO:0030992; GO:0031514; GO:0036064; GO:0042073; GO:0048264; GO:0048793; GO:0060041; GO:0060271 cilium assembly [GO:0060271]; determination of ventral identity [GO:0048264]; intraciliary transport [GO:0042073]; pronephros development [GO:0048793]; retina development in camera-type eye [GO:0060041] ciliary basal body [GO:0036064]; intraciliary transport particle B [GO:0030992]; microtubule organizing center [GO:0005815]; motile cilium [GO:0031514] g15722.t1 P0DSP1 28.444 559 6.22e-27 123.0 sp|P0DSP1|SORL_RAT Sortilin-related receptor OS=Rattus norvegicus OX=10116 GN=Sorl1 PE=1 SV=1 SORL_RAT reviewed Sortilin-related receptor (Low-density lipoprotein receptor relative with 11 ligand-binding repeats) (LDLR relative with 11 ligand-binding repeats) (LR11) (Sorting protein-related receptor containing LDLR class A repeats) (SorLA) Rattus norvegicus (Rat) GO:0000139; GO:0001540; GO:0002024; GO:0004888; GO:0005615; GO:0005641; GO:0005768; GO:0005769; GO:0005771; GO:0005783; GO:0005789; GO:0005794; GO:0005802; GO:0005829; GO:0005886; GO:0006605; GO:0006622; GO:0006892; GO:0006898; GO:0007218; GO:0009986; GO:0010897; GO:0014910; GO:0016020; GO:0016477; GO:0019828; GO:0030169; GO:0030514; GO:0030658; GO:0031267; GO:0031333; GO:0031901; GO:0031985; GO:0032585; GO:0034067; GO:0034205; GO:0038020; GO:0042147; GO:0042923; GO:0043025; GO:0045053; GO:0045732; GO:0046628; GO:0050768; GO:0055037; GO:0055038; GO:0070863; GO:0097356; GO:0099638; GO:0140318; GO:1900168; GO:1902430; GO:1902953; GO:1902955; GO:1902966; GO:1902992; GO:1902997; GO:1904179; GO:1990845; GO:2001137 adaptive thermogenesis [GO:1990845]; amyloid-beta formation [GO:0034205]; cell migration [GO:0016477]; diet induced thermogenesis [GO:0002024]; endosome to plasma membrane protein transport [GO:0099638]; insulin receptor recycling [GO:0038020]; negative regulation of amyloid precursor protein catabolic process [GO:1902992]; negative regulation of amyloid-beta formation [GO:1902430]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of neurofibrillary tangle assembly [GO:1902997]; negative regulation of neurogenesis [GO:0050768]; negative regulation of protein-containing complex assembly [GO:0031333]; negative regulation of triglyceride catabolic process [GO:0010897]; neuropeptide signaling pathway [GO:0007218]; positive regulation of adipose tissue development [GO:1904179]; positive regulation of early endosome to recycling endosome transport [GO:1902955]; positive regulation of endocytic recycling [GO:2001137]; positive regulation of ER to Golgi vesicle-mediated transport [GO:1902953]; positive regulation of glial cell-derived neurotrophic factor production [GO:1900168]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein exit from endoplasmic reticulum [GO:0070863]; positive regulation of protein localization to early endosome [GO:1902966]; post-Golgi vesicle-mediated transport [GO:0006892]; protein localization to Golgi apparatus [GO:0034067]; protein retention in Golgi apparatus [GO:0045053]; protein targeting [GO:0006605]; protein targeting to lysosome [GO:0006622]; receptor-mediated endocytosis [GO:0006898]; regulation of smooth muscle cell migration [GO:0014910]; retrograde transport, endosome to Golgi [GO:0042147] cell surface [GO:0009986]; cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; Golgi cisterna [GO:0031985]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; multivesicular body [GO:0005771]; multivesicular body membrane [GO:0032585]; neuronal cell body [GO:0043025]; nuclear envelope lumen [GO:0005641]; perinucleolar compartment [GO:0097356]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; trans-Golgi network [GO:0005802]; transport vesicle membrane [GO:0030658] amyloid-beta binding [GO:0001540]; aspartic-type endopeptidase inhibitor activity [GO:0019828]; low-density lipoprotein particle binding [GO:0030169]; neuropeptide binding [GO:0042923]; protein transporter activity [GO:0140318]; small GTPase binding [GO:0031267]; transmembrane signaling receptor activity [GO:0004888] g15722.t1 P0DSP1 26.685 371 2.1e-21 95.1 sp|P0DSP1|SORL_RAT Sortilin-related receptor OS=Rattus norvegicus OX=10116 GN=Sorl1 PE=1 SV=1 SORL_RAT reviewed Sortilin-related receptor (Low-density lipoprotein receptor relative with 11 ligand-binding repeats) (LDLR relative with 11 ligand-binding repeats) (LR11) (Sorting protein-related receptor containing LDLR class A repeats) (SorLA) Rattus norvegicus (Rat) GO:0000139; GO:0001540; GO:0002024; GO:0004888; GO:0005615; GO:0005641; GO:0005768; GO:0005769; GO:0005771; GO:0005783; GO:0005789; GO:0005794; GO:0005802; GO:0005829; GO:0005886; GO:0006605; GO:0006622; GO:0006892; GO:0006898; GO:0007218; GO:0009986; GO:0010897; GO:0014910; GO:0016020; GO:0016477; GO:0019828; GO:0030169; GO:0030514; GO:0030658; GO:0031267; GO:0031333; GO:0031901; GO:0031985; GO:0032585; GO:0034067; GO:0034205; GO:0038020; GO:0042147; GO:0042923; GO:0043025; GO:0045053; GO:0045732; GO:0046628; GO:0050768; GO:0055037; GO:0055038; GO:0070863; GO:0097356; GO:0099638; GO:0140318; GO:1900168; GO:1902430; GO:1902953; GO:1902955; GO:1902966; GO:1902992; GO:1902997; GO:1904179; GO:1990845; GO:2001137 adaptive thermogenesis [GO:1990845]; amyloid-beta formation [GO:0034205]; cell migration [GO:0016477]; diet induced thermogenesis [GO:0002024]; endosome to plasma membrane protein transport [GO:0099638]; insulin receptor recycling [GO:0038020]; negative regulation of amyloid precursor protein catabolic process [GO:1902992]; negative regulation of amyloid-beta formation [GO:1902430]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of neurofibrillary tangle assembly [GO:1902997]; negative regulation of neurogenesis [GO:0050768]; negative regulation of protein-containing complex assembly [GO:0031333]; negative regulation of triglyceride catabolic process [GO:0010897]; neuropeptide signaling pathway [GO:0007218]; positive regulation of adipose tissue development [GO:1904179]; positive regulation of early endosome to recycling endosome transport [GO:1902955]; positive regulation of endocytic recycling [GO:2001137]; positive regulation of ER to Golgi vesicle-mediated transport [GO:1902953]; positive regulation of glial cell-derived neurotrophic factor production [GO:1900168]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein exit from endoplasmic reticulum [GO:0070863]; positive regulation of protein localization to early endosome [GO:1902966]; post-Golgi vesicle-mediated transport [GO:0006892]; protein localization to Golgi apparatus [GO:0034067]; protein retention in Golgi apparatus [GO:0045053]; protein targeting [GO:0006605]; protein targeting to lysosome [GO:0006622]; receptor-mediated endocytosis [GO:0006898]; regulation of smooth muscle cell migration [GO:0014910]; retrograde transport, endosome to Golgi [GO:0042147] cell surface [GO:0009986]; cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; Golgi cisterna [GO:0031985]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; multivesicular body [GO:0005771]; multivesicular body membrane [GO:0032585]; neuronal cell body [GO:0043025]; nuclear envelope lumen [GO:0005641]; perinucleolar compartment [GO:0097356]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; trans-Golgi network [GO:0005802]; transport vesicle membrane [GO:0030658] amyloid-beta binding [GO:0001540]; aspartic-type endopeptidase inhibitor activity [GO:0019828]; low-density lipoprotein particle binding [GO:0030169]; neuropeptide binding [GO:0042923]; protein transporter activity [GO:0140318]; small GTPase binding [GO:0031267]; transmembrane signaling receptor activity [GO:0004888] g15722.t1 P0DSP1 48.0 25 2.1e-21 30.8 sp|P0DSP1|SORL_RAT Sortilin-related receptor OS=Rattus norvegicus OX=10116 GN=Sorl1 PE=1 SV=1 SORL_RAT reviewed Sortilin-related receptor (Low-density lipoprotein receptor relative with 11 ligand-binding repeats) (LDLR relative with 11 ligand-binding repeats) (LR11) (Sorting protein-related receptor containing LDLR class A repeats) (SorLA) Rattus norvegicus (Rat) GO:0000139; GO:0001540; GO:0002024; GO:0004888; GO:0005615; GO:0005641; GO:0005768; GO:0005769; GO:0005771; GO:0005783; GO:0005789; GO:0005794; GO:0005802; GO:0005829; GO:0005886; GO:0006605; GO:0006622; GO:0006892; GO:0006898; GO:0007218; GO:0009986; GO:0010897; GO:0014910; GO:0016020; GO:0016477; GO:0019828; GO:0030169; GO:0030514; GO:0030658; GO:0031267; GO:0031333; GO:0031901; GO:0031985; GO:0032585; GO:0034067; GO:0034205; GO:0038020; GO:0042147; GO:0042923; GO:0043025; GO:0045053; GO:0045732; GO:0046628; GO:0050768; GO:0055037; GO:0055038; GO:0070863; GO:0097356; GO:0099638; GO:0140318; GO:1900168; GO:1902430; GO:1902953; GO:1902955; GO:1902966; GO:1902992; GO:1902997; GO:1904179; GO:1990845; GO:2001137 adaptive thermogenesis [GO:1990845]; amyloid-beta formation [GO:0034205]; cell migration [GO:0016477]; diet induced thermogenesis [GO:0002024]; endosome to plasma membrane protein transport [GO:0099638]; insulin receptor recycling [GO:0038020]; negative regulation of amyloid precursor protein catabolic process [GO:1902992]; negative regulation of amyloid-beta formation [GO:1902430]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of neurofibrillary tangle assembly [GO:1902997]; negative regulation of neurogenesis [GO:0050768]; negative regulation of protein-containing complex assembly [GO:0031333]; negative regulation of triglyceride catabolic process [GO:0010897]; neuropeptide signaling pathway [GO:0007218]; positive regulation of adipose tissue development [GO:1904179]; positive regulation of early endosome to recycling endosome transport [GO:1902955]; positive regulation of endocytic recycling [GO:2001137]; positive regulation of ER to Golgi vesicle-mediated transport [GO:1902953]; positive regulation of glial cell-derived neurotrophic factor production [GO:1900168]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein exit from endoplasmic reticulum [GO:0070863]; positive regulation of protein localization to early endosome [GO:1902966]; post-Golgi vesicle-mediated transport [GO:0006892]; protein localization to Golgi apparatus [GO:0034067]; protein retention in Golgi apparatus [GO:0045053]; protein targeting [GO:0006605]; protein targeting to lysosome [GO:0006622]; receptor-mediated endocytosis [GO:0006898]; regulation of smooth muscle cell migration [GO:0014910]; retrograde transport, endosome to Golgi [GO:0042147] cell surface [GO:0009986]; cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; Golgi cisterna [GO:0031985]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; multivesicular body [GO:0005771]; multivesicular body membrane [GO:0032585]; neuronal cell body [GO:0043025]; nuclear envelope lumen [GO:0005641]; perinucleolar compartment [GO:0097356]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; trans-Golgi network [GO:0005802]; transport vesicle membrane [GO:0030658] amyloid-beta binding [GO:0001540]; aspartic-type endopeptidase inhibitor activity [GO:0019828]; low-density lipoprotein particle binding [GO:0030169]; neuropeptide binding [GO:0042923]; protein transporter activity [GO:0140318]; small GTPase binding [GO:0031267]; transmembrane signaling receptor activity [GO:0004888] g15722.t1 P0DSP1 25.989 531 5.5000000000000005e-21 103.0 sp|P0DSP1|SORL_RAT Sortilin-related receptor OS=Rattus norvegicus OX=10116 GN=Sorl1 PE=1 SV=1 SORL_RAT reviewed Sortilin-related receptor (Low-density lipoprotein receptor relative with 11 ligand-binding repeats) (LDLR relative with 11 ligand-binding repeats) (LR11) (Sorting protein-related receptor containing LDLR class A repeats) (SorLA) Rattus norvegicus (Rat) GO:0000139; GO:0001540; GO:0002024; GO:0004888; GO:0005615; GO:0005641; GO:0005768; GO:0005769; GO:0005771; GO:0005783; GO:0005789; GO:0005794; GO:0005802; GO:0005829; GO:0005886; GO:0006605; GO:0006622; GO:0006892; GO:0006898; GO:0007218; GO:0009986; GO:0010897; GO:0014910; GO:0016020; GO:0016477; GO:0019828; GO:0030169; GO:0030514; GO:0030658; GO:0031267; GO:0031333; GO:0031901; GO:0031985; GO:0032585; GO:0034067; GO:0034205; GO:0038020; GO:0042147; GO:0042923; GO:0043025; GO:0045053; GO:0045732; GO:0046628; GO:0050768; GO:0055037; GO:0055038; GO:0070863; GO:0097356; GO:0099638; GO:0140318; GO:1900168; GO:1902430; GO:1902953; GO:1902955; GO:1902966; GO:1902992; GO:1902997; GO:1904179; GO:1990845; GO:2001137 adaptive thermogenesis [GO:1990845]; amyloid-beta formation [GO:0034205]; cell migration [GO:0016477]; diet induced thermogenesis [GO:0002024]; endosome to plasma membrane protein transport [GO:0099638]; insulin receptor recycling [GO:0038020]; negative regulation of amyloid precursor protein catabolic process [GO:1902992]; negative regulation of amyloid-beta formation [GO:1902430]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of neurofibrillary tangle assembly [GO:1902997]; negative regulation of neurogenesis [GO:0050768]; negative regulation of protein-containing complex assembly [GO:0031333]; negative regulation of triglyceride catabolic process [GO:0010897]; neuropeptide signaling pathway [GO:0007218]; positive regulation of adipose tissue development [GO:1904179]; positive regulation of early endosome to recycling endosome transport [GO:1902955]; positive regulation of endocytic recycling [GO:2001137]; positive regulation of ER to Golgi vesicle-mediated transport [GO:1902953]; positive regulation of glial cell-derived neurotrophic factor production [GO:1900168]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein exit from endoplasmic reticulum [GO:0070863]; positive regulation of protein localization to early endosome [GO:1902966]; post-Golgi vesicle-mediated transport [GO:0006892]; protein localization to Golgi apparatus [GO:0034067]; protein retention in Golgi apparatus [GO:0045053]; protein targeting [GO:0006605]; protein targeting to lysosome [GO:0006622]; receptor-mediated endocytosis [GO:0006898]; regulation of smooth muscle cell migration [GO:0014910]; retrograde transport, endosome to Golgi [GO:0042147] cell surface [GO:0009986]; cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; Golgi cisterna [GO:0031985]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; multivesicular body [GO:0005771]; multivesicular body membrane [GO:0032585]; neuronal cell body [GO:0043025]; nuclear envelope lumen [GO:0005641]; perinucleolar compartment [GO:0097356]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; trans-Golgi network [GO:0005802]; transport vesicle membrane [GO:0030658] amyloid-beta binding [GO:0001540]; aspartic-type endopeptidase inhibitor activity [GO:0019828]; low-density lipoprotein particle binding [GO:0030169]; neuropeptide binding [GO:0042923]; protein transporter activity [GO:0140318]; small GTPase binding [GO:0031267]; transmembrane signaling receptor activity [GO:0004888] g15723.t2 Q9FXA7 27.481 262 9.71e-21 94.7 sp|Q9FXA7|RGXT3_ARATH UDP-D-xylose:L-fucose alpha-1,3-D-xylosyltransferase 3 OS=Arabidopsis thaliana OX=3702 GN=RGXT3 PE=1 SV=1 g15727.t1 E1BD59 25.281 356 6.53e-29 128.0 sp|E1BD59|TRI56_BOVIN E3 ubiquitin-protein ligase TRIM56 OS=Bos taurus OX=9913 GN=TRIM56 PE=2 SV=1 TRI56_BOVIN reviewed E3 ubiquitin-protein ligase TRIM56 (EC 2.3.2.27) (Tripartite motif-containing protein 56) Bos taurus (Bovine) GO:0005654; GO:0005737; GO:0006513; GO:0008270; GO:0032728; GO:0034340; GO:0045087; GO:0051607; GO:0060340; GO:0061630; GO:0070534 defense response to virus [GO:0051607]; innate immune response [GO:0045087]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of type I interferon-mediated signaling pathway [GO:0060340]; protein K63-linked ubiquitination [GO:0070534]; protein monoubiquitination [GO:0006513]; response to type I interferon [GO:0034340] cytoplasm [GO:0005737]; nucleoplasm [GO:0005654] ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] g15728.t1 E1BD59 26.667 360 5.67e-32 135.0 sp|E1BD59|TRI56_BOVIN E3 ubiquitin-protein ligase TRIM56 OS=Bos taurus OX=9913 GN=TRIM56 PE=2 SV=1 TRI56_BOVIN reviewed E3 ubiquitin-protein ligase TRIM56 (EC 2.3.2.27) (Tripartite motif-containing protein 56) Bos taurus (Bovine) GO:0005654; GO:0005737; GO:0006513; GO:0008270; GO:0032728; GO:0034340; GO:0045087; GO:0051607; GO:0060340; GO:0061630; GO:0070534 defense response to virus [GO:0051607]; innate immune response [GO:0045087]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of type I interferon-mediated signaling pathway [GO:0060340]; protein K63-linked ubiquitination [GO:0070534]; protein monoubiquitination [GO:0006513]; response to type I interferon [GO:0034340] cytoplasm [GO:0005737]; nucleoplasm [GO:0005654] ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] g15729.t1 Q6QI68 56.436 101 5.76e-38 126.0 sp|Q6QI68|PEN2_RAT Gamma-secretase subunit PEN-2 OS=Rattus norvegicus OX=10116 GN=Psenen PE=3 SV=1 g15730.t1 A1A4K8 83.598 189 1.62e-114 330.0 sp|A1A4K8|U2AF1_BOVIN Splicing factor U2AF 35 kDa subunit OS=Bos taurus OX=9913 GN=U2AF1 PE=2 SV=1 U2AF1_BOVIN reviewed Splicing factor U2AF 35 kDa subunit (U2 auxiliary factor 35 kDa subunit) (U2 snRNP auxiliary factor small subunit) Bos taurus (Bovine) GO:0000398; GO:0005681; GO:0008270; GO:0016607; GO:0030628; GO:0089701 mRNA splicing, via spliceosome [GO:0000398] nuclear speck [GO:0016607]; spliceosomal complex [GO:0005681]; U2AF complex [GO:0089701] pre-mRNA 3'-splice site binding [GO:0030628]; zinc ion binding [GO:0008270] g15731.t1 Q21565 50.597 419 1.02e-111 352.0 sp|Q21565|AMT3_CAEEL Putative ammonium transporter 3 OS=Caenorhabditis elegans OX=6239 GN=amt-3 PE=3 SV=2 g15736.t1 Q9DBG7 56.372 667 0.0 679.0 sp|Q9DBG7|SRPRA_MOUSE Signal recognition particle receptor subunit alpha OS=Mus musculus OX=10090 GN=Srpra PE=1 SV=1 SRPRA_MOUSE reviewed Signal recognition particle receptor subunit alpha (SR-alpha) (Docking protein alpha) (DP-alpha) Mus musculus (Mouse) GO:0003924; GO:0005047; GO:0005525; GO:0005785; GO:0005789; GO:0006617; GO:0006886; GO:0016020; GO:0045047 intracellular protein transport [GO:0006886]; protein targeting to ER [GO:0045047]; SRP-dependent cotranslational protein targeting to membrane, signal sequence recognition [GO:0006617] endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; signal recognition particle receptor complex [GO:0005785] GTP binding [GO:0005525]; GTPase activity [GO:0003924]; signal recognition particle binding [GO:0005047] g15737.t1 P56819 52.119 472 6.29e-154 452.0 sp|P56819|BACE1_RAT Beta-secretase 1 OS=Rattus norvegicus OX=10116 GN=Bace1 PE=2 SV=1 g15738.t1 P54823 72.066 426 0.0 645.0 sp|P54823|DDX6_MOUSE Probable ATP-dependent RNA helicase DDX6 OS=Mus musculus OX=10090 GN=Ddx6 PE=1 SV=1 DDX6_MOUSE reviewed Probable ATP-dependent RNA helicase DDX6 (EC 3.6.4.13) (ATP-dependent RNA helicase p54) (DEAD box protein 6) (Oncogene RCK homolog) Mus musculus (Mouse) GO:0000792; GO:0000932; GO:0001520; GO:0003724; GO:0003729; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0005912; GO:0010494; GO:0016442; GO:0016887; GO:0017148; GO:0019074; GO:0019827; GO:0019904; GO:0033391; GO:0033962; GO:0034063; GO:0035278; GO:0036464; GO:0045665; GO:0048471; GO:0048515; GO:0061830; GO:0097227 miRNA-mediated gene silencing by inhibition of translation [GO:0035278]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of translation [GO:0017148]; P-body assembly [GO:0033962]; spermatid differentiation [GO:0048515]; stem cell population maintenance [GO:0019827]; stress granule assembly [GO:0034063]; viral RNA genome packaging [GO:0019074] adherens junction [GO:0005912]; chromatoid body [GO:0033391]; concave side of sperm head [GO:0061830]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; heterochromatin [GO:0000792]; nucleus [GO:0005634]; outer dense fiber [GO:0001520]; P-body [GO:0000932]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; RISC complex [GO:0016442]; sperm annulus [GO:0097227] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; mRNA binding [GO:0003729]; protein domain specific binding [GO:0019904]; RNA helicase activity [GO:0003724] g15739.t1 Q178A5 81.657 169 2.2199999999999997e-106 304.0 sp|Q178A5|UFC1_AEDAE Ubiquitin-fold modifier-conjugating enzyme 1 OS=Aedes aegypti OX=7159 GN=AAEL005968 PE=3 SV=1 g15740.t1 Q66IH2 44.286 280 7.97e-55 199.0 sp|Q66IH2|TBRG1_XENTR Transforming growth factor beta regulator 1 OS=Xenopus tropicalis OX=8364 GN=tbrg1 PE=2 SV=1 g15742.t1 O70628 59.223 515 0.0 654.0 sp|O70628|PDE9A_MOUSE High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A OS=Mus musculus OX=10090 GN=Pde9a PE=1 SV=1 PDE9A_MOUSE reviewed High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (EC 3.1.4.35) Mus musculus (Mouse) GO:0004115; GO:0005654; GO:0005783; GO:0005794; GO:0005829; GO:0005886; GO:0007165; GO:0010613; GO:0032587; GO:0042383; GO:0042802; GO:0043204; GO:0046068; GO:0046069; GO:0046872; GO:0047555; GO:0048471; GO:0141162; GO:1900273; GO:2000178 cGMP catabolic process [GO:0046069]; cGMP metabolic process [GO:0046068]; negative regulation of cAMP/PKA signal transduction [GO:0141162]; negative regulation of neural precursor cell proliferation [GO:2000178]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of long-term synaptic potentiation [GO:1900273]; signal transduction [GO:0007165] cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587]; sarcolemma [GO:0042383] 3',5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; 3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872] g15744.t1 Q9D404 61.52 408 4.25e-168 484.0 sp|Q9D404|OXSM_MOUSE 3-oxoacyl-[acyl-carrier-protein] synthase, mitochondrial OS=Mus musculus OX=10090 GN=Oxsm PE=1 SV=1 OXSM_MOUSE reviewed 3-oxoacyl-[acyl-carrier-protein] synthase, mitochondrial (EC 2.3.1.41) (Beta-ketoacyl-ACP synthase) Mus musculus (Mouse) GO:0004315; GO:0005739; GO:0005829; GO:0006633; GO:0006637; GO:0051790; GO:0051792 acyl-CoA metabolic process [GO:0006637]; fatty acid biosynthetic process [GO:0006633]; medium-chain fatty acid biosynthetic process [GO:0051792]; short-chain fatty acid biosynthetic process [GO:0051790] cytosol [GO:0005829]; mitochondrion [GO:0005739] 3-oxoacyl-[acyl-carrier-protein] synthase activity [GO:0004315] g15746.t1 A2AJ76 31.148 244 8.899999999999999e-24 110.0 sp|A2AJ76|HMCN2_MOUSE Hemicentin-2 OS=Mus musculus OX=10090 GN=Hmcn2 PE=1 SV=1 HMCN2_MOUSE reviewed Hemicentin-2 Mus musculus (Mouse) GO:0005509; GO:0005576; GO:0005604; GO:0005886; GO:0005938; GO:0007156; GO:0008046; GO:0030054; GO:0030424; GO:0031012; GO:0032154; GO:0043025; GO:0050808 homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; synapse organization [GO:0050808] axon [GO:0030424]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886] axon guidance receptor activity [GO:0008046]; calcium ion binding [GO:0005509] g15746.t2 Q9UGM3 39.255 349 9.49e-55 213.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g15746.t2 Q9UGM3 37.228 368 1.96e-53 209.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g15746.t2 Q9UGM3 37.875 367 4.12e-53 207.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g15746.t2 Q9UGM3 37.228 368 5e-53 207.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g15746.t2 Q9UGM3 37.534 365 9.45e-53 206.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g15746.t2 Q9UGM3 36.486 370 2.99e-51 202.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g15746.t2 Q9UGM3 35.25 400 3.38e-51 201.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g15746.t2 Q9UGM3 35.366 246 8.31e-30 132.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 DMBT1_HUMAN reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein) Homo sapiens (Human) GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062 defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] g15746.t3 O75095 32.362 309 3.5e-34 138.0 sp|O75095|MEGF6_HUMAN Multiple epidermal growth factor-like domains protein 6 OS=Homo sapiens OX=9606 GN=MEGF6 PE=1 SV=4 g15746.t3 O75095 35.859 198 1.71e-24 109.0 sp|O75095|MEGF6_HUMAN Multiple epidermal growth factor-like domains protein 6 OS=Homo sapiens OX=9606 GN=MEGF6 PE=1 SV=4 g15746.t3 O75095 36.449 214 7.78e-24 107.0 sp|O75095|MEGF6_HUMAN Multiple epidermal growth factor-like domains protein 6 OS=Homo sapiens OX=9606 GN=MEGF6 PE=1 SV=4 g15747.t1 O75095 30.804 448 6.09e-41 164.0 sp|O75095|MEGF6_HUMAN Multiple epidermal growth factor-like domains protein 6 OS=Homo sapiens OX=9606 GN=MEGF6 PE=1 SV=4 g15749.t1 P14198 45.89 146 1.4299999999999999e-30 122.0 sp|P14198|AAC4_DICDI AAC-rich mRNA clone AAC4 protein OS=Dictyostelium discoideum OX=44689 GN=AAC4 PE=2 SV=3 g15750.t1 Q2T9R6 65.809 272 1.9699999999999998e-146 414.0 sp|Q2T9R6|NIT2_BOVIN Omega-amidase NIT2 OS=Bos taurus OX=9913 GN=NIT2 PE=2 SV=1 g15751.t1 P27577 46.154 481 1.66e-113 347.0 sp|P27577|ETS1_MOUSE Protein C-ets-1 OS=Mus musculus OX=10090 GN=Ets1 PE=1 SV=2 ETS1_MOUSE reviewed Protein C-ets-1 (p54) Mus musculus (Mouse) GO:0000976; GO:0000978; GO:0000981; GO:0001222; GO:0001228; GO:0002376; GO:0003676; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0005667; GO:0005737; GO:0006357; GO:0006366; GO:0008284; GO:0010595; GO:0010628; GO:0010715; GO:0030154; GO:0030335; GO:0030578; GO:0035035; GO:0042802; GO:0042981; GO:0043536; GO:0043565; GO:0045648; GO:0045765; GO:0045766; GO:0045786; GO:0045893; GO:0045944; GO:0046677; GO:0048870; GO:0050728; GO:0050729; GO:0061629; GO:0140297; GO:1902895; GO:1904996; GO:1990837 cell differentiation [GO:0030154]; cell motility [GO:0048870]; immune system process [GO:0002376]; negative regulation of cell cycle [GO:0045786]; negative regulation of inflammatory response [GO:0050728]; PML body organization [GO:0030578]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of gene expression [GO:0010628]; positive regulation of inflammatory response [GO:0050729]; positive regulation of leukocyte adhesion to vascular endothelial cell [GO:1904996]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of angiogenesis [GO:0045765]; regulation of apoptotic process [GO:0042981]; regulation of extracellular matrix disassembly [GO:0010715]; regulation of transcription by RNA polymerase II [GO:0006357]; response to antibiotic [GO:0046677]; transcription by RNA polymerase II [GO:0006366] cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667] DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription factor binding [GO:0140297]; histone acetyltransferase binding [GO:0035035]; identical protein binding [GO:0042802]; nucleic acid binding [GO:0003676]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]; transcription corepressor binding [GO:0001222] g15753.t1 Q90837 47.872 564 2.31e-143 425.0 sp|Q90837|ERG_CHICK Transcriptional regulator Erg OS=Gallus gallus OX=9031 GN=ERG PE=2 SV=1 g15753.t2 Q90837 49.183 551 1.25e-148 438.0 sp|Q90837|ERG_CHICK Transcriptional regulator Erg OS=Gallus gallus OX=9031 GN=ERG PE=2 SV=1 g15753.t3 Q01414 86.857 175 6.31e-92 275.0 sp|Q01414|ERG_LYTVA Transcriptional regulator ERG homolog (Fragment) OS=Lytechinus variegatus OX=7654 GN=ERG PE=3 SV=1 g15756.t1 O75343 50.0 576 1.95e-179 530.0 sp|O75343|GCYB2_HUMAN Guanylate cyclase soluble subunit beta-2 OS=Homo sapiens OX=9606 GN=GUCY1B2 PE=5 SV=2 GCYB2_HUMAN reviewed Guanylate cyclase soluble subunit beta-2 (GCS-beta-2) (EC 4.6.1.2) Homo sapiens (Human) GO:0004383; GO:0005525; GO:0005829; GO:0008074; GO:0019934; GO:0020037; GO:0046872; GO:0070482 cGMP-mediated signaling [GO:0019934]; response to oxygen levels [GO:0070482] cytosol [GO:0005829]; guanylate cyclase complex, soluble [GO:0008074] GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; heme binding [GO:0020037]; metal ion binding [GO:0046872] g15757.t1 F1NY98 34.171 1513 0.0 829.0 sp|F1NY98|DSCAM_CHICK Cell adhesion molecule DSCAM OS=Gallus gallus OX=9031 GN=DSCAM PE=1 SV=3 DSCAM_CHICK reviewed Cell adhesion molecule DSCAM (Down syndrome cell adhesion molecule homolog) Gallus gallus (Chicken) GO:0005886; GO:0007156; GO:0007162; GO:0007411; GO:0007416; GO:0007626; GO:0010842; GO:0030425; GO:0030426; GO:0035176; GO:0035249; GO:0042327; GO:0043025; GO:0045202; GO:0048813; GO:0048842; GO:0060060; GO:0060219; GO:0060996; GO:0070593; GO:1990782; GO:1990890 axon guidance [GO:0007411]; camera-type eye photoreceptor cell differentiation [GO:0060219]; dendrite morphogenesis [GO:0048813]; dendrite self-avoidance [GO:0070593]; dendritic spine development [GO:0060996]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; locomotory behavior [GO:0007626]; negative regulation of cell adhesion [GO:0007162]; positive regulation of axon extension involved in axon guidance [GO:0048842]; positive regulation of phosphorylation [GO:0042327]; post-embryonic retina morphogenesis in camera-type eye [GO:0060060]; retina layer formation [GO:0010842]; social behavior [GO:0035176]; synapse assembly [GO:0007416]; synaptic transmission, glutamatergic [GO:0035249] dendrite [GO:0030425]; growth cone [GO:0030426]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; synapse [GO:0045202] netrin receptor binding [GO:1990890]; protein tyrosine kinase binding [GO:1990782] g15760.t1 Q9NYK5 42.105 304 4.02e-77 243.0 sp|Q9NYK5|RM39_HUMAN Large ribosomal subunit protein mL39 OS=Homo sapiens OX=9606 GN=MRPL39 PE=1 SV=3 g15761.t1 Q32LN4 49.818 548 3.01e-110 342.0 sp|Q32LN4|CFA45_BOVIN Cilia- and flagella-associated protein 45 OS=Bos taurus OX=9913 GN=CFAP45 PE=1 SV=2 CFA45_BOVIN reviewed Cilia- and flagella-associated protein 45 Bos taurus (Bovine) GO:0005576; GO:0005879; GO:0016208; GO:0030317; GO:0036126; GO:0060287; GO:0060296; GO:0061966; GO:0090660; GO:0097728; GO:0160112 cerebrospinal fluid circulation [GO:0090660]; epithelial cilium movement involved in determination of left/right asymmetry [GO:0060287]; establishment of left/right asymmetry [GO:0061966]; flagellated sperm motility [GO:0030317]; regulation of cilium beat frequency involved in ciliary motility [GO:0060296] 9+0 motile cilium [GO:0097728]; axonemal B tubule inner sheath [GO:0160112]; axonemal microtubule [GO:0005879]; extracellular region [GO:0005576]; sperm flagellum [GO:0036126] AMP binding [GO:0016208] g15763.t1 P53804 34.715 193 2.0099999999999997e-23 102.0 sp|P53804|TTC3_HUMAN E3 ubiquitin-protein ligase TTC3 OS=Homo sapiens OX=9606 GN=TTC3 PE=1 SV=2 TTC3_HUMAN reviewed E3 ubiquitin-protein ligase TTC3 (EC 2.3.2.27) (Protein DCRR1) (RING finger protein 105) (RING-type E3 ubiquitin transferase TTC3) (TPR repeat protein D) (Tetratricopeptide repeat protein 3) (TPR repeat protein 3) Homo sapiens (Human) GO:0004842; GO:0005634; GO:0005654; GO:0005730; GO:0005794; GO:0005829; GO:0006511; GO:0008270; GO:0061630; GO:0070936 protein K48-linked ubiquitination [GO:0070936]; ubiquitin-dependent protein catabolic process [GO:0006511] cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] g15764.t1 P53804 29.796 245 1.8099999999999999e-28 129.0 sp|P53804|TTC3_HUMAN E3 ubiquitin-protein ligase TTC3 OS=Homo sapiens OX=9606 GN=TTC3 PE=1 SV=2 TTC3_HUMAN reviewed E3 ubiquitin-protein ligase TTC3 (EC 2.3.2.27) (Protein DCRR1) (RING finger protein 105) (RING-type E3 ubiquitin transferase TTC3) (TPR repeat protein D) (Tetratricopeptide repeat protein 3) (TPR repeat protein 3) Homo sapiens (Human) GO:0004842; GO:0005634; GO:0005654; GO:0005730; GO:0005794; GO:0005829; GO:0006511; GO:0008270; GO:0061630; GO:0070936 protein K48-linked ubiquitination [GO:0070936]; ubiquitin-dependent protein catabolic process [GO:0006511] cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] g15767.t1 A0A1L8EYB2 35.093 1080 8.82e-161 538.0 sp|A0A1L8EYB2|DAAF8_XENLA Dynein axonemal assembly factor 8 OS=Xenopus laevis OX=8355 GN=dnaaf8 PE=1 SV=1 g15768.t1 Q6ZW76 53.309 272 3.0200000000000002e-77 266.0 sp|Q6ZW76|ANKS3_HUMAN Ankyrin repeat and SAM domain-containing protein 3 OS=Homo sapiens OX=9606 GN=ANKS3 PE=1 SV=1 ANKS3_HUMAN reviewed Ankyrin repeat and SAM domain-containing protein 3 Homo sapiens (Human) GO:0005737; GO:0005929 cilium [GO:0005929]; cytoplasm [GO:0005737] g15768.t1 Q6ZW76 42.13 216 1.74e-42 168.0 sp|Q6ZW76|ANKS3_HUMAN Ankyrin repeat and SAM domain-containing protein 3 OS=Homo sapiens OX=9606 GN=ANKS3 PE=1 SV=1 ANKS3_HUMAN reviewed Ankyrin repeat and SAM domain-containing protein 3 Homo sapiens (Human) GO:0005737; GO:0005929 cilium [GO:0005929]; cytoplasm [GO:0005737] g15768.t2 Q6ZW76 53.309 272 1.3e-76 265.0 sp|Q6ZW76|ANKS3_HUMAN Ankyrin repeat and SAM domain-containing protein 3 OS=Homo sapiens OX=9606 GN=ANKS3 PE=1 SV=1 ANKS3_HUMAN reviewed Ankyrin repeat and SAM domain-containing protein 3 Homo sapiens (Human) GO:0005737; GO:0005929 cilium [GO:0005929]; cytoplasm [GO:0005737] g15768.t2 Q6ZW76 42.13 216 1.56e-42 168.0 sp|Q6ZW76|ANKS3_HUMAN Ankyrin repeat and SAM domain-containing protein 3 OS=Homo sapiens OX=9606 GN=ANKS3 PE=1 SV=1 ANKS3_HUMAN reviewed Ankyrin repeat and SAM domain-containing protein 3 Homo sapiens (Human) GO:0005737; GO:0005929 cilium [GO:0005929]; cytoplasm [GO:0005737] g15769.t1 P18321 77.143 140 4.22e-74 220.0 sp|P18321|PROF_CLYJA Profilin OS=Clypeaster japonicus OX=7644 PE=1 SV=2 g15771.t1 P51175 38.298 470 2.38e-101 316.0 sp|P51175|PPOX_MOUSE Protoporphyrinogen oxidase OS=Mus musculus OX=10090 GN=Ppox PE=1 SV=1 g15772.t1 P60882 38.058 381 7.99e-53 168.0 sp|P60882|MEGF8_MOUSE Multiple epidermal growth factor-like domains protein 8 OS=Mus musculus OX=10090 GN=Megf8 PE=1 SV=2 MEGF8_MOUSE reviewed Multiple epidermal growth factor-like domains protein 8 (Multiple EGF-like domains protein 8) (Epidermal growth factor-like protein 4) (EGF-like protein 4) Mus musculus (Mouse) GO:0000151; GO:0001701; GO:0003143; GO:0005509; GO:0005634; GO:0007224; GO:0007368; GO:0007507; GO:0010468; GO:0016020; GO:0016567; GO:0030326; GO:0030509; GO:0035108; GO:0035904; GO:0042074; GO:0042733; GO:0045879; GO:0048704; GO:0048842; GO:0055113; GO:0060173; GO:0060971; GO:0060972; GO:0060976; GO:0061371; GO:0061626; GO:0065003; GO:0071907; GO:0097094; GO:0097155; GO:1990403 aorta development [GO:0035904]; BMP signaling pathway [GO:0030509]; cell migration involved in gastrulation [GO:0042074]; coronary vasculature development [GO:0060976]; craniofacial suture morphogenesis [GO:0097094]; determination of digestive tract left/right asymmetry [GO:0071907]; determination of heart left/right asymmetry [GO:0061371]; determination of left/right symmetry [GO:0007368]; embryonic brain development [GO:1990403]; embryonic digit morphogenesis [GO:0042733]; embryonic heart tube left/right pattern formation [GO:0060971]; embryonic heart tube morphogenesis [GO:0003143]; embryonic limb morphogenesis [GO:0030326]; embryonic skeletal system morphogenesis [GO:0048704]; epiboly involved in gastrulation with mouth forming second [GO:0055113]; fasciculation of sensory neuron axon [GO:0097155]; heart development [GO:0007507]; in utero embryonic development [GO:0001701]; left/right pattern formation [GO:0060972]; limb development [GO:0060173]; limb morphogenesis [GO:0035108]; negative regulation of smoothened signaling pathway [GO:0045879]; pharyngeal arch artery morphogenesis [GO:0061626]; positive regulation of axon extension involved in axon guidance [GO:0048842]; protein ubiquitination [GO:0016567]; protein-containing complex assembly [GO:0065003]; regulation of gene expression [GO:0010468]; smoothened signaling pathway [GO:0007224] membrane [GO:0016020]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151] calcium ion binding [GO:0005509] g15772.t1 P60882 43.243 74 7.99e-53 62.0 sp|P60882|MEGF8_MOUSE Multiple epidermal growth factor-like domains protein 8 OS=Mus musculus OX=10090 GN=Megf8 PE=1 SV=2 MEGF8_MOUSE reviewed Multiple epidermal growth factor-like domains protein 8 (Multiple EGF-like domains protein 8) (Epidermal growth factor-like protein 4) (EGF-like protein 4) Mus musculus (Mouse) GO:0000151; GO:0001701; GO:0003143; GO:0005509; GO:0005634; GO:0007224; GO:0007368; GO:0007507; GO:0010468; GO:0016020; GO:0016567; GO:0030326; GO:0030509; GO:0035108; GO:0035904; GO:0042074; GO:0042733; GO:0045879; GO:0048704; GO:0048842; GO:0055113; GO:0060173; GO:0060971; GO:0060972; GO:0060976; GO:0061371; GO:0061626; GO:0065003; GO:0071907; GO:0097094; GO:0097155; GO:1990403 aorta development [GO:0035904]; BMP signaling pathway [GO:0030509]; cell migration involved in gastrulation [GO:0042074]; coronary vasculature development [GO:0060976]; craniofacial suture morphogenesis [GO:0097094]; determination of digestive tract left/right asymmetry [GO:0071907]; determination of heart left/right asymmetry [GO:0061371]; determination of left/right symmetry [GO:0007368]; embryonic brain development [GO:1990403]; embryonic digit morphogenesis [GO:0042733]; embryonic heart tube left/right pattern formation [GO:0060971]; embryonic heart tube morphogenesis [GO:0003143]; embryonic limb morphogenesis [GO:0030326]; embryonic skeletal system morphogenesis [GO:0048704]; epiboly involved in gastrulation with mouth forming second [GO:0055113]; fasciculation of sensory neuron axon [GO:0097155]; heart development [GO:0007507]; in utero embryonic development [GO:0001701]; left/right pattern formation [GO:0060972]; limb development [GO:0060173]; limb morphogenesis [GO:0035108]; negative regulation of smoothened signaling pathway [GO:0045879]; pharyngeal arch artery morphogenesis [GO:0061626]; positive regulation of axon extension involved in axon guidance [GO:0048842]; protein ubiquitination [GO:0016567]; protein-containing complex assembly [GO:0065003]; regulation of gene expression [GO:0010468]; smoothened signaling pathway [GO:0007224] membrane [GO:0016020]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151] calcium ion binding [GO:0005509] g15773.t1 P60882 35.539 1829 0.0 1002.0 sp|P60882|MEGF8_MOUSE Multiple epidermal growth factor-like domains protein 8 OS=Mus musculus OX=10090 GN=Megf8 PE=1 SV=2 MEGF8_MOUSE reviewed Multiple epidermal growth factor-like domains protein 8 (Multiple EGF-like domains protein 8) (Epidermal growth factor-like protein 4) (EGF-like protein 4) Mus musculus (Mouse) GO:0000151; GO:0001701; GO:0003143; GO:0005509; GO:0005634; GO:0007224; GO:0007368; GO:0007507; GO:0010468; GO:0016020; GO:0016567; GO:0030326; GO:0030509; GO:0035108; GO:0035904; GO:0042074; GO:0042733; GO:0045879; GO:0048704; GO:0048842; GO:0055113; GO:0060173; GO:0060971; GO:0060972; GO:0060976; GO:0061371; GO:0061626; GO:0065003; GO:0071907; GO:0097094; GO:0097155; GO:1990403 aorta development [GO:0035904]; BMP signaling pathway [GO:0030509]; cell migration involved in gastrulation [GO:0042074]; coronary vasculature development [GO:0060976]; craniofacial suture morphogenesis [GO:0097094]; determination of digestive tract left/right asymmetry [GO:0071907]; determination of heart left/right asymmetry [GO:0061371]; determination of left/right symmetry [GO:0007368]; embryonic brain development [GO:1990403]; embryonic digit morphogenesis [GO:0042733]; embryonic heart tube left/right pattern formation [GO:0060971]; embryonic heart tube morphogenesis [GO:0003143]; embryonic limb morphogenesis [GO:0030326]; embryonic skeletal system morphogenesis [GO:0048704]; epiboly involved in gastrulation with mouth forming second [GO:0055113]; fasciculation of sensory neuron axon [GO:0097155]; heart development [GO:0007507]; in utero embryonic development [GO:0001701]; left/right pattern formation [GO:0060972]; limb development [GO:0060173]; limb morphogenesis [GO:0035108]; negative regulation of smoothened signaling pathway [GO:0045879]; pharyngeal arch artery morphogenesis [GO:0061626]; positive regulation of axon extension involved in axon guidance [GO:0048842]; protein ubiquitination [GO:0016567]; protein-containing complex assembly [GO:0065003]; regulation of gene expression [GO:0010468]; smoothened signaling pathway [GO:0007224] membrane [GO:0016020]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151] calcium ion binding [GO:0005509] g15773.t1 P60882 27.949 390 1.88e-23 113.0 sp|P60882|MEGF8_MOUSE Multiple epidermal growth factor-like domains protein 8 OS=Mus musculus OX=10090 GN=Megf8 PE=1 SV=2 MEGF8_MOUSE reviewed Multiple epidermal growth factor-like domains protein 8 (Multiple EGF-like domains protein 8) (Epidermal growth factor-like protein 4) (EGF-like protein 4) Mus musculus (Mouse) GO:0000151; GO:0001701; GO:0003143; GO:0005509; GO:0005634; GO:0007224; GO:0007368; GO:0007507; GO:0010468; GO:0016020; GO:0016567; GO:0030326; GO:0030509; GO:0035108; GO:0035904; GO:0042074; GO:0042733; GO:0045879; GO:0048704; GO:0048842; GO:0055113; GO:0060173; GO:0060971; GO:0060972; GO:0060976; GO:0061371; GO:0061626; GO:0065003; GO:0071907; GO:0097094; GO:0097155; GO:1990403 aorta development [GO:0035904]; BMP signaling pathway [GO:0030509]; cell migration involved in gastrulation [GO:0042074]; coronary vasculature development [GO:0060976]; craniofacial suture morphogenesis [GO:0097094]; determination of digestive tract left/right asymmetry [GO:0071907]; determination of heart left/right asymmetry [GO:0061371]; determination of left/right symmetry [GO:0007368]; embryonic brain development [GO:1990403]; embryonic digit morphogenesis [GO:0042733]; embryonic heart tube left/right pattern formation [GO:0060971]; embryonic heart tube morphogenesis [GO:0003143]; embryonic limb morphogenesis [GO:0030326]; embryonic skeletal system morphogenesis [GO:0048704]; epiboly involved in gastrulation with mouth forming second [GO:0055113]; fasciculation of sensory neuron axon [GO:0097155]; heart development [GO:0007507]; in utero embryonic development [GO:0001701]; left/right pattern formation [GO:0060972]; limb development [GO:0060173]; limb morphogenesis [GO:0035108]; negative regulation of smoothened signaling pathway [GO:0045879]; pharyngeal arch artery morphogenesis [GO:0061626]; positive regulation of axon extension involved in axon guidance [GO:0048842]; protein ubiquitination [GO:0016567]; protein-containing complex assembly [GO:0065003]; regulation of gene expression [GO:0010468]; smoothened signaling pathway [GO:0007224] membrane [GO:0016020]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151] calcium ion binding [GO:0005509] g15773.t2 P60882 36.689 2374 0.0 1392.0 sp|P60882|MEGF8_MOUSE Multiple epidermal growth factor-like domains protein 8 OS=Mus musculus OX=10090 GN=Megf8 PE=1 SV=2 MEGF8_MOUSE reviewed Multiple epidermal growth factor-like domains protein 8 (Multiple EGF-like domains protein 8) (Epidermal growth factor-like protein 4) (EGF-like protein 4) Mus musculus (Mouse) GO:0000151; GO:0001701; GO:0003143; GO:0005509; GO:0005634; GO:0007224; GO:0007368; GO:0007507; GO:0010468; GO:0016020; GO:0016567; GO:0030326; GO:0030509; GO:0035108; GO:0035904; GO:0042074; GO:0042733; GO:0045879; GO:0048704; GO:0048842; GO:0055113; GO:0060173; GO:0060971; GO:0060972; GO:0060976; GO:0061371; GO:0061626; GO:0065003; GO:0071907; GO:0097094; GO:0097155; GO:1990403 aorta development [GO:0035904]; BMP signaling pathway [GO:0030509]; cell migration involved in gastrulation [GO:0042074]; coronary vasculature development [GO:0060976]; craniofacial suture morphogenesis [GO:0097094]; determination of digestive tract left/right asymmetry [GO:0071907]; determination of heart left/right asymmetry [GO:0061371]; determination of left/right symmetry [GO:0007368]; embryonic brain development [GO:1990403]; embryonic digit morphogenesis [GO:0042733]; embryonic heart tube left/right pattern formation [GO:0060971]; embryonic heart tube morphogenesis [GO:0003143]; embryonic limb morphogenesis [GO:0030326]; embryonic skeletal system morphogenesis [GO:0048704]; epiboly involved in gastrulation with mouth forming second [GO:0055113]; fasciculation of sensory neuron axon [GO:0097155]; heart development [GO:0007507]; in utero embryonic development [GO:0001701]; left/right pattern formation [GO:0060972]; limb development [GO:0060173]; limb morphogenesis [GO:0035108]; negative regulation of smoothened signaling pathway [GO:0045879]; pharyngeal arch artery morphogenesis [GO:0061626]; positive regulation of axon extension involved in axon guidance [GO:0048842]; protein ubiquitination [GO:0016567]; protein-containing complex assembly [GO:0065003]; regulation of gene expression [GO:0010468]; smoothened signaling pathway [GO:0007224] membrane [GO:0016020]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151] calcium ion binding [GO:0005509] g15773.t2 P60882 25.738 474 4.74e-22 108.0 sp|P60882|MEGF8_MOUSE Multiple epidermal growth factor-like domains protein 8 OS=Mus musculus OX=10090 GN=Megf8 PE=1 SV=2 MEGF8_MOUSE reviewed Multiple epidermal growth factor-like domains protein 8 (Multiple EGF-like domains protein 8) (Epidermal growth factor-like protein 4) (EGF-like protein 4) Mus musculus (Mouse) GO:0000151; GO:0001701; GO:0003143; GO:0005509; GO:0005634; GO:0007224; GO:0007368; GO:0007507; GO:0010468; GO:0016020; GO:0016567; GO:0030326; GO:0030509; GO:0035108; GO:0035904; GO:0042074; GO:0042733; GO:0045879; GO:0048704; GO:0048842; GO:0055113; GO:0060173; GO:0060971; GO:0060972; GO:0060976; GO:0061371; GO:0061626; GO:0065003; GO:0071907; GO:0097094; GO:0097155; GO:1990403 aorta development [GO:0035904]; BMP signaling pathway [GO:0030509]; cell migration involved in gastrulation [GO:0042074]; coronary vasculature development [GO:0060976]; craniofacial suture morphogenesis [GO:0097094]; determination of digestive tract left/right asymmetry [GO:0071907]; determination of heart left/right asymmetry [GO:0061371]; determination of left/right symmetry [GO:0007368]; embryonic brain development [GO:1990403]; embryonic digit morphogenesis [GO:0042733]; embryonic heart tube left/right pattern formation [GO:0060971]; embryonic heart tube morphogenesis [GO:0003143]; embryonic limb morphogenesis [GO:0030326]; embryonic skeletal system morphogenesis [GO:0048704]; epiboly involved in gastrulation with mouth forming second [GO:0055113]; fasciculation of sensory neuron axon [GO:0097155]; heart development [GO:0007507]; in utero embryonic development [GO:0001701]; left/right pattern formation [GO:0060972]; limb development [GO:0060173]; limb morphogenesis [GO:0035108]; negative regulation of smoothened signaling pathway [GO:0045879]; pharyngeal arch artery morphogenesis [GO:0061626]; positive regulation of axon extension involved in axon guidance [GO:0048842]; protein ubiquitination [GO:0016567]; protein-containing complex assembly [GO:0065003]; regulation of gene expression [GO:0010468]; smoothened signaling pathway [GO:0007224] membrane [GO:0016020]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151] calcium ion binding [GO:0005509] g15774.t1 Q80VI1 26.221 389 4.82e-21 101.0 sp|Q80VI1|TRI56_MOUSE E3 ubiquitin-protein ligase TRIM56 OS=Mus musculus OX=10090 GN=Trim56 PE=1 SV=1 TRI56_MOUSE reviewed E3 ubiquitin-protein ligase TRIM56 (EC 2.3.2.27) (Tripartite motif-containing protein 56) Mus musculus (Mouse) GO:0005654; GO:0005737; GO:0006513; GO:0008270; GO:0032728; GO:0034340; GO:0044790; GO:0045087; GO:0045089; GO:0046597; GO:0051607; GO:0060340; GO:0061630; GO:0070534; GO:0140896; GO:1901224 cGAS/STING signaling pathway [GO:0140896]; defense response to virus [GO:0051607]; host-mediated suppression of symbiont invasion [GO:0046597]; innate immune response [GO:0045087]; positive regulation of innate immune response [GO:0045089]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of non-canonical NF-kappaB signal transduction [GO:1901224]; positive regulation of type I interferon-mediated signaling pathway [GO:0060340]; protein K63-linked ubiquitination [GO:0070534]; protein monoubiquitination [GO:0006513]; response to type I interferon [GO:0034340]; suppression of viral release by host [GO:0044790] cytoplasm [GO:0005737]; nucleoplasm [GO:0005654] ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] g15775.t1 Q4V8D1 33.264 484 1.33e-87 282.0 sp|Q4V8D1|CP2U1_RAT Cytochrome P450 2U1 OS=Rattus norvegicus OX=10116 GN=Cyp2u1 PE=1 SV=1 CP2U1_RAT reviewed Cytochrome P450 2U1 (Long-chain fatty acid omega-monooxygenase) (EC 1.14.14.80) Rattus norvegicus (Rat) GO:0005506; GO:0005737; GO:0005743; GO:0005789; GO:0006082; GO:0006805; GO:0008202; GO:0008395; GO:0016712; GO:0020037; GO:0052869; GO:0097267; GO:0102033 omega-hydroxylase P450 pathway [GO:0097267]; organic acid metabolic process [GO:0006082]; steroid metabolic process [GO:0008202]; xenobiotic metabolic process [GO:0006805] cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; mitochondrial inner membrane [GO:0005743] arachidonate omega-hydroxylase activity [GO:0052869]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; long-chain fatty acid omega-hydroxylase activity [GO:0102033]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; steroid hydroxylase activity [GO:0008395] g15777.t1 Q5U239 53.774 212 5.500000000000001e-73 238.0 sp|Q5U239|TM145_XENLA Transmembrane protein 145 OS=Xenopus laevis OX=8355 GN=tmem145 PE=2 SV=1 g15778.t1 Q5U239 50.644 233 1.22e-71 232.0 sp|Q5U239|TM145_XENLA Transmembrane protein 145 OS=Xenopus laevis OX=8355 GN=tmem145 PE=2 SV=1 g15779.t1 O75899 33.731 587 5.04e-112 360.0 sp|O75899|GABR2_HUMAN Gamma-aminobutyric acid type B receptor subunit 2 OS=Homo sapiens OX=9606 GN=GABBR2 PE=1 SV=1 GABR2_HUMAN reviewed Gamma-aminobutyric acid type B receptor subunit 2 (GABA-B receptor 2) (GABA-B-R2) (GABA-BR2) (GABABR2) (Gb2) (G-protein coupled receptor 51) (HG20) Homo sapiens (Human) GO:0004888; GO:0004965; GO:0005737; GO:0005886; GO:0007186; GO:0007193; GO:0007194; GO:0007214; GO:0007268; GO:0038039; GO:0043005; GO:0045211; GO:0046982; GO:0051932; GO:0150099; GO:1902710; GO:1902712 adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; chemical synaptic transmission [GO:0007268]; G protein-coupled receptor signaling pathway [GO:0007186]; gamma-aminobutyric acid signaling pathway [GO:0007214]; negative regulation of adenylate cyclase activity [GO:0007194]; neuron-glial cell signaling [GO:0150099]; synaptic transmission, GABAergic [GO:0051932] cytoplasm [GO:0005737]; G protein-coupled GABA receptor complex [GO:1902712]; G protein-coupled receptor heterodimeric complex [GO:0038039]; GABA receptor complex [GO:1902710]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211] G protein-coupled GABA receptor activity [GO:0004965]; protein heterodimerization activity [GO:0046982]; transmembrane signaling receptor activity [GO:0004888] g15781.t1 Q62849 55.592 617 0.0 579.0 sp|Q62849|PCSK7_RAT Proprotein convertase subtilisin/kexin type 7 OS=Rattus norvegicus OX=10116 GN=Pcsk7 PE=1 SV=1 PCSK7_RAT reviewed Proprotein convertase subtilisin/kexin type 7 (EC 3.4.21.-) (Prohormone convertase 7) (Proprotein convertase 7) (PC7) (rPC7) (Subtilisin/kexin-like protease PC7) Rattus norvegicus (Rat) GO:0000139; GO:0004252; GO:0005802; GO:0008233; GO:0016485 protein processing [GO:0016485] Golgi membrane [GO:0000139]; trans-Golgi network [GO:0005802] peptidase activity [GO:0008233]; serine-type endopeptidase activity [GO:0004252] g15782.t1 O75899 32.053 599 9.69e-91 310.0 sp|O75899|GABR2_HUMAN Gamma-aminobutyric acid type B receptor subunit 2 OS=Homo sapiens OX=9606 GN=GABBR2 PE=1 SV=1 GABR2_HUMAN reviewed Gamma-aminobutyric acid type B receptor subunit 2 (GABA-B receptor 2) (GABA-B-R2) (GABA-BR2) (GABABR2) (Gb2) (G-protein coupled receptor 51) (HG20) Homo sapiens (Human) GO:0004888; GO:0004965; GO:0005737; GO:0005886; GO:0007186; GO:0007193; GO:0007194; GO:0007214; GO:0007268; GO:0038039; GO:0043005; GO:0045211; GO:0046982; GO:0051932; GO:0150099; GO:1902710; GO:1902712 adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; chemical synaptic transmission [GO:0007268]; G protein-coupled receptor signaling pathway [GO:0007186]; gamma-aminobutyric acid signaling pathway [GO:0007214]; negative regulation of adenylate cyclase activity [GO:0007194]; neuron-glial cell signaling [GO:0150099]; synaptic transmission, GABAergic [GO:0051932] cytoplasm [GO:0005737]; G protein-coupled GABA receptor complex [GO:1902712]; G protein-coupled receptor heterodimeric complex [GO:0038039]; GABA receptor complex [GO:1902710]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211] G protein-coupled GABA receptor activity [GO:0004965]; protein heterodimerization activity [GO:0046982]; transmembrane signaling receptor activity [GO:0004888] g15783.t1 Q9WV18 44.604 139 4.72e-27 110.0 sp|Q9WV18|GABR1_MOUSE Gamma-aminobutyric acid type B receptor subunit 1 OS=Mus musculus OX=10090 GN=Gabbr1 PE=1 SV=1 GABR1_MOUSE reviewed Gamma-aminobutyric acid type B receptor subunit 1 (GABA-B receptor 1) (GABA-B-R1) (GABA-BR1) (GABABR1) (Gb1) Mus musculus (Mouse) GO:0001649; GO:0004965; GO:0005615; GO:0005737; GO:0005789; GO:0005886; GO:0007193; GO:0007214; GO:0008021; GO:0008285; GO:0014048; GO:0014049; GO:0014053; GO:0016020; GO:0030673; GO:0031966; GO:0032811; GO:0033602; GO:0035094; GO:0038037; GO:0038039; GO:0042734; GO:0043025; GO:0043197; GO:0043198; GO:0045211; GO:0045471; GO:0046982; GO:0050805; GO:0051932; GO:0060124; GO:0097060; GO:0098685; GO:0098793; GO:0098978; GO:0098982; GO:0099579; GO:0150047; GO:0150099; GO:1902710; GO:1902712; GO:1990430 adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; gamma-aminobutyric acid signaling pathway [GO:0007214]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of dopamine secretion [GO:0033602]; negative regulation of epinephrine secretion [GO:0032811]; negative regulation of gamma-aminobutyric acid secretion [GO:0014053]; negative regulation of synaptic transmission [GO:0050805]; neuron-glial cell signaling [GO:0150099]; osteoblast differentiation [GO:0001649]; positive regulation of glutamate secretion [GO:0014049]; positive regulation of growth hormone secretion [GO:0060124]; regulation of glutamate secretion [GO:0014048]; response to ethanol [GO:0045471]; response to nicotine [GO:0035094]; synaptic transmission, GABAergic [GO:0051932] axolemma [GO:0030673]; cytoplasm [GO:0005737]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; endoplasmic reticulum membrane [GO:0005789]; extracellular space [GO:0005615]; G protein-coupled GABA receptor complex [GO:1902712]; G protein-coupled receptor dimeric complex [GO:0038037]; G protein-coupled receptor heterodimeric complex [GO:0038039]; GABA receptor complex [GO:1902710]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; mitochondrial membrane [GO:0031966]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynapse [GO:0098793]; presynaptic membrane [GO:0042734]; Schaffer collateral - CA1 synapse [GO:0098685]; synaptic membrane [GO:0097060]; synaptic vesicle [GO:0008021] extracellular matrix protein binding [GO:1990430]; G protein-coupled GABA receptor activity [GO:0004965]; G protein-coupled neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential [GO:0099579]; G protein-coupled neurotransmitter receptor activity involved in regulation of presynaptic membrane potential [GO:0150047]; protein heterodimerization activity [GO:0046982] g15784.t1 Q96GN5 68.462 130 2.7099999999999996e-60 201.0 sp|Q96GN5|CDA7L_HUMAN Cell division cycle-associated 7-like protein OS=Homo sapiens OX=9606 GN=CDCA7L PE=1 SV=2 CDA7L_HUMAN reviewed Cell division cycle-associated 7-like protein (Protein JPO2) (Transcription factor RAM2) Homo sapiens (Human) GO:0001650; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0006355; GO:0008284 positive regulation of cell population proliferation [GO:0008284]; regulation of DNA-templated transcription [GO:0006355] cytosol [GO:0005829]; fibrillar center [GO:0001650]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] g15784.t2 Q96GN5 68.462 130 3.17e-60 201.0 sp|Q96GN5|CDA7L_HUMAN Cell division cycle-associated 7-like protein OS=Homo sapiens OX=9606 GN=CDCA7L PE=1 SV=2 CDA7L_HUMAN reviewed Cell division cycle-associated 7-like protein (Protein JPO2) (Transcription factor RAM2) Homo sapiens (Human) GO:0001650; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0006355; GO:0008284 positive regulation of cell population proliferation [GO:0008284]; regulation of DNA-templated transcription [GO:0006355] cytosol [GO:0005829]; fibrillar center [GO:0001650]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] g15789.t1 P19356 44.543 339 2.31e-98 297.0 sp|P19356|HEM3_RAT Porphobilinogen deaminase OS=Rattus norvegicus OX=10116 GN=Hmbs PE=1 SV=2 HEM3_RAT reviewed Porphobilinogen deaminase (PBG-D) (EC 2.5.1.61) (Hydroxymethylbilane synthase) (HMBS) (Pre-uroporphyrinogen synthase) Rattus norvegicus (Rat) GO:0000793; GO:0001666; GO:0001889; GO:0004418; GO:0004852; GO:0005737; GO:0005829; GO:0006778; GO:0006779; GO:0006782; GO:0006783; GO:0006784; GO:0006785; GO:0009410; GO:0009725; GO:0009743; GO:0010038; GO:0010043; GO:0010288; GO:0030424; GO:0031100; GO:0031406; GO:0031667; GO:0032025; GO:0032355; GO:0033014; GO:0033273; GO:0043176; GO:0043200; GO:0048471; GO:0048708; GO:0051597; GO:0071236; GO:0071243; GO:0071284; GO:0071345; GO:0071418; GO:0071549 animal organ regeneration [GO:0031100]; astrocyte differentiation [GO:0048708]; cellular response to amine stimulus [GO:0071418]; cellular response to antibiotic [GO:0071236]; cellular response to arsenic-containing substance [GO:0071243]; cellular response to cytokine stimulus [GO:0071345]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to lead ion [GO:0071284]; heme A biosynthetic process [GO:0006784]; heme B biosynthetic process [GO:0006785]; heme biosynthetic process [GO:0006783]; liver development [GO:0001889]; porphyrin-containing compound biosynthetic process [GO:0006779]; porphyrin-containing compound metabolic process [GO:0006778]; protoporphyrinogen IX biosynthetic process [GO:0006782]; response to amino acid [GO:0043200]; response to carbohydrate [GO:0009743]; response to cobalt ion [GO:0032025]; response to estradiol [GO:0032355]; response to hormone [GO:0009725]; response to hypoxia [GO:0001666]; response to lead ion [GO:0010288]; response to metal ion [GO:0010038]; response to methylmercury [GO:0051597]; response to nutrient levels [GO:0031667]; response to vitamin [GO:0033273]; response to xenobiotic stimulus [GO:0009410]; response to zinc ion [GO:0010043]; tetrapyrrole biosynthetic process [GO:0033014] axon [GO:0030424]; condensed chromosome [GO:0000793]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; perinuclear region of cytoplasm [GO:0048471] amine binding [GO:0043176]; carboxylic acid binding [GO:0031406]; hydroxymethylbilane synthase activity [GO:0004418]; uroporphyrinogen-III synthase activity [GO:0004852] g15790.t1 P53619 66.731 520 0.0 717.0 sp|P53619|COPD_BOVIN Coatomer subunit delta OS=Bos taurus OX=9913 GN=ARCN1 PE=1 SV=1 COPD_BOVIN reviewed Coatomer subunit delta (Archain) (Delta-coat protein) (Delta-COP) Bos taurus (Bovine) GO:0000139; GO:0005783; GO:0006888; GO:0006890; GO:0006891; GO:0008344; GO:0015031; GO:0021691; GO:0030126; GO:0043473; GO:0051645 adult locomotory behavior [GO:0008344]; cerebellar Purkinje cell layer maturation [GO:0021691]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi localization [GO:0051645]; intra-Golgi vesicle-mediated transport [GO:0006891]; pigmentation [GO:0043473]; protein transport [GO:0015031]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890] COPI vesicle coat [GO:0030126]; endoplasmic reticulum [GO:0005783]; Golgi membrane [GO:0000139] g15791.t1 Q6DCX5 26.0 450 4.15e-29 122.0 sp|Q6DCX5|PCFT_XENLA Proton-coupled folate transporter OS=Xenopus laevis OX=8355 GN=slc46a1 PE=2 SV=1 PCFT_XENLA reviewed Proton-coupled folate transporter (Heme carrier protein 1) (Solute carrier family 46 member 1) Xenopus laevis (African clawed frog) GO:0005542; GO:0005768; GO:0005886; GO:0010008; GO:0015293; GO:0015350; GO:0016323; GO:0016324; GO:0022857; GO:0055085 transmembrane transport [GO:0055085] apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; endosome [GO:0005768]; endosome membrane [GO:0010008]; plasma membrane [GO:0005886] folic acid binding [GO:0005542]; methotrexate transmembrane transporter activity [GO:0015350]; symporter activity [GO:0015293]; transmembrane transporter activity [GO:0022857] g15796.t1 Q8BR86 33.877 552 2.27e-77 269.0 sp|Q8BR86|KIRR3_MOUSE Kin of IRRE-like protein 3 OS=Mus musculus OX=10090 GN=Kirrel3 PE=1 SV=1 KIRR3_MOUSE reviewed Kin of IRRE-like protein 3 (Kin of irregular chiasm-like protein 3) (Nephrin-like protein 2) (mKirre) [Cleaved into: Processed kin of IRRE-like protein 3] Mus musculus (Mouse) GO:0001764; GO:0002121; GO:0005576; GO:0005886; GO:0005911; GO:0007156; GO:0007416; GO:0008021; GO:0016020; GO:0021740; GO:0021766; GO:0030097; GO:0030165; GO:0030424; GO:0030425; GO:0043198; GO:0048812; GO:0050839; GO:0072102; GO:0098609 cell-cell adhesion [GO:0098609]; glomerulus morphogenesis [GO:0072102]; hemopoiesis [GO:0030097]; hippocampus development [GO:0021766]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; inter-male aggressive behavior [GO:0002121]; neuron migration [GO:0001764]; neuron projection morphogenesis [GO:0048812]; principal sensory nucleus of trigeminal nerve development [GO:0021740]; synapse assembly [GO:0007416] axon [GO:0030424]; cell-cell junction [GO:0005911]; dendrite [GO:0030425]; dendritic shaft [GO:0043198]; extracellular region [GO:0005576]; membrane [GO:0016020]; plasma membrane [GO:0005886]; synaptic vesicle [GO:0008021] cell adhesion molecule binding [GO:0050839]; PDZ domain binding [GO:0030165] g15797.t1 O60500 31.76 1017 1.72e-127 425.0 sp|O60500|NPHN_HUMAN Nephrin OS=Homo sapiens OX=9606 GN=NPHS1 PE=1 SV=1 NPHN_HUMAN reviewed Nephrin (Renal glomerulus-specific cell adhesion receptor) Homo sapiens (Human) GO:0005886; GO:0005911; GO:0005925; GO:0007254; GO:0007519; GO:0007520; GO:0010467; GO:0017022; GO:0030838; GO:0032836; GO:0035418; GO:0036057; GO:0036060; GO:0042995; GO:0050839; GO:0070062; GO:0072015; GO:0098609 cell-cell adhesion [GO:0098609]; gene expression [GO:0010467]; glomerular basement membrane development [GO:0032836]; JNK cascade [GO:0007254]; myoblast fusion [GO:0007520]; podocyte development [GO:0072015]; positive regulation of actin filament polymerization [GO:0030838]; protein localization to synapse [GO:0035418]; skeletal muscle tissue development [GO:0007519]; slit diaphragm assembly [GO:0036060] cell projection [GO:0042995]; cell-cell junction [GO:0005911]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]; slit diaphragm [GO:0036057] cell adhesion molecule binding [GO:0050839]; myosin binding [GO:0017022] g15799.t1 Q3UY23 34.097 393 9.35e-54 192.0 sp|Q3UY23|FDXA1_MOUSE Ferredoxin-fold anticodon-binding domain-containing protein 1 homolog OS=Mus musculus OX=10090 GN=Fdxacb1 PE=2 SV=2 g15800.t1 P17074 69.63 135 1.32e-66 202.0 sp|P17074|RS19_RAT Small ribosomal subunit protein eS19 OS=Rattus norvegicus OX=10116 GN=Rps19 PE=1 SV=3 g15802.t1 Q7ZZ00 38.983 236 5.0499999999999997e-48 165.0 sp|Q7ZZ00|ZN511_DANRE Zinc finger protein 511 OS=Danio rerio OX=7955 GN=znf511 PE=2 SV=1 g15803.t1 Q6VTH5 59.817 219 3.4e-87 264.0 sp|Q6VTH5|RSPH1_CYPCA Radial spoke head 1 homolog OS=Cyprinus carpio OX=7962 GN=rsph1 PE=1 SV=1 g15805.t1 Q9JJA2 56.77 613 0.0 641.0 sp|Q9JJA2|COG8_MOUSE Conserved oligomeric Golgi complex subunit 8 OS=Mus musculus OX=10090 GN=Cog8 PE=1 SV=3 g15807.t1 A0A1W2PQ73 87.069 116 4.03e-66 224.0 sp|A0A1W2PQ73|ERFL_HUMAN ETS domain-containing transcription factor ERF-like OS=Homo sapiens OX=9606 GN=ERFL PE=3 SV=1 g15811.t1 Q9H3H5 62.871 404 2.56e-164 471.0 sp|Q9H3H5|GPT_HUMAN UDP-N-acetylglucosamine--dolichyl-phosphate N-acetylglucosaminephosphotransferase OS=Homo sapiens OX=9606 GN=DPAGT1 PE=1 SV=2 g15814.t1 P11475 32.117 411 1.71e-50 179.0 sp|P11475|ERR2_RAT Steroid hormone receptor ERR2 OS=Rattus norvegicus OX=10116 GN=Esrrb PE=2 SV=1 g15816.t1 Q8WY36 55.172 145 7.860000000000001e-37 151.0 sp|Q8WY36|BBX_HUMAN HMG box transcription factor BBX OS=Homo sapiens OX=9606 GN=BBX PE=1 SV=1 BBX_HUMAN reviewed HMG box transcription factor BBX (Bobby sox homolog) (HMG box-containing protein 2) Homo sapiens (Human) GO:0000785; GO:0000977; GO:0000981; GO:0005634; GO:0006357; GO:0060348; GO:1990837 bone development [GO:0060348]; regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; nucleus [GO:0005634] DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837] g15838.t1 P36425 44.966 149 1.28e-33 130.0 sp|P36425|SP17_RABIT Sperm surface protein Sp17 OS=Oryctolagus cuniculus OX=9986 GN=SPA17 PE=1 SV=2 g15842.t1 Q98930 42.726 1629 0.0 1191.0 sp|Q98930|SORL_CHICK Sortilin-related receptor (Fragment) OS=Gallus gallus OX=9031 GN=SORL1 PE=2 SV=1 g15842.t2 Q98930 42.492 1645 0.0 1191.0 sp|Q98930|SORL_CHICK Sortilin-related receptor (Fragment) OS=Gallus gallus OX=9031 GN=SORL1 PE=2 SV=1 g15843.t1 Q5R9J9 66.055 218 2.01e-114 328.0 sp|Q5R9J9|TPPC4_PONAB Trafficking protein particle complex subunit 4 OS=Pongo abelii OX=9601 GN=TRAPPC4 PE=2 SV=1 g15844.t1 Q6GPD0 55.611 597 0.0 668.0 sp|Q6GPD0|RHG32_XENLA Rho GTPase-activating protein 32 OS=Xenopus laevis OX=8355 GN=arhgap32 PE=2 SV=1 g15844.t2 Q6GPD0 55.611 597 0.0 668.0 sp|Q6GPD0|RHG32_XENLA Rho GTPase-activating protein 32 OS=Xenopus laevis OX=8355 GN=arhgap32 PE=2 SV=1 g15845.t1 P54310 45.53 481 5.42e-131 412.0 sp|P54310|LIPS_MOUSE Hormone-sensitive lipase OS=Mus musculus OX=10090 GN=Lipe PE=1 SV=2 LIPS_MOUSE reviewed Hormone-sensitive lipase (HSL) (EC 3.1.1.79) (Monoacylglycerol lipase LIPE) (EC 3.1.1.23) (Retinyl ester hydrolase) (REH) Mus musculus (Mouse) GO:0004771; GO:0004806; GO:0005615; GO:0005634; GO:0005737; GO:0005739; GO:0005811; GO:0005829; GO:0005901; GO:0006361; GO:0006363; GO:0008203; GO:0016020; GO:0016042; GO:0016298; GO:0016788; GO:0017171; GO:0019433; GO:0019901; GO:0042134; GO:0042758; GO:0046340; GO:0046485; GO:0047372; GO:0047376; GO:0050253; GO:0070417; GO:0120516 cellular response to cold [GO:0070417]; cholesterol metabolic process [GO:0008203]; diacylglycerol catabolic process [GO:0046340]; ether lipid metabolic process [GO:0046485]; lipid catabolic process [GO:0016042]; long-chain fatty acid catabolic process [GO:0042758]; termination of RNA polymerase I transcription [GO:0006363]; transcription initiation at RNA polymerase I promoter [GO:0006361]; triglyceride catabolic process [GO:0019433] caveola [GO:0005901]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; lipid droplet [GO:0005811]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleus [GO:0005634] all-trans-retinyl-palmitate hydrolase, all-trans-retinol forming activity [GO:0047376]; diacylglycerol lipase activity [GO:0120516]; hydrolase activity, acting on ester bonds [GO:0016788]; lipase activity [GO:0016298]; monoacylglycerol lipase activity [GO:0047372]; protein kinase binding [GO:0019901]; retinyl-palmitate esterase activity [GO:0050253]; rRNA primary transcript binding [GO:0042134]; serine hydrolase activity [GO:0017171]; sterol ester esterase activity [GO:0004771]; triacylglycerol lipase activity [GO:0004806] g15845.t1 P54310 49.438 89 1.42e-22 107.0 sp|P54310|LIPS_MOUSE Hormone-sensitive lipase OS=Mus musculus OX=10090 GN=Lipe PE=1 SV=2 LIPS_MOUSE reviewed Hormone-sensitive lipase (HSL) (EC 3.1.1.79) (Monoacylglycerol lipase LIPE) (EC 3.1.1.23) (Retinyl ester hydrolase) (REH) Mus musculus (Mouse) GO:0004771; GO:0004806; GO:0005615; GO:0005634; GO:0005737; GO:0005739; GO:0005811; GO:0005829; GO:0005901; GO:0006361; GO:0006363; GO:0008203; GO:0016020; GO:0016042; GO:0016298; GO:0016788; GO:0017171; GO:0019433; GO:0019901; GO:0042134; GO:0042758; GO:0046340; GO:0046485; GO:0047372; GO:0047376; GO:0050253; GO:0070417; GO:0120516 cellular response to cold [GO:0070417]; cholesterol metabolic process [GO:0008203]; diacylglycerol catabolic process [GO:0046340]; ether lipid metabolic process [GO:0046485]; lipid catabolic process [GO:0016042]; long-chain fatty acid catabolic process [GO:0042758]; termination of RNA polymerase I transcription [GO:0006363]; transcription initiation at RNA polymerase I promoter [GO:0006361]; triglyceride catabolic process [GO:0019433] caveola [GO:0005901]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; lipid droplet [GO:0005811]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleus [GO:0005634] all-trans-retinyl-palmitate hydrolase, all-trans-retinol forming activity [GO:0047376]; diacylglycerol lipase activity [GO:0120516]; hydrolase activity, acting on ester bonds [GO:0016788]; lipase activity [GO:0016298]; monoacylglycerol lipase activity [GO:0047372]; protein kinase binding [GO:0019901]; retinyl-palmitate esterase activity [GO:0050253]; rRNA primary transcript binding [GO:0042134]; serine hydrolase activity [GO:0017171]; sterol ester esterase activity [GO:0004771]; triacylglycerol lipase activity [GO:0004806] g15847.t1 Q9UKI9 68.557 194 2.33e-80 266.0 sp|Q9UKI9|PO2F3_HUMAN POU domain, class 2, transcription factor 3 OS=Homo sapiens OX=9606 GN=POU2F3 PE=1 SV=3 PO2F3_HUMAN reviewed POU domain, class 2, transcription factor 3 (Octamer-binding protein 11) (Oct-11) (Octamer-binding transcription factor 11) (OTF-11) (Transcription factor PLA-1) (Transcription factor Skn-1) Homo sapiens (Human) GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0005634; GO:0005654; GO:0005667; GO:0005730; GO:0005829; GO:0005886; GO:0006357; GO:0008544; GO:0016604; GO:0030216; GO:0042060; GO:0042802; GO:0043565; GO:0043922; GO:0045944; GO:1990837 epidermis development [GO:0008544]; host-mediated suppression of viral transcription [GO:0043922]; keratinocyte differentiation [GO:0030216]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; wound healing [GO:0042060] chromatin [GO:0000785]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; transcription regulator complex [GO:0005667] DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837] g15847.t2 Q9UKI9 68.557 194 4.33e-81 267.0 sp|Q9UKI9|PO2F3_HUMAN POU domain, class 2, transcription factor 3 OS=Homo sapiens OX=9606 GN=POU2F3 PE=1 SV=3 PO2F3_HUMAN reviewed POU domain, class 2, transcription factor 3 (Octamer-binding protein 11) (Oct-11) (Octamer-binding transcription factor 11) (OTF-11) (Transcription factor PLA-1) (Transcription factor Skn-1) Homo sapiens (Human) GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0005634; GO:0005654; GO:0005667; GO:0005730; GO:0005829; GO:0005886; GO:0006357; GO:0008544; GO:0016604; GO:0030216; GO:0042060; GO:0042802; GO:0043565; GO:0043922; GO:0045944; GO:1990837 epidermis development [GO:0008544]; host-mediated suppression of viral transcription [GO:0043922]; keratinocyte differentiation [GO:0030216]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; wound healing [GO:0042060] chromatin [GO:0000785]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; transcription regulator complex [GO:0005667] DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837] g15847.t3 Q9UKI9 68.557 194 4.24e-81 267.0 sp|Q9UKI9|PO2F3_HUMAN POU domain, class 2, transcription factor 3 OS=Homo sapiens OX=9606 GN=POU2F3 PE=1 SV=3 PO2F3_HUMAN reviewed POU domain, class 2, transcription factor 3 (Octamer-binding protein 11) (Oct-11) (Octamer-binding transcription factor 11) (OTF-11) (Transcription factor PLA-1) (Transcription factor Skn-1) Homo sapiens (Human) GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0005634; GO:0005654; GO:0005667; GO:0005730; GO:0005829; GO:0005886; GO:0006357; GO:0008544; GO:0016604; GO:0030216; GO:0042060; GO:0042802; GO:0043565; GO:0043922; GO:0045944; GO:1990837 epidermis development [GO:0008544]; host-mediated suppression of viral transcription [GO:0043922]; keratinocyte differentiation [GO:0030216]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; wound healing [GO:0042060] chromatin [GO:0000785]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; transcription regulator complex [GO:0005667] DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837] g15847.t4 Q28BL7 63.717 226 2.93e-82 278.0 sp|Q28BL7|PO2F1_XENTR POU domain, class 2, transcription factor 1 OS=Xenopus tropicalis OX=8364 GN=pou2f1 PE=2 SV=1 PO2F1_XENTR reviewed POU domain, class 2, transcription factor 1 (Octamer-binding protein 1) (Oct-1) (Octamer-binding transcription factor 1) (OTF-1) Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0000978; GO:0000981; GO:0005634; GO:0005667; GO:0005737; GO:0006357; GO:0007219; GO:0042981; GO:0043565; GO:0045893; GO:0045944; GO:0060019 Notch signaling pathway [GO:0007219]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; radial glial cell differentiation [GO:0060019]; regulation of apoptotic process [GO:0042981]; regulation of transcription by RNA polymerase II [GO:0006357] cytoplasm [GO:0005737]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667] DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565] g15848.t1 P97499 26.087 713 4.82e-38 159.0 sp|P97499|TEP1_MOUSE Telomerase protein component 1 OS=Mus musculus OX=10090 GN=Tep1 PE=1 SV=1 TEP1_MOUSE reviewed Telomerase protein component 1 (Telomerase-associated protein 1) (Telomerase protein 1) (p240) (p80 telomerase homolog) Mus musculus (Mouse) GO:0000722; GO:0000781; GO:0002039; GO:0003720; GO:0003723; GO:0005524; GO:0005697; GO:0005737; GO:0016363; GO:0019899; GO:0070034; GO:1990904 telomere maintenance via recombination [GO:0000722] chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; nuclear matrix [GO:0016363]; ribonucleoprotein complex [GO:1990904]; telomerase holoenzyme complex [GO:0005697] ATP binding [GO:0005524]; enzyme binding [GO:0019899]; p53 binding [GO:0002039]; RNA binding [GO:0003723]; telomerase activity [GO:0003720]; telomerase RNA binding [GO:0070034] g15850.t1 Q3UPY5 47.619 609 0.0 538.0 sp|Q3UPY5|GLBL2_MOUSE Beta-galactosidase-1-like protein 2 OS=Mus musculus OX=10090 GN=Glb1l2 PE=1 SV=1 g15851.t1 A6QNK1 34.133 375 1.4799999999999999e-55 194.0 sp|A6QNK1|G3ST1_BOVIN Galactosylceramide sulfotransferase OS=Bos taurus OX=9913 GN=GAL3ST1 PE=2 SV=1 G3ST1_BOVIN reviewed Galactosylceramide sulfotransferase (GalCer sulfotransferase) (EC 2.8.2.11) (3'-phosphoadenosine-5'-phosphosulfate:GalCer sulfotransferase) (3'-phosphoadenylylsulfate:galactosylceramide 3'-sulfotransferase) (Cerebroside sulfotransferase) Bos taurus (Bovine) GO:0000139; GO:0001733; GO:0006665; GO:0006681; GO:0006682; GO:0042552; GO:0046486 galactosylceramide biosynthetic process [GO:0006682]; galactosylceramide metabolic process [GO:0006681]; glycerolipid metabolic process [GO:0046486]; myelination [GO:0042552]; sphingolipid metabolic process [GO:0006665] Golgi membrane [GO:0000139] galactosylceramide sulfotransferase activity [GO:0001733] g15854.t1 P20749 46.371 248 6.22e-60 207.0 sp|P20749|BCL3_HUMAN B-cell lymphoma 3 protein OS=Homo sapiens OX=9606 GN=BCL3 PE=1 SV=2 BCL3_HUMAN reviewed B-cell lymphoma 3 protein (BCL-3) (Proto-oncogene BCL3) Homo sapiens (Human) GO:0002268; GO:0002315; GO:0002455; GO:0002467; GO:0003713; GO:0003714; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006606; GO:0006974; GO:0007249; GO:0009615; GO:0010225; GO:0019730; GO:0030198; GO:0030330; GO:0030496; GO:0030674; GO:0032088; GO:0032717; GO:0032720; GO:0032729; GO:0032733; GO:0032991; GO:0032996; GO:0033257; GO:0036064; GO:0042088; GO:0042742; GO:0042771; GO:0042826; GO:0042832; GO:0042981; GO:0043066; GO:0045064; GO:0045727; GO:0045892; GO:0045893; GO:0045944; GO:0046426; GO:0048471; GO:0048536; GO:0051101; GO:0070231; GO:0070233; GO:0140297; GO:1901222 antimicrobial humoral response [GO:0019730]; canonical NF-kappaB signal transduction [GO:0007249]; defense response to bacterium [GO:0042742]; defense response to protozoan [GO:0042832]; DNA damage response [GO:0006974]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; extracellular matrix organization [GO:0030198]; follicular dendritic cell differentiation [GO:0002268]; germinal center formation [GO:0002467]; humoral immune response mediated by circulating immunoglobulin [GO:0002455]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; marginal zone B cell differentiation [GO:0002315]; negative regulation of apoptotic process [GO:0043066]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of interleukin-8 production [GO:0032717]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of receptor signaling pathway via JAK-STAT [GO:0046426]; negative regulation of T cell apoptotic process [GO:0070233]; negative regulation of tumor necrosis factor production [GO:0032720]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of interleukin-10 production [GO:0032733]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of translation [GO:0045727]; positive regulation of type II interferon production [GO:0032729]; protein import into nucleus [GO:0006606]; regulation of apoptotic process [GO:0042981]; regulation of DNA binding [GO:0051101]; regulation of non-canonical NF-kappaB signal transduction [GO:1901222]; response to UV-C [GO:0010225]; response to virus [GO:0009615]; spleen development [GO:0048536]; T cell apoptotic process [GO:0070231]; T-helper 1 type immune response [GO:0042088]; T-helper 2 cell differentiation [GO:0045064] Bcl3-Bcl10 complex [GO:0032996]; Bcl3/NF-kappaB2 complex [GO:0033257]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; midbody [GO:0030496]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991] DNA-binding transcription factor binding [GO:0140297]; histone deacetylase binding [GO:0042826]; protein-macromolecule adaptor activity [GO:0030674]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714] g15855.t1 A8KB59 37.356 174 5.99e-36 128.0 sp|A8KB59|DRC12_DANRE Dynein regulatory complex protein 12 OS=Danio rerio OX=7955 GN=drc12 PE=2 SV=1 g15856.t1 P38117 74.4 250 7.26e-121 348.0 sp|P38117|ETFB_HUMAN Electron transfer flavoprotein subunit beta OS=Homo sapiens OX=9606 GN=ETFB PE=1 SV=3 ETFB_HUMAN reviewed Electron transfer flavoprotein subunit beta (Beta-ETF) Homo sapiens (Human) GO:0005739; GO:0005759; GO:0009055; GO:0009063; GO:0022904; GO:0033539; GO:0045251 amino acid catabolic process [GO:0009063]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; respiratory electron transport chain [GO:0022904] electron transfer flavoprotein complex [GO:0045251]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] electron transfer activity [GO:0009055] g15858.t1 Q4R7L3 85.442 419 0.0 680.0 sp|Q4R7L3|PRS6B_MACFA 26S proteasome regulatory subunit 6B OS=Macaca fascicularis OX=9541 GN=PSMC4 PE=2 SV=1 g15867.t1 Q63060 60.901 555 0.0 682.0 sp|Q63060|GLPK_RAT Glycerol kinase OS=Rattus norvegicus OX=10116 GN=Gk PE=2 SV=2 g15869.t1 P35556 28.831 496 2.23e-36 140.0 sp|P35556|FBN2_HUMAN Fibrillin-2 OS=Homo sapiens OX=9606 GN=FBN2 PE=1 SV=3 FBN2_HUMAN reviewed Fibrillin-2 [Cleaved into: Placensin] Homo sapiens (Human) GO:0001527; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0006006; GO:0030023; GO:0030326; GO:0030501; GO:0031012; GO:0035583; GO:0042593; GO:0043010; GO:0045669; GO:0048048; GO:0060346 bone trabecula formation [GO:0060346]; camera-type eye development [GO:0043010]; embryonic eye morphogenesis [GO:0048048]; embryonic limb morphogenesis [GO:0030326]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; positive regulation of bone mineralization [GO:0030501]; positive regulation of osteoblast differentiation [GO:0045669]; sequestering of TGFbeta in extracellular matrix [GO:0035583] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; microfibril [GO:0001527] calcium ion binding [GO:0005509]; extracellular matrix constituent conferring elasticity [GO:0030023]; extracellular matrix structural constituent [GO:0005201]; hormone activity [GO:0005179] g15869.t1 P35556 36.364 66 2.23e-36 35.4 sp|P35556|FBN2_HUMAN Fibrillin-2 OS=Homo sapiens OX=9606 GN=FBN2 PE=1 SV=3 FBN2_HUMAN reviewed Fibrillin-2 [Cleaved into: Placensin] Homo sapiens (Human) GO:0001527; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0006006; GO:0030023; GO:0030326; GO:0030501; GO:0031012; GO:0035583; GO:0042593; GO:0043010; GO:0045669; GO:0048048; GO:0060346 bone trabecula formation [GO:0060346]; camera-type eye development [GO:0043010]; embryonic eye morphogenesis [GO:0048048]; embryonic limb morphogenesis [GO:0030326]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; positive regulation of bone mineralization [GO:0030501]; positive regulation of osteoblast differentiation [GO:0045669]; sequestering of TGFbeta in extracellular matrix [GO:0035583] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; microfibril [GO:0001527] calcium ion binding [GO:0005509]; extracellular matrix constituent conferring elasticity [GO:0030023]; extracellular matrix structural constituent [GO:0005201]; hormone activity [GO:0005179] g15869.t1 P35556 29.2 500 4.1400000000000003e-29 129.0 sp|P35556|FBN2_HUMAN Fibrillin-2 OS=Homo sapiens OX=9606 GN=FBN2 PE=1 SV=3 FBN2_HUMAN reviewed Fibrillin-2 [Cleaved into: Placensin] Homo sapiens (Human) GO:0001527; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0006006; GO:0030023; GO:0030326; GO:0030501; GO:0031012; GO:0035583; GO:0042593; GO:0043010; GO:0045669; GO:0048048; GO:0060346 bone trabecula formation [GO:0060346]; camera-type eye development [GO:0043010]; embryonic eye morphogenesis [GO:0048048]; embryonic limb morphogenesis [GO:0030326]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; positive regulation of bone mineralization [GO:0030501]; positive regulation of osteoblast differentiation [GO:0045669]; sequestering of TGFbeta in extracellular matrix [GO:0035583] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; microfibril [GO:0001527] calcium ion binding [GO:0005509]; extracellular matrix constituent conferring elasticity [GO:0030023]; extracellular matrix structural constituent [GO:0005201]; hormone activity [GO:0005179] g15869.t1 P35556 26.964 560 9.070000000000001e-27 122.0 sp|P35556|FBN2_HUMAN Fibrillin-2 OS=Homo sapiens OX=9606 GN=FBN2 PE=1 SV=3 FBN2_HUMAN reviewed Fibrillin-2 [Cleaved into: Placensin] Homo sapiens (Human) GO:0001527; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0006006; GO:0030023; GO:0030326; GO:0030501; GO:0031012; GO:0035583; GO:0042593; GO:0043010; GO:0045669; GO:0048048; GO:0060346 bone trabecula formation [GO:0060346]; camera-type eye development [GO:0043010]; embryonic eye morphogenesis [GO:0048048]; embryonic limb morphogenesis [GO:0030326]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; positive regulation of bone mineralization [GO:0030501]; positive regulation of osteoblast differentiation [GO:0045669]; sequestering of TGFbeta in extracellular matrix [GO:0035583] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; microfibril [GO:0001527] calcium ion binding [GO:0005509]; extracellular matrix constituent conferring elasticity [GO:0030023]; extracellular matrix structural constituent [GO:0005201]; hormone activity [GO:0005179] g15869.t1 P35556 29.424 469 1.3e-22 108.0 sp|P35556|FBN2_HUMAN Fibrillin-2 OS=Homo sapiens OX=9606 GN=FBN2 PE=1 SV=3 FBN2_HUMAN reviewed Fibrillin-2 [Cleaved into: Placensin] Homo sapiens (Human) GO:0001527; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0006006; GO:0030023; GO:0030326; GO:0030501; GO:0031012; GO:0035583; GO:0042593; GO:0043010; GO:0045669; GO:0048048; GO:0060346 bone trabecula formation [GO:0060346]; camera-type eye development [GO:0043010]; embryonic eye morphogenesis [GO:0048048]; embryonic limb morphogenesis [GO:0030326]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; positive regulation of bone mineralization [GO:0030501]; positive regulation of osteoblast differentiation [GO:0045669]; sequestering of TGFbeta in extracellular matrix [GO:0035583] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; microfibril [GO:0001527] calcium ion binding [GO:0005509]; extracellular matrix constituent conferring elasticity [GO:0030023]; extracellular matrix structural constituent [GO:0005201]; hormone activity [GO:0005179] g15869.t1 P35556 28.858 499 1.49e-22 93.6 sp|P35556|FBN2_HUMAN Fibrillin-2 OS=Homo sapiens OX=9606 GN=FBN2 PE=1 SV=3 FBN2_HUMAN reviewed Fibrillin-2 [Cleaved into: Placensin] Homo sapiens (Human) GO:0001527; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0006006; GO:0030023; GO:0030326; GO:0030501; GO:0031012; GO:0035583; GO:0042593; GO:0043010; GO:0045669; GO:0048048; GO:0060346 bone trabecula formation [GO:0060346]; camera-type eye development [GO:0043010]; embryonic eye morphogenesis [GO:0048048]; embryonic limb morphogenesis [GO:0030326]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; positive regulation of bone mineralization [GO:0030501]; positive regulation of osteoblast differentiation [GO:0045669]; sequestering of TGFbeta in extracellular matrix [GO:0035583] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; microfibril [GO:0001527] calcium ion binding [GO:0005509]; extracellular matrix constituent conferring elasticity [GO:0030023]; extracellular matrix structural constituent [GO:0005201]; hormone activity [GO:0005179] g15869.t1 P35556 51.064 47 1.49e-22 36.2 sp|P35556|FBN2_HUMAN Fibrillin-2 OS=Homo sapiens OX=9606 GN=FBN2 PE=1 SV=3 FBN2_HUMAN reviewed Fibrillin-2 [Cleaved into: Placensin] Homo sapiens (Human) GO:0001527; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0006006; GO:0030023; GO:0030326; GO:0030501; GO:0031012; GO:0035583; GO:0042593; GO:0043010; GO:0045669; GO:0048048; GO:0060346 bone trabecula formation [GO:0060346]; camera-type eye development [GO:0043010]; embryonic eye morphogenesis [GO:0048048]; embryonic limb morphogenesis [GO:0030326]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; positive regulation of bone mineralization [GO:0030501]; positive regulation of osteoblast differentiation [GO:0045669]; sequestering of TGFbeta in extracellular matrix [GO:0035583] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; microfibril [GO:0001527] calcium ion binding [GO:0005509]; extracellular matrix constituent conferring elasticity [GO:0030023]; extracellular matrix structural constituent [GO:0005201]; hormone activity [GO:0005179] g15869.t2 P35556 28.227 581 9.01e-40 163.0 sp|P35556|FBN2_HUMAN Fibrillin-2 OS=Homo sapiens OX=9606 GN=FBN2 PE=1 SV=3 FBN2_HUMAN reviewed Fibrillin-2 [Cleaved into: Placensin] Homo sapiens (Human) GO:0001527; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0006006; GO:0030023; GO:0030326; GO:0030501; GO:0031012; GO:0035583; GO:0042593; GO:0043010; GO:0045669; GO:0048048; GO:0060346 bone trabecula formation [GO:0060346]; camera-type eye development [GO:0043010]; embryonic eye morphogenesis [GO:0048048]; embryonic limb morphogenesis [GO:0030326]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; positive regulation of bone mineralization [GO:0030501]; positive regulation of osteoblast differentiation [GO:0045669]; sequestering of TGFbeta in extracellular matrix [GO:0035583] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; microfibril [GO:0001527] calcium ion binding [GO:0005509]; extracellular matrix constituent conferring elasticity [GO:0030023]; extracellular matrix structural constituent [GO:0005201]; hormone activity [GO:0005179] g15869.t2 P35556 27.815 604 1.85e-34 146.0 sp|P35556|FBN2_HUMAN Fibrillin-2 OS=Homo sapiens OX=9606 GN=FBN2 PE=1 SV=3 FBN2_HUMAN reviewed Fibrillin-2 [Cleaved into: Placensin] Homo sapiens (Human) GO:0001527; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0006006; GO:0030023; GO:0030326; GO:0030501; GO:0031012; GO:0035583; GO:0042593; GO:0043010; GO:0045669; GO:0048048; GO:0060346 bone trabecula formation [GO:0060346]; camera-type eye development [GO:0043010]; embryonic eye morphogenesis [GO:0048048]; embryonic limb morphogenesis [GO:0030326]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; positive regulation of bone mineralization [GO:0030501]; positive regulation of osteoblast differentiation [GO:0045669]; sequestering of TGFbeta in extracellular matrix [GO:0035583] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; microfibril [GO:0001527] calcium ion binding [GO:0005509]; extracellular matrix constituent conferring elasticity [GO:0030023]; extracellular matrix structural constituent [GO:0005201]; hormone activity [GO:0005179] g15869.t2 P35556 29.074 540 5.6699999999999996e-30 132.0 sp|P35556|FBN2_HUMAN Fibrillin-2 OS=Homo sapiens OX=9606 GN=FBN2 PE=1 SV=3 FBN2_HUMAN reviewed Fibrillin-2 [Cleaved into: Placensin] Homo sapiens (Human) GO:0001527; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0006006; GO:0030023; GO:0030326; GO:0030501; GO:0031012; GO:0035583; GO:0042593; GO:0043010; GO:0045669; GO:0048048; GO:0060346 bone trabecula formation [GO:0060346]; camera-type eye development [GO:0043010]; embryonic eye morphogenesis [GO:0048048]; embryonic limb morphogenesis [GO:0030326]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; positive regulation of bone mineralization [GO:0030501]; positive regulation of osteoblast differentiation [GO:0045669]; sequestering of TGFbeta in extracellular matrix [GO:0035583] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; microfibril [GO:0001527] calcium ion binding [GO:0005509]; extracellular matrix constituent conferring elasticity [GO:0030023]; extracellular matrix structural constituent [GO:0005201]; hormone activity [GO:0005179] g15869.t2 P35556 30.092 545 7.070000000000001e-26 119.0 sp|P35556|FBN2_HUMAN Fibrillin-2 OS=Homo sapiens OX=9606 GN=FBN2 PE=1 SV=3 FBN2_HUMAN reviewed Fibrillin-2 [Cleaved into: Placensin] Homo sapiens (Human) GO:0001527; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0006006; GO:0030023; GO:0030326; GO:0030501; GO:0031012; GO:0035583; GO:0042593; GO:0043010; GO:0045669; GO:0048048; GO:0060346 bone trabecula formation [GO:0060346]; camera-type eye development [GO:0043010]; embryonic eye morphogenesis [GO:0048048]; embryonic limb morphogenesis [GO:0030326]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; positive regulation of bone mineralization [GO:0030501]; positive regulation of osteoblast differentiation [GO:0045669]; sequestering of TGFbeta in extracellular matrix [GO:0035583] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; microfibril [GO:0001527] calcium ion binding [GO:0005509]; extracellular matrix constituent conferring elasticity [GO:0030023]; extracellular matrix structural constituent [GO:0005201]; hormone activity [GO:0005179] g15875.t1 Q811U4 31.622 370 6.39e-42 167.0 sp|Q811U4|MFN1_MOUSE Mitofusin-1 OS=Mus musculus OX=10090 GN=Mfn1 PE=1 SV=3 MFN1_MOUSE reviewed Mitofusin-1 (EC 3.6.5.-) (Transmembrane GTPase MFN1) Mus musculus (Mouse) GO:0003924; GO:0005525; GO:0005739; GO:0005741; GO:0005743; GO:0007005; GO:0008053; GO:0010636; GO:0010918; GO:0016020; GO:0042802; GO:0046039; GO:0048312; GO:0051646; GO:0061003; GO:0090258; GO:0098799 GTP metabolic process [GO:0046039]; intracellular distribution of mitochondria [GO:0048312]; mitochondrial fusion [GO:0008053]; mitochondrion localization [GO:0051646]; mitochondrion organization [GO:0007005]; negative regulation of mitochondrial fission [GO:0090258]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of mitochondrial fusion [GO:0010636]; positive regulation of mitochondrial membrane potential [GO:0010918] membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; outer mitochondrial membrane protein complex [GO:0098799] GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802] g15876.t1 Q810T5 66.435 432 0.0 606.0 sp|Q810T5|KAT7_RAT Histone acetyltransferase KAT7 OS=Rattus norvegicus OX=10116 GN=Kat7 PE=1 SV=1 KAT7_RAT reviewed Histone acetyltransferase KAT7 (EC 2.3.1.48) (Histone acetyltransferase binding to ORC1) (Lysine acetyltransferase 7) (MOZ, YBF2/SAS3, SAS2 and TIP60 protein 2) (MYST-2) Rattus norvegicus (Rat) GO:0000123; GO:0000775; GO:0000785; GO:0001558; GO:0001779; GO:0003682; GO:0003688; GO:0003712; GO:0004402; GO:0005634; GO:0005654; GO:0005694; GO:0005829; GO:0006260; GO:0006275; GO:0006281; GO:0006355; GO:0006357; GO:0008270; GO:0010484; GO:0010485; GO:0018393; GO:0030174; GO:0030217; GO:0031098; GO:0032786; GO:0036408; GO:0036409; GO:0043161; GO:0043994; GO:0043995; GO:0043996; GO:0043997; GO:0044016; GO:0045648; GO:0045740; GO:0045815; GO:0045944; GO:0051726; GO:0072708; GO:0072710; GO:0072716; GO:0072720; GO:0072739; GO:0090734; GO:0140889; GO:1900182; GO:1902035; GO:2000278; GO:2000819 DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA replication-dependent chromatin disassembly [GO:0140889]; internal peptidyl-lysine acetylation [GO:0018393]; natural killer cell differentiation [GO:0001779]; positive regulation of DNA replication [GO:0045740]; positive regulation of DNA-templated transcription, elongation [GO:0032786]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of hematopoietic stem cell proliferation [GO:1902035]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of cell cycle [GO:0051726]; regulation of cell growth [GO:0001558]; regulation of DNA biosynthetic process [GO:2000278]; regulation of DNA replication [GO:0006275]; regulation of DNA-templated DNA replication initiation [GO:0030174]; regulation of DNA-templated transcription [GO:0006355]; regulation of nucleotide-excision repair [GO:2000819]; regulation of transcription by RNA polymerase II [GO:0006357]; response to actinomycin D [GO:0072716]; response to anisomycin [GO:0072739]; response to dithiothreitol [GO:0072720]; response to hydroxyurea [GO:0072710]; response to sorbitol [GO:0072708]; stress-activated protein kinase signaling cascade [GO:0031098]; T cell differentiation [GO:0030217]; transcription initiation-coupled chromatin remodeling [GO:0045815] chromatin [GO:0000785]; chromosome [GO:0005694]; chromosome, centromeric region [GO:0000775]; cytosol [GO:0005829]; histone acetyltransferase complex [GO:0000123]; histone H3-K14 acetyltransferase complex [GO:0036409]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of DNA damage [GO:0090734] chromatin binding [GO:0003682]; DNA replication origin binding [GO:0003688]; histone acetyltransferase activity [GO:0004402]; histone H3 acetyltransferase activity [GO:0010484]; histone H3K14 acetyltransferase activity [GO:0036408]; histone H3K23 acetyltransferase activity [GO:0043994]; histone H3K4 acetyltransferase activity [GO:0044016]; histone H4 acetyltransferase activity [GO:0010485]; histone H4K12 acetyltransferase activity [GO:0043997]; histone H4K5 acetyltransferase activity [GO:0043995]; histone H4K8 acetyltransferase activity [GO:0043996]; transcription coregulator activity [GO:0003712]; zinc ion binding [GO:0008270] g15876.t2 Q810T5 66.589 431 0.0 610.0 sp|Q810T5|KAT7_RAT Histone acetyltransferase KAT7 OS=Rattus norvegicus OX=10116 GN=Kat7 PE=1 SV=1 KAT7_RAT reviewed Histone acetyltransferase KAT7 (EC 2.3.1.48) (Histone acetyltransferase binding to ORC1) (Lysine acetyltransferase 7) (MOZ, YBF2/SAS3, SAS2 and TIP60 protein 2) (MYST-2) Rattus norvegicus (Rat) GO:0000123; GO:0000775; GO:0000785; GO:0001558; GO:0001779; GO:0003682; GO:0003688; GO:0003712; GO:0004402; GO:0005634; GO:0005654; GO:0005694; GO:0005829; GO:0006260; GO:0006275; GO:0006281; GO:0006355; GO:0006357; GO:0008270; GO:0010484; GO:0010485; GO:0018393; GO:0030174; GO:0030217; GO:0031098; GO:0032786; GO:0036408; GO:0036409; GO:0043161; GO:0043994; GO:0043995; GO:0043996; GO:0043997; GO:0044016; GO:0045648; GO:0045740; GO:0045815; GO:0045944; GO:0051726; GO:0072708; GO:0072710; GO:0072716; GO:0072720; GO:0072739; GO:0090734; GO:0140889; GO:1900182; GO:1902035; GO:2000278; GO:2000819 DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA replication-dependent chromatin disassembly [GO:0140889]; internal peptidyl-lysine acetylation [GO:0018393]; natural killer cell differentiation [GO:0001779]; positive regulation of DNA replication [GO:0045740]; positive regulation of DNA-templated transcription, elongation [GO:0032786]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of hematopoietic stem cell proliferation [GO:1902035]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of cell cycle [GO:0051726]; regulation of cell growth [GO:0001558]; regulation of DNA biosynthetic process [GO:2000278]; regulation of DNA replication [GO:0006275]; regulation of DNA-templated DNA replication initiation [GO:0030174]; regulation of DNA-templated transcription [GO:0006355]; regulation of nucleotide-excision repair [GO:2000819]; regulation of transcription by RNA polymerase II [GO:0006357]; response to actinomycin D [GO:0072716]; response to anisomycin [GO:0072739]; response to dithiothreitol [GO:0072720]; response to hydroxyurea [GO:0072710]; response to sorbitol [GO:0072708]; stress-activated protein kinase signaling cascade [GO:0031098]; T cell differentiation [GO:0030217]; transcription initiation-coupled chromatin remodeling [GO:0045815] chromatin [GO:0000785]; chromosome [GO:0005694]; chromosome, centromeric region [GO:0000775]; cytosol [GO:0005829]; histone acetyltransferase complex [GO:0000123]; histone H3-K14 acetyltransferase complex [GO:0036409]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of DNA damage [GO:0090734] chromatin binding [GO:0003682]; DNA replication origin binding [GO:0003688]; histone acetyltransferase activity [GO:0004402]; histone H3 acetyltransferase activity [GO:0010484]; histone H3K14 acetyltransferase activity [GO:0036408]; histone H3K23 acetyltransferase activity [GO:0043994]; histone H3K4 acetyltransferase activity [GO:0044016]; histone H4 acetyltransferase activity [GO:0010485]; histone H4K12 acetyltransferase activity [GO:0043997]; histone H4K5 acetyltransferase activity [GO:0043995]; histone H4K8 acetyltransferase activity [GO:0043996]; transcription coregulator activity [GO:0003712]; zinc ion binding [GO:0008270] g15879.t1 Q9MYV9 29.841 439 3.52e-43 174.0 sp|Q9MYV9|TRPC5_BOVIN Short transient receptor potential channel 5 OS=Bos taurus OX=9913 GN=TRPC5 PE=2 SV=2 g15879.t1 Q9MYV9 34.359 195 8.37e-24 112.0 sp|Q9MYV9|TRPC5_BOVIN Short transient receptor potential channel 5 OS=Bos taurus OX=9913 GN=TRPC5 PE=2 SV=2 g15880.t1 Q9VJJ7 27.669 459 5.0799999999999996e-42 171.0 sp|Q9VJJ7|TRPG_DROME Transient receptor potential-gamma protein OS=Drosophila melanogaster OX=7227 GN=Trpgamma PE=1 SV=2 TRPG_DROME reviewed Transient receptor potential-gamma protein (TRPgamma) (Transient receptor potential cation channel gamma) Drosophila melanogaster (Fruit fly) GO:0005261; GO:0005262; GO:0005886; GO:0006812; GO:0006816; GO:0007628; GO:0008381; GO:0009416; GO:0015279; GO:0016028; GO:0033583; GO:0034703; GO:0043025; GO:0050884; GO:0050908; GO:0051480; GO:0070588; GO:0070679; GO:1990635 adult walking behavior [GO:0007628]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; detection of light stimulus involved in visual perception [GO:0050908]; monoatomic cation transport [GO:0006812]; neuromuscular process controlling posture [GO:0050884]; regulation of cytosolic calcium ion concentration [GO:0051480]; response to light stimulus [GO:0009416] cation channel complex [GO:0034703]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; proximal dendrite [GO:1990635]; rhabdomere [GO:0016028]; rhabdomere membrane [GO:0033583] calcium channel activity [GO:0005262]; inositol 1,4,5 trisphosphate binding [GO:0070679]; mechanosensitive monoatomic ion channel activity [GO:0008381]; monoatomic cation channel activity [GO:0005261]; store-operated calcium channel activity [GO:0015279] g15882.t1 Q9C040 34.969 163 3.64e-26 108.0 sp|Q9C040|TRIM2_HUMAN Tripartite motif-containing protein 2 OS=Homo sapiens OX=9606 GN=TRIM2 PE=1 SV=1 TRIM2_HUMAN reviewed Tripartite motif-containing protein 2 (EC 2.3.2.27) (E3 ubiquitin-protein ligase TRIM2) (RING finger protein 86) (RING-type E3 ubiquitin transferase TRIM2) Homo sapiens (Human) GO:0000209; GO:0004842; GO:0005737; GO:0008270; GO:0043161; GO:0043523; GO:0061630; GO:1990830 cellular response to leukemia inhibitory factor [GO:1990830]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; regulation of neuron apoptotic process [GO:0043523] cytoplasm [GO:0005737] ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] g15885.t1 P19813 45.597 511 1.42e-162 478.0 sp|P19813|TREA_RABIT Trehalase OS=Oryctolagus cuniculus OX=9986 GN=TREH PE=1 SV=1 g15886.t1 P83565 44.928 138 4.380000000000001e-27 105.0 sp|P83565|RM40_RAT Large ribosomal subunit protein mL40 OS=Rattus norvegicus OX=10116 GN=Mrpl40 PE=1 SV=2 g15888.t1 Q8NCU4 36.486 148 4.78e-23 97.4 sp|Q8NCU4|CC191_HUMAN Coiled-coil domain-containing protein 191 OS=Homo sapiens OX=9606 GN=CCDC191 PE=1 SV=1 g15890.t1 Q5I0K5 46.575 146 7.05e-31 118.0 sp|Q5I0K5|ABHDA_RAT Palmitoyl-protein thioesterase ABHD10, mitochondrial OS=Rattus norvegicus OX=10116 GN=Abhd10 PE=1 SV=2 ABHDA_RAT reviewed Palmitoyl-protein thioesterase ABHD10, mitochondrial (EC 3.1.2.22) (Acyl-protein thioesterase ABHD10) (Alpha/beta hydrolase domain-containing protein 10) (Abhydrolase domain-containing protein 10) (Mycophenolic acid acyl-glucuronide esterase, mitochondrial) (EC 3.1.1.93) Rattus norvegicus (Rat) GO:0002084; GO:0004553; GO:0005739; GO:0005829; GO:0006805; GO:0008474; GO:0102390 protein depalmitoylation [GO:0002084]; xenobiotic metabolic process [GO:0006805] cytosol [GO:0005829]; mitochondrion [GO:0005739] hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]; mycophenolic acid acyl-glucuronide esterase activity [GO:0102390]; palmitoyl-(protein) hydrolase activity [GO:0008474] g15891.t1 Q6PE15 49.425 87 9.98e-26 99.8 sp|Q6PE15|ABHDA_MOUSE Palmitoyl-protein thioesterase ABHD10, mitochondrial OS=Mus musculus OX=10090 GN=Abhd10 PE=1 SV=1 ABHDA_MOUSE reviewed Palmitoyl-protein thioesterase ABHD10, mitochondrial (EC 3.1.2.22) (Acyl-protein thioesterase ABHD10) (Alpha/beta hydrolase domain-containing protein 10) (Abhydrolase domain-containing protein 10) (Mycophenolic acid acyl-glucuronide esterase, mitochondrial) (EC 3.1.1.93) Mus musculus (Mouse) GO:0002084; GO:0004553; GO:0005739; GO:0005829; GO:0006805; GO:0008474; GO:0102390 protein depalmitoylation [GO:0002084]; xenobiotic metabolic process [GO:0006805] cytosol [GO:0005829]; mitochondrion [GO:0005739] hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]; mycophenolic acid acyl-glucuronide esterase activity [GO:0102390]; palmitoyl-(protein) hydrolase activity [GO:0008474] g15893.t1 B0BN95 30.488 246 8.72e-28 115.0 sp|B0BN95|HARB1_RAT Putative nuclease HARBI1 OS=Rattus norvegicus OX=10116 GN=Harbi1 PE=2 SV=1 HARB1_RAT reviewed Putative nuclease HARBI1 (EC 3.1.-.-) (Harbinger transposase-derived nuclease) Rattus norvegicus (Rat) GO:0004518; GO:0005634; GO:0005829; GO:0005886; GO:0016787; GO:0034451; GO:0046872 centriolar satellite [GO:0034451]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886] hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]; nuclease activity [GO:0004518] g15895.t1 Q9H892 31.433 719 1.36e-85 288.0 sp|Q9H892|TTC12_HUMAN Tetratricopeptide repeat protein 12 OS=Homo sapiens OX=9606 GN=TTC12 PE=1 SV=2 g15922.t1 P18887 37.337 383 5.81e-73 251.0 sp|P18887|XRCC1_HUMAN DNA repair protein XRCC1 OS=Homo sapiens OX=9606 GN=XRCC1 PE=1 SV=3 XRCC1_HUMAN reviewed DNA repair protein XRCC1 (X-ray repair cross-complementing protein 1) Homo sapiens (Human) GO:0000012; GO:0000781; GO:0000785; GO:0005634; GO:0005654; GO:0005730; GO:0006284; GO:0006302; GO:0006303; GO:0010836; GO:0019899; GO:0021766; GO:0032356; GO:0033194; GO:0061819; GO:0070522; GO:0072572; GO:0090734; GO:0160002; GO:1905051; GO:1905765; GO:1990599 base-excision repair [GO:0006284]; double-strand break repair [GO:0006302]; double-strand break repair via nonhomologous end joining [GO:0006303]; hippocampus development [GO:0021766]; negative regulation of protection from non-homologous end joining at telomere [GO:1905765]; negative regulation of protein ADP-ribosylation [GO:0010836]; regulation of base-excision repair [GO:1905051]; response to hydroperoxide [GO:0033194]; single strand break repair [GO:0000012]; telomeric DNA-containing double minutes formation [GO:0061819] chromatin [GO:0000785]; chromosome, telomeric region [GO:0000781]; ERCC4-ERCC1 complex [GO:0070522]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of DNA damage [GO:0090734] 3' overhang single-stranded DNA endodeoxyribonuclease activity [GO:1990599]; ADP-D-ribose modification-dependent protein binding [GO:0160002]; enzyme binding [GO:0019899]; oxidized DNA binding [GO:0032356]; poly-ADP-D-ribose binding [GO:0072572] g15922.t1 P18887 55.34 206 3.68e-64 227.0 sp|P18887|XRCC1_HUMAN DNA repair protein XRCC1 OS=Homo sapiens OX=9606 GN=XRCC1 PE=1 SV=3 XRCC1_HUMAN reviewed DNA repair protein XRCC1 (X-ray repair cross-complementing protein 1) Homo sapiens (Human) GO:0000012; GO:0000781; GO:0000785; GO:0005634; GO:0005654; GO:0005730; GO:0006284; GO:0006302; GO:0006303; GO:0010836; GO:0019899; GO:0021766; GO:0032356; GO:0033194; GO:0061819; GO:0070522; GO:0072572; GO:0090734; GO:0160002; GO:1905051; GO:1905765; GO:1990599 base-excision repair [GO:0006284]; double-strand break repair [GO:0006302]; double-strand break repair via nonhomologous end joining [GO:0006303]; hippocampus development [GO:0021766]; negative regulation of protection from non-homologous end joining at telomere [GO:1905765]; negative regulation of protein ADP-ribosylation [GO:0010836]; regulation of base-excision repair [GO:1905051]; response to hydroperoxide [GO:0033194]; single strand break repair [GO:0000012]; telomeric DNA-containing double minutes formation [GO:0061819] chromatin [GO:0000785]; chromosome, telomeric region [GO:0000781]; ERCC4-ERCC1 complex [GO:0070522]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of DNA damage [GO:0090734] 3' overhang single-stranded DNA endodeoxyribonuclease activity [GO:1990599]; ADP-D-ribose modification-dependent protein binding [GO:0160002]; enzyme binding [GO:0019899]; oxidized DNA binding [GO:0032356]; poly-ADP-D-ribose binding [GO:0072572] g15929.t1 Q9R008 46.394 416 4.22e-103 314.0 sp|Q9R008|KIME_MOUSE Mevalonate kinase OS=Mus musculus OX=10090 GN=Mvk PE=1 SV=1 KIME_MOUSE reviewed Mevalonate kinase (MK) (EC 2.7.1.36) Mus musculus (Mouse) GO:0000287; GO:0003729; GO:0004496; GO:0005524; GO:0005737; GO:0005777; GO:0005829; GO:0006695; GO:0008299; GO:0017148; GO:0019287; GO:0033489; GO:0033490; GO:0036197; GO:0042802; GO:0050728; GO:1990825 cholesterol biosynthetic process [GO:0006695]; cholesterol biosynthetic process via desmosterol [GO:0033489]; cholesterol biosynthetic process via lathosterol [GO:0033490]; isopentenyl diphosphate biosynthetic process, mevalonate pathway [GO:0019287]; isoprenoid biosynthetic process [GO:0008299]; negative regulation of inflammatory response [GO:0050728]; negative regulation of translation [GO:0017148]; zymosterol biosynthetic process [GO:0036197] cytoplasm [GO:0005737]; cytosol [GO:0005829]; peroxisome [GO:0005777] ATP binding [GO:0005524]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; mevalonate kinase activity [GO:0004496]; mRNA binding [GO:0003729]; sequence-specific mRNA binding [GO:1990825] g15933.t1 O15374 24.771 327 7.77e-25 110.0 sp|O15374|MOT5_HUMAN Monocarboxylate transporter 5 OS=Homo sapiens OX=9606 GN=SLC16A4 PE=1 SV=1 g15937.t1 Q9HCK4 35.48 854 6.99e-141 474.0 sp|Q9HCK4|ROBO2_HUMAN Roundabout homolog 2 OS=Homo sapiens OX=9606 GN=ROBO2 PE=1 SV=2 ROBO2_HUMAN reviewed Roundabout homolog 2 Homo sapiens (Human) GO:0001656; GO:0001657; GO:0003129; GO:0003148; GO:0003180; GO:0003184; GO:0003272; GO:0005886; GO:0006935; GO:0007156; GO:0007411; GO:0007417; GO:0007420; GO:0008046; GO:0009986; GO:0016199; GO:0021891; GO:0030673; GO:0031290; GO:0032870; GO:0035904; GO:0042802; GO:0045747; GO:0050772; GO:0050925; GO:0051964; GO:0060412; GO:0061364; GO:0070062; GO:0098609 aorta development [GO:0035904]; aortic valve morphogenesis [GO:0003180]; apoptotic process involved in luteolysis [GO:0061364]; axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; brain development [GO:0007420]; cell-cell adhesion [GO:0098609]; cellular response to hormone stimulus [GO:0032870]; central nervous system development [GO:0007417]; chemotaxis [GO:0006935]; endocardial cushion formation [GO:0003272]; heart induction [GO:0003129]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; metanephros development [GO:0001656]; negative regulation of negative chemotaxis [GO:0050925]; negative regulation of synapse assembly [GO:0051964]; olfactory bulb interneuron development [GO:0021891]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of axonogenesis [GO:0050772]; positive regulation of Notch signaling pathway [GO:0045747]; pulmonary valve morphogenesis [GO:0003184]; retinal ganglion cell axon guidance [GO:0031290]; ureteric bud development [GO:0001657]; ventricular septum morphogenesis [GO:0060412] axolemma [GO:0030673]; cell surface [GO:0009986]; extracellular exosome [GO:0070062]; plasma membrane [GO:0005886] axon guidance receptor activity [GO:0008046]; identical protein binding [GO:0042802] g15937.t1 Q9HCK4 28.529 333 2.4399999999999997e-24 115.0 sp|Q9HCK4|ROBO2_HUMAN Roundabout homolog 2 OS=Homo sapiens OX=9606 GN=ROBO2 PE=1 SV=2 ROBO2_HUMAN reviewed Roundabout homolog 2 Homo sapiens (Human) GO:0001656; GO:0001657; GO:0003129; GO:0003148; GO:0003180; GO:0003184; GO:0003272; GO:0005886; GO:0006935; GO:0007156; GO:0007411; GO:0007417; GO:0007420; GO:0008046; GO:0009986; GO:0016199; GO:0021891; GO:0030673; GO:0031290; GO:0032870; GO:0035904; GO:0042802; GO:0045747; GO:0050772; GO:0050925; GO:0051964; GO:0060412; GO:0061364; GO:0070062; GO:0098609 aorta development [GO:0035904]; aortic valve morphogenesis [GO:0003180]; apoptotic process involved in luteolysis [GO:0061364]; axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; brain development [GO:0007420]; cell-cell adhesion [GO:0098609]; cellular response to hormone stimulus [GO:0032870]; central nervous system development [GO:0007417]; chemotaxis [GO:0006935]; endocardial cushion formation [GO:0003272]; heart induction [GO:0003129]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; metanephros development [GO:0001656]; negative regulation of negative chemotaxis [GO:0050925]; negative regulation of synapse assembly [GO:0051964]; olfactory bulb interneuron development [GO:0021891]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of axonogenesis [GO:0050772]; positive regulation of Notch signaling pathway [GO:0045747]; pulmonary valve morphogenesis [GO:0003184]; retinal ganglion cell axon guidance [GO:0031290]; ureteric bud development [GO:0001657]; ventricular septum morphogenesis [GO:0060412] axolemma [GO:0030673]; cell surface [GO:0009986]; extracellular exosome [GO:0070062]; plasma membrane [GO:0005886] axon guidance receptor activity [GO:0008046]; identical protein binding [GO:0042802] g15938.t1 O44997 23.506 1004 7.3e-49 195.0 sp|O44997|DAPK_CAEEL Death-associated protein kinase dapk-1 OS=Caenorhabditis elegans OX=6239 GN=dapk-1 PE=1 SV=2 g15946.t1 P40873 30.548 383 8.12e-55 189.0 sp|P40873|MSOX_ARTST Monomeric sarcosine oxidase OS=Arthrobacter sp. (strain TE1826) OX=68999 GN=soxA PE=1 SV=2 g15948.t1 Q9HCK4 36.522 805 2.73e-139 468.0 sp|Q9HCK4|ROBO2_HUMAN Roundabout homolog 2 OS=Homo sapiens OX=9606 GN=ROBO2 PE=1 SV=2 ROBO2_HUMAN reviewed Roundabout homolog 2 Homo sapiens (Human) GO:0001656; GO:0001657; GO:0003129; GO:0003148; GO:0003180; GO:0003184; GO:0003272; GO:0005886; GO:0006935; GO:0007156; GO:0007411; GO:0007417; GO:0007420; GO:0008046; GO:0009986; GO:0016199; GO:0021891; GO:0030673; GO:0031290; GO:0032870; GO:0035904; GO:0042802; GO:0045747; GO:0050772; GO:0050925; GO:0051964; GO:0060412; GO:0061364; GO:0070062; GO:0098609 aorta development [GO:0035904]; aortic valve morphogenesis [GO:0003180]; apoptotic process involved in luteolysis [GO:0061364]; axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; brain development [GO:0007420]; cell-cell adhesion [GO:0098609]; cellular response to hormone stimulus [GO:0032870]; central nervous system development [GO:0007417]; chemotaxis [GO:0006935]; endocardial cushion formation [GO:0003272]; heart induction [GO:0003129]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; metanephros development [GO:0001656]; negative regulation of negative chemotaxis [GO:0050925]; negative regulation of synapse assembly [GO:0051964]; olfactory bulb interneuron development [GO:0021891]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of axonogenesis [GO:0050772]; positive regulation of Notch signaling pathway [GO:0045747]; pulmonary valve morphogenesis [GO:0003184]; retinal ganglion cell axon guidance [GO:0031290]; ureteric bud development [GO:0001657]; ventricular septum morphogenesis [GO:0060412] axolemma [GO:0030673]; cell surface [GO:0009986]; extracellular exosome [GO:0070062]; plasma membrane [GO:0005886] axon guidance receptor activity [GO:0008046]; identical protein binding [GO:0042802] g15948.t1 Q9HCK4 32.927 410 1.35e-41 171.0 sp|Q9HCK4|ROBO2_HUMAN Roundabout homolog 2 OS=Homo sapiens OX=9606 GN=ROBO2 PE=1 SV=2 ROBO2_HUMAN reviewed Roundabout homolog 2 Homo sapiens (Human) GO:0001656; GO:0001657; GO:0003129; GO:0003148; GO:0003180; GO:0003184; GO:0003272; GO:0005886; GO:0006935; GO:0007156; GO:0007411; GO:0007417; GO:0007420; GO:0008046; GO:0009986; GO:0016199; GO:0021891; GO:0030673; GO:0031290; GO:0032870; GO:0035904; GO:0042802; GO:0045747; GO:0050772; GO:0050925; GO:0051964; GO:0060412; GO:0061364; GO:0070062; GO:0098609 aorta development [GO:0035904]; aortic valve morphogenesis [GO:0003180]; apoptotic process involved in luteolysis [GO:0061364]; axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; brain development [GO:0007420]; cell-cell adhesion [GO:0098609]; cellular response to hormone stimulus [GO:0032870]; central nervous system development [GO:0007417]; chemotaxis [GO:0006935]; endocardial cushion formation [GO:0003272]; heart induction [GO:0003129]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; metanephros development [GO:0001656]; negative regulation of negative chemotaxis [GO:0050925]; negative regulation of synapse assembly [GO:0051964]; olfactory bulb interneuron development [GO:0021891]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of axonogenesis [GO:0050772]; positive regulation of Notch signaling pathway [GO:0045747]; pulmonary valve morphogenesis [GO:0003184]; retinal ganglion cell axon guidance [GO:0031290]; ureteric bud development [GO:0001657]; ventricular septum morphogenesis [GO:0060412] axolemma [GO:0030673]; cell surface [GO:0009986]; extracellular exosome [GO:0070062]; plasma membrane [GO:0005886] axon guidance receptor activity [GO:0008046]; identical protein binding [GO:0042802] g15948.t1 Q9HCK4 31.095 283 7.13e-24 114.0 sp|Q9HCK4|ROBO2_HUMAN Roundabout homolog 2 OS=Homo sapiens OX=9606 GN=ROBO2 PE=1 SV=2 ROBO2_HUMAN reviewed Roundabout homolog 2 Homo sapiens (Human) GO:0001656; GO:0001657; GO:0003129; GO:0003148; GO:0003180; GO:0003184; GO:0003272; GO:0005886; GO:0006935; GO:0007156; GO:0007411; GO:0007417; GO:0007420; GO:0008046; GO:0009986; GO:0016199; GO:0021891; GO:0030673; GO:0031290; GO:0032870; GO:0035904; GO:0042802; GO:0045747; GO:0050772; GO:0050925; GO:0051964; GO:0060412; GO:0061364; GO:0070062; GO:0098609 aorta development [GO:0035904]; aortic valve morphogenesis [GO:0003180]; apoptotic process involved in luteolysis [GO:0061364]; axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; brain development [GO:0007420]; cell-cell adhesion [GO:0098609]; cellular response to hormone stimulus [GO:0032870]; central nervous system development [GO:0007417]; chemotaxis [GO:0006935]; endocardial cushion formation [GO:0003272]; heart induction [GO:0003129]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; metanephros development [GO:0001656]; negative regulation of negative chemotaxis [GO:0050925]; negative regulation of synapse assembly [GO:0051964]; olfactory bulb interneuron development [GO:0021891]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of axonogenesis [GO:0050772]; positive regulation of Notch signaling pathway [GO:0045747]; pulmonary valve morphogenesis [GO:0003184]; retinal ganglion cell axon guidance [GO:0031290]; ureteric bud development [GO:0001657]; ventricular septum morphogenesis [GO:0060412] axolemma [GO:0030673]; cell surface [GO:0009986]; extracellular exosome [GO:0070062]; plasma membrane [GO:0005886] axon guidance receptor activity [GO:0008046]; identical protein binding [GO:0042802] g15948.t2 Q9HCK4 36.352 806 2.97e-139 469.0 sp|Q9HCK4|ROBO2_HUMAN Roundabout homolog 2 OS=Homo sapiens OX=9606 GN=ROBO2 PE=1 SV=2 ROBO2_HUMAN reviewed Roundabout homolog 2 Homo sapiens (Human) GO:0001656; GO:0001657; GO:0003129; GO:0003148; GO:0003180; GO:0003184; GO:0003272; GO:0005886; GO:0006935; GO:0007156; GO:0007411; GO:0007417; GO:0007420; GO:0008046; GO:0009986; GO:0016199; GO:0021891; GO:0030673; GO:0031290; GO:0032870; GO:0035904; GO:0042802; GO:0045747; GO:0050772; GO:0050925; GO:0051964; GO:0060412; GO:0061364; GO:0070062; GO:0098609 aorta development [GO:0035904]; aortic valve morphogenesis [GO:0003180]; apoptotic process involved in luteolysis [GO:0061364]; axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; brain development [GO:0007420]; cell-cell adhesion [GO:0098609]; cellular response to hormone stimulus [GO:0032870]; central nervous system development [GO:0007417]; chemotaxis [GO:0006935]; endocardial cushion formation [GO:0003272]; heart induction [GO:0003129]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; metanephros development [GO:0001656]; negative regulation of negative chemotaxis [GO:0050925]; negative regulation of synapse assembly [GO:0051964]; olfactory bulb interneuron development [GO:0021891]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of axonogenesis [GO:0050772]; positive regulation of Notch signaling pathway [GO:0045747]; pulmonary valve morphogenesis [GO:0003184]; retinal ganglion cell axon guidance [GO:0031290]; ureteric bud development [GO:0001657]; ventricular septum morphogenesis [GO:0060412] axolemma [GO:0030673]; cell surface [GO:0009986]; extracellular exosome [GO:0070062]; plasma membrane [GO:0005886] axon guidance receptor activity [GO:0008046]; identical protein binding [GO:0042802] g15948.t2 Q9HCK4 32.927 410 1.1599999999999999e-41 172.0 sp|Q9HCK4|ROBO2_HUMAN Roundabout homolog 2 OS=Homo sapiens OX=9606 GN=ROBO2 PE=1 SV=2 ROBO2_HUMAN reviewed Roundabout homolog 2 Homo sapiens (Human) GO:0001656; GO:0001657; GO:0003129; GO:0003148; GO:0003180; GO:0003184; GO:0003272; GO:0005886; GO:0006935; GO:0007156; GO:0007411; GO:0007417; GO:0007420; GO:0008046; GO:0009986; GO:0016199; GO:0021891; GO:0030673; GO:0031290; GO:0032870; GO:0035904; GO:0042802; GO:0045747; GO:0050772; GO:0050925; GO:0051964; GO:0060412; GO:0061364; GO:0070062; GO:0098609 aorta development [GO:0035904]; aortic valve morphogenesis [GO:0003180]; apoptotic process involved in luteolysis [GO:0061364]; axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; brain development [GO:0007420]; cell-cell adhesion [GO:0098609]; cellular response to hormone stimulus [GO:0032870]; central nervous system development [GO:0007417]; chemotaxis [GO:0006935]; endocardial cushion formation [GO:0003272]; heart induction [GO:0003129]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; metanephros development [GO:0001656]; negative regulation of negative chemotaxis [GO:0050925]; negative regulation of synapse assembly [GO:0051964]; olfactory bulb interneuron development [GO:0021891]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of axonogenesis [GO:0050772]; positive regulation of Notch signaling pathway [GO:0045747]; pulmonary valve morphogenesis [GO:0003184]; retinal ganglion cell axon guidance [GO:0031290]; ureteric bud development [GO:0001657]; ventricular septum morphogenesis [GO:0060412] axolemma [GO:0030673]; cell surface [GO:0009986]; extracellular exosome [GO:0070062]; plasma membrane [GO:0005886] axon guidance receptor activity [GO:0008046]; identical protein binding [GO:0042802] g15948.t2 Q9HCK4 31.095 283 5.74e-24 114.0 sp|Q9HCK4|ROBO2_HUMAN Roundabout homolog 2 OS=Homo sapiens OX=9606 GN=ROBO2 PE=1 SV=2 ROBO2_HUMAN reviewed Roundabout homolog 2 Homo sapiens (Human) GO:0001656; GO:0001657; GO:0003129; GO:0003148; GO:0003180; GO:0003184; GO:0003272; GO:0005886; GO:0006935; GO:0007156; GO:0007411; GO:0007417; GO:0007420; GO:0008046; GO:0009986; GO:0016199; GO:0021891; GO:0030673; GO:0031290; GO:0032870; GO:0035904; GO:0042802; GO:0045747; GO:0050772; GO:0050925; GO:0051964; GO:0060412; GO:0061364; GO:0070062; GO:0098609 aorta development [GO:0035904]; aortic valve morphogenesis [GO:0003180]; apoptotic process involved in luteolysis [GO:0061364]; axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; brain development [GO:0007420]; cell-cell adhesion [GO:0098609]; cellular response to hormone stimulus [GO:0032870]; central nervous system development [GO:0007417]; chemotaxis [GO:0006935]; endocardial cushion formation [GO:0003272]; heart induction [GO:0003129]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; metanephros development [GO:0001656]; negative regulation of negative chemotaxis [GO:0050925]; negative regulation of synapse assembly [GO:0051964]; olfactory bulb interneuron development [GO:0021891]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of axonogenesis [GO:0050772]; positive regulation of Notch signaling pathway [GO:0045747]; pulmonary valve morphogenesis [GO:0003184]; retinal ganglion cell axon guidance [GO:0031290]; ureteric bud development [GO:0001657]; ventricular septum morphogenesis [GO:0060412] axolemma [GO:0030673]; cell surface [GO:0009986]; extracellular exosome [GO:0070062]; plasma membrane [GO:0005886] axon guidance receptor activity [GO:0008046]; identical protein binding [GO:0042802] g15954.t1 Q9NXL6 46.907 776 0.0 592.0 sp|Q9NXL6|SIDT1_HUMAN SID1 transmembrane family member 1 OS=Homo sapiens OX=9606 GN=SIDT1 PE=1 SV=2 g15954.t2 Q9NXL6 47.273 770 0.0 595.0 sp|Q9NXL6|SIDT1_HUMAN SID1 transmembrane family member 1 OS=Homo sapiens OX=9606 GN=SIDT1 PE=1 SV=2 g15955.t1 P54612 80.612 588 0.0 985.0 sp|P54612|2AAA_PIG Serine/threonine-protein phosphatase 2A 65 kDa regulatory subunit A alpha isoform OS=Sus scrofa OX=9823 GN=PPP2R1A PE=2 SV=2 g15960.t1 Q24152 71.429 70 1.29e-35 118.0 sp|Q24152|CKS1_DROME Cyclin-dependent kinases regulatory subunit OS=Drosophila melanogaster OX=7227 GN=Cks30A PE=3 SV=1 CKS1_DROME reviewed Cyclin-dependent kinases regulatory subunit Drosophila melanogaster (Fruit fly) GO:0000307; GO:0007057; GO:0007143; GO:0007144; GO:0007346; GO:0007488; GO:0019005; GO:0019901; GO:0031145; GO:0035186; GO:0042393; GO:0043130; GO:0051225; GO:0051301; GO:0061575 anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell division [GO:0051301]; female meiosis I [GO:0007144]; female meiotic nuclear division [GO:0007143]; histoblast morphogenesis [GO:0007488]; regulation of mitotic cell cycle [GO:0007346]; spindle assembly [GO:0051225]; spindle assembly involved in female meiosis I [GO:0007057]; syncytial blastoderm mitotic cell cycle [GO:0035186] cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; SCF ubiquitin ligase complex [GO:0019005] cyclin-dependent protein serine/threonine kinase activator activity [GO:0061575]; histone binding [GO:0042393]; protein kinase binding [GO:0019901]; ubiquitin binding [GO:0043130] g15961.t1 P70097 41.379 145 8.73e-39 133.0 sp|P70097|C560_CRIGR Succinate dehydrogenase cytochrome b560 subunit, mitochondrial OS=Cricetulus griseus OX=10029 GN=SDHC PE=2 SV=1 g15962.t1 Q924A2 85.47 117 1.18e-54 216.0 sp|Q924A2|CIC_MOUSE Protein capicua homolog OS=Mus musculus OX=10090 GN=Cic PE=1 SV=2 g15962.t1 Q924A2 39.914 233 3.51e-33 145.0 sp|Q924A2|CIC_MOUSE Protein capicua homolog OS=Mus musculus OX=10090 GN=Cic PE=1 SV=2 g15966.t1 Q4R5Y0 50.45 111 2.73e-32 115.0 sp|Q4R5Y0|CFA68_MACFA Cilia- and flagella-associated protein 68 OS=Macaca fascicularis OX=9541 GN=CFAP68 PE=2 SV=1 g15967.t1 O35162 50.746 469 1.26e-151 441.0 sp|O35162|HSP13_RAT Heat shock 70 kDa protein 13 OS=Rattus norvegicus OX=10116 GN=Hspa13 PE=1 SV=2 g15972.t1 Q8BRC6 46.226 212 2.89e-51 180.0 sp|Q8BRC6|CFA91_MOUSE Cilia- and flagella-associated protein 91 OS=Mus musculus OX=10090 GN=Cfap91 PE=1 SV=3 g15973.t1 Q95LR0 60.851 470 3.97e-165 498.0 sp|Q95LR0|CFA91_MACFA Cilia- and flagella-associated protein 91 OS=Macaca fascicularis OX=9541 GN=CFAP91 PE=2 SV=3 g15975.t1 Q5R6L1 65.132 152 4.15e-51 185.0 sp|Q5R6L1|PKNX2_PONAB Homeobox protein PKNOX2 OS=Pongo abelii OX=9601 GN=PKNOX2 PE=2 SV=1 g15975.t1 Q5R6L1 75.439 114 5.27e-50 182.0 sp|Q5R6L1|PKNX2_PONAB Homeobox protein PKNOX2 OS=Pongo abelii OX=9601 GN=PKNOX2 PE=2 SV=1 g15975.t2 Q5R6L1 65.132 152 4.07e-51 185.0 sp|Q5R6L1|PKNX2_PONAB Homeobox protein PKNOX2 OS=Pongo abelii OX=9601 GN=PKNOX2 PE=2 SV=1 g15975.t2 Q5R6L1 75.439 114 5.17e-50 182.0 sp|Q5R6L1|PKNX2_PONAB Homeobox protein PKNOX2 OS=Pongo abelii OX=9601 GN=PKNOX2 PE=2 SV=1 g15976.t1 Q92542 36.061 721 5.770000000000001e-132 408.0 sp|Q92542|NICA_HUMAN Nicastrin OS=Homo sapiens OX=9606 GN=NCSTN PE=1 SV=2 NICA_HUMAN reviewed Nicastrin Homo sapiens (Human) GO:0000139; GO:0002262; GO:0005765; GO:0005769; GO:0005783; GO:0005789; GO:0005794; GO:0005886; GO:0005925; GO:0006508; GO:0006509; GO:0007212; GO:0007215; GO:0007219; GO:0007220; GO:0007611; GO:0008021; GO:0010008; GO:0016020; GO:0016485; GO:0021549; GO:0022010; GO:0030534; GO:0030674; GO:0031293; GO:0034205; GO:0035577; GO:0042098; GO:0042383; GO:0042470; GO:0042500; GO:0042734; GO:0042982; GO:0042983; GO:0042986; GO:0042987; GO:0050673; GO:0051117; GO:0051402; GO:0061133; GO:0070062; GO:0070765; GO:0070851; GO:0071277; GO:1900271; GO:1990926 adult behavior [GO:0030534]; amyloid precursor protein biosynthetic process [GO:0042983]; amyloid precursor protein catabolic process [GO:0042987]; amyloid precursor protein metabolic process [GO:0042982]; amyloid-beta formation [GO:0034205]; cellular response to calcium ion [GO:0071277]; central nervous system myelination [GO:0022010]; cerebellum development [GO:0021549]; epithelial cell proliferation [GO:0050673]; G protein-coupled dopamine receptor signaling pathway [GO:0007212]; glutamate receptor signaling pathway [GO:0007215]; learning or memory [GO:0007611]; membrane protein ectodomain proteolysis [GO:0006509]; membrane protein intracellular domain proteolysis [GO:0031293]; myeloid cell homeostasis [GO:0002262]; neuron apoptotic process [GO:0051402]; Notch receptor processing [GO:0007220]; Notch signaling pathway [GO:0007219]; positive regulation of amyloid precursor protein biosynthetic process [GO:0042986]; protein processing [GO:0016485]; proteolysis [GO:0006508]; regulation of long-term synaptic potentiation [GO:1900271]; short-term synaptic potentiation [GO:1990926]; T cell proliferation [GO:0042098] azurophil granule membrane [GO:0035577]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; gamma-secretase complex [GO:0070765]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; lysosomal membrane [GO:0005765]; melanosome [GO:0042470]; membrane [GO:0016020]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; sarcolemma [GO:0042383]; synaptic vesicle [GO:0008021] aspartic endopeptidase activity, intramembrane cleaving [GO:0042500]; ATPase binding [GO:0051117]; endopeptidase activator activity [GO:0061133]; growth factor receptor binding [GO:0070851]; protein-macromolecule adaptor activity [GO:0030674] g15978.t1 Q8NCN5 43.568 723 0.0 617.0 sp|Q8NCN5|PDPR_HUMAN Pyruvate dehydrogenase phosphatase regulatory subunit, mitochondrial OS=Homo sapiens OX=9606 GN=PDPR PE=1 SV=2 g15979.t1 Q91XQ0 66.465 4631 0.0 6134.0 sp|Q91XQ0|DYH8_MOUSE Dynein axonemal heavy chain 8 OS=Mus musculus OX=10090 GN=Dnah8 PE=1 SV=2 DYH8_MOUSE reviewed Dynein axonemal heavy chain 8 (Axonemal beta dynein heavy chain 8) (Ciliary dynein heavy chain 8) Mus musculus (Mouse) GO:0003777; GO:0005524; GO:0005874; GO:0005930; GO:0008569; GO:0036126; GO:0036157; GO:0036158; GO:0045505; GO:0051959; GO:0060294; GO:0097228 cilium movement involved in cell motility [GO:0060294]; outer dynein arm assembly [GO:0036158] axoneme [GO:0005930]; microtubule [GO:0005874]; outer dynein arm [GO:0036157]; sperm flagellum [GO:0036126]; sperm principal piece [GO:0097228] ATP binding [GO:0005524]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]; minus-end-directed microtubule motor activity [GO:0008569] g15980.t1 P57071 28.913 543 8.34e-49 191.0 sp|P57071|PRD15_HUMAN PR domain zinc finger protein 15 OS=Homo sapiens OX=9606 GN=PRDM15 PE=1 SV=5 PRD15_HUMAN reviewed PR domain zinc finger protein 15 (EC 2.1.1.-) (PR domain-containing protein 15) (Zinc finger protein 298) Homo sapiens (Human) GO:0000978; GO:0001228; GO:0005634; GO:0005654; GO:0006357; GO:0008168; GO:0008270; GO:0016604; GO:0032259; GO:0043409; GO:0045944; GO:0090263; GO:1990841; GO:2000035 methylation [GO:0032259]; negative regulation of MAPK cascade [GO:0043409]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of stem cell division [GO:2000035]; regulation of transcription by RNA polymerase II [GO:0006357] nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; methyltransferase activity [GO:0008168]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270] g15980.t1 P57071 44.311 167 2e-35 149.0 sp|P57071|PRD15_HUMAN PR domain zinc finger protein 15 OS=Homo sapiens OX=9606 GN=PRDM15 PE=1 SV=5 PRD15_HUMAN reviewed PR domain zinc finger protein 15 (EC 2.1.1.-) (PR domain-containing protein 15) (Zinc finger protein 298) Homo sapiens (Human) GO:0000978; GO:0001228; GO:0005634; GO:0005654; GO:0006357; GO:0008168; GO:0008270; GO:0016604; GO:0032259; GO:0043409; GO:0045944; GO:0090263; GO:1990841; GO:2000035 methylation [GO:0032259]; negative regulation of MAPK cascade [GO:0043409]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of stem cell division [GO:2000035]; regulation of transcription by RNA polymerase II [GO:0006357] nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; methyltransferase activity [GO:0008168]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270] g15981.t1 Q9CR00 51.0 200 5.4900000000000006e-70 215.0 sp|Q9CR00|PSMD9_MOUSE 26S proteasome non-ATPase regulatory subunit 9 OS=Mus musculus OX=10090 GN=Psmd9 PE=1 SV=1 g15983.t1 Q15102 52.153 209 2.4399999999999997e-81 245.0 sp|Q15102|PA1B3_HUMAN Platelet-activating factor acetylhydrolase IB subunit alpha1 OS=Homo sapiens OX=9606 GN=PAFAH1B3 PE=1 SV=1 PA1B3_HUMAN reviewed Platelet-activating factor acetylhydrolase IB subunit alpha1 (EC 3.1.1.47) (PAF acetylhydrolase 29 kDa subunit) (PAF-AH 29 kDa subunit) (PAF-AH subunit gamma) (PAFAH subunit gamma) Homo sapiens (Human) GO:0003847; GO:0005737; GO:0005829; GO:0006629; GO:0007283; GO:0007399; GO:0008247; GO:0016020; GO:0016042; GO:0042802; GO:0042803; GO:0044877; GO:0046982; GO:0047179 lipid catabolic process [GO:0016042]; lipid metabolic process [GO:0006629]; nervous system development [GO:0007399]; spermatogenesis [GO:0007283] 1-alkyl-2-acetylglycerophosphocholine esterase complex [GO:0008247]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020] 1-alkyl-2-acetylglycerophosphocholine esterase activity [GO:0003847]; identical protein binding [GO:0042802]; platelet-activating factor acetyltransferase activity [GO:0047179]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877] g15986.t1 Q6NUB3 38.2 500 4.52e-110 340.0 sp|Q6NUB3|S22AF_XENLA Solute carrier family 22 member 15 OS=Xenopus laevis OX=8355 GN=slc22a15 PE=2 SV=2 g15987.t1 P13607 77.304 1031 0.0 1563.0 sp|P13607|ATNA_DROME Sodium/potassium-transporting ATPase subunit alpha OS=Drosophila melanogaster OX=7227 GN=Atpalpha PE=1 SV=3 g15988.t1 Q5PQJ7 40.515 427 1.37e-92 290.0 sp|Q5PQJ7|TBCEL_RAT Tubulin-specific chaperone cofactor E-like protein OS=Rattus norvegicus OX=10116 GN=Tbcel PE=1 SV=1 TBCEL_RAT reviewed Tubulin-specific chaperone cofactor E-like protein (Leucine-rich repeat-containing protein 35) Rattus norvegicus (Rat) GO:0000226; GO:0005737; GO:0005856; GO:0007021; GO:0007023; GO:0043014 microtubule cytoskeleton organization [GO:0000226]; post-chaperonin tubulin folding pathway [GO:0007023]; tubulin complex assembly [GO:0007021] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856] alpha-tubulin binding [GO:0043014] g15993.t1 Q0VD42 33.898 236 1.21e-36 133.0 sp|Q0VD42|TLCD5_BOVIN TLC domain-containing protein 5 OS=Bos taurus OX=9913 GN=TLCD5 PE=2 SV=1 g15996.t1 Q3TYE7 36.638 232 1.9e-53 175.0 sp|Q3TYE7|TLCD5_MOUSE TLC domain-containing protein 5 OS=Mus musculus OX=10090 GN=Tlcd5 PE=2 SV=1 g15997.t1 Q6ZRR5 43.725 247 1.3999999999999999e-67 213.0 sp|Q6ZRR5|TLCD5_HUMAN TLC domain-containing protein 5 OS=Homo sapiens OX=9606 GN=TLCD5 PE=2 SV=2 g16002.t1 P70490 36.628 172 9.2e-25 104.0 sp|P70490|MFGM_RAT Lactadherin OS=Rattus norvegicus OX=10116 GN=Mfge8 PE=2 SV=1 MFGM_RAT reviewed Lactadherin (MFGM) (Milk fat globule-EGF factor 8) (MFG-E8) (O-acetyl GD3 ganglioside synthase) (AGS) (SED1) Rattus norvegicus (Rat) GO:0001525; GO:0001786; GO:0002080; GO:0005178; GO:0005615; GO:0006910; GO:0006911; GO:0007155; GO:0007338; GO:0008284; GO:0008429; GO:0009897; GO:0043277; GO:0043627; GO:0050766 angiogenesis [GO:0001525]; apoptotic cell clearance [GO:0043277]; cell adhesion [GO:0007155]; phagocytosis, engulfment [GO:0006911]; phagocytosis, recognition [GO:0006910]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of phagocytosis [GO:0050766]; response to estrogen [GO:0043627]; single fertilization [GO:0007338] acrosomal membrane [GO:0002080]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615] integrin binding [GO:0005178]; phosphatidylethanolamine binding [GO:0008429]; phosphatidylserine binding [GO:0001786] g16004.t1 O75899 30.488 492 3.23e-61 220.0 sp|O75899|GABR2_HUMAN Gamma-aminobutyric acid type B receptor subunit 2 OS=Homo sapiens OX=9606 GN=GABBR2 PE=1 SV=1 GABR2_HUMAN reviewed Gamma-aminobutyric acid type B receptor subunit 2 (GABA-B receptor 2) (GABA-B-R2) (GABA-BR2) (GABABR2) (Gb2) (G-protein coupled receptor 51) (HG20) Homo sapiens (Human) GO:0004888; GO:0004965; GO:0005737; GO:0005886; GO:0007186; GO:0007193; GO:0007194; GO:0007214; GO:0007268; GO:0038039; GO:0043005; GO:0045211; GO:0046982; GO:0051932; GO:0150099; GO:1902710; GO:1902712 adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; chemical synaptic transmission [GO:0007268]; G protein-coupled receptor signaling pathway [GO:0007186]; gamma-aminobutyric acid signaling pathway [GO:0007214]; negative regulation of adenylate cyclase activity [GO:0007194]; neuron-glial cell signaling [GO:0150099]; synaptic transmission, GABAergic [GO:0051932] cytoplasm [GO:0005737]; G protein-coupled GABA receptor complex [GO:1902712]; G protein-coupled receptor heterodimeric complex [GO:0038039]; GABA receptor complex [GO:1902710]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211] G protein-coupled GABA receptor activity [GO:0004965]; protein heterodimerization activity [GO:0046982]; transmembrane signaling receptor activity [GO:0004888] g16008.t1 O75899 28.708 627 1.3499999999999999e-67 241.0 sp|O75899|GABR2_HUMAN Gamma-aminobutyric acid type B receptor subunit 2 OS=Homo sapiens OX=9606 GN=GABBR2 PE=1 SV=1 GABR2_HUMAN reviewed Gamma-aminobutyric acid type B receptor subunit 2 (GABA-B receptor 2) (GABA-B-R2) (GABA-BR2) (GABABR2) (Gb2) (G-protein coupled receptor 51) (HG20) Homo sapiens (Human) GO:0004888; GO:0004965; GO:0005737; GO:0005886; GO:0007186; GO:0007193; GO:0007194; GO:0007214; GO:0007268; GO:0038039; GO:0043005; GO:0045211; GO:0046982; GO:0051932; GO:0150099; GO:1902710; GO:1902712 adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; chemical synaptic transmission [GO:0007268]; G protein-coupled receptor signaling pathway [GO:0007186]; gamma-aminobutyric acid signaling pathway [GO:0007214]; negative regulation of adenylate cyclase activity [GO:0007194]; neuron-glial cell signaling [GO:0150099]; synaptic transmission, GABAergic [GO:0051932] cytoplasm [GO:0005737]; G protein-coupled GABA receptor complex [GO:1902712]; G protein-coupled receptor heterodimeric complex [GO:0038039]; GABA receptor complex [GO:1902710]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211] G protein-coupled GABA receptor activity [GO:0004965]; protein heterodimerization activity [GO:0046982]; transmembrane signaling receptor activity [GO:0004888] g16008.t2 O75899 28.73 630 4.4899999999999997e-69 246.0 sp|O75899|GABR2_HUMAN Gamma-aminobutyric acid type B receptor subunit 2 OS=Homo sapiens OX=9606 GN=GABBR2 PE=1 SV=1 GABR2_HUMAN reviewed Gamma-aminobutyric acid type B receptor subunit 2 (GABA-B receptor 2) (GABA-B-R2) (GABA-BR2) (GABABR2) (Gb2) (G-protein coupled receptor 51) (HG20) Homo sapiens (Human) GO:0004888; GO:0004965; GO:0005737; GO:0005886; GO:0007186; GO:0007193; GO:0007194; GO:0007214; GO:0007268; GO:0038039; GO:0043005; GO:0045211; GO:0046982; GO:0051932; GO:0150099; GO:1902710; GO:1902712 adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; chemical synaptic transmission [GO:0007268]; G protein-coupled receptor signaling pathway [GO:0007186]; gamma-aminobutyric acid signaling pathway [GO:0007214]; negative regulation of adenylate cyclase activity [GO:0007194]; neuron-glial cell signaling [GO:0150099]; synaptic transmission, GABAergic [GO:0051932] cytoplasm [GO:0005737]; G protein-coupled GABA receptor complex [GO:1902712]; G protein-coupled receptor heterodimeric complex [GO:0038039]; GABA receptor complex [GO:1902710]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211] G protein-coupled GABA receptor activity [GO:0004965]; protein heterodimerization activity [GO:0046982]; transmembrane signaling receptor activity [GO:0004888] g16010.t1 G5ECB2 34.254 181 7.55e-22 95.9 sp|G5ECB2|GABR2_CAEEL Gamma-aminobutyric acid type B receptor subunit 2 OS=Caenorhabditis elegans OX=6239 GN=gbb-2 PE=1 SV=1 GABR2_CAEEL reviewed Gamma-aminobutyric acid type B receptor subunit 2 Caenorhabditis elegans GO:0004965; GO:0007186; GO:0007214; GO:0009410; GO:0032223; GO:0038039; GO:0040012; GO:1902712 G protein-coupled receptor signaling pathway [GO:0007186]; gamma-aminobutyric acid signaling pathway [GO:0007214]; negative regulation of synaptic transmission, cholinergic [GO:0032223]; regulation of locomotion [GO:0040012]; response to xenobiotic stimulus [GO:0009410] G protein-coupled GABA receptor complex [GO:1902712]; G protein-coupled receptor heterodimeric complex [GO:0038039] G protein-coupled GABA receptor activity [GO:0004965] g16013.t1 O75899 28.594 633 1.66e-62 231.0 sp|O75899|GABR2_HUMAN Gamma-aminobutyric acid type B receptor subunit 2 OS=Homo sapiens OX=9606 GN=GABBR2 PE=1 SV=1 GABR2_HUMAN reviewed Gamma-aminobutyric acid type B receptor subunit 2 (GABA-B receptor 2) (GABA-B-R2) (GABA-BR2) (GABABR2) (Gb2) (G-protein coupled receptor 51) (HG20) Homo sapiens (Human) GO:0004888; GO:0004965; GO:0005737; GO:0005886; GO:0007186; GO:0007193; GO:0007194; GO:0007214; GO:0007268; GO:0038039; GO:0043005; GO:0045211; GO:0046982; GO:0051932; GO:0150099; GO:1902710; GO:1902712 adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; chemical synaptic transmission [GO:0007268]; G protein-coupled receptor signaling pathway [GO:0007186]; gamma-aminobutyric acid signaling pathway [GO:0007214]; negative regulation of adenylate cyclase activity [GO:0007194]; neuron-glial cell signaling [GO:0150099]; synaptic transmission, GABAergic [GO:0051932] cytoplasm [GO:0005737]; G protein-coupled GABA receptor complex [GO:1902712]; G protein-coupled receptor heterodimeric complex [GO:0038039]; GABA receptor complex [GO:1902710]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211] G protein-coupled GABA receptor activity [GO:0004965]; protein heterodimerization activity [GO:0046982]; transmembrane signaling receptor activity [GO:0004888] g16014.t1 O75899 28.549 634 6.08e-62 230.0 sp|O75899|GABR2_HUMAN Gamma-aminobutyric acid type B receptor subunit 2 OS=Homo sapiens OX=9606 GN=GABBR2 PE=1 SV=1 GABR2_HUMAN reviewed Gamma-aminobutyric acid type B receptor subunit 2 (GABA-B receptor 2) (GABA-B-R2) (GABA-BR2) (GABABR2) (Gb2) (G-protein coupled receptor 51) (HG20) Homo sapiens (Human) GO:0004888; GO:0004965; GO:0005737; GO:0005886; GO:0007186; GO:0007193; GO:0007194; GO:0007214; GO:0007268; GO:0038039; GO:0043005; GO:0045211; GO:0046982; GO:0051932; GO:0150099; GO:1902710; GO:1902712 adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; chemical synaptic transmission [GO:0007268]; G protein-coupled receptor signaling pathway [GO:0007186]; gamma-aminobutyric acid signaling pathway [GO:0007214]; negative regulation of adenylate cyclase activity [GO:0007194]; neuron-glial cell signaling [GO:0150099]; synaptic transmission, GABAergic [GO:0051932] cytoplasm [GO:0005737]; G protein-coupled GABA receptor complex [GO:1902712]; G protein-coupled receptor heterodimeric complex [GO:0038039]; GABA receptor complex [GO:1902710]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211] G protein-coupled GABA receptor activity [GO:0004965]; protein heterodimerization activity [GO:0046982]; transmembrane signaling receptor activity [GO:0004888] g16014.t2 O75899 27.857 560 2.12e-49 192.0 sp|O75899|GABR2_HUMAN Gamma-aminobutyric acid type B receptor subunit 2 OS=Homo sapiens OX=9606 GN=GABBR2 PE=1 SV=1 GABR2_HUMAN reviewed Gamma-aminobutyric acid type B receptor subunit 2 (GABA-B receptor 2) (GABA-B-R2) (GABA-BR2) (GABABR2) (Gb2) (G-protein coupled receptor 51) (HG20) Homo sapiens (Human) GO:0004888; GO:0004965; GO:0005737; GO:0005886; GO:0007186; GO:0007193; GO:0007194; GO:0007214; GO:0007268; GO:0038039; GO:0043005; GO:0045211; GO:0046982; GO:0051932; GO:0150099; GO:1902710; GO:1902712 adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; chemical synaptic transmission [GO:0007268]; G protein-coupled receptor signaling pathway [GO:0007186]; gamma-aminobutyric acid signaling pathway [GO:0007214]; negative regulation of adenylate cyclase activity [GO:0007194]; neuron-glial cell signaling [GO:0150099]; synaptic transmission, GABAergic [GO:0051932] cytoplasm [GO:0005737]; G protein-coupled GABA receptor complex [GO:1902712]; G protein-coupled receptor heterodimeric complex [GO:0038039]; GABA receptor complex [GO:1902710]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211] G protein-coupled GABA receptor activity [GO:0004965]; protein heterodimerization activity [GO:0046982]; transmembrane signaling receptor activity [GO:0004888] g16015.t1 P70490 38.372 172 1.52e-25 106.0 sp|P70490|MFGM_RAT Lactadherin OS=Rattus norvegicus OX=10116 GN=Mfge8 PE=2 SV=1 MFGM_RAT reviewed Lactadherin (MFGM) (Milk fat globule-EGF factor 8) (MFG-E8) (O-acetyl GD3 ganglioside synthase) (AGS) (SED1) Rattus norvegicus (Rat) GO:0001525; GO:0001786; GO:0002080; GO:0005178; GO:0005615; GO:0006910; GO:0006911; GO:0007155; GO:0007338; GO:0008284; GO:0008429; GO:0009897; GO:0043277; GO:0043627; GO:0050766 angiogenesis [GO:0001525]; apoptotic cell clearance [GO:0043277]; cell adhesion [GO:0007155]; phagocytosis, engulfment [GO:0006911]; phagocytosis, recognition [GO:0006910]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of phagocytosis [GO:0050766]; response to estrogen [GO:0043627]; single fertilization [GO:0007338] acrosomal membrane [GO:0002080]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615] integrin binding [GO:0005178]; phosphatidylethanolamine binding [GO:0008429]; phosphatidylserine binding [GO:0001786] g16015.t1 P70490 35.443 158 4.91e-21 94.0 sp|P70490|MFGM_RAT Lactadherin OS=Rattus norvegicus OX=10116 GN=Mfge8 PE=2 SV=1 MFGM_RAT reviewed Lactadherin (MFGM) (Milk fat globule-EGF factor 8) (MFG-E8) (O-acetyl GD3 ganglioside synthase) (AGS) (SED1) Rattus norvegicus (Rat) GO:0001525; GO:0001786; GO:0002080; GO:0005178; GO:0005615; GO:0006910; GO:0006911; GO:0007155; GO:0007338; GO:0008284; GO:0008429; GO:0009897; GO:0043277; GO:0043627; GO:0050766 angiogenesis [GO:0001525]; apoptotic cell clearance [GO:0043277]; cell adhesion [GO:0007155]; phagocytosis, engulfment [GO:0006911]; phagocytosis, recognition [GO:0006910]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of phagocytosis [GO:0050766]; response to estrogen [GO:0043627]; single fertilization [GO:0007338] acrosomal membrane [GO:0002080]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615] integrin binding [GO:0005178]; phosphatidylethanolamine binding [GO:0008429]; phosphatidylserine binding [GO:0001786] g16016.t1 Q9Z1L4 33.125 160 1.32e-22 95.1 sp|Q9Z1L4|XLRS1_MOUSE Retinoschisin OS=Mus musculus OX=10090 GN=Rs1 PE=1 SV=1 XLRS1_MOUSE reviewed Retinoschisin (X-linked juvenile retinoschisis protein homolog) Mus musculus (Mouse) GO:0001786; GO:0001917; GO:0005546; GO:0005547; GO:0005576; GO:0005615; GO:0007155; GO:0007601; GO:0009897; GO:0009986; GO:0010314; GO:0010842; GO:0032266; GO:0032991; GO:0043325; GO:0044877; GO:0051260; GO:0070273; GO:0080025; GO:0098984 cell adhesion [GO:0007155]; protein homooligomerization [GO:0051260]; retina layer formation [GO:0010842]; visual perception [GO:0007601] cell surface [GO:0009986]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; neuron to neuron synapse [GO:0098984]; photoreceptor inner segment [GO:0001917]; protein-containing complex [GO:0032991] phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphatidylinositol-4-phosphate binding [GO:0070273]; phosphatidylinositol-5-phosphate binding [GO:0010314]; phosphatidylserine binding [GO:0001786]; protein-containing complex binding [GO:0044877] g16031.t1 D0Z9R0 36.934 287 1.2200000000000001e-58 196.0 sp|D0Z9R0|TATD_EDWPI 3'-5' ssDNA/RNA exonuclease TatD OS=Edwardsiella piscicida OX=1263550 GN=tatD PE=3 SV=1 g16032.t1 Q5EA95 63.636 385 1.1300000000000001e-161 464.0 sp|Q5EA95|IFT57_BOVIN Intraflagellar transport protein 57 homolog OS=Bos taurus OX=9913 GN=IFT57 PE=1 SV=1 g16033.t1 P19217 37.942 311 7.06e-59 194.0 sp|P19217|ST1E1_BOVIN Sulfotransferase 1E1 OS=Bos taurus OX=9913 GN=SULT1E1 PE=1 SV=1 ST1E1_BOVIN reviewed Sulfotransferase 1E1 (ST1E1) (EC 2.8.2.4) (Estrogen sulfotransferase) (Sulfotransferase, estrogen-preferring) Bos taurus (Bovine) GO:0004062; GO:0004304; GO:0005496; GO:0005737; GO:0005829; GO:0008210; GO:0050294; GO:0051923 estrogen metabolic process [GO:0008210]; sulfation [GO:0051923] cytoplasm [GO:0005737]; cytosol [GO:0005829] aryl sulfotransferase activity [GO:0004062]; estrone sulfotransferase activity [GO:0004304]; steroid binding [GO:0005496]; steroid sulfotransferase activity [GO:0050294] g16035.t1 A6NGN9 31.56 282 5.830000000000001e-27 115.0 sp|A6NGN9|IGLO5_HUMAN IgLON family member 5 OS=Homo sapiens OX=9606 GN=IGLON5 PE=1 SV=4 g16036.t1 Q8AVC3 49.08 489 7.78e-130 390.0 sp|Q8AVC3|G6PT3_XENLA Glucose-6-phosphate exchanger SLC37A2 OS=Xenopus laevis OX=8355 GN=slc37a2 PE=2 SV=1 g16037.t1 P79385 38.037 163 5.38e-25 105.0 sp|P79385|MFGM_PIG Lactadherin OS=Sus scrofa OX=9823 GN=MFGE8 PE=1 SV=2 g16037.t1 P79385 35.443 158 1.5199999999999998e-23 101.0 sp|P79385|MFGM_PIG Lactadherin OS=Sus scrofa OX=9823 GN=MFGE8 PE=1 SV=2 g16039.t1 P70490 38.323 167 1.93e-25 104.0 sp|P70490|MFGM_RAT Lactadherin OS=Rattus norvegicus OX=10116 GN=Mfge8 PE=2 SV=1 MFGM_RAT reviewed Lactadherin (MFGM) (Milk fat globule-EGF factor 8) (MFG-E8) (O-acetyl GD3 ganglioside synthase) (AGS) (SED1) Rattus norvegicus (Rat) GO:0001525; GO:0001786; GO:0002080; GO:0005178; GO:0005615; GO:0006910; GO:0006911; GO:0007155; GO:0007338; GO:0008284; GO:0008429; GO:0009897; GO:0043277; GO:0043627; GO:0050766 angiogenesis [GO:0001525]; apoptotic cell clearance [GO:0043277]; cell adhesion [GO:0007155]; phagocytosis, engulfment [GO:0006911]; phagocytosis, recognition [GO:0006910]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of phagocytosis [GO:0050766]; response to estrogen [GO:0043627]; single fertilization [GO:0007338] acrosomal membrane [GO:0002080]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615] integrin binding [GO:0005178]; phosphatidylethanolamine binding [GO:0008429]; phosphatidylserine binding [GO:0001786] g16047.t1 Q9WV18 27.746 519 6.41e-45 176.0 sp|Q9WV18|GABR1_MOUSE Gamma-aminobutyric acid type B receptor subunit 1 OS=Mus musculus OX=10090 GN=Gabbr1 PE=1 SV=1 GABR1_MOUSE reviewed Gamma-aminobutyric acid type B receptor subunit 1 (GABA-B receptor 1) (GABA-B-R1) (GABA-BR1) (GABABR1) (Gb1) Mus musculus (Mouse) GO:0001649; GO:0004965; GO:0005615; GO:0005737; GO:0005789; GO:0005886; GO:0007193; GO:0007214; GO:0008021; GO:0008285; GO:0014048; GO:0014049; GO:0014053; GO:0016020; GO:0030673; GO:0031966; GO:0032811; GO:0033602; GO:0035094; GO:0038037; GO:0038039; GO:0042734; GO:0043025; GO:0043197; GO:0043198; GO:0045211; GO:0045471; GO:0046982; GO:0050805; GO:0051932; GO:0060124; GO:0097060; GO:0098685; GO:0098793; GO:0098978; GO:0098982; GO:0099579; GO:0150047; GO:0150099; GO:1902710; GO:1902712; GO:1990430 adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; gamma-aminobutyric acid signaling pathway [GO:0007214]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of dopamine secretion [GO:0033602]; negative regulation of epinephrine secretion [GO:0032811]; negative regulation of gamma-aminobutyric acid secretion [GO:0014053]; negative regulation of synaptic transmission [GO:0050805]; neuron-glial cell signaling [GO:0150099]; osteoblast differentiation [GO:0001649]; positive regulation of glutamate secretion [GO:0014049]; positive regulation of growth hormone secretion [GO:0060124]; regulation of glutamate secretion [GO:0014048]; response to ethanol [GO:0045471]; response to nicotine [GO:0035094]; synaptic transmission, GABAergic [GO:0051932] axolemma [GO:0030673]; cytoplasm [GO:0005737]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; endoplasmic reticulum membrane [GO:0005789]; extracellular space [GO:0005615]; G protein-coupled GABA receptor complex [GO:1902712]; G protein-coupled receptor dimeric complex [GO:0038037]; G protein-coupled receptor heterodimeric complex [GO:0038039]; GABA receptor complex [GO:1902710]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; mitochondrial membrane [GO:0031966]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynapse [GO:0098793]; presynaptic membrane [GO:0042734]; Schaffer collateral - CA1 synapse [GO:0098685]; synaptic membrane [GO:0097060]; synaptic vesicle [GO:0008021] extracellular matrix protein binding [GO:1990430]; G protein-coupled GABA receptor activity [GO:0004965]; G protein-coupled neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential [GO:0099579]; G protein-coupled neurotransmitter receptor activity involved in regulation of presynaptic membrane potential [GO:0150047]; protein heterodimerization activity [GO:0046982] g16049.t1 Q6P4R8 54.313 313 2.56e-96 338.0 sp|Q6P4R8|NFRKB_HUMAN Nuclear factor related to kappa-B-binding protein OS=Homo sapiens OX=9606 GN=NFRKB PE=1 SV=2 NFRKB_HUMAN reviewed Nuclear factor related to kappa-B-binding protein (DNA-binding protein R kappa-B) (INO80 complex subunit G) Homo sapiens (Human) GO:0000723; GO:0002020; GO:0003677; GO:0005634; GO:0005654; GO:0006275; GO:0006281; GO:0006282; GO:0006310; GO:0006338; GO:0031011; GO:0033044; GO:0045739; GO:0045893; GO:0045995; GO:0051726; GO:0060382; GO:1904507 chromatin remodeling [GO:0006338]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; positive regulation of DNA repair [GO:0045739]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of telomere maintenance in response to DNA damage [GO:1904507]; regulation of cell cycle [GO:0051726]; regulation of chromosome organization [GO:0033044]; regulation of DNA repair [GO:0006282]; regulation of DNA replication [GO:0006275]; regulation of DNA strand elongation [GO:0060382]; regulation of embryonic development [GO:0045995]; telomere maintenance [GO:0000723] Ino80 complex [GO:0031011]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] DNA binding [GO:0003677]; protease binding [GO:0002020] g16049.t1 Q6P4R8 31.169 308 6.5e-40 165.0 sp|Q6P4R8|NFRKB_HUMAN Nuclear factor related to kappa-B-binding protein OS=Homo sapiens OX=9606 GN=NFRKB PE=1 SV=2 NFRKB_HUMAN reviewed Nuclear factor related to kappa-B-binding protein (DNA-binding protein R kappa-B) (INO80 complex subunit G) Homo sapiens (Human) GO:0000723; GO:0002020; GO:0003677; GO:0005634; GO:0005654; GO:0006275; GO:0006281; GO:0006282; GO:0006310; GO:0006338; GO:0031011; GO:0033044; GO:0045739; GO:0045893; GO:0045995; GO:0051726; GO:0060382; GO:1904507 chromatin remodeling [GO:0006338]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; positive regulation of DNA repair [GO:0045739]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of telomere maintenance in response to DNA damage [GO:1904507]; regulation of cell cycle [GO:0051726]; regulation of chromosome organization [GO:0033044]; regulation of DNA repair [GO:0006282]; regulation of DNA replication [GO:0006275]; regulation of DNA strand elongation [GO:0060382]; regulation of embryonic development [GO:0045995]; telomere maintenance [GO:0000723] Ino80 complex [GO:0031011]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] DNA binding [GO:0003677]; protease binding [GO:0002020] g16050.t1 Q6DFI2 56.444 225 2.04e-87 261.0 sp|Q6DFI2|TM147_XENLA BOS complex subunit TMEM147 OS=Xenopus laevis OX=8355 GN=tmem147 PE=2 SV=1 TM147_XENLA reviewed BOS complex subunit TMEM147 (Transmembrane protein 147) Xenopus laevis (African clawed frog) GO:0005789; GO:0005886; GO:0031965; GO:0036228; GO:0043022; GO:0160063 multi-pass transmembrane protein insertion into ER membrane [GO:0160063]; protein localization to nuclear inner membrane [GO:0036228] endoplasmic reticulum membrane [GO:0005789]; nuclear membrane [GO:0031965]; plasma membrane [GO:0005886] ribosome binding [GO:0043022] g16051.t1 A1A4I1 56.311 206 1.9e-71 244.0 sp|A1A4I1|S20A2_BOVIN Sodium-dependent phosphate transporter 2 OS=Bos taurus OX=9913 GN=SLC20A2 PE=2 SV=1 S20A2_BOVIN reviewed Sodium-dependent phosphate transporter 2 (Phosphate transporter 2) (PiT-2) (Solute carrier family 20 member 2) Bos taurus (Bovine) GO:0005315; GO:0005436; GO:0005886; GO:0016324; GO:0030501; GO:0031526; GO:0035435 phosphate ion transmembrane transport [GO:0035435]; positive regulation of bone mineralization [GO:0030501] apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; plasma membrane [GO:0005886] phosphate transmembrane transporter activity [GO:0005315]; sodium:phosphate symporter activity [GO:0005436] g16051.t1 A1A4I1 61.176 170 3.83e-64 224.0 sp|A1A4I1|S20A2_BOVIN Sodium-dependent phosphate transporter 2 OS=Bos taurus OX=9913 GN=SLC20A2 PE=2 SV=1 S20A2_BOVIN reviewed Sodium-dependent phosphate transporter 2 (Phosphate transporter 2) (PiT-2) (Solute carrier family 20 member 2) Bos taurus (Bovine) GO:0005315; GO:0005436; GO:0005886; GO:0016324; GO:0030501; GO:0031526; GO:0035435 phosphate ion transmembrane transport [GO:0035435]; positive regulation of bone mineralization [GO:0030501] apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; plasma membrane [GO:0005886] phosphate transmembrane transporter activity [GO:0005315]; sodium:phosphate symporter activity [GO:0005436] g16055.t1 P51521 60.215 93 8.64e-32 131.0 sp|P51521|OVO_DROME Transcriptional regulator ovo OS=Drosophila melanogaster OX=7227 GN=ovo PE=1 SV=2 OVO_DROME reviewed Transcriptional regulator ovo (Transcriptional repressor shavenbaby) (Transcriptional repressor svb) [Cleaved into: Transcriptional activator shavenbaby (Transcriptional activator svb)] Drosophila melanogaster (Fruit fly) GO:0000122; GO:0000978; GO:0000981; GO:0001223; GO:0003677; GO:0005634; GO:0005654; GO:0005737; GO:0006357; GO:0007010; GO:0008270; GO:0008343; GO:0008360; GO:0009913; GO:0016348; GO:0018992; GO:0032196; GO:0035017; GO:0035316; GO:0043565; GO:0045892; GO:0045893; GO:0045944; GO:0048067; GO:0048477; GO:1990837 adult feeding behavior [GO:0008343]; cuticle pattern formation [GO:0035017]; cuticle pigmentation [GO:0048067]; cytoskeleton organization [GO:0007010]; epidermal cell differentiation [GO:0009913]; germ-line sex determination [GO:0018992]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; non-sensory hair organization [GO:0035316]; oogenesis [GO:0048477]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell shape [GO:0008360]; regulation of transcription by RNA polymerase II [GO:0006357]; transposition [GO:0032196] cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription coactivator binding [GO:0001223]; zinc ion binding [GO:0008270] g16056.t1 G5EDU6 67.153 137 5.28e-55 195.0 sp|G5EDU6|OVOLH_CAEEL Transcription factor ovo-like homolog lin-48 OS=Caenorhabditis elegans OX=6239 GN=lin-48 PE=1 SV=1 OVOLH_CAEEL reviewed Transcription factor ovo-like homolog lin-48 (Abnormal cell lineage protein 48) Caenorhabditis elegans GO:0000978; GO:0000981; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0007442; GO:0008270; GO:0009651; GO:0009887; GO:0009913; GO:0045138 animal organ morphogenesis [GO:0009887]; epidermal cell differentiation [GO:0009913]; hindgut morphogenesis [GO:0007442]; nematode male tail tip morphogenesis [GO:0045138]; regulation of DNA-templated transcription [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; response to salt stress [GO:0009651] nucleus [GO:0005634] DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270] g16058.t1 Q3C1V8 52.459 122 1.02e-27 109.0 sp|Q3C1V8|BSH_HUMAN Brain-specific homeobox protein homolog OS=Homo sapiens OX=9606 GN=BSX PE=1 SV=2 BSH_HUMAN reviewed Brain-specific homeobox protein homolog Homo sapiens (Human) GO:0000785; GO:0000978; GO:0000981; GO:0005634; GO:0005667; GO:0006357; GO:0007626; GO:0019827; GO:0030154; GO:0042755; GO:0045944; GO:0060056; GO:1990837 cell differentiation [GO:0030154]; eating behavior [GO:0042755]; locomotory behavior [GO:0007626]; mammary gland involution [GO:0060056]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; stem cell population maintenance [GO:0019827] chromatin [GO:0000785]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667] DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837] g16061.t1 Q39565 27.743 483 4.23e-37 149.0 sp|Q39565|DYHB_CHLRE Dynein beta chain, flagellar outer arm OS=Chlamydomonas reinhardtii OX=3055 GN=ODA4 PE=3 SV=1 g16062.t1 Q39565 24.444 585 1.99e-44 182.0 sp|Q39565|DYHB_CHLRE Dynein beta chain, flagellar outer arm OS=Chlamydomonas reinhardtii OX=3055 GN=ODA4 PE=3 SV=1 g16062.t1 Q39565 34.05 279 6.559999999999999e-40 167.0 sp|Q39565|DYHB_CHLRE Dynein beta chain, flagellar outer arm OS=Chlamydomonas reinhardtii OX=3055 GN=ODA4 PE=3 SV=1 g16062.t1 Q39565 36.82 239 1.17e-36 157.0 sp|Q39565|DYHB_CHLRE Dynein beta chain, flagellar outer arm OS=Chlamydomonas reinhardtii OX=3055 GN=ODA4 PE=3 SV=1 g16063.t1 Q39565 30.804 224 7.540000000000001e-27 114.0 sp|Q39565|DYHB_CHLRE Dynein beta chain, flagellar outer arm OS=Chlamydomonas reinhardtii OX=3055 GN=ODA4 PE=3 SV=1 g16064.t1 F1SC07 29.297 1024 6.37e-113 388.0 sp|F1SC07|DYH11_PIG Dynein axonemal heavy chain 11 OS=Sus scrofa OX=9823 GN=DNAH11 PE=1 SV=4 g16064.t2 F1SC07 29.505 1010 7.409999999999999e-114 390.0 sp|F1SC07|DYH11_PIG Dynein axonemal heavy chain 11 OS=Sus scrofa OX=9823 GN=DNAH11 PE=1 SV=4 g16066.t1 Q9NYC9 23.529 697 2.83e-28 129.0 sp|Q9NYC9|DYH9_HUMAN Dynein axonemal heavy chain 9 OS=Homo sapiens OX=9606 GN=DNAH9 PE=1 SV=3 DYH9_HUMAN reviewed Dynein axonemal heavy chain 9 (Axonemal beta dynein heavy chain 9) (Ciliary dynein heavy chain 9) Homo sapiens (Human) GO:0003341; GO:0005524; GO:0005576; GO:0005874; GO:0005930; GO:0008569; GO:0030030; GO:0030286; GO:0031514; GO:0036157; GO:0045505; GO:0051649; GO:0051959; GO:0060294; GO:0090660; GO:0097386; GO:0097729; GO:0120135; GO:0120197 cell projection organization [GO:0030030]; cerebrospinal fluid circulation [GO:0090660]; cilium movement [GO:0003341]; cilium movement involved in cell motility [GO:0060294]; establishment of localization in cell [GO:0051649]; mucociliary clearance [GO:0120197] 9+2 motile cilium [GO:0097729]; axoneme [GO:0005930]; distal portion of axoneme [GO:0120135]; dynein complex [GO:0030286]; extracellular region [GO:0005576]; glial cell projection [GO:0097386]; microtubule [GO:0005874]; motile cilium [GO:0031514]; outer dynein arm [GO:0036157] ATP binding [GO:0005524]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; minus-end-directed microtubule motor activity [GO:0008569] g16069.t1 Q0KHY3 28.656 1019 5.2099999999999996e-83 302.0 sp|Q0KHY3|MESH_DROME Protein mesh OS=Drosophila melanogaster OX=7227 GN=mesh PE=1 SV=2 MESH_DROME reviewed Protein mesh Drosophila melanogaster (Fruit fly) GO:0005615; GO:0005920; GO:0007160; GO:0016327; GO:0090528 cell-matrix adhesion [GO:0007160]; smooth septate junction assembly [GO:0090528] apicolateral plasma membrane [GO:0016327]; extracellular space [GO:0005615]; smooth septate junction [GO:0005920] g16070.t1 Q9DBX3 28.636 440 6.21e-44 173.0 sp|Q9DBX3|SUSD2_MOUSE Sushi domain-containing protein 2 OS=Mus musculus OX=10090 GN=Susd2 PE=1 SV=1 g16071.t1 O08523 32.704 318 3.92e-38 148.0 sp|O08523|TECTA_MOUSE Alpha-tectorin OS=Mus musculus OX=10090 GN=Tecta PE=1 SV=2 TECTA_MOUSE reviewed Alpha-tectorin Mus musculus (Mouse) GO:0005201; GO:0005886; GO:0007160; GO:0007605; GO:0031012; GO:0060088; GO:0098552 auditory receptor cell stereocilium organization [GO:0060088]; cell-matrix adhesion [GO:0007160]; sensory perception of sound [GO:0007605] extracellular matrix [GO:0031012]; plasma membrane [GO:0005886]; side of membrane [GO:0098552] extracellular matrix structural constituent [GO:0005201] g16072.t1 Q9DBX3 27.958 769 1.1000000000000001e-70 258.0 sp|Q9DBX3|SUSD2_MOUSE Sushi domain-containing protein 2 OS=Mus musculus OX=10090 GN=Susd2 PE=1 SV=1 g16075.t1 Q5ZI69 35.359 362 1.1699999999999999e-60 206.0 sp|Q5ZI69|RM37_CHICK Large ribosomal subunit protein mL37 OS=Gallus gallus OX=9031 GN=MRPL37 PE=2 SV=2 g16076.t1 Q91757 75.949 395 0.0 609.0 sp|Q91757|GSK3B_XENLA Glycogen synthase kinase-3 beta OS=Xenopus laevis OX=8355 GN=gsk3b PE=1 SV=1 GSK3B_XENLA reviewed Glycogen synthase kinase-3 beta (GSK-3 beta) (EC 2.7.11.26) (Xgsk-3 protein) Xenopus laevis (African clawed frog) GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0007399; GO:0008013; GO:0008286; GO:0010508; GO:0010719; GO:0010975; GO:0016055; GO:0030154; GO:0030424; GO:0030877; GO:0032007; GO:0032436; GO:0043525; GO:0045892; GO:0048511; GO:0050321; GO:0070507; GO:0090090; GO:0098978 cell differentiation [GO:0030154]; insulin receptor signaling pathway [GO:0008286]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of TOR signaling [GO:0032007]; nervous system development [GO:0007399]; positive regulation of autophagy [GO:0010508]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; regulation of microtubule cytoskeleton organization [GO:0070507]; regulation of neuron projection development [GO:0010975]; rhythmic process [GO:0048511]; Wnt signaling pathway [GO:0016055] axon [GO:0030424]; beta-catenin destruction complex [GO:0030877]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; nucleus [GO:0005634]; plasma membrane [GO:0005886] ATP binding [GO:0005524]; beta-catenin binding [GO:0008013]; protein serine/threonine kinase activity [GO:0004674]; tau-protein kinase activity [GO:0050321] g16082.t1 Q8BUW1 38.062 289 5.86e-39 148.0 sp|Q8BUW1|KCNKA_MOUSE Potassium channel subfamily K member 10 OS=Mus musculus OX=10090 GN=Kcnk10 PE=1 SV=1 KCNKA_MOUSE reviewed Potassium channel subfamily K member 10 (Outward rectifying potassium channel protein TREK-2) (TREK-2 K(+) channel subunit) Mus musculus (Mouse) GO:0005267; GO:0005886; GO:0015271; GO:0022841; GO:0046872; GO:0050877; GO:0071805; GO:0098782; GO:1904551 cellular response to arachidonate [GO:1904551]; nervous system process [GO:0050877]; potassium ion transmembrane transport [GO:0071805] plasma membrane [GO:0005886] mechanosensitive potassium channel activity [GO:0098782]; metal ion binding [GO:0046872]; outward rectifier potassium channel activity [GO:0015271]; potassium channel activity [GO:0005267]; potassium ion leak channel activity [GO:0022841] g16085.t1 Q641Y2 80.786 458 0.0 783.0 sp|Q641Y2|NDUS2_RAT NADH dehydrogenase [ubiquinone] iron-sulfur protein 2, mitochondrial OS=Rattus norvegicus OX=10116 GN=Ndufs2 PE=1 SV=1 NDUS2_RAT reviewed NADH dehydrogenase [ubiquinone] iron-sulfur protein 2, mitochondrial (EC 7.1.1.2) (Complex I-49kD) (CI-49kD) (NADH-ubiquinone oxidoreductase 49 kDa subunit) Rattus norvegicus (Rat) GO:0003954; GO:0005739; GO:0005743; GO:0006120; GO:0008137; GO:0019826; GO:0022008; GO:0031625; GO:0032981; GO:0042063; GO:0042775; GO:0045271; GO:0046872; GO:0048038; GO:0051287; GO:0051539; GO:0061351; GO:0071453 cellular response to oxygen levels [GO:0071453]; gliogenesis [GO:0042063]; mitochondrial ATP synthesis coupled electron transport [GO:0042775]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; mitochondrial respiratory chain complex I assembly [GO:0032981]; neural precursor cell proliferation [GO:0061351]; neurogenesis [GO:0022008] mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; respiratory chain complex I [GO:0045271] 4 iron, 4 sulfur cluster binding [GO:0051539]; metal ion binding [GO:0046872]; NAD binding [GO:0051287]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; NADH dehydrogenase activity [GO:0003954]; oxygen sensor activity [GO:0019826]; quinone binding [GO:0048038]; ubiquitin protein ligase binding [GO:0031625] g16089.t1 Q90Z04 26.479 676 1.1e-45 183.0 sp|Q90Z04|CDON_XENLA Cell adhesion molecule-related/down-regulated by oncogenes OS=Xenopus laevis OX=8355 GN=cdon PE=2 SV=1 g16089.t1 Q90Z04 35.621 306 3.27e-33 143.0 sp|Q90Z04|CDON_XENLA Cell adhesion molecule-related/down-regulated by oncogenes OS=Xenopus laevis OX=8355 GN=cdon PE=2 SV=1 g16090.t1 Q24372 26.891 357 9.89e-27 112.0 sp|Q24372|LACH_DROME Lachesin OS=Drosophila melanogaster OX=7227 GN=Lac PE=1 SV=2 LACH_DROME reviewed Lachesin Drosophila melanogaster (Fruit fly) GO:0005886; GO:0005918; GO:0007156; GO:0007424; GO:0016331; GO:0019991; GO:0035151; GO:0035160; GO:0042803; GO:0043005; GO:0061343; GO:0098552 cell adhesion involved in heart morphogenesis [GO:0061343]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; maintenance of epithelial integrity, open tracheal system [GO:0035160]; morphogenesis of embryonic epithelium [GO:0016331]; open tracheal system development [GO:0007424]; regulation of tube size, open tracheal system [GO:0035151]; septate junction assembly [GO:0019991] neuron projection [GO:0043005]; plasma membrane [GO:0005886]; septate junction [GO:0005918]; side of membrane [GO:0098552] protein homodimerization activity [GO:0042803] g16096.t1 Q9VBW3 53.604 222 3.1200000000000004e-66 233.0 sp|Q9VBW3|CAD96_DROME Tyrosine kinase receptor Cad96Ca OS=Drosophila melanogaster OX=7227 GN=Cad96Ca PE=2 SV=2 CAD96_DROME reviewed Tyrosine kinase receptor Cad96Ca (EC 2.7.10.1) (Cadherin-96Ca) (Tyrosine kinase receptor HD-14) Drosophila melanogaster (Fruit fly) GO:0004713; GO:0004714; GO:0005509; GO:0005524; GO:0005886; GO:0006468; GO:0007030; GO:0007156; GO:0007169; GO:0016339; GO:0042060; GO:0043235; GO:0045177; GO:0045792; GO:0051897; GO:0090303 calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; Golgi organization [GO:0007030]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell size [GO:0045792]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of wound healing [GO:0090303]; protein phosphorylation [GO:0006468]; wound healing [GO:0042060] apical part of cell [GO:0045177]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; protein tyrosine kinase activity [GO:0004713]; transmembrane receptor protein tyrosine kinase activity [GO:0004714] g16101.t1 Q9HAR2 35.671 328 3.45e-52 206.0 sp|Q9HAR2|AGRL3_HUMAN Adhesion G protein-coupled receptor L3 OS=Homo sapiens OX=9606 GN=ADGRL3 PE=1 SV=2 g16103.t1 Q9VBW3 51.802 222 8e-69 245.0 sp|Q9VBW3|CAD96_DROME Tyrosine kinase receptor Cad96Ca OS=Drosophila melanogaster OX=7227 GN=Cad96Ca PE=2 SV=2 CAD96_DROME reviewed Tyrosine kinase receptor Cad96Ca (EC 2.7.10.1) (Cadherin-96Ca) (Tyrosine kinase receptor HD-14) Drosophila melanogaster (Fruit fly) GO:0004713; GO:0004714; GO:0005509; GO:0005524; GO:0005886; GO:0006468; GO:0007030; GO:0007156; GO:0007169; GO:0016339; GO:0042060; GO:0043235; GO:0045177; GO:0045792; GO:0051897; GO:0090303 calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; Golgi organization [GO:0007030]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell size [GO:0045792]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of wound healing [GO:0090303]; protein phosphorylation [GO:0006468]; wound healing [GO:0042060] apical part of cell [GO:0045177]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; protein tyrosine kinase activity [GO:0004713]; transmembrane receptor protein tyrosine kinase activity [GO:0004714] g16107.t1 Q9HAR2 38.819 237 9.06e-30 131.0 sp|Q9HAR2|AGRL3_HUMAN Adhesion G protein-coupled receptor L3 OS=Homo sapiens OX=9606 GN=ADGRL3 PE=1 SV=2 g16113.t1 Q9VBW3 52.778 252 1.7199999999999998e-82 292.0 sp|Q9VBW3|CAD96_DROME Tyrosine kinase receptor Cad96Ca OS=Drosophila melanogaster OX=7227 GN=Cad96Ca PE=2 SV=2 CAD96_DROME reviewed Tyrosine kinase receptor Cad96Ca (EC 2.7.10.1) (Cadherin-96Ca) (Tyrosine kinase receptor HD-14) Drosophila melanogaster (Fruit fly) GO:0004713; GO:0004714; GO:0005509; GO:0005524; GO:0005886; GO:0006468; GO:0007030; GO:0007156; GO:0007169; GO:0016339; GO:0042060; GO:0043235; GO:0045177; GO:0045792; GO:0051897; GO:0090303 calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; Golgi organization [GO:0007030]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell size [GO:0045792]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of wound healing [GO:0090303]; protein phosphorylation [GO:0006468]; wound healing [GO:0042060] apical part of cell [GO:0045177]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; protein tyrosine kinase activity [GO:0004713]; transmembrane receptor protein tyrosine kinase activity [GO:0004714] g16114.t1 Q24488 31.0 300 2.85e-30 127.0 sp|Q24488|ROR1_DROME Tyrosine-protein kinase transmembrane receptor Ror OS=Drosophila melanogaster OX=7227 GN=Ror PE=1 SV=1 ROR1_DROME reviewed Tyrosine-protein kinase transmembrane receptor Ror (dRor) (EC 2.7.10.1) Drosophila melanogaster (Fruit fly) GO:0004713; GO:0004714; GO:0005524; GO:0005886; GO:0006468; GO:0007169; GO:0007417; GO:0016020; GO:0017147; GO:0030424; GO:0043235 cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; central nervous system development [GO:0007417]; protein phosphorylation [GO:0006468] axon [GO:0030424]; membrane [GO:0016020]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] ATP binding [GO:0005524]; protein tyrosine kinase activity [GO:0004713]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; Wnt-protein binding [GO:0017147] g16115.t1 Q62689 25.955 628 1.4899999999999998e-30 130.0 sp|Q62689|JAK2_RAT Tyrosine-protein kinase JAK2 OS=Rattus norvegicus OX=10116 GN=Jak2 PE=1 SV=1 JAK2_RAT reviewed Tyrosine-protein kinase JAK2 (EC 2.7.10.2) (Janus kinase 2) (JAK-2) Rattus norvegicus (Rat) GO:0000791; GO:0001774; GO:0004713; GO:0004715; GO:0005102; GO:0005131; GO:0005143; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0005901; GO:0005925; GO:0006366; GO:0006979; GO:0007155; GO:0007165; GO:0007167; GO:0007204; GO:0007259; GO:0008284; GO:0008285; GO:0008631; GO:0009755; GO:0009898; GO:0010572; GO:0010667; GO:0010811; GO:0012505; GO:0019221; GO:0019897; GO:0019901; GO:0020037; GO:0022408; GO:0030099; GO:0030154; GO:0030218; GO:0030335; GO:0030526; GO:0030546; GO:0031103; GO:0031234; GO:0031663; GO:0031702; GO:0031959; GO:0032024; GO:0032729; GO:0032731; GO:0032760; GO:0032819; GO:0033130; GO:0033194; GO:0033209; GO:0034050; GO:0034612; GO:0035166; GO:0035401; GO:0035556; GO:0035722; GO:0036016; GO:0038043; GO:0038065; GO:0038155; GO:0038156; GO:0038157; GO:0038162; GO:0038163; GO:0042022; GO:0042102; GO:0042169; GO:0042307; GO:0042393; GO:0042531; GO:0042802; GO:0042976; GO:0042981; GO:0043065; GO:0043066; GO:0043161; GO:0043410; GO:0043524; GO:0043548; GO:0043560; GO:0043687; GO:0045063; GO:0045121; GO:0045348; GO:0045428; GO:0045429; GO:0045597; GO:0045944; GO:0046427; GO:0046677; GO:0046777; GO:0046872; GO:0048008; GO:0050727; GO:0050804; GO:0050867; GO:0051142; GO:0051428; GO:0051897; GO:0060333; GO:0060391; GO:0060396; GO:0060397; GO:0060399; GO:0060400; GO:0061180; GO:0070665; GO:0070671; GO:0071222; GO:0071549; GO:0072536; GO:0097191; GO:0098794; GO:0098978; GO:0120162; GO:0140546; GO:1900016; GO:1901731; GO:1902728; GO:1904037; GO:1904707; GO:1905539; GO:1905869; GO:2001235 activation of Janus kinase activity [GO:0042976]; axon regeneration [GO:0031103]; cell adhesion [GO:0007155]; cell differentiation [GO:0030154]; cell surface receptor signaling pathway via JAK-STAT [GO:0007259]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to interleukin-3 [GO:0036016]; cellular response to lipopolysaccharide [GO:0071222]; collagen-activated signaling pathway [GO:0038065]; cytokine-mediated signaling pathway [GO:0019221]; defense response to symbiont [GO:0140546]; enzyme-linked receptor protein signaling pathway [GO:0007167]; erythrocyte differentiation [GO:0030218]; erythropoietin-mediated signaling pathway [GO:0038162]; extrinsic apoptotic signaling pathway [GO:0097191]; granulocyte-macrophage colony-stimulating factor signaling pathway [GO:0038157]; growth hormone receptor signaling pathway [GO:0060396]; growth hormone receptor signaling pathway via JAK-STAT [GO:0060397]; hormone-mediated signaling pathway [GO:0009755]; interleukin-12-mediated signaling pathway [GO:0035722]; interleukin-23-mediated signaling pathway [GO:0038155]; interleukin-3-mediated signaling pathway [GO:0038156]; interleukin-5-mediated signaling pathway [GO:0038043]; intracellular signal transduction [GO:0035556]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; mammary gland epithelium development [GO:0061180]; microglial cell activation [GO:0001774]; modulation of chemical synaptic transmission [GO:0050804]; myeloid cell differentiation [GO:0030099]; negative regulation of 3'-UTR-mediated mRNA stabilization [GO:1905869]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell-cell adhesion [GO:0022408]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of growth hormone receptor signaling pathway [GO:0060400]; negative regulation of neuron apoptotic process [GO:0043524]; nuclear receptor-mediated mineralocorticoid signaling pathway [GO:0031959]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of apoptotic process [GO:0043065]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of cell activation [GO:0050867]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cell-substrate adhesion [GO:0010811]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of epithelial cell apoptotic process [GO:1904037]; positive regulation of growth factor dependent skeletal muscle satellite cell proliferation [GO:1902728]; positive regulation of growth hormone receptor signaling pathway [GO:0060399]; positive regulation of insulin secretion [GO:0032024]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of leukocyte proliferation [GO:0070665]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of MHC class II biosynthetic process [GO:0045348]; positive regulation of natural killer cell proliferation [GO:0032819]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of NK T cell proliferation [GO:0051142]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of platelet activation [GO:0010572]; positive regulation of platelet aggregation [GO:1901731]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of SMAD protein signal transduction [GO:0060391]; positive regulation of T cell proliferation [GO:0042102]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]; positive regulation of type II interferon production [GO:0032729]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; post-embryonic hemopoiesis [GO:0035166]; post-translational protein modification [GO:0043687]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autophosphorylation [GO:0046777]; regulation of apoptotic process [GO:0042981]; regulation of inflammatory response [GO:0050727]; regulation of nitric oxide biosynthetic process [GO:0045428]; regulation of postsynapse to nucleus signaling pathway [GO:1905539]; response to antibiotic [GO:0046677]; response to hydroperoxide [GO:0033194]; response to interleukin-12 [GO:0070671]; response to oxidative stress [GO:0006979]; response to tumor necrosis factor [GO:0034612]; signal transduction [GO:0007165]; symbiont-induced defense-related programmed cell death [GO:0034050]; T-helper 1 cell differentiation [GO:0045063]; thrombopoietin-mediated signaling pathway [GO:0038163]; transcription by RNA polymerase II [GO:0006366]; tumor necrosis factor-mediated signaling pathway [GO:0033209]; type II interferon-mediated signaling pathway [GO:0060333] caveola [GO:0005901]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; euchromatin [GO:0000791]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; extrinsic component of plasma membrane [GO:0019897]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; granulocyte macrophage colony-stimulating factor receptor complex [GO:0030526]; interleukin-12 receptor complex [GO:0042022]; interleukin-23 receptor complex [GO:0072536]; membrane raft [GO:0045121]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynapse [GO:0098794] acetylcholine receptor binding [GO:0033130]; ATP binding [GO:0005524]; growth hormone receptor binding [GO:0005131]; heme binding [GO:0020037]; histone binding [GO:0042393]; histone H3Y41 kinase activity [GO:0035401]; identical protein binding [GO:0042802]; insulin receptor substrate binding [GO:0043560]; interleukin-12 receptor binding [GO:0005143]; metal ion binding [GO:0046872]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; peptide hormone receptor binding [GO:0051428]; phosphatidylinositol 3-kinase binding [GO:0043548]; protein kinase binding [GO:0019901]; protein tyrosine kinase activity [GO:0004713]; SH2 domain binding [GO:0042169]; signaling receptor activator activity [GO:0030546]; signaling receptor binding [GO:0005102]; type 1 angiotensin receptor binding [GO:0031702] g16116.t1 P18101 97.656 128 1.07e-89 258.0 sp|P18101|RL40_DROME Ubiquitin-ribosomal protein eL40 fusion protein OS=Drosophila melanogaster OX=7227 GN=RpL40 PE=1 SV=2 g16117.t1 P45844 55.577 529 0.0 560.0 sp|P45844|ABCG1_HUMAN ATP-binding cassette sub-family G member 1 OS=Homo sapiens OX=9606 GN=ABCG1 PE=1 SV=3 ABCG1_HUMAN reviewed ATP-binding cassette sub-family G member 1 (EC 7.6.2.-) (ATP-binding cassette transporter 8) (White protein homolog) Homo sapiens (Human) GO:0000139; GO:0005524; GO:0005543; GO:0005654; GO:0005739; GO:0005768; GO:0005789; GO:0005794; GO:0005886; GO:0008203; GO:0009897; GO:0010745; GO:0010875; GO:0010887; GO:0015485; GO:0016887; GO:0019534; GO:0032367; GO:0033344; GO:0033700; GO:0033993; GO:0034041; GO:0034374; GO:0034375; GO:0034436; GO:0042632; GO:0042803; GO:0042987; GO:0043531; GO:0043691; GO:0045542; GO:0046982; GO:0050714; GO:0055037; GO:0055085; GO:0055091; GO:0071403; GO:0090181; GO:0090554; GO:0120020; GO:0140328; GO:1902004; GO:1990961 amyloid precursor protein catabolic process [GO:0042987]; cellular response to high density lipoprotein particle stimulus [GO:0071403]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; glycoprotein transport [GO:0034436]; high-density lipoprotein particle remodeling [GO:0034375]; intracellular cholesterol transport [GO:0032367]; low-density lipoprotein particle remodeling [GO:0034374]; negative regulation of cholesterol storage [GO:0010887]; negative regulation of macrophage derived foam cell differentiation [GO:0010745]; phospholipid efflux [GO:0033700]; phospholipid homeostasis [GO:0055091]; positive regulation of amyloid-beta formation [GO:1902004]; positive regulation of cholesterol biosynthetic process [GO:0045542]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of protein secretion [GO:0050714]; regulation of cholesterol metabolic process [GO:0090181]; response to lipid [GO:0033993]; reverse cholesterol transport [GO:0043691]; transmembrane transport [GO:0055085]; xenobiotic detoxification by transmembrane export across the plasma membrane [GO:1990961] endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; external side of plasma membrane [GO:0009897]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037] ABC-type sterol transporter activity [GO:0034041]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; cholesterol binding [GO:0015485]; cholesterol transfer activity [GO:0120020]; floppase activity [GO:0140328]; phosphatidylcholine floppase activity [GO:0090554]; phospholipid binding [GO:0005543]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; toxin transmembrane transporter activity [GO:0019534] g16118.t1 D3ZCM3 68.841 138 4.73e-52 191.0 sp|D3ZCM3|ABCG4_RAT ATP-binding cassette subfamily G member 4 OS=Rattus norvegicus OX=10116 GN=Abcg4 PE=2 SV=1 ABCG4_RAT reviewed ATP-binding cassette subfamily G member 4 (EC 7.6.2.-) (ATP-binding cassette, sub-family G (WHITE), member 4) Rattus norvegicus (Rat) GO:0005524; GO:0005768; GO:0005886; GO:0006355; GO:0010008; GO:0010875; GO:0015918; GO:0016887; GO:0031410; GO:0033344; GO:0034041; GO:0042632; GO:0042802; GO:0042803; GO:0045542; GO:0046982; GO:0055085; GO:0071403; GO:1990830 cellular response to high density lipoprotein particle stimulus [GO:0071403]; cellular response to leukemia inhibitory factor [GO:1990830]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; positive regulation of cholesterol biosynthetic process [GO:0045542]; positive regulation of cholesterol efflux [GO:0010875]; regulation of DNA-templated transcription [GO:0006355]; sterol transport [GO:0015918]; transmembrane transport [GO:0055085] cytoplasmic vesicle [GO:0031410]; endosome [GO:0005768]; endosome membrane [GO:0010008]; plasma membrane [GO:0005886] ABC-type sterol transporter activity [GO:0034041]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; identical protein binding [GO:0042802]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803] g16119.t1 Q02356 46.857 350 1.37e-71 242.0 sp|Q02356|AMPD2_RAT AMP deaminase 2 OS=Rattus norvegicus OX=10116 GN=Ampd2 PE=1 SV=2 g16119.t2 Q02356 46.742 353 2.9300000000000003e-72 243.0 sp|Q02356|AMPD2_RAT AMP deaminase 2 OS=Rattus norvegicus OX=10116 GN=Ampd2 PE=1 SV=2 g16120.t1 Q02356 73.762 404 0.0 612.0 sp|Q02356|AMPD2_RAT AMP deaminase 2 OS=Rattus norvegicus OX=10116 GN=Ampd2 PE=1 SV=2 g16121.t1 A1YG88 36.427 431 3.3e-75 250.0 sp|A1YG88|ZNF16_PANPA Zinc finger protein 16 OS=Pan paniscus OX=9597 GN=ZNF16 PE=3 SV=1 g16121.t1 A1YG88 31.959 388 2e-52 189.0 sp|A1YG88|ZNF16_PANPA Zinc finger protein 16 OS=Pan paniscus OX=9597 GN=ZNF16 PE=3 SV=1 g16121.t1 A1YG88 34.663 326 8.270000000000001e-51 185.0 sp|A1YG88|ZNF16_PANPA Zinc finger protein 16 OS=Pan paniscus OX=9597 GN=ZNF16 PE=3 SV=1 g16122.t1 B5X1G3 70.11 455 0.0 659.0 sp|B5X1G3|GPHR_SALSA Golgi pH regulator OS=Salmo salar OX=8030 GN=gpr89 PE=2 SV=1 g16123.t1 Q9UHP3 42.03 1123 0.0 769.0 sp|Q9UHP3|UBP25_HUMAN Ubiquitin carboxyl-terminal hydrolase 25 OS=Homo sapiens OX=9606 GN=USP25 PE=1 SV=4 g16123.t2 Q9UHP3 41.778 1125 0.0 761.0 sp|Q9UHP3|UBP25_HUMAN Ubiquitin carboxyl-terminal hydrolase 25 OS=Homo sapiens OX=9606 GN=USP25 PE=1 SV=4 g16128.t1 P56182 37.037 216 3.56e-39 154.0 sp|P56182|RRP1_HUMAN Ribosomal RNA processing protein 1 homolog A OS=Homo sapiens OX=9606 GN=RRP1 PE=1 SV=1 RRP1_HUMAN reviewed Ribosomal RNA processing protein 1 homolog A (Novel nuclear protein 1) (NNP-1) (Nucleolar protein Nop52) (RRP1-like protein) Homo sapiens (Human) GO:0003723; GO:0005634; GO:0005694; GO:0005730; GO:0006364; GO:0030688 rRNA processing [GO:0006364] chromosome [GO:0005694]; nucleolus [GO:0005730]; nucleus [GO:0005634]; preribosome, small subunit precursor [GO:0030688] RNA binding [GO:0003723] g16129.t1 O35075 65.753 292 1.12e-152 432.0 sp|O35075|VP26C_MOUSE Vacuolar protein sorting-associated protein 26C OS=Mus musculus OX=10090 GN=Vps26c PE=1 SV=1 g16130.t1 P50516 83.902 615 0.0 1098.0 sp|P50516|VATA_MOUSE V-type proton ATPase catalytic subunit A OS=Mus musculus OX=10090 GN=Atp6v1a PE=1 SV=2 g16131.t1 Q9NHD5 76.73 159 4.31e-90 264.0 sp|Q9NHD5|SAN_DROME Probable N-acetyltransferase san OS=Drosophila melanogaster OX=7227 GN=san PE=1 SV=1 SAN_DROME reviewed Probable N-acetyltransferase san (EC 2.3.1.258) (N-epsilon-acetyltransferase san) (EC 2.3.1.-) (Protein atado) (Protein separation anxiety) Drosophila melanogaster (Fruit fly) GO:0000278; GO:0004596; GO:0005737; GO:0005829; GO:0006474; GO:0007064; GO:0008080; GO:0031248; GO:0031415; GO:0120518 mitotic cell cycle [GO:0000278]; mitotic sister chromatid cohesion [GO:0007064]; N-terminal protein amino acid acetylation [GO:0006474] cytoplasm [GO:0005737]; cytosol [GO:0005829]; NatA complex [GO:0031415]; protein acetyltransferase complex [GO:0031248] N-acetyltransferase activity [GO:0008080]; protein N-terminal-methionine acetyltransferase activity [GO:0120518]; protein-N-terminal amino-acid acetyltransferase activity [GO:0004596] g16133.t1 Q9MYV9 33.528 343 3.96e-50 192.0 sp|Q9MYV9|TRPC5_BOVIN Short transient receptor potential channel 5 OS=Bos taurus OX=9913 GN=TRPC5 PE=2 SV=2 g16133.t1 Q9MYV9 34.025 241 4.7300000000000004e-26 118.0 sp|Q9MYV9|TRPC5_BOVIN Short transient receptor potential channel 5 OS=Bos taurus OX=9913 GN=TRPC5 PE=2 SV=2 g16134.t1 Q9QX29 31.163 430 1.34e-49 194.0 sp|Q9QX29|TRPC5_MOUSE Short transient receptor potential channel 5 OS=Mus musculus OX=10090 GN=Trpc5 PE=1 SV=2 g16134.t1 Q9QX29 29.333 300 7.87e-29 128.0 sp|Q9QX29|TRPC5_MOUSE Short transient receptor potential channel 5 OS=Mus musculus OX=10090 GN=Trpc5 PE=1 SV=2 g16135.t1 O14757 55.741 479 3.56e-176 504.0 sp|O14757|CHK1_HUMAN Serine/threonine-protein kinase Chk1 OS=Homo sapiens OX=9606 GN=CHEK1 PE=1 SV=2 CHK1_HUMAN reviewed Serine/threonine-protein kinase Chk1 (EC 2.7.11.1) (CHK1 checkpoint homolog) (Cell cycle checkpoint kinase) (Checkpoint kinase-1) Homo sapiens (Human) GO:0000077; GO:0000086; GO:0000785; GO:0000794; GO:0001833; GO:0004672; GO:0004674; GO:0005524; GO:0005615; GO:0005634; GO:0005654; GO:0005657; GO:0005737; GO:0005813; GO:0005829; GO:0006260; GO:0006281; GO:0006338; GO:0006468; GO:0006915; GO:0006974; GO:0006997; GO:0007095; GO:0010569; GO:0018107; GO:0019904; GO:0032991; GO:0035402; GO:0042127; GO:0042770; GO:0044818; GO:0045787; GO:0045814; GO:0045839; GO:0046602; GO:0070317; GO:0071260; GO:0090399; GO:0106310; GO:1901796; GO:1902742 apoptotic process [GO:0006915]; apoptotic process involved in development [GO:1902742]; cellular response to mechanical stimulus [GO:0071260]; chromatin remodeling [GO:0006338]; DNA damage checkpoint signaling [GO:0000077]; DNA damage response [GO:0006974]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; G2/M transition of mitotic cell cycle [GO:0000086]; inner cell mass cell proliferation [GO:0001833]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; mitotic G2/M transition checkpoint [GO:0044818]; negative regulation of G0 to G1 transition [GO:0070317]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of mitotic nuclear division [GO:0045839]; nucleus organization [GO:0006997]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of cell cycle [GO:0045787]; protein phosphorylation [GO:0006468]; regulation of cell population proliferation [GO:0042127]; regulation of double-strand break repair via homologous recombination [GO:0010569]; regulation of mitotic centrosome separation [GO:0046602]; regulation of signal transduction by p53 class mediator [GO:1901796]; replicative senescence [GO:0090399]; signal transduction in response to DNA damage [GO:0042770] centrosome [GO:0005813]; chromatin [GO:0000785]; condensed nuclear chromosome [GO:0000794]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; replication fork [GO:0005657] ATP binding [GO:0005524]; histone H3T11 kinase activity [GO:0035402]; protein domain specific binding [GO:0019904]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g16136.t1 Q9VBW3 46.358 302 2.68e-86 288.0 sp|Q9VBW3|CAD96_DROME Tyrosine kinase receptor Cad96Ca OS=Drosophila melanogaster OX=7227 GN=Cad96Ca PE=2 SV=2 CAD96_DROME reviewed Tyrosine kinase receptor Cad96Ca (EC 2.7.10.1) (Cadherin-96Ca) (Tyrosine kinase receptor HD-14) Drosophila melanogaster (Fruit fly) GO:0004713; GO:0004714; GO:0005509; GO:0005524; GO:0005886; GO:0006468; GO:0007030; GO:0007156; GO:0007169; GO:0016339; GO:0042060; GO:0043235; GO:0045177; GO:0045792; GO:0051897; GO:0090303 calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; Golgi organization [GO:0007030]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell size [GO:0045792]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of wound healing [GO:0090303]; protein phosphorylation [GO:0006468]; wound healing [GO:0042060] apical part of cell [GO:0045177]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; protein tyrosine kinase activity [GO:0004713]; transmembrane receptor protein tyrosine kinase activity [GO:0004714] g16136.t2 Q9VBW3 46.358 302 5.63e-86 287.0 sp|Q9VBW3|CAD96_DROME Tyrosine kinase receptor Cad96Ca OS=Drosophila melanogaster OX=7227 GN=Cad96Ca PE=2 SV=2 CAD96_DROME reviewed Tyrosine kinase receptor Cad96Ca (EC 2.7.10.1) (Cadherin-96Ca) (Tyrosine kinase receptor HD-14) Drosophila melanogaster (Fruit fly) GO:0004713; GO:0004714; GO:0005509; GO:0005524; GO:0005886; GO:0006468; GO:0007030; GO:0007156; GO:0007169; GO:0016339; GO:0042060; GO:0043235; GO:0045177; GO:0045792; GO:0051897; GO:0090303 calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; Golgi organization [GO:0007030]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell size [GO:0045792]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of wound healing [GO:0090303]; protein phosphorylation [GO:0006468]; wound healing [GO:0042060] apical part of cell [GO:0045177]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; protein tyrosine kinase activity [GO:0004713]; transmembrane receptor protein tyrosine kinase activity [GO:0004714] g16137.t1 Q9VBW3 50.165 303 1.82e-98 313.0 sp|Q9VBW3|CAD96_DROME Tyrosine kinase receptor Cad96Ca OS=Drosophila melanogaster OX=7227 GN=Cad96Ca PE=2 SV=2 CAD96_DROME reviewed Tyrosine kinase receptor Cad96Ca (EC 2.7.10.1) (Cadherin-96Ca) (Tyrosine kinase receptor HD-14) Drosophila melanogaster (Fruit fly) GO:0004713; GO:0004714; GO:0005509; GO:0005524; GO:0005886; GO:0006468; GO:0007030; GO:0007156; GO:0007169; GO:0016339; GO:0042060; GO:0043235; GO:0045177; GO:0045792; GO:0051897; GO:0090303 calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; Golgi organization [GO:0007030]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell size [GO:0045792]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of wound healing [GO:0090303]; protein phosphorylation [GO:0006468]; wound healing [GO:0042060] apical part of cell [GO:0045177]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; protein tyrosine kinase activity [GO:0004713]; transmembrane receptor protein tyrosine kinase activity [GO:0004714] g16142.t1 Q9VBW3 46.557 305 2.35e-91 304.0 sp|Q9VBW3|CAD96_DROME Tyrosine kinase receptor Cad96Ca OS=Drosophila melanogaster OX=7227 GN=Cad96Ca PE=2 SV=2 CAD96_DROME reviewed Tyrosine kinase receptor Cad96Ca (EC 2.7.10.1) (Cadherin-96Ca) (Tyrosine kinase receptor HD-14) Drosophila melanogaster (Fruit fly) GO:0004713; GO:0004714; GO:0005509; GO:0005524; GO:0005886; GO:0006468; GO:0007030; GO:0007156; GO:0007169; GO:0016339; GO:0042060; GO:0043235; GO:0045177; GO:0045792; GO:0051897; GO:0090303 calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; Golgi organization [GO:0007030]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell size [GO:0045792]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of wound healing [GO:0090303]; protein phosphorylation [GO:0006468]; wound healing [GO:0042060] apical part of cell [GO:0045177]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; protein tyrosine kinase activity [GO:0004713]; transmembrane receptor protein tyrosine kinase activity [GO:0004714] g16142.t2 Q9VBW3 46.557 305 2.24e-91 304.0 sp|Q9VBW3|CAD96_DROME Tyrosine kinase receptor Cad96Ca OS=Drosophila melanogaster OX=7227 GN=Cad96Ca PE=2 SV=2 CAD96_DROME reviewed Tyrosine kinase receptor Cad96Ca (EC 2.7.10.1) (Cadherin-96Ca) (Tyrosine kinase receptor HD-14) Drosophila melanogaster (Fruit fly) GO:0004713; GO:0004714; GO:0005509; GO:0005524; GO:0005886; GO:0006468; GO:0007030; GO:0007156; GO:0007169; GO:0016339; GO:0042060; GO:0043235; GO:0045177; GO:0045792; GO:0051897; GO:0090303 calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; Golgi organization [GO:0007030]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell size [GO:0045792]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of wound healing [GO:0090303]; protein phosphorylation [GO:0006468]; wound healing [GO:0042060] apical part of cell [GO:0045177]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; protein tyrosine kinase activity [GO:0004713]; transmembrane receptor protein tyrosine kinase activity [GO:0004714] g16145.t1 Q10651 30.585 376 1.02e-49 186.0 sp|Q10651|A4_CAEEL Amyloid-beta-like protein OS=Caenorhabditis elegans OX=6239 GN=apl-1 PE=1 SV=2 A4_CAEEL reviewed Amyloid-beta-like protein Caenorhabditis elegans GO:0002119; GO:0005769; GO:0007409; GO:0007417; GO:0008201; GO:0010171; GO:0016020; GO:0031410; GO:0042395; GO:0043005; GO:0043025; GO:0046914 axonogenesis [GO:0007409]; body morphogenesis [GO:0010171]; central nervous system development [GO:0007417]; ecdysis, collagen and cuticulin-based cuticle [GO:0042395]; nematode larval development [GO:0002119] cytoplasmic vesicle [GO:0031410]; early endosome [GO:0005769]; membrane [GO:0016020]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025] heparin binding [GO:0008201]; transition metal ion binding [GO:0046914] g16151.t1 Q68CR1 32.318 919 3.3199999999999997e-140 452.0 sp|Q68CR1|SE1L3_HUMAN Protein sel-1 homolog 3 OS=Homo sapiens OX=9606 GN=SEL1L3 PE=1 SV=2 SE1L3_HUMAN reviewed Protein sel-1 homolog 3 (Suppressor of lin-12-like protein 3) (Sel-1L3) Homo sapiens (Human) GO:0016020 membrane [GO:0016020] g16151.t2 Q68CR1 30.967 972 5.6300000000000006e-133 434.0 sp|Q68CR1|SE1L3_HUMAN Protein sel-1 homolog 3 OS=Homo sapiens OX=9606 GN=SEL1L3 PE=1 SV=2 SE1L3_HUMAN reviewed Protein sel-1 homolog 3 (Suppressor of lin-12-like protein 3) (Sel-1L3) Homo sapiens (Human) GO:0016020 membrane [GO:0016020] g16153.t1 Q9HAR2 35.422 367 3.7299999999999997e-48 190.0 sp|Q9HAR2|AGRL3_HUMAN Adhesion G protein-coupled receptor L3 OS=Homo sapiens OX=9606 GN=ADGRL3 PE=1 SV=2 g16154.t1 Q6QNK2 31.675 382 4.3400000000000004e-32 138.0 sp|Q6QNK2|AGRD1_HUMAN Adhesion G-protein coupled receptor D1 OS=Homo sapiens OX=9606 GN=ADGRD1 PE=1 SV=1 AGRD1_HUMAN reviewed Adhesion G-protein coupled receptor D1 (G-protein coupled receptor 133) (G-protein coupled receptor PGR25) [Cleaved into: Adhesion G-protein coupled receptor D1, N-terminal fragment (ADGRD1 N-terminal fragment); Adhesion G-protein coupled receptor D1, C-terminal fragment (ADGRD1 C-terminal fragment)] Homo sapiens (Human) GO:0004930; GO:0005654; GO:0005829; GO:0005886; GO:0007166; GO:0007186; GO:0007189; GO:0014819; GO:0016020; GO:0016607 adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186]; regulation of skeletal muscle contraction [GO:0014819] cytosol [GO:0005829]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] G protein-coupled receptor activity [GO:0004930] g16155.t1 O15394 25.547 411 3.9400000000000004e-31 132.0 sp|O15394|NCAM2_HUMAN Neural cell adhesion molecule 2 OS=Homo sapiens OX=9606 GN=NCAM2 PE=1 SV=2 g16158.t1 Q9VBW3 50.331 302 1.3499999999999999e-95 325.0 sp|Q9VBW3|CAD96_DROME Tyrosine kinase receptor Cad96Ca OS=Drosophila melanogaster OX=7227 GN=Cad96Ca PE=2 SV=2 CAD96_DROME reviewed Tyrosine kinase receptor Cad96Ca (EC 2.7.10.1) (Cadherin-96Ca) (Tyrosine kinase receptor HD-14) Drosophila melanogaster (Fruit fly) GO:0004713; GO:0004714; GO:0005509; GO:0005524; GO:0005886; GO:0006468; GO:0007030; GO:0007156; GO:0007169; GO:0016339; GO:0042060; GO:0043235; GO:0045177; GO:0045792; GO:0051897; GO:0090303 calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; Golgi organization [GO:0007030]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell size [GO:0045792]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of wound healing [GO:0090303]; protein phosphorylation [GO:0006468]; wound healing [GO:0042060] apical part of cell [GO:0045177]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; protein tyrosine kinase activity [GO:0004713]; transmembrane receptor protein tyrosine kinase activity [GO:0004714] g16163.t1 Q5PQS6 44.697 132 5.39e-28 110.0 sp|Q5PQS6|SMG9_RAT Nonsense-mediated mRNA decay factor SMG9 OS=Rattus norvegicus OX=10116 GN=Smg9 PE=1 SV=1 SMG9_RAT reviewed Nonsense-mediated mRNA decay factor SMG9 Rattus norvegicus (Rat) GO:0000184; GO:0001654; GO:0001701; GO:0007420; GO:0007507; GO:0042802; GO:0043066 brain development [GO:0007420]; eye development [GO:0001654]; heart development [GO:0007507]; in utero embryonic development [GO:0001701]; negative regulation of apoptotic process [GO:0043066]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184] identical protein binding [GO:0042802] g16164.t1 B5X165 44.498 209 4.43e-49 175.0 sp|B5X165|SMG9_SALSA Nonsense-mediated mRNA decay factor SMG9 OS=Salmo salar OX=8030 GN=smg9 PE=2 SV=1 g16164.t2 B5X165 44.498 209 3.45e-49 176.0 sp|B5X165|SMG9_SALSA Nonsense-mediated mRNA decay factor SMG9 OS=Salmo salar OX=8030 GN=smg9 PE=2 SV=1 g16166.t1 E1BD59 25.0 348 1.27e-28 124.0 sp|E1BD59|TRI56_BOVIN E3 ubiquitin-protein ligase TRIM56 OS=Bos taurus OX=9913 GN=TRIM56 PE=2 SV=1 TRI56_BOVIN reviewed E3 ubiquitin-protein ligase TRIM56 (EC 2.3.2.27) (Tripartite motif-containing protein 56) Bos taurus (Bovine) GO:0005654; GO:0005737; GO:0006513; GO:0008270; GO:0032728; GO:0034340; GO:0045087; GO:0051607; GO:0060340; GO:0061630; GO:0070534 defense response to virus [GO:0051607]; innate immune response [GO:0045087]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of type I interferon-mediated signaling pathway [GO:0060340]; protein K63-linked ubiquitination [GO:0070534]; protein monoubiquitination [GO:0006513]; response to type I interferon [GO:0034340] cytoplasm [GO:0005737]; nucleoplasm [GO:0005654] ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] g16167.t1 Q06546 42.677 396 7.979999999999999e-94 293.0 sp|Q06546|GABPA_HUMAN GA-binding protein alpha chain OS=Homo sapiens OX=9606 GN=GABPA PE=1 SV=1 GABPA_HUMAN reviewed GA-binding protein alpha chain (GABP subunit alpha) (Nuclear respiratory factor 2 subunit alpha) (Transcription factor E4TF1-60) Homo sapiens (Human) GO:0000122; GO:0000785; GO:0000976; GO:0000978; GO:0000981; GO:0001228; GO:0001825; GO:0003682; GO:0003700; GO:0005634; GO:0005654; GO:0006357; GO:0030154; GO:0045653; GO:0045944; GO:1990837 blastocyst formation [GO:0001825]; cell differentiation [GO:0030154]; negative regulation of megakaryocyte differentiation [GO:0045653]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976] g16168.t1 Q8BX09 67.857 504 0.0 626.0 sp|Q8BX09|RBBP5_MOUSE Retinoblastoma-binding protein 5 OS=Mus musculus OX=10090 GN=Rbbp5 PE=1 SV=2 RBBP5_MOUSE reviewed Retinoblastoma-binding protein 5 (RBBP-5) Mus musculus (Mouse) GO:0000976; GO:0005634; GO:0005654; GO:0005730; GO:0006974; GO:0010467; GO:0035097; GO:0042393; GO:0043627; GO:0044665; GO:0044666; GO:0045815; GO:0048188; GO:0071339 DNA damage response [GO:0006974]; gene expression [GO:0010467]; response to estrogen [GO:0043627]; transcription initiation-coupled chromatin remodeling [GO:0045815] histone methyltransferase complex [GO:0035097]; MLL1 complex [GO:0071339]; MLL1/2 complex [GO:0044665]; MLL3/4 complex [GO:0044666]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Set1C/COMPASS complex [GO:0048188] histone binding [GO:0042393]; transcription cis-regulatory region binding [GO:0000976] g16169.t1 O18638 49.282 209 2.93e-65 206.0 sp|O18638|OAF_DROVI Out at first protein OS=Drosophila virilis OX=7244 GN=oaf PE=3 SV=1 g16170.t1 P47955 73.016 63 2.74e-26 97.1 sp|P47955|RLA1_MOUSE Large ribosomal subunit protein P1 OS=Mus musculus OX=10090 GN=Rplp1 PE=1 SV=1 RLA1_MOUSE reviewed Large ribosomal subunit protein P1 (60S acidic ribosomal protein P1) Mus musculus (Mouse) GO:0002181; GO:0003735; GO:0005737; GO:0005829; GO:0005840; GO:0006414; GO:0006417; GO:0022625; GO:0022626; GO:0030295; GO:0043021; GO:0045202; GO:0098794 cytoplasmic translation [GO:0002181]; regulation of translation [GO:0006417]; translational elongation [GO:0006414] cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; postsynapse [GO:0098794]; ribosome [GO:0005840]; synapse [GO:0045202] protein kinase activator activity [GO:0030295]; ribonucleoprotein complex binding [GO:0043021]; structural constituent of ribosome [GO:0003735] g16171.t1 Q6ZSM3 29.241 448 1.73e-50 182.0 sp|Q6ZSM3|MOT12_HUMAN Monocarboxylate transporter 12 OS=Homo sapiens OX=9606 GN=SLC16A12 PE=1 SV=3 MOT12_HUMAN reviewed Monocarboxylate transporter 12 (MCT 12) (Creatine transporter 2) (CRT2) (Solute carrier family 16 member 12) Homo sapiens (Human) GO:0005308; GO:0005886; GO:0015292; GO:0015881; GO:0016323; GO:0022857; GO:0046449; GO:0150104 creatine transmembrane transport [GO:0015881]; creatinine metabolic process [GO:0046449]; transport across blood-brain barrier [GO:0150104] basolateral plasma membrane [GO:0016323]; plasma membrane [GO:0005886] creatine transmembrane transporter activity [GO:0005308]; transmembrane transporter activity [GO:0022857]; uniporter activity [GO:0015292] g16172.t1 P31646 48.904 593 0.0 538.0 sp|P31646|S6A13_RAT Sodium- and chloride-dependent GABA transporter 2 OS=Rattus norvegicus OX=10116 GN=Slc6a13 PE=1 SV=1 S6A13_RAT reviewed Sodium- and chloride-dependent GABA transporter 2 (GAT-2) (Solute carrier family 6 member 13) Rattus norvegicus (Rat) GO:0005283; GO:0005308; GO:0005332; GO:0005369; GO:0005886; GO:0006836; GO:0006865; GO:0008028; GO:0015171; GO:0015185; GO:0015718; GO:0015734; GO:0015881; GO:0016323; GO:0016597; GO:0035725; GO:0042995; GO:0051939; GO:0089718 amino acid import across plasma membrane [GO:0089718]; amino acid transport [GO:0006865]; creatine transmembrane transport [GO:0015881]; gamma-aminobutyric acid import [GO:0051939]; monocarboxylic acid transport [GO:0015718]; neurotransmitter transport [GO:0006836]; sodium ion transmembrane transport [GO:0035725]; taurine transmembrane transport [GO:0015734] basolateral plasma membrane [GO:0016323]; cell projection [GO:0042995]; plasma membrane [GO:0005886] amino acid binding [GO:0016597]; amino acid transmembrane transporter activity [GO:0015171]; amino acid:sodium symporter activity [GO:0005283]; creatine transmembrane transporter activity [GO:0005308]; gamma-aminobutyric acid transmembrane transporter activity [GO:0015185]; gamma-aminobutyric acid:sodium:chloride symporter activity [GO:0005332]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; taurine:sodium symporter activity [GO:0005369] g16173.t1 Q5U2M6 62.312 398 0.0 533.0 sp|Q5U2M6|DCAF8_RAT DDB1- and CUL4-associated factor 8 OS=Rattus norvegicus OX=10116 GN=Dcaf8 PE=1 SV=1 g16175.t1 Q02960 37.931 116 2.78e-22 87.4 sp|Q02960|MIF_CHICK Macrophage migration inhibitory factor OS=Gallus gallus OX=9031 GN=MIF PE=3 SV=3 g16183.t1 O75899 26.04 553 3.31e-40 160.0 sp|O75899|GABR2_HUMAN Gamma-aminobutyric acid type B receptor subunit 2 OS=Homo sapiens OX=9606 GN=GABBR2 PE=1 SV=1 GABR2_HUMAN reviewed Gamma-aminobutyric acid type B receptor subunit 2 (GABA-B receptor 2) (GABA-B-R2) (GABA-BR2) (GABABR2) (Gb2) (G-protein coupled receptor 51) (HG20) Homo sapiens (Human) GO:0004888; GO:0004965; GO:0005737; GO:0005886; GO:0007186; GO:0007193; GO:0007194; GO:0007214; GO:0007268; GO:0038039; GO:0043005; GO:0045211; GO:0046982; GO:0051932; GO:0150099; GO:1902710; GO:1902712 adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; chemical synaptic transmission [GO:0007268]; G protein-coupled receptor signaling pathway [GO:0007186]; gamma-aminobutyric acid signaling pathway [GO:0007214]; negative regulation of adenylate cyclase activity [GO:0007194]; neuron-glial cell signaling [GO:0150099]; synaptic transmission, GABAergic [GO:0051932] cytoplasm [GO:0005737]; G protein-coupled GABA receptor complex [GO:1902712]; G protein-coupled receptor heterodimeric complex [GO:0038039]; GABA receptor complex [GO:1902710]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211] G protein-coupled GABA receptor activity [GO:0004965]; protein heterodimerization activity [GO:0046982]; transmembrane signaling receptor activity [GO:0004888] g16186.t1 Q07864 69.759 830 0.0 1162.0 sp|Q07864|DPOE1_HUMAN DNA polymerase epsilon catalytic subunit A OS=Homo sapiens OX=9606 GN=POLE PE=1 SV=5 DPOE1_HUMAN reviewed DNA polymerase epsilon catalytic subunit A (EC 2.7.7.7) (3'-5' exodeoxyribonuclease) (EC 3.1.11.-) (DNA polymerase II subunit A) Homo sapiens (Human) GO:0000082; GO:0000166; GO:0000278; GO:0000731; GO:0003677; GO:0003682; GO:0003887; GO:0005634; GO:0005654; GO:0005886; GO:0006260; GO:0006261; GO:0006272; GO:0006287; GO:0006297; GO:0008270; GO:0008310; GO:0008622; GO:0045004; GO:0048568; GO:0051539 base-excision repair, gap-filling [GO:0006287]; DNA replication [GO:0006260]; DNA replication proofreading [GO:0045004]; DNA synthesis involved in DNA repair [GO:0000731]; DNA-templated DNA replication [GO:0006261]; embryonic organ development [GO:0048568]; G1/S transition of mitotic cell cycle [GO:0000082]; leading strand elongation [GO:0006272]; mitotic cell cycle [GO:0000278]; nucleotide-excision repair, DNA gap filling [GO:0006297] epsilon DNA polymerase complex [GO:0008622]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886] 4 iron, 4 sulfur cluster binding [GO:0051539]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; nucleotide binding [GO:0000166]; single-stranded DNA 3'-5' DNA exonuclease activity [GO:0008310]; zinc ion binding [GO:0008270] g16187.t1 Q07864 75.516 339 1.74e-168 523.0 sp|Q07864|DPOE1_HUMAN DNA polymerase epsilon catalytic subunit A OS=Homo sapiens OX=9606 GN=POLE PE=1 SV=5 DPOE1_HUMAN reviewed DNA polymerase epsilon catalytic subunit A (EC 2.7.7.7) (3'-5' exodeoxyribonuclease) (EC 3.1.11.-) (DNA polymerase II subunit A) Homo sapiens (Human) GO:0000082; GO:0000166; GO:0000278; GO:0000731; GO:0003677; GO:0003682; GO:0003887; GO:0005634; GO:0005654; GO:0005886; GO:0006260; GO:0006261; GO:0006272; GO:0006287; GO:0006297; GO:0008270; GO:0008310; GO:0008622; GO:0045004; GO:0048568; GO:0051539 base-excision repair, gap-filling [GO:0006287]; DNA replication [GO:0006260]; DNA replication proofreading [GO:0045004]; DNA synthesis involved in DNA repair [GO:0000731]; DNA-templated DNA replication [GO:0006261]; embryonic organ development [GO:0048568]; G1/S transition of mitotic cell cycle [GO:0000082]; leading strand elongation [GO:0006272]; mitotic cell cycle [GO:0000278]; nucleotide-excision repair, DNA gap filling [GO:0006297] epsilon DNA polymerase complex [GO:0008622]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886] 4 iron, 4 sulfur cluster binding [GO:0051539]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; nucleotide binding [GO:0000166]; single-stranded DNA 3'-5' DNA exonuclease activity [GO:0008310]; zinc ion binding [GO:0008270] g16188.t1 Q07864 63.758 149 8.26e-57 194.0 sp|Q07864|DPOE1_HUMAN DNA polymerase epsilon catalytic subunit A OS=Homo sapiens OX=9606 GN=POLE PE=1 SV=5 DPOE1_HUMAN reviewed DNA polymerase epsilon catalytic subunit A (EC 2.7.7.7) (3'-5' exodeoxyribonuclease) (EC 3.1.11.-) (DNA polymerase II subunit A) Homo sapiens (Human) GO:0000082; GO:0000166; GO:0000278; GO:0000731; GO:0003677; GO:0003682; GO:0003887; GO:0005634; GO:0005654; GO:0005886; GO:0006260; GO:0006261; GO:0006272; GO:0006287; GO:0006297; GO:0008270; GO:0008310; GO:0008622; GO:0045004; GO:0048568; GO:0051539 base-excision repair, gap-filling [GO:0006287]; DNA replication [GO:0006260]; DNA replication proofreading [GO:0045004]; DNA synthesis involved in DNA repair [GO:0000731]; DNA-templated DNA replication [GO:0006261]; embryonic organ development [GO:0048568]; G1/S transition of mitotic cell cycle [GO:0000082]; leading strand elongation [GO:0006272]; mitotic cell cycle [GO:0000278]; nucleotide-excision repair, DNA gap filling [GO:0006297] epsilon DNA polymerase complex [GO:0008622]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886] 4 iron, 4 sulfur cluster binding [GO:0051539]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; nucleotide binding [GO:0000166]; single-stranded DNA 3'-5' DNA exonuclease activity [GO:0008310]; zinc ion binding [GO:0008270] g16189.t1 Q9WVF7 51.533 848 0.0 896.0 sp|Q9WVF7|DPOE1_MOUSE DNA polymerase epsilon catalytic subunit A OS=Mus musculus OX=10090 GN=Pole PE=1 SV=3 g16191.t1 Q9PTN2 41.284 109 3.22e-22 102.0 sp|Q9PTN2|VDRA_DANRE Vitamin D3 receptor A OS=Danio rerio OX=7955 GN=vdra PE=1 SV=2 g16192.t1 Q63504 32.934 167 3.7799999999999994e-23 99.4 sp|Q63504|NR1D2_RAT Nuclear receptor subfamily 1 group D member 2 OS=Rattus norvegicus OX=10116 GN=Nr1d2 PE=2 SV=1 NR1D2_RAT reviewed Nuclear receptor subfamily 1 group D member 2 (EAR4) (Rev-erb-beta) Rattus norvegicus (Rat) GO:0000122; GO:0000978; GO:0000987; GO:0001227; GO:0003677; GO:0003700; GO:0004879; GO:0005634; GO:0005654; GO:0005737; GO:0006355; GO:0008270; GO:0009755; GO:0019216; GO:0030154; GO:0030522; GO:0042752; GO:0045892; GO:0045893; GO:0045944; GO:0048512; GO:0050727; GO:0050728; GO:0055088; GO:0097009; GO:1990837; GO:2001014 cell differentiation [GO:0030154]; circadian behavior [GO:0048512]; energy homeostasis [GO:0097009]; hormone-mediated signaling pathway [GO:0009755]; intracellular receptor signaling pathway [GO:0030522]; lipid homeostasis [GO:0055088]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of inflammatory response [GO:0050728]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of circadian rhythm [GO:0042752]; regulation of DNA-templated transcription [GO:0006355]; regulation of inflammatory response [GO:0050727]; regulation of lipid metabolic process [GO:0019216]; regulation of skeletal muscle cell differentiation [GO:2001014] cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; nuclear receptor activity [GO:0004879]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; zinc ion binding [GO:0008270] g16193.t1 Q9UJM8 47.934 363 1.69e-114 340.0 sp|Q9UJM8|HAOX1_HUMAN 2-Hydroxyacid oxidase 1 OS=Homo sapiens OX=9606 GN=HAO1 PE=1 SV=1 g16194.t1 Q8R034 61.194 67 6.38e-25 91.3 sp|Q8R034|APC13_MOUSE Anaphase-promoting complex subunit 13 OS=Mus musculus OX=10090 GN=Anapc13 PE=3 SV=1 g16195.t1 P02269 98.947 95 3.57e-63 192.0 sp|P02269|H2A_ASTRU Histone H2A OS=Asterias rubens OX=7604 PE=1 SV=2 g16196.t1 Q9BQA5 44.665 403 1.07e-112 346.0 sp|Q9BQA5|HINFP_HUMAN Histone H4 transcription factor OS=Homo sapiens OX=9606 GN=HINFP PE=1 SV=2 HINFP_HUMAN reviewed Histone H4 transcription factor (Histone nuclear factor P) (HiNF-P) (MBD2-interacting zinc finger protein) (Methyl-CpG-binding protein 2-interacting zinc finger protein) Homo sapiens (Human) GO:0000077; GO:0000082; GO:0000976; GO:0000977; GO:0000978; GO:0000981; GO:0001227; GO:0001228; GO:0001701; GO:0003677; GO:0003682; GO:0003700; GO:0005634; GO:0005654; GO:0006281; GO:0006351; GO:0006355; GO:0006357; GO:0008270; GO:0010628; GO:0010629; GO:0015030; GO:0019899; GO:0042393; GO:0044843; GO:0045184; GO:0045445; GO:0045892; GO:0045893; GO:0045944 cell cycle G1/S phase transition [GO:0044843]; DNA damage checkpoint signaling [GO:0000077]; DNA repair [GO:0006281]; DNA-templated transcription [GO:0006351]; establishment of protein localization [GO:0045184]; G1/S transition of mitotic cell cycle [GO:0000082]; in utero embryonic development [GO:0001701]; myoblast differentiation [GO:0045445]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of gene expression [GO:0010629]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA-templated transcription [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357] Cajal body [GO:0015030]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; enzyme binding [GO:0019899]; histone binding [GO:0042393]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; transcription cis-regulatory region binding [GO:0000976]; zinc ion binding [GO:0008270] g16202.t1 Q56A55 61.75 583 0.0 697.0 sp|Q56A55|MITOS_DANRE Mitochondrial potassium channel ATP-binding subunit OS=Danio rerio OX=7955 GN=abcb8 PE=2 SV=2 MITOS_DANRE reviewed Mitochondrial potassium channel ATP-binding subunit (ATP-binding cassette sub-family B member 8, mitochondrial) (ABCB8) (Mitochondrial sulfonylurea-receptor) (MITOSUR) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005524; GO:0005739; GO:0005743; GO:0016020; GO:0016887; GO:0042626; GO:0055085; GO:0062157; GO:0071805; GO:0140359 potassium ion transmembrane transport [GO:0071805]; transmembrane transport [GO:0055085] membrane [GO:0016020]; mitochondrial ATP-gated potassium channel complex [GO:0062157]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739] ABC-type transporter activity [GO:0140359]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626] g16205.t1 Q69D48 52.745 419 6.94e-141 414.0 sp|Q69D48|RHBGA_XENLA Ammonium transporter Rh type B-A OS=Xenopus laevis OX=8355 GN=rhbg-a PE=2 SV=1 g16206.t1 O62809 46.269 134 3.1800000000000004e-35 129.0 sp|O62809|OX2R_PIG Orexin receptor type 2 OS=Sus scrofa OX=9823 GN=HCRTR2 PE=2 SV=2 g16207.t1 P56719 33.333 264 1.6e-32 127.0 sp|P56719|OX2R_RAT Orexin receptor type 2 OS=Rattus norvegicus OX=10116 GN=Hcrtr2 PE=2 SV=1 g16208.t1 Q9D8P4 48.872 133 4.899999999999999e-38 132.0 sp|Q9D8P4|RM17_MOUSE Large ribosomal subunit protein bL17m OS=Mus musculus OX=10090 GN=Mrpl17 PE=1 SV=1 g16209.t1 Q8JG30 40.136 294 2.91e-51 174.0 sp|Q8JG30|ST1B1_CHICK Sulfotransferase 1B1 OS=Gallus gallus OX=9031 GN=SULT1B1 PE=1 SV=1 g16210.t1 E9PZ19 38.168 655 3.24e-138 455.0 sp|E9PZ19|TUTLB_MOUSE Protein turtle homolog B OS=Mus musculus OX=10090 GN=Igsf9b PE=1 SV=1 TUTLB_MOUSE reviewed Protein turtle homolog B (Immunoglobulin superfamily member 9B) Mus musculus (Mouse) GO:0007156; GO:0007399; GO:0014069; GO:0019900; GO:0030425; GO:0043005; GO:0043025; GO:0045211; GO:0060077; GO:0097151; GO:0098982; GO:0099560; GO:0099629 homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; nervous system development [GO:0007399]; positive regulation of inhibitory postsynaptic potential [GO:0097151]; synaptic membrane adhesion [GO:0099560] dendrite [GO:0030425]; GABA-ergic synapse [GO:0098982]; inhibitory synapse [GO:0060077]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; postsynaptic specialization of symmetric synapse [GO:0099629] kinase binding [GO:0019900] g16212.t1 Q91WR3 37.571 700 8.130000000000001e-132 408.0 sp|Q91WR3|ASCC2_MOUSE Activating signal cointegrator 1 complex subunit 2 OS=Mus musculus OX=10090 GN=Ascc2 PE=1 SV=1 g16214.t1 Q66KL9 74.074 108 2.1699999999999998e-54 190.0 sp|Q66KL9|RBM42_XENTR RNA-binding protein 42 OS=Xenopus tropicalis OX=8364 GN=rbm42 PE=2 SV=1 g16215.t1 O75845 47.387 287 7.17e-99 295.0 sp|O75845|SC5D_HUMAN Lathosterol oxidase OS=Homo sapiens OX=9606 GN=SC5D PE=1 SV=2 g16222.t1 O00303 58.868 265 1.3e-114 337.0 sp|O00303|EIF3F_HUMAN Eukaryotic translation initiation factor 3 subunit F OS=Homo sapiens OX=9606 GN=EIF3F PE=1 SV=1 EIF3F_HUMAN reviewed Eukaryotic translation initiation factor 3 subunit F (eIF3f) (Deubiquitinating enzyme eIF3f) (EC 3.4.19.12) (Eukaryotic translation initiation factor 3 subunit 5) (eIF-3-epsilon) (eIF3 p47) Homo sapiens (Human) GO:0001732; GO:0003743; GO:0004843; GO:0005829; GO:0005852; GO:0006413; GO:0006508; GO:0016020; GO:0016282; GO:0031369; GO:0033290; GO:0042802; GO:0045202; GO:0071541; GO:0075522; GO:0140492 formation of cytoplasmic translation initiation complex [GO:0001732]; IRES-dependent viral translational initiation [GO:0075522]; proteolysis [GO:0006508]; translational initiation [GO:0006413] cytosol [GO:0005829]; eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; eukaryotic translation initiation factor 3 complex, eIF3m [GO:0071541]; membrane [GO:0016020]; synapse [GO:0045202] cysteine-type deubiquitinase activity [GO:0004843]; identical protein binding [GO:0042802]; metal-dependent deubiquitinase activity [GO:0140492]; translation initiation factor activity [GO:0003743]; translation initiation factor binding [GO:0031369] g16223.t1 A7RR34 47.368 171 1.76e-41 139.0 sp|A7RR34|FLTOP_NEMVE Protein Flattop homolog OS=Nematostella vectensis OX=45351 GN=v1g200856 PE=3 SV=1 g16224.t1 P46530 31.136 1365 2.07e-87 324.0 sp|P46530|NOTC1_DANRE Neurogenic locus notch homolog protein 1 OS=Danio rerio OX=7955 GN=notch1a PE=2 SV=1 NOTC1_DANRE reviewed Neurogenic locus notch homolog protein 1 (Notch 1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001525; GO:0001756; GO:0001840; GO:0002244; GO:0005112; GO:0005509; GO:0005634; GO:0005886; GO:0006355; GO:0007219; GO:0007368; GO:0009952; GO:0021514; GO:0021523; GO:0021531; GO:0021986; GO:0031016; GO:0031017; GO:0035907; GO:0038023; GO:0042663; GO:0048259; GO:0048337; GO:0048699; GO:0048936; GO:0050768; GO:0055016; GO:0060218; GO:0060271; GO:0061314; GO:1901222 angiogenesis [GO:0001525]; anterior/posterior pattern specification [GO:0009952]; cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; dorsal aorta development [GO:0035907]; exocrine pancreas development [GO:0031017]; generation of neurons [GO:0048699]; habenula development [GO:0021986]; hematopoietic progenitor cell differentiation [GO:0002244]; hematopoietic stem cell differentiation [GO:0060218]; hypochord development [GO:0055016]; negative regulation of neurogenesis [GO:0050768]; neural plate development [GO:0001840]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; pancreas development [GO:0031016]; peripheral nervous system neuron axonogenesis [GO:0048936]; positive regulation of mesodermal cell fate specification [GO:0048337]; regulation of DNA-templated transcription [GO:0006355]; regulation of endodermal cell fate specification [GO:0042663]; regulation of non-canonical NF-kappaB signal transduction [GO:1901222]; regulation of receptor-mediated endocytosis [GO:0048259]; somatic motor neuron differentiation [GO:0021523]; somitogenesis [GO:0001756]; spinal cord radial glial cell differentiation [GO:0021531]; ventral spinal cord interneuron differentiation [GO:0021514] nucleus [GO:0005634]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; Notch binding [GO:0005112]; signaling receptor activity [GO:0038023] g16224.t1 P46530 29.1 1378 1.7e-66 255.0 sp|P46530|NOTC1_DANRE Neurogenic locus notch homolog protein 1 OS=Danio rerio OX=7955 GN=notch1a PE=2 SV=1 NOTC1_DANRE reviewed Neurogenic locus notch homolog protein 1 (Notch 1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001525; GO:0001756; GO:0001840; GO:0002244; GO:0005112; GO:0005509; GO:0005634; GO:0005886; GO:0006355; GO:0007219; GO:0007368; GO:0009952; GO:0021514; GO:0021523; GO:0021531; GO:0021986; GO:0031016; GO:0031017; GO:0035907; GO:0038023; GO:0042663; GO:0048259; GO:0048337; GO:0048699; GO:0048936; GO:0050768; GO:0055016; GO:0060218; GO:0060271; GO:0061314; GO:1901222 angiogenesis [GO:0001525]; anterior/posterior pattern specification [GO:0009952]; cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; dorsal aorta development [GO:0035907]; exocrine pancreas development [GO:0031017]; generation of neurons [GO:0048699]; habenula development [GO:0021986]; hematopoietic progenitor cell differentiation [GO:0002244]; hematopoietic stem cell differentiation [GO:0060218]; hypochord development [GO:0055016]; negative regulation of neurogenesis [GO:0050768]; neural plate development [GO:0001840]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; pancreas development [GO:0031016]; peripheral nervous system neuron axonogenesis [GO:0048936]; positive regulation of mesodermal cell fate specification [GO:0048337]; regulation of DNA-templated transcription [GO:0006355]; regulation of endodermal cell fate specification [GO:0042663]; regulation of non-canonical NF-kappaB signal transduction [GO:1901222]; regulation of receptor-mediated endocytosis [GO:0048259]; somatic motor neuron differentiation [GO:0021523]; somitogenesis [GO:0001756]; spinal cord radial glial cell differentiation [GO:0021531]; ventral spinal cord interneuron differentiation [GO:0021514] nucleus [GO:0005634]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; Notch binding [GO:0005112]; signaling receptor activity [GO:0038023] g16224.t1 P46530 29.17 1313 1.85e-62 242.0 sp|P46530|NOTC1_DANRE Neurogenic locus notch homolog protein 1 OS=Danio rerio OX=7955 GN=notch1a PE=2 SV=1 NOTC1_DANRE reviewed Neurogenic locus notch homolog protein 1 (Notch 1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001525; GO:0001756; GO:0001840; GO:0002244; GO:0005112; GO:0005509; GO:0005634; GO:0005886; GO:0006355; GO:0007219; GO:0007368; GO:0009952; GO:0021514; GO:0021523; GO:0021531; GO:0021986; GO:0031016; GO:0031017; GO:0035907; GO:0038023; GO:0042663; GO:0048259; GO:0048337; GO:0048699; GO:0048936; GO:0050768; GO:0055016; GO:0060218; GO:0060271; GO:0061314; GO:1901222 angiogenesis [GO:0001525]; anterior/posterior pattern specification [GO:0009952]; cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; dorsal aorta development [GO:0035907]; exocrine pancreas development [GO:0031017]; generation of neurons [GO:0048699]; habenula development [GO:0021986]; hematopoietic progenitor cell differentiation [GO:0002244]; hematopoietic stem cell differentiation [GO:0060218]; hypochord development [GO:0055016]; negative regulation of neurogenesis [GO:0050768]; neural plate development [GO:0001840]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; pancreas development [GO:0031016]; peripheral nervous system neuron axonogenesis [GO:0048936]; positive regulation of mesodermal cell fate specification [GO:0048337]; regulation of DNA-templated transcription [GO:0006355]; regulation of endodermal cell fate specification [GO:0042663]; regulation of non-canonical NF-kappaB signal transduction [GO:1901222]; regulation of receptor-mediated endocytosis [GO:0048259]; somatic motor neuron differentiation [GO:0021523]; somitogenesis [GO:0001756]; spinal cord radial glial cell differentiation [GO:0021531]; ventral spinal cord interneuron differentiation [GO:0021514] nucleus [GO:0005634]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; Notch binding [GO:0005112]; signaling receptor activity [GO:0038023] g16224.t1 P46530 28.181 1061 3.55e-44 182.0 sp|P46530|NOTC1_DANRE Neurogenic locus notch homolog protein 1 OS=Danio rerio OX=7955 GN=notch1a PE=2 SV=1 NOTC1_DANRE reviewed Neurogenic locus notch homolog protein 1 (Notch 1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001525; GO:0001756; GO:0001840; GO:0002244; GO:0005112; GO:0005509; GO:0005634; GO:0005886; GO:0006355; GO:0007219; GO:0007368; GO:0009952; GO:0021514; GO:0021523; GO:0021531; GO:0021986; GO:0031016; GO:0031017; GO:0035907; GO:0038023; GO:0042663; GO:0048259; GO:0048337; GO:0048699; GO:0048936; GO:0050768; GO:0055016; GO:0060218; GO:0060271; GO:0061314; GO:1901222 angiogenesis [GO:0001525]; anterior/posterior pattern specification [GO:0009952]; cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; dorsal aorta development [GO:0035907]; exocrine pancreas development [GO:0031017]; generation of neurons [GO:0048699]; habenula development [GO:0021986]; hematopoietic progenitor cell differentiation [GO:0002244]; hematopoietic stem cell differentiation [GO:0060218]; hypochord development [GO:0055016]; negative regulation of neurogenesis [GO:0050768]; neural plate development [GO:0001840]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; pancreas development [GO:0031016]; peripheral nervous system neuron axonogenesis [GO:0048936]; positive regulation of mesodermal cell fate specification [GO:0048337]; regulation of DNA-templated transcription [GO:0006355]; regulation of endodermal cell fate specification [GO:0042663]; regulation of non-canonical NF-kappaB signal transduction [GO:1901222]; regulation of receptor-mediated endocytosis [GO:0048259]; somatic motor neuron differentiation [GO:0021523]; somitogenesis [GO:0001756]; spinal cord radial glial cell differentiation [GO:0021531]; ventral spinal cord interneuron differentiation [GO:0021514] nucleus [GO:0005634]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; Notch binding [GO:0005112]; signaling receptor activity [GO:0038023] g16224.t2 P46530 31.136 1365 2.18e-87 324.0 sp|P46530|NOTC1_DANRE Neurogenic locus notch homolog protein 1 OS=Danio rerio OX=7955 GN=notch1a PE=2 SV=1 NOTC1_DANRE reviewed Neurogenic locus notch homolog protein 1 (Notch 1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001525; GO:0001756; GO:0001840; GO:0002244; GO:0005112; GO:0005509; GO:0005634; GO:0005886; GO:0006355; GO:0007219; GO:0007368; GO:0009952; GO:0021514; GO:0021523; GO:0021531; GO:0021986; GO:0031016; GO:0031017; GO:0035907; GO:0038023; GO:0042663; GO:0048259; GO:0048337; GO:0048699; GO:0048936; GO:0050768; GO:0055016; GO:0060218; GO:0060271; GO:0061314; GO:1901222 angiogenesis [GO:0001525]; anterior/posterior pattern specification [GO:0009952]; cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; dorsal aorta development [GO:0035907]; exocrine pancreas development [GO:0031017]; generation of neurons [GO:0048699]; habenula development [GO:0021986]; hematopoietic progenitor cell differentiation [GO:0002244]; hematopoietic stem cell differentiation [GO:0060218]; hypochord development [GO:0055016]; negative regulation of neurogenesis [GO:0050768]; neural plate development [GO:0001840]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; pancreas development [GO:0031016]; peripheral nervous system neuron axonogenesis [GO:0048936]; positive regulation of mesodermal cell fate specification [GO:0048337]; regulation of DNA-templated transcription [GO:0006355]; regulation of endodermal cell fate specification [GO:0042663]; regulation of non-canonical NF-kappaB signal transduction [GO:1901222]; regulation of receptor-mediated endocytosis [GO:0048259]; somatic motor neuron differentiation [GO:0021523]; somitogenesis [GO:0001756]; spinal cord radial glial cell differentiation [GO:0021531]; ventral spinal cord interneuron differentiation [GO:0021514] nucleus [GO:0005634]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; Notch binding [GO:0005112]; signaling receptor activity [GO:0038023] g16224.t2 P46530 29.1 1378 1.7700000000000001e-66 255.0 sp|P46530|NOTC1_DANRE Neurogenic locus notch homolog protein 1 OS=Danio rerio OX=7955 GN=notch1a PE=2 SV=1 NOTC1_DANRE reviewed Neurogenic locus notch homolog protein 1 (Notch 1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001525; GO:0001756; GO:0001840; GO:0002244; GO:0005112; GO:0005509; GO:0005634; GO:0005886; GO:0006355; GO:0007219; GO:0007368; GO:0009952; GO:0021514; GO:0021523; GO:0021531; GO:0021986; GO:0031016; GO:0031017; GO:0035907; GO:0038023; GO:0042663; GO:0048259; GO:0048337; GO:0048699; GO:0048936; GO:0050768; GO:0055016; GO:0060218; GO:0060271; GO:0061314; GO:1901222 angiogenesis [GO:0001525]; anterior/posterior pattern specification [GO:0009952]; cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; dorsal aorta development [GO:0035907]; exocrine pancreas development [GO:0031017]; generation of neurons [GO:0048699]; habenula development [GO:0021986]; hematopoietic progenitor cell differentiation [GO:0002244]; hematopoietic stem cell differentiation [GO:0060218]; hypochord development [GO:0055016]; negative regulation of neurogenesis [GO:0050768]; neural plate development [GO:0001840]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; pancreas development [GO:0031016]; peripheral nervous system neuron axonogenesis [GO:0048936]; positive regulation of mesodermal cell fate specification [GO:0048337]; regulation of DNA-templated transcription [GO:0006355]; regulation of endodermal cell fate specification [GO:0042663]; regulation of non-canonical NF-kappaB signal transduction [GO:1901222]; regulation of receptor-mediated endocytosis [GO:0048259]; somatic motor neuron differentiation [GO:0021523]; somitogenesis [GO:0001756]; spinal cord radial glial cell differentiation [GO:0021531]; ventral spinal cord interneuron differentiation [GO:0021514] nucleus [GO:0005634]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; Notch binding [GO:0005112]; signaling receptor activity [GO:0038023] g16224.t2 P46530 29.17 1313 1.92e-62 242.0 sp|P46530|NOTC1_DANRE Neurogenic locus notch homolog protein 1 OS=Danio rerio OX=7955 GN=notch1a PE=2 SV=1 NOTC1_DANRE reviewed Neurogenic locus notch homolog protein 1 (Notch 1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001525; GO:0001756; GO:0001840; GO:0002244; GO:0005112; GO:0005509; GO:0005634; GO:0005886; GO:0006355; GO:0007219; GO:0007368; GO:0009952; GO:0021514; GO:0021523; GO:0021531; GO:0021986; GO:0031016; GO:0031017; GO:0035907; GO:0038023; GO:0042663; GO:0048259; GO:0048337; GO:0048699; GO:0048936; GO:0050768; GO:0055016; GO:0060218; GO:0060271; GO:0061314; GO:1901222 angiogenesis [GO:0001525]; anterior/posterior pattern specification [GO:0009952]; cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; dorsal aorta development [GO:0035907]; exocrine pancreas development [GO:0031017]; generation of neurons [GO:0048699]; habenula development [GO:0021986]; hematopoietic progenitor cell differentiation [GO:0002244]; hematopoietic stem cell differentiation [GO:0060218]; hypochord development [GO:0055016]; negative regulation of neurogenesis [GO:0050768]; neural plate development [GO:0001840]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; pancreas development [GO:0031016]; peripheral nervous system neuron axonogenesis [GO:0048936]; positive regulation of mesodermal cell fate specification [GO:0048337]; regulation of DNA-templated transcription [GO:0006355]; regulation of endodermal cell fate specification [GO:0042663]; regulation of non-canonical NF-kappaB signal transduction [GO:1901222]; regulation of receptor-mediated endocytosis [GO:0048259]; somatic motor neuron differentiation [GO:0021523]; somitogenesis [GO:0001756]; spinal cord radial glial cell differentiation [GO:0021531]; ventral spinal cord interneuron differentiation [GO:0021514] nucleus [GO:0005634]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; Notch binding [GO:0005112]; signaling receptor activity [GO:0038023] g16224.t2 P46530 28.181 1061 3.65e-44 182.0 sp|P46530|NOTC1_DANRE Neurogenic locus notch homolog protein 1 OS=Danio rerio OX=7955 GN=notch1a PE=2 SV=1 NOTC1_DANRE reviewed Neurogenic locus notch homolog protein 1 (Notch 1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001525; GO:0001756; GO:0001840; GO:0002244; GO:0005112; GO:0005509; GO:0005634; GO:0005886; GO:0006355; GO:0007219; GO:0007368; GO:0009952; GO:0021514; GO:0021523; GO:0021531; GO:0021986; GO:0031016; GO:0031017; GO:0035907; GO:0038023; GO:0042663; GO:0048259; GO:0048337; GO:0048699; GO:0048936; GO:0050768; GO:0055016; GO:0060218; GO:0060271; GO:0061314; GO:1901222 angiogenesis [GO:0001525]; anterior/posterior pattern specification [GO:0009952]; cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; dorsal aorta development [GO:0035907]; exocrine pancreas development [GO:0031017]; generation of neurons [GO:0048699]; habenula development [GO:0021986]; hematopoietic progenitor cell differentiation [GO:0002244]; hematopoietic stem cell differentiation [GO:0060218]; hypochord development [GO:0055016]; negative regulation of neurogenesis [GO:0050768]; neural plate development [GO:0001840]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; pancreas development [GO:0031016]; peripheral nervous system neuron axonogenesis [GO:0048936]; positive regulation of mesodermal cell fate specification [GO:0048337]; regulation of DNA-templated transcription [GO:0006355]; regulation of endodermal cell fate specification [GO:0042663]; regulation of non-canonical NF-kappaB signal transduction [GO:1901222]; regulation of receptor-mediated endocytosis [GO:0048259]; somatic motor neuron differentiation [GO:0021523]; somitogenesis [GO:0001756]; spinal cord radial glial cell differentiation [GO:0021531]; ventral spinal cord interneuron differentiation [GO:0021514] nucleus [GO:0005634]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; Notch binding [GO:0005112]; signaling receptor activity [GO:0038023] g16226.t1 Q9IBG7 36.72 689 1.43e-123 408.0 sp|Q9IBG7|KCP_XENLA Kielin/chordin-like protein OS=Xenopus laevis OX=8355 GN=kcp PE=2 SV=1 g16226.t1 Q9IBG7 32.733 333 4.42e-33 140.0 sp|Q9IBG7|KCP_XENLA Kielin/chordin-like protein OS=Xenopus laevis OX=8355 GN=kcp PE=2 SV=1 g16226.t1 Q9IBG7 33.234 334 5.11e-30 131.0 sp|Q9IBG7|KCP_XENLA Kielin/chordin-like protein OS=Xenopus laevis OX=8355 GN=kcp PE=2 SV=1 g16226.t1 Q9IBG7 31.755 359 1.9500000000000002e-29 129.0 sp|Q9IBG7|KCP_XENLA Kielin/chordin-like protein OS=Xenopus laevis OX=8355 GN=kcp PE=2 SV=1 g16226.t1 Q9IBG7 31.339 351 3.7100000000000005e-27 122.0 sp|Q9IBG7|KCP_XENLA Kielin/chordin-like protein OS=Xenopus laevis OX=8355 GN=kcp PE=2 SV=1 g16226.t1 Q9IBG7 31.686 344 1.02e-26 120.0 sp|Q9IBG7|KCP_XENLA Kielin/chordin-like protein OS=Xenopus laevis OX=8355 GN=kcp PE=2 SV=1 g16226.t1 Q9IBG7 31.544 298 1.12e-26 120.0 sp|Q9IBG7|KCP_XENLA Kielin/chordin-like protein OS=Xenopus laevis OX=8355 GN=kcp PE=2 SV=1 g16226.t1 Q9IBG7 28.241 432 5.430000000000001e-26 118.0 sp|Q9IBG7|KCP_XENLA Kielin/chordin-like protein OS=Xenopus laevis OX=8355 GN=kcp PE=2 SV=1 g16226.t1 Q9IBG7 28.134 359 4.44e-25 115.0 sp|Q9IBG7|KCP_XENLA Kielin/chordin-like protein OS=Xenopus laevis OX=8355 GN=kcp PE=2 SV=1 g16226.t1 Q9IBG7 31.818 330 5.519999999999999e-23 108.0 sp|Q9IBG7|KCP_XENLA Kielin/chordin-like protein OS=Xenopus laevis OX=8355 GN=kcp PE=2 SV=1 g16226.t1 Q9IBG7 27.628 409 7.949999999999999e-23 108.0 sp|Q9IBG7|KCP_XENLA Kielin/chordin-like protein OS=Xenopus laevis OX=8355 GN=kcp PE=2 SV=1 g16226.t1 Q9IBG7 30.606 330 4.07e-21 102.0 sp|Q9IBG7|KCP_XENLA Kielin/chordin-like protein OS=Xenopus laevis OX=8355 GN=kcp PE=2 SV=1 g16228.t1 Q08D62 34.682 346 1.43e-53 189.0 sp|Q08D62|MAEL_XENTR Protein maelstrom homolog OS=Xenopus tropicalis OX=8364 GN=mael PE=2 SV=1 g16268.t1 P20825 35.989 364 3.62e-66 231.0 sp|P20825|POL2_DROME Retrovirus-related Pol polyprotein from transposon 297 OS=Drosophila melanogaster OX=7227 GN=pol PE=4 SV=1 g9578.t1 Q32P12 45.714 210 9.93e-53 190.0 sp|Q32P12|HROB_MOUSE Homologous recombination OB-fold protein OS=Mus musculus OX=10090 GN=Hrob PE=1 SV=2 HROB_MOUSE reviewed Homologous recombination OB-fold protein Mus musculus (Mouse) GO:0000725; GO:0000731; GO:0003697; GO:0005634; GO:0006974; GO:0007292; GO:0036297; GO:0048232; GO:0090734 DNA damage response [GO:0006974]; DNA synthesis involved in DNA repair [GO:0000731]; female gamete generation [GO:0007292]; interstrand cross-link repair [GO:0036297]; male gamete generation [GO:0048232]; recombinational repair [GO:0000725] nucleus [GO:0005634]; site of DNA damage [GO:0090734] single-stranded DNA binding [GO:0003697] g9581.t1 Q9HD67 60.106 757 0.0 914.0 sp|Q9HD67|MYO10_HUMAN Unconventional myosin-X OS=Homo sapiens OX=9606 GN=MYO10 PE=1 SV=3 g9581.t1 Q9HD67 49.455 918 0.0 889.0 sp|Q9HD67|MYO10_HUMAN Unconventional myosin-X OS=Homo sapiens OX=9606 GN=MYO10 PE=1 SV=3 g9581.t2 Q9HD67 60.106 757 0.0 914.0 sp|Q9HD67|MYO10_HUMAN Unconventional myosin-X OS=Homo sapiens OX=9606 GN=MYO10 PE=1 SV=3 g9581.t2 Q9HD67 49.563 916 0.0 889.0 sp|Q9HD67|MYO10_HUMAN Unconventional myosin-X OS=Homo sapiens OX=9606 GN=MYO10 PE=1 SV=3 g9581.t3 Q9HD67 60.106 757 0.0 915.0 sp|Q9HD67|MYO10_HUMAN Unconventional myosin-X OS=Homo sapiens OX=9606 GN=MYO10 PE=1 SV=3 g9581.t3 Q9HD67 44.898 980 0.0 823.0 sp|Q9HD67|MYO10_HUMAN Unconventional myosin-X OS=Homo sapiens OX=9606 GN=MYO10 PE=1 SV=3 g9582.t1 Q9PW80 40.101 596 3.99e-111 347.0 sp|Q9PW80|IF2B3_DANRE Insulin-like growth factor 2 mRNA-binding protein 3 OS=Danio rerio OX=7955 GN=igf2bp3 PE=1 SV=1 IF2B3_DANRE reviewed Insulin-like growth factor 2 mRNA-binding protein 3 (IGF2 mRNA-binding protein 3) (IMP-3) (Decapentaplegic and Vg-related 1 RNA-binding protein) (IGF-II mRNA-binding protein 3) (VICKZ family member 3) (Vg1 RNA-binding protein) (Vg1-RBP) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000932; GO:0003729; GO:0003730; GO:0005634; GO:0005737; GO:0005829; GO:0006417; GO:0007281; GO:0007399; GO:0007530; GO:0008354; GO:0010494; GO:0045995; GO:0051028; GO:0070934; GO:1990247 CRD-mediated mRNA stabilization [GO:0070934]; germ cell development [GO:0007281]; germ cell migration [GO:0008354]; mRNA transport [GO:0051028]; nervous system development [GO:0007399]; regulation of embryonic development [GO:0045995]; regulation of translation [GO:0006417]; sex determination [GO:0007530] cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; nucleus [GO:0005634]; P-body [GO:0000932] mRNA 3'-UTR binding [GO:0003730]; mRNA binding [GO:0003729]; N6-methyladenosine-containing RNA reader activity [GO:1990247] g9582.t2 Q9PW80 40.034 597 2.7e-109 342.0 sp|Q9PW80|IF2B3_DANRE Insulin-like growth factor 2 mRNA-binding protein 3 OS=Danio rerio OX=7955 GN=igf2bp3 PE=1 SV=1 IF2B3_DANRE reviewed Insulin-like growth factor 2 mRNA-binding protein 3 (IGF2 mRNA-binding protein 3) (IMP-3) (Decapentaplegic and Vg-related 1 RNA-binding protein) (IGF-II mRNA-binding protein 3) (VICKZ family member 3) (Vg1 RNA-binding protein) (Vg1-RBP) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000932; GO:0003729; GO:0003730; GO:0005634; GO:0005737; GO:0005829; GO:0006417; GO:0007281; GO:0007399; GO:0007530; GO:0008354; GO:0010494; GO:0045995; GO:0051028; GO:0070934; GO:1990247 CRD-mediated mRNA stabilization [GO:0070934]; germ cell development [GO:0007281]; germ cell migration [GO:0008354]; mRNA transport [GO:0051028]; nervous system development [GO:0007399]; regulation of embryonic development [GO:0045995]; regulation of translation [GO:0006417]; sex determination [GO:0007530] cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; nucleus [GO:0005634]; P-body [GO:0000932] mRNA 3'-UTR binding [GO:0003730]; mRNA binding [GO:0003729]; N6-methyladenosine-containing RNA reader activity [GO:1990247] g9582.t3 Q9PW80 39.967 598 2.75e-109 342.0 sp|Q9PW80|IF2B3_DANRE Insulin-like growth factor 2 mRNA-binding protein 3 OS=Danio rerio OX=7955 GN=igf2bp3 PE=1 SV=1 IF2B3_DANRE reviewed Insulin-like growth factor 2 mRNA-binding protein 3 (IGF2 mRNA-binding protein 3) (IMP-3) (Decapentaplegic and Vg-related 1 RNA-binding protein) (IGF-II mRNA-binding protein 3) (VICKZ family member 3) (Vg1 RNA-binding protein) (Vg1-RBP) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000932; GO:0003729; GO:0003730; GO:0005634; GO:0005737; GO:0005829; GO:0006417; GO:0007281; GO:0007399; GO:0007530; GO:0008354; GO:0010494; GO:0045995; GO:0051028; GO:0070934; GO:1990247 CRD-mediated mRNA stabilization [GO:0070934]; germ cell development [GO:0007281]; germ cell migration [GO:0008354]; mRNA transport [GO:0051028]; nervous system development [GO:0007399]; regulation of embryonic development [GO:0045995]; regulation of translation [GO:0006417]; sex determination [GO:0007530] cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; nucleus [GO:0005634]; P-body [GO:0000932] mRNA 3'-UTR binding [GO:0003730]; mRNA binding [GO:0003729]; N6-methyladenosine-containing RNA reader activity [GO:1990247] g9583.t1 Q9NVE5 52.143 420 3.5800000000000004e-110 381.0 sp|Q9NVE5|UBP40_HUMAN Ubiquitin carboxyl-terminal hydrolase 40 OS=Homo sapiens OX=9606 GN=USP40 PE=1 SV=3 UBP40_HUMAN reviewed Ubiquitin carboxyl-terminal hydrolase 40 (EC 3.4.19.12) (Deubiquitinating enzyme 40) (Ubiquitin thioesterase 40) (Ubiquitin-specific-processing protease 40) Homo sapiens (Human) GO:0004843; GO:0005634; GO:0005737; GO:0005829; GO:0006508; GO:0016579; GO:0031647; GO:0043066 negative regulation of apoptotic process [GO:0043066]; protein deubiquitination [GO:0016579]; proteolysis [GO:0006508]; regulation of protein stability [GO:0031647] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634] cysteine-type deubiquitinase activity [GO:0004843] g9583.t1 Q9NVE5 32.561 863 1.74e-103 362.0 sp|Q9NVE5|UBP40_HUMAN Ubiquitin carboxyl-terminal hydrolase 40 OS=Homo sapiens OX=9606 GN=USP40 PE=1 SV=3 UBP40_HUMAN reviewed Ubiquitin carboxyl-terminal hydrolase 40 (EC 3.4.19.12) (Deubiquitinating enzyme 40) (Ubiquitin thioesterase 40) (Ubiquitin-specific-processing protease 40) Homo sapiens (Human) GO:0004843; GO:0005634; GO:0005737; GO:0005829; GO:0006508; GO:0016579; GO:0031647; GO:0043066 negative regulation of apoptotic process [GO:0043066]; protein deubiquitination [GO:0016579]; proteolysis [GO:0006508]; regulation of protein stability [GO:0031647] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634] cysteine-type deubiquitinase activity [GO:0004843] g9584.t1 Q5ZJU3 56.964 560 0.0 621.0 sp|Q5ZJU3|ASNS_CHICK Asparagine synthetase [glutamine-hydrolyzing] OS=Gallus gallus OX=9031 GN=ASNS PE=2 SV=3 g9586.t1 Q503Y4 54.505 222 4.48e-75 229.0 sp|Q503Y4|OVCA2_DANRE Esterase OVCA2 OS=Danio rerio OX=7955 GN=ovca2 PE=2 SV=1 g9587.t1 Q5E9J7 59.524 168 7.64e-73 221.0 sp|Q5E9J7|ADAT2_BOVIN tRNA-specific adenosine deaminase 2 OS=Bos taurus OX=9913 GN=DEADC1 PE=2 SV=1 g9588.t1 Q9D4P0 76.705 176 2.26e-101 292.0 sp|Q9D4P0|ARL5B_MOUSE ADP-ribosylation factor-like protein 5B OS=Mus musculus OX=10090 GN=Arl5b PE=2 SV=3 g9589.t1 Q9H0H5 38.179 681 8.95e-131 402.0 sp|Q9H0H5|RGAP1_HUMAN Rac GTPase-activating protein 1 OS=Homo sapiens OX=9606 GN=RACGAP1 PE=1 SV=1 RGAP1_HUMAN reviewed Rac GTPase-activating protein 1 (Male germ cell RacGap) (MgcRacGAP) (Protein CYK4 homolog) (CYK4) (HsCYK-4) Homo sapiens (Human) GO:0000281; GO:0000915; GO:0001669; GO:0005096; GO:0005547; GO:0005634; GO:0005654; GO:0005739; GO:0005819; GO:0005829; GO:0005874; GO:0006811; GO:0007266; GO:0007283; GO:0007405; GO:0008017; GO:0008270; GO:0009898; GO:0019901; GO:0030218; GO:0030496; GO:0030674; GO:0032154; GO:0032467; GO:0043014; GO:0043015; GO:0045995; GO:0048487; GO:0051056; GO:0051233; GO:0051256; GO:0051988; GO:0070062; GO:0072686; GO:0090543; GO:0097149; GO:1902358 actomyosin contractile ring assembly [GO:0000915]; erythrocyte differentiation [GO:0030218]; mitotic cytokinesis [GO:0000281]; mitotic spindle midzone assembly [GO:0051256]; monoatomic ion transport [GO:0006811]; neuroblast proliferation [GO:0007405]; positive regulation of cytokinesis [GO:0032467]; regulation of attachment of spindle microtubules to kinetochore [GO:0051988]; regulation of embryonic development [GO:0045995]; regulation of small GTPase mediated signal transduction [GO:0051056]; Rho protein signal transduction [GO:0007266]; spermatogenesis [GO:0007283]; sulfate transmembrane transport [GO:1902358] acrosomal vesicle [GO:0001669]; centralspindlin complex [GO:0097149]; cleavage furrow [GO:0032154]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; Flemming body [GO:0090543]; microtubule [GO:0005874]; midbody [GO:0030496]; mitochondrion [GO:0005739]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819]; spindle midzone [GO:0051233] alpha-tubulin binding [GO:0043014]; beta-tubulin binding [GO:0048487]; gamma-tubulin binding [GO:0043015]; GTPase activator activity [GO:0005096]; microtubule binding [GO:0008017]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; protein kinase binding [GO:0019901]; protein-macromolecule adaptor activity [GO:0030674]; zinc ion binding [GO:0008270] g9590.t1 Q25117 86.015 522 0.0 845.0 sp|Q25117|ATPB_HEMPU ATP synthase subunit beta, mitochondrial OS=Hemicentrotus pulcherrimus OX=7650 PE=2 SV=1 g9592.t1 P08183 53.834 1265 0.0 1264.0 sp|P08183|MDR1_HUMAN ATP-dependent translocase ABCB1 OS=Homo sapiens OX=9606 GN=ABCB1 PE=1 SV=3 MDR1_HUMAN reviewed ATP-dependent translocase ABCB1 (ATP-binding cassette sub-family B member 1) (Multidrug resistance protein 1) (EC 7.6.2.2) (P-glycoprotein 1) (Phospholipid transporter ABCB1) (EC 7.6.2.1) (CD antigen CD243) Homo sapiens (Human) GO:0000086; GO:0001666; GO:0001890; GO:0005524; GO:0005737; GO:0005886; GO:0006805; GO:0007565; GO:0007595; GO:0007623; GO:0008559; GO:0009410; GO:0009914; GO:0009986; GO:0015562; GO:0016020; GO:0016324; GO:0016887; GO:0022857; GO:0031526; GO:0031625; GO:0032570; GO:0033189; GO:0033280; GO:0033762; GO:0035633; GO:0036146; GO:0042626; GO:0042910; GO:0043215; GO:0045332; GO:0046686; GO:0046865; GO:0046943; GO:0050892; GO:0055085; GO:0060856; GO:0070062; GO:0070633; GO:0071217; GO:0071222; GO:0071236; GO:0071312; GO:0071356; GO:0071392; GO:0071475; GO:0071549; GO:0072089; GO:0090554; GO:0090555; GO:0097068; GO:0097305; GO:0097327; GO:0098591; GO:0099038; GO:0099040; GO:0140115; GO:0140328; GO:0140341; GO:0150104; GO:1902396; GO:1903416; GO:1904057; GO:1904148; GO:1904446; GO:1904478; GO:1905039; GO:1905231; GO:1905232; GO:1905233; GO:1905235; GO:1905237; GO:1990961; GO:1990962; GO:1990963; GO:2001025; GO:2001225 carboxylic acid transmembrane transport [GO:1905039]; cellular hyperosmotic salinity response [GO:0071475]; cellular response to alkaloid [GO:0071312]; cellular response to antibiotic [GO:0071236]; cellular response to borneol [GO:1905231]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to estradiol stimulus [GO:0071392]; cellular response to external biotic stimulus [GO:0071217]; cellular response to L-glutamate [GO:1905232]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to mycotoxin [GO:0036146]; cellular response to nonylphenol [GO:1904148]; cellular response to tumor necrosis factor [GO:0071356]; ceramide translocation [GO:0099040]; circadian rhythm [GO:0007623]; daunorubicin transport [GO:0043215]; establishment of blood-brain barrier [GO:0060856]; establishment of blood-retinal barrier [GO:1990963]; export across plasma membrane [GO:0140115]; female pregnancy [GO:0007565]; G2/M transition of mitotic cell cycle [GO:0000086]; hormone transport [GO:0009914]; intestinal absorption [GO:0050892]; lactation [GO:0007595]; maintenance of blood-brain barrier [GO:0035633]; negative regulation of sensory perception of pain [GO:1904057]; phospholipid translocation [GO:0045332]; placenta development [GO:0001890]; positive regulation of establishment of Sertoli cell barrier [GO:1904446]; positive regulation of response to drug [GO:2001025]; protein localization to bicellular tight junction [GO:1902396]; regulation of chloride transport [GO:2001225]; regulation of intestinal absorption [GO:1904478]; response to alcohol [GO:0097305]; response to antineoplastic agent [GO:0097327]; response to cadmium ion [GO:0046686]; response to codeine [GO:1905233]; response to cyclosporin A [GO:1905237]; response to glucagon [GO:0033762]; response to glycoside [GO:1903416]; response to hypoxia [GO:0001666]; response to progesterone [GO:0032570]; response to quercetin [GO:1905235]; response to thyroxine [GO:0097068]; response to vitamin A [GO:0033189]; response to vitamin D [GO:0033280]; response to xenobiotic stimulus [GO:0009410]; stem cell proliferation [GO:0072089]; terpenoid transport [GO:0046865]; transepithelial transport [GO:0070633]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104]; xenobiotic detoxification by transmembrane export across the plasma membrane [GO:1990961]; xenobiotic metabolic process [GO:0006805]; xenobiotic transport across blood-brain barrier [GO:1990962] apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; external side of apical plasma membrane [GO:0098591]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; plasma membrane [GO:0005886] ABC-type xenobiotic transporter activity [GO:0008559]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; carboxylic acid transmembrane transporter activity [GO:0046943]; ceramide floppase activity [GO:0099038]; efflux transmembrane transporter activity [GO:0015562]; floppase activity [GO:0140328]; phosphatidylcholine floppase activity [GO:0090554]; phosphatidylethanolamine flippase activity [GO:0090555]; phosphatidylethanolamine floppase activity [GO:0140341]; transmembrane transporter activity [GO:0022857]; ubiquitin protein ligase binding [GO:0031625]; xenobiotic transmembrane transporter activity [GO:0042910] g9592.t1 P08183 44.712 539 1.03e-114 393.0 sp|P08183|MDR1_HUMAN ATP-dependent translocase ABCB1 OS=Homo sapiens OX=9606 GN=ABCB1 PE=1 SV=3 MDR1_HUMAN reviewed ATP-dependent translocase ABCB1 (ATP-binding cassette sub-family B member 1) (Multidrug resistance protein 1) (EC 7.6.2.2) (P-glycoprotein 1) (Phospholipid transporter ABCB1) (EC 7.6.2.1) (CD antigen CD243) Homo sapiens (Human) GO:0000086; GO:0001666; GO:0001890; GO:0005524; GO:0005737; GO:0005886; GO:0006805; GO:0007565; GO:0007595; GO:0007623; GO:0008559; GO:0009410; GO:0009914; GO:0009986; GO:0015562; GO:0016020; GO:0016324; GO:0016887; GO:0022857; GO:0031526; GO:0031625; GO:0032570; GO:0033189; GO:0033280; GO:0033762; GO:0035633; GO:0036146; GO:0042626; GO:0042910; GO:0043215; GO:0045332; GO:0046686; GO:0046865; GO:0046943; GO:0050892; GO:0055085; GO:0060856; GO:0070062; GO:0070633; GO:0071217; GO:0071222; GO:0071236; GO:0071312; GO:0071356; GO:0071392; GO:0071475; GO:0071549; GO:0072089; GO:0090554; GO:0090555; GO:0097068; GO:0097305; GO:0097327; GO:0098591; GO:0099038; GO:0099040; GO:0140115; GO:0140328; GO:0140341; GO:0150104; GO:1902396; GO:1903416; GO:1904057; GO:1904148; GO:1904446; GO:1904478; GO:1905039; GO:1905231; GO:1905232; GO:1905233; GO:1905235; GO:1905237; GO:1990961; GO:1990962; GO:1990963; GO:2001025; GO:2001225 carboxylic acid transmembrane transport [GO:1905039]; cellular hyperosmotic salinity response [GO:0071475]; cellular response to alkaloid [GO:0071312]; cellular response to antibiotic [GO:0071236]; cellular response to borneol [GO:1905231]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to estradiol stimulus [GO:0071392]; cellular response to external biotic stimulus [GO:0071217]; cellular response to L-glutamate [GO:1905232]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to mycotoxin [GO:0036146]; cellular response to nonylphenol [GO:1904148]; cellular response to tumor necrosis factor [GO:0071356]; ceramide translocation [GO:0099040]; circadian rhythm [GO:0007623]; daunorubicin transport [GO:0043215]; establishment of blood-brain barrier [GO:0060856]; establishment of blood-retinal barrier [GO:1990963]; export across plasma membrane [GO:0140115]; female pregnancy [GO:0007565]; G2/M transition of mitotic cell cycle [GO:0000086]; hormone transport [GO:0009914]; intestinal absorption [GO:0050892]; lactation [GO:0007595]; maintenance of blood-brain barrier [GO:0035633]; negative regulation of sensory perception of pain [GO:1904057]; phospholipid translocation [GO:0045332]; placenta development [GO:0001890]; positive regulation of establishment of Sertoli cell barrier [GO:1904446]; positive regulation of response to drug [GO:2001025]; protein localization to bicellular tight junction [GO:1902396]; regulation of chloride transport [GO:2001225]; regulation of intestinal absorption [GO:1904478]; response to alcohol [GO:0097305]; response to antineoplastic agent [GO:0097327]; response to cadmium ion [GO:0046686]; response to codeine [GO:1905233]; response to cyclosporin A [GO:1905237]; response to glucagon [GO:0033762]; response to glycoside [GO:1903416]; response to hypoxia [GO:0001666]; response to progesterone [GO:0032570]; response to quercetin [GO:1905235]; response to thyroxine [GO:0097068]; response to vitamin A [GO:0033189]; response to vitamin D [GO:0033280]; response to xenobiotic stimulus [GO:0009410]; stem cell proliferation [GO:0072089]; terpenoid transport [GO:0046865]; transepithelial transport [GO:0070633]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104]; xenobiotic detoxification by transmembrane export across the plasma membrane [GO:1990961]; xenobiotic metabolic process [GO:0006805]; xenobiotic transport across blood-brain barrier [GO:1990962] apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; external side of apical plasma membrane [GO:0098591]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; plasma membrane [GO:0005886] ABC-type xenobiotic transporter activity [GO:0008559]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; carboxylic acid transmembrane transporter activity [GO:0046943]; ceramide floppase activity [GO:0099038]; efflux transmembrane transporter activity [GO:0015562]; floppase activity [GO:0140328]; phosphatidylcholine floppase activity [GO:0090554]; phosphatidylethanolamine flippase activity [GO:0090555]; phosphatidylethanolamine floppase activity [GO:0140341]; transmembrane transporter activity [GO:0022857]; ubiquitin protein ligase binding [GO:0031625]; xenobiotic transmembrane transporter activity [GO:0042910] g9593.t1 O81884 43.438 320 2.17e-83 268.0 sp|O81884|GALDH_ARATH L-galactose dehydrogenase OS=Arabidopsis thaliana OX=3702 GN=LGALDH PE=1 SV=1 g9595.t1 P08183 48.692 803 0.0 704.0 sp|P08183|MDR1_HUMAN ATP-dependent translocase ABCB1 OS=Homo sapiens OX=9606 GN=ABCB1 PE=1 SV=3 MDR1_HUMAN reviewed ATP-dependent translocase ABCB1 (ATP-binding cassette sub-family B member 1) (Multidrug resistance protein 1) (EC 7.6.2.2) (P-glycoprotein 1) (Phospholipid transporter ABCB1) (EC 7.6.2.1) (CD antigen CD243) Homo sapiens (Human) GO:0000086; GO:0001666; GO:0001890; GO:0005524; GO:0005737; GO:0005886; GO:0006805; GO:0007565; GO:0007595; GO:0007623; GO:0008559; GO:0009410; GO:0009914; GO:0009986; GO:0015562; GO:0016020; GO:0016324; GO:0016887; GO:0022857; GO:0031526; GO:0031625; GO:0032570; GO:0033189; GO:0033280; GO:0033762; GO:0035633; GO:0036146; GO:0042626; GO:0042910; GO:0043215; GO:0045332; GO:0046686; GO:0046865; GO:0046943; GO:0050892; GO:0055085; GO:0060856; GO:0070062; GO:0070633; GO:0071217; GO:0071222; GO:0071236; GO:0071312; GO:0071356; GO:0071392; GO:0071475; GO:0071549; GO:0072089; GO:0090554; GO:0090555; GO:0097068; GO:0097305; GO:0097327; GO:0098591; GO:0099038; GO:0099040; GO:0140115; GO:0140328; GO:0140341; GO:0150104; GO:1902396; GO:1903416; GO:1904057; GO:1904148; GO:1904446; GO:1904478; GO:1905039; GO:1905231; GO:1905232; GO:1905233; GO:1905235; GO:1905237; GO:1990961; GO:1990962; GO:1990963; GO:2001025; GO:2001225 carboxylic acid transmembrane transport [GO:1905039]; cellular hyperosmotic salinity response [GO:0071475]; cellular response to alkaloid [GO:0071312]; cellular response to antibiotic [GO:0071236]; cellular response to borneol [GO:1905231]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to estradiol stimulus [GO:0071392]; cellular response to external biotic stimulus [GO:0071217]; cellular response to L-glutamate [GO:1905232]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to mycotoxin [GO:0036146]; cellular response to nonylphenol [GO:1904148]; cellular response to tumor necrosis factor [GO:0071356]; ceramide translocation [GO:0099040]; circadian rhythm [GO:0007623]; daunorubicin transport [GO:0043215]; establishment of blood-brain barrier [GO:0060856]; establishment of blood-retinal barrier [GO:1990963]; export across plasma membrane [GO:0140115]; female pregnancy [GO:0007565]; G2/M transition of mitotic cell cycle [GO:0000086]; hormone transport [GO:0009914]; intestinal absorption [GO:0050892]; lactation [GO:0007595]; maintenance of blood-brain barrier [GO:0035633]; negative regulation of sensory perception of pain [GO:1904057]; phospholipid translocation [GO:0045332]; placenta development [GO:0001890]; positive regulation of establishment of Sertoli cell barrier [GO:1904446]; positive regulation of response to drug [GO:2001025]; protein localization to bicellular tight junction [GO:1902396]; regulation of chloride transport [GO:2001225]; regulation of intestinal absorption [GO:1904478]; response to alcohol [GO:0097305]; response to antineoplastic agent [GO:0097327]; response to cadmium ion [GO:0046686]; response to codeine [GO:1905233]; response to cyclosporin A [GO:1905237]; response to glucagon [GO:0033762]; response to glycoside [GO:1903416]; response to hypoxia [GO:0001666]; response to progesterone [GO:0032570]; response to quercetin [GO:1905235]; response to thyroxine [GO:0097068]; response to vitamin A [GO:0033189]; response to vitamin D [GO:0033280]; response to xenobiotic stimulus [GO:0009410]; stem cell proliferation [GO:0072089]; terpenoid transport [GO:0046865]; transepithelial transport [GO:0070633]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104]; xenobiotic detoxification by transmembrane export across the plasma membrane [GO:1990961]; xenobiotic metabolic process [GO:0006805]; xenobiotic transport across blood-brain barrier [GO:1990962] apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; external side of apical plasma membrane [GO:0098591]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; plasma membrane [GO:0005886] ABC-type xenobiotic transporter activity [GO:0008559]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; carboxylic acid transmembrane transporter activity [GO:0046943]; ceramide floppase activity [GO:0099038]; efflux transmembrane transporter activity [GO:0015562]; floppase activity [GO:0140328]; phosphatidylcholine floppase activity [GO:0090554]; phosphatidylethanolamine flippase activity [GO:0090555]; phosphatidylethanolamine floppase activity [GO:0140341]; transmembrane transporter activity [GO:0022857]; ubiquitin protein ligase binding [GO:0031625]; xenobiotic transmembrane transporter activity [GO:0042910] g9595.t1 P08183 45.009 531 3.4100000000000005e-132 432.0 sp|P08183|MDR1_HUMAN ATP-dependent translocase ABCB1 OS=Homo sapiens OX=9606 GN=ABCB1 PE=1 SV=3 MDR1_HUMAN reviewed ATP-dependent translocase ABCB1 (ATP-binding cassette sub-family B member 1) (Multidrug resistance protein 1) (EC 7.6.2.2) (P-glycoprotein 1) (Phospholipid transporter ABCB1) (EC 7.6.2.1) (CD antigen CD243) Homo sapiens (Human) GO:0000086; GO:0001666; GO:0001890; GO:0005524; GO:0005737; GO:0005886; GO:0006805; GO:0007565; GO:0007595; GO:0007623; GO:0008559; GO:0009410; GO:0009914; GO:0009986; GO:0015562; GO:0016020; GO:0016324; GO:0016887; GO:0022857; GO:0031526; GO:0031625; GO:0032570; GO:0033189; GO:0033280; GO:0033762; GO:0035633; GO:0036146; GO:0042626; GO:0042910; GO:0043215; GO:0045332; GO:0046686; GO:0046865; GO:0046943; GO:0050892; GO:0055085; GO:0060856; GO:0070062; GO:0070633; GO:0071217; GO:0071222; GO:0071236; GO:0071312; GO:0071356; GO:0071392; GO:0071475; GO:0071549; GO:0072089; GO:0090554; GO:0090555; GO:0097068; GO:0097305; GO:0097327; GO:0098591; GO:0099038; GO:0099040; GO:0140115; GO:0140328; GO:0140341; GO:0150104; GO:1902396; GO:1903416; GO:1904057; GO:1904148; GO:1904446; GO:1904478; GO:1905039; GO:1905231; GO:1905232; GO:1905233; GO:1905235; GO:1905237; GO:1990961; GO:1990962; GO:1990963; GO:2001025; GO:2001225 carboxylic acid transmembrane transport [GO:1905039]; cellular hyperosmotic salinity response [GO:0071475]; cellular response to alkaloid [GO:0071312]; cellular response to antibiotic [GO:0071236]; cellular response to borneol [GO:1905231]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to estradiol stimulus [GO:0071392]; cellular response to external biotic stimulus [GO:0071217]; cellular response to L-glutamate [GO:1905232]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to mycotoxin [GO:0036146]; cellular response to nonylphenol [GO:1904148]; cellular response to tumor necrosis factor [GO:0071356]; ceramide translocation [GO:0099040]; circadian rhythm [GO:0007623]; daunorubicin transport [GO:0043215]; establishment of blood-brain barrier [GO:0060856]; establishment of blood-retinal barrier [GO:1990963]; export across plasma membrane [GO:0140115]; female pregnancy [GO:0007565]; G2/M transition of mitotic cell cycle [GO:0000086]; hormone transport [GO:0009914]; intestinal absorption [GO:0050892]; lactation [GO:0007595]; maintenance of blood-brain barrier [GO:0035633]; negative regulation of sensory perception of pain [GO:1904057]; phospholipid translocation [GO:0045332]; placenta development [GO:0001890]; positive regulation of establishment of Sertoli cell barrier [GO:1904446]; positive regulation of response to drug [GO:2001025]; protein localization to bicellular tight junction [GO:1902396]; regulation of chloride transport [GO:2001225]; regulation of intestinal absorption [GO:1904478]; response to alcohol [GO:0097305]; response to antineoplastic agent [GO:0097327]; response to cadmium ion [GO:0046686]; response to codeine [GO:1905233]; response to cyclosporin A [GO:1905237]; response to glucagon [GO:0033762]; response to glycoside [GO:1903416]; response to hypoxia [GO:0001666]; response to progesterone [GO:0032570]; response to quercetin [GO:1905235]; response to thyroxine [GO:0097068]; response to vitamin A [GO:0033189]; response to vitamin D [GO:0033280]; response to xenobiotic stimulus [GO:0009410]; stem cell proliferation [GO:0072089]; terpenoid transport [GO:0046865]; transepithelial transport [GO:0070633]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104]; xenobiotic detoxification by transmembrane export across the plasma membrane [GO:1990961]; xenobiotic metabolic process [GO:0006805]; xenobiotic transport across blood-brain barrier [GO:1990962] apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; external side of apical plasma membrane [GO:0098591]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; plasma membrane [GO:0005886] ABC-type xenobiotic transporter activity [GO:0008559]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; carboxylic acid transmembrane transporter activity [GO:0046943]; ceramide floppase activity [GO:0099038]; efflux transmembrane transporter activity [GO:0015562]; floppase activity [GO:0140328]; phosphatidylcholine floppase activity [GO:0090554]; phosphatidylethanolamine flippase activity [GO:0090555]; phosphatidylethanolamine floppase activity [GO:0140341]; transmembrane transporter activity [GO:0022857]; ubiquitin protein ligase binding [GO:0031625]; xenobiotic transmembrane transporter activity [GO:0042910] g9598.t1 P21440 57.983 476 9.86e-178 536.0 sp|P21440|MDR3_MOUSE Phosphatidylcholine translocator ABCB4 OS=Mus musculus OX=10090 GN=Abcb4 PE=1 SV=2 MDR3_MOUSE reviewed Phosphatidylcholine translocator ABCB4 (EC 7.6.2.1) (ATP-binding cassette sub-family B member 4) (Multidrug resistance protein 2) (Multidrug resistance protein 3) (P-glycoprotein 2) (P-glycoprotein 3) Mus musculus (Mouse) GO:0000139; GO:0005524; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0005925; GO:0016020; GO:0016324; GO:0016887; GO:0030136; GO:0032376; GO:0032782; GO:0042626; GO:0045121; GO:0045332; GO:0046581; GO:0055088; GO:0061092; GO:0090554; GO:0140359; GO:1901557; GO:1903413; GO:2001140 bile acid secretion [GO:0032782]; cellular response to bile acid [GO:1903413]; lipid homeostasis [GO:0055088]; phospholipid translocation [GO:0045332]; positive regulation of cholesterol transport [GO:0032376]; positive regulation of phospholipid translocation [GO:0061092]; positive regulation of phospholipid transport [GO:2001140]; response to fenofibrate [GO:1901557] apical plasma membrane [GO:0016324]; clathrin-coated vesicle [GO:0030136]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; Golgi membrane [GO:0000139]; intercellular canaliculus [GO:0046581]; membrane [GO:0016020]; membrane raft [GO:0045121]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] ABC-type transporter activity [GO:0140359]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; phosphatidylcholine floppase activity [GO:0090554] g9598.t1 P21440 41.176 476 1.92e-102 336.0 sp|P21440|MDR3_MOUSE Phosphatidylcholine translocator ABCB4 OS=Mus musculus OX=10090 GN=Abcb4 PE=1 SV=2 MDR3_MOUSE reviewed Phosphatidylcholine translocator ABCB4 (EC 7.6.2.1) (ATP-binding cassette sub-family B member 4) (Multidrug resistance protein 2) (Multidrug resistance protein 3) (P-glycoprotein 2) (P-glycoprotein 3) Mus musculus (Mouse) GO:0000139; GO:0005524; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0005925; GO:0016020; GO:0016324; GO:0016887; GO:0030136; GO:0032376; GO:0032782; GO:0042626; GO:0045121; GO:0045332; GO:0046581; GO:0055088; GO:0061092; GO:0090554; GO:0140359; GO:1901557; GO:1903413; GO:2001140 bile acid secretion [GO:0032782]; cellular response to bile acid [GO:1903413]; lipid homeostasis [GO:0055088]; phospholipid translocation [GO:0045332]; positive regulation of cholesterol transport [GO:0032376]; positive regulation of phospholipid translocation [GO:0061092]; positive regulation of phospholipid transport [GO:2001140]; response to fenofibrate [GO:1901557] apical plasma membrane [GO:0016324]; clathrin-coated vesicle [GO:0030136]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; Golgi membrane [GO:0000139]; intercellular canaliculus [GO:0046581]; membrane [GO:0016020]; membrane raft [GO:0045121]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] ABC-type transporter activity [GO:0140359]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; phosphatidylcholine floppase activity [GO:0090554] g9599.t1 P53708 36.032 1013 2.2e-177 548.0 sp|P53708|ITA8_HUMAN Integrin alpha-8 OS=Homo sapiens OX=9606 GN=ITGA8 PE=1 SV=3 ITA8_HUMAN reviewed Integrin alpha-8 [Cleaved into: Integrin alpha-8 heavy chain; Integrin alpha-8 light chain] Homo sapiens (Human) GO:0001656; GO:0001822; GO:0005783; GO:0005886; GO:0005925; GO:0007160; GO:0007179; GO:0007229; GO:0007399; GO:0007613; GO:0008305; GO:0009986; GO:0030030; GO:0030198; GO:0030511; GO:0032591; GO:0034446; GO:0034678; GO:0038023; GO:0042472; GO:0043204; GO:0045177; GO:0045184; GO:0045944; GO:0046872; GO:0048333; GO:0048745; GO:0051145; GO:0098609; GO:0098839; GO:0098978 cell projection organization [GO:0030030]; cell-cell adhesion [GO:0098609]; cell-matrix adhesion [GO:0007160]; establishment of protein localization [GO:0045184]; extracellular matrix organization [GO:0030198]; inner ear morphogenesis [GO:0042472]; integrin-mediated signaling pathway [GO:0007229]; kidney development [GO:0001822]; memory [GO:0007613]; mesodermal cell differentiation [GO:0048333]; metanephros development [GO:0001656]; nervous system development [GO:0007399]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; smooth muscle cell differentiation [GO:0051145]; smooth muscle tissue development [GO:0048745]; substrate adhesion-dependent cell spreading [GO:0034446]; transforming growth factor beta receptor signaling pathway [GO:0007179] apical part of cell [GO:0045177]; cell surface [GO:0009986]; dendritic spine membrane [GO:0032591]; endoplasmic reticulum [GO:0005783]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; integrin alpha8-beta1 complex [GO:0034678]; integrin complex [GO:0008305]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839] metal ion binding [GO:0046872]; signaling receptor activity [GO:0038023] g9600.t1 Q5XJR6 54.015 137 2.92e-51 164.0 sp|Q5XJR6|ORML3_DANRE ORM1-like protein 3 OS=Danio rerio OX=7955 GN=ormdl3 PE=2 SV=1 ORML3_DANRE reviewed ORM1-like protein 3 Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005783; GO:0005789; GO:0006672; GO:0017059; GO:0030148; GO:0090156; GO:2000303 ceramide metabolic process [GO:0006672]; intracellular sphingolipid homeostasis [GO:0090156]; regulation of ceramide biosynthetic process [GO:2000303]; sphingolipid biosynthetic process [GO:0030148] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; serine palmitoyltransferase complex [GO:0017059] g9605.t1 P54277 33.615 946 1.98e-139 442.0 sp|P54277|PMS1_HUMAN PMS1 protein homolog 1 OS=Homo sapiens OX=9606 GN=PMS1 PE=1 SV=1 PMS1_HUMAN reviewed PMS1 protein homolog 1 (DNA mismatch repair protein PMS1) Homo sapiens (Human) GO:0003677; GO:0005524; GO:0005634; GO:0006298; GO:0009410; GO:0016887; GO:0019899; GO:0030983; GO:0032389; GO:0140664 mismatch repair [GO:0006298]; response to xenobiotic stimulus [GO:0009410] MutLalpha complex [GO:0032389]; nucleus [GO:0005634] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent DNA damage sensor activity [GO:0140664]; DNA binding [GO:0003677]; enzyme binding [GO:0019899]; mismatched DNA binding [GO:0030983] g9605.t2 P54277 31.72 971 5.6500000000000004e-123 398.0 sp|P54277|PMS1_HUMAN PMS1 protein homolog 1 OS=Homo sapiens OX=9606 GN=PMS1 PE=1 SV=1 PMS1_HUMAN reviewed PMS1 protein homolog 1 (DNA mismatch repair protein PMS1) Homo sapiens (Human) GO:0003677; GO:0005524; GO:0005634; GO:0006298; GO:0009410; GO:0016887; GO:0019899; GO:0030983; GO:0032389; GO:0140664 mismatch repair [GO:0006298]; response to xenobiotic stimulus [GO:0009410] MutLalpha complex [GO:0032389]; nucleus [GO:0005634] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent DNA damage sensor activity [GO:0140664]; DNA binding [GO:0003677]; enzyme binding [GO:0019899]; mismatched DNA binding [GO:0030983] g9606.t1 Q9ET66 37.838 185 2.88e-25 105.0 sp|Q9ET66|PI16_MOUSE Peptidase inhibitor 16 OS=Mus musculus OX=10090 GN=Pi16 PE=1 SV=2 PI16_MOUSE reviewed Peptidase inhibitor 16 (PI-16) (Cysteine-rich protease inhibitor) (CD antigen CD364) Mus musculus (Mouse) GO:0005615; GO:0030414; GO:0061052 negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052] extracellular space [GO:0005615] peptidase inhibitor activity [GO:0030414] g9607.t1 Q863I2 59.961 517 0.0 594.0 sp|Q863I2|OXSR1_PIG Serine/threonine-protein kinase OSR1 OS=Sus scrofa OX=9823 GN=OXSR1 PE=2 SV=1 g9611.t1 Q2PC93 31.493 1286 2.48e-135 483.0 sp|Q2PC93|SSPO_CHICK SCO-spondin OS=Gallus gallus OX=9031 GN=SSPO PE=2 SV=1 g9611.t1 Q2PC93 31.173 1142 7.94e-110 399.0 sp|Q2PC93|SSPO_CHICK SCO-spondin OS=Gallus gallus OX=9031 GN=SSPO PE=2 SV=1 g9611.t1 Q2PC93 28.722 1142 1.4e-96 355.0 sp|Q2PC93|SSPO_CHICK SCO-spondin OS=Gallus gallus OX=9031 GN=SSPO PE=2 SV=1 g9611.t1 Q2PC93 29.229 804 1.73e-72 276.0 sp|Q2PC93|SSPO_CHICK SCO-spondin OS=Gallus gallus OX=9031 GN=SSPO PE=2 SV=1 g9611.t1 Q2PC93 29.567 832 7.52e-69 264.0 sp|Q2PC93|SSPO_CHICK SCO-spondin OS=Gallus gallus OX=9031 GN=SSPO PE=2 SV=1 g9611.t1 Q2PC93 28.339 861 1.49e-56 223.0 sp|Q2PC93|SSPO_CHICK SCO-spondin OS=Gallus gallus OX=9031 GN=SSPO PE=2 SV=1 g9611.t1 Q2PC93 32.021 559 3.1e-55 219.0 sp|Q2PC93|SSPO_CHICK SCO-spondin OS=Gallus gallus OX=9031 GN=SSPO PE=2 SV=1 g9611.t1 Q2PC93 28.293 820 1.72e-39 167.0 sp|Q2PC93|SSPO_CHICK SCO-spondin OS=Gallus gallus OX=9031 GN=SSPO PE=2 SV=1 g9611.t1 Q2PC93 34.462 325 2.64e-37 160.0 sp|Q2PC93|SSPO_CHICK SCO-spondin OS=Gallus gallus OX=9031 GN=SSPO PE=2 SV=1 g9611.t1 Q2PC93 31.377 443 9.7e-36 154.0 sp|Q2PC93|SSPO_CHICK SCO-spondin OS=Gallus gallus OX=9031 GN=SSPO PE=2 SV=1 g9611.t1 Q2PC93 36.395 294 3.52e-33 146.0 sp|Q2PC93|SSPO_CHICK SCO-spondin OS=Gallus gallus OX=9031 GN=SSPO PE=2 SV=1 g9611.t1 Q2PC93 32.059 340 2.44e-32 143.0 sp|Q2PC93|SSPO_CHICK SCO-spondin OS=Gallus gallus OX=9031 GN=SSPO PE=2 SV=1 g9611.t1 Q2PC93 29.387 473 2.9299999999999997e-30 136.0 sp|Q2PC93|SSPO_CHICK SCO-spondin OS=Gallus gallus OX=9031 GN=SSPO PE=2 SV=1 g9611.t1 Q2PC93 30.769 299 1.92e-28 130.0 sp|Q2PC93|SSPO_CHICK SCO-spondin OS=Gallus gallus OX=9031 GN=SSPO PE=2 SV=1 g9611.t1 Q2PC93 27.723 404 6.96e-25 119.0 sp|Q2PC93|SSPO_CHICK SCO-spondin OS=Gallus gallus OX=9031 GN=SSPO PE=2 SV=1 g9611.t1 Q2PC93 28.618 304 4.4e-24 116.0 sp|Q2PC93|SSPO_CHICK SCO-spondin OS=Gallus gallus OX=9031 GN=SSPO PE=2 SV=1 g9611.t1 Q2PC93 27.523 545 5.169999999999999e-23 112.0 sp|Q2PC93|SSPO_CHICK SCO-spondin OS=Gallus gallus OX=9031 GN=SSPO PE=2 SV=1 g9611.t1 Q2PC93 31.752 274 4.97e-22 109.0 sp|Q2PC93|SSPO_CHICK SCO-spondin OS=Gallus gallus OX=9031 GN=SSPO PE=2 SV=1 g9611.t1 Q2PC93 32.343 303 4.66e-21 106.0 sp|Q2PC93|SSPO_CHICK SCO-spondin OS=Gallus gallus OX=9031 GN=SSPO PE=2 SV=1 g9613.t1 Q2PC93 36.931 1538 0.0 936.0 sp|Q2PC93|SSPO_CHICK SCO-spondin OS=Gallus gallus OX=9031 GN=SSPO PE=2 SV=1 g9614.t1 Q700K0 34.142 577 7.41e-69 258.0 sp|Q700K0|SSPO_RAT SCO-spondin OS=Rattus norvegicus OX=10116 GN=Sspo PE=2 SV=1 g9614.t1 Q700K0 34.951 412 1.14e-53 210.0 sp|Q700K0|SSPO_RAT SCO-spondin OS=Rattus norvegicus OX=10116 GN=Sspo PE=2 SV=1 g9614.t1 Q700K0 29.358 654 5.33e-51 202.0 sp|Q700K0|SSPO_RAT SCO-spondin OS=Rattus norvegicus OX=10116 GN=Sspo PE=2 SV=1 g9614.t1 Q700K0 27.677 719 1.18e-49 197.0 sp|Q700K0|SSPO_RAT SCO-spondin OS=Rattus norvegicus OX=10116 GN=Sspo PE=2 SV=1 g9614.t1 Q700K0 28.794 705 4.29e-41 170.0 sp|Q700K0|SSPO_RAT SCO-spondin OS=Rattus norvegicus OX=10116 GN=Sspo PE=2 SV=1 g9614.t1 Q700K0 24.074 918 2.6099999999999997e-34 147.0 sp|Q700K0|SSPO_RAT SCO-spondin OS=Rattus norvegicus OX=10116 GN=Sspo PE=2 SV=1 g9614.t1 Q700K0 31.419 296 3.14e-28 128.0 sp|Q700K0|SSPO_RAT SCO-spondin OS=Rattus norvegicus OX=10116 GN=Sspo PE=2 SV=1 g9614.t1 Q700K0 37.97 266 4.660000000000001e-27 124.0 sp|Q700K0|SSPO_RAT SCO-spondin OS=Rattus norvegicus OX=10116 GN=Sspo PE=2 SV=1 g9614.t1 Q700K0 30.095 422 5.61e-27 124.0 sp|Q700K0|SSPO_RAT SCO-spondin OS=Rattus norvegicus OX=10116 GN=Sspo PE=2 SV=1 g9614.t1 Q700K0 29.619 341 1.38e-24 116.0 sp|Q700K0|SSPO_RAT SCO-spondin OS=Rattus norvegicus OX=10116 GN=Sspo PE=2 SV=1 g9614.t1 Q700K0 32.692 312 2.9e-24 115.0 sp|Q700K0|SSPO_RAT SCO-spondin OS=Rattus norvegicus OX=10116 GN=Sspo PE=2 SV=1 g9619.t1 P0DSP1 39.56 182 3.9799999999999998e-25 114.0 sp|P0DSP1|SORL_RAT Sortilin-related receptor OS=Rattus norvegicus OX=10116 GN=Sorl1 PE=1 SV=1 SORL_RAT reviewed Sortilin-related receptor (Low-density lipoprotein receptor relative with 11 ligand-binding repeats) (LDLR relative with 11 ligand-binding repeats) (LR11) (Sorting protein-related receptor containing LDLR class A repeats) (SorLA) Rattus norvegicus (Rat) GO:0000139; GO:0001540; GO:0002024; GO:0004888; GO:0005615; GO:0005641; GO:0005768; GO:0005769; GO:0005771; GO:0005783; GO:0005789; GO:0005794; GO:0005802; GO:0005829; GO:0005886; GO:0006605; GO:0006622; GO:0006892; GO:0006898; GO:0007218; GO:0009986; GO:0010897; GO:0014910; GO:0016020; GO:0016477; GO:0019828; GO:0030169; GO:0030514; GO:0030658; GO:0031267; GO:0031333; GO:0031901; GO:0031985; GO:0032585; GO:0034067; GO:0034205; GO:0038020; GO:0042147; GO:0042923; GO:0043025; GO:0045053; GO:0045732; GO:0046628; GO:0050768; GO:0055037; GO:0055038; GO:0070863; GO:0097356; GO:0099638; GO:0140318; GO:1900168; GO:1902430; GO:1902953; GO:1902955; GO:1902966; GO:1902992; GO:1902997; GO:1904179; GO:1990845; GO:2001137 adaptive thermogenesis [GO:1990845]; amyloid-beta formation [GO:0034205]; cell migration [GO:0016477]; diet induced thermogenesis [GO:0002024]; endosome to plasma membrane protein transport [GO:0099638]; insulin receptor recycling [GO:0038020]; negative regulation of amyloid precursor protein catabolic process [GO:1902992]; negative regulation of amyloid-beta formation [GO:1902430]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of neurofibrillary tangle assembly [GO:1902997]; negative regulation of neurogenesis [GO:0050768]; negative regulation of protein-containing complex assembly [GO:0031333]; negative regulation of triglyceride catabolic process [GO:0010897]; neuropeptide signaling pathway [GO:0007218]; positive regulation of adipose tissue development [GO:1904179]; positive regulation of early endosome to recycling endosome transport [GO:1902955]; positive regulation of endocytic recycling [GO:2001137]; positive regulation of ER to Golgi vesicle-mediated transport [GO:1902953]; positive regulation of glial cell-derived neurotrophic factor production [GO:1900168]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein exit from endoplasmic reticulum [GO:0070863]; positive regulation of protein localization to early endosome [GO:1902966]; post-Golgi vesicle-mediated transport [GO:0006892]; protein localization to Golgi apparatus [GO:0034067]; protein retention in Golgi apparatus [GO:0045053]; protein targeting [GO:0006605]; protein targeting to lysosome [GO:0006622]; receptor-mediated endocytosis [GO:0006898]; regulation of smooth muscle cell migration [GO:0014910]; retrograde transport, endosome to Golgi [GO:0042147] cell surface [GO:0009986]; cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; Golgi cisterna [GO:0031985]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; multivesicular body [GO:0005771]; multivesicular body membrane [GO:0032585]; neuronal cell body [GO:0043025]; nuclear envelope lumen [GO:0005641]; perinucleolar compartment [GO:0097356]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; trans-Golgi network [GO:0005802]; transport vesicle membrane [GO:0030658] amyloid-beta binding [GO:0001540]; aspartic-type endopeptidase inhibitor activity [GO:0019828]; low-density lipoprotein particle binding [GO:0030169]; neuropeptide binding [GO:0042923]; protein transporter activity [GO:0140318]; small GTPase binding [GO:0031267]; transmembrane signaling receptor activity [GO:0004888] g9619.t1 P0DSP1 37.853 177 2.3499999999999997e-23 108.0 sp|P0DSP1|SORL_RAT Sortilin-related receptor OS=Rattus norvegicus OX=10116 GN=Sorl1 PE=1 SV=1 SORL_RAT reviewed Sortilin-related receptor (Low-density lipoprotein receptor relative with 11 ligand-binding repeats) (LDLR relative with 11 ligand-binding repeats) (LR11) (Sorting protein-related receptor containing LDLR class A repeats) (SorLA) Rattus norvegicus (Rat) GO:0000139; GO:0001540; GO:0002024; GO:0004888; GO:0005615; GO:0005641; GO:0005768; GO:0005769; GO:0005771; GO:0005783; GO:0005789; GO:0005794; GO:0005802; GO:0005829; GO:0005886; GO:0006605; GO:0006622; GO:0006892; GO:0006898; GO:0007218; GO:0009986; GO:0010897; GO:0014910; GO:0016020; GO:0016477; GO:0019828; GO:0030169; GO:0030514; GO:0030658; GO:0031267; GO:0031333; GO:0031901; GO:0031985; GO:0032585; GO:0034067; GO:0034205; GO:0038020; GO:0042147; GO:0042923; GO:0043025; GO:0045053; GO:0045732; GO:0046628; GO:0050768; GO:0055037; GO:0055038; GO:0070863; GO:0097356; GO:0099638; GO:0140318; GO:1900168; GO:1902430; GO:1902953; GO:1902955; GO:1902966; GO:1902992; GO:1902997; GO:1904179; GO:1990845; GO:2001137 adaptive thermogenesis [GO:1990845]; amyloid-beta formation [GO:0034205]; cell migration [GO:0016477]; diet induced thermogenesis [GO:0002024]; endosome to plasma membrane protein transport [GO:0099638]; insulin receptor recycling [GO:0038020]; negative regulation of amyloid precursor protein catabolic process [GO:1902992]; negative regulation of amyloid-beta formation [GO:1902430]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of neurofibrillary tangle assembly [GO:1902997]; negative regulation of neurogenesis [GO:0050768]; negative regulation of protein-containing complex assembly [GO:0031333]; negative regulation of triglyceride catabolic process [GO:0010897]; neuropeptide signaling pathway [GO:0007218]; positive regulation of adipose tissue development [GO:1904179]; positive regulation of early endosome to recycling endosome transport [GO:1902955]; positive regulation of endocytic recycling [GO:2001137]; positive regulation of ER to Golgi vesicle-mediated transport [GO:1902953]; positive regulation of glial cell-derived neurotrophic factor production [GO:1900168]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein exit from endoplasmic reticulum [GO:0070863]; positive regulation of protein localization to early endosome [GO:1902966]; post-Golgi vesicle-mediated transport [GO:0006892]; protein localization to Golgi apparatus [GO:0034067]; protein retention in Golgi apparatus [GO:0045053]; protein targeting [GO:0006605]; protein targeting to lysosome [GO:0006622]; receptor-mediated endocytosis [GO:0006898]; regulation of smooth muscle cell migration [GO:0014910]; retrograde transport, endosome to Golgi [GO:0042147] cell surface [GO:0009986]; cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; Golgi cisterna [GO:0031985]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; multivesicular body [GO:0005771]; multivesicular body membrane [GO:0032585]; neuronal cell body [GO:0043025]; nuclear envelope lumen [GO:0005641]; perinucleolar compartment [GO:0097356]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; trans-Golgi network [GO:0005802]; transport vesicle membrane [GO:0030658] amyloid-beta binding [GO:0001540]; aspartic-type endopeptidase inhibitor activity [GO:0019828]; low-density lipoprotein particle binding [GO:0030169]; neuropeptide binding [GO:0042923]; protein transporter activity [GO:0140318]; small GTPase binding [GO:0031267]; transmembrane signaling receptor activity [GO:0004888] g9619.t1 P0DSP1 34.634 205 1.04e-22 106.0 sp|P0DSP1|SORL_RAT Sortilin-related receptor OS=Rattus norvegicus OX=10116 GN=Sorl1 PE=1 SV=1 SORL_RAT reviewed Sortilin-related receptor (Low-density lipoprotein receptor relative with 11 ligand-binding repeats) (LDLR relative with 11 ligand-binding repeats) (LR11) (Sorting protein-related receptor containing LDLR class A repeats) (SorLA) Rattus norvegicus (Rat) GO:0000139; GO:0001540; GO:0002024; GO:0004888; GO:0005615; GO:0005641; GO:0005768; GO:0005769; GO:0005771; GO:0005783; GO:0005789; GO:0005794; GO:0005802; GO:0005829; GO:0005886; GO:0006605; GO:0006622; GO:0006892; GO:0006898; GO:0007218; GO:0009986; GO:0010897; GO:0014910; GO:0016020; GO:0016477; GO:0019828; GO:0030169; GO:0030514; GO:0030658; GO:0031267; GO:0031333; GO:0031901; GO:0031985; GO:0032585; GO:0034067; GO:0034205; GO:0038020; GO:0042147; GO:0042923; GO:0043025; GO:0045053; GO:0045732; GO:0046628; GO:0050768; GO:0055037; GO:0055038; GO:0070863; GO:0097356; GO:0099638; GO:0140318; GO:1900168; GO:1902430; GO:1902953; GO:1902955; GO:1902966; GO:1902992; GO:1902997; GO:1904179; GO:1990845; GO:2001137 adaptive thermogenesis [GO:1990845]; amyloid-beta formation [GO:0034205]; cell migration [GO:0016477]; diet induced thermogenesis [GO:0002024]; endosome to plasma membrane protein transport [GO:0099638]; insulin receptor recycling [GO:0038020]; negative regulation of amyloid precursor protein catabolic process [GO:1902992]; negative regulation of amyloid-beta formation [GO:1902430]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of neurofibrillary tangle assembly [GO:1902997]; negative regulation of neurogenesis [GO:0050768]; negative regulation of protein-containing complex assembly [GO:0031333]; negative regulation of triglyceride catabolic process [GO:0010897]; neuropeptide signaling pathway [GO:0007218]; positive regulation of adipose tissue development [GO:1904179]; positive regulation of early endosome to recycling endosome transport [GO:1902955]; positive regulation of endocytic recycling [GO:2001137]; positive regulation of ER to Golgi vesicle-mediated transport [GO:1902953]; positive regulation of glial cell-derived neurotrophic factor production [GO:1900168]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein exit from endoplasmic reticulum [GO:0070863]; positive regulation of protein localization to early endosome [GO:1902966]; post-Golgi vesicle-mediated transport [GO:0006892]; protein localization to Golgi apparatus [GO:0034067]; protein retention in Golgi apparatus [GO:0045053]; protein targeting [GO:0006605]; protein targeting to lysosome [GO:0006622]; receptor-mediated endocytosis [GO:0006898]; regulation of smooth muscle cell migration [GO:0014910]; retrograde transport, endosome to Golgi [GO:0042147] cell surface [GO:0009986]; cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; Golgi cisterna [GO:0031985]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; multivesicular body [GO:0005771]; multivesicular body membrane [GO:0032585]; neuronal cell body [GO:0043025]; nuclear envelope lumen [GO:0005641]; perinucleolar compartment [GO:0097356]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; trans-Golgi network [GO:0005802]; transport vesicle membrane [GO:0030658] amyloid-beta binding [GO:0001540]; aspartic-type endopeptidase inhibitor activity [GO:0019828]; low-density lipoprotein particle binding [GO:0030169]; neuropeptide binding [GO:0042923]; protein transporter activity [GO:0140318]; small GTPase binding [GO:0031267]; transmembrane signaling receptor activity [GO:0004888] g9621.t1 Q2PC93 42.167 932 0.0 770.0 sp|Q2PC93|SSPO_CHICK SCO-spondin OS=Gallus gallus OX=9031 GN=SSPO PE=2 SV=1 g9621.t1 Q2PC93 40.596 436 2.0399999999999998e-94 331.0 sp|Q2PC93|SSPO_CHICK SCO-spondin OS=Gallus gallus OX=9031 GN=SSPO PE=2 SV=1 g9621.t1 Q2PC93 29.521 376 8.41e-38 158.0 sp|Q2PC93|SSPO_CHICK SCO-spondin OS=Gallus gallus OX=9031 GN=SSPO PE=2 SV=1 g9621.t1 Q2PC93 27.177 379 5.6e-37 155.0 sp|Q2PC93|SSPO_CHICK SCO-spondin OS=Gallus gallus OX=9031 GN=SSPO PE=2 SV=1 g9621.t1 Q2PC93 40.769 130 1.97e-21 105.0 sp|Q2PC93|SSPO_CHICK SCO-spondin OS=Gallus gallus OX=9031 GN=SSPO PE=2 SV=1 g9622.t1 Q2PC93 28.297 417 3.2e-33 134.0 sp|Q2PC93|SSPO_CHICK SCO-spondin OS=Gallus gallus OX=9031 GN=SSPO PE=2 SV=1 g9624.t1 B0CM26 47.238 887 0.0 759.0 sp|B0CM26|CFA69_PAPAN Cilia- and flagella-associated protein 69 OS=Papio anubis OX=9555 GN=CFAP69 PE=3 SV=1 g9625.t1 O16025 29.577 710 2.18e-87 297.0 sp|O16025|AOSL_PLEHO Allene oxide synthase-lipoxygenase protein OS=Plexaura homomalla OX=47982 PE=1 SV=1 g9626.t1 P51399 30.49 551 3.8300000000000003e-72 246.0 sp|P51399|LOX5_MESAU Polyunsaturated fatty acid 5-lipoxygenase OS=Mesocricetus auratus OX=10036 GN=ALOX5 PE=2 SV=2 g9629.t1 Q8MIR4 41.815 562 2.47e-126 385.0 sp|Q8MIR4|COASY_PIG Bifunctional coenzyme A synthase OS=Sus scrofa OX=9823 GN=COASY PE=1 SV=1 g9630.t1 Q505D1 62.381 210 4.4e-88 284.0 sp|Q505D1|ANR28_MOUSE Serine/threonine-protein phosphatase 6 regulatory ankyrin repeat subunit A OS=Mus musculus OX=10090 GN=Ankrd28 PE=1 SV=1 g9630.t1 Q505D1 35.0 200 7.81e-28 114.0 sp|Q505D1|ANR28_MOUSE Serine/threonine-protein phosphatase 6 regulatory ankyrin repeat subunit A OS=Mus musculus OX=10090 GN=Ankrd28 PE=1 SV=1 g9630.t1 Q505D1 34.595 185 1.1e-23 102.0 sp|Q505D1|ANR28_MOUSE Serine/threonine-protein phosphatase 6 regulatory ankyrin repeat subunit A OS=Mus musculus OX=10090 GN=Ankrd28 PE=1 SV=1 g9630.t1 Q505D1 30.769 247 4.4199999999999994e-23 100.0 sp|Q505D1|ANR28_MOUSE Serine/threonine-protein phosphatase 6 regulatory ankyrin repeat subunit A OS=Mus musculus OX=10090 GN=Ankrd28 PE=1 SV=1 g9630.t1 Q505D1 31.579 190 1.9300000000000001e-22 99.0 sp|Q505D1|ANR28_MOUSE Serine/threonine-protein phosphatase 6 regulatory ankyrin repeat subunit A OS=Mus musculus OX=10090 GN=Ankrd28 PE=1 SV=1 g9630.t1 Q505D1 30.769 208 1.1500000000000002e-21 96.7 sp|Q505D1|ANR28_MOUSE Serine/threonine-protein phosphatase 6 regulatory ankyrin repeat subunit A OS=Mus musculus OX=10090 GN=Ankrd28 PE=1 SV=1 g9631.t1 O15084 52.821 833 0.0 840.0 sp|O15084|ANR28_HUMAN Serine/threonine-protein phosphatase 6 regulatory ankyrin repeat subunit A OS=Homo sapiens OX=9606 GN=ANKRD28 PE=1 SV=5 ANR28_HUMAN reviewed Serine/threonine-protein phosphatase 6 regulatory ankyrin repeat subunit A (PP6-ARS-A) (Serine/threonine-protein phosphatase 6 regulatory subunit ARS-A) (Ankyrin repeat domain-containing protein 28) (Phosphatase interactor targeting protein hnRNP K) (PITK) Homo sapiens (Human) GO:0005654; GO:0005829; GO:0008287; GO:0019888; GO:0030027; GO:0051894 positive regulation of focal adhesion assembly [GO:0051894] cytosol [GO:0005829]; lamellipodium [GO:0030027]; nucleoplasm [GO:0005654]; protein serine/threonine phosphatase complex [GO:0008287] protein phosphatase regulator activity [GO:0019888] g9631.t1 O15084 30.513 839 4.5e-78 276.0 sp|O15084|ANR28_HUMAN Serine/threonine-protein phosphatase 6 regulatory ankyrin repeat subunit A OS=Homo sapiens OX=9606 GN=ANKRD28 PE=1 SV=5 ANR28_HUMAN reviewed Serine/threonine-protein phosphatase 6 regulatory ankyrin repeat subunit A (PP6-ARS-A) (Serine/threonine-protein phosphatase 6 regulatory subunit ARS-A) (Ankyrin repeat domain-containing protein 28) (Phosphatase interactor targeting protein hnRNP K) (PITK) Homo sapiens (Human) GO:0005654; GO:0005829; GO:0008287; GO:0019888; GO:0030027; GO:0051894 positive regulation of focal adhesion assembly [GO:0051894] cytosol [GO:0005829]; lamellipodium [GO:0030027]; nucleoplasm [GO:0005654]; protein serine/threonine phosphatase complex [GO:0008287] protein phosphatase regulator activity [GO:0019888] g9631.t1 O15084 28.349 769 1.1799999999999999e-61 229.0 sp|O15084|ANR28_HUMAN Serine/threonine-protein phosphatase 6 regulatory ankyrin repeat subunit A OS=Homo sapiens OX=9606 GN=ANKRD28 PE=1 SV=5 ANR28_HUMAN reviewed Serine/threonine-protein phosphatase 6 regulatory ankyrin repeat subunit A (PP6-ARS-A) (Serine/threonine-protein phosphatase 6 regulatory subunit ARS-A) (Ankyrin repeat domain-containing protein 28) (Phosphatase interactor targeting protein hnRNP K) (PITK) Homo sapiens (Human) GO:0005654; GO:0005829; GO:0008287; GO:0019888; GO:0030027; GO:0051894 positive regulation of focal adhesion assembly [GO:0051894] cytosol [GO:0005829]; lamellipodium [GO:0030027]; nucleoplasm [GO:0005654]; protein serine/threonine phosphatase complex [GO:0008287] protein phosphatase regulator activity [GO:0019888] g9631.t1 O15084 32.267 688 2.6299999999999997e-61 228.0 sp|O15084|ANR28_HUMAN Serine/threonine-protein phosphatase 6 regulatory ankyrin repeat subunit A OS=Homo sapiens OX=9606 GN=ANKRD28 PE=1 SV=5 ANR28_HUMAN reviewed Serine/threonine-protein phosphatase 6 regulatory ankyrin repeat subunit A (PP6-ARS-A) (Serine/threonine-protein phosphatase 6 regulatory subunit ARS-A) (Ankyrin repeat domain-containing protein 28) (Phosphatase interactor targeting protein hnRNP K) (PITK) Homo sapiens (Human) GO:0005654; GO:0005829; GO:0008287; GO:0019888; GO:0030027; GO:0051894 positive regulation of focal adhesion assembly [GO:0051894] cytosol [GO:0005829]; lamellipodium [GO:0030027]; nucleoplasm [GO:0005654]; protein serine/threonine phosphatase complex [GO:0008287] protein phosphatase regulator activity [GO:0019888] g9631.t1 O15084 28.837 645 4.6e-49 191.0 sp|O15084|ANR28_HUMAN Serine/threonine-protein phosphatase 6 regulatory ankyrin repeat subunit A OS=Homo sapiens OX=9606 GN=ANKRD28 PE=1 SV=5 ANR28_HUMAN reviewed Serine/threonine-protein phosphatase 6 regulatory ankyrin repeat subunit A (PP6-ARS-A) (Serine/threonine-protein phosphatase 6 regulatory subunit ARS-A) (Ankyrin repeat domain-containing protein 28) (Phosphatase interactor targeting protein hnRNP K) (PITK) Homo sapiens (Human) GO:0005654; GO:0005829; GO:0008287; GO:0019888; GO:0030027; GO:0051894 positive regulation of focal adhesion assembly [GO:0051894] cytosol [GO:0005829]; lamellipodium [GO:0030027]; nucleoplasm [GO:0005654]; protein serine/threonine phosphatase complex [GO:0008287] protein phosphatase regulator activity [GO:0019888] g9631.t2 O15084 53.659 820 0.0 847.0 sp|O15084|ANR28_HUMAN Serine/threonine-protein phosphatase 6 regulatory ankyrin repeat subunit A OS=Homo sapiens OX=9606 GN=ANKRD28 PE=1 SV=5 ANR28_HUMAN reviewed Serine/threonine-protein phosphatase 6 regulatory ankyrin repeat subunit A (PP6-ARS-A) (Serine/threonine-protein phosphatase 6 regulatory subunit ARS-A) (Ankyrin repeat domain-containing protein 28) (Phosphatase interactor targeting protein hnRNP K) (PITK) Homo sapiens (Human) GO:0005654; GO:0005829; GO:0008287; GO:0019888; GO:0030027; GO:0051894 positive regulation of focal adhesion assembly [GO:0051894] cytosol [GO:0005829]; lamellipodium [GO:0030027]; nucleoplasm [GO:0005654]; protein serine/threonine phosphatase complex [GO:0008287] protein phosphatase regulator activity [GO:0019888] g9631.t2 O15084 30.86 849 4.3100000000000004e-77 273.0 sp|O15084|ANR28_HUMAN Serine/threonine-protein phosphatase 6 regulatory ankyrin repeat subunit A OS=Homo sapiens OX=9606 GN=ANKRD28 PE=1 SV=5 ANR28_HUMAN reviewed Serine/threonine-protein phosphatase 6 regulatory ankyrin repeat subunit A (PP6-ARS-A) (Serine/threonine-protein phosphatase 6 regulatory subunit ARS-A) (Ankyrin repeat domain-containing protein 28) (Phosphatase interactor targeting protein hnRNP K) (PITK) Homo sapiens (Human) GO:0005654; GO:0005829; GO:0008287; GO:0019888; GO:0030027; GO:0051894 positive regulation of focal adhesion assembly [GO:0051894] cytosol [GO:0005829]; lamellipodium [GO:0030027]; nucleoplasm [GO:0005654]; protein serine/threonine phosphatase complex [GO:0008287] protein phosphatase regulator activity [GO:0019888] g9631.t2 O15084 32.526 661 3.67e-61 227.0 sp|O15084|ANR28_HUMAN Serine/threonine-protein phosphatase 6 regulatory ankyrin repeat subunit A OS=Homo sapiens OX=9606 GN=ANKRD28 PE=1 SV=5 ANR28_HUMAN reviewed Serine/threonine-protein phosphatase 6 regulatory ankyrin repeat subunit A (PP6-ARS-A) (Serine/threonine-protein phosphatase 6 regulatory subunit ARS-A) (Ankyrin repeat domain-containing protein 28) (Phosphatase interactor targeting protein hnRNP K) (PITK) Homo sapiens (Human) GO:0005654; GO:0005829; GO:0008287; GO:0019888; GO:0030027; GO:0051894 positive regulation of focal adhesion assembly [GO:0051894] cytosol [GO:0005829]; lamellipodium [GO:0030027]; nucleoplasm [GO:0005654]; protein serine/threonine phosphatase complex [GO:0008287] protein phosphatase regulator activity [GO:0019888] g9631.t2 O15084 28.951 639 2.9099999999999996e-48 188.0 sp|O15084|ANR28_HUMAN Serine/threonine-protein phosphatase 6 regulatory ankyrin repeat subunit A OS=Homo sapiens OX=9606 GN=ANKRD28 PE=1 SV=5 ANR28_HUMAN reviewed Serine/threonine-protein phosphatase 6 regulatory ankyrin repeat subunit A (PP6-ARS-A) (Serine/threonine-protein phosphatase 6 regulatory subunit ARS-A) (Ankyrin repeat domain-containing protein 28) (Phosphatase interactor targeting protein hnRNP K) (PITK) Homo sapiens (Human) GO:0005654; GO:0005829; GO:0008287; GO:0019888; GO:0030027; GO:0051894 positive regulation of focal adhesion assembly [GO:0051894] cytosol [GO:0005829]; lamellipodium [GO:0030027]; nucleoplasm [GO:0005654]; protein serine/threonine phosphatase complex [GO:0008287] protein phosphatase regulator activity [GO:0019888] g9631.t3 Q505D1 53.724 819 0.0 851.0 sp|Q505D1|ANR28_MOUSE Serine/threonine-protein phosphatase 6 regulatory ankyrin repeat subunit A OS=Mus musculus OX=10090 GN=Ankrd28 PE=1 SV=1 g9631.t3 Q505D1 31.132 848 6.09e-80 281.0 sp|Q505D1|ANR28_MOUSE Serine/threonine-protein phosphatase 6 regulatory ankyrin repeat subunit A OS=Mus musculus OX=10090 GN=Ankrd28 PE=1 SV=1 g9631.t3 Q505D1 33.584 664 3.09e-62 230.0 sp|Q505D1|ANR28_MOUSE Serine/threonine-protein phosphatase 6 regulatory ankyrin repeat subunit A OS=Mus musculus OX=10090 GN=Ankrd28 PE=1 SV=1 g9631.t3 Q505D1 29.359 671 1.81e-54 207.0 sp|Q505D1|ANR28_MOUSE Serine/threonine-protein phosphatase 6 regulatory ankyrin repeat subunit A OS=Mus musculus OX=10090 GN=Ankrd28 PE=1 SV=1 g9631.t4 Q505D1 53.005 832 0.0 843.0 sp|Q505D1|ANR28_MOUSE Serine/threonine-protein phosphatase 6 regulatory ankyrin repeat subunit A OS=Mus musculus OX=10090 GN=Ankrd28 PE=1 SV=1 g9631.t4 Q505D1 30.634 852 4.53e-77 273.0 sp|Q505D1|ANR28_MOUSE Serine/threonine-protein phosphatase 6 regulatory ankyrin repeat subunit A OS=Mus musculus OX=10090 GN=Ankrd28 PE=1 SV=1 g9631.t4 Q505D1 32.939 677 5.85e-60 224.0 sp|Q505D1|ANR28_MOUSE Serine/threonine-protein phosphatase 6 regulatory ankyrin repeat subunit A OS=Mus musculus OX=10090 GN=Ankrd28 PE=1 SV=1 g9631.t4 Q505D1 28.84 638 1.3899999999999998e-48 189.0 sp|Q505D1|ANR28_MOUSE Serine/threonine-protein phosphatase 6 regulatory ankyrin repeat subunit A OS=Mus musculus OX=10090 GN=Ankrd28 PE=1 SV=1 g9632.t1 Q8BYR1 34.79 618 1.89e-89 291.0 sp|Q8BYR1|TYW4_MOUSE tRNA wybutosine-synthesizing protein 4 OS=Mus musculus OX=10090 GN=Lcmt2 PE=2 SV=4 TYW4_MOUSE reviewed tRNA wybutosine-synthesizing protein 4 (tRNA yW-synthesizing protein 4) (EC 2.1.1.290) (EC 2.3.1.231) (Leucine carboxyl methyltransferase 2) (p21WAF1/CIP1 promoter-interacting protein) (tRNA(Phe) (7-(3-amino-3-(methoxycarbonyl)propyl)wyosine(37)-N)-methoxycarbonyltransferase) (tRNA(Phe) (7-(3-amino-3-carboxypropyl)wyosine(37)-O)-methyltransferase) Mus musculus (Mouse) GO:0003880; GO:0008175; GO:0030488; GO:0031591 tRNA methylation [GO:0030488]; wybutosine biosynthetic process [GO:0031591] protein C-terminal carboxyl O-methyltransferase activity [GO:0003880]; tRNA methyltransferase activity [GO:0008175] g9633.t1 P62997 70.248 121 3.4899999999999996e-55 180.0 sp|P62997|TRA2B_RAT Transformer-2 protein homolog beta OS=Rattus norvegicus OX=10116 GN=Tra2b PE=1 SV=1 TRA2B_RAT reviewed Transformer-2 protein homolog beta (TRA-2 beta) (TRA2-beta) (RA301) (Splicing factor, arginine/serine-rich 10) (Transformer-2 protein homolog B) Rattus norvegicus (Rat) GO:0000302; GO:0000381; GO:0000398; GO:0001673; GO:0003723; GO:0003729; GO:0005634; GO:0005637; GO:0005654; GO:0005681; GO:0019904; GO:0021796; GO:0032991; GO:0036002; GO:0042802; GO:0043484; GO:0048026; GO:0048471; GO:0070717; GO:0071333; GO:1990403 cellular response to glucose stimulus [GO:0071333]; cerebral cortex regionalization [GO:0021796]; embryonic brain development [GO:1990403]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of RNA splicing [GO:0043484]; response to reactive oxygen species [GO:0000302] male germ cell nucleus [GO:0001673]; nuclear inner membrane [GO:0005637]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; spliceosomal complex [GO:0005681] identical protein binding [GO:0042802]; mRNA binding [GO:0003729]; poly-purine tract binding [GO:0070717]; pre-mRNA binding [GO:0036002]; protein domain specific binding [GO:0019904]; RNA binding [GO:0003723] g9634.t1 Q3UZ18 27.811 338 1.2000000000000002e-27 125.0 sp|Q3UZ18|ICE2_MOUSE Little elongation complex subunit 2 OS=Mus musculus OX=10090 GN=Ice2 PE=1 SV=2 g9636.t1 P08183 48.857 1269 0.0 1164.0 sp|P08183|MDR1_HUMAN ATP-dependent translocase ABCB1 OS=Homo sapiens OX=9606 GN=ABCB1 PE=1 SV=3 MDR1_HUMAN reviewed ATP-dependent translocase ABCB1 (ATP-binding cassette sub-family B member 1) (Multidrug resistance protein 1) (EC 7.6.2.2) (P-glycoprotein 1) (Phospholipid transporter ABCB1) (EC 7.6.2.1) (CD antigen CD243) Homo sapiens (Human) GO:0000086; GO:0001666; GO:0001890; GO:0005524; GO:0005737; GO:0005886; GO:0006805; GO:0007565; GO:0007595; GO:0007623; GO:0008559; GO:0009410; GO:0009914; GO:0009986; GO:0015562; GO:0016020; GO:0016324; GO:0016887; GO:0022857; GO:0031526; GO:0031625; GO:0032570; GO:0033189; GO:0033280; GO:0033762; GO:0035633; GO:0036146; GO:0042626; GO:0042910; GO:0043215; GO:0045332; GO:0046686; GO:0046865; GO:0046943; GO:0050892; GO:0055085; GO:0060856; GO:0070062; GO:0070633; GO:0071217; GO:0071222; GO:0071236; GO:0071312; GO:0071356; GO:0071392; GO:0071475; GO:0071549; GO:0072089; GO:0090554; GO:0090555; GO:0097068; GO:0097305; GO:0097327; GO:0098591; GO:0099038; GO:0099040; GO:0140115; GO:0140328; GO:0140341; GO:0150104; GO:1902396; GO:1903416; GO:1904057; GO:1904148; GO:1904446; GO:1904478; GO:1905039; GO:1905231; GO:1905232; GO:1905233; GO:1905235; GO:1905237; GO:1990961; GO:1990962; GO:1990963; GO:2001025; GO:2001225 carboxylic acid transmembrane transport [GO:1905039]; cellular hyperosmotic salinity response [GO:0071475]; cellular response to alkaloid [GO:0071312]; cellular response to antibiotic [GO:0071236]; cellular response to borneol [GO:1905231]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to estradiol stimulus [GO:0071392]; cellular response to external biotic stimulus [GO:0071217]; cellular response to L-glutamate [GO:1905232]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to mycotoxin [GO:0036146]; cellular response to nonylphenol [GO:1904148]; cellular response to tumor necrosis factor [GO:0071356]; ceramide translocation [GO:0099040]; circadian rhythm [GO:0007623]; daunorubicin transport [GO:0043215]; establishment of blood-brain barrier [GO:0060856]; establishment of blood-retinal barrier [GO:1990963]; export across plasma membrane [GO:0140115]; female pregnancy [GO:0007565]; G2/M transition of mitotic cell cycle [GO:0000086]; hormone transport [GO:0009914]; intestinal absorption [GO:0050892]; lactation [GO:0007595]; maintenance of blood-brain barrier [GO:0035633]; negative regulation of sensory perception of pain [GO:1904057]; phospholipid translocation [GO:0045332]; placenta development [GO:0001890]; positive regulation of establishment of Sertoli cell barrier [GO:1904446]; positive regulation of response to drug [GO:2001025]; protein localization to bicellular tight junction [GO:1902396]; regulation of chloride transport [GO:2001225]; regulation of intestinal absorption [GO:1904478]; response to alcohol [GO:0097305]; response to antineoplastic agent [GO:0097327]; response to cadmium ion [GO:0046686]; response to codeine [GO:1905233]; response to cyclosporin A [GO:1905237]; response to glucagon [GO:0033762]; response to glycoside [GO:1903416]; response to hypoxia [GO:0001666]; response to progesterone [GO:0032570]; response to quercetin [GO:1905235]; response to thyroxine [GO:0097068]; response to vitamin A [GO:0033189]; response to vitamin D [GO:0033280]; response to xenobiotic stimulus [GO:0009410]; stem cell proliferation [GO:0072089]; terpenoid transport [GO:0046865]; transepithelial transport [GO:0070633]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104]; xenobiotic detoxification by transmembrane export across the plasma membrane [GO:1990961]; xenobiotic metabolic process [GO:0006805]; xenobiotic transport across blood-brain barrier [GO:1990962] apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; external side of apical plasma membrane [GO:0098591]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; plasma membrane [GO:0005886] ABC-type xenobiotic transporter activity [GO:0008559]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; carboxylic acid transmembrane transporter activity [GO:0046943]; ceramide floppase activity [GO:0099038]; efflux transmembrane transporter activity [GO:0015562]; floppase activity [GO:0140328]; phosphatidylcholine floppase activity [GO:0090554]; phosphatidylethanolamine flippase activity [GO:0090555]; phosphatidylethanolamine floppase activity [GO:0140341]; transmembrane transporter activity [GO:0022857]; ubiquitin protein ligase binding [GO:0031625]; xenobiotic transmembrane transporter activity [GO:0042910] g9636.t1 P08183 40.347 518 9.46e-113 387.0 sp|P08183|MDR1_HUMAN ATP-dependent translocase ABCB1 OS=Homo sapiens OX=9606 GN=ABCB1 PE=1 SV=3 MDR1_HUMAN reviewed ATP-dependent translocase ABCB1 (ATP-binding cassette sub-family B member 1) (Multidrug resistance protein 1) (EC 7.6.2.2) (P-glycoprotein 1) (Phospholipid transporter ABCB1) (EC 7.6.2.1) (CD antigen CD243) Homo sapiens (Human) GO:0000086; GO:0001666; GO:0001890; GO:0005524; GO:0005737; GO:0005886; GO:0006805; GO:0007565; GO:0007595; GO:0007623; GO:0008559; GO:0009410; GO:0009914; GO:0009986; GO:0015562; GO:0016020; GO:0016324; GO:0016887; GO:0022857; GO:0031526; GO:0031625; GO:0032570; GO:0033189; GO:0033280; GO:0033762; GO:0035633; GO:0036146; GO:0042626; GO:0042910; GO:0043215; GO:0045332; GO:0046686; GO:0046865; GO:0046943; GO:0050892; GO:0055085; GO:0060856; GO:0070062; GO:0070633; GO:0071217; GO:0071222; GO:0071236; GO:0071312; GO:0071356; GO:0071392; GO:0071475; GO:0071549; GO:0072089; GO:0090554; GO:0090555; GO:0097068; GO:0097305; GO:0097327; GO:0098591; GO:0099038; GO:0099040; GO:0140115; GO:0140328; GO:0140341; GO:0150104; GO:1902396; GO:1903416; GO:1904057; GO:1904148; GO:1904446; GO:1904478; GO:1905039; GO:1905231; GO:1905232; GO:1905233; GO:1905235; GO:1905237; GO:1990961; GO:1990962; GO:1990963; GO:2001025; GO:2001225 carboxylic acid transmembrane transport [GO:1905039]; cellular hyperosmotic salinity response [GO:0071475]; cellular response to alkaloid [GO:0071312]; cellular response to antibiotic [GO:0071236]; cellular response to borneol [GO:1905231]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to estradiol stimulus [GO:0071392]; cellular response to external biotic stimulus [GO:0071217]; cellular response to L-glutamate [GO:1905232]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to mycotoxin [GO:0036146]; cellular response to nonylphenol [GO:1904148]; cellular response to tumor necrosis factor [GO:0071356]; ceramide translocation [GO:0099040]; circadian rhythm [GO:0007623]; daunorubicin transport [GO:0043215]; establishment of blood-brain barrier [GO:0060856]; establishment of blood-retinal barrier [GO:1990963]; export across plasma membrane [GO:0140115]; female pregnancy [GO:0007565]; G2/M transition of mitotic cell cycle [GO:0000086]; hormone transport [GO:0009914]; intestinal absorption [GO:0050892]; lactation [GO:0007595]; maintenance of blood-brain barrier [GO:0035633]; negative regulation of sensory perception of pain [GO:1904057]; phospholipid translocation [GO:0045332]; placenta development [GO:0001890]; positive regulation of establishment of Sertoli cell barrier [GO:1904446]; positive regulation of response to drug [GO:2001025]; protein localization to bicellular tight junction [GO:1902396]; regulation of chloride transport [GO:2001225]; regulation of intestinal absorption [GO:1904478]; response to alcohol [GO:0097305]; response to antineoplastic agent [GO:0097327]; response to cadmium ion [GO:0046686]; response to codeine [GO:1905233]; response to cyclosporin A [GO:1905237]; response to glucagon [GO:0033762]; response to glycoside [GO:1903416]; response to hypoxia [GO:0001666]; response to progesterone [GO:0032570]; response to quercetin [GO:1905235]; response to thyroxine [GO:0097068]; response to vitamin A [GO:0033189]; response to vitamin D [GO:0033280]; response to xenobiotic stimulus [GO:0009410]; stem cell proliferation [GO:0072089]; terpenoid transport [GO:0046865]; transepithelial transport [GO:0070633]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104]; xenobiotic detoxification by transmembrane export across the plasma membrane [GO:1990961]; xenobiotic metabolic process [GO:0006805]; xenobiotic transport across blood-brain barrier [GO:1990962] apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; external side of apical plasma membrane [GO:0098591]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; plasma membrane [GO:0005886] ABC-type xenobiotic transporter activity [GO:0008559]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; carboxylic acid transmembrane transporter activity [GO:0046943]; ceramide floppase activity [GO:0099038]; efflux transmembrane transporter activity [GO:0015562]; floppase activity [GO:0140328]; phosphatidylcholine floppase activity [GO:0090554]; phosphatidylethanolamine flippase activity [GO:0090555]; phosphatidylethanolamine floppase activity [GO:0140341]; transmembrane transporter activity [GO:0022857]; ubiquitin protein ligase binding [GO:0031625]; xenobiotic transmembrane transporter activity [GO:0042910] g9636.t1 P08183 40.076 524 1.18e-103 362.0 sp|P08183|MDR1_HUMAN ATP-dependent translocase ABCB1 OS=Homo sapiens OX=9606 GN=ABCB1 PE=1 SV=3 MDR1_HUMAN reviewed ATP-dependent translocase ABCB1 (ATP-binding cassette sub-family B member 1) (Multidrug resistance protein 1) (EC 7.6.2.2) (P-glycoprotein 1) (Phospholipid transporter ABCB1) (EC 7.6.2.1) (CD antigen CD243) Homo sapiens (Human) GO:0000086; GO:0001666; GO:0001890; GO:0005524; GO:0005737; GO:0005886; GO:0006805; GO:0007565; GO:0007595; GO:0007623; GO:0008559; GO:0009410; GO:0009914; GO:0009986; GO:0015562; GO:0016020; GO:0016324; GO:0016887; GO:0022857; GO:0031526; GO:0031625; GO:0032570; GO:0033189; GO:0033280; GO:0033762; GO:0035633; GO:0036146; GO:0042626; GO:0042910; GO:0043215; GO:0045332; GO:0046686; GO:0046865; GO:0046943; GO:0050892; GO:0055085; GO:0060856; GO:0070062; GO:0070633; GO:0071217; GO:0071222; GO:0071236; GO:0071312; GO:0071356; GO:0071392; GO:0071475; GO:0071549; GO:0072089; GO:0090554; GO:0090555; GO:0097068; GO:0097305; GO:0097327; GO:0098591; GO:0099038; GO:0099040; GO:0140115; GO:0140328; GO:0140341; GO:0150104; GO:1902396; GO:1903416; GO:1904057; GO:1904148; GO:1904446; GO:1904478; GO:1905039; GO:1905231; GO:1905232; GO:1905233; GO:1905235; GO:1905237; GO:1990961; GO:1990962; GO:1990963; GO:2001025; GO:2001225 carboxylic acid transmembrane transport [GO:1905039]; cellular hyperosmotic salinity response [GO:0071475]; cellular response to alkaloid [GO:0071312]; cellular response to antibiotic [GO:0071236]; cellular response to borneol [GO:1905231]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to estradiol stimulus [GO:0071392]; cellular response to external biotic stimulus [GO:0071217]; cellular response to L-glutamate [GO:1905232]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to mycotoxin [GO:0036146]; cellular response to nonylphenol [GO:1904148]; cellular response to tumor necrosis factor [GO:0071356]; ceramide translocation [GO:0099040]; circadian rhythm [GO:0007623]; daunorubicin transport [GO:0043215]; establishment of blood-brain barrier [GO:0060856]; establishment of blood-retinal barrier [GO:1990963]; export across plasma membrane [GO:0140115]; female pregnancy [GO:0007565]; G2/M transition of mitotic cell cycle [GO:0000086]; hormone transport [GO:0009914]; intestinal absorption [GO:0050892]; lactation [GO:0007595]; maintenance of blood-brain barrier [GO:0035633]; negative regulation of sensory perception of pain [GO:1904057]; phospholipid translocation [GO:0045332]; placenta development [GO:0001890]; positive regulation of establishment of Sertoli cell barrier [GO:1904446]; positive regulation of response to drug [GO:2001025]; protein localization to bicellular tight junction [GO:1902396]; regulation of chloride transport [GO:2001225]; regulation of intestinal absorption [GO:1904478]; response to alcohol [GO:0097305]; response to antineoplastic agent [GO:0097327]; response to cadmium ion [GO:0046686]; response to codeine [GO:1905233]; response to cyclosporin A [GO:1905237]; response to glucagon [GO:0033762]; response to glycoside [GO:1903416]; response to hypoxia [GO:0001666]; response to progesterone [GO:0032570]; response to quercetin [GO:1905235]; response to thyroxine [GO:0097068]; response to vitamin A [GO:0033189]; response to vitamin D [GO:0033280]; response to xenobiotic stimulus [GO:0009410]; stem cell proliferation [GO:0072089]; terpenoid transport [GO:0046865]; transepithelial transport [GO:0070633]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104]; xenobiotic detoxification by transmembrane export across the plasma membrane [GO:1990961]; xenobiotic metabolic process [GO:0006805]; xenobiotic transport across blood-brain barrier [GO:1990962] apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; external side of apical plasma membrane [GO:0098591]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; plasma membrane [GO:0005886] ABC-type xenobiotic transporter activity [GO:0008559]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; carboxylic acid transmembrane transporter activity [GO:0046943]; ceramide floppase activity [GO:0099038]; efflux transmembrane transporter activity [GO:0015562]; floppase activity [GO:0140328]; phosphatidylcholine floppase activity [GO:0090554]; phosphatidylethanolamine flippase activity [GO:0090555]; phosphatidylethanolamine floppase activity [GO:0140341]; transmembrane transporter activity [GO:0022857]; ubiquitin protein ligase binding [GO:0031625]; xenobiotic transmembrane transporter activity [GO:0042910] g9637.t1 Q5R9A7 28.939 660 4.21e-81 277.0 sp|Q5R9A7|LYCHS_PONAB Lysosomal cholesterol signaling protein OS=Pongo abelii OX=9601 GN=GPR155 PE=2 SV=1 LYCHS_PONAB reviewed Lysosomal cholesterol signaling protein (LYCHOS) (Integral membrane protein GPR155) Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0005765; GO:0015485; GO:0030514; GO:0034198; GO:0035556; GO:0055085; GO:0071397; GO:1904263 cellular response to amino acid starvation [GO:0034198]; cellular response to cholesterol [GO:0071397]; intracellular signal transduction [GO:0035556]; negative regulation of BMP signaling pathway [GO:0030514]; positive regulation of TORC1 signaling [GO:1904263]; transmembrane transport [GO:0055085] lysosomal membrane [GO:0005765] cholesterol binding [GO:0015485] g9638.t1 Q5R9A7 48.515 101 1.92e-35 104.0 sp|Q5R9A7|LYCHS_PONAB Lysosomal cholesterol signaling protein OS=Pongo abelii OX=9601 GN=GPR155 PE=2 SV=1 LYCHS_PONAB reviewed Lysosomal cholesterol signaling protein (LYCHOS) (Integral membrane protein GPR155) Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0005765; GO:0015485; GO:0030514; GO:0034198; GO:0035556; GO:0055085; GO:0071397; GO:1904263 cellular response to amino acid starvation [GO:0034198]; cellular response to cholesterol [GO:0071397]; intracellular signal transduction [GO:0035556]; negative regulation of BMP signaling pathway [GO:0030514]; positive regulation of TORC1 signaling [GO:1904263]; transmembrane transport [GO:0055085] lysosomal membrane [GO:0005765] cholesterol binding [GO:0015485] g9638.t1 Q5R9A7 69.231 39 1.92e-35 64.3 sp|Q5R9A7|LYCHS_PONAB Lysosomal cholesterol signaling protein OS=Pongo abelii OX=9601 GN=GPR155 PE=2 SV=1 LYCHS_PONAB reviewed Lysosomal cholesterol signaling protein (LYCHOS) (Integral membrane protein GPR155) Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0005765; GO:0015485; GO:0030514; GO:0034198; GO:0035556; GO:0055085; GO:0071397; GO:1904263 cellular response to amino acid starvation [GO:0034198]; cellular response to cholesterol [GO:0071397]; intracellular signal transduction [GO:0035556]; negative regulation of BMP signaling pathway [GO:0030514]; positive regulation of TORC1 signaling [GO:1904263]; transmembrane transport [GO:0055085] lysosomal membrane [GO:0005765] cholesterol binding [GO:0015485] g9639.t1 Q8TDX5 69.048 336 0.0 520.0 sp|Q8TDX5|ACMSD_HUMAN 2-amino-3-carboxymuconate-6-semialdehyde decarboxylase OS=Homo sapiens OX=9606 GN=ACMSD PE=1 SV=1 ACMSD_HUMAN reviewed 2-amino-3-carboxymuconate-6-semialdehyde decarboxylase (EC 4.1.1.45) (Picolinate carboxylase) Homo sapiens (Human) GO:0001760; GO:0005737; GO:0005829; GO:0006569; GO:0008270; GO:0016787; GO:0019748; GO:1904985; GO:1905004; GO:1905012 L-tryptophan catabolic process [GO:0006569]; negative regulation of quinolinate biosynthetic process [GO:1904985]; picolinic acid biosynthetic process [GO:1905004]; regulation of 'de novo' NAD biosynthetic process from L-tryptophan [GO:1905012]; secondary metabolic process [GO:0019748] cytoplasm [GO:0005737]; cytosol [GO:0005829] aminocarboxymuconate-semialdehyde decarboxylase activity [GO:0001760]; hydrolase activity [GO:0016787]; zinc ion binding [GO:0008270] g9640.t1 Q6DHF7 54.155 349 2.5099999999999998e-104 315.0 sp|Q6DHF7|GTPBA_DANRE GTP-binding protein 10 OS=Danio rerio OX=7955 GN=gtpbp10 PE=2 SV=1 g9642.t1 Q9NXF1 30.544 717 2.28e-63 234.0 sp|Q9NXF1|TEX10_HUMAN Testis-expressed protein 10 OS=Homo sapiens OX=9606 GN=TEX10 PE=1 SV=2 TEX10_HUMAN reviewed Testis-expressed protein 10 Homo sapiens (Human) GO:0005634; GO:0005654; GO:0005730; GO:0005739; GO:0071339 mitochondrion [GO:0005739]; MLL1 complex [GO:0071339]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] g9643.t1 Q5F485 65.854 615 0.0 791.0 sp|Q5F485|DDX42_CHICK ATP-dependent RNA helicase DDX42 OS=Gallus gallus OX=9031 GN=DDX42 PE=2 SV=1 DDX42_CHICK reviewed ATP-dependent RNA helicase DDX42 (EC 3.6.4.13) (DEAD box protein 42) Gallus gallus (Chicken) GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005737; GO:0008104; GO:0016887; GO:0042981; GO:0071004; GO:1903241 intracellular protein localization [GO:0008104]; regulation of apoptotic process [GO:0042981]; U2-type prespliceosome assembly [GO:1903241] cytoplasm [GO:0005737]; nucleus [GO:0005634]; U2-type prespliceosome [GO:0071004] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724] g9644.t1 P46905 28.754 313 2.64e-35 133.0 sp|P46905|YCCK_BACSU Uncharacterized oxidoreductase YccK OS=Bacillus subtilis (strain 168) OX=224308 GN=yccK PE=3 SV=2 g9645.t1 Q6XL69 27.301 326 3.78e-22 100.0 sp|Q6XL69|OPN4_RUTRU Melanopsin OS=Rutilus rutilus OX=48668 GN=opn4 PE=2 SV=1 g9647.t1 P09917 31.04 683 1.18e-103 333.0 sp|P09917|LOX5_HUMAN Polyunsaturated fatty acid 5-lipoxygenase OS=Homo sapiens OX=9606 GN=ALOX5 PE=1 SV=2 LOX5_HUMAN reviewed Polyunsaturated fatty acid 5-lipoxygenase (EC 1.13.11.-) (Arachidonate 5-lipoxygenase) (5-LO) (5-lipoxygenase) (EC 1.13.11.34) Homo sapiens (Human) GO:0001937; GO:0002232; GO:0002523; GO:0002540; GO:0004051; GO:0004052; GO:0005506; GO:0005576; GO:0005615; GO:0005635; GO:0005641; GO:0005654; GO:0005829; GO:0006691; GO:0006959; GO:0016363; GO:0016491; GO:0016525; GO:0016701; GO:0016787; GO:0019369; GO:0019370; GO:0019372; GO:0030501; GO:0031965; GO:0034440; GO:0034774; GO:0036336; GO:0036403; GO:0042593; GO:0042759; GO:0045598; GO:0048471; GO:0050727; GO:0050728; GO:0050796; GO:0061044; GO:0061045; GO:0106014; GO:1900015; GO:1900407; GO:1901753; GO:1903426; GO:1903573; GO:1903671; GO:1904813; GO:1904999; GO:2001301 arachidonate metabolic process [GO:0019369]; dendritic cell migration [GO:0036336]; glucose homeostasis [GO:0042593]; humoral immune response [GO:0006959]; leukocyte chemotaxis involved in inflammatory response [GO:0002232]; leukocyte migration involved in inflammatory response [GO:0002523]; leukotriene A4 biosynthetic process [GO:1901753]; leukotriene biosynthetic process [GO:0019370]; leukotriene metabolic process [GO:0006691]; leukotriene production involved in inflammatory response [GO:0002540]; lipid oxidation [GO:0034440]; lipoxin biosynthetic process [GO:2001301]; lipoxygenase pathway [GO:0019372]; long-chain fatty acid biosynthetic process [GO:0042759]; negative regulation of angiogenesis [GO:0016525]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of inflammatory response [GO:0050728]; negative regulation of response to endoplasmic reticulum stress [GO:1903573]; negative regulation of sprouting angiogenesis [GO:1903671]; negative regulation of vascular wound healing [GO:0061044]; negative regulation of wound healing [GO:0061045]; positive regulation of bone mineralization [GO:0030501]; positive regulation of leukocyte adhesion to arterial endothelial cell [GO:1904999]; regulation of cellular response to oxidative stress [GO:1900407]; regulation of cytokine production involved in inflammatory response [GO:1900015]; regulation of fat cell differentiation [GO:0045598]; regulation of inflammatory response [GO:0050727]; regulation of inflammatory response to wounding [GO:0106014]; regulation of insulin secretion [GO:0050796]; regulation of reactive oxygen species biosynthetic process [GO:1903426] cytosol [GO:0005829]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; ficolin-1-rich granule lumen [GO:1904813]; nuclear envelope [GO:0005635]; nuclear envelope lumen [GO:0005641]; nuclear matrix [GO:0016363]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; secretory granule lumen [GO:0034774] arachidonate 12(S)-lipoxygenase activity [GO:0004052]; arachidonate 5-lipoxygenase activity [GO:0004051]; arachidonate 8(S)-lipoxygenase activity [GO:0036403]; hydrolase activity [GO:0016787]; iron ion binding [GO:0005506]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen [GO:0016701] g9648.t1 P09917 31.287 684 7.2e-100 323.0 sp|P09917|LOX5_HUMAN Polyunsaturated fatty acid 5-lipoxygenase OS=Homo sapiens OX=9606 GN=ALOX5 PE=1 SV=2 LOX5_HUMAN reviewed Polyunsaturated fatty acid 5-lipoxygenase (EC 1.13.11.-) (Arachidonate 5-lipoxygenase) (5-LO) (5-lipoxygenase) (EC 1.13.11.34) Homo sapiens (Human) GO:0001937; GO:0002232; GO:0002523; GO:0002540; GO:0004051; GO:0004052; GO:0005506; GO:0005576; GO:0005615; GO:0005635; GO:0005641; GO:0005654; GO:0005829; GO:0006691; GO:0006959; GO:0016363; GO:0016491; GO:0016525; GO:0016701; GO:0016787; GO:0019369; GO:0019370; GO:0019372; GO:0030501; GO:0031965; GO:0034440; GO:0034774; GO:0036336; GO:0036403; GO:0042593; GO:0042759; GO:0045598; GO:0048471; GO:0050727; GO:0050728; GO:0050796; GO:0061044; GO:0061045; GO:0106014; GO:1900015; GO:1900407; GO:1901753; GO:1903426; GO:1903573; GO:1903671; GO:1904813; GO:1904999; GO:2001301 arachidonate metabolic process [GO:0019369]; dendritic cell migration [GO:0036336]; glucose homeostasis [GO:0042593]; humoral immune response [GO:0006959]; leukocyte chemotaxis involved in inflammatory response [GO:0002232]; leukocyte migration involved in inflammatory response [GO:0002523]; leukotriene A4 biosynthetic process [GO:1901753]; leukotriene biosynthetic process [GO:0019370]; leukotriene metabolic process [GO:0006691]; leukotriene production involved in inflammatory response [GO:0002540]; lipid oxidation [GO:0034440]; lipoxin biosynthetic process [GO:2001301]; lipoxygenase pathway [GO:0019372]; long-chain fatty acid biosynthetic process [GO:0042759]; negative regulation of angiogenesis [GO:0016525]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of inflammatory response [GO:0050728]; negative regulation of response to endoplasmic reticulum stress [GO:1903573]; negative regulation of sprouting angiogenesis [GO:1903671]; negative regulation of vascular wound healing [GO:0061044]; negative regulation of wound healing [GO:0061045]; positive regulation of bone mineralization [GO:0030501]; positive regulation of leukocyte adhesion to arterial endothelial cell [GO:1904999]; regulation of cellular response to oxidative stress [GO:1900407]; regulation of cytokine production involved in inflammatory response [GO:1900015]; regulation of fat cell differentiation [GO:0045598]; regulation of inflammatory response [GO:0050727]; regulation of inflammatory response to wounding [GO:0106014]; regulation of insulin secretion [GO:0050796]; regulation of reactive oxygen species biosynthetic process [GO:1903426] cytosol [GO:0005829]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; ficolin-1-rich granule lumen [GO:1904813]; nuclear envelope [GO:0005635]; nuclear envelope lumen [GO:0005641]; nuclear matrix [GO:0016363]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; secretory granule lumen [GO:0034774] arachidonate 12(S)-lipoxygenase activity [GO:0004052]; arachidonate 5-lipoxygenase activity [GO:0004051]; arachidonate 8(S)-lipoxygenase activity [GO:0036403]; hydrolase activity [GO:0016787]; iron ion binding [GO:0005506]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen [GO:0016701] g9649.t1 Q0D4Z6 27.728 559 3.57e-47 179.0 sp|Q0D4Z6|GH38_ORYSJ Indole-3-acetic acid-amido synthetase GH3.8 OS=Oryza sativa subsp. japonica OX=39947 GN=GH3.8 PE=1 SV=1 GH38_ORYSJ reviewed Indole-3-acetic acid-amido synthetase GH3.8 (EC 6.3.2.-) (Auxin-responsive GH3-like protein 8) (OsGH3-8) (OsMGH3) Oryza sativa subsp. japonica (Rice) GO:0005737; GO:0006952; GO:0009555; GO:0009851; GO:0010279; GO:0016208; GO:0016881; GO:0140964; GO:1900424 auxin biosynthetic process [GO:0009851]; defense response [GO:0006952]; intracellular auxin homeostasis [GO:0140964]; pollen development [GO:0009555]; regulation of defense response to bacterium [GO:1900424] cytoplasm [GO:0005737] acid-amino acid ligase activity [GO:0016881]; AMP binding [GO:0016208]; indole-3-acetic acid amido synthetase activity [GO:0010279] g9650.t1 Q10473 41.27 504 3.07e-129 395.0 sp|Q10473|GALT1_RAT Polypeptide N-acetylgalactosaminyltransferase 1 OS=Rattus norvegicus OX=10116 GN=Galnt1 PE=1 SV=1 GALT1_RAT reviewed Polypeptide N-acetylgalactosaminyltransferase 1 (EC 2.4.1.41) (Polypeptide GalNAc transferase 1) (GalNAc-T1) (pp-GaNTase 1) (Protein-UDP acetylgalactosaminyltransferase 1) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 1) [Cleaved into: Polypeptide N-acetylgalactosaminyltransferase 1 soluble form] Rattus norvegicus (Rat) GO:0004653; GO:0005576; GO:0005794; GO:0006493; GO:0030145; GO:0030246; GO:0032580; GO:0048471 protein O-linked glycosylation [GO:0006493] extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; perinuclear region of cytoplasm [GO:0048471] carbohydrate binding [GO:0030246]; manganese ion binding [GO:0030145]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653] g9651.t1 Q99LE6 62.881 590 0.0 713.0 sp|Q99LE6|ABCF2_MOUSE ATP-binding cassette sub-family F member 2 OS=Mus musculus OX=10090 GN=Abcf2 PE=1 SV=1 g9652.t1 A7YY46 49.518 311 1.33e-105 317.0 sp|A7YY46|PNKD_BOVIN Probable thioesterase PNKD OS=Bos taurus OX=9913 GN=PNKD PE=2 SV=1 PNKD_BOVIN reviewed Probable thioesterase PNKD (EC 3.1.2.-) Bos taurus (Bovine) GO:0004416; GO:0005739; GO:0005886; GO:0019243; GO:0046872; GO:0046929 methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione [GO:0019243]; negative regulation of neurotransmitter secretion [GO:0046929] mitochondrion [GO:0005739]; plasma membrane [GO:0005886] hydroxyacylglutathione hydrolase activity [GO:0004416]; metal ion binding [GO:0046872] g9653.t1 Q9EP75 34.375 512 2.2399999999999998e-95 301.0 sp|Q9EP75|CP4FE_MOUSE Leukotriene-B4 omega-hydroxylase 3 OS=Mus musculus OX=10090 GN=Cyp4f14 PE=1 SV=1 g9654.t1 Q9HBI6 33.333 471 6.6e-78 255.0 sp|Q9HBI6|CP4FB_HUMAN Cytochrome P450 4F11 OS=Homo sapiens OX=9606 GN=CYP4F11 PE=1 SV=3 CP4FB_HUMAN reviewed Cytochrome P450 4F11 (CYPIVF11) (EC 1.14.14.1) (3-hydroxy fatty acids omega-hydroxylase CYP4F11) (Docosahexaenoic acid omega-hydroxylase) (EC 1.14.14.79) (Long-chain fatty acid omega-monooxygenase) (EC 1.14.14.80) (Phylloquinone omega-hydroxylase CYP4F11) (EC 1.14.14.78) Homo sapiens (Human) GO:0004497; GO:0005504; GO:0005506; GO:0005789; GO:0006631; GO:0007596; GO:0016709; GO:0019369; GO:0020037; GO:0031408; GO:0042361; GO:0042376; GO:0042377; GO:0052869; GO:0097267; GO:0102033; GO:1903604 arachidonate metabolic process [GO:0019369]; blood coagulation [GO:0007596]; cytochrome metabolic process [GO:1903604]; fatty acid metabolic process [GO:0006631]; menaquinone catabolic process [GO:0042361]; omega-hydroxylase P450 pathway [GO:0097267]; oxylipin biosynthetic process [GO:0031408]; phylloquinone catabolic process [GO:0042376]; vitamin K catabolic process [GO:0042377] endoplasmic reticulum membrane [GO:0005789] arachidonate omega-hydroxylase activity [GO:0052869]; fatty acid binding [GO:0005504]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; long-chain fatty acid omega-hydroxylase activity [GO:0102033]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen [GO:0016709] g9658.t1 Q9DC50 41.92 427 4.85e-111 342.0 sp|Q9DC50|OCTC_MOUSE Peroxisomal carnitine O-octanoyltransferase OS=Mus musculus OX=10090 GN=Crot PE=1 SV=1 OCTC_MOUSE reviewed Peroxisomal carnitine O-octanoyltransferase (COT) (EC 2.3.1.137) Mus musculus (Mouse) GO:0005739; GO:0005777; GO:0006091; GO:0006631; GO:0006635; GO:0008458; GO:0009410; GO:0009437; GO:0015908; GO:0015936; GO:0051791 carnitine metabolic process [GO:0009437]; coenzyme A metabolic process [GO:0015936]; fatty acid beta-oxidation [GO:0006635]; fatty acid metabolic process [GO:0006631]; fatty acid transport [GO:0015908]; generation of precursor metabolites and energy [GO:0006091]; medium-chain fatty acid metabolic process [GO:0051791]; response to xenobiotic stimulus [GO:0009410] mitochondrion [GO:0005739]; peroxisome [GO:0005777] carnitine O-octanoyltransferase activity [GO:0008458] g9659.t1 O19094 47.581 124 1.42e-33 127.0 sp|O19094|OCTC_BOVIN Peroxisomal carnitine O-octanoyltransferase OS=Bos taurus OX=9913 GN=CROT PE=1 SV=1 g9659.t2 O19094 45.161 124 2.85e-32 123.0 sp|O19094|OCTC_BOVIN Peroxisomal carnitine O-octanoyltransferase OS=Bos taurus OX=9913 GN=CROT PE=1 SV=1 g9659.t3 O19094 40.559 143 4.66e-30 118.0 sp|O19094|OCTC_BOVIN Peroxisomal carnitine O-octanoyltransferase OS=Bos taurus OX=9913 GN=CROT PE=1 SV=1 g9662.t1 Q504Y3 41.791 134 1.3800000000000002e-27 113.0 sp|Q504Y3|ZCPW2_HUMAN Zinc finger CW-type PWWP domain protein 2 OS=Homo sapiens OX=9606 GN=ZCWPW2 PE=1 SV=1 ZCPW2_HUMAN reviewed Zinc finger CW-type PWWP domain protein 2 Homo sapiens (Human) GO:0005634; GO:0008270; GO:0140002 nucleus [GO:0005634] histone H3K4me3 reader activity [GO:0140002]; zinc ion binding [GO:0008270] g9663.t1 A4D263 30.562 445 5.11e-43 160.0 sp|A4D263|SMIP7_HUMAN Protein SPMIP7 OS=Homo sapiens OX=9606 GN=SPMIP7 PE=1 SV=2 g9664.t1 D4AD75 48.933 656 0.0 595.0 sp|D4AD75|D19L1_RAT Protein C-mannosyl-transferase DPY19L1 OS=Rattus norvegicus OX=10116 GN=Dpy19l1 PE=3 SV=1 g9666.t1 A3KP77 43.704 270 1.99e-71 224.0 sp|A3KP77|OXND1_DANRE Oxidoreductase NAD-binding domain-containing protein 1 OS=Danio rerio OX=7955 GN=oxnad1 PE=2 SV=1 g9666.t2 A3KP77 41.481 270 2.66e-66 211.0 sp|A3KP77|OXND1_DANRE Oxidoreductase NAD-binding domain-containing protein 1 OS=Danio rerio OX=7955 GN=oxnad1 PE=2 SV=1 g9666.t3 A3KP77 41.481 270 1.5500000000000001e-66 212.0 sp|A3KP77|OXND1_DANRE Oxidoreductase NAD-binding domain-containing protein 1 OS=Danio rerio OX=7955 GN=oxnad1 PE=2 SV=1 g9666.t4 A3KP77 42.574 202 4.51e-45 153.0 sp|A3KP77|OXND1_DANRE Oxidoreductase NAD-binding domain-containing protein 1 OS=Danio rerio OX=7955 GN=oxnad1 PE=2 SV=1 g9668.t1 Q8IWW6 29.67 819 2.98e-92 310.0 sp|Q8IWW6|RHG12_HUMAN Rho GTPase-activating protein 12 OS=Homo sapiens OX=9606 GN=ARHGAP12 PE=1 SV=1 RHG12_HUMAN reviewed Rho GTPase-activating protein 12 (Rho-type GTPase-activating protein 12) Homo sapiens (Human) GO:0001891; GO:0002011; GO:0005096; GO:0005737; GO:0005886; GO:0006911; GO:0007015; GO:0007264; GO:0051058; GO:0098794; GO:0098978; GO:0150052 actin filament organization [GO:0007015]; morphogenesis of an epithelial sheet [GO:0002011]; negative regulation of small GTPase mediated signal transduction [GO:0051058]; phagocytosis, engulfment [GO:0006911]; regulation of postsynapse assembly [GO:0150052]; small GTPase-mediated signal transduction [GO:0007264] cytoplasm [GO:0005737]; glutamatergic synapse [GO:0098978]; phagocytic cup [GO:0001891]; plasma membrane [GO:0005886]; postsynapse [GO:0098794] GTPase activator activity [GO:0005096] g9672.t1 Q9JJA4 54.333 300 1.32e-111 334.0 sp|Q9JJA4|WDR12_MOUSE Ribosome biogenesis protein WDR12 OS=Mus musculus OX=10090 GN=Wdr12 PE=1 SV=1 g9673.t1 Q8TCB7 62.132 272 2.26e-126 364.0 sp|Q8TCB7|METL6_HUMAN tRNA N(3)-cytidine methyltransferase METTL6 OS=Homo sapiens OX=9606 GN=METTL6 PE=1 SV=2 METL6_HUMAN reviewed tRNA N(3)-cytidine methyltransferase METTL6 (EC 2.1.1.-) (Methyltransferase-like protein 6) (hMETTL6) Homo sapiens (Human) GO:0005634; GO:0005737; GO:0006400; GO:0019899; GO:0030488; GO:0052735 tRNA methylation [GO:0030488]; tRNA modification [GO:0006400] cytoplasm [GO:0005737]; nucleus [GO:0005634] enzyme binding [GO:0019899]; tRNA (cytidine-3-)-methyltransferase activity [GO:0052735] g9674.t1 Q5RAM8 54.386 114 6.650000000000001e-37 135.0 sp|Q5RAM8|EAF1_PONAB ELL-associated factor 1 OS=Pongo abelii OX=9601 GN=EAF1 PE=2 SV=1 g9676.t1 G5EFJ9 60.861 511 0.0 591.0 sp|G5EFJ9|UN103_CAEEL Potassium voltage-gated channel unc-103 OS=Caenorhabditis elegans OX=6239 GN=unc-103 PE=1 SV=1 UN103_CAEEL reviewed Potassium voltage-gated channel unc-103 (Ether-a-go-go-related gene potassium channel homolog) (ERG homolog) (Eag-related protein homolog) (Ether-a-go-go-related protein homolog) (Uncoordinated protein 103) Caenorhabditis elegans GO:0005242; GO:0005886; GO:0006937; GO:0007617; GO:0034702; GO:0042391; GO:0046662; GO:0071805 mating behavior [GO:0007617]; potassium ion transmembrane transport [GO:0071805]; regulation of egg-laying behavior [GO:0046662]; regulation of membrane potential [GO:0042391]; regulation of muscle contraction [GO:0006937] monoatomic ion channel complex [GO:0034702]; plasma membrane [GO:0005886] inward rectifier potassium channel activity [GO:0005242] g9677.t1 O54853 54.545 154 8.9e-46 174.0 sp|O54853|KCNH6_RAT Voltage-gated inwardly rectifying potassium channel KCNH6 OS=Rattus norvegicus OX=10116 GN=Kcnh6 PE=1 SV=1 KCNH6_RAT reviewed Voltage-gated inwardly rectifying potassium channel KCNH6 (Ether-a-go-go-related gene potassium channel 2) (ERG-2) (Eag-related protein 2) (Ether-a-go-go-related protein 2) (Potassium voltage-gated channel subfamily H member 6) (Voltage-gated potassium channel subunit Kv11.2) Rattus norvegicus (Rat) GO:0005242; GO:0005249; GO:0005267; GO:0005886; GO:0006813; GO:0034702; GO:0044877; GO:0060307; GO:0071805; GO:0086013; GO:0086091 membrane repolarization during cardiac muscle cell action potential [GO:0086013]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of ventricular cardiac muscle cell membrane repolarization [GO:0060307] monoatomic ion channel complex [GO:0034702]; plasma membrane [GO:0005886] inward rectifier potassium channel activity [GO:0005242]; potassium channel activity [GO:0005267]; protein-containing complex binding [GO:0044877]; voltage-gated potassium channel activity [GO:0005249] g9679.t1 Q8VC88 56.044 182 7.1e-74 224.0 sp|Q8VC88|GRAN_MOUSE Grancalcin OS=Mus musculus OX=10090 GN=Gca PE=1 SV=1 g9679.t2 Q8VC88 57.692 182 1.58e-75 228.0 sp|Q8VC88|GRAN_MOUSE Grancalcin OS=Mus musculus OX=10090 GN=Gca PE=1 SV=1 g9680.t1 Q9NRG9 49.491 491 1.48e-149 442.0 sp|Q9NRG9|AAAS_HUMAN Aladin OS=Homo sapiens OX=9606 GN=AAAS PE=1 SV=1 AAAS_HUMAN reviewed Aladin (Adracalin) Homo sapiens (Human) GO:0000922; GO:0001578; GO:0005634; GO:0005635; GO:0005643; GO:0005654; GO:0005813; GO:0005829; GO:0006749; GO:0006913; GO:0006979; GO:0007612; GO:0009566; GO:0015031; GO:0016020; GO:0031965; GO:0035264; GO:0046822; GO:0051028; GO:0072686; GO:0090307; GO:0097229 fertilization [GO:0009566]; glutathione metabolic process [GO:0006749]; learning [GO:0007612]; microtubule bundle formation [GO:0001578]; mitotic spindle assembly [GO:0090307]; mRNA transport [GO:0051028]; multicellular organism growth [GO:0035264]; nucleocytoplasmic transport [GO:0006913]; protein transport [GO:0015031]; regulation of nucleocytoplasmic transport [GO:0046822]; response to oxidative stress [GO:0006979] centrosome [GO:0005813]; cytosol [GO:0005829]; membrane [GO:0016020]; mitotic spindle [GO:0072686]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; sperm end piece [GO:0097229]; spindle pole [GO:0000922] g9681.t1 G5CTG8 28.452 239 2.0299999999999998e-24 102.0 sp|G5CTG8|AQP11_MILTA Aquaporin-11 OS=Milnesium tardigradum OX=46460 GN=AQP11 PE=2 SV=2 g9682.t1 Q9W3M3 42.619 420 4.51e-102 337.0 sp|Q9W3M3|UBR3_DROME E3 ubiquitin-protein ligase Ubr3 OS=Drosophila melanogaster OX=7227 GN=Ubr3 PE=1 SV=4 UBR3_DROME reviewed E3 ubiquitin-protein ligase Ubr3 (EC 2.3.2.27) (E3 ubiquitin-protein transferase Ubr3) Drosophila melanogaster (Fruit fly) GO:0000151; GO:0005634; GO:0005737; GO:0005829; GO:0007605; GO:0008270; GO:0016567; GO:0043025; GO:0043066; GO:0045880; GO:0051865; GO:0061630; GO:0070936; GO:0071596 negative regulation of apoptotic process [GO:0043066]; positive regulation of smoothened signaling pathway [GO:0045880]; protein autoubiquitination [GO:0051865]; protein K48-linked ubiquitination [GO:0070936]; protein ubiquitination [GO:0016567]; sensory perception of sound [GO:0007605]; ubiquitin-dependent protein catabolic process via the N-end rule pathway [GO:0071596] cytoplasm [GO:0005737]; cytosol [GO:0005829]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151] ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] g9683.t1 Q6ZT12 33.293 817 8.050000000000001e-122 421.0 sp|Q6ZT12|UBR3_HUMAN E3 ubiquitin-protein ligase UBR3 OS=Homo sapiens OX=9606 GN=UBR3 PE=1 SV=2 UBR3_HUMAN reviewed E3 ubiquitin-protein ligase UBR3 (EC 2.3.2.27) (N-recognin-3) (RING-type E3 ubiquitin transferase UBR3) (Ubiquitin-protein ligase E3-alpha-3) (Ubiquitin-protein ligase E3-alpha-III) (Zinc finger protein 650) Homo sapiens (Human) GO:0000151; GO:0001701; GO:0001967; GO:0004842; GO:0005737; GO:0006511; GO:0007608; GO:0008270; GO:0009792; GO:0016020; GO:0016567; GO:0042048; GO:0045732; GO:0061630; GO:0071596; GO:1904878 embryo development ending in birth or egg hatching [GO:0009792]; in utero embryonic development [GO:0001701]; negative regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904878]; olfactory behavior [GO:0042048]; positive regulation of protein catabolic process [GO:0045732]; protein ubiquitination [GO:0016567]; sensory perception of smell [GO:0007608]; suckling behavior [GO:0001967]; ubiquitin-dependent protein catabolic process [GO:0006511]; ubiquitin-dependent protein catabolic process via the N-end rule pathway [GO:0071596] cytoplasm [GO:0005737]; membrane [GO:0016020]; ubiquitin ligase complex [GO:0000151] ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] g9683.t1 Q6ZT12 43.405 417 1.2299999999999998e-89 325.0 sp|Q6ZT12|UBR3_HUMAN E3 ubiquitin-protein ligase UBR3 OS=Homo sapiens OX=9606 GN=UBR3 PE=1 SV=2 UBR3_HUMAN reviewed E3 ubiquitin-protein ligase UBR3 (EC 2.3.2.27) (N-recognin-3) (RING-type E3 ubiquitin transferase UBR3) (Ubiquitin-protein ligase E3-alpha-3) (Ubiquitin-protein ligase E3-alpha-III) (Zinc finger protein 650) Homo sapiens (Human) GO:0000151; GO:0001701; GO:0001967; GO:0004842; GO:0005737; GO:0006511; GO:0007608; GO:0008270; GO:0009792; GO:0016020; GO:0016567; GO:0042048; GO:0045732; GO:0061630; GO:0071596; GO:1904878 embryo development ending in birth or egg hatching [GO:0009792]; in utero embryonic development [GO:0001701]; negative regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904878]; olfactory behavior [GO:0042048]; positive regulation of protein catabolic process [GO:0045732]; protein ubiquitination [GO:0016567]; sensory perception of smell [GO:0007608]; suckling behavior [GO:0001967]; ubiquitin-dependent protein catabolic process [GO:0006511]; ubiquitin-dependent protein catabolic process via the N-end rule pathway [GO:0071596] cytoplasm [GO:0005737]; membrane [GO:0016020]; ubiquitin ligase complex [GO:0000151] ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] g9687.t1 P70277 30.659 349 1.46e-37 142.0 sp|P70277|SIA7B_MOUSE Alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 2 OS=Mus musculus OX=10090 GN=St6galnac2 PE=1 SV=2 SIA7B_MOUSE reviewed Alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 2 (EC 2.4.3.3) (Gal-beta-1,3-GalNAc alpha-2,6-sialyltransferase) (GalNAc alpha-2,6-sialyltransferase II) (ST6GalNAc II) (ST6GalNAcII) (Sialyltransferase 7B) (SIAT7-B) Mus musculus (Mouse) GO:0000139; GO:0001665; GO:0006493; GO:1990743 protein O-linked glycosylation [GO:0006493]; protein sialylation [GO:1990743] Golgi membrane [GO:0000139] alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity [GO:0001665] g9688.t1 Q9X248 38.34 253 2.51e-46 158.0 sp|Q9X248|FABG_THEMA 3-oxoacyl-[acyl-carrier-protein] reductase FabG OS=Thermotoga maritima (strain ATCC 43589 / DSM 3109 / JCM 10099 / NBRC 100826 / MSB8) OX=243274 GN=fabG PE=3 SV=1 g9690.t1 Q9MYV9 28.966 832 4.5399999999999994e-89 306.0 sp|Q9MYV9|TRPC5_BOVIN Short transient receptor potential channel 5 OS=Bos taurus OX=9913 GN=TRPC5 PE=2 SV=2 g9691.t1 Q5BLE8 50.263 571 0.0 601.0 sp|Q5BLE8|RETST_DANRE All-trans-retinol 13,14-reductase OS=Danio rerio OX=7955 GN=retsat PE=1 SV=1 g9692.t1 Q09274 26.934 349 4.83e-34 145.0 sp|Q09274|UN105_CAEEL Degenerin-like protein unc-105 OS=Caenorhabditis elegans OX=6239 GN=unc-105 PE=1 SV=3 UN105_CAEEL reviewed Degenerin-like protein unc-105 (Uncoordinated protein 105) Caenorhabditis elegans GO:0005216; GO:0005886; GO:0006816; GO:0007517; GO:0015280; GO:0015693; GO:0016020; GO:0030154; GO:0035725 calcium ion transport [GO:0006816]; cell differentiation [GO:0030154]; magnesium ion transport [GO:0015693]; muscle organ development [GO:0007517]; sodium ion transmembrane transport [GO:0035725] membrane [GO:0016020]; plasma membrane [GO:0005886] ligand-gated sodium channel activity [GO:0015280]; monoatomic ion channel activity [GO:0005216] g9693.t1 Q9W4Y2 32.886 447 5.34e-56 199.0 sp|Q9W4Y2|PDFR_DROME PDF receptor OS=Drosophila melanogaster OX=7227 GN=Pdfr PE=1 SV=2 PDFR_DROME reviewed PDF receptor (Pigment-dispersing factor receptor) (Protein groom-of-PDF) Drosophila melanogaster (Fruit fly) GO:0004948; GO:0005886; GO:0007166; GO:0007186; GO:0007188; GO:0007189; GO:0007218; GO:0007623; GO:0008188; GO:0008528; GO:0016020; GO:0042332; GO:0042745; GO:0042749; GO:0042752; GO:0043005; GO:0043025; GO:0045475; GO:0048512; GO:0050850; GO:0055070; GO:0060086; GO:1901562 adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; cell surface receptor signaling pathway [GO:0007166]; circadian behavior [GO:0048512]; circadian rhythm [GO:0007623]; circadian sleep/wake cycle [GO:0042745]; circadian temperature homeostasis [GO:0060086]; copper ion homeostasis [GO:0055070]; G protein-coupled receptor signaling pathway [GO:0007186]; gravitaxis [GO:0042332]; locomotor rhythm [GO:0045475]; neuropeptide signaling pathway [GO:0007218]; positive regulation of calcium-mediated signaling [GO:0050850]; regulation of circadian rhythm [GO:0042752]; regulation of circadian sleep/wake cycle [GO:0042749]; response to paraquat [GO:1901562] membrane [GO:0016020]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886] calcitonin receptor activity [GO:0004948]; G protein-coupled peptide receptor activity [GO:0008528]; neuropeptide receptor activity [GO:0008188] g9695.t1 Q9W4Y2 38.587 368 1.2200000000000001e-70 237.0 sp|Q9W4Y2|PDFR_DROME PDF receptor OS=Drosophila melanogaster OX=7227 GN=Pdfr PE=1 SV=2 PDFR_DROME reviewed PDF receptor (Pigment-dispersing factor receptor) (Protein groom-of-PDF) Drosophila melanogaster (Fruit fly) GO:0004948; GO:0005886; GO:0007166; GO:0007186; GO:0007188; GO:0007189; GO:0007218; GO:0007623; GO:0008188; GO:0008528; GO:0016020; GO:0042332; GO:0042745; GO:0042749; GO:0042752; GO:0043005; GO:0043025; GO:0045475; GO:0048512; GO:0050850; GO:0055070; GO:0060086; GO:1901562 adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; cell surface receptor signaling pathway [GO:0007166]; circadian behavior [GO:0048512]; circadian rhythm [GO:0007623]; circadian sleep/wake cycle [GO:0042745]; circadian temperature homeostasis [GO:0060086]; copper ion homeostasis [GO:0055070]; G protein-coupled receptor signaling pathway [GO:0007186]; gravitaxis [GO:0042332]; locomotor rhythm [GO:0045475]; neuropeptide signaling pathway [GO:0007218]; positive regulation of calcium-mediated signaling [GO:0050850]; regulation of circadian rhythm [GO:0042752]; regulation of circadian sleep/wake cycle [GO:0042749]; response to paraquat [GO:1901562] membrane [GO:0016020]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886] calcitonin receptor activity [GO:0004948]; G protein-coupled peptide receptor activity [GO:0008528]; neuropeptide receptor activity [GO:0008188] g9697.t1 Q7Z3C6 50.514 681 0.0 639.0 sp|Q7Z3C6|ATG9A_HUMAN Autophagy-related protein 9A OS=Homo sapiens OX=9606 GN=ATG9A PE=1 SV=3 ATG9A_HUMAN reviewed Autophagy-related protein 9A (APG9-like 1) (mATG9) Homo sapiens (Human) GO:0000045; GO:0000139; GO:0000407; GO:0000423; GO:0005739; GO:0005768; GO:0005770; GO:0005776; GO:0005789; GO:0005794; GO:0005802; GO:0010936; GO:0016020; GO:0017128; GO:0031902; GO:0031966; GO:0032688; GO:0034045; GO:0034067; GO:0034497; GO:0034727; GO:0045087; GO:0055037; GO:0055038; GO:0060349; GO:0061709; GO:0097060; GO:0097300 autophagosome assembly [GO:0000045]; bone morphogenesis [GO:0060349]; innate immune response [GO:0045087]; mitophagy [GO:0000423]; negative regulation of interferon-beta production [GO:0032688]; negative regulation of macrophage cytokine production [GO:0010936]; piecemeal microautophagy of the nucleus [GO:0034727]; programmed necrotic cell death [GO:0097300]; protein localization to Golgi apparatus [GO:0034067]; protein localization to phagophore assembly site [GO:0034497]; reticulophagy [GO:0061709] autophagosome [GO:0005776]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; membrane [GO:0016020]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; phagophore assembly site [GO:0000407]; phagophore assembly site membrane [GO:0034045]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; synaptic membrane [GO:0097060]; trans-Golgi network [GO:0005802] phospholipid scramblase activity [GO:0017128] g9698.t1 O14807 73.563 174 5.06e-84 250.0 sp|O14807|RASM_HUMAN Ras-related protein M-Ras OS=Homo sapiens OX=9606 GN=MRAS PE=1 SV=2 RASM_HUMAN reviewed Ras-related protein M-Ras (EC 3.6.5.2) (Ras-related protein R-Ras3) Homo sapiens (Human) GO:0000164; GO:0003924; GO:0003925; GO:0005525; GO:0005886; GO:0007265; GO:0019003; GO:0030036; GO:0030742; GO:1990830 actin cytoskeleton organization [GO:0030036]; cellular response to leukemia inhibitory factor [GO:1990830]; Ras protein signal transduction [GO:0007265] plasma membrane [GO:0005886]; protein phosphatase type 1 complex [GO:0000164] G protein activity [GO:0003925]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTP-dependent protein binding [GO:0030742]; GTPase activity [GO:0003924] g9698.t2 O14807 73.988 173 8.99e-86 255.0 sp|O14807|RASM_HUMAN Ras-related protein M-Ras OS=Homo sapiens OX=9606 GN=MRAS PE=1 SV=2 RASM_HUMAN reviewed Ras-related protein M-Ras (EC 3.6.5.2) (Ras-related protein R-Ras3) Homo sapiens (Human) GO:0000164; GO:0003924; GO:0003925; GO:0005525; GO:0005886; GO:0007265; GO:0019003; GO:0030036; GO:0030742; GO:1990830 actin cytoskeleton organization [GO:0030036]; cellular response to leukemia inhibitory factor [GO:1990830]; Ras protein signal transduction [GO:0007265] plasma membrane [GO:0005886]; protein phosphatase type 1 complex [GO:0000164] G protein activity [GO:0003925]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTP-dependent protein binding [GO:0030742]; GTPase activity [GO:0003924] g9699.t1 Q29RV1 56.863 561 0.0 617.0 sp|Q29RV1|PDIA4_BOVIN Protein disulfide-isomerase A4 OS=Bos taurus OX=9913 GN=PDIA4 PE=2 SV=1 g9699.t1 Q29RV1 54.082 98 5.1600000000000003e-26 116.0 sp|Q29RV1|PDIA4_BOVIN Protein disulfide-isomerase A4 OS=Bos taurus OX=9913 GN=PDIA4 PE=2 SV=1 g9701.t1 Q00535 85.333 150 3.87e-93 275.0 sp|Q00535|CDK5_HUMAN Cyclin-dependent kinase 5 OS=Homo sapiens OX=9606 GN=CDK5 PE=1 SV=3 CDK5_HUMAN reviewed Cyclin-dependent kinase 5 (EC 2.7.11.1) (Cell division protein kinase 5) (Cyclin-dependent-like kinase 5) (Serine/threonine-protein kinase PSSALRE) (Tau protein kinase II catalytic subunit) (TPKII catalytic subunit) Homo sapiens (Human) GO:0000226; GO:0000307; GO:0001764; GO:0001963; GO:0002039; GO:0004672; GO:0004674; GO:0004693; GO:0005176; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0006886; GO:0007160; GO:0007268; GO:0007409; GO:0007416; GO:0007519; GO:0008045; GO:0008542; GO:0014044; GO:0014069; GO:0016020; GO:0016079; GO:0016241; GO:0016301; GO:0016533; GO:0019233; GO:0021697; GO:0021766; GO:0021819; GO:0021954; GO:0022038; GO:0030027; GO:0030036; GO:0030054; GO:0030175; GO:0030182; GO:0030334; GO:0030424; GO:0030425; GO:0030426; GO:0030517; GO:0030547; GO:0030549; GO:0031175; GO:0031397; GO:0031594; GO:0031914; GO:0032801; GO:0035249; GO:0035255; GO:0035418; GO:0042981; GO:0043005; GO:0043025; GO:0043113; GO:0043125; GO:0043204; GO:0043525; GO:0045786; GO:0045861; GO:0045892; GO:0045956; GO:0046826; GO:0048148; GO:0048156; GO:0048167; GO:0048488; GO:0048489; GO:0048511; GO:0048675; GO:0048709; GO:0048813; GO:0050321; GO:0051301; GO:0051402; GO:0051726; GO:0051879; GO:0051966; GO:0060079; GO:0061001; GO:0070509; GO:0090314; GO:0098793; GO:0099533; GO:0106310; GO:1901987; GO:1903076; GO:1903234; GO:1903421; GO:1904646 actin cytoskeleton organization [GO:0030036]; axon extension [GO:0048675]; axonogenesis [GO:0007409]; behavioral response to cocaine [GO:0048148]; calcium ion import [GO:0070509]; cell division [GO:0051301]; cell-matrix adhesion [GO:0007160]; cellular response to amyloid-beta [GO:1904646]; central nervous system neuron development [GO:0021954]; cerebellar cortex formation [GO:0021697]; chemical synaptic transmission [GO:0007268]; corpus callosum development [GO:0022038]; dendrite morphogenesis [GO:0048813]; excitatory postsynaptic potential [GO:0060079]; hippocampus development [GO:0021766]; intracellular protein transport [GO:0006886]; layer formation in cerebral cortex [GO:0021819]; microtubule cytoskeleton organization [GO:0000226]; motor neuron axon guidance [GO:0008045]; negative regulation of axon extension [GO:0030517]; negative regulation of calcium ion-dependent exocytosis of neurotransmitter [GO:1903234]; negative regulation of cell cycle [GO:0045786]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of protein export from nucleus [GO:0046826]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of proteolysis [GO:0045861]; negative regulation of synaptic plasticity [GO:0031914]; neuron apoptotic process [GO:0051402]; neuron differentiation [GO:0030182]; neuron migration [GO:0001764]; neuron projection development [GO:0031175]; oligodendrocyte differentiation [GO:0048709]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of presynaptic cytosolic calcium concentration [GO:0099533]; positive regulation of protein targeting to membrane [GO:0090314]; protein localization to synapse [GO:0035418]; receptor catabolic process [GO:0032801]; receptor clustering [GO:0043113]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of cell cycle phase transition [GO:1901987]; regulation of cell migration [GO:0030334]; regulation of dendritic spine morphogenesis [GO:0061001]; regulation of macroautophagy [GO:0016241]; regulation of protein localization to plasma membrane [GO:1903076]; regulation of synaptic plasticity [GO:0048167]; regulation of synaptic transmission, glutamatergic [GO:0051966]; regulation of synaptic vesicle recycling [GO:1903421]; rhythmic process [GO:0048511]; Schwann cell development [GO:0014044]; sensory perception of pain [GO:0019233]; skeletal muscle tissue development [GO:0007519]; synapse assembly [GO:0007416]; synaptic transmission, dopaminergic [GO:0001963]; synaptic transmission, glutamatergic [GO:0035249]; synaptic vesicle endocytosis [GO:0048488]; synaptic vesicle exocytosis [GO:0016079]; synaptic vesicle transport [GO:0048489]; visual learning [GO:0008542] axon [GO:0030424]; cell junction [GO:0030054]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; filopodium [GO:0030175]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; membrane [GO:0016020]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; presynapse [GO:0098793]; protein kinase 5 complex [GO:0016533] acetylcholine receptor activator activity [GO:0030549]; ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; ErbB-2 class receptor binding [GO:0005176]; ErbB-3 class receptor binding [GO:0043125]; Hsp90 protein binding [GO:0051879]; ionotropic glutamate receptor binding [GO:0035255]; kinase activity [GO:0016301]; p53 binding [GO:0002039]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; signaling receptor inhibitor activity [GO:0030547]; tau protein binding [GO:0048156]; tau-protein kinase activity [GO:0050321] g9702.t1 Q03114 69.072 97 1.3e-43 146.0 sp|Q03114|CDK5_RAT Cyclin-dependent kinase 5 OS=Rattus norvegicus OX=10116 GN=Cdk5 PE=1 SV=1 g9703.t1 P18841 31.548 336 6.41e-24 107.0 sp|P18841|ADA1B_MESAU Alpha-1B adrenergic receptor OS=Mesocricetus auratus OX=10036 GN=ADRA1B PE=1 SV=1 g9706.t1 O15973 27.439 328 9.77e-26 111.0 sp|O15973|OPSD1_MIZYE Rhodopsin, GQ-coupled OS=Mizuhopecten yessoensis OX=6573 GN=SCOP1 PE=1 SV=1 g9708.t1 E1B836 56.0 250 1.52e-92 276.0 sp|E1B836|ENKUR_BOVIN Enkurin OS=Bos taurus OX=9913 GN=ENKUR PE=1 SV=2 ENKUR_BOVIN reviewed Enkurin Bos taurus (Bovine) GO:0001669; GO:0005516; GO:0005879; GO:0017124; GO:0030317; GO:0036126; GO:0061966; GO:0097228; GO:0097728; GO:0160112 establishment of left/right asymmetry [GO:0061966]; flagellated sperm motility [GO:0030317] 9+0 motile cilium [GO:0097728]; acrosomal vesicle [GO:0001669]; axonemal B tubule inner sheath [GO:0160112]; axonemal microtubule [GO:0005879]; sperm flagellum [GO:0036126]; sperm principal piece [GO:0097228] calmodulin binding [GO:0005516]; SH3 domain binding [GO:0017124] g9709.t1 Q3SZ18 69.856 209 1.4799999999999997e-104 303.0 sp|Q3SZ18|HPRT_BOVIN Hypoxanthine-guanine phosphoribosyltransferase OS=Bos taurus OX=9913 GN=HPRT1 PE=2 SV=3 HPRT_BOVIN reviewed Hypoxanthine-guanine phosphoribosyltransferase (HGPRT) (HGPRTase) (EC 2.4.2.8) Bos taurus (Bovine) GO:0000166; GO:0000287; GO:0004422; GO:0005737; GO:0005829; GO:0006164; GO:0006166; GO:0006178; GO:0032263; GO:0032264; GO:0042802; GO:0043103; GO:0045964; GO:0046038; GO:0046040; GO:0046100; GO:0052657 GMP catabolic process [GO:0046038]; GMP salvage [GO:0032263]; guanine salvage [GO:0006178]; hypoxanthine metabolic process [GO:0046100]; hypoxanthine salvage [GO:0043103]; IMP metabolic process [GO:0046040]; IMP salvage [GO:0032264]; positive regulation of dopamine metabolic process [GO:0045964]; purine nucleotide biosynthetic process [GO:0006164]; purine ribonucleoside salvage [GO:0006166] cytoplasm [GO:0005737]; cytosol [GO:0005829] guanine phosphoribosyltransferase activity [GO:0052657]; hypoxanthine phosphoribosyltransferase activity [GO:0004422]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; nucleotide binding [GO:0000166] g9714.t1 Q14527 52.559 508 0.0 561.0 sp|Q14527|HLTF_HUMAN Helicase-like transcription factor OS=Homo sapiens OX=9606 GN=HLTF PE=1 SV=2 g9714.t1 Q14527 51.59 283 1.1e-78 282.0 sp|Q14527|HLTF_HUMAN Helicase-like transcription factor OS=Homo sapiens OX=9606 GN=HLTF PE=1 SV=2 g9715.t1 Q9VCA2 29.422 571 2.37e-57 204.0 sp|Q9VCA2|ORCT_DROME Organic cation transporter protein OS=Drosophila melanogaster OX=7227 GN=Orct PE=1 SV=1 g9717.t1 Q9VCA2 36.915 363 3.19e-63 214.0 sp|Q9VCA2|ORCT_DROME Organic cation transporter protein OS=Drosophila melanogaster OX=7227 GN=Orct PE=1 SV=1 g9719.t1 Q9VCA2 33.393 557 1.08e-77 258.0 sp|Q9VCA2|ORCT_DROME Organic cation transporter protein OS=Drosophila melanogaster OX=7227 GN=Orct PE=1 SV=1 g9720.t1 Q9VCA2 30.282 568 1.01e-67 231.0 sp|Q9VCA2|ORCT_DROME Organic cation transporter protein OS=Drosophila melanogaster OX=7227 GN=Orct PE=1 SV=1 g9721.t1 Q95R48 32.143 560 1.36e-75 253.0 sp|Q95R48|OCTL_DROME Organic cation transporter-like protein OS=Drosophila melanogaster OX=7227 GN=Orct2 PE=2 SV=2 g9722.t1 Q66J52 28.602 465 2.58e-60 212.0 sp|Q66J52|S226B_XENLA Solute carrier family 22 member 6-B OS=Xenopus laevis OX=8355 GN=slc22a6-b PE=2 SV=1 g9723.t1 A6QLA0 47.238 688 0.0 553.0 sp|A6QLA0|NFX1_BOVIN Transcriptional repressor NF-X1 OS=Bos taurus OX=9913 GN=NFX1 PE=2 SV=1 g9724.t1 A6QLA0 44.966 149 4.6200000000000004e-33 128.0 sp|A6QLA0|NFX1_BOVIN Transcriptional repressor NF-X1 OS=Bos taurus OX=9913 GN=NFX1 PE=2 SV=1 g9725.t1 P79145 52.427 309 2.82e-60 199.0 sp|P79145|CREM_CANLF cAMP-responsive element modulator OS=Canis lupus familiaris OX=9615 GN=CREM PE=2 SV=2 g9726.t1 O95299 45.317 331 4.16e-99 301.0 sp|O95299|NDUAA_HUMAN NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 10, mitochondrial OS=Homo sapiens OX=9606 GN=NDUFA10 PE=1 SV=1 NDUAA_HUMAN reviewed NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 10, mitochondrial (Complex I-42kD) (CI-42kD) (NADH-ubiquinone oxidoreductase 42 kDa subunit) Homo sapiens (Human) GO:0005737; GO:0005739; GO:0005743; GO:0005759; GO:0006120; GO:0008137; GO:0009060; GO:0042776; GO:0045271 aerobic respiration [GO:0009060]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; proton motive force-driven mitochondrial ATP synthesis [GO:0042776] cytoplasm [GO:0005737]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; respiratory chain complex I [GO:0045271] NADH dehydrogenase (ubiquinone) activity [GO:0008137] g9727.t1 Q6PHS6 39.968 628 2.92e-160 488.0 sp|Q6PHS6|SNX13_MOUSE Sorting nexin-13 OS=Mus musculus OX=10090 GN=Snx13 PE=2 SV=1 g9728.t1 Q6PHS6 41.695 295 1.4099999999999999e-61 214.0 sp|Q6PHS6|SNX13_MOUSE Sorting nexin-13 OS=Mus musculus OX=10090 GN=Snx13 PE=2 SV=1 g9729.t1 Q8WZA2 56.183 1027 0.0 1150.0 sp|Q8WZA2|RPGF4_HUMAN Rap guanine nucleotide exchange factor 4 OS=Homo sapiens OX=9606 GN=RAPGEF4 PE=1 SV=1 RPGF4_HUMAN reviewed Rap guanine nucleotide exchange factor 4 (Exchange factor directly activated by cAMP 2) (Exchange protein directly activated by cAMP 2) (EPAC 2) (cAMP-regulated guanine nucleotide exchange factor II) (cAMP-GEFII) Homo sapiens (Human) GO:0002250; GO:0005085; GO:0005829; GO:0005886; GO:0007186; GO:0007189; GO:0007265; GO:0016020; GO:0017156; GO:0017157; GO:0030073; GO:0030552; GO:0030674; GO:0031267; GO:0032024; GO:0098686; GO:0098693 adaptive immune response [GO:0002250]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; calcium-ion regulated exocytosis [GO:0017156]; G protein-coupled receptor signaling pathway [GO:0007186]; insulin secretion [GO:0030073]; positive regulation of insulin secretion [GO:0032024]; Ras protein signal transduction [GO:0007265]; regulation of exocytosis [GO:0017157]; regulation of synaptic vesicle cycle [GO:0098693] cytosol [GO:0005829]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; membrane [GO:0016020]; plasma membrane [GO:0005886] cAMP binding [GO:0030552]; guanyl-nucleotide exchange factor activity [GO:0005085]; protein-macromolecule adaptor activity [GO:0030674]; small GTPase binding [GO:0031267] g9729.t2 Q8WZA2 54.848 1052 0.0 1135.0 sp|Q8WZA2|RPGF4_HUMAN Rap guanine nucleotide exchange factor 4 OS=Homo sapiens OX=9606 GN=RAPGEF4 PE=1 SV=1 RPGF4_HUMAN reviewed Rap guanine nucleotide exchange factor 4 (Exchange factor directly activated by cAMP 2) (Exchange protein directly activated by cAMP 2) (EPAC 2) (cAMP-regulated guanine nucleotide exchange factor II) (cAMP-GEFII) Homo sapiens (Human) GO:0002250; GO:0005085; GO:0005829; GO:0005886; GO:0007186; GO:0007189; GO:0007265; GO:0016020; GO:0017156; GO:0017157; GO:0030073; GO:0030552; GO:0030674; GO:0031267; GO:0032024; GO:0098686; GO:0098693 adaptive immune response [GO:0002250]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; calcium-ion regulated exocytosis [GO:0017156]; G protein-coupled receptor signaling pathway [GO:0007186]; insulin secretion [GO:0030073]; positive regulation of insulin secretion [GO:0032024]; Ras protein signal transduction [GO:0007265]; regulation of exocytosis [GO:0017157]; regulation of synaptic vesicle cycle [GO:0098693] cytosol [GO:0005829]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; membrane [GO:0016020]; plasma membrane [GO:0005886] cAMP binding [GO:0030552]; guanyl-nucleotide exchange factor activity [GO:0005085]; protein-macromolecule adaptor activity [GO:0030674]; small GTPase binding [GO:0031267] g9730.t1 Q9Z2J0 51.937 568 0.0 568.0 sp|Q9Z2J0|S23A1_MOUSE Solute carrier family 23 member 1 OS=Mus musculus OX=10090 GN=Slc23a1 PE=1 SV=2 S23A1_MOUSE reviewed Solute carrier family 23 member 1 (Na(+)/L-ascorbic acid transporter 1) (Sodium-dependent vitamin C transporter 1) (Yolk sac permease-like molecule 3) Mus musculus (Mouse) GO:0005737; GO:0005886; GO:0005903; GO:0006814; GO:0007420; GO:0008520; GO:0009636; GO:0009925; GO:0015081; GO:0015143; GO:0015229; GO:0015882; GO:0016324; GO:0030324; GO:0033300; GO:0043229; GO:0070837 brain development [GO:0007420]; dehydroascorbic acid transport [GO:0070837]; L-ascorbic acid transmembrane transport [GO:0015882]; lung development [GO:0030324]; response to toxic substance [GO:0009636]; sodium ion transport [GO:0006814] apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; brush border [GO:0005903]; cytoplasm [GO:0005737]; intracellular organelle [GO:0043229]; plasma membrane [GO:0005886] dehydroascorbic acid transmembrane transporter activity [GO:0033300]; L-ascorbate:sodium symporter activity [GO:0008520]; L-ascorbic acid transmembrane transporter activity [GO:0015229]; sodium ion transmembrane transporter activity [GO:0015081]; urate transmembrane transporter activity [GO:0015143] g9730.t2 Q9Z2J0 51.845 569 0.0 567.0 sp|Q9Z2J0|S23A1_MOUSE Solute carrier family 23 member 1 OS=Mus musculus OX=10090 GN=Slc23a1 PE=1 SV=2 S23A1_MOUSE reviewed Solute carrier family 23 member 1 (Na(+)/L-ascorbic acid transporter 1) (Sodium-dependent vitamin C transporter 1) (Yolk sac permease-like molecule 3) Mus musculus (Mouse) GO:0005737; GO:0005886; GO:0005903; GO:0006814; GO:0007420; GO:0008520; GO:0009636; GO:0009925; GO:0015081; GO:0015143; GO:0015229; GO:0015882; GO:0016324; GO:0030324; GO:0033300; GO:0043229; GO:0070837 brain development [GO:0007420]; dehydroascorbic acid transport [GO:0070837]; L-ascorbic acid transmembrane transport [GO:0015882]; lung development [GO:0030324]; response to toxic substance [GO:0009636]; sodium ion transport [GO:0006814] apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; brush border [GO:0005903]; cytoplasm [GO:0005737]; intracellular organelle [GO:0043229]; plasma membrane [GO:0005886] dehydroascorbic acid transmembrane transporter activity [GO:0033300]; L-ascorbate:sodium symporter activity [GO:0008520]; L-ascorbic acid transmembrane transporter activity [GO:0015229]; sodium ion transmembrane transporter activity [GO:0015081]; urate transmembrane transporter activity [GO:0015143] g9733.t1 Q7ZX22 44.81 790 0.0 647.0 sp|Q7ZX22|WDR24_XENLA GATOR2 complex protein WDR24 OS=Xenopus laevis OX=8355 GN=wdr24 PE=2 SV=1 WDR24_XENLA reviewed GATOR2 complex protein WDR24 (EC 2.3.2.27) Xenopus laevis (African clawed frog) GO:0005765; GO:0005774; GO:0005829; GO:0006914; GO:0008270; GO:0016239; GO:0031669; GO:0034198; GO:0061630; GO:0061700; GO:0085020; GO:1904263 autophagy [GO:0006914]; cellular response to amino acid starvation [GO:0034198]; cellular response to nutrient levels [GO:0031669]; positive regulation of macroautophagy [GO:0016239]; positive regulation of TORC1 signaling [GO:1904263]; protein K6-linked ubiquitination [GO:0085020] cytosol [GO:0005829]; GATOR2 complex [GO:0061700]; lysosomal membrane [GO:0005765]; vacuolar membrane [GO:0005774] ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] g9735.t1 B5DE93 59.57 465 3.569999999999999e-170 541.0 sp|B5DE93|CDK12_XENTR Cyclin-dependent kinase 12 OS=Xenopus tropicalis OX=8364 GN=cdk12 PE=2 SV=1 CDK12_XENTR reviewed Cyclin-dependent kinase 12 (EC 2.7.11.22) (EC 2.7.11.23) (Cell division protein kinase 12) Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0004693; GO:0005524; GO:0005634; GO:0006397; GO:0008024; GO:0008353; GO:0008380; GO:0016607; GO:0019908; GO:0030332; GO:0032968; GO:0043405; GO:0045944; GO:0106310 mRNA processing [GO:0006397]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription elongation by RNA polymerase II [GO:0032968]; regulation of MAP kinase activity [GO:0043405]; RNA splicing [GO:0008380] cyclin/CDK positive transcription elongation factor complex [GO:0008024]; nuclear cyclin-dependent protein kinase holoenzyme complex [GO:0019908]; nuclear speck [GO:0016607]; nucleus [GO:0005634] ATP binding [GO:0005524]; cyclin binding [GO:0030332]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; protein serine kinase activity [GO:0106310]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353] g9738.t1 Q96G46 41.845 607 4.82e-155 466.0 sp|Q96G46|DUS3L_HUMAN tRNA-dihydrouridine(47) synthase [NAD(P)(+)]-like OS=Homo sapiens OX=9606 GN=DUS3L PE=1 SV=2 DUS3L_HUMAN reviewed tRNA-dihydrouridine(47) synthase [NAD(P)(+)]-like (EC 1.3.1.89) (mRNA-dihydrouridine synthase DUS3L) (EC 1.3.1.-) (tRNA-dihydrouridine synthase 3-like) Homo sapiens (Human) GO:0002943; GO:0003723; GO:0006397; GO:0006417; GO:0008270; GO:0017150; GO:0050660; GO:0102265; GO:0106414 mRNA processing [GO:0006397]; regulation of translation [GO:0006417]; tRNA dihydrouridine synthesis [GO:0002943] flavin adenine dinucleotide binding [GO:0050660]; mRNA dihydrouridine synthase activity [GO:0106414]; RNA binding [GO:0003723]; tRNA dihydrouridine synthase activity [GO:0017150]; tRNA-dihydrouridine47 synthase activity [GO:0102265]; zinc ion binding [GO:0008270] g9738.t1 Q96G46 80.597 67 3.76e-30 130.0 sp|Q96G46|DUS3L_HUMAN tRNA-dihydrouridine(47) synthase [NAD(P)(+)]-like OS=Homo sapiens OX=9606 GN=DUS3L PE=1 SV=2 DUS3L_HUMAN reviewed tRNA-dihydrouridine(47) synthase [NAD(P)(+)]-like (EC 1.3.1.89) (mRNA-dihydrouridine synthase DUS3L) (EC 1.3.1.-) (tRNA-dihydrouridine synthase 3-like) Homo sapiens (Human) GO:0002943; GO:0003723; GO:0006397; GO:0006417; GO:0008270; GO:0017150; GO:0050660; GO:0102265; GO:0106414 mRNA processing [GO:0006397]; regulation of translation [GO:0006417]; tRNA dihydrouridine synthesis [GO:0002943] flavin adenine dinucleotide binding [GO:0050660]; mRNA dihydrouridine synthase activity [GO:0106414]; RNA binding [GO:0003723]; tRNA dihydrouridine synthase activity [GO:0017150]; tRNA-dihydrouridine47 synthase activity [GO:0102265]; zinc ion binding [GO:0008270] g9741.t1 P94681 35.319 235 3.84e-31 119.0 sp|P94681|TSAC_COMTE 4-formylbenzenesulfonate dehydrogenase TsaC1/TsaC2 OS=Comamonas testosteroni OX=285 GN=tsaC1 PE=1 SV=1 g9742.t1 P12716 99.202 376 0.0 785.0 sp|P12716|ACTC_PISOC Actin, cytoplasmic OS=Pisaster ochraceus OX=7612 PE=3 SV=1 g9743.t1 P48465 42.895 373 4.43e-88 273.0 sp|P48465|ACT_CRYNH Actin OS=Cryptococcus neoformans var. grubii serotype A (strain H99 / ATCC 208821 / CBS 10515 / FGSC 9487) OX=235443 GN=CNAG_00483 PE=3 SV=2 g9744.t1 P12716 98.054 257 0.0 525.0 sp|P12716|ACTC_PISOC Actin, cytoplasmic OS=Pisaster ochraceus OX=7612 PE=3 SV=1 g9745.t1 P12431 95.556 90 5.09e-62 196.0 sp|P12431|ACTM_STRPU Actin, muscle OS=Strongylocentrotus purpuratus OX=7668 PE=3 SV=1 g9746.t1 Q5EB77 76.329 207 7.36e-113 323.0 sp|Q5EB77|RAB18_RAT Ras-related protein Rab-18 OS=Rattus norvegicus OX=10116 GN=Rab18 PE=2 SV=1 RAB18_RAT reviewed Ras-related protein Rab-18 (EC 3.6.5.2) Rattus norvegicus (Rat) GO:0001654; GO:0003924; GO:0003925; GO:0005525; GO:0005789; GO:0005794; GO:0005811; GO:0006886; GO:0007420; GO:0012505; GO:0016324; GO:0019003; GO:0033106; GO:0034389; GO:0045202; GO:0046872; GO:0051170; GO:0071782; GO:0071786 brain development [GO:0007420]; endoplasmic reticulum tubular network organization [GO:0071786]; eye development [GO:0001654]; import into nucleus [GO:0051170]; intracellular protein transport [GO:0006886]; lipid droplet organization [GO:0034389] apical plasma membrane [GO:0016324]; cis-Golgi network membrane [GO:0033106]; endomembrane system [GO:0012505]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum tubular network [GO:0071782]; Golgi apparatus [GO:0005794]; lipid droplet [GO:0005811]; synapse [GO:0045202] G protein activity [GO:0003925]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872] g9749.t1 Q5ZL23 50.996 251 2.22e-84 286.0 sp|Q5ZL23|AB1IP_CHICK Amyloid beta A4 precursor protein-binding family B member 1-interacting protein OS=Gallus gallus OX=9031 GN=APBB1IP PE=2 SV=1 g9750.t1 O95786 26.928 713 2.2e-63 236.0 sp|O95786|RIGI_HUMAN Antiviral innate immune response receptor RIG-I OS=Homo sapiens OX=9606 GN=RIGI PE=1 SV=2 RIGI_HUMAN reviewed Antiviral innate immune response receptor RIG-I (ATP-dependent RNA helicase DDX58) (EC 3.6.4.13) (DEAD box protein 58) (RIG-I-like receptor 1) (RLR-1) (RNA sensor RIG-I) (Retinoic acid-inducible gene 1 protein) (RIG-1) (Retinoic acid-inducible gene I protein) (RIG-I) Homo sapiens (Human) GO:0002230; GO:0002735; GO:0002753; GO:0003690; GO:0003724; GO:0003725; GO:0003727; GO:0005524; GO:0005525; GO:0005737; GO:0005829; GO:0005923; GO:0008270; GO:0009597; GO:0009615; GO:0010467; GO:0010628; GO:0015629; GO:0016887; GO:0030334; GO:0031625; GO:0032587; GO:0032725; GO:0032727; GO:0032728; GO:0032755; GO:0032757; GO:0032760; GO:0034344; GO:0038187; GO:0039529; GO:0042802; GO:0043330; GO:0045087; GO:0045944; GO:0051607; GO:0060760; GO:0071360; GO:0140374; GO:1990904 antiviral innate immune response [GO:0140374]; cellular response to exogenous dsRNA [GO:0071360]; cytoplasmic pattern recognition receptor signaling pathway [GO:0002753]; defense response to virus [GO:0051607]; detection of virus [GO:0009597]; gene expression [GO:0010467]; innate immune response [GO:0045087]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of gene expression [GO:0010628]; positive regulation of granulocyte macrophage colony-stimulating factor production [GO:0032725]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of myeloid dendritic cell cytokine production [GO:0002735]; positive regulation of response to cytokine stimulus [GO:0060760]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]; regulation of cell migration [GO:0030334]; regulation of type III interferon production [GO:0034344]; response to exogenous dsRNA [GO:0043330]; response to virus [GO:0009615]; RIG-I signaling pathway [GO:0039529] actin cytoskeleton [GO:0015629]; bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; ribonucleoprotein complex [GO:1990904]; ruffle membrane [GO:0032587] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; double-stranded DNA binding [GO:0003690]; double-stranded RNA binding [GO:0003725]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; pattern recognition receptor activity [GO:0038187]; RNA helicase activity [GO:0003724]; single-stranded RNA binding [GO:0003727]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270] g9752.t1 Q8R5F7 29.971 694 4.64e-61 225.0 sp|Q8R5F7|IFIH1_MOUSE Interferon-induced helicase C domain-containing protein 1 OS=Mus musculus OX=10090 GN=Ifih1 PE=1 SV=1 IFIH1_MOUSE reviewed Interferon-induced helicase C domain-containing protein 1 (EC 3.6.4.13) (Helicase with 2 CARD domains) (Helicard) (Interferon induced with helicase C domain protein 1) (Melanoma differentiation-associated protein 5) (MDA-5) (RIG-I-like receptor 2) (RLR-2) Mus musculus (Mouse) GO:0003677; GO:0003723; GO:0003724; GO:0003725; GO:0003727; GO:0005524; GO:0005634; GO:0005737; GO:0005739; GO:0008270; GO:0009299; GO:0009615; GO:0016887; GO:0016925; GO:0019904; GO:0032727; GO:0032728; GO:0032755; GO:0032760; GO:0038187; GO:0039530; GO:0042802; GO:0043021; GO:0045071; GO:0045087; GO:0051259; GO:0051607; GO:0060337; GO:0060760; GO:0071360; GO:0098586; GO:0140374 antiviral innate immune response [GO:0140374]; cellular response to exogenous dsRNA [GO:0071360]; cellular response to virus [GO:0098586]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; MDA-5 signaling pathway [GO:0039530]; mRNA transcription [GO:0009299]; negative regulation of viral genome replication [GO:0045071]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of response to cytokine stimulus [GO:0060760]; positive regulation of tumor necrosis factor production [GO:0032760]; protein complex oligomerization [GO:0051259]; protein sumoylation [GO:0016925]; response to virus [GO:0009615]; type I interferon-mediated signaling pathway [GO:0060337] cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleus [GO:0005634] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA binding [GO:0003677]; double-stranded RNA binding [GO:0003725]; identical protein binding [GO:0042802]; pattern recognition receptor activity [GO:0038187]; protein domain specific binding [GO:0019904]; ribonucleoprotein complex binding [GO:0043021]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; single-stranded RNA binding [GO:0003727]; zinc ion binding [GO:0008270] g9753.t1 Q6I6G8 58.853 802 0.0 835.0 sp|Q6I6G8|HECW2_MOUSE E3 ubiquitin-protein ligase HECW2 OS=Mus musculus OX=10090 GN=Hecw2 PE=1 SV=1 HECW2_MOUSE reviewed E3 ubiquitin-protein ligase HECW2 (EC 2.3.2.26) (HECT, C2 and WW domain-containing protein 2) (HECT-type E3 ubiquitin transferase HECW2) (NEDD4-like E3 ubiquitin-protein ligase 2) Mus musculus (Mouse) GO:0005737; GO:0006511; GO:0016567; GO:0030071; GO:0048814; GO:0061630; GO:0072686 protein ubiquitination [GO:0016567]; regulation of dendrite morphogenesis [GO:0048814]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; ubiquitin-dependent protein catabolic process [GO:0006511] cytoplasm [GO:0005737]; mitotic spindle [GO:0072686] ubiquitin protein ligase activity [GO:0061630] g9753.t1 Q6I6G8 45.748 341 1.91e-77 288.0 sp|Q6I6G8|HECW2_MOUSE E3 ubiquitin-protein ligase HECW2 OS=Mus musculus OX=10090 GN=Hecw2 PE=1 SV=1 HECW2_MOUSE reviewed E3 ubiquitin-protein ligase HECW2 (EC 2.3.2.26) (HECT, C2 and WW domain-containing protein 2) (HECT-type E3 ubiquitin transferase HECW2) (NEDD4-like E3 ubiquitin-protein ligase 2) Mus musculus (Mouse) GO:0005737; GO:0006511; GO:0016567; GO:0030071; GO:0048814; GO:0061630; GO:0072686 protein ubiquitination [GO:0016567]; regulation of dendrite morphogenesis [GO:0048814]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; ubiquitin-dependent protein catabolic process [GO:0006511] cytoplasm [GO:0005737]; mitotic spindle [GO:0072686] ubiquitin protein ligase activity [GO:0061630] g9754.t1 Q9GM70 58.519 270 4.49e-118 354.0 sp|Q9GM70|ST17A_RABIT Serine/threonine-protein kinase 17A OS=Oryctolagus cuniculus OX=9986 GN=STK17A PE=2 SV=1 g9755.t1 Q8VCH0 64.172 441 0.0 516.0 sp|Q8VCH0|THIKB_MOUSE 3-ketoacyl-CoA thiolase B, peroxisomal OS=Mus musculus OX=10090 GN=Acaa1b PE=1 SV=1 g9756.t1 Q96JG6 61.721 802 0.0 968.0 sp|Q96JG6|VPS50_HUMAN Syndetin OS=Homo sapiens OX=9606 GN=VPS50 PE=1 SV=3 g9757.t1 Q8CI71 37.821 156 1.39e-22 95.5 sp|Q8CI71|VPS50_MOUSE Syndetin OS=Mus musculus OX=10090 GN=Vps50 PE=1 SV=2 g9758.t1 Q9R1S8 42.5 160 1.99e-23 105.0 sp|Q9R1S8|CAN7_MOUSE Calpain-7 OS=Mus musculus OX=10090 GN=Capn7 PE=2 SV=1 g9759.t1 Q9R1S8 58.919 370 8.92e-152 449.0 sp|Q9R1S8|CAN7_MOUSE Calpain-7 OS=Mus musculus OX=10090 GN=Capn7 PE=2 SV=1 g9760.t1 A0FKG7 48.0 125 8.11e-35 130.0 sp|A0FKG7|CAN7_PIG Calpain-7 OS=Sus scrofa OX=9823 GN=CAPN7 PE=2 SV=1 g9761.t1 Q66IA6 37.584 149 2.2500000000000002e-29 110.0 sp|Q66IA6|LYPD6_DANRE Ly6/PLAUR domain-containing protein 6 OS=Danio rerio OX=7955 GN=lypd6 PE=1 SV=1 LYPD6_DANRE reviewed Ly6/PLAUR domain-containing protein 6 Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005886; GO:0030111; GO:0030550; GO:0045121; GO:0060061; GO:0060828; GO:0090263; GO:0098552 positive regulation of canonical Wnt signaling pathway [GO:0090263]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of Wnt signaling pathway [GO:0030111]; Spemann organizer formation [GO:0060061] membrane raft [GO:0045121]; plasma membrane [GO:0005886]; side of membrane [GO:0098552] acetylcholine receptor inhibitor activity [GO:0030550] g9763.t1 Q08CH6 50.779 321 8.97e-96 292.0 sp|Q08CH6|CATIP_DANRE Ciliogenesis-associated TTC17-interacting protein OS=Danio rerio OX=7955 GN=catip PE=1 SV=1 CATIP_DANRE reviewed Ciliogenesis-associated TTC17-interacting protein Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005634; GO:0005737; GO:0005886; GO:0015629; GO:0030041; GO:0044782; GO:0060271; GO:0061371 actin filament polymerization [GO:0030041]; cilium assembly [GO:0060271]; cilium organization [GO:0044782]; determination of heart left/right asymmetry [GO:0061371] actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886] g9764.t1 O08810 82.202 972 0.0 1649.0 sp|O08810|U5S1_MOUSE 116 kDa U5 small nuclear ribonucleoprotein component OS=Mus musculus OX=10090 GN=Eftud2 PE=1 SV=1 U5S1_MOUSE reviewed 116 kDa U5 small nuclear ribonucleoprotein component (Elongation factor Tu GTP-binding domain-containing protein 2) (U5 snRNP-specific protein, 116 kDa) (U5-116 kDa) Mus musculus (Mouse) GO:0000398; GO:0003924; GO:0005525; GO:0005634; GO:0005654; GO:0005681; GO:0005829; GO:0015030; GO:0016607; GO:0030623; GO:0046540; GO:0071005; GO:0071007; GO:0071013 mRNA splicing, via spliceosome [GO:0000398] Cajal body [GO:0015030]; catalytic step 2 spliceosome [GO:0071013]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U2-type catalytic step 2 spliceosome [GO:0071007]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540] GTP binding [GO:0005525]; GTPase activity [GO:0003924]; U5 snRNA binding [GO:0030623] g9770.t1 Q16602 42.019 426 5.7e-99 311.0 sp|Q16602|CALRL_HUMAN Calcitonin gene-related peptide type 1 receptor OS=Homo sapiens OX=9606 GN=CALCRL PE=1 SV=3 CALRL_HUMAN reviewed Calcitonin gene-related peptide type 1 receptor (CGRP type 1 receptor) (Calcitonin receptor-like receptor) (CRLR) Homo sapiens (Human) GO:0001525; GO:0001605; GO:0001635; GO:0004930; GO:0004948; GO:0005737; GO:0005764; GO:0005768; GO:0005783; GO:0005886; GO:0006816; GO:0007166; GO:0007187; GO:0007189; GO:0007507; GO:0015031; GO:0031623; GO:0071329; GO:1903143; GO:1904707; GO:1990406; GO:1990408; GO:1990409; GO:1990410; GO:1990874 adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adrenomedullin receptor signaling pathway [GO:1990410]; angiogenesis [GO:0001525]; calcitonin gene-related peptide receptor signaling pathway [GO:1990408]; calcium ion transport [GO:0006816]; cell surface receptor signaling pathway [GO:0007166]; cellular response to sucrose stimulus [GO:0071329]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; heart development [GO:0007507]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; protein transport [GO:0015031]; receptor internalization [GO:0031623]; vascular associated smooth muscle cell proliferation [GO:1990874] adrenomedullin receptor complex [GO:1903143]; CGRP receptor complex [GO:1990406]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; lysosome [GO:0005764]; plasma membrane [GO:0005886] adrenomedullin binding [GO:1990409]; adrenomedullin receptor activity [GO:0001605]; calcitonin gene-related peptide receptor activity [GO:0001635]; calcitonin receptor activity [GO:0004948]; G protein-coupled receptor activity [GO:0004930] g9771.t1 O42603 35.949 395 5.840000000000001e-59 205.0 sp|O42603|CRFR2_XENLA Corticotropin-releasing factor receptor 2 OS=Xenopus laevis OX=8355 GN=crhr2 PE=2 SV=1 g9774.t1 Q80UG8 55.577 520 0.0 597.0 sp|Q80UG8|TTLL4_MOUSE Tubulin monoglutamylase TTLL4 OS=Mus musculus OX=10090 GN=Ttll4 PE=1 SV=3 TTLL4_MOUSE reviewed Tubulin monoglutamylase TTLL4 (EC 6.3.2.-) (Protein monoglutamylase TTLL4) (Tubulin--tyrosine ligase-like protein 4) Mus musculus (Mouse) GO:0000226; GO:0005524; GO:0005737; GO:0005874; GO:0015631; GO:0018095; GO:0018200; GO:0036064; GO:0046872; GO:0070739; GO:0070740; GO:0097731; GO:0106437; GO:0120222 microtubule cytoskeleton organization [GO:0000226]; peptidyl-glutamic acid modification [GO:0018200]; protein polyglutamylation [GO:0018095]; regulation of blastocyst development [GO:0120222] 9+0 non-motile cilium [GO:0097731]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; microtubule [GO:0005874] ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein-glutamic acid ligase activity [GO:0070739]; protein-glutamic acid ligase activity, initiating [GO:0106437]; tubulin binding [GO:0015631]; tubulin-glutamic acid ligase activity [GO:0070740] g9775.t1 O95954 60.037 538 0.0 633.0 sp|O95954|FTCD_HUMAN Formimidoyltransferase-cyclodeaminase OS=Homo sapiens OX=9606 GN=FTCD PE=1 SV=2 FTCD_HUMAN reviewed Formimidoyltransferase-cyclodeaminase (Formiminotransferase-cyclodeaminase) (FTCD) (LCHC1) [Includes: Glutamate formimidoyltransferase (EC 2.1.2.5) (Glutamate formiminotransferase) (Glutamate formyltransferase); Formimidoyltetrahydrofolate cyclodeaminase (EC 4.3.1.4) (Formiminotetrahydrofolate cyclodeaminase)] Homo sapiens (Human) GO:0000139; GO:0005542; GO:0005737; GO:0005783; GO:0005793; GO:0005794; GO:0005814; GO:0005829; GO:0005886; GO:0006760; GO:0007010; GO:0008017; GO:0019556; GO:0019557; GO:0030409; GO:0030412; GO:0030868; GO:0070062 cytoskeleton organization [GO:0007010]; folic acid-containing compound metabolic process [GO:0006760]; L-histidine catabolic process to glutamate and formamide [GO:0019556]; L-histidine catabolic process to glutamate and formate [GO:0019557] centriole [GO:0005814]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886]; smooth endoplasmic reticulum membrane [GO:0030868] folic acid binding [GO:0005542]; formimidoyltetrahydrofolate cyclodeaminase activity [GO:0030412]; glutamate formimidoyltransferase activity [GO:0030409]; microtubule binding [GO:0008017] g9776.t1 Q3ZC25 34.171 199 2.66e-25 104.0 sp|Q3ZC25|T106B_BOVIN Transmembrane protein 106B OS=Bos taurus OX=9913 GN=TMEM106B PE=2 SV=1 T106B_BOVIN reviewed Transmembrane protein 106B Bos taurus (Bovine) GO:0005764; GO:0005765; GO:0005886; GO:0007040; GO:0007041; GO:0031902; GO:0032418; GO:0048813; GO:0051117 dendrite morphogenesis [GO:0048813]; lysosomal transport [GO:0007041]; lysosome localization [GO:0032418]; lysosome organization [GO:0007040] late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; plasma membrane [GO:0005886] ATPase binding [GO:0051117] g9778.t1 O54826 79.255 188 7.91e-102 350.0 sp|O54826|AF10_MOUSE Protein AF-10 OS=Mus musculus OX=10090 GN=Mllt10 PE=1 SV=2 g9780.t1 Q61712 68.794 141 9.079999999999999e-54 183.0 sp|Q61712|DNJC1_MOUSE DnaJ homolog subfamily C member 1 OS=Mus musculus OX=10090 GN=Dnajc1 PE=1 SV=1 DNJC1_MOUSE reviewed DnaJ homolog subfamily C member 1 (DnaJ protein homolog MTJ1) Mus musculus (Mouse) GO:0003677; GO:0005634; GO:0005783; GO:0005788; GO:0005789; GO:0005886; GO:0006417; GO:0006457; GO:0012505; GO:0016020; GO:0031965; GO:0043022; GO:0050708; GO:0051087 protein folding [GO:0006457]; regulation of protein secretion [GO:0050708]; regulation of translation [GO:0006417] endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; plasma membrane [GO:0005886] DNA binding [GO:0003677]; protein-folding chaperone binding [GO:0051087]; ribosome binding [GO:0043022] g9781.t1 Q96KC8 35.593 236 7.51e-31 124.0 sp|Q96KC8|DNJC1_HUMAN DnaJ homolog subfamily C member 1 OS=Homo sapiens OX=9606 GN=DNAJC1 PE=1 SV=1 DNJC1_HUMAN reviewed DnaJ homolog subfamily C member 1 (DnaJ protein homolog MTJ1) Homo sapiens (Human) GO:0001671; GO:0003677; GO:0005783; GO:0005789; GO:0005886; GO:0006417; GO:0006457; GO:0012505; GO:0016020; GO:0031965; GO:0045861; GO:0050708; GO:0051087 negative regulation of proteolysis [GO:0045861]; protein folding [GO:0006457]; regulation of protein secretion [GO:0050708]; regulation of translation [GO:0006417] endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; plasma membrane [GO:0005886] ATPase activator activity [GO:0001671]; DNA binding [GO:0003677]; protein-folding chaperone binding [GO:0051087] g9782.t1 O02695 56.111 540 0.0 569.0 sp|O02695|PTPR2_MACNE Receptor-type tyrosine-protein phosphatase N2 OS=Macaca nemestrina OX=9545 GN=PTPRN2 PE=2 SV=1 g9783.t1 A4IIW9 28.653 527 3.4e-40 160.0 sp|A4IIW9|LIGO1_XENTR Leucine-rich repeat and immunoglobulin-like domain-containing nogo receptor-interacting protein 1 OS=Xenopus tropicalis OX=8364 GN=lingo1 PE=2 SV=1 g9784.t1 Q8IVI9 25.697 502 1.12e-36 145.0 sp|Q8IVI9|NOSTN_HUMAN Nostrin OS=Homo sapiens OX=9606 GN=NOSTRIN PE=1 SV=2 NOSTN_HUMAN reviewed Nostrin (BM247 homolog) (Nitric oxide synthase traffic inducer) (Nitric oxide synthase trafficker) (eNOS-trafficking inducer) Homo sapiens (Human) GO:0003677; GO:0005634; GO:0005856; GO:0005886; GO:0006897; GO:0007165; GO:0030666; GO:0045892 endocytosis [GO:0006897]; negative regulation of DNA-templated transcription [GO:0045892]; signal transduction [GO:0007165] cytoskeleton [GO:0005856]; endocytic vesicle membrane [GO:0030666]; nucleus [GO:0005634]; plasma membrane [GO:0005886] DNA binding [GO:0003677] g9788.t1 Q8WPA2 30.537 298 9.28e-27 113.0 sp|Q8WPA2|AR_BOMMO Allatostatin-A receptor OS=Bombyx mori OX=7091 GN=AR PE=2 SV=1 g9791.t1 Q7TNE1 59.305 403 1.4599999999999998e-180 514.0 sp|Q7TNE1|SUCHY_MOUSE Succinyl-CoA:glutarate CoA-transferase OS=Mus musculus OX=10090 GN=Sugct PE=1 SV=2 g9793.t1 Q9JK91 58.961 770 0.0 929.0 sp|Q9JK91|MLH1_MOUSE DNA mismatch repair protein Mlh1 OS=Mus musculus OX=10090 GN=Mlh1 PE=1 SV=2 MLH1_MOUSE reviewed DNA mismatch repair protein Mlh1 (MutL protein homolog 1) Mus musculus (Mouse) GO:0000289; GO:0000712; GO:0000793; GO:0000794; GO:0000795; GO:0001673; GO:0002204; GO:0003682; GO:0003697; GO:0005524; GO:0005634; GO:0005654; GO:0005694; GO:0005712; GO:0005715; GO:0006281; GO:0006298; GO:0006303; GO:0006974; GO:0007060; GO:0007129; GO:0007131; GO:0007140; GO:0007283; GO:0008047; GO:0008630; GO:0009617; GO:0016321; GO:0016446; GO:0016447; GO:0016887; GO:0019899; GO:0032137; GO:0032389; GO:0032407; GO:0043060; GO:0045132; GO:0045141; GO:0045143; GO:0045190; GO:0045950; GO:0048298; GO:0048304; GO:0048477; GO:0051257; GO:0051321; GO:0140664 DNA damage response [GO:0006974]; DNA repair [GO:0006281]; double-strand break repair via nonhomologous end joining [GO:0006303]; female meiosis chromosome segregation [GO:0016321]; homologous chromosome pairing at meiosis [GO:0007129]; homologous chromosome segregation [GO:0045143]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; isotype switching [GO:0045190]; male meiosis chromosome segregation [GO:0007060]; male meiotic nuclear division [GO:0007140]; meiotic cell cycle [GO:0051321]; meiotic chromosome segregation [GO:0045132]; meiotic metaphase I homologous chromosome alignment [GO:0043060]; meiotic spindle midzone assembly [GO:0051257]; meiotic telomere clustering [GO:0045141]; mismatch repair [GO:0006298]; negative regulation of mitotic recombination [GO:0045950]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; oogenesis [GO:0048477]; positive regulation of isotype switching to IgA isotypes [GO:0048298]; positive regulation of isotype switching to IgG isotypes [GO:0048304]; reciprocal meiotic recombination [GO:0007131]; resolution of meiotic recombination intermediates [GO:0000712]; response to bacterium [GO:0009617]; somatic hypermutation of immunoglobulin genes [GO:0016446]; somatic recombination of immunoglobulin gene segments [GO:0016447]; somatic recombination of immunoglobulin genes involved in immune response [GO:0002204]; spermatogenesis [GO:0007283] chiasma [GO:0005712]; chromosome [GO:0005694]; condensed chromosome [GO:0000793]; condensed nuclear chromosome [GO:0000794]; late recombination nodule [GO:0005715]; male germ cell nucleus [GO:0001673]; MutLalpha complex [GO:0032389]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; synaptonemal complex [GO:0000795] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent DNA damage sensor activity [GO:0140664]; chromatin binding [GO:0003682]; enzyme activator activity [GO:0008047]; enzyme binding [GO:0019899]; guanine/thymine mispair binding [GO:0032137]; MutSalpha complex binding [GO:0032407]; single-stranded DNA binding [GO:0003697] g9795.t1 F4KGU4 31.058 1626 0.0 638.0 sp|F4KGU4|DEAHC_ARATH ATP-dependent RNA helicase DEAH12, chloroplastic OS=Arabidopsis thaliana OX=3702 GN=At5g10370 PE=3 SV=1 g9796.t1 Q9BUQ8 69.927 685 0.0 885.0 sp|Q9BUQ8|DDX23_HUMAN Probable ATP-dependent RNA helicase DDX23 OS=Homo sapiens OX=9606 GN=DDX23 PE=1 SV=3 g9797.t1 Q7K237 47.843 255 2.7800000000000003e-73 234.0 sp|Q7K237|C1GLT_DROME Glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase 1 OS=Drosophila melanogaster OX=7227 GN=C1GalTA PE=1 SV=1 C1GLT_DROME reviewed Glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase 1 (EC 2.4.1.122) (Core 1 O-glycan T-synthase) (Core 1 UDP-galactose:N-acetylgalactosamine-alpha-R beta 1,3-galactosyltransferase 1) (Core 1 beta1,3-galactosyltransferase 1) (C1GalT1) (Core 1 beta3-Gal-T1) Drosophila melanogaster (Fruit fly) GO:0000139; GO:0000166; GO:0007528; GO:0009247; GO:0016020; GO:0016263; GO:0016266; GO:0021551; GO:0030145; GO:0042803; GO:0048531; GO:0051489; GO:0055001; GO:1902037 central nervous system morphogenesis [GO:0021551]; glycolipid biosynthetic process [GO:0009247]; muscle cell development [GO:0055001]; negative regulation of hematopoietic stem cell differentiation [GO:1902037]; neuromuscular junction development [GO:0007528]; protein O-linked glycosylation via N-acetyl-galactosamine [GO:0016266]; regulation of filopodium assembly [GO:0051489] Golgi membrane [GO:0000139]; membrane [GO:0016020] beta-1,3-galactosyltransferase activity [GO:0048531]; glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase activity [GO:0016263]; manganese ion binding [GO:0030145]; nucleotide binding [GO:0000166]; protein homodimerization activity [GO:0042803] g9798.t1 Q7K237 46.545 275 1.5500000000000002e-73 236.0 sp|Q7K237|C1GLT_DROME Glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase 1 OS=Drosophila melanogaster OX=7227 GN=C1GalTA PE=1 SV=1 C1GLT_DROME reviewed Glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase 1 (EC 2.4.1.122) (Core 1 O-glycan T-synthase) (Core 1 UDP-galactose:N-acetylgalactosamine-alpha-R beta 1,3-galactosyltransferase 1) (Core 1 beta1,3-galactosyltransferase 1) (C1GalT1) (Core 1 beta3-Gal-T1) Drosophila melanogaster (Fruit fly) GO:0000139; GO:0000166; GO:0007528; GO:0009247; GO:0016020; GO:0016263; GO:0016266; GO:0021551; GO:0030145; GO:0042803; GO:0048531; GO:0051489; GO:0055001; GO:1902037 central nervous system morphogenesis [GO:0021551]; glycolipid biosynthetic process [GO:0009247]; muscle cell development [GO:0055001]; negative regulation of hematopoietic stem cell differentiation [GO:1902037]; neuromuscular junction development [GO:0007528]; protein O-linked glycosylation via N-acetyl-galactosamine [GO:0016266]; regulation of filopodium assembly [GO:0051489] Golgi membrane [GO:0000139]; membrane [GO:0016020] beta-1,3-galactosyltransferase activity [GO:0048531]; glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase activity [GO:0016263]; manganese ion binding [GO:0030145]; nucleotide binding [GO:0000166]; protein homodimerization activity [GO:0042803] g9799.t1 P78329 35.244 471 6.39e-95 301.0 sp|P78329|CP4F2_HUMAN Cytochrome P450 4F2 OS=Homo sapiens OX=9606 GN=CYP4F2 PE=1 SV=1 CP4F2_HUMAN reviewed Cytochrome P450 4F2 (EC 1.14.14.1) (20-hydroxyeicosatetraenoic acid synthase) (20-HETE synthase) (Arachidonic acid omega-hydroxylase) (CYPIVF2) (Cytochrome P450-LTB-omega) (Docosahexaenoic acid omega-hydroxylase) (EC 1.14.14.79) (Leukotriene-B(4) 20-monooxygenase 1) (Leukotriene-B(4) omega-hydroxylase 1) (EC 1.14.14.94) (Phylloquinone omega-hydroxylase CYP4F2) (EC 1.14.14.78) Homo sapiens (Human) GO:0000038; GO:0001676; GO:0003091; GO:0003095; GO:0004497; GO:0005506; GO:0005737; GO:0005789; GO:0006690; GO:0006691; GO:0006805; GO:0007596; GO:0008217; GO:0008392; GO:0010430; GO:0016324; GO:0016709; GO:0018685; GO:0019369; GO:0019373; GO:0020037; GO:0032304; GO:0032305; GO:0036101; GO:0042360; GO:0042361; GO:0042376; GO:0042377; GO:0043231; GO:0050051; GO:0052869; GO:0052871; GO:0055078; GO:0097258; GO:0097259; GO:0097267; GO:0102033 arachidonate metabolic process [GO:0019369]; blood coagulation [GO:0007596]; epoxygenase P450 pathway [GO:0019373]; fatty acid omega-oxidation [GO:0010430]; icosanoid metabolic process [GO:0006690]; leukotriene B4 catabolic process [GO:0036101]; leukotriene metabolic process [GO:0006691]; long-chain fatty acid metabolic process [GO:0001676]; menaquinone catabolic process [GO:0042361]; negative regulation of icosanoid secretion [GO:0032304]; omega-hydroxylase P450 pathway [GO:0097267]; phylloquinone catabolic process [GO:0042376]; positive regulation of icosanoid secretion [GO:0032305]; pressure natriuresis [GO:0003095]; regulation of blood pressure [GO:0008217]; renal water homeostasis [GO:0003091]; sodium ion homeostasis [GO:0055078]; very long-chain fatty acid metabolic process [GO:0000038]; vitamin E metabolic process [GO:0042360]; vitamin K catabolic process [GO:0042377]; xenobiotic metabolic process [GO:0006805] apical plasma membrane [GO:0016324]; cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231] 20-aldehyde-leukotriene B4 20-monooxygenase activity [GO:0097259]; 20-hydroxy-leukotriene B4 omega oxidase activity [GO:0097258]; alkane 1-monooxygenase activity [GO:0018685]; alpha-tocopherol omega-hydroxylase activity [GO:0052871]; arachidonate epoxygenase activity [GO:0008392]; arachidonate omega-hydroxylase activity [GO:0052869]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; leukotriene-B4 20-monooxygenase activity [GO:0050051]; long-chain fatty acid omega-hydroxylase activity [GO:0102033]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen [GO:0016709] g9800.t1 P33274 33.136 169 1.11e-26 109.0 sp|P33274|CP4F1_RAT Cytochrome P450 4F1 OS=Rattus norvegicus OX=10116 GN=Cyp4f1 PE=1 SV=1 CP4F1_RAT reviewed Cytochrome P450 4F1 (CYPIVF1) (Cytochrome P450-A3) (Leukotriene-B4 20-monooxygenase) (EC 1.14.14.94) Rattus norvegicus (Rat) GO:0005506; GO:0005789; GO:0006690; GO:0008391; GO:0009636; GO:0019369; GO:0020037; GO:0036101; GO:0050051; GO:0050544; GO:0052869; GO:0097267 arachidonate metabolic process [GO:0019369]; icosanoid metabolic process [GO:0006690]; leukotriene B4 catabolic process [GO:0036101]; omega-hydroxylase P450 pathway [GO:0097267]; response to toxic substance [GO:0009636] endoplasmic reticulum membrane [GO:0005789] arachidonate binding [GO:0050544]; arachidonate monooxygenase activity [GO:0008391]; arachidonate omega-hydroxylase activity [GO:0052869]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; leukotriene-B4 20-monooxygenase activity [GO:0050051] g9801.t1 P51869 52.439 82 1.6300000000000001e-21 90.9 sp|P51869|CP4F4_RAT Cytochrome P450 4F4 OS=Rattus norvegicus OX=10116 GN=Cyp4f4 PE=1 SV=1 g9802.t1 P51869 34.927 481 9.44e-91 290.0 sp|P51869|CP4F4_RAT Cytochrome P450 4F4 OS=Rattus norvegicus OX=10116 GN=Cyp4f4 PE=1 SV=1 g9805.t1 P70170 39.008 1310 0.0 874.0 sp|P70170|ABCC9_MOUSE ATP-binding cassette sub-family C member 9 OS=Mus musculus OX=10090 GN=Abcc9 PE=1 SV=2 g9806.t1 O60706 31.212 330 8.37e-39 150.0 sp|O60706|ABCC9_HUMAN ATP-binding cassette sub-family C member 9 OS=Homo sapiens OX=9606 GN=ABCC9 PE=1 SV=2 ABCC9_HUMAN reviewed ATP-binding cassette sub-family C member 9 (Sulfonylurea receptor 2) Homo sapiens (Human) GO:0000165; GO:0001508; GO:0001666; GO:0003007; GO:0005267; GO:0005524; GO:0005739; GO:0005886; GO:0006357; GO:0007005; GO:0007519; GO:0008281; GO:0008282; GO:0010467; GO:0014823; GO:0015459; GO:0016887; GO:0019395; GO:0019829; GO:0030017; GO:0031004; GO:0033198; GO:0035865; GO:0042311; GO:0042383; GO:0042542; GO:0042626; GO:0043066; GO:0043225; GO:0043627; GO:0044325; GO:0044877; GO:0045333; GO:0045776; GO:0046034; GO:0048144; GO:0051607; GO:0055085; GO:0060976; GO:0061337; GO:0062197; GO:0071277; GO:0071318; GO:0071466; GO:0071805; GO:0072592; GO:0086003; GO:0098655; GO:0098662; GO:0099104; GO:0140359; GO:0150104; GO:1901379; GO:1901652; GO:1903409; GO:1904880; GO:1990573 action potential [GO:0001508]; ATP metabolic process [GO:0046034]; cardiac conduction [GO:0061337]; cardiac muscle cell contraction [GO:0086003]; cellular respiration [GO:0045333]; cellular response to ATP [GO:0071318]; cellular response to calcium ion [GO:0071277]; cellular response to chemical stress [GO:0062197]; cellular response to potassium ion [GO:0035865]; cellular response to xenobiotic stimulus [GO:0071466]; coronary vasculature development [GO:0060976]; defense response to virus [GO:0051607]; fatty acid oxidation [GO:0019395]; fibroblast proliferation [GO:0048144]; gene expression [GO:0010467]; heart morphogenesis [GO:0003007]; inorganic cation transmembrane transport [GO:0098662]; MAPK cascade [GO:0000165]; mitochondrion organization [GO:0007005]; monoatomic cation transmembrane transport [GO:0098655]; negative regulation of apoptotic process [GO:0043066]; negative regulation of blood pressure [GO:0045776]; oxygen metabolic process [GO:0072592]; potassium ion import across plasma membrane [GO:1990573]; potassium ion transmembrane transport [GO:0071805]; reactive oxygen species biosynthetic process [GO:1903409]; regulation of potassium ion transmembrane transport [GO:1901379]; regulation of transcription by RNA polymerase II [GO:0006357]; response to activity [GO:0014823]; response to ATP [GO:0033198]; response to estrogen [GO:0043627]; response to hydrogen peroxide [GO:0042542]; response to hydrogen sulfide [GO:1904880]; response to hypoxia [GO:0001666]; response to peptide [GO:1901652]; skeletal muscle tissue development [GO:0007519]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104]; vasodilation [GO:0042311] inward rectifying potassium channel [GO:0008282]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; potassium ion-transporting ATPase complex [GO:0031004]; sarcolemma [GO:0042383]; sarcomere [GO:0030017] ABC-type transporter activity [GO:0140359]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled inorganic anion transmembrane transporter activity [GO:0043225]; ATPase-coupled monoatomic cation transmembrane transporter activity [GO:0019829]; ATPase-coupled transmembrane transporter activity [GO:0042626]; potassium channel activator activity [GO:0099104]; potassium channel activity [GO:0005267]; potassium channel regulator activity [GO:0015459]; protein-containing complex binding [GO:0044877]; sulfonylurea receptor activity [GO:0008281]; transmembrane transporter binding [GO:0044325] g9807.t1 Q9D024 47.397 365 1.16e-93 293.0 sp|Q9D024|CCD47_MOUSE PAT complex subunit CCDC47 OS=Mus musculus OX=10090 GN=Ccdc47 PE=1 SV=2 CCD47_MOUSE reviewed PAT complex subunit CCDC47 (Adipocyte-specific protein 4) (Calumin) (Coiled-coil domain-containing protein 47) Mus musculus (Mouse) GO:0005509; GO:0005783; GO:0005789; GO:0005791; GO:0006983; GO:0007029; GO:0009791; GO:0030867; GO:0032469; GO:0036503; GO:0043022; GO:0044183; GO:0045048; GO:0055074; GO:0101031; GO:0160063; GO:0160064 calcium ion homeostasis [GO:0055074]; endoplasmic reticulum calcium ion homeostasis [GO:0032469]; endoplasmic reticulum organization [GO:0007029]; ER overload response [GO:0006983]; ERAD pathway [GO:0036503]; multi-pass transmembrane protein insertion into ER membrane [GO:0160063]; post-embryonic development [GO:0009791]; protein insertion into ER membrane [GO:0045048] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; multi-pass translocon complex [GO:0160064]; protein folding chaperone complex [GO:0101031]; rough endoplasmic reticulum [GO:0005791]; rough endoplasmic reticulum membrane [GO:0030867] calcium ion binding [GO:0005509]; protein folding chaperone [GO:0044183]; ribosome binding [GO:0043022] g9808.t1 Q9VCA2 32.759 406 1.59e-60 208.0 sp|Q9VCA2|ORCT_DROME Organic cation transporter protein OS=Drosophila melanogaster OX=7227 GN=Orct PE=1 SV=1 g9810.t1 P48994 28.496 758 3.1000000000000003e-73 264.0 sp|P48994|TRPL_DROME Transient-receptor-potential-like protein OS=Drosophila melanogaster OX=7227 GN=trpl PE=1 SV=2 g9812.t1 O70507 46.281 484 2.0200000000000003e-124 398.0 sp|O70507|HCN4_MOUSE Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4 OS=Mus musculus OX=10090 GN=Hcn4 PE=1 SV=3 HCN4_MOUSE reviewed Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4 (Brain cyclic nucleotide-gated channel 3) (BCNG-3) Mus musculus (Mouse) GO:0001701; GO:0002027; GO:0003254; GO:0005222; GO:0005248; GO:0005249; GO:0005886; GO:0006812; GO:0008016; GO:0016323; GO:0030424; GO:0030425; GO:0030552; GO:0035725; GO:0042391; GO:0042802; GO:0043025; GO:0043195; GO:0048471; GO:0055117; GO:0071320; GO:0071321; GO:0071805; GO:0086015; GO:0086041; GO:0086046; GO:0086091; GO:0098719; GO:0098855; GO:0098909; GO:1990573 cellular response to cAMP [GO:0071320]; cellular response to cGMP [GO:0071321]; in utero embryonic development [GO:0001701]; membrane depolarization during SA node cell action potential [GO:0086046]; monoatomic cation transport [GO:0006812]; potassium ion import across plasma membrane [GO:1990573]; potassium ion transmembrane transport [GO:0071805]; regulation of cardiac muscle cell action potential involved in regulation of contraction [GO:0098909]; regulation of cardiac muscle contraction [GO:0055117]; regulation of heart contraction [GO:0008016]; regulation of heart rate [GO:0002027]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of membrane depolarization [GO:0003254]; regulation of membrane potential [GO:0042391]; SA node cell action potential [GO:0086015]; sodium ion import across plasma membrane [GO:0098719]; sodium ion transmembrane transport [GO:0035725] axon [GO:0030424]; basolateral plasma membrane [GO:0016323]; dendrite [GO:0030425]; HCN channel complex [GO:0098855]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; terminal bouton [GO:0043195] cAMP binding [GO:0030552]; identical protein binding [GO:0042802]; intracellularly cAMP-activated cation channel activity [GO:0005222]; voltage-gated potassium channel activity [GO:0005249]; voltage-gated potassium channel activity involved in SA node cell action potential depolarization [GO:0086041]; voltage-gated sodium channel activity [GO:0005248] g9816.t1 Q95ZJ1 44.574 516 5.97e-153 459.0 sp|Q95ZJ1|GALT5_CAEEL Polypeptide N-acetylgalactosaminyltransferase 5 OS=Caenorhabditis elegans OX=6239 GN=gly-5 PE=2 SV=2 g9817.t1 Q8K4T5 43.434 198 1.9400000000000003e-43 147.0 sp|Q8K4T5|DUS19_MOUSE Dual specificity protein phosphatase 19 OS=Mus musculus OX=10090 GN=Dusp19 PE=2 SV=1 DUS19_MOUSE reviewed Dual specificity protein phosphatase 19 (EC 3.1.3.16) (EC 3.1.3.48) (Protein phosphatase SKRP1) (Stress-activated protein kinase pathway-regulating phosphatase 1) Mus musculus (Mouse) GO:0004722; GO:0004725; GO:0004860; GO:0005078; GO:0005737; GO:0007254; GO:0008138; GO:0008330; GO:0008579; GO:0030295; GO:0031434; GO:0031435; GO:0043409; GO:0043410; GO:0046328; GO:0046329; GO:0046330 JNK cascade [GO:0007254]; negative regulation of JNK cascade [GO:0046329]; negative regulation of MAPK cascade [GO:0043409]; positive regulation of JNK cascade [GO:0046330]; positive regulation of MAPK cascade [GO:0043410]; regulation of JNK cascade [GO:0046328] cytoplasm [GO:0005737] JUN kinase phosphatase activity [GO:0008579]; MAP-kinase scaffold activity [GO:0005078]; mitogen-activated protein kinase kinase binding [GO:0031434]; mitogen-activated protein kinase kinase kinase binding [GO:0031435]; protein kinase activator activity [GO:0030295]; protein kinase inhibitor activity [GO:0004860]; protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; protein tyrosine/threonine phosphatase activity [GO:0008330] g9818.t1 Q5BJY3 60.748 107 3.71e-40 138.0 sp|Q5BJY3|IN80C_RAT INO80 complex subunit C OS=Rattus norvegicus OX=10116 GN=Ino80c PE=2 SV=1 IN80C_RAT reviewed INO80 complex subunit C Rattus norvegicus (Rat) GO:0000723; GO:0001650; GO:0005654; GO:0005829; GO:0006275; GO:0006281; GO:0006282; GO:0006310; GO:0006338; GO:0031011; GO:0033044; GO:0045739; GO:0045893; GO:0045995; GO:0051726; GO:0060382; GO:0071339; GO:1904507 chromatin remodeling [GO:0006338]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; positive regulation of DNA repair [GO:0045739]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of telomere maintenance in response to DNA damage [GO:1904507]; regulation of cell cycle [GO:0051726]; regulation of chromosome organization [GO:0033044]; regulation of DNA repair [GO:0006282]; regulation of DNA replication [GO:0006275]; regulation of DNA strand elongation [GO:0060382]; regulation of embryonic development [GO:0045995]; telomere maintenance [GO:0000723] cytosol [GO:0005829]; fibrillar center [GO:0001650]; Ino80 complex [GO:0031011]; MLL1 complex [GO:0071339]; nucleoplasm [GO:0005654] g9819.t1 Q8IUC8 47.013 519 3.46e-158 472.0 sp|Q8IUC8|GLT13_HUMAN Polypeptide N-acetylgalactosaminyltransferase 13 OS=Homo sapiens OX=9606 GN=GALNT13 PE=1 SV=2 GLT13_HUMAN reviewed Polypeptide N-acetylgalactosaminyltransferase 13 (EC 2.4.1.41) (Polypeptide GalNAc transferase 13) (GalNAc-T13) (pp-GaNTase 13) (Protein-UDP acetylgalactosaminyltransferase 13) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 13) Homo sapiens (Human) GO:0000139; GO:0004653; GO:0005794; GO:0006493; GO:0016266; GO:0030246; GO:0046872 protein O-linked glycosylation [GO:0006493]; protein O-linked glycosylation via N-acetyl-galactosamine [GO:0016266] Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139] carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653] g9820.t1 O08912 64.223 573 0.0 763.0 sp|O08912|GALT1_MOUSE Polypeptide N-acetylgalactosaminyltransferase 1 OS=Mus musculus OX=10090 GN=Galnt1 PE=1 SV=1 GALT1_MOUSE reviewed Polypeptide N-acetylgalactosaminyltransferase 1 (EC 2.4.1.41) (Polypeptide GalNAc transferase 1) (GalNAc-T1) (pp-GaNTase 1) (Protein-UDP acetylgalactosaminyltransferase 1) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 1) [Cleaved into: Polypeptide N-acetylgalactosaminyltransferase 1 soluble form] Mus musculus (Mouse) GO:0004653; GO:0005576; GO:0005794; GO:0006493; GO:0030145; GO:0030246; GO:0032580; GO:0048471 protein O-linked glycosylation [GO:0006493] extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; perinuclear region of cytoplasm [GO:0048471] carbohydrate binding [GO:0030246]; manganese ion binding [GO:0030145]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653] g9821.t1 Q8BKE6 33.404 470 4.99e-86 274.0 sp|Q8BKE6|CP20A_MOUSE Cytochrome P450 20A1 OS=Mus musculus OX=10090 GN=Cyp20a1 PE=1 SV=1 g9823.t1 Q8BKE6 32.957 443 3.23e-78 253.0 sp|Q8BKE6|CP20A_MOUSE Cytochrome P450 20A1 OS=Mus musculus OX=10090 GN=Cyp20a1 PE=1 SV=1 g9824.t1 Q9TRY9 55.433 635 0.0 722.0 sp|Q9TRY9|BGAL_CANLF Beta-galactosidase OS=Canis lupus familiaris OX=9615 GN=GLB1 PE=1 SV=3 g9826.t1 Q08D69 39.095 862 0.0 615.0 sp|Q08D69|MED16_XENTR Mediator of RNA polymerase II transcription subunit 16 OS=Xenopus tropicalis OX=8364 GN=med16 PE=2 SV=1 g9829.t1 A2ARA8 31.943 1055 4.12e-142 456.0 sp|A2ARA8|ITA8_MOUSE Integrin alpha-8 OS=Mus musculus OX=10090 GN=Itga8 PE=1 SV=1 ITA8_MOUSE reviewed Integrin alpha-8 [Cleaved into: Integrin alpha-8 heavy chain; Integrin alpha-8 light chain] Mus musculus (Mouse) GO:0001656; GO:0001822; GO:0005783; GO:0005886; GO:0005925; GO:0007160; GO:0007229; GO:0007399; GO:0007613; GO:0008305; GO:0009986; GO:0030030; GO:0030198; GO:0030511; GO:0032591; GO:0034446; GO:0038023; GO:0042472; GO:0043204; GO:0045177; GO:0045184; GO:0045944; GO:0046872; GO:0048333; GO:0048745; GO:0051145; GO:0098609; GO:0098839; GO:0098978 cell projection organization [GO:0030030]; cell-cell adhesion [GO:0098609]; cell-matrix adhesion [GO:0007160]; establishment of protein localization [GO:0045184]; extracellular matrix organization [GO:0030198]; inner ear morphogenesis [GO:0042472]; integrin-mediated signaling pathway [GO:0007229]; kidney development [GO:0001822]; memory [GO:0007613]; mesodermal cell differentiation [GO:0048333]; metanephros development [GO:0001656]; nervous system development [GO:0007399]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; smooth muscle cell differentiation [GO:0051145]; smooth muscle tissue development [GO:0048745]; substrate adhesion-dependent cell spreading [GO:0034446] apical part of cell [GO:0045177]; cell surface [GO:0009986]; dendritic spine membrane [GO:0032591]; endoplasmic reticulum [GO:0005783]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; integrin complex [GO:0008305]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839] metal ion binding [GO:0046872]; signaling receptor activity [GO:0038023] g9830.t1 O75600 66.162 396 1.83e-171 489.0 sp|O75600|KBL_HUMAN 2-amino-3-ketobutyrate coenzyme A ligase, mitochondrial OS=Homo sapiens OX=9606 GN=GCAT PE=1 SV=1 KBL_HUMAN reviewed 2-amino-3-ketobutyrate coenzyme A ligase, mitochondrial (AKB ligase) (EC 2.3.1.29) (Aminoacetone synthase) (Glycine acetyltransferase) Homo sapiens (Human) GO:0005634; GO:0005654; GO:0005739; GO:0006520; GO:0006567; GO:0008890; GO:0016607; GO:0030170 amino acid metabolic process [GO:0006520]; L-threonine catabolic process [GO:0006567] mitochondrion [GO:0005739]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] glycine C-acetyltransferase activity [GO:0008890]; pyridoxal phosphate binding [GO:0030170] g9831.t1 Q10943 84.746 177 7.65e-111 316.0 sp|Q10943|ARF12_CAEEL ADP-ribosylation factor 1-like 2 OS=Caenorhabditis elegans OX=6239 GN=arf-1 PE=2 SV=2 ARF12_CAEEL reviewed ADP-ribosylation factor 1-like 2 (EC 3.6.5.2) (ADP-ribosylation factor-related protein 1) Caenorhabditis elegans GO:0000139; GO:0003925; GO:0005525; GO:0005737; GO:0005783; GO:0005886; GO:0006886; GO:0007005; GO:0007276; GO:0009792; GO:0016192; GO:0048259; GO:0048599; GO:1904748 embryo development ending in birth or egg hatching [GO:0009792]; gamete generation [GO:0007276]; intracellular protein transport [GO:0006886]; mitochondrion organization [GO:0007005]; oocyte development [GO:0048599]; regulation of apoptotic process involved in development [GO:1904748]; regulation of receptor-mediated endocytosis [GO:0048259]; vesicle-mediated transport [GO:0016192] cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886] G protein activity [GO:0003925]; GTP binding [GO:0005525] g9832.t1 P84079 90.96 177 7.6e-119 337.0 sp|P84079|ARF1_RAT ADP-ribosylation factor 1 OS=Rattus norvegicus OX=10116 GN=Arf1 PE=1 SV=2 ARF1_RAT reviewed ADP-ribosylation factor 1 (EC 3.6.5.2) Rattus norvegicus (Rat) GO:0000139; GO:0000287; GO:0002090; GO:0003925; GO:0005525; GO:0005737; GO:0005770; GO:0005778; GO:0005794; GO:0005802; GO:0005829; GO:0005886; GO:0006878; GO:0006886; GO:0007015; GO:0012505; GO:0014069; GO:0016192; GO:0019003; GO:0019904; GO:0030017; GO:0030137; GO:0031252; GO:0032991; GO:0034315; GO:0034379; GO:0043005; GO:0045807; GO:0045956; GO:0050714; GO:0055108; GO:0060292; GO:0060999; GO:0070142; GO:0097061; GO:0097212; GO:0098974; GO:0098978; GO:1902307; GO:1902824; GO:1902953; GO:1903725; GO:1990386; GO:1990583 actin filament organization [GO:0007015]; dendritic spine organization [GO:0097061]; Golgi to transport vesicle transport [GO:0055108]; intracellular copper ion homeostasis [GO:0006878]; intracellular protein transport [GO:0006886]; long-term synaptic depression [GO:0060292]; lysosomal membrane organization [GO:0097212]; mitotic cleavage furrow ingression [GO:1990386]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of endocytosis [GO:0045807]; positive regulation of ER to Golgi vesicle-mediated transport [GO:1902953]; positive regulation of late endosome to lysosome transport [GO:1902824]; positive regulation of protein secretion [GO:0050714]; positive regulation of sodium ion transmembrane transport [GO:1902307]; postsynaptic actin cytoskeleton organization [GO:0098974]; regulation of Arp2/3 complex-mediated actin nucleation [GO:0034315]; regulation of phospholipid metabolic process [GO:1903725]; regulation of receptor internalization [GO:0002090]; synaptic vesicle budding [GO:0070142]; very-low-density lipoprotein particle assembly [GO:0034379]; vesicle-mediated transport [GO:0016192] cell leading edge [GO:0031252]; COPI-coated vesicle [GO:0030137]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; late endosome [GO:0005770]; neuron projection [GO:0043005]; peroxisomal membrane [GO:0005778]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; protein-containing complex [GO:0032991]; sarcomere [GO:0030017]; trans-Golgi network [GO:0005802] G protein activity [GO:0003925]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; magnesium ion binding [GO:0000287]; phospholipase D activator activity [GO:1990583]; protein domain specific binding [GO:0019904] g9833.t1 Q9JHI9 36.953 617 2.83e-112 353.0 sp|Q9JHI9|S40A1_MOUSE Ferroportin OS=Mus musculus OX=10090 GN=Slc40a1 PE=1 SV=1 S40A1_MOUSE reviewed Ferroportin (Ferroportin-1) (Iron-regulated transporter 1) (Metal transporter protein 1) (MTP1) (Solute carrier family 40 member 1) Mus musculus (Mouse) GO:0002260; GO:0003158; GO:0005381; GO:0005654; GO:0005829; GO:0005886; GO:0006826; GO:0006879; GO:0008021; GO:0015093; GO:0016323; GO:0017046; GO:0034755; GO:0042802; GO:0043066; GO:0045944; GO:0046872; GO:0048536; GO:0060345; GO:0060586; GO:1903988 endothelium development [GO:0003158]; intracellular iron ion homeostasis [GO:0006879]; iron ion export across plasma membrane [GO:1903988]; iron ion transmembrane transport [GO:0034755]; iron ion transport [GO:0006826]; lymphocyte homeostasis [GO:0002260]; multicellular organismal-level iron ion homeostasis [GO:0060586]; negative regulation of apoptotic process [GO:0043066]; positive regulation of transcription by RNA polymerase II [GO:0045944]; spleen development [GO:0048536]; spleen trabecula formation [GO:0060345] basolateral plasma membrane [GO:0016323]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; synaptic vesicle [GO:0008021] ferrous iron transmembrane transporter activity [GO:0015093]; identical protein binding [GO:0042802]; iron ion transmembrane transporter activity [GO:0005381]; metal ion binding [GO:0046872]; peptide hormone binding [GO:0017046] g9834.t1 O76536 29.213 1157 5.4e-65 246.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g9834.t1 O76536 29.538 1212 1.54e-63 241.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g9834.t1 O76536 30.98 1020 3.04e-60 231.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g9834.t1 O76536 28.685 1133 4.75e-57 221.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g9834.t1 O76536 30.435 460 2.08e-35 151.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g9835.t1 P78424 67.857 196 1.88e-83 280.0 sp|P78424|PO6F2_HUMAN POU domain, class 6, transcription factor 2 OS=Homo sapiens OX=9606 GN=POU6F2 PE=1 SV=3 PO6F2_HUMAN reviewed POU domain, class 6, transcription factor 2 (Retina-derived POU domain factor 1) (RPF-1) Homo sapiens (Human) GO:0000785; GO:0000978; GO:0000981; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0007402; GO:0007417; GO:0007601 central nervous system development [GO:0007417]; ganglion mother cell fate determination [GO:0007402]; regulation of DNA-templated transcription [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; visual perception [GO:0007601] chromatin [GO:0000785]; nucleus [GO:0005634] DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978] g9835.t2 P78424 67.513 197 1.4899999999999998e-82 277.0 sp|P78424|PO6F2_HUMAN POU domain, class 6, transcription factor 2 OS=Homo sapiens OX=9606 GN=POU6F2 PE=1 SV=3 PO6F2_HUMAN reviewed POU domain, class 6, transcription factor 2 (Retina-derived POU domain factor 1) (RPF-1) Homo sapiens (Human) GO:0000785; GO:0000978; GO:0000981; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0007402; GO:0007417; GO:0007601 central nervous system development [GO:0007417]; ganglion mother cell fate determination [GO:0007402]; regulation of DNA-templated transcription [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; visual perception [GO:0007601] chromatin [GO:0000785]; nucleus [GO:0005634] DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978] g9835.t3 P78424 67.513 197 7.349999999999999e-82 275.0 sp|P78424|PO6F2_HUMAN POU domain, class 6, transcription factor 2 OS=Homo sapiens OX=9606 GN=POU6F2 PE=1 SV=3 PO6F2_HUMAN reviewed POU domain, class 6, transcription factor 2 (Retina-derived POU domain factor 1) (RPF-1) Homo sapiens (Human) GO:0000785; GO:0000978; GO:0000981; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0007402; GO:0007417; GO:0007601 central nervous system development [GO:0007417]; ganglion mother cell fate determination [GO:0007402]; regulation of DNA-templated transcription [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; visual perception [GO:0007601] chromatin [GO:0000785]; nucleus [GO:0005634] DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978] g9836.t1 P49754 52.434 452 3.2500000000000002e-167 497.0 sp|P49754|VPS41_HUMAN Vacuolar protein sorting-associated protein 41 homolog OS=Homo sapiens OX=9606 GN=VPS41 PE=1 SV=3 VPS41_HUMAN reviewed Vacuolar protein sorting-associated protein 41 homolog (S53) Homo sapiens (Human) GO:0005764; GO:0005765; GO:0005770; GO:0005794; GO:0005798; GO:0005829; GO:0006623; GO:0008017; GO:0008270; GO:0008333; GO:0009267; GO:0010008; GO:0015630; GO:0016020; GO:0016192; GO:0016236; GO:0030136; GO:0030897; GO:0031901; GO:0031902; GO:0034058; GO:0035542; GO:0042802; GO:0048193; GO:1902501; GO:1902774 cellular response to starvation [GO:0009267]; endosomal vesicle fusion [GO:0034058]; endosome to lysosome transport [GO:0008333]; Golgi vesicle transport [GO:0048193]; late endosome to lysosome transport [GO:1902774]; macroautophagy [GO:0016236]; protein targeting to vacuole [GO:0006623]; regulation of SNARE complex assembly [GO:0035542]; vesicle-mediated transport [GO:0016192] clathrin-coated vesicle [GO:0030136]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; Golgi-associated vesicle [GO:0005798]; HOPS complex [GO:0030897]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal HOPS complex [GO:1902501]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630] identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; zinc ion binding [GO:0008270] g9837.t1 E7F590 58.824 357 3.04e-142 427.0 sp|E7F590|VPS41_DANRE Vacuolar protein sorting-associated protein 41 homolog OS=Danio rerio OX=7955 GN=vps41 PE=1 SV=1 VPS41_DANRE reviewed Vacuolar protein sorting-associated protein 41 homolog Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005765; GO:0005770; GO:0005794; GO:0005829; GO:0006623; GO:0008270; GO:0008333; GO:0009267; GO:0016192; GO:0016236; GO:0030136; GO:0030897; GO:0031901; GO:0031902; GO:0034058 cellular response to starvation [GO:0009267]; endosomal vesicle fusion [GO:0034058]; endosome to lysosome transport [GO:0008333]; macroautophagy [GO:0016236]; protein targeting to vacuole [GO:0006623]; vesicle-mediated transport [GO:0016192] clathrin-coated vesicle [GO:0030136]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; Golgi apparatus [GO:0005794]; HOPS complex [GO:0030897]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765] zinc ion binding [GO:0008270] g9838.t1 Q5R4Q7 26.014 296 1.81e-22 107.0 sp|Q5R4Q7|LZTR1_PONAB Leucine-zipper-like transcriptional regulator 1 OS=Pongo abelii OX=9601 GN=LZTR1 PE=2 SV=1 g9839.t1 E1C2U2 37.331 1184 0.0 685.0 sp|E1C2U2|RIF1_CHICK Telomere-associated protein RIF1 OS=Gallus gallus OX=9031 GN=RIF1 PE=3 SV=3 RIF1_CHICK reviewed Telomere-associated protein RIF1 (Rap1-interacting factor 1 homolog) Gallus gallus (Chicken) GO:0000781; GO:0005634; GO:0005819; GO:0006281; GO:0006974; GO:0035861; GO:0045830; GO:2000042; GO:2001034 DNA damage response [GO:0006974]; DNA repair [GO:0006281]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; positive regulation of double-strand break repair via nonhomologous end joining [GO:2001034]; positive regulation of isotype switching [GO:0045830] chromosome, telomeric region [GO:0000781]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; spindle [GO:0005819] g9842.t1 Q5EA97 42.248 258 4.3999999999999995e-42 147.0 sp|Q5EA97|S38AB_BOVIN Putative sodium-coupled neutral amino acid transporter 11 OS=Bos taurus OX=9913 GN=SLC38A11 PE=2 SV=1 g9842.t1 Q5EA97 54.545 33 4.3999999999999995e-42 45.8 sp|Q5EA97|S38AB_BOVIN Putative sodium-coupled neutral amino acid transporter 11 OS=Bos taurus OX=9913 GN=SLC38A11 PE=2 SV=1 g9845.t1 Q8K1Q0 65.922 179 7.7e-81 251.0 sp|Q8K1Q0|NMT1_RAT Glycylpeptide N-tetradecanoyltransferase 1 OS=Rattus norvegicus OX=10116 GN=Nmt1 PE=1 SV=1 g9846.t1 Q9N181 70.485 227 2.7e-115 346.0 sp|Q9N181|NMT2_BOVIN Glycylpeptide N-tetradecanoyltransferase 2 OS=Bos taurus OX=9913 GN=NMT2 PE=2 SV=1 g9847.t1 Q3KQ77 49.724 181 6.47e-59 186.0 sp|Q3KQ77|CLXN_XENLA Calaxin OS=Xenopus laevis OX=8355 GN=clxn PE=2 SV=1 g9848.t1 Q5RBS7 51.613 124 2.17e-41 136.0 sp|Q5RBS7|CB076_PONAB UPF0538 protein C2orf76 homolog OS=Pongo abelii OX=9601 PE=2 SV=1 g9848.t2 Q5RBS7 50.806 124 6.02e-39 132.0 sp|Q5RBS7|CB076_PONAB UPF0538 protein C2orf76 homolog OS=Pongo abelii OX=9601 PE=2 SV=1 g9849.t1 O57525 33.778 450 1.08e-81 266.0 sp|O57525|CP17A_RANDY Steroid 17-alpha-hydroxylase/17,20 lyase OS=Rana dybowskii OX=71582 GN=CYP17A1 PE=2 SV=1 g9850.t1 O73853 34.156 486 3.46e-88 282.0 sp|O73853|CP17A_ICTPU Steroid 17-alpha-hydroxylase/17,20 lyase OS=Ictalurus punctatus OX=7998 GN=cyp17a1 PE=2 SV=1 g9851.t1 Q61466 75.176 427 0.0 627.0 sp|Q61466|SMRD1_MOUSE SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily D member 1 OS=Mus musculus OX=10090 GN=Smarcd1 PE=1 SV=3 g9852.t1 Q5R4U2 59.124 137 5.83e-53 186.0 sp|Q5R4U2|RBM48_PONAB RNA-binding protein 48 OS=Pongo abelii OX=9601 GN=RBM48 PE=2 SV=1 g9853.t1 Q0P4C4 53.333 225 2.01e-77 236.0 sp|Q0P4C4|DCAKD_DANRE Dephospho-CoA kinase domain-containing protein OS=Danio rerio OX=7955 GN=dcakd PE=2 SV=1 g9856.t1 Q6IQX7 35.668 771 2.57e-155 473.0 sp|Q6IQX7|CHSS2_MOUSE Chondroitin sulfate synthase 2 OS=Mus musculus OX=10090 GN=Chpf PE=1 SV=1 CHSS2_MOUSE reviewed Chondroitin sulfate synthase 2 (EC 2.4.1.175) (EC 2.4.1.226) (Chondroitin glucuronyltransferase 2) (Chondroitin-polymerizing factor) (ChPF) (Glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase II) (N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase II) (N-acetylgalactosaminyltransferase 2) Mus musculus (Mouse) GO:0005759; GO:0005794; GO:0005829; GO:0016757; GO:0032580; GO:0046872; GO:0047238; GO:0050510; GO:0050650 chondroitin sulfate proteoglycan biosynthetic process [GO:0050650] cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; mitochondrial matrix [GO:0005759] glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity [GO:0047238]; glycosyltransferase activity [GO:0016757]; metal ion binding [GO:0046872]; N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity [GO:0050510] g9857.t1 P54814 91.667 408 0.0 741.0 sp|P54814|PRS8_MANSE 26S proteasome regulatory subunit 8 OS=Manduca sexta OX=7130 PE=2 SV=1 g9858.t1 Q95245 36.364 231 2.73e-21 93.2 sp|Q95245|CY561_PIG Transmembrane ascorbate-dependent reductase CYB561 OS=Sus scrofa OX=9823 GN=CYB561 PE=2 SV=1 g9859.t1 B0FYY4 41.191 789 0.0 555.0 sp|B0FYY4|ITB1_SHEEP Integrin beta-1 OS=Ovis aries OX=9940 GN=ITGB1 PE=2 SV=1 ITB1_SHEEP reviewed Integrin beta-1 (Fibronectin receptor subunit beta) (Integrin subunit beta-1) (VLA-4 subunit beta) (CD antigen CD29) Ovis aries (Sheep) GO:0001968; GO:0005925; GO:0007229; GO:0007517; GO:0007520; GO:0009986; GO:0010710; GO:0016020; GO:0016477; GO:0019901; GO:0019960; GO:0030027; GO:0030335; GO:0031623; GO:0032587; GO:0033627; GO:0034679; GO:0042470; GO:0043236; GO:0045202; GO:0045445; GO:0045906; GO:0046872; GO:0046982; GO:0055037; GO:0071404; GO:0098609; GO:0098639; GO:0098640; GO:1903078 cell adhesion mediated by integrin [GO:0033627]; cell migration [GO:0016477]; cell-cell adhesion [GO:0098609]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; integrin-mediated signaling pathway [GO:0007229]; muscle organ development [GO:0007517]; myoblast differentiation [GO:0045445]; myoblast fusion [GO:0007520]; negative regulation of vasoconstriction [GO:0045906]; positive regulation of cell migration [GO:0030335]; positive regulation of protein localization to plasma membrane [GO:1903078]; receptor internalization [GO:0031623]; regulation of collagen catabolic process [GO:0010710] cell surface [GO:0009986]; focal adhesion [GO:0005925]; integrin alpha9-beta1 complex [GO:0034679]; lamellipodium [GO:0030027]; melanosome [GO:0042470]; membrane [GO:0016020]; recycling endosome [GO:0055037]; ruffle membrane [GO:0032587]; synapse [GO:0045202] C-X3-C chemokine binding [GO:0019960]; collagen binding involved in cell-matrix adhesion [GO:0098639]; fibronectin binding [GO:0001968]; integrin binding involved in cell-matrix adhesion [GO:0098640]; laminin binding [GO:0043236]; metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]; protein kinase binding [GO:0019901] g9863.t1 P29558 52.632 342 4.1099999999999994e-95 295.0 sp|P29558|RBMS1_HUMAN RNA-binding motif, single-stranded-interacting protein 1 OS=Homo sapiens OX=9606 GN=RBMS1 PE=1 SV=3 RBMS1_HUMAN reviewed RNA-binding motif, single-stranded-interacting protein 1 (Single-stranded DNA-binding protein MSSP-1) (Suppressor of CDC2 with RNA-binding motif 2) Homo sapiens (Human) GO:0003690; GO:0003697; GO:0003723; GO:0003730; GO:0005634; GO:0005829; GO:0006260; GO:0006396; GO:0008143; GO:0008266; GO:1990904 DNA replication [GO:0006260]; RNA processing [GO:0006396] cytosol [GO:0005829]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904] double-stranded DNA binding [GO:0003690]; mRNA 3'-UTR binding [GO:0003730]; poly(A) binding [GO:0008143]; poly(U) RNA binding [GO:0008266]; RNA binding [GO:0003723]; single-stranded DNA binding [GO:0003697] g9863.t2 P29558 52.632 342 1.2699999999999999e-95 296.0 sp|P29558|RBMS1_HUMAN RNA-binding motif, single-stranded-interacting protein 1 OS=Homo sapiens OX=9606 GN=RBMS1 PE=1 SV=3 RBMS1_HUMAN reviewed RNA-binding motif, single-stranded-interacting protein 1 (Single-stranded DNA-binding protein MSSP-1) (Suppressor of CDC2 with RNA-binding motif 2) Homo sapiens (Human) GO:0003690; GO:0003697; GO:0003723; GO:0003730; GO:0005634; GO:0005829; GO:0006260; GO:0006396; GO:0008143; GO:0008266; GO:1990904 DNA replication [GO:0006260]; RNA processing [GO:0006396] cytosol [GO:0005829]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904] double-stranded DNA binding [GO:0003690]; mRNA 3'-UTR binding [GO:0003730]; poly(A) binding [GO:0008143]; poly(U) RNA binding [GO:0008266]; RNA binding [GO:0003723]; single-stranded DNA binding [GO:0003697] g9865.t1 Q58CU2 70.0 140 5.05e-68 220.0 sp|Q58CU2|E41L5_BOVIN Band 4.1-like protein 5 OS=Bos taurus OX=9913 GN=EPB41L5 PE=1 SV=1 g9866.t1 Q9MYU8 57.542 179 1.23e-66 216.0 sp|Q9MYU8|E41L5_CANLF Band 4.1-like protein 5 OS=Canis lupus familiaris OX=9615 GN=EPB41L5 PE=2 SV=1 g9867.t1 Q53S58 34.05 279 4.6699999999999995e-30 118.0 sp|Q53S58|TM177_HUMAN Transmembrane protein 177 OS=Homo sapiens OX=9606 GN=TMEM177 PE=1 SV=1 TM177_HUMAN reviewed Transmembrane protein 177 Homo sapiens (Human) GO:0005739; GO:0005743; GO:0016020 membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739] g9868.t1 Q9WU22 52.653 735 0.0 731.0 sp|Q9WU22|PTN4_MOUSE Tyrosine-protein phosphatase non-receptor type 4 OS=Mus musculus OX=10090 GN=Ptpn4 PE=1 SV=2 PTN4_MOUSE reviewed Tyrosine-protein phosphatase non-receptor type 4 (EC 3.1.3.48) (Testis-enriched protein tyrosine phosphatase) Mus musculus (Mouse) GO:0004725; GO:0004726; GO:0005737; GO:0005856; GO:0008092; GO:0009898; GO:0016020; GO:0035254 cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytoskeleton [GO:0005856]; membrane [GO:0016020] cytoskeletal protein binding [GO:0008092]; glutamate receptor binding [GO:0035254]; non-membrane spanning protein tyrosine phosphatase activity [GO:0004726]; protein tyrosine phosphatase activity [GO:0004725] g9868.t2 Q9WU22 52.71 738 0.0 732.0 sp|Q9WU22|PTN4_MOUSE Tyrosine-protein phosphatase non-receptor type 4 OS=Mus musculus OX=10090 GN=Ptpn4 PE=1 SV=2 PTN4_MOUSE reviewed Tyrosine-protein phosphatase non-receptor type 4 (EC 3.1.3.48) (Testis-enriched protein tyrosine phosphatase) Mus musculus (Mouse) GO:0004725; GO:0004726; GO:0005737; GO:0005856; GO:0008092; GO:0009898; GO:0016020; GO:0035254 cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytoskeleton [GO:0005856]; membrane [GO:0016020] cytoskeletal protein binding [GO:0008092]; glutamate receptor binding [GO:0035254]; non-membrane spanning protein tyrosine phosphatase activity [GO:0004726]; protein tyrosine phosphatase activity [GO:0004725] g9870.t1 P29074 53.571 140 1.18e-42 152.0 sp|P29074|PTN4_HUMAN Tyrosine-protein phosphatase non-receptor type 4 OS=Homo sapiens OX=9606 GN=PTPN4 PE=1 SV=1 PTN4_HUMAN reviewed Tyrosine-protein phosphatase non-receptor type 4 (EC 3.1.3.48) (Protein-tyrosine phosphatase MEG1) (MEG) (PTPase-MEG1) Homo sapiens (Human) GO:0004725; GO:0004726; GO:0005654; GO:0005737; GO:0005829; GO:0005856; GO:0006470; GO:0008092; GO:0009898; GO:0035254 protein dephosphorylation [GO:0006470] cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; nucleoplasm [GO:0005654] cytoskeletal protein binding [GO:0008092]; glutamate receptor binding [GO:0035254]; non-membrane spanning protein tyrosine phosphatase activity [GO:0004726]; protein tyrosine phosphatase activity [GO:0004725] g9871.t1 Q80UA9 69.307 202 4.69e-102 296.0 sp|Q80UA9|INSI2_RAT Insulin-induced gene 2 protein OS=Rattus norvegicus OX=10116 GN=Insig2 PE=2 SV=1 INSI2_RAT reviewed Insulin-induced gene 2 protein (INSIG-2) Rattus norvegicus (Rat) GO:0005783; GO:0005789; GO:0006607; GO:0006641; GO:0006695; GO:0006991; GO:0008142; GO:0008203; GO:0010894; GO:0016126; GO:0032868; GO:0032869; GO:0032933; GO:0032937; GO:0033993; GO:0036316; GO:0042472; GO:0042474; GO:0045542; GO:0045717; GO:0051604; GO:0060021; GO:0060363; GO:0070542; GO:0140311 cellular response to insulin stimulus [GO:0032869]; cholesterol biosynthetic process [GO:0006695]; cholesterol metabolic process [GO:0008203]; cranial suture morphogenesis [GO:0060363]; inner ear morphogenesis [GO:0042472]; middle ear morphogenesis [GO:0042474]; negative regulation of fatty acid biosynthetic process [GO:0045717]; negative regulation of steroid biosynthetic process [GO:0010894]; NLS-bearing protein import into nucleus [GO:0006607]; positive regulation of cholesterol biosynthetic process [GO:0045542]; protein maturation [GO:0051604]; response to fatty acid [GO:0070542]; response to insulin [GO:0032868]; response to lipid [GO:0033993]; response to sterol depletion [GO:0006991]; roof of mouth development [GO:0060021]; SREBP signaling pathway [GO:0032933]; SREBP-SCAP complex retention in endoplasmic reticulum [GO:0036316]; sterol biosynthetic process [GO:0016126]; triglyceride metabolic process [GO:0006641] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; SREBP-SCAP-Insig complex [GO:0032937] oxysterol binding [GO:0008142]; protein sequestering activity [GO:0140311] g9872.t1 Q07537 38.462 507 2.2700000000000002e-121 373.0 sp|Q07537|GALT1_BOVIN Polypeptide N-acetylgalactosaminyltransferase 1 OS=Bos taurus OX=9913 GN=GALNT1 PE=1 SV=1 GALT1_BOVIN reviewed Polypeptide N-acetylgalactosaminyltransferase 1 (EC 2.4.1.41) (Polypeptide GalNAc transferase 1) (GalNAc-T1) (pp-GaNTase 1) (Protein-UDP acetylgalactosaminyltransferase 1) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 1) [Cleaved into: Polypeptide N-acetylgalactosaminyltransferase 1 soluble form] Bos taurus (Bovine) GO:0004653; GO:0005576; GO:0005794; GO:0006493; GO:0030145; GO:0030246; GO:0032580; GO:0048471 protein O-linked glycosylation [GO:0006493] extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; perinuclear region of cytoplasm [GO:0048471] carbohydrate binding [GO:0030246]; manganese ion binding [GO:0030145]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653] g9874.t1 Q9H3G5 52.905 482 4.27e-174 500.0 sp|Q9H3G5|CPVL_HUMAN Probable serine carboxypeptidase CPVL OS=Homo sapiens OX=9606 GN=CPVL PE=1 SV=2 g9875.t1 Q5RFE4 49.37 476 2.7299999999999997e-150 440.0 sp|Q5RFE4|CPVL_PONAB Probable serine carboxypeptidase CPVL OS=Pongo abelii OX=9601 GN=CPVL PE=2 SV=1 g9876.t1 Q9CZD3 66.572 703 0.0 950.0 sp|Q9CZD3|GARS_MOUSE Glycine--tRNA ligase OS=Mus musculus OX=10090 GN=Gars1 PE=1 SV=1 GARS_MOUSE reviewed Glycine--tRNA ligase (EC 6.1.1.14) (Diadenosine tetraphosphate synthetase) (Ap4A synthetase) (EC 2.7.7.-) (Glycyl-tRNA synthetase 1) (GlyRS) Mus musculus (Mouse) GO:0004081; GO:0004820; GO:0005524; GO:0005737; GO:0005739; GO:0005829; GO:0006418; GO:0006426; GO:0015966; GO:0030141; GO:0030424; GO:0042802; GO:0046983; GO:0070062; GO:0070150; GO:0141192 diadenosine tetraphosphate biosynthetic process [GO:0015966]; glycyl-tRNA aminoacylation [GO:0006426]; mitochondrial glycyl-tRNA aminoacylation [GO:0070150]; tRNA aminoacylation for protein translation [GO:0006418] axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; mitochondrion [GO:0005739]; secretory granule [GO:0030141] ATP binding [GO:0005524]; ATP:ATP adenylyltransferase activity [GO:0141192]; bis(5'-nucleosyl)-tetraphosphatase (asymmetrical) activity [GO:0004081]; glycine-tRNA ligase activity [GO:0004820]; identical protein binding [GO:0042802]; protein dimerization activity [GO:0046983] g9877.t1 Q1ECX4 53.333 690 0.0 645.0 sp|Q1ECX4|TLK2_DANRE Serine/threonine-protein kinase tousled-like 2 OS=Danio rerio OX=7955 GN=tlk2 PE=2 SV=2 TLK2_DANRE reviewed Serine/threonine-protein kinase tousled-like 2 (EC 2.7.11.1) (PKU-alpha) (Tousled-like kinase 2) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005856; GO:0007059; GO:0035556; GO:0048471; GO:0106310 chromosome segregation [GO:0007059]; intracellular signal transduction [GO:0035556] cytoskeleton [GO:0005856]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471] ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g9880.t1 Q7KW14 55.556 126 2.4099999999999997e-34 147.0 sp|Q7KW14|CCDCX_DROME Coiled-coil domain-containing protein CG32809 OS=Drosophila melanogaster OX=7227 GN=CG32809 PE=2 SV=1 g9880.t1 Q7KW14 34.409 186 3.85e-26 121.0 sp|Q7KW14|CCDCX_DROME Coiled-coil domain-containing protein CG32809 OS=Drosophila melanogaster OX=7227 GN=CG32809 PE=2 SV=1 g9881.t1 Q9NVS9 56.79 243 3.23e-97 290.0 sp|Q9NVS9|PNPO_HUMAN Pyridoxine-5'-phosphate oxidase OS=Homo sapiens OX=9606 GN=PNPO PE=1 SV=1 g9882.t1 Q4KM84 44.444 216 1.5800000000000001e-57 192.0 sp|Q4KM84|MET18_RAT Histidine protein methyltransferase 1 homolog OS=Rattus norvegicus OX=10116 GN=Mettl18 PE=2 SV=1 MET18_RAT reviewed Histidine protein methyltransferase 1 homolog (EC 2.1.1.85) (Methyltransferase-like protein 18) Rattus norvegicus (Rat) GO:0005634; GO:0005730; GO:0005829; GO:0006417; GO:0006448; GO:0018026; GO:0018064; GO:0031072; GO:0032991; GO:0090069; GO:2000232 peptidyl-lysine monomethylation [GO:0018026]; regulation of ribosome biogenesis [GO:0090069]; regulation of rRNA processing [GO:2000232]; regulation of translation [GO:0006417]; regulation of translational elongation [GO:0006448] cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleus [GO:0005634]; protein-containing complex [GO:0032991] heat shock protein binding [GO:0031072]; protein-L-histidine N-tele-methyltransferase activity [GO:0018064] g9884.t1 O43543 32.086 187 1.96e-22 99.0 sp|O43543|XRCC2_HUMAN DNA repair protein XRCC2 OS=Homo sapiens OX=9606 GN=XRCC2 PE=1 SV=1 XRCC2_HUMAN reviewed DNA repair protein XRCC2 (X-ray repair cross-complementing protein 2) Homo sapiens (Human) GO:0000278; GO:0000724; GO:0001701; GO:0001756; GO:0003677; GO:0005524; GO:0005654; GO:0005657; GO:0005813; GO:0006281; GO:0007098; GO:0010165; GO:0010332; GO:0022008; GO:0033063; GO:0035264; GO:0042148; GO:0043524; GO:0050769; GO:0051321; GO:0140664; GO:2000269 centrosome cycle [GO:0007098]; DNA repair [GO:0006281]; DNA strand invasion [GO:0042148]; double-strand break repair via homologous recombination [GO:0000724]; in utero embryonic development [GO:0001701]; meiotic cell cycle [GO:0051321]; mitotic cell cycle [GO:0000278]; multicellular organism growth [GO:0035264]; negative regulation of neuron apoptotic process [GO:0043524]; neurogenesis [GO:0022008]; positive regulation of neurogenesis [GO:0050769]; regulation of fibroblast apoptotic process [GO:2000269]; response to gamma radiation [GO:0010332]; response to X-ray [GO:0010165]; somitogenesis [GO:0001756] centrosome [GO:0005813]; nucleoplasm [GO:0005654]; Rad51B-Rad51C-Rad51D-XRCC2 complex [GO:0033063]; replication fork [GO:0005657] ATP binding [GO:0005524]; ATP-dependent DNA damage sensor activity [GO:0140664]; DNA binding [GO:0003677] g9886.t1 Q6AZB8 33.143 175 2.8e-28 110.0 sp|Q6AZB8|HARB1_DANRE Putative nuclease HARBI1 OS=Danio rerio OX=7955 GN=harbi1 PE=2 SV=1 HARB1_DANRE reviewed Putative nuclease HARBI1 (EC 3.1.-.-) (Harbinger transposase-derived nuclease) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0004518; GO:0005634; GO:0005737; GO:0016787; GO:0046872 cytoplasm [GO:0005737]; nucleus [GO:0005634] hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]; nuclease activity [GO:0004518] g9889.t1 A0ZSK4 52.41 166 7.209999999999999e-52 179.0 sp|A0ZSK4|STXB_SYNVE Neoverrucotoxin subunit beta OS=Synanceia verrucosa OX=51996 PE=1 SV=1 STXB_SYNVE reviewed Neoverrucotoxin subunit beta (NeoVTX subunit beta) Synanceia verrucosa (Reef stonefish) GO:0005576; GO:0031640; GO:0090729 killing of cells of another organism [GO:0031640] extracellular region [GO:0005576] toxin activity [GO:0090729] g9894.t1 Q6P2X9 22.983 409 9.82e-21 97.8 sp|Q6P2X9|MOT12_XENTR Monocarboxylate transporter 12 OS=Xenopus tropicalis OX=8364 GN=slc16a12 PE=2 SV=1 g9900.t1 A0JPH4 33.447 1462 0.0 722.0 sp|A0JPH4|SCAP_XENLA Sterol regulatory element-binding protein cleavage-activating protein OS=Xenopus laevis OX=8355 GN=scap PE=2 SV=1 SCAP_XENLA reviewed Sterol regulatory element-binding protein cleavage-activating protein (SCAP) (SREBP cleavage-activating protein) Xenopus laevis (African clawed frog) GO:0000139; GO:0005789; GO:0008203; GO:0012507; GO:0032933; GO:0032934; GO:0032936; GO:0045540; GO:0090110 cholesterol metabolic process [GO:0008203]; COPII-coated vesicle cargo loading [GO:0090110]; regulation of cholesterol biosynthetic process [GO:0045540]; SREBP signaling pathway [GO:0032933] endoplasmic reticulum membrane [GO:0005789]; ER to Golgi transport vesicle membrane [GO:0012507]; Golgi membrane [GO:0000139]; SREBP-SCAP complex [GO:0032936] sterol binding [GO:0032934] g9901.t1 Q9PRL8 53.659 82 2.66e-22 85.1 sp|Q9PRL8|ACBP_CHICK Acyl-CoA-binding protein OS=Gallus gallus OX=9031 GN=DBI PE=1 SV=1 g9903.t1 Q9BGP6 31.154 260 1.9099999999999997e-24 112.0 sp|Q9BGP6|LRRT3_MACFA Leucine-rich repeat transmembrane neuronal protein 3 OS=Macaca fascicularis OX=9541 GN=LRRTM3 PE=2 SV=1 g9904.t1 A0A1D5PUP4 43.966 928 0.0 804.0 sp|A0A1D5PUP4|RECK_CHICK Reversion-inducing cysteine-rich protein with Kazal motifs OS=Gallus gallus OX=9031 GN=RECK PE=1 SV=1 RECK_CHICK reviewed Reversion-inducing cysteine-rich protein with Kazal motifs Gallus gallus (Chicken) GO:0001955; GO:0002040; GO:0004866; GO:0004867; GO:0005615; GO:0005886; GO:0008191; GO:0015026; GO:0030198; GO:0045765; GO:0060070; GO:0060828; GO:0090210; GO:0098552; GO:1903053; GO:1990909 blood vessel maturation [GO:0001955]; canonical Wnt signaling pathway [GO:0060070]; extracellular matrix organization [GO:0030198]; regulation of angiogenesis [GO:0045765]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of establishment of blood-brain barrier [GO:0090210]; regulation of extracellular matrix organization [GO:1903053]; sprouting angiogenesis [GO:0002040] extracellular space [GO:0005615]; plasma membrane [GO:0005886]; side of membrane [GO:0098552]; Wnt signalosome [GO:1990909] coreceptor activity [GO:0015026]; endopeptidase inhibitor activity [GO:0004866]; metalloendopeptidase inhibitor activity [GO:0008191]; serine-type endopeptidase inhibitor activity [GO:0004867] g9905.t1 Q63ZL2 55.66 212 2.36e-78 236.0 sp|Q63ZL2|HOP2_XENLA Homologous-pairing protein 2 homolog OS=Xenopus laevis OX=8355 GN=psmc3ip PE=2 SV=1 g9907.t1 B2ZFP3 57.846 325 5.830000000000001e-124 387.0 sp|B2ZFP3|SMAL1_DANRE SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A-like protein 1 OS=Danio rerio OX=7955 GN=smarcal1 PE=2 SV=1 SMAL1_DANRE reviewed SNF2 related chromatin remodeling annealing helicase 1 (EC 3.6.4.-) (EC 5.6.2.-) (HepA-related protein) (SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A-like protein 1) (Sucrose nonfermenting protein 2-like 1) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000278; GO:0001525; GO:0005524; GO:0005634; GO:0006281; GO:0006357; GO:0010172; GO:0016887; GO:0030097; GO:0031297; GO:0036310; GO:0043596; GO:0048589; GO:0051216 angiogenesis [GO:0001525]; cartilage development [GO:0051216]; developmental growth [GO:0048589]; DNA repair [GO:0006281]; embryonic body morphogenesis [GO:0010172]; hemopoiesis [GO:0030097]; mitotic cell cycle [GO:0000278]; regulation of transcription by RNA polymerase II [GO:0006357]; replication fork processing [GO:0031297] nuclear replication fork [GO:0043596]; nucleus [GO:0005634] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent DNA/DNA annealing activity [GO:0036310] g9908.t1 Q0P4U8 53.419 234 1.3100000000000001e-73 248.0 sp|Q0P4U8|SMAL1_XENTR SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A-like protein 1 OS=Xenopus tropicalis OX=8364 GN=smarcal1 PE=2 SV=1 SMAL1_XENTR reviewed SNF2 related chromatin remodeling annealing helicase 1 (EC 3.6.4.-) (EC 5.6.2.-) (HepA-related protein) (SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A-like protein 1) (Sucrose nonfermenting protein 2-like 1) Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0005524; GO:0005634; GO:0006281; GO:0006357; GO:0016887; GO:0031297; GO:0036310; GO:0043596 DNA repair [GO:0006281]; regulation of transcription by RNA polymerase II [GO:0006357]; replication fork processing [GO:0031297] nuclear replication fork [GO:0043596]; nucleus [GO:0005634] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent DNA/DNA annealing activity [GO:0036310] g9909.t1 Q91VY9 48.511 235 1.2500000000000001e-73 241.0 sp|Q91VY9|ZN622_MOUSE Cytoplasmic 60S subunit biogenesis factor ZNF622 OS=Mus musculus OX=10090 GN=Znf622 PE=1 SV=1 g9909.t1 Q91VY9 50.42 119 3.75e-27 116.0 sp|Q91VY9|ZN622_MOUSE Cytoplasmic 60S subunit biogenesis factor ZNF622 OS=Mus musculus OX=10090 GN=Znf622 PE=1 SV=1 g9910.t1 O61462 85.87 92 2.9299999999999997e-41 133.0 sp|O61462|RL37A_CRYST Large ribosomal subunit protein eL43 OS=Cryptochiton stelleri OX=6655 GN=RPL37A PE=3 SV=3 g9911.t1 Q9CQV4 38.71 217 2.6900000000000003e-47 174.0 sp|Q9CQV4|RETR3_MOUSE Reticulophagy regulator 3 OS=Mus musculus OX=10090 GN=Retreg3 PE=1 SV=1 RETR3_MOUSE reviewed Reticulophagy regulator 3 Mus musculus (Mouse) GO:0005783; GO:0005789; GO:0007029; GO:0010976; GO:0030574; GO:0032991; GO:0061709; GO:0071782; GO:0071786; GO:0140506 collagen catabolic process [GO:0030574]; endoplasmic reticulum organization [GO:0007029]; endoplasmic reticulum tubular network organization [GO:0071786]; positive regulation of neuron projection development [GO:0010976]; reticulophagy [GO:0061709] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum tubular network [GO:0071782]; protein-containing complex [GO:0032991] endoplasmic reticulum-autophagosome adaptor activity [GO:0140506] g9914.t1 Q7ZWB7 75.882 340 0.0 560.0 sp|Q7ZWB7|BBS5_DANRE BBSome complex member BBS5 OS=Danio rerio OX=7955 GN=bbs5 PE=2 SV=1 BBS5_DANRE reviewed BBSome complex member BBS5 (Bardet-Biedl syndrome 5 protein homolog) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001947; GO:0007369; GO:0032266; GO:0032402; GO:0034451; GO:0034464; GO:0036064; GO:0043010; GO:0051877; GO:0060170; GO:0060271; GO:0062139; GO:0070121; GO:0072116 camera-type eye development [GO:0043010]; camera-type eye photoreceptor cell development [GO:0062139]; cilium assembly [GO:0060271]; gastrulation [GO:0007369]; heart looping [GO:0001947]; Kupffer's vesicle development [GO:0070121]; melanosome transport [GO:0032402]; pigment granule aggregation in cell center [GO:0051877]; pronephros formation [GO:0072116] BBSome [GO:0034464]; centriolar satellite [GO:0034451]; ciliary basal body [GO:0036064]; ciliary membrane [GO:0060170] phosphatidylinositol-3-phosphate binding [GO:0032266] g9918.t1 Q2PW47 34.615 1066 0.0 598.0 sp|Q2PW47|MED24_DANRE Mediator of RNA polymerase II transcription subunit 24 OS=Danio rerio OX=7955 GN=med24 PE=2 SV=2 MED24_DANRE reviewed Mediator of RNA polymerase II transcription subunit 24 (Mediator complex subunit 24) (Protein lessen) (Thyroid hormone receptor-associated protein 4 homolog) (Trap100 homolog) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0003712; GO:0016592; GO:0046549; GO:0048484; GO:0048538; GO:0060261; GO:0061453 enteric nervous system development [GO:0048484]; interstitial cell of Cajal differentiation [GO:0061453]; positive regulation of transcription initiation by RNA polymerase II [GO:0060261]; retinal cone cell development [GO:0046549]; thymus development [GO:0048538] mediator complex [GO:0016592] transcription coregulator activity [GO:0003712] g9921.t1 P02599 43.284 134 6.440000000000001e-31 111.0 sp|P02599|CALM_DICDI Calmodulin OS=Dictyostelium discoideum OX=44689 GN=calA PE=1 SV=3 CALM_DICDI reviewed Calmodulin (CaM) Dictyostelium discoideum (Social amoeba) GO:0000226; GO:0000281; GO:0000331; GO:0001778; GO:0004112; GO:0005509; GO:0005615; GO:0005634; GO:0005737; GO:0006611; GO:0017024; GO:0019887; GO:0019900; GO:0019901; GO:0030234; GO:0031012; GO:0031013; GO:0031285; GO:0045861; GO:0048306; GO:0050839; GO:0051284; GO:0061122; GO:0072666; GO:0170005; GO:1903665 establishment of protein localization to vacuole [GO:0072666]; microtubule cytoskeleton organization [GO:0000226]; mitotic cytokinesis [GO:0000281]; negative regulation of asexual reproduction [GO:1903665]; negative regulation of proteolysis [GO:0045861]; plasma membrane repair [GO:0001778]; positive regulation of positive chemotaxis to cAMP [GO:0061122]; positive regulation of sequestering of calcium ion [GO:0051284]; protein export from nucleus [GO:0006611]; regulation of sorocarp stalk cell differentiation [GO:0031285] contractile vacuole [GO:0000331]; cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; nucleus [GO:0005634] calcium ion binding [GO:0005509]; calcium-dependent protein binding [GO:0048306]; cell adhesion molecule binding [GO:0050839]; cyclic nucleotide phosphodiesterase activator activity [GO:0170005]; cyclic-nucleotide phosphodiesterase activity [GO:0004112]; enzyme regulator activity [GO:0030234]; kinase binding [GO:0019900]; myosin I binding [GO:0017024]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; troponin I binding [GO:0031013] g9922.t1 A0A0R4ITC5 63.594 3395 0.0 4246.0 sp|A0A0R4ITC5|TRRAP_DANRE Transformation/transcription domain-associated protein OS=Danio rerio OX=7955 GN=trrap PE=3 SV=1 TRRAP_DANRE reviewed Transformation/transcription domain-associated protein Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000124; GO:0001964; GO:0005634; GO:0006355; GO:0035267; GO:0035675; GO:0042481; GO:0060536; GO:0140861 cartilage morphogenesis [GO:0060536]; DNA repair-dependent chromatin remodeling [GO:0140861]; neuromast hair cell development [GO:0035675]; regulation of DNA-templated transcription [GO:0006355]; regulation of odontogenesis [GO:0042481]; startle response [GO:0001964] NuA4 histone acetyltransferase complex [GO:0035267]; nucleus [GO:0005634]; SAGA complex [GO:0000124] g9922.t1 A0A0R4ITC5 57.021 470 4.03e-136 486.0 sp|A0A0R4ITC5|TRRAP_DANRE Transformation/transcription domain-associated protein OS=Danio rerio OX=7955 GN=trrap PE=3 SV=1 TRRAP_DANRE reviewed Transformation/transcription domain-associated protein Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000124; GO:0001964; GO:0005634; GO:0006355; GO:0035267; GO:0035675; GO:0042481; GO:0060536; GO:0140861 cartilage morphogenesis [GO:0060536]; DNA repair-dependent chromatin remodeling [GO:0140861]; neuromast hair cell development [GO:0035675]; regulation of DNA-templated transcription [GO:0006355]; regulation of odontogenesis [GO:0042481]; startle response [GO:0001964] NuA4 histone acetyltransferase complex [GO:0035267]; nucleus [GO:0005634]; SAGA complex [GO:0000124] g9922.t2 A0A0R4ITC5 63.594 3395 0.0 4247.0 sp|A0A0R4ITC5|TRRAP_DANRE Transformation/transcription domain-associated protein OS=Danio rerio OX=7955 GN=trrap PE=3 SV=1 TRRAP_DANRE reviewed Transformation/transcription domain-associated protein Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000124; GO:0001964; GO:0005634; GO:0006355; GO:0035267; GO:0035675; GO:0042481; GO:0060536; GO:0140861 cartilage morphogenesis [GO:0060536]; DNA repair-dependent chromatin remodeling [GO:0140861]; neuromast hair cell development [GO:0035675]; regulation of DNA-templated transcription [GO:0006355]; regulation of odontogenesis [GO:0042481]; startle response [GO:0001964] NuA4 histone acetyltransferase complex [GO:0035267]; nucleus [GO:0005634]; SAGA complex [GO:0000124] g9922.t2 A0A0R4ITC5 57.143 469 3.95e-135 483.0 sp|A0A0R4ITC5|TRRAP_DANRE Transformation/transcription domain-associated protein OS=Danio rerio OX=7955 GN=trrap PE=3 SV=1 TRRAP_DANRE reviewed Transformation/transcription domain-associated protein Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000124; GO:0001964; GO:0005634; GO:0006355; GO:0035267; GO:0035675; GO:0042481; GO:0060536; GO:0140861 cartilage morphogenesis [GO:0060536]; DNA repair-dependent chromatin remodeling [GO:0140861]; neuromast hair cell development [GO:0035675]; regulation of DNA-templated transcription [GO:0006355]; regulation of odontogenesis [GO:0042481]; startle response [GO:0001964] NuA4 histone acetyltransferase complex [GO:0035267]; nucleus [GO:0005634]; SAGA complex [GO:0000124] g9926.t1 Q9UBU7 33.724 341 1.98e-35 149.0 sp|Q9UBU7|DBF4A_HUMAN Protein DBF4 homolog A OS=Homo sapiens OX=9606 GN=DBF4 PE=1 SV=1 DBF4A_HUMAN reviewed Protein DBF4 homolog A (Activator of S phase kinase) (Chiffon homolog A) (DBF4-type zinc finger-containing protein 1) Homo sapiens (Human) GO:0000082; GO:0003676; GO:0005654; GO:0006260; GO:0008047; GO:0008270; GO:0010571; GO:0016604; GO:0031431; GO:0043539; GO:1901987 DNA replication [GO:0006260]; G1/S transition of mitotic cell cycle [GO:0000082]; positive regulation of nuclear cell cycle DNA replication [GO:0010571]; regulation of cell cycle phase transition [GO:1901987] Dbf4-dependent protein kinase complex [GO:0031431]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654] enzyme activator activity [GO:0008047]; nucleic acid binding [GO:0003676]; protein serine/threonine kinase activator activity [GO:0043539]; zinc ion binding [GO:0008270] g9929.t1 Q91090 36.025 322 3.72e-50 173.0 sp|Q91090|PON2_MELGA Serum paraoxonase/arylesterase 2 OS=Meleagris gallopavo OX=9103 GN=PON2 PE=2 SV=1 g9930.t1 Q14449 39.065 535 1.3699999999999999e-120 374.0 sp|Q14449|GRB14_HUMAN Growth factor receptor-bound protein 14 OS=Homo sapiens OX=9606 GN=GRB14 PE=1 SV=2 GRB14_HUMAN reviewed Growth factor receptor-bound protein 14 (GRB14 adapter protein) Homo sapiens (Human) GO:0005737; GO:0005829; GO:0005886; GO:0007165; GO:0008286; GO:0010008; GO:0030674; GO:0030971; GO:0046627; GO:0060090 insulin receptor signaling pathway [GO:0008286]; negative regulation of insulin receptor signaling pathway [GO:0046627]; signal transduction [GO:0007165] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; plasma membrane [GO:0005886] molecular adaptor activity [GO:0060090]; protein-macromolecule adaptor activity [GO:0030674]; receptor tyrosine kinase binding [GO:0030971] g9930.t2 Q14449 39.065 535 1.18e-120 374.0 sp|Q14449|GRB14_HUMAN Growth factor receptor-bound protein 14 OS=Homo sapiens OX=9606 GN=GRB14 PE=1 SV=2 GRB14_HUMAN reviewed Growth factor receptor-bound protein 14 (GRB14 adapter protein) Homo sapiens (Human) GO:0005737; GO:0005829; GO:0005886; GO:0007165; GO:0008286; GO:0010008; GO:0030674; GO:0030971; GO:0046627; GO:0060090 insulin receptor signaling pathway [GO:0008286]; negative regulation of insulin receptor signaling pathway [GO:0046627]; signal transduction [GO:0007165] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; plasma membrane [GO:0005886] molecular adaptor activity [GO:0060090]; protein-macromolecule adaptor activity [GO:0030674]; receptor tyrosine kinase binding [GO:0030971] g9932.t2 Q9D9H8 49.194 124 1.12e-34 130.0 sp|Q9D9H8|CB069_MOUSE Mitochondrial protein C2orf69 homolog OS=Mus musculus OX=10090 PE=2 SV=3 g9934.t1 P19217 38.246 285 1.29e-63 206.0 sp|P19217|ST1E1_BOVIN Sulfotransferase 1E1 OS=Bos taurus OX=9913 GN=SULT1E1 PE=1 SV=1 ST1E1_BOVIN reviewed Sulfotransferase 1E1 (ST1E1) (EC 2.8.2.4) (Estrogen sulfotransferase) (Sulfotransferase, estrogen-preferring) Bos taurus (Bovine) GO:0004062; GO:0004304; GO:0005496; GO:0005737; GO:0005829; GO:0008210; GO:0050294; GO:0051923 estrogen metabolic process [GO:0008210]; sulfation [GO:0051923] cytoplasm [GO:0005737]; cytosol [GO:0005829] aryl sulfotransferase activity [GO:0004062]; estrone sulfotransferase activity [GO:0004304]; steroid binding [GO:0005496]; steroid sulfotransferase activity [GO:0050294] g9934.t2 P19217 38.246 285 1.97e-63 207.0 sp|P19217|ST1E1_BOVIN Sulfotransferase 1E1 OS=Bos taurus OX=9913 GN=SULT1E1 PE=1 SV=1 ST1E1_BOVIN reviewed Sulfotransferase 1E1 (ST1E1) (EC 2.8.2.4) (Estrogen sulfotransferase) (Sulfotransferase, estrogen-preferring) Bos taurus (Bovine) GO:0004062; GO:0004304; GO:0005496; GO:0005737; GO:0005829; GO:0008210; GO:0050294; GO:0051923 estrogen metabolic process [GO:0008210]; sulfation [GO:0051923] cytoplasm [GO:0005737]; cytosol [GO:0005829] aryl sulfotransferase activity [GO:0004062]; estrone sulfotransferase activity [GO:0004304]; steroid binding [GO:0005496]; steroid sulfotransferase activity [GO:0050294] g9939.t1 Q91WG5 65.064 312 6.81e-148 436.0 sp|Q91WG5|AAKG2_MOUSE 5'-AMP-activated protein kinase subunit gamma-2 OS=Mus musculus OX=10090 GN=Prkag2 PE=1 SV=2 AAKG2_MOUSE reviewed 5'-AMP-activated protein kinase subunit gamma-2 (AMPK gamma2) (AMPK subunit gamma-2) Mus musculus (Mouse) GO:0004679; GO:0004862; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005977; GO:0006110; GO:0006633; GO:0008603; GO:0008607; GO:0016208; GO:0019217; GO:0019887; GO:0019901; GO:0030295; GO:0031588; GO:0031669; GO:0035556; GO:0042149; GO:0043531; GO:0043609; GO:0045722 cellular response to glucose starvation [GO:0042149]; cellular response to nutrient levels [GO:0031669]; fatty acid biosynthetic process [GO:0006633]; glycogen metabolic process [GO:0005977]; intracellular signal transduction [GO:0035556]; positive regulation of gluconeogenesis [GO:0045722]; regulation of carbon utilization [GO:0043609]; regulation of fatty acid metabolic process [GO:0019217]; regulation of glycolytic process [GO:0006110] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleotide-activated protein kinase complex [GO:0031588]; nucleus [GO:0005634] ADP binding [GO:0043531]; AMP binding [GO:0016208]; AMP-activated protein kinase activity [GO:0004679]; ATP binding [GO:0005524]; cAMP-dependent protein kinase inhibitor activity [GO:0004862]; cAMP-dependent protein kinase regulator activity [GO:0008603]; phosphorylase kinase regulator activity [GO:0008607]; protein kinase activator activity [GO:0030295]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887] g9939.t2 Q9UGJ0 64.65 314 3.2600000000000004e-148 437.0 sp|Q9UGJ0|AAKG2_HUMAN 5'-AMP-activated protein kinase subunit gamma-2 OS=Homo sapiens OX=9606 GN=PRKAG2 PE=1 SV=1 AAKG2_HUMAN reviewed 5'-AMP-activated protein kinase subunit gamma-2 (AMPK gamma2) (AMPK subunit gamma-2) (H91620p) Homo sapiens (Human) GO:0004679; GO:0004862; GO:0005524; GO:0005615; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005977; GO:0006110; GO:0006633; GO:0006754; GO:0008603; GO:0008607; GO:0016126; GO:0016208; GO:0019217; GO:0019887; GO:0019901; GO:0030295; GO:0031588; GO:0031669; GO:0035556; GO:0042149; GO:0043531; GO:0043609; GO:0045722; GO:0046320; GO:0046324; GO:0051726 ATP biosynthetic process [GO:0006754]; cellular response to glucose starvation [GO:0042149]; cellular response to nutrient levels [GO:0031669]; fatty acid biosynthetic process [GO:0006633]; glycogen metabolic process [GO:0005977]; intracellular signal transduction [GO:0035556]; positive regulation of gluconeogenesis [GO:0045722]; regulation of carbon utilization [GO:0043609]; regulation of cell cycle [GO:0051726]; regulation of D-glucose import [GO:0046324]; regulation of fatty acid metabolic process [GO:0019217]; regulation of fatty acid oxidation [GO:0046320]; regulation of glycolytic process [GO:0006110]; sterol biosynthetic process [GO:0016126] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; nucleoplasm [GO:0005654]; nucleotide-activated protein kinase complex [GO:0031588]; nucleus [GO:0005634] ADP binding [GO:0043531]; AMP binding [GO:0016208]; AMP-activated protein kinase activity [GO:0004679]; ATP binding [GO:0005524]; cAMP-dependent protein kinase inhibitor activity [GO:0004862]; cAMP-dependent protein kinase regulator activity [GO:0008603]; phosphorylase kinase regulator activity [GO:0008607]; protein kinase activator activity [GO:0030295]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887] g9940.t1 Q9D4H8 59.383 746 0.0 939.0 sp|Q9D4H8|CUL2_MOUSE Cullin-2 OS=Mus musculus OX=10090 GN=Cul2 PE=1 SV=2 CUL2_MOUSE reviewed Cullin-2 (CUL-2) Mus musculus (Mouse) GO:0005654; GO:0005730; GO:0016567; GO:0019005; GO:0030163; GO:0030674; GO:0030891; GO:0031146; GO:0031462; GO:0031625; GO:0044877; GO:0140627; GO:0160072 protein catabolic process [GO:0030163]; protein ubiquitination [GO:0016567]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; ubiquitin-dependent protein catabolic process via the C-end degron rule pathway [GO:0140627] Cul2-RING ubiquitin ligase complex [GO:0031462]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; SCF ubiquitin ligase complex [GO:0019005]; VCB complex [GO:0030891] protein-containing complex binding [GO:0044877]; protein-macromolecule adaptor activity [GO:0030674]; ubiquitin ligase complex scaffold activity [GO:0160072]; ubiquitin protein ligase binding [GO:0031625] g9941.t1 Q6P6V1 49.682 628 0.0 610.0 sp|Q6P6V1|GLT11_RAT Polypeptide N-acetylgalactosaminyltransferase 11 OS=Rattus norvegicus OX=10116 GN=Galnt11 PE=1 SV=1 GLT11_RAT reviewed Polypeptide N-acetylgalactosaminyltransferase 11 (EC 2.4.1.41) (Polypeptide GalNAc transferase 11) (GalNAc-T11) (pp-GaNTase 11) (Protein-UDP acetylgalactosaminyltransferase 11) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 11) Rattus norvegicus (Rat) GO:0000139; GO:0004653; GO:0005112; GO:0005794; GO:0006493; GO:0007220; GO:0007368; GO:0008593; GO:0030246; GO:0046872; GO:0060271; GO:0061314 cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; Notch receptor processing [GO:0007220]; Notch signaling involved in heart development [GO:0061314]; protein O-linked glycosylation [GO:0006493]; regulation of Notch signaling pathway [GO:0008593] Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139] carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; Notch binding [GO:0005112]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653] g9942.t1 Q9DC11 47.917 240 1.32e-66 227.0 sp|Q9DC11|PXDC2_MOUSE Plexin domain-containing protein 2 OS=Mus musculus OX=10090 GN=Plxdc2 PE=1 SV=1 PXDC2_MOUSE reviewed Plexin domain-containing protein 2 (Tumor endothelial marker 7-related protein) Mus musculus (Mouse) GO:0005886; GO:0031012 extracellular matrix [GO:0031012]; plasma membrane [GO:0005886] g9944.t1 Q7TS68 47.599 479 1.12e-137 407.0 sp|Q7TS68|NSUN6_MOUSE tRNA (cytosine(72)-C(5))-methyltransferase NSUN6 OS=Mus musculus OX=10090 GN=Nsun6 PE=2 SV=2 g9945.t1 O73817 72.683 205 6.0100000000000005e-105 302.0 sp|O73817|PSB3_ONCMY Proteasome subunit beta type-3 OS=Oncorhynchus mykiss OX=8022 GN=psmb3 PE=2 SV=1 g9946.t1 Q7ZWZ5 73.134 469 0.0 733.0 sp|Q7ZWZ5|CISY_XENLA Citrate synthase, mitochondrial OS=Xenopus laevis OX=8355 GN=cs PE=2 SV=1 g9947.t1 Q5DC69 62.245 98 4.85e-42 136.0 sp|Q5DC69|CH10_SCHJA 10 kDa heat shock protein, mitochondrial OS=Schistosoma japonicum OX=6182 GN=SJCHGC01960 PE=3 SV=2 g9948.t1 P10809 74.153 561 0.0 852.0 sp|P10809|CH60_HUMAN 60 kDa heat shock protein, mitochondrial OS=Homo sapiens OX=9606 GN=HSPD1 PE=1 SV=2 CH60_HUMAN reviewed 60 kDa heat shock protein, mitochondrial (EC 5.6.1.7) (60 kDa chaperonin) (Chaperonin 60) (CPN60) (Heat shock protein 60) (HSP-60) (Hsp60) (Heat shock protein family D member 1) (HuCHA60) (Mitochondrial matrix protein P1) (P60 lymphocyte protein) Homo sapiens (Human) GO:0001530; GO:0002039; GO:0002755; GO:0002842; GO:0003688; GO:0003697; GO:0003723; GO:0003725; GO:0005524; GO:0005615; GO:0005737; GO:0005739; GO:0005743; GO:0005759; GO:0005769; GO:0005829; GO:0005886; GO:0005905; GO:0006457; GO:0006458; GO:0006986; GO:0008035; GO:0008637; GO:0009409; GO:0009986; GO:0016020; GO:0016853; GO:0016887; GO:0019899; GO:0030135; GO:0030141; GO:0031625; GO:0032727; GO:0032729; GO:0032733; GO:0032735; GO:0032755; GO:0032991; GO:0034185; GO:0034186; GO:0034514; GO:0042026; GO:0042100; GO:0042110; GO:0042113; GO:0043032; GO:0043066; GO:0045041; GO:0046696; GO:0048291; GO:0050821; GO:0050870; GO:0051082; GO:0051087; GO:0051131; GO:0051604; GO:0051702; GO:0070062; GO:0097225; GO:0097524; GO:0098761; GO:0140494; GO:0140608; GO:0140662; GO:1900118; GO:1900119 'de novo' protein folding [GO:0006458]; apoptotic mitochondrial changes [GO:0008637]; B cell activation [GO:0042113]; B cell proliferation [GO:0042100]; biological process involved in interaction with symbiont [GO:0051702]; cellular response to interleukin-7 [GO:0098761]; chaperone-mediated protein complex assembly [GO:0051131]; isotype switching to IgG isotypes [GO:0048291]; mitochondrial unfolded protein response [GO:0034514]; MyD88-dependent toll-like receptor signaling pathway [GO:0002755]; negative regulation of apoptotic process [GO:0043066]; negative regulation of execution phase of apoptosis [GO:1900118]; positive regulation of execution phase of apoptosis [GO:1900119]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interleukin-10 production [GO:0032733]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of macrophage activation [GO:0043032]; positive regulation of T cell activation [GO:0050870]; positive regulation of T cell mediated immune response to tumor cell [GO:0002842]; positive regulation of type II interferon production [GO:0032729]; protein folding [GO:0006457]; protein import into mitochondrial intermembrane space [GO:0045041]; protein maturation [GO:0051604]; protein refolding [GO:0042026]; protein stabilization [GO:0050821]; response to cold [GO:0009409]; response to unfolded protein [GO:0006986]; T cell activation [GO:0042110] cell surface [GO:0009986]; clathrin-coated pit [GO:0005905]; coated vesicle [GO:0030135]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; lipopolysaccharide receptor complex [GO:0046696]; membrane [GO:0016020]; migrasome [GO:0140494]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; secretory granule [GO:0030141]; sperm midpiece [GO:0097225]; sperm plasma membrane [GO:0097524] apolipoprotein A-I binding [GO:0034186]; apolipoprotein binding [GO:0034185]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent protein folding chaperone [GO:0140662]; cysteine-type endopeptidase activator activity [GO:0140608]; DNA replication origin binding [GO:0003688]; double-stranded RNA binding [GO:0003725]; enzyme binding [GO:0019899]; high-density lipoprotein particle binding [GO:0008035]; isomerase activity [GO:0016853]; lipopolysaccharide binding [GO:0001530]; p53 binding [GO:0002039]; protein-folding chaperone binding [GO:0051087]; RNA binding [GO:0003723]; single-stranded DNA binding [GO:0003697]; ubiquitin protein ligase binding [GO:0031625]; unfolded protein binding [GO:0051082] g9949.t1 Q6P1L5 37.811 402 1.2e-33 137.0 sp|Q6P1L5|F117B_HUMAN Protein FAM117B OS=Homo sapiens OX=9606 GN=FAM117B PE=1 SV=2 F117B_HUMAN reviewed Protein FAM117B (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 13 protein) Homo sapiens (Human) g9952.t1 Q5U5D4 37.652 903 0.0 572.0 sp|Q5U5D4|MIOSA_XENLA GATOR2 complex protein MIOS-A OS=Xenopus laevis OX=8355 GN=mios-a PE=2 SV=1 g9953.t1 Q55DF5 45.283 106 1.6299999999999997e-23 97.4 sp|Q55DF5|JMJCD_DICDI JmjC domain-containing protein D OS=Dictyostelium discoideum OX=44689 GN=jcdD PE=4 SV=1 g9954.t1 Q5R4U9 52.727 165 1.14e-59 187.0 sp|Q5R4U9|SORCN_PONAB Sorcin OS=Pongo abelii OX=9601 GN=SRI PE=2 SV=1 SORCN_PONAB reviewed Sorcin Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0002020; GO:0005509; GO:0005654; GO:0005829; GO:0005886; GO:0006816; GO:0010459; GO:0010880; GO:0030018; GO:0033017; GO:0042584; GO:0046982; GO:0051281; GO:0055118; GO:0061178; GO:0070062; GO:0086004; GO:0140297; GO:0140311; GO:0140416; GO:1901077; GO:1901844 calcium ion transport [GO:0006816]; negative regulation of cardiac muscle contraction [GO:0055118]; negative regulation of heart rate [GO:0010459]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; regulation of cardiac muscle cell contraction [GO:0086004]; regulation of cell communication by electrical coupling involved in cardiac conduction [GO:1901844]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]; regulation of relaxation of muscle [GO:1901077]; regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0010880] chromaffin granule membrane [GO:0042584]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; sarcoplasmic reticulum membrane [GO:0033017]; Z disc [GO:0030018] calcium ion binding [GO:0005509]; DNA-binding transcription factor binding [GO:0140297]; protease binding [GO:0002020]; protein heterodimerization activity [GO:0046982]; protein sequestering activity [GO:0140311]; transcription regulator inhibitor activity [GO:0140416] g9958.t1 Q29041 53.023 215 5.03e-71 229.0 sp|Q29041|FCN2_PIG Ficolin-2 OS=Sus scrofa OX=9823 GN=FCN2 PE=1 SV=1 FCN2_PIG reviewed Ficolin-2 (Collagen/fibrinogen domain-containing protein 2) (Ficolin-B) (Ficolin-beta) (L-ficolin) Sus scrofa (Pig) GO:0001867; GO:0003823; GO:0005102; GO:0005581; GO:0005615; GO:0030246; GO:0038187; GO:0046872; GO:0070892; GO:0097367; GO:0106139 complement activation, lectin pathway [GO:0001867] collagen trimer [GO:0005581]; extracellular space [GO:0005615]; symbiont cell surface [GO:0106139] antigen binding [GO:0003823]; carbohydrate binding [GO:0030246]; carbohydrate derivative binding [GO:0097367]; lipoteichoic acid immune receptor activity [GO:0070892]; metal ion binding [GO:0046872]; pattern recognition receptor activity [GO:0038187]; signaling receptor binding [GO:0005102] g9959.t1 Q8IWA0 37.339 774 1.1600000000000001e-160 492.0 sp|Q8IWA0|WDR75_HUMAN WD repeat-containing protein 75 OS=Homo sapiens OX=9606 GN=WDR75 PE=1 SV=1 WDR75_HUMAN reviewed WD repeat-containing protein 75 (U3 small nucleolar RNA-associated protein 17 homolog) Homo sapiens (Human) GO:0003723; GO:0005654; GO:0005730; GO:0006364; GO:0032040; GO:0042274; GO:0045943; GO:2000234 positive regulation of rRNA processing [GO:2000234]; positive regulation of transcription by RNA polymerase I [GO:0045943]; ribosomal small subunit biogenesis [GO:0042274]; rRNA processing [GO:0006364] nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; small-subunit processome [GO:0032040] RNA binding [GO:0003723] g9960.t1 Q9H9Y6 55.194 1136 0.0 1295.0 sp|Q9H9Y6|RPA2_HUMAN DNA-directed RNA polymerase I subunit RPA2 OS=Homo sapiens OX=9606 GN=POLR1B PE=1 SV=2 RPA2_HUMAN reviewed DNA-directed RNA polymerase I subunit RPA2 (RNA polymerase I subunit 2) (EC 2.7.7.6) (DNA-directed RNA polymerase I 135 kDa polypeptide) (RPA135) Homo sapiens (Human) GO:0001650; GO:0003677; GO:0003899; GO:0005654; GO:0005694; GO:0005736; GO:0005829; GO:0007566; GO:0008270; GO:0009303; GO:0014029; GO:0017126; GO:0032549; GO:0071667 embryo implantation [GO:0007566]; neural crest formation [GO:0014029]; nucleologenesis [GO:0017126]; rRNA transcription [GO:0009303] chromosome [GO:0005694]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; RNA polymerase I complex [GO:0005736] DNA binding [GO:0003677]; DNA-directed RNA polymerase activity [GO:0003899]; DNA/RNA hybrid binding [GO:0071667]; ribonucleoside binding [GO:0032549]; zinc ion binding [GO:0008270] g9960.t2 Q9H9Y6 55.194 1136 0.0 1294.0 sp|Q9H9Y6|RPA2_HUMAN DNA-directed RNA polymerase I subunit RPA2 OS=Homo sapiens OX=9606 GN=POLR1B PE=1 SV=2 RPA2_HUMAN reviewed DNA-directed RNA polymerase I subunit RPA2 (RNA polymerase I subunit 2) (EC 2.7.7.6) (DNA-directed RNA polymerase I 135 kDa polypeptide) (RPA135) Homo sapiens (Human) GO:0001650; GO:0003677; GO:0003899; GO:0005654; GO:0005694; GO:0005736; GO:0005829; GO:0007566; GO:0008270; GO:0009303; GO:0014029; GO:0017126; GO:0032549; GO:0071667 embryo implantation [GO:0007566]; neural crest formation [GO:0014029]; nucleologenesis [GO:0017126]; rRNA transcription [GO:0009303] chromosome [GO:0005694]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; RNA polymerase I complex [GO:0005736] DNA binding [GO:0003677]; DNA-directed RNA polymerase activity [GO:0003899]; DNA/RNA hybrid binding [GO:0071667]; ribonucleoside binding [GO:0032549]; zinc ion binding [GO:0008270] g9961.t1 P09917 30.78 705 2.13e-98 321.0 sp|P09917|LOX5_HUMAN Polyunsaturated fatty acid 5-lipoxygenase OS=Homo sapiens OX=9606 GN=ALOX5 PE=1 SV=2 LOX5_HUMAN reviewed Polyunsaturated fatty acid 5-lipoxygenase (EC 1.13.11.-) (Arachidonate 5-lipoxygenase) (5-LO) (5-lipoxygenase) (EC 1.13.11.34) Homo sapiens (Human) GO:0001937; GO:0002232; GO:0002523; GO:0002540; GO:0004051; GO:0004052; GO:0005506; GO:0005576; GO:0005615; GO:0005635; GO:0005641; GO:0005654; GO:0005829; GO:0006691; GO:0006959; GO:0016363; GO:0016491; GO:0016525; GO:0016701; GO:0016787; GO:0019369; GO:0019370; GO:0019372; GO:0030501; GO:0031965; GO:0034440; GO:0034774; GO:0036336; GO:0036403; GO:0042593; GO:0042759; GO:0045598; GO:0048471; GO:0050727; GO:0050728; GO:0050796; GO:0061044; GO:0061045; GO:0106014; GO:1900015; GO:1900407; GO:1901753; GO:1903426; GO:1903573; GO:1903671; GO:1904813; GO:1904999; GO:2001301 arachidonate metabolic process [GO:0019369]; dendritic cell migration [GO:0036336]; glucose homeostasis [GO:0042593]; humoral immune response [GO:0006959]; leukocyte chemotaxis involved in inflammatory response [GO:0002232]; leukocyte migration involved in inflammatory response [GO:0002523]; leukotriene A4 biosynthetic process [GO:1901753]; leukotriene biosynthetic process [GO:0019370]; leukotriene metabolic process [GO:0006691]; leukotriene production involved in inflammatory response [GO:0002540]; lipid oxidation [GO:0034440]; lipoxin biosynthetic process [GO:2001301]; lipoxygenase pathway [GO:0019372]; long-chain fatty acid biosynthetic process [GO:0042759]; negative regulation of angiogenesis [GO:0016525]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of inflammatory response [GO:0050728]; negative regulation of response to endoplasmic reticulum stress [GO:1903573]; negative regulation of sprouting angiogenesis [GO:1903671]; negative regulation of vascular wound healing [GO:0061044]; negative regulation of wound healing [GO:0061045]; positive regulation of bone mineralization [GO:0030501]; positive regulation of leukocyte adhesion to arterial endothelial cell [GO:1904999]; regulation of cellular response to oxidative stress [GO:1900407]; regulation of cytokine production involved in inflammatory response [GO:1900015]; regulation of fat cell differentiation [GO:0045598]; regulation of inflammatory response [GO:0050727]; regulation of inflammatory response to wounding [GO:0106014]; regulation of insulin secretion [GO:0050796]; regulation of reactive oxygen species biosynthetic process [GO:1903426] cytosol [GO:0005829]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; ficolin-1-rich granule lumen [GO:1904813]; nuclear envelope [GO:0005635]; nuclear envelope lumen [GO:0005641]; nuclear matrix [GO:0016363]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; secretory granule lumen [GO:0034774] arachidonate 12(S)-lipoxygenase activity [GO:0004052]; arachidonate 5-lipoxygenase activity [GO:0004051]; arachidonate 8(S)-lipoxygenase activity [GO:0036403]; hydrolase activity [GO:0016787]; iron ion binding [GO:0005506]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen [GO:0016701] g9966.t1 Q5R8L2 55.777 251 3.4899999999999996e-91 290.0 sp|Q5R8L2|BMI1_PONAB Polycomb complex protein BMI-1 OS=Pongo abelii OX=9601 GN=BMI1 PE=2 SV=1 BMI1_PONAB reviewed Polycomb complex protein BMI-1 (Polycomb group RING finger protein 4) Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0000122; GO:0000151; GO:0005737; GO:0006338; GO:0008270; GO:0031519; GO:0035102; GO:0045814; GO:0051443; GO:1990841 chromatin remodeling [GO:0006338]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of ubiquitin-protein transferase activity [GO:0051443] cytoplasm [GO:0005737]; PcG protein complex [GO:0031519]; PRC1 complex [GO:0035102]; ubiquitin ligase complex [GO:0000151] promoter-specific chromatin binding [GO:1990841]; zinc ion binding [GO:0008270] g9967.t1 Q32KX7 46.586 249 2e-73 231.0 sp|Q32KX7|BMI1_BOVIN Polycomb complex protein BMI-1 OS=Bos taurus OX=9913 GN=BMI1 PE=2 SV=1 BMI1_BOVIN reviewed Polycomb complex protein BMI-1 (Polycomb group RING finger protein 4) Bos taurus (Bovine) GO:0000122; GO:0000151; GO:0000792; GO:0001701; GO:0005829; GO:0006338; GO:0006346; GO:0006959; GO:0007420; GO:0008270; GO:0016604; GO:0021903; GO:0030097; GO:0030890; GO:0031519; GO:0033092; GO:0035102; GO:0045814; GO:0048103; GO:0048146; GO:0048704; GO:0051443; GO:0071535; GO:0097027; GO:0097190; GO:1990841; GO:2000011; GO:2001234 apoptotic signaling pathway [GO:0097190]; brain development [GO:0007420]; chromatin remodeling [GO:0006338]; DNA methylation-dependent constitutive heterochromatin formation [GO:0006346]; embryonic skeletal system morphogenesis [GO:0048704]; hemopoiesis [GO:0030097]; humoral immune response [GO:0006959]; in utero embryonic development [GO:0001701]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of immature T cell proliferation in thymus [GO:0033092]; positive regulation of ubiquitin-protein transferase activity [GO:0051443]; regulation of adaxial/abaxial pattern formation [GO:2000011]; rostrocaudal neural tube patterning [GO:0021903]; somatic stem cell division [GO:0048103] cytosol [GO:0005829]; heterochromatin [GO:0000792]; nuclear body [GO:0016604]; PcG protein complex [GO:0031519]; PRC1 complex [GO:0035102]; ubiquitin ligase complex [GO:0000151] promoter-specific chromatin binding [GO:1990841]; RING-like zinc finger domain binding [GO:0071535]; ubiquitin-protein transferase activator activity [GO:0097027]; zinc ion binding [GO:0008270] g9968.t1 Q6NZC7 52.547 746 0.0 792.0 sp|Q6NZC7|S23IP_MOUSE SEC23-interacting protein OS=Mus musculus OX=10090 GN=Sec23ip PE=1 SV=2 S23IP_MOUSE reviewed SEC23-interacting protein Mus musculus (Mouse) GO:0001675; GO:0004620; GO:0005737; GO:0005794; GO:0005801; GO:0007286; GO:0007338; GO:0012507; GO:0030134; GO:0046872; GO:0048471; GO:0070971; GO:0097038 acrosome assembly [GO:0001675]; single fertilization [GO:0007338]; spermatid development [GO:0007286] cis-Golgi network [GO:0005801]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; cytoplasm [GO:0005737]; endoplasmic reticulum exit site [GO:0070971]; ER to Golgi transport vesicle membrane [GO:0012507]; Golgi apparatus [GO:0005794]; perinuclear endoplasmic reticulum [GO:0097038]; perinuclear region of cytoplasm [GO:0048471] metal ion binding [GO:0046872]; phospholipase activity [GO:0004620] g9969.t1 Q5F495 89.268 205 3.43e-139 392.0 sp|Q5F495|PHOCN_CHICK MOB-like protein phocein OS=Gallus gallus OX=9031 GN=MOB4 PE=2 SV=1 g9970.t1 Q9Z1W4 36.986 365 5.3e-71 233.0 sp|Q9Z1W4|GDF11_MOUSE Growth/differentiation factor 11 OS=Mus musculus OX=10090 GN=Gdf11 PE=1 SV=1 GDF11_MOUSE reviewed Growth/differentiation factor 11 (GDF-11) (Bone morphogenetic protein 11) (BMP-11) Mus musculus (Mouse) GO:0001501; GO:0001656; GO:0001657; GO:0005125; GO:0005615; GO:0007179; GO:0008083; GO:0008285; GO:0009887; GO:0009952; GO:0021512; GO:0031016; GO:0032924; GO:0032991; GO:0045596; GO:0045665; GO:0048469; GO:0048593; GO:0060021; GO:0060391 activin receptor signaling pathway [GO:0032924]; animal organ morphogenesis [GO:0009887]; anterior/posterior pattern specification [GO:0009952]; camera-type eye morphogenesis [GO:0048593]; cell maturation [GO:0048469]; metanephros development [GO:0001656]; negative regulation of cell differentiation [GO:0045596]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of neuron differentiation [GO:0045665]; pancreas development [GO:0031016]; positive regulation of SMAD protein signal transduction [GO:0060391]; roof of mouth development [GO:0060021]; skeletal system development [GO:0001501]; spinal cord anterior/posterior patterning [GO:0021512]; transforming growth factor beta receptor signaling pathway [GO:0007179]; ureteric bud development [GO:0001657] extracellular space [GO:0005615]; protein-containing complex [GO:0032991] cytokine activity [GO:0005125]; growth factor activity [GO:0008083] g9971.t1 Q6GR35 48.193 166 2.52e-57 183.0 sp|Q6GR35|ABITM_XENLA Protein Abitram OS=Xenopus laevis OX=8355 GN=abitram PE=2 SV=1 ABITM_XENLA reviewed Protein Abitram (Actin-binding transcription modulator) (Protein Simiate) Xenopus laevis (African clawed frog) GO:0003785; GO:0005634; GO:0016607; GO:0030027; GO:0030425; GO:0030426; GO:0030833; GO:0032433; GO:0048813; GO:0051015; GO:0051489 dendrite morphogenesis [GO:0048813]; regulation of actin filament polymerization [GO:0030833]; regulation of filopodium assembly [GO:0051489] dendrite [GO:0030425]; filopodium tip [GO:0032433]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; nuclear speck [GO:0016607]; nucleus [GO:0005634] actin filament binding [GO:0051015]; actin monomer binding [GO:0003785] g9973.t1 Q5ZJL4 66.268 418 0.0 586.0 sp|Q5ZJL4|CLP1_CHICK Polyribonucleotide 5'-hydroxyl-kinase Clp1 OS=Gallus gallus OX=9031 GN=CLP1 PE=2 SV=2 CLP1_CHICK reviewed Polyribonucleotide 5'-hydroxyl-kinase Clp1 (EC 2.7.1.78) (Polyadenylation factor Clp1) (Polynucleotide kinase Clp1) (Pre-mRNA cleavage complex II protein Clp1) Gallus gallus (Chicken) GO:0000214; GO:0005524; GO:0005634; GO:0005654; GO:0005829; GO:0005849; GO:0006388; GO:0021695; GO:0031124; GO:0046404; GO:0051731; GO:0051736; GO:0070922; GO:0098795 cerebellar cortex development [GO:0021695]; global gene silencing by mRNA cleavage [GO:0098795]; mRNA 3'-end processing [GO:0031124]; RISC complex assembly [GO:0070922]; tRNA splicing, via endonucleolytic cleavage and ligation [GO:0006388] cytosol [GO:0005829]; mRNA cleavage factor complex [GO:0005849]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; tRNA-intron endonuclease complex [GO:0000214] ATP binding [GO:0005524]; ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity [GO:0046404]; ATP-dependent polyribonucleotide 5'-hydroxyl-kinase activity [GO:0051736]; polynucleotide 5'-hydroxyl-kinase activity [GO:0051731] g9974.t1 O54946 46.617 266 2.38e-46 161.0 sp|O54946|DNJB6_MOUSE DnaJ homolog subfamily B member 6 OS=Mus musculus OX=10090 GN=Dnajb6 PE=1 SV=4 DNJB6_MOUSE reviewed DnaJ homolog subfamily B member 6 (Heat shock protein J2) (HSJ-2) (MRJ) (mDj4) Mus musculus (Mouse) GO:0001671; GO:0003677; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006457; GO:0030018; GO:0030036; GO:0030198; GO:0030544; GO:0031072; GO:0032880; GO:0034504; GO:0042802; GO:0044183; GO:0045109; GO:0045892; GO:0048471; GO:0050877; GO:0051082; GO:0051087; GO:0060710; GO:0060715; GO:0060717; GO:0090084 actin cytoskeleton organization [GO:0030036]; chorio-allantoic fusion [GO:0060710]; chorion development [GO:0060717]; extracellular matrix organization [GO:0030198]; intermediate filament organization [GO:0045109]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of inclusion body assembly [GO:0090084]; nervous system process [GO:0050877]; protein folding [GO:0006457]; protein localization to nucleus [GO:0034504]; regulation of protein localization [GO:0032880]; syncytiotrophoblast cell differentiation involved in labyrinthine layer development [GO:0060715] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; Z disc [GO:0030018] ATPase activator activity [GO:0001671]; DNA binding [GO:0003677]; heat shock protein binding [GO:0031072]; Hsp70 protein binding [GO:0030544]; identical protein binding [GO:0042802]; protein folding chaperone [GO:0044183]; protein-folding chaperone binding [GO:0051087]; unfolded protein binding [GO:0051082] g9974.t2 Q5XGU5 54.065 246 1.3099999999999998e-55 181.0 sp|Q5XGU5|DNJ6B_XENLA DnaJ homolog subfamily B member 6-B OS=Xenopus laevis OX=8355 GN=dnajb6-b PE=2 SV=1 g9977.t1 P13497 26.577 444 2.0299999999999997e-34 145.0 sp|P13497|BMP1_HUMAN Bone morphogenetic protein 1 OS=Homo sapiens OX=9606 GN=BMP1 PE=1 SV=2 BMP1_HUMAN reviewed Bone morphogenetic protein 1 (BMP-1) (EC 3.4.24.19) (Mammalian tolloid protein) (mTld) (Procollagen C-proteinase) (PCP) Homo sapiens (Human) GO:0001501; GO:0001502; GO:0001503; GO:0004222; GO:0004252; GO:0005125; GO:0005509; GO:0005576; GO:0005615; GO:0005794; GO:0006508; GO:0008083; GO:0008233; GO:0008237; GO:0008270; GO:0009953; GO:0016485; GO:0030154; GO:0030199; GO:0031982; GO:0042802; GO:0061036 cartilage condensation [GO:0001502]; cell differentiation [GO:0030154]; collagen fibril organization [GO:0030199]; dorsal/ventral pattern formation [GO:0009953]; ossification [GO:0001503]; positive regulation of cartilage development [GO:0061036]; protein processing [GO:0016485]; proteolysis [GO:0006508]; skeletal system development [GO:0001501] extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; vesicle [GO:0031982] calcium ion binding [GO:0005509]; cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; identical protein binding [GO:0042802]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; peptidase activity [GO:0008233]; serine-type endopeptidase activity [GO:0004252]; zinc ion binding [GO:0008270] g9978.t1 O57382 25.18 417 4.5e-31 133.0 sp|O57382|TLL2_XENLA Tolloid-like protein 2 OS=Xenopus laevis OX=8355 GN=tll2 PE=2 SV=1 g9979.t1 O83041 46.129 310 1.7399999999999999e-93 281.0 sp|O83041|PIP_LEPBY Probable proline iminopeptidase OS=Leptolyngbya boryana OX=1184 GN=pip PE=3 SV=1 g9980.t1 Q6ZW61 28.501 407 7.45e-31 134.0 sp|Q6ZW61|BBS12_HUMAN Chaperonin-containing T-complex member BBS12 OS=Homo sapiens OX=9606 GN=BBS12 PE=1 SV=2 BBS12_HUMAN reviewed Chaperonin-containing T-complex member BBS12 (Bardet-Biedl syndrome 12 protein) Homo sapiens (Human) GO:0005524; GO:0005929; GO:0042073; GO:0042755; GO:0045444; GO:0045494; GO:0045599; GO:0048863; GO:0051131; GO:2000737 chaperone-mediated protein complex assembly [GO:0051131]; eating behavior [GO:0042755]; fat cell differentiation [GO:0045444]; intraciliary transport [GO:0042073]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of stem cell differentiation [GO:2000737]; photoreceptor cell maintenance [GO:0045494]; stem cell differentiation [GO:0048863] cilium [GO:0005929] ATP binding [GO:0005524] g9981.t1 Q8CC21 39.331 239 2.23e-41 155.0 sp|Q8CC21|TTC19_MOUSE Tetratricopeptide repeat protein 19, mitochondrial OS=Mus musculus OX=10090 GN=Ttc19 PE=1 SV=1 g9981.t2 Q8CC21 39.331 239 1.4999999999999998e-42 155.0 sp|Q8CC21|TTC19_MOUSE Tetratricopeptide repeat protein 19, mitochondrial OS=Mus musculus OX=10090 GN=Ttc19 PE=1 SV=1 g9982.t1 P37879 74.662 517 0.0 838.0 sp|P37879|SYK_CRIGR Lysine--tRNA ligase OS=Cricetulus griseus OX=10029 GN=KARS1 PE=1 SV=1 g9982.t2 Q99MN1 73.282 524 0.0 838.0 sp|Q99MN1|SYK_MOUSE Lysine--tRNA ligase OS=Mus musculus OX=10090 GN=Kars1 PE=1 SV=1 SYK_MOUSE reviewed Lysine--tRNA ligase (EC 2.7.7.-) (EC 6.1.1.6) (Lysyl-tRNA synthetase) (LysRS) Mus musculus (Mouse) GO:0000049; GO:0002276; GO:0002863; GO:0003877; GO:0004824; GO:0005524; GO:0005615; GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0005886; GO:0006430; GO:0010165; GO:0015966; GO:0016597; GO:0017101; GO:0042802; GO:0042803; GO:0043032; GO:0045893; GO:0070371; GO:0097110 basophil activation involved in immune response [GO:0002276]; diadenosine tetraphosphate biosynthetic process [GO:0015966]; ERK1 and ERK2 cascade [GO:0070371]; lysyl-tRNA aminoacylation [GO:0006430]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of inflammatory response to antigenic stimulus [GO:0002863]; positive regulation of macrophage activation [GO:0043032]; response to X-ray [GO:0010165] aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886] amino acid binding [GO:0016597]; ATP binding [GO:0005524]; ATP:ADP adenylyltransferase activity [GO:0003877]; identical protein binding [GO:0042802]; lysine-tRNA ligase activity [GO:0004824]; protein homodimerization activity [GO:0042803]; scaffold protein binding [GO:0097110]; tRNA binding [GO:0000049] g9983.t1 Q28614 40.214 373 2.88e-88 275.0 sp|Q28614|UT2_RABIT Urea transporter 2 OS=Oryctolagus cuniculus OX=9986 GN=SLC14A2 PE=2 SV=1 g9984.t1 P16446 37.453 267 1.7500000000000001e-47 162.0 sp|P16446|PIPNA_RAT Phosphatidylinositol transfer protein alpha isoform OS=Rattus norvegicus OX=10116 GN=Pitpna PE=1 SV=2 g9985.t1 Q9VJJ7 27.737 822 7.65e-70 253.0 sp|Q9VJJ7|TRPG_DROME Transient receptor potential-gamma protein OS=Drosophila melanogaster OX=7227 GN=Trpgamma PE=1 SV=2 TRPG_DROME reviewed Transient receptor potential-gamma protein (TRPgamma) (Transient receptor potential cation channel gamma) Drosophila melanogaster (Fruit fly) GO:0005261; GO:0005262; GO:0005886; GO:0006812; GO:0006816; GO:0007628; GO:0008381; GO:0009416; GO:0015279; GO:0016028; GO:0033583; GO:0034703; GO:0043025; GO:0050884; GO:0050908; GO:0051480; GO:0070588; GO:0070679; GO:1990635 adult walking behavior [GO:0007628]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; detection of light stimulus involved in visual perception [GO:0050908]; monoatomic cation transport [GO:0006812]; neuromuscular process controlling posture [GO:0050884]; regulation of cytosolic calcium ion concentration [GO:0051480]; response to light stimulus [GO:0009416] cation channel complex [GO:0034703]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; proximal dendrite [GO:1990635]; rhabdomere [GO:0016028]; rhabdomere membrane [GO:0033583] calcium channel activity [GO:0005262]; inositol 1,4,5 trisphosphate binding [GO:0070679]; mechanosensitive monoatomic ion channel activity [GO:0008381]; monoatomic cation channel activity [GO:0005261]; store-operated calcium channel activity [GO:0015279] g9987.t1 O61366 52.518 278 1.06e-88 300.0 sp|O61366|GPRS_DROME Serine-enriched protein OS=Drosophila melanogaster OX=7227 GN=gprs PE=4 SV=3 g9990.t1 Q13797 30.019 1066 2.01e-117 390.0 sp|Q13797|ITA9_HUMAN Integrin alpha-9 OS=Homo sapiens OX=9606 GN=ITGA9 PE=1 SV=2 ITA9_HUMAN reviewed Integrin alpha-9 (Integrin alpha-RLC) Homo sapiens (Human) GO:0005886; GO:0007155; GO:0007160; GO:0007229; GO:0008305; GO:0009925; GO:0009986; GO:0030593; GO:0034679; GO:0038023; GO:0045906; GO:0046872; GO:0098609; GO:0098640 cell adhesion [GO:0007155]; cell-cell adhesion [GO:0098609]; cell-matrix adhesion [GO:0007160]; integrin-mediated signaling pathway [GO:0007229]; negative regulation of vasoconstriction [GO:0045906]; neutrophil chemotaxis [GO:0030593] basal plasma membrane [GO:0009925]; cell surface [GO:0009986]; integrin alpha9-beta1 complex [GO:0034679]; integrin complex [GO:0008305]; plasma membrane [GO:0005886] integrin binding involved in cell-matrix adhesion [GO:0098640]; metal ion binding [GO:0046872]; signaling receptor activity [GO:0038023] g9991.t1 Q8TCT0 31.25 464 4.96e-71 238.0 sp|Q8TCT0|CERK1_HUMAN Ceramide kinase OS=Homo sapiens OX=9606 GN=CERK PE=1 SV=1 CERK1_HUMAN reviewed Ceramide kinase (hCERK) (EC 2.7.1.138) (Acylsphingosine kinase) (Lipid kinase 4) (LK4) Homo sapiens (Human) GO:0000287; GO:0001729; GO:0005524; GO:0005737; GO:0005886; GO:0006672; GO:0006688; GO:0016020 ceramide metabolic process [GO:0006672]; glycosphingolipid biosynthetic process [GO:0006688] cytoplasm [GO:0005737]; membrane [GO:0016020]; plasma membrane [GO:0005886] ATP binding [GO:0005524]; ceramide kinase activity [GO:0001729]; magnesium ion binding [GO:0000287] g9993.t1 D3ZH22 40.0 190 4.53e-43 147.0 sp|D3ZH22|SWET1_RAT Sugar transporter SWEET1 OS=Rattus norvegicus OX=10116 GN=Slc50a1 PE=1 SV=1 g9994.t1 B8JK39 27.76 634 2.99e-49 189.0 sp|B8JK39|ITA9_MOUSE Integrin alpha-9 OS=Mus musculus OX=10090 GN=Itga9 PE=1 SV=1 ITA9_MOUSE reviewed Integrin alpha-9 Mus musculus (Mouse) GO:0005518; GO:0007155; GO:0007229; GO:0009925; GO:0009986; GO:0030593; GO:0034679; GO:0038023; GO:0043236; GO:0045906; GO:0046872; GO:0098609; GO:0098640 cell adhesion [GO:0007155]; cell-cell adhesion [GO:0098609]; integrin-mediated signaling pathway [GO:0007229]; negative regulation of vasoconstriction [GO:0045906]; neutrophil chemotaxis [GO:0030593] basal plasma membrane [GO:0009925]; cell surface [GO:0009986]; integrin alpha9-beta1 complex [GO:0034679] collagen binding [GO:0005518]; integrin binding involved in cell-matrix adhesion [GO:0098640]; laminin binding [GO:0043236]; metal ion binding [GO:0046872]; signaling receptor activity [GO:0038023] g9995.t1 Q00651 40.0 420 1.8e-81 275.0 sp|Q00651|ITA4_MOUSE Integrin alpha-4 OS=Mus musculus OX=10090 GN=Itga4 PE=1 SV=1 ITA4_MOUSE reviewed Integrin alpha-4 (CD49 antigen-like family member D) (Integrin alpha-IV) (Lymphocyte Peyer patch adhesion molecules subunit alpha) (LPAM subunit alpha) (VLA-4 subunit alpha) (CD antigen CD49d) Mus musculus (Mouse) GO:0001968; GO:0001974; GO:0002687; GO:0003366; GO:0003823; GO:0005886; GO:0005911; GO:0007155; GO:0007157; GO:0007159; GO:0007160; GO:0007229; GO:0007507; GO:0009897; GO:0009986; GO:0016477; GO:0030426; GO:0033631; GO:0034113; GO:0034446; GO:0034668; GO:0034669; GO:0038023; GO:0043025; GO:0043113; GO:0045906; GO:0046872; GO:0050839; GO:0050901; GO:0050904; GO:0060324; GO:0060385; GO:0060485; GO:0060710; GO:0061032; GO:0072678; GO:0090074; GO:0098609; GO:0098657; GO:1903039; GO:1903238; GO:1904646; GO:1905564; GO:1990138; GO:1990405; GO:1990771; GO:2000353; GO:2000406 axonogenesis involved in innervation [GO:0060385]; blood vessel remodeling [GO:0001974]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; cell-cell adhesion [GO:0098609]; cell-cell adhesion mediated by integrin [GO:0033631]; cell-matrix adhesion [GO:0007160]; cell-matrix adhesion involved in ameboidal cell migration [GO:0003366]; cellular response to amyloid-beta [GO:1904646]; chorio-allantoic fusion [GO:0060710]; clathrin-dependent extracellular exosome endocytosis [GO:1990771]; diapedesis [GO:0050904]; face development [GO:0060324]; heart development [GO:0007507]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; heterotypic cell-cell adhesion [GO:0034113]; import into cell [GO:0098657]; integrin-mediated signaling pathway [GO:0007229]; leukocyte cell-cell adhesion [GO:0007159]; leukocyte tethering or rolling [GO:0050901]; mesenchyme development [GO:0060485]; negative regulation of protein homodimerization activity [GO:0090074]; negative regulation of vasoconstriction [GO:0045906]; neuron projection extension [GO:1990138]; positive regulation of endothelial cell apoptotic process [GO:2000353]; positive regulation of leukocyte cell-cell adhesion [GO:1903039]; positive regulation of leukocyte migration [GO:0002687]; positive regulation of leukocyte tethering or rolling [GO:1903238]; positive regulation of T cell migration [GO:2000406]; positive regulation of vascular endothelial cell proliferation [GO:1905564]; receptor clustering [GO:0043113]; substrate adhesion-dependent cell spreading [GO:0034446]; T cell migration [GO:0072678]; visceral serous pericardium development [GO:0061032] cell surface [GO:0009986]; cell-cell junction [GO:0005911]; external side of plasma membrane [GO:0009897]; growth cone [GO:0030426]; integrin alpha4-beta1 complex [GO:0034668]; integrin alpha4-beta7 complex [GO:0034669]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886] antigen binding [GO:0003823]; cell adhesion molecule binding [GO:0050839]; fibronectin binding [GO:0001968]; metal ion binding [GO:0046872]; protein antigen binding [GO:1990405]; signaling receptor activity [GO:0038023] g9996.t1 P12606 39.951 811 0.0 554.0 sp|P12606|ITB1A_XENLA Integrin beta-1-A OS=Xenopus laevis OX=8355 GN=itgb1-a PE=2 SV=1 g9999.t1 Q502K1 45.361 291 3.82e-82 256.0 sp|Q502K1|EXOG_DANRE Nuclease EXOG, mitochondrial OS=Danio rerio OX=7955 GN=exog PE=2 SV=2 g10000.t1 Q8C163 38.281 256 1.4e-52 178.0 sp|Q8C163|EXOG_MOUSE Nuclease EXOG, mitochondrial OS=Mus musculus OX=10090 GN=Exog PE=1 SV=1 EXOG_MOUSE reviewed Nuclease EXOG, mitochondrial (EC 3.1.30.-) (Endonuclease G-like 1) (Endo G-like 1) Mus musculus (Mouse) GO:0000014; GO:0003676; GO:0004519; GO:0004521; GO:0005634; GO:0005739; GO:0005743; GO:0006309; GO:0008409; GO:0032991; GO:0046872 apoptotic DNA fragmentation [GO:0006309] mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; protein-containing complex [GO:0032991] 5'-3' exonuclease activity [GO:0008409]; endonuclease activity [GO:0004519]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; RNA endonuclease activity [GO:0004521]; single-stranded DNA endodeoxyribonuclease activity [GO:0000014] g10003.t1 Q4PJW3 64.189 444 0.0 604.0 sp|Q4PJW3|CP51A_BOVIN Lanosterol 14-alpha demethylase OS=Bos taurus OX=9913 GN=CYP51A1 PE=2 SV=1 CP51A_BOVIN reviewed Lanosterol 14-alpha demethylase (LDM) (EC 1.14.14.154) (CYPLI) (Cytochrome P450 51A1) (CYP51) (Cytochrome P450-14DM) (Cytochrome P45014DM) (Cytochrome P450LI) (Sterol 14-alpha demethylase) Bos taurus (Bovine) GO:0005506; GO:0005789; GO:0006694; GO:0008398; GO:0016491; GO:0020037; GO:0033488 cholesterol biosynthetic process via 24,25-dihydrolanosterol [GO:0033488]; steroid biosynthetic process [GO:0006694] endoplasmic reticulum membrane [GO:0005789] heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity [GO:0016491]; sterol 14-demethylase activity [GO:0008398] g10004.t1 P48449 63.8 721 0.0 984.0 sp|P48449|LSS_HUMAN Lanosterol synthase OS=Homo sapiens OX=9606 GN=LSS PE=1 SV=1 LSS_HUMAN reviewed Lanosterol synthase (EC 5.4.99.7) (2,3-epoxysqualene--lanosterol cyclase) (Oxidosqualene--lanosterol cyclase) (OSC) (hOSC) Homo sapiens (Human) GO:0000250; GO:0005789; GO:0005811; GO:0006694; GO:0006695; GO:0016020; GO:0016104; GO:0031647 cholesterol biosynthetic process [GO:0006695]; regulation of protein stability [GO:0031647]; steroid biosynthetic process [GO:0006694]; triterpenoid biosynthetic process [GO:0016104] endoplasmic reticulum membrane [GO:0005789]; lipid droplet [GO:0005811]; membrane [GO:0016020] lanosterol synthase activity [GO:0000250] g10005.t1 Q99996 36.124 418 7.449999999999999e-52 201.0 sp|Q99996|AKAP9_HUMAN A-kinase anchor protein 9 OS=Homo sapiens OX=9606 GN=AKAP9 PE=1 SV=4 AKAP9_HUMAN reviewed A-kinase anchor protein 9 (AKAP-9) (A-kinase anchor protein 350 kDa) (AKAP 350) (hgAKAP 350) (A-kinase anchor protein 450 kDa) (AKAP 450) (AKAP 120-like protein) (Centrosome- and Golgi-localized PKN-associated protein) (CG-NAP) (Protein hyperion) (Protein kinase A-anchoring protein 9) (PRKA9) (Protein yotiao) Homo sapiens (Human) GO:0003677; GO:0005102; GO:0005794; GO:0005795; GO:0005801; GO:0005813; GO:0005829; GO:0005856; GO:0007020; GO:0007165; GO:0007268; GO:0008076; GO:0015459; GO:0031116; GO:0031503; GO:0034237; GO:0034705; GO:0043025; GO:0044307; GO:0044325; GO:0051602; GO:0051661; GO:0060090; GO:0060306; GO:0060307; GO:0071320; GO:0086091; GO:0097060; GO:0098909; GO:0098978; GO:0099104; GO:0099147; GO:1903358 cellular response to cAMP [GO:0071320]; chemical synaptic transmission [GO:0007268]; maintenance of centrosome location [GO:0051661]; microtubule nucleation [GO:0007020]; positive regulation of microtubule polymerization [GO:0031116]; protein-containing complex localization [GO:0031503]; regulation of cardiac muscle cell action potential involved in regulation of contraction [GO:0098909]; regulation of Golgi organization [GO:1903358]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of membrane repolarization [GO:0060306]; regulation of ventricular cardiac muscle cell membrane repolarization [GO:0060307]; response to electrical stimulus [GO:0051602]; signal transduction [GO:0007165] centrosome [GO:0005813]; cis-Golgi network [GO:0005801]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dendritic branch [GO:0044307]; extrinsic component of postsynaptic density membrane [GO:0099147]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; Golgi stack [GO:0005795]; neuronal cell body [GO:0043025]; potassium channel complex [GO:0034705]; synaptic membrane [GO:0097060]; voltage-gated potassium channel complex [GO:0008076] DNA binding [GO:0003677]; molecular adaptor activity [GO:0060090]; potassium channel activator activity [GO:0099104]; potassium channel regulator activity [GO:0015459]; protein kinase A regulatory subunit binding [GO:0034237]; signaling receptor binding [GO:0005102]; transmembrane transporter binding [GO:0044325] g10006.t1 Q70FJ1 29.651 688 4.82e-37 159.0 sp|Q70FJ1|AKAP9_MOUSE A-kinase anchor protein 9 OS=Mus musculus OX=10090 GN=Akap9 PE=1 SV=2 AKAP9_MOUSE reviewed A-kinase anchor protein 9 (AKAP-9) (Protein kinase A-anchoring protein 9) (PRKA9) Mus musculus (Mouse) GO:0000242; GO:0005737; GO:0005794; GO:0005795; GO:0005801; GO:0005813; GO:0007020; GO:0007165; GO:0007283; GO:0008076; GO:0015459; GO:0031116; GO:0031503; GO:0034237; GO:0034705; GO:0036064; GO:0043025; GO:0044307; GO:0044325; GO:0051661; GO:0060009; GO:0060090; GO:0060306; GO:0060307; GO:0071320; GO:0086091; GO:0097060; GO:0097729; GO:0098909; GO:0098978; GO:0099104; GO:0099147; GO:0120219; GO:1903358 cellular response to cAMP [GO:0071320]; maintenance of centrosome location [GO:0051661]; microtubule nucleation [GO:0007020]; positive regulation of microtubule polymerization [GO:0031116]; protein-containing complex localization [GO:0031503]; regulation of cardiac muscle cell action potential involved in regulation of contraction [GO:0098909]; regulation of Golgi organization [GO:1903358]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of membrane repolarization [GO:0060306]; regulation of ventricular cardiac muscle cell membrane repolarization [GO:0060307]; Sertoli cell development [GO:0060009]; signal transduction [GO:0007165]; spermatogenesis [GO:0007283] 9+2 motile cilium [GO:0097729]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cis-Golgi network [GO:0005801]; cytoplasm [GO:0005737]; dendritic branch [GO:0044307]; extrinsic component of postsynaptic density membrane [GO:0099147]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; Golgi stack [GO:0005795]; neuronal cell body [GO:0043025]; pericentriolar material [GO:0000242]; potassium channel complex [GO:0034705]; subapical part of cell [GO:0120219]; synaptic membrane [GO:0097060]; voltage-gated potassium channel complex [GO:0008076] molecular adaptor activity [GO:0060090]; potassium channel activator activity [GO:0099104]; potassium channel regulator activity [GO:0015459]; protein kinase A regulatory subunit binding [GO:0034237]; transmembrane transporter binding [GO:0044325] g10006.t1 Q70FJ1 29.396 364 2.4199999999999998e-23 114.0 sp|Q70FJ1|AKAP9_MOUSE A-kinase anchor protein 9 OS=Mus musculus OX=10090 GN=Akap9 PE=1 SV=2 AKAP9_MOUSE reviewed A-kinase anchor protein 9 (AKAP-9) (Protein kinase A-anchoring protein 9) (PRKA9) Mus musculus (Mouse) GO:0000242; GO:0005737; GO:0005794; GO:0005795; GO:0005801; GO:0005813; GO:0007020; GO:0007165; GO:0007283; GO:0008076; GO:0015459; GO:0031116; GO:0031503; GO:0034237; GO:0034705; GO:0036064; GO:0043025; GO:0044307; GO:0044325; GO:0051661; GO:0060009; GO:0060090; GO:0060306; GO:0060307; GO:0071320; GO:0086091; GO:0097060; GO:0097729; GO:0098909; GO:0098978; GO:0099104; GO:0099147; GO:0120219; GO:1903358 cellular response to cAMP [GO:0071320]; maintenance of centrosome location [GO:0051661]; microtubule nucleation [GO:0007020]; positive regulation of microtubule polymerization [GO:0031116]; protein-containing complex localization [GO:0031503]; regulation of cardiac muscle cell action potential involved in regulation of contraction [GO:0098909]; regulation of Golgi organization [GO:1903358]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of membrane repolarization [GO:0060306]; regulation of ventricular cardiac muscle cell membrane repolarization [GO:0060307]; Sertoli cell development [GO:0060009]; signal transduction [GO:0007165]; spermatogenesis [GO:0007283] 9+2 motile cilium [GO:0097729]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cis-Golgi network [GO:0005801]; cytoplasm [GO:0005737]; dendritic branch [GO:0044307]; extrinsic component of postsynaptic density membrane [GO:0099147]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; Golgi stack [GO:0005795]; neuronal cell body [GO:0043025]; pericentriolar material [GO:0000242]; potassium channel complex [GO:0034705]; subapical part of cell [GO:0120219]; synaptic membrane [GO:0097060]; voltage-gated potassium channel complex [GO:0008076] molecular adaptor activity [GO:0060090]; potassium channel activator activity [GO:0099104]; potassium channel regulator activity [GO:0015459]; protein kinase A regulatory subunit binding [GO:0034237]; transmembrane transporter binding [GO:0044325] g10007.t1 Q6PB06 32.181 376 4.4e-45 162.0 sp|Q6PB06|HYKK_XENLA Hydroxylysine kinase OS=Xenopus laevis OX=8355 GN=hykk PE=2 SV=1 g10008.t1 Q6PB06 32.52 369 1.18e-53 185.0 sp|Q6PB06|HYKK_XENLA Hydroxylysine kinase OS=Xenopus laevis OX=8355 GN=hykk PE=2 SV=1 g10010.t1 Q6PB06 34.367 387 1.9499999999999997e-52 182.0 sp|Q6PB06|HYKK_XENLA Hydroxylysine kinase OS=Xenopus laevis OX=8355 GN=hykk PE=2 SV=1 g10011.t1 A2RU49 26.276 392 7.85e-41 152.0 sp|A2RU49|HYKK_HUMAN Hydroxylysine kinase OS=Homo sapiens OX=9606 GN=HYKK PE=1 SV=2 HYKK_HUMAN reviewed Hydroxylysine kinase (5-hydroxy-L-lysine kinase) (EC 2.7.1.81) (Aminoglycoside phosphotransferase domain-containing protein 1) Homo sapiens (Human) GO:0005759; GO:0006554; GO:0019202; GO:0047992 lysine catabolic process [GO:0006554] mitochondrial matrix [GO:0005759] amino acid kinase activity [GO:0019202]; hydroxylysine kinase activity [GO:0047992] g10012.t1 P59110 38.874 373 8.700000000000001e-73 251.0 sp|P59110|SENP1_MOUSE Sentrin-specific protease 1 OS=Mus musculus OX=10090 GN=Senp1 PE=1 SV=1 SENP1_MOUSE reviewed Sentrin-specific protease 1 (EC 3.4.22.-) (SUMO-1 protease 2) (SuPr-2) (Sentrin/SUMO-specific protease SENP1) Mus musculus (Mouse) GO:0005634; GO:0005654; GO:0005925; GO:0006508; GO:0010724; GO:0016925; GO:0016926; GO:0016929; GO:0031965; GO:0032435; GO:0043488; GO:0045944; GO:0061157; GO:0070139; GO:0098978; GO:0099523; GO:0099524; GO:0150052 mRNA destabilization [GO:0061157]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein desumoylation [GO:0016926]; protein sumoylation [GO:0016925]; proteolysis [GO:0006508]; regulation of definitive erythrocyte differentiation [GO:0010724]; regulation of mRNA stability [GO:0043488]; regulation of postsynapse assembly [GO:0150052] focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynaptic cytosol [GO:0099524]; presynaptic cytosol [GO:0099523] deSUMOylase activity [GO:0016929]; SUMO-specific endopeptidase activity [GO:0070139] g10013.t1 Q6ZWH5 53.69 840 0.0 814.0 sp|Q6ZWH5|NEK10_HUMAN Serine/threonine-protein kinase Nek10 OS=Homo sapiens OX=9606 GN=NEK10 PE=1 SV=3 NEK10_HUMAN reviewed Serine/threonine-protein kinase Nek10 (EC 2.7.11.1) (Never in mitosis A-related kinase 10) (NimA-related protein kinase 10) Homo sapiens (Human) GO:0004672; GO:0004674; GO:0005524; GO:0005576; GO:0006468; GO:0031954; GO:0043406; GO:0046872; GO:0070372; GO:0106310; GO:0120197; GO:1902749; GO:1902911 mucociliary clearance [GO:0120197]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of protein autophosphorylation [GO:0031954]; protein phosphorylation [GO:0006468]; regulation of cell cycle G2/M phase transition [GO:1902749]; regulation of ERK1 and ERK2 cascade [GO:0070372] extracellular region [GO:0005576]; protein kinase complex [GO:1902911] ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g10013.t1 Q6ZWH5 45.455 176 6.810000000000001e-27 123.0 sp|Q6ZWH5|NEK10_HUMAN Serine/threonine-protein kinase Nek10 OS=Homo sapiens OX=9606 GN=NEK10 PE=1 SV=3 NEK10_HUMAN reviewed Serine/threonine-protein kinase Nek10 (EC 2.7.11.1) (Never in mitosis A-related kinase 10) (NimA-related protein kinase 10) Homo sapiens (Human) GO:0004672; GO:0004674; GO:0005524; GO:0005576; GO:0006468; GO:0031954; GO:0043406; GO:0046872; GO:0070372; GO:0106310; GO:0120197; GO:1902749; GO:1902911 mucociliary clearance [GO:0120197]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of protein autophosphorylation [GO:0031954]; protein phosphorylation [GO:0006468]; regulation of cell cycle G2/M phase transition [GO:1902749]; regulation of ERK1 and ERK2 cascade [GO:0070372] extracellular region [GO:0005576]; protein kinase complex [GO:1902911] ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g10013.t2 Q6ZWH5 54.002 837 0.0 814.0 sp|Q6ZWH5|NEK10_HUMAN Serine/threonine-protein kinase Nek10 OS=Homo sapiens OX=9606 GN=NEK10 PE=1 SV=3 NEK10_HUMAN reviewed Serine/threonine-protein kinase Nek10 (EC 2.7.11.1) (Never in mitosis A-related kinase 10) (NimA-related protein kinase 10) Homo sapiens (Human) GO:0004672; GO:0004674; GO:0005524; GO:0005576; GO:0006468; GO:0031954; GO:0043406; GO:0046872; GO:0070372; GO:0106310; GO:0120197; GO:1902749; GO:1902911 mucociliary clearance [GO:0120197]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of protein autophosphorylation [GO:0031954]; protein phosphorylation [GO:0006468]; regulation of cell cycle G2/M phase transition [GO:1902749]; regulation of ERK1 and ERK2 cascade [GO:0070372] extracellular region [GO:0005576]; protein kinase complex [GO:1902911] ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g10013.t2 Q6ZWH5 45.455 176 6.51e-27 123.0 sp|Q6ZWH5|NEK10_HUMAN Serine/threonine-protein kinase Nek10 OS=Homo sapiens OX=9606 GN=NEK10 PE=1 SV=3 NEK10_HUMAN reviewed Serine/threonine-protein kinase Nek10 (EC 2.7.11.1) (Never in mitosis A-related kinase 10) (NimA-related protein kinase 10) Homo sapiens (Human) GO:0004672; GO:0004674; GO:0005524; GO:0005576; GO:0006468; GO:0031954; GO:0043406; GO:0046872; GO:0070372; GO:0106310; GO:0120197; GO:1902749; GO:1902911 mucociliary clearance [GO:0120197]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of protein autophosphorylation [GO:0031954]; protein phosphorylation [GO:0006468]; regulation of cell cycle G2/M phase transition [GO:1902749]; regulation of ERK1 and ERK2 cascade [GO:0070372] extracellular region [GO:0005576]; protein kinase complex [GO:1902911] ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g10014.t1 Q07537 54.344 587 0.0 653.0 sp|Q07537|GALT1_BOVIN Polypeptide N-acetylgalactosaminyltransferase 1 OS=Bos taurus OX=9913 GN=GALNT1 PE=1 SV=1 GALT1_BOVIN reviewed Polypeptide N-acetylgalactosaminyltransferase 1 (EC 2.4.1.41) (Polypeptide GalNAc transferase 1) (GalNAc-T1) (pp-GaNTase 1) (Protein-UDP acetylgalactosaminyltransferase 1) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 1) [Cleaved into: Polypeptide N-acetylgalactosaminyltransferase 1 soluble form] Bos taurus (Bovine) GO:0004653; GO:0005576; GO:0005794; GO:0006493; GO:0030145; GO:0030246; GO:0032580; GO:0048471 protein O-linked glycosylation [GO:0006493] extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; perinuclear region of cytoplasm [GO:0048471] carbohydrate binding [GO:0030246]; manganese ion binding [GO:0030145]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653] g10014.t2 Q07537 56.184 566 0.0 661.0 sp|Q07537|GALT1_BOVIN Polypeptide N-acetylgalactosaminyltransferase 1 OS=Bos taurus OX=9913 GN=GALNT1 PE=1 SV=1 GALT1_BOVIN reviewed Polypeptide N-acetylgalactosaminyltransferase 1 (EC 2.4.1.41) (Polypeptide GalNAc transferase 1) (GalNAc-T1) (pp-GaNTase 1) (Protein-UDP acetylgalactosaminyltransferase 1) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 1) [Cleaved into: Polypeptide N-acetylgalactosaminyltransferase 1 soluble form] Bos taurus (Bovine) GO:0004653; GO:0005576; GO:0005794; GO:0006493; GO:0030145; GO:0030246; GO:0032580; GO:0048471 protein O-linked glycosylation [GO:0006493] extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; perinuclear region of cytoplasm [GO:0048471] carbohydrate binding [GO:0030246]; manganese ion binding [GO:0030145]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653] g10017.t1 Q8IVF7 49.67 455 1.58e-130 425.0 sp|Q8IVF7|FMNL3_HUMAN Formin-like protein 3 OS=Homo sapiens OX=9606 GN=FMNL3 PE=1 SV=3 g10017.t1 Q8IVF7 61.702 235 1.1900000000000001e-77 279.0 sp|Q8IVF7|FMNL3_HUMAN Formin-like protein 3 OS=Homo sapiens OX=9606 GN=FMNL3 PE=1 SV=3 g10017.t1 Q8IVF7 56.627 83 9.95e-22 105.0 sp|Q8IVF7|FMNL3_HUMAN Formin-like protein 3 OS=Homo sapiens OX=9606 GN=FMNL3 PE=1 SV=3 g10019.t1 Q58L90 38.854 157 1.23e-24 103.0 sp|Q58L90|FA5V_OXYMI Venom prothrombin activator omicarin-C non-catalytic subunit OS=Oxyuranus microlepidotus OX=111177 PE=2 SV=1 FA5V_OXYMI reviewed Venom prothrombin activator omicarin-C non-catalytic subunit (vPA) (Venom coagulation factor Va-like protein) [Cleaved into: Omicarin-C non-catalytic subunit heavy chain; Omicarin-C non-catalytic subunit light chain] Oxyuranus microlepidotus (Inland taipan) (Diemenia microlepidota) GO:0005507; GO:0005576; GO:0005886; GO:0016504; GO:0032991; GO:0038023; GO:0044469; GO:0090729 venom-mediated blood coagulation [GO:0044469] extracellular region [GO:0005576]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] copper ion binding [GO:0005507]; peptidase activator activity [GO:0016504]; signaling receptor activity [GO:0038023]; toxin activity [GO:0090729] g10020.t1 Q9NS86 56.0 375 7.599999999999999e-138 404.0 sp|Q9NS86|LANC2_HUMAN LanC-like protein 2 OS=Homo sapiens OX=9606 GN=LANCL2 PE=1 SV=1 LANC2_HUMAN reviewed LanC-like protein 2 (Testis-specific adriamycin sensitivity protein) Homo sapiens (Human) GO:0005524; GO:0005525; GO:0005634; GO:0005654; GO:0005829; GO:0005886; GO:0005975; GO:0009789; GO:0010314; GO:0030864; GO:0031179; GO:0032266; GO:0045892; GO:0070273 carbohydrate metabolic process [GO:0005975]; negative regulation of DNA-templated transcription [GO:0045892]; peptide modification [GO:0031179]; positive regulation of abscisic acid-activated signaling pathway [GO:0009789] cortical actin cytoskeleton [GO:0030864]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886] ATP binding [GO:0005524]; GTP binding [GO:0005525]; phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol-4-phosphate binding [GO:0070273]; phosphatidylinositol-5-phosphate binding [GO:0010314] g10021.t1 Q7ZSX3 61.111 162 5.3699999999999996e-55 179.0 sp|Q7ZSX3|PTF1A_DANRE Pancreas transcription factor 1 subunit alpha OS=Danio rerio OX=7955 GN=ptf1a PE=2 SV=1 PTF1A_DANRE reviewed Pancreas transcription factor 1 subunit alpha (Pancreas-specific transcription factor 1a) (bHLH transcription factor p48) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000977; GO:0000981; GO:0003677; GO:0003700; GO:0005634; GO:0005667; GO:0005737; GO:0006355; GO:0006357; GO:0009887; GO:0009888; GO:0030154; GO:0030902; GO:0031016; GO:0031017; GO:0032502; GO:0035881; GO:0043565; GO:0045893; GO:0046983; GO:0048384; GO:0048666; GO:0048699 amacrine cell differentiation [GO:0035881]; animal organ morphogenesis [GO:0009887]; cell differentiation [GO:0030154]; developmental process [GO:0032502]; exocrine pancreas development [GO:0031017]; generation of neurons [GO:0048699]; hindbrain development [GO:0030902]; neuron development [GO:0048666]; pancreas development [GO:0031016]; positive regulation of DNA-templated transcription [GO:0045893]; regulation of DNA-templated transcription [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; retinoic acid receptor signaling pathway [GO:0048384]; tissue development [GO:0009888] cytoplasm [GO:0005737]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667] DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein dimerization activity [GO:0046983]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565] g10022.t1 P83038 61.864 472 0.0 568.0 sp|P83038|HDAC4_CHICK Histone deacetylase 4 OS=Gallus gallus OX=9031 GN=HDAC4 PE=2 SV=1 HDAC4_CHICK reviewed Histone deacetylase 4 (HD4) (EC 3.5.1.98) Gallus gallus (Chicken) GO:0000118; GO:0000122; GO:0004407; GO:0005737; GO:0006325; GO:0006954; GO:0007399; GO:0030183; GO:0040029; GO:0042113; GO:0045843; GO:0045892; GO:0046872; GO:0140297; GO:0141221 B cell activation [GO:0042113]; B cell differentiation [GO:0030183]; chromatin organization [GO:0006325]; epigenetic regulation of gene expression [GO:0040029]; inflammatory response [GO:0006954]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of striated muscle tissue development [GO:0045843]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399] cytoplasm [GO:0005737]; histone deacetylase complex [GO:0000118] DNA-binding transcription factor binding [GO:0140297]; histone deacetylase activity [GO:0004407]; histone deacetylase activity, hydrolytic mechanism [GO:0141221]; metal ion binding [GO:0046872] g10022.t2 P83038 61.864 472 0.0 568.0 sp|P83038|HDAC4_CHICK Histone deacetylase 4 OS=Gallus gallus OX=9031 GN=HDAC4 PE=2 SV=1 HDAC4_CHICK reviewed Histone deacetylase 4 (HD4) (EC 3.5.1.98) Gallus gallus (Chicken) GO:0000118; GO:0000122; GO:0004407; GO:0005737; GO:0006325; GO:0006954; GO:0007399; GO:0030183; GO:0040029; GO:0042113; GO:0045843; GO:0045892; GO:0046872; GO:0140297; GO:0141221 B cell activation [GO:0042113]; B cell differentiation [GO:0030183]; chromatin organization [GO:0006325]; epigenetic regulation of gene expression [GO:0040029]; inflammatory response [GO:0006954]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of striated muscle tissue development [GO:0045843]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399] cytoplasm [GO:0005737]; histone deacetylase complex [GO:0000118] DNA-binding transcription factor binding [GO:0140297]; histone deacetylase activity [GO:0004407]; histone deacetylase activity, hydrolytic mechanism [GO:0141221]; metal ion binding [GO:0046872] g10022.t3 P83038 61.864 472 0.0 567.0 sp|P83038|HDAC4_CHICK Histone deacetylase 4 OS=Gallus gallus OX=9031 GN=HDAC4 PE=2 SV=1 HDAC4_CHICK reviewed Histone deacetylase 4 (HD4) (EC 3.5.1.98) Gallus gallus (Chicken) GO:0000118; GO:0000122; GO:0004407; GO:0005737; GO:0006325; GO:0006954; GO:0007399; GO:0030183; GO:0040029; GO:0042113; GO:0045843; GO:0045892; GO:0046872; GO:0140297; GO:0141221 B cell activation [GO:0042113]; B cell differentiation [GO:0030183]; chromatin organization [GO:0006325]; epigenetic regulation of gene expression [GO:0040029]; inflammatory response [GO:0006954]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of striated muscle tissue development [GO:0045843]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399] cytoplasm [GO:0005737]; histone deacetylase complex [GO:0000118] DNA-binding transcription factor binding [GO:0140297]; histone deacetylase activity [GO:0004407]; histone deacetylase activity, hydrolytic mechanism [GO:0141221]; metal ion binding [GO:0046872] g10022.t4 P83038 61.864 472 0.0 568.0 sp|P83038|HDAC4_CHICK Histone deacetylase 4 OS=Gallus gallus OX=9031 GN=HDAC4 PE=2 SV=1 HDAC4_CHICK reviewed Histone deacetylase 4 (HD4) (EC 3.5.1.98) Gallus gallus (Chicken) GO:0000118; GO:0000122; GO:0004407; GO:0005737; GO:0006325; GO:0006954; GO:0007399; GO:0030183; GO:0040029; GO:0042113; GO:0045843; GO:0045892; GO:0046872; GO:0140297; GO:0141221 B cell activation [GO:0042113]; B cell differentiation [GO:0030183]; chromatin organization [GO:0006325]; epigenetic regulation of gene expression [GO:0040029]; inflammatory response [GO:0006954]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of striated muscle tissue development [GO:0045843]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399] cytoplasm [GO:0005737]; histone deacetylase complex [GO:0000118] DNA-binding transcription factor binding [GO:0140297]; histone deacetylase activity [GO:0004407]; histone deacetylase activity, hydrolytic mechanism [GO:0141221]; metal ion binding [GO:0046872] g10022.t5 P83038 63.805 431 2.82e-178 550.0 sp|P83038|HDAC4_CHICK Histone deacetylase 4 OS=Gallus gallus OX=9031 GN=HDAC4 PE=2 SV=1 HDAC4_CHICK reviewed Histone deacetylase 4 (HD4) (EC 3.5.1.98) Gallus gallus (Chicken) GO:0000118; GO:0000122; GO:0004407; GO:0005737; GO:0006325; GO:0006954; GO:0007399; GO:0030183; GO:0040029; GO:0042113; GO:0045843; GO:0045892; GO:0046872; GO:0140297; GO:0141221 B cell activation [GO:0042113]; B cell differentiation [GO:0030183]; chromatin organization [GO:0006325]; epigenetic regulation of gene expression [GO:0040029]; inflammatory response [GO:0006954]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of striated muscle tissue development [GO:0045843]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399] cytoplasm [GO:0005737]; histone deacetylase complex [GO:0000118] DNA-binding transcription factor binding [GO:0140297]; histone deacetylase activity [GO:0004407]; histone deacetylase activity, hydrolytic mechanism [GO:0141221]; metal ion binding [GO:0046872] g10023.t1 Q8BHN5 40.842 475 7.7e-112 342.0 sp|Q8BHN5|RBM45_MOUSE RNA-binding protein 45 OS=Mus musculus OX=10090 GN=Rbm45 PE=1 SV=1 g10024.t1 Q5ZHP8 52.956 406 1.39e-141 412.0 sp|Q5ZHP8|METL2_CHICK tRNA N(3)-cytidine methyltransferase METTL2 OS=Gallus gallus OX=9031 GN=METTL2 PE=2 SV=1 g10024.t2 Q5ZHP8 51.042 384 3.04e-130 383.0 sp|Q5ZHP8|METL2_CHICK tRNA N(3)-cytidine methyltransferase METTL2 OS=Gallus gallus OX=9031 GN=METTL2 PE=2 SV=1 g10026.t1 Q642F4 44.28 271 6.66e-67 214.0 sp|Q642F4|SC22A_RAT Vesicle-trafficking protein SEC22a OS=Rattus norvegicus OX=10116 GN=Sec22a PE=2 SV=1 g10027.t1 O35760 61.364 220 3.69e-96 285.0 sp|O35760|IDI1_RAT Isopentenyl-diphosphate Delta-isomerase 1 OS=Rattus norvegicus OX=10116 GN=Idi1 PE=2 SV=2 g10028.t1 Q66H85 36.049 405 1.9000000000000002e-58 216.0 sp|Q66H85|ANKZ1_RAT tRNA endonuclease ANKZF1 OS=Rattus norvegicus OX=10116 GN=Ankzf1 PE=2 SV=1 g10029.t1 Q8TCD6 38.306 248 2.0099999999999999e-60 194.0 sp|Q8TCD6|PHOP2_HUMAN Pyridoxal phosphate phosphatase PHOSPHO2 OS=Homo sapiens OX=9606 GN=PHOSPHO2 PE=1 SV=1 g10030.t1 E1BJL9 42.328 189 1.17e-25 108.0 sp|E1BJL9|CF210_BOVIN Cilia- and flagella- associated protein 210 OS=Bos taurus OX=9913 GN=CFAP210 PE=1 SV=3 g10031.t1 E1BJL9 36.842 285 1.0900000000000001e-29 120.0 sp|E1BJL9|CF210_BOVIN Cilia- and flagella- associated protein 210 OS=Bos taurus OX=9913 GN=CFAP210 PE=1 SV=3 g10032.t1 Q0VFE3 44.156 308 1.38e-80 251.0 sp|Q0VFE3|PGAP3_XENTR GPI-specific phospholipase A2-like PGAP3 OS=Xenopus tropicalis OX=8364 GN=pgap3 PE=2 SV=1 g10033.t1 Q80U56 63.436 227 1.67e-76 249.0 sp|Q80U56|AVL9_MOUSE Late secretory pathway protein AVL9 homolog OS=Mus musculus OX=10090 GN=Avl9 PE=1 SV=2 g10034.t1 Q80U56 46.914 243 2.63e-69 233.0 sp|Q80U56|AVL9_MOUSE Late secretory pathway protein AVL9 homolog OS=Mus musculus OX=10090 GN=Avl9 PE=1 SV=2 g10035.t1 A5GFY8 51.589 535 0.0 531.0 sp|A5GFY8|SERA_PIG D-3-phosphoglycerate dehydrogenase OS=Sus scrofa OX=9823 GN=PHGDH PE=3 SV=1 SERA_PIG reviewed D-3-phosphoglycerate dehydrogenase (3-PGDH) (EC 1.1.1.95) (2-oxoglutarate reductase) (EC 1.1.1.399) (Malate dehydrogenase) (EC 1.1.1.37) Sus scrofa (Pig) GO:0004617; GO:0006564; GO:0030060; GO:0051287 L-serine biosynthetic process [GO:0006564] L-malate dehydrogenase (NAD+) activity [GO:0030060]; NAD binding [GO:0051287]; phosphoglycerate dehydrogenase activity [GO:0004617] g10046.t1 O75533 91.142 429 0.0 818.0 sp|O75533|SF3B1_HUMAN Splicing factor 3B subunit 1 OS=Homo sapiens OX=9606 GN=SF3B1 PE=1 SV=3 SF3B1_HUMAN reviewed Splicing factor 3B subunit 1 (Pre-mRNA-splicing factor SF3b 155 kDa subunit) (SF3b155) (Spliceosome-associated protein 155) (SAP 155) Homo sapiens (Human) GO:0000245; GO:0000375; GO:0000398; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0005681; GO:0005684; GO:0005686; GO:0005689; GO:0005730; GO:0006338; GO:0008380; GO:0016607; GO:0034693; GO:0045943; GO:0045944; GO:0045945; GO:0071004; GO:0071005; GO:0071013; GO:0110016; GO:1903241; GO:1990935 chromatin remodeling [GO:0006338]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of transcription by RNA polymerase I [GO:0045943]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription by RNA polymerase III [GO:0045945]; RNA splicing [GO:0008380]; RNA splicing, via transesterification reactions [GO:0000375]; spliceosomal complex assembly [GO:0000245]; U2-type prespliceosome assembly [GO:1903241] B-WICH complex [GO:0110016]; catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U11/U12 snRNP [GO:0034693]; U12-type spliceosomal complex [GO:0005689]; U2 snRNP [GO:0005686]; U2-type precatalytic spliceosome [GO:0071005]; U2-type prespliceosome [GO:0071004]; U2-type spliceosomal complex [GO:0005684] mRNA binding [GO:0003729]; RNA binding [GO:0003723]; splicing factor binding [GO:1990935] g10047.t1 Q99NB9 74.519 883 0.0 1234.0 sp|Q99NB9|SF3B1_MOUSE Splicing factor 3B subunit 1 OS=Mus musculus OX=10090 GN=Sf3b1 PE=1 SV=1 g10048.t1 Q3THF9 62.147 177 5.11e-78 238.0 sp|Q3THF9|CQ10B_MOUSE Coenzyme Q-binding protein COQ10 homolog B, mitochondrial OS=Mus musculus OX=10090 GN=Coq10b PE=1 SV=1 g10052.t1 Q5C9Z4 46.881 529 6.530000000000001e-163 499.0 sp|Q5C9Z4|NOM1_HUMAN Nucleolar MIF4G domain-containing protein 1 OS=Homo sapiens OX=9606 GN=NOM1 PE=1 SV=1 NOM1_HUMAN reviewed Nucleolar MIF4G domain-containing protein 1 (SGD1 homolog) Homo sapiens (Human) GO:0003723; GO:0005730; GO:0042274; GO:0048820 hair follicle maturation [GO:0048820]; ribosomal small subunit biogenesis [GO:0042274] nucleolus [GO:0005730] RNA binding [GO:0003723] g10053.t1 Q1RMT1 61.867 375 4.75e-148 425.0 sp|Q1RMT1|ERCC3_BOVIN General transcription and DNA repair factor IIH helicase/translocase subunit XPB OS=Bos taurus OX=9913 GN=ERCC3 PE=2 SV=1 ERCC3_BOVIN reviewed General transcription and DNA repair factor IIH helicase/translocase subunit XPB (TFIIH subunit XPB) (EC 5.6.2.4) (DNA 3'-5' helicase/translocase XPB) (DNA excision repair protein ERCC-3) Bos taurus (Bovine) GO:0000112; GO:0000439; GO:0003677; GO:0005524; GO:0005669; GO:0005675; GO:0006265; GO:0006281; GO:0006283; GO:0006289; GO:0006366; GO:0006367; GO:0006915; GO:0006979; GO:0008104; GO:0009411; GO:0009650; GO:0016887; GO:0035315; GO:0043065; GO:0043138; GO:0048568; GO:0097550; GO:1901990; GO:1990841 apoptotic process [GO:0006915]; DNA repair [GO:0006281]; DNA topological change [GO:0006265]; embryonic organ development [GO:0048568]; hair cell differentiation [GO:0035315]; intracellular protein localization [GO:0008104]; nucleotide-excision repair [GO:0006289]; positive regulation of apoptotic process [GO:0043065]; regulation of mitotic cell cycle phase transition [GO:1901990]; response to oxidative stress [GO:0006979]; response to UV [GO:0009411]; transcription by RNA polymerase II [GO:0006366]; transcription initiation at RNA polymerase II promoter [GO:0006367]; transcription-coupled nucleotide-excision repair [GO:0006283]; UV protection [GO:0009650] nucleotide-excision repair factor 3 complex [GO:0000112]; transcription factor TFIID complex [GO:0005669]; transcription factor TFIIH core complex [GO:0000439]; transcription factor TFIIH holo complex [GO:0005675]; transcription preinitiation complex [GO:0097550] 3'-5' DNA helicase activity [GO:0043138]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA binding [GO:0003677]; promoter-specific chromatin binding [GO:1990841] g10053.t1 Q1RMT1 75.0 68 4.75e-148 122.0 sp|Q1RMT1|ERCC3_BOVIN General transcription and DNA repair factor IIH helicase/translocase subunit XPB OS=Bos taurus OX=9913 GN=ERCC3 PE=2 SV=1 ERCC3_BOVIN reviewed General transcription and DNA repair factor IIH helicase/translocase subunit XPB (TFIIH subunit XPB) (EC 5.6.2.4) (DNA 3'-5' helicase/translocase XPB) (DNA excision repair protein ERCC-3) Bos taurus (Bovine) GO:0000112; GO:0000439; GO:0003677; GO:0005524; GO:0005669; GO:0005675; GO:0006265; GO:0006281; GO:0006283; GO:0006289; GO:0006366; GO:0006367; GO:0006915; GO:0006979; GO:0008104; GO:0009411; GO:0009650; GO:0016887; GO:0035315; GO:0043065; GO:0043138; GO:0048568; GO:0097550; GO:1901990; GO:1990841 apoptotic process [GO:0006915]; DNA repair [GO:0006281]; DNA topological change [GO:0006265]; embryonic organ development [GO:0048568]; hair cell differentiation [GO:0035315]; intracellular protein localization [GO:0008104]; nucleotide-excision repair [GO:0006289]; positive regulation of apoptotic process [GO:0043065]; regulation of mitotic cell cycle phase transition [GO:1901990]; response to oxidative stress [GO:0006979]; response to UV [GO:0009411]; transcription by RNA polymerase II [GO:0006366]; transcription initiation at RNA polymerase II promoter [GO:0006367]; transcription-coupled nucleotide-excision repair [GO:0006283]; UV protection [GO:0009650] nucleotide-excision repair factor 3 complex [GO:0000112]; transcription factor TFIID complex [GO:0005669]; transcription factor TFIIH core complex [GO:0000439]; transcription factor TFIIH holo complex [GO:0005675]; transcription preinitiation complex [GO:0097550] 3'-5' DNA helicase activity [GO:0043138]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA binding [GO:0003677]; promoter-specific chromatin binding [GO:1990841] g10054.t1 Q1RMT1 78.779 344 0.0 558.0 sp|Q1RMT1|ERCC3_BOVIN General transcription and DNA repair factor IIH helicase/translocase subunit XPB OS=Bos taurus OX=9913 GN=ERCC3 PE=2 SV=1 ERCC3_BOVIN reviewed General transcription and DNA repair factor IIH helicase/translocase subunit XPB (TFIIH subunit XPB) (EC 5.6.2.4) (DNA 3'-5' helicase/translocase XPB) (DNA excision repair protein ERCC-3) Bos taurus (Bovine) GO:0000112; GO:0000439; GO:0003677; GO:0005524; GO:0005669; GO:0005675; GO:0006265; GO:0006281; GO:0006283; GO:0006289; GO:0006366; GO:0006367; GO:0006915; GO:0006979; GO:0008104; GO:0009411; GO:0009650; GO:0016887; GO:0035315; GO:0043065; GO:0043138; GO:0048568; GO:0097550; GO:1901990; GO:1990841 apoptotic process [GO:0006915]; DNA repair [GO:0006281]; DNA topological change [GO:0006265]; embryonic organ development [GO:0048568]; hair cell differentiation [GO:0035315]; intracellular protein localization [GO:0008104]; nucleotide-excision repair [GO:0006289]; positive regulation of apoptotic process [GO:0043065]; regulation of mitotic cell cycle phase transition [GO:1901990]; response to oxidative stress [GO:0006979]; response to UV [GO:0009411]; transcription by RNA polymerase II [GO:0006366]; transcription initiation at RNA polymerase II promoter [GO:0006367]; transcription-coupled nucleotide-excision repair [GO:0006283]; UV protection [GO:0009650] nucleotide-excision repair factor 3 complex [GO:0000112]; transcription factor TFIID complex [GO:0005669]; transcription factor TFIIH core complex [GO:0000439]; transcription factor TFIIH holo complex [GO:0005675]; transcription preinitiation complex [GO:0097550] 3'-5' DNA helicase activity [GO:0043138]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA binding [GO:0003677]; promoter-specific chromatin binding [GO:1990841] g10056.t1 Q9JLI7 84.418 507 0.0 863.0 sp|Q9JLI7|SPAG6_MOUSE Sperm-associated antigen 6 OS=Mus musculus OX=10090 GN=Spag6 PE=1 SV=1 SPAG6_MOUSE reviewed Sperm-associated antigen 6 (Axoneme central apparatus protein) (Protein PF16 homolog) Mus musculus (Mouse) GO:0001669; GO:0001771; GO:0002177; GO:0002467; GO:0003351; GO:0003356; GO:0005576; GO:0005813; GO:0005829; GO:0005874; GO:0005930; GO:0006931; GO:0007283; GO:0007288; GO:0008017; GO:0008104; GO:0010761; GO:0015630; GO:0030317; GO:0031410; GO:0043149; GO:0043583; GO:0044458; GO:0045198; GO:0046847; GO:0051301; GO:0090175; GO:0090660; GO:0097228; GO:0120197; GO:0120249; GO:1905515; GO:1990138; GO:1990716 cell division [GO:0051301]; cerebrospinal fluid circulation [GO:0090660]; ear development [GO:0043583]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; establishment of epithelial cell apical/basal polarity [GO:0045198]; fibroblast migration [GO:0010761]; filopodium assembly [GO:0046847]; flagellated sperm motility [GO:0030317]; germinal center formation [GO:0002467]; immunological synapse formation [GO:0001771]; intracellular protein localization [GO:0008104]; motile cilium assembly [GO:0044458]; mucociliary clearance [GO:0120197]; neuron projection extension [GO:1990138]; non-motile cilium assembly [GO:1905515]; regulation of cilium beat frequency [GO:0003356]; regulation of establishment of planar polarity [GO:0090175]; sperm axoneme assembly [GO:0007288]; spermatogenesis [GO:0007283]; stress fiber assembly [GO:0043149]; substrate-dependent cell migration, cell attachment to substrate [GO:0006931] acrosomal vesicle [GO:0001669]; axonemal central apparatus [GO:1990716]; axoneme [GO:0005930]; centrosome [GO:0005813]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; extracellular region [GO:0005576]; lateral wall of outer hair cell [GO:0120249]; manchette [GO:0002177]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; sperm principal piece [GO:0097228] microtubule binding [GO:0008017] g10059.t1 P18293 43.718 979 0.0 752.0 sp|P18293|ANPRA_MOUSE Atrial natriuretic peptide receptor 1 OS=Mus musculus OX=10090 GN=Npr1 PE=1 SV=2 ANPRA_MOUSE reviewed Atrial natriuretic peptide receptor 1 (EC 4.6.1.2) (Atrial natriuretic peptide receptor type A) (ANP-A) (ANPR-A) (NPR-A) (Guanylate cyclase A) (GC-A) Mus musculus (Mouse) GO:0001653; GO:0004383; GO:0004672; GO:0005524; GO:0005525; GO:0005886; GO:0006182; GO:0007166; GO:0007168; GO:0008217; GO:0010753; GO:0016941; GO:0017046; GO:0019934; GO:0035556; GO:0042417; GO:0042562; GO:0043114; GO:0043235; GO:0048662; GO:0097746; GO:1990620 blood vessel diameter maintenance [GO:0097746]; cell surface receptor signaling pathway [GO:0007166]; cGMP biosynthetic process [GO:0006182]; cGMP-mediated signaling [GO:0019934]; dopamine metabolic process [GO:0042417]; intracellular signal transduction [GO:0035556]; negative regulation of smooth muscle cell proliferation [GO:0048662]; positive regulation of cGMP-mediated signaling [GO:0010753]; receptor guanylyl cyclase signaling pathway [GO:0007168]; regulation of blood pressure [GO:0008217]; regulation of vascular permeability [GO:0043114] ANPR-A receptor complex [GO:1990620]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] ATP binding [GO:0005524]; GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; hormone binding [GO:0042562]; natriuretic peptide receptor activity [GO:0016941]; peptide hormone binding [GO:0017046]; peptide receptor activity [GO:0001653]; protein kinase activity [GO:0004672] g10060.t1 P23258 86.755 453 0.0 822.0 sp|P23258|TBG1_HUMAN Tubulin gamma-1 chain OS=Homo sapiens OX=9606 GN=TUBG1 PE=1 SV=2 TBG1_HUMAN reviewed Tubulin gamma-1 chain (Gamma-1-tubulin) (Gamma-tubulin complex component 1) (GCP-1) Homo sapiens (Human) GO:0000070; GO:0000212; GO:0000226; GO:0000242; GO:0000278; GO:0000794; GO:0000930; GO:0000931; GO:0005200; GO:0005525; GO:0005634; GO:0005737; GO:0005813; GO:0005814; GO:0005819; GO:0005827; GO:0005829; GO:0005881; GO:0007020; GO:0007052; GO:0031122; GO:0031252; GO:0036064; GO:0042802; GO:0043005; GO:0045177; GO:0055037; GO:0097730; GO:0140490; GO:1990498 cytoplasmic microtubule organization [GO:0031122]; meiotic spindle organization [GO:0000212]; microtubule cytoskeleton organization [GO:0000226]; microtubule nucleation [GO:0007020]; mitotic cell cycle [GO:0000278]; mitotic sister chromatid segregation [GO:0000070]; mitotic spindle organization [GO:0007052] apical part of cell [GO:0045177]; cell leading edge [GO:0031252]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; condensed nuclear chromosome [GO:0000794]; cytoplasm [GO:0005737]; cytoplasmic microtubule [GO:0005881]; cytosol [GO:0005829]; gamma-tubulin complex [GO:0000930]; gamma-tubulin ring complex [GO:0000931]; mitotic spindle microtubule [GO:1990498]; neuron projection [GO:0043005]; non-motile cilium [GO:0097730]; nucleus [GO:0005634]; pericentriolar material [GO:0000242]; polar microtubule [GO:0005827]; recycling endosome [GO:0055037]; spindle [GO:0005819] GTP binding [GO:0005525]; identical protein binding [GO:0042802]; microtubule nucleator activity [GO:0140490]; structural constituent of cytoskeleton [GO:0005200] g10061.t1 Q4G0U5 31.702 429 8.330000000000001e-59 211.0 sp|Q4G0U5|PCDP1_HUMAN Cilia- and flagella-associated protein 221 OS=Homo sapiens OX=9606 GN=CFAP221 PE=1 SV=2 PCDP1_HUMAN reviewed Cilia- and flagella-associated protein 221 (Primary ciliary dyskinesia protein 1) Homo sapiens (Human) GO:0002177; GO:0005516; GO:0005576; GO:0005737; GO:0005929; GO:0005930; GO:0036126; GO:0044458; GO:0051649; GO:0060271; GO:0090660; GO:0097386; GO:0097729; GO:0120197; GO:0120316 cerebrospinal fluid circulation [GO:0090660]; cilium assembly [GO:0060271]; establishment of localization in cell [GO:0051649]; motile cilium assembly [GO:0044458]; mucociliary clearance [GO:0120197]; sperm flagellum assembly [GO:0120316] 9+2 motile cilium [GO:0097729]; axoneme [GO:0005930]; cilium [GO:0005929]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; glial cell projection [GO:0097386]; manchette [GO:0002177]; sperm flagellum [GO:0036126] calmodulin binding [GO:0005516] g10063.t1 A9Q751 52.518 139 7.98e-49 164.0 sp|A9Q751|PCDP1_MOUSE Cilia- and flagella-associated protein 221 OS=Mus musculus OX=10090 GN=Cfap221 PE=1 SV=1 PCDP1_MOUSE reviewed Cilia- and flagella-associated protein 221 (Primary ciliary dyskinesia protein 1) Mus musculus (Mouse) GO:0002177; GO:0005516; GO:0005576; GO:0005737; GO:0005930; GO:0036126; GO:0044458; GO:0090660; GO:0097729; GO:0120197 cerebrospinal fluid circulation [GO:0090660]; motile cilium assembly [GO:0044458]; mucociliary clearance [GO:0120197] 9+2 motile cilium [GO:0097729]; axoneme [GO:0005930]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; manchette [GO:0002177]; sperm flagellum [GO:0036126] calmodulin binding [GO:0005516] g10063.t1 A9Q751 52.174 46 7.98e-49 50.8 sp|A9Q751|PCDP1_MOUSE Cilia- and flagella-associated protein 221 OS=Mus musculus OX=10090 GN=Cfap221 PE=1 SV=1 PCDP1_MOUSE reviewed Cilia- and flagella-associated protein 221 (Primary ciliary dyskinesia protein 1) Mus musculus (Mouse) GO:0002177; GO:0005516; GO:0005576; GO:0005737; GO:0005930; GO:0036126; GO:0044458; GO:0090660; GO:0097729; GO:0120197 cerebrospinal fluid circulation [GO:0090660]; motile cilium assembly [GO:0044458]; mucociliary clearance [GO:0120197] 9+2 motile cilium [GO:0097729]; axoneme [GO:0005930]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; manchette [GO:0002177]; sperm flagellum [GO:0036126] calmodulin binding [GO:0005516] g10067.t1 B0BN95 30.488 246 9.41e-28 115.0 sp|B0BN95|HARB1_RAT Putative nuclease HARBI1 OS=Rattus norvegicus OX=10116 GN=Harbi1 PE=2 SV=1 HARB1_RAT reviewed Putative nuclease HARBI1 (EC 3.1.-.-) (Harbinger transposase-derived nuclease) Rattus norvegicus (Rat) GO:0004518; GO:0005634; GO:0005829; GO:0005886; GO:0016787; GO:0034451; GO:0046872 centriolar satellite [GO:0034451]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886] hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]; nuclease activity [GO:0004518] g10069.t1 Q9Y238 34.507 1733 0.0 891.0 sp|Q9Y238|DLEC1_HUMAN Deleted in lung and esophageal cancer protein 1 OS=Homo sapiens OX=9606 GN=DLEC1 PE=1 SV=2 DLEC1_HUMAN reviewed Deleted in lung and esophageal cancer protein 1 (Deleted in lung cancer protein 1) (DLC-1) Homo sapiens (Human) GO:0002357; GO:0005737; GO:0005829; GO:0005929; GO:0007283; GO:0008285; GO:0015631; GO:0030154; GO:0043014; GO:0048487 cell differentiation [GO:0030154]; defense response to tumor cell [GO:0002357]; negative regulation of cell population proliferation [GO:0008285]; spermatogenesis [GO:0007283] cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829] alpha-tubulin binding [GO:0043014]; beta-tubulin binding [GO:0048487]; tubulin binding [GO:0015631] g10070.t1 Q61263 41.141 491 1.7500000000000002e-110 343.0 sp|Q61263|SOAT1_MOUSE Sterol O-acyltransferase 1 OS=Mus musculus OX=10090 GN=Soat1 PE=1 SV=2 SOAT1_MOUSE reviewed Sterol O-acyltransferase 1 (EC 2.3.1.26) (Acyl-coenzyme A:cholesterol acyltransferase 1) (ACAT-1) (Cholesterol acyltransferase 1) Mus musculus (Mouse) GO:0000062; GO:0004772; GO:0005783; GO:0005789; GO:0008203; GO:0010742; GO:0010878; GO:0015485; GO:0016020; GO:0033344; GO:0034379; GO:0034736; GO:0042632; GO:0042802; GO:0042986 cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; cholesterol storage [GO:0010878]; macrophage derived foam cell differentiation [GO:0010742]; positive regulation of amyloid precursor protein biosynthetic process [GO:0042986]; very-low-density lipoprotein particle assembly [GO:0034379] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020] cholesterol binding [GO:0015485]; cholesterol O-acyltransferase activity [GO:0034736]; fatty-acyl-CoA binding [GO:0000062]; identical protein binding [GO:0042802]; sterol O-acyltransferase activity [GO:0004772] g10071.t1 Q8TDX9 31.702 429 4.84e-46 187.0 sp|Q8TDX9|PK1L1_HUMAN Polycystin-1-like protein 1 OS=Homo sapiens OX=9606 GN=PKD1L1 PE=1 SV=1 PK1L1_HUMAN reviewed Polycystin-1-like protein 1 (Polycystin-1L1) (PC1-like 1 protein) (Polycystic kidney disease protein 1-like 1) Homo sapiens (Human) GO:0003127; GO:0005262; GO:0005929; GO:0016020; GO:0034704; GO:0050982; GO:0060170; GO:0070986; GO:0097730; GO:0098609 cell-cell adhesion [GO:0098609]; detection of mechanical stimulus [GO:0050982]; detection of nodal flow [GO:0003127]; left/right axis specification [GO:0070986] calcium channel complex [GO:0034704]; ciliary membrane [GO:0060170]; cilium [GO:0005929]; membrane [GO:0016020]; non-motile cilium [GO:0097730] calcium channel activity [GO:0005262] g10072.t1 B8UU59 29.412 935 3.03e-93 337.0 sp|B8UU59|PK1L_ACRMI Polycystin-1-related protein (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g10076.t1 P08635 40.756 238 5.21e-63 201.0 sp|P08635|SAST_RAT S-acyl fatty acid synthase thioesterase, medium chain OS=Rattus norvegicus OX=10116 GN=Olah PE=1 SV=1 SAST_RAT reviewed S-acyl fatty acid synthase thioesterase, medium chain (EC 3.1.2.14) (Medium-chain S-acyl fatty acid synthetase thioester hydrolase) (Oleoyl-ACP hydrolase) (Thioesterase II) (Thioesterase domain-containing protein 1) Rattus norvegicus (Rat) GO:0005829; GO:0008610; GO:0016297; GO:0051792 lipid biosynthetic process [GO:0008610]; medium-chain fatty acid biosynthetic process [GO:0051792] cytosol [GO:0005829] fatty acyl-[ACP] hydrolase activity [GO:0016297] g10079.t1 Q99558 32.899 307 6.030000000000001e-37 155.0 sp|Q99558|M3K14_HUMAN Mitogen-activated protein kinase kinase kinase 14 OS=Homo sapiens OX=9606 GN=MAP3K14 PE=1 SV=2 M3K14_HUMAN reviewed Mitogen-activated protein kinase kinase kinase 14 (EC 2.7.11.25) (NF-kappa-beta-inducing kinase) (HsNIK) (Serine/threonine-protein kinase NIK) Homo sapiens (Human) GO:0000165; GO:0001650; GO:0004672; GO:0004674; GO:0004709; GO:0005524; GO:0005654; GO:0005829; GO:0006955; GO:0038061; GO:0051607; GO:0071260; GO:0106310 cellular response to mechanical stimulus [GO:0071260]; defense response to virus [GO:0051607]; immune response [GO:0006955]; MAPK cascade [GO:0000165]; non-canonical NF-kappaB signal transduction [GO:0038061] cytosol [GO:0005829]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654] ATP binding [GO:0005524]; MAP kinase kinase kinase activity [GO:0004709]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g10080.t1 Q05AM5 49.106 727 0.0 639.0 sp|Q05AM5|ELP2_DANRE Elongator complex protein 2 OS=Danio rerio OX=7955 GN=elp2 PE=2 SV=1 g10082.t1 Q05AM5 47.115 104 3.2500000000000003e-21 90.5 sp|Q05AM5|ELP2_DANRE Elongator complex protein 2 OS=Danio rerio OX=7955 GN=elp2 PE=2 SV=1 g10083.t1 Q99728 42.973 370 5.98e-90 306.0 sp|Q99728|BARD1_HUMAN BRCA1-associated RING domain protein 1 OS=Homo sapiens OX=9606 GN=BARD1 PE=1 SV=2 BARD1_HUMAN reviewed BRCA1-associated RING domain protein 1 (BARD-1) (EC 2.3.2.27) (RING-type E3 ubiquitin transferase BARD1) Homo sapiens (Human) GO:0000151; GO:0000152; GO:0001894; GO:0003723; GO:0004842; GO:0005634; GO:0005654; GO:0005737; GO:0006281; GO:0006282; GO:0006338; GO:0006357; GO:0006974; GO:0008270; GO:0016567; GO:0016607; GO:0019900; GO:0031436; GO:0031441; GO:0035825; GO:0036464; GO:0042325; GO:0042803; GO:0043065; GO:0043066; GO:0044818; GO:0045732; GO:0045786; GO:0046826; GO:0046982; GO:0051726; GO:0061649; GO:0070531; GO:0070532; GO:0070533; GO:0071479; GO:0085020; GO:0110025; GO:0140863; GO:0140864; GO:2000001 cellular response to ionizing radiation [GO:0071479]; chromatin remodeling [GO:0006338]; DNA damage response [GO:0006974]; DNA repair [GO:0006281]; DNA strand resection involved in replication fork processing [GO:0110025]; homologous recombination [GO:0035825]; mitotic G2/M transition checkpoint [GO:0044818]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell cycle [GO:0045786]; negative regulation of mRNA 3'-end processing [GO:0031441]; negative regulation of protein export from nucleus [GO:0046826]; positive regulation of apoptotic process [GO:0043065]; positive regulation of protein catabolic process [GO:0045732]; protein K6-linked ubiquitination [GO:0085020]; protein ubiquitination [GO:0016567]; regulation of cell cycle [GO:0051726]; regulation of DNA damage checkpoint [GO:2000001]; regulation of DNA repair [GO:0006282]; regulation of phosphorylation [GO:0042325]; regulation of transcription by RNA polymerase II [GO:0006357]; tissue homeostasis [GO:0001894] BRCA1-A complex [GO:0070531]; BRCA1-B complex [GO:0070532]; BRCA1-BARD1 complex [GO:0031436]; BRCA1-C complex [GO:0070533]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; nuclear speck [GO:0016607]; nuclear ubiquitin ligase complex [GO:0000152]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151] histone H2AK127 ubiquitin ligase activity [GO:0140863]; histone H2AK129 ubiquitin ligase activity [GO:0140864]; kinase binding [GO:0019900]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; ubiquitin-modified histone reader activity [GO:0061649]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] g10084.t1 F8WLE0 30.266 489 1.2200000000000001e-43 169.0 sp|F8WLE0|KIF28_RAT Kinesin-like protein KIF28 OS=Rattus norvegicus OX=10116 GN=Kif28 PE=2 SV=1 KIF28_RAT reviewed Kinesin-like protein KIF28 (Kinesin family member 28) (Kinesin-like protein 6) Rattus norvegicus (Rat) GO:0003777; GO:0005524; GO:0005737; GO:0005871; GO:0005874; GO:0007005; GO:0008017; GO:0016887; GO:0031966; GO:0047496; GO:0072384 mitochondrion organization [GO:0007005]; organelle transport along microtubule [GO:0072384]; vesicle transport along microtubule [GO:0047496] cytoplasm [GO:0005737]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; mitochondrial membrane [GO:0031966] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777] g10085.t1 D3YXS5 53.186 361 1.21e-109 349.0 sp|D3YXS5|KIF28_MOUSE Kinesin-like protein KIF28 OS=Mus musculus OX=10090 GN=Kif28 PE=3 SV=1 g10088.t1 O75400 65.854 328 3.91e-128 398.0 sp|O75400|PR40A_HUMAN Pre-mRNA-processing factor 40 homolog A OS=Homo sapiens OX=9606 GN=PRPF40A PE=1 SV=2 PR40A_HUMAN reviewed Pre-mRNA-processing factor 40 homolog A (Fas ligand-associated factor 1) (Formin-binding protein 11) (Formin-binding protein 3) (Huntingtin yeast partner A) (Huntingtin-interacting protein 10) (HIP-10) (Huntingtin-interacting protein A) (Renal carcinoma antigen NY-REN-6) Homo sapiens (Human) GO:0000398; GO:0003723; GO:0005654; GO:0005685; GO:0007010; GO:0008360; GO:0016020; GO:0016363; GO:0016477; GO:0016607; GO:0032465; GO:0045292; GO:0051301; GO:0071004 cell division [GO:0051301]; cell migration [GO:0016477]; cytoskeleton organization [GO:0007010]; mRNA cis splicing, via spliceosome [GO:0045292]; mRNA splicing, via spliceosome [GO:0000398]; regulation of cell shape [GO:0008360]; regulation of cytokinesis [GO:0032465] membrane [GO:0016020]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; U1 snRNP [GO:0005685]; U2-type prespliceosome [GO:0071004] RNA binding [GO:0003723] g10090.t1 O75400 58.929 112 3.9200000000000003e-31 127.0 sp|O75400|PR40A_HUMAN Pre-mRNA-processing factor 40 homolog A OS=Homo sapiens OX=9606 GN=PRPF40A PE=1 SV=2 PR40A_HUMAN reviewed Pre-mRNA-processing factor 40 homolog A (Fas ligand-associated factor 1) (Formin-binding protein 11) (Formin-binding protein 3) (Huntingtin yeast partner A) (Huntingtin-interacting protein 10) (HIP-10) (Huntingtin-interacting protein A) (Renal carcinoma antigen NY-REN-6) Homo sapiens (Human) GO:0000398; GO:0003723; GO:0005654; GO:0005685; GO:0007010; GO:0008360; GO:0016020; GO:0016363; GO:0016477; GO:0016607; GO:0032465; GO:0045292; GO:0051301; GO:0071004 cell division [GO:0051301]; cell migration [GO:0016477]; cytoskeleton organization [GO:0007010]; mRNA cis splicing, via spliceosome [GO:0045292]; mRNA splicing, via spliceosome [GO:0000398]; regulation of cell shape [GO:0008360]; regulation of cytokinesis [GO:0032465] membrane [GO:0016020]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; U1 snRNP [GO:0005685]; U2-type prespliceosome [GO:0071004] RNA binding [GO:0003723] g10094.t1 P79701 49.864 367 2.3e-105 351.0 sp|P79701|VGFR3_COTCO Vascular endothelial growth factor receptor 3 OS=Coturnix coturnix OX=9091 GN=FLT4 PE=2 SV=1 VGFR3_COTCO reviewed Vascular endothelial growth factor receptor 3 (VEGFR-3) (EC 2.7.10.1) (Endothelial kinase receptor EK2) (Quek 2) (Quek2) Coturnix coturnix (Common quail) (Tetrao coturnix) GO:0001525; GO:0005021; GO:0005524; GO:0005634; GO:0005737; GO:0005886; GO:0019838; GO:0030154; GO:0030335; GO:0038084; GO:0042803; GO:0043235; GO:0043408; GO:0046777; GO:0048010 angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; positive regulation of cell migration [GO:0030335]; protein autophosphorylation [GO:0046777]; regulation of MAPK cascade [GO:0043408]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]; vascular endothelial growth factor signaling pathway [GO:0038084] cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] ATP binding [GO:0005524]; growth factor binding [GO:0019838]; protein homodimerization activity [GO:0042803]; vascular endothelial growth factor receptor activity [GO:0005021] g10100.t1 Q9EST2 28.511 235 7.54e-22 96.7 sp|Q9EST2|HNMT_CAVPO Histamine N-methyltransferase OS=Cavia porcellus OX=10141 GN=HNMT PE=2 SV=1 g10104.t1 P53396 81.579 456 0.0 795.0 sp|P53396|ACLY_HUMAN ATP-citrate synthase OS=Homo sapiens OX=9606 GN=ACLY PE=1 SV=3 ACLY_HUMAN reviewed ATP-citrate synthase (EC 2.3.3.8) (ATP-citrate (pro-S-)-lyase) (ACL) (Citrate cleavage enzyme) Homo sapiens (Human) GO:0003878; GO:0005524; GO:0005576; GO:0005654; GO:0005829; GO:0006085; GO:0006101; GO:0006107; GO:0006633; GO:0006695; GO:0008610; GO:0015936; GO:0016020; GO:0035578; GO:0035869; GO:0036064; GO:0046872; GO:0070062; GO:0097228; GO:0110076; GO:1904813 acetyl-CoA biosynthetic process [GO:0006085]; cholesterol biosynthetic process [GO:0006695]; citrate metabolic process [GO:0006101]; coenzyme A metabolic process [GO:0015936]; fatty acid biosynthetic process [GO:0006633]; lipid biosynthetic process [GO:0008610]; negative regulation of ferroptosis [GO:0110076]; oxaloacetate metabolic process [GO:0006107] azurophil granule lumen [GO:0035578]; ciliary basal body [GO:0036064]; ciliary transition zone [GO:0035869]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; sperm principal piece [GO:0097228] ATP binding [GO:0005524]; ATP citrate synthase activity [GO:0003878]; metal ion binding [GO:0046872] g10105.t1 Q91V92 60.687 262 7.79e-96 306.0 sp|Q91V92|ACLY_MOUSE ATP-citrate synthase OS=Mus musculus OX=10090 GN=Acly PE=1 SV=1 ACLY_MOUSE reviewed ATP-citrate synthase (EC 2.3.3.8) (ATP-citrate (pro-S-)-lyase) (Citrate cleavage enzyme) Mus musculus (Mouse) GO:0003878; GO:0005524; GO:0005654; GO:0005739; GO:0005829; GO:0006084; GO:0006085; GO:0006101; GO:0006107; GO:0006633; GO:0008610; GO:0036064; GO:0046872; GO:0071616; GO:0110076; GO:2001295 acetyl-CoA biosynthetic process [GO:0006085]; acetyl-CoA metabolic process [GO:0006084]; acyl-CoA biosynthetic process [GO:0071616]; citrate metabolic process [GO:0006101]; fatty acid biosynthetic process [GO:0006633]; lipid biosynthetic process [GO:0008610]; malonyl-CoA biosynthetic process [GO:2001295]; negative regulation of ferroptosis [GO:0110076]; oxaloacetate metabolic process [GO:0006107] ciliary basal body [GO:0036064]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654] ATP binding [GO:0005524]; ATP citrate synthase activity [GO:0003878]; metal ion binding [GO:0046872] g10105.t2 Q32PF2 62.55 251 3.83e-96 307.0 sp|Q32PF2|ACLY_BOVIN ATP-citrate synthase OS=Bos taurus OX=9913 GN=ACLY PE=2 SV=1 ACLY_BOVIN reviewed ATP-citrate synthase (EC 2.3.3.8) (ATP-citrate (pro-S-)-lyase) (Citrate cleavage enzyme) Bos taurus (Bovine) GO:0003878; GO:0005524; GO:0005829; GO:0006085; GO:0006101; GO:0006633; GO:0008610; GO:0046872 acetyl-CoA biosynthetic process [GO:0006085]; citrate metabolic process [GO:0006101]; fatty acid biosynthetic process [GO:0006633]; lipid biosynthetic process [GO:0008610] cytosol [GO:0005829] ATP binding [GO:0005524]; ATP citrate synthase activity [GO:0003878]; metal ion binding [GO:0046872] g10106.t1 Q91V92 66.887 302 4.8999999999999996e-142 431.0 sp|Q91V92|ACLY_MOUSE ATP-citrate synthase OS=Mus musculus OX=10090 GN=Acly PE=1 SV=1 ACLY_MOUSE reviewed ATP-citrate synthase (EC 2.3.3.8) (ATP-citrate (pro-S-)-lyase) (Citrate cleavage enzyme) Mus musculus (Mouse) GO:0003878; GO:0005524; GO:0005654; GO:0005739; GO:0005829; GO:0006084; GO:0006085; GO:0006101; GO:0006107; GO:0006633; GO:0008610; GO:0036064; GO:0046872; GO:0071616; GO:0110076; GO:2001295 acetyl-CoA biosynthetic process [GO:0006085]; acetyl-CoA metabolic process [GO:0006084]; acyl-CoA biosynthetic process [GO:0071616]; citrate metabolic process [GO:0006101]; fatty acid biosynthetic process [GO:0006633]; lipid biosynthetic process [GO:0008610]; malonyl-CoA biosynthetic process [GO:2001295]; negative regulation of ferroptosis [GO:0110076]; oxaloacetate metabolic process [GO:0006107] ciliary basal body [GO:0036064]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654] ATP binding [GO:0005524]; ATP citrate synthase activity [GO:0003878]; metal ion binding [GO:0046872] g10108.t1 A9JRX0 29.487 312 7.42e-21 98.6 sp|A9JRX0|MSL1_DANRE Male-specific lethal 1-like 1 OS=Danio rerio OX=7955 GN=msl1l1 PE=2 SV=1 MSL1_DANRE reviewed Male-specific lethal 1-like 1 (MSL1-like 1) (Male-specific lethal-1 homolog 1) (MSL-1) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005634; GO:0005654; GO:0006338; GO:0016607; GO:0045893; GO:0072487 chromatin remodeling [GO:0006338]; positive regulation of DNA-templated transcription [GO:0045893] MSL complex [GO:0072487]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] g10109.t1 O88377 63.255 381 9.029999999999999e-152 438.0 sp|O88377|PI42B_RAT Phosphatidylinositol 5-phosphate 4-kinase type-2 beta OS=Rattus norvegicus OX=10116 GN=Pip4k2b PE=1 SV=1 PI42B_RAT reviewed Phosphatidylinositol 5-phosphate 4-kinase type-2 beta (EC 2.7.1.149) (1-phosphatidylinositol 5-phosphate 4-kinase 2-beta) (Diphosphoinositide kinase 2-beta) (Phosphatidylinositol 5-phosphate 4-kinase type II beta) (PI(5)P 4-kinase type II beta) (PIP4KII-beta) (Phosphatidylinositol-phosphate kinase IIgamma) (PIPKIIgamma) (PtdIns(5)P-4-kinase isoform 2-beta) Rattus norvegicus (Rat) GO:0005524; GO:0005525; GO:0005634; GO:0005654; GO:0005776; GO:0005789; GO:0005886; GO:0010506; GO:0016308; GO:0016309; GO:0042803; GO:0046488; GO:0046627; GO:0046854; GO:0061909; GO:1902635; GO:2000786 1-phosphatidyl-1D-myo-inositol 4,5-bisphosphate biosynthetic process [GO:1902635]; autophagosome-lysosome fusion [GO:0061909]; negative regulation of insulin receptor signaling pathway [GO:0046627]; phosphatidylinositol metabolic process [GO:0046488]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; positive regulation of autophagosome assembly [GO:2000786]; regulation of autophagy [GO:0010506] autophagosome [GO:0005776]; endoplasmic reticulum membrane [GO:0005789]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886] 1-phosphatidylinositol-4-phosphate 5-kinase activity [GO:0016308]; 1-phosphatidylinositol-5-phosphate 4-kinase activity [GO:0016309]; ATP binding [GO:0005524]; GTP binding [GO:0005525]; protein homodimerization activity [GO:0042803] g10110.t1 Q6BD04 44.681 329 3.91e-88 274.0 sp|Q6BD04|GPR54_ORENI G-protein coupled receptor 54 OS=Oreochromis niloticus OX=8128 GN=gpr54 PE=2 SV=1 g10113.t1 P28798 41.316 547 3.96e-119 382.0 sp|P28798|GRN_MOUSE Progranulin OS=Mus musculus OX=10090 GN=Grn PE=1 SV=2 GRN_MOUSE reviewed Progranulin (PGRN) (Acrogranin) (Epithelin/granulin precursor) (Glycoprotein of 88 Kda) (GP88) (Glycoprotein 88) (PC cell-derived growth factor) (PCDGF) (Proepithelin) (PEPI) [Cleaved into: Paragranulin; Granulin-1; Granulin-2; Granulin-3; Granulin-4; Granulin-5; Granulin-6; Granulin-7] Mus musculus (Mouse) GO:0001835; GO:0002265; GO:0002282; GO:0005125; GO:0005576; GO:0005615; GO:0005739; GO:0005764; GO:0005765; GO:0005768; GO:0005770; GO:0005783; GO:0005794; GO:0005802; GO:0005886; GO:0007040; GO:0007041; GO:0007042; GO:0007566; GO:0008284; GO:0010595; GO:0010976; GO:0016020; GO:0030335; GO:0031982; GO:0032355; GO:0035641; GO:0035988; GO:0043524; GO:0043525; GO:0045202; GO:0045766; GO:0045824; GO:0048488; GO:0048680; GO:0050679; GO:0050727; GO:0050728; GO:0050821; GO:0051087; GO:0060041; GO:0060179; GO:0060266; GO:0060999; GO:0061351; GO:0098793; GO:0098978; GO:0099558; GO:0106016; GO:0150053; GO:1900426; GO:1902564; GO:1903334; GO:1903979; GO:1905146; GO:1905247; GO:1905671; GO:1905673 astrocyte activation involved in immune response [GO:0002265]; blastocyst hatching [GO:0001835]; chondrocyte proliferation [GO:0035988]; embryo implantation [GO:0007566]; locomotory exploration behavior [GO:0035641]; lysosomal lumen acidification [GO:0007042]; lysosomal protein catabolic process [GO:1905146]; lysosomal transport [GO:0007041]; lysosome organization [GO:0007040]; maintenance of synapse structure [GO:0099558]; male mating behavior [GO:0060179]; microglial cell activation involved in immune response [GO:0002282]; negative regulation of inflammatory response [GO:0050728]; negative regulation of innate immune response [GO:0045824]; negative regulation of microglial cell activation [GO:1903979]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of neutrophil activation [GO:1902564]; negative regulation of respiratory burst involved in inflammatory response [GO:0060266]; neural precursor cell proliferation [GO:0061351]; positive regulation of angiogenesis [GO:0045766]; positive regulation of aspartic-type peptidase activity [GO:1905247]; positive regulation of axon regeneration [GO:0048680]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of defense response to bacterium [GO:1900426]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of inflammatory response to wounding [GO:0106016]; positive regulation of lysosome organization [GO:1905673]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of neuron projection development [GO:0010976]; positive regulation of protein folding [GO:1903334]; protein stabilization [GO:0050821]; regulation of inflammatory response [GO:0050727]; regulation of lysosome organization [GO:1905671]; response to estradiol [GO:0032355]; retina development in camera-type eye [GO:0060041]; synaptic vesicle endocytosis [GO:0048488] cerebellar climbing fiber to Purkinje cell synapse [GO:0150053]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; synapse [GO:0045202]; trans-Golgi network [GO:0005802]; vesicle [GO:0031982] cytokine activity [GO:0005125]; protein-folding chaperone binding [GO:0051087] g10113.t1 P28798 40.625 544 1.17e-117 379.0 sp|P28798|GRN_MOUSE Progranulin OS=Mus musculus OX=10090 GN=Grn PE=1 SV=2 GRN_MOUSE reviewed Progranulin (PGRN) (Acrogranin) (Epithelin/granulin precursor) (Glycoprotein of 88 Kda) (GP88) (Glycoprotein 88) (PC cell-derived growth factor) (PCDGF) (Proepithelin) (PEPI) [Cleaved into: Paragranulin; Granulin-1; Granulin-2; Granulin-3; Granulin-4; Granulin-5; Granulin-6; Granulin-7] Mus musculus (Mouse) GO:0001835; GO:0002265; GO:0002282; GO:0005125; GO:0005576; GO:0005615; GO:0005739; GO:0005764; GO:0005765; GO:0005768; GO:0005770; GO:0005783; GO:0005794; GO:0005802; GO:0005886; GO:0007040; GO:0007041; GO:0007042; GO:0007566; GO:0008284; GO:0010595; GO:0010976; GO:0016020; GO:0030335; GO:0031982; GO:0032355; GO:0035641; GO:0035988; GO:0043524; GO:0043525; GO:0045202; GO:0045766; GO:0045824; GO:0048488; GO:0048680; GO:0050679; GO:0050727; GO:0050728; GO:0050821; GO:0051087; GO:0060041; GO:0060179; GO:0060266; GO:0060999; GO:0061351; GO:0098793; GO:0098978; GO:0099558; GO:0106016; GO:0150053; GO:1900426; GO:1902564; GO:1903334; GO:1903979; GO:1905146; GO:1905247; GO:1905671; GO:1905673 astrocyte activation involved in immune response [GO:0002265]; blastocyst hatching [GO:0001835]; chondrocyte proliferation [GO:0035988]; embryo implantation [GO:0007566]; locomotory exploration behavior [GO:0035641]; lysosomal lumen acidification [GO:0007042]; lysosomal protein catabolic process [GO:1905146]; lysosomal transport [GO:0007041]; lysosome organization [GO:0007040]; maintenance of synapse structure [GO:0099558]; male mating behavior [GO:0060179]; microglial cell activation involved in immune response [GO:0002282]; negative regulation of inflammatory response [GO:0050728]; negative regulation of innate immune response [GO:0045824]; negative regulation of microglial cell activation [GO:1903979]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of neutrophil activation [GO:1902564]; negative regulation of respiratory burst involved in inflammatory response [GO:0060266]; neural precursor cell proliferation [GO:0061351]; positive regulation of angiogenesis [GO:0045766]; positive regulation of aspartic-type peptidase activity [GO:1905247]; positive regulation of axon regeneration [GO:0048680]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of defense response to bacterium [GO:1900426]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of inflammatory response to wounding [GO:0106016]; positive regulation of lysosome organization [GO:1905673]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of neuron projection development [GO:0010976]; positive regulation of protein folding [GO:1903334]; protein stabilization [GO:0050821]; regulation of inflammatory response [GO:0050727]; regulation of lysosome organization [GO:1905671]; response to estradiol [GO:0032355]; retina development in camera-type eye [GO:0060041]; synaptic vesicle endocytosis [GO:0048488] cerebellar climbing fiber to Purkinje cell synapse [GO:0150053]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; synapse [GO:0045202]; trans-Golgi network [GO:0005802]; vesicle [GO:0031982] cytokine activity [GO:0005125]; protein-folding chaperone binding [GO:0051087] g10113.t1 P28798 41.101 545 7.849999999999999e-115 371.0 sp|P28798|GRN_MOUSE Progranulin OS=Mus musculus OX=10090 GN=Grn PE=1 SV=2 GRN_MOUSE reviewed Progranulin (PGRN) (Acrogranin) (Epithelin/granulin precursor) (Glycoprotein of 88 Kda) (GP88) (Glycoprotein 88) (PC cell-derived growth factor) (PCDGF) (Proepithelin) (PEPI) [Cleaved into: Paragranulin; Granulin-1; Granulin-2; Granulin-3; Granulin-4; Granulin-5; Granulin-6; Granulin-7] Mus musculus (Mouse) GO:0001835; GO:0002265; GO:0002282; GO:0005125; GO:0005576; GO:0005615; GO:0005739; GO:0005764; GO:0005765; GO:0005768; GO:0005770; GO:0005783; GO:0005794; GO:0005802; GO:0005886; GO:0007040; GO:0007041; GO:0007042; GO:0007566; GO:0008284; GO:0010595; GO:0010976; GO:0016020; GO:0030335; GO:0031982; GO:0032355; GO:0035641; GO:0035988; GO:0043524; GO:0043525; GO:0045202; GO:0045766; GO:0045824; GO:0048488; GO:0048680; GO:0050679; GO:0050727; GO:0050728; GO:0050821; GO:0051087; GO:0060041; GO:0060179; GO:0060266; GO:0060999; GO:0061351; GO:0098793; GO:0098978; GO:0099558; GO:0106016; GO:0150053; GO:1900426; GO:1902564; GO:1903334; GO:1903979; GO:1905146; GO:1905247; GO:1905671; GO:1905673 astrocyte activation involved in immune response [GO:0002265]; blastocyst hatching [GO:0001835]; chondrocyte proliferation [GO:0035988]; embryo implantation [GO:0007566]; locomotory exploration behavior [GO:0035641]; lysosomal lumen acidification [GO:0007042]; lysosomal protein catabolic process [GO:1905146]; lysosomal transport [GO:0007041]; lysosome organization [GO:0007040]; maintenance of synapse structure [GO:0099558]; male mating behavior [GO:0060179]; microglial cell activation involved in immune response [GO:0002282]; negative regulation of inflammatory response [GO:0050728]; negative regulation of innate immune response [GO:0045824]; negative regulation of microglial cell activation [GO:1903979]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of neutrophil activation [GO:1902564]; negative regulation of respiratory burst involved in inflammatory response [GO:0060266]; neural precursor cell proliferation [GO:0061351]; positive regulation of angiogenesis [GO:0045766]; positive regulation of aspartic-type peptidase activity [GO:1905247]; positive regulation of axon regeneration [GO:0048680]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of defense response to bacterium [GO:1900426]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of inflammatory response to wounding [GO:0106016]; positive regulation of lysosome organization [GO:1905673]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of neuron projection development [GO:0010976]; positive regulation of protein folding [GO:1903334]; protein stabilization [GO:0050821]; regulation of inflammatory response [GO:0050727]; regulation of lysosome organization [GO:1905671]; response to estradiol [GO:0032355]; retina development in camera-type eye [GO:0060041]; synaptic vesicle endocytosis [GO:0048488] cerebellar climbing fiber to Purkinje cell synapse [GO:0150053]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; synapse [GO:0045202]; trans-Golgi network [GO:0005802]; vesicle [GO:0031982] cytokine activity [GO:0005125]; protein-folding chaperone binding [GO:0051087] g10113.t1 P28798 40.832 529 1.86e-114 370.0 sp|P28798|GRN_MOUSE Progranulin OS=Mus musculus OX=10090 GN=Grn PE=1 SV=2 GRN_MOUSE reviewed Progranulin (PGRN) (Acrogranin) (Epithelin/granulin precursor) (Glycoprotein of 88 Kda) (GP88) (Glycoprotein 88) (PC cell-derived growth factor) (PCDGF) (Proepithelin) (PEPI) [Cleaved into: Paragranulin; Granulin-1; Granulin-2; Granulin-3; Granulin-4; Granulin-5; Granulin-6; Granulin-7] Mus musculus (Mouse) GO:0001835; GO:0002265; GO:0002282; GO:0005125; GO:0005576; GO:0005615; GO:0005739; GO:0005764; GO:0005765; GO:0005768; GO:0005770; GO:0005783; GO:0005794; GO:0005802; GO:0005886; GO:0007040; GO:0007041; GO:0007042; GO:0007566; GO:0008284; GO:0010595; GO:0010976; GO:0016020; GO:0030335; GO:0031982; GO:0032355; GO:0035641; GO:0035988; GO:0043524; GO:0043525; GO:0045202; GO:0045766; GO:0045824; GO:0048488; GO:0048680; GO:0050679; GO:0050727; GO:0050728; GO:0050821; GO:0051087; GO:0060041; GO:0060179; GO:0060266; GO:0060999; GO:0061351; GO:0098793; GO:0098978; GO:0099558; GO:0106016; GO:0150053; GO:1900426; GO:1902564; GO:1903334; GO:1903979; GO:1905146; GO:1905247; GO:1905671; GO:1905673 astrocyte activation involved in immune response [GO:0002265]; blastocyst hatching [GO:0001835]; chondrocyte proliferation [GO:0035988]; embryo implantation [GO:0007566]; locomotory exploration behavior [GO:0035641]; lysosomal lumen acidification [GO:0007042]; lysosomal protein catabolic process [GO:1905146]; lysosomal transport [GO:0007041]; lysosome organization [GO:0007040]; maintenance of synapse structure [GO:0099558]; male mating behavior [GO:0060179]; microglial cell activation involved in immune response [GO:0002282]; negative regulation of inflammatory response [GO:0050728]; negative regulation of innate immune response [GO:0045824]; negative regulation of microglial cell activation [GO:1903979]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of neutrophil activation [GO:1902564]; negative regulation of respiratory burst involved in inflammatory response [GO:0060266]; neural precursor cell proliferation [GO:0061351]; positive regulation of angiogenesis [GO:0045766]; positive regulation of aspartic-type peptidase activity [GO:1905247]; positive regulation of axon regeneration [GO:0048680]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of defense response to bacterium [GO:1900426]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of inflammatory response to wounding [GO:0106016]; positive regulation of lysosome organization [GO:1905673]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of neuron projection development [GO:0010976]; positive regulation of protein folding [GO:1903334]; protein stabilization [GO:0050821]; regulation of inflammatory response [GO:0050727]; regulation of lysosome organization [GO:1905671]; response to estradiol [GO:0032355]; retina development in camera-type eye [GO:0060041]; synaptic vesicle endocytosis [GO:0048488] cerebellar climbing fiber to Purkinje cell synapse [GO:0150053]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; synapse [GO:0045202]; trans-Golgi network [GO:0005802]; vesicle [GO:0031982] cytokine activity [GO:0005125]; protein-folding chaperone binding [GO:0051087] g10113.t1 P28798 40.111 541 2.64e-112 364.0 sp|P28798|GRN_MOUSE Progranulin OS=Mus musculus OX=10090 GN=Grn PE=1 SV=2 GRN_MOUSE reviewed Progranulin (PGRN) (Acrogranin) (Epithelin/granulin precursor) (Glycoprotein of 88 Kda) (GP88) (Glycoprotein 88) (PC cell-derived growth factor) (PCDGF) (Proepithelin) (PEPI) [Cleaved into: Paragranulin; Granulin-1; Granulin-2; Granulin-3; Granulin-4; Granulin-5; Granulin-6; Granulin-7] Mus musculus (Mouse) GO:0001835; GO:0002265; GO:0002282; GO:0005125; GO:0005576; GO:0005615; GO:0005739; GO:0005764; GO:0005765; GO:0005768; GO:0005770; GO:0005783; GO:0005794; GO:0005802; GO:0005886; GO:0007040; GO:0007041; GO:0007042; GO:0007566; GO:0008284; GO:0010595; GO:0010976; GO:0016020; GO:0030335; GO:0031982; GO:0032355; GO:0035641; GO:0035988; GO:0043524; GO:0043525; GO:0045202; GO:0045766; GO:0045824; GO:0048488; GO:0048680; GO:0050679; GO:0050727; GO:0050728; GO:0050821; GO:0051087; GO:0060041; GO:0060179; GO:0060266; GO:0060999; GO:0061351; GO:0098793; GO:0098978; GO:0099558; GO:0106016; GO:0150053; GO:1900426; GO:1902564; GO:1903334; GO:1903979; GO:1905146; GO:1905247; GO:1905671; GO:1905673 astrocyte activation involved in immune response [GO:0002265]; blastocyst hatching [GO:0001835]; chondrocyte proliferation [GO:0035988]; embryo implantation [GO:0007566]; locomotory exploration behavior [GO:0035641]; lysosomal lumen acidification [GO:0007042]; lysosomal protein catabolic process [GO:1905146]; lysosomal transport [GO:0007041]; lysosome organization [GO:0007040]; maintenance of synapse structure [GO:0099558]; male mating behavior [GO:0060179]; microglial cell activation involved in immune response [GO:0002282]; negative regulation of inflammatory response [GO:0050728]; negative regulation of innate immune response [GO:0045824]; negative regulation of microglial cell activation [GO:1903979]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of neutrophil activation [GO:1902564]; negative regulation of respiratory burst involved in inflammatory response [GO:0060266]; neural precursor cell proliferation [GO:0061351]; positive regulation of angiogenesis [GO:0045766]; positive regulation of aspartic-type peptidase activity [GO:1905247]; positive regulation of axon regeneration [GO:0048680]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of defense response to bacterium [GO:1900426]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of inflammatory response to wounding [GO:0106016]; positive regulation of lysosome organization [GO:1905673]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of neuron projection development [GO:0010976]; positive regulation of protein folding [GO:1903334]; protein stabilization [GO:0050821]; regulation of inflammatory response [GO:0050727]; regulation of lysosome organization [GO:1905671]; response to estradiol [GO:0032355]; retina development in camera-type eye [GO:0060041]; synaptic vesicle endocytosis [GO:0048488] cerebellar climbing fiber to Purkinje cell synapse [GO:0150053]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; synapse [GO:0045202]; trans-Golgi network [GO:0005802]; vesicle [GO:0031982] cytokine activity [GO:0005125]; protein-folding chaperone binding [GO:0051087] g10113.t1 P28798 42.576 458 1.03e-100 333.0 sp|P28798|GRN_MOUSE Progranulin OS=Mus musculus OX=10090 GN=Grn PE=1 SV=2 GRN_MOUSE reviewed Progranulin (PGRN) (Acrogranin) (Epithelin/granulin precursor) (Glycoprotein of 88 Kda) (GP88) (Glycoprotein 88) (PC cell-derived growth factor) (PCDGF) (Proepithelin) (PEPI) [Cleaved into: Paragranulin; Granulin-1; Granulin-2; Granulin-3; Granulin-4; Granulin-5; Granulin-6; Granulin-7] Mus musculus (Mouse) GO:0001835; GO:0002265; GO:0002282; GO:0005125; GO:0005576; GO:0005615; GO:0005739; GO:0005764; GO:0005765; GO:0005768; GO:0005770; GO:0005783; GO:0005794; GO:0005802; GO:0005886; GO:0007040; GO:0007041; GO:0007042; GO:0007566; GO:0008284; GO:0010595; GO:0010976; GO:0016020; GO:0030335; GO:0031982; GO:0032355; GO:0035641; GO:0035988; GO:0043524; GO:0043525; GO:0045202; GO:0045766; GO:0045824; GO:0048488; GO:0048680; GO:0050679; GO:0050727; GO:0050728; GO:0050821; GO:0051087; GO:0060041; GO:0060179; GO:0060266; GO:0060999; GO:0061351; GO:0098793; GO:0098978; GO:0099558; GO:0106016; GO:0150053; GO:1900426; GO:1902564; GO:1903334; GO:1903979; GO:1905146; GO:1905247; GO:1905671; GO:1905673 astrocyte activation involved in immune response [GO:0002265]; blastocyst hatching [GO:0001835]; chondrocyte proliferation [GO:0035988]; embryo implantation [GO:0007566]; locomotory exploration behavior [GO:0035641]; lysosomal lumen acidification [GO:0007042]; lysosomal protein catabolic process [GO:1905146]; lysosomal transport [GO:0007041]; lysosome organization [GO:0007040]; maintenance of synapse structure [GO:0099558]; male mating behavior [GO:0060179]; microglial cell activation involved in immune response [GO:0002282]; negative regulation of inflammatory response [GO:0050728]; negative regulation of innate immune response [GO:0045824]; negative regulation of microglial cell activation [GO:1903979]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of neutrophil activation [GO:1902564]; negative regulation of respiratory burst involved in inflammatory response [GO:0060266]; neural precursor cell proliferation [GO:0061351]; positive regulation of angiogenesis [GO:0045766]; positive regulation of aspartic-type peptidase activity [GO:1905247]; positive regulation of axon regeneration [GO:0048680]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of defense response to bacterium [GO:1900426]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of inflammatory response to wounding [GO:0106016]; positive regulation of lysosome organization [GO:1905673]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of neuron projection development [GO:0010976]; positive regulation of protein folding [GO:1903334]; protein stabilization [GO:0050821]; regulation of inflammatory response [GO:0050727]; regulation of lysosome organization [GO:1905671]; response to estradiol [GO:0032355]; retina development in camera-type eye [GO:0060041]; synaptic vesicle endocytosis [GO:0048488] cerebellar climbing fiber to Purkinje cell synapse [GO:0150053]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; synapse [GO:0045202]; trans-Golgi network [GO:0005802]; vesicle [GO:0031982] cytokine activity [GO:0005125]; protein-folding chaperone binding [GO:0051087] g10113.t1 P28798 43.236 377 3.69e-81 280.0 sp|P28798|GRN_MOUSE Progranulin OS=Mus musculus OX=10090 GN=Grn PE=1 SV=2 GRN_MOUSE reviewed Progranulin (PGRN) (Acrogranin) (Epithelin/granulin precursor) (Glycoprotein of 88 Kda) (GP88) (Glycoprotein 88) (PC cell-derived growth factor) (PCDGF) (Proepithelin) (PEPI) [Cleaved into: Paragranulin; Granulin-1; Granulin-2; Granulin-3; Granulin-4; Granulin-5; Granulin-6; Granulin-7] Mus musculus (Mouse) GO:0001835; GO:0002265; GO:0002282; GO:0005125; GO:0005576; GO:0005615; GO:0005739; GO:0005764; GO:0005765; GO:0005768; GO:0005770; GO:0005783; GO:0005794; GO:0005802; GO:0005886; GO:0007040; GO:0007041; GO:0007042; GO:0007566; GO:0008284; GO:0010595; GO:0010976; GO:0016020; GO:0030335; GO:0031982; GO:0032355; GO:0035641; GO:0035988; GO:0043524; GO:0043525; GO:0045202; GO:0045766; GO:0045824; GO:0048488; GO:0048680; GO:0050679; GO:0050727; GO:0050728; GO:0050821; GO:0051087; GO:0060041; GO:0060179; GO:0060266; GO:0060999; GO:0061351; GO:0098793; GO:0098978; GO:0099558; GO:0106016; GO:0150053; GO:1900426; GO:1902564; GO:1903334; GO:1903979; GO:1905146; GO:1905247; GO:1905671; GO:1905673 astrocyte activation involved in immune response [GO:0002265]; blastocyst hatching [GO:0001835]; chondrocyte proliferation [GO:0035988]; embryo implantation [GO:0007566]; locomotory exploration behavior [GO:0035641]; lysosomal lumen acidification [GO:0007042]; lysosomal protein catabolic process [GO:1905146]; lysosomal transport [GO:0007041]; lysosome organization [GO:0007040]; maintenance of synapse structure [GO:0099558]; male mating behavior [GO:0060179]; microglial cell activation involved in immune response [GO:0002282]; negative regulation of inflammatory response [GO:0050728]; negative regulation of innate immune response [GO:0045824]; negative regulation of microglial cell activation [GO:1903979]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of neutrophil activation [GO:1902564]; negative regulation of respiratory burst involved in inflammatory response [GO:0060266]; neural precursor cell proliferation [GO:0061351]; positive regulation of angiogenesis [GO:0045766]; positive regulation of aspartic-type peptidase activity [GO:1905247]; positive regulation of axon regeneration [GO:0048680]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of defense response to bacterium [GO:1900426]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of inflammatory response to wounding [GO:0106016]; positive regulation of lysosome organization [GO:1905673]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of neuron projection development [GO:0010976]; positive regulation of protein folding [GO:1903334]; protein stabilization [GO:0050821]; regulation of inflammatory response [GO:0050727]; regulation of lysosome organization [GO:1905671]; response to estradiol [GO:0032355]; retina development in camera-type eye [GO:0060041]; synaptic vesicle endocytosis [GO:0048488] cerebellar climbing fiber to Purkinje cell synapse [GO:0150053]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; synapse [GO:0045202]; trans-Golgi network [GO:0005802]; vesicle [GO:0031982] cytokine activity [GO:0005125]; protein-folding chaperone binding [GO:0051087] g10113.t1 P28798 38.462 208 4.23e-30 130.0 sp|P28798|GRN_MOUSE Progranulin OS=Mus musculus OX=10090 GN=Grn PE=1 SV=2 GRN_MOUSE reviewed Progranulin (PGRN) (Acrogranin) (Epithelin/granulin precursor) (Glycoprotein of 88 Kda) (GP88) (Glycoprotein 88) (PC cell-derived growth factor) (PCDGF) (Proepithelin) (PEPI) [Cleaved into: Paragranulin; Granulin-1; Granulin-2; Granulin-3; Granulin-4; Granulin-5; Granulin-6; Granulin-7] Mus musculus (Mouse) GO:0001835; GO:0002265; GO:0002282; GO:0005125; GO:0005576; GO:0005615; GO:0005739; GO:0005764; GO:0005765; GO:0005768; GO:0005770; GO:0005783; GO:0005794; GO:0005802; GO:0005886; GO:0007040; GO:0007041; GO:0007042; GO:0007566; GO:0008284; GO:0010595; GO:0010976; GO:0016020; GO:0030335; GO:0031982; GO:0032355; GO:0035641; GO:0035988; GO:0043524; GO:0043525; GO:0045202; GO:0045766; GO:0045824; GO:0048488; GO:0048680; GO:0050679; GO:0050727; GO:0050728; GO:0050821; GO:0051087; GO:0060041; GO:0060179; GO:0060266; GO:0060999; GO:0061351; GO:0098793; GO:0098978; GO:0099558; GO:0106016; GO:0150053; GO:1900426; GO:1902564; GO:1903334; GO:1903979; GO:1905146; GO:1905247; GO:1905671; GO:1905673 astrocyte activation involved in immune response [GO:0002265]; blastocyst hatching [GO:0001835]; chondrocyte proliferation [GO:0035988]; embryo implantation [GO:0007566]; locomotory exploration behavior [GO:0035641]; lysosomal lumen acidification [GO:0007042]; lysosomal protein catabolic process [GO:1905146]; lysosomal transport [GO:0007041]; lysosome organization [GO:0007040]; maintenance of synapse structure [GO:0099558]; male mating behavior [GO:0060179]; microglial cell activation involved in immune response [GO:0002282]; negative regulation of inflammatory response [GO:0050728]; negative regulation of innate immune response [GO:0045824]; negative regulation of microglial cell activation [GO:1903979]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of neutrophil activation [GO:1902564]; negative regulation of respiratory burst involved in inflammatory response [GO:0060266]; neural precursor cell proliferation [GO:0061351]; positive regulation of angiogenesis [GO:0045766]; positive regulation of aspartic-type peptidase activity [GO:1905247]; positive regulation of axon regeneration [GO:0048680]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of defense response to bacterium [GO:1900426]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of inflammatory response to wounding [GO:0106016]; positive regulation of lysosome organization [GO:1905673]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of neuron projection development [GO:0010976]; positive regulation of protein folding [GO:1903334]; protein stabilization [GO:0050821]; regulation of inflammatory response [GO:0050727]; regulation of lysosome organization [GO:1905671]; response to estradiol [GO:0032355]; retina development in camera-type eye [GO:0060041]; synaptic vesicle endocytosis [GO:0048488] cerebellar climbing fiber to Purkinje cell synapse [GO:0150053]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; synapse [GO:0045202]; trans-Golgi network [GO:0005802]; vesicle [GO:0031982] cytokine activity [GO:0005125]; protein-folding chaperone binding [GO:0051087] g10115.t1 Q5R9F4 51.064 188 1.61e-59 191.0 sp|Q5R9F4|RND3_PONAB Rho-related GTP-binding protein RhoE OS=Pongo abelii OX=9601 GN=RND3 PE=2 SV=1 g10117.t1 Q864U1 41.827 208 2.15e-45 186.0 sp|Q864U1|BRCA1_BOVIN Breast cancer type 1 susceptibility protein homolog OS=Bos taurus OX=9913 GN=BRCA1 PE=1 SV=1 BRCA1_BOVIN reviewed Breast cancer type 1 susceptibility protein homolog (EC 2.3.2.27) (RING-type E3 ubiquitin transferase BRCA1) Bos taurus (Bovine) GO:0000724; GO:0003677; GO:0003713; GO:0004842; GO:0005634; GO:0005694; GO:0005737; GO:0006357; GO:0006633; GO:0007095; GO:0008270; GO:0031436; GO:0043009; GO:0045717; GO:0045893; GO:0045944; GO:0051865; GO:0061630; GO:0070013; GO:0070063; GO:0070531; GO:0085020 chordate embryonic development [GO:0043009]; double-strand break repair via homologous recombination [GO:0000724]; fatty acid biosynthetic process [GO:0006633]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; negative regulation of fatty acid biosynthetic process [GO:0045717]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein autoubiquitination [GO:0051865]; protein K6-linked ubiquitination [GO:0085020]; regulation of transcription by RNA polymerase II [GO:0006357] BRCA1-A complex [GO:0070531]; BRCA1-BARD1 complex [GO:0031436]; chromosome [GO:0005694]; cytoplasm [GO:0005737]; intracellular organelle lumen [GO:0070013]; nucleus [GO:0005634] DNA binding [GO:0003677]; RNA polymerase binding [GO:0070063]; transcription coactivator activity [GO:0003713]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] g10118.t1 Q6KB59 29.63 297 5.45e-29 119.0 sp|Q6KB59|SIA4A_PANTR CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1 OS=Pan troglodytes OX=9598 GN=ST3GAL1 PE=2 SV=1 SIA4A_PANTR reviewed CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1 (Alpha 2,3-ST 1) (Beta-galactoside alpha-2,3-sialyltransferase 1) (EC 2.4.3.4) (Gal-NAc6S) (Gal-beta-1,3-GalNAc-alpha-2,3-sialyltransferase) (Monosialoganglioside sialyltransferase) (EC 2.4.3.2) (SIATFL) (ST3Gal I) (ST3GalI) (ST3GalA.1) (ST3O) (Sialyltransferase 4A) (SIAT4-A) Pan troglodytes (Chimpanzee) GO:0001574; GO:0003836; GO:0005576; GO:0006054; GO:0006487; GO:0016020; GO:0032588; GO:0047288; GO:0097503; GO:1990675; GO:1990676; GO:1990743 ganglioside biosynthetic process [GO:0001574]; N-acetylneuraminate metabolic process [GO:0006054]; protein N-linked glycosylation [GO:0006487]; protein sialylation [GO:1990743]; sialylation [GO:0097503] extracellular region [GO:0005576]; Golgi medial cisterna membrane [GO:1990675]; Golgi trans cisterna membrane [GO:1990676]; membrane [GO:0016020]; trans-Golgi network membrane [GO:0032588] beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminide alpha-2,3- sialyltransferase [GO:0047288]; beta-galactoside (CMP) alpha-2,3-sialyltransferase activity [GO:0003836] g10119.t1 Q02745 37.561 205 1.65e-35 132.0 sp|Q02745|SIA4A_PIG CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1 OS=Sus scrofa OX=9823 GN=ST3GAL1 PE=1 SV=1 g10121.t1 Q92184 31.231 333 6.080000000000001e-37 141.0 sp|Q92184|SIA7B_CHICK Alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 2 OS=Gallus gallus OX=9031 GN=ST6GALNAC2 PE=1 SV=1 g10122.t1 Q92184 29.909 331 1.21e-35 135.0 sp|Q92184|SIA7B_CHICK Alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 2 OS=Gallus gallus OX=9031 GN=ST6GALNAC2 PE=1 SV=1 g10123.t1 P70277 29.787 329 1.58e-34 134.0 sp|P70277|SIA7B_MOUSE Alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 2 OS=Mus musculus OX=10090 GN=St6galnac2 PE=1 SV=2 SIA7B_MOUSE reviewed Alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 2 (EC 2.4.3.3) (Gal-beta-1,3-GalNAc alpha-2,6-sialyltransferase) (GalNAc alpha-2,6-sialyltransferase II) (ST6GalNAc II) (ST6GalNAcII) (Sialyltransferase 7B) (SIAT7-B) Mus musculus (Mouse) GO:0000139; GO:0001665; GO:0006493; GO:1990743 protein O-linked glycosylation [GO:0006493]; protein sialylation [GO:1990743] Golgi membrane [GO:0000139] alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity [GO:0001665] g10124.t1 Q9UJ37 35.417 240 1.58e-36 139.0 sp|Q9UJ37|SIA7B_HUMAN Alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 2 OS=Homo sapiens OX=9606 GN=ST6GALNAC2 PE=1 SV=1 SIA7B_HUMAN reviewed Alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 2 (EC 2.4.3.3) (GalNAc alpha-2,6-sialyltransferase II) (ST6GalNAc II) (ST6GalNAcII) (SThM) (Sialyltransferase 7B) (SIAT7-B) Homo sapiens (Human) GO:0000139; GO:0001665; GO:0006493; GO:0008373; GO:0009101; GO:0016266; GO:0019082; GO:1990743 glycoprotein biosynthetic process [GO:0009101]; protein O-linked glycosylation [GO:0006493]; protein O-linked glycosylation via N-acetyl-galactosamine [GO:0016266]; protein sialylation [GO:1990743]; viral protein processing [GO:0019082] Golgi membrane [GO:0000139] alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity [GO:0001665]; sialyltransferase activity [GO:0008373] g10125.t1 P70277 32.308 325 1.0900000000000001e-36 140.0 sp|P70277|SIA7B_MOUSE Alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 2 OS=Mus musculus OX=10090 GN=St6galnac2 PE=1 SV=2 SIA7B_MOUSE reviewed Alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 2 (EC 2.4.3.3) (Gal-beta-1,3-GalNAc alpha-2,6-sialyltransferase) (GalNAc alpha-2,6-sialyltransferase II) (ST6GalNAc II) (ST6GalNAcII) (Sialyltransferase 7B) (SIAT7-B) Mus musculus (Mouse) GO:0000139; GO:0001665; GO:0006493; GO:1990743 protein O-linked glycosylation [GO:0006493]; protein sialylation [GO:1990743] Golgi membrane [GO:0000139] alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity [GO:0001665] g10127.t1 A2A4P0 84.912 623 0.0 1066.0 sp|A2A4P0|DHX8_MOUSE ATP-dependent RNA helicase DHX8 OS=Mus musculus OX=10090 GN=Dhx8 PE=2 SV=1 g10128.t1 A2A4P0 57.692 78 1.61e-26 104.0 sp|A2A4P0|DHX8_MOUSE ATP-dependent RNA helicase DHX8 OS=Mus musculus OX=10090 GN=Dhx8 PE=2 SV=1 g10129.t1 Q14562 54.167 216 1.31e-58 211.0 sp|Q14562|DHX8_HUMAN ATP-dependent RNA helicase DHX8 OS=Homo sapiens OX=9606 GN=DHX8 PE=1 SV=1 g10129.t1 Q14562 50.725 138 6.13e-29 124.0 sp|Q14562|DHX8_HUMAN ATP-dependent RNA helicase DHX8 OS=Homo sapiens OX=9606 GN=DHX8 PE=1 SV=1 g10130.t1 Q6JEL2 48.873 577 0.0 548.0 sp|Q6JEL2|KLH10_HUMAN Kelch-like protein 10 OS=Homo sapiens OX=9606 GN=KLHL10 PE=1 SV=1 KLH10_HUMAN reviewed Kelch-like protein 10 Homo sapiens (Human) GO:0000902; GO:0005737; GO:0007286; GO:0008584; GO:0009566; GO:0016567; GO:0031463; GO:0043161; GO:0048808; GO:0048873; GO:1990756 cell morphogenesis [GO:0000902]; fertilization [GO:0009566]; homeostasis of number of cells within a tissue [GO:0048873]; male genitalia morphogenesis [GO:0048808]; male gonad development [GO:0008584]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; spermatid development [GO:0007286] Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737] ubiquitin-like ligase-substrate adaptor activity [GO:1990756] g10135.t1 P61291 56.79 243 1.44e-97 288.0 sp|P61291|PSME3_PIG Proteasome activator complex subunit 3 OS=Sus scrofa OX=9823 GN=PSME3 PE=2 SV=1 g10136.t1 Q9D9X6 41.834 447 9.590000000000001e-117 370.0 sp|Q9D9X6|ZSWM2_MOUSE E3 ubiquitin-protein ligase Zswim2 OS=Mus musculus OX=10090 GN=Zswim2 PE=1 SV=1 ZSWM2_MOUSE reviewed E3 ubiquitin-protein ligase Zswim2 (EC 2.3.2.27) (MEKK1-related protein X) (MEX) (RING-type E3 ubiquitin transferase Zswim2) (ZZ-type zinc finger-containing protein 2) (Zinc finger SWIM domain-containing protein 2) Mus musculus (Mouse) GO:0000209; GO:0004842; GO:0006915; GO:0008270; GO:0061630; GO:1902043 apoptotic process [GO:0006915]; positive regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902043]; protein polyubiquitination [GO:0000209] ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] g10137.t1 A2RUV4 42.651 415 7.17e-87 320.0 sp|A2RUV4|RHG21_XENTR Rho GTPase-activating protein 21 OS=Xenopus tropicalis OX=8364 GN=arhgap21 PE=2 SV=1 g10137.t1 A2RUV4 57.237 152 3.4e-41 171.0 sp|A2RUV4|RHG21_XENTR Rho GTPase-activating protein 21 OS=Xenopus tropicalis OX=8364 GN=arhgap21 PE=2 SV=1 g10138.t1 Q5PQL2 72.474 287 4.66e-142 404.0 sp|Q5PQL2|CNOT9_RAT CCR4-NOT transcription complex subunit 9 OS=Rattus norvegicus OX=10116 GN=Cnot9 PE=1 SV=1 CNOT9_RAT reviewed CCR4-NOT transcription complex subunit 9 (Cell differentiation protein RQCD1 homolog) (Rcd-1) Rattus norvegicus (Rat) GO:0000932; GO:0003713; GO:0005154; GO:0005634; GO:0005829; GO:0006402; GO:0017148; GO:0019221; GO:0019900; GO:0019904; GO:0030014; GO:0030015; GO:0031047; GO:0032991; GO:0033147; GO:0042803; GO:0045742 cytokine-mediated signaling pathway [GO:0019221]; mRNA catabolic process [GO:0006402]; negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; negative regulation of translation [GO:0017148]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; regulatory ncRNA-mediated gene silencing [GO:0031047] CCR4-NOT complex [GO:0030014]; CCR4-NOT core complex [GO:0030015]; cytosol [GO:0005829]; nucleus [GO:0005634]; P-body [GO:0000932]; protein-containing complex [GO:0032991] epidermal growth factor receptor binding [GO:0005154]; kinase binding [GO:0019900]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]; transcription coactivator activity [GO:0003713] g10140.t1 Q5ZKI4 63.926 596 0.0 707.0 sp|Q5ZKI4|CCD93_CHICK Coiled-coil domain-containing protein 93 OS=Gallus gallus OX=9031 GN=CCDC93 PE=2 SV=1 g10141.t1 Q9MYM7 49.206 189 4.66e-55 186.0 sp|Q9MYM7|B3GT1_PONPY Beta-1,3-galactosyltransferase 1 OS=Pongo pygmaeus OX=9600 GN=B3GALT1 PE=3 SV=1 g10142.t1 Q6P9U3 41.969 193 6.79e-50 163.0 sp|Q6P9U3|COMD3_RAT COMM domain-containing protein 3 OS=Rattus norvegicus OX=10116 GN=Commd3 PE=1 SV=1 g10143.t1 Q9UJ83 54.448 281 6.49e-101 310.0 sp|Q9UJ83|HACL1_HUMAN 2-hydroxyacyl-CoA lyase 1 OS=Homo sapiens OX=9606 GN=HACL1 PE=1 SV=2 HACL1_HUMAN reviewed 2-hydroxyacyl-CoA lyase 1 (EC 4.1.2.63) (2-hydroxyphytanoyl-CoA lyase) (2-HPCL) (Phytanoyl-CoA 2-hydroxylase 2) Homo sapiens (Human) GO:0000287; GO:0001561; GO:0005524; GO:0005654; GO:0005777; GO:0005782; GO:0005829; GO:0006625; GO:0006631; GO:0016830; GO:0030976; GO:0042802; GO:0097089; GO:0106359; GO:0106376; GO:1903512 fatty acid alpha-oxidation [GO:0001561]; fatty acid metabolic process [GO:0006631]; methyl-branched fatty acid metabolic process [GO:0097089]; phytanic acid metabolic process [GO:1903512]; protein targeting to peroxisome [GO:0006625] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777] 2-hydroxyacyl-CoA lyase activity [GO:0106359]; 2-hydroxyphytanoyl-CoA lyase activity [GO:0106376]; ATP binding [GO:0005524]; carbon-carbon lyase activity [GO:0016830]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; thiamine pyrophosphate binding [GO:0030976] g10145.t1 Q9UJ83 60.784 255 7.690000000000001e-97 298.0 sp|Q9UJ83|HACL1_HUMAN 2-hydroxyacyl-CoA lyase 1 OS=Homo sapiens OX=9606 GN=HACL1 PE=1 SV=2 HACL1_HUMAN reviewed 2-hydroxyacyl-CoA lyase 1 (EC 4.1.2.63) (2-hydroxyphytanoyl-CoA lyase) (2-HPCL) (Phytanoyl-CoA 2-hydroxylase 2) Homo sapiens (Human) GO:0000287; GO:0001561; GO:0005524; GO:0005654; GO:0005777; GO:0005782; GO:0005829; GO:0006625; GO:0006631; GO:0016830; GO:0030976; GO:0042802; GO:0097089; GO:0106359; GO:0106376; GO:1903512 fatty acid alpha-oxidation [GO:0001561]; fatty acid metabolic process [GO:0006631]; methyl-branched fatty acid metabolic process [GO:0097089]; phytanic acid metabolic process [GO:1903512]; protein targeting to peroxisome [GO:0006625] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777] 2-hydroxyacyl-CoA lyase activity [GO:0106359]; 2-hydroxyphytanoyl-CoA lyase activity [GO:0106376]; ATP binding [GO:0005524]; carbon-carbon lyase activity [GO:0016830]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; thiamine pyrophosphate binding [GO:0030976] g10148.t1 Q6DFQ7 44.245 278 3.01e-58 196.0 sp|Q6DFQ7|TM198_XENTR Transmembrane protein 198 OS=Xenopus tropicalis OX=8364 GN=tmem198 PE=1 SV=1 TM198_XENTR reviewed Transmembrane protein 198 Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0005886; GO:0012506; GO:0016055; GO:0031410 Wnt signaling pathway [GO:0016055] cytoplasmic vesicle [GO:0031410]; plasma membrane [GO:0005886]; vesicle membrane [GO:0012506] g10152.t1 Q5RCZ2 36.364 231 5.07e-36 130.0 sp|Q5RCZ2|CY561_PONAB Transmembrane ascorbate-dependent reductase CYB561 OS=Pongo abelii OX=9601 GN=CYB561 PE=2 SV=1 CY561_PONAB reviewed Transmembrane ascorbate-dependent reductase CYB561 (EC 7.2.1.-) (Cytochrome b-561) (Cytochrome b561) Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0005765; GO:0042584; GO:0046872; GO:0140575; GO:0140576 ascorbate homeostasis [GO:0140576] chromaffin granule membrane [GO:0042584]; lysosomal membrane [GO:0005765] metal ion binding [GO:0046872]; transmembrane monodehydroascorbate reductase activity [GO:0140575] g10153.t1 Q6P1H1 37.719 228 2.77e-47 160.0 sp|Q6P1H1|CYAC3_MOUSE Lysosomal membrane ascorbate-dependent ferrireductase CYB561A3 OS=Mus musculus OX=10090 GN=Cyb561a3 PE=1 SV=1 CYAC3_MOUSE reviewed Lysosomal membrane ascorbate-dependent ferrireductase CYB561A3 (EC 7.2.1.3) (Cytochrome b ascorbate-dependent protein 3) (Cytochrome b561 family member A3) (Lysosomal cytochrome b) (LCytb) Mus musculus (Mouse) GO:0005730; GO:0005764; GO:0005765; GO:0006879; GO:0016491; GO:0031902; GO:0046872; GO:0140571 intracellular iron ion homeostasis [GO:0006879] late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; nucleolus [GO:0005730] metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; transmembrane ascorbate ferrireductase activity [GO:0140571] g10154.t1 Q9VIM5 71.237 299 1.6599999999999998e-138 396.0 sp|Q9VIM5|ARPC2_DROME Actin-related protein 2/3 complex subunit 2 OS=Drosophila melanogaster OX=7227 GN=Arpc2 PE=1 SV=2 g10155.t1 O60239 44.747 257 2.3e-56 200.0 sp|O60239|3BP5_HUMAN SH3 domain-binding protein 5 OS=Homo sapiens OX=9606 GN=SH3BP5 PE=1 SV=2 3BP5_HUMAN reviewed SH3 domain-binding protein 5 (SH3BP-5) (SH3 domain-binding protein that preferentially associates with BTK) Homo sapiens (Human) GO:0004860; GO:0005085; GO:0005654; GO:0005737; GO:0005739; GO:0007165; GO:0016604; GO:0017124; GO:0030659; GO:0035556 intracellular signal transduction [GO:0035556]; signal transduction [GO:0007165] cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; mitochondrion [GO:0005739]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654] guanyl-nucleotide exchange factor activity [GO:0005085]; protein kinase inhibitor activity [GO:0004860]; SH3 domain binding [GO:0017124] g10156.t1 P51400 34.698 513 5.0100000000000005e-79 263.0 sp|P51400|RED1_RAT Double-stranded RNA-specific editase 1 OS=Rattus norvegicus OX=10116 GN=Adarb1 PE=1 SV=1 g10157.t1 Q7ZYA5 36.177 293 2.76e-40 145.0 sp|Q7ZYA5|PRKAA_XENLA Interferon-inducible double-stranded RNA-dependent protein kinase activator A homolog A OS=Xenopus laevis OX=8355 GN=prkra-a PE=2 SV=1 g10158.t1 Q9BSH4 41.296 247 6.97e-60 194.0 sp|Q9BSH4|TACO1_HUMAN Translational activator of cytochrome c oxidase 1 OS=Homo sapiens OX=9606 GN=TACO1 PE=1 SV=1 TACO1_HUMAN reviewed Translational activator of cytochrome c oxidase 1 (Coiled-coil domain-containing protein 44) (Translational activator of mitochondrially-encoded cytochrome c oxidase I) Homo sapiens (Human) GO:0003729; GO:0005739; GO:0019843; GO:0033617; GO:0061743; GO:0070129; GO:0097177 mitochondrial respiratory chain complex IV assembly [GO:0033617]; motor learning [GO:0061743]; regulation of mitochondrial translation [GO:0070129] mitochondrion [GO:0005739] mitochondrial ribosome binding [GO:0097177]; mRNA binding [GO:0003729]; rRNA binding [GO:0019843] g10160.t2 P98069 32.231 242 3.38e-33 134.0 sp|P98069|BMPH_STRPU Bone morphogenetic protein 1 homolog OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g10160.t3 P98069 32.231 242 3.38e-33 134.0 sp|P98069|BMPH_STRPU Bone morphogenetic protein 1 homolog OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g10160.t4 P98069 32.231 242 3.2200000000000004e-33 132.0 sp|P98069|BMPH_STRPU Bone morphogenetic protein 1 homolog OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g10162.t1 P35353 42.857 371 2.83e-57 204.0 sp|P35353|CRFR1_RAT Corticotropin-releasing factor receptor 1 OS=Rattus norvegicus OX=10116 GN=Crhr1 PE=1 SV=1 CRFR1_RAT reviewed Corticotropin-releasing factor receptor 1 (CRF-R-1) (CRF-R1) (CRFR-1) (Corticotropin-releasing hormone receptor 1) (CRH-R-1) (CRH-R1) Rattus norvegicus (Rat) GO:0001666; GO:0001965; GO:0004930; GO:0005771; GO:0005802; GO:0005886; GO:0007166; GO:0007188; GO:0007189; GO:0007200; GO:0007204; GO:0007218; GO:0007613; GO:0007631; GO:0008528; GO:0008542; GO:0015056; GO:0016020; GO:0021854; GO:0030325; GO:0030425; GO:0030855; GO:0031982; GO:0032811; GO:0035640; GO:0035641; GO:0035902; GO:0042277; GO:0042596; GO:0043005; GO:0043025; GO:0043306; GO:0043404; GO:0043524; GO:0044877; GO:0045177; GO:0048148; GO:0048149; GO:0048167; GO:0048266; GO:0051424; GO:0051458; GO:0051602; GO:0051867; GO:0060291; GO:0071376; GO:0098839; GO:0098978; GO:0141163; GO:2000252; GO:2000852 adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; adrenal gland development [GO:0030325]; behavioral response to cocaine [GO:0048148]; behavioral response to ethanol [GO:0048149]; behavioral response to pain [GO:0048266]; cell surface receptor signaling pathway [GO:0007166]; cellular response to corticotropin-releasing hormone stimulus [GO:0071376]; corticotropin secretion [GO:0051458]; epithelial cell differentiation [GO:0030855]; exploration behavior [GO:0035640]; fear response [GO:0042596]; feeding behavior [GO:0007631]; general adaptation syndrome, behavioral process [GO:0051867]; hypothalamus development [GO:0021854]; locomotory exploration behavior [GO:0035641]; long-term synaptic potentiation [GO:0060291]; memory [GO:0007613]; negative regulation of epinephrine secretion [GO:0032811]; negative regulation of feeding behavior [GO:2000252]; negative regulation of neuron apoptotic process [GO:0043524]; neuropeptide signaling pathway [GO:0007218]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of cAMP/PKA signal transduction [GO:0141163]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of mast cell degranulation [GO:0043306]; regulation of corticosterone secretion [GO:2000852]; regulation of synaptic plasticity [GO:0048167]; response to electrical stimulus [GO:0051602]; response to hypoxia [GO:0001666]; response to immobilization stress [GO:0035902]; visual learning [GO:0008542] apical part of cell [GO:0045177]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; multivesicular body [GO:0005771]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; trans-Golgi network [GO:0005802]; vesicle [GO:0031982] corticotrophin-releasing factor receptor activity [GO:0015056]; corticotropin-releasing hormone binding [GO:0051424]; corticotropin-releasing hormone receptor activity [GO:0043404]; G protein-coupled peptide receptor activity [GO:0008528]; G protein-coupled receptor activity [GO:0004930]; G-protein alpha-subunit binding [GO:0001965]; peptide binding [GO:0042277]; protein-containing complex binding [GO:0044877] g10163.t1 O42603 40.613 261 3.89e-45 165.0 sp|O42603|CRFR2_XENLA Corticotropin-releasing factor receptor 2 OS=Xenopus laevis OX=8355 GN=crhr2 PE=2 SV=1 g10164.t1 Q6NX27 45.125 441 1.73e-120 361.0 sp|Q6NX27|MINY3_XENTR Ubiquitin carboxyl-terminal hydrolase MINDY-3 OS=Xenopus tropicalis OX=8364 GN=mindy3 PE=2 SV=1 g10168.t1 Q6BD04 40.789 304 5.05e-68 221.0 sp|Q6BD04|GPR54_ORENI G-protein coupled receptor 54 OS=Oreochromis niloticus OX=8128 GN=gpr54 PE=2 SV=1 g10172.t1 O05408 36.728 324 6.3699999999999994e-52 178.0 sp|O05408|YRPG_BACSU Uncharacterized oxidoreductase YrpG OS=Bacillus subtilis (strain 168) OX=224308 GN=yrpG PE=3 SV=2 g10173.t1 Q0VD31 41.944 360 7.67e-84 270.0 sp|Q0VD31|FBXL4_BOVIN F-box/LRR-repeat protein 4 OS=Bos taurus OX=9913 GN=FBXL4 PE=2 SV=1 g10176.t1 Q9MYM7 46.939 98 3.28e-25 90.9 sp|Q9MYM7|B3GT1_PONPY Beta-1,3-galactosyltransferase 1 OS=Pongo pygmaeus OX=9600 GN=B3GALT1 PE=3 SV=1 g10176.t1 Q9MYM7 45.946 37 3.28e-25 45.1 sp|Q9MYM7|B3GT1_PONPY Beta-1,3-galactosyltransferase 1 OS=Pongo pygmaeus OX=9600 GN=B3GALT1 PE=3 SV=1 g10179.t1 P22045 39.085 284 5.85e-64 205.0 sp|P22045|PGFS_LEIMA 9,11-endoperoxide prostaglandin H2 reductase OS=Leishmania major OX=5664 GN=P100/11E PE=1 SV=3 g10180.t1 B2GUE2 45.96 396 1.01e-62 211.0 sp|B2GUE2|LRRF2_XENTR Leucine-rich repeat flightless-interacting protein 2 OS=Xenopus tropicalis OX=8364 GN=lrrfip2 PE=2 SV=1 g10181.t1 Q7K237 52.632 247 4.06e-86 268.0 sp|Q7K237|C1GLT_DROME Glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase 1 OS=Drosophila melanogaster OX=7227 GN=C1GalTA PE=1 SV=1 C1GLT_DROME reviewed Glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase 1 (EC 2.4.1.122) (Core 1 O-glycan T-synthase) (Core 1 UDP-galactose:N-acetylgalactosamine-alpha-R beta 1,3-galactosyltransferase 1) (Core 1 beta1,3-galactosyltransferase 1) (C1GalT1) (Core 1 beta3-Gal-T1) Drosophila melanogaster (Fruit fly) GO:0000139; GO:0000166; GO:0007528; GO:0009247; GO:0016020; GO:0016263; GO:0016266; GO:0021551; GO:0030145; GO:0042803; GO:0048531; GO:0051489; GO:0055001; GO:1902037 central nervous system morphogenesis [GO:0021551]; glycolipid biosynthetic process [GO:0009247]; muscle cell development [GO:0055001]; negative regulation of hematopoietic stem cell differentiation [GO:1902037]; neuromuscular junction development [GO:0007528]; protein O-linked glycosylation via N-acetyl-galactosamine [GO:0016266]; regulation of filopodium assembly [GO:0051489] Golgi membrane [GO:0000139]; membrane [GO:0016020] beta-1,3-galactosyltransferase activity [GO:0048531]; glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase activity [GO:0016263]; manganese ion binding [GO:0030145]; nucleotide binding [GO:0000166]; protein homodimerization activity [GO:0042803] g10183.t1 Q2PC93 30.428 1239 1.33e-156 537.0 sp|Q2PC93|SSPO_CHICK SCO-spondin OS=Gallus gallus OX=9031 GN=SSPO PE=2 SV=1 g10183.t1 Q2PC93 27.438 441 7.1e-32 140.0 sp|Q2PC93|SSPO_CHICK SCO-spondin OS=Gallus gallus OX=9031 GN=SSPO PE=2 SV=1 g10183.t1 Q2PC93 26.685 371 1.98e-25 119.0 sp|Q2PC93|SSPO_CHICK SCO-spondin OS=Gallus gallus OX=9031 GN=SSPO PE=2 SV=1 g10184.t1 Q2PC93 31.296 1227 1.1199999999999999e-150 534.0 sp|Q2PC93|SSPO_CHICK SCO-spondin OS=Gallus gallus OX=9031 GN=SSPO PE=2 SV=1 g10184.t1 Q2PC93 31.264 435 2.3899999999999998e-45 186.0 sp|Q2PC93|SSPO_CHICK SCO-spondin OS=Gallus gallus OX=9031 GN=SSPO PE=2 SV=1 g10184.t1 Q2PC93 26.849 365 3.36e-27 127.0 sp|Q2PC93|SSPO_CHICK SCO-spondin OS=Gallus gallus OX=9031 GN=SSPO PE=2 SV=1 g10184.t1 Q2PC93 26.039 361 1.31e-24 118.0 sp|Q2PC93|SSPO_CHICK SCO-spondin OS=Gallus gallus OX=9031 GN=SSPO PE=2 SV=1 g10186.t1 A0A125QXJ1 68.687 297 1.57e-127 388.0 sp|A0A125QXJ1|ABCB6_MESAU ATP-binding cassette sub-family B member 6 OS=Mesocricetus auratus OX=10036 GN=ABCB6 PE=2 SV=1 ABCB6_MESAU reviewed ATP-binding cassette sub-family B member 6 (ABC-type heme transporter ABCB6) (EC 7.6.2.5) (Mitochondrial ABC transporter 3) (Mt-ABC transporter 3) (P-glycoprotein-related protein) (Ubiquitously-expressed mammalian ABC half transporter) Mesocricetus auratus (Golden hamster) GO:0000139; GO:0005524; GO:0005576; GO:0005741; GO:0005765; GO:0005789; GO:0005794; GO:0005886; GO:0006778; GO:0015439; GO:0016887; GO:0020037; GO:0031901; GO:0032585; GO:0033162; GO:0035351; GO:0036020; GO:0042168; GO:0098849; GO:0140359 cellular detoxification of cadmium ion [GO:0098849]; heme metabolic process [GO:0042168]; heme transmembrane transport [GO:0035351]; porphyrin-containing compound metabolic process [GO:0006778] early endosome membrane [GO:0031901]; endolysosome membrane [GO:0036020]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; lysosomal membrane [GO:0005765]; melanosome membrane [GO:0033162]; mitochondrial outer membrane [GO:0005741]; multivesicular body membrane [GO:0032585]; plasma membrane [GO:0005886] ABC-type heme transporter activity [GO:0015439]; ABC-type transporter activity [GO:0140359]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; heme binding [GO:0020037] g10188.t1 E7F9L8 58.689 1007 0.0 1181.0 sp|E7F9L8|MYO1D_DANRE Unconventional myosin-Id OS=Danio rerio OX=7955 GN=myo1d PE=2 SV=1 MYO1D_DANRE reviewed Unconventional myosin-Id (Myosin 1d) (Myosin1D) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000146; GO:0003146; GO:0005516; GO:0005524; GO:0005576; GO:0005737; GO:0005769; GO:0005886; GO:0005902; GO:0005938; GO:0006897; GO:0007015; GO:0015031; GO:0015629; GO:0016459; GO:0030048; GO:0030425; GO:0035469; GO:0043204; GO:0051015; GO:0060287; GO:0061966; GO:0070121; GO:0071910 actin filament organization [GO:0007015]; actin filament-based movement [GO:0030048]; determination of liver left/right asymmetry [GO:0071910]; determination of pancreatic left/right asymmetry [GO:0035469]; endocytosis [GO:0006897]; epithelial cilium movement involved in determination of left/right asymmetry [GO:0060287]; establishment of left/right asymmetry [GO:0061966]; heart jogging [GO:0003146]; Kupffer's vesicle development [GO:0070121]; protein transport [GO:0015031] actin cytoskeleton [GO:0015629]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; early endosome [GO:0005769]; extracellular region [GO:0005576]; microvillus [GO:0005902]; myosin complex [GO:0016459]; perikaryon [GO:0043204]; plasma membrane [GO:0005886] actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146] g10190.t1 P61810 67.442 86 1.66e-32 117.0 sp|P61810|CD5R1_RAT Cyclin-dependent kinase 5 activator 1 OS=Rattus norvegicus OX=10116 GN=Cdk5r1 PE=1 SV=1 CD5R1_RAT reviewed Cyclin-dependent kinase 5 activator 1 (CDK5 activator 1) (Cyclin-dependent kinase 5 regulatory subunit 1) (TPKII regulatory subunit) [Cleaved into: Cyclin-dependent kinase 5 activator 1, p35 (p35); Cyclin-dependent kinase 5 activator 1, p25 (p25) (Tau protein kinase II 23 kDa subunit) (p23)] Rattus norvegicus (Rat) GO:0000307; GO:0001764; GO:0002020; GO:0003779; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005886; GO:0007158; GO:0007213; GO:0007411; GO:0007413; GO:0007420; GO:0009792; GO:0014069; GO:0016020; GO:0016301; GO:0016533; GO:0019901; GO:0021549; GO:0021722; GO:0021766; GO:0021799; GO:0021819; GO:0030182; GO:0030424; GO:0030425; GO:0030426; GO:0031175; GO:0031594; GO:0032956; GO:0035235; GO:0035255; GO:0043025; GO:0043197; GO:0043204; GO:0043292; GO:0043525; GO:0043539; GO:0045296; GO:0045348; GO:0045892; GO:0046875; GO:0048013; GO:0048471; GO:0048511; GO:0048675; GO:0051015; GO:0051879; GO:0061001; GO:0061575; GO:0070315; GO:0070507; GO:0090314; GO:0098693; GO:0098793; GO:1903265 axon extension [GO:0048675]; axon guidance [GO:0007411]; axonal fasciculation [GO:0007413]; brain development [GO:0007420]; cerebellum development [GO:0021549]; cerebral cortex radially oriented cell migration [GO:0021799]; embryo development ending in birth or egg hatching [GO:0009792]; ephrin receptor signaling pathway [GO:0048013]; G protein-coupled acetylcholine receptor signaling pathway [GO:0007213]; G1 to G0 transition involved in cell differentiation [GO:0070315]; hippocampus development [GO:0021766]; ionotropic glutamate receptor signaling pathway [GO:0035235]; layer formation in cerebral cortex [GO:0021819]; negative regulation of DNA-templated transcription [GO:0045892]; neuron cell-cell adhesion [GO:0007158]; neuron differentiation [GO:0030182]; neuron migration [GO:0001764]; neuron projection development [GO:0031175]; positive regulation of MHC class II biosynthetic process [GO:0045348]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of tumor necrosis factor-mediated signaling pathway [GO:1903265]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of dendritic spine morphogenesis [GO:0061001]; regulation of microtubule cytoskeleton organization [GO:0070507]; regulation of synaptic vesicle cycle [GO:0098693]; rhythmic process [GO:0048511]; superior olivary nucleus maturation [GO:0021722] axon [GO:0030424]; contractile muscle fiber [GO:0043292]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; growth cone [GO:0030426]; membrane [GO:0016020]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; presynapse [GO:0098793]; protein kinase 5 complex [GO:0016533] actin binding [GO:0003779]; actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; cyclin-dependent protein serine/threonine kinase activator activity [GO:0061575]; ephrin receptor binding [GO:0046875]; Hsp90 protein binding [GO:0051879]; ionotropic glutamate receptor binding [GO:0035255]; kinase activity [GO:0016301]; protease binding [GO:0002020]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activator activity [GO:0043539] g10192.t1 F6P3G4 72.115 416 0.0 595.0 sp|F6P3G4|PS11A_DANRE 26S proteasome non-ATPase regulatory subunit 11A OS=Danio rerio OX=7955 GN=psmd11a PE=2 SV=1 g10193.t1 Q99LX5 50.495 101 1.31e-26 107.0 sp|Q99LX5|MMTA2_MOUSE Multiple myeloma tumor-associated protein 2 homolog OS=Mus musculus OX=10090 GN=Mmtag2 PE=2 SV=1 g10194.t1 Q2PC93 33.05 1295 0.0 629.0 sp|Q2PC93|SSPO_CHICK SCO-spondin OS=Gallus gallus OX=9031 GN=SSPO PE=2 SV=1 g10204.t1 Q4R6W9 47.368 114 4.18e-26 104.0 sp|Q4R6W9|SNPC1_MACFA snRNA-activating protein complex subunit 1 OS=Macaca fascicularis OX=9541 GN=SNAPC1 PE=2 SV=1 SNPC1_MACFA reviewed snRNA-activating protein complex subunit 1 (SNAPc subunit 1) (Small nuclear RNA-activating complex polypeptide 1) (snRNA-activating protein complex 43 kDa subunit) (SNAPc 43 kDa subunit) Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey) GO:0005654; GO:0005730; GO:0019185; GO:0042795; GO:0042796; GO:0043565 snRNA transcription by RNA polymerase II [GO:0042795]; snRNA transcription by RNA polymerase III [GO:0042796] nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; snRNA-activating protein complex [GO:0019185] sequence-specific DNA binding [GO:0043565] g10205.t1 Q05A80 38.636 132 3.88e-22 97.1 sp|Q05A80|CAPR2_MOUSE Caprin-2 OS=Mus musculus OX=10090 GN=Caprin2 PE=1 SV=1 CAPR2_MOUSE reviewed Caprin-2 (C1q domain-containing protein 1) (Cytoplasmic activation/proliferation-associated protein 2) (RNA granule protein 140) Mus musculus (Mouse) GO:0003723; GO:0005102; GO:0005654; GO:0005737; GO:0005739; GO:0005813; GO:0005829; GO:0005886; GO:0017148; GO:0030154; GO:0030308; GO:0043235; GO:0045944; GO:0046872; GO:0050775; GO:0061003; GO:0090263 cell differentiation [GO:0030154]; negative regulation of cell growth [GO:0030308]; negative regulation of translation [GO:0017148]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of transcription by RNA polymerase II [GO:0045944] centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] metal ion binding [GO:0046872]; RNA binding [GO:0003723]; signaling receptor binding [GO:0005102] g10209.t1 Q8R5C8 48.87 354 6.72e-116 362.0 sp|Q8R5C8|ZMY11_MOUSE Zinc finger MYND domain-containing protein 11 OS=Mus musculus OX=10090 GN=Zmynd11 PE=1 SV=2 ZMY11_MOUSE reviewed Zinc finger MYND domain-containing protein 11 Mus musculus (Mouse) GO:0003690; GO:0003714; GO:0005634; GO:0005654; GO:0005694; GO:0008270; GO:0009966; GO:0034243; GO:0043124; GO:0046329; GO:0051607; GO:0140003; GO:2001237 defense response to virus [GO:0051607]; negative regulation of canonical NF-kappaB signal transduction [GO:0043124]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of JNK cascade [GO:0046329]; regulation of signal transduction [GO:0009966]; regulation of transcription elongation by RNA polymerase II [GO:0034243] chromosome [GO:0005694]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] double-stranded DNA binding [GO:0003690]; histone H3K36me3 reader activity [GO:0140003]; transcription corepressor activity [GO:0003714]; zinc ion binding [GO:0008270] g10210.t1 Q95V11 88.756 587 0.0 1099.0 sp|Q95V11|CMAH_ASTRU Cytidine monophosphate-N-acetylneuraminic acid hydroxylase OS=Asterias rubens OX=7604 GN=cnh PE=1 SV=1 g10211.t1 Q5F450 53.188 1145 0.0 1187.0 sp|Q5F450|PAN2_CHICK PAN2-PAN3 deadenylation complex catalytic subunit PAN2 OS=Gallus gallus OX=9031 GN=PAN2 PE=2 SV=1 PAN2_CHICK reviewed PAN2-PAN3 deadenylation complex catalytic subunit PAN2 (EC 3.1.13.4) (Inactive ubiquitin carboxyl-terminal hydrolase 52) (PAB1P-dependent poly(A)-specific ribonuclease) (Poly(A)-nuclease deadenylation complex subunit 2) (PAN deadenylation complex subunit 2) Gallus gallus (Chicken) GO:0000175; GO:0000289; GO:0000932; GO:0003676; GO:0004535; GO:0005634; GO:0006397; GO:0010606; GO:0031251; GO:0046872 mRNA processing [GO:0006397]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; positive regulation of cytoplasmic mRNA processing body assembly [GO:0010606] nucleus [GO:0005634]; P-body [GO:0000932]; PAN complex [GO:0031251] 3'-5'-RNA exonuclease activity [GO:0000175]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; poly(A)-specific ribonuclease activity [GO:0004535] g10212.t1 Q9CZ28 65.021 243 1.51e-107 313.0 sp|Q9CZ28|SNF8_MOUSE Vacuolar-sorting protein SNF8 OS=Mus musculus OX=10090 GN=Snf8 PE=1 SV=1 SNF8_MOUSE reviewed Vacuolar-sorting protein SNF8 (ESCRT-II complex subunit VPS22) Mus musculus (Mouse) GO:0000814; GO:0005634; GO:0005654; GO:0005667; GO:0005737; GO:0005829; GO:0005886; GO:0006357; GO:0008289; GO:0010008; GO:0010628; GO:0016020; GO:0016236; GO:0016247; GO:0031902; GO:0032456; GO:0036258; GO:0042176; GO:0042803; GO:0043328; GO:0045022; GO:0045732; GO:0048471; GO:0055037; GO:0061635; GO:0071985; GO:1903543 early endosome to late endosome transport [GO:0045022]; endocytic recycling [GO:0032456]; macroautophagy [GO:0016236]; multivesicular body assembly [GO:0036258]; multivesicular body sorting pathway [GO:0071985]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of gene expression [GO:0010628]; positive regulation of protein catabolic process [GO:0045732]; protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043328]; regulation of protein catabolic process [GO:0042176]; regulation of protein complex stability [GO:0061635]; regulation of transcription by RNA polymerase II [GO:0006357] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; ESCRT II complex [GO:0000814]; late endosome membrane [GO:0031902]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; transcription regulator complex [GO:0005667] channel regulator activity [GO:0016247]; lipid binding [GO:0008289]; protein homodimerization activity [GO:0042803] g10214.t1 P40144 55.052 1059 0.0 1146.0 sp|P40144|ADCY5_RABIT Adenylate cyclase type 5 OS=Oryctolagus cuniculus OX=9986 GN=ADCY5 PE=1 SV=1 g10216.t1 P48758 50.725 276 1.8999999999999998e-90 280.0 sp|P48758|CBR1_MOUSE Carbonyl reductase [NADPH] 1 OS=Mus musculus OX=10090 GN=Cbr1 PE=1 SV=3 g10216.t1 P48758 50.481 208 4.5700000000000005e-59 199.0 sp|P48758|CBR1_MOUSE Carbonyl reductase [NADPH] 1 OS=Mus musculus OX=10090 GN=Cbr1 PE=1 SV=3 g10217.t1 B2GV72 48.175 274 6.3099999999999995e-90 271.0 sp|B2GV72|CRB3_RAT Carbonyl reductase [NADPH] 3 OS=Rattus norvegicus OX=10116 GN=Cbr3 PE=1 SV=1 CRB3_RAT reviewed Carbonyl reductase [NADPH] 3 (EC 1.1.1.184) (Monomeric carbonyl reductase 3) (Quinone reductase CBR3) (EC 1.6.5.10) Rattus norvegicus (Rat) GO:0000253; GO:0004090; GO:0005654; GO:0005829; GO:0008753; GO:0042376; GO:0050890; GO:0070402 cognition [GO:0050890]; phylloquinone catabolic process [GO:0042376] cytosol [GO:0005829]; nucleoplasm [GO:0005654] 3-beta-hydroxysteroid 3-dehydrogenase (NADP+) activity [GO:0000253]; carbonyl reductase (NADPH) activity [GO:0004090]; NADPH binding [GO:0070402]; NADPH dehydrogenase (quinone) activity [GO:0008753] g10219.t1 P42325 58.065 186 7.01e-71 214.0 sp|P42325|NCAH_DROME Neurocalcin homolog OS=Drosophila melanogaster OX=7227 GN=Nca PE=1 SV=2 NCAH_DROME reviewed Neurocalcin homolog (DrosNCa) Drosophila melanogaster (Fruit fly) GO:0005509; GO:0009966; GO:0045938; GO:1902848 negative regulation of neuronal signal transduction [GO:1902848]; positive regulation of circadian sleep/wake cycle, sleep [GO:0045938]; regulation of signal transduction [GO:0009966] calcium ion binding [GO:0005509] g10222.t1 Q9H3L0 44.518 301 2.81e-76 239.0 sp|Q9H3L0|MMAD_HUMAN Cobalamin trafficking protein CblD OS=Homo sapiens OX=9606 GN=MMADHC PE=1 SV=2 MMAD_HUMAN reviewed Cobalamin trafficking protein CblD (CblD) (Methylmalonic aciduria and homocystinuria type D protein, mitochondrial) Homo sapiens (Human) GO:0005737; GO:0005739; GO:0005829; GO:0009235; GO:0140104 cobalamin metabolic process [GO:0009235] cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739] molecular carrier activity [GO:0140104] g10222.t2 Q9H3L0 44.518 301 5.22e-75 238.0 sp|Q9H3L0|MMAD_HUMAN Cobalamin trafficking protein CblD OS=Homo sapiens OX=9606 GN=MMADHC PE=1 SV=2 MMAD_HUMAN reviewed Cobalamin trafficking protein CblD (CblD) (Methylmalonic aciduria and homocystinuria type D protein, mitochondrial) Homo sapiens (Human) GO:0005737; GO:0005739; GO:0005829; GO:0009235; GO:0140104 cobalamin metabolic process [GO:0009235] cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739] molecular carrier activity [GO:0140104] g10223.t1 Q6BD04 37.537 341 4.21e-71 230.0 sp|Q6BD04|GPR54_ORENI G-protein coupled receptor 54 OS=Oreochromis niloticus OX=8128 GN=gpr54 PE=2 SV=1 g10224.t1 Q91616 78.378 111 1.06e-55 189.0 sp|Q91616|NDF1_XENLA Neurogenic differentiation factor 1 OS=Xenopus laevis OX=8355 GN=neurod1 PE=1 SV=1 NDF1_XENLA reviewed Neurogenic differentiation factor 1 (NeuroD1) Xenopus laevis (African clawed frog) GO:0000981; GO:0005634; GO:0005737; GO:0007423; GO:0045944; GO:0046982; GO:0061564; GO:0070888 axon development [GO:0061564]; positive regulation of transcription by RNA polymerase II [GO:0045944]; sensory organ development [GO:0007423] cytoplasm [GO:0005737]; nucleus [GO:0005634] DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; E-box binding [GO:0070888]; protein heterodimerization activity [GO:0046982] g10225.t1 Q5U4E6 32.026 306 9.42e-21 102.0 sp|Q5U4E6|GOGA4_RAT Golgin subfamily A member 4 OS=Rattus norvegicus OX=10116 GN=Golga4 PE=1 SV=2 GOGA4_RAT reviewed Golgin subfamily A member 4 Rattus norvegicus (Rat) GO:0000139; GO:0005654; GO:0005737; GO:0005794; GO:0031267; GO:0043001; GO:0045773; GO:0048193; GO:0051020 Golgi to plasma membrane protein transport [GO:0043001]; Golgi vesicle transport [GO:0048193]; positive regulation of axon extension [GO:0045773] cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; nucleoplasm [GO:0005654] GTPase binding [GO:0051020]; small GTPase binding [GO:0031267] g10225.t2 Q5U4E6 34.799 273 1.08e-22 107.0 sp|Q5U4E6|GOGA4_RAT Golgin subfamily A member 4 OS=Rattus norvegicus OX=10116 GN=Golga4 PE=1 SV=2 GOGA4_RAT reviewed Golgin subfamily A member 4 Rattus norvegicus (Rat) GO:0000139; GO:0005654; GO:0005737; GO:0005794; GO:0031267; GO:0043001; GO:0045773; GO:0048193; GO:0051020 Golgi to plasma membrane protein transport [GO:0043001]; Golgi vesicle transport [GO:0048193]; positive regulation of axon extension [GO:0045773] cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; nucleoplasm [GO:0005654] GTPase binding [GO:0051020]; small GTPase binding [GO:0031267] g10227.t1 Q13439 37.629 582 1.47e-68 258.0 sp|Q13439|GOGA4_HUMAN Golgin subfamily A member 4 OS=Homo sapiens OX=9606 GN=GOLGA4 PE=1 SV=1 g10227.t2 Q13439 36.895 599 2.06e-68 258.0 sp|Q13439|GOGA4_HUMAN Golgin subfamily A member 4 OS=Homo sapiens OX=9606 GN=GOLGA4 PE=1 SV=1 g10228.t1 A6P320 28.144 167 6.24e-24 106.0 sp|A6P320|MARHB_RAT E3 ubiquitin-protein ligase MARCHF11 OS=Rattus norvegicus OX=10116 GN=Marchf11 PE=1 SV=1 MARHB_RAT reviewed E3 ubiquitin-protein ligase MARCHF11 (EC 2.3.2.27) (Membrane-associated RING finger protein 11) (Membrane-associated RING-CH protein XI) (MARCH-XI) (RING-type E3 ubiquitin transferase MARCHF11) Rattus norvegicus (Rat) GO:0004842; GO:0008270; GO:0016567; GO:0030659; GO:0061630 protein ubiquitination [GO:0016567] cytoplasmic vesicle membrane [GO:0030659] ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] g10232.t1 Q708S5 27.809 356 3.0399999999999997e-34 143.0 sp|Q708S5|ASIC2_DANRE Acid-sensing ion channel 2 OS=Danio rerio OX=7955 GN=asic2 PE=1 SV=1 g10233.t1 Q21974 30.836 347 3.25e-36 151.0 sp|Q21974|UNC8_CAEEL Degenerin unc-8 OS=Caenorhabditis elegans OX=6239 GN=unc-8 PE=2 SV=1 UNC8_CAEEL reviewed Degenerin unc-8 (Putative ligand-gated sodium channel unc-8) (Uncoordinated protein 8) Caenorhabditis elegans GO:0005261; GO:0005886; GO:0006812; GO:0015280; GO:0016322; GO:0035725; GO:0040011; GO:0043025 locomotion [GO:0040011]; monoatomic cation transport [GO:0006812]; neuron remodeling [GO:0016322]; sodium ion transmembrane transport [GO:0035725] neuronal cell body [GO:0043025]; plasma membrane [GO:0005886] ligand-gated sodium channel activity [GO:0015280]; monoatomic cation channel activity [GO:0005261] g10234.t1 Q6X0I2 37.453 267 1.2700000000000001e-37 158.0 sp|Q6X0I2|VGR_SOLIN Vitellogenin receptor OS=Solenopsis invicta OX=13686 GN=VgR PE=2 SV=1 g10236.t1 D3Z8N4 40.86 558 3.2100000000000003e-133 405.0 sp|D3Z8N4|KLH20_RAT Kelch-like protein 20 OS=Rattus norvegicus OX=10116 GN=Klhl20 PE=3 SV=1 g10236.t1 D3Z8N4 34.884 172 1.11e-24 112.0 sp|D3Z8N4|KLH20_RAT Kelch-like protein 20 OS=Rattus norvegicus OX=10116 GN=Klhl20 PE=3 SV=1 g10237.t1 P49442 47.901 405 4.7600000000000004e-110 331.0 sp|P49442|INPP_MOUSE Inositol polyphosphate 1-phosphatase OS=Mus musculus OX=10090 GN=Inpp1 PE=1 SV=2 g10239.t1 Q8HZY8 35.441 601 6.0999999999999996e-89 291.0 sp|Q8HZY8|CC148_MACFA Coiled-coil domain-containing protein 148 OS=Macaca fascicularis OX=9541 GN=CCDC148 PE=2 SV=1 g10240.t1 Q9JLC8 29.768 2412 0.0 868.0 sp|Q9JLC8|SACS_MOUSE Sacsin OS=Mus musculus OX=10090 GN=Sacs PE=1 SV=2 g10240.t1 Q9JLC8 31.818 440 3.22e-42 176.0 sp|Q9JLC8|SACS_MOUSE Sacsin OS=Mus musculus OX=10090 GN=Sacs PE=1 SV=2 g10240.t1 Q9JLC8 24.617 914 1.81e-39 166.0 sp|Q9JLC8|SACS_MOUSE Sacsin OS=Mus musculus OX=10090 GN=Sacs PE=1 SV=2 g10243.t1 Q9JLC8 27.332 611 3.57e-38 155.0 sp|Q9JLC8|SACS_MOUSE Sacsin OS=Mus musculus OX=10090 GN=Sacs PE=1 SV=2 g10246.t1 P98158 43.125 160 1.3300000000000001e-21 99.0 sp|P98158|LRP2_RAT Low-density lipoprotein receptor-related protein 2 OS=Rattus norvegicus OX=10116 GN=Lrp2 PE=1 SV=1 g10247.t1 P98165 42.23 296 3.59e-39 154.0 sp|P98165|VLDLR_CHICK Very low-density lipoprotein receptor OS=Gallus gallus OX=9031 GN=VLDLR PE=1 SV=1 g10247.t1 P98165 37.151 358 6.59e-37 148.0 sp|P98165|VLDLR_CHICK Very low-density lipoprotein receptor OS=Gallus gallus OX=9031 GN=VLDLR PE=1 SV=1 g10248.t1 Q9NZR2 33.272 544 7.56e-60 233.0 sp|Q9NZR2|LRP1B_HUMAN Low-density lipoprotein receptor-related protein 1B OS=Homo sapiens OX=9606 GN=LRP1B PE=1 SV=2 LRP1B_HUMAN reviewed Low-density lipoprotein receptor-related protein 1B (LRP-1B) (Low-density lipoprotein receptor-related protein-deleted in tumor) (LRP-DIT) Homo sapiens (Human) GO:0005041; GO:0005509; GO:0005886; GO:0006898; GO:0015031; GO:0043235 protein transport [GO:0015031]; receptor-mediated endocytosis [GO:0006898] plasma membrane [GO:0005886]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; low-density lipoprotein particle receptor activity [GO:0005041] g10248.t1 Q9NZR2 34.722 504 7.840000000000001e-58 226.0 sp|Q9NZR2|LRP1B_HUMAN Low-density lipoprotein receptor-related protein 1B OS=Homo sapiens OX=9606 GN=LRP1B PE=1 SV=2 LRP1B_HUMAN reviewed Low-density lipoprotein receptor-related protein 1B (LRP-1B) (Low-density lipoprotein receptor-related protein-deleted in tumor) (LRP-DIT) Homo sapiens (Human) GO:0005041; GO:0005509; GO:0005886; GO:0006898; GO:0015031; GO:0043235 protein transport [GO:0015031]; receptor-mediated endocytosis [GO:0006898] plasma membrane [GO:0005886]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; low-density lipoprotein particle receptor activity [GO:0005041] g10248.t1 Q9NZR2 35.628 494 1.36e-56 222.0 sp|Q9NZR2|LRP1B_HUMAN Low-density lipoprotein receptor-related protein 1B OS=Homo sapiens OX=9606 GN=LRP1B PE=1 SV=2 LRP1B_HUMAN reviewed Low-density lipoprotein receptor-related protein 1B (LRP-1B) (Low-density lipoprotein receptor-related protein-deleted in tumor) (LRP-DIT) Homo sapiens (Human) GO:0005041; GO:0005509; GO:0005886; GO:0006898; GO:0015031; GO:0043235 protein transport [GO:0015031]; receptor-mediated endocytosis [GO:0006898] plasma membrane [GO:0005886]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; low-density lipoprotein particle receptor activity [GO:0005041] g10248.t1 Q9NZR2 32.967 546 4.8099999999999994e-54 214.0 sp|Q9NZR2|LRP1B_HUMAN Low-density lipoprotein receptor-related protein 1B OS=Homo sapiens OX=9606 GN=LRP1B PE=1 SV=2 LRP1B_HUMAN reviewed Low-density lipoprotein receptor-related protein 1B (LRP-1B) (Low-density lipoprotein receptor-related protein-deleted in tumor) (LRP-DIT) Homo sapiens (Human) GO:0005041; GO:0005509; GO:0005886; GO:0006898; GO:0015031; GO:0043235 protein transport [GO:0015031]; receptor-mediated endocytosis [GO:0006898] plasma membrane [GO:0005886]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; low-density lipoprotein particle receptor activity [GO:0005041] g10248.t1 Q9NZR2 35.06 502 7.51e-53 210.0 sp|Q9NZR2|LRP1B_HUMAN Low-density lipoprotein receptor-related protein 1B OS=Homo sapiens OX=9606 GN=LRP1B PE=1 SV=2 LRP1B_HUMAN reviewed Low-density lipoprotein receptor-related protein 1B (LRP-1B) (Low-density lipoprotein receptor-related protein-deleted in tumor) (LRP-DIT) Homo sapiens (Human) GO:0005041; GO:0005509; GO:0005886; GO:0006898; GO:0015031; GO:0043235 protein transport [GO:0015031]; receptor-mediated endocytosis [GO:0006898] plasma membrane [GO:0005886]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; low-density lipoprotein particle receptor activity [GO:0005041] g10248.t1 Q9NZR2 32.316 557 1.16e-51 206.0 sp|Q9NZR2|LRP1B_HUMAN Low-density lipoprotein receptor-related protein 1B OS=Homo sapiens OX=9606 GN=LRP1B PE=1 SV=2 LRP1B_HUMAN reviewed Low-density lipoprotein receptor-related protein 1B (LRP-1B) (Low-density lipoprotein receptor-related protein-deleted in tumor) (LRP-DIT) Homo sapiens (Human) GO:0005041; GO:0005509; GO:0005886; GO:0006898; GO:0015031; GO:0043235 protein transport [GO:0015031]; receptor-mediated endocytosis [GO:0006898] plasma membrane [GO:0005886]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; low-density lipoprotein particle receptor activity [GO:0005041] g10248.t1 Q9NZR2 37.135 377 1.06e-40 170.0 sp|Q9NZR2|LRP1B_HUMAN Low-density lipoprotein receptor-related protein 1B OS=Homo sapiens OX=9606 GN=LRP1B PE=1 SV=2 LRP1B_HUMAN reviewed Low-density lipoprotein receptor-related protein 1B (LRP-1B) (Low-density lipoprotein receptor-related protein-deleted in tumor) (LRP-DIT) Homo sapiens (Human) GO:0005041; GO:0005509; GO:0005886; GO:0006898; GO:0015031; GO:0043235 protein transport [GO:0015031]; receptor-mediated endocytosis [GO:0006898] plasma membrane [GO:0005886]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; low-density lipoprotein particle receptor activity [GO:0005041] g10248.t1 Q9NZR2 33.333 417 1.35e-38 163.0 sp|Q9NZR2|LRP1B_HUMAN Low-density lipoprotein receptor-related protein 1B OS=Homo sapiens OX=9606 GN=LRP1B PE=1 SV=2 LRP1B_HUMAN reviewed Low-density lipoprotein receptor-related protein 1B (LRP-1B) (Low-density lipoprotein receptor-related protein-deleted in tumor) (LRP-DIT) Homo sapiens (Human) GO:0005041; GO:0005509; GO:0005886; GO:0006898; GO:0015031; GO:0043235 protein transport [GO:0015031]; receptor-mediated endocytosis [GO:0006898] plasma membrane [GO:0005886]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; low-density lipoprotein particle receptor activity [GO:0005041] g10248.t1 Q9NZR2 34.048 420 5.159999999999999e-38 161.0 sp|Q9NZR2|LRP1B_HUMAN Low-density lipoprotein receptor-related protein 1B OS=Homo sapiens OX=9606 GN=LRP1B PE=1 SV=2 LRP1B_HUMAN reviewed Low-density lipoprotein receptor-related protein 1B (LRP-1B) (Low-density lipoprotein receptor-related protein-deleted in tumor) (LRP-DIT) Homo sapiens (Human) GO:0005041; GO:0005509; GO:0005886; GO:0006898; GO:0015031; GO:0043235 protein transport [GO:0015031]; receptor-mediated endocytosis [GO:0006898] plasma membrane [GO:0005886]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; low-density lipoprotein particle receptor activity [GO:0005041] g10248.t1 Q9NZR2 32.671 453 6.42e-38 160.0 sp|Q9NZR2|LRP1B_HUMAN Low-density lipoprotein receptor-related protein 1B OS=Homo sapiens OX=9606 GN=LRP1B PE=1 SV=2 LRP1B_HUMAN reviewed Low-density lipoprotein receptor-related protein 1B (LRP-1B) (Low-density lipoprotein receptor-related protein-deleted in tumor) (LRP-DIT) Homo sapiens (Human) GO:0005041; GO:0005509; GO:0005886; GO:0006898; GO:0015031; GO:0043235 protein transport [GO:0015031]; receptor-mediated endocytosis [GO:0006898] plasma membrane [GO:0005886]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; low-density lipoprotein particle receptor activity [GO:0005041] g10248.t1 Q9NZR2 34.307 411 5.44e-37 158.0 sp|Q9NZR2|LRP1B_HUMAN Low-density lipoprotein receptor-related protein 1B OS=Homo sapiens OX=9606 GN=LRP1B PE=1 SV=2 LRP1B_HUMAN reviewed Low-density lipoprotein receptor-related protein 1B (LRP-1B) (Low-density lipoprotein receptor-related protein-deleted in tumor) (LRP-DIT) Homo sapiens (Human) GO:0005041; GO:0005509; GO:0005886; GO:0006898; GO:0015031; GO:0043235 protein transport [GO:0015031]; receptor-mediated endocytosis [GO:0006898] plasma membrane [GO:0005886]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; low-density lipoprotein particle receptor activity [GO:0005041] g10248.t1 Q9NZR2 33.577 411 1.9900000000000002e-36 156.0 sp|Q9NZR2|LRP1B_HUMAN Low-density lipoprotein receptor-related protein 1B OS=Homo sapiens OX=9606 GN=LRP1B PE=1 SV=2 LRP1B_HUMAN reviewed Low-density lipoprotein receptor-related protein 1B (LRP-1B) (Low-density lipoprotein receptor-related protein-deleted in tumor) (LRP-DIT) Homo sapiens (Human) GO:0005041; GO:0005509; GO:0005886; GO:0006898; GO:0015031; GO:0043235 protein transport [GO:0015031]; receptor-mediated endocytosis [GO:0006898] plasma membrane [GO:0005886]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; low-density lipoprotein particle receptor activity [GO:0005041] g10248.t1 Q9NZR2 33.1 429 2.36e-34 149.0 sp|Q9NZR2|LRP1B_HUMAN Low-density lipoprotein receptor-related protein 1B OS=Homo sapiens OX=9606 GN=LRP1B PE=1 SV=2 LRP1B_HUMAN reviewed Low-density lipoprotein receptor-related protein 1B (LRP-1B) (Low-density lipoprotein receptor-related protein-deleted in tumor) (LRP-DIT) Homo sapiens (Human) GO:0005041; GO:0005509; GO:0005886; GO:0006898; GO:0015031; GO:0043235 protein transport [GO:0015031]; receptor-mediated endocytosis [GO:0006898] plasma membrane [GO:0005886]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; low-density lipoprotein particle receptor activity [GO:0005041] g10248.t1 Q9NZR2 28.324 519 1.6500000000000002e-31 140.0 sp|Q9NZR2|LRP1B_HUMAN Low-density lipoprotein receptor-related protein 1B OS=Homo sapiens OX=9606 GN=LRP1B PE=1 SV=2 LRP1B_HUMAN reviewed Low-density lipoprotein receptor-related protein 1B (LRP-1B) (Low-density lipoprotein receptor-related protein-deleted in tumor) (LRP-DIT) Homo sapiens (Human) GO:0005041; GO:0005509; GO:0005886; GO:0006898; GO:0015031; GO:0043235 protein transport [GO:0015031]; receptor-mediated endocytosis [GO:0006898] plasma membrane [GO:0005886]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; low-density lipoprotein particle receptor activity [GO:0005041] g10248.t1 Q9NZR2 30.435 460 1.67e-29 133.0 sp|Q9NZR2|LRP1B_HUMAN Low-density lipoprotein receptor-related protein 1B OS=Homo sapiens OX=9606 GN=LRP1B PE=1 SV=2 LRP1B_HUMAN reviewed Low-density lipoprotein receptor-related protein 1B (LRP-1B) (Low-density lipoprotein receptor-related protein-deleted in tumor) (LRP-DIT) Homo sapiens (Human) GO:0005041; GO:0005509; GO:0005886; GO:0006898; GO:0015031; GO:0043235 protein transport [GO:0015031]; receptor-mediated endocytosis [GO:0006898] plasma membrane [GO:0005886]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; low-density lipoprotein particle receptor activity [GO:0005041] g10248.t1 Q9NZR2 35.673 342 1.9600000000000002e-29 133.0 sp|Q9NZR2|LRP1B_HUMAN Low-density lipoprotein receptor-related protein 1B OS=Homo sapiens OX=9606 GN=LRP1B PE=1 SV=2 LRP1B_HUMAN reviewed Low-density lipoprotein receptor-related protein 1B (LRP-1B) (Low-density lipoprotein receptor-related protein-deleted in tumor) (LRP-DIT) Homo sapiens (Human) GO:0005041; GO:0005509; GO:0005886; GO:0006898; GO:0015031; GO:0043235 protein transport [GO:0015031]; receptor-mediated endocytosis [GO:0006898] plasma membrane [GO:0005886]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; low-density lipoprotein particle receptor activity [GO:0005041] g10248.t1 Q9NZR2 29.209 493 7.21e-29 131.0 sp|Q9NZR2|LRP1B_HUMAN Low-density lipoprotein receptor-related protein 1B OS=Homo sapiens OX=9606 GN=LRP1B PE=1 SV=2 LRP1B_HUMAN reviewed Low-density lipoprotein receptor-related protein 1B (LRP-1B) (Low-density lipoprotein receptor-related protein-deleted in tumor) (LRP-DIT) Homo sapiens (Human) GO:0005041; GO:0005509; GO:0005886; GO:0006898; GO:0015031; GO:0043235 protein transport [GO:0015031]; receptor-mediated endocytosis [GO:0006898] plasma membrane [GO:0005886]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; low-density lipoprotein particle receptor activity [GO:0005041] g10248.t1 Q9NZR2 34.167 360 1.58e-28 130.0 sp|Q9NZR2|LRP1B_HUMAN Low-density lipoprotein receptor-related protein 1B OS=Homo sapiens OX=9606 GN=LRP1B PE=1 SV=2 LRP1B_HUMAN reviewed Low-density lipoprotein receptor-related protein 1B (LRP-1B) (Low-density lipoprotein receptor-related protein-deleted in tumor) (LRP-DIT) Homo sapiens (Human) GO:0005041; GO:0005509; GO:0005886; GO:0006898; GO:0015031; GO:0043235 protein transport [GO:0015031]; receptor-mediated endocytosis [GO:0006898] plasma membrane [GO:0005886]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; low-density lipoprotein particle receptor activity [GO:0005041] g10248.t1 Q9NZR2 34.356 326 9.93e-28 127.0 sp|Q9NZR2|LRP1B_HUMAN Low-density lipoprotein receptor-related protein 1B OS=Homo sapiens OX=9606 GN=LRP1B PE=1 SV=2 LRP1B_HUMAN reviewed Low-density lipoprotein receptor-related protein 1B (LRP-1B) (Low-density lipoprotein receptor-related protein-deleted in tumor) (LRP-DIT) Homo sapiens (Human) GO:0005041; GO:0005509; GO:0005886; GO:0006898; GO:0015031; GO:0043235 protein transport [GO:0015031]; receptor-mediated endocytosis [GO:0006898] plasma membrane [GO:0005886]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; low-density lipoprotein particle receptor activity [GO:0005041] g10248.t1 Q9NZR2 31.268 339 1.2600000000000001e-27 127.0 sp|Q9NZR2|LRP1B_HUMAN Low-density lipoprotein receptor-related protein 1B OS=Homo sapiens OX=9606 GN=LRP1B PE=1 SV=2 LRP1B_HUMAN reviewed Low-density lipoprotein receptor-related protein 1B (LRP-1B) (Low-density lipoprotein receptor-related protein-deleted in tumor) (LRP-DIT) Homo sapiens (Human) GO:0005041; GO:0005509; GO:0005886; GO:0006898; GO:0015031; GO:0043235 protein transport [GO:0015031]; receptor-mediated endocytosis [GO:0006898] plasma membrane [GO:0005886]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; low-density lipoprotein particle receptor activity [GO:0005041] g10248.t1 Q9NZR2 34.154 325 1.31e-25 120.0 sp|Q9NZR2|LRP1B_HUMAN Low-density lipoprotein receptor-related protein 1B OS=Homo sapiens OX=9606 GN=LRP1B PE=1 SV=2 LRP1B_HUMAN reviewed Low-density lipoprotein receptor-related protein 1B (LRP-1B) (Low-density lipoprotein receptor-related protein-deleted in tumor) (LRP-DIT) Homo sapiens (Human) GO:0005041; GO:0005509; GO:0005886; GO:0006898; GO:0015031; GO:0043235 protein transport [GO:0015031]; receptor-mediated endocytosis [GO:0006898] plasma membrane [GO:0005886]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; low-density lipoprotein particle receptor activity [GO:0005041] g10248.t1 Q9NZR2 36.641 262 1.6e-25 120.0 sp|Q9NZR2|LRP1B_HUMAN Low-density lipoprotein receptor-related protein 1B OS=Homo sapiens OX=9606 GN=LRP1B PE=1 SV=2 LRP1B_HUMAN reviewed Low-density lipoprotein receptor-related protein 1B (LRP-1B) (Low-density lipoprotein receptor-related protein-deleted in tumor) (LRP-DIT) Homo sapiens (Human) GO:0005041; GO:0005509; GO:0005886; GO:0006898; GO:0015031; GO:0043235 protein transport [GO:0015031]; receptor-mediated endocytosis [GO:0006898] plasma membrane [GO:0005886]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; low-density lipoprotein particle receptor activity [GO:0005041] g10248.t1 Q9NZR2 31.62 389 5.8999999999999995e-24 115.0 sp|Q9NZR2|LRP1B_HUMAN Low-density lipoprotein receptor-related protein 1B OS=Homo sapiens OX=9606 GN=LRP1B PE=1 SV=2 LRP1B_HUMAN reviewed Low-density lipoprotein receptor-related protein 1B (LRP-1B) (Low-density lipoprotein receptor-related protein-deleted in tumor) (LRP-DIT) Homo sapiens (Human) GO:0005041; GO:0005509; GO:0005886; GO:0006898; GO:0015031; GO:0043235 protein transport [GO:0015031]; receptor-mediated endocytosis [GO:0006898] plasma membrane [GO:0005886]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; low-density lipoprotein particle receptor activity [GO:0005041] g10248.t1 Q9NZR2 34.049 326 2.0499999999999999e-23 113.0 sp|Q9NZR2|LRP1B_HUMAN Low-density lipoprotein receptor-related protein 1B OS=Homo sapiens OX=9606 GN=LRP1B PE=1 SV=2 LRP1B_HUMAN reviewed Low-density lipoprotein receptor-related protein 1B (LRP-1B) (Low-density lipoprotein receptor-related protein-deleted in tumor) (LRP-DIT) Homo sapiens (Human) GO:0005041; GO:0005509; GO:0005886; GO:0006898; GO:0015031; GO:0043235 protein transport [GO:0015031]; receptor-mediated endocytosis [GO:0006898] plasma membrane [GO:0005886]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; low-density lipoprotein particle receptor activity [GO:0005041] g10248.t1 Q9NZR2 33.951 324 5.1999999999999994e-23 112.0 sp|Q9NZR2|LRP1B_HUMAN Low-density lipoprotein receptor-related protein 1B OS=Homo sapiens OX=9606 GN=LRP1B PE=1 SV=2 LRP1B_HUMAN reviewed Low-density lipoprotein receptor-related protein 1B (LRP-1B) (Low-density lipoprotein receptor-related protein-deleted in tumor) (LRP-DIT) Homo sapiens (Human) GO:0005041; GO:0005509; GO:0005886; GO:0006898; GO:0015031; GO:0043235 protein transport [GO:0015031]; receptor-mediated endocytosis [GO:0006898] plasma membrane [GO:0005886]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; low-density lipoprotein particle receptor activity [GO:0005041] g10248.t1 Q9NZR2 32.857 350 6.69e-22 108.0 sp|Q9NZR2|LRP1B_HUMAN Low-density lipoprotein receptor-related protein 1B OS=Homo sapiens OX=9606 GN=LRP1B PE=1 SV=2 LRP1B_HUMAN reviewed Low-density lipoprotein receptor-related protein 1B (LRP-1B) (Low-density lipoprotein receptor-related protein-deleted in tumor) (LRP-DIT) Homo sapiens (Human) GO:0005041; GO:0005509; GO:0005886; GO:0006898; GO:0015031; GO:0043235 protein transport [GO:0015031]; receptor-mediated endocytosis [GO:0006898] plasma membrane [GO:0005886]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; low-density lipoprotein particle receptor activity [GO:0005041] g10248.t1 Q9NZR2 33.591 259 1.4500000000000002e-21 107.0 sp|Q9NZR2|LRP1B_HUMAN Low-density lipoprotein receptor-related protein 1B OS=Homo sapiens OX=9606 GN=LRP1B PE=1 SV=2 LRP1B_HUMAN reviewed Low-density lipoprotein receptor-related protein 1B (LRP-1B) (Low-density lipoprotein receptor-related protein-deleted in tumor) (LRP-DIT) Homo sapiens (Human) GO:0005041; GO:0005509; GO:0005886; GO:0006898; GO:0015031; GO:0043235 protein transport [GO:0015031]; receptor-mediated endocytosis [GO:0006898] plasma membrane [GO:0005886]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; low-density lipoprotein particle receptor activity [GO:0005041] g10248.t1 Q9NZR2 33.333 294 6.15e-21 105.0 sp|Q9NZR2|LRP1B_HUMAN Low-density lipoprotein receptor-related protein 1B OS=Homo sapiens OX=9606 GN=LRP1B PE=1 SV=2 LRP1B_HUMAN reviewed Low-density lipoprotein receptor-related protein 1B (LRP-1B) (Low-density lipoprotein receptor-related protein-deleted in tumor) (LRP-DIT) Homo sapiens (Human) GO:0005041; GO:0005509; GO:0005886; GO:0006898; GO:0015031; GO:0043235 protein transport [GO:0015031]; receptor-mediated endocytosis [GO:0006898] plasma membrane [GO:0005886]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; low-density lipoprotein particle receptor activity [GO:0005041] g10249.t1 Q5R5M8 55.02 249 4.54e-90 284.0 sp|Q5R5M8|ECHP_PONAB Peroxisomal bifunctional enzyme OS=Pongo abelii OX=9601 GN=EHHADH PE=2 SV=1 ECHP_PONAB reviewed Peroxisomal bifunctional enzyme (PBE) (PBFE) (Multifunctional enzyme 1) (MFE1) [Includes: Enoyl-CoA hydratase/3,2-trans-enoyl-CoA isomerase (EC 4.2.1.17) (EC 5.3.3.8); 3-hydroxyacyl-CoA dehydrogenase (EC 1.1.1.35)] Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0003857; GO:0004165; GO:0004300; GO:0005777; GO:0006635; GO:0016509; GO:0016863; GO:0018812; GO:0070403 fatty acid beta-oxidation [GO:0006635] peroxisome [GO:0005777] (3S)-3-hydroxyacyl-CoA dehydrogenase (NAD+) activity [GO:0003857]; 3-hydroxyacyl-CoA dehydratase activity [GO:0018812]; delta(3)-delta(2)-enoyl-CoA isomerase activity [GO:0004165]; enoyl-CoA hydratase activity [GO:0004300]; intramolecular oxidoreductase activity, transposing C=C bonds [GO:0016863]; long-chain (3S)-3-hydroxyacyl-CoA dehydrogenase (NAD+) activity [GO:0016509]; NAD+ binding [GO:0070403] g10250.t1 Q6NYL3 43.548 434 4.48e-84 275.0 sp|Q6NYL3|ECHP_DANRE Peroxisomal bifunctional enzyme OS=Danio rerio OX=7955 GN=ehhadh PE=2 SV=1 ECHP_DANRE reviewed Peroxisomal bifunctional enzyme (PBE) (PBFE) (Multifunctional enzyme 1) (MFE1) [Includes: Enoyl-CoA hydratase/3,2-trans-enoyl-CoA isomerase (EC 4.2.1.17) (EC 5.3.3.8); 3-hydroxyacyl-CoA dehydrogenase (EC 1.1.1.35)] Danio rerio (Zebrafish) (Brachydanio rerio) GO:0003857; GO:0004165; GO:0004300; GO:0005777; GO:0006635; GO:0016509; GO:0016863; GO:0018812; GO:0070403 fatty acid beta-oxidation [GO:0006635] peroxisome [GO:0005777] (3S)-3-hydroxyacyl-CoA dehydrogenase (NAD+) activity [GO:0003857]; 3-hydroxyacyl-CoA dehydratase activity [GO:0018812]; delta(3)-delta(2)-enoyl-CoA isomerase activity [GO:0004165]; enoyl-CoA hydratase activity [GO:0004300]; intramolecular oxidoreductase activity, transposing C=C bonds [GO:0016863]; long-chain (3S)-3-hydroxyacyl-CoA dehydrogenase (NAD+) activity [GO:0016509]; NAD+ binding [GO:0070403] g10251.t1 O54749 40.204 490 7.18e-114 348.0 sp|O54749|CP2J5_MOUSE Cytochrome P450 2J5 OS=Mus musculus OX=10090 GN=Cyp2j5 PE=1 SV=1 g10254.t1 Q8R205 38.062 289 3.7e-50 177.0 sp|Q8R205|ZC3HA_MOUSE Zinc finger CCCH domain-containing protein 10 OS=Mus musculus OX=10090 GN=Zc3h10 PE=1 SV=1 g10257.t1 Q98989 27.664 441 8.91e-29 125.0 sp|Q98989|STXA_SYNHO Stonustoxin subunit alpha OS=Synanceia horrida OX=13279 PE=1 SV=3 g10258.t1 Q98989 27.964 447 3.39e-32 135.0 sp|Q98989|STXA_SYNHO Stonustoxin subunit alpha OS=Synanceia horrida OX=13279 PE=1 SV=3 g10259.t1 Q91453 33.203 256 2.59e-26 111.0 sp|Q91453|STXB_SYNHO Stonustoxin subunit beta OS=Synanceia horrida OX=13279 PE=1 SV=3 STXB_SYNHO reviewed Stonustoxin subunit beta (SNTX subunit beta) (DELTA-synanceitoxin-Sh1b) (DELTA-SYTX-Sh1b) (Trachynilysin subunit beta) (TLY subunit beta) Synanceia horrida (Estuarine stonefish) (Scorpaena horrida) GO:0005576; GO:0015459; GO:0031640; GO:0090729 killing of cells of another organism [GO:0031640] extracellular region [GO:0005576] potassium channel regulator activity [GO:0015459]; toxin activity [GO:0090729] g10260.t1 Q99715 41.753 194 7.34e-36 147.0 sp|Q99715|COCA1_HUMAN Collagen alpha-1(XII) chain OS=Homo sapiens OX=9606 GN=COL12A1 PE=1 SV=2 COCA1_HUMAN reviewed Collagen alpha-1(XII) chain Homo sapiens (Human) GO:0005576; GO:0005595; GO:0005615; GO:0005788; GO:0007155; GO:0030020; GO:0030199; GO:0031012; GO:0035987; GO:0070062; GO:1903561 cell adhesion [GO:0007155]; collagen fibril organization [GO:0030199]; endodermal cell differentiation [GO:0035987] collagen type XII trimer [GO:0005595]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular vesicle [GO:1903561] extracellular matrix structural constituent conferring tensile strength [GO:0030020] g10260.t1 Q99715 34.946 186 5.5700000000000006e-27 120.0 sp|Q99715|COCA1_HUMAN Collagen alpha-1(XII) chain OS=Homo sapiens OX=9606 GN=COL12A1 PE=1 SV=2 COCA1_HUMAN reviewed Collagen alpha-1(XII) chain Homo sapiens (Human) GO:0005576; GO:0005595; GO:0005615; GO:0005788; GO:0007155; GO:0030020; GO:0030199; GO:0031012; GO:0035987; GO:0070062; GO:1903561 cell adhesion [GO:0007155]; collagen fibril organization [GO:0030199]; endodermal cell differentiation [GO:0035987] collagen type XII trimer [GO:0005595]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular vesicle [GO:1903561] extracellular matrix structural constituent conferring tensile strength [GO:0030020] g10260.t1 Q99715 35.714 182 2.5e-26 118.0 sp|Q99715|COCA1_HUMAN Collagen alpha-1(XII) chain OS=Homo sapiens OX=9606 GN=COL12A1 PE=1 SV=2 COCA1_HUMAN reviewed Collagen alpha-1(XII) chain Homo sapiens (Human) GO:0005576; GO:0005595; GO:0005615; GO:0005788; GO:0007155; GO:0030020; GO:0030199; GO:0031012; GO:0035987; GO:0070062; GO:1903561 cell adhesion [GO:0007155]; collagen fibril organization [GO:0030199]; endodermal cell differentiation [GO:0035987] collagen type XII trimer [GO:0005595]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular vesicle [GO:1903561] extracellular matrix structural constituent conferring tensile strength [GO:0030020] g10260.t1 Q99715 32.8 250 2.46e-22 105.0 sp|Q99715|COCA1_HUMAN Collagen alpha-1(XII) chain OS=Homo sapiens OX=9606 GN=COL12A1 PE=1 SV=2 COCA1_HUMAN reviewed Collagen alpha-1(XII) chain Homo sapiens (Human) GO:0005576; GO:0005595; GO:0005615; GO:0005788; GO:0007155; GO:0030020; GO:0030199; GO:0031012; GO:0035987; GO:0070062; GO:1903561 cell adhesion [GO:0007155]; collagen fibril organization [GO:0030199]; endodermal cell differentiation [GO:0035987] collagen type XII trimer [GO:0005595]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular vesicle [GO:1903561] extracellular matrix structural constituent conferring tensile strength [GO:0030020] g10261.t1 O35701 36.975 238 3.7200000000000004e-35 141.0 sp|O35701|MATN3_MOUSE Matrilin-3 OS=Mus musculus OX=10090 GN=Matn3 PE=1 SV=2 MATN3_MOUSE reviewed Matrilin-3 Mus musculus (Mouse) GO:0005509; GO:0005576; GO:0030198; GO:0031012; GO:0051216; GO:0120216 cartilage development [GO:0051216]; extracellular matrix organization [GO:0030198] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; matrilin complex [GO:0120216] calcium ion binding [GO:0005509] g10262.t1 Q21281 40.254 236 2.25e-36 152.0 sp|Q21281|MUP4_CAEEL Transmembrane matrix receptor MUP-4 OS=Caenorhabditis elegans OX=6239 GN=mup-4 PE=1 SV=4 MUP4_CAEEL reviewed Transmembrane matrix receptor MUP-4 (Muscle-positioning protein 4) Caenorhabditis elegans GO:0005201; GO:0005509; GO:0005576; GO:0005856; GO:0005886; GO:0007155; GO:0030056; GO:0098733 cell adhesion [GO:0007155] cytoskeleton [GO:0005856]; extracellular region [GO:0005576]; hemidesmosome [GO:0030056]; hemidesmosome associated protein complex [GO:0098733]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201] g10264.t1 Q99715 42.268 194 1.28e-36 150.0 sp|Q99715|COCA1_HUMAN Collagen alpha-1(XII) chain OS=Homo sapiens OX=9606 GN=COL12A1 PE=1 SV=2 COCA1_HUMAN reviewed Collagen alpha-1(XII) chain Homo sapiens (Human) GO:0005576; GO:0005595; GO:0005615; GO:0005788; GO:0007155; GO:0030020; GO:0030199; GO:0031012; GO:0035987; GO:0070062; GO:1903561 cell adhesion [GO:0007155]; collagen fibril organization [GO:0030199]; endodermal cell differentiation [GO:0035987] collagen type XII trimer [GO:0005595]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular vesicle [GO:1903561] extracellular matrix structural constituent conferring tensile strength [GO:0030020] g10264.t1 Q99715 34.426 183 8.200000000000001e-27 120.0 sp|Q99715|COCA1_HUMAN Collagen alpha-1(XII) chain OS=Homo sapiens OX=9606 GN=COL12A1 PE=1 SV=2 COCA1_HUMAN reviewed Collagen alpha-1(XII) chain Homo sapiens (Human) GO:0005576; GO:0005595; GO:0005615; GO:0005788; GO:0007155; GO:0030020; GO:0030199; GO:0031012; GO:0035987; GO:0070062; GO:1903561 cell adhesion [GO:0007155]; collagen fibril organization [GO:0030199]; endodermal cell differentiation [GO:0035987] collagen type XII trimer [GO:0005595]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular vesicle [GO:1903561] extracellular matrix structural constituent conferring tensile strength [GO:0030020] g10264.t1 Q99715 34.615 182 4.3400000000000003e-26 117.0 sp|Q99715|COCA1_HUMAN Collagen alpha-1(XII) chain OS=Homo sapiens OX=9606 GN=COL12A1 PE=1 SV=2 COCA1_HUMAN reviewed Collagen alpha-1(XII) chain Homo sapiens (Human) GO:0005576; GO:0005595; GO:0005615; GO:0005788; GO:0007155; GO:0030020; GO:0030199; GO:0031012; GO:0035987; GO:0070062; GO:1903561 cell adhesion [GO:0007155]; collagen fibril organization [GO:0030199]; endodermal cell differentiation [GO:0035987] collagen type XII trimer [GO:0005595]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular vesicle [GO:1903561] extracellular matrix structural constituent conferring tensile strength [GO:0030020] g10265.t1 Q21281 38.559 236 2.3000000000000003e-31 133.0 sp|Q21281|MUP4_CAEEL Transmembrane matrix receptor MUP-4 OS=Caenorhabditis elegans OX=6239 GN=mup-4 PE=1 SV=4 MUP4_CAEEL reviewed Transmembrane matrix receptor MUP-4 (Muscle-positioning protein 4) Caenorhabditis elegans GO:0005201; GO:0005509; GO:0005576; GO:0005856; GO:0005886; GO:0007155; GO:0030056; GO:0098733 cell adhesion [GO:0007155] cytoskeleton [GO:0005856]; extracellular region [GO:0005576]; hemidesmosome [GO:0030056]; hemidesmosome associated protein complex [GO:0098733]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201] g10266.t1 Q96PC2 35.013 397 2.1500000000000003e-73 236.0 sp|Q96PC2|IP6K3_HUMAN Inositol hexakisphosphate kinase 3 OS=Homo sapiens OX=9606 GN=IP6K3 PE=1 SV=2 IP6K3_HUMAN reviewed Inositol hexakisphosphate kinase 3 (InsP6 kinase 3) (EC 2.7.4.21) (Inositol hexaphosphate kinase 3) Homo sapiens (Human) GO:0000827; GO:0000828; GO:0000829; GO:0000831; GO:0000832; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006468; GO:0032958; GO:0040011; GO:0043647; GO:0046488; GO:0046854; GO:0052836; GO:0052839 inositol phosphate biosynthetic process [GO:0032958]; inositol phosphate metabolic process [GO:0043647]; locomotion [GO:0040011]; phosphatidylinositol metabolic process [GO:0046488]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; protein phosphorylation [GO:0006468] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634] ATP binding [GO:0005524]; diphosphoinositol pentakisphosphate kinase activity [GO:0000829]; diphosphoinositol tetrakisphosphate kinase activity [GO:0052839]; inositol 5-diphosphate pentakisphosphate 5-kinase activity [GO:0052836]; inositol hexakisphosphate 5-kinase activity [GO:0000832]; inositol hexakisphosphate 6-kinase activity [GO:0000831]; inositol hexakisphosphate kinase activity [GO:0000828]; inositol-1,3,4,5,6-pentakisphosphate kinase activity [GO:0000827] g10268.t1 F1QVR8 69.712 208 1.27e-105 312.0 sp|F1QVR8|METL5_DANRE rRNA N(6)-adenosine-methyltransferase METTL5 OS=Danio rerio OX=7955 GN=mettl5 PE=2 SV=1 g10269.t1 A0A0R4IXF6 65.39 783 0.0 1009.0 sp|A0A0R4IXF6|KAT2A_DANRE Histone acetyltransferase KAT2A OS=Danio rerio OX=7955 GN=kat2a PE=2 SV=1 KAT2A_DANRE reviewed Histone acetyltransferase KAT2A (EC 2.3.1.48) (Histone glutaryltransferase KAT2A) (EC 2.3.1.-) (Histone succinyltransferase KAT2A) (EC 2.3.1.-) (Lysine acetyltransferase 2A) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000123; GO:0001819; GO:0003682; GO:0003713; GO:0004402; GO:0005634; GO:0005813; GO:0006338; GO:0007507; GO:0007616; GO:0010484; GO:0018393; GO:0040029; GO:0043992; GO:0045589; GO:0045893; GO:0045944; GO:0048167; GO:0050863; GO:0060173; GO:0060349; GO:0061035; GO:0061733; GO:0106078; GO:0106227; GO:0106229; GO:0140187; GO:0140672; GO:1903010 bone morphogenesis [GO:0060349]; chromatin remodeling [GO:0006338]; epigenetic regulation of gene expression [GO:0040029]; heart development [GO:0007507]; internal peptidyl-lysine acetylation [GO:0018393]; limb development [GO:0060173]; long-term memory [GO:0007616]; peptidyl-lysine glutarylation [GO:0106227]; positive regulation of cytokine production [GO:0001819]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of bone development [GO:1903010]; regulation of cartilage development [GO:0061035]; regulation of regulatory T cell differentiation [GO:0045589]; regulation of synaptic plasticity [GO:0048167]; regulation of T cell activation [GO:0050863] ATAC complex [GO:0140672]; centrosome [GO:0005813]; histone acetyltransferase complex [GO:0000123]; nucleus [GO:0005634] chromatin binding [GO:0003682]; histone acetyltransferase activity [GO:0004402]; histone glutaryltransferase activity [GO:0106229]; histone H1-4K34 acetyltransferase activity [GO:0140187]; histone H3 acetyltransferase activity [GO:0010484]; histone H3K9 acetyltransferase activity [GO:0043992]; histone succinyltransferase activity [GO:0106078]; protein-lysine-acetyltransferase activity [GO:0061733]; transcription coactivator activity [GO:0003713] g10270.t1 Q5ZI03 46.734 199 1.1900000000000001e-56 197.0 sp|Q5ZI03|CIR1_CHICK Corepressor interacting with RBPJ 1 OS=Gallus gallus OX=9031 GN=CIR1 PE=2 SV=1 g10272.t1 O42596 33.017 633 3.77e-77 280.0 sp|O42596|ADA22_XENLA Disintegrin and metalloproteinase domain-containing protein 22 OS=Xenopus laevis OX=8355 GN=adam22 PE=2 SV=2 g10273.t1 P25107 46.97 132 1.52e-28 118.0 sp|P25107|PTH1R_DIDVI Parathyroid hormone/parathyroid hormone-related peptide receptor OS=Didelphis virginiana OX=9267 GN=PTH1R PE=2 SV=2 g10273.t2 Q91085 38.25 400 4.52e-78 257.0 sp|Q91085|VIPR_MELGA Vasoactive intestinal polypeptide receptor OS=Meleagris gallopavo OX=9103 GN=VIPR1 PE=2 SV=2 VIPR_MELGA reviewed Vasoactive intestinal polypeptide receptor (VIP receptor) (VIP-R) Meleagris gallopavo (Wild turkey) GO:0004999; GO:0005886; GO:0007166; GO:0007188; GO:0008528; GO:0017046 adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; cell surface receptor signaling pathway [GO:0007166] plasma membrane [GO:0005886] G protein-coupled peptide receptor activity [GO:0008528]; peptide hormone binding [GO:0017046]; vasoactive intestinal polypeptide receptor activity [GO:0004999] g10277.t1 Q0VA42 55.028 358 4.0499999999999996e-140 430.0 sp|Q0VA42|MINY4_XENTR Probable ubiquitin carboxyl-terminal hydrolase MINDY-4 OS=Xenopus tropicalis OX=8364 GN=mindy4 PE=2 SV=1 g10280.t1 Q8C172 48.495 299 1.1399999999999999e-95 293.0 sp|Q8C172|CERS6_MOUSE Ceramide synthase 6 OS=Mus musculus OX=10090 GN=Cers6 PE=1 SV=1 CERS6_MOUSE reviewed Ceramide synthase 6 (CerS6) (EC 2.3.1.-) (LAG1 longevity assurance homolog 6) (Sphingoid base N-palmitoyltransferase CERS6) (EC 2.3.1.291) Mus musculus (Mouse) GO:0003677; GO:0005783; GO:0005789; GO:0006954; GO:0030148; GO:0046513; GO:0050291; GO:1900143 ceramide biosynthetic process [GO:0046513]; inflammatory response [GO:0006954]; positive regulation of oligodendrocyte apoptotic process [GO:1900143]; sphingolipid biosynthetic process [GO:0030148] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789] DNA binding [GO:0003677]; sphingosine N-acyltransferase activity [GO:0050291] g10281.t1 P61354 75.735 136 1.05e-72 216.0 sp|P61354|RL27_RAT Large ribosomal subunit protein eL27 OS=Rattus norvegicus OX=10116 GN=Rpl27 PE=2 SV=2 g10282.t1 Q7T3H1 40.928 237 6.33e-53 179.0 sp|Q7T3H1|DCTN2_DANRE Dynactin subunit 2 OS=Danio rerio OX=7955 GN=dctn2 PE=2 SV=1 DCTN2_DANRE reviewed Dynactin subunit 2 Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001754; GO:0005737; GO:0005813; GO:0005869; GO:0005874; GO:0007052; GO:0007097; GO:0010001; GO:0016020; GO:0030286; GO:0030719; GO:0031982; GO:0035088; GO:0045494; GO:0060117 auditory receptor cell development [GO:0060117]; establishment or maintenance of apical/basal cell polarity [GO:0035088]; eye photoreceptor cell differentiation [GO:0001754]; glial cell differentiation [GO:0010001]; mitotic spindle organization [GO:0007052]; nuclear migration [GO:0007097]; P granule organization [GO:0030719]; photoreceptor cell maintenance [GO:0045494] centrosome [GO:0005813]; cytoplasm [GO:0005737]; dynactin complex [GO:0005869]; dynein complex [GO:0030286]; membrane [GO:0016020]; microtubule [GO:0005874]; vesicle [GO:0031982] g10282.t2 Q7T3H1 39.024 246 1.88e-52 178.0 sp|Q7T3H1|DCTN2_DANRE Dynactin subunit 2 OS=Danio rerio OX=7955 GN=dctn2 PE=2 SV=1 DCTN2_DANRE reviewed Dynactin subunit 2 Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001754; GO:0005737; GO:0005813; GO:0005869; GO:0005874; GO:0007052; GO:0007097; GO:0010001; GO:0016020; GO:0030286; GO:0030719; GO:0031982; GO:0035088; GO:0045494; GO:0060117 auditory receptor cell development [GO:0060117]; establishment or maintenance of apical/basal cell polarity [GO:0035088]; eye photoreceptor cell differentiation [GO:0001754]; glial cell differentiation [GO:0010001]; mitotic spindle organization [GO:0007052]; nuclear migration [GO:0007097]; P granule organization [GO:0030719]; photoreceptor cell maintenance [GO:0045494] centrosome [GO:0005813]; cytoplasm [GO:0005737]; dynactin complex [GO:0005869]; dynein complex [GO:0030286]; membrane [GO:0016020]; microtubule [GO:0005874]; vesicle [GO:0031982] g10283.t1 Q7T3H1 58.095 105 2.3000000000000003e-31 118.0 sp|Q7T3H1|DCTN2_DANRE Dynactin subunit 2 OS=Danio rerio OX=7955 GN=dctn2 PE=2 SV=1 DCTN2_DANRE reviewed Dynactin subunit 2 Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001754; GO:0005737; GO:0005813; GO:0005869; GO:0005874; GO:0007052; GO:0007097; GO:0010001; GO:0016020; GO:0030286; GO:0030719; GO:0031982; GO:0035088; GO:0045494; GO:0060117 auditory receptor cell development [GO:0060117]; establishment or maintenance of apical/basal cell polarity [GO:0035088]; eye photoreceptor cell differentiation [GO:0001754]; glial cell differentiation [GO:0010001]; mitotic spindle organization [GO:0007052]; nuclear migration [GO:0007097]; P granule organization [GO:0030719]; photoreceptor cell maintenance [GO:0045494] centrosome [GO:0005813]; cytoplasm [GO:0005737]; dynactin complex [GO:0005869]; dynein complex [GO:0030286]; membrane [GO:0016020]; microtubule [GO:0005874]; vesicle [GO:0031982] g10284.t1 P35978 71.23 935 0.0 1242.0 sp|P35978|KINH_STRPU Kinesin heavy chain OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g10285.t1 P58557 41.104 163 7.900000000000001e-44 145.0 sp|P58557|YBEY_HUMAN Endoribonuclease YbeY OS=Homo sapiens OX=9606 GN=YBEY PE=1 SV=2 g10286.t1 Q1MTN8 29.53 298 9.139999999999999e-30 120.0 sp|Q1MTN8|ACL4_SCHPO Probable assembly chaperone of rpl4 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) OX=284812 GN=SPBC16D10.01c PE=3 SV=2 g10287.t1 P57760 43.345 293 6.94e-84 259.0 sp|P57760|STK16_RAT Serine/threonine-protein kinase 16 OS=Rattus norvegicus OX=10116 GN=Stk16 PE=2 SV=2 g10288.t1 Q805E5 33.448 290 1.74e-37 139.0 sp|Q805E5|CHSTE_DANRE Carbohydrate sulfotransferase 14 OS=Danio rerio OX=7955 GN=chst14 PE=2 SV=1 CHSTE_DANRE reviewed Carbohydrate sulfotransferase 14 (EC 2.8.2.-) (Dermatan 4-sulfotransferase 1) (D4ST-1) (zD4ST-1) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000139; GO:0001537; GO:0008146; GO:0016051; GO:0050655 carbohydrate biosynthetic process [GO:0016051]; dermatan sulfate proteoglycan metabolic process [GO:0050655] Golgi membrane [GO:0000139] dermatan 4-sulfotransferase activity [GO:0001537]; sulfotransferase activity [GO:0008146] g10290.t1 Q7K237 56.902 297 3.7200000000000002e-121 360.0 sp|Q7K237|C1GLT_DROME Glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase 1 OS=Drosophila melanogaster OX=7227 GN=C1GalTA PE=1 SV=1 C1GLT_DROME reviewed Glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase 1 (EC 2.4.1.122) (Core 1 O-glycan T-synthase) (Core 1 UDP-galactose:N-acetylgalactosamine-alpha-R beta 1,3-galactosyltransferase 1) (Core 1 beta1,3-galactosyltransferase 1) (C1GalT1) (Core 1 beta3-Gal-T1) Drosophila melanogaster (Fruit fly) GO:0000139; GO:0000166; GO:0007528; GO:0009247; GO:0016020; GO:0016263; GO:0016266; GO:0021551; GO:0030145; GO:0042803; GO:0048531; GO:0051489; GO:0055001; GO:1902037 central nervous system morphogenesis [GO:0021551]; glycolipid biosynthetic process [GO:0009247]; muscle cell development [GO:0055001]; negative regulation of hematopoietic stem cell differentiation [GO:1902037]; neuromuscular junction development [GO:0007528]; protein O-linked glycosylation via N-acetyl-galactosamine [GO:0016266]; regulation of filopodium assembly [GO:0051489] Golgi membrane [GO:0000139]; membrane [GO:0016020] beta-1,3-galactosyltransferase activity [GO:0048531]; glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase activity [GO:0016263]; manganese ion binding [GO:0030145]; nucleotide binding [GO:0000166]; protein homodimerization activity [GO:0042803] g10291.t1 Q18515 34.272 213 1.89e-36 136.0 sp|Q18515|C1GLT_CAEEL Glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase 1 OS=Caenorhabditis elegans OX=6239 GN=C38H2.2 PE=1 SV=2 C1GLT_CAEEL reviewed Glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase 1 (EC 2.4.1.122) (Core 1 O-glycan T-synthase) (Ce-T-synthase) (Core 1 UDP-galactose:N-acetylgalactosamine-alpha-R beta 1,3-galactosyltransferase 1) (Core 1 beta1,3-galactosyltransferase 1) (C1GalT1) (Core 1 beta3-Gal-T1) Caenorhabditis elegans GO:0000166; GO:0016020; GO:0016263; GO:0030145 membrane [GO:0016020] glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase activity [GO:0016263]; manganese ion binding [GO:0030145]; nucleotide binding [GO:0000166] g10292.t1 Q9DAP0 48.077 156 1.32e-25 108.0 sp|Q9DAP0|LRC46_MOUSE Leucine-rich repeat-containing protein 46 OS=Mus musculus OX=10090 GN=Lrrc46 PE=1 SV=2 LRC46_MOUSE reviewed Leucine-rich repeat-containing protein 46 Mus musculus (Mouse) GO:0007283; GO:0007286; GO:0007338; GO:0035082; GO:0036126; GO:0097225; GO:0098727; GO:0120316; GO:0120317 axoneme assembly [GO:0035082]; maintenance of cell number [GO:0098727]; single fertilization [GO:0007338]; sperm flagellum assembly [GO:0120316]; sperm mitochondrial sheath assembly [GO:0120317]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283] sperm flagellum [GO:0036126]; sperm midpiece [GO:0097225] g10294.t1 E7F7V7 29.477 363 2.78e-28 117.0 sp|E7F7V7|GAL2B_DANRE Galanin receptor 2b OS=Danio rerio OX=7955 GN=galr2b PE=2 SV=1 g10295.t1 F1R332 28.939 311 2.73e-24 105.0 sp|F1R332|GAL2A_DANRE Galanin receptor 2a OS=Danio rerio OX=7955 GN=galr2a PE=2 SV=2 g10296.t1 Q7ZT72 50.463 216 1.1800000000000001e-64 209.0 sp|Q7ZT72|FCN1B_XENLA Ficolin-1-B OS=Xenopus laevis OX=8355 GN=fcn1-b PE=2 SV=1 FCN1B_XENLA reviewed Ficolin-1-B Xenopus laevis (African clawed frog) GO:0001867; GO:0003823; GO:0005102; GO:0005581; GO:0005615; GO:0030246; GO:0033691; GO:0038187; GO:0046872; GO:0097367; GO:0106139 complement activation, lectin pathway [GO:0001867] collagen trimer [GO:0005581]; extracellular space [GO:0005615]; symbiont cell surface [GO:0106139] antigen binding [GO:0003823]; carbohydrate binding [GO:0030246]; carbohydrate derivative binding [GO:0097367]; metal ion binding [GO:0046872]; pattern recognition receptor activity [GO:0038187]; sialic acid binding [GO:0033691]; signaling receptor binding [GO:0005102] g10297.t1 A2AV25 44.531 256 5.9e-63 207.0 sp|A2AV25|FBCD1_MOUSE Fibrinogen C domain-containing protein 1 OS=Mus musculus OX=10090 GN=Fibcd1 PE=2 SV=1 g10298.t1 Q15485 48.148 216 4.02e-62 202.0 sp|Q15485|FCN2_HUMAN Ficolin-2 OS=Homo sapiens OX=9606 GN=FCN2 PE=1 SV=2 FCN2_HUMAN reviewed Ficolin-2 (37 kDa elastin-binding protein) (EBP-37) (Collagen/fibrinogen domain-containing protein 2) (Ficolin-B) (Ficolin-beta) (Hucolin) (L-ficolin) (Serum lectin p35) Homo sapiens (Human) GO:0001867; GO:0002752; GO:0003823; GO:0005102; GO:0005576; GO:0005581; GO:0005615; GO:0006508; GO:0008228; GO:0009897; GO:0038187; GO:0043394; GO:0043654; GO:0046872; GO:0048306; GO:0050829; GO:0050830; GO:0070062; GO:0070892; GO:0072562; GO:0097367; GO:0106139; GO:1903028; GO:1905370; GO:2001065 cell surface pattern recognition receptor signaling pathway [GO:0002752]; complement activation, lectin pathway [GO:0001867]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; opsonization [GO:0008228]; positive regulation of opsonization [GO:1903028]; proteolysis [GO:0006508]; recognition of apoptotic cell [GO:0043654] blood microparticle [GO:0072562]; collagen trimer [GO:0005581]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; serine-type endopeptidase complex [GO:1905370]; symbiont cell surface [GO:0106139] antigen binding [GO:0003823]; calcium-dependent protein binding [GO:0048306]; carbohydrate derivative binding [GO:0097367]; lipoteichoic acid immune receptor activity [GO:0070892]; mannan binding [GO:2001065]; metal ion binding [GO:0046872]; pattern recognition receptor activity [GO:0038187]; proteoglycan binding [GO:0043394]; signaling receptor binding [GO:0005102] g10300.t1 Q6PBA2 43.094 181 7.93e-41 139.0 sp|Q6PBA2|LS12A_DANRE Protein LSM12 homolog A OS=Danio rerio OX=7955 GN=lsm12a PE=2 SV=1 g10302.t1 P97831 63.462 156 1.2800000000000001e-58 188.0 sp|P97831|TWST2_RAT Twist-related protein 2 OS=Rattus norvegicus OX=10116 GN=Twist2 PE=2 SV=2 g10304.t1 Q60539 65.347 101 1.23e-32 119.0 sp|Q60539|TCF15_MESAU Transcription factor 15 OS=Mesocricetus auratus OX=10036 GN=TCF15 PE=2 SV=1 g10305.t1 Q96M86 23.506 1004 1.09e-59 232.0 sp|Q96M86|DNHD1_HUMAN Dynein heavy chain domain-containing protein 1 OS=Homo sapiens OX=9606 GN=DNHD1 PE=1 SV=2 DNHD1_HUMAN reviewed Dynein heavy chain domain-containing protein 1 (Coiled-coil domain-containing protein 35) (Dynein heavy chain domain 1-like protein) Homo sapiens (Human) GO:0005524; GO:0008569; GO:0030317; GO:0036126; GO:0036156; GO:0045505; GO:0051959; GO:0070062; GO:0120316 flagellated sperm motility [GO:0030317]; sperm flagellum assembly [GO:0120316] extracellular exosome [GO:0070062]; inner dynein arm [GO:0036156]; sperm flagellum [GO:0036126] ATP binding [GO:0005524]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; minus-end-directed microtubule motor activity [GO:0008569] g10305.t1 Q96M86 27.866 506 4.95e-49 197.0 sp|Q96M86|DNHD1_HUMAN Dynein heavy chain domain-containing protein 1 OS=Homo sapiens OX=9606 GN=DNHD1 PE=1 SV=2 DNHD1_HUMAN reviewed Dynein heavy chain domain-containing protein 1 (Coiled-coil domain-containing protein 35) (Dynein heavy chain domain 1-like protein) Homo sapiens (Human) GO:0005524; GO:0008569; GO:0030317; GO:0036126; GO:0036156; GO:0045505; GO:0051959; GO:0070062; GO:0120316 flagellated sperm motility [GO:0030317]; sperm flagellum assembly [GO:0120316] extracellular exosome [GO:0070062]; inner dynein arm [GO:0036156]; sperm flagellum [GO:0036126] ATP binding [GO:0005524]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; minus-end-directed microtubule motor activity [GO:0008569] g10306.t1 Q9P225 41.905 105 2.01e-25 103.0 sp|Q9P225|DYH2_HUMAN Dynein axonemal heavy chain 2 OS=Homo sapiens OX=9606 GN=DNAH2 PE=1 SV=3 DYH2_HUMAN reviewed Dynein axonemal heavy chain 2 (Axonemal beta dynein heavy chain 2) (Ciliary dynein heavy chain 2) (Dynein heavy chain domain-containing protein 3) Homo sapiens (Human) GO:0003777; GO:0005524; GO:0005858; GO:0005874; GO:0005930; GO:0008569; GO:0030286; GO:0031514; GO:0036126; GO:0036156; GO:0036159; GO:0045505; GO:0051959; GO:0060285; GO:0060294; GO:0097729 cilium movement involved in cell motility [GO:0060294]; cilium-dependent cell motility [GO:0060285]; inner dynein arm assembly [GO:0036159] 9+2 motile cilium [GO:0097729]; axonemal dynein complex [GO:0005858]; axoneme [GO:0005930]; dynein complex [GO:0030286]; inner dynein arm [GO:0036156]; microtubule [GO:0005874]; motile cilium [GO:0031514]; sperm flagellum [GO:0036126] ATP binding [GO:0005524]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]; minus-end-directed microtubule motor activity [GO:0008569] g10307.t1 D3Z2X2 26.415 424 6.22e-22 107.0 sp|D3Z2X2|DNHD1_MOUSE Dynein heavy chain domain-containing protein 1 OS=Mus musculus OX=10090 GN=Dnhd1 PE=1 SV=3 DNHD1_MOUSE reviewed Dynein heavy chain domain-containing protein 1 (Coiled-coil domain-containing protein 35) (Dynein heavy chain domain 1-like protein) Mus musculus (Mouse) GO:0005524; GO:0008569; GO:0030317; GO:0036126; GO:0036156; GO:0045505; GO:0051959; GO:0120316 flagellated sperm motility [GO:0030317]; sperm flagellum assembly [GO:0120316] inner dynein arm [GO:0036156]; sperm flagellum [GO:0036126] ATP binding [GO:0005524]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; minus-end-directed microtubule motor activity [GO:0008569] g10308.t1 Q9H8W5 24.274 482 5.18e-26 117.0 sp|Q9H8W5|TRI45_HUMAN E3 ubiquitin-protein ligase TRIM45 OS=Homo sapiens OX=9606 GN=TRIM45 PE=1 SV=2 TRI45_HUMAN reviewed E3 ubiquitin-protein ligase TRIM45 (EC 2.3.2.27) (RING finger protein 99) Homo sapiens (Human) GO:0005654; GO:0005737; GO:0005829; GO:0008270; GO:0043161; GO:0045171; GO:0050728; GO:0060348; GO:0061630; GO:0070936 bone development [GO:0060348]; negative regulation of inflammatory response [GO:0050728]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K48-linked ubiquitination [GO:0070936] cytoplasm [GO:0005737]; cytosol [GO:0005829]; intercellular bridge [GO:0045171]; nucleoplasm [GO:0005654] ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] g10310.t1 Q9MBF8 28.233 634 3.17e-60 228.0 sp|Q9MBF8|DYH1B_CHLRE Dynein-1-beta heavy chain, flagellar inner arm I1 complex OS=Chlamydomonas reinhardtii OX=3055 GN=DHC10 PE=1 SV=1 DYH1B_CHLRE reviewed Dynein-1-beta heavy chain, flagellar inner arm I1 complex (1-beta DHC) (Dynein-1, subspecies f) Chlamydomonas reinhardtii (Chlamydomonas smithii) GO:0003777; GO:0005524; GO:0005874; GO:0005930; GO:0008017; GO:0008569; GO:0031514; GO:0036156; GO:0036159; GO:0045505; GO:0051959; GO:0060294 cilium movement involved in cell motility [GO:0060294]; inner dynein arm assembly [GO:0036159] axoneme [GO:0005930]; inner dynein arm [GO:0036156]; microtubule [GO:0005874]; motile cilium [GO:0031514] ATP binding [GO:0005524]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; minus-end-directed microtubule motor activity [GO:0008569] g10313.t1 Q8N9W6 59.375 128 1.1700000000000002e-43 153.0 sp|Q8N9W6|BOLL_HUMAN Protein boule-like OS=Homo sapiens OX=9606 GN=BOLL PE=1 SV=2 g10313.t2 Q8N9W6 59.375 128 9.920000000000001e-43 154.0 sp|Q8N9W6|BOLL_HUMAN Protein boule-like OS=Homo sapiens OX=9606 GN=BOLL PE=1 SV=2 g10314.t1 P12607 48.223 197 2.5599999999999997e-52 185.0 sp|P12607|ITB1B_XENLA Integrin beta-1-B OS=Xenopus laevis OX=8355 GN=itgb1-b PE=2 SV=1 g10316.t1 P05106 46.07 369 4.8e-101 320.0 sp|P05106|ITB3_HUMAN Integrin beta-3 OS=Homo sapiens OX=9606 GN=ITGB3 PE=1 SV=2 ITB3_HUMAN reviewed Integrin beta-3 (Platelet membrane glycoprotein IIIa) (GPIIIa) (CD antigen CD61) Homo sapiens (Human) GO:0001618; GO:0001938; GO:0001954; GO:0001968; GO:0002020; GO:0003756; GO:0005080; GO:0005161; GO:0005178; GO:0005634; GO:0005654; GO:0005886; GO:0005911; GO:0005925; GO:0007044; GO:0007155; GO:0007160; GO:0007229; GO:0007566; GO:0007596; GO:0008305; GO:0009897; GO:0009986; GO:0010595; GO:0010628; GO:0010745; GO:0010763; GO:0010888; GO:0010989; GO:0014823; GO:0014909; GO:0014911; GO:0015026; GO:0016324; GO:0016477; GO:0019899; GO:0030168; GO:0030949; GO:0031092; GO:0031258; GO:0031527; GO:0031528; GO:0031589; GO:0032369; GO:0032587; GO:0032880; GO:0032956; GO:0032991; GO:0033627; GO:0033630; GO:0033690; GO:0034113; GO:0034446; GO:0034683; GO:0035295; GO:0035313; GO:0035866; GO:0035867; GO:0035868; GO:0036120; GO:0038027; GO:0042060; GO:0042470; GO:0042802; GO:0043184; GO:0043235; GO:0043277; GO:0045124; GO:0045202; GO:0045211; GO:0045766; GO:0045780; GO:0046718; GO:0046872; GO:0048008; GO:0048146; GO:0048333; GO:0048661; GO:0050748; GO:0050839; GO:0050840; GO:0050919; GO:0051279; GO:0051611; GO:0060055; GO:0070051; GO:0070062; GO:0070374; GO:0070442; GO:0070527; GO:0071062; GO:0071133; GO:0071260; GO:0071466; GO:0072126; GO:0072378; GO:0098690; GO:0098880; GO:0098978; GO:0099149; GO:0150054; GO:1900026; GO:1900731; GO:1900748; GO:1901163; GO:1903053; GO:1990314; GO:2000352; GO:2000406 angiogenesis involved in wound healing [GO:0060055]; apolipoprotein A-I-mediated signaling pathway [GO:0038027]; apoptotic cell clearance [GO:0043277]; blood coagulation [GO:0007596]; blood coagulation, fibrin clot formation [GO:0072378]; cell adhesion [GO:0007155]; cell adhesion mediated by integrin [GO:0033627]; cell migration [GO:0016477]; cell-matrix adhesion [GO:0007160]; cell-substrate adhesion [GO:0031589]; cell-substrate junction assembly [GO:0007044]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to mechanical stimulus [GO:0071260]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; cellular response to xenobiotic stimulus [GO:0071466]; embryo implantation [GO:0007566]; heterotypic cell-cell adhesion [GO:0034113]; integrin-mediated signaling pathway [GO:0007229]; maintenance of postsynaptic specialization structure [GO:0098880]; mesodermal cell differentiation [GO:0048333]; negative chemotaxis [GO:0050919]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of lipid storage [GO:0010888]; negative regulation of lipid transport [GO:0032369]; negative regulation of lipoprotein metabolic process [GO:0050748]; negative regulation of low-density lipoprotein particle clearance [GO:0010989]; negative regulation of macrophage derived foam cell differentiation [GO:0010745]; platelet activation [GO:0030168]; platelet aggregation [GO:0070527]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of adenylate cyclase-inhibiting opioid receptor signaling pathway [GO:1900731]; positive regulation of angiogenesis [GO:0045766]; positive regulation of bone resorption [GO:0045780]; positive regulation of cell adhesion mediated by integrin [GO:0033630]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of gene expression [GO:0010628]; positive regulation of glomerular mesangial cell proliferation [GO:0072126]; positive regulation of osteoblast proliferation [GO:0033690]; positive regulation of smooth muscle cell migration [GO:0014911]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; positive regulation of T cell migration [GO:2000406]; positive regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030949]; positive regulation of vascular endothelial growth factor signaling pathway [GO:1900748]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of bone resorption [GO:0045124]; regulation of extracellular matrix organization [GO:1903053]; regulation of postsynaptic neurotransmitter receptor diffusion trapping [GO:0150054]; regulation of postsynaptic neurotransmitter receptor internalization [GO:0099149]; regulation of protein localization [GO:0032880]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; regulation of serotonin uptake [GO:0051611]; regulation of trophoblast cell migration [GO:1901163]; response to activity [GO:0014823]; smooth muscle cell migration [GO:0014909]; substrate adhesion-dependent cell spreading [GO:0034446]; symbiont entry into host cell [GO:0046718]; tube development [GO:0035295]; wound healing [GO:0042060]; wound healing, spreading of epidermal cells [GO:0035313] alpha9-beta1 integrin-ADAM8 complex [GO:0071133]; alphav-beta3 integrin-HMGB1 complex [GO:0035868]; alphav-beta3 integrin-IGF-1-IGF1R complex [GO:0035867]; alphav-beta3 integrin-PKCalpha complex [GO:0035866]; alphav-beta3 integrin-vitronectin complex [GO:0071062]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; cell-cell junction [GO:0005911]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; filopodium membrane [GO:0031527]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; glycinergic synapse [GO:0098690]; integrin alphaIIb-beta3 complex [GO:0070442]; integrin alphav-beta3 complex [GO:0034683]; integrin complex [GO:0008305]; lamellipodium membrane [GO:0031258]; melanosome [GO:0042470]; microvillus membrane [GO:0031528]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; platelet alpha granule membrane [GO:0031092]; postsynaptic membrane [GO:0045211]; protein-containing complex [GO:0032991]; receptor complex [GO:0043235]; ruffle membrane [GO:0032587]; synapse [GO:0045202] cell adhesion molecule binding [GO:0050839]; coreceptor activity [GO:0015026]; enzyme binding [GO:0019899]; extracellular matrix binding [GO:0050840]; fibrinogen binding [GO:0070051]; fibronectin binding [GO:0001968]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; metal ion binding [GO:0046872]; platelet-derived growth factor receptor binding [GO:0005161]; protease binding [GO:0002020]; protein disulfide isomerase activity [GO:0003756]; protein kinase C binding [GO:0005080]; vascular endothelial growth factor receptor 2 binding [GO:0043184]; virus receptor activity [GO:0001618] g10318.t1 B8JK39 33.163 781 2.05e-105 357.0 sp|B8JK39|ITA9_MOUSE Integrin alpha-9 OS=Mus musculus OX=10090 GN=Itga9 PE=1 SV=1 ITA9_MOUSE reviewed Integrin alpha-9 Mus musculus (Mouse) GO:0005518; GO:0007155; GO:0007229; GO:0009925; GO:0009986; GO:0030593; GO:0034679; GO:0038023; GO:0043236; GO:0045906; GO:0046872; GO:0098609; GO:0098640 cell adhesion [GO:0007155]; cell-cell adhesion [GO:0098609]; integrin-mediated signaling pathway [GO:0007229]; negative regulation of vasoconstriction [GO:0045906]; neutrophil chemotaxis [GO:0030593] basal plasma membrane [GO:0009925]; cell surface [GO:0009986]; integrin alpha9-beta1 complex [GO:0034679] collagen binding [GO:0005518]; integrin binding involved in cell-matrix adhesion [GO:0098640]; laminin binding [GO:0043236]; metal ion binding [GO:0046872]; signaling receptor activity [GO:0038023] g10319.t1 P16332 73.628 747 0.0 1168.0 sp|P16332|MUTA_MOUSE Methylmalonyl-CoA mutase, mitochondrial OS=Mus musculus OX=10090 GN=Mmut PE=1 SV=2 MUTA_MOUSE reviewed Methylmalonyl-CoA mutase, mitochondrial (MCM) (EC 5.4.99.2) (Methylmalonyl-CoA isomerase) Mus musculus (Mouse) GO:0003924; GO:0004494; GO:0005737; GO:0005739; GO:0005759; GO:0009791; GO:0019678; GO:0031419; GO:0042802; GO:0042803; GO:0046872; GO:0050667; GO:0072341; GO:1901290 homocysteine metabolic process [GO:0050667]; post-embryonic development [GO:0009791]; propionate metabolic process, methylmalonyl pathway [GO:0019678]; succinyl-CoA biosynthetic process [GO:1901290] cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] cobalamin binding [GO:0031419]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; methylmalonyl-CoA mutase activity [GO:0004494]; modified amino acid binding [GO:0072341]; protein homodimerization activity [GO:0042803] g10320.t1 P00029 69.903 103 8.14e-52 161.0 sp|P00029|CYC_ASTRU Cytochrome c OS=Asterias rubens OX=7604 PE=1 SV=2 g10322.t1 P24534 57.269 227 2.78e-74 227.0 sp|P24534|EF1B_HUMAN Elongation factor 1-beta OS=Homo sapiens OX=9606 GN=EEF1B2 PE=1 SV=3 EF1B_HUMAN reviewed Elongation factor 1-beta (EF-1-beta) (eEF-1B alpha) Homo sapiens (Human) GO:0003746; GO:0005085; GO:0005737; GO:0005829; GO:0005853; GO:0006414; GO:0045471 response to ethanol [GO:0045471]; translational elongation [GO:0006414] cytoplasm [GO:0005737]; cytosol [GO:0005829]; eukaryotic translation elongation factor 1 complex [GO:0005853] guanyl-nucleotide exchange factor activity [GO:0005085]; translation elongation factor activity [GO:0003746] g10323.t1 Q66HF1 74.862 724 0.0 1137.0 sp|Q66HF1|NDUS1_RAT NADH-ubiquinone oxidoreductase 75 kDa subunit, mitochondrial OS=Rattus norvegicus OX=10116 GN=Ndufs1 PE=1 SV=1 NDUS1_RAT reviewed NADH-ubiquinone oxidoreductase 75 kDa subunit, mitochondrial (EC 7.1.1.2) Rattus norvegicus (Rat) GO:0005739; GO:0005743; GO:0005758; GO:0006120; GO:0008137; GO:0009055; GO:0016651; GO:0032981; GO:0045271; GO:0045333; GO:0046872; GO:0051537; GO:0051539 cellular respiration [GO:0045333]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; mitochondrial respiratory chain complex I assembly [GO:0032981] mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; respiratory chain complex I [GO:0045271] 2 iron, 2 sulfur cluster binding [GO:0051537]; 4 iron, 4 sulfur cluster binding [GO:0051539]; electron transfer activity [GO:0009055]; metal ion binding [GO:0046872]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; oxidoreductase activity, acting on NAD(P)H [GO:0016651] g10324.t1 Q9TV66 43.678 522 4.61e-134 422.0 sp|Q9TV66|HCN4_RABIT Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4 OS=Oryctolagus cuniculus OX=9986 GN=HCN4 PE=1 SV=1 g10325.t1 Q8TEW0 36.298 697 2.1e-92 317.0 sp|Q8TEW0|PARD3_HUMAN Partitioning defective 3 homolog OS=Homo sapiens OX=9606 GN=PARD3 PE=1 SV=2 g10326.t1 Q9Z340 51.44 243 7.11e-62 221.0 sp|Q9Z340|PARD3_RAT Partitioning defective 3 homolog OS=Rattus norvegicus OX=10116 GN=Pard3 PE=1 SV=1 PARD3_RAT reviewed Partitioning defective 3 homolog (PAR-3) (PARD-3) (Atypical PKC isotype-specific-interacting protein) (ASIP) (Atypical PKC-specific-binding protein) (ASBP) Rattus norvegicus (Rat) GO:0000226; GO:0002092; GO:0003383; GO:0005546; GO:0005547; GO:0005737; GO:0005819; GO:0005886; GO:0005911; GO:0005912; GO:0005923; GO:0005938; GO:0006612; GO:0007155; GO:0008104; GO:0010801; GO:0012505; GO:0016324; GO:0019903; GO:0022011; GO:0030010; GO:0030054; GO:0031252; GO:0031643; GO:0032266; GO:0032970; GO:0032991; GO:0033269; GO:0035091; GO:0042802; GO:0043025; GO:0043219; GO:0043220; GO:0043296; GO:0044295; GO:0044319; GO:0045197; GO:0051301; GO:0051642; GO:0051660; GO:0060341; GO:0070830; GO:0090162; GO:0120157 apical constriction [GO:0003383]; bicellular tight junction assembly [GO:0070830]; cell adhesion [GO:0007155]; cell division [GO:0051301]; centrosome localization [GO:0051642]; establishment of cell polarity [GO:0030010]; establishment of centrosome localization [GO:0051660]; establishment of epithelial cell polarity [GO:0090162]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; intracellular protein localization [GO:0008104]; microtubule cytoskeleton organization [GO:0000226]; myelination in peripheral nervous system [GO:0022011]; negative regulation of peptidyl-threonine phosphorylation [GO:0010801]; positive regulation of myelination [GO:0031643]; positive regulation of receptor internalization [GO:0002092]; protein targeting to membrane [GO:0006612]; regulation of actin filament-based process [GO:0032970]; regulation of cellular localization [GO:0060341]; wound healing, spreading of cells [GO:0044319] adherens junction [GO:0005912]; apical junction complex [GO:0043296]; apical plasma membrane [GO:0016324]; axonal growth cone [GO:0044295]; bicellular tight junction [GO:0005923]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cell leading edge [GO:0031252]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; endomembrane system [GO:0012505]; internode region of axon [GO:0033269]; lateral loop [GO:0043219]; neuronal cell body [GO:0043025]; PAR polarity complex [GO:0120157]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; Schmidt-Lanterman incisure [GO:0043220]; spindle [GO:0005819] identical protein binding [GO:0042802]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; protein phosphatase binding [GO:0019903] g7597.t1 Q5RJA1 47.573 515 1.8e-154 474.0 sp|Q5RJA1|RFX6_DANRE DNA-binding protein RFX6 OS=Danio rerio OX=7955 GN=rfx6 PE=2 SV=2 RFX6_DANRE reviewed DNA-binding protein RFX6 (Regulatory factor X 6) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000976; GO:0000978; GO:0000981; GO:0003309; GO:0003310; GO:0003311; GO:0005634; GO:0006357; GO:0031018; GO:0035774; GO:0042593; GO:0045893; GO:0045944; GO:0050796; GO:0090104 endocrine pancreas development [GO:0031018]; glucose homeostasis [GO:0042593]; pancreatic A cell differentiation [GO:0003310]; pancreatic D cell differentiation [GO:0003311]; pancreatic epsilon cell differentiation [GO:0090104]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of insulin secretion [GO:0050796]; regulation of transcription by RNA polymerase II [GO:0006357]; type B pancreatic cell differentiation [GO:0003309] nucleus [GO:0005634] DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription cis-regulatory region binding [GO:0000976] g7598.t1 Q39244 47.244 254 2.82e-60 193.0 sp|Q39244|RU1A_ARATH U1 small nuclear ribonucleoprotein A OS=Arabidopsis thaliana OX=3702 GN=U1A PE=1 SV=1 g7600.t1 Q5M8V8 59.712 139 1.4200000000000001e-58 182.0 sp|Q5M8V8|RBTN2_XENTR Rhombotin-2 OS=Xenopus tropicalis OX=8364 GN=lmo2 PE=2 SV=1 g7601.t1 A5PKG8 62.069 174 5.22e-58 194.0 sp|A5PKG8|DBX1_BOVIN Homeobox protein DBX1 OS=Bos taurus OX=9913 GN=DBX1 PE=2 SV=1 g7602.t1 O93529 55.556 108 4.31e-28 115.0 sp|O93529|FOXB1_XENLA Forkhead box protein B1 OS=Xenopus laevis OX=8355 GN=foxb1 PE=2 SV=1 g7603.t1 Q3UIL6 38.636 308 1.14e-53 209.0 sp|Q3UIL6|PKHA7_MOUSE Pleckstrin homology domain-containing family A member 7 OS=Mus musculus OX=10090 GN=Plekha7 PE=1 SV=2 PKHA7_MOUSE reviewed Pleckstrin homology domain-containing family A member 7 (PH domain-containing family A member 7) (Heart adapter protein 1) Mus musculus (Mouse) GO:0005654; GO:0005813; GO:0005829; GO:0005911; GO:0005915; GO:0030054; GO:0042311; GO:0044331; GO:0045218; GO:0046930; GO:0046931; GO:0070097; GO:0090136 cell-cell adhesion mediated by cadherin [GO:0044331]; epithelial cell-cell adhesion [GO:0090136]; pore complex assembly [GO:0046931]; vasodilation [GO:0042311]; zonula adherens maintenance [GO:0045218] cell junction [GO:0030054]; cell-cell junction [GO:0005911]; centrosome [GO:0005813]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; pore complex [GO:0046930]; zonula adherens [GO:0005915] delta-catenin binding [GO:0070097] g7605.t1 Q02357 25.983 458 7.6900000000000005e-22 106.0 sp|Q02357|ANK1_MOUSE Ankyrin-1 OS=Mus musculus OX=10090 GN=Ank1 PE=1 SV=2 g7612.t1 Q9DE27 84.199 462 0.0 717.0 sp|Q9DE27|RUVB2_XENLA RuvB-like 2 OS=Xenopus laevis OX=8355 GN=ruvbl2 PE=2 SV=1 g7613.t1 P37059 38.08 323 2.0300000000000002e-57 197.0 sp|P37059|DHB2_HUMAN 17-beta-hydroxysteroid dehydrogenase type 2 OS=Homo sapiens OX=9606 GN=HSD17B2 PE=1 SV=1 DHB2_HUMAN reviewed 17-beta-hydroxysteroid dehydrogenase type 2 (17-beta-HSD 2) (20 alpha-hydroxysteroid dehydrogenase) (20-alpha-HSD) (E2DH) (Estradiol 17-beta-dehydrogenase 2) (EC 1.1.1.62) (Microsomal 17-beta-hydroxysteroid dehydrogenase) (Short chain dehydrogenase/reductase family 9C member 2) (Testosterone 17-beta-dehydrogenase) (EC 1.1.1.239) Homo sapiens (Human) GO:0001701; GO:0001890; GO:0004303; GO:0005789; GO:0006703; GO:0008202; GO:0008209; GO:0032526; GO:0047006; GO:0047035 androgen metabolic process [GO:0008209]; estrogen biosynthetic process [GO:0006703]; in utero embryonic development [GO:0001701]; placenta development [GO:0001890]; response to retinoic acid [GO:0032526]; steroid metabolic process [GO:0008202] endoplasmic reticulum membrane [GO:0005789] 17-alpha,20-alpha-dihydroxypregn-4-en-3-one dehydrogenase [NAD(P)+] activity [GO:0047006]; estradiol 17-beta-dehydrogenase [NAD(P)+] activity [GO:0004303]; testosterone dehydrogenase (NAD+) activity [GO:0047035] g7614.t1 P50239 29.195 298 3.0000000000000003e-31 129.0 sp|P50239|E75_GALME Ecdysone-inducible protein E75 OS=Galleria mellonella OX=7137 GN=E75 PE=2 SV=1 g7615.t1 O77245 38.418 354 2.8e-71 241.0 sp|O77245|E75_METEN Nuclear hormone receptor E75 OS=Metapenaeus ensis OX=32278 GN=E75 PE=2 SV=1 g7615.t2 O77245 38.418 354 5.88e-71 241.0 sp|O77245|E75_METEN Nuclear hormone receptor E75 OS=Metapenaeus ensis OX=32278 GN=E75 PE=2 SV=1 g7616.t1 P79955 46.667 555 7.949999999999999e-150 453.0 sp|P79955|CTK2_XENLA Carboxy-terminal kinesin 2 OS=Xenopus laevis OX=8355 PE=2 SV=1 g7616.t2 P79955 46.667 555 6.619999999999999e-150 452.0 sp|P79955|CTK2_XENLA Carboxy-terminal kinesin 2 OS=Xenopus laevis OX=8355 PE=2 SV=1 g7619.t1 P42577 65.854 164 1.11e-79 236.0 sp|P42577|FRIS_LYMST Soma ferritin OS=Lymnaea stagnalis OX=6523 PE=2 SV=2 g7620.t1 P42577 67.262 168 6.28e-82 243.0 sp|P42577|FRIS_LYMST Soma ferritin OS=Lymnaea stagnalis OX=6523 PE=2 SV=2 g7621.t1 Q7TQI7 47.629 991 0.0 886.0 sp|Q7TQI7|ABTB2_MOUSE Ankyrin repeat and BTB/POZ domain-containing protein 2 OS=Mus musculus OX=10090 GN=Abtb2 PE=1 SV=1 g7623.t1 A0A1B0GTJ6 32.89 301 2.21e-27 112.0 sp|A0A1B0GTJ6|SAXO3_HUMAN Stabilizer of axonemal microtubules 3 OS=Homo sapiens OX=9606 GN=SAXO3 PE=1 SV=1 g7624.t1 Q8K342 28.723 282 4.24e-24 105.0 sp|Q8K342|RASF9_MOUSE Ras association domain-containing protein 9 OS=Mus musculus OX=10090 GN=Rassf9 PE=2 SV=1 g7628.t1 Q2TBF2 33.428 353 1.1e-49 182.0 sp|Q2TBF2|WSCD2_HUMAN Sialate:O-sulfotransferase 2 OS=Homo sapiens OX=9606 GN=WSCD2 PE=1 SV=2 WSCD2_HUMAN reviewed Sialate:O-sulfotransferase 2 (WSC domain-containing protein 2) Homo sapiens (Human) GO:0000139; GO:0008146 Golgi membrane [GO:0000139] sulfotransferase activity [GO:0008146] g7628.t2 Q2TBF2 33.428 353 1.7e-49 182.0 sp|Q2TBF2|WSCD2_HUMAN Sialate:O-sulfotransferase 2 OS=Homo sapiens OX=9606 GN=WSCD2 PE=1 SV=2 WSCD2_HUMAN reviewed Sialate:O-sulfotransferase 2 (WSC domain-containing protein 2) Homo sapiens (Human) GO:0000139; GO:0008146 Golgi membrane [GO:0000139] sulfotransferase activity [GO:0008146] g7629.t1 Q2TBF2 28.779 344 5.36e-37 144.0 sp|Q2TBF2|WSCD2_HUMAN Sialate:O-sulfotransferase 2 OS=Homo sapiens OX=9606 GN=WSCD2 PE=1 SV=2 WSCD2_HUMAN reviewed Sialate:O-sulfotransferase 2 (WSC domain-containing protein 2) Homo sapiens (Human) GO:0000139; GO:0008146 Golgi membrane [GO:0000139] sulfotransferase activity [GO:0008146] g7635.t1 Q4LAL6 60.15 133 2.73e-41 154.0 sp|Q4LAL6|ALX4_BOVIN Homeobox protein aristaless-like 4 OS=Bos taurus OX=9913 GN=ALX4 PE=2 SV=1 g7642.t1 Q568Y5 28.571 245 1.2099999999999999e-24 101.0 sp|Q568Y5|TSN11_RAT Tetraspanin-11 OS=Rattus norvegicus OX=10116 GN=Tspan11 PE=2 SV=1 g7645.t1 Q28F07 76.647 334 0.0 548.0 sp|Q28F07|ANM1_XENTR Protein arginine N-methyltransferase 1 OS=Xenopus tropicalis OX=8364 GN=prmt1 PE=2 SV=1 ANM1_XENTR reviewed Protein arginine N-methyltransferase 1 (EC 2.1.1.319) (Heterogeneous nuclear ribonucleoprotein methyltransferase-like protein 2) (Histone-arginine N-methyltransferase PRMT1) Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0003713; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006338; GO:0006355; GO:0006479; GO:0007552; GO:0008170; GO:0008276; GO:0008284; GO:0008380; GO:0016274; GO:0018216; GO:0022008; GO:0035241; GO:0035242; GO:0042054; GO:0042802; GO:0044020; GO:0045652; GO:0045653; GO:0045893; GO:0048738; GO:0051260; GO:0061431; GO:0106080; GO:1904047; GO:1904263; GO:1905168 cardiac muscle tissue development [GO:0048738]; cellular response to methionine [GO:0061431]; chromatin remodeling [GO:0006338]; metamorphosis [GO:0007552]; negative regulation of megakaryocyte differentiation [GO:0045653]; neurogenesis [GO:0022008]; peptidyl-arginine methylation [GO:0018216]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of TORC1 signaling [GO:1904263]; protein homooligomerization [GO:0051260]; protein methylation [GO:0006479]; regulation of DNA-templated transcription [GO:0006355]; regulation of megakaryocyte differentiation [GO:0045652]; RNA splicing [GO:0008380] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] GATOR1 complex binding [GO:0106080]; histone H4R3 methyltransferase activity [GO:0044020]; histone methyltransferase activity [GO:0042054]; identical protein binding [GO:0042802]; N-methyltransferase activity [GO:0008170]; protein methyltransferase activity [GO:0008276]; protein-arginine N-methyltransferase activity [GO:0016274]; protein-arginine omega-N asymmetric methyltransferase activity [GO:0035242]; protein-arginine omega-N monomethyltransferase activity [GO:0035241]; S-adenosyl-L-methionine binding [GO:1904047]; transcription coactivator activity [GO:0003713] g7645.t2 Q28F07 75.964 337 0.0 543.0 sp|Q28F07|ANM1_XENTR Protein arginine N-methyltransferase 1 OS=Xenopus tropicalis OX=8364 GN=prmt1 PE=2 SV=1 ANM1_XENTR reviewed Protein arginine N-methyltransferase 1 (EC 2.1.1.319) (Heterogeneous nuclear ribonucleoprotein methyltransferase-like protein 2) (Histone-arginine N-methyltransferase PRMT1) Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0003713; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006338; GO:0006355; GO:0006479; GO:0007552; GO:0008170; GO:0008276; GO:0008284; GO:0008380; GO:0016274; GO:0018216; GO:0022008; GO:0035241; GO:0035242; GO:0042054; GO:0042802; GO:0044020; GO:0045652; GO:0045653; GO:0045893; GO:0048738; GO:0051260; GO:0061431; GO:0106080; GO:1904047; GO:1904263; GO:1905168 cardiac muscle tissue development [GO:0048738]; cellular response to methionine [GO:0061431]; chromatin remodeling [GO:0006338]; metamorphosis [GO:0007552]; negative regulation of megakaryocyte differentiation [GO:0045653]; neurogenesis [GO:0022008]; peptidyl-arginine methylation [GO:0018216]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of TORC1 signaling [GO:1904263]; protein homooligomerization [GO:0051260]; protein methylation [GO:0006479]; regulation of DNA-templated transcription [GO:0006355]; regulation of megakaryocyte differentiation [GO:0045652]; RNA splicing [GO:0008380] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] GATOR1 complex binding [GO:0106080]; histone H4R3 methyltransferase activity [GO:0044020]; histone methyltransferase activity [GO:0042054]; identical protein binding [GO:0042802]; N-methyltransferase activity [GO:0008170]; protein methyltransferase activity [GO:0008276]; protein-arginine N-methyltransferase activity [GO:0016274]; protein-arginine omega-N asymmetric methyltransferase activity [GO:0035242]; protein-arginine omega-N monomethyltransferase activity [GO:0035241]; S-adenosyl-L-methionine binding [GO:1904047]; transcription coactivator activity [GO:0003713] g7646.t1 Q568Y5 39.545 220 6.83e-35 128.0 sp|Q568Y5|TSN11_RAT Tetraspanin-11 OS=Rattus norvegicus OX=10116 GN=Tspan11 PE=2 SV=1 g7650.t1 A5D8P8 47.541 183 1.48e-52 173.0 sp|A5D8P8|EMC10_XENLA ER membrane protein complex subunit 10 OS=Xenopus laevis OX=8355 GN=emc10 PE=2 SV=1 g7651.t1 Q4V920 44.889 450 1.0699999999999999e-134 397.0 sp|Q4V920|PACN1_DANRE Protein kinase C and casein kinase substrate in neurons protein 1 OS=Danio rerio OX=7955 GN=pacsin1b PE=1 SV=1 PACN1_DANRE reviewed Protein kinase C and casein kinase substrate in neurons protein 1 (Syndapin-1) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005543; GO:0005737; GO:0005768; GO:0005829; GO:0005886; GO:0006897; GO:0007010; GO:0007015; GO:0030100; GO:0030659; GO:0032587; GO:0043005; GO:0045202; GO:0048812; GO:0060088; GO:0060271; GO:0097320; GO:1900006 actin filament organization [GO:0007015]; auditory receptor cell stereocilium organization [GO:0060088]; cilium assembly [GO:0060271]; cytoskeleton organization [GO:0007010]; endocytosis [GO:0006897]; neuron projection morphogenesis [GO:0048812]; plasma membrane tubulation [GO:0097320]; positive regulation of dendrite development [GO:1900006]; regulation of endocytosis [GO:0030100] cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; endosome [GO:0005768]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587]; synapse [GO:0045202] phospholipid binding [GO:0005543] g7651.t2 Q4V920 45.843 445 5.83e-134 395.0 sp|Q4V920|PACN1_DANRE Protein kinase C and casein kinase substrate in neurons protein 1 OS=Danio rerio OX=7955 GN=pacsin1b PE=1 SV=1 PACN1_DANRE reviewed Protein kinase C and casein kinase substrate in neurons protein 1 (Syndapin-1) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005543; GO:0005737; GO:0005768; GO:0005829; GO:0005886; GO:0006897; GO:0007010; GO:0007015; GO:0030100; GO:0030659; GO:0032587; GO:0043005; GO:0045202; GO:0048812; GO:0060088; GO:0060271; GO:0097320; GO:1900006 actin filament organization [GO:0007015]; auditory receptor cell stereocilium organization [GO:0060088]; cilium assembly [GO:0060271]; cytoskeleton organization [GO:0007010]; endocytosis [GO:0006897]; neuron projection morphogenesis [GO:0048812]; plasma membrane tubulation [GO:0097320]; positive regulation of dendrite development [GO:1900006]; regulation of endocytosis [GO:0030100] cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; endosome [GO:0005768]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587]; synapse [GO:0045202] phospholipid binding [GO:0005543] g7653.t1 Q91955 46.018 113 7.640000000000001e-29 103.0 sp|Q91955|MTPN_CHICK Myotrophin OS=Gallus gallus OX=9031 GN=MTPN PE=3 SV=1 g7654.t1 G1T168 73.846 130 5.75e-62 191.0 sp|G1T168|RS10_RABIT Small ribosomal subunit protein eS10 OS=Oryctolagus cuniculus OX=9986 GN=RPS10 PE=1 SV=3 g7655.t1 F1RMN2 38.605 215 6.1e-29 112.0 sp|F1RMN2|TM86B_PIG Lysoplasmalogenase TMEM86B OS=Sus scrofa OX=9823 GN=TMEM86B PE=3 SV=1 g7656.t1 Q9D8N3 40.491 163 4.63e-25 100.0 sp|Q9D8N3|TM86A_MOUSE Lysoplasmalogenase TMEM86A OS=Mus musculus OX=10090 GN=Tmem86a PE=1 SV=1 TM86A_MOUSE reviewed Lysoplasmalogenase TMEM86A (EC 3.3.2.2) (Transmembrane protein 86A) Mus musculus (Mouse) GO:0005789; GO:0006629; GO:0016020; GO:0016787; GO:0047408 lipid metabolic process [GO:0006629] endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020] alkenylglycerophosphocholine hydrolase activity [GO:0047408]; hydrolase activity [GO:0016787] g7659.t1 Q9Y2H1 72.234 461 0.0 676.0 sp|Q9Y2H1|ST38L_HUMAN Serine/threonine-protein kinase 38-like OS=Homo sapiens OX=9606 GN=STK38L PE=1 SV=3 ST38L_HUMAN reviewed Serine/threonine-protein kinase 38-like (EC 2.7.11.1) (NDR2 protein kinase) (Nuclear Dbf2-related kinase 2) Homo sapiens (Human) GO:0000287; GO:0003779; GO:0004674; GO:0005524; GO:0005737; GO:0005829; GO:0006468; GO:0010507; GO:0015629; GO:0016020; GO:0035556; GO:0051128; GO:0106310 intracellular signal transduction [GO:0035556]; negative regulation of autophagy [GO:0010507]; protein phosphorylation [GO:0006468]; regulation of cellular component organization [GO:0051128] actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020] actin binding [GO:0003779]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g7661.t1 Q96AE7 31.993 572 1.96e-72 254.0 sp|Q96AE7|TTC17_HUMAN Tetratricopeptide repeat protein 17 OS=Homo sapiens OX=9606 GN=TTC17 PE=1 SV=1 g7661.t1 Q96AE7 31.364 220 1.1300000000000001e-26 119.0 sp|Q96AE7|TTC17_HUMAN Tetratricopeptide repeat protein 17 OS=Homo sapiens OX=9606 GN=TTC17 PE=1 SV=1 g7663.t1 E7F211 43.296 358 3.61e-78 264.0 sp|E7F211|TTC17_DANRE Tetratricopeptide repeat protein 17 OS=Danio rerio OX=7955 GN=ttc17 PE=3 SV=1 TTC17_DANRE reviewed Tetratricopeptide repeat protein 17 (TPR repeat protein 17) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005737; GO:0005886; GO:0015629; GO:0030041; GO:0044782; GO:0061371 actin filament polymerization [GO:0030041]; cilium organization [GO:0044782]; determination of heart left/right asymmetry [GO:0061371] actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886] g7663.t1 E7F211 26.512 215 4.8599999999999996e-23 104.0 sp|E7F211|TTC17_DANRE Tetratricopeptide repeat protein 17 OS=Danio rerio OX=7955 GN=ttc17 PE=3 SV=1 TTC17_DANRE reviewed Tetratricopeptide repeat protein 17 (TPR repeat protein 17) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005737; GO:0005886; GO:0015629; GO:0030041; GO:0044782; GO:0061371 actin filament polymerization [GO:0030041]; cilium organization [GO:0044782]; determination of heart left/right asymmetry [GO:0061371] actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886] g7664.t1 Q8HYJ4 33.463 257 3.53e-28 119.0 sp|Q8HYJ4|FUT5_PONPY 4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5 OS=Pongo pygmaeus OX=9600 GN=FUT5 PE=3 SV=1 g7667.t1 Q9D1D1 30.709 254 1.1800000000000001e-32 123.0 sp|Q9D1D1|TSN11_MOUSE Tetraspanin-11 OS=Mus musculus OX=10090 GN=Tspan11 PE=2 SV=1 g7668.t2 P30932 35.366 246 2.32e-23 97.8 sp|P30932|CD9_BOVIN CD9 antigen OS=Bos taurus OX=9913 GN=CD9 PE=2 SV=2 g7671.t1 Q7ZXF5 52.539 512 0.0 574.0 sp|Q7ZXF5|FACR1_XENLA Fatty acyl-CoA reductase 1 OS=Xenopus laevis OX=8355 GN=far1 PE=2 SV=1 FACR1_XENLA reviewed Fatty acyl-CoA reductase 1 (Far1) (EC 1.2.1.84) Xenopus laevis (African clawed frog) GO:0005777; GO:0005778; GO:0008611; GO:0010025; GO:0035336; GO:0080019; GO:0102965 ether lipid biosynthetic process [GO:0008611]; long-chain fatty-acyl-CoA metabolic process [GO:0035336]; wax biosynthetic process [GO:0010025] peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777] alcohol-forming long-chain fatty acyl-CoA reductase activity [GO:0102965]; alcohol-forming very long-chain fatty acyl-CoA reductase activity [GO:0080019] g7674.t1 Q8NI77 49.032 620 0.0 578.0 sp|Q8NI77|KI18A_HUMAN Kinesin-like protein KIF18A OS=Homo sapiens OX=9606 GN=KIF18A PE=1 SV=2 KI18A_HUMAN reviewed Kinesin-like protein KIF18A (Marrow stromal KIF18A) (MS-KIF18A) Homo sapiens (Human) GO:0000070; GO:0000776; GO:0001726; GO:0003779; GO:0005524; GO:0005634; GO:0005737; GO:0005813; GO:0005828; GO:0005829; GO:0005871; GO:0005901; GO:0007018; GO:0007019; GO:0007080; GO:0007140; GO:0008017; GO:0008574; GO:0015031; GO:0015630; GO:0016887; GO:0051010; GO:0061673; GO:0070463; GO:0070507; GO:0071392; GO:0072520; GO:1990023 cellular response to estradiol stimulus [GO:0071392]; male meiotic nuclear division [GO:0007140]; microtubule depolymerization [GO:0007019]; microtubule-based movement [GO:0007018]; mitotic metaphase chromosome alignment [GO:0007080]; mitotic sister chromatid segregation [GO:0000070]; protein transport [GO:0015031]; regulation of microtubule cytoskeleton organization [GO:0070507]; seminiferous tubule development [GO:0072520] caveola [GO:0005901]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; kinesin complex [GO:0005871]; kinetochore [GO:0000776]; kinetochore microtubule [GO:0005828]; microtubule cytoskeleton [GO:0015630]; mitotic spindle astral microtubule [GO:0061673]; mitotic spindle midzone [GO:1990023]; nucleus [GO:0005634]; ruffle [GO:0001726] actin binding [GO:0003779]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule plus-end binding [GO:0051010]; plus-end-directed microtubule motor activity [GO:0008574]; tubulin-dependent ATPase activity [GO:0070463] g7675.t1 A6NJ78 48.293 410 6.55e-123 364.0 sp|A6NJ78|MET15_HUMAN 12S rRNA N(4)-cytidine methyltransferase METTL15 OS=Homo sapiens OX=9606 GN=METTL15 PE=1 SV=1 MET15_HUMAN reviewed 12S rRNA N(4)-cytidine methyltransferase METTL15 (12S rRNA m4C methyltransferase) (EC 2.1.1.-) (Methyltransferase 5 domain-containing protein 1) (Methyltransferase-like protein 15) Homo sapiens (Human) GO:0005739; GO:0005759; GO:0070475; GO:0071424; GO:0180026 mitochondrial small ribosomal subunit assembly [GO:0180026]; rRNA base methylation [GO:0070475] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] rRNA (cytosine-N4-)-methyltransferase activity [GO:0071424] g7677.t1 Q8C8U0 38.14 215 9.8e-31 127.0 sp|Q8C8U0|LIPB1_MOUSE Liprin-beta-1 OS=Mus musculus OX=10090 GN=Ppfibp1 PE=1 SV=3 g7678.t1 Q86W92 52.493 381 1.7e-120 377.0 sp|Q86W92|LIPB1_HUMAN Liprin-beta-1 OS=Homo sapiens OX=9606 GN=PPFIBP1 PE=1 SV=2 LIPB1_HUMAN reviewed Liprin-beta-1 (Protein tyrosine phosphatase receptor type f polypeptide-interacting protein-binding protein 1) (PTPRF-interacting protein-binding protein 1) (hSGT2) Homo sapiens (Human) GO:0005829; GO:0005886; GO:0005925; GO:0005938; GO:0007155; GO:0007528; GO:0043622; GO:0045296; GO:0048786 cell adhesion [GO:0007155]; cortical microtubule organization [GO:0043622]; neuromuscular junction development [GO:0007528] cell cortex [GO:0005938]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]; presynaptic active zone [GO:0048786] cadherin binding [GO:0045296] g7679.t1 Q7Z6G8 50.859 291 4.92e-83 278.0 sp|Q7Z6G8|ANS1B_HUMAN Ankyrin repeat and sterile alpha motif domain-containing protein 1B OS=Homo sapiens OX=9606 GN=ANKS1B PE=1 SV=2 g7680.t1 Q7Z6G8 40.129 466 9.03e-88 298.0 sp|Q7Z6G8|ANS1B_HUMAN Ankyrin repeat and sterile alpha motif domain-containing protein 1B OS=Homo sapiens OX=9606 GN=ANKS1B PE=1 SV=2 g7680.t2 Q7Z6G8 40.129 466 2.77e-83 298.0 sp|Q7Z6G8|ANS1B_HUMAN Ankyrin repeat and sterile alpha motif domain-containing protein 1B OS=Homo sapiens OX=9606 GN=ANKS1B PE=1 SV=2 g7680.t3 Q7Z6G8 40.129 466 3.3e-83 298.0 sp|Q7Z6G8|ANS1B_HUMAN Ankyrin repeat and sterile alpha motif domain-containing protein 1B OS=Homo sapiens OX=9606 GN=ANKS1B PE=1 SV=2 g7682.t1 F7D3V9 27.633 883 2.68e-83 295.0 sp|F7D3V9|LGR5_XENTR Leucine-rich repeat-containing G-protein coupled receptor 5 OS=Xenopus tropicalis OX=8364 GN=lgr5 PE=2 SV=2 g7684.t1 Q5TKA1 55.536 560 0.0 552.0 sp|Q5TKA1|LIN9_HUMAN Protein lin-9 homolog OS=Homo sapiens OX=9606 GN=LIN9 PE=1 SV=1 LIN9_HUMAN reviewed Protein lin-9 homolog (HuLin-9) (hLin-9) (Beta subunit-associated regulator of apoptosis) (TUDOR gene similar protein) (Type I interferon receptor beta chain-associated protein) (pRB-associated protein) Homo sapiens (Human) GO:0003677; GO:0005654; GO:0006351; GO:0006357; GO:0017053; GO:0051726; GO:0071897 DNA biosynthetic process [GO:0071897]; DNA-templated transcription [GO:0006351]; regulation of cell cycle [GO:0051726]; regulation of transcription by RNA polymerase II [GO:0006357] nucleoplasm [GO:0005654]; transcription repressor complex [GO:0017053] DNA binding [GO:0003677] g7687.t1 Q14008 39.394 429 3.92e-83 281.0 sp|Q14008|CKAP5_HUMAN Cytoskeleton-associated protein 5 OS=Homo sapiens OX=9606 GN=CKAP5 PE=1 SV=3 g7687.t2 Q14008 39.815 432 2.7e-84 285.0 sp|Q14008|CKAP5_HUMAN Cytoskeleton-associated protein 5 OS=Homo sapiens OX=9606 GN=CKAP5 PE=1 SV=3 g7688.t1 Q9PT63 58.683 501 1.1e-179 594.0 sp|Q9PT63|CKAP5_XENLA Cytoskeleton-associated protein 5-A OS=Xenopus laevis OX=8355 GN=ckap5-a PE=1 SV=1 g7688.t1 Q9PT63 50.099 507 3.33e-146 499.0 sp|Q9PT63|CKAP5_XENLA Cytoskeleton-associated protein 5-A OS=Xenopus laevis OX=8355 GN=ckap5-a PE=1 SV=1 g7688.t1 Q9PT63 46.681 452 1.02e-112 400.0 sp|Q9PT63|CKAP5_XENLA Cytoskeleton-associated protein 5-A OS=Xenopus laevis OX=8355 GN=ckap5-a PE=1 SV=1 g7688.t2 Q14008 47.843 1020 0.0 900.0 sp|Q14008|CKAP5_HUMAN Cytoskeleton-associated protein 5 OS=Homo sapiens OX=9606 GN=CKAP5 PE=1 SV=3 g7688.t2 Q14008 57.57 502 6.62e-174 576.0 sp|Q14008|CKAP5_HUMAN Cytoskeleton-associated protein 5 OS=Homo sapiens OX=9606 GN=CKAP5 PE=1 SV=3 g7690.t1 Q5R868 30.545 275 8.64e-28 114.0 sp|Q5R868|PGAP4_PONAB GPI-N-acetylgalactosamine transferase PGAP4 OS=Pongo abelii OX=9601 GN=PGAP4 PE=2 SV=1 g7691.t1 P83877 88.732 142 4.55e-96 276.0 sp|P83877|TXN4A_MOUSE Thioredoxin-like protein 4A OS=Mus musculus OX=10090 GN=Txnl4a PE=1 SV=1 TXN4A_MOUSE reviewed Thioredoxin-like protein 4A (DIM1 protein homolog) (Spliceosomal U5 snRNP-specific 15 kDa protein) (Thioredoxin-like U5 snRNP protein U5-15kD) Mus musculus (Mouse) GO:0000398; GO:0004596; GO:0005634; GO:0005654; GO:0005681; GO:0005682; GO:0005737; GO:0005794; GO:0005813; GO:0005829; GO:0005929; GO:0031415; GO:0036064; GO:0046540; GO:0051301; GO:0071005 cell division [GO:0051301]; mRNA splicing, via spliceosome [GO:0000398] centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; NatA complex [GO:0031415]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682] protein-N-terminal amino-acid acetyltransferase activity [GO:0004596] g7692.t1 P34943 50.442 339 1.61e-122 361.0 sp|P34943|NDUA9_BOVIN NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 9, mitochondrial OS=Bos taurus OX=9913 GN=NDUFA9 PE=1 SV=1 g7693.t1 Q8BGA5 61.25 320 1.78e-131 384.0 sp|Q8BGA5|KRR1_MOUSE KRR1 small subunit processome component homolog OS=Mus musculus OX=10090 GN=Krr1 PE=2 SV=1 KRR1_MOUSE reviewed KRR1 small subunit processome component homolog (HIV-1 Rev-binding protein 2 homolog) (KRR-R motif-containing protein 1) Mus musculus (Mouse) GO:0003723; GO:0005654; GO:0005694; GO:0005730; GO:0006364; GO:0032040; GO:0042274; GO:0045171 ribosomal small subunit biogenesis [GO:0042274]; rRNA processing [GO:0006364] chromosome [GO:0005694]; intercellular bridge [GO:0045171]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; small-subunit processome [GO:0032040] RNA binding [GO:0003723] g7694.t1 Q6YGZ5 50.248 605 0.0 549.0 sp|Q6YGZ5|BMAL1_TYTAL Basic helix-loop-helix ARNT-like protein 1 OS=Tyto alba OX=56313 GN=BMAL1 PE=2 SV=1 g7694.t2 Q6YGZ5 50.248 605 0.0 549.0 sp|Q6YGZ5|BMAL1_TYTAL Basic helix-loop-helix ARNT-like protein 1 OS=Tyto alba OX=56313 GN=BMAL1 PE=2 SV=1 g7695.t1 Q62018 78.579 887 0.0 1434.0 sp|Q62018|CTR9_MOUSE RNA polymerase-associated protein CTR9 homolog OS=Mus musculus OX=10090 GN=Ctr9 PE=1 SV=2 CTR9_MOUSE reviewed RNA polymerase-associated protein CTR9 homolog (SH2 domain-binding protein 1) (Tetratricopeptide repeat-containing, SH2-binding phosphoprotein of 150 kDa) (TPR-containing, SH2-binding phosphoprotein of 150 kDa) (p150TSP) Mus musculus (Mouse) GO:0000122; GO:0000791; GO:0000993; GO:0001711; GO:0001826; GO:0001829; GO:0001832; GO:0001835; GO:0005634; GO:0005654; GO:0006325; GO:0006368; GO:0007259; GO:0016055; GO:0016593; GO:0016607; GO:0019827; GO:0042169; GO:0045638; GO:0045814; GO:0045944; GO:0070102; GO:0071222 blastocyst growth [GO:0001832]; blastocyst hatching [GO:0001835]; cell surface receptor signaling pathway via JAK-STAT [GO:0007259]; cellular response to lipopolysaccharide [GO:0071222]; chromatin organization [GO:0006325]; endodermal cell fate commitment [GO:0001711]; inner cell mass cell differentiation [GO:0001826]; interleukin-6-mediated signaling pathway [GO:0070102]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of myeloid cell differentiation [GO:0045638]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; stem cell population maintenance [GO:0019827]; transcription elongation by RNA polymerase II [GO:0006368]; trophectodermal cell differentiation [GO:0001829]; Wnt signaling pathway [GO:0016055] Cdc73/Paf1 complex [GO:0016593]; euchromatin [GO:0000791]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] RNA polymerase II complex binding [GO:0000993]; SH2 domain binding [GO:0042169] g7696.t1 Q9D4V0 47.175 354 4.79e-118 348.0 sp|Q9D4V0|EKI1_MOUSE Ethanolamine kinase 1 OS=Mus musculus OX=10090 GN=Etnk1 PE=1 SV=2 g7697.t1 Q9DER7 27.949 551 7.519999999999999e-54 208.0 sp|Q9DER7|TLL1_CHICK Tolloid-like protein 1 OS=Gallus gallus OX=9031 GN=TLL1 PE=2 SV=1 g7697.t1 Q9DER7 25.822 608 3.4600000000000004e-47 187.0 sp|Q9DER7|TLL1_CHICK Tolloid-like protein 1 OS=Gallus gallus OX=9031 GN=TLL1 PE=2 SV=1 g7697.t1 Q9DER7 24.948 485 5.08e-32 139.0 sp|Q9DER7|TLL1_CHICK Tolloid-like protein 1 OS=Gallus gallus OX=9031 GN=TLL1 PE=2 SV=1 g7699.t1 F1RWC3 25.427 586 3.72e-24 113.0 sp|F1RWC3|CUBN_PIG Cubilin OS=Sus scrofa OX=9823 GN=CUBN PE=1 SV=3 CUBN_PIG reviewed Cubilin (Intrinsic factor-cobalamin receptor) Sus scrofa (Pig) GO:0004252; GO:0005509; GO:0005615; GO:0005765; GO:0005768; GO:0005905; GO:0008203; GO:0015031; GO:0016324; GO:0031419 cholesterol metabolic process [GO:0008203]; protein transport [GO:0015031] apical plasma membrane [GO:0016324]; clathrin-coated pit [GO:0005905]; endosome [GO:0005768]; extracellular space [GO:0005615]; lysosomal membrane [GO:0005765] calcium ion binding [GO:0005509]; cobalamin binding [GO:0031419]; serine-type endopeptidase activity [GO:0004252] g7699.t1 F1RWC3 23.744 577 1.18e-22 108.0 sp|F1RWC3|CUBN_PIG Cubilin OS=Sus scrofa OX=9823 GN=CUBN PE=1 SV=3 CUBN_PIG reviewed Cubilin (Intrinsic factor-cobalamin receptor) Sus scrofa (Pig) GO:0004252; GO:0005509; GO:0005615; GO:0005765; GO:0005768; GO:0005905; GO:0008203; GO:0015031; GO:0016324; GO:0031419 cholesterol metabolic process [GO:0008203]; protein transport [GO:0015031] apical plasma membrane [GO:0016324]; clathrin-coated pit [GO:0005905]; endosome [GO:0005768]; extracellular space [GO:0005615]; lysosomal membrane [GO:0005765] calcium ion binding [GO:0005509]; cobalamin binding [GO:0031419]; serine-type endopeptidase activity [GO:0004252] g7705.t1 Q9VBW3 42.295 305 1.06e-76 259.0 sp|Q9VBW3|CAD96_DROME Tyrosine kinase receptor Cad96Ca OS=Drosophila melanogaster OX=7227 GN=Cad96Ca PE=2 SV=2 CAD96_DROME reviewed Tyrosine kinase receptor Cad96Ca (EC 2.7.10.1) (Cadherin-96Ca) (Tyrosine kinase receptor HD-14) Drosophila melanogaster (Fruit fly) GO:0004713; GO:0004714; GO:0005509; GO:0005524; GO:0005886; GO:0006468; GO:0007030; GO:0007156; GO:0007169; GO:0016339; GO:0042060; GO:0043235; GO:0045177; GO:0045792; GO:0051897; GO:0090303 calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; Golgi organization [GO:0007030]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell size [GO:0045792]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of wound healing [GO:0090303]; protein phosphorylation [GO:0006468]; wound healing [GO:0042060] apical part of cell [GO:0045177]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; protein tyrosine kinase activity [GO:0004713]; transmembrane receptor protein tyrosine kinase activity [GO:0004714] g7708.t1 Q9VBW3 41.806 299 5.210000000000001e-73 252.0 sp|Q9VBW3|CAD96_DROME Tyrosine kinase receptor Cad96Ca OS=Drosophila melanogaster OX=7227 GN=Cad96Ca PE=2 SV=2 CAD96_DROME reviewed Tyrosine kinase receptor Cad96Ca (EC 2.7.10.1) (Cadherin-96Ca) (Tyrosine kinase receptor HD-14) Drosophila melanogaster (Fruit fly) GO:0004713; GO:0004714; GO:0005509; GO:0005524; GO:0005886; GO:0006468; GO:0007030; GO:0007156; GO:0007169; GO:0016339; GO:0042060; GO:0043235; GO:0045177; GO:0045792; GO:0051897; GO:0090303 calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; Golgi organization [GO:0007030]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell size [GO:0045792]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of wound healing [GO:0090303]; protein phosphorylation [GO:0006468]; wound healing [GO:0042060] apical part of cell [GO:0045177]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; protein tyrosine kinase activity [GO:0004713]; transmembrane receptor protein tyrosine kinase activity [GO:0004714] g7710.t1 P54145 50.353 425 1.12e-98 310.0 sp|P54145|AMT1_CAEEL Putative ammonium transporter 1 OS=Caenorhabditis elegans OX=6239 GN=amt-1 PE=3 SV=1 g7713.t1 Q9VBW3 41.806 299 8.3e-74 253.0 sp|Q9VBW3|CAD96_DROME Tyrosine kinase receptor Cad96Ca OS=Drosophila melanogaster OX=7227 GN=Cad96Ca PE=2 SV=2 CAD96_DROME reviewed Tyrosine kinase receptor Cad96Ca (EC 2.7.10.1) (Cadherin-96Ca) (Tyrosine kinase receptor HD-14) Drosophila melanogaster (Fruit fly) GO:0004713; GO:0004714; GO:0005509; GO:0005524; GO:0005886; GO:0006468; GO:0007030; GO:0007156; GO:0007169; GO:0016339; GO:0042060; GO:0043235; GO:0045177; GO:0045792; GO:0051897; GO:0090303 calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; Golgi organization [GO:0007030]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell size [GO:0045792]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of wound healing [GO:0090303]; protein phosphorylation [GO:0006468]; wound healing [GO:0042060] apical part of cell [GO:0045177]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; protein tyrosine kinase activity [GO:0004713]; transmembrane receptor protein tyrosine kinase activity [GO:0004714] g7715.t1 Q9VBW3 45.993 287 4.3300000000000004e-85 273.0 sp|Q9VBW3|CAD96_DROME Tyrosine kinase receptor Cad96Ca OS=Drosophila melanogaster OX=7227 GN=Cad96Ca PE=2 SV=2 CAD96_DROME reviewed Tyrosine kinase receptor Cad96Ca (EC 2.7.10.1) (Cadherin-96Ca) (Tyrosine kinase receptor HD-14) Drosophila melanogaster (Fruit fly) GO:0004713; GO:0004714; GO:0005509; GO:0005524; GO:0005886; GO:0006468; GO:0007030; GO:0007156; GO:0007169; GO:0016339; GO:0042060; GO:0043235; GO:0045177; GO:0045792; GO:0051897; GO:0090303 calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; Golgi organization [GO:0007030]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell size [GO:0045792]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of wound healing [GO:0090303]; protein phosphorylation [GO:0006468]; wound healing [GO:0042060] apical part of cell [GO:0045177]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; protein tyrosine kinase activity [GO:0004713]; transmembrane receptor protein tyrosine kinase activity [GO:0004714] g7718.t1 D4A734 24.724 453 7.32e-26 113.0 sp|D4A734|MOT12_RAT Monocarboxylate transporter 12 OS=Rattus norvegicus OX=10116 GN=Slc16a12 PE=1 SV=1 g7719.t1 Q9VBW3 40.356 337 2.1e-78 267.0 sp|Q9VBW3|CAD96_DROME Tyrosine kinase receptor Cad96Ca OS=Drosophila melanogaster OX=7227 GN=Cad96Ca PE=2 SV=2 CAD96_DROME reviewed Tyrosine kinase receptor Cad96Ca (EC 2.7.10.1) (Cadherin-96Ca) (Tyrosine kinase receptor HD-14) Drosophila melanogaster (Fruit fly) GO:0004713; GO:0004714; GO:0005509; GO:0005524; GO:0005886; GO:0006468; GO:0007030; GO:0007156; GO:0007169; GO:0016339; GO:0042060; GO:0043235; GO:0045177; GO:0045792; GO:0051897; GO:0090303 calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; Golgi organization [GO:0007030]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell size [GO:0045792]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of wound healing [GO:0090303]; protein phosphorylation [GO:0006468]; wound healing [GO:0042060] apical part of cell [GO:0045177]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; protein tyrosine kinase activity [GO:0004713]; transmembrane receptor protein tyrosine kinase activity [GO:0004714] g7722.t1 Q9VBW3 40.717 307 7.11e-76 259.0 sp|Q9VBW3|CAD96_DROME Tyrosine kinase receptor Cad96Ca OS=Drosophila melanogaster OX=7227 GN=Cad96Ca PE=2 SV=2 CAD96_DROME reviewed Tyrosine kinase receptor Cad96Ca (EC 2.7.10.1) (Cadherin-96Ca) (Tyrosine kinase receptor HD-14) Drosophila melanogaster (Fruit fly) GO:0004713; GO:0004714; GO:0005509; GO:0005524; GO:0005886; GO:0006468; GO:0007030; GO:0007156; GO:0007169; GO:0016339; GO:0042060; GO:0043235; GO:0045177; GO:0045792; GO:0051897; GO:0090303 calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; Golgi organization [GO:0007030]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell size [GO:0045792]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of wound healing [GO:0090303]; protein phosphorylation [GO:0006468]; wound healing [GO:0042060] apical part of cell [GO:0045177]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; protein tyrosine kinase activity [GO:0004713]; transmembrane receptor protein tyrosine kinase activity [GO:0004714] g7727.t1 O88572 54.718 1632 0.0 1752.0 sp|O88572|LRP6_MOUSE Low-density lipoprotein receptor-related protein 6 OS=Mus musculus OX=10090 GN=Lrp6 PE=1 SV=1 LRP6_MOUSE reviewed Low-density lipoprotein receptor-related protein 6 (LRP-6) Mus musculus (Mouse) GO:0001702; GO:0001756; GO:0001843; GO:0001947; GO:0002053; GO:0003344; GO:0003401; GO:0005041; GO:0005102; GO:0005109; GO:0005769; GO:0005783; GO:0005886; GO:0006355; GO:0007204; GO:0007268; GO:0007399; GO:0008078; GO:0009880; GO:0009950; GO:0009952; GO:0009986; GO:0010976; GO:0014029; GO:0014033; GO:0015026; GO:0016020; GO:0016055; GO:0017147; GO:0019210; GO:0019534; GO:0021587; GO:0021794; GO:0021795; GO:0021861; GO:0021872; GO:0021915; GO:0021943; GO:0021987; GO:0030291; GO:0030326; GO:0030900; GO:0030901; GO:0030917; GO:0031410; GO:0034185; GO:0034392; GO:0035108; GO:0035115; GO:0035116; GO:0035261; GO:0036342; GO:0042074; GO:0042127; GO:0042475; GO:0042733; GO:0042802; GO:0042803; GO:0042813; GO:0043025; GO:0043065; GO:0045121; GO:0045202; GO:0045599; GO:0045778; GO:0045780; GO:0045787; GO:0045893; GO:0045944; GO:0046849; GO:0048596; GO:0048699; GO:0048705; GO:0050680; GO:0051593; GO:0060021; GO:0060026; GO:0060042; GO:0060059; GO:0060070; GO:0060284; GO:0060325; GO:0060444; GO:0060535; GO:0060596; GO:0060603; GO:0060856; GO:0071397; GO:0071542; GO:0072659; GO:0090009; GO:0090118; GO:0090245; GO:0098609; GO:0110135; GO:1990851; GO:1990909; GO:1990963; GO:2000051 anterior/posterior pattern specification [GO:0009952]; axis elongation [GO:0003401]; axis elongation involved in somitogenesis [GO:0090245]; bone remodeling [GO:0046849]; branching involved in mammary gland duct morphogenesis [GO:0060444]; canonical Wnt signaling pathway [GO:0060070]; cell migration involved in gastrulation [GO:0042074]; cell-cell adhesion [GO:0098609]; cellular response to cholesterol [GO:0071397]; cerebellum morphogenesis [GO:0021587]; cerebral cortex cell migration [GO:0021795]; cerebral cortex development [GO:0021987]; chemical synaptic transmission [GO:0007268]; convergent extension [GO:0060026]; dopaminergic neuron differentiation [GO:0071542]; dorsal/ventral axis specification [GO:0009950]; embryonic camera-type eye morphogenesis [GO:0048596]; embryonic digit morphogenesis [GO:0042733]; embryonic forelimb morphogenesis [GO:0035115]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic limb morphogenesis [GO:0030326]; embryonic pattern specification [GO:0009880]; embryonic retina morphogenesis in camera-type eye [GO:0060059]; establishment of blood-brain barrier [GO:0060856]; establishment of blood-retinal barrier [GO:1990963]; external genitalia morphogenesis [GO:0035261]; face morphogenesis [GO:0060325]; forebrain development [GO:0030900]; forebrain generation of neurons [GO:0021872]; forebrain radial glial cell differentiation [GO:0021861]; formation of radial glial scaffolds [GO:0021943]; gastrulation with mouth forming second [GO:0001702]; generation of neurons [GO:0048699]; heart looping [GO:0001947]; limb morphogenesis [GO:0035108]; mammary gland duct morphogenesis [GO:0060603]; mammary placode formation [GO:0060596]; mesodermal cell migration [GO:0008078]; midbrain development [GO:0030901]; midbrain-hindbrain boundary development [GO:0030917]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of non-canonical Wnt signaling pathway [GO:2000051]; negative regulation of smooth muscle cell apoptotic process [GO:0034392]; nervous system development [GO:0007399]; neural crest cell differentiation [GO:0014033]; neural crest formation [GO:0014029]; neural tube closure [GO:0001843]; neural tube development [GO:0021915]; Norrin signaling pathway [GO:0110135]; odontogenesis of dentin-containing tooth [GO:0042475]; pericardium morphogenesis [GO:0003344]; positive regulation of apoptotic process [GO:0043065]; positive regulation of bone resorption [GO:0045780]; positive regulation of cell cycle [GO:0045787]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of neuron projection development [GO:0010976]; positive regulation of ossification [GO:0045778]; positive regulation of transcription by RNA polymerase II [GO:0045944]; post-anal tail morphogenesis [GO:0036342]; primitive streak formation [GO:0090009]; protein localization to plasma membrane [GO:0072659]; receptor-mediated endocytosis involved in cholesterol transport [GO:0090118]; regulation of cell development [GO:0060284]; regulation of cell population proliferation [GO:0042127]; regulation of DNA-templated transcription [GO:0006355]; response to folic acid [GO:0051593]; retina morphogenesis in camera-type eye [GO:0060042]; roof of mouth development [GO:0060021]; skeletal system morphogenesis [GO:0048705]; somitogenesis [GO:0001756]; thalamus development [GO:0021794]; trachea cartilage morphogenesis [GO:0060535]; Wnt signaling pathway [GO:0016055] cell surface [GO:0009986]; cytoplasmic vesicle [GO:0031410]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; membrane [GO:0016020]; membrane raft [GO:0045121]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; synapse [GO:0045202]; Wnt signalosome [GO:1990909]; Wnt-Frizzled-LRP5/6 complex [GO:1990851] apolipoprotein binding [GO:0034185]; coreceptor activity [GO:0015026]; frizzled binding [GO:0005109]; identical protein binding [GO:0042802]; kinase inhibitor activity [GO:0019210]; low-density lipoprotein particle receptor activity [GO:0005041]; protein homodimerization activity [GO:0042803]; protein serine/threonine kinase inhibitor activity [GO:0030291]; signaling receptor binding [GO:0005102]; toxin transmembrane transporter activity [GO:0019534]; Wnt receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147] g7728.t1 Q96QU6 37.674 430 7.309999999999999e-104 323.0 sp|Q96QU6|1A1L1_HUMAN 1-aminocyclopropane-1-carboxylate synthase-like protein 1 OS=Homo sapiens OX=9606 GN=ACCS PE=1 SV=1 g7732.t1 A2A6H3 37.562 402 1.0300000000000001e-79 258.0 sp|A2A6H3|FBX47_MOUSE F-box only protein 47 OS=Mus musculus OX=10090 GN=Fbxo47 PE=2 SV=2 g7733.t1 Q3T0K1 56.678 307 4.64e-113 333.0 sp|Q3T0K1|CALU_BOVIN Calumenin OS=Bos taurus OX=9913 GN=CALU PE=2 SV=1 CALU_BOVIN reviewed Calumenin Bos taurus (Bovine) GO:0005509; GO:0005576; GO:0005783; GO:0005789; GO:0005794; GO:0033018; GO:0042470 endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; melanosome [GO:0042470]; sarcoplasmic reticulum lumen [GO:0033018] calcium ion binding [GO:0005509] g7733.t2 Q3T0K1 57.468 308 1.2e-117 345.0 sp|Q3T0K1|CALU_BOVIN Calumenin OS=Bos taurus OX=9913 GN=CALU PE=2 SV=1 CALU_BOVIN reviewed Calumenin Bos taurus (Bovine) GO:0005509; GO:0005576; GO:0005783; GO:0005789; GO:0005794; GO:0033018; GO:0042470 endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; melanosome [GO:0042470]; sarcoplasmic reticulum lumen [GO:0033018] calcium ion binding [GO:0005509] g7734.t1 Q9GZR5 46.181 288 1.7e-90 274.0 sp|Q9GZR5|ELOV4_HUMAN Very long chain fatty acid elongase 4 OS=Homo sapiens OX=9606 GN=ELOVL4 PE=1 SV=1 ELOV4_HUMAN reviewed Very long chain fatty acid elongase 4 (EC 2.3.1.199) (3-keto acyl-CoA synthase ELOVL4) (ELOVL fatty acid elongase 4) (ELOVL FA elongase 4) (Elongation of very long chain fatty acids protein 4) (Very long chain 3-ketoacyl-CoA synthase 4) (Very long chain 3-oxoacyl-CoA synthase 4) Homo sapiens (Human) GO:0005783; GO:0005789; GO:0006633; GO:0006636; GO:0008020; GO:0009922; GO:0019367; GO:0030148; GO:0034625; GO:0034626; GO:0035338; GO:0042761 fatty acid biosynthetic process [GO:0006633]; fatty acid elongation, monounsaturated fatty acid [GO:0034625]; fatty acid elongation, polyunsaturated fatty acid [GO:0034626]; fatty acid elongation, saturated fatty acid [GO:0019367]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; sphingolipid biosynthetic process [GO:0030148]; unsaturated fatty acid biosynthetic process [GO:0006636]; very long-chain fatty acid biosynthetic process [GO:0042761] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789] fatty acid elongase activity [GO:0009922]; G protein-coupled photoreceptor activity [GO:0008020] g7735.t1 Q3S8M4 51.838 272 2.35e-96 289.0 sp|Q3S8M4|ELOV4_MACMU Very long chain fatty acid elongase 4 OS=Macaca mulatta OX=9544 GN=ELOVL4 PE=3 SV=1 ELOV4_MACMU reviewed Very long chain fatty acid elongase 4 (EC 2.3.1.199) (3-keto acyl-CoA synthase ELOVL4) (ELOVL fatty acid elongase 4) (ELOVL FA elongase 4) (Elongation of very long chain fatty acids protein 4) (Very long chain 3-ketoacyl-CoA synthase 4) (Very long chain 3-oxoacyl-CoA synthase 4) Macaca mulatta (Rhesus macaque) GO:0005783; GO:0005789; GO:0006636; GO:0009922; GO:0019367; GO:0030148; GO:0034625; GO:0034626; GO:0035338; GO:0042761 fatty acid elongation, monounsaturated fatty acid [GO:0034625]; fatty acid elongation, polyunsaturated fatty acid [GO:0034626]; fatty acid elongation, saturated fatty acid [GO:0019367]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; sphingolipid biosynthetic process [GO:0030148]; unsaturated fatty acid biosynthetic process [GO:0006636]; very long-chain fatty acid biosynthetic process [GO:0042761] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789] fatty acid elongase activity [GO:0009922] g7739.t1 O93257 49.396 579 0.0 561.0 sp|O93257|XRCC6_CHICK X-ray repair cross-complementing protein 5 OS=Gallus gallus OX=9031 GN=XRCC6 PE=2 SV=1 g7740.t1 Q8TC57 32.934 501 1.53e-66 227.0 sp|Q8TC57|M1AP_HUMAN Meiosis 1 arrest protein OS=Homo sapiens OX=9606 GN=M1AP PE=1 SV=1 M1AP_HUMAN reviewed Meiosis 1 arrest protein (Meiosis 1-arresting protein) (Meiosis 1-associated protein) (Spermatogenesis-associated protein 37) Homo sapiens (Human) GO:0005737; GO:0006325; GO:0006396; GO:0007127; GO:0007283; GO:0007292; GO:0016020; GO:0030154; GO:0042802; GO:0051308 cell differentiation [GO:0030154]; chromatin organization [GO:0006325]; female gamete generation [GO:0007292]; male meiosis chromosome separation [GO:0051308]; meiosis I [GO:0007127]; RNA processing [GO:0006396]; spermatogenesis [GO:0007283] cytoplasm [GO:0005737]; membrane [GO:0016020] identical protein binding [GO:0042802] g7741.t1 Q3U1J4 74.781 1142 0.0 1806.0 sp|Q3U1J4|DDB1_MOUSE DNA damage-binding protein 1 OS=Mus musculus OX=10090 GN=Ddb1 PE=1 SV=2 DDB1_MOUSE reviewed DNA damage-binding protein 1 (DDB p127 subunit) (Damage-specific DNA-binding protein 1) (UV-damaged DNA-binding factor) Mus musculus (Mouse) GO:0003684; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006281; GO:0006511; GO:0006974; GO:0007056; GO:0010498; GO:0016055; GO:0016567; GO:0019076; GO:0030674; GO:0031464; GO:0031465; GO:0032991; GO:0034644; GO:0035861; GO:0042752; GO:0043066; GO:0043161; GO:0044725; GO:0044877; GO:0045070; GO:0045722; GO:0045732; GO:0046726; GO:0048511; GO:0051702; GO:0051898; GO:0060337; GO:0070914; GO:0071987; GO:0080008; GO:0097510; GO:0097602; GO:0160072; GO:1901990 base-excision repair, AP site formation via deaminated base removal [GO:0097510]; biological process involved in interaction with symbiont [GO:0051702]; cellular response to UV [GO:0034644]; DNA damage response [GO:0006974]; DNA repair [GO:0006281]; epigenetic programming in the zygotic pronuclei [GO:0044725]; negative regulation of apoptotic process [GO:0043066]; negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051898]; positive regulation by virus of viral protein levels in host cell [GO:0046726]; positive regulation of gluconeogenesis [GO:0045722]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of viral genome replication [GO:0045070]; proteasomal protein catabolic process [GO:0010498]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of circadian rhythm [GO:0042752]; regulation of mitotic cell cycle phase transition [GO:1901990]; rhythmic process [GO:0048511]; spindle assembly involved in female meiosis [GO:0007056]; type I interferon-mediated signaling pathway [GO:0060337]; ubiquitin-dependent protein catabolic process [GO:0006511]; UV-damage excision repair [GO:0070914]; viral release from host cell [GO:0019076]; Wnt signaling pathway [GO:0016055] Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]; Cul4B-RING E3 ubiquitin ligase complex [GO:0031465]; cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; site of double-strand break [GO:0035861] cullin family protein binding [GO:0097602]; damaged DNA binding [GO:0003684]; protein-containing complex binding [GO:0044877]; protein-macromolecule adaptor activity [GO:0030674]; ubiquitin ligase complex scaffold activity [GO:0160072]; WD40-repeat domain binding [GO:0071987] g7742.t1 O94739 53.125 160 2.47e-53 169.0 sp|O94739|CALM_PLEOS Calmodulin OS=Pleurotus ostreatus OX=5322 GN=CMD1 PE=2 SV=3 g7743.t1 P70389 32.338 402 2.39e-27 122.0 sp|P70389|ALS_MOUSE Insulin-like growth factor-binding protein complex acid labile subunit OS=Mus musculus OX=10090 GN=Igfals PE=1 SV=1 g7744.t1 P47238 61.678 441 3.19e-150 437.0 sp|P47238|PAX6_COTJA Paired box protein Pax-6 OS=Coturnix japonica OX=93934 GN=PAX6 PE=2 SV=1 g7744.t2 P47238 61.678 441 1.99e-150 437.0 sp|P47238|PAX6_COTJA Paired box protein Pax-6 OS=Coturnix japonica OX=93934 GN=PAX6 PE=2 SV=1 g7749.t1 Q9CQU8 40.252 159 3.52e-42 141.0 sp|Q9CQU8|IMP1L_MOUSE Mitochondrial inner membrane protease subunit 1 OS=Mus musculus OX=10090 GN=Immp1l PE=1 SV=1 g7750.t1 Q62448 47.368 874 0.0 725.0 sp|Q62448|IF4G2_MOUSE Eukaryotic translation initiation factor 4 gamma 2 OS=Mus musculus OX=10090 GN=Eif4g2 PE=1 SV=2 IF4G2_MOUSE reviewed Eukaryotic translation initiation factor 4 gamma 2 (eIF-4-gamma 2) (eIF-4G 2) (eIF4G 2) (Novel APOBEC-1 target 1) (Translation repressor NAT1) (p97) Mus musculus (Mouse) GO:0003729; GO:0003743; GO:0005737; GO:0005829; GO:0006413; GO:0006446; GO:0008135; GO:0010507; GO:0014069; GO:0016281; GO:0030307; GO:0030424; GO:0045727; GO:0045773; GO:0060999 negative regulation of autophagy [GO:0010507]; positive regulation of axon extension [GO:0045773]; positive regulation of cell growth [GO:0030307]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of translation [GO:0045727]; regulation of translational initiation [GO:0006446]; translational initiation [GO:0006413] axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; eukaryotic translation initiation factor 4F complex [GO:0016281]; postsynaptic density [GO:0014069] mRNA binding [GO:0003729]; translation factor activity, RNA binding [GO:0008135]; translation initiation factor activity [GO:0003743] g7755.t1 Q6GP15 50.943 212 3.15e-63 235.0 sp|Q6GP15|MED25_XENLA Mediator of RNA polymerase II transcription subunit 25 OS=Xenopus laevis OX=8355 GN=med25 PE=2 SV=1 g7755.t1 Q6GP15 45.699 186 3.73e-33 142.0 sp|Q6GP15|MED25_XENLA Mediator of RNA polymerase II transcription subunit 25 OS=Xenopus laevis OX=8355 GN=med25 PE=2 SV=1 g7756.t1 Q96EB1 50.267 187 2.86e-58 191.0 sp|Q96EB1|ELP4_HUMAN Elongator complex protein 4 OS=Homo sapiens OX=9606 GN=ELP4 PE=1 SV=2 ELP4_HUMAN reviewed Elongator complex protein 4 (hELP4) (PAX6 neighbor gene protein) Homo sapiens (Human) GO:0002098; GO:0005654; GO:0005737; GO:0006357; GO:0006417; GO:0008023; GO:0033588 regulation of transcription by RNA polymerase II [GO:0006357]; regulation of translation [GO:0006417]; tRNA wobble uridine modification [GO:0002098] cytoplasm [GO:0005737]; elongator holoenzyme complex [GO:0033588]; nucleoplasm [GO:0005654]; transcription elongation factor complex [GO:0008023] g7757.t1 Q5XG58 55.621 169 1.78e-49 167.0 sp|Q5XG58|ELP4_XENLA Elongator complex protein 4 OS=Xenopus laevis OX=8355 GN=elp4 PE=2 SV=1 g7760.t1 Q84DC4 34.884 473 3.4900000000000005e-73 242.0 sp|Q84DC4|MANHY_PSEPU Mandelamide hydrolase OS=Pseudomonas putida OX=303 GN=mdlY PE=1 SV=1 g7761.t1 Q84DC4 41.872 203 1.33e-33 129.0 sp|Q84DC4|MANHY_PSEPU Mandelamide hydrolase OS=Pseudomonas putida OX=303 GN=mdlY PE=1 SV=1 g7763.t1 Q84DC4 34.755 469 4.2200000000000004e-70 235.0 sp|Q84DC4|MANHY_PSEPU Mandelamide hydrolase OS=Pseudomonas putida OX=303 GN=mdlY PE=1 SV=1 g7768.t1 P78524 43.187 477 1.62e-96 335.0 sp|P78524|DEN2B_HUMAN DENN domain-containing protein 2B OS=Homo sapiens OX=9606 GN=DENND2B PE=1 SV=3 DEN2B_HUMAN reviewed DENN domain-containing protein 2B (HeLa tumor suppression 1) (Suppression of tumorigenicity 5 protein) Homo sapiens (Human) GO:0005085; GO:0005886; GO:0005938; GO:0055037; GO:0070374 positive regulation of ERK1 and ERK2 cascade [GO:0070374] cell cortex [GO:0005938]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037] guanyl-nucleotide exchange factor activity [GO:0005085] g7768.t2 Q924W7 43.187 477 8.29e-97 336.0 sp|Q924W7|DEN2B_MOUSE DENN domain-containing protein 2B OS=Mus musculus OX=10090 GN=Dennd2b PE=1 SV=1 g7769.t1 Q01134 46.462 325 9.98e-94 293.0 sp|Q01134|CHKA_RAT Choline kinase alpha OS=Rattus norvegicus OX=10116 GN=Chka PE=1 SV=2 g7775.t1 Q0V8T4 31.959 194 6.560000000000001e-21 100.0 sp|Q0V8T4|CTP5C_RAT Contactin-associated protein like 5-3 OS=Rattus norvegicus OX=10116 GN=Cntnap5c PE=2 SV=1 CTP5C_RAT reviewed Contactin-associated protein like 5-3 (Cell recognition molecule Caspr5-3) (Cell recognition molecule Caspr5c) (Contactin-associated protein-like 5c) Rattus norvegicus (Rat) GO:0001895; GO:0005509; GO:0005604; GO:0007155; GO:0016020; GO:0030054 cell adhesion [GO:0007155]; retina homeostasis [GO:0001895] basement membrane [GO:0005604]; cell junction [GO:0030054]; membrane [GO:0016020] calcium ion binding [GO:0005509] g7778.t1 Q5ZEQ8 28.341 434 3.4899999999999994e-42 160.0 sp|Q5ZEQ8|FJX1_XIPMA Four-jointed box protein 1 OS=Xiphophorus maculatus OX=8083 GN=fjx1 PE=2 SV=1 g7780.t1 B9EJ86 62.78 446 0.0 566.0 sp|B9EJ86|OSBL8_MOUSE Oxysterol-binding protein-related protein 8 OS=Mus musculus OX=10090 GN=Osbpl8 PE=1 SV=1 OSBL8_MOUSE reviewed Oxysterol-binding protein-related protein 8 (ORP-8) (OSBP-related protein 8) Mus musculus (Mouse) GO:0001786; GO:0005783; GO:0005789; GO:0005829; GO:0015485; GO:0015914; GO:0016020; GO:0030336; GO:0031965; GO:0032541; GO:0045444; GO:0046326; GO:0046628; GO:0051897; GO:0070273; GO:0070328; GO:0090204; GO:0140343 fat cell differentiation [GO:0045444]; negative regulation of cell migration [GO:0030336]; phospholipid transport [GO:0015914]; positive regulation of D-glucose import [GO:0046326]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; protein localization to nuclear pore [GO:0090204]; triglyceride homeostasis [GO:0070328] cortical endoplasmic reticulum [GO:0032541]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; nuclear membrane [GO:0031965] cholesterol binding [GO:0015485]; phosphatidylinositol-4-phosphate binding [GO:0070273]; phosphatidylserine binding [GO:0001786]; phosphatidylserine transfer activity [GO:0140343] g7781.t1 B9EJ86 42.541 362 5.04e-82 270.0 sp|B9EJ86|OSBL8_MOUSE Oxysterol-binding protein-related protein 8 OS=Mus musculus OX=10090 GN=Osbpl8 PE=1 SV=1 OSBL8_MOUSE reviewed Oxysterol-binding protein-related protein 8 (ORP-8) (OSBP-related protein 8) Mus musculus (Mouse) GO:0001786; GO:0005783; GO:0005789; GO:0005829; GO:0015485; GO:0015914; GO:0016020; GO:0030336; GO:0031965; GO:0032541; GO:0045444; GO:0046326; GO:0046628; GO:0051897; GO:0070273; GO:0070328; GO:0090204; GO:0140343 fat cell differentiation [GO:0045444]; negative regulation of cell migration [GO:0030336]; phospholipid transport [GO:0015914]; positive regulation of D-glucose import [GO:0046326]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; protein localization to nuclear pore [GO:0090204]; triglyceride homeostasis [GO:0070328] cortical endoplasmic reticulum [GO:0032541]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; nuclear membrane [GO:0031965] cholesterol binding [GO:0015485]; phosphatidylinositol-4-phosphate binding [GO:0070273]; phosphatidylserine binding [GO:0001786]; phosphatidylserine transfer activity [GO:0140343] g7785.t1 Q8IWQ3 58.954 631 0.0 649.0 sp|Q8IWQ3|BRSK2_HUMAN Serine/threonine-protein kinase BRSK2 OS=Homo sapiens OX=9606 GN=BRSK2 PE=1 SV=3 g7791.t1 Q8BSS9 52.039 1226 0.0 994.0 sp|Q8BSS9|LIPA2_MOUSE Liprin-alpha-2 OS=Mus musculus OX=10090 GN=Ppfia2 PE=1 SV=2 LIPA2_MOUSE reviewed Liprin-alpha-2 (Protein tyrosine phosphatase receptor type f polypeptide-interacting protein alpha-2) (PTPRF-interacting protein alpha-2) Mus musculus (Mouse) GO:0008021; GO:0009986; GO:0014069; GO:0030424; GO:0042734; GO:0043197; GO:0044877; GO:0045202; GO:0048786; GO:0050808; GO:0060998; GO:0061001; GO:0098919; GO:0098978; GO:0099181; GO:0099519; GO:0099523; GO:0099572; GO:2000300 dense core granule cytoskeletal transport [GO:0099519]; regulation of dendritic spine development [GO:0060998]; regulation of dendritic spine morphogenesis [GO:0061001]; regulation of synaptic vesicle exocytosis [GO:2000300]; synapse organization [GO:0050808] axon [GO:0030424]; cell surface [GO:0009986]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; postsynaptic density [GO:0014069]; postsynaptic specialization [GO:0099572]; presynaptic active zone [GO:0048786]; presynaptic cytosol [GO:0099523]; presynaptic membrane [GO:0042734]; synapse [GO:0045202]; synaptic vesicle [GO:0008021] protein-containing complex binding [GO:0044877]; structural constituent of postsynaptic density [GO:0098919]; structural constituent of presynapse [GO:0099181] g7793.t1 Q3T906 62.857 70 6.98e-26 103.0 sp|Q3T906|GNPTA_HUMAN N-acetylglucosamine-1-phosphotransferase subunits alpha/beta OS=Homo sapiens OX=9606 GN=GNPTAB PE=1 SV=1 GNPTA_HUMAN reviewed N-acetylglucosamine-1-phosphotransferase subunits alpha/beta (EC 2.7.8.17) (GlcNAc-1-phosphotransferase subunits alpha/beta) (Stealth protein GNPTAB) (UDP-N-acetylglucosamine-1-phosphotransferase subunits alpha/beta) [Cleaved into: N-acetylglucosamine-1-phosphotransferase subunit alpha; N-acetylglucosamine-1-phosphotransferase subunit beta] Homo sapiens (Human) GO:0000139; GO:0003976; GO:0005509; GO:0005794; GO:0007040; GO:0016256; GO:0033299; GO:0046835 carbohydrate phosphorylation [GO:0046835]; lysosome organization [GO:0007040]; N-glycan processing to lysosome [GO:0016256]; secretion of lysosomal enzymes [GO:0033299] Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139] calcium ion binding [GO:0005509]; UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity [GO:0003976] g7794.t1 Q5RGJ8 45.648 517 3.98e-143 448.0 sp|Q5RGJ8|GNPTA_DANRE N-acetylglucosamine-1-phosphotransferase subunits alpha/beta OS=Danio rerio OX=7955 GN=gnptab PE=1 SV=1 GNPTA_DANRE reviewed N-acetylglucosamine-1-phosphotransferase subunits alpha/beta (EC 2.7.8.17) (GlcNAc-1-phosphotransferase subunits alpha/beta) (Stealth protein gnptab) (UDP-N-acetylglucosamine-1-phosphotransferase subunits alpha/beta) [Cleaved into: N-acetylglucosamine-1-phosphotransferase subunit alpha; N-acetylglucosamine-1-phosphotransferase subunit beta] Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000139; GO:0002063; GO:0003007; GO:0003976; GO:0005509; GO:0005794; GO:0007040; GO:0016256; GO:0046835; GO:0048701; GO:0048703; GO:0051216; GO:0060348 bone development [GO:0060348]; carbohydrate phosphorylation [GO:0046835]; cartilage development [GO:0051216]; chondrocyte development [GO:0002063]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic viscerocranium morphogenesis [GO:0048703]; heart morphogenesis [GO:0003007]; lysosome organization [GO:0007040]; N-glycan processing to lysosome [GO:0016256] Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139] calcium ion binding [GO:0005509]; UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity [GO:0003976] g7795.t1 Q5RGJ8 56.712 365 1.48e-127 410.0 sp|Q5RGJ8|GNPTA_DANRE N-acetylglucosamine-1-phosphotransferase subunits alpha/beta OS=Danio rerio OX=7955 GN=gnptab PE=1 SV=1 GNPTA_DANRE reviewed N-acetylglucosamine-1-phosphotransferase subunits alpha/beta (EC 2.7.8.17) (GlcNAc-1-phosphotransferase subunits alpha/beta) (Stealth protein gnptab) (UDP-N-acetylglucosamine-1-phosphotransferase subunits alpha/beta) [Cleaved into: N-acetylglucosamine-1-phosphotransferase subunit alpha; N-acetylglucosamine-1-phosphotransferase subunit beta] Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000139; GO:0002063; GO:0003007; GO:0003976; GO:0005509; GO:0005794; GO:0007040; GO:0016256; GO:0046835; GO:0048701; GO:0048703; GO:0051216; GO:0060348 bone development [GO:0060348]; carbohydrate phosphorylation [GO:0046835]; cartilage development [GO:0051216]; chondrocyte development [GO:0002063]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic viscerocranium morphogenesis [GO:0048703]; heart morphogenesis [GO:0003007]; lysosome organization [GO:0007040]; N-glycan processing to lysosome [GO:0016256] Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139] calcium ion binding [GO:0005509]; UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity [GO:0003976] g7796.t1 Q5BK09 41.202 233 1.2200000000000001e-43 152.0 sp|Q5BK09|DRAM2_RAT DNA damage-regulated autophagy modulator protein 2 OS=Rattus norvegicus OX=10116 GN=Dram2 PE=2 SV=1 g7797.t1 Q8N682 38.071 197 3.34e-32 122.0 sp|Q8N682|DRAM1_HUMAN DNA damage-regulated autophagy modulator protein 1 OS=Homo sapiens OX=9606 GN=DRAM1 PE=1 SV=1 g7798.t1 Q8N682 34.211 228 3.8e-28 111.0 sp|Q8N682|DRAM1_HUMAN DNA damage-regulated autophagy modulator protein 1 OS=Homo sapiens OX=9606 GN=DRAM1 PE=1 SV=1 g7799.t1 Q9DC58 35.814 215 4.49e-34 127.0 sp|Q9DC58|DRAM1_MOUSE DNA damage-regulated autophagy modulator protein 1 OS=Mus musculus OX=10090 GN=Dram1 PE=2 SV=2 g7803.t1 Q1LZB6 37.5 200 2e-37 146.0 sp|Q1LZB6|CAPR1_BOVIN Caprin-1 OS=Bos taurus OX=9913 GN=CAPRIN1 PE=2 SV=1 CAPR1_BOVIN reviewed Caprin-1 (Cytoplasmic activation- and proliferation-associated protein 1) (RNA granule protein 105) Bos taurus (Bovine) GO:0000290; GO:0000932; GO:0003723; GO:0003729; GO:0005524; GO:0005737; GO:0005829; GO:0007416; GO:0008298; GO:0010494; GO:0017148; GO:0030027; GO:0030425; GO:0031252; GO:0034063; GO:0035591; GO:0043232; GO:0045202; GO:0045947; GO:0048699; GO:0050775; GO:0061003; GO:0062029; GO:0106288; GO:0140677; GO:0140693 deadenylation-dependent decapping of nuclear-transcribed mRNA [GO:0000290]; generation of neurons [GO:0048699]; intracellular mRNA localization [GO:0008298]; negative regulation of translation [GO:0017148]; negative regulation of translational initiation [GO:0045947]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of stress granule assembly [GO:0062029]; regulation of deadenylation-dependent decapping of nuclear-transcribed mRNA [GO:0106288]; stress granule assembly [GO:0034063]; synapse assembly [GO:0007416] cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; dendrite [GO:0030425]; intracellular membraneless organelle [GO:0043232]; lamellipodium [GO:0030027]; P-body [GO:0000932]; synapse [GO:0045202] ATP binding [GO:0005524]; molecular condensate scaffold activity [GO:0140693]; molecular function activator activity [GO:0140677]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; signaling adaptor activity [GO:0035591] g7805.t1 Q29RP8 61.168 291 1.62e-122 362.0 sp|Q29RP8|KMT5B_BOVIN Histone-lysine N-methyltransferase KMT5B OS=Bos taurus OX=9913 GN=KMT5B PE=2 SV=1 KMT5B_BOVIN reviewed Histone-lysine N-methyltransferase KMT5B (Lysine-specific methyltransferase 5B) (Suppressor of variegation 4-20 homolog 1) (Su(var)4-20 homolog 1) (Suv4-20h1) ([histone H4]-N-methyl-L-lysine20 N-methyltransferase KMT5B) (EC 2.1.1.362) ([histone H4]-lysine20 N-methyltransferase KMT5B) (EC 2.1.1.361) Bos taurus (Bovine) GO:0003682; GO:0005634; GO:0005694; GO:0006281; GO:0007517; GO:0032259; GO:0042054; GO:0042799; GO:0045830; GO:0046872; GO:0140941; GO:0140944; GO:1904047; GO:2001034 DNA repair [GO:0006281]; methylation [GO:0032259]; muscle organ development [GO:0007517]; positive regulation of double-strand break repair via nonhomologous end joining [GO:2001034]; positive regulation of isotype switching [GO:0045830] chromosome [GO:0005694]; nucleus [GO:0005634] chromatin binding [GO:0003682]; histone H4K20 methyltransferase activity [GO:0042799]; histone H4K20 monomethyltransferase activity [GO:0140944]; histone H4K20me methyltransferase activity [GO:0140941]; histone methyltransferase activity [GO:0042054]; metal ion binding [GO:0046872]; S-adenosyl-L-methionine binding [GO:1904047] g7807.t1 Q9P000 51.295 193 2.03e-61 192.0 sp|Q9P000|COMD9_HUMAN COMM domain-containing protein 9 OS=Homo sapiens OX=9606 GN=COMMD9 PE=1 SV=2 COMD9_HUMAN reviewed COMM domain-containing protein 9 Homo sapiens (Human) GO:0005576; GO:0005654; GO:0005794; GO:0005829; GO:0006814; GO:0034774; GO:0042632; GO:1904813 cholesterol homeostasis [GO:0042632]; sodium ion transport [GO:0006814] cytosol [GO:0005829]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; secretory granule lumen [GO:0034774] g7808.t1 Q9Y4K3 45.378 238 1.84e-64 224.0 sp|Q9Y4K3|TRAF6_HUMAN TNF receptor-associated factor 6 OS=Homo sapiens OX=9606 GN=TRAF6 PE=1 SV=1 TRAF6_HUMAN reviewed TNF receptor-associated factor 6 (EC 2.3.2.27) (E3 ubiquitin-protein ligase TRAF6) (Interleukin-1 signal transducer) (RING finger protein 85) (RING-type E3 ubiquitin transferase TRAF6) Homo sapiens (Human) GO:0000045; GO:0000122; GO:0000209; GO:0001503; GO:0001701; GO:0001843; GO:0002223; GO:0002637; GO:0002726; GO:0002753; GO:0002755; GO:0004842; GO:0005164; GO:0005634; GO:0005737; GO:0005811; GO:0005829; GO:0005886; GO:0005938; GO:0006974; GO:0007249; GO:0008270; GO:0009898; GO:0010008; GO:0019886; GO:0023035; GO:0030316; GO:0030674; GO:0031234; GO:0031398; GO:0031624; GO:0031663; GO:0031666; GO:0032147; GO:0032481; GO:0032735; GO:0032743; GO:0032755; GO:0032991; GO:0033209; GO:0034138; GO:0034142; GO:0034450; GO:0035591; GO:0035631; GO:0035666; GO:0038061; GO:0038095; GO:0038172; GO:0038173; GO:0042088; GO:0042102; GO:0042475; GO:0042802; GO:0042826; GO:0042981; GO:0043011; GO:0043122; GO:0043123; GO:0043422; GO:0043507; GO:0045087; GO:0045453; GO:0045672; GO:0045892; GO:0045944; GO:0046330; GO:0048471; GO:0050852; GO:0051092; GO:0051865; GO:0061630; GO:0070498; GO:0070534; GO:0070555; GO:0071222; GO:0071345; GO:0097400; GO:0098696; GO:0098978; GO:0140374; GO:0141198; GO:1904996 activation of protein kinase activity [GO:0032147]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; antiviral innate immune response [GO:0140374]; autophagosome assembly [GO:0000045]; bone resorption [GO:0045453]; canonical NF-kappaB signal transduction [GO:0007249]; CD40 signaling pathway [GO:0023035]; cellular response to cytokine stimulus [GO:0071345]; cellular response to lipopolysaccharide [GO:0071222]; cytoplasmic pattern recognition receptor signaling pathway [GO:0002753]; DNA damage response [GO:0006974]; Fc-epsilon receptor signaling pathway [GO:0038095]; in utero embryonic development [GO:0001701]; innate immune response [GO:0045087]; interleukin-1-mediated signaling pathway [GO:0070498]; interleukin-17-mediated signaling pathway [GO:0097400]; interleukin-17A-mediated signaling pathway [GO:0038173]; interleukin-33-mediated signaling pathway [GO:0038172]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; MyD88-dependent toll-like receptor signaling pathway [GO:0002755]; myeloid dendritic cell differentiation [GO:0043011]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural tube closure [GO:0001843]; non-canonical NF-kappaB signal transduction [GO:0038061]; odontogenesis of dentin-containing tooth [GO:0042475]; ossification [GO:0001503]; osteoclast differentiation [GO:0030316]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of JNK cascade [GO:0046330]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of leukocyte adhesion to vascular endothelial cell [GO:1904996]; positive regulation of lipopolysaccharide-mediated signaling pathway [GO:0031666]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of T cell cytokine production [GO:0002726]; positive regulation of T cell proliferation [GO:0042102]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of type I interferon production [GO:0032481]; protein autoubiquitination [GO:0051865]; protein branched polyubiquitination [GO:0141198]; protein K63-linked ubiquitination [GO:0070534]; protein polyubiquitination [GO:0000209]; regulation of apoptotic process [GO:0042981]; regulation of canonical NF-kappaB signal transduction [GO:0043122]; regulation of immunoglobulin production [GO:0002637]; regulation of neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0098696]; response to interleukin-1 [GO:0070555]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; T cell receptor signaling pathway [GO:0050852]; T-helper 1 type immune response [GO:0042088]; toll-like receptor 3 signaling pathway [GO:0034138]; toll-like receptor 4 signaling pathway [GO:0034142]; TRIF-dependent toll-like receptor signaling pathway [GO:0035666]; tumor necrosis factor-mediated signaling pathway [GO:0033209] CD40 receptor complex [GO:0035631]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; glutamatergic synapse [GO:0098978]; lipid droplet [GO:0005811]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] histone deacetylase binding [GO:0042826]; identical protein binding [GO:0042802]; protein kinase B binding [GO:0043422]; protein-macromolecule adaptor activity [GO:0030674]; signaling adaptor activity [GO:0035591]; tumor necrosis factor receptor binding [GO:0005164]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; ubiquitin-ubiquitin ligase activity [GO:0034450]; zinc ion binding [GO:0008270] g7808.t1 Q9Y4K3 38.839 224 3.3e-36 146.0 sp|Q9Y4K3|TRAF6_HUMAN TNF receptor-associated factor 6 OS=Homo sapiens OX=9606 GN=TRAF6 PE=1 SV=1 TRAF6_HUMAN reviewed TNF receptor-associated factor 6 (EC 2.3.2.27) (E3 ubiquitin-protein ligase TRAF6) (Interleukin-1 signal transducer) (RING finger protein 85) (RING-type E3 ubiquitin transferase TRAF6) Homo sapiens (Human) GO:0000045; GO:0000122; GO:0000209; GO:0001503; GO:0001701; GO:0001843; GO:0002223; GO:0002637; GO:0002726; GO:0002753; GO:0002755; GO:0004842; GO:0005164; GO:0005634; GO:0005737; GO:0005811; GO:0005829; GO:0005886; GO:0005938; GO:0006974; GO:0007249; GO:0008270; GO:0009898; GO:0010008; GO:0019886; GO:0023035; GO:0030316; GO:0030674; GO:0031234; GO:0031398; GO:0031624; GO:0031663; GO:0031666; GO:0032147; GO:0032481; GO:0032735; GO:0032743; GO:0032755; GO:0032991; GO:0033209; GO:0034138; GO:0034142; GO:0034450; GO:0035591; GO:0035631; GO:0035666; GO:0038061; GO:0038095; GO:0038172; GO:0038173; GO:0042088; GO:0042102; GO:0042475; GO:0042802; GO:0042826; GO:0042981; GO:0043011; GO:0043122; GO:0043123; GO:0043422; GO:0043507; GO:0045087; GO:0045453; GO:0045672; GO:0045892; GO:0045944; GO:0046330; GO:0048471; GO:0050852; GO:0051092; GO:0051865; GO:0061630; GO:0070498; GO:0070534; GO:0070555; GO:0071222; GO:0071345; GO:0097400; GO:0098696; GO:0098978; GO:0140374; GO:0141198; GO:1904996 activation of protein kinase activity [GO:0032147]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; antiviral innate immune response [GO:0140374]; autophagosome assembly [GO:0000045]; bone resorption [GO:0045453]; canonical NF-kappaB signal transduction [GO:0007249]; CD40 signaling pathway [GO:0023035]; cellular response to cytokine stimulus [GO:0071345]; cellular response to lipopolysaccharide [GO:0071222]; cytoplasmic pattern recognition receptor signaling pathway [GO:0002753]; DNA damage response [GO:0006974]; Fc-epsilon receptor signaling pathway [GO:0038095]; in utero embryonic development [GO:0001701]; innate immune response [GO:0045087]; interleukin-1-mediated signaling pathway [GO:0070498]; interleukin-17-mediated signaling pathway [GO:0097400]; interleukin-17A-mediated signaling pathway [GO:0038173]; interleukin-33-mediated signaling pathway [GO:0038172]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; MyD88-dependent toll-like receptor signaling pathway [GO:0002755]; myeloid dendritic cell differentiation [GO:0043011]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural tube closure [GO:0001843]; non-canonical NF-kappaB signal transduction [GO:0038061]; odontogenesis of dentin-containing tooth [GO:0042475]; ossification [GO:0001503]; osteoclast differentiation [GO:0030316]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of JNK cascade [GO:0046330]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of leukocyte adhesion to vascular endothelial cell [GO:1904996]; positive regulation of lipopolysaccharide-mediated signaling pathway [GO:0031666]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of T cell cytokine production [GO:0002726]; positive regulation of T cell proliferation [GO:0042102]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of type I interferon production [GO:0032481]; protein autoubiquitination [GO:0051865]; protein branched polyubiquitination [GO:0141198]; protein K63-linked ubiquitination [GO:0070534]; protein polyubiquitination [GO:0000209]; regulation of apoptotic process [GO:0042981]; regulation of canonical NF-kappaB signal transduction [GO:0043122]; regulation of immunoglobulin production [GO:0002637]; regulation of neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0098696]; response to interleukin-1 [GO:0070555]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; T cell receptor signaling pathway [GO:0050852]; T-helper 1 type immune response [GO:0042088]; toll-like receptor 3 signaling pathway [GO:0034138]; toll-like receptor 4 signaling pathway [GO:0034142]; TRIF-dependent toll-like receptor signaling pathway [GO:0035666]; tumor necrosis factor-mediated signaling pathway [GO:0033209] CD40 receptor complex [GO:0035631]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; glutamatergic synapse [GO:0098978]; lipid droplet [GO:0005811]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] histone deacetylase binding [GO:0042826]; identical protein binding [GO:0042802]; protein kinase B binding [GO:0043422]; protein-macromolecule adaptor activity [GO:0030674]; signaling adaptor activity [GO:0035591]; tumor necrosis factor receptor binding [GO:0005164]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; ubiquitin-ubiquitin ligase activity [GO:0034450]; zinc ion binding [GO:0008270] g7809.t1 Q9HAP6 75.253 198 3.76e-94 276.0 sp|Q9HAP6|LIN7B_HUMAN Protein lin-7 homolog B OS=Homo sapiens OX=9606 GN=LIN7B PE=1 SV=1 LIN7B_HUMAN reviewed Protein lin-7 homolog B (Lin-7B) (hLin7B) (Mammalian lin-seven protein 2) (MALS-2) (Vertebrate lin-7 homolog 2) (Veli-2) (hVeli2) Homo sapiens (Human) GO:0005886; GO:0005911; GO:0005923; GO:0006887; GO:0007269; GO:0008582; GO:0015031; GO:0016323; GO:0019904; GO:0030674; GO:0045202; GO:0048489; GO:0097025; GO:0098793; GO:0098839 exocytosis [GO:0006887]; neurotransmitter secretion [GO:0007269]; protein transport [GO:0015031]; regulation of synaptic assembly at neuromuscular junction [GO:0008582]; synaptic vesicle transport [GO:0048489] basolateral plasma membrane [GO:0016323]; bicellular tight junction [GO:0005923]; cell-cell junction [GO:0005911]; MPP7-DLG1-LIN7 complex [GO:0097025]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; presynapse [GO:0098793]; synapse [GO:0045202] protein domain specific binding [GO:0019904]; protein-macromolecule adaptor activity [GO:0030674] g7810.t1 Q6P806 51.483 472 1.2700000000000002e-167 483.0 sp|Q6P806|SAM50_XENTR Sorting and assembly machinery component 50 homolog OS=Xenopus tropicalis OX=8364 GN=samm50 PE=2 SV=1 g7813.t1 Q8BGC4 50.142 351 3.66e-106 319.0 sp|Q8BGC4|PTGR3_MOUSE Prostaglandin reductase-3 OS=Mus musculus OX=10090 GN=Ptgr3 PE=1 SV=1 PTGR3_MOUSE reviewed Prostaglandin reductase-3 (PTGR-3) (EC 1.3.1.48) (15-oxoprostaglandin 13-reductase) (Zinc-binding alcohol dehydrogenase domain-containing protein 2) Mus musculus (Mouse) GO:0005739; GO:0005777; GO:0006629; GO:0008270; GO:0045599; GO:0047522 lipid metabolic process [GO:0006629]; negative regulation of fat cell differentiation [GO:0045599] mitochondrion [GO:0005739]; peroxisome [GO:0005777] 15-oxoprostaglandin 13-reductase [NAD(P)+] activity [GO:0047522]; zinc ion binding [GO:0008270] g7813.t2 Q8BGC4 50.142 351 4.59e-106 319.0 sp|Q8BGC4|PTGR3_MOUSE Prostaglandin reductase-3 OS=Mus musculus OX=10090 GN=Ptgr3 PE=1 SV=1 PTGR3_MOUSE reviewed Prostaglandin reductase-3 (PTGR-3) (EC 1.3.1.48) (15-oxoprostaglandin 13-reductase) (Zinc-binding alcohol dehydrogenase domain-containing protein 2) Mus musculus (Mouse) GO:0005739; GO:0005777; GO:0006629; GO:0008270; GO:0045599; GO:0047522 lipid metabolic process [GO:0006629]; negative regulation of fat cell differentiation [GO:0045599] mitochondrion [GO:0005739]; peroxisome [GO:0005777] 15-oxoprostaglandin 13-reductase [NAD(P)+] activity [GO:0047522]; zinc ion binding [GO:0008270] g7814.t1 Q8CDK2 53.546 564 0.0 607.0 sp|Q8CDK2|CBPC2_MOUSE Cytosolic carboxypeptidase 2 OS=Mus musculus OX=10090 GN=Agbl2 PE=1 SV=1 g7814.t2 Q0P4M4 55.657 548 0.0 603.0 sp|Q0P4M4|CBPC2_XENTR Cytosolic carboxypeptidase 2 OS=Xenopus tropicalis OX=8364 GN=agbl2 PE=2 SV=1 CBPC2_XENTR reviewed Cytosolic carboxypeptidase 2 (EC 3.4.17.-) (ATP/GTP-binding protein-like 2) (Protein deglutamylase CCP2) Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0004181; GO:0005737; GO:0005814; GO:0005829; GO:0006508; GO:0008270; GO:0015630; GO:0015631; GO:0035610; GO:0036064 protein side chain deglutamylation [GO:0035610]; proteolysis [GO:0006508] centriole [GO:0005814]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule cytoskeleton [GO:0015630] metallocarboxypeptidase activity [GO:0004181]; tubulin binding [GO:0015631]; zinc ion binding [GO:0008270] g7817.t1 Q8IYG6 40.374 374 4.38e-73 248.0 sp|Q8IYG6|LRC56_HUMAN Leucine-rich repeat-containing protein 56 OS=Homo sapiens OX=9606 GN=LRRC56 PE=1 SV=1 LRC56_HUMAN reviewed Leucine-rich repeat-containing protein 56 Homo sapiens (Human) GO:0005929; GO:0030030 cell projection organization [GO:0030030] cilium [GO:0005929] g7818.t1 Q99P31 35.127 316 2.7799999999999997e-46 164.0 sp|Q99P31|HPBP1_MOUSE Hsp70-binding protein 1 OS=Mus musculus OX=10090 GN=Hspbp1 PE=1 SV=1 g7819.t1 P50430 42.23 547 1.1300000000000001e-129 391.0 sp|P50430|ARSB_RAT Arylsulfatase B OS=Rattus norvegicus OX=10116 GN=Arsb PE=2 SV=2 g7820.t1 O14095 41.071 168 1.4300000000000001e-31 119.0 sp|O14095|PLP1_SCHPO Thioredoxin domain-containing protein plp1 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) OX=284812 GN=plp1 PE=1 SV=2 g7821.t1 P0C872 27.451 306 4.13e-30 121.0 sp|P0C872|JMJD7_MOUSE Bifunctional peptidase and (3S)-lysyl hydroxylase Jmjd7 OS=Mus musculus OX=10090 GN=Jmjd7 PE=1 SV=1 g7822.t1 Q5F3N9 58.209 201 6.36e-86 262.0 sp|Q5F3N9|ILRUN_CHICK Protein ILRUN OS=Gallus gallus OX=9031 GN=ILRUN PE=2 SV=1 g7823.t1 Q0VC50 45.153 392 8.679999999999999e-106 321.0 sp|Q0VC50|RT4I1_BOVIN NAD(P)H oxidoreductase RTN4IP1, mitochondrial OS=Bos taurus OX=9913 GN=RTN4IP1 PE=2 SV=1 RT4I1_BOVIN reviewed NAD(P)H oxidoreductase RTN4IP1, mitochondrial (EC 1.6.5.-) (Reticulon-4-interacting protein 1) Bos taurus (Bovine) GO:0000166; GO:0005739; GO:0005741; GO:0005759; GO:0006744; GO:0007399; GO:0008270; GO:0008753; GO:0050136; GO:0050773 nervous system development [GO:0007399]; regulation of dendrite development [GO:0050773]; ubiquinone biosynthetic process [GO:0006744] mitochondrial matrix [GO:0005759]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739] NADH dehydrogenase (quinone) (non-electrogenic) activity [GO:0050136]; NADPH dehydrogenase (quinone) activity [GO:0008753]; nucleotide binding [GO:0000166]; zinc ion binding [GO:0008270] g7824.t1 Q91VM3 56.25 352 1.08e-131 381.0 sp|Q91VM3|WIPI4_MOUSE WD repeat domain phosphoinositide-interacting protein 4 OS=Mus musculus OX=10090 GN=Wdr45 PE=1 SV=1 g7824.t2 Q91VM3 55.742 357 5.66e-132 382.0 sp|Q91VM3|WIPI4_MOUSE WD repeat domain phosphoinositide-interacting protein 4 OS=Mus musculus OX=10090 GN=Wdr45 PE=1 SV=1 g7825.t1 E7EY42 57.653 392 5e-173 497.0 sp|E7EY42|PTSS2_DANRE Phosphatidylserine synthase 2 OS=Danio rerio OX=7955 GN=ptdss2 PE=3 SV=1 PTSS2_DANRE reviewed Phosphatidylserine synthase 2 (PSS-2) (PtdSer synthase 2) (EC 2.7.8.29) (Serine-exchange enzyme II) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005789; GO:0006659; GO:0106245 phosphatidylserine biosynthetic process [GO:0006659] endoplasmic reticulum membrane [GO:0005789] L-serine-phosphatidylethanolamine phosphatidyltransferase activity [GO:0106245] g7826.t1 P61082 82.609 184 3.14e-112 320.0 sp|P61082|UBC12_MOUSE NEDD8-conjugating enzyme Ubc12 OS=Mus musculus OX=10090 GN=Ube2m PE=1 SV=1 UBC12_MOUSE reviewed NEDD8-conjugating enzyme Ubc12 (EC 2.3.2.34) (NEDD8 carrier protein) (Ubiquitin-conjugating enzyme E2 M) Mus musculus (Mouse) GO:0004842; GO:0005524; GO:0005634; GO:0005829; GO:0019788; GO:0036211; GO:0043525; GO:0045116; GO:0061654; GO:0098793; GO:0098794; GO:0098978; GO:0150052 positive regulation of neuron apoptotic process [GO:0043525]; protein modification process [GO:0036211]; protein neddylation [GO:0045116]; regulation of postsynapse assembly [GO:0150052] cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; nucleus [GO:0005634]; postsynapse [GO:0098794]; presynapse [GO:0098793] ATP binding [GO:0005524]; NEDD8 conjugating enzyme activity [GO:0061654]; NEDD8 transferase activity [GO:0019788]; ubiquitin-protein transferase activity [GO:0004842] g7827.t1 P62250 84.828 145 2.69e-80 236.0 sp|P62250|RS16_RAT Small ribosomal subunit protein uS9 OS=Rattus norvegicus OX=10116 GN=Rps16 PE=1 SV=2 g7828.t1 Q2TA32 65.868 167 3.36e-91 235.0 sp|Q2TA32|TYSY_BOVIN Thymidylate synthase OS=Bos taurus OX=9913 GN=TYMS PE=2 SV=1 TYSY_BOVIN reviewed Thymidylate synthase (TS) (TSase) (EC 2.1.1.45) Bos taurus (Bovine) GO:0004799; GO:0005634; GO:0005737; GO:0005739; GO:0005743; GO:0005759; GO:0005829; GO:0006231; GO:0006235; GO:0032259 dTMP biosynthetic process [GO:0006231]; dTTP biosynthetic process [GO:0006235]; methylation [GO:0032259] cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleus [GO:0005634] thymidylate synthase activity [GO:0004799] g7828.t1 Q2TA32 48.214 112 3.36e-91 104.0 sp|Q2TA32|TYSY_BOVIN Thymidylate synthase OS=Bos taurus OX=9913 GN=TYMS PE=2 SV=1 TYSY_BOVIN reviewed Thymidylate synthase (TS) (TSase) (EC 2.1.1.45) Bos taurus (Bovine) GO:0004799; GO:0005634; GO:0005737; GO:0005739; GO:0005743; GO:0005759; GO:0005829; GO:0006231; GO:0006235; GO:0032259 dTMP biosynthetic process [GO:0006231]; dTTP biosynthetic process [GO:0006235]; methylation [GO:0032259] cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleus [GO:0005634] thymidylate synthase activity [GO:0004799] g7828.t1 Q2TA32 53.333 30 3.36e-91 39.3 sp|Q2TA32|TYSY_BOVIN Thymidylate synthase OS=Bos taurus OX=9913 GN=TYMS PE=2 SV=1 TYSY_BOVIN reviewed Thymidylate synthase (TS) (TSase) (EC 2.1.1.45) Bos taurus (Bovine) GO:0004799; GO:0005634; GO:0005737; GO:0005739; GO:0005743; GO:0005759; GO:0005829; GO:0006231; GO:0006235; GO:0032259 dTMP biosynthetic process [GO:0006231]; dTTP biosynthetic process [GO:0006235]; methylation [GO:0032259] cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleus [GO:0005634] thymidylate synthase activity [GO:0004799] g7829.t1 E7FAG6 53.812 223 9.48e-70 261.0 sp|E7FAG6|AMR1A_DANRE Activating molecule in BECN1-regulated autophagy protein 1A OS=Danio rerio OX=7955 GN=ambra1a PE=2 SV=2 g7829.t1 E7FAG6 47.418 213 2.93e-50 199.0 sp|E7FAG6|AMR1A_DANRE Activating molecule in BECN1-regulated autophagy protein 1A OS=Danio rerio OX=7955 GN=ambra1a PE=2 SV=2 g7830.t1 Q96EQ9 32.867 429 1.51e-52 194.0 sp|Q96EQ9|PRDM9_MOUSE Histone-lysine N-methyltransferase PRDM9 OS=Mus musculus OX=10090 GN=Prdm9 PE=1 SV=2 g7831.t1 A5A6N3 35.845 491 1.46e-69 232.0 sp|A5A6N3|ATG13_PANTR Autophagy-related protein 13 OS=Pan troglodytes OX=9598 GN=ATG13 PE=2 SV=1 g7832.t1 Q9NQ89 46.223 556 2.19e-166 487.0 sp|Q9NQ89|FERY3_HUMAN Ferry endosomal RAB5 effector complex subunit 3 OS=Homo sapiens OX=9606 GN=FERRY3 PE=1 SV=1 FERY3_HUMAN reviewed Ferry endosomal RAB5 effector complex subunit 3 (Fy-3) Homo sapiens (Human) GO:0005737; GO:0005769; GO:0032991; GO:0043304 regulation of mast cell degranulation [GO:0043304] cytoplasm [GO:0005737]; early endosome [GO:0005769]; protein-containing complex [GO:0032991] g7834.t1 Q9D4H2 36.504 778 8.01e-114 365.0 sp|Q9D4H2|GCC1_MOUSE GRIP and coiled-coil domain-containing protein 1 OS=Mus musculus OX=10090 GN=Gcc1 PE=1 SV=2 g7835.t1 Q96JT2 40.984 183 3.5800000000000004e-33 136.0 sp|Q96JT2|S45A3_HUMAN Solute carrier family 45 member 3 OS=Homo sapiens OX=9606 GN=SLC45A3 PE=1 SV=1 g7835.t1 Q96JT2 36.111 144 1.7599999999999998e-24 110.0 sp|Q96JT2|S45A3_HUMAN Solute carrier family 45 member 3 OS=Homo sapiens OX=9606 GN=SLC45A3 PE=1 SV=1 g7839.t1 Q803A7 63.169 486 0.0 660.0 sp|Q803A7|SPCS_DANRE O-phosphoseryl-tRNA(Sec) selenium transferase OS=Danio rerio OX=7955 GN=sepsecs PE=2 SV=1 SPCS_DANRE reviewed O-phosphoseryl-tRNA(Sec) selenium transferase (EC 2.9.1.2) (Selenocysteine synthase) (Sec synthase) (Selenocysteinyl-tRNA(Sec) synthase) (Sep-tRNA:Sec-tRNA synthase) (SepSecS) (Soluble liver antigen/liver pancreas antigen-like) (UGA suppressor tRNA-associated protein homolog) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000049; GO:0001514; GO:0001717; GO:0005737; GO:0098621 conversion of seryl-tRNAsec to selenocys-tRNAsec [GO:0001717]; selenocysteine incorporation [GO:0001514] cytoplasm [GO:0005737] O-phosphoseryl-tRNA(Sec) selenium transferase activity [GO:0098621]; tRNA binding [GO:0000049] g7840.t1 Q9Y234 41.076 353 9.23e-96 293.0 sp|Q9Y234|LIPT_HUMAN Lipoyl amidotransferase LIPT1, mitochondrial OS=Homo sapiens OX=9606 GN=LIPT1 PE=1 SV=1 LIPT_HUMAN reviewed Lipoyl amidotransferase LIPT1, mitochondrial (EC 2.3.1.200) (Lipoate biosynthesis protein) (Lipoate-protein ligase) (Lipoyl ligase) (Lipoyltransferase 1) (EC 2.3.1.-) Homo sapiens (Human) GO:0005737; GO:0005739; GO:0005759; GO:0006629; GO:0009249; GO:0016410; GO:0017118; GO:0036211 lipid metabolic process [GO:0006629]; protein lipoylation [GO:0009249]; protein modification process [GO:0036211] cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] lipoyltransferase activity [GO:0017118]; N-acyltransferase activity [GO:0016410] g7841.t1 Q7T3H7 56.614 189 1.3100000000000001e-73 224.0 sp|Q7T3H7|MED18_DANRE Mediator of RNA polymerase II transcription subunit 18 OS=Danio rerio OX=7955 GN=med18 PE=2 SV=1 g7842.t1 O53532 33.884 363 3.24e-60 201.0 sp|O53532|Y2258_MYCTU S-adenosylmethionine-dependent methyltransferase Rv2258c OS=Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv) OX=83332 GN=Rv2258c PE=1 SV=1 g7844.t1 Q9CRG1 31.476 359 2.88e-38 147.0 sp|Q9CRG1|TM7S3_MOUSE Transmembrane 7 superfamily member 3 OS=Mus musculus OX=10090 GN=Tm7sf3 PE=2 SV=2 g7845.t1 Q5R561 63.125 160 1.3899999999999999e-61 196.0 sp|Q5R561|FGOP2_PONAB FGFR1 oncogene partner 2 homolog OS=Pongo abelii OX=9601 GN=FGFR1OP2 PE=2 SV=1 g7846.t1 Q9N0J9 30.962 239 1.73e-25 103.0 sp|Q9N0J9|CD81_SAGOE CD81 protein OS=Saguinus oedipus OX=9490 GN=CD81 PE=1 SV=1 g7850.t1 O75954 41.624 197 1.17e-36 132.0 sp|O75954|TSN9_HUMAN Tetraspanin-9 OS=Homo sapiens OX=9606 GN=TSPAN9 PE=1 SV=1 g7851.t1 Q6GMK6 45.299 234 1.92e-55 180.0 sp|Q6GMK6|TSN9_DANRE Tetraspanin-9 OS=Danio rerio OX=7955 GN=tspan9 PE=2 SV=1 g7852.t1 Q9VC49 94.03 67 2.4499999999999997e-42 134.0 sp|Q9VC49|RPAB5_DROME DNA-directed RNA polymerases I, II, and III subunit RPABC5 OS=Drosophila melanogaster OX=7227 GN=Polr2L PE=1 SV=1 g7853.t1 Q32KQ7 47.312 279 9.2e-78 242.0 sp|Q32KQ7|CSTP1_BOVIN Centriolar satellite-associated tubulin polyglutamylase complex regulator 1 OS=Bos taurus OX=9913 GN=CSTPP1 PE=2 SV=1 g7854.t1 Q9QYP1 54.872 1837 0.0 1929.0 sp|Q9QYP1|LRP4_RAT Low-density lipoprotein receptor-related protein 4 OS=Rattus norvegicus OX=10116 GN=Lrp4 PE=1 SV=2 LRP4_RAT reviewed Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7) Rattus norvegicus (Rat) GO:0001822; GO:0001942; GO:0005509; GO:0005886; GO:0006897; GO:0007167; GO:0008104; GO:0009953; GO:0009954; GO:0009986; GO:0014069; GO:0015026; GO:0016055; GO:0016601; GO:0030279; GO:0030326; GO:0030425; GO:0030971; GO:0031594; GO:0034185; GO:0035022; GO:0042475; GO:0042733; GO:0042803; GO:0043025; GO:0043113; GO:0044853; GO:0045202; GO:0048699; GO:0048813; GO:0050771; GO:0050808; GO:0051124; GO:0060173; GO:0071340; GO:0090090; GO:0097060; GO:0097104; GO:0097105; GO:0097110; GO:0150052; GO:0150094; GO:1901631; GO:1904395 amyloid-beta clearance by cellular catabolic process [GO:0150094]; dendrite morphogenesis [GO:0048813]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; embryonic limb morphogenesis [GO:0030326]; endocytosis [GO:0006897]; enzyme-linked receptor protein signaling pathway [GO:0007167]; generation of neurons [GO:0048699]; hair follicle development [GO:0001942]; intracellular protein localization [GO:0008104]; kidney development [GO:0001822]; limb development [GO:0060173]; negative regulation of axonogenesis [GO:0050771]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of ossification [GO:0030279]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of presynaptic membrane organization [GO:1901631]; positive regulation of Rac protein signal transduction [GO:0035022]; positive regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904395]; postsynaptic membrane assembly [GO:0097104]; presynaptic membrane assembly [GO:0097105]; proximal/distal pattern formation [GO:0009954]; Rac protein signal transduction [GO:0016601]; receptor clustering [GO:0043113]; regulation of postsynapse assembly [GO:0150052]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; synapse organization [GO:0050808]; synaptic assembly at neuromuscular junction [GO:0051124]; Wnt signaling pathway [GO:0016055] cell surface [GO:0009986]; dendrite [GO:0030425]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic density [GO:0014069]; synapse [GO:0045202]; synaptic membrane [GO:0097060] apolipoprotein binding [GO:0034185]; calcium ion binding [GO:0005509]; coreceptor activity [GO:0015026]; protein homodimerization activity [GO:0042803]; receptor tyrosine kinase binding [GO:0030971]; scaffold protein binding [GO:0097110] g7854.t2 Q9QYP1 55.396 1807 0.0 1917.0 sp|Q9QYP1|LRP4_RAT Low-density lipoprotein receptor-related protein 4 OS=Rattus norvegicus OX=10116 GN=Lrp4 PE=1 SV=2 LRP4_RAT reviewed Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7) Rattus norvegicus (Rat) GO:0001822; GO:0001942; GO:0005509; GO:0005886; GO:0006897; GO:0007167; GO:0008104; GO:0009953; GO:0009954; GO:0009986; GO:0014069; GO:0015026; GO:0016055; GO:0016601; GO:0030279; GO:0030326; GO:0030425; GO:0030971; GO:0031594; GO:0034185; GO:0035022; GO:0042475; GO:0042733; GO:0042803; GO:0043025; GO:0043113; GO:0044853; GO:0045202; GO:0048699; GO:0048813; GO:0050771; GO:0050808; GO:0051124; GO:0060173; GO:0071340; GO:0090090; GO:0097060; GO:0097104; GO:0097105; GO:0097110; GO:0150052; GO:0150094; GO:1901631; GO:1904395 amyloid-beta clearance by cellular catabolic process [GO:0150094]; dendrite morphogenesis [GO:0048813]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; embryonic limb morphogenesis [GO:0030326]; endocytosis [GO:0006897]; enzyme-linked receptor protein signaling pathway [GO:0007167]; generation of neurons [GO:0048699]; hair follicle development [GO:0001942]; intracellular protein localization [GO:0008104]; kidney development [GO:0001822]; limb development [GO:0060173]; negative regulation of axonogenesis [GO:0050771]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of ossification [GO:0030279]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of presynaptic membrane organization [GO:1901631]; positive regulation of Rac protein signal transduction [GO:0035022]; positive regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904395]; postsynaptic membrane assembly [GO:0097104]; presynaptic membrane assembly [GO:0097105]; proximal/distal pattern formation [GO:0009954]; Rac protein signal transduction [GO:0016601]; receptor clustering [GO:0043113]; regulation of postsynapse assembly [GO:0150052]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; synapse organization [GO:0050808]; synaptic assembly at neuromuscular junction [GO:0051124]; Wnt signaling pathway [GO:0016055] cell surface [GO:0009986]; dendrite [GO:0030425]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic density [GO:0014069]; synapse [GO:0045202]; synaptic membrane [GO:0097060] apolipoprotein binding [GO:0034185]; calcium ion binding [GO:0005509]; coreceptor activity [GO:0015026]; protein homodimerization activity [GO:0042803]; receptor tyrosine kinase binding [GO:0030971]; scaffold protein binding [GO:0097110] g7854.t3 Q9QYP1 55.698 1799 0.0 1928.0 sp|Q9QYP1|LRP4_RAT Low-density lipoprotein receptor-related protein 4 OS=Rattus norvegicus OX=10116 GN=Lrp4 PE=1 SV=2 LRP4_RAT reviewed Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7) Rattus norvegicus (Rat) GO:0001822; GO:0001942; GO:0005509; GO:0005886; GO:0006897; GO:0007167; GO:0008104; GO:0009953; GO:0009954; GO:0009986; GO:0014069; GO:0015026; GO:0016055; GO:0016601; GO:0030279; GO:0030326; GO:0030425; GO:0030971; GO:0031594; GO:0034185; GO:0035022; GO:0042475; GO:0042733; GO:0042803; GO:0043025; GO:0043113; GO:0044853; GO:0045202; GO:0048699; GO:0048813; GO:0050771; GO:0050808; GO:0051124; GO:0060173; GO:0071340; GO:0090090; GO:0097060; GO:0097104; GO:0097105; GO:0097110; GO:0150052; GO:0150094; GO:1901631; GO:1904395 amyloid-beta clearance by cellular catabolic process [GO:0150094]; dendrite morphogenesis [GO:0048813]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; embryonic limb morphogenesis [GO:0030326]; endocytosis [GO:0006897]; enzyme-linked receptor protein signaling pathway [GO:0007167]; generation of neurons [GO:0048699]; hair follicle development [GO:0001942]; intracellular protein localization [GO:0008104]; kidney development [GO:0001822]; limb development [GO:0060173]; negative regulation of axonogenesis [GO:0050771]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of ossification [GO:0030279]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of presynaptic membrane organization [GO:1901631]; positive regulation of Rac protein signal transduction [GO:0035022]; positive regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904395]; postsynaptic membrane assembly [GO:0097104]; presynaptic membrane assembly [GO:0097105]; proximal/distal pattern formation [GO:0009954]; Rac protein signal transduction [GO:0016601]; receptor clustering [GO:0043113]; regulation of postsynapse assembly [GO:0150052]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; synapse organization [GO:0050808]; synaptic assembly at neuromuscular junction [GO:0051124]; Wnt signaling pathway [GO:0016055] cell surface [GO:0009986]; dendrite [GO:0030425]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic density [GO:0014069]; synapse [GO:0045202]; synaptic membrane [GO:0097060] apolipoprotein binding [GO:0034185]; calcium ion binding [GO:0005509]; coreceptor activity [GO:0015026]; protein homodimerization activity [GO:0042803]; receptor tyrosine kinase binding [GO:0030971]; scaffold protein binding [GO:0097110] g7857.t1 P42577 46.341 164 1.03e-46 152.0 sp|P42577|FRIS_LYMST Soma ferritin OS=Lymnaea stagnalis OX=6523 PE=2 SV=2 g7858.t1 P42577 46.471 170 4.0499999999999996e-45 148.0 sp|P42577|FRIS_LYMST Soma ferritin OS=Lymnaea stagnalis OX=6523 PE=2 SV=2 g7862.t1 O70244 29.167 744 1.98e-70 267.0 sp|O70244|CUBN_RAT Cubilin OS=Rattus norvegicus OX=10116 GN=Cubn PE=1 SV=2 CUBN_RAT reviewed Cubilin (460 kDa receptor) (Glycoprotein 280) (gp280) (Intrinsic factor-cobalamin receptor) (Intrinsic factor-vitamin B12 receptor) Rattus norvegicus (Rat) GO:0001701; GO:0005509; GO:0005737; GO:0005765; GO:0005768; GO:0005783; GO:0005794; GO:0005798; GO:0005886; GO:0005903; GO:0005905; GO:0006898; GO:0007584; GO:0008203; GO:0009235; GO:0009617; GO:0010008; GO:0015889; GO:0016020; GO:0016324; GO:0020028; GO:0030135; GO:0030139; GO:0030492; GO:0030666; GO:0031419; GO:0031526; GO:0031528; GO:0032991; GO:0038024; GO:0042366; GO:0042802; GO:0042803; GO:0042953; GO:0043202; GO:0043235; GO:0045177; GO:0051649; GO:0070062 cholesterol metabolic process [GO:0008203]; cobalamin catabolic process [GO:0042366]; cobalamin metabolic process [GO:0009235]; cobalamin transport [GO:0015889]; endocytic hemoglobin import into cell [GO:0020028]; establishment of localization in cell [GO:0051649]; in utero embryonic development [GO:0001701]; lipoprotein transport [GO:0042953]; receptor-mediated endocytosis [GO:0006898]; response to bacterium [GO:0009617]; response to nutrient [GO:0007584] apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; brush border [GO:0005903]; brush border membrane [GO:0031526]; clathrin-coated pit [GO:0005905]; coated vesicle [GO:0030135]; cytoplasm [GO:0005737]; endocytic vesicle [GO:0030139]; endocytic vesicle membrane [GO:0030666]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi-associated vesicle [GO:0005798]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; microvillus membrane [GO:0031528]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; cargo receptor activity [GO:0038024]; cobalamin binding [GO:0031419]; hemoglobin binding [GO:0030492]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803] g7862.t1 O70244 26.554 1126 6.53e-66 252.0 sp|O70244|CUBN_RAT Cubilin OS=Rattus norvegicus OX=10116 GN=Cubn PE=1 SV=2 CUBN_RAT reviewed Cubilin (460 kDa receptor) (Glycoprotein 280) (gp280) (Intrinsic factor-cobalamin receptor) (Intrinsic factor-vitamin B12 receptor) Rattus norvegicus (Rat) GO:0001701; GO:0005509; GO:0005737; GO:0005765; GO:0005768; GO:0005783; GO:0005794; GO:0005798; GO:0005886; GO:0005903; GO:0005905; GO:0006898; GO:0007584; GO:0008203; GO:0009235; GO:0009617; GO:0010008; GO:0015889; GO:0016020; GO:0016324; GO:0020028; GO:0030135; GO:0030139; GO:0030492; GO:0030666; GO:0031419; GO:0031526; GO:0031528; GO:0032991; GO:0038024; GO:0042366; GO:0042802; GO:0042803; GO:0042953; GO:0043202; GO:0043235; GO:0045177; GO:0051649; GO:0070062 cholesterol metabolic process [GO:0008203]; cobalamin catabolic process [GO:0042366]; cobalamin metabolic process [GO:0009235]; cobalamin transport [GO:0015889]; endocytic hemoglobin import into cell [GO:0020028]; establishment of localization in cell [GO:0051649]; in utero embryonic development [GO:0001701]; lipoprotein transport [GO:0042953]; receptor-mediated endocytosis [GO:0006898]; response to bacterium [GO:0009617]; response to nutrient [GO:0007584] apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; brush border [GO:0005903]; brush border membrane [GO:0031526]; clathrin-coated pit [GO:0005905]; coated vesicle [GO:0030135]; cytoplasm [GO:0005737]; endocytic vesicle [GO:0030139]; endocytic vesicle membrane [GO:0030666]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi-associated vesicle [GO:0005798]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; microvillus membrane [GO:0031528]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; cargo receptor activity [GO:0038024]; cobalamin binding [GO:0031419]; hemoglobin binding [GO:0030492]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803] g7862.t1 O70244 28.497 765 1.56e-64 248.0 sp|O70244|CUBN_RAT Cubilin OS=Rattus norvegicus OX=10116 GN=Cubn PE=1 SV=2 CUBN_RAT reviewed Cubilin (460 kDa receptor) (Glycoprotein 280) (gp280) (Intrinsic factor-cobalamin receptor) (Intrinsic factor-vitamin B12 receptor) Rattus norvegicus (Rat) GO:0001701; GO:0005509; GO:0005737; GO:0005765; GO:0005768; GO:0005783; GO:0005794; GO:0005798; GO:0005886; GO:0005903; GO:0005905; GO:0006898; GO:0007584; GO:0008203; GO:0009235; GO:0009617; GO:0010008; GO:0015889; GO:0016020; GO:0016324; GO:0020028; GO:0030135; GO:0030139; GO:0030492; GO:0030666; GO:0031419; GO:0031526; GO:0031528; GO:0032991; GO:0038024; GO:0042366; GO:0042802; GO:0042803; GO:0042953; GO:0043202; GO:0043235; GO:0045177; GO:0051649; GO:0070062 cholesterol metabolic process [GO:0008203]; cobalamin catabolic process [GO:0042366]; cobalamin metabolic process [GO:0009235]; cobalamin transport [GO:0015889]; endocytic hemoglobin import into cell [GO:0020028]; establishment of localization in cell [GO:0051649]; in utero embryonic development [GO:0001701]; lipoprotein transport [GO:0042953]; receptor-mediated endocytosis [GO:0006898]; response to bacterium [GO:0009617]; response to nutrient [GO:0007584] apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; brush border [GO:0005903]; brush border membrane [GO:0031526]; clathrin-coated pit [GO:0005905]; coated vesicle [GO:0030135]; cytoplasm [GO:0005737]; endocytic vesicle [GO:0030139]; endocytic vesicle membrane [GO:0030666]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi-associated vesicle [GO:0005798]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; microvillus membrane [GO:0031528]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; cargo receptor activity [GO:0038024]; cobalamin binding [GO:0031419]; hemoglobin binding [GO:0030492]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803] g7862.t1 O70244 25.171 1172 9.13e-62 239.0 sp|O70244|CUBN_RAT Cubilin OS=Rattus norvegicus OX=10116 GN=Cubn PE=1 SV=2 CUBN_RAT reviewed Cubilin (460 kDa receptor) (Glycoprotein 280) (gp280) (Intrinsic factor-cobalamin receptor) (Intrinsic factor-vitamin B12 receptor) Rattus norvegicus (Rat) GO:0001701; GO:0005509; GO:0005737; GO:0005765; GO:0005768; GO:0005783; GO:0005794; GO:0005798; GO:0005886; GO:0005903; GO:0005905; GO:0006898; GO:0007584; GO:0008203; GO:0009235; GO:0009617; GO:0010008; GO:0015889; GO:0016020; GO:0016324; GO:0020028; GO:0030135; GO:0030139; GO:0030492; GO:0030666; GO:0031419; GO:0031526; GO:0031528; GO:0032991; GO:0038024; GO:0042366; GO:0042802; GO:0042803; GO:0042953; GO:0043202; GO:0043235; GO:0045177; GO:0051649; GO:0070062 cholesterol metabolic process [GO:0008203]; cobalamin catabolic process [GO:0042366]; cobalamin metabolic process [GO:0009235]; cobalamin transport [GO:0015889]; endocytic hemoglobin import into cell [GO:0020028]; establishment of localization in cell [GO:0051649]; in utero embryonic development [GO:0001701]; lipoprotein transport [GO:0042953]; receptor-mediated endocytosis [GO:0006898]; response to bacterium [GO:0009617]; response to nutrient [GO:0007584] apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; brush border [GO:0005903]; brush border membrane [GO:0031526]; clathrin-coated pit [GO:0005905]; coated vesicle [GO:0030135]; cytoplasm [GO:0005737]; endocytic vesicle [GO:0030139]; endocytic vesicle membrane [GO:0030666]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi-associated vesicle [GO:0005798]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; microvillus membrane [GO:0031528]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; cargo receptor activity [GO:0038024]; cobalamin binding [GO:0031419]; hemoglobin binding [GO:0030492]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803] g7862.t1 O70244 25.837 836 1.06e-57 225.0 sp|O70244|CUBN_RAT Cubilin OS=Rattus norvegicus OX=10116 GN=Cubn PE=1 SV=2 CUBN_RAT reviewed Cubilin (460 kDa receptor) (Glycoprotein 280) (gp280) (Intrinsic factor-cobalamin receptor) (Intrinsic factor-vitamin B12 receptor) Rattus norvegicus (Rat) GO:0001701; GO:0005509; GO:0005737; GO:0005765; GO:0005768; GO:0005783; GO:0005794; GO:0005798; GO:0005886; GO:0005903; GO:0005905; GO:0006898; GO:0007584; GO:0008203; GO:0009235; GO:0009617; GO:0010008; GO:0015889; GO:0016020; GO:0016324; GO:0020028; GO:0030135; GO:0030139; GO:0030492; GO:0030666; GO:0031419; GO:0031526; GO:0031528; GO:0032991; GO:0038024; GO:0042366; GO:0042802; GO:0042803; GO:0042953; GO:0043202; GO:0043235; GO:0045177; GO:0051649; GO:0070062 cholesterol metabolic process [GO:0008203]; cobalamin catabolic process [GO:0042366]; cobalamin metabolic process [GO:0009235]; cobalamin transport [GO:0015889]; endocytic hemoglobin import into cell [GO:0020028]; establishment of localization in cell [GO:0051649]; in utero embryonic development [GO:0001701]; lipoprotein transport [GO:0042953]; receptor-mediated endocytosis [GO:0006898]; response to bacterium [GO:0009617]; response to nutrient [GO:0007584] apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; brush border [GO:0005903]; brush border membrane [GO:0031526]; clathrin-coated pit [GO:0005905]; coated vesicle [GO:0030135]; cytoplasm [GO:0005737]; endocytic vesicle [GO:0030139]; endocytic vesicle membrane [GO:0030666]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi-associated vesicle [GO:0005798]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; microvillus membrane [GO:0031528]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; cargo receptor activity [GO:0038024]; cobalamin binding [GO:0031419]; hemoglobin binding [GO:0030492]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803] g7862.t1 O70244 24.069 1155 1.2799999999999999e-48 196.0 sp|O70244|CUBN_RAT Cubilin OS=Rattus norvegicus OX=10116 GN=Cubn PE=1 SV=2 CUBN_RAT reviewed Cubilin (460 kDa receptor) (Glycoprotein 280) (gp280) (Intrinsic factor-cobalamin receptor) (Intrinsic factor-vitamin B12 receptor) Rattus norvegicus (Rat) GO:0001701; GO:0005509; GO:0005737; GO:0005765; GO:0005768; GO:0005783; GO:0005794; GO:0005798; GO:0005886; GO:0005903; GO:0005905; GO:0006898; GO:0007584; GO:0008203; GO:0009235; GO:0009617; GO:0010008; GO:0015889; GO:0016020; GO:0016324; GO:0020028; GO:0030135; GO:0030139; GO:0030492; GO:0030666; GO:0031419; GO:0031526; GO:0031528; GO:0032991; GO:0038024; GO:0042366; GO:0042802; GO:0042803; GO:0042953; GO:0043202; GO:0043235; GO:0045177; GO:0051649; GO:0070062 cholesterol metabolic process [GO:0008203]; cobalamin catabolic process [GO:0042366]; cobalamin metabolic process [GO:0009235]; cobalamin transport [GO:0015889]; endocytic hemoglobin import into cell [GO:0020028]; establishment of localization in cell [GO:0051649]; in utero embryonic development [GO:0001701]; lipoprotein transport [GO:0042953]; receptor-mediated endocytosis [GO:0006898]; response to bacterium [GO:0009617]; response to nutrient [GO:0007584] apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; brush border [GO:0005903]; brush border membrane [GO:0031526]; clathrin-coated pit [GO:0005905]; coated vesicle [GO:0030135]; cytoplasm [GO:0005737]; endocytic vesicle [GO:0030139]; endocytic vesicle membrane [GO:0030666]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi-associated vesicle [GO:0005798]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; microvillus membrane [GO:0031528]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; cargo receptor activity [GO:0038024]; cobalamin binding [GO:0031419]; hemoglobin binding [GO:0030492]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803] g7862.t1 O70244 26.149 696 7.309999999999999e-46 187.0 sp|O70244|CUBN_RAT Cubilin OS=Rattus norvegicus OX=10116 GN=Cubn PE=1 SV=2 CUBN_RAT reviewed Cubilin (460 kDa receptor) (Glycoprotein 280) (gp280) (Intrinsic factor-cobalamin receptor) (Intrinsic factor-vitamin B12 receptor) Rattus norvegicus (Rat) GO:0001701; GO:0005509; GO:0005737; GO:0005765; GO:0005768; GO:0005783; GO:0005794; GO:0005798; GO:0005886; GO:0005903; GO:0005905; GO:0006898; GO:0007584; GO:0008203; GO:0009235; GO:0009617; GO:0010008; GO:0015889; GO:0016020; GO:0016324; GO:0020028; GO:0030135; GO:0030139; GO:0030492; GO:0030666; GO:0031419; GO:0031526; GO:0031528; GO:0032991; GO:0038024; GO:0042366; GO:0042802; GO:0042803; GO:0042953; GO:0043202; GO:0043235; GO:0045177; GO:0051649; GO:0070062 cholesterol metabolic process [GO:0008203]; cobalamin catabolic process [GO:0042366]; cobalamin metabolic process [GO:0009235]; cobalamin transport [GO:0015889]; endocytic hemoglobin import into cell [GO:0020028]; establishment of localization in cell [GO:0051649]; in utero embryonic development [GO:0001701]; lipoprotein transport [GO:0042953]; receptor-mediated endocytosis [GO:0006898]; response to bacterium [GO:0009617]; response to nutrient [GO:0007584] apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; brush border [GO:0005903]; brush border membrane [GO:0031526]; clathrin-coated pit [GO:0005905]; coated vesicle [GO:0030135]; cytoplasm [GO:0005737]; endocytic vesicle [GO:0030139]; endocytic vesicle membrane [GO:0030666]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi-associated vesicle [GO:0005798]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; microvillus membrane [GO:0031528]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; cargo receptor activity [GO:0038024]; cobalamin binding [GO:0031419]; hemoglobin binding [GO:0030492]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803] g7862.t1 O70244 26.876 733 1.35e-41 172.0 sp|O70244|CUBN_RAT Cubilin OS=Rattus norvegicus OX=10116 GN=Cubn PE=1 SV=2 CUBN_RAT reviewed Cubilin (460 kDa receptor) (Glycoprotein 280) (gp280) (Intrinsic factor-cobalamin receptor) (Intrinsic factor-vitamin B12 receptor) Rattus norvegicus (Rat) GO:0001701; GO:0005509; GO:0005737; GO:0005765; GO:0005768; GO:0005783; GO:0005794; GO:0005798; GO:0005886; GO:0005903; GO:0005905; GO:0006898; GO:0007584; GO:0008203; GO:0009235; GO:0009617; GO:0010008; GO:0015889; GO:0016020; GO:0016324; GO:0020028; GO:0030135; GO:0030139; GO:0030492; GO:0030666; GO:0031419; GO:0031526; GO:0031528; GO:0032991; GO:0038024; GO:0042366; GO:0042802; GO:0042803; GO:0042953; GO:0043202; GO:0043235; GO:0045177; GO:0051649; GO:0070062 cholesterol metabolic process [GO:0008203]; cobalamin catabolic process [GO:0042366]; cobalamin metabolic process [GO:0009235]; cobalamin transport [GO:0015889]; endocytic hemoglobin import into cell [GO:0020028]; establishment of localization in cell [GO:0051649]; in utero embryonic development [GO:0001701]; lipoprotein transport [GO:0042953]; receptor-mediated endocytosis [GO:0006898]; response to bacterium [GO:0009617]; response to nutrient [GO:0007584] apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; brush border [GO:0005903]; brush border membrane [GO:0031526]; clathrin-coated pit [GO:0005905]; coated vesicle [GO:0030135]; cytoplasm [GO:0005737]; endocytic vesicle [GO:0030139]; endocytic vesicle membrane [GO:0030666]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi-associated vesicle [GO:0005798]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; microvillus membrane [GO:0031528]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; cargo receptor activity [GO:0038024]; cobalamin binding [GO:0031419]; hemoglobin binding [GO:0030492]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803] g7862.t1 O70244 24.72 1072 2.83e-39 165.0 sp|O70244|CUBN_RAT Cubilin OS=Rattus norvegicus OX=10116 GN=Cubn PE=1 SV=2 CUBN_RAT reviewed Cubilin (460 kDa receptor) (Glycoprotein 280) (gp280) (Intrinsic factor-cobalamin receptor) (Intrinsic factor-vitamin B12 receptor) Rattus norvegicus (Rat) GO:0001701; GO:0005509; GO:0005737; GO:0005765; GO:0005768; GO:0005783; GO:0005794; GO:0005798; GO:0005886; GO:0005903; GO:0005905; GO:0006898; GO:0007584; GO:0008203; GO:0009235; GO:0009617; GO:0010008; GO:0015889; GO:0016020; GO:0016324; GO:0020028; GO:0030135; GO:0030139; GO:0030492; GO:0030666; GO:0031419; GO:0031526; GO:0031528; GO:0032991; GO:0038024; GO:0042366; GO:0042802; GO:0042803; GO:0042953; GO:0043202; GO:0043235; GO:0045177; GO:0051649; GO:0070062 cholesterol metabolic process [GO:0008203]; cobalamin catabolic process [GO:0042366]; cobalamin metabolic process [GO:0009235]; cobalamin transport [GO:0015889]; endocytic hemoglobin import into cell [GO:0020028]; establishment of localization in cell [GO:0051649]; in utero embryonic development [GO:0001701]; lipoprotein transport [GO:0042953]; receptor-mediated endocytosis [GO:0006898]; response to bacterium [GO:0009617]; response to nutrient [GO:0007584] apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; brush border [GO:0005903]; brush border membrane [GO:0031526]; clathrin-coated pit [GO:0005905]; coated vesicle [GO:0030135]; cytoplasm [GO:0005737]; endocytic vesicle [GO:0030139]; endocytic vesicle membrane [GO:0030666]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi-associated vesicle [GO:0005798]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; microvillus membrane [GO:0031528]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; cargo receptor activity [GO:0038024]; cobalamin binding [GO:0031419]; hemoglobin binding [GO:0030492]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803] g7862.t1 O70244 29.474 380 9.14e-26 120.0 sp|O70244|CUBN_RAT Cubilin OS=Rattus norvegicus OX=10116 GN=Cubn PE=1 SV=2 CUBN_RAT reviewed Cubilin (460 kDa receptor) (Glycoprotein 280) (gp280) (Intrinsic factor-cobalamin receptor) (Intrinsic factor-vitamin B12 receptor) Rattus norvegicus (Rat) GO:0001701; GO:0005509; GO:0005737; GO:0005765; GO:0005768; GO:0005783; GO:0005794; GO:0005798; GO:0005886; GO:0005903; GO:0005905; GO:0006898; GO:0007584; GO:0008203; GO:0009235; GO:0009617; GO:0010008; GO:0015889; GO:0016020; GO:0016324; GO:0020028; GO:0030135; GO:0030139; GO:0030492; GO:0030666; GO:0031419; GO:0031526; GO:0031528; GO:0032991; GO:0038024; GO:0042366; GO:0042802; GO:0042803; GO:0042953; GO:0043202; GO:0043235; GO:0045177; GO:0051649; GO:0070062 cholesterol metabolic process [GO:0008203]; cobalamin catabolic process [GO:0042366]; cobalamin metabolic process [GO:0009235]; cobalamin transport [GO:0015889]; endocytic hemoglobin import into cell [GO:0020028]; establishment of localization in cell [GO:0051649]; in utero embryonic development [GO:0001701]; lipoprotein transport [GO:0042953]; receptor-mediated endocytosis [GO:0006898]; response to bacterium [GO:0009617]; response to nutrient [GO:0007584] apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; brush border [GO:0005903]; brush border membrane [GO:0031526]; clathrin-coated pit [GO:0005905]; coated vesicle [GO:0030135]; cytoplasm [GO:0005737]; endocytic vesicle [GO:0030139]; endocytic vesicle membrane [GO:0030666]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi-associated vesicle [GO:0005798]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; microvillus membrane [GO:0031528]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; cargo receptor activity [GO:0038024]; cobalamin binding [GO:0031419]; hemoglobin binding [GO:0030492]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803] g7862.t1 O70244 27.763 389 2.19e-23 113.0 sp|O70244|CUBN_RAT Cubilin OS=Rattus norvegicus OX=10116 GN=Cubn PE=1 SV=2 CUBN_RAT reviewed Cubilin (460 kDa receptor) (Glycoprotein 280) (gp280) (Intrinsic factor-cobalamin receptor) (Intrinsic factor-vitamin B12 receptor) Rattus norvegicus (Rat) GO:0001701; GO:0005509; GO:0005737; GO:0005765; GO:0005768; GO:0005783; GO:0005794; GO:0005798; GO:0005886; GO:0005903; GO:0005905; GO:0006898; GO:0007584; GO:0008203; GO:0009235; GO:0009617; GO:0010008; GO:0015889; GO:0016020; GO:0016324; GO:0020028; GO:0030135; GO:0030139; GO:0030492; GO:0030666; GO:0031419; GO:0031526; GO:0031528; GO:0032991; GO:0038024; GO:0042366; GO:0042802; GO:0042803; GO:0042953; GO:0043202; GO:0043235; GO:0045177; GO:0051649; GO:0070062 cholesterol metabolic process [GO:0008203]; cobalamin catabolic process [GO:0042366]; cobalamin metabolic process [GO:0009235]; cobalamin transport [GO:0015889]; endocytic hemoglobin import into cell [GO:0020028]; establishment of localization in cell [GO:0051649]; in utero embryonic development [GO:0001701]; lipoprotein transport [GO:0042953]; receptor-mediated endocytosis [GO:0006898]; response to bacterium [GO:0009617]; response to nutrient [GO:0007584] apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; brush border [GO:0005903]; brush border membrane [GO:0031526]; clathrin-coated pit [GO:0005905]; coated vesicle [GO:0030135]; cytoplasm [GO:0005737]; endocytic vesicle [GO:0030139]; endocytic vesicle membrane [GO:0030666]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi-associated vesicle [GO:0005798]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; microvillus membrane [GO:0031528]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; cargo receptor activity [GO:0038024]; cobalamin binding [GO:0031419]; hemoglobin binding [GO:0030492]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803] g7863.t1 O43895 41.642 682 1.99e-173 514.0 sp|O43895|XPP2_HUMAN Xaa-Pro aminopeptidase 2 OS=Homo sapiens OX=9606 GN=XPNPEP2 PE=1 SV=3 XPP2_HUMAN reviewed Xaa-Pro aminopeptidase 2 (EC 3.4.11.9) (Aminoacylproline aminopeptidase) (Membrane-bound aminopeptidase P) (Membrane-bound APP) (Membrane-bound AmP) (mAmP) (X-Pro aminopeptidase 2) Homo sapiens (Human) GO:0004177; GO:0005576; GO:0005886; GO:0006508; GO:0016020; GO:0046872; GO:0070006; GO:0070062; GO:0098552 proteolysis [GO:0006508] extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; membrane [GO:0016020]; plasma membrane [GO:0005886]; side of membrane [GO:0098552] aminopeptidase activity [GO:0004177]; metal ion binding [GO:0046872]; metalloaminopeptidase activity [GO:0070006] g7865.t1 A2AJ76 27.022 581 1.7500000000000002e-43 177.0 sp|A2AJ76|HMCN2_MOUSE Hemicentin-2 OS=Mus musculus OX=10090 GN=Hmcn2 PE=1 SV=1 HMCN2_MOUSE reviewed Hemicentin-2 Mus musculus (Mouse) GO:0005509; GO:0005576; GO:0005604; GO:0005886; GO:0005938; GO:0007156; GO:0008046; GO:0030054; GO:0030424; GO:0031012; GO:0032154; GO:0043025; GO:0050808 homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; synapse organization [GO:0050808] axon [GO:0030424]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886] axon guidance receptor activity [GO:0008046]; calcium ion binding [GO:0005509] g7865.t1 A2AJ76 25.557 583 6.61e-39 162.0 sp|A2AJ76|HMCN2_MOUSE Hemicentin-2 OS=Mus musculus OX=10090 GN=Hmcn2 PE=1 SV=1 HMCN2_MOUSE reviewed Hemicentin-2 Mus musculus (Mouse) GO:0005509; GO:0005576; GO:0005604; GO:0005886; GO:0005938; GO:0007156; GO:0008046; GO:0030054; GO:0030424; GO:0031012; GO:0032154; GO:0043025; GO:0050808 homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; synapse organization [GO:0050808] axon [GO:0030424]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886] axon guidance receptor activity [GO:0008046]; calcium ion binding [GO:0005509] g7865.t1 A2AJ76 26.14 570 1.3e-38 161.0 sp|A2AJ76|HMCN2_MOUSE Hemicentin-2 OS=Mus musculus OX=10090 GN=Hmcn2 PE=1 SV=1 HMCN2_MOUSE reviewed Hemicentin-2 Mus musculus (Mouse) GO:0005509; GO:0005576; GO:0005604; GO:0005886; GO:0005938; GO:0007156; GO:0008046; GO:0030054; GO:0030424; GO:0031012; GO:0032154; GO:0043025; GO:0050808 homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; synapse organization [GO:0050808] axon [GO:0030424]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886] axon guidance receptor activity [GO:0008046]; calcium ion binding [GO:0005509] g7865.t1 A2AJ76 26.126 555 2.04e-38 160.0 sp|A2AJ76|HMCN2_MOUSE Hemicentin-2 OS=Mus musculus OX=10090 GN=Hmcn2 PE=1 SV=1 HMCN2_MOUSE reviewed Hemicentin-2 Mus musculus (Mouse) GO:0005509; GO:0005576; GO:0005604; GO:0005886; GO:0005938; GO:0007156; GO:0008046; GO:0030054; GO:0030424; GO:0031012; GO:0032154; GO:0043025; GO:0050808 homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; synapse organization [GO:0050808] axon [GO:0030424]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886] axon guidance receptor activity [GO:0008046]; calcium ion binding [GO:0005509] g7865.t1 A2AJ76 26.75 557 3.75e-38 160.0 sp|A2AJ76|HMCN2_MOUSE Hemicentin-2 OS=Mus musculus OX=10090 GN=Hmcn2 PE=1 SV=1 HMCN2_MOUSE reviewed Hemicentin-2 Mus musculus (Mouse) GO:0005509; GO:0005576; GO:0005604; GO:0005886; GO:0005938; GO:0007156; GO:0008046; GO:0030054; GO:0030424; GO:0031012; GO:0032154; GO:0043025; GO:0050808 homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; synapse organization [GO:0050808] axon [GO:0030424]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886] axon guidance receptor activity [GO:0008046]; calcium ion binding [GO:0005509] g7865.t1 A2AJ76 26.117 582 3.6700000000000002e-37 156.0 sp|A2AJ76|HMCN2_MOUSE Hemicentin-2 OS=Mus musculus OX=10090 GN=Hmcn2 PE=1 SV=1 HMCN2_MOUSE reviewed Hemicentin-2 Mus musculus (Mouse) GO:0005509; GO:0005576; GO:0005604; GO:0005886; GO:0005938; GO:0007156; GO:0008046; GO:0030054; GO:0030424; GO:0031012; GO:0032154; GO:0043025; GO:0050808 homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; synapse organization [GO:0050808] axon [GO:0030424]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886] axon guidance receptor activity [GO:0008046]; calcium ion binding [GO:0005509] g7865.t1 A2AJ76 24.334 563 1.8700000000000001e-35 151.0 sp|A2AJ76|HMCN2_MOUSE Hemicentin-2 OS=Mus musculus OX=10090 GN=Hmcn2 PE=1 SV=1 HMCN2_MOUSE reviewed Hemicentin-2 Mus musculus (Mouse) GO:0005509; GO:0005576; GO:0005604; GO:0005886; GO:0005938; GO:0007156; GO:0008046; GO:0030054; GO:0030424; GO:0031012; GO:0032154; GO:0043025; GO:0050808 homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; synapse organization [GO:0050808] axon [GO:0030424]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886] axon guidance receptor activity [GO:0008046]; calcium ion binding [GO:0005509] g7865.t1 A2AJ76 24.776 557 1e-34 149.0 sp|A2AJ76|HMCN2_MOUSE Hemicentin-2 OS=Mus musculus OX=10090 GN=Hmcn2 PE=1 SV=1 HMCN2_MOUSE reviewed Hemicentin-2 Mus musculus (Mouse) GO:0005509; GO:0005576; GO:0005604; GO:0005886; GO:0005938; GO:0007156; GO:0008046; GO:0030054; GO:0030424; GO:0031012; GO:0032154; GO:0043025; GO:0050808 homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; synapse organization [GO:0050808] axon [GO:0030424]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886] axon guidance receptor activity [GO:0008046]; calcium ion binding [GO:0005509] g7865.t1 A2AJ76 25.729 583 3.76e-34 147.0 sp|A2AJ76|HMCN2_MOUSE Hemicentin-2 OS=Mus musculus OX=10090 GN=Hmcn2 PE=1 SV=1 HMCN2_MOUSE reviewed Hemicentin-2 Mus musculus (Mouse) GO:0005509; GO:0005576; GO:0005604; GO:0005886; GO:0005938; GO:0007156; GO:0008046; GO:0030054; GO:0030424; GO:0031012; GO:0032154; GO:0043025; GO:0050808 homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; synapse organization [GO:0050808] axon [GO:0030424]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886] axon guidance receptor activity [GO:0008046]; calcium ion binding [GO:0005509] g7865.t1 A2AJ76 25.838 507 8.78e-32 139.0 sp|A2AJ76|HMCN2_MOUSE Hemicentin-2 OS=Mus musculus OX=10090 GN=Hmcn2 PE=1 SV=1 HMCN2_MOUSE reviewed Hemicentin-2 Mus musculus (Mouse) GO:0005509; GO:0005576; GO:0005604; GO:0005886; GO:0005938; GO:0007156; GO:0008046; GO:0030054; GO:0030424; GO:0031012; GO:0032154; GO:0043025; GO:0050808 homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; synapse organization [GO:0050808] axon [GO:0030424]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886] axon guidance receptor activity [GO:0008046]; calcium ion binding [GO:0005509] g7865.t1 A2AJ76 23.171 574 9.010000000000001e-32 139.0 sp|A2AJ76|HMCN2_MOUSE Hemicentin-2 OS=Mus musculus OX=10090 GN=Hmcn2 PE=1 SV=1 HMCN2_MOUSE reviewed Hemicentin-2 Mus musculus (Mouse) GO:0005509; GO:0005576; GO:0005604; GO:0005886; GO:0005938; GO:0007156; GO:0008046; GO:0030054; GO:0030424; GO:0031012; GO:0032154; GO:0043025; GO:0050808 homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; synapse organization [GO:0050808] axon [GO:0030424]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886] axon guidance receptor activity [GO:0008046]; calcium ion binding [GO:0005509] g7865.t1 A2AJ76 27.8 500 1.95e-31 138.0 sp|A2AJ76|HMCN2_MOUSE Hemicentin-2 OS=Mus musculus OX=10090 GN=Hmcn2 PE=1 SV=1 HMCN2_MOUSE reviewed Hemicentin-2 Mus musculus (Mouse) GO:0005509; GO:0005576; GO:0005604; GO:0005886; GO:0005938; GO:0007156; GO:0008046; GO:0030054; GO:0030424; GO:0031012; GO:0032154; GO:0043025; GO:0050808 homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; synapse organization [GO:0050808] axon [GO:0030424]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886] axon guidance receptor activity [GO:0008046]; calcium ion binding [GO:0005509] g7865.t1 A2AJ76 25.8 531 6.98e-30 133.0 sp|A2AJ76|HMCN2_MOUSE Hemicentin-2 OS=Mus musculus OX=10090 GN=Hmcn2 PE=1 SV=1 HMCN2_MOUSE reviewed Hemicentin-2 Mus musculus (Mouse) GO:0005509; GO:0005576; GO:0005604; GO:0005886; GO:0005938; GO:0007156; GO:0008046; GO:0030054; GO:0030424; GO:0031012; GO:0032154; GO:0043025; GO:0050808 homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; synapse organization [GO:0050808] axon [GO:0030424]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886] axon guidance receptor activity [GO:0008046]; calcium ion binding [GO:0005509] g7865.t1 A2AJ76 24.772 549 1.8899999999999999e-28 128.0 sp|A2AJ76|HMCN2_MOUSE Hemicentin-2 OS=Mus musculus OX=10090 GN=Hmcn2 PE=1 SV=1 HMCN2_MOUSE reviewed Hemicentin-2 Mus musculus (Mouse) GO:0005509; GO:0005576; GO:0005604; GO:0005886; GO:0005938; GO:0007156; GO:0008046; GO:0030054; GO:0030424; GO:0031012; GO:0032154; GO:0043025; GO:0050808 homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; synapse organization [GO:0050808] axon [GO:0030424]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886] axon guidance receptor activity [GO:0008046]; calcium ion binding [GO:0005509] g7865.t1 A2AJ76 23.188 552 6.94e-28 126.0 sp|A2AJ76|HMCN2_MOUSE Hemicentin-2 OS=Mus musculus OX=10090 GN=Hmcn2 PE=1 SV=1 HMCN2_MOUSE reviewed Hemicentin-2 Mus musculus (Mouse) GO:0005509; GO:0005576; GO:0005604; GO:0005886; GO:0005938; GO:0007156; GO:0008046; GO:0030054; GO:0030424; GO:0031012; GO:0032154; GO:0043025; GO:0050808 homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; synapse organization [GO:0050808] axon [GO:0030424]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886] axon guidance receptor activity [GO:0008046]; calcium ion binding [GO:0005509] g7865.t1 A2AJ76 24.444 585 1.93e-26 122.0 sp|A2AJ76|HMCN2_MOUSE Hemicentin-2 OS=Mus musculus OX=10090 GN=Hmcn2 PE=1 SV=1 HMCN2_MOUSE reviewed Hemicentin-2 Mus musculus (Mouse) GO:0005509; GO:0005576; GO:0005604; GO:0005886; GO:0005938; GO:0007156; GO:0008046; GO:0030054; GO:0030424; GO:0031012; GO:0032154; GO:0043025; GO:0050808 homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; synapse organization [GO:0050808] axon [GO:0030424]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886] axon guidance receptor activity [GO:0008046]; calcium ion binding [GO:0005509] g7868.t1 Q5G872 46.457 1016 0.0 902.0 sp|Q5G872|SCUB2_DANRE Signal peptide, CUB and EGF-like domain-containing protein 2 OS=Danio rerio OX=7955 GN=scube2 PE=2 SV=1 SCUB2_DANRE reviewed Signal peptide, CUB and EGF-like domain-containing protein 2 (Protein You) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001756; GO:0002040; GO:0005509; GO:0005576; GO:0005615; GO:0007165; GO:0007224; GO:0007517; GO:0008015; GO:0009897; GO:0009986; GO:0030141; GO:0042694; GO:0051146; GO:0055001 blood circulation [GO:0008015]; muscle cell development [GO:0055001]; muscle cell fate specification [GO:0042694]; muscle organ development [GO:0007517]; signal transduction [GO:0007165]; smoothened signaling pathway [GO:0007224]; somitogenesis [GO:0001756]; sprouting angiogenesis [GO:0002040]; striated muscle cell differentiation [GO:0051146] cell surface [GO:0009986]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; secretory granule [GO:0030141] calcium ion binding [GO:0005509] g7871.t1 Q9D4C1 35.802 324 2.24e-42 163.0 sp|Q9D4C1|LMTD1_MOUSE Lamin tail domain-containing protein 1 OS=Mus musculus OX=10090 GN=Lmntd1 PE=2 SV=1 LMTD1_MOUSE reviewed Lamin tail domain-containing protein 1 (Intermediate filament tail domain-containing protein 1) (Lamin-A-related sequence 1 protein) Mus musculus (Mouse) GO:0005634; GO:0005635; GO:0005737; GO:0005882; GO:0008283 cell population proliferation [GO:0008283] cytoplasm [GO:0005737]; intermediate filament [GO:0005882]; nuclear envelope [GO:0005635]; nucleus [GO:0005634] g7872.t1 P84104 70.886 79 1.81e-32 119.0 sp|P84104|SRSF3_MOUSE Serine/arginine-rich splicing factor 3 OS=Mus musculus OX=10090 GN=Srsf3 PE=1 SV=1 SRSF3_MOUSE reviewed Serine/arginine-rich splicing factor 3 (Pre-mRNA-splicing factor SRP20) (Protein X16) (Splicing factor, arginine/serine-rich 3) Mus musculus (Mouse) GO:0000381; GO:0003723; GO:0003729; GO:0005737; GO:0006397; GO:0006406; GO:0008286; GO:0008380; GO:0016607; GO:0031053; GO:0043274; GO:0048024; GO:0070878; GO:0160134; GO:1990825; GO:1990830 cellular response to leukemia inhibitory factor [GO:1990830]; insulin receptor signaling pathway [GO:0008286]; mRNA export from nucleus [GO:0006406]; mRNA processing [GO:0006397]; primary miRNA processing [GO:0031053]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of mRNA splicing, via spliceosome [GO:0048024]; RNA splicing [GO:0008380] cytoplasm [GO:0005737]; nuclear speck [GO:0016607] mRNA binding [GO:0003729]; phospholipase binding [GO:0043274]; primary miRNA binding [GO:0070878]; protein-RNA sequence-specific adaptor activity [GO:0160134]; RNA binding [GO:0003723]; sequence-specific mRNA binding [GO:1990825] g7881.t1 Q801S4 42.169 415 2.32e-93 289.0 sp|Q801S4|K0930_XENLA Uncharacterized protein KIAA0930 homolog OS=Xenopus laevis OX=8355 PE=2 SV=2 g7883.t1 Q8CHP8 43.506 308 4.1600000000000003e-88 269.0 sp|Q8CHP8|PGP_MOUSE Glycerol-3-phosphate phosphatase OS=Mus musculus OX=10090 GN=Pgp PE=1 SV=1 PGP_MOUSE reviewed Glycerol-3-phosphate phosphatase (G3PP) (EC 3.1.3.21) (Aspartate-based ubiquitous Mg(2+)-dependent phosphatase) (AUM) (EC 3.1.3.48) (Phosphoglycolate phosphatase) (PGP) Mus musculus (Mouse) GO:0000121; GO:0000287; GO:0004725; GO:0005737; GO:0006114; GO:0006650; GO:0008967; GO:0043136; GO:0043262; GO:0045721 glycerol biosynthetic process [GO:0006114]; glycerophospholipid metabolic process [GO:0006650]; negative regulation of gluconeogenesis [GO:0045721] cytoplasm [GO:0005737] ADP phosphatase activity [GO:0043262]; magnesium ion binding [GO:0000287]; phosphoglycolate phosphatase activity [GO:0008967]; protein tyrosine phosphatase activity [GO:0004725]; sn-glycerol 1-phosphatase activity [GO:0000121]; sn-glycerol 3-phosphatase activity [GO:0043136] g7883.t2 Q2T9S4 42.623 305 7.230000000000001e-85 261.0 sp|Q2T9S4|PGP_BOVIN Glycerol-3-phosphate phosphatase OS=Bos taurus OX=9913 GN=PGP PE=2 SV=1 PGP_BOVIN reviewed Glycerol-3-phosphate phosphatase (G3PP) (EC 3.1.3.21) (Aspartate-based ubiquitous Mg(2+)-dependent phosphatase) (AUM) (EC 3.1.3.48) (Phosphoglycolate phosphatase) (PGP) Bos taurus (Bovine) GO:0000121; GO:0000287; GO:0004725; GO:0005737; GO:0006114; GO:0006650; GO:0008967; GO:0043136; GO:0045721 glycerol biosynthetic process [GO:0006114]; glycerophospholipid metabolic process [GO:0006650]; negative regulation of gluconeogenesis [GO:0045721] cytoplasm [GO:0005737] magnesium ion binding [GO:0000287]; phosphoglycolate phosphatase activity [GO:0008967]; protein tyrosine phosphatase activity [GO:0004725]; sn-glycerol 1-phosphatase activity [GO:0000121]; sn-glycerol 3-phosphatase activity [GO:0043136] g7883.t3 Q8CHP8 41.304 322 5.07e-83 257.0 sp|Q8CHP8|PGP_MOUSE Glycerol-3-phosphate phosphatase OS=Mus musculus OX=10090 GN=Pgp PE=1 SV=1 PGP_MOUSE reviewed Glycerol-3-phosphate phosphatase (G3PP) (EC 3.1.3.21) (Aspartate-based ubiquitous Mg(2+)-dependent phosphatase) (AUM) (EC 3.1.3.48) (Phosphoglycolate phosphatase) (PGP) Mus musculus (Mouse) GO:0000121; GO:0000287; GO:0004725; GO:0005737; GO:0006114; GO:0006650; GO:0008967; GO:0043136; GO:0043262; GO:0045721 glycerol biosynthetic process [GO:0006114]; glycerophospholipid metabolic process [GO:0006650]; negative regulation of gluconeogenesis [GO:0045721] cytoplasm [GO:0005737] ADP phosphatase activity [GO:0043262]; magnesium ion binding [GO:0000287]; phosphoglycolate phosphatase activity [GO:0008967]; protein tyrosine phosphatase activity [GO:0004725]; sn-glycerol 1-phosphatase activity [GO:0000121]; sn-glycerol 3-phosphatase activity [GO:0043136] g7885.t1 Q9VBW3 47.797 295 6.16e-81 272.0 sp|Q9VBW3|CAD96_DROME Tyrosine kinase receptor Cad96Ca OS=Drosophila melanogaster OX=7227 GN=Cad96Ca PE=2 SV=2 CAD96_DROME reviewed Tyrosine kinase receptor Cad96Ca (EC 2.7.10.1) (Cadherin-96Ca) (Tyrosine kinase receptor HD-14) Drosophila melanogaster (Fruit fly) GO:0004713; GO:0004714; GO:0005509; GO:0005524; GO:0005886; GO:0006468; GO:0007030; GO:0007156; GO:0007169; GO:0016339; GO:0042060; GO:0043235; GO:0045177; GO:0045792; GO:0051897; GO:0090303 calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; Golgi organization [GO:0007030]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell size [GO:0045792]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of wound healing [GO:0090303]; protein phosphorylation [GO:0006468]; wound healing [GO:0042060] apical part of cell [GO:0045177]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; protein tyrosine kinase activity [GO:0004713]; transmembrane receptor protein tyrosine kinase activity [GO:0004714] g7891.t1 P14381 33.929 168 1.8400000000000002e-21 95.1 sp|P14381|YTX2_XENLA Transposon TX1 uncharacterized 149 kDa protein OS=Xenopus laevis OX=8355 PE=4 SV=1 g7893.t1 Q8BXB6 29.832 714 3e-80 274.0 sp|Q8BXB6|SO2B1_MOUSE Solute carrier organic anion transporter family member 2B1 OS=Mus musculus OX=10090 GN=Slco2b1 PE=1 SV=1 SO2B1_MOUSE reviewed Solute carrier organic anion transporter family member 2B1 (Organic anion transporting polypeptide 2B1) (OATP2B1) (Solute carrier family 21 member 9) Mus musculus (Mouse) GO:0005886; GO:0006879; GO:0008283; GO:0008514; GO:0009925; GO:0010106; GO:0010496; GO:0015125; GO:0015132; GO:0015347; GO:0015711; GO:0015721; GO:0016323; GO:0016324; GO:0022857; GO:0042908; GO:0043252; GO:0055085; GO:0071718; GO:0140420 bile acid and bile salt transport [GO:0015721]; cell population proliferation [GO:0008283]; cellular response to iron ion starvation [GO:0010106]; heme import into cell [GO:0140420]; intercellular transport [GO:0010496]; intracellular iron ion homeostasis [GO:0006879]; organic anion transport [GO:0015711]; sodium-independent icosanoid transport [GO:0071718]; sodium-independent organic anion transport [GO:0043252]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908] apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; plasma membrane [GO:0005886] bile acid transmembrane transporter activity [GO:0015125]; organic anion transmembrane transporter activity [GO:0008514]; prostaglandin transmembrane transporter activity [GO:0015132]; sodium-independent organic anion transmembrane transporter activity [GO:0015347]; transmembrane transporter activity [GO:0022857] g7894.t1 Q1L8X9 55.922 515 0.0 592.0 sp|Q1L8X9|VGLU3_DANRE Vesicular glutamate transporter 3 OS=Danio rerio OX=7955 GN=slc17a8 PE=3 SV=2 VGLU3_DANRE reviewed Vesicular glutamate transporter 3 (VGluT3) (Solute carrier family 17 member 8) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005254; GO:0005313; GO:0005326; GO:0005436; GO:0005886; GO:0015813; GO:0030672; GO:0034707; GO:0035249; GO:0043005; GO:0044341; GO:0050803; GO:0050957; GO:0051631; GO:0051938; GO:0051951; GO:0055062; GO:0060005; GO:0060076; GO:0098700; GO:0140788 equilibrioception [GO:0050957]; L-glutamate import [GO:0051938]; L-glutamate transmembrane transport [GO:0015813]; neurotransmitter loading into synaptic vesicle [GO:0098700]; phosphate ion homeostasis [GO:0055062]; positive regulation of glutamate uptake involved in transmission of nerve impulse [GO:0051951]; regulation of acetylcholine uptake [GO:0051631]; regulation of synapse structure or activity [GO:0050803]; sodium-dependent phosphate transport [GO:0044341]; synaptic transmission, glutamatergic [GO:0035249]; vestibular reflex [GO:0060005] chloride channel complex [GO:0034707]; excitatory synapse [GO:0060076]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; synaptic vesicle membrane [GO:0030672] chloride channel activity [GO:0005254]; L-glutamate transmembrane transporter activity [GO:0005313]; L-glutamate uniporter activity [GO:0140788]; neurotransmitter transmembrane transporter activity [GO:0005326]; sodium:phosphate symporter activity [GO:0005436] g7896.t1 Q9NYQ6 28.261 230 4.59e-21 103.0 sp|Q9NYQ6|CELR1_HUMAN Cadherin EGF LAG seven-pass G-type receptor 1 OS=Homo sapiens OX=9606 GN=CELSR1 PE=1 SV=1 CELR1_HUMAN reviewed Cadherin EGF LAG seven-pass G-type receptor 1 (Cadherin family member 9) (Flamingo homolog 2) (hFmi2) Homo sapiens (Human) GO:0001736; GO:0001764; GO:0001843; GO:0004930; GO:0005509; GO:0005654; GO:0005886; GO:0005912; GO:0007156; GO:0007266; GO:0007409; GO:0007417; GO:0016020; GO:0032956; GO:0042249; GO:0044331; GO:0045176; GO:0048105; GO:0060071; GO:0060488; GO:0060489; GO:0060490; GO:0090251 apical protein localization [GO:0045176]; axonogenesis [GO:0007409]; cell-cell adhesion mediated by cadherin [GO:0044331]; central nervous system development [GO:0007417]; establishment of body hair planar orientation [GO:0048105]; establishment of planar polarity [GO:0001736]; establishment of planar polarity of embryonic epithelium [GO:0042249]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; lateral sprouting involved in lung morphogenesis [GO:0060490]; neural tube closure [GO:0001843]; neuron migration [GO:0001764]; orthogonal dichotomous subdivision of terminal units involved in lung branching morphogenesis [GO:0060488]; planar dichotomous subdivision of terminal units involved in lung branching morphogenesis [GO:0060489]; protein localization involved in establishment of planar polarity [GO:0090251]; regulation of actin cytoskeleton organization [GO:0032956]; Rho protein signal transduction [GO:0007266]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071] adherens junction [GO:0005912]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; G protein-coupled receptor activity [GO:0004930] g7898.t1 O88917 34.066 182 1.4399999999999997e-23 111.0 sp|O88917|AGRL1_RAT Adhesion G protein-coupled receptor L1 OS=Rattus norvegicus OX=10116 GN=Adgrl1 PE=1 SV=1 AGRL1_RAT reviewed Adhesion G protein-coupled receptor L1 (Calcium-independent alpha-latrotoxin receptor 1) (CIRL-1) (Latrophilin-1) Rattus norvegicus (Rat) GO:0004930; GO:0005886; GO:0007166; GO:0007186; GO:0015643; GO:0016524; GO:0030246; GO:0030424; GO:0030426; GO:0042734; GO:0043005; GO:0045202; GO:0050839; GO:0051965; GO:0098978 cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186]; positive regulation of synapse assembly [GO:0051965] axon [GO:0030424]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; synapse [GO:0045202] carbohydrate binding [GO:0030246]; cell adhesion molecule binding [GO:0050839]; G protein-coupled receptor activity [GO:0004930]; latrotoxin receptor activity [GO:0016524]; toxic substance binding [GO:0015643] g7900.t1 Q5ZMW3 56.874 531 0.0 597.0 sp|Q5ZMW3|API5_CHICK Apoptosis inhibitor 5 OS=Gallus gallus OX=9031 GN=API5 PE=2 SV=1 g7901.t1 Q3B726 45.113 133 2.4400000000000003e-27 115.0 sp|Q3B726|RPA43_HUMAN DNA-directed RNA polymerase I subunit RPA43 OS=Homo sapiens OX=9606 GN=POLR1F PE=1 SV=1 RPA43_HUMAN reviewed DNA-directed RNA polymerase I subunit RPA43 (DNA-directed RNA polymerase I subunit F) (Twist neighbor protein) Homo sapiens (Human) GO:0005654; GO:0005736; GO:0006352; GO:0006362; GO:1990830 cellular response to leukemia inhibitory factor [GO:1990830]; DNA-templated transcription initiation [GO:0006352]; transcription elongation by RNA polymerase I [GO:0006362] nucleoplasm [GO:0005654]; RNA polymerase I complex [GO:0005736] g7902.t1 Q6P829 53.43 277 5.07e-100 298.0 sp|Q6P829|NOSIP_XENTR Nitric oxide synthase-interacting protein OS=Xenopus tropicalis OX=8364 GN=nosip PE=2 SV=1 g7904.t1 P45447 58.333 84 8.92e-33 127.0 sp|P45447|E78C_DROME Ecdysone-induced protein 78C OS=Drosophila melanogaster OX=7227 GN=Eip78C PE=2 SV=4 g7904.t2 P45447 58.333 84 9.89e-33 127.0 sp|P45447|E78C_DROME Ecdysone-induced protein 78C OS=Drosophila melanogaster OX=7227 GN=Eip78C PE=2 SV=4 g7906.t1 O08587 34.957 349 6.28e-45 166.0 sp|O08587|NUP50_RAT Nuclear pore complex protein Nup50 OS=Rattus norvegicus OX=10116 GN=Nup50 PE=2 SV=2 g7908.t1 O75899 34.615 702 6.2000000000000006e-121 389.0 sp|O75899|GABR2_HUMAN Gamma-aminobutyric acid type B receptor subunit 2 OS=Homo sapiens OX=9606 GN=GABBR2 PE=1 SV=1 GABR2_HUMAN reviewed Gamma-aminobutyric acid type B receptor subunit 2 (GABA-B receptor 2) (GABA-B-R2) (GABA-BR2) (GABABR2) (Gb2) (G-protein coupled receptor 51) (HG20) Homo sapiens (Human) GO:0004888; GO:0004965; GO:0005737; GO:0005886; GO:0007186; GO:0007193; GO:0007194; GO:0007214; GO:0007268; GO:0038039; GO:0043005; GO:0045211; GO:0046982; GO:0051932; GO:0150099; GO:1902710; GO:1902712 adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; chemical synaptic transmission [GO:0007268]; G protein-coupled receptor signaling pathway [GO:0007186]; gamma-aminobutyric acid signaling pathway [GO:0007214]; negative regulation of adenylate cyclase activity [GO:0007194]; neuron-glial cell signaling [GO:0150099]; synaptic transmission, GABAergic [GO:0051932] cytoplasm [GO:0005737]; G protein-coupled GABA receptor complex [GO:1902712]; G protein-coupled receptor heterodimeric complex [GO:0038039]; GABA receptor complex [GO:1902710]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211] G protein-coupled GABA receptor activity [GO:0004965]; protein heterodimerization activity [GO:0046982]; transmembrane signaling receptor activity [GO:0004888] g7909.t1 Q0IIF9 32.301 452 4.5899999999999995e-82 268.0 sp|Q0IIF9|CP2U1_BOVIN Cytochrome P450 2U1 OS=Bos taurus OX=9913 GN=CYP2U1 PE=2 SV=1 CP2U1_BOVIN reviewed Cytochrome P450 2U1 (Long-chain fatty acid omega-monooxygenase) (EC 1.14.14.80) Bos taurus (Bovine) GO:0005506; GO:0005737; GO:0005743; GO:0005789; GO:0006082; GO:0006805; GO:0008202; GO:0008395; GO:0016712; GO:0020037; GO:0052869; GO:0102033 organic acid metabolic process [GO:0006082]; steroid metabolic process [GO:0008202]; xenobiotic metabolic process [GO:0006805] cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; mitochondrial inner membrane [GO:0005743] arachidonate omega-hydroxylase activity [GO:0052869]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; long-chain fatty acid omega-hydroxylase activity [GO:0102033]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; steroid hydroxylase activity [GO:0008395] g7910.t1 O88871 32.816 515 1.28e-71 249.0 sp|O88871|GABR2_RAT Gamma-aminobutyric acid type B receptor subunit 2 OS=Rattus norvegicus OX=10116 GN=Gabbr2 PE=1 SV=2 GABR2_RAT reviewed Gamma-aminobutyric acid type B receptor subunit 2 (GABA-B receptor 2) (GABA-B-R2) (GABA-BR2) (GABABR2) (Gb2) (G-protein coupled receptor 51) Rattus norvegicus (Rat) GO:0004965; GO:0005737; GO:0005886; GO:0007193; GO:0007214; GO:0030425; GO:0038039; GO:0042734; GO:0043005; GO:0043204; GO:0045211; GO:0046982; GO:0051932; GO:0098978; GO:0098982; GO:0150099; GO:1902710; GO:1902712 adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; gamma-aminobutyric acid signaling pathway [GO:0007214]; neuron-glial cell signaling [GO:0150099]; synaptic transmission, GABAergic [GO:0051932] cytoplasm [GO:0005737]; dendrite [GO:0030425]; G protein-coupled GABA receptor complex [GO:1902712]; G protein-coupled receptor heterodimeric complex [GO:0038039]; GABA receptor complex [GO:1902710]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; neuron projection [GO:0043005]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734] G protein-coupled GABA receptor activity [GO:0004965]; protein heterodimerization activity [GO:0046982] g7913.t1 O75899 35.616 146 1.25e-24 104.0 sp|O75899|GABR2_HUMAN Gamma-aminobutyric acid type B receptor subunit 2 OS=Homo sapiens OX=9606 GN=GABBR2 PE=1 SV=1 GABR2_HUMAN reviewed Gamma-aminobutyric acid type B receptor subunit 2 (GABA-B receptor 2) (GABA-B-R2) (GABA-BR2) (GABABR2) (Gb2) (G-protein coupled receptor 51) (HG20) Homo sapiens (Human) GO:0004888; GO:0004965; GO:0005737; GO:0005886; GO:0007186; GO:0007193; GO:0007194; GO:0007214; GO:0007268; GO:0038039; GO:0043005; GO:0045211; GO:0046982; GO:0051932; GO:0150099; GO:1902710; GO:1902712 adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; chemical synaptic transmission [GO:0007268]; G protein-coupled receptor signaling pathway [GO:0007186]; gamma-aminobutyric acid signaling pathway [GO:0007214]; negative regulation of adenylate cyclase activity [GO:0007194]; neuron-glial cell signaling [GO:0150099]; synaptic transmission, GABAergic [GO:0051932] cytoplasm [GO:0005737]; G protein-coupled GABA receptor complex [GO:1902712]; G protein-coupled receptor heterodimeric complex [GO:0038039]; GABA receptor complex [GO:1902710]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211] G protein-coupled GABA receptor activity [GO:0004965]; protein heterodimerization activity [GO:0046982]; transmembrane signaling receptor activity [GO:0004888] g7915.t1 A3RL54 64.326 897 0.0 1065.0 sp|A3RL54|SL9C1_STRPU Sperm-specific sodium:proton exchanger OS=Strongylocentrotus purpuratus OX=7668 GN=SLC9C1 PE=1 SV=1 SL9C1_STRPU reviewed Sperm-specific sodium:proton exchanger (Solute carrier family 9 member C1) (Voltage-gated Na(+)/H(+) exchanger) Strongylocentrotus purpuratus (Purple sea urchin) GO:0005886; GO:0007338; GO:0015385; GO:0015386; GO:0030552; GO:0030553; GO:0036126; GO:0042803; GO:0051453; GO:0061827; GO:0071805; GO:0098719 potassium ion transmembrane transport [GO:0071805]; regulation of intracellular pH [GO:0051453]; single fertilization [GO:0007338]; sodium ion import across plasma membrane [GO:0098719] plasma membrane [GO:0005886]; sperm flagellum [GO:0036126]; sperm head [GO:0061827] cAMP binding [GO:0030552]; cGMP binding [GO:0030553]; potassium:proton antiporter activity [GO:0015386]; protein homodimerization activity [GO:0042803]; sodium:proton antiporter activity [GO:0015385] g7916.t1 A3RL54 74.306 144 6.34e-65 217.0 sp|A3RL54|SL9C1_STRPU Sperm-specific sodium:proton exchanger OS=Strongylocentrotus purpuratus OX=7668 GN=SLC9C1 PE=1 SV=1 SL9C1_STRPU reviewed Sperm-specific sodium:proton exchanger (Solute carrier family 9 member C1) (Voltage-gated Na(+)/H(+) exchanger) Strongylocentrotus purpuratus (Purple sea urchin) GO:0005886; GO:0007338; GO:0015385; GO:0015386; GO:0030552; GO:0030553; GO:0036126; GO:0042803; GO:0051453; GO:0061827; GO:0071805; GO:0098719 potassium ion transmembrane transport [GO:0071805]; regulation of intracellular pH [GO:0051453]; single fertilization [GO:0007338]; sodium ion import across plasma membrane [GO:0098719] plasma membrane [GO:0005886]; sperm flagellum [GO:0036126]; sperm head [GO:0061827] cAMP binding [GO:0030552]; cGMP binding [GO:0030553]; potassium:proton antiporter activity [GO:0015386]; protein homodimerization activity [GO:0042803]; sodium:proton antiporter activity [GO:0015385] g7918.t1 Q80YD6 38.929 411 3.2100000000000003e-72 236.0 sp|Q80YD6|SRGEF_MOUSE Secretion-regulating guanine nucleotide exchange factor OS=Mus musculus OX=10090 GN=Sergef PE=2 SV=2 g7919.t1 P18576 60.526 152 6.88e-40 147.0 sp|P18576|NFYA_RAT Nuclear transcription factor Y subunit alpha OS=Rattus norvegicus OX=10116 GN=Nfya PE=1 SV=1 NFYA_RAT reviewed Nuclear transcription factor Y subunit alpha (CAAT box DNA-binding protein subunit A) (CCAAT-binding transcription factor subunit A) (CBF-A) (Nuclear transcription factor Y subunit A) (NF-YA) Rattus norvegicus (Rat) GO:0000978; GO:0000981; GO:0001221; GO:0001228; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0006355; GO:0006357; GO:0006366; GO:0016602; GO:0032993; GO:0043565; GO:0045893; GO:0045944; GO:0048511; GO:0090575; GO:2000036; GO:2000648 positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of stem cell proliferation [GO:2000648]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA-templated transcription [GO:0006355]; regulation of stem cell population maintenance [GO:2000036]; regulation of transcription by RNA polymerase II [GO:0006357]; rhythmic process [GO:0048511]; transcription by RNA polymerase II [GO:0006366] CCAAT-binding factor complex [GO:0016602]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-DNA complex [GO:0032993]; RNA polymerase II transcription regulator complex [GO:0090575] DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription coregulator binding [GO:0001221] g7920.t1 O08696 46.377 138 5.78e-27 121.0 sp|O08696|FOXM1_MOUSE Forkhead box protein M1 OS=Mus musculus OX=10090 GN=Foxm1 PE=1 SV=2 g7923.t1 Q8CIW5 48.967 484 3.1299999999999997e-140 427.0 sp|Q8CIW5|PEO1_MOUSE Twinkle mtDNA helicase OS=Mus musculus OX=10090 GN=Twnk PE=2 SV=1 PEO1_MOUSE reviewed Twinkle mtDNA helicase (EC 5.6.2.3) (Progressive external ophthalmoplegia 1 protein homolog) (T7 gp4-like protein with intramitochondrial nucleoid localization) (T7-like mitochondrial DNA helicase) (Twinkle protein, mitochondrial) Mus musculus (Mouse) GO:0000262; GO:0002020; GO:0003678; GO:0003697; GO:0005524; GO:0005739; GO:0005743; GO:0006260; GO:0006261; GO:0006264; GO:0006390; GO:0008289; GO:0016887; GO:0034214; GO:0042645; GO:0042802; GO:0043139 DNA replication [GO:0006260]; DNA-templated DNA replication [GO:0006261]; mitochondrial DNA replication [GO:0006264]; mitochondrial transcription [GO:0006390]; protein hexamerization [GO:0034214] mitochondrial chromosome [GO:0000262]; mitochondrial inner membrane [GO:0005743]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739] 5'-3' DNA helicase activity [GO:0043139]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA helicase activity [GO:0003678]; identical protein binding [GO:0042802]; lipid binding [GO:0008289]; protease binding [GO:0002020]; single-stranded DNA binding [GO:0003697] g7924.t1 Q96RR1 70.968 93 4.31e-39 142.0 sp|Q96RR1|PEO1_HUMAN Twinkle mtDNA helicase OS=Homo sapiens OX=9606 GN=TWNK PE=1 SV=1 PEO1_HUMAN reviewed Twinkle mtDNA helicase (EC 5.6.2.3) (Progressive external ophthalmoplegia 1 protein) (T7 gp4-like protein with intramitochondrial nucleoid localization) (T7-like mitochondrial DNA helicase) (Twinkle protein, mitochondrial) Homo sapiens (Human) GO:0000262; GO:0002020; GO:0003678; GO:0003697; GO:0005524; GO:0005739; GO:0005743; GO:0005759; GO:0006261; GO:0006264; GO:0006390; GO:0008289; GO:0016887; GO:0034214; GO:0042645; GO:0042802; GO:0043139 DNA-templated DNA replication [GO:0006261]; mitochondrial DNA replication [GO:0006264]; mitochondrial transcription [GO:0006390]; protein hexamerization [GO:0034214] mitochondrial chromosome [GO:0000262]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739] 5'-3' DNA helicase activity [GO:0043139]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA helicase activity [GO:0003678]; identical protein binding [GO:0042802]; lipid binding [GO:0008289]; protease binding [GO:0002020]; single-stranded DNA binding [GO:0003697] g7925.t1 Q8VI63 45.089 224 2.8699999999999997e-62 197.0 sp|Q8VI63|MOB2_MOUSE MOB kinase activator 2 OS=Mus musculus OX=10090 GN=Mob2 PE=1 SV=1 MOB2_MOUSE reviewed MOB kinase activator 2 (Mob2 homolog) (Mps one binder kinase activator-like 2) (Ovary-specific MOB-like protein) Mus musculus (Mouse) GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0007165; GO:0010976; GO:0030036; GO:0030295; GO:0044306; GO:0046872; GO:0048471 actin cytoskeleton organization [GO:0030036]; positive regulation of neuron projection development [GO:0010976]; signal transduction [GO:0007165] cytoplasm [GO:0005737]; cytosol [GO:0005829]; neuron projection terminus [GO:0044306]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471] metal ion binding [GO:0046872]; protein kinase activator activity [GO:0030295] g7927.t1 Q28GV1 37.16 662 2.48e-87 287.0 sp|Q28GV1|CNDH2_XENTR Condensin-2 complex subunit H2 OS=Xenopus tropicalis OX=8364 GN=ncaph2 PE=2 SV=1 g7928.t1 Q7ZWN0 49.449 635 0.0 587.0 sp|Q7ZWN0|LMF2_XENLA Lipase maturation factor 2 OS=Xenopus laevis OX=8355 GN=lmf2 PE=2 SV=1 g7933.t1 E7F7V7 28.267 329 1.88e-23 103.0 sp|E7F7V7|GAL2B_DANRE Galanin receptor 2b OS=Danio rerio OX=7955 GN=galr2b PE=2 SV=1 g7934.t1 E7F7V7 28.616 318 1.3700000000000001e-27 114.0 sp|E7F7V7|GAL2B_DANRE Galanin receptor 2b OS=Danio rerio OX=7955 GN=galr2b PE=2 SV=1 g7937.t1 Q9Z321 66.923 260 1.85e-112 345.0 sp|Q9Z321|TOP3B_MOUSE DNA topoisomerase 3-beta-1 OS=Mus musculus OX=10090 GN=Top3b PE=1 SV=1 g7938.t1 O95985 69.002 471 0.0 697.0 sp|O95985|TOP3B_HUMAN DNA topoisomerase 3-beta-1 OS=Homo sapiens OX=9606 GN=TOP3B PE=1 SV=1 TOP3B_HUMAN reviewed DNA topoisomerase 3-beta-1 (EC 5.6.2.1) (DNA topoisomerase III beta-1) Homo sapiens (Human) GO:0000793; GO:0003677; GO:0003723; GO:0003916; GO:0003917; GO:0005634; GO:0006265; GO:0006281; GO:0006310; GO:0007059; GO:0140225; GO:0140226 chromosome segregation [GO:0007059]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA topological change [GO:0006265] condensed chromosome [GO:0000793]; DNA topoisomerase III-beta-TDRD3 complex [GO:0140225]; nucleus [GO:0005634] DNA binding [GO:0003677]; DNA topoisomerase activity [GO:0003916]; DNA topoisomerase type I (single strand cut, ATP-independent) activity [GO:0003917]; RNA binding [GO:0003723]; RNA topoisomerase activity [GO:0140226] g7948.t1 P97315 55.556 171 1.64e-35 126.0 sp|P97315|CSRP1_MOUSE Cysteine and glycine-rich protein 1 OS=Mus musculus OX=10090 GN=Csrp1 PE=1 SV=3 g7949.t1 A5WVX9 48.191 608 0.0 592.0 sp|A5WVX9|ZDH17_DANRE Palmitoyltransferase ZDHHC17 OS=Danio rerio OX=7955 GN=zdhhc17 PE=2 SV=1 ZDH17_DANRE reviewed Palmitoyltransferase ZDHHC17 (EC 2.3.1.225) (Acyltransferase ZDHHC17) (EC 2.3.1.-) (DHHC domain-containing cysteine-rich protein 17) (Zinc finger DHHC domain-containing protein 17) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000139; GO:0007409; GO:0019705; GO:0019706; GO:0030659; GO:0042734; GO:0046959; GO:0051386; GO:0070372; GO:0140439 axonogenesis [GO:0007409]; habituation [GO:0046959]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of neurotrophin TRK receptor signaling pathway [GO:0051386] cytoplasmic vesicle membrane [GO:0030659]; Golgi membrane [GO:0000139]; presynaptic membrane [GO:0042734] protein-cysteine S-myristoyltransferase activity [GO:0019705]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]; protein-cysteine S-stearoyltransferase activity [GO:0140439] g7952.t1 G1SNY0 79.72 143 8.810000000000001e-64 194.0 sp|G1SNY0|RL27A_RABIT Large ribosomal subunit protein uL15 OS=Oryctolagus cuniculus OX=9986 GN=RPL27A PE=1 SV=2 g7953.t1 Q99PP7 47.111 225 5.02e-56 197.0 sp|Q99PP7|TRI33_MOUSE E3 ubiquitin-protein ligase TRIM33 OS=Mus musculus OX=10090 GN=Trim33 PE=1 SV=2 g7954.t1 O15164 39.831 236 3.97e-47 181.0 sp|O15164|TIF1A_HUMAN Transcription intermediary factor 1-alpha OS=Homo sapiens OX=9606 GN=TRIM24 PE=1 SV=3 TIF1A_HUMAN reviewed Transcription intermediary factor 1-alpha (TIF1-alpha) (EC 2.3.2.27) (E3 ubiquitin-protein ligase TRIM24) (RING finger protein 82) (RING-type E3 ubiquitin transferase TIF1-alpha) (Tripartite motif-containing protein 24) Homo sapiens (Human) GO:0000785; GO:0000791; GO:0001673; GO:0002039; GO:0003682; GO:0003713; GO:0004672; GO:0005102; GO:0005634; GO:0005654; GO:0005726; GO:0005739; GO:0005829; GO:0006366; GO:0008270; GO:0010628; GO:0016567; GO:0016922; GO:0030163; GO:0031647; GO:0034056; GO:0042981; GO:0043434; GO:0045892; GO:0050673; GO:0050680; GO:0055074; GO:0061630; GO:0070562; GO:0071391; GO:0140118; GO:1901796 calcium ion homeostasis [GO:0055074]; cellular response to estrogen stimulus [GO:0071391]; epithelial cell proliferation [GO:0050673]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of epithelial cell proliferation [GO:0050680]; positive regulation of gene expression [GO:0010628]; protein catabolic process [GO:0030163]; protein ubiquitination [GO:0016567]; regulation of apoptotic process [GO:0042981]; regulation of protein stability [GO:0031647]; regulation of signal transduction by p53 class mediator [GO:1901796]; regulation of vitamin D receptor signaling pathway [GO:0070562]; response to peptide hormone [GO:0043434]; transcription by RNA polymerase II [GO:0006366] chromatin [GO:0000785]; cytosol [GO:0005829]; euchromatin [GO:0000791]; male germ cell nucleus [GO:0001673]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perichromatin fibrils [GO:0005726] chromatin binding [GO:0003682]; estrogen response element binding [GO:0034056]; histone H3K23ac reader activity [GO:0140118]; nuclear receptor binding [GO:0016922]; p53 binding [GO:0002039]; protein kinase activity [GO:0004672]; signaling receptor binding [GO:0005102]; transcription coactivator activity [GO:0003713]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] g7955.t1 Q4QRH7 41.69 355 3.4899999999999995e-54 184.0 sp|Q4QRH7|PEX16_DANRE Peroxisomal membrane protein PEX16 OS=Danio rerio OX=7955 GN=pex16 PE=2 SV=1 g7963.t1 Q9V6X7 34.688 369 1.33e-71 232.0 sp|Q9V6X7|OFUT1_DROME GDP-fucose protein O-fucosyltransferase 1 OS=Drosophila melanogaster OX=7227 GN=O-fut1 PE=1 SV=1 OFUT1_DROME reviewed GDP-fucose protein O-fucosyltransferase 1 (EC 2.4.1.221) (Neurotic protein) (Peptide-O-fucosyltransferase 1) (O-FucT-1) Drosophila melanogaster (Fruit fly) GO:0005112; GO:0005783; GO:0005788; GO:0006004; GO:0007219; GO:0036066; GO:0045165; GO:0045747; GO:0045807; GO:0046922 cell fate commitment [GO:0045165]; fucose metabolic process [GO:0006004]; Notch signaling pathway [GO:0007219]; positive regulation of endocytosis [GO:0045807]; positive regulation of Notch signaling pathway [GO:0045747]; protein O-linked glycosylation via fucose [GO:0036066] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788] Notch binding [GO:0005112]; peptide-O-fucosyltransferase activity [GO:0046922] g7964.t1 O75936 33.766 385 2.59e-69 225.0 sp|O75936|BODG_HUMAN Gamma-butyrobetaine dioxygenase OS=Homo sapiens OX=9606 GN=BBOX1 PE=1 SV=1 BODG_HUMAN reviewed Gamma-butyrobetaine dioxygenase (EC 1.14.11.1) (Gamma-butyrobetaine hydroxylase) (Gamma-BBH) (Gamma-butyrobetaine,2-oxoglutarate dioxygenase) Homo sapiens (Human) GO:0005506; GO:0005739; GO:0005829; GO:0008270; GO:0008336; GO:0042802; GO:0045329; GO:0070062 carnitine biosynthetic process [GO:0045329] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; mitochondrion [GO:0005739] gamma-butyrobetaine dioxygenase activity [GO:0008336]; identical protein binding [GO:0042802]; iron ion binding [GO:0005506]; zinc ion binding [GO:0008270] g7965.t1 Q9QZU7 37.566 378 3.6500000000000004e-88 278.0 sp|Q9QZU7|BODG_RAT Gamma-butyrobetaine dioxygenase OS=Rattus norvegicus OX=10116 GN=Bbox1 PE=1 SV=1 g7966.t1 O75936 36.915 363 5.879999999999999e-82 259.0 sp|O75936|BODG_HUMAN Gamma-butyrobetaine dioxygenase OS=Homo sapiens OX=9606 GN=BBOX1 PE=1 SV=1 BODG_HUMAN reviewed Gamma-butyrobetaine dioxygenase (EC 1.14.11.1) (Gamma-butyrobetaine hydroxylase) (Gamma-BBH) (Gamma-butyrobetaine,2-oxoglutarate dioxygenase) Homo sapiens (Human) GO:0005506; GO:0005739; GO:0005829; GO:0008270; GO:0008336; GO:0042802; GO:0045329; GO:0070062 carnitine biosynthetic process [GO:0045329] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; mitochondrion [GO:0005739] gamma-butyrobetaine dioxygenase activity [GO:0008336]; identical protein binding [GO:0042802]; iron ion binding [GO:0005506]; zinc ion binding [GO:0008270] g7967.t1 Q9QZU7 36.074 377 1.24e-82 260.0 sp|Q9QZU7|BODG_RAT Gamma-butyrobetaine dioxygenase OS=Rattus norvegicus OX=10116 GN=Bbox1 PE=1 SV=1 g7972.t1 Q16629 43.357 143 2.4700000000000002e-29 112.0 sp|Q16629|SRSF7_HUMAN Serine/arginine-rich splicing factor 7 OS=Homo sapiens OX=9606 GN=SRSF7 PE=1 SV=1 SRSF7_HUMAN reviewed Serine/arginine-rich splicing factor 7 (Splicing factor 9G8) (Splicing factor, arginine/serine-rich 7) Homo sapiens (Human) GO:0000381; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0005737; GO:0006397; GO:0008270; GO:0008380; GO:0016607; GO:0019904; GO:0048025; GO:0051028; GO:0070062; GO:1990830 cellular response to leukemia inhibitory factor [GO:1990830]; mRNA processing [GO:0006397]; mRNA transport [GO:0051028]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA splicing [GO:0008380] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] mRNA binding [GO:0003729]; protein domain specific binding [GO:0019904]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270] g7973.t1 Q16629 45.37 108 4.9199999999999993e-23 95.1 sp|Q16629|SRSF7_HUMAN Serine/arginine-rich splicing factor 7 OS=Homo sapiens OX=9606 GN=SRSF7 PE=1 SV=1 SRSF7_HUMAN reviewed Serine/arginine-rich splicing factor 7 (Splicing factor 9G8) (Splicing factor, arginine/serine-rich 7) Homo sapiens (Human) GO:0000381; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0005737; GO:0006397; GO:0008270; GO:0008380; GO:0016607; GO:0019904; GO:0048025; GO:0051028; GO:0070062; GO:1990830 cellular response to leukemia inhibitory factor [GO:1990830]; mRNA processing [GO:0006397]; mRNA transport [GO:0051028]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA splicing [GO:0008380] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] mRNA binding [GO:0003729]; protein domain specific binding [GO:0019904]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270] g7975.t1 Q8INF0 46.93 684 0.0 567.0 sp|Q8INF0|GCY8E_DROME Soluble guanylate cyclase 88E OS=Drosophila melanogaster OX=7227 GN=Gyc88E PE=1 SV=4 GCY8E_DROME reviewed Soluble guanylate cyclase 88E (EC 4.6.1.2) Drosophila melanogaster (Fruit fly) GO:0000302; GO:0001666; GO:0003924; GO:0004383; GO:0005525; GO:0008074; GO:0019825; GO:0019826; GO:0019899; GO:0020037; GO:0038060; GO:0042803; GO:0046872; GO:0046982; GO:0070025; GO:0070026; GO:0070482 nitric oxide-cGMP-mediated signaling [GO:0038060]; response to hypoxia [GO:0001666]; response to oxygen levels [GO:0070482]; response to reactive oxygen species [GO:0000302] guanylate cyclase complex, soluble [GO:0008074] carbon monoxide binding [GO:0070025]; enzyme binding [GO:0019899]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; guanylate cyclase activity [GO:0004383]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; nitric oxide binding [GO:0070026]; oxygen binding [GO:0019825]; oxygen sensor activity [GO:0019826]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803] g7982.t1 Q9QZU7 36.585 369 1.86e-78 249.0 sp|Q9QZU7|BODG_RAT Gamma-butyrobetaine dioxygenase OS=Rattus norvegicus OX=10116 GN=Bbox1 PE=1 SV=1 g7983.t1 O70497 55.45 211 1.11e-72 227.0 sp|O70497|FCN2_MOUSE Ficolin-2 OS=Mus musculus OX=10090 GN=Fcn2 PE=2 SV=2 g7985.t1 Q9QYP1 36.721 305 3.3e-45 173.0 sp|Q9QYP1|LRP4_RAT Low-density lipoprotein receptor-related protein 4 OS=Rattus norvegicus OX=10116 GN=Lrp4 PE=1 SV=2 LRP4_RAT reviewed Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7) Rattus norvegicus (Rat) GO:0001822; GO:0001942; GO:0005509; GO:0005886; GO:0006897; GO:0007167; GO:0008104; GO:0009953; GO:0009954; GO:0009986; GO:0014069; GO:0015026; GO:0016055; GO:0016601; GO:0030279; GO:0030326; GO:0030425; GO:0030971; GO:0031594; GO:0034185; GO:0035022; GO:0042475; GO:0042733; GO:0042803; GO:0043025; GO:0043113; GO:0044853; GO:0045202; GO:0048699; GO:0048813; GO:0050771; GO:0050808; GO:0051124; GO:0060173; GO:0071340; GO:0090090; GO:0097060; GO:0097104; GO:0097105; GO:0097110; GO:0150052; GO:0150094; GO:1901631; GO:1904395 amyloid-beta clearance by cellular catabolic process [GO:0150094]; dendrite morphogenesis [GO:0048813]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; embryonic limb morphogenesis [GO:0030326]; endocytosis [GO:0006897]; enzyme-linked receptor protein signaling pathway [GO:0007167]; generation of neurons [GO:0048699]; hair follicle development [GO:0001942]; intracellular protein localization [GO:0008104]; kidney development [GO:0001822]; limb development [GO:0060173]; negative regulation of axonogenesis [GO:0050771]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of ossification [GO:0030279]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of presynaptic membrane organization [GO:1901631]; positive regulation of Rac protein signal transduction [GO:0035022]; positive regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904395]; postsynaptic membrane assembly [GO:0097104]; presynaptic membrane assembly [GO:0097105]; proximal/distal pattern formation [GO:0009954]; Rac protein signal transduction [GO:0016601]; receptor clustering [GO:0043113]; regulation of postsynapse assembly [GO:0150052]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; synapse organization [GO:0050808]; synaptic assembly at neuromuscular junction [GO:0051124]; Wnt signaling pathway [GO:0016055] cell surface [GO:0009986]; dendrite [GO:0030425]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic density [GO:0014069]; synapse [GO:0045202]; synaptic membrane [GO:0097060] apolipoprotein binding [GO:0034185]; calcium ion binding [GO:0005509]; coreceptor activity [GO:0015026]; protein homodimerization activity [GO:0042803]; receptor tyrosine kinase binding [GO:0030971]; scaffold protein binding [GO:0097110] g7985.t1 Q9QYP1 41.463 205 8.619999999999999e-42 163.0 sp|Q9QYP1|LRP4_RAT Low-density lipoprotein receptor-related protein 4 OS=Rattus norvegicus OX=10116 GN=Lrp4 PE=1 SV=2 LRP4_RAT reviewed Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7) Rattus norvegicus (Rat) GO:0001822; GO:0001942; GO:0005509; GO:0005886; GO:0006897; GO:0007167; GO:0008104; GO:0009953; GO:0009954; GO:0009986; GO:0014069; GO:0015026; GO:0016055; GO:0016601; GO:0030279; GO:0030326; GO:0030425; GO:0030971; GO:0031594; GO:0034185; GO:0035022; GO:0042475; GO:0042733; GO:0042803; GO:0043025; GO:0043113; GO:0044853; GO:0045202; GO:0048699; GO:0048813; GO:0050771; GO:0050808; GO:0051124; GO:0060173; GO:0071340; GO:0090090; GO:0097060; GO:0097104; GO:0097105; GO:0097110; GO:0150052; GO:0150094; GO:1901631; GO:1904395 amyloid-beta clearance by cellular catabolic process [GO:0150094]; dendrite morphogenesis [GO:0048813]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; embryonic limb morphogenesis [GO:0030326]; endocytosis [GO:0006897]; enzyme-linked receptor protein signaling pathway [GO:0007167]; generation of neurons [GO:0048699]; hair follicle development [GO:0001942]; intracellular protein localization [GO:0008104]; kidney development [GO:0001822]; limb development [GO:0060173]; negative regulation of axonogenesis [GO:0050771]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of ossification [GO:0030279]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of presynaptic membrane organization [GO:1901631]; positive regulation of Rac protein signal transduction [GO:0035022]; positive regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904395]; postsynaptic membrane assembly [GO:0097104]; presynaptic membrane assembly [GO:0097105]; proximal/distal pattern formation [GO:0009954]; Rac protein signal transduction [GO:0016601]; receptor clustering [GO:0043113]; regulation of postsynapse assembly [GO:0150052]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; synapse organization [GO:0050808]; synaptic assembly at neuromuscular junction [GO:0051124]; Wnt signaling pathway [GO:0016055] cell surface [GO:0009986]; dendrite [GO:0030425]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic density [GO:0014069]; synapse [GO:0045202]; synaptic membrane [GO:0097060] apolipoprotein binding [GO:0034185]; calcium ion binding [GO:0005509]; coreceptor activity [GO:0015026]; protein homodimerization activity [GO:0042803]; receptor tyrosine kinase binding [GO:0030971]; scaffold protein binding [GO:0097110] g7985.t1 Q9QYP1 34.915 295 2.83e-41 162.0 sp|Q9QYP1|LRP4_RAT Low-density lipoprotein receptor-related protein 4 OS=Rattus norvegicus OX=10116 GN=Lrp4 PE=1 SV=2 LRP4_RAT reviewed Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7) Rattus norvegicus (Rat) GO:0001822; GO:0001942; GO:0005509; GO:0005886; GO:0006897; GO:0007167; GO:0008104; GO:0009953; GO:0009954; GO:0009986; GO:0014069; GO:0015026; GO:0016055; GO:0016601; GO:0030279; GO:0030326; GO:0030425; GO:0030971; GO:0031594; GO:0034185; GO:0035022; GO:0042475; GO:0042733; GO:0042803; GO:0043025; GO:0043113; GO:0044853; GO:0045202; GO:0048699; GO:0048813; GO:0050771; GO:0050808; GO:0051124; GO:0060173; GO:0071340; GO:0090090; GO:0097060; GO:0097104; GO:0097105; GO:0097110; GO:0150052; GO:0150094; GO:1901631; GO:1904395 amyloid-beta clearance by cellular catabolic process [GO:0150094]; dendrite morphogenesis [GO:0048813]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; embryonic limb morphogenesis [GO:0030326]; endocytosis [GO:0006897]; enzyme-linked receptor protein signaling pathway [GO:0007167]; generation of neurons [GO:0048699]; hair follicle development [GO:0001942]; intracellular protein localization [GO:0008104]; kidney development [GO:0001822]; limb development [GO:0060173]; negative regulation of axonogenesis [GO:0050771]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of ossification [GO:0030279]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of presynaptic membrane organization [GO:1901631]; positive regulation of Rac protein signal transduction [GO:0035022]; positive regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904395]; postsynaptic membrane assembly [GO:0097104]; presynaptic membrane assembly [GO:0097105]; proximal/distal pattern formation [GO:0009954]; Rac protein signal transduction [GO:0016601]; receptor clustering [GO:0043113]; regulation of postsynapse assembly [GO:0150052]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; synapse organization [GO:0050808]; synaptic assembly at neuromuscular junction [GO:0051124]; Wnt signaling pathway [GO:0016055] cell surface [GO:0009986]; dendrite [GO:0030425]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic density [GO:0014069]; synapse [GO:0045202]; synaptic membrane [GO:0097060] apolipoprotein binding [GO:0034185]; calcium ion binding [GO:0005509]; coreceptor activity [GO:0015026]; protein homodimerization activity [GO:0042803]; receptor tyrosine kinase binding [GO:0030971]; scaffold protein binding [GO:0097110] g7985.t1 Q9QYP1 33.692 279 5.15e-40 158.0 sp|Q9QYP1|LRP4_RAT Low-density lipoprotein receptor-related protein 4 OS=Rattus norvegicus OX=10116 GN=Lrp4 PE=1 SV=2 LRP4_RAT reviewed Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7) Rattus norvegicus (Rat) GO:0001822; GO:0001942; GO:0005509; GO:0005886; GO:0006897; GO:0007167; GO:0008104; GO:0009953; GO:0009954; GO:0009986; GO:0014069; GO:0015026; GO:0016055; GO:0016601; GO:0030279; GO:0030326; GO:0030425; GO:0030971; GO:0031594; GO:0034185; GO:0035022; GO:0042475; GO:0042733; GO:0042803; GO:0043025; GO:0043113; GO:0044853; GO:0045202; GO:0048699; GO:0048813; GO:0050771; GO:0050808; GO:0051124; GO:0060173; GO:0071340; GO:0090090; GO:0097060; GO:0097104; GO:0097105; GO:0097110; GO:0150052; GO:0150094; GO:1901631; GO:1904395 amyloid-beta clearance by cellular catabolic process [GO:0150094]; dendrite morphogenesis [GO:0048813]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; embryonic limb morphogenesis [GO:0030326]; endocytosis [GO:0006897]; enzyme-linked receptor protein signaling pathway [GO:0007167]; generation of neurons [GO:0048699]; hair follicle development [GO:0001942]; intracellular protein localization [GO:0008104]; kidney development [GO:0001822]; limb development [GO:0060173]; negative regulation of axonogenesis [GO:0050771]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of ossification [GO:0030279]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of presynaptic membrane organization [GO:1901631]; positive regulation of Rac protein signal transduction [GO:0035022]; positive regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904395]; postsynaptic membrane assembly [GO:0097104]; presynaptic membrane assembly [GO:0097105]; proximal/distal pattern formation [GO:0009954]; Rac protein signal transduction [GO:0016601]; receptor clustering [GO:0043113]; regulation of postsynapse assembly [GO:0150052]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; synapse organization [GO:0050808]; synaptic assembly at neuromuscular junction [GO:0051124]; Wnt signaling pathway [GO:0016055] cell surface [GO:0009986]; dendrite [GO:0030425]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic density [GO:0014069]; synapse [GO:0045202]; synaptic membrane [GO:0097060] apolipoprotein binding [GO:0034185]; calcium ion binding [GO:0005509]; coreceptor activity [GO:0015026]; protein homodimerization activity [GO:0042803]; receptor tyrosine kinase binding [GO:0030971]; scaffold protein binding [GO:0097110] g7986.t1 Q8VI56 43.192 213 9.87e-44 174.0 sp|Q8VI56|LRP4_MOUSE Low-density lipoprotein receptor-related protein 4 OS=Mus musculus OX=10090 GN=Lrp4 PE=1 SV=3 LRP4_MOUSE reviewed Low-density lipoprotein receptor-related protein 4 (LRP-4) (LDLR dan) Mus musculus (Mouse) GO:0001822; GO:0001942; GO:0005509; GO:0005886; GO:0006897; GO:0007167; GO:0008104; GO:0009953; GO:0009954; GO:0009986; GO:0014069; GO:0015026; GO:0016055; GO:0030279; GO:0030326; GO:0030425; GO:0030971; GO:0031594; GO:0034185; GO:0035022; GO:0042475; GO:0042733; GO:0042803; GO:0043025; GO:0043113; GO:0044853; GO:0045202; GO:0048699; GO:0048813; GO:0050771; GO:0050808; GO:0051124; GO:0060173; GO:0071340; GO:0090090; GO:0097060; GO:0097104; GO:0097105; GO:0097110; GO:0150052; GO:0150094; GO:1901631; GO:1904395 amyloid-beta clearance by cellular catabolic process [GO:0150094]; dendrite morphogenesis [GO:0048813]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; embryonic limb morphogenesis [GO:0030326]; endocytosis [GO:0006897]; enzyme-linked receptor protein signaling pathway [GO:0007167]; generation of neurons [GO:0048699]; hair follicle development [GO:0001942]; intracellular protein localization [GO:0008104]; kidney development [GO:0001822]; limb development [GO:0060173]; negative regulation of axonogenesis [GO:0050771]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of ossification [GO:0030279]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of presynaptic membrane organization [GO:1901631]; positive regulation of Rac protein signal transduction [GO:0035022]; positive regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904395]; postsynaptic membrane assembly [GO:0097104]; presynaptic membrane assembly [GO:0097105]; proximal/distal pattern formation [GO:0009954]; receptor clustering [GO:0043113]; regulation of postsynapse assembly [GO:0150052]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; synapse organization [GO:0050808]; synaptic assembly at neuromuscular junction [GO:0051124]; Wnt signaling pathway [GO:0016055] cell surface [GO:0009986]; dendrite [GO:0030425]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic density [GO:0014069]; synapse [GO:0045202]; synaptic membrane [GO:0097060] apolipoprotein binding [GO:0034185]; calcium ion binding [GO:0005509]; coreceptor activity [GO:0015026]; protein homodimerization activity [GO:0042803]; receptor tyrosine kinase binding [GO:0030971]; scaffold protein binding [GO:0097110] g7986.t1 Q8VI56 36.727 275 4.1999999999999995e-42 169.0 sp|Q8VI56|LRP4_MOUSE Low-density lipoprotein receptor-related protein 4 OS=Mus musculus OX=10090 GN=Lrp4 PE=1 SV=3 LRP4_MOUSE reviewed Low-density lipoprotein receptor-related protein 4 (LRP-4) (LDLR dan) Mus musculus (Mouse) GO:0001822; GO:0001942; GO:0005509; GO:0005886; GO:0006897; GO:0007167; GO:0008104; GO:0009953; GO:0009954; GO:0009986; GO:0014069; GO:0015026; GO:0016055; GO:0030279; GO:0030326; GO:0030425; GO:0030971; GO:0031594; GO:0034185; GO:0035022; GO:0042475; GO:0042733; GO:0042803; GO:0043025; GO:0043113; GO:0044853; GO:0045202; GO:0048699; GO:0048813; GO:0050771; GO:0050808; GO:0051124; GO:0060173; GO:0071340; GO:0090090; GO:0097060; GO:0097104; GO:0097105; GO:0097110; GO:0150052; GO:0150094; GO:1901631; GO:1904395 amyloid-beta clearance by cellular catabolic process [GO:0150094]; dendrite morphogenesis [GO:0048813]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; embryonic limb morphogenesis [GO:0030326]; endocytosis [GO:0006897]; enzyme-linked receptor protein signaling pathway [GO:0007167]; generation of neurons [GO:0048699]; hair follicle development [GO:0001942]; intracellular protein localization [GO:0008104]; kidney development [GO:0001822]; limb development [GO:0060173]; negative regulation of axonogenesis [GO:0050771]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of ossification [GO:0030279]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of presynaptic membrane organization [GO:1901631]; positive regulation of Rac protein signal transduction [GO:0035022]; positive regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904395]; postsynaptic membrane assembly [GO:0097104]; presynaptic membrane assembly [GO:0097105]; proximal/distal pattern formation [GO:0009954]; receptor clustering [GO:0043113]; regulation of postsynapse assembly [GO:0150052]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; synapse organization [GO:0050808]; synaptic assembly at neuromuscular junction [GO:0051124]; Wnt signaling pathway [GO:0016055] cell surface [GO:0009986]; dendrite [GO:0030425]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic density [GO:0014069]; synapse [GO:0045202]; synaptic membrane [GO:0097060] apolipoprotein binding [GO:0034185]; calcium ion binding [GO:0005509]; coreceptor activity [GO:0015026]; protein homodimerization activity [GO:0042803]; receptor tyrosine kinase binding [GO:0030971]; scaffold protein binding [GO:0097110] g7986.t1 Q8VI56 35.145 276 1.6499999999999999e-41 167.0 sp|Q8VI56|LRP4_MOUSE Low-density lipoprotein receptor-related protein 4 OS=Mus musculus OX=10090 GN=Lrp4 PE=1 SV=3 LRP4_MOUSE reviewed Low-density lipoprotein receptor-related protein 4 (LRP-4) (LDLR dan) Mus musculus (Mouse) GO:0001822; GO:0001942; GO:0005509; GO:0005886; GO:0006897; GO:0007167; GO:0008104; GO:0009953; GO:0009954; GO:0009986; GO:0014069; GO:0015026; GO:0016055; GO:0030279; GO:0030326; GO:0030425; GO:0030971; GO:0031594; GO:0034185; GO:0035022; GO:0042475; GO:0042733; GO:0042803; GO:0043025; GO:0043113; GO:0044853; GO:0045202; GO:0048699; GO:0048813; GO:0050771; GO:0050808; GO:0051124; GO:0060173; GO:0071340; GO:0090090; GO:0097060; GO:0097104; GO:0097105; GO:0097110; GO:0150052; GO:0150094; GO:1901631; GO:1904395 amyloid-beta clearance by cellular catabolic process [GO:0150094]; dendrite morphogenesis [GO:0048813]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; embryonic limb morphogenesis [GO:0030326]; endocytosis [GO:0006897]; enzyme-linked receptor protein signaling pathway [GO:0007167]; generation of neurons [GO:0048699]; hair follicle development [GO:0001942]; intracellular protein localization [GO:0008104]; kidney development [GO:0001822]; limb development [GO:0060173]; negative regulation of axonogenesis [GO:0050771]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of ossification [GO:0030279]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of presynaptic membrane organization [GO:1901631]; positive regulation of Rac protein signal transduction [GO:0035022]; positive regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904395]; postsynaptic membrane assembly [GO:0097104]; presynaptic membrane assembly [GO:0097105]; proximal/distal pattern formation [GO:0009954]; receptor clustering [GO:0043113]; regulation of postsynapse assembly [GO:0150052]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; synapse organization [GO:0050808]; synaptic assembly at neuromuscular junction [GO:0051124]; Wnt signaling pathway [GO:0016055] cell surface [GO:0009986]; dendrite [GO:0030425]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic density [GO:0014069]; synapse [GO:0045202]; synaptic membrane [GO:0097060] apolipoprotein binding [GO:0034185]; calcium ion binding [GO:0005509]; coreceptor activity [GO:0015026]; protein homodimerization activity [GO:0042803]; receptor tyrosine kinase binding [GO:0030971]; scaffold protein binding [GO:0097110] g7986.t1 Q8VI56 35.192 287 1.09e-39 161.0 sp|Q8VI56|LRP4_MOUSE Low-density lipoprotein receptor-related protein 4 OS=Mus musculus OX=10090 GN=Lrp4 PE=1 SV=3 LRP4_MOUSE reviewed Low-density lipoprotein receptor-related protein 4 (LRP-4) (LDLR dan) Mus musculus (Mouse) GO:0001822; GO:0001942; GO:0005509; GO:0005886; GO:0006897; GO:0007167; GO:0008104; GO:0009953; GO:0009954; GO:0009986; GO:0014069; GO:0015026; GO:0016055; GO:0030279; GO:0030326; GO:0030425; GO:0030971; GO:0031594; GO:0034185; GO:0035022; GO:0042475; GO:0042733; GO:0042803; GO:0043025; GO:0043113; GO:0044853; GO:0045202; GO:0048699; GO:0048813; GO:0050771; GO:0050808; GO:0051124; GO:0060173; GO:0071340; GO:0090090; GO:0097060; GO:0097104; GO:0097105; GO:0097110; GO:0150052; GO:0150094; GO:1901631; GO:1904395 amyloid-beta clearance by cellular catabolic process [GO:0150094]; dendrite morphogenesis [GO:0048813]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; embryonic limb morphogenesis [GO:0030326]; endocytosis [GO:0006897]; enzyme-linked receptor protein signaling pathway [GO:0007167]; generation of neurons [GO:0048699]; hair follicle development [GO:0001942]; intracellular protein localization [GO:0008104]; kidney development [GO:0001822]; limb development [GO:0060173]; negative regulation of axonogenesis [GO:0050771]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of ossification [GO:0030279]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of presynaptic membrane organization [GO:1901631]; positive regulation of Rac protein signal transduction [GO:0035022]; positive regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904395]; postsynaptic membrane assembly [GO:0097104]; presynaptic membrane assembly [GO:0097105]; proximal/distal pattern formation [GO:0009954]; receptor clustering [GO:0043113]; regulation of postsynapse assembly [GO:0150052]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; synapse organization [GO:0050808]; synaptic assembly at neuromuscular junction [GO:0051124]; Wnt signaling pathway [GO:0016055] cell surface [GO:0009986]; dendrite [GO:0030425]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic density [GO:0014069]; synapse [GO:0045202]; synaptic membrane [GO:0097060] apolipoprotein binding [GO:0034185]; calcium ion binding [GO:0005509]; coreceptor activity [GO:0015026]; protein homodimerization activity [GO:0042803]; receptor tyrosine kinase binding [GO:0030971]; scaffold protein binding [GO:0097110] g7988.t1 Q8VI56 44.131 213 1.43e-43 174.0 sp|Q8VI56|LRP4_MOUSE Low-density lipoprotein receptor-related protein 4 OS=Mus musculus OX=10090 GN=Lrp4 PE=1 SV=3 LRP4_MOUSE reviewed Low-density lipoprotein receptor-related protein 4 (LRP-4) (LDLR dan) Mus musculus (Mouse) GO:0001822; GO:0001942; GO:0005509; GO:0005886; GO:0006897; GO:0007167; GO:0008104; GO:0009953; GO:0009954; GO:0009986; GO:0014069; GO:0015026; GO:0016055; GO:0030279; GO:0030326; GO:0030425; GO:0030971; GO:0031594; GO:0034185; GO:0035022; GO:0042475; GO:0042733; GO:0042803; GO:0043025; GO:0043113; GO:0044853; GO:0045202; GO:0048699; GO:0048813; GO:0050771; GO:0050808; GO:0051124; GO:0060173; GO:0071340; GO:0090090; GO:0097060; GO:0097104; GO:0097105; GO:0097110; GO:0150052; GO:0150094; GO:1901631; GO:1904395 amyloid-beta clearance by cellular catabolic process [GO:0150094]; dendrite morphogenesis [GO:0048813]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; embryonic limb morphogenesis [GO:0030326]; endocytosis [GO:0006897]; enzyme-linked receptor protein signaling pathway [GO:0007167]; generation of neurons [GO:0048699]; hair follicle development [GO:0001942]; intracellular protein localization [GO:0008104]; kidney development [GO:0001822]; limb development [GO:0060173]; negative regulation of axonogenesis [GO:0050771]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of ossification [GO:0030279]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of presynaptic membrane organization [GO:1901631]; positive regulation of Rac protein signal transduction [GO:0035022]; positive regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904395]; postsynaptic membrane assembly [GO:0097104]; presynaptic membrane assembly [GO:0097105]; proximal/distal pattern formation [GO:0009954]; receptor clustering [GO:0043113]; regulation of postsynapse assembly [GO:0150052]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; synapse organization [GO:0050808]; synaptic assembly at neuromuscular junction [GO:0051124]; Wnt signaling pathway [GO:0016055] cell surface [GO:0009986]; dendrite [GO:0030425]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic density [GO:0014069]; synapse [GO:0045202]; synaptic membrane [GO:0097060] apolipoprotein binding [GO:0034185]; calcium ion binding [GO:0005509]; coreceptor activity [GO:0015026]; protein homodimerization activity [GO:0042803]; receptor tyrosine kinase binding [GO:0030971]; scaffold protein binding [GO:0097110] g7988.t1 Q8VI56 36.727 275 5.76e-40 163.0 sp|Q8VI56|LRP4_MOUSE Low-density lipoprotein receptor-related protein 4 OS=Mus musculus OX=10090 GN=Lrp4 PE=1 SV=3 LRP4_MOUSE reviewed Low-density lipoprotein receptor-related protein 4 (LRP-4) (LDLR dan) Mus musculus (Mouse) GO:0001822; GO:0001942; GO:0005509; GO:0005886; GO:0006897; GO:0007167; GO:0008104; GO:0009953; GO:0009954; GO:0009986; GO:0014069; GO:0015026; GO:0016055; GO:0030279; GO:0030326; GO:0030425; GO:0030971; GO:0031594; GO:0034185; GO:0035022; GO:0042475; GO:0042733; GO:0042803; GO:0043025; GO:0043113; GO:0044853; GO:0045202; GO:0048699; GO:0048813; GO:0050771; GO:0050808; GO:0051124; GO:0060173; GO:0071340; GO:0090090; GO:0097060; GO:0097104; GO:0097105; GO:0097110; GO:0150052; GO:0150094; GO:1901631; GO:1904395 amyloid-beta clearance by cellular catabolic process [GO:0150094]; dendrite morphogenesis [GO:0048813]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; embryonic limb morphogenesis [GO:0030326]; endocytosis [GO:0006897]; enzyme-linked receptor protein signaling pathway [GO:0007167]; generation of neurons [GO:0048699]; hair follicle development [GO:0001942]; intracellular protein localization [GO:0008104]; kidney development [GO:0001822]; limb development [GO:0060173]; negative regulation of axonogenesis [GO:0050771]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of ossification [GO:0030279]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of presynaptic membrane organization [GO:1901631]; positive regulation of Rac protein signal transduction [GO:0035022]; positive regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904395]; postsynaptic membrane assembly [GO:0097104]; presynaptic membrane assembly [GO:0097105]; proximal/distal pattern formation [GO:0009954]; receptor clustering [GO:0043113]; regulation of postsynapse assembly [GO:0150052]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; synapse organization [GO:0050808]; synaptic assembly at neuromuscular junction [GO:0051124]; Wnt signaling pathway [GO:0016055] cell surface [GO:0009986]; dendrite [GO:0030425]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic density [GO:0014069]; synapse [GO:0045202]; synaptic membrane [GO:0097060] apolipoprotein binding [GO:0034185]; calcium ion binding [GO:0005509]; coreceptor activity [GO:0015026]; protein homodimerization activity [GO:0042803]; receptor tyrosine kinase binding [GO:0030971]; scaffold protein binding [GO:0097110] g7988.t1 Q8VI56 36.264 273 3.21e-39 160.0 sp|Q8VI56|LRP4_MOUSE Low-density lipoprotein receptor-related protein 4 OS=Mus musculus OX=10090 GN=Lrp4 PE=1 SV=3 LRP4_MOUSE reviewed Low-density lipoprotein receptor-related protein 4 (LRP-4) (LDLR dan) Mus musculus (Mouse) GO:0001822; GO:0001942; GO:0005509; GO:0005886; GO:0006897; GO:0007167; GO:0008104; GO:0009953; GO:0009954; GO:0009986; GO:0014069; GO:0015026; GO:0016055; GO:0030279; GO:0030326; GO:0030425; GO:0030971; GO:0031594; GO:0034185; GO:0035022; GO:0042475; GO:0042733; GO:0042803; GO:0043025; GO:0043113; GO:0044853; GO:0045202; GO:0048699; GO:0048813; GO:0050771; GO:0050808; GO:0051124; GO:0060173; GO:0071340; GO:0090090; GO:0097060; GO:0097104; GO:0097105; GO:0097110; GO:0150052; GO:0150094; GO:1901631; GO:1904395 amyloid-beta clearance by cellular catabolic process [GO:0150094]; dendrite morphogenesis [GO:0048813]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; embryonic limb morphogenesis [GO:0030326]; endocytosis [GO:0006897]; enzyme-linked receptor protein signaling pathway [GO:0007167]; generation of neurons [GO:0048699]; hair follicle development [GO:0001942]; intracellular protein localization [GO:0008104]; kidney development [GO:0001822]; limb development [GO:0060173]; negative regulation of axonogenesis [GO:0050771]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of ossification [GO:0030279]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of presynaptic membrane organization [GO:1901631]; positive regulation of Rac protein signal transduction [GO:0035022]; positive regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904395]; postsynaptic membrane assembly [GO:0097104]; presynaptic membrane assembly [GO:0097105]; proximal/distal pattern formation [GO:0009954]; receptor clustering [GO:0043113]; regulation of postsynapse assembly [GO:0150052]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; synapse organization [GO:0050808]; synaptic assembly at neuromuscular junction [GO:0051124]; Wnt signaling pathway [GO:0016055] cell surface [GO:0009986]; dendrite [GO:0030425]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic density [GO:0014069]; synapse [GO:0045202]; synaptic membrane [GO:0097060] apolipoprotein binding [GO:0034185]; calcium ion binding [GO:0005509]; coreceptor activity [GO:0015026]; protein homodimerization activity [GO:0042803]; receptor tyrosine kinase binding [GO:0030971]; scaffold protein binding [GO:0097110] g7988.t1 Q8VI56 33.696 276 2.93e-38 158.0 sp|Q8VI56|LRP4_MOUSE Low-density lipoprotein receptor-related protein 4 OS=Mus musculus OX=10090 GN=Lrp4 PE=1 SV=3 LRP4_MOUSE reviewed Low-density lipoprotein receptor-related protein 4 (LRP-4) (LDLR dan) Mus musculus (Mouse) GO:0001822; GO:0001942; GO:0005509; GO:0005886; GO:0006897; GO:0007167; GO:0008104; GO:0009953; GO:0009954; GO:0009986; GO:0014069; GO:0015026; GO:0016055; GO:0030279; GO:0030326; GO:0030425; GO:0030971; GO:0031594; GO:0034185; GO:0035022; GO:0042475; GO:0042733; GO:0042803; GO:0043025; GO:0043113; GO:0044853; GO:0045202; GO:0048699; GO:0048813; GO:0050771; GO:0050808; GO:0051124; GO:0060173; GO:0071340; GO:0090090; GO:0097060; GO:0097104; GO:0097105; GO:0097110; GO:0150052; GO:0150094; GO:1901631; GO:1904395 amyloid-beta clearance by cellular catabolic process [GO:0150094]; dendrite morphogenesis [GO:0048813]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; embryonic limb morphogenesis [GO:0030326]; endocytosis [GO:0006897]; enzyme-linked receptor protein signaling pathway [GO:0007167]; generation of neurons [GO:0048699]; hair follicle development [GO:0001942]; intracellular protein localization [GO:0008104]; kidney development [GO:0001822]; limb development [GO:0060173]; negative regulation of axonogenesis [GO:0050771]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of ossification [GO:0030279]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of presynaptic membrane organization [GO:1901631]; positive regulation of Rac protein signal transduction [GO:0035022]; positive regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904395]; postsynaptic membrane assembly [GO:0097104]; presynaptic membrane assembly [GO:0097105]; proximal/distal pattern formation [GO:0009954]; receptor clustering [GO:0043113]; regulation of postsynapse assembly [GO:0150052]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; synapse organization [GO:0050808]; synaptic assembly at neuromuscular junction [GO:0051124]; Wnt signaling pathway [GO:0016055] cell surface [GO:0009986]; dendrite [GO:0030425]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic density [GO:0014069]; synapse [GO:0045202]; synaptic membrane [GO:0097060] apolipoprotein binding [GO:0034185]; calcium ion binding [GO:0005509]; coreceptor activity [GO:0015026]; protein homodimerization activity [GO:0042803]; receptor tyrosine kinase binding [GO:0030971]; scaffold protein binding [GO:0097110] g7988.t2 Q8VI56 44.131 213 7.03e-44 174.0 sp|Q8VI56|LRP4_MOUSE Low-density lipoprotein receptor-related protein 4 OS=Mus musculus OX=10090 GN=Lrp4 PE=1 SV=3 LRP4_MOUSE reviewed Low-density lipoprotein receptor-related protein 4 (LRP-4) (LDLR dan) Mus musculus (Mouse) GO:0001822; GO:0001942; GO:0005509; GO:0005886; GO:0006897; GO:0007167; GO:0008104; GO:0009953; GO:0009954; GO:0009986; GO:0014069; GO:0015026; GO:0016055; GO:0030279; GO:0030326; GO:0030425; GO:0030971; GO:0031594; GO:0034185; GO:0035022; GO:0042475; GO:0042733; GO:0042803; GO:0043025; GO:0043113; GO:0044853; GO:0045202; GO:0048699; GO:0048813; GO:0050771; GO:0050808; GO:0051124; GO:0060173; GO:0071340; GO:0090090; GO:0097060; GO:0097104; GO:0097105; GO:0097110; GO:0150052; GO:0150094; GO:1901631; GO:1904395 amyloid-beta clearance by cellular catabolic process [GO:0150094]; dendrite morphogenesis [GO:0048813]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; embryonic limb morphogenesis [GO:0030326]; endocytosis [GO:0006897]; enzyme-linked receptor protein signaling pathway [GO:0007167]; generation of neurons [GO:0048699]; hair follicle development [GO:0001942]; intracellular protein localization [GO:0008104]; kidney development [GO:0001822]; limb development [GO:0060173]; negative regulation of axonogenesis [GO:0050771]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of ossification [GO:0030279]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of presynaptic membrane organization [GO:1901631]; positive regulation of Rac protein signal transduction [GO:0035022]; positive regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904395]; postsynaptic membrane assembly [GO:0097104]; presynaptic membrane assembly [GO:0097105]; proximal/distal pattern formation [GO:0009954]; receptor clustering [GO:0043113]; regulation of postsynapse assembly [GO:0150052]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; synapse organization [GO:0050808]; synaptic assembly at neuromuscular junction [GO:0051124]; Wnt signaling pathway [GO:0016055] cell surface [GO:0009986]; dendrite [GO:0030425]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic density [GO:0014069]; synapse [GO:0045202]; synaptic membrane [GO:0097060] apolipoprotein binding [GO:0034185]; calcium ion binding [GO:0005509]; coreceptor activity [GO:0015026]; protein homodimerization activity [GO:0042803]; receptor tyrosine kinase binding [GO:0030971]; scaffold protein binding [GO:0097110] g7988.t2 Q8VI56 36.727 275 3.12e-40 163.0 sp|Q8VI56|LRP4_MOUSE Low-density lipoprotein receptor-related protein 4 OS=Mus musculus OX=10090 GN=Lrp4 PE=1 SV=3 LRP4_MOUSE reviewed Low-density lipoprotein receptor-related protein 4 (LRP-4) (LDLR dan) Mus musculus (Mouse) GO:0001822; GO:0001942; GO:0005509; GO:0005886; GO:0006897; GO:0007167; GO:0008104; GO:0009953; GO:0009954; GO:0009986; GO:0014069; GO:0015026; GO:0016055; GO:0030279; GO:0030326; GO:0030425; GO:0030971; GO:0031594; GO:0034185; GO:0035022; GO:0042475; GO:0042733; GO:0042803; GO:0043025; GO:0043113; GO:0044853; GO:0045202; GO:0048699; GO:0048813; GO:0050771; GO:0050808; GO:0051124; GO:0060173; GO:0071340; GO:0090090; GO:0097060; GO:0097104; GO:0097105; GO:0097110; GO:0150052; GO:0150094; GO:1901631; GO:1904395 amyloid-beta clearance by cellular catabolic process [GO:0150094]; dendrite morphogenesis [GO:0048813]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; embryonic limb morphogenesis [GO:0030326]; endocytosis [GO:0006897]; enzyme-linked receptor protein signaling pathway [GO:0007167]; generation of neurons [GO:0048699]; hair follicle development [GO:0001942]; intracellular protein localization [GO:0008104]; kidney development [GO:0001822]; limb development [GO:0060173]; negative regulation of axonogenesis [GO:0050771]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of ossification [GO:0030279]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of presynaptic membrane organization [GO:1901631]; positive regulation of Rac protein signal transduction [GO:0035022]; positive regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904395]; postsynaptic membrane assembly [GO:0097104]; presynaptic membrane assembly [GO:0097105]; proximal/distal pattern formation [GO:0009954]; receptor clustering [GO:0043113]; regulation of postsynapse assembly [GO:0150052]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; synapse organization [GO:0050808]; synaptic assembly at neuromuscular junction [GO:0051124]; Wnt signaling pathway [GO:0016055] cell surface [GO:0009986]; dendrite [GO:0030425]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic density [GO:0014069]; synapse [GO:0045202]; synaptic membrane [GO:0097060] apolipoprotein binding [GO:0034185]; calcium ion binding [GO:0005509]; coreceptor activity [GO:0015026]; protein homodimerization activity [GO:0042803]; receptor tyrosine kinase binding [GO:0030971]; scaffold protein binding [GO:0097110] g7988.t2 Q8VI56 36.264 273 1.77e-39 160.0 sp|Q8VI56|LRP4_MOUSE Low-density lipoprotein receptor-related protein 4 OS=Mus musculus OX=10090 GN=Lrp4 PE=1 SV=3 LRP4_MOUSE reviewed Low-density lipoprotein receptor-related protein 4 (LRP-4) (LDLR dan) Mus musculus (Mouse) GO:0001822; GO:0001942; GO:0005509; GO:0005886; GO:0006897; GO:0007167; GO:0008104; GO:0009953; GO:0009954; GO:0009986; GO:0014069; GO:0015026; GO:0016055; GO:0030279; GO:0030326; GO:0030425; GO:0030971; GO:0031594; GO:0034185; GO:0035022; GO:0042475; GO:0042733; GO:0042803; GO:0043025; GO:0043113; GO:0044853; GO:0045202; GO:0048699; GO:0048813; GO:0050771; GO:0050808; GO:0051124; GO:0060173; GO:0071340; GO:0090090; GO:0097060; GO:0097104; GO:0097105; GO:0097110; GO:0150052; GO:0150094; GO:1901631; GO:1904395 amyloid-beta clearance by cellular catabolic process [GO:0150094]; dendrite morphogenesis [GO:0048813]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; embryonic limb morphogenesis [GO:0030326]; endocytosis [GO:0006897]; enzyme-linked receptor protein signaling pathway [GO:0007167]; generation of neurons [GO:0048699]; hair follicle development [GO:0001942]; intracellular protein localization [GO:0008104]; kidney development [GO:0001822]; limb development [GO:0060173]; negative regulation of axonogenesis [GO:0050771]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of ossification [GO:0030279]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of presynaptic membrane organization [GO:1901631]; positive regulation of Rac protein signal transduction [GO:0035022]; positive regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904395]; postsynaptic membrane assembly [GO:0097104]; presynaptic membrane assembly [GO:0097105]; proximal/distal pattern formation [GO:0009954]; receptor clustering [GO:0043113]; regulation of postsynapse assembly [GO:0150052]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; synapse organization [GO:0050808]; synaptic assembly at neuromuscular junction [GO:0051124]; Wnt signaling pathway [GO:0016055] cell surface [GO:0009986]; dendrite [GO:0030425]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic density [GO:0014069]; synapse [GO:0045202]; synaptic membrane [GO:0097060] apolipoprotein binding [GO:0034185]; calcium ion binding [GO:0005509]; coreceptor activity [GO:0015026]; protein homodimerization activity [GO:0042803]; receptor tyrosine kinase binding [GO:0030971]; scaffold protein binding [GO:0097110] g7988.t2 Q8VI56 33.696 276 1.66e-38 158.0 sp|Q8VI56|LRP4_MOUSE Low-density lipoprotein receptor-related protein 4 OS=Mus musculus OX=10090 GN=Lrp4 PE=1 SV=3 LRP4_MOUSE reviewed Low-density lipoprotein receptor-related protein 4 (LRP-4) (LDLR dan) Mus musculus (Mouse) GO:0001822; GO:0001942; GO:0005509; GO:0005886; GO:0006897; GO:0007167; GO:0008104; GO:0009953; GO:0009954; GO:0009986; GO:0014069; GO:0015026; GO:0016055; GO:0030279; GO:0030326; GO:0030425; GO:0030971; GO:0031594; GO:0034185; GO:0035022; GO:0042475; GO:0042733; GO:0042803; GO:0043025; GO:0043113; GO:0044853; GO:0045202; GO:0048699; GO:0048813; GO:0050771; GO:0050808; GO:0051124; GO:0060173; GO:0071340; GO:0090090; GO:0097060; GO:0097104; GO:0097105; GO:0097110; GO:0150052; GO:0150094; GO:1901631; GO:1904395 amyloid-beta clearance by cellular catabolic process [GO:0150094]; dendrite morphogenesis [GO:0048813]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; embryonic limb morphogenesis [GO:0030326]; endocytosis [GO:0006897]; enzyme-linked receptor protein signaling pathway [GO:0007167]; generation of neurons [GO:0048699]; hair follicle development [GO:0001942]; intracellular protein localization [GO:0008104]; kidney development [GO:0001822]; limb development [GO:0060173]; negative regulation of axonogenesis [GO:0050771]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of ossification [GO:0030279]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of presynaptic membrane organization [GO:1901631]; positive regulation of Rac protein signal transduction [GO:0035022]; positive regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904395]; postsynaptic membrane assembly [GO:0097104]; presynaptic membrane assembly [GO:0097105]; proximal/distal pattern formation [GO:0009954]; receptor clustering [GO:0043113]; regulation of postsynapse assembly [GO:0150052]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; synapse organization [GO:0050808]; synaptic assembly at neuromuscular junction [GO:0051124]; Wnt signaling pathway [GO:0016055] cell surface [GO:0009986]; dendrite [GO:0030425]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic density [GO:0014069]; synapse [GO:0045202]; synaptic membrane [GO:0097060] apolipoprotein binding [GO:0034185]; calcium ion binding [GO:0005509]; coreceptor activity [GO:0015026]; protein homodimerization activity [GO:0042803]; receptor tyrosine kinase binding [GO:0030971]; scaffold protein binding [GO:0097110] g7988.t3 Q8VI56 44.131 213 7.03e-44 174.0 sp|Q8VI56|LRP4_MOUSE Low-density lipoprotein receptor-related protein 4 OS=Mus musculus OX=10090 GN=Lrp4 PE=1 SV=3 LRP4_MOUSE reviewed Low-density lipoprotein receptor-related protein 4 (LRP-4) (LDLR dan) Mus musculus (Mouse) GO:0001822; GO:0001942; GO:0005509; GO:0005886; GO:0006897; GO:0007167; GO:0008104; GO:0009953; GO:0009954; GO:0009986; GO:0014069; GO:0015026; GO:0016055; GO:0030279; GO:0030326; GO:0030425; GO:0030971; GO:0031594; GO:0034185; GO:0035022; GO:0042475; GO:0042733; GO:0042803; GO:0043025; GO:0043113; GO:0044853; GO:0045202; GO:0048699; GO:0048813; GO:0050771; GO:0050808; GO:0051124; GO:0060173; GO:0071340; GO:0090090; GO:0097060; GO:0097104; GO:0097105; GO:0097110; GO:0150052; GO:0150094; GO:1901631; GO:1904395 amyloid-beta clearance by cellular catabolic process [GO:0150094]; dendrite morphogenesis [GO:0048813]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; embryonic limb morphogenesis [GO:0030326]; endocytosis [GO:0006897]; enzyme-linked receptor protein signaling pathway [GO:0007167]; generation of neurons [GO:0048699]; hair follicle development [GO:0001942]; intracellular protein localization [GO:0008104]; kidney development [GO:0001822]; limb development [GO:0060173]; negative regulation of axonogenesis [GO:0050771]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of ossification [GO:0030279]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of presynaptic membrane organization [GO:1901631]; positive regulation of Rac protein signal transduction [GO:0035022]; positive regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904395]; postsynaptic membrane assembly [GO:0097104]; presynaptic membrane assembly [GO:0097105]; proximal/distal pattern formation [GO:0009954]; receptor clustering [GO:0043113]; regulation of postsynapse assembly [GO:0150052]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; synapse organization [GO:0050808]; synaptic assembly at neuromuscular junction [GO:0051124]; Wnt signaling pathway [GO:0016055] cell surface [GO:0009986]; dendrite [GO:0030425]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic density [GO:0014069]; synapse [GO:0045202]; synaptic membrane [GO:0097060] apolipoprotein binding [GO:0034185]; calcium ion binding [GO:0005509]; coreceptor activity [GO:0015026]; protein homodimerization activity [GO:0042803]; receptor tyrosine kinase binding [GO:0030971]; scaffold protein binding [GO:0097110] g7988.t3 Q8VI56 36.727 275 3.12e-40 163.0 sp|Q8VI56|LRP4_MOUSE Low-density lipoprotein receptor-related protein 4 OS=Mus musculus OX=10090 GN=Lrp4 PE=1 SV=3 LRP4_MOUSE reviewed Low-density lipoprotein receptor-related protein 4 (LRP-4) (LDLR dan) Mus musculus (Mouse) GO:0001822; GO:0001942; GO:0005509; GO:0005886; GO:0006897; GO:0007167; GO:0008104; GO:0009953; GO:0009954; GO:0009986; GO:0014069; GO:0015026; GO:0016055; GO:0030279; GO:0030326; GO:0030425; GO:0030971; GO:0031594; GO:0034185; GO:0035022; GO:0042475; GO:0042733; GO:0042803; GO:0043025; GO:0043113; GO:0044853; GO:0045202; GO:0048699; GO:0048813; GO:0050771; GO:0050808; GO:0051124; GO:0060173; GO:0071340; GO:0090090; GO:0097060; GO:0097104; GO:0097105; GO:0097110; GO:0150052; GO:0150094; GO:1901631; GO:1904395 amyloid-beta clearance by cellular catabolic process [GO:0150094]; dendrite morphogenesis [GO:0048813]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; embryonic limb morphogenesis [GO:0030326]; endocytosis [GO:0006897]; enzyme-linked receptor protein signaling pathway [GO:0007167]; generation of neurons [GO:0048699]; hair follicle development [GO:0001942]; intracellular protein localization [GO:0008104]; kidney development [GO:0001822]; limb development [GO:0060173]; negative regulation of axonogenesis [GO:0050771]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of ossification [GO:0030279]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of presynaptic membrane organization [GO:1901631]; positive regulation of Rac protein signal transduction [GO:0035022]; positive regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904395]; postsynaptic membrane assembly [GO:0097104]; presynaptic membrane assembly [GO:0097105]; proximal/distal pattern formation [GO:0009954]; receptor clustering [GO:0043113]; regulation of postsynapse assembly [GO:0150052]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; synapse organization [GO:0050808]; synaptic assembly at neuromuscular junction [GO:0051124]; Wnt signaling pathway [GO:0016055] cell surface [GO:0009986]; dendrite [GO:0030425]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic density [GO:0014069]; synapse [GO:0045202]; synaptic membrane [GO:0097060] apolipoprotein binding [GO:0034185]; calcium ion binding [GO:0005509]; coreceptor activity [GO:0015026]; protein homodimerization activity [GO:0042803]; receptor tyrosine kinase binding [GO:0030971]; scaffold protein binding [GO:0097110] g7988.t3 Q8VI56 36.264 273 1.77e-39 160.0 sp|Q8VI56|LRP4_MOUSE Low-density lipoprotein receptor-related protein 4 OS=Mus musculus OX=10090 GN=Lrp4 PE=1 SV=3 LRP4_MOUSE reviewed Low-density lipoprotein receptor-related protein 4 (LRP-4) (LDLR dan) Mus musculus (Mouse) GO:0001822; GO:0001942; GO:0005509; GO:0005886; GO:0006897; GO:0007167; GO:0008104; GO:0009953; GO:0009954; GO:0009986; GO:0014069; GO:0015026; GO:0016055; GO:0030279; GO:0030326; GO:0030425; GO:0030971; GO:0031594; GO:0034185; GO:0035022; GO:0042475; GO:0042733; GO:0042803; GO:0043025; GO:0043113; GO:0044853; GO:0045202; GO:0048699; GO:0048813; GO:0050771; GO:0050808; GO:0051124; GO:0060173; GO:0071340; GO:0090090; GO:0097060; GO:0097104; GO:0097105; GO:0097110; GO:0150052; GO:0150094; GO:1901631; GO:1904395 amyloid-beta clearance by cellular catabolic process [GO:0150094]; dendrite morphogenesis [GO:0048813]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; embryonic limb morphogenesis [GO:0030326]; endocytosis [GO:0006897]; enzyme-linked receptor protein signaling pathway [GO:0007167]; generation of neurons [GO:0048699]; hair follicle development [GO:0001942]; intracellular protein localization [GO:0008104]; kidney development [GO:0001822]; limb development [GO:0060173]; negative regulation of axonogenesis [GO:0050771]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of ossification [GO:0030279]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of presynaptic membrane organization [GO:1901631]; positive regulation of Rac protein signal transduction [GO:0035022]; positive regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904395]; postsynaptic membrane assembly [GO:0097104]; presynaptic membrane assembly [GO:0097105]; proximal/distal pattern formation [GO:0009954]; receptor clustering [GO:0043113]; regulation of postsynapse assembly [GO:0150052]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; synapse organization [GO:0050808]; synaptic assembly at neuromuscular junction [GO:0051124]; Wnt signaling pathway [GO:0016055] cell surface [GO:0009986]; dendrite [GO:0030425]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic density [GO:0014069]; synapse [GO:0045202]; synaptic membrane [GO:0097060] apolipoprotein binding [GO:0034185]; calcium ion binding [GO:0005509]; coreceptor activity [GO:0015026]; protein homodimerization activity [GO:0042803]; receptor tyrosine kinase binding [GO:0030971]; scaffold protein binding [GO:0097110] g7988.t3 Q8VI56 33.696 276 1.66e-38 158.0 sp|Q8VI56|LRP4_MOUSE Low-density lipoprotein receptor-related protein 4 OS=Mus musculus OX=10090 GN=Lrp4 PE=1 SV=3 LRP4_MOUSE reviewed Low-density lipoprotein receptor-related protein 4 (LRP-4) (LDLR dan) Mus musculus (Mouse) GO:0001822; GO:0001942; GO:0005509; GO:0005886; GO:0006897; GO:0007167; GO:0008104; GO:0009953; GO:0009954; GO:0009986; GO:0014069; GO:0015026; GO:0016055; GO:0030279; GO:0030326; GO:0030425; GO:0030971; GO:0031594; GO:0034185; GO:0035022; GO:0042475; GO:0042733; GO:0042803; GO:0043025; GO:0043113; GO:0044853; GO:0045202; GO:0048699; GO:0048813; GO:0050771; GO:0050808; GO:0051124; GO:0060173; GO:0071340; GO:0090090; GO:0097060; GO:0097104; GO:0097105; GO:0097110; GO:0150052; GO:0150094; GO:1901631; GO:1904395 amyloid-beta clearance by cellular catabolic process [GO:0150094]; dendrite morphogenesis [GO:0048813]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; embryonic limb morphogenesis [GO:0030326]; endocytosis [GO:0006897]; enzyme-linked receptor protein signaling pathway [GO:0007167]; generation of neurons [GO:0048699]; hair follicle development [GO:0001942]; intracellular protein localization [GO:0008104]; kidney development [GO:0001822]; limb development [GO:0060173]; negative regulation of axonogenesis [GO:0050771]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of ossification [GO:0030279]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of presynaptic membrane organization [GO:1901631]; positive regulation of Rac protein signal transduction [GO:0035022]; positive regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904395]; postsynaptic membrane assembly [GO:0097104]; presynaptic membrane assembly [GO:0097105]; proximal/distal pattern formation [GO:0009954]; receptor clustering [GO:0043113]; regulation of postsynapse assembly [GO:0150052]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; synapse organization [GO:0050808]; synaptic assembly at neuromuscular junction [GO:0051124]; Wnt signaling pathway [GO:0016055] cell surface [GO:0009986]; dendrite [GO:0030425]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic density [GO:0014069]; synapse [GO:0045202]; synaptic membrane [GO:0097060] apolipoprotein binding [GO:0034185]; calcium ion binding [GO:0005509]; coreceptor activity [GO:0015026]; protein homodimerization activity [GO:0042803]; receptor tyrosine kinase binding [GO:0030971]; scaffold protein binding [GO:0097110] g7996.t1 Q8CJ96 31.519 441 5.3099999999999995e-34 134.0 sp|Q8CJ96|RASF8_MOUSE Ras association domain-containing protein 8 OS=Mus musculus OX=10090 GN=Rassf8 PE=2 SV=1 g7999.t1 Q6BDS2 46.024 415 1.0700000000000001e-105 373.0 sp|Q6BDS2|BLT3A_HUMAN Bridge-like lipid transfer protein family member 3A OS=Homo sapiens OX=9606 GN=BLTP3A PE=1 SV=1 BLT3A_HUMAN reviewed Bridge-like lipid transfer protein family member 3A (ICBP90-binding protein 1) (UHRF1-binding protein 1) (Ubiquitin-like containing PHD and RING finger domains 1-binding protein 1) Homo sapiens (Human) GO:0005770; GO:0042802; GO:0042826 late endosome [GO:0005770] histone deacetylase binding [GO:0042826]; identical protein binding [GO:0042802] g7999.t1 Q6BDS2 29.846 325 3.91e-32 140.0 sp|Q6BDS2|BLT3A_HUMAN Bridge-like lipid transfer protein family member 3A OS=Homo sapiens OX=9606 GN=BLTP3A PE=1 SV=1 BLT3A_HUMAN reviewed Bridge-like lipid transfer protein family member 3A (ICBP90-binding protein 1) (UHRF1-binding protein 1) (Ubiquitin-like containing PHD and RING finger domains 1-binding protein 1) Homo sapiens (Human) GO:0005770; GO:0042802; GO:0042826 late endosome [GO:0005770] histone deacetylase binding [GO:0042826]; identical protein binding [GO:0042802] g7999.t2 Q6BDS2 46.024 415 8.319999999999999e-106 373.0 sp|Q6BDS2|BLT3A_HUMAN Bridge-like lipid transfer protein family member 3A OS=Homo sapiens OX=9606 GN=BLTP3A PE=1 SV=1 BLT3A_HUMAN reviewed Bridge-like lipid transfer protein family member 3A (ICBP90-binding protein 1) (UHRF1-binding protein 1) (Ubiquitin-like containing PHD and RING finger domains 1-binding protein 1) Homo sapiens (Human) GO:0005770; GO:0042802; GO:0042826 late endosome [GO:0005770] histone deacetylase binding [GO:0042826]; identical protein binding [GO:0042802] g7999.t2 Q6BDS2 29.846 325 3.8e-32 140.0 sp|Q6BDS2|BLT3A_HUMAN Bridge-like lipid transfer protein family member 3A OS=Homo sapiens OX=9606 GN=BLTP3A PE=1 SV=1 BLT3A_HUMAN reviewed Bridge-like lipid transfer protein family member 3A (ICBP90-binding protein 1) (UHRF1-binding protein 1) (Ubiquitin-like containing PHD and RING finger domains 1-binding protein 1) Homo sapiens (Human) GO:0005770; GO:0042802; GO:0042826 late endosome [GO:0005770] histone deacetylase binding [GO:0042826]; identical protein binding [GO:0042802] g7999.t3 Q6BDS2 46.024 415 1.26e-105 373.0 sp|Q6BDS2|BLT3A_HUMAN Bridge-like lipid transfer protein family member 3A OS=Homo sapiens OX=9606 GN=BLTP3A PE=1 SV=1 BLT3A_HUMAN reviewed Bridge-like lipid transfer protein family member 3A (ICBP90-binding protein 1) (UHRF1-binding protein 1) (Ubiquitin-like containing PHD and RING finger domains 1-binding protein 1) Homo sapiens (Human) GO:0005770; GO:0042802; GO:0042826 late endosome [GO:0005770] histone deacetylase binding [GO:0042826]; identical protein binding [GO:0042802] g7999.t3 Q6BDS2 29.217 332 6.0099999999999994e-30 134.0 sp|Q6BDS2|BLT3A_HUMAN Bridge-like lipid transfer protein family member 3A OS=Homo sapiens OX=9606 GN=BLTP3A PE=1 SV=1 BLT3A_HUMAN reviewed Bridge-like lipid transfer protein family member 3A (ICBP90-binding protein 1) (UHRF1-binding protein 1) (Ubiquitin-like containing PHD and RING finger domains 1-binding protein 1) Homo sapiens (Human) GO:0005770; GO:0042802; GO:0042826 late endosome [GO:0005770] histone deacetylase binding [GO:0042826]; identical protein binding [GO:0042802] g8005.t1 Q61121 50.82 122 5.98e-32 120.0 sp|Q61121|GPR19_MOUSE Probable G-protein coupled receptor 19 OS=Mus musculus OX=10090 GN=Gpr19 PE=2 SV=2 g8006.t1 Q12541 31.853 518 3.48e-52 191.0 sp|Q12541|LAC1_AGABI Laccase-1 OS=Agaricus bisporus OX=5341 GN=lcc1 PE=1 SV=1 g8014.t1 Q28EB4 65.372 309 2.88e-125 370.0 sp|Q28EB4|NP1L1_XENTR Nucleosome assembly protein 1-like 1 OS=Xenopus tropicalis OX=8364 GN=nap1l1 PE=2 SV=1 NP1L1_XENTR reviewed Nucleosome assembly protein 1-like 1 (Histone H2A-H2B chaperone NAP1L1) Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0000785; GO:0003682; GO:0005634; GO:0005737; GO:0006334; GO:0007283; GO:0030332; GO:0042393; GO:0042802; GO:0045944; GO:0060215 nucleosome assembly [GO:0006334]; positive regulation of transcription by RNA polymerase II [GO:0045944]; primitive hemopoiesis [GO:0060215]; spermatogenesis [GO:0007283] chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleus [GO:0005634] chromatin binding [GO:0003682]; cyclin binding [GO:0030332]; histone binding [GO:0042393]; identical protein binding [GO:0042802] g8014.t2 Q28EB4 64.013 314 5.92e-125 369.0 sp|Q28EB4|NP1L1_XENTR Nucleosome assembly protein 1-like 1 OS=Xenopus tropicalis OX=8364 GN=nap1l1 PE=2 SV=1 NP1L1_XENTR reviewed Nucleosome assembly protein 1-like 1 (Histone H2A-H2B chaperone NAP1L1) Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0000785; GO:0003682; GO:0005634; GO:0005737; GO:0006334; GO:0007283; GO:0030332; GO:0042393; GO:0042802; GO:0045944; GO:0060215 nucleosome assembly [GO:0006334]; positive regulation of transcription by RNA polymerase II [GO:0045944]; primitive hemopoiesis [GO:0060215]; spermatogenesis [GO:0007283] chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleus [GO:0005634] chromatin binding [GO:0003682]; cyclin binding [GO:0030332]; histone binding [GO:0042393]; identical protein binding [GO:0042802] g8015.t1 Q66JY6 32.492 317 1.01e-32 131.0 sp|Q66JY6|ARG39_MOUSE Rho guanine nucleotide exchange factor 39 OS=Mus musculus OX=10090 GN=Arhgef39 PE=2 SV=2 g8017.t1 Q8BJ56 48.193 249 5.4500000000000006e-73 244.0 sp|Q8BJ56|PLPL2_MOUSE Patatin-like phospholipase domain-containing protein 2 OS=Mus musculus OX=10090 GN=Pnpla2 PE=1 SV=1 PLPL2_MOUSE reviewed Patatin-like phospholipase domain-containing protein 2 (EC 3.1.1.3) (Adipose triglyceride lipase) (Calcium-independent phospholipase A2-zeta) (iPLA2-zeta) (EC 3.1.1.4) (Desnutrin) Mus musculus (Mouse) GO:0001523; GO:0004623; GO:0004806; GO:0005654; GO:0005737; GO:0005811; GO:0005829; GO:0005886; GO:0006651; GO:0010891; GO:0010898; GO:0016020; GO:0016042; GO:0016411; GO:0019433; GO:0019915; GO:0034389; GO:0035356; GO:0050253; GO:0051264; GO:0051265; GO:0055088; GO:0160077; GO:1905691 diacylglycerol biosynthetic process [GO:0006651]; intracellular triglyceride homeostasis [GO:0035356]; lipid catabolic process [GO:0016042]; lipid droplet disassembly [GO:1905691]; lipid droplet fusion [GO:0160077]; lipid droplet organization [GO:0034389]; lipid homeostasis [GO:0055088]; lipid storage [GO:0019915]; negative regulation of triglyceride storage [GO:0010891]; positive regulation of triglyceride catabolic process [GO:0010898]; retinoid metabolic process [GO:0001523]; triglyceride catabolic process [GO:0019433] cytoplasm [GO:0005737]; cytosol [GO:0005829]; lipid droplet [GO:0005811]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] acylglycerol O-acyltransferase activity [GO:0016411]; diolein transacylation activity [GO:0051265]; mono-olein transacylation activity [GO:0051264]; phospholipase A2 activity [GO:0004623]; retinyl-palmitate esterase activity [GO:0050253]; triacylglycerol lipase activity [GO:0004806] g8018.t1 A6H8T2 38.043 368 1.1300000000000001e-72 254.0 sp|A6H8T2|DNAI7_DANRE Dynein axonemal intermediate chain 7 OS=Danio rerio OX=7955 GN=dnai7 PE=2 SV=2 g8018.t1 A6H8T2 44.651 215 2e-34 144.0 sp|A6H8T2|DNAI7_DANRE Dynein axonemal intermediate chain 7 OS=Danio rerio OX=7955 GN=dnai7 PE=2 SV=2 g8019.t1 Q80YS5 47.541 122 2.31e-26 115.0 sp|Q80YS5|LRC27_MOUSE Leucine-rich repeat-containing protein 27 OS=Mus musculus OX=10090 GN=Lrrc27 PE=2 SV=1 g8019.t2 Q80YS5 47.541 122 1.79e-26 115.0 sp|Q80YS5|LRC27_MOUSE Leucine-rich repeat-containing protein 27 OS=Mus musculus OX=10090 GN=Lrrc27 PE=2 SV=1 g8019.t3 Q80YS5 47.541 122 3.03e-26 114.0 sp|Q80YS5|LRC27_MOUSE Leucine-rich repeat-containing protein 27 OS=Mus musculus OX=10090 GN=Lrrc27 PE=2 SV=1 g8020.t1 Q4QQM4 42.353 170 2.4699999999999997e-40 139.0 sp|Q4QQM4|P5I11_MOUSE Tumor protein p53-inducible protein 11 OS=Mus musculus OX=10090 GN=Trp53i11 PE=1 SV=1 g8020.t2 Q4QQM4 42.353 170 3.4e-40 139.0 sp|Q4QQM4|P5I11_MOUSE Tumor protein p53-inducible protein 11 OS=Mus musculus OX=10090 GN=Trp53i11 PE=1 SV=1 g8022.t1 Q0P5X1 35.417 384 1.55e-59 223.0 sp|Q0P5X1|LRIQ1_MOUSE Leucine-rich repeat- and IQ domain-containing protein 1 OS=Mus musculus OX=10090 GN=Lrriq1 PE=2 SV=2 g8024.t1 Q54F25 28.868 433 1.2900000000000001e-37 145.0 sp|Q54F25|CLN3_DICDI Battenin OS=Dictyostelium discoideum OX=44689 GN=cln3 PE=3 SV=1 CLN3_DICDI reviewed Battenin (Protein CLN3 homolog) Dictyostelium discoideum (Social amoeba) GO:0000281; GO:0000331; GO:0005765; GO:0005794; GO:0006907; GO:0006971; GO:0006972; GO:0008285; GO:0009992; GO:0030139; GO:0031152; GO:0031156; GO:0031589; GO:0050708; GO:0050709; GO:0050714; GO:0098609 aggregation involved in sorocarp development [GO:0031152]; cell-cell adhesion [GO:0098609]; cell-substrate adhesion [GO:0031589]; hyperosmotic response [GO:0006972]; hypotonic response [GO:0006971]; intracellular water homeostasis [GO:0009992]; mitotic cytokinesis [GO:0000281]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of protein secretion [GO:0050709]; pinocytosis [GO:0006907]; positive regulation of protein secretion [GO:0050714]; regulation of protein secretion [GO:0050708]; regulation of sorocarp development [GO:0031156] contractile vacuole [GO:0000331]; endocytic vesicle [GO:0030139]; Golgi apparatus [GO:0005794]; lysosomal membrane [GO:0005765] g8024.t2 Q54F25 27.391 460 4.48e-36 141.0 sp|Q54F25|CLN3_DICDI Battenin OS=Dictyostelium discoideum OX=44689 GN=cln3 PE=3 SV=1 CLN3_DICDI reviewed Battenin (Protein CLN3 homolog) Dictyostelium discoideum (Social amoeba) GO:0000281; GO:0000331; GO:0005765; GO:0005794; GO:0006907; GO:0006971; GO:0006972; GO:0008285; GO:0009992; GO:0030139; GO:0031152; GO:0031156; GO:0031589; GO:0050708; GO:0050709; GO:0050714; GO:0098609 aggregation involved in sorocarp development [GO:0031152]; cell-cell adhesion [GO:0098609]; cell-substrate adhesion [GO:0031589]; hyperosmotic response [GO:0006972]; hypotonic response [GO:0006971]; intracellular water homeostasis [GO:0009992]; mitotic cytokinesis [GO:0000281]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of protein secretion [GO:0050709]; pinocytosis [GO:0006907]; positive regulation of protein secretion [GO:0050714]; regulation of protein secretion [GO:0050708]; regulation of sorocarp development [GO:0031156] contractile vacuole [GO:0000331]; endocytic vesicle [GO:0030139]; Golgi apparatus [GO:0005794]; lysosomal membrane [GO:0005765] g8027.t1 O08873 59.195 522 1.18e-176 577.0 sp|O08873|MADD_RAT MAP kinase-activating death domain protein OS=Rattus norvegicus OX=10116 GN=Madd PE=1 SV=1 MADD_RAT reviewed MAP kinase-activating death domain protein (Rab3 GDP/GTP exchange factor) (RabGEF) (Rab3 GDP/GTP exchange protein) (RabGEP) Rattus norvegicus (Rat) GO:0005085; GO:0005829; GO:0005886; GO:0008021; GO:0016020; GO:0032483; GO:0042981; GO:0043410; GO:0045202; GO:0048490; GO:0051726; GO:0060125; GO:0097194; GO:1902041; GO:1902277; GO:1904115; GO:2001234; GO:2001236 anterograde synaptic vesicle transport [GO:0048490]; execution phase of apoptosis [GO:0097194]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of growth hormone secretion [GO:0060125]; negative regulation of pancreatic amylase secretion [GO:1902277]; positive regulation of MAPK cascade [GO:0043410]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of extrinsic apoptotic signaling pathway [GO:2001236]; regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902041]; regulation of Rab protein signal transduction [GO:0032483] axon cytoplasm [GO:1904115]; cytosol [GO:0005829]; membrane [GO:0016020]; plasma membrane [GO:0005886]; synapse [GO:0045202]; synaptic vesicle [GO:0008021] guanyl-nucleotide exchange factor activity [GO:0005085] g8027.t1 O08873 52.511 438 2.09e-120 419.0 sp|O08873|MADD_RAT MAP kinase-activating death domain protein OS=Rattus norvegicus OX=10116 GN=Madd PE=1 SV=1 MADD_RAT reviewed MAP kinase-activating death domain protein (Rab3 GDP/GTP exchange factor) (RabGEF) (Rab3 GDP/GTP exchange protein) (RabGEP) Rattus norvegicus (Rat) GO:0005085; GO:0005829; GO:0005886; GO:0008021; GO:0016020; GO:0032483; GO:0042981; GO:0043410; GO:0045202; GO:0048490; GO:0051726; GO:0060125; GO:0097194; GO:1902041; GO:1902277; GO:1904115; GO:2001234; GO:2001236 anterograde synaptic vesicle transport [GO:0048490]; execution phase of apoptosis [GO:0097194]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of growth hormone secretion [GO:0060125]; negative regulation of pancreatic amylase secretion [GO:1902277]; positive regulation of MAPK cascade [GO:0043410]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of extrinsic apoptotic signaling pathway [GO:2001236]; regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902041]; regulation of Rab protein signal transduction [GO:0032483] axon cytoplasm [GO:1904115]; cytosol [GO:0005829]; membrane [GO:0016020]; plasma membrane [GO:0005886]; synapse [GO:0045202]; synaptic vesicle [GO:0008021] guanyl-nucleotide exchange factor activity [GO:0005085] g8027.t1 O08873 39.683 189 7.77e-27 124.0 sp|O08873|MADD_RAT MAP kinase-activating death domain protein OS=Rattus norvegicus OX=10116 GN=Madd PE=1 SV=1 MADD_RAT reviewed MAP kinase-activating death domain protein (Rab3 GDP/GTP exchange factor) (RabGEF) (Rab3 GDP/GTP exchange protein) (RabGEP) Rattus norvegicus (Rat) GO:0005085; GO:0005829; GO:0005886; GO:0008021; GO:0016020; GO:0032483; GO:0042981; GO:0043410; GO:0045202; GO:0048490; GO:0051726; GO:0060125; GO:0097194; GO:1902041; GO:1902277; GO:1904115; GO:2001234; GO:2001236 anterograde synaptic vesicle transport [GO:0048490]; execution phase of apoptosis [GO:0097194]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of growth hormone secretion [GO:0060125]; negative regulation of pancreatic amylase secretion [GO:1902277]; positive regulation of MAPK cascade [GO:0043410]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of extrinsic apoptotic signaling pathway [GO:2001236]; regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902041]; regulation of Rab protein signal transduction [GO:0032483] axon cytoplasm [GO:1904115]; cytosol [GO:0005829]; membrane [GO:0016020]; plasma membrane [GO:0005886]; synapse [GO:0045202]; synaptic vesicle [GO:0008021] guanyl-nucleotide exchange factor activity [GO:0005085] g8027.t2 O08873 59.195 522 1.09e-176 577.0 sp|O08873|MADD_RAT MAP kinase-activating death domain protein OS=Rattus norvegicus OX=10116 GN=Madd PE=1 SV=1 MADD_RAT reviewed MAP kinase-activating death domain protein (Rab3 GDP/GTP exchange factor) (RabGEF) (Rab3 GDP/GTP exchange protein) (RabGEP) Rattus norvegicus (Rat) GO:0005085; GO:0005829; GO:0005886; GO:0008021; GO:0016020; GO:0032483; GO:0042981; GO:0043410; GO:0045202; GO:0048490; GO:0051726; GO:0060125; GO:0097194; GO:1902041; GO:1902277; GO:1904115; GO:2001234; GO:2001236 anterograde synaptic vesicle transport [GO:0048490]; execution phase of apoptosis [GO:0097194]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of growth hormone secretion [GO:0060125]; negative regulation of pancreatic amylase secretion [GO:1902277]; positive regulation of MAPK cascade [GO:0043410]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of extrinsic apoptotic signaling pathway [GO:2001236]; regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902041]; regulation of Rab protein signal transduction [GO:0032483] axon cytoplasm [GO:1904115]; cytosol [GO:0005829]; membrane [GO:0016020]; plasma membrane [GO:0005886]; synapse [GO:0045202]; synaptic vesicle [GO:0008021] guanyl-nucleotide exchange factor activity [GO:0005085] g8027.t2 O08873 52.511 438 2.36e-120 419.0 sp|O08873|MADD_RAT MAP kinase-activating death domain protein OS=Rattus norvegicus OX=10116 GN=Madd PE=1 SV=1 MADD_RAT reviewed MAP kinase-activating death domain protein (Rab3 GDP/GTP exchange factor) (RabGEF) (Rab3 GDP/GTP exchange protein) (RabGEP) Rattus norvegicus (Rat) GO:0005085; GO:0005829; GO:0005886; GO:0008021; GO:0016020; GO:0032483; GO:0042981; GO:0043410; GO:0045202; GO:0048490; GO:0051726; GO:0060125; GO:0097194; GO:1902041; GO:1902277; GO:1904115; GO:2001234; GO:2001236 anterograde synaptic vesicle transport [GO:0048490]; execution phase of apoptosis [GO:0097194]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of growth hormone secretion [GO:0060125]; negative regulation of pancreatic amylase secretion [GO:1902277]; positive regulation of MAPK cascade [GO:0043410]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of extrinsic apoptotic signaling pathway [GO:2001236]; regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902041]; regulation of Rab protein signal transduction [GO:0032483] axon cytoplasm [GO:1904115]; cytosol [GO:0005829]; membrane [GO:0016020]; plasma membrane [GO:0005886]; synapse [GO:0045202]; synaptic vesicle [GO:0008021] guanyl-nucleotide exchange factor activity [GO:0005085] g8027.t2 O08873 40.782 179 9.58e-28 126.0 sp|O08873|MADD_RAT MAP kinase-activating death domain protein OS=Rattus norvegicus OX=10116 GN=Madd PE=1 SV=1 MADD_RAT reviewed MAP kinase-activating death domain protein (Rab3 GDP/GTP exchange factor) (RabGEF) (Rab3 GDP/GTP exchange protein) (RabGEP) Rattus norvegicus (Rat) GO:0005085; GO:0005829; GO:0005886; GO:0008021; GO:0016020; GO:0032483; GO:0042981; GO:0043410; GO:0045202; GO:0048490; GO:0051726; GO:0060125; GO:0097194; GO:1902041; GO:1902277; GO:1904115; GO:2001234; GO:2001236 anterograde synaptic vesicle transport [GO:0048490]; execution phase of apoptosis [GO:0097194]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of growth hormone secretion [GO:0060125]; negative regulation of pancreatic amylase secretion [GO:1902277]; positive regulation of MAPK cascade [GO:0043410]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of extrinsic apoptotic signaling pathway [GO:2001236]; regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902041]; regulation of Rab protein signal transduction [GO:0032483] axon cytoplasm [GO:1904115]; cytosol [GO:0005829]; membrane [GO:0016020]; plasma membrane [GO:0005886]; synapse [GO:0045202]; synaptic vesicle [GO:0008021] guanyl-nucleotide exchange factor activity [GO:0005085] g8027.t3 O08873 59.195 522 2.1899999999999998e-176 576.0 sp|O08873|MADD_RAT MAP kinase-activating death domain protein OS=Rattus norvegicus OX=10116 GN=Madd PE=1 SV=1 MADD_RAT reviewed MAP kinase-activating death domain protein (Rab3 GDP/GTP exchange factor) (RabGEF) (Rab3 GDP/GTP exchange protein) (RabGEP) Rattus norvegicus (Rat) GO:0005085; GO:0005829; GO:0005886; GO:0008021; GO:0016020; GO:0032483; GO:0042981; GO:0043410; GO:0045202; GO:0048490; GO:0051726; GO:0060125; GO:0097194; GO:1902041; GO:1902277; GO:1904115; GO:2001234; GO:2001236 anterograde synaptic vesicle transport [GO:0048490]; execution phase of apoptosis [GO:0097194]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of growth hormone secretion [GO:0060125]; negative regulation of pancreatic amylase secretion [GO:1902277]; positive regulation of MAPK cascade [GO:0043410]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of extrinsic apoptotic signaling pathway [GO:2001236]; regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902041]; regulation of Rab protein signal transduction [GO:0032483] axon cytoplasm [GO:1904115]; cytosol [GO:0005829]; membrane [GO:0016020]; plasma membrane [GO:0005886]; synapse [GO:0045202]; synaptic vesicle [GO:0008021] guanyl-nucleotide exchange factor activity [GO:0005085] g8027.t3 O08873 52.511 438 3.62e-120 419.0 sp|O08873|MADD_RAT MAP kinase-activating death domain protein OS=Rattus norvegicus OX=10116 GN=Madd PE=1 SV=1 MADD_RAT reviewed MAP kinase-activating death domain protein (Rab3 GDP/GTP exchange factor) (RabGEF) (Rab3 GDP/GTP exchange protein) (RabGEP) Rattus norvegicus (Rat) GO:0005085; GO:0005829; GO:0005886; GO:0008021; GO:0016020; GO:0032483; GO:0042981; GO:0043410; GO:0045202; GO:0048490; GO:0051726; GO:0060125; GO:0097194; GO:1902041; GO:1902277; GO:1904115; GO:2001234; GO:2001236 anterograde synaptic vesicle transport [GO:0048490]; execution phase of apoptosis [GO:0097194]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of growth hormone secretion [GO:0060125]; negative regulation of pancreatic amylase secretion [GO:1902277]; positive regulation of MAPK cascade [GO:0043410]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of extrinsic apoptotic signaling pathway [GO:2001236]; regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902041]; regulation of Rab protein signal transduction [GO:0032483] axon cytoplasm [GO:1904115]; cytosol [GO:0005829]; membrane [GO:0016020]; plasma membrane [GO:0005886]; synapse [GO:0045202]; synaptic vesicle [GO:0008021] guanyl-nucleotide exchange factor activity [GO:0005085] g8027.t3 O08873 39.683 189 8.350000000000001e-27 124.0 sp|O08873|MADD_RAT MAP kinase-activating death domain protein OS=Rattus norvegicus OX=10116 GN=Madd PE=1 SV=1 MADD_RAT reviewed MAP kinase-activating death domain protein (Rab3 GDP/GTP exchange factor) (RabGEF) (Rab3 GDP/GTP exchange protein) (RabGEP) Rattus norvegicus (Rat) GO:0005085; GO:0005829; GO:0005886; GO:0008021; GO:0016020; GO:0032483; GO:0042981; GO:0043410; GO:0045202; GO:0048490; GO:0051726; GO:0060125; GO:0097194; GO:1902041; GO:1902277; GO:1904115; GO:2001234; GO:2001236 anterograde synaptic vesicle transport [GO:0048490]; execution phase of apoptosis [GO:0097194]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of growth hormone secretion [GO:0060125]; negative regulation of pancreatic amylase secretion [GO:1902277]; positive regulation of MAPK cascade [GO:0043410]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of extrinsic apoptotic signaling pathway [GO:2001236]; regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902041]; regulation of Rab protein signal transduction [GO:0032483] axon cytoplasm [GO:1904115]; cytosol [GO:0005829]; membrane [GO:0016020]; plasma membrane [GO:0005886]; synapse [GO:0045202]; synaptic vesicle [GO:0008021] guanyl-nucleotide exchange factor activity [GO:0005085] g8027.t4 O08873 59.195 522 6.02e-177 577.0 sp|O08873|MADD_RAT MAP kinase-activating death domain protein OS=Rattus norvegicus OX=10116 GN=Madd PE=1 SV=1 MADD_RAT reviewed MAP kinase-activating death domain protein (Rab3 GDP/GTP exchange factor) (RabGEF) (Rab3 GDP/GTP exchange protein) (RabGEP) Rattus norvegicus (Rat) GO:0005085; GO:0005829; GO:0005886; GO:0008021; GO:0016020; GO:0032483; GO:0042981; GO:0043410; GO:0045202; GO:0048490; GO:0051726; GO:0060125; GO:0097194; GO:1902041; GO:1902277; GO:1904115; GO:2001234; GO:2001236 anterograde synaptic vesicle transport [GO:0048490]; execution phase of apoptosis [GO:0097194]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of growth hormone secretion [GO:0060125]; negative regulation of pancreatic amylase secretion [GO:1902277]; positive regulation of MAPK cascade [GO:0043410]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of extrinsic apoptotic signaling pathway [GO:2001236]; regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902041]; regulation of Rab protein signal transduction [GO:0032483] axon cytoplasm [GO:1904115]; cytosol [GO:0005829]; membrane [GO:0016020]; plasma membrane [GO:0005886]; synapse [GO:0045202]; synaptic vesicle [GO:0008021] guanyl-nucleotide exchange factor activity [GO:0005085] g8027.t4 O08873 41.06 811 4e-154 515.0 sp|O08873|MADD_RAT MAP kinase-activating death domain protein OS=Rattus norvegicus OX=10116 GN=Madd PE=1 SV=1 MADD_RAT reviewed MAP kinase-activating death domain protein (Rab3 GDP/GTP exchange factor) (RabGEF) (Rab3 GDP/GTP exchange protein) (RabGEP) Rattus norvegicus (Rat) GO:0005085; GO:0005829; GO:0005886; GO:0008021; GO:0016020; GO:0032483; GO:0042981; GO:0043410; GO:0045202; GO:0048490; GO:0051726; GO:0060125; GO:0097194; GO:1902041; GO:1902277; GO:1904115; GO:2001234; GO:2001236 anterograde synaptic vesicle transport [GO:0048490]; execution phase of apoptosis [GO:0097194]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of growth hormone secretion [GO:0060125]; negative regulation of pancreatic amylase secretion [GO:1902277]; positive regulation of MAPK cascade [GO:0043410]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of extrinsic apoptotic signaling pathway [GO:2001236]; regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902041]; regulation of Rab protein signal transduction [GO:0032483] axon cytoplasm [GO:1904115]; cytosol [GO:0005829]; membrane [GO:0016020]; plasma membrane [GO:0005886]; synapse [GO:0045202]; synaptic vesicle [GO:0008021] guanyl-nucleotide exchange factor activity [GO:0005085] g8028.t1 E9Q2Z1 54.386 171 9.279999999999999e-42 172.0 sp|E9Q2Z1|CECR2_MOUSE Chromatin remodeling regulator CECR2 OS=Mus musculus OX=10090 GN=Cecr2 PE=1 SV=1 CECR2_MOUSE reviewed Chromatin remodeling regulator CECR2 (Cat eye syndrome critical region protein 2 homolog) Mus musculus (Mouse) GO:0000791; GO:0001842; GO:0001843; GO:0005634; GO:0006338; GO:0007338; GO:0021915; GO:0031010; GO:0060122; GO:0090102; GO:0090537; GO:0097194; GO:0140658 chromatin remodeling [GO:0006338]; cochlea development [GO:0090102]; execution phase of apoptosis [GO:0097194]; inner ear receptor cell stereocilium organization [GO:0060122]; neural fold formation [GO:0001842]; neural tube closure [GO:0001843]; neural tube development [GO:0021915]; single fertilization [GO:0007338] CERF complex [GO:0090537]; euchromatin [GO:0000791]; ISWI-type complex [GO:0031010]; nucleus [GO:0005634] ATP-dependent chromatin remodeler activity [GO:0140658] g8028.t1 E9Q2Z1 45.536 112 3.27e-22 108.0 sp|E9Q2Z1|CECR2_MOUSE Chromatin remodeling regulator CECR2 OS=Mus musculus OX=10090 GN=Cecr2 PE=1 SV=1 CECR2_MOUSE reviewed Chromatin remodeling regulator CECR2 (Cat eye syndrome critical region protein 2 homolog) Mus musculus (Mouse) GO:0000791; GO:0001842; GO:0001843; GO:0005634; GO:0006338; GO:0007338; GO:0021915; GO:0031010; GO:0060122; GO:0090102; GO:0090537; GO:0097194; GO:0140658 chromatin remodeling [GO:0006338]; cochlea development [GO:0090102]; execution phase of apoptosis [GO:0097194]; inner ear receptor cell stereocilium organization [GO:0060122]; neural fold formation [GO:0001842]; neural tube closure [GO:0001843]; neural tube development [GO:0021915]; single fertilization [GO:0007338] CERF complex [GO:0090537]; euchromatin [GO:0000791]; ISWI-type complex [GO:0031010]; nucleus [GO:0005634] ATP-dependent chromatin remodeler activity [GO:0140658] g8029.t1 Q2VQV9 43.796 411 3.32e-110 336.0 sp|Q2VQV9|ADA2_XENLA Adenosine deaminase 2 OS=Xenopus laevis OX=8355 GN=ada2 PE=1 SV=1 ADA2_XENLA reviewed Adenosine deaminase 2 (EC 3.5.4.4) (Cat eye syndrome critical region protein 1) Xenopus laevis (African clawed frog) GO:0004000; GO:0005615; GO:0006154; GO:0008270; GO:0031685; GO:0043394; GO:0046103 adenosine catabolic process [GO:0006154]; inosine biosynthetic process [GO:0046103] extracellular space [GO:0005615] adenosine deaminase activity [GO:0004000]; adenosine receptor binding [GO:0031685]; proteoglycan binding [GO:0043394]; zinc ion binding [GO:0008270] g8030.t1 A0A1B8YAB1 27.919 591 6.69e-61 216.0 sp|A0A1B8YAB1|KBTB8_XENTR Kelch repeat and BTB domain-containing protein 8 OS=Xenopus tropicalis OX=8364 GN=kbtbd8 PE=3 SV=1 g8033.t1 O88974 46.519 316 1.72e-78 290.0 sp|O88974|SETB1_MOUSE Histone-lysine N-methyltransferase SETDB1 OS=Mus musculus OX=10090 GN=Setdb1 PE=1 SV=1 g8033.t1 O88974 40.26 231 1.08e-40 169.0 sp|O88974|SETB1_MOUSE Histone-lysine N-methyltransferase SETDB1 OS=Mus musculus OX=10090 GN=Setdb1 PE=1 SV=1 g8033.t1 O88974 62.712 118 3.8099999999999996e-38 160.0 sp|O88974|SETB1_MOUSE Histone-lysine N-methyltransferase SETDB1 OS=Mus musculus OX=10090 GN=Setdb1 PE=1 SV=1 g8035.t1 Q9H0A0 69.76 1002 0.0 1352.0 sp|Q9H0A0|NAT10_HUMAN RNA cytidine acetyltransferase OS=Homo sapiens OX=9606 GN=NAT10 PE=1 SV=2 g8035.t2 Q9H0A0 69.76 1002 0.0 1352.0 sp|Q9H0A0|NAT10_HUMAN RNA cytidine acetyltransferase OS=Homo sapiens OX=9606 GN=NAT10 PE=1 SV=2 g8036.t1 Q8BFQ8 48.0 250 1.11e-68 214.0 sp|Q8BFQ8|GALD1_MOUSE Glutamine amidotransferase-like class 1 domain-containing protein 1 OS=Mus musculus OX=10090 GN=Gatd1 PE=1 SV=1 g8036.t2 Q8BFQ8 55.556 216 9.91e-76 231.0 sp|Q8BFQ8|GALD1_MOUSE Glutamine amidotransferase-like class 1 domain-containing protein 1 OS=Mus musculus OX=10090 GN=Gatd1 PE=1 SV=1 g8036.t3 Q3B7H1 64.286 140 1.03e-46 159.0 sp|Q3B7H1|GALD1_DANRE Glutamine amidotransferase-like class 1 domain-containing protein 1 OS=Danio rerio OX=7955 GN=gatd1 PE=2 SV=1 g8040.t1 Q594P2 36.184 152 9.27e-24 99.4 sp|Q594P2|MYOC_FELCA Myocilin OS=Felis catus OX=9685 GN=MYOC PE=2 SV=1 MYOC_FELCA reviewed Myocilin [Cleaved into: Myocilin, N-terminal fragment (Myocilin 20 kDa N-terminal fragment); Myocilin, C-terminal fragment (Myocilin 35 kDa N-terminal fragment)] Felis catus (Cat) (Felis silvestris catus) GO:0001649; GO:0001953; GO:0005615; GO:0005741; GO:0005743; GO:0005758; GO:0005783; GO:0005791; GO:0005794; GO:0005929; GO:0007165; GO:0014734; GO:0022011; GO:0030335; GO:0031175; GO:0031410; GO:0033268; GO:0035024; GO:0035567; GO:0038133; GO:0043408; GO:0045162; GO:0046872; GO:0051496; GO:0051497; GO:0051894; GO:0051897; GO:0051901; GO:0060348; GO:0070062; GO:1900026 bone development [GO:0060348]; clustering of voltage-gated sodium channels [GO:0045162]; ERBB2-ERBB3 signaling pathway [GO:0038133]; myelination in peripheral nervous system [GO:0022011]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of Rho protein signal transduction [GO:0035024]; negative regulation of stress fiber assembly [GO:0051497]; neuron projection development [GO:0031175]; non-canonical Wnt signaling pathway [GO:0035567]; osteoblast differentiation [GO:0001649]; positive regulation of cell migration [GO:0030335]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of mitochondrial depolarization [GO:0051901]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; regulation of MAPK cascade [GO:0043408]; signal transduction [GO:0007165]; skeletal muscle hypertrophy [GO:0014734] cilium [GO:0005929]; cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrial outer membrane [GO:0005741]; node of Ranvier [GO:0033268]; rough endoplasmic reticulum [GO:0005791] metal ion binding [GO:0046872] g8042.t1 Q8BM13 22.674 516 1.3e-28 122.0 sp|Q8BM13|NOE2_MOUSE Noelin-2 OS=Mus musculus OX=10090 GN=Olfm2 PE=1 SV=2 NOE2_MOUSE reviewed Noelin-2 (Olfactomedin-2) Mus musculus (Mouse) GO:0005576; GO:0005615; GO:0005634; GO:0005654; GO:0005737; GO:0007165; GO:0007601; GO:0007626; GO:0009306; GO:0032281; GO:0051152; GO:0097060; GO:0098978; GO:0099147; GO:0099645; GO:1905174 locomotory behavior [GO:0007626]; neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0099645]; positive regulation of smooth muscle cell differentiation [GO:0051152]; protein secretion [GO:0009306]; regulation of vascular associated smooth muscle cell dedifferentiation [GO:1905174]; signal transduction [GO:0007165]; visual perception [GO:0007601] AMPA glutamate receptor complex [GO:0032281]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extrinsic component of postsynaptic density membrane [GO:0099147]; glutamatergic synapse [GO:0098978]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; synaptic membrane [GO:0097060] g8043.t1 Q9IAK4 21.26 508 4.24e-31 129.0 sp|Q9IAK4|NOE1_CHICK Noelin OS=Gallus gallus OX=9031 GN=OLFM1 PE=1 SV=1 NOE1_CHICK reviewed Noelin (Neuronal olfactomedin-related ER localized protein) (Olfactomedin-1) (Pancortin) Gallus gallus (Chicken) GO:0003190; GO:0005615; GO:0005783; GO:0007165; GO:0010628; GO:0010629; GO:0010718; GO:0023041; GO:0030424; GO:0030516; GO:0043025; GO:0043065; GO:0043204; GO:0044295; GO:0045202; GO:0060317 atrioventricular valve formation [GO:0003190]; cardiac epithelial to mesenchymal transition [GO:0060317]; negative regulation of gene expression [GO:0010629]; neuronal signal transduction [GO:0023041]; positive regulation of apoptotic process [GO:0043065]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of gene expression [GO:0010628]; regulation of axon extension [GO:0030516]; signal transduction [GO:0007165] axon [GO:0030424]; axonal growth cone [GO:0044295]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; synapse [GO:0045202] g8044.t1 O95897 22.797 522 2.4200000000000002e-29 124.0 sp|O95897|NOE2_HUMAN Noelin-2 OS=Homo sapiens OX=9606 GN=OLFM2 PE=1 SV=2 NOE2_HUMAN reviewed Noelin-2 (Olfactomedin-2) Homo sapiens (Human) GO:0005576; GO:0005615; GO:0005634; GO:0005654; GO:0005737; GO:0007165; GO:0009306; GO:0032281; GO:0045202; GO:0051152; GO:1905174 positive regulation of smooth muscle cell differentiation [GO:0051152]; protein secretion [GO:0009306]; regulation of vascular associated smooth muscle cell dedifferentiation [GO:1905174]; signal transduction [GO:0007165] AMPA glutamate receptor complex [GO:0032281]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; synapse [GO:0045202] g8045.t1 Q8BM13 22.718 515 2.0400000000000002e-29 124.0 sp|Q8BM13|NOE2_MOUSE Noelin-2 OS=Mus musculus OX=10090 GN=Olfm2 PE=1 SV=2 NOE2_MOUSE reviewed Noelin-2 (Olfactomedin-2) Mus musculus (Mouse) GO:0005576; GO:0005615; GO:0005634; GO:0005654; GO:0005737; GO:0007165; GO:0007601; GO:0007626; GO:0009306; GO:0032281; GO:0051152; GO:0097060; GO:0098978; GO:0099147; GO:0099645; GO:1905174 locomotory behavior [GO:0007626]; neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0099645]; positive regulation of smooth muscle cell differentiation [GO:0051152]; protein secretion [GO:0009306]; regulation of vascular associated smooth muscle cell dedifferentiation [GO:1905174]; signal transduction [GO:0007165]; visual perception [GO:0007601] AMPA glutamate receptor complex [GO:0032281]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extrinsic component of postsynaptic density membrane [GO:0099147]; glutamatergic synapse [GO:0098978]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; synaptic membrane [GO:0097060] g8046.t1 P59438 35.728 515 5.9099999999999995e-89 317.0 sp|P59438|HPS5_MOUSE BLOC-2 complex member HPS5 OS=Mus musculus OX=10090 GN=Hps5 PE=1 SV=2 HPS5_MOUSE reviewed BLOC-2 complex member HPS5 (Hermansky-Pudlak syndrome 5 protein homolog) (Ruby-eye protein 2) (Ru2) Mus musculus (Mouse) GO:0005737; GO:0005769; GO:0005829; GO:0007596; GO:0031084; GO:0043473; GO:0048066; GO:0060155; GO:1903232 blood coagulation [GO:0007596]; developmental pigmentation [GO:0048066]; melanosome assembly [GO:1903232]; pigmentation [GO:0043473]; platelet dense granule organization [GO:0060155] BLOC-2 complex [GO:0031084]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769] g8051.t1 P22439 49.231 455 3.8299999999999997e-115 350.0 sp|P22439|ODPX_BOVIN Pyruvate dehydrogenase protein X component OS=Bos taurus OX=9913 GN=PDHX PE=1 SV=3 g8057.t1 Q5ZLP2 74.561 228 2.89e-127 362.0 sp|Q5ZLP2|MTNB_CHICK Methylthioribulose-1-phosphate dehydratase OS=Gallus gallus OX=9031 GN=APIP PE=2 SV=1 g8066.t1 Q5M7C8 46.789 218 8.16e-55 194.0 sp|Q5M7C8|HORM1_XENLA HORMA domain-containing protein 1 OS=Xenopus laevis OX=8355 GN=hormad1 PE=2 SV=1 g8067.t1 M0R2J8 33.485 878 1.26e-132 461.0 sp|M0R2J8|DCDC1_HUMAN Doublecortin domain-containing protein 1 OS=Homo sapiens OX=9606 GN=DCDC1 PE=1 SV=1 DCDC1_HUMAN reviewed Doublecortin domain-containing protein 1 (Doublecortin domain-containing 5 protein) Homo sapiens (Human) GO:0005874; GO:0008017; GO:0030246; GO:0030496; GO:0035556; GO:0051301; GO:0072686; GO:0090543; GO:1902412 cell division [GO:0051301]; intracellular signal transduction [GO:0035556]; regulation of mitotic cytokinesis [GO:1902412] Flemming body [GO:0090543]; microtubule [GO:0005874]; midbody [GO:0030496]; mitotic spindle [GO:0072686] carbohydrate binding [GO:0030246]; microtubule binding [GO:0008017] g8067.t1 M0R2J8 32.455 835 6.43e-117 414.0 sp|M0R2J8|DCDC1_HUMAN Doublecortin domain-containing protein 1 OS=Homo sapiens OX=9606 GN=DCDC1 PE=1 SV=1 DCDC1_HUMAN reviewed Doublecortin domain-containing protein 1 (Doublecortin domain-containing 5 protein) Homo sapiens (Human) GO:0005874; GO:0008017; GO:0030246; GO:0030496; GO:0035556; GO:0051301; GO:0072686; GO:0090543; GO:1902412 cell division [GO:0051301]; intracellular signal transduction [GO:0035556]; regulation of mitotic cytokinesis [GO:1902412] Flemming body [GO:0090543]; microtubule [GO:0005874]; midbody [GO:0030496]; mitotic spindle [GO:0072686] carbohydrate binding [GO:0030246]; microtubule binding [GO:0008017] g8068.t1 Q6NTN5 45.679 1458 0.0 1151.0 sp|Q6NTN5|MTMRD_XENLA Myotubularin-related protein 13 OS=Xenopus laevis OX=8355 GN=sbf2 PE=2 SV=1 g8068.t2 Q6NTN5 46.191 1444 0.0 1157.0 sp|Q6NTN5|MTMRD_XENLA Myotubularin-related protein 13 OS=Xenopus laevis OX=8355 GN=sbf2 PE=2 SV=1 g8068.t3 Q6NTN5 46.122 1444 0.0 1157.0 sp|Q6NTN5|MTMRD_XENLA Myotubularin-related protein 13 OS=Xenopus laevis OX=8355 GN=sbf2 PE=2 SV=1 g8069.t1 O95248 50.0 278 1.3e-83 288.0 sp|O95248|MTMR5_HUMAN Myotubularin-related protein 5 OS=Homo sapiens OX=9606 GN=SBF1 PE=1 SV=4 g8069.t1 O95248 60.0 115 2.94e-37 151.0 sp|O95248|MTMR5_HUMAN Myotubularin-related protein 5 OS=Homo sapiens OX=9606 GN=SBF1 PE=1 SV=4 g8072.t1 P41247 32.107 299 3.1299999999999996e-42 150.0 sp|P41247|PLPL4_HUMAN Patatin-like phospholipase domain-containing protein 4 OS=Homo sapiens OX=9606 GN=PNPLA4 PE=1 SV=3 PLPL4_HUMAN reviewed Patatin-like phospholipase domain-containing protein 4 (EC 3.1.1.3) (Calcium-independent phospholipase A2-eta) (iPLA2-eta) (EC 3.1.1.4) (Protein GS2) Homo sapiens (Human) GO:0004623; GO:0004806; GO:0005737; GO:0005739; GO:0005811; GO:0005829; GO:0016020; GO:0016411; GO:0019433; GO:0047376; GO:0050253; GO:0051264; GO:0051265; GO:0055088 lipid homeostasis [GO:0055088]; triglyceride catabolic process [GO:0019433] cytoplasm [GO:0005737]; cytosol [GO:0005829]; lipid droplet [GO:0005811]; membrane [GO:0016020]; mitochondrion [GO:0005739] acylglycerol O-acyltransferase activity [GO:0016411]; all-trans-retinyl-palmitate hydrolase, all-trans-retinol forming activity [GO:0047376]; diolein transacylation activity [GO:0051265]; mono-olein transacylation activity [GO:0051264]; phospholipase A2 activity [GO:0004623]; retinyl-palmitate esterase activity [GO:0050253]; triacylglycerol lipase activity [GO:0004806] g8075.t1 Q5REB8 57.92 625 0.0 792.0 sp|Q5REB8|ACSS3_PONAB Acyl-CoA synthetase short-chain family member 3, mitochondrial OS=Pongo abelii OX=9601 GN=ACSS3 PE=2 SV=1 ACSS3_PONAB reviewed Acyl-CoA synthetase short-chain family member 3, mitochondrial (EC 6.2.1.1) (Acetate--CoA ligase 3) (Propionate--CoA ligase) (EC 6.2.1.17) Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0003987; GO:0005524; GO:0005759; GO:0006629; GO:0031956; GO:0050218 lipid metabolic process [GO:0006629] mitochondrial matrix [GO:0005759] acetate-CoA ligase activity [GO:0003987]; ATP binding [GO:0005524]; medium-chain fatty acid-CoA ligase activity [GO:0031956]; propionate-CoA ligase activity [GO:0050218] g8076.t1 Q6P3W7 49.611 643 0.0 575.0 sp|Q6P3W7|SCYL2_HUMAN SCY1-like protein 2 OS=Homo sapiens OX=9606 GN=SCYL2 PE=1 SV=1 SCYL2_HUMAN reviewed SCY1-like protein 2 (Coated vesicle-associated kinase of 104 kDa) Homo sapiens (Human) GO:0004672; GO:0005102; GO:0005524; GO:0005794; GO:0007420; GO:0008333; GO:0010008; GO:0021860; GO:0030136; GO:0031623; GO:0072583; GO:0090090 brain development [GO:0007420]; clathrin-dependent endocytosis [GO:0072583]; endosome to lysosome transport [GO:0008333]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; pyramidal neuron development [GO:0021860]; receptor internalization [GO:0031623] clathrin-coated vesicle [GO:0030136]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794] ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; signaling receptor binding [GO:0005102] g8078.t1 Q6P3W7 56.311 206 1.88e-74 244.0 sp|Q6P3W7|SCYL2_HUMAN SCY1-like protein 2 OS=Homo sapiens OX=9606 GN=SCYL2 PE=1 SV=1 SCYL2_HUMAN reviewed SCY1-like protein 2 (Coated vesicle-associated kinase of 104 kDa) Homo sapiens (Human) GO:0004672; GO:0005102; GO:0005524; GO:0005794; GO:0007420; GO:0008333; GO:0010008; GO:0021860; GO:0030136; GO:0031623; GO:0072583; GO:0090090 brain development [GO:0007420]; clathrin-dependent endocytosis [GO:0072583]; endosome to lysosome transport [GO:0008333]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; pyramidal neuron development [GO:0021860]; receptor internalization [GO:0031623] clathrin-coated vesicle [GO:0030136]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794] ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; signaling receptor binding [GO:0005102] g8079.t1 P15305 25.532 141 5.46e-22 93.6 sp|P15305|DYHC_ONCMY Dynein heavy chain (Fragment) OS=Oncorhynchus mykiss OX=8022 PE=2 SV=1 g8079.t1 P15305 28.244 131 1.04e-21 92.8 sp|P15305|DYHC_ONCMY Dynein heavy chain (Fragment) OS=Oncorhynchus mykiss OX=8022 PE=2 SV=1 g8079.t1 P15305 27.143 140 1.86e-21 92.0 sp|P15305|DYHC_ONCMY Dynein heavy chain (Fragment) OS=Oncorhynchus mykiss OX=8022 PE=2 SV=1 g8079.t1 P15305 25.735 136 6.21e-21 90.9 sp|P15305|DYHC_ONCMY Dynein heavy chain (Fragment) OS=Oncorhynchus mykiss OX=8022 PE=2 SV=1 g8080.t1 O70230 41.558 231 3.83e-33 130.0 sp|O70230|ZN143_MOUSE Zinc finger protein 143 OS=Mus musculus OX=10090 GN=Znf143 PE=1 SV=2 g8081.t1 Q91853 83.908 174 2.19e-105 323.0 sp|Q91853|ZN143_XENLA Zinc finger protein 143 OS=Xenopus laevis OX=8355 GN=znf143 PE=1 SV=2 ZN143_XENLA reviewed Zinc finger protein 143 (Selenocysteine tRNA gene transcription-activating factor) Xenopus laevis (African clawed frog) GO:0000976; GO:0000978; GO:0000981; GO:0001822; GO:0005634; GO:0006357; GO:0008270; GO:0042789; GO:0042797; GO:0045944; GO:0045945; GO:1905382 kidney development [GO:0001822]; mRNA transcription by RNA polymerase II [GO:0042789]; positive regulation of snRNA transcription by RNA polymerase II [GO:1905382]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription by RNA polymerase III [GO:0045945]; regulation of transcription by RNA polymerase II [GO:0006357]; tRNA transcription by RNA polymerase III [GO:0042797] nucleus [GO:0005634] DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription cis-regulatory region binding [GO:0000976]; zinc ion binding [GO:0008270] g8083.t1 Q9Y3E0 70.874 103 2.8e-39 132.0 sp|Q9Y3E0|GOT1B_HUMAN Vesicle transport protein GOT1B OS=Homo sapiens OX=9606 GN=GOLT1B PE=1 SV=1 g8085.t1 P63142 62.705 488 0.0 538.0 sp|P63142|KCNA2_RAT Potassium voltage-gated channel subfamily A member 2 OS=Rattus norvegicus OX=10116 GN=Kcna2 PE=1 SV=1 KCNA2_RAT reviewed Potassium voltage-gated channel subfamily A member 2 (RAK) (RBK2) (RCK5) (Voltage-gated potassium channel subunit Kv1.2) Rattus norvegicus (Rat) GO:0001508; GO:0005249; GO:0005251; GO:0005768; GO:0005789; GO:0005886; GO:0008076; GO:0014059; GO:0015271; GO:0016020; GO:0019228; GO:0019233; GO:0019894; GO:0021554; GO:0021633; GO:0021987; GO:0022038; GO:0030027; GO:0030424; GO:0030425; GO:0031258; GO:0032809; GO:0033010; GO:0034705; GO:0042734; GO:0043194; GO:0043204; GO:0043679; GO:0044224; GO:0044305; GO:0045188; GO:0045211; GO:0051260; GO:0071805; GO:0097623; GO:0098978; GO:0099508; GO:1905030 action potential [GO:0001508]; cerebral cortex development [GO:0021987]; corpus callosum development [GO:0022038]; neuronal action potential [GO:0019228]; optic nerve development [GO:0021554]; optic nerve structural organization [GO:0021633]; potassium ion export across plasma membrane [GO:0097623]; potassium ion transmembrane transport [GO:0071805]; protein homooligomerization [GO:0051260]; regulation of circadian sleep/wake cycle, non-REM sleep [GO:0045188]; regulation of dopamine secretion [GO:0014059]; sensory perception of pain [GO:0019233] axon [GO:0030424]; axon initial segment [GO:0043194]; axon terminus [GO:0043679]; calyx of Held [GO:0044305]; dendrite [GO:0030425]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; glutamatergic synapse [GO:0098978]; juxtaparanode region of axon [GO:0044224]; lamellipodium [GO:0030027]; lamellipodium membrane [GO:0031258]; membrane [GO:0016020]; neuronal cell body membrane [GO:0032809]; paranodal junction [GO:0033010]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; potassium channel complex [GO:0034705]; presynaptic membrane [GO:0042734]; voltage-gated potassium channel complex [GO:0008076] delayed rectifier potassium channel activity [GO:0005251]; kinesin binding [GO:0019894]; outward rectifier potassium channel activity [GO:0015271]; voltage-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential [GO:1905030]; voltage-gated monoatomic ion channel activity involved in regulation of presynaptic membrane potential [GO:0099508]; voltage-gated potassium channel activity [GO:0005249] g8091.t1 Q3UR85 48.611 504 4.34e-152 484.0 sp|Q3UR85|MYRF_MOUSE Myelin regulatory factor OS=Mus musculus OX=10090 GN=Myrf PE=1 SV=2 MYRF_MOUSE reviewed Myelin regulatory factor (EC 3.4.-.-) (Myelin gene regulatory factor) [Cleaved into: Myelin regulatory factor, N-terminal; Myelin regulatory factor, C-terminal] Mus musculus (Mouse) GO:0000981; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0005789; GO:0005794; GO:0005829; GO:0006357; GO:0008233; GO:0014003; GO:0016540; GO:0022010; GO:0031643; GO:0032286; GO:0035902; GO:0042220; GO:0042802; GO:0043565; GO:0045893; GO:0048709; GO:0048714 central nervous system myelin maintenance [GO:0032286]; central nervous system myelination [GO:0022010]; oligodendrocyte development [GO:0014003]; oligodendrocyte differentiation [GO:0048709]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of myelination [GO:0031643]; positive regulation of oligodendrocyte differentiation [GO:0048714]; protein autoprocessing [GO:0016540]; regulation of transcription by RNA polymerase II [GO:0006357]; response to cocaine [GO:0042220]; response to immobilization stress [GO:0035902] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; peptidase activity [GO:0008233]; sequence-specific DNA binding [GO:0043565] g8092.t1 O74549 33.951 162 1.26e-22 94.4 sp|O74549|UBC12_SCHPO NEDD8-conjugating enzyme ubc12 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) OX=284812 GN=ubc12 PE=3 SV=1 g8093.t1 P61082 33.974 156 3.24e-22 93.2 sp|P61082|UBC12_MOUSE NEDD8-conjugating enzyme Ubc12 OS=Mus musculus OX=10090 GN=Ube2m PE=1 SV=1 UBC12_MOUSE reviewed NEDD8-conjugating enzyme Ubc12 (EC 2.3.2.34) (NEDD8 carrier protein) (Ubiquitin-conjugating enzyme E2 M) Mus musculus (Mouse) GO:0004842; GO:0005524; GO:0005634; GO:0005829; GO:0019788; GO:0036211; GO:0043525; GO:0045116; GO:0061654; GO:0098793; GO:0098794; GO:0098978; GO:0150052 positive regulation of neuron apoptotic process [GO:0043525]; protein modification process [GO:0036211]; protein neddylation [GO:0045116]; regulation of postsynapse assembly [GO:0150052] cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; nucleus [GO:0005634]; postsynapse [GO:0098794]; presynapse [GO:0098793] ATP binding [GO:0005524]; NEDD8 conjugating enzyme activity [GO:0061654]; NEDD8 transferase activity [GO:0019788]; ubiquitin-protein transferase activity [GO:0004842] g8095.t1 Q99JX1 69.159 107 3.05e-50 161.0 sp|Q99JX1|TAF11_MOUSE Transcription initiation factor TFIID subunit 11 OS=Mus musculus OX=10090 GN=Taf11 PE=1 SV=1 g8096.t1 Q15256 40.643 342 6.06e-77 253.0 sp|Q15256|PTPRR_HUMAN Receptor-type tyrosine-protein phosphatase R OS=Homo sapiens OX=9606 GN=PTPRR PE=1 SV=2 g8101.t1 P20070 69.708 274 4.55e-145 413.0 sp|P20070|NB5R3_RAT NADH-cytochrome b5 reductase 3 OS=Rattus norvegicus OX=10116 GN=Cyb5r3 PE=1 SV=2 g8101.t2 P20070 69.708 274 4.5300000000000004e-145 413.0 sp|P20070|NB5R3_RAT NADH-cytochrome b5 reductase 3 OS=Rattus norvegicus OX=10116 GN=Cyb5r3 PE=1 SV=2 g8110.t1 Q0VCK5 56.771 192 3.1799999999999996e-68 227.0 sp|Q0VCK5|AP2A2_BOVIN AP-2 complex subunit alpha-2 OS=Bos taurus OX=9913 GN=AP2A2 PE=1 SV=1 AP2A2_BOVIN reviewed AP-2 complex subunit alpha-2 (100 kDa coated vesicle protein C) (Adaptor protein complex AP-2 subunit alpha-2) (Adaptor-related protein complex 2 subunit alpha-2) (Alpha-adaptin C) (Alpha2-adaptin) (Clathrin assembly protein complex 2 alpha-C large chain) (Plasma membrane adaptor HA2/AP2 adaptin alpha C subunit) Bos taurus (Bovine) GO:0006886; GO:0008289; GO:0019901; GO:0030122; GO:0035615; GO:0048268; GO:0048488; GO:0072583; GO:0097718; GO:0098793 clathrin coat assembly [GO:0048268]; clathrin-dependent endocytosis [GO:0072583]; intracellular protein transport [GO:0006886]; synaptic vesicle endocytosis [GO:0048488] AP-2 adaptor complex [GO:0030122]; presynapse [GO:0098793] clathrin adaptor activity [GO:0035615]; disordered domain specific binding [GO:0097718]; lipid binding [GO:0008289]; protein kinase binding [GO:0019901] g8110.t2 Q0VCK5 52.381 210 1.04e-64 218.0 sp|Q0VCK5|AP2A2_BOVIN AP-2 complex subunit alpha-2 OS=Bos taurus OX=9913 GN=AP2A2 PE=1 SV=1 AP2A2_BOVIN reviewed AP-2 complex subunit alpha-2 (100 kDa coated vesicle protein C) (Adaptor protein complex AP-2 subunit alpha-2) (Adaptor-related protein complex 2 subunit alpha-2) (Alpha-adaptin C) (Alpha2-adaptin) (Clathrin assembly protein complex 2 alpha-C large chain) (Plasma membrane adaptor HA2/AP2 adaptin alpha C subunit) Bos taurus (Bovine) GO:0006886; GO:0008289; GO:0019901; GO:0030122; GO:0035615; GO:0048268; GO:0048488; GO:0072583; GO:0097718; GO:0098793 clathrin coat assembly [GO:0048268]; clathrin-dependent endocytosis [GO:0072583]; intracellular protein transport [GO:0006886]; synaptic vesicle endocytosis [GO:0048488] AP-2 adaptor complex [GO:0030122]; presynapse [GO:0098793] clathrin adaptor activity [GO:0035615]; disordered domain specific binding [GO:0097718]; lipid binding [GO:0008289]; protein kinase binding [GO:0019901] g8111.t1 Q7QG73 75.54 695 0.0 1043.0 sp|Q7QG73|AP2A_ANOGA AP-2 complex subunit alpha OS=Anopheles gambiae OX=7165 GN=alpha-Adaptin PE=3 SV=4 g8113.t1 P97283 60.09 1115 0.0 1357.0 sp|P97283|DPOD1_MESAU DNA polymerase delta catalytic subunit OS=Mesocricetus auratus OX=10036 GN=POLD1 PE=2 SV=1 g8114.t1 Q32LN0 76.344 93 1.43e-42 155.0 sp|Q32LN0|EHF_BOVIN ETS homologous factor OS=Bos taurus OX=9913 GN=EHF PE=2 SV=1 EHF_BOVIN reviewed ETS homologous factor (ETS domain-containing transcription factor) Bos taurus (Bovine) GO:0000981; GO:0001228; GO:0005634; GO:0006357; GO:0030154; GO:1990837 cell differentiation [GO:0030154]; regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific double-stranded DNA binding [GO:1990837] g8114.t2 Q32LN0 76.344 93 1.62e-42 155.0 sp|Q32LN0|EHF_BOVIN ETS homologous factor OS=Bos taurus OX=9913 GN=EHF PE=2 SV=1 EHF_BOVIN reviewed ETS homologous factor (ETS domain-containing transcription factor) Bos taurus (Bovine) GO:0000981; GO:0001228; GO:0005634; GO:0006357; GO:0030154; GO:1990837 cell differentiation [GO:0030154]; regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific double-stranded DNA binding [GO:1990837] g8117.t1 Q96KP4 66.525 472 0.0 662.0 sp|Q96KP4|CNDP2_HUMAN Cytosolic non-specific dipeptidase OS=Homo sapiens OX=9606 GN=CNDP2 PE=1 SV=2 CNDP2_HUMAN reviewed Cytosolic non-specific dipeptidase (EC 3.4.13.18) (CNDP dipeptidase 2) (Glutamate carboxypeptidase-like protein 1) (Peptidase A) (Threonyl dipeptidase) Homo sapiens (Human) GO:0004180; GO:0005654; GO:0005829; GO:0006508; GO:0016805; GO:0046872; GO:0070062; GO:0070573 proteolysis [GO:0006508] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654] carboxypeptidase activity [GO:0004180]; dipeptidase activity [GO:0016805]; metal ion binding [GO:0046872]; metallodipeptidase activity [GO:0070573] g8119.t1 P40616 77.844 167 3.58e-96 279.0 sp|P40616|ARL1_HUMAN ADP-ribosylation factor-like protein 1 OS=Homo sapiens OX=9606 GN=ARL1 PE=1 SV=1 ARL1_HUMAN reviewed ADP-ribosylation factor-like protein 1 Homo sapiens (Human) GO:0000139; GO:0003924; GO:0005525; GO:0005737; GO:0005794; GO:0005802; GO:0005829; GO:0006886; GO:0007030; GO:0008047; GO:0009404; GO:0016192; GO:0019904; GO:0032588; GO:0034067; GO:0042147; GO:0046872; GO:1990583 Golgi organization [GO:0007030]; intracellular protein transport [GO:0006886]; protein localization to Golgi apparatus [GO:0034067]; retrograde transport, endosome to Golgi [GO:0042147]; toxin metabolic process [GO:0009404]; vesicle-mediated transport [GO:0016192] cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; trans-Golgi network [GO:0005802]; trans-Golgi network membrane [GO:0032588] enzyme activator activity [GO:0008047]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; phospholipase D activator activity [GO:1990583]; protein domain specific binding [GO:0019904] g8120.t1 Q6DCP5 43.243 222 1.13e-47 174.0 sp|Q6DCP5|SAAL1_XENLA Protein saal1 OS=Xenopus laevis OX=8355 GN=saal1 PE=2 SV=1 g8121.t1 O02703 34.225 187 9.87e-28 105.0 sp|O02703|BAX_BOVIN Apoptosis regulator BAX OS=Bos taurus OX=9913 GN=BAX PE=2 SV=1 g8122.t1 Q9M9E8 29.278 263 5.35e-23 105.0 sp|Q9M9E8|JMJ21_ARATH Lysine-specific demethylase JMJ21 OS=Arabidopsis thaliana OX=3702 GN=JMJ21 PE=2 SV=3 g8123.t1 Q3SZJ4 53.659 328 2.3900000000000003e-110 327.0 sp|Q3SZJ4|PTGR1_BOVIN Prostaglandin reductase 1 OS=Bos taurus OX=9913 GN=PTGR1 PE=2 SV=1 PTGR1_BOVIN reviewed Prostaglandin reductase 1 (PRG-1) (15-oxoprostaglandin 13-reductase) (EC 1.3.1.48) (Dithiolethione-inducible gene 1 protein) (D3T-inducible gene 1 protein) (DIG-1) (Leukotriene B4 12-hydroxydehydrogenase) (NAD(P)H-dependent alkenal/one oxidoreductase) (EC 1.3.1.74) Bos taurus (Bovine) GO:0005737; GO:0006693; GO:0035798; GO:0036102; GO:0036185; GO:0047522; GO:0097257; GO:2001302 leukotriene B4 metabolic process [GO:0036102]; lipoxin A4 metabolic process [GO:2001302]; prostaglandin metabolic process [GO:0006693] cytoplasm [GO:0005737] 13-lipoxin reductase activity [GO:0036185]; 15-oxoprostaglandin 13-reductase [NAD(P)+] activity [GO:0047522]; 2-alkenal reductase (NADPH) activity [GO:0035798]; leukotriene B4 12-hydroxy dehydrogenase activity [GO:0097257] g8124.t1 Q9FXA7 27.863 262 7.94e-23 101.0 sp|Q9FXA7|RGXT3_ARATH UDP-D-xylose:L-fucose alpha-1,3-D-xylosyltransferase 3 OS=Arabidopsis thaliana OX=3702 GN=RGXT3 PE=1 SV=1 g8125.t1 P49109 45.759 507 2.95e-157 461.0 sp|P49109|FMO5_CAVPO Flavin-containing monooxygenase 5 OS=Cavia porcellus OX=10141 GN=FMO5 PE=1 SV=2 g8126.t1 Q9EPL8 59.002 461 0.0 579.0 sp|Q9EPL8|IPO7_MOUSE Importin-7 OS=Mus musculus OX=10090 GN=Ipo7 PE=1 SV=2 IPO7_MOUSE reviewed Importin-7 (Imp7) (Ran-binding protein 7) (RanBP7) Mus musculus (Mouse) GO:0005634; GO:0005635; GO:0005654; GO:0005737; GO:0005829; GO:0006606; GO:0031267; GO:0042393; GO:0045087; GO:0045668; GO:0046332; GO:1900182; GO:1901331 innate immune response [GO:0045087]; negative regulation of osteoblast differentiation [GO:0045668]; positive regulation of odontoblast differentiation [GO:1901331]; positive regulation of protein localization to nucleus [GO:1900182]; protein import into nucleus [GO:0006606] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] histone binding [GO:0042393]; SMAD binding [GO:0046332]; small GTPase binding [GO:0031267] g8126.t1 Q9EPL8 58.077 260 6.66e-96 327.0 sp|Q9EPL8|IPO7_MOUSE Importin-7 OS=Mus musculus OX=10090 GN=Ipo7 PE=1 SV=2 IPO7_MOUSE reviewed Importin-7 (Imp7) (Ran-binding protein 7) (RanBP7) Mus musculus (Mouse) GO:0005634; GO:0005635; GO:0005654; GO:0005737; GO:0005829; GO:0006606; GO:0031267; GO:0042393; GO:0045087; GO:0045668; GO:0046332; GO:1900182; GO:1901331 innate immune response [GO:0045087]; negative regulation of osteoblast differentiation [GO:0045668]; positive regulation of odontoblast differentiation [GO:1901331]; positive regulation of protein localization to nucleus [GO:1900182]; protein import into nucleus [GO:0006606] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] histone binding [GO:0042393]; SMAD binding [GO:0046332]; small GTPase binding [GO:0031267] g8129.t1 Q03311 32.874 581 3.1800000000000004e-64 225.0 sp|Q03311|CHLE_MOUSE Cholinesterase OS=Mus musculus OX=10090 GN=Bche PE=1 SV=2 CHLE_MOUSE reviewed Cholinesterase (EC 3.1.1.8) (Acylcholine acylhydrolase) (Butyrylcholine esterase) (Choline esterase II) (Pseudocholinesterase) Mus musculus (Mouse) GO:0003990; GO:0004104; GO:0005615; GO:0005641; GO:0005783; GO:0005788; GO:0005886; GO:0006581; GO:0007584; GO:0007612; GO:0008285; GO:0009410; GO:0014016; GO:0019695; GO:0033265; GO:0042802; GO:0043279; GO:0050805; GO:0051384; GO:0051593 acetylcholine catabolic process [GO:0006581]; choline metabolic process [GO:0019695]; learning [GO:0007612]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of synaptic transmission [GO:0050805]; neuroblast differentiation [GO:0014016]; response to alkaloid [GO:0043279]; response to folic acid [GO:0051593]; response to glucocorticoid [GO:0051384]; response to nutrient [GO:0007584]; response to xenobiotic stimulus [GO:0009410] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; extracellular space [GO:0005615]; nuclear envelope lumen [GO:0005641]; plasma membrane [GO:0005886] acetylcholinesterase activity [GO:0003990]; choline binding [GO:0033265]; cholinesterase activity [GO:0004104]; identical protein binding [GO:0042802] g8130.t1 P32780 47.5 560 0.0 523.0 sp|P32780|TF2H1_HUMAN General transcription factor IIH subunit 1 OS=Homo sapiens OX=9606 GN=GTF2H1 PE=1 SV=1 TF2H1_HUMAN reviewed General transcription factor IIH subunit 1 (Basic transcription factor 2 62 kDa subunit) (BTF2 p62) (General transcription factor IIH polypeptide 1) (TFIIH basal transcription factor complex p62 subunit) Homo sapiens (Human) GO:0000079; GO:0000439; GO:0003682; GO:0005654; GO:0005675; GO:0006281; GO:0006289; GO:0006360; GO:0006366; GO:0006367; GO:0009755; GO:0045893; GO:0046966 DNA repair [GO:0006281]; hormone-mediated signaling pathway [GO:0009755]; nucleotide-excision repair [GO:0006289]; positive regulation of DNA-templated transcription [GO:0045893]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; transcription by RNA polymerase I [GO:0006360]; transcription by RNA polymerase II [GO:0006366]; transcription initiation at RNA polymerase II promoter [GO:0006367] nucleoplasm [GO:0005654]; transcription factor TFIIH core complex [GO:0000439]; transcription factor TFIIH holo complex [GO:0005675] chromatin binding [GO:0003682]; nuclear thyroid hormone receptor binding [GO:0046966] g8133.t1 D2YVJ8 36.774 155 7.860000000000001e-26 99.4 sp|D2YVJ8|LECM_TROCA C-type lectin mannose-binding isoform OS=Tropidechis carinatus OX=100989 PE=2 SV=1 g8134.t1 Q8WPD0 40.373 161 1.7800000000000001e-29 108.0 sp|Q8WPD0|LECG_PATPE Alpha-N-acetylgalactosamine-specific lectin OS=Patiria pectinifera OX=7594 PE=1 SV=1 g8135.t1 Q9VCA2 33.333 312 1.58e-49 176.0 sp|Q9VCA2|ORCT_DROME Organic cation transporter protein OS=Drosophila melanogaster OX=7227 GN=Orct PE=1 SV=1 g8137.t1 Q9WTW5 28.673 565 1.36e-53 193.0 sp|Q9WTW5|S22A3_MOUSE Solute carrier family 22 member 3 OS=Mus musculus OX=10090 GN=Slc22a3 PE=1 SV=1 S22A3_MOUSE reviewed Solute carrier family 22 member 3 (Organic cation transporter 3) (OCT3) Mus musculus (Mouse) GO:0005326; GO:0005330; GO:0005640; GO:0005886; GO:0006836; GO:0006837; GO:0008504; GO:0008514; GO:0012505; GO:0015101; GO:0015606; GO:0015651; GO:0015695; GO:0015697; GO:0015711; GO:0015718; GO:0015844; GO:0015848; GO:0015850; GO:0015872; GO:0015874; GO:0016323; GO:0016324; GO:0019534; GO:0022857; GO:0031966; GO:0032098; GO:0042908; GO:0043025; GO:0048241; GO:0051608; GO:0051610; GO:0051615; GO:0051620; GO:0051625; GO:0090494; GO:0098793; GO:1990748 cellular detoxification [GO:1990748]; dopamine transport [GO:0015872]; dopamine uptake [GO:0090494]; epinephrine transport [GO:0048241]; epinephrine uptake [GO:0051625]; histamine transport [GO:0051608]; histamine uptake [GO:0051615]; monoamine transport [GO:0015844]; monocarboxylic acid transport [GO:0015718]; neurotransmitter transport [GO:0006836]; norepinephrine transport [GO:0015874]; norepinephrine uptake [GO:0051620]; organic anion transport [GO:0015711]; organic cation transport [GO:0015695]; organic hydroxy compound transport [GO:0015850]; quaternary ammonium group transport [GO:0015697]; regulation of appetite [GO:0032098]; serotonin transport [GO:0006837]; serotonin uptake [GO:0051610]; spermidine transport [GO:0015848]; xenobiotic transport [GO:0042908] apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; endomembrane system [GO:0012505]; mitochondrial membrane [GO:0031966]; neuronal cell body [GO:0043025]; nuclear outer membrane [GO:0005640]; plasma membrane [GO:0005886]; presynapse [GO:0098793] dopamine:sodium symporter activity [GO:0005330]; monoamine transmembrane transporter activity [GO:0008504]; neurotransmitter transmembrane transporter activity [GO:0005326]; organic anion transmembrane transporter activity [GO:0008514]; organic cation transmembrane transporter activity [GO:0015101]; quaternary ammonium group transmembrane transporter activity [GO:0015651]; spermidine transmembrane transporter activity [GO:0015606]; toxin transmembrane transporter activity [GO:0019534]; transmembrane transporter activity [GO:0022857] g8138.t1 Q9VCA2 33.7 273 6.66e-41 154.0 sp|Q9VCA2|ORCT_DROME Organic cation transporter protein OS=Drosophila melanogaster OX=7227 GN=Orct PE=1 SV=1 g8146.t1 Q4V7T8 65.258 213 1.42e-102 298.0 sp|Q4V7T8|ROP1L_XENLA Ropporin-1-like protein OS=Xenopus laevis OX=8355 GN=ropn1l PE=2 SV=1 g8147.t1 Q6PFL8 54.878 164 2.0899999999999997e-54 173.0 sp|Q6PFL8|THYN1_DANRE Thymocyte nuclear protein 1 OS=Danio rerio OX=7955 GN=thyn1 PE=2 SV=1 g8148.t1 Q6ING7 52.092 478 1.83e-177 514.0 sp|Q6ING7|FLAD1_XENLA FAD synthase OS=Xenopus laevis OX=8355 GN=flad1 PE=2 SV=1 g8149.t1 Q5F408 59.046 608 0.0 701.0 sp|Q5F408|SYCC_CHICK Cysteine--tRNA ligase, cytoplasmic OS=Gallus gallus OX=9031 GN=CARS1 PE=2 SV=1 SYCC_CHICK reviewed Cysteine--tRNA ligase, cytoplasmic (EC 6.1.1.16) (Cysteinyl-tRNA synthetase) (CysRS) Gallus gallus (Chicken) GO:0000049; GO:0004817; GO:0005524; GO:0005737; GO:0006423; GO:0046872 cysteinyl-tRNA aminoacylation [GO:0006423] cytoplasm [GO:0005737] ATP binding [GO:0005524]; cysteine-tRNA ligase activity [GO:0004817]; metal ion binding [GO:0046872]; tRNA binding [GO:0000049] g8150.t1 Q9GKM4 61.789 369 3.72e-175 496.0 sp|Q9GKM4|BCAT1_SHEEP Branched-chain-amino-acid aminotransferase, cytosolic OS=Ovis aries OX=9940 GN=BCAT1 PE=2 SV=1 g8151.t1 Q4R684 32.273 220 6.36e-25 107.0 sp|Q4R684|AMZ2_MACFA Archaemetzincin-2 OS=Macaca fascicularis OX=9541 GN=AMZ2 PE=2 SV=2 g8152.t1 Q5E9H2 32.0 400 2.59e-72 237.0 sp|Q5E9H2|1A1L1_BOVIN 1-aminocyclopropane-1-carboxylate synthase-like protein 1 OS=Bos taurus OX=9913 GN=ACCS PE=2 SV=1 g8154.t1 A2AIG8 35.22 318 3.46e-72 234.0 sp|A2AIG8|1A1L1_MOUSE 1-aminocyclopropane-1-carboxylate synthase-like protein 1 OS=Mus musculus OX=10090 GN=Accs PE=2 SV=1 g8155.t1 O59028 38.511 309 6.810000000000001e-59 196.0 sp|O59028|MDH_PYRHO Malate dehydrogenase OS=Pyrococcus horikoshii (strain ATCC 700860 / DSM 12428 / JCM 9974 / NBRC 100139 / OT-3) OX=70601 GN=mdh PE=1 SV=1 g8156.t1 O59028 38.136 354 1.4999999999999998e-68 223.0 sp|O59028|MDH_PYRHO Malate dehydrogenase OS=Pyrococcus horikoshii (strain ATCC 700860 / DSM 12428 / JCM 9974 / NBRC 100139 / OT-3) OX=70601 GN=mdh PE=1 SV=1 g8157.t1 Q7ZW02 54.891 368 1.68e-134 394.0 sp|Q7ZW02|CHPT1_DANRE Cholinephosphotransferase 1 OS=Danio rerio OX=7955 GN=chpt1 PE=2 SV=1 CHPT1_DANRE reviewed Cholinephosphotransferase 1 (EC 2.7.8.2) (Diacylglycerol cholinephosphotransferase 1) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000139; GO:0004142; GO:0005789; GO:0005794; GO:0046872 endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139] diacylglycerol cholinephosphotransferase activity [GO:0004142]; metal ion binding [GO:0046872] g8165.t1 Q9D5U8 27.113 284 1.94e-24 114.0 sp|Q9D5U8|CNBD2_MOUSE Cyclic nucleotide-binding domain-containing protein 2 OS=Mus musculus OX=10090 GN=Cnbd2 PE=1 SV=2 CNBD2_MOUSE reviewed Cyclic nucleotide-binding domain-containing protein 2 (Cyclic nucleotide receptor involved in sperm function) Mus musculus (Mouse) GO:0005829; GO:0007283; GO:0030552 spermatogenesis [GO:0007283] cytosol [GO:0005829] cAMP binding [GO:0030552] g8169.t1 Q4W1X2 39.771 523 7.18e-126 381.0 sp|Q4W1X2|GLFA_ASPFM UDP-galactopyranose mutase OS=Aspergillus fumigatus OX=746128 GN=glfA PE=1 SV=1 GLFA_ASPFM reviewed UDP-galactopyranose mutase (UGM) (EC 5.4.99.9) Aspergillus fumigatus (Neosartorya fumigata) GO:0000166; GO:0008767; GO:0071555 cell wall organization [GO:0071555] nucleotide binding [GO:0000166]; UDP-galactopyranose mutase activity [GO:0008767] g8171.t1 P46023 30.162 862 1.83e-99 346.0 sp|P46023|GR101_LYMST G-protein coupled receptor GRL101 OS=Lymnaea stagnalis OX=6523 PE=2 SV=1 g8171.t1 P46023 28.916 332 8.45e-22 106.0 sp|P46023|GR101_LYMST G-protein coupled receptor GRL101 OS=Lymnaea stagnalis OX=6523 PE=2 SV=1 g8172.t1 P79385 31.268 339 3.45e-33 137.0 sp|P79385|MFGM_PIG Lactadherin OS=Sus scrofa OX=9823 GN=MFGE8 PE=1 SV=2 g8172.t1 P79385 24.874 398 1.4700000000000001e-21 102.0 sp|P79385|MFGM_PIG Lactadherin OS=Sus scrofa OX=9823 GN=MFGE8 PE=1 SV=2 g8176.t1 P49286 29.48 346 6.54e-33 129.0 sp|P49286|MTR1B_HUMAN Melatonin receptor type 1B OS=Homo sapiens OX=9606 GN=MTNR1B PE=1 SV=1 MTR1B_HUMAN reviewed Melatonin receptor type 1B (Mel-1B-R) (Mel1b receptor) Homo sapiens (Human) GO:0004930; GO:0005886; GO:0007186; GO:0007187; GO:0007268; GO:0008502; GO:0010754; GO:0042593; GO:0043010; GO:0043524; GO:0045202; GO:0045906; GO:0046010; GO:0046676; GO:0050796; GO:0051481; GO:0051970; GO:0051971; GO:0098908 camera-type eye development [GO:0043010]; chemical synaptic transmission [GO:0007268]; G protein-coupled receptor signaling pathway [GO:0007186]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; glucose homeostasis [GO:0042593]; negative regulation of cGMP-mediated signaling [GO:0010754]; negative regulation of cytosolic calcium ion concentration [GO:0051481]; negative regulation of insulin secretion [GO:0046676]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of transmission of nerve impulse [GO:0051970]; negative regulation of vasoconstriction [GO:0045906]; positive regulation of circadian sleep/wake cycle, non-REM sleep [GO:0046010]; positive regulation of transmission of nerve impulse [GO:0051971]; regulation of insulin secretion [GO:0050796]; regulation of neuronal action potential [GO:0098908] plasma membrane [GO:0005886]; synapse [GO:0045202] G protein-coupled receptor activity [GO:0004930]; melatonin receptor activity [GO:0008502] g8177.t1 Q9DEX3 55.409 379 3.5999999999999996e-150 433.0 sp|Q9DEX3|CATD_CLUHA Cathepsin D OS=Clupea harengus OX=7950 GN=ctsd PE=1 SV=1 CATD_CLUHA reviewed Cathepsin D (EC 3.4.23.5) Clupea harengus (Atlantic herring) GO:0004190; GO:0005764; GO:0006508 proteolysis [GO:0006508] lysosome [GO:0005764] aspartic-type endopeptidase activity [GO:0004190] g8178.t1 Q9NYB5 33.939 660 1.64e-106 345.0 sp|Q9NYB5|SO1C1_HUMAN Solute carrier organic anion transporter family member 1C1 OS=Homo sapiens OX=9606 GN=SLCO1C1 PE=1 SV=1 g8182.t1 Q5ZL34 56.545 191 1.37e-53 198.0 sp|Q5ZL34|CPSF6_CHICK Cleavage and polyadenylation specificity factor subunit 6 OS=Gallus gallus OX=9031 GN=CPSF6 PE=2 SV=1 CPSF6_CHICK reviewed Cleavage and polyadenylation specificity factor subunit 6 Gallus gallus (Chicken) GO:0003729; GO:0005634; GO:0005654; GO:0005726; GO:0005737; GO:0005847; GO:0005849; GO:0016607; GO:0035061; GO:0042382; GO:0046833; GO:0051290; GO:0110104; GO:0180010 co-transcriptional mRNA 3'-end processing, cleavage and polyadenylation pathway [GO:0180010]; mRNA alternative polyadenylation [GO:0110104]; positive regulation of RNA export from nucleus [GO:0046833]; protein heterotetramerization [GO:0051290] cytoplasm [GO:0005737]; interchromatin granule [GO:0035061]; mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; mRNA cleavage factor complex [GO:0005849]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; paraspeckles [GO:0042382]; perichromatin fibrils [GO:0005726] mRNA binding [GO:0003729] g8182.t1 Q5ZL34 58.219 146 6.58e-33 138.0 sp|Q5ZL34|CPSF6_CHICK Cleavage and polyadenylation specificity factor subunit 6 OS=Gallus gallus OX=9031 GN=CPSF6 PE=2 SV=1 CPSF6_CHICK reviewed Cleavage and polyadenylation specificity factor subunit 6 Gallus gallus (Chicken) GO:0003729; GO:0005634; GO:0005654; GO:0005726; GO:0005737; GO:0005847; GO:0005849; GO:0016607; GO:0035061; GO:0042382; GO:0046833; GO:0051290; GO:0110104; GO:0180010 co-transcriptional mRNA 3'-end processing, cleavage and polyadenylation pathway [GO:0180010]; mRNA alternative polyadenylation [GO:0110104]; positive regulation of RNA export from nucleus [GO:0046833]; protein heterotetramerization [GO:0051290] cytoplasm [GO:0005737]; interchromatin granule [GO:0035061]; mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; mRNA cleavage factor complex [GO:0005849]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; paraspeckles [GO:0042382]; perichromatin fibrils [GO:0005726] mRNA binding [GO:0003729] g8183.t1 P27701 27.869 244 9.480000000000001e-26 105.0 sp|P27701|CD82_HUMAN CD82 antigen OS=Homo sapiens OX=9606 GN=CD82 PE=1 SV=1 CD82_HUMAN reviewed CD82 antigen (C33 antigen) (IA4) (Inducible membrane protein R2) (Metastasis suppressor Kangai-1) (Suppressor of tumorigenicity 6 protein) (Tetraspanin-27) (Tspan-27) (CD antigen CD82) Homo sapiens (Human) GO:0005886; GO:0045335; GO:0070062 extracellular exosome [GO:0070062]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886] g8184.t1 P47772 80.124 161 5.1799999999999996e-89 259.0 sp|P47772|RS13_ICTPU Small ribosomal subunit protein uS15 OS=Ictalurus punctatus OX=7998 GN=rps13 PE=2 SV=3 g8185.t1 P13834 56.667 510 0.0 622.0 sp|P13834|GYS1_RABIT Glycogen [starch] synthase, muscle OS=Oryctolagus cuniculus OX=9986 GN=GYS1 PE=1 SV=4 g8186.t1 Q8BL97 56.41 117 3.05e-34 126.0 sp|Q8BL97|SRSF7_MOUSE Serine/arginine-rich splicing factor 7 OS=Mus musculus OX=10090 GN=Srsf7 PE=1 SV=1 SRSF7_MOUSE reviewed Serine/arginine-rich splicing factor 7 (Splicing factor, arginine/serine-rich 7) Mus musculus (Mouse) GO:0000381; GO:0003729; GO:0005654; GO:0005737; GO:0006397; GO:0008270; GO:0008380; GO:0016607; GO:0019904; GO:0048025; GO:0051028; GO:1990830 cellular response to leukemia inhibitory factor [GO:1990830]; mRNA processing [GO:0006397]; mRNA transport [GO:0051028]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA splicing [GO:0008380] cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654] mRNA binding [GO:0003729]; protein domain specific binding [GO:0019904]; zinc ion binding [GO:0008270] g8187.t1 Q8BL97 58.407 113 8e-37 132.0 sp|Q8BL97|SRSF7_MOUSE Serine/arginine-rich splicing factor 7 OS=Mus musculus OX=10090 GN=Srsf7 PE=1 SV=1 SRSF7_MOUSE reviewed Serine/arginine-rich splicing factor 7 (Splicing factor, arginine/serine-rich 7) Mus musculus (Mouse) GO:0000381; GO:0003729; GO:0005654; GO:0005737; GO:0006397; GO:0008270; GO:0008380; GO:0016607; GO:0019904; GO:0048025; GO:0051028; GO:1990830 cellular response to leukemia inhibitory factor [GO:1990830]; mRNA processing [GO:0006397]; mRNA transport [GO:0051028]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA splicing [GO:0008380] cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654] mRNA binding [GO:0003729]; protein domain specific binding [GO:0019904]; zinc ion binding [GO:0008270] g8188.t1 A0A0P0XM10 36.117 479 4.39e-78 255.0 sp|A0A0P0XM10|PAO6_ORYSJ Polyamine oxidase 6 OS=Oryza sativa subsp. japonica OX=39947 GN=PAO6 PE=2 SV=1 g8189.t1 O64411 38.022 455 1.96e-83 270.0 sp|O64411|PAO1_MAIZE Polyamine oxidase 1 OS=Zea mays OX=4577 GN=MPAO1 PE=1 SV=1 g8190.t1 Q29496 40.766 444 8.33e-116 353.0 sp|Q29496|CP3AO_SHEEP Cytochrome P450 3A24 OS=Ovis aries OX=9940 GN=CYP3A24 PE=2 SV=1 g8193.t1 Q0VBY7 38.053 113 3.2799999999999995e-23 91.3 sp|Q0VBY7|DJC24_BOVIN DnaJ homolog subfamily C member 24 OS=Bos taurus OX=9913 GN=DNAJC24 PE=2 SV=3 g8194.t1 O14727 36.14 1259 0.0 789.0 sp|O14727|APAF_HUMAN Apoptotic protease-activating factor 1 OS=Homo sapiens OX=9606 GN=APAF1 PE=1 SV=2 APAF_HUMAN reviewed Apoptotic protease-activating factor 1 (APAF-1) Homo sapiens (Human) GO:0000166; GO:0001666; GO:0001822; GO:0001843; GO:0005524; GO:0005576; GO:0005634; GO:0005829; GO:0006915; GO:0007399; GO:0007584; GO:0008656; GO:0010659; GO:0030154; GO:0030900; GO:0031072; GO:0032991; GO:0034774; GO:0042802; GO:0042981; GO:0043065; GO:0043293; GO:0043531; GO:0051402; GO:0070059; GO:0070062; GO:0071560; GO:0072432; GO:0097193; GO:0140608; GO:1902510; GO:1904813; GO:2001235 apoptotic process [GO:0006915]; cardiac muscle cell apoptotic process [GO:0010659]; cell differentiation [GO:0030154]; cellular response to transforming growth factor beta stimulus [GO:0071560]; forebrain development [GO:0030900]; intrinsic apoptotic signaling pathway [GO:0097193]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; kidney development [GO:0001822]; nervous system development [GO:0007399]; neural tube closure [GO:0001843]; neuron apoptotic process [GO:0051402]; positive regulation of apoptotic process [GO:0043065]; positive regulation of apoptotic signaling pathway [GO:2001235]; regulation of apoptotic DNA fragmentation [GO:1902510]; regulation of apoptotic process [GO:0042981]; response to G1 DNA damage checkpoint signaling [GO:0072432]; response to hypoxia [GO:0001666]; response to nutrient [GO:0007584] apoptosome [GO:0043293]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; secretory granule lumen [GO:0034774] ADP binding [GO:0043531]; ATP binding [GO:0005524]; cysteine-type endopeptidase activator activity [GO:0140608]; cysteine-type endopeptidase activator activity involved in apoptotic process [GO:0008656]; heat shock protein binding [GO:0031072]; identical protein binding [GO:0042802]; nucleotide binding [GO:0000166] g8195.t1 Q9CR89 59.718 355 2.57e-156 448.0 sp|Q9CR89|ERGI2_MOUSE Endoplasmic reticulum-Golgi intermediate compartment protein 2 OS=Mus musculus OX=10090 GN=Ergic2 PE=1 SV=1 g8207.t1 Q9VBW3 46.026 302 8.22e-82 278.0 sp|Q9VBW3|CAD96_DROME Tyrosine kinase receptor Cad96Ca OS=Drosophila melanogaster OX=7227 GN=Cad96Ca PE=2 SV=2 CAD96_DROME reviewed Tyrosine kinase receptor Cad96Ca (EC 2.7.10.1) (Cadherin-96Ca) (Tyrosine kinase receptor HD-14) Drosophila melanogaster (Fruit fly) GO:0004713; GO:0004714; GO:0005509; GO:0005524; GO:0005886; GO:0006468; GO:0007030; GO:0007156; GO:0007169; GO:0016339; GO:0042060; GO:0043235; GO:0045177; GO:0045792; GO:0051897; GO:0090303 calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; Golgi organization [GO:0007030]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell size [GO:0045792]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of wound healing [GO:0090303]; protein phosphorylation [GO:0006468]; wound healing [GO:0042060] apical part of cell [GO:0045177]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; protein tyrosine kinase activity [GO:0004713]; transmembrane receptor protein tyrosine kinase activity [GO:0004714] g8209.t1 Q61194 41.07 1383 0.0 1032.0 sp|Q61194|P3C2A_MOUSE Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit alpha OS=Mus musculus OX=10090 GN=Pik3c2a PE=1 SV=2 g8209.t2 Q61194 41.352 1376 0.0 1036.0 sp|Q61194|P3C2A_MOUSE Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit alpha OS=Mus musculus OX=10090 GN=Pik3c2a PE=1 SV=2 g8210.t1 Q9JI85 41.969 386 9.98e-71 235.0 sp|Q9JI85|NUCB2_RAT Nucleobindin-2 OS=Rattus norvegicus OX=10116 GN=Nucb2 PE=1 SV=1 NUCB2_RAT reviewed Nucleobindin-2 (DNA-binding protein NEFA) (Prepronesfatin) [Cleaved into: Nesfatin-1] Rattus norvegicus (Rat) GO:0001965; GO:0003677; GO:0005085; GO:0005164; GO:0005509; GO:0005615; GO:0005634; GO:0005640; GO:0005737; GO:0005783; GO:0005793; GO:0005794; GO:0005797; GO:0007264; GO:0009749; GO:0032099; GO:0042594; GO:0044752; GO:0045599; GO:0046321; GO:0046627; GO:0070093; GO:0141162; GO:1901142; GO:1990680; GO:2000845 insulin metabolic process [GO:1901142]; negative regulation of appetite [GO:0032099]; negative regulation of cAMP/PKA signal transduction [GO:0141162]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of glucagon secretion [GO:0070093]; negative regulation of insulin receptor signaling pathway [GO:0046627]; positive regulation of fatty acid oxidation [GO:0046321]; positive regulation of testosterone secretion [GO:2000845]; response to glucose [GO:0009749]; response to human chorionic gonadotropin [GO:0044752]; response to melanocyte-stimulating hormone [GO:1990680]; response to starvation [GO:0042594]; small GTPase-mediated signal transduction [GO:0007264] cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; Golgi medial cisterna [GO:0005797]; nuclear outer membrane [GO:0005640]; nucleus [GO:0005634] calcium ion binding [GO:0005509]; DNA binding [GO:0003677]; G-protein alpha-subunit binding [GO:0001965]; guanyl-nucleotide exchange factor activity [GO:0005085]; tumor necrosis factor receptor binding [GO:0005164] g8211.t1 Q6ZPK0 38.683 243 2.52e-36 144.0 sp|Q6ZPK0|PF21A_MOUSE PHD finger protein 21A OS=Mus musculus OX=10090 GN=Phf21a PE=1 SV=3 g8212.t1 P48053 33.202 1012 2.58e-174 538.0 sp|P48053|YPD1_CAEEL Uncharacterized protein C05D11.1 OS=Caenorhabditis elegans OX=6239 GN=C05D11.1 PE=4 SV=2 g8213.t1 B1H349 65.68 169 2.34e-50 191.0 sp|B1H349|SOX6_XENTR Transcription factor Sox-6 OS=Xenopus tropicalis OX=8364 GN=sox6 PE=2 SV=1 g8214.t1 P48547 46.866 367 9.6e-96 303.0 sp|P48547|KCNC1_HUMAN Voltage-gated potassium channel KCNC1 OS=Homo sapiens OX=9606 GN=KCNC1 PE=1 SV=1 KCNC1_HUMAN reviewed Voltage-gated potassium channel KCNC1 (NGK2) (Potassium voltage-gated channel subfamily C member 1) (Voltage-gated potassium channel subunit Kv3.1) (Voltage-gated potassium channel subunit Kv4) Homo sapiens (Human) GO:0001508; GO:0005249; GO:0005251; GO:0005886; GO:0006813; GO:0008076; GO:0009636; GO:0009642; GO:0009986; GO:0010996; GO:0014075; GO:0019894; GO:0021549; GO:0021554; GO:0021759; GO:0022038; GO:0030673; GO:0032590; GO:0032809; GO:0035864; GO:0042734; GO:0043679; GO:0044305; GO:0044325; GO:0045211; GO:0051260; GO:0051262; GO:0071466; GO:0071774; GO:0071805; GO:0099508; GO:1901381; GO:1990089 action potential [GO:0001508]; cellular response to xenobiotic stimulus [GO:0071466]; cerebellum development [GO:0021549]; corpus callosum development [GO:0022038]; globus pallidus development [GO:0021759]; optic nerve development [GO:0021554]; positive regulation of potassium ion transmembrane transport [GO:1901381]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; protein tetramerization [GO:0051262]; response to amine [GO:0014075]; response to auditory stimulus [GO:0010996]; response to fibroblast growth factor [GO:0071774]; response to light intensity [GO:0009642]; response to nerve growth factor [GO:1990089]; response to potassium ion [GO:0035864]; response to toxic substance [GO:0009636] axolemma [GO:0030673]; axon terminus [GO:0043679]; calyx of Held [GO:0044305]; cell surface [GO:0009986]; dendrite membrane [GO:0032590]; neuronal cell body membrane [GO:0032809]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; voltage-gated potassium channel complex [GO:0008076] delayed rectifier potassium channel activity [GO:0005251]; kinesin binding [GO:0019894]; transmembrane transporter binding [GO:0044325]; voltage-gated monoatomic ion channel activity involved in regulation of presynaptic membrane potential [GO:0099508]; voltage-gated potassium channel activity [GO:0005249] g8216.t1 Q9NTG7 66.495 194 6.03e-96 294.0 sp|Q9NTG7|SIR3_HUMAN NAD-dependent protein deacetylase sirtuin-3, mitochondrial OS=Homo sapiens OX=9606 GN=SIRT3 PE=1 SV=2 g8218.t1 Q6EV70 43.681 364 7.26e-101 309.0 sp|Q6EV70|OFUT1_RAT GDP-fucose protein O-fucosyltransferase 1 OS=Rattus norvegicus OX=10116 GN=Pofut1 PE=1 SV=1 OFUT1_RAT reviewed GDP-fucose protein O-fucosyltransferase 1 (EC 2.4.1.221) (Peptide-O-fucosyltransferase 1) (O-FucT-1) Rattus norvegicus (Rat) GO:0001525; GO:0001756; GO:0005783; GO:0006004; GO:0007219; GO:0007399; GO:0007507; GO:0008593; GO:0016020; GO:0036066; GO:0046922 angiogenesis [GO:0001525]; fucose metabolic process [GO:0006004]; heart development [GO:0007507]; nervous system development [GO:0007399]; Notch signaling pathway [GO:0007219]; protein O-linked glycosylation via fucose [GO:0036066]; regulation of Notch signaling pathway [GO:0008593]; somitogenesis [GO:0001756] endoplasmic reticulum [GO:0005783]; membrane [GO:0016020] peptide-O-fucosyltransferase activity [GO:0046922] g8219.t1 Q16527 51.759 199 8.39e-45 150.0 sp|Q16527|CSRP2_HUMAN Cysteine and glycine-rich protein 2 OS=Homo sapiens OX=9606 GN=CSRP2 PE=1 SV=3 CSRP2_HUMAN reviewed Cysteine and glycine-rich protein 2 (Cysteine-rich protein 2) (CRP2) (LIM domain only protein 5) (LMO-5) (Smooth muscle cell LIM protein) (SmLIM) Homo sapiens (Human) GO:0005634; GO:0005737; GO:0005925; GO:0008307; GO:0030018; GO:0030154; GO:0042805; GO:0045214; GO:0046872; GO:0060537 cell differentiation [GO:0030154]; muscle tissue development [GO:0060537]; sarcomere organization [GO:0045214] cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; nucleus [GO:0005634]; Z disc [GO:0030018] actinin binding [GO:0042805]; metal ion binding [GO:0046872]; structural constituent of muscle [GO:0008307] g8221.t1 Q9TRY0 52.546 432 1.03e-155 453.0 sp|Q9TRY0|FKBP4_BOVIN Peptidyl-prolyl cis-trans isomerase FKBP4 OS=Bos taurus OX=9913 GN=FKBP4 PE=1 SV=4 g8222.t1 Q5ZIL6 62.642 265 2.4300000000000002e-85 259.0 sp|Q5ZIL6|TM41B_CHICK Transmembrane protein 41B OS=Gallus gallus OX=9031 GN=TMEM41B PE=2 SV=1 g8223.t1 O95922 74.292 424 0.0 682.0 sp|O95922|TTLL1_HUMAN Polyglutamylase complex subunit TTLL1 OS=Homo sapiens OX=9606 GN=TTLL1 PE=1 SV=1 TTLL1_HUMAN reviewed Polyglutamylase complex subunit TTLL1 (EC 6.3.2.-) (Tubulin polyglutamylase TTLL1) (Tubulin polyglutamylase complex subunit 3) (PGs3) (Tubulin--tyrosine ligase-like protein 1) Homo sapiens (Human) GO:0000226; GO:0002395; GO:0005524; GO:0005576; GO:0005874; GO:0005930; GO:0007288; GO:0015631; GO:0018095; GO:0021702; GO:0031514; GO:0036064; GO:0046872; GO:0070740; GO:0106438; GO:0120197; GO:0120222 cerebellar Purkinje cell differentiation [GO:0021702]; immune response in nasopharyngeal-associated lymphoid tissue [GO:0002395]; microtubule cytoskeleton organization [GO:0000226]; mucociliary clearance [GO:0120197]; protein polyglutamylation [GO:0018095]; regulation of blastocyst development [GO:0120222]; sperm axoneme assembly [GO:0007288] axoneme [GO:0005930]; ciliary basal body [GO:0036064]; extracellular region [GO:0005576]; microtubule [GO:0005874]; motile cilium [GO:0031514] ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein-glutamic acid ligase activity, elongating [GO:0106438]; tubulin binding [GO:0015631]; tubulin-glutamic acid ligase activity [GO:0070740] g8225.t1 Q9P1Y6 52.709 203 7.72e-55 216.0 sp|Q9P1Y6|PHRF1_HUMAN PHD and RING finger domain-containing protein 1 OS=Homo sapiens OX=9606 GN=PHRF1 PE=1 SV=3 g8225.t1 Q9P1Y6 62.5 72 1.0600000000000001e-21 107.0 sp|Q9P1Y6|PHRF1_HUMAN PHD and RING finger domain-containing protein 1 OS=Homo sapiens OX=9606 GN=PHRF1 PE=1 SV=3 g8232.t1 Q6QNK2 37.222 360 1.67e-58 218.0 sp|Q6QNK2|AGRD1_HUMAN Adhesion G-protein coupled receptor D1 OS=Homo sapiens OX=9606 GN=ADGRD1 PE=1 SV=1 AGRD1_HUMAN reviewed Adhesion G-protein coupled receptor D1 (G-protein coupled receptor 133) (G-protein coupled receptor PGR25) [Cleaved into: Adhesion G-protein coupled receptor D1, N-terminal fragment (ADGRD1 N-terminal fragment); Adhesion G-protein coupled receptor D1, C-terminal fragment (ADGRD1 C-terminal fragment)] Homo sapiens (Human) GO:0004930; GO:0005654; GO:0005829; GO:0005886; GO:0007166; GO:0007186; GO:0007189; GO:0014819; GO:0016020; GO:0016607 adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186]; regulation of skeletal muscle contraction [GO:0014819] cytosol [GO:0005829]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] G protein-coupled receptor activity [GO:0004930] g8234.t1 Q0VCJ7 65.347 202 2.2199999999999998e-95 279.0 sp|Q0VCJ7|RERG_BOVIN Ras-related and estrogen-regulated growth inhibitor OS=Bos taurus OX=9913 GN=RERG PE=2 SV=1 g8236.t1 Q9H2X6 59.906 641 0.0 706.0 sp|Q9H2X6|HIPK2_HUMAN Homeodomain-interacting protein kinase 2 OS=Homo sapiens OX=9606 GN=HIPK2 PE=1 SV=2 g8245.t1 Q9M2U3 26.421 299 2.78e-28 117.0 sp|Q9M2U3|ALPL_ARATH Protein ALP1-like OS=Arabidopsis thaliana OX=3702 GN=At3g55350 PE=2 SV=1 g8256.t1 Q32NG4 50.495 101 7.67e-27 106.0 sp|Q32NG4|GALD1_XENLA Glutamine amidotransferase-like class 1 domain-containing protein 1 OS=Xenopus laevis OX=8355 GN=gatd1 PE=2 SV=1 g8304.t1 E1BD59 24.202 376 2.25e-24 109.0 sp|E1BD59|TRI56_BOVIN E3 ubiquitin-protein ligase TRIM56 OS=Bos taurus OX=9913 GN=TRIM56 PE=2 SV=1 TRI56_BOVIN reviewed E3 ubiquitin-protein ligase TRIM56 (EC 2.3.2.27) (Tripartite motif-containing protein 56) Bos taurus (Bovine) GO:0005654; GO:0005737; GO:0006513; GO:0008270; GO:0032728; GO:0034340; GO:0045087; GO:0051607; GO:0060340; GO:0061630; GO:0070534 defense response to virus [GO:0051607]; innate immune response [GO:0045087]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of type I interferon-mediated signaling pathway [GO:0060340]; protein K63-linked ubiquitination [GO:0070534]; protein monoubiquitination [GO:0006513]; response to type I interferon [GO:0034340] cytoplasm [GO:0005737]; nucleoplasm [GO:0005654] ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] g8305.t1 E1BD59 23.76 383 2.67e-25 115.0 sp|E1BD59|TRI56_BOVIN E3 ubiquitin-protein ligase TRIM56 OS=Bos taurus OX=9913 GN=TRIM56 PE=2 SV=1 TRI56_BOVIN reviewed E3 ubiquitin-protein ligase TRIM56 (EC 2.3.2.27) (Tripartite motif-containing protein 56) Bos taurus (Bovine) GO:0005654; GO:0005737; GO:0006513; GO:0008270; GO:0032728; GO:0034340; GO:0045087; GO:0051607; GO:0060340; GO:0061630; GO:0070534 defense response to virus [GO:0051607]; innate immune response [GO:0045087]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of type I interferon-mediated signaling pathway [GO:0060340]; protein K63-linked ubiquitination [GO:0070534]; protein monoubiquitination [GO:0006513]; response to type I interferon [GO:0034340] cytoplasm [GO:0005737]; nucleoplasm [GO:0005654] ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] g11469.t1 Q09575 32.069 290 1.04e-39 157.0 sp|Q09575|YRD6_CAEEL Uncharacterized protein K02A2.6 OS=Caenorhabditis elegans OX=6239 GN=K02A2.6 PE=4 SV=1 g9474.t1 Q02858 32.735 223 1.2e-24 114.0 sp|Q02858|TIE2_MOUSE Angiopoietin-1 receptor OS=Mus musculus OX=10090 GN=Tek PE=1 SV=2 TIE2_MOUSE reviewed Angiopoietin-1 receptor (EC 2.7.10.1) (Endothelial tyrosine kinase) (HYK) (STK1) (Tunica interna endothelial cell kinase) (Tyrosine kinase with Ig and EGF homology domains-2) (Tyrosine-protein kinase receptor TEK) (Tyrosine-protein kinase receptor TIE-2) (mTIE2) (p140 TEK) (CD antigen CD202b) Mus musculus (Mouse) GO:0001525; GO:0001569; GO:0001570; GO:0001666; GO:0001935; GO:0001936; GO:0002040; GO:0002720; GO:0004713; GO:0004714; GO:0005524; GO:0005576; GO:0005813; GO:0005886; GO:0005902; GO:0005911; GO:0005925; GO:0007160; GO:0007166; GO:0007169; GO:0007507; GO:0009925; GO:0009986; GO:0010595; GO:0016020; GO:0016323; GO:0016324; GO:0016525; GO:0018108; GO:0019838; GO:0030097; GO:0030334; GO:0030949; GO:0032526; GO:0032878; GO:0034446; GO:0036064; GO:0038023; GO:0042307; GO:0042802; GO:0043066; GO:0043235; GO:0043410; GO:0043627; GO:0045121; GO:0045765; GO:0045766; GO:0045785; GO:0048014; GO:0048471; GO:0051894; GO:0051897; GO:0060347; GO:0070374; GO:0071260; GO:0072012; GO:0098609; GO:1901222; GO:1902533; GO:2000352 angiogenesis [GO:0001525]; branching involved in blood vessel morphogenesis [GO:0001569]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; cell surface receptor signaling pathway [GO:0007166]; cell-cell adhesion [GO:0098609]; cell-matrix adhesion [GO:0007160]; cellular response to mechanical stimulus [GO:0071260]; endothelial cell proliferation [GO:0001935]; glomerulus vasculature development [GO:0072012]; heart development [GO:0007507]; heart trabecula formation [GO:0060347]; hemopoiesis [GO:0030097]; negative regulation of angiogenesis [GO:0016525]; negative regulation of apoptotic process [GO:0043066]; negative regulation of endothelial cell apoptotic process [GO:2000352]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cytokine production involved in immune response [GO:0002720]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of intracellular signal transduction [GO:1902533]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030949]; regulation of angiogenesis [GO:0045765]; regulation of cell migration [GO:0030334]; regulation of endothelial cell proliferation [GO:0001936]; regulation of establishment or maintenance of cell polarity [GO:0032878]; regulation of non-canonical NF-kappaB signal transduction [GO:1901222]; response to estrogen [GO:0043627]; response to hypoxia [GO:0001666]; response to retinoic acid [GO:0032526]; sprouting angiogenesis [GO:0002040]; substrate adhesion-dependent cell spreading [GO:0034446]; Tie signaling pathway [GO:0048014]; vasculogenesis [GO:0001570] apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; cell-cell junction [GO:0005911]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; membrane [GO:0016020]; membrane raft [GO:0045121]; microvillus [GO:0005902]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] ATP binding [GO:0005524]; growth factor binding [GO:0019838]; identical protein binding [GO:0042802]; protein tyrosine kinase activity [GO:0004713]; signaling receptor activity [GO:0038023]; transmembrane receptor protein tyrosine kinase activity [GO:0004714] g9474.t2 Q02858 32.364 275 2.0499999999999998e-34 145.0 sp|Q02858|TIE2_MOUSE Angiopoietin-1 receptor OS=Mus musculus OX=10090 GN=Tek PE=1 SV=2 TIE2_MOUSE reviewed Angiopoietin-1 receptor (EC 2.7.10.1) (Endothelial tyrosine kinase) (HYK) (STK1) (Tunica interna endothelial cell kinase) (Tyrosine kinase with Ig and EGF homology domains-2) (Tyrosine-protein kinase receptor TEK) (Tyrosine-protein kinase receptor TIE-2) (mTIE2) (p140 TEK) (CD antigen CD202b) Mus musculus (Mouse) GO:0001525; GO:0001569; GO:0001570; GO:0001666; GO:0001935; GO:0001936; GO:0002040; GO:0002720; GO:0004713; GO:0004714; GO:0005524; GO:0005576; GO:0005813; GO:0005886; GO:0005902; GO:0005911; GO:0005925; GO:0007160; GO:0007166; GO:0007169; GO:0007507; GO:0009925; GO:0009986; GO:0010595; GO:0016020; GO:0016323; GO:0016324; GO:0016525; GO:0018108; GO:0019838; GO:0030097; GO:0030334; GO:0030949; GO:0032526; GO:0032878; GO:0034446; GO:0036064; GO:0038023; GO:0042307; GO:0042802; GO:0043066; GO:0043235; GO:0043410; GO:0043627; GO:0045121; GO:0045765; GO:0045766; GO:0045785; GO:0048014; GO:0048471; GO:0051894; GO:0051897; GO:0060347; GO:0070374; GO:0071260; GO:0072012; GO:0098609; GO:1901222; GO:1902533; GO:2000352 angiogenesis [GO:0001525]; branching involved in blood vessel morphogenesis [GO:0001569]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; cell surface receptor signaling pathway [GO:0007166]; cell-cell adhesion [GO:0098609]; cell-matrix adhesion [GO:0007160]; cellular response to mechanical stimulus [GO:0071260]; endothelial cell proliferation [GO:0001935]; glomerulus vasculature development [GO:0072012]; heart development [GO:0007507]; heart trabecula formation [GO:0060347]; hemopoiesis [GO:0030097]; negative regulation of angiogenesis [GO:0016525]; negative regulation of apoptotic process [GO:0043066]; negative regulation of endothelial cell apoptotic process [GO:2000352]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cytokine production involved in immune response [GO:0002720]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of intracellular signal transduction [GO:1902533]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030949]; regulation of angiogenesis [GO:0045765]; regulation of cell migration [GO:0030334]; regulation of endothelial cell proliferation [GO:0001936]; regulation of establishment or maintenance of cell polarity [GO:0032878]; regulation of non-canonical NF-kappaB signal transduction [GO:1901222]; response to estrogen [GO:0043627]; response to hypoxia [GO:0001666]; response to retinoic acid [GO:0032526]; sprouting angiogenesis [GO:0002040]; substrate adhesion-dependent cell spreading [GO:0034446]; Tie signaling pathway [GO:0048014]; vasculogenesis [GO:0001570] apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; cell-cell junction [GO:0005911]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; membrane [GO:0016020]; membrane raft [GO:0045121]; microvillus [GO:0005902]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] ATP binding [GO:0005524]; growth factor binding [GO:0019838]; identical protein binding [GO:0042802]; protein tyrosine kinase activity [GO:0004713]; signaling receptor activity [GO:0038023]; transmembrane receptor protein tyrosine kinase activity [GO:0004714] g9476.t1 P14381 38.329 347 8.7e-60 213.0 sp|P14381|YTX2_XENLA Transposon TX1 uncharacterized 149 kDa protein OS=Xenopus laevis OX=8355 PE=4 SV=1 g9477.t1 Q02858 32.803 314 4.24e-41 167.0 sp|Q02858|TIE2_MOUSE Angiopoietin-1 receptor OS=Mus musculus OX=10090 GN=Tek PE=1 SV=2 TIE2_MOUSE reviewed Angiopoietin-1 receptor (EC 2.7.10.1) (Endothelial tyrosine kinase) (HYK) (STK1) (Tunica interna endothelial cell kinase) (Tyrosine kinase with Ig and EGF homology domains-2) (Tyrosine-protein kinase receptor TEK) (Tyrosine-protein kinase receptor TIE-2) (mTIE2) (p140 TEK) (CD antigen CD202b) Mus musculus (Mouse) GO:0001525; GO:0001569; GO:0001570; GO:0001666; GO:0001935; GO:0001936; GO:0002040; GO:0002720; GO:0004713; GO:0004714; GO:0005524; GO:0005576; GO:0005813; GO:0005886; GO:0005902; GO:0005911; GO:0005925; GO:0007160; GO:0007166; GO:0007169; GO:0007507; GO:0009925; GO:0009986; GO:0010595; GO:0016020; GO:0016323; GO:0016324; GO:0016525; GO:0018108; GO:0019838; GO:0030097; GO:0030334; GO:0030949; GO:0032526; GO:0032878; GO:0034446; GO:0036064; GO:0038023; GO:0042307; GO:0042802; GO:0043066; GO:0043235; GO:0043410; GO:0043627; GO:0045121; GO:0045765; GO:0045766; GO:0045785; GO:0048014; GO:0048471; GO:0051894; GO:0051897; GO:0060347; GO:0070374; GO:0071260; GO:0072012; GO:0098609; GO:1901222; GO:1902533; GO:2000352 angiogenesis [GO:0001525]; branching involved in blood vessel morphogenesis [GO:0001569]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; cell surface receptor signaling pathway [GO:0007166]; cell-cell adhesion [GO:0098609]; cell-matrix adhesion [GO:0007160]; cellular response to mechanical stimulus [GO:0071260]; endothelial cell proliferation [GO:0001935]; glomerulus vasculature development [GO:0072012]; heart development [GO:0007507]; heart trabecula formation [GO:0060347]; hemopoiesis [GO:0030097]; negative regulation of angiogenesis [GO:0016525]; negative regulation of apoptotic process [GO:0043066]; negative regulation of endothelial cell apoptotic process [GO:2000352]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cytokine production involved in immune response [GO:0002720]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of intracellular signal transduction [GO:1902533]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030949]; regulation of angiogenesis [GO:0045765]; regulation of cell migration [GO:0030334]; regulation of endothelial cell proliferation [GO:0001936]; regulation of establishment or maintenance of cell polarity [GO:0032878]; regulation of non-canonical NF-kappaB signal transduction [GO:1901222]; response to estrogen [GO:0043627]; response to hypoxia [GO:0001666]; response to retinoic acid [GO:0032526]; sprouting angiogenesis [GO:0002040]; substrate adhesion-dependent cell spreading [GO:0034446]; Tie signaling pathway [GO:0048014]; vasculogenesis [GO:0001570] apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; cell-cell junction [GO:0005911]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; membrane [GO:0016020]; membrane raft [GO:0045121]; microvillus [GO:0005902]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] ATP binding [GO:0005524]; growth factor binding [GO:0019838]; identical protein binding [GO:0042802]; protein tyrosine kinase activity [GO:0004713]; signaling receptor activity [GO:0038023]; transmembrane receptor protein tyrosine kinase activity [GO:0004714] g3400.t1 Q04202 32.636 239 9.050000000000001e-26 103.0 sp|Q04202|TCB2_CAEBR Transposable element Tcb2 transposase OS=Caenorhabditis briggsae OX=6238 PE=3 SV=1 g3404.t1 Q5RBK0 31.183 186 1.27e-30 122.0 sp|Q5RBK0|GIN1_PONAB Gypsy retrotransposon integrase-like protein 1 OS=Pongo abelii OX=9601 GN=GIN1 PE=2 SV=1 g3432.t1 Q96DM1 26.966 445 2.66e-33 139.0 sp|Q96DM1|PGBD4_HUMAN PiggyBac transposable element-derived protein 4 OS=Homo sapiens OX=9606 GN=PGBD4 PE=1 SV=3 g9551.t1 E1BD59 24.054 370 4.7500000000000003e-26 117.0 sp|E1BD59|TRI56_BOVIN E3 ubiquitin-protein ligase TRIM56 OS=Bos taurus OX=9913 GN=TRIM56 PE=2 SV=1 TRI56_BOVIN reviewed E3 ubiquitin-protein ligase TRIM56 (EC 2.3.2.27) (Tripartite motif-containing protein 56) Bos taurus (Bovine) GO:0005654; GO:0005737; GO:0006513; GO:0008270; GO:0032728; GO:0034340; GO:0045087; GO:0051607; GO:0060340; GO:0061630; GO:0070534 defense response to virus [GO:0051607]; innate immune response [GO:0045087]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of type I interferon-mediated signaling pathway [GO:0060340]; protein K63-linked ubiquitination [GO:0070534]; protein monoubiquitination [GO:0006513]; response to type I interferon [GO:0034340] cytoplasm [GO:0005737]; nucleoplasm [GO:0005654] ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] g17685.t1 Q08431 30.164 305 2.47e-35 134.0 sp|Q08431|MFGM_HUMAN Lactadherin OS=Homo sapiens OX=9606 GN=MFGE8 PE=1 SV=3 MFGM_HUMAN reviewed Lactadherin (Breast epithelial antigen BA46) (HMFG) (MFGM) (Milk fat globule-EGF factor 8) (MFG-E8) (SED1) [Cleaved into: Lactadherin short form; Medin] Homo sapiens (Human) GO:0001525; GO:0001786; GO:0002080; GO:0005178; GO:0005576; GO:0005615; GO:0005788; GO:0007155; GO:0007338; GO:0009897; GO:0016020; GO:0031012; GO:0043277; GO:0070062; GO:1903561 angiogenesis [GO:0001525]; apoptotic cell clearance [GO:0043277]; cell adhesion [GO:0007155]; single fertilization [GO:0007338] acrosomal membrane [GO:0002080]; endoplasmic reticulum lumen [GO:0005788]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular vesicle [GO:1903561]; membrane [GO:0016020] integrin binding [GO:0005178]; phosphatidylserine binding [GO:0001786] g17687.t1 Q9W3K5 61.429 140 4.06e-53 181.0 sp|Q9W3K5|GSH1_DROME Glutamate--cysteine ligase OS=Drosophila melanogaster OX=7227 GN=Gclc PE=2 SV=1 GSH1_DROME reviewed Glutamate--cysteine ligase (EC 6.3.2.2) (Gamma-ECS) (GCS) (Gamma-glutamylcysteine synthetase) Drosophila melanogaster (Fruit fly) GO:0004357; GO:0005524; GO:0005634; GO:0006749; GO:0006750; GO:0007409; GO:0007476; GO:0017109; GO:0046688; GO:0048471 axonogenesis [GO:0007409]; glutathione biosynthetic process [GO:0006750]; glutathione metabolic process [GO:0006749]; imaginal disc-derived wing morphogenesis [GO:0007476]; response to copper ion [GO:0046688] glutamate-cysteine ligase complex [GO:0017109]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471] ATP binding [GO:0005524]; glutamate-cysteine ligase activity [GO:0004357] g9554.t1 Q3SZZ7 44.118 204 4.36e-46 162.0 sp|Q3SZZ7|FGL1_BOVIN Fibrinogen-like protein 1 OS=Bos taurus OX=9913 GN=FGL1 PE=2 SV=1 FGL1_BOVIN reviewed Fibrinogen-like protein 1 Bos taurus (Bovine) GO:0002250; GO:0005576; GO:0005615; GO:0007596; GO:0048018; GO:0050776; GO:0050868; GO:0072574 adaptive immune response [GO:0002250]; blood coagulation [GO:0007596]; hepatocyte proliferation [GO:0072574]; negative regulation of T cell activation [GO:0050868]; regulation of immune response [GO:0050776] extracellular region [GO:0005576]; extracellular space [GO:0005615] receptor ligand activity [GO:0048018] g11494.t1 P35072 38.095 273 8.15e-65 207.0 sp|P35072|TCB1_CAEBR Transposable element Tcb1 transposase OS=Caenorhabditis briggsae OX=6238 PE=3 SV=1 g9471.t1 E1BD59 24.868 378 4.46e-28 123.0 sp|E1BD59|TRI56_BOVIN E3 ubiquitin-protein ligase TRIM56 OS=Bos taurus OX=9913 GN=TRIM56 PE=2 SV=1 TRI56_BOVIN reviewed E3 ubiquitin-protein ligase TRIM56 (EC 2.3.2.27) (Tripartite motif-containing protein 56) Bos taurus (Bovine) GO:0005654; GO:0005737; GO:0006513; GO:0008270; GO:0032728; GO:0034340; GO:0045087; GO:0051607; GO:0060340; GO:0061630; GO:0070534 defense response to virus [GO:0051607]; innate immune response [GO:0045087]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of type I interferon-mediated signaling pathway [GO:0060340]; protein K63-linked ubiquitination [GO:0070534]; protein monoubiquitination [GO:0006513]; response to type I interferon [GO:0034340] cytoplasm [GO:0005737]; nucleoplasm [GO:0005654] ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] g2048.t1 E1BD59 24.932 369 5.26e-26 117.0 sp|E1BD59|TRI56_BOVIN E3 ubiquitin-protein ligase TRIM56 OS=Bos taurus OX=9913 GN=TRIM56 PE=2 SV=1 TRI56_BOVIN reviewed E3 ubiquitin-protein ligase TRIM56 (EC 2.3.2.27) (Tripartite motif-containing protein 56) Bos taurus (Bovine) GO:0005654; GO:0005737; GO:0006513; GO:0008270; GO:0032728; GO:0034340; GO:0045087; GO:0051607; GO:0060340; GO:0061630; GO:0070534 defense response to virus [GO:0051607]; innate immune response [GO:0045087]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of type I interferon-mediated signaling pathway [GO:0060340]; protein K63-linked ubiquitination [GO:0070534]; protein monoubiquitination [GO:0006513]; response to type I interferon [GO:0034340] cytoplasm [GO:0005737]; nucleoplasm [GO:0005654] ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] g16296.t1 A0JP70 40.816 147 4.64e-27 108.0 sp|A0JP70|WDR90_XENTR WD repeat-containing protein 90 OS=Xenopus tropicalis OX=8364 GN=wdr90 PE=2 SV=1 g16296.t2 A0JP70 43.885 139 3.03e-28 112.0 sp|A0JP70|WDR90_XENTR WD repeat-containing protein 90 OS=Xenopus tropicalis OX=8364 GN=wdr90 PE=2 SV=1 g16308.t1 P23471 45.902 183 2.79e-47 173.0 sp|P23471|PTPRZ_HUMAN Receptor-type tyrosine-protein phosphatase zeta OS=Homo sapiens OX=9606 GN=PTPRZ1 PE=1 SV=4 PTPRZ_HUMAN reviewed Receptor-type tyrosine-protein phosphatase zeta (R-PTP-zeta) (EC 3.1.3.48) (Protein-tyrosine phosphatase receptor type Z polypeptide 1) (Protein-tyrosine phosphatase receptor type Z polypeptide 2) (R-PTP-zeta-2) Homo sapiens (Human) GO:0002244; GO:0004725; GO:0005001; GO:0005178; GO:0005576; GO:0005886; GO:0006470; GO:0007165; GO:0007409; GO:0007417; GO:0007611; GO:0031175; GO:0031641; GO:0035335; GO:0043524; GO:0045202; GO:0048709; GO:0048714; GO:0070445; GO:0072534 axonogenesis [GO:0007409]; central nervous system development [GO:0007417]; hematopoietic progenitor cell differentiation [GO:0002244]; learning or memory [GO:0007611]; negative regulation of neuron apoptotic process [GO:0043524]; neuron projection development [GO:0031175]; oligodendrocyte differentiation [GO:0048709]; peptidyl-tyrosine dephosphorylation [GO:0035335]; positive regulation of oligodendrocyte differentiation [GO:0048714]; protein dephosphorylation [GO:0006470]; regulation of myelination [GO:0031641]; regulation of oligodendrocyte progenitor proliferation [GO:0070445]; signal transduction [GO:0007165] extracellular region [GO:0005576]; perineuronal net [GO:0072534]; plasma membrane [GO:0005886]; synapse [GO:0045202] integrin binding [GO:0005178]; protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001] g8271.t1 Q92889 49.43 263 8.61e-72 238.0 sp|Q92889|XPF_HUMAN DNA repair endonuclease XPF OS=Homo sapiens OX=9606 GN=ERCC4 PE=1 SV=3 g9457.t1 Q05004 25.054 463 2.8499999999999997e-28 122.0 sp|Q05004|NXPE1_RABIT NXPE family member 1 OS=Oryctolagus cuniculus OX=9986 GN=NXPE1 PE=2 SV=1 g9461.t1 Q5RDJ2 29.615 260 1.7100000000000003e-21 102.0 sp|Q5RDJ2|ZMYM2_PONAB Zinc finger MYM-type protein 2 OS=Pongo abelii OX=9601 GN=ZMYM2 PE=2 SV=1 ZMYM2_PONAB reviewed Zinc finger MYM-type protein 2 (Zinc finger protein 198) Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0005634; GO:0008270 nucleus [GO:0005634] zinc ion binding [GO:0008270] g9462.t1 Q9UBW7 29.615 260 1.6600000000000001e-21 102.0 sp|Q9UBW7|ZMYM2_HUMAN Zinc finger MYM-type protein 2 OS=Homo sapiens OX=9606 GN=ZMYM2 PE=1 SV=1 ZMYM2_HUMAN reviewed Zinc finger MYM-type protein 2 (Fused in myeloproliferative disorders protein) (Rearranged in atypical myeloproliferative disorder protein) (Zinc finger protein 198) Homo sapiens (Human) GO:0005634; GO:0005829; GO:0008270; GO:0016605; GO:0031624; GO:0045892 negative regulation of DNA-templated transcription [GO:0045892] cytosol [GO:0005829]; nucleus [GO:0005634]; PML body [GO:0016605] ubiquitin conjugating enzyme binding [GO:0031624]; zinc ion binding [GO:0008270] g11503.t1 E7F211 37.134 307 3.59e-49 177.0 sp|E7F211|TTC17_DANRE Tetratricopeptide repeat protein 17 OS=Danio rerio OX=7955 GN=ttc17 PE=3 SV=1 TTC17_DANRE reviewed Tetratricopeptide repeat protein 17 (TPR repeat protein 17) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005737; GO:0005886; GO:0015629; GO:0030041; GO:0044782; GO:0061371 actin filament polymerization [GO:0030041]; cilium organization [GO:0044782]; determination of heart left/right asymmetry [GO:0061371] actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886] g2053.t1 Q9BRZ2 26.786 280 1.4699999999999999e-24 112.0 sp|Q9BRZ2|TRI56_HUMAN E3 ubiquitin-protein ligase TRIM56 OS=Homo sapiens OX=9606 GN=TRIM56 PE=1 SV=3 g2044.t1 E7F211 49.333 150 1.3600000000000001e-31 124.0 sp|E7F211|TTC17_DANRE Tetratricopeptide repeat protein 17 OS=Danio rerio OX=7955 GN=ttc17 PE=3 SV=1 TTC17_DANRE reviewed Tetratricopeptide repeat protein 17 (TPR repeat protein 17) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005737; GO:0005886; GO:0015629; GO:0030041; GO:0044782; GO:0061371 actin filament polymerization [GO:0030041]; cilium organization [GO:0044782]; determination of heart left/right asymmetry [GO:0061371] actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886] g1997.t1 E1BD59 23.784 370 1.29e-25 115.0 sp|E1BD59|TRI56_BOVIN E3 ubiquitin-protein ligase TRIM56 OS=Bos taurus OX=9913 GN=TRIM56 PE=2 SV=1 TRI56_BOVIN reviewed E3 ubiquitin-protein ligase TRIM56 (EC 2.3.2.27) (Tripartite motif-containing protein 56) Bos taurus (Bovine) GO:0005654; GO:0005737; GO:0006513; GO:0008270; GO:0032728; GO:0034340; GO:0045087; GO:0051607; GO:0060340; GO:0061630; GO:0070534 defense response to virus [GO:0051607]; innate immune response [GO:0045087]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of type I interferon-mediated signaling pathway [GO:0060340]; protein K63-linked ubiquitination [GO:0070534]; protein monoubiquitination [GO:0006513]; response to type I interferon [GO:0034340] cytoplasm [GO:0005737]; nucleoplasm [GO:0005654] ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] g11524.t1 Q15485 52.885 208 6.49e-71 222.0 sp|Q15485|FCN2_HUMAN Ficolin-2 OS=Homo sapiens OX=9606 GN=FCN2 PE=1 SV=2 FCN2_HUMAN reviewed Ficolin-2 (37 kDa elastin-binding protein) (EBP-37) (Collagen/fibrinogen domain-containing protein 2) (Ficolin-B) (Ficolin-beta) (Hucolin) (L-ficolin) (Serum lectin p35) Homo sapiens (Human) GO:0001867; GO:0002752; GO:0003823; GO:0005102; GO:0005576; GO:0005581; GO:0005615; GO:0006508; GO:0008228; GO:0009897; GO:0038187; GO:0043394; GO:0043654; GO:0046872; GO:0048306; GO:0050829; GO:0050830; GO:0070062; GO:0070892; GO:0072562; GO:0097367; GO:0106139; GO:1903028; GO:1905370; GO:2001065 cell surface pattern recognition receptor signaling pathway [GO:0002752]; complement activation, lectin pathway [GO:0001867]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; opsonization [GO:0008228]; positive regulation of opsonization [GO:1903028]; proteolysis [GO:0006508]; recognition of apoptotic cell [GO:0043654] blood microparticle [GO:0072562]; collagen trimer [GO:0005581]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; serine-type endopeptidase complex [GO:1905370]; symbiont cell surface [GO:0106139] antigen binding [GO:0003823]; calcium-dependent protein binding [GO:0048306]; carbohydrate derivative binding [GO:0097367]; lipoteichoic acid immune receptor activity [GO:0070892]; mannan binding [GO:2001065]; metal ion binding [GO:0046872]; pattern recognition receptor activity [GO:0038187]; proteoglycan binding [GO:0043394]; signaling receptor binding [GO:0005102] g935.t1 P14381 36.325 234 4.48e-43 159.0 sp|P14381|YTX2_XENLA Transposon TX1 uncharacterized 149 kDa protein OS=Xenopus laevis OX=8355 PE=4 SV=1 g3435.t1 E1BD59 23.873 377 1.6e-26 116.0 sp|E1BD59|TRI56_BOVIN E3 ubiquitin-protein ligase TRIM56 OS=Bos taurus OX=9913 GN=TRIM56 PE=2 SV=1 TRI56_BOVIN reviewed E3 ubiquitin-protein ligase TRIM56 (EC 2.3.2.27) (Tripartite motif-containing protein 56) Bos taurus (Bovine) GO:0005654; GO:0005737; GO:0006513; GO:0008270; GO:0032728; GO:0034340; GO:0045087; GO:0051607; GO:0060340; GO:0061630; GO:0070534 defense response to virus [GO:0051607]; innate immune response [GO:0045087]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of type I interferon-mediated signaling pathway [GO:0060340]; protein K63-linked ubiquitination [GO:0070534]; protein monoubiquitination [GO:0006513]; response to type I interferon [GO:0034340] cytoplasm [GO:0005737]; nucleoplasm [GO:0005654] ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] g23329.t1 Q05004 23.904 456 2.77e-26 117.0 sp|Q05004|NXPE1_RABIT NXPE family member 1 OS=Oryctolagus cuniculus OX=9986 GN=NXPE1 PE=2 SV=1 g9535.t1 Q92889 47.284 313 6.08e-76 254.0 sp|Q92889|XPF_HUMAN DNA repair endonuclease XPF OS=Homo sapiens OX=9606 GN=ERCC4 PE=1 SV=3 g9536.t1 Q92889 48.83 342 3.07e-98 312.0 sp|Q92889|XPF_HUMAN DNA repair endonuclease XPF OS=Homo sapiens OX=9606 GN=ERCC4 PE=1 SV=3 g6375.t1 Q15485 54.271 199 2.1e-66 212.0 sp|Q15485|FCN2_HUMAN Ficolin-2 OS=Homo sapiens OX=9606 GN=FCN2 PE=1 SV=2 FCN2_HUMAN reviewed Ficolin-2 (37 kDa elastin-binding protein) (EBP-37) (Collagen/fibrinogen domain-containing protein 2) (Ficolin-B) (Ficolin-beta) (Hucolin) (L-ficolin) (Serum lectin p35) Homo sapiens (Human) GO:0001867; GO:0002752; GO:0003823; GO:0005102; GO:0005576; GO:0005581; GO:0005615; GO:0006508; GO:0008228; GO:0009897; GO:0038187; GO:0043394; GO:0043654; GO:0046872; GO:0048306; GO:0050829; GO:0050830; GO:0070062; GO:0070892; GO:0072562; GO:0097367; GO:0106139; GO:1903028; GO:1905370; GO:2001065 cell surface pattern recognition receptor signaling pathway [GO:0002752]; complement activation, lectin pathway [GO:0001867]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; opsonization [GO:0008228]; positive regulation of opsonization [GO:1903028]; proteolysis [GO:0006508]; recognition of apoptotic cell [GO:0043654] blood microparticle [GO:0072562]; collagen trimer [GO:0005581]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; serine-type endopeptidase complex [GO:1905370]; symbiont cell surface [GO:0106139] antigen binding [GO:0003823]; calcium-dependent protein binding [GO:0048306]; carbohydrate derivative binding [GO:0097367]; lipoteichoic acid immune receptor activity [GO:0070892]; mannan binding [GO:2001065]; metal ion binding [GO:0046872]; pattern recognition receptor activity [GO:0038187]; proteoglycan binding [GO:0043394]; signaling receptor binding [GO:0005102] g6376.t1 Q15485 56.989 186 2.57e-70 223.0 sp|Q15485|FCN2_HUMAN Ficolin-2 OS=Homo sapiens OX=9606 GN=FCN2 PE=1 SV=2 FCN2_HUMAN reviewed Ficolin-2 (37 kDa elastin-binding protein) (EBP-37) (Collagen/fibrinogen domain-containing protein 2) (Ficolin-B) (Ficolin-beta) (Hucolin) (L-ficolin) (Serum lectin p35) Homo sapiens (Human) GO:0001867; GO:0002752; GO:0003823; GO:0005102; GO:0005576; GO:0005581; GO:0005615; GO:0006508; GO:0008228; GO:0009897; GO:0038187; GO:0043394; GO:0043654; GO:0046872; GO:0048306; GO:0050829; GO:0050830; GO:0070062; GO:0070892; GO:0072562; GO:0097367; GO:0106139; GO:1903028; GO:1905370; GO:2001065 cell surface pattern recognition receptor signaling pathway [GO:0002752]; complement activation, lectin pathway [GO:0001867]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; opsonization [GO:0008228]; positive regulation of opsonization [GO:1903028]; proteolysis [GO:0006508]; recognition of apoptotic cell [GO:0043654] blood microparticle [GO:0072562]; collagen trimer [GO:0005581]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; serine-type endopeptidase complex [GO:1905370]; symbiont cell surface [GO:0106139] antigen binding [GO:0003823]; calcium-dependent protein binding [GO:0048306]; carbohydrate derivative binding [GO:0097367]; lipoteichoic acid immune receptor activity [GO:0070892]; mannan binding [GO:2001065]; metal ion binding [GO:0046872]; pattern recognition receptor activity [GO:0038187]; proteoglycan binding [GO:0043394]; signaling receptor binding [GO:0005102] g6376.t2 Q15485 54.774 199 5.51e-70 218.0 sp|Q15485|FCN2_HUMAN Ficolin-2 OS=Homo sapiens OX=9606 GN=FCN2 PE=1 SV=2 FCN2_HUMAN reviewed Ficolin-2 (37 kDa elastin-binding protein) (EBP-37) (Collagen/fibrinogen domain-containing protein 2) (Ficolin-B) (Ficolin-beta) (Hucolin) (L-ficolin) (Serum lectin p35) Homo sapiens (Human) GO:0001867; GO:0002752; GO:0003823; GO:0005102; GO:0005576; GO:0005581; GO:0005615; GO:0006508; GO:0008228; GO:0009897; GO:0038187; GO:0043394; GO:0043654; GO:0046872; GO:0048306; GO:0050829; GO:0050830; GO:0070062; GO:0070892; GO:0072562; GO:0097367; GO:0106139; GO:1903028; GO:1905370; GO:2001065 cell surface pattern recognition receptor signaling pathway [GO:0002752]; complement activation, lectin pathway [GO:0001867]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; opsonization [GO:0008228]; positive regulation of opsonization [GO:1903028]; proteolysis [GO:0006508]; recognition of apoptotic cell [GO:0043654] blood microparticle [GO:0072562]; collagen trimer [GO:0005581]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; serine-type endopeptidase complex [GO:1905370]; symbiont cell surface [GO:0106139] antigen binding [GO:0003823]; calcium-dependent protein binding [GO:0048306]; carbohydrate derivative binding [GO:0097367]; lipoteichoic acid immune receptor activity [GO:0070892]; mannan binding [GO:2001065]; metal ion binding [GO:0046872]; pattern recognition receptor activity [GO:0038187]; proteoglycan binding [GO:0043394]; signaling receptor binding [GO:0005102] g9567.t1 E1BD59 26.95 282 2.8299999999999997e-24 109.0 sp|E1BD59|TRI56_BOVIN E3 ubiquitin-protein ligase TRIM56 OS=Bos taurus OX=9913 GN=TRIM56 PE=2 SV=1 TRI56_BOVIN reviewed E3 ubiquitin-protein ligase TRIM56 (EC 2.3.2.27) (Tripartite motif-containing protein 56) Bos taurus (Bovine) GO:0005654; GO:0005737; GO:0006513; GO:0008270; GO:0032728; GO:0034340; GO:0045087; GO:0051607; GO:0060340; GO:0061630; GO:0070534 defense response to virus [GO:0051607]; innate immune response [GO:0045087]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of type I interferon-mediated signaling pathway [GO:0060340]; protein K63-linked ubiquitination [GO:0070534]; protein monoubiquitination [GO:0006513]; response to type I interferon [GO:0034340] cytoplasm [GO:0005737]; nucleoplasm [GO:0005654] ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] g7596.t1 Q15262 39.301 229 3.2299999999999997e-46 168.0 sp|Q15262|PTPRK_HUMAN Receptor-type tyrosine-protein phosphatase kappa OS=Homo sapiens OX=9606 GN=PTPRK PE=1 SV=2 PTPRK_HUMAN reviewed Receptor-type tyrosine-protein phosphatase kappa (Protein-tyrosine phosphatase kappa) (R-PTP-kappa) (EC 3.1.3.48) Homo sapiens (Human) GO:0004725; GO:0005001; GO:0005814; GO:0005886; GO:0005911; GO:0005912; GO:0006470; GO:0007155; GO:0007165; GO:0007179; GO:0008013; GO:0008285; GO:0009986; GO:0010839; GO:0016020; GO:0016477; GO:0019901; GO:0030054; GO:0030336; GO:0031175; GO:0031256; GO:0034394; GO:0034614; GO:0034644; GO:0045295; GO:0045786; GO:0045892; GO:0048041; GO:0120212 cell adhesion [GO:0007155]; cell migration [GO:0016477]; cellular response to reactive oxygen species [GO:0034614]; cellular response to UV [GO:0034644]; focal adhesion assembly [GO:0048041]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of keratinocyte proliferation [GO:0010839]; neuron projection development [GO:0031175]; protein dephosphorylation [GO:0006470]; protein localization to cell surface [GO:0034394]; signal transduction [GO:0007165]; transforming growth factor beta receptor signaling pathway [GO:0007179] adherens junction [GO:0005912]; cell junction [GO:0030054]; cell surface [GO:0009986]; cell-cell junction [GO:0005911]; centriole [GO:0005814]; leading edge membrane [GO:0031256]; membrane [GO:0016020]; plasma membrane [GO:0005886]; sperm head-tail coupling apparatus [GO:0120212] beta-catenin binding [GO:0008013]; gamma-catenin binding [GO:0045295]; protein kinase binding [GO:0019901]; protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001] g7596.t1 Q15262 29.73 222 2.9800000000000003e-27 113.0 sp|Q15262|PTPRK_HUMAN Receptor-type tyrosine-protein phosphatase kappa OS=Homo sapiens OX=9606 GN=PTPRK PE=1 SV=2 PTPRK_HUMAN reviewed Receptor-type tyrosine-protein phosphatase kappa (Protein-tyrosine phosphatase kappa) (R-PTP-kappa) (EC 3.1.3.48) Homo sapiens (Human) GO:0004725; GO:0005001; GO:0005814; GO:0005886; GO:0005911; GO:0005912; GO:0006470; GO:0007155; GO:0007165; GO:0007179; GO:0008013; GO:0008285; GO:0009986; GO:0010839; GO:0016020; GO:0016477; GO:0019901; GO:0030054; GO:0030336; GO:0031175; GO:0031256; GO:0034394; GO:0034614; GO:0034644; GO:0045295; GO:0045786; GO:0045892; GO:0048041; GO:0120212 cell adhesion [GO:0007155]; cell migration [GO:0016477]; cellular response to reactive oxygen species [GO:0034614]; cellular response to UV [GO:0034644]; focal adhesion assembly [GO:0048041]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of keratinocyte proliferation [GO:0010839]; neuron projection development [GO:0031175]; protein dephosphorylation [GO:0006470]; protein localization to cell surface [GO:0034394]; signal transduction [GO:0007165]; transforming growth factor beta receptor signaling pathway [GO:0007179] adherens junction [GO:0005912]; cell junction [GO:0030054]; cell surface [GO:0009986]; cell-cell junction [GO:0005911]; centriole [GO:0005814]; leading edge membrane [GO:0031256]; membrane [GO:0016020]; plasma membrane [GO:0005886]; sperm head-tail coupling apparatus [GO:0120212] beta-catenin binding [GO:0008013]; gamma-catenin binding [GO:0045295]; protein kinase binding [GO:0019901]; protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001] g11554.t1 Q7SZN0 37.019 208 3.05e-30 123.0 sp|Q7SZN0|FA5V_PSETE Venom prothrombin activator pseutarin-C non-catalytic subunit OS=Pseudonaja textilis OX=8673 PE=1 SV=1 FA5V_PSETE reviewed Venom prothrombin activator pseutarin-C non-catalytic subunit (PCNS) (vPA) (Venom coagulation factor Va-like protein) [Cleaved into: Pseutarin-C non-catalytic subunit heavy chain; Pseutarin-C non-catalytic subunit light chain] Pseudonaja textilis (Eastern brown snake) GO:0005507; GO:0005576; GO:0005886; GO:0016504; GO:0032991; GO:0038023; GO:0044469; GO:0090729 venom-mediated blood coagulation [GO:0044469] extracellular region [GO:0005576]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] copper ion binding [GO:0005507]; peptidase activator activity [GO:0016504]; signaling receptor activity [GO:0038023]; toxin activity [GO:0090729] g8290.t1 Q2M1K9 30.677 251 2.0500000000000003e-21 97.4 sp|Q2M1K9|ZN423_HUMAN Zinc finger protein 423 OS=Homo sapiens OX=9606 GN=ZNF423 PE=1 SV=1 ZN423_HUMAN reviewed Zinc finger protein 423 (Olf1/EBF-associated zinc finger protein) (hOAZ) (Smad- and Olf-interacting zinc finger protein) Homo sapiens (Human) GO:0000978; GO:0000981; GO:0005634; GO:0005654; GO:0006355; GO:0007219; GO:0007399; GO:0008270; GO:0030154; GO:0030513; GO:0043565; GO:0045892; GO:0045893; GO:0061512; GO:0120163 cell differentiation [GO:0030154]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of DNA-templated transcription [GO:0045892]; nervous system development [GO:0007399]; Notch signaling pathway [GO:0007219]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of DNA-templated transcription [GO:0045893]; protein localization to cilium [GO:0061512]; regulation of DNA-templated transcription [GO:0006355] nucleoplasm [GO:0005654]; nucleus [GO:0005634] DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270] g8290.t2 O08961 33.908 522 3.2100000000000004e-73 263.0 sp|O08961|ZN423_RAT Zinc finger protein 423 OS=Rattus norvegicus OX=10116 GN=Znf423 PE=1 SV=2 g9517.t1 P16423 26.99 578 6.59e-44 177.0 sp|P16423|POLR_DROME Retrovirus-related Pol polyprotein from type-2 retrotransposable element R2DM OS=Drosophila melanogaster OX=7227 GN=pol PE=4 SV=1 g8280.t1 E1BD59 25.649 308 7.14e-26 116.0 sp|E1BD59|TRI56_BOVIN E3 ubiquitin-protein ligase TRIM56 OS=Bos taurus OX=9913 GN=TRIM56 PE=2 SV=1 TRI56_BOVIN reviewed E3 ubiquitin-protein ligase TRIM56 (EC 2.3.2.27) (Tripartite motif-containing protein 56) Bos taurus (Bovine) GO:0005654; GO:0005737; GO:0006513; GO:0008270; GO:0032728; GO:0034340; GO:0045087; GO:0051607; GO:0060340; GO:0061630; GO:0070534 defense response to virus [GO:0051607]; innate immune response [GO:0045087]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of type I interferon-mediated signaling pathway [GO:0060340]; protein K63-linked ubiquitination [GO:0070534]; protein monoubiquitination [GO:0006513]; response to type I interferon [GO:0034340] cytoplasm [GO:0005737]; nucleoplasm [GO:0005654] ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] g2011.t1 Q92889 70.395 152 6.35e-69 228.0 sp|Q92889|XPF_HUMAN DNA repair endonuclease XPF OS=Homo sapiens OX=9606 GN=ERCC4 PE=1 SV=3 g9528.t1 A0NLY7 31.754 211 1.0399999999999998e-23 100.0 sp|A0NLY7|ISAHY_ROSAI Isatin hydrolase OS=Roseibium aggregatum (strain ATCC 25650 / DSM 13394 / JCM 20685 / NBRC 16684 / NCIMB 2208 / IAM 12614 / B1) OX=384765 GN=SIAM614_09648 PE=1 SV=1 ISAHY_ROSAI reviewed Isatin hydrolase (EC 3.5.2.20) (Isatin amidohydrolase) (Isatin hydrolase isoform b) (IH-b) Roseibium aggregatum (strain ATCC 25650 / DSM 13394 / JCM 20685 / NBRC 16684 / NCIMB 2208 / IAM 12614 / B1) (Stappia aggregata) GO:0004061; GO:0016812; GO:0019441; GO:0030145 L-tryptophan catabolic process to kynurenine [GO:0019441] arylformamidase activity [GO:0004061]; hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides [GO:0016812]; manganese ion binding [GO:0030145] g9529.t1 A0NLY7 32.5 200 6.649999999999999e-24 99.4 sp|A0NLY7|ISAHY_ROSAI Isatin hydrolase OS=Roseibium aggregatum (strain ATCC 25650 / DSM 13394 / JCM 20685 / NBRC 16684 / NCIMB 2208 / IAM 12614 / B1) OX=384765 GN=SIAM614_09648 PE=1 SV=1 ISAHY_ROSAI reviewed Isatin hydrolase (EC 3.5.2.20) (Isatin amidohydrolase) (Isatin hydrolase isoform b) (IH-b) Roseibium aggregatum (strain ATCC 25650 / DSM 13394 / JCM 20685 / NBRC 16684 / NCIMB 2208 / IAM 12614 / B1) (Stappia aggregata) GO:0004061; GO:0016812; GO:0019441; GO:0030145 L-tryptophan catabolic process to kynurenine [GO:0019441] arylformamidase activity [GO:0004061]; hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides [GO:0016812]; manganese ion binding [GO:0030145] g10368.t1 E1BD59 24.734 376 4.12e-28 124.0 sp|E1BD59|TRI56_BOVIN E3 ubiquitin-protein ligase TRIM56 OS=Bos taurus OX=9913 GN=TRIM56 PE=2 SV=1 TRI56_BOVIN reviewed E3 ubiquitin-protein ligase TRIM56 (EC 2.3.2.27) (Tripartite motif-containing protein 56) Bos taurus (Bovine) GO:0005654; GO:0005737; GO:0006513; GO:0008270; GO:0032728; GO:0034340; GO:0045087; GO:0051607; GO:0060340; GO:0061630; GO:0070534 defense response to virus [GO:0051607]; innate immune response [GO:0045087]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of type I interferon-mediated signaling pathway [GO:0060340]; protein K63-linked ubiquitination [GO:0070534]; protein monoubiquitination [GO:0006513]; response to type I interferon [GO:0034340] cytoplasm [GO:0005737]; nucleoplasm [GO:0005654] ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] g16292.t1 Q04202 37.544 285 1.54e-54 181.0 sp|Q04202|TCB2_CAEBR Transposable element Tcb2 transposase OS=Caenorhabditis briggsae OX=6238 PE=3 SV=1 g10349.t1 Q06807 38.182 385 1.41e-80 271.0 sp|Q06807|TIE2_BOVIN Angiopoietin-1 receptor OS=Bos taurus OX=9913 GN=TEK PE=2 SV=1 TIE2_BOVIN reviewed Angiopoietin-1 receptor (EC 2.7.10.1) (Endothelial tyrosine kinase) (Tyrosine kinase with Ig and EGF homology domains-2) (Tyrosine-protein kinase receptor TIE-2) (CD antigen CD202b) Bos taurus (Bovine) GO:0001525; GO:0001935; GO:0001936; GO:0002040; GO:0004714; GO:0005524; GO:0005576; GO:0005856; GO:0005886; GO:0005925; GO:0007169; GO:0007507; GO:0010595; GO:0016525; GO:0030097; GO:0032878; GO:0034446; GO:0043235; GO:0043410; GO:0045766; GO:0048014; GO:0051894; GO:0051897; GO:0060347; GO:0070374; GO:1902533; GO:2000352 angiogenesis [GO:0001525]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; endothelial cell proliferation [GO:0001935]; heart development [GO:0007507]; heart trabecula formation [GO:0060347]; hemopoiesis [GO:0030097]; negative regulation of angiogenesis [GO:0016525]; negative regulation of endothelial cell apoptotic process [GO:2000352]; positive regulation of angiogenesis [GO:0045766]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of intracellular signal transduction [GO:1902533]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; regulation of endothelial cell proliferation [GO:0001936]; regulation of establishment or maintenance of cell polarity [GO:0032878]; sprouting angiogenesis [GO:0002040]; substrate adhesion-dependent cell spreading [GO:0034446]; Tie signaling pathway [GO:0048014] cytoskeleton [GO:0005856]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] ATP binding [GO:0005524]; transmembrane receptor protein tyrosine kinase activity [GO:0004714] g929.t1 Q92889 76.364 55 3.33e-21 90.1 sp|Q92889|XPF_HUMAN DNA repair endonuclease XPF OS=Homo sapiens OX=9606 GN=ERCC4 PE=1 SV=3 g10362.t1 Q2M1K9 32.644 919 1.32e-130 431.0 sp|Q2M1K9|ZN423_HUMAN Zinc finger protein 423 OS=Homo sapiens OX=9606 GN=ZNF423 PE=1 SV=1 ZN423_HUMAN reviewed Zinc finger protein 423 (Olf1/EBF-associated zinc finger protein) (hOAZ) (Smad- and Olf-interacting zinc finger protein) Homo sapiens (Human) GO:0000978; GO:0000981; GO:0005634; GO:0005654; GO:0006355; GO:0007219; GO:0007399; GO:0008270; GO:0030154; GO:0030513; GO:0043565; GO:0045892; GO:0045893; GO:0061512; GO:0120163 cell differentiation [GO:0030154]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of DNA-templated transcription [GO:0045892]; nervous system development [GO:0007399]; Notch signaling pathway [GO:0007219]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of DNA-templated transcription [GO:0045893]; protein localization to cilium [GO:0061512]; regulation of DNA-templated transcription [GO:0006355] nucleoplasm [GO:0005654]; nucleus [GO:0005634] DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270] g11506.t1 Q96DM1 29.975 407 2.27e-40 158.0 sp|Q96DM1|PGBD4_HUMAN PiggyBac transposable element-derived protein 4 OS=Homo sapiens OX=9606 GN=PGBD4 PE=1 SV=3 g14494.t1 Q96DM1 25.476 420 6.990000000000001e-35 143.0 sp|Q96DM1|PGBD4_HUMAN PiggyBac transposable element-derived protein 4 OS=Homo sapiens OX=9606 GN=PGBD4 PE=1 SV=3 g2003.t1 M9PH32 24.234 359 2.22e-26 119.0 sp|M9PH32|MEI26_DROME Protein meiotic P26 OS=Drosophila melanogaster OX=7227 GN=mei-P26 PE=1 SV=1 MEI26_DROME reviewed Protein meiotic P26 Drosophila melanogaster (Fruit fly) GO:0004842; GO:0005737; GO:0008270; GO:0016567; GO:0036464 protein ubiquitination [GO:0016567] cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464] ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] g9531.t1 Q767L8 43.925 214 8.37e-49 178.0 sp|Q767L8|MDC1_PIG Mediator of DNA damage checkpoint protein 1 OS=Sus scrofa OX=9823 GN=MDC1 PE=3 SV=1 g9532.t1 Q15485 52.404 208 4.9900000000000004e-70 219.0 sp|Q15485|FCN2_HUMAN Ficolin-2 OS=Homo sapiens OX=9606 GN=FCN2 PE=1 SV=2 FCN2_HUMAN reviewed Ficolin-2 (37 kDa elastin-binding protein) (EBP-37) (Collagen/fibrinogen domain-containing protein 2) (Ficolin-B) (Ficolin-beta) (Hucolin) (L-ficolin) (Serum lectin p35) Homo sapiens (Human) GO:0001867; GO:0002752; GO:0003823; GO:0005102; GO:0005576; GO:0005581; GO:0005615; GO:0006508; GO:0008228; GO:0009897; GO:0038187; GO:0043394; GO:0043654; GO:0046872; GO:0048306; GO:0050829; GO:0050830; GO:0070062; GO:0070892; GO:0072562; GO:0097367; GO:0106139; GO:1903028; GO:1905370; GO:2001065 cell surface pattern recognition receptor signaling pathway [GO:0002752]; complement activation, lectin pathway [GO:0001867]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; opsonization [GO:0008228]; positive regulation of opsonization [GO:1903028]; proteolysis [GO:0006508]; recognition of apoptotic cell [GO:0043654] blood microparticle [GO:0072562]; collagen trimer [GO:0005581]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; serine-type endopeptidase complex [GO:1905370]; symbiont cell surface [GO:0106139] antigen binding [GO:0003823]; calcium-dependent protein binding [GO:0048306]; carbohydrate derivative binding [GO:0097367]; lipoteichoic acid immune receptor activity [GO:0070892]; mannan binding [GO:2001065]; metal ion binding [GO:0046872]; pattern recognition receptor activity [GO:0038187]; proteoglycan binding [GO:0043394]; signaling receptor binding [GO:0005102] g2038.t1 Q92889 54.577 284 2.53e-106 334.0 sp|Q92889|XPF_HUMAN DNA repair endonuclease XPF OS=Homo sapiens OX=9606 GN=ERCC4 PE=1 SV=3 g18844.t1 E1BD59 24.468 376 1.07e-27 122.0 sp|E1BD59|TRI56_BOVIN E3 ubiquitin-protein ligase TRIM56 OS=Bos taurus OX=9913 GN=TRIM56 PE=2 SV=1 TRI56_BOVIN reviewed E3 ubiquitin-protein ligase TRIM56 (EC 2.3.2.27) (Tripartite motif-containing protein 56) Bos taurus (Bovine) GO:0005654; GO:0005737; GO:0006513; GO:0008270; GO:0032728; GO:0034340; GO:0045087; GO:0051607; GO:0060340; GO:0061630; GO:0070534 defense response to virus [GO:0051607]; innate immune response [GO:0045087]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of type I interferon-mediated signaling pathway [GO:0060340]; protein K63-linked ubiquitination [GO:0070534]; protein monoubiquitination [GO:0006513]; response to type I interferon [GO:0034340] cytoplasm [GO:0005737]; nucleoplasm [GO:0005654] ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] g21597.t1 Q9NXP7 33.562 146 1.7400000000000003e-21 100.0 sp|Q9NXP7|GIN1_HUMAN Gypsy retrotransposon integrase-like protein 1 OS=Homo sapiens OX=9606 GN=GIN1 PE=1 SV=3 g16316.t1 Q9H5L6 28.709 519 2.36e-47 180.0 sp|Q9H5L6|THAP9_HUMAN DNA transposase THAP9 OS=Homo sapiens OX=9606 GN=THAP9 PE=1 SV=2 g3441.t1 Q498E6 44.444 126 1.04e-22 100.0 sp|Q498E6|KT5AB_XENLA N-lysine methyltransferase KMT5A-B OS=Xenopus laevis OX=8355 GN=kmt5a-b PE=1 SV=1 KT5AB_XENLA reviewed N-lysine methyltransferase KMT5A-B (EC 2.1.1.-) (Histone-lysine N-methyltransferase KMT5A-B) (EC 2.1.1.361) (Lysine-specific methylase 5A-B) (Mitotic phosphoprotein 36) (SET domain-containing protein 8-B) Xenopus laevis (African clawed frog) GO:0005634; GO:0005700; GO:0006357; GO:0032259; GO:0042054; GO:0042799; GO:0043516; GO:0051301; GO:0140944 cell division [GO:0051301]; methylation [GO:0032259]; regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043516]; regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634]; polytene chromosome [GO:0005700] histone H4K20 methyltransferase activity [GO:0042799]; histone H4K20 monomethyltransferase activity [GO:0140944]; histone methyltransferase activity [GO:0042054] g3442.t1 P91685 29.358 436 3.4199999999999996e-48 179.0 sp|P91685|GRM_DROME Metabotropic glutamate receptor OS=Drosophila melanogaster OX=7227 GN=mGluR PE=1 SV=2 GRM_DROME reviewed Metabotropic glutamate receptor (DmGluRA) Drosophila melanogaster (Fruit fly) GO:0001641; GO:0004930; GO:0005886; GO:0007216; GO:0007528; GO:0007612; GO:0007614; GO:0007616; GO:0008049; GO:0008066; GO:0015485; GO:0016020; GO:0016595; GO:0038038; GO:0045121; GO:0051966; GO:0072553 G protein-coupled glutamate receptor signaling pathway [GO:0007216]; learning [GO:0007612]; long-term memory [GO:0007616]; male courtship behavior [GO:0008049]; neuromuscular junction development [GO:0007528]; regulation of synaptic transmission, glutamatergic [GO:0051966]; short-term memory [GO:0007614]; terminal button organization [GO:0072553] G protein-coupled receptor homodimeric complex [GO:0038038]; membrane [GO:0016020]; membrane raft [GO:0045121]; plasma membrane [GO:0005886] cholesterol binding [GO:0015485]; G protein-coupled receptor activity [GO:0004930]; glutamate binding [GO:0016595]; glutamate receptor activity [GO:0008066]; group II metabotropic glutamate receptor activity [GO:0001641] g2001.t1 Q86WI1 41.659 1109 0.0 822.0 sp|Q86WI1|PKHL1_HUMAN Fibrocystin-L OS=Homo sapiens OX=9606 GN=PKHD1L1 PE=1 SV=2 PKHL1_HUMAN reviewed Fibrocystin-L (Polycystic kidney and hepatic disease 1-like protein 1) (PKHD1-like protein 1) Homo sapiens (Human) GO:0005615; GO:0005829; GO:0006955; GO:0007605; GO:0016020; GO:0032426; GO:0038023; GO:0060171; GO:0120234 immune response [GO:0006955]; sensory perception of sound [GO:0007605] cytosol [GO:0005829]; extracellular space [GO:0005615]; membrane [GO:0016020]; stereocilium coat [GO:0120234]; stereocilium membrane [GO:0060171]; stereocilium tip [GO:0032426] signaling receptor activity [GO:0038023] g2001.t1 Q86WI1 29.577 355 1.03e-23 114.0 sp|Q86WI1|PKHL1_HUMAN Fibrocystin-L OS=Homo sapiens OX=9606 GN=PKHD1L1 PE=1 SV=2 PKHL1_HUMAN reviewed Fibrocystin-L (Polycystic kidney and hepatic disease 1-like protein 1) (PKHD1-like protein 1) Homo sapiens (Human) GO:0005615; GO:0005829; GO:0006955; GO:0007605; GO:0016020; GO:0032426; GO:0038023; GO:0060171; GO:0120234 immune response [GO:0006955]; sensory perception of sound [GO:0007605] cytosol [GO:0005829]; extracellular space [GO:0005615]; membrane [GO:0016020]; stereocilium coat [GO:0120234]; stereocilium membrane [GO:0060171]; stereocilium tip [GO:0032426] signaling receptor activity [GO:0038023] g3434.t1 O35474 33.333 339 2.1e-34 138.0 sp|O35474|EDIL3_MOUSE EGF-like repeat and discoidin I-like domain-containing protein 3 OS=Mus musculus OX=10090 GN=Edil3 PE=1 SV=2 g16317.t1 Q9ULL4 33.548 775 2.3200000000000002e-117 393.0 sp|Q9ULL4|PLXB3_HUMAN Plexin-B3 OS=Homo sapiens OX=9606 GN=PLXNB3 PE=1 SV=2 PLXB3_HUMAN reviewed Plexin-B3 Homo sapiens (Human) GO:0001938; GO:0002116; GO:0005886; GO:0007156; GO:0007162; GO:0007416; GO:0008360; GO:0009986; GO:0010593; GO:0010976; GO:0017154; GO:0019904; GO:0030336; GO:0034260; GO:0050772; GO:0050918; GO:0051022; GO:0060326; GO:0071526; GO:0098632 cell chemotaxis [GO:0060326]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell adhesion [GO:0007162]; negative regulation of cell migration [GO:0030336]; negative regulation of GTPase activity [GO:0034260]; negative regulation of lamellipodium assembly [GO:0010593]; positive chemotaxis [GO:0050918]; positive regulation of axonogenesis [GO:0050772]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of neuron projection development [GO:0010976]; regulation of cell shape [GO:0008360]; semaphorin-plexin signaling pathway [GO:0071526]; synapse assembly [GO:0007416] cell surface [GO:0009986]; plasma membrane [GO:0005886]; semaphorin receptor complex [GO:0002116] cell-cell adhesion mediator activity [GO:0098632]; protein domain specific binding [GO:0019904]; Rho GDP-dissociation inhibitor binding [GO:0051022]; semaphorin receptor activity [GO:0017154] g16317.t2 Q9ULL4 33.419 778 6.78e-117 392.0 sp|Q9ULL4|PLXB3_HUMAN Plexin-B3 OS=Homo sapiens OX=9606 GN=PLXNB3 PE=1 SV=2 PLXB3_HUMAN reviewed Plexin-B3 Homo sapiens (Human) GO:0001938; GO:0002116; GO:0005886; GO:0007156; GO:0007162; GO:0007416; GO:0008360; GO:0009986; GO:0010593; GO:0010976; GO:0017154; GO:0019904; GO:0030336; GO:0034260; GO:0050772; GO:0050918; GO:0051022; GO:0060326; GO:0071526; GO:0098632 cell chemotaxis [GO:0060326]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell adhesion [GO:0007162]; negative regulation of cell migration [GO:0030336]; negative regulation of GTPase activity [GO:0034260]; negative regulation of lamellipodium assembly [GO:0010593]; positive chemotaxis [GO:0050918]; positive regulation of axonogenesis [GO:0050772]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of neuron projection development [GO:0010976]; regulation of cell shape [GO:0008360]; semaphorin-plexin signaling pathway [GO:0071526]; synapse assembly [GO:0007416] cell surface [GO:0009986]; plasma membrane [GO:0005886]; semaphorin receptor complex [GO:0002116] cell-cell adhesion mediator activity [GO:0098632]; protein domain specific binding [GO:0019904]; Rho GDP-dissociation inhibitor binding [GO:0051022]; semaphorin receptor activity [GO:0017154] g16318.t1 Q9HCM2 28.053 524 1.79e-46 178.0 sp|Q9HCM2|PLXA4_HUMAN Plexin-A4 OS=Homo sapiens OX=9606 GN=PLXNA4 PE=1 SV=4 PLXA4_HUMAN reviewed Plexin-A4 Homo sapiens (Human) GO:0002116; GO:0005886; GO:0007411; GO:0007416; GO:0008045; GO:0017154; GO:0021612; GO:0021615; GO:0021637; GO:0021644; GO:0021784; GO:0021785; GO:0021793; GO:0021960; GO:0030334; GO:0035050; GO:0048485; GO:0048841; GO:0050923; GO:0071526; GO:0097492; GO:0099558; GO:0150053 anterior commissure morphogenesis [GO:0021960]; axon guidance [GO:0007411]; branchiomotor neuron axon guidance [GO:0021785]; chemorepulsion of branchiomotor axon [GO:0021793]; embryonic heart tube development [GO:0035050]; facial nerve structural organization [GO:0021612]; glossopharyngeal nerve morphogenesis [GO:0021615]; maintenance of synapse structure [GO:0099558]; motor neuron axon guidance [GO:0008045]; postganglionic parasympathetic fiber development [GO:0021784]; regulation of axon extension involved in axon guidance [GO:0048841]; regulation of cell migration [GO:0030334]; regulation of negative chemotaxis [GO:0050923]; semaphorin-plexin signaling pathway [GO:0071526]; sympathetic nervous system development [GO:0048485]; sympathetic neuron axon guidance [GO:0097492]; synapse assembly [GO:0007416]; trigeminal nerve structural organization [GO:0021637]; vagus nerve morphogenesis [GO:0021644] cerebellar climbing fiber to Purkinje cell synapse [GO:0150053]; plasma membrane [GO:0005886]; semaphorin receptor complex [GO:0002116] semaphorin receptor activity [GO:0017154] g8301.t1 P51805 29.602 402 2.1500000000000001e-47 177.0 sp|P51805|PLXA3_HUMAN Plexin-A3 OS=Homo sapiens OX=9606 GN=PLXNA3 PE=1 SV=3 PLXA3_HUMAN reviewed Plexin-A3 (Plexin-4) (Semaphorin receptor SEX) Homo sapiens (Human) GO:0002116; GO:0005886; GO:0007411; GO:0007416; GO:0008045; GO:0017154; GO:0021612; GO:0021628; GO:0021637; GO:0021766; GO:0021785; GO:0021828; GO:0021860; GO:0030334; GO:0048843; GO:0048846; GO:0050919; GO:0051495; GO:0071526; GO:0097485 axon extension involved in axon guidance [GO:0048846]; axon guidance [GO:0007411]; branchiomotor neuron axon guidance [GO:0021785]; facial nerve structural organization [GO:0021612]; gonadotrophin-releasing hormone neuronal migration to the hypothalamus [GO:0021828]; hippocampus development [GO:0021766]; motor neuron axon guidance [GO:0008045]; negative chemotaxis [GO:0050919]; negative regulation of axon extension involved in axon guidance [GO:0048843]; neuron projection guidance [GO:0097485]; olfactory nerve formation [GO:0021628]; positive regulation of cytoskeleton organization [GO:0051495]; pyramidal neuron development [GO:0021860]; regulation of cell migration [GO:0030334]; semaphorin-plexin signaling pathway [GO:0071526]; synapse assembly [GO:0007416]; trigeminal nerve structural organization [GO:0021637] plasma membrane [GO:0005886]; semaphorin receptor complex [GO:0002116] semaphorin receptor activity [GO:0017154] g9468.t1 P18910 75.472 53 7.09e-22 89.4 sp|P18910|ANPRA_RAT Atrial natriuretic peptide receptor 1 OS=Rattus norvegicus OX=10116 GN=Npr1 PE=1 SV=1 ANPRA_RAT reviewed Atrial natriuretic peptide receptor 1 (EC 4.6.1.2) (Atrial natriuretic peptide receptor type A) (ANP-A) (ANPR-A) (NPR-A) (Guanylate cyclase A) (GC-A) Rattus norvegicus (Rat) GO:0001653; GO:0004383; GO:0004672; GO:0005524; GO:0005525; GO:0005886; GO:0006182; GO:0007166; GO:0007168; GO:0008217; GO:0010753; GO:0016941; GO:0017046; GO:0019934; GO:0035556; GO:0042417; GO:0042562; GO:0043114; GO:0043235; GO:0048662; GO:0097746; GO:1990620 blood vessel diameter maintenance [GO:0097746]; cell surface receptor signaling pathway [GO:0007166]; cGMP biosynthetic process [GO:0006182]; cGMP-mediated signaling [GO:0019934]; dopamine metabolic process [GO:0042417]; intracellular signal transduction [GO:0035556]; negative regulation of smooth muscle cell proliferation [GO:0048662]; positive regulation of cGMP-mediated signaling [GO:0010753]; receptor guanylyl cyclase signaling pathway [GO:0007168]; regulation of blood pressure [GO:0008217]; regulation of vascular permeability [GO:0043114] ANPR-A receptor complex [GO:1990620]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] ATP binding [GO:0005524]; GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; hormone binding [GO:0042562]; natriuretic peptide receptor activity [GO:0016941]; peptide hormone binding [GO:0017046]; peptide receptor activity [GO:0001653]; protein kinase activity [GO:0004672] g9469.t1 P18910 42.618 657 3.03e-165 503.0 sp|P18910|ANPRA_RAT Atrial natriuretic peptide receptor 1 OS=Rattus norvegicus OX=10116 GN=Npr1 PE=1 SV=1 ANPRA_RAT reviewed Atrial natriuretic peptide receptor 1 (EC 4.6.1.2) (Atrial natriuretic peptide receptor type A) (ANP-A) (ANPR-A) (NPR-A) (Guanylate cyclase A) (GC-A) Rattus norvegicus (Rat) GO:0001653; GO:0004383; GO:0004672; GO:0005524; GO:0005525; GO:0005886; GO:0006182; GO:0007166; GO:0007168; GO:0008217; GO:0010753; GO:0016941; GO:0017046; GO:0019934; GO:0035556; GO:0042417; GO:0042562; GO:0043114; GO:0043235; GO:0048662; GO:0097746; GO:1990620 blood vessel diameter maintenance [GO:0097746]; cell surface receptor signaling pathway [GO:0007166]; cGMP biosynthetic process [GO:0006182]; cGMP-mediated signaling [GO:0019934]; dopamine metabolic process [GO:0042417]; intracellular signal transduction [GO:0035556]; negative regulation of smooth muscle cell proliferation [GO:0048662]; positive regulation of cGMP-mediated signaling [GO:0010753]; receptor guanylyl cyclase signaling pathway [GO:0007168]; regulation of blood pressure [GO:0008217]; regulation of vascular permeability [GO:0043114] ANPR-A receptor complex [GO:1990620]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] ATP binding [GO:0005524]; GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; hormone binding [GO:0042562]; natriuretic peptide receptor activity [GO:0016941]; peptide hormone binding [GO:0017046]; peptide receptor activity [GO:0001653]; protein kinase activity [GO:0004672] g23308.t1 O08856 46.226 106 8.240000000000001e-22 100.0 sp|O08856|ELL_MOUSE RNA polymerase II elongation factor ELL OS=Mus musculus OX=10090 GN=Ell PE=2 SV=2 g23309.t1 P55199 34.518 197 6.27e-23 99.4 sp|P55199|ELL_HUMAN RNA polymerase II elongation factor ELL OS=Homo sapiens OX=9606 GN=ELL PE=1 SV=1 ELL_HUMAN reviewed RNA polymerase II elongation factor ELL (Eleven-nineteen lysine-rich leukemia protein) Homo sapiens (Human) GO:0000791; GO:0000987; GO:0001701; GO:0005654; GO:0005829; GO:0006368; GO:0008023; GO:0015030; GO:0016604; GO:0016607; GO:0019902; GO:0032786; GO:0032968; GO:0035363; GO:0042795; GO:0042796; GO:0045945 in utero embryonic development [GO:0001701]; positive regulation of DNA-templated transcription, elongation [GO:0032786]; positive regulation of transcription by RNA polymerase III [GO:0045945]; positive regulation of transcription elongation by RNA polymerase II [GO:0032968]; snRNA transcription by RNA polymerase II [GO:0042795]; snRNA transcription by RNA polymerase III [GO:0042796]; transcription elongation by RNA polymerase II [GO:0006368] Cajal body [GO:0015030]; cytosol [GO:0005829]; euchromatin [GO:0000791]; histone locus body [GO:0035363]; nuclear body [GO:0016604]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; transcription elongation factor complex [GO:0008023] cis-regulatory region sequence-specific DNA binding [GO:0000987]; phosphatase binding [GO:0019902] g11511.t1 Q9NYV6 50.538 186 4.3399999999999996e-61 205.0 sp|Q9NYV6|RRN3_HUMAN RNA polymerase I-specific transcription initiation factor RRN3 OS=Homo sapiens OX=9606 GN=RRN3 PE=1 SV=1 RRN3_HUMAN reviewed RNA polymerase I-specific transcription initiation factor RRN3 (Transcription initiation factor IA) (TIF-IA) Homo sapiens (Human) GO:0001042; GO:0001164; GO:0001181; GO:0001701; GO:0005634; GO:0005654; GO:0005730; GO:0006361; GO:0007000; GO:0007028; GO:0042254; GO:0045893; GO:0048144; GO:0048872; GO:0072332; GO:1902254; GO:2000142 cytoplasm organization [GO:0007028]; fibroblast proliferation [GO:0048144]; homeostasis of number of cells [GO:0048872]; in utero embryonic development [GO:0001701]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator [GO:1902254]; nucleolus organization [GO:0007000]; positive regulation of DNA-templated transcription [GO:0045893]; regulation of DNA-templated transcription initiation [GO:2000142]; ribosome biogenesis [GO:0042254]; transcription initiation at RNA polymerase I promoter [GO:0006361] nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] RNA polymerase I core binding [GO:0001042]; RNA polymerase I core promoter sequence-specific DNA binding [GO:0001164]; RNA polymerase I general transcription initiation factor activity [GO:0001181] g2041.t1 Q15485 59.677 186 3.1e-75 236.0 sp|Q15485|FCN2_HUMAN Ficolin-2 OS=Homo sapiens OX=9606 GN=FCN2 PE=1 SV=2 FCN2_HUMAN reviewed Ficolin-2 (37 kDa elastin-binding protein) (EBP-37) (Collagen/fibrinogen domain-containing protein 2) (Ficolin-B) (Ficolin-beta) (Hucolin) (L-ficolin) (Serum lectin p35) Homo sapiens (Human) GO:0001867; GO:0002752; GO:0003823; GO:0005102; GO:0005576; GO:0005581; GO:0005615; GO:0006508; GO:0008228; GO:0009897; GO:0038187; GO:0043394; GO:0043654; GO:0046872; GO:0048306; GO:0050829; GO:0050830; GO:0070062; GO:0070892; GO:0072562; GO:0097367; GO:0106139; GO:1903028; GO:1905370; GO:2001065 cell surface pattern recognition receptor signaling pathway [GO:0002752]; complement activation, lectin pathway [GO:0001867]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; opsonization [GO:0008228]; positive regulation of opsonization [GO:1903028]; proteolysis [GO:0006508]; recognition of apoptotic cell [GO:0043654] blood microparticle [GO:0072562]; collagen trimer [GO:0005581]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; serine-type endopeptidase complex [GO:1905370]; symbiont cell surface [GO:0106139] antigen binding [GO:0003823]; calcium-dependent protein binding [GO:0048306]; carbohydrate derivative binding [GO:0097367]; lipoteichoic acid immune receptor activity [GO:0070892]; mannan binding [GO:2001065]; metal ion binding [GO:0046872]; pattern recognition receptor activity [GO:0038187]; proteoglycan binding [GO:0043394]; signaling receptor binding [GO:0005102] g2041.t2 Q0P4P2 36.749 283 1.52e-51 181.0 sp|Q0P4P2|FBCD1_XENTR Fibrinogen C domain-containing protein 1 OS=Xenopus tropicalis OX=8364 GN=fibcd1 PE=2 SV=1 g2042.t1 Q5TM68 40.31 129 3.63e-25 103.0 sp|Q5TM68|MDC1_MACMU Mediator of DNA damage checkpoint protein 1 OS=Macaca mulatta OX=9544 GN=MDC1 PE=3 SV=1 g9482.t1 P15919 32.335 334 1.75e-45 170.0 sp|P15919|RAG1_MOUSE V(D)J recombination-activating protein 1 OS=Mus musculus OX=10090 GN=Rag1 PE=1 SV=2 RAG1_MOUSE reviewed V(D)J recombination-activating protein 1 (RAG-1) [Includes: Endonuclease RAG1 (EC 3.1.-.-); E3 ubiquitin-protein ligase RAG1 (EC 2.3.2.27) (RING-type E3 ubiquitin transferase RAG1)] Mus musculus (Mouse) GO:0002250; GO:0002331; GO:0004519; GO:0004842; GO:0005634; GO:0005654; GO:0006310; GO:0006325; GO:0008270; GO:0008542; GO:0016787; GO:0030183; GO:0033077; GO:0033151; GO:0042393; GO:0042802; GO:0042803; GO:0043029; GO:0043565; GO:0045580; GO:0045582; GO:0046872; GO:0048538; GO:0051865; GO:0061630; GO:0070233; GO:0070244; GO:0097519; GO:1905347; GO:2000822 adaptive immune response [GO:0002250]; B cell differentiation [GO:0030183]; chromatin organization [GO:0006325]; DNA recombination [GO:0006310]; negative regulation of T cell apoptotic process [GO:0070233]; negative regulation of thymocyte apoptotic process [GO:0070244]; positive regulation of T cell differentiation [GO:0045582]; pre-B cell allelic exclusion [GO:0002331]; protein autoubiquitination [GO:0051865]; regulation of behavioral fear response [GO:2000822]; regulation of T cell differentiation [GO:0045580]; T cell differentiation in thymus [GO:0033077]; T cell homeostasis [GO:0043029]; thymus development [GO:0048538]; V(D)J recombination [GO:0033151]; visual learning [GO:0008542] DNA recombinase complex [GO:0097519]; endodeoxyribonuclease complex [GO:1905347]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] endonuclease activity [GO:0004519]; histone binding [GO:0042393]; hydrolase activity [GO:0016787]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; sequence-specific DNA binding [GO:0043565]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] g9485.t1 Q96DM1 23.985 517 2.21e-31 134.0 sp|Q96DM1|PGBD4_HUMAN PiggyBac transposable element-derived protein 4 OS=Homo sapiens OX=9606 GN=PGBD4 PE=1 SV=3 g11533.t1 Q9QY40 29.078 1128 9.819999999999999e-134 450.0 sp|Q9QY40|PLXB3_MOUSE Plexin-B3 OS=Mus musculus OX=10090 GN=Plxnb3 PE=1 SV=2 PLXB3_MOUSE reviewed Plexin-B3 (Plexin-6) Mus musculus (Mouse) GO:0001938; GO:0002116; GO:0005886; GO:0007156; GO:0007162; GO:0007416; GO:0008360; GO:0009986; GO:0010593; GO:0010976; GO:0017154; GO:0019904; GO:0030336; GO:0034260; GO:0050772; GO:0050918; GO:0051022; GO:0060326; GO:0071526; GO:0098632 cell chemotaxis [GO:0060326]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell adhesion [GO:0007162]; negative regulation of cell migration [GO:0030336]; negative regulation of GTPase activity [GO:0034260]; negative regulation of lamellipodium assembly [GO:0010593]; positive chemotaxis [GO:0050918]; positive regulation of axonogenesis [GO:0050772]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of neuron projection development [GO:0010976]; regulation of cell shape [GO:0008360]; semaphorin-plexin signaling pathway [GO:0071526]; synapse assembly [GO:0007416] cell surface [GO:0009986]; plasma membrane [GO:0005886]; semaphorin receptor complex [GO:0002116] cell-cell adhesion mediator activity [GO:0098632]; protein domain specific binding [GO:0019904]; Rho GDP-dissociation inhibitor binding [GO:0051022]; semaphorin receptor activity [GO:0017154] g25.t1 E1BD59 23.784 370 5.19e-25 114.0 sp|E1BD59|TRI56_BOVIN E3 ubiquitin-protein ligase TRIM56 OS=Bos taurus OX=9913 GN=TRIM56 PE=2 SV=1 TRI56_BOVIN reviewed E3 ubiquitin-protein ligase TRIM56 (EC 2.3.2.27) (Tripartite motif-containing protein 56) Bos taurus (Bovine) GO:0005654; GO:0005737; GO:0006513; GO:0008270; GO:0032728; GO:0034340; GO:0045087; GO:0051607; GO:0060340; GO:0061630; GO:0070534 defense response to virus [GO:0051607]; innate immune response [GO:0045087]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of type I interferon-mediated signaling pathway [GO:0060340]; protein K63-linked ubiquitination [GO:0070534]; protein monoubiquitination [GO:0006513]; response to type I interferon [GO:0034340] cytoplasm [GO:0005737]; nucleoplasm [GO:0005654] ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] g9572.t1 Q5ZHN3 54.955 111 3.520000000000001e-27 108.0 sp|Q5ZHN3|WIPI2_CHICK WD repeat domain phosphoinositide-interacting protein 2 OS=Gallus gallus OX=9031 GN=WIPI2 PE=2 SV=1 g24177.t1 Q9R1R2 28.261 230 1.19e-21 102.0 sp|Q9R1R2|TRIM3_MOUSE Tripartite motif-containing protein 3 OS=Mus musculus OX=10090 GN=Trim3 PE=1 SV=1 TRIM3_MOUSE reviewed Tripartite motif-containing protein 3 (EC 2.3.2.27) (RING finger protein 22) (RING finger protein HAC1) Mus musculus (Mouse) GO:0000209; GO:0002224; GO:0004842; GO:0005737; GO:0005769; GO:0005794; GO:0008270; GO:0015031; GO:0016567; GO:0030425; GO:0034141; GO:0042802; GO:0043161; GO:0061351; GO:0061630; GO:0070534; GO:0098794; GO:0098978; GO:0140252 neural precursor cell proliferation [GO:0061351]; positive regulation of toll-like receptor 3 signaling pathway [GO:0034141]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K63-linked ubiquitination [GO:0070534]; protein polyubiquitination [GO:0000209]; protein transport [GO:0015031]; protein ubiquitination [GO:0016567]; regulation protein catabolic process at postsynapse [GO:0140252]; toll-like receptor signaling pathway [GO:0002224] cytoplasm [GO:0005737]; dendrite [GO:0030425]; early endosome [GO:0005769]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; postsynapse [GO:0098794] identical protein binding [GO:0042802]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] g10344.t1 P14381 35.402 435 1.82e-74 258.0 sp|P14381|YTX2_XENLA Transposon TX1 uncharacterized 149 kDa protein OS=Xenopus laevis OX=8355 PE=4 SV=1 g8273.t1 P26638 74.627 134 1.97e-74 220.0 sp|P26638|SYSC_MOUSE Serine--tRNA ligase, cytoplasmic OS=Mus musculus OX=10090 GN=Sars1 PE=1 SV=3 g8273.t1 P26638 87.5 40 1.97e-74 80.1 sp|P26638|SYSC_MOUSE Serine--tRNA ligase, cytoplasmic OS=Mus musculus OX=10090 GN=Sars1 PE=1 SV=3 g22389.t1 E1BD59 23.67 376 1.1e-23 106.0 sp|E1BD59|TRI56_BOVIN E3 ubiquitin-protein ligase TRIM56 OS=Bos taurus OX=9913 GN=TRIM56 PE=2 SV=1 TRI56_BOVIN reviewed E3 ubiquitin-protein ligase TRIM56 (EC 2.3.2.27) (Tripartite motif-containing protein 56) Bos taurus (Bovine) GO:0005654; GO:0005737; GO:0006513; GO:0008270; GO:0032728; GO:0034340; GO:0045087; GO:0051607; GO:0060340; GO:0061630; GO:0070534 defense response to virus [GO:0051607]; innate immune response [GO:0045087]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of type I interferon-mediated signaling pathway [GO:0060340]; protein K63-linked ubiquitination [GO:0070534]; protein monoubiquitination [GO:0006513]; response to type I interferon [GO:0034340] cytoplasm [GO:0005737]; nucleoplasm [GO:0005654] ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] g11478.t1 Q86PM4 56.757 74 1.79e-25 102.0 sp|Q86PM4|FGFR_HYDVU Fibroblast growth factor receptor OS=Hydra vulgaris OX=6087 GN=FGFR PE=2 SV=1 g11479.t1 O73791 38.696 230 6.36e-36 148.0 sp|O73791|TIE2_DANRE Angiopoietin-1 receptor OS=Danio rerio OX=7955 GN=tek PE=1 SV=1 g11479.t2 Q06805 35.223 247 4.29e-36 149.0 sp|Q06805|TIE1_BOVIN Tyrosine-protein kinase receptor Tie-1 OS=Bos taurus OX=9913 GN=TIE1 PE=2 SV=1 g2033.t1 Q92889 57.692 130 3.65e-47 167.0 sp|Q92889|XPF_HUMAN DNA repair endonuclease XPF OS=Homo sapiens OX=9606 GN=ERCC4 PE=1 SV=3 g2033.t2 Q92889 55.944 143 2.26e-51 179.0 sp|Q92889|XPF_HUMAN DNA repair endonuclease XPF OS=Homo sapiens OX=9606 GN=ERCC4 PE=1 SV=3 g2039.t1 Q9W3K5 58.247 194 9.94e-72 233.0 sp|Q9W3K5|GSH1_DROME Glutamate--cysteine ligase OS=Drosophila melanogaster OX=7227 GN=Gclc PE=2 SV=1 GSH1_DROME reviewed Glutamate--cysteine ligase (EC 6.3.2.2) (Gamma-ECS) (GCS) (Gamma-glutamylcysteine synthetase) Drosophila melanogaster (Fruit fly) GO:0004357; GO:0005524; GO:0005634; GO:0006749; GO:0006750; GO:0007409; GO:0007476; GO:0017109; GO:0046688; GO:0048471 axonogenesis [GO:0007409]; glutathione biosynthetic process [GO:0006750]; glutathione metabolic process [GO:0006749]; imaginal disc-derived wing morphogenesis [GO:0007476]; response to copper ion [GO:0046688] glutamate-cysteine ligase complex [GO:0017109]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471] ATP binding [GO:0005524]; glutamate-cysteine ligase activity [GO:0004357] g2004.t1 Q9W3K5 59.906 212 1.6400000000000003e-79 262.0 sp|Q9W3K5|GSH1_DROME Glutamate--cysteine ligase OS=Drosophila melanogaster OX=7227 GN=Gclc PE=2 SV=1 GSH1_DROME reviewed Glutamate--cysteine ligase (EC 6.3.2.2) (Gamma-ECS) (GCS) (Gamma-glutamylcysteine synthetase) Drosophila melanogaster (Fruit fly) GO:0004357; GO:0005524; GO:0005634; GO:0006749; GO:0006750; GO:0007409; GO:0007476; GO:0017109; GO:0046688; GO:0048471 axonogenesis [GO:0007409]; glutathione biosynthetic process [GO:0006750]; glutathione metabolic process [GO:0006749]; imaginal disc-derived wing morphogenesis [GO:0007476]; response to copper ion [GO:0046688] glutamate-cysteine ligase complex [GO:0017109]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471] ATP binding [GO:0005524]; glutamate-cysteine ligase activity [GO:0004357] g5343.t1 E1BD59 25.135 370 1.05e-26 119.0 sp|E1BD59|TRI56_BOVIN E3 ubiquitin-protein ligase TRIM56 OS=Bos taurus OX=9913 GN=TRIM56 PE=2 SV=1 TRI56_BOVIN reviewed E3 ubiquitin-protein ligase TRIM56 (EC 2.3.2.27) (Tripartite motif-containing protein 56) Bos taurus (Bovine) GO:0005654; GO:0005737; GO:0006513; GO:0008270; GO:0032728; GO:0034340; GO:0045087; GO:0051607; GO:0060340; GO:0061630; GO:0070534 defense response to virus [GO:0051607]; innate immune response [GO:0045087]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of type I interferon-mediated signaling pathway [GO:0060340]; protein K63-linked ubiquitination [GO:0070534]; protein monoubiquitination [GO:0006513]; response to type I interferon [GO:0034340] cytoplasm [GO:0005737]; nucleoplasm [GO:0005654] ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] g5348.t1 Q5NVR2 70.652 92 8.080000000000001e-29 109.0 sp|Q5NVR2|MDHM_PONAB Malate dehydrogenase, mitochondrial OS=Pongo abelii OX=9601 GN=MDH2 PE=2 SV=1 g23326.t1 Q8TER0 39.683 126 8.169999999999999e-23 96.7 sp|Q8TER0|SNED1_HUMAN Sushi, nidogen and EGF-like domain-containing protein 1 OS=Homo sapiens OX=9606 GN=SNED1 PE=1 SV=2 g9537.t1 P59644 37.759 241 7.37e-48 173.0 sp|P59644|PI5PA_MOUSE Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A OS=Mus musculus OX=10090 GN=Inpp5j PE=1 SV=2 PI5PA_MOUSE reviewed Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A (EC 3.1.3.36) (Inositol polyphosphate 5-phosphatase J) (Phosphatidylinositol 1,3,4,5-tetrakisphosphate 5-phosphatase) (EC 3.1.3.56) (Phosphatidylinositol 1,4,5-trisphosphate 5-phosphatase) (EC 3.1.3.56) Mus musculus (Mouse) GO:0001726; GO:0004439; GO:0004445; GO:0005737; GO:0005886; GO:0010977; GO:0017124; GO:0030426; GO:0031115; GO:0032587; GO:0034485; GO:0043005; GO:0043198; GO:0046030; GO:0046856; GO:0052658; GO:0052659 negative regulation of microtubule polymerization [GO:0031115]; negative regulation of neuron projection development [GO:0010977]; phosphatidylinositol dephosphorylation [GO:0046856] cytoplasm [GO:0005737]; dendritic shaft [GO:0043198]; growth cone [GO:0030426]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; ruffle membrane [GO:0032587] inositol trisphosphate phosphatase activity [GO:0046030]; inositol-1,3,4,5-tetrakisphosphate 5-phosphatase activity [GO:0052659]; inositol-1,4,5-trisphosphate 5-phosphatase activity [GO:0052658]; inositol-polyphosphate 5-phosphatase activity [GO:0004445]; phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity [GO:0034485]; phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity [GO:0004439]; SH3 domain binding [GO:0017124] g2037.t1 E1BD59 24.932 369 7.000000000000001e-26 116.0 sp|E1BD59|TRI56_BOVIN E3 ubiquitin-protein ligase TRIM56 OS=Bos taurus OX=9913 GN=TRIM56 PE=2 SV=1 TRI56_BOVIN reviewed E3 ubiquitin-protein ligase TRIM56 (EC 2.3.2.27) (Tripartite motif-containing protein 56) Bos taurus (Bovine) GO:0005654; GO:0005737; GO:0006513; GO:0008270; GO:0032728; GO:0034340; GO:0045087; GO:0051607; GO:0060340; GO:0061630; GO:0070534 defense response to virus [GO:0051607]; innate immune response [GO:0045087]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of type I interferon-mediated signaling pathway [GO:0060340]; protein K63-linked ubiquitination [GO:0070534]; protein monoubiquitination [GO:0006513]; response to type I interferon [GO:0034340] cytoplasm [GO:0005737]; nucleoplasm [GO:0005654] ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] g10333.t1 P35590 34.058 276 3.54e-39 154.0 sp|P35590|TIE1_HUMAN Tyrosine-protein kinase receptor Tie-1 OS=Homo sapiens OX=9606 GN=TIE1 PE=1 SV=1 TIE1_HUMAN reviewed Tyrosine-protein kinase receptor Tie-1 (EC 2.7.10.1) Homo sapiens (Human) GO:0001525; GO:0001570; GO:0001701; GO:0001936; GO:0003180; GO:0004714; GO:0005524; GO:0005886; GO:0007165; GO:0007169; GO:0007498; GO:0016525; GO:0030336; GO:0032526; GO:0043235; GO:0045026; GO:0045766; GO:0048771; GO:0060836; GO:0060854; GO:1901201 angiogenesis [GO:0001525]; aortic valve morphogenesis [GO:0003180]; branching involved in lymph vessel morphogenesis [GO:0060854]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; in utero embryonic development [GO:0001701]; lymphatic endothelial cell differentiation [GO:0060836]; mesoderm development [GO:0007498]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell migration [GO:0030336]; plasma membrane fusion [GO:0045026]; positive regulation of angiogenesis [GO:0045766]; regulation of endothelial cell proliferation [GO:0001936]; regulation of extracellular matrix assembly [GO:1901201]; response to retinoic acid [GO:0032526]; signal transduction [GO:0007165]; tissue remodeling [GO:0048771]; vasculogenesis [GO:0001570] plasma membrane [GO:0005886]; receptor complex [GO:0043235] ATP binding [GO:0005524]; transmembrane receptor protein tyrosine kinase activity [GO:0004714] g10333.t2 P35590 33.453 278 4.42e-39 154.0 sp|P35590|TIE1_HUMAN Tyrosine-protein kinase receptor Tie-1 OS=Homo sapiens OX=9606 GN=TIE1 PE=1 SV=1 TIE1_HUMAN reviewed Tyrosine-protein kinase receptor Tie-1 (EC 2.7.10.1) Homo sapiens (Human) GO:0001525; GO:0001570; GO:0001701; GO:0001936; GO:0003180; GO:0004714; GO:0005524; GO:0005886; GO:0007165; GO:0007169; GO:0007498; GO:0016525; GO:0030336; GO:0032526; GO:0043235; GO:0045026; GO:0045766; GO:0048771; GO:0060836; GO:0060854; GO:1901201 angiogenesis [GO:0001525]; aortic valve morphogenesis [GO:0003180]; branching involved in lymph vessel morphogenesis [GO:0060854]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; in utero embryonic development [GO:0001701]; lymphatic endothelial cell differentiation [GO:0060836]; mesoderm development [GO:0007498]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell migration [GO:0030336]; plasma membrane fusion [GO:0045026]; positive regulation of angiogenesis [GO:0045766]; regulation of endothelial cell proliferation [GO:0001936]; regulation of extracellular matrix assembly [GO:1901201]; response to retinoic acid [GO:0032526]; signal transduction [GO:0007165]; tissue remodeling [GO:0048771]; vasculogenesis [GO:0001570] plasma membrane [GO:0005886]; receptor complex [GO:0043235] ATP binding [GO:0005524]; transmembrane receptor protein tyrosine kinase activity [GO:0004714] g14493.t1 Q9NRA2 53.846 143 1.17e-38 140.0 sp|Q9NRA2|S17A5_HUMAN Sialin OS=Homo sapiens OX=9606 GN=SLC17A5 PE=1 SV=2 g10378.t1 Q6BEA0 36.421 475 4.33e-84 286.0 sp|Q6BEA0|PLXA4_DANRE Plexin-A4 OS=Danio rerio OX=7955 GN=plxna4 PE=2 SV=1 PLXA4_DANRE reviewed Plexin-A4 Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001763; GO:0002116; GO:0005886; GO:0007411; GO:0007414; GO:0007416; GO:0016020; GO:0017154; GO:0030334; GO:0071526 axon guidance [GO:0007411]; axonal defasciculation [GO:0007414]; morphogenesis of a branching structure [GO:0001763]; regulation of cell migration [GO:0030334]; semaphorin-plexin signaling pathway [GO:0071526]; synapse assembly [GO:0007416] membrane [GO:0016020]; plasma membrane [GO:0005886]; semaphorin receptor complex [GO:0002116] semaphorin receptor activity [GO:0017154] g10353.t1 Q15485 57.219 187 1.08e-60 197.0 sp|Q15485|FCN2_HUMAN Ficolin-2 OS=Homo sapiens OX=9606 GN=FCN2 PE=1 SV=2 FCN2_HUMAN reviewed Ficolin-2 (37 kDa elastin-binding protein) (EBP-37) (Collagen/fibrinogen domain-containing protein 2) (Ficolin-B) (Ficolin-beta) (Hucolin) (L-ficolin) (Serum lectin p35) Homo sapiens (Human) GO:0001867; GO:0002752; GO:0003823; GO:0005102; GO:0005576; GO:0005581; GO:0005615; GO:0006508; GO:0008228; GO:0009897; GO:0038187; GO:0043394; GO:0043654; GO:0046872; GO:0048306; GO:0050829; GO:0050830; GO:0070062; GO:0070892; GO:0072562; GO:0097367; GO:0106139; GO:1903028; GO:1905370; GO:2001065 cell surface pattern recognition receptor signaling pathway [GO:0002752]; complement activation, lectin pathway [GO:0001867]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; opsonization [GO:0008228]; positive regulation of opsonization [GO:1903028]; proteolysis [GO:0006508]; recognition of apoptotic cell [GO:0043654] blood microparticle [GO:0072562]; collagen trimer [GO:0005581]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; serine-type endopeptidase complex [GO:1905370]; symbiont cell surface [GO:0106139] antigen binding [GO:0003823]; calcium-dependent protein binding [GO:0048306]; carbohydrate derivative binding [GO:0097367]; lipoteichoic acid immune receptor activity [GO:0070892]; mannan binding [GO:2001065]; metal ion binding [GO:0046872]; pattern recognition receptor activity [GO:0038187]; proteoglycan binding [GO:0043394]; signaling receptor binding [GO:0005102] g10360.t1 O73791 41.111 180 6.77e-30 123.0 sp|O73791|TIE2_DANRE Angiopoietin-1 receptor OS=Danio rerio OX=7955 GN=tek PE=1 SV=1 g12.t1 P14381 32.453 265 3.73e-31 125.0 sp|P14381|YTX2_XENLA Transposon TX1 uncharacterized 149 kDa protein OS=Xenopus laevis OX=8355 PE=4 SV=1 g21602.t1 O14522 33.73 252 8.640000000000001e-44 162.0 sp|O14522|PTPRT_HUMAN Receptor-type tyrosine-protein phosphatase T OS=Homo sapiens OX=9606 GN=PTPRT PE=1 SV=6 PTPRT_HUMAN reviewed Receptor-type tyrosine-protein phosphatase T (R-PTP-T) (EC 3.1.3.48) (Receptor-type tyrosine-protein phosphatase rho) (RPTP-rho) Homo sapiens (Human) GO:0004725; GO:0005001; GO:0005886; GO:0006470; GO:0007155; GO:0007156; GO:0007165; GO:0007169; GO:0008013; GO:0009986; GO:0016020; GO:0016790; GO:0019903; GO:0030336; GO:0031175; GO:0042803; GO:0045294; GO:0045295; GO:0045296; GO:0051393; GO:0070097; GO:0071354; GO:0097677; GO:1904893 cell adhesion [GO:0007155]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; cellular response to interleukin-6 [GO:0071354]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell migration [GO:0030336]; negative regulation of receptor signaling pathway via STAT [GO:1904893]; neuron projection development [GO:0031175]; protein dephosphorylation [GO:0006470]; signal transduction [GO:0007165] cell surface [GO:0009986]; membrane [GO:0016020]; plasma membrane [GO:0005886] alpha-actinin binding [GO:0051393]; alpha-catenin binding [GO:0045294]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; delta-catenin binding [GO:0070097]; gamma-catenin binding [GO:0045295]; protein homodimerization activity [GO:0042803]; protein phosphatase binding [GO:0019903]; protein tyrosine phosphatase activity [GO:0004725]; STAT family protein binding [GO:0097677]; thiolester hydrolase activity [GO:0016790]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001] g21602.t1 O14522 31.12 241 8.299999999999999e-30 121.0 sp|O14522|PTPRT_HUMAN Receptor-type tyrosine-protein phosphatase T OS=Homo sapiens OX=9606 GN=PTPRT PE=1 SV=6 PTPRT_HUMAN reviewed Receptor-type tyrosine-protein phosphatase T (R-PTP-T) (EC 3.1.3.48) (Receptor-type tyrosine-protein phosphatase rho) (RPTP-rho) Homo sapiens (Human) GO:0004725; GO:0005001; GO:0005886; GO:0006470; GO:0007155; GO:0007156; GO:0007165; GO:0007169; GO:0008013; GO:0009986; GO:0016020; GO:0016790; GO:0019903; GO:0030336; GO:0031175; GO:0042803; GO:0045294; GO:0045295; GO:0045296; GO:0051393; GO:0070097; GO:0071354; GO:0097677; GO:1904893 cell adhesion [GO:0007155]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; cellular response to interleukin-6 [GO:0071354]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell migration [GO:0030336]; negative regulation of receptor signaling pathway via STAT [GO:1904893]; neuron projection development [GO:0031175]; protein dephosphorylation [GO:0006470]; signal transduction [GO:0007165] cell surface [GO:0009986]; membrane [GO:0016020]; plasma membrane [GO:0005886] alpha-actinin binding [GO:0051393]; alpha-catenin binding [GO:0045294]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; delta-catenin binding [GO:0070097]; gamma-catenin binding [GO:0045295]; protein homodimerization activity [GO:0042803]; protein phosphatase binding [GO:0019903]; protein tyrosine phosphatase activity [GO:0004725]; STAT family protein binding [GO:0097677]; thiolester hydrolase activity [GO:0016790]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001] g2029.t1 Q9P2E3 31.266 403 3.3699999999999998e-46 174.0 sp|Q9P2E3|ZNFX1_HUMAN NFX1-type zinc finger-containing protein 1 OS=Homo sapiens OX=9606 GN=ZNFX1 PE=1 SV=2 ZNFX1_HUMAN reviewed NFX1-type zinc finger-containing protein 1 Homo sapiens (Human) GO:0002218; GO:0003723; GO:0004386; GO:0005741; GO:0008270; GO:0010494; GO:0031048; GO:0031380; GO:0042742; GO:0045071; GO:0045087; GO:0051607 activation of innate immune response [GO:0002218]; defense response to bacterium [GO:0042742]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; negative regulation of viral genome replication [GO:0045071]; regulatory ncRNA-mediated heterochromatin formation [GO:0031048] cytoplasmic stress granule [GO:0010494]; mitochondrial outer membrane [GO:0005741]; nuclear RNA-directed RNA polymerase complex [GO:0031380] helicase activity [GO:0004386]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270] g2030.t1 Q9P2E3 40.833 240 2.9e-46 172.0 sp|Q9P2E3|ZNFX1_HUMAN NFX1-type zinc finger-containing protein 1 OS=Homo sapiens OX=9606 GN=ZNFX1 PE=1 SV=2 ZNFX1_HUMAN reviewed NFX1-type zinc finger-containing protein 1 Homo sapiens (Human) GO:0002218; GO:0003723; GO:0004386; GO:0005741; GO:0008270; GO:0010494; GO:0031048; GO:0031380; GO:0042742; GO:0045071; GO:0045087; GO:0051607 activation of innate immune response [GO:0002218]; defense response to bacterium [GO:0042742]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; negative regulation of viral genome replication [GO:0045071]; regulatory ncRNA-mediated heterochromatin formation [GO:0031048] cytoplasmic stress granule [GO:0010494]; mitochondrial outer membrane [GO:0005741]; nuclear RNA-directed RNA polymerase complex [GO:0031380] helicase activity [GO:0004386]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270] g2031.t1 Q8R151 43.594 640 6.109999999999999e-126 419.0 sp|Q8R151|ZNFX1_MOUSE NFX1-type zinc finger-containing protein 1 OS=Mus musculus OX=10090 GN=Znfx1 PE=1 SV=3 ZNFX1_MOUSE reviewed NFX1-type zinc finger-containing protein 1 Mus musculus (Mouse) GO:0002218; GO:0003723; GO:0004386; GO:0005741; GO:0008270; GO:0010494; GO:0031048; GO:0031380; GO:0042742; GO:0045071; GO:0045087; GO:0051607 activation of innate immune response [GO:0002218]; defense response to bacterium [GO:0042742]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; negative regulation of viral genome replication [GO:0045071]; regulatory ncRNA-mediated heterochromatin formation [GO:0031048] cytoplasmic stress granule [GO:0010494]; mitochondrial outer membrane [GO:0005741]; nuclear RNA-directed RNA polymerase complex [GO:0031380] helicase activity [GO:0004386]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270] g2046.t1 Q91453 26.408 515 9.2e-46 174.0 sp|Q91453|STXB_SYNHO Stonustoxin subunit beta OS=Synanceia horrida OX=13279 PE=1 SV=3 STXB_SYNHO reviewed Stonustoxin subunit beta (SNTX subunit beta) (DELTA-synanceitoxin-Sh1b) (DELTA-SYTX-Sh1b) (Trachynilysin subunit beta) (TLY subunit beta) Synanceia horrida (Estuarine stonefish) (Scorpaena horrida) GO:0005576; GO:0015459; GO:0031640; GO:0090729 killing of cells of another organism [GO:0031640] extracellular region [GO:0005576] potassium channel regulator activity [GO:0015459]; toxin activity [GO:0090729] g23325.t1 Q96DM1 30.556 396 1.5299999999999998e-42 163.0 sp|Q96DM1|PGBD4_HUMAN PiggyBac transposable element-derived protein 4 OS=Homo sapiens OX=9606 GN=PGBD4 PE=1 SV=3 g12449.t1 Q9V4A7 34.322 236 3.4300000000000005e-27 112.0 sp|Q9V4A7|PLXB_DROME Plexin-B OS=Drosophila melanogaster OX=7227 GN=PlexB PE=1 SV=2 PLXB_DROME reviewed Plexin-B Drosophila melanogaster (Fruit fly) GO:0002116; GO:0005886; GO:0007162; GO:0007411; GO:0007416; GO:0008045; GO:0008360; GO:0017154; GO:0030334; GO:0030425; GO:0050772; GO:0070593; GO:0071526; GO:0071678; GO:0097374 axon guidance [GO:0007411]; dendrite self-avoidance [GO:0070593]; motor neuron axon guidance [GO:0008045]; negative regulation of cell adhesion [GO:0007162]; olfactory bulb axon guidance [GO:0071678]; positive regulation of axonogenesis [GO:0050772]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; semaphorin-plexin signaling pathway [GO:0071526]; sensory neuron axon guidance [GO:0097374]; synapse assembly [GO:0007416] dendrite [GO:0030425]; plasma membrane [GO:0005886]; semaphorin receptor complex [GO:0002116] semaphorin receptor activity [GO:0017154] g11538.t1 Q06807 36.747 166 7.749999999999999e-23 101.0 sp|Q06807|TIE2_BOVIN Angiopoietin-1 receptor OS=Bos taurus OX=9913 GN=TEK PE=2 SV=1 TIE2_BOVIN reviewed Angiopoietin-1 receptor (EC 2.7.10.1) (Endothelial tyrosine kinase) (Tyrosine kinase with Ig and EGF homology domains-2) (Tyrosine-protein kinase receptor TIE-2) (CD antigen CD202b) Bos taurus (Bovine) GO:0001525; GO:0001935; GO:0001936; GO:0002040; GO:0004714; GO:0005524; GO:0005576; GO:0005856; GO:0005886; GO:0005925; GO:0007169; GO:0007507; GO:0010595; GO:0016525; GO:0030097; GO:0032878; GO:0034446; GO:0043235; GO:0043410; GO:0045766; GO:0048014; GO:0051894; GO:0051897; GO:0060347; GO:0070374; GO:1902533; GO:2000352 angiogenesis [GO:0001525]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; endothelial cell proliferation [GO:0001935]; heart development [GO:0007507]; heart trabecula formation [GO:0060347]; hemopoiesis [GO:0030097]; negative regulation of angiogenesis [GO:0016525]; negative regulation of endothelial cell apoptotic process [GO:2000352]; positive regulation of angiogenesis [GO:0045766]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of intracellular signal transduction [GO:1902533]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; regulation of endothelial cell proliferation [GO:0001936]; regulation of establishment or maintenance of cell polarity [GO:0032878]; sprouting angiogenesis [GO:0002040]; substrate adhesion-dependent cell spreading [GO:0034446]; Tie signaling pathway [GO:0048014] cytoskeleton [GO:0005856]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] ATP binding [GO:0005524]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]